-DOCSTART- JJ O O
-EMPTYLINE- $ O O
004668411 CD O O
CTMC NNP B-NP O
68299235 CD O O
763052 CD O O
9/29/1993 CD O O
12:00:00 CD O O
AM NNP B-NP O
Discharge NNP I-NP O
Summary NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date NNP I-NP O
: : O O
09/29/1993 CD O O
Report NNP B-NP O
Status NNP I-NP O
: : O O
Signed VBN O O
Discharge NNP B-NP O
Date NNP I-NP O
: : O O
10/04/1993 CD O O
HISTORY NNP B-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
is VBZ O O
a DT B-NP O
28-year-old JJ I-NP O
woman NN I-NP O
who WP O B-person
is VBZ O O
HIV NNP B-NP B-problem
positive JJ O I-problem
for IN B-VP O
two CD O O
years NNS B-NP O
. . B-VP O
   
She PRP O B-person
presented VBD B-VP O
with IN B-VP O
left JJ B-NP B-problem
upper JJ I-NP I-problem
quadrant NN I-NP I-problem
pain NN I-NP I-problem
as RB O O
well RB O O
as IN B-VP O
nausea NN B-NP B-problem
and CC O O
vomiting NN B-NP B-problem
which WDT O B-pronoun
is VBZ O O
a DT B-NP B-problem
long-standing JJ I-NP I-problem
complaint NN I-NP I-problem
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
diagnosed VBN O O
in IN B-VP O
1991 CD O O
during IN B-VP O
the DT B-NP O
birth NN I-NP O
of IN B-VP O
her PRP$ O B-person
her PRP$ O B-person
child NN B-NP I-person
. . B-VP O
   
She PRP O B-person
claims VBZ O O
she PRP O B-person
does VBZ O O
not RB O O
know VB O O
why WRB O O
she PRP O B-person
is VBZ O O
HIV NNP B-NP B-problem
positive JJ O I-problem
. . B-VP O
   
She PRP O B-person
is VBZ O O
from IN B-VP O
Maryland NNP B-NP O
, , O O
apparently RB O O
had VBD B-VP O
no DT B-NP O
blood NN I-NP B-treatment
transfusions NNS I-NP I-treatment
before IN B-VP O
the DT B-NP O
birth NN I-NP O
of IN B-VP O
her PRP$ O B-person
her PRP$ O B-person
children NNS B-NP I-person
so IN B-VP O
it PRP O B-pronoun
is VBZ O O
presumed VBN O O
heterosexual JJ B-NP B-problem
transmission NN I-NP I-problem
. . B-VP O
   
At IN B-VP O
that DT B-NP O
time NN I-NP O
, , O O
she PRP O B-person
also RB O O
had VBD B-VP O
cat VBN O B-problem
scratch NN B-NP I-problem
fever NN I-NP I-problem
and CC O O
she PRP O B-person
had VBD B-VP O
resection NN B-NP B-treatment
of IN B-VP O
an DT B-NP B-problem
abscess NN I-NP I-problem
in IN B-VP I-problem
the DT B-NP I-problem
left NN I-NP I-problem
lower JJR B-NP I-problem
extremity NN I-NP I-problem
. . B-VP O
   
She PRP O B-person
has VBZ O O
not RB O O
used VBN O O
any DT B-NP B-treatment
anti JJ I-NP I-treatment
retroviral JJ I-NP I-treatment
therapy NN I-NP I-treatment
since IN B-VP O
then RB O O
, , O O
because IN B-VP O
of IN B-VP O
pancytopenia NN B-NP B-problem
and CC O O
vomiting VBG O B-problem
on IN B-VP O
DDI NNP B-NP B-treatment
. . B-VP O
   
She PRP O B-person
has VBZ O O
complaints NNS B-NP O
of IN B-VP O
nausea NN B-NP B-problem
and CC O O
vomiting NN B-NP B-problem
as RB O O
well RB O O
as IN B-VP O
left VBN O B-problem
upper JJ B-NP I-problem
quadrant NN I-NP I-problem
pain NN I-NP I-problem
on IN B-VP O
and CC O O
off IN B-VP O
getting VBG O O
progressively RB O O
worse JJR O O
over IN B-VP O
the DT B-NP O
past JJ I-NP O
month NN I-NP O
. . B-VP O
   
She PRP O B-person
has VBZ O O
had VBD B-VP O
similar JJ B-NP B-problem
pain NN I-NP I-problem
intermittently RB O O
for IN B-VP O
last JJ B-NP O
year NN I-NP O
. . B-VP O
   
She PRP O B-person
described VBD B-VP O
the DT B-NP B-problem
pain NN I-NP I-problem
as IN B-VP O
a DT B-NP B-problem
burning NN I-NP I-problem
pain NN I-NP I-problem
which WDT O B-pronoun
is VBZ O O
positional JJ O O
, , O O
worse JJR O O
when WRB O O
she PRP O B-person
walks VBD B-VP O
or CC O O
does VBZ O O
any DT B-NP O
type NN I-NP O
of IN B-VP O
exercise NN B-NP O
. . B-VP O
   
She PRP O B-person
has VBZ O O
no DT B-NP O
relief NN I-NP O
from IN B-VP O
antacids NNS B-NP B-treatment
or CC O O
H2 NNP B-NP B-treatment
blockers NNS I-NP I-treatment
. . B-VP O
   
In IN B-VP O
10/92 CD O O
, , O O
she PRP O B-person
had VBD B-VP O
a DT B-NP B-test
CT NNP I-NP I-test
scan NN I-NP I-test
which WDT O B-pronoun
showed VBD B-VP O
fatty JJ B-NP B-problem
infiltration NN I-NP I-problem
of IN B-VP I-problem
her PRP$ O B-person
her PRP$ O I-problem
liver NN B-NP I-problem
diffusely RB O I-problem
with IN B-VP O
a DT O B-problem
1 CD O I-problem
cm NN B-NP I-problem
cyst NN I-NP I-problem
in IN B-VP I-problem
the DT B-NP I-problem
right JJ I-NP I-problem
lobe NN I-NP I-problem
of IN B-VP I-problem
the DT B-NP I-problem
liver NN I-NP I-problem
. . B-VP O
   
She PRP O B-person
had VBD B-VP O
a DT B-NP O
normal JJ I-NP O
pancreas NN I-NP O
at IN B-VP O
that DT B-NP B-pronoun
time NN I-NP O
, , O O
however RB O O
, , O O
hyperdense JJ B-NP B-problem
kidneys NN I-NP I-problem
. . B-VP O
   
Her PRP$ O B-person
Her PRP$ O B-test
alkaline JJ B-NP I-test
phosphatase NN I-NP I-test
was VBD B-VP O
slightly RB O B-problem
elevated VBN O I-problem
but CC O O
otherwise RB O O
relatively RB O O
normal JJ O O
. . B-VP O
   
Her PRP$ O B-test
Her PRP$ O B-person
amylase NN B-NP I-test
was VBD B-VP O
mildly RB O B-problem
elevated VBN O I-problem
but CC O O
has VBZ O O
been VBN O O
down RB O O
since IN B-VP O
then RB O O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
has VBZ O O
had VBN O O
progressive JJ B-NP B-problem
failure NN I-NP I-problem
to TO O I-problem
thrive VB O I-problem
and CC O O
steady JJ B-NP B-problem
weight NN I-NP I-problem
loss NN I-NP I-problem
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
brought VBN O O
in IN B-VP O
for IN B-VP O
an DT B-NP B-test
esophagogastroduodenoscopy NN I-NP I-test
on IN B-VP O
9/26 CD O O
but CC O O
she PRP O B-person
basically RB O O
was VBD B-VP O
not RB O O
sufficiently RB O O
sedated VBN O B-treatment
and CC O O
readmitted VBN O O
at IN B-VP O
this DT B-NP B-pronoun
time NN I-NP O
for IN B-VP O
a DT B-NP B-test
GI NNP I-NP I-test
work-up NN I-NP I-test
as RB O O
well RB O O
as IN B-VP O
an DT B-NP B-test
evaluation NN I-NP I-test
of IN B-VP O
new JJ B-NP B-problem
abscess NN I-NP I-problem
in IN B-VP I-problem
her PRP$ O I-problem
her PRP$ O B-person
left JJ B-NP I-problem
lower JJR I-NP I-problem
calf NN I-NP I-problem
and CC O O
right JJ B-NP O
medial NN I-NP O
lower JJR B-NP O
extremity NN I-NP O
quadriceps NNS I-NP O
muscle NN I-NP O
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
also RB O O
admitted VBN O O
to TO O O
be VB O O
connected VBN O O
up RP O O
with IN B-VP O
social JJ B-NP O
services NNS I-NP O
for IN B-VP O
HIV NNP B-NP B-problem
patients NNS I-NP O
. . B-VP O
   
PAST NNP B-NP O
MEDICAL NNP I-NP O
HISTORY NNP I-NP O
: : O O
As IN B-VP O
above IN B-VP O
. . B-VP O
   
ALLERGIES NN B-NP O
: : O O
BACTRIM NNP B-NP B-treatment
. . B-VP O
   
MEDICATIONS NN B-NP O
: : O O
On IN B-VP O
admission NN B-NP O
included VBD B-VP O
Percocet NNP B-NP B-treatment
, , O O
Prinovil NNP B-NP B-treatment
, , O O
Dapsone NNP B-NP B-treatment
, , O O
Mycelex NNP B-NP B-treatment
troches NNS I-NP I-treatment
. . B-VP O
   
SOCIAL NNP B-NP O
HISTORY NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
recently RB O O
separated VBN O O
from IN B-VP O
her PRP$ O B-person
her PRP$ O B-person
husband NN B-NP I-person
. . B-VP O
   
She PRP O B-person
lives VBZ O O
with IN B-VP O
her PRP$ O B-person
her PRP$ O B-person
daughter NN B-NP I-person
. . B-VP O
   
She PRP O B-person
does VBZ O O
not RB O O
drink VB O O
, , O O
use VB O O
IV NNP B-NP O
drugs NNS I-NP O
or CC O O
smoke NN B-NP O
. . B-VP O
   
PHYSICAL JJ B-NP O
EXAMINATION NN I-NP O
: : O O
On IN B-VP O
admission NN B-NP O
revealed VBD B-VP O
a DT B-NP O
cachetic JJ I-NP O
woman NN I-NP O
in IN B-VP O
no DT B-NP O
acute JJ I-NP B-problem
distress NN I-NP I-problem
with IN B-VP O
stable JJ B-NP O
vital JJ I-NP O
signs NNS I-NP O
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
afebrile RB O B-problem
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
not RB O O
orthostatic JJ O B-problem
. . B-VP O
   
Blood NNP B-NP B-test
pressure NN I-NP I-test
110/80 CD O O
. . B-VP O
   
HEENT NNP B-NP B-test
exam NN I-NP I-test
was VBD B-VP O
within IN B-VP O
normal JJ B-NP O
limits NNS I-NP O
. . B-VP O
   
Lungs NNS B-NP O
were VBD B-VP O
clear JJ O O
to TO O O
auscultation NN B-NP B-test
and CC O O
percussion NN B-NP B-test
bilaterally RB O O
. . B-VP O
   
Cardiovascular JJ B-NP B-test
exam NN I-NP I-test
revealed VBD B-VP O
a DT B-NP O
regular JJ I-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
without IN B-VP O
murmur NN B-NP B-problem
. . B-VP O
   
Abdomen NNP B-NP O
was VBD B-VP O
soft JJ O O
, , O O
nontender NN B-NP B-problem
, , O O
nondistended VBD B-VP B-problem
with IN B-VP O
positive JJ B-NP O
bowel NN I-NP O
sounds NNS I-NP O
. . B-VP O
   
There EX O O
was VBD B-VP O
no DT B-NP O
hepatosplenomegaly NN I-NP B-problem
. . B-VP O
   
Extremities NNS B-NP O
revealed VBD B-VP O
a DT O B-problem
2 CD O I-problem
x NN B-NP I-problem
3 CD O I-problem
cm JJ B-NP I-problem
tender NN I-NP I-problem
mass NN I-NP I-problem
in IN B-VP I-problem
the DT B-NP I-problem
lateral JJ I-NP I-problem
left NN I-NP I-problem
calf NN I-NP I-problem
, , O O
medial JJ O B-problem
1 CD O I-problem
cm JJ B-NP I-problem
mass NN I-NP I-problem
above IN B-VP I-problem
her PRP$ O I-problem
her PRP$ O B-person
knee NN B-NP I-problem
. . B-VP O
   
There EX O O
was VBD B-VP O
no DT B-NP O
evidence NN I-NP O
of IN B-VP O
edema NN B-NP B-problem
. . B-VP O
   
LABORATORY NNP B-NP O
DATA NNP I-NP O
: : O O
On IN B-VP O
admission NN B-NP O
included VBD B-VP O
BUN NNP B-NP B-test
/ NNP I-NP O
creatinine NN I-NP B-test
of IN B-VP O
33/2.1 CD O O
. . B-VP O
   
Sodium NN B-NP B-test
141 CD O O
. . B-VP O
   
Potassium NN B-NP B-test
4.2 CD O O
. . B-VP O
   
Hematocrit $ O B-test
23 CD O O
. . B-VP O
   
White NNP B-NP B-test
blood NN I-NP I-test
cell NN I-NP I-test
count NN I-NP I-test
was VBD B-VP O
2.1 CD O O
with IN B-VP O
56 CD O B-test
polys NNS B-NP I-test
and CC O O
1 CD O B-test
band NN B-NP I-test
. . B-VP O
   
Platelet NNP B-NP B-test
count NN I-NP I-test
411,000 CD O O
. . B-VP O
   
Amylase VB O B-test
143 CD O O
. . B-VP O
   
Lipase NNP B-NP B-test
was VBD B-VP O
elevated VBN O B-problem
to TO O O
600 CD O O
. . B-VP O
   
ESR NN B-NP B-test
was VBD B-VP O
greater JJR O O
than IN B-VP O
140 CD O O
. . B-VP O
   
Alkaline NNP B-NP B-test
phosphatase NN I-NP I-test
190 CD O O
. . B-VP O
   
ALT $ O B-test
52 CD O O
. . B-VP O
   
AST $ O B-test
65 CD O O
. . B-VP O
   
Beta NNP B-NP B-test
hCG NN I-NP I-test
was VBD B-VP O
negative JJ O O
. . B-VP O
   
Urinalysis NN B-NP B-test
was VBD B-VP O
positive JJ O B-problem
for IN B-VP I-problem
protein NN B-NP I-problem
. . B-VP O
   
Bilirubin NNP B-NP B-test
0.4 CD O O
. . B-VP O
   
Chest NNP B-NP B-test
x-ray NN I-NP I-test
revealed VBD B-VP O
clear JJ B-NP O
lung NN I-NP O
fields NNS I-NP O
. . B-VP O
   
There EX O O
was VBD B-VP O
no DT B-NP O
evidence NN I-NP O
of IN B-VP O
rib JJ B-NP B-problem
fracture NN I-NP I-problem
. . B-VP O
   
HOSPITAL NNP B-NP O
COURSE NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
admitted VBN O O
and CC O O
many JJ B-NP B-test
cultures NNS I-NP I-test
were VBD B-VP O
sent VBN O O
which WDT O B-pronoun
were VBD B-VP O
all DT O O
negative JJ O O
. . B-VP O
   
She PRP O B-person
did VBD B-VP O
not RB O O
have VB O O
any DT O O
of IN B-VP O
her PRP$ O B-person
her PRP$ O B-problem
pain NN B-NP I-problem
in IN B-VP O
the DT B-NP O
hospital NN I-NP O
. . B-VP O
   
On IN B-VP O
the DT B-NP O
third JJ I-NP O
hospital NN I-NP O
day NN I-NP O
, , O O
she PRP O B-person
did VBD B-VP O
have VB O O
some DT B-NP B-problem
pain NN I-NP I-problem
and CC O O
was VBD B-VP O
treated VBN O O
with IN B-VP O
Percocet NNP B-NP B-treatment
. . B-VP O
   
She PRP O B-person
went VBD B-VP O
for IN B-VP O
a DT B-NP B-treatment
debridement NN I-NP I-treatment
of IN B-VP O
her PRP$ O B-problem
her PRP$ O B-person
left JJ B-NP I-problem
calf NN I-NP I-problem
lesion NN I-NP I-problem
on IN B-VP O
10/2/93 CD O O
and CC O O
was VBD B-VP O
started VBN O O
empirically RB O O
on IN B-VP O
IV NNP B-NP B-treatment
ceftriaxone NN I-NP I-treatment
which WDT O B-pronoun
was VBD B-VP O
changed VBN O O
to TO O O
po VB O B-treatment
doxycycline NN B-NP I-treatment
on IN B-VP O
the DT B-NP O
day NN I-NP O
of IN B-VP O
discharge NN B-NP O
. . B-VP O
   
A DT B-NP B-test
follow-up JJ I-NP I-test
CT NNP I-NP I-test
scan NN I-NP I-test
was VBD B-VP O
done VBN O O
which WDT O B-pronoun
did VBD B-VP O
not RB O O
show VB O O
any DT B-NP O
evidence NN I-NP O
for IN B-VP O
splenomegaly NN B-NP B-problem
or CC O O
hepatomegaly NN B-NP B-problem
. . B-VP O
   
The DT O B-problem
1 CD O I-problem
cm NN B-NP I-problem
cyst NN I-NP I-problem
which WDT O B-pronoun
was VBD B-VP O
seen VBN O O
in IN B-VP O
10/92 CD O O
was VBD B-VP O
still RB O O
present JJ O O
. . B-VP O
   
There EX O O
was VBD B-VP O
a DT B-NP O
question NN I-NP O
of IN B-VP O
a DT B-NP B-problem
cyst NN I-NP I-problem
in IN B-VP I-problem
her PRP$ O I-problem
her PRP$ O B-person
kidney NN B-NP I-problem
with IN B-VP O
a DT B-NP B-problem
stone NN I-NP I-problem
right RB O O
below IN B-VP O
the DT B-NP B-problem
cyst NN I-NP I-problem
, , O O
although IN B-VP O
this DT O B-pronoun
did VBD B-VP O
not RB O O
seem VB O O
to TO O O
be VB O O
clinically RB O O
significant JJ O O
. . B-VP O
   
DISPOSITION NN B-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
discharged VBN O O
to TO O O
home NN B-NP O
in IN B-VP O
stable JJ B-NP O
condition NN I-NP O
. . B-VP O
   
Cultures NNS B-NP B-test
were VBD B-VP O
pending VBG O O
on IN B-VP O
her PRP$ O B-test
her PRP$ O B-person
aspirate NN B-NP I-test
and CC O O
will MD O O
be VB O O
treated VBN O O
with IN B-VP O
po JJ B-NP B-treatment
doxycycline NN I-NP I-treatment
. . B-VP O
   
Dictated VBN O O
By IN B-VP O
: : O O
JIMCHARL NNP B-NP B-person
B. NNP I-NP I-person
BUN NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
OC33 NNP I-NP O
Attending NNP I-NP B-person
: : O O
I PRP O B-person
BUN NNP B-NP I-person
, , O I-person
M.D. NNP B-NP I-person
GR67 NNP I-NP O
EF283/9675 NNP I-NP O
Batch NNP I-NP O
: : O O
2027 CD O O
Index NNP B-NP O
No. NNP I-NP O
BOKMII88JZ NNP I-NP O
D NNP I-NP O
: : O O
10/03/93 CD O O
T NN B-NP O
: : O O
10/07/93 CD O O
-EMPTYLINE- NN B-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- VBZ O O
169333047 CD O O
FIH NNP B-NP O
4852999 CD O O
72670/2ol1 CD O O
131444 CD O O
9/7/1993 CD O O
12:00:00 CD O O
AM NNP B-NP O
Discharge NNP I-NP O
Summary NNP I-NP O
Unsigned VBD B-VP O
DIS NNP B-NP O
Report NNP I-NP O
Status NNP I-NP O
: : O O
Unsigned VBN O O
ADMISSION NNP B-NP O
DATE NNP I-NP O
: : O O
09-07-93 JJ B-NP O
DISCHARGE NNP I-NP O
DATE NNP I-NP O
: : O O
09-08-93 JJ B-NP O
PATIENT NNP I-NP B-person
DIED NNP I-NP O
ON NNP I-NP O
9/8/93 CD O O
. . B-VP O
   
ADMISSION JJ B-NP O
DIAGNOSIS NNP I-NP O
: : O O
Renal JJ B-NP B-problem
tubular JJ I-NP I-problem
acidosis NN I-NP I-problem
distal JJ B-NP I-problem
type NN I-NP I-problem
I PRP O I-problem
; : O O
shock NN B-NP B-problem
; : O O
seizure NN B-NP B-problem
disorder NN I-NP I-problem
; : O O
severe JJ B-NP B-problem
acidosis NN I-NP I-problem
and CC O O
severe JJ B-NP B-problem
electrolyte NN I-NP I-problem
imbalance NN I-NP I-problem
; : O O
rule NN B-NP O
out IN B-VP O
sepsis NN B-NP B-problem
. . B-VP O
   
DISCHARGE NNP B-NP O
DIAGNOSIS NNP I-NP O
: : O O
Renal JJ B-NP B-problem
tubular JJ I-NP I-problem
acidosis NN I-NP I-problem
distal JJ B-NP I-problem
type NN I-NP I-problem
I PRP O I-problem
; : O O
shock NN B-NP B-problem
; : O O
severe JJ B-NP B-problem
acidosis NN I-NP I-problem
and CC O O
severe JJ B-NP B-problem
electrolyte NN I-NP I-problem
imbalance NN I-NP I-problem
; : O O
seizure NN B-NP B-problem
disorder NN I-NP I-problem
; : O O
rule NN B-NP O
out IN B-VP O
sepsis NN B-NP B-problem
, , O O
varicella NN B-NP B-problem
. . B-VP O
   
HISTORY NNP B-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS NNP I-NP O
: : O O
Date NN B-NP O
of IN B-VP O
birth NN B-NP O
: : O O
10/4/88 CD O O
. . B-VP O
   
This DT B-NP B-person
patient NN I-NP I-person
is VBZ O O
a DT O O
5 CD O O
year NN B-NP O
old JJ B-NP O
white JJ I-NP O
female NN I-NP O
with IN B-VP O
a DT B-NP O
history NN I-NP O
of IN B-VP O
type NN B-NP B-problem
I PRP O I-problem
renal VBP O I-problem
tubular JJ B-NP I-problem
acidosis NN I-NP I-problem
on IN B-VP O
nephrocalcinosis NN B-NP B-problem
who WP O B-person
was VBD B-VP O
admitted VBN O O
to TO O O
Noughwell NNP B-NP O
Entanbon NNP I-NP O
Health NNP I-NP O
of IN B-VP O
Washington NNP B-NP O
on IN B-VP O
9/5/93 CD O O
at IN B-VP O
21:16 CD O O
hours NNS B-NP O
with IN B-VP O
a DT B-NP O
2-3 JJ I-NP O
day NN I-NP O
history NN I-NP O
of IN B-VP O
chills NNS B-NP B-problem
, , O O
fevers NNS B-NP B-problem
, , O O
cough NN B-NP B-problem
, , O O
vomiting VBG O B-problem
and CC O O
weakness NN B-NP B-problem
( ( O O
unable JJ O O
to TO O O
walk VB O O
) ) O O
. . B-VP O
   
At IN B-VP O
Noughwell NNP B-NP O
Entanbon NNP I-NP O
Health NNP I-NP O
, , O O
her PRP$ O B-test
her PRP$ O B-person
temperature NN B-NP I-test
was VBD B-VP O
101 CD O O
, , O O
pulse RB O B-test
135 CD O O
, , O O
blood NN B-NP B-test
pressure NN I-NP I-test
94/74 CD O O
, , O O
respiratory NN B-NP B-test
rate NN I-NP I-test
20 CD O O
. . B-VP O
   
Positive JJ B-NP O
findings NNS I-NP O
of IN B-VP O
physical JJ B-NP B-test
examination NN I-NP I-test
include VBP O O
chicken VBN O B-problem
pox JJ B-NP I-problem
lesions NNS I-NP I-problem
on IN B-VP I-problem
thorax NN B-NP I-problem
, , O O
sunken JJ B-NP B-problem
eyes NNS I-NP I-problem
, , O O
thick JJ B-NP B-problem
nasal NN I-NP I-problem
discharge NN I-NP I-problem
, , O O
dry JJ B-NP B-problem
lips NNS I-NP I-problem
, , O I-problem
tongue NN B-NP I-problem
and CC O I-problem
mucous JJ B-NP I-problem
membranes NNS I-NP I-problem
, , O O
red JJ B-NP B-problem
tonsils NNS I-NP I-problem
. . B-VP O
   
The DT B-NP O
remainder NN I-NP O
of IN B-VP O
the DT B-NP B-test
physical JJ I-NP I-test
examination NN I-NP I-test
was VBD B-VP O
considered VBN O O
within IN B-VP O
normal JJ B-NP O
limits NNS I-NP O
. . B-VP O
   
Admission NNP B-NP O
diagnosis NN I-NP O
at IN B-VP O
Ni NNP B-NP O
Hospital NNP I-NP O
&apos;s NN I-NP O
: : O O
vomiting NN B-NP B-problem
and CC O O
dehydration NN B-NP B-problem
, , O O
hypokalemia NN B-NP B-problem
, , O O
hyponatremia NN B-NP B-problem
, , O O
tonsillitis NN B-NP B-problem
. . B-VP O
   
A DT B-NP B-treatment
peripheral JJ I-NP I-treatment
intravenous JJ I-NP I-treatment
line NN I-NP I-treatment
was VBD B-VP O
started VBN O O
on IN B-VP O
Labor NNP B-NP O
Day NNP I-NP O
in IN B-VP O
the DT B-NP O
a.m. NN I-NP O
No NNP I-NP O
respiratory NN I-NP B-problem
distress NN I-NP I-problem
was VBD B-VP O
noted VBN O O
. . B-VP O
   
Oral JJ B-NP B-problem
cyanosis NN I-NP I-problem
and CC O O
shallow JJ B-NP B-problem
respirations NNS I-NP I-problem
were VBD B-VP O
noted VBN O O
on IN B-VP O
9/7/93 CD O O
at IN B-VP O
2:45 CD O O
a.m. RB O O
Therefore RB O O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
intubated VBN O O
at IN B-VP O
3:45 CD O O
a.m. NN B-NP O
on IN B-VP O
9/7/93 CD O O
. . B-VP O
   
Chest JJS B-NP B-test
x-ray NN I-NP I-test
was VBD B-VP O
unremarkable JJ O O
. . B-VP O
   
Cardiovascular NNP B-NP O
stable JJ O O
, , O O
significant JJ B-NP B-problem
hypertension NN I-NP I-problem
was VBD B-VP O
noted VBN O O
on IN B-VP O
9/7/93 CD O O
at IN B-VP O
5:10 CD O O
a.m. NN B-NP O
and CC O O
therefore RB O O
10 CD O B-treatment
cc&apos;s NN B-NP I-treatment
per IN B-VP I-treatment
kilo FW O I-treatment
albumin NN B-NP I-treatment
was VBD B-VP O
given VBN O O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
admitted VBN O O
was VBD B-VP O
started VBN O O
on IN B-VP O
clear JJ B-NP B-treatment
fluids NNS I-NP I-treatment
, , O O
tolerated VBD B-VP O
, , O O
with IN B-VP O
D5 NNP B-NP B-treatment
normal JJ B-NP I-treatment
saline NN I-NP I-treatment
plus CC O O
40 CD O O
mEq NN B-NP O
per IN B-VP O
liter NN B-NP O
of IN B-VP O
KCL NNP B-NP B-treatment
at IN B-VP O
a DT B-NP O
rate NN I-NP O
of IN B-VP O
50 CD O O
cc NNS B-NP O
&apos;s FW O O
per IN B-VP O
hour NN B-NP O
for IN B-VP O
9 CD O O
hours NNS B-NP O
. . B-VP O
   
( ( O O
100 CD O O
cc&apos;s NN B-NP O
per IN B-VP O
kilo NN B-NP O
) ) O O
. . B-VP O
   
Sodium NN B-NP B-test
and CC O O
potassium NN B-NP B-test
at IN B-VP O
this DT B-NP O
time NN I-NP O
were VBD B-VP O
128/1.5 CD O O
. . B-VP O
   
At IN B-VP O
Labor NNP B-NP O
Day NNP I-NP O
, , O O
9:30 CD O O
a.m. NN B-NP O
, , O O
the DT B-NP B-treatment
fluids NNS I-NP I-treatment
were VBD B-VP O
increased VBN O O
to TO O O
100 CD O O
cc&apos;s NNS B-NP O
per IN B-VP O
hour NN B-NP O
( ( O O
200 CD O O
cc&apos;s NN B-NP O
per IN B-VP O
kilo NN B-NP O
for IN B-VP O
5 CD O O
hours NNS B-NP O
) ) O O
. . B-VP O
   
Electrolytes VBZ O B-test
at IN B-VP O
this DT B-NP O
point NN I-NP O
were VBD B-VP O
sodium JJ O B-test
132 CD O O
, , O O
potassium NN B-NP B-test
1.8 CD O O
. . B-VP O
   
At IN B-VP O
9/6/93 CD O O
, , O O
2:30 CD O O
p.m. NN B-NP O
, , O O
fluids NNS B-NP B-treatment
were VBD B-VP O
decreased VBN O O
to TO O O
75 CD O O
cc&apos;s NNS B-NP O
per IN B-VP O
hour NN B-NP O
, , O O
150 CD O O
cc&apos;s NN B-NP O
per IN B-VP O
kilo NN B-NP O
, , O O
40 CD O O
mEq NN B-NP O
of IN B-VP O
K NNP B-NP B-treatment
phosphate NN I-NP I-treatment
added VBD B-VP O
to TO O O
the DT B-NP B-treatment
intravenous JJ I-NP I-treatment
fluids NNS I-NP I-treatment
. . B-VP O
   
Electrolytes NNS B-NP B-test
at IN B-VP O
this DT B-NP O
point NN I-NP O
were VBD B-VP O
a DT B-NP B-test
sodium NN I-NP I-test
of IN B-VP O
143 CD O O
and CC O O
potassium NN B-NP B-test
1.7 CD O O
. . B-VP O
   
On IN B-VP O
9/6/93 CD O O
, , O O
22:00 CD O O
, , O O
fluids NNS B-NP B-treatment
were VBD B-VP O
changed VBN O O
to TO O O
D5 NNP B-NP B-treatment
normal JJ B-NP I-treatment
saline NN I-NP I-treatment
plus CC O O
40 CD O O
KCL NNP B-NP B-treatment
and CC O O
40 CD O O
K NNP B-NP B-treatment
phosphate NN I-NP I-treatment
at IN B-VP O
75 CD O O
cc NN B-NP O
&apos;s FW O O
per IN B-VP O
hour NN B-NP O
. . B-VP O
   
This DT B-NP O
rate NN I-NP O
was VBD B-VP O
maintained VBN O O
for IN B-VP O
11 CD O O
hours NNS B-NP O
. . B-VP O
   
Electrolytes NNS B-NP B-test
at IN B-VP O
this DT B-NP O
time NN I-NP O
were VBD B-VP O
a DT B-NP B-test
sodium NN I-NP I-test
of IN B-VP O
148 CD O O
, , O O
potassium NN B-NP B-test
1.7 CD O O
. . B-VP O
   
At IN B-VP O
9/7/93 CD O O
, , O O
1:00 CD O O
a.m. NN B-NP O
, , O O
intravenous JJ B-NP B-treatment
fluids NNS I-NP I-treatment
rate NN I-NP O
was VBD B-VP O
decreased VBN O O
to TO O O
50 CD O O
cc&apos;s NNS B-NP O
per IN B-VP O
hour NN B-NP O
, , O O
total JJ B-NP B-treatment
fluids NNS I-NP I-treatment
given VBN O O
during IN B-VP O
the DT O O
first JJ O O
24 CD O O
hours NNS B-NP O
were VBD B-VP O
140 CD O O
to TO O O
150 CD O O
cc&apos;s NNS B-NP O
per IN B-VP O
kilo FW O O
per IN B-VP O
day NN B-NP O
. . B-VP O
   
At IN B-VP O
this DT B-NP O
time NN I-NP O
, , O O
sodium NN B-NP B-test
was VBD B-VP O
147 CD O O
, , O O
potassium NN B-NP B-test
2.6 CD O O
, , O O
total JJ B-NP B-treatment
sodium NN I-NP I-treatment
given VBN O O
during IN B-VP O
the DT O O
first JJ O O
24 CD O O
hours NNS B-NP O
20 CD O O
mEq NNS B-NP O
per IN B-VP O
kilo FW O O
per IN B-VP O
day NN B-NP O
. . B-VP O
   
On IN B-VP O
9/7/93 CD O O
at IN B-VP O
4:00 CD O O
a.m. RB O O
, , O O
albumin JJ O B-treatment
bolus CC O I-treatment
5% CD O O
10 CD O O
cc&apos;s NN B-NP O
per IN B-VP O
kilo NN B-NP O
was VBD B-VP O
given VBN O O
, , O O
a DT B-NP O
total NN I-NP O
of IN B-VP O
120 CD O O
cc&apos;s NN B-NP O
, , O O
electrolytes NNS B-NP B-test
were VBD B-VP O
sodium JJ O B-test
155 CD O O
, , O O
potassium NN B-NP B-test
3.1 CD O O
. . B-VP O
   
At IN B-VP O
9/7/93 CD O O
at IN B-VP O
5:00 CD O O
a.m. RB O O
, , O O
sodium NN B-NP B-treatment
bicarbonate NN I-NP I-treatment
given VBN O O
60 CD O O
mEq NNS B-NP O
, , O O
calcium NN B-NP B-treatment
bolus NN I-NP I-treatment
10 CD O O
cc&apos;s NN B-NP O
given VBN O O
. . B-VP O
   
On IN B-VP O
9/7 CD O O
, , O O
5:30 CD O O
a.m. NN B-NP O
, , O O
D5 NNP B-NP B-treatment
quarter NN I-NP I-treatment
normal JJ B-NP I-treatment
saline NN I-NP I-treatment
, , O O
and CC O O
40 CD O O
of IN B-VP O
K NNP B-NP B-treatment
phosphate NN I-NP I-treatment
at IN B-VP O
100 CD O O
cc&apos;s NNS B-NP O
per IN B-VP O
hour NN B-NP O
was VBD B-VP O
given VBN O O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
taking VBG O O
PO NNP B-NP O
initially RB O O
until IN B-VP O
9/6/93 CD O O
at IN B-VP O
17:45 CD O O
. . B-VP O
   
There EX O O
were VBD B-VP O
no DT B-NP O
abnormal JJ I-NP B-problem
findings NNS I-NP I-problem
in IN B-VP O
abdominal JJ B-NP B-test
exam NN I-NP I-test
. . B-VP O
   
On IN B-VP O
9/5/93 CD O O
, , O O
hematocrit NN B-NP B-test
48 CD O O
, , O O
white JJ B-NP B-test
blood NN I-NP I-test
count NN I-NP I-test
11.2 CD O O
, , O O
neutrophiles NNS B-NP B-test
67 CD O O
, , O O
bands VBZ O B-test
14 CD O O
, , O O
lymphs VBD B-VP B-test
11 CD O O
, , O O
monos FW O B-test
6% CD O O
, , O O
meta NN B-NP B-test
2% CD O O
, , O O
platelets NNS B-NP B-test
220,000 CD O O
. . B-VP O
   
Copious JJ B-NP B-problem
urine JJ I-NP I-problem
output NN I-NP I-problem
, , O O
BUN NNP B-NP B-test
1.0 CD O O
, , O O
creatinine NN B-NP B-test
.8 NNP I-NP O
. . B-VP O
   
Normal NNP B-NP O
neurologic JJ B-NP O
exam NN I-NP O
on IN B-VP O
admission NN B-NP O
, , O O
then RB O O
lethargic VBZ O B-problem
on IN B-VP O
9/6/93 CD O O
at IN B-VP O
17:45 CD O O
, , O O
then RB O O
patient NN B-NP B-person
became VBD B-VP O
unresponsive JJ O B-problem
, , O O
areflexic JJ O B-problem
and CC O O
limp NN B-NP B-problem
at IN B-VP O
9/6/93 CD O O
, , O O
at IN B-VP O
17:45 CD O O
to TO O O
22:00 CD O O
. . B-VP O
   
Patient NN B-NP B-person
was VBD B-VP O
having VBG O O
seizures NNS B-NP B-problem
, , O O
twitching VBG O B-problem
of IN B-VP I-problem
face NN B-NP I-problem
and CC O O
rapid JJ B-NP B-problem
movements NNS I-NP I-problem
of IN B-VP I-problem
eyes NNS B-NP I-problem
. . B-VP O
   
Pupils NNP B-NP B-problem
dilated VBD B-VP I-problem
and CC O I-problem
sluggish JJ O I-problem
. . B-VP O
   
Valium NN B-NP B-treatment
was VBD B-VP O
given VBN O O
at IN B-VP O
9/7/93 CD O O
, , O O
00:02 CD O O
. . B-VP O
   
IV NNP B-NP B-treatment
ampicillin NN I-NP I-treatment
, , O O
chloramphenicol NN B-NP B-treatment
, , O O
ceftriaxone NN B-NP B-treatment
, , O O
and CC O O
culture NN B-NP B-test
were VBD B-VP O
sent VBN O O
. . B-VP O
   
Finally RB O O
, , O O
Fairm NNP B-NP B-person
of IN B-VP I-person
Ijordcompmac NNP B-NP I-person
Hospital NNP I-NP I-person
transport NN I-NP I-person
team NN I-NP I-person
was VBD B-VP O
called VBN O O
and CC O O
transport NN B-NP B-person
team NN I-NP I-person
arrived VBD B-VP O
on IN B-VP O
9/7/93 CD O O
, , O O
6:30 CD O O
a.m. NN B-NP O
, , O O
and CC O O
on IN B-VP O
arrival JJ B-NP O
patient NN I-NP B-person
was VBD B-VP O
seizing VBG O O
with IN B-VP O
rhythmic JJ B-NP B-problem
eye NN I-NP I-problem
movement NN I-NP I-problem
to TO O I-problem
left VB O I-problem
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
unresponsive JJ O B-problem
, , O O
poor JJ B-NP B-problem
perfusion NN I-NP I-problem
. . B-VP O
   
Temperature NN B-NP B-test
was VBD B-VP O
101.8 CD O O
. . B-VP O
   
A DT O B-treatment
second JJ O I-treatment
intravenous JJ O I-treatment
was VBD B-VP O
started VBN O O
and CC O O
given VBN O O
normal JJ B-NP B-treatment
saline NN I-NP I-treatment
bolus NN I-NP I-treatment
, , O O
change NN B-NP O
in IN B-VP O
intravenous JJ B-NP B-treatment
fluids NNS I-NP I-treatment
to TO O O
D5 NNP B-NP B-treatment
water NN I-NP I-treatment
with IN B-VP O
80 CD O O
mEq NNS B-NP O
of IN B-VP O
bicarbonate NN B-NP B-treatment
, , O O
plus CC O O
40 CD O O
mEq NN B-NP O
of IN B-VP O
KCL NNP B-NP B-treatment
at IN B-VP O
45 CD O O
cc&apos;s NNS B-NP O
per IN B-VP O
hour NN B-NP O
, , O O
bicarbonate VB O B-treatment
given VBN O O
2 CD O O
mEq NNS B-NP O
per IN B-VP O
kilo NN B-NP O
, , O O
attempted VBN O O
to TO O O
start VB O O
dopa NN B-NP B-treatment
for IN B-VP O
poor JJ B-NP B-problem
perfusion NN I-NP I-problem
but CC O O
worsening VBG O B-problem
perfusion NN B-NP I-problem
. . B-VP O
   
Therefore RB O O
, , O O
dopa NN B-NP B-treatment
was VBD B-VP O
stopped VBN O O
. . B-VP O
   
Total JJ B-NP O
volume NN I-NP O
given VBN O O
as IN B-VP O
bolus JJ O B-treatment
50 CD O O
cc&apos;s NN B-NP O
per IN B-VP O
kilo NN B-NP O
, , O O
sodium NN B-NP B-treatment
bicarbonate NN I-NP I-treatment
at IN B-VP O
2 CD O O
mEq NNS B-NP O
per IN B-VP O
kilo NN B-NP O
was VBD B-VP O
given VBN O O
. . B-VP O
   
Last JJ B-NP O
ABG NNP I-NP B-test
there EX O O
was VBD B-VP O
6.98 CD O O
, , O O
31 CD O O
, , O O
171 CD O O
, , O O
bicarbonate NN B-NP B-test
of IN B-VP O
7 CD O O
. . B-VP O
   
Phenobarbital NNP B-NP B-treatment
and CC O O
Dilantin NNP B-NP B-treatment
given VBN O O
for IN B-VP O
seizure NN B-NP B-treatment
control NN I-NP I-treatment
. . B-VP O
   
Electrolytes NNS B-NP B-test
before IN B-VP O
departure NN B-NP O
for IN B-VP O
Fairm NNP B-NP O
of IN B-VP O
Ijordcompmac NNP B-NP O
Hospital NNP I-NP O
was VBD B-VP O
a DT B-NP B-test
sodium NN I-NP I-test
of IN B-VP O
176 CD O O
, , O O
potassium NN B-NP B-test
2.5 CD O O
, , O O
chloride RB O B-test
140 CD O O
, , O O
bicarbonate NN B-NP B-test
14 CD O O
, , O O
calcium NN B-NP B-test
7.2 CD O O
, , O O
magnesium NN B-NP B-test
2.7 CD O O
. . B-VP O
   
Admission NN B-NP O
to TO O O
the DT B-NP O
Pediatric NNP I-NP O
Intensive NNP I-NP O
Care NNP I-NP O
Unit NNP I-NP O
at IN B-VP O
Fairm NNP B-NP O
of IN B-VP O
Ijordcompmac NNP B-NP O
Hospital NNP I-NP O
was VBD B-VP O
9/7/93 CD O O
, , O O
11:15 CD O O
a.m. NN B-NP O
Lines NNS I-NP B-treatment
placed VBN O O
were VBD B-VP O
a DT B-NP B-treatment
right JJ I-NP I-treatment
femoral JJ I-NP I-treatment
triple JJ I-NP I-treatment
lumen NNS I-NP I-treatment
, , O O
endotracheal JJ B-NP B-treatment
tube NN I-NP I-treatment
4.0 CD O O
, , O O
arterial JJ B-NP B-treatment
line NN I-NP I-treatment
, , O O
right JJ B-NP B-treatment
radial JJ I-NP I-treatment
line NN I-NP I-treatment
, , O O
Foley NNP B-NP B-treatment
placed VBD B-VP O
, , O O
peripheral JJ B-NP B-treatment
intravenous JJ I-NP I-treatment
line NN I-NP I-treatment
, , O O
nasogastric JJ B-NP B-treatment
tube NN I-NP I-treatment
. . B-VP O
   
On IN B-VP O
admission NN B-NP O
to TO O O
Fairm NNP B-NP O
of IN B-VP O
Ijordcompmac NNP B-NP O
Hospital NNP I-NP O
, , O O
temperature NN B-NP B-test
100.2 CD O O
, , O O
pulse RB O B-test
149 CD O O
, , O O
respiratory NN B-NP B-test
rate NN I-NP I-test
50 CD O O
, , O O
blood NN B-NP B-test
pressure NN I-NP I-test
98/66 CD O O
, , O O
mean JJ B-NP B-test
arterial JJ I-NP I-test
pressure NN I-NP I-test
of IN B-VP O
73 CD O O
, , O O
weight VBD B-VP B-test
12 CD O O
kilos NN B-NP O
. . B-VP O
   
PAST NNP B-NP O
MEDICAL NNP I-NP O
HISTORY NNP I-NP O
: : O O
RTA NN B-NP B-problem
diagnosed VBD B-VP O
at IN B-VP O
14 CD O O
months NNS B-NP O
of IN B-VP O
age NN B-NP O
, , O O
she PRP O B-person
had VBD B-VP O
a DT B-NP O
history NN I-NP O
of IN B-VP O
scarlet NN B-NP B-problem
fever NN I-NP I-problem
at IN B-VP O
14 CD O O
months NNS B-NP O
of IN B-VP O
age NN B-NP O
. . B-VP O
   
She PRP O B-person
also RB O O
had VBD B-VP O
a DT B-NP O
recent JJ I-NP O
exposure NN I-NP O
to TO O O
varicella NN B-NP B-problem
. . B-VP O
   
Her PRP$ O B-person
Her PRP$ O B-person
brother NN B-NP I-person
had VBD B-VP O
developed VBN O O
the DT B-NP B-problem
typical JJ I-NP I-problem
rash NN I-NP I-problem
on IN B-VP O
9/3/93 CD O O
. . B-VP O
   
ALLERGIES NNS B-NP O
: : O O
None NN B-NP O
known VBN O O
. . B-VP O
   
SOCIAL NNP B-NP O
HISTORY NNP I-NP O
: : O O
Mom NN B-NP B-person
on IN B-VP O
Medicaid NNP B-NP O
, , O O
recovered VBD B-VP O
alcoholic JJ O O
. . B-VP O
   
11 CD O B-person
year NN B-NP I-person
old JJ B-NP I-person
brother,6 NN I-NP I-person
year NN I-NP I-person
old JJ B-NP I-person
sister NN I-NP I-person
, , O O
healthy JJ O O
. . B-VP O
   
Mom NNP B-NP B-person
separated VBD B-VP O
. . B-VP O
   
HOSPITAL NNP B-NP O
COURSE NNP I-NP O
: : O O
On IN B-VP O
admission NN B-NP O
, , O O
FI02 NNP B-NP B-treatment
was VBD B-VP O
50-60% JJ O O
, , O O
PID NNP B-NP B-treatment
30-32/PEEP CD O B-treatment
of IN B-VP O
5.7 CD O O
, , O O
total JJ B-NP B-test
volume NN I-NP I-test
was VBD B-VP O
between IN B-VP O
140 CD O O
to TO O O
210 CD O O
during IN B-VP O
Intensive NNP B-NP O
Care NNP I-NP O
Unit NNP I-NP O
stay NN I-NP O
. . B-VP O
   
Chest NNP B-NP B-test
x-ray NN I-NP I-test
showed VBD B-VP O
right JJ B-NP B-problem
upper JJ I-NP I-problem
lobe NN I-NP I-problem
pneumonia NN I-NP I-problem
. . B-VP O
   
Cardiovascular JJ O O
: : O O
CVP NN B-NP B-test
on IN B-VP O
admission NN B-NP O
was VBD B-VP O
1 CD O O
cm NN B-NP O
of IN B-VP O
water NN B-NP O
. . B-VP O
   
Then RB O O
during IN B-VP O
the DT B-NP O
Intensive NNP I-NP O
Care NNP I-NP O
Unit NNP I-NP O
stay NN I-NP O
, , O O
the DT B-NP O
CVP NNP I-NP B-test
remained VBD B-VP O
between IN B-VP O
7 CD O O
to TO O O
8 CD O O
after IN B-VP O
volume NN B-NP B-treatment
resuscitation NN I-NP I-treatment
. . B-VP O
   
Dopamine NNP B-NP B-treatment
and CC O O
epinephrine VB O B-treatment
given VBN O O
for IN B-VP O
cardiovascular JJ B-NP B-treatment
support NN I-NP I-treatment
. . B-VP O
   
Her PRP$ O B-test
Her PRP$ O B-person
electrocardiogram JJ B-NP I-test
findings NNS I-NP O
were VBD B-VP O
compatible JJ O O
with IN B-VP O
hypokalemia NN B-NP B-problem
( ( O O
flattening VBG O B-problem
T NNP B-NP I-problem
waves NNS I-NP I-problem
and CC O O
ST NNP B-NP B-problem
changes NNS I-NP I-problem
) ) O O
. . B-VP O
   
Fluids NNP B-NP O
/ JJ B-NP O
electrolytes/nutrition NN I-NP O
: : O O
On IN B-VP O
admission NN B-NP O
to TO O O
Fairm NNP B-NP O
of IN B-VP O
Ijordcompmac NNP B-NP O
Hospital NNP I-NP O
, , O O
hypernatremia NN B-NP B-problem
and CC O O
hypovolemic JJ B-NP B-problem
shock NN I-NP I-problem
. . B-VP O
   
Fluids NNS B-NP B-treatment
of IN B-VP I-treatment
D5 NNP B-NP I-treatment
water NN I-NP I-treatment
with IN B-VP O
30 CD O O
mEq NNS B-NP O
of IN B-VP O
sodium NN B-NP B-treatment
acetate NN I-NP I-treatment
per IN B-VP O
liter NN B-NP O
, , O O
30 CD O O
ml NN B-NP O
per IN B-VP O
liter NN B-NP O
of IN B-VP O
phosphate NN B-NP B-treatment
, , O O
and CC O O
30 CD O O
mEq NN B-NP O
of IN B-VP O
K NNP B-NP B-treatment
acetate VBP O I-treatment
per IN B-VP O
liter NN B-NP O
at IN B-VP O
90 CD O O
cc&apos;s NNS B-NP O
per IN B-VP O
hour NN B-NP O
was VBD B-VP O
given VBN O O
. . B-VP O
   
Free JJ B-NP B-treatment
water NN I-NP I-treatment
deficit NN I-NP I-treatment
over IN B-VP O
48 CD O O
hours NNS B-NP O
was VBD B-VP O
given VBN O O
, , O O
plus CC O O
maintenance NN B-NP O
, , O O
plus CC O O
adjusting VBG O O
the DT B-NP O
ongoing JJ I-NP O
losses NNS I-NP O
. . B-VP O
   
Pediatric NNP B-NP O
Nephrology NNP I-NP O
recommended VBD B-VP O
on IN B-VP O
9/7/93 CD O O
, , O O
5:50 CD O O
p.m. NN B-NP O
, , O O
10 CD O O
cc NN B-NP O
&apos;s FW O O
per IN B-VP O
kilo NN B-NP O
of IN B-VP O
150 CD O O
mEq NN B-NP O
of IN B-VP O
sodium NN B-NP B-treatment
bicarbonate NN I-NP I-treatment
per IN B-VP O
liter NN B-NP O
, , O O
( ( O O
1.5 CD O O
mEq NN B-NP O
per IN B-VP O
kilo NN B-NP O
bicarbonate NN I-NP B-treatment
, , O O
one CD O O
dose NN B-NP O
of IN B-VP O
Lasix NNP B-NP B-treatment
and CC O O
volume NN B-NP B-treatment
as IN B-VP O
needed VBN O O
) ) O O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
required VBN O O
multiple JJ B-NP B-treatment
boluses NNS I-NP I-treatment
of IN B-VP I-treatment
albumin NN B-NP I-treatment
for IN B-VP O
hypotension NN B-NP B-problem
, , O O
patient NN B-NP B-person
also RB O O
required VBD B-VP O
multiple JJ B-NP B-treatment
boluses NNS I-NP I-treatment
of IN B-VP I-treatment
calcium NN B-NP I-treatment
because IN B-VP O
of IN B-VP O
hypocalcemia NN B-NP B-problem
and CC O O
hypotension NN B-NP B-problem
. . B-VP O
   
Magnesium NNP B-NP B-treatment
2.0 CD O O
mEq NN B-NP O
per IN B-VP O
liter NN B-NP O
, , O O
phosphate VBP O B-treatment
8 CD O O
mg NN B-NP O
/ NNP I-NP O
dl NN I-NP O
. . B-VP O
   
Gastrointestinal JJ O O
: : O O
Normal NNP B-NP O
. . B-VP O
   
NPO NNP B-NP B-treatment
. . B-VP O
   
Albumin NNP B-NP B-test
was VBD B-VP O
4.9 CD O O
. . B-VP O
   
Globulin NNP B-NP B-test
was VBD B-VP O
1.6 CD O O
, , O O
uric JJ B-NP B-test
acid NN I-NP I-test
was VBD B-VP O
6.5 CD O O
, , O O
alkaline JJ B-NP B-test
phosphatase NN I-NP I-test
150 CD O O
, , O O
SGPT NNP B-NP B-test
11 CD O O
, , O O
SGOT NNP B-NP B-test
85 CD O O
, , O O
LDH NNP B-NP B-test
524 CD O O
, , O O
CK NNP B-NP B-test
152 CD O O
, , O O
NH3 NNP B-NP B-test
81 CD O O
. . B-VP O
   
Hematologic NN B-NP O
: : O O
White NNP B-NP B-test
cell NN I-NP I-test
count NN I-NP I-test
9.4 CD O O
, , O O
hematocrit NN B-NP B-test
42 CD O O
, , O O
platelets NNS B-NP B-test
151,000 CD O O
. . B-VP O
   
Differential NNP B-NP B-test
was VBD B-VP O
polys JJ O B-test
59 CD O O
, , O O
bands VBZ O B-test
3 CD O O
, , O O
lymphs VBD B-VP B-test
25 CD O O
. . B-VP O
   
Repeat NNP B-NP B-test
white JJ B-NP I-test
cell NN I-NP I-test
count NN I-NP I-test
6.4 CD O O
, , O O
hematocrit NN B-NP B-test
34 CD O O
, , O O
platelets NNS B-NP B-test
103 CD O O
. . B-VP O
   
PT VB O B-test
11.6/10.1 CD O O
, , O O
repeat NN B-NP B-test
PT NNP I-NP I-test
12.8/10.5 CD O O
. . B-VP O
   
PTT VB O B-test
36.4 CD O O
, , O O
repeat NN B-NP B-test
PTT NNP I-NP I-test
50.9 CD O O
. . B-VP O
   
Fibrinogen NN B-NP B-test
211 CD O O
. . B-VP O
   
Renal JJ O O
: : O O
Urine NN B-NP B-test
output NN I-NP I-test
was VBD B-VP O
about RB O O
5 CD O O
to TO O O
8 CD O O
cc&apos;s NNS B-NP O
per IN B-VP O
kilo FW O O
per IN B-VP O
hour NN B-NP O
. . B-VP O
   
Renal JJ B-NP B-test
ultrasound NN I-NP I-test
was VBD B-VP O
scheduled VBN O O
during IN B-VP O
the DT B-NP O
Intensive NNP I-NP O
Care NNP I-NP O
Unit NNP I-NP O
stay NN I-NP O
. . B-VP O
   
Urinalysis NN B-NP B-test
showed VBD B-VP O
specific JJ B-NP B-test
gravity NN I-NP I-test
1.005 CD O O
, , O O
pH NN B-NP B-test
8.0 CD O O
, , O O
positive JJ B-NP B-problem
proteins NNS I-NP I-problem
, , O O
positive JJ B-NP B-problem
red JJ I-NP I-problem
blood NN I-NP I-problem
cells NNS I-NP I-problem
, , O O
negative JJ B-NP O
white JJ I-NP O
cell NN I-NP O
count NN I-NP O
, , O O
positive JJ B-NP B-problem
glucose NN I-NP I-problem
. . B-VP O
   
Neurologic CC O O
: : O O
Patient NN B-NP B-person
did VBD B-VP O
not RB O O
receive VB O O
sedation NN B-NP B-treatment
or CC O O
muscle NN B-NP B-treatment
relaxant NN I-NP I-treatment
since IN B-VP O
admission NN B-NP O
to TO O O
the DT B-NP O
Pediatric NNP I-NP O
Intensive NNP I-NP O
Care NNP I-NP O
Unit NNP I-NP O
. . B-VP O
   
Phenobarbital JJ B-NP B-test
levels NNS I-NP I-test
were VBD B-VP O
31.4 CD O O
, , O O
30.2 CD O O
, , O O
and CC O O
50 CD O O
. . B-VP O
   
Dilantin NNP B-NP B-test
level NN I-NP I-test
was VBD B-VP O
22.6 CD O O
, , O O
20.2 CD O O
, , O O
20 CD O O
. . B-VP O
   
Neurology NNP B-NP B-person
consultation NN I-NP O
on IN B-VP O
the DT B-NP O
evening NN I-NP O
of IN B-VP O
9/7/93 CD O O
revealed JJ B-NP O
supple NN I-NP O
neck NN I-NP O
, , O O
no DT B-NP B-problem
response NN I-NP I-problem
to TO O O
external JJ B-NP B-test
rub NN I-NP I-test
. . B-VP O
   
Pupils NNS B-NP O
were VBD B-VP O
3.5 CD O O
OD NNP B-NP O
, , O O
and CC O O
3.0 CD O O
OS NNP B-NP O
, , O O
irregular JJ O B-problem
and CC O O
non JJ B-NP B-problem
reactive NN I-NP I-problem
. . B-VP O
   
Corneal NNP B-NP B-test
reflexes NNS I-NP I-test
and CC O O
oculocephalic JJ B-NP B-test
reflexes NNS I-NP I-test
were VBD B-VP O
absent JJ O B-problem
. . B-VP O
   
There EX O O
was VBD B-VP O
no DT B-NP B-problem
gag NN I-NP I-problem
. . B-VP O
   
Muscle NNP B-NP B-test
tone NN I-NP I-test
was VBD B-VP O
increased VBN O B-problem
throughout IN B-VP I-problem
, , O O
and CC O O
the DT B-NP O
legs NNS I-NP O
were VBD B-VP O
both DT O B-problem
extended VBN O I-problem
and CC O I-problem
internally RB O I-problem
rotated VBN O I-problem
. . B-VP O
   
Deep JJ B-NP B-test
tendon NN I-NP I-test
reflexes NNS I-NP I-test
could MD O O
not RB O O
be VB O O
elicited VBN O O
and CC O O
plantar JJ B-NP B-test
responses NNS I-NP I-test
were VBD B-VP O
silent JJ O B-problem
. . B-VP O
   
Repeat NNP B-NP B-test
neurological JJ B-NP I-test
examination NN I-NP I-test
revealed VBD B-VP O
no DT B-NP B-problem
spontaneous JJ I-NP I-problem
movement NN I-NP I-problem
and CC O O
no DT B-NP B-problem
response NN I-NP I-problem
to TO O O
voice NN B-NP B-test
or CC O I-test
noxious JJ B-NP I-test
stimulation NN I-NP I-test
. . B-VP O
   
Pupils NNS B-NP O
were VBD B-VP O
dilated VBN O B-problem
and CC O O
non JJ B-NP B-problem
reactive NN I-NP I-problem
. . B-VP O
   
Disc NNP B-NP O
margins NNS I-NP O
appeared VBD B-VP O
blurred VBN O B-problem
on IN B-VP O
funduscopic NN B-NP B-test
exam NN I-NP I-test
. . B-VP O
   
A DT B-NP B-test
non JJ I-NP I-test
contrast NN I-NP I-test
head NN I-NP I-test
CT NNP I-NP I-test
scan NN I-NP I-test
was VBD B-VP O
obtained VBN O O
and CC O O
CT NNP B-NP B-test
revealed VBD B-VP O
severe JJ B-NP B-problem
cerebral JJ I-NP I-problem
edema NN I-NP I-problem
with IN B-VP O
thalamic JJ B-NP B-problem
mid NN I-NP I-problem
brain NN I-NP I-problem
, , O I-problem
pons NNS B-NP I-problem
, , O I-problem
medullar JJ B-NP I-problem
low JJ I-NP I-problem
attenuation NN I-NP I-problem
, , O O
diffuse VB O B-problem
cerebral JJ B-NP I-problem
edema NN I-NP I-problem
, , O O
loss NN B-NP B-problem
of IN B-VP I-problem
gray JJ B-NP I-problem
white JJ I-NP I-problem
matter NN I-NP I-problem
differentiation NN I-NP I-problem
. . B-VP O
   
Cerebral JJ B-NP B-test
blood NN I-NP I-test
flow NN I-NP I-test
was VBD B-VP O
done VBN O O
on IN B-VP O
9/7/93 CD O O
at IN B-VP O
2:30 CD O O
p.m. NN B-NP O
, , O O
revealed VBD B-VP O
complete JJ B-NP B-problem
absence NN I-NP I-problem
of IN B-VP I-problem
blood NN B-NP I-problem
flow NN I-NP I-problem
to TO O I-problem
brain NN B-NP I-problem
. . B-VP O
   
There EX O O
was VBD B-VP O
a DT B-NP B-problem
tiny JJ I-NP I-problem
region NN I-NP I-problem
of IN B-VP I-problem
activity NN B-NP I-problem
in IN B-VP O
what WP O O
appears VBZ O O
to TO O O
be VB O O
anterior JJ B-NP O
scalp NN I-NP O
. . B-VP O
   
Infectious JJ B-NP O
Disease NN I-NP O
: : O O
Ampicillin NNP B-NP B-treatment
and CC O O
chloramphenicol NN B-NP B-treatment
were VBD B-VP O
given VBN O O
at IN B-VP O
Noughwell NNP B-NP O
Entanbon NNP I-NP O
Health NNP I-NP O
, , O O
and CC O O
ceftriaxone NN B-NP B-treatment
was VBD B-VP O
given VBN O O
at IN B-VP O
Fairm NNP B-NP O
of IN B-VP O
Ijordcompmac NNP B-NP O
Hospital NNP I-NP O
. . B-VP O
   
Acyclovir NNP B-NP B-treatment
was VBD B-VP O
started VBN O O
, , O O
also RB O O
considering VBG O O
the DT B-NP B-problem
varicella NN I-NP I-problem
at IN B-VP O
120 CD O O
mg NNS B-NP O
intravenously RB O O
every DT O O
8 CD O O
hours NNS B-NP O
. . B-VP O
   
Urine NNP B-NP B-test
cultures NNS I-NP I-test
, , O O
blood NN B-NP B-test
cultures NNS I-NP I-test
and CC O O
sputum JJ B-NP B-test
cultures NNS I-NP I-test
were VBD B-VP O
sent VBN O O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
finally RB O O
died VBD B-VP O
. . B-VP O
   
The DT B-NP O
situation NN I-NP O
of IN B-VP O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
extensively RB O O
discussed VBN O O
with IN B-VP O
the DT B-NP B-person
parents NNS I-NP I-person
, , O O
and CC O O
the DT O B-person
attending VBG O I-person
physician NN B-NP I-person
from IN B-VP O
Neurology NNP B-NP B-person
, , O O
Dr. NNP B-NP B-person
Breunkote NNP I-NP I-person
, , O O
and CC O O
the DT O B-person
attending VBG O I-person
physician NN B-NP I-person
from IN B-VP O
Pediatric NNP B-NP O
Intensive NNP I-NP O
Care NNP I-NP O
Unit NNP I-NP O
, , O O
Dr. NNP B-NP B-person
Boormcose NNP I-NP I-person
, , O O
and CC O O
the DT B-NP O
decision NN I-NP O
was VBD B-VP O
finally RB O O
made VBN O O
with IN B-VP O
the DT B-NP B-person
family NN I-NP I-person
and CC O O
attendings NNS B-NP B-person
to TO O O
disconnect VB O O
the DT B-NP B-person
patient NN I-NP I-person
from IN B-VP O
the DT B-NP B-treatment
mechanical JJ I-NP I-treatment
ventilation NN I-NP I-treatment
due JJ O O
to TO O O
severe VB O B-problem
neurological JJ B-NP I-problem
injury NN I-NP I-problem
and CC O O
poor JJ B-NP B-problem
prognosis NN I-NP I-problem
. . B-VP O
   
ZAKAY NNP B-NP B-person
COUGH NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
TR NNP I-NP O
: : O O
jx NN B-NP O
/ NNP I-NP O
bmot NN I-NP O
DD NNP I-NP O
: : O O
10-20-93 JJ B-NP O
TD NN I-NP O
: : O O
10/21/93 CD O O
CC NN B-NP O
: : O O
edited VBD B-VP O
10/24/93 CD O O
rc NN B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- VBD B-VP O
989519730 CD O O
WGH NNP B-NP O
4708487 CD O O
265076 CD O O
4927849 CD O O
05/09/2004 CD O O
12:00:00 CD O O
AM NNP B-NP O
Discharge NNP I-NP O
Summary NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Report NNP I-NP O
Status NNP I-NP O
: : O O
Signed VBD B-VP O
DISCHARGE NNP B-NP O
SUMMARY NNP I-NP O
NAME NN I-NP O
: : O O
GINSLENT NNP B-NP B-person
, , O I-person
A NNP B-NP I-person
L NNP I-NP I-person
UNIT NNP I-NP O
NUMBER NNP I-NP O
: : O O
537-43-35 JJ B-NP O
ADMISSION NNP I-NP O
DATE NNP I-NP O
: : O O
05/09/2004 CD O O
DISCHARGE NNP B-NP O
DATE NNP I-NP O
: : O O
05/16/2004 CD O O
PRINCIPAL NNP B-NP O
DIAGNOSIS NNP I-NP O
: : O O
Colon NN B-NP B-problem
cancer NN I-NP I-problem
. . B-VP O
   
ASSOCIATED NNP B-NP O
DIAGNOSES NNPS I-NP O
: : O O
History NN B-NP O
of IN B-VP O
diverticulitis NN B-NP B-problem
, , O O
status NN B-NP O
post NN I-NP O
cholecystectomy NN I-NP B-treatment
, , O O
status NN B-NP O
post NN I-NP O
appendectomy NN I-NP B-treatment
, , O O
and CC O O
hypertension NN B-NP B-problem
. . B-VP O
   
PRINCIPAL JJ B-NP O
PROCEDURE NN I-NP O
: : O O
Transverse JJ B-NP B-treatment
colectomy NN I-NP I-treatment
for IN B-VP O
tumor NN B-NP B-problem
. . B-VP O
   
ASSOCIATED NNP B-NP O
PROCEDURES NNP I-NP O
: : O O
None NN B-NP O
. . B-VP O
   
HISTORY NNP B-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
is VBZ O O
an DT B-NP O
84-year-old JJ I-NP O
woman NN I-NP O
with IN B-VP O
a DT B-NP O
history NN I-NP O
of IN B-VP O
diverticulitis NN B-NP B-problem
who WP O B-person
was VBD B-VP O
found VBN O O
to TO O O
have VB O O
colon NN B-NP B-problem
cancer NN I-NP I-problem
on IN B-VP O
colonoscopy NN B-NP B-test
, , O O
which WDT O B-pronoun
was VBD B-VP O
performed VBN O O
in IN B-VP O
March NNP B-NP O
of IN B-VP O
2004 CD O O
. . B-VP O
   
An DT O B-problem
invasive JJ O I-problem
moderately RB O I-problem
differentiated JJ B-NP I-problem
adenocarcinoma NN I-NP I-problem
was VBD B-VP O
noted VBN O O
in IN B-VP O
the DT B-NP O
transverse NN I-NP O
colon NN I-NP O
at IN B-VP O
80 CD O O
cm NN B-NP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
reports VBZ O O
a DT B-NP O
history NN I-NP O
of IN B-VP O
bloating NN B-NP B-problem
and CC O O
flatulence NN B-NP B-problem
as RB O O
well RB O O
as IN B-VP O
increased VBN O B-problem
fatigue NN B-NP I-problem
. . B-VP O
   
She PRP O B-person
has VBZ O O
also RB O O
had VBD B-VP O
some DT B-NP B-problem
discomfort NN I-NP I-problem
in IN B-VP I-problem
her PRP$ O I-problem
her PRP$ O B-person
left JJ B-NP I-problem
lower JJR I-NP I-problem
abdomen NNS I-NP I-problem
and CC O O
notes NNS B-NP O
diarrhea VBP O B-problem
every DT B-NP O
4-5 JJ I-NP O
days NNS I-NP O
. . B-VP O
   
She PRP O B-person
says VBZ O O
that IN B-VP O
her PRP$ O B-person
appetite NN B-NP O
is VBZ O O
good JJ O O
and CC O O
has VBZ O O
noted VBN O O
no DT B-NP O
weight JJ I-NP B-problem
loss NN I-NP I-problem
. . B-VP O
   
PAST NNP B-NP O
MEDICAL NNP I-NP O
HISTORY NNP I-NP O
: : O O
Cholecystectomy NN B-NP B-treatment
in IN B-VP O
1994 CD O O
, , O O
colonoscopy NN B-NP B-test
2004 CD O O
, , O O
status NN B-NP O
post NN I-NP O
tonsillectomy NN I-NP B-treatment
, , O O
status NN B-NP O
post NN I-NP O
appendectomy NN I-NP B-treatment
, , O O
status NN B-NP O
post NN I-NP O
ORIF NNP I-NP B-treatment
of IN B-VP I-treatment
left JJ B-NP I-treatment
wrist NN I-NP I-treatment
, , O O
status NN B-NP O
post NN I-NP O
left VBD B-VP B-treatment
ear JJ B-NP I-treatment
surgery NN I-NP I-treatment
, , O O
NSVD NNP B-NP B-treatment
x5 NNP I-NP O
, , O O
and CC O O
hypertension NN B-NP B-problem
. . B-VP O
   
MEDICATIONS NN B-NP O
: : O O
Premarin NNP B-NP B-treatment
vaginal JJ O I-treatment
once RB O O
a DT B-NP O
month NN I-NP O
, , O O
enalapril NN B-NP B-treatment
, , O O
Tylenol NNP B-NP B-treatment
, , O O
vitamins NNS B-NP B-treatment
, , O O
and CC O O
Halcion NNP B-NP B-treatment
at IN B-VP O
night NN B-NP O
. . B-VP O
   
ALLERGIES NNP B-NP O
: : O O
No DT B-NP O
known JJ I-NP B-problem
drug NN I-NP I-problem
allergies NNS I-NP I-problem
. . B-VP O
   
SOCIAL NNP B-NP O
HISTORY NN I-NP O
: : O O
She PRP O B-person
is VBZ O O
married JJ O O
and CC O O
lives VBZ O O
in IN B-VP O
an DT B-NP O
assisted JJ I-NP O
living NN I-NP O
facility NN I-NP O
with IN B-VP O
her PRP$ O B-person
her PRP$ O B-person
husband NN B-NP I-person
. . B-VP O
   
She PRP O B-person
has VBZ O O
five CD O O
grown JJ B-NP O
children NNS I-NP O
. . B-VP O
   
PHYSICAL JJ B-NP O
EXAMINATION NN I-NP O
: : O O
On IN B-VP O
exam NN B-NP B-test
she PRP O B-person
is VBZ O O
afebrile JJ O B-problem
. . B-VP O
   
Her PRP$ O B-person
Her NNP B-NP B-test
vital NN I-NP I-test
signs NNS I-NP I-test
are VBP O O
stable JJ O O
. . B-VP O
   
Baseline NNP B-NP B-test
blood NN I-NP I-test
pressure NN I-NP I-test
of IN B-VP O
144/61 CD O O
, , O O
heart NN B-NP B-test
rate NN I-NP I-test
of IN B-VP O
73 CD O O
, , O O
and CC O O
oxygen JJ B-NP B-test
saturation NN I-NP I-test
of IN B-VP O
96% CD O O
on IN B-VP O
room NN B-NP O
air NN I-NP O
. . B-VP O
   
She PRP O B-person
is VBZ O O
a DT B-NP O
pleasant JJ I-NP O
well NN I-NP O
appearing VBG O O
elderly JJ B-NP O
woman NN I-NP O
in IN B-VP O
no DT B-NP O
acute JJ I-NP B-problem
distress NN I-NP I-problem
. . B-VP O
   
Lungs NNS B-NP O
are VBP O O
clear JJ O O
to TO O O
auscultation VB O B-test
bilaterally RB O O
. . B-VP O
   
Heart NNP B-NP O
is VBZ O O
regular JJ O O
without IN B-VP O
murmurs NNS B-NP B-problem
, , O O
rubs NNS B-NP B-problem
, , O O
or CC O O
gallops NNS B-NP B-problem
. . B-VP O
   
Abdomen NNP B-NP O
is VBZ O O
soft JJ O O
, , O O
nontender NN B-NP B-problem
, , O O
and CC O O
nondistended VBD B-VP B-problem
. . B-VP O
   
Her PRP$ O B-person
extremities NNS B-NP O
are VBP O O
without IN B-VP O
edema NN B-NP B-problem
and CC O O
are VBP O O
warm JJ O O
. . B-VP O
   
HOSPITAL NNP B-NP O
COURSE NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
consented VBN O O
for IN B-VP O
surgery NN B-NP B-treatment
and CC O O
on IN B-VP O
the DT B-NP O
day NN I-NP O
of IN B-VP O
admission NN B-NP O
was VBD B-VP O
taken VBN O O
to TO O O
the DT B-NP O
operating NN I-NP O
room NN I-NP O
for IN B-VP O
transverse JJ B-NP B-treatment
colectomy NN I-NP I-treatment
for IN B-VP O
tumor NN B-NP B-problem
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
tolerated VBD B-VP O
the DT B-NP B-treatment
procedure NN I-NP I-treatment
well RB O O
and CC O O
there EX O O
are VBP O O
no DT B-NP O
complications NNS I-NP B-problem
. . B-VP O
   
Her PRP$ O B-person
postoperative JJ B-NP O
course NN I-NP O
was VBD B-VP O
unremarkable JJ O O
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
maintained VBN O O
on IN B-VP O
an DT O B-treatment
epidural JJ O I-treatment
and CC O O
PCA NNP B-NP B-treatment
for IN B-VP O
pain NN B-NP B-problem
control NN I-NP I-problem
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
kept VBN O O
NPO NNP B-NP B-treatment
initially RB O O
and CC O O
her PRP$ O B-person
diet NN B-NP O
was VBD B-VP O
slowly RB O O
advanced JJ O O
as IN B-VP O
tolerated VBN O O
. . B-VP O
   
When WRB O O
she PRP O B-person
was VBD B-VP O
taking VBG O O
clear JJ B-NP B-treatment
liquids NNS I-NP I-treatment
, , O O
her PRP$ O B-person
her PRP$ O B-treatment
pain NN B-NP I-treatment
medication NN I-NP I-treatment
was VBD B-VP O
switched VBN O O
to TO O O
p.o. VB O B-treatment
pain JJ B-NP I-treatment
regimen NNS I-NP I-treatment
with IN B-VP O
good JJ B-NP O
affect NN I-NP O
. . B-VP O
   
For IN B-VP O
blood NN B-NP B-treatment
pressure NN I-NP I-treatment
control NN I-NP I-treatment
she PRP O B-person
was VBD B-VP O
maintained VBN O O
on IN B-VP O
metoprolol NN B-NP B-treatment
at IN B-VP O
the DT B-NP O
request NN I-NP O
of IN B-VP O
her PRP$ O B-person
her PRP$ O B-person
primary JJ B-NP I-person
care NN I-NP I-person
physician NN I-NP I-person
and CC O O
enalapril NN B-NP B-treatment
was VBD B-VP O
discontinued VBN O O
. . B-VP O
   
With IN B-VP O
the DT B-NP O
help NN I-NP O
of IN B-VP O
physical JJ B-NP B-treatment
therapy NN I-NP I-treatment
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
ambulated VBN O O
and CC O O
on IN B-VP O
postoperative JJ O O
seven CD O O
, , O O
with IN B-VP O
the DT B-NP B-person
patient NN I-NP I-person
tolerating VBG O O
a DT B-NP B-treatment
post NN I-NP I-treatment
surgical JJ B-NP I-treatment
soft JJ I-NP I-treatment
diet NNS I-NP I-treatment
and CC O O
with IN B-VP O
pain NN B-NP B-problem
well RB O O
controlled VBN O O
on IN B-VP O
oral JJ B-NP B-treatment
pain NN I-NP I-treatment
medications NNS I-NP I-treatment
, , O O
she PRP O B-person
was VBD B-VP O
discharged VBN O O
to TO O O
rehabilitation VB O O
facility NN B-NP O
. . B-VP O
   
DISCHARGE NNP B-NP O
MEDICATIONS NNP I-NP O
: : O O
1. CD O O
Tylenol NNP B-NP B-treatment
650 CD O O
mg NN B-NP O
p.o. NN I-NP O
q.4.h. NN I-NP O
p.r.n. NN I-NP O
pain NN I-NP B-problem
. . B-VP O
   
2. CD O O
Metoprolol NNP B-NP B-treatment
25 CD O O
mg NN B-NP O
p.o. NN I-NP O
b.i.d. VBD B-VP O
3. CD O O
Motrin NNP B-NP B-treatment
400 CD O O
mg NN B-NP O
p.o. NN I-NP O
b.i.d. NN I-NP O
p.r.n. NN I-NP O
pain NN I-NP B-problem
. . B-VP O
   
4. CD O O
Halcion NNP B-NP B-treatment
0.25 CD O O
mg NN B-NP O
p.o. NN I-NP O
at IN B-VP O
night NN B-NP O
. . B-VP O
   
5. CD O O
Dulcolax NNP B-NP B-treatment
10 CD O O
to TO O O
20 CD O O
mg NNS B-NP O
PR NNP I-NP O
b.i.d. NN I-NP O
p.r.n. NN I-NP O
constipation NN I-NP B-problem
. . B-VP O
   
6. CD O O
Senna NNP B-NP B-treatment
2 CD O O
tablets NNS B-NP O
p.o. JJ B-NP O
b.i.d. JJ I-NP O
DISCHARGE NNP I-NP O
INSTRUCTIONS NNP I-NP O
: : O O
Consume VB O O
a DT O O
diet JJ O O
as IN B-VP O
tolerated JJ O O
avoiding VBG O O
carbonated VBN O O
beverages NNS B-NP O
. . B-VP O
   
Her PRP$ O B-person
activity NN B-NP O
level NN I-NP O
is VBZ O O
as RB O O
tolerated VBN O O
. . B-VP O
   
She PRP O B-person
is VBZ O O
to TO O O
contact VB O O
Dr. NNP B-NP B-person
Warm NNP I-NP I-person
&apos;s NNP I-NP I-person
office NN I-NP O
to TO O O
schedule VB O O
a DT B-NP O
follow NN I-NP O
up RP O O
appointment NN B-NP O
. . B-VP O
   
She PRP O B-person
is VBZ O O
to TO O O
also RB O O
call VB O O
the DT B-NP O
office NN I-NP O
if IN B-VP O
she PRP O B-person
has VBZ O O
any DT O O
fever RB O B-problem
greater JJR O I-problem
than IN B-VP I-problem
101 CD O I-problem
, , O O
bleeding VBG O B-problem
from IN B-VP I-problem
the DT B-NP I-problem
surgical JJ I-NP I-problem
wounds NNS I-NP I-problem
, , O O
or CC O O
pus NN B-NP B-problem
from IN B-VP I-problem
the DT B-NP I-problem
wounds NNS I-NP I-problem
. . B-VP O
   
She PRP O B-person
is VBZ O O
to TO O O
be VB O O
maintained VBN O O
on IN B-VP O
metoprolol NN B-NP B-treatment
for IN B-VP O
blood NN B-NP B-treatment
pressure NN I-NP I-treatment
control NN I-NP I-treatment
and CC O O
the DT B-NP O
restarting NN I-NP O
of IN B-VP O
her PRP$ O B-treatment
her PRP$ O B-person
ACE NNP B-NP I-treatment
inhibitor NN I-NP I-treatment
is VBZ O O
to TO O O
be VB O O
decided VBN O O
by IN B-VP O
her PRP$ O B-person
her PRP$ O B-person
primary JJ B-NP I-person
care NN I-NP I-person
physician NN I-NP I-person
. . B-VP O
   
ALEN NNP B-NP B-person
L NNP I-NP I-person
CREDKOTE NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
DICTATING NNP I-NP O
FOR NNP I-NP O
: : O O
Electronically RB O O
Signed VBD B-VP O
OIE NNP B-NP B-person
LIMOR NNP I-NP I-person
WARM NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
05/18/2004 CD O O
11:28 CD O O
_____________________________ NN B-NP O
OIE NNP I-NP B-person
LIMOR NNP I-NP I-person
WARM NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
TR NNP I-NP O
: : O O
ep JJ B-NP O
DD NNP I-NP O
: : O O
05/16/2004 CD O O
TD NN B-NP O
: : O O
05/16/2004 CD O O
7:28 CD O O
A DT O O
265076 CD O O
cc NN B-NP O
: : O O
OIE NNP B-NP B-person
LIMOR NNP I-NP I-person
WARM NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
CH NNP I-NP B-person
GILD NNP I-NP I-person
WARM NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
Admission NNP I-NP O
Date NNP I-NP O
: : O O
2013-11-21 JJ B-NP O
Discharge NN I-NP O
Date NNP I-NP O
: : O O
2013-11-26 JJ B-NP O
Date NNP I-NP O
of IN B-VP O
Birth NNP B-NP O
: : O O
1949-07-18 JJ B-NP O
Sex NN I-NP O
: : O O
F NNP B-NP O
Service NNP I-NP O
: : O O
PLASTIC NN B-NP O
Allergies NNS I-NP O
: : O O
Trazodone CD O B-treatment
/ NNP B-NP O
Ambien NNP I-NP B-treatment
/ NNP I-NP O
Sinequan NNP I-NP B-treatment
Attending NNP I-NP B-person
: : O O
Bobby NNP B-NP B-person
Z.S. NNP I-NP I-person
Ruiz NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
Chief NNP I-NP O
Complaint NNP I-NP O
: : O O
ACQUIRED VBP O B-problem
DEFECT NNP B-NP I-problem
FROM NNP I-NP O
BASAL NNP I-NP B-treatment
CELL NNP I-NP I-treatment
CARCINOMA NNP I-NP I-treatment
RESECTION NNP I-NP I-treatment
Major NNP I-NP O
Surgical NNP I-NP O
or CC O O
Invasive JJ B-NP O
Procedure NN I-NP O
: : O O
RIGHT RB O B-treatment
NOSE NNP B-NP I-treatment
/ NNP I-NP I-treatment
ALA NNP I-NP I-treatment
RECONSTRUCTION NNP I-NP I-treatment
USING NNP I-NP O
RIGHT NNP I-NP B-treatment
CHEEK NNP I-NP I-treatment
ADVANCEMENT NNP I-NP I-treatment
AND NNP I-NP O
FOREHEAD NNP I-NP B-treatment
LOCAL NNP I-NP I-treatment
FLAP NNP I-NP I-treatment
History NNP I-NP O
of IN B-VP O
Present NNP B-NP O
Illness NNP I-NP O
: : O O
MS. NNP B-NP B-person
Marshall NNP I-NP I-person
IS VBZ O O
A DT B-NP O
64-YEAR JJ I-NP O
OLD NNP I-NP O
, , O O
MENTALLY NNP B-NP B-problem
RETARDED NNP I-NP I-problem
, , O O
FEMALE NNP B-NP O
WHO NNP I-NP B-person
PRESENTED NNP I-NP O
WITH NNP I-NP O
AN NNP I-NP B-problem
AQUIRED NNP I-NP I-problem
DEFECT NNP I-NP I-problem
OF IN B-VP I-problem
THE NNP B-NP I-problem
RIGHT NNP I-NP I-problem
NASAL NNP I-NP I-problem
ALA NNP I-NP I-problem
AND NNP I-NP I-problem
MEDIAL NNP I-NP I-problem
CHEEK NNP I-NP I-problem
REGION NNP I-NP I-problem
AFTER NNP I-NP O
BASAL NNP I-NP B-problem
CELL NNP I-NP I-problem
CARCINOMA NNP I-NP I-problem
WAS NNP I-NP O
RESECTED NNP I-NP O
BY NNP I-NP O
DERMATOLOGY NNP I-NP B-person
. . B-VP O
   
Past NNP B-NP O
Medical JJ B-NP O
History NN I-NP O
: : O O
MENTAL NNP B-NP B-problem
RETARDATION NNP I-NP I-problem
DIABETES NNP I-NP B-problem
BIPOLAR NNP I-NP B-problem
DISORDER NNP I-NP I-problem
Social NNP I-NP O
History NNP I-NP O
: : O O
LIVES NNP B-NP O
IN NNP I-NP O
A NNP I-NP O
NURSING NNP I-NP O
HOME NNP I-NP O
, , O O
HAS NNP B-NP O
A NNP I-NP B-person
BROTHER NNP I-NP I-person
WHO NNP I-NP B-person
IS VBZ O O
THE NNP B-NP B-person
HEALTH NNP I-NP I-person
CARE NNP I-NP I-person
PROXY NNP I-NP I-person
. . B-VP O
   
NO NNP B-NP O
Tifany NNP I-NP O
, , O O
ETOH NNP B-NP O
, , O O
OR NNP B-NP O
REC NNP I-NP O
DRUG NNP I-NP O
USE NNP I-NP O
. . B-VP O
   
Physical JJ B-NP O
Exam NN I-NP O
: : O O
ON NNP B-NP O
PRESENTATION NNP I-NP O
, , O O
PT NNP B-NP B-person
WAS NNP I-NP O
AFEBRILE NNP I-NP B-problem
WITH NNP I-NP O
NORMAL NNP I-NP O
VITAL NNP I-NP O
SIGNS NNP I-NP O
GEN NNP I-NP O
: : O O
NO DT B-NP O
ACUTE NNP I-NP B-problem
DISTRESS NNP I-NP I-problem
, , O O
ABLE NNP B-NP O
TO NNP I-NP O
COMMUNICATE NNP I-NP O
AND NNP I-NP O
FOLLOW NNP I-NP O
ORDERS NNP I-NP O
HEAD NNP I-NP O
AND NNP I-NP O
NECK NNP I-NP O
: : O O
5 CD O B-problem
CM NNP B-NP I-problem
CIRCULAR NNP I-NP I-problem
FULL NNP I-NP I-problem
THICKNESS NNP I-NP I-problem
DEFECT NNP I-NP I-problem
AT NNP I-NP O
THE NNP I-NP O
JUNCTION NNP I-NP O
OF IN B-VP O
THE NNP B-NP O
RIGHT NNP I-NP O
ALA NNP I-NP O
AND NNP I-NP O
CHEEK NNP I-NP O
HEART NNP I-NP O
: : O O
REGULAR JJ B-NP O
RATE NN I-NP O
AND NNP I-NP O
RHYTHM NNP I-NP O
LUNGS NNP I-NP O
: : O O
CLEAR JJ B-NP O
TO NNP I-NP O
ASCULATION NNP I-NP B-test
ABDOMEN NNP I-NP O
: : O O
SOFT JJ O O
, , O O
NON-TENDER JJ O B-problem
, , O O
NON-DISTENDED JJ B-NP B-problem
EXTREMITIES NNP I-NP O
: : O O
NO DT B-NP O
EDEMA NNP I-NP B-problem
, , O O
CYANOSIS NNP B-NP B-problem
, , O O
FULL NNP B-NP O
RANGE NNP I-NP O
OF NNP I-NP O
MOTION NNP I-NP O
Brief NNP I-NP O
Hospital NNP I-NP O
Course NNP I-NP O
: : O O
UPON NNP B-NP O
ADMISSION NNP I-NP O
, , O O
THE NNP B-NP B-person
PATIENT NNP I-NP I-person
WAS NNP I-NP O
PRE-OP NNP I-NP O
'D POS O O
AND NNP B-NP O
MADE NNP I-NP O
NPO NNP I-NP B-treatment
/ NNP I-NP O
IVF NNP I-NP B-treatment
. . B-VP O
   
SHE NNP B-NP B-person
WENT VBD B-VP O
TO NNP B-NP O
SURGERY NNP I-NP B-treatment
THE NNP I-NP O
NEXT NNP I-NP O
MORNING NNP I-NP O
AND NNP I-NP O
TOLERATED NNP I-NP O
THE NNP I-NP B-treatment
SURGERY NNP I-NP I-treatment
WELL NNP I-NP O
. . B-VP O
   
HOWEVER NNP B-NP O
, , O O
SHE NNP B-NP B-person
WAS NNP I-NP O
SLOW NNP I-NP O
TO NNP I-NP O
AWAKE NNP I-NP O
FROM NNP I-NP O
ANESTHESIA NNP I-NP B-treatment
, , O O
AND NNP B-NP O
WAS NNP I-NP O
ADMITTED NNP I-NP O
TO NNP I-NP O
THE NNP I-NP O
CMED NNP I-NP O
CCU NNP I-NP O
OBSERVATION NNP I-NP B-test
. . B-VP O
   
SHE NNP B-NP B-person
WAS VBD B-VP O
TRANSFERED NNP B-NP O
TO NNP I-NP O
THE NNP I-NP O
FLOOR NNP I-NP O
POST-OP NNP I-NP O
DAY NNP I-NP O
2 CD O O
WHERE NNP B-NP O
SHE NNP I-NP B-person
HAD VBD B-VP O
BEEN NNP B-NP O
AFEBRILE NNP I-NP B-problem
WITH NNP I-NP O
NORMAL NNP I-NP O
VITALS NNP I-NP O
, , O O
MAKING NNP B-NP O
GOOD NNP I-NP O
URINE NNP I-NP O
, , O O
AND NNP B-NP O
TOLERATING NNP I-NP O
A NNP I-NP O
REGULAR NNP I-NP O
DIET NNP I-NP O
. . B-VP O
   
HER PRP$ O B-problem
HER NNP B-NP B-person
WOUND NNP I-NP I-problem
HAS NNP I-NP O
REMAIND NNP I-NP O
DRY NNP I-NP O
AND NNP I-NP O
CLOSED NNP I-NP O
, , O O
WITHOUT NNP B-NP O
EVIDENCE NNP I-NP O
OF NNP I-NP O
INFECTION NNP I-NP B-problem
OR NNP I-NP O
BREAKDOWN NNP I-NP B-problem
. . B-VP O
   
SHE NNP B-NP B-person
HAS VBZ O O
BEEN VBN O O
WATCHED NNP B-NP O
BY NNP I-NP O
A NNP I-NP B-person
SITTER NNP I-NP I-person
AT NNP I-NP O
ALL NNP I-NP O
TIMES NNP I-NP O
. . B-VP O
   
SHE NNP B-NP B-person
WILL MD O O
BE VB O O
DISCHARGED VBN O O
TODAY NNP B-NP O
BACK NNP I-NP O
TO NNP I-NP O
HER NNP I-NP B-person
NURSING NNP I-NP O
HOME NNP I-NP O
IN NNP I-NP O
GOOD NNP I-NP O
CONDITION NNP I-NP O
, , O O
ON NNP B-NP O
PAIN NNP I-NP B-treatment
MEDS NNP I-NP I-treatment
, , O O
ANTIBIOTICS NNP B-NP B-treatment
, , O O
AND NNP B-NP O
WITH NNP I-NP O
ANTICIPATED NNP I-NP O
1:1 CD O O
WATCH NNP B-NP O
. . B-VP O
   
SHE NNP B-NP B-person
WILL VBD B-VP O
FOLLOW NNP B-NP O
UP NNP I-NP O
WITH NNP I-NP O
DR. NNP I-NP B-person
Karen NNP I-NP I-person
IN NNP I-NP O
1 CD O O
WEEK NNP B-NP O
. . B-VP O
   
STAGE NNP B-NP O
TWO NNP I-NP O
OF IN B-VP O
HER NNP B-NP B-person
HER NNP I-NP B-treatment
SURGERY NNP I-NP I-treatment
WILL MD O O
BE VB O O
DONE NNP B-NP O
IN NNP I-NP O
3 CD O O
WEEKS NNP B-NP O
. . B-VP O
   
Discharge NNP B-NP O
Medications NNPS I-NP O
: : O O
1. CD O O
Paroxetine NNP B-NP B-treatment
HCl NNP I-NP I-treatment
10 CD O O
mg NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Tablet NNP B-NP O
PO NNP I-NP O
AM NNP I-NP O
(). NNP I-NP O
2. CD O O
Multivitamin NNP B-NP B-treatment
Capsule NNP I-NP I-treatment
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Cap NNP B-NP O
PO NNP I-NP O
QAM NNP I-NP O
( ( O O
once RB O O
a DT B-NP O
day NN I-NP O
( ( O O
in IN B-VP O
the DT B-NP O
morning NN I-NP O
)). NN I-NP O
3. CD O O
Divalproex NNP B-NP B-treatment
Sodium NNP I-NP I-treatment
500 CD O O
mg NN B-NP O
Tablet NNP I-NP O
, , O O
Delayed NNP B-NP O
Release NNP I-NP O
( ( O O
E.C. NNP B-NP O
) ) O O
Sig NN B-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Tablet NN B-NP O
, , O O
Delayed NNP B-NP O
Release NNP I-NP O
( ( O O
E.C. NNP B-NP O
) ) O O
PO NNP B-NP O
QAM NNP I-NP O
( ( O O
once RB O O
a DT B-NP O
day NN I-NP O
( ( O O
in IN B-VP O
the DT B-NP O
morning NN I-NP O
)). NN I-NP O
4. CD O O
Docusate NNP B-NP B-treatment
Sodium NNP I-NP I-treatment
100 CD O O
mg NN B-NP O
Capsule NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Capsule NNP B-NP O
PO NNP I-NP O
BID NNP I-NP O
( ( O O
2 CD O O
times NNS B-NP O
a DT B-NP O
day NN I-NP O
) ) O O
as IN B-VP O
needed VBN O O
: : O O
constipation NN B-NP B-problem
. . B-VP O
   
Disp NNP B-NP O
:* VBD B-VP O
30 CD O O
Capsule NNP B-NP O
(s)* NNP I-NP O
Refills NNP I-NP O
:* VBZ O O
0 CD O O
* NN B-NP O
5. CD O O
Triamcinolone NNP B-NP B-treatment
Acetonide NNP I-NP I-treatment
0.1 CD O O
% NN B-NP O
Cream NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Appl NNP B-NP O
Topical NNP I-NP O
BID NNP I-NP O
( ( O O
2 CD O O
times NNS B-NP O
a DT B-NP O
day NN I-NP O
). POS O O
6. CD O O
Divalproex NNP B-NP B-treatment
Sodium NNP I-NP I-treatment
Oral NNP I-NP O
7. CD O O
Atorvastatin NNP B-NP B-treatment
10 CD O O
mg NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Tablet NNP B-NP O
PO NNP I-NP O
HS NNP I-NP O
( ( O O
at IN B-VP O
bedtime NN B-NP O
). $ O O
8. CD O O
Oxybutynin NNP B-NP B-treatment
Chloride NNP I-NP I-treatment
5 CD O O
mg NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Tablet NNP B-NP O
PO NNP I-NP O
QPM NNP I-NP O
( ( O O
once RB O O
a DT B-NP O
day NN I-NP O
( ( O O
in IN B-VP O
the DT B-NP O
evening NN I-NP O
)). JJ O O
9. CD O O
Hydrocodone-Acetaminophen JJ B-NP B-treatment
5-500 JJ I-NP O
mg NN I-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
1-2 JJ B-NP O
Tablets NNS I-NP O
PO NNP I-NP O
Q4H NNP I-NP O
( ( O O
every DT O O
4 CD O O
hours NNS B-NP O
). JJ B-NP O
Disp NNP I-NP O
:* NNP I-NP O
40 CD O O
Tablet NNP B-NP O
(s)* NNP I-NP O
Refills NNP I-NP O
:* VBZ O O
0 CD O O
* JJ O O
10. CD O O
Bacitracin-Polymyxin-Neosp JJ B-NP B-treatment
HC NNP I-NP I-treatment
Ointment NNP I-NP I-treatment
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Topical NNP B-NP O
three CD O O
times NNS B-NP O
a DT B-NP O
day NN I-NP O
. . B-VP O
   
Disp NNP B-NP O
:* VBD B-VP O
1 CD O O
500 CD O O
/ JJ B-NP O
gram NN I-NP O
* NNP I-NP O
Refills NNP I-NP O
:* VBZ O O
2 CD O O
* NN B-NP O
Discharge NNP I-NP O
Disposition NNP I-NP O
: : O O
Extended VBN O O
Care NNP B-NP O
Discharge NNP I-NP O
Diagnosis NNP I-NP O
: : O O
AQUIRED NNP B-NP B-problem
DEFORMITY NNP I-NP I-problem
OF IN B-VP I-problem
THE NNP B-NP I-problem
RIGHT NNP I-NP I-problem
ALA NNP I-NP I-problem
/ NNP I-NP I-problem
NOSE NNP I-NP I-problem
AND NNP I-NP I-problem
MEDIAL NNP I-NP I-problem
CHEEK NNP I-NP I-problem
FROM NNP I-NP O
BASAL NNP I-NP B-treatment
CELL NNP I-NP I-treatment
CARCINOMA NNP I-NP I-treatment
RESECTION NNP I-NP I-treatment
Discharge NNP I-NP O
Condition NNP I-NP O
: : O O
GOOD JJ B-NP O
Discharge NN I-NP O
Instructions NNS I-NP O
: : O O
PLEASE NNP B-NP O
GIVE NNP I-NP O
PATIENT NNP I-NP B-person
MEDICATIONS NNP I-NP B-treatment
AS NNP I-NP O
PRESCRIBED NNP I-NP O
AND NNP I-NP O
READ NNP I-NP O
WARNING NNP I-NP O
LABELS NNP I-NP O
CAREFULLY NNP I-NP O
. . B-VP O
   
IF NNP B-NP O
SIGNS NNP I-NP B-problem
AND NNP I-NP I-problem
SYMPTOMS NNP I-NP I-problem
OF NNP I-NP O
INFECTION NNP I-NP B-problem
, , O O
SUCH NNP B-NP O
AS IN B-VP O
FEVERS NNP B-NP B-problem
/ NNP I-NP O
CHILLS NNP I-NP B-problem
, , O O
PURULENT NNP B-NP B-problem
DISCHARGE NNP I-NP I-problem
FROM NNP I-NP I-problem
WOUND NNP I-NP I-problem
/ NNP I-NP I-problem
INCISION NNP I-NP I-problem
SITE NNP I-NP I-problem
, , O O
INCREASED NNP B-NP B-problem
REDNESS NNP I-NP I-problem
, , O O
INCREASED NNP B-NP B-problem
PAIN NNP I-NP I-problem
, , O O
PLEASE NNP B-NP O
CALL NNP I-NP O
OR NNP I-NP O
GO NNP I-NP O
TO NNP I-NP O
THE NNP I-NP O
EMERGENCY NNP I-NP O
ROOM NNP I-NP O
. . B-VP O
   
REMEMBER VB O O
TO NNP B-NP O
CALL NNP I-NP O
TO NNP I-NP O
SCHEDULE NNP I-NP O
HER NNP I-NP B-person
FOLLOW NNP I-NP O
UP NNP I-NP O
APPOINTMENT NNP I-NP O
( ( O O
BELOW NNP B-NP O
). NNP I-NP O
LIGHT NNP I-NP O
ACTIVITIES NNP I-NP O
UNTIL NNP I-NP O
SEEN NNP I-NP O
IN NNP I-NP O
CLINIC NNP I-NP O
. . B-VP O
   
STAGE NNP B-NP O
2 CD O O
OF IN B-VP O
THE DT B-NP B-treatment
SURGERY NNP I-NP I-treatment
WILL MD O O
BE VB O O
DONE NNP B-NP O
IN NNP I-NP O
3 CD O O
WEEKS NNP B-NP O
. . B-VP O
   
MAY NNP B-NP O
SHOWER NNP I-NP O
-- : O O
DAB NNP B-NP O
DRY NNP I-NP O
, , O O
DO NNP B-NP O
NOT NNP I-NP O
SCRUB NNP I-NP O
. . B-VP O
   
PLEASE NNP B-NP O
CLEAN NNP I-NP O
INCISION NNP I-NP B-problem
SITE NNP I-NP I-problem
WITH NNP I-NP O
NORMAL NNP I-NP B-treatment
SALINE NNP I-NP I-treatment
OR NNP I-NP O
CLEAN NNP I-NP O
WATER NNP I-NP O
THREE NNP I-NP O
TIMES NNP I-NP O
A NNP I-NP O
DAY NNP I-NP O
AND NNP I-NP O
PLACE NNP I-NP O
ANTIBIOTIC NNP I-NP B-treatment
OINTMENT NNP I-NP I-treatment
( ( O O
GIVEN NNP B-NP O
) ) O O
ON NNP B-NP O
TOP NNP I-NP O
OF NNP I-NP O
WOUND NNP I-NP B-problem
. . B-VP O
   
PLEASE NNP B-NP O
KEEP NNP I-NP O
PATIENT NNP I-NP B-person
AWAY NNP I-NP O
FROM IN B-VP O
THE NNP B-NP O
SUN NNP I-NP O
. . B-VP O
   
MOST JJS B-NP O
IMPORTANTLY NNP I-NP O
, , O O
THE NNP B-NP B-person
PATIENT NNP I-NP I-person
MUST NNP I-NP O
BE NNP I-NP O
WATCH NNP I-NP O
ONE-ON-ONE NNP I-NP O
SO NNP I-NP O
THAT IN B-VP B-pronoun
SHE NNP B-NP B-person
DOES NNP I-NP O
NOT NNP I-NP O
PICK NNP I-NP O
AT NNP I-NP O
HER NNP I-NP B-problem
HER NNP I-NP B-person
WOUND NNP I-NP I-problem
. . B-VP O
   
Followup NNP B-NP O
Instructions NNPS I-NP O
: : O O
PLEASE VB O O
CALL NNP B-NP O
DR.Parson NNP I-NP B-person
OFFICE NNP I-NP O
FOR NNP I-NP O
A NNP I-NP O
FOLLOW NNP I-NP O
UP NNP I-NP O
( ( O O
989-5361 CD O O
Mauricio NNP B-NP O
( ( O O
540-4644 JJ B-NP O
Nancy NNP I-NP B-person
Lois NNP I-NP I-person
MD NNP I-NP I-person
88-449 CD O O
Completed VBN O O
by IN B-VP O
: : O O
Mary NNP B-NP B-person
Lisa NNP I-NP I-person
MD NNP I-NP I-person
53-914 JJ B-NP O
2013-11-26 JJ I-NP O
@ NN I-NP O
1134 CD O O
Signed NNP B-NP O
electronically RB O O
by IN B-VP O
: : O O
DR. NNP B-NP B-person
David NNP I-NP I-person
Randazzo NNP I-NP I-person
on IN B-VP O
: : O O
MON NNP B-NP O
2013-12-16 CD O O
7:25 CD O O
AM NNP B-NP O
( ( O O
End NNP B-NP O
of IN B-VP O
Report NNP B-NP O
) ) O O
-EMPTYLINE- VBP O O
-DOCSTART- JJ O O
-EMPTYLINE- $ O O
190510002 CD O O
TGCHO NNP B-NP O
3067319 CD O O
364639 CD O O
3/16/2003 CD O O
12:00:00 CD O O
AM NNP B-NP O
ED NNP I-NP O
Discharge NNP I-NP O
Summary NNP I-NP O
Unsigned VBD B-VP O
DIS NNP B-NP O
Report NNP I-NP O
Status NNP I-NP O
: : O O
Unsigned VBD B-VP O
ED NNP B-NP O
DISCHARGE NNP I-NP O
NOTIFICATION NNP I-NP O
KOTE NNP I-NP B-person
, , O I-person
LYFRANKLAPALM NNP B-NP I-person
MRN NNP I-NP O
: : O O
3067319 CD O O
Age NNP B-NP O
: : O O
56y CD O O
REGISTRATION NNP B-NP O
DATE NNP I-NP O
: : O O
03/16/2003 CD O O
05:16 CD O O
PM NNP B-NP O
PRELIMINARY NNP I-NP O
REPORT NNP I-NP O
This DT O B-pronoun
is VBZ O O
to TO O O
notify VB O O
you PRP O B-person
that IN B-VP B-pronoun
your PRP$ O B-person
your PRP$ O B-person
patient NN B-NP I-person
, , O O
KOTE NNP B-NP B-person
, , O I-person
LYFRANKLAPALM NNP B-NP I-person
arrived VBD B-VP O
in IN B-VP O
the DT B-NP O
Emergency NNP I-NP O
Department NNP I-NP O
at IN B-VP O
Tecal NNP B-NP O
Galecounxopt NNP I-NP O
Community NNP I-NP O
Hospital NNP I-NP O
on IN B-VP O
03/16/2003 CD O O
05:16 CD O O
PM NNP B-NP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
presented VBN O O
with IN B-VP O
a DT B-NP O
chief JJ I-NP O
complaint NN I-NP O
of IN B-VP O
INCREASED NNP B-NP B-problem
LETHARGY NNP I-NP I-problem
. . B-VP O
   
Following VBG O O
evaluation NN B-NP B-test
and CC O O
treatment NN B-NP B-treatment
, , O O
the DT B-NP B-person
patient NN I-NP I-person
&apos;s JJ B-NP O
disposition NN I-NP O
at IN B-VP O
the DT B-NP O
end NN I-NP O
of IN B-VP O
the DT B-NP O
visit NN I-NP O
was VBD B-VP O
ADMITTED NNP B-NP O
AS IN B-VP O
AN NNP B-NP O
INPATIENT NNP I-NP O
TO NNP I-NP O
TECAL NNP I-NP O
GALENCOUNXOPT NNP I-NP O
COMMUNITY NNP I-NP O
HOSPITAL NNP I-NP O
. . B-VP O
   
The DT O B-person
The DT B-NP B-person
patient JJ I-NP I-person
patient NN I-NP I-person
&apos;s NNP I-NP I-person
preliminary JJ O I-person
admitting VBG O I-person
physician NN B-NP I-person
is VBZ O O
SCIMEWHILDAJESC NNP B-NP B-person
, , O I-person
LA NNP B-NP I-person
R NNP I-NP I-person
and CC O O
the DT B-NP O
preliminary JJ I-NP O
diagnosis NN I-NP O
is VBZ O O
DEHYDRATION NNP B-NP B-problem
.. NNP I-NP O
Please NNP I-NP O
note VB O O
this DT B-NP B-pronoun
information NN I-NP O
may MD O O
have VB O O
been VBN O O
updated VBN O O
on IN B-VP O
the DT B-NP O
inpatient JJ I-NP O
unit NN I-NP O
. . B-VP O
   
If IN B-VP O
you PRP O B-person
need VBP O O
additional JJ B-NP O
information NN I-NP O
please NN I-NP O
call VB O O
418-196-2156 JJ O O
. . B-VP O
   
PCP NNPS B-NP B-person
Name NN I-NP O
: : O O
NONE NN B-NP O
, , O O
PHYSICIAN NNP B-NP O
Provider NNP I-NP O
Number NNP I-NP O
: : O O
75055 CD O O
-EMPTYLINE- NN B-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
﻿Admission NN I-NP O
Date NNP I-NP O
: : O O
2015-10-10 JJ B-NP O
Discharge NN I-NP O
Date NNP I-NP O
: : O O
2015-10-21 JJ B-NP O
Date NNP I-NP O
of IN B-VP O
Birth NNP B-NP O
: : O O
1953-07-19 JJ B-NP O
Sex NN I-NP O
: : O O
M NNP B-NP O
Service NNP I-NP O
: : O O
CMED NNP B-NP O
CSRU NNP I-NP O
Allergies NNPS I-NP O
: : O O
Coumadin NNP B-NP B-treatment
Attending NNP I-NP O
: : O O
James NNP B-NP B-person
I PRP O I-person
Schultz, NNP B-NP I-person
M.D. NNP I-NP I-person
Chief NNP I-NP O
Complaint NNP I-NP O
: : O O
fever NN B-NP B-problem
, , O O
left VBD B-VP B-problem
lower JJR B-NP I-problem
extremity NN I-NP I-problem
redness NN I-NP I-problem
, , O O
dysuria NN B-NP B-problem
, , O O
inability NN B-NP B-problem
to TO O I-problem
urinate VB O I-problem
Major NNP B-NP O
Surgical NNP I-NP O
or CC O O
Invasive JJ B-NP O
Procedure NN I-NP O
: : O O
Transesophageal JJ B-NP B-test
Echocardiogram NNP I-NP I-test
History NNP I-NP O
of IN B-VP O
Present NNP B-NP O
Illness NNP I-NP O
: : O O
62 CD O O
year-old JJ B-NP O
status-post JJ I-NP O
gastric JJ I-NP B-treatment
bypass NN I-NP I-treatment
and CC O O
laprascopic NN B-NP B-treatment
cholecystectomy VBP O I-treatment
7 CD O O
weeks NNS B-NP O
prior RB O O
to TO O O
admission NN B-NP O
who WP O B-person
presented VBD B-VP O
with IN B-VP O
fever NN B-NP B-problem
, , O O
chills NNS B-NP B-problem
, , O O
and CC O O
left VBD B-VP B-problem
lower JJR B-NP I-problem
extemity NN I-NP I-problem
redness NN I-NP I-problem
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
has VBZ O O
a DT B-NP O
history NN I-NP O
of IN B-VP O
multiple JJ B-NP O
hospitalizations NNS I-NP O
for IN B-VP O
lower JJR B-NP B-problem
extremity NN I-NP I-problem
cellulitis NN I-NP I-problem
and CC O O
noted VBD B-VP O
that IN B-VP B-pronoun
his PRP$ O B-person
his PRP$ O B-problem
symptoms NNS B-NP I-problem
and CC O O
the DT B-NP O
appearance NN I-NP O
of IN B-VP O
his PRP$ O B-person
left JJ B-NP O
leg NN I-NP O
mirrored VBD B-VP O
previous JJ B-NP B-problem
episodes NNS I-NP I-problem
. . B-VP O
   
He PRP O B-person
denied VBD B-VP O
recent JJ B-NP B-problem
trauma NN I-NP I-problem
to TO O I-problem
the DT B-NP I-problem
area NN I-NP I-problem
or CC O O
travel NN B-NP O
. . B-VP O
   
Review NNP B-NP B-test
of IN B-VP I-test
systems NNS B-NP I-test
was VBD B-VP O
significant JJ O O
only RB O O
for IN B-VP O
painful JJ B-NP B-problem
urination NN I-NP I-problem
over IN B-VP O
the DT B-NP O
past JJ I-NP O
few JJ I-NP O
days NNS I-NP O
and CC O O
a DT B-NP B-problem
reduction NN I-NP I-problem
in IN B-VP I-problem
urine JJ B-NP I-problem
output NN I-NP I-problem
. . B-VP O
   
He PRP O B-person
denied VBD B-VP O
chest JJS B-NP B-problem
pain NN I-NP I-problem
, , O O
shortness NN B-NP B-problem
of IN B-VP I-problem
breath NN B-NP I-problem
, , O O
palpitations NNS B-NP B-problem
, , O O
abdominal JJ B-NP B-problem
pain NN I-NP I-problem
, , O O
N/V NNP B-NP B-problem
, , O O
penile JJ B-NP B-problem
discharge NN I-NP I-problem
. . B-VP O
   
Past NNP B-NP O
Medical JJ B-NP O
History NN I-NP O
: : O O
1. CD O O
Morbid NNP B-NP B-problem
obesity NN I-NP I-problem
2. CD O O
Frequent NNP B-NP B-problem
cellulitis NN I-NP I-problem
3. CD O O
Lymphedema NNP B-NP B-problem
. . B-VP O
   
4. CD O O
CAD NNP B-NP B-problem
s/p NN I-NP O
velocity NN I-NP B-treatment
stenting VBG O I-treatment
proximal JJ B-NP I-treatment
LAD NNP I-NP I-treatment
2002 CD O O
5. CD O O
Osteoarthritis NN B-NP B-problem
of IN B-VP I-problem
the DT B-NP I-problem
knees NNS I-NP I-problem
6. CD O O
Hypertension NNP B-NP B-problem
7. CD O O
Hypercholesterolemia NNP B-NP B-problem
8. CD O O
Obstructive NNP B-NP B-problem
sleep NN I-NP I-problem
apnea NN I-NP I-problem
9. CD O O
CVA NNP B-NP B-problem
x2 NN I-NP O
with IN B-VP O
left-sided JJ B-NP B-problem
weakness NN I-NP I-problem
10. CD O O
Gastric NNP B-NP B-treatment
bypass NN I-NP I-treatment
surgery NN I-NP I-treatment
7 CD O O
weeks NNS B-NP O
PTA NNP I-NP O
11. CD O O
Lap NNP B-NP B-treatment
cholecystectomy VBD B-VP I-treatment
7 CD O O
weeks NNS B-NP O
PTA NNP I-NP O
Physical NNP I-NP O
Exam NNP I-NP O
: : O O
VS NNP B-NP B-test
T NNP I-NP O
101.4 CD O O
BP NNP B-NP B-test
85/50 CD O O
HR NNP B-NP B-test
130 CD O O
RR NNP B-NP B-test
20 CD O O
O2 NNP B-NP B-test
Sat NNP I-NP I-test
: : O O
98% CD O O
RA NNP B-NP O
GEN NNP I-NP O
: : O O
Obese JJ B-NP B-problem
male NN I-NP O
, , O O
AAOx3 NNP B-NP O
HEENT NNP I-NP O
: : O O
MM NNP B-NP B-problem
dry NN I-NP I-problem
, , O O
JVD NNP B-NP B-problem
cannot NN I-NP O
be VB O O
assessed VBN O O
CV NNP B-NP O
: : O O
Irregularly RB O B-problem
irregular JJ B-NP I-problem
rhytmm NN I-NP I-problem
, , O O
no DT B-NP O
m/r/g NN I-NP B-problem
Chest NNP I-NP O
: : O O
CTAB NNP B-NP O
ABD NNP I-NP O
: : O O
Obese JJ O B-problem
, , O O
NT/ND NNP B-NP B-problem
, , O O
no DT O O
rebound/guarding VBG O B-problem
EXT NN B-NP O
: : O O
3+ CD O B-problem
bilateral JJ B-NP I-problem
edema NN I-NP I-problem
, , O O
LLE NNP B-NP B-problem
edema NN I-NP I-problem
and CC O O
erythema NN B-NP B-problem
, , O O
no DT B-NP O
chords NNS I-NP B-problem
, , O O
+ NNP B-NP O
warmth NN I-NP B-problem
, , O O
+ NNP B-NP O
chronic VBZ O B-problem
venous JJ B-NP I-problem
changes NNS I-NP I-problem
, , O O
negative JJ B-NP O
Homens NNP I-NP O
Pertinent NNP I-NP O
Results NNP I-NP O
: : O O
2015-10-10 JJ O O
02:16PM CD O O
WBC NNP B-NP B-test
- : O O
6.3 CD O O
RBC NNP B-NP B-test
- : O O
4.90 CD O O
HGB NNP B-NP B-test
- : O O
14.1 CD O O
HCT NNP B-NP B-test
- : O O
41.0 CD O O
MCV NNP B-NP B-test
- : O O
84 CD O O
MCH NNP B-NP B-test
- : O O
28.7 CD O O
MCHC NNP B-NP B-test
- : O O
34.4 CD O O
RDW NNP B-NP B-test
- : O O
15.0 CD O O
2015-10-10 JJ O O
02:16PM CD O O
NEUTS NNP B-NP B-test
- : O O
92 CD O O
* NN B-NP O
BANDS NNP I-NP B-test
- : O O
4 CD O O
LYMPHS NNP B-NP B-test
- : O O
2 CD O O
* JJ B-NP O
MONOS NNP I-NP B-test
- : O O
2 CD O O
EOS NNP B-NP B-test
- : O O
0 CD O O
BASOS NNP B-NP B-test
- : O O
0 CD O O
ATYPS NNP B-NP B-test
- : O O
0 CD O O
METAS NNP B-NP B-test
- : O O
0 CD O O
MYELOS NNP B-NP B-test
- : O O
0 CD O O
2015-10-10 JJ O O
02:16PM CD O O
PLT NNP B-NP B-test
SMR NNP I-NP I-test
- : O O
NORMAL NNP B-NP O
PLT NNP I-NP B-test
COUNT NNP I-NP I-test
- : O O
143 CD O O
*# JJ O O
2015-10-10 JJ O O
02:16PM CD O O
URINE NNP B-NP B-test
BLOOD NNP I-NP B-test
- : O O
NEG NNP B-NP O
NITRITE NNP I-NP B-test
- : O O
NEG NNP B-NP O
PROTEIN NNP I-NP B-test
- : O O
NEG NNP B-NP O
GLUCOSE NNP I-NP B-test
- : O O
NEG NNP B-NP O
KETONE NNP I-NP B-test
- : O O
NEG NNP B-NP O
BILIRUBIN NNP I-NP B-test
- : O O
NEG NNP B-NP O
UROBILNGN NNP I-NP B-test
- : O O
NEG NNP B-NP O
PH NNP I-NP B-test
- : O O
5.0 CD O O
LEUK NNP B-NP B-test
- : O O
SM NNP B-NP O
2015-10-10 JJ O O
02:16PM CD O O
CALCIUM NNP B-NP B-test
- : O O
9.6 CD O O
PHOSPHATE NNP B-NP B-test
- : O O
0.8 CD O O
*# JJ B-NP O
MAGNESIUM NNP I-NP B-test
- : O O
1.4 CD O O
* JJ O O
2015-10-10 JJ O O
02:16PM CD O O
CK-MB JJ O B-test
- : O O
2 CD O O
cTropnT NN B-NP B-test
-< VBD B-VP O
0.01 CD O O
2015-10-10 JJ O O
02:16PM CD O O
CK(CPK) NNP B-NP B-test
- : O O
109 CD O O
2015-10-10 JJ O O
02:34PM CD O O
LACTATE NNP B-NP B-test
- : O O
2.4 CD O O
* JJ O O
2015-10-10 JJ O O
07:42PM CD O O
PT NNP B-NP B-test
- : O O
16.6 CD O O
* NN B-NP O
PTT NNP I-NP B-test
- : O O
32.2 CD O O
INR(PT) NNP B-NP B-test
- : O O
1.7 CD O O
2015-10-10 JJ O O
07:42PM CD O O
ALBUMIN NNP B-NP B-test
- : O O
3.0 CD O O
* JJ B-NP O
CALCIUM NNP I-NP B-test
- : O O
7.6 CD O O
* NN B-NP O
PHOSPHATE NNP I-NP B-test
- : O O
1.6 CD O O
* JJ B-NP O
MAGNESIUM NNP I-NP B-test
- : O O
1.1 CD O O
* JJ O O
2015-10-10 JJ O O
07:42PM CD O O
ALT(SGPT) NNP B-NP B-test
- : O O
28 CD O O
AST(SGOT) NNP B-NP B-test
- : O O
27 CD O O
LD(LDH) NNP B-NP B-test
- : O O
191 CD O O
CK(CPK) NNP B-NP B-test
- : O O
58 CD O O
ALK NNP B-NP B-test
PHOS NNP I-NP I-test
- : O O
63 CD O O
AMYLASE NNP B-NP B-test
- : O O
27 CD O O
TOT NNP B-NP B-test
BILI NNP I-NP I-test
- : O O
0.9 CD O O
2015-10-10 JJ O O
08:19PM CD O O
LACTATE NNP B-NP B-test
- : O O
1.9 CD O O
Brief JJ B-NP O
Hospital JJ I-NP O
Course NN I-NP O
: : O O
This DT O B-pronoun
This DT O B-person
62 CD O I-person
year-old JJ B-NP I-person
obese JJ I-NP B-problem
obese JJ I-NP I-person
male JJ I-NP I-problem
male NN I-NP I-person
was VBD B-VP I-person
admitted VBN O O
with IN B-VP O
cellulitis NN B-NP B-problem
and CC O O
presumed JJ B-NP O
bacteremia NN I-NP B-problem
. . B-VP O
   
In IN B-VP O
the DT B-NP O
John NNP I-NP O
, , O O
he PRP O B-person
was VBD B-VP O
found VBN O O
to TO O O
be VB O O
in IN B-VP O
hypotensive JJ B-NP B-problem
atrial JJ I-NP I-problem
fibrillation NN I-NP I-problem
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
admitted VBN O O
to TO O O
the DT B-NP O
Medical NNP I-NP O
ICU NNP I-NP O
where WRB O O
his PRP$ O B-person
his PRP$ O B-problem
hypotension NN B-NP I-problem
was VBD B-VP O
managed VBN O O
with IN B-VP O
IVF NNP B-NP B-treatment
hydration NN I-NP I-treatment
and CC O O
he PRP O B-person
was VBD B-VP O
maintained VBN O O
on IN B-VP O
a DT B-NP B-treatment
diltiazam NN I-NP I-treatment
drip NN I-NP I-treatment
for IN B-VP O
atrial JJ B-NP B-problem
fibrillation NN I-NP I-problem
. . B-VP O
   
After IN B-VP O
his PRP$ O B-person
his PRP$ O B-test
heart NN B-NP I-test
rate NN I-NP I-test
was VBD B-VP O
controlled VBN O O
, , O O
he PRP O B-person
was VBD B-VP O
transitioned VBN O O
to TO O O
oral JJ B-NP B-treatment
medications NNS I-NP I-treatment
and CC O O
transferred VBN O O
to TO O O
the DT B-NP O
medicine NN I-NP O
service NN I-NP O
. . B-VP O
   
1. CD O O
Cellulitis NNP B-NP B-problem
/ NNP I-NP O
Bacteremia NNP I-NP B-problem
Review NNP I-NP O
of IN B-VP O
the DT B-NP O
medical JJ I-NP O
record NN I-NP O
revealed VBD B-VP O
several JJ B-NP O
previous JJ I-NP O
admissions NNS I-NP O
for IN B-VP O
cellulitis NN B-NP B-problem
and CC O O
bacteremia NN B-NP B-problem
. . B-VP O
   
Blood NNP B-NP B-test
cultures NNS I-NP I-test
on IN B-VP O
this DT B-NP B-pronoun
admission NN I-NP O
and CC O O
were VBD B-VP O
positive JJ O O
for IN B-VP O
Beta NNP B-NP B-problem
streptococcus NN I-NP I-problem
Group NNP I-NP I-problem
B NNP I-NP I-problem
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
had VBD B-VP O
previous JJ B-NP O
episodes NNS I-NP O
of IN B-VP O
the DT B-NP B-problem
same JJ I-NP I-problem
infection NN I-NP I-problem
, , O O
with IN B-VP O
lower JJR B-NP B-problem
extremity NN I-NP I-problem
cellulitis NN I-NP I-problem
the DT B-NP O
likely JJ I-NP O
source NN I-NP O
. . B-VP O
   
A DT B-NP B-test
left JJ I-NP I-test
lower JJR I-NP I-test
extremity NN I-NP I-test
ultrasound NN I-NP I-test
was VBD B-VP O
negative JJ O O
for IN B-VP O
deep JJ B-NP B-problem
venous JJ I-NP I-problem
thrombosis NN I-NP I-problem
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
too RB O O
large JJ O O
to TO O O
have VB O O
a DT B-NP B-test
CTA NNP I-NP I-test
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
initially RB O O
treated VBN O O
with IN B-VP O
vancomycin NN B-NP B-treatment
and CC O O
zosyn NN B-NP B-treatment
while IN B-VP O
awaiting VBG O O
culture NN B-NP B-test
results NNS I-NP O
. . B-VP O
   
Once IN B-VP O
the DT B-NP B-problem
organism NN I-NP I-problem
was VBD B-VP O
identified VBN O O
, , O O
he PRP O B-person
was VBD B-VP O
transitioned VBN O O
to TO O O
a DT B-NP O
regimen NN I-NP O
of IN B-VP O
intravenous JJ B-NP B-treatment
penicillin NN I-NP I-treatment
and CC O O
oral JJ B-NP B-treatment
levofloxacin NN I-NP I-treatment
, , O O
which WDT O B-pronoun
had VBD B-VP O
successfully RB O O
treated VBN O O
the DT B-NP B-problem
infection NN I-NP I-problem
during IN B-VP O
his PRP$ O B-person
most RBS O O
recent JJ B-NP O
admission NN I-NP O
1 CD O O
year NN B-NP O
prior RB O O
. . B-VP O
   
He PRP O B-person
completed VBD B-VP O
7 CD O O
days NNS B-NP O
of IN B-VP O
levofloxacin NN B-NP B-treatment
and CC O O
had VBD B-VP O
a DT B-NP B-treatment
PICC NNP I-NP I-treatment
line NN I-NP I-treatment
placed VBD B-VP O
to TO O O
facilitate VB O O
a DT O O
2 CD O O
week NN B-NP O
course NN I-NP O
of IN B-VP O
IV NNP B-NP B-treatment
Penicillin NNP I-NP I-treatment
. . B-VP O
   
2. CD O O
Atrial JJ B-NP B-problem
fibrillation NN I-NP I-problem
The DT B-NP B-person
patient NN I-NP I-person
's POS O O
development NN B-NP O
of IN B-VP O
atrial JJ B-NP B-problem
fibrillation NN I-NP I-problem
was VBD B-VP O
believed VBN O O
to TO O O
be VB O O
secondary JJ O O
to TO O O
infection NN B-NP B-problem
and CC O O
structural JJ B-NP B-problem
heart NN I-NP I-problem
disease NN I-NP I-problem
. . B-VP O
   
It PRP O B-pronoun
was VBD B-VP O
initially RB O O
managed VBN O O
with IN B-VP O
intravenous JJ B-NP B-treatment
diltiazam NNS I-NP I-treatment
, , O O
and CC O O
it PRP O B-pronoun
was VBD B-VP O
later RB O O
managed VBN O O
with IN B-VP O
metoprolol NN B-NP B-treatment
and CC O O
anticoagulation NN B-NP B-treatment
. . B-VP O
   
A DT B-NP B-test
transthoracic NN I-NP I-test
echocardiogram NN I-NP I-test
showed VBD B-VP O
a DT O B-problem
mildly RB O I-problem
dilated VBN O I-problem
and CC O I-problem
elongated VBN O I-problem
left JJ B-NP I-problem
atrium NN I-NP I-problem
, , O O
with IN B-VP O
a DT O B-problem
markedly RB O I-problem
dilated VBN O I-problem
right JJ B-NP I-problem
atrium NN I-NP I-problem
. . B-VP O
   
He PRP O B-person
had VBD B-VP O
occasional JJ B-NP O
episodes NNS I-NP O
of IN B-VP O
rapid JJ B-NP B-problem
atrial JJ I-NP I-problem
fibrillation NN I-NP I-problem
that WDT O B-pronoun
were VBD B-VP O
controlled VBN O O
with IN B-VP O
responded VBN O O
to TO O O
IV NNP B-NP B-treatment
metoprolol NN I-NP I-treatment
. . B-VP O
   
However RB O O
, , O O
his PRP$ O B-person
his PRP$ O B-test
rate NN B-NP I-test
proved VBD B-VP O
difficult JJ O O
to TO O O
control VB O O
despite IN B-VP O
metoprolol NNS B-NP B-treatment
and CC O O
diltiazam NN B-NP B-treatment
. . B-VP O
   
The DT B-NP B-person
EP NNP I-NP I-person
service NN I-NP I-person
was VBD B-VP O
consulted VBN O O
and CC O O
recommended VBN O O
transesophageal NN B-NP B-test
echocardiogram NN I-NP I-test
and CC O O
cardioversion NN B-NP B-treatment
. . B-VP O
   
The DT B-NP B-test
TEE NNP I-NP I-test
was VBD B-VP O
negative JJ O O
for IN B-VP O
thrombus NN B-NP B-problem
and CC O O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
successfully RB O O
cardioverted VBN O O
to TO O O
normal JJ B-NP O
sinus NNS I-NP O
rhythm VBP O O
with IN B-VP O
ibutilide NN B-NP B-treatment
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
subsequently RB O O
started VBN O O
on IN B-VP O
amiodarone NN B-NP B-treatment
and CC O O
is VBZ O O
scheduled VBN O O
to TO O O
complete VB O O
a DT O O
10 CD O O
week NN B-NP O
course NN I-NP O
. . B-VP O
   
EKG NNP B-NP B-test
before IN B-VP O
discharge NN B-NP O
showed VBD B-VP O
mild JJ B-NP B-problem
QT NNP I-NP I-problem
prolongation NN I-NP I-problem
and CC O O
no DT B-NP O
effect NN I-NP O
from IN B-VP O
amiodarone NN B-NP B-treatment
. . B-VP O
   
EKG NNP B-NP B-test
and CC O O
LFTs NNP B-NP B-test
should MD O O
be VB O O
monitored VBN O O
by IN B-VP O
his PRP$ O B-person
his PRP$ O B-person
PCP NNP B-NP I-person
, , O O
William NNP B-NP B-person
given VBN O O
the DT B-NP O
high JJ I-NP O
dose NN I-NP O
of IN B-VP O
amiodarone NN B-NP B-treatment
he PRP O B-person
will MD O O
receive VB O O
. . B-VP O
   
3. CD O O
FEN NNP B-NP O
He PRP O B-person
was VBD B-VP O
followed VBN O O
by IN B-VP O
the DT B-NP B-person
nutrition NN I-NP I-person
team NN I-NP I-person
throughout IN B-VP O
his PRP$ O B-person
admission NN B-NP O
and CC O O
their PRP$ O B-person
recommendations NNS B-NP O
were VBD B-VP O
followed VBN O O
. . B-VP O
   
He PRP O B-person
demonstrated VBD B-VP O
several JJ B-NP B-problem
asymptomatic JJ I-NP I-problem
electrolyte NN I-NP I-problem
deficiecies NNS I-NP I-problem
; : O O
these DT O B-pronoun
were VBD B-VP O
likely RB O O
due JJ O O
to TO O O
inadequate VB O B-problem
absorption NN B-NP I-problem
following VBG O O
his PRP$ O B-person
his PRP$ O B-treatment
surgery NN B-NP I-treatment
and CC O O
he PRP O B-person
responded VBD B-VP O
well RB O O
to TO O O
repletion NN B-NP B-treatment
. . B-VP O
   
Vitamin NNP B-NP B-test
D NNP I-NP I-test
and CC O O
parathyroid JJ B-NP B-test
tests NNS I-NP I-test
were VBD B-VP O
pending VBG O O
at IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
discharge NN B-NP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
discharged VBN O O
to TO O O
Kindred NNP B-NP O
Park NNP I-NP O
View NNP I-NP O
Specialty NNP I-NP O
Hospital NNP I-NP O
of IN B-VP O
Springfield NNP B-NP O
Rehabilitation NNP I-NP O
Hospital NNP I-NP O
in IN B-VP O
good JJ B-NP O
condition NN I-NP O
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
sent VBN O O
with IN B-VP O
a DT B-NP B-test
King NNP I-NP I-test
of IN B-VP I-test
Hearts NNP B-NP I-test
monitor NN I-NP I-test
and CC O O
scheduled VBN O O
for IN B-VP O
follow-up NN B-NP O
with IN B-VP O
cardiology NN B-NP B-person
and CC O O
his PRP$ O B-person
his PRP$ O B-person
primary JJ B-NP I-person
care NN I-NP I-person
physician NN I-NP I-person
. . B-VP O
   
Discharge NNP B-NP O
Medications NNPS I-NP O
: : O O
1. CD O O
Amiodarone NNP B-NP B-treatment
HCl NNP I-NP I-treatment
400 CD O O
mg NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Tablet NNP B-NP O
PO NNP I-NP O
one CD O O
tid NN B-NP O
for IN B-VP O
2 CD O O
weeks NNS B-NP O
, , O O
then RB O O
1 CD O O
qd NN B-NP O
for IN B-VP O
2 CD O O
months NNS B-NP O
for IN B-VP O
2 CD O O
months NNS B-NP O
: : O O
Please NNP B-NP O
take VB O O
1 CD O O
tablet NN B-NP O
3 CD O O
times NNS B-NP O
per IN B-VP O
day NN B-NP O
for IN B-VP O
2 CD O O
weeks NNS B-NP O
, , O O
then RB O O
take VB O O
1 CD O O
tablet NNS B-NP O
per IN B-VP O
day NN B-NP O
for IN B-VP O
2 CD O O
months NNS B-NP O
. . B-VP O
   
Disp NNP B-NP O
:* VBD B-VP O
105 CD O O
Tablet NNP B-NP O
(s)* NNP I-NP O
Refills NNP I-NP O
:* VBZ O O
0 CD O O
* NN B-NP O
2. CD O O
Atorvastatin NNP B-NP B-treatment
Calcium NNP I-NP I-treatment
20 CD O O
mg NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Tablet NNP B-NP O
PO NNP I-NP O
QD NNP I-NP O
( ( O O
once RB O O
a DT B-NP O
day NN I-NP O
). NNP I-NP O
Disp NNP I-NP O
:* VBD B-VP O
30 CD O O
Tablet NNP B-NP O
(s)* NNP I-NP O
Refills NNP I-NP O
:* VBZ O O
1 CD O O
* NN B-NP O
3. CD O O
Zolpidem NNP B-NP B-treatment
Tartrate NNP I-NP I-treatment
5 CD O O
mg NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
1-2 JJ B-NP O
Tablets NNS I-NP O
PO NNP I-NP O
HS NNP I-NP O
( ( O O
at IN B-VP O
bedtime NN B-NP O
). NNP I-NP O
Disp NNP I-NP O
:* VBD B-VP O
30 CD O O
Tablet NNP B-NP O
(s)* NNP I-NP O
Refills NNP I-NP O
:* VBZ O O
0 CD O O
* NN B-NP O
4. CD O O
Potassium NNP B-NP B-treatment
& CC O I-treatment
Sodium NNP B-NP I-treatment
Phosphates NNP I-NP I-treatment
( ( O O
875 CD O O
) ) O O
623 CD O O
9797 CD O O
mg NN B-NP O
Packet NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Packet NNP B-NP O
PO NNP I-NP O
BID NNP I-NP O
( ( O O
2 CD O O
times NNS B-NP O
a DT B-NP O
day NN I-NP O
). NNP I-NP O
Disp NNP I-NP O
:* VBD B-VP O
60 CD O O
Packet NNP B-NP O
(s)* NNP I-NP O
Refills NNP I-NP O
:* VBZ O O
2 CD O O
* NN B-NP O
5. CD O O
Warfarin NNP B-NP B-treatment
Sodium NNP I-NP I-treatment
5 CD O O
mg NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Tablet NNP B-NP O
PO NNP I-NP O
HS NNP I-NP O
( ( O O
at IN B-VP O
bedtime NN B-NP O
). NNP I-NP O
Disp NNP I-NP O
:* VBD B-VP O
30 CD O O
Tablet NNP B-NP O
(s)* NNP I-NP O
Refills NNP I-NP O
:* VBZ O O
0 CD O O
* NN B-NP O
6. CD O O
Penicillin NNP B-NP B-treatment
G NNP I-NP I-treatment
Pot NNP I-NP I-treatment
in IN B-VP I-treatment
Dextrose NNP B-NP I-treatment
2,000,000 CD O O
unit NN B-NP O
/ VBD B-VP O
50 CD O O
mL NN B-NP O
Piggyback NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Intravenous JJ B-NP O
Q4H NNP I-NP O
( ( O O
every DT O O
4 CD O O
hours NNS B-NP O
). JJ B-NP O
Disp NNP I-NP O
:* NNP I-NP O
30 CD O O
bags NNS B-NP O
* JJ B-NP O
Refills NNP I-NP O
:* VBZ O O
0 CD O O
* NN B-NP O
7. CD O O
Aspirin NNP B-NP B-treatment
325 CD O O
mg NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Tablet NNP B-NP O
PO NNP I-NP O
QD NNP I-NP O
( ( O O
once RB O O
a DT B-NP O
day NN I-NP O
). POS O O
8. CD O O
Acetaminophen NNP B-NP B-treatment
325 CD O O
mg NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
1-2 JJ B-NP O
Tablets NNS I-NP O
PO NNP I-NP O
Q4-6H NNP I-NP O
( ( O O
every DT O O
4 CD O O
to TO O O
6 CD O O
hours NNS B-NP O
) ) O O
as IN B-VP O
needed VBN O O
. . B-VP O
   
9. CD O O
Pantoprazole NNP B-NP B-treatment
Sodium NNP I-NP I-treatment
40 CD O O
mg NN B-NP O
Tablet NNP I-NP O
, , O O
Delayed NNP B-NP O
Release NNP I-NP O
( ( O O
E.C. NNP B-NP O
) ) O O
Sig NN B-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Tablet NN B-NP O
, , O O
Delayed NNP B-NP O
Release NNP I-NP O
( ( O O
E.C. NNP B-NP O
) ) O O
PO NNP B-NP O
Q24H NNP I-NP O
( ( O O
every DT O O
24 CD O O
hours NNS B-NP O
). RB O O
10. CD O O
Calcium NNP B-NP B-treatment
Carbonate NNP I-NP I-treatment
500 CD O O
mg NN B-NP O
Tablet NNP I-NP O
, , O O
Chewable JJ B-NP O
Sig NN I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Tablet NN B-NP O
, , O O
Chewable JJ B-NP O
PO NNP I-NP O
BID NNP I-NP O
( ( O O
2 CD O O
times NNS B-NP O
a DT B-NP O
day NN I-NP O
). NNP I-NP O
Disp NNP I-NP O
:* VBD B-VP O
60 CD O O
Tablet NNP B-NP O
, , O O
Chewable NNP B-NP O
(s)* NNP I-NP O
Refills NNP I-NP O
:* VBZ O O
2 CD O O
* NN B-NP O
Discharge NNP I-NP O
Disposition NNP I-NP O
: : O O
Extended VBN O O
Care NNP B-NP O
Facility NNP I-NP O
: : O O
McLean NNP B-NP O
Hospital NNP I-NP O
& CC O O
Rehab NNP B-NP O
Center NNP I-NP O
- : O O
Tewksbury NN B-NP O
State NNP I-NP O
Hospital NNP I-NP O
Discharge NNP I-NP O
Diagnosis NNP I-NP O
: : O O
Atrial JJ B-NP B-problem
fibrillation NN I-NP I-problem
, , O O
Cellulitis NNP B-NP B-problem
, , O O
Bacteremia NNP B-NP B-problem
Discharge NNP I-NP O
Condition NNP I-NP O
: : O O
Good JJ B-NP O
Discharge NN I-NP O
Instructions NNS I-NP O
: : O O
Please NNP B-NP O
take VB O O
all DT O O
over IN B-VP O
your PRP$ O B-person
your PRP$ O B-treatment
medications NNS B-NP I-treatment
. . B-VP O
   
Please NNP B-NP O
make VB O O
a DT B-NP O
follow-up JJ I-NP O
appointments NNS I-NP O
with IN B-VP O
Dr. NNP B-NP B-person
Robinson NNP I-NP I-person
Dr. NNP I-NP B-person
Sturtevant NNP I-NP I-person
. . B-VP O
   
Return NNP B-NP O
to TO O O
the DT B-NP O
Emergency NNP I-NP O
Department NNP I-NP O
if IN B-VP O
you PRP O B-person
develop VBP O O
fevers NNS B-NP B-problem
, , O O
chills NNS B-NP B-problem
, , O O
chest JJS B-NP B-problem
pain NN I-NP I-problem
, , O O
shortness NN B-NP B-problem
of IN B-VP I-problem
breath NN B-NP I-problem
, , O O
palpitations NNS B-NP B-problem
, , O O
or CC O O
lightheadedness NN B-NP B-problem
. . B-VP O
   
Followup JJ B-NP O
Instructions NNS I-NP O
: : O O
Please NNP B-NP O
keep VB O O
your PRP$ O B-person
appointment NN B-NP O
with IN B-VP O
Dr. NNP B-NP B-person
Ryan NNP I-NP I-person
on IN B-VP O
Monday NNP B-NP O
, , O O
12-07 JJ O O
at IN B-VP O
11 CD O O
AM NNP B-NP O
. . B-VP O
   
Please NNP B-NP O
call VB O O
Dr. NNP B-NP B-person
Pytel NNP I-NP I-person
( ( O O
760 CD O O
) ) O O
496-3627 CD O O
and CC O O
make VB O O
a DT B-NP O
follow-up JJ I-NP O
appointment NN I-NP O
for IN B-VP O
1 CD O O
week NN B-NP O
, , O O
and CC O O
discuss VB O O
resuming VBG O O
your PRP$ O B-person
your PRP$ O B-treatment
other JJ B-NP I-treatment
outpatient JJ I-NP I-treatment
medications NNS I-NP I-treatment
at IN B-VP O
that DT B-NP B-pronoun
time NN I-NP O
. . B-VP O
   
Janine NNP B-NP B-person
Karina NNP I-NP I-person
MD NNP I-NP I-person
98-439 CD O O
Completed VBN O O
by IN B-VP O
: : O O
Opal NNP B-NP B-person
Anne NNP I-NP I-person
MD NNP I-NP I-person
40-158 JJ B-NP O
2015-10-22 JJ I-NP O
@ NN I-NP O
1759 CD O O
Signed NNP B-NP O
electronically RB O O
by IN B-VP O
: : O O
DR. NNP B-NP B-person
Stephen NNP I-NP I-person
Williams NNP I-NP I-person
on IN B-VP O
: : O O
SAT NNP B-NP O
2015-10-24 CD O O
9:46 CD O O
AM NNP B-NP O
( ( O O
End NNP B-NP O
of IN B-VP O
Report NNP B-NP O
) ) O O
-EMPTYLINE- VBP O O
-DOCSTART- JJ B-NP O
-EMPTYLINE- NNP I-NP O
Admission NNP I-NP O
Date NNP I-NP O
: : O O
2011-10-28 JJ B-NP O
Discharge NN I-NP O
Date NNP I-NP O
: : O O
2011-12-01 JJ B-NP O
Date NNP I-NP O
of IN B-VP O
Birth NNP B-NP O
: : O O
1964-04-14 JJ B-NP O
Sex NN I-NP O
: : O O
F NNP B-NP O
Service NNP I-NP O
: : O O
Bone NNP B-NP O
marrow NN I-NP O
transplant NN I-NP O
service NN I-NP O
Again NNP I-NP O
, , O O
this DT O B-pronoun
was VBD B-VP O
a DT B-NP O
47-year-old JJ I-NP O
female NN I-NP O
admitted VBN O O
with IN B-VP O
Berkitt's NNP B-NP B-problem
lymphoma NN I-NP I-problem
. . B-VP O
   
HOSPITAL NNP B-NP O
COURSE NNP I-NP O
OVER IN B-VP O
THESE NNP B-NP B-pronoun
PREVIOUS NNP I-NP O
DAYS NNP I-NP O
: : O O
1. CD O O
Liver NNP B-NP B-problem
lesions NNS I-NP I-problem
: : O O
The DT B-NP B-person
patient NN I-NP I-person
went VBD B-VP O
for IN B-VP O
a DT B-NP B-test
repeat NN I-NP I-test
MRI NNP I-NP I-test
which WDT O B-pronoun
showed VBD B-VP O
no DT B-NP O
change NN I-NP O
in IN B-VP O
the DT O B-problem
previously RB O I-problem
noted VBN O I-problem
enumerable JJ B-NP I-problem
hepatic JJ I-NP I-problem
cyst NN I-NP I-problem
in IN B-VP I-problem
her PRP$ O B-person
her PRP$ O I-problem
liver NN B-NP I-problem
. . B-VP O
   
A DT B-NP B-person
Hepatology NNP I-NP I-person
consult NN I-NP I-person
was VBD B-VP O
obtained VBN O O
who WP O B-person
felt VBD B-VP O
that IN B-VP B-pronoun
the DT O O
most RBS O O
likely JJ B-NP O
etiology NN I-NP O
of IN B-VP O
these DT O B-pronoun
these DT B-NP B-problem
cysts NNS I-NP I-problem
were VBD B-VP O
from IN B-VP O
hepatic JJ B-NP B-problem
candidiasis NN I-NP I-problem
, , O O
although IN B-VP O
one CD O O
could MD O O
not RB O O
rule VB O O
out RP O O
lymphoma NN B-NP B-problem
involving VBG O O
from IN B-VP O
Burkitt's NNP B-NP B-problem
. . B-VP O
   
She PRP O B-person
will MD O O
be VB O O
discharged VBN O O
on IN B-VP O
AmBisome NNP B-NP B-treatment
300 CD O O
mg NN B-NP O
IV NNP I-NP O
q.d. NN I-NP O
for IN B-VP O
treatment NN B-NP O
of IN B-VP O
her PRP$ O B-person
her PRP$ O B-problem
hepatic JJ B-NP I-problem
candidiasis NN I-NP I-problem
. . B-VP O
   
This DT O B-pronoun
This DT B-NP B-treatment
regimen NNS I-NP I-treatment
, , O O
that IN B-VP B-pronoun
being VBG O O
AmBisome NNP B-NP B-treatment
, , O O
was VBD B-VP O
recommended VBN O O
by IN B-VP O
the DT B-NP B-person
Infectious NNP I-NP I-person
Disease NNP I-NP I-person
physicians NNS I-NP I-person
, , O O
who WP O B-person
felt VBD B-VP O
that IN B-VP B-pronoun
AmBisome NNP B-NP B-treatment
was VBD B-VP O
a DT B-NP O
better JJR I-NP O
drug NN I-NP O
of IN B-VP O
choice NN B-NP O
as IN B-VP O
compared VBN O O
to TO O O
fluconazole VB O B-treatment
. . B-VP O
   
2. CD O O
Heme NN B-NP O
: : O O
The DT O B-person
The DT B-NP B-test
patient JJ I-NP I-person
patient NN I-NP I-test
's POS O I-test
platelets NNS B-NP I-test
, , O O
white JJ B-NP B-test
count NN I-NP I-test
, , O O
and CC O O
hematocrit NNS B-NP B-test
have VBP O O
all DT O O
been VBN O O
stable JJ O O
. . B-VP O
   
Her PRP$ O B-person
Her NNP B-NP B-test
white JJ B-NP I-test
count NN I-NP I-test
remained VBD B-VP O
elevated JJ O B-problem
despite IN B-VP O
discontinuing VBG O O
her PRP$ O B-treatment
her PRP$ O B-person
G-CSF NNP B-NP I-treatment
. . B-VP O
   
However RB O O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
is VBZ O O
not RB O O
febrile JJ O B-problem
and CC O O
her PRP$ O B-test
her PRP$ O B-person
white JJ B-NP I-test
count NN I-NP I-test
should MD O O
be VB O O
continued VBN O O
to TO O O
be VB O O
watched VBN O O
. . B-VP O
   
3. CD O O
On IN B-VP O
the DT B-NP O
morning NN I-NP O
of IN B-VP O
12-01 JJ O O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
had VBD B-VP O
some DT B-NP O
transient JJ I-NP O
episodes NNS I-NP O
of IN B-VP O
hypotension NN B-NP B-problem
with IN B-VP O
SBP NNP B-NP B-test
s NN I-NP I-test
in IN B-VP O
the DT O O
70 CD O O
s. NN B-NP O
Her NNP I-NP B-person
Her NNP I-NP B-treatment
captopril NN I-NP I-treatment
was VBD B-VP O
discontinued VBN O O
, , O O
and CC O O
she PRP O B-person
was VBD B-VP O
given VBN O O
two CD O B-treatment
IV NNP B-NP I-treatment
fluid NN I-NP I-treatment
boluses NNS I-NP I-treatment
with IN B-VP O
appropriate JJ B-NP O
response NN I-NP O
. . B-VP O
   
Her PRP$ O B-test
Her PRP$ O B-person
blood NN B-NP I-test
pressures NNS I-NP I-test
and CC O O
all DT O O
of IN B-VP O
her PRP$ O B-person
her PRP$ O B-test
vital JJ B-NP I-test
signs NNS I-NP I-test
are VBP O O
stable JJ O O
. . B-VP O
   
4. CD O O
FEN NN B-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
continued VBN O O
on IN B-VP O
TPN NNP B-NP B-treatment
over IN B-VP O
the DT B-NP O
past JJ I-NP O
couple NN I-NP O
days NNS I-NP O
. . B-VP O
   
She PRP O B-person
is VBZ O O
also RB O O
started VBN O O
on IN B-VP O
marinol NN B-NP B-treatment
2.5 CD O O
mg NN B-NP O
p.o. NN I-NP O
b.i.d. NN I-NP O
and CC O O
encouraged VBD B-VP O
p.o. NNS B-NP O
intake VB O O
. . B-VP O
   
CONDITION NNP B-NP O
ON NNP I-NP O
DISCHARGE NNP I-NP O
: : O O
Guarded VBN O B-problem
, , O O
but CC O O
stable JJ O O
. . B-VP O
   
DISCHARGE JJ B-NP O
DIAGNOSES NNP I-NP O
: : O O
1. CD O O
Burkitt's NNP B-NP B-problem
lymphoma NN I-NP I-problem
. . B-VP O
   
2. CD O O
Hepatic JJ B-NP B-problem
candidiasis NN I-NP I-problem
. . B-VP O
   
DISCHARGE NNP B-NP O
STATUS NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
will MD O O
be VB O O
discharged VBN O O
to TO O O
an DT B-NP O
outside JJ I-NP O
hospital NN I-NP O
. . B-VP O
   
DISCHARGE JJ B-NP O
MEDICATIONS NNP I-NP O
: : O O
1. CD O O
AmBisome NNP B-NP B-treatment
300 CD O O
mg NN B-NP O
IV NNP I-NP O
q.d. VBZ O O
2. CD O O
Marinol NNP B-NP B-treatment
2.5 CD O O
mg NN B-NP O
p.o. NN I-NP O
b.i.d. NN I-NP O
before IN B-VP O
breakfast NN B-NP O
and CC O O
dinner NN B-NP O
. . B-VP O
   
3. CD O O
Atarax NNP B-NP B-treatment
25 CD O O
mg NN B-NP O
IV NNP I-NP O
/ NNP I-NP O
p.o. NN I-NP O
q. VBD B-VP O
4-6 JJ B-NP O
h. NN I-NP O
prn NN I-NP O
for IN B-VP O
itching VBG O B-problem
. . B-VP O
   
4. CD O O
Colace NNP B-NP B-treatment
100 CD O O
mg NN B-NP O
p.o. NN I-NP O
b.i.d. VBD B-VP O
5. CD O O
Protonix NNP B-NP B-treatment
40 CD O O
mg NN B-NP O
p.o. NN I-NP O
/ NNP I-NP O
IV NNP I-NP O
q.d. VBD B-VP O
6. CD O O
Nystatin NNP B-NP B-treatment
06-18 JJ B-NP O
mL NN I-NP O
swish NN I-NP O
and CC O O
swallow JJ B-NP O
q.6. NN I-NP O
prn NN I-NP O
. . B-VP O
   
7. CD O O
Peridex NN B-NP B-treatment
15 CD O O
mL NN B-NP O
swish NN I-NP O
and CC O O
swallow JJ B-NP O
prn NN I-NP O
. . B-VP O
   
Maria NNP B-NP B-person
Scheer NNP I-NP I-person
, , O O
M.D.12.699 NNP B-NP O
Dictated VBN O O
By IN B-VP O
: : O O
Inez NNP B-NP B-person
Q NNP I-NP I-person
Hubbard NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
MEDQUIST36 NNP I-NP O
D NNP I-NP O
: : O O
2011-12-01 JJ O O
13:09 CD O O
T NN B-NP O
: : O O
2011-12-01 JJ O O
13:20 CD O O
JOB NNP B-NP O
#: VBD B-VP O
66182 CD O O
Signed VBN O O
electronically RB O O
by IN B-VP O
: : O O
DR. NNP B-NP B-person
Richard NNP I-NP I-person
Blakey NNP I-NP I-person
on IN B-VP O
: : O O
FRI NNP B-NP O
2011-12-23 CD O O
9:54 CD O O
AM NNP B-NP O
( ( O O
End NNP B-NP O
of IN B-VP O
Report NNP B-NP O
) ) O O
-EMPTYLINE- VBP O O
-DOCSTART- JJ O O
-EMPTYLINE- $ O O
194830718 CD O O
YC NNP B-NP O
29157608 CD O O
520377 CD O O
10/25/1997 CD O O
12:00:00 CD O O
AM NNP B-NP O
DIVERTICULITIS NNP I-NP B-problem
, , O O
S NNP B-NP O
/ NNP I-NP O
P NNP I-NP O
AORTIC NNP I-NP B-treatment
VALVE NNP I-NP I-treatment
REPLACEMENT NNP I-NP I-treatment
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date NNP I-NP O
: : O O
10/25/1997 CD O O
Report NNP B-NP O
Status NNP I-NP O
: : O O
Signed VBN O O
Discharge NNP B-NP O
Date NNP I-NP O
: : O O
11/03/1997 CD O O
CHIEF NNP B-NP O
COMPLAINT NNP I-NP O
: : O O
Diverticulitis NN B-NP B-problem
, , O O
presenting VBG O O
for IN B-VP O
sigmoid JJ B-NP B-treatment
colectomy NN I-NP I-treatment
. . B-VP O
   
HISTORY NNP B-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
is VBZ O O
a DT B-NP O
67-year-old JJ I-NP O
woman NN I-NP O
with IN B-VP O
occasional JJ B-NP B-problem
abdominal JJ I-NP I-problem
pain NN I-NP I-problem
in IN B-VP I-problem
the DT B-NP I-problem
right NN I-NP I-problem
lower RBR O I-problem
quadrant NN B-NP I-problem
and CC O O
left VBD B-VP O
lower JJR B-NP O
quadrant NN I-NP O
. . B-VP O
   
She PRP O B-person
has VBZ O O
not RB O O
complained VBN O O
of IN B-VP O
any DT B-NP B-problem
fever NN I-NP I-problem
, , O O
shaking VBG O B-problem
, , O O
or CC O O
chills NNS B-NP B-problem
. . B-VP O
   
No DT B-NP O
nausea NN I-NP B-problem
or CC O O
vomiting NN B-NP B-problem
, , O O
no DT B-NP O
change NN I-NP B-problem
in IN B-VP I-problem
her PRP$ O B-person
her PRP$ O I-problem
bowel NN B-NP I-problem
movements NNS I-NP I-problem
. . B-VP O
   
She PRP O B-person
has VBZ O O
had VBD B-VP O
attacks NNS B-NP B-problem
treated VBN O O
with IN B-VP O
antibiotics NNS B-NP B-treatment
in IN B-VP O
the DT B-NP O
past NN I-NP O
notably RB O O
in IN B-VP O
12/96 CD O O
and CC O O
08/97 CD O O
. . B-VP O
   
She PRP O B-person
has VBZ O O
had VBD B-VP O
a DT B-NP O
diagnosis NN I-NP O
of IN B-VP O
diverticulitis NN B-NP B-problem
flairs NNS I-NP I-problem
and CC O O
baseline JJ B-NP B-problem
diverticulosis NN I-NP I-problem
flairing NN I-NP I-problem
in IN B-VP O
09/96 CD O O
. . B-VP O
   
Also RB O O
, , O O
three CD O O
years NNS B-NP O
prior RB O O
in IN B-VP O
1993 CD O O
, , O O
she PRP O B-person
had VBD B-VP O
an DT B-NP B-problem
attack NN I-NP I-problem
of IN B-VP I-problem
diverticulitis NN B-NP I-problem
. . B-VP O
   
She PRP O B-person
has VBZ O O
been VBN O O
worked VBN O O
up RP O O
with IN B-VP O
barium NN B-NP B-test
enema NN I-NP I-test
in IN B-VP O
09/97 CD O O
which WDT O B-pronoun
showed VBD B-VP O
multiple JJ B-NP B-problem
diverticula NN I-NP I-problem
throughout IN B-VP I-problem
the DT B-NP I-problem
colon NN I-NP I-problem
, , O O
but CC O O
mostly RB O O
in IN B-VP O
the DT B-NP O
sigmoid NN I-NP O
. . B-VP O
   
At IN B-VP O
this DT B-NP O
time NN I-NP O
, , O O
there EX O O
was VBD B-VP O
diverticulosis NN B-NP B-problem
with IN B-VP O
no DT B-NP O
acute JJ I-NP B-problem
diverticulitis NN I-NP I-problem
. . B-VP O
   
There EX O O
was VBD B-VP O
also RB O O
no DT B-NP O
obstruction NN I-NP B-problem
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
is VBZ O O
also RB O O
status NN B-NP O
post NN I-NP O
aortic JJ B-NP B-treatment
valve NN I-NP I-treatment
replacement NN I-NP I-treatment
in IN B-VP O
1996 CD O O
, , O O
and CC O O
presented VBD B-VP O
for IN B-VP O
heparinization NN B-NP B-treatment
prior RB O O
to TO O O
her PRP$ O B-treatment
her PRP$ O B-person
elective JJ B-NP I-treatment
valve NN I-NP I-treatment
surgery NN I-NP I-treatment
. . B-VP O
   
PAST NNP B-NP O
MEDICAL NNP I-NP O
HISTORY NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
has VBZ O O
hypothyroidism NN B-NP B-problem
, , O O
hypertension NN B-NP B-problem
, , O O
and CC O O
rheumatic JJ B-NP B-problem
fever NN I-NP I-problem
age NN I-NP O
6 CD O O
with IN B-VP O
aortic JJ B-NP B-problem
stenosis NN I-NP I-problem
. . B-VP O
   
PAST JJ B-NP O
SURGICAL JJ I-NP O
HISTORY NN I-NP O
: : O O
Aortic JJ B-NP B-treatment
valve NN I-NP I-treatment
replacement NN I-NP I-treatment
in IN B-VP O
11/96 CD O O
with IN B-VP O
a DT B-NP B-treatment
St. NNP I-NP I-treatment
Jude NNP I-NP I-treatment
valve NN I-NP I-treatment
and CC O O
chronic JJ B-NP B-treatment
Coumadin NNP I-NP I-treatment
therapy NN I-NP I-treatment
; : O O
breast CC O B-test
biopsy VB O I-test
negative JJ O O
in IN B-VP O
1984 CD O O
; : O O
appendectomy JJ B-NP B-treatment
age NN I-NP O
15 CD O O
; : O O
tonsillectomy NN B-NP B-treatment
and CC O O
adenoidectomy JJ B-NP B-treatment
age NN I-NP O
6 CD O O
; : O O
hysterotomy JJ B-NP B-treatment
age NN I-NP O
30 CD O O
; : O O
C-section NNP B-NP B-treatment
age NN I-NP O
37 CD O O
due JJ O O
to TO O O
placenta VB O B-problem
previa NN B-NP I-problem
. . B-VP O
   
MEDICATIONS NN B-NP O
: : O O
Lopressor NNP B-NP B-treatment
50 CD O O
mg NN B-NP O
q.a.m. NN I-NP O
, , O O
25 CD O O
mg NN B-NP O
q.p.m. NN I-NP O
, , O O
and CC O O
25 CD O O
mg NN B-NP O
q.h.s.; NN I-NP O
Synthroid NNP I-NP B-treatment
88 CD O O
mcg NN B-NP O
q.d.; NN I-NP O
Norvasc NNP I-NP B-treatment
5 CD O O
mg NN B-NP O
q.d.; NN I-NP O
Lescol NNP I-NP B-treatment
20 CD O O
mg NN B-NP O
q.p.m. NN I-NP O
with IN B-VP O
meal NN B-NP O
; : O O
Coumadin NNP B-NP B-treatment
is VBZ O O
usually RB O O
4 CD O O
mg NNS B-NP O
p.o. RB O O
3x CD O O
a DT B-NP O
week NN I-NP O
and CC O O
3 CD O O
mg NN B-NP O
4x CD O O
a DT B-NP O
week NN I-NP O
. . B-VP O
   
It PRP O B-pronoun
was VBD B-VP O
held VBN O O
the DT B-NP O
day NN I-NP O
prior RB O O
to TO O O
admission NN B-NP O
. . B-VP O
   
ALLERGIES NN B-NP O
: : O O
Percodan NNP B-NP B-treatment
and CC O O
codeine NN B-NP B-treatment
. . B-VP O
   
SOCIAL NNP B-NP O
HISTORY NNP I-NP O
: : O O
Alcohol NN B-NP O
and CC O O
tobacco NN B-NP O
histories NNS I-NP O
are VBP O O
negative JJ O O
. . B-VP O
   
REVIEW NNP B-NP O
OF NNPS I-NP O
SYSTEMS NNP I-NP O
: : O O
Negative JJ O O
for IN B-VP O
congestive JJ B-NP B-problem
heart NN I-NP I-problem
failure NN I-NP I-problem
, , O O
positive JJ O O
for IN B-VP O
occasional JJ B-NP B-problem
dyspnea NN I-NP I-problem
on IN B-VP O
exertion NN B-NP O
, , O O
negative JJ O O
for IN B-VP O
dyspnea NN B-NP B-problem
and CC O O
she PRP O B-person
has VBZ O O
excellent JJ B-NP O
exercise NN I-NP O
tolerance NN I-NP O
. . B-VP O
   
There EX O O
is VBZ O O
occasional JJ B-NP B-problem
left JJ I-NP I-problem
chest NN I-NP I-problem
tightening NN I-NP I-problem
which WDT O B-pronoun
is VBZ O O
brief JJ O O
. . B-VP O
   
No DT B-NP O
bleeding NN I-NP B-problem
in IN B-VP I-problem
her PRP$ O B-person
her PRP$ O I-problem
urine NN B-NP I-problem
or CC O I-problem
stool NN B-NP I-problem
. . B-VP O
   
Occasional NNP B-NP B-problem
bleeding NN I-NP I-problem
when WRB O O
she PRP O B-person
flosses VBZ O O
and CC O O
occasional JJ B-NP B-problem
dizziness NN I-NP I-problem
secondary JJ O O
to TO O O
a DT B-NP B-problem
drop NN I-NP I-problem
in IN B-VP O
blood NN B-NP B-test
pressure NN I-NP I-test
transiently RB O O
at IN B-VP O
home NN B-NP O
. . B-VP O
   
PHYSICAL JJ B-NP O
EXAMINATION NN I-NP O
: : O O
VITAL NNP B-NP O
SIGNS NNP I-NP O
- : O O
Temp NN B-NP B-test
98.8 CD O O
, , O O
pulse RB O B-test
60 CD O O
, , O O
BP NNP B-NP B-test
150/94 CD O O
, , O O
respiratory NN B-NP B-test
rate NN I-NP I-test
18 CD O O
, , O O
and CC O O
saturation NN B-NP B-test
96% CD O O
on IN B-VP O
room NN B-NP O
air NN I-NP O
. . B-VP O
   
GENERAL NNP B-NP O
- : O O
The DT B-NP B-person
patient NN I-NP I-person
is VBZ O O
a DT B-NP O
pleasant JJ I-NP O
older JJR I-NP O
woman NN I-NP O
in IN B-VP O
no DT B-NP O
acute JJ I-NP B-problem
distress NN I-NP I-problem
. . B-VP O
   
HEENT NNP B-NP O
- : O O
Normocephalic NNP B-NP O
, , O O
atraumatic JJ O B-problem
. . B-VP O
   
Oropharynx NNP B-NP O
is VBZ O O
not RB O O
injected VBN O B-problem
. . B-VP O
   
NECK NNP B-NP O
- : O O
No DT B-NP O
carotid NN I-NP B-problem
bruits NNS I-NP I-problem
, , O O
with IN B-VP O
2+ CD O B-test
carotid NN B-NP I-test
pulses NNS I-NP I-test
. . B-VP O
   
LUNGS NNP B-NP O
- : O O
Clear JJ O O
. . B-VP O
   
HEART NNP B-NP O
- : O O
Regular JJ O O
, , O O
with IN B-VP O
a DT B-NP B-problem
III NNP I-NP I-problem
/ NNP I-NP I-problem
VI NNP I-NP I-problem
murmur NN I-NP I-problem
at IN B-VP I-problem
the DT O I-problem
upper JJ O I-problem
left VBD B-VP I-problem
sternal JJ B-NP I-problem
border NN I-NP I-problem
. . B-VP O
   
ABDOMEN NNP B-NP O
- : O O
There EX O O
is VBZ O O
a DT B-NP O
soft JJ I-NP O
abdomen NNS I-NP O
with IN B-VP O
a DT B-NP O
question NN I-NP O
of IN B-VP O
eventful JJ B-NP B-problem
hernia NN I-NP I-problem
. . B-VP O
   
RECTAL NNP B-NP O
- : O O
Guaiac NNP B-NP B-test
negative JJ O O
with IN B-VP O
normal JJ B-NP O
tone NN I-NP O
. . B-VP O
   
EXTREMITIES NNP B-NP O
- : O O
Bilateral NNP B-NP B-test
radial NN I-NP I-test
, , O O
dorsalis NN B-NP B-test
pedis NN I-NP I-test
, , O O
posterior JJ B-NP B-test
tibial NN I-NP I-test
, , O O
and CC O O
femoral JJ B-NP B-test
pulses NNS I-NP I-test
are VBP O O
all DT O O
2+ CD O O
. . B-VP O
   
No DT B-NP O
clubbing NN I-NP B-problem
, , O O
cyanosis NN B-NP B-problem
, , O O
or CC O O
edema NN B-NP B-problem
of IN B-VP I-problem
the DT B-NP I-problem
extremities NNS I-NP I-problem
. . B-VP O
   
LABORATORY NNP B-NP O
DATA NNP I-NP O
: : O O
Coagulation NN B-NP B-test
profile NN I-NP I-test
notable JJ O O
for IN B-VP O
a DT B-NP B-test
PT NNP I-NP I-test
18 CD O O
, , O O
PTT NNP B-NP B-test
36.7 CD O O
and CC O O
an DT B-NP B-test
INR NNP I-NP I-test
of IN B-VP O
2.4 CD O O
. . B-VP O
   
HOSPITAL NNP B-NP O
COURSE NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
admitted VBN O O
and CC O O
begun VBN O O
on IN B-VP O
cefotetan NN B-NP B-treatment
and CC O O
Flagyl NNP B-NP B-treatment
, , O O
as RB O O
well RB O O
as IN B-VP O
heparin NN B-NP B-treatment
. . B-VP O
   
Her PRP$ O B-person
Her NNP B-NP B-test
INR NNP I-NP I-test
dropped VBD B-VP O
to TO O O
1.6 CD O O
prior RB O O
to TO O O
surgery NN B-NP B-treatment
, , O O
and CC O O
her PRP$ O B-person
her PRP$ O B-test
PTT NN B-NP I-test
was VBD B-VP O
in IN B-VP O
the DT B-NP O
mid NN I-NP O
80s CD O O
prior RB O O
to TO O O
surgery NN B-NP B-treatment
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
admitted VBN O O
and CC O O
placed VBN O O
on IN B-VP O
a DT B-NP B-treatment
bowel NN I-NP I-treatment
prep NN I-NP I-treatment
two CD O O
days NNS B-NP O
before IN B-VP O
surgery NN B-NP B-treatment
and CC O O
was VBD B-VP O
taken VBN O O
to TO O O
the DT B-NP O
Operating NN I-NP O
Room NN I-NP O
on IN B-VP O
hospital JJ B-NP O
day NN I-NP O
# # O O
3 CD O O
, , O O
10/28/97 CD O O
. . B-VP O
   
At IN B-VP O
that DT B-NP B-pronoun
time NN I-NP O
, , O O
she PRP O B-person
underwent JJ B-NP O
sigmoid JJ I-NP B-treatment
colectomy NN I-NP I-treatment
and CC O O
ventral JJ B-NP B-treatment
hernia NN I-NP I-treatment
repair NN I-NP I-treatment
. . B-VP O
   
( ( O O
A DT B-NP O
full JJ I-NP O
account NN I-NP O
of IN B-VP O
this DT O B-pronoun
this DT B-NP B-treatment
operation NN I-NP I-treatment
can MD O O
be VB O O
found VBN O O
in IN B-VP O
the DT B-NP O
Operative NNP I-NP O
Note NNP I-NP O
) ) O O
. . B-VP O
   
She PRP O B-person
tolerated VBD B-VP O
this DT B-NP B-treatment
procedure NN I-NP I-treatment
without IN B-VP O
complications NNS B-NP B-problem
initially RB O O
and CC O O
was VBD B-VP O
taken VBN O O
to TO O O
the DT B-NP O
Recovery NNP I-NP O
Room NNP I-NP O
in IN B-VP O
stable JJ B-NP O
condition NN I-NP O
. . B-VP O
   
Postoperatively RB O O
, , O O
she PRP O B-person
had VBD B-VP O
her PRP O B-person
her PRP$ O B-treatment
heparin NN B-NP I-treatment
restarted VBN O O
, , O O
and CC O O
had VBD B-VP O
a DT B-NP B-test
PTT NNP I-NP I-test
rising VBG O O
to TO O O
142.8 CD O O
and CC O O
then RB O O
down RB O O
to TO O O
92 CD O O
. . B-VP O
   
Her PRP$ O B-person
primary JJ B-NP O
postoperative JJ I-NP O
development NN I-NP O
was VBD B-VP O
the DT B-NP B-problem
passage NN I-NP I-problem
of IN B-VP I-problem
some DT B-NP I-problem
blood NN I-NP I-problem
clots NNS I-NP I-problem
and CC O O
blood NN B-NP B-problem
per IN B-VP I-problem
rectum NN B-NP I-problem
on IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
# # O O
2 CD O O
. . B-VP O
   
She PRP O B-person
continued VBD B-VP O
to TO O O
pass VB O O
blood NN B-NP B-problem
per IN B-VP I-problem
rectum NN B-NP I-problem
and CC O O
was VBD B-VP O
transfused VBN O O
with IN B-VP O
one CD O B-treatment
unit NN B-NP I-treatment
of IN B-VP I-treatment
packed JJ B-NP I-treatment
red JJ I-NP I-treatment
blood NN I-NP I-treatment
cells NNS I-NP I-treatment
. . B-VP O
   
Her PRP$ O B-person
Her PRP$ O B-test
preoperative JJ B-NP I-test
hematocrit NN I-NP I-test
was VBD B-VP O
41 CD O O
and CC O O
her PRP$ O B-person
her PRP$ O B-test
hematocrit NN B-NP I-test
dropped VBD B-VP O
to TO O O
30.4 CD O O
on IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
# # O O
2 CD O O
. . B-VP O
   
This DT O B-pronoun
was VBD B-VP O
a DT B-NP O
drop NN I-NP O
from IN B-VP O
an DT B-NP B-test
immediate JJ I-NP I-test
postoperative JJ I-NP I-test
hematocrit NN I-NP I-test
of IN B-VP O
35.4 CD O O
. . B-VP O
   
Upon IN B-VP O
receiving VBG O O
the DT O B-treatment
one CD O I-treatment
unit NN B-NP I-treatment
of IN B-VP I-treatment
red JJ B-NP I-treatment
blood NN I-NP I-treatment
cells NNS I-NP I-treatment
, , O O
her PRP$ O B-person
her PRP$ O B-test
hematocrit NN B-NP I-test
returned VBD B-VP O
to TO O O
33 CD O O
, , O O
and CC O O
in IN B-VP O
the DT O O
two CD O O
days NNS B-NP O
subsequent JJ O O
to TO O O
the DT B-NP B-treatment
transfusion NN I-NP I-treatment
, , O O
returned VBD B-VP O
to TO O O
34 CD O O
. . B-VP O
   
Otherwise RB O O
, , O O
her PRP O B-person
postoperative JJ B-NP O
course NN I-NP O
was VBD B-VP O
uneventful JJ O O
with IN B-VP O
gradual JJ B-NP O
resolution NN I-NP O
of IN B-VP O
the DT B-NP O
passage NN I-NP O
of IN B-VP O
blood NN B-NP B-problem
per IN B-VP I-problem
rectum NN B-NP I-problem
. . B-VP O
   
Her PRP$ O B-person
Her PRP$ O B-treatment
heparin NN B-NP I-treatment
was VBD B-VP O
discontinued VBN O O
when WRB O O
it PRP O B-pronoun
was VBD B-VP O
noted VBN O O
that IN B-VP B-pronoun
she PRP O B-person
was VBD B-VP O
bleeding VBG O B-problem
per IN B-VP I-problem
rectum NN B-NP I-problem
and CC O O
her PRP$ O B-person
her PRP$ O B-test
PTT NNP B-NP I-test
drifted VBD B-VP O
to TO O O
a DT B-NP O
normal JJ I-NP O
range NN I-NP O
of IN B-VP O
35 CD O O
by IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
# # O O
3 CD O O
. . B-VP O
   
On IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
# # O O
1 CD O O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
restarted VBN O O
on IN B-VP O
2 CD O O
mg NN B-NP O
of IN B-VP O
Coumadin NNP B-NP B-treatment
. . B-VP O
   
However RB O O
, , O O
due JJ O O
to TO O O
the DT B-NP O
episode NN I-NP O
of IN B-VP O
bleeding VBG O B-problem
on IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
# # O O
2 CD O O
, , O O
the DT B-NP B-treatment
Coumadin NNP I-NP I-treatment
was VBD B-VP O
held VBN O O
for IN B-VP O
two CD O O
consecutive JJ B-NP O
days NNS I-NP O
, , O O
and CC O O
then RB O O
restarted VBD B-VP O
on IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
# # O O
4 CD O O
. . B-VP O
   
At IN B-VP O
this DT B-NP B-pronoun
time NN I-NP O
, , O O
she PRP O B-person
is VBZ O O
given VBN O O
3 CD O O
mg NNS B-NP O
and CC O O
was VBD B-VP O
gradually RB O O
increased VBN O O
to TO O O
her PRP$ O B-person
her PRP$ O B-treatment
regular JJ B-NP I-treatment
regimen NNS I-NP I-treatment
of IN B-VP O
4 CD O O
mg NNS B-NP O
alternating VBG O O
with IN B-VP O
3 CD O O
mg. NNS B-NP O
The DT O B-person
The DT B-NP B-test
patient JJ I-NP I-person
patient NN I-NP I-test
&apos;s NNP I-NP I-test
INR NNP I-NP I-test
had VBD B-VP O
dropped VBN O O
to TO O O
1.7 CD O O
at IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
operation NN B-NP B-treatment
, , O O
and CC O O
remained VBD B-VP O
in IN B-VP O
this DT B-NP B-pronoun
range NN I-NP O
initially RB O O
, , O O
but CC O O
began VBD B-VP O
to TO O O
rise VB O O
to TO O O
2.0 CD O O
with IN B-VP O
her PRP$ O B-person
her PRP$ O B-treatment
Coumadin NNP B-NP I-treatment
dosing NN I-NP I-treatment
. . B-VP O
   
At IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
discharge NN B-NP O
, , O O
it PRP O B-pronoun
was VBD B-VP O
1.9 CD O O
, , O O
for IN B-VP O
which WDT O B-pronoun
she PRP O B-person
received VBD B-VP O
4 CD O O
mg. NN B-NP O
On IN B-VP O
the DT B-NP O
next JJ I-NP O
day NN I-NP O
, , O O
it PRP O B-pronoun
was VBD B-VP O
1.6 CD O O
and CC O O
she PRP O B-person
returned VBD B-VP O
to TO O O
a DT B-NP B-treatment
normal JJ I-NP I-treatment
dosing NN I-NP I-treatment
of IN B-VP O
4 CD O O
mg NN B-NP O
followed VBN O O
by IN B-VP O
outpatient JJ B-NP B-test
draws NNS I-NP I-test
to TO O O
determine VB O O
the DT B-NP B-treatment
further JJ I-NP I-treatment
Coumadin NNP I-NP I-treatment
dosing NN I-NP I-treatment
. . B-VP O
   
This DT O B-pronoun
was VBD B-VP O
postoperative JJ B-NP O
day NN I-NP O
# # O O
6 CD O O
, , O O
at IN B-VP O
which WDT O B-pronoun
time NN B-NP O
she PRP O B-person
is VBZ O O
ready JJ O O
for IN B-VP O
discharge NN B-NP O
. . B-VP O
   
The DT B-NP O
rest NN I-NP O
of IN B-VP O
her PRP$ O B-person
hospital JJ B-NP O
course NN I-NP O
was VBD B-VP O
unremarkable JJ O O
, , O O
with IN B-VP O
perioperative JJ B-NP B-treatment
ampicillin NN I-NP I-treatment
, , O O
gentamicin NN B-NP B-treatment
and CC O O
Flagyl NNP B-NP B-treatment
discontinued VBD B-VP O
on IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
# # O O
1 CD O O
. . B-VP O
   
She PRP O B-person
had VBD B-VP O
some DT B-NP B-problem
initial JJ I-NP I-problem
nausea NN I-NP I-problem
but CC O O
had VBD B-VP O
no DT B-NP O
emesis NN I-NP B-problem
. . B-VP O
   
Her PRP$ O B-person
Her PRP$ O B-treatment
nasogastric JJ B-NP I-treatment
tube NN I-NP I-treatment
was VBD B-VP O
discontinued VBN O O
on IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
# # O O
1 CD O O
, , O O
and CC O O
she PRP O B-person
tolerated VBD B-VP O
a DT B-NP O
regular JJ I-NP O
diet NN I-NP O
by IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
# # O O
3 CD O O
. . B-VP O
   
She PRP O B-person
had VBD B-VP O
flatus NN B-NP O
and CC O O
regular JJ B-NP O
bowel NN I-NP O
movements NNS I-NP O
by IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
# # O O
5 CD O O
. . B-VP O
   
She PRP O B-person
also RB O O
complained VBD B-VP O
of IN B-VP O
some DT B-NP B-problem
slight JJ I-NP I-problem
dizziness NN I-NP I-problem
upon IN B-VP O
getting VBG O O
up RP O O
. . B-VP O
   
For IN B-VP O
this DT B-NP B-pronoun
reason NN I-NP O
, , O O
her PRP$ O B-person
her PRP$ O B-treatment
normal JJ B-NP I-treatment
Lopressor NNP I-NP I-treatment
and CC O O
Norvasc NNP B-NP B-treatment
were VBD B-VP O
held VBN O O
. . B-VP O
   
It PRP O B-pronoun
was VBD B-VP O
felt VBN O O
that IN B-VP B-pronoun
this DT O B-pronoun
was VBD B-VP O
re-equalibration NN B-NP O
after IN B-VP O
being VBG O O
sedentary JJ O O
and CC O O
mostly RB O O
in IN B-VP O
bed NN B-NP O
following VBG O O
the DT B-NP B-treatment
operation NN I-NP I-treatment
. . B-VP O
   
She PRP O B-person
had VBD B-VP O
some DT B-NP B-problem
slight JJ I-NP I-problem
headaches NNS I-NP I-problem
which WDT O B-pronoun
resolved VBD B-VP O
with IN B-VP O
Tylenol NNP B-NP B-treatment
, , O O
and CC O O
the DT B-NP B-problem
dizziness NN I-NP I-problem
resolved VBD B-VP O
as RB O O
well RB O O
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
ready JJ O O
for IN B-VP O
discharge NN B-NP O
on IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
# # O O
6 CD O O
. . B-VP O
   
Her PRP$ O B-person
Her PRP$ O B-problem
wound NN B-NP I-problem
remained VBD B-VP O
benign JJ O O
and CC O O
was VBD B-VP O
healing VBG O O
nicely RB O O
at IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
discharge NN B-NP O
. . B-VP O
   
DISCHARGE NNP B-NP O
MEDICATIONS NNP I-NP O
: : O O
Lopressor NNP B-NP B-treatment
50 CD O O
mg NN B-NP O
q.a.m. NN I-NP O
, , O O
25 CD O O
mg NN B-NP O
q.p.m. NN I-NP O
, , O O
and CC O O
25 CD O O
mg NNS B-NP O
q.h.s. RB O O
, , O O
Synthroid NNP B-NP B-treatment
88 CD O O
mcg NN B-NP O
q.d. NN I-NP O
, , O O
Norvasc NNP B-NP B-treatment
5 CD O O
mg NN B-NP O
q.d. NN I-NP O
, , O O
Lescol NNP B-NP B-treatment
20 CD O O
mg NN B-NP O
q.p.m. NN I-NP O
with IN B-VP O
meal NN B-NP O
, , O O
Coumadin NNP B-NP B-treatment
is VBZ O O
usually RB O O
4 CD O O
mg NNS B-NP O
p.o. RB O O
3x CD O O
a DT B-NP O
week NN I-NP O
and CC O O
3 CD O O
mg NN B-NP O
4x CD O O
a DT B-NP O
week NN I-NP O
; : O O
Percocet NNP B-NP B-treatment
1-2 CD O O
tabs NN B-NP O
q.4h. NN I-NP O
p.r.n. NN I-NP O
pain NN I-NP B-problem
. . B-VP O
   
DISCHARGE NNP B-NP O
FOLLOW-UP JJ O O
: : O O
Follow-up JJ O O
with IN B-VP O
Dr. NNP B-NP B-person
Jesc NNP I-NP I-person
in IN B-VP O
the DT B-NP O
office NN I-NP O
. . B-VP O
   
DISCHARGE NNP B-NP O
DISPOSITION NNP I-NP O
: : O O
Her PRP$ O B-person
disposition NN B-NP O
was VBD B-VP O
to TO O O
home NN B-NP O
. . B-VP O
   
CONDITION NNP B-NP O
ON NNP I-NP O
DISCHARGE NNP I-NP O
: : O O
Stable JJ O O
. . B-VP O
   
Estimated VBN O O
disability NN B-NP O
was VBD B-VP O
none NN B-NP O
. . B-VP O
   
Dictated VBN O O
By IN B-VP O
: : O O
BELL NNP B-NP B-person
REXBEATHEFARST NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
NM82 NNP I-NP O
Attending NNP I-NP B-person
: : O O
LINEMASE NNP B-NP B-person
D. NNP I-NP I-person
JESC NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
ZP2 NNP I-NP O
SF477/5317 NNP I-NP O
Batch NNP I-NP O
: : O O
31967 CD O O
Index NNP B-NP O
No. NN I-NP O
PAWU09891C NNP I-NP O
D NNP I-NP O
: : O O
11/07/97 CD O O
T NN B-NP O
: : O O
11/07/97 CD O O
-EMPTYLINE- NN B-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
Admission NNP I-NP O
Date NNP I-NP O
: : O O
2016-05-05 JJ B-NP O
Discharge NN I-NP O
Date NNP I-NP O
: : O O
2016-06-15 JJ B-NP O
Date NNP I-NP O
of IN B-VP O
Birth NNP B-NP O
: : O O
2016-05-05 JJ B-NP O
Sex NN I-NP O
: : O O
F NNP B-NP O
Service NNP I-NP O
: : O O
NEONATOLOGY NNP B-NP O
HISTORY NNP I-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
is VBZ O O
a DT O O
30 CD O O
and CC O O
08-01 JJ B-NP O
week NN I-NP O
gestation NN I-NP O
female NN I-NP O
, , O O
triplet VB O B-person
number NN B-NP I-person
two CD O I-person
, , O O
delivered VBN O O
by IN B-VP O
cesarean JJ B-NP B-treatment
section NN I-NP I-treatment
due JJ O O
to TO O O
progressive JJ B-NP B-problem
preterm JJ I-NP I-problem
labor NN I-NP I-problem
and CC O O
triplet NN B-NP B-problem
gestation NN I-NP I-problem
. . B-VP O
   
PERINATAL NNP B-NP O
HISTORY NNP I-NP O
: : O O
Mother NN B-NP B-person
is VBZ O O
a DT O O
29 CD O O
year-old JJ B-NP O
gravida NN I-NP O
4 CD O O
, , O O
para VBD B-VP O
1 CD O O
mother NN B-NP O
, , O O
Marian NNP B-NP O
Jane NNP I-NP O
conception NN I-NP O
, , O O
EDC NNP B-NP O
2016-07-08 CD O O
. . B-VP O
   
Prenatal NNP B-NP B-test
screen NN I-NP I-test
, , O O
O NNP B-NP O
positive JJ O O
, , O O
antibody JJ O B-test
negative JJ O O
, , O O
RPR NNP B-NP B-test
nonreactive NN I-NP O
, , O O
hepatitis NN B-NP B-test
B NNP I-NP I-test
surface NN I-NP I-test
antigen NN I-NP I-test
negative JJ O O
, , O O
reportedly RB O O
GBS NNP B-NP B-test
negative JJ O O
, , O O
Rubella NNP B-NP B-test
immune NN I-NP O
. . B-VP O
   
Pregnancy NNP B-NP O
complicated VBN O O
by IN B-VP O
gestational JJ B-NP B-problem
diabetes NNS I-NP I-problem
mellitus VBP O I-problem
, , O O
then RB O O
possible JJ B-NP O
preterm JJ I-NP B-problem
labor NN I-NP I-problem
. . B-VP O
   
Mother NNP B-NP B-person
presented VBD B-VP O
with IN B-VP O
abdominal JJ B-NP B-problem
discomfort NN I-NP I-problem
and CC O O
vaginal JJ B-NP B-problem
pressure NN I-NP I-problem
at IN B-VP O
23 CD O O
and CC O O
1/7 CD O O
weeks NNS B-NP O
. . B-VP O
   
At IN B-VP O
that DT B-NP O
time NN I-NP O
she PRP O B-person
was VBD B-VP O
admitted VBN O O
and CC O O
received VBN O O
a DT B-NP B-treatment
full JJ I-NP I-treatment
course NN I-NP I-treatment
of IN B-VP I-treatment
betamethasone NN B-NP I-treatment
at IN B-VP O
24 CD O O
weeks NNS B-NP O
and CC O O
remained VBD B-VP O
in IN B-VP O
house NN B-NP O
until IN B-VP O
delivery NN B-NP B-treatment
. . B-VP O
   
Mother NNP B-NP B-person
presented VBD B-VP O
on IN B-VP O
day NN B-NP O
of IN B-VP O
delivery NN B-NP B-treatment
with IN B-VP O
preterm JJ B-NP B-problem
labor NN I-NP I-problem
, , O O
cervical JJ B-NP B-problem
dilation NN I-NP I-problem
, , O O
therefore RB O O
delivered VBN O O
by IN B-VP O
repeat NN B-NP B-treatment
cesarean JJ B-NP I-treatment
section NN I-NP I-treatment
. . B-VP O
   
This DT B-NP B-person
triplet NN I-NP I-person
required VBN O O
only RB O O
blow VB O B-treatment
by IN B-VP I-treatment
oxygen NN B-NP I-treatment
and CC O O
routine JJ B-NP B-treatment
care NN I-NP I-treatment
in IN B-VP O
delivery NN B-NP O
room NN I-NP O
. . B-VP O
   
Apgars NNS B-NP B-test
were VBD B-VP O
8 CD O O
at IN B-VP O
one CD O O
minute NN B-NP O
and CC O O
9 CD O O
at IN B-VP O
five CD O O
minutes NNS B-NP O
. . B-VP O
   
Infant NNP B-NP B-person
demonstrated VBD B-VP O
mild NN B-NP B-problem
increased VBD B-VP I-problem
work NN B-NP I-problem
of IN B-VP I-problem
breathing VBG O I-problem
in IN B-VP O
the DT B-NP O
delivery NN I-NP O
room NN I-NP O
. . B-VP O
   
Infant NNP B-NP B-person
transported VBD B-VP O
to TO O O
Neonatal NNP B-NP O
Intensive NNP I-NP O
Care NNP I-NP O
Unit NNP I-NP O
on IN B-VP O
facial JJ B-NP B-treatment
CPAP NNP I-NP I-treatment
. . B-VP O
   
PHYSICAL NNP B-NP O
EXAMINATION NNP I-NP O
ON NNP I-NP O
ADMISSION NNP I-NP O
: : O O
Birth NN B-NP B-test
weight NN I-NP I-test
1455 CD O O
grams NN B-NP O
( ( O O
50th CD O O
percentile NN B-NP O
), JJ B-NP O
head NN I-NP B-test
circumference NN I-NP I-test
29.25 CD O O
cm NN B-NP O
( ( O O
50th CD O O
percentile NN B-NP O
), NN I-NP O
length NN I-NP B-test
41.5 CD O O
cm NN B-NP O
( ( O O
50th CD O O
percentile NN B-NP O
). NN I-NP O
Nondysmorphic NNP I-NP B-problem
with IN B-VP O
overall JJ B-NP O
appearance NN I-NP O
consistent NN I-NP O
with IN B-VP O
gestational JJ B-NP O
age NN I-NP O
. . B-VP O
   
Anterior NNP B-NP O
fontanel NN I-NP O
soft NN I-NP O
, , O O
open JJ O O
, , O O
flat JJ O O
, , O O
red JJ B-NP B-test
reflex JJ I-NP I-test
present NN I-NP O
bilaterally RB O O
, , O O
palate JJ B-NP O
intact NN I-NP O
. . B-VP O
   
Intermittent NNP B-NP B-problem
grunting NN I-NP I-problem
, , O O
moderate JJ B-NP B-problem
intercostal JJ I-NP I-problem
retractions NNS I-NP I-problem
, , O O
diminished VBD B-VP B-problem
air NN B-NP I-problem
entry NN I-NP I-problem
, , O O
regular JJ B-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
without IN B-VP O
murmur NN B-NP B-problem
, , O O
2+ CD O O
femoral JJ B-NP B-test
pulses NNS I-NP I-test
. . B-VP O
   
Abdomen NNP B-NP O
benign NN I-NP O
with IN B-VP O
no DT B-NP O
hepatosplenomegaly NN I-NP B-problem
or CC O O
masses NNS B-NP B-problem
. . B-VP O
   
No DT B-NP O
external JJ I-NP O
female NN I-NP O
genitalia NN I-NP O
. . B-VP O
   
Normal NNP B-NP O
back RB O O
and CC O O
extremities NNS B-NP O
with IN B-VP O
stable JJ B-NP O
hips NNS I-NP O
, , O O
appropriate JJ B-NP O
tone NN I-NP O
, , O O
skin FW O O
pink NN B-NP O
with IN B-VP O
fair JJ B-NP O
perfusion NN I-NP O
. . B-VP O
   
HOSPITAL NNP B-NP O
COURSE NNP I-NP O
: : O O
1. CD O O
Pulmonary NNP B-NP O
: : O O
On IN B-VP O
admission NN B-NP O
the DT B-NP B-person
infant NN I-NP I-person
required VBN O O
CPAP NNP B-NP B-treatment
6 CD O O
cm NN B-NP O
of IN B-VP O
water NN B-NP O
, , O O
30% CD O B-treatment
oxygen NN B-NP I-treatment
. . B-VP O
   
Initial JJ B-NP B-test
capillary JJ I-NP I-test
blood NN I-NP I-test
gas NN I-NP I-test
was VBD B-VP O
pH JJ O B-test
7.29 CD O O
, , O O
CO2 NNP B-NP B-test
47 CD O O
. . B-VP O
   
Infant NN B-NP B-person
was VBD B-VP O
intubated VBN O B-treatment
on IN B-VP O
day NN B-NP O
of IN B-VP O
life NN B-NP O
two CD O O
for IN B-VP O
increased JJ B-NP B-problem
respiratory NN I-NP I-problem
distress NN I-NP I-problem
and CC O O
received VBD B-VP O
one CD O O
dose NN B-NP O
of IN B-VP O
surfactant NN B-NP B-treatment
. . B-VP O
   
Infant NNP B-NP B-person
was VBD B-VP O
extubated VBN O B-treatment
on IN B-VP O
day NN B-NP O
of IN B-VP O
life NN B-NP O
four CD O O
to TO O O
CPAP NNP B-NP B-treatment
and CC O O
transitioned VBD B-VP O
to TO O O
room NN B-NP O
air NN I-NP O
on IN B-VP O
day NN B-NP O
of IN B-VP O
life NN B-NP O
six CD O O
. . B-VP O
   
The DT B-NP B-person
infant NN I-NP I-person
has VBZ O O
remained VBN O O
in IN B-VP O
room NN B-NP O
air NN I-NP O
throughout IN B-VP O
the DT B-NP O
hospitalization NN I-NP O
. . B-VP O
   
Caffeine NNP B-NP B-treatment
citrate NN I-NP I-treatment
was VBD B-VP O
started VBN O O
on IN B-VP O
day NN B-NP O
of IN B-VP O
life NN B-NP O
six CD O O
and CC O O
was VBD B-VP O
discontinued VBN O O
on IN B-VP O
05-23 JJ O O
( ( O O
day NN B-NP O
of IN B-VP O
life NN B-NP O
18 CD O O
). VBZ O O
The DT B-NP B-problem
last JJ I-NP I-problem
apnea NN I-NP I-problem
and CC O O
bradycardia NN B-NP B-problem
was VBD B-VP O
on IN B-VP O
06-10 NNP B-NP O
. . B-VP O
   
2. CD O O
Cardiovascular JJ O O
: : O O
The DT B-NP B-person
infant NN I-NP I-person
has VBZ O O
remained VBN O O
hemodynamically RB O O
stable JJ O O
throughout IN B-VP O
this DT B-NP O
hospitalization NN I-NP O
, , O O
no DT B-NP O
murmur NN I-NP B-problem
. . B-VP O
   
Heart NNP B-NP B-test
rate NN I-NP I-test
150 CD O O
to TO O O
160 CD O O
, , O O
mean JJ B-NP B-test
blood NN I-NP I-test
pressure NN I-NP I-test
40 CD O O
to TO O O
54 CD O O
. . B-VP O
   
3. CD O O
Fluid NNP B-NP O
, , O O
electrolytes VBZ O O
and CC O O
nutrition NN B-NP O
: : O O
Infant NN B-NP B-person
was VBD B-VP O
initially RB O O
nothing NN B-NP B-treatment
by IN B-VP I-treatment
mouth NN B-NP I-treatment
receiving VBG O O
80 CD O O
cc JJ O O
per IN B-VP O
kilogram FW O O
per IN B-VP O
day NN B-NP O
of IN B-VP O
D10W NNP B-NP B-treatment
intravenously RB O I-treatment
. . B-VP O
   
Infant NNP B-NP B-person
was VBD B-VP O
started VBN O O
on IN B-VP O
enteral JJ B-NP B-treatment
feedings NNS I-NP I-treatment
on IN B-VP O
day NN B-NP O
of IN B-VP O
life NN B-NP O
four CD O O
and CC O O
advanced VBD B-VP O
to TO O O
full JJ B-NP O
volume NN I-NP O
feedings NNS I-NP O
of IN B-VP O
150 CD O O
cc NNS B-NP O
per IN B-VP O
kilogram FW O O
per IN B-VP O
day NN B-NP O
by IN B-VP O
day NN B-NP O
of IN B-VP O
life NN B-NP O
seven CD O O
. . B-VP O
   
During IN B-VP O
feeding VBG O B-treatment
advancement JJ B-NP I-treatment
infant NN I-NP B-person
was VBD B-VP O
given VBN O O
parenteral JJ B-NP B-treatment
nutrition NN I-NP I-treatment
and CC O O
intralipids NNS B-NP B-treatment
. . B-VP O
   
The DT B-NP B-person
infant NN I-NP I-person
tolerated VBD B-VP O
feeding JJ B-NP B-treatment
advancement NN I-NP I-treatment
without IN B-VP O
difficulty NN B-NP B-problem
. . B-VP O
   
Infant NNP B-NP B-person
was VBD B-VP O
advanced VBN O O
to TO O O
maximum VB O O
caloric JJ B-NP O
density NN I-NP O
of IN B-VP O
breast NN B-NP O
milk NN I-NP O
or CC O O
premature NN B-NP B-treatment
Enfamil NNP I-NP I-treatment
26 CD O O
calories NNS B-NP O
per IN B-VP O
ounce NN B-NP O
with IN B-VP O
ProMod NNP B-NP B-treatment
by IN B-VP O
day NN B-NP O
of IN B-VP O
life NN B-NP O
11 CD O O
. . B-VP O
   
Infant NN B-NP B-person
is VBZ O O
currently RB O O
on IN B-VP O
breast NN B-NP O
milk NN I-NP O
or CC O O
Enfamil NNP B-NP B-treatment
24 CD O O
calories NNS B-NP O
per IN B-VP O
ounce NN B-NP O
po NN I-NP O
minimum JJ O O
140 CD O O
cc NN B-NP O
per IN B-VP O
kilogram FW O O
per IN B-VP O
day NN B-NP O
. . B-VP O
   
The DT O B-test
most RBS O I-test
recent JJ B-NP I-test
weight NN I-NP I-test
is VBZ O O
2525 CD O O
g. NN B-NP O
Head NNP I-NP B-test
circumference NN I-NP I-test
24.5 CD O O
cm NN B-NP O
, , O O
length VBZ O B-test
45.5 CD O O
cm NN B-NP O
. . B-VP O
   
The DT O B-test
most RBS O I-test
recent JJ B-NP I-test
electrolytes NNS I-NP I-test
on IN B-VP O
day NN B-NP O
of IN B-VP O
life NN B-NP O
five CD O O
were VBD B-VP O
sodium NN B-NP B-test
145 CD O O
, , O O
chloride RB O B-test
115 CD O O
, , O O
potassium NN B-NP B-test
4 CD O O
, , O O
TCO2 NNP B-NP B-test
of IN B-VP O
21 CD O O
. . B-VP O
   
On IN B-VP O
day NN B-NP O
of IN B-VP O
life NN B-NP O
25 CD O O
, , O O
calcium NN B-NP B-test
10.1 CD O O
, , O O
phosphorus NN B-NP B-test
6.9 CD O O
, , O O
alkaline JJ B-NP B-test
phosphatase NN I-NP I-test
341 CD O O
. . B-VP O
   
4. CD O O
Gastrointestinal JJ O O
: : O O
Infant NN B-NP B-person
was VBD B-VP O
started VBN O O
on IN B-VP O
double JJ B-NP B-treatment
phototherapy NN I-NP I-treatment
on IN B-VP O
day NN B-NP O
of IN B-VP O
life NN B-NP O
two CD O O
for IN B-VP O
a DT B-NP B-test
maximum JJ I-NP I-test
bilirubin JJ I-NP I-test
level NN I-NP I-test
of IN B-VP O
8.1 CD O O
with IN B-VP O
a DT B-NP B-test
direct NN I-NP I-test
of IN B-VP O
0.3 CD O O
. . B-VP O
   
Infant NN B-NP B-person
decreased VBD B-VP O
to TO O O
single JJ B-NP B-treatment
phototherapy NN I-NP I-treatment
and CC O O
phototherapy NN B-NP B-treatment
was VBD B-VP O
discontinued VBN O O
on IN B-VP O
day NN B-NP O
of IN B-VP O
life NN B-NP O
six CD O O
. . B-VP O
   
Rebound VB O B-test
bilirubin JJ B-NP I-test
level NN I-NP I-test
on IN B-VP O
day NN B-NP O
of IN B-VP O
life NN B-NP O
seven CD O O
was VBD B-VP O
5.3 CD O O
with IN B-VP O
a DT B-NP B-test
direct NN I-NP I-test
of IN B-VP O
0.3 CD O O
. . B-VP O
   
5. CD O O
Hematology NN B-NP O
: : O O
The DT B-NP B-person
infant NN I-NP I-person
did VBD B-VP O
not RB O O
receive VB O O
any DT B-NP B-treatment
blood NN I-NP I-treatment
transfusions NNS I-NP I-treatment
this DT B-NP B-treatment
hospitalization NN I-NP I-treatment
. . B-VP O
   
The DT O B-test
most RBS O I-test
recent JJ B-NP I-test
hematocrit NN I-NP I-test
on IN B-VP O
day NN B-NP O
of IN B-VP O
life NN B-NP O
two CD O O
was VBD B-VP O
47% CD O O
. . B-VP O
   
CBC VB O B-test
on IN B-VP O
admission NN B-NP O
white JJ B-NP B-test
blood NN I-NP I-test
cell NN I-NP I-test
count NN I-NP I-test
8.9 CD O O
, , O O
hematocrit NN B-NP B-test
47% CD O O
, , O O
platelets NNS B-NP B-test
243,000 CD O O
, , O O
6% CD O O
neutrophils NNS B-NP B-test
, , O O
0 CD O O
bands NNS B-NP B-test
. . B-VP O
   
Repeat NNP B-NP B-test
CBC NNP I-NP I-test
on IN B-VP O
day NN B-NP O
of IN B-VP O
life NN B-NP O
two CD O O
showed VBD B-VP O
a DT B-NP B-test
white JJ I-NP I-test
blood NN I-NP I-test
cell NN I-NP I-test
count NN I-NP I-test
of IN B-VP O
8.4 CD O O
, , O O
platelets NNS B-NP B-test
95 CD O O
, , O O
41% CD O O
neutrophils NNS B-NP B-test
, , O O
0 CD O O
bands NNS B-NP B-test
. . B-VP O
   
Repeat NNP B-NP B-test
platelet NN I-NP I-test
count NN I-NP I-test
on IN B-VP O
day NN B-NP O
of IN B-VP O
life NN B-NP O
three CD O O
was VBD B-VP O
229 CD O O
. . B-VP O
   
6. CD O O
Infectious JJ B-NP O
disease NN I-NP O
: : O O
The DT B-NP B-person
infant NN I-NP I-person
received VBD B-VP O
48 CD O O
hours NNS B-NP O
of IN B-VP O
ampicillin NN B-NP B-treatment
and CC O O
gentamicin NN B-NP B-treatment
for IN B-VP O
rule NN B-NP O
out IN B-VP O
sepsis NN B-NP B-problem
. . B-VP O
   
Blood NNP B-NP B-test
cultures NNS I-NP I-test
remained VBD B-VP O
negative JJ O O
to TO O O
date NN B-NP O
. . B-VP O
   
Infant NNP B-NP B-person
has VBZ O O
not RB O O
had VBN O O
any DT B-NP B-problem
issues NNS I-NP I-problem
with IN B-VP I-problem
sepsis NN B-NP I-problem
this DT B-NP B-treatment
hospitalization NN I-NP I-treatment
. . B-VP O
   
7. CD O O
Neurology NN B-NP O
: : O O
Head NNP B-NP B-test
ultrasound IN B-VP I-test
on IN B-VP O
day NN B-NP O
of IN B-VP O
life NN B-NP O
seven CD O O
showed VBD B-VP O
no DT B-NP O
intraventricular JJ I-NP B-problem
hemorrhage NN I-NP I-problem
. . B-VP O
   
A DT B-NP B-test
repeat NN I-NP I-test
head NN I-NP I-test
ultrasound NN I-NP I-test
on IN B-VP O
day NN B-NP O
of IN B-VP O
life NN B-NP O
33 CD O O
06-07 NN B-NP O
showed VBD B-VP O
a DT B-NP B-problem
slight JJ I-NP I-problem
increase NN I-NP I-problem
of IN B-VP I-problem
echogenicity NN B-NP I-problem
in IN B-VP I-problem
the DT B-NP I-problem
caudothalamic JJ I-NP I-problem
groove NN I-NP I-problem
, , O O
which WDT O B-pronoun
may MD O O
represent VB O O
tiny JJ B-NP B-problem
bilateral JJ I-NP I-problem
germinal JJ I-NP I-problem
matrix NN I-NP I-problem
hemorrhages NNS I-NP I-problem
, , O O
no DT B-NP O
periventricular JJ I-NP B-problem
leukomalacia NN I-NP I-problem
. . B-VP O
   
A DT B-NP B-test
repeat NN I-NP I-test
head NN I-NP I-test
ultrasound NN I-NP I-test
is VBZ O O
recommended VBN O O
in IN B-VP O
one CD O O
month NN B-NP O
. . B-VP O
   
Normal NNP B-NP O
neurological JJ B-NP O
examination NN I-NP O
. . B-VP O
   
Sensory NNP B-NP B-test
, , O I-test
hearing VBG O I-test
screening NN B-NP I-test
was VBD B-VP O
performed VBN O O
with IN B-VP O
automated JJ B-NP O
auditory NN I-NP O
brain NN I-NP O
stem NN I-NP O
responses NNS I-NP O
. . B-VP O
   
Infant NN B-NP B-person
passed VBD B-VP O
both DT B-NP O
ears NNS I-NP O
. . B-VP O
   
Ophthalmology NNP B-NP O
, , O O
eyes NNS B-NP O
examined VBD B-VP O
most JJS O O
recently RB O O
on IN B-VP O
05-30 JJ B-NP O
revealing JJ I-NP O
immaturity NN I-NP B-problem
of IN B-VP I-problem
the DT B-NP I-problem
retinal JJ I-NP I-problem
vessels NNS I-NP I-problem
, , O O
but CC O O
no DT B-NP O
ROP NNP I-NP B-problem
as IN B-VP O
of IN B-VP O
yet RB O O
. . B-VP O
   
A DT O B-test
follow JJ O I-test
up RP O I-test
examination NN B-NP I-test
should MD O O
be VB O O
scheduled VBN O O
for IN B-VP O
the DT B-NP O
week NN I-NP O
of IN B-VP O
06-20 NN B-NP O
. . B-VP O
   
Ophthalmologist NNP B-NP B-person
is VBZ O O
Dr. NNP B-NP B-person
Cruea NNP I-NP I-person
Franklin NNP I-NP I-person
. . B-VP O
   
8. CD O O
Psycho NNP B-NP O
/ JJ O O
social JJ O O
: : O O
Parents NNS B-NP B-person
involved VBN O O
. . B-VP O
   
Triplet NNP B-NP B-person
number NN I-NP I-person
one CD O I-person
is VBZ O O
still RB O O
in IN B-VP O
the DT B-NP O
Neonatal NNP I-NP O
Intensive NNP I-NP O
Care NNP I-NP O
Unit NNP I-NP O
and CC O O
triplet NN B-NP B-person
number NN I-NP I-person
three CD O I-person
is VBZ O O
home VBN O O
with IN B-VP O
family NN B-NP B-person
and CC O O
there EX O O
is VBZ O O
also RB O O
a DT O B-person
2 CD O I-person
year-old JJ B-NP I-person
sibling NN I-NP I-person
. . B-VP O
   
CONDITION NNP B-NP O
ON NNP I-NP O
DISCHARGE NNP I-NP O
: : O O
Stable JJ O O
on IN B-VP O
room NN B-NP O
air NN I-NP O
. . B-VP O
   
DISCHARGE NNP B-NP O
DISPOSITION NNP I-NP O
: : O O
Home NN B-NP O
with IN B-VP O
parents NNS B-NP B-person
. . B-VP O
   
NAME NN B-NP O
OF NNP I-NP O
PRIMARY NNP I-NP B-person
PEDIATRICIAN NNP I-NP I-person
: : O O
Dr. NNP B-NP B-person
Janetta NNP I-NP I-person
Burmaster NNP I-NP I-person
, , O O
phone NN B-NP O
number NN I-NP O
( ( O O
262 CD O O
) ) O O
892 CD O O
0330 CD O O
, , O O
fax VBD B-VP O
491-6171 JJ O O
. . B-VP O
   
CARE NNP B-NP O
AND CC O O
RECOMMENDATIONS NNP B-NP O
: : O O
Feedings NNS B-NP O
breast VBP O O
milk NN B-NP O
or CC O O
Enfamil NNP B-NP B-treatment
24 CD O O
calories NNS B-NP O
per IN B-VP O
ounce NN B-NP O
, , O O
breast NN B-NP O
milk NN I-NP O
mixed VBN O O
with IN B-VP O
4 CD O O
calories NNS B-NP O
per IN B-VP O
ounce NN B-NP O
of IN B-VP O
Enfamil NNP B-NP B-treatment
powder NN I-NP I-treatment
, , O O
minimum NN B-NP O
of IN B-VP O
140 CD O O
cc NNS B-NP O
per IN B-VP O
kilogram FW O O
per IN B-VP O
day NN B-NP O
po NN I-NP O
. . B-VP O
   
MEDICATIONS NN B-NP O
: : O O
Ferrous JJ B-NP B-treatment
sulfate NN I-NP I-treatment
25 CD O O
mg NN B-NP O
per IN B-VP O
ml NN B-NP O
, , O O
2 CD O O
mg NN B-NP O
per IN B-VP O
kilogram FW O O
per IN B-VP O
day NN B-NP O
. . B-VP O
   
Car NNP B-NP B-test
seat NN I-NP I-test
position NN I-NP I-test
screening VBG O I-test
passed VBN O O
on IN B-VP O
06-07 NN B-NP O
. . B-VP O
   
Hearing VBG O B-test
screen NN B-NP I-test
passed VBN O O
on IN B-VP O
2016-06-07 JJ O O
. . B-VP O
   
State NNP B-NP B-test
newborn JJ B-NP I-test
screens NNS I-NP I-test
were VBD B-VP O
sent VBN O O
on IN B-VP O
05-08 JJ O O
and CC O O
05-19 JJ O O
. . B-VP O
   
No DT B-NP O
abnormal JJ I-NP B-problem
results NNS I-NP I-problem
have VBP O O
been VBN O O
reported VBN O O
. . B-VP O
   
Immunizations NNS B-NP B-treatment
, , O O
the DT B-NP B-person
infant NN I-NP I-person
received VBD B-VP O
hepatitis NN B-NP B-treatment
B NNP I-NP I-treatment
vaccine NN I-NP I-treatment
on IN B-VP O
2016-06-02 JJ O O
. . B-VP O
   
Immunizations NNS B-NP B-treatment
recommended VBD B-VP O
, , O O
Synagis NNP B-NP B-treatment
RSV NNP I-NP I-treatment
prophylaxis NN I-NP I-treatment
should MD O O
be VB O O
considered VBN O O
from IN B-VP O
October NNP B-NP O
through IN B-VP O
April NNP B-NP O
for IN B-VP O
infants NNS B-NP B-person
who WP O B-person
meet VBP O O
any DT O O
of IN B-VP O
the DT O O
following JJ O O
three CD O O
criteria NNS B-NP O
, , O O
born VBN O O
at IN B-VP O
less JJR O O
then RB O O
32 CD O O
weeks NNS B-NP O
, , O O
born VBN O O
between IN B-VP O
32 CD O O
and CC O O
35 CD O O
weeks NNS B-NP O
with IN B-VP O
two CD O O
of IN B-VP O
three CD O O
of IN B-VP O
the DT O O
following JJ O O
, , O O
day NN B-NP O
care NN I-NP O
during IN B-VP O
RSV NNP B-NP O
season NN I-NP O
, , O O
smoker NN B-NP O
on IN B-VP O
the DT B-NP O
household NN I-NP O
, , O O
neuromuscular JJ B-NP B-problem
disease NN I-NP I-problem
, , O O
airway JJ B-NP B-problem
abnormalities NNS I-NP I-problem
or CC O O
school NN B-NP B-person
age NN I-NP I-person
siblings NNS I-NP I-person
or CC O O
with IN B-VP O
chronic JJ B-NP B-problem
lung NN I-NP I-problem
disease NN I-NP I-problem
. . B-VP O
   
Influenza NNP B-NP B-treatment
immunization NN I-NP I-treatment
is VBZ O O
recommended VBN O O
annually RB O O
in IN B-VP O
the DT B-NP O
fall NN I-NP O
for IN B-VP O
all DT B-NP B-person
infants NNS I-NP I-person
once IN B-VP O
they PRP O B-pronoun
reach VBP O O
six CD O O
months NNS B-NP O
of IN B-VP O
age NN B-NP O
. . B-VP O
   
Before IN B-VP O
this DT B-NP O
age NN I-NP O
and CC O O
for IN B-VP O
the DT O O
first JJ O O
24 CD O O
months NNS B-NP O
of IN B-VP O
the DT B-NP B-person
child NN I-NP I-person
's POS O I-person
life NN B-NP O
immunization NN I-NP B-treatment
against IN B-VP O
influenza NN B-NP B-problem
is VBZ O O
recommended VBN O O
for IN B-VP O
household NN B-NP O
contacts NNS I-NP O
and CC O O
out IN B-VP O
of IN B-VP O
home NN B-NP O
caregivers NNS I-NP O
. . B-VP O
   
FOLLOW NNP B-NP O
UP IN B-VP O
APPOINTMENTS NNP B-NP O
: : O O
1. CD O O
Primary NNP B-NP B-person
pediatrician NN I-NP I-person
. . B-VP O
   
2. CD O O
Ophthalmology NNP B-NP B-person
Dr. NNP I-NP B-person
Wilson NNP I-NP I-person
. . B-VP O
   
3. CD O O
Visiting NNP B-NP B-person
Nurse NNP I-NP I-person
Association NNP I-NP I-person
early JJ B-NP O
intervention NN I-NP O
program NN I-NP O
. . B-VP O
   
DISCHARGE NNP B-NP O
DIAGNOSES NNP I-NP O
: : O O
1. CD O O
Prematurity NNP B-NP B-problem
triplet NN I-NP B-person
number NN I-NP I-person
two CD O I-person
. . B-VP O
   
2. CD O O
Status NNP B-NP O
post NN I-NP O
respiratory NN I-NP B-problem
distress NN I-NP I-problem
. . B-VP O
   
3. CD O O
Status NNP B-NP O
post NN I-NP O
rule NN I-NP O
out IN B-VP O
sepsis NN B-NP B-problem
, , O O
ruled VBD B-VP O
out RP O O
. . B-VP O
   
4. CD O O
Status NNP B-NP O
post NN I-NP O
apnea NN I-NP B-problem
of IN B-VP I-problem
prematurity NN B-NP I-problem
. . B-VP O
   
5. CD O O
Status NNP B-NP O
post NN I-NP O
indirect NN I-NP B-problem
hyperbilirubinemia NN I-NP I-problem
. . B-VP O
   
Richard NNP B-NP B-person
Hartney NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
02-219 CD O O
Dictated VBN O O
By IN B-VP O
: : O O
Leonard NNP B-NP B-person
J. NNP I-NP I-person
Pellegrino NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
MEDQUIST36 NNP I-NP O
D NNP I-NP O
: : O O
2016-06-14 JJ O O
11:22 CD O O
T NN B-NP O
: : O O
2016-06-15 JJ O O
07:09 CD O O
JOB NNP B-NP O
#: VBD B-VP O
47623 CD O O
Signed VBN O O
electronically RB O O
by IN B-VP O
: : O O
DR. NNP B-NP B-person
Thomas NNP I-NP I-person
M. NNP I-NP I-person
Muth NNP I-NP I-person
on IN B-VP O
: : O O
WED JJ O O
2016-06-15 JJ O O
9:49 CD O O
AM NNP B-NP O
( ( O O
End NNP B-NP O
of IN B-VP O
Report NNP B-NP O
) ) O O
-EMPTYLINE- VBP O O
-DOCSTART- JJ B-NP O
-EMPTYLINE- NNP I-NP O
Admission NNP I-NP O
Date NNP I-NP O
: : O O
2011-01-19 JJ B-NP O
Discharge NN I-NP O
Date NNP I-NP O
: : O O
2011-01-25 JJ B-NP O
Date NNP I-NP O
of IN B-VP O
Birth NNP B-NP O
: : O O
1943-01-22 JJ B-NP O
Sex NN I-NP O
: : O O
M NNP B-NP O
Service NNP I-NP O
: : O O
MEDICINE NNP B-NP O
INDICATION NNP I-NP O
FOR NNP I-NP O
ADMISSION NNP I-NP O
: : O O
Transfer NN B-NP O
from IN B-VP O
Rehab NNP B-NP O
Hospital NNP I-NP O
of IN B-VP O
the DT B-NP O
Cape NNP I-NP O
& CC O O
Islands NNP B-NP O
Hospital NNP I-NP O
for IN B-VP O
an DT B-NP B-test
endoscopic NN I-NP I-test
retrogram NN I-NP I-test
cholangiopancreatography NN I-NP I-test
. . B-VP O
   
HISTORY NNP B-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS NNP I-NP O
: : O O
Mr. NNP B-NP B-person
Eugene NNP I-NP I-person
is VBZ O O
a DT O O
67 CD O O
year NN B-NP O
old JJ B-NP O
male NN I-NP O
with IN B-VP O
a DT B-NP O
remote JJ I-NP O
history NN I-NP O
of IN B-VP O
chronic JJ B-NP B-problem
pancreatitis NN I-NP I-problem
due JJ O O
to TO O O
alcohol VB O O
abuse IN B-VP O
30 CD O O
years NNS B-NP O
ago RB O O
, , O O
who WP O B-person
is VBZ O O
transferred VBN O O
now RB O O
from IN B-VP O
Rehab NNP B-NP O
Hospital NNP I-NP O
of IN B-VP O
the DT B-NP O
Cape NNP I-NP O
& CC O O
Islands NNP B-NP O
Hospital NNP I-NP O
for IN B-VP O
an DT B-NP B-test
ERCP NNP I-NP I-test
and CC O O
work-up NN B-NP B-test
for IN B-VP O
a DT B-NP B-problem
cystic JJ I-NP I-problem
lesion NN I-NP I-problem
at IN B-VP O
the DT B-NP O
head NN I-NP O
of IN B-VP O
his PRP$ O B-person
pancreas NNS B-NP O
on IN B-VP O
CT NNP B-NP B-test
scan JJ O I-test
shown VBN O O
at IN B-VP O
the DT B-NP O
outside JJ I-NP O
hospital NN I-NP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
presented VBD B-VP O
initially RB O O
to TO O O
Rehab NNP B-NP O
Hospital NNP I-NP O
of IN B-VP O
the DT B-NP O
Cape NNP I-NP O
& CC O O
Islands NNP B-NP O
Hospital NNP I-NP O
at IN B-VP O
the DT B-NP O
end NN I-NP O
of IN B-VP O
December NNP B-NP O
for IN B-VP O
abdominal JJ B-NP B-problem
pain NN I-NP I-problem
, , O O
and CC O O
was VBD B-VP O
found VBN O O
to TO O O
have VB O O
pancreatitis NN B-NP B-problem
. . B-VP O
   
During IN B-VP O
this DT B-NP O
admission NN I-NP O
, , O O
two CD O B-test
CT NNP B-NP I-test
scans NNS I-NP I-test
had VBD B-VP O
shown VBN O O
a DT B-NP O
question NN I-NP O
of IN B-VP O
an DT B-NP B-problem
enlargement NN I-NP I-problem
of IN B-VP I-problem
the DT B-NP I-problem
head NN I-NP I-problem
of IN B-VP I-problem
his PRP$ O B-person
his PRP$ O I-problem
pancreas NNS B-NP I-problem
versus VBP O O
early JJ B-NP B-problem
pseudocyst NN I-NP I-problem
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
discharged VBN O O
home RB O O
early RB O O
from IN B-VP O
this DT B-NP O
admission NN I-NP O
due JJ O O
to TO O O
family NN B-NP O
needs NNS I-NP O
. . B-VP O
   
While IN B-VP O
at IN B-VP O
home NN B-NP O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
did VBD B-VP O
not RB O O
do VB O O
well RB O O
and CC O O
could MD O O
tolerate VB O O
minimal JJ B-NP O
food NN I-NP O
intake NN I-NP O
and CC O O
lost VBN O O
about IN B-VP O
20 CD O O
pounds NNS B-NP O
in IN B-VP O
one CD O O
month NN B-NP O
. . B-VP O
   
On IN B-VP O
an DT B-NP O
office NN I-NP O
visit NN I-NP O
on IN B-VP O
01-14 NN B-NP O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
found VBN O O
to TO O O
have VB O O
significantly RB O B-problem
elevated VBN O I-problem
alkaline JJ B-NP I-problem
phosphatase NN I-NP I-problem
. . B-VP O
   
That IN B-VP O
evening NN B-NP O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
again RB O O
developed VBD B-VP O
abdominal JJ B-NP B-problem
pain NN I-NP I-problem
" NNS I-NP O
like IN B-VP O
his PRP$ O B-person
his PRP$ O B-problem
pancreatitis NN B-NP I-problem
" NN I-NP O
with IN B-VP O
nausea NN B-NP B-problem
and CC O O
vomiting NN B-NP B-problem
, , O O
for IN B-VP O
which WDT O B-pronoun
he PRP O B-person
was VBD B-VP O
admitted VBN O O
to TO O O
the DT B-NP O
Rehab NNP I-NP O
Hospital NNP I-NP O
of IN B-VP O
the DT B-NP O
Cape NNP I-NP O
& CC O O
Islands NNP B-NP O
Hospital NNP I-NP O
. . B-VP O
   
In IN B-VP O
the DT B-NP O
Emergency NNP I-NP O
Department NNP I-NP O
at IN B-VP O
the DT B-NP O
Rehab NNP I-NP O
Hospital NNP I-NP O
of IN B-VP O
the DT B-NP O
Cape NNP I-NP O
& CC O O
Islands NNP B-NP O
Hospital NNP I-NP O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
noted VBN O O
to TO O O
have VB O O
vomited VBN O O
some DT B-NP O
heme NN I-NP O
positive JJ B-NP O
material NN I-NP O
. . B-VP O
   
His PRP$ O B-person
His PRP$ O B-test
complete JJ B-NP I-test
blood NN I-NP I-test
count NN I-NP I-test
showed VBD B-VP O
11% CD O B-problem
bandemia NN B-NP I-problem
with IN B-VP O
a DT B-NP B-test
total JJ I-NP I-test
white JJ I-NP I-test
count NN I-NP I-test
of IN B-VP O
10 CD O O
. . B-VP O
   
A DT B-NP B-test
HIDA JJ I-NP I-test
scan NN I-NP I-test
showed VBD B-VP O
no DT B-NP B-problem
flow NN I-NP I-problem
, , O O
question NN B-NP O
of IN B-VP O
pancreatitis NN B-NP B-problem
versus NN I-NP O
common JJ B-NP B-problem
bile NN I-NP I-problem
duct NN I-NP I-problem
obstruction NN I-NP I-problem
. . B-VP O
   
His PRP$ O B-person
His PRP$ O B-test
electrocardiogram NN B-NP I-test
showed VBD B-VP O
a DT B-NP O
normal JJ I-NP O
sinus NN I-NP O
rhythm NN I-NP O
. . B-VP O
   
A DT B-NP B-test
chest JJ I-NP I-test
x-ray NN I-NP I-test
was VBD B-VP O
unremarkable JJ O O
. . B-VP O
   
During IN B-VP O
his PRP$ O B-person
admission NN B-NP O
to TO O O
Rehab NNP B-NP O
Hospital NNP I-NP O
of IN B-VP O
the DT B-NP O
Cape NNP I-NP O
& CC O O
Islands NNP B-NP O
Hospital NNP I-NP O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
had VBD B-VP O
dropped VBN O O
his PRP$ O B-person
his PRP$ O B-test
hematocrit NN B-NP I-test
to TO O O
the DT O O
30 CD O O
s NN B-NP O
with IN B-VP O
recorded JJ B-NP B-problem
melena NN I-NP I-problem
. . B-VP O
   
He PRP O B-person
received VBD B-VP O
an DT B-NP B-test
MRCP NNP I-NP I-test
which WDT O B-pronoun
was VBD B-VP O
negative JJ O O
for IN B-VP O
evidence NN B-NP O
of IN B-VP O
stones NNS B-NP B-problem
. . B-VP O
   
An DT O B-test
ultrasound JJ O I-test
showed VBD B-VP O
normal JJ B-NP O
gallbladder NN I-NP O
with IN B-VP O
no DT B-NP O
wall NN I-NP B-problem
thickening VBG O I-problem
but CC O O
a DT O B-problem
dilated JJ O I-problem
common JJ O I-problem
bile IN B-VP I-problem
duct NN B-NP I-problem
of IN B-VP O
8 CD O O
mm NNS B-NP O
measured VBN O O
on IN B-VP O
CT NNP B-NP B-test
scan JJ O I-test
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
had VBD B-VP O
an DT B-NP B-test
attempted JJ I-NP I-test
ERCP NN I-NP I-test
on IN B-VP O
01-18 NN B-NP O
, , O O
which WDT O B-pronoun
was VBD B-VP O
unsuccessful JJ O O
due JJ O O
to TO O O
a DT B-NP B-problem
long JJ I-NP I-problem
nipple NN I-NP I-problem
like IN B-VP I-problem
papilla NN B-NP I-problem
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
therefore RB O O
transferred VBN O O
to TO O O
Saints NNP B-NP O
Medical NNP I-NP O
Center NNP I-NP O
for IN B-VP O
endoscopic JJ B-NP B-test
retrogram NN I-NP I-test
cholangiopancreatography NN I-NP I-test
. . B-VP O
   
The DT O B-person
The DT B-NP B-test
patient JJ I-NP I-person
patient NN I-NP I-test
's POS O I-person
's POS O I-test
blood NN B-NP I-test
cultures NNS I-NP I-test
at IN B-VP O
outside JJ B-NP O
hospital NN I-NP O
grew VBD B-VP O
out RP O O
Streptococcus NNP B-NP B-problem
sanguis-gordonii NN I-NP I-problem
on IN B-VP O
01-18 NN B-NP O
. . B-VP O
   
This DT O B-pronoun
was VBD B-VP O
sensitive JJ O O
to TO O O
Clindamycin NNP B-NP B-treatment
, , O O
Erythromycin NNP B-NP B-treatment
, , O O
penicillin NN B-NP B-treatment
S NNP I-NP I-treatment
and CC O O
Vancomycin NNP B-NP B-treatment
. . B-VP O
   
Prior NNP B-NP O
to TO O O
this DT B-NP O
result NN I-NP O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
had VBD B-VP O
already RB O O
been VBN O O
on IN B-VP O
Ampicillin NNP B-NP B-treatment
, , O O
Sulbactam NNP B-NP B-treatment
and CC O O
Gentamycin NNP B-NP B-treatment
. . B-VP O
   
It PRP O B-pronoun
appears VBZ O O
from IN B-VP O
the DT B-NP O
Discharge NNP I-NP O
summary NN I-NP O
that IN B-VP O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
placed VBN O O
on IN B-VP O
Unasyn NNP B-NP B-treatment
3 CD O O
grams NNS B-NP O
intravenously RB O O
every DT O O
six CD O O
hours NNS B-NP O
after IN B-VP O
his PRP$ O B-person
his PRP$ O B-test
ERCP NNP B-NP I-test
. . B-VP O
   
PAST NNP B-NP O
MEDICAL NNP I-NP O
HISTORY NNP I-NP O
: : O O
1. CD O O
Type NNP B-NP B-problem
2 CD O I-problem
diabetes NNS B-NP I-problem
mellitus RB O I-problem
. . B-VP O
   
2. CD O O
Right JJ B-NP B-problem
rotator NN I-NP I-problem
cuff JJ B-NP I-problem
injury NN I-NP I-problem
. . B-VP O
   
3. CD O O
Gastroesophageal NNP B-NP B-problem
reflux JJ B-NP I-problem
disease NN I-NP I-problem
with IN B-VP O
esophageal JJ B-NP B-treatment
dilatation NN I-NP I-treatment
for IN B-VP O
stricture NN B-NP B-problem
. . B-VP O
   
4. CD O O
Recent JJ B-NP B-problem
pancreatitis NN I-NP I-problem
; : O O
prior JJ B-NP O
history NN I-NP O
for IN B-VP O
recurrent NN B-NP B-problem
pancreatitis NN I-NP I-problem
30 CD O O
years NNS B-NP O
ago RB O O
from IN B-VP O
alcohol NN B-NP O
. . B-VP O
   
5. CD O O
History NN B-NP O
of IN B-VP O
Streptococcemia NNP B-NP B-problem
in IN B-VP O
the DT B-NP O
year NN I-NP O
2008 CD O O
; : O O
source NN B-NP O
was VBD B-VP O
unclear JJ O O
but CC O O
presumed VBN O O
to TO O O
be VB O O
urinary JJ O O
. . B-VP O
   
6. CD O O
Status NNP B-NP O
post NN I-NP O
tonsillectomy NN I-NP B-treatment
as IN B-VP O
a DT B-NP O
child NN I-NP O
. . B-VP O
   
MEDICATIONS NNP B-NP O
AT NNP I-NP O
HOME NNP I-NP O
: : O O
1. CD O O
Prilosec NNP B-NP B-treatment
20 CD O O
mg NN B-NP O
p.o. NN I-NP O
q. JJ B-NP O
day NN I-NP O
. . B-VP O
   
2. CD O O
Flomax NNP B-NP B-treatment
4 CD O O
mg NN B-NP O
p.o. NN I-NP O
q. JJ B-NP O
day NN I-NP O
. . B-VP O
   
3. CD O O
Humalog NNP B-NP B-treatment
75/25 CD O O
, , O O
subcutaneously RB O O
. . B-VP O
   
4. CD O O
Regular JJ B-NP B-treatment
insulin NN I-NP I-treatment
15 CD O O
units NNS B-NP O
q. JJ O O
a.m. RB O O
and CC O O
14 CD O O
units NNS B-NP O
q. RB O O
p.m. VBP O O
MEDICATIONS NNP B-NP O
ON NNP I-NP O
ADMISSION NNP I-NP O
FROM NNP I-NP O
TRANSFER NNP I-NP O
: : O O
1. CD O O
Unasyn NNP B-NP B-treatment
3 CD O O
grams NNS B-NP O
intravenous JJ O O
every DT O O
six CD O O
hours NNS B-NP O
. . B-VP O
   
2. CD O O
NPH NNP B-NP B-treatment
10 CD O O
units NNS B-NP O
subcutaneously RB O O
every DT B-NP O
morning NN I-NP O
and CC O O
8 CD O O
units NNS B-NP O
subcutaneously RB O O
every DT B-NP O
evening NN I-NP O
. . B-VP O
   
3. CD O O
Flomax NNP B-NP B-treatment
0.4 CD O O
mg NN B-NP O
p.o. NN I-NP O
q. JJ B-NP O
day NN I-NP O
. . B-VP O
   
4. CD O O
Prilosec NNP B-NP B-treatment
30 CD O O
mg NN B-NP O
p.o. NN I-NP O
q. JJ B-NP O
day NN I-NP O
. . B-VP O
   
5. CD O O
Regular JJ B-NP B-treatment
insulin NN I-NP I-treatment
sliding VBG O I-treatment
scale NN B-NP I-treatment
. . B-VP O
   
6. CD O O
Tylenol NNP B-NP B-treatment
. . B-VP O
   
ALLERGIES NN B-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
is VBZ O O
allergic JJ O B-problem
to TO O O
Ciprofloxacin NNP B-NP B-treatment
, , O O
morphine NN B-NP B-treatment
sulfate NN I-NP I-treatment
and CC O O
Droperidol NNP B-NP B-treatment
. . B-VP O
   
SOCIAL NNP B-NP O
HISTORY NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
lives VBZ O O
with IN B-VP O
his PRP$ O B-person
his PRP$ O B-person
disabled JJ B-NP I-person
wife NN I-NP I-person
who WP O B-person
has VBZ O O
a DT B-NP B-problem
psychiatric JJ I-NP I-problem
condition NN I-NP I-problem
. . B-VP O
   
He PRP O B-person
had VBD B-VP O
a DT B-NP O
history NN I-NP O
of IN B-VP O
alcohol NN B-NP O
abuse NN I-NP O
but CC O O
has VBZ O O
been VBN O O
sober VBN O O
for IN B-VP O
30 CD O O
years NNS B-NP O
. . B-VP O
   
He PRP O B-person
is VBZ O O
a DT B-NP O
retired JJ I-NP O
painter NN I-NP O
. . B-VP O
   
PHYSICAL JJ B-NP O
EXAMINATION NN I-NP O
: : O O
On IN B-VP O
admission NN B-NP O
showed VBD B-VP O
a DT B-NP B-test
temperature NN I-NP I-test
of IN B-VP O
97.1 CD O O
F. NNP B-NP O
; : O O
heart NN B-NP B-test
rate NN I-NP I-test
of IN B-VP O
65 CD O O
; : O O
blood NN B-NP B-test
pressure NN I-NP I-test
of IN B-VP O
146/74 CD O O
; : O O
respiratory JJ B-NP B-test
rate NN I-NP I-test
of IN B-VP O
20 CD O O
; : O O
oxygen NN B-NP B-test
saturation NN I-NP I-test
98% CD O O
on IN B-VP O
three CD O O
liters NNS B-NP O
and CC O O
95% CD O O
on IN B-VP O
room NN B-NP O
air NN I-NP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
alert JJ O O
, , O O
awake JJ O O
and CC O O
oriented VBN O O
, , O O
pleasant JJ O O
, , O O
and CC O O
in IN B-VP O
no DT B-NP O
acute JJ I-NP B-problem
distress NN I-NP I-problem
. . B-VP O
   
Head NNP B-NP B-test
, , O I-test
eyes NNS B-NP I-test
, , O I-test
ears NNS B-NP I-test
, , O I-test
nose RB O I-test
and CC O I-test
throat VB O I-test
examination NN B-NP I-test
revealed VBD B-VP O
mucous JJ B-NP O
membranes NNS I-NP O
that WDT O O
were VBD B-VP O
moist RBS O O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
has VBZ O O
two CD O O
teeth NN B-NP O
. . B-VP O
   
He PRP O B-person
has VBZ O O
fine JJ B-NP O
dental JJ I-NP O
hygiene NN I-NP O
. . B-VP O
   
He PRP O B-person
had VBD B-VP O
no DT B-NP O
icterus NN I-NP B-problem
. . B-VP O
   
Cardiovascular JJ B-NP O
system NN I-NP O
revealed VBD B-VP O
normal JJ B-NP O
S1 NNP I-NP O
and CC O O
S2 NNP B-NP O
, , O O
no DT B-NP O
murmurs NN I-NP B-problem
or CC O O
gallops NNS B-NP B-problem
and CC O O
regular JJ B-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
. . B-VP O
   
Pulmonary JJ B-NP B-test
examination NN I-NP I-test
revealed VBD B-VP O
lungs NNS B-NP O
clear JJ O O
to TO O O
auscultation VB O B-test
bilaterally RB O O
. . B-VP O
   
Abdominal JJ B-NP B-test
examination NN I-NP I-test
revealed VBD B-VP O
an DT B-NP O
abdomen NNS I-NP O
that WDT O O
is VBZ O O
nondistended VBN O B-problem
, , O O
nontender NN B-NP B-problem
. . B-VP O
   
He PRP O B-person
had VBD B-VP O
normoactive JJ B-NP O
bowel NN I-NP O
sounds NNS I-NP O
. . B-VP O
   
His PRP$ O B-person
His PRP$ O B-test
liver NN B-NP I-test
span NN I-NP I-test
was VBD B-VP O
8 CD O O
cm NN B-NP O
. . B-VP O
   
The DT B-NP O
antrum NN I-NP O
was VBD B-VP O
palpable JJ O O
3 CD O O
cm NN B-NP O
below IN B-VP O
the DT B-NP O
costal JJ I-NP O
margin NN I-NP O
. . B-VP O
   
The DT B-NP O
spleen JJ I-NP O
tip NN I-NP O
was VBD B-VP O
palpable JJ O O
. . B-VP O
   
There EX O O
was VBD B-VP O
no DT B-NP O
rebound NN I-NP B-problem
; : O O
no DT B-NP O
Munos NNP I-NP B-problem
sign NN I-NP I-problem
. . B-VP O
   
Extremities NNS B-NP O
reveal VBP O O
no DT B-NP O
edema NN I-NP B-problem
, , O O
no DT O O
swelling VBG O B-problem
. . B-VP O
   
Neurologic NNP B-NP B-test
examination NN I-NP I-test
revealed VBD B-VP O
an DT B-NP O
alert NN I-NP O
and CC O O
oriented VBN O O
individual JJ O O
. . B-VP O
   
His PRP$ O B-person
face NN B-NP O
was VBD B-VP O
symmetric JJ O O
; : O O
tongue NN B-NP O
was VBD B-VP O
midline NN B-NP O
. . B-VP O
   
His PRP$ O B-person
language NN B-NP O
was VBD B-VP O
fluent JJ O O
and CC O O
normal JJ O O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
moving VBG O O
all DT O O
four CD O O
extremities NNS B-NP O
with IN B-VP O
ease NN B-NP O
. . B-VP O
   
There EX O O
was VBD B-VP O
no DT B-NP O
formal JJ I-NP B-test
strength NN I-NP I-test
test NN I-NP I-test
done VBN O O
. . B-VP O
   
LABORATORY NN B-NP O
: : O O
Studies NNS B-NP O
revealed VBD B-VP O
a DT B-NP B-test
hematocrit NN I-NP I-test
of IN B-VP O
32.6 CD O O
, , O O
white JJ B-NP B-test
count NN I-NP I-test
of IN B-VP O
6.0 CD O O
. . B-VP O
   
His PRP$ O B-person
His PRP$ O B-test
platelet NN B-NP I-test
count NN I-NP I-test
was VBD B-VP O
267 CD O O
. . B-VP O
   
His PRP$ O B-person
His PRP$ O B-test
MCV NNP B-NP I-test
was VBD B-VP O
88 CD O O
, , O O
red JJ B-NP B-test
cell NN I-NP I-test
distribution NN I-NP I-test
was VBD B-VP O
13.4 CD O O
. . B-VP O
   
Chemistry NN B-NP O
on IN B-VP O
admission NN B-NP O
showed VBD B-VP O
a DT B-NP B-test
sodium NN I-NP I-test
of IN B-VP O
141 CD O O
, , O O
potassium NN B-NP B-test
of IN B-VP O
4.3 CD O O
, , O O
chloride NN B-NP B-test
of IN B-VP O
107 CD O O
, , O O
bicarbonate NN B-NP B-test
of IN B-VP O
25 CD O O
, , O O
BUN NNP B-NP B-test
of IN B-VP O
4 CD O O
, , O O
creatinine NN B-NP B-test
of IN B-VP O
0.6 CD O O
and CC O O
a DT B-NP B-test
sugar NN I-NP I-test
of IN B-VP O
177 CD O O
. . B-VP O
   
Liver NNP B-NP B-test
function NN I-NP I-test
tests NNS I-NP I-test
revealed VBD B-VP O
an DT B-NP B-test
ALT NNP I-NP I-test
of IN B-VP O
31 CD O O
, , O O
AST NNP B-NP B-test
of IN B-VP O
36 CD O O
, , O O
alkaline JJ B-NP B-test
phosphatase NN I-NP I-test
of IN B-VP O
509 CD O O
. . B-VP O
   
Total JJ B-NP B-test
bilirubin NN I-NP I-test
was VBD B-VP O
0.8 CD O O
. . B-VP O
   
Albumin NNP B-NP B-test
was VBD B-VP O
2.6 CD O O
. . B-VP O
   
His PRP$ O B-person
His PRP$ O B-test
blood NN B-NP I-test
cultures NNS I-NP I-test
were VBD B-VP O
drawn VBN O O
and CC O O
pending VBG O O
. . B-VP O
   
Urinalysis NN B-NP B-test
revealed VBD B-VP O
trace NN B-NP B-problem
glucose NN I-NP I-problem
, , O O
no DT B-NP O
ketones NNS I-NP B-problem
, , O O
no DT B-NP O
red JJ I-NP B-problem
cells NNS I-NP I-problem
, , O O
no DT B-NP O
white JJ I-NP B-problem
cells NNS I-NP I-problem
and CC O O
less JJR O O
than IN B-VP O
one CD O O
epithelial JJ B-NP O
cells NNS I-NP O
. . B-VP O
   
COURSE NNP B-NP O
IN NNP I-NP O
HOSPITAL NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
taken VBN O O
down RB O O
to TO O O
the DT B-NP B-test
endoscopic NN I-NP I-test
retrogram NN I-NP I-test
cholangiopancreatogram NN I-NP I-test
upon IN B-VP O
admission NN B-NP O
. . B-VP O
   
On IN B-VP O
this DT B-NP B-test
examination NN I-NP I-test
, , O O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
found VBN O O
to TO O O
have VB O O
mild JJ B-NP B-problem
biliary JJ I-NP I-problem
stricture NN I-NP I-problem
most RBS O O
likely JJ O O
secondary JJ O O
to TO O O
chronic JJ B-NP B-problem
pancreatitis NN I-NP I-problem
. . B-VP O
   
Cytology NNP B-NP B-test
was VBD B-VP O
obtained VBN O O
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
also RB O O
found VBN O O
to TO O O
have VB O O
dilated VBN O B-problem
pancreatic JJ B-NP I-problem
ducts NNS I-NP I-problem
with IN B-VP O
calcifications NNS B-NP B-problem
consistent JJ O O
with IN B-VP O
chronic JJ B-NP B-problem
pancreatitis NN I-NP I-problem
. . B-VP O
   
The DT B-NP B-person
patient JJ I-NP I-person
underwent NN I-NP O
a DT B-NP B-treatment
percutaneous JJ I-NP I-treatment
sphincterotomy NN I-NP I-treatment
extended VBD B-VP O
to TO O O
a DT B-NP B-treatment
full JJ I-NP I-treatment
sphincterectomy NN I-NP I-treatment
. . B-VP O
   
He PRP O B-person
also RB O O
had VBD B-VP O
successful JJ B-NP B-treatment
extraction NN I-NP I-treatment
of IN B-VP O
stone NN B-NP B-problem
fragments NNS I-NP I-problem
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
tolerated VBD B-VP O
this DT O B-treatment
this DT B-NP B-pronoun
procedure NN I-NP I-treatment
well RB O O
and CC O O
had VBD B-VP O
no DT B-NP O
complications NNS I-NP B-problem
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
subsequently RB O O
underwent VBD B-VP O
a DT B-NP B-test
CT NNP I-NP I-test
scan JJ B-NP I-test
angiogram NN I-NP I-test
with IN B-VP O
Pancreas NNP B-NP B-test
protocol NN I-NP I-test
to TO O O
assess VB O O
the DT B-NP O
pseudocyst NN I-NP B-problem
versus NN I-NP O
enlarged VBD B-VP B-problem
pancreas JJ B-NP I-problem
head NN I-NP I-problem
. . B-VP O
   
The DT B-NP O
results NNS I-NP O
of IN B-VP O
this DT B-NP B-test
study NN I-NP I-test
indicated VBD B-VP O
that IN B-VP O
this DT B-NP B-pronoun
structure NN I-NP O
at IN B-VP O
the DT B-NP O
head NN I-NP O
of IN B-VP O
his PRP$ O B-person
pancreas NN B-NP O
is VBZ O O
most RBS O O
likely JJ O O
a DT B-NP B-problem
forming JJ I-NP I-problem
pseudocyst NN I-NP I-problem
; : O O
however RB O O
, , O O
the DT B-NP O
suspicion NN I-NP O
of IN B-VP O
malignancy NN B-NP B-problem
is VBZ O O
still RB O O
possible JJ O O
and CC O O
the DT B-NP B-person
patient NN I-NP I-person
underwent VBD B-VP O
an DT B-NP B-test
ultrasound NN I-NP I-test
guided VBD B-VP I-test
biopsy NN B-NP I-test
of IN B-VP O
this DT B-NP B-problem
mass NN I-NP I-problem
on IN B-VP O
2011-01-20 JJ O O
. . B-VP O
   
The DT B-NP O
cytology NN I-NP O
for IN B-VP O
this DT B-NP B-test
biopsy NN I-NP I-test
is VBZ O O
still RB O O
pending VBG O O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
recovered VBD B-VP O
well RB O O
status NN B-NP O
post NN I-NP O
these DT O B-pronoun
these DT O B-test
two CD O I-test
procedures NNS B-NP I-test
. . B-VP O
   
He PRP O B-person
had VBD B-VP O
no DT B-NP O
complications NNS I-NP B-problem
and CC O O
no DT O O
subsequently RB O B-problem
pancreatitis NN B-NP I-problem
. . B-VP O
   
His PRP$ O B-person
His PRP$ O B-test
alkaline NN B-NP I-test
phosphatase NN I-NP I-test
and CC O O
all PDT O B-problem
the DT B-NP I-problem
other JJ I-NP I-problem
abnormal JJ I-NP I-problem
liver NN I-NP I-problem
function NN I-NP I-problem
tests NNS I-NP I-problem
were VBD B-VP O
resolving VBG O O
. . B-VP O
   
He PRP O B-person
had VBD B-VP O
no DT B-NP O
pain NN I-NP B-problem
and CC O O
did VBD B-VP O
not RB O O
require VB O O
any DT B-NP B-treatment
pain NN I-NP I-treatment
medications NNS I-NP I-treatment
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
tolerating VBG O O
food NN B-NP O
very RB O O
well RB O O
and CC O O
was VBD B-VP O
afebrile VBN O B-problem
throughout IN B-VP O
admission NN B-NP O
. . B-VP O
   
With IN B-VP O
regards NNS B-NP O
to TO O O
the DT O B-person
the DT B-NP B-problem
patient JJ I-NP I-person
patient NN I-NP I-problem
's POS O I-problem
documented JJ B-NP I-problem
Strep NNP I-NP I-problem
septicemia NN I-NP I-problem
in IN B-VP O
the DT B-NP O
outside JJ I-NP O
hospital NN I-NP O
, , O O
the DT B-NP B-person
Infectious NNP I-NP I-person
Disease NNP I-NP I-person
Team NNP I-NP I-person
was VBD B-VP O
formally RB O O
consulted VBN O O
. . B-VP O
   
Upon IN B-VP O
obtaining VBG O O
more JJR B-NP O
information NN I-NP O
from IN B-VP O
Rehab NNP B-NP O
Hospital NNP I-NP O
of IN B-VP O
the DT B-NP O
Cape NNP I-NP O
& CC O O
Islands NNP B-NP O
Hospital NNP I-NP O
, , O O
it PRP O O
appears VBZ O O
that IN B-VP O
the DT B-NP B-person
patient NN I-NP I-person
had VBD B-VP O
two CD O O
out IN B-VP O
of IN B-VP O
four CD O O
bottles NNS B-NP O
growing VBG O O
out RP O O
Streptococcus NNP B-NP B-problem
sanguis NN I-NP I-problem
in IN B-VP O
the DT B-NP O
outside JJ I-NP O
hospital NN I-NP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
appeared VBD B-VP O
to TO O O
have VB O O
been VBN O O
covered VBN O O
by IN B-VP O
Ampicillin NNP B-NP B-treatment
, , O O
Gentamycin NNP B-NP B-treatment
and CC O O
then RB O O
Unasyn NNP B-NP B-treatment
in IN B-VP O
the DT B-NP O
outside JJ I-NP O
hospital NN I-NP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
, , O O
on IN B-VP O
admission NN B-NP O
, , O O
was VBD B-VP O
placed VBN O O
on IN B-VP O
Ampicillin NNP B-NP B-treatment
, , O O
Gentamycin NNP B-NP B-treatment
and CC O O
Flagyl NNP B-NP B-treatment
. . B-VP O
   
With IN B-VP O
repeated JJ B-NP B-test
blood NN I-NP I-test
cultures NNS I-NP I-test
that WDT O B-pronoun
were VBD B-VP O
negative JJ O O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
reduced VBN O O
to TO O O
single JJ B-NP O
Mckenzie NNP I-NP O
of IN B-VP O
intravenous JJ B-NP B-treatment
Ampicillin NNP I-NP I-treatment
. . B-VP O
   
For IN B-VP O
this DT B-NP B-problem
documented JJ I-NP I-problem
septicemia NN I-NP I-problem
, , O O
this DT B-NP B-person
patient NN I-NP I-person
went VBD B-VP O
for IN B-VP O
a DT B-NP B-test
endocarditis NN I-NP I-test
work-up NN I-NP I-test
. . B-VP O
   
He PRP O B-person
had VBD B-VP O
a DT B-NP B-test
transthoracic NN I-NP I-test
echocardiogram NN I-NP I-test
which WDT O B-pronoun
revealed VBD B-VP O
no DT B-NP O
vegetations NNS I-NP B-problem
. . B-VP O
   
On IN B-VP O
this DT B-NP B-test
echocardiogram NN I-NP I-test
, , O O
he PRP O B-person
was VBD B-VP O
found VBN O O
to TO O O
have VB O O
mildly RB O B-problem
dilated VBN O I-problem
left JJ B-NP I-problem
atrium NN I-NP I-problem
, , O O
mild JJ O B-problem
symmetric JJ O I-problem
left VBD B-VP I-problem
ventricular JJ B-NP I-problem
hypertrophy NN I-NP I-problem
, , O O
and CC O O
a DT B-NP O
normal JJ I-NP O
ejection NN I-NP O
fraction NN I-NP O
of IN B-VP O
greater JJR O O
than IN B-VP O
55% CD O O
. . B-VP O
   
There EX O O
were VBD B-VP O
no DT B-NP O
other JJ I-NP B-problem
abnormalities NNS I-NP I-problem
noted VBN O O
on IN B-VP O
this DT B-NP B-test
study NN I-NP I-test
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
then RB O O
underwent VBD B-VP O
a DT B-NP B-test
transesophageal JJ I-NP I-test
echocardiogram NN I-NP I-test
on IN B-VP O
01-24 NN B-NP O
. . B-VP O
   
On IN B-VP O
this DT B-NP B-test
echocardiogram NN I-NP I-test
, , O O
he PRP O B-person
was VBD B-VP O
again RB O O
noted VBN O O
to TO O O
not RB O O
have VB O O
any DT B-NP O
evidence NN I-NP O
for IN B-VP O
valvular JJ B-NP B-problem
vegetations NNS I-NP I-problem
. . B-VP O
   
A DT B-NP B-problem
complex JJ I-NP I-problem
plaque NN I-NP I-problem
was VBD B-VP O
found VBN O O
in IN B-VP O
the DT B-NP O
aortic JJ I-NP O
arch NN I-NP O
in IN B-VP O
the DT B-NP O
descending NN I-NP O
thoracic NN I-NP O
aorta RB O O
, , O O
although IN B-VP O
this DT B-NP B-problem
plaque NN I-NP I-problem
is VBZ O O
non-mobile JJ O O
. . B-VP O
   
There EX O O
was VBD B-VP O
focal JJ B-NP B-problem
mitral JJ I-NP I-problem
valve NN I-NP I-problem
prolapse NN I-NP I-problem
noted VBD B-VP O
without IN B-VP O
pathologic JJ B-NP B-problem
mitral JJ I-NP I-problem
regurgitation NN I-NP I-problem
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
noted VBN O O
to TO O O
have VB O O
trace NN B-NP B-problem
aortic JJ B-NP I-problem
regurgitation NN I-NP I-problem
. . B-VP O
   
A DT B-NP B-test
Panorex NNP I-NP I-test
x-ray NN I-NP I-test
of IN B-VP O
his PRP$ O B-person
two CD O O
teeth NNS B-NP O
were VBD B-VP O
obtained VBN O O
and CC O O
a DT B-NP B-test
Dental NNP I-NP I-test
Consultation NNP I-NP I-test
was VBD B-VP O
done VBN O O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
thought VBN O O
to TO O O
have VB O O
normal JJ B-NP O
dental JJ I-NP O
hygiene NN I-NP O
and CC O O
low JJ B-NP O
suspicion NN I-NP O
for IN B-VP O
a DT B-NP O
source NN I-NP O
of IN B-VP O
his PRP$ O B-person
his PRP$ O B-problem
alpha NN B-NP I-problem
septicemia NN I-NP I-problem
from IN B-VP I-problem
his PRP$ O B-person
his PRP$ O I-problem
mouth NN B-NP I-problem
. . B-VP O
   
Infectious JJ B-NP B-person
Disease NNP I-NP I-person
Department NNP I-NP I-person
as RB O O
well RB O O
as IN B-VP O
Cardiology NNP B-NP B-person
had VBD B-VP O
recommended VBN O O
a DT O O
formal JJ O O
14 CD O O
- : O O
day NN B-NP O
course NN I-NP O
of IN B-VP O
intravenous JJ B-NP B-treatment
antibiotics NNS I-NP I-treatment
to TO O O
treat VB O O
a DT B-NP B-problem
documented JJ I-NP I-problem
alpha JJ I-NP I-problem
Streptococcal NNP I-NP I-problem
septicemia NN I-NP I-problem
from IN B-VP O
outside JJ B-NP O
hospital NN I-NP O
blood NN I-NP B-test
cultures NNS I-NP I-test
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
's POS O O
insurance NN B-NP O
company NN I-NP O
, , O O
however RB O O
, , O O
would MD O O
not RB O O
pay VB O O
for IN B-VP O
home NN B-NP B-treatment
antibiotics NNS I-NP I-treatment
. . B-VP O
   
After IN B-VP O
much JJ B-NP O
discussion NN I-NP O
with IN B-VP O
the DT B-NP B-person
patient NN I-NP I-person
, , O O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
informed VBN O O
of IN B-VP O
the DT B-NP O
risks NNS I-NP O
of IN B-VP O
not RB O O
finishing VBG O O
a DT O O
14 CD O O
day NN B-NP O
course NN I-NP O
of IN B-VP O
intravenous JJ B-NP B-treatment
antibiotics NNS I-NP I-treatment
and CC O O
chose VB O O
to TO O O
go VB O O
home NN B-NP O
. . B-VP O
   
He PRP O B-person
had VBD B-VP O
three CD O O
days NNS B-NP O
of IN B-VP O
antibiotics NNS B-NP B-treatment
remaining VBG O O
at IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
discharge NN B-NP O
. . B-VP O
   
It PRP O O
was VBD B-VP O
discussed VBN O O
with IN B-VP O
the DT B-NP B-person
patient NN I-NP I-person
to TO O O
send VB O O
him PRP O B-person
out RP O O
on IN B-VP O
Augmentin NNP B-NP B-treatment
500 CD O O
mg NN B-NP O
three CD O O
times NNS B-NP O
a DT B-NP O
day NN I-NP O
for IN B-VP O
ten RB O O
more JJR B-NP O
days NNS I-NP O
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
to TO O O
follow-up JJ O O
with IN B-VP O
his PRP$ O B-person
his PRP$ O B-person
primary JJ B-NP I-person
care NN I-NP I-person
physician NN I-NP I-person
within IN B-VP O
two CD O O
to TO O O
three CD O O
days NNS B-NP O
for IN B-VP O
repeat NN B-NP B-test
laboratory NN I-NP I-test
studies NNS I-NP I-test
and CC O O
blood NN B-NP B-test
cultures NNS I-NP I-test
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
to TO O O
return VB O O
to TO O O
the DT B-NP O
hospital NN I-NP O
with IN B-VP O
any DT B-NP O
signs NNS I-NP O
of IN B-VP O
shaking VBG O B-problem
chills NNS B-NP B-problem
or CC O O
fever NN B-NP B-problem
. . B-VP O
   
DISCHARGE NNP B-NP O
DIAGNOSES NNP I-NP O
: : O O
1. CD O O
Pancreatitis NN B-NP B-problem
status NN I-NP O
post NN I-NP O
endoscopic NN I-NP B-test
retrogram NN I-NP I-test
cholangiopancreatography NN I-NP I-test
and CC O O
sphincterotomy NN B-NP B-treatment
. . B-VP O
   
2. CD O O
Alpha NNP B-NP B-problem
Streptococcus NNP I-NP I-problem
septicemia NN I-NP I-problem
. . B-VP O
   
DISCHARGE NNP B-NP O
MEDICATIONS NNP I-NP O
: : O O
1. CD O O
Augmentin NNP B-NP B-treatment
500 CD O O
mg NN B-NP O
p.o. NN I-NP O
three CD O O
times NNS B-NP O
a DT B-NP O
day NN I-NP O
times NNS I-NP O
ten JJ B-NP O
days NNS I-NP O
. . B-VP O
   
2. CD O O
Flomax NNP B-NP B-treatment
0.4 CD O O
mg NN B-NP O
p.o. NN I-NP O
q. JJ B-NP O
day NN I-NP O
. . B-VP O
   
3. CD O O
Prilosec NNP B-NP B-treatment
20 CD O O
mg NN B-NP O
p.o. NN I-NP O
q. JJ B-NP O
day NN I-NP O
. . B-VP O
   
4. CD O O
Humalog NNP B-NP B-treatment
and CC O O
Regular NNP B-NP B-treatment
insulin NN I-NP I-treatment
subcutaneously RB O O
. . B-VP O
   
Hallo NNP B-NP B-person
MING NNP I-NP I-person
LI NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
40-963 CD O O
Dictated VBN O O
By IN B-VP O
: : O O
Annie NNP B-NP B-person
D. NNP I-NP I-person
Martinez NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
MEDQUIST36 NNP I-NP O
D NNP I-NP O
: : O O
2011-01-25 JJ O O
14:08 CD O O
T NN B-NP O
: : O O
2011-01-26 JJ O O
11:30 CD O O
JOB NNP B-NP O
#: VBD B-VP O
09167 CD O O
Signed VBN O O
electronically RB O O
by IN B-VP O
: : O O
DR. NNP B-NP B-person
Dorothy NNP I-NP I-person
L. NNP I-NP I-person
Brennan NNP I-NP I-person
on IN B-VP O
: : O O
Russell NNP B-NP O
2011-01-27 CD O O
11:38 CD O O
AM NNP B-NP O
( ( O O
End NNP B-NP O
of IN B-VP O
Report NNP B-NP O
) ) O O
-EMPTYLINE- VBP O O
-DOCSTART- JJ O O
-EMPTYLINE- $ O O
196768414 CD O O
YC NNP B-NP O
36611261 CD O O
5472577 CD O O
5/7/2003 CD O O
12:00:00 CD O O
AM NNP B-NP O
SAVD NNP I-NP B-treatment
DIS NNP I-NP O
Admission NNP I-NP O
Date NNP I-NP O
: : O O
05/07/2003 CD O O
Report NNP B-NP O
Status NNP I-NP O
: : O O
Discharge NN B-NP O
Date NNP I-NP O
: : O O
05/09/2003 CD O O
****** NN B-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
BOORMKAYSSCAJE NNP I-NP B-person
, , O I-person
PA NNP B-NP I-person
A. NNP I-NP I-person
967-94-23-8 CD O O
R21 NNP B-NP O
Room NNP I-NP O
: : O O
FISHIP NNP B-NP O
HOSPITAL NNP I-NP O
Service NNP I-NP O
: : O O
OBS NNP B-NP O
DISCHARGE NNP I-NP O
PATIENT NNP I-NP B-person
ON NNP I-NP O
: : O O
05/09/03 CD O O
AT NNP B-NP O
10:00 CD O O
AM NNP B-NP O
CONTINGENT NNP I-NP O
UPON NNP I-NP O
Not RB O O
Applicable NNP B-NP O
WILL NNP I-NP O
D NNP I-NP O
/ NNP I-NP O
C NNP I-NP O
ORDER NNP I-NP O
BE NNP I-NP O
USED NNP I-NP O
AS IN B-VP O
THE NNP B-NP O
D NNP I-NP O
/ NNP I-NP O
C NNP I-NP O
SUMMARY NNP I-NP O
: : O O
YES JJ B-NP O
Attending NN I-NP B-person
: : O O
DOUETLEPSGISS NNP B-NP B-person
, , O I-person
VALETO NNP B-NP I-person
, , O I-person
M.D. NNP B-NP I-person
DISPOSITION NNP I-NP O
: : O O
Home NNP B-NP O
DISCHARGE NNP I-NP O
MEDICATIONS NNP I-NP O
: : O O
DIET NN B-NP O
: : O O
No DT B-NP O
Restrictions NNP I-NP O
ACTIVITY NNP I-NP O
: : O O
Resume NNP B-NP O
regular JJ B-NP O
exercise NN I-NP O
FOLLOW NNP I-NP O
UP NNP I-NP O
APPOINTMENT NNP I-NP O
( ( O O
S NNP B-NP O
) ) O O
: : O O
dr. JJ O B-person
kote VBP O I-person
6 CD O O
weeks NNS B-NP O
, , O O
No NNP B-NP O
Known NNP I-NP B-problem
Allergies NNP I-NP I-problem
ADMIT NNP I-NP O
DIAGNOSIS NNP I-NP O
: : O O
Spontaneous JJ B-NP B-problem
vaginal JJ I-NP I-problem
delivery NN I-NP I-problem
Laceration NNP I-NP I-problem
2 CD O O
degrees NNS B-NP O
PRINCIPAL NNP I-NP O
DISCHARGE NNP I-NP O
DIAGNOSIS NNP I-NP O
; : O O
Responsible NNP B-NP O
After IN B-VP O
Study NNP B-NP O
for IN B-VP O
Causing NNP B-NP O
Admission NNP I-NP O
) ) O O
SAVD NNP B-NP B-treatment
OTHER NNP I-NP O
DIAGNOSIS NNP I-NP O
; : O O
Conditions NNP B-NP O
, , O O
Infections NNP B-NP O
, , O O
Complications NNP B-NP O
, , O O
affecting VBG O O
Treatment NNP B-NP O
/ NNP I-NP O
Stay NNP I-NP O
SAVD NNP I-NP B-treatment
OPERATIONS NNP I-NP O
AND NNP I-NP O
PROCEDURES NNP I-NP O
: : O O
OTHER NNP B-NP O
TREATMENTS NNP I-NP O
/ NNP I-NP O
PROCEDURES NNP I-NP O
( ( O O
NOT NNP B-NP O
IN NNP I-NP O
O.R. NNP I-NP O
) ) O O
none NN B-NP O
BRIEF NNP I-NP O
RESUME NNP I-NP O
OF NNP I-NP O
HOSPITAL NNP I-NP O
COURSE NNP I-NP O
: : O O
G3 NNP B-NP O
T2 NNP I-NP O
P0 NNP I-NP O
A0 NNP I-NP O
L2 NNP I-NP O
Estimated VBD B-VP O
EDC NNP B-NP O
: : O O
Maternal JJ B-NP O
transfer NN I-NP O
: : O O
No DT B-NP O
ADDITIONAL NNP I-NP O
COMMENTS NN I-NP O
: : O O
DISCHARGE JJ B-NP O
CONDITION NNP I-NP O
: : O O
Stable JJ B-NP O
TO NNP I-NP O
DO NNP I-NP O
/ NNP I-NP O
PLAN NNP I-NP O
: : O O
No DT B-NP O
dictated JJ I-NP O
summary NN I-NP O
ENTERED NN I-NP O
BY NNP I-NP O
: : O O
DOUETLEPSGISS NNP B-NP B-person
, , O I-person
VALETO NNP B-NP I-person
, , O I-person
M.D. NNP B-NP I-person
( ( O O
MC71 NNP B-NP O
) ) O O
05/07/03 CD O O
03:46 CD O O
PM NNP B-NP O
****** JJ B-NP O
END NNP I-NP O
OF NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- VBD B-VP O
139391631 CD O O
GH NNP B-NP O
97368061 CD O O
7/20/1999 CD O O
12:00:00 CD O O
AM NNP B-NP O
NEUROPATHIC NNP I-NP B-problem
PAIN NNP I-NP I-problem
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date NNP I-NP O
: : O O
07/20/1999 CD O O
Report NNP B-NP O
Status NNP I-NP O
: : O O
Signed VBN O O
Discharge NNP B-NP O
Date NNP I-NP O
: : O O
07/26/1999 CD O O
PRINCIPAL NNP B-NP O
DIAGNOSIS NNP I-NP O
: : O O
Post NNP B-NP B-problem
thoracotomy VBZ O I-problem
syndrome NN B-NP I-problem
. . B-VP O
   
PRINCIPAL JJ B-NP O
PROCEDURE NN I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
had VBD B-VP O
a DT B-NP B-treatment
spinal JJ I-NP I-treatment
cord NN I-NP I-treatment
stimulator NN I-NP I-treatment
trial NN I-NP I-treatment
on IN B-VP O
07/21/99 CD O O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
had VBD B-VP O
an DT B-NP B-treatment
epidural JJ I-NP I-treatment
trial NN I-NP I-treatment
on IN B-VP O
07/24/99 CD O O
. . B-VP O
   
HISTORY NN B-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
is VBZ O O
a DT O O
65 CD O O
year NN B-NP O
old JJ B-NP O
female NN I-NP O
with IN B-VP O
post NN B-NP B-problem
thoracotomy NN I-NP I-problem
syndrome NN I-NP I-problem
that WDT O B-pronoun
occurred VBD B-VP O
on IN B-VP O
the DT B-NP O
site NN I-NP O
of IN B-VP O
her PRP$ O B-person
her PRP$ O B-problem
thoracotomy JJ B-NP I-problem
incision NN I-NP I-problem
. . B-VP O
   
She PRP O B-person
had VBD B-VP O
a DT B-NP B-problem
thoracic JJ I-NP I-problem
aortic JJ I-NP I-problem
aneurysm NN I-NP I-problem
repaired VBN O O
in IN B-VP O
the DT O O
past JJ O O
and CC O O
subsequently RB O O
developed VBD B-VP O
neuropathic JJ B-NP B-problem
pain NN I-NP I-problem
at IN B-VP O
the DT B-NP B-problem
incision NN I-NP I-problem
site NN I-NP I-problem
. . B-VP O
   
She PRP O B-person
is VBZ O O
currently RB O O
on IN B-VP O
Vicodin NNP B-NP B-treatment
, , O O
one CD O O
to TO O O
two CD O O
tablets NNS B-NP O
every DT O O
four CD O O
hours NNS B-NP O
p.r.n. RB O O
, , O O
Fentanyl NNP B-NP B-treatment
patch VBP O I-treatment
25 CD O O
mcg FW O O
an DT B-NP O
hour NN I-NP O
, , O O
change NN B-NP O
of IN B-VP O
patch NN B-NP O
every DT O O
72 CD O O
hours NNS B-NP O
, , O O
Elavil NNP B-NP B-treatment
50 CD O O
mgq NN B-NP O
.h.s. NN I-NP O
, , O O
Neurontin NNP B-NP B-treatment
600 CD O O
mg NN B-NP O
p.o. NN I-NP O
t.i.d. NN I-NP O
with IN B-VP O
still RB O O
what WP O O
she PRP O B-person
reports VBZ O O
as IN B-VP O
stabbing VBG O B-problem
left-sided JJ B-NP I-problem
chest NN I-NP I-problem
pain NN I-NP I-problem
that WDT O B-problem
can MD O O
be VB O O
as RB O O
severe JJ O O
as IN B-VP O
a DT O O
7/10. CD O O
She PRP O B-person
has VBZ O O
failed VBN O O
conservative JJ B-NP B-treatment
therapy NN I-NP I-treatment
and CC O O
is VBZ O O
admitted VBN O O
for IN B-VP O
a DT B-NP B-treatment
spinal JJ I-NP I-treatment
cord NN I-NP I-treatment
stimulator NN I-NP I-treatment
trial NN I-NP I-treatment
. . B-VP O
   
PAST NNP B-NP O
MEDICAL NNP I-NP O
HISTORY NNP I-NP O
: : O O
1. CD O O
Hypertension NNP B-NP B-problem
. . B-VP O
   
2. CD O O
Hypothyroidism NNP B-NP B-problem
. . B-VP O
   
3. CD O O
Paraplegia NNP B-NP B-problem
status NN I-NP O
post NN I-NP O
thoracic NN I-NP B-treatment
aortic JJ B-NP I-treatment
aneurysm NN I-NP I-treatment
repair NN I-NP I-treatment
. . B-VP O
   
4. CD O O
Left NNP B-NP B-problem
hemidiaphragmatic JJ B-NP I-problem
paralysis NN I-NP I-problem
, , O O
history NN B-NP O
of IN B-VP O
recurrent NN B-NP B-problem
lung NN I-NP I-problem
infections NNS I-NP I-problem
. . B-VP O
   
5. CD O O
Sacral JJ B-NP B-problem
decubitus NN I-NP I-problem
ulcer NN I-NP I-problem
. . B-VP O
   
6. CD O O
Home NNP B-NP B-treatment
oxygen NN I-NP I-treatment
at IN B-VP O
two CD O O
liters NNS B-NP O
a DT B-NP O
minute NN I-NP O
when WRB O O
she PRP O B-person
is VBZ O O
at IN B-VP O
home NN B-NP O
; : O O
she PRP O B-person
does VBZ O O
not RB O O
use VB O O
the DT B-NP B-treatment
oxygen NN I-NP I-treatment
when WRB O O
she PRP O B-person
is VBZ O O
in IN B-VP O
a DT B-NP B-treatment
wheelchair NN I-NP I-treatment
or CC O O
is VBZ O O
out IN B-VP O
of IN B-VP O
the DT B-NP O
house NN I-NP O
. . B-VP O
   
MEDICATIONS NNP B-NP O
ON NNP I-NP O
DISCHARGE NNP I-NP O
: : O O
1. CD O O
Atrovent NNP B-NP B-treatment
nebulizers NNS I-NP I-treatment
0.5 CD O O
mg NNS B-NP O
mixed JJ O O
with IN B-VP O
albuterol NN B-NP B-treatment
, , O O
nebulizer NN B-NP B-treatment
is VBZ O O
given VBN O O
every DT O O
six CD O O
hours NNS B-NP O
. . B-VP O
   
2. CD O O
Norvasc NNP B-NP B-treatment
2.5 CD O O
mg NN B-NP O
p.o. NN I-NP O
q JJ B-NP O
day NN I-NP O
. . B-VP O
   
3. CD O O
Colistin NNP B-NP B-treatment
30 CD O O
mg NN B-NP O
nebulizer NN I-NP O
twice RB O O
a DT B-NP O
day NN I-NP O
, , O O
give VB O O
30 CD O O
minutes NNS B-NP O
post VBP O O
albuterol NN B-NP B-treatment
and CC O O
Atrovent NNP B-NP B-treatment
. . B-VP O
   
4. CD O O
Pressure NN B-NP B-treatment
, , O I-treatment
dermal JJ B-NP I-treatment
ulcer NN I-NP I-treatment
care NN I-NP I-treatment
b.i.d. IN B-VP O
dressing VBG O B-treatment
change NN B-NP I-treatment
with IN B-VP O
antibiotic JJ B-NP B-treatment
solution NN I-NP I-treatment
. . B-VP O
   
5. CD O O
Neurontin NNP B-NP B-treatment
600 CD O O
mg NN B-NP O
p.o. NN I-NP O
t.i.d. VBD B-VP O
6. CD O O
Colace NNP B-NP B-treatment
100 CD O O
mg NN B-NP O
p.o. NN I-NP O
b.i.d. VBD B-VP O
7. CD O O
Albuterol NNP B-NP B-treatment
neb RB O I-treatment
2.5 CD O O
mg NN B-NP O
every DT O O
six CD O O
hours NNS B-NP O
, , O O
30 CD O O
minutes NNS B-NP O
before IN B-VP O
Colistin NNP B-NP B-treatment
. . B-VP O
   
8. CD O O
Amitriptyline NNP B-NP B-treatment
50 CD O O
mg VBD B-VP O
q.h.s. RB O O
9. CD O O
Vitamin NNP B-NP B-treatment
C NNP I-NP I-treatment
500 CD O O
mg NN B-NP O
p.o. NN I-NP O
b.i.d. VBD B-VP O
10. CD O O
Calcium NNP B-NP B-treatment
carbonate NN I-NP I-treatment
125.0 CD O O
mg NN B-NP O
t.i.d. NN I-NP O
11. CD O O
Fentanyl NNP B-NP B-treatment
patch NN I-NP I-treatment
25 CD O O
mcg NN B-NP O
an DT B-NP O
hour NN I-NP O
, , O O
change NN B-NP O
patch NN I-NP B-treatment
every DT O O
72 CD O O
hours NNS B-NP O
. . B-VP O
   
12. CD O O
Folate NNP B-NP B-treatment
1 CD O O
mg NN B-NP O
p.o. NN I-NP O
q JJ B-NP O
day NN I-NP O
. . B-VP O
   
13. CD O O
Synthroid JJ O B-treatment
50 CD O O
mcg NN B-NP O
p.o. NN I-NP O
q JJ B-NP O
day NN I-NP O
. . B-VP O
   
14. CD O O
Zinc NNP B-NP B-treatment
sulfate NN I-NP I-treatment
220 CD O O
mg NN B-NP O
p.o. NN I-NP O
q JJ B-NP O
day NN I-NP O
. . B-VP O
   
15. CD O O
Multivitamin NNP B-NP B-treatment
, , O O
one CD O O
tablet NN B-NP O
p.o. NN I-NP O
q JJ B-NP O
day NN I-NP O
. . B-VP O
   
16. CD O O
Hydrocodone $ O B-treatment
5 CD O O
mg NN B-NP O
with IN B-VP O
Tylenol NNP B-NP B-treatment
, , O O
one CD O O
to TO O O
two CD O O
tablets NNS B-NP O
every DT O O
four CD O O
hours NNS B-NP O
p.r.n. RB O O
pain VBP O B-problem
. . B-VP O
   
17. CD O O
Milk NN B-NP B-treatment
of IN B-VP I-treatment
Magnesia NNP B-NP I-treatment
30 CD O O
cc NN B-NP O
p.o. NN I-NP O
q JJ B-NP O
day NN I-NP O
constipation NN I-NP B-problem
. . B-VP O
   
ALLERGIES NN B-NP O
: : O O
PENICILLIN NNP B-NP B-treatment
. . B-VP O
   
SOCIAL NNP B-NP O
HISTORY NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
lives VBZ O O
in IN B-VP O
Napro NNP B-NP O
with IN B-VP O
her PRP$ O B-person
her PRP$ O B-person
husband NN B-NP I-person
who WP O B-person
is VBZ O O
her PRP$ O B-person
her PRP$ O B-person
primary JJ B-NP I-person
caregiver NN I-NP I-person
. . B-VP O
   
She PRP O B-person
is VBZ O O
not RB O O
a DT B-NP O
smoker NN I-NP O
. . B-VP O
   
She PRP O B-person
has VBZ O O
approximately RB O O
one CD O O
glass NN B-NP O
of IN B-VP O
wine JJ O O
every DT B-NP O
day NN I-NP O
. . B-VP O
   
PHYSICAL JJ B-NP O
EXAMINATION NN I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
is VBZ O O
well-appearing JJ O O
in IN B-VP O
no DT B-NP O
acute JJ I-NP B-problem
distress NN I-NP I-problem
. . B-VP O
   
Blood NNP B-NP B-test
pressure NN I-NP I-test
is VBZ O O
150/90 CD O O
, , O O
heart NN B-NP B-test
rate NN I-NP I-test
of IN B-VP O
90 CD O O
, , O O
respiratory NN B-NP B-test
rate NN I-NP I-test
20 CD O O
with IN B-VP O
saturation NN B-NP B-test
of IN B-VP O
98% CD O O
. . B-VP O
   
HEENT NN B-NP O
: : O O
Pupils NNS B-NP O
are VBP O O
equal JJ O O
and CC O O
reactive JJ O O
to TO O O
light NN B-NP O
. . B-VP O
   
The DT B-NP B-person
patient JJ I-NP I-person
wears NNS I-NP O
dentures VBZ O B-treatment
. . B-VP O
   
Neck NN B-NP O
: : O O
Full NNP B-NP O
range NN I-NP O
of IN B-VP O
motion NN B-NP O
with IN B-VP O
no DT B-NP O
lymphadenopathy NN I-NP B-problem
. . B-VP O
   
Chest JJS O O
: : O O
Clear JJ O O
to TO O O
auscultation VB O O
on IN B-VP O
the DT B-NP O
right NN I-NP O
. . B-VP O
   
Decreased VBN O B-problem
breath NN B-NP I-problem
sounds NNS I-NP I-problem
on IN B-VP I-problem
the DT B-NP I-problem
left JJ I-NP I-problem
base NN I-NP I-problem
with IN B-VP O
coarse JJ B-NP B-problem
rales NNS I-NP I-problem
on IN B-VP I-problem
the DT B-NP I-problem
left JJ I-NP I-problem
base NN I-NP I-problem
. . B-VP O
   
Cardiovascular JJ O O
: : O O
Regular JJ B-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
with IN B-VP O
normal JJ B-NP O
S1 NNP I-NP O
and CC O O
S2 NNP B-NP O
. . B-VP O
   
Abdomen NNS B-NP O
: : O O
Soft NNP B-NP O
, , O O
nondistended VBD B-VP B-problem
, , O O
nontender NN B-NP B-problem
. . B-VP O
   
Positive JJ B-NP O
bowel NN I-NP O
sounds NNS I-NP O
. . B-VP O
   
Back RB O O
: : O O
Clear JJ O O
. . B-VP O
   
Epidural JJ B-NP O
site NN I-NP O
is VBZ O O
without IN B-VP O
erythema NN B-NP B-problem
, , O O
drainage NN B-NP B-problem
or CC O O
tenderness NN B-NP B-problem
. . B-VP O
   
Left NNP B-NP O
buttock NN I-NP O
area NN I-NP O
has VBZ O O
a DT B-NP B-treatment
dressing NN I-NP I-treatment
over IN B-VP O
the DT B-NP B-problem
sacral JJ I-NP I-problem
decubitus NN I-NP I-problem
ulcer NN I-NP I-problem
. . B-VP O
   
Extremities NNS B-NP O
: : O O
Well-profused JJ O O
. . B-VP O
   
4/5 CD O O
motor NN B-NP O
strength NN I-NP O
in IN B-VP O
the DT B-NP O
upper JJ I-NP O
extremities NNS I-NP O
bilaterally RB O O
. . B-VP O
   
Flaccid NNP B-NP B-problem
paralysis NN I-NP I-problem
of IN B-VP I-problem
bilateral JJ B-NP I-problem
lower JJR I-NP I-problem
extremities NNS I-NP I-problem
. . B-VP O
   
HOSPITAL NNP B-NP O
COURSE NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
admitted VBN O O
on IN B-VP O
07/20/99 CD O O
for IN B-VP O
a DT B-NP O
history NN I-NP O
of IN B-VP O
left JJ B-NP B-problem
chest JJS I-NP I-problem
wall NN I-NP I-problem
pain NN I-NP I-problem
from IN B-VP O
postthoracotomy JJ B-NP B-problem
syndrome NN I-NP I-problem
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
developed VBD B-VP O
the DT B-NP B-problem
syndrome NN I-NP I-problem
after IN B-VP O
her PRP$ O B-treatment
her PRP$ O B-person
thoracic NN B-NP I-treatment
aortic JJ B-NP I-treatment
aneurysm NN I-NP I-treatment
repair NN I-NP I-treatment
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
failed VBD B-VP O
the DT B-NP B-treatment
conservative JJ I-NP I-treatment
therapy NN I-NP I-treatment
and CC O O
is VBZ O O
admitted VBN O O
for IN B-VP O
a DT B-NP B-treatment
spinal JJ I-NP I-treatment
cord NN I-NP I-treatment
stimulator NN I-NP I-treatment
trial NN I-NP I-treatment
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
had VBD B-VP O
a DT B-NP B-treatment
spinal JJ I-NP I-treatment
cord NN I-NP I-treatment
stimulator NN I-NP I-treatment
placed VBD B-VP O
on IN B-VP O
07/21/99 CD O O
. . B-VP O
   
She PRP O B-person
underwent VBD B-VP O
the DT B-NP B-treatment
procedure NN I-NP I-treatment
and CC O O
tolerated VBD B-VP O
the DT B-NP B-treatment
procedure NN I-NP I-treatment
very RB O O
well RB O O
. . B-VP O
   
The DT B-NP B-treatment
spinal JJ I-NP I-treatment
cord NN I-NP I-treatment
stimulator NN I-NP I-treatment
was VBD B-VP O
programmed VBN O O
with IN B-VP O
setting NN B-NP O
of IN B-VP O
a DT B-NP O
rate NN I-NP O
of IN B-VP O
80 CD O O
, , O O
power NN B-NP O
450 CD O O
and CC O O
4.0 CD O O
amps NNS B-NP O
. . B-VP O
   
Channel NNP B-NP O
1 CD O O
was VBD B-VP O
negative JJ O O
, , O O
2 CD O O
was VBD B-VP O
neutral JJ O O
, , O O
3 CD O O
was VBD B-VP O
neutral JJ O O
, , O O
4 CD O O
was VBD B-VP O
positive JJ O O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
the DT O O
next JJ O O
two CD O O
days NNS B-NP O
did VBD B-VP O
not RB O O
notice VB O O
any DT B-NP O
significant JJ I-NP O
change NN I-NP O
in IN B-VP O
her PRP$ O B-person
her PRP$ O B-problem
pain NN B-NP I-problem
pattern NN I-NP I-problem
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
also RB O O
noted VBN O O
to TO O O
have VB O O
a DT B-NP O
lot NN I-NP O
of IN B-VP O
musculoskeletal JJ B-NP B-problem
component NN I-NP I-problem
of IN B-VP I-problem
her PRP$ O I-problem
her PRP$ O B-person
pain NN B-NP I-problem
. . B-VP O
   
So RB O O
, , O O
an DT B-NP B-treatment
epidural JJ I-NP I-treatment
catheter NN I-NP I-treatment
was VBD B-VP O
placed VBN O O
on IN B-VP O
07/23/99 CD O O
. . B-VP O
   
The DT B-NP B-treatment
epidural NN I-NP I-treatment
was VBD B-VP O
placed VBN O O
in IN B-VP O
the DT B-NP O
L1-2 JJ I-NP O
region NN I-NP O
and CC O O
the DT B-NP B-treatment
catheter NN I-NP I-treatment
was VBD B-VP O
placed VBN O O
in IN B-VP O
the DT B-NP O
T7 NNP I-NP O
region NN I-NP O
using VBG O O
fluoroscope NN B-NP B-test
to TO O O
guide VB O O
the DT B-NP B-treatment
catheter NN I-NP I-treatment
. . B-VP O
   
Within IN B-VP O
the DT B-NP O
next JJ I-NP O
couple NN I-NP O
of IN B-VP O
days NNS B-NP O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
noticed VBD B-VP O
a DT B-NP O
significant JJ I-NP O
improvement NN I-NP O
in IN B-VP O
her PRP$ O B-person
her PRP$ O B-problem
pain NN B-NP I-problem
pattern NN I-NP I-problem
. . B-VP O
   
The DT B-NP B-problem
stabbing NN I-NP I-problem
, , O I-problem
sharp JJ B-NP I-problem
pain NN I-NP I-problem
that IN B-VP O
she PRP O B-person
occasionally RB O O
has VBZ O O
on IN B-VP O
the DT B-NP O
left NN I-NP O
chest JJS B-NP O
wall NN I-NP O
was VBD B-VP O
significantly RB O O
diminished VBN O O
and CC O O
she PRP O B-person
also RB O O
noticed VBD B-VP O
periods NNS B-NP O
of IN B-VP O
time NN B-NP O
when WRB O O
she PRP O B-person
did VBD B-VP O
not RB O O
have VB O O
any DT O O
of IN B-VP O
that DT O B-pronoun
that DT B-NP B-problem
pain NN I-NP I-problem
. . B-VP O
   
The DT B-NP B-treatment
epidural JJ I-NP I-treatment
catheter NN I-NP I-treatment
had VBD B-VP O
a DT B-NP B-treatment
morphine JJ I-NP I-treatment
infusion NN I-NP I-treatment
initially RB O O
started VBD B-VP O
at IN B-VP O
1 CD O O
mg NNS B-NP O
a DT B-NP O
day NN I-NP O
and CC O O
increased VBD B-VP O
to TO O O
3 CD O O
mg NNS B-NP O
a DT B-NP O
day NN I-NP O
in IN B-VP O
a DT B-NP O
period NN I-NP O
of IN B-VP O
three CD O O
days NNS B-NP O
. . B-VP O
   
The DT B-NP B-treatment
epidural NN I-NP I-treatment
was VBD B-VP O
discontinued VBN O O
on IN B-VP O
07/26/99 CD O O
and CC O O
was VBD B-VP O
considered VBN O O
a DT B-NP B-treatment
successful JJ I-NP I-treatment
trial NN I-NP I-treatment
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
will MD O O
schedule VB O O
with IN B-VP O
the DT B-NP O
Pain NNP I-NP O
Clinic NNP I-NP O
regarding VBG O O
upcoming JJ B-NP B-treatment
epidural JJ I-NP I-treatment
pump NN I-NP I-treatment
placement NN I-NP I-treatment
. . B-VP O
   
During IN B-VP O
her PRP$ O B-person
hospitalization NN B-NP O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
also RB O O
seen VBN O O
by IN B-VP O
the DT B-NP O
Plastic NNP I-NP O
Service NNP I-NP O
. . B-VP O
   
Dr. NNP B-NP B-person
Falccouette NNP I-NP I-person
would MD O O
like VB O O
to TO O O
perform VB O O
an DT B-NP B-treatment
excision NN I-NP I-treatment
and CC O O
closure NN B-NP B-treatment
flap NN I-NP I-treatment
of IN B-VP O
her PRP$ O B-person
her PRP$ O B-problem
left JJ B-NP I-problem
ischial JJ I-NP I-problem
decubitusin NN I-NP I-problem
the DT B-NP O
near JJ I-NP O
future NN I-NP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
discharged VBN O O
in IN B-VP O
stable JJ B-NP O
conditionand NN I-NP O
will MD O O
follow VB O O
up RP O O
for IN B-VP O
( ( O O
1 CD O O
) ) O O
sacral JJ B-NP B-treatment
decubitus NN I-NP I-treatment
closure NN I-NP I-treatment
, , O O
and CC O O
( ( O O
2 CD O O
) ) O O
placement NN B-NP B-treatment
of IN B-VP I-treatment
epidural JJ B-NP I-treatment
pump NN I-NP I-treatment
in IN B-VP O
the DT B-NP O
future NN I-NP O
. . B-VP O
   
DISCHARGE NNP B-NP O
INSTRUCTIONS NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
will MD O O
have VB O O
SMH NNP B-NP O
Service NNP I-NP O
that WDT O B-pronoun
comes VBZ O O
to TO O O
her PRP$ O B-person
home NN B-NP O
once IN B-VP O
a DT B-NP O
day NN I-NP O
for IN B-VP O
adressing VBG O B-treatment
change NN B-NP I-treatment
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
will MD O O
follow VB O O
up RP O O
with IN B-VP O
Dr. NNP B-NP B-person
Kayschird NNP I-NP I-person
to TO O O
schedule VB O O
for IN B-VP O
the DT B-NP B-treatment
epidural JJ I-NP I-treatment
pump NN I-NP I-treatment
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
will MD O O
follow VB O O
up RP O O
with IN B-VP O
Dr. NNP B-NP B-person
Falccouette NNP I-NP I-person
to TO O O
schedule VB O O
for IN B-VP O
excision NN B-NP B-treatment
and CC O O
closure NN B-NP B-treatment
of IN B-VP O
her PRP$ O B-person
her PRP$ O B-problem
left JJ B-NP I-problem
ischial JJ I-NP I-problem
sacral JJ I-NP I-problem
decubitus NN I-NP I-problem
. . B-VP O
   
Dictated VBN O O
By IN B-VP O
: : O O
ECI NNP B-NP B-person
JESCSLAND NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
OO63 NNP I-NP O
Attending NNP I-NP O
: : O O
FOMAIRE NNP B-NP B-person
KOTEKOTEJESCDREWE NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
RY93 NNP I-NP O
KE526/9219 NNP I-NP O
Batch NNP I-NP O
: : O O
37707 CD O O
Index NNP B-NP O
No. NN I-NP O
RWRF75BSI NNP I-NP O
D NNP I-NP O
: : O O
07/26/99 CD O O
T NN B-NP O
: : O O
07/26/99 CD O O
CC NN B-NP O
: : O O
JOFREDD NNP B-NP B-person
N. NNP I-NP I-person
FALCCOUETTE NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
SV7 NNP I-NP O
[ NNP I-NP O
report_end VBP O O
] NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
Admission NNP I-NP O
Date NNP I-NP O
: : O O
2010-10-04 JJ B-NP O
Discharge NN I-NP O
Date NNP I-NP O
: : O O
2010-10-17 JJ B-NP O
Date NNP I-NP O
of IN B-VP O
Birth NNP B-NP O
: : O O
1929-11-09 JJ B-NP O
Sex NN I-NP O
: : O O
F NNP B-NP O
Service NNP I-NP O
: : O O
There EX O O
will MD O O
be VB O O
further JJ B-NP O
addendum NN I-NP O
. . B-VP O
   
Respiratory NNP B-NP B-problem
distress JJ O I-problem
- : O O
On IN B-VP O
10-12 NNS B-NP O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
transferred VBN O O
to TO O O
Medicine NNP B-NP O
Intensive NNP I-NP O
Care NNP I-NP O
Unit NNP I-NP O
secondary JJ O O
to TO O O
respiratory VB O B-problem
distress NN B-NP I-problem
. . B-VP O
   
In IN B-VP O
the DT B-NP O
Medicine NNP I-NP O
Intensive NNP I-NP O
Care NNP I-NP O
Unit NNP I-NP O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
initially RB O O
placed VBN O O
on IN B-VP O
high-flow JJ O B-treatment
60% CD O I-treatment
oxygen NN B-NP I-treatment
face NN I-NP I-treatment
mask NN I-NP I-treatment
and CC O O
they PRP O B-pronoun
diuresed VBD B-VP O
approximately RB O O
5 CD O O
liters NNS B-NP O
off RB O O
into IN B-VP O
the DT B-NP B-treatment
intravenous JJ I-NP I-treatment
Lasix NNP I-NP I-treatment
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
actually RB O O
was VBD B-VP O
improved VBN O O
. . B-VP O
   
She PRP O B-person
came VBD B-VP O
back RB O O
to TO O O
the DT B-NP O
floor NN I-NP O
on IN B-VP O
10-14 NN B-NP O
. . B-VP O
   
Since IN B-VP O
then RB O O
the DT B-NP B-person
patient NN I-NP I-person
's POS O O
oxygenation NN B-NP O
has VBZ O O
been VBN O O
improving VBG O O
and CC O O
today NN B-NP O
, , O O
10-17 JJ O O
, , O O
she PRP O B-person
is VBZ O O
requiring VBG O O
.5 JJ B-NP O
liters NNS I-NP O
of IN B-VP O
keep NN B-NP O
her PRP$ O B-person
her PRP$ O B-test
saturations NNS B-NP I-test
above IN B-VP O
94 CD O O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
continues VBZ O O
to TO O O
be VB O O
diuresed VBN O O
with IN B-VP O
approximately RB O O
20 CD O O
mg NNS B-NP O
of IN B-VP O
Lasix NNP B-NP B-treatment
a DT B-NP O
day NN I-NP O
and CC O O
she PRP O B-person
has VBZ O O
had VBD B-VP O
good JJ B-NP O
urine JJ I-NP O
output NN I-NP O
. . B-VP O
   
Anemia NNP B-NP B-problem
- : O O
The DT O B-person
The DT B-NP B-test
patient JJ I-NP I-person
patient NN I-NP I-test
's POS O I-test
hematocrit NN B-NP I-test
dropped VBD B-VP O
in IN B-VP O
the DT B-NP O
Intensive NNP I-NP O
Care NNP I-NP O
Unit NNP I-NP O
to TO O O
the DT B-NP O
mid NN I-NP O
20s CD O O
and CC O O
she PRP O B-person
received VBD B-VP O
one CD O O
unit NN B-NP O
of IN B-VP O
packed JJ B-NP O
red JJ I-NP B-treatment
blood NN I-NP I-treatment
cells NNS I-NP I-treatment
with IN B-VP O
a DT B-NP O
good JJ I-NP O
response NN I-NP O
up RB O O
to TO O O
30 CD O O
. . B-VP O
   
Hypotension NNP B-NP B-problem
- : O O
On IN B-VP O
the DT B-NP O
night NN I-NP O
of IN B-VP O
10-16 JJ O O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
diuresed VBN O O
with IN B-VP O
20 CD O O
mg NNS B-NP O
of IN B-VP O
intravenous JJ B-NP B-treatment
Lasix NNP I-NP I-treatment
. . B-VP O
   
This DT O B-pronoun
is VBZ O O
the DT B-NP O
normal JJ I-NP O
dose NN I-NP O
that IN B-VP B-pronoun
she PRP O B-person
puts VBZ O O
out RP O O
too RB O O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
became VBD B-VP O
hypotensive JJ O B-problem
into IN B-VP O
the DT O O
70 CD O O
s NN B-NP O
without IN B-VP O
any DT B-NP B-problem
symptoms NNS I-NP I-problem
. . B-VP O
   
Her PRP$ O B-person
Her PRP$ O B-test
oxygen NN B-NP I-test
saturations NNS I-NP I-test
were VBD B-VP O
greater JJR O O
than IN B-VP O
94% CD O O
at IN B-VP O
the DT B-NP O
time NN I-NP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
given VBN O O
250 CD O O
cc NN B-NP O
of IN B-VP O
normal JJ B-NP B-treatment
saline NN I-NP I-treatment
and CC O O
her PRP$ O B-person
her PRP$ O B-test
blood NN B-NP I-test
pressure NN I-NP I-test
responded VBD B-VP O
coming VBG O O
back RB O O
up RB O O
to TO O O
the DT O O
high JJ O O
90 CD O O
s. NN B-NP O
No NNP I-NP O
further RB O O
episodes VBZ O O
of IN B-VP O
hypotension NN B-NP B-problem
were VBD B-VP O
noted VBN O O
. . B-VP O
   
As IN B-VP O
of IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
this DT B-NP B-pronoun
dictation NN I-NP O
, , O O
on IN B-VP O
2010-10-17 JJ O O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
appears VBZ O O
to TO O O
be VB O O
getting VBG O O
better RBR O O
. . B-VP O
   
Recent JJ B-NP B-test
chest NN I-NP I-test
x-ray NN I-NP I-test
shows NNS I-NP O
resolving VBG O B-problem
right RB O I-problem
lower JJR B-NP I-problem
lobe NN I-NP I-problem
pneumonia NN I-NP I-problem
. . B-VP O
   
She PRP O B-person
continues VBZ O O
on IN B-VP O
her PRP$ O B-treatment
her PRP$ O B-person
Prednisone NNP B-NP I-treatment
taper NN I-NP I-treatment
for IN B-VP O
her PRP$ O B-person
her PRP$ O B-problem
asthma NN B-NP I-problem
and CC O O
this DT O B-pronoun
is VBZ O O
day NN B-NP O
# # O O
14 CD O O
of IN B-VP O
antibiotics NNS B-NP B-treatment
. . B-VP O
   
MARK NNP B-NP B-person
Shorter NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
94-264 CD O O
Dictated VBN O O
By IN B-VP O
: : O O
Donna NNP B-NP B-person
Q NNP I-NP I-person
Fisher NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
MEDQUIST36 NNP I-NP O
D NNP I-NP O
: : O O
2010-10-17 JJ O O
12:22 CD O O
T NN B-NP O
: : O O
2010-10-17 JJ O O
17:21 CD O O
JOB NNP B-NP O
#: JJ O O
33371 CD O O
( ( O O
End NN B-NP O
of IN B-VP O
Report NNP B-NP O
) ) O O
-EMPTYLINE- VBP O O
-DOCSTART- JJ O O
-EMPTYLINE- $ O O
207132235 CD O O
SC NNP B-NP O
51203606 CD O O
132775 CD O O
9/20/2000 CD O O
12:00:00 CD O O
AM NNP B-NP O
ENDOMETRIAL NNP I-NP B-problem
CARCINOMA NNP I-NP I-problem
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date NNP I-NP O
: : O O
09/20/2000 CD O O
Report NNP B-NP O
Status NNP I-NP O
: : O O
Signed VBN O O
Discharge NNP B-NP O
Date NNP I-NP O
: : O O
09/22/2000 CD O O
ADMISSION NNP B-NP O
DIAGNOSIS NNP I-NP O
: : O O
ENDOMETRIAL NNP B-NP B-problem
CANCER NNP I-NP I-problem
. . B-VP O
   
DISCHARGE NNP B-NP O
DIAGNOSIS NNP I-NP O
: : O O
ENDOMETRIAL NNP B-NP B-problem
CANCER NNP I-NP I-problem
. . B-VP O
   
PROCEDURES NNP B-NP O
: : O O
TOTAL NNP B-NP B-treatment
ABDOMINAL NNP I-NP I-treatment
HYSTERECTOMY NNP I-NP I-treatment
AND NNP I-NP O
BILATERAL NNP I-NP B-treatment
SALPINGO-OOPHORECTOMY NNP I-NP I-treatment
HISTORY NNP I-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS NNP I-NP O
: : O O
This DT O B-pronoun
is VBZ O O
a DT B-NP O
48-year-old JJ I-NP O
G NNP I-NP O
3 CD O O
P NNP B-NP O
3 CD O O
who WP O B-person
presented VBD B-VP O
to TO O O
Dr. NNP B-NP B-person
Fuscmadril NNP I-NP I-person
&apos;s NNP I-NP O
clinic NN I-NP O
after IN B-VP O
having VBG O O
an DT B-NP B-problem
abnormal JJ I-NP I-problem
pap NN I-NP I-problem
smear NN I-NP I-problem
followed VBN O O
by IN B-VP O
an DT B-NP B-test
endometrial JJ I-NP I-test
biopsy NN I-NP I-test
that WDT O B-pronoun
was VBD B-VP O
suggestive JJ O O
of IN B-VP O
grade NN B-NP B-problem
1 CD O I-problem
endometrial JJ B-NP I-problem
cancer NN I-NP I-problem
. . B-VP O
   
This DT O B-pronoun
is VBZ O O
a DT B-NP O
patient NN I-NP B-person
who WP O B-person
, , O O
over IN B-VP O
the DT B-NP O
past JJ I-NP O
year NN I-NP O
, , O O
has VBZ O O
had VBN O O
no DT B-NP B-problem
menses NNS I-NP I-problem
and CC O O
thought VBD B-VP O
she PRP O B-person
had VBD B-VP O
become VBN O O
menopausal NN B-NP B-problem
. . B-VP O
   
She PRP O B-person
then RB O O
began VBD B-VP O
spotting VBG O B-problem
for IN B-VP O
several JJ B-NP O
months NNS I-NP O
with IN B-VP O
some DT B-NP B-problem
constant JJ I-NP I-problem
brown JJ I-NP I-problem
discharge NN I-NP I-problem
. . B-VP O
   
A DT B-NP B-test
pap JJ I-NP I-test
smear NN I-NP I-test
that WDT O B-pronoun
was VBD B-VP O
obtained VBN O O
by IN B-VP O
her PRP$ O B-person
her PRP$ O B-person
primary JJ B-NP I-person
care NN I-NP I-person
physician NN I-NP I-person
showed VBD B-VP O
an DT B-NP B-problem
endometrial JJ I-NP I-problem
cell NN I-NP I-problem
and CC O O
thus RB O O
she PRP O B-person
was VBD B-VP O
referred VBN O O
to TO O O
a DT B-NP O
gynecologist NN I-NP O
for IN B-VP O
an DT B-NP B-test
endometrial JJ I-NP I-test
biopsy NN I-NP I-test
. . B-VP O
   
The DT B-NP B-test
endometrial JJ I-NP I-test
biopsy NN I-NP I-test
showed VBD B-VP O
grade JJ O B-problem
1 CD O I-problem
endometrial JJ B-NP I-problem
cancer NN I-NP I-problem
. . B-VP O
   
A DT B-NP O
decision NN I-NP O
was VBD B-VP O
made VBN O O
to TO O O
proceed VB O O
with IN B-VP O
surgical JJ B-NP B-treatment
management NN I-NP I-treatment
for IN B-VP O
this DT B-NP B-pronoun
finding NN I-NP O
. . B-VP O
   
PAST NNP B-NP O
MEDICAL NNP I-NP O
HISTORY NNP I-NP O
: : O O
Migraines NNS B-NP B-problem
. . B-VP O
   
ALLERGIES NNS B-NP O
: : O O
Penicillin NNP B-NP B-treatment
. . B-VP O
   
PAST NNP B-NP O
SURGICAL NNP I-NP O
HISTORY NNP I-NP O
: : O O
Two CD O B-treatment
cesarean JJ B-NP I-treatment
sections NNS I-NP I-treatment
. . B-VP O
   
PAST JJ B-NP O
GYN NNP I-NP O
HISTORY NNP I-NP O
: : O O
Menarche NN B-NP O
at IN B-VP O
13 CD O O
, , O O
regular JJ B-NP O
menses NNS I-NP O
to TO O O
the DT B-NP O
age NN I-NP O
of IN B-VP O
46 CD O O
. . B-VP O
   
Then RB O O
becoming VBG O O
irregular NN B-NP B-problem
for IN B-VP O
several JJ B-NP O
years NNS I-NP O
. . B-VP O
   
She PRP O B-person
had VBD B-VP O
her PRP O B-person
her PRP$ O B-person
first JJ B-NP I-person
child NN I-NP I-person
at IN B-VP O
age NN B-NP O
21 CD O O
. . B-VP O
   
She PRP O B-person
has VBZ O O
had VBD B-VP O
one CD O O
normal JJ B-NP B-treatment
spontaneous JJ I-NP I-treatment
vaginal JJ I-NP I-treatment
delivery NN I-NP I-treatment
and CC O O
two CD O O
cesarean JJ B-NP B-treatment
sections NNS I-NP I-treatment
. . B-VP O
   
SOCIAL NNP B-NP O
HISTORY NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
a DT B-NP O
prior JJ I-NP O
off-and-on JJ I-NP O
smoker NN I-NP O
but CC O O
has VBZ O O
quit VBN O O
in IN B-VP O
01/19 CD O O
. . B-VP O
   
She PRP O B-person
is VBZ O O
married JJ O O
. . B-VP O
   
MEDICATIONS NNP B-NP O
ON NNP I-NP O
ADMISSION NNP I-NP O
: : O O
Imitrex NNP B-NP B-treatment
; : O O
Indocin NNP B-NP B-treatment
; : O O
Celebrex NNP B-NP B-treatment
; : O O
Verapamil NNP B-NP B-treatment
for IN B-VP O
migraines NNS B-NP B-problem
. . B-VP O
   
FAMILY NNP B-NP O
HISTORY NNP I-NP O
: : O O
Mother NN B-NP O
with IN B-VP O
colonic JJ B-NP B-problem
polyps NNS I-NP I-problem
. . B-VP O
   
She PRP O B-person
has VBZ O O
a DT B-NP B-person
maternal JJ I-NP I-person
uncle NN I-NP I-person
and CC O O
maternal JJ B-NP B-person
aunt NN I-NP I-person
both DT O O
with IN B-VP O
colon NN B-NP B-problem
cancer NN I-NP I-problem
who WP O B-person
have VBP O O
passed VBN O O
away RB O O
from IN B-VP O
this DT O B-pronoun
this DT B-NP B-problem
disease NN I-NP I-problem
. . B-VP O
   
There EX O O
was VBD B-VP O
no DT B-NP O
additional JJ I-NP O
history NN I-NP O
of IN B-VP O
breast NN B-NP B-problem
, , O I-problem
ovarian JJ O I-problem
or CC O I-problem
uterine JJ B-NP I-problem
cancer NN I-NP I-problem
in IN B-VP O
her PRP$ O B-person
her PRP$ O B-person
family NN B-NP I-person
. . B-VP O
   
PHYSICAL JJ B-NP O
EXAMINATION NN I-NP O
: : O O
GENERAL NN B-NP O
: : O O
She PRP O B-person
is VBZ O O
a DT O O
well-developed JJ O O
, , O O
well-nourished JJ B-NP O
female NN I-NP O
. . B-VP O
   
She PRP O B-person
is VBZ O O
5 CD O O
foot NN B-NP O
4 CD O O
inches NNS B-NP O
and CC O O
159 CD O O
pounds NNS B-NP O
. . B-VP O
   
BREASTS NNP B-NP O
: : O O
No DT B-NP O
masses NNS I-NP B-problem
. . B-VP O
   
LUNGS NN B-NP O
: : O O
Clear JJ O O
to TO O O
auscultation NN B-NP B-test
. . B-VP O
   
HEART NN B-NP O
: : O O
Regular JJ B-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
. . B-VP O
   
ABDOMEN NNP B-NP O
: : O O
Soft JJ O O
, , O O
mildly RB O B-problem
obese JJ O I-problem
with IN B-VP O
Pfannenstiel NNP B-NP B-problem
scar NN I-NP I-problem
visualized VBN O O
. . B-VP O
   
PELVIC NNS B-NP O
: : O O
Normal NNP B-NP O
introitus NN I-NP O
, , O O
normal JJ O O
appearing VBG O O
cervix NN B-NP O
, , O O
a DT O O
small JJ O O
, , O O
mobile JJ B-NP O
uterus NN I-NP O
. . B-VP O
   
No DT B-NP O
additional JJ I-NP B-problem
masses NNS I-NP I-problem
or CC O O
nodules NNS B-NP B-problem
appreciated VBN O O
on IN B-VP O
exam NN B-NP B-test
. . B-VP O
   
HOSPITAL NNP B-NP O
COURSE NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
admitted VBN O O
on IN B-VP O
the DT B-NP O
day NN I-NP O
of IN B-VP O
her PRP$ O B-person
her PRP$ O B-treatment
surgery NN B-NP I-treatment
which WDT O B-pronoun
was VBD B-VP O
09/20/00 CD O O
. . B-VP O
   
She PRP O B-person
underwent VBD B-VP O
a DT B-NP B-treatment
TAH-BSO NNP I-NP I-treatment
which WDT O B-pronoun
was VBD B-VP O
uncomplicated VBN O B-problem
. . B-VP O
   
Details NNS B-NP O
of IN B-VP O
the DT B-NP B-treatment
procedure NN I-NP I-treatment
can MD O O
be VB O O
found VBN O O
in IN B-VP O
the DT B-NP O
operative JJ I-NP O
dictation NN I-NP O
. . B-VP O
   
In IN B-VP O
short JJ O O
, , O O
frozen JJ B-NP B-test
pathology NN I-NP I-test
from IN B-VP I-test
the DT B-NP I-test
uterus NN I-NP I-test
showed VBD B-VP O
that IN B-VP B-pronoun
there EX O O
was VBD B-VP O
a DT O B-problem
grade JJ O I-problem
1 CD O I-problem
cancer NN B-NP I-problem
with IN B-VP O
no DT B-NP O
invasion NN I-NP B-problem
of IN B-VP I-problem
the DT B-NP I-problem
myometrium NN I-NP I-problem
. . B-VP O
   
There EX O O
was VBD B-VP O
no DT B-NP O
nodal JJ I-NP B-test
dissection NN I-NP I-test
done VBN O O
at IN B-VP O
that DT B-NP B-pronoun
time NN I-NP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
tolerated VBD B-VP O
the DT B-NP B-treatment
procedure NN I-NP I-treatment
extremely RB O O
well RB O O
and CC O O
did VBD B-VP O
well RB O O
during IN B-VP O
her PRP$ O B-person
postoperative JJ B-NP O
course NN I-NP O
. . B-VP O
   
By IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
#2 IN B-VP O
she PRP O B-person
was VBD B-VP O
eating VBG O O
, , O O
ambulating VBG O O
and CC O O
voiding VBG O O
on IN B-VP O
her PRP$ O B-person
own JJ O O
. . B-VP O
   
She PRP O B-person
decided VBD B-VP O
to TO O O
now RB O O
be VB O O
discharged VBN O O
home NN B-NP O
at IN B-VP O
this DT B-NP B-pronoun
time NN I-NP O
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
discharged VBN O O
home NN B-NP O
with IN B-VP O
the DT B-NP B-treatment
following JJ I-NP I-treatment
medications NNS I-NP I-treatment
: : O O
DISCHARGE NNP B-NP O
MEDICATIONS NNP I-NP O
: : O O
Percocet NNP B-NP B-treatment
; : O O
Colace NNP B-NP B-treatment
. . B-VP O
   
FOLLOWUP NN B-NP O
: : O O
She PRP O B-person
will MD O O
have VB O O
a DT O O
follow JJ O O
up RP O O
appointment NN B-NP O
with IN B-VP O
Dr. NNP B-NP B-person
Fuscmadril NNP I-NP I-person
in IN B-VP O
four CD O O
weeks NNS B-NP O
. . B-VP O
   
Dictated VBN O O
By IN B-VP O
: : O O
ARL NNP B-NP B-person
STIREDELS NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
ZJ05 NNP I-NP O
Attending NNP I-NP B-person
: : O O
EAN NNP B-NP B-person
L. NNP I-NP I-person
FUSCMADRIL NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
RY2 NNP I-NP O
JE898/7007 NNP I-NP O
Batch NNP I-NP O
: : O O
91309 CD O O
Index NNP B-NP O
No. NN I-NP O
DOABVQ3G8W NNP I-NP O
D NNP I-NP O
: : O O
09/22/00 CD O O
T NN B-NP O
: : O O
09/23/00 CD O O
-EMPTYLINE- NN B-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
Admission NNP I-NP O
Date NNP I-NP O
: : O O
2010-08-30 JJ B-NP O
Discharge NN I-NP O
Date NNP I-NP O
: : O O
2010-09-06 JJ B-NP O
Date NNP I-NP O
of IN B-VP O
Birth NNP B-NP O
: : O O
1946-01-08 JJ B-NP O
Sex NN I-NP O
: : O O
M NNP B-NP O
Service NNP I-NP O
: : O O
Cardiothoracic NNP B-NP O
HISTORY NNP I-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS NNP I-NP O
: : O O
This DT O B-pronoun
is VBZ O O
a DT B-NP O
64-year-old JJ I-NP O
man NN I-NP O
with IN B-VP O
a DT B-NP O
history NN I-NP O
of IN B-VP O
coronary JJ B-NP B-problem
artery NN I-NP I-problem
disease NN I-NP I-problem
, , O O
endocarditis NN B-NP B-problem
status NN I-NP O
post NN I-NP O
coronary JJ B-NP B-treatment
artery NN I-NP I-treatment
bypass NN I-NP I-treatment
grafting NN I-NP I-treatment
and CC O O
mitral JJ O B-treatment
valve FW O I-treatment
replacement NN B-NP I-treatment
on IN B-VP O
2010-08-13 JJ O O
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
transferred VBN O O
to TO O O
Erich NNP B-NP O
Lindemann NNP I-NP O
Mental NNP I-NP O
Health NNP I-NP O
Center NNP I-NP O
from IN B-VP O
the DT B-NP O
rehabilitation NN I-NP O
center NN I-NP O
where WRB O O
he PRP O B-person
had VBD B-VP O
been VBN O O
discharged VBN O O
to TO O O
on IN B-VP O
2010-08-25 JJ O O
following VBG O O
his PRP$ O B-person
his PRP$ O B-treatment
CABG/MVR NNP B-NP I-treatment
. . B-VP O
   
At IN B-VP O
the DT B-NP O
rehabilitation NN I-NP O
center NN I-NP O
the DT B-NP B-person
patient NN I-NP I-person
developed VBD B-VP O
shortness NN B-NP B-problem
of IN B-VP I-problem
breath NN B-NP I-problem
. . B-VP O
   
A DT B-NP B-test
chest JJ I-NP I-test
x-ray NN I-NP I-test
done VBN O O
at IN B-VP O
that DT B-NP B-pronoun
time NN I-NP O
revealed VBD B-VP O
a DT B-NP B-problem
left-sided JJ I-NP I-problem
infiltrate NN I-NP I-problem
versus NN I-NP O
effusion NN I-NP B-problem
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
transferred VBN O O
to TO O O
Mass. NNP B-NP O
Eye NNP I-NP O
& CC O O
Ear NNP B-NP O
Infirmary NNP I-NP O
for IN B-VP O
treatment NN B-NP B-treatment
. . B-VP O
   
At IN B-VP O
the DT B-NP O
time NN I-NP O
he PRP O B-person
complained VBD B-VP O
of IN B-VP O
no DT B-NP O
chest NN I-NP B-problem
pain NN I-NP I-problem
, , O O
weakness NN B-NP B-problem
or CC O O
cough NN B-NP B-problem
, , O O
although IN B-VP O
he PRP O B-person
is VBZ O O
intermittently RB O B-problem
short JJ O I-problem
of IN B-VP I-problem
breath NN B-NP I-problem
. . B-VP O
   
He PRP O B-person
had VBD B-VP O
been VBN O O
anticoagulated VBN O B-treatment
during IN B-VP O
his PRP$ O B-person
stay NN B-NP O
at IN B-VP O
rehabilitation NN B-NP O
for IN B-VP O
atrial JJ B-NP B-problem
fibrillation NN I-NP I-problem
. . B-VP O
   
PAST NNP B-NP O
MEDICAL NNP I-NP O
HISTORY NNP I-NP O
: : O O
1. CD O O
Significant NNP B-NP O
for IN B-VP O
coronary JJ B-NP B-problem
artery NN I-NP I-problem
disease NN I-NP I-problem
status NN I-NP O
post NN I-NP O
CABG/MVR NNP I-NP B-treatment
. . B-VP O
   
2. CD O O
Endocarditis NNP B-NP B-problem
. . B-VP O
   
3. CD O O
Rectal JJ B-NP B-problem
cancer NN I-NP I-problem
. . B-VP O
   
4. CD O O
Atrial JJ B-NP B-problem
fibrillation NN I-NP I-problem
. . B-VP O
   
ALLERGIES CC O O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
has VBZ O O
no DT O O
known VBN O B-problem
drug NN B-NP I-problem
allergies NNS I-NP I-problem
. . B-VP O
   
MEDICATIONS NNP B-NP O
ON NNP I-NP O
TRANSFER NNP I-NP O
: : O O
1. CD O O
Amiodarone $ O B-treatment
200 CD O O
mg NN B-NP O
q.d. NN I-NP O
2. CD O O
Lasix NNP B-NP B-treatment
20 CD O O
mg NN B-NP O
b.i.d. NN I-NP O
3. CD O O
Potassium NNP B-NP B-treatment
chloride NN I-NP I-treatment
20 CD O O
mEq NN B-NP O
b.i.d. NN I-NP O
4. CD O O
Ampicillin NNP B-NP B-treatment
2 CD O O
grams NNS B-NP O
q. RB O O
4 CD O O
hours NNS B-NP O
. . B-VP O
   
5. CD O O
Albuterol NNP B-NP B-treatment
and CC O O
Atrovent NNP B-NP B-treatment
p.r.n. VBD B-VP O
6. CD O O
Aspirin NNP B-NP B-treatment
325 CD O O
q.d. NN B-NP O
7. CD O O
Coumadin NNP B-NP B-treatment
5 CD O O
q.d. NN B-NP O
8. CD O O
Nystatin NNP B-NP B-treatment
swish JJ O O
and CC O O
swallow JJ O O
5 CD O O
cc NN B-NP O
t.i.d. NN I-NP O
9. CD O O
Colace NNP B-NP B-treatment
100 CD O O
b.i.d. NN B-NP O
10. CD O O
Percocet NNP B-NP B-treatment
5/325 CD O O
, , O O
1-2 JJ B-NP O
tablets NNS I-NP O
q. VBD B-VP O
4 CD O O
hours NNS B-NP O
p.r.n. JJ B-NP O
LABORATORY NNP I-NP O
DATA NNP I-NP O
: : O O
White NNP B-NP B-test
count NN I-NP I-test
12.6 CD O O
, , O O
hematocrit NN B-NP B-test
28.9 CD O O
, , O O
platelet NN B-NP B-test
count NN I-NP I-test
259 CD O O
, , O O
PT NNP B-NP B-test
21.4 CD O O
, , O O
PTT NNP B-NP B-test
40.2 CD O O
, , O O
INR NNP B-NP B-test
3.0 CD O O
, , O O
sodium NN B-NP B-test
137 CD O O
, , O O
potassium NN B-NP B-test
4.2 CD O O
, , O O
chloride RB O B-test
100 CD O O
, , O O
CO2 NNP B-NP B-test
27 CD O O
, , O O
BUN NNP B-NP B-test
26 CD O O
, , O O
creatinine NN B-NP B-test
1.3 CD O O
, , O O
glucose VBD B-VP B-test
120 CD O O
. . B-VP O
   
Chest NNP B-NP B-test
x-ray NN I-NP I-test
shows VBZ O O
a DT B-NP B-problem
large JJ I-NP I-problem
left JJ I-NP I-problem
pleural JJ I-NP I-problem
effusion NN I-NP I-problem
. . B-VP O
   
PHYSICAL JJ B-NP O
EXAMINATION NN I-NP O
: : O O
On IN B-VP O
admission NN B-NP O
vital JJ B-NP B-test
signs NNS I-NP I-test
were VBD B-VP O
temperature JJ O B-test
100.1 CD O O
, , O O
heart NN B-NP B-test
rate NN I-NP I-test
83 CD O O
and CC O O
sinus JJ B-NP O
rhythm NN I-NP O
, , O O
blood NN B-NP B-test
pressure NN I-NP I-test
108/50 CD O O
, , O O
respiratory NN B-NP B-test
rate NN I-NP I-test
25 CD O O
, , O O
oxygen NN B-NP B-test
saturation NN I-NP I-test
97% CD O O
on IN B-VP O
three CD O B-treatment
liters NNS B-NP I-treatment
. . B-VP O
   
Generally RB O O
he PRP O B-person
was VBD B-VP O
a DT B-NP O
pleasant JJ I-NP O
man NN I-NP O
with IN B-VP O
mild JJ B-NP B-problem
respiratory NN I-NP I-problem
distress NN I-NP I-problem
. . B-VP O
   
Lungs NNS B-NP O
had VBD B-VP O
decreased VBN O B-problem
breath NN B-NP I-problem
sounds NNS I-NP I-problem
on IN B-VP O
the DT B-NP O
left NN I-NP O
. . B-VP O
   
Cardiac NNP B-NP B-test
examination NN I-NP I-test
showed VBD B-VP O
regular JJ B-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
, , O O
S1 NNP B-NP O
and CC O O
S2 NNP B-NP O
. . B-VP O
   
Chest NNP B-NP B-problem
incision NN I-NP I-problem
was VBD B-VP O
with IN B-VP O
Steri-Strips NNP B-NP B-treatment
, , O O
open JJ O O
to TO O O
air NN B-NP O
, , O O
clean JJ O O
and CC O O
dry JJ O O
. . B-VP O
   
Abdomen NNP B-NP O
was VBD B-VP O
soft JJ O O
and CC O O
nontender NN B-NP B-problem
, , O O
nondistended VBD B-VP B-problem
, , O O
with IN B-VP O
positive JJ B-NP O
bowel NN I-NP O
sounds NNS I-NP O
. . B-VP O
   
Extremities NNS B-NP O
had VBD B-VP O
bilateral JJ B-NP B-problem
pedal JJ I-NP I-problem
edema NN I-NP I-problem
. . B-VP O
   
Right NNP B-NP B-problem
leg NN I-NP I-problem
wound NN I-NP I-problem
had VBD B-VP O
Steri-Strips NNP B-NP B-treatment
, , O O
open JJ O O
to TO O O
air NN B-NP O
, , O O
clean JJ O O
and CC O O
dry JJ O O
. . B-VP O
   
HOSPITAL NNP B-NP O
COURSE NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
admitted VBN O O
to TO O O
Vencor NNP B-NP O
Hospital NNP I-NP O
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
given VBN O O
fresh JJ B-NP B-treatment
frozen JJ I-NP I-treatment
plasma NN I-NP I-treatment
to TO O O
correct VB O O
his PRP$ O B-test
his PRP$ O B-person
INR NNP B-NP I-test
and CC O O
a DT B-NP B-treatment
left JJ I-NP I-treatment
chest NN I-NP I-treatment
tube NN I-NP I-treatment
was VBD B-VP O
placed VBN O O
. . B-VP O
   
Over IN B-VP O
the DT O O
first JJ O O
12 CD O O
hours NNS B-NP O
the DT B-NP B-treatment
chest JJS I-NP I-treatment
tube NN I-NP I-treatment
drained VBD B-VP O
2,500 CD O O
cc NN B-NP O
. . B-VP O
   
On IN B-VP O
hospital JJ B-NP O
day NN I-NP O
two CD O O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
transferred VBN O O
from IN B-VP O
the DT B-NP O
cardiac NN I-NP O
surgery NN I-NP O
recovery NN I-NP O
unit NN I-NP O
to TO O O
07-02 NN B-NP O
for IN B-VP O
continuing VBG O O
care NN B-NP O
. . B-VP O
   
He PRP O B-person
remained VBD B-VP O
hemodynamically RB O O
stable JJ O O
. . B-VP O
   
His PRP$ O B-person
His PRP$ O B-problem
chest NN B-NP I-problem
tube NN I-NP I-problem
drainage NN I-NP I-problem
reduced VBD B-VP O
significantly RB O O
after IN B-VP O
the DT O O
first JJ O O
24 CD O O
hours NNS B-NP O
and CC O O
on IN B-VP O
hospital JJ B-NP O
day NN I-NP O
three CD O O
his PRP$ O B-person
his PRP$ O B-treatment
chest NN B-NP I-treatment
tube NN I-NP I-treatment
was VBD B-VP O
discontinued VBN O O
. . B-VP O
   
Over IN B-VP O
the DT B-NP O
next JJ I-NP O
several JJ I-NP O
days NNS I-NP O
the DT B-NP B-person
patient NN I-NP I-person
remained VBD B-VP O
in IN B-VP O
the DT B-NP O
hospital NN I-NP O
to TO O O
reassess VB O O
for IN B-VP O
recurrent JJ B-NP B-problem
pleural JJ I-NP I-problem
effusion NN I-NP I-problem
. . B-VP O
   
On IN B-VP O
09-02 JJ O O
it PRP O B-pronoun
was VBD B-VP O
decided VBN O O
that IN B-VP B-pronoun
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
stable JJ O O
and CC O O
ready JJ O O
to TO O O
be VB O O
transferred VBN O O
back RB O O
to TO O O
rehabilitation NN B-NP O
, , O O
however RB O O
case NN B-NP O
management NN I-NP O
was VBD B-VP O
unable JJ O O
to TO O O
get VB O O
authorization NN B-NP O
from IN B-VP O
the DT B-NP B-person
patient NN I-NP I-person
's POS O O
insurance NN B-NP O
company NN I-NP O
and CC O O
he PRP O B-person
remained VBD B-VP O
in IN B-VP O
the DT B-NP O
hospital NN I-NP O
throughout IN B-VP O
the DT B-NP O
holiday NN I-NP O
weekend NN I-NP O
awaiting VBG O O
insurance NN B-NP O
authorization NN I-NP O
for IN B-VP O
transfer NN B-NP O
back RB O O
to TO O O
rehabilitation NN B-NP O
. . B-VP O
   
At IN B-VP O
this DT B-NP B-pronoun
time NN I-NP O
the DT O B-person
the DT B-NP B-test
patient JJ I-NP I-person
patient NN I-NP I-test
's POS O I-test
physical JJ B-NP I-test
examination NN I-NP I-test
is VBZ O O
as IN B-VP O
follows VBZ O O
: : O O
Vital JJ B-NP B-test
signs NNS I-NP I-test
were VBD B-VP O
temperature JJ O B-test
97.8 CD O O
, , O O
heart NN B-NP B-test
rate NN I-NP I-test
80 CD O O
and CC O O
sinus JJ B-NP O
rhythm NN I-NP O
, , O O
blood NN B-NP B-test
pressure NN I-NP I-test
140/82 CD O O
, , O O
respiratory NN B-NP B-test
rate NN I-NP I-test
18 CD O O
, , O O
O2 NNP B-NP B-test
saturation NN I-NP I-test
96% CD O O
on IN B-VP O
room NN B-NP O
air NN I-NP O
. . B-VP O
   
Weight MD O B-test
on IN B-VP I-test
admission NN B-NP I-test
was VBD B-VP O
64 CD O O
kg NN B-NP O
, , O O
at IN B-VP O
discharge NN B-NP O
was VBD B-VP O
51.6 CD O O
kg NN B-NP O
. . B-VP O
   
Laboratory NNP B-NP O
data NN I-NP O
showed VBD B-VP O
an DT B-NP B-test
hematocrit NN I-NP I-test
of IN B-VP O
31.6 CD O O
, , O O
PT NNP B-NP B-test
13 CD O O
, , O O
INR NNP B-NP B-test
1.2 CD O O
, , O O
potassium NN B-NP B-test
4.5 CD O O
, , O O
BUN NNP B-NP B-test
18 CD O O
, , O O
creatinine NN B-NP B-test
0.9 CD O O
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
alert JJ O O
and CC O O
oriented VBD B-VP O
x NNP B-NP O
3 CD O O
, , O O
moved VBD B-VP O
all DT B-NP O
extremities NNS I-NP O
, , O O
followed VBD B-VP O
commands NNS B-NP O
. . B-VP O
   
Respiratory NNP B-NP B-test
examination NN I-NP I-test
was VBD B-VP O
clear JJ O O
to TO O O
auscultation VB O B-test
bilaterally RB O I-test
. . B-VP O
   
Cardiac NNP B-NP O
showed VBD B-VP O
a DT B-NP O
regular JJ I-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
, , O O
S1 NNP B-NP O
and CC O O
S2 NNP B-NP O
. . B-VP O
   
Sternum NNP B-NP O
was VBD B-VP O
stable JJ O O
. . B-VP O
   
Incisions NNS B-NP B-problem
had VBD B-VP O
Steri-Strips NNP B-NP B-treatment
, , O O
open JJ O O
to TO O O
air NN B-NP O
, , O O
clean JJ O O
and CC O O
dry JJ O O
. . B-VP O
   
Abdomen NNP B-NP O
was VBD B-VP O
soft JJ O O
, , O O
nontender NN B-NP B-problem
, , O O
nondistended VBD B-VP B-problem
, , O O
with IN B-VP O
normal JJ B-NP O
active JJ I-NP O
bowel NN I-NP O
sounds NNS I-NP O
. . B-VP O
   
Extremities NNS B-NP O
were VBD B-VP O
warm JJ O O
and CC O O
well RB O O
perfused VBN O O
with IN B-VP O
no DT B-NP O
edema NN I-NP B-problem
. . B-VP O
   
Right NNP B-NP B-problem
lower JJR B-NP I-problem
extremity NN I-NP I-problem
incision NN I-NP I-problem
with IN B-VP O
Steri-Strips NNP B-NP B-treatment
, , O O
open JJ O O
to TO O O
air NN B-NP O
, , O O
clean JJ O O
and CC O O
dry JJ O O
. . B-VP O
   
DISCHARGE JJ B-NP O
MEDICATIONS NNP I-NP O
: : O O
1. CD O O
Colace NNP B-NP B-treatment
100 CD O O
mg NN B-NP O
b.i.d. NN I-NP O
2. CD O O
Aspirin NNP B-NP B-treatment
325 CD O O
mg NN B-NP O
q.d. NN I-NP O
3. CD O O
Nystatin NNP B-NP B-treatment
swish JJ O O
and CC O O
swallow JJ O O
, , O O
5 CD O O
cc NN B-NP O
q. NN I-NP O
8 CD O O
hours NNS B-NP O
. . B-VP O
   
4. CD O O
Ampicillin NNP B-NP B-treatment
2 CD O O
grams NNS B-NP O
IV NNP I-NP O
q. VBD B-VP O
6 CD O O
through IN B-VP O
09-08 NN B-NP O
. . B-VP O
   
5. CD O O
Amiodarone $ O B-treatment
200 CD O O
mg NN B-NP O
q.d. NN I-NP O
6. CD O O
Percocet NNP B-NP B-treatment
5/325 CD O O
, , O O
1-2 JJ B-NP O
tablets NNS I-NP O
q. VBD B-VP O
6 CD O O
hours NNS B-NP O
p.r.n. VBP O O
7. CD O O
Milk NNP B-NP B-treatment
of IN B-VP I-treatment
Magnesia NNP B-NP I-treatment
30 CD O O
cc NN B-NP O
q.h.s. NN I-NP O
p.r.n. JJ B-NP O
CONDITION NNP I-NP O
ON NNP I-NP O
DISCHARGE NNP I-NP O
: : O O
Good JJ O O
. . B-VP O
   
DISPOSITION NN B-NP O
: : O O
He PRP O B-person
is VBZ O O
to TO O O
be VB O O
discharged VBN O O
to TO O O
rehabilitation NN B-NP O
. . B-VP O
   
FOHintonP NN B-NP O
: : O O
He PRP O B-person
is VBZ O O
to TO O O
see VB O O
Dr. NNP B-NP B-person
les NNS I-NP I-person
Dina NNP I-NP I-person
in IN B-VP O
one CD O O
month NN B-NP O
, , O O
Dr. NNP B-NP B-person
Bennett NNP I-NP I-person
in IN B-VP O
one CD O O
month NN B-NP O
and CC O O
Dr. NNP B-NP B-person
Duval NNP I-NP I-person
in IN B-VP O
one CD O O
month NN B-NP O
. . B-VP O
   
Russell NNP B-NP B-person
von NNP I-NP I-person
der NN I-NP I-person
Hassler NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
47-736 CD O O
Dictated VBN O O
By IN B-VP O
: : O O
Leonard NNP B-NP B-person
S. NNP I-NP I-person
Perdue NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
MEDQUIST36 NNP I-NP O
D NNP I-NP O
: : O O
2010-09-06 JJ O O
08:54 CD O O
T NN B-NP O
: : O O
2010-09-06 JJ O O
09:17 CD O O
JOB# NNPS B-NP O
: : O O
92751 CD O O
Signed VBN O O
electronically RB O O
by IN B-VP O
: : O O
DR. NNP B-NP B-person
Gene NNP I-NP I-person
au VBP O I-person
Holden NNP B-NP I-person
on IN B-VP O
: : O O
FRI NNP B-NP O
2010-10-01 CD O O
3:26 CD O O
PM NNP B-NP O
( ( O O
End NNP B-NP O
of IN B-VP O
Report NNP B-NP O
) ) O O
-EMPTYLINE- VBP O O
-DOCSTART- JJ B-NP O
-EMPTYLINE- NNP I-NP O
Admission NNP I-NP O
Date NNP I-NP O
: : O O
2019-01-19 JJ B-NP O
Discharge NN I-NP O
Date NNP I-NP O
: : O O
2019-01-24 JJ B-NP O
Date NNP I-NP O
of IN B-VP O
Birth NNP B-NP O
: : O O
1981-03-17 JJ B-NP O
Sex NN I-NP O
: : O O
M NNP B-NP O
Service NNP I-NP O
: : O O
MEDICINE JJ B-NP O
Allergies NNS I-NP O
: : O O
Patient NN B-NP B-person
recorded VBD B-VP O
as IN B-VP O
having VBG O O
No NNP B-NP O
Known NNP I-NP B-problem
Allergies NNPS I-NP I-problem
to TO O O
Drugs NNP B-NP B-treatment
Attending NNP I-NP O
: : O O
Antonio NNP B-NP B-person
I PRP O I-person
Staples NNP B-NP I-person
, , O I-person
M.D. NNP B-NP I-person
Chief NNP I-NP O
Complaint NNP I-NP O
: : O O
nausea NN B-NP B-problem
and CC O O
vomiting VBG O B-problem
Major JJ B-NP O
Surgical NNP I-NP O
or CC O O
Invasive JJ B-NP O
Procedure NN I-NP O
: : O O
01-23 JJ B-NP O
PORT NNP I-NP B-treatment
line NN I-NP I-treatment
removal NN I-NP I-treatment
. . B-VP O
   
01-23 JJ B-NP O
PICC NNP I-NP B-treatment
placement NN I-NP I-treatment
. . B-VP O
   
01-24 JJ B-NP O
PICC NNP I-NP B-treatment
removal NN I-NP I-treatment
. . B-VP O
   
History NN B-NP O
of IN B-VP O
Present NNP B-NP O
Illness NNP I-NP O
: : O O
This DT O B-pronoun
is VBZ O O
a DT O O
37 CD O O
y/o JJ B-NP O
male JJ I-NP O
patient NN I-NP B-person
with IN B-VP O
PMH NNP B-NP O
Type NNP I-NP B-problem
I PRP O I-problem
DM NNP B-NP I-problem
, , O O
HTN NNP B-NP B-problem
, , O O
gastroparesis NN B-NP B-problem
, , O O
ESRD NNP B-NP B-problem
on IN B-VP O
HD NNP B-NP B-treatment
( ( O O
last JJ O O
in IN B-VP O
12/26 CD O O
per IN B-VP O
patient NN B-NP B-person
) ) O O
who WP O B-person
presents VBZ O O
to TO O O
CMED NNP B-NP O
CCU NNP I-NP O
with IN B-VP O
hypertensive JJ B-NP B-problem
urgency NN I-NP I-problem
unable JJ O O
from IN B-VP O
the DT B-NP O
Larry NNP I-NP O
. . B-VP O
   
The DT O B-person
patient JJ O I-person
early JJ O O
this DT B-NP B-pronoun
morning NN I-NP O
to TO O O
the DT B-NP O
Ruthie NNP I-NP O
with IN B-VP O
his PRP$ O B-person
his PRP$ O B-problem
usual JJ B-NP I-problem
nausea NN I-NP I-problem
, , O O
vomiting VBG O B-problem
, , O O
abdominal JJ B-NP B-problem
pain NN I-NP I-problem
and CC O O
was VBD B-VP O
found VBN O O
to TO O O
be VB O O
hypertensive JJ O B-problem
to TO O O
256/110 CD O O
, , O O
HR NNP B-NP B-test
102 CD O O
, , O O
T NNP B-NP B-test
99.2 CD O O
, , O O
RR NNP B-NP B-test
22 CD O O
, , O O
92% CD O O
RA NNP B-NP O
. . B-VP O
   
History NNP B-NP O
is VBZ O O
difficult JJ O O
to TO O O
obtain VB O O
from IN B-VP O
patient JJ B-NP B-person
d/t NN I-NP O
somnolence NN I-NP B-problem
and CC O O
lack NN B-NP B-problem
of IN B-VP I-problem
desire NN B-NP I-problem
to TO O O
participate VB O O
in IN B-VP O
interview NN B-NP O
, , O O
but CC O O
per IN B-VP O
Frank NNP B-NP O
note NN I-NP O
he PRP O B-person
was VBD B-VP O
diaphoretic JJ O B-problem
and CC O O
' POS O O
writing NN B-NP O
in IN B-VP O
pain NN B-NP B-problem
', CD O O
vomiting VBG O B-problem
clear JJ B-NP I-problem
substance NN I-NP I-problem
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
given VBN O O
ativan RP O B-treatment
a DT B-NP O
total NN I-NP O
of IN B-VP O
4 CD O O
mg NN B-NP O
of IN B-VP O
ativan NN B-NP B-treatment
, , O O
6 CD O O
mg NN B-NP O
of IN B-VP O
dilaudid NN B-NP B-treatment
, , O O
labetolol VBZ O B-treatment
20 CD O O
mg NN B-NP O
IV NNP I-NP O
x VBZ O O
1 CD O O
and CC O O
hydralazine VB O B-treatment
10 CD O O
mg NN B-NP O
IV NNP I-NP O
x VBZ O O
1 CD O O
without IN B-VP O
good JJ B-NP O
response NN I-NP O
( ( O O
200/99 CD O O
). NN B-NP O
He PRP O B-person
recieved VBD B-VP O
2L CD O B-treatment
NS NNP B-NP I-treatment
and CC O O
was VBD B-VP O
started VBN O O
on IN B-VP O
labetolol NN B-NP B-treatment
gtt NN I-NP I-treatment
and CC O O
BP NNP B-NP B-test
decreased VBD B-VP O
to TO O O
161/79 CD O O
. . B-VP O
   
Tranferred VBN O O
to TO O O
CMED NNP B-NP O
CCU NNP I-NP O
for IN B-VP O
further JJ B-NP O
management NN I-NP O
while IN B-VP O
on IN B-VP O
labetolol JJ B-NP B-treatment
gtt NN I-NP I-treatment
. . B-VP O
   
Of IN B-VP O
note NN B-NP O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
is VBZ O O
admitted VBN O O
to TO O O
hospital VB O O
3 CD O O
times NNS B-NP O
every DT B-NP O
month NN I-NP O
for IN B-VP O
similar JJ B-NP O
complaints NNS I-NP O
with IN B-VP O
last JJ B-NP O
admission NN I-NP O
1/20-2/1/07 JJ O O
. . B-VP O
   
At IN B-VP O
that DT B-NP B-pronoun
time NN I-NP O
BP NNP I-NP B-test
was VBD B-VP O
attributed VBN O O
to TO O O
abdominal JJ B-NP B-problem
pain NN I-NP I-problem
and CC O O
inability NN B-NP O
to TO O O
take VB O O
PO NNP B-NP O
meds NNS I-NP O
d/t VBP O O
nausea NN B-NP B-problem
/ NN I-NP O
vomiting NN I-NP B-problem
. . B-VP O
   
Also RB O O
had VBD B-VP O
labile JJ B-NP B-problem
blood NN I-NP I-problem
sugars NNS I-NP I-problem
with IN B-VP O
repeated JJ B-NP O
episodes NNS I-NP O
of IN B-VP O
hypoglycemia NN B-NP B-problem
, , O O
and CC O O
Strickland NNP B-NP B-person
recommended VBD B-VP O
sugars NNS B-NP B-test
in IN B-VP O
the DT B-NP O
range NN I-NP O
of IN B-VP O
150-200 JJ O O
. . B-VP O
   
He PRP O B-person
eloped VBD B-VP O
prior RB O O
to TO O O
formal VB O O
discharge NN B-NP O
when WRB O O
his PRP$ O B-person
his PRP$ O B-test
FS NNP B-NP I-test
was VBD B-VP O
found VBN O O
to TO O O
be VB O O
critically RB O B-problem
high JJ O I-problem
- : O O
recommended VBD B-VP O
to TO O O
patient VB O B-person
that IN B-VP B-pronoun
he PRP O B-person
stay VB O O
for IN B-VP O
repeat NN B-NP O
, , O O
but CC O O
left VBD B-VP O
AMA NNP B-NP O
without IN B-VP O
signing VBG O O
any DT B-NP O
forms NNS I-NP O
. . B-VP O
   
Upon IN B-VP O
transfer NN B-NP O
to TO O O
the DT B-NP O
CMED NNP I-NP O
CCU NNP I-NP O
the DT B-NP B-person
patient NN I-NP I-person
appears VBZ O O
somewhat RB O B-problem
uncomfortable JJ O I-problem
, , O O
reporting VBG O O
nausea NN B-NP B-problem
and CC O O
abdominal JJ B-NP B-problem
pain NN I-NP I-problem
, , O O
but CC O O
when WRB O O
questioned VBD B-VP O
he PRP O B-person
was VBD B-VP O
unable JJ B-NP O
/ JJ I-NP O
unwilling NN I-NP O
to TO O O
participate VB O O
in IN B-VP O
HPI NNP B-NP O
or CC O O
exam VB O B-test
d/t JJ B-NP O
sleepiness NN I-NP B-problem
. . B-VP O
   
He PRP O B-person
denied VBD B-VP O
CP NNP B-NP B-problem
, , O O
SOB NNP B-NP B-problem
, , O O
HA NNP B-NP B-problem
, , O O
vision NN B-NP B-problem
changes NNS I-NP I-problem
, , O O
neck NN B-NP B-problem
stiffness NN I-NP I-problem
, , O O
dysuria NN B-NP B-problem
, , O O
or CC O O
other JJ B-NP B-problem
symptoms NNS I-NP I-problem
. . B-VP O
   
In IN B-VP O
the DT B-NP O
CMED NNP I-NP O
CCU NNP I-NP O
he PRP O B-person
became VBD B-VP O
hypotensive JJ O B-problem
to TO O O
SBP VB O B-test
80 CD O O
s. JJ B-NP O
Labetalol NNP I-NP B-treatment
was VBD B-VP O
stopped VBN O O
and CC O O
he PRP O B-person
received VBD B-VP O
a DT O B-treatment
500 CD O I-treatment
cc NN B-NP I-treatment
fluid NN I-NP I-treatment
bolus NN I-NP I-treatment
and CC O O
his PRP$ O B-person
his PRP$ O B-test
blood NN B-NP I-test
pressure NN I-NP I-test
rose VBD B-VP O
to TO O O
SBP NNP B-NP B-test
90 CD O O
s. NN B-NP O
Cardiac NNP I-NP O
and CC O O
infectious JJ B-NP O
sources NNS I-NP O
of IN B-VP O
hypotension NN B-NP B-problem
were VBD B-VP O
considered VBN O O
, , O O
but CC O O
cardiac JJ B-NP B-test
enzymes NNS I-NP I-test
were VBD B-VP O
not RB O O
changed VBN O O
from IN B-VP O
prior JJ B-NP O
studies NNS I-NP O
and CC O O
he PRP O B-person
had VBD B-VP O
no DT B-NP O
localizing JJ I-NP B-problem
signs NNS I-NP I-problem
of IN B-VP I-problem
infection NN B-NP I-problem
; : O O
blood NN B-NP B-test
cultures NNS I-NP I-test
were VBD B-VP O
sent VBN O O
and CC O O
a DT B-NP B-test
ultrasound NN I-NP I-test
of IN B-VP O
the DT B-NP B-treatment
L NNP I-NP I-treatment
arm NN I-NP I-treatment
AVF NNP I-NP I-treatment
ordered VBD B-VP O
to TO O O
rule VB O O
out RP O O
abscess NN B-NP B-problem
at IN B-VP I-problem
the DT B-NP I-problem
site NN I-NP I-problem
. . B-VP O
   
He PRP O B-person
received VBD B-VP O
a DT B-NP B-treatment
partial JJ I-NP I-treatment
HD NNP I-NP I-treatment
session NN I-NP I-treatment
, , O O
limited VBN O O
by IN B-VP O
hypotension NN B-NP B-problem
. . B-VP O
   
Over IN B-VP O
night NN B-NP O
, , O O
his PRP$ O B-person
his PRP$ O B-test
blood NN B-NP I-test
pressure NN I-NP I-test
trended VBD B-VP O
up RB O O
to TO O O
130 CD O O
s NNS B-NP O
systolic JJ O O
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
restarted VBN O O
on IN B-VP O
his PRP$ O B-person
his PRP$ O B-treatment
home NN B-NP I-treatment
blood NN I-NP I-treatment
pressure NN I-NP I-treatment
regimen NNS I-NP I-treatment
. . B-VP O
   
Renal NNP B-NP O
consult NN I-NP O
team NN I-NP O
saw VBD B-VP O
him PRP O B-person
2019-01-20 JJ O O
and CC O O
plan NN B-NP O
to TO O O
next JJ B-NP O
dialyze NN I-NP O
him PRP O B-person
on IN B-VP O
2019-01-21 JJ O O
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
to TO O O
be VB O O
called VBN O O
out RP O O
to TO O O
the DT B-NP O
medical JJ I-NP O
floor NN I-NP O
on IN B-VP O
2019-01-20 JJ O O
but CC O O
became VBD B-VP O
somnolent JJ O B-problem
after IN B-VP O
receiving VBG O O
pain NN B-NP B-treatment
and CC O I-treatment
anti-nausea NN B-NP I-treatment
meds NNS I-NP I-treatment
, , O O
so IN B-VP O
he PRP O B-person
stayed VBD B-VP O
in IN B-VP O
the DT B-NP O
ICU NNP I-NP O
for IN B-VP O
closer JJR B-NP O
monitoring NN I-NP O
of IN B-VP O
respiratory NN B-NP O
status NN I-NP O
, , O O
which WDT O B-pronoun
spontaneously RB O O
improved VBN O O
. . B-VP O
   
His PRP$ O B-person
His PRP$ O B-test
blood NN B-NP I-test
sugar NN I-NP I-test
at IN B-VP O
10 CD O O
pm NN B-NP O
was VBD B-VP O
low JJ O O
at IN B-VP O
22 CD O O
and CC O O
he PRP O B-person
was VBD B-VP O
disoriented VBN O B-problem
, , O O
which WDT O B-pronoun
resolved VBD B-VP O
with IN B-VP O
two CD O O
glasses NNS B-NP O
of IN B-VP O
juice NN B-NP O
; : O O
he PRP O B-person
did VBD B-VP O
not RB O O
receive VB O O
his PRP$ O B-person
standing VBG O O
dose NN B-NP O
of IN B-VP O
NPH NNP B-NP B-treatment
that IN B-VP B-pronoun
evening VBG O O
. . B-VP O
   
Blood NNP B-NP B-test
cultures NNS I-NP I-test
returned VBD B-VP O
positive JJ O O
with IN B-VP O
GPC NNP B-NP B-problem
in IN B-VP I-problem
pairs NNS B-NP I-problem
and CC O I-problem
clusters NNS B-NP I-problem
, , O O
so IN B-VP O
a DT B-NP B-test
TTE NNP I-NP I-test
and CC O O
surveillance NN B-NP B-test
cultures NNS I-NP I-test
were VBD B-VP O
ordered VBN O O
and CC O O
vancomycin NN B-NP B-treatment
was VBD B-VP O
started VBN O O
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
then RB O O
called VBN O O
out RP O O
to TO O O
the DT B-NP O
medical JJ I-NP O
floor NN I-NP O
on IN B-VP O
01-21 NN B-NP O
. . B-VP O
   
Past NNP B-NP O
Medical JJ B-NP O
History NN I-NP O
: : O O
1. CD O O
DM NNP B-NP B-problem
type NN I-NP I-problem
I PRP O I-problem
2. CD O O
ESRD NNP B-NP B-problem
on IN B-VP O
hemodialysis NN B-NP B-treatment
started VBN O O
2017-01-07 CD O O
on IN B-VP O
Tu NNP B-NP O
, , O O
Th NNP B-NP O
, , O O
Sat NNP B-NP O
3. CD O O
Severe NNP B-NP B-problem
autonomic JJ B-NP I-problem
dysfunction NN I-NP I-problem
with IN B-VP O
multiple JJ B-NP O
hospitalizations NNS I-NP O
for IN B-VP O
hypertensive JJ B-NP B-problem
emergency NN I-NP I-problem
, , O O
gastroparesis NN B-NP B-problem
, , O O
and CC O O
orthostatic JJ B-NP B-problem
hypotension NN I-NP I-problem
. . B-VP O
   
4. CD O O
History NN B-NP O
of IN B-VP O
esophageal JJ B-NP B-problem
erosion NN I-NP I-problem
, , O O
MW NNP B-NP B-problem
tear VBP O I-problem
5. CD O O
CAD NNP B-NP B-problem
with IN B-VP O
1-vessel JJ B-NP B-problem
disease NN I-NP I-problem
( ( O O
50% CD O B-problem
stenosis NN B-NP I-problem
D1 NNP I-NP I-problem
in IN B-VP O
2014-06-07 JJ B-NP O
), NNP I-NP O
normal JJ B-NP O
stress NN I-NP O
2015-10-07 JJ O O
6. CD O O
hx NN B-NP O
of IN B-VP O
Foot NNP B-NP B-problem
Ulcer NNP I-NP I-problem
7. CD O O
h/o NN B-NP O
clot NN I-NP B-problem
in IN B-VP O
AV NNP B-NP B-treatment
graft NN I-NP I-treatment
x2 NN I-NP O
( ( O O
March NNP B-NP O
and CC O O
2018-07-07 JJ O O
) ) O O
Social NNP B-NP O
History NNP I-NP O
: : O O
Denies NNPS B-NP O
alcohol NN I-NP O
or CC O O
tobacco NN B-NP O
use NN I-NP O
. . B-VP O
   
Endorses NNS B-NP O
occassional JJ B-NP O
marijuana NN I-NP O
use NN I-NP O
. . B-VP O
   
Lives VBZ O O
with IN B-VP O
his PRP$ O B-person
his PRP$ O B-person
Carney NNP B-NP I-person
Hospital NNP I-NP I-person
mother NN I-NP I-person
and CC O O
their PRP$ O B-person
their PRP$ O B-person
three CD O I-person
children NNS B-NP I-person
. . B-VP O
   
Family RB O O
History NN B-NP O
: : O O
His PRP$ O B-person
His PRP$ O B-person
father NN B-NP I-person
recently RB O O
died VBD B-VP O
of IN B-VP O
ESRD NNP B-NP B-problem
and CC O O
diabetes NNS B-NP B-problem
. . B-VP O
   
His PRP$ O B-person
His PRP$ O B-person
mother NN B-NP I-person
is VBZ O O
in IN B-VP O
her PRP$ O B-person
50 CD O O
s NN B-NP O
and CC O O
has VBZ O O
hypertension NN B-NP B-problem
. . B-VP O
   
He PRP O B-person
has VBZ O O
two CD O B-person
sisters NNS B-NP I-person
, , O O
one CD O O
with IN B-VP O
diabetes NNS B-NP B-problem
, , O O
and CC O O
six CD O B-person
brothers NNS B-NP I-person
, , O O
one CD O O
with IN B-VP O
diabetes NNS B-NP B-problem
. . B-VP O
   
Physical JJ B-NP O
Exam NN I-NP O
: : O O
Vitals NNS B-NP B-test
: : O O
97.4 CD O O
, , O O
164/90 CD O O
, , O O
102 CD O O
, , O O
10 CD O O
, , O O
97% CD O O
4L CD O O
General JJ O O
: : O O
sleepy NN B-NP B-problem
, , O O
arouses VBZ O O
to TO O O
voice VB O O
but CC O O
limited JJ B-NP O
participation NN I-NP O
with IN B-VP O
physical JJ B-NP B-test
exam NN I-NP I-test
HEENT NNP I-NP O
: : O O
PERRL NNP B-NP O
, , O O
left VBD B-VP B-problem
pupil RP O I-problem
smaller JJR O I-problem
than IN B-VP I-problem
right NN B-NP I-problem
, , O O
pt NN B-NP B-person
will MD O O
not RB O O
participate VB O O
in IN B-VP O
EOMI NNP B-NP O
, , O O
sclera NN B-NP O
anicteric NN I-NP B-problem
, , O O
MM NNP B-NP B-problem
dry NN I-NP I-problem
, , O O
No NNP B-NP O
OP NNP I-NP B-problem
lesions NNS I-NP I-problem
Neck NNP I-NP O
: : O O
Supple NN B-NP O
, , O O
no DT B-NP O
JVD NNP I-NP B-problem
CV NNP I-NP O
: : O O
RRR NNP B-NP O
, , O O
nl JJ B-NP O
S1 NNP I-NP O
, , O O
S2 NNP B-NP O
, , O O
2/6 CD O B-problem
systolic JJ B-NP I-problem
murmur NN I-NP I-problem
at IN B-VP I-problem
LUSB NNP B-NP I-problem
Lungs NNP I-NP O
: : O O
CTAB NNP B-NP O
post NN I-NP O
Chest NNP I-NP O
: : O O
HD NNP B-NP B-treatment
line NN I-NP I-treatment
in IN B-VP O
place NN B-NP O
without IN B-VP O
erythema JJ B-NP B-problem
Abd NNP I-NP O
: : O O
Soft JJ O O
, , O O
ND NNP B-NP B-problem
, , O O
nontender NN B-NP B-problem
, , O O
+ NNP B-NP O
BS NNP I-NP O
, , O O
no DT B-NP O
guarding NN I-NP B-problem
, , O O
no DT B-NP O
rebound NN I-NP B-problem
, , O O
multiple RB O B-problem
well RB O I-problem
healed VBN O I-problem
scars NNS B-NP I-problem
Ext NNP I-NP O
: : O O
no DT B-NP O
c/c/e NN I-NP B-problem
, , O O
left VBD B-VP B-problem
arm NN B-NP I-problem
with IN B-VP I-problem
fistula NN B-NP I-problem
with IN B-VP O
good JJ B-NP O
thrill NN I-NP O
Skin NNP I-NP O
: : O O
no DT B-NP O
rashes NNS I-NP B-problem
Brief NNP I-NP O
Hospital NNP I-NP O
Course NNP I-NP O
: : O O
Pt NNP B-NP B-person
admitted VBD B-VP O
to TO O O
medical JJ B-NP O
floor NN I-NP O
in IN B-VP O
hemodynamically RB O O
stable JJ B-NP O
condition NN I-NP O
without IN B-VP O
specific JJ B-NP B-problem
complaints NNS I-NP I-problem
. . B-VP O
   
# # O O
hypertensive JJ B-NP B-problem
urgency NN I-NP I-problem
: : O O
Upon IN B-VP O
presentation NN B-NP O
it PRP O B-pronoun
was VBD B-VP O
unclear JJ O O
when WRB O O
last JJ B-NP O
time NN I-NP O
was VBD B-VP O
that IN B-VP B-pronoun
patient JJ O B-person
took VBD B-VP O
meds NNS B-NP B-treatment
, , O O
but CC O O
hypertension NN B-NP B-problem
likely RB O O
d/t JJ B-NP O
inability NN I-NP B-problem
to TO O I-problem
take VB O I-problem
meds NNS B-NP I-problem
in IN B-VP O
setting NN B-NP O
of IN B-VP O
N/V NNP B-NP B-problem
. . B-VP O
   
Also RB O O
contribution NN B-NP O
of IN B-VP O
autonomic JJ B-NP B-problem
dysfunction NN I-NP I-problem
. . B-VP O
   
No DT B-NP O
evidence NN I-NP O
of IN B-VP O
active JJ B-NP B-problem
end NN I-NP I-problem
organ JJ B-NP I-problem
damage NN I-NP I-problem
. . B-VP O
   
Pt NNP B-NP B-person
was VBD B-VP O
treated VBN O O
with IN B-VP O
labetalol JJ B-NP B-treatment
gtt NN I-NP I-treatment
in IN B-VP O
CMED NNP B-NP O
CCU NNP I-NP O
which WDT O B-pronoun
was VBD B-VP O
weaned VBN O O
off RP O O
on IN B-VP O
01-20 NN B-NP O
. . B-VP O
   
carduac NN B-NP B-problem
enzymes VBZ O I-problem
mildly RB O I-problem
elevated VBN O I-problem
, , O O
felt VBD B-VP O
02-08 JJ B-NP O
demand NN I-NP B-problem
ischemia NN I-NP I-problem
in IN B-VP O
setting VBG O O
of IN B-VP O
hypertensive JJ B-NP B-problem
urgency NN I-NP I-problem
, , O O
CK NNP B-NP B-test
and CC O O
MB NNP B-NP B-test
trended VBD B-VP O
Mcewen NNP B-NP O
at IN B-VP O
time NN B-NP O
of IN B-VP O
admission NN B-NP O
to TO O O
medical JJ B-NP O
floor NN I-NP O
. . B-VP O
   
Pt NNP B-NP B-problem
Pt NNP I-NP B-person
's POS O I-problem
hypertensive JJ B-NP I-problem
urgency NN I-NP I-problem
was VBD B-VP O
resolved VBN O O
upon IN B-VP O
admission NN B-NP O
to TO O O
the DT B-NP O
medical JJ I-NP O
floor NN I-NP O
. . B-VP O
   
His PRP$ O B-person
His PRP$ O B-test
SBP NNP B-NP I-test
s NN I-NP I-test
ranged VBD B-VP O
140 CD O O
s- JJ O O
170 CD O O
s NN B-NP O
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
restarted VBN O O
on IN B-VP O
his PRP$ O B-person
home NN B-NP O
regimen NNS I-NP O
of IN B-VP O
antihypertensives NNS B-NP B-treatment
without IN B-VP O
difficulty NN B-NP O
( ( O O
metoprolol JJ O B-treatment
75 CD O O
tid NN B-NP O
, , O O
clonidine JJ B-NP B-treatment
patch NN I-NP I-treatment
and CC O I-treatment
oral JJ O I-treatment
, , O O
nifedipine JJ O B-treatment
30 CD O O
SR NNP B-NP O
q JJ O O
daily RB O O
). IN B-VP O
he PRP O B-person
was VBD B-VP O
discharged VBN O O
home NN B-NP O
with IN B-VP O
change NN B-NP O
in IN B-VP O
his PRP$ O B-person
regimen NNS B-NP O
. . B-VP O
   
# # O O
bacteremia NN B-NP B-problem
: : O O
pt NN B-NP B-person
with IN B-VP O
2/4 CD O O
bottles NNS B-NP O
coag VBP O B-problem
neg JJ B-NP I-problem
staph NN I-NP I-problem
on IN B-VP O
01-19 NN B-NP O
and CC O O
again RB O O
on IN B-VP O
01-20 NN B-NP O
. . B-VP O
   
PORT NNP B-NP B-treatment
was VBD B-VP O
felt VBN O O
most JJS B-NP O
likely JJ I-NP O
source NN I-NP O
, , O O
and CC O O
pt NN B-NP B-person
has VBZ O O
had VBN O O
at IN B-VP O
least JJS O O
2 CD O O
sets NNS B-NP O
of IN B-VP O
+ NNP B-NP B-problem
blood NN I-NP I-problem
cultures NNS I-NP I-problem
since IN B-VP O
it PRP O B-pronoun
was VBD B-VP O
placed VBN O O
. . B-VP O
   
TTE NNP B-NP B-test
was VBD B-VP O
obtained VBN O O
which WDT O B-pronoun
was VBD B-VP O
not RB O O
concerning VBG O O
for IN B-VP O
endocarditis NN B-NP B-problem
. . B-VP O
   
pt NN B-NP B-person
without IN B-VP O
stigmata NN B-NP B-problem
of IN B-VP I-problem
SBE NNP B-NP I-problem
. . B-VP O
   
ID NNP B-NP B-person
consult NN I-NP O
obtained VBD B-VP O
which WDT O B-person
recommended VBD B-VP O
removal NN B-NP B-treatment
of IN B-VP I-treatment
PORT NNP B-NP I-treatment
, , O O
which WDT O B-treatment
was VBD B-VP O
taken VBN O O
out RP O O
on IN B-VP O
01-23 NN B-NP O
. . B-VP O
   
Pt NNP B-NP B-person
will MD O O
compelete VB O O
a DT O O
2 CD O O
week NN B-NP O
course NN I-NP O
of IN B-VP O
vancomycin NN B-NP B-treatment
at IN B-VP O
hemodialysis NN B-NP B-treatment
, , O O
which WDT O B-pronoun
has VBZ O O
been VBN O O
arranged VBN O O
by IN B-VP O
renal JJ B-NP O
service NN I-NP O
. . B-VP O
   
A DT B-NP B-treatment
PICC NNP I-NP I-treatment
was VBD B-VP O
breifly NN B-NP O
placed VBN O O
, , O O
however RB O O
removed VBN O O
as IN B-VP O
it PRP O B-pronoun
is VBZ O O
unclear JJ O O
if IN B-VP O
pt NNS B-NP B-person
can MD O O
reliably RB O O
flush VB O O
this DT O B-pronoun
. . B-VP O
   
PORT NNP B-NP B-treatment
will MD O O
be VB O O
replaced VBN O O
on IN B-VP O
2019-02-11 JJ O O
per IN B-VP O
IR NNP B-NP B-person
( ( O O
Dr. NNP B-NP B-person
Welsh NNP I-NP I-person
placed VBD B-VP O
last JJ B-NP O
PORT NNP I-NP B-treatment
, , O O
then RB O O
removed VBD B-VP O
it PRP O B-treatment
on IN B-VP O
01-23 JJ B-NP O
), NN I-NP O
ordered VBD B-VP O
placed VBN O O
in IN B-VP O
OMR NNP B-NP O
. . B-VP O
   
Indication NN B-NP O
: : O O
diabetic JJ B-NP B-problem
gastropathy NN I-NP I-problem
causing VBG O O
inability NN B-NP B-problem
to TO O I-problem
toleral JJ B-NP I-problem
oral JJ I-NP I-problem
antihypertensive JJ I-NP I-problem
medication NN I-NP I-problem
prompting VBG O O
repeated VBN O O
Donald NNP B-NP O
presentation NN I-NP O
for IN B-VP O
hypertensive JJ B-NP B-problem
urgency NN I-NP I-problem
. . B-VP O
   
Pt NNP B-NP B-person
with IN B-VP O
surveillance NN B-NP B-test
cultures NNS I-NP I-test
and CC O O
port VB O B-test
tip NN B-NP I-test
cultures NNS I-NP I-test
showing VBG O O
NGTD NNP B-NP O
on IN B-VP O
01-24 NN B-NP O
, , O O
he PRP O B-person
will MD O O
have VB O O
futher JJR B-NP B-test
surveillance NN I-NP I-test
cultures NNS I-NP I-test
drawn VBN O O
at IN B-VP O
hemodialysis NN B-NP B-treatment
and CC O O
followed VBN O O
by IN B-VP O
his PRP$ O B-person
his PRP$ O B-person
nephrologist NN B-NP I-person
. . B-VP O
   
# # O O
n/v/ JJ B-NP B-problem
abdominal JJ I-NP B-problem
pain NN I-NP I-problem
: : O O
pt NN B-NP B-person
with IN B-VP O
multiple JJ B-NP O
admissions NNS I-NP O
with IN B-VP O
similar JJ B-NP B-problem
complaints NNS I-NP I-problem
, , O O
etiology NN B-NP O
02-08 JJ B-NP O
gastroparesis NN I-NP B-problem
, , O O
improves VBZ O O
considerably RB O O
with IN B-VP O
ativan NN B-NP B-treatment
, , O O
dilaudid NN B-NP B-treatment
, , O O
reglan NN B-NP B-treatment
, , O O
pt NN B-NP B-person
was VBD B-VP O
tolerating VBG O O
PO NNP B-NP B-treatment
meds NNS I-NP I-treatment
/ VBP O O
diet JJ O O
at IN B-VP O
time NN B-NP O
of IN B-VP O
admission NN B-NP O
to TO O O
medical JJ B-NP O
service NN I-NP O
and CC O O
was VBD B-VP O
restarted VBN O O
on IN B-VP O
oral JJ B-NP B-treatment
reglan NN I-NP I-treatment
. . B-VP O
   
# # O O
DMI NNP B-NP B-problem
: : O O
Pt NN B-NP B-person
on IN B-VP O
sliding VBG O B-treatment
scale NN B-NP I-treatment
as IN B-VP O
inpatient NN B-NP O
and CC O O
taking VBG O O
NPH NNP B-NP B-treatment
2 CD O O
units NNS B-NP O
BID NNP I-NP O
at IN B-VP O
home NN B-NP O
. . B-VP O
   
pt NN B-NP B-person
with IN B-VP O
two CD O O
episodes NNS B-NP O
of IN B-VP O
hypoglycemia NN B-NP B-problem
( ( O O
FSBS NNP B-NP B-test
22 CD O O
and CC O O
27 CD O O
), NNP B-NP O
etiology NN I-NP O
unclear JJ O O
, , O O
pt NN B-NP B-person
followed VBN O O
by IN B-VP O
Strickland NNP B-NP B-person
, , O O
who WP O B-person
recommend VBP O O
no DT B-NP O
changes NNS I-NP O
to TO O O
current JJ B-NP B-treatment
insulin NN I-NP I-treatment
regimen NN I-NP I-treatment
. . B-VP O
   
will MD O O
discharge VB O O
pt NN B-NP B-person
with IN B-VP O
instructions NNS B-NP O
to TO O O
continue VB O O
NPH NNP B-NP B-treatment
2 CD O O
UNITS NNP B-NP O
BID NNP I-NP O
as IN B-VP O
Frederick NNP B-NP B-person
Tracey NNP I-NP I-person
recs NN I-NP O
. . B-VP O
   
# # O O
CAD NNP B-NP B-problem
- : O O
pt NN B-NP B-person
denied VBD B-VP O
cp JJ B-NP B-problem
/ NN I-NP O
sob NN I-NP B-problem
throughout IN B-VP O
hospitalization NN B-NP O
. . B-VP O
   
Troponins NNS B-NP B-test
rose VBD B-VP O
at IN B-VP O
admission NN B-NP O
, , O O
however RB O O
CK NNP B-NP B-test
and CC O O
MB NNP B-NP B-test
trending VBG O O
Mcewen NNP B-NP O
wat JJ B-NP O
time NN I-NP O
of IN B-VP O
admission NN B-NP O
to TO O O
medical JJ B-NP O
service NN I-NP O
. . B-VP O
   
Etiology NNP B-NP O
felt VBD B-VP O
most JJS B-NP O
likely JJ I-NP O
demand NN I-NP B-problem
ischemia NN I-NP I-problem
in IN B-VP O
setting VBG O O
of IN B-VP O
original JJ B-NP B-problem
hypertensive JJ I-NP I-problem
urgency NN I-NP I-problem
with IN B-VP O
persistent JJ B-NP B-problem
elevation NN I-NP I-problem
of IN B-VP I-problem
trop JJ B-NP I-problem
02-08 JJ I-NP O
ESRD NNP I-NP B-problem
. . B-VP O
   
Pt NNP B-NP B-person
was VBD B-VP O
continued VBN O O
on IN B-VP O
aspirin NN B-NP B-treatment
, , O O
metoprolol NN B-NP B-treatment
, , O O
nifedipine NN B-NP B-treatment
. . B-VP O
   
# # O O
ESRD NN B-NP B-problem
: : O O
etiology NN B-NP O
likely JJ B-NP O
02-08 JJ I-NP O
DM NNP I-NP B-problem
and CC O O
HTN NNP B-NP B-problem
, , O O
pt NN B-NP B-person
tolerating VBG O O
HD NNP B-NP B-treatment
well RB O O
, , O O
and CC O O
underwent JJ B-NP O
dialysis NN I-NP B-treatment
without IN B-VP O
difficulty NN B-NP B-problem
on IN B-VP O
01-24 JJ O O
. . B-VP O
   
pt NN B-NP B-person
will MD O O
be VB O O
discharged VBN O O
home NN B-NP O
with IN B-VP O
plan NN B-NP O
to TO O O
continue VB O O
current JJ B-NP B-treatment
dialysis NN I-NP I-treatment
schedule NN I-NP I-treatment
( ( O O
Tue NNP B-NP O
/ NNP I-NP O
Th NNP I-NP O
/ NNP I-NP O
Sat NNP I-NP O
). NNP I-NP O
In IN B-VP O
addition NN B-NP O
pt NN I-NP B-person
will MD O O
be VB O O
given VBN O O
vancomycin NNS B-NP B-treatment
at IN B-VP O
dialysis NN B-NP B-treatment
x $ O O
2 CD O O
week NN B-NP O
course NN I-NP O
( ( O O
last JJ B-NP O
day NN I-NP O
2019-02-05 JJ O O
) ) O O
given VBN O O
his PRP$ O B-problem
his PRP$ O B-person
PORT NNP B-NP I-problem
line NN I-NP I-problem
infection NN I-NP I-problem
. . B-VP O
   
He PRP O B-person
will MD O O
have VB O O
levels NNS B-NP B-test
drawn VBN O O
at IN B-VP O
dialysis NN B-NP B-treatment
and CC O O
be VB O O
dosed VBN O O
with IN B-VP O
vancomycin NN B-NP B-treatment
as IN B-VP O
appropriate NN B-NP O
. . B-VP O
   
Plan NN B-NP O
is VBZ O O
for IN B-VP O
surveillance NN B-NP B-test
cultures NNS I-NP I-test
to TO O O
be VB O O
drawn VBN O O
at IN B-VP O
dialysis NN B-NP B-treatment
. . B-VP O
   
If IN B-VP O
negative JJ O O
, , O O
pt NN B-NP B-person
is VBZ O O
scheduled VBN O O
for IN B-VP O
presumptively RB O B-treatment
replacement NN B-NP I-treatment
of IN B-VP I-treatment
PORT NNP B-NP I-treatment
on IN B-VP O
2019-02-11 JJ O O
with IN B-VP O
interventional JJ B-NP B-person
radiology NN I-NP I-person
( ( O O
dr. JJ B-NP B-person
Arevalo NNP I-NP I-person
). NNP I-NP O
Pt NNP I-NP B-person
continued VBD B-VP O
on IN B-VP O
home NN B-NP O
regimen NNS I-NP O
of IN B-VP O
calcium NN B-NP B-treatment
acetate NN I-NP I-treatment
667 CD O O
mg NN B-NP O
, , O O
3 CD O O
capsules NNS B-NP O
TID NNP I-NP O
. . B-VP O
   
# # O O
AV NNP B-NP B-treatment
fistula NN I-NP I-treatment
: : O O
pt NN B-NP B-person
with IN B-VP O
h/o JJ B-NP O
numerous JJ I-NP B-problem
clots NNS I-NP I-problem
in IN B-VP O
AV NNP B-NP B-treatment
fistula NN I-NP I-treatment
. . B-VP O
   
No DT B-NP O
signs NNS I-NP O
of IN B-VP O
infection NN B-NP B-problem
presently RB O O
, , O O
and CC O O
tolerating VBG O O
dialysis NN B-NP B-treatment
without IN B-VP O
difficulty NN B-NP B-problem
. . B-VP O
   
Pt NNP B-NP B-person
was VBD B-VP O
subtherapeuticon JJ B-NP B-problem
INR NNP I-NP I-problem
on IN B-VP O
admission NN B-NP O
, , O O
thus RB O O
treated VBN O O
with IN B-VP O
heparin JJ B-NP B-treatment
gtt NN I-NP I-treatment
. . B-VP O
   
coumadin JJ O B-treatment
held VBD B-VP O
on IN B-VP O
01-22 NN B-NP O
for IN B-VP O
PORT NNP B-NP B-treatment
removal NN I-NP I-treatment
, , O O
and CC O O
restarted VBN O O
on IN B-VP O
01-24 NN B-NP O
. . B-VP O
   
Pt NNP B-NP B-person
discharged VBD B-VP O
with IN B-VP O
instructions NNS B-NP O
to TO O O
continue VB O O
coumadin JJ O B-treatment
1.5 CD O O
mg NN B-NP O
po NN I-NP O
q JJ O O
daily JJ O O
with IN B-VP O
goal NN B-NP B-test
INR NNP I-NP I-test
02-09 NNP I-NP O
. . B-VP O
   
# # O O
DISPO NNP B-NP O
: : O O
pt NN B-NP B-person
discharged VBD B-VP O
home NN B-NP O
on IN B-VP O
01-24 JJ O O
with IN B-VP O
instructions NNS B-NP O
to TO O O
complete VB O O
2 CD O O
week NN B-NP O
course NN I-NP O
of IN B-VP O
vancomycin NN B-NP B-treatment
at IN B-VP O
hemodialysis NN B-NP B-treatment
for IN B-VP O
his PRP$ O B-person
his PRP$ O B-problem
PORT NNP B-NP I-problem
line NN I-NP I-problem
infection NN I-NP I-problem
. . B-VP O
   
an DT B-NP O
appointment NN I-NP O
was VBD B-VP O
made VBN O O
with IN B-VP O
interventional JJ B-NP B-person
radiology NN I-NP I-person
on IN B-VP O
2019-02-11 JJ O O
to TO O O
replace VB O O
his PRP$ O B-person
his PRP$ O B-treatment
PORT NNP B-NP I-treatment
, , O O
under IN B-VP O
the DT B-NP O
assumption NN I-NP O
that IN B-VP B-pronoun
his PRP$ O B-person
his PRP$ O B-test
surveillance NN B-NP I-test
cultures NNS I-NP I-test
from IN B-VP O
dialysis NN B-NP B-treatment
remain VBP O O
negative JJ O O
. . B-VP O
   
discussed VBN O O
this DT B-NP B-pronoun
plan NN I-NP O
with IN B-VP O
renal JJ B-NP O
service NN I-NP O
( ( O O
Anthony NNP B-NP B-person
Mcknight NNP I-NP I-person
) ) O O
who WP O B-person
will MD O O
communicate VB O O
with IN B-VP O
pt JJ B-NP B-person
pt NN I-NP B-person
's POS O I-person
outpatient JJ B-NP I-person
dialysis NN I-NP I-person
service NN I-NP I-person
. . B-VP O
   
Medications NNS B-NP O
on IN B-VP O
Admission NN B-NP O
: : O O
Metoclopramide NNP B-NP B-treatment
10 CD O O
mg NN B-NP O
PO NNP I-NP O
Q6 NNP I-NP O
Metoprolol NNP I-NP B-treatment
Tartrate NNP I-NP I-treatment
75 CD O O
mg NN B-NP O
PO NNP I-NP O
TID NNP I-NP O
Calcium NNP I-NP B-treatment
Acetate NNP I-NP I-treatment
1340 CD O O
mg NN B-NP O
tid NN I-NP O
with IN B-VP O
meals NNS B-NP O
Anzemet NNP I-NP B-treatment
12.5 CD O O
IV NNP B-NP O
prn NN I-NP O
Prochlorperazine NNP I-NP B-treatment
10 CD O O
mg NN B-NP O
IV NNP I-NP O
Q6H NNP I-NP O
prn VBD B-VP O
Ativan NNP B-NP B-treatment
1 CD O O
mg NN B-NP O
PO NNP I-NP O
Q6H NNP I-NP O
prn NN I-NP O
Dilaudid NNP I-NP B-treatment
4mg CD O O
PO NNP B-NP O
Q3-4H NNP I-NP O
prn NN I-NP O
Insulin NNP I-NP B-treatment
NPH NNP I-NP I-treatment
2 CD O O
units NNS B-NP O
Subcutaneous NNP I-NP O
twice RB O O
a DT B-NP O
day NN I-NP O
. . B-VP O
   
Clonidine VB O B-treatment
0.3 CD O O
mg NN B-NP O
/ VBD B-VP O
24 CD O O
hr NN B-NP O
Patch NNP I-NP O
Weekly NNP I-NP O
Transdermal NNP I-NP O
QTHUR NNP I-NP O
Clonidine NNP I-NP B-treatment
0.2 CD O O
mg NN B-NP O
PO NNP I-NP O
TID NNP I-NP O
Prochlorperazine NNP I-NP B-treatment
10 CD O O
mg NN B-NP O
q NN I-NP O
6 CD O O
h NN B-NP O
Coumadin NNP I-NP B-treatment
1.5 CD O O
mg NN B-NP O
PO NNP I-NP O
QHS NNP I-NP O
Nifedipine NNP I-NP B-treatment
30 CD O O
SR NNP B-NP O
mg NN I-NP O
PO NNP I-NP O
QD NNP I-NP O
Bisacodyl NNP I-NP B-treatment
prn NN I-NP O
Protonix NNP I-NP B-treatment
40 CD O O
QD NNP B-NP O
Discharge NNP I-NP O
Medications NNP I-NP O
: : O O
1. CD O O
Metoclopramide NNP B-NP B-treatment
10 CD O O
mg NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Tablet NNP B-NP O
PO NNP I-NP O
Q6H NNP I-NP O
( ( O O
every DT O O
6 CD O O
hours NNS B-NP O
). RB O O
2. CD O O
Metoprolol NNP B-NP B-treatment
Tartrate NNP I-NP I-treatment
25 CD O O
mg NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
Three CD O O
( ( O O
3 CD O O
) ) O O
Tablet NNP B-NP O
PO NNP I-NP O
TID NNP I-NP O
( ( O O
3 CD O O
times NNS B-NP O
a DT B-NP O
day NN I-NP O
). POS O O
3. CD O O
Calcium NNP B-NP B-treatment
Acetate NNP I-NP I-treatment
667 CD O O
mg NN B-NP O
Capsule NNP I-NP O
Sig NNP I-NP O
: : O O
Three CD O O
( ( O O
3 CD O O
) ) O O
Capsule NNP B-NP O
PO NNP I-NP O
TID NNP I-NP O
W/ NNP I-NP O
MEALS NNP I-NP O
( ( O O
3 CD O O
TIMES NNP B-NP O
A NNP I-NP O
DAY NNP I-NP O
WITH NNP I-NP O
MEALS NNP I-NP O
). VBD B-VP O
4. CD O O
Ativan NNP B-NP B-treatment
1 CD O O
mg NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Tablet NNP B-NP O
PO NNP I-NP O
q6h NN I-NP O
prn NN I-NP O
. . B-VP O
   
5. CD O O
Dilaudid NNP B-NP B-treatment
4 CD O O
mg NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Tablet NNP B-NP O
PO NNP I-NP O
q3-4hr JJ B-NP O
prn NN I-NP O
. . B-VP O
   
6. CD O O
Clonidine NNP B-NP B-treatment
0.3 CD O O
mg NN B-NP O
/ VBD B-VP O
24 CD O O
hr NN B-NP O
Patch NNP I-NP O
Weekly NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Patch NNP B-NP O
Weekly NNP I-NP O
Transdermal NNP I-NP O
Q NNP I-NP O
WED NNP I-NP O
( ( O O
every DT B-NP O
Wednesday NNP I-NP O
). VBZ O O
7. CD O O
Clonidine NNP B-NP B-treatment
0.2 CD O O
mg NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Tablet NNP B-NP O
PO NNP I-NP O
TID NNP I-NP O
( ( O O
3 CD O O
times NNS B-NP O
a DT B-NP O
day NN I-NP O
). POS O O
8. CD O O
Warfarin NNP B-NP B-treatment
1 CD O O
mg NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
1.5 CD O O
Tablets NNS B-NP O
PO NNP I-NP O
DAILY NNP I-NP O
( ( O O
Daily NNP B-NP O
). VBZ O O
9. CD O O
Nifedipine NNP B-NP B-treatment
30 CD O O
mg NN B-NP O
Tablet NNP I-NP O
Sustained NNP I-NP O
Release NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Tablet NN B-NP O
Sustained VBN O O
Release NNP B-NP O
PO NNP I-NP O
DAILY NNP I-NP O
( ( O O
Daily NNP B-NP O
). VBZ O O
10. CD O O
Pantoprazole NNP B-NP B-treatment
40 CD O O
mg NN B-NP O
Tablet NNP I-NP O
, , O O
Delayed NNP B-NP O
Release NNP I-NP O
( ( O O
E.C. NNP B-NP O
) ) O O
Sig NN B-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Tablet NN B-NP O
, , O O
Delayed NNP B-NP O
Release NNP I-NP O
( ( O O
E.C. NNP B-NP O
) ) O O
PO NNP B-NP O
Q24H NNP I-NP O
( ( O O
every DT O O
24 CD O O
hours NNS B-NP O
). RB O O
11. CD O O
Bisacodyl NNP B-NP B-treatment
5 CD O O
mg NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Tablet NNP B-NP O
PO NNP I-NP O
once RB O O
a DT B-NP O
day NN I-NP O
as IN B-VP O
needed VBN O O
for IN B-VP O
constipation NN B-NP B-problem
. . B-VP O
   
12. CD O O
Vancomycin NNP B-NP B-treatment
in IN B-VP I-treatment
Dextrose NNP B-NP I-treatment
1 CD O O
g NN B-NP O
/ VBD B-VP O
200 CD O O
mL NN B-NP O
Piggyback NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Intravenous JJ B-NP O
QHD NNP I-NP O
( ( O O
each DT B-NP O
hemodialysis NN I-NP B-treatment
): VBD B-VP O
2 CD O O
week NN B-NP O
course NN I-NP O
to TO O O
be VB O O
given VBN O O
at IN B-VP O
dialysis NN B-NP O
, , O O
last JJ B-NP O
day NN I-NP O
2019-02-05 JJ O O
. . B-VP O
   
Disp NNP B-NP O
:* NNP I-NP O
qs NN I-NP O
* NNP I-NP O
Refills NNP I-NP O
:* VBZ O O
2 CD O O
* NN B-NP O
13. CD O O
Aspirin NNP B-NP B-treatment
81 CD O O
mg NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Tablet NNP B-NP O
PO NNP I-NP O
once RB O O
a DT B-NP O
day NN I-NP O
. . B-VP O
   
14. CD O O
Humalog NNP B-NP B-treatment
100 CD O O
unit NN B-NP O
/ NNP I-NP O
mL NN I-NP O
Solution NNP I-NP O
Sig NNP I-NP O
: : O O
USE NN B-NP O
AS IN B-VP O
DIRECTED NNP B-NP O
Subcutaneous NNP I-NP O
four CD O O
times NNS B-NP O
a DT B-NP O
day NN I-NP O
: : O O
please NN B-NP O
use NN I-NP O
attached VBD B-VP O
sliding VBG O B-treatment
scale NN B-NP I-treatment
. . B-VP O
   
Disp NNP B-NP O
:* NNP I-NP O
qs NN I-NP O
* NNP I-NP O
Refills NNP I-NP O
:* VBZ O O
2 CD O O
* NN B-NP O
15. CD O O
Insulin NNP B-NP B-treatment
NPH NNP I-NP I-treatment
Human NNP I-NP I-treatment
Recomb NNP I-NP I-treatment
100 CD O O
unit NN B-NP O
/ NNP I-NP O
mL NN I-NP O
Suspension NNP I-NP O
Sig NNP I-NP O
: : O O
2 CD O O
UNITS NNP B-NP O
Subcutaneous NNP I-NP O
twice RB O O
a DT B-NP O
day NN I-NP O
. . B-VP O
   
Disp NNP B-NP O
:* NNP I-NP O
qs NN I-NP O
* NNP I-NP O
Refills NNP I-NP O
:* VBZ O O
2 CD O O
* NN B-NP O
Discharge NNP I-NP O
Disposition NNP I-NP O
: : O O
Home NNP B-NP O
Discharge NNP I-NP O
Diagnosis NNP I-NP O
: : O O
primary NN B-NP O
: : O O
bacteremia NN B-NP B-problem
02-08 JJ B-NP O
PORT NNP I-NP B-problem
line NN I-NP I-problem
infection NN I-NP I-problem
hypertensive JJ B-NP B-problem
urgency NN I-NP I-problem
diabetic JJ B-NP B-problem
gastropathy NN I-NP I-problem
Discharge NNP I-NP O
Condition NNP I-NP O
: : O O
stable JJ O O
. . B-VP O
   
Discharge JJ B-NP O
Instructions NNS I-NP O
: : O O
please NN B-NP O
continue VB O O
to TO O O
take VB O O
all DT O O
of IN B-VP O
your PRP$ O B-person
your PRP$ O B-treatment
medications NNS B-NP I-treatment
as IN B-VP O
prescribed NN B-NP O
. . B-VP O
   
you PRP O B-person
were VBD B-VP O
started VBN O O
on IN B-VP O
a DT O O
2 CD O O
week NN B-NP O
course NN I-NP O
of IN B-VP O
vancomycin NN B-NP B-treatment
to TO O O
be VB O O
given VBN O O
at IN B-VP O
hemodialysis NN B-NP B-treatment
for IN B-VP O
your PRP$ O B-person
your PRP$ O B-problem
line NN B-NP I-problem
infection NN I-NP I-problem
. . B-VP O
   
you PRP O B-person
will MD O O
have VB O O
your PRP$ O B-treatment
your PRP$ O B-person
PORT NNP B-NP I-treatment
replaced VBD B-VP O
after IN B-VP O
2 CD O O
weeks NNS B-NP O
of IN B-VP O
antibiotics NNS B-NP B-treatment
if IN B-VP O
your PRP$ O B-person
your PRP$ O B-test
blood NN B-NP I-test
cultures NNS I-NP I-test
remain VBP O O
negative JJ O O
. . B-VP O
   
if IN B-VP O
you PRP O B-person
have VBP O O
recurrent JJ B-NP B-problem
fevers NNS I-NP I-problem
, , O O
chills NNS B-NP B-problem
, , O O
naseau NN B-NP B-problem
, , O O
vomitting VBG O B-problem
, , O O
chest JJS B-NP B-problem
pain NN I-NP I-problem
, , O O
shortness NN B-NP B-problem
of IN B-VP I-problem
breath NN B-NP I-problem
, , O O
or CC O O
other JJ B-NP B-problem
worrisome NN I-NP I-problem
symptoms NNS I-NP I-problem
, , O O
please VB O O
contact VB O O
your PRP$ O B-person
your PRP$ O B-person
primary JJ B-NP I-person
care NN I-NP I-person
physician NN I-NP I-person
or CC O O
the DT B-NP O
emergency NN I-NP O
department NN I-NP O
. . B-VP O
   
Followup NNP B-NP O
Instructions NNPS I-NP O
: : O O
please NN B-NP O
follow VB O O
up RP O O
with IN B-VP O
your PRP$ O B-person
your PRP$ O B-person
primary JJ B-NP I-person
care NN I-NP I-person
doctor NN I-NP I-person
within IN B-VP O
4 CD O O
weeks NNS B-NP O
. . B-VP O
   
please VB O O
follow-up JJ O O
with IN B-VP O
your PRP$ O B-person
your PRP$ O B-person
dialysis NN B-NP I-person
physician NN I-NP I-person
regarding VBG O O
replacing VBG O O
your PRP$ O B-treatment
your PRP$ O B-person
PORT NNP B-NP I-treatment
. . B-VP O
   
please VB O O
follow-up JJ O O
with IN B-VP O
dr. JJ B-NP B-person
Lillian JJ I-NP I-person
becker NN I-NP I-person
in IN B-VP O
gastroenterology NN B-NP O
within IN B-VP O
1-2 JJ B-NP O
weeks NNS I-NP O
, , O O
an DT B-NP O
appointment NN I-NP O
has VBZ O O
been VBN O O
made VBN O O
for IN B-VP O
on IN B-VP O
you PRP O B-person
2019-02-11 VBP O O
at IN B-VP O
3PM CD O O
. . B-VP O
   
( ( O O
447 CD O O
) ) O O
671-2034 NN B-NP O
( ( O O
Caldwell NNP B-NP O
building NN I-NP O
, , O O
1st CD O O
floor NN B-NP O
, , O O
1718 CD O O
S. NNP B-NP O
Sixth NNP I-NP O
Blvd. NNP I-NP O
). NNP I-NP O
upon IN B-VP O
arriving VBG O O
home NN B-NP O
please NN I-NP O
contact VB O O
the DT B-NP O
King NNP I-NP O
and CC O O
arrange NN B-NP O
to TO O O
be VB O O
seen VBN O O
within IN B-VP O
1-2 JJ B-NP O
weeks NNS I-NP O
. . B-VP O
   
Adam NNP B-NP B-person
Ruth NNP I-NP I-person
MD NNP I-NP I-person
61-358 JJ O O
Completed VBN O O
by IN B-VP O
: : O O
Elwood NNP B-NP B-person
Edmond NNP I-NP I-person
MD NNP I-NP I-person
68-884 JJ B-NP O
2019-01-31 JJ I-NP O
@ NN I-NP O
1141 CD O O
Signed NNP B-NP O
electronically RB O O
by IN B-VP O
: : O O
DR. NNP B-NP B-person
Pamula NNP I-NP I-person
Pugh NNP I-NP I-person
on IN B-VP O
: : O O
Russell NNP B-NP O
2019-01-31 CD O O
12:12 CD O O
PM NNP B-NP O
( ( O O
End NNP B-NP O
of IN B-VP O
Report NNP B-NP O
) ) O O
-EMPTYLINE- VBP O O
-DOCSTART- JJ O O
-EMPTYLINE- $ O O
032890433 CD O O
CTMC NNP B-NP O
75066875 CD O O
828710 CD O O
02/21/1991 CD O O
12:00:00 CD O O
AM NNP B-NP O
Discharge NNP I-NP O
Summary NNP I-NP O
Unsigned VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date NNP I-NP O
: : O O
02/21/1991 CD O O
Report NNP B-NP O
Status NNP I-NP O
: : O O
Unsigned VBN O O
Discharge NNP B-NP O
Date NNP I-NP O
: : O O
02/26/1991 CD O O
DISCHARGE NNP B-NP O
DIAGNOSIS NNP I-NP O
: : O O
LEFT NNP B-NP B-problem
RENAL NNP I-NP I-problem
MASS NNP I-NP I-problem
. . B-VP O
   
HISTORY NNP B-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
a DT O O
63 CD O O
year NN B-NP O
old JJ B-NP O
female NN I-NP O
with IN B-VP O
long-standing JJ B-NP O
history NN I-NP O
of IN B-VP O
polycythemia NN B-NP B-problem
vera NN I-NP I-problem
, , O O
managed VBD B-VP O
medically RB O O
, , O O
who WP O B-person
on IN B-VP O
a DT B-NP B-test
routine JJ I-NP I-test
follow-up JJ I-NP I-test
examination NN I-NP I-test
complained VBD B-VP O
of IN B-VP O
left JJ B-NP B-problem
side NN I-NP I-problem
pain NN I-NP I-problem
and CC O O
had VBD B-VP O
an DT B-NP B-test
ultrasound NN I-NP I-test
that WDT O B-pronoun
demonstrated VBD B-VP O
a DT O B-problem
complex JJ O I-problem
left VBD B-VP I-problem
renal JJ B-NP I-problem
mass NN I-NP I-problem
. . B-VP O
   
A DT B-NP B-test
computerized JJ I-NP I-test
tomography NN I-NP I-test
scan JJ O I-test
demonstrated VBD B-VP O
a DT B-NP B-problem
contrast NN I-NP I-problem
enhancing VBG O I-problem
complex JJ O I-problem
left VBD B-VP I-problem
renal JJ B-NP I-problem
mass NN I-NP I-problem
. . B-VP O
   
Metastatic JJ B-NP B-test
work-up NN I-NP I-test
was VBD B-VP O
negative JJ O O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
presented VBD B-VP O
for IN B-VP O
nephrectomy NN B-NP B-treatment
. . B-VP O
   
PAST NNP B-NP O
MEDICAL NNP I-NP O
HISTORY NNP I-NP O
included VBD B-VP O
polycythemia NN B-NP B-problem
vera NN I-NP I-problem
. . B-VP O
   
PAST JJ B-NP O
SURGICAL NNP I-NP O
HISTORY NNP I-NP O
included VBD B-VP O
appendectomy NN B-NP B-treatment
and CC O O
bunionectomy NN B-NP B-treatment
. . B-VP O
   
MEDICATIONS NNP B-NP O
ON NNP I-NP O
ADMISSION NNP I-NP O
were VBD B-VP O
Hydrea NNP B-NP B-treatment
. . B-VP O
   
REVIEW NNP B-NP B-test
OF IN B-VP I-test
SYSTEMS NNP B-NP I-test
was VBD B-VP O
negative JJ O O
in IN B-VP O
detail NN B-NP O
. . B-VP O
   
PHYSICAL JJ B-NP O
EXAMINATION NN I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
a DT B-NP O
robust JJ I-NP O
white JJ I-NP O
female NN I-NP O
in IN B-VP O
no DT B-NP O
acute NN I-NP B-problem
distress NN I-NP I-problem
, , O O
afebrile RB O B-problem
, , O O
blood NN B-NP B-test
pressure NN I-NP I-test
165/80 CD O O
. . B-VP O
   
Head NN B-NP O
and CC O O
neck NN B-NP O
were VBD B-VP O
unremarkable JJ O O
. . B-VP O
   
Lungs NNS B-NP O
were VBD B-VP O
clear JJ O O
. . B-VP O
   
Heart NNP B-NP O
had VBD B-VP O
regular JJ B-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
. . B-VP O
   
Abdomen NNP B-NP O
was VBD B-VP O
benign JJ O O
. . B-VP O
   
Rectal JJ B-NP B-test
examination NN I-NP I-test
was VBD B-VP O
guaiac JJ O B-test
negative JJ O O
. . B-VP O
   
Extremities NNS B-NP B-test
and CC O I-test
neurological JJ B-NP I-test
examinations NNS I-NP I-test
were VBD B-VP O
unremarkable JJ O O
. . B-VP O
   
HOSPITAL NNP B-NP O
COURSE NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
taken VBN O O
to TO O O
the DT B-NP O
operating NN I-NP O
room NN I-NP O
by IN B-VP O
Dr. NNP B-NP B-person
Suot NNP I-NP I-person
N. NNP I-NP I-person
Dragtente NNP I-NP I-person
on IN B-VP O
02-21-91 NNP B-NP O
, , O O
where WRB O O
a DT B-NP B-treatment
left JJ I-NP I-treatment
radical JJ I-NP I-treatment
nephrectomy NN I-NP I-treatment
was VBD B-VP O
performed VBN O O
. . B-VP O
   
At IN B-VP O
operation NN B-NP B-treatment
, , O O
there EX O O
was VBD B-VP O
no DT B-NP O
gross JJ I-NP B-problem
adenopathy NN I-NP I-problem
or CC O O
renal JJ B-NP B-problem
vein NN I-NP I-problem
involvement NN I-NP I-problem
, , O O
and CC O O
it PRP O B-pronoun
was VBD B-VP O
felt VBN O O
that IN B-VP B-pronoun
the DT B-NP B-problem
tumor NN I-NP I-problem
was VBD B-VP O
completely RB O O
excised VBN O O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
thereafter RB O O
had VBD B-VP O
a DT B-NP O
benign JJ I-NP O
convalescence NN I-NP O
, , O O
and CC O O
was VBD B-VP O
discharged VBN O O
on IN B-VP O
the DT B-NP O
5th JJ I-NP O
postoperative JJ I-NP O
day NN I-NP O
. . B-VP O
   
The DT B-NP O
oncology NN I-NP B-person
fellows VBZ O I-person
from IN B-VP O
Venbonlea NNP B-NP O
Health NNP I-NP O
followed VBD B-VP O
her PRP$ O B-person
course NN B-NP O
and CC O O
recommended VBD B-VP O
holding VBG O O
off RP O O
on IN B-VP O
her PRP$ O B-treatment
her PRP$ O B-person
Hydrea NN B-NP I-treatment
while IN B-VP O
she PRP O B-person
is VBZ O O
hospitalized VBN O O
, , O O
and CC O O
they PRP O B-pronoun
will MD O O
follow VB O O
her PRP O B-person
as IN B-VP O
an DT B-NP O
outpatient NN I-NP O
and CC O O
restart VB O O
her PRP$ O B-treatment
her PRP$ O B-person
Hydrea NN B-NP I-treatment
when WRB O O
her PRP$ O B-person
her PRP$ O B-test
hematocrit NN B-NP I-test
is VBZ O O
over IN B-VP O
40% CD O O
. . B-VP O
   
DISPOSITION NN B-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
discharged VBN O O
to TO O O
home NN B-NP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
discharged VBN O O
on IN B-VP O
a DT B-NP O
regular JJ I-NP O
diet NN I-NP O
. . B-VP O
   
CONDITION NNP B-NP O
ON NNP I-NP O
DISCHARGE NNP I-NP O
was VBD B-VP O
stable JJ O O
. . B-VP O
   
FOLLOW-UP NNP B-NP O
will MD O O
be VB O O
with IN B-VP O
Dr. NNP B-NP B-person
Suot NNP I-NP I-person
N. NNP I-NP I-person
Dragtente NNP I-NP I-person
and CC O O
with IN B-VP O
her PRP$ O B-person
Venbonlea NNP B-NP O
Health NNP I-NP O
oncology NN I-NP B-person
fellows NNS I-NP I-person
. . B-VP O
   
MEDICATIONS NNP B-NP O
ON NNP I-NP O
DISCHARGE NNP I-NP O
included VBD B-VP O
Percocet NNP B-NP B-treatment
1 CD O O
to TO O O
2 CD O O
tablets NNS B-NP O
by IN B-VP O
mouth NN B-NP O
every DT O O
4 CD O O
hours NNS B-NP O
as IN B-VP O
needed VBN O O
for IN B-VP O
pain NN B-NP B-problem
, , O O
Colace NNP B-NP B-treatment
100 CD O O
milligrams NNS B-NP O
by IN B-VP O
mouth NN B-NP O
twice RB O O
a DT B-NP O
day NN I-NP O
. . B-VP O
   
PL926/1533 NNP B-NP O
SUOT NNP I-NP B-person
N. NNP I-NP I-person
DRAGTENTE NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
GJ7 NNP I-NP O
D NNP I-NP O
: : O O
02/26/91 CD O O
Batch NN B-NP O
: : O O
8776 CD O O
Report NN B-NP O
: : O O
P9055V6 NNP B-NP O
T NNP I-NP O
: : O O
03/02/91 CD O O
Dicatated VBN O O
By IN B-VP O
: : O O
ESPEXIINE NNP B-NP B-person
BRIZ NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
XT67 NNP I-NP O
cc NN I-NP O
: : O O
1. CD O O
VENBONLEA NNP B-NP O
HEALTH NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- VBD B-VP O
225281111 CD O O
GH NNP B-NP O
59035229 CD O O
7/4/1999 CD O O
12:00:00 CD O O
AM NNP B-NP O
Discharge NNP I-NP O
Summary NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date NNP I-NP O
: : O O
07/04/1999 CD O O
Report NNP B-NP O
Status NNP I-NP O
: : O O
Signed VBN O O
Discharge NNP B-NP O
Date NNP I-NP O
: : O O
07/09/1999 CD O O
ADMISSION NNP B-NP O
DIAGNOSIS NNP I-NP O
: : O O
ABDOMINAL NNP B-NP B-problem
PAIN NNP I-NP I-problem
. . B-VP O
   
DISCHARGE NNP B-NP O
DIAGNOSIS NNP I-NP O
: : O O
PARTIAL NNP B-NP B-problem
SMALL NNP I-NP I-problem
BOWEL NNP I-NP I-problem
OBSTRUCTION NNP I-NP I-problem
. . B-VP O
   
HISTORY NNP B-NP O
OF IN B-VP O
THE NNP B-NP O
PRESENT NNP I-NP O
ILLNESS NNP I-NP O
: : O O
This DT O B-pronoun
is VBZ O O
a DT O O
49 CD O O
year-old JJ B-NP O
male NN I-NP O
with IN B-VP O
a DT B-NP O
history NN I-NP O
of IN B-VP O
a DT B-NP B-treatment
low JJ I-NP I-treatment
anterior JJ I-NP I-treatment
resection NN I-NP I-treatment
in IN B-VP O
May NNP B-NP O
of IN B-VP O
1998 CD O O
and CC O O
a DT B-NP B-problem
recurrence NN I-NP I-problem
of IN B-VP O
metastasis NN B-NP B-problem
with IN B-VP O
asleeve NN B-NP O
of IN B-VP O
section NN B-NP O
of IN B-VP O
left JJ B-NP B-treatment
colon NN I-NP I-treatment
diverting VBG O I-treatment
ileostomy NN B-NP I-treatment
for IN B-VP O
recurrent NN B-NP B-problem
metastasis NN I-NP I-problem
later RB O O
in IN B-VP O
May NNP B-NP O
of IN B-VP O
1999 CD O O
who WP O B-person
presents VBZ O O
with IN B-VP O
anterior JJ B-NP B-problem
midepigastric JJ I-NP I-problem
abdominal JJ I-NP I-problem
pain NN I-NP I-problem
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
states VBZ O O
that IN B-VP B-pronoun
the DT B-NP B-problem
pain NN I-NP I-problem
began VBD B-VP O
at IN B-VP O
10:30 CD O O
on IN B-VP O
the DT B-NP O
day NN I-NP O
of IN B-VP O
admission NN B-NP O
with IN B-VP O
increase NN B-NP O
during IN B-VP O
the DT B-NP O
day NN I-NP O
of IN B-VP O
admission NN B-NP O
with IN B-VP O
positive JJ B-NP O
nausea NN I-NP B-problem
and CC O O
vomiting NN B-NP B-problem
, , O O
no DT B-NP O
diarrhea NN I-NP B-problem
, , O O
decreased VBN O B-problem
output NN B-NP I-problem
from IN B-VP I-problem
the DT B-NP I-problem
ostomy NN I-NP I-problem
, , O O
and CC O O
the DT B-NP B-problem
pain NN I-NP I-problem
was VBD B-VP O
radiating VBG O O
to TO O O
the DT B-NP O
back NN I-NP O
. . B-VP O
   
PAST NNP B-NP O
MEDICAL NNP I-NP O
HISTORY NNP I-NP O
: : O O
As IN B-VP O
above IN B-VP O
. . B-VP O
   
PAST JJ B-NP O
SURGICAL JJ I-NP O
HISTORY NN I-NP O
: : O O
As IN B-VP O
above IN B-VP O
. . B-VP O
   
MEDICATIONS NNP B-NP O
ON NNP I-NP O
ADMISSION NNP I-NP O
: : O O
Percocet NNP B-NP B-treatment
and CC O O
Naprosyn NNP B-NP B-treatment
. . B-VP O
   
ALLERGIES NNP B-NP O
: : O O
Demerol NNP B-NP B-treatment
. . B-VP O
   
SOCIAL NNP B-NP O
HISTORY NNP I-NP O
: : O O
No DT B-NP O
tobacco NN I-NP O
and CC O O
no DT B-NP O
alcohol NN I-NP O
use NN I-NP O
. . B-VP O
   
PHYSICAL NNP B-NP O
EXAMINATION NNP I-NP O
ON NNP I-NP O
ADMISSION NNP I-NP O
: : O O
Temperature NN B-NP B-test
98.8 CD O O
, , O O
heart NN B-NP B-test
rate NN I-NP I-test
68 CD O O
, , O O
blood NN B-NP B-test
pressure NN I-NP I-test
107/82 CD O O
, , O O
and CC O O
oxygen NN B-NP B-test
saturation NN I-NP I-test
99% CD O O
on IN B-VP O
room NN B-NP O
air NN I-NP O
. . B-VP O
   
CHEST NN B-NP O
: : O O
Clear JJ O O
to TO O O
auscultation NN B-NP B-test
. . B-VP O
   
HEART NN B-NP O
: : O O
Regular JJ B-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
with IN B-VP O
no DT B-NP O
murmurs NN I-NP B-problem
. . B-VP O
   
ABDOMEN NNP B-NP O
: : O O
Soft JJ O O
, , O O
mildly RB O B-problem
distended VBD B-VP I-problem
, , O O
and CC O O
tympanic JJ O B-problem
with IN B-VP O
midepigastric JJ B-NP B-problem
tenderness NN I-NP I-problem
to TO O O
palpation NN B-NP B-test
and CC O O
no DT B-NP O
rebound NN I-NP B-problem
. . B-VP O
   
The DT B-NP B-treatment
ostomy NN I-NP I-treatment
was VBD B-VP O
pink VBN O O
with IN B-VP O
minimal JJ B-NP O
fluid NN I-NP O
in IN B-VP O
the DT B-NP B-treatment
ostomy JJ I-NP I-treatment
bag NN I-NP I-treatment
. . B-VP O
   
It PRP O B-pronoun
was VBD B-VP O
guaiac JJ O B-test
negative JJ O O
. . B-VP O
   
EXTREMITIES NNS B-NP O
: : O O
No DT B-NP O
signs NNS I-NP O
of IN B-VP O
edema NN B-NP B-problem
and CC O O
the DT B-NP B-person
patient NN I-NP I-person
had VBD B-VP O
warm JJ O O
and CC O O
palpable JJ B-NP O
pulses NNS I-NP O
distally RB O O
. . B-VP O
   
HOSPITAL NNP B-NP O
COURSE NNP I-NP O
: : O O
Assessment NN B-NP B-test
was VBD B-VP O
continued VBN O O
with IN B-VP O
laboratory NN B-NP B-test
studies NNS I-NP I-test
which WDT O B-pronoun
showed VBD B-VP O
the DT B-NP B-person
patient NN I-NP I-person
to TO O O
have VB O O
a DT B-NP O
white JJ I-NP B-test
blood NN I-NP I-test
cell NN I-NP I-test
count NN I-NP I-test
of IN B-VP O
9 CD O O
, , O O
hematocrit NN B-NP B-test
39 CD O O
, , O O
and CC O O
platelets VBZ O B-test
470 CD O O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
had VBD B-VP O
a DT B-NP O
normal JJ I-NP O
amylase NN I-NP O
and CC O O
lipase NN B-NP B-test
, , O O
and CC O O
a DT B-NP O
normal JJ I-NP O
basic JJ I-NP O
metabolic JJ I-NP O
panel NN I-NP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
had VBD B-VP O
KUB NNP B-NP B-test
that IN B-VP B-pronoun
showed VBD B-VP O
multiple JJ B-NP B-problem
dilated JJ I-NP I-problem
loops NNS I-NP I-problem
of IN B-VP I-problem
small JJ B-NP I-problem
bowel NN I-NP I-problem
and CC O O
was VBD B-VP O
admitted VBN O O
for IN B-VP O
a DT B-NP O
partial JJ I-NP B-problem
small JJ I-NP I-problem
bowel NN I-NP I-problem
obstruction NN I-NP I-problem
. . B-VP O
   
An DT B-NP B-treatment
nasogastric JJ I-NP I-treatment
tube NN I-NP I-treatment
was VBD B-VP O
placed VBN O O
and CC O O
had VBD B-VP O
an DT B-NP B-treatment
H2 NNP I-NP I-treatment
blocker NN I-NP I-treatment
started VBD B-VP O
, , O O
and CC O O
was VBD B-VP O
admitted VBN O O
for IN B-VP O
bowel NN B-NP B-treatment
rest NN I-NP I-treatment
and CC O O
decompression NN B-NP B-treatment
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
tolerated VBD B-VP O
the DT B-NP B-treatment
nasogastric JJ I-NP I-treatment
tube NN I-NP I-treatment
well RB O O
. . B-VP O
   
The DT B-NP B-treatment
nasogastric JJ I-NP I-treatment
tube NN I-NP I-treatment
was VBD B-VP O
removed VBN O O
on IN B-VP O
hsp JJ B-NP O
day NN I-NP O
# # O O
3 CD O O
. . B-VP O
   
The DT B-NP B-problem
pain NN I-NP I-problem
improved VBD B-VP O
quickly RB O O
and CC O O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
started VBN O O
on IN B-VP O
a DT B-NP O
clear JJ I-NP B-treatment
liquid NN I-NP I-treatment
diet NN I-NP I-treatment
which WDT O B-pronoun
was VBD B-VP O
advanced VBN O O
as IN B-VP O
tolerated VBN O O
. . B-VP O
   
On IN B-VP O
7/9/99 CD O O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
tolerating VBG O O
a DT B-NP O
house NN I-NP O
diet NN I-NP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
had VBD B-VP O
some DT O B-problem
minimal JJ O I-problem
back RB O I-problem
pain NN B-NP I-problem
that IN B-VP B-pronoun
occurred VBD B-VP O
after IN B-VP O
food NN B-NP O
but CC O O
with IN B-VP O
negative JJ B-NP O
urinalysis NN I-NP O
and CC O O
negative JJ B-NP O
fever NN I-NP B-problem
spikes NNS I-NP I-problem
over IN B-VP O
the DT B-NP O
entire JJ I-NP O
course NN I-NP O
of IN B-VP O
this DT B-NP B-pronoun
stay NN I-NP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
will MD O O
be VB O O
discharged VBN O O
home NN B-NP O
on IN B-VP O
Zantac NNP B-NP B-treatment
, , O O
Simethicone NNP B-NP B-treatment
, , O O
and CC O O
preoperative JJ B-NP B-treatment
medications NNS I-NP I-treatment
with IN B-VP O
follow-up JJ O O
with IN B-VP O
Dr. NNP B-NP B-person
Ur NNP I-NP I-person
in IN B-VP O
two CD O O
weeks NNS B-NP O
. . B-VP O
   
Dictated VBN O O
By IN B-VP O
: : O O
NISTE NNP B-NP B-person
BLOCKER NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
AQ36 NNP I-NP O
Attending NNP I-NP B-person
: : O O
STIE NNP B-NP B-person
FYFE NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
BW3 NNP I-NP O
BL436/5666 NNP I-NP O
Batch NNP I-NP O
: : O O
85114 CD O O
Index NNP B-NP O
No. NN I-NP O
FNQXCX58 NNP I-NP O
EM NNP I-NP O
D NNP I-NP O
: : O O
07/09/99 CD O O
T NN B-NP O
: : O O
07/09/99 CD O O
HP8 NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
Admission NNP I-NP O
Date NNP I-NP O
: : O O
2019-06-25 JJ B-NP O
Discharge NN I-NP O
Date NNP I-NP O
: : O O
2019-07-01 JJ B-NP O
Date NNP I-NP O
of IN B-VP O
Birth NNP B-NP O
: : O O
1950-04-19 JJ B-NP O
Sex NN I-NP O
: : O O
M NNP B-NP O
Service NNP I-NP O
: : O O
CARDIOTHORACIC JJ B-NP O
Allergies NNS I-NP O
: : O O
Penicillins NNS B-NP B-treatment
/ VBP O O
Norvasc NNP B-NP B-treatment
/ NNP I-NP O
Verapamil NNP I-NP B-treatment
Attending NNP I-NP O
: : O O
Christopher NNP B-NP B-person
Q NNP I-NP I-person
Thompson NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
Chief NNP I-NP O
Complaint NNP I-NP O
: : O O
preop NN B-NP B-test
w/ NN I-NP I-test
for IN B-VP O
knee NN B-NP B-treatment
surgery NN I-NP I-treatment
revealed VBD B-VP O
cardiac JJ B-NP B-problem
dz NN I-NP I-problem
, , O O
asymptomatic JJ B-NP B-problem
Major NNP I-NP O
Surgical NNP I-NP O
or CC O O
Invasive JJ B-NP O
Procedure NN I-NP O
: : O O
CABGx4 NNP B-NP B-treatment
( ( O O
06-26 JJ O O
) ) O O
History NN B-NP O
of IN B-VP O
Present NNP B-NP O
Illness NNP I-NP O
: : O O
69yoM CD O O
with IN B-VP O
OA NNP B-NP B-problem
having VBG O O
workup NN B-NP B-test
for IN B-VP O
knee NN B-NP B-treatment
replacements NNS I-NP I-treatment
found VBD B-VP O
to TO O O
be VB O O
in IN B-VP O
Afib NNP B-NP B-problem
, , O O
had VBD B-VP O
stress JJ B-NP B-test
test NN I-NP I-test
that WDT O B-pronoun
was VBD B-VP O
positive JJ O O
followed VBN O O
by IN B-VP O
cardiac JJ B-NP B-test
catheterization NN I-NP I-test
which WDT O B-pronoun
revealed VBD B-VP O
severe JJ O B-problem
3VD CD O I-problem
. . B-VP O
   
Then RB O O
referred VBD B-VP O
for IN B-VP O
CABG NNP B-NP B-treatment
Past NNP I-NP O
Medical NNP I-NP O
History NN I-NP O
: : O O
HTN NNP B-NP B-problem
chol NN I-NP B-problem
AFib NNP I-NP B-problem
OA NNP I-NP B-problem
needs VBZ O O
bilat JJ B-NP B-treatment
arthroplasty NN I-NP I-treatment
CRI NNP I-NP B-problem
Social NNP I-NP O
History NNP I-NP O
: : O O
Lives VBZ O O
with IN B-VP O
wife NN B-NP B-person
. . B-VP O
   
Remote NNP B-NP O
Timothy NNP I-NP O
, , O O
quit NN B-NP O
1990 CD O O
. . B-VP O
   
+ VB O O
ETOH NNP B-NP O
( ( O O
1-2 JJ B-NP O
drinks NNS I-NP O
/ VBP O O
Rivero NNP B-NP O
) ) O O
Family NNP B-NP O
History NNP I-NP O
: : O O
Brother NNP B-NP B-person
died VBD B-VP O
64 CD O O
/ NNP B-NP O
MI NNP I-NP B-problem
Physical NNP I-NP O
Exam NNP I-NP O
: : O O
Admission NNP B-NP O
VS NNP I-NP B-test
T NNP I-NP B-test
98 CD O O
HR NNP B-NP O
74 CD O B-test
BP NNP B-NP B-test
136/88 CD O O
RR NNP B-NP O
18 CD O O
Gen NNP B-NP O
NAD NNP I-NP B-problem
Neuro NNP I-NP O
A&Ox3 NNP I-NP O
, , O O
nonfocal JJ B-NP O
Chest NNP I-NP O
CTA NNP I-NP O
bilat JJ B-NP O
CV NNP I-NP O
irreg-irreg NN I-NP B-problem
, , O O
no DT B-NP O
M/R NNP I-NP B-problem
Abdn NNP I-NP O
soft JJ O O
, , O O
NT/ND/+BS NNP B-NP B-problem
Ext NNP I-NP O
warm VBZ O O
no DT B-NP O
edema NN I-NP B-problem
Discharge NNP I-NP O
T99.9 NNP I-NP B-test
HR NNP I-NP O
70AF CD O B-test
BP NNP B-NP B-test
120/69 CD O O
RR NNP B-NP O
20 CD O O
O2sat NNP B-NP O
94%RA CD O O
Neuro NNP B-NP O
A&Ox3 NNP I-NP O
MAE NNP I-NP O
, , O O
non RB O B-test
focal JJ B-NP I-test
exam NN I-NP I-test
Pulm NNP I-NP O
CTAB NNP I-NP O
CV NNP I-NP O
irreg NN I-NP B-problem
irreg NN I-NP I-problem
, , O O
sternum NN B-NP B-problem
stable JJ B-NP I-problem
incision NN I-NP I-problem
CDI NNP I-NP O
Abdm NNP I-NP O
soft JJ O O
, , O O
NT/ND/+BS NNP B-NP B-problem
Ext NNP I-NP O
warm VBD B-VP O
2+ CD O B-problem
edema JJ B-NP I-problem
Pertinent JJ I-NP O
Results NNS I-NP O
: : O O
2019-06-25 JJ O O
04:10 CD O O
PM NNP B-NP O
GLUCOSE NNP I-NP B-test
- : O O
97 CD O O
UREA NNP B-NP B-test
N NNP I-NP O
- : O O
44 CD O O
* NN B-NP O
CREAT NNP I-NP B-test
- : O O
2.0 CD O O
* JJ B-NP O
SODIUM NNP I-NP B-test
- : O O
143 CD O O
POTASSIUM NNP B-NP B-test
- : O O
4.1 CD O O
CHLORIDE NNP B-NP B-test
- : O O
107 CD O O
TOTAL NNP B-NP B-test
CO2 NNP I-NP I-test
- : O O
27 CD O O
ANION NNP B-NP B-test
GAP NNP I-NP I-test
- : O O
13 CD O O
2019-06-25 JJ O O
04:10 CD O O
PM NNP B-NP O
ALT(SGPT) NNP I-NP B-test
- : O O
19 CD O O
AST(SGOT) NNP B-NP B-test
- : O O
19 CD O O
LD(LDH) NNP B-NP B-test
- : O O
153 CD O O
ALK NNP B-NP B-test
PHOS NNP I-NP I-test
- : O O
58 CD O O
TOT NNP B-NP B-test
BILI NNP I-NP I-test
- : O O
0.4 CD O O
2019-06-25 JJ O O
04:10 CD O O
PM NNP B-NP O
ALBUMIN NNP I-NP B-test
- : O O
4.3 CD O O
2019-06-25 JJ O O
04:10 CD O O
PM NNP B-NP O
%HbA1c NNP I-NP B-test
- : O O
5.7 CD O O
2019-06-25 JJ O O
04:10 CD O O
PM NNP B-NP O
TSH NNP I-NP B-test
- : O O
1.2 CD O O
2019-06-25 JJ O O
04:10 CD O O
PM NNP B-NP O
WBC NNP I-NP B-test
- : O O
7.0 CD O O
RBC NNP B-NP B-test
- : O O
3.92 CD O O
* NN B-NP O
HGB NNP I-NP B-test
- : O O
12.6 CD O O
* NN B-NP O
HCT NNP I-NP B-test
- : O O
36.4 CD O O
* NN B-NP O
MCV NNP I-NP B-test
- : O O
93 CD O O
MCH NNP B-NP B-test
- : O O
32.1 CD O O
* NN B-NP O
MCHC NNP I-NP B-test
- : O O
34.6 CD O O
RDW NNP B-NP B-test
- : O O
13.6 CD O O
2019-06-25 JJ O O
04:10 CD O O
PM NNP B-NP O
PLT NNP I-NP B-test
COUNT NNP I-NP I-test
- : O O
207 CD O O
2019-06-25 JJ O O
04:10 CD O O
PM NNP B-NP O
PT NNP I-NP B-test
- : O O
11.8 CD O O
PTT NNP B-NP B-test
- : O O
22.4 CD O O
INR(PT) NNP B-NP B-test
- : O O
1.0 CD O O
2019-07-01 JJ O O
07:30 CD O O
AM NNP B-NP O
BLOOD NNP I-NP B-test
WBC NNP I-NP B-test
- : O O
8.7 CD O O
RBC NNP B-NP B-test
- : O O
3.18 CD O O
* NN B-NP O
Hgb NNP I-NP B-test
- : O O
10.4 CD O O
* NN B-NP O
Hct NNP I-NP B-test
- : O O
30.4 CD O O
* NN B-NP O
MCV NNP I-NP B-test
- : O O
96 CD O O
MCH NNP B-NP B-test
- : O O
32.7 CD O O
* NN B-NP O
MCHC NNP I-NP B-test
- : O O
34.3 CD O O
RDW NNP B-NP B-test
- : O O
13.5 CD O O
Plt NNP B-NP B-test
Ct NNP I-NP I-test
- : O O
303 CD O O
2019-07-01 JJ O O
07:30 CD O O
AM NNP B-NP O
BLOOD NNP I-NP B-test
Plt NNP I-NP B-test
Ct NNP I-NP I-test
- : O O
303 CD O O
2019-07-01 JJ O O
07:30 CD O O
AM NNP B-NP O
BLOOD NNP I-NP B-test
PT NNP I-NP B-test
- : O O
14.4 CD O O
* NN B-NP O
PTT NNP I-NP B-test
- : O O
24.2 CD O O
INR(PT)- JJ O B-test
1.3 CD O O
* JJ O O
2019-06-30 JJ O O
06:45 CD O O
AM NNP B-NP O
BLOOD NNP I-NP B-test
Glucose NNP I-NP B-test
- : O O
99 CD O O
UreaN NNP B-NP B-test
- : O O
40 CD O O
* NN B-NP O
Creat NNP I-NP B-test
- : O O
1.9 CD O O
* NN B-NP O
Na NNP I-NP B-test
- : O O
137 CD O O
K NNP B-NP O
- : O O
4.1 CD O O
Cl NNP B-NP B-test
- : O O
99 CD O O
HCO3 NNP B-NP B-test
- : O O
28 CD O O
AnGap NNP B-NP B-test
- : O O
14 CD O O
CHEST NNP B-NP B-test
( ( O I-test
PORTABLE NNP B-NP I-test
A DT B-NP I-test
P) NNP I-NP I-test
2019-06-30 JJ O O
11:26 CD O O
AM NNP B-NP O
CHEST NNP I-NP B-test
( ( O I-test
PORTABLE NNP B-NP I-test
AP NNP I-NP I-test
) ) O I-test
Reason NNP B-NP O
: : O O
Effusion NN B-NP B-problem
? . B-VP O
Pntx NNP B-NP B-problem
? . B-VP O
UNDERLYING NNP B-NP O
MEDICAL NNP I-NP O
CONDITION NNP I-NP O
: : O O
69 CD O O
year NN B-NP O
old JJ B-NP O
man NN I-NP O
with IN B-VP O
s/p JJ B-NP O
Off NNP I-NP B-treatment
Pump NNP I-NP I-treatment
CABG NNP I-NP I-treatment
REASON NNP I-NP O
FOR NNP I-NP O
THIS NNP I-NP B-pronoun
EXAMINATION NNP I-NP O
: : O O
Effusion NN B-NP B-problem
? . B-VP O
Pntx NNP B-NP B-problem
? . B-VP O
PORTABLE NNP B-NP B-test
CHEST NNPS I-NP I-test
ON NNP I-NP O
2019-06-30 JJ B-NP O
AT NNP I-NP O
11:39 CD O O
INDICATION NNP B-NP O
: : O O
CABG NN B-NP B-treatment
with IN B-VP O
chest JJ B-NP B-treatment
tube NN I-NP I-treatment
in IN B-VP O
place NN B-NP O
. . B-VP O
   
COMPARISON NN B-NP O
: : O O
2019-06-29 JJ O O
. . B-VP O
   
FINDINGS NN B-NP O
: : O O
Left VBN O B-treatment
chest JJS B-NP I-treatment
tube NN I-NP I-treatment
remains VBZ O O
in IN B-VP O
place NN B-NP O
with IN B-VP O
some DT B-NP B-problem
density NN I-NP I-problem
adjacent JJ O I-problem
to TO O I-problem
the DT B-NP I-problem
tip NN I-NP I-problem
, , O O
but CC O O
there EX O O
is VBZ O O
no DT B-NP O
significant JJ I-NP B-problem
interval JJ I-NP I-problem
change NN I-NP I-problem
vs NN I-NP O
. . B-VP O
   
prior RB O O
. . B-VP O
   
Specifically RB O O
, , O O
there EX O O
is VBZ O O
no DT B-NP O
pneumothorax NN I-NP B-problem
and CC O O
no DT B-NP O
interval JJ I-NP B-problem
development NN I-NP I-problem
of IN B-VP I-problem
effusion NN B-NP I-problem
. . B-VP O
   
Cardiac NNP B-NP O
silhouette NN I-NP O
and CC O O
mediastinal JJ B-NP O
contours NNS I-NP O
are VBP O O
stable JJ O O
. . B-VP O
   
IMPRESSION NN B-NP O
: : O O
No DT B-NP O
change NN I-NP O
vs NN I-NP O
. . B-VP O
   
prior RB O O
. . B-VP O
   
DR. NNP B-NP B-person
James NNP I-NP I-person
A NNP I-NP I-person
Roberts NNP I-NP I-person
Brief NNP I-NP O
Hospital NNP I-NP O
Course NNP I-NP O
: : O O
69 CD O O
yo NNS B-NP O
M NNP I-NP O
with IN B-VP O
known VBN O B-problem
Atrial NNP B-NP I-problem
fibrillation NN I-NP I-problem
and CC O O
coronary JJ B-NP B-problem
artery NN I-NP I-problem
disease NN I-NP I-problem
admitted VBD B-VP O
preop NN B-NP O
for IN B-VP O
transition NN B-NP O
fro NN I-NP O
Coumadin NNP I-NP B-treatment
to TO O O
Heparin NNP B-NP B-treatment
. . B-VP O
   
Brought NNP B-NP O
to TO O O
the DT B-NP O
OR NNP I-NP O
on IN B-VP O
06-26 NN B-NP O
for IN B-VP O
CABG NNP B-NP B-treatment
, , O O
please VB O O
see VB O O
OR NNP B-NP O
report VB O O
for IN B-VP O
details NNS B-NP O
. . B-VP O
   
In IN B-VP O
summary JJ B-NP O
pt NN I-NP B-person
had VBD B-VP O
off RP O B-treatment
pump JJ B-NP I-treatment
CABGx4 NNP I-NP I-treatment
with IN B-VP O
LIMA-LAD NNP B-NP B-treatment
, , O O
SVG NNP B-NP B-treatment
OM-Y NNP I-NP I-treatment
graft NN I-NP I-treatment
- : O I-treatment
Diag NNP B-NP I-treatment
, , O O
SVG-PDA NNP B-NP B-treatment
. . B-VP O
   
Pt NNP B-NP B-person
tolerated VBD B-VP O
surgery NN B-NP B-treatment
well RB O O
and CC O O
was VBD B-VP O
transferred VBN O O
to TO O O
CT NNP B-NP O
CMED NNP I-NP O
ICU NNP I-NP O
. . B-VP O
   
He PRP O B-person
did VBD B-VP O
well RB O O
in IN B-VP O
immediate JJ B-NP O
post-op JJ I-NP O
period NN I-NP O
was VBD B-VP O
extubated VBN O B-treatment
and CC O O
on IN B-VP O
POD1 NNP B-NP O
he PRP O B-person
was VBD B-VP O
transferred VBN O O
to TO O O
the DT B-NP O
step NN I-NP O
down RP O O
floor NN B-NP O
. . B-VP O
   
On IN B-VP O
POD2 NNP B-NP O
his PRP$ O B-person
his PRP$ O B-treatment
chest NN B-NP I-treatment
tubes NNS I-NP I-treatment
and CC O O
epicardial JJ B-NP B-treatment
pacing NN I-NP I-treatment
wires NNS I-NP I-treatment
were VBD B-VP O
removed VBN O O
and CC O O
his PRP$ O B-person
his PRP$ O B-treatment
Coumadin NNP B-NP I-treatment
was VBD B-VP O
restarted VBN O O
. . B-VP O
   
Over IN B-VP O
the DT B-NP O
next JJ I-NP O
several JJ I-NP O
days NNS I-NP O
his PRP$ O B-person
activity NN B-NP O
was VBD B-VP O
advanced VBN O O
on IN B-VP O
POD5 NNP B-NP O
it PRP O B-pronoun
was VBD B-VP O
decided VBN O O
he PRP O B-person
was VBD B-VP O
stable JJ O O
and CC O O
ready JJ O O
to TO O O
be VB O O
discharged VBN O O
home NN B-NP O
with IN B-VP O
visiting VBG O O
nurses NNS B-NP O
. . B-VP O
   
Medications NNS B-NP O
on IN B-VP O
Admission NN B-NP O
: : O O
Atenolol $ O B-treatment
200 CD O O
' '' O O
HCTZ NNP B-NP B-treatment
25 CD O O
' '' O O
Lisinopril NNP B-NP B-treatment
20 CD O O
' '' O O
Ultram NNP B-NP B-treatment
50 CD O O
' '' O O
Prilosec NNP B-NP B-treatment
20 CD O O
' '' O O
Zocor NNP B-NP B-treatment
40 CD O O
' '' O O
Levitra NNP B-NP B-treatment
/ NNP I-NP O
prn NN I-NP O
Warfarin NNP I-NP B-treatment
4 CD O O
' POS O O
Discharge NNP B-NP O
Medications NNS I-NP O
: : O O
1. CD O O
Metoprolol NNP B-NP B-treatment
Tartrate NNP I-NP I-treatment
25 CD O O
mg NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Tablet NNP B-NP O
PO NNP I-NP O
BID NNP I-NP O
( ( O O
2 CD O O
times NNS B-NP O
a DT B-NP O
Ellis NNP I-NP O
). NNP I-NP O
Disp NNP I-NP O
:* VBD B-VP O
60 CD O O
Tablet NNP B-NP O
(s)* NNP I-NP O
Refills NNP I-NP O
:* VBZ O O
2 CD O O
* NN B-NP O
2. CD O O
Furosemide NNP B-NP B-treatment
20 CD O O
mg NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Tablet NNP B-NP O
PO NNP I-NP O
once RB O O
a DT B-NP O
Leukhardt NNP I-NP O
for IN B-VP O
2 CD O O
weeks NNS B-NP O
. . B-VP O
   
Disp NNP B-NP O
:* VBD B-VP O
14 CD O O
Tablet NNP B-NP O
(s)* NNP I-NP O
Refills NNP I-NP O
:* VBZ O O
0 CD O O
* NN B-NP O
3. CD O O
Potassium NNP B-NP B-treatment
Chloride NNP I-NP I-treatment
10 CD O O
mEq NN B-NP O
Tablet NNP I-NP O
Sustained NNP I-NP O
Release NNP I-NP O
Sig NNP I-NP O
: : O O
Two CD O O
( ( O O
2 CD O O
) ) O O
Tablet NN B-NP O
Sustained VBN O O
Release NNP B-NP O
PO NNP I-NP O
once RB O O
a DT B-NP O
Sine NN I-NP O
for IN B-VP O
2 CD O O
weeks NNS B-NP O
. . B-VP O
   
Disp NNP B-NP O
:* VBD B-VP O
28 CD O O
Tablet NNP B-NP O
Sustained NNP I-NP O
Release NNP I-NP O
(s)* NNP I-NP O
Refills NNP I-NP O
:* VBZ O O
0 CD O O
* NN B-NP O
4. CD O O
Docusate NNP B-NP B-treatment
Sodium NNP I-NP I-treatment
100 CD O O
mg NN B-NP O
Capsule NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Capsule NNP B-NP O
PO NNP I-NP O
BID NNP I-NP O
( ( O O
2 CD O O
times NNS B-NP O
a DT B-NP O
Costa NNP I-NP O
). NNP I-NP O
Disp NNP I-NP O
:* VBD B-VP O
60 CD O O
Capsule NNP B-NP O
(s)* NNP I-NP O
Refills NNP I-NP O
:* VBZ O O
2 CD O O
* NN B-NP O
5. CD O O
Aspirin NNP B-NP B-treatment
81 CD O O
mg NN B-NP O
Tablet NNP I-NP O
, , O O
Delayed NNP B-NP O
Release NNP I-NP O
( ( O O
E.C. NNP B-NP O
) ) O O
Sig NN B-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Tablet NN B-NP O
, , O O
Delayed NNP B-NP O
Release NNP I-NP O
( ( O O
E.C. NNP B-NP O
) ) O O
PO NNP B-NP O
DAILY NNP I-NP O
( ( O O
Daily NNP B-NP O
). NNP I-NP O
Disp NNP I-NP O
:* VBD B-VP O
30 CD O O
Tablet NNP B-NP O
, , O O
Delayed NNP B-NP O
Release NNP I-NP O
( ( O O
E.C. NNP B-NP O
)(s)* NNP I-NP O
Refills NNP I-NP O
:* VBZ O O
2 CD O O
* NN B-NP O
6. CD O O
Warfarin NNP B-NP B-treatment
2 CD O O
mg NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
Two CD O O
( ( O O
2 CD O O
) ) O O
Tablet NNP B-NP O
PO NNP I-NP O
once RB O O
a DT B-NP O
Avrett NN I-NP O
: : O O
target NN B-NP B-test
INR NNP I-NP I-test
1.5-2 JJ O O
. . B-VP O
   
Disp NNP B-NP O
:* VBD B-VP O
60 CD O O
Tablet NNP B-NP O
(s)* NNP I-NP O
Refills NNP I-NP O
:* VBZ O O
2 CD O O
* NN B-NP O
7. CD O O
Oxycodone NNP B-NP B-treatment
- : O I-treatment
Acetaminophen NNP B-NP I-treatment
5-325 JJ B-NP O
mg NN I-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
1-2 JJ B-NP O
Tablets NNS I-NP O
PO NNP I-NP O
every DT B-NP O
4-6 JJ I-NP O
hours NNS I-NP O
as IN B-VP O
needed VBN O O
for IN B-VP O
pain NN B-NP B-problem
. . B-VP O
   
Disp NNP B-NP O
:* VBD B-VP O
50 CD O O
Tablet NNP B-NP O
(s)* NNP I-NP O
Refills NNP I-NP O
:* VBZ O O
0 CD O O
* NN B-NP O
8. CD O O
Simvastatin NNP B-NP B-treatment
40 CD O O
mg NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Tablet NNP B-NP O
PO NNP I-NP O
DAILY NNP I-NP O
( ( O O
Daily NNP B-NP O
). NNP I-NP O
Disp NNP I-NP O
:* VBD B-VP O
30 CD O O
Tablet NNP B-NP O
(s)* NNP I-NP O
Refills NNP I-NP O
:* VBZ O O
2 CD O O
* NN B-NP O
9. CD O O
Prilosec NNP B-NP B-treatment
20 CD O O
mg NN B-NP O
Capsule NNP I-NP O
, , O O
Delayed NNP B-NP O
Release NNP I-NP O
( ( O O
E.C. NNP B-NP O
) ) O O
Sig NN B-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Capsule NN B-NP O
, , O O
Delayed NNP B-NP O
Release NNP I-NP O
( ( O O
E.C. NNP B-NP O
) ) O O
PO NNP B-NP O
once RB O O
a DT B-NP O
Gray NNP I-NP O
. . B-VP O
   
10. CD O O
Ultram NNP B-NP B-treatment
50 CD O O
mg NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Tablet NNP B-NP O
PO NNP I-NP O
Q6 NNP I-NP O
hrs NN I-NP O
/ NNP I-NP O
PRN NNP I-NP O
. . B-VP O
   
Discharge NNP B-NP O
Disposition NNP I-NP O
: : O O
Home NN B-NP O
with IN B-VP O
Service NNP B-NP O
Discharge NNP I-NP O
Diagnosis NNP I-NP O
: : O O
s/p NN B-NP O
off IN B-VP B-treatment
pump NN B-NP I-treatment
CABGx4 NNP I-NP I-treatment
LIMA-LAD NNP I-NP B-treatment
,Y NNP I-NP B-treatment
SVG-OM-Diag, NNP I-NP I-treatment
SVG-PDA NNP I-NP B-treatment
( ( O O
06-26 CD O O
) ) O O
PMH NN B-NP O
: : O O
HTN NNP B-NP B-problem
, , O O
chol NN B-NP B-problem
, , O O
AF NNP B-NP B-problem
, , O O
OA NNP B-NP B-problem
, , O O
CRI NNP B-NP B-problem
, , O O
s/p VBD B-VP O
bilat JJ B-NP B-treatment
knee NN I-NP I-treatment
surgery NN I-NP I-treatment
Discharge NNP I-NP O
Condition NNP I-NP O
: : O O
good JJ B-NP O
Discharge NN I-NP O
Instructions NNS I-NP O
: : O O
Keep VB O O
wounds NNS B-NP B-problem
clean JJ O O
and CC O O
dry JJ O O
. . B-VP O
   
OK UH O O
to TO O O
shower VB O O
, , O O
no DT B-NP O
bathing NN I-NP O
or CC O O
swimming NN B-NP O
. . B-VP O
   
Take VB O O
all DT B-NP B-treatment
medications NNS I-NP I-treatment
as IN B-VP O
prescribed JJ B-NP O
Call NNP I-NP O
for IN B-VP O
any DT B-NP O
fever NN I-NP B-problem
, , O O
redness NN B-NP B-problem
or CC O O
drainage NN B-NP B-problem
from IN B-VP O
wounds NNS B-NP B-problem
. . B-VP O
   
Followup NNP B-NP O
Instructions NNPS I-NP O
: : O O
Wound NNP B-NP O
clinic NN I-NP O
in IN B-VP O
2 CD O O
weeks NNS B-NP O
Dr NNP I-NP B-person
Anderson NNP I-NP I-person
in IN B-VP O
2-3 JJ B-NP O
weeks NNS I-NP O
Dr NNP I-NP B-person
Brown NNP I-NP I-person
in IN B-VP O
4 CD O O
weeks NNS B-NP O
Ada NNP I-NP B-person
Jordan NNP I-NP I-person
MD NNP I-NP I-person
62-102 JJ O O
Completed VBN O O
by IN B-VP O
: : O O
MARK NNP B-NP B-person
Eugene NNP I-NP I-person
NP NNP I-NP I-person
80-AUO JJ B-NP O
2019-07-01 JJ I-NP O
@ NN I-NP O
1417 CD O O
Signed NNP B-NP O
electronically RB O O
by IN B-VP O
: : O O
DR. NNP B-NP B-person
Elizabeth NNP I-NP I-person
P. NNP I-NP I-person
Fernandez NNP I-NP I-person
on IN B-VP O
: : O O
TUE NNP B-NP O
2019-07-30 JJ O O
8:03 CD O O
AM NNP B-NP O
( ( O O
End NNP B-NP O
of IN B-VP O
Report NNP B-NP O
) ) O O
-EMPTYLINE- VBP O O
-DOCSTART- JJ B-NP O
-EMPTYLINE- NNP I-NP O
Admission NNP I-NP O
Date NNP I-NP O
: : O O
2017-08-12 JJ B-NP O
Discharge NN I-NP O
Date NNP I-NP O
: : O O
2017-08-16 JJ B-NP O
Date NNP I-NP O
of IN B-VP O
Birth NNP B-NP O
: : O O
1995-02-03 JJ B-NP O
Sex NN I-NP O
: : O O
F NNP B-NP O
Service NNP I-NP O
: : O O
SURGERY JJ B-NP O
Allergies NNS I-NP O
: : O O
Shellfish JJ B-NP O
Attending NN I-NP O
: : O O
Maria NNP B-NP B-person
X NNP I-NP I-person
White NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
Chief NNP I-NP O
Complaint NNP I-NP O
: : O O
Motor NNP B-NP O
vehicle NN I-NP O
accident NN I-NP O
Major NNP I-NP O
Surgical NNP I-NP O
or CC O O
Invasive JJ B-NP O
Procedure NN I-NP O
: : O O
None NN B-NP O
History NN I-NP O
of IN B-VP O
Present NNP B-NP O
Illness NNP I-NP O
: : O O
22 CD O O
year NN B-NP O
old JJ B-NP O
female NN I-NP O
transfer NN I-NP O
from IN B-VP O
outside JJ B-NP O
hospital NN I-NP O
after IN B-VP O
a DT B-NP O
motor NN I-NP O
vehicle NN I-NP O
accident NN I-NP O
with IN B-VP O
diagnosed JJ B-NP B-problem
liver NN I-NP I-problem
laceration NN I-NP I-problem
by IN B-VP O
CT NNP B-NP B-test
scan JJ O I-test
. . B-VP O
   
Past NNP B-NP O
Medical JJ B-NP O
History NN I-NP O
: : O O
None NN B-NP O
Social NNP I-NP O
History NNP I-NP O
: : O O
Social NNP B-NP O
alcohol VBD B-VP O
Family NNP B-NP O
History NNP I-NP O
: : O O
Non NNP B-NP O
pertinent NN I-NP O
to TO O O
admission VB O O
Physical NNP B-NP O
Exam NNP I-NP O
: : O O
Patient NN B-NP B-person
was VBD B-VP O
alert JJ O O
, , O O
oriented JJ B-NP O
x3 NN I-NP O
. . B-VP O
   
Neck NN B-NP O
with IN B-VP O
cervical JJ B-NP B-treatment
collar NN I-NP I-treatment
. . B-VP O
   
Left NNP B-NP B-problem
forarm NN I-NP I-problem
and CC O I-problem
right JJ B-NP I-problem
knee NN I-NP I-problem
abrasions NNS I-NP I-problem
. . B-VP O
   
Chest JJS O O
clear JJ O O
to TO O O
auscultation VB O B-test
bilateral JJ O O
, , O O
S1 NNP B-NP O
S2 NNP I-NP O
normal JJ O O
and CC O O
with IN B-VP O
no DT B-NP O
murmors NNS I-NP B-problem
. . B-VP O
   
Abdominal NNP B-NP B-problem
pain NN I-NP I-problem
predominally RB O O
on IN B-VP O
the DT B-NP O
right JJ I-NP O
upper NN I-NP O
quadrant NN I-NP O
, , O O
no DT B-NP O
signs NNS I-NP O
of IN B-VP O
peritoneal JJ B-NP B-problem
irritation NN I-NP I-problem
. . B-VP O
   
Pertinent JJ B-NP O
Results NNS I-NP O
: : O O
2017-08-12 JJ O O
11:41 CD O O
PM NNP B-NP O
GLUCOSE NNP I-NP B-test
- : O O
74 CD O O
UREA NNP B-NP B-test
N NNP I-NP I-test
- : O O
9 CD O O
CREAT NNP B-NP B-test
- : O O
0.7 CD O O
SODIUM NNP B-NP B-test
- : O O
139 CD O O
POTASSIUM NNP B-NP B-test
- : O O
3.5 CD O O
CHLORIDE NNP B-NP B-test
- : O O
106 CD O O
TOTAL NNP B-NP B-test
CO2 NNP I-NP I-test
- : O O
23 CD O O
ANION NNP B-NP B-test
GAP NNP I-NP I-test
- : O O
14 CD O O
2017-08-12 JJ O O
11:41PM CD O O
ALT(SGPT) NNP B-NP B-test
- : O O
241 CD O O
* NN B-NP O
AST(SGOT) NNP I-NP B-test
- : O O
207 CD O O
* JJ B-NP O
ALK NNP I-NP B-test
PHOS NNP I-NP I-test
- : O O
51 CD O O
TOT NNP B-NP B-test
BILI NNP I-NP I-test
- : O O
0.8 CD O O
2017-08-12 JJ O O
11:41 CD O O
PM NNP B-NP O
CALCIUM NNP I-NP B-test
- : O O
8.2 CD O O
* NN B-NP O
PHOSPHATE NNP I-NP B-test
- : O O
3.1 CD O O
MAGNESIUM NNP B-NP B-test
- : O O
2.2 CD O O
2017-08-12 JJ O O
03:15 CD O O
PM NNP B-NP O
GLUCOSE NNP I-NP B-test
- : O O
75 CD O O
UREA NNP B-NP B-test
N NNP I-NP I-test
- : O O
10 CD O O
CREAT NNP B-NP B-test
- : O O
0.6 CD O O
SODIUM NNP B-NP B-test
- : O O
137 CD O O
POTASSIUM NNP B-NP B-test
- : O O
3.7 CD O O
CHLORIDE NNP B-NP B-test
- : O O
103 CD O O
TOTAL NNP B-NP B-test
CO2 NNP I-NP I-test
- : O O
23 CD O O
ANION NNP B-NP B-test
GAP NNP I-NP I-test
- : O O
15 CD O O
2017-08-12 JJ O O
03:15 CD O O
PM NNP B-NP O
ALT(SGPT) NNP I-NP B-test
- : O O
318 CD O O
* NN B-NP O
AST(SGOT) NNP I-NP B-test
- : O O
307 CD O O
* JJ B-NP O
ALK NNP I-NP B-test
PHOS NNP I-NP I-test
- : O O
61 CD O O
TOT NNP B-NP B-test
BILI NNP I-NP I-test
- : O O
0.9 CD O O
2017-08-12 JJ O O
03:15 CD O O
PM NNP B-NP O
WBC NNP I-NP B-test
- : O O
8.3 CD O O
RBC NNP B-NP B-test
- : O O
3.64 CD O O
* NN B-NP O
HGB NNP I-NP B-test
- : O O
12.6 CD O O
HCT NNP B-NP B-test
- : O O
36.1 CD O O
MCV NNP B-NP B-test
- : O O
99 CD O O
* NN B-NP O
MCH NNP I-NP B-test
- : O O
34.7 CD O O
* NN B-NP O
MCHC NNP I-NP B-test
- : O O
35.0 CD O O
RDW NNP B-NP B-test
- : O O
12.4 CD O O
2017-08-12 JJ O O
03:15 CD O O
PM NNP B-NP O
PT NNP I-NP B-test
- : O O
11.6 CD O O
PTT NNP B-NP B-test
- : O O
26.0 CD O O
INR(PT) NNP B-NP B-test
- : O O
0.9 CD O O
Brief JJ B-NP O
Hospital JJ I-NP O
Course NN I-NP O
: : O O
Patient NN B-NP B-person
was VBD B-VP O
admited VBN O O
, , O O
pain NN B-NP B-problem
was VBD B-VP O
managed VBN O O
with IN B-VP O
a DT B-NP B-treatment
PCA NNP I-NP I-treatment
and CC O O
later RB O O
with IN B-VP O
PO NNP B-NP B-treatment
medication NN I-NP I-treatment
. . B-VP O
   
The DT B-NP B-problem
liver JJ I-NP I-problem
laceration NN I-NP I-problem
was VBD B-VP O
stable JJ O O
, , O O
no DT B-NP O
sign NN I-NP O
of IN B-VP O
rupture NN B-NP B-problem
or CC O O
further JJ B-NP B-problem
complication NN I-NP I-problem
, , O O
did VBD B-VP O
not RB O O
required VBN O O
surgical JJ B-NP B-treatment
managment NN I-NP I-treatment
. . B-VP O
   
The DT B-NP B-test
liver NN I-NP I-test
enzimes VBZ O I-test
come VBP O O
down RP O O
, , O O
no DT B-NP O
signs NNS I-NP O
of IN B-VP O
biliary JJ B-NP B-problem
stasis NN I-NP I-problem
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
able JJ O O
to TO O O
tolerate VB O O
diet JJ O O
, , O O
ambulate NN B-NP O
, , O O
having VBG O O
a DT B-NP O
bowel NN I-NP O
movement NN I-NP O
and CC O O
dischargo NN B-NP O
home NN I-NP O
in IN B-VP O
good JJ B-NP O
conditions NNS I-NP O
. . B-VP O
   
Medications NNS B-NP O
on IN B-VP O
Admission NN B-NP O
: : O O
None NN B-NP O
Discharge NNP I-NP O
Medications NNP I-NP O
: : O O
1. CD O O
Docusate NNP B-NP B-treatment
Sodium NNP I-NP I-treatment
100 CD O O
mg NN B-NP O
Capsule NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Capsule NNP B-NP O
PO NNP I-NP O
BID NNP I-NP O
( ( O O
2 CD O O
times NNS B-NP O
a DT B-NP O
day NN I-NP O
) ) O O
for IN B-VP O
4 CD O O
days NNS B-NP O
. . B-VP O
   
Disp NNP B-NP O
:* VBD B-VP O
8 CD O O
Capsule NNP B-NP O
(s)* NNP I-NP O
Refills NNP I-NP O
:* VBZ O O
0 CD O O
* NN B-NP O
2. CD O O
Hydromorphone NNP B-NP B-treatment
2 CD O O
mg NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Tablet NNP B-NP O
PO NNP I-NP O
Q2H NNP I-NP O
( ( O O
every DT O O
2 CD O O
hours NNS B-NP O
) ) O O
as IN B-VP O
needed VBN O O
for IN B-VP O
Pain NNP B-NP B-problem
for IN B-VP O
4 CD O O
days NNS B-NP O
. . B-VP O
   
Disp NNP B-NP O
:* VBD B-VP O
30 CD O O
Tablet NNP B-NP O
(s)* NNP I-NP O
Refills NNP I-NP O
:* VBZ O O
0 CD O O
* NN B-NP O
Discharge NNP I-NP O
Disposition NNP I-NP O
: : O O
Home NNP B-NP O
Discharge NNP I-NP O
Diagnosis NNP I-NP O
: : O O
Motor NNP B-NP O
vehicle NN I-NP O
accident NN I-NP O
Discharge NNP I-NP O
Condition NNP I-NP O
: : O O
Good JJ B-NP O
Discharge NN I-NP O
Instructions NNS I-NP O
: : O O
- : O O
Follow VB O O
up RP O O
with IN B-VP O
Trauma NNP B-NP O
Surgery NNP I-NP O
Clinic NNP I-NP O
with IN B-VP O
the DT B-NP O
Result NN I-NP O
from IN B-VP O
the DT B-NP B-test
CT NNP I-NP I-test
scan JJ B-NP I-test
abdomen NNS I-NP I-test
- : O O
Call NN B-NP O
for IN B-VP O
appointment NN B-NP O
to TO O O
( ( O O
289 CD O O
) ) O O
411-5387 NN B-NP O
for IN B-VP O
the DT B-NP O
Trauma NNP I-NP O
Clinic NNP I-NP O
and CC O O
Abdominal NNP B-NP B-test
CT NNP I-NP I-test
scan NN I-NP I-test
of IN B-VP I-test
the DT B-NP I-test
Abdomen NNP I-NP I-test
in IN B-VP O
4 CD O O
weeks NNS B-NP O
- : O O
If IN B-VP O
any DT B-NP B-problem
abdominal JJ I-NP I-problem
pain NN I-NP I-problem
, , O O
fever NN B-NP B-problem
or CC O O
dizziness NN B-NP B-problem
, , O O
go VB O O
to TO O O
the DT B-NP O
Emergency NNP I-NP O
Room NNP I-NP O
- : O O
Avoid NNP B-NP O
contact NN I-NP O
sport NN I-NP O
until IN B-VP O
seen VBN O O
in IN B-VP O
the DT B-NP O
Clinic NNP I-NP O
- : O O
Analgesic NNP B-NP B-treatment
( ( O I-treatment
Percocet NNP B-NP I-treatment
) ) O I-treatment
as IN B-VP O
needed VBN O O
Followup NNP B-NP O
Instructions NNS I-NP O
: : O O
- : O O
Trauma NN B-NP O
Surgery NNP I-NP O
Clinic NNP I-NP O
in IN B-VP O
four CD O O
weeks NNS B-NP O
with IN B-VP O
CT NNP B-NP B-test
abdomen NNS I-NP I-test
results NNS I-NP O
. . B-VP O
   
Call NNP B-NP O
Trauma NNP I-NP O
Clinic NNP I-NP O
to TO O O
coordinate VB O O
the DT B-NP B-test
study NN I-NP I-test
, , O O
result NN B-NP O
and CC O O
appointment NN B-NP O
dates NNS I-NP O
(( VBP O O
289 CD O O
) ) O O
411-5387 CD O O
). NNP B-NP O
Ida NNP I-NP B-person
Doris NNP I-NP I-person
MD NNP I-NP I-person
79-274 JJ O O
Completed VBN O O
by IN B-VP O
: : O O
Jane NNP B-NP B-person
Ashmore NNP I-NP I-person
MD NNP I-NP I-person
50-063 JJ B-NP O
2017-08-16 JJ I-NP O
@ NN I-NP O
0950 CD O O
Signed NNP B-NP O
electronically RB O O
by IN B-VP O
: : O O
DR. NNP B-NP B-person
Jennifer NNP I-NP I-person
Green NNP I-NP I-person
on IN B-VP O
: : O O
FRI NNP B-NP O
2017-09-01 CD O O
1:04 CD O O
PM NNP B-NP O
( ( O O
End NNP B-NP O
of IN B-VP O
Report NNP B-NP O
) ) O O
-EMPTYLINE- VBP O O
-DOCSTART- JJ O O
-EMPTYLINE- $ O O
767751445 CD O O
ELMVH NNP B-NP O
45154940 CD O O
6035801 CD O O
12/6/2005 CD O O
12:00:00 CD O O
AM NNP B-NP O
COPD NNP I-NP B-problem
exacerbation NN I-NP I-problem
with IN B-VP O
NSTEMI NNP B-NP B-problem
DIS NNP I-NP O
Admission NNP I-NP O
Date NNP I-NP O
: : O O
12/06/2005 CD O O
Report NNP B-NP O
Status NNP I-NP O
: : O O
Discharge NN B-NP O
Date NNP I-NP O
: : O O
12/10/2005 CD O O
****** NNP B-NP O
FINAL NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
SCHOELLSULLKOTEFONG NNP I-NP B-person
, , O I-person
MAUSTINIE NNP B-NP I-person
161-66-98-5 CD O O
W53 NNP B-NP O
Room NNP I-NP O
: : O O
66R-249 JJ B-NP O
Service NNP I-NP O
: : O O
MED NNP B-NP O
DISCHARGE NNP I-NP O
PATIENT NNP I-NP B-person
ON NNP I-NP O
: : O O
12/09/05 CD O O
AT NNP B-NP O
08:00 CD O O
PM NNP B-NP O
CONTINGENT NNP I-NP O
UPON NNP I-NP O
Attending NNP I-NP B-person
Attending NNP I-NP B-test
evaluation NN I-NP I-test
WILL NNP I-NP O
D NNP I-NP O
/ NNP I-NP O
C NNP I-NP O
ORDER NNP I-NP O
BE NNP I-NP O
USED NNP I-NP O
AS IN B-VP O
THE NNP B-NP O
D NNP I-NP O
/ NNP I-NP O
C NNP I-NP O
SUMMARY NNP I-NP O
: : O O
YES JJ B-NP O
Attending NN I-NP B-person
: : O O
FREIERMFUSC NNP B-NP B-person
, , O I-person
SHAIGAYDONA NNP B-NP I-person
, , O I-person
M.D. NNP B-NP I-person
, , O O
M.DIV. NNP B-NP O
CODE NNP I-NP O
STATUS NNP I-NP O
: : O O
Full NNP B-NP O
code NN I-NP O
DISPOSITION NNP I-NP O
: : O O
Home NNP B-NP O
w/ NN I-NP O
services NNS I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS NNP I-NP O
: : O O
VITAMIN NNP B-NP B-treatment
C NNP I-NP I-treatment
( ( O I-treatment
ASCORBIC NNP B-NP I-treatment
ACID NNP I-NP I-treatment
) ) O I-treatment
1,000 CD O O
MG NNP B-NP O
PO NNP I-NP O
QD NNP I-NP O
ECASA NNP I-NP B-treatment
( ( O I-treatment
ASPIRIN NNP B-NP I-treatment
ENTERIC NNP I-NP I-treatment
COATED NNP I-NP I-treatment
) ) O I-treatment
81 CD O O
MG NNP B-NP O
PO NNP I-NP O
QD NNP I-NP O
CALCIUM NNP I-NP B-treatment
CARBONATE NNP I-NP I-treatment
( ( O I-treatment
500 CD O I-treatment
MG NNP B-NP I-treatment
ELEMENTAL NNP I-NP I-treatment
CA++ NNP I-NP I-treatment
) ) O I-treatment
500 CD O O
MG NNP B-NP O
PO NNP I-NP O
BID NNP I-NP O
PREDNISONE NNP I-NP B-treatment
20 CD O O
MG NNP B-NP O
PO NNP I-NP O
QAM NNP I-NP O
Starting VBG O O
Today NNP B-NP O
( ( O O
12/09 CD O O
) ) O O
Instructions NNS B-NP O
: : O O
taper NN B-NP O
over IN B-VP O
2 CD O O
weeks NNS B-NP O
MULTIVITAMIN NNP I-NP B-treatment
THERAPEUTIC NNP I-NP I-treatment
( ( O I-treatment
THERAPEUTIC NNP B-NP I-treatment
MULTIVI NNP I-NP I-treatment
... : O I-treatment
) ) O I-treatment
5 CD O O
MILLILITERS NNP B-NP O
PO NNP I-NP O
QD NNP I-NP O
Override NNP I-NP O
Notice NNP I-NP O
: : O O
Override NNP B-NP O
added VBD B-VP O
on IN B-VP O
12/07/05 CD O O
by IN B-VP O
BELB NNP B-NP B-person
, , O I-person
BRITHERL NNP B-NP I-person
, , O I-person
M.D. NNP B-NP I-person
on IN B-VP O
order NN B-NP O
for IN B-VP O
ATORVASTATIN NNP B-NP B-treatment
PO NNP I-NP I-treatment
( ( O O
ref JJ O O
# # O O
33823759 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP B-problem
INTERACTION NNP I-NP I-problem
: : O O
NIACIN NNP B-NP B-treatment
, , O O
VIT NNP B-NP B-treatment
. . B-VP O
   
B-3 NNP B-NP O
and CC O O
ATORVASTATIN NNP B-NP B-treatment
CALCIUM NNP I-NP I-treatment
Reason NNP I-NP O
for IN B-VP O
override NN B-NP O
: : O O
md NN B-NP B-person
aware JJ B-NP O
Previous NNP I-NP O
override NN I-NP O
information NN I-NP O
: : O O
Override NNP B-NP O
added VBD B-VP O
on IN B-VP O
12/06/05 CD O O
by IN B-VP O
BELB NNP B-NP B-person
, , O I-person
BRITHERL NNP B-NP I-person
, , O I-person
M.D. NNP B-NP I-person
on IN B-VP O
order NN B-NP O
for IN B-VP O
ZOCOR NNP B-NP B-treatment
PO NNP I-NP I-treatment
( ( O O
ref JJ O O
# # O O
33033281 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP B-problem
INTERACTION NNP I-NP I-problem
: : O O
NIACIN NNP B-NP B-treatment
, , O O
VIT NNP B-NP B-treatment
. . B-VP O
   
B-3 NNP B-NP O
and CC O O
SIMVASTATIN NNP B-NP B-treatment
Reason NNP I-NP O
for IN B-VP O
override NN B-NP O
: : O O
md NN B-NP B-person
aware JJ B-NP O
FLOVENT NNP I-NP B-treatment
( ( O I-treatment
FLUTICASONE NNP B-NP I-treatment
PROPIONATE NNP I-NP I-treatment
) ) O I-treatment
44 CD O O
MCG NNP B-NP O
INH NNP I-NP O
BID NNP I-NP O
Starting VBG O O
Today NNP B-NP O
( ( O O
12/09 CD O O
) ) O O
LEVAQUIN NNP B-NP B-treatment
( ( O I-treatment
LEVOFLOXACIN NNP B-NP I-treatment
) ) O I-treatment
500 CD O O
MG NNP B-NP O
PO NNP I-NP O
QD NNP I-NP O
Food NNP I-NP O
/ NNP I-NP O
Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Administer NNP I-NP O
iron NN I-NP B-treatment
products NNS I-NP I-treatment
a DT B-NP O
minimum NN I-NP O
of IN B-VP O
2 CD O O
hours NNS B-NP O
before IN B-VP O
or CC O O
after IN B-VP O
a DT B-NP O
levofloxacin NN I-NP B-treatment
or CC O O
ciprofloxacin NN B-NP B-treatment
dose VBP O O
dose JJ O O
If IN B-VP O
on IN B-VP O
tube NN B-NP B-treatment
feeds NNS I-NP I-treatment
, , O O
please VB O O
cycle NN B-NP O
( ( O O
hold VB O O
1 CD O O
hr NN B-NP O
before IN B-VP O
to TO O O
2 CD O O
hr NNS B-NP O
after IN B-VP O
) ) O O
Take VBP O O
2 CD O O
hours NNS B-NP O
before IN B-VP O
or CC O O
2 CD O O
hours NNS B-NP O
after IN B-VP O
dairy NN B-NP O
products NNS I-NP O
. . B-VP O
   
Alert NNP B-NP O
overridden JJ O O
: : O O
Override NNP B-NP O
added VBD B-VP O
on IN B-VP O
12/06/05 CD O O
by IN B-VP O
BELB NNP B-NP B-person
, , O I-person
BRITHERL NNP B-NP I-person
, , O I-person
M.D. NNP B-NP I-person
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP B-problem
INTERACTION NNP I-NP I-problem
: : O O
SALMETEROL NNP B-NP B-treatment
XINAFOATE NNP I-NP I-treatment
and CC O O
LEVOFLOXACIN NNP B-NP B-treatment
Reason NNP I-NP O
for IN B-VP O
override NN B-NP O
: : O O
md NN B-NP B-person
aware JJ B-NP O
SEREVENT NNP I-NP B-treatment
DISKUS NNP I-NP I-treatment
( ( O I-treatment
SALMETEROL NNP B-NP I-treatment
DISKUS NNP I-NP I-treatment
) ) O I-treatment
1 CD O O
PUFF NNP B-NP O
INH NNP I-NP O
BID NNP I-NP O
Override NNP I-NP O
Notice NNP I-NP O
: : O O
Override NNP B-NP O
added VBD B-VP O
on IN B-VP O
12/06/05 CD O O
by IN B-VP O
BELB NNP B-NP B-person
, , O I-person
BRITHERL NNP B-NP I-person
, , O I-person
M.D. NNP B-NP I-person
on IN B-VP O
order NN B-NP O
for IN B-VP O
LEVAQUIN NNP B-NP B-treatment
PO NNP I-NP I-treatment
( ( O O
ref JJ O O
# # O O
57095042 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP B-problem
INTERACTION NNP I-NP I-problem
: : O O
SALMETEROL NNP B-NP B-treatment
XINAFOATE NNP I-NP I-treatment
and CC O O
LEVOFLOXACIN NNP B-NP B-treatment
Reason NNP I-NP O
for IN B-VP O
override NN B-NP O
: : O O
md NN B-NP B-person
aware JJ B-NP O
LISINOPRIL NNP I-NP B-treatment
5 CD O O
MG NNP B-NP O
PO NNP I-NP O
QD NNP I-NP O
Alert NNP I-NP O
overridden NN I-NP O
: : O O
Override NNP B-NP O
added VBD B-VP O
on IN B-VP O
12/08/05 CD O O
by IN B-VP O
: : O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP B-problem
INTERACTION NNP I-NP I-problem
: : O O
POTASSIUM NNP B-NP B-treatment
CHLORIDE NNP I-NP I-treatment
and CC O O
LISINOPRIL NNP B-NP B-treatment
Reason NNP I-NP O
for IN B-VP O
override NN B-NP O
: : O O
md NN B-NP B-person
aware JJ B-NP O
TOPROL NNP I-NP B-treatment
XL NNP I-NP I-treatment
( ( O I-treatment
METOPROLOL NNP B-NP I-treatment
SUCCINATE NNP I-NP I-treatment
EXTENDED NNP I-NP I-treatment
RELEASE NNP I-NP I-treatment
) ) O I-treatment
25 CD O O
MG NNP B-NP O
PO NNP I-NP O
QD NNP I-NP O
Starting VBG O O
Today NNP B-NP O
( ( O O
12/09 CD O O
) ) O O
Food NNP B-NP O
/ NNP I-NP O
Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Take NNP I-NP O
consistently RB O O
with IN B-VP O
meals NNS B-NP O
or CC O O
on IN B-VP O
empty JJ B-NP O
stomach NN I-NP O
. . B-VP O
   
ALENDRONATE $ O B-treatment
70 CD O O
MG NNP B-NP O
PO NNP I-NP O
QWEEK NNP I-NP O
Food NNP I-NP O
/ NNP I-NP O
Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Give NNP I-NP O
on IN B-VP O
an DT B-NP O
empty JJ I-NP O
stomach NN I-NP O
( ( O O
give JJ O O
1hr CD O O
before IN B-VP O
or CC O O
2hr CD O O
after IN B-VP O
food NN B-NP O
) ) O O
Take VBP O O
with IN B-VP O
8 CD O O
oz NN B-NP O
of IN B-VP O
plain JJ B-NP O
water NN I-NP O
ALBUTEROL NNP I-NP B-treatment
INHALER NNP I-NP I-treatment
2 CD O O
PUFF NNP B-NP O
INH NNP I-NP O
QID NNP I-NP O
Starting VBG O O
Today NNP B-NP O
( ( O O
12/09 CD O O
) ) O O
ATROVENT NNP B-NP B-treatment
INHALER NNP I-NP I-treatment
( ( O I-treatment
IPRATROPIUM NNP B-NP I-treatment
INHALER NNP I-NP I-treatment
) ) O I-treatment
2 CD O O
PUFF NNP B-NP O
INH NNP I-NP O
QID NNP I-NP O
Starting VBG O O
Today NNP B-NP O
( ( O O
12/09 CD O O
) ) O O
DIET NN B-NP O
: : O O
No DT B-NP O
Restrictions NNP I-NP O
ACTIVITY NNP I-NP O
: : O O
Resume NNP B-NP O
regular JJ B-NP O
exercise NN I-NP O
FOLLOW NNP I-NP O
UP NNP I-NP O
APPOINTMENT NNP I-NP O
( ( O O
S NNP B-NP O
) ) O O
: : O O
Gento NNP B-NP B-person
Yaneslaunt NNP I-NP I-person
03/17/06 CD O O
scheduled VBN O O
, , O O
Arois NNP B-NP B-person
Maillliepslighsint NNP I-NP I-person
02/18/06 CD O O
scheduled VBN O O
, , O O
ALLERGY NNP B-NP O
: : O O
NKA NNP B-NP B-problem
ADMIT NNP I-NP O
DIAGNOSIS NNP I-NP O
: : O O
COPD NNP B-NP B-problem
exacerbation NN I-NP I-problem
PRINCIPAL NNP I-NP O
DISCHARGE NNP I-NP O
DIAGNOSIS NNP I-NP O
; : O O
Responsible NNP B-NP O
After IN B-VP O
Study NNP B-NP O
for IN B-VP O
Causing NNP B-NP O
Admission NNP I-NP O
) ) O O
COPD NNP B-NP B-problem
exacerbation NN I-NP I-problem
with IN B-VP O
NSTEMI NNP B-NP B-problem
OTHER NNP I-NP O
DIAGNOSIS NNP I-NP O
; : O O
Conditions NNP B-NP O
, , O O
Infections NNP B-NP O
, , O O
Complications NNP B-NP O
, , O O
affecting VBG O O
Treatment NNP B-NP O
/ NNP I-NP O
Stay NNP I-NP O
severe RB O B-problem
COPD NNP B-NP I-problem
Pneumonia NNP I-NP B-problem
recovering VBG O O
alcoholic JJ O O
recovering VBG O O
barbituate NN B-NP O
abuse NN I-NP O
unexplained VBD B-VP B-problem
hct JJ B-NP I-problem
drop NN I-NP I-problem
poor JJ B-NP B-problem
appetite JJ I-NP I-problem
x NN I-NP O
1 CD O O
week NN B-NP O
STEROID NNP I-NP B-problem
PSYCHOSIS NNP I-NP I-problem
NO NNP I-NP O
BENZOS NNP I-NP B-treatment
OPERATIONS NNP I-NP O
AND NNP I-NP O
PROCEDURES NNP I-NP O
: : O O
none NN B-NP O
OTHER NNP I-NP O
TREATMENTS NNP I-NP O
/ NNP I-NP O
PROCEDURES NNP I-NP O
( ( O O
NOT NNP B-NP O
IN NNP I-NP O
O.R. NNP I-NP O
) ) O O
Heparin NNP B-NP B-treatment
while IN B-VP O
having VBG O O
a DT B-NP B-problem
demand NN I-NP I-problem
ischemic JJ B-NP I-problem
episode NN I-NP I-problem
BRIEF NNP I-NP O
RESUME NNP I-NP O
OF NNP I-NP O
HOSPITAL NNP I-NP O
COURSE NNP I-NP O
: : O O
* JJ B-NP O
CC NNP I-NP O
: : O O
82F CD O O
with IN B-VP O
COPD NNP B-NP B-problem
exacerpation NN I-NP I-problem
* NNP I-NP O
DDx NNP I-NP O
: : O O
COPD NNP B-NP B-problem
exacerpation NN I-NP I-problem
with IN B-VP O
troponin NN B-NP B-problem
leak NN I-NP I-problem
likely JJ B-NP O
NSTEMI NNP I-NP B-problem
secondary JJ O O
to TO O O
demand VB O B-problem
ischemia NN B-NP I-problem
. . B-VP O
   
* JJ B-NP O
HPI NNP I-NP O
: : O O
4 CD O O
days NNS B-NP O
of IN B-VP O
worsening VBG O B-problem
SOB NNP B-NP I-problem
with IN B-VP O
sore NN B-NP B-problem
throat NN I-NP I-problem
and CC O O
cough JJ B-NP B-problem
productive NN I-NP I-problem
of IN B-VP I-problem
yellow JJ B-NP I-problem
/ NNP I-NP I-problem
green JJ B-NP I-problem
sputum NN I-NP I-problem
. . B-VP O
   
Fatigue NNP B-NP B-problem
secondary JJ O O
to TO O O
worsening VBG O B-problem
dyspnea NN B-NP I-problem
. . B-VP O
   
took VBD B-VP O
Prednisone NNP B-NP B-treatment
40 CD O I-treatment
at IN B-VP O
home NN B-NP O
and CC O O
presented VBN O O
to TO O O
ED NNP B-NP O
where WRB O O
found VBN O O
to TO O O
have VB O O
1mm CD O B-problem
lateral JJ B-NP I-problem
ST NNP I-NP I-problem
depressions NNS I-NP I-problem
and CC O O
slight JJ B-NP B-problem
troponin NN I-NP I-problem
and CC O I-problem
MB NNP B-NP I-problem
leak NN I-NP I-problem
. . B-VP O
   
no DT B-NP O
N NNP I-NP B-problem
/ NNP I-NP O
V/HA NNP I-NP B-problem
/ NNP I-NP O
D NNP I-NP B-problem
no DT B-NP O
sweats NNS I-NP B-problem
, , O O
no DT B-NP O
chills NNS I-NP B-problem
, , O O
of IN B-VP O
abdominal JJ B-NP B-problem
pain NN I-NP I-problem
, , O O
no DT B-NP O
chest NN I-NP B-problem
pain NN I-NP I-problem
, , O O
no DT B-NP O
pleuricy NN I-NP B-problem
, , O O
no DT B-NP O
LEE NNP I-NP B-problem
, , O O
no DT B-NP O
paresthesias NN I-NP B-problem
, , O O
no DT B-NP O
numbness NN I-NP B-problem
, , O O
no DT B-NP O
shoulder NN I-NP B-problem
pain NN I-NP I-problem
, , O O
no DT B-NP O
jaw NN I-NP B-problem
pain NN I-NP I-problem
. . B-VP O
   
* JJ B-NP O
PMH NN I-NP O
: : O O
COPD NNP B-NP B-problem
( ( O O
s JJ B-NP O
/ NN I-NP O
p NN I-NP O
lung NN I-NP B-treatment
resection NN I-NP I-treatment
FEV1 NNP I-NP B-test
25% CD O O
) ) O O
, , O O
chronic JJ B-NP B-problem
pericardial JJ I-NP I-problem
effusion NN I-NP I-problem
, , O O
PVD NNP B-NP B-problem
, , O O
R NNP B-NP B-problem
renal JJ B-NP I-problem
artery NN I-NP I-problem
stenosis NN I-NP I-problem
, , O O
osteoporosis NN B-NP B-problem
, , O O
presbylaryngis JJ B-NP B-problem
************** NNP I-NP O
PATIENT NNP I-NP B-person
STATUS NNP I-NP O
******************** NNP I-NP O
98.4 CD O O
, , O O
94 CD O O
, , O O
22 CD O O
, , O O
120/96 CD O O
, , O O
98% CD O O
on IN B-VP O
2L. CD O O
NAD NNP B-NP B-problem
, , O O
using VBG O B-problem
scalenes NNS B-NP I-problem
, , O O
AT NNP B-NP O
/ NNP I-NP O
NC NNP I-NP O
, , O O
no DT B-NP O
oral JJ I-NP B-problem
lesions NNS I-NP I-problem
, , O O
Bibasilar NNP B-NP B-problem
rales VBZ O I-problem
otherwise RB O O
clear JJ O O
, , O O
good JJ B-NP O
air NN I-NP O
movement NN I-NP O
, , O O
RRR NNP B-NP O
, , O O
no DT B-NP O
MRG NNP I-NP O
, , O O
NTND NNP B-NP O
+BS NNP I-NP O
, , O O
no DT B-NP O
CCE NNP I-NP O
, , O O
2+ CD O O
DPs NNP B-NP O
. . B-VP O
   
Guiac NNP B-NP O
negative JJ B-NP O
*************** NNP I-NP O
STUDIES NNP I-NP O
*********************** NNP I-NP O
LABS NNP I-NP O
: : O O
WBC $ O B-test
12.91 CD O O
CXR NNP B-NP B-test
: : O O
small JJ B-NP B-problem
pleural JJ I-NP I-problem
effusion NN I-NP I-problem
, , O O
flat JJ O O
diaphrams VBZ O O
no DT B-NP O
acute JJ I-NP B-problem
changes NNS I-NP I-problem
Echo NNP I-NP B-test
- : O O
*********** JJ B-NP O
HOSPITAL NNP I-NP O
COURSE NNP I-NP O
**************** VBD B-VP O
1. CD O O
CV NN B-NP O
: : O O
likely JJ O O
having VBG O O
a DT B-NP B-problem
NSTEMI NNP I-NP I-problem
secondary JJ O O
to TO O O
demand VB O B-problem
. . B-VP O
   
Cardiac NNP B-NP B-test
enzymes VBZ O I-test
trending VBG O O
down RP O O
on IN B-VP O
12.7.05 CD O O
, , O O
anticoagulated VBN O O
while IN B-VP O
having VBG O O
leak NN B-NP B-problem
. . B-VP O
   
I PRP O O
- : O O
heparin NN B-NP B-treatment
for IN B-VP O
PTT NNP B-NP B-problem
50-70 JJ B-NP O
durin NN I-NP O
enzyme NN I-NP B-problem
leak NN I-NP I-problem
. . B-VP O
   
metoprolol CC O B-treatment
12 CD O O
QID NNP B-NP O
. . B-VP O
   
Cardiac NNP B-NP B-test
enzymes VBZ O I-test
BID NNP B-NP O
while IN B-VP O
actively RB O O
having VBG O O
leak NN B-NP B-problem
, , O O
ASA NNP B-NP B-treatment
R NNP I-NP O
- : O O
monitor NN B-NP O
on IN B-VP O
telemetry NN B-NP B-test
P NNP I-NP O
- : O O
no DT B-NP O
evidence NN I-NP B-problem
of IN B-VP I-problem
failure NN B-NP I-problem
- : O O
Echo NN B-NP B-test
: : O O
2. CD O O
COPD NN B-NP B-problem
: : O O
likely JJ B-NP O
exacerbation NN I-NP B-problem
possibly RB O O
from IN B-VP O
URI NNP B-NP B-problem
/ NNP I-NP O
pneumonia NN I-NP B-problem
. . B-VP O
   
Aputum NNP B-NP B-test
cultures VBZ O I-test
pending VBG O O
. . B-VP O
   
Treated VBN O O
with IN B-VP O
: : O O
atrovent NN B-NP B-treatment
NEB NNP I-NP I-treatment
QID NNP I-NP O
, , O O
albuterol NN B-NP B-treatment
Neb NNP I-NP I-treatment
QID NNP I-NP O
, , O O
ipratropium NN B-NP B-treatment
NEB NNP I-NP I-treatment
BID NNP I-NP O
, , O O
flovent JJ B-NP B-treatment
INH NNP I-NP I-treatment
BID NNP I-NP O
, , O O
Serevent NNP B-NP B-treatment
INH NNP I-NP I-treatment
BID NNP I-NP O
, , O O
and CC O O
prednisone RB O B-treatment
30 CD O O
QD NNP B-NP O
taper NN I-NP O
. . B-VP O
   
Levaquin NNP B-NP B-treatment
500 CD O O
QD NNP B-NP O
empirically RB O O
3. CD O O
GI NNP B-NP O
: : O O
PPI NNP B-NP B-treatment
prophylaxis VBZ O I-treatment
4. CD O O
FEN NN B-NP O
: : O O
MVI NNP B-NP B-treatment
, , O O
Cardiac NNP B-NP O
diet VBP O O
ADDITIONAL NNP B-NP O
COMMENTS NNP I-NP O
: : O O
Please NNP B-NP O
make VB O O
an DT B-NP O
appointment NN I-NP O
to TO O O
see VB O O
dr. JJ B-NP B-person
Arois NNP I-NP I-person
Maillliepslighsint NNP I-NP I-person
within2-3 JJ B-NP O
weeks NNS I-NP O
after IN B-VP O
you PRP O B-person
leave VBP O O
the DT B-NP O
hospital NN I-NP O
Please NNP I-NP O
taper VBZ O O
off IN B-VP O
your PRP$ O B-person
prednisone NN B-NP B-treatment
within IN B-VP O
2 CD O O
weeks NNS B-NP O
DISCHARGE NNP I-NP O
CONDITION NNP I-NP O
: : O O
Stable JJ B-NP O
TO NNP I-NP O
DO NNP I-NP O
/ NNP I-NP O
PLAN NN I-NP O
: : O O
PT NN B-NP O
: : O O
please NN B-NP O
evaluate VB O O
ambutlation NN B-NP O
ability NN I-NP O
and CC O O
O2 NNP B-NP B-test
requirement NN I-NP I-test
Please NNP I-NP O
evaluate VB O O
resolution NN B-NP O
of IN B-VP O
cardiac JJ B-NP B-problem
troponin NN I-NP I-problem
leak NN I-NP I-problem
and CC O O
stable JJ B-NP O
EKG NNP I-NP O
. . B-VP O
   
Please NNP B-NP O
evaluate JJ B-NP O
resolution NN I-NP O
of IN B-VP O
COPD NNP B-NP B-problem
exacerbation NN I-NP I-problem
and CC O O
need NN B-NP O
for IN B-VP O
any DT B-NP B-treatment
further JJ I-NP I-treatment
antibiocis NN I-NP I-treatment
No NNP I-NP O
dictated VBD B-VP O
summary JJ B-NP O
ENTERED NNP I-NP O
BY NNP I-NP O
: : O O
BELB NNP B-NP B-person
, , O I-person
BRITHERL NNP B-NP I-person
, , O I-person
M.D. NNP B-NP I-person
( ( O O
IL35 NNP B-NP O
) ) O O
12/10/05 CD O O
02:50 CD O O
PM NNP B-NP O
****** JJ B-NP O
END NNP I-NP O
OF NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
Admission NNP I-NP O
Date NNP I-NP O
: : O O
2016-08-08 JJ B-NP O
Discharge NN I-NP O
Date NNP I-NP O
: : O O
2016-08-15 JJ B-NP O
Date NNP I-NP O
of IN B-VP O
Birth NNP B-NP O
: : O O
1978-08-02 JJ B-NP O
Sex NN I-NP O
: : O O
F NNP B-NP O
Service: NNP I-NP O
PROCEDURE NNP I-NP O
: : O O
Cadaveric NNP B-NP B-treatment
pancreas NNS I-NP I-treatment
transplantation NN I-NP I-treatment
. . B-VP O
   
HISTORY NNP B-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
is VBZ O O
a DT O O
37 CD O O
year NN B-NP O
old JJ B-NP O
lady NN I-NP O
with IN B-VP O
type JJ O B-problem
1 CD O I-problem
diabetes NNS B-NP I-problem
mellitus RB O I-problem
, , O O
who WP O B-person
is VBZ O O
four CD O O
months NNS B-NP O
postcadaveric JJ B-NP B-treatment
kidney NN I-NP I-treatment
transplantation NN I-NP I-treatment
and CC O O
now RB O O
has VBZ O O
good JJ B-NP O
graft NN I-NP O
function NN I-NP O
. . B-VP O
   
She PRP O B-person
presents VBZ O O
for IN B-VP O
cadaveric JJ B-NP B-treatment
pancreas JJ I-NP I-treatment
transplantation NN I-NP I-treatment
. . B-VP O
   
Her PRP$ O B-problem
Her PRP$ O B-person
diabetes NN B-NP I-problem
mellitus NN I-NP I-problem
has VBZ O O
been VBN O O
complicated VBN O O
by IN B-VP O
retinopathy NN B-NP B-problem
and CC O O
nephropathy JJ O B-problem
as RB O O
well RB O O
as IN B-VP O
peripheral JJ B-NP B-problem
neuropathy NN I-NP I-problem
. . B-VP O
   
She PRP O B-person
takes VBZ O O
14 CD O O
units NNS B-NP O
of IN B-VP O
NPH NNP B-NP B-treatment
insulin NN I-NP I-treatment
twice RB O O
a DT B-NP O
day NN I-NP O
supplementing VBG O O
with IN B-VP O
a DT O B-treatment
sliding VBG O I-treatment
scale NN B-NP I-treatment
. . B-VP O
   
PHYSICAL JJ B-NP O
EXAMINATION NN I-NP O
: : O O
On IN B-VP O
examination NN B-NP B-test
, , O O
she PRP O B-person
is VBZ O O
in IN B-VP O
no DT B-NP O
apparent JJ I-NP B-problem
distress NN I-NP I-problem
and CC O O
is VBZ O O
alert JJ O O
and CC O O
oriented JJ O O
. . B-VP O
   
Her PRP$ O B-test
Her PRP$ O B-person
chest NN B-NP I-test
and CC O I-test
cardiovascular JJ B-NP I-test
examinations NNS I-NP I-test
are VBP O O
unremarkable JJ O O
. . B-VP O
   
She PRP O B-person
is VBZ O O
afebrile JJ O B-problem
with IN B-VP O
stable JJ B-NP O
vital JJ I-NP O
signs NNS I-NP O
. . B-VP O
   
Her PRP$ O B-person
abdomen NNS B-NP O
is VBZ O O
soft JJ O O
and CC O O
nontender NN B-NP B-problem
with IN B-VP O
a DT B-NP B-problem
well NN I-NP I-problem
healed VBN O I-problem
left VBD B-VP I-problem
lower RBR O I-problem
quadrant JJ B-NP I-problem
incision NN I-NP I-problem
from IN B-VP O
her PRP$ O B-person
her PRP$ O B-treatment
kidney NN B-NP I-treatment
transplantation NN I-NP I-treatment
. . B-VP O
   
She PRP O B-person
has VBZ O O
good JJ B-NP O
femoral JJ I-NP O
pulses NNS I-NP O
bilaterally RB O O
. . B-VP O
   
HOSPITAL NNP B-NP O
COURSE NN I-NP O
: : O O
She PRP O B-person
underwent JJ B-NP O
cadaveric JJ I-NP B-treatment
pancreas NNS I-NP I-treatment
transplantation NN I-NP I-treatment
without IN B-VP O
complication NN B-NP B-problem
. . B-VP O
   
She PRP O B-person
received VBD B-VP O
induction NN B-NP B-treatment
therapy NN I-NP I-treatment
with IN B-VP O
thymoglobulin JJ O B-treatment
intraoperative JJ O O
and CC O O
postoperatively RB O O
for IN B-VP O
five CD O O
days NNS B-NP O
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
kept VBN O O
on IN B-VP O
a DT B-NP B-treatment
similar JJ I-NP I-treatment
immunosuppressive JJ I-NP I-treatment
regimen NNS I-NP I-treatment
as IN B-VP O
with IN B-VP O
her PRP$ O B-person
her PRP$ O B-treatment
kidney NN B-NP I-treatment
transplant NN I-NP I-treatment
. . B-VP O
   
She PRP O B-person
had VBD B-VP O
excellent JJ B-NP O
pancreas NNS I-NP O
graft VBP O O
function NN B-NP O
immediately RB O O
. . B-VP O
   
Her PRP$ O B-person
renal JJ B-NP O
function NN I-NP O
also RB O O
remained VBD B-VP O
stable JJ O O
in IN B-VP O
the DT B-NP O
perioperative JJ I-NP O
period NN I-NP O
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
quickly RB O O
placed VBN O O
on IN B-VP O
a DT O O
diet JJ O O
and CC O O
advanced VBD B-VP O
to TO O O
regular JJ B-NP O
diet NN I-NP O
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
discharged VBN O O
home NN B-NP O
in IN B-VP O
stable JJ B-NP O
condition NN I-NP O
on IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
six CD O O
. . B-VP O
   
CONDITION VB O O
ON NNP B-NP O
DISCHARGE NNP I-NP O
: : O O
Stable JJ O O
. . B-VP O
   
DISCHARGE JJ B-NP O
INSTRUCTIONS NN I-NP O
: : O O
She PRP O B-person
will MD O O
begin VB O O
weekly JJ B-NP O
follow-up NN I-NP O
in IN B-VP O
the DT B-NP O
Transplant NNP I-NP O
Center NNP I-NP O
. . B-VP O
   
She PRP O B-person
is VBZ O O
to TO O O
not RB O O
lift VB O O
anything NN B-NP O
greater JJR O O
than IN B-VP O
ten VB O O
pounds NNS B-NP O
for IN B-VP O
six CD O O
weeks NNS B-NP O
. . B-VP O
   
She PRP O B-person
is VBZ O O
to TO O O
continue VB O O
monitoring VBG O O
her PRP$ O B-person
her PRP$ O B-test
blood NN B-NP I-test
sugar NN I-NP I-test
twice RB O O
a DT B-NP O
day NN I-NP O
. . B-VP O
   
She PRP O B-person
has VBZ O O
undergone JJ B-NP O
full JJ I-NP O
teaching NN I-NP O
in IN B-VP O
regards NNS B-NP O
to TO O O
immunosuppressant VB O B-treatment
medications NNS B-NP I-treatment
. . B-VP O
   
In IN B-VP O
addition NN B-NP O
, , O O
she PRP O B-person
will MD O O
take VB O O
Valganciclovir NNP B-NP B-treatment
for IN B-VP O
three CD O O
months NNS B-NP O
posttransplant JJ O O
. . B-VP O
   
DISCHARGE JJ B-NP O
DIAGNOSES NNP I-NP O
: : O O
1. CD O O
Status NNP B-NP O
post NN I-NP O
cadaveric NN I-NP B-treatment
pancreas NN I-NP I-treatment
transplant NN I-NP I-treatment
. . B-VP O
   
2. CD O O
Type JJ O B-problem
1 CD O I-problem
diabetes NNS B-NP I-problem
mellitus RB O I-problem
. . B-VP O
   
3. CD O O
End NN B-NP B-problem
stage NN I-NP I-problem
renal JJ B-NP I-problem
disease NN I-NP I-problem
, , O O
status NN B-NP O
post NN I-NP O
kidney NN I-NP B-treatment
transplantation NN I-NP I-treatment
. . B-VP O
   
Dictated VBN O O
By IN B-VP O
: : O O
Jon NNP B-NP B-person
O NNP I-NP I-person
Shappy NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
MEDQUIST36 NNP I-NP O
D NNP I-NP O
: : O O
2016-11-10 JJ O O
18:28 CD O O
T NN B-NP O
: : O O
2016-11-12 JJ O O
11:51 CD O O
JOB NNP B-NP O
# # O O
: : O O
63429 CD O O
Signed VBN O O
electronically RB O O
by IN B-VP O
: : O O
DR. NNP B-NP B-person
Jacob NNP I-NP I-person
Butler NNP I-NP I-person
on IN B-VP O
: : O O
WED JJ O O
2016-11-16 JJ O O
7:45 CD O O
AM NNP B-NP O
( ( O O
End NNP B-NP O
of IN B-VP O
Report NNP B-NP O
) ) O O
-EMPTYLINE- VBP O O
-DOCSTART- JJ O O
-EMPTYLINE- $ O O
268157859 CD O O
YC NNP B-NP O
35980943 CD O O
4198660 CD O O
5/30/2005 CD O O
12:00:00 CD O O
AM NNP B-NP O
s JJ B-NP O
/ NNP I-NP O
p NN I-NP O
total JJ B-NP B-treatment
thyoidectomy NN I-NP I-treatment
DIS NNP I-NP O
Admission NNP I-NP O
Date NNP I-NP O
: : O O
05/30/2005 CD O O
Report NNP B-NP O
Status NNP I-NP O
: : O O
Discharge NN B-NP O
Date NNP I-NP O
: : O O
05/31/2005 CD O O
****** NN B-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
KOTEBITZWEERTS NNP I-NP B-person
, , O I-person
LIXYNA NNP B-NP I-person
N NNP I-NP I-person
306-08-68-0 JJ B-NP O
K78 NNP I-NP O
Room NNP I-NP O
: : O O
58W-275 JJ B-NP O
Service NNP I-NP O
: : O O
GGI NNP B-NP O
DISCHARGE NNP I-NP O
PATIENT NNP I-NP B-person
ON NNP I-NP O
: : O O
05/31/05 CD O O
AT NNP B-NP O
02:00 CD O O
PM NNP B-NP O
CONTINGENT NNP I-NP O
UPON NNP I-NP O
Not RB O O
Applicable NNP B-NP O
WILL NNP I-NP O
D NNP I-NP O
/ NNP I-NP O
C NNP I-NP O
ORDER NNP I-NP O
BE NNP I-NP O
USED NNP I-NP O
AS IN B-VP O
THE NNP B-NP O
D NNP I-NP O
/ NNP I-NP O
C NNP I-NP O
SUMMARY NNP I-NP O
: : O O
YES JJ B-NP O
Attending NN I-NP B-person
: : O O
TLAND NN B-NP B-person
, , O I-person
JR NNP B-NP I-person
, , O I-person
VOTRIBRENDEVE NNP B-NP I-person
N. NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
DISPOSITION NNP I-NP O
: : O O
Home NNP B-NP O
DISCHARGE NNP I-NP O
MEDICATIONS NNP I-NP O
: : O O
ROCALTROL NNP B-NP B-treatment
( ( O I-treatment
CALCITRIOL NNP B-NP I-treatment
) ) O I-treatment
0.5 CD O O
MCG NNP B-NP O
PO NNP I-NP O
QD NNP I-NP O
Starting VBG O O
Today NNP B-NP O
( ( O O
05/31 CD O O
) ) O O
Instructions NNS B-NP O
: : O O
Start VB O O
on IN B-VP O
day NN B-NP O
of IN B-VP O
surgery NN B-NP B-treatment
and CC O O
continue VB O O
throughout IN B-VP O
hospitalization NN B-NP O
. . B-VP O
   
SYNTHROID NNP B-NP B-treatment
( ( O I-treatment
LEVOTHYROXINE NNP B-NP I-treatment
SODIUM NNP I-NP I-treatment
) ) O I-treatment
125 CD O O
MCG NNP B-NP O
PO NNP I-NP O
QD NNP I-NP O
Instructions NNS I-NP O
: : O O
( ( O O
typical JJ B-NP O
dose NN I-NP O
is VBZ O O
1 CD O O
mcg NN B-NP O
per IN B-VP O
lb. NN B-NP O
) ) O O
OXYCODONE NNP B-NP B-treatment
5-10 JJ B-NP O
MG NNP I-NP O
PO NNP I-NP O
Q4H NNP I-NP O
PRN NNP I-NP O
Pain NNP I-NP B-problem
ADVAIR NNP I-NP B-treatment
DISKUS NNP I-NP I-treatment
100/50 CD O O
( ( O O
FLUTICASONE NNP B-NP B-treatment
PROPIONATE/... NNP I-NP I-treatment
) ) O O
1 CD O O
PUFF NNP B-NP O
INH NNP I-NP O
BID NNP I-NP O
CALCIUM NNP I-NP B-treatment
CARBONATE NNP I-NP I-treatment
2,400 CD O O
MG NNP B-NP O
PO NNP I-NP O
QID NNP I-NP O
Starting VBG O O
Today NNP B-NP O
( ( O O
05/31 CD O O
) ) O O
DIET NN B-NP O
: : O O
No DT B-NP O
Restrictions NNP I-NP O
ACTIVITY NNP I-NP O
: : O O
Resume NNP B-NP O
regular JJ B-NP O
exercise NN I-NP O
FOLLOW NNP I-NP O
UP NNP I-NP O
APPOINTMENT NNP I-NP O
( ( O O
S NNP B-NP O
) ) O O
: : O O
Dr. NNP B-NP B-person
Tland NNP I-NP I-person
, , O O
462-352-5678 JJ B-NP O
1-2 JJ I-NP O
weeks NNS I-NP O
please VB O O
call NN B-NP O
for IN B-VP O
appointment NN B-NP O
if IN B-VP O
not RB O O
made VBN O O
, , O O
ALLERGY NNP B-NP O
: : O O
NKA NNP B-NP B-problem
ADMIT NNP I-NP O
DIAGNOSIS NNP I-NP O
: : O O
total JJ B-NP B-treatment
thyroidectomy NN I-NP I-treatment
PRINCIPAL NNP I-NP O
DISCHARGE NNP I-NP O
DIAGNOSIS NNP I-NP O
; : O O
Responsible NNP B-NP O
After IN B-VP O
Study NNP B-NP O
for IN B-VP O
Causing NNP B-NP O
Admission NNP I-NP O
) ) O O
s VBD B-VP O
/ NNP B-NP O
p NN I-NP O
total JJ B-NP B-treatment
thyoidectomy NN I-NP I-treatment
OTHER NNP I-NP O
DIAGNOSIS NNP I-NP O
; : O O
Conditions NNP B-NP O
, , O O
Infections NNP B-NP O
, , O O
Complications NNP B-NP O
, , O O
affecting VBG O O
Treatment NNP B-NP O
/ NNP I-NP O
Stay NNP I-NP O
asthma IN B-VP B-problem
OPERATIONS NNP B-NP O
AND CC O O
PROCEDURES NNP B-NP O
: : O O
05/30/05 CD O O
TLAND NNP B-NP B-person
, , O I-person
JR NNP B-NP I-person
, , O I-person
VOTRIBRENDEVE NNP B-NP I-person
N. NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
TOTAL NNP I-NP B-treatment
THYROIDECTOMY NNP I-NP I-treatment
OTHER NNP I-NP O
TREATMENTS NNP I-NP O
/ NNP I-NP O
PROCEDURES NNP I-NP O
( ( O O
NOT NNP B-NP O
IN NNP I-NP O
O.R. NNP I-NP O
) ) O O
none NN B-NP O
BRIEF NNP I-NP O
RESUME NNP I-NP O
OF NNP I-NP O
HOSPITAL NNP I-NP O
COURSE NNP I-NP O
: : O O
40F CD O O
with IN B-VP O
hurtle NN B-NP B-problem
cell NN I-NP I-problem
tumor NN I-NP I-problem
of IN B-VP I-problem
thyroid NN B-NP I-problem
had VBD B-VP O
total JJ B-NP B-treatment
thyroidectomy NN I-NP I-treatment
without IN B-VP O
complication NN B-NP B-problem
. . B-VP O
   
POD# CC O O
1 CD O O
pt NN B-NP B-person
was VBD B-VP O
tolerating VBG O O
regular JJ B-NP O
diet NN I-NP O
, , O O
ambulating VBG O O
, , O O
afebrile NN B-NP B-problem
, , O O
and CC O O
calcium NN B-NP B-test
was VBD B-VP O
stable JJ O O
. . B-VP O
   
Incicsion NN B-NP B-problem
was VBD B-VP O
clean JJ O O
dry JJ O O
and CC O O
intact JJ O O
and CC O O
pt NN B-NP B-person
was VBD B-VP O
discharged VBN O O
home NN B-NP O
in IN B-VP O
stable JJ B-NP O
condition NN I-NP O
ADDITIONAL NNP I-NP O
COMMENTS NNP I-NP O
: : O O
Keep VB O O
incision NN B-NP B-problem
clean JJ O O
and CC O O
dry JJ O O
, , O O
may MD O O
shower VB O O
Wed NNP B-NP O
. . B-VP O
   
Do NNP B-NP O
not RB O O
drive VB O O
if IN B-VP O
taking VBG O O
narcotics NNS B-NP B-treatment
Call NNP I-NP O
doctor NN I-NP B-person
if IN B-VP O
fever NN B-NP B-problem
&gt; VBP O O
101.5 CD O O
, , O O
worsening VBG O B-problem
pain NN B-NP I-problem
, , O O
swelling VBG O B-problem
, , O O
or CC O O
redness NN B-NP B-problem
of IN B-VP I-problem
wound NN B-NP I-problem
, , O O
numbness NN B-NP B-problem
or CC O I-problem
tingling NN B-NP I-problem
in IN B-VP I-problem
extremities NNS B-NP I-problem
or CC O O
face NN B-NP O
or CC O O
any DT B-NP O
other JJ I-NP O
concerns NNS I-NP O
. . B-VP O
   
DISCHARGE NNP B-NP O
CONDITION NNP I-NP O
: : O O
Stable JJ B-NP O
TO NNP I-NP O
DO NNP I-NP O
/ NNP I-NP O
PLAN NNP I-NP O
: : O O
No DT B-NP O
dictated JJ I-NP O
summary NN I-NP O
ENTERED NN I-NP O
BY NNP I-NP O
: : O O
LILLETLANDTRIEV NNP B-NP B-person
, , O I-person
ROSEEN NNP B-NP I-person
ERTONDON NNP I-NP I-person
( ( O O
BZ30 NNP B-NP O
) ) O O
05/31/05 CD O O
09:05 CD O O
AM NNP B-NP O
****** JJ B-NP O
END NN I-NP O
OF NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
Admission NNP I-NP O
Date NNP I-NP O
: : O O
2018-12-04 JJ B-NP O
Discharge NN I-NP O
Date NNP I-NP O
: : O O
2018-12-12 JJ B-NP O
Date NNP I-NP O
of IN B-VP O
Birth NNP B-NP O
: : O O
1984-02-13 JJ B-NP O
Sex NN I-NP O
: : O O
F NNP B-NP O
Service NNP I-NP O
: : O O
OBSTETRICS/GYNECOLOGY JJ B-NP O
Allergies NNS I-NP O
: : O O
Ciprofloxacin NNP B-NP B-treatment
/ NNP I-NP O
Flagyl NNP I-NP B-treatment
Attending NNP I-NP B-person
: : O O
Ana NNP B-NP B-person
K NNP I-NP I-person
Warren NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
Chief NNP I-NP O
Complaint NNP I-NP O
: : O O
Pelvic NNP B-NP B-problem
organ IN B-VP I-problem
prolapse NN B-NP I-problem
Major NNP I-NP O
Surgical NNP I-NP O
or CC O O
Invasive JJ B-NP O
Procedure NN I-NP O
: : O O
total JJ B-NP B-treatment
vaginal JJ I-NP I-treatment
hysterectomy; NN I-NP I-treatment
combined VBN O O
anterior-posterior JJ B-NP B-treatment
colporrhaphy NN I-NP I-treatment
with IN B-VP O
posterior JJ B-NP B-treatment
mesh; NN I-NP I-treatment
subpubic JJ B-NP B-treatment
urethral JJ I-NP I-treatment
sling; NN I-NP I-treatment
sacrospinous JJ B-NP B-test
colpopexy NN I-NP I-test
exploratory NN I-NP I-test
laparotomy JJ B-NP I-test
Reexploration NNP I-NP B-test
of IN B-VP I-test
vaginal JJ B-NP I-test
surgical JJ I-NP I-test
area NN I-NP I-test
pelvic JJ B-NP I-test
angiography NN I-NP I-test
History NNP I-NP O
of IN B-VP O
Present NNP B-NP O
Illness NNP I-NP O
: : O O
34 CD O O
yo NNS B-NP O
G3P3 NNP I-NP O
with IN B-VP O
pelvic JJ B-NP B-problem
organ NNS I-NP I-problem
prolapse NN I-NP I-problem
after IN B-VP O
her PRP$ O B-person
second JJ B-NP O
delivery; NN I-NP O
after IN B-VP O
her PRP$ O B-person
third JJ B-NP O
delivery NN I-NP O
it PRP O B-pronoun
became VBD B-VP O
much JJ O B-problem
worse JJR O I-problem
. . B-VP O
   
She PRP O B-person
feels VBZ O O
like IN B-VP O
"everything VBG O O
is VBZ O O
falling VBG O O
out." IN B-VP O
She PRP O B-person
urinates VBZ O O
frequently RB O O
, , O O
but CC O O
occasionally RB O O
the DT B-NP O
urine NN I-NP O
is VBZ O O
very RB O B-problem
slow JJ O I-problem
to TO O I-problem
start VB O I-problem
. . B-VP O
   
She PRP O B-person
is VBZ O O
unable JJ O O
to TO O O
run VB O O
without IN B-VP O
losing VBG O O
urine NN B-NP O
. . B-VP O
   
The DT B-NP B-problem
prolapse NN I-NP I-problem
is VBZ O O
especailly RB O O
large JJ O B-problem
and CC O I-problem
uncomfotable JJ O I-problem
when WRB O O
she PRP O B-person
tries VBZ O O
to TO O O
move VB O O
her PRP$ O B-person
bowels NNS B-NP O
and CC O O
it PRP O B-pronoun
is VBZ O O
easier JJR O O
for IN B-VP O
her PRP$ O B-person
to TO O O
do VB O O
sowhile VB O O
standing VBG O O
rather RB O O
than IN B-VP O
sitting VBG O O
. . B-VP O
   
She PRP O B-person
has VBZ O O
deep JJ B-NP B-problem
pain NN I-NP I-problem
in IN B-VP O
intercourse NN B-NP O
. . B-VP O
   
Past NNP B-NP O
Medical JJ B-NP O
History NN I-NP O
: : O O
Medical NNP B-NP O
Chronic NNP I-NP B-problem
back RB O I-problem
pain NN B-NP I-problem
: : O O
several JJ B-NP B-problem
discs NNS I-NP I-problem
and CC O O
spondylolisthesis NN B-NP B-problem
Surgical NNP I-NP O
Left NNP I-NP B-treatment
salpingo VBZ O I-treatment
oophorectomy JJ O I-treatment
2002 CD O O
for IN B-VP O
torsion; NN B-NP B-problem
coloposcopy NN I-NP B-test
and CC O O
cryotherapy NN B-NP B-treatment
2001; CD O O
appendectomy; NN B-NP B-treatment
T NNP I-NP B-treatment
+ VBZ O I-treatment
A NNP B-NP I-treatment
Ob NNP I-NP O
3 CD O O
FTNDs NNP B-NP O
Social NNP I-NP O
History NNP I-NP O
: : O O
Occasional NNP B-NP O
EtOH NNP I-NP O
1ppd CD O O
tobacco NN B-NP O
Family NNP I-NP O
History NNP I-NP O
: : O O
Mother NN B-NP B-person
had VBD B-VP O
breast VBN O B-problem
cancer NN B-NP I-problem
Physical NNP I-NP O
Exam NNP I-NP O
: : O O
112 CD O O
# # O O
138/94 CD O O
Gen NNP B-NP O
: : O O
NAD JJ B-NP B-problem
Heart NNP I-NP O
: : O O
RRR NNP B-NP O
, , O O
no DT B-NP O
murmurs JJ I-NP B-problem
Lungs NNS I-NP O
: : O O
Clear JJ O O
to TO O O
percussion NN B-NP B-test
and CC O O
auscultation NN B-NP B-test
Breast NNP I-NP O
: : O O
Negative JJ B-NP O
Abdomen NNS I-NP O
: : O O
Negative JJ B-NP O
Pelvic NNP I-NP O
Ext NNP I-NP O
gen NN I-NP O
: : O O
negative JJ B-NP O
Support NN I-NP O
: : O O
Anterior NNP B-NP B-problem
wall NN I-NP I-problem
prolapses VBZ O I-problem
3 CD O O
cm NN B-NP O
past IN B-VP O
the DT B-NP O
hymen NNS I-NP O
with IN B-VP O
loss NN B-NP B-problem
of IN B-VP I-problem
urine NN B-NP I-problem
on IN B-VP I-problem
valsalva; NN B-NP I-problem
cervix NN I-NP O
1cm CD O O
above IN B-VP O
the DT B-NP O
hymen; NN I-NP O
posterior NN I-NP B-problem
prolapse NN I-NP I-problem
only RB O O
to TO O O
the DT B-NP O
hymen NNS I-NP O
but CC O O
3.4 CD O O
cm NN B-NP O
of IN B-VP O
perineal JJ B-NP B-problem
descent NN I-NP I-problem
. . B-VP O
   
Vagina NNP B-NP O
: : O O
Negative JJ B-NP O
Cervix NN I-NP O
: : O O
Negative JJ B-NP O
Uterus NN I-NP O
: : O O
Anterior NNP B-NP O
, , O O
tender NN B-NP B-problem
on IN B-VP O
motion NN B-NP O
Adnexa NNP I-NP O
: : O O
Right RB O O
not RB O O
palpable JJ O O
, , O O
left VBD B-VP O
absent JJ B-NP O
Rectal NNP I-NP O
: : O O
Neg NNP B-NP O
Pertinent NNP I-NP O
Results NNP I-NP O
: : O O
RADIOLABLED NNP B-NP B-test
RED NNP I-NP I-test
CELL NNP I-NP I-test
STUDY NNP I-NP I-test
12-05 JJ B-NP O
IMPRESSION NNP I-NP O
: : O O
No DT B-NP O
evidence NN I-NP O
of IN B-VP O
acute JJ B-NP B-problem
bleed NN I-NP I-problem
in IN B-VP I-problem
the DT B-NP I-problem
abdomen NNS I-NP I-problem
or CC O I-problem
pelvis NN B-NP I-problem
. . B-VP O
   
PELVIC NNP B-NP B-test
ARTEROGRAM NNP I-NP I-test
12-05 JJ B-NP O
FINDINGS NNP I-NP O
: : O O
Images NNS B-NP O
demonstrate VBP O O
diffusely RB O B-problem
small JJ B-NP I-problem
caliber NN I-NP I-problem
vasculature NN I-NP I-problem
consistent JJ O O
with IN B-VP O
shock NN B-NP B-problem
. . B-VP O
   
There EX O O
is VBZ O O
luminal JJ B-NP B-problem
irregularity NN I-NP I-problem
seen VBN O O
in IN B-VP O
segments NNS B-NP O
of IN B-VP O
both DT O O
the DT B-NP O
left NN I-NP O
and CC O O
right JJ B-NP O
external JJ I-NP O
iliac NN I-NP O
arteries NNS I-NP O
consistent VBP O O
with IN B-VP O
spasm NN B-NP B-problem
. . B-VP O
   
Specifically RB O O
, , O O
no DT B-NP O
extravasation NN I-NP B-problem
of IN B-VP I-problem
contrast NN B-NP I-problem
, , O O
obstruction NN B-NP B-problem
of IN B-VP I-problem
blood NN B-NP I-problem
flow NN I-NP I-problem
, , O O
AV NNP B-NP B-problem
fistulization NN I-NP I-problem
or CC O O
intimal JJ B-NP B-problem
injury NN I-NP I-problem
was VBD B-VP O
observed VBN O O
. . B-VP O
   
Thus NNP B-NP O
, , O O
no DT B-NP O
embolotherapy NN I-NP B-treatment
was VBD B-VP O
embarked VBN O O
upon IN B-VP O
. . B-VP O
   
IMPRESSION NN B-NP O
: : O O
No DT B-NP O
active JJ I-NP B-problem
bleeding NN I-NP I-problem
was VBD B-VP O
observed VBN O O
. . B-VP O
   
PATHOLOGY NNP B-NP O
uterus JJ O O
, , O O
tubes NNS B-NP O
, , O O
ovaries NNS B-NP O
12-04 VBP O O
1. CD O O
Uterus NNP B-NP O
and CC O O
cervix NN B-NP O
, , O O
hysterectomy NN B-NP B-treatment
( ( O O
A-E NNP B-NP O
): NNP I-NP O
A. NNP I-NP O
Secretory NNP I-NP B-problem
endometrium NN I-NP I-problem
. . B-VP O
   
B. NNP B-NP O
Cervix NNP I-NP O
with IN B-VP O
squamous JJ B-NP B-problem
metaplasia NN I-NP I-problem
. . B-VP O
   
C. NNP B-NP O
Unremarkable JJ B-NP O
myometrium NN I-NP O
. . B-VP O
   
D. NNP B-NP O
One CD O B-treatment
intrauterine NN B-NP I-treatment
device NN I-NP I-treatment
, , O O
gross JJ B-NP O
description NN I-NP O
. . B-VP O
   
2. CD O O
Vaginal JJ B-NP O
epithelium NN I-NP O
( ( O O
F NNP B-NP O
): NNP I-NP O
Squamous NNP I-NP B-problem
mucosa NN I-NP I-problem
and CC O O
skin NN B-NP O
with IN B-VP O
no DT B-NP O
significant JJ I-NP B-problem
pathologic JJ I-NP I-problem
change NN I-NP I-problem
. . B-VP O
   
2018-12-04 JJ O O
06:37PM CD O O
BLOOD NNP B-NP O
WBC NNP I-NP B-test
- : O O
20.0* CD O O
RBC NNP B-NP B-test
- : O O
3.31* CD O O
Hgb NNP B-NP B-test
- : O O
10.2*# CD O O
Hct NNP B-NP B-test
- : O O
31.2* CD O O
MCV NNP B-NP B-test
- : O O
95 CD O O
MCH NNP B-NP B-test
- : O O
30.9 CD O O
MCHC NNP B-NP B-test
- : O O
32.7 CD O O
RDW NNP B-NP B-test
- : O O
13.6 CD O O
Plt NNP B-NP B-test
Ct NNP I-NP I-test
- : O O
297 CD O O
2018-12-04 JJ O O
08:48PM CD O O
BLOOD NNP B-NP O
Hct NNP I-NP B-test
- : O O
19.5*# CD O O
2018-12-05 JJ O O
01:46AM CD O O
BLOOD NNP B-NP O
WBC NNP I-NP B-test
- : O O
20.0* CD O O
RBC NNP B-NP B-test
- : O O
3.96* CD O O
Hgb NNP B-NP B-test
- : O O
12.5 CD O O
Hct NNP B-NP B-test
- : O O
34.4*# CD O O
MCV NNP B-NP B-test
- : O O
87# CD O O
MCH NNP B-NP B-test
- : O O
31.5 CD O O
MCHC NNP B-NP B-test
- : O O
36.4*# CD O O
RDW NNP B-NP B-test
- : O O
13.6 CD O O
Plt NNP B-NP B-test
Ct NNP I-NP I-test
- : O O
89*# CD O O
2018-12-05 JJ O O
09:45AM CD O O
BLOOD NNP B-NP O
WBC NNP I-NP B-test
- : O O
12.7* CD O O
RBC NNP B-NP B-test
- : O O
3.17* CD O O
Hgb NNP B-NP B-test
- : O O
9.9* CD O O
Hct NNP B-NP B-test
- : O O
27.6* CD O O
MCV NNP B-NP B-test
- : O O
87 CD O O
MCH NNP B-NP B-test
- : O O
31.3 CD O O
MCHC NNP B-NP B-test
- : O O
35.9* CD O O
RDW NNP B-NP B-test
- : O O
14.2 CD O O
Plt NNP B-NP B-test
Ct NNP I-NP I-test
- : O O
104* CD O O
2018-12-06 JJ O O
04:09AM CD O O
BLOOD NNP B-NP O
WBC NNP I-NP B-test
- : O O
12.1* CD O O
RBC NNP B-NP B-test
- : O O
3.73* CD O O
Hgb NNP B-NP B-test
- : O O
11.3* CD O O
Hct NNP B-NP B-test
- : O O
31.5* CD O O
MCV NNP B-NP B-test
- : O O
84 CD O O
MCH NNP B-NP B-test
- : O O
30.2 CD O O
MCHC NNP B-NP B-test
- : O O
35.8* CD O O
RDW NNP B-NP B-test
- : O O
15.4 CD O O
Plt NNP B-NP B-test
Ct NNP I-NP I-test
- : O O
91* CD O O
2018-12-07 JJ O O
12:15AM CD O O
BLOOD NNP B-NP O
Hct NNP I-NP B-test
- : O O
28.7* CD O O
2018-12-08 JJ O O
06:30AM CD O O
BLOOD NNP B-NP O
Hct NNP I-NP B-test
- : O O
27.9* CD O O
2018-12-10 JJ O O
04:45AM CD O O
BLOOD NNP B-NP O
WBC NNP I-NP B-test
- : O O
12.6* CD O O
RBC NNP B-NP B-test
- : O O
3.53* CD O O
Hgb NNP B-NP B-test
- : O O
10.5* CD O O
Hct NNP B-NP B-test
- : O O
30.1* CD O O
MCV NNP B-NP B-test
- : O O
85 CD O O
MCH NNP B-NP B-test
- : O O
29.8 CD O O
MCHC NNP B-NP B-test
- : O O
35.0 CD O O
RDW NNP B-NP B-test
- : O O
14.6 CD O O
Plt NNP B-NP B-test
Ct NNP I-NP I-test
- : O O
308# CD O O
2018-12-04 JJ O O
06:37PM CD O O
BLOOD NNP B-NP O
PT NNP I-NP B-test
- : O O
13.0 CD O O
PTT NNP B-NP B-test
- : O O
26.1 CD O O
INR NNP B-NP B-test
( ( O O
PT NNP B-NP B-test
) ) O O
- : O O
1.1 CD O O
2018-12-05 JJ O O
02:03PM CD O O
BLOOD NNP B-NP O
PT NNP I-NP B-test
- : O O
13.2* CD O O
PTT NNP B-NP B-test
- : O O
24.2 CD O O
INR NNP B-NP B-test
( ( O O
PT NNP B-NP B-test
) ) O O
- : O O
1.1 CD O O
2018-12-06 JJ O O
04:09AM CD O O
BLOOD NNP B-NP O
PT NNP I-NP B-test
- : O O
11.6 CD O O
PTT NNP B-NP B-test
- : O O
23.8 CD O O
INR NNP B-NP B-test
( ( O O
PT NNP B-NP B-test
) ) O O
- : O O
1.0 CD O O
2018-12-04 JJ O O
06:37PM CD O O
BLOOD NNP B-NP O
Glucose NNP I-NP B-test
- : O O
146* CD O O
UreaN NNP B-NP B-test
- : O O
12 CD O O
Creat NNP B-NP B-test
- : O O
0.6 CD O O
Na NNP B-NP B-test
- : O O
140 CD O O
K NNP B-NP B-test
- : O O
4.1 CD O O
Cl NNP B-NP B-test
- : O O
108 CD O O
HCO3 NNP B-NP B-test
- : O O
21* CD O O
AnGap NNP B-NP B-test
- : O O
15 CD O O
2018-12-06 JJ O O
04:09AM CD O O
BLOOD NNP B-NP O
Glucose NNP I-NP B-test
- : O O
96 CD O O
UreaN NNP B-NP B-test
- : O O
5* CD O O
Creat NNP B-NP B-test
- : O O
0.4 CD O O
Na NNP B-NP B-test
- : O O
139 CD O O
K NNP B-NP B-test
- : O O
3.1* CD O O
Cl NNP B-NP B-test
- : O O
108 CD O O
HCO3 NNP B-NP B-test
- : O O
26 CD O O
AnGap NNP B-NP B-test
- : O O
8 CD O O
2018-12-08 JJ O O
09:20PM CD O O
BLOOD NNP B-NP O
UreaN NNP I-NP B-test
- : O O
4* CD O O
Creat NNP B-NP B-test
- : O O
0.3* CD O O
Na NNP B-NP B-test
- : O O
140 CD O O
K NNP B-NP B-test
- : O O
4.0 CD O O
Cl NNP B-NP B-test
- : O O
108 CD O O
HCO3 NNP B-NP B-test
- : O O
27 CD O O
AnGap NNP B-NP B-test
- : O O
9 CD O O
2018-12-04 JJ O O
06:37PM CD O O
BLOOD NNP B-NP O
Calcium NNP I-NP B-test
- : O O
7.9* CD O O
Phos NNP B-NP B-test
- : O O
4.5 CD O O
Mg NNP B-NP B-test
- : O O
1.5* CD O O
2018-12-06 JJ O O
01:03PM CD O O
BLOOD NNP B-NP O
Calcium NNP I-NP B-test
- : O O
7.3* CD O O
Phos NNP B-NP B-test
- : O O
2.3* CD O O
Mg NNP B-NP B-test
- : O O
1.7 CD O O
2018-12-07 JJ O O
06:30AM CD O O
BLOOD NNP B-NP O
Calcium NNP I-NP B-test
- : O O
7.5* CD O O
Mg NNP B-NP B-test
- : O O
1.6 CD O O
2018-12-08 JJ O O
09:20PM CD O O
BLOOD NNP B-NP O
Calcium NNP I-NP B-test
- : O O
7.5* CD O O
Phos NNP B-NP B-test
- : O O
2.7 CD O O
Mg NNP B-NP B-test
- : O O
1.9 CD O O
2018-12-04 JJ O O
10:53PM CD O O
BLOOD NNP B-NP O
Type NNP I-NP O
- : O O
ART NNP B-NP O
pO2 VBZ O B-test
- : O O
229* CD O O
pCO2 NN B-NP B-test
- : O O
44 CD O O
pH NN B-NP B-test
- : O O
7.26* CD O O
calTCO2 NN B-NP B-test
- : O O
21 CD O O
Base NNP B-NP B-test
XS NNP I-NP I-test
- : O O
-6 NN B-NP O
Intubat NNP I-NP O
- : O O
INTUBATED NNP B-NP O
Vent NNP I-NP O
- : O O
CONTROLLED VBD B-VP O
2018-12-05 JJ O O
09:09AM CD O O
BLOOD NNP B-NP O
Type NNP I-NP O
- : O O
ART NNP B-NP O
Temp NNP I-NP B-test
- : O O
37.2 CD O O
Rates NNPS B-NP B-test
- : O O
/12 NN B-NP O
Tidal NNP I-NP B-test
V NNP I-NP I-test
- : O O
560 CD O O
PEEP NNP B-NP B-test
- : O O
5 CD O O
FiO2 NNP B-NP B-test
- : O O
50 CD O O
pO2 NN B-NP B-test
- : O O
176* CD O O
pCO2 NN B-NP B-test
- : O O
42 CD O O
pH NN B-NP B-test
- : O O
7.35 CD O O
calTCO2 NN B-NP B-test
- : O O
24 CD O O
Base NNP B-NP B-test
XS NNP I-NP I-test
- : O O
-2 NN B-NP O
Intubat NNP I-NP O
- : O O
INTUBATED NNP B-NP O
Vent NNP I-NP O
- : O O
SPONTANEOU NNP B-NP O
Brief NNP I-NP O
Hospital NNP I-NP O
Course NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
taken VBN O O
to TO O O
the DT B-NP O
operating NN I-NP O
room NN I-NP O
on IN B-VP O
2018-12-04 JJ O O
for IN B-VP O
TVH NNP B-NP B-treatment
, , O O
sacrospinous JJ B-NP B-treatment
fixation NN I-NP I-treatment
, , O O
SPARC NNP B-NP B-treatment
, , O O
anterior RB O B-treatment
and CC O I-treatment
posterior JJ B-NP I-treatment
repair NN I-NP I-treatment
with IN B-VP I-treatment
mesh NN B-NP I-treatment
, , O O
cystoscopy; NN B-NP B-test
for IN B-VP O
pelvic JJ B-NP B-problem
organ JJ I-NP I-problem
prolapse NN I-NP I-problem
. . B-VP O
   
There EX O O
were VBD B-VP O
no DT B-NP O
intraoperative JJ I-NP B-problem
complications NNS I-NP I-problem
and CC O O
the DT B-NP O
surgical JJ I-NP O
field NN I-NP O
was VBD B-VP O
hemostatic JJ O O
at IN B-VP O
the DT B-NP O
conclusion NN I-NP O
of IN B-VP O
the DT B-NP O
case NN I-NP O
( ( O O
see VB O O
operative JJ B-NP O
report NN I-NP O
for IN B-VP O
full JJ B-NP O
description NN I-NP O
) ) O O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
tolerated VBD B-VP O
the DT B-NP B-treatment
procedure NN I-NP I-treatment
well RB O O
and CC O O
was VBD B-VP O
stable JJ O O
in IN B-VP O
the DT B-NP O
PACU NNP I-NP O
and CC O O
admitted VBN O O
to TO O O
the DT B-NP O
CMED NNP I-NP O
CCU NNP I-NP O
floor NN I-NP O
for IN B-VP O
routine JJ B-NP B-treatment
care NN I-NP I-treatment
. . B-VP O
   
At IN B-VP O
1645 CD O O
12-04 JJ O O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
noted VBN O O
to TO O O
be VB O O
hypotensive JJ O B-problem
to TO O O
70/40 CD O O
HR NNP B-NP B-test
84 CD O O
with IN B-VP O
symptoms NNS B-NP B-problem
of IN B-VP I-problem
lightheadedness NN B-NP I-problem
while IN B-VP O
lying VBG O O
supine NN B-NP O
. . B-VP O
   
There EX O O
was VBD B-VP O
no DT B-NP O
active JJ I-NP B-problem
bleeding NN I-NP I-problem
noted VBD B-VP O
at IN B-VP O
the DT B-NP O
surgical JJ I-NP O
site NN I-NP O
on IN B-VP O
examination NN B-NP B-test
. . B-VP O
   
A DT B-NP B-test
STAT NNP I-NP I-test
HCT NNP I-NP I-test
drawn NN I-NP O
at IN B-VP O
this DT B-NP B-pronoun
time NN I-NP O
was VBD B-VP O
31.2 CD O O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
re-evalutated VBN O O
at IN B-VP O
2000 CD O O
and CC O O
was VBD B-VP O
found VBN O O
to TO O O
be VB O O
tacchycardic JJ O B-problem
to TO O O
115 CD O O
with IN B-VP O
BP NNP B-NP B-test
104/50 CD O O
using VBG O O
a DT B-NP O
manual JJ I-NP O
cuff NN I-NP O
. . B-VP O
   
Urine NNP B-NP B-test
output NN I-NP I-test
during IN B-VP O
the DT O O
prior JJ O O
two CD O O
hours NNS B-NP O
had VBD B-VP O
been VBN O O
50cc CD O O
and CC O O
24cc CD O O
. . B-VP O
   
A DT B-NP B-test
STAT NNP I-NP I-test
HCT NNP I-NP I-test
drawn NN I-NP O
at IN B-VP O
this DT B-NP B-pronoun
time NN I-NP O
was VBD B-VP O
19.5 CD O O
. . B-VP O
   
The DT B-NP O
clinical JJ I-NP O
picture NN I-NP O
was VBD B-VP O
concerning VBG O O
for IN B-VP O
a DT B-NP B-problem
post-operative JJ I-NP I-problem
hematoma NN I-NP I-problem
. . B-VP O
   
The DT B-NP O
ICU NNP I-NP O
was VBD B-VP O
alerted VBN O O
to TO O O
the DT B-NP B-person
patient NN I-NP I-person
's POS O O
disposition NN B-NP O
and CC O O
the DT B-NP O
operating NN I-NP O
room NN I-NP O
was VBD B-VP O
activated VBN O O
for IN B-VP O
urgent JJ B-NP B-test
re-exploration NN I-NP I-test
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
taken VBN O O
to TO O O
the DT B-NP O
OR NNP I-NP O
on IN B-VP O
POD#0 NNP B-NP O
for IN B-VP O
re-exploration NN B-NP B-test
with IN B-VP I-test
incision NN B-NP I-test
at IN B-VP O
2243 CD O O
. . B-VP O
   
Exploratory NNP B-NP B-test
laparotomy NN I-NP I-test
revealed VBD B-VP O
hemoperitonium NN B-NP B-problem
and CC O O
approximately RB O O
1 CD O O
L NNP B-NP O
of IN B-VP O
blood NN B-NP B-problem
was VBD B-VP O
evacuated VBN O O
. . B-VP O
   
There EX O O
was VBD B-VP O
approximately RB O O
500cc CD O O
of IN B-VP O
retroperitoneal NN B-NP B-problem
clot NN I-NP I-problem
. . B-VP O
   
Despite IN B-VP O
laparotomy JJ O B-test
and CC O O
re-exploration NN B-NP B-test
through IN B-VP I-test
the DT B-NP I-test
vaginal JJ I-NP I-test
cuff NN I-NP I-test
, , O O
no DT B-NP O
source NN I-NP O
for IN B-VP O
the DT B-NP B-problem
bleeding NN I-NP I-problem
could MD O O
be VB O O
found VBN O O
. . B-VP O
   
At IN B-VP O
the DT B-NP O
conclusion NN I-NP O
of IN B-VP O
the DT B-NP O
case NN I-NP O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
continued VBD B-VP O
to TO O O
bleed VB O O
, , O O
allbeit VB O O
at IN B-VP O
a DT B-NP O
less JJR I-NP O
brisk JJ I-NP O
pace NN I-NP O
. . B-VP O
   
The DT B-NP B-treatment
endotracheal JJ I-NP I-treatment
tube NN I-NP I-treatment
was VBD B-VP O
left VBN O O
in IN B-VP O
place NN B-NP O
. . B-VP O
   
Intraoperatively RB O O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
recieved VBD B-VP O
5u CD O O
PRBC NNP B-NP B-treatment
. . B-VP O
   
IR NNP B-NP B-person
was VBD B-VP O
consulted VBN O O
to TO O O
identify VB O O
the DT B-NP B-problem
bleeding NN I-NP I-problem
vessel NN I-NP I-problem
with IN B-VP O
angiography NN B-NP B-test
, , O O
then RB O O
perform VB O O
embolization NN B-NP B-treatment
. . B-VP O
   
Tagged VBN O B-test
cell NN B-NP I-test
and CC O I-test
angiographic JJ B-NP I-test
studies NNS I-NP I-test
performed VBD B-VP O
immediately RB O O
after IN B-VP O
re-exploration NN B-NP B-test
on IN B-VP O
12-05 NNS B-NP O
did VBD B-VP O
not RB O O
indetify VB O O
active JJ B-NP B-problem
bleeding NN I-NP I-problem
and CC O O
no DT B-NP O
emobolization NN I-NP B-treatment
was VBD B-VP O
indicated VBN O O
. . B-VP O
   
THe NNP B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
stable JJ O O
and CC O O
remained VBD B-VP O
intubated VBN O B-problem
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
admitted VBN O O
to TO O O
the DT B-NP O
ICU NNP I-NP O
for IN B-VP O
further JJ B-NP B-treatment
care NN I-NP I-treatment
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
's POS O O
ICU NNP B-NP O
course NN I-NP O
was VBD B-VP O
uneventful JJ O O
. . B-VP O
   
There EX O O
was VBD B-VP O
no DT B-NP O
evidence NN I-NP O
of IN B-VP O
continued JJ B-NP O
bleeding NN I-NP B-problem
and CC O O
her PRP$ O B-person
her PRP$ O B-test
HCT NNP B-NP I-test
remained VBD B-VP O
stable JJ O O
around IN B-VP O
30 CD O O
. . B-VP O
   
The DT O B-person
pt JJ O I-person
self-extubated JJ O O
on IN B-VP O
POD NNP B-NP O
#1 NNP I-NP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
developed VBD B-VP O
a DT B-NP B-problem
low JJ I-NP I-problem
grade NN I-NP I-problem
fever NN I-NP I-problem
to TO O O
100.1 CD O O
on IN B-VP O
POD#1 NNP B-NP O
which WDT O B-pronoun
persisted VBD B-VP O
to TO O O
POD#2 NNP B-NP O
and CC O O
imperic JJ B-NP B-treatment
treatment NN I-NP I-treatment
with IN B-VP O
gent/clinda NN B-NP B-treatment
was VBD B-VP O
started VBN O O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
stable JJ O O
for IN B-VP O
transfer NN B-NP O
to TO O O
the DT B-NP O
CMED NNP I-NP O
floor NN I-NP O
on IN B-VP O
POD#3 NNP B-NP O
. . B-VP O
   
Antibiotics NNPS B-NP B-treatment
were VBD B-VP O
discontinued VBN O O
on IN B-VP O
POD#8 NNP B-NP O
and CC O O
pt NN B-NP O
remained VBD B-VP O
afebrile JJ O B-problem
thereafter RB O O
. . B-VP O
   
On IN B-VP O
POD#9 NNP B-NP O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
afebrile RB O B-problem
, , O O
tolerating VBG O O
a DT B-NP O
regular JJ I-NP O
diet NN I-NP O
, , O O
ambultating VBG O O
without IN B-VP O
difficulty NN B-NP B-problem
and CC O O
voiding VBG O O
spontaneously RB O O
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
discharged VBN O O
home NN B-NP O
with IN B-VP O
follow-up JJ O O
in IN B-VP O
two CD O O
weeks NNS B-NP O
. . B-VP O
   
Medications NNS B-NP O
on IN B-VP O
Admission NN B-NP O
: : O O
Zoloft JJ O B-treatment
100mg CD O O
QD NNP B-NP O
Ritalin NNP I-NP B-treatment
0.5mg CD O O
BID NNP B-NP O
Loraze3pam NNP I-NP B-treatment
0.5mg CD O O
BID NNP B-NP O
Percocet NNP I-NP B-treatment
5/325 CD O O
QHS NNP B-NP O
Allergies NNPS I-NP O
: : O O
Cipro NNP B-NP B-treatment
, , O O
Flagyl NNP B-NP B-treatment
Discharge NNP I-NP O
Medications NNP I-NP O
: : O O
1. CD O O
Ibuprofen NNP B-NP B-treatment
600 CD O O
mg NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Tablet NNP B-NP O
PO NNP I-NP O
Q6H NNP I-NP O
( ( O O
every DT O O
6 CD O O
hours NNS B-NP O
) ) O O
as IN B-VP O
needed VBN O O
. . B-VP O
   
Disp NN B-NP O
: : O O
*60 JJ B-NP O
Tablets* NNP I-NP O
Refills NNP I-NP O
: : O O
*1* JJ O O
2. CD O O
Oxycodone-Acetaminophen JJ B-NP B-treatment
5-325 JJ I-NP O
mg NN I-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
1-2 JJ B-NP O
Tablets NNS I-NP O
PO NNP I-NP O
Q4-6H NNP I-NP O
( ( O O
every DT O O
4 CD O O
to TO O O
6 CD O O
hours NNS B-NP O
) ) O O
as IN B-VP O
needed VBN O O
. . B-VP O
   
Disp NN B-NP O
: : O O
*60 JJ B-NP O
Tablet( NNP I-NP O
s NN I-NP O
)* NNP I-NP O
Refills NNP I-NP O
: : O O
*0* NN B-NP O
3. CD O O
Docusate NNP B-NP B-treatment
Sodium NNP I-NP I-treatment
100 CD O O
mg NN B-NP O
Capsule NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Capsule NNP B-NP O
PO NNP I-NP O
BID NNP I-NP O
( ( O O
2 CD O O
times NNS B-NP O
a DT B-NP O
day NN I-NP O
) ) O O
. . B-VP O
   
Disp NN B-NP O
: : O O
*60 JJ B-NP O
Capsule( NNP I-NP O
s NN I-NP O
)* NNP I-NP O
Refills NNP I-NP O
: : O O
*2* NN B-NP O
Continue NNP I-NP O
home NN I-NP B-treatment
meds NNS I-NP I-treatment
. . B-VP O
   
Discharge NNP B-NP O
Disposition NNP I-NP O
: : O O
Home NNP B-NP O
Discharge NNP I-NP O
Diagnosis NNP I-NP O
: : O O
pelvic JJ O B-problem
organ MD O I-problem
prolapse VB O I-problem
stress NN B-NP B-problem
urinary JJ B-NP I-problem
incontinence NN I-NP I-problem
retroperitoneal NN I-NP B-problem
bleed NN I-NP I-problem
hemoperitoneum NN I-NP I-problem
Discharge NNP I-NP O
Condition NNP I-NP O
: : O O
stable JJ B-NP O
Discharge NN I-NP O
Instructions NNS I-NP O
: : O O
No DT B-NP O
heavy JJ I-NP O
lifting NN I-NP O
for IN B-VP O
6 CD O O
weeks NNS B-NP O
No DT B-NP O
abdominal JJ I-NP O
exercises NNS I-NP O
for IN B-VP O
6 CD O O
weeks NNS B-NP O
Nothing NN I-NP O
in IN B-VP O
the DT B-NP O
vagina NN I-NP O
for IN B-VP O
6 CD O O
weeks NNS B-NP O
Keep NNP I-NP O
stools NNS I-NP O
soft JJ B-NP O
Followup NNP I-NP O
Instructions NNS I-NP O
: : O O
Please VB O O
call VB O O
Dr. NNP B-NP B-person
Lewis NNP I-NP I-person
office NN I-NP O
for IN B-VP O
an DT B-NP O
appointment NN I-NP O
in IN B-VP O
2 CD O O
weeks NNS B-NP O
. . B-VP O
   
Adam NNP B-NP B-person
Saundra NNP I-NP I-person
MD NNP I-NP I-person
46-863 JJ O O
Completed VBN O O
by IN B-VP O
: : O O
Michael NNP B-NP B-person
KNIGHT NNP I-NP I-person
MD NNP I-NP I-person
21-317 JJ B-NP O
2018-12-16 JJ I-NP O
@ NN I-NP O
1245 CD O O
Signed NNP B-NP O
electronically RB O O
by IN B-VP O
: : O O
DR. NNP B-NP B-person
Wanda NNP I-NP I-person
Detz NNP I-NP I-person
on IN B-VP O
: : O O
TUE NNP B-NP O
2018-12-18 CD O O
8:13 CD O O
AM NNP B-NP O
( ( O O
End NNP B-NP O
of IN B-VP O
Report NNP B-NP O
) ) O O
-EMPTYLINE- VBP O O
-DOCSTART- JJ B-NP O
-EMPTYLINE- NNP I-NP O
Admission NNP I-NP O
Date NNP I-NP O
: : O O
2014-10-21 JJ B-NP O
Discharge NN I-NP O
Date NNP I-NP O
: : O O
2014-11-21 JJ B-NP O
Date NNP I-NP O
of IN B-VP O
Birth NNP B-NP O
: : O O
1942-03-10 JJ B-NP O
Sex NN I-NP O
: : O O
M NNP B-NP O
Service NNP I-NP O
: : O O
SURGERY JJ B-NP O
Allergies NNS I-NP O
: : O O
Iodine NNP B-NP B-treatment
; : O O
Iodine NNP B-NP B-treatment
Containing NNP I-NP I-treatment
Attending NNP I-NP O
: : O O
Dona NNP B-NP B-person
J. NNP I-NP I-person
O. NNP I-NP I-person
Anderson NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
Chief NNP I-NP O
Complaint NNP I-NP O
: : O O
s/p NN B-NP O
Fall NNP I-NP O
Major NNP I-NP O
Surgical NNP I-NP O
or CC O O
Invasive JJ B-NP O
Procedure NN I-NP O
: : O O
Tracheostomy JJ B-NP B-treatment
2014-11-11 JJ I-NP O
Bronchoscopy NNP I-NP B-test
2014-11-05 CD O O
Past NNP B-NP O
Medical NNP I-NP O
History NN I-NP O
: : O O
Atrial JJ B-NP B-problem
fibrillation NN I-NP I-problem
( ( O O
on IN B-VP O
Coumadin NNP B-NP B-treatment
) ) O O
Coronary NNP B-NP B-problem
Artery NNP I-NP I-problem
Disease NNP I-NP I-problem
Ulcerative NNP I-NP B-problem
Colitis NNP I-NP I-problem
w/ VBD B-VP O
colostomy JJ B-NP B-treatment
Hypertension NNP I-NP B-problem
Pacemaker NNP I-NP B-treatment
CVA NNP I-NP B-problem
2012 CD O O
w/ NN B-NP O
right RB O B-problem
sided VBD B-VP I-problem
weakness NN B-NP I-problem
Cataracts NNPS I-NP B-problem
, , O O
s/p VB O O
cataract NN B-NP B-treatment
surgery NN I-NP I-treatment
s/p NN I-NP O
TURP NNP I-NP B-treatment
Social NNP I-NP O
History NNP I-NP O
: : O O
Lives VBZ O O
with IN B-VP O
wife NN B-NP O
; : O O
+ETOH CC O O
use VB O O
Family JJ B-NP O
History NN I-NP O
: : O O
Noncontributory JJ B-NP O
Pertinent JJ I-NP O
Results NNS I-NP O
: : O O
2014-10-21 JJ O O
08:10 CD O O
PM NNP B-NP O
GLUCOSE NNP I-NP B-test
- : O O
126 CD O O
* JJ B-NP O
UREA NNP I-NP B-test
N NNP I-NP I-test
- : O O
9 CD O O
CREAT NNP B-NP B-test
- : O O
0.8 CD O O
SODIUM NNP B-NP B-test
- : O O
135 CD O O
POTASSIUM NNP B-NP B-test
- : O O
3.4 CD O O
CHLORIDE NNP B-NP B-test
- : O O
99 CD O O
TOTAL NNP B-NP B-test
CO2 NNP I-NP I-test
- : O O
25 CD O O
ANION NNP B-NP B-test
GAP NNP I-NP I-test
- : O O
14 CD O O
2014-10-21 JJ O O
08:10 CD O O
PM NNP B-NP O
CALCIUM NNP I-NP B-test
- : O O
8.2 CD O O
* NN B-NP O
PHOSPHATE NNP I-NP B-test
- : O O
2.1 CD O O
* JJ B-NP O
MAGNESIUM NNP I-NP B-test
- : O O
1.9 CD O O
2014-10-21 JJ O O
08:10 CD O O
PM NNP B-NP O
WBC NNP I-NP B-test
- : O O
6.5 CD O O
RBC NNP B-NP B-test
- : O O
3.68 CD O O
* NN B-NP O
HGB NNP I-NP B-test
- : O O
11.6 CD O O
* NN B-NP O
HCT NNP I-NP B-test
- : O O
32.5 CD O O
* NN B-NP O
MCV NNP I-NP B-test
- : O O
88 CD O O
MCH NNP B-NP B-test
- : O O
31.5 CD O O
MCHC NNP B-NP B-test
- : O O
35.6 CD O O
* NN B-NP O
RDW NNP I-NP B-test
- : O O
13.6 CD O O
2014-10-21 JJ O O
08:10 CD O O
PM NNP B-NP O
PLT NNP I-NP B-test
COUNT NNP I-NP I-test
- : O O
207 CD O O
2014-10-21 JJ O O
08:10 CD O O
PM NNP B-NP O
PT NNP I-NP B-test
- : O O
15.0 CD O O
* NN B-NP O
PTT NNP I-NP B-test
- : O O
31.3 CD O O
INR(PT) NNP B-NP B-test
- : O O
1.5 CD O O
2014-10-21 JJ O O
02:56 CD O O
PM NNP B-NP O
TYPE NNP I-NP O
- : O O
ART NNP B-NP O
TEMP NNP I-NP B-test
- : O O
36.6 CD O O
RATES NNPS B-NP B-test
- : O O
14 CD O O
/ JJ B-NP O
TIDAL NNP I-NP B-test
VOL NNP I-NP I-test
- : O O
550 CD O O
PEEP NNP B-NP B-treatment
- : O O
5 CD O O
O2 NNP B-NP B-treatment
- : O O
100 CD O O
PO2 NNP B-NP B-test
- : O O
416 CD O O
* NN B-NP O
PCO2 NNP I-NP B-test
- : O O
39 CD O O
PH NNP B-NP B-test
- : O O
7.41 CD O O
TOTAL NNP B-NP B-test
CO2 NNP I-NP I-test
- : O O
26 CD O O
BASE NNP B-NP B-test
XS NNP I-NP I-test
- : O O
0 CD O O
AADO2 NNP B-NP B-test
- : O O
279 CD O O
REQ NNP B-NP B-test
O2 NNP I-NP I-test
- : O O
52 CD O O
- : O O
ASSIST NNP B-NP B-treatment
/ NNP I-NP I-treatment
CON NNP I-NP I-treatment
INTUBATED NNP I-NP O
- : O O
INTUBATED NNP B-NP O
2014-10-21 JJ O O
09:35 CD O O
AM NNP B-NP O
ASA NNP I-NP B-test
- : O O
NEG NNP B-NP O
ETHANOL NNP I-NP B-test
- : O O
NEG NNP B-NP O
ACETMNPHN NNP I-NP B-test
- : O O
NEG NNP B-NP O
bnzodzpn SYM O B-test
- : O O
NEG NNP B-NP O
barbitrt SYM O B-test
- : O O
NEG NNP B-NP O
tricyclic JJ O B-test
- : O O
NEG NNP B-NP O
2014-10-21 JJ O O
09:35 CD O O
AM NNP B-NP O
URINE NNP I-NP B-test
bnzodzpn SYM O B-test
- : O O
NEG NNP B-NP O
barbitrt SYM O B-test
- : O O
NEG NN B-NP O
opiates VBZ O B-test
- : O O
NEG NNP B-NP O
cocaine NN I-NP B-test
- : O O
NEG NNP B-NP O
amphetmn SYM O B-test
- : O O
NEG NNP B-NP O
mthdone SYM O B-test
- : O O
NEG NNP B-NP O
CT NNP I-NP B-test
C NNP I-NP I-test
- : O I-test
SPINE NNP B-NP I-test
W/O NNP I-NP I-test
CONTRAST NNP I-NP I-test
2014-10-21 JJ O O
9:59 CD O O
AM NNP B-NP O
CT NNP I-NP B-test
C NNP I-NP I-test
- : O I-test
SPINE NNP B-NP I-test
W/O NNP I-NP I-test
CONTRAST NNP I-NP I-test
; : O O
CT NNP B-NP O
RECONSTRUCTION NNP I-NP O
Reason NNP I-NP O
: : O O
72 CD O B-person
male NN B-NP I-person
s/p NN I-NP O
fall VBP O O
down RB O O
20 CD O O
stairs NNS B-NP O
UNDERLYING NNP I-NP O
MEDICAL NNP I-NP O
CONDITION NNP I-NP O
: : O O
72 CD O B-person
year NN B-NP I-person
old JJ B-NP I-person
man NN I-NP I-person
with IN B-VP O
REASON NNP B-NP O
FOR NNP I-NP O
THIS NNP I-NP B-pronoun
THIS NNP I-NP B-test
EXAMINATION NNP I-NP I-test
: : O O
72 CD O B-person
male NN B-NP I-person
s/p NN I-NP O
fall VBP O O
down RB O O
20 CD O O
stairs JJ B-NP O
CONTRAINDICATIONS NNP I-NP O
for IN B-VP O
IV NNP B-NP O
CONTRAST NNP I-NP O
: : O O
None NN B-NP O
. . B-VP O
   
INDICATIONS NN B-NP O
: : O O
Fall NNP B-NP O
down RB O O
20 CD O O
stairs NNS B-NP O
. . B-VP O
   
TECHNIQUE NN B-NP O
: : O O
Noncontrast NNP B-NP B-test
cervical JJ B-NP I-test
spine NN I-NP I-test
CT NNP I-NP I-test
. . B-VP O
   
COMPARISON NN B-NP O
: : O O
None NN B-NP O
. . B-VP O
   
NOTE NN B-NP O
: : O O
This DT B-NP B-test
study NN I-NP I-test
was VBD B-VP O
initially RB O O
performed VBN O O
on IN B-VP O
2014-10-21 JJ O O
. . B-VP O
   
Findings NNS B-NP O
were VBD B-VP O
discussed VBN O O
with IN B-VP O
Dr. NNP B-NP B-person
Leanne NNP I-NP I-person
Vazquez NNP I-NP I-person
at IN B-VP O
the DT B-NP O
time NN I-NP O
this DT O B-pronoun
this DT B-NP B-test
study NN I-NP I-test
was VBD B-VP O
performed VBN O O
, , O O
but CC O O
the DT B-NP B-test
study NN I-NP I-test
was VBD B-VP O
not RB O O
dictated VBN O O
until IN B-VP O
the DT B-NP O
morning NN I-NP O
of IN B-VP O
2014-10-22 JJ O O
, , O O
due JJ O O
to TO O O
PACS NNP B-NP O
malfunction NN I-NP O
. . B-VP O
   
NONCONTRAST NNP B-NP B-test
CERVICAL NNP I-NP I-test
SPINE NNP I-NP I-test
CT NNP I-NP I-test
: : O O
There EX O O
are VBP O O
minimally RB O B-problem
displaced VBN O I-problem
and CC O I-problem
comminuted VBN O I-problem
fractures NNS B-NP I-problem
through IN B-VP I-problem
the DT B-NP I-problem
left JJ I-NP I-problem
C7 NNP I-NP I-problem
and CC O I-problem
T1 NNP B-NP I-problem
transverse NN I-NP I-problem
processes VBZ O I-problem
. . B-VP O
   
The DT B-NP O
margins NNS I-NP O
do VBP O O
not RB O O
appear VB O O
to TO O O
extend VB O O
into IN B-VP O
the DT B-NP O
foramina JJ I-NP O
transversaria NN I-NP O
. . B-VP O
   
Positioning VBG O O
limits JJ B-NP O
assessment NN I-NP B-test
of IN B-VP I-test
alignment NN B-NP I-test
due JJ O O
to TO O O
extreme JJ B-NP B-problem
head NN I-NP I-problem
tilting VBG O I-problem
to TO O I-problem
the DT B-NP I-problem
right NN I-NP I-problem
, , O O
but CC O O
this DT O B-pronoun
is VBZ O O
likely JJ O O
the DT O O
best JJS O O
obtainable JJ O O
secondary JJ O O
to TO O O
intubation NN B-NP B-treatment
and CC O O
nasogastric JJ B-NP B-treatment
tube NN I-NP I-treatment
placement NN I-NP I-treatment
. . B-VP O
   
Allowing VBG O O
for IN B-VP O
the DT B-NP O
limitations NNS I-NP O
, , O O
the DT B-NP O
vertebral JJ I-NP O
bodies NNS I-NP O
are VBP O O
normal JJ O O
in IN B-VP O
height NN B-NP O
and CC O O
normally RB O O
aligned VBN O O
. . B-VP O
   
There EX O O
is VBZ O O
no DT B-NP O
atlantoaxial JJ I-NP B-problem
subluxation NN I-NP I-problem
. . B-VP O
   
The DT B-NP O
lateral JJ I-NP O
masses NNS I-NP O
of IN B-VP O
C1 NNP B-NP O
articulate VB O O
normally RB O O
about IN B-VP O
the DT B-NP O
odontoid JJ I-NP O
process NN I-NP O
. . B-VP O
   
Prevertebral NNP B-NP B-problem
soft JJ B-NP I-problem
tissue NN I-NP I-problem
swelling VBG O I-problem
cannot NN B-NP O
be VB O O
excluded VBN O O
secondary JJ O O
to TO O O
intubation NN B-NP B-treatment
. . B-VP O
   
Extensive JJ B-NP B-problem
carotid NN I-NP I-problem
arterial JJ B-NP I-problem
calcifications NNS I-NP I-problem
are VBP O O
present JJ O O
in IN B-VP O
the DT B-NP O
bulb NN I-NP O
regions NNS I-NP O
bilaterally RB O O
. . B-VP O
   
Biapical NNP B-NP B-problem
lung NN I-NP I-problem
scarring NN I-NP I-problem
and CC O O
mild JJ B-NP B-problem
bronchiectasis NN I-NP I-problem
are VBP O O
present JJ O O
. . B-VP O
   
Also RB O O
noted VBD B-VP O
is VBZ O O
sclerosis JJ O B-problem
and CC O O
opacification NN B-NP B-problem
of IN B-VP I-problem
the DT B-NP I-problem
visualized JJ I-NP I-problem
left NN I-NP I-problem
mastoid NN I-NP I-problem
air NN I-NP I-problem
cells NNS I-NP I-problem
and CC O I-problem
mastoid JJ B-NP I-problem
tip NN I-NP I-problem
, , O O
likely JJ B-NP O
chronic JJ I-NP B-problem
inflammatory NN I-NP O
disease NN I-NP O
. . B-VP O
   
IMPRESSION NN B-NP O
: : O O
Minimally RB O B-problem
displaced VBD B-VP I-problem
, , O I-problem
comminuted VBD B-VP I-problem
fractures NNS B-NP I-problem
of IN B-VP I-problem
the DT B-NP I-problem
left NN I-NP I-problem
C7 NNP I-NP I-problem
and CC O I-problem
T1 NNP B-NP I-problem
transverse NN I-NP I-problem
processes NNS I-NP I-problem
. . B-VP O
   
No DT B-NP O
evidence NN I-NP O
of IN B-VP O
extension NN B-NP B-problem
into IN B-VP I-problem
the DT B-NP I-problem
foramina JJ I-NP I-problem
transversaria NN I-NP I-problem
. . B-VP O
   
CT NNP B-NP B-test
HEAD NNP I-NP I-test
W/O NNP I-NP I-test
CONTRAST NNP I-NP I-test
2014-10-21 JJ O O
9:42 CD O O
AM NNP B-NP O
CT NNP I-NP B-test
HEAD NNP I-NP I-test
W/O NNP I-NP I-test
CONTRAST NNP I-NP I-test
Reason NNP I-NP O
: : O O
bleed NN B-NP B-problem
? . B-VP O
UNDERLYING NNP B-NP O
MEDICAL NNP I-NP O
CONDITION NNP I-NP O
: : O O
72 CD O B-person
year NN B-NP I-person
old JJ B-NP I-person
man NN I-NP I-person
with IN B-VP O
intraparenchymal JJ B-NP B-problem
bleed NN I-NP I-problem
s/p VBP O O
fall NN B-NP O
REASON NNP I-NP O
FOR NNP I-NP O
THIS NNP I-NP B-pronoun
THIS NNP I-NP B-test
EXAMINATION NNP I-NP I-test
: : O O
bleed NN B-NP B-problem
? . B-VP O
CONTRAINDICATIONS NNP B-NP O
for IN B-VP O
IV NNP B-NP O
CONTRAST NNP I-NP O
: : O O
None NN B-NP O
. . B-VP O
   
INDICATION NN B-NP O
: : O O
Intraparenchymal JJ B-NP B-problem
hemorrhage NN I-NP I-problem
after IN B-VP O
fall NN B-NP O
. . B-VP O
   
Assess NNP B-NP O
for IN B-VP O
hemorrhage NN B-NP B-problem
. . B-VP O
   
TECHNIQUE NN B-NP O
: : O O
Non-contrast JJ B-NP B-test
head NN I-NP I-test
CT NNP I-NP I-test
. . B-VP O
   
COMPARISON NNP B-NP O
: : O O
No DT B-NP O
prior JJ I-NP B-test
studies NNS I-NP I-test
are VBP O O
available JJ O O
. . B-VP O
   
By IN B-VP O
report NN B-NP O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
has VBZ O O
an DT B-NP B-test
outside JJ I-NP I-test
study NN I-NP I-test
. . B-VP O
   
Should MD O O
this DT B-NP B-pronoun
become NN I-NP O
available JJ O O
, , O O
an DT B-NP O
addendum NN I-NP O
will MD O O
be VB O O
issued VBN O O
to TO O O
this DT B-NP B-pronoun
report NN I-NP O
following VBG O O
the DT B-NP O
comparison NN I-NP O
with IN B-VP O
the DT B-NP B-test
outside JJ I-NP I-test
examination NN I-NP I-test
. . B-VP O
   
NOTE NN B-NP O
: : O O
This DT B-NP B-test
study NN I-NP I-test
was VBD B-VP O
initially RB O O
performed VBN O O
on IN B-VP O
the DT B-NP O
morning NN I-NP O
of IN B-VP O
10-21 JJ O O
, , O O
and CC O O
is VBZ O O
being VBG O O
dictated VBN O O
on IN B-VP O
the DT B-NP O
morning NN I-NP O
of IN B-VP O
10-22 NNS B-NP O
due JJ O O
to TO O O
PACS NNP B-NP O
malfunction NN I-NP O
. . B-VP O
   
Findings NNS B-NP O
were VBD B-VP O
called VBN O O
to TO O O
Dr. NNP B-NP B-person
Leanne NNP I-NP I-person
Vazquez NNP I-NP I-person
on IN B-VP O
the DT B-NP O
morning NN I-NP O
of IN B-VP O
10-21 JJ O O
. . B-VP O
   
NON-CONTRAST JJ B-NP B-test
HEAD NNP I-NP I-test
CT NNP I-NP I-test
: : O O
There EX O O
is VBZ O O
a DT B-NP B-problem
small JJ I-NP I-problem
amount NN I-NP I-problem
of IN B-VP I-problem
hemorrhage NN B-NP I-problem
within IN B-VP O
the DT B-NP O
occipital JJ I-NP O
horns NNS I-NP O
of IN B-VP O
both DT B-NP O
lateral JJ I-NP O
ventricles NNS I-NP O
, , O O
right RB O O
greater JJR O O
than IN B-VP O
left VBN O O
. . B-VP O
   
Located VBN O O
within IN B-VP O
the DT B-NP O
atrium NN I-NP O
of IN B-VP O
the DT B-NP O
right JJ I-NP O
lateral JJ I-NP O
ventricle NN I-NP O
is VBZ O O
an DT O B-problem
18 CD O I-problem
x NN B-NP I-problem
10 CD O I-problem
mm NN B-NP I-problem
nodular JJ B-NP I-problem
area NN I-NP I-problem
of IN B-VP I-problem
increased VBN O I-problem
density NN B-NP I-problem
which WDT O B-pronoun
is VBZ O O
separate JJ O O
from IN B-VP O
the DT B-NP O
choroid NN I-NP O
plexus NN I-NP O
. . B-VP O
   
There EX O O
is VBZ O O
no DT B-NP O
evidence NN I-NP O
of IN B-VP O
surrounding VBG O B-problem
edema NN B-NP I-problem
. . B-VP O
   
There EX O O
is VBZ O O
diffuse NN B-NP B-problem
brain NN I-NP I-problem
atrophy NN I-NP I-problem
and CC O O
chronic JJ B-NP B-problem
microvascular NN I-NP I-problem
infarction NN I-NP I-problem
throughout IN B-VP I-problem
the DT B-NP I-problem
white JJ I-NP I-problem
matter NN I-NP I-problem
. . B-VP O
   
There EX O O
is VBZ O O
a DT B-NP B-problem
remote JJ I-NP I-problem
right JJ I-NP I-problem
frontal NN I-NP I-problem
infarct NN I-NP I-problem
. . B-VP O
   
There EX O O
is VBZ O O
no DT B-NP O
evidence NN I-NP O
of IN B-VP O
subarachnoid JJ B-NP B-problem
hemorrhage NN I-NP I-problem
or CC O O
acute JJ B-NP B-problem
major JJ I-NP I-problem
vascular JJ I-NP I-problem
territorial JJ I-NP I-problem
infarction NN I-NP I-problem
. . B-VP O
   
The DT B-NP O
ventricles NNS I-NP O
do VBP O O
not RB O O
appear VB O O
dilated JJ B-NP O
relative NN I-NP O
to TO O O
the DT B-NP O
sulci NN I-NP O
, , O O
and CC O O
there EX O O
is VBZ O O
no DT B-NP O
shift NN I-NP B-problem
of IN B-VP I-problem
normally RB O I-problem
midline JJ B-NP I-problem
structures NNS I-NP I-problem
. . B-VP O
   
There EX O O
is VBZ O O
no DT B-NP O
skull JJ I-NP B-problem
fracture NN I-NP I-problem
. . B-VP O
   
There EX O O
is VBZ O O
opacification NN B-NP B-problem
of IN B-VP I-problem
the DT B-NP I-problem
posterior JJ I-NP I-problem
nasal JJ I-NP I-problem
cavity NN I-NP I-problem
and CC O I-problem
nasopharynx NN B-NP I-problem
but CC O O
an DT B-NP B-treatment
NG NNP I-NP I-treatment
tube NN I-NP I-treatment
is VBZ O O
present JJ O O
, , O O
and CC O O
the DT B-NP B-person
patient NN I-NP I-person
is VBZ O O
intubated VBN O B-treatment
. . B-VP O
   
Opacified NNP B-NP B-problem
and CC O I-problem
sclerotic JJ B-NP I-problem
left NN I-NP I-problem
mastoid NN I-NP I-problem
air NN I-NP I-problem
cells NNS I-NP I-problem
are VBP O O
noted VBN O O
. . B-VP O
   
IMPRESSION NN B-NP O
: : O O
1. CD O O
Small NNP B-NP O
amount NN I-NP O
of IN B-VP O
intraventricular JJ B-NP B-problem
hemorrhage NN I-NP I-problem
. . B-VP O
   
2. CD O O
Ovoid NNP B-NP B-problem
18 CD O I-problem
- : O I-problem
mm NN B-NP I-problem
density NN I-NP I-problem
within IN B-VP I-problem
the DT B-NP I-problem
atrium NN I-NP I-problem
of IN B-VP O
the DT B-NP O
right JJ I-NP O
lateral JJ I-NP O
ventricle NN I-NP O
. . B-VP O
   
This DT O B-pronoun
could MD O O
represent VB O O
either CC O O
an DT O B-problem
atypically RB O I-problem
located VBN O I-problem
blood NN B-NP I-problem
clot NN I-NP I-problem
or CC O O
an DT B-NP B-problem
intraventricular JJ I-NP I-problem
mass NN I-NP I-problem
, , O O
and CC O O
further JJ B-NP O
evaluation NN I-NP O
with IN B-VP O
contrast NN B-NP B-test
- : O I-test
enhanced JJ B-NP I-test
MRI NNP I-NP I-test
of IN B-VP I-test
the DT B-NP I-test
brain NN I-NP I-test
, , O O
when WRB O O
clinically RB O O
feasible JJ O O
, , O O
is VBZ O O
recommended VBN O O
. . B-VP O
   
Results NNS B-NP O
were VBD B-VP O
discussed VBN O O
with IN B-VP O
Dr. NNP B-NP B-person
Leanne NNP I-NP I-person
Vazquez NNP I-NP I-person
in IN B-VP O
the DT B-NP O
early JJ I-NP O
afternoon NN I-NP O
on IN B-VP O
2014-10-21 JJ O O
. . B-VP O
   
CT NNP B-NP B-test
HEAD NNP I-NP I-test
W/O NNP I-NP I-test
CONTRAST NNP I-NP I-test
2014-11-14 JJ O O
12:34 CD O O
PM NNP B-NP O
CT NNP I-NP B-test
HEAD NNP I-NP I-test
W/O NNP I-NP I-test
CONTRAST NNP I-NP I-test
Reason NNP I-NP O
: : O O
altered VBD B-VP B-problem
mental JJ B-NP I-problem
status NN I-NP I-problem
UNDERLYING NNP I-NP O
MEDICAL NNP I-NP O
CONDITION NNP I-NP O
: : O O
72 CD O B-person
year NN B-NP I-person
old JJ B-NP I-person
man NN I-NP I-person
with IN B-VP O
REASON NNP B-NP O
FOR NNP I-NP O
THIS NNP I-NP B-pronoun
THIS NNP I-NP B-test
EXAMINATION NNP I-NP I-test
: : O O
altered VBD B-VP B-problem
mental JJ B-NP I-problem
status NN I-NP I-problem
CONTRAINDICATIONS NNP I-NP O
for IN B-VP O
IV NNP B-NP O
CONTRAST NNP I-NP O
: : O O
None NN B-NP O
. . B-VP O
   
INDICATION NN B-NP O
: : O O
72-year-old JJ B-NP B-person
male NN I-NP I-person
with IN B-VP O
altered JJ B-NP B-problem
mental JJ I-NP I-problem
status NN I-NP I-problem
. . B-VP O
   
TECHNIQUE NN B-NP O
: : O O
Axial JJ B-NP B-test
noncontrast NN I-NP I-test
CT NNP I-NP I-test
scans NNS I-NP I-test
of IN B-VP I-test
the DT B-NP I-test
brain NN I-NP I-test
were VBD B-VP O
obtained VBN O O
. . B-VP O
   
Comparison NNP B-NP O
is VBZ O O
made VBN O O
to TO O O
a DT B-NP B-test
previous JJ I-NP I-test
study NN I-NP I-test
from IN B-VP O
2014-10-27 JJ O O
. . B-VP O
   
FINDINGS NN B-NP O
: : O O
There EX O O
are VBP O O
numerous JJ B-NP O
areas NNS I-NP O
of IN B-VP O
decreased JJ B-NP B-problem
attenuation NN I-NP I-problem
in IN B-VP I-problem
the DT B-NP I-problem
periventricular NN I-NP I-problem
and CC O I-problem
subcortical JJ B-NP I-problem
white JJ I-NP I-problem
matter NN I-NP I-problem
of IN B-VP O
both DT B-NP O
cerebral JJ I-NP O
hemispheres NNS I-NP O
, , O O
indicating VBG O O
chronic JJ B-NP B-problem
microvascular JJ I-NP I-problem
infarction NN I-NP I-problem
. . B-VP O
   
There EX O O
is VBZ O O
also RB O O
an DT B-NP B-problem
old JJ I-NP I-problem
right JJ I-NP I-problem
frontal NN I-NP I-problem
lobe NN I-NP I-problem
cortical JJ B-NP I-problem
infarction NN I-NP I-problem
. . B-VP O
   
A DT B-NP B-problem
small JJ I-NP I-problem
right JJ I-NP I-problem
occipital JJ I-NP I-problem
lobe NN I-NP I-problem
chronic JJ B-NP I-problem
infarction NN I-NP I-problem
is VBZ O O
also RB O O
evident JJ O O
. . B-VP O
   
There EX O O
is VBZ O O
a DT B-NP B-problem
small JJ I-NP I-problem
amount NN I-NP I-problem
of IN B-VP I-problem
blood NN B-NP I-problem
layering NN I-NP I-problem
in IN B-VP I-problem
both DT B-NP I-problem
lateral JJ I-NP I-problem
ventricles NNS I-NP I-problem
, , O O
and CC O O
this DT O B-pronoun
has VBZ O O
decreased VBN O O
since IN B-VP O
the DT B-NP B-test
previous JJ I-NP I-test
study NN I-NP I-test
. . B-VP O
   
The DT B-NP O
size NN I-NP O
and CC O O
shape NN B-NP O
of IN B-VP O
the DT B-NP O
ventricles NNS I-NP O
is VBZ O O
unchanged JJ O O
. . B-VP O
   
No DT B-NP O
new JJ I-NP B-problem
hemorrhage NN I-NP I-problem
is VBZ O O
observed VBN O O
. . B-VP O
   
There EX O O
is VBZ O O
opacification NN B-NP B-problem
of IN B-VP I-problem
the DT B-NP I-problem
mastoid JJ I-NP I-problem
air NN I-NP I-problem
cells NNS I-NP I-problem
, , O O
greater JJR O O
on IN B-VP O
the DT B-NP O
left NN I-NP O
than IN B-VP O
the DT B-NP O
right NN I-NP O
. . B-VP O
   
There EX O O
is VBZ O O
some DT B-NP B-problem
fluid NN I-NP I-problem
or CC O O
mucosal NN B-NP B-problem
thickening NN I-NP I-problem
in IN B-VP I-problem
the DT B-NP I-problem
ethmoid NN I-NP I-problem
and CC O I-problem
sphenoid JJ B-NP I-problem
sinuses NNS I-NP I-problem
. . B-VP O
   
IMPRESSION NN B-NP O
: : O O
No DT B-NP O
new JJ I-NP B-problem
cortical JJ I-NP I-problem
territorial JJ I-NP I-problem
infarction NN I-NP I-problem
or CC O O
hemorrhage NN B-NP B-problem
is VBZ O O
identified VBN O O
. . B-VP O
   
There EX O O
is VBZ O O
decreased JJ B-NP B-problem
intraventricular JJ I-NP I-problem
blood NN I-NP I-problem
, , O O
compared VBN O O
to TO O O
the DT B-NP B-test
previous JJ I-NP I-test
study NN I-NP I-test
, , O O
and CC O O
there EX O O
are VBP O O
no DT B-NP O
signs NNS I-NP O
of IN B-VP O
hydrocephalus NN B-NP B-problem
. . B-VP O
   
CHEST NNP B-NP B-test
( ( O I-test
PORTABLE NNP B-NP I-test
AP NNP I-NP I-test
) ) O I-test
2014-11-12 CD O O
9:10 CD O O
AM NNP B-NP O
CHEST NNP I-NP B-test
( ( O I-test
PORTABLE NNP B-NP I-test
AP NNP I-NP I-test
) ) O I-test
Reason NNP B-NP O
: : O O
Fever NN B-NP B-problem
, , O O
f/u JJ B-NP O
infiltrte NN I-NP B-problem
UNDERLYING NNP I-NP O
MEDICAL NNP I-NP O
CONDITION NNP I-NP O
: : O O
72 CD O B-person
yo NNS B-NP I-person
M NNP I-NP I-person
with IN B-VP O
rib NN B-NP B-problem
fx NN I-NP I-problem
s/p NN I-NP O
trauma NN I-NP B-problem
, , O O
failure NN B-NP O
on IN B-VP O
previous JJ B-NP B-test
CXR NNP I-NP I-test
, , O O
now RB O O
with IN B-VP O
fever NN B-NP B-problem
. . B-VP O
   
REASON NNP B-NP O
FOR IN B-VP O
THIS NNP B-NP B-pronoun
THIS NNP I-NP B-test
EXAMINATION NNP I-NP I-test
: : O O
Fever NN B-NP B-problem
, , O O
f/u JJ B-NP O
infiltrte JJ I-NP B-problem
HISTORY NN I-NP O
: : O O
Trauma NN B-NP B-problem
, , O O
congestive JJ B-NP B-problem
heart NN I-NP I-problem
failure NN I-NP I-problem
, , O O
fever NN B-NP B-problem
, , O O
pneumonia NN B-NP B-problem
. . B-VP O
   
Portable JJ B-NP B-test
supine JJ I-NP I-test
chest NN I-NP I-test
radiograph NN I-NP I-test
shows VBZ O O
improvement NN B-NP O
in IN B-VP O
edema NN B-NP B-problem
compared VBN O O
to TO O O
studies NNS B-NP B-test
from IN B-VP O
four CD O O
and CC O O
five CD O O
days NNS B-NP O
earlier RBR O O
with IN B-VP O
no DT B-NP O
significant JJ I-NP B-problem
radiographic JJ I-NP I-problem
change NN I-NP I-problem
in IN B-VP O
right JJ B-NP B-problem
upper JJ I-NP I-problem
lobe NN I-NP I-problem
consolidation NN I-NP I-problem
consistent NN I-NP O
with IN B-VP O
pneumonia NN B-NP B-problem
. . B-VP O
   
Some DT B-NP B-problem
interstitial JJ I-NP I-problem
edema NN I-NP I-problem
still RB O O
persists VBZ O O
, , O O
but CC O O
there EX O O
is VBZ O O
no DT B-NP O
central JJ I-NP B-problem
pulmonary JJ I-NP I-problem
vascular JJ I-NP I-problem
congestion NN I-NP I-problem
. . B-VP O
   
Cardiac NNP B-NP B-test
size NN I-NP I-test
is VBZ O O
unchanged JJ O O
. . B-VP O
   
The DT B-NP O
amount NN I-NP O
of IN B-VP O
fluid NN B-NP B-problem
layering NN I-NP I-problem
at IN B-VP I-problem
the DT B-NP I-problem
apices NNS I-NP I-problem
and CC O I-problem
the DT B-NP I-problem
pleural JJ I-NP I-problem
spaces NNS I-NP I-problem
appear VBP O O
slightly RB O O
decreased VBN O O
. . B-VP O
   
Multiple JJ B-NP B-problem
left-sided JJ I-NP I-problem
rib NN I-NP I-problem
fractures NNS I-NP I-problem
are VBP O O
seen VBN O O
. . B-VP O
   
Supporting VBG O B-treatment
tubes NNS B-NP I-treatment
and CC O I-treatment
lines NNS B-NP I-treatment
are VBP O O
in IN B-VP O
unchanged JJ B-NP O
position NN I-NP O
and CC O O
the DT B-NP B-person
patient NN I-NP I-person
has VBZ O O
a DT B-NP B-treatment
single JJ I-NP I-treatment
lead NN I-NP I-treatment
pacemaker NN I-NP I-treatment
projected VBN O O
on IN B-VP O
the DT B-NP O
left NN I-NP O
. . B-VP O
   
Calcification NN B-NP B-problem
is VBZ O O
seen VBN O O
at IN B-VP O
both DT B-NP O
carotid JJ I-NP O
bifurcations NNS I-NP O
. . B-VP O
   
CONCLUSION NN B-NP O
: : O O
Improvement NN B-NP O
in IN B-VP O
congestion NN B-NP B-problem
from IN B-VP O
edema NN B-NP B-problem
with IN B-VP O
no DT B-NP O
worsening NN I-NP O
, , O O
but CC O O
no DT B-NP O
significant JJ I-NP O
improvement NN I-NP O
, , O O
in IN B-VP O
the DT B-NP B-problem
right JJ I-NP I-problem
upper JJ I-NP I-problem
lobe NN I-NP I-problem
pneumonia NN I-NP I-problem
. . B-VP O
   
Supporting VBG O B-treatment
lines NNS B-NP I-treatment
and CC O I-treatment
tubes NNS B-NP I-treatment
in IN B-VP O
unchanged JJ B-NP O
position NN I-NP O
. . B-VP O
   
Brief JJ B-NP O
Hospital JJ I-NP O
Course NN I-NP O
: : O O
Admitted VBN O O
to TO O O
TSICU NNP B-NP O
for IN B-VP O
subarachnoid JJ B-NP B-problem
hemorrhage NN I-NP I-problem
and CC O O
multiple JJ B-NP B-problem
spinal JJ I-NP I-problem
fractures NNS I-NP I-problem
. . B-VP O
   
Intubated VBN O B-treatment
and CC O O
sedated VBN O B-treatment
for IN B-VP O
desats NNS B-NP B-problem
on IN B-VP O
2014-10-27 JJ O O
. . B-VP O
   
Evaluated VBN O O
by IN B-VP O
neurosurgery NN B-NP B-person
and CC O O
deemed VBD B-VP O
stable JJ O O
on IN B-VP O
2014-10-22 JJ O O
. . B-VP O
   
CT NNP B-NP B-test
head NN I-NP I-test
remained VBD B-VP O
stable JJ O O
for IN B-VP O
SAH NNP B-NP B-problem
. . B-VP O
   
Evaluated VBN O O
by IN B-VP O
orthopedic JJ B-NP B-person
spine JJ I-NP I-person
surgeons NNS I-NP I-person
with IN B-VP O
recommendations NNS B-NP O
for IN B-VP O
soft JJ O B-treatment
c-collar JJ O I-treatment
for IN B-VP O
comfort NN B-NP O
. . B-VP O
   
In IN B-VP O
TSICU NNP B-NP O
, , O O
developed VBD B-VP O
MRSA NNP B-NP B-problem
pneumonia NN I-NP I-problem
with IN B-VP O
question NN B-NP O
of IN B-VP O
aspiration NN B-NP B-problem
, , O O
treated VBD B-VP O
Zosyn NNP B-NP B-treatment
--> NNP I-NP O
vanc NN I-NP B-treatment
/ NNP I-NP O
levo VBZ O B-treatment
--> NNP B-NP O
then RB O O
2 CD O O
week NN B-NP O
course NN I-NP O
of IN B-VP O
Linazolid NNP B-NP B-treatment
with IN B-VP O
resolution NN B-NP O
of IN B-VP O
fevers NNS B-NP B-problem
and CC O O
decreased VBD B-VP B-problem
pulmonary JJ B-NP I-problem
secretions NNS I-NP I-problem
. . B-VP O
   
2014-11-11 JJ O O
: : O O
Tracheostomy NN B-NP B-treatment
performed VBD B-VP O
without IN B-VP O
complication NN B-NP B-problem
. . B-VP O
   
Patient NNP B-NP B-person
tolerated VBD B-VP O
decreasing VBG O B-treatment
ventillary JJ B-NP I-treatment
support. NN I-NP I-treatment
Mental NNP I-NP O
status NN I-NP O
improved VBN O O
with IN B-VP O
the DT B-NP O
discontinuation NN I-NP O
of IN B-VP O
his PRP$ O B-person
his PRP$ O B-treatment
bensodiazapines NNS B-NP I-treatment
. . B-VP O
   
Failed VBD B-VP B-problem
swallow JJ B-NP I-problem
study NN I-NP I-problem
x VBD B-VP O
2 CD O O
in IN B-VP O
early JJ B-NP O
November NNP I-NP O
. . B-VP O
   
Decision NN B-NP O
to TO O O
continue VB O O
Dobhoff NNP B-NP B-treatment
at IN B-VP O
rehab NN B-NP O
given VBN O O
continued JJ B-NP O
clinical JJ I-NP O
improvement NN I-NP O
and CC O O
his PRP$ O B-person
poor JJ B-NP O
candidacy NN I-NP O
for IN B-VP O
G/J NNP B-NP B-treatment
tube NN I-NP I-treatment
. . B-VP O
   
Communicating VBG O O
by IN B-VP O
speech NN B-NP O
s/p NN I-NP O
PMV NNP I-NP B-treatment
placement NN I-NP I-treatment
. . B-VP O
   
Continued VBN O O
in IN B-VP O
Melrose-J NNP B-NP O
for IN B-VP O
comfort NN B-NP O
per IN B-VP O
orthopedics NNS B-NP B-person
. . B-VP O
   
Stable JJ O O
during IN B-VP O
his PRP$ O B-person
course NN B-NP O
on IN B-VP O
the DT B-NP O
surgical JJ I-NP O
Beth NNP I-NP O
Israel NNP I-NP O
Deaconess NNP I-NP O
Hospital-Needham NNP I-NP O
. . B-VP O
   
Occasionally RB O O
required JJ B-NP O
Haldol NNP I-NP B-treatment
/ NNP I-NP O
ativan NN I-NP B-treatment
at IN B-VP O
night NN B-NP O
for IN B-VP O
agitation NN B-NP B-problem
. . B-VP O
   
Progressed VBD B-VP O
adequately RB O O
with IN B-VP O
physical JJ B-NP B-treatment
/ NNP I-NP I-treatment
occupational JJ B-NP I-treatment
therapy NN I-NP I-treatment
, , O O
however RB O O
was VBD B-VP O
noted VBN O O
to TO O O
develop VB O O
an DT B-NP B-problem
early JJ I-NP I-problem
bilateral JJ I-NP I-problem
upper JJ I-NP I-problem
extermity NN I-NP I-problem
contracture NN I-NP I-problem
at IN B-VP I-problem
the DT B-NP I-problem
elbows NNS I-NP I-problem
and CC O I-problem
wrists NNS B-NP I-problem
. . B-VP O
   
Serial JJ B-NP B-test
CT NNP I-NP I-test
head NN I-NP I-test
revealed VBD B-VP O
decreased JJ B-NP B-problem
blood NN I-NP I-problem
through IN B-VP O
2014-11-14 JJ O O
. . B-VP O
   
Discharge NN B-NP O
Medications NNS I-NP O
: : O O
1. CD O O
Heparin NNP B-NP B-treatment
( ( O I-treatment
Porcine NNP B-NP I-treatment
) ) O I-treatment
5,000 CD O O
unit/mL JJ B-NP O
Solution NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Injection NN B-NP O
TID NNP I-NP O
( ( O O
3 CD O O
times NNS B-NP O
a DT B-NP O
day NN I-NP O
). POS O O
2. CD O O
Lisinopril NNP B-NP B-treatment
15 CD O O
mg NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Tablet NNP B-NP O
PO NNP I-NP O
DAILY NNP I-NP O
( ( O O
Daily NNP B-NP O
). VBZ O O
3. CD O O
Lansoprazole NNP B-NP B-treatment
30 CD O O
mg NN B-NP O
Susp NNP I-NP O
, , O O
Delayed NNP B-NP O
Release NNP I-NP O
for IN B-VP O
Recon NNP B-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
PO NNP B-NP O
DAILY NNP I-NP O
( ( O O
Daily NNP B-NP O
). VBZ O O
4. CD O O
Linezolid NNP B-NP B-treatment
600 CD O O
mg NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Tablet NNP B-NP O
PO NNP I-NP O
Q12H NNP I-NP O
( ( O O
every DT O O
12 CD O O
hours NNS B-NP O
): VBN O O
Last JJ O O
dose JJ O O
2014-11-20 JJ O O
. . B-VP O
   
5. CD O O
Metoprolol NNP B-NP B-treatment
Tartrate NNP I-NP I-treatment
25 CD O O
mg NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Tablet NNP B-NP O
PO NNP I-NP O
TID NNP I-NP O
( ( O O
3 CD O O
times NNS B-NP O
a DT B-NP O
day NN I-NP O
). POS O O
6. CD O O
Digoxin NNP B-NP B-treatment
125 CD O O
mcg NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Tablet NNP B-NP O
PO NNP I-NP O
DAILY NNP I-NP O
( ( O O
Daily NNP B-NP O
). VBZ O O
7. CD O O
Docusate NNP B-NP B-treatment
Sodium NNP I-NP I-treatment
150 CD O O
mg NN B-NP O
/ VBD B-VP O
15 CD O O
mL NN B-NP O
Liquid NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
PO NNP B-NP O
BID NNP I-NP O
( ( O O
2 CD O O
times NNS B-NP O
a DT B-NP O
day NN I-NP O
). POS O O
8. CD O O
Bisacodyl NNP B-NP B-treatment
5 CD O O
mg NN B-NP O
Tablet NNP I-NP O
, , O O
Delayed NNP B-NP O
Release NNP I-NP O
( ( O O
E.C. NNP B-NP O
) ) O O
Sig NNP B-NP O
: : O O
Two CD O O
( ( O O
2 CD O O
) ) O O
Tablet NN B-NP O
, , O O
Delayed NNP B-NP O
Release NNP I-NP O
( ( O O
E.C. NNP B-NP O
) ) O O
PO NNP B-NP O
DAILY NNP I-NP O
( ( O O
Daily NNP B-NP O
) ) O O
as IN B-VP O
needed VBN O O
for IN B-VP O
constipation NN B-NP B-problem
. . B-VP O
   
9. CD O O
Magnesium NNP B-NP B-treatment
Hydroxide NNP I-NP I-treatment
400 CD O O
mg NN B-NP O
/ VBD B-VP O
5 CD O O
mL JJ B-NP O
Suspension NNP I-NP O
Sig NNP I-NP O
: : O O
Thirty NNP B-NP O
( ( O O
30 CD O O
) ) O O
ML NNP B-NP O
PO NNP I-NP O
Q6H NNP I-NP O
( ( O O
every DT O O
6 CD O O
hours NNS B-NP O
) ) O O
as IN B-VP O
needed VBN O O
for IN B-VP O
consitpation NN B-NP B-problem
. . B-VP O
   
Discharge NNP B-NP O
Disposition NNP I-NP O
: : O O
Extended VBN O O
Care NNP B-NP O
Facility NNP I-NP O
: : O O
Children NNP B-NP O
's POS O O
Hospital NNP B-NP O
of IN B-VP O
Waltham NNP B-NP O
Discharge NNP I-NP O
Diagnosis NNP I-NP O
: : O O
s/p NN B-NP O
Fall NNP I-NP O
Subarachnoid NNP I-NP B-problem
hemorrhage NN I-NP I-problem
w/ VBD B-VP O
bilateral JJ B-NP B-problem
intraventricular JJ I-NP I-problem
hemorrhage NN I-NP I-problem
Left VBD B-VP B-problem
T1 NNP B-NP I-problem
transverse NN I-NP I-problem
process NN I-NP I-problem
fracture NN I-NP I-problem
C7 NNP I-NP B-problem
& CC O I-problem
T1 NNP B-NP I-problem
mimimally RB O I-problem
displaced VBD B-VP I-problem
transverse JJ B-NP I-problem
process NN I-NP I-problem
fracture NN I-NP I-problem
Left NNP I-NP B-problem
rib NN I-NP I-problem
fractures NNS I-NP I-problem
05-22 JJ B-NP O
Discharge NNP I-NP O
Condition NNP I-NP O
: : O O
Stable JJ B-NP O
Discharge NN I-NP O
Instructions NNS I-NP O
: : O O
You PRP O B-person
must MD O O
continue VB O O
to TO O O
wear VB O O
your PRP$ O B-person
your PRP$ O B-treatment
cervical JJ B-NP I-treatment
collar NN I-NP I-treatment
for IN B-VP O
the DT O O
next JJ O O
4 CD O O
weeks NNS B-NP O
( ( O O
through IN B-VP O
12-11 CD O O
). NNS B-NP O
Follow NNP I-NP O
up RP O O
with IN B-VP O
Trauma NNP B-NP B-person
in IN B-VP O
3-4 JJ B-NP O
weeks NNS I-NP O
after IN B-VP O
your PRP$ O B-person
discharge NN B-NP O
. . B-VP O
   
Follow VB O O
up RP O O
Instructions NNS B-NP O
: : O O
Call NN B-NP O
( ( O O
909 CD O O
) ) O O
566-1185 CD O O
to TO O O
schedule VB O O
appointment NN B-NP O
in IN B-VP O
Trauma NNP B-NP O
Clinic NNP I-NP O
in IN B-VP O
3-4 JJ B-NP O
weeks NNS I-NP O
. . B-VP O
   
Follow VB O O
up RP O O
with IN B-VP O
Dr. NNP B-NP B-person
Topping NNP I-NP I-person
after IN B-VP O
your PRP$ O B-person
discharge NN B-NP O
from IN B-VP O
rehabilitation NN B-NP O
Call NNP I-NP O
887 CD O O
415 CD O O
4220 CD O O
to TO O O
schedule VB O O
an DT B-NP O
appointment NN I-NP O
with IN B-VP O
Orthopedics NNS B-NP B-person
for IN B-VP O
late JJ B-NP O
November NNP I-NP O
. . B-VP O
   
David NNP B-NP B-person
Thomas NNP I-NP I-person
MD NNP I-NP I-person
60-008 JJ O O
Completed VBN O O
by IN B-VP O
: : O O
Russell NNP B-NP B-person
Anthony NNP I-NP I-person
Conner NNP I-NP I-person
MD NNP I-NP I-person
87-672 JJ B-NP O
2014-11-21 JJ I-NP O
@ NN I-NP O
1110 CD O O
Signed NNP B-NP O
electronically RB O O
by IN B-VP O
: : O O
DR. NNP B-NP B-person
Melissa NNP I-NP I-person
Higuera NNP I-NP I-person
on IN B-VP O
: : O O
SUN NNP B-NP O
2014-11-23 CD O O
6:13 CD O O
PM NNP B-NP O
( ( O O
End NNP B-NP O
of IN B-VP O
Report NNP B-NP O
) ) O O
-EMPTYLINE- VBP O O
-DOCSTART- JJ O O
-EMPTYLINE- $ O O
277175072 CD O O
NVH NNP B-NP O
87686746 CD O O
1/3/1997 CD O O
12:00:00 CD O O
AM NNP B-NP O
10% CD O B-problem
BODY NNP B-NP I-problem
BURNS NNP I-NP I-problem
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date NNP I-NP O
: : O O
01/03/1997 CD O O
Report NNP B-NP O
Status NNP I-NP O
: : O O
Signed VBN O O
Discharge NNP B-NP O
Date NNP I-NP O
: : O O
01/07/1997 CD O O
FINAL NNP B-NP O
DIAGNOSIS NN I-NP O
: : O O
(1) JJ B-NP O
THIRD NNP I-NP B-problem
DEGREE NNP I-NP I-problem
BURN NNP I-NP I-problem
TO NNP I-NP I-problem
RIGHT NNP I-NP I-problem
HAND NNP I-NP I-problem
AND NNP I-NP I-problem
FOREARM NNP I-NP I-problem
(2) NNP I-NP O
SECOND NNP I-NP B-problem
DEGREE NNP I-NP I-problem
BURN NNP I-NP I-problem
TO NNP I-NP I-problem
FACE NNP I-NP I-problem
PROCEDURE NNP I-NP O
: : O O
(1) JJ O O
1/5/97 CD O O
: : O O
DEBRIDEMENT NN B-NP B-treatment
OF IN B-VP O
BURN NNP B-NP B-problem
AND NNP I-NP O
APPLICATION NNP I-NP B-treatment
OF NNP I-NP I-treatment
ARTIFICIAL NNP I-NP I-treatment
SKIN NNP I-NP I-treatment
HISTORY NNP I-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
is VBZ O O
a DT O O
59 CD O O
year NN B-NP O
old JJ B-NP O
gentleman NN I-NP O
who WP O B-person
experienced VBD B-VP O
a DT B-NP B-problem
flash JJ I-NP I-problem
burn NN I-NP I-problem
from IN B-VP O
grease NN B-NP O
while IN B-VP O
working VBG O O
on IN B-VP O
a DT B-NP O
stove NN I-NP O
on IN B-VP O
the DT B-NP O
night NN I-NP O
prior RB O O
to TO O O
admission NN B-NP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
at IN B-VP O
that DT B-NP B-pronoun
time NN I-NP O
treated VBD B-VP O
himself PRP O B-person
symptomatically RB O O
at IN B-VP O
home NN B-NP O
but CC O O
presented VBD B-VP O
to TO O O
Roing NNP B-NP O
Hospital NNP I-NP O
on IN B-VP O
the DT B-NP O
day NN I-NP O
after IN B-VP O
the DT B-NP O
event NN I-NP O
and CC O O
was VBD B-VP O
transferred VBN O O
to TO O O
the DT B-NP O
Nimaconwood NNP I-NP O
Valley NNP I-NP O
Hospital NNP I-NP O
immediately RB O O
for IN B-VP O
evaluation NN B-NP B-test
because IN B-VP O
of IN B-VP O
his PRP$ O B-person
his PRP$ O B-problem
extensive JJ B-NP I-problem
burns NNS I-NP I-problem
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
walking VBG O O
, , O O
talking VBG O O
, , O O
and CC O O
was VBD B-VP O
breathing VBG O O
without IN B-VP O
difficulty NN B-NP B-problem
on IN B-VP O
arrival NN B-NP O
. . B-VP O
   
PAST JJ B-NP O
SURGICAL JJ I-NP O
HISTORY NN I-NP O
: : O O
No DT B-NP O
significant JJ I-NP O
history NN I-NP O
. . B-VP O
   
PAST NNP B-NP O
MEDICAL NNP I-NP O
HISTORY NN I-NP O
: : O O
Only RB O O
significant JJ O O
for IN B-VP O
excessive JJ B-NP O
alcohol NN I-NP O
use NN I-NP O
. . B-VP O
   
MEDICATIONS NNS B-NP O
: : O O
None NN B-NP O
. . B-VP O
   
ALLERGIES NNP B-NP O
: : O O
No DT B-NP O
known JJ I-NP B-problem
drug NN I-NP I-problem
allergies NNS I-NP I-problem
. . B-VP O
   
PHYSICAL JJ B-NP O
EXAMINATION NN I-NP O
: : O O
99% CD O O
saturation NN B-NP B-test
on IN B-VP O
room NN B-NP O
air NN I-NP O
. . B-VP O
   
Heart NNP B-NP B-test
rate NN I-NP I-test
76 CD O O
, , O O
blood NN B-NP B-test
pressure NN I-NP I-test
169/100 CD O O
. . B-VP O
   
Other JJ B-NP B-test
vital JJ I-NP I-test
signs NNS I-NP I-test
were VBD B-VP O
within IN B-VP O
normal JJ B-NP O
limits NNS I-NP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
not RB O O
anxious JJ O O
or CC O O
ill-appearing JJ O B-problem
. . B-VP O
   
HEENT NN B-NP O
: : O O
Extensive JJ B-NP B-problem
first JJ I-NP I-problem
degree NN I-NP I-problem
and CC O I-problem
second JJ B-NP I-problem
degree NN I-NP I-problem
burns NNS I-NP I-problem
around IN B-VP I-problem
the DT B-NP I-problem
face NN I-NP I-problem
, , O O
superficial JJ O O
in IN B-VP O
nature NN B-NP O
, , O O
with IN B-VP O
no DT B-NP O
blistering NN I-NP B-problem
. . B-VP O
   
His PRP$ O B-person
oropharynx NN B-NP O
was VBD B-VP O
wide JJ O O
open JJ O O
with IN B-VP O
no DT B-NP O
evidence NN I-NP O
of IN B-VP O
burn NN B-NP B-problem
. . B-VP O
   
Lungs NNS B-NP O
clear JJ O O
to TO O O
auscultation VB O B-test
bilaterally RB O O
. . B-VP O
   
Heart NN B-NP O
: : O O
Regular JJ O O
. . B-VP O
   
Abdomen NNS B-NP O
: : O O
Soft NNP B-NP O
, , O O
nontender NN B-NP B-problem
, , O O
nondistended VBN O B-problem
. . B-VP O
   
Extremities NNS B-NP O
: : O O
Good JJ B-NP O
pulses NNS I-NP O
bilaterally RB O O
. . B-VP O
   
Skin NN B-NP O
: : O O
Third JJ B-NP B-problem
degree JJ I-NP I-problem
burn NN I-NP I-problem
on IN B-VP I-problem
dorsum NN B-NP I-problem
of IN B-VP O
forearm NN B-NP O
and CC O O
on IN B-VP O
dorsum NN B-NP O
of IN B-VP O
hand NN B-NP O
with IN B-VP O
extensive JJ B-NP B-problem
second JJ I-NP I-problem
degree NN I-NP I-problem
burn NN I-NP I-problem
around IN B-VP O
the DT B-NP O
remainder NN I-NP O
of IN B-VP O
his PRP$ O B-person
hand NN B-NP O
circumferentially RB O O
and CC O O
on IN B-VP O
his PRP$ O B-person
forearm NN B-NP O
. . B-VP O
   
Pulses NNS B-NP O
were VBD B-VP O
intact JJ O O
. . B-VP O
   
No DT B-NP O
evidence NN I-NP O
of IN B-VP O
compartment JJ B-NP B-problem
syndrome NN I-NP I-problem
. . B-VP O
   
Evaluation NN B-NP B-test
in IN B-VP O
the DT B-NP O
emergency NN I-NP O
room NN I-NP O
revealed VBD B-VP O
the DT B-NP B-person
patient NN I-NP I-person
to TO O O
be VB O O
stable JJ O O
and CC O O
he PRP O B-person
was VBD B-VP O
evaluated VBN O O
by IN B-VP O
ophthalmology NN B-NP B-person
who WP O B-person
also RB O O
felt VBD B-VP O
that IN B-VP B-pronoun
the DT B-NP B-person
patient NN I-NP I-person
had VBD B-VP O
no DT B-NP O
injury NN I-NP B-problem
to TO O I-problem
his PRP$ O B-person
his PRP$ O I-problem
eyes NNS B-NP I-problem
. . B-VP O
   
HOSPITAL NNP B-NP O
COURSE NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
taken VBN O O
from IN B-VP O
the DT B-NP O
emergency NN I-NP O
room NN I-NP O
and CC O O
transferred VBD B-VP O
to TO O O
the DT B-NP O
Surgical NNP I-NP O
Intensive NNP I-NP O
Care NNP I-NP O
Unit NNP I-NP O
for IN B-VP O
airway JJ B-NP B-test
observation NN I-NP I-test
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
given VBN O O
three CD O O
liters NNS B-NP O
of IN B-VP O
IV NNP B-NP B-treatment
hydration NN I-NP I-treatment
with IN B-VP O
good JJ B-NP O
urine NN I-NP O
output NN I-NP O
response NN I-NP O
. . B-VP O
   
His PRP$ O B-problem
His PRP$ O B-person
wounds NNS B-NP I-problem
were VBD B-VP O
dressed VBN O O
with IN B-VP O
antiointment NN B-NP B-treatment
and CC O O
Xeroform NN B-NP B-treatment
with IN B-VP O
the DT B-NP O
plan NN I-NP O
to TO O O
take VB O O
him PRP O B-person
to TO O O
the DT B-NP O
operating NN I-NP O
room NN I-NP O
for IN B-VP O
debridement NN B-NP B-treatment
under IN B-VP O
general JJ B-NP B-treatment
anesthesia NN I-NP I-treatment
and CC O O
application NN B-NP B-treatment
of IN B-VP I-treatment
artificial JJ B-NP I-treatment
skin NN I-NP I-treatment
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
remained VBD B-VP O
hemodynamically RB O O
stable JJ O O
with IN B-VP O
good JJ B-NP O
urine NN I-NP O
output NN I-NP O
. . B-VP O
   
While IN B-VP O
in IN B-VP O
the DT B-NP O
Intensive NNP I-NP O
Care NNP I-NP O
Unit NNP I-NP O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
put VBN O O
on IN B-VP O
delirium NN B-NP B-treatment
tremons NNS I-NP I-treatment
prophylaxis VBP O I-treatment
with IN B-VP O
Serax NNP B-NP B-treatment
around IN B-VP O
the DT B-NP O
clock NN I-NP O
. . B-VP O
   
There EX O O
was VBD B-VP O
no DT B-NP O
evidence NN I-NP O
while IN B-VP O
in IN B-VP O
the DT B-NP O
hospital NN I-NP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
taken VBN O O
to TO O O
the DT B-NP O
operating NN I-NP O
room NN I-NP O
on IN B-VP O
1/5/97 CD O O
. . B-VP O
   
At IN B-VP O
that DT B-NP B-pronoun
time NN I-NP O
the DT B-NP B-person
patient JJ I-NP I-person
underwent JJ I-NP O
debridement NN I-NP B-treatment
of IN B-VP O
his PRP$ O B-person
his PRP$ O B-problem
facial JJ B-NP I-problem
wounds NNS I-NP I-problem
and CC O O
debridement NN B-NP B-treatment
of IN B-VP I-treatment
his PRP$ O B-person
his PRP$ O I-treatment
right JJ B-NP I-treatment
hand NN I-NP I-treatment
and CC O I-treatment
forearm NN B-NP I-treatment
with IN B-VP O
application NN B-NP B-treatment
of IN B-VP I-treatment
artificial JJ B-NP I-treatment
skin NN I-NP I-treatment
which WDT O B-pronoun
is VBZ O O
the DT B-NP O
dermagraft NN I-NP B-treatment
TC NNP I-NP I-treatment
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
tolerated VBD B-VP O
the DT B-NP B-treatment
procedure NN I-NP I-treatment
well RB O O
. . B-VP O
   
There EX O O
were VBD B-VP O
no DT B-NP O
complications NNS I-NP B-problem
. . B-VP O
   
Postoperatively RB O O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
transferred VBN O O
out IN B-VP O
of IN B-VP O
the DT B-NP O
Intensive NNP I-NP O
Care NNP I-NP O
Unit NNP I-NP O
to TO O O
the DT B-NP O
burn NN I-NP O
floor NN I-NP O
where WRB O O
he PRP O B-person
received VBD B-VP O
dressing VBG O B-treatment
changes NNS B-NP I-treatment
p.r.n. VBP O O
The DT B-NP B-person
patient NN I-NP I-person
remained VBD B-VP O
afebrile JJ O B-problem
and CC O O
other JJ B-NP B-test
vital JJ I-NP I-test
signs NNS I-NP I-test
were VBD B-VP O
within IN B-VP O
normal JJ B-NP O
limits NNS I-NP O
. . B-VP O
   
On IN B-VP O
the DT B-NP O
day NN I-NP O
of IN B-VP O
discharge NN B-NP O
the DT O B-treatment
the DT B-NP B-person
patient JJ I-NP I-treatment
patient NN I-NP I-person
&apos;s NN I-NP I-treatment
dressing NN I-NP I-treatment
was VBD B-VP O
taken VBN O O
down RP O O
completely RB O O
and CC O O
evaluation NN B-NP B-test
of IN B-VP O
the DT B-NP B-treatment
derma NN I-NP I-treatment
graft NN I-NP I-treatment
was VBD B-VP O
made VBN O O
. . B-VP O
   
At IN B-VP O
that DT B-NP B-pronoun
time NN I-NP O
it PRP O B-pronoun
appeared VBD B-VP O
well RB O O
adhered VBN O O
to TO O O
the DT B-NP O
underlying JJ I-NP O
skin NN I-NP O
. . B-VP O
   
There EX O O
was VBD B-VP O
no DT B-NP O
evidence NN I-NP O
of IN B-VP O
infection NN B-NP B-problem
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
screened VBN O O
by IN B-VP O
the DT B-NP O
rehabilitation NN I-NP O
facility NN I-NP O
and CC O O
felt VBD B-VP O
to TO O O
be VB O O
an DT B-NP O
acceptable JJ I-NP O
candidate NN I-NP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
and CC O O
his PRP$ O B-person
his PRP$ O B-person
family NN B-NP I-person
agreed VBD B-VP O
to TO O O
transfer VB O O
from IN B-VP O
Nimaconwood NNP B-NP O
Valley NNP I-NP O
Hospital NNP I-NP O
to TO O O
Ianehutche NNP B-NP O
Medical NNP I-NP O
Center NNP I-NP O
. . B-VP O
   
DISPOSITION NN B-NP O
: : O O
DISCHARGE JJ B-NP O
MEDICATIONS NNP I-NP O
: : O O
Colace NN B-NP B-treatment
100 CD O O
mg NN B-NP O
p.o. NN I-NP O
b.i.d. NN I-NP O
, , O O
Folate NNP B-NP B-treatment
1 CD O O
mg NN B-NP O
q.d. NN I-NP O
, , O O
Artificial NNP B-NP B-treatment
Tears NNP I-NP I-treatment
2 CD O O
drops NNS B-NP O
each DT B-NP O
eye NN I-NP O
b.i.d. NN I-NP O
and CC O O
p.r.n. NN B-NP O
, , O O
Serax NNP B-NP B-treatment
15 CD O O
mg NN B-NP O
p.o. NN I-NP O
q6h SYM O O
- : O O
hold NN B-NP O
if IN B-VP O
patient JJ O B-person
excessively RB O B-problem
sleepy JJ O I-problem
, , O O
Thiamine NNP B-NP B-treatment
100 CD O O
mg NN B-NP O
p.o. NN I-NP O
q.d. NN I-NP O
, , O O
MS NNP B-NP B-treatment
- : O I-treatment
Contin NN B-NP I-treatment
30 CD O O
mg NN B-NP O
p.o.b.i.d. NN I-NP O
, , O O
multivitamin NN B-NP B-treatment
q.d. NN I-NP O
, , O O
MSIR NNP B-NP B-treatment
15 CD O O
mg NN B-NP O
p.o. NN I-NP O
q3-4h JJ B-NP O
p.r.n. NN I-NP O
pain NN I-NP B-problem
, , O O
and CC O O
Axid NNP B-NP B-treatment
150 CD O O
mg NN B-NP O
p.o. NN I-NP O
b.i.d. IN B-VP O
The DT B-NP B-person
patient NN I-NP I-person
is VBZ O O
to TO O O
undergo VB O O
dry JJ B-NP B-treatment
dressing NN I-NP I-treatment
changes NNS I-NP I-treatment
and CC O O
splint NN B-NP B-treatment
to TO O I-treatment
his PRP$ O B-person
his PRP$ O I-treatment
right JJ B-NP I-treatment
arm NN I-NP I-treatment
q.d. NN I-NP O
DIET NNP I-NP O
: : O O
Regular JJ O O
. . B-VP O
   
FOLLOWUP NN B-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
is VBZ O O
to TO O O
be VB O O
seen VBN O O
in IN B-VP O
the DT B-NP O
burn NN I-NP O
clinic JJ O O
two CD O O
days NNS B-NP O
after IN B-VP O
discharge NN B-NP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
discharged VBN O O
in IN B-VP O
stable JJ B-NP O
condition NN I-NP O
. . B-VP O
   
Dictated VBN O O
By IN B-VP O
: : O O
TELSHEY NNP B-NP B-person
K. NNP I-NP I-person
PAP NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
IK06 NNP I-NP O
Attending NNP I-NP B-person
: : O O
TELSHEY NNP B-NP B-person
K. NNP I-NP I-person
PAP NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
BH2 NNP I-NP O
MC084/4189 NNP I-NP O
Batch NNP I-NP O
: : O O
9441 CD O O
Index NNP B-NP O
No. NNP I-NP O
YROINI4 NNP I-NP O
PGM NNP I-NP O
D NNP I-NP O
: : O O
01/07/97 CD O O
T NN B-NP O
: : O O
01/07/97 CD O O
CC NN B-NP O
: : O O
1. CD O O
ERFIBOULDNON NNP B-NP O
VALLEY NNP I-NP O
MEMORIAL NNP I-NP O
HOSPITAL NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
Admission NNP I-NP O
Date NNP I-NP O
: : O O
2011-03-06 JJ B-NP O
Discharge NN I-NP O
Date NNP I-NP O
: : O O
2011-03-21 JJ B-NP O
Date NNP I-NP O
of IN B-VP O
Birth NNP B-NP O
: : O O
1945-09-15 JJ B-NP O
Sex NN I-NP O
: : O O
M NNP B-NP O
Service: NNP I-NP O
ADDENDUM NNP I-NP O
: : O O
Addendum NN B-NP O
to TO O O
hospital JJ B-NP O
course NN I-NP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
's POS O O
actual JJ B-NP O
date NN I-NP O
of IN B-VP O
discharge NN B-NP O
was VBD B-VP O
2011-03-21 JJ O O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
will MD O O
be VB O O
discharged VBN O O
to TO O O
rehabilitation VB O B-treatment
in IN B-VP O
Brain NNP B-NP O
Tree NNP I-NP O
Maryland NNP I-NP O
. . B-VP O
   
Service NNP B-NP O
is VBZ O O
actually RB O O
Medicine NNP B-NP O
, , O O
Newburyport NNP B-NP O
Firm NNP I-NP O
not RB O O
C-CMED NNP B-NP O
. . B-VP O
   
The DT B-NP O
Jewish JJ I-NP O
Memorial NNP I-NP O
Hospital NNP I-NP O
hospital NN I-NP O
course NN I-NP O
over IN B-VP O
the DT B-NP O
1-day JJ I-NP O
addendum NN I-NP O
is VBZ O O
improving VBG O O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
is VBZ O O
diuresing VBG O O
well RB O O
, , O O
negative JJ O O
2 CD O O
liters NNS B-NP O
again RB O O
per IN B-VP O
day NN B-NP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
will MD O O
be VB O O
continued VBN O O
on IN B-VP O
medications NNS B-NP B-treatment
per IN B-VP O
Discharge NNP B-NP O
Summary NNP I-NP O
with IN B-VP O
the DT B-NP O
addition NN I-NP O
of IN B-VP O
captopril NN B-NP B-treatment
ACE NNP I-NP I-treatment
inhibitor NN I-NP I-treatment
since IN B-VP O
the DT O B-person
the DT B-NP B-test
patient JJ I-NP I-person
patient NN I-NP I-test
's POS O I-person
's POS O I-test
blood NN B-NP I-test
pressure NN I-NP I-test
is VBZ O O
stable JJ O O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
with IN B-VP O
no DT B-NP O
new JJ I-NP B-problem
events NNS I-NP I-problem
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
's POS O O
condition NN B-NP O
on IN B-VP O
discharge NN B-NP O
was VBD B-VP O
stable JJ O O
and CC O O
improved VBN O O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
continues VBZ O O
to TO O O
improve VB O O
with IN B-VP O
regard NN B-NP O
to TO O O
his PRP$ O B-problem
his PRP$ O B-person
scrotal NN B-NP I-problem
and CC O I-problem
lower JJR B-NP I-problem
extremity NN I-NP I-problem
edema NN I-NP I-problem
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
has VBZ O O
no DT B-NP O
lower JJR I-NP B-problem
extremity NN I-NP I-problem
ulcers NNS I-NP I-problem
, , O O
and CC O O
all DT B-NP B-problem
former JJ I-NP I-problem
leg NN I-NP I-problem
excoriations NNS I-NP I-problem
are VBP O O
healing VBG O O
well RB O O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
ambulating VBG O O
three CD O O
to TO O O
four CD O O
times NNS B-NP O
per IN B-VP O
day NN B-NP O
and CC O O
able JJ O O
to TO O O
get VB O O
out IN B-VP O
of IN B-VP O
bed NN B-NP O
using VBG O O
a DT B-NP B-treatment
walker NN I-NP I-treatment
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
will MD O O
get VB O O
rehabilitation NN B-NP B-treatment
and CC O O
continue VB O O
to TO O O
get VB O O
care NN B-NP O
for IN B-VP O
his PRP$ O B-problem
his PRP$ O B-person
fluid NN B-NP I-problem
status NN I-NP I-problem
. . B-VP O
   
Shirley NNP B-NP B-person
H.Q. NNP I-NP I-person
Neller NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
56-333 CD O O
Dictated NNP B-NP O
By:Caroline NNP I-NP B-person
D NNP I-NP I-person
Dempsey NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
MEDQUIST36 NNP I-NP O
D NNP I-NP O
: : O O
2011-03-21 JJ O O
14:42 CD O O
T NN B-NP O
: : O O
2011-03-23 JJ O O
13:01 CD O O
JOB# NNPS B-NP O
: : O O
42266 CD O O
Signed VBN O O
electronically RB O O
by IN B-VP O
: : O O
DR. NNP B-NP B-person
Shirley NNP I-NP I-person
X NNP I-NP I-person
Schaack NNP I-NP I-person
on IN B-VP O
: : O O
Russell NNP B-NP O
2011-03-24 CD O O
7:54 CD O O
AM NNP B-NP O
( ( O O
End NNP B-NP O
of IN B-VP O
Report NNP B-NP O
) ) O O
-EMPTYLINE- VBP O O
-DOCSTART- JJ B-NP O
-EMPTYLINE- NNP I-NP O
Admission NNP I-NP O
Date NNP I-NP O
: : O O
2015-10-26 JJ B-NP O
Discharge NN I-NP O
Date NNP I-NP O
: : O O
2015-10-30 JJ B-NP O
Date NNP I-NP O
of IN B-VP O
Birth NNP B-NP O
: : O O
1998-01-05 JJ B-NP O
Sex NN I-NP O
: : O O
M NNP B-NP O
Service NNP I-NP O
: : O O
SURGERY JJ B-NP B-person
Allergies NNS I-NP O
: : O O
Sulfa NNP B-NP B-treatment
( ( O I-treatment
Sulfonamides NNP B-NP I-treatment
) ) O I-treatment
/ VBP O O
Penicillins NNS B-NP B-treatment
Attending VBG O O
: : O O
Mary NNP B-NP B-person
T NNP I-NP I-person
Davis NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
Chief NNP I-NP O
Complaint NNP I-NP O
: : O O
s/p NN B-NP O
Pedestrian JJ B-NP B-person
struck NN I-NP O
by IN B-VP O
auto NN B-NP O
Major NNP I-NP O
Surgical NNP I-NP O
or CC O O
Invasive JJ B-NP O
Procedure NN I-NP O
: : O O
2015-10-27 JJ B-NP O
Open NNP I-NP B-treatment
reduction NN I-NP I-treatment
and CC O O
internal JJ B-NP B-treatment
fixation NN I-NP I-treatment
of IN B-VP O
right JJ B-NP B-problem
tib/fib NN I-NP I-problem
fractures VBZ O I-problem
History NNP B-NP O
of IN B-VP O
Present NNP B-NP O
Illness NNP I-NP O
: : O O
17 CD O B-person
yo NNS B-NP I-person
male JJ O I-person
pedestrian JJ O I-person
who WP O B-person
was VBD B-VP O
struck VBN O O
by IN B-VP O
auto NN B-NP O
at IN B-VP O
unknown JJ B-NP O
speed NN I-NP O
; : O O
+LOC NNP B-NP B-problem
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
medflighted VBN O O
to TO O O
The DT B-NP O
Hospital NNP I-NP O
for IN B-VP O
Orthopedics NNP B-NP O
for IN B-VP O
ongoing VBG O B-treatment
trauma NN B-NP I-treatment
care NN I-NP I-treatment
. . B-VP O
   
Upon IN B-VP O
arrival JJ B-NP O
GCS NNP I-NP B-test
15 CD O O
, , O O
alert NN B-NP O
and CC O O
oriented VBN O O
x3 NN B-NP O
. . B-VP O
   
Past NNP B-NP O
Medical JJ B-NP O
History NN I-NP O
: : O O
Attention NNP B-NP B-problem
deficit NN I-NP I-problem
disorder NN I-NP I-problem
( ( O O
diagnosed VBN O O
@ RB O O
14 CD O O
yrs NN B-NP O
of IN B-VP O
age NN B-NP O
) ) O O
Social NNP B-NP O
History NNP I-NP O
: : O O
High JJ B-NP O
school NN I-NP O
student NN I-NP O
Resides NNP I-NP O
with IN B-VP O
parents NNS B-NP B-person
and CC O O
siblings NNS B-NP B-person
Family NNP I-NP B-person
History NNP I-NP O
: : O O
Noncontributory JJ B-NP O
Pertinent JJ I-NP O
Results NNS I-NP O
: : O O
2015-10-26 JJ O O
08:48 CD O O
PM NNP B-NP O
GLUCOSE NNP I-NP B-test
- : O O
101 CD O O
LACTATE NNP B-NP B-test
- : O O
2.9 CD O O
* NN B-NP O
NA+ NNP I-NP B-test
- : O O
142 CD O O
K+ NNP B-NP B-test
- : O O
3.6 CD O O
CL- JJ O B-test
- : O O
102 CD O O
TCO2 NNP B-NP B-test
- : O O
26 CD O O
2015-10-26 JJ O O
08:34 CD O O
PM NNP B-NP O
UREA NNP I-NP B-test
N NNP I-NP I-test
- : O O
12 CD O O
CREAT NNP B-NP B-test
- : O O
1.0 CD O O
2015-10-26 JJ O O
08:34 CD O O
PM NNP B-NP O
AMYLASE NNP I-NP B-test
- : O O
44 CD O O
2015-10-26 JJ O O
08:34 CD O O
PM NNP B-NP O
ASA NNP I-NP B-test
- : O O
NEG NNP B-NP O
ETHANOL NNP I-NP B-test
- : O O
NEG NNP B-NP O
ACETMNPHN NNP I-NP B-test
- : O O
NEG NNP B-NP O
bnzodzpn SYM O B-test
- : O O
NEG NNP B-NP O
barbitrt SYM O B-test
- : O O
NEG NNP B-NP O
tricyclic JJ O B-test
- : O O
NEG NNP B-NP O
2015-10-26 JJ O O
08:34 CD O O
PM NNP B-NP O
WBC NNP I-NP B-test
- : O O
16.0 CD O O
* NN B-NP O
RBC NNP I-NP B-test
- : O O
4.89 CD O O
HGB NNP B-NP B-test
- : O O
14.5 CD O O
HCT NNP B-NP B-test
- : O O
40.4 CD O O
MCV NNP B-NP B-test
- : O O
83 CD O O
MCH NNP B-NP B-test
- : O O
29.7 CD O O
MCHC NNP B-NP B-test
- : O O
35.9 CD O O
* NN B-NP O
RDW NNP I-NP B-test
- : O O
13.4 CD O O
2015-10-26 JJ O O
08:34 CD O O
PM NNP B-NP O
PLT NNP I-NP B-test
COUNT NNP I-NP I-test
- : O O
247 CD O O
2015-10-26 JJ O O
08:34 CD O O
PM NNP B-NP O
PT NNP I-NP B-test
- : O O
12.7 CD O O
PTT NNP B-NP B-test
- : O O
23.8 CD O O
INR(PT) NNP B-NP B-test
- : O O
1.1 CD O O
CT NNP B-NP B-test
HEAD NNP I-NP I-test
W/O NNP I-NP I-test
CONTRAST NNP I-NP I-test
Reason NNP I-NP O
: : O O
STUCK NN B-NP O
BY NNP I-NP O
AUTO NNP I-NP O
UNDERLYING NNP I-NP O
MEDICAL NNP I-NP O
CONDITION NNP I-NP O
: : O O
56 CD O B-person
year NN B-NP I-person
old JJ B-NP I-person
man NN I-NP I-person
s/p VBZ O O
struck VBN O O
by IN B-VP O
auto NN B-NP O
REASON NNP I-NP O
FOR NNP I-NP O
THIS NNP I-NP B-pronoun
THIS NNP I-NP B-test
EXAMINATION NNP I-NP I-test
: : O O
eval NN B-NP B-test
for IN B-VP O
bleed NN B-NP B-problem
CONTRAINDICATIONS NNP I-NP O
for IN B-VP O
IV NNP B-NP O
CONTRAST NNP I-NP O
: : O O
None NN B-NP O
. . B-VP O
   
INDICATION NN B-NP O
: : O O
Struck VBN O O
by IN B-VP O
car NN B-NP O
. . B-VP O
   
COMPARISONS NN B-NP O
: : O O
None NN B-NP O
. . B-VP O
   
TECHNIQUE NN B-NP O
: : O O
Axial JJ B-NP B-test
MDCT NNP I-NP I-test
images NNS I-NP I-test
of IN B-VP I-test
the DT B-NP I-test
brain NN I-NP I-test
without IN B-VP I-test
IV NNP B-NP I-test
contrast NN I-NP I-test
. . B-VP O
   
FINDINGS NN B-NP O
: : O O
There EX O O
is VBZ O O
a DT B-NP B-problem
linear JJ I-NP I-problem
nondepressed JJ I-NP I-problem
right JJ I-NP I-problem
temporal JJ I-NP I-problem
calvarial JJ I-NP I-problem
fracture NN I-NP I-problem
extending VBG O O
into IN B-VP O
the DT B-NP O
mastoid JJ I-NP O
process NN I-NP O
. . B-VP O
   
There EX O O
is VBZ O O
a DT B-NP B-problem
small JJ I-NP I-problem
subdural JJ I-NP I-problem
hematoma NN I-NP I-problem
with IN B-VP O
components NNS B-NP O
of IN B-VP O
pneumocephalus JJ O B-problem
tracking VBG O O
from IN B-VP O
the DT B-NP O
mastoid NN I-NP O
air NN I-NP O
cells NNS I-NP O
. . B-VP O
   
There EX O O
is VBZ O O
no DT B-NP O
shift NN I-NP B-problem
of IN B-VP I-problem
normally RB O I-problem
midline JJ B-NP I-problem
structures NNS I-NP I-problem
. . B-VP O
   
There EX O O
is VBZ O O
also RB O O
a DT B-NP B-problem
left JJ I-NP I-problem
occipital JJ I-NP I-problem
scalp JJ I-NP I-problem
contusion NN I-NP I-problem
but CC O O
no DT B-NP O
associated JJ I-NP B-problem
skull NN I-NP I-problem
fracture NN I-NP I-problem
. . B-VP O
   
Prominent JJ B-NP B-treatment
sutures NNS I-NP I-treatment
in IN B-VP O
this DT O B-pronoun
this DT B-NP B-person
young JJ I-NP I-person
patient NN I-NP I-person
, , O O
the DT B-NP B-treatment
right JJ I-NP I-treatment
calvarial JJ I-NP I-treatment
suture NN I-NP I-treatment
extending VBG O O
into IN B-VP O
the DT B-NP O
right JJ I-NP O
temporal JJ I-NP O
bones NNS I-NP O
appears VBZ O O
more JJR O O
prominent JJ O O
than IN B-VP O
its PRP$ O O
counterpart NN B-NP O
on IN B-VP O
the DT B-NP O
left NN I-NP O
, , O O
however RB O O
, , O O
does VBZ O O
not RB O O
appear VB O O
to TO O O
represent VB O O
an DT B-NP B-problem
acute JJ I-NP I-problem
fracture NN I-NP I-problem
. . B-VP O
   
No DT B-NP O
other JJ I-NP B-problem
acute NN I-NP I-problem
fractures NNS I-NP I-problem
are VBP O O
appreciated VBN O O
. . B-VP O
   
There EX O O
is VBZ O O
small JJ B-NP O
amount NN I-NP O
of IN B-VP O
mucosal NN B-NP B-problem
thickening VBG O I-problem
in IN B-VP I-problem
the DT B-NP I-problem
sphenoid NN I-NP I-problem
sinuses VBZ O I-problem
. . B-VP O
   
No DT B-NP O
air-fluid JJ I-NP B-test
levels NNS I-NP I-test
to TO O O
suggest VB O O
occult NN B-NP B-problem
facial JJ B-NP I-problem
fractures NNS I-NP I-problem
. . B-VP O
   
Orbits NNS B-NP O
are VBP O O
unremarkable JJ O O
. . B-VP O
   
IMPRESSION NN B-NP O
: : O O
Linear JJ B-NP B-problem
right JJ I-NP I-problem
temporal JJ I-NP I-problem
calvarial JJ I-NP I-problem
fracture NN I-NP I-problem
extending VBG O O
into IN B-VP O
the DT B-NP O
mastoid JJ I-NP O
process NN I-NP O
with IN B-VP O
small JJ O B-problem
associated VBN O I-problem
right JJ B-NP I-problem
posterior NN I-NP I-problem
convexity NN I-NP I-problem
subdural JJ B-NP I-problem
hematoma NN I-NP I-problem
and CC O O
pneumocephalus NN B-NP B-problem
. . B-VP O
   
Discussed VBN O O
with IN B-VP O
trauma JJ B-NP B-person
team NN I-NP I-person
during IN B-VP O
the DT B-NP B-test
study NN I-NP I-test
. . B-VP O
   
CT NNP B-NP B-test
C-SPINE NNP I-NP I-test
W/O NNP I-NP I-test
CONTRAST NNP I-NP I-test
Reason NNP I-NP O
: : O O
STUCK NN B-NP O
BY NNP I-NP O
AUTO NNP I-NP O
UNDERLYING NNP I-NP O
MEDICAL NNP I-NP O
CONDITION NNP I-NP O
: : O O
56 CD O B-person
year NN B-NP I-person
old JJ B-NP I-person
man NN I-NP I-person
s/p VBZ O O
struck VBN O O
by IN B-VP O
auto NN B-NP O
REASON NNP I-NP O
FOR NNP I-NP O
THIS NNP I-NP B-pronoun
THIS NNP I-NP B-test
EXAMINATION NNP I-NP I-test
: : O O
eval NN B-NP B-test
for IN B-VP O
fx JJ B-NP B-problem
CONTRAINDICATIONS NNP I-NP O
for IN B-VP O
IV NNP B-NP O
CONTRAST NNP I-NP O
: : O O
None NN B-NP O
. . B-VP O
   
INDICATION NN B-NP O
: : O O
18-year-old JJ B-NP B-person
hit NN I-NP O
by IN B-VP O
car NN B-NP O
. . B-VP O
   
Head NNP B-NP B-problem
injury NN I-NP I-problem
to TO O I-problem
the DT B-NP I-problem
occiput NN I-NP I-problem
. . B-VP O
   
COMPARISONS NN B-NP O
: : O O
None NN B-NP O
. . B-VP O
   
TECHNIQUE NN B-NP O
: : O O
Axial JJ B-NP B-test
MDCT NNP I-NP I-test
images NNS I-NP I-test
of IN B-VP I-test
the DT B-NP I-test
cervical JJ I-NP I-test
spine NN I-NP I-test
with IN B-VP O
coronal JJ O O
and CC O O
sagittal JJ B-NP O
reformats NNS I-NP O
without IN B-VP O
IV NNP B-NP O
contrast NN I-NP O
. . B-VP O
   
FINDINGS NNS B-NP O
: : O O
C1 NNP B-NP O
through IN B-VP O
T1 NNP B-NP O
are VBP O O
well RB O O
visualized VBN O O
. . B-VP O
   
There EX O O
is VBZ O O
normal JJ B-NP O
alignment NN I-NP O
of IN B-VP O
the DT B-NP O
cervical JJ I-NP O
vertebral JJ I-NP O
bodies NNS I-NP O
without IN B-VP O
acute JJ B-NP B-problem
fracture NN I-NP I-problem
or CC O O
traumatic JJ B-NP B-problem
malalignment NN I-NP I-problem
. . B-VP O
   
The DT B-NP O
posterior JJ I-NP O
elements NNS I-NP O
are VBP O O
intact JJ O O
. . B-VP O
   
There EX O O
is VBZ O O
no DT B-NP O
significant JJ I-NP B-problem
prevertebral JJ I-NP I-problem
soft JJ I-NP I-problem
tissue NN I-NP I-problem
swelling VBG O I-problem
. . B-VP O
   
The DT B-NP O
C1-C2 JJ I-NP O
relationship NN I-NP O
is VBZ O O
within IN B-VP O
normal JJ B-NP O
limits NNS I-NP O
. . B-VP O
   
The DT B-NP O
dens NNS I-NP O
is VBZ O O
intact JJ O O
. . B-VP O
   
The DT B-NP O
lung NN I-NP O
apices NNS I-NP O
are VBP O O
clear JJ O O
without IN B-VP O
pneumothorax NN B-NP B-problem
. . B-VP O
   
The DT B-NP O
upper JJ I-NP O
ribs NN I-NP O
are VBP O O
intact JJ O O
. . B-VP O
   
There EX O O
is VBZ O O
a DT B-NP B-problem
linear JJ I-NP I-problem
right JJ I-NP I-problem
temporal JJ I-NP I-problem
calvarial JJ I-NP I-problem
fracture NN I-NP I-problem
extending VBG O O
into IN B-VP O
the DT B-NP O
right JJ I-NP O
temporal JJ I-NP O
bones NNS I-NP O
. . B-VP O
   
This DT O B-pronoun
appears VBZ O O
to TO O O
stop VB O O
short NN B-NP O
of IN B-VP O
the DT B-NP O
carotid JJ I-NP O
canal NN I-NP O
. . B-VP O
   
Multiple NNP B-NP O
posterior JJ B-NP O
right NN I-NP O
- : O O
sided VBN O O
mastoid JJ B-NP O
air NN I-NP O
cells NNS I-NP O
are VBP O O
opacified VBN O B-problem
with IN B-VP I-problem
blood NN B-NP I-problem
. . B-VP O
   
IMPRESSION NN B-NP O
: : O O
1) CD O O
No NNP B-NP O
acute JJ B-NP B-problem
cervical JJ I-NP I-problem
spine NN I-NP I-problem
fracture NN I-NP I-problem
. . B-VP O
   
2) CD O O
Linear JJ B-NP B-problem
right JJ I-NP I-problem
temporal JJ I-NP I-problem
calvarial JJ I-NP I-problem
fracture NN I-NP I-problem
extending VBG O O
into IN B-VP O
the DT B-NP O
mastoid NN I-NP O
with IN B-VP O
a DT B-NP B-problem
small JJ I-NP I-problem
right JJ I-NP I-problem
posterior NN I-NP I-problem
convexity NN I-NP I-problem
subdural JJ B-NP I-problem
hematoma NN I-NP I-problem
and CC O O
pneumocephalus NN B-NP B-problem
; : O O
see VB O O
head JJ B-NP B-test
CT NNP I-NP I-test
report NN I-NP O
. . B-VP O
   
CHEST NNP B-NP B-test
( ( O I-test
PA NNP B-NP I-test
& CC O I-test
LAT NNP B-NP I-test
) ) O I-test
Reason NNP B-NP O
: : O O
Please NNP B-NP O
r/o VB O O
acute JJ B-NP B-problem
process NN I-NP I-problem
. . B-VP O
   
UNDERLYING NNP B-NP O
MEDICAL NNP I-NP O
CONDITION NNP I-NP O
: : O O
17 CD O B-person
year NN B-NP I-person
old JJ B-NP I-person
man NN I-NP I-person
with IN B-VP O
post-op JJ B-NP B-problem
fever NN I-NP I-problem
. . B-VP O
   
REASON NNP B-NP O
FOR IN B-VP O
THIS NNP B-NP B-pronoun
THIS NNP I-NP B-test
EXAMINATION NNP I-NP I-test
: : O O
Please NNP B-NP O
r/o VB O O
acute JJ B-NP B-problem
process NN I-NP I-problem
. . B-VP O
   
INDICATION NN B-NP O
: : O O
Postoperative JJ B-NP B-problem
fever NN I-NP I-problem
. . B-VP O
   
COMPARISONS NN B-NP O
: : O O
Comparison NN B-NP O
is VBZ O O
made VBN O O
to TO O O
2015-10-27 JJ O O
. . B-VP O
   
TECHNIQUE NN B-NP O
: : O O
PA NNP B-NP B-test
and CC O I-test
lateral JJ B-NP I-test
views NNS I-NP I-test
of IN B-VP I-test
the DT B-NP I-test
chest NN I-NP I-test
. . B-VP O
   
FINDINGS NN B-NP O
: : O O
The DT B-NP O
heart NN I-NP O
is VBZ O O
of IN B-VP O
normal JJ B-NP O
size NN I-NP O
. . B-VP O
   
Mediastinal NNP B-NP O
and CC O O
hilar JJ B-NP O
contours NNS I-NP O
are VBP O O
within IN B-VP O
normal JJ B-NP O
limits NNS I-NP O
. . B-VP O
   
The DT B-NP O
lung NN I-NP O
fields NNS I-NP O
are VBP O O
clear JJ O O
. . B-VP O
   
There EX O O
are VBP O O
no DT B-NP O
pleural JJ I-NP B-problem
effusions NNS I-NP I-problem
or CC O O
focal JJ B-NP B-problem
consolidations NNS I-NP I-problem
. . B-VP O
   
There EX O O
is VBZ O O
no DT B-NP O
evidence NN I-NP O
of IN B-VP O
CHF NNP B-NP B-problem
. . B-VP O
   
IMPRESSION NN B-NP O
: : O O
No DT B-NP O
evidence NN I-NP O
of IN B-VP O
significant JJ B-NP B-problem
abnormality NN I-NP I-problem
. . B-VP O
   
TIB NNP B-NP B-test
/ NNP I-NP I-test
FIB NNP I-NP I-test
( ( O I-test
AP NNP B-NP I-test
& CC O I-test
LAT NNP B-NP I-test
) ) O I-test
SOFT NNP B-NP O
TISSUE NNP I-NP O
Reason NNP I-NP O
: : O O
eval NN B-NP B-test
for IN B-VP I-test
alignment NN B-NP I-test
, , O I-test
post NN B-NP I-test
op NN I-NP I-test
changes NNS I-NP I-test
UNDERLYING NNP I-NP O
MEDICAL NNP I-NP O
CONDITION NNP I-NP O
: : O O
56 CD O B-person
year NN B-NP I-person
old JJ B-NP I-person
man NN I-NP I-person
with IN B-VP O
open JJ B-NP B-problem
RLE NNP I-NP I-problem
fx NN I-NP I-problem
now RB O O
s/p VBZ O B-treatment
fixation NN B-NP I-treatment
REASON NNP I-NP O
FOR NNP I-NP O
THIS NNP I-NP B-pronoun
THIS NNP I-NP B-test
EXAMINATION NNP I-NP I-test
: : O O
eval NN B-NP B-test
for IN B-VP I-test
alignment NN B-NP I-test
, , O I-test
post NN B-NP I-test
op NN I-NP I-test
changes NNS I-NP I-test
INDICATION NNP I-NP O
: : O O
Fracture NN B-NP B-problem
. . B-VP O
   
Assess NNP B-NP O
for IN B-VP O
alignment NN B-NP O
. . B-VP O
   
RIGHT NNP B-NP B-test
TIBIA NNP I-NP I-test
/ NNP I-NP I-test
FIBULA NNP I-NP I-test
, , O I-test
AP NNP B-NP I-test
AND NNP I-NP I-test
LATERAL NNP I-NP I-test
VIEWS NNP I-NP I-test
: : O O
An DT B-NP B-treatment
intramedullary JJ I-NP I-treatment
rod NN I-NP I-treatment
is VBZ O O
seen VBN O O
fixating VBG O O
a DT B-NP B-problem
proximal JJ I-NP I-problem
diaphyseal NN I-NP I-problem
comminuted VBN O I-problem
tibial JJ B-NP I-problem
fracture NN I-NP I-problem
with IN B-VP O
six CD O B-treatment
proximal JJ O I-treatment
and CC O I-treatment
two CD O I-treatment
distal JJ B-NP I-treatment
screws NNS I-NP I-treatment
. . B-VP O
   
Additionally RB O O
, , O O
a DT B-NP B-treatment
side NN I-NP I-treatment
plate NN I-NP I-treatment
is VBZ O O
seen VBN O O
medially RB O O
fixating VBG O O
the DT B-NP B-problem
fracture NN I-NP I-problem
. . B-VP O
   
There EX O O
is VBZ O O
a DT B-NP B-problem
non-displaced JJ I-NP I-problem
comminuted JJ I-NP I-problem
fracture NN I-NP I-problem
of IN B-VP I-problem
the DT B-NP I-problem
proximal JJ I-NP I-problem
fibular JJ I-NP I-problem
diaphysis NN I-NP I-problem
. . B-VP O
   
There EX O O
is VBZ O O
surrounding VBG O O
soft JJ B-NP B-problem
tissue NN I-NP I-problem
swelling VBG O I-problem
. . B-VP O
   
Os NNP B-NP O
trigonum NN I-NP O
is VBZ O O
visualized VBN O O
. . B-VP O
   
IMPRESSION NN B-NP O
: : O O
Comminuted VBN O B-problem
proximal JJ B-NP I-problem
tibiofibular JJ I-NP I-problem
fractures NNS I-NP I-problem
status NN I-NP B-treatment
post NN I-NP I-treatment
ORIF NNP I-NP I-treatment
of IN B-VP I-treatment
the DT B-NP I-treatment
tibia NN I-NP I-treatment
with IN B-VP O
an DT B-NP B-treatment
intramedullary JJ I-NP I-treatment
rod NN I-NP I-treatment
and CC O I-treatment
side NN B-NP I-treatment
plate NN I-NP I-treatment
. . B-VP O
   
No DT B-NP O
evidence NN I-NP O
of IN B-VP O
immediate JJ B-NP B-problem
hardware NN I-NP I-problem
complication NN I-NP I-problem
. . B-VP O
   
CT NNP B-NP B-test
HEAD NNP I-NP I-test
W/O NNP I-NP I-test
CONTRAST NNP I-NP I-test
Reason NNP I-NP O
: : O O
follow VB O B-test
up RP O I-test
ct NN B-NP I-test
UNDERLYING NNP I-NP O
MEDICAL NNP I-NP O
CONDITION NNP I-NP O
: : O O
17 CD O B-person
year NN B-NP I-person
old JJ B-NP I-person
man NN I-NP I-person
with IN B-VP O
pneumocephalus JJ B-NP B-problem
s/p NN I-NP O
CMED NNP I-NP O
CCU NNP I-NP O
v. NN I-NP O
mvc NN I-NP O
REASON NNP I-NP O
FOR NNP I-NP O
THIS NNP I-NP B-pronoun
THIS NNP I-NP B-test
EXAMINATION NNP I-NP I-test
: : O O
follow VB O B-test
up RP O I-test
ct NN B-NP I-test
CONTRAINDICATIONS NNP I-NP O
for IN B-VP O
IV NNP B-NP O
CONTRAST NNP I-NP O
: : O O
None NN B-NP O
. . B-VP O
   
CLINICAL JJ B-NP O
HISTORY NN I-NP O
: : O O
History NN B-NP O
of IN B-VP O
pneumocephalus NN B-NP B-problem
status NN I-NP O
post NN I-NP O
pedestrian JJ B-NP B-person
versus NN I-NP O
motor NN I-NP O
vehicle NN I-NP O
collision NN I-NP O
. . B-VP O
   
Follow VB O B-test
up RP O I-test
CT NNP B-NP I-test
scan JJ O I-test
. . B-VP O
   
COMPARISON NN B-NP O
: : O O
Non-contrast JJ B-NP B-test
head NN I-NP I-test
CT NNP I-NP I-test
from IN B-VP O
2015-10-27 JJ O O
. . B-VP O
   
TECHNIQUE NN B-NP O
: : O O
Non-contrast JJ B-NP B-test
head NN I-NP I-test
CT NNP I-NP I-test
. . B-VP O
   
FINDINGS NN B-NP O
: : O O
The DT O O
previously RB O O
noted VBN O O
subdural JJ B-NP B-problem
hemorrhage NN I-NP I-problem
in IN B-VP I-problem
the DT B-NP I-problem
right JJ I-NP I-problem
posterior NN I-NP I-problem
fossa NN I-NP I-problem
appears VBZ O O
less RBR O O
conspicuous JJ O O
. . B-VP O
   
The DT B-NP O
pneumocephalus JJ I-NP B-problem
adjacent NN I-NP O
to TO O O
the DT B-NP B-problem
linear JJ I-NP I-problem
skull NN I-NP I-problem
fracture NN I-NP I-problem
appears VBZ O O
to TO O O
have VB O O
decreased VBN O O
in IN B-VP O
size NN B-NP O
. . B-VP O
   
There EX O O
are VBP O O
persistent JJ B-NP B-problem
bifrontal NN I-NP I-problem
and CC O I-problem
right JJ B-NP I-problem
parietal NN I-NP I-problem
hemorrhagic JJ B-NP I-problem
contusions NNS I-NP I-problem
with IN B-VP O
surrounding VBG O B-problem
edema NN B-NP I-problem
and CC O O
possible JJ O O
small JJ O B-problem
left VBD B-VP I-problem
frontal JJ B-NP I-problem
subarachnoid JJ I-NP I-problem
hemorrhage NN I-NP I-problem
( ( O O
adjacent JJ O O
to TO O O
falx VB O O
) ) O O
which WDT O B-pronoun
are VBP O O
largely RB O O
unchanged JJ O O
. . B-VP O
   
There EX O O
is VBZ O O
no DT B-NP O
shift NN I-NP B-problem
of IN B-VP I-problem
normally RB O I-problem
midline JJ B-NP I-problem
structures NNS I-NP I-problem
or CC O O
hydrocephalus NN B-NP B-problem
. . B-VP O
   
The DT B-NP O
ventricles NNS I-NP O
, , O O
cisterns NNS B-NP O
and CC O O
sulci NNS B-NP O
are VBP O O
normal JJ O O
. . B-VP O
   
The DT B-NP B-test
air- JJ I-NP I-test
fluid NN I-NP I-test
level NN I-NP I-test
in IN B-VP I-test
the DT B-NP I-test
right JJ I-NP I-test
sphenoid NN I-NP I-test
sinus NN I-NP I-test
and CC O O
bilateral JJ B-NP B-problem
opacification NN I-NP I-problem
of IN B-VP I-problem
the DT B-NP I-problem
mastoid JJ I-NP I-problem
air NN I-NP I-problem
cells NNS I-NP I-problem
are VBP O O
unchanged JJ O O
. . B-VP O
   
IMPRESSION NN B-NP O
: : O O
1. CD O O
Decreased VBD B-VP O
size NN B-NP O
of IN B-VP O
right JJ B-NP B-problem
posterior JJ I-NP I-problem
subdural JJ I-NP I-problem
hemorrhage NN I-NP I-problem
. . B-VP O
   
2. CD O O
Multifocal JJ B-NP B-problem
hemorrhagic NN I-NP I-problem
contusions NNS I-NP I-problem
and CC O O
surrounding VBG O B-problem
edema NN B-NP I-problem
are VBP O O
largely RB O O
unchanged JJ O O
. . B-VP O
   
Brief JJ B-NP O
Hospital JJ I-NP O
Course NN I-NP O
: : O O
He PRP O B-person
was VBD B-VP O
admitted VBN O O
to TO O O
the DT B-NP O
trauma NN I-NP B-person
service NN I-NP I-person
. . B-VP O
   
Orthopedics NNS B-NP B-person
and CC O O
Neurosurgery NNP B-NP B-person
were VBD B-VP O
consulted VBN O O
because IN B-VP O
of IN B-VP O
his PRP$ O B-person
his PRP$ O B-problem
injuries NNS B-NP I-problem
. . B-VP O
   
His PRP$ O B-person
His PRP$ O B-problem
Neurosurgical JJ B-NP I-problem
issues NNS I-NP I-problem
were VBD B-VP O
nonoperative JJ O O
; : O O
he PRP O B-person
was VBD B-VP O
loaded VBN O O
with IN B-VP O
Dilantin NNP B-NP B-treatment
; : O O
serial JJ B-NP B-test
head NN I-NP I-test
CT NNP I-NP I-test
scans NNS I-NP I-test
were VBD B-VP O
performed VBN O O
and CC O O
were VBD B-VP O
stable JJ O O
. . B-VP O
   
He PRP O B-person
will MD O O
need VB O O
to TO O O
follow VB O O
up RP O O
with IN B-VP O
Dr. NNP B-NP B-person
Mckinney NNP I-NP I-person
in IN B-VP O
4 CD O O
weeks NNS B-NP O
for IN B-VP O
repeat NN B-NP B-test
head NN I-NP I-test
imaging NN I-NP I-test
and CC O O
continue NN B-NP O
with IN B-VP O
Dilantin NNP B-NP B-treatment
for IN B-VP O
one CD O O
month NN B-NP O
. . B-VP O
   
His PRP$ O B-person
His PRP$ O B-problem
right NN B-NP I-problem
tib NN I-NP I-problem
/ NNP I-NP I-problem
fib NN I-NP I-problem
fracture NN I-NP I-problem
was VBD B-VP O
repaired VBN O O
by IN B-VP O
Orthopedics NNS B-NP B-person
on IN B-VP O
10-27 JJ O O
; : O O
postoperatively RB O O
there EX O O
were VBD B-VP O
no DT B-NP O
complications NNS I-NP B-problem
. . B-VP O
   
Weight NNP B-NP O
bearing VBG O O
status NN B-NP O
was VBD B-VP O
increased VBN O O
to TO O O
weight VB O O
bearing NN B-NP O
as IN B-VP O
tolerated JJ O O
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
fitted VBN O O
with IN B-VP O
a DT B-NP B-treatment
hinged JJ I-NP I-treatment
Mcdonald NNP I-NP I-treatment
brace NN I-NP I-treatment
for IN B-VP O
his PRP$ O B-person
his PRP$ O B-problem
LLE NNP B-NP I-problem
. . B-VP O
   
He PRP O B-person
will MD O O
need VB O O
to TO O O
continue VB O O
on IN B-VP O
Lovenox NNP B-NP B-treatment
injections NNS I-NP I-treatment
for IN B-VP O
at IN B-VP O
least JJS B-NP O
4-6 JJ I-NP O
weeks NNS I-NP O
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
transfused VBN O O
with IN B-VP O
3 CD O B-treatment
u JJ O I-treatment
packed VBD B-VP I-treatment
cells NNS B-NP I-treatment
for IN B-VP O
a DT B-NP B-test
hematocrit NN I-NP I-test
of IN B-VP O
21 CD O O
, , O O
post NN B-NP B-test
transfusion NN I-NP I-test
HCT NNP I-NP I-test
was VBD B-VP O
26.1 CD O O
; : O O
there EX O O
was VBD B-VP O
a DT B-NP O
questionable JJ I-NP O
transfusion NN I-NP B-problem
reaction NN I-NP I-problem
at IN B-VP O
the DT B-NP O
end NN I-NP O
of IN B-VP O
his PRP$ O B-person
his PRP$ O B-treatment
first JJ B-NP I-treatment
unit NN I-NP I-treatment
of IN B-VP I-treatment
packed JJ B-NP I-treatment
cells NNS I-NP I-treatment
; : O O
he PRP O B-person
did VBD B-VP O
subsequently RB O O
receive VB O O
the DT O B-treatment
remaining VBG O I-treatment
2 CD O I-treatment
units NNS B-NP I-treatment
without IN B-VP O
any DT B-NP B-problem
further JJ I-NP I-problem
reaction NN I-NP I-problem
. . B-VP O
   
Physical JJ O B-person
and CC O I-person
Occupational JJ B-NP I-person
therapy NN I-NP I-person
were VBD B-VP O
consulted VBN O O
and CC O O
have VBP O O
recommended VBN O O
home NN B-NP O
with IN B-VP O
services NNS B-NP O
. . B-VP O
   
Medications NNS B-NP O
on IN B-VP O
Admission NN B-NP O
: : O O
None NN B-NP O
Allergic NNP I-NP B-problem
to TO O O
PCN NNP B-NP B-treatment
and CC O O
Sulfa NNP B-NP B-treatment
Discharge NNP I-NP O
Medications NNP I-NP O
: : O O
1. CD O O
Phenytoin NNP B-NP B-treatment
50 CD O O
mg NN B-NP O
Tablet NNP I-NP O
, , O O
Chewable JJ B-NP O
Sig NN I-NP O
: : O O
Two CD O O
( ( O O
2 CD O O
) ) O O
Tablet NN B-NP O
, , O O
Chewable NNP B-NP O
PO NNP I-NP O
three CD O O
times NNS B-NP O
a DT B-NP O
day NN I-NP O
for IN B-VP O
1 CD O O
months NNS B-NP O
. . B-VP O
   
Disp NNP B-NP O
:* VBD B-VP O
180 CD O O
Tablet NNP B-NP O
, , O O
Chewable NNP B-NP O
(s)* NNP I-NP O
Refills NNP I-NP O
:* VBZ O O
0 CD O O
* NN B-NP O
2. CD O O
Oxycodone NNP B-NP B-treatment
5 CD O O
mg NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
Two CD O O
( ( O O
2 CD O O
) ) O O
Tablet NNP B-NP O
PO NNP I-NP O
Q4H NNP I-NP O
( ( O O
every DT O O
4 CD O O
hours NNS B-NP O
) ) O O
as IN B-VP O
needed VBN O O
for IN B-VP O
pain NN B-NP B-problem
. . B-VP O
   
Disp NNP B-NP O
:* VBD B-VP O
75 CD O O
Tablet NNP B-NP O
(s)* NNP I-NP O
Refills NNP I-NP O
:* VBZ O O
0 CD O O
* NN B-NP O
3. CD O O
Docusate NNP B-NP B-treatment
Sodium NNP I-NP I-treatment
100 CD O O
mg NN B-NP O
Capsule NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Capsule NNP B-NP O
PO NNP I-NP O
BID NNP I-NP O
( ( O O
2 CD O O
times NNS B-NP O
a DT B-NP O
day NN I-NP O
). POS O O
4. CD O O
Magnesium NNP B-NP B-treatment
Hydroxide NNP I-NP I-treatment
400 CD O O
mg NN B-NP O
/ VBD B-VP O
5 CD O O
mL JJ B-NP O
Suspension NNP I-NP O
Sig NNP I-NP O
: : O O
Thirty NNP B-NP O
( ( O O
30 CD O O
) ) O O
ML NNP B-NP O
PO NNP I-NP O
Q6H NNP I-NP O
( ( O O
every DT O O
6 CD O O
hours NNS B-NP O
) ) O O
as IN B-VP O
needed VBN O O
for IN B-VP O
constipation NN B-NP B-problem
. . B-VP O
   
5. CD O O
Lovenox NNP B-NP B-treatment
40 CD O O
mg NN B-NP O
/ VBD B-VP O
0.4 CD O O
mL NN B-NP O
Syringe NNP I-NP O
Sig NNP I-NP O
: : O O
0.4 CD O O
ML NNP B-NP O
's POS O O
Subcutaneous NNP B-NP O
once RB O O
a DT B-NP O
day NN I-NP O
for IN B-VP O
30 CD O O
days NNS B-NP O
. . B-VP O
   
Disp NNP B-NP O
:* VBD B-VP O
30 CD O O
* NNP B-NP O
Refills NNP I-NP O
:* VBZ O O
0 CD O O
* NN B-NP O
Discharge NNP I-NP O
Disposition NNP I-NP O
: : O O
Home NN B-NP O
with IN B-VP O
Service NNP B-NP O
Discharge NNP I-NP O
Diagnosis NNP I-NP O
: : O O
s/p NN B-NP O
Pedestrian JJ B-NP B-person
Struck NNP I-NP O
by IN B-VP O
Auto NNP B-NP O
Subdural NNP I-NP B-problem
hematoma NN I-NP I-problem
Skull NNP I-NP B-problem
fracture NN I-NP I-problem
Right NNP I-NP B-problem
comminuted VBD B-VP I-problem
tibia JJ B-NP I-problem
/ NNP I-NP I-problem
fibula NN I-NP I-problem
fracture NN I-NP I-problem
Discharge NNP I-NP O
Condition NNP I-NP O
: : O O
Good JJ B-NP O
Discharge NN I-NP O
Instructions NNS I-NP O
: : O O
Return NN B-NP O
to TO O O
the DT B-NP O
emergency NN I-NP O
room NN I-NP O
if IN B-VP O
you PRP O B-person
develop VBP O O
fevers NNS B-NP B-problem
, , O O
chills NNS B-NP B-problem
, , O O
severe JJ B-NP B-problem
headaches NNS I-NP I-problem
, , O O
visual JJ B-NP B-problem
disturbances NNS I-NP I-problem
, , O O
nause RB O B-problem
, , O O
vomiting VBG O B-problem
and CC O O
/ CD O O
or CC O O
any DT B-NP B-problem
other JJ I-NP I-problem
symptoms NNS I-NP I-problem
that WDT O B-pronoun
are VBP O O
concerning VBG O O
to TO O O
you PRP O B-person
. . B-VP O
   
You PRP O B-person
will MD O O
need VB O O
to TO O O
conrtinue VB O O
with IN B-VP O
your PRP$ O B-person
your PRP$ O B-treatment
Lovenox JJ B-NP I-treatment
injections NNS I-NP I-treatment
for IN B-VP O
at IN B-VP O
least JJS B-NP O
4-6 JJ I-NP O
weeks NNS I-NP O
as IN B-VP O
instructed VBN O O
by IN B-VP O
Orthopedics NNP B-NP B-person
Followup NNP I-NP O
Instructions NNP I-NP O
: : O O
Follow NNP B-NP O
up RP O O
with IN B-VP O
Dr. NNP B-NP B-person
Garza NNP I-NP I-person
, , O O
Orthopaedics NNP B-NP B-person
in IN B-VP O
10-14 JJ B-NP O
days NNS I-NP O
, , O O
call VB O O
953 CD O O
6923 CD O O
for IN B-VP O
an DT B-NP O
appointment NN I-NP O
. . B-VP O
   
Follow VB O O
up RP O O
with IN B-VP O
Dr. NNP B-NP B-person
Melendez NNP I-NP I-person
, , O O
Neurosurgery NNP B-NP B-person
in IN B-VP O
4 CD O O
weeks NNS B-NP O
; : O O
call VB O O
745 CD O O
8256 CD O O
ext SYM O O
- : O O
6468 CD O O
for IN B-VP O
an DT B-NP O
appointment NN I-NP O
. . B-VP O
   
Inform VB O O
the DT B-NP O
office NN I-NP O
that IN B-VP B-pronoun
you PRP O B-person
will MD O O
need VB O O
a DT B-NP B-test
repeat NN I-NP I-test
head NN I-NP I-test
CT NNP I-NP I-test
scan NN I-NP I-test
for IN B-VP O
this DT B-NP B-pronoun
appointment NN I-NP O
. . B-VP O
   
Lori NNP B-NP B-person
Dorothy NNP I-NP I-person
MD NNP I-NP I-person
79-290 JJ O O
Completed VBN O O
by IN B-VP O
: : O O
Christopher NNP B-NP B-person
Sandy NNP I-NP I-person
NP NNP I-NP I-person
80-BYL JJ B-NP O
2015-11-03 JJ I-NP O
@ NN I-NP O
1526 CD O O
Signed NNP B-NP O
electronically RB O O
by IN B-VP O
: : O O
DR. NNP B-NP B-person
Muriel NNP I-NP I-person
Zech NNP I-NP I-person
on IN B-VP O
: : O O
WED JJ O O
2015-11-04 JJ O O
11:30 CD O O
AM NNP B-NP O
( ( O O
End NNP B-NP O
of IN B-VP O
Report NNP B-NP O
) ) O O
-EMPTYLINE- VBP O O
-DOCSTART- JJ O O
-EMPTYLINE- $ O O
285864187 CD O O
OMH NNP B-NP O
7792851 CD O O
920021 CD O O
1/1/1998 CD O O
12:00:00 CD O O
AM NNP B-NP O
1) CD O O
STAPH NNP B-NP B-problem
. . B-VP O
   
SEPSIS NNP B-NP O
RELATED NNP I-NP O
TO NNP I-NP O
PICC NNP I-NP B-treatment
LINE NNP I-NP I-treatment
. . B-VP O
   
2) CD O O
PREVIOUS NNP B-NP B-problem
ANOXIC NNP I-NP I-problem
Unsigned VBD B-VP O
DIS NNP B-NP O
Report NNP I-NP O
Status NNP I-NP O
: : O O
Unsigned VBD B-VP O
DISCHARGE NNP B-NP O
SUMMARY NNP I-NP O
NAME NN I-NP O
: : O O
GACH NNP B-NP B-person
, , O I-person
CH NNP B-NP I-person
UNIT NNP I-NP O
NUMBER NNP I-NP O
: : O O
397-72-29 JJ B-NP O
ADMISSION NNP I-NP O
DATE NNP I-NP O
: : O O
01/01/98 CD O O
DISCHARGE NNP B-NP O
DATE NNP I-NP O
: : O O
01/07/98 CD O O
DIAGNOSES NNP B-NP O
: : O O
1) CD O O
Staph. NNP B-NP B-problem
sepsis NN I-NP I-problem
related VBN O O
to TO O O
PICC NNP B-NP B-treatment
line NN I-NP I-treatment
. . B-VP O
   
2) CD O O
Previous JJ B-NP B-problem
anoxicbrain NN I-NP I-problem
damage NN I-NP I-problem
. . B-VP O
   
3) CD O O
Previous JJ B-NP B-problem
myocardial JJ I-NP I-problem
infarction NN I-NP I-problem
. . B-VP O
   
4) CD O O
coronary JJ B-NP B-problem
artery NN I-NP I-problem
disease NN I-NP I-problem
. . B-VP O
   
5) CD O O
status NN B-NP O
post NN I-NP O
CABG NNP I-NP B-treatment
surgery NN I-NP I-treatment
in IN B-VP O
11/97 CD O O
. . B-VP O
   
6) CD O O
paroxysmal JJ B-NP B-problem
atrial JJ I-NP I-problem
fibrillation NN I-NP I-problem
. . B-VP O
   
7) CD O O
mild JJ B-NP B-problem
chronic JJ I-NP I-problem
renal JJ I-NP I-problem
insufficiency NN I-NP I-problem
. . B-VP O
   
PRINCIPAL JJ B-NP O
PROCEDURE NNP I-NP O
: : O O
None NN B-NP O
. . B-VP O
   
CLINICAL JJ B-NP O
INFECTION NN I-NP O
: : O O
Positive JJ B-NP B-problem
blood NN I-NP I-problem
cultures NNS I-NP I-problem
with IN B-VP O
Staph. NNP B-NP B-problem
aureus VBP O I-problem
sensitiveto NN B-NP O
Methicillin NNP I-NP B-treatment
. . B-VP O
   
MEDICATIONS NNP B-NP O
ON NNP I-NP O
DISCHARGE NNP I-NP O
: : O O
Hydralazine $ O B-treatment
10 CD O O
mgs NN B-NP O
PO NNP I-NP O
t.i.d. NN I-NP O
, , O O
Digoxin NNP B-NP B-treatment
0.125 CD O O
mgs NN B-NP O
PO NNP I-NP O
q.d. NN I-NP O
, , O O
thiamine VB O B-treatment
100 CD O O
mgs NN B-NP O
PO NNP I-NP O
q.d. NN I-NP O
, , O O
multi-vitamin JJ O B-treatment
1 CD O O
tab. NN B-NP O
PO NNP I-NP O
q.d. NN I-NP O
, , O O
Peri NNP B-NP B-treatment
- : O I-treatment
Colace NN B-NP I-treatment
100 CD O O
mgs NN B-NP O
PO NNP I-NP O
t.i.d. NN I-NP O
, , O O
folate VBP O B-treatment
1 CD O O
mg NN B-NP O
PO NNP I-NP O
q.d. NN I-NP O
, , O O
Norvasc NNP B-NP B-treatment
2.5 CD O O
mgs NN B-NP O
PO NNP I-NP O
q.HS NN I-NP O
, , O O
Ritalin NNP B-NP B-treatment
10 CD O O
mgs NN B-NP O
PO NNP I-NP O
b.i.d. NN I-NP O
, , O O
Trazodone NNP B-NP B-treatment
25 CD O O
mgs NN B-NP O
PO NNP I-NP O
q.HS NN I-NP O
, , O O
Nafcillin NNP B-NP B-treatment
2 CD O O
gramsIV NN B-NP O
q.4H NN I-NP O
which WDT O B-pronoun
wil VBZ O O
conclude NN B-NP O
at IN B-VP O
the DT B-NP O
end NN I-NP O
of IN B-VP O
the DT B-NP O
day NN I-NP O
on IN B-VP O
1/16/98 CD O O
, , O O
Atroventnebulizer NNP B-NP B-treatment
PRN NNP I-NP O
, , O O
Albuterol NNP B-NP B-treatment
nebulizer NN I-NP I-treatment
PRN NNP I-NP O
, , O O
Tylenol NNP B-NP B-treatment
650 CD O O
mgs NN B-NP O
PO NNP I-NP O
q.4H NN I-NP O
PRN NNP I-NP O
pain NN I-NP B-problem
. . B-VP O
   
HISTORY NNP B-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS NNP I-NP O
: : O O
Mr. NNP B-NP B-person
Gach NNP I-NP I-person
is VBZ O O
an DT O O
80 CD O O
year NN B-NP O
old JJ B-NP O
man NN I-NP O
with IN B-VP O
aprevious JJ B-NP O
history NN I-NP O
of IN B-VP O
coronary JJ B-NP B-problem
artery NN I-NP I-problem
disease NN I-NP I-problem
who WP O B-person
was VBD B-VP O
transferred VBN O O
from IN B-VP O
Linghs NNP B-NP O
County NNP I-NP O
Medical NNP I-NP O
Center NNP I-NP O
to TO O O
Oaksgekesser/ NNP B-NP O
Memorial NNP I-NP O
Hospital NNP I-NP O
because IN B-VP O
of IN B-VP O
an DT O B-problem
apparent JJ O I-problem
infected VBN O I-problem
wound NN B-NP I-problem
, , O O
including VBG O O
the DT B-NP B-treatment
PICC NNP I-NP I-treatment
line NN I-NP I-treatment
in IN B-VP O
his PRP$ O B-person
right JJ B-NP O
elbow NN I-NP O
and CC O O
positive JJ B-NP B-problem
blood NN I-NP I-problem
cultures NNS I-NP I-problem
for IN B-VP O
Staph. NNP B-NP B-problem
aureus NN I-NP I-problem
associated VBN O O
with IN B-VP O
fever NN B-NP B-problem
. . B-VP O
   
He PRP O B-person
has VBZ O O
a DT B-NP O
history NN I-NP O
of IN B-VP O
myocardial JJ B-NP B-problem
infarctions NNS I-NP I-problem
in IN B-VP O
1981 CD O O
, , O O
1992 CD O O
and CC O O
08/97 CD O O
with IN B-VP O
thelast JJ B-NP O
episode NN I-NP O
complicated VBN O O
by IN B-VP O
anoxic JJ B-NP B-problem
encephalopathy NN I-NP I-problem
. . B-VP O
   
He PRP O B-person
gradually RB O O
improved VBD B-VP O
but CC O O
had VBD B-VP O
recurrent VBN O B-problem
angina RB O I-problem
requiring VBG O O
cardiac JJ B-NP B-test
catheterization NN I-NP I-test
, , O O
demonstrating VBG O O
90% CD O O
left VBD B-VP O
main JJ O O
, , O O
95% CD O O
ostial JJ B-NP O
LAD NNP I-NP O
and CC O O
30 CD O O
to TO O O
40% CD O O
mid-LAD NN B-NP O
with IN B-VP O
an DT B-NP B-problem
occluded JJ I-NP I-problem
RCA NNP I-NP I-problem
. . B-VP O
   
CABG NNP B-NP B-treatment
surgery NN I-NP I-treatment
with IN B-VP O
two CD O B-treatment
vessel JJ B-NP I-treatment
bypass NN I-NP I-treatment
was VBD B-VP O
done VBN O O
on IN B-VP O
11/18/97 CD O O
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
then RB O O
transferred VBN O O
to TO O O
Linghs NNP B-NP O
County NNP I-NP O
Medical NNP I-NP O
Center NNP I-NP O
. . B-VP O
   
A NNP B-NP B-treatment
PICC NNP I-NP I-treatment
line NN I-NP I-treatment
was VBD B-VP O
placed VBN O O
in IN B-VP O
his PRP$ O B-person
left JJ B-NP O
antecubital JJ I-NP O
fossa NN I-NP O
and CC O O
on IN B-VP O
the DT B-NP O
day NN I-NP O
of IN B-VP O
New NNP B-NP O
Years NNP I-NP O
Eve NNP I-NP O
he PRP O B-person
developed VBD B-VP O
a DT B-NP B-problem
fever NN I-NP I-problem
of IN B-VP O
102 CD O O
and CC O O
became VBD B-VP O
lethargic JJ O B-problem
. . B-VP O
   
The DT B-NP B-treatment
PICC NNP I-NP I-treatment
line NN I-NP I-treatment
site NN I-NP I-treatment
was VBD B-VP O
erythematous JJ O B-problem
. . B-VP O
   
Blood NN B-NP B-test
cultures NNS I-NP I-test
grew VBD B-VP O
out RP O O
4 CD O O
out IN B-VP O
of IN B-VP O
4 CD O O
bottles NNS B-NP O
for IN B-VP O
gram NN B-NP B-problem
positive JJ B-NP I-problem
cocci NN I-NP I-problem
, , O O
which WDT O B-pronoun
thereafter RB O O
proved VBD B-VP O
to TO O O
be VB O O
Staph. NNP B-NP B-problem
aureus JJ B-NP I-problem
Methicillin NNP I-NP B-treatment
sensitive NN I-NP O
. . B-VP O
   
He PRP O B-person
had VBD B-VP O
no DT B-NP O
chest NN I-NP B-problem
pain NN I-NP I-problem
, , O O
shortness NN B-NP B-problem
of IN B-VP I-problem
breath NN B-NP I-problem
or CC O O
diarrhea NN B-NP B-problem
. . B-VP O
   
PAST NNP B-NP O
MEDICAL NNP I-NP O
HISTORY NNP I-NP O
: : O O
Includes VBZ O O
ischemic JJ B-NP B-problem
cardiomyopathy NN I-NP I-problem
with IN B-VP O
an DT B-NP B-test
echocardiogram NN I-NP I-test
done VBN O O
on IN B-VP O
11/13/97 CD O O
showing VBG O O
an DT B-NP B-test
ejection NN I-NP I-test
fraction NN I-NP I-test
of IN B-VP O
28% CD O O
and CC O O
LV NNP B-NP O
that WDT O B-pronoun
is VBZ O O
diffusely RB O B-problem
hypokinetic JJ O I-problem
. . B-VP O
   
OTHER NNP B-NP O
MEDICAL NNP I-NP O
PROBLEMS NNP I-NP O
: : O O
1) CD O O
Dementia NNP B-NP B-problem
, , O O
2) CD O O
paroxysmal JJ B-NP B-problem
atrial JJ I-NP I-problem
fibrillation, NN I-NP I-problem
3) CD O O
hypertension NN B-NP B-problem
, , O O
4) CD O O
peripheral JJ B-NP B-problem
vascular JJ I-NP I-problem
disease NN I-NP I-problem
with IN B-VP O
previous JJ B-NP B-treatment
left JJ I-NP I-treatment
femoral JJ I-NP I-treatment
popliteal NN I-NP I-treatment
bypass NN I-NP I-treatment
, , O O
5) CD O O
diabetes NNS B-NP B-problem
mellitus RB O I-problem
, , O O
6) CD O O
chronic JJ B-NP B-problem
renal JJ I-NP I-problem
insufficiency, NN I-NP I-problem
7) CD O O
COPD NNP B-NP B-problem
, , O O
8) CD O O
previous JJ B-NP B-treatment
abdominal JJ I-NP I-treatment
aortic JJ I-NP I-treatment
aneurysm NN I-NP I-treatment
repair NN I-NP I-treatment
in IN B-VP O
1981 CD O O
, , O O
9) CD O O
benign JJ B-NP B-problem
prostatic JJ I-NP I-problem
hypertrophy NN I-NP I-problem
status NN I-NP O
post NN I-NP O
TURP NNP I-NP B-treatment
surgery NN I-NP I-treatment
in IN B-VP O
1982 CD O O
. . B-VP O
   
MEDICATIONS NNP B-NP O
ON NNP I-NP O
ADMISSION NNP I-NP O
: : O O
Aspirin $ O B-treatment
325 CD O O
mgs NN B-NP O
PO NNP I-NP O
q.d. NN I-NP O
, , O O
Prilosec NNP B-NP B-treatment
20 CD O O
mgs NN B-NP O
PO NNP I-NP O
q.d. NN I-NP O
, , O O
Azmacort NNP B-NP B-treatment
2 CD O O
puffs NNS B-NP O
q.i.d. JJ B-NP O
PRN NNP I-NP O
, , O O
Atrovent NNP B-NP B-treatment
2 CD O O
puffs NNS B-NP O
q.i.d. JJ B-NP O
PRN NNP I-NP O
, , O O
heparin VBD B-VP B-treatment
5,000 CD O O
units NNS B-NP O
subcu. JJ B-NP O
b.i.d. NN I-NP O
, , O O
Digoxin NNP B-NP B-treatment
0.125 CD O O
mgs NN B-NP O
PO NNP I-NP O
q.d. NN I-NP O
, , O O
Wellbutrin NNP B-NP B-treatment
37.5 CD O O
mgs NN B-NP O
PO NNP I-NP O
b.i.d. NN I-NP O
, , O O
Kaopectate NNP B-NP B-treatment
PRN NNP I-NP O
, , O O
Betoptic NNP B-NP B-treatment
0.25% CD O O
OU NNP B-NP O
q.d. NN I-NP O
, , O O
Ritalin NNP B-NP B-treatment
10 CD O O
mgs NN B-NP O
PO NNP I-NP O
q.a.m. NN I-NP O
and CC O O
at IN B-VP O
noon JJ B-NP O
time NN I-NP O
, , O O
Norvasc NNP B-NP B-treatment
2.5 CD O O
mgs NN B-NP O
PO NNP I-NP O
q.d. VBZ O O
The DT B-NP B-person
patient NN I-NP I-person
reported VBD B-VP O
disorientation NN B-NP B-problem
with IN B-VP O
Ambien NNP B-NP B-treatment
and CC O O
Halcyon NNP B-NP B-treatment
. . B-VP O
   
REVIEW NNP B-NP O
OF NNPS I-NP O
SYSTEMS NNP I-NP O
: : O O
No DT B-NP O
other JJ I-NP B-problem
medical JJ I-NP I-problem
problems NNS I-NP I-problem
other JJ O O
than IN B-VP O
stated VBN O O
above IN B-VP O
. . B-VP O
   
PHYSICAL JJ B-NP O
EXAMINATION NN I-NP O
: : O O
Elderly JJ B-NP O
white JJ I-NP O
male NN I-NP O
who WP O B-person
was VBD B-VP O
somnolent NN B-NP B-problem
, , O O
looking VBG O O
his PRP$ O B-person
stated JJ B-NP O
age NN I-NP O
. . B-VP O
   
His PRP$ O B-test
His PRP$ O B-person
temperature NN B-NP I-test
was VBD B-VP O
97.5 CD O O
, , O O
pulse RB O B-test
90 CD O O
, , O O
respiratory NN B-NP B-test
rate NN I-NP I-test
20 CD O O
, , O O
blood NN B-NP B-test
pressure NN I-NP I-test
104/60 CD O O
, , O O
o2 PRP O B-test
sat. VBP O I-test
97%. CD O O
Eyes NNP B-NP O
- : O O
pupils NNS B-NP O
equal JJ O O
, , O O
round NN B-NP O
, , O O
reactive JJ O O
to TO O O
light JJ O O
, , O O
sclera JJ O O
non-icteric JJ O B-problem
. . B-VP O
   
Neck NNP B-NP O
- : O O
supple NN B-NP O
without IN B-VP O
masses NNS B-NP B-problem
or CC O O
thyromegaly NN B-NP B-problem
. . B-VP O
   
Lungs NNP B-NP O
- : O O
clear JJ O O
to TO O O
percussion NN B-NP B-test
and CC O O
auscultation NN B-NP B-test
on IN B-VP O
both DT B-NP O
sides NNS I-NP O
. . B-VP O
   
Cardiovascular JJ B-NP O
examination NN I-NP O
- : O O
normal JJ B-NP O
jugular JJ I-NP O
venous JJ I-NP O
pressure NN I-NP O
, , O O
normal JJ B-NP O
carotid NN I-NP O
upstrokes NNS I-NP O
with IN B-VP O
bruits NNS B-NP B-problem
, , O O
there EX O O
are VBP O O
distant JJ B-NP B-problem
heart NN I-NP I-problem
sounds VBZ O I-problem
, , O O
S1 NNP B-NP O
and CC O O
S2 NNP B-NP O
are VBP O O
normal JJ O O
, , O O
there EX O O
are VBP O O
no DT B-NP O
murmurs NN I-NP B-problem
detected VBD B-VP O
. . B-VP O
   
Abdomen NNP B-NP O
- : O O
soft JJ O O
, , O O
non-tender JJ O B-problem
without IN B-VP O
organomegaly NN B-NP B-problem
or CC O O
masses NNS B-NP B-problem
. . B-VP O
   
Extremities NNS B-NP O
- : O O
without IN B-VP O
cyanosis NN B-NP B-problem
or CC O O
edema NN B-NP B-problem
. . B-VP O
   
Neurologic NNP B-NP B-test
examination NN I-NP I-test
- : O O
somnolent NN B-NP B-problem
, , O O
awake NN B-NP O
, , O O
arousable JJ O O
to TO O O
commands NNS B-NP O
, , O O
though IN B-VP O
he PRP O B-person
falls VBZ O O
asleep RB O O
rapidly RB O O
. . B-VP O
   
Deep NNP B-NP B-test
tendon NN I-NP I-test
reflexes NNS I-NP I-test
are VBP O O
2+ CD O O
and CC O O
symmetric JJ O O
, , O O
toes NNS B-NP O
were VBD B-VP O
up RB O B-problem
going VBG O I-problem
bilaterally RB O I-problem
. . B-VP O
   
LABORATORY NNP B-NP O
DATA NNP I-NP O
: : O O
Sodium NN B-NP B-test
131 CD O O
, , O O
potassium NN B-NP B-test
4.5 CD O O
, , O O
BUN NNP B-NP B-test
45 CD O O
, , O O
creatinine NN B-NP B-test
2.0 CD O O
, , O O
glucose RB O B-test
134 CD O O
, , O O
bilirubin VBD B-VP B-test
0.4. CD O O
Blood NNP B-NP B-test
gas NN I-NP I-test
on IN B-VP O
5 CD O B-treatment
liters NNS B-NP I-treatment
nasal JJ O I-treatment
o2 SYM O I-treatment
- : O O
PO2 NN B-NP B-test
106 CD O O
, , O O
PCO227 NNP B-NP B-test
, , O O
pH VBD B-VP B-test
7.41 CD O O
. . B-VP O
   
Blood NN B-NP B-test
cultures NNS I-NP I-test
were VBD B-VP O
obtained VBN O O
, , O O
urine JJ B-NP B-test
cultures NNS I-NP I-test
were VBD B-VP O
obtained VBN O O
. . B-VP O
   
Chest NNP B-NP B-test
x-ray JJ O I-test
- : O O
low JJ B-NP B-problem
lung NN I-NP I-problem
volumes NNS I-NP I-problem
, , O O
bibasilar JJ B-NP B-problem
opacities NNS I-NP I-problem
, , O O
no DT B-NP O
evidence NN I-NP O
of IN B-VP O
heart NN B-NP B-problem
failure NN I-NP I-problem
. . B-VP O
   
EKG NNP B-NP B-test
- : O O
technically RB O O
poor JJ O O
tracing VBG O O
with IN B-VP O
what WP O O
appears VBZ O O
to TO O O
be VB O O
normal JJ B-NP O
sinus NNS I-NP O
rhythm VBP O O
with IN B-VP O
very RB O B-problem
small JJ B-NP I-problem
P NNP I-NP I-problem
waves NNS I-NP I-problem
, , O O
there EX O O
are VBP O O
Q-waves NNS B-NP B-problem
in IN B-VP I-problem
leads NNS B-NP I-problem
V1 NNP I-NP I-problem
and CC O I-problem
V2 NNP B-NP I-problem
, , O O
as RB O O
well RB O O
as IN B-VP O
in IN B-VP O
V3 NNP B-NP O
. . B-VP O
   
There EX O O
are VBP O O
non-specific JJ B-NP B-problem
ST NNP I-NP I-problem
T NNP I-NP I-problem
wave VBP O I-problem
changes. VBZ O I-problem
The DT B-NP B-test
blood NN I-NP I-test
cultures NNS I-NP I-test
at IN B-VP O
Linghs NNP B-NP O
County NNP I-NP O
Medical NNP I-NP O
Center NNP I-NP O
grew VBD B-VP O
out RP O O
Staph. NNP B-NP B-problem
aureus RB O I-problem
sensitive JJ O O
to TO O O
methicillin VB O B-treatment
. . B-VP O
   
The DT B-NP B-test
blood NN I-NP I-test
cultures NNS I-NP I-test
obtained VBD B-VP O
a DT B-NP O
Oaksgekesser/ NNP I-NP O
Memorial NNP I-NP O
Hospital NNP I-NP O
were VBD B-VP O
negative JJ O O
. . B-VP O
   
An DT B-NP B-test
echocardiogram NN I-NP I-test
obtained VBN O O
at IN B-VP O
Oaksgekesser/ NNP B-NP O
Memorial NNP I-NP O
Hospital NNP I-NP O
obtained VBD B-VP O
as IN B-VP O
a DT B-NP B-test
transthoracic NN I-NP I-test
echocardiogram NN I-NP I-test
showed VBD B-VP O
an DT B-NP B-test
ejection NN I-NP I-test
fraction NN I-NP I-test
of IN B-VP O
33% CD O O
, , O O
wall NN B-NP B-test
thickness NN I-NP I-test
12 CD O O
mms NN B-NP O
at IN B-VP O
the DT B-NP O
septum NN I-NP O
, , O O
posterior VBP O B-test
wall NN B-NP I-test
11 CD O O
mms. NN B-NP O
, , O O
left VBD B-VP B-test
atrial JJ B-NP I-test
size NN I-NP I-test
40 CD O O
mms NN B-NP O
. . B-VP O
   
There EX O O
is VBZ O O
anteroseptal JJ B-NP B-problem
hypokinesis NN I-NP I-problem
with IN B-VP O
mid NN B-NP B-problem
and CC O I-problem
apical JJ B-NP I-problem
akinesis NN I-NP I-problem
. . B-VP O
   
HOSPITAL NNP B-NP O
COURSE NNP I-NP O
AND NNP I-NP O
TREATMENT NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
treated VBN O O
with IN B-VP O
intravenous JJ B-NP B-treatment
antibiotics NNS I-NP I-treatment
. . B-VP O
   
A DT B-NP B-test
lumbar JJ I-NP I-test
puncture NN I-NP I-test
was VBD B-VP O
obtained VBN O O
which WDT O B-pronoun
showed VBD B-VP O
normal JJ B-NP O
pressure NN I-NP O
and CC O O
no DT B-NP O
cells NNS I-NP B-problem
. . B-VP O
   
The DT B-NP B-test
CSF NNP I-NP I-test
culture NN I-NP I-test
was VBD B-VP O
negative JJ O O
. . B-VP O
   
A DT B-NP B-test
stool JJ I-NP I-test
assay NN I-NP I-test
was VBD B-VP O
taken VBN O O
for IN B-VP O
Clostridium NNP B-NP B-problem
difficile NN I-NP I-problem
which WDT O B-pronoun
was VBD B-VP O
negative JJ O O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
gradually RB O O
improved VBN O O
on IN B-VP O
the DT B-NP B-treatment
current JJ I-NP I-treatment
therapy NN I-NP I-treatment
and CC O O
was VBD B-VP O
quite RB O O
awake JJ O O
and CC O O
alert JJ O O
, , O O
though IN B-VP O
still RB O O
appeared VBN O O
to TO O O
have VB O O
some DT B-NP O
evidence NN I-NP O
of IN B-VP O
dementia NN B-NP B-problem
and CC O O
disorientation NN B-NP B-problem
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
encouraged VBN O O
to TO O O
eat VB O O
and CC O O
it PRP O B-pronoun
was VBD B-VP O
decided VBN O O
not RB O O
to TO O O
place VB O O
either RB O O
a DT B-NP B-treatment
feeding NN I-NP I-treatment
tube NN I-NP I-treatment
or CC O O
to TO O O
start VB O O
TPN NNP B-NP B-treatment
. . B-VP O
   
Dr. NNP B-NP B-person
Rhalttland NNP I-NP I-person
was VBD B-VP O
called VBN O O
at IN B-VP O
Sondi NNP B-NP O
Memorial NNP I-NP O
to TO O O
update VB O O
him PRP O B-person
on IN B-VP O
the DT B-NP B-person
patient NN I-NP I-person
&apos;s JJ B-NP O
condition NN I-NP O
. . B-VP O
   
He PRP O B-person
still RB O O
needs VBZ O O
much JJ B-NP B-treatment
intensive JJ I-NP I-treatment
rehabilitation NN I-NP I-treatment
, , O O
encouragement NN B-NP O
to TO O O
eat VB O O
and CC O O
encouragement VB O O
to TO O O
get VB O O
out IN B-VP O
of IN B-VP O
bed NN B-NP O
to TO O O
use VB O O
the DT B-NP O
bathroom NN I-NP O
rather RB O O
than IN B-VP O
abed VB O B-treatment
pain NN B-NP I-treatment
or CC O O
a DT B-NP B-treatment
diaper NN I-NP I-treatment
. . B-VP O
   
He PRP O B-person
is VBZ O O
being VBG O O
transferred VBN O O
to TO O O
Linghs NNP B-NP O
County NNP I-NP O
Medical NNP I-NP O
Center NNP I-NP O
for IN B-VP O
further JJ B-NP B-treatment
care NN I-NP I-treatment
. . B-VP O
   
CONDITION NN B-NP O
: : O O
Stable JJ O O
and CC O O
improved JJ O O
. . B-VP O
   
LAKO NNP B-NP B-person
C. NNP I-NP I-person
WARM NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
STAT NNP I-NP O
TR NNP I-NP O
: : O O
lv JJ B-NP O
DD NNP I-NP O
: : O O
01/06/98 CD O O
TD NN B-NP O
: : O O
01/06/98 CD O O
7:41 CD O O
Pcc NN B-NP O
: : O O
LAKO NNP B-NP B-person
C NNP I-NP I-person
WARM NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
Admission NNP I-NP O
Date NNP I-NP O
: : O O
2014-05-08 JJ B-NP O
Discharge NN I-NP O
Date NNP I-NP O
: : O O
2014-05-19 JJ B-NP O
Date NNP I-NP O
of IN B-VP O
Birth NNP B-NP O
: : O O
1946-01-06 JJ B-NP O
Sex NN I-NP O
: : O O
F NNP B-NP O
Service NNP I-NP O
: : O O
CARDIOTHORACIC JJ B-NP B-person
Allergies NNS I-NP O
: : O O
Patient NN B-NP B-person
recorded VBD B-VP O
as IN B-VP O
having VBG O O
No NNP B-NP O
Known NNP I-NP B-problem
Allergies NNPS I-NP I-problem
to TO O O
Drugs NNP B-NP B-treatment
Attending NNP I-NP B-person
: : O O
Jana NNP B-NP B-person
V NNP I-NP I-person
Pennington NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
Chief NNP I-NP O
Complaint NNP I-NP O
: : O O
lightheadedness NN B-NP B-problem
, , O O
slight VBD B-VP B-problem
DOE NNP B-NP I-problem
Major NNP I-NP O
Surgical NNP I-NP O
or CC O O
Invasive JJ B-NP O
Procedure NN I-NP O
: : O O
2014-05-11 JJ B-NP O
Redo NNP I-NP B-treatment
AVR NNP I-NP I-treatment
with IN B-VP O
aortic JJ B-NP B-treatment
root NN I-NP I-treatment
enlargement NN I-NP I-treatment
( ( O O
21 CD O I-treatment
mm NN B-NP I-treatment
CE NNP I-NP I-treatment
Magna NNP I-NP I-treatment
pericardial JJ B-NP I-treatment
valve NN I-NP O
) ) O O
History NN B-NP O
of IN B-VP O
Present NNP B-NP O
Illness NNP I-NP O
: : O O
68 CD O B-person
yo NNS B-NP I-person
female JJ O I-person
trasnferred VBN O O
in IN B-VP O
from IN B-VP O
Catholic NNP B-NP O
CMED NNP I-NP O
CSRU. NNP I-NP O
Ctr. NNP I-NP O
with IN B-VP O
periprosthetic JJ B-NP B-problem
aortic JJ I-NP I-problem
valve NN I-NP I-problem
stenosis NN I-NP I-problem
and CC O O
aortic JJ B-NP B-problem
valve NN I-NP I-problem
thrombus NN I-NP I-problem
. . B-VP O
   
No DT B-NP O
cath NN I-NP B-test
done VBN O O
, , O O
but CC O O
echo VBP O B-test
05-07 JJ O O
showed VBD B-VP O
EF NNP B-NP B-test
60-65% JJ O O
, , O O
stenotic JJ B-NP B-problem
mech. NN I-NP I-problem
valve NN I-NP I-problem
, , O O
mean JJ B-NP B-test
gradient NN I-NP I-test
33 CD O O
mm NN B-NP O
, , O O
decreased VBD B-VP B-problem
disc JJ B-NP I-problem
motion NN I-NP I-problem
, , O O
mobile JJ B-NP B-problem
mass NN I-NP I-problem
in IN B-VP I-problem
LVOT NNP B-NP I-problem
, , O O
mild NN B-NP B-problem
AI NNP I-NP I-problem
, , O O
mild NN B-NP B-problem
to TO O I-problem
moderate VB O I-problem
MR NNP B-NP I-problem
, , O O
trace NN B-NP B-problem
TR. NNP I-NP I-problem
Referred NNP I-NP O
for IN B-VP O
surgical JJ B-NP B-test
evaluation NN I-NP I-test
. . B-VP O
   
Past NNP B-NP O
Medical JJ B-NP O
History NN I-NP O
: : O O
HTN NNP B-NP B-problem
elev. VBP O B-problem
lipids NNS B-NP I-problem
hypothyroidism NN I-NP B-problem
back RB O B-problem
pain NN B-NP I-problem
GERD NNP I-NP B-problem
PSH NNP I-NP O
: : O O
s/p NN B-NP O
AVR NNP I-NP B-treatment
2000 CD O O
remote NN B-NP B-treatment
tonsillectomy/adenoidectomy NN I-NP I-treatment
partial JJ B-NP B-treatment
thyroidectomy NN I-NP I-treatment
rem. NN I-NP B-treatment
right JJ B-NP I-treatment
wrist NN I-NP I-treatment
ganglion NN I-NP I-treatment
cyst NN I-NP I-treatment
left VBD B-VP B-treatment
foot JJ B-NP I-treatment
bunionectomy NN I-NP I-treatment
breast NN I-NP B-test
biopsies NNS I-NP I-test
Social NNP I-NP O
History NN I-NP O
: : O O
retired VBN O O
, , O O
lives VBZ O O
alone RB O O
, , O O
widowed VBD B-VP O
quit NN B-NP O
smoking NN I-NP O
20+ CD O O
years NNS B-NP O
ago RB O O
no DT B-NP O
ETOH NNP I-NP O
use VBP O O
Family NNP B-NP O
History NNP I-NP O
: : O O
father NN B-NP B-person
died VBD B-VP O
at IN B-VP O
57 CD O O
of IN B-VP O
heart NN B-NP B-problem
problems NNS I-NP I-problem
brother RB O B-person
died VBD B-VP O
at IN B-VP O
age NN B-NP O
7 CD O O
of IN B-VP O
"leaky JJ B-NP B-problem
valve" NNS I-NP I-problem
sister NN I-NP B-person
with IN B-VP O
CAD/CABG NNP B-NP B-problem
Physical NNP I-NP O
Exam: NNP I-NP O
180/88 CD O O
HR NNP B-NP B-test
68 CD O O
RR NNP B-NP B-test
18 CD O O
95% CD O O
sat VBD B-VP B-test
65.5" CD O O
87 CD O O
kg NN B-NP O
NAD NNP I-NP B-problem
skin/HEENT NN I-NP O
unremarkable JJ B-NP O
neck NN I-NP O
supple NN I-NP O
, , O O
murmur NN B-NP B-problem
radiates NNS I-NP O
bilat. VBP O O
to TO O O
carotids VB O O
CTAB NNP B-NP O
RRR NNP I-NP O
with IN B-VP O
holosystolic JJ B-NP B-problem
murmur NN I-NP I-problem
soft JJ O O
, , O O
NT NNP B-NP B-problem
, , O O
ND NNP B-NP B-problem
, , O O
+ NNP B-NP O
BS NNP I-NP O
warm NN I-NP O
, , O O
well-perfused JJ O O
, , O O
no DT B-NP O
edema NN I-NP B-problem
, , O B-problem
superficial JJ B-NP I-problem
varicosities NNS I-NP O
neuro VBP O O
grossly RB O O
intact JJ O O
2+ CD O O
bil. NN B-NP O
fem/ NN I-NP O
radials NNS I-NP O
1+ CD O O
bil. NN B-NP O
DP/PTs NNP I-NP O
Pertinent NNP I-NP O
Results NNP I-NP O
: : O O
Cardiology NNP B-NP O
Report NNP I-NP O
ECHO NNP I-NP B-test
Study NNP I-NP I-test
Date NNP I-NP O
of IN B-VP O
2014-05-11 JJ B-NP O
POST-BYPASS NN I-NP O
: : O O
Pt NN B-NP B-person
is VBZ O O
being VBG O O
AV NNP B-NP O
paced VBD B-VP O
, , O O
on IN B-VP O
an DT B-NP B-treatment
infusion NN I-NP I-treatment
of IN B-VP I-treatment
phenylephrine NN B-NP I-treatment
1. CD O O
A NNP B-NP B-treatment
bioprosthesis NN I-NP I-treatment
is VBZ O O
well RB O O
seated VBN O O
in IN B-VP O
the DT B-NP O
aortic JJ I-NP O
position NN I-NP O
, , O O
leaflets VBZ O O
open JJ O O
well RB O O
, , O O
trace JJ B-NP B-problem
central JJ I-NP I-problem
AI NNP I-NP I-problem
is VBZ O O
seen VBN O O
. . B-VP O
   
Trace NNP B-NP B-problem
AI NNP I-NP I-problem
is VBZ O O
also RB O O
noted VBN O O
between IN B-VP O
the DT B-NP O
left NN I-NP O
and CC O O
right JJ B-NP O
coronary NN I-NP O
cusps NN I-NP O
. . B-VP O
   
There EX O O
is VBZ O O
a DT B-NP B-problem
small JJ I-NP I-problem
paravavluar NN I-NP I-problem
leak NN I-NP I-problem
in IN B-VP O
the DT B-NP O
area NN I-NP O
adjacent NN I-NP O
to TO O O
the DT B-NP O
anterior JJ I-NP O
mitral JJ I-NP O
leaflet NN I-NP O
, , O O
resulting VBG O O
in IN B-VP O
some DT B-NP B-problem
trace NN I-NP I-problem
insuffiency NN I-NP I-problem
outside IN B-VP O
the DT O O
sewing VBG O O
ring NN B-NP O
. . B-VP O
   
2. CD O O
Mitral JJ B-NP B-problem
regurgitation NN I-NP I-problem
is VBZ O O
unchanged JJ O O
from IN B-VP O
before IN B-VP O
. . B-VP O
   
3. CD O O
Biventricular JJ B-NP O
systolic JJ I-NP O
function NN I-NP O
is VBZ O O
unchanged JJ O O
. . B-VP O
   
4. CD O O
Aorta NNP B-NP O
is VBZ O O
intact JJ B-NP O
post NN I-NP O
decannulation NN I-NP B-treatment
5. CD O O
Other JJ B-NP O
findings NNS I-NP O
are VBP O O
unchanged JJ O O
6. CD O O
All NNP B-NP O
findings NNS I-NP O
discussed VBN O O
with IN B-VP O
surgeon NN B-NP B-person
at IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
the DT B-NP B-test
exam NN I-NP I-test
. . B-VP O
   
2014-05-18 JJ O O
05:45AM CD O O
BLOOD NNP B-NP O
Hct NNP I-NP B-test
- : O O
29.2* CD O O
2014-05-17 JJ O O
04:40AM CD O O
BLOOD NNP B-NP O
WBC NNP I-NP B-test
- : O O
12.4* CD O O
RBC NNP B-NP B-test
- : O O
2.89* CD O O
Hgb NNP B-NP B-test
- : O O
9.0* CD O O
Hct NNP B-NP B-test
- : O O
26.0* CD O O
MCV NNP B-NP B-test
- : O O
90 CD O O
MCH NNP B-NP B-test
- : O O
31.3 CD O O
MCHC NNP B-NP B-test
- : O O
34.9 CD O O
RDW NNP B-NP B-test
- : O O
13.5 CD O O
Plt NNP B-NP B-test
Ct NNP I-NP I-test
- : O O
262 CD O O
2014-05-18 JJ O O
05:45AM CD O O
BLOOD NNP B-NP O
PT NNP I-NP B-test
- : O O
16.8* CD O O
PTT NNP B-NP B-test
- : O O
65.3* CD O O
INR NNP B-NP B-test
( ( O O
PT NNP B-NP B-test
) ) O O
- : O O
1.5* CD O O
2014-05-19 JJ O O
07:10AM CD O O
BLOOD NNP B-NP O
Glucose NNP I-NP B-test
- : O O
115* CD O O
UreaN NNP B-NP B-test
- : O O
20 CD O O
Creat NNP B-NP B-test
- : O O
1.3* CD O O
Na NNP B-NP B-test
- : O O
137 CD O O
K NNP B-NP B-test
- : O O
4.8 CD O O
Cl NNP B-NP B-test
- : O O
96 CD O O
HCO3 NNP B-NP B-test
- : O O
34* CD O O
AnGap NNP B-NP B-test
- : O O
12 CD O O
Brief JJ B-NP O
Hospital JJ I-NP O
Course NN I-NP O
: : O O
Admitted JJ B-NP O
05-08 NN I-NP O
to TO O O
cardiology VB O B-person
service NN B-NP O
for IN B-VP O
surgical JJ B-NP B-test
work-up NN I-NP I-test
. . B-VP O
   
INR NNP B-NP B-test
2.7 CD O O
and CC O O
echo RB O B-test
repeated VBN O O
, , O O
coumadin JJ B-NP B-treatment
held NN I-NP O
, , O O
and CC O O
heparin JJ B-NP B-treatment
drips NNS I-NP I-treatment
started VBD B-VP O
. . B-VP O
   
Review NNP B-NP O
of IN B-VP O
OSH NNP B-NP B-test
echo FW O I-test
revealed VBD B-VP O
peak JJ B-NP B-test
gradient NN I-NP I-test
of IN B-VP O
64mm CD O O
( ( O O
not RB O O
30 CD O O
's POS O O
) ) O O
. . B-VP O
   
New NNP B-NP B-test
echo NN I-NP I-test
showed VBD B-VP O
pannus IN B-VP B-problem
involving VBG O O
the DT B-NP O
valve NN I-NP O
and CC O O
? . B-VP O
thrombus NN B-NP B-problem
. . B-VP O
   
Seen JJ O O
by IN B-VP O
Dr. NNP B-NP B-person
Laura NNP I-NP I-person
of IN B-VP O
cardiac JJ B-NP B-person
surgery NN I-NP I-person
and CC O O
underwent JJ B-NP O
redo NN I-NP B-treatment
AVR NNP I-NP I-treatment
with IN B-VP O
aortic JJ B-NP B-treatment
root NN I-NP I-treatment
enlargement NN I-NP I-treatment
on IN B-VP O
05-11 NN B-NP O
. . B-VP O
   
Transferred VBN O O
to TO O O
the DT B-NP O
CSRU NNP I-NP O
in IN B-VP O
stable JJ B-NP O
condition NN I-NP O
on IN B-VP O
phenylephrine NN B-NP B-treatment
and CC O O
propofol JJ B-NP B-treatment
drips NNS I-NP I-treatment
. . B-VP O
   
Weaned VBN O O
to TO O O
extubation VB O O
on IN B-VP O
POD NNP B-NP O
#2 NNP I-NP O
and CC O O
off IN B-VP O
all DT B-NP B-treatment
drips NNS I-NP I-treatment
. . B-VP O
   
Episode NNP B-NP B-problem
of IN B-VP I-problem
AFib NNP B-NP I-problem
that IN B-VP B-pronoun
evening VBG O O
treated VBN O O
with IN B-VP O
amiodarone NN B-NP B-treatment
and CC O O
converted VBD B-VP O
to TO O O
SR NNP B-NP O
. . B-VP O
   
Transferred VBN O O
to TO O O
the DT B-NP O
floor NN I-NP O
on IN B-VP O
POD NNP B-NP O
#3 NNP I-NP O
to TO O O
begin VB O O
increasing VBG O O
her PRP$ O B-person
activity NN B-NP O
level NN I-NP O
. . B-VP O
   
Chest NNP B-NP B-treatment
tubes NN I-NP I-treatment
and CC O O
wires NNS B-NP B-treatment
removed VBN O O
without IN B-VP O
incident NN B-NP B-problem
. . B-VP O
   
Cleared NNP B-NP O
for IN B-VP O
discharge NN B-NP O
to TO O O
home NN B-NP O
with IN B-VP O
services NNS B-NP O
. . B-VP O
   
Pt. NNP B-NP B-person
to TO O O
make VB O O
all DT B-NP O
follow-up JJ I-NP O
appts. NNS I-NP O
per IN B-VP O
discharge NN B-NP O
instructions NNS I-NP O
. . B-VP O
   
Medications NNS B-NP O
on IN B-VP O
Admission NN B-NP O
: : O O
synthroid JJ O B-treatment
75 CD O O
mcg JJ B-NP O
daily JJ I-NP O
HCTZ NNP I-NP B-treatment
37.5 CD O O
mg JJ B-NP O
daily JJ I-NP O
MVI NNP I-NP B-treatment
daily RB O O
Vit.C NNP B-NP B-treatment
500 CD O O
mg JJ B-NP O
daily JJ I-NP O
prevacid NN I-NP B-treatment
15 CD O O
mg JJ B-NP O
daily JJ I-NP O
coumadin NN I-NP B-treatment
( ( O O
held VBN O O
) ) O B-treatment
toprol NN B-NP I-treatment
XL $ O O
100 CD O O
mg JJ B-NP O
daily JJ I-NP B-treatment
zocor NN I-NP O
40 CD O O
mg JJ B-NP O
daily JJ I-NP O
KCl NNP I-NP B-treatment
12-27 JJ B-NP O
mEq NNS I-NP O
daily JJ O O
cozaar VBP O B-treatment
25 CD O O
mg JJ B-NP O
daily JJ I-NP O
Discharge NNP I-NP O
Medications NNS I-NP O
: : O O
1. CD O O
Metoprolol NNP B-NP B-treatment
Tartrate NNP I-NP I-treatment
25 CD O O
mg NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
Three CD O O
( ( O O
3 CD O O
) ) O O
Tablet NNP B-NP O
PO NNP I-NP O
BID NNP I-NP O
( ( O O
2 CD O O
times NNS B-NP O
a DT B-NP O
day NN I-NP O
) ) O O
. . B-VP O
   
Disp NN B-NP O
: : O O
*180 NN B-NP O
Tablet( NNP I-NP O
s NN I-NP O
)* NNP I-NP O
Refills NNP I-NP O
: : O O
*2* NN B-NP O
2. CD O O
Docusate NNP B-NP B-treatment
Sodium NNP I-NP I-treatment
100 CD O O
mg NN B-NP O
Capsule NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Capsule NNP B-NP O
PO NNP I-NP O
BID NNP I-NP O
( ( O O
2 CD O O
times NNS B-NP O
a DT B-NP O
day NN I-NP O
) ) O O
for IN B-VP O
1 CD O O
months NNS B-NP O
. . B-VP O
   
Disp NNP B-NP O
: : O O
*60 NN B-NP O
Capsule( NNP I-NP O
s NN I-NP O
)* NNP I-NP O
Refills NNP I-NP O
: : O O
*0* NN B-NP O
3. CD O O
Aspirin NNP B-NP B-treatment
81 CD O O
mg NN B-NP O
Tablet NNP I-NP O
, , O O
Delayed NNP B-NP O
Release NNP I-NP O
( ( O O
E.C. NNP B-NP O
) ) O O
Sig NN B-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Tablet NN B-NP O
, , O O
Delayed NNP B-NP O
Release NNP I-NP O
( ( O O
E.C. NNP B-NP O
) ) O O
PO NNP B-NP O
DAILY NNP I-NP O
( ( O O
Daily NNP B-NP O
) ) O O
. . B-VP O
   
Disp NN B-NP O
: : O O
*30 JJ B-NP O
Tablet NNP I-NP O
, , O O
Delayed NNP B-NP O
Release NNP I-NP O
( ( O O
E.C. NNP B-NP O
)( NNP I-NP O
s VBD B-VP O
)* JJ B-NP O
Refills NNS I-NP O
: : O O
*2* VB O O
4. CD O O
Oxycodone-Acetaminophen JJ B-NP B-treatment
5-325 JJ I-NP O
mg NN I-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
1-2 JJ B-NP O
Tablets NNS I-NP O
PO NNP I-NP O
Q4H NNP I-NP O
( ( O O
every DT O O
4 CD O O
hours NNS B-NP O
) ) O O
as IN B-VP O
needed VBN O O
for IN B-VP O
pain NN B-NP B-problem
. . B-VP O
   
Disp NN B-NP O
: : O O
*40 JJ B-NP O
Tablet( NNP I-NP O
s NN I-NP O
)* NNP I-NP O
Refills NNP I-NP O
: : O O
*0* NN B-NP O
5. CD O O
Levothyroxine NNP B-NP B-treatment
75 CD O O
mcg NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Tablet NNP B-NP O
PO NNP I-NP O
DAILY NNP I-NP O
( ( O O
Daily NNP B-NP O
) ) O O
. . B-VP O
   
Disp NN B-NP O
: : O O
*30 JJ B-NP O
Tablet( NNP I-NP O
s NN I-NP O
)* NNP I-NP O
Refills NNP I-NP O
: : O O
*2* NN B-NP O
6. CD O O
Simvastatin NNP B-NP B-treatment
40 CD O O
mg NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Tablet NNP B-NP O
PO NNP I-NP O
DAILY NNP I-NP O
( ( O O
Daily NNP B-NP O
) ) O O
. . B-VP O
   
Disp NN B-NP O
: : O O
*30 JJ B-NP O
Tablet( NNP I-NP O
s NN I-NP O
)* NNP I-NP O
Refills NNP I-NP O
: : O O
*2* NN B-NP O
7. CD O O
Pantoprazole NNP B-NP B-treatment
40 CD O O
mg NN B-NP O
Tablet NNP I-NP O
, , O O
Delayed NNP B-NP O
Release NNP I-NP O
( ( O O
E.C. NNP B-NP O
) ) O O
Sig NN B-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Tablet NN B-NP O
, , O O
Delayed NNP B-NP O
Release NNP I-NP O
( ( O O
E.C. NNP B-NP O
) ) O O
PO NNP B-NP O
Q24H NNP I-NP O
( ( O O
every DT O O
24 CD O O
hours NNS B-NP O
) ) O O
. . B-VP O
   
Disp NN B-NP O
: : O O
*30 JJ B-NP O
Tablet NNP I-NP O
, , O O
Delayed NNP B-NP O
Release NNP I-NP O
( ( O O
E.C. NNP B-NP O
)( NNP I-NP O
s VBD B-VP O
)* JJ B-NP O
Refills NNS I-NP O
: : O O
*2* $ O O
8. CD O O
Amiodarone NNP B-NP B-treatment
200 CD O O
mg NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
Two CD O O
( ( O O
2 CD O O
) ) O O
Tablet NNP B-NP O
PO NNP I-NP O
DAILY NNP I-NP O
( ( O O
Daily NNP B-NP O
) ) O O
for IN B-VP O
2 CD O O
days NNS B-NP O
: : O O
for IN B-VP O
2 CD O O
days NNS B-NP O
, , O O
then RB O O
start VB O O
200 CD O O
mg JJ O O
daily JJ O O
ongoing VBG O O
on IN B-VP O
05-20 NNP B-NP O
. . B-VP O
   
Disp NN B-NP O
: : O O
*60 JJ B-NP O
Tablet( NNP I-NP O
s NN I-NP O
)* NNP I-NP O
Refills NNP I-NP O
: : O O
*1* NN B-NP O
9. CD O O
Potassium NNP B-NP B-treatment
Chloride NNP I-NP I-treatment
10 CD O O
mEq NN B-NP O
Capsule NNP I-NP O
, , O O
Sustained VBD B-VP O
Release NNP B-NP O
Sig NNP I-NP O
: : O O
Two CD O O
( ( O O
2 CD O O
) ) O O
Capsule NN B-NP O
, , O O
Sustained VBD B-VP O
Release NNP B-NP O
PO NNP I-NP O
once RB O O
a DT B-NP O
day NN I-NP O
for IN B-VP O
7 CD O O
days NNS B-NP O
. . B-VP O
   
Disp NN B-NP O
: : O O
*14 NN B-NP O
Capsule NNP I-NP O
, , O O
Sustained VBD B-VP O
Release( NNP B-NP O
s NN I-NP O
)* NNP I-NP O
Refills NNP I-NP O
: : O O
*0* NN B-NP O
10. CD O O
Furosemide NNP B-NP B-treatment
20 CD O O
mg NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Tablet NNP B-NP O
PO NNP I-NP O
twice RB O O
a DT B-NP O
day NN I-NP O
for IN B-VP O
7 CD O O
days NNS B-NP O
. . B-VP O
   
Disp NN B-NP O
: : O O
*14 JJ B-NP O
Tablet( NNP I-NP O
s NN I-NP O
)* NNP I-NP O
Refills NNP I-NP O
: : O O
*0* JJ B-NP O
Discharge NNP I-NP O
Disposition NNP I-NP O
: : O O
Home NN B-NP O
with IN B-VP O
Service NNP B-NP O
Discharge NNP I-NP O
Diagnosis NNP I-NP O
: : O O
prosthetic JJ B-NP B-problem
aortic JJ I-NP I-problem
valve NN I-NP I-problem
stenosis NN I-NP I-problem
HTN NNP I-NP B-problem
elev. VBZ O B-problem
lipds JJ B-NP I-problem
hypothyroidism NN I-NP B-problem
back RB O B-problem
pain NN B-NP I-problem
GERD NNP I-NP B-problem
A NNP I-NP B-problem
Fib NNP I-NP I-problem
s/p NN I-NP O
AVR NNP I-NP B-treatment
2000 CD O O
Discharge NNP B-NP O
Condition NNP I-NP O
: : O O
stable JJ B-NP O
Discharge NN I-NP O
Instructions NNS I-NP O
: : O O
no DT O O
driving VBG O O
for IN B-VP O
one CD O O
month NN B-NP O
no DT O O
lifting VBG O O
greater JJR O O
than IN B-VP O
10 CD O O
pounds NNS B-NP O
for IN B-VP O
10 CD O O
weeks NNS B-NP O
no DT B-NP O
lotions NNS I-NP O
, , O O
creams NNS B-NP O
or CC O O
powders NNS B-NP O
on IN B-VP O
any DT B-NP O
incision NN I-NP B-problem
may MD O O
shower VB O O
over IN B-VP O
incisions NNS B-NP B-problem
and CC O O
pat VB O O
dry JJ B-NP O
call NN I-NP O
for IN B-VP O
fever NN B-NP B-problem
greater JJR O O
than IN B-VP O
100.5 CD O O
, , O O
redness NN B-NP B-problem
or CC O O
drainage NN B-NP B-problem
Followup JJ B-NP O
Instructions NNS I-NP O
: : O O
see VB O O
Dr. NNP B-NP B-person
Rodriguez NNP I-NP I-person
in IN B-VP O
1-2 JJ B-NP O
weeks NNS I-NP O
see VBP O O
Dr. NNP B-NP B-person
Laura NNP I-NP I-person
in IN B-VP O
4 CD O O
weeks NNS B-NP O
( ( O O
944 CD O O
) ) O O
596 CD O O
7247 CD O O
Anthony NNP B-NP B-person
Louis NNP I-NP I-person
MD NNP I-NP I-person
43-293 JJ O O
Completed VBN O O
by IN B-VP O
: : O O
Jerry NNP B-NP B-person
Pamela NNP I-NP I-person
NP NNP I-NP I-person
80-BXH JJ B-NP O
2014-05-19 JJ I-NP O
@ NN I-NP O
1424 CD O O
Signed NNP B-NP O
electronically RB O O
by IN B-VP O
: : O O
DR. NNP B-NP B-person
Andre NNP I-NP I-person
D. NNP I-NP I-person
Bruner NNP I-NP I-person
on IN B-VP O
: : O O
WED JJ O O
2014-05-21 JJ O O
5:55 CD O O
PM NNP B-NP O
( ( O O
End NNP B-NP O
of IN B-VP O
Report NNP B-NP O
) ) O O
-EMPTYLINE- VBP O O
-DOCSTART- JJ B-NP O
-EMPTYLINE- NNP I-NP O
Admission NNP I-NP O
Date NNP I-NP O
: : O O
2014-03-31 JJ B-NP O
Discharge NN I-NP O
Date NNP I-NP O
: : O O
2014-04-09 JJ B-NP O
Date NNP I-NP O
of IN B-VP O
Birth NNP B-NP O
: : O O
1964-04-26 JJ B-NP O
Sex NN I-NP O
: : O O
M NNP B-NP O
Service NNP I-NP O
: : O O
Liver NNP B-NP B-person
Transplant NNP I-NP I-person
Surgery NNP I-NP I-person
Service NNP I-NP O
ADMISSION NNP I-NP O
DIAGNOSIS NNP I-NP O
: : O O
Hepatitis NNP B-NP B-problem
C NNP I-NP I-problem
cirrhosis NN I-NP I-problem
. . B-VP O
   
HISTORY NNP B-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
is VBZ O O
a DT O O
49 CD O O
year-old JJ B-NP O
man NN I-NP O
with IN B-VP O
hepatitis NN B-NP B-problem
C NNP I-NP I-problem
cirrhosis NN I-NP I-problem
complicated VBN O O
by IN B-VP O
encephalopathy NN B-NP B-problem
, , O O
positive JJ B-NP B-problem
esophageal NN I-NP I-problem
varices NNS I-NP I-problem
, , O O
now RB O O
with IN B-VP O
worsening VBG O B-problem
confusion NN B-NP I-problem
and CC O O
lethargy NN B-NP B-problem
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
has VBZ O O
been VBN O O
admitted VBN O O
5 CD O O
x NN B-NP O
in IN B-VP O
the DT B-NP O
past NN I-NP O
to TO O O
Nantucket NNP B-NP O
Cottage NNP I-NP O
Hospital NNP I-NP O
since IN B-VP O
11-30 CD O O
for IN B-VP O
encephalopathy NN B-NP B-problem
. . B-VP O
   
Most JJS O O
recently RB O O
admitted VBN O O
on IN B-VP O
2014-03-19 JJ O O
to TO O O
2014-03-22 JJ O O
. . B-VP O
   
Infectious JJ B-NP B-test
work-up NN I-NP I-test
was VBD B-VP O
negative JJ O O
. . B-VP O
   
Trazodone NN B-NP B-treatment
stopped VBD B-VP O
. . B-VP O
   
Patient NNP B-NP B-person
was VBD B-VP O
started VBN O O
on IN B-VP O
Lactulose NNP B-NP B-treatment
and CC O O
Rifaximine NNP B-NP B-treatment
which WDT O B-pronoun
improved VBD B-VP O
his PRP$ O B-person
mental JJ B-NP O
status NN I-NP O
. . B-VP O
   
Today NN B-NP O
, , O O
on IN B-VP O
2014-03-03 JJ O O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
seen VBN O O
in IN B-VP O
clinic JJ O O
with IN B-VP O
increased JJ B-NP B-problem
lethargy NN I-NP I-problem
, , O O
confusion NN B-NP B-problem
. . B-VP O
   
Wife CC O B-person
reports NNS B-NP O
that IN B-VP B-pronoun
the DT B-NP B-person
patient NN I-NP I-person
has VBZ O O
a DT B-NP O
history NN I-NP O
of IN B-VP O
lethargy NN B-NP B-problem
and CC O O
confusion NN B-NP B-problem
, , O O
similar JJ O O
to TO O O
the DT B-NP B-problem
symptoms NNS I-NP I-problem
for IN B-VP O
which WDT O B-pronoun
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
recently RB O O
admitted VBN O O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
also RB O O
reports VBZ O O
that IN B-VP B-pronoun
he PRP O B-person
has VBZ O O
had VBN O O
" VBN O O
yellowish JJ B-NP B-problem
eyes NNS I-NP I-problem
, , O O
some DT B-NP B-problem
shaking NN I-NP I-problem
and CC O O
his PRP$ O B-person
breath NN B-NP O
smelled VBD B-VP O
more RBR O O
like IN B-VP O
ammonia NN B-NP O
over IN B-VP O
the DT O O
past JJ O O
3 CD O O
days NNS B-NP O
." VBP O O
The DT B-NP B-person
patient NN I-NP I-person
has VBZ O O
been VBN O O
compliant JJ O O
with IN B-VP O
his PRP$ O B-person
his PRP$ O B-treatment
medications NNS B-NP I-treatment
. . B-VP O
   
He PRP O B-person
has VBZ O O
had VBD B-VP O
one CD O O
bowel NN B-NP O
movement NN I-NP O
today NN I-NP O
which WDT O B-pronoun
is VBZ O O
on IN B-VP O
2014-03-31 JJ O O
. . B-VP O
   
He PRP O B-person
has VBZ O O
had VBN O O
night NN B-NP B-problem
sweats NNS I-NP I-problem
for IN B-VP O
the DT O O
past JJ O O
2 CD O O
weeks NNS B-NP O
. . B-VP O
   
He PRP O B-person
denies VBZ O O
any DT B-NP B-problem
abdominal JJ I-NP I-problem
pain NN I-NP I-problem
. . B-VP O
   
He PRP O B-person
gets VBZ O O
cold JJ O B-problem
easily RB O O
but CC O O
denies VBZ O O
fevers NNS B-NP B-problem
. . B-VP O
   
His PRP$ O B-person
stools NNS B-NP O
have VBP O O
been VBN O O
brown VBN O O
to TO O O
green VB O O
. . B-VP O
   
PAST NNP B-NP O
MEDICAL NNP I-NP O
HISTORY NNP I-NP O
: : O O
HCV NNP B-NP B-problem
cirrhosis NN I-NP I-problem
. . B-VP O
   
Underwent JJ B-NP O
treatment NN I-NP B-treatment
with IN B-VP O
Interferon NNP B-NP B-treatment
10 CD O O
years NNS B-NP O
ago RB O O
. . B-VP O
   
He PRP O B-person
stopped VBD B-VP O
secondary JJ O O
to TO O O
aggressive JJ B-NP B-problem
behavior NN I-NP I-problem
. . B-VP O
   
History NN B-NP O
of IN B-VP O
hepatic JJ B-NP B-problem
encephalopathy NN I-NP I-problem
. . B-VP O
   
Esophageal JJ B-NP B-problem
varices NNS I-NP I-problem
. . B-VP O
   
EGD VB O B-test
on IN B-VP O
2013-12-08 JJ O O
demonstrated JJ O O
5 CD O B-problem
cores NNS B-NP I-problem
of IN B-VP I-problem
varices NNS B-NP I-problem
, , O O
grade VBD B-VP O
1 CD O O
to TO O O
2 CD O O
at IN B-VP O
the DT B-NP O
lower JJR I-NP O
third NN I-NP O
of IN B-VP O
the DT B-NP O
esophagus NN I-NP O
. . B-VP O
   
Four CD O B-treatment
bands NNS B-NP I-treatment
were VBD B-VP O
placed VBN O O
without IN B-VP O
difficulty NN B-NP O
. . B-VP O
   
Also RB O O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
has VBZ O O
a DT B-NP O
past JJ I-NP O
medical JJ I-NP O
history NN I-NP O
of IN B-VP O
hypertension NN B-NP B-problem
, , O O
glucose JJ B-NP B-problem
intolerance NN I-NP I-problem
, , O O
peripheral JJ B-NP B-problem
neuropathy NN I-NP I-problem
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
taken VBN O O
off RB O O
of IN B-VP O
Neurontin NNP B-NP B-treatment
because IN B-VP O
it PRP O B-pronoun
started VBD B-VP O
to TO O O
worsen VB O O
his PRP$ O B-person
mental JJ B-NP O
status NN I-NP O
. . B-VP O
   
MEDICATIONS NNP B-NP O
ON NNP I-NP O
ADMISSION NNP I-NP O
: : O O
Nadolol NNP B-NP B-treatment
20 CD O O
mg NN B-NP O
q. JJ B-NP O
Day NNP I-NP O
. . B-VP O
   
Protonix NNP B-NP B-treatment
20 CD O O
mg NN B-NP O
q. NN I-NP O
24 CD O O
hours NNS B-NP O
. . B-VP O
   
Osamine VB O B-treatment
200 CD O O
mg NN B-NP O
t.i.d. NN I-NP O
Lactulose NNP I-NP B-treatment
30 CD O O
mg NN B-NP O
q.i.d. NN I-NP O
Lasix NNP I-NP B-treatment
40 CD O O
mg NN B-NP O
q. JJ B-NP O
Day NNP I-NP O
. . B-VP O
   
Insulin NNP B-NP B-treatment
regular JJ O I-treatment
. . B-VP O
   
Amlodipine $ O B-treatment
5 CD O O
mg JJ B-NP O
q. JJ I-NP O
Day NNP I-NP O
. . B-VP O
   
Retazepine NNP B-NP B-treatment
50 CD O O
mg NN B-NP O
q JJ B-NP O
h.s. NN I-NP O
Testosterone NNP I-NP B-treatment
4 CD O O
mg NN B-NP O
q. NN I-NP O
24 CD O O
hours NNS B-NP O
. . B-VP O
   
ALLERGIES NNS B-NP O
: : O O
No DT B-NP O
known JJ I-NP B-problem
drug NN I-NP I-problem
allergies NNS I-NP I-problem
. . B-VP O
   
SOCIAL NNP B-NP O
HISTORY NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
is VBZ O O
married JJ O O
and CC O O
lives VBZ O O
with IN B-VP O
his PRP$ O B-person
his PRP$ O B-person
wife NN B-NP I-person
. . B-VP O
   
Previously RB O O
employed VBN O O
as IN B-VP O
a DT B-NP O
security NN I-NP O
guard NN I-NP O
at IN B-VP O
a DT B-NP O
nuclear JJ I-NP O
power NN I-NP O
plant NN I-NP O
. . B-VP O
   
Quit NNP B-NP O
tobacco VBZ O O
20 CD O O
years NNS B-NP O
ago RB O O
and CC O O
currently RB O O
denies VBZ O O
any DT B-NP O
cigarette NN I-NP O
. . B-VP O
   
Alcohol NN B-NP O
: : O O
No DT B-NP O
alcohol NN I-NP O
use NN I-NP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
contracted VBD B-VP O
HCV NNP B-NP B-problem
20 CD O O
years NNS B-NP O
ago RB O O
secondary JJ O O
to TO O O
IV NNP B-NP O
drug NN I-NP O
use NN I-NP O
. . B-VP O
   
FAMILY NNP B-NP O
HISTORY NNP I-NP O
: : O O
Father NNP B-NP O
died VBD B-VP O
of IN B-VP B-problem
metastatic JJ B-NP I-problem
colon NN I-NP I-problem
cancer NN I-NP O
. . B-VP O
   
Mother NNP B-NP B-person
died VBD B-VP O
of IN B-VP O
end NN B-NP B-problem
stage NN I-NP I-problem
renal JJ B-NP I-problem
disease NN I-NP I-problem
. . B-VP O
   
PHYSICAL JJ B-NP O
EXAMINATION NN I-NP O
: : O O
Vital JJ B-NP B-test
signs NNS I-NP I-test
were VBD B-VP O
stable JJ O O
. . B-VP O
   
Weight NNP B-NP B-test
was VBD B-VP O
122.5 CD O O
. . B-VP O
   
General JJ O O
: : O O
Patient NN B-NP B-person
is VBZ O O
in IN B-VP O
no DT B-NP O
acute JJ I-NP B-problem
distress NN I-NP I-problem
. . B-VP O
   
Lethargic NNP B-NP B-problem
, , O O
occasionally RB O O
falling VBG O O
asleep RB O O
. . B-VP O
   
HEENT NN B-NP O
: : O O
Pupils NNP B-NP O
equal JJ O O
, , O O
round NN B-NP O
and CC O O
reactive JJ O O
to TO O O
light JJ O O
. . B-VP O
   
Sclera NNP B-NP B-problem
mildly RB O I-problem
icteric JJ O I-problem
. . B-VP O
   
Neck NN B-NP O
: : O O
No DT B-NP O
LAD NNP I-NP B-problem
. . B-VP O
   
Lungs NNS B-NP O
clear JJ O O
to TO O O
auscultation VB O B-test
bilaterally RB O O
. . B-VP O
   
CV NN B-NP O
: : O O
Regular JJ B-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
. . B-VP O
   
Normal NNP B-NP O
S1 NNP I-NP O
and CC O O
S2 NNP B-NP O
without IN B-VP O
murmurs NNS B-NP B-problem
or CC O O
rubs NNS B-NP B-problem
. . B-VP O
   
Positive JJ B-NP B-problem
gynecomastia NN I-NP I-problem
. . B-VP O
   
Abdomen NNS B-NP O
: : O O
Positive NNP B-NP O
bowel NN I-NP O
sounds NNS I-NP O
, , O O
soft JJ O O
, , O O
nondistended JJ O B-problem
, , O O
nontender NN B-NP B-problem
. . B-VP O
   
Obvious JJ B-NP B-problem
ascites NNS I-NP I-problem
. . B-VP O
   
1+ CD O B-problem
edema NN B-NP I-problem
bilaterally RB O I-problem
. . B-VP O
   
Neurologic NN B-NP O
: : O O
Awake NNP B-NP O
, , O O
alert NN B-NP O
and CC O O
oriented VBN O O
x3 NNP B-NP O
. . B-VP O
   
Cranial NNP B-NP O
nerves VBZ O O
2 CD O O
through IN B-VP O
12 CD O O
intact JJ O O
. . B-VP O
   
There EX O O
was VBD B-VP O
mild JJ B-NP B-problem
asterixis NN I-NP I-problem
. . B-VP O
   
HOSPITAL NNP B-NP O
COURSE NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
admitted VBN O O
. . B-VP O
   
Patient NNP B-NP B-person
continued VBD B-VP O
on IN B-VP O
Lactulose NNP B-NP B-treatment
. . B-VP O
   
The DT B-NP O
goal NN I-NP O
was VBD B-VP O
3 CD O O
to TO O O
4 CD O O
stools NNS B-NP O
per IN B-VP O
day NN B-NP O
. . B-VP O
   
Continue VB O O
on IN B-VP O
Rifaximine NNP B-NP B-treatment
. . B-VP O
   
Continue NNP B-NP O
Lasix NNP I-NP B-treatment
. . B-VP O
   
Physical NNP B-NP B-person
therapy NN I-NP I-person
was VBD B-VP O
consulted VBN O O
on IN B-VP O
2014-04-01 JJ O O
. . B-VP O
   
On IN B-VP O
2014-04-02 JJ O O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
awake RB O O
, , O O
alert NN B-NP O
and CC O O
oriented VBN O O
, , O O
taking VBG O O
Lactulose NNP B-NP B-treatment
. . B-VP O
   
Difficulty NN B-NP B-problem
with IN B-VP I-problem
word NN B-NP I-problem
finding NN I-NP I-problem
at IN B-VP O
times NNS B-NP O
. . B-VP O
   
Denies VBZ O O
any DT B-NP B-problem
pain NN I-NP I-problem
or CC O O
discomfort NN B-NP B-problem
. . B-VP O
   
Abdomen NNS B-NP O
: : O O
Slightly RB O B-problem
distended VBD B-VP I-problem
, , O O
nontender NN B-NP B-problem
. . B-VP O
   
Positive JJ B-NP O
bowel NN I-NP O
sounds NNS I-NP O
. . B-VP O
   
Positive JJ B-NP O
flatus NN I-NP O
. . B-VP O
   
Good JJ B-NP O
op NN I-NP O
site NN I-NP O
. . B-VP O
   
Ultrasound NNP B-NP B-test
was VBD B-VP O
performed VBN O O
on IN B-VP O
2014-04-01 JJ B-NP O
demonstrating NN I-NP O
severe JJ B-NP B-problem
portal JJ I-NP I-problem
hypertension NN I-NP I-problem
with IN B-VP O
massive JJ B-NP B-problem
peri NN I-NP I-problem
splenic JJ B-NP I-problem
varices NNS I-NP I-problem
and CC O O
splenorenal JJ B-NP B-problem
shunt NN I-NP I-problem
. . B-VP O
   
Portal NNP B-NP O
vein NN I-NP O
was VBD B-VP O
fully RB O O
patent JJ O O
. . B-VP O
   
Repeat NNP B-NP B-problem
hepato JJ B-NP I-problem
fungal NN I-NP I-problem
flare NN I-NP I-problem
. . B-VP O
   
On IN B-VP O
2014-04-04 JJ O O
, , O O
the DT B-NP B-person
transplant NN I-NP I-person
service NN I-NP I-person
was VBD B-VP O
consulted VBN O O
because IN B-VP O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
possibly RB O O
going VBG O O
to TO O O
the DT B-NP O
operating NN I-NP O
room NN I-NP O
for IN B-VP O
transplant NN B-NP B-treatment
on IN B-VP O
2014-04-04 JJ O O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
did VBD B-VP O
go VB O O
to TO O O
operating VBG O O
room NN B-NP O
on IN B-VP O
2014-04-04 JJ O O
and CC O O
the DT B-NP B-person
patient NN I-NP I-person
had VBD B-VP O
cadaveric JJ B-NP B-treatment
liver NN I-NP I-treatment
transplant NN I-NP I-treatment
performed VBN O O
by IN B-VP O
Dr. NNP B-NP B-person
Michael NNP I-NP I-person
Sanders NNP I-NP I-person
. . B-VP O
   
Please NNP B-NP O
see VB O O
detailed JJ B-NP O
operative JJ I-NP O
note NN I-NP O
for IN B-VP O
more JJR B-NP O
information NN I-NP O
about IN B-VP O
the DT B-NP B-treatment
procedure NN I-NP I-treatment
. . B-VP O
   
Postoperatively RB O O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
transferred VBN O O
to TO O O
the DT B-NP O
ICU NNP I-NP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
received VBD B-VP O
MMF NNP B-NP B-treatment
1 CD O O
gram NN B-NP O
b.i.d. NN I-NP O
, , O O
Flagyl NNP B-NP B-treatment
500 CD O O
mg NN B-NP O
IV NNP I-NP O
x1 NNP I-NP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
also RB O O
received VBD B-VP O
Unasyn NNP B-NP B-treatment
for IN B-VP O
2 CD O O
days NNS B-NP O
, , O O
Fluconazole NNP B-NP B-treatment
, , O O
heparin NN B-NP B-treatment
, , O O
Protonix NNP B-NP B-treatment
, , O O
insulin NN B-NP B-treatment
, , O O
morphine NN B-NP B-treatment
, , O O
Bactrim NNP B-NP B-treatment
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
on IN B-VP O
Propofol NNP B-NP B-treatment
for IN B-VP O
2 CD O O
days NNS B-NP O
. . B-VP O
   
LABORATORY NNP B-NP O
DATA NNP I-NP O
: : O O
On IN B-VP O
2014-04-04 JJ O O
, , O O
labs NNS B-NP B-test
were VBD B-VP O
as IN B-VP O
follows VBZ O O
: : O O
WBC NNP B-NP B-test
of IN B-VP O
8.3 CD O O
; : O O
hematocrit NN B-NP B-test
of IN B-VP O
30.6 CD O O
; : O O
platelets NNS B-NP B-test
69 CD O O
; : O O
sodium NN B-NP B-test
132 CD O O
; : O O
3.9 CD O O
, , O O
102 CD O O
, , O O
22 CD O O
, , O O
serum JJR B-NP B-test
creatinine NN I-NP I-test
of IN B-VP O
13 CD O O
and CC O O
1.1 CD O O
. . B-VP O
   
Glucose VB O B-test
114 CD O O
. . B-VP O
   
AST $ O B-test
87 CD O O
. . B-VP O
   
ALT $ O B-test
44 CD O O
. . B-VP O
   
Alkaline NNP B-NP B-test
phosphatase NN I-NP I-test
169 CD O O
. . B-VP O
   
PT NNP B-NP B-test
of IN B-VP O
20.6 CD O O
. . B-VP O
   
PTT NNP B-NP B-test
of IN B-VP O
38.7 CD O O
. . B-VP O
   
INR NNP B-NP B-test
of IN B-VP O
2.0 CD O O
. . B-VP O
   
On IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
number NN I-NP O
1 CD O O
, , O O
duplex JJ B-NP B-test
ultrasound NN I-NP I-test
of IN B-VP I-test
the DT O B-person
the DT B-NP I-test
patient JJ I-NP I-person
patient NN I-NP I-test
's POS O I-test
liver NN B-NP I-test
was VBD B-VP O
performed VBN O O
demonstrating VBG O O
normal JJ O O
appearing VBG O O
portal JJ B-NP O
veins NNS I-NP O
and CC O O
hepatic JJ B-NP O
arteries NNS I-NP O
. . B-VP O
   
There EX O O
was VBD B-VP O
normal JJ B-NP O
flow NN I-NP O
within IN B-VP O
the DT B-NP O
middle JJ I-NP O
hepatic JJ I-NP O
vein NN I-NP O
. . B-VP O
   
There EX O O
appears VBZ O O
to TO O O
be VB O O
a DT O B-problem
decreased JJ O I-problem
and CC O I-problem
sluggish JJ B-NP I-problem
flow NN I-NP I-problem
within IN B-VP I-problem
the DT B-NP I-problem
right NN I-NP I-problem
and CC O I-problem
left VBD B-VP I-problem
hepatic JJ B-NP I-problem
veins NNS I-NP I-problem
with IN B-VP O
loss NN B-NP B-problem
of IN B-VP I-problem
normal JJ B-NP I-problem
respiratory JJ I-NP I-problem
variations NNS I-NP I-problem
, , O I-problem
wave VBP O I-problem
forms NNS B-NP I-problem
and CC O I-problem
the DT B-NP I-problem
intrahepatic JJ I-NP I-problem
portion NN I-NP I-problem
. . B-VP O
   
Additionally RB O O
, , O O
there EX O O
is VBZ O O
diminished JJ B-NP B-problem
color NN I-NP I-problem
flow NN I-NP I-problem
with IN B-VP O
confluence NN B-NP O
of IN B-VP O
the DT B-NP O
hepatic JJ I-NP O
veins NNS I-NP O
. . B-VP O
   
These DT B-NP B-pronoun
findings NNS I-NP O
may MD O O
reflect VB O O
thrombus NN B-NP B-problem
within IN B-VP I-problem
the DT B-NP I-problem
left NN I-NP I-problem
and CC O I-problem
right JJ B-NP I-problem
hepatic NN I-NP I-problem
veins NNS I-NP I-problem
. . B-VP O
   
Caval NNP B-NP B-problem
narrowing NN I-NP I-problem
is VBZ O O
seen VBN O O
, , O O
most RBS O O
likely JJ B-NP O
correlation NN I-NP O
to TO O O
clinical JJ B-NP O
history NN I-NP O
is VBZ O O
recommended VBN O O
and CC O O
further JJ B-NP O
evaluation NN I-NP O
of IN B-VP O
the DT B-NP B-test
CT NNP I-NP I-test
or CC O O
short-term JJ B-NP B-test
ultrasounds NNS I-NP I-test
for IN B-VP O
follow-up NN B-NP O
was VBD B-VP O
recommended VBN O O
. . B-VP O
   
The DT B-NP B-treatment
Feeney NNP I-NP I-treatment
Gann-Burlington NNP I-NP I-treatment
drain NN I-NP I-treatment
on IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
number NN I-NP O
demonstrated VBD B-VP O
medial JJ B-NP B-test
output NN I-NP I-test
of IN B-VP O
780 CD O O
with IN B-VP O
lateral JJ B-NP B-test
output NN I-NP I-test
of IN B-VP O
150 CD O O
. . B-VP O
   
Patient JJ O B-person
went VBD B-VP O
to TO O O
the DT B-NP O
floor NN I-NP O
and CC O O
patient NN B-NP B-person
was VBD B-VP O
on IN B-VP O
the DT B-NP O
floor NN I-NP O
on IN B-VP O
2014-04-07 JJ O O
. . B-VP O
   
Patient NNP B-NP B-person
continued VBD B-VP O
getting VBG O O
Acyclovir NNP B-NP B-treatment
, , O O
Prednisone NNP B-NP B-treatment
, , O O
MMF NNP B-NP B-treatment
one CD O O
gram NN B-NP O
b.i.d NN I-NP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
on IN B-VP O
FK NNP B-NP B-treatment
2 CD O I-treatment
and CC O O
2 CD O O
that WDT O B-pronoun
was VBD B-VP O
started VBN O O
on IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
number NN I-NP O
2 CD O O
. . B-VP O
   
Diet NNP B-NP O
was VBD B-VP O
advanced VBN O O
. . B-VP O
   
Patient NN B-NP B-person
was VBD B-VP O
ambulating VBG O O
. . B-VP O
   
Waltham-Ludlow JJ B-NP B-treatment
drains NNS I-NP I-treatment
put VBD B-VP O
out RP O O
on IN B-VP O
the DT O O
13th CD O O
620 CD O O
and CC O O
380 CD O O
. . B-VP O
   
Physical JJ B-NP B-person
therapy NN I-NP I-person
was VBD B-VP O
re RB O O
consulted VBN O O
. . B-VP O
   
Omalley NNP B-NP B-person
was VBD B-VP O
consulted VBN O O
on IN B-VP O
2014-04-08 JJ O O
for IN B-VP O
better JJR B-NP O
glucose NN I-NP B-treatment
control NN I-NP I-treatment
since IN B-VP O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
on IN B-VP O
steroids NNS B-NP B-treatment
. . B-VP O
   
Social NNP B-NP B-person
work NN I-NP I-person
was VBD B-VP O
consulted VBN O O
. . B-VP O
   
Patient NNP B-NP B-person
continued VBD B-VP O
to TO O O
do VB O O
very RB O O
well RB O O
, , O O
ambulating VBG O O
, , O O
following VBG O O
the DT O O
diet JJ O O
. . B-VP O
   
Patient NN B-NP B-person
was VBD B-VP O
transfused VBN O O
1 CD O B-treatment
unit NN B-NP I-treatment
of IN B-VP I-treatment
platelets NNS B-NP I-treatment
on IN B-VP O
2014-04-08 JJ O O
for IN B-VP O
platelet NN B-NP B-test
count NN I-NP I-test
of IN B-VP O
66 CD O O
. . B-VP O
   
A DT B-NP B-test
heparin JJ I-NP I-test
independent JJ I-NP I-test
antibody NN I-NP I-test
was VBD B-VP O
sent VBN O O
off RP O O
on IN B-VP O
2014-04-07 JJ O O
which WDT O B-pronoun
was VBD B-VP O
unremarkable JJ O O
. . B-VP O
   
On IN B-VP O
2014-04-09 JJ O O
, , O O
patient JJ O B-person
continued VBD B-VP O
to TO O O
do VB O O
very RB O O
well RB O O
, , O O
ambulating VBG O O
, , O O
tolerating VBG O O
a DT O O
diet JJ O O
, , O O
urinating VBG O O
without IN B-VP O
difficulty NN B-NP B-problem
. . B-VP O
   
Drains VBZ O B-treatment
continued JJ O O
to TO O O
put VB O O
out RP O O
significant JJ B-NP O
amount NN I-NP O
of IN B-VP O
fluid NN B-NP O
. . B-VP O
   
Patient NNP B-NP B-person
Patient NNP I-NP B-test
's POS O I-test
labs NN B-NP I-test
from IN B-VP O
2014-04-10 JJ O O
were VBD B-VP O
the DT O O
following JJ O O
: : O O
7.1 CD O O
, , O O
hematocrit NN B-NP B-test
of IN B-VP O
30.8 CD O O
, , O O
platelets NNS B-NP B-test
90 CD O O
. . B-VP O
   
Sodium NN B-NP B-test
of IN B-VP O
138 CD O O
; : O O
potassium NN B-NP B-test
3.5 CD O O
; : O O
106 CD O O
, , O O
28 CD O O
, , O O
31 CD O O
, , O O
1.0 CD O O
, , O O
glucose VBD B-VP B-test
134 CD O O
. . B-VP O
   
AST $ O B-test
82 CD O O
. . B-VP O
   
ALT $ O B-test
176 CD O O
. . B-VP O
   
Alkaline NNP B-NP B-test
phosphatase NN I-NP I-test
78 CD O O
which WDT O B-pronoun
all DT O O
have VBP O O
significantly RB O O
decreased VBN O O
since IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
number NN I-NP O
1 CD O O
. . B-VP O
   
Total JJ B-NP B-test
bilirubin NN I-NP I-test
was VBD B-VP O
0.9 CD O O
. . B-VP O
   
On IN B-VP O
2014-04-09 JJ O O
, , O O
FK NNP B-NP B-test
level NN I-NP I-test
was VBD B-VP O
10.3 CD O O
. . B-VP O
   
Patient NN B-NP B-person
left VBD B-VP O
on IN B-VP O
2014-04-09 JJ O O
with IN B-VP O
VNA NNP B-NP O
to TO O O
home NN B-NP O
. . B-VP O
   
DISCHARGE NNP B-NP O
MEDICATIONS NNP I-NP O
: : O O
Protonix NNP B-NP B-treatment
40 CD O O
mg NN B-NP O
q. NN I-NP O
24 CD O O
. . B-VP O
   
Moltipine VB O B-treatment
5 CD O O
mg JJ B-NP O
q. JJ I-NP O
Day NNP I-NP O
. . B-VP O
   
Fluconazole NNP B-NP B-treatment
400 CD O O
mg NN B-NP O
q. NN I-NP O
24 CD O O
hours NNS B-NP O
. . B-VP O
   
Prednisone VB O B-treatment
20 CD O O
mg JJ B-NP O
q. JJ I-NP O
Day NNP I-NP O
. . B-VP O
   
MMF NNP B-NP B-treatment
1000 CD O O
mg NN B-NP O
b.i.d. NN I-NP O
. . B-VP O
   
Lopressor NNP B-NP B-treatment
50 CD O O
m NN B-NP O
b.i.d. NN I-NP O
Percocet NNP I-NP B-treatment
1 CD O O
to TO O O
2 CD O O
tabs NNS B-NP O
q. RB O O
4 CD O O
to TO O O
6 CD O O
hours NNS B-NP O
prn RB O O
. . B-VP O
   
Colace NNP B-NP B-treatment
100 CD O O
mg NN B-NP O
b.i.d. NN I-NP O
Bactrim NNP I-NP B-treatment
SS NNP I-NP O
1 CD O O
tab NN B-NP O
q. JJ B-NP O
Day NNP I-NP O
. . B-VP O
   
Tacrolimus NNP B-NP B-treatment
3 CD O O
mg NN B-NP O
b.i.d. NN I-NP O
Lasix NNP I-NP B-treatment
20 CD O O
mg NN B-NP O
b.i.d. NN I-NP O
Valcyte NNP I-NP B-treatment
900 CD O O
mg NN B-NP O
q. JJ B-NP O
Day NNP I-NP O
. . B-VP O
   
Patient NNP B-NP B-person
is VBZ O O
on IN B-VP O
insulin NN B-NP B-treatment
sliding VBG O I-treatment
scale NN B-NP I-treatment
with IN B-VP O
fixed JJ B-NP O
dose NN I-NP O
. . B-VP O
   
FOLLOW NNP B-NP O
UP IN B-VP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
is VBZ O O
to TO O O
follow-up JJ O O
with IN B-VP O
Dr. NNP B-NP B-person
Amanda NNP I-NP I-person
Pepper NNP I-NP I-person
on IN B-VP O
the DT B-NP O
following JJ I-NP O
dates NNS I-NP O
: : O O
2014-04-14 JJ O O
at IN B-VP O
9 CD O O
a.m. RB O O
, , O O
2014-04-24 JJ O O
at IN B-VP O
10:20 CD O O
a.m. NN B-NP O
and CC O O
2014-05-01 JJ O O
at IN B-VP O
10:20 CD O O
a.m. RB O O
If IN B-VP O
the DT B-NP B-person
patient NN I-NP I-person
can MD O O
not RB O O
make VB O O
those DT B-NP B-pronoun
appointments NNS I-NP O
or CC O O
has VBZ O O
any DT B-NP O
questions NNS I-NP O
about IN B-VP O
the DT B-NP O
appointments NNS I-NP O
, , O O
please VB O O
call VB O O
787-984-9608 JJ O O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
is VBZ O O
to TO O O
call VB O O
787-984-9608 JJ O O
if IN B-VP O
any DT B-NP O
fevers NNS I-NP B-problem
, , O O
chills NNS B-NP B-problem
, , O O
nausea NN B-NP B-problem
and CC O O
vomiting NN B-NP B-problem
, , O O
abdominal JJ B-NP B-problem
pain NN I-NP I-problem
, , O O
inability NN B-NP B-problem
to TO O I-problem
take VB O I-problem
medications NNS B-NP I-problem
, , O O
inability NN B-NP B-problem
to TO O I-problem
eat VB O I-problem
or CC O I-problem
drink VB O I-problem
. . B-VP O
   
Patient NNP B-NP B-person
needs VBZ O O
to TO O O
have VB O O
labs VBN O B-test
every DT B-NP O
Monday NNP I-NP O
and CC O O
Thursday NNP B-NP O
including VBG O O
a DT B-NP B-test
CBC NNP I-NP I-test
, , O O
chem-10 NN B-NP B-test
, , O O
AST NNP B-NP B-test
, , O O
ALT NNP B-NP B-test
, , O O
alkaline JJ B-NP B-test
phosphatase NN I-NP I-test
, , O O
albumin NN B-NP B-test
, , O O
total JJ B-NP B-test
bilirubin NN I-NP I-test
and CC O O
Prograf NNP B-NP B-test
level VBP O I-test
need NN B-NP O
to TO O O
be VB O O
obtained VBN O O
. . B-VP O
   
Please NNP B-NP O
fax JJ B-NP O
results NNS I-NP O
to TO O O
( ( O O
728 CD O O
) ) O O
250-3265 JJ O O
. . B-VP O
   
All DT B-NP B-test
cultures NNS I-NP I-test
have VBP O O
been VBN O O
unremarkable JJ O O
. . B-VP O
   
Cultures NNS B-NP B-test
were VBD B-VP O
obtained VBN O O
on IN B-VP O
2014-03-31 JJ O O
. . B-VP O
   
Urine JJ B-NP B-test
culture NN I-NP I-test
and CC O O
blood NN B-NP B-test
culture NN I-NP I-test
have VBP O O
been VBN O O
unremarkable JJ O O
on IN B-VP O
2014-04-03 JJ O O
. . B-VP O
   
Hepatitis NNP B-NP B-test
viral JJ B-NP I-test
load NN I-NP I-test
was VBD B-VP O
76,500 CD O O
. . B-VP O
   
Pathology NN B-NP O
demonstrates VBZ O O
that IN B-VP B-pronoun
the DT B-NP B-test
pathology NN I-NP I-test
results NNS I-NP I-test
of IN B-VP I-test
the DT B-NP I-test
liver NN I-NP I-test
were VBD B-VP O
not RB O O
finalized VBN O O
. . B-VP O
   
Darrell NNP B-NP B-person
Diiorio NNP I-NP I-person
, , O I-person
MD NNP B-NP I-person
, , O I-person
PHD NNP B-NP I-person
02-366 CD O O
Dictated VBN O O
By IN B-VP O
: : O O
Deborah NNP B-NP B-person
JP NNP I-NP I-person
Allen NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
MEDQUIST36 NNP I-NP O
D NNP I-NP O
: : O O
2014-04-11 JJ O O
14:30:39 CD O O
T NN B-NP O
: : O O
2014-04-11 JJ O O
15:05:40 CD O O
Job NNP B-NP O
#: VBD B-VP O
88167 CD O O
Signed VBN O O
electronically RB O O
by IN B-VP O
: : O O
DR. NNP B-NP B-person
Greg NNP I-NP I-person
Jones NNP I-NP I-person
on IN B-VP O
: : O O
FRI NNP B-NP O
2014-04-25 CD O O
2:37 CD O O
PM NNP B-NP O
( ( O O
End NNP B-NP O
of IN B-VP O
Report NNP B-NP O
) ) O O
-EMPTYLINE- VBP O O
-DOCSTART- JJ O O
-EMPTYLINE- $ O O
289724916 CD O O
HLGMC NNP B-NP O
0051811 CD O O
56075/pu8n CD O O
6/30/1992 CD O O
12:00:00 CD O O
AM NNP B-NP O
CARCINOMA NNP I-NP B-problem
OF IN B-VP I-problem
THE NNP B-NP I-problem
KIDNEY NNP I-NP I-problem
, , O O
HYPOVOLEMIA NNP B-NP B-problem
, , O O
METASTATIC NNP B-NP B-problem
LIVER NNP I-NP I-problem
Unsigned VBD B-VP O
DIS NNP B-NP O
Report NNP I-NP O
Status NNP I-NP O
: : O O
Unsigned VBN O O
ADMISSION NNP B-NP O
DATE NNP I-NP O
: : O O
6-30-92 JJ B-NP O
DISCHARGE NNP I-NP O
DATE NNP I-NP O
: : O O
7-1-92 JJ O O
( ( O O
SOUTHOBASSKING&apos;S NNP B-NP O
VILLEMARG NNP I-NP O
HOSPITAL NNP I-NP O
) ) O O
PRINCIPAL NNP B-NP O
DIAGNOSIS NNP I-NP O
: : O O
carcinoma NN B-NP B-problem
of IN B-VP I-problem
the DT B-NP I-problem
kidney NN I-NP I-problem
, , O O
hypovolemia NN B-NP B-problem
, , O O
metastatic JJ B-NP B-problem
liver NN I-NP I-problem
disease NN I-NP I-problem
and CC O O
intrathoracic NN B-NP B-problem
lymphadenopathy NN I-NP I-problem
. . B-VP O
   
HISTORY NNP B-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS NNP I-NP O
: : O O
The DT B-NP O
history NN I-NP O
of IN B-VP O
this DT O B-person
this DT O B-pronoun
49 CD O I-person
year NN B-NP I-person
old JJ B-NP I-person
male NN I-NP I-person
is VBZ O O
provided VBN O O
in IN B-VP O
detail NN B-NP O
in IN B-VP O
the DT B-NP O
typed JJ I-NP O
admission NN I-NP O
note NN I-NP O
dated VBD B-VP O
June NNP B-NP O
30 CD O O
, , O O
1992 CD O O
. . B-VP O
   
PHYSICAL JJ B-NP O
EXAMINATION NN I-NP O
: : O O
( ( O O
at IN B-VP O
time NN B-NP O
of IN B-VP O
admission NN B-NP O
) ) O O
the DT B-NP B-test
blood NN I-NP I-test
pressure NN I-NP I-test
100/65 CD O O
; : O O
head NN B-NP O
, , O O
eyes NNS B-NP O
, , O O
ears NNS B-NP O
, , O O
nose RB O O
, , O O
throat NN B-NP O
: : O O
no DT B-NP O
masses NNS I-NP B-problem
, , O O
neck NN B-NP O
revealed VBD B-VP O
lymphadenopathy NN B-NP B-problem
. . B-VP O
   
The DT B-NP O
lungs NNS I-NP O
were VBD B-VP O
clear JJ O O
, , O O
heart NN B-NP O
normal JJ O O
. . B-VP O
   
Abdomen NNS B-NP O
: : O O
liver NN B-NP B-problem
massively RB O I-problem
enlarged VBD B-VP I-problem
down RB O O
15 CD O O
cm NN B-NP O
. . B-VP O
   
Extremities NNS B-NP O
: : O O
normal JJ O O
; : O O
neurological JJ B-NP B-test
examination NN I-NP I-test
: : O O
generally RB O O
intact JJ O O
. . B-VP O
   
LABORATORY NNP B-NP O
DATA NNP I-NP O
: : O O
( ( O O
at IN B-VP O
time NN B-NP O
of IN B-VP O
admission NN B-NP O
) ) O O
hematocrit NN B-NP B-test
32.7 CD O O
; : O O
white JJ B-NP B-test
blood NN I-NP I-test
count NN I-NP I-test
9,000 CD O O
; : O O
platelet NN B-NP B-test
count NN I-NP I-test
336,000 CD O O
; : O O
sodium NN B-NP B-test
126 CD O O
, , O O
potassium NN B-NP B-test
4.3 CD O O
, , O O
chloride RB O B-test
93 CD O O
, , O O
CO2 NNP B-NP B-test
19 CD O O
, , O O
BUN NNP B-NP B-test
36 CD O O
, , O O
creatinine NN B-NP B-test
1.5 CD O O
, , O O
blood NN B-NP B-test
sugar NN I-NP I-test
84 CD O O
, , O O
calcium NN B-NP B-test
11.7 CD O O
; : O O
the DT O B-test
chest JJS O I-test
X-ray JJ O I-test
normal JJ O O
. . B-VP O
   
KUB NNP B-NP B-test
: : O O
consistent NN B-NP O
with IN B-VP O
adynamic JJ B-NP B-problem
ileus NN I-NP I-problem
. . B-VP O
   
HOSPITAL NNP B-NP O
COURSE NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
worsened VBD B-VP O
rapidly RB O O
following VBG O O
admission NN B-NP O
and CC O O
it PRP O B-pronoun
was VBD B-VP O
clear JJ O O
to TO O O
his PRP$ O B-person
his PRP$ O B-person
family NN B-NP I-person
and CC O O
to TO O O
his PRP$ O B-person
his PRP$ O B-person
physician NN B-NP I-person
that IN B-VP B-pronoun
he PRP O B-person
was VBD B-VP O
pre-terminal JJ O O
. . B-VP O
   
All DT B-NP O
efforts NNS I-NP O
were VBD B-VP O
directed VBN O O
to TO O O
his PRP$ O B-person
comfort NN B-NP O
and CC O O
he PRP O B-person
died VBD B-VP O
on IN B-VP O
July NNP B-NP O
1 CD O O
, , O O
1992 CD O O
. . B-VP O
   
Autopsy NNP B-NP O
permission NN I-NP O
was VBD B-VP O
declined VBN O O
by IN B-VP O
the DT B-NP B-person
family NN I-NP I-person
. . B-VP O
   
NU NNP B-NP B-person
L. NNP I-NP I-person
GALL NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
TR NNP I-NP O
: : O O
vb NN B-NP O
/ NNP I-NP O
bmot NN I-NP O
DD NNP I-NP O
: : O O
7-30-92 JJ B-NP O
TD NN I-NP O
: : O O
08/03/92 CD O O
CC NN B-NP O
: : O O
DR. NNP B-NP B-person
VERD NNP I-NP I-person
CHURLAUNT NNP I-NP I-person
DR. NNP I-NP B-person
NU NNP I-NP I-person
L. NNP I-NP I-person
GALL NNP I-NP I-person
, , O O
LI NNP B-NP O
HOSPITAL NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
Admission NNP I-NP O
Date NNP I-NP O
: : O O
2014-04-21 JJ B-NP O
Discharge NN I-NP O
Date NNP I-NP O
: : O O
2014-04-24 JJ B-NP O
Date NNP I-NP O
of IN B-VP O
Birth NNP B-NP O
: : O O
1960-10-27 JJ B-NP O
Sex NN I-NP O
: : O O
M NNP B-NP O
Service NNP I-NP O
: : O O
CARDIOTHORACIC JJ B-NP O
Allergies NNS I-NP O
: : O O
Patient NN B-NP B-person
recorded VBD B-VP O
as IN B-VP O
having VBG O O
No NNP B-NP O
Known NNP I-NP B-problem
Allergies NNPS I-NP I-problem
to TO O I-problem
Drugs NNP B-NP I-problem
Attending NNP I-NP B-person
: : O O
Mary NNP B-NP B-person
X NNP I-NP I-person
Baxter NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
Chief NNP I-NP O
Complaint NNP I-NP O
: : O O
TIA/Palpitations NNS B-NP B-problem
Major NNP I-NP O
Surgical NNP I-NP O
or CC O O
Invasive JJ B-NP O
Procedure NN I-NP O
: : O O
2014-04-21 JJ O O
- : O O
PFO JJ B-NP B-treatment
closure NN I-NP I-treatment
via IN B-VP O
Right NNP B-NP B-treatment
mini FW O I-treatment
thoracotomy JJ B-NP I-treatment
History NNP I-NP O
of IN B-VP O
Present NNP B-NP O
Illness NNP I-NP O
: : O O
This DT O B-person
This DT O B-pronoun
53-year-old JJ O I-person
with IN B-VP O
a DT B-NP O
history NN I-NP O
of IN B-VP O
multiple JJ B-NP B-problem
transient JJ I-NP I-problem
ischemic JJ I-NP I-problem
attacks NNS I-NP I-problem
in IN B-VP O
the DT B-NP O
past NN I-NP O
was VBD B-VP O
investigated VBN O O
and CC O O
was VBD B-VP O
found VBN O O
to TO O O
have VB O O
a DT B-NP B-problem
small JJ I-NP I-problem
patent NN I-NP I-problem
foramen NNS I-NP I-problem
ovale VBP O I-problem
, , O O
and CC O O
he PRP O B-person
was VBD B-VP O
electively RB O O
admitted VBN O O
for IN B-VP O
closure NN B-NP B-treatment
of IN B-VP O
the DT O O
same JJ O O
. . B-VP O
   
His PRP$ O B-person
His PRP$ O B-test
preoperative JJ B-NP I-test
investigations NNS I-NP I-test
with IN B-VP O
coronary JJ B-NP B-test
angiogram NN I-NP I-test
showed VBD B-VP O
normal JJ B-NP O
coronary JJ I-NP O
arteries NNS I-NP O
. . B-VP O
   
His PRP$ O B-person
left JJ B-NP O
ventricular JJ I-NP O
function NN I-NP O
was VBD B-VP O
well RB O O
preserved VBN O O
. . B-VP O
   
He PRP O B-person
had VBD B-VP O
no DT B-NP O
valvular JJ I-NP B-problem
disease NN I-NP I-problem
. . B-VP O
   
Past NNP B-NP O
Medical JJ B-NP O
History NN I-NP O
: : O O
Right JJ B-NP B-problem
Upper NNP I-NP I-problem
lobe NN I-NP I-problem
nodule NN I-NP I-problem
TIA NNP I-NP B-problem
's POS O I-problem
Childhood NNP B-NP B-problem
skull NN I-NP I-problem
fracture NN I-NP I-problem
PFO NNP I-NP B-problem
Social NNP I-NP O
History NNP I-NP O
: : O O
Lives VBZ O O
with IN B-VP O
wife NN B-NP B-person
. . B-VP O
   
1 CD O O
ETO NNP B-NP O
drink VBP O O
daily RB O O
. . B-VP O
   
Quit NNP B-NP O
smoking VBG O O
30 CD O O
years NNS B-NP O
ago RB O O
after IN B-VP O
smoking VBG O O
1ppd CD O O
. . B-VP O
   
Retired VBN O O
. . B-VP O
   
Family JJ B-NP O
History NN I-NP O
: : O O
Brother NN B-NP B-person
with IN B-VP O
MI NNP B-NP B-problem
at IN B-VP O
age NN B-NP O
35 CD O O
Father NNP B-NP B-person
with IN B-VP O
MI/CABG NNP B-NP B-problem
died VBD B-VP O
at IN B-VP O
age NN B-NP O
60 CD O O
. . B-VP O
   
Physical JJ B-NP O
Exam NN I-NP O
: : O O
Vitals NNS B-NP O
: : O O
BP NNP B-NP B-test
144/90 CD O O
, , O O
HR NNP B-NP B-test
64 CD O O
, , O O
RR NNP B-NP B-test
14 CD O O
General NNP B-NP O
: : O O
well RB O O
developed VB O O
male NN B-NP O
in IN B-VP O
no DT B-NP O
acute NN I-NP B-problem
distress NN I-NP I-problem
HEENT NNP I-NP O
: : O O
oropharynx NN B-NP O
benign NN I-NP O
, , O O
poor JJ B-NP B-problem
dental JJ I-NP I-problem
health NN I-NP I-problem
Neck NN I-NP O
: : O O
supple NN B-NP O
, , O O
no DT B-NP O
JVD NNP I-NP B-problem
Heart NNP I-NP O
: : O O
regular JJ B-NP O
rate NN I-NP O
, , O O
normal JJ B-NP O
s1s2 NN I-NP O
, , O O
no DT B-NP O
murmur JJ I-NP B-problem
Lungs NNS I-NP O
: : O O
clear JJ O O
bilaterally RB O O
Abdomen NNS B-NP O
: : O O
soft JJ O O
, , O O
nontender NN B-NP B-problem
, , O O
normoactive JJ B-NP O
bowel NN I-NP O
sounds VBZ O O
Ext NNP B-NP O
: : O O
warm NN B-NP O
, , O O
no DT B-NP O
edema NN I-NP B-problem
, , O O
no DT B-NP O
varicosities NNS I-NP B-problem
Pulses VBZ O O
: : O O
2+ CD O O
distally RB O O
Neuro NNP B-NP O
: : O O
nonfocal JJ B-NP O
Pertinent NNP I-NP O
Results: NNP I-NP O
2014-04-24 JJ O O
07:30AM CD O O
BLOOD NNP B-NP B-test
Hct NNP I-NP B-test
- : O O
25.9* CD O O
2014-04-23 JJ O O
07:05AM CD O O
BLOOD NNP B-NP B-test
WBC NNP I-NP B-test
- : O O
5.9 CD O O
RBC NNP B-NP B-test
- : O O
2.72* CD O O
Hgb NNP B-NP B-test
- : O O
8.6* CD O O
Hct NNP B-NP B-test
- : O O
25.2* CD O O
MCV NNP B-NP B-test
- : O O
93 CD O O
MCH NNP B-NP B-test
- : O O
31.5 CD O O
MCHC NNP B-NP B-test
- : O O
34.0 CD O O
RDW NNP B-NP B-test
- : O O
13.0 CD O O
Plt NNP B-NP B-test
Ct NNP I-NP I-test
- : O O
150 CD O O
2014-04-23 JJ O O
07:05AM CD O O
BLOOD NNP B-NP B-test
Plt NNP I-NP B-test
Ct NNP I-NP I-test
- : O O
150 CD O O
2014-04-24 JJ O O
07:30AM CD O O
BLOOD NNP B-NP B-test
UreaN NNP I-NP B-test
- : O O
11 CD O O
Creat NNP B-NP B-test
- : O O
0.8 CD O O
K NNP B-NP O
- : O O
4.4 CD O O
2014-04-21 JJ B-NP O
ECHO NNP I-NP B-test
No NNP I-NP O
spontaneous JJ B-NP B-problem
echo NN I-NP I-problem
contrast NN I-NP I-problem
is VBZ O O
seen VBN O O
in IN B-VP O
the DT B-NP O
body NN I-NP O
of IN B-VP O
the DT B-NP O
left JJ I-NP O
atrium NN I-NP O
. . B-VP O
   
No DT B-NP O
mass/thrombus NN I-NP B-problem
is VBZ O O
seen VBN O O
in IN B-VP O
the DT B-NP O
left JJ I-NP O
atrium NN I-NP O
or CC O O
left VBN O O
atrial JJ B-NP O
appendage NN I-NP O
. . B-VP O
   
No DT B-NP O
spontaneous JJ I-NP B-problem
echo NN I-NP I-problem
contrast NN I-NP I-problem
is VBZ O O
seen VBN O O
in IN B-VP O
the DT B-NP O
body NN I-NP O
of IN B-VP O
the DT B-NP O
right JJ I-NP O
atrium NN I-NP O
. . B-VP O
   
A DT B-NP B-problem
patent NN I-NP I-problem
foramen NNS I-NP I-problem
ovale/secundum VBP O I-problem
ASD NNP B-NP I-problem
is VBZ O O
present JJ O O
. . B-VP O
   
A DT B-NP B-problem
left-to-right JJ I-NP I-problem
shunt NN I-NP I-problem
across IN B-VP I-problem
the DT B-NP I-problem
interatrial JJ I-NP I-problem
septum NN I-NP I-problem
is VBZ O O
seen VBN O O
at IN B-VP O
rest NN B-NP O
. . B-VP O
   
A DT B-NP B-problem
right-to-left JJ I-NP I-problem
shunt NN I-NP I-problem
across IN B-VP I-problem
the DT B-NP I-problem
interatrial JJ I-NP I-problem
septum NN I-NP I-problem
is VBZ O O
seen VBN O O
at IN B-VP O
rest NN B-NP O
with IN B-VP O
injection NN B-NP B-test
of IN B-VP I-test
agitated JJ B-NP I-test
saline NN I-NP I-test
contrast NN I-NP I-test
. . B-VP O
   
The DT B-NP O
inferior JJ I-NP O
vena NN I-NP O
cava NN I-NP O
is VBZ O O
dilated VBN O B-problem
( ( O O
>2.5 NNP B-NP O
cm NN I-NP O
) ) O O
. . B-VP O
   
Left VBN O O
ventricular JJ B-NP O
wall NN I-NP O
thickness NN I-NP O
, , O O
cavity NN B-NP O
size NN I-NP O
, , O O
and CC O O
systolic JJ B-NP O
function NN I-NP O
are VBP O O
normal JJ O O
( ( O O
LVEF NNP B-NP B-test
>55% NNP I-NP I-test
) ) O O
. . B-VP O
   
Left VBN O O
ventricular JJ B-NP O
wall NN I-NP O
thicknesses NNS I-NP O
are VBP O O
normal JJ O O
. . B-VP O
   
Regional JJ O O
left VBD B-VP O
ventricular JJ B-NP O
wall NN I-NP O
motion NN I-NP O
is VBZ O O
normal JJ O O
. . B-VP O
   
Overall JJ O O
left VBD B-VP O
ventricular JJ B-NP O
systolic JJ I-NP O
function NN I-NP O
is VBZ O O
normal JJ O O
( ( O O
LVEF>55% NNP B-NP B-test
) ) O O
. . B-VP O
   
Right JJ B-NP O
ventricular JJ I-NP O
chamber NN I-NP O
size NN I-NP O
and CC O O
free JJ B-NP O
wall NN I-NP O
motion NN I-NP O
are VBP O O
normal JJ O O
. . B-VP O
   
The DT B-NP O
ascending NN I-NP O
, , O O
transverse NN B-NP O
and CC O O
descending VBG O O
thoracic NN B-NP O
aorta NNS I-NP O
are VBP O O
normal JJ O O
in IN B-VP O
diameter NN B-NP O
and CC O O
free JJ O O
of IN B-VP O
atherosclerotic JJ B-NP B-problem
plaque NN I-NP I-problem
. . B-VP O
   
The DT B-NP O
aortic JJ I-NP O
valve NN I-NP O
leaflets NNS I-NP O
( ( O O
3 CD O O
) ) O O
appear VBP O O
structurally RB O O
normal JJ O O
with IN B-VP O
good JJ B-NP O
leaflet NN I-NP O
excursion NN I-NP O
and CC O O
no DT B-NP O
aortic JJ I-NP B-problem
regurgitation NN I-NP I-problem
. . B-VP O
   
No CC O O
aortic JJ B-NP B-problem
regurgitation NN I-NP I-problem
is VBZ O O
seen VBN O O
. . B-VP O
   
The DT B-NP O
mitral JJ I-NP O
valve NN I-NP O
appears VBZ O O
structurally RB O O
normal JJ O O
with IN B-VP O
trivial JJ B-NP B-problem
mitral JJ I-NP I-problem
regurgitation NN I-NP I-problem
. . B-VP O
   
The DT B-NP O
mitral JJ I-NP O
valve NN I-NP O
leaflets NNS I-NP O
are VBP O O
structurally RB O O
normal JJ O O
. . B-VP O
   
There EX O O
is VBZ O O
no DT B-NP O
pericardial JJ I-NP B-problem
effusion NN I-NP I-problem
. . B-VP O
   
POST NNP B-NP O
BYPASS NNP I-NP B-treatment
Flow NNP I-NP B-problem
across IN B-VP I-problem
the DT B-NP I-problem
interatrial JJ I-NP I-problem
septum NN I-NP I-problem
is VBZ O O
no RB O O
longer RBR O O
visualized VBN O O
with IN B-VP O
color NN B-NP B-test
flow NN I-NP I-test
doppler NN I-NP I-test
or CC O O
with IN B-VP O
injection NN B-NP B-test
of IN B-VP I-test
agitatated JJ B-NP I-test
saline NN I-NP I-test
at IN B-VP O
rest NN B-NP O
or CC O O
with IN B-VP O
valsalva NN B-NP O
. . B-VP O
   
The DT B-NP B-test
study NN I-NP I-test
is VBZ O O
otherwise RB O O
unchanged JJ O O
from IN B-VP O
pre-bypass NN B-NP O
. . B-VP O
   
2014-04-22 JJ B-NP O
CXR NNP I-NP B-test
Previous NNP I-NP B-problem
right NN I-NP I-problem
pneumothorax NN I-NP I-problem
has VBZ O O
resolved VBN O O
except IN B-VP O
for IN B-VP O
what WP O O
is VBZ O O
either CC O O
a DT B-NP B-problem
small JJ I-NP I-problem
fissural JJ I-NP I-problem
component NN I-NP I-problem
or CC O O
a DT B-NP B-problem
bulla NN I-NP I-problem
adjacent NN I-NP O
to TO O O
the DT B-NP O
minor JJ I-NP O
fissure NN I-NP O
. . B-VP O
   
May NNP B-NP O
be VB O O
a DT B-NP B-problem
small JJ I-NP I-problem
right JJ I-NP I-problem
pleural JJ I-NP I-problem
effusion NN I-NP I-problem
. . B-VP O
   
Right JJ B-NP B-treatment
apical JJ I-NP I-treatment
pleural JJ I-NP I-treatment
tube NN I-NP I-treatment
in IN B-VP O
place NN B-NP O
. . B-VP O
   
Left NNP B-NP O
lung VBD B-VP O
clear JJ O O
from IN B-VP O
basal JJ B-NP B-problem
atelectasis NN I-NP I-problem
. . B-VP O
   
Paratracheal NNP B-NP B-problem
mediastinal JJ B-NP I-problem
hematoma NN I-NP I-problem
is VBZ O O
resolving VBG O O
. . B-VP O
   
Heart NNP B-NP O
size NN I-NP O
is VBZ O O
normal JJ O O
. . B-VP O
   
Tip NNP B-NP O
of IN B-VP O
the DT B-NP B-treatment
left JJ I-NP I-treatment
internal JJ I-NP I-treatment
jugular NN I-NP I-treatment
line NN I-NP I-treatment
projects NNS I-NP O
over IN B-VP O
the DT B-NP O
SVC NNP I-NP O
. . B-VP O
   
Brief NNP B-NP O
Hospital JJ B-NP O
Course NN I-NP O
: : O O
Mr. NNP B-NP B-person
Freeman NNP I-NP I-person
was VBD B-VP O
admitted VBN O O
to TO O O
the DT B-NP O
Nantucket NNP I-NP O
Cottage NNP I-NP O
Hospital NNP I-NP O
on IN B-VP O
2014-04-21 JJ O O
for IN B-VP O
surgical JJ B-NP B-treatment
management NN I-NP I-treatment
of IN B-VP O
his PRP$ O B-person
his PRP$ O B-problem
PFO NN B-NP I-problem
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
taken VBN O O
to TO O O
the DT B-NP O
operating NN I-NP O
room NN I-NP O
where WRB O O
he PRP O B-person
underwent VBD B-VP O
a DT O B-treatment
mini-thoracotomy JJ O I-treatment
with IN B-VP O
closure NN B-NP B-treatment
of IN B-VP O
his PRP$ O B-person
his PRP$ O B-problem
patent NN B-NP I-problem
foramen NNS I-NP I-problem
ovale VBP O I-problem
( ( O I-problem
PFO NNP B-NP I-problem
) ) O I-problem
. . B-VP O
   
Postoperatively RB O O
he PRP O B-person
was VBD B-VP O
taken VBN O O
to TO O O
the DT B-NP O
cardiac JJ I-NP O
surgical JJ I-NP O
intensive JJ I-NP O
care NN I-NP O
unit NN I-NP O
for IN B-VP O
monitoring NN B-NP O
. . B-VP O
   
Within IN B-VP O
a DT B-NP O
few JJ I-NP O
hours NNS I-NP O
, , O O
he PRP O B-person
woke VBD B-VP O
neurologically RB O O
intact JJ O O
and CC O O
was VBD B-VP O
extubated VBN O B-treatment
. . B-VP O
   
Aspirin NNP B-NP B-treatment
was VBD B-VP O
resumed. VBN O O
On IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
one CD O O
, , O O
he PRP O B-person
was VBD B-VP O
transferred VBN O O
to TO O O
the DT B-NP O
cardiac JJ I-NP O
surgical JJ I-NP O
step NN I-NP O
down RB O O
unit NN B-NP O
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
gently RB O O
diuresed VBN O O
towards IN B-VP O
his PRP$ O B-person
preoperative JJ B-NP O
weight NN I-NP O
. . B-VP O
   
The DT B-NP O
physical JJ I-NP B-person
therapy NN I-NP I-person
service NN I-NP O
was VBD B-VP O
consulted VBN O O
for IN B-VP O
assistance NN B-NP O
with IN B-VP O
his PRP$ O B-person
postoperative JJ B-NP O
strength NN I-NP O
and CC O O
mobility NN B-NP O
. . B-VP O
   
Iron NNP B-NP B-treatment
and CC O O
vitamin JJ B-NP B-treatment
C NNP I-NP I-treatment
were VBD B-VP O
started VBN O O
for IN B-VP O
postoperative JJ B-NP B-problem
anemia NN I-NP I-problem
. . B-VP O
   
Mr. NNP B-NP B-person
Freeman NNP I-NP I-person
maintained VBD B-VP O
stable JJ B-NP O
hemodynamics NNS I-NP O
with IN B-VP O
a DT B-NP O
normal JJ I-NP O
sinus NN I-NP O
rhythm NN I-NP O
throughout IN B-VP O
his PRP$ O B-person
postoperative JJ B-NP O
course NN I-NP O
. . B-VP O
   
He PRP O B-person
continued VBD B-VP O
to TO O O
make VB O O
steady JJ B-NP O
progress NN I-NP O
and CC O O
was VBD B-VP O
discharged VBN O O
home NN B-NP O
on IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
three CD O O
. . B-VP O
   
He PRP O B-person
will MD O O
follow-up VB O O
with IN B-VP O
Dr. NNP B-NP B-person
de FW O I-person
la FW O I-person
Cisneros NNP B-NP I-person
, , O O
Dr. NNP B-NP B-person
Belt NNP I-NP I-person
, , O O
his PRP$ O B-person
his PRP$ O B-person
cardiologist NN B-NP I-person
and CC O O
his PRP$ O B-person
his PRP$ O B-person
primary JJ B-NP I-person
care NN I-NP I-person
physician NN I-NP I-person
as IN B-VP O
an DT B-NP O
outpatient NN I-NP O
. . B-VP O
   
Medications NNS B-NP O
on IN B-VP O
Admission NN B-NP O
: : O O
Plavix NNP B-NP B-treatment
75mg CD O O
daily JJ O O
aspirin RB O B-treatment
81mg CD O O
daily JJ B-NP O
Discharge NNP I-NP O
Medications NNS I-NP O
: : O O
1. CD O O
Potassium NNP B-NP B-treatment
Chloride NNP I-NP I-treatment
10 CD O O
mEq NN B-NP O
Capsule NNP I-NP O
, , O O
Sustained VBD B-VP O
Release NNP B-NP O
Sig NNP I-NP O
: : O O
Two CD O O
( ( O O
2 CD O O
) ) O O
Capsule NN B-NP O
, , O O
Sustained VBD B-VP O
Release NNP B-NP O
PO NNP I-NP O
Q12H NNP I-NP O
( ( O O
every DT O O
12 CD O O
hours NNS B-NP O
) ) O O
for IN B-VP O
5 CD O O
days NNS B-NP O
. . B-VP O
   
Disp NN B-NP O
: : O O
*10 NN B-NP O
Capsule NNP I-NP O
, , O O
Sustained VBD B-VP O
Release( NNP B-NP O
s NN I-NP O
)* NNP I-NP O
Refills NNP I-NP O
: : O O
*0* NN B-NP O
2. CD O O
Docusate NNP B-NP B-treatment
Sodium NNP I-NP I-treatment
100 CD O O
mg NN B-NP O
Capsule NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Capsule NNP B-NP O
PO NNP I-NP O
BID NNP I-NP O
( ( O O
2 CD O O
times NNS B-NP O
a DT B-NP O
day NN I-NP O
) ) O O
. . B-VP O
   
Disp NN B-NP O
: : O O
*60 JJ B-NP O
Capsule( NNP I-NP O
s NN I-NP O
)* NNP I-NP O
Refills NNP I-NP O
: : O O
*0* NN B-NP O
3. CD O O
Aspirin NNP B-NP B-treatment
81 CD O O
mg NN B-NP O
Tablet NNP I-NP O
, , O O
Delayed NNP B-NP O
Release NNP I-NP O
( ( O O
E.C. NNP B-NP O
) ) O O
Sig NN B-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Tablet NN B-NP O
, , O O
Delayed NNP B-NP O
Release NNP I-NP O
( ( O O
E.C. NNP B-NP O
) ) O O
PO NNP B-NP O
DAILY NNP I-NP O
( ( O O
Daily NNP B-NP O
) ) O O
. . B-VP O
   
Disp NN B-NP O
: : O O
*30 JJ B-NP O
Tablet NNP I-NP O
, , O O
Delayed NNP B-NP O
Release NNP I-NP O
( ( O O
E.C. NNP B-NP O
)( NNP I-NP O
s VBD B-VP O
)* JJ B-NP O
Refills NNS I-NP O
: : O O
*2* VB O O
4. CD O O
Oxycodone-Acetaminophen JJ B-NP B-treatment
5-325 JJ I-NP O
mg NN I-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
1-2 JJ B-NP O
Tablets NNS I-NP O
PO NNP I-NP O
every DT B-NP O
4-6 JJ I-NP O
hours NNS I-NP O
as IN B-VP O
needed VBN O O
for IN B-VP O
pain NN B-NP B-problem
. . B-VP O
   
Disp NN B-NP O
: : O O
*50 JJ B-NP O
Tablet( NNP I-NP O
s NN I-NP O
)* NNP I-NP O
Refills NNP I-NP O
: : O O
*0* NN B-NP O
5. CD O O
Ferrous JJ B-NP B-treatment
Sulfate NNP I-NP I-treatment
325 CD O O
( ( O O
65 CD O O
) ) O O
mg NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Tablet NNP B-NP O
PO NNP I-NP O
DAILY NNP I-NP O
( ( O O
Daily NNP B-NP O
) ) O O
: : O O
Take VB O O
for IN B-VP O
one CD O O
month NN B-NP O
then RB O O
stop VB O O
. . B-VP O
   
Disp NNP B-NP O
: : O O
*30 NN B-NP O
Tablet( NNP I-NP O
s NN I-NP O
)* NNP I-NP O
Refills NNP I-NP O
: : O O
*0* JJ O O
6. CD O O
Camphor-Menthol JJ O B-treatment
0.5-0.5 CD O O
% NN B-NP O
Lotion NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Appl NNP B-NP O
Topical NNP I-NP O
TID NNP I-NP O
( ( O O
3 CD O O
times NNS B-NP O
a DT B-NP O
day NN I-NP O
) ) O O
as IN B-VP O
needed VBN O O
. . B-VP O
   
Disp NN B-NP O
: : O O
*qs JJ B-NP O
qs* NN I-NP O
Refills NNS I-NP O
: : O O
*0* $ O O
7. CD O O
Ascorbic NNP B-NP B-treatment
Acid NNP I-NP I-treatment
500 CD O O
mg NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Tablet NNP B-NP O
PO NNP I-NP O
BID NNP I-NP O
( ( O O
2 CD O O
times NNS B-NP O
a DT B-NP O
day NN I-NP O
) ) O O
: : O O
Take VB O O
for IN B-VP O
one CD O O
month NN B-NP O
then RB O O
stop VB O O
. . B-VP O
   
Disp NNP B-NP O
: : O O
*60 NN B-NP O
Tablet( NNP I-NP O
s NN I-NP O
)* NNP I-NP O
Refills NNP I-NP O
: : O O
*0* NN B-NP O
8. CD O O
Furosemide NNP B-NP B-treatment
20 CD O O
mg NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Tablet NNP B-NP O
PO NNP I-NP O
BID NNP I-NP O
( ( O O
2 CD O O
times NNS B-NP O
a DT B-NP O
day NN I-NP O
) ) O O
for IN B-VP O
5 CD O O
days NNS B-NP O
. . B-VP O
   
Disp NN B-NP O
: : O O
*10 JJ B-NP O
Tablet( NNP I-NP O
s NN I-NP O
)* NNP I-NP O
Refills NNP I-NP O
: : O O
*0* JJ B-NP O
Discharge NNP I-NP O
Disposition NNP I-NP O
: : O O
Home NN B-NP O
with IN B-VP O
Service NNP B-NP O
Discharge NNP I-NP O
Diagnosis NNP I-NP O
: : O O
PFO NNP B-NP B-problem
TIA NNP I-NP B-problem
lung NN I-NP I-problem
nodule NN I-NP I-problem
( ( O O
followed VBN O O
by IN B-VP O
Dr. NNP B-NP B-person
Belt NNP I-NP I-person
) ) O O
s/p VBP O O
fissurectomy/skull JJ B-NP B-problem
Fx NNP I-NP I-problem
Discharge NNP I-NP O
Condition NNP I-NP O
: : O O
Good JJ B-NP O
Discharge NN I-NP O
Instructions NNS I-NP O
: : O O
1) CD O O
Shower NNP B-NP O
, , O O
wash JJ B-NP O
incisions NNS I-NP B-problem
with IN B-VP O
mild JJ B-NP O
soap NN I-NP O
and CC O O
water NN B-NP O
and CC O O
pat NN B-NP O
dry NN I-NP O
. . B-VP O
   
No DT B-NP O
lotions NNS I-NP B-treatment
, , O O
creams NNS B-NP B-treatment
or CC O O
powders NNS B-NP B-treatment
to TO O O
incisions NNS B-NP B-problem
. . B-VP O
   
2) CD O O
Call NN B-NP O
with IN B-VP O
fever NN B-NP B-problem
>101 NN I-NP I-problem
, , O O
redness NN B-NP B-problem
or CC O O
drainage NN B-NP B-problem
from IN B-VP I-problem
incision NN B-NP I-problem
, , O O
or CC O O
weight VBD B-VP B-problem
gain NN B-NP I-problem
more JJR O I-problem
than IN B-VP I-problem
2 CD O I-problem
pounds NNS B-NP I-problem
in IN B-VP O
one CD O O
day NN B-NP O
or CC O O
five CD O O
pounds NNS B-NP O
in IN B-VP O
one CD O O
week NN B-NP O
. . B-VP O
   
3) CD O O
No DT O O
driving VBG O O
while NN B-NP O
on IN B-VP O
narcotics NNS B-NP B-treatment
. . B-VP O
   
4) CD O O
Take NNP B-NP O
lasix NN I-NP B-treatment
twice RB O O
daily RB O O
with IN B-VP O
potassium NN B-NP B-treatment
for IN B-VP O
five CD O O
days NNS B-NP O
then RB O O
stop VB O O
. . B-VP O
   
5) CD O O
Take NNP B-NP O
Vitamin NNP I-NP B-treatment
C NNP I-NP I-treatment
with IN B-VP O
iron NN B-NP B-treatment
for IN B-VP O
one CD O O
month NN B-NP O
then RB O O
stop VB O O
. . B-VP O
   
6) CD O O
Call NN B-NP O
with IN B-VP O
any DT B-NP O
questions NNS I-NP O
or CC O O
concerns NNS B-NP O
. . B-VP O
   
Followup NNP B-NP O
Instructions: NNP I-NP O
Follow NNP I-NP O
up RP O O
with IN B-VP O
Dr. NNP B-NP B-person
Heird NNP I-NP I-person
in IN B-VP O
four CD O O
weeks NNS B-NP O
, , O O
671 CD O O
745 CD O O
2553 CD O O
Follow NNP B-NP O
up RB O O
with IN B-VP O
Dr. NNP B-NP B-person
Knowlton NNP I-NP I-person
in IN B-VP O
1-2 JJ B-NP O
weeks NNS I-NP O
, , O O
(246) JJ O O
828-4417 CD O O
Follow NNP B-NP O
up RB O O
with IN B-VP O
Dr. NNP B-NP B-person
Eckman NNP I-NP I-person
in IN B-VP O
2-3 JJ B-NP O
weeks NNS I-NP O
, , O O
(506) JJ O O
946-4576 CD O O
Call NNP B-NP O
all DT B-NP O
providers NNS I-NP O
for IN B-VP O
appointments NNS B-NP O
. . B-VP O
   
CAT NNP B-NP O
SCAN NNP I-NP O
Phone NNP I-NP O
: : O O
(476) NN B-NP O
713 CD O O
6117 CD O O
Date/Time NN B-NP O
: : O O
2014-10-16 JJ O O
9:15 CD O O
Edna NNP B-NP B-person
Arnold NNP I-NP I-person
, , O I-person
MD NNP B-NP I-person
Phone NNP I-NP O
: : O O
(300) JJ B-NP O
922-6590 JJ I-NP O
Date/Time NN I-NP O
: : O O
2014-10-16 JJ O O
2:30 CD O O
Melonson NNP B-NP B-person
de FW O I-person
la FW O I-person
Donnelly NNP B-NP I-person
MD NNP I-NP I-person
08-301 NN I-NP O
Completed VBN O O
by IN B-VP O
: : O O
Jeremy NNP B-NP B-person
N. NNP I-NP I-person
P. NNP I-NP I-person
Moschella NNP I-NP I-person
PA NNP I-NP I-person
80-BYE JJ B-NP O
2014-04-24 JJ I-NP O
@ NN I-NP O
1103 CD O O
Signed NNP B-NP O
electronically RB O O
by IN B-VP O
: : O O
DR. NNP B-NP B-person
Dorothy NNP I-NP I-person
au VBP O I-person
Pratt NNP B-NP I-person
on IN B-VP O
: : O O
FRI NNP B-NP O
2014-06-06 CD O O
10:27 CD O O
AM NNP B-NP O
( ( O O
End NNP B-NP O
of IN B-VP O
Report NNP B-NP O
) ) O O
-EMPTYLINE- VBP O O
-DOCSTART- JJ O O
-EMPTYLINE- $ O O
242460787 CD O O
DH NNP B-NP O
5950242 CD O O
67766054 CD O O
86004855 CD O O
09/26/2004 CD O O
12:00:00 CD O O
AM NNP B-NP O
Face NNP I-NP O
Sheet NNP I-NP O
/ NNP I-NP O
Discharge NNP I-NP O
Order NNP I-NP O
SIGNED NNP I-NP O
DIS NNP I-NP O
[ NNP I-NP O
report NN I-NP O
_ NNP I-NP O
end NN I-NP O
] NN I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- VBD B-VP O
723989226 CD O O
OMH NNP B-NP O
6410178 CD O O
996067 CD O O
3/30/1999 CD O O
12:00:00 CD O O
AM NNP B-NP O
Discharge NNP I-NP O
Summary NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Report NNP I-NP O
Status NNP I-NP O
: : O O
Signed VBD B-VP O
DISCHARGE NNP B-NP O
SUMMARY NNP I-NP O
NAME NN I-NP O
: : O O
NETSHUFFSCARVTRACE NNP B-NP B-person
, , O I-person
RIRA NNP B-NP I-person
UNIT NNP I-NP O
NUMBER NNP I-NP O
: : O O
005-27-20 JJ B-NP O
ADMISSION NNP I-NP O
DATE NNP I-NP O
: : O O
03/30/1999 CD O O
DISCHARGE NNP B-NP O
DATE NNP I-NP O
: : O O
09/16/2006 CD O O
PRINCIPAL NNP B-NP O
DIAGNOSIS NNP I-NP O
: : O O
Severe NNP B-NP B-problem
chronic JJ B-NP I-problem
obstructive JJ I-NP I-problem
pulmonary JJ I-NP I-problem
disease NN I-NP I-problem
. . B-VP O
   
Respiratory JJ B-NP B-problem
failure NN I-NP I-problem
. . B-VP O
   
Congestive JJ B-NP B-problem
heart NN I-NP I-problem
failure NN I-NP I-problem
. . B-VP O
   
Right NNP B-NP B-problem
lower JJR B-NP I-problem
lobe NN I-NP I-problem
pneumonia NN I-NP I-problem
. . B-VP O
   
Atonic JJ B-NP B-problem
bladder NN I-NP I-problem
with IN B-VP O
suprapubic JJ B-NP B-treatment
catheter NN I-NP I-treatment
. . B-VP O
   
Anxiety NNP B-NP B-problem
. . B-VP O
   
Coronary JJ B-NP B-problem
artery NN I-NP I-problem
disease NN I-NP I-problem
. . B-VP O
   
History NNP B-NP O
of IN B-VP O
colon NN B-NP B-problem
cancer NN I-NP I-problem
status NN I-NP O
post NN I-NP O
hemicolectomy NN I-NP B-treatment
. . B-VP O
   
HISTORY NNP B-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS NNP I-NP O
: : O O
This DT O B-pronoun
is VBZ O O
a DT O O
76 CD O O
year NN B-NP O
old JJ B-NP O
white JJ I-NP O
male NN I-NP O
with IN B-VP O
severe JJ B-NP B-problem
chronic JJ I-NP I-problem
obstructive JJ I-NP I-problem
pulmonary JJ I-NP I-problem
disease NN I-NP I-problem
who WP O B-person
has VBZ O O
had VBN O O
several JJ B-NP O
recent JJ I-NP O
admissions NNS I-NP O
to TO O O
Oaksgekesser/ NNP B-NP O
Memorial NNP I-NP O
Hospital NNP I-NP O
for IN B-VP O
respiratory NN B-NP B-problem
insuffiencey NN I-NP I-problem
most RBS O O
often RB O O
secondary JJ O O
to TO O O
pneumonia VB O B-problem
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
most RBS O O
recently RB O O
discharged VBN O O
from IN B-VP O
Oaksgekesser/ NNP B-NP O
Memorial NNP I-NP O
Hospital NNP I-NP O
on IN B-VP O
03/06/99 CD O O
and CC O O
was VBD B-VP O
then RB O O
transferred VBN O O
to TO O O
Linghs NNP B-NP O
County NNP I-NP O
Medical NNP I-NP O
Center NNP I-NP O
from IN B-VP O
which WDT O B-pronoun
he PRP O B-person
was VBD B-VP O
discharged VBN O O
on IN B-VP O
03/20/99 CD O O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
doing VBG O O
relatively RB O O
at IN B-VP O
home NN B-NP O
until IN B-VP O
one CD O O
day NN B-NP O
prior RB O O
to TO O O
admission NN B-NP O
he PRP O B-person
complained VBD B-VP O
discomfort NN B-NP B-problem
over IN B-VP O
a DT B-NP B-treatment
suprapubic JJ I-NP I-treatment
catheter NN I-NP I-treatment
area NN I-NP I-treatment
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
had VBD B-VP O
missed VBN O O
his PRP$ O B-person
usual JJ B-NP O
monthly JJ I-NP O
change NN I-NP O
of IN B-VP O
his PRP$ O B-person
his PRP$ O B-treatment
suprapubic JJ B-NP I-treatment
catheter NN I-NP I-treatment
and CC O O
felt VBD B-VP O
discomfort NN B-NP B-problem
and CC O O
noticed VBD B-VP O
some DT B-NP B-problem
blood NN I-NP I-problem
at IN B-VP I-problem
the DT B-NP I-problem
site NN I-NP I-problem
of IN B-VP O
the DT B-NP B-treatment
catheter NN I-NP I-treatment
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
brought VBN O O
to TO O O
the DT B-NP O
Emergency NNP I-NP O
Room NNP I-NP O
one CD O O
day NN B-NP O
prior RB O O
to TO O O
admission NN B-NP O
where WRB O O
he PRP O B-person
was VBD B-VP O
evaluated VBN O O
by IN B-VP O
Urology NNP B-NP B-person
and CC O O
had VBD B-VP O
his PRP$ O B-treatment
his PRP$ O B-person
catheter NN B-NP I-treatment
changed VBD B-VP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
at IN B-VP O
that DT B-NP O
time NN I-NP O
noted VBD B-VP O
slight JJ B-NP B-problem
shortness NN I-NP I-problem
of IN B-VP I-problem
breath NN B-NP I-problem
but CC O O
was VBD B-VP O
sent VBN O O
home NN B-NP O
anyway RB O O
. . B-VP O
   
On IN B-VP O
the DT B-NP O
day NN I-NP O
of IN B-VP O
admission NN B-NP O
the DT B-NP B-person
patient NN I-NP I-person
noticed VBD B-VP O
increasing VBG O B-problem
shortness NN B-NP I-problem
of IN B-VP I-problem
breath NN B-NP I-problem
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
noted VBN O O
to TO O O
be VB O O
confused VBN O B-problem
and CC O O
to TO O O
be VB O O
disoriented VBN O B-problem
toward IN B-VP O
the DT B-NP O
end NN I-NP O
of IN B-VP O
the DT B-NP O
day NN I-NP O
after IN B-VP O
complaining VBG O O
of IN B-VP O
shortness NN B-NP B-problem
of IN B-VP I-problem
breath NN B-NP I-problem
for IN B-VP O
most JJS O O
of IN B-VP O
the DT B-NP O
day NN I-NP O
. . B-VP O
   
The DT O B-person
patient JJ O I-person
denies VBZ O O
any DT B-NP O
recent JJ I-NP B-problem
upper JJ I-NP I-problem
respiratory NN I-NP I-problem
infections NNS I-NP I-problem
, , O O
no DT B-NP O
fevers NNS I-NP B-problem
, , O O
no DT B-NP O
chills NNS I-NP B-problem
, , O O
no DT B-NP O
change NN I-NP B-problem
in IN B-VP I-problem
cough NN B-NP I-problem
, , O O
sputum NN B-NP B-problem
. . B-VP O
   
He PRP O B-person
also RB O O
denies VBZ O O
any DT B-NP O
chest NN I-NP B-problem
pain NN I-NP I-problem
. . B-VP O
   
No DT B-NP O
orthopnea NN I-NP B-problem
. . B-VP O
   
No DT B-NP O
paroxysmal JJ I-NP B-problem
nocturnal JJ I-NP I-problem
dyspnea NN I-NP I-problem
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
had VBD B-VP O
been VBN O O
taking VBG O O
his PRP$ O B-treatment
his PRP$ O B-person
usual JJ B-NP I-treatment
medications NNS I-NP I-treatment
and CC O O
using VBG O O
his PRP$ O B-treatment
his PRP$ O B-person
nasal NN B-NP I-treatment
oxygen NN I-NP I-treatment
at IN B-VP O
home NN B-NP O
. . B-VP O
   
By IN B-VP O
the DT B-NP O
time NN I-NP O
the DT B-NP B-person
patient NN I-NP I-person
arrived VBD B-VP O
at IN B-VP O
the DT B-NP O
Oaksgekesser/ NNP I-NP O
Memorial NNP I-NP O
Hospital NNP I-NP O
Emergency NNP I-NP O
Room NNP I-NP O
he PRP O B-person
was VBD B-VP O
in IN B-VP O
moderate JJ B-NP B-problem
respiratory NN I-NP I-problem
distress NN I-NP I-problem
. . B-VP O
   
His PRP$ O B-person
His PRP$ O B-test
initial JJ B-NP I-test
blood NN I-NP I-test
gases NNS I-NP I-test
on IN B-VP O
40% CD O B-treatment
02 CD O I-treatment
was VBD B-VP O
P02 NNP B-NP B-test
102 CD O O
, , O O
PC02 NNP B-NP B-test
115 CD O O
, , O O
PH NNP B-NP B-test
7.11 CD O O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
given VBN O O
respiratory JJ B-NP B-treatment
therapy NN I-NP I-treatment
in IN B-VP O
the DT B-NP O
way NN I-NP O
of IN B-VP O
nebulizer NN B-NP B-treatment
treatments NNS I-NP I-treatment
in IN B-VP O
the DT B-NP O
Oaksgekesser/ NNP I-NP O
Memorial NNP I-NP O
Hospital NNP I-NP O
Emergency NNP I-NP O
Room NNP I-NP O
because IN B-VP O
of IN B-VP O
a DT B-NP O
longstanding JJ I-NP O
desire NN I-NP O
by IN B-VP O
patient NN B-NP B-person
and CC O O
family NN B-NP B-person
to TO O O
refrain VB O O
from IN B-VP O
intubation NN B-NP B-treatment
to TO O O
be VB O O
considered VBN O O
Do NNP B-NP O
Not RB O O
Resuscitate NNP B-NP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
not RB O O
intubated VBN O O
. . B-VP O
   
However RB O O
he PRP O B-person
was VBD B-VP O
transferred VBN O O
to TO O O
the DT B-NP O
Medical NNP I-NP O
Intensive NNP I-NP O
Care NNP I-NP O
Unit NNP I-NP O
where WRB O O
he PRP O B-person
received VBD B-VP O
continuous JJ B-NP B-treatment
respiratory NN I-NP I-treatment
therapy NN I-NP I-treatment
in IN B-VP O
theway NN B-NP O
of IN B-VP O
Albuterol NNP B-NP B-treatment
nebulizers NNS I-NP I-treatment
as RB O O
well RB O O
as IN B-VP O
nasal JJ B-NP B-treatment
oxygen NN I-NP I-treatment
, , O O
intravenous JJ B-NP B-treatment
steroids NNS I-NP I-treatment
and CC O O
intravenous JJ B-NP B-treatment
antibiotics NNS I-NP I-treatment
. . B-VP O
   
A DT B-NP B-test
chest JJ I-NP I-test
x-ray NN I-NP I-test
in IN B-VP O
the DT B-NP O
Oaksgekesser/ NNP I-NP O
Memorial NNP I-NP O
Hospital NNP I-NP O
Emergency NNP I-NP O
Room NNP I-NP O
showed VBD B-VP O
new JJ B-NP B-problem
changes NNS I-NP I-problem
on IN B-VP O
his PRP$ O B-person
his PRP$ O B-test
chest JJS O I-test
x-ray JJ O I-test
on IN B-VP O
top NN B-NP O
of IN B-VP O
his PRP$ O B-problem
his PRP$ O B-person
usual JJ B-NP I-problem
severe JJ I-NP I-problem
bilateral JJ I-NP I-problem
emphysema_____ NN I-NP I-problem
with IN B-VP O
scarring NN B-NP B-problem
in IN B-VP I-problem
both DT B-NP I-problem
lungs NNS I-NP I-problem
. . B-VP O
   
There EX O O
were VBD B-VP O
new JJ B-NP B-problem
air NN I-NP I-problem
space NN I-NP I-problem
opacifications NNS I-NP I-problem
in IN B-VP I-problem
the DT B-NP I-problem
left NN I-NP I-problem
apex NN I-NP I-problem
and CC O I-problem
the DT B-NP I-problem
right JJ I-NP I-problem
lower JJR I-NP I-problem
lobe NN I-NP I-problem
. . B-VP O
   
These DT O B-pronoun
were VBD B-VP O
thought VBN O O
to TO O O
be VB O O
consistent JJ O O
either CC O O
with IN B-VP O
pneumonia NN B-NP B-problem
or CC O O
asymmetric JJ B-NP B-problem
pulmonary JJ I-NP I-problem
edema NN I-NP I-problem
. . B-VP O
   
PAST NNP B-NP O
MEDICAL NNP I-NP O
HISTORY NNP I-NP O
: : O O
Associated NNP B-NP B-problem
medical JJ B-NP I-problem
problems NNS I-NP I-problem
include VBP O O
: : O O
1. CD O O
Atonic NNP B-NP B-problem
bladder NN I-NP I-problem
with IN B-VP O
a DT B-NP B-treatment
suprapubic JJ I-NP I-treatment
tube NN I-NP I-treatment
. . B-VP O
   
2. CD O O
Anxiety NNP B-NP B-problem
. . B-VP O
   
3. CD O O
Coronary JJ B-NP B-problem
artery NN I-NP I-problem
disease NN I-NP I-problem
with IN B-VP O
a DT B-NP O
history NN I-NP O
of IN B-VP O
angina NN B-NP B-problem
in IN B-VP O
the DT B-NP O
distant JJ I-NP O
past NN I-NP O
. . B-VP O
   
4. CD O O
History NNP B-NP O
of IN B-VP O
colon NN B-NP B-problem
cancer NN I-NP I-problem
with IN B-VP O
a DT B-NP B-treatment
colectomy NN I-NP I-treatment
in IN B-VP O
the DT B-NP O
past NN I-NP O
. . B-VP O
   
MEDICATIONS NNP B-NP O
ON NNP I-NP O
ADMISSION NNP I-NP O
: : O O
1. CD O O
Ativan NNP B-NP B-treatment
1 CD O O
mg NN B-NP O
po NN I-NP O
twice RB O O
a DT B-NP O
day NN I-NP O
. . B-VP O
   
2. CD O O
Trusopt NNP B-NP B-treatment
1 CD O O
gtt NN B-NP O
left VBD B-VP O
eye NN B-NP O
three CD O O
times NNS B-NP O
a DT B-NP O
day NN I-NP O
. . B-VP O
   
3. CD O O
Xalatan VBD B-VP B-treatment
0.005% CD O O
one CD O O
gtt NN B-NP O
left VBD B-VP O
eye NN B-NP O
qhs NN I-NP O
. . B-VP O
   
4. CD O O
Brimonidine NNP B-NP B-treatment
1 CD O O
gtt NN B-NP O
left VBD B-VP O
eye NN B-NP O
three CD O O
times NNS B-NP O
a DT B-NP O
day NN I-NP O
. . B-VP O
   
5. CD O O
Combivent JJ O B-treatment
3 CD O O
puffs NNS B-NP O
four CD O O
times NNS B-NP O
per IN B-VP O
day NN B-NP O
. . B-VP O
   
6. CD O O
Aerobid NNP B-NP B-treatment
three CD O O
puffs NNS B-NP O
twice RB O O
a DT B-NP O
day NN I-NP O
. . B-VP O
   
7. CD O O
Sorbitol NNP B-NP B-treatment
30 CD O O
cc NN B-NP O
every DT B-NP O
other JJ I-NP O
day NN I-NP O
. . B-VP O
   
PHYSICAL JJ B-NP O
EXAMINATION NN I-NP O
: : O O
He PRP O B-person
was VBD B-VP O
an DT B-NP O
elderly JJ I-NP O
frail NN I-NP O
gentleman NN I-NP O
in IN B-VP O
moderate JJ B-NP B-problem
respiratory NN I-NP I-problem
distress NN I-NP I-problem
. . B-VP O
   
He PRP O B-person
had VBD B-VP O
a DT B-NP B-test
blood NN I-NP I-test
pressure NN I-NP I-test
110/70 CD O O
, , O O
heart NN B-NP B-test
rate NN I-NP I-test
110 CD O O
beats NNS B-NP O
per IN B-VP O
minute NN B-NP O
and CC O O
regular JJ O O
, , O O
respiratory JJ B-NP B-test
rate NN I-NP I-test
25 CD O O
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
in IN B-VP O
moderate JJ B-NP B-problem
respiratory NN I-NP I-problem
distress NN I-NP I-problem
. . B-VP O
   
His PRP$ O B-test
His PRP$ O B-person
temperature NN B-NP I-test
was VBD B-VP O
98F CD O O
. . B-VP O
   
He PRP O B-person
had VBD B-VP O
a DT B-NP O
normal JJ I-NP O
head NN I-NP B-test
, , O I-test
eyes NNS B-NP I-test
, , O I-test
ears NNS B-NP I-test
, , O I-test
nose RB O I-test
and CC O I-test
throat VB O I-test
exam NN B-NP I-test
. . B-VP O
   
Neck NNP B-NP B-test
exam VBD B-VP I-test
revealed VBD B-VP O
no DT B-NP O
jugular JJ I-NP B-problem
venous JJ I-NP I-problem
distention NN I-NP I-problem
and CC O O
no DT B-NP O
masses NNS I-NP B-problem
. . B-VP O
   
Lung NNP B-NP B-test
exam NN I-NP I-test
revealed VBD B-VP O
decreased JJ B-NP B-problem
breath NN I-NP I-problem
sounds VBZ O I-problem
as RB O O
well RB O O
as IN B-VP O
crackles NNS B-NP B-problem
in IN B-VP I-problem
the DT B-NP I-problem
bases NNS I-NP I-problem
. . B-VP O
   
There EX O O
were VBD B-VP O
no DT B-NP O
wheezes NN I-NP B-problem
or CC O O
rhonchi NN B-NP B-problem
. . B-VP O
   
Heart NNP B-NP B-test
exam VBZ O I-test
revealed VBD B-VP O
a DT B-NP O
soft JJ I-NP O
S1 NNP I-NP O
and CC O O
S2 NNP B-NP O
, , O O
no DT B-NP O
murmur NN I-NP B-problem
was VBD B-VP O
heard VBN O O
, , O O
no DT B-NP O
S3 NNP I-NP B-problem
. . B-VP O
   
Abdomen NNP B-NP O
was VBD B-VP O
soft JJ O O
, , O O
nontender FW O B-problem
with IN B-VP O
no DT B-NP O
masses NNS I-NP B-problem
palpable JJ O I-problem
. . B-VP O
   
Rectal JJ B-NP B-test
exam NN I-NP I-test
was VBD B-VP O
unremarkable JJ O O
with IN B-VP O
stool JJ B-NP B-test
heme NN I-NP I-test
negative JJ O O
. . B-VP O
   
Neurological JJ B-NP B-test
exam NN I-NP I-test
revealed VBD B-VP O
an DT B-NP O
alert NN I-NP O
and CC O O
oriented VBD B-VP O
x $ O O
3 CD O O
elderly JJ B-NP O
male NN I-NP O
. . B-VP O
   
He PRP O B-person
moved VBD B-VP O
all DT B-NP O
extremities NNS I-NP O
. . B-VP O
   
Deep NNP B-NP B-test
tendon NN I-NP I-test
reflexes NNS I-NP I-test
were VBD B-VP O
symmetrical JJ O O
in IN B-VP O
all DT B-NP O
extremities NNS I-NP O
. . B-VP O
   
LABORATORY NNP B-NP O
AND CC O O
RADIOLOGIC NNP B-NP O
DATA NNP I-NP O
: : O O
Sodium NN B-NP B-test
148 CD O O
, , O O
potassium NN B-NP B-test
3.4 CD O O
, , O O
glucose RB O B-test
174 CD O O
, , O O
P02 NNP B-NP B-test
102 CD O O
, , O O
PC02 NNP B-NP B-test
115 CD O O
, , O O
PH NNP B-NP B-test
7.11 CD O O
on IN B-VP O
40% CD O B-treatment
02 CD O I-treatment
. . B-VP O
   
Blood NNP B-NP B-test
urea JJ B-NP I-test
nitrogen NN I-NP I-test
11 CD O O
, , O O
creatinine NN B-NP B-test
.6 NN I-NP O
, , O O
uric JJ B-NP B-test
acid NN I-NP I-test
3.0 CD O O
, , O O
alkaline JJ B-NP B-test
phosphatase NN I-NP I-test
78 CD O O
, , O O
creatinine NN B-NP B-problem
phosphokinase NN I-NP I-problem
isoenzymes VBZ O I-problem
too RB O I-problem
low JJ O I-problem
, , O O
hematocrit JJ O B-test
41 CD O O
, , O O
white JJ B-NP B-test
blood NN I-NP I-test
cell NN I-NP I-test
count NN I-NP I-test
11.6 CD O O
. . B-VP O
   
Urine NN B-NP B-test
analysis NN I-NP I-test
showed VBD B-VP O
20-50 JJ B-NP O
white JJ I-NP B-test
blood NN I-NP I-test
cells NNS I-NP I-test
and CC O O
3-5 JJ B-NP O
red JJ I-NP B-test
blood NN I-NP I-test
cells NNS I-NP I-test
. . B-VP O
   
Electrocardiogram NNP B-NP B-test
showed VBD B-VP O
sinus JJ B-NP B-problem
tachycardia NN I-NP I-problem
at IN B-VP O
a DT B-NP O
rate NN I-NP O
of IN B-VP O
123 CD O O
beats NNS B-NP O
per IN B-VP O
minute NN B-NP O
compared VBN O O
to TO O O
previous JJ B-NP B-test
electrocardiogram NN I-NP I-test
of IN B-VP O
1/29 CD O O
there EX O O
were VBD B-VP O
no DT B-NP O
significant JJ I-NP B-problem
changes NNS I-NP I-problem
. . B-VP O
   
HOSPITAL NNP B-NP O
COURSE NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
stabilized VBN O O
in IN B-VP O
the DT B-NP O
Medical NNP I-NP O
Intensive NNP I-NP O
Care NNP I-NP O
Unit NNP I-NP O
. . B-VP O
   
He PRP O B-person
stayed VBD B-VP O
in IN B-VP O
the DT B-NP O
unit NN I-NP O
for IN B-VP O
about IN B-VP O
one CD O O
day NN B-NP O
. . B-VP O
   
During IN B-VP O
that DT B-NP B-pronoun
period NN I-NP O
of IN B-VP O
time NN B-NP O
he PRP O B-person
received VBD B-VP O
nebulizer JJ B-NP B-treatment
treatments NNS I-NP I-treatment
with IN B-VP O
Albuterol NNP B-NP B-treatment
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
also RB O O
started VBN O O
on IN B-VP O
intravenous JJ B-NP B-treatment
Ticarcillin NNP I-NP I-treatment
for IN B-VP O
possible JJ B-NP O
gram NN I-NP B-problem
negative JJ B-NP I-problem
pneumonia NN I-NP I-problem
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
diuresed VBN O O
with IN B-VP O
intravenous JJ B-NP B-treatment
Lasix NNP I-NP I-treatment
to TO O O
which WDT O B-pronoun
he PRP O B-person
responded VBD B-VP O
with IN B-VP O
at IN B-VP O
lease NN B-NP O
a DT O O
2L CD O O
urine JJ B-NP B-test
output NN I-NP I-test
on IN B-VP O
the DT B-NP O
first JJ I-NP O
day NN I-NP O
and CC O O
1.5L CD O O
the DT B-NP O
second JJ I-NP O
day NN I-NP O
. . B-VP O
   
After IN B-VP O
one CD O O
day NN B-NP O
in IN B-VP O
the DT B-NP O
Medical NNP I-NP O
Intensive NNP I-NP O
Care NNP I-NP O
Unit NNP I-NP O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
stable JJ O O
enough RB O O
to TO O O
go VB O O
to TO O O
the DT B-NP O
floor NN I-NP O
where WRB O O
he PRP O B-person
continued VBD B-VP O
the DT B-NP O
rest NN I-NP O
of IN B-VP O
his PRP$ O B-person
his PRP$ O B-treatment
treatment NN B-NP I-treatment
. . B-VP O
   
This DT O B-pronoun
consisted VBD B-VP O
of IN B-VP O
continued JJ B-NP O
nebulizer JJ I-NP B-treatment
treatments NNS I-NP I-treatment
as RB O O
well RB O O
as IN B-VP O
intravenous JJ B-NP B-treatment
antibiotics NNS I-NP I-treatment
and CC O O
intravenous JJ B-NP B-treatment
Solu-Medrol NNP I-NP I-treatment
. . B-VP O
   
As IN B-VP O
the DT O B-treatment
the DT B-NP B-person
patient JJ I-NP I-treatment
patient NN I-NP I-person
&apos;s NN I-NP I-treatment
diuresis NN I-NP I-treatment
continued VBD B-VP O
his PRP$ O B-person
respiratory NN B-NP O
status NN I-NP O
improved VBN O O
. . B-VP O
   
A DT B-NP B-test
chest JJ I-NP I-test
x-ray NN I-NP I-test
showed VBD B-VP O
clearing NN B-NP O
of IN B-VP O
the DT B-NP B-problem
opacities NNS I-NP I-problem
in IN B-VP O
the DT O B-test
chest JJS O I-test
x-ray JJ O I-test
that WDT O B-pronoun
were VBD B-VP O
consistent JJ O O
with IN B-VP O
pulmonary JJ B-NP B-problem
edema NN I-NP I-problem
because IN B-VP O
he PRP O B-person
continued VBD B-VP O
to TO O O
have VB O O
some DT B-NP B-problem
abnormality NN I-NP I-problem
in IN B-VP I-problem
the DT B-NP I-problem
right NN I-NP I-problem
lower JJR B-NP I-problem
lobe NN I-NP I-problem
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
continued VBN O O
on IN B-VP O
antibiotics NNS B-NP B-treatment
for IN B-VP O
possible JJ B-NP O
pneumonia NN I-NP B-problem
. . B-VP O
   
The DT B-NP B-treatment
antibiotic JJ I-NP I-treatment
chosen NN I-NP O
was VBD B-VP O
Levaquin NNP B-NP B-treatment
500 CD O O
mg NN B-NP O
1 CD O O
tab NN B-NP O
per IN B-VP O
day NN B-NP O
. . B-VP O
   
This DT O B-pronoun
was VBD B-VP O
started VBN O O
on IN B-VP O
4/2/99 CD O O
and CC O O
should MD O O
be VB O O
continued VBN O O
for IN B-VP O
ten JJ B-NP O
days NNS I-NP O
. . B-VP O
   
The DT B-NP B-treatment
Ticarcillin NNP I-NP I-treatment
was VBD B-VP O
stopped VBN O O
after IN B-VP O
two CD O O
days NNS B-NP O
when WRB O O
it PRP O B-pronoun
was VBD B-VP O
felt VBN O O
that IN B-VP B-pronoun
he PRP O B-person
did VBD B-VP O
not RB O O
have VB O O
a DT B-NP B-problem
serious JJ I-NP I-problem
pneumonia NN I-NP I-problem
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
&apos;s NNP I-NP O
respiratory NN I-NP O
status NN I-NP O
continued VBD B-VP O
to TO O O
improve VB O O
but CC O O
towards IN B-VP O
the DT B-NP O
last JJ I-NP O
2-3 JJ I-NP O
days NNS I-NP O
of IN B-VP O
his PRP$ O B-person
hospitalization NN B-NP O
the DT B-NP O
amount NN I-NP O
of IN B-VP O
improvement NN B-NP O
was VBD B-VP O
minimal JJ O O
. . B-VP O
   
It PRP O B-pronoun
was VBD B-VP O
felt VBN O O
that IN B-VP B-pronoun
his PRP$ O B-person
respiratory NN B-NP O
status NN I-NP O
has VBZ O O
been VBN O O
maximally RB O O
treated VBN O O
by IN B-VP O
then RB O O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
&apos;s NNP I-NP O
major JJ B-NP O
improvement NN I-NP O
came VBD B-VP O
after IN B-VP O
the DT O O
first JJ O O
two CD O O
days NNS B-NP O
with IN B-VP O
brisk JJ B-NP B-treatment
diuresis NN I-NP I-treatment
with IN B-VP O
Lasix NNP B-NP B-treatment
. . B-VP O
   
While IN B-VP O
in IN B-VP O
the DT B-NP O
Oaksgekesser/ NNP I-NP O
Memorial NNP I-NP O
Hospital NNP I-NP O
the DT B-NP B-person
patient NN I-NP I-person
on IN B-VP O
4/4/99 CD O O
complained NNS B-NP O
of IN B-VP O
mild JJ B-NP B-problem
epigastric JJ I-NP I-problem
discomfort NN I-NP I-problem
because IN B-VP O
he PRP O B-person
was VBD B-VP O
put VBN O O
in IN B-VP O
Cimetidine NNP B-NP B-treatment
while IN B-VP O
in IN B-VP O
the DT B-NP O
Intensive NNP I-NP O
Care NNP I-NP O
Unit NNP I-NP O
for IN B-VP O
prophylaxis NN B-NP B-treatment
against IN B-VP O
peptic JJ B-NP B-problem
ulcer JJ I-NP I-problem
disease NN I-NP I-problem
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
upgraded VBN O O
to TO O O
Prilosec VB O B-treatment
20 CD O O
mg NNS B-NP O
per IN B-VP O
day NN B-NP O
for IN B-VP O
possible JJ B-NP O
treatment NN I-NP O
of IN B-VP O
gastritis NN B-NP B-problem
or CC O O
gastroesophageal NN B-NP B-problem
reflux JJ B-NP I-problem
disease NN I-NP I-problem
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
did VBD B-VP O
have VB O O
any DT B-NP O
nausea NN I-NP B-problem
, , O O
vomiting VBG O B-problem
or CC O O
evidence NN B-NP O
of IN B-VP O
gastrointestinal JJ B-NP B-problem
bleeding NN I-NP I-problem
. . B-VP O
   
The DT O B-person
The DT B-NP B-problem
patient JJ I-NP I-person
patient NN I-NP I-problem
&apos;s NNP I-NP I-problem
abdominal JJ B-NP I-problem
pain NN I-NP I-problem
should MD O O
be VB O O
followed VBN O O
over IN B-VP O
the DT B-NP O
next JJ I-NP O
week NN I-NP O
or CC O O
so RB O O
in IN B-VP O
case NN B-NP O
it PRP O B-pronoun
does VBZ O O
not RB O O
respond VB O O
to TO O O
Prilosec NNP B-NP B-treatment
. . B-VP O
   
While IN B-VP O
in IN B-VP O
Oaksgekesser/ NNP B-NP O
Memorial NNP I-NP O
Hospital NNP I-NP O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
never RB O O
able JJ O O
to TO O O
get VB O O
out IN B-VP O
of IN B-VP O
bed NN B-NP O
and CC O O
walk NN B-NP O
independently RB O O
. . B-VP O
   
It PRP O B-pronoun
is VBZ O O
hoped VBN O O
that IN B-VP B-pronoun
when WRB O O
he PRP O B-person
is VBZ O O
transferred VBN O O
to TO O O
a DT B-NP O
rehab NN I-NP O
facility NN I-NP O
that IN B-VP B-pronoun
he PRP O B-person
will MD O O
continue VB O O
with IN B-VP O
physical JJ B-NP B-treatment
therapy NN I-NP I-treatment
to TO O O
regain VB O O
his PRP$ O B-person
strength NN B-NP O
and CC O O
regain NN B-NP O
independence NN I-NP O
in IN B-VP O
activities NNS B-NP O
of IN B-VP O
daily JJ B-NP O
living NN I-NP O
. . B-VP O
   
Discussion NN B-NP O
with IN B-VP O
the DT B-NP B-person
family NN I-NP I-person
regarding VBG O O
the DT B-NP O
possibility NN I-NP O
of IN B-VP O
sending VBG O O
him PRP O B-person
to TO O O
a DT B-NP O
nursing NN I-NP O
home NN I-NP O
was VBD B-VP O
entertained VBN O O
however RB O O
the DT B-NP B-person
family NN I-NP I-person
strongly RB O O
refused VBD B-VP O
to TO O O
allow VB O O
him PRP O B-person
to TO O O
go VB O O
a DT B-NP O
nursing NN I-NP O
home NN I-NP O
. . B-VP O
   
They PRP O B-pronoun
wanted VBD B-VP O
the DT B-NP B-person
patient NN I-NP I-person
to TO O O
return VB O O
to TO O O
his PRP$ O B-person
home NN B-NP O
after IN B-VP O
a DT B-NP O
stay NN I-NP O
at IN B-VP O
a DT B-NP O
rehab NN I-NP O
facility NN I-NP O
. . B-VP O
   
CONDITION NNP B-NP O
ON NNP I-NP O
DISCHARGE NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
&apos;s NNP I-NP O
respiratory NN I-NP O
status NN I-NP O
was VBD B-VP O
stable JJ O O
. . B-VP O
   
I PRP O B-person
think VBP O O
his PRP$ O B-person
breathing NN B-NP O
was VBD B-VP O
as RB O O
good JJ O O
as IN B-VP O
to TO O O
be VB O O
expected VBN O O
with IN B-VP O
the DT B-NP O
amount NN I-NP O
of IN B-VP O
severe JJ B-NP B-problem
chronic JJ I-NP I-problem
obstructive JJ I-NP I-problem
pulmonary JJ I-NP I-problem
disease NN I-NP I-problem
he PRP O B-person
had VBD B-VP O
. . B-VP O
   
He PRP O B-person
needed VBD B-VP O
to TO O O
go VB O O
to TO O O
a DT B-NP O
rehab NN I-NP O
facility NN I-NP O
for IN B-VP O
continued JJ B-NP B-treatment
respiratory JJ I-NP I-treatment
therapy NN I-NP I-treatment
and CC O O
for IN B-VP O
Physical NNP B-NP B-treatment
Therapy NNP I-NP I-treatment
to TO O O
increase VB O O
his PRP$ O B-person
muscle NN B-NP O
strength NN I-NP O
. . B-VP O
   
MEDICATIONS NNP B-NP O
ON NNP I-NP O
DISCHARGE NNP I-NP O
: : O O
1. CD O O
Albuterol NNP B-NP B-treatment
2.5 CD O O
mg NN B-NP O
in IN B-VP O
2.5 CD O B-treatment
normal JJ B-NP I-treatment
saline NN I-NP I-treatment
q4h NN I-NP O
. . B-VP O
   
2. CD O O
Heparin JJ O B-treatment
5000 CD O O
units NNS B-NP O
subcutaneously RB O O
twice RB O O
a DT B-NP O
day NN I-NP O
. . B-VP O
   
3. CD O O
Ativan NNP B-NP B-treatment
.5 NNP I-NP O
mg NNP I-NP O
twice RB O O
a DT B-NP O
day NN I-NP O
. . B-VP O
   
4. CD O O
Nasal NNP B-NP B-treatment
oxygen NN I-NP I-treatment
3L CD O O
per IN B-VP O
minute NN B-NP O
. . B-VP O
   
5. CD O O
Levaquin NNP B-NP B-treatment
500 CD O O
mg NN B-NP O
per IN B-VP O
day NN B-NP O
to TO O O
be VB O O
continued VBN O O
until IN B-VP O
4/12/99 CD O O
. . B-VP O
   
6. CD O O
Lasix NNP B-NP B-treatment
40 CD O O
mg NN B-NP O
per IN B-VP O
day NN B-NP O
. . B-VP O
   
7. CD O O
Prednisone NN B-NP B-treatment
40 CD O O
mg NN B-NP O
per IN B-VP O
day NN B-NP O
to TO O O
be VB O O
tapered VBN O O
over IN B-VP O
two CD O O
weeks NNS B-NP O
. . B-VP O
   
8. CD O O
Xalatan JJ B-NP B-treatment
eyedrops NNS I-NP I-treatment
1 CD O O
gtt NN B-NP O
in IN B-VP O
left JJ B-NP O
eye NN I-NP O
per IN B-VP O
day NN B-NP O
. . B-VP O
   
9. CD O O
Alphagan NNP B-NP B-treatment
1 CD O O
gtt NN B-NP O
in IN B-VP O
left NN B-NP O
eye NN I-NP O
three CD O O
times NNS B-NP O
a DT B-NP O
day NN I-NP O
. . B-VP O
   
10. CD O O
Trusopt NNP B-NP B-treatment
1gtt CD O O
in IN B-VP O
left NN B-NP O
eye NN I-NP O
three CD O O
times NNS B-NP O
a DT B-NP O
day NN I-NP O
. . B-VP O
   
11. CD O O
Prilosec NNP B-NP B-treatment
20 CD O O
mg NN B-NP O
per IN B-VP O
day NN B-NP O
. . B-VP O
   
FOLLOWUP NN B-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
should MD O O
have VB O O
follow VB O O
up RP O O
with IN B-VP O
his PRP$ O B-person
his PRP$ O B-person
primary JJ B-NP I-person
care NN I-NP I-person
physician JJ B-NP I-person
Dr. NNP I-NP I-person
Rod NNP I-NP I-person
Linkeboltshieltrus NNP I-NP I-person
at IN B-VP O
the DT B-NP O
TRE NNP I-NP O
453 CD O O
about IN B-VP O
one CD O O
week NN B-NP O
after IN B-VP O
discharge NN B-NP O
from IN B-VP O
rehab JJ B-NP O
facility NN I-NP O
. . B-VP O
   
The DT B-NP O
telephone NN I-NP O
number NN I-NP O
at IN B-VP O
his PRP$ O B-person
office NN B-NP O
is VBZ O O
236-4518 JJ O O
. . B-VP O
   
ROD NNP B-NP B-person
END NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
TR NNP I-NP O
: : O O
lh JJ B-NP O
DD NNP I-NP O
: : O O
04/05/1999 CD O O
TD NN B-NP O
: : O O
04/05/1999 CD O O
3:06 CD O O
Pcc NN B-NP O
: : O O
ROD JJ B-NP B-person
END NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
C.R.TRYGLO NNP I-NP O
HOSPITAL NNP I-NP O
OF NNP I-NP O
STAT NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- VBD B-VP O
040076444 CD O O
PUOMC NNP B-NP O
2267360 CD O O
95601/1m70 CD O O
602566 CD O O
10/17/1995 CD O O
12:00:00 CD O O
AM NNP B-NP O
Discharge NNP I-NP O
Summary NNP I-NP O
Unsigned VBD B-VP O
DIS NNP B-NP O
Report NNP I-NP O
Status NNP I-NP O
: : O O
Unsigned VBN O O
ADMISSION NNP B-NP O
DATE NNP I-NP O
: : O O
10/17/95 CD O O
DISCHARGE NNP B-NP O
DATE NNP I-NP O
: : O O
10/20/95 CD O O
HISTORY NNP B-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS NNP I-NP O
: : O O
This DT O B-pronoun
is VBZ O O
a DT B-NP O
73-year-old JJ I-NP O
man NN I-NP O
with IN B-VP O
squamous JJ B-NP B-problem
cell NN I-NP I-problem
carcinoma NN I-NP I-problem
of IN B-VP I-problem
the DT B-NP I-problem
lung NN I-NP I-problem
, , O O
status NN B-NP O
post NN I-NP O
lobectomy NN I-NP B-treatment
and CC O O
resection NN B-NP B-treatment
of IN B-VP O
left JJ B-NP B-problem
cervical JJ I-NP I-problem
recurrence NN I-NP I-problem
, , O O
admitted VBN O O
here RB O O
with IN B-VP O
fever NN B-NP B-problem
and CC O O
neutropenia NN B-NP B-problem
. . B-VP O
   
Recently RB O O
he PRP O B-person
had VBD B-VP O
been VBN O O
receiving VBG O O
a DT B-NP O
combination NN I-NP O
of IN B-VP O
outpatient JJ B-NP B-treatment
chemotherapy NN I-NP I-treatment
with IN B-VP O
the DT B-NP O
CAMP NNP I-NP O
Program NNP I-NP O
. . B-VP O
   
Other JJ B-NP B-problem
medical JJ I-NP I-problem
problems NNS I-NP I-problem
include VBP O O
hypothyroidism NN B-NP B-problem
, , O O
hypercholesterolemia NN B-NP B-problem
, , O O
hypertension NN B-NP B-problem
and CC O O
neuropathy JJ O B-problem
from IN B-VP O
Taxol NNP B-NP B-treatment
. . B-VP O
   
PHYSICAL NNP B-NP O
EXAMINATION NN I-NP O
: : O O
He PRP O B-person
was VBD B-VP O
a DT O O
well-developed JJ O O
, , O O
well-nourished JJ B-NP O
man NN I-NP O
who WP O B-person
was VBD B-VP O
breathing VBG O O
comfortably RB O O
. . B-VP O
   
Temperature NN B-NP B-test
was VBD B-VP O
101.3 CD O O
. . B-VP O
   
HEENT NNP B-NP O
were VBD B-VP O
normal JJ O O
. . B-VP O
   
Neck NNP B-NP O
was VBD B-VP O
supple JJ O O
. . B-VP O
   
Lungs NNS B-NP O
were VBD B-VP O
clear JJ O O
to TO O O
percussion NN B-NP B-test
and CC O O
auscultation NN B-NP B-test
with IN B-VP O
a DT B-NP B-problem
few JJ I-NP I-problem
scattered JJ I-NP I-problem
rales NNS I-NP I-problem
, , O O
left VBD B-VP O
greater JJR O O
than IN B-VP O
right RB O O
. . B-VP O
   
Abdominal JJ B-NP B-test
examination NN I-NP I-test
was VBD B-VP O
normal JJ O O
. . B-VP O
   
Extremities NNS B-NP O
were VBD B-VP O
normal JJ O O
. . B-VP O
   
Neurological JJ B-NP B-test
examination NN I-NP I-test
was VBD B-VP O
nonfocal JJ O O
. . B-VP O
   
LABORATORY NNP B-NP O
DATA NNP I-NP O
: : O O
The DT B-NP B-test
WBC NNP I-NP I-test
was VBD B-VP O
0.9 CD O O
, , O O
the DT B-NP B-test
ANC NNP I-NP I-test
was VBD B-VP O
540 CD O O
, , O O
platelets NNS B-NP B-test
were VBD B-VP O
156,000 CD O O
. . B-VP O
   
HOSPITAL NNP B-NP O
COURSE NNP I-NP O
: : O O
He PRP O B-person
was VBD B-VP O
started VBN O O
on IN B-VP O
Neupogen NNP B-NP B-treatment
, , O O
400 CD O O
mcg. NN B-NP O
subq. NN I-NP O
q.d. NN I-NP O
He PRP O B-person
was VBD B-VP O
initially RB O O
treated VBN O O
with IN B-VP O
antibiotic JJ B-NP B-treatment
therapy NN I-NP I-treatment
. . B-VP O
   
Chest NNP B-NP B-test
x-ray NN I-NP I-test
showed VBD B-VP O
questionable JJ B-NP O
nodule NN I-NP B-problem
in IN B-VP I-problem
the DT B-NP I-problem
right NN I-NP I-problem
lower JJR B-NP I-problem
lobe NN I-NP I-problem
, , O O
reasonably RB O O
stable JJ O O
. . B-VP O
   
Calcium NN B-NP B-test
8.7 CD O O
, , O O
bilirubin NN B-NP B-test
0.3/1.3 CD O O
, , O O
creatinine NN B-NP B-test
1.1 CD O O
, , O O
glucose VBD B-VP B-test
128 CD O O
. . B-VP O
   
Hematocrit $ O B-test
24.6 CD O O
. . B-VP O
   
WBC NNP B-NP B-test
rose VBD B-VP O
to TO O O
1.7 CD O O
on IN B-VP O
10/19 CD O O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
had VBD B-VP O
some DT B-NP B-problem
diarrhea NN I-NP I-problem
. . B-VP O
   
There EX O O
was VBD B-VP O
no DT B-NP O
diarrhea NN I-NP B-problem
on IN B-VP O
10/20 CD O O
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
feeling VBG O O
well RB O O
and CC O O
afebrile RB O B-problem
. . B-VP O
   
The DT B-NP B-problem
neutropenia NN I-NP I-problem
resolved VBD B-VP O
and CC O O
he PRP O B-person
was VBD B-VP O
felt VBN O O
to TO O O
be VB O O
in IN B-VP O
satisfactory JJ B-NP O
condition NN I-NP O
on IN B-VP O
discharge NN B-NP O
on IN B-VP O
10/20/95 CD O O
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
discharged VBN O O
home NN B-NP O
on IN B-VP O
Neupogen NNP B-NP B-treatment
. . B-VP O
   
DISCHARGE NNP B-NP O
DIAGNOSIS NNP I-NP O
: : O O
Fever NNP B-NP B-problem
neutropenia RB O B-problem
, , O O
metastatic JJ B-NP B-problem
squamous JJ I-NP I-problem
cell NN I-NP I-problem
carcinoma NN I-NP I-problem
of IN B-VP I-problem
the DT B-NP I-problem
lung NN I-NP I-problem
, , O O
hypertension NN B-NP B-problem
. . B-VP O
   
DISCHARGE NNP B-NP O
MEDICATIONS NNP I-NP O
: : O O
Include NNP B-NP O
Neupogen NNP I-NP B-treatment
, , O O
480 CD O O
mcg. NN B-NP O
subq. NN I-NP O
q.d. NN I-NP O
and CC O O
usual JJ B-NP B-treatment
medications NNS I-NP I-treatment
. . B-VP O
   
GUABENFRANDA NNP B-NP B-person
D. NNP I-NP I-person
PATCH NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
TR NNP I-NP O
: : O O
wl NN B-NP O
/ NNP I-NP O
bmot NN I-NP O
DD NNP I-NP O
: : O O
11/01/95 CD O O
TD NN B-NP O
: : O O
11/02/95 CD O O
CC NN B-NP O
: : O O
-EMPTYLINE- JJ B-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
779878634 CD O O
TGCHO NNP B-NP O
9260099 CD O O
612765 CD O O
12/11/2003 CD O O
12:00:00 CD O O
AM NNP B-NP O
Discharge NNP I-NP O
Summary NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Report NNP I-NP O
Status NNP I-NP O
: : O O
Signed VBD B-VP O
DISCHARGE NNP B-NP O
SUMMARY NNP I-NP O
NAME NNP I-NP O
: : O O
A DT O B-person
, , O I-person
REBAY NNP B-NP I-person
J NNP I-NP I-person
UNIT NNP I-NP O
NUMBER NNP I-NP O
: : O O
984-98-62 JJ B-NP O
ADMISSION NNP I-NP O
DATE NNP I-NP O
: : O O
12/11/2003 CD O O
DISCHARGE NNP B-NP O
DATE NNP I-NP O
: : O O
01/08/2004 CD O O
The DT B-NP B-person
patient NN I-NP I-person
has VBZ O O
a DT O O
known VBN O O
history NN B-NP O
of IN B-VP O
pancreatic JJ B-NP B-problem
adenocarcinoma NN I-NP I-problem
. . B-VP O
   
He PRP O B-person
is VBZ O O
admitted VBN O O
at IN B-VP O
this DT B-NP B-pronoun
time NN I-NP O
because IN B-VP O
of IN B-VP O
significant JJ B-NP B-problem
GI NNP I-NP I-problem
bleeding NN I-NP I-problem
. . B-VP O
   
REVIEW NNP B-NP O
OF NNPS I-NP O
SYSTEMS NNP I-NP O
: : O O
Significant NN B-NP O
for IN B-VP O
fatigue NN B-NP B-problem
and CC O O
increased VBD B-VP B-problem
abdominal JJ B-NP I-problem
discomfort NN I-NP I-problem
. . B-VP O
   
MEDICATIONS NNP B-NP O
AT IN B-VP O
THE NNP B-NP O
TIME NNP I-NP O
OF NNP I-NP O
ADMISSION NNP I-NP O
: : O O
Insulin NNP B-NP B-treatment
, , O O
Celexa NNP B-NP B-treatment
, , O O
Protonix NNP B-NP B-treatment
, , O O
Ambien NNP B-NP B-treatment
and CC O O
Pancreas NNP B-NP B-treatment
. . B-VP O
   
PHYSICAL NNP B-NP O
EXAMINATION NN I-NP O
: : O O
Vital JJ B-NP B-test
signs NNS I-NP I-test
showed VBD B-VP O
his PRP$ O B-person
his PRP$ O B-test
blood NN B-NP I-test
pressure NN I-NP I-test
to TO O O
be VB O O
slightly RB O B-problem
decreased VBN O I-problem
at IN B-VP O
120/60 CD O O
, , O O
pulse RB O B-test
64 CD O O
, , O O
respirations NNS B-NP B-test
16 CD O O
, , O O
temperature NN B-NP B-test
98.8 CD O O
, , O O
O2 NNP B-NP B-test
sat VBD B-VP I-test
95 CD O O
. . B-VP O
   
HEENT NN B-NP O
: : O O
Evidence NN B-NP B-problem
of IN B-VP I-problem
anemia NN B-NP I-problem
with IN B-VP O
being VBG O B-problem
pale JJ O I-problem
, , O O
but CC O O
anicteric RB O O
, , O O
no DT B-NP O
oral JJ I-NP B-problem
lesions NNS I-NP I-problem
. . B-VP O
   
Neck NNP B-NP O
supple NN I-NP O
. . B-VP O
   
Lungs NNS B-NP O
clear JJ O O
. . B-VP O
   
Back RB O O
without IN B-VP O
CVA NNP B-NP B-problem
or CC O I-problem
spinal JJ B-NP I-problem
tenderness NN I-NP I-problem
. . B-VP O
   
Heart NNP B-NP O
regular JJ B-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
. . B-VP O
   
Abdomen NNS B-NP O
: : O O
Bowel NNP B-NP O
sounds VBZ O O
positive JJ O O
, , O O
soft JJ O O
, , O O
mildly RB O B-problem
tender NN B-NP I-problem
in IN B-VP I-problem
the DT B-NP I-problem
epigastrium NN I-NP I-problem
without IN B-VP O
hepatosplenomegaly NN B-NP B-problem
, , O O
mass NN B-NP B-problem
or CC O O
tenderness NN B-NP B-problem
. . B-VP O
   
Extremities NNS B-NP O
: : O O
Trace NNP B-NP B-problem
edema NN I-NP I-problem
without IN B-VP O
cyanosis NN B-NP B-problem
or CC O O
clubbing NN B-NP B-problem
. . B-VP O
   
His PRP$ O B-person
His PRP$ O B-test
hematocrit NN B-NP I-test
at IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
admission NN B-NP O
was VBD B-VP O
20.5 CD O O
, , O O
after IN B-VP O
having VBG O O
been VBN O O
32 CD O O
one CD O O
week NN B-NP O
earlier RBR O O
. . B-VP O
   
ASSESSMENT NN B-NP O
: : O O
The DT B-NP B-test
assessment NN I-NP I-test
was VBD B-VP O
that IN B-VP B-pronoun
he PRP O B-person
had VBD B-VP O
a DT B-NP B-problem
GI NNP I-NP I-problem
bleed NN I-NP I-problem
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
transfused VBN O O
and CC O O
then RB O O
evaluated VBN O O
by IN B-VP O
GI NNP B-NP B-person
. . B-VP O
   
Endoscopy NNP B-NP B-test
showed VBD B-VP O
multiple JJ B-NP B-problem
angio NN I-NP I-problem
ectasias NN I-NP I-problem
throughout IN B-VP I-problem
the DT B-NP I-problem
stomach NN I-NP I-problem
. . B-VP O
   
He PRP O B-person
received VBD B-VP O
multiple JJ B-NP B-treatment
treatments NNS I-NP I-treatment
for IN B-VP O
this DT O B-pronoun
over IN B-VP O
the DT B-NP O
succeeding JJ I-NP O
weeks NNS I-NP O
. . B-VP O
   
In IN B-VP O
addition NN B-NP O
, , O O
he PRP O B-person
was VBD B-VP O
transfused VBN O O
. . B-VP O
   
His PRP$ O B-test
His PRP$ O B-person
platelet NN B-NP I-test
count NN I-NP I-test
was VBD B-VP O
maintained VBN O O
with IN B-VP O
platelet NN B-NP B-treatment
transfusion NN I-NP I-treatment
as IN B-VP O
necessary JJ O O
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
treated VBN O O
with IN B-VP O
Octreotide NNP B-NP B-treatment
to TO O O
try VB O O
to TO O O
slow VB O O
down RP O O
the DT B-NP B-problem
bleeding NN I-NP I-problem
. . B-VP O
   
Despite IN B-VP O
all PDT O O
these DT B-NP B-pronoun
measures NNS I-NP O
, , O O
his PRP$ O B-person
his PRP$ O B-problem
bleeding NN B-NP I-problem
was VBD B-VP O
never RB O O
totally RB O O
controlled JJ O O
. . B-VP O
   
He PRP O B-person
then RB O O
had VBD B-VP O
an DT B-NP B-treatment
angiogram NN I-NP I-treatment
with IN B-VP I-treatment
Gel NNP B-NP I-treatment
foam NN I-NP I-treatment
to TO O O
try VB O O
to TO O O
control VB O O
his PRP$ O B-problem
his PRP$ O B-person
GI NNP B-NP I-problem
bleed NN I-NP I-problem
. . B-VP O
   
Again NNP B-NP O
, , O O
this DT O B-pronoun
was VBD B-VP O
unsuccessful JJ O O
. . B-VP O
   
At IN B-VP O
that DT B-NP B-pronoun
point NN I-NP O
he PRP O B-person
had VBD B-VP O
a DT B-NP B-problem
change NN I-NP I-problem
in IN B-VP I-problem
mental JJ B-NP I-problem
status NN I-NP I-problem
and CC O O
was VBD B-VP O
no RB O B-problem
longer RB O I-problem
responsive VB O I-problem
. . B-VP O
   
Given VBN O O
this DT O B-pronoun
, , O O
the DT B-NP O
decision NN I-NP O
was VBD B-VP O
made VBN O O
to TO O O
make VB O O
his PRP$ O B-person
his PRP$ O B-treatment
care NN B-NP I-treatment
comfort NN I-NP I-treatment
measures VBZ O I-treatment
only RB O O
. . B-VP O
   
At IN B-VP O
this DT B-NP B-pronoun
point NN I-NP O
, , O O
he PRP O B-person
was VBD B-VP O
made VBN O O
comfort NN B-NP B-treatment
measures NNS I-NP I-treatment
and CC O O
expired VBD B-VP O
comfortably RB O O
. . B-VP O
   
The DT B-NP O
cause NN I-NP O
of IN B-VP O
death NN B-NP B-problem
was VBD B-VP O
a DT B-NP O
combination NN I-NP O
of IN B-VP O
GI NNP B-NP B-problem
bleeding VBG O I-problem
felt VBD B-VP O
to TO O O
be VB O O
ultimately RB O O
related VBN O O
to TO O O
his PRP$ O B-problem
his PRP$ O B-person
known VBN O I-problem
metastatic JJ B-NP I-problem
pancreatic JJ I-NP I-problem
cancer NN I-NP I-problem
. . B-VP O
   
TA NNP B-NP B-person
KO NNP I-NP I-person
FOSSA NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
DICTATING NNP I-NP O
FOR NNP I-NP O
: : O O
Electronically RB O O
Signed VBD B-VP O
TA NNP B-NP B-person
KO NNP I-NP I-person
FOSSA NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
02/05/2004 CD O O
17:03 CD O O
_____________________________ NN B-NP O
TA NNP I-NP B-person
KO NNP I-NP I-person
FOSSA NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
TR NNP I-NP O
: : O O
mb NN B-NP O
DD NNP I-NP O
: : O O
01/23/2004 CD O O
TD NN B-NP O
: : O O
01/26/2004 CD O O
2:16 CD O O
A DT O O
612765 CD O O
cc NN B-NP O
: : O O
TA NNP B-NP B-person
KO NNP I-NP I-person
FOSSA NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- VBD B-VP O
313251236 CD O O
WGH NNP B-NP O
1429918 CD O O
816995 CD O O
0854768 CD O O
5/1/2004 CD O O
12:00:00 CD O O
AM NNP B-NP O
ED NNP I-NP O
Discharge NNP I-NP O
Summary NNP I-NP O
Unsigned VBD B-VP O
DIS NNP B-NP O
Report NNP I-NP O
Status NNP I-NP O
: : O O
Unsigned VBD B-VP O
ED NNP B-NP O
DISCHARGE NNP I-NP O
NOTIFICATION NNP I-NP O
KATESJESC NNP I-NP B-person
, , O I-person
RAI NNP B-NP I-person
MRN NNP I-NP O
: : O O
1429918 CD O O
Age NNP B-NP O
: : O O
60y CD O O
REGISTRATION NNP B-NP O
DATE NNP I-NP O
: : O O
05/01/2004 CD O O
06:30 CD O O
PM NNP B-NP O
PRELIMINARY NNP I-NP O
REPORT NNP I-NP O
This DT O B-pronoun
is VBZ O O
to TO O O
notify VB O O
you PRP O B-person
that IN B-VP B-pronoun
your PRP$ O B-person
your PRP$ O B-person
patient NN B-NP I-person
, , O O
KATESJESC NNP B-NP B-person
, , O I-person
RAI NNP B-NP I-person
arrived VBD B-VP O
in IN B-VP O
the DT B-NP O
Emergency NNP I-NP O
Department NNP I-NP O
at IN B-VP O
Well NNP B-NP O
General NNP I-NP O
Hospital NNP I-NP O
on IN B-VP O
05/01/2004 CD O O
06:30 CD O O
PM NNP B-NP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
presented VBN O O
with IN B-VP O
a DT B-NP O
chief JJ I-NP O
complaint NN I-NP O
of IN B-VP O
SSCP NNP B-NP B-problem
. . B-VP O
   
Following VBG O O
evaluation NN B-NP B-test
and CC O O
treatment NN B-NP B-treatment
, , O O
the DT B-NP B-person
patient NN I-NP I-person
&apos;s JJ B-NP O
disposition NN I-NP O
at IN B-VP O
the DT B-NP O
end NN I-NP O
of IN B-VP O
the DT B-NP O
visit NN I-NP O
was VBD B-VP O
ADMITTED NNP B-NP O
AS IN B-VP O
AN NNP B-NP O
INPATIENT NNP I-NP O
TO NNP I-NP O
WELL NNP I-NP O
GENERAL NNP I-NP O
HOSPITAL NNP I-NP O
. . B-VP O
   
The DT O B-person
The DT B-NP B-person
patient JJ I-NP I-person
patient NN I-NP I-person
&apos;s NNP I-NP I-person
preliminary JJ O I-person
admitting VBG O I-person
physician NN B-NP I-person
is VBZ O O
REKE NNP B-NP B-person
, , O I-person
ATOTA NNP B-NP I-person
S NNP I-NP I-person
and CC O O
the DT B-NP O
preliminary JJ I-NP O
diagnosis NN I-NP O
is VBZ O O
ACS NNP B-NP B-problem
.. NNP I-NP O
Please NNP I-NP O
note VB O O
this DT B-NP B-pronoun
information NN I-NP O
may MD O O
have VB O O
been VBN O O
updated VBN O O
on IN B-VP O
the DT B-NP O
inpatient JJ I-NP O
unit NN I-NP O
. . B-VP O
   
If IN B-VP O
you PRP O B-person
need VBP O O
additional JJ B-NP O
information NN I-NP O
please NN I-NP O
call VB O O
366-686-5449 JJ O O
. . B-VP O
   
PCP NNPS B-NP B-person
Name NN I-NP O
: : O O
REKE NNP B-NP B-person
, , O I-person
ATOTA NNP B-NP I-person
S NNP I-NP I-person
Provider NNP I-NP O
Number NNP I-NP O
: : O O
36860 CD O O
-EMPTYLINE- NN B-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
Admission NNP I-NP O
Date NNP I-NP O
: : O O
2014-11-29 JJ B-NP O
Discharge NN I-NP O
Date NNP I-NP O
: : O O
2014-12-05 JJ B-NP O
Date NNP I-NP O
of IN B-VP O
Birth NNP B-NP O
: : O O
1967-08-29 JJ B-NP O
Sex NN I-NP O
: : O O
F NNP B-NP O
Service NNP I-NP O
: : O O
MEDICINE JJ B-NP O
Allergies NNS I-NP O
: : O O
Penicillins NNS B-NP B-treatment
/ VBP O O
Estrogens NNP B-NP B-treatment
/ NNP I-NP O
Ancef NNP I-NP B-treatment
/ NNP I-NP O
Tegretol NNP I-NP B-treatment
/ NNP I-NP O
Keflex NNP I-NP B-treatment
Attending NNP I-NP B-person
: : O O
Mary NNP B-NP B-person
S. NNP I-NP I-person
Corral NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
Chief NNP I-NP O
Complaint NNP I-NP O
: : O O
hypotension NN B-NP B-problem
Major NNP I-NP O
Surgical NNP I-NP O
or CC O O
Invasive NNP B-NP O
Procedure: NNP I-NP O
Nephrostomy NNP I-NP B-treatment
tube JJ B-NP I-treatment
placement NN I-NP I-treatment
History NNP I-NP O
of IN B-VP O
Present NNP B-NP O
Illness NNP I-NP O
: : O O
47 CD O B-person
yo NN B-NP I-person
F NNP I-NP I-person
w/ NN I-NP O
h/o VBD B-VP O
steroid-induced JJ B-NP B-problem
hyperglycemia NN I-NP I-problem
, , O O
SLE NNP B-NP B-problem
w/ VBZ O O
h/o NN B-NP O
pericarditis NN I-NP B-problem
, , O O
transverse JJ B-NP B-problem
myelitis NN I-NP I-problem
w/ NN I-NP O
paraplegia NN I-NP B-problem
and CC O O
neurogenic JJ B-NP B-problem
bladder NN I-NP I-problem
s/p NN I-NP B-treatment
urostomy JJ B-NP I-treatment
w/ JJ I-NP O
ileal NN I-NP B-treatment
conduit NN I-NP I-treatment
, , O O
h/o NN B-NP O
ureteropelvic JJ B-NP B-problem
stone NN I-NP I-problem
and CC O O
urosepsis NN B-NP B-problem
, , O O
and CC O O
h/o JJ B-NP O
RLE NNP I-NP B-problem
DVT NNP I-NP I-problem
a/w VBZ O O
F NNP B-NP O
2014-11-29 JJ O O
transferred VBD B-VP O
to TO O O
CMED NNP B-NP O
2014-11-30 JJ O O
for IN B-VP O
hypotn NN B-NP B-problem
resistant NN I-NP O
to TO O O
IVFs NNP B-NP B-treatment
and CC O O
stress JJ B-NP B-treatment
steroids NNS I-NP I-treatment
. . B-VP O
   
Patient NNP B-NP B-person
initially RB O O
p/w VBZ O O
c/o JJ B-NP O
sudden JJ I-NP B-problem
onset NN I-NP I-problem
N/abd NNP I-NP I-problem
pain/chills VBZ O I-problem
w/ JJ B-NP O
T NNP I-NP B-test
103 CD O O
at IN B-VP O
NH NNP B-NP O
. . B-VP O
   
Rigors NNS B-NP B-problem
progressed VBD B-VP O
so RB O O
she PRP O B-person
was VBD B-VP O
brought VBN O O
to TO O O
Robert NNP B-NP O
. . B-VP O
   
She PRP O B-person
reported VBD B-VP O
h/o JJ B-NP O
fatigue NN I-NP B-problem
and CC O O
anorexia NN B-NP B-problem
for IN B-VP O
the DT B-NP O
past JJ I-NP O
few JJ I-NP O
days NNS I-NP O
and CC O O
had VBD B-VP O
noticed VBN O O
foul JJ O B-problem
smelling VBG O I-problem
urine NN B-NP I-problem
and CC O O
some DT B-NP O
abdominal JJ I-NP B-problem
distension NN I-NP I-problem
, , O O
similar JJ O O
to TO O O
prior VB O O
episodes NNS B-NP O
of IN B-VP O
pyelo NN B-NP B-problem
. . B-VP O
   
She PRP O B-person
also RB O O
c/o VBP O O
LLQ NNP B-NP B-problem
and CC O I-problem
groin NN B-NP I-problem
pain NN I-NP I-problem
which WDT O B-pronoun
responded VBD B-VP O
to TO O O
tylenol VB O B-treatment
. . B-VP O
   
She PRP O B-person
denies VBZ O O
V NNP B-NP B-problem
or CC O O
D NNP B-NP B-problem
. . B-VP O
   
No DT B-NP O
AMS NNP I-NP B-problem
. . B-VP O
   
No NNP B-NP O
c/o NN I-NP O
CP NNP I-NP B-problem
. . B-VP O
   
On IN B-VP O
arrival NN B-NP O
to TO O O
Shirley NNP B-NP O
, , O O
temperature NN B-NP B-test
was VBD B-VP O
101.2 CD O O
. . B-VP O
   
CT NNP B-NP B-test
abd NN I-NP I-test
showed VBD B-VP O
an DT O B-problem
8 CD O I-problem
mm NN B-NP I-problem
right RB O I-problem
proximal JJ B-NP I-problem
ureteral JJ I-NP I-problem
stone NN I-NP I-problem
with IN B-VP O
right-sided JJ B-NP B-problem
hydronephrosis NN I-NP I-problem
and CC O O
inflammatory NN B-NP B-problem
stranding NN I-NP I-problem
, , O O
in IN B-VP O
addition NN B-NP O
to TO O O
pyelonephritis NN B-NP B-problem
of IN B-VP I-problem
the DT B-NP I-problem
left JJ I-NP I-problem
kidney NN I-NP I-problem
without IN B-VP O
left NN B-NP B-problem
sided VBD B-VP I-problem
hydronephrosis NN B-NP I-problem
. . B-VP O
   
Labs NNP B-NP B-test
were VBD B-VP O
remarkable JJ O O
for IN B-VP O
wbc JJ O B-test
23.5 CD O O
w/ NN B-NP O
1% CD O O
bands NNS B-NP B-test
which WDT O B-pronoun
decreased VBD B-VP O
to TO O O
14 CD O O
today NN B-NP O
but CC O O
now RB O O
w/ VBZ O O
15% CD O O
bands NNS B-NP B-test
on IN B-VP O
vanc NN B-NP B-treatment
( ( O O
h/o JJ B-NP O
MRSA NNP I-NP B-problem
urosepsis NN I-NP I-problem
) ) O O
and CC O O
gent NN B-NP B-treatment
( ( O O
mult JJ B-NP B-problem
drug NN I-NP I-problem
allergies NNS I-NP I-problem
) ) O O
. . B-VP O
   
AG NNP B-NP B-test
on IN B-VP O
admission NN B-NP O
18 CD O O
( ( O O
bicarb NN B-NP B-test
17 CD O O
, , O O
down RB O O
from IN B-VP O
23 CD O O
on IN B-VP O
a DT B-NP O
previous JJ I-NP O
admission NN I-NP O
) ) O O
, , O O
down RB O O
to TO O O
AG NNP B-NP B-test
15 CD O O
this DT B-NP B-pronoun
AM NNP I-NP O
. . B-VP O
   
ABG NNP B-NP B-test
prior RB O O
to TO O O
transfer VB O O
( ( O O
on IN B-VP O
room NN B-NP O
air NN I-NP O
) ) O O
: : O O
7.43/24/69 CD O O
w/ NN B-NP O
lactate NN I-NP B-test
1.3 CD O O
( ( O O
down IN B-VP O
from IN B-VP O
1.4 CD O O
on IN B-VP O
the DT B-NP O
prior JJ I-NP O
day NN I-NP O
) ) O O
. . B-VP O
   
Currently RB O O
, , O O
03-14 JJ B-NP O
blood NN I-NP B-test
cx NNS I-NP I-test
are VBP O O
growing VBG O O
GNR NNP B-NP B-problem
in IN B-VP O
both DT B-NP O
anaerobic JJ I-NP O
bottles NNS I-NP O
. . B-VP O
   
Urine NNP B-NP B-test
cx NN I-NP I-test
is VBZ O O
pending VBG O O
. . B-VP O
   
Prior NNP B-NP O
to TO O O
transfer VB O O
, , O O
patient NN B-NP B-person
dropped VBD B-VP O
bp NN B-NP B-test
to TO O O
68/40s CD O O
. . B-VP O
   
BP NNPS B-NP B-test
did VBD B-VP O
not RB O O
improve VB O O
despite IN B-VP O
2 CD O O
L NNP B-NP O
NS NNP I-NP B-treatment
and CC O O
100 CD O O
mg NN B-NP O
IV NNP I-NP B-treatment
hydrocortisone NN I-NP I-treatment
. . B-VP O
   
A DT B-NP B-treatment
central JJ I-NP I-treatment
line NN I-NP I-treatment
was VBD B-VP O
placed VBN O O
and CC O O
she PRP O B-person
was VBD B-VP O
sent VBN O O
to TO O O
IR NNP B-NP O
for IN B-VP O
a DT B-NP B-treatment
right JJ I-NP I-treatment
nephrostomy NN I-NP I-treatment
tube NN I-NP I-treatment
. . B-VP O
   
Past NNP B-NP O
Medical JJ B-NP O
History NN I-NP O
: : O O
## NN B-NP O
h/o NN I-NP O
nephrolithiasis NN I-NP B-problem
s/p NN I-NP O
lithotripsy NN I-NP B-treatment
and CC O O
h/o NN B-NP O
left VBD B-VP B-problem
ureteropelvic JJ B-NP I-problem
junction NN I-NP I-problem
stone NN I-NP I-problem
'03 POS O O
spontaneously RB O O
passing VBG O O
by IN B-VP B-test
U/S NNP B-NP O
, , O O
no DT B-NP O
evidence NN I-NP O
of IN B-VP B-problem
right JJ B-NP I-problem
stone NN I-NP O
on IN B-VP B-test
most JJS O I-test
recent JJ O I-test
u/s JJ O O
5 CD O O
months NNS B-NP O
ago RB O O
## NNP B-NP O
h/o NN I-NP O
pyelo NN I-NP B-problem
, , O O
last JJ B-NP O
episode NN I-NP O
in IN B-VP O
'03 NNP B-NP O
( ( O B-problem
MRSA NNP B-NP I-problem
in IN B-VP I-problem
blood NN B-NP I-problem
and CC O I-problem
urine NN B-NP O
) ) O O
## VBZ O O
SLE NNP B-NP B-problem
w/ NN I-NP O
h/o NN I-NP O
pericarditis NN I-NP B-problem
, , O O
last JJ B-NP O
flare JJ I-NP O
couple NN I-NP O
years NNS I-NP O
ago RB O O
, , O O
didn NN B-NP O
't POS O O
flare NN B-NP O
w/ NN I-NP O
urosepsis NN I-NP B-problem
## NNP I-NP O
Devic NNP I-NP B-problem
's POS O I-problem
disease NN B-NP I-problem
: : O O
Recurrent JJ B-NP B-problem
transverse NN I-NP I-problem
myelitis NN I-NP I-problem
with IN B-VP O
sequelae NN B-NP O
of IN B-VP O
paraplegia-exacerbation NN B-NP B-problem
in IN B-VP O
93 CD O O
Recurrent JJ B-NP B-problem
bilateral JJ I-NP I-problem
optic JJ I-NP I-problem
neuritis NN I-NP I-problem
with IN B-VP O
legal JJ O O
( ( O O
neurologist JJ O B-person
: : O O
Dr. NNP B-NP B-person
Heaton NNP I-NP I-person
, , O O
UMass NNP B-NP O
Memorial NNP I-NP O
Medical NNP I-NP O
Center NNP I-NP O
) ) O O
- : O O
( ( O O
steroids NNS B-NP B-treatment
increased VBD B-VP O
to TO O O
40 CD O O
qd NNS B-NP O
in IN B-VP O
Renee NNP B-NP O
for IN B-VP O
concern NN B-NP O
for IN B-VP O
recurrent NN B-NP B-problem
optic JJ B-NP I-problem
neuritis NN I-NP I-problem
which WDT O B-pronoun
turned VBD B-VP O
out RP O O
to TO O O
be VB O O
capsular JJ B-NP B-problem
ossification NN I-NP I-problem
) ) O O
## NN B-NP O
blindness NN I-NP B-problem
in IN B-VP I-problem
right NN B-NP I-problem
CMED NNP I-NP O
CSRU NNP I-NP O
. . B-VP O
   
## JJ B-NP O
Bilateral NNP I-NP B-problem
knee NN I-NP I-problem
arthritis NN I-NP I-problem
## NNP I-NP O
Suspected NNP I-NP O
glaucoma NN I-NP B-problem
in IN B-VP I-problem
left NN B-NP I-problem
CMED NNP I-NP O
CSRU NNP I-NP O
, , O O
turned VBD B-VP O
out RP O O
to TO O O
be VB O O
capsular JJ B-NP B-problem
ossification NN I-NP I-problem
or CC O O
a DT B-NP B-problem
secondary JJ I-NP I-problem
cataract NN I-NP I-problem
, , O O
corrected VBN O O
w/ NN B-NP O
laser NN I-NP B-treatment
surgery NN I-NP I-treatment
2014-11-03 JJ B-NP O
## NNP I-NP O
Urostomy NNP I-NP B-treatment
s/p JJ B-NP O
ileal NN I-NP B-treatment
loop NN I-NP I-treatment
conduit NN I-NP I-treatment
in IN B-VP O
2007 CD O O
for IN B-VP O
neurogenic JJ B-NP B-problem
bladder NN I-NP I-problem
w/ NN I-NP O
persistent JJ B-NP B-problem
leak JJ I-NP I-problem
## JJ I-NP O
Steroid-induced JJ I-NP B-problem
hyperglycemia NN I-NP I-problem
## NNP I-NP O
Hypothyroid NNP I-NP B-problem
## NNP I-NP O
Osteoporosis NNP I-NP B-problem
## NNP I-NP O
Hx NNP I-NP O
of IN B-VP O
DVT NNP B-NP B-problem
in IN B-VP I-problem
RLE NNP B-NP I-problem
'93 NNP I-NP O
- : O O
on IN B-VP B-treatment
coumadin NN B-NP O
for IN B-VP O
a DT B-NP O
couple NN I-NP O
years NNS I-NP O
and CC O O
then RB O B-treatment
ASA NNP B-NP O
until IN B-VP O
a DT B-NP O
couple JJ I-NP O
months NNS I-NP O
ago IN B-VP O
Social NNP B-NP O
History NNP I-NP O
: : O O
Retired NNP B-NP O
ICU NNP I-NP O
nurse NN I-NP O
. . B-VP O
   
Thomas NNP B-NP O
Haas NNP I-NP O
x VBD B-VP O
15 CD O O
yrs NNS B-NP O
but CC O O
maintains VBZ O O
her PRP$ O B-person
certification NN B-NP O
. . B-VP O
   
Lives VBZ O O
at IN B-VP O
Lowell NNP B-NP O
Home NNP I-NP O
NH NNP I-NP O
x VBD B-VP O
11 CD O O
yrs NNS B-NP O
due JJ O O
to TO O O
chronic JJ B-NP B-problem
CMED NNP I-NP I-problem
issues NNS I-NP I-problem
. . B-VP O
   
Her PRP$ O B-person
Her PRP$ O B-person
doctor NN B-NP I-person
there EX O O
is VBZ O O
Dr. NNP B-NP B-person
Gerald NNP I-NP I-person
Jones NNP I-NP I-person
. . B-VP O
   
No NNP B-NP O
h/o NN I-NP O
tobacco NN I-NP O
, , O O
alcohol NN B-NP O
, , O O
or CC O O
IVDA NNP B-NP O
. . B-VP O
   
Wheelchair NNP B-NP B-problem
dependent JJ B-NP I-problem
+ NN I-NP O
requires VBZ O O
Hoyer NNP B-NP B-treatment
lift NN I-NP I-treatment
. . B-VP O
   
UE NNP B-NP O
strength NN I-NP O
intact JJ O O
but CC O O
poor JJ B-NP B-problem
motor NN I-NP I-problem
movements NNS I-NP I-problem
due JJ O O
to TO O O
loss NN B-NP B-problem
of IN B-VP I-problem
sensation NN B-NP I-problem
. . B-VP O
   
Family JJ B-NP B-person
History NN I-NP O
: : O O
Mother NN B-NP B-person
died VBD B-VP O
at IN B-VP O
51 CD O O
metastatic JJ B-NP B-problem
BCA NNP I-NP I-problem
Father NNP I-NP B-person
died VBD B-VP O
at IN B-VP O
36 CD O O
aplastic JJ B-NP B-problem
anemia NN I-NP I-problem
only RB O O
child JJ B-NP O
Physical NNP I-NP O
Exam NNP I-NP O
: : O O
T CD O B-test
100.0 CD O O
bp NN B-NP B-test
109/56 CD O O
CVP NNP B-NP B-test
11 CD O O
hr NN B-NP B-test
113 CD O O
rr NN B-NP B-test
16 CD O O
O2 NNP B-NP B-test
95% CD O O
on IN B-VP O
3L CD O B-treatment
NC NNP B-NP I-treatment
mixed JJ B-NP O
Quinn NNP I-NP O
82% CD O O
genrl NN B-NP O
: : O O
in IN B-VP O
nad NN B-NP B-problem
, , O O
resting VBG O O
comfortably RB O O
heent NN B-NP O
: : O O
perrla NN B-NP O
( ( O O
4->3 JJ B-NP O
mm NN I-NP O
) ) O O
bilaterally RB O O
, , O O
blind NN B-NP B-problem
in IN B-VP I-problem
right JJ B-NP I-problem
visual JJ I-NP I-problem
field NN I-NP I-problem
, , O O
eomi RB O O
, , O O
dry JJ B-NP B-problem
mm NN I-NP I-problem
, , O O
? . B-VP O
thrush JJ B-NP B-problem
neck NN I-NP O
: : O O
no DT B-NP O
bruits NNS I-NP B-problem
cv NN I-NP O
: : O O
rrr NN B-NP O
, , O O
no DT B-NP O
m/r/g NN I-NP B-problem
, , O O
faint NN B-NP B-problem
s1/s2 NN I-NP I-problem
pulm NN I-NP O
: : O O
cta NN B-NP O
bilaterally RB O O
abd VBZ O O
: : O O
midline NN B-NP B-problem
scar NN I-NP I-problem
( ( O O
from IN B-VP O
urostomy NN B-NP B-treatment
) ) O O
, , O O
nabs UH O O
, , O O
soft JJ O O
, , O O
appears VBZ O O
distended JJ O B-problem
but CC O O
patient JJ B-NP B-person
denies NNS I-NP O
, , O O
ostomy JJ B-NP B-treatment
RLQ NNP I-NP O
c/d/i NN I-NP O
, , O O
NT NNP B-NP B-problem
to TO O O
palpation VB O B-test
back RB O O
: : O O
right NN B-NP B-treatment
flank NN I-NP I-treatment
urostomy JJ B-NP I-treatment
tube NN I-NP I-treatment
, , O O
c/d/i NN B-NP O
, , O O
nt NN B-NP B-problem
to TO O O
palpation NN B-NP B-test
extr NN I-NP O
: : O O
no DT B-NP O
Gardner NNP I-NP B-test
neuro NN I-NP O
: : O O
a DT O O
, , O O
ox3 NN B-NP O
, , O O
wiggles VBZ O O
toes NNS B-NP O
bilaterally RB O O
, , O O
unable JJ O B-problem
to TO O I-problem
lift VB O I-problem
LE NNP B-NP I-problem
, , O O
06-12 JJ B-NP O
grip NN I-NP O
bilaterally RB O O
w/ JJ B-NP O
UE NNP I-NP O
, , O O
decrease NN B-NP B-problem
sensation NN I-NP I-problem
to TO O O
soft JJ B-NP O
touch NN I-NP O
in IN B-VP O
left JJ B-NP O
UE NNP I-NP O
and CC O O
LE NNP B-NP O
Pertinent NNP I-NP O
Results NNP I-NP O
: : O O
2014-11-29 JJ O O
05:11PM CD O O
WBC NNP B-NP B-test
- : O O
23.5*# CD O O
RBC NNP B-NP B-test
- : O O
3.81* CD O O
HGB NNP B-NP B-test
- : O O
9.4* CD O O
HCT NNP B-NP B-test
- : O O
29.2* CD O O
MCV NNP B-NP B-test
- : O O
77*# CD O O
MCH NNP B-NP B-test
- : O O
24.6*# CD O O
MCHC NNP B-NP B-test
- : O O
32.1 CD O O
RDW NNP B-NP B-test
- : O O
18.1* CD O O
2014-11-29 JJ O O
05:11PM CD O O
NEUTS NNP B-NP B-test
- : O O
93* CD O O
BANDS NNP B-NP B-test
- : O O
1 CD O O
LYMPHS NNP B-NP B-test
- : O O
0 CD O O
MONOS NNP B-NP B-test
- : O O
6 CD O O
EOS NNP B-NP B-test
- : O O
0 CD O O
BASOS NNP B-NP B-test
- : O O
0 CD O O
ATYPS NNP B-NP B-test
- : O O
0 CD O O
METAS NNP B-NP B-test
- : O O
0 CD O O
MYELOS NNP B-NP B-test
- : O O
0 CD O O
2014-11-29 JJ O O
05:11PM CD O O
GLUCOSE NNP B-NP B-test
- : O O
229* CD O O
UREA NNP B-NP B-test
N NNP I-NP O
- : O O
25* CD O O
CREAT NNP B-NP B-test
- : O O
0.8 CD O O
SODIUM NNP B-NP B-test
- : O O
136 CD O O
POTASSIUM NNP B-NP B-test
- : O O
5.3* CD O O
CHLORIDE NNP B-NP B-test
- : O O
101 CD O O
TOTAL NNP B-NP B-test
CO2 NNP I-NP I-test
- : O O
17* CD O O
ANION NNP B-NP B-test
GAP NNP I-NP I-test
- : O O
23* CD O O
2014-11-29 JJ O O
05:11PM CD O O
LD NNP B-NP B-test
( ( O I-test
LDH NNP B-NP I-test
) ) O I-test
- : O O
214 CD O O
2014-11-29 JJ O O
06:41PM CD O O
LACTATE NNP B-NP B-test
- : O O
1.4 CD O O
2014-11-29 JJ O O
05:11PM CD O O
URINE NNP B-NP B-test
COLOR NNP I-NP B-test
- : O O
Straw NN B-NP O
APPEAR NNP I-NP B-test
- : O O
Hazy NNP B-NP O
SP NNP I-NP O
Thibodeaux NNP I-NP B-test
- : O O
1.008 CD O O
2014-11-29 JJ O O
05:11PM CD O O
URINE NNP B-NP B-test
BLOOD NNP I-NP B-test
- : O O
LG NNP B-NP O
NITRITE NNP I-NP B-test
- : O O
NEG NNP B-NP O
PROTEIN NNP I-NP B-test
- : O O
TR NNP B-NP O
GLUCOSE NNP I-NP B-test
- : O O
NEG NNP B-NP O
KETONE NNP I-NP B-test
- : O O
NEG NNP B-NP O
BILIRUBIN NNP I-NP B-test
- : O O
NEG NNP B-NP O
UROBILNGN NNP I-NP B-test
- : O O
NEG NNP B-NP O
PH NNP I-NP B-test
- : O O
9.0* CD O O
LEUK NNP B-NP B-test
- : O O
SM NNP B-NP O
2014-11-29 JJ O O
05:11PM CD O O
URINE NNP B-NP B-test
RBC NNP I-NP B-test
- : O O
21-50* JJ B-NP O
WBC NNP I-NP B-test
- : O O
04-12 NN B-NP O
BACTERIA NNP I-NP B-test
- : O O
MANY JJ B-NP O
YEAST NNP I-NP B-test
- : O O
NONE NN B-NP O
EPI NNP I-NP B-test
- : O O
0-2 JJ O O
2014-11-29 JJ O O
05:11PM CD O O
URINE NNP B-NP B-test
3PHOSPHAT CD O B-test
- : O O
OCC NNP B-NP O
2014-11-29 JJ B-NP O
CT NNP I-NP B-test
CAP NNP I-NP I-test
: : O O
1. CD O O
An DT O B-problem
8 CD O I-problem
x NN B-NP I-problem
7 CD O I-problem
x JJ O I-problem
7 CD O I-problem
mm JJ B-NP I-problem
stone NN I-NP I-problem
in IN B-VP I-problem
the DT B-NP I-problem
proximal JJ I-NP I-problem
right JJ I-NP I-problem
ureter NN I-NP I-problem
with IN B-VP O
associated JJ B-NP O
right JJ I-NP B-problem
hydronephrosis NN I-NP I-problem
and CC O O
inflammatory JJ B-NP B-problem
perinephric JJ I-NP I-problem
stranding NN I-NP I-problem
. . B-VP O
   
Additional JJ B-NP B-problem
smaller JJR I-NP I-problem
non-obstructing JJ I-NP I-problem
right JJ I-NP I-problem
renal JJ I-NP I-problem
stones NNS I-NP I-problem
. . B-VP O
   
2. CD O O
Left VBD B-VP B-problem
renal JJ B-NP I-problem
stones NNS I-NP I-problem
without IN B-VP O
evidence NN B-NP O
of IN B-VP O
hydronephrosis NN B-NP B-problem
. . B-VP O
   
Ileal NNP B-NP B-treatment
conduit NN I-NP I-treatment
is VBZ O O
not RB O O
well RB O O
evaluated VBN O O
. . B-VP O
   
3. CD O O
Right JJ B-NP B-problem
breast NN I-NP I-problem
calcification NN I-NP I-problem
. . B-VP O
   
Correlation NN B-NP O
with IN B-VP O
mammography NN B-NP B-test
is VBZ O O
suggested VBN O O
. . B-VP O
   
. . B-VP O
   
2014-11-29 JJ B-NP O
CXR NNP I-NP B-test
: : O O
No DT B-NP O
evidence NN I-NP O
of IN B-VP O
pneumonia NN B-NP B-problem
. . B-VP O
   
. . B-VP O
   
2014-11-29 JJ B-NP O
CT NNP I-NP B-test
AP NNP I-NP I-test
#2 NNP I-NP I-test
( ( O I-test
with IN B-VP I-test
contrast NN B-NP I-test
) ) O I-test
: : O O
1. CD O O
Eight NNP B-NP B-problem
mm NNS I-NP I-problem
right RB O I-problem
proximal JJ B-NP I-problem
ureteral JJ I-NP I-problem
stone NN I-NP I-problem
with IN B-VP O
right-sided JJ B-NP B-problem
hydronephrosis NN I-NP I-problem
and CC O O
inflammatory JJ B-NP B-problem
stranding NN I-NP I-problem
. . B-VP O
   
Pyelonephritis NN B-NP B-problem
of IN B-VP I-problem
the DT B-NP I-problem
left JJ I-NP I-problem
kidney NN I-NP I-problem
without IN B-VP O
left NN B-NP B-problem
sided VBD B-VP I-problem
hydronephrosis NN B-NP I-problem
. . B-VP O
   
2. CD O O
No DT B-NP O
evidence NN I-NP O
of IN B-VP O
intraabdominal JJ B-NP B-problem
abscess NN I-NP I-problem
or CC O O
of IN B-VP O
diverticulitis NN B-NP B-problem
. . B-VP O
   
3. CD O O
Bilateral NNP B-NP B-problem
round NN I-NP I-problem
, , O I-problem
hypodense JJ B-NP I-problem
renal JJ I-NP I-problem
lesions NNS I-NP I-problem
, , O O
too RB O O
small JJ O O
to TO O O
accurately RB O O
characterize VB O O
but CC O O
likely JJ O O
representing VBG O O
cysts NNS B-NP B-problem
. . B-VP O
   
4. CD O O
1.4 CD O B-problem
cm NN B-NP I-problem
hypodense NN I-NP I-problem
lesion NN I-NP I-problem
in IN B-VP I-problem
right JJ B-NP I-problem
lobe NN I-NP I-problem
of IN B-VP I-problem
the DT B-NP I-problem
liver NN I-NP I-problem
is VBZ O O
incompletely RB O O
characterized VBN O O
. . B-VP O
   
. . B-VP O
   
2014-11-30 JJ B-NP O
CT NNP I-NP B-test
CAP NNP I-NP I-test
: : O O
1. CD O O
Nephrostomy NNP B-NP B-treatment
tube NN I-NP I-treatment
in IN B-VP I-treatment
the DT B-NP I-treatment
right JJ I-NP I-treatment
kidney NN I-NP I-treatment
with IN B-VP O
an DT O B-problem
8 CD O I-problem
mm NN B-NP I-problem
right RB O I-problem
ureteric JJ B-NP I-problem
stone NN I-NP I-problem
. . B-VP O
   
2. CD O O
6 CD O B-problem
mm NN B-NP I-problem
nonobstructing VBG O I-problem
calculus NN B-NP I-problem
in IN B-VP I-problem
the DT B-NP I-problem
left JJ I-NP I-problem
kidney NN I-NP I-problem
. . B-VP O
   
3. CD O O
Calcified JJ B-NP B-problem
focus NN I-NP I-problem
and CC O O
a DT B-NP B-problem
small JJ I-NP I-problem
hypodense NN I-NP I-problem
lesion NN I-NP I-problem
in IN B-VP I-problem
the DT B-NP I-problem
right JJ I-NP I-problem
lobe NN I-NP I-problem
of IN B-VP I-problem
the DT B-NP I-problem
liver NN I-NP I-problem
, , O O
incompletely RB O O
characterized VBN O O
. . B-VP O
   
4. CD O O
Bibasilar JJ O B-problem
and CC O I-problem
dependent JJ B-NP I-problem
atelectasis NN I-NP I-problem
. . B-VP O
   
. . B-VP O
   
2014-11-29 JJ O O
5:10 CD O O
pm NN B-NP O
BLOOD NNP I-NP B-test
CULTURE NNP I-NP I-test
2. CD O O
**FINAL JJ B-NP O
REPORT NNP I-NP O
2014-12-04** CD O O
AEROBIC NNP B-NP B-test
BOTTLE NNP I-NP I-test
( ( O O
Final NNP B-NP O
2014-12-04 CD O O
) ) O O
: : O O
KLEBSIELLA NNP B-NP B-problem
PNEUMONIAE NNP I-NP I-problem
. . B-VP O
   
IDENTIFICATION NNP B-NP B-test
AND CC O O
SENSITIVITIES NNP B-NP B-test
PERFORMED NNP I-NP O
FROM NNP I-NP O
ANAEROBIC NNP I-NP B-test
BOTTLE NNP I-NP I-test
. . B-VP O
   
OF CC O O
TWO NNP B-NP B-problem
COLONIAL NNP I-NP I-problem
MORPHOLOGIES NNP I-NP I-problem
. . B-VP O
   
ANAEROBIC NNP B-NP B-test
BOTTLE NNP I-NP I-test
( ( O O
Final NNP B-NP O
2014-12-04 CD O O
) ) O O
: : O O
REPORTED VBN O O
BY NNP B-NP O
PHONE NNP I-NP O
TO NNP I-NP O
Robert NNP I-NP B-person
BURGER NNP I-NP I-person
2014-11-30 JJ O O
10:35A CD O O
. . B-VP O
   
KLEBSIELLA NNP B-NP B-problem
PNEUMONIAE NNP I-NP I-problem
. . B-VP O
   
FINAL NNP B-NP B-test
SENSITIVITIES NNP I-NP I-test
. . B-VP O
   
Trimethoprim/Sulfa NNP B-NP B-test
sensitivity NN I-NP I-test
testing VBG O I-test
available JJ O O
on IN B-VP O
request NN B-NP O
. . B-VP O
   
KLEBSIELLA NNP B-NP B-problem
PNEUMONIAE NNP I-NP I-problem
. . B-VP O
   
FINAL NNP B-NP B-test
SENSITIVITIES NNP I-NP I-test
. . B-VP O
   
Trimethoprim/Sulfa NNP B-NP B-test
sensitivity NN I-NP I-test
testing VBG O I-test
available JJ O O
on IN B-VP O
request NN B-NP O
. . B-VP O
   
2ND CD O O
STRAIN NNP B-NP O
. . B-VP O
   
SENSITIVITIES NN B-NP B-test
: : O O
MIC NNP B-NP B-test
expressed VBD B-VP O
in IN B-VP O
MCG/ML NNP B-NP O
_________________________________________________________ NNP I-NP O
KLEBSIELLA NNP I-NP B-problem
PNEUMONIAE NNP I-NP I-problem
KLEBSIELLA NNP I-NP B-problem
PNEUMONIAE NNP I-NP I-problem
AMPICILLIN/SULBACTAM-- NNP I-NP B-treatment
=>32 NNP I-NP O
R NNP I-NP O
=>32 NNP I-NP O
R NNP I-NP O
CEFAZOLIN------------- NNP I-NP B-treatment
<=4 NNP I-NP O
S NNP I-NP O
<=4 NNP I-NP O
S NNP I-NP O
CEFEPIME-------------- NNP I-NP B-treatment
<=1 NNP I-NP O
S NNP I-NP O
<=1 NNP I-NP O
S NNP I-NP O
CEFTAZIDIME----------- NNP I-NP B-treatment
<=1 NNP I-NP O
S NNP I-NP O
<=1 NNP I-NP O
S NNP I-NP O
CEFTRIAXONE----------- NNP I-NP B-treatment
<=1 NNP I-NP O
S NNP I-NP O
<=1 NNP I-NP O
S NNP I-NP O
CEFUROXIME------------ NNP I-NP B-treatment
4 CD O O
S NNP B-NP O
4 CD O O
S NNP B-NP O
CIPROFLOXACIN--------- NNP I-NP B-treatment
=>4 NNP I-NP O
R NNP I-NP O
=>4 NNP I-NP O
R NNP I-NP O
GENTAMICIN------------ NNP I-NP B-treatment
8 CD O O
I PRP O O
8 CD O O
I PRP O O
IMIPENEM-------------- NNP B-NP B-treatment
<=1 NNP I-NP O
S NNP I-NP O
<=1 NNP I-NP O
S NNP I-NP O
LEVOFLOXACIN---------- NNP I-NP B-treatment
=>8 NNP I-NP O
R NNP I-NP O
=>8 NNP I-NP O
R NNP I-NP O
MEROPENEM------------- NNP I-NP B-treatment
<=0.25 NNP I-NP O
S NNP I-NP O
<=0.25 NNP I-NP O
S NNP I-NP O
PIPERACILLIN/TAZO----- NNP I-NP B-treatment
<=4 NNP I-NP O
S NNP I-NP O
<=4 NNP I-NP O
S NNP I-NP O
TOBRAMYCIN------------ NNP I-NP B-treatment
4 CD O O
S NNP B-NP O
8 CD O O
I PRP O O
. . B-VP O
   
2014-11-30 JJ O O
1:50 CD O O
pm NN B-NP O
URINE,KIDNEY NNP I-NP O
PERC. NNP I-NP O
NEPH. NNP I-NP O
. . B-VP O
   
**FINAL JJ B-NP O
REPORT NNP I-NP O
2014-12-03** JJ B-NP O
FLUID NNP I-NP B-test
CULTURE NNP I-NP I-test
( ( O O
Final NNP B-NP O
2014-12-03 CD O O
) ) O O
: : O O
Due JJ O O
to TO O O
mixed JJ B-NP B-problem
bacterial JJ I-NP I-problem
types NNS I-NP I-problem
( ( O O
>= $ O B-problem
3 CD O I-problem
colony NN B-NP I-problem
types NNS I-NP O
) ) O B-test
an DT B-NP I-test
abbreviated JJ I-NP I-test
workup NN I-NP O
is VBZ O O
performed VBN O O
appropriate JJ O O
to TO O O
the DT B-NP O
isolates NNS I-NP O
recovered VBD B-VP O
from IN B-VP O
the DT B-NP O
site NN I-NP O
( ( O O
including VBG O B-test
a DT B-NP I-test
screen NN I-NP O
for IN B-VP B-problem
Pseudomonas NNP B-NP I-problem
aeruginosa NN I-NP O
, , O B-problem
Staphylococcus NNP B-NP I-problem
aureus NN I-NP O
and CC O B-problem
beta NN B-NP I-problem
streptococcus NN I-NP O
) ) O O
. . B-VP O
   
STAPH NNP B-NP B-problem
AUREUS NNP I-NP I-problem
COAG NNP I-NP I-problem
+ NNP I-NP I-problem
. . B-VP O
   
>100,000 CD O O
ORGANISMS/ML. NNP B-NP B-test
. . B-VP O
   
OF CC O O
TWO NNP B-NP B-problem
COLONIAL NNP I-NP I-problem
MORPHOLOGIES NNP I-NP I-problem
. . B-VP O
   
Oxacillin NNP B-NP B-problem
RESISTANT NNP I-NP I-problem
Staphylococci NNP I-NP I-problem
MUST NNP I-NP O
be VB O O
reported VBN O O
as IN B-VP O
also RB O O
RESISTANT NNP B-NP O
to TO O O
other JJ B-NP O
penicillins NNS I-NP B-treatment
, , O O
cephalosporins NNS B-NP B-treatment
, , O O
carbacephems NNS B-NP B-treatment
, , O O
carbapenems NNS B-NP B-treatment
, , O O
and CC O O
beta-lactamase JJ B-NP B-treatment
inhibitor NN I-NP I-treatment
combinations NNS I-NP I-treatment
. . B-VP O
   
Rifampin NNP B-NP B-treatment
should MD O O
not RB O O
be VB O O
used VBN O O
alone RB O O
for IN B-VP O
therapy NN B-NP B-treatment
. . B-VP O
   
GRAM NNP B-NP O
NEGATIVE NNP I-NP O
ROD( NNP I-NP O
S NNP I-NP O
) ) O O
. . B-VP O
   
>100,000 CD O O
ORGANISMS/ML. NNP B-NP B-test
. . B-VP O
   
OF CC O O
TWO NNP B-NP B-problem
COLONIAL NNP I-NP I-problem
MORPHOLOGIES NNP I-NP I-problem
. . B-VP O
   
SENSITIVITIES NN B-NP B-test
: : O O
MIC NNP B-NP B-test
expressed VBD B-VP O
in IN B-VP O
MCG/ML NNP B-NP O
_________________________________________________________ NNP I-NP O
STAPH NNP I-NP B-problem
AUREUS NNP I-NP I-problem
COAG NNP I-NP I-problem
+ NNP I-NP O
GENTAMICIN------------ NNP I-NP B-treatment
=>16 NNP I-NP O
R NNP I-NP O
LEVOFLOXACIN---------- NNP I-NP B-treatment
=>8 NNP I-NP O
R NNP I-NP O
NITROFURANTOIN-------- NNP I-NP B-treatment
<=16 NNP I-NP O
S NNP I-NP O
OXACILLIN------------- NNP I-NP B-treatment
=>4 NNP I-NP O
R NNP I-NP O
PENICILLIN------------ NNP I-NP B-treatment
=>0.5 NNP I-NP O
R NNP I-NP O
TETRACYCLINE---------- NNP I-NP B-treatment
=>16 NNP I-NP O
R NNP I-NP O
VANCOMYCIN------------ NNP I-NP B-treatment
<=1 NNP I-NP O
S NNP I-NP O
. . B-VP O
   
2014-12-03 JJ B-NP O
BLOOD NNP I-NP B-test
CULTURE NNP I-NP I-test
AEROBIC NNP I-NP B-test
BOTTLE NNP I-NP I-test
- : O O
PENDING NN B-NP O
; : O O
ANAEROBIC NNP B-NP B-test
BOTTLE NNP I-NP I-test
- : O O
PENDING VBD B-VP O
2014-12-03 JJ B-NP O
BLOOD NNP I-NP B-test
CULTURE NNP I-NP I-test
AEROBIC NNP I-NP B-test
BOTTLE NNP I-NP I-test
- : O O
PENDING NN B-NP O
; : O O
ANAEROBIC NNP B-NP B-test
BOTTLE NNP I-NP I-test
- : O O
PENDING NN B-NP O
2014-12-02 JJ B-NP O
URINE NNP I-NP B-test
URINE NNP I-NP B-test
CULTURE NNP I-NP I-test
- : O O
FINAL NN B-NP O
No DT B-NP O
Growth NNP I-NP O
2014-12-02 JJ B-NP O
CATHETER NNP I-NP B-treatment
TIP NNP I-NP I-treatment
- : O I-treatment
IV NNP B-NP I-treatment
WOUND NNP I-NP B-test
CULTURE NNP I-NP I-test
- : O O
FINAL NN B-NP O
No DT B-NP O
Growth NNP I-NP O
2014-12-02 JJ B-NP O
BLOOD NNP I-NP B-test
CULTURE NNP I-NP I-test
AEROBIC NNP I-NP B-test
BOTTLE NNP I-NP I-test
- : O O
PENDING NN B-NP O
; : O O
ANAEROBIC NNP B-NP B-test
BOTTLE NNP I-NP I-test
- : O O
PENDING NN B-NP O
Brief JJ B-NP O
Hospital NNP I-NP O
Course NNP I-NP O
: : O O
47 CD O B-person
yo NN B-NP I-person
F NNP I-NP I-person
w/ NN I-NP O
h/o VBD B-VP O
steroid-induced JJ B-NP B-problem
hyperglycemia NN I-NP I-problem
, , O O
SLE NNP B-NP B-problem
w/ VBZ O O
h/o NN B-NP O
pericarditis NN I-NP B-problem
, , O O
transverse JJ B-NP B-problem
myelitis NN I-NP I-problem
w/ NN I-NP O
paraplegia NN I-NP B-problem
and CC O O
neurogenic JJ B-NP B-problem
bladder NN I-NP I-problem
s/p NN I-NP O
urostomy JJ B-NP B-treatment
w/ JJ I-NP O
ileal NN I-NP B-treatment
conduit NN I-NP I-treatment
, , O O
h/o NN B-NP O
ureteropelvic JJ B-NP B-problem
stone NN I-NP I-problem
and CC O O
urosepsis NN B-NP B-problem
, , O O
and CC O O
h/o JJ B-NP O
RLE NNP I-NP B-problem
DVT NNP I-NP I-problem
admitted VBD B-VP O
11-29 JJ B-NP O
w/ NN I-NP O
left VBD B-VP B-problem
pyelo NN B-NP I-problem
and CC O O
right JJ O B-problem
8 CD O I-problem
mm NN B-NP I-problem
proximal JJ B-NP I-problem
ureteral JJ I-NP I-problem
stone NN I-NP I-problem
w/ NN I-NP O
right JJ B-NP B-problem
hydro NN I-NP I-problem
s/p NN I-NP O
perc NN I-NP B-treatment
urostomy JJ B-NP I-treatment
tube NN I-NP I-treatment
to TO O O
relieve VB O O
right JJ B-NP B-problem
hydro NN I-NP I-problem
. . B-VP O
   
. . B-VP O
   
## JJ B-NP O
GNR NNP I-NP B-problem
sepsis: NN I-NP I-problem
Upon NNP I-NP O
admission NN I-NP O
, , O O
pt NN B-NP B-person
was VBD B-VP O
febrile JJ O B-problem
to TO O O
101.2 CD O O
with IN B-VP O
U/A NNP B-NP B-test
consistent NN I-NP O
with IN B-VP O
UTI NNP B-NP B-problem
. . B-VP O
   
A NNP B-NP B-test
CT NNP I-NP I-test
abd NN I-NP I-test
showed VBD B-VP O
8mm CD O B-problem
obstructing VBG O I-problem
stone NN B-NP I-problem
, , O O
hydro NN B-NP B-problem
with IN B-VP O
stranding VBG O B-problem
consistent JJ O O
with IN B-VP O
pylonephritis NN B-NP B-problem
. . B-VP O
   
Her PRP$ O B-person
presentation NN B-NP O
was VBD B-VP O
thought VBN O O
likely RB O O
due JJ O O
to TO O O
urosepsis VB O B-problem
given VBN O O
h/o JJ B-NP O
foul NN I-NP B-problem
smelling VBG O I-problem
urine JJ O I-problem
and CC O O
in IN B-VP O
setting NN B-NP O
of IN B-VP O
stone NN B-NP B-problem
w/ NN I-NP O
hydro NN I-NP B-problem
+ NNP I-NP O
pyelo NN I-NP B-problem
by IN B-VP O
CT. NNP B-NP B-test
The DT B-NP B-person
patient NN I-NP I-person
went VBD B-VP O
to TO O O
IR NNP B-NP O
on IN B-VP O
2014-11-30 JJ O O
given VBN O O
evidence NN B-NP O
of IN B-VP O
right JJ B-NP B-problem
hydronephrosis NN I-NP I-problem
on IN B-VP O
imaging VBG O B-test
for IN B-VP O
decompression NN B-NP B-treatment
and CC O O
drainage. NN B-NP B-treatment
Upon NNP I-NP O
admission NN I-NP O
, , O O
she PRP O B-person
was VBD B-VP O
treated VBN O O
with IN B-VP O
Vancomycin NNP B-NP B-treatment
and CC O O
Gentamycin NNP B-NP B-treatment
and CC O O
Flagyl NNP B-NP B-treatment
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
started VBN O O
on IN B-VP O
the DT B-NP B-treatment
MUST NNP I-NP I-treatment
protocol NN I-NP I-treatment
with IN B-VP O
high JJ B-NP B-treatment
dose JJ I-NP I-treatment
steroids NNS I-NP I-treatment
as IN B-VP O
well RB O O
and CC O O
a DT B-NP O
goal NN I-NP O
SVO2 NNP I-NP B-test
>70% NN I-NP O
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
hypoxic JJ O B-problem
requiring VBG O O
3L CD O B-treatment
nasal JJ B-NP I-treatment
cannula NN I-NP I-treatment
O2 NNP I-NP I-treatment
. . B-VP O
   
She PRP O B-person
subsequently RB O O
developed VBD B-VP O
hypotension NN B-NP B-problem
with IN B-VP O
SBP NNP B-NP B-test
in IN B-VP O
the DT B-NP O
70s NNS I-NP O
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
transferred VBN O O
to TO O O
the DT B-NP O
CMED NNP I-NP O
where WRB O O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
continued VBN O O
on IN B-VP O
the DT B-NP B-treatment
MUST NNP I-NP I-treatment
protocol NN I-NP I-treatment
with IN B-VP O
goais NN B-NP O
of IN B-VP O
CVP NNP B-NP B-test
10-12 CD O O
, , O O
SVO2 NNP B-NP B-test
greater JJR O O
than IN B-VP O
70% CD O O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
bolused VBN O O
with IN B-VP O
NS NNP B-NP B-treatment
and CC O O
did VBD B-VP O
not RB O O
required VBN O O
pressors NNS B-NP B-treatment
. . B-VP O
   
On IN B-VP O
the DT B-NP O
day NN I-NP O
after IN B-VP O
admission NN B-NP O
to TO O O
the DT B-NP O
CMED NNP I-NP O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
noted VBN O O
to TO O O
have VB O O
small JJ B-NP B-problem
oxygen NN I-NP I-problem
requirement NN I-NP I-problem
with IN B-VP O
2L CD O B-treatment
NC NNP B-NP I-treatment
. . B-VP O
   
Repeat NNP B-NP B-test
imaging VBG O I-test
revealed VBD B-VP O
evidence NN B-NP O
of IN B-VP O
mild JJ B-NP B-problem
pulmonary JJ I-NP I-problem
congestion NN I-NP I-problem
which WDT O B-pronoun
was VBD B-VP O
thought VBN O O
to TO O O
account VB O O
for IN B-VP O
the DT O B-person
the DT B-NP B-problem
patient JJ I-NP I-person
patient NN I-NP I-problem
's POS O I-problem
mild JJ B-NP I-problem
hypoxia NN I-NP I-problem
. . B-VP O
   
Given VBN O O
that IN B-VP B-pronoun
the DT B-NP B-person
patient NN I-NP I-person
had VBD B-VP O
been VBN O O
maintaining VBG O O
a DT B-NP B-test
MAP NNP I-NP I-test
of IN B-VP O
60 CD O O
without IN B-VP O
fluids NNS B-NP B-treatment
or CC O O
pressors NNS B-NP B-treatment
, , O O
her PRP$ O B-person
goal NN B-NP O
CVP NNP I-NP B-test
was VBD B-VP O
decreased VBN O O
to TO O O
>8 VB O O
to TO O O
avoid VB O O
fluid JJ B-NP B-problem
overload NN I-NP I-problem
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
continued VBN O O
on IN B-VP O
Vancomycin NNP B-NP B-treatment
and CC O O
Gentamycin NNP B-NP B-treatment
while IN B-VP O
speciation NN B-NP B-test
and CC O O
sensitivities NNS B-NP B-test
were VBD B-VP O
pending VBG O O
. . B-VP O
   
Ciprofloxacin NNP B-NP B-treatment
was VBD B-VP O
added VBN O O
on IN B-VP O
2014-12-01 JJ O O
for IN B-VP O
synergy NN B-NP O
when WRB O O
surveillance NN B-NP B-test
cultures NNS I-NP I-test
were VBD B-VP O
found VBN O O
to TO O O
be VB O O
growing VBG O O
again RB O O
GNR NNP B-NP B-problem
. . B-VP O
   
Gent NNP B-NP B-treatment
and CC O O
Cipro NNP B-NP B-treatment
were VBD B-VP O
then RB O O
discontinued VBN O O
and CC O O
changed VBN O O
to TO O O
meropenem VB O B-treatment
when WRB O O
blood NN B-NP B-test
culture NN I-NP I-test
sensitivities NNS I-NP I-test
became VBD B-VP O
available JJ O O
revealing VBG O O
GNR NNP B-NP B-problem
sensitive JJ O O
to TO O O
Jacoby NNP B-NP B-treatment
but CC O O
resistant JJ O O
to TO O O
both DT B-NP O
Gent NNP I-NP B-treatment
and CC O O
Cipro NNP B-NP B-treatment
. . B-VP O
   
Additionaly NNP B-NP O
surveillance NN I-NP B-test
cultures NNS I-NP I-test
were VBD B-VP O
drawn VBN O O
daily RB O O
and CC O O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
transferred VBN O O
back RB O O
to TO O O
the DT B-NP O
floor NN I-NP O
with IN B-VP O
no DT B-NP O
subsequent JJ I-NP B-problem
pressor NN I-NP I-problem
requirement NN I-NP I-problem
. . B-VP O
   
Blood NNP B-NP B-test
cltures NNS I-NP I-test
from IN B-VP O
11-30 JJ O O
grew VBD B-VP O
KLEBSIELLA NNP B-NP B-problem
PNEUMONIAE NNP I-NP I-problem
and CC O O
12-01 JJ O O
grew VBD B-VP O
KLEBSIELLA NNP B-NP B-problem
PNEUMONIAE NNP I-NP I-problem
and CC O O
PROTEUS NNP B-NP B-problem
MIRABILIS NNP I-NP I-problem
both DT O O
sensitive JJ O O
to TO O O
the DT B-NP B-treatment
Meropenam NNP I-NP I-treatment
which WDT O B-pronoun
she PRP O B-person
had VBD B-VP O
already RB O O
been VBN O O
receiving VBG O O
. . B-VP O
   
Urine JJ B-NP B-test
cultures NNS I-NP I-test
from IN B-VP O
11-30 JJ O O
grew VBD B-VP O
STAPH NNP B-NP B-problem
AUREUS NNP I-NP I-problem
COAG NNP I-NP I-problem
+ NNP I-NP I-problem
, , O O
and CC O O
GRAM NNP B-NP B-problem
NEGATIVE NNP I-NP I-problem
RODS NNP I-NP I-problem
of IN B-VP O
two CD O O
morphologies NNS B-NP O
( ( O O
not RB O O
further RB O O
speciated VBN O O
) ) O O
. . B-VP O
   
She PRP O B-person
defervesed VBD B-VP O
by IN B-VP O
12-02 JJ O O
and CC O O
remained VBD B-VP O
clinically RB O O
stable JJ O O
with IN B-VP O
normal JJ B-NP O
blood NN I-NP O
pressures NNS I-NP O
until IN B-VP O
the DT B-NP O
day NN I-NP O
of IN B-VP O
discharge NN B-NP O
. . B-VP O
   
At IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
discharge NN B-NP O
, , O O
blood NN B-NP B-test
cultures NNS I-NP I-test
from IN B-VP O
12-02 JJ O O
and CC O O
12-03 NNS B-NP O
have VBP O O
no DT B-NP O
growth NN I-NP B-problem
to TO O O
date NN B-NP O
. . B-VP O
   
She PRP O B-person
received VBD B-VP O
a DT B-NP B-treatment
midline NN I-NP I-treatment
on IN B-VP O
12-04 JJ O O
with IN B-VP O
a DT B-NP O
goal NN I-NP O
of IN B-VP O
16 CD O O
days NNS B-NP O
of IN B-VP O
further JJ B-NP B-treatment
antibiotic JJ I-NP I-treatment
treatment NN I-NP I-treatment
with IN B-VP O
Meropenam NNP B-NP B-treatment
( ( O O
for IN B-VP O
a DT B-NP O
total NN I-NP O
of IN B-VP O
3 CD O O
weeks NNS B-NP O
) ) O O
upon IN B-VP O
discharge NN B-NP O
back RB O O
to TO O O
the DT B-NP O
nursing NN I-NP O
home NN I-NP O
where WRB O O
she PRP O B-person
lives VBZ O O
. . B-VP O
   
. . B-VP O
   
## JJ B-NP O
Right JJ I-NP B-problem
hydronephrosis NN I-NP I-problem
: : O O
Given VBN O O
right RB O B-problem
sided VBN O I-problem
hydronephrosis NN B-NP I-problem
and CC O O
GNR NNP B-NP B-problem
bactermeia NN I-NP I-problem
, , O O
a DT B-NP B-treatment
percutaneous JJ I-NP I-treatment
nephrostomy NN I-NP I-treatment
tube NN I-NP I-treatment
was VBD B-VP O
placed VBN O O
by IN B-VP O
IR NNP B-NP O
2014-11-30 JJ O O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
put VBD B-VP O
out RP O O
1385 CD O O
cc NN B-NP O
urine JJ O O
the DT B-NP O
day NN I-NP O
after IN B-VP O
placement NN B-NP O
, , O O
950 CD O O
cc NN B-NP O
of IN B-VP O
which WDT O B-pronoun
came VBD B-VP O
from IN B-VP O
nephrostomy JJ B-NP B-treatment
tube NN I-NP I-treatment
. . B-VP O
   
The DT B-NP B-treatment
tube NN I-NP I-treatment
appeared VBD B-VP O
to TO O O
be VB O O
functioning VBG O O
well RB O O
, , O O
draining VBG O O
urine JJ O O
with IN B-VP O
occasional JJ B-NP B-problem
clot NN I-NP I-problem
passage NN I-NP I-problem
. . B-VP O
   
Urology NNP B-NP B-person
was VBD B-VP O
notified VBN O O
about IN B-VP O
the DT B-NP B-problem
clots NNS I-NP I-problem
and CC O O
occasional JJ B-NP B-problem
blood NN I-NP I-problem
tinged VBD B-VP I-problem
urine JJ O I-problem
but CC O O
they PRP O B-pronoun
did VBD B-VP O
not RB O O
make VB O O
any DT B-NP O
further JJ I-NP O
recommendations NNS I-NP O
. . B-VP O
   
Cultures NNS B-NP B-test
from IN B-VP I-test
urine JJ B-NP I-test
drawn NN I-NP O
from IN B-VP O
the DT B-NP B-treatment
nephrostomy JJ I-NP I-treatment
tube NN I-NP I-treatment
are VBP O O
currently RB O O
growing VBG O O
> PRP O O
100K CD O O
GNR NNP B-NP B-problem
, , O O
possibly RB O O
of IN B-VP O
two CD O B-problem
colony NN B-NP I-problem
morphologies NNS I-NP I-problem
, , O O
speciation NN B-NP B-test
and CC O O
sensitivity NN B-NP B-test
pending NN I-NP O
. . B-VP O
   
. . B-VP O
   
## JJ B-NP O
Hct NNP I-NP B-problem
drop NN I-NP I-problem
: : O O
On IN B-VP O
admission NN B-NP O
to TO O O
hospital VB O O
patient NN B-NP B-person
had VBD B-VP O
Hct NNP B-NP B-test
of IN B-VP O
29.2 CD O O
. . B-VP O
   
In IN B-VP O
the DT B-NP O
setting NN I-NP O
of IN B-VP O
Right NNP B-NP B-treatment
sublavian JJ B-NP I-treatment
line NN I-NP I-treatment
placement NN I-NP I-treatment
as RB O O
well RB O O
as IN B-VP O
nephrostomy JJ B-NP B-treatment
tube NN I-NP I-treatment
placement VBD B-VP I-treatment
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
noted VBN O O
to TO O O
have VB O O
a DT B-NP B-problem
drifting NN I-NP I-problem
Hct NNP I-NP I-problem
, , O O
concerning VBG O O
for IN B-VP O
bleed NN B-NP B-problem
, , O O
with IN B-VP O
nadir NN B-NP B-test
of IN B-VP O
22.8 CD O O
on IN B-VP O
2014-12-01 JJ O O
. . B-VP O
   
A DT B-NP B-test
CT NNP I-NP I-test
abdomen NN I-NP I-test
was VBD B-VP O
performed VBN O O
which WDT O B-pronoun
did VBD B-VP O
not RB O O
demonstrate VB O O
any DT B-NP B-problem
retroperitoneal JJ I-NP I-problem
bleed NN I-NP I-problem
. . B-VP O
   
Hct NNP B-NP B-test
stabilized VBD B-VP O
to TO O O
24 CD O O
for IN B-VP O
three CD O O
days NNS B-NP O
prior RB O O
to TO O O
discharge VB O O
. . B-VP O
   
This DT O B-pronoun
can MD O O
be VB O O
followed VBN O O
as IN B-VP O
an DT B-NP O
outpatient NN I-NP O
. . B-VP O
   
Anemia NNP B-NP B-test
workup NN I-NP I-test
revealed VBD B-VP O
a DT B-NP O
picture NN I-NP O
of IN B-VP O
anemia NN B-NP B-problem
of IN B-VP I-problem
chronic JJ B-NP I-problem
disease NN I-NP I-problem
( ( O O
TIBC NNP B-NP B-test
225 CD O O
, , O O
B12 NNP B-NP B-test
and CC O O
Folate NNP B-NP B-test
normal JJ O O
, , O O
Hapto NNP B-NP B-test
397 CD O O
, , O O
Ferritin NNP B-NP B-test
51 CD O O
, , O O
TRF NNP B-NP B-test
173 CD O O
, , O O
Iron NNP B-NP B-test
35 CD O O
) ) O O
. . B-VP O
   
. . B-VP O
   
## JJ B-NP O
Hypoxia: NNP I-NP B-problem
The DT B-NP B-person
patient NN I-NP I-person
on IN B-VP O
admission NN B-NP O
was VBD B-VP O
requiring VBG O O
3 CD O B-treatment
L NNP B-NP I-treatment
NC NNP I-NP I-treatment
in IN B-VP O
the DT B-NP O
setting NN I-NP O
of IN B-VP O
receiving VBG O O
2L CD O B-treatment
NS NNP B-NP I-treatment
and CC O O
chest JJS B-NP B-test
film NN I-NP I-test
which WDT O B-pronoun
demonstrated VBD B-VP O
pulmonary JJ B-NP B-problem
congestion NN I-NP I-problem
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
not RB O O
diuresed VBN O O
but CC O O
allowed VBN O O
to TO O O
auto-diurese JJ O O
any DT B-NP O
additional JJ I-NP O
fluids NNS I-NP O
and CC O O
is VBZ O O
currently RB O O
with IN B-VP O
O2 NNP B-NP B-test
sats NNS I-NP I-test
97-98% VBP O O
on IN B-VP O
room NN B-NP O
air NN I-NP O
. . B-VP O
   
As IN B-VP O
her PRP$ O B-person
her PRP$ O B-test
BP NNP B-NP I-test
remained VBD B-VP O
stable JJ O O
she PRP O B-person
did VBD B-VP O
not RB O O
receiving VBG O O
any DT B-NP B-treatment
standing JJ I-NP I-treatment
fluids NNS I-NP I-treatment
but CC O O
was VBD B-VP O
be VB O O
bolused VBN O B-treatment
as IN B-VP O
appropriate NN B-NP O
for IN B-VP O
a DT B-NP B-test
MAP NNP I-NP I-test
< $ O O
60 CD O O
or CC O O
CVP NNP B-NP B-test
< VBZ O O
8 CD O O
with IN B-VP O
careful JJ B-NP O
monitoring NN I-NP O
of IN B-VP O
pulmonary JJ B-NP O
status NN I-NP O
. . B-VP O
   
Patient NNP B-NP B-person
had VBD B-VP O
an DT B-NP B-test
echocardiogram NN I-NP I-test
in IN B-VP O
2012 CD O O
which WDT O B-pronoun
demonstrated VBD B-VP O
an DT B-NP B-test
EF NNP I-NP I-test
of IN B-VP O
60-65% NNP B-NP O
. . B-VP O
   
her PRP$ O B-person
her PRP$ O B-problem
O2 NNP B-NP I-problem
requirement NN I-NP I-problem
by IN B-VP O
discharge NN B-NP O
was VBD B-VP O
96% CD O O
on IN B-VP O
room NN B-NP O
air NN I-NP O
with IN B-VP O
no DT B-NP O
SOB NNP I-NP B-problem
. . B-VP O
   
. . B-VP O
   
## JJ B-NP O
Steroid-induced JJ I-NP B-problem
hyperglycemia NN I-NP I-problem
: : O O
At IN B-VP O
home NN B-NP O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
received VBD B-VP O
metformin NNS B-NP B-treatment
and CC O O
SSI NNP B-NP B-treatment
. . B-VP O
   
The DT O B-treatment
The DT B-NP B-person
patient JJ I-NP I-treatment
patient NN I-NP I-person
's POS O I-treatment
metformin NN B-NP I-treatment
was VBD B-VP O
held VBN O O
and CC O O
she PRP O B-person
has VBZ O O
been VBN O O
maintained VBN O O
on IN B-VP O
SSI NNP B-NP B-treatment
qid NN I-NP O
while IN B-VP O
in IN B-VP O
the DT B-NP O
CMED NNP I-NP O
. . B-VP O
   
As IN B-VP O
the DT B-NP B-person
patient NN I-NP I-person
appeared VBD B-VP O
to TO O O
be VB O O
clinically RB O O
stable JJ O O
, , O O
her PRP$ O B-person
her PRP$ O B-treatment
stress NN B-NP I-treatment
dose JJ B-NP I-treatment
steroids NNS I-NP I-treatment
were VBD B-VP O
discontinued VBN O O
and CC O O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
changed VBN O O
back RB O O
to TO O O
her PRP$ O B-person
home NN B-NP O
dose NN I-NP O
of IN B-VP O
Prednisone NNP B-NP B-treatment
40mg CD O O
PO NNP B-NP O
qd NN I-NP O
for IN B-VP O
maintenance NN B-NP O
with IN B-VP O
anticipated JJ B-NP O
decrease NN I-NP O
in IN B-VP O
her PRP$ O B-person
her PRP$ O B-test
blood NN B-NP I-test
sugars NNS I-NP I-test
. . B-VP O
   
Her PRP$ O B-person
Her PRP$ O B-treatment
Metformin NNP B-NP I-treatment
was VBD B-VP O
re-added JJ O O
2 CD O O
days NNS B-NP O
prior RB O O
to TO O O
discharge VB O O
as RB O O
well RB O O
and CC O O
fingerstick JJ B-NP B-test
glucoses NNS I-NP I-test
on IN B-VP O
the DT B-NP O
day NN I-NP O
of IN B-VP O
discharge NN B-NP O
were VBD B-VP O
93 CD O O
and CC O O
156 CD O O
, , O O
respectively RB O O
. . B-VP O
   
. . B-VP O
   
## JJ B-NP O
Hypothyroidism NN I-NP B-problem
: : O O
Repeat NNP B-NP B-test
TSH NNP I-NP I-test
and CC O O
Free NNP B-NP B-test
T4 NNP I-NP I-test
were VBD B-VP O
appropriate JJ O O
on IN B-VP O
current JJ B-NP B-treatment
outpatient JJ I-NP I-treatment
regimen. NN I-NP I-treatment
Patient NNP I-NP B-person
was VBD B-VP O
continued VBN O O
on IN B-VP O
Levothyroxine NNP B-NP B-treatment
75mcg CD O O
po NN B-NP O
qd NN I-NP O
. . B-VP O
   
. . B-VP O
   
## JJ B-NP O
H/o NNP I-NP O
transverse NN I-NP B-problem
myelitis/optic JJ B-NP I-problem
neuritis NN I-NP I-problem
: : O O
On IN B-VP O
stress NN B-NP B-treatment
dose JJ B-NP I-treatment
steroids NNS I-NP I-treatment
originally RB O O
given VBN O O
MUST NNP B-NP B-treatment
protocol NN I-NP I-treatment
and CC O O
sepsis NN B-NP B-problem
, , O O
as IN B-VP O
patient JJ O B-person
clinically RB O O
stabilized VBN O O
, , O O
she PRP O B-person
was VBD B-VP O
changed VBN O O
back RB O O
to TO O O
home NN B-NP O
dose NN I-NP O
of IN B-VP O
Prednisone NNP B-NP B-treatment
40mg CD O O
pO NN B-NP O
qd NN I-NP O
. . B-VP O
   
. . B-VP O
   
## JJ B-NP O
SLE NN I-NP B-problem
: : O O
Currently RB O O
no DT B-NP O
sx NN I-NP B-problem
of IN B-VP I-problem
active JJ B-NP I-problem
disease NN I-NP I-problem
. . B-VP O
   
No DT B-NP O
manifestations NNS I-NP O
of IN B-VP O
SLE NNP B-NP B-problem
during IN B-VP O
this DT B-NP B-pronoun
admission NN I-NP O
. . B-VP O
   
. . B-VP O
   
# # O O
Osteoporosis NNP B-NP B-problem
- : O O
We PRP O B-person
continued VBD B-VP O
actonel/vit JJ B-NP B-treatment
D NNP I-NP I-treatment
, , O O
Tums NNP B-NP B-treatment
. . B-VP O
   
## VB O O
Capsular JJ B-NP B-problem
ossification NN I-NP I-problem
: : O O
We PRP O B-person
continued VBD B-VP O
CMED NNP B-NP B-treatment
CSRU NNP I-NP I-treatment
gtt NN I-NP I-treatment
. . B-VP O
   
. . B-VP O
   
## JJ B-NP O
FEN: NNP I-NP O
She PRP O B-person
had VBD B-VP O
a DT B-NP B-problem
low JJ I-NP I-problem
bicarb NN I-NP I-problem
likely RB O O
due JJ O O
to TO O O
renal JJ B-NP B-problem
wasting NN I-NP I-problem
but CC O O
there EX O O
is VBZ O O
an DT B-NP B-problem
anion NN I-NP I-problem
gap NN I-NP I-problem
present NN I-NP O
. . B-VP O
   
Serum NNP B-NP B-test
acetone NN I-NP I-test
was VBD B-VP O
normal JJ O O
. . B-VP O
   
We PRP O B-person
followed VBD B-VP O
lactate NN B-NP B-test
while IN B-VP O
she PRP O B-person
was VBD B-VP O
in IN B-VP O
the DT B-NP O
CMED NNP I-NP O
which WDT O B-pronoun
was VBD B-VP O
normal JJ O O
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
NPO NNP B-NP B-treatment
periodically RB O O
but CC O O
maintained VBD B-VP O
a DT O O
normal JJ O O
diet JJ O O
prior JJ O O
to TO O O
discharge VB O O
. . B-VP O
   
. . B-VP O
   
# # O O
PPX NNP B-NP O
- : O O
SQ NNP B-NP B-treatment
Heparin NNP I-NP I-treatment
during IN B-VP O
this DT B-NP B-pronoun
admission NN I-NP O
, , O O
PPI NNP B-NP B-treatment
. . B-VP O
   
## JJ B-NP O
Communication NN I-NP O
: : O O
patient NN B-NP B-person
. . B-VP O
   
## JJ B-NP O
Dispo NN I-NP O
: : O O
To TO O O
nursing NN B-NP O
home NN I-NP O
for IN B-VP O
follow JJ O O
up RP O O
with IN B-VP O
Dr. NNP B-NP B-person
Hipp NNP I-NP I-person
( ( O O
urology NN B-NP O
) ) O O
this DT O B-pronoun
coming VBG O O
Monday NNP B-NP O
, , O O
12-08 JJ O O
at IN B-VP O
1:30pm CD O O
and CC O O
with IN B-VP O
her PRP$ O B-person
her PRP$ O B-person
PCP NN B-NP I-person
at IN B-VP O
the DT B-NP O
nursing NN I-NP O
home NN I-NP O
Medications NNP I-NP O
on IN B-VP O
Admission NNP B-NP O
: : O O
Home NN B-NP B-treatment
Meds NNS I-NP I-treatment
: : O O
Ascorbic NNP B-NP B-treatment
Acid NNP I-NP I-treatment
500 CD O O
TID NNP B-NP O
Cranberry NNP I-NP B-treatment
Extract NNP I-NP I-treatment
425 CD O O
BID NNP B-NP O
Bisacodyl NNP I-NP B-treatment
10mg CD O O
Senna NNP B-NP B-treatment
Dephenhydramine NNP I-NP B-treatment
50mg CD O O
prn NN B-NP O
loperamide NN I-NP B-treatment
prn NN I-NP O
famotidine NN I-NP B-treatment
20mg CD O O
KCL NNP B-NP B-treatment
20mg CD O O
QD NNP B-NP O
Metformin NNP I-NP B-treatment
1000 CD O O
qd NN B-NP O
tums NNS I-NP B-treatment
1500 CD O O
bid NN B-NP O
MVI NNP I-NP B-treatment
Timolol NNP I-NP B-treatment
1 CD O O
Drop NNP B-NP O
BID NNP I-NP O
0.5% CD O O
L NNP B-NP O
CMED NNP I-NP O
CSRU NNP I-NP O
Synthroid NNP I-NP B-treatment
75 CD O O
QD NNP B-NP O
Compro NNP I-NP B-treatment
25mg CD O O
pr NN B-NP O
Citrucel NNP I-NP B-treatment
Vitamin NNP I-NP B-treatment
D NNP I-NP I-treatment
50k CD O O
Qmondays NNP B-NP O
Oxazepam NNP I-NP B-treatment
15mg CD O O
qhs NN B-NP O
tizamidine NN I-NP B-treatment
8mg CD O O
qhs NN B-NP O
actonel NN I-NP B-treatment
35 CD O O
qwed VBD B-VP O
Diovan NNP B-NP B-treatment
80 CD O O
qd NN B-NP O
prednisone NN I-NP B-treatment
40 CD O O
qd NN B-NP O
bactrim JJ B-NP B-treatment
ds NN I-NP I-treatment
qmwf NN I-NP O
baclofen JJ B-NP B-treatment
pump NN I-NP I-treatment
2-3yrs JJ B-NP O
Insulin NNP I-NP B-treatment
SS NNP I-NP I-treatment
. . B-VP O
   
Meds NNS B-NP O
on IN B-VP O
transfer NN B-NP O
: : O O
Actonel $ O B-treatment
35 CD O O
mg JJ B-NP O
Oral NNP I-NP O
qwednesdays NNS I-NP O
Ascorbic NNP I-NP B-treatment
Acid NNP I-NP I-treatment
500 CD O O
mg NN B-NP O
PO NNP I-NP O
TID NNP I-NP O
Sodium NNP I-NP B-treatment
Polystyrene NNP I-NP I-treatment
Sulfonate NNP I-NP I-treatment
15 CD O O
gm NN B-NP O
PO NNP I-NP O
ONCE RB O O
11-29 CD O O
@ JJ O O
2201 CD O O
Famotidine NNP B-NP B-treatment
20 CD O O
mg NN B-NP O
PO NNP I-NP O
DAILY NNP I-NP O
Sulfameth/Trimethoprim NNP I-NP B-treatment
DS NNP I-NP O
1 CD O O
TAB NNP B-NP O
PO NNP I-NP O
QMOWEFR NNP I-NP O
Gentamicin NNP I-NP B-treatment
80 CD O O
mg NN B-NP O
IV NNP I-NP O
Q8H NNP I-NP O
Timolol NNP I-NP B-treatment
Maleate NNP I-NP I-treatment
0.5% CD O O
1 CD O O
DROP NNP B-NP O
OS NNP I-NP O
BID NNP I-NP O
Heparin NNP I-NP B-treatment
5000 CD O O
UNIT NNP B-NP O
SC NNP I-NP O
TID NNP I-NP O
Tizanidine NNP I-NP B-treatment
HCl NNP I-NP I-treatment
8 CD O O
mg NN B-NP O
PO NNP I-NP O
QHS NNP I-NP O
Hydrocortisone NNP I-NP B-treatment
Na NNP I-NP I-treatment
Succ. NNP I-NP I-treatment
100 CD O O
mg NN B-NP O
IV NNP I-NP O
Q8H NNP I-NP O
11-30 CD O O
@ NN B-NP O
0906 CD O O
Valsartan NNP B-NP B-treatment
80 CD O O
mg NN B-NP O
PO NNP I-NP O
DAILY NNP I-NP O
Insulin NNP I-NP B-treatment
SC NNP I-NP I-treatment
( ( O O
per IN B-VP O
Insulin NNP B-NP O
Flowsheet NNP I-NP O
) ) O O
Vancomycin NNP B-NP B-treatment
HCl NNP I-NP I-treatment
1000 CD O O
mg NN B-NP O
IV NNP I-NP O
Q NNP I-NP O
12H CD O O
Levothyroxine NNP B-NP B-treatment
Sodium NNP I-NP I-treatment
75 CD O O
mcg NN B-NP O
PO NNP I-NP O
DAILY NNP I-NP O
Vitamin NNP I-NP B-treatment
D NNP I-NP I-treatment
50,000 CD O O
UNIT NNP B-NP O
PO NNP I-NP O
QWEDNESDAYS NNP I-NP O
Discharge NNP I-NP O
Disposition NNP I-NP O
: : O O
Extended VBN O O
Care NNP B-NP O
Discharge NNP I-NP O
Diagnosis NNP I-NP O
: : O O
GNR NNP B-NP B-problem
Sepsis NNP I-NP I-problem
; : O O
Steroid NNP B-NP B-problem
induced VBD B-VP I-problem
hyperglycemia NN B-NP I-problem
; : O O
Hydronephrosis NNP B-NP B-problem
; : O O
SLE NNP B-NP B-problem
Discharge NNP I-NP O
Condition NNP I-NP O
: : O O
Stable JJ B-NP O
Discharge NN I-NP O
Instructions NNS I-NP O
: : O O
Pls NNP B-NP O
take VB O O
all DT B-NP B-treatment
meds NNS I-NP I-treatment
as IN B-VP O
prescribed NN B-NP O
. . B-VP O
   
Call VB O O
your PRP$ O B-person
your PRP$ O B-person
doctor NN B-NP I-person
immediately RB O O
if IN B-VP O
any DT B-NP B-problem
new JJ I-NP I-problem
symptoms NNS I-NP I-problem
develop VBP O O
including VBG O O
fevers NNS B-NP B-problem
, , O O
rash NN B-NP B-problem
, , O O
increase NN B-NP B-problem
in IN B-VP I-problem
bloody JJ B-NP I-problem
urine NN I-NP I-problem
in IN B-VP O
nephrostomy NN B-NP B-treatment
or CC O O
urostomy NN B-NP B-treatment
bags NNS I-NP I-treatment
, , O O
etc FW O O
. . B-VP O
   
Follow VB O O
up RP O O
appointments NNS B-NP O
listed VBN O O
below IN B-VP O
. . B-VP O
   
Followup NNP B-NP O
Instructions NNS I-NP O
: : O O
With IN B-VP O
Dr. NNP B-NP B-person
Vivian NNP I-NP I-person
Hansen NNP I-NP I-person
, , O O
UMass NNP B-NP O
Memorial NNP I-NP O
Medical NNP I-NP O
Center NNP I-NP O
, , O O
3rd CD O O
floor NN B-NP O
Morris NNP I-NP O
on IN B-VP O
Monday NNP B-NP O
12-08 CD O O
at IN B-VP O
@ $ O O
1:30pm CD O O
( ( O O
you PRP O B-person
also RB O O
have VBP O O
an DT B-NP O
appointment NN I-NP O
scheduled VBN O O
with IN B-VP O
Dr. NNP B-NP B-person
Hipp NNP I-NP I-person
for IN B-VP O
01-14 NN B-NP O
) ) O O
. . B-VP O
   
. . B-VP O
   
Provider NN B-NP O
: : O O
Sheena NNP B-NP B-person
Phone NNP I-NP O
: : O O
361-438-6334 JJ B-NP O
Date/Time NN I-NP O
: : O O
2015-01-07 JJ O O
8:30 CD O O
Colleen NNP B-NP B-person
Thomas NNP I-NP I-person
MD NNP I-NP I-person
80-548 CD O O
Completed VBN O O
by IN B-VP O
: : O O
Edward NNP B-NP B-person
James NNP I-NP I-person
MD NNP I-NP I-person
50-497 JJ B-NP O
2014-12-05 JJ I-NP O
@ NN I-NP O
1042 CD O O
Signed NNP B-NP O
electronically RB O O
by IN B-VP O
: : O O
DR. NNP B-NP B-person
Ronald NNP I-NP I-person
Z. NNP I-NP I-person
Thome NNP I-NP I-person
on IN B-VP O
: : O O
Robert NNP B-NP O
2015-01-15 CD O O
5:13 CD O O
PM NNP B-NP O
( ( O O
End NNP B-NP O
of IN B-VP O
Report NNP B-NP O
) ) O O
-EMPTYLINE- VBP O O
-DOCSTART- JJ O O
-EMPTYLINE- $ O O
655488444 CD O O
BH NNP B-NP O
7432347 CD O O
065055 CD O O
2/10/2000 CD O O
12:00:00 CD O O
AM NNP B-NP O
ED NNP I-NP O
Discharge NNP I-NP O
Summary NNP I-NP O
Unsigned VBD B-VP O
DIS NNP B-NP O
Report NNP I-NP O
Status NNP I-NP O
: : O O
Unsigned VBD B-VP O
ED NNP B-NP O
DISCHARGE NNP I-NP O
NOTIFICATION NNP I-NP O
FREIREKOTE NNP I-NP B-person
, , O I-person
SONYLA NNP B-NP I-person
MRN NNP I-NP O
: : O O
7432347 CD O O
Age NNP B-NP O
: : O O
35y CD O O
REGISTRATION NNP B-NP O
DATE NNP I-NP O
: : O O
02/10/2000 CD O O
03:19 CD O O
PM NNP B-NP O
PRELIMINARY NNP I-NP O
REPORT NNP I-NP O
This DT O B-pronoun
is VBZ O O
to TO O O
notify VB O O
you PRP O B-person
that IN B-VP B-pronoun
your PRP$ O B-person
patient NN B-NP B-person
, , O O
FREIREKOTE NNP B-NP B-person
, , O I-person
SONYLA NNP B-NP I-person
arrived VBD B-VP O
in IN B-VP O
the DT B-NP O
Emergency NNP I-NP O
Department NNP I-NP O
at IN B-VP O
Bri NNP B-NP O
Health NNP I-NP O
on IN B-VP O
02/10/2000 CD O O
03:19 CD O O
PM NNP B-NP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
presented VBN O O
with IN B-VP O
a DT B-NP O
chief JJ I-NP O
complaint NN I-NP O
of IN B-VP O
FOUND NNP B-NP B-problem
DOWN NNP I-NP I-problem
. . B-VP O
   
Following VBG O O
evaluation NN B-NP B-test
and CC O O
treatment NN B-NP B-treatment
, , O O
the DT B-NP B-person
patient NN I-NP I-person
's POS O O
disposition NN B-NP O
at IN B-VP O
the DT B-NP O
end NN I-NP O
of IN B-VP O
the DT B-NP O
visit NN I-NP O
was VBD B-VP O
ADMITTED NNP B-NP O
AS IN B-VP O
AN NNP B-NP O
INPATIENT NNP I-NP O
TO NNP I-NP O
BRI NNP I-NP O
HEALTH NNP I-NP O
. . B-VP O
   
Your PRP$ O B-person
patient NN B-NP B-person
was VBD B-VP O
admitted VBN O O
under IN B-VP O
the DT B-NP O
care NN I-NP O
of IN B-VP O
REEFRAUP NNP B-NP B-person
, , O I-person
JA NNP B-NP I-person
Y NNP I-NP I-person
with IN B-VP O
a DT B-NP O
preliminary JJ I-NP O
diagnosis NN I-NP O
of IN B-VP O
SYNCOPE NNP B-NP B-problem
. . B-VP O
   
If IN B-VP O
you PRP O B-person
need VBP O O
additional JJ B-NP O
information NN I-NP O
please NN I-NP O
call VB O O
442-025-0303 JJ O O
. . B-VP O
   
[ JJ B-NP O
report NN I-NP O
_ VBD B-VP O
end JJ B-NP O
] NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
Admission NNP I-NP O
Date NNP I-NP O
: : O O
2014-04-23 JJ B-NP O
Discharge NN I-NP O
Date NNP I-NP O
: : O O
2014-04-28 JJ B-NP O
Date NNP I-NP O
of IN B-VP O
Birth NNP B-NP O
: : O O
1980-02-05 JJ B-NP O
Sex NN I-NP O
: : O O
F NNP B-NP O
Service NNP I-NP O
: : O O
MEDICINE JJ B-NP O
Allergies NNS I-NP O
: : O O
Penicillins NNS B-NP B-treatment
/ VBP O O
Sulfonamides NNP B-NP B-treatment
Attending NNP I-NP B-person
: : O O
Louie NNP B-NP B-person
A. NN I-NP I-person
Keith NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
Chief NNP I-NP O
Complaint NNP I-NP O
: : O O
Benzo NNP B-NP B-problem
overdose VBP O I-problem
Major NNP B-NP O
Surgical NNP I-NP O
or CC O O
Invasive JJ B-NP O
Procedure NN I-NP O
: : O O
Intubation NN B-NP B-treatment
for IN B-VP I-treatment
airway JJ B-NP I-treatment
protection NN I-NP I-treatment
History NNP I-NP O
of IN B-VP O
Present NNP B-NP O
Illness NNP I-NP O
: : O O
HPI NN B-NP O
: : O O
Ms. NNP B-NP B-person
Franklin NNP I-NP I-person
is VBZ O O
a DT O O
34 CD O O
- : O O
year-old JJ B-NP O
woman NN I-NP O
with IN B-VP O
Bipolar NNP B-NP B-problem
disorder NN I-NP I-problem
and CC O O
group NN B-NP O
home NN I-NP O
resident NN I-NP O
who WP O B-person
by IN B-VP O
way NN B-NP O
of IN B-VP O
EMS NNP B-NP B-person
for IN B-VP O
apparent JJ B-NP B-problem
alprazolam NN I-NP I-problem
overdose NN I-NP I-problem
. . B-VP O
   
In IN B-VP O
the DT B-NP O
St. NNP I-NP O
Margaret NNP I-NP O
's POS O O
Center NNP B-NP O
for IN B-VP O
Women NNP B-NP O
& CC O O
Infants NNP B-NP O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
lethargic JJ O B-problem
and CC O O
unable JJ O O
to TO O O
give VB O O
a DT B-NP O
history NN I-NP O
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
promptly RB O O
intubated VBN O O
for IN B-VP O
airway NN B-NP O
protection NN I-NP O
and CC O O
in IN B-VP O
order NN B-NP O
to TO O O
administer VB O O
charcoal NN B-NP B-treatment
. . B-VP O
   
Patient NNP B-NP B-person
was VBD B-VP O
found VBN O O
at IN B-VP O
group NN B-NP O
home NN I-NP O
in IN B-VP O
am VBP O O
laying VBG O O
on IN B-VP O
floor NN B-NP O
by IN B-VP O
bed NN B-NP O
unresponsive JJ O B-problem
, , O O
last JJ O O
seen VBN O O
awake RB O O
8 CD O O
hours NNS B-NP O
prior RB O O
at IN B-VP O
dinner NN B-NP O
. . B-VP O
   
Group NNP B-NP O
home NN I-NP O
states NNS I-NP O
that WDT O B-pronoun
patient VBP O B-person
" NN B-NP O
may MD O O
have VB O O
taken VBN O O
too RB O O
many JJ B-NP O
Xanax NNP I-NP B-treatment
. . B-VP O
   
Patient NNP B-NP B-person
has VBZ O O
a DT B-NP O
history NN I-NP O
of IN B-VP O
suicidal JJ B-NP B-problem
ideations NNS I-NP I-problem
and CC O O
self JJ B-NP B-problem
mutilation NN I-NP I-problem
. . B-VP O
   
Later NNP B-NP O
patient NN I-NP B-person
told VBD B-VP O
CMED NNP B-NP B-person
CCU NNP I-NP I-person
that IN B-VP B-pronoun
she PRP O B-person
was VBD B-VP O
feeling VBG O O
down RB O O
and CC O O
impulsively RB O O
ingested JJ O O
5 CD O O
days NNS B-NP O
worth IN B-VP O
of IN B-VP O
medications NNS B-NP B-treatment
, , O O
she PRP O B-person
states VBZ O O
that IN B-VP B-pronoun
her PRP$ O B-person
intent NN B-NP O
at IN B-VP O
that DT B-NP B-pronoun
time NN I-NP O
was VBD B-VP O
to TO O O
end VB O O
her PRP$ O B-person
life NN B-NP O
. . B-VP O
   
Past NNP B-NP O
Medical JJ B-NP O
History NN I-NP O
: : O O
1. CD O O
Bipolar NNP B-NP B-problem
disorder NN I-NP I-problem
. . B-VP O
   
2. CD O O
Asthma NNP B-NP B-problem
. . B-VP O
   
3. CD O O
Posttraumatic JJ B-NP B-problem
stress NN I-NP I-problem
disorder NN I-NP I-problem
. . B-VP O
   
4. CD O O
GERD NNP B-NP B-problem
5. CD O O
Chronic NNP B-NP B-problem
constipation NN I-NP I-problem
from IN B-VP O
laxative JJ B-NP B-problem
abuse NN I-NP I-problem
. . B-VP O
   
Social JJ B-NP O
History NN I-NP O
: : O O
Denies VBZ O O
any DT B-NP O
recent JJ I-NP O
use NN I-NP O
of IN B-VP O
EtOH NNP B-NP O
or CC O O
illicit JJ B-NP O
drugs NNS I-NP O
. . B-VP O
   
Per NNP B-NP O
OMR NNP I-NP O
, , O O
h/o NN B-NP O
sporadic JJ B-NP O
marijuana NN I-NP O
use NN I-NP O
. . B-VP O
   
Now RB O O
living VBG O O
at IN B-VP O
the DT B-NP O
DBT NNP I-NP O
House NNP I-NP O
on IN B-VP O
Treva NNP B-NP O
Williamson NNP I-NP O
in IN B-VP O
Westborough NNP B-NP O
. . B-VP O
   
In IN B-VP O
currently RB O O
in IN B-VP O
a DT B-NP O
relationship NN I-NP O
with IN B-VP O
a DT B-NP B-person
man NN I-NP I-person
whom WP O O
she PRP O B-person
met VBD B-VP O
during IN B-VP O
a DT B-NP O
previous JJ I-NP O
inpt NN I-NP O
admission NN I-NP O
. . B-VP O
   
Per NNP B-NP O
OMR NNP I-NP O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
is VBZ O O
currently RB O O
not RB O O
in IN B-VP O
contact NN B-NP O
with IN B-VP O
her PRP$ O B-person
her PRP$ O B-person
family NN B-NP I-person
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
raised VBN O O
in IN B-VP O
multiple JJ B-NP O
foster NN I-NP O
care NN I-NP O
homes NNS I-NP O
because IN B-VP O
her PRP$ O B-person
her PRP$ O B-person
mother NN B-NP I-person
could MD O O
not RB O O
care VB O O
for IN B-VP O
her PRP$ O B-person
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
physically RB O O
abused JJ O O
and CC O O
severely RB O O
neglected VBN O O
as IN B-VP O
a DT B-NP O
child NN I-NP O
and CC O O
been VBN O O
sexually RB O O
assaulted VBN O O
. . B-VP O
   
She PRP O B-person
has VBZ O O
no DT B-NP O
current JJ I-NP O
romantic JJ I-NP O
relationship NN I-NP O
. . B-VP O
   
She PRP O B-person
has VBZ O O
never RB O O
been VBN O O
married VBN O O
. . B-VP O
   
She PRP O B-person
has VBZ O O
completed VBN O O
up RP O O
to TO O O
the DT B-NP O
tenth JJ I-NP O
grade NN I-NP O
of IN B-VP O
high JJ B-NP O
school NN I-NP O
. . B-VP O
   
She PRP O B-person
has VBZ O O
no DT B-NP O
current JJ I-NP O
legal JJ I-NP O
issues NNS I-NP O
. . B-VP O
   
Family RB O O
History NN B-NP O
: : O O
Substance NN B-NP O
abuse NN I-NP O
in IN B-VP O
mother NN B-NP B-person
and CC O O
brother NN B-NP B-person
. . B-VP O
   
Two CD O B-person
sisters NNS B-NP I-person
with IN B-VP O
h/o JJ B-NP O
depression NN I-NP B-problem
and CC O O
suicidality NN B-NP B-problem
. . B-VP O
   
Physical JJ B-NP O
Exam NN I-NP O
: : O O
VS NNP B-NP B-test
95.4 CD O O
HR NNP B-NP B-test
62 CD O O
BP NNP B-NP B-test
99/70 CD O O
RR NNP B-NP B-test
20 CD O O
O2Sat NNP B-NP B-test
100% CD O O
Gen NNP B-NP O
: : O O
Intubated VBN O B-treatment
and CC O O
sedated VBN O B-treatment
HEENT NNP B-NP O
: : O O
ATNC NNP B-NP B-problem
, , O O
Pupils NNP B-NP O
dialted VBD B-VP O
at IN B-VP O
5 CD O O
mm NNS B-NP O
but CC O O
minimally RB O B-problem
reactive JJ O I-problem
, , O O
anicteric JJ B-NP B-problem
Chest NNP I-NP O
: : O O
CTA NNP B-NP O
ant/lat JJ B-NP O
Cor NNP I-NP O
: : O O
RR NNP B-NP O
nl MD O O
S1 NNP B-NP O
S2 NNP I-NP O
no DT B-NP O
m NN I-NP B-problem
Abd NNP I-NP O
: : O O
Soft JJ O O
, , O O
nd JJ O B-problem
, , O O
hypoactive JJ B-NP B-problem
bowel NN I-NP I-problem
sounds VBZ O I-problem
Ext JJ O O
: : O O
WWP NNP B-NP B-problem
, , O O
multiple JJ B-NP B-problem
linear JJ I-NP I-problem
scars NNS I-NP I-problem
and CC O O
burns NNS B-NP B-problem
on IN B-VP I-problem
hands NNS B-NP I-problem
and CC O I-problem
arms NNS B-NP I-problem
Neuro NNP I-NP O
: : O O
Sedated VBN O B-treatment
, , O O
DTRs NNP B-NP B-test
: : O O
Skin NN B-NP O
: : O O
No DT B-NP O
rashes NNS I-NP B-problem
or CC O O
petechiae NN B-NP B-problem
, , O O
linear JJ O B-problem
and CC O I-problem
burn JJ B-NP I-problem
scars NNS I-NP I-problem
as IN B-VP O
above IN B-VP O
Pertinent NNP B-NP O
Results NNS I-NP O
: : O O
2014-04-23 JJ O O
07:56 CD O O
AM NNP B-NP O
WBC NNP I-NP B-test
- : O O
9.4 CD O O
# # O O
RBC NNP B-NP B-test
- : O O
4.75 CD O O
HGB NNP B-NP B-test
- : O O
14.7 CD O O
HCT NNP B-NP B-test
- : O O
42.2 CD O O
MCV NNP B-NP B-test
- : O O
89 CD O O
MCH NNP B-NP B-test
- : O O
30.9 CD O O
MCHC NNP B-NP B-test
- : O O
34.8 CD O O
RDW NNP B-NP B-test
- : O O
13.6 CD O O
2014-04-23 JJ O O
07:56 CD O O
AM NNP B-NP O
PLT NNP I-NP B-test
COUNT NNP I-NP I-test
- : O O
330 CD O O
2014-04-23 JJ O O
07:56 CD O O
AM NNP B-NP O
NEUTS NNP I-NP B-test
- : O O
73.0 CD O O
* NN B-NP O
LYMPHS NNP I-NP B-test
- : O O
21.8 CD O O
MONOS NNP B-NP B-test
- : O O
3.8 CD O O
EOS NNP B-NP B-test
- : O O
1.1 CD O O
BASOS NNP B-NP B-test
- : O O
0.3 CD O O
2014-04-23 JJ O O
07:56 CD O O
AM NNP B-NP O
ASA NNP I-NP B-test
- : O O
NEG NNP B-NP O
ETHANOL NNP I-NP B-test
- : O O
NEG NNP B-NP O
ACETMNPHN NNP I-NP B-test
- : O O
NEG NNP B-NP O
bnzodzpn SYM O B-test
- : O O
NEG NNP B-NP O
barbitrt SYM O B-test
- : O O
NEG NNP B-NP O
tricyclic JJ O B-test
- : O O
POS NNP B-NP O
2014-04-23 JJ O O
07:56 CD O O
AM NNP B-NP O
LITHIUM NNP I-NP B-test
- : O O
LESS JJR O O
THAN JJ O O
2014-04-23 JJ O O
07:56 CD O O
AM NNP B-NP O
DIGOXIN NNP I-NP B-test
-< NNP I-NP O
0.2 CD O O
* NNP B-NP O
2014-04-23 JJ O O
07:56 CD O O
AM NNP B-NP O
GLUCOSE NNP I-NP B-test
- : O O
116 CD O O
* JJ B-NP O
UREA NNP I-NP B-test
N NNP I-NP I-test
- : O O
14 CD O O
CREAT NNP B-NP B-test
- : O O
1.0 CD O O
SODIUM NNP B-NP B-test
- : O O
137 CD O O
POTASSIUM NNP B-NP B-test
- : O O
4.5 CD O O
CHLORIDE NNP B-NP B-test
- : O O
105 CD O O
TOTAL NNP B-NP B-test
CO2 NNP I-NP I-test
- : O O
20 CD O O
* JJ B-NP O
ANION NNP I-NP B-test
GAP NNP I-NP I-test
- : O O
17 CD O O
2014-04-23 JJ O O
07:56 CD O O
AM NNP B-NP O
CALCIUM NNP I-NP B-test
- : O O
9.7 CD O O
PHOSPHATE NNP B-NP B-test
- : O O
3.7 CD O O
MAGNESIUM NNP B-NP B-test
- : O O
2.1 CD O O
2014-04-23 JJ O O
07:56 CD O O
AM NNP B-NP O
ALT NNP I-NP B-test
( ( O I-test
SGPT NNP B-NP I-test
)- CD O I-test
21 CD O O
AST NNP B-NP B-test
( ( O I-test
SGOT NNP B-NP I-test
)- RB O O
40 CD O O
ALK NNP B-NP B-test
PHOS NNP I-NP I-test
- : O O
70 CD O O
AMYLASE NNP B-NP B-test
- : O O
59 CD O O
TOT NNP B-NP B-test
BILI NNP I-NP I-test
- : O O
0.4 CD O O
2014-04-23 JJ O O
07:56 CD O O
AM NNP B-NP O
LIPASE NNP I-NP B-test
- : O O
66 CD O O
* JJ O O
2014-04-23 JJ O O
08:00 CD O O
AM NNP B-NP O
URINE NNP I-NP B-test
BLOOD NNP I-NP B-test
- : O O
NEG NNP B-NP O
NITRITE NNP I-NP B-test
- : O O
NEG NNP B-NP O
PROTEIN NNP I-NP B-test
- : O O
NEG NNP B-NP O
GLUCOSE NNP I-NP B-test
- : O O
NEG NNP B-NP O
KETONE NNP I-NP B-test
- : O O
TR NNP B-NP O
BILIRUBIN NNP I-NP B-test
- : O O
NEG NNP B-NP O
UROBILNGN NNP I-NP B-test
- : O O
NEG NNP B-NP O
PH NNP I-NP B-test
- : O O
6.5 CD O O
LEUK NNP B-NP B-test
- : O O
NEG NNP B-NP O
2014-04-23 JJ O O
08:13 CD O O
AM NNP B-NP O
URINE NNP I-NP B-test
bnzodzpn SYM O B-test
- : O O
POS NNP B-NP O
barbitrt SYM O B-test
- : O O
NEG NN B-NP O
opiates VBZ O B-test
- : O O
NEG NNP B-NP O
cocaine NN I-NP B-test
- : O O
NEG NNP B-NP O
amphetmn SYM O B-test
- : O O
NEG NNP B-NP O
mthdone SYM O B-test
- : O O
NEG NNP B-NP O
2014-04-23 JJ O O
01:38 CD O O
PM NNP B-NP O
CK NNP I-NP B-test
( ( O I-test
CPK NNP B-NP I-test
)- JJ O I-test
4713 CD O O
* JJ O O
2014-04-23 JJ O O
03:45 CD O O
PM NNP B-NP O
URINE NNP I-NP B-test
UCG NNP I-NP B-test
- : O O
NEGATIVE JJ O O
2014-04-23 JJ O O
03:56 CD O O
PM NNP B-NP O
D-DIMER NNP I-NP B-test
- : O O
7998 CD O O
* JJ B-NP O
CXR NNP I-NP B-test
: : O O
Probable JJ B-NP O
ateletasis NN I-NP B-problem
of IN B-VP I-problem
lingula NN B-NP I-problem
, , O O
consistent JJ O O
with IN B-VP O
pneumonitis NN B-NP B-problem
EKG NN I-NP B-test
: : O O
NSR NNP B-NP O
R NNP I-NP B-test
60 CD O O
Normal NNP B-NP O
axis NN I-NP O
, , O O
intervals NNS B-NP O
, , O O
incomplete JJ B-NP B-problem
RBBB NNP I-NP I-problem
, , O O
flat JJ B-NP B-problem
T NNP I-NP I-problem
aVL NN I-NP I-problem
, , O O
V2 NNP B-NP O
, , O O
TWI NNP B-NP B-problem
V1 NNP I-NP I-problem
CT NNP I-NP B-test
Chest NNP I-NP I-test
- : O O
shows VBZ O O
bilateral JJ B-NP B-problem
segmental NN I-NP I-problem
, , O I-problem
subsegmental JJ B-NP I-problem
PEs NNP I-NP I-problem
B/L NNP I-NP B-test
LE NNP I-NP I-test
LENIs NNP I-NP I-test
- : O O
negative JJ B-NP O
Brief JJ I-NP O
Hospital JJ I-NP O
Course NN I-NP O
: : O O
CMED NNP B-NP O
CSRU NNP I-NP O
Course NNP I-NP O
: : O O
Patient NN B-NP B-person
was VBD B-VP O
intubated VBN O O
in IN B-VP O
John NNP B-NP O
for IN B-VP O
airway NN B-NP O
protection NN I-NP O
and CC O O
administation NN B-NP O
of IN B-VP O
charcoal NN B-NP B-treatment
. . B-VP O
   
Toxicology NNP B-NP B-person
consulted VBD B-VP O
and CC O O
felt VBD B-VP O
that DT B-NP B-pronoun
patient NN I-NP B-person
most RBS O O
likely JJ O O
had VBD B-VP O
benzo VBN O B-problem
overdose RB O I-problem
. . B-VP O
   
ABG NNP B-NP B-test
revealed VBD B-VP O
widened VBD B-VP B-problem
A-a NNP B-NP I-problem
gradient NN I-NP I-problem
so RB O O
a DT B-NP B-test
d-dimer NN I-NP I-test
was VBD B-VP O
sent VBN O O
which WDT O B-pronoun
was VBD B-VP O
elevated VBN O B-problem
. . B-VP O
   
Patient NNP B-NP B-person
had VBD B-VP O
CTA NNP B-NP B-test
which WDT O B-pronoun
showed VBD B-VP O
bilateral JJ B-NP B-problem
pulmonary JJ I-NP I-problem
embolisms NNS I-NP I-problem
. . B-VP O
   
Patient NNP B-NP B-person
was VBD B-VP O
started VBN O O
on IN B-VP O
heparin NN B-NP B-treatment
drip NN I-NP I-treatment
and CC O O
bilateral JJ B-NP B-test
lower JJR I-NP I-test
extremeties NNS I-NP I-test
were VBD B-VP O
done VBN O O
which WDT O B-pronoun
were VBD B-VP O
negative JJ O O
for IN B-VP O
DVT NNP B-NP B-problem
. . B-VP O
   
Patient NNP B-NP B-person
was VBD B-VP O
exubated VBN O O
after IN B-VP O
1 CD O O
day NN B-NP O
in IN B-VP O
ICU NNP B-NP O
after IN B-VP O
waking VBG O O
up RP O O
. . B-VP O
   
Overnight NNP B-NP O
in IN B-VP O
the DT B-NP O
ICU NNP I-NP O
patient NN I-NP B-person
was VBD B-VP O
noticed VBN O O
to TO O O
have VB O O
painful JJ B-NP B-problem
bullae NN I-NP I-problem
on IN B-VP I-problem
hands NNS B-NP I-problem
and CC O I-problem
arm NN B-NP I-problem
along IN B-VP O
with IN B-VP O
swelling VBG O B-problem
. . B-VP O
   
Dermatology NNP B-NP B-person
and CC O O
plastic NN B-NP B-person
surgery NN I-NP I-person
were VBD B-VP O
consulted VBN O O
who WP O B-person
felt VBD B-VP O
that IN B-VP B-pronoun
symptoms NNS B-NP B-problem
were VBD B-VP O
due JJ O O
to TO O O
trauma VB O B-problem
; : O O
it PRP O B-pronoun
was VBD B-VP O
not RB O O
felt VBN O O
that IN B-VP B-pronoun
patient NN B-NP B-person
had VBD B-VP O
compartment JJ B-NP B-problem
syndrome NN I-NP I-problem
. . B-VP O
   
Patient NNP B-NP B-person
was VBD B-VP O
splinted VBN O O
and CC O O
UE NNP B-NP O
were VBD B-VP O
kept VBN O O
elevated VBN O O
. . B-VP O
   
Patient NNP B-NP B-person
was VBD B-VP O
gradually RB O O
put VBN O O
back RP O O
on IN B-VP O
her PRP$ O B-person
her PRP$ O B-treatment
outpatient JJ B-NP I-treatment
xanax NN I-NP I-treatment
dose NN I-NP I-treatment
of IN B-VP O
1 CD O O
mg NNS B-NP O
qid NN I-NP O
and CC O O
clozaril NN B-NP B-treatment
was VBD B-VP O
restarted VBN O O
. . B-VP O
   
Patient NNP B-NP B-person
was VBD B-VP O
transferred VBN O O
to TO O O
floor NN B-NP O
after IN B-VP O
spending VBG O O
1 CD O O
day NN B-NP O
in IN B-VP O
the DT B-NP O
ICU NNP I-NP O
. . B-VP O
   
Once RB O O
on IN B-VP O
the DT B-NP O
floor NN I-NP O
patient NN I-NP B-person
stable JJ O O
. . B-VP O
   
Plastic NN B-NP B-person
did VBD B-VP O
not RB O O
feel VB O O
that IN B-VP B-pronoun
patient NN B-NP B-person
had VBD B-VP O
any DT B-NP B-problem
compartment JJ I-NP I-problem
syndrome NN I-NP I-problem
and CC O O
recommended VBD B-VP O
aggresive JJ B-NP B-treatment
upper JJ I-NP I-treatment
extremity NN I-NP I-treatment
elevation NN I-NP I-treatment
for IN B-VP O
swelling VBG O B-treatment
reduction NN B-NP I-treatment
. . B-VP O
   
While IN B-VP O
on IN B-VP O
the DT B-NP O
floor NN I-NP O
patient NN I-NP B-person
's POS O O
hands NNS B-NP O
improved VBN O O
with IN B-VP O
good JJ B-NP O
range NN I-NP O
of IN B-VP O
motion NN B-NP O
of IN B-VP O
left JJ B-NP O
hand NN I-NP O
, , O O
however RB O O
Jones NNP B-NP O
some DT B-NP B-problem
poor JJ I-NP I-problem
range NN I-NP I-problem
of IN B-VP I-problem
motion NN B-NP I-problem
of IN B-VP O
right JJ O O
. . B-VP O
   
X-ray NN B-NP B-test
of IN B-VP I-test
the DT B-NP I-test
hands NNS I-NP I-test
and CC O I-test
wrist NN B-NP I-test
were VBD B-VP O
obtained VBN O O
which WDT O B-pronoun
were VBD B-VP O
negative JJ O O
. . B-VP O
   
Patient NNP B-NP B-person
seen VBN O O
by IN B-VP O
PT NNP B-NP B-person
and CC O O
OT NNP B-NP B-person
who WP O B-person
recommended VBD B-VP O
hand NN B-NP B-treatment
exercises NNS I-NP I-treatment
and CC O O
splints NNS B-NP B-treatment
for IN B-VP O
patient NN B-NP B-person
. . B-VP O
   
Patient NN B-NP B-person
was VBD B-VP O
put VBN O O
on IN B-VP O
coumadin NN B-NP B-treatment
that WDT O B-pronoun
was VBD B-VP O
bridged VBN O O
with IN B-VP O
lovenox JJ B-NP B-treatment
unti JJ I-NP O
lINR JJ I-NP B-treatment
theraputic JJ I-NP I-treatment
01-23 NN I-NP O
. . B-VP O
   
Patient NNP B-NP B-person
conitnued VBD B-VP O
to TO O O
have VB O O
SI NNP B-NP B-problem
while IN B-VP O
on IN B-VP O
floor NN B-NP O
and CC O O
was VBD B-VP O
transferred VBN O O
to TO O O
psychiatry VB O O
. . B-VP O
   
While IN B-VP O
on IN B-VP O
the DT B-NP O
floor NN I-NP O
patient JJ B-NP B-person
patient NN I-NP B-test
's POS O I-test
urinalysis JJ B-NP I-test
suggestive NN I-NP O
of IN B-VP O
UTI NNP B-NP B-problem
and CC O O
was VBD B-VP O
put VBN O O
on IN B-VP O
6 CD O O
day NN B-NP O
course NN I-NP O
of IN B-VP O
levofloxacin NN B-NP B-treatment
. . B-VP O
   
Medications NNS B-NP O
on IN B-VP O
Admission NN B-NP O
: : O O
Propanolol NNP B-NP B-treatment
XL NNP I-NP I-treatment
80 CD O O
mg NN B-NP O
qd VBD B-VP O
Modifinal NNP B-NP B-treatment
100 CD O O
mg NN B-NP O
po NN I-NP O
qd NN I-NP O
Lamictal NNP I-NP B-treatment
100 CD O O
mg NN B-NP O
po NN I-NP O
bid NN I-NP O
Alprazolam NNP I-NP B-treatment
1 CD O O
mg NN B-NP O
po NN I-NP O
qid NN I-NP O
Senna NNP I-NP B-treatment
Trazadone NNP I-NP B-treatment
200 CD O O
mg NN B-NP O
po NN I-NP O
qhs NN I-NP O
Clomipramine NNP I-NP B-treatment
100 CD O O
mg NN B-NP O
po NN I-NP O
qhs NN I-NP O
Pantopraozle NNP I-NP B-treatment
40 CD O O
mg NN B-NP O
po NN I-NP O
qd NN I-NP O
Clozapine NNP I-NP B-treatment
300 CD O O
mg NN B-NP O
po NN I-NP O
qhs NN I-NP O
Folate NNP I-NP B-treatment
1 CD O O
mg NN B-NP O
po NN I-NP O
qd NN I-NP O
Multivitamin NNP I-NP B-treatment
Discharge NNP I-NP O
Medications NNP I-NP O
: : O O
1. CD O O
Acetaminophen NNP B-NP B-treatment
325 CD O O
mg NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
1-2 JJ B-NP O
Tablets NNS I-NP O
PO NNP I-NP O
Q4-6H NNP I-NP O
( ( O O
every DT O O
4 CD O O
to TO O O
6 CD O O
hours NNS B-NP O
) ) O O
as IN B-VP O
needed VBN O O
. . B-VP O
   
2. CD O O
Lamotrigine JJ O B-treatment
100 CD O O
mg JJ B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Tablet NNP B-NP O
PO NNP I-NP O
BID NNP I-NP O
( ( O O
2 CD O O
times NNS B-NP O
a DT B-NP O
day NN I-NP O
) ) O O
. . B-VP O
   
3. CD O O
Pantoprazole NNP B-NP B-treatment
Sodium NNP I-NP I-treatment
40 CD O O
mg NN B-NP O
Tablet NNP I-NP O
, , O O
Delayed NNP B-NP O
Release NNP I-NP O
( ( O O
E.C. NNP B-NP O
) ) O O
Sig NN B-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Tablet NN B-NP O
, , O O
Delayed NNP B-NP O
Release NNP I-NP O
( ( O O
E.C. NNP B-NP O
) ) O O
PO NNP B-NP O
Q24H NNP I-NP O
( ( O O
every DT O O
24 CD O O
hours NNS B-NP O
) ) O O
. . B-VP O
   
4. CD O O
Folic NNP B-NP B-treatment
Acid NNP I-NP I-treatment
1 CD O O
mg NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Tablet NNP B-NP O
PO NNP I-NP O
DAILY NNP I-NP O
( ( O O
Daily NNP B-NP O
) ) O O
. . B-VP O
   
5. CD O O
Multivitamin NNP B-NP B-treatment
Capsule NNP I-NP I-treatment
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Cap NNP B-NP O
PO NNP I-NP O
DAILY NNP I-NP O
( ( O O
Daily NNP B-NP O
) ) O O
. . B-VP O
   
6. CD O O
Senna NNP B-NP B-treatment
8.6 CD O O
mg NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Tablet NNP B-NP O
PO NNP I-NP O
BID NNP I-NP O
( ( O O
2 CD O O
times NNS B-NP O
a DT B-NP O
day NN I-NP O
) ) O O
. . B-VP O
   
7. CD O O
Clozapine NNP B-NP B-treatment
25 CD O O
mg NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Tablet NNP B-NP O
PO NNP I-NP O
HS NNP I-NP O
( ( O O
at IN B-VP O
bedtime NN B-NP O
) ) O O
. . B-VP O
   
8. CD O O
Warfarin NNP B-NP B-treatment
Sodium NNP I-NP I-treatment
3 CD O O
mg NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Tablet NN B-NP O
PO NNP I-NP O
at IN B-VP O
bedtime NN B-NP O
. . B-VP O
   
9. CD O O
Docusate NNP B-NP B-treatment
Sodium NNP I-NP I-treatment
100 CD O O
mg NN B-NP O
Capsule NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Capsule NNP B-NP O
PO NNP I-NP O
BID NNP I-NP O
( ( O O
2 CD O O
times NNS B-NP O
a DT B-NP O
day NN I-NP O
) ) O O
. . B-VP O
   
10. CD O O
Trazodone NNP B-NP B-treatment
HCl NNP I-NP I-treatment
100 CD O O
mg NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
Two CD O O
( ( O O
2 CD O O
) ) O O
Tablet NNP B-NP O
PO NNP I-NP O
HS NNP I-NP O
( ( O O
at IN B-VP O
bedtime NN B-NP O
) ) O O
as IN B-VP O
needed VBN O O
. . B-VP O
   
11. CD O O
Alprazolam NNP B-NP B-treatment
1 CD O O
mg NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Tablet NNP B-NP O
PO NNP I-NP O
QID NNP I-NP O
( ( O O
4 CD O O
times NNS B-NP O
a DT B-NP O
day NN I-NP O
) ) O O
. . B-VP O
   
12. CD O O
Levofloxacin NNP B-NP B-treatment
500 CD O O
mg NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Tablet NNP B-NP O
PO NNP I-NP O
Q24H NNP I-NP O
( ( O O
every DT O O
24 CD O O
hours NNS B-NP O
) ) O O
for IN B-VP O
3 CD O O
days NNS B-NP O
. . B-VP O
   
13. CD O O
Bisacodyl NNP B-NP B-treatment
5 CD O O
mg NN B-NP O
Tablet NNP I-NP O
, , O O
Delayed NNP B-NP O
Release NNP I-NP O
( ( O O
E.C. NNP B-NP O
) ) O O
Sig NNP B-NP O
: : O O
Two CD O O
( ( O O
2 CD O O
) ) O O
Tablet NN B-NP O
, , O O
Delayed NNP B-NP O
Release NNP I-NP O
( ( O O
E.C. NNP B-NP O
) ) O O
PO NNP B-NP O
DAILY NNP I-NP O
( ( O O
Daily NNP B-NP O
) ) O O
as IN B-VP O
needed VBN O O
. . B-VP O
   
14. CD O O
Nicotine JJ O B-treatment
14 CD O O
mg NN B-NP O
/ VBD B-VP O
24 CD O O
hr NN B-NP O
Patch NNP I-NP O
24 CD O O
HR NNP B-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Patch VB O O
24 CD O O
HR NNP B-NP O
Transdermal NNP I-NP O
DAILY NNP I-NP O
( ( O O
Daily NNP B-NP O
) ) O O
. . B-VP O
   
Discharge NNP B-NP O
Disposition NNP I-NP O
: : O O
Extended VBN O O
Care NNP B-NP O
Discharge NNP I-NP O
Diagnosis NNP I-NP O
: : O O
Benzodiazapine NNP B-NP B-problem
Overdose NNP I-NP I-problem
Traumatic NNP I-NP B-problem
/ NNP I-NP I-problem
pressure NN I-NP I-problem
bullae NN I-NP I-problem
Bipolar NNP I-NP B-problem
Disorder NNP I-NP I-problem
Discharge NNP I-NP O
Condition NNP I-NP O
: : O O
Stable JJ O O
- : O O
Swelling VBG O B-problem
in IN B-VP I-problem
hands NNS B-NP I-problem
reduced VBN O O
and CC O O
range NN B-NP O
of IN B-VP O
motion NN B-NP O
continue NN I-NP O
to TO O O
improve VB O O
. . B-VP O
   
Discharge NNP B-NP O
Instructions NNPS I-NP O
: : O O
Please NNP B-NP O
continue VB O O
to TO O O
take VB O O
coumadin NN B-NP B-treatment
as IN B-VP O
directed VBN O O
by IN B-VP O
your PRP$ O B-person
your PRP$ O B-person
doctors NNS B-NP I-person
until IN B-VP O
told VBN O O
to TO O O
stop VB O O
for IN B-VP O
clots NNS B-NP B-problem
found VBN O O
in IN B-VP O
your PRP$ O B-person
lungs NNS B-NP O
. . B-VP O
   
Please NNP B-NP O
continue VBP O O
to TO O O
take VB O O
antibiotics NNS B-NP B-treatment
as IN B-VP O
directed VBN O O
for IN B-VP O
urinary JJ B-NP B-problem
tract NN I-NP I-problem
infection NN I-NP I-problem
for IN B-VP O
3 CD O O
more JJR B-NP O
days NNS I-NP O
. . B-VP O
   
Please NNP B-NP O
conitnue NN I-NP O
to TO O O
keep VB O O
hands NNS B-NP O
elevated VBN O O
in IN B-VP O
bed NN B-NP O
until IN B-VP O
follow VB O O
up RP O O
appointment NN B-NP O
with IN B-VP O
plastic NN B-NP B-person
surgery NN I-NP I-person
. . B-VP O
   
Followup NNP B-NP O
Instructions NNPS I-NP O
: : O O
Patient NN B-NP B-person
will MD O O
be VB O O
admitted VBN O O
to TO O O
psychiatry VB O O
service NN B-NP O
Patient NNP I-NP B-person
should MD O O
follow VB O O
up RP O O
with IN B-VP O
at IN B-VP O
plastic NN B-NP O
surgery NN I-NP O
clinic NN I-NP O
in IN B-VP O
2 CD O O
weeks NNS B-NP O
. . B-VP O
   
Appointment NNP B-NP O
setup NN I-NP O
for IN B-VP O
Tues. NNP B-NP O
05-13 NN I-NP O
at IN B-VP O
10 CD O O
am VBP O O
. . B-VP O
   
3rd CD O O
floor NN B-NP O
Henderson NNP I-NP O
Building NNP I-NP O
with IN B-VP O
Dr. NNP B-NP B-person
Black NNP I-NP I-person
( ( O O
650 CD O O
) ) O O
866-1361 CD O O
Raymond NNP B-NP B-person
William NNP I-NP I-person
MD NNP I-NP I-person
50-154 JJ O O
Completed VBN O O
by IN B-VP O
: : O O
Simon NNP B-NP B-person
Claudine NNP I-NP I-person
Audrey NNP I-NP I-person
MD NNP I-NP I-person
82-812 JJ B-NP O
2014-04-28 JJ I-NP O
@ NN I-NP O
1227 CD O O
Signed NNP B-NP O
electronically RB O O
by IN B-VP O
: : O O
DR. NNP B-NP B-person
Tracey NNP I-NP I-person
Mccourtney NNP I-NP I-person
on IN B-VP O
: : O O
MON NNP B-NP O
2014-05-05 CD O O
10:26 CD O O
PM NNP B-NP O
( ( O O
End NNP B-NP O
of IN B-VP O
Report NNP B-NP O
) ) O O
-EMPTYLINE- VBP O O
-DOCSTART- JJ O O
-EMPTYLINE- $ O O
316810105 CD O O
BH NNP B-NP O
5442905 CD O O
550393 CD O O
03/17/2003 CD O O
12:00:00 CD O O
AM NNP B-NP O
ED NNP I-NP O
Discharge NNP I-NP O
Summary NNP I-NP O
Unsigned VBD B-VP O
DIS NNP B-NP O
Report NNP I-NP O
Status NNP I-NP O
: : O O
Unsigned VBD B-VP O
ED NNP B-NP O
DISCHARGE NNP I-NP O
NOTIFICATION NNP I-NP O
KAYSLANCE NNP I-NP B-person
, , O I-person
ICEROYLN NNP B-NP I-person
MRN NNP I-NP O
: : O O
5442905 CD O O
Age NNP B-NP O
: : O O
58y CD O O
REGISTRATION NNP B-NP O
DATE NNP I-NP O
: : O O
03/17/2003 CD O O
02:52 CD O O
AM NNP B-NP O
PRELIMINARY NNP I-NP O
REPORT NNP I-NP O
This DT O B-pronoun
is VBZ O O
to TO O O
notify VB O O
you PRP O B-person
that IN B-VP B-pronoun
your PRP$ O B-person
your PRP$ O B-person
patient NN B-NP I-person
, , O O
KAYSLANCE NNP B-NP B-person
, , O I-person
ICEROYLN NNP B-NP I-person
arrived VBD B-VP O
in IN B-VP O
the DT B-NP O
Emergency NNP I-NP O
Department NNP I-NP O
at IN B-VP O
Bri NNP B-NP O
Health NNP I-NP O
on IN B-VP O
03/17/2003 CD O O
02:52 CD O O
AM NNP B-NP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
presented VBN O O
with IN B-VP O
a DT B-NP O
chief JJ I-NP O
complaint NN I-NP O
of IN B-VP O
LEFT NNP B-NP B-problem
LEG NNP I-NP I-problem
FX NNP I-NP I-problem
HIP NNP I-NP I-problem
. . B-VP O
   
Following VBG O O
evaluation NN B-NP B-test
and CC O O
treatment NN B-NP B-treatment
, , O O
the DT B-NP B-person
patient NN I-NP I-person
&apos;s JJ B-NP O
disposition NN I-NP O
at IN B-VP O
the DT B-NP O
end NN I-NP O
ofthe NN I-NP O
visit NN I-NP O
was VBD B-VP O
ADMITTED NNP B-NP O
AS IN B-VP O
AN NNP B-NP O
INPATIENT NNP I-NP O
TO NNP I-NP O
BRI NNP I-NP O
HEALTH NNP I-NP O
. . B-VP O
   
The DT O B-person
The DT B-NP B-person
patient JJ I-NP I-person
patient NN I-NP I-person
&apos;s NNP I-NP I-person
preliminary JJ O I-person
admitting VBG O I-person
physician NN B-NP I-person
is VBZ O O
HEAGLEINCHIRD NNP B-NP B-person
, , O I-person
JEANSIA NNP B-NP I-person
S NNP I-NP I-person
and CC O O
the DT B-NP O
preliminary JJ I-NP O
diagnosis NN I-NP O
is VBZ O O
HIP NNP B-NP B-problem
FRACTURE NNP I-NP I-problem
. . B-VP O
   
Please NNP B-NP O
note VB O O
this DT B-NP B-pronoun
information NN I-NP O
may MD O O
have VB O O
been VBN O O
updated VBN O O
on IN B-VP O
the DT B-NP O
inpatient JJ I-NP O
unit NN I-NP O
. . B-VP O
   
If IN B-VP O
you PRP O B-person
need VBP O O
additional JJ B-NP O
information NN I-NP O
please NN I-NP O
call VB O O
442-025-0303 JJ O O
. . B-VP O
   
PCP NNPS B-NP B-person
Name NN I-NP O
: : O O
NONE NN B-NP O
, , O O
PHYSICIAN NNP B-NP O
Provider NNP I-NP O
Number NNP I-NP O
: : O O
27715 CD O O
-EMPTYLINE- NN B-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
Admission NNP I-NP O
Date NNP I-NP O
: : O O
2010-09-06 JJ B-NP O
Discharge NN I-NP O
Date NNP I-NP O
: : O O
2010-09-17 JJ B-NP O
Date NNP I-NP O
of IN B-VP O
Birth NNP B-NP O
: : O O
1968-04-26 JJ B-NP O
Sex NN I-NP O
: : O O
M NNP B-NP O
Service NNP I-NP O
: : O O
ADDENDUM NN B-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
extubated VBN O O
overnight RB O O
without IN B-VP O
incident NN B-NP B-problem
. . B-VP O
   
He PRP O B-person
had VBD B-VP O
a DT B-NP O
good JJ I-NP O
cardiac NN I-NP O
index NN I-NP O
off IN B-VP O
all DT B-NP B-treatment
inotropic JJ I-NP I-treatment
medications NNS I-NP I-treatment
and CC O O
his PRP$ O B-person
his PRP$ O B-treatment
Swan-Ganz JJ B-NP I-treatment
catheter NN I-NP I-treatment
was VBD B-VP O
discontinued VBN O O
. . B-VP O
   
The DT B-NP B-person
patient JJ I-NP I-person
underwent NN I-NP O
an DT B-NP B-treatment
exchange NN I-NP I-treatment
peritoneal JJ B-NP I-treatment
dialysis NN I-NP I-treatment
. . B-VP O
   
The DT B-NP O
Parrack NNP I-NP O
Diabetes NNP I-NP O
Center NNP I-NP O
was VBD B-VP O
consulted VBN O O
to TO O O
help VB O O
manage VB O O
the DT O B-problem
the DT B-NP B-person
patient JJ I-NP I-problem
patient NN I-NP I-person
's POS O I-problem
hyperglycemia NN B-NP I-problem
. . B-VP O
   
By IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
two CD O O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
had VBD B-VP O
remained VBN O O
in IN B-VP O
sinus NN B-NP O
rhythm NN I-NP O
and CC O O
his PRP$ O B-treatment
his PRP$ O B-person
Lopressor NNP B-NP I-treatment
was VBD B-VP O
increased VBN O O
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
having VBG O O
a DT B-NP O
bit NN I-NP O
of IN B-VP O
a DT B-NP B-problem
respiratory JJ I-NP I-problem
acidosis NN I-NP I-problem
, , O O
therefore RB O O
, , O O
bicarbonate NN B-NP B-treatment
was VBD B-VP O
added VBN O O
to TO O O
the DT B-NP B-treatment
dialysate NN I-NP I-treatment
. . B-VP O
   
His PRP$ O B-person
His PRP$ O B-treatment
mediastinal JJ B-NP I-treatment
chest NN I-NP I-treatment
tubes NNS I-NP I-treatment
were VBD B-VP O
removed VBN O O
, , O O
however RB O O
, , O O
his PRP$ O B-person
his PRP$ O B-treatment
pleural JJ B-NP I-treatment
chest NN I-NP I-treatment
tubes NNS I-NP I-treatment
remained VBN O O
in IN B-VP O
place NN B-NP O
. . B-VP O
   
On IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
three CD O O
, , O O
it PRP O B-pronoun
was VBD B-VP O
apparent JJ O O
that IN B-VP B-pronoun
, , O O
despite IN B-VP O
an DT B-NP B-test
oxygen NN I-NP I-test
saturation NN I-NP I-test
of IN B-VP O
99% CD O O
on IN B-VP O
three CD O O
liters NNS B-NP O
, , O O
that IN B-VP B-pronoun
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
still RB O O
in IN B-VP O
a DT B-NP B-problem
respiratory JJ I-NP I-problem
acidosis NN I-NP I-problem
, , O O
and CC O O
he PRP O B-person
received VBD B-VP O
aggressive JJ B-NP B-treatment
pulmonary JJ I-NP I-treatment
toilette NN I-NP I-treatment
. . B-VP O
   
His PRP$ O B-treatment
His PRP$ O B-person
pleural JJ B-NP I-treatment
chest NN I-NP I-treatment
tubes NNS I-NP I-treatment
were VBD B-VP O
removed VBN O O
. . B-VP O
   
On IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
four CD O O
, , O O
the DT O B-treatment
the DT B-NP B-person
patient JJ I-NP I-treatment
patient NN I-NP I-person
Cordis NNP I-NP I-treatment
was VBD B-VP O
removed VBN O O
. . B-VP O
   
His PRP$ O B-treatment
His PRP$ O B-person
Lopressor NNP B-NP I-treatment
was VBD B-VP O
increased VBN O O
another DT B-NP O
increment NN I-NP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
subsequently RB O O
transferred VBN O O
to TO O O
the DT B-NP O
floor NN I-NP O
on IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
five CD O O
in IN B-VP O
stable JJ O O
and CC O O
good JJ B-NP O
condition NN I-NP O
. . B-VP O
   
Once RB O O
on IN B-VP O
the DT B-NP O
floor NN I-NP O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
had VBD B-VP O
an DT B-NP O
uneventful JJ I-NP O
hospital NN I-NP O
course NN I-NP O
, , O O
remaining VBG O O
afebrile NN B-NP B-problem
for IN B-VP O
the DT B-NP O
remainder NN I-NP O
of IN B-VP O
his PRP$ O B-person
hospital NN B-NP O
stay NN I-NP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
's POS O O
only JJ B-NP O
issue NN I-NP O
was VBD B-VP O
his PRP$ O B-problem
his PRP$ O B-person
hypertension NN B-NP I-problem
. . B-VP O
   
On IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
seven CD O O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
had VBD B-VP O
a DT B-NP B-test
peak JJ I-NP I-test
blood NN I-NP I-test
pressure NN I-NP I-test
of IN B-VP O
210/100 CD O O
. . B-VP O
   
The DT B-NP O
decision NN I-NP O
was VBD B-VP O
made VBN O O
to TO O O
start VB O O
the DT B-NP B-person
patient NN I-NP I-person
on IN B-VP O
lisinopril NN B-NP B-treatment
, , O O
and CC O O
the DT B-NP O
initial JJ I-NP O
dose NN I-NP O
of IN B-VP O
7.5 CD O O
mg NN B-NP O
was VBD B-VP O
increased VBN O O
to TO O O
10 CD O O
mg NNS B-NP O
daily RB O O
by IN B-VP O
the DT B-NP O
day NN I-NP O
of IN B-VP O
discharge NN B-NP O
in IN B-VP O
order NN B-NP O
to TO O O
control VB O O
his PRP$ O B-person
his PRP$ O B-test
pressure NN B-NP I-test
more RBR O O
tightly RB O O
. . B-VP O
   
On IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
seven CD O O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
refusing VBG O O
to TO O O
be VB O O
discharged VBN O O
to TO O O
a DT B-NP O
rehabilitation NN I-NP O
facility NN I-NP O
despite IN B-VP O
his PRP$ O B-person
doctor NN B-NP O
's POS O O
insistence NN B-NP O
that IN B-VP B-pronoun
he PRP O B-person
would MD O O
do VB O O
much RB O O
better RBR O O
in IN B-VP O
an DT B-NP O
assisted JJ I-NP O
environment NN I-NP O
. . B-VP O
   
Nevertheless NNP B-NP O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
adamant JJ O O
about IN B-VP O
going VBG O O
home NN B-NP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
discharged VBN O O
on IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
seven CD O O
and CC O O
arrangements NNS B-NP O
were VBD B-VP O
made VBN O O
to TO O O
have VB O O
physical JJ B-NP B-person
therapy NN I-NP I-person
perform NN I-NP O
a DT B-NP B-test
home NN I-NP I-test
safety NN I-NP I-test
evaluation NN I-NP I-test
for IN B-VP O
the DT B-NP B-person
patient NN I-NP I-person
, , O O
to TO O O
which WDT O B-pronoun
he PRP O B-person
agreed VBD B-VP O
. . B-VP O
   
DISCHARGE NNP B-NP O
DIAGNOSIS NNP I-NP O
: : O O
Coronary JJ B-NP B-problem
artery NN I-NP I-problem
disease NN I-NP I-problem
, , O O
status NN B-NP O
post NN I-NP O
coronary JJ B-NP B-treatment
artery NN I-NP I-treatment
bypass NN I-NP I-treatment
grafting VBG O I-treatment
times NNS B-NP O
three CD O O
. . B-VP O
   
DISCHARGE JJ B-NP O
MEDICATIONS NNP I-NP O
: : O O
Lopressor NNP B-NP B-treatment
100 CD O O
mg NN B-NP O
p.o.b.i.d. NN I-NP O
Lisinopril NNP I-NP B-treatment
10 CD O O
mg NN B-NP O
p.o.q.d. NN I-NP O
Lipitor NNP I-NP B-treatment
10 CD O O
mg NN B-NP O
p.o.q.d. NN I-NP O
Aspirin NNP I-NP B-treatment
81 CD O O
mg NN B-NP O
p.o.q.d. NN I-NP O
Percocet NNP I-NP B-treatment
one CD O O
to TO O O
two CD O O
tablets NNS B-NP O
p.o.q. VBP O O
3-4 JJ B-NP O
h. NN I-NP O
p.r.n. NN I-NP O
pain NN I-NP B-problem
. . B-VP O
   
Colace NNP B-NP B-treatment
100 CD O O
mg NN B-NP O
p.o.b.i.d. NN I-NP O
DISCHARGE NNP I-NP O
PHYSICAL NNP I-NP O
EXAMINATION NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
had VBD B-VP O
a DT B-NP B-test
temperature NN I-NP I-test
of IN B-VP O
98.4 CD O O
, , O O
heart NN B-NP B-test
rate NN I-NP I-test
72 CD O O
, , O O
blood NN B-NP B-test
pressure NN I-NP I-test
154/89 CD O O
, , O O
respiratory NN B-NP B-test
rate NN I-NP I-test
18 CD O O
and CC O O
oxygen JJ B-NP B-test
saturation NN I-NP I-test
90% CD O O
in IN B-VP O
room NN B-NP O
air NN I-NP O
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
alert JJ O O
and CC O O
oriented VBN O O
. . B-VP O
   
His PRP$ O B-person
neck NN B-NP O
was VBD B-VP O
supple RB O O
without IN B-VP O
lymphadenopathy NN B-NP B-problem
. . B-VP O
   
He PRP O B-person
had VBD B-VP O
faint NN B-NP B-problem
bibasilar JJ B-NP I-problem
crackles NNS I-NP I-problem
on IN B-VP O
lung NN B-NP B-test
examination NN I-NP I-test
. . B-VP O
   
His PRP$ O B-person
heart NN B-NP O
had VBD B-VP O
a DT B-NP O
regular JJ I-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
with IN B-VP O
no DT B-NP O
murmur NN I-NP B-problem
, , O O
rub NN B-NP B-problem
or CC O O
gallop NN B-NP B-problem
. . B-VP O
   
His PRP$ O B-person
abdomen NNS B-NP O
was VBD B-VP O
soft JJ O O
, , O O
nontender NN B-NP B-problem
and CC O O
nondistended VBN O B-problem
with IN B-VP O
a DT B-NP B-problem
nonerythematous JJ I-NP I-problem
peritoneal JJ I-NP I-problem
dialysis NN I-NP I-problem
insertion NN I-NP I-problem
site NN I-NP I-problem
. . B-VP O
   
Extremities NNS B-NP O
were VBD B-VP O
warm JJ O O
and CC O O
well RB O O
perfused VBN O O
. . B-VP O
   
DR NNP B-NP B-person
. . B-VP I-person
   
Kemp NNP B-NP I-person
, , O I-person
Julie NNP B-NP I-person
R. NNP I-NP I-person
02-358 NNP I-NP O
Dictated VBN O O
By IN B-VP O
: : O O
Judy NNP B-NP B-person
Y NNP I-NP I-person
Carnevale NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
MEDQUIST36 NNP I-NP O
D NNP I-NP O
: : O O
2010-09-18 JJ O O
19:42 CD O O
T NN B-NP O
: : O O
2010-09-22 JJ O O
11:10 CD O O
JOB NNP B-NP O
# # O O
: : O O
34822 CD O O
Signed VBN O O
electronically RB O O
by IN B-VP O
: : O O
DR. NNP B-NP B-person
Dalila NNP I-NP I-person
Talbot NNP I-NP I-person
on IN B-VP O
: : O O
Robert NNP B-NP O
2010-09-23 CD O O
4:07 CD O O
PM NNP B-NP O
( ( O O
End NNP B-NP O
of IN B-VP O
Report NNP B-NP O
) ) O O
-EMPTYLINE- VBP O O
-DOCSTART- JJ B-NP O
-EMPTYLINE- NNP I-NP O
Admission NNP I-NP O
Date NNP I-NP O
: : O O
2015-06-04 JJ B-NP O
Discharge NN I-NP O
Date NNP I-NP O
: : O O
2015-06-08 JJ B-NP O
Date NNP I-NP O
of IN B-VP O
Birth NNP B-NP O
: : O O
1958-03-17 JJ B-NP O
Sex NN I-NP O
: : O O
F NNP B-NP O
Service NNP I-NP O
: : O O
CCU NNP B-NP O
HISTORY NNP I-NP O
OF IN B-VP O
THE NNP B-NP O
PRESENT NNP I-NP O
ILLNESS NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
is VBZ O O
a DT O O
57 JJ O O
- : O O
year-old JJ B-NP O
female NN I-NP O
with IN B-VP O
a DT B-NP O
history NN I-NP O
of IN B-VP O
hypertension NN B-NP B-problem
and CC O O
hypercholesterolemia NN B-NP B-problem
but CC O O
no DT B-NP O
prior JJ I-NP B-problem
coronary JJ I-NP I-problem
artery NN I-NP I-problem
disease NN I-NP I-problem
history NN I-NP I-problem
who WP O B-person
presented VBD B-VP O
with IN B-VP O
chest NN B-NP B-problem
pain NN I-NP I-problem
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
reports VBZ O O
the DT B-NP B-problem
pain NN I-NP I-problem
began VBD B-VP O
at IN B-VP O
4:00 CD O O
p.m. NN B-NP O
on IN B-VP O
the DT B-NP O
day NN I-NP O
of IN B-VP O
admission NN B-NP O
. . B-VP O
   
She PRP O B-person
reports VBZ O O
that IN B-VP B-pronoun
it PRP O B-pronoun
had VBD B-VP O
essentially RB O O
started VBN O O
earlier RBR O O
in IN B-VP O
the DT B-NP O
day NN I-NP O
with IN B-VP O
some DT B-NP B-problem
GERD-like NNP I-NP I-problem
symptoms NNS I-NP I-problem
. . B-VP O
   
She PRP O B-person
had VBD B-VP O
taken VBN O O
Maalox NNP B-NP B-treatment
but CC O O
had VBD B-VP O
no DT B-NP O
relief NN I-NP O
with IN B-VP O
this DT O B-pronoun
. . B-VP O
   
The DT B-NP B-problem
pain NN I-NP I-problem
was VBD B-VP O
intermittent JJ O O
through IN B-VP O
the DT B-NP O
day NN I-NP O
and CC O O
then RB O O
at IN B-VP O
4:00 CD O O
p.m. NN B-NP O
increased VBD B-VP O
and CC O O
was VBD B-VP O
also RB O O
associated VBN O O
with IN B-VP O
nausea NN B-NP B-problem
and CC O O
diaphoresis NN B-NP B-problem
. . B-VP O
   
She PRP O B-person
reports VBZ O O
that IN B-VP B-pronoun
the DT B-NP B-problem
pain NN I-NP I-problem
shot NN I-NP O
through IN B-VP O
her PRP$ O B-person
back NN B-NP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
has VBZ O O
never RB O O
had VBN O O
these DT O B-problem
these DT B-NP B-pronoun
symptoms NNS I-NP I-problem
in IN B-VP O
the DT B-NP O
past NN I-NP O
. . B-VP O
   
She PRP O B-person
arrived VBD B-VP O
in IN B-VP O
the DT B-NP O
Emergency NNP I-NP O
Room NNP I-NP O
at IN B-VP O
8:00 CD O O
p.m. NN B-NP O
At IN B-VP O
that DT B-NP B-pronoun
time NN I-NP O
, , O O
the DT B-NP B-problem
pain NN I-NP I-problem
was VBD B-VP O
unremitting VBG O O
. . B-VP O
   
In IN B-VP O
the DT B-NP O
Emergency NNP I-NP O
Room NNP I-NP O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
given VBN O O
Lopressor NNP B-NP B-treatment
, , O O
nitroglycerin NN B-NP B-treatment
, , O O
and CC O O
aspirin RB O B-treatment
. . B-VP O
   
A DT B-NP B-treatment
TP3A NNP I-NP I-treatment
inhibitor NN I-NP I-treatment
was VBD B-VP O
not RB O O
given VBN O O
for IN B-VP O
concern NN B-NP O
for IN B-VP O
dissection NN B-NP B-problem
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
found VBN O O
to TO O O
have VB O O
5057 CD O O
E. NNP B-NP O
Sixth NNP I-NP O
Blvd. NNP I-NP O
elevations NNS I-NP B-problem
in IN B-VP I-problem
I PRP O I-problem
, , O I-problem
aVL RB O I-problem
, , O I-problem
and CC O I-problem
V1 NNP B-NP I-problem
through IN B-VP I-problem
V2 NNP B-NP I-problem
and CC O O
ST NNP B-NP B-problem
depressions NNS I-NP I-problem
in IN B-VP I-problem
II NNP B-NP I-problem
, , O I-problem
III NNP B-NP I-problem
, , O I-problem
and CC O I-problem
aVF RB O I-problem
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
taken VBN O O
emergently RB O O
to TO O O
the DT B-NP O
Cardiac NNP I-NP O
Catheterization NNP I-NP O
Laboratory NNP I-NP O
. . B-VP O
   
PAST NNP B-NP O
MEDICAL NNP I-NP O
HISTORY NNP I-NP O
: : O O
1. CD O O
Hypertension NNP B-NP B-problem
. . B-VP O
   
2. CD O O
Hypercholesterolemia NNP B-NP B-problem
. . B-VP O
   
3. CD O O
Chondrocalcinosis NNP B-NP B-problem
. . B-VP O
   
4. CD O O
Carpal JJ B-NP B-problem
tunnel NN I-NP I-problem
syndrome NN I-NP I-problem
. . B-VP O
   
5. CD O O
GERD NNP B-NP B-problem
. . B-VP O
   
ADMISSION NNP B-NP O
MEDICATIONS NNP I-NP O
: : O O
1. CD O O
Atenolol NNP B-NP B-treatment
25 CD O O
. . B-VP O
   
2. CD O O
Crestor NNP B-NP B-treatment
10 CD O O
q.d. NN B-NP O
3. CD O O
Uniretic JJ O B-treatment
15/25 CD O O
. . B-VP O
   
ALLERGIES NN B-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
has VBZ O O
no DT O O
known VBN O B-problem
drug NN B-NP I-problem
allergies NNS I-NP I-problem
. . B-VP O
   
SOCIAL NNP B-NP O
HISTORY NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
denied VBD B-VP O
tobacco NN B-NP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
denied VBD B-VP O
alcohol NN B-NP O
or CC O O
other JJ B-NP O
drug NN I-NP O
use NN I-NP O
. . B-VP O
   
PHYSICAL JJ B-NP O
EXAMINATION NN I-NP O
: : O O
Vital JJ B-NP O
signs NNS I-NP O
: : O O
On IN B-VP O
admission NN B-NP O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
afebrile RB O B-problem
, , O O
blood NN B-NP B-test
pressure NN I-NP I-test
146/88 CD O O
, , O O
pulse RB O B-test
71 CD O O
, , O O
respirations NNS B-NP B-test
18 CD O O
. . B-VP O
   
General JJ O O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
a DT O O
well RB O O
appearing VBG O O
female NN B-NP O
in IN B-VP O
no DT B-NP O
acute JJ I-NP B-problem
distress NN I-NP I-problem
. . B-VP O
   
Cardiac JJ O O
: : O O
Regular JJ B-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
, , O O
normal JJ B-NP O
S1 NNP I-NP O
, , O O
S2 NNP B-NP O
. . B-VP O
   
No DT B-NP O
murmurs NN I-NP B-problem
were VBD B-VP O
appreciated VBN O O
. . B-VP O
   
Lungs NNS B-NP O
: : O O
Clear JJ O O
to TO O O
auscultation VB O B-test
bilaterally RB O O
. . B-VP O
   
Abdomen NNS B-NP O
: : O O
Soft NNP B-NP O
, , O O
nontender NN B-NP B-problem
, , O O
nondistended VBN O B-problem
, , O O
good JJ B-NP O
bowel NN I-NP O
sounds NNS I-NP O
. . B-VP O
   
Extremities NNS B-NP O
: : O O
There EX O O
was VBD B-VP O
no DT B-NP O
edema NN I-NP B-problem
in IN B-VP I-problem
the DT B-NP I-problem
extremities NNS I-NP I-problem
. . B-VP O
   
The DT B-NP B-test
dorsalis NN I-NP I-test
pedis NN I-NP I-test
pulses NNS I-NP I-test
were VBD B-VP O
2+ CD O O
bilaterally RB O O
. . B-VP O
   
LABORATORY NNP B-NP O
AND CC O O
RADIOLOGIC NNP B-NP O
DATA NNP I-NP O
: : O O
On IN B-VP O
admission NN B-NP O
, , O O
white JJ B-NP B-test
count NN I-NP I-test
10.8 CD O O
, , O O
hematocrit NN B-NP B-test
38.2 CD O O
, , O O
platelets NNS B-NP B-test
324,000 CD O O
. . B-VP O
   
HOSPITAL NNP B-NP O
COURSE NNP I-NP O
: : O O
1. CD O O
CORONARY NNP B-NP B-problem
ARTERY NNP I-NP I-problem
DISEASE NNP I-NP I-problem
: : O O
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
taken VBN O O
to TO O O
Cardiac NNP B-NP O
Catheterization NNP I-NP O
where WRB O O
she PRP O B-person
was VBD B-VP O
found VBN O O
to TO O O
have VB O O
two CD O B-problem
vessel JJ B-NP I-problem
disease NN I-NP I-problem
. . B-VP O
   
The DT B-NP O
proximal JJ I-NP O
LAD NNP I-NP O
was VBD B-VP O
found VBN O O
to TO O O
have VB O O
a DT O B-problem
90% CD O I-problem
lesion NN B-NP I-problem
with IN B-VP O
a DT B-NP O
septal JJ I-NP O
branch NN I-NP O
with IN B-VP O
a DT O B-problem
95% CD O I-problem
stenosis NN B-NP I-problem
and CC O O
a DT B-NP O
diagonal JJ I-NP O
branch NN I-NP O
with IN B-VP O
99% CD O B-problem
stenosis NN B-NP I-problem
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
had VBD B-VP O
twin VBN O B-treatment
LAD NNP B-NP I-treatment
stents NNS I-NP I-treatment
to TO O O
the DT B-NP O
LAD NNP I-NP O
diagonal NN I-NP O
and CC O O
LAD NNP B-NP O
septal JJ B-NP O
branches NNS I-NP O
with IN B-VP O
Taxus NNP B-NP B-treatment
stents NNS I-NP I-treatment
. . B-VP O
   
This DT O B-pronoun
restored VBD B-VP O
flow NN B-NP O
appropriately RB O O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
also RB O O
had VBD B-VP O
proximal JJ B-NP B-problem
RCA NNP I-NP I-problem
lesion NN I-NP I-problem
of IN B-VP I-problem
80% CD O I-problem
and CC O O
a DT B-NP B-problem
mid JJ I-NP I-problem
RCA NNP I-NP I-problem
lesion NN I-NP I-problem
of IN B-VP I-problem
80-90% CD O I-problem
which WDT O B-pronoun
were VBD B-VP O
not RB O O
intervened VBN O O
upon IN B-VP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
given VBN O O
an DT B-NP B-treatment
aspirin NN I-NP I-treatment
and CC O O
Plavix NNP B-NP B-treatment
and CC O O
in IN B-VP O
addition NN B-NP O
started VBN O O
on IN B-VP O
a DT B-NP B-treatment
beta NN I-NP I-treatment
Elmore NNP I-NP I-treatment
, , O O
Maxine NNP B-NP B-treatment
ACE NNP I-NP I-treatment
inhibitor NN I-NP I-treatment
, , O O
and CC O O
these DT O B-pronoun
were VBD B-VP O
titrated VBN O O
up RP O O
as IN B-VP O
her PRP$ O B-person
her PRP$ O B-test
blood NN B-NP I-test
pressure NN I-NP I-test
tolerated VBD B-VP O
. . B-VP O
   
Given VBN O O
the DT B-NP O
fact NN I-NP O
that IN B-VP B-pronoun
the DT B-NP B-person
patient NN I-NP I-person
had VBD B-VP O
issues NNS B-NP O
with IN B-VP O
muscle NN B-NP B-problem
cramping VBG O I-problem
with IN B-VP O
Atorvastatin NNP B-NP B-treatment
in IN B-VP O
the DT B-NP O
past NN I-NP O
, , O O
she PRP O B-person
was VBD B-VP O
started VBN O O
on IN B-VP O
Pravastatin NNP B-NP B-treatment
which WDT O B-pronoun
should MD O O
give VB O O
less JJR O O
of IN B-VP O
these DT O B-problem
these DT B-NP B-pronoun
side NN I-NP I-problem
effects NNS I-NP I-problem
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
will MD O O
follow-up VB O O
with IN B-VP O
Cardiology NNP B-NP O
in IN B-VP O
one CD O O
months NNS B-NP O
time NN I-NP O
for IN B-VP O
further JJ B-NP B-treatment
management NN I-NP I-treatment
of IN B-VP O
her PRP$ O B-person
her PRP$ O B-problem
coronary JJ B-NP I-problem
artery NN I-NP I-problem
disease NN I-NP I-problem
and CC O O
further JJ B-NP B-test
evaluation NN I-NP I-test
of IN B-VP O
her PRP$ O B-person
her PRP$ O B-problem
remaining VBG O I-problem
RCA JJ B-NP I-problem
lesions NNS I-NP I-problem
. . B-VP O
   
2. CD O O
PUMP NN B-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
had VBD B-VP O
an DT B-NP B-test
echocardiogram NN I-NP I-test
to TO O O
assess VB O O
her PRP$ O B-person
LV NNP B-NP O
function NN I-NP O
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
found VBN O O
to TO O O
have VB O O
an DT B-NP B-test
ejection NN I-NP I-test
fraction NN I-NP I-test
of IN B-VP O
30-35% JJ O O
as RB O O
well RB O O
as IN B-VP O
an DT B-NP B-problem
akinetic JJ I-NP I-problem
apex NN I-NP I-problem
and CC O O
apical JJ B-NP B-problem
mid NN I-NP I-problem
and CC O I-problem
septal JJ B-NP I-problem
akinesis NN I-NP I-problem
. . B-VP O
   
Given VBN O O
the DT B-NP O
fact NN I-NP O
that IN B-VP B-pronoun
the DT B-NP B-person
patient NN I-NP I-person
had VBD B-VP O
significant JJ B-NP B-problem
apical JJ I-NP I-problem
akinesis NN I-NP I-problem
, , O O
she PRP O B-person
was VBD B-VP O
started VBN O O
on IN B-VP O
heparin NN B-NP B-treatment
with IN B-VP O
a DT B-NP O
transition NN I-NP O
to TO O O
Coumadin NNP B-NP B-treatment
for IN B-VP O
anticoagulation NN B-NP B-treatment
for IN B-VP O
stroke NN B-NP B-treatment
prevention NN I-NP I-treatment
in IN B-VP O
the DT B-NP O
setting NN I-NP O
of IN B-VP O
apical JJ B-NP B-problem
akinesis NN I-NP I-problem
. . B-VP O
   
On IN B-VP O
discharge NN B-NP O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
given VBN O O
Lovenox NNP B-NP B-treatment
injections NNS I-NP I-treatment
which WDT O B-pronoun
should MD O O
be VB O O
continued VBN O O
until IN B-VP O
the DT B-NP B-person
patient NN I-NP I-person
reaches VBZ O O
a DT B-NP O
therapeutic JJ I-NP O
dose NN I-NP O
of IN B-VP O
Coumadin NNP B-NP B-treatment
. . B-VP O
   
3. CD O O
RHYTHM NN B-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
monitored VBN O O
on IN B-VP O
telemetry NN B-NP B-test
throughout IN B-VP O
her PRP$ O B-person
hospitalization NN B-NP O
with IN B-VP O
no DT B-NP O
significant JJ I-NP B-problem
events NNS I-NP I-problem
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
had VBD B-VP O
an DT B-NP B-test
EP NNP I-NP I-test
evaluation NN I-NP I-test
and CC O O
will MD O O
be VB O O
followed-up JJ O O
by IN B-VP O
Dr. NNP B-NP B-person
Welch NNP I-NP I-person
. . B-VP O
   
14-087 CD O O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
had VBD B-VP O
a DT B-NP B-test
signal-averaged JJ I-NP I-test
EKG NNP I-NP I-test
. . B-VP O
   
She PRP O B-person
will MD O O
follow-up VB O O
with IN B-VP O
Dr. NNP B-NP B-person
Welch NNP I-NP I-person
with IN B-VP O
an DT B-NP B-test
echocardiogram NN I-NP I-test
on IN B-VP O
2015-07-24 JJ O O
in IN B-VP O
a DT B-NP O
meeting NN I-NP O
to TO O O
discuss VB O O
risk NN B-NP O
stratification NN I-NP O
for IN B-VP O
sudden JJ B-NP B-problem
cardiac JJ I-NP I-problem
death NN I-NP I-problem
and CC O O
possible JJ B-NP O
ICD NNP I-NP B-treatment
placement NN I-NP I-treatment
. . B-VP O
   
4. CD O O
NEUROLOGY NN B-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
complained VBD B-VP O
of IN B-VP O
left JJ B-NP B-problem
lower JJR I-NP I-problem
extremity NN I-NP I-problem
weakness NN I-NP I-problem
with IN B-VP O
ambulation NN B-NP O
two CD O O
days NNS B-NP O
after IN B-VP O
her PRP$ O B-person
her PRP$ O B-test
cardiac JJ B-NP I-test
catheterization NN I-NP I-test
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
had VBD B-VP O
no DT B-NP O
evidence NN I-NP O
for IN B-VP O
weakness NN B-NP B-problem
on IN B-VP O
examination NN B-NP B-test
with IN B-VP O
good JJ B-NP O
proximal NN I-NP O
and CC O O
distal JJ B-NP O
strength NN I-NP O
in IN B-VP O
the DT B-NP O
lower JJR I-NP O
extremities NNS I-NP O
as RB O O
well RB O O
as IN B-VP O
intact JJ B-NP O
sensation NN I-NP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
worked VBD B-VP O
with IN B-VP O
Physical NNP B-NP B-person
Therapy NNP I-NP I-person
and CC O O
was VBD B-VP O
able JJ O O
to TO O O
ambulate VB O O
without IN B-VP O
difficulty NN B-NP O
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
also RB O O
able JJ O O
to TO O O
ascend VB O O
stairs NNS B-NP O
without IN B-VP O
difficulty NN B-NP B-problem
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
already RB O O
on IN B-VP O
an DT B-NP B-treatment
aspirin NN I-NP I-treatment
and CC O O
Plavix NNP B-NP B-treatment
should MD O O
this DT O B-pronoun
represent VB O O
a DT B-NP B-problem
small JJ I-NP I-problem
stroke NN I-NP I-problem
. . B-VP O
   
However RB O O
, , O O
there EX O O
was VBD B-VP O
no DT B-NP O
evidence NN I-NP O
for IN B-VP O
neurologic JJ B-NP B-problem
deficit NN I-NP I-problem
on IN B-VP O
examination NN B-NP B-test
and CC O O
this DT O B-pronoun
will MD O O
be VB O O
followed-up JJ O O
by IN B-VP O
her PRP$ O B-person
her PRP$ O B-person
primary JJ B-NP I-person
care NN I-NP I-person
physician NN I-NP I-person
. . B-VP O
   
5. CD O O
HEMATOLOGY NN B-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
discharged VBN O O
on IN B-VP O
Coumadin NNP B-NP B-treatment
for IN B-VP O
apical JJ B-NP B-problem
akinesis NN I-NP I-problem
and CC O O
stroke NN B-NP B-problem
risk NN I-NP I-problem
. . B-VP O
   
This DT O B-pronoun
will MD O O
be VB O O
further RB O O
monitored VBN O O
by IN B-VP O
her PRP$ O B-person
her PRP$ O B-person
primary JJ B-NP I-person
care NN I-NP I-person
physician NN I-NP I-person
, , O O
Dr. NNP B-NP B-person
Banks NNP I-NP I-person
, , O O
who WP O B-person
will MD O O
adjust VB O O
her PRP$ O B-person
her PRP$ O B-treatment
Coumadin NNP B-NP I-treatment
dose NN I-NP I-treatment
. . B-VP O
   
CONDITION NNP B-NP O
ON NNP I-NP O
DISCHARGE NNP I-NP O
: : O O
Stable JJ O O
. . B-VP O
   
DISCHARGE JJ B-NP O
STATUS NNP I-NP O
: : O O
To TO O O
home NN B-NP O
. . B-VP O
   
DISCHARGE NNP B-NP O
DIAGNOSIS NNP I-NP O
: : O O
ST NNP B-NP B-problem
elevation NN I-NP I-problem
myocardial JJ B-NP I-problem
infarction NN I-NP I-problem
, , O O
status NN B-NP O
post NN I-NP O
left VBD B-VP B-treatment
anterior JJ O I-treatment
descending VBG O I-treatment
artery JJ B-NP I-treatment
stent NN I-NP I-treatment
. . B-VP O
   
DISCHARGE NNP B-NP O
MEDICATIONS NNP I-NP O
: : O O
1. CD O O
Aspirin NNP B-NP B-treatment
325 CD O O
q.d. NN B-NP O
2. CD O O
Lisinopril NNP B-NP B-treatment
5 CD O O
q.d. NN B-NP O
3. CD O O
Toprol NNP B-NP B-treatment
XL NNP I-NP I-treatment
100 CD O O
q.d. NN B-NP O
4. CD O O
Coumadin NNP B-NP B-treatment
5 CD O O
q.d. NN B-NP O
5. CD O O
Plavix NNP B-NP B-treatment
75 CD O O
q.d. NN B-NP O
6. CD O O
Lovenox NNP B-NP B-treatment
60 CD O O
mg NN B-NP O
b.i.d. NN I-NP O
until IN B-VP O
therapeutic JJ O O
on IN B-VP O
Coumadin NNP B-NP B-treatment
. . B-VP O
   
7. CD O O
Pravastatin NNP B-NP B-treatment
80 CD O O
q.d. VBD B-VP O
FOLLOW-UP NNP B-NP O
PLANS NNS I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
will MD O O
follow-up VB O O
with IN B-VP O
her PRP$ O B-person
her PRP$ O B-person
primary JJ B-NP I-person
care NN I-NP I-person
physician NN I-NP I-person
in IN B-VP O
the DT B-NP O
week NN I-NP O
following VBG O O
discharge NN B-NP O
for IN B-VP O
further JJ B-NP O
monitoring NN I-NP O
of IN B-VP O
her PRP$ O B-person
her PRP$ O B-test
INR NNP B-NP I-test
and CC O O
adjustment NN B-NP O
of IN B-VP O
her PRP$ O B-person
her PRP$ O B-treatment
Coumadin NNP B-NP I-treatment
dose NN I-NP I-treatment
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
will MD O O
also RB O O
follow-up VB O O
with IN B-VP O
Electrophysiology NNP B-NP O
with IN B-VP O
Dr. NNP B-NP B-person
Welch NNP I-NP I-person
on IN B-VP O
2015-07-24 JJ O O
. . B-VP O
   
In IN B-VP O
addition NN B-NP O
to TO O O
this DT O B-pronoun
, , O O
the DT B-NP B-person
patient NN I-NP I-person
will MD O O
follow-up VB O O
with IN B-VP O
Cardiology NNP B-NP O
, , O O
Dr. NNP B-NP B-person
Foster NNP I-NP I-person
, , O O
and CC O O
Dr. NNP B-NP B-person
Upshaw NNP I-NP I-person
, , O O
on IN B-VP O
2015-07-06 JJ O O
for IN B-VP O
further JJ B-NP B-test
monitoring NN I-NP I-test
. . B-VP O
   
Joshua NNP B-NP B-person
PINTO NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
12.932 CD O O
Dictated VBN O O
By IN B-VP O
: : O O
Greg NNP B-NP B-person
E. NNP I-NP I-person
Riordan NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
MEDQUIST36 NNP I-NP O
D NNP I-NP O
: : O O
2015-06-10 JJ O O
09:17 CD O O
T NN B-NP O
: : O O
2015-06-12 JJ O O
16:28 CD O O
JOB NNP B-NP O
#: VBD B-VP O
74717 CD O O
Signed VBN O O
electronically RB O O
by IN B-VP O
: : O O
DR. NNP B-NP B-person
David NNP I-NP I-person
PINTO NNP I-NP I-person
on IN B-VP O
: : O O
FRI NNP B-NP O
2015-06-19 CD O O
5:36 CD O O
PM NNP B-NP O
( ( O O
End NNP B-NP O
of IN B-VP O
Report NNP B-NP O
) ) O O
-EMPTYLINE- VBP O O
-DOCSTART- JJ O O
-EMPTYLINE- $ O O
348983165 CD O O
FIH NNP B-NP O
4912803 CD O O
97509/32z1 CD O O
028205 CD O O
4/14/1994 CD O O
12:00:00 CD O O
AM NNP B-NP O
SELF NNP I-NP B-problem
INFLICTED NNP I-NP I-problem
GUNSHOT NNP I-NP I-problem
WOUND NNP I-NP I-problem
TO NNP I-NP I-problem
THE NNP I-NP I-problem
HEAD NNP I-NP I-problem
. . B-VP O
   
Unsigned VBD B-VP O
DIS NNP B-NP O
Report NNP I-NP O
Status NNP I-NP O
: : O O
Unsigned VBN O O
ADMISSION NNP B-NP O
DATE NNP I-NP O
: : O O
4/14/94 CD O O
DISCHARGE NNP B-NP O
DATE NNP I-NP O
: : O O
4/20/94 CD O O
PRINCIPAL NNP B-NP O
DIAGNOSIS NNP I-NP O
: : O O
Self NNP B-NP B-problem
inflicted VBD B-VP I-problem
gunshot JJ B-NP I-problem
wound NN I-NP I-problem
to TO O I-problem
the DT B-NP I-problem
head NN I-NP I-problem
. . B-VP O
   
ASSOCIATED JJ B-NP O
DIAGNOSIS NN I-NP O
: : O O
hypertension NN B-NP B-problem
, , O O
poor JJ B-NP B-problem
dentition NN I-NP I-problem
. . B-VP O
   
PRINCIPAL JJ B-NP O
PROCEDURE NN I-NP O
: : O O
Suture NN B-NP B-treatment
of IN B-VP O
right JJ B-NP B-problem
temporal JJ I-NP I-problem
head NN I-NP I-problem
wound NN I-NP I-problem
, , O O
performed VBN O O
on IN B-VP O
April NNP B-NP O
14 CD O O
, , O O
1994 CD O O
. . B-VP O
   
HISTORY NNP B-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS NNP I-NP O
: : O O
Mr. NNP B-NP B-person
Le NNP I-NP I-person
is VBZ O O
a DT B-NP O
seventy NN I-NP O
three CD O O
year NN B-NP O
old JJ B-NP O
male NN I-NP O
who WP O B-person
presents VBZ O O
to TO O O
the DT B-NP O
Fairm NNP I-NP O
of IN B-VP O
Ijordcompmac NNP B-NP O
Hospital NNP I-NP O
, , O O
following VBG O O
a DT B-NP B-problem
self NN I-NP I-problem
inflicted VBN O I-problem
gunshot JJ B-NP I-problem
wound NN I-NP I-problem
to TO O I-problem
the DT B-NP I-problem
head NN I-NP I-problem
. . B-VP O
   
Mr. NNP B-NP B-person
Le NNP I-NP I-person
was VBD B-VP O
found VBN O O
in IN B-VP O
bed NN B-NP O
with IN B-VP O
a DT O O
32 CD O O
caliber NN B-NP O
revolver NN I-NP O
at IN B-VP O
his PRP$ O B-person
side NN B-NP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
apparently RB O O
alone RB O O
at IN B-VP O
home NN B-NP O
, , O O
his PRP$ O B-person
his PRP$ O B-person
neighbors NNS B-NP I-person
heard VBP O O
a DT B-NP O
single JJ I-NP O
shot NN I-NP O
, , O O
and CC O O
the DT B-NP B-person
paramedics NNS I-NP I-person
were VBD B-VP O
called VBN O O
. . B-VP O
   
Upon IN B-VP O
arrival NN B-NP O
, , O O
they PRP O B-pronoun
found VBD B-VP O
the DT B-NP B-person
patient NN I-NP I-person
in IN B-VP O
bed NN B-NP O
, , O O
with IN B-VP O
notes NNS B-NP O
nearby RB O O
, , O O
listing VBG O O
his PRP$ O B-person
funeral JJ B-NP O
home NN I-NP O
preferences NNS I-NP O
and CC O O
information NN B-NP O
on IN B-VP O
his PRP$ O B-person
his PRP$ O B-person
next NN B-NP I-person
of IN B-VP I-person
kin NN B-NP I-person
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
indicates VBZ O O
that IN B-VP B-pronoun
his PRP$ O B-person
his PRP$ O B-person
neighbors NNS B-NP I-person
were VBD B-VP O
making VBG O O
excessive JJ B-NP O
noise NN I-NP O
upstairs NN I-NP O
from IN B-VP O
his PRP$ O B-person
dwelling NN B-NP O
, , O O
and CC O O
he PRP O B-person
found VBD B-VP O
it PRP O B-pronoun
unbearable JJ O O
. . B-VP O
   
He PRP O B-person
therefore RB O O
decided VBD B-VP O
to TO O O
take VB O O
his PRP$ O B-person
life NN B-NP O
with IN B-VP O
a DT B-NP O
gun NN I-NP O
which WDT O B-pronoun
he PRP O B-person
had VBD B-VP O
found VBN O O
in IN B-VP O
the DT B-NP O
house NN I-NP O
. . B-VP O
   
Apparently RB O O
, , O O
the DT B-NP O
gun NN I-NP O
belonged VBD B-VP O
to TO O O
his PRP$ O B-person
his PRP$ O B-person
father NN B-NP I-person
. . B-VP O
   
On IN B-VP O
further JJ B-NP O
questioning NN I-NP O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
described VBD B-VP O
that IN B-VP B-pronoun
his PRP$ O B-person
his PRP$ O B-person
father NN B-NP I-person
passed VBD B-VP O
away RB O O
approximately RB O O
forty JJ O O
to TO O O
fifty VB O O
years NNS B-NP O
prior RB O O
to TO O O
his PRP$ O B-person
admission NN B-NP O
, , O O
and CC O O
the DT B-NP O
gun NN I-NP O
was VBD B-VP O
found VBN O O
in IN B-VP O
a DT B-NP O
box NN I-NP O
in IN B-VP O
their PRP$ O B-person
home NN B-NP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
expressed VBD B-VP O
concern NN B-NP O
that IN B-VP B-pronoun
he PRP O B-person
had VBD B-VP O
several JJ B-NP O
utility NN I-NP O
bills NNS I-NP O
that IN B-VP B-pronoun
he PRP O B-person
was VBD B-VP O
unable JJ O O
to TO O O
pay VB O O
. . B-VP O
   
The DT O B-person
The DT B-NP B-person
patient JJ I-NP I-person
patient NN I-NP I-person
&apos;s NN I-NP I-person
sister NN I-NP I-person
died VBD B-VP O
eight CD O O
years NNS B-NP O
prior RB O O
to TO O O
the DT B-NP B-person
patient NN I-NP I-person
&apos;s NNP I-NP O
admission NN I-NP O
of IN B-VP O
leukemia NN B-NP B-problem
, , O O
and CC O O
he PRP O B-person
otherwise RB O O
has VBZ O O
no DT O O
next JJ O B-person
of IN B-VP I-person
kin NN B-NP I-person
with IN B-VP O
the DT B-NP O
exception NN I-NP O
of IN B-VP O
one CD O B-person
brother NN B-NP I-person
in IN B-VP O
Washington NNP B-NP O
, , O O
with IN B-VP O
whom WP O O
his PRP$ O B-person
relationship NN B-NP O
is VBZ O O
tenuous JJ O O
. . B-VP O
   
On IN B-VP O
initial JJ B-NP O
questioning NN I-NP O
, , O O
however RB O O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
denies VBZ O O
any DT B-NP O
recent JJ I-NP O
losses NNS I-NP O
. . B-VP O
   
On IN B-VP O
admission NN B-NP O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
denies VBZ O O
any DT B-NP B-problem
suicidal NN I-NP I-problem
or CC O I-problem
homicidal JJ B-NP I-problem
ideation NN I-NP I-problem
. . B-VP O
   
PAST NNP B-NP O
MEDICAL NNP I-NP O
HISTORY NNP I-NP O
: : O O
1. CD O O
hypertension NN B-NP B-problem
, , O O
2. CD O O
poor JJ B-NP B-problem
dentition NN I-NP I-problem
. . B-VP O
   
ADVERSE JJ B-NP O
DRUG NNP I-NP O
REACTIONS NNP I-NP O
: : O O
no DT B-NP O
known JJ I-NP B-problem
drug NN I-NP I-problem
allergies NNS I-NP I-problem
. . B-VP O
   
MEDICATIONS NNP B-NP O
ON NNP I-NP O
ADMISSION NNP I-NP O
: : O O
NOne NN B-NP O
. . B-VP O
   
SOCIAL NNP B-NP O
HISTORY NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
is VBZ O O
retired VBN O O
employee NN B-NP O
of IN B-VP O
the DT B-NP O
City NNP I-NP O
of IN B-VP O
Avi NNP B-NP O
Den NNP I-NP O
, , O O
Hawaii NNP B-NP O
, , O O
lives VBZ O O
on IN B-VP O
a DT B-NP O
pension NN I-NP O
and CC O O
Social NNP B-NP O
Security NNP I-NP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
has VBZ O O
never RB O O
been VBN O O
married VBN O O
and CC O O
has VBZ O O
no DT B-NP O
children NNS I-NP B-person
. . B-VP O
   
He PRP O B-person
has VBZ O O
a DT B-NP O
sixty NN I-NP O
to TO O O
seventy VB O O
five CD O O
pack JJ B-NP O
year NN I-NP O
smoking VBG O O
history NN B-NP O
and CC O O
drinks NNS B-NP O
alcohol VBP O O
approximately RB O O
one CD O O
time NN B-NP O
per IN B-VP O
week NN B-NP O
. . B-VP O
   
He PRP O B-person
denies VBZ O O
any DT B-NP O
ilicit JJ I-NP O
drug NN I-NP O
use NN I-NP O
. . B-VP O
   
PHYSICAL JJ B-NP O
EXAMINATION NN I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
is VBZ O O
an DT B-NP O
obese JJ I-NP O
male NN I-NP O
in IN B-VP O
no DT B-NP O
acute JJ I-NP B-problem
distress NN I-NP I-problem
. . B-VP O
   
The DT B-NP B-test
vital JJ I-NP I-test
signs NNS I-NP I-test
temperature NN I-NP B-test
98.0 CD O O
, , O O
heart NN B-NP B-test
rate NN I-NP I-test
78 CD O O
, , O O
blood NN B-NP B-test
pressure NN I-NP I-test
186/69 CD O O
, , O O
respirations NNS B-NP B-test
18 CD O O
. . B-VP O
   
The DT B-NP B-test
head NN I-NP I-test
, , O I-test
eyes NNS B-NP I-test
, , O I-test
ears NNS B-NP I-test
, , O I-test
nose RB O I-test
, , O I-test
throat NN B-NP I-test
examination NN I-NP I-test
revealed VBD B-VP O
an DT B-NP B-problem
entry NN I-NP I-problem
wound VBD B-VP I-problem
approximately RB O O
1 CD O O
1/2 CD O O
inches NNS B-NP O
above IN B-VP O
the DT B-NP O
right JJ I-NP O
ear NN I-NP O
, , O O
which WDT O B-pronoun
is VBZ O O
approximately RB O O
1 CD O O
cm. NNS B-NP O
in IN B-VP O
length NN B-NP O
and CC O O
surrounded VBN O O
by IN B-VP O
powder NN B-NP B-problem
burn NN I-NP I-problem
. . B-VP O
   
There EX O O
is VBZ O O
a DT B-NP B-problem
lump NN I-NP I-problem
in IN B-VP I-problem
the DT B-NP I-problem
right JJ I-NP I-problem
parietal JJ I-NP I-problem
region NN I-NP I-problem
, , O O
which WDT O B-pronoun
corresponds VBZ O O
with IN B-VP O
the DT B-NP O
bullet NN I-NP O
seen VBN O O
on IN B-VP O
the DT B-NP B-test
computerized JJ I-NP I-test
tomography NN I-NP I-test
scan NN I-NP I-test
. . B-VP O
   
There EX O O
is VBZ O O
no DT O O
bruising VBG O B-problem
about IN B-VP I-problem
the DT B-NP I-problem
eyes NNS I-NP I-problem
or CC O I-problem
mastoid NN B-NP I-problem
sinuses NNS I-NP I-problem
, , O O
and CC O O
there EX O O
is VBZ O O
no DT B-NP O
fluid NN I-NP B-problem
from IN B-VP I-problem
the DT B-NP I-problem
nose NN I-NP I-problem
or CC O I-problem
ears NNS B-NP I-problem
. . B-VP O
   
The DT B-NP O
neck NN I-NP O
was VBD B-VP O
supple JJ O O
, , O O
and CC O O
without IN B-VP O
adenopathy JJ O B-problem
. . B-VP O
   
The DT B-NP O
lungs NNS I-NP O
are VBP O O
clear JJ O O
to TO O O
auscultation VB O B-test
bilaterally RB O O
. . B-VP O
   
The DT B-NP B-test
heart NN I-NP I-test
sounds VBZ O I-test
are VBP O O
regular JJ B-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
and CC O O
no DT B-NP O
murmur NN I-NP B-problem
, , O O
rub NN B-NP B-problem
or CC O O
gallop NN B-NP B-problem
are VBP O O
appreciated VBN O O
. . B-VP O
   
The DT B-NP O
abdomen NNS I-NP O
is VBZ O O
soft JJ O O
, , O O
nontender NN B-NP B-problem
, , O O
nondistended VBN O B-problem
, , O O
without IN B-VP O
hepatosplenomegaly NN B-NP B-problem
. . B-VP O
   
There EX O O
are VBP O O
no DT B-NP O
masses NNS I-NP B-problem
and CC O O
the DT B-NP B-test
bowel NN I-NP I-test
sounds NNS I-NP I-test
are VBP O O
present JJ O O
. . B-VP O
   
The DT B-NP O
extremities NNS I-NP O
are VBP O O
well RB O O
perfused VBN O O
and CC O O
there EX O O
is VBZ O O
no DT B-NP O
clubbing NN I-NP B-problem
, , O O
cyanosis NN B-NP B-problem
or CC O O
edema NN B-NP B-problem
. . B-VP O
   
Neurological JJ O O
: : O O
examination NN B-NP B-test
revealed VBD B-VP O
a DT B-NP O
patient NN I-NP B-person
who WP O B-person
was VBD B-VP O
alert JJ O O
and CC O O
oriented VBD B-VP O
X NNP B-NP O
3 CD O O
, , O O
with IN B-VP O
short JJ B-NP O
term NN I-NP O
recall NN I-NP O
of IN B-VP O
2/3 CD O O
objects NNS B-NP O
at IN B-VP O
five CD O O
minutes NNS B-NP O
and CC O O
fluent JJ B-NP O
speech NN I-NP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
remembers VBZ O O
the DT B-NP B-person
presidents NNS I-NP I-person
as IN B-VP O
Carter-Bush-Regan-Truman-Roosevelt NNP B-NP B-person
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
able JJ O O
to TO O O
spell VB O O
world NN B-NP O
backwards NNS I-NP O
on IN B-VP O
the DT B-NP O
third JJ I-NP O
attempt NN I-NP O
. . B-VP O
   
He PRP O B-person
performed VBD B-VP O
serial JJ O B-test
7 CD O I-test
&apos;s NN B-NP O
accurately RB O O
. . B-VP O
   
He PRP O B-person
demonstrated VBD B-VP O
poor JJ B-NP B-problem
ability NN I-NP I-problem
for IN B-VP I-problem
abstract JJ B-NP I-problem
thinking NN I-NP I-problem
. . B-VP O
   
Cranial JJ B-NP O
nerves NNS I-NP O
II-XII NNP I-NP O
were VBD B-VP O
grossly RB O O
intact JJ O O
. . B-VP O
   
The DT O O
pupils JJ O O
equal JJ O O
, , O O
round NN B-NP O
, , O O
reactive JJ O O
to TO O O
light JJ O O
and CC O O
accommodation NN B-NP O
, , O O
and CC O O
the DT B-NP B-test
extra JJ I-NP I-test
ocular JJ I-NP I-test
movements NNS I-NP I-test
are VBP O O
intact JJ O O
. . B-VP O
   
The DT B-NP O
fundi NN I-NP O
are VBP O O
benign JJ O O
and CC O O
the DT B-NP O
discs NN I-NP O
are VBP O O
sharp JJ O O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
&apos;s NNP I-NP O
strength NN I-NP O
is VBZ O O
5/5 CD O O
throughout IN B-VP O
and CC O O
the DT B-NP O
sensorium NN I-NP O
is VBZ O O
intact JJ O O
. . B-VP O
   
The DT B-NP B-test
deep JJ I-NP I-test
tendon NN I-NP I-test
reflexes NNS I-NP I-test
are VBP O O
2+ CD O O
and CC O O
symmetrical JJ O O
throughout IN B-VP O
. . B-VP O
   
LABORATORY NNP B-NP O
DATA NNP I-NP O
: : O O
A DT B-NP B-test
panel NN I-NP I-test
of IN B-VP I-test
serum NN B-NP I-test
electrolytes NNS I-NP I-test
is VBZ O O
normal JJ O O
. . B-VP O
   
The DT B-NP B-test
white JJ I-NP I-test
blood NN I-NP I-test
count NN I-NP I-test
is VBZ O O
9.4 CD O O
, , O O
hematocrit NN B-NP B-test
47.1 CD O O
, , O O
and CC O O
the DT B-NP B-test
platelets NNS I-NP I-test
253,000 CD O O
. . B-VP O
   
Blood NN B-NP B-test
coagulation NN I-NP I-test
times NNS I-NP I-test
are VBP O O
normal JJ O O
. . B-VP O
   
Serum NNP B-NP B-test
toxic JJ B-NP I-test
screen NN I-NP I-test
is VBZ O O
negative JJ O O
. . B-VP O
   
Leukocyte NNP B-NP B-test
differential JJ B-NP I-test
count NN I-NP I-test
reveals NNS I-NP O
64 CD O B-test
neutrophils NNS B-NP I-test
, , O O
24% CD O B-test
lymphocytes NNS B-NP I-test
, , O O
8% CD O B-test
monocytes NNS B-NP I-test
, , O O
2% CD O B-test
eosinophils NNS B-NP I-test
, , O O
and CC O O
2% CD O B-test
basophils NNS B-NP I-test
. . B-VP O
   
A DT B-NP B-test
panel NN I-NP I-test
of IN B-VP I-test
serum NN B-NP I-test
enzymes NNS I-NP I-test
suggest VBP O O
normal JJ B-NP O
hepatic JJ I-NP O
function NN I-NP O
. . B-VP O
   
A DT B-NP B-test
computerized JJ I-NP I-test
tomography NN I-NP I-test
scan NN I-NP I-test
of IN B-VP I-test
the DT B-NP I-test
head NN I-NP I-test
reveals VBZ O O
a DT B-NP B-problem
small JJ I-NP I-problem
external JJ I-NP I-problem
skull NN I-NP I-problem
fracture NN I-NP I-problem
, , O O
approximately RB O O
1-2 JJ B-NP O
millemeters NNS I-NP O
in IN B-VP O
size NN B-NP O
, , O O
near IN B-VP O
the DT B-NP O
right JJ I-NP O
frontoparietal NN I-NP O
apex NN I-NP O
. . B-VP O
   
A DT B-NP B-problem
right JJ I-NP I-problem
parietal NN I-NP I-problem
contusion NN I-NP I-problem
is VBZ O O
also RB O O
identified VBN O O
, , O O
with IN B-VP O
blood NN B-NP B-problem
tracking VBG O I-problem
into IN B-VP I-problem
the DT B-NP I-problem
middle JJ I-NP I-problem
focus NN I-NP I-problem
. . B-VP O
   
Standard NNP B-NP B-test
12 CD O I-test
lead NN B-NP I-test
electrocardiogram NN I-NP I-test
revealed VBD B-VP O
normal JJ B-NP O
sinus NN I-NP O
rhythm NN I-NP O
at IN B-VP O
a DT B-NP B-test
rate NN I-NP I-test
of IN B-VP O
85 CD O O
, , O O
with IN B-VP O
poor JJ B-NP B-problem
R NNP I-NP I-problem
wave NN I-NP I-problem
progression NN I-NP I-problem
in IN B-VP O
leads NNS B-NP O
V1 NNP I-NP O
through IN B-VP O
V3 NNP B-NP O
suggesting VBG O O
the DT B-NP O
possibility NN I-NP O
of IN B-VP O
an DT B-NP B-problem
old JJ I-NP I-problem
anteroseptal JJ I-NP I-problem
myocardial JJ I-NP I-problem
infarction NN I-NP I-problem
. . B-VP O
   
Nonspecific NNP B-NP B-problem
ST NNP I-NP I-problem
segment NN I-NP I-problem
and CC O I-problem
T NNP B-NP I-problem
wave VBP O I-problem
abnormalities NNS B-NP I-problem
are VBP O O
present JJ O O
as IN B-VP O
well RB O O
. . B-VP O
   
Otherwise NNP B-NP O
, , O O
the DT B-NP O
axis NN I-NP O
is VBZ O O
normal JJ O O
and CC O O
the DT B-NP O
intervals NNS I-NP O
are VBP O O
normal JJ O O
. . B-VP O
   
HOSPITAL NNP B-NP O
COURSE NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
admitted VBN O O
to TO O O
the DT B-NP O
Fairm NNP I-NP O
of IN B-VP O
Ijordcompmac NNP B-NP O
Hospital NNP I-NP O
, , O O
on IN B-VP O
the DT B-NP O
Neurological NNP I-NP O
Surgery NNP I-NP O
Service NNP I-NP O
of IN B-VP O
Lupevickette NNP B-NP B-person
L. NNP I-NP I-person
Ca NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
Prior NNP I-NP O
to TO O O
his PRP$ O B-person
admission NN B-NP O
, , O O
the DT O B-person
the DT B-NP B-problem
patient JJ I-NP I-person
patient NN I-NP I-problem
&apos;s NNP I-NP I-problem
gunshot NN I-NP I-problem
wound NN I-NP I-problem
was VBD B-VP O
sutured VBN O O
close RB O O
in IN B-VP O
the DT B-NP O
emergency NN I-NP O
room NN I-NP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
placed VBN O O
on IN B-VP O
suicide JJ B-NP B-treatment
precautions NNS I-NP I-treatment
, , O O
and CC O O
was VBD B-VP O
hydrated VBN O O
with IN B-VP O
an DT B-NP B-treatment
infusion NN I-NP I-treatment
of IN B-VP I-treatment
intravenous JJ B-NP I-treatment
fluid NN I-NP I-treatment
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
seen VBN O O
in IN B-VP O
consultation NN B-NP O
by IN B-VP O
the DT B-NP B-person
Psychiatry NNP I-NP I-person
Service NNP I-NP I-person
, , O O
who WP O B-person
began VBD B-VP O
a DT B-NP O
battery NN I-NP O
of IN B-VP O
testing VBG O B-test
, , O O
which WDT O B-pronoun
continues VBZ O O
at IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
discharge NN B-NP O
. . B-VP O
   
The DT B-NP B-person
Consulting NNP I-NP I-person
Psychiatrist NNP I-NP I-person
recommended VBD B-VP O
a DT B-NP O
minimum NN I-NP O
of IN B-VP O
2 CD O B-treatment
point NN B-NP I-treatment
restraints NNS I-NP I-treatment
at IN B-VP O
all DT B-NP O
times NNS I-NP O
, , O O
and CC O O
recommended VBD B-VP O
the DT B-NP B-person
patient NN I-NP I-person
be VB O O
monitored VBN O O
by IN B-VP O
a DT B-NP B-person
sitter NN I-NP I-person
. . B-VP O
   
Allowing VBG O O
the DT B-NP B-person
patient NN I-NP I-person
to TO O O
ambulate VB O O
was VBD B-VP O
not RB O O
recommended VBN O O
. . B-VP O
   
From IN B-VP O
a DT B-NP O
medical JJ I-NP O
standpoint NN I-NP O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
did VBD B-VP O
well RB O O
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
initially RB O O
admitted VBN O O
to TO O O
the DT B-NP O
Neurological NNP I-NP O
Intensive NNP I-NP O
Care NNP I-NP O
Unit NNP I-NP O
where WRB O O
he PRP O B-person
was VBD B-VP O
closely RB O O
monitored VBN O O
during IN B-VP O
the DT O O
first JJ O O
two CD O O
days NNS B-NP O
of IN B-VP O
his PRP$ O B-person
hospitalization NN B-NP O
. . B-VP O
   
The DT B-NP O
chief JJ I-NP O
obstacle NN I-NP O
was VBD B-VP O
bringing VBG O O
his PRP$ O B-person
his PRP$ O B-test
blood NN B-NP I-test
pressure NN I-NP I-test
under IN B-VP O
control NN B-NP O
and CC O O
this DT O B-pronoun
was VBD B-VP O
ultimately RB O O
achieved VBN O O
with IN B-VP O
a DT B-NP O
combination NN I-NP O
of IN B-VP O
Captopril NNP B-NP B-treatment
and CC O O
Nifedipine NNP B-NP B-treatment
. . B-VP O
   
After IN B-VP O
his PRP$ O B-person
his PRP$ O B-test
blood NN B-NP I-test
pressure NN I-NP I-test
had VBD B-VP O
stabilized VBN O O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
transferred VBN O O
to TO O O
the DT B-NP O
Neurology NNP I-NP O
Ward NNP I-NP O
. . B-VP O
   
Close NNP B-NP B-test
monitoring NN I-NP I-test
demonstrated VBD B-VP O
his PRP$ O B-person
his PRP$ O B-test
blood NN B-NP I-test
pressure NN I-NP I-test
to TO O O
be VB O O
stable JJ O O
and CC O O
within IN B-VP O
an DT B-NP O
acceptable JJ I-NP O
rang NN I-NP O
on IN B-VP O
his PRP$ O B-person
his PRP$ O B-treatment
dosage NN B-NP I-treatment
regimen NNS I-NP I-treatment
. . B-VP O
   
The DT B-NP B-person
Psychiatry NNP I-NP I-person
Service NNP I-NP I-person
followed VBD B-VP O
up RP O O
extensively RB O O
with IN B-VP O
the DT B-NP B-person
patient NN I-NP I-person
, , O O
and CC O O
his PRP$ O B-person
Psychiatric NNP B-NP O
progress NN I-NP O
is VBZ O O
detailed VBN O O
in IN B-VP O
the DT B-NP O
Psychiatry NNP I-NP O
transfer NN I-NP O
note NN I-NP O
. . B-VP O
   
By IN B-VP O
the DT B-NP O
7th JJ I-NP O
hospital NN I-NP O
day NN I-NP O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
medically RB O O
stable JJ O O
. . B-VP O
   
He PRP O B-person
had VBD B-VP O
undergone JJ B-NP O
full JJ I-NP B-test
Psychiatric NNP I-NP I-test
evaluation NN I-NP I-test
, , O O
and CC O O
was VBD B-VP O
prepared VBN O O
for IN B-VP O
transfer NN B-NP O
to TO O O
a DT B-NP O
Psychiatric NNP I-NP O
Hospital NNP I-NP O
. . B-VP O
   
Therefore RB O O
, , O O
because IN B-VP O
of IN B-VP O
his PRP$ O B-person
need NN B-NP O
for IN B-VP O
intense JJ B-NP B-treatment
psychiatric JJ I-NP I-treatment
care NN I-NP I-treatment
, , O O
the DT B-NP B-person
patient NN I-NP I-person
is VBZ O O
discharged VBN O O
to TO O O
the DT B-NP O
Vo NNP I-NP O
Black NNP I-NP O
Doylestrictshore NNP I-NP O
Ft. NNP I-NP O
Clinics NNP I-NP O
Medical NNP I-NP O
Center NNP I-NP O
on IN B-VP O
the DT B-NP O
7th JJ I-NP O
hospital NN I-NP O
day NN I-NP O
. . B-VP O
   
CONDITION NNP B-NP O
ON NNP I-NP O
DISCHARGE NNP I-NP O
: : O O
Improved VBN O O
. . B-VP O
   
DOCTORS NNP B-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
: : O O
Discharged VBD B-VP O
to TO O O
Sonpathcermu NNP B-NP O
Jords NNP I-NP O
Hospital NNP I-NP O
. . B-VP O
   
2. CD O O
diet JJ O O
as IN B-VP O
tolerated VBN O O
. . B-VP O
   
3. CD O O
Activity NNP B-NP O
ad NN I-NP O
lib NN I-NP O
, , O O
with IN B-VP O
restrictions NNS B-NP O
as IN B-VP O
indicated VBN O O
by IN B-VP O
the DT B-NP O
Psychiatry NNP I-NP O
Transfer NNP I-NP O
Note NNP I-NP O
. . B-VP O
   
4. CD O O
Followup NNP B-NP O
with IN B-VP O
Dr. NNP B-NP B-person
Rourdrick NNP I-NP I-person
in IN B-VP O
four CD O O
weeks NNS B-NP O
time NN I-NP O
. . B-VP O
   
MEDICATIONS NNP B-NP O
ON NNP I-NP O
DISCHARGE NNP I-NP O
: : O O
Dilantin NNP B-NP B-treatment
100 CD O O
mg. NN B-NP O
po NN I-NP O
tid NN I-NP O
, , O O
Mylanta NNP B-NP B-treatment
30 CD O O
cc. NN B-NP O
po NN I-NP O
q VBD B-VP O
4 CD O O
hours NNS B-NP O
prn RB O O
, , O O
Dyspepsia NNP B-NP B-problem
, , O O
Milk NNP B-NP B-treatment
of IN B-VP I-treatment
Magnesia NNP B-NP I-treatment
30 CD O O
cc. NN B-NP O
po NN I-NP O
q VBD B-VP O
4 CD O O
hours NNS B-NP O
prn JJ B-NP O
constipation NN I-NP B-problem
, , O O
Cimetidine NNP B-NP B-treatment
400 CD O O
mg. NN B-NP O
po NN I-NP O
bid NN I-NP O
, , O O
Haloperidol NNP B-NP B-treatment
1 CD O O
mg. NN B-NP O
po NN I-NP O
or CC O O
IM NNP B-NP O
q $ O O
3 CD O O
hours NNS B-NP O
prn JJ B-NP O
agitation NN I-NP B-problem
. . B-VP O
   
Colace NNP B-NP B-treatment
100 CD O O
mg. NN B-NP O
po NN I-NP O
bid NN I-NP O
, , O O
Captopril NNP B-NP B-treatment
50 CD O O
mg. NN B-NP O
po NN I-NP O
tid NN I-NP O
, , O O
Nifedipine NNP B-NP B-treatment
20 CD O O
mg. NN B-NP O
po NN I-NP O
q VBD B-VP O
6 CD O O
hours NNS B-NP O
and CC O O
Nifedipine NNP B-NP B-treatment
20 CD O O
mg. NN B-NP O
po NN I-NP O
or CC O O
sublingual JJ B-NP O
q NN I-NP O
3 CD O O
hours NNS B-NP O
prn VBP O O
systolic JJ B-NP B-problem
blood NN I-NP I-problem
pressure NN I-NP I-problem
greater JJR O I-problem
than IN B-VP I-problem
160 CD O I-problem
millemeters NNS B-NP O
of IN B-VP O
Mercury NNP B-NP O
. . B-VP O
   
LUPEVICKETTE NNP B-NP B-person
CA NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
TR NNP I-NP O
: : O O
yz NN B-NP O
/ NNP I-NP O
bmot NN I-NP O
DD NNP I-NP O
: : O O
4/19/94 CD O O
TD NN B-NP O
: : O O
04/19/94 CD O O
CC NN B-NP O
: : O O
stat NN B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
Admission NNP I-NP O
Date NNP I-NP O
: : O O
2013-11-01 JJ B-NP O
Discharge NN I-NP O
Date NNP I-NP O
: : O O
2013-12-10 JJ B-NP O
Date NNP I-NP O
of IN B-VP O
Birth NNP B-NP O
: : O O
2013-11-01 JJ B-NP O
Sex NN I-NP O
: : O O
F NNP B-NP O
Service NNP I-NP O
: : O O
Neonatology NNP B-NP O
HISTORY NNP I-NP O
: : O O
Mychelia NNP B-NP B-person
Boyd NNP I-NP I-person
was VBD B-VP O
born VBN O O
at IN B-VP O
28-2/7 JJ B-NP O
weeks NNS I-NP O
gestation NN I-NP O
and CC O O
delivered VBN O O
due JJ O O
to TO O O
unstoppable JJ B-NP B-problem
premature NN I-NP I-problem
labor NN I-NP I-problem
. . B-VP O
   
Mother NNP B-NP B-person
is VBZ O O
an DT B-NP O
18-year-old JJ I-NP O
prima NN I-NP O
gravida NN I-NP O
, , O O
estimated VBN O O
date NN B-NP O
of IN B-VP O
delivery NN B-NP O
2014-01-22 JJ O O
. . B-VP O
   
Prenatal JJ B-NP B-test
screens NNS I-NP I-test
include VBP O O
blood NN B-NP B-test
type NN I-NP I-test
O NNP I-NP O
negative JJ O O
. . B-VP O
   
Other JJ B-NP B-test
prenatal JJ I-NP I-test
screens NNS I-NP I-test
were VBD B-VP O
unknown JJ O O
at IN B-VP O
time NN B-NP O
of IN B-VP O
delivery NN B-NP B-treatment
. . B-VP O
   
Pregnancy NN B-NP O
was VBD B-VP O
uncomplicated VBN O O
until IN B-VP O
the DT B-NP O
day NN I-NP O
of IN B-VP O
delivery NN B-NP B-treatment
when WRB O O
mother NN B-NP B-person
presented VBD B-VP O
to TO O O
HealthSouth NNP B-NP O
New NNP I-NP O
England NNP I-NP O
Rehab NNP I-NP O
Hospital NNP I-NP O
Hospital NNP I-NP O
with IN B-VP O
bleeding NN B-NP B-problem
and CC O O
was VBD B-VP O
sent VBN O O
home NN B-NP O
. . B-VP O
   
She PRP O B-person
then RB O O
presented VBD B-VP O
to TO O O
Jordan NNP B-NP O
Hospital NNP I-NP O
Hospital NNP I-NP O
where WRB O O
she PRP O B-person
was VBD B-VP O
noted VBN O O
to TO O O
be VB O O
5 CD O B-problem
cm NNS B-NP I-problem
dilated VBN O I-problem
with IN B-VP O
a DT B-NP B-problem
transverse JJ I-NP I-problem
lie NN I-NP I-problem
presentation NN I-NP I-problem
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
given VBN O O
betamethasone NN B-NP B-treatment
times CC O O
one CD O O
and CC O O
transferred VBD B-VP O
to TO O O
the DT B-NP O
Nantucket NNP I-NP O
Cottage NNP I-NP O
Hospital NNP I-NP O
where WRB O O
she PRP O B-person
was VBD B-VP O
delivered VBN O O
by IN B-VP O
cesarean JJ B-NP B-treatment
section NN I-NP I-treatment
with IN B-VP O
rupture NN B-NP B-problem
of IN B-VP I-problem
membranes NNS B-NP I-problem
at IN B-VP O
time NN B-NP O
of IN B-VP O
delivery NN B-NP B-treatment
notable JJ O O
for IN B-VP O
slight JJ B-NP B-problem
meconium NN I-NP I-problem
stained VBD B-VP I-problem
amniotic JJ B-NP I-problem
fluid NN I-NP I-problem
. . B-VP O
   
The DT B-NP B-person
baby NN I-NP I-person
emerged VBD B-VP O
with IN B-VP O
spontaneous JJ B-NP O
cry NN I-NP O
, , O O
received VBD B-VP O
routine JJ B-NP B-treatment
care NN I-NP I-treatment
and CC O O
then RB O O
was VBD B-VP O
intubated VBN O O
in IN B-VP O
the DT B-NP O
Delivery NNP I-NP O
Room NNP I-NP O
due JJ O O
to TO O O
inconsistent JJ B-NP B-problem
respiratory NN I-NP I-problem
effort NN I-NP I-problem
and CC O O
increased JJ B-NP B-problem
work NN I-NP I-problem
of IN B-VP I-problem
breathing VBG O I-problem
. . B-VP O
   
Apgars NNS B-NP B-test
were VBD B-VP O
6 CD O O
at IN B-VP O
one CD O O
minute NN B-NP O
and CC O O
8 CD O O
at IN B-VP O
five CD O O
minutes NNS B-NP O
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
transferred VBN O O
to TO O O
the DT B-NP O
newborn JJ I-NP O
Intensive NNP I-NP O
Care NNP I-NP O
Unit NNP I-NP O
for IN B-VP O
further JJ B-NP B-treatment
management NN I-NP I-treatment
. . B-VP O
   
PHYSICAL JJ B-NP O
EXAMINATION NN I-NP O
: : O O
Her PRP$ O B-person
Her PRP$ O B-test
admission NN B-NP I-test
physical NN I-NP I-test
revealed VBD B-VP O
a DT B-NP B-test
birth NN I-NP I-test
weight NN I-NP I-test
of IN B-VP O
901 CD O O
gm NN B-NP O
, , O O
20th CD O O
percentile NN B-NP O
; : O O
length CC O B-test
34 CD O O
cm NN B-NP O
, , O O
25th CD O O
percentile NN B-NP O
; : O O
head NN B-NP B-test
circumference NN I-NP I-test
25 CD O O
cm NN B-NP O
, , O O
25th CD O O
percentile NN B-NP O
. . B-VP O
   
Anterior NNP B-NP O
fontanelle JJ O O
open JJ O O
, , O O
soft JJ O O
and CC O O
flat JJ O O
. . B-VP O
   
Red JJ B-NP B-test
reflex NN I-NP I-test
was VBD B-VP O
difficult JJ O O
to TO O O
appreciate VB O O
bilaterally RB O O
. . B-VP O
   
Pupils NNS B-NP O
were VBD B-VP O
large JJ O O
but CC O O
equal JJ O O
and CC O O
reactive JJ O O
. . B-VP O
   
Palate NNP B-NP O
deferred VBD B-VP O
due JJ O O
to TO O O
oral JJ B-NP B-treatment
intubation NN I-NP I-treatment
. . B-VP O
   
No DT B-NP O
defect NN I-NP B-problem
noted VBD B-VP O
during IN B-VP O
procedure NN B-NP B-treatment
. . B-VP O
   
Increased VBN O B-problem
work NN B-NP I-problem
of IN B-VP I-problem
breathing VBG O I-problem
prior JJ O O
to TO O O
intubation NN B-NP B-treatment
, , O O
but CC O O
presently RB O O
comfortable JJ O O
. . B-VP O
   
Breath NNP B-NP O
sounds VBZ O O
slightly RB O B-problem
crackly JJ O I-problem
, , O O
symmetric JJ B-NP O
equal JJ I-NP O
air NN I-NP O
entry NN I-NP O
. . B-VP O
   
Cardiovascular JJ B-NP O
regular JJ I-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
without IN B-VP O
murmur NN B-NP B-problem
. . B-VP O
   
Peripheral JJ B-NP B-test
pulses NNS I-NP I-test
plus CC O O
2 CD O O
and CC O O
symmetric JJ O O
. . B-VP O
   
Abdomen NNP B-NP O
soft JJ O O
without IN B-VP O
hepatosplenomegaly NN B-NP B-problem
. . B-VP O
   
Three-vessel NNP B-NP O
cord NN I-NP O
, , O O
clamped VBD B-VP O
. . B-VP O
   
Normal NNP B-NP O
female JJ B-NP O
external JJ I-NP O
genitalia NN I-NP O
. . B-VP O
   
Normal NNP B-NP O
back RB O O
and CC O O
hips NNS B-NP O
. . B-VP O
   
Skin NNP B-NP O
was VBD B-VP O
pink JJ O O
and CC O O
well-perfused JJ O O
. . B-VP O
   
Appropriate NNP B-NP O
tone NN I-NP O
and CC O O
activity NN B-NP O
. . B-VP O
   
HOSPITAL NNP B-NP O
COURSE NNP I-NP O
BY NNP I-NP O
SYSTEM NNP I-NP O
: : O O
Respiratory NN B-NP O
: : O O
The DT B-NP B-person
baby NN I-NP I-person
was VBD B-VP O
intubated VBN O O
in IN B-VP O
the DT B-NP O
Delivery NNP I-NP O
Room NNP I-NP O
, , O O
received VBD B-VP O
two CD O O
doses NNS B-NP O
of IN B-VP O
surfactant NN B-NP B-treatment
. . B-VP O
   
Radiograph NNP B-NP B-test
revealed VBD B-VP O
bilateral JJ B-NP B-problem
diffuse NN I-NP I-problem
granular JJ B-NP I-problem
pattern NN I-NP I-problem
consistent JJ O O
with IN B-VP O
surfactant JJ B-NP B-problem
deficiency NN I-NP I-problem
. . B-VP O
   
Maximum NNP B-NP B-treatment
mechanical JJ B-NP I-treatment
ventilation NN I-NP I-treatment
PIP NNP I-NP B-treatment
26 CD O O
, , O O
PEEP NNP B-NP B-treatment
6 CD O O
, , O O
rate NN B-NP B-treatment
of IN B-VP O
25 CD O O
, , O O
maximum JJ B-NP B-treatment
FIO2 NNP I-NP I-treatment
35 CD O O
percent NN B-NP O
. . B-VP O
   
Mychelia NNP B-NP B-person
was VBD B-VP O
extubated VBN O O
to TO O O
a DT B-NP B-treatment
CPAP NNP I-NP I-treatment
of IN B-VP O
6 CD O O
cm NNS B-NP O
on IN B-VP O
day NN B-NP O
of IN B-VP O
life NN B-NP O
two CD O O
where WRB O O
she PRP O B-person
remained VBD B-VP O
until IN B-VP O
day NN B-NP O
of IN B-VP O
life NN B-NP O
20 CD O O
. . B-VP O
   
On IN B-VP O
day NN B-NP O
of IN B-VP O
life NN B-NP O
two CD O O
, , O O
she PRP O B-person
was VBD B-VP O
also RB O O
loaded VBN O O
with IN B-VP O
caffeine NN B-NP B-treatment
and CC O O
continues VBZ O O
on IN B-VP O
caffeine NN B-NP B-treatment
at IN B-VP O
time NN B-NP O
of IN B-VP O
transfer NN B-NP O
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
transitioned VBN O O
to TO O O
a DT B-NP B-treatment
nasal JJ I-NP I-treatment
cannula NN I-NP I-treatment
on IN B-VP O
day NN B-NP O
of IN B-VP O
life NN B-NP O
20 CD O O
and CC O O
remains VBZ O O
on IN B-VP O
nasal JJ B-NP B-treatment
cannula NN I-NP I-treatment
O2 NNP I-NP I-treatment
100 CD O O
percent NN B-NP O
at IN B-VP O
13 CD O O
cc NN B-NP O
flow NN I-NP O
. . B-VP O
   
She PRP O B-person
averaged VBD B-VP O
2-3 JJ B-NP O
apnea NN I-NP B-problem
episodes VBZ O I-problem
a DT B-NP O
day NN I-NP O
with IN B-VP O
bradycardia NN B-NP B-problem
and CC O O
desaturations NNS B-NP B-problem
. . B-VP O
   
She PRP O B-person
has VBZ O O
a DT B-NP O
comfortable JJ I-NP O
respiratory NN I-NP B-test
rate NN I-NP I-test
and CC O O
good JJ B-NP O
air NN I-NP O
exchange NN I-NP O
. . B-VP O
   
Cardiovascular NN B-NP O
: : O O
She PRP O B-person
received VBD B-VP O
a DT B-NP B-treatment
normal JJ I-NP I-treatment
saline NN I-NP I-treatment
bolus NN I-NP I-treatment
times NNS I-NP O
one CD O O
initially RB O O
for IN B-VP O
poor JJ B-NP B-problem
perfusion NN I-NP I-problem
and CC O O
was VBD B-VP O
started VBN O O
on IN B-VP O
dopamine NN B-NP B-treatment
with IN B-VP O
a DT B-NP O
maximum JJ I-NP O
infusion NN I-NP O
rate NN I-NP O
of IN B-VP O
6 CD O O
mcg NNS B-NP O
per IN B-VP O
kg FW O O
per IN B-VP O
hour NN B-NP O
. . B-VP O
   
This DT O B-pronoun
was VBD B-VP O
discontinued VBN O O
on IN B-VP O
day NN B-NP O
of IN B-VP O
life NN B-NP O
two CD O O
to TO O O
maintain VB O O
a DT B-NP B-test
mean JJ I-NP I-test
arterial JJ I-NP I-test
pressure NN I-NP I-test
of IN B-VP O
greater JJR O O
than IN B-VP O
33 CD O O
. . B-VP O
   
She PRP O B-person
has VBZ O O
remained VBN O O
hemodynamically RB O O
stable JJ O O
during IN B-VP O
the DT B-NP O
remainder NN I-NP O
of IN B-VP O
her PRP$ O B-person
hospitalization NN B-NP O
here RB O O
. . B-VP O
   
Fluids NNP B-NP O
, , O O
electrolytes VBZ O O
, , O O
nutrition NN B-NP O
: : O O
Initially RB O O
maintained VBD B-VP O
NPO NNP B-NP B-treatment
. . B-VP O
   
UAC NNP B-NP B-treatment
and CC O I-treatment
UVC NNP B-NP I-treatment
lines NNS I-NP I-treatment
were VBD B-VP O
placed VBN O O
upon IN B-VP O
admission NN B-NP O
to TO O O
the DT B-NP O
CMED NNP I-NP O
. . B-VP O
   
The DT B-NP B-treatment
UAC NNP I-NP I-treatment
was VBD B-VP O
left VBN O O
in IN B-VP O
place NN B-NP O
until IN B-VP O
day NN B-NP O
of IN B-VP O
life NN B-NP O
two CD O O
and CC O O
was VBD B-VP O
removed VBN O O
after IN B-VP O
wean NN B-NP O
from IN B-VP O
dopamine NN B-NP B-treatment
. . B-VP O
   
UVC NNP B-NP B-treatment
remained VBD B-VP O
in IN B-VP O
place NN B-NP O
through IN B-VP O
day NN B-NP O
of IN B-VP O
life NN B-NP O
six CD O O
and CC O O
was VBD B-VP O
utilized VBN O O
to TO O O
administer VB O O
parenteral JJ B-NP B-treatment
nutrition NN I-NP I-treatment
. . B-VP O
   
Electrolytes NNS B-NP B-test
and CC O O
glucose NN B-NP B-test
remained VBN O O
in IN B-VP O
the DT B-NP O
normal JJ I-NP O
range NN I-NP O
throughout IN B-VP O
the DT B-NP O
first JJ I-NP O
week NN I-NP O
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
started VBN O O
on IN B-VP O
enteral JJ B-NP B-treatment
feeds NNS I-NP I-treatment
on IN B-VP O
day NN B-NP O
of IN B-VP O
life NN B-NP O
six CD O O
with IN B-VP O
a DT B-NP O
slow JJ I-NP O
advance NN I-NP O
secondary JJ O O
to TO O O
increased VBN O B-problem
abdominal JJ B-NP I-problem
girth NN I-NP I-problem
which WDT O B-pronoun
was VBD B-VP O
felt VBN O O
to TO O O
be VB O O
due JJ O O
to TO O O
CPAP NNP B-NP B-treatment
. . B-VP O
   
She PRP O B-person
passed VBD B-VP O
meconium NN B-NP O
. . B-VP O
   
She PRP O B-person
achieved VBD B-VP O
full JJ B-NP O
feeds NNS I-NP O
on IN B-VP O
day NN B-NP O
of IN B-VP O
life NN B-NP O
13 CD O O
. . B-VP O
   
Calories NNS B-NP O
were VBD B-VP O
gradually RB O O
increased VBN O O
to TO O O
breast VB O O
milk NN B-NP O
30 CD O O
calories NNS B-NP O
with IN B-VP O
ProMod NNP B-NP B-treatment
consisting VBG O O
of IN B-VP O
four CD O O
of IN B-VP O
human JJ B-NP O
milk NN I-NP O
fortifier NN I-NP O
, , O O
four CD O O
of IN B-VP O
MCT NNP B-NP B-treatment
and CC O O
two CD O O
of IN B-VP O
Polycose NNP B-NP B-treatment
with IN B-VP O
a DT B-NP O
12-28 JJ I-NP O
teaspoon NN I-NP O
of IN B-VP O
ProMod NNP B-NP B-treatment
per IN B-VP O
50 CD O O
ml NN B-NP O
of IN B-VP O
breast NN B-NP O
milk NN I-NP O
or CC O O
60 CD O O
ml NN B-NP O
of IN B-VP O
formula NN B-NP O
. . B-VP O
   
On IN B-VP O
day NN B-NP O
of IN B-VP O
life NN B-NP O
six CD O O
due JJ O O
to TO O O
concerns NNS B-NP O
for IN B-VP O
hyperglycemia NN B-NP B-problem
and CC O O
abdominal JJ B-NP B-problem
distention NN I-NP I-problem
, , O O
sepsis NN B-NP B-test
evaluation NN I-NP I-test
was VBD B-VP O
obtained VBN O O
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
noted VBN O O
at IN B-VP O
this DT B-NP B-pronoun
time NN I-NP O
to TO O O
have VB O O
hyperglycemia VBN O B-problem
requiring VBG O O
two CD O O
subcutaneous JJ B-NP O
doses NNS I-NP O
of IN B-VP O
insulin NN B-NP B-treatment
and CC O O
a DT B-NP B-treatment
decreased JJ I-NP I-treatment
glucose JJ I-NP I-treatment
infusion NN I-NP I-treatment
rate NN I-NP I-treatment
to TO O O
achieve VB O O
euglycemia NN B-NP O
. . B-VP O
   
This DT O B-pronoun
resolved VBD B-VP O
that DT B-NP B-pronoun
same JJ I-NP O
day NN I-NP O
. . B-VP O
   
Urine NNP B-NP B-test
output NN I-NP I-test
was VBD B-VP O
always RB O O
noted VBN O O
to TO O O
be VB O O
of IN B-VP O
sufficient JJ B-NP O
quantity NN I-NP O
. . B-VP O
   
Gastrointestinal JJ O O
: : O O
Mychelia NNP B-NP B-person
demonstrated VBD B-VP O
slow JJ B-NP B-problem
gastrointestinal JJ I-NP I-problem
motility NN I-NP I-problem
and CC O O
abdominal JJ B-NP B-problem
distention NN I-NP I-problem
felt VBD B-VP O
to TO O O
be VB O O
due JJ O O
to TO O O
CPAP NNP B-NP B-treatment
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
slow JJ O O
to TO O O
advance VB O O
on IN B-VP O
enteral JJ B-NP O
feeds NNS I-NP O
and CC O O
gradually RB O O
attained VBN O O
full JJ B-NP O
enteral JJ I-NP O
volume NN I-NP O
on IN B-VP O
day NN B-NP O
of IN B-VP O
life NN B-NP O
13 CD O O
. . B-VP O
   
On IN B-VP O
day NN B-NP O
of IN B-VP O
life NN B-NP O
15 CD O O
, , O O
she PRP O B-person
was VBD B-VP O
made VBN O O
NPO NNP B-NP B-treatment
for IN B-VP O
a DT B-NP B-problem
distended JJ I-NP I-problem
abdomen NNS I-NP I-problem
and CC O O
a DT B-NP B-problem
bilious JJ I-NP I-problem
spit NN I-NP I-problem
. . B-VP O
   
Serial JJ B-NP B-test
KUBs NNP I-NP I-test
revealed VBD B-VP O
nonspecific JJ B-NP B-problem
changes NNS I-NP I-problem
with IN B-VP O
dilated JJ B-NP B-problem
loops NNS I-NP I-problem
. . B-VP O
   
No DT B-NP O
pneumatosis NN I-NP B-problem
or CC O O
free JJ B-NP B-problem
air NN I-NP I-problem
was VBD B-VP O
seen VBN O O
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
noted VBN O O
to TO O O
have VB O O
bluish JJ B-NP B-problem
discoloration NN I-NP I-problem
thought VBD B-VP O
to TO O O
perhaps RB O O
be VB O O
a DT B-NP B-problem
bruise NN I-NP I-problem
on IN B-VP I-problem
her PRP$ O B-person
her PRP$ O I-problem
left JJ B-NP I-problem
lower JJR I-NP I-problem
quadrant NN I-NP I-problem
. . B-VP O
   
There EX O O
was VBD B-VP O
no DT B-NP O
radiographic JJ I-NP O
correlation NN I-NP O
with IN B-VP O
this DT O B-pronoun
. . B-VP O
   
Feeds NNS B-NP O
were VBD B-VP O
restarted VBN O O
. . B-VP O
   
Again NN B-NP O
, , O O
she PRP O B-person
was VBD B-VP O
advanced VBN O O
to TO O O
full JJ B-NP O
volume NN I-NP O
but CC O O
was VBD B-VP O
made VBN O O
NPO NNP B-NP B-treatment
on IN B-VP O
day NN B-NP O
of IN B-VP O
life NN B-NP O
20 CD O O
for IN B-VP O
abdominal JJ B-NP B-problem
distention NN I-NP I-problem
. . B-VP O
   
This DT O B-treatment
This DT B-NP B-pronoun
NPO NNP I-NP I-treatment
was VBD B-VP O
temporary JJ O O
for IN B-VP O
that DT B-NP B-pronoun
day NN I-NP O
and CC O O
she PRP O B-person
then RB O O
resumed VBD B-VP O
feedings NNS B-NP O
and CC O O
has VBZ O O
been VBN O O
tolerating VBG O O
full JJ B-NP B-treatment
enteral JJ I-NP I-treatment
feeds NNS I-NP I-treatment
well RB O O
, , O O
improved VBN O O
since IN B-VP O
off NN B-NP O
of IN B-VP O
CPAP NNP B-NP B-treatment
, , O O
passing VBG O O
normal JJ B-NP O
stools NNS I-NP O
, , O O
guaiac JJ O B-test
negative JJ O O
. . B-VP O
   
Mychelia NNP B-NP B-person
was VBD B-VP O
also RB O O
treated VBN O O
for IN B-VP O
physiologic JJ B-NP B-problem
jaundice NN I-NP I-problem
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
started VBN O O
under IN B-VP O
phototherapy NN B-NP B-treatment
on IN B-VP O
day NN B-NP O
of IN B-VP O
life NN B-NP O
one CD O O
through IN B-VP O
day NN B-NP O
of IN B-VP O
life NN B-NP O
three CD O O
with IN B-VP O
a DT B-NP B-test
peak JJ I-NP I-test
serum NN I-NP I-test
bilirubin NN I-NP I-test
of IN B-VP O
4.7/0.3 CD O O
. . B-VP O
   
This DT B-NP B-pronoun
issue NN I-NP O
resolved VBD B-VP O
. . B-VP O
   
Hematologic NNP B-NP O
and CC O O
Infectious JJ B-NP O
Disease NNP I-NP O
: : O O
Initial JJ B-NP B-test
CBC NNP I-NP I-test
was VBD B-VP O
notable JJ O O
for IN B-VP O
a DT B-NP B-test
white JJ I-NP I-test
count NN I-NP I-test
of IN B-VP O
5.5 CD O O
with IN B-VP O
49 CD O B-test
polys NNS B-NP I-test
, , O O
1 CD O B-test
band NN B-NP I-test
and CC O O
47 CD O B-test
lymphs NN B-NP I-test
. . B-VP O
   
Initial JJ B-NP B-test
hematocrit NN I-NP I-test
was VBD B-VP O
46.3 CD O O
percent NN B-NP O
and CC O O
platelets NNS B-NP B-test
320,000 CD O O
. . B-VP O
   
Her PRP$ O B-person
Her PRP$ O B-test
initial JJ B-NP I-test
blood NN I-NP I-test
culture NN I-NP I-test
remained VBD B-VP O
negative JJ O O
and CC O O
she PRP O B-person
received VBD B-VP O
48 CD O O
hours NNS B-NP O
of IN B-VP O
ampicillin NN B-NP B-treatment
and CC O O
gentamicin NN B-NP B-treatment
. . B-VP O
   
As IN B-VP O
previously RB O O
noted VBN O O
on IN B-VP O
day NN B-NP O
of IN B-VP O
life NN B-NP O
six CD O O
with IN B-VP O
hyperglycemia NN B-NP B-problem
, , O O
abdominal JJ B-NP B-problem
distention NN I-NP I-problem
, , O O
a DT B-NP B-test
CBC NNP I-NP I-test
and CC O O
blood NN B-NP B-test
culture NN I-NP I-test
were VBD B-VP O
again RB O O
obtained VBN O O
revealing VBG O O
a DT B-NP B-test
white JJ I-NP I-test
count NN I-NP I-test
of IN B-VP O
9.1 CD O O
with IN B-VP O
30 CD O B-test
polys NNS B-NP I-test
, , O O
0 CD O B-test
bands NNS B-NP I-test
and CC O O
58 CD O B-test
lymphs NN B-NP I-test
. . B-VP O
   
Hematocrit NNP B-NP B-test
at IN B-VP O
that DT B-NP B-pronoun
time NN I-NP O
was VBD B-VP O
noted VBN O O
to TO O O
be VB O O
31 CD O O
and CC O O
platelets NNS B-NP B-test
370,000 CD O O
. . B-VP O
   
Blood NN B-NP B-test
culture NN I-NP I-test
grew VBD B-VP O
staph JJ B-NP B-problem
coagulase NN I-NP I-problem
negative JJ O I-problem
and CC O O
the DT B-NP O
baby NN I-NP O
received VBD B-VP O
seven CD O O
days NNS B-NP O
of IN B-VP O
vancomycin NN B-NP B-treatment
and CC O O
gentamicin NN B-NP B-treatment
. . B-VP O
   
A DT B-NP B-test
lumbar JJ I-NP I-test
puncture NN I-NP I-test
was VBD B-VP O
also RB O O
performed VBN O O
to TO O O
rule VB O O
out RP O O
meningitis NN B-NP B-problem
. . B-VP O
   
This DT O B-test
This DT B-NP B-pronoun
culture NN I-NP I-test
remained VBD B-VP O
negative JJ O O
with IN B-VP O
normal JJ B-NP O
cell NN I-NP O
counts NNS I-NP O
and CC O O
chemistries NNS B-NP O
. . B-VP O
   
Antibiotic JJ B-NP B-test
levels NNS I-NP I-test
were VBD B-VP O
monitored VBN O O
and CC O O
doses NNS B-NP O
adjusted VBN O O
accordingly RB O O
. . B-VP O
   
Mychelia NNP B-NP B-person
required VBD B-VP O
two CD O B-treatment
transfusions NNS B-NP I-treatment
during IN B-VP O
her PRP$ O B-person
hospital NN B-NP O
stay NN I-NP O
. . B-VP O
   
On IN B-VP O
day NN B-NP O
of IN B-VP O
life NN B-NP O
15 CD O O
for IN B-VP O
a DT B-NP B-test
hematocrit NN I-NP I-test
of IN B-VP O
29 CD O O
, , O O
she PRP O B-person
received VBD B-VP O
20 CD O O
cc NN B-NP O
of IN B-VP O
packed JJ B-NP B-treatment
red JJ I-NP I-treatment
blood NN I-NP I-treatment
cells NNS I-NP I-treatment
. . B-VP O
   
She PRP O B-person
started VBD B-VP O
on IN B-VP O
iron NN B-NP B-treatment
and CC O O
vitamin NN B-NP B-treatment
E NNP I-NP I-treatment
supplements NNS I-NP I-treatment
on IN B-VP O
day NN B-NP O
of IN B-VP O
life NN B-NP O
25 CD O O
and CC O O
continues VBZ O O
on IN B-VP O
that DT O B-pronoun
at IN B-VP O
this DT B-NP B-pronoun
time NN I-NP O
of IN B-VP O
transfer NN B-NP O
. . B-VP O
   
However RB O O
, , O O
on IN B-VP O
day NN B-NP O
of IN B-VP O
life NN B-NP O
34 CD O O
, , O O
12-04 CD O O
, , O O
she PRP O B-person
was VBD B-VP O
noted VBN O O
to TO O O
be VB O O
pale JJ O B-problem
and CC O O
less JJR B-NP B-problem
stress NN I-NP I-problem
tolerant NN I-NP I-problem
, , O O
mottling VBG O O
easily RB O O
with IN B-VP O
care NN B-NP O
. . B-VP O
   
A DT B-NP B-test
hematocrit NN I-NP I-test
and CC O O
reticulocyte NN B-NP B-test
count NN I-NP I-test
showed VBD B-VP O
a DT B-NP B-test
hematocrit NN I-NP I-test
of IN B-VP O
23 CD O O
percent NN B-NP O
and CC O O
a DT B-NP B-test
reticulocyte NN I-NP I-test
count NN I-NP I-test
of IN B-VP O
1.9 CD O O
percent NN B-NP O
. . B-VP O
   
Therefore RB O O
, , O O
with IN B-VP O
blood NN B-NP B-treatment
available JJ O O
from IN B-VP O
the DT B-NP O
first JJ I-NP O
aliquot NN I-NP O
, , O O
a DT O O
second JJ O O
20 CD O O
cc NN B-NP O
per IN B-VP O
kg NN B-NP O
of IN B-VP O
packed JJ B-NP B-treatment
red JJ I-NP I-treatment
blood NN I-NP I-treatment
cells NNS I-NP I-treatment
were VBD B-VP O
infused VBN O O
without IN B-VP O
incident NN B-NP O
. . B-VP O
   
Neurological JJ O O
: : O O
Initial JJ B-NP B-test
head NN I-NP I-test
ultrasound NN I-NP I-test
on IN B-VP O
day NN B-NP O
of IN B-VP O
life NN B-NP O
seven CD O O
was VBD B-VP O
normal JJ O O
. . B-VP O
   
At IN B-VP O
one CD O O
month NN B-NP O
of IN B-VP O
age NN B-NP O
, , O O
on IN B-VP O
12-03 JJ O O
, , O O
she PRP O B-person
was VBD B-VP O
noted VBN O O
to TO O O
have VB O O
an DT B-NP B-problem
absent JJ I-NP I-problem
septum NN I-NP I-problem
pellucidum NN I-NP I-problem
. . B-VP O
   
An DT B-NP B-test
MRI NNP I-NP I-test
obtained VBD B-VP O
and CC O O
reviewed VBN O O
by IN B-VP O
the DT B-NP O
Hallmark NNP I-NP O
Health NNP I-NP O
System NNP I-NP O
Radiology NNP I-NP O
Department NNP I-NP O
revealed VBD B-VP O
focal JJ B-NP B-problem
gyral JJ I-NP I-problem
morphology NN I-NP I-problem
consistent JJ O O
with IN B-VP O
prematurity NN B-NP B-problem
, , O O
normal JJ B-NP O
midline NN I-NP O
structures NNS I-NP O
, , O O
normal JJ B-NP O
myelination NN I-NP O
, , O O
no DT B-NP O
lesions NNS I-NP B-problem
, , O O
no DT B-NP O
signal JJ I-NP B-problem
abnormalities NNS I-NP I-problem
or CC O O
extracerebral JJ B-NP B-problem
collections NNS I-NP I-problem
. . B-VP O
   
The DT B-NP O
cortical JJ I-NP O
ribbon NN I-NP O
is VBZ O O
intact JJ O O
. . B-VP O
   
The DT B-NP O
major JJ I-NP O
vascular JJ I-NP O
structures NNS I-NP O
at IN B-VP O
the DT B-NP O
skull JJ I-NP O
base NN I-NP O
are VBP O O
normal JJ O O
. . B-VP O
   
The DT B-NP O
septal JJ I-NP O
leaflets NNS I-NP O
may MD O O
be VB O O
partially RB O B-problem
absent JJ O I-problem
, , O O
but CC O O
there EX O O
are VBP O O
no DT B-NP O
coronal JJ I-NP B-test
images NNS I-NP I-test
provided VBN O O
for IN B-VP O
confirmation NN B-NP O
and CC O O
the DT B-NP O
pituitary JJ I-NP O
stalk NN I-NP O
is VBZ O O
present JJ O O
. . B-VP O
   
An DT B-NP O
Ophthalmology NNP I-NP B-person
consult NN I-NP O
was VBD B-VP O
obtained VBN O O
to TO O O
determine VB O O
the DT B-NP O
presence NN I-NP O
of IN B-VP O
optic JJ B-NP O
nerves NNS I-NP O
. . B-VP O
   
These DT O B-pronoun
were VBD B-VP O
both DT O O
determined VBN O O
to TO O O
be VB O O
present JJ O O
and CC O O
intact JJ O O
. . B-VP O
   
Endocrine NN B-NP B-person
was VBD B-VP O
also RB O O
consulted VBN O O
. . B-VP O
   
Several JJ B-NP B-test
labs NNS I-NP I-test
were VBD B-VP O
ordered VBN O O
. . B-VP O
   
Electrolytes NNS B-NP B-test
and CC O O
thyroid JJ B-NP B-test
studies NNS I-NP I-test
were VBD B-VP O
noted VBN O O
to TO O O
be VB O O
in IN B-VP O
the DT B-NP O
normal JJ I-NP O
range NN I-NP O
with IN B-VP O
serum JJ B-NP B-test
sodium NN I-NP I-test
of IN B-VP O
136 CD O O
, , O O
potassium NN B-NP B-test
4.7 CD O O
, , O O
chloride RB O B-test
98 CD O O
and CC O O
CO2 NNP B-NP B-test
34 CD O O
. . B-VP O
   
She PRP O B-person
had VBD B-VP O
a DT B-NP B-test
calcium NN I-NP I-test
of IN B-VP O
10.3 CD O O
, , O O
a DT B-NP B-test
phosphorus NN I-NP I-test
of IN B-VP O
4.8 CD O O
and CC O O
alkaline JJ B-NP B-test
phosphatase NN I-NP I-test
of IN B-VP O
440 CD O O
. . B-VP O
   
Thyroid NNP B-NP B-test
function NN I-NP I-test
studies NNS I-NP I-test
revealed VBD B-VP O
a DT B-NP B-test
TSH NNP I-NP I-test
of IN B-VP O
2.2 CD O O
, , O O
T4 NNP B-NP B-test
of IN B-VP O
5.7 CD O O
, , O O
T3 NNP B-NP B-test
of IN B-VP O
101 CD O O
and CC O O
a DT B-NP B-test
cortisol JJ I-NP I-test
level NN I-NP I-test
of IN B-VP O
43 CD O O
, , O O
all DT O O
within IN B-VP O
the DT B-NP O
normal JJ I-NP O
range NN I-NP O
. . B-VP O
   
A DT B-NP B-test
growth NN I-NP I-test
hormone NN I-NP I-test
was VBD B-VP O
sent VBN O O
and CC O O
the DT B-NP O
results NNS I-NP O
were VBD B-VP O
pending VBG O O
at IN B-VP O
time NN B-NP O
of IN B-VP O
transfer NN B-NP O
. . B-VP O
   
In IN B-VP O
addition NN B-NP O
, , O O
an DT B-NP B-test
FSH NNP I-NP I-test
and CC O O
LH NNP B-NP B-test
were VBD B-VP O
obtained VBN O O
on IN B-VP O
12-10 JJ O O
and CC O O
results NNS B-NP O
are VBP O O
pending VBG O O
at IN B-VP O
time NN B-NP O
of IN B-VP O
transfer NN B-NP O
. . B-VP O
   
Please NNP B-NP O
contact JJ B-NP O
lab NN I-NP O
control NN I-NP O
at IN B-VP O
Mattapan NNP B-NP O
Community NNP I-NP O
Health NNP I-NP O
Center NNP I-NP O
for IN B-VP O
results NNS B-NP O
: : O O
( ( O O
409 CD O O
) ) O O
238-8236 CD O O
. . B-VP O
   
The DT O B-person
The DT B-NP B-test
baby NN I-NP I-person
baby NN I-NP I-test
's POS O I-test
neurologic JJ B-NP I-test
examination NN I-NP I-test
is VBZ O O
appropriate JJ O O
for IN B-VP O
corrected JJ B-NP O
gestational JJ I-NP O
age NN I-NP O
which WDT O B-pronoun
is VBZ O O
33 CD O O
and CC O O
6/7 CD O O
weeks NNS B-NP O
on IN B-VP O
day NN B-NP O
of IN B-VP O
transfer NN B-NP O
. . B-VP O
   
By IN B-VP O
mother NN B-NP B-person
's POS O O
report NN B-NP O
, , O O
a DT B-NP B-person
maternal JJ I-NP I-person
cousin NN I-NP I-person
also RB O O
has VBZ O O
an DT B-NP B-problem
absent JJ I-NP I-problem
septum NN I-NP I-problem
pellucidum NN I-NP I-problem
. . B-VP O
   
Given VBN O O
normal JJ B-NP O
pituitary JJ I-NP O
tests NNS I-NP O
thus RB O O
far RB O O
and CC O O
normal JJ B-NP O
optic JJ I-NP O
nerve NN I-NP O
, , O O
no DT B-NP O
evidence NN I-NP O
of IN B-VP O
septic JJ B-NP B-problem
optic JJ I-NP I-problem
dysplasia NN I-NP I-problem
. . B-VP O
   
Pediatrician NN B-NP B-person
should MD O O
have VB O O
low JJ B-NP O
threshold NN I-NP O
for IN B-VP O
endocrinology NN B-NP O
reconsult NN I-NP O
if IN B-VP O
any DT B-NP B-problem
signs NNS I-NP I-problem
of IN B-VP I-problem
pituitary JJ B-NP I-problem
problems NNS I-NP I-problem
. . B-VP O
   
Sensory NN B-NP O
: : O O
Audiology NNP B-NP O
hearing NN I-NP O
has VBZ O O
not RB O O
yet RB O O
been VBN O O
obtained VBN O O
. . B-VP O
   
This DT O B-pronoun
is VBZ O O
recommended VBN O O
prior RB O O
to TO O O
discharge VB O O
from IN B-VP O
hospital NN B-NP O
to TO O O
home NN B-NP O
. . B-VP O
   
Ophthalmology NN B-NP O
: : O O
Initial JJ B-NP B-test
ROP NNP I-NP I-test
screen NN I-NP I-test
was VBD B-VP O
done VBN O O
on IN B-VP O
12-02 JJ O O
and CC O O
revealed JJ B-NP O
immature NN I-NP B-problem
retinas NN I-NP I-problem
to TO O I-problem
zone CD O I-problem
2 CD O I-problem
bilaterally RB O I-problem
. . B-VP O
   
They PRP O B-pronoun
recommended VBD B-VP O
follow-up JJ B-NP B-test
examination NN I-NP I-test
due JJ O O
on IN B-VP O
the DT B-NP O
week NN I-NP O
of IN B-VP O
12/20 CD O O
. . B-VP O
   
Psychosocial JJ O O
: : O O
Gardner NNP B-NP B-person
State NNP I-NP I-person
Hospital NNP I-NP I-person
social JJ B-NP I-person
worker NN I-NP I-person
has VBZ O O
assisted VBN O O
in IN B-VP O
working VBG O O
with IN B-VP O
this DT O B-person
this DT B-NP B-pronoun
family NN I-NP I-person
. . B-VP O
   
The DT B-NP B-person
contact NN I-NP I-person
may MD O O
be VB O O
reached VBN O O
at IN B-VP O
( ( O O
754 CD O O
) ) O O
791 CD O O
7976 CD O O
. . B-VP O
   
Parents NNS B-NP B-person
have VBP O O
been VBN O O
very RB O O
involved JJ O O
and CC O O
appropriate JJ O O
with IN B-VP O
infant NN B-NP B-person
and CC O O
have VBP O O
eagerly RB O O
learned VBN O O
to TO O O
care VB O O
for IN B-VP O
their PRP$ O B-person
their PRP$ O B-person
baby NN B-NP I-person
. . B-VP O
   
Condition NN B-NP O
at IN B-VP O
time NN B-NP O
of IN B-VP O
transfer NN B-NP O
is VBZ O O
good JJ O O
. . B-VP O
   
Discharge NNP B-NP O
disposition NN I-NP O
is VBZ O O
to TO O O
level VB O O
2 CD O O
nursery NN B-NP O
at IN B-VP O
Jordan NNP B-NP O
Hospital NNP I-NP O
Hospital NNP I-NP O
. . B-VP O
   
Name NN B-NP O
of IN B-VP O
primary JJ B-NP B-person
pediatrician NN I-NP I-person
is VBZ O O
Ashley NNP B-NP B-person
Daley NNP I-NP I-person
of IN B-VP O
Village NNP B-NP O
Pediatrics NNPS I-NP O
in IN B-VP O
Stockbridge NNP B-NP O
. . B-VP O
   
Feedings NNS B-NP O
at IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
transfer NN B-NP O
include VBP O O
breast NN B-NP O
milk NN I-NP O
30 CD O O
with IN B-VP O
ProMod NNP B-NP B-treatment
at IN B-VP O
150 CD O O
cc NN B-NP O
per IN B-VP O
kg FW O O
per IN B-VP O
day NN B-NP O
, , O O
all DT B-NP O
gavage NN I-NP B-treatment
given VBN O O
over IN B-VP O
one CD O O
hour NN B-NP O
. . B-VP O
   
Medications NNS B-NP B-treatment
include VBP O O
Fer-In-Norman NNP B-NP B-treatment
, , O O
vitamin NN B-NP B-treatment
E NNP I-NP I-treatment
5 CD O O
international JJ B-NP O
units NNS I-NP O
each DT B-NP O
day NN I-NP O
and CC O O
caffeine NN B-NP B-treatment
citrate NN I-NP I-treatment
once IN B-VP O
a DT B-NP O
day NN I-NP O
. . B-VP O
   
Car NNP B-NP B-test
seat NN I-NP I-test
positioning VBG O I-test
screening NN B-NP I-test
has VBZ O O
not RB O O
been VBN O O
obtained VBN O O
. . B-VP O
   
Newborn NNP B-NP B-test
state NN I-NP I-test
screens NNS I-NP I-test
have VBP O O
been VBN O O
sent VBN O O
per IN B-VP O
protocol NN B-NP O
. . B-VP O
   
Results NNS B-NP O
have VBP O O
been VBN O O
in IN B-VP O
the DT B-NP O
normal JJ I-NP O
range NN I-NP O
. . B-VP O
   
IMMUNIZATIONS NNP B-NP O
RECEIVED NNP I-NP O
: : O O
Mychelia NNP B-NP B-person
received VBD B-VP O
hepatitis NN B-NP B-treatment
B NNP I-NP I-treatment
vaccine NN I-NP I-treatment
on IN B-VP O
11-02 JJ O O
due JJ O O
to TO O O
unknown JJ B-NP O
maternal JJ I-NP O
hepatitis NN I-NP O
B NNP I-NP O
surface NN I-NP O
antigen NN I-NP O
status NN I-NP O
. . B-VP O
   
She PRP O B-person
also RB O O
received VBD B-VP O
hepatitis NN B-NP B-treatment
B NNP I-NP I-treatment
immune NN I-NP I-treatment
globulin NN I-NP I-treatment
on IN B-VP O
11-02 JJ O O
. . B-VP O
   
On IN B-VP O
12-06 JJ O O
, , O O
she PRP O B-person
received VBD B-VP O
her PRP O B-person
her PRP$ O B-treatment
second JJ B-NP I-treatment
hepatitis NN I-NP I-treatment
B NNP I-NP I-treatment
vaccine NN I-NP I-treatment
. . B-VP O
   
Her PRP$ O B-person
Her PRP$ O B-treatment
two CD O I-treatment
month NN B-NP I-treatment
immunizations NNS I-NP I-treatment
have VBP O O
not RB O O
yet RB O O
been VBN O O
given VBN O O
. . B-VP O
   
IMMUNIZATIONS NNP B-NP O
RECOMMENDED NNP I-NP O
: : O O
Synagis NNP B-NP B-treatment
RSV NNP I-NP I-treatment
prophylaxis NN I-NP I-treatment
should MD O O
be VB O O
considered VBN O O
from IN B-VP O
November NNP B-NP O
through IN B-VP O
March NNP B-NP O
for IN B-VP O
infants NNS B-NP B-person
who WP O B-person
meet VBP O O
any DT O O
of IN B-VP O
the DT O O
following JJ O O
three CD O O
criteria NNS B-NP O
: : O O
1) CD O O
born NN B-NP O
at IN B-VP O
less JJR O O
than IN B-VP O
32 CD O O
weeks NNS B-NP O
, , O O
2) CD O O
born VBN O O
at IN B-VP O
between IN B-VP O
32 CD O O
and CC O O
35 CD O O
weeks NNS B-NP O
with IN B-VP O
two CD O O
of IN B-VP O
the DT B-NP O
following NN I-NP O
: : O O
Daycare NNP B-NP O
during IN B-VP O
RSV NNP B-NP O
season NN I-NP O
, , O O
a DT B-NP O
smoker NN I-NP O
in IN B-VP O
the DT B-NP O
household NN I-NP O
, , O O
neuromuscular JJ B-NP B-problem
disease NN I-NP I-problem
, , O O
airway JJ B-NP B-problem
abnormalities NNS I-NP I-problem
or CC O O
school NN B-NP B-person
age NN I-NP I-person
siblings NNS I-NP I-person
or CC O O
3) CD O O
infants NNS B-NP B-person
with IN B-VP O
chronic JJ B-NP B-problem
lung NN I-NP I-problem
disease NN I-NP I-problem
. . B-VP O
   
Influenza NNP B-NP B-treatment
immunization NN I-NP I-treatment
is VBZ O O
recommended VBN O O
annually RB O O
in IN B-VP O
the DT B-NP O
fall NN I-NP O
for IN B-VP O
all DT B-NP O
infants NNS I-NP B-person
once IN B-VP O
they PRP O B-pronoun
reach VBP O O
6 CD O O
months NNS B-NP O
of IN B-VP O
age NN B-NP O
. . B-VP O
   
Before IN B-VP O
this DT B-NP B-pronoun
age NN I-NP O
and CC O O
for IN B-VP O
the DT O O
first JJ O O
24 CD O O
months NNS B-NP O
of IN B-VP O
the DT B-NP B-person
infant NN I-NP I-person
's POS O O
life NN B-NP O
, , O O
immunization NN B-NP B-treatment
against IN B-VP O
influenza NN B-NP B-problem
is VBZ O O
recommended VBN O O
for IN B-VP O
household NN B-NP B-person
contacts NNS I-NP I-person
and CC O O
out IN B-VP B-person
of IN B-VP I-person
home NN B-NP I-person
caregivers NNS I-NP I-person
. . B-VP O
   
Follow-up JJ B-NP O
appointments NNS I-NP O
recommended VBN O O
with IN B-VP O
the DT B-NP B-person
primary JJ I-NP I-person
pediatrician NN I-NP I-person
, , O O
Dr. NNP B-NP B-person
Marilyn NNP I-NP I-person
Daley NNP I-NP I-person
of IN B-VP O
Stockbridge NNP B-NP O
, , O O
Village NNP B-NP O
Pediatrics NNP I-NP O
, , O O
Dr. NNP B-NP B-person
Lynn NNP I-NP I-person
Warren NNP I-NP I-person
of IN B-VP O
Neurology NNP B-NP B-person
from IN B-VP O
Emerson NNP B-NP O
Hospital NNP I-NP O
and CC O O
Ophthalmology NNP B-NP O
to TO O O
follow VB O O
her PRP$ O B-person
ophthalmology NN B-NP O
status NN I-NP O
. . B-VP O
   
DISCHARGE NNP B-NP O
DIAGNOSES NNP I-NP O
: : O O
1. CD O O
Prematurity NN B-NP B-problem
at IN B-VP O
28-2/7 JJ B-NP O
weeks NNS I-NP O
. . B-VP O
   
2. CD O O
Surfactant JJ B-NP B-problem
deficiency NN I-NP I-problem
. . B-VP O
   
3. CD O O
Hypotension NNP B-NP B-problem
. . B-VP O
   
4. CD O O
Sepsis NN B-NP B-problem
suspect NN I-NP O
. . B-VP O
   
5. CD O O
Physiologic NNP B-NP B-problem
jaundice NN I-NP I-problem
. . B-VP O
   
6. CD O O
Coagulase NNP B-NP B-problem
negative JJ B-NP I-problem
bacteremia NN I-NP I-problem
. . B-VP O
   
7. CD O O
Anemia NNP B-NP B-problem
of IN B-VP I-problem
prematurity NN B-NP I-problem
. . B-VP O
   
8. CD O O
Apnea NNP B-NP B-problem
of IN B-VP I-problem
prematurity NN B-NP I-problem
. . B-VP O
   
9. CD O O
Absent NNP B-NP B-problem
septum NN I-NP I-problem
pellucidum NN I-NP I-problem
. . B-VP O
   
Rosalie NNP B-NP B-person
Gloria NNP I-NP I-person
, , O O
North NNP B-NP O
Dakota NNP I-NP O
67177 CD O O
Dictated VBN O O
By IN B-VP O
: : O O
George NNP B-NP B-person
D NNP I-NP I-person
Gregory NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
MEDQUIST36 NNP I-NP O
D NNP I-NP O
: : O O
2013-12-10 JJ O O
12:41:22 CD O O
T NN B-NP O
: : O O
2013-12-10 JJ O O
14:03:32 CD O O
Job NNP B-NP O
# # O O
: : O O
48183 CD O O
Signed VBN O O
electronically RB O O
by IN B-VP O
: : O O
DR. NNP B-NP B-person
Yolanda NNP I-NP I-person
Corona NNP I-NP I-person
on IN B-VP O
: : O O
WED JJ O O
2013-12-11 JJ O O
11:46 CD O O
AM NNP B-NP O
( ( O O
End NNP B-NP O
of IN B-VP O
Report NNP B-NP O
) ) O O
-EMPTYLINE- VBP O O
-DOCSTART- JJ B-NP O
-EMPTYLINE- NNP I-NP O
Admission NNP I-NP O
Date NNP I-NP O
: : O O
2011-02-06 JJ B-NP O
Discharge NN I-NP O
Date NNP I-NP O
: : O O
2011-02-08 JJ B-NP O
Date NNP I-NP O
of IN B-VP O
Birth NNP B-NP O
: : O O
Sex NN B-NP O
: : O O
M NNP B-NP O
Service NNP I-NP O
: : O O
HISTORY NN B-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS NNP I-NP O
: : O O
Mr. NNP B-NP B-person
Pohl NNP I-NP I-person
is VBZ O O
a DT O O
53 JJ O O
- : O O
year-old JJ B-NP O
male NN I-NP O
with IN B-VP O
history NN B-NP O
of IN B-VP O
alcohol NN B-NP O
use NN I-NP O
and CC O O
hypertension NN B-NP B-problem
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
found VBN O O
in IN B-VP O
his PRP$ O B-person
apartment NN B-NP O
lobby NN I-NP O
" NN I-NP O
shouting VBG O O
" NNS B-NP O
and CC O O
very RB O B-problem
agitated JJ O I-problem
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
states VBZ O O
that IN B-VP B-pronoun
he PRP O B-person
recalls VBZ O O
going VBG O O
out RP O O
alone RB O O
to TO O O
a DT O O
cafe JJ O O
the DT B-NP O
evening NN I-NP O
prior RB O O
to TO O O
admission NN B-NP O
. . B-VP O
   
There EX O O
he PRP O B-person
recalls VBZ O O
having VBG O O
pizza VBN O O
and CC O O
two CD O O
glasses NNS B-NP O
of IN B-VP O
red JJ B-NP O
wine NN I-NP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
told VBD B-VP O
other JJ B-NP B-person
staff NN I-NP I-person
that IN B-VP B-pronoun
he PRP O B-person
had VBD B-VP O
a DT B-NP O
few JJ I-NP O
cocktails NNS I-NP O
and CC O O
drinking VBG O O
a DT B-NP O
few JJ I-NP O
more JJR I-NP O
glasses NNS I-NP O
of IN B-VP O
wine NN B-NP O
when WRB O O
he PRP O B-person
ran VBD B-VP O
into IN B-VP O
some DT B-NP O
friends NNS I-NP O
at IN B-VP O
a DT B-NP O
bar NN I-NP O
. . B-VP O
   
He PRP O B-person
denies VBZ O O
any DT B-NP O
other JJ I-NP O
drug NN I-NP O
or CC O O
toxin NN B-NP O
ingestion NN I-NP O
. . B-VP O
   
He PRP O B-person
does VBZ O O
not RB O O
recall VB O O
walking VBG O O
home NN B-NP O
, , O O
but CC O O
he PRP O B-person
states VBZ O O
that IN B-VP B-pronoun
the DT B-NP O
way NN I-NP O
is VBZ O O
well RB O O
known VBN O O
to TO O O
him PRP O B-person
. . B-VP O
   
He PRP O B-person
has VBZ O O
no DT B-NP O
further JJ I-NP O
recollection NN I-NP O
, , O O
until IN B-VP O
he PRP O B-person
presented VBD B-VP O
to TO O O
the DT B-NP O
emergency NN I-NP O
room NN I-NP O
. . B-VP O
   
He PRP O B-person
by IN B-VP O
emergency NN B-NP O
room NN I-NP O
report NN I-NP O
, , O O
was VBD B-VP O
found VBN O O
in IN B-VP O
his PRP$ O B-person
apartment NN B-NP O
lobby NN I-NP O
agitated VBN O B-problem
. . B-VP O
   
EMS NNP B-NP O
was VBD B-VP O
called VBN O O
and CC O O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
taken VBN O O
to TO O O
the DT B-NP O
emergency NN I-NP O
room NN I-NP O
. . B-VP O
   
Blood NNP B-NP B-test
alcohol NN I-NP I-test
level NN I-NP I-test
was VBD B-VP O
383 CD O O
. . B-VP O
   
Agitated VBN O B-problem
in IN B-VP O
emergency NN B-NP O
room NN I-NP O
requiring VBG O O
4 CD O B-treatment
leather NN B-NP I-treatment
restraints NNS I-NP I-treatment
, , O O
received VBD B-VP O
5 CD O O
mg NN B-NP O
of IN B-VP O
Haldol NNP B-NP B-treatment
, , O O
2 CD O O
mg NN B-NP O
of IN B-VP O
Ativan NNP B-NP B-treatment
. . B-VP O
   
He PRP O B-person
became VBD B-VP O
hypotensive JJ O B-problem
in IN B-VP O
the DT B-NP O
emergency NN I-NP O
room NN I-NP O
with IN B-VP O
a DT B-NP B-test
systolic JJ I-NP I-test
blood NN I-NP I-test
pressure NN I-NP I-test
in IN B-VP O
the DT O O
80 CD O O
's POS O O
and CC O O
had VBD B-VP O
decreased VBN O B-problem
respiratory NN B-NP I-problem
rate NN I-NP I-problem
. . B-VP O
   
He PRP O B-person
received VBD B-VP O
a DT B-NP B-treatment
normal JJ I-NP I-treatment
saline JJ I-NP I-treatment
bolus NN I-NP I-treatment
of IN B-VP O
2 CD O O
liters NNS B-NP O
of IN B-VP O
good JJ B-NP O
blood NN I-NP O
pressure NN I-NP O
response NN I-NP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
then RB O O
admitted VBN O O
to TO O O
the DT B-NP O
medical JJ I-NP O
Intensive NNP I-NP O
Care NNP I-NP O
Unit NNP I-NP O
for IN B-VP O
observation NN B-NP O
of IN B-VP O
his PRP$ O B-person
his PRP$ O B-test
blood NN B-NP I-test
pressure NN I-NP I-test
and CC O O
then RB O O
transferred VBD B-VP O
to TO O O
our PRP$ O B-person
service NN B-NP O
on IN B-VP O
medicine NN B-NP O
when WRB O O
the DT B-NP B-test
blood NN I-NP I-test
pressures NNS I-NP I-test
remained VBD B-VP O
stable JJ B-NP O
overnight NN I-NP O
. . B-VP O
   
The DT O B-person
patient JJ O I-person
denies VBZ O O
any DT B-NP B-problem
chest NN I-NP I-problem
pain NN I-NP I-problem
, , O O
shortness NN B-NP B-problem
of IN B-VP I-problem
breath NN B-NP I-problem
, , O O
dysuria NN B-NP B-problem
, , O O
diarrhea NN B-NP B-problem
, , O O
bright JJ B-NP B-problem
red JJ I-NP I-problem
blood NN I-NP I-problem
per IN B-VP I-problem
rectum NN B-NP I-problem
. . B-VP O
   
He PRP O B-person
does VBZ O O
complain VB O O
of IN B-VP O
cold NN B-NP B-problem
symptoms NNS I-NP I-problem
times NNS I-NP O
one CD O O
week NN B-NP O
. . B-VP O
   
The DT B-NP B-person
patient JJ I-NP I-person
states NNS I-NP O
in IN B-VP O
the DT B-NP O
past NN I-NP O
that IN B-VP B-pronoun
he PRP O B-person
has VBZ O O
participated VBN O O
in IN B-VP O
several JJ B-NP O
alcohol NN I-NP B-treatment
treatment NN I-NP I-treatment
programs NNS I-NP I-treatment
, , O O
most JJS O O
recently RB O O
Star NNP B-NP O
which WDT O B-pronoun
is VBZ O O
similar JJ B-NP O
Alcoholics NNPS I-NP O
Anonymous NNP I-NP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
admits VBZ O O
that IN B-VP B-pronoun
he PRP O B-person
has VBZ O O
had VBD B-VP O
many JJ B-NP O
stressors NNS I-NP O
in IN B-VP O
his PRP$ O B-person
life NN B-NP O
lately RB O O
. . B-VP O
   
His PRP$ O B-person
job NN B-NP O
as IN B-VP O
a DT B-NP O
computer NN I-NP O
programmer NN I-NP O
is VBZ O O
unstable JJ O O
. . B-VP O
   
His PRP$ O B-person
His PRP$ O B-person
brother NN B-NP I-person
is VBZ O O
mentally RB O B-problem
handicapped JJ O I-problem
and CC O O
might MD O O
be VB O O
sent VBN O O
away RB O O
from IN B-VP O
his PRP$ O B-person
instate JJ B-NP O
institution NN I-NP O
. . B-VP O
   
He PRP O B-person
is VBZ O O
also RB O O
concerned VBN O O
about IN B-VP O
the DT B-NP O
threat NN I-NP O
of IN B-VP O
war NN B-NP O
and CC O O
is VBZ O O
ready JJ O O
to TO O O
" VB O O
move NN B-NP O
to TO O O
Madagascar NNP B-NP O
". NNP I-NP O
He PRP O B-person
states VBZ O O
that IN B-VP B-pronoun
he PRP O B-person
primarily RB O O
relies VBZ O O
on IN B-VP O
friends NNS B-NP B-person
. . B-VP O
   
In IN B-VP O
the DT B-NP O
past NN I-NP O
, , O O
he PRP O B-person
has VBZ O O
been VBN O O
very RB O B-problem
depressed JJ O I-problem
and CC O O
has VBZ O O
seen VBN O O
a DT B-NP B-treatment
counselor NN I-NP I-treatment
at IN B-VP O
Greenfield NNP B-NP O
Community NNP I-NP O
College NNP I-NP O
Community NNP I-NP O
Health NNP I-NP O
. . B-VP O
   
PAST NNP B-NP O
MEDICAL NNP I-NP O
HISTORY NNP I-NP O
: : O O
1. CD O O
Hypertension NNP B-NP B-problem
. . B-VP O
   
2. CD O O
History NN B-NP O
of IN B-VP O
colonic JJ B-NP B-problem
polyps NNS I-NP I-problem
times NNS I-NP O
3 CD O O
, , O O
benign NN B-NP O
in IN B-VP O
2007 CD O O
, , O O
repeat NN B-NP B-test
colonoscopy NN I-NP I-test
due JJ O O
to TO O O
in IN B-VP O
2010 CD O O
. . B-VP O
   
3. CD O O
History NN B-NP O
of IN B-VP O
right JJ B-NP B-problem
inguinal JJ I-NP I-problem
hernia NN I-NP I-problem
in IN B-VP O
2002 CD O O
. . B-VP O
   
FAMILY NNP B-NP B-person
HISTORY NNP I-NP O
: : O O
Noncontributory NN B-NP O
. . B-VP O
   
SOCIAL NNP B-NP O
HISTORY NNP I-NP O
: : O O
Positive JJ B-NP O
tobacco NN I-NP O
, , O O
10 CD O O
pack NN B-NP O
year NN I-NP O
history NN I-NP O
, , O O
quit NN B-NP O
for IN B-VP O
8 CD O O
years NNS B-NP O
in IN B-VP O
his PRP$ O B-person
40 CD O O
's POS O O
and CC O O
now RB O O
no DT B-NP O
cigarettes NNS I-NP O
for IN B-VP O
one CD O O
week NN B-NP O
using VBG O O
no DT B-NP O
pharmacal JJ I-NP B-treatment
therapy NN I-NP I-treatment
. . B-VP O
   
Positive NNP B-NP O
for IN B-VP O
ETOH NNP B-NP O
( ( O O
10 CD O O
glasses NNS B-NP O
a DT B-NP O
week NN I-NP O
), RB O O
positive JJ O O
for IN B-VP O
drugs NNS B-NP O
, , O O
marijuana NN B-NP O
in IN B-VP O
college NN B-NP O
. . B-VP O
   
He PRP O B-person
denies VBZ O O
any DT B-NP O
IV NNP I-NP O
drug NN I-NP O
use NN I-NP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
currently RB O O
lives VBZ O O
lone NN B-NP O
in IN B-VP O
Malden NNP B-NP O
. . B-VP O
   
He PRP O B-person
came VBD B-VP O
out RP O O
here RB O O
for IN B-VP O
college NN B-NP O
at IN B-VP O
BU NNP B-NP O
and CC O O
works VBZ O O
as IN B-VP O
a DT B-NP O
computer NN I-NP O
programmer NN I-NP O
. . B-VP O
   
Primarily RB O O
the DT B-NP B-person
family NN I-NP I-person
lives VBZ O O
in IN B-VP O
Wisconsin NNP B-NP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
has VBZ O O
only RB O O
male JJ B-NP O
sexual JJ I-NP O
partners NNS I-NP O
and CC O O
in IN B-VP O
the DT O O
last JJ O O
six CD O O
months NNS B-NP O
has VBZ O O
two CD O O
regular JJ B-NP O
partners NNS I-NP O
who WP O B-person
reportedly RB O O
are VBP O O
human JJ B-NP B-problem
immunodeficiency NN I-NP I-problem
virus NN I-NP I-problem
negative JJ O O
and CC O O
no DT B-NP O
IV NNP I-NP O
drug NN I-NP O
use NN I-NP O
. . B-VP O
   
He PRP O B-person
uses VBZ O O
condoms NNS B-NP B-treatment
consistently RB O O
. . B-VP O
   
Major JJ B-NP O
stressors NNS I-NP O
in IN B-VP O
his PRP$ O B-person
life NN B-NP O
include VBP O O
unstable JJ B-NP O
job NN I-NP O
, , O O
brother NN B-NP B-person
is VBZ O O
mentally RB O B-problem
handicapped JJ O I-problem
, , O O
war NN B-NP O
. . B-VP O
   
ALLERGIES NN B-NP O
: : O O
No DT B-NP O
known JJ I-NP B-problem
drug NN I-NP I-problem
allergies NNS I-NP I-problem
. . B-VP O
   
MEDICATIONS NNP B-NP O
AT NNP I-NP O
HOME NNP I-NP O
: : O O
1. CD O O
Lisinopril NNP B-NP B-treatment
5 CD O O
mg NN B-NP O
p.o. NN I-NP O
q.d. VBD B-VP O
2. CD O O
Mavik NNP B-NP B-treatment
question NN I-NP O
of IN B-VP O
dosage NN B-NP O
. . B-VP O
   
3. CD O O
Hydrochlorothiazide NNP B-NP B-treatment
question NN I-NP O
of IN B-VP O
dosage NN B-NP O
. . B-VP O
   
MEDICATIONS NNP B-NP O
ON NNP I-NP O
TRANSFER NNP I-NP O
: : O O
1. CD O O
Ranitidine NNP B-NP B-treatment
150 CD O O
mg NN B-NP O
b.i.d. NN I-NP O
2. CD O O
Thiamine NNP B-NP B-treatment
100 CD O O
mg NN B-NP O
q.d. NN I-NP O
3. CD O O
Folic NNP B-NP B-treatment
acid VBD B-VP I-treatment
1 CD O O
mg NN B-NP O
q. NN I-NP O
d. VBZ O O
4. CD O O
Multivitamin NNP B-NP B-treatment
PHYSICAL NNP I-NP O
EXAMINATION NNP I-NP O
: : O O
Vitals NNS B-NP B-test
on IN B-VP I-test
admission NN B-NP I-test
: : O O
Please NNP B-NP O
refer VB O O
to TO O O
addendum VB O O
. . B-VP O
   
Vital JJ B-NP B-test
signs NNS I-NP I-test
were VBD B-VP O
stable JJ O O
. . B-VP O
   
Systolic JJ B-NP B-test
blood NN I-NP I-test
pressure NN I-NP I-test
in IN B-VP O
the DT O O
120 CD O O
's POS O O
to TO O O
130 CD O O
's. NNS B-NP O
Pulse NNP I-NP B-test
in IN B-VP O
the DT O O
60 CD O O
's POS O O
to TO O O
70 CD O O
's. PDT O O
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
a DT B-NP O
thin JJ I-NP O
well-appearing JJ I-NP O
man NN I-NP O
who WP O B-person
was VBD B-VP O
visibly RB O B-problem
restless JJ O I-problem
in IN B-VP O
bed NN B-NP O
. . B-VP O
   
Neurological JJ O O
: : O O
He PRP O B-person
was VBD B-VP O
alert JJ O O
and CC O O
oriented VBD B-VP O
times NNS B-NP O
3 CD O O
and CC O O
with IN B-VP O
slightly RB O B-problem
pressured VBN O I-problem
speech NN B-NP I-problem
. . B-VP O
   
He PRP O B-person
states VBZ O O
that IN B-VP B-pronoun
mood NN B-NP O
is VBZ O O
depressed VBN O B-problem
. . B-VP O
   
He PRP O B-person
denies VBZ O O
auditory NN B-NP B-problem
, , O I-problem
visual JJ O I-problem
or CC O I-problem
tactile JJ B-NP I-problem
hallucinations NNS I-NP I-problem
. . B-VP O
   
Cranial JJ B-NP O
nerves NNS I-NP O
II-XII NNP I-NP O
are VBP O O
grossly RB O O
intact JJ O O
, , O O
5/5 CD O O
strength NN B-NP B-test
in IN B-VP I-test
all DT B-NP I-test
extremities NNS I-NP I-test
, , O O
sensation NN B-NP O
is VBZ O O
intact JJ O O
in IN B-VP O
all DT B-NP O
extremities NNS I-NP O
. . B-VP O
   
Head NNP B-NP O
, , O O
ears VBZ O O
, , O O
eyes NNS B-NP O
, , O O
nose RB O O
and CC O O
throat NN B-NP O
: : O O
Atraumatic JJ O B-problem
and CC O O
normocephalic JJ O O
. . B-VP O
   
Sclerae NNP B-NP O
were VBD B-VP O
anicteric JJ O B-problem
. . B-VP O
   
Oropharynx NNP B-NP O
was VBD B-VP O
benign VBN O O
without IN B-VP O
exudate NN B-NP B-problem
. . B-VP O
   
Neck NN B-NP O
: : O O
Supple NN B-NP O
. . B-VP O
   
Cardiovascular JJ O O
: : O O
Regular JJ B-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
with IN B-VP O
normal JJ B-NP O
S1 NNP I-NP O
and CC O O
S2 NNP B-NP O
. . B-VP O
   
NO NNP B-NP O
murmurs NN I-NP B-problem
, , O O
rubs NN B-NP B-problem
or CC O O
gallops NNS B-NP B-problem
. . B-VP O
   
Chest JJS O O
: : O O
Rare JJ B-NP B-problem
crackles NNS I-NP I-problem
on IN B-VP I-problem
the DT B-NP I-problem
right JJ I-NP I-problem
base NN I-NP I-problem
, , O O
otherwise RB O O
clear JJ O O
to TO O O
auscultation VB O B-test
bilaterally RB O I-test
. . B-VP O
   
Abdomen NNS B-NP O
: : O O
Positive NNP B-NP O
bowel NN I-NP O
sounds NNS I-NP O
, , O O
nontender NN B-NP B-problem
and CC O O
nondistended VBD B-VP B-problem
. . B-VP O
   
No DT B-NP O
hepatosplenomegaly NN I-NP B-problem
. . B-VP O
   
Extremities NNS B-NP O
: : O O
He PRP O B-person
had VBD B-VP O
Dorsalis NNP B-NP B-test
pedis NN I-NP I-test
in IN B-VP O
radial JJ B-NP B-test
pulses NNS I-NP I-test
, , O O
hands NNS B-NP B-problem
and CC O I-problem
feet NNS B-NP I-problem
notably RB O I-problem
tremulous JJ O I-problem
without IN B-VP O
asterixis NN B-NP B-problem
. . B-VP O
   
No DT B-NP O
stigmata NN I-NP B-problem
of IN B-VP O
IV NNP B-NP O
drug NN I-NP O
use NN I-NP O
. . B-VP O
   
LABORATORY NNP B-NP O
DATA NNP I-NP O
: : O O
CBC NN B-NP B-test
: : O O
White NNP B-NP B-test
blood NN I-NP I-test
cell NN I-NP I-test
count NN I-NP I-test
is VBZ O O
8.8 CD O O
, , O O
hematocrit NN B-NP B-test
35.5 CD O O
platelets NNS B-NP B-test
266 CD O O
, , O O
PT NNP B-NP B-test
13 CD O O
, , O O
PT-T NNP B-NP B-test
23.3 CD O O
, , O O
INR NNP B-NP B-test
was VBD B-VP O
1.1 CD O O
. . B-VP O
   
Chem-7 NN B-NP B-test
: : O O
Sodium NN B-NP B-test
145 CD O O
, , O O
potassium NN B-NP B-test
3.4 CD O O
, , O O
chloride RB O B-test
116 CD O O
, , O O
bicarb NN B-NP B-test
21 CD O O
, , O O
BUN NNP B-NP B-test
12 CD O O
, , O O
creatinine NN B-NP B-test
0.6 CD O O
, , O O
glucose RB O B-test
96 CD O O
, , O O
calcium NN B-NP B-test
7.2 CD O O
, , O O
phos NN B-NP B-test
3.6 CD O O
, , O O
magnesium NN B-NP B-test
1.7 CD O O
. . B-VP O
   
Liver NNP B-NP B-test
function NN I-NP I-test
tests NNS I-NP I-test
: : O O
ALT NNP B-NP B-test
38 CD O O
, , O O
AST NNP B-NP B-test
34 CD O O
, , O O
alk NN B-NP B-test
phos NN I-NP I-test
is VBZ O I-test
107 CD O O
, , O O
albumin NN B-NP B-test
is VBZ O O
3.2 CD O O
, , O O
peak NN B-NP B-test
bili NN I-NP I-test
is VBZ O I-test
0.3 CD O O
, , O O
amylase NN B-NP B-test
31 CD O O
, , O O
and CC O O
lipase NN B-NP B-test
is VBZ O O
32 CD O O
. . B-VP O
   
UA NNP B-NP B-test
was VBD B-VP O
negative JJ O O
. . B-VP O
   
Urine NNP B-NP B-test
tox NN I-NP I-test
was VBD B-VP O
negative JJ O O
. . B-VP O
   
Serum NNP B-NP B-test
tox NN I-NP I-test
was VBD B-VP O
positive JJ O O
for IN B-VP O
ETOH NNP B-NP B-test
at IN B-VP O
383 CD O O
, , O O
otherwise RB O O
negative JJ O O
. . B-VP O
   
Serum NNP B-NP B-test
osmolality NN I-NP I-test
was VBD B-VP O
38397 CD O O
, , O O
calculated VBN O B-test
osmolality NN B-NP I-test
gap NN I-NP I-test
was VBD B-VP O
21 CD O O
. . B-VP O
   
Radiology NN B-NP O
: : O O
chest JJS O B-test
x-ray JJ O I-test
from IN B-VP O
02-07 JJ O O
had VBD B-VP O
linear JJ B-NP B-problem
atelectasis NN I-NP I-problem
in IN B-VP I-problem
right JJ B-NP I-problem
lower JJR I-NP I-problem
lobe NN I-NP I-problem
with IN B-VP O
no DT B-NP O
evidence NN I-NP O
of IN B-VP O
a DT B-NP B-problem
band-like JJ I-NP I-problem
opacity NN I-NP I-problem
in IN B-VP I-problem
the DT B-NP I-problem
left NN I-NP I-problem
lower JJR B-NP I-problem
lobe NN I-NP I-problem
which WDT O B-pronoun
was VBD B-VP O
evident JJ O O
on IN B-VP O
the DT O B-test
chest JJS O I-test
x-ray JJ O I-test
on IN B-VP O
02-06 NN B-NP O
. . B-VP O
   
CT NNP B-NP B-test
of IN B-VP I-test
the DT B-NP I-test
head NN I-NP I-test
on IN B-VP O
02-06 NN B-NP O
was VBD B-VP O
negative JJ O O
for IN B-VP O
hemorrhage NN B-NP B-problem
. . B-VP O
   
There EX O O
was VBD B-VP O
bran NN B-NP B-problem
atrophy NN I-NP I-problem
and CC O O
right JJ B-NP B-problem
temporal JJ I-NP I-problem
encephalomalacia NN I-NP I-problem
. . B-VP O
   
ASSESSMENT NNP B-NP O
AND CC O O
PLAN NN B-NP O
: : O O
Mr. NNP B-NP B-person
Pohl NNP I-NP I-person
is VBZ O O
a DT O O
53 JJ O O
- : O O
year-old JJ B-NP O
male NN I-NP O
with IN B-VP O
a DT B-NP O
history NN I-NP O
of IN B-VP O
ETOH NNP B-NP O
, , O O
hypertension NN B-NP B-problem
who WP O B-person
presented VBD B-VP O
int NN B-NP O
he PRP O O
emergency NN B-NP O
room NN I-NP O
with IN B-VP O
increased JJ B-NP B-problem
agitation NN I-NP I-problem
, , O O
like IN B-VP O
secondary JJ O O
to TO O O
ETOH NNP B-NP B-problem
intoxication NN I-NP I-problem
and CC O O
developed VBD B-VP O
subsequent JJ B-NP B-problem
hypotension NN I-NP I-problem
, , O O
systolic JJ B-NP B-test
blood NN I-NP I-test
pressures NNS I-NP I-test
in IN B-VP O
the DT O O
80 CD O O
's, POS O O
status NN B-NP O
post NN I-NP O
Ativan NNP I-NP B-treatment
and CC O O
Haldol NNP B-NP B-treatment
, , O O
but CC O O
was VBD B-VP O
responsive JJ O O
to TO O O
fluid VB O B-treatment
resuscitation NN B-NP I-treatment
at IN B-VP O
4 CD O O
liters NNS B-NP O
and CC O O
was VBD B-VP O
admitted VBN O O
to TO O O
the DT B-NP O
CMED NNP I-NP O
CCU NNP I-NP O
for IN B-VP O
hemodynamic JJ B-NP B-test
monitoring NN I-NP I-test
. . B-VP O
   
On IN B-VP O
hospital JJ B-NP O
day NN I-NP O
#2 NNP I-NP O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
transferred VBN O O
to TO O O
the DT B-NP O
Medicine NNP I-NP O
Ludlow NNP I-NP O
Team NNP I-NP O
. . B-VP O
   
Plan NN B-NP O
for IN B-VP O
patient JJ O B-person
regarding VBG O O
cardiac NN B-NP O
, , O O
unlike IN B-VP O
hypotension NN B-NP B-problem
of IN B-VP I-problem
cardiac JJ B-NP I-problem
origin NN I-NP I-problem
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
responded VBD B-VP O
well RB O O
to TO O O
fluid VB O B-treatment
resuscitation NN B-NP I-treatment
. . B-VP O
   
Elevated VBN O B-problem
CK NNP B-NP I-problem
on IN B-VP O
02-07 NN B-NP O
is VBZ O O
likely JJ O O
secondary JJ O O
to TO O O
mild VB O B-problem
rhabdomyolysis NN B-NP I-problem
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
hemodynamically RB O O
stable JJ B-NP O
overnight NN I-NP O
in IN B-VP O
the DT B-NP O
CMED NNP I-NP O
CCU NNP I-NP O
. . B-VP O
   
We PRP O B-person
decided VBD B-VP O
to TO O O
discontinue VB O O
telemetry NN B-NP B-test
and CC O O
held VBD B-VP O
all DT B-NP B-treatment
hypertension NN I-NP I-treatment
medications NNS I-NP I-treatment
including VBG O O
Lisinopril NNP B-NP B-treatment
, , O O
Mavik NNP B-NP B-treatment
, , O O
hydrochlorothiazide NN B-NP B-treatment
. . B-VP O
   
2. CD O O
For IN B-VP O
pulmonary NN B-NP O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
had VBD B-VP O
a DT B-NP O
good JJ I-NP O
O2 NNP I-NP B-test
saturations NNS I-NP I-test
on IN B-VP O
room NN B-NP O
air NN I-NP O
. . B-VP O
   
He PRP O B-person
had VBD B-VP O
atelectasis NN B-NP B-problem
in IN B-VP I-problem
the DT B-NP I-problem
right NN I-NP I-problem
lower RBR O I-problem
lobe NN B-NP I-problem
by IN B-VP O
chest JJ B-NP B-test
x-ray NN I-NP I-test
. . B-VP O
   
We PRP O B-person
encouraged VBD B-VP O
activity NN B-NP O
and CC O O
patient NN B-NP B-person
out IN B-VP O
of IN B-VP O
bed NN B-NP O
. . B-VP O
   
3. CD O O
Gastrointestinal JJ O O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
on IN B-VP O
ranitidine NN B-NP B-treatment
150 CD O O
mg NN B-NP O
p.o. NN I-NP O
b.i.d. NN I-NP O
for IN B-VP O
gastrointestinal JJ B-NP B-treatment
prophylaxis NN I-NP I-treatment
. . B-VP O
   
4. CD O O
Urology NN B-NP O
: : O O
Foley NNP B-NP B-treatment
was VBD B-VP O
discontinued VBN O O
in IN B-VP O
the DT B-NP O
CMED NNP I-NP O
CCU NNP I-NP O
at IN B-VP O
12 CD O O
p.m. NN B-NP O
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
urinating VBG O O
without IN B-VP O
difficulty NN B-NP B-problem
. . B-VP O
   
We PRP O B-person
gave VBD B-VP O
the DT B-NP B-person
patient NN I-NP I-person
bathroom NN I-NP O
privileges NNS I-NP O
. . B-VP O
   
5. CD O O
FEN NN B-NP O
: : O O
We PRP O B-person
continued VBD B-VP O
IV NNP B-NP B-treatment
fluids NNS I-NP I-treatment
at IN B-VP O
100 CD O O
cc NNS B-NP O
per IN B-VP O
hour NN B-NP O
for IN B-VP O
one CD O O
liter NN B-NP O
secondary JJ O O
to TO O O
a DT B-NP O
concern NN I-NP O
for IN B-VP O
rhabdomyolysis NN B-NP B-problem
plus CC O O
kidney NN B-NP B-treatment
protective JJ B-NP I-treatment
effects NNS I-NP I-treatment
. . B-VP O
   
K NNP B-NP B-test
was VBD B-VP O
3.4 CD O O
, , O O
repleted VBN O O
, , O O
potassium NN B-NP B-treatment
chloride NN I-NP I-treatment
40 CD O O
mEq NN B-NP O
times NNS I-NP O
1 CD O O
dose JJ B-NP O
p.o. NNS I-NP O
Calcium NNP I-NP B-test
with IN B-VP O
7.2 CD O O
corrected VBD B-VP O
to TO O O
less JJR O O
than IN B-VP O
8.0, CD O O
completed VBD B-VP O
calcium NN B-NP B-treatment
carbonate NN I-NP I-treatment
at IN B-VP O
500 CD O O
mg NNS B-NP O
blood NN I-NP B-test
pressure.o. NN I-NP I-test
t.i.d. NN I-NP O
while IN B-VP O
in IN B-VP O
the DT B-NP O
hospital NN I-NP O
. . B-VP O
   
Mag NNP B-NP B-test
was VBD B-VP O
1.7 CD O O
, , O O
repleted VBN O O
with IN B-VP O
magnesium NN B-NP B-treatment
oxide NN I-NP I-treatment
with IN B-VP O
400 CD O O
mg NN B-NP O
p.o. NN I-NP O
times NNS I-NP O
one CD O O
dose NN B-NP O
. . B-VP O
   
Diet NNP B-NP O
as IN B-VP O
tolerated VBN O O
. . B-VP O
   
6. CD O O
Substance NN B-NP O
use NN I-NP O
and CC O O
psychiatry NN B-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
states VBZ O O
that IN B-VP B-pronoun
he PRP O B-person
was VBD B-VP O
willing JJ O O
to TO O O
speak VB O O
with IN B-VP O
someone NN B-NP O
from IN B-VP O
addiction NN B-NP B-person
services NNS I-NP I-person
. . B-VP O
   
We PRP O B-person
were VBD B-VP O
concerned VBN O O
regarding VBG O O
possibly RB O O
binge VB O O
drinking NN B-NP O
or CC O O
ETOH NNP B-NP O
abuse NN I-NP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
seemed VBD B-VP O
notably RB O B-problem
anxious JJ O I-problem
and CC O O
depressed JJ O B-problem
. . B-VP O
   
It PRP O B-pronoun
is VBZ O O
possible JJ O O
that IN B-VP B-pronoun
the DT B-NP B-person
patient NN I-NP I-person
is VBZ O O
self JJ O O
medicating VBG O O
for IN B-VP O
underlying VBG O B-problem
psychiatric JJ B-NP I-problem
disorder NN I-NP I-problem
. . B-VP O
   
We PRP O B-person
will MD O O
monitor VB O B-test
for IN B-VP O
signs NNS B-NP O
of IN B-VP O
alcohol NN B-NP B-problem
withdrawal NN I-NP I-problem
according VBG O O
to TO O O
the DT B-NP B-test
CIWA NNP I-NP I-test
scale NN I-NP I-test
. . B-VP O
   
We PRP O B-person
will MD O O
given VBN O O
valium VB O B-treatment
5 CD O O
mg NN B-NP O
p.o. NN I-NP O
q. VBD B-VP O
3 CD O O
hours NNS B-NP O
for IN B-VP O
withdrawal NN B-NP B-problem
. . B-VP O
   
We PRP O B-person
will MD O O
consult VB O O
addiction NN B-NP B-person
service NN I-NP I-person
in IN B-VP O
the DT B-NP O
a.m. NN I-NP O
We PRP O B-person
will MD O O
consider VB O O
psychiatry NN B-NP B-person
consult NN I-NP O
in IN B-VP O
the DT B-NP O
future NN I-NP O
to TO O O
assess VB O O
for IN B-VP O
underlying VBG O B-problem
anxiety NN B-NP I-problem
disorder NN I-NP I-problem
or CC O O
depression NN B-NP B-problem
. . B-VP O
   
DISPOSITION NN B-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
may MD O O
be VB O O
discharge JJ B-NP O
Harry NNP I-NP O
02-08 JJ B-NP O
pending JJ I-NP O
observations NNS I-NP B-test
for IN B-VP O
delirium NN B-NP B-problem
tremens NNS I-NP I-problem
after IN B-VP O
discussion NN B-NP O
with IN B-VP O
primary JJ B-NP B-person
care NN I-NP I-person
physician NN I-NP I-person
, , O O
Dr. NNP B-NP B-person
Blue NNP I-NP I-person
who WP O B-person
knows VBZ O O
the DT B-NP B-person
patient NN I-NP I-person
well RB O O
. . B-VP O
   
HOSPITAL NNP B-NP O
COURSE NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
transferred VBN O O
to TO O O
medicine VB O O
service NN B-NP O
on IN B-VP O
hospital JJ B-NP O
day NN I-NP O
#2 NNP I-NP O
after IN B-VP O
remaining VBG O O
hemodynamically RB O O
stable JJ O O
in IN B-VP O
the DT B-NP O
CMED NNP I-NP O
CCU NNP I-NP O
overnight VBD B-VP O
. . B-VP O
   
1. CD O O
Blood NNP B-NP B-test
pressure NN I-NP I-test
: : O O
The DT O B-person
The DT B-NP B-test
patient JJ I-NP I-person
patient NN I-NP I-test
's POS O I-test
blood NN B-NP I-test
pressure NN I-NP I-test
remained VBD B-VP O
stable JJ O O
on IN B-VP O
hospital JJ B-NP O
day NN I-NP O
#2 NNP I-NP O
through IN B-VP O
hospital JJ B-NP O
day NN I-NP O
#3 NNP I-NP O
status NN I-NP O
post NN I-NP O
IV NNP I-NP B-treatment
hydration NN I-NP I-treatment
with IN B-VP O
systolic JJ B-NP B-test
blood NN I-NP I-test
pressures NNS I-NP I-test
in IN B-VP O
the DT O O
120 CD O O
's POS O O
to TO O O
130 CD O O
's. NN B-NP O
We PRP O B-person
continued VBD B-VP O
to TO O O
hold VB O O
the DT B-NP B-person
patient NN I-NP I-person
's POS O O
home NN B-NP B-treatment
blood NN I-NP I-treatment
pressure NN I-NP I-treatment
medications NNS I-NP I-treatment
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
asymptomatic JJ O B-problem
without IN B-VP O
chest JJS B-NP B-problem
pain NN I-NP I-problem
, , O O
shortness NN B-NP B-problem
of IN B-VP I-problem
breath NN B-NP I-problem
and CC O O
no DT B-NP O
mental JJ I-NP B-problem
status NN I-NP I-problem
changes NNS I-NP I-problem
. . B-VP O
   
2. CD O O
Substance NN B-NP O
abuse NN I-NP O
: : O O
On IN B-VP O
Hospital NNP B-NP O
day NN I-NP O
#2 NNP I-NP O
through IN B-VP O
hospital JJ B-NP O
day NN I-NP O
#3 NNP I-NP O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
had VBD B-VP O
mild JJ B-NP B-problem
tremor NN I-NP I-problem
on IN B-VP I-problem
hands NNS B-NP I-problem
, , O O
but CC O O
improved VBD B-VP O
over IN B-VP O
hospital JJ B-NP O
course NN I-NP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
became VBD B-VP O
notably RB O B-problem
less RBR O I-problem
anxious JJ O I-problem
throughout IN B-VP O
hospital JJ B-NP O
stay NN I-NP O
. . B-VP O
   
CIWA NNP B-NP B-test
scale NN I-NP I-test
over IN B-VP O
night NN B-NP O
was VBD B-VP O
1 CD O O
for IN B-VP O
tremor NN B-NP B-problem
and CC O O
the DT B-NP B-person
patient NN I-NP I-person
did VBD B-VP O
not RB O O
require VB O O
any DT B-NP O
Valium NNP I-NP B-treatment
for IN B-VP O
alcohol NN B-NP B-problem
withdrawal NN I-NP I-problem
. . B-VP O
   
We PRP O B-person
believe VBP O O
that IN B-VP B-pronoun
the DT B-NP B-person
patient NN I-NP I-person
is VBZ O O
able JJ O O
to TO O O
be VB O O
discharged VBN O O
and CC O O
to TO O O
follow VB O O
up RP O O
with IN B-VP O
Dr. NNP B-NP B-person
Sandra NNP I-NP I-person
Rose NNP I-NP I-person
, , O O
addiction NN B-NP B-person
services NNS I-NP I-person
as IN B-VP O
an DT B-NP O
outpatient NN I-NP O
. . B-VP O
   
Call VB O O
for IN B-VP O
further JJ B-NP O
referral NN I-NP O
. . B-VP O
   
3. CD O O
FEN NN B-NP O
: : O O
Calcium NN B-NP B-treatment
carbonate NN I-NP I-treatment
500 CD O O
mg NN B-NP O
p.o. NN I-NP O
t.i.d. NN I-NP O
, , O O
Mag NNP B-NP B-treatment
oxide RB O I-treatment
400 CD O O
mg NN B-NP O
p.o. NN I-NP O
times NNS I-NP O
one CD O O
dose NN B-NP O
, , O O
potassium NN B-NP B-treatment
chloride NN I-NP I-treatment
repleted VBD B-VP O
40 CD O O
mEq NN B-NP O
times NNS I-NP O
one CD O O
dose NN B-NP O
. . B-VP O
   
DISCHARGE JJ B-NP O
DIAGNOSIS NNP I-NP O
: : O O
1. CD O O
ETOH NNP B-NP B-problem
intoxication NN I-NP I-problem
. . B-VP O
   
2. CD O O
Hypertension NNP B-NP B-problem
. . B-VP O
   
3. CD O O
History NN B-NP O
of IN B-VP O
colonic JJ B-NP B-problem
polyp NN I-NP I-problem
times NNS I-NP O
3 CD O O
, , O O
benign NN B-NP O
in IN B-VP O
2007 CD O O
, , O O
repeat NN B-NP B-test
colonoscopy NN I-NP I-test
due JJ O O
in IN B-VP O
2010 CD O O
. . B-VP O
   
4. CD O O
History NN B-NP B-problem
of IN B-VP I-problem
right JJ B-NP I-problem
inguinal JJ I-NP I-problem
hernia NN I-NP I-problem
in IN B-VP O
2002 CD O O
. . B-VP O
   
DISCHARGE NNP B-NP O
STATUS NNP I-NP O
: : O O
Home NN B-NP O
. . B-VP O
   
FOLLOW NNP B-NP O
UP IN B-VP O
: : O O
Follow VB O O
up RP O O
with IN B-VP O
Dr. NNP B-NP B-person
Marcia NNP I-NP I-person
Bender NNP I-NP I-person
to TO O O
be VB O O
arranged VBN O O
by IN B-VP O
the DT B-NP B-person
patient NN I-NP I-person
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
will MD O O
also RB O O
call VB O O
clinical JJ B-NP B-person
nurse NN I-NP I-person
specialist NN I-NP I-person
, , O O
Sandra NNP B-NP B-person
Rose NNP I-NP I-person
at IN B-VP O
( ( O O
968 CD O O
) ) O O
347-9868 CD O O
for IN B-VP O
further JJ B-NP O
referral NN I-NP O
to TO O O
addiction NN B-NP O
services NNS I-NP O
. . B-VP O
   
DISCHARGE JJ B-NP O
MEDICATIONS NNP I-NP O
: : O O
Return NN B-NP O
to TO O O
home NN B-NP B-treatment
medications NNS I-NP I-treatment
: : O O
1. CD O O
Lisinopril NNP B-NP B-treatment
5 CD O O
mg NN B-NP O
p.o.q.d. NN I-NP O
2. CD O O
Mavik NNP B-NP B-treatment
unknown JJ B-NP O
dosage NN I-NP O
. . B-VP O
   
3. CD O O
Hydrochlorothiazide NNP B-NP B-treatment
unknown JJ B-NP O
dosage NN I-NP O
. . B-VP O
   
MARK NNP B-NP B-person
T NNP I-NP I-person
Ragin NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
34-329 CD O O
Dictated VBN O O
By IN B-VP O
: : O O
Alice NNP B-NP B-person
T. NNP I-NP I-person
Mahoney NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
MEDQUIST36 NNP I-NP O
D NNP I-NP O
: : O O
2011-02-08 JJ O O
12:05 CD O O
T NN B-NP O
: : O O
2011-02-08 JJ O O
12:15 CD O O
JOB NNP B-NP O
#: VBD B-VP O
77892 CD O O
Signed VBN O O
electronically RB O O
by IN B-VP O
: : O O
DR. NNP B-NP B-person
Richard NNP I-NP I-person
Carlson NNP I-NP I-person
on IN B-VP O
: : O O
SUN NNP B-NP O
2011-02-20 CD O O
1:40 CD O O
PM NNP B-NP O
( ( O O
End NNP B-NP O
of IN B-VP O
Report NNP B-NP O
) ) O O
-EMPTYLINE- VBP O O
-DOCSTART- JJ O O
-EMPTYLINE- $ O O
054478430 CD O O
ELMVH NNP B-NP O
79660638 CD O O
1835979 CD O O
12/11/2005 CD O O
12:00:00 CD O O
AM NNP B-NP O
Right NNP I-NP B-problem
LE NNP I-NP I-problem
pain VBP O I-problem
DIS NNP B-NP O
Admission NNP I-NP O
Date NNP I-NP O
: : O O
12/11/2005 CD O O
Report NNP B-NP O
Status NNP I-NP O
: : O O
Discharge NN B-NP O
Date NNP I-NP O
: : O O
12/13/2005 CD O O
****** NNP B-NP O
FINAL NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
HIBBSKOTE NNP I-NP B-person
, , O I-person
SIALIND NNP B-NP I-person
071-43-95-1 JJ B-NP O
W78 NNP I-NP O
Room NNP I-NP O
: : O O
65Q-505 JJ B-NP O
Service NNP I-NP O
: : O O
ORT NNP B-NP O
DISCHARGE NNP I-NP O
PATIENT NNP I-NP B-person
ON NNP I-NP O
: : O O
12/13/05 CD O O
AT NNP B-NP O
12:00 CD O O
PM NNP B-NP O
CONTINGENT NNP I-NP O
UPON NNP I-NP O
Not RB O O
Applicable NNP B-NP O
WILL NNP I-NP O
D NNP I-NP O
/ NNP I-NP O
C NNP I-NP O
ORDER NNP I-NP O
BE NNP I-NP O
USED NNP I-NP O
AS IN B-VP O
THE NNP B-NP O
D NNP I-NP O
/ NNP I-NP O
C NNP I-NP O
SUMMARY NNP I-NP O
: : O O
YES JJ B-NP O
Attending NN I-NP B-person
: : O O
HEAD NNP B-NP B-person
, , O I-person
SANTDEL NNP B-NP I-person
L. NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
CODE NNP I-NP O
STATUS NNP I-NP O
: : O O
Full NNP B-NP O
code NN I-NP O
DISPOSITION NNP I-NP O
: : O O
Home NNP B-NP O
DISCHARGE NNP I-NP O
MEDICATIONS NNP I-NP O
: : O O
TYLENOL NNP B-NP B-treatment
( ( O I-treatment
ACETAMINOPHEN NNP B-NP I-treatment
) ) O I-treatment
325-650 CD O O
MG NNP B-NP O
PO NNP I-NP O
Q4H NNP I-NP O
PRN NNP I-NP O
Pain NNP I-NP B-problem
, , O O
Headache NNP B-NP B-problem
, , O O
Temperature NNP B-NP B-test
greater JJR O O
than IN B-VP O
: : O O
101 CD O O
COLACE NNP B-NP B-treatment
( ( O I-treatment
DOCUSATE NNP B-NP I-treatment
SODIUM NNP I-NP I-treatment
) ) O I-treatment
100 CD O O
MG NNP B-NP O
PO NNP I-NP O
BID NNP I-NP O
OXYCODONE NNP I-NP B-treatment
10-25 JJ B-NP O
MG NNP I-NP O
PO NNP I-NP O
Q3H NNP I-NP O
PRN NNP I-NP O
Pain NNP I-NP B-problem
HOLD NNP I-NP O
IF NNP I-NP O
: : O O
excesive JJ B-NP B-problem
sedation NN I-NP I-problem
RR NNP I-NP B-test
&lt; VBZ O O
6 CD O O
FLEXERIL NNP B-NP B-treatment
( ( O I-treatment
CYCLOBENZAPRINE NNP B-NP I-treatment
HCL NNP I-NP I-treatment
) ) O I-treatment
10 CD O O
MG NNP B-NP O
PO NNP I-NP O
TID NNP I-NP O
PRN NNP I-NP O
Pain NNP I-NP B-problem
DIET NNP I-NP O
: : O O
House NNP B-NP O
/ VBZ O O
ADA NNP B-NP O
2100 CD O O
cals NNS B-NP O
/ JJ B-NP O
day NN I-NP O
/ NNP I-NP O
Low NNP I-NP O
saturated VBD B-VP O
fat JJ B-NP O
low JJ I-NP O
cholesterol NN I-NP O
&lt; NNP I-NP O
FDI NNP I-NP O
&gt; NNP I-NP O
ACTIVITY NNP I-NP O
: : O O
Walking NN B-NP O
as IN B-VP O
tolerated VBN O O
FOLLOW NNP B-NP O
UP NNP I-NP O
APPOINTMENT NNP I-NP O
( ( O O
S NNP B-NP O
) ) O O
: : O O
Dr. NNP B-NP B-person
Maa NNP I-NP I-person
Bloch NNP I-NP I-person
( ( O O
WAMA NNP B-NP O
HEALTH NNP I-NP O
) ) O O
Call NNP B-NP O
ASAP NNP I-NP O
to TO O O
schedule VB O O
in IN B-VP O
1-2 JJ B-NP O
days NNS I-NP O
Phoen NNPS I-NP O
: : O O
381-389-5852 JJ O O
, , O O
Dr. NNP B-NP B-person
Santdel NNP I-NP I-person
Head NNP I-NP I-person
Call NNP I-NP O
ASAP NNP I-NP O
to TO O O
schedule VB O O
in IN B-VP O
2 CD O O
weeks NNS B-NP O
. . B-VP O
   
449-059-6882 JJ O O
, , O O
ALLERGY NNP B-NP O
: : O O
NKA NNP B-NP B-problem
ADMIT NNP I-NP O
DIAGNOSIS NNP I-NP O
: : O O
R NNP B-NP B-problem
leg VBZ O I-problem
pain NN B-NP I-problem
PRINCIPAL NNP I-NP O
DISCHARGE NNP I-NP O
DIAGNOSIS NNP I-NP O
; : O O
Responsible NNP B-NP O
After IN B-VP O
Study NNP B-NP O
for IN B-VP O
Causing NNP B-NP O
Admission NNP I-NP O
) ) O O
Right NNP B-NP B-problem
LE NNP I-NP I-problem
pain VBP O I-problem
OTHER NNP B-NP O
DIAGNOSIS NNP I-NP O
; : O O
Conditions NNP B-NP O
, , O O
Infections NNP B-NP O
, , O O
Complications NNP B-NP O
, , O O
affecting VBG O O
Treatment NNP B-NP O
/ NNP I-NP O
Stay NNP I-NP O
DM NNP I-NP B-problem
OPERATIONS NNP I-NP O
AND NNP I-NP O
PROCEDURES NNP I-NP O
: : O O
None NN B-NP O
OTHER NNP I-NP O
TREATMENTS NNP I-NP O
/ NNP I-NP O
PROCEDURES NNP I-NP O
( ( O O
NOT NNP B-NP O
IN NNP I-NP O
O.R. NNP I-NP O
) ) O O
PT NNP B-NP B-test
Spien NNP I-NP I-test
MRI NNP I-NP I-test
Pelvis NNP I-NP B-test
XR NNP I-NP I-test
R NNP I-NP B-test
hip NN I-NP I-test
Xray NNP I-NP I-test
BRIEF NNP I-NP O
RESUME NNP I-NP O
OF NNP I-NP O
HOSPITAL NNP I-NP O
COURSE NNP I-NP O
: : O O
HPI NN B-NP O
: : O O
Hibbskote NNP B-NP B-person
has VBZ O O
severe RB O B-problem
low JJ O I-problem
back RB O I-problem
pain NN B-NP I-problem
radiating VBG O O
down RP O O
the DT B-NP O
right JJ I-NP O
leg NN I-NP O
. . B-VP O
   
She PRP O B-person
has VBZ O O
been VBN O O
suffering VBG O O
from IN B-VP O
this DT B-NP B-problem
problem NN I-NP I-problem
for IN B-VP O
the DT B-NP O
last JJ I-NP O
few JJ I-NP O
weeks NNS I-NP O
. . B-VP O
   
A DT B-NP O
week NN I-NP O
and CC O O
half NN B-NP O
ago RB O O
, , O O
she PRP O B-person
had VBD B-VP O
a DT B-NP B-treatment
steroid JJ I-NP I-treatment
injection NN I-NP I-treatment
in IN B-VP O
an DT B-NP O
efforts NNS I-NP O
to TO O O
ameliorate VB O O
the DT B-NP B-problem
pain NN I-NP I-problem
. . B-VP O
   
She PRP O B-person
presents VBZ O O
now RB O O
with IN B-VP O
worsening VBG O B-problem
low JJ O I-problem
back RB O I-problem
pain NN B-NP I-problem
radiating VBG O O
down RP O O
the DT B-NP O
right JJ I-NP O
leg NN I-NP O
. . B-VP O
   
She PRP O B-person
denies VBZ O O
numbness RB O B-problem
or CC O O
weakness NN B-NP B-problem
in IN B-VP O
any DT B-NP O
part NN I-NP O
of IN B-VP O
the DT B-NP O
body NN I-NP O
. . B-VP O
   
She PRP O B-person
denies VBZ O O
fever NN B-NP B-problem
. . B-VP O
   
She PRP O B-person
denies VBZ O O
nausea NN B-NP B-problem
, , O O
vomiting NN B-NP B-problem
, , O O
and CC O O
diarrhea NN B-NP B-problem
. . B-VP O
   
She PRP O B-person
denies VBZ O O
chest JJS B-NP B-problem
pain NN I-NP I-problem
. . B-VP O
   
She PRP O B-person
says VBZ O O
the DT B-NP B-problem
pain NN I-NP I-problem
is VBZ O O
sharp JJ O O
in IN B-VP O
character NN B-NP O
, , O O
and CC O O
radiates VBZ O O
with IN B-VP O
a DT B-NP B-problem
shock NN I-NP I-problem
like IN B-VP I-problem
intensity NN B-NP I-problem
down IN B-VP I-problem
the DT B-NP I-problem
right JJ I-NP I-problem
leg NN I-NP I-problem
. . B-VP O
   
She PRP O B-person
says VBZ O O
that IN B-VP B-pronoun
oral JJ B-NP B-treatment
analgesics NNS I-NP I-treatment
have VBP O O
been VBN O O
of IN B-VP O
little JJ B-NP O
help NN I-NP O
. . B-VP O
   
On IN B-VP O
detailed JJ B-NP B-test
review NN I-NP I-test
of IN B-VP I-test
systems NNS B-NP I-test
, , O O
she PRP O B-person
admitted VBD B-VP O
to TO O O
one CD O O
episode NN B-NP O
of IN B-VP O
urinary JJ B-NP B-problem
incontinence NN I-NP I-problem
. . B-VP O
   
She PRP O B-person
denied VBD B-VP O
any DT B-NP B-problem
changes NNS I-NP I-problem
in IN B-VP I-problem
bowel NN B-NP I-problem
habits NNS I-NP I-problem
. . B-VP O
   
PAST NNP B-NP O
MEDICAL NNP I-NP O
HISTORY NNP I-NP O
: : O O
Non-insulin-requiring JJ B-NP B-problem
diabetes NNS I-NP I-problem
mellitus NN I-NP I-problem
, , O O
and CC O O
hypercholesterolemia NN B-NP B-problem
. . B-VP O
   
PAST JJ B-NP O
SURGICAL JJ I-NP O
HISTORY NN I-NP O
: : O O
As IN B-VP O
given VBN O O
above IN B-VP O
. . B-VP O
   
SOCIAL NNP B-NP O
HISTORY NNP I-NP O
: : O O
Negative JJ O O
for IN B-VP O
tobacco NN B-NP O
, , O O
drugs NNS B-NP O
, , O O
or CC O O
domestic JJ B-NP O
violence NN I-NP O
. . B-VP O
   
FAMILY NNP B-NP O
HISTORY NNP I-NP O
: : O O
Negative NNP B-NP O
. . B-VP O
   
REVIEW NNP B-NP O
OF NNPS I-NP O
SYSTEMS NNP I-NP O
: : O O
All DT B-NP O
systems NNS I-NP O
were VBD B-VP O
reviewed VBN O O
and CC O O
were VBD B-VP O
negative JJ O O
except IN B-VP O
as IN B-VP O
given VBN O O
above IN B-VP O
. . B-VP O
   
MEDICATIONS NN B-NP O
: : O O
Metformin NNP B-NP B-treatment
, , O O
Zocor NNP B-NP B-treatment
, , O O
and CC O O
analgesics NNS B-NP B-treatment
. . B-VP O
   
ALLERGIES NNS B-NP O
: : O O
None NN B-NP O
. . B-VP O
   
PHYSICAL JJ B-NP O
EXAMINATION NN I-NP O
: : O O
Awake NNP B-NP O
, , O O
alert NN B-NP O
, , O O
spontaneous JJ O O
and CC O O
appropriate JJ O O
, , O O
and CC O O
somewhat RB O B-problem
uncomfortable JJ O I-problem
due JJ O O
to TO O O
pain VB O B-problem
but CC O O
looked VBD B-VP O
well RB O O
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
afebrile JJ O B-problem
and CC O O
had VBD B-VP O
normal JJ B-NP O
vital JJ I-NP O
signs NNS I-NP O
. . B-VP O
   
The DT B-NP B-test
oxygen NN I-NP I-test
saturation NN I-NP I-test
was VBD B-VP O
normal JJ O O
at IN B-VP O
98% CD O O
on IN B-VP O
room NN B-NP O
air NN I-NP O
. . B-VP O
   
There EX O O
was VBD B-VP O
no DT B-NP O
evidence NN I-NP O
of IN B-VP O
head NN B-NP B-problem
trauma NN I-NP I-problem
. . B-VP O
   
There EX O O
was VBD B-VP O
no DT B-NP O
scleral JJ I-NP B-problem
icterus NN I-NP I-problem
. . B-VP O
   
The DT B-NP O
oropharynx NN I-NP O
was VBD B-VP O
clear JJ O O
. . B-VP O
   
The DT B-NP O
neck NN I-NP O
was VBD B-VP O
supple JJ O O
with IN B-VP O
no DT B-NP O
lymphadenopathy NN I-NP B-problem
. . B-VP O
   
The DT B-NP O
chest NN I-NP O
was VBD B-VP O
clear JJ O O
with IN B-VP O
normal JJ B-NP O
excursion NN I-NP O
. . B-VP O
   
Heart NNP B-NP O
was VBD B-VP O
regular JJ O O
with IN B-VP O
no DT B-NP O
murmurs NNS I-NP B-problem
, , O O
rubs NNS B-NP B-problem
, , O O
or CC O O
gallops NNS B-NP B-problem
. . B-VP O
   
The DT B-NP O
abdomen NNS I-NP O
was VBD B-VP O
soft JJ O O
and CC O O
nontender NN B-NP B-problem
with IN B-VP O
no DT B-NP O
masses NNS I-NP B-problem
, , O O
no DT B-NP O
organomegaly NN I-NP B-problem
. . B-VP O
   
The DT B-NP O
skin NN I-NP O
and CC O O
extremities NNS B-NP O
were VBD B-VP O
normal JJ O O
with IN B-VP O
no DT B-NP O
cyanosis NN I-NP B-problem
, , O O
clubbing VBG O B-problem
, , O O
edema NN B-NP B-problem
, , O O
lesions NNS B-NP B-problem
, , O O
or CC O O
rashes NNS B-NP B-problem
. . B-VP O
   
Neurologic NNP B-NP B-test
examination NN I-NP I-test
was VBD B-VP O
normal JJ O O
. . B-VP O
   
Strength NNP B-NP O
, , O O
sensation NN B-NP O
, , O O
coordination NN B-NP O
and CC O O
cranial JJ B-NP O
nerve NN I-NP O
function NN I-NP O
were VBD B-VP O
all DT O O
normal JJ O O
. . B-VP O
   
Straight NNP B-NP B-test
leg NN I-NP I-test
raise NN I-NP I-test
test NN I-NP I-test
was VBD B-VP O
difficult JJ O O
to TO O O
perform VB O O
due JJ O O
to TO O O
pain VB O B-problem
but CC O O
seemed VBD B-VP O
to TO O O
be VB O O
positive JJ O B-problem
on IN B-VP O
the DT B-NP O
right NN I-NP O
. . B-VP O
   
Psychiatric JJ B-NP B-test
examination NN I-NP I-test
was VBD B-VP O
normal JJ O O
. . B-VP O
   
Examination NN B-NP B-test
of IN B-VP I-test
the DT B-NP I-test
back NN I-NP I-test
revealed VBD B-VP O
lumbar NN B-NP B-problem
tenderness NN I-NP I-problem
with IN B-VP O
no DT B-NP O
point NN I-NP B-problem
tenderness NN I-NP I-problem
. . B-VP O
   
HOSPITAL NNP B-NP O
COURSE NNP I-NP O
: : O O
Patient NN B-NP B-person
was VBD B-VP O
evaluated VBN O O
by IN B-VP O
the DT B-NP B-person
orthopedic JJ I-NP I-person
service NN I-NP I-person
. . B-VP O
   
An DT B-NP B-test
MRI NNP I-NP I-test
of IN B-VP I-test
the DT B-NP I-test
spine NN I-NP I-test
showed VBD B-VP O
L4/5 NNP B-NP B-problem
facet JJ B-NP I-problem
enhancement NN I-NP I-problem
. . B-VP O
   
It PRP O B-pronoun
was VBD B-VP O
evaluated VBN O O
by IN B-VP O
the DT B-NP O
IR NNP I-NP B-person
radiology NN I-NP I-person
. . B-VP O
   
Thad NNP B-NP B-problem
lesion NN I-NP I-problem
was VBD B-VP O
read VBN O O
as IN B-VP O
a DT B-NP B-problem
facet NN I-NP I-problem
hypertrophy NN I-NP I-problem
and CC O O
not RB O O
an DT B-NP B-problem
infectious JJ I-NP I-problem
process NN I-NP I-problem
. . B-VP O
   
Patient NNP B-NP B-person
remained VBD B-VP O
afebrile JJ O B-problem
. . B-VP O
   
ESR NNP B-NP B-test
was VBD B-VP O
within IN B-VP O
normal JJ B-NP O
limits NNS I-NP O
and CC O O
CPR NNP B-NP B-test
was VBD B-VP O
mildly RB O B-problem
elevated VBN O I-problem
. . B-VP O
   
An DT B-NP B-test
AP NNP I-NP I-test
of IN B-VP I-test
pelvis NN B-NP I-test
and CC O O
R NNP B-NP B-test
hip NN I-NP I-test
films NNS I-NP I-test
were VBD B-VP O
unremarkable JJ O O
. . B-VP O
   
Physical JJ B-NP B-test
examination NN I-NP I-test
of IN B-VP I-test
the DT B-NP I-test
RLE NNP I-NP I-test
showed VBD B-VP O
mild JJ B-NP B-problem
pain NN I-NP I-problem
in IN B-VP I-problem
right JJ B-NP I-problem
hip NN I-NP I-problem
with IN B-VP O
some DT B-NP O
movements NNS I-NP O
. . B-VP O
   
When WRB O O
patient NN B-NP B-person
was VBD B-VP O
distracted VBN O O
, , O O
some DT B-NP O
maneuvers NNS I-NP O
were VBD B-VP O
not RB O O
painful JJ O B-problem
. . B-VP O
   
Patient NNP B-NP B-person
remained VBD B-VP O
cardiovascularly RB O O
stable JJ O O
. . B-VP O
   
Patient NNP B-NP B-person
was VBD B-VP O
weaned VBN O O
from IN B-VP O
supplemental JJ B-NP B-treatment
oxygen NN I-NP I-treatment
and CC O O
tolerated VBD B-VP O
a DT B-NP O
regular JJ I-NP O
diet JJ I-NP O
prior NN I-NP O
to TO O O
discharge VB O O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
received VBD B-VP O
pneumoboots NNS B-NP B-treatment
and CC O O
lovenox NN B-NP B-treatment
for IN B-VP O
DVT NNP B-NP B-treatment
prophylaxis NN I-NP I-treatment
. . B-VP O
   
. . B-VP O
   
Patient NN B-NP B-person
was VBD B-VP O
instructed VBN O O
by IN B-VP O
PT NNP B-NP B-person
on IN B-VP O
the DT B-NP O
correct JJ I-NP O
way NN I-NP O
to TO O O
ambulate VB O O
, , O O
weight JJ B-NP O
bearing NN I-NP O
as IN B-VP O
tolerated VBN O O
in IN B-VP O
the DT B-NP O
RLE NNP I-NP O
. . B-VP O
   
. . B-VP O
   
Patient NN B-NP B-person
was VBD B-VP O
able JJ O O
to TO O O
void VB O O
and CC O O
ambulated VBN O O
without IN B-VP O
assistance NN B-NP O
as IN B-VP O
directed VBN O O
by IN B-VP O
P.T. NNP B-NP B-person
The DT B-NP B-person
team NN I-NP I-person
decided VBD B-VP O
that IN B-VP B-pronoun
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
ready JJ O O
for IN B-VP O
discharge NN B-NP O
. . B-VP O
   
Patient NNP B-NP B-person
should MD O O
follow VB O O
up RP O O
with IN B-VP O
her PRP$ O B-person
her PRP$ O B-person
pain NN B-NP I-person
doctor NN I-NP I-person
, , O O
Dr. NNP B-NP B-person
Maa NNP I-NP I-person
Bloch NNP I-NP I-person
381-389-5852 CD O O
, , O O
for IN B-VP O
her PRP$ O B-person
her PRP$ O B-treatment
chronic JJ B-NP I-treatment
pain NN I-NP I-treatment
management NN I-NP I-treatment
ADDITIONAL NNP I-NP O
COMMENTS NNP I-NP O
: : O O
Do VBP O O
not RB O O
drive VB O O
or CC O O
drink VB O O
alcohol NN B-NP O
while IN B-VP O
taking VBG O O
narcotics NNS B-NP B-treatment
. . B-VP O
   
Resume NNP B-NP O
all DT O O
of IN B-VP O
your PRP$ O B-person
your PRP$ O B-treatment
home NN B-NP I-treatment
medications NNS I-NP I-treatment
, , O O
but CC O O
please VB O O
avoid JJ B-NP O
motrin NN I-NP B-treatment
/ NNP I-NP I-treatment
advil NN I-NP I-treatment
for IN B-VP O
1 CD O O
week NN B-NP O
. . B-VP O
   
Call VB O O
449-059-6882 JJ O O
if IN B-VP O
you PRP O B-person
have VBP O O
any DT B-NP O
questions NNS I-NP O
. . B-VP O
   
If IN B-VP O
you PRP O B-person
have VBP O O
fevers NNS B-NP B-problem
&gt; VBP O O
101.5 CD O O
F NNP B-NP O
, , O O
vomiting VBG O B-problem
, , O O
or CC O O
increased VBD B-VP B-problem
redness NN B-NP I-problem
, , O O
swelling VBG O B-problem
, , O O
or CC O O
discharge NN B-NP B-problem
from IN B-VP O
your PRP$ O B-person
your PRP$ O B-problem
incision NN B-NP I-problem
, , O O
call VB O O
your PRP$ O B-person
your PRP$ O B-person
MD NN B-NP I-person
or CC O O
go VB O O
to TO O O
the DT B-NP O
nearest JJS I-NP O
ER NN I-NP O
. . B-VP O
   
You PRP O B-person
may MD O O
bear VB O O
weight NN B-NP O
on IN B-VP O
your PRP$ O B-person
both DT B-NP O
legs NNS I-NP O
. . B-VP O
   
Call VB O O
381-389-5852 JJ O O
to TO O O
schedule VB O O
an DT B-NP O
apointment NN I-NP O
with IN B-VP O
your PRP$ O B-person
your PRP$ O B-person
pain NN B-NP I-person
doctor NN I-NP I-person
( ( O O
Dr. NNP B-NP B-person
Maa NNP I-NP I-person
Bloch NNP I-NP I-person
) ) O O
ASAP NNP B-NP O
DISCHARGE NNP I-NP O
CONDITION NNP I-NP O
: : O O
Stable JJ B-NP O
TO NNP I-NP O
DO NNP I-NP O
/ NNP I-NP O
PLAN NNP I-NP O
: : O O
No DT B-NP O
dictated JJ I-NP O
summary NN I-NP O
ENTERED NN I-NP O
BY NNP I-NP O
: : O O
FLOMKOTEWIERST NNP B-NP B-person
, , O I-person
NEENIE NNP B-NP I-person
LAURE NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
( ( O O
DK739 NNP B-NP O
) ) O O
12/13/05 CD O O
01:01 CD O O
PM NNP B-NP O
****** JJ B-NP O
END NNP I-NP O
OF NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- VBD B-VP O
788268693 CD O O
DH NNP B-NP O
7258512 CD O O
020586 CD O O
0831510 CD O O
4/30/2005 CD O O
12:00:00 CD O O
AM NNP B-NP O
ED NNP I-NP O
Discharge NNP I-NP O
Summary NNP I-NP O
Unsigned VBD B-VP O
DIS NNP B-NP O
Report NNP I-NP O
Status NNP I-NP O
: : O O
Unsigned VBD B-VP O
ED NNP B-NP O
DISCHARGE NNP I-NP O
NOTIFICATION NNP I-NP O
/ NNP I-NP O
SUMMARY NNP I-NP O
FREIERMDREPS NNP I-NP B-person
, , O I-person
RI NNP B-NP I-person
MRN NNP I-NP O
: : O O
7258512 CD O O
Age NNP B-NP O
: : O O
44y CD O O
REGISTRATION NNP B-NP O
DATE NNP I-NP O
: : O O
04/30/2005 CD O O
02:55 CD O O
PM NNP B-NP O
Provider NN I-NP B-person
: : O O
RONRIN NNP B-NP B-person
SHUFF NNP I-NP I-person
PRELIMINARY NNP I-NP O
REPORT NNP I-NP O
Benefits NNP I-NP O
Assigned NNP I-NP O
: : O O
Y PRP$ O O
Discharge NNP B-NP O
Note NNP I-NP O
Date NNP I-NP O
/ JJ B-NP O
Time NNP I-NP O
: : O O
04/30/2005 CD O O
15:49 CD O O
Discharge NN B-NP O
Status NNP I-NP O
: : O O
Discharged VBN O O
Condition NNP B-NP O
on IN B-VP O
Discharge NNP B-NP O
: : O O
Stable JJ B-NP O
Patient NNP I-NP B-person
States NNPS I-NP O
Complaint NNP I-NP O
: : O O
R NNP B-NP B-problem
ELBOW NNP I-NP I-problem
INJURY NNP I-NP I-problem
Standardized NNP I-NP O
Discharge NNP I-NP O
Instructions NNS I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
given VBN O O
printed JJ B-NP O
instructions NNS I-NP O
for IN B-VP O
sprains NNS B-NP B-problem
, , O O
fractures NNS B-NP B-problem
and CC O O
bruises NNS B-NP B-problem
( ( O O
English NNP B-NP O
) ) O O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
given VBN O O
a DT B-NP O
work NN I-NP O
note NN I-NP O
( ( O O
English NNP B-NP O
) ) O O
. . B-VP O
   
Diagnosis NN B-NP O
: : O O
R NNP B-NP B-problem
elbow VBZ O I-problem
strain NN B-NP I-problem
Treatment NNP I-NP O
Rendered NNP I-NP O
: : O O
xray SYM O B-test
- : O O
no DT B-NP O
evidence NN I-NP O
of IN B-VP O
effusion NN B-NP B-problem
or CC O O
fracture NN B-NP B-problem
Discharge NNP I-NP O
Medications NNP I-NP O
: : O O
motrin JJ B-NP B-treatment
400-600 JJ I-NP O
mg NN I-NP O
every DT O O
8 CD O O
hours NNS B-NP O
as IN B-VP O
needed VBN O O
for IN B-VP O
pain NN B-NP B-problem
Follow NNP I-NP O
up RP O O
Service NNP B-NP O
: : O O
It PRP O B-pronoun
is VBZ O O
recommended VBN O O
that IN B-VP B-pronoun
you PRP O B-person
receive VBP O O
follow-up JJ B-NP O
care NN I-NP O
with IN B-VP O
the DT B-NP O
Department NNP I-NP O
of IN B-VP O
Orthopaedics NNPS B-NP O
if IN B-VP O
your PRP$ O B-problem
your PRP$ O B-person
symptoms NNS B-NP I-problem
are VBP O O
not RB O O
improved VBN O O
in IN B-VP O
5-7 JJ B-NP O
days NNS I-NP O
. . B-VP O
   
Please VB O O
call NN B-NP O
( ( O O
890 CD O O
) ) O O
541-3008 CD O O
to TO O O
schedule VB O O
an DT B-NP O
appointment NN I-NP O
. . B-VP O
   
For IN B-VP O
managed VBN O O
care NN B-NP O
plans NNS I-NP O
, , O O
check VB O O
with IN B-VP O
your PRP$ O B-person
your PRP$ O B-person
PCP NN B-NP I-person
before IN B-VP O
making VBG O O
this DT B-NP B-pronoun
appointment NN I-NP O
. . B-VP O
   
Disposition NNP B-NP O
, , O O
Follow NNP B-NP O
up RB O O
and CC O O
Instructions NNS B-NP O
to TO O O
Patient VB O B-person
: : O O
Use NNP B-NP O
ice NN I-NP B-treatment
to TO O O
sore VB O B-problem
areas NNS B-NP I-problem
for IN B-VP O
the DT B-NP O
next JJ I-NP O
few JJ I-NP O
days NNS I-NP O
. . B-VP O
   
Do VBP O O
no DT B-NP O
strenuous JJ I-NP O
activity NN I-NP O
until IN B-VP O
your PRP$ O B-person
your PRP$ O B-problem
symptoms NNS B-NP I-problem
are VBP O O
improved VBN O O
. . B-VP O
   
Do VB O O
gentle JJ B-NP B-treatment
range NN I-NP I-treatment
of IN B-VP I-treatment
motion NN B-NP I-treatment
exercises NNS I-NP I-treatment
for IN B-VP O
the DT B-NP O
next JJ I-NP O
few JJ I-NP O
days NNS I-NP O
. . B-VP O
   
PCP JJ B-NP B-person
Name NN I-NP O
: : O O
CREDKOTE NNP B-NP B-person
, , O I-person
ALEN NNP B-NP I-person
Provider NNP I-NP O
Number NNP I-NP O
: : O O
18160 CD O O
This DT B-NP B-pronoun
report NN I-NP O
was VBD B-VP O
created VBN O O
by IN B-VP O
SHUFF NNP B-NP B-person
, , O I-person
RONRIN NNP B-NP I-person
04/30/2005 CD O O
03:52 CD O O
PM NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- VBD B-VP O
385215362 CD O O
CTMC NNP B-NP O
47531332 CD O O
8504886 CD O O
11/17/2003 CD O O
12:00:00 CD O O
AM NNP B-NP O
Discharge NNP I-NP O
Summary NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date NNP I-NP O
: : O O
11/17/2003 CD O O
Report NNP B-NP O
Status NNP I-NP O
: : O O
Signed VBN O O
Discharge NNP B-NP O
Date NNP I-NP O
: : O O
PRINCIPAL JJ B-NP O
DIAGNOSIS NNP I-NP O
: : O O
PROGRESSIVE NNP B-NP B-problem
ACANTHAMOEBA NNP I-NP I-problem
INFECTION NNP I-NP I-problem
. . B-VP O
   
HISTORY NNP B-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
is VBZ O O
a DT B-NP O
65-year-old JJ I-NP O
man NN I-NP O
with IN B-VP O
refractory JJ B-NP B-problem
CLL NNP I-NP I-problem
, , O O
status NN B-NP O
post NN I-NP O
non-myeloblative JJ B-NP B-treatment
stem NN I-NP I-treatment
cell NN I-NP I-treatment
transplant NN I-NP I-treatment
approximately RB O O
nine CD O O
months NNS B-NP O
prior RB O O
to TO O O
admission NN B-NP O
, , O O
and CC O O
status NN B-NP O
post NN I-NP O
prolonged VBD B-VP O
recent JJ B-NP O
Retelk NNP I-NP O
County NNP I-NP O
Medical NNP I-NP O
Center NNP I-NP O
stay NN I-NP O
for IN B-VP O
Acanthamoeba NNP B-NP B-problem
infection NN I-NP I-problem
of IN B-VP I-problem
skin NN B-NP I-problem
and CC O O
sinuses NNS B-NP O
, , O O
complicated VBN O O
by IN B-VP O
ARS NNP B-NP B-problem
due JJ O O
to TO O O
medication NN B-NP B-problem
toxicity NN I-NP I-problem
, , O O
as RB O O
well RB O O
as IN B-VP O
GVHD NNP B-NP B-problem
and CC O O
recent JJ B-NP B-problem
CMV NNP I-NP I-problem
infection NN I-NP I-problem
, , O O
readmitted VBN O O
for IN B-VP O
new JJ B-NP B-problem
fever NN I-NP I-problem
, , O O
increasing VBG O B-problem
creatinine NN B-NP I-problem
, , O O
hepatomegaly NN B-NP B-problem
and CC O O
fluid NN B-NP B-problem
surge NN I-NP I-problem
spacing NN I-NP I-problem
, , O O
in IN B-VP O
the DT B-NP O
setting NN I-NP O
of IN B-VP O
hyponatremia NN B-NP B-problem
. . B-VP O
   
Patient NNP B-NP B-person
initially RB O O
presented VBD B-VP O
in IN B-VP O
1991 CD O O
with IN B-VP O
cervical JJ B-NP B-problem
lymphadenopathy NN I-NP I-problem
, , O O
was VBD B-VP O
treated VBN O O
with IN B-VP O
MACE NNP B-NP B-treatment
/ NNP I-NP O
CytaBOM NNP I-NP B-treatment
, , O O
and CC O O
did VBD B-VP O
well RB O O
until IN B-VP O
1997 CD O O
, , O O
when WRB O O
he PRP O B-person
received VBD B-VP O
six CD O O
cycles NNS B-NP O
of IN B-VP O
fludarabine NN B-NP B-treatment
for IN B-VP O
progressive JJ B-NP B-problem
disease NN I-NP I-problem
. . B-VP O
   
In IN B-VP O
November NNP B-NP O
, , O O
2001 CD O O
, , O O
he PRP O B-person
progressed VBD B-VP O
to TO O O
leukemic JJ B-NP B-problem
phase NN I-NP I-problem
, , O O
received VBD B-VP O
Rituxan NNP B-NP B-treatment
and CC O O
CVP NNP B-NP B-treatment
. . B-VP O
   
Started VBD B-VP O
Campath NNP B-NP B-treatment
in IN B-VP O
July NNP B-NP O
, , O O
2001 CD O O
, , O O
complicated VBN O O
by IN B-VP O
lymphopenia NN B-NP B-problem
/ NNP I-NP O
neutropenia NN I-NP B-problem
and CC O O
CMV NNP B-NP B-problem
infection NN I-NP I-problem
, , O O
and CC O O
underwent JJ B-NP O
MUD NNP I-NP B-treatment
stem NN I-NP I-treatment
cell NN I-NP I-treatment
transplant NN I-NP I-treatment
in IN B-VP O
December NNP B-NP O
, , O O
2002 CD O O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
had VBD B-VP O
bone VBN O B-test
marrow NN B-NP I-test
biopsy NN I-NP I-test
, , O O
August NNP B-NP O
, , O O
2003 CD O O
, , O O
for IN B-VP O
persistent JJ B-NP B-problem
pancytopenia NN I-NP I-problem
, , O O
revealing VBG O O
mild JJ B-NP B-problem
hypercelluarity NN I-NP I-problem
with IN B-VP O
80% CD O B-problem
leukemic JJ B-NP I-problem
cells NNS I-NP I-problem
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
again RB O O
treated VBN O O
with IN B-VP O
Campath NNP B-NP B-treatment
, , O O
had VBD B-VP O
recurrent VBN O B-problem
fever RB O I-problem
in IN B-VP O
association NN B-NP O
with IN B-VP O
sinus NN B-NP B-problem
symptoms NNS I-NP I-problem
, , O O
with IN B-VP O
CT NNP B-NP B-test
scan JJ B-NP I-test
showing NN I-NP O
left VBD B-VP B-problem
maxillary JJ B-NP I-problem
sinusitis NN I-NP I-problem
in IN B-VP O
association NN B-NP O
with IN B-VP O
new JJ B-NP B-problem
skin NN I-NP I-problem
nodules NNS I-NP I-problem
on IN B-VP I-problem
right JJ B-NP I-problem
elbow NN I-NP I-problem
and CC O I-problem
buttocks NNS B-NP I-problem
. . B-VP O
   
Patient NNP B-NP B-person
was VBD B-VP O
hospitalized VBN O O
September NNP B-NP O
26 CD O O
to TO O O
November NNP B-NP O
11 CD O O
for IN B-VP O
what WP O O
was VBD B-VP O
diagnosed VBN O O
by IN B-VP O
skin NN B-NP B-test
biopsy NN I-NP I-test
and CC O O
sinus JJ B-NP B-test
washings NNS I-NP I-test
as IN B-VP O
Acanthamoeba NNP B-NP B-problem
infection NN I-NP I-problem
of IN B-VP I-problem
skin NN B-NP I-problem
and CC O O
sinuses NNS B-NP O
, , O O
without IN B-VP O
any DT B-NP O
progression NN I-NP O
to TO O O
neurologic JJ B-NP B-problem
infection NN I-NP I-problem
( ( O O
as IN B-VP O
assessed VBN O O
by IN B-VP O
head NN B-NP B-test
CT NNP I-NP I-test
and CC O O
MRI NNP B-NP B-test
) ) O O
. . B-VP O
   
ID NNP B-NP B-person
consult NN I-NP O
was VBD B-VP O
obtained VBN O O
and CC O O
he PRP O B-person
was VBD B-VP O
initially RB O O
treated VBN O O
with IN B-VP O
azithromycin NN B-NP B-treatment
, , O O
itraconazole NN B-NP B-treatment
, , O O
and CC O O
pentamidine NN B-NP B-treatment
, , O O
with IN B-VP O
progression NN B-NP O
of IN B-VP O
skin JJ B-NP B-problem
infection NN I-NP I-problem
. . B-VP O
   
Subsequent JJ B-NP O
discontinuance NN I-NP O
of IN B-VP O
azithromycin NN B-NP B-treatment
, , O O
trial NN B-NP B-treatment
of IN B-VP I-treatment
5-FC JJ O I-treatment
, , O O
with IN B-VP O
increasing VBG O B-problem
neutropenia JJ O I-problem
requiring VBG O O
discontinuance NN B-NP O
, , O O
change NN B-NP O
if IN B-VP O
itraconazole JJ O B-treatment
to TO O O
voriconazole VB O B-treatment
, , O O
given VBN O O
continued VBD B-VP B-problem
neutropenia JJ O I-problem
, , O O
and CC O O
trial NN B-NP O
of IN B-VP O
sulfadiazine NN B-NP B-treatment
, , O O
discontinued VBN O O
for IN B-VP O
increasing VBG O B-problem
ARS NNP B-NP I-problem
. . B-VP O
   
Patient NNP B-NP B-person
was VBD B-VP O
maintained VBN O O
on IN B-VP O
p.o. JJ B-NP B-treatment
voriconazole NN I-NP I-treatment
and CC O O
IV NNP B-NP B-treatment
pentamidine NN I-NP I-treatment
, , O O
with IN B-VP O
pentamidine JJ B-NP B-treatment
nasal JJ I-NP I-treatment
washings NNS I-NP I-treatment
, , O O
with IN B-VP O
re-CT NN B-NP B-test
of IN B-VP I-test
sinuses NNS B-NP I-test
near IN B-VP O
end NN B-NP O
of IN B-VP O
stay NN B-NP O
showing VBG O O
no DT B-NP O
change NN I-NP O
in IN B-VP O
disease NN B-NP B-problem
burden NN I-NP I-problem
. . B-VP O
   
He PRP O B-person
has VBZ O O
had VBN O O
recurrent VBN O B-problem
CMB NNP B-NP I-problem
infection NN I-NP I-problem
in IN B-VP O
the DT B-NP O
setting NN I-NP O
of IN B-VP O
Campath NNP B-NP B-treatment
therapy NN I-NP I-treatment
, , O O
requiring VBG O O
IV NNP B-NP B-treatment
Foscarnet NNP I-NP I-treatment
therapy NN I-NP I-treatment
during IN B-VP O
stay NN B-NP O
, , O O
with IN B-VP O
inability NN B-NP O
to TO O O
tolerate VB O O
valganciclovir JJ B-NP B-treatment
maintenance NN I-NP I-treatment
suppression NN I-NP I-treatment
subsequently RB O O
due JJ O O
to TO O O
increasing VBG O B-problem
ARS NNP B-NP I-problem
. . B-VP O
   
Hypercapture NN B-NP B-test
near IN B-VP O
end NN B-NP O
of IN B-VP O
stay NN B-NP O
was VBD B-VP O
negative JJ O O
. . B-VP O
   
Patient NNP B-NP B-person
experienced VBD B-VP O
acute JJ B-NP B-problem
renal JJ I-NP I-problem
failure NN I-NP I-problem
on IN B-VP O
chronic JJ B-NP B-problem
renal JJ I-NP I-problem
insufficiency NN I-NP I-problem
, , O O
with IN B-VP O
previous JJ B-NP B-test
baseline NN I-NP I-test
creatinine NN I-NP I-test
1.6 CD O O
, , O O
felt VBD B-VP O
to TO O O
be VB O O
due JJ O O
to TO O O
medication NN B-NP B-problem
toxicity NN I-NP I-problem
, , O O
requiring VBG O O
Kayexalate NNP B-NP B-treatment
and CC O O
Phoslo NNP B-NP B-treatment
to TO O O
manage VB O O
electrolytes NNS B-NP B-test
, , O O
but CC O O
never RB O O
any DT B-NP O
need NN I-NP O
for IN B-VP O
hemodialysis NN B-NP B-treatment
, , O O
with IN B-VP O
mild JJ B-NP O
improvement NN I-NP O
of IN B-VP O
creatinine NN B-NP B-test
by IN B-VP O
discharge NN B-NP O
, , O O
with IN B-VP O
peak JJ B-NP B-test
creatinine NN I-NP I-test
3.4 CD O O
, , O O
discharge NN B-NP B-test
creatinine NN I-NP I-test
2.6 CD O O
. . B-VP O
   
Patient NN B-NP B-person
struggled VBD B-VP O
with IN B-VP O
GVHD NNP B-NP B-problem
, , O O
with IN B-VP O
extensive JJ B-NP B-problem
skin NN I-NP I-problem
involvement NN I-NP I-problem
, , O O
taking VBG O O
Cellcept NNP B-NP B-treatment
, , O O
prednisone NN B-NP B-treatment
and CC O O
cyclosporine NN B-NP B-treatment
at IN B-VP O
time NN B-NP O
of IN B-VP O
last JJ B-NP O
admission NN I-NP O
. . B-VP O
   
Cellcept NNP B-NP B-treatment
was VBD B-VP O
discontinued VBN O O
in IN B-VP O
the DT B-NP O
setting NN I-NP O
of IN B-VP O
infection NN B-NP B-problem
, , O O
but CC O O
attempts NNS B-NP O
to TO O O
decrease VB O O
prednisone NN B-NP B-treatment
or CC O O
cyclosporine NN B-NP B-treatment
were VBD B-VP O
unsuccessful JJ O O
. . B-VP O
   
Patient JJ B-NP B-person
returns NNS I-NP O
from IN B-VP O
rehabilitation NN B-NP B-treatment
after IN B-VP O
discharge NN B-NP O
on IN B-VP O
November NNP B-NP O
11 CD O O
, , O O
with IN B-VP O
new JJ B-NP B-problem
fever NN I-NP I-problem
up RB O O
to TO O O
102.0 CD O O
in IN B-VP O
DSCI NNP B-NP O
clinic NN I-NP O
, , O O
increasing VBG O B-problem
hepatomegaly NN B-NP I-problem
as IN B-VP O
assessed VBN O O
by IN B-VP O
examination NN B-NP B-test
in IN B-VP O
clinic NN B-NP O
, , O O
and CC O O
increasing VBG O B-problem
creatinine NN B-NP I-problem
. . B-VP O
   
Patient NNP B-NP B-person
reports VBZ O O
no DT B-NP O
significant JJ I-NP O
changes NNS I-NP O
in IN B-VP O
how WRB O O
he PRP O B-person
feels VBZ O O
over IN B-VP O
the DT B-NP O
past JJ I-NP O
week NN I-NP O
. . B-VP O
   
Denies VBZ O O
cough NN B-NP B-problem
, , O O
shortness NN B-NP B-problem
of IN B-VP I-problem
breath NN B-NP I-problem
, , O O
chest NN B-NP B-problem
pain NN I-NP I-problem
, , O O
nausea NN B-NP B-problem
, , O O
vomiting VBG O B-problem
, , O O
diarrhea NN B-NP B-problem
, , O O
dysuria NN B-NP B-problem
, , O O
neck NN B-NP B-problem
stiffness NN I-NP I-problem
, , O O
new JJ B-NP B-problem
skin NN I-NP I-problem
lesions NNS I-NP I-problem
, , O O
worsening VBG O B-problem
red JJ B-NP I-problem
petechiae NN I-NP I-problem
, , O O
or CC O O
increasing VBG O B-problem
sinus NN B-NP I-problem
symptoms NNS I-NP I-problem
. . B-VP O
   
Patient JJ B-NP B-person
reports NNS I-NP O
persistent JJ O B-problem
mild RB O I-problem
right JJ B-NP I-problem
upper JJ I-NP I-problem
quadrant NN I-NP I-problem
discomfort NN I-NP I-problem
, , O O
recent JJ B-NP B-problem
poor JJ I-NP I-problem
appetite NN I-NP I-problem
. . B-VP O
   
PAST NNP B-NP O
MEDICAL NNP I-NP O
HISTORY NNP I-NP O
: : O O
Refractory JJ B-NP B-problem
CLL NNP I-NP I-problem
with IN B-VP O
bone NN B-NP B-problem
marrow NN I-NP I-problem
involvement NN I-NP I-problem
, , O O
status NN B-NP O
post NN I-NP O
MUD NNP I-NP B-treatment
, , O I-treatment
mini-allo JJ B-NP I-treatment
stem NN I-NP I-treatment
cell NN I-NP I-treatment
transplant NN I-NP I-treatment
, , O O
December NNP B-NP O
, , O O
2002 CD O O
, , O O
Acanthamoeba NNP B-NP B-problem
infection NN I-NP I-problem
of IN B-VP I-problem
skin NN B-NP I-problem
and CC O I-problem
sinuses NNS B-NP I-problem
, , O O
recently RB O O
treated VBN O O
with IN B-VP O
IV NNP B-NP B-treatment
pentamidine NN I-NP I-treatment
and CC O O
p.o. JJ B-NP B-treatment
voriconazole NN I-NP I-treatment
, , O O
history NN B-NP O
of IN B-VP O
recurrent NN B-NP B-problem
CMB NNP I-NP I-problem
infection NN I-NP I-problem
, , O O
recent JJ B-NP B-problem
ARS NNP I-NP I-problem
on IN B-VP O
CRI NNP B-NP B-problem
, , O O
thought VBD B-VP O
due JJ O O
to TO O O
medication NN B-NP B-problem
toxicity NN I-NP I-problem
( ( O O
creatinine NN B-NP B-test
on IN B-VP O
discharge NN B-NP O
from IN B-VP O
Retelk NNP B-NP O
County NNP I-NP O
Medical NNP I-NP O
Center NNP I-NP O
on IN B-VP O
October NNP B-NP O
16 CD O O
was VBD B-VP O
2.6) CD O O
. . B-VP O
   
No DT B-NP O
history NN I-NP O
of IN B-VP O
hemodialysis NN B-NP B-treatment
. . B-VP O
   
Graft NNP B-NP B-problem
versus NN I-NP I-problem
host NN I-NP I-problem
disease NN I-NP I-problem
, , O O
recently RB O O
on IN B-VP O
cyclosporine NN B-NP B-treatment
50 CD O O
b.i.d. NN B-NP O
and CC O O
prednisone NN B-NP B-treatment
60 CD O O
q.d. JJ B-NP O
History NNP I-NP O
of IN B-VP O
SVT NNP B-NP B-problem
. . B-VP O
   
MEDICATIONS NNP B-NP O
ON NNP I-NP O
ADMISSION NNP I-NP O
: : O O
Pentamidine NN B-NP B-treatment
300 CD O O
mg NN B-NP O
IV NNP I-NP O
q. VBZ O O
36 CD O O
hours NNS B-NP O
, , O O
Pentamidine NNP B-NP B-treatment
nasal NN I-NP I-treatment
wash VBZ O I-treatment
60 CD O O
mg NN B-NP O
per IN B-VP O
6 CD O O
ml NN B-NP O
of IN B-VP O
sterile JJ B-NP B-treatment
water NN I-NP I-treatment
q.d. NN I-NP O
, , O O
voriconazole JJ O B-treatment
200 CD O O
mg NN B-NP O
p.o. NN I-NP O
b.i.d. NN I-NP O
, , O O
acyclovir RB O B-treatment
400 CD O O
mg NNS B-NP O
p.o. JJ B-NP O
b.i.d. NN I-NP O
, , O O
cyclosporine VBP O B-treatment
50 CD O O
mg NN B-NP O
p.o. NN I-NP O
b.i.d. NN I-NP O
, , O O
prednisone NN B-NP B-treatment
60 CD O O
mg NN B-NP O
p.o. NN I-NP O
q.d. NN I-NP O
, , O O
GCSF NNP B-NP B-treatment
480 CD O O
mcg NN B-NP O
IV NNP I-NP O
q.d. NN I-NP O
, , O O
Epogen NNP B-NP B-treatment
40,000 CD O O
units NNS B-NP O
subcu RB O O
q. JJ B-NP O
week NN I-NP O
, , O O
Protonix NNP B-NP B-treatment
40 CD O O
mg NN B-NP O
q.d. NN I-NP O
, , O O
Simethicone NNP B-NP B-treatment
80 CD O O
mg NN B-NP O
p.o. NN I-NP O
q. NN I-NP O
8 CD O O
, , O O
nitroglycerin JJ B-NP B-treatment
paste NN I-NP I-treatment
1 CD O O
&quot; NNP B-NP O
q. VBD B-VP O
4 CD O O
h. NN B-NP O
p.r.n. NN I-NP O
, , O O
flunisolide RB O B-treatment
nasal JJ B-NP I-treatment
inhaler NN I-NP I-treatment
, , O O
2 CD O O
puffs NNS B-NP O
q. RB O O
8 CD O O
, , O O
OxyCodone NNP B-NP B-treatment
10-15 CD O O
mg NN B-NP O
p.o. NN I-NP O
q. VBD B-VP O
6 CD O O
p.r.n. NN B-NP O
, , O O
Sudafed NNP B-NP B-treatment
30 CD O O
mg NN B-NP O
q. NN I-NP O
6 CD O O
p.o. NN B-NP O
p.r.n. NN I-NP O
, , O O
Fluconazole NNP B-NP B-treatment
2% CD O I-treatment
cream NN B-NP I-treatment
b.i.d. NN I-NP O
to TO O O
erythematous JJ B-NP B-problem
skin NN I-NP I-problem
lesions NNS I-NP I-problem
, , O O
Ditropan NNP B-NP B-treatment
5 CD O O
mg NN B-NP O
p.o. NN I-NP O
b.i.d. NN I-NP O
, , O O
Tylenol NNP B-NP B-treatment
650 CD O O
mg NN B-NP O
p.o. NN I-NP O
q. VBD B-VP O
4 CD O O
h. NN B-NP O
p.r.n. NN I-NP O
, , O O
Ambien NNP B-NP B-treatment
5-10 JJ B-NP O
mg NN I-NP O
p.o. NN I-NP O
q. JJ B-NP O
h.s. NN I-NP O
p.r.n. NN I-NP O
, , O O
Neurontin NNP B-NP B-treatment
100 CD O O
mg NN B-NP O
q. NN I-NP O
a.m. NN I-NP O
, , O O
200 CD O O
mg NN B-NP O
q. CD O O
p.m. NN B-NP O
, , O O
Aquaphor NNP B-NP B-treatment
cream NN I-NP I-treatment
b.i.d. NN I-NP O
p.r.n. NN I-NP O
, , O O
Lotrimin NNP B-NP B-treatment
1% CD O I-treatment
cream NN B-NP I-treatment
b.i.d. NN I-NP O
to TO O O
feet NNS B-NP O
, , O O
Dulcolax NNP B-NP B-treatment
5-10 JJ B-NP O
mg NN I-NP O
p.o. NN I-NP O
q.d. NN I-NP O
p.r.n. NN I-NP O
, , O O
Phoslo NNP B-NP B-treatment
667 CD O O
mg NN B-NP O
p.o. NN I-NP O
t.i.d. NN I-NP O
, , O O
Peridex NNP B-NP B-treatment
0.12% CD O O
, , O O
15 CD O O
ml NN B-NP O
p.o. NN I-NP O
b.i.d. NN I-NP O
mouthwash NN I-NP O
, , O O
Benadryl NNP B-NP B-treatment
25-50 CD O O
mg NN B-NP O
q. JJ B-NP O
4-6 JJ I-NP O
h. NN I-NP O
p.r.n. NN I-NP O
pruritus NN I-NP B-problem
, , O O
Sarna NNP B-NP B-treatment
cream NN I-NP I-treatment
q.d. NN I-NP O
p.r.n. NN I-NP O
pruritus NN I-NP B-problem
, , O O
Nystatin NNP B-NP B-treatment
5 CD O O
ml NN B-NP O
p.o. NN I-NP O
q.i.d. JJ O O
swish JJ O O
and CC O O
! . B-VP O
spit NN B-NP O
, , O O
folate VBP O B-treatment
1 CD O O
mg NN B-NP O
p.o. NN I-NP O
q.d. NN I-NP O
, , O O
vitamin NN B-NP B-treatment
E NNP I-NP I-treatment
400 CD O O
units NNS B-NP O
p.o. JJ B-NP O
q.d. NN I-NP O
, , O O
Haldol NNP B-NP B-treatment
2 CD O O
mg NN B-NP O
IV NNP I-NP O
q. VBZ O O
6 CD O O
p.r.n. NN B-NP O
agitation NN I-NP B-problem
, , O O
Colace NNP B-NP B-treatment
100 CD O O
mg NN B-NP O
b.i.d. NN I-NP O
, , O O
Senna NNP B-NP B-treatment
2 CD O O
tablets NNS B-NP O
p.o. JJ B-NP O
b.i.d. JJ I-NP O
ALLERGIES NNP I-NP O
: : O O
BACTRIM NNP B-NP B-treatment
( ( O O
SEVERE NNP B-NP B-problem
RASH NNP I-NP I-problem
) ) O O
, , O O
GANCICLOVIR NNP B-NP B-treatment
( ( O O
RASH NNP B-NP B-problem
, , O O
HAS NNP B-NP O
BEEN NNP I-NP O
DESENSITIZED NNP I-NP O
) ) O O
. . B-VP O
   
SOCIAL NNP B-NP O
HISTORY NNP I-NP O
: : O O
Patient NN B-NP B-person
works VBZ O O
formerly RB O O
as IN B-VP O
a DT B-NP O
structural JJ I-NP O
engineer NN I-NP O
, , O O
has VBZ O O
not RB O O
been VBN O O
employed VBN O O
over IN B-VP O
the DT O O
last JJ O O
two CD O O
years NNS B-NP O
. . B-VP O
   
Patient NN B-NP B-person
is VBZ O O
married VBN O O
, , O O
an DT B-NP O
immigrant NN I-NP O
from IN B-VP O
Mondca NNP B-NP O
, , O O
South NNP B-NP O
Carolina NNP I-NP O
who WP O B-person
lived VBD B-VP O
close RB O O
to TO O O
Scond NNP B-NP O
at IN B-VP O
time NN B-NP O
of IN B-VP O
nuclear JJ B-NP O
disaster NN I-NP O
. . B-VP O
   
PHYSICAL JJ B-NP O
EXAMINATION NN I-NP O
: : O O
VITAL JJ B-NP O
SIGNS NN I-NP O
: : O O
98.6 CD O O
, , O O
85 CD O O
, , O O
130/80 CD O O
, , O O
20 CD O O
, , O O
97% CD O O
on IN B-VP O
room NN B-NP O
air NN I-NP O
, , O O
82.2 CD O O
kg NN B-NP O
. . B-VP O
   
GENERAL NNP B-NP O
: : O O
Comfortable JJ O O
, , O O
conversational JJ O O
, , O O
appears VBZ O O
same JJ O O
as IN B-VP O
week NN B-NP O
prior RB O O
, , O O
no DT B-NP O
apparent JJ I-NP B-problem
distress NN I-NP I-problem
. . B-VP O
   
HEENT NN B-NP O
: : O O
Pupils NNS B-NP O
were VBD B-VP O
equal JJ O O
, , O O
round NN B-NP O
, , O O
reactive JJ O O
to TO O O
light JJ O O
, , O O
anicteric JJ O B-problem
. . B-VP O
   
Oropharynx CC O O
clear JJ O O
. . B-VP O
   
CARDIOVASCULAR NN B-NP O
: : O O
Regular JJ O O
, , O O
normal JJ B-NP O
S1 NNP I-NP O
and CC O O
S2 NNP B-NP O
, , O O
no DT B-NP O
murmurs NN I-NP B-problem
, , O O
gallops NNS B-NP B-problem
or CC O O
rubs NNS B-NP B-problem
. . B-VP O
   
JVP NNP B-NP B-test
flat JJ O O
. . B-VP O
   
RESPIRATORY NN B-NP O
: : O O
Lungs NNS B-NP O
clear VBP O O
to TO O O
auscultation VB O B-test
bilaterally RB O I-test
. . B-VP O
   
ABDOMEN NN B-NP O
: : O O
Normoactive JJ B-NP O
bowel NN I-NP O
sounds NNS I-NP O
, , O O
soft JJ O O
, , O O
mild JJ B-NP B-problem
right JJ I-NP I-problem
upper NN I-NP I-problem
quadrant NN I-NP I-problem
tenderness NN I-NP I-problem
, , O O
not RB O O
dissimilar JJ O O
from IN B-VP O
week NN B-NP O
prior RB O O
, , O O
pronounced VBD B-VP B-problem
hepatomegaly NN B-NP I-problem
with IN B-VP O
liver NN B-NP O
edge VBP O O
7 CD O O
cm NN B-NP O
below IN B-VP O
costal JJ B-NP O
margin NN I-NP O
, , O O
midclavicular JJ B-NP O
line NN I-NP O
, , O O
no DT B-NP O
splenomegaly NN I-NP B-problem
, , O O
no DT B-NP O
CVA NNP I-NP B-problem
tenderness NN I-NP I-problem
. . B-VP O
   
EXTREMITIES NN B-NP O
: : O O
Slightly RB O B-problem
cool VBP O I-problem
, , O O
3-4+ JJ B-NP B-problem
edema NN I-NP I-problem
bilaterally RB O I-problem
. . B-VP O
   
DERMATOLOGY NN B-NP O
: : O O
Erythematous JJ B-NP B-problem
eruption NN I-NP I-problem
on IN B-VP O
80% CD O O
of IN B-VP O
body NN B-NP O
, , O O
not RB O O
much JJ B-NP O
change NN I-NP O
from IN B-VP O
week NN B-NP O
prior RB O O
. . B-VP O
   
Erythematous JJ B-NP B-problem
nodules NNS I-NP I-problem
on IN B-VP I-problem
arms NNS B-NP I-problem
at IN B-VP O
elbows NNS B-NP O
and CC O O
on IN B-VP O
right JJ B-NP O
thigh NN I-NP O
, , O O
as IN B-VP O
previous JJ O O
. . B-VP O
   
NEUROLOGIC NN B-NP O
: : O O
Alert NNP B-NP O
and CC O O
appropriate JJ O O
. . B-VP O
   
ADMISSION NNP B-NP O
LABORATORY NNP I-NP O
DATA NNP I-NP O
: : O O
Sodium NN B-NP B-test
129 CD O O
, , O O
creatinine NN B-NP B-test
3.0 CD O O
, , O O
BUN NNP B-NP B-test
70 CD O O
, , O O
potassium NN B-NP B-test
5.0 CD O O
, , O O
bicarbonate NN B-NP B-test
23 CD O O
, , O O
chloride RB O B-test
99 CD O O
, , O O
ALT NNP B-NP B-test
36 CD O O
, , O O
AST NNP B-NP B-test
30 CD O O
, , O O
alkaline JJ B-NP B-test
phosphatase NN I-NP I-test
215 CD O O
, , O O
total JJ B-NP B-test
bilirubin NN I-NP I-test
1.1 CD O O
, , O O
albumin RB O B-test
2.6 CD O O
, , O O
white JJ B-NP B-test
blood NN I-NP I-test
cell NN I-NP I-test
count NN I-NP I-test
2.0 CD O O
, , O O
hematocrit NN B-NP B-test
30.5 CD O O
, , O O
platelets NNS B-NP B-test
60 CD O O
. . B-VP O
   
HOSPITAL NNP B-NP O
COURSE NNP I-NP O
: : O O
Patient NN B-NP B-person
was VBD B-VP O
admitted VBN O O
for IN B-VP O
diagnosis NN B-NP O
and CC O O
treatment NN B-NP B-treatment
of IN B-VP O
new JJ B-NP B-problem
fever NN I-NP I-problem
. . B-VP O
   
Workup NNP B-NP B-test
on IN B-VP I-test
admission NN B-NP I-test
included VBD B-VP O
a DT B-NP B-test
chest JJ I-NP I-test
x-ray JJ I-NP I-test
negative NN I-NP O
for IN B-VP O
pneumonia NN B-NP B-problem
, , O O
an DT B-NP B-test
MRI NNP I-NP I-test
of IN B-VP I-test
the DT B-NP I-test
liver NN I-NP I-test
to TO O O
investigate VB O O
for IN B-VP O
focal JJ B-NP B-problem
lesion NN I-NP I-problem
, , O O
with IN B-VP O
no DT B-NP O
evidence NN I-NP O
for IN B-VP O
abscess NN B-NP B-problem
or CC O O
focal JJ B-NP B-problem
lesion NN I-NP I-problem
on IN B-VP O
report NN B-NP O
. . B-VP O
   
Blood NNP B-NP B-test
and CC O I-test
urine JJ B-NP I-test
cultures NNS I-NP I-test
with IN B-VP O
only RB O O
positive JJ B-NP O
culture NN I-NP O
a DT B-NP B-test
blood NN I-NP I-test
culture NN I-NP I-test
on IN B-VP O
November NNP B-NP O
20 CD O O
, , O O
with IN B-VP O
one CD O O
of IN B-VP O
two CD O O
bottles NNS B-NP O
positive JJ O O
for IN B-VP O
coagulase NN B-NP B-problem
negative JJ B-NP I-problem
Staphylococcus NNP I-NP I-problem
. . B-VP O
   
A NNP B-NP B-test
repeat NN I-NP I-test
CMV NNP I-NP I-test
hypercapture NN I-NP I-test
, , O O
negative JJ O O
for IN B-VP O
presence NN B-NP O
of IN B-VP O
CMV NNP B-NP B-problem
. . B-VP O
   
A NNP B-NP B-test
repeat NN I-NP I-test
CAT NNP I-NP I-test
scan NN I-NP I-test
of IN B-VP I-test
the DT B-NP I-test
sinuses NNS I-NP I-test
with IN B-VP O
finding NN B-NP O
of IN B-VP O
progressive JJ B-NP B-problem
thickening NN I-NP I-problem
of IN B-VP I-problem
the DT B-NP I-problem
left JJ I-NP I-problem
maxillary JJ I-NP I-problem
sinus NN I-NP I-problem
and CC O O
both DT B-NP O
sets NNS I-NP O
of IN B-VP O
ethmoid JJ B-NP O
air NN I-NP O
cells NNS I-NP O
since IN B-VP O
prior JJ B-NP O
study NN I-NP O
of IN B-VP O
November NNP B-NP O
9 CD O O
, , O O
indicating VBG O O
progressive JJ B-NP B-problem
infection NN I-NP I-problem
of IN B-VP I-problem
Acanthamoeba NNP B-NP I-problem
and CC O O
any DT B-NP O
possible JJ I-NP O
superinfection NN I-NP B-problem
with IN B-VP O
bacterial JJ B-NP B-problem
sinusitis NN I-NP I-problem
. . B-VP O
   
In IN B-VP O
the DT B-NP O
days NNS I-NP O
following VBG O O
admission NN B-NP O
, , O O
there EX O O
was VBD B-VP O
clear JJ B-NP O
evidence NN I-NP O
for IN B-VP O
progression NN B-NP O
of IN B-VP O
erythematous JJ B-NP B-problem
nodules NNS I-NP I-problem
over IN B-VP I-problem
both DT B-NP I-problem
arms NNS I-NP I-problem
and CC O O
right JJ B-NP O
thigh NN I-NP O
at IN B-VP O
foci NN B-NP O
of IN B-VP O
Acanthamoeba NNP B-NP B-problem
infection NN I-NP I-problem
, , O O
suggesting VBG O O
progressive JJ B-NP B-problem
skin NN I-NP I-problem
involvement NN I-NP I-problem
with IN B-VP O
Acanthamoeba NNP B-NP B-problem
. . B-VP O
   
Infectious JJ B-NP B-person
disease NN I-NP I-person
consult NN I-NP O
was VBD B-VP O
obtained VBN O O
and CC O O
recommendation NN B-NP O
was VBD B-VP O
to TO O O
switch VB O O
from IN B-VP O
voriconazole NN B-NP B-treatment
to TO O O
itraconazole VB O B-treatment
, , O O
on IN B-VP O
which WDT O B-pronoun
there EX O O
was VBD B-VP O
more RBR O O
existing JJ B-NP O
data NNS I-NP O
on IN B-VP O
treatment NN B-NP B-treatment
of IN B-VP O
Acanthamoeba NNP B-NP B-problem
infection NN I-NP I-problem
. . B-VP O
   
Pentamidine NNP B-NP B-treatment
intravenous JJ O I-treatment
and CC O I-treatment
nasal JJ B-NP I-treatment
washings NNS I-NP I-treatment
were VBD B-VP O
continued VBN O O
. . B-VP O
   
Clinical JJ B-NP O
progression NN I-NP O
of IN B-VP O
skin NN B-NP B-problem
and CC O I-problem
sinus JJ B-NP I-problem
infection NN I-NP I-problem
on IN B-VP O
maximal JJ B-NP B-treatment
antimicrobial JJ I-NP I-treatment
therapy NN I-NP I-treatment
continued VBD B-VP O
, , O O
with IN B-VP O
emergence NN B-NP O
on IN B-VP O
November NNP B-NP O
20 CD O O
of IN B-VP O
a DT B-NP B-problem
new JJ I-NP I-problem
right-sided JJ I-NP I-problem
ptosis NN I-NP I-problem
in IN B-VP O
association NN B-NP O
with IN B-VP O
a DT B-NP B-problem
left NN I-NP I-problem
homonymous JJ B-NP I-problem
hemianopsia NN I-NP I-problem
, , O O
and CC O O
fleeting VBG O B-problem
confusion NN B-NP I-problem
while IN B-VP O
febrile NN B-NP B-problem
, , O O
prompting VBG O O
head NN B-NP B-test
MRI NNP I-NP I-test
which WDT O B-pronoun
revealed VBD B-VP O
a DT O O
large JJ O O
5 CD O O
x JJ O O
2 CD O O
x JJ O O
4.3 CD O O
cm JJ B-NP O
region NN I-NP O
in IN B-VP O
the DT B-NP O
right JJ I-NP O
occipital JJ I-NP O
lobe NN I-NP O
of IN B-VP O
hemorrhage NN B-NP B-problem
and CC O O
edema NN B-NP B-problem
, , O O
with IN B-VP O
dural JJ O B-problem
and CC O I-problem
, , O I-problem
likely RB O I-problem
, , O I-problem
leptomeningeal JJ B-NP I-problem
enhancement NN I-NP I-problem
in IN B-VP O
association NN B-NP O
with IN B-VP O
small JJ B-NP B-problem
foci NNS I-NP I-problem
in IN B-VP I-problem
the DT B-NP I-problem
right JJ I-NP I-problem
cerebellum NN I-NP I-problem
and CC O O
pons NNS B-NP O
, , O O
concerning VBG O O
for IN B-VP O
early JJ B-NP B-problem
lesions NNS I-NP I-problem
of IN B-VP O
similar JJ B-NP O
type NN I-NP O
. . B-VP O
   
Idiosyncratic JJ B-NP B-problem
reaction NN I-NP I-problem
to TO O O
cyclosporine VB O B-treatment
was VBD B-VP O
considered VBN O O
as IN B-VP O
cause NN B-NP O
for IN B-VP O
cerebritis NN B-NP B-problem
, , O O
and CC O O
cyclosporine NN B-NP B-treatment
was VBD B-VP O
discontinued VBN O O
. . B-VP O
   
However RB O O
, , O O
much RB O O
more RBR O O
likely JJ B-NP O
explanation NN I-NP O
is VBZ O O
progressive JJ B-NP B-problem
infection NN I-NP I-problem
of IN B-VP O
Acanthamoeba NNP B-NP B-problem
with IN B-VP O
new JJ B-NP B-problem
neurologic JJ I-NP I-problem
involvement NN I-NP I-problem
. . B-VP O
   
Most JJS B-NP O
likely JJ I-NP O
source NN I-NP O
of IN B-VP O
fevers NNS B-NP B-problem
was VBD B-VP O
judged VBN O O
to TO O O
be VB O O
progressive JJ B-NP B-problem
Acanthamoeba NNP I-NP I-problem
infection NN I-NP I-problem
, , O O
even RB O O
on IN B-VP O
maximal JJ B-NP B-treatment
antimicrobial JJ I-NP I-treatment
therapy NN I-NP I-treatment
. . B-VP O
   
A DT B-NP B-test
single JJ I-NP I-test
blood NN I-NP I-test
culture NN I-NP I-test
positive JJ O O
for IN B-VP O
coagulase NN B-NP B-problem
negative JJ B-NP I-problem
Staphylococcus NNP I-NP I-problem
was VBD B-VP O
treated VBN O O
with IN B-VP O
a DT B-NP O
course NN I-NP O
of IN B-VP O
vancomycin NN B-NP B-treatment
in IN B-VP O
the DT B-NP O
setting NN I-NP O
of IN B-VP O
a DT B-NP B-treatment
PICC NNP I-NP I-treatment
line NN I-NP I-treatment
and CC O O
a DT B-NP B-test
chest JJ I-NP I-test
x-ray NN I-NP I-test
on IN B-VP O
November NNP B-NP O
20 CD O O
indicating VBG O O
possible JJ O O
developing VBG O B-problem
pneumonia NN B-NP I-problem
, , O O
resulted VBD B-VP O
in IN B-VP O
a DT B-NP O
course NN I-NP O
of IN B-VP O
levofloxacin NN B-NP B-treatment
, , O O
for IN B-VP O
both DT B-NP O
possible JJ I-NP O
pneumonia NN I-NP B-problem
, , O O
as RB O O
well RB O O
as IN B-VP O
treatment NN B-NP B-treatment
of IN B-VP O
any DT B-NP B-problem
bacterial JJ I-NP I-problem
superinfection NN I-NP I-problem
of IN B-VP O
Acanthamoeba NNP B-NP B-problem
sinusitis NN I-NP I-problem
. . B-VP O
   
Patient NNP B-NP B-person
experienced VBD B-VP O
steady JJ B-NP O
decline NN I-NP O
, , O O
with IN B-VP O
persistent JJ B-NP B-problem
fevers NNS I-NP I-problem
despite IN B-VP O
all DT O B-treatment
above IN B-VP I-treatment
measures NNS B-NP I-treatment
, , O O
progressive JJ B-NP O
areas NNS I-NP O
of IN B-VP O
skin JJ B-NP B-problem
infection NN I-NP I-problem
, , O O
more RBR O O
frequent JJ B-NP O
episodes NNS I-NP O
of IN B-VP O
confusion NN B-NP B-problem
, , O O
and CC O O
decreasing VBG O B-problem
oxygen NN B-NP I-problem
saturation NN I-NP I-problem
in IN B-VP O
the DT B-NP O
setting NN I-NP O
of IN B-VP O
bilateral JJ B-NP B-problem
effusion NN I-NP I-problem
, , O O
in IN B-VP O
the DT B-NP O
setting NN I-NP O
of IN B-VP O
fluid NN B-NP B-problem
surge NN I-NP I-problem
spacing VBG O I-problem
. . B-VP O
   
On IN B-VP O
November NNP B-NP O
30 CD O O
, , O O
a DT B-NP O
family NN I-NP O
meeting NN I-NP O
with IN B-VP O
patient JJ B-NP B-person
patient NN I-NP B-person
&apos;s NNP I-NP I-person
daughter NN I-NP I-person
and CC O O
spouse NN B-NP B-person
, , O O
along IN B-VP O
with IN B-VP O
primary JJ B-NP B-person
oncologist NN I-NP I-person
, , O O
Dr. NNP B-NP B-person
Tomedankell NNP I-NP I-person
Bile NNP I-NP I-person
, , O O
attending VBG O B-person
physician NN B-NP I-person
, , O O
Dr. NNP B-NP B-person
Mellerny NNP I-NP I-person
Close NNP I-NP I-person
, , O O
and CC O O
house NN B-NP B-person
staff NN I-NP I-person
, , O O
was VBD B-VP O
held VBN O O
to TO O O
discuss VB O O
patient JJ B-NP B-person
patient NN I-NP B-problem
&apos;s NNP I-NP I-problem
critical JJ B-NP I-problem
condition NN I-NP I-problem
and CC O O
inability NN B-NP O
to TO O O
prevent VB O O
progression NN B-NP O
of IN B-VP O
skin NN B-NP B-problem
, , O I-problem
sinus NN B-NP I-problem
and CC O I-problem
neurological JJ B-NP I-problem
Acanthamoeba NNP I-NP I-problem
infection NN I-NP I-problem
on IN B-VP O
maximal JJ B-NP B-treatment
antimicrobial JJ I-NP I-treatment
therapy NN I-NP I-treatment
. . B-VP O
   
Decision NN B-NP O
was VBD B-VP O
made VBN O O
to TO O O
withdraw VB O O
aggressive JJ B-NP B-treatment
measures NNS I-NP I-treatment
of IN B-VP I-treatment
care NN B-NP I-treatment
, , O O
with IN B-VP O
priority NN B-NP O
on IN B-VP O
patient JJ B-NP B-person
&apos;s NN I-NP O
comfort NN I-NP O
. . B-VP O
   
Pentamidine NNP B-NP B-treatment
, , O O
itraconazole NN B-NP B-treatment
, , O O
Levaquin NNP B-NP B-treatment
, , O O
acyclovir NN B-NP B-treatment
and CC O O
GCSF NNP B-NP B-treatment
were VBD B-VP O
discontinued VBN O O
, , O O
along IN B-VP O
with IN B-VP O
other JJ B-NP B-treatment
medications NNS I-NP I-treatment
nonessential JJ O O
to TO O O
patient VB O B-person
&apos;s JJ B-NP O
comfort NN I-NP O
. . B-VP O
   
DNR NNP B-NP O
/ NNP I-NP O
DNI NNP I-NP O
status NN I-NP O
initially RB O O
established VBD B-VP O
early JJ O O
during IN B-VP O
hospital JJ B-NP O
stay NN I-NP O
remained VBD B-VP O
in IN B-VP O
effect NN B-NP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
made VBN O O
comfortable JJ O O
with IN B-VP O
morphine NN B-NP B-treatment
for IN B-VP O
pain NN B-NP B-problem
and CC O O
for IN B-VP O
air NN B-NP B-problem
hunger NN I-NP I-problem
, , O O
and CC O O
sinus VBD B-VP B-treatment
suctioning NN B-NP I-treatment
was VBD B-VP O
continued VBN O O
to TO O O
relieve VB O O
congestion NN B-NP B-problem
, , O O
in IN B-VP O
conjunction NN B-NP O
with IN B-VP O
continuation NN B-NP O
of IN B-VP O
nasal JJ B-NP B-treatment
sprays NNS I-NP I-treatment
. . B-VP O
   
Tylenol NNP B-NP B-treatment
was VBD B-VP O
continued VBN O O
to TO O O
control VB O O
fevers NNS B-NP B-problem
and CC O O
prednisone NN B-NP B-treatment
was VBD B-VP O
continued VBN O O
to TO O O
control VB O O
inflammation NN B-NP B-problem
and CC O O
prevent JJ B-NP O
precipitation NN I-NP O
of IN B-VP O
adrenal JJ B-NP B-problem
insufficiency NN I-NP I-problem
. . B-VP O
   
Such JJ B-NP O
measures NNS I-NP O
have VBP O O
been VBN O O
continued VBN O O
through IN B-VP O
December NNP B-NP O
3 CD O O
, , O O
and CC O O
patient NN B-NP B-person
remains VBZ O O
comfortable JJ O O
through IN B-VP O
this DT B-NP B-pronoun
time NN I-NP O
. . B-VP O
   
This DT B-NP B-pronoun
interim JJ I-NP O
dictation NN I-NP O
to TO O O
be VB O O
followed VBN O O
by IN B-VP O
an DT B-NP O
addendum NN I-NP O
detailing VBG O O
end NN B-NP O
of IN B-VP O
hospital JJ B-NP O
course NN I-NP O
. . B-VP O
   
Dictated VBN O O
By IN B-VP O
: : O O
SHAA NNP B-NP B-person
KACHOLERA NNP I-NP I-person
STONGE NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
LN00 NNP I-NP O
Attending NNP I-NP B-person
: : O O
LA NNP B-NP B-person
K. NNP I-NP I-person
SKI NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
OF1 NNP I-NP O
WS584/564649 NNP I-NP O
Batch NNP I-NP O
: : O O
2235 CD O O
Index NNP B-NP O
No. NNP I-NP O
UWHS3TCPJ2 NNP I-NP O
D NNP I-NP O
: : O O
12/03/03 CD O O
T NN B-NP O
: : O O
12/04/03 CD O O
-EMPTYLINE- NN B-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
Admission NNP I-NP O
Date NNP I-NP O
: : O O
2013-11-11 JJ B-NP O
Discharge NN I-NP O
Date NNP I-NP O
: : O O
2013-11-13 JJ B-NP O
Date NNP I-NP O
of IN B-VP O
Birth NNP B-NP O
: : O O
1938-06-09 JJ B-NP O
Sex NN I-NP O
: : O O
M NNP B-NP O
Service NNP I-NP O
: : O O
CMED JJ B-NP O
Allergies NNS I-NP O
: : O O
No DT B-NP O
Drug NNP I-NP B-problem
Allergy NNP I-NP I-problem
Information NNP I-NP O
on IN B-VP O
File NNP B-NP O
Attending NNP I-NP B-person
: : O O
Leroy NNP B-NP B-person
F NNP I-NP I-person
Stalnaker NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
Chief NNP I-NP O
Complaint NNP I-NP O
: : O O
Left NNP B-NP B-problem
sided VBD B-VP I-problem
weakness NN B-NP I-problem
, , O O
slurred VBD B-VP B-problem
speech NN B-NP I-problem
. . B-VP O
   
Major JJ O O
Surgical JJ O O
or CC O O
Invasive JJ B-NP O
Procedure NN I-NP O
: : O O
Intubation NN B-NP B-treatment
and CC O O
mechanical JJ B-NP B-treatment
ventilation NN I-NP I-treatment
. . B-VP O
   
History NNP B-NP O
of IN B-VP O
Present NNP B-NP O
Illness NNP I-NP O
: : O O
Patient NN B-NP B-person
is VBZ O O
a DT O O
75 CD O O
year NN B-NP O
old JJ B-NP O
right NN I-NP O
handed VBD B-VP O
male NN B-NP O
with IN B-VP O
past JJ B-NP O
medical JJ I-NP O
history NN I-NP O
of IN B-VP O
coronary JJ B-NP B-problem
artery NN I-NP I-problem
disease NN I-NP I-problem
s/p JJ B-NP O
NQWMI NNP I-NP B-problem
02-25 NN I-NP O
, , O O
s/p NN B-NP O
LAD NNP I-NP B-treatment
angioplasty NN I-NP I-treatment
and CC O O
stent JJ B-NP B-treatment
05-26 NN I-NP O
, , O O
dementia NN B-NP B-problem
, , O O
hyperlipidemia NN B-NP B-problem
, , O O
aortic JJ B-NP B-problem
stenosis NN I-NP I-problem
, , O O
atrial JJ B-NP B-problem
fibrillation NN I-NP I-problem
on IN B-VP O
coumadin NN B-NP B-treatment
who WP O B-person
presented VBD B-VP O
from IN B-VP O
his PRP$ O B-person
his PRP$ O B-person
CMED NNP B-NP I-person
CSRU NNP I-NP I-person
doctor NN I-NP I-person
's POS O O
office NN B-NP O
wtih NN I-NP O
acute NN I-NP B-problem
onset NN I-NP I-problem
left VBD B-VP I-problem
sided JJ B-NP I-problem
weakness NN I-NP I-problem
and CC O O
dysarthria NN B-NP B-problem
. . B-VP O
   
Patient NN B-NP B-person
was VBD B-VP O
in IN B-VP O
his PRP$ O B-person
usual JJ B-NP O
state NN I-NP O
of IN B-VP O
health NN B-NP O
until IN B-VP O
around IN B-VP O
12:15 CD O O
on IN B-VP O
day NN B-NP O
of IN B-VP O
admission NN B-NP O
. . B-VP O
   
Was NNP B-NP O
at IN B-VP O
this DT O B-person
this DT B-NP B-pronoun
doctor NN I-NP I-person
's POS O O
office NN B-NP O
and CC O O
complained VBD B-VP O
of IN B-VP O
severe JJ B-NP B-problem
headache NN I-NP I-problem
. . B-VP O
   
Thereafter NNP B-NP O
, , O O
wife NN B-NP B-person
noted VBD B-VP O
development NN B-NP O
of IN B-VP O
left NN B-NP B-problem
sided VBD B-VP I-problem
weakness NN B-NP I-problem
, , O O
facial JJ B-NP B-problem
droop NN I-NP I-problem
, , O O
slurring VBG O B-problem
of IN B-VP I-problem
speech NN B-NP I-problem
. . B-VP O
   
Sent NNP B-NP O
to TO O O
Hahnemann NNP B-NP O
General NNP I-NP O
Hospital NNP I-NP O
for IN B-VP O
evaluation NN B-NP B-test
emergently RB O O
. . B-VP O
   
Tom NNP B-NP O
course NN I-NP O
: : O O
Arrived VBN O O
at IN B-VP O
Hahnemann NNP B-NP O
General NNP I-NP O
Hospital NNP I-NP O
at IN B-VP O
12:30 CD O O
. . B-VP O
   
Finger NNP B-NP B-test
stick JJ B-NP I-test
blood NN I-NP I-test
glucose VBD B-VP I-test
120 CD O O
. . B-VP O
   
Rest NNP B-NP O
of IN B-VP O
vitals NNS B-NP B-test
BP NNP I-NP B-test
112/70 CD O O
, , O O
HR NNP B-NP B-test
60 CD O O
. . B-VP O
   
Blood NN B-NP B-test
pressure NN I-NP I-test
up IN B-VP O
to TO O O
230 CD O O
s NNS B-NP O
systolic JJ O O
. . B-VP O
   
Seen NNP B-NP O
emergently RB O O
by IN B-VP O
stroke NN B-NP O
team NN I-NP O
. . B-VP O
   
Initial JJ B-NP B-test
NIH NNP I-NP I-test
stroke VBD B-VP I-test
scale NN B-NP I-test
of IN B-VP O
33 CD O O
. . B-VP O
   
Head NN B-NP B-test
CT NNP I-NP I-test
showed VBD B-VP O
large JJ B-NP B-problem
right JJ I-NP I-problem
intracerebral JJ I-NP I-problem
hemorrhage NN I-NP I-problem
. . B-VP O
   
Intubated VBN O O
for IN B-VP O
airway NN B-NP B-treatment
protection NN I-NP I-treatment
at IN B-VP O
13:35 CD O O
after IN B-VP O
Fentanyl NNP B-NP B-treatment
, , O O
Etomidate NNP B-NP B-treatment
, , O O
Vecuronium NNP B-NP B-treatment
and CC O O
Succhinylcholine NNP B-NP B-treatment
given VBN O O
. . B-VP O
   
Started VBN O O
on IN B-VP O
Labetalol NNP B-NP B-treatment
and CC O O
then RB O O
Nipride NNP B-NP B-treatment
drip NN I-NP I-treatment
for IN B-VP O
BP NNP B-NP B-treatment
control NN I-NP I-treatment
; : O O
discontinued VBN O O
as IN B-VP O
goal NN B-NP B-test
BP NNP I-NP I-test
in IN B-VP O
130-160 JJ B-NP O
s. NN I-NP O
Received VBD B-VP O
10 CD O B-treatment
mg NNS B-NP I-treatment
SC NNP I-NP I-treatment
Vitamin NNP I-NP I-treatment
K NNP I-NP I-treatment
and CC O O
2 CD O B-treatment
units NNS B-NP I-treatment
FFP NNP I-NP I-treatment
while IN B-VP O
in IN B-VP O
Gary NNP B-NP O
. . B-VP O
   
Pupils NNP B-NP O
noted VBD B-VP O
to TO O O
be VB O O
fixed VBN O B-problem
and CC O O
dilated VBN O B-problem
at IN B-VP O
14:10 CD O O
. . B-VP O
   
Loaded VBN O O
with IN B-VP O
Dilantin NNP B-NP B-treatment
and CC O O
50 CD O B-treatment
grams NNS B-NP I-treatment
Mannitol NNP I-NP I-treatment
. . B-VP O
   
Transferred VBN O O
to TO O O
intensive JJ B-NP O
care NN I-NP O
unit NN I-NP O
. . B-VP O
   
Past NNP B-NP O
Medical JJ B-NP O
History NN I-NP O
: : O O
1. CD O O
Atrial NNP B-NP B-problem
fibrillation NN I-NP I-problem
, , O O
on IN B-VP O
coumadin NN B-NP B-treatment
2. CD O O
Coronary JJ B-NP B-problem
artery NN I-NP I-problem
disease NN I-NP I-problem
status NN I-NP O
post NN I-NP O
NQWMI NNP I-NP B-problem
02-25 NN I-NP O
, , O O
s/p NN B-NP O
LAD NNP I-NP B-treatment
angioplasty NN I-NP I-treatment
and CC O O
stent JJ O B-treatment
05-26 JJ O O
. . B-VP O
   
Known VBN O B-problem
non-dominant JJ O I-problem
90% CD O I-problem
RCA NNP B-NP I-problem
lesion NN I-NP I-problem
not RB O O
intervened VBN O O
upon IN B-VP O
. . B-VP O
   
3. CD O O
Dementia NNP B-NP B-problem
4. CD O O
Mild-moderate NNP B-NP B-problem
aortic JJ B-NP I-problem
stenosis NN I-NP I-problem
5. CD O O
Hyperlipidemia NNP B-NP B-problem
6. CD O O
Colon NNP B-NP B-problem
cancer NN I-NP I-problem
7. CD O O
Obstructive JJ B-NP B-problem
sleep NN I-NP I-problem
apnea NN I-NP I-problem
8. CD O O
Anxiety NNP B-NP B-problem
9. CD O O
Diabetes NNP B-NP B-problem
mellitus NN I-NP I-problem
, , O O
on IN B-VP O
oral JJ B-NP B-treatment
medications NNS I-NP I-treatment
Social JJ B-NP O
History NN I-NP O
: : O O
Married NNP B-NP O
. . B-VP O
   
Lives VBZ O O
with IN B-VP O
wife NN B-NP B-person
. . B-VP O
   
One CD O B-person
son NN B-NP I-person
, , O O
in IN B-VP O
area NN B-NP O
. . B-VP O
   
Social NNP B-NP O
alcohol NN I-NP O
. . B-VP O
   
No DT B-NP O
tobacco NN I-NP O
, , O O
drug NN B-NP O
use NN I-NP O
. . B-VP O
   
Family JJ B-NP B-person
History NN I-NP O
: : O O
Non-contributory JJ O O
. . B-VP O
   
Physical JJ B-NP O
Exam NN I-NP O
: : O O
PHYSICAL JJ B-NP B-test
EXAM NNP I-NP I-test
( ( O O
Examined VBD B-VP O
off IN B-VP O
of IN B-VP O
Propofol NNP B-NP B-treatment
): NNP I-NP O
Tc NNP I-NP B-test
: : O O
96.7 CD O O
BP NNP B-NP B-test
: : O O
120/48 CD O O
HR NNP B-NP B-test
: : O O
61 CD O O
RR NN B-NP B-test
: : O O
14 CD O O
O2Sat. NN B-NP B-test
: : O O
100% CD O O
, , O O
ventilated VBN O B-treatment
. . B-VP O
   
Gen NN B-NP O
: : O O
WD/WN NNP B-NP O
male NN I-NP O
, , O O
comfortable JJ O O
appearing VBG O O
, , O O
intubated VBN O B-treatment
, , O O
not RB O O
sedated VBN O B-treatment
. . B-VP O
   
HEENT NN B-NP O
: : O O
NC/AT NNP B-NP B-problem
. . B-VP O
   
Anicteric NNP B-NP B-problem
. . B-VP O
   
MMM NNP B-NP O
. . B-VP O
   
+Endotracheal NN B-NP B-treatment
tube NN I-NP I-treatment
. . B-VP O
   
Neck NN B-NP O
: : O O
Supple NNP B-NP O
. . B-VP O
   
No CC O O
masses NNS B-NP B-problem
or CC O O
LAD NNP B-NP B-problem
. . B-VP O
   
No DT B-NP O
JVD NNP I-NP B-problem
. . B-VP O
   
No DT B-NP O
thyromegaly NN I-NP B-problem
. . B-VP O
   
No DT B-NP O
carotid NN I-NP B-problem
bruits VBZ O I-problem
. . B-VP O
   
Lungs NNS B-NP O
: : O O
Coarse NNP B-NP B-problem
breath NN I-NP I-problem
sounds VBZ O I-problem
anterolaterally RB O I-problem
. . B-VP O
   
Cardiac JJ O O
: : O O
Irregularly RB O B-problem
irregular NN B-NP I-problem
. . B-VP O
   
S1/S2 NNP B-NP O
. . B-VP O
   
No DT B-NP O
M/R/G NNP I-NP B-problem
. . B-VP O
   
Abd NNP B-NP O
: : O O
Soft JJ O O
, , O O
NT NNP B-NP B-problem
, , O O
ND NNP B-NP B-problem
, , O O
+NABS NNP B-NP O
. . B-VP O
   
No NNP B-NP O
rebound NN I-NP B-problem
or CC O O
guarding NN B-NP B-problem
. . B-VP O
   
No DT B-NP O
HSM NNP I-NP B-problem
. . B-VP O
   
Extrem NN B-NP O
: : O O
Warm JJ O O
and CC O O
well-perfused JJ O O
. . B-VP O
   
No DT B-NP O
C/C/E NNP I-NP B-problem
. . B-VP O
   
Neuro NN B-NP O
: : O O
Mental JJ B-NP O
status NN I-NP O
: : O O
No DT B-NP B-problem
response NN I-NP I-problem
to TO O I-problem
voice NN B-NP I-problem
, , O O
sternal JJ B-NP B-test
rub NN I-NP I-test
. . B-VP O
   
Grimaces NNS B-NP O
to TO O O
nasal VB O B-test
tickle NN B-NP I-test
. . B-VP O
   
Cranial JJ B-NP O
Nerves NNS I-NP O
: : O O
Pupils NNS B-NP B-problem
fixed VBN O I-problem
at IN B-VP O
7 CD O O
mm NNS B-NP O
bilaterally RB O O
. . B-VP O
   
Very RB O O
weak JJ B-NP O
flicker NN I-NP O
of IN B-VP O
inner JJ B-NP O
canthus NNS I-NP O
on IN B-VP O
left NN B-NP O
with IN B-VP O
corneal JJ B-NP B-test
stimulation NN I-NP I-test
. . B-VP O
   
No DT B-NP B-problem
oculocephalic JJ I-NP I-problem
reflex NN I-NP I-problem
. . B-VP O
   
Left NNP B-NP B-problem
facial JJ B-NP I-problem
droop NN I-NP I-problem
. . B-VP O
   
No DT B-NP B-problem
gag NN I-NP I-problem
provoked VBD B-VP O
, , O O
but CC O O
biting VBG O O
ETT NNP B-NP B-treatment
at IN B-VP O
times NNS B-NP O
. . B-VP O
   
Tongue NNP B-NP O
midline NN I-NP O
. . B-VP O
   
Motor NNP B-NP O
: : O O
Normal JJ B-NP O
bulk NN I-NP O
. . B-VP O
   
Increased VBD B-VP O
tone NN B-NP O
x4 NN I-NP O
with IN B-VP O
LEs NNP B-NP O
> NNP I-NP O
UEs NNP I-NP O
. . B-VP O
   
No DT B-NP B-problem
withdrawal NN I-NP I-problem
to TO O O
noxious JJ B-NP B-test
stimuli NNS I-NP I-test
. . B-VP O
   
Bilateral NNP B-NP O
feet NNS I-NP O
externally RB O O
rotated VBN O O
. . B-VP O
   
Sensation NN B-NP O
: : O O
No DT B-NP B-problem
withdrawal NN I-NP I-problem
to TO O O
noxious JJ B-NP B-test
stimuli NNS I-NP I-test
. . B-VP O
   
Reflexes NNS B-NP B-test
: : O O
Absent NN B-NP O
in IN B-VP O
LUE NNP B-NP O
, , O O
left VBD B-VP O
ankle NN B-NP O
. . B-VP O
   
Striking VBG O O
left VBD B-VP O
patellar JJ B-NP O
tendon NN I-NP O
results NNS I-NP O
in IN B-VP O
sustained JJ B-NP B-problem
clonus NN I-NP I-problem
of IN B-VP I-problem
left JJ B-NP I-problem
leg NN I-NP I-problem
. . B-VP O
   
Toes NNP B-NP B-problem
upgoing VBG O I-problem
bilaterally RB O I-problem
. . B-VP O
   
02-27 JJ B-NP O
RUE NNP I-NP O
, , O O
absent NN B-NP O
right RB O O
ankle RB O O
. . B-VP O
   
Coordination NN B-NP O
: : O O
Unable JJ O O
to TO O O
assess VB O O
. . B-VP O
   
Gait NN B-NP O
: : O O
Unable JJ O O
to TO O O
assess VB O O
. . B-VP O
   
Pertinent JJ B-NP O
Results NNS I-NP O
: : O O
2013-11-11 JJ O O
12:39 CD O O
PM NNP B-NP O
WBC NNP I-NP B-test
- : O O
9.1 CD O O
RBC NNP B-NP B-test
- : O O
4.29 CD O O
* NN B-NP O
HGB NNP I-NP B-test
- : O O
14.1 CD O O
HCT NNP B-NP B-test
- : O O
38.7 CD O O
* NN B-NP O
MCV NNP I-NP B-test
- : O O
90 CD O O
MCH NNP B-NP B-test
- : O O
32.8 CD O O
* NN B-NP O
MCHC NNP I-NP B-test
- : O O
36.4 CD O O
* NN B-NP O
RDW NNP I-NP B-test
- : O O
14.7 CD O O
2013-11-11 JJ O O
12:39 CD O O
PM NNP B-NP O
PLT NNP I-NP B-test
COUNT NNP I-NP I-test
- : O O
147 CD O O
* JJ O O
2013-11-11 JJ O O
12:39 CD O O
PM NNP B-NP O
PT NNP I-NP B-test
- : O O
20.0 CD O O
* NN B-NP O
PTT NNP I-NP B-test
- : O O
32.4 CD O O
INR NNP B-NP B-test
( ( O I-test
PT NNP B-NP I-test
)- JJ O I-test
2.5 CD O O
2013-11-11 JJ O O
12:39 CD O O
PM NNP B-NP O
GLUCOSE NNP I-NP B-test
- : O O
101 CD O O
UREA NNP B-NP B-test
N NNP I-NP I-test
- : O O
25 CD O O
* NN B-NP O
CREAT NNP I-NP B-test
- : O O
1.0 CD O O
SODIUM NNP B-NP B-test
- : O O
142 CD O O
POTASSIUM NNP B-NP B-test
- : O O
4.2 CD O O
CHLORIDE NNP B-NP B-test
- : O O
106 CD O O
TOTAL NNP B-NP B-test
CO2 NNP I-NP I-test
- : O O
27 CD O O
ANION NNP B-NP B-test
GAP NNP I-NP I-test
- : O O
13 CD O O
2013-11-11 JJ O O
12:39 CD O O
PM NNP B-NP O
CK NNP I-NP B-test
( ( O I-test
CPK NNP B-NP I-test
)- CD O I-test
200 CD O O
* JJ O O
2013-11-11 JJ O O
12:39 CD O O
PM NNP B-NP O
cTropnT NN I-NP B-test
-< VBD B-VP O
0.01 CD O O
2013-11-11 JJ O O
12:39 CD O O
PM NNP B-NP O
CK-MB NNP I-NP B-test
- : O O
7 CD O O
2013-11-11 JJ O O
09:45 CD O O
PM NNP B-NP O
CK NNP I-NP B-test
( ( O I-test
CPK NNP B-NP I-test
)- CD O I-test
196 CD O O
* JJ O O
2013-11-11 JJ O O
09:45 CD O O
PM NNP B-NP O
CK-MB NNP I-NP B-test
- : O O
3 CD O O
cTropnT NN B-NP B-test
-< VBD B-VP O
0.01 CD O O
2013-11-12 JJ O O
03:30 CD O O
AM NNP B-NP O
BLOOD NNP I-NP B-test
CK NNP I-NP B-test
( ( O I-test
CPK NNP B-NP I-test
)- CD O I-test
312 CD O O
* JJ O O
2013-11-12 JJ O O
03:30 CD O O
AM NNP B-NP O
BLOOD NNP I-NP B-test
CK-MB NNP I-NP B-test
- : O O
5 CD O O
cTropnT NN B-NP B-test
-< VBD B-VP O
0.01 CD O O
2013-11-11 JJ O O
01:55 CD O O
PM NNP B-NP O
URINE NNP I-NP B-test
BLOOD NNP I-NP B-test
- : O O
SM NNP B-NP O
NITRITE NNP I-NP B-test
- : O O
NEG NNP B-NP O
PROTEIN NNP I-NP B-test
- : O O
100 CD O O
GLUCOSE NNP B-NP B-test
- : O O
NEG NNP B-NP O
KETONE NNP I-NP B-test
- : O O
NEG NNP B-NP O
BILIRUBIN NNP I-NP B-test
- : O O
NEG NNP B-NP O
UROBILNGN NNP I-NP B-test
- : O O
NEG NNP B-NP O
PH NNP I-NP B-test
- : O O
6.5 CD O O
LEUK NNP B-NP B-test
- : O O
NEG NNP B-NP O
2013-11-12 JJ O O
11:16 CD O O
AM NNP B-NP O
BLOOD NNP I-NP B-test
ASA NNP I-NP B-test
- : O O
NEG NNP B-NP O
Ethanol NNP I-NP B-test
- : O O
NEG NNP B-NP O
Acetmnp NNP I-NP B-test
- : O O
NEG NNP B-NP O
Bnzodzp NNP I-NP B-test
- : O O
NEG NNP B-NP O
Barbitr NNP I-NP B-test
- : O O
NEG NNP B-NP O
Tricycl NNP I-NP B-test
- : O O
NEG NNP B-NP O
2013-11-12 JJ O O
10:17 CD O O
AM NNP B-NP O
URINE NNP I-NP B-test
bnzodzp SYM O B-test
- : O O
NEG NNP B-NP O
barbitr SYM O B-test
- : O O
NEG NN B-NP O
opiates VBZ O B-test
- : O O
NEG NNP B-NP O
cocaine NN I-NP B-test
- : O O
NEG NNP B-NP O
amphetm SYM O B-test
- : O O
NEG NNP B-NP O
mthdone SYM O B-test
- : O O
NEG NNP B-NP O
CT NNP I-NP B-test
head NN I-NP I-test
without IN B-VP I-test
contrast NN B-NP I-test
2013-11-11 JJ O O
: : O O
FINDINGS NN B-NP O
: : O O
There EX O O
is VBZ O O
a DT B-NP O
large JJ I-NP O
region NN I-NP O
of IN B-VP O
high JJ B-NP B-problem
attenuation NN I-NP I-problem
within IN B-VP I-problem
the DT B-NP I-problem
right JJ I-NP I-problem
frontal NN I-NP I-problem
lobe NN I-NP I-problem
and CC O O
the DT B-NP O
region NN I-NP O
of IN B-VP O
the DT B-NP O
right JJ I-NP O
basal NN I-NP O
ganglia NN I-NP O
. . B-VP O
   
This DT O B-pronoun
is VBZ O O
consistent JJ O O
with IN B-VP O
intraparenchymal JJ B-NP B-problem
hemorrhage NN I-NP I-problem
, , O O
more RBR O O
likely JJ B-NP O
hypertensive NN I-NP B-problem
in IN B-VP O
etiology NN B-NP O
. . B-VP O
   
No DT B-NP O
significant JJ I-NP B-problem
subarachnoid NN I-NP I-problem
or CC O O
intraventricular JJ B-NP B-problem
hemorrhage NN I-NP I-problem
is VBZ O O
appreciated VBN O O
. . B-VP O
   
There EX O O
is VBZ O O
mass JJ B-NP B-problem
effect NN I-NP I-problem
present NN I-NP O
with IN B-VP O
shift NN B-NP B-problem
of IN B-VP I-problem
the DT O I-problem
normally RB O I-problem
midline JJ B-NP I-problem
structures NNS I-NP I-problem
towards IN B-VP O
the DT B-NP O
left NN I-NP O
. . B-VP O
   
There EX O O
is VBZ O O
also RB O O
left VBN O B-problem
sided JJ B-NP I-problem
subfalcine NN I-NP I-problem
herniation NN I-NP I-problem
. . B-VP O
   
There EX O O
is VBZ O O
no DT B-NP O
hydrocephalus NN I-NP B-problem
. . B-VP O
   
The DT B-NP O
visualized JJ I-NP O
osseous JJ I-NP O
structures NNS I-NP O
and CC O O
paranasal NN B-NP O
sinuses NNS I-NP O
are VBP O O
unremarkable JJ O O
. . B-VP O
   
IMPRESSION NN B-NP O
: : O O
Large JJ B-NP B-problem
intraparenchymal JJ I-NP I-problem
hemorrhage NN I-NP I-problem
within IN B-VP I-problem
the DT B-NP I-problem
right JJ I-NP I-problem
frontal NN I-NP I-problem
lobe NN I-NP I-problem
. . B-VP O
   
This DT O B-pronoun
most RBS O O
likely JJ B-NP O
relates NNS I-NP O
to TO O O
hypertensive JJ B-NP B-problem
hemorrhage NN I-NP I-problem
, , O O
as IN B-VP O
opposed VBN O O
to TO O O
a DT O B-problem
ruptured VBN O I-problem
right NN B-NP I-problem
middle JJ B-NP I-problem
cerebral JJ I-NP I-problem
artery NN I-NP I-problem
aneurysm NN I-NP I-problem
. . B-VP O
   
Brief JJ B-NP O
Hospital JJ I-NP O
Course NN I-NP O
: : O O
Patient NN B-NP B-person
was VBD B-VP O
a DT O O
75 CD O O
year NN B-NP O
old JJ B-NP O
right NN I-NP O
handed VBD B-VP O
male NN B-NP O
with IN B-VP O
past JJ B-NP O
medical JJ I-NP O
history NN I-NP O
of IN B-VP O
atrial JJ B-NP B-problem
fibrillation NN I-NP I-problem
on IN B-VP O
coumadin NN B-NP B-treatment
, , O O
coronary JJ B-NP B-problem
artery NN I-NP I-problem
disease NN I-NP I-problem
, , O O
hyperlipidemia NN B-NP B-problem
, , O O
dementia NN B-NP B-problem
with IN B-VP O
sudden JJ B-NP B-problem
onset NN I-NP I-problem
left VBD B-VP I-problem
sided JJ B-NP I-problem
weakness NN I-NP I-problem
, , O O
dysarthria NN B-NP B-problem
. . B-VP O
   
Head NNP B-NP B-test
CT NNP I-NP I-test
demonstrated VBD B-VP O
a DT B-NP B-problem
large JJ I-NP I-problem
right JJ I-NP I-problem
intracerebral JJ I-NP I-problem
hemorrhage NN I-NP I-problem
, , O O
centered VBN O O
around IN B-VP O
basal NN B-NP O
ganglia NNS I-NP O
and CC O O
putamen NNS B-NP O
. . B-VP O
   
We PRP O B-person
felt VBD B-VP O
this DT O B-pronoun
was VBD B-VP O
likely JJ O O
secondary JJ O O
to TO O O
hypertension NN B-NP B-problem
. . B-VP O
   
While IN B-VP O
still RB O O
in IN B-VP O
the DT B-NP O
emergency NN I-NP O
department NN I-NP O
, , O O
he PRP O B-person
had VBD B-VP O
rapid JJ B-NP B-problem
decompensation NN I-NP I-problem
necessitating VBG O O
intubation NN B-NP O
for IN B-VP O
airway NN B-NP B-treatment
protection NN I-NP I-treatment
. . B-VP O
   
Examination NNP B-NP B-test
post NN I-NP O
intubation NN I-NP O
but CC O O
off IN B-VP O
intubations NNS B-NP B-treatment
showed VBD B-VP O
clinical JJ B-NP O
evidence NN I-NP O
of IN B-VP O
elevated JJ B-NP B-problem
intracranial JJ I-NP I-problem
pressure NN I-NP I-problem
and CC O O
brainstem NN B-NP B-problem
compression NN I-NP I-problem
. . B-VP O
   
The DT B-NP O
overall JJ I-NP O
prognosis NN I-NP O
was VBD B-VP O
guarded VBN O O
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
admitted VBN O O
to TO O O
the DT B-NP O
Neurology NNP I-NP O
/ NNP I-NP O
Neurosurgery NNP I-NP O
ICU NNP I-NP O
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
loaded VBN O O
with IN B-VP O
Mannitol NNP B-NP B-treatment
and CC O O
Dilantin NNP B-NP B-treatment
in IN B-VP O
the DT B-NP O
emergency NN I-NP O
room NN I-NP O
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
evaluated VBN O O
by IN B-VP O
the DT B-NP O
Neurosurgery NNP I-NP B-person
service NN I-NP I-person
and CC O O
they PRP O B-pronoun
did VBD B-VP O
not RB O O
feel VB O O
a DT B-NP B-treatment
surgical JJ I-NP I-treatment
intervention NN I-NP I-treatment
or CC O O
ventriculary JJ B-NP B-treatment
drain NN I-NP I-treatment
was VBD B-VP O
warranted VBN O O
. . B-VP O
   
After IN B-VP O
arrival NN B-NP O
in IN B-VP O
the DT B-NP O
ICU NNP I-NP O
, , O O
patient NN B-NP B-person
was VBD B-VP O
followed VBN O O
with IN B-VP O
neuro JJ B-NP B-test
checks NNS I-NP I-test
every DT O O
1 CD O O
hour NN B-NP O
. . B-VP O
   
Sedation NN B-NP B-treatment
was VBD B-VP O
held VBN O O
to TO O O
allow VB O O
for IN B-VP O
frequent JJ B-NP B-test
exams NNS I-NP I-test
. . B-VP O
   
Head NN B-NP O
of IN B-VP O
bed NN B-NP O
was VBD B-VP O
kept VBN O O
at IN B-VP O
30 CD O O
degrees NNS B-NP O
. . B-VP O
   
Labetalol NNP B-NP B-treatment
continuous JJ B-NP I-treatment
infusion NN I-NP I-treatment
was VBD B-VP O
titrated VBN O O
for IN B-VP O
systolic JJ B-NP B-test
blood NN I-NP I-test
pressure NN I-NP I-test
of IN B-VP O
130-160 JJ O O
. . B-VP O
   
Mannitol NNP B-NP B-treatment
and CC O O
Dilantin NNP B-NP B-treatment
were VBD B-VP O
continued VBN O O
. . B-VP O
   
After IN B-VP O
lengthy JJ B-NP O
discussion NN I-NP O
, , O O
the DT O B-person
the DT B-NP B-person
patient JJ I-NP I-person
patient NN I-NP I-person
's POS O I-person
wife NN B-NP I-person
opted VBD B-VP O
to TO O O
make VB O O
him PRP O B-person
DNR NNP B-NP O
on IN B-VP O
afternoon NN B-NP O
of IN B-VP O
2013-11-11 JJ O O
. . B-VP O
   
Overnight NNP B-NP O
, , O O
fresh JJ B-NP B-treatment
frozen JJ I-NP I-treatment
plasma NN I-NP I-treatment
was VBD B-VP O
given VBN O O
for IN B-VP O
goal NN B-NP B-test
INR NNP I-NP I-test
of IN B-VP O
< NNP B-NP O
1.4 CD O O
. . B-VP O
   
On IN B-VP O
serial JJ B-NP B-test
exams NNS I-NP I-test
by IN B-VP O
neurology NN B-NP B-person
and CC O O
ICU NNP B-NP B-person
attendings NNS I-NP I-person
in IN B-VP O
the DT B-NP O
morning NN I-NP O
on IN B-VP O
2013-11-12 JJ O O
, , O O
patient JJ O B-person
had VBD B-VP O
no DT B-NP B-problem
clinical JJ I-NP I-problem
signs NNS I-NP I-problem
of IN B-VP I-problem
brainstem NN B-NP I-problem
activity NN I-NP I-problem
. . B-VP O
   
Namely RB O O
, , O O
he PRP O B-person
was VBD B-VP O
unresponsive JJ O B-problem
. . B-VP O
   
Pupils NNS B-NP O
were VBD B-VP O
fixed VBN O B-problem
and CC O O
dilated VBN O B-problem
. . B-VP O
   
No DT B-NP B-problem
corneal NN I-NP I-problem
, , O I-problem
gag NN B-NP I-problem
, , O I-problem
oculocephalic JJ O I-problem
, , O I-problem
and CC O I-problem
oculovestibular JJ B-NP I-problem
reflexes NNS I-NP I-problem
were VBD B-VP O
elicited VBN O O
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
not RB O O
overbreathing VBG O O
his PRP$ O B-person
his PRP$ O B-treatment
ventilator NN B-NP I-treatment
. . B-VP O
   
At IN B-VP O
this DT B-NP B-pronoun
point NN I-NP O
, , O O
patient NN B-NP B-person
was VBD B-VP O
felt VBN O O
to TO O O
have VB O O
clinical JJ B-NP O
signs NNS I-NP O
consistent JJ O O
with IN B-VP O
brain NN B-NP B-problem
death NN I-NP I-problem
. . B-VP O
   
Plans NNPS B-NP O
were VBD B-VP O
made VBN O O
to TO O O
proceed VB O O
with IN B-VP O
apnea JJ O B-test
testing VBG O I-test
. . B-VP O
   
However RB O O
, , O O
after IN B-VP O
discussion NN B-NP O
with IN B-VP O
patient JJ B-NP B-person
patient NN I-NP B-person
's POS O I-person
wife NN B-NP I-person
, , O O
this DT O B-pronoun
was VBD B-VP O
postponed VBN O O
with IN B-VP O
test NN B-NP B-test
planned VBN O O
on IN B-VP O
2013-11-13 JJ O O
. . B-VP O
   
Full NNP B-NP B-treatment
medical JJ B-NP I-treatment
care NN I-NP I-treatment
and CC O O
managment NN B-NP B-treatment
continued VBD B-VP O
overnight JJ O O
11/9-11/20/2002 JJ O O
. . B-VP O
   
At IN B-VP O
approximately RB O O
06:00 CD O O
on IN B-VP O
2013-11-13 JJ O O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
became VBD B-VP O
bradycardic JJ O B-problem
. . B-VP O
   
He PRP O B-person
lapsed VBD B-VP O
first RB O O
into IN B-VP O
a DT B-NP B-problem
junctional JJ I-NP I-problem
rhythm NN I-NP I-problem
and CC O O
then RB O O
had VBD B-VP O
very RB O B-problem
infrequent JJ B-NP I-problem
ventricular JJ I-NP I-problem
escape NN I-NP I-problem
beats NNS I-NP I-problem
on IN B-VP O
telemetry NN B-NP B-test
. . B-VP O
   
Finally RB O O
, , O O
he PRP O B-person
went VBD B-VP O
asystolic JJ O B-problem
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
not RB O O
resuscitated VBN O O
as IN B-VP O
per IN B-VP O
previous JJ B-NP O
conversations NNS I-NP O
with IN B-VP O
his PRP$ O B-person
his PRP$ O B-person
wife NN B-NP I-person
. . B-VP O
   
Ronald NNP B-NP B-person
was VBD B-VP O
pronounced VBN O O
dead JJ O B-problem
at IN B-VP O
06:59 CD O O
am VBP O O
. . B-VP O
   
The DT O B-person
The DT B-NP B-person
patient JJ I-NP I-person
patient NN I-NP I-person
's POS O I-person
wife NN B-NP I-person
was VBD B-VP O
notified VBN O O
. . B-VP O
   
The DT B-NP O
attending NN I-NP O
was VBD B-VP O
notified VBN O O
as IN B-VP O
well RB O O
. . B-VP O
   
Medications NNS B-NP O
on IN B-VP O
Admission NN B-NP O
: : O O
1. CD O O
Coumadin NNP B-NP B-treatment
2. CD O O
Lipitor NNP B-NP B-treatment
3. CD O O
Toprol NNP B-NP B-treatment
XL NNP I-NP I-treatment
4. CD O O
ASA NNP B-NP B-treatment
5. CD O O
Zoloft NNP B-NP B-treatment
6. CD O O
Glucophage NNP B-NP B-treatment
7. CD O O
Aricept NNP B-NP B-treatment
8. CD O O
Namenda NNP B-NP B-treatment
9. CD O O
Artificial NNP B-NP B-treatment
Tears NNP I-NP I-treatment
Discharge NNP I-NP O
Medications NNS I-NP O
: : O O
Not RB O O
applicable JJ O O
. . B-VP O
   
Discharge NNP B-NP O
Disposition NNP I-NP O
: : O O
Extended VBN O O
Care NNP B-NP O
Facility NNP I-NP O
: : O O
Patient NN B-NP B-person
deceased VBD B-VP O
. . B-VP O
   
Discharge NNP B-NP O
Diagnosis NNP I-NP O
: : O O
Not RB O O
applicable; VB O O
patient NN B-NP B-person
deceased VBN O O
. . B-VP O
   
Discharge NNP B-NP O
Condition NNP I-NP O
: : O O
Not RB O O
applicable JJ O O
. . B-VP O
   
Discharge NN B-NP O
Instructions NNS I-NP O
: : O O
Not RB O O
applicable JJ O O
. . B-VP O
   
Followup JJ B-NP O
Instructions NNS I-NP O
: : O O
Not RB O O
applicable JJ O O
. . B-VP O
   
William NNP B-NP B-person
William NNP I-NP I-person
MD NNP I-NP I-person
, , O I-person
PHD NNP B-NP I-person
13-279 CD O O
Completed VBN O O
by IN B-VP O
: : O O
Barbara NNP B-NP B-person
Josephine NNP I-NP I-person
MD NNP I-NP I-person
21-547 JJ O O
2013-11-15 CD O O
@ JJ O O
1413 CD O O
Signed VBN O O
electronically RB O O
by IN B-VP O
: : O O
DR. NNP B-NP B-person
Exie NNP I-NP I-person
Culbreath NNP I-NP I-person
on IN B-VP O
: : O O
MON NNP B-NP O
2013-11-18 CD O O
10:06 CD O O
AM NNP B-NP O
( ( O O
End NNP B-NP O
of IN B-VP O
Report NNP B-NP O
) ) O O
-EMPTYLINE- VBP O O
-DOCSTART- JJ O O
-EMPTYLINE- $ O O
006544894 CD O O
NVH NNP B-NP O
65104826 CD O O
1/2/2004 CD O O
12:00:00 CD O O
AM NNP B-NP O
VT NNP I-NP B-problem
s/p NN I-NP O
cardiac JJ B-NP B-test
cath NN I-NP I-test
, , O O
stent NN B-NP B-treatment
and CC O O
amp NN B-NP O
; : O O
amio CC O B-treatment
loading VBG O I-treatment
DIS NNP B-NP O
Admission NNP I-NP O
Date NNP I-NP O
: : O O
01/02/2004 CD O O
Report NNP B-NP O
Status NNP I-NP O
: : O O
Discharge NN B-NP O
Date NNP I-NP O
: : O O
01/07/2004 CD O O
****** NN B-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
NERSLET NNP I-NP B-person
, , O I-person
BERISS NNP B-NP I-person
665-07-74-6Q06 JJ B-NP O
Room NN I-NP O
: : O O
89H-593 JJ B-NP O
Service NNP I-NP O
: : O O
CAR NNP B-NP O
DISCHARGE NNP I-NP O
PATIENT NNP I-NP B-person
ON NNP I-NP O
: : O O
01/07/04 CD O O
AT NNP B-NP O
02:00 CD O O
PM NNP B-NP O
CONTINGENT NNP I-NP O
UPON NNP I-NP O
Not RB O O
Applicable NNP B-NP O
WILL NNP I-NP O
D NNP I-NP O
/ NNP I-NP O
C NNP I-NP O
ORDER NNP I-NP O
BE NNP I-NP O
USED NNP I-NP O
AS IN B-VP O
THE NNP B-NP O
D NNP I-NP O
/ NNP I-NP O
C NNP I-NP O
SUMMARY NNP I-NP O
: : O O
YES JJ B-NP O
Attending NN I-NP B-person
: : O O
MOST JJS O B-person
, , O I-person
ANNETIFF NNP B-NP I-person
SIAYUDE NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
DISPOSITION NNP I-NP O
: : O O
Home NNP B-NP O
DISCHARGE NNP I-NP O
MEDICATIONS NNP I-NP O
: : O O
AMIODARONE $ O B-treatment
400 CD O O
MG NNP B-NP O
PO NNP I-NP O
BID NNP I-NP O
Starting VBG O O
Today NNP B-NP O
( ( O O
01/06 CD O O
) ) O O
Instructions NNS B-NP O
: : O O
For IN B-VP O
7 CD O O
days NNS B-NP O
Alert NNP I-NP O
overridden NN I-NP O
: : O O
Override NNP B-NP O
added VBD B-VP O
on IN B-VP O
01/03/04 CD O O
by IN B-VP O
TIKNEAV NNP B-NP B-person
, , O I-person
JEFFCI NNP B-NP I-person
SUOT NNP I-NP I-person
A. NN I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
SERIOUS NNP I-NP B-problem
INTERACTION NNP I-NP I-problem
: : O O
DIGOXIN NNP B-NP B-treatment
and CC O O
AMIODARONE NNP B-NP B-treatment
HCL NNP I-NP I-treatment
Reason NNP I-NP O
for IN B-VP O
override NN B-NP O
: : O O
ok JJ B-NP O
ENTERIC NNP I-NP B-treatment
COATED NNP I-NP I-treatment
ASA NNP I-NP I-treatment
( ( O I-treatment
ASPIRIN NNP B-NP I-treatment
ENTERIC NNP I-NP I-treatment
COATED NNP I-NP I-treatment
) ) O I-treatment
325 CD O O
MG NNP B-NP O
PO NNP I-NP O
QD NNP I-NP O
DIGOXIN NNP I-NP B-treatment
0.0625 CD O O
MG NNP B-NP O
PO NNP I-NP O
QD NNP I-NP O
Override NNP I-NP O
Notice NNP I-NP O
: : O O
Override NNP B-NP O
added VBD B-VP O
on IN B-VP O
01/03/04 CD O O
by IN B-VP O
TIKNEAV NNP B-NP B-person
, , O I-person
JEFFCI NNP B-NP I-person
SUOT NNP I-NP I-person
A. NN I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
on IN B-VP O
order NN B-NP O
for IN B-VP O
AMIODARONE NNP B-NP B-treatment
PO NNP I-NP I-treatment
( ( O O
ref JJ O O
# # O O
23731718 CD O O
) ) O O
SERIOUS NNP B-NP B-problem
INTERACTION NNP I-NP I-problem
: : O O
DIGOXIN NNP B-NP B-treatment
and CC O O
AMIODARONE NNP B-NP B-treatment
HCL NNP I-NP I-treatment
Reason NNP I-NP O
for IN B-VP O
override NN B-NP O
: : O O
ok RB O O
Previous NNP B-NP O
override JJ B-NP O
information NN I-NP O
: : O O
Override NNP B-NP O
added VBD B-VP O
on IN B-VP O
01/02/04 CD O O
by IN B-VP O
KOTESLENT NNP B-NP B-person
, , O I-person
ANT NNP B-NP I-person
ODEWYJU NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
on IN B-VP O
order NN B-NP O
for IN B-VP O
AMIODARONE NNP B-NP B-treatment
IV NNP I-NP I-treatment
1 CD O O
( ( O O
ref JJ O O
# # O O
45803793 CD O O
) ) O O
SERIOUS NNP B-NP B-problem
INTERACTION NNP I-NP I-problem
: : O O
DIGOXIN NNP B-NP B-treatment
and CC O O
AMIODARONE NNP B-NP B-treatment
HCL NNP I-NP I-treatment
Reason NNP I-NP O
for IN B-VP O
override NN B-NP O
: : O O
will MD O O
follow VB O O
Previous NNP B-NP O
override JJ B-NP O
information NN I-NP O
: : O O
Override NNP B-NP O
added VBD B-VP O
on IN B-VP O
01/02/04 CD O O
by IN B-VP O
KOTESLENT NNP B-NP B-person
, , O I-person
ANT NNP B-NP I-person
ODEWYJU NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
SERIOUS NNP I-NP B-problem
INTERACTION NNP I-NP I-problem
: : O O
AMIODARONE NNP B-NP B-treatment
HCL NNP I-NP I-treatment
and CC O O
DIGOXIN NNP B-NP B-treatment
Reason NNP I-NP O
for IN B-VP O
override NN B-NP O
: : O O
will MD O O
follow VB O O
MVI NNP B-NP B-treatment
THERAPEUTIC NNP I-NP I-treatment
W NNP I-NP I-treatment
/ NNP I-NP I-treatment
MINERALS NNP I-NP I-treatment
( ( O I-treatment
THERAP NNP B-NP I-treatment
VITS NNP I-NP I-treatment
/ NNP I-NP I-treatment
MINERALS NNP I-NP I-treatment
) ) O I-treatment
1 CD O O
TAB NNP B-NP O
PO NNP I-NP O
QD NNP I-NP O
Override NNP I-NP O
Notice NNP I-NP O
: : O O
Override NNP B-NP O
added VBD B-VP O
on IN B-VP O
01/02/04 CD O O
by IN B-VP O
KOTESLENT NNP B-NP B-person
, , O I-person
ANT NNP B-NP I-person
ODEWYJU NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
on IN B-VP O
order NN B-NP O
for IN B-VP O
ZOCOR NNP B-NP B-treatment
PO NNP I-NP I-treatment
( ( O O
ref JJ O O
# # O O
71920299 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP B-problem
INTERACTION NNP I-NP I-problem
: : O O
NIACIN NNP B-NP B-treatment
, , O O
VIT NNP B-NP B-treatment
. . B-VP O
   
B-3 NNP B-NP O
and CC O O
SIMVASTATIN NNP B-NP B-treatment
Reason NNP I-NP O
for IN B-VP O
override NN B-NP O
: : O O
wil NN B-NP O
follow VBP O O
ZOCOR NNP B-NP B-treatment
( ( O I-treatment
SIMVASTATIN NNP B-NP I-treatment
) ) O I-treatment
40 CD O O
MG NNP B-NP O
PO NNP I-NP O
QHS NNP I-NP O
Food NNP I-NP O
/ NNP I-NP O
Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Avoid NNP I-NP O
grapefruit NN I-NP O
unless IN B-VP O
MD NNP B-NP O
instructs NNS I-NP O
otherwise RB O O
. . B-VP O
   
Alert NNP B-NP O
overridden JJ O O
: : O O
Override NNP B-NP O
added VBD B-VP O
on IN B-VP O
01/02/04 CD O O
by IN B-VP O
KOTESLENT NNP B-NP B-person
, , O I-person
ANT NNP B-NP I-person
ODEWYJU NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP B-problem
INTERACTION NNP I-NP I-problem
: : O O
NIACIN NNP B-NP B-treatment
, , O O
VIT NNP B-NP B-treatment
. . B-VP O
   
B-3 NNP B-NP O
and CC O O
SIMVASTATIN NNP B-NP B-treatment
Reason NNP I-NP O
for IN B-VP O
override NN B-NP O
: : O O
wil NN B-NP O
follow VBP O O
TOPROL NNP B-NP B-treatment
XL NNP I-NP I-treatment
( ( O I-treatment
METOPROLOL NNP B-NP I-treatment
( ( O I-treatment
SUST. NNP B-NP I-treatment
REL. NNP I-NP I-treatment
) ) O I-treatment
) ) O I-treatment
100 CD O O
MG NNP B-NP O
PO NNP I-NP O
QD NNP I-NP O
Food NNP I-NP O
/ NNP I-NP O
Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Take NNP I-NP O
consistently RB O O
with IN B-VP O
meals NNS B-NP O
or CC O O
on IN B-VP O
empty JJ B-NP O
stomach NN I-NP O
. . B-VP O
   
Number NNP B-NP O
of IN B-VP O
Doses NNP B-NP O
Required NNP I-NP O
( ( O O
approximate JJ O O
) ) O O
: : O O
5 CD O B-treatment
PLAVIX NNP B-NP I-treatment
( ( O I-treatment
CLOPIDOGREL NNP B-NP I-treatment
) ) O I-treatment
75 CD O O
MG NNP B-NP O
PO NNP I-NP O
QD NNP I-NP O
Starting VBG O O
Today NNP B-NP O
( ( O O
01/06 CD O O
) ) O O
KEFLEX NNP B-NP B-treatment
( ( O I-treatment
CEPHALEXIN NNP B-NP I-treatment
) ) O I-treatment
500 CD O O
MG NNP B-NP O
PO NNP I-NP O
QID NNP I-NP O
X NNP I-NP O
40 CD O O
doses VBZ O O
AMIODARONE NNP B-NP B-treatment
400 CD O O
MG NNP B-NP O
PO NNP I-NP O
QD NNP I-NP O
Instructions NNS I-NP O
: : O O
After IN B-VP O
7 CD O O
days NNS B-NP O
Alert NNP I-NP O
overridden NN I-NP O
: : O O
Override NNP B-NP O
added VBD B-VP O
on IN B-VP O
01/07/04 CD O O
by: NN B-NP O
SERIOUS NNP I-NP B-problem
INTERACTION NNP I-NP I-problem
: : O O
DIGOXIN NNP B-NP B-treatment
and CC O O
AMIODARONE NNP B-NP B-treatment
HCL NNP I-NP I-treatment
Reason NNP I-NP O
for IN B-VP O
override NN B-NP O
: : O O
ok JJ B-NP O
DIET NNP I-NP O
: : O O
House NNP B-NP O
/ VBD B-VP O
Low NNP B-NP O
chol NN I-NP O
/ NNP I-NP O
low JJ B-NP O
sat. NN I-NP O
fat NN I-NP O
ACTIVITY NNP I-NP O
: : O O
Walking NN B-NP O
as IN B-VP O
tolerated VBN O O
FOLLOW NNP B-NP O
UP NNP I-NP O
APPOINTMENT NNP I-NP O
( ( O O
S NNP B-NP O
) ) O O
: : O O
Dr. NNP B-NP B-person
Levels NNP I-NP I-person
( ( O O
Electrophysiology NNP B-NP O
) ) O O
4 CD O O
weeks NNS B-NP O
, , O O
PCP NNP B-NP B-person
1-2 JJ B-NP O
weeks NNS I-NP O
, , O O
ALLERGY NNP B-NP O
: : O O
NKA NNP B-NP B-problem
ADMIT NNP I-NP O
DIAGNOSIS NNP I-NP O
: : O O
PRINCIPAL NNP B-NP O
DISCHARGE NNP I-NP O
DIAGNOSIS NNP I-NP O
; : O O
Responsible NNP B-NP O
After IN B-VP O
Study NNP B-NP O
for IN B-VP O
Causing NNP B-NP O
Admission NNP I-NP O
) ) O O
VT NNP B-NP B-problem
s NN I-NP O
/ NNP I-NP O
p NN I-NP O
cardiac JJ B-NP B-test
cath NN I-NP I-test
, , O O
stent NN B-NP B-treatment
and CC O O
amio NN B-NP B-treatment
loading VBG O I-treatment
OTHER NNP B-NP O
DIAGNOSIS NNP I-NP O
; : O O
Conditions NNP B-NP O
, , O O
Infections NNP B-NP O
, , O O
Complications NNP B-NP O
, , O O
affecting VBG O O
Treatment NNP B-NP O
/ NNP I-NP O
Stay NNP I-NP O
VT NNP I-NP B-problem
, , O O
CAD NNP B-NP B-problem
s VBD B-VP O
/ NNP B-NP O
p NN I-NP O
MI NNP I-NP B-problem
ischemic VBZ O B-problem
cardiomyopathy JJ B-NP I-problem
bilateral JJ I-NP B-treatment
knee NN I-NP I-treatment
replacement NN I-NP I-treatment
OPERATIONS NNP I-NP O
AND CC O O
PROCEDURES NNP B-NP O
: : O O
OTHER NNP B-NP O
TREATMENTS NNP I-NP O
/ NNP I-NP O
PROCEDURES NNP I-NP O
( ( O O
NOT NNP B-NP O
IN NNP I-NP O
O.R. NNP I-NP O
) ) O O
Cardiac NNP B-NP B-test
Cath NNP I-NP I-test
1/6/0004 CD O O
BRIEF NNP B-NP O
RESUME NNP I-NP O
OF NNP I-NP O
HOSPITAL NNP I-NP O
COURSE NNP I-NP O
: : O O
78 CD O O
M NNP B-NP O
w/ NN I-NP O
longstanding VBG O B-problem
CAD NNP B-NP I-problem
s NN I-NP O
/ NNP I-NP O
p NN I-NP O
CABG NNP I-NP B-treatment
'97 NNP I-NP O
, , O O
had VBD B-VP O
PPM NNP B-NP B-treatment
and CC O O
AICD NNP B-NP B-treatment
placed VBD B-VP O
in IN B-VP O
'02 NN B-NP O
after IN B-VP O
admitted VBN O O
for IN B-VP O
presyncope NN B-NP B-problem
and CC O O
found VBN O O
to TO O O
have VB O O
inducible JJ B-NP B-problem
VT NNP I-NP I-problem
. . B-VP O
   
in IN B-VP O
USOH NNP B-NP O
until IN B-VP O
this DT O B-pronoun
am VBP O O
when WRB O O
felt NN B-NP O
LH NNP I-NP B-problem
and CC O O
then RB O O
ICD NNP B-NP B-treatment
discharge NN I-NP I-treatment
. . B-VP O
   
Subsequent JJ O O
4 CD O B-treatment
ICD NNP B-NP I-treatment
discharges NNS I-NP I-treatment
at IN B-VP O
rest NN B-NP O
. . B-VP O
   
Denies VBZ O O
change NN B-NP B-problem
in IN B-VP I-problem
ET NNP B-NP I-problem
, , O O
chest JJS B-NP B-problem
pain NN I-NP I-problem
, , O O
SOB NNP B-NP B-problem
. . B-VP O
   
Went NNP B-NP O
to TO O O
OSH NNP B-NP O
c VB O O
further RBR O B-treatment
ICD NNP B-NP I-treatment
shocks NNS I-NP I-treatment
, , O O
VT NNP B-NP B-problem
on IN B-VP O
monitor NN B-NP B-test
but CC O O
stable JJ B-NP O
VS NNP I-NP O
. . B-VP O
   
Given NNP B-NP O
amio JJ B-NP B-treatment
bolu NN I-NP I-treatment
, , O O
started VBD B-VP O
on IN B-VP O
gtt NN B-NP B-treatment
and CC O O
transferred VBD B-VP O
to TO O O
NVH NNP B-NP O
for IN B-VP O
further JJ B-NP B-test
evaluation NN I-NP I-test
. . B-VP O
   
Exam NNP B-NP B-test
remarkable JJ O O
for IN B-VP O
b NN B-NP B-problem
/ NNP I-NP I-problem
l NN I-NP I-problem
carotid NN I-NP I-problem
bruits NNS I-NP I-problem
, , O O
soft JJ B-NP B-problem
murmur NN I-NP I-problem
at IN B-VP I-problem
L NNP B-NP I-problem
sternal JJ B-NP I-problem
border NN I-NP I-problem
, , O O
clear JJ B-NP O
chest NN I-NP O
, , O O
1+ CD O B-problem
b NN B-NP I-problem
/ NN I-NP I-problem
l NN I-NP I-problem
edema NN I-NP I-problem
. . B-VP O
   
Labs NNP B-NP B-test
at IN B-VP O
OSH NNP B-NP O
c VBP O O
Cr NNP B-NP B-test
: : O O
1.9 CD O O
, , O O
Hct NNP B-NP B-test
: : O O
39.1 CD O O
, , O O
gluc NN B-NP B-test
: : O O
214 CD O O
, , O O
CK NNP B-NP B-test
: : O O
130 CD O O
, , O O
MB NNP B-NP B-test
: : O O
2.6. CD O O
ECG NNP B-NP B-test
is VBZ O O
AV NNP B-NP O
paced VBD B-VP O
but CC O O
prior JJ B-NP O
shower JJR I-NP B-problem
R NNP I-NP I-problem
on IN B-VP I-problem
T NNP B-NP I-problem
VPB NNP I-NP I-problem
c VBP O O
monomorphic JJ B-NP B-problem
VT NNP I-NP I-problem
then RB O O
overdrive RB O O
paced VBN O O
. . B-VP O
   
**** JJ B-NP O
Course NNP I-NP O
1) CD O O
CV NNP B-NP O
( ( O O
R NNP B-NP O
) ) O O
finished VBD B-VP O
amio JJ B-NP B-treatment
IV NNP I-NP I-treatment
load NN I-NP I-treatment
then RB O O
started VBD B-VP O
on IN B-VP O
po NN B-NP O
, , O O
agressive JJ B-NP B-treatment
lytes NNS I-NP I-treatment
; : O O
although IN B-VP O
interrogation NN B-NP B-test
showed VBD B-VP O
>100 NNP B-NP O
episodes NNS I-NP O
of IN B-VP O
VT NNP B-NP B-problem
( ( O O
as IN B-VP O
/ NNP B-NP O
x NNP I-NP O
) ) O O
, , O O
pt JJ B-NP O
prefers NNS I-NP O
med VBD B-VP B-treatment
therapy NN B-NP I-treatment
as IN B-VP O
opposed VBN O O
to TO O O
ablation NN B-NP B-treatment
( ( O O
I PRP O O
) ) O O
enzymes VBZ O B-test
mildly RB O B-problem
elevated VBN O I-problem
but CC O O
not RB O O
actively RB O B-problem
ischemic JJ O I-problem
; : O O
lipids NNS B-NP B-test
, , O O
ASA NNP B-NP B-treatment
, , O O
statin NN B-NP B-treatment
, , O O
BB NNP B-NP B-treatment
; : O O
Adenosine NNP B-NP B-test
thal VBZ O I-test
1/4 CD O O
and CC O O
echo $ O B-test
1/4 CD O O
to TO O O
look VB O O
for IN B-VP O
signs NNS B-NP O
of IN B-VP O
ischemia NN B-NP B-problem
as IN B-VP O
active JJ B-NP O
cause NN I-NP O
for IN B-VP O
VT NNP B-NP B-problem
( ( O O
P NNP B-NP O
) ) O O
JVP NNP B-NP B-test
at IN B-VP O
angle NN B-NP O
of IN B-VP O
jaw NN B-NP O
1/4 CD O O
--> NN B-NP O
giving VBG O O
20 CD O B-treatment
Lasix NNP B-NP I-treatment
; : O O
dig VBZ O B-test
level NN B-NP I-test
1/4 CD O O
1.3 CD O O
--> JJ O O
1/2 CD O O
dose NN B-NP O
as IN B-VP O
on IN B-VP O
Amio NNP B-NP B-treatment
2) CD O O
Endo NNP B-NP O
: : O O
elevated VBN O B-problem
glu NN B-NP I-problem
on IN B-VP O
admit NN B-NP O
BMP NNP I-NP B-test
and CC O O
FSG NNP B-NP B-test
also RB O O
concurring VBG O O
--> NNP B-NP O
follow NN I-NP O
and CC O O
Lispro NNP B-NP B-treatment
; : O O
will MD O O
probably RB O O
need VB O O
w JJ B-NP B-test
/ NNP I-NP I-test
u NN I-NP I-test
as IN B-VP O
outpt JJ O O
3) CD O O
Pulm NN B-NP O
: : O O
baseline NN B-NP B-test
PFTs NNP I-NP I-test
as IN B-VP O
staring VBG O O
amio JJ O B-treatment
4) CD O O
GI NN B-NP O
: : O O
baseline NN B-NP B-test
LFTs NNP I-NP I-test
wnl NN I-NP O
; : O O
taking VBG O O
cardiac JJ B-NP B-treatment
/ NNP I-NP I-treatment
ADA NNP I-NP I-treatment
diet NN I-NP I-treatment
as IN B-VP O
glu NN B-NP B-test
remains VBZ O O
elevated JJ O B-problem
5) CD O O
Renal JJ O O
: : O O
baseline NN B-NP B-problem
CRI NNP I-NP I-problem
( ( O O
1.2-1.6 JJ O O
) ) O O
with IN B-VP O
elevation NN B-NP B-problem
at IN B-VP O
admission NN B-NP O
probably RB O O
prerenal JJ O O
; : O O
will MD O O
monitor VB O O
BUN NNP B-NP B-test
/ NNP I-NP O
Cr NNP I-NP B-test
after IN B-VP O
giving VBG O O
Lasix NNP B-NP B-treatment
6) CD O O
Proph NNP B-NP O
: : O O
PPI NNP B-NP B-treatment
and CC O O
pneumoboots JJ B-NP B-treatment
HOSPITAL NNP I-NP O
COURSE NNP I-NP O
and CC O O
OUTCOME NNP B-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
admitted VBN O O
to TO O O
the DT B-NP O
cardiology NN I-NP O
service NN I-NP O
and CC O O
commenced VBD B-VP O
amiodarone NN B-NP B-treatment
loading NN I-NP I-treatment
. . B-VP O
   
Adenosine NNP B-NP B-test
stress NN I-NP I-test
MIBI NNP I-NP I-test
revealed VBD B-VP O
a DT B-NP B-problem
small JJ I-NP I-problem
reversible JJ I-NP I-problem
defect NN I-NP I-problem
in IN B-VP I-problem
the DT B-NP I-problem
PDA NNP I-NP I-problem
territory NN I-NP I-problem
and CC O O
the DT B-NP B-person
patient JJ I-NP I-person
underwent JJ I-NP O
coronary JJ I-NP B-test
catheterisation NN I-NP I-test
on IN B-VP O
1/6/0004 CD O O
which WDT O B-pronoun
revealed VBD B-VP O
a DT O B-problem
70% CD O I-problem
lesion NN B-NP I-problem
in IN B-VP I-problem
the DT B-NP I-problem
SVG NNP I-NP I-problem
to TO O I-problem
PDA NNP B-NP I-problem
-> NNP I-NP O
cypher RB O B-treatment
stented VBD B-VP I-treatment
successfully RB O O
. . B-VP O
   
He PRP O B-person
had VBD B-VP O
occasional JJ B-NP B-problem
ventricular JJ I-NP I-problem
extopyon NN I-NP I-problem
telemetry NN I-NP B-test
but CC O O
no DT B-NP O
further JJ I-NP B-problem
recurrence NN I-NP I-problem
of IN B-VP O
ventricular JJ B-NP B-problem
tachycardia NN I-NP I-problem
. . B-VP O
   
During IN B-VP O
his PRP$ O B-person
admission NN B-NP O
, , O O
his PRP$ O B-person
his PRP$ O B-test
am VBP O I-test
fasting VBG O I-test
glucose NN B-NP I-test
levels NNS I-NP I-test
were VBD B-VP O
intermittently RB O B-problem
elevated VBN O I-problem
and CC O O
his PRP$ O B-person
his PRP$ O B-test
HbA1C NNP B-NP I-test
was VBD B-VP O
greater JJR O O
than IN B-VP O
7 CD O O
. . B-VP O
   
I PRP O B-person
have VBP O O
explained VBN O O
to TO O O
him PRP O B-person
that IN B-VP B-pronoun
he PRP O B-person
may MD O O
have VB O O
developed VBN O O
some DT B-NP B-problem
glucose JJ I-NP I-problem
intolerance NN I-NP I-problem
and CC O O
that DT O B-pronoun
, , O O
in IN B-VP O
the DT B-NP O
first JJ I-NP O
instance NN I-NP O
, , O O
he PRP O B-person
should MD O O
see VB O O
his PRP$ O B-person
his PRP$ O B-person
Primary NNP B-NP I-person
Care NNP I-NP I-person
Physician NNP I-NP I-person
and CC O O
attempt VB O O
dietary JJ B-NP B-treatment
control NN I-NP I-treatment
. . B-VP O
   
On IN B-VP O
the DT B-NP O
day NN I-NP O
prior RB O O
to TO O O
discharge VB O O
he PRP O B-person
noticed VBD B-VP O
a DT B-NP O
small JJ I-NP O
area NN I-NP O
of IN B-VP O
erythema NN B-NP B-problem
surrounding VBG O O
his PRP$ O B-person
his PRP$ O B-treatment
R NNP B-NP I-treatment
antecubital NN I-NP I-treatment
venous JJ B-NP I-treatment
access NN I-NP I-treatment
site NN I-NP I-treatment
. . B-VP O
   
This DT O B-pronoun
will MD O O
be VB O O
treated VBN O O
empirically RB O O
with IN B-VP O
a DT O O
10 CD O O
day NN B-NP O
course NN I-NP O
of IN B-VP O
Keflex NNP B-NP B-treatment
. . B-VP O
   
I PRP O B-person
have VBP O O
instructed VBN O O
him PRP O B-person
to TO O O
see VB O O
his PRP$ O B-person
his PRP$ O B-person
PCP NN B-NP I-person
if IN B-VP O
it PRP O B-pronoun
does VBZ O O
not RB O O
improve VB O O
in IN B-VP O
a DT B-NP O
few JJ I-NP O
days NNS I-NP O
or CC O O
if IN B-VP O
he PRP O B-person
develops VBZ O O
fevers NNS B-NP B-problem
. . B-VP O
   
In IN B-VP O
terms NNS B-NP O
of IN B-VP O
his PRP$ O B-person
his PRP$ O B-treatment
amiodarone NN B-NP I-treatment
, , O O
he PRP O B-person
will MD O O
be VB O O
discharged VBN O O
on IN B-VP O
400mg CD O O
po NNS B-NP O
bid NN I-NP O
for IN B-VP O
a DT O O
further JJ O O
7 CD O O
days NNS B-NP O
followed VBN O O
by IN B-VP O
400mg CD O O
qd JJ O O
thereafter RB O O
. . B-VP O
   
He PRP O B-person
will MD O O
followup VB O O
with IN B-VP O
Dr. NNP B-NP B-person
Levels NNP I-NP I-person
in IN B-VP O
device NN B-NP O
clinic NN I-NP O
in IN B-VP O
4 CD O O
weeks NNS B-NP O
. . B-VP O
   
I PRP O B-person
have VBP O O
advised VBN O O
him PRP O B-person
that IN B-VP B-pronoun
he PRP O B-person
must MD O O
not RB O O
drive VB O O
until IN B-VP O
he PRP O B-person
is VBZ O O
seena JJ B-NP O
gain NN I-NP O
in IN B-VP O
clinic NN B-NP O
and CC O O
his PRP$ O B-person
his PRP$ O B-treatment
device NN B-NP I-treatment
interrogated VBD B-VP O
. . B-VP O
   
ADDITIONAL JJ B-NP O
COMMENTS NN I-NP O
: : O O
DISCHARGE JJ B-NP O
CONDITION NNP I-NP O
: : O O
Stable JJ B-NP O
TO NNP I-NP O
DO NNP I-NP O
/ NNP I-NP O
PLAN NNP I-NP O
: : O O
No DT B-NP O
dictated JJ I-NP O
summary NN I-NP O
ENTERED NN I-NP O
BY NNP I-NP O
: : O O
STENVERS NNS B-NP B-person
, , O I-person
IMARL NNP B-NP I-person
, , O I-person
M.D. NNP B-NP I-person
( ( O O
AW45 NNP B-NP O
) ) O O
01/07/04 CD O O
02:14 CD O O
PM NNP B-NP O
****** JJ B-NP O
END NNP I-NP O
OF NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
Admission NNP I-NP O
Date NNP I-NP O
: : O O
2012-04-30 JJ B-NP O
Discharge NN I-NP O
Date NNP I-NP O
: : O O
2012-05-14 JJ B-NP O
Date NNP I-NP O
of IN B-VP O
Birth NNP B-NP O
: : O O
1956-11-04 JJ B-NP O
Sex NN I-NP O
: : O O
M NNP B-NP O
Service NNP I-NP O
: : O O
O-CMED JJ B-NP O
CCU NNP I-NP O
HISTORY NNP I-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
is VBZ O O
a DT O O
55 CD O O
- : O O
year-old JJ B-NP O
male NN I-NP O
with IN B-VP O
recently RB O B-problem
diagnosed VBN O I-problem
abdominal JJ B-NP I-problem
carcinomatosis NN I-NP I-problem
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
presented VBN O O
with IN B-VP O
abdominal JJ B-NP B-problem
pain NN I-NP I-problem
and CC O O
bloating NN B-NP B-problem
and CC O O
was VBD B-VP O
found VBN O O
to TO O O
have VB O O
a DT B-NP B-problem
large JJ I-NP I-problem
omental JJ I-NP I-problem
mass NN I-NP I-problem
. . B-VP O
   
Biopsy NNP B-NP B-test
revealed VBD B-VP O
adenocarcinoma NN B-NP B-problem
. . B-VP O
   
Histochemical JJ B-NP B-test
stains NNS I-NP I-test
are VBP O O
consistent JJ O O
with IN B-VP O
hepatobiliary JJ B-NP O
origin NN I-NP O
. . B-VP O
   
Endoscopies NNS B-NP B-test
were VBD B-VP O
negative JJ O O
except IN B-VP O
for IN B-VP O
an DT B-NP B-problem
extrinsic JJ I-NP I-problem
mass NN I-NP I-problem
present NN I-NP I-problem
on IN B-VP I-problem
the DT B-NP I-problem
stomach NN I-NP I-problem
. . B-VP O
   
The DT B-NP B-person
patient JJ I-NP I-person
presents NNS I-NP O
with IN B-VP O
increased JJ B-NP B-problem
abdominal JJ I-NP I-problem
pain NN I-NP I-problem
and CC O O
poor JJ B-NP B-problem
oral JJ I-NP I-problem
intake NN I-NP I-problem
as RB O O
well RB O O
as IN B-VP O
generalized VBN O B-problem
weakness NN B-NP I-problem
. . B-VP O
   
On IN B-VP O
presentation NN B-NP O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
denied VBD B-VP O
chest JJS B-NP B-problem
pain NN I-NP I-problem
, , O O
shortness NN B-NP B-problem
of IN B-VP I-problem
breath NN B-NP I-problem
, , O O
and CC O O
cough NN B-NP B-problem
. . B-VP O
   
PAST NNP B-NP O
MEDICAL NNP I-NP O
HISTORY NNP I-NP O
: : O O
1. CD O O
Benign NNP B-NP B-problem
prostatic JJ B-NP I-problem
hypertrophy NN I-NP I-problem
. . B-VP O
   
2. CD O O
Osteoarthritis NNP B-NP B-problem
. . B-VP O
   
3. CD O O
Gastrointestinal JJ B-NP B-problem
adenocarcinoma NN I-NP I-problem
( ( O O
as IN B-VP O
noted VBN O O
in IN B-VP O
History NNP B-NP O
of IN B-VP O
Present NNP B-NP O
Illness NNP I-NP O
) ) O O
. . B-VP O
   
MEDICATIONS NNP B-NP O
ON NNP I-NP O
ADMISSION NNP I-NP O
: : O O
Colace NN B-NP B-treatment
, , O O
Senna NNP B-NP B-treatment
, , O O
Dulcolax NNP B-NP B-treatment
, , O O
Tylenol NNP B-NP B-treatment
, , O O
oxycodone NN B-NP B-treatment
as IN B-VP O
needed VBN O O
, , O O
Ambien NNP B-NP B-treatment
, , O O
and CC O O
Protonix NNP B-NP B-treatment
. . B-VP O
   
ALLERGIES NNP B-NP O
: : O O
No DT B-NP O
known JJ I-NP B-problem
drug NN I-NP I-problem
allergies NNS I-NP I-problem
. . B-VP O
   
FAMILY NNP B-NP O
HISTORY NNP I-NP O
: : O O
Mother NN B-NP B-person
had VBD B-VP O
adrenal JJ B-NP B-problem
cancer NN I-NP I-problem
. . B-VP O
   
Father NNP B-NP B-person
had VBD B-VP O
coronary JJ B-NP B-problem
artery NN I-NP I-problem
disease NN I-NP I-problem
. . B-VP O
   
SOCIAL NNP B-NP O
HISTORY NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
employed VBN O O
as IN B-VP O
a DT B-NP O
salesman NN I-NP O
. . B-VP O
   
He PRP O B-person
denied VBD B-VP O
the DT B-NP O
use NN I-NP O
of IN B-VP O
tobacco NN B-NP O
and CC O O
drugs NNS B-NP O
. . B-VP O
   
He PRP O B-person
uses VBZ O O
alcohol NN B-NP O
occasionally RB O O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
is VBZ O O
married VBN O O
with IN B-VP O
two CD O O
children NNS B-NP O
. . B-VP O
   
REVIEW NNP B-NP O
OF NNPS I-NP O
SYSTEMS NNP I-NP O
: : O O
Review NNP B-NP B-test
of IN B-VP I-test
systems NNS B-NP I-test
was VBD B-VP O
significant JJ O O
for IN B-VP O
progressive JJ B-NP B-problem
abdominal JJ I-NP I-problem
discomfort NN I-NP I-problem
, , O O
decreased VBD B-VP B-problem
oral JJ B-NP I-problem
intake NN I-NP I-problem
, , O O
and CC O O
weakness NN B-NP B-problem
in IN B-VP O
the DT O O
past JJ O O
nine CD O O
weeks NNS B-NP O
. . B-VP O
   
PHYSICAL NNP B-NP O
EXAMINATION NNP I-NP O
ON NNP I-NP O
PRESENTATION NNP I-NP O
: : O O
Physical JJ B-NP B-test
examination NN I-NP I-test
revealed VBD B-VP O
temperature NN B-NP B-test
was VBD B-VP O
96.9 CD O O
, , O O
heart NN B-NP B-test
rate NN I-NP I-test
was VBD B-VP O
121 CD O O
, , O O
blood NN B-NP B-test
pressure NN I-NP I-test
was VBD B-VP O
122/86 CD O O
, , O O
respiratory NN B-NP B-test
rate NN I-NP I-test
was VBD B-VP O
22 CD O O
, , O O
and CC O O
oxygen NN B-NP B-test
saturation NN I-NP I-test
was VBD B-VP O
96% CD O O
on IN B-VP O
room NN B-NP O
air NN I-NP O
. . B-VP O
   
In IN B-VP O
general JJ O O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
looked VBD B-VP O
acutely RB O B-problem
and CC O I-problem
chronically RB O I-problem
ill VB O I-problem
. . B-VP O
   
Head NNP B-NP B-test
, , O I-test
eyes NNS B-NP I-test
, , O I-test
ears NNS B-NP I-test
, , O I-test
nose RB O I-test
, , O I-test
and CC O I-test
throat NN B-NP I-test
examination NN I-NP I-test
revealed VBD B-VP O
the DT B-NP O
oropharynx NN I-NP O
was VBD B-VP O
clear JJ O O
. . B-VP O
   
Sclerae NNP B-NP O
were VBD B-VP O
anicteric JJ O B-problem
. . B-VP O
   
Mucous JJ B-NP O
membranes NNS I-NP O
were VBD B-VP O
moist JJ O O
. . B-VP O
   
Cardiovascular JJ B-NP B-test
examination NN I-NP I-test
revealed VBD B-VP O
tachycardic JJ B-NP B-problem
first JJ I-NP I-problem
heart NN I-NP I-problem
sound NN I-NP I-problem
and CC O I-problem
second JJ B-NP I-problem
heart NN I-NP I-problem
sound NN I-NP I-problem
. . B-VP O
   
No DT B-NP O
murmurs NN I-NP B-problem
, , O O
rubs NN B-NP B-problem
, , O O
or CC O O
gallops NNS B-NP B-problem
. . B-VP O
   
Lungs NNS B-NP O
revealed VBD B-VP O
decreased JJ B-NP B-problem
breath NN I-NP I-problem
sounds NNS I-NP I-problem
and CC O O
dullness NN B-NP B-problem
to TO O O
percussion NN B-NP B-test
in IN B-VP O
the DT B-NP O
left NN I-NP O
lung NN I-NP O
base NN I-NP O
. . B-VP O
   
The DT B-NP O
abdomen NNS I-NP O
was VBD B-VP O
distended VBN O B-problem
and CC O O
firm NN B-NP B-problem
. . B-VP O
   
Positive NNP B-NP O
bowel NN I-NP O
sounds NNS I-NP O
. . B-VP O
   
Extremity NNP B-NP B-test
examination NN I-NP I-test
revealed VBD B-VP O
no DT B-NP O
clubbing NN I-NP B-problem
, , O O
cyanosis NN B-NP B-problem
, , O O
or CC O O
edema NN B-NP B-problem
. . B-VP O
   
IMPRESSION NN B-NP O
: : O O
This DT O B-pronoun
was VBD B-VP O
a DT O O
55 CD O O
- : O O
year-old JJ B-NP O
gentleman NN I-NP O
with IN B-VP O
recently RB O B-problem
diagnosed VBN O I-problem
abdominal JJ B-NP I-problem
carcinomatosis NN I-NP I-problem
admitted VBN O O
with IN B-VP O
increased JJ B-NP B-problem
abdominal JJ I-NP I-problem
pain NN I-NP I-problem
and CC O O
poor JJ B-NP B-problem
oral JJ I-NP I-problem
intake NN I-NP I-problem
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
admitted VBN O O
to TO O O
the DT B-NP O
O-CMED NNP I-NP O
Service NNP I-NP O
for IN B-VP O
further JJ B-NP B-treatment
management NN I-NP I-treatment
. . B-VP O
   
HOSPITAL NNP B-NP O
COURSE NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
admitted VBN O O
to TO O O
the DT B-NP O
O-CMED NNP I-NP O
Service NNP I-NP O
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
placed VBN O O
on IN B-VP O
a DT B-NP B-treatment
patient-controlled JJ I-NP I-treatment
patient-controlled JJ I-NP B-person
analgesia NN I-NP I-treatment
for IN B-VP O
pain NN B-NP B-treatment
control NN I-NP I-treatment
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
administered VBN O O
intravenous JJ B-NP B-treatment
fluids NNS I-NP I-treatment
and CC O O
oral JJ B-NP O
diet NN I-NP O
as IN B-VP O
tolerated VBN O O
. . B-VP O
   
On IN B-VP O
the DT B-NP O
night NN I-NP O
of IN B-VP O
05-01 NN B-NP O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
complained VBD B-VP O
of IN B-VP O
increased JJ B-NP B-problem
vomiting NN I-NP I-problem
. . B-VP O
   
He PRP O B-person
also RB O O
complained VBD B-VP O
of IN B-VP O
increased JJ B-NP B-problem
shortness NN I-NP I-problem
of IN B-VP I-problem
breath NN B-NP I-problem
and CC O O
" NNP B-NP O
difficulty NN I-NP B-problem
catching VBG O I-problem
his PRP$ O I-problem
his PRP$ O B-person
breath NN B-NP I-problem
." NN I-NP O
On IN B-VP O
room NN B-NP O
air NN I-NP O
, , O O
the DT O B-person
the DT B-NP B-test
patient JJ I-NP I-person
patient NN I-NP I-test
's POS O I-test
oxygen NN B-NP I-test
saturation NN I-NP I-test
was VBD B-VP O
80% CD O O
. . B-VP O
   
His PRP$ O B-test
His PRP$ O B-person
saturation NN B-NP I-test
increased VBD B-VP O
to TO O O
87% CD O O
on IN B-VP O
a DT B-NP B-treatment
nonrebreather NN I-NP I-treatment
. . B-VP O
   
A DT B-NP B-test
chest JJ I-NP I-test
x-ray NN I-NP I-test
disclosed VBD B-VP O
a DT B-NP B-problem
left JJ I-NP I-problem
pleural JJ I-NP I-problem
effusion NN I-NP I-problem
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
bolused VBN O O
with IN B-VP O
intravenous JJ B-NP B-treatment
heparin NNS I-NP I-treatment
due JJ O O
to TO O O
concern NN B-NP O
for IN B-VP O
pulmonary JJ B-NP B-problem
embolism NN I-NP I-problem
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
expressed VBD B-VP O
a DT B-NP O
desire NN I-NP O
to TO O O
be VB O O
full JJ B-NP O
code NN I-NP O
, , O O
so IN B-VP O
he PRP O B-person
was VBD B-VP O
transferred VBN O O
to TO O O
the DT B-NP O
Intensive NNP I-NP O
Care NNP I-NP O
Unit NNP I-NP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
became VBD B-VP O
more RBR O O
comfortable JJ O O
being VBG O O
seated VBN O O
upright JJ O O
with IN B-VP O
nebulizer JJ B-NP B-treatment
treatments NNS I-NP I-treatment
. . B-VP O
   
An DT B-NP B-test
angiogram NN I-NP I-test
was VBD B-VP O
done VBN O O
which WDT O B-pronoun
disclosed VBD B-VP O
possible JJ B-NP O
subsegmental JJ I-NP B-problem
pulmonary JJ I-NP I-problem
emboli NN I-NP I-problem
of IN B-VP I-problem
the DT B-NP I-problem
upper JJ I-NP I-problem
lobes NN I-NP I-problem
as RB O O
well RB O O
as IN B-VP O
infiltrates NNS B-NP B-problem
consistent JJ O O
with IN B-VP O
aspiration NN B-NP B-problem
pneumonia NN I-NP I-problem
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
placed VBN O O
on IN B-VP O
Flagyl NNP B-NP B-treatment
and CC O O
Levaquin NNP B-NP B-treatment
for IN B-VP O
treatment NN B-NP B-treatment
of IN B-VP O
pneumonia NN B-NP B-problem
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
continued VBN O O
on IN B-VP O
heparin NN B-NP B-treatment
for IN B-VP O
treatment NN B-NP B-treatment
of IN B-VP O
the DT B-NP B-problem
pulmonary JJ I-NP I-problem
emboli NN I-NP I-problem
. . B-VP O
   
While IN B-VP O
in IN B-VP O
the DT B-NP O
Intensive NNP I-NP O
Care NNP I-NP O
Unit NNP I-NP O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
noted VBN O O
to TO O O
have VB O O
increasing VBG O B-problem
abdominal JJ B-NP I-problem
distention NN I-NP I-problem
. . B-VP O
   
On IN B-VP O
05-03 JJ O O
the DT B-NP B-person
patient NN I-NP I-person
underwent VBD B-VP O
an DT B-NP B-test
abdominal JJ I-NP I-test
ultrasound NN I-NP I-test
with IN B-VP O
paracentesis NN B-NP B-treatment
, , O O
and CC O O
5 CD O O
liters NNS B-NP O
of IN B-VP O
fluid NN B-NP B-problem
were VBD B-VP O
removed VBN O O
. . B-VP O
   
On IN B-VP O
05-04 JJ O O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
transferred VBN O O
back RB O O
to TO O O
the DT B-NP O
O-CMED NNP I-NP O
CSRU NNP I-NP O
Service NNP I-NP O
. . B-VP O
   
Due NNP B-NP O
to TO O O
persistent VB O B-problem
gastric JJ B-NP I-problem
secretions NNS I-NP I-problem
, , O O
an DT B-NP B-treatment
nasogastric JJ I-NP I-treatment
tube NN I-NP I-treatment
was VBD B-VP O
placed VBN O O
for IN B-VP O
decompression NN B-NP B-treatment
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
noted VBN O O
to TO O O
have VB O O
a DT B-NP O
functional JJ I-NP O
ileus NN I-NP O
. . B-VP O
   
Octreotide NNP B-NP B-treatment
was VBD B-VP O
initiated VBN O O
in IN B-VP O
an DT B-NP O
attempt NN I-NP O
to TO O O
decrease VB O O
the DT B-NP B-problem
gastric JJ I-NP I-problem
secretions NNS I-NP I-problem
. . B-VP O
   
On IN B-VP O
05-13 NN B-NP O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
's POS O O
respiratory NN B-NP O
status NN I-NP O
declined VBD B-VP O
further RB O O
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
noted VBN O O
not RB O O
have VB O O
an DT O B-problem
increasing VBG O I-problem
left-sided JJ B-NP I-problem
pleural JJ I-NP I-problem
effusion NN I-NP I-problem
. . B-VP O
   
A DT B-NP B-treatment
thoracentesis NN I-NP I-treatment
was VBD B-VP O
done VBN O O
with IN B-VP O
removal NN B-NP B-treatment
of IN B-VP O
1.5 CD O O
liters NNS B-NP O
of IN B-VP O
fluid NN B-NP B-problem
. . B-VP O
   
A DT B-NP B-treatment
paracentesis NN I-NP I-treatment
was VBD B-VP O
repeated VBN O O
with IN B-VP O
removal NN B-NP B-treatment
of IN B-VP O
2.5 CD O O
liters NNS B-NP O
of IN B-VP O
fluid NN B-NP B-problem
. . B-VP O
   
On IN B-VP O
the DT B-NP O
night NN I-NP O
of IN B-VP O
05-13 NN B-NP O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
continued VBD B-VP O
to TO O O
decline VB O O
. . B-VP O
   
The DT B-NP O
family NN I-NP O
decided VBD B-VP O
to TO O O
pursue VB O O
comfort NN B-NP B-treatment
measures NNS I-NP I-treatment
. . B-VP O
   
Morphine NNP B-NP B-treatment
was VBD B-VP O
administered VBN O O
to TO O O
insure VB O O
patient NN B-NP B-person
's POS O O
comfort NN B-NP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
expired VBD B-VP O
at IN B-VP O
6 CD O O
p.m. NN B-NP O
on IN B-VP O
05-14 NN B-NP O
. . B-VP O
   
FINAL NNP B-NP O
DISCHARGE NNP I-NP O
DIAGNOSES NNP I-NP O
: : O O
1. CD O O
Gastrointestinal NNP B-NP B-problem
adenocarcinoma NN I-NP I-problem
; : O O
primary JJ B-NP O
unknown NN I-NP O
( ( O O
likely JJ B-NP O
hepatobiliary NN I-NP O
) ) O O
. . B-VP O
   
2. CD O O
Aspiration NNP B-NP B-problem
pneumonia NN I-NP I-problem
. . B-VP O
   
3. CD O O
Pulmonary JJ B-NP B-problem
emboli NN I-NP I-problem
. . B-VP O
   
4. CD O O
Hypoxia NNP B-NP B-problem
. . B-VP O
   
5. CD O O
Dehydration NNP B-NP B-problem
. . B-VP O
   
6. CD O O
Ileus NNP B-NP B-problem
. . B-VP O
   
Pearl NNP B-NP B-person
Y. NNP I-NP I-person
Simmons NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
68-957 CD O O
Dictated VBN O O
By IN B-VP O
: : O O
Lynn NNP B-NP B-person
J NNP I-NP I-person
Crump NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
MEDQUIST36 NNP I-NP O
D NNP I-NP O
: : O O
2012-05-14 JJ O O
19:24 CD O O
T NN B-NP O
: : O O
2012-05-19 JJ O O
05:00 CD O O
JOB NNP B-NP O
# # O O
: : O O
79196 CD O O
Signed VBN O O
electronically RB O O
by IN B-VP O
: : O O
DR. NNP B-NP B-person
Catherine NNP I-NP I-person
GOLDSTEIN NNP I-NP I-person
on IN B-VP O
: : O O
Andrea JJ O O
2012-06-07 JJ O O
8:18 CD O O
AM NNP B-NP O
( ( O O
End NNP B-NP O
of IN B-VP O
Report NNP B-NP O
) ) O O
-EMPTYLINE- VBP O O
-DOCSTART- JJ O O
-EMPTYLINE- $ O O
387946944 CD O O
FIH NNP B-NP O
6652087 CD O O
713765 CD O O
7284844 CD O O
9/21/2003 CD O O
12:00:00 CD O O
AM NNP B-NP O
ED NNP I-NP O
Discharge NNP I-NP O
Summary NNP I-NP O
Unsigned VBD B-VP O
DIS NNP B-NP O
Report NNP I-NP O
Status NNP I-NP O
: : O O
Unsigned VBD B-VP O
ED NNP B-NP O
DISCHARGE NNP I-NP O
NOTIFICATION NNP I-NP O
DOUETTWIDOUET NNP I-NP B-person
, , O I-person
TAROBY NNP B-NP I-person
MRN NNP I-NP O
: : O O
6652087 CD O O
Age NNP B-NP O
: : O O
80y CD O O
REGISTRATION NNP B-NP O
DATE NNP I-NP O
: : O O
09/21/2003 CD O O
06:51 CD O O
PM NNP B-NP O
PRELIMINARY NNP I-NP O
REPORT NNP I-NP O
This DT O B-pronoun
is VBZ O O
to TO O O
notify VB O O
you PRP O B-person
that IN B-VP B-pronoun
your PRP$ O B-person
your PRP$ O B-person
patient NN B-NP I-person
, , O O
DOUETTWIDOUET NNP B-NP B-person
, , O I-person
TAROBY NNP B-NP I-person
arrived VBD B-VP O
in IN B-VP O
the DT B-NP O
Emergency NNP I-NP O
Department NNP I-NP O
at IN B-VP O
Fairm NNP B-NP O
of IN B-VP O
Ijordcompmac NNP B-NP O
Hospital NNP I-NP O
on IN B-VP O
09/21/2003 CD O O
06:51 CD O O
PM NNP B-NP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
presented VBN O O
with IN B-VP O
a DT B-NP O
chief JJ I-NP O
complaint NN I-NP O
of IN B-VP O
WEAK NNP B-NP B-problem
. . B-VP O
   
Following VBG O O
evaluation NN B-NP B-test
and CC O O
treatment NN B-NP B-treatment
, , O O
the DT B-NP B-person
patient NN I-NP I-person
&apos;s JJ B-NP O
disposition NN I-NP O
at IN B-VP O
the DT B-NP O
end NN I-NP O
of IN B-VP O
the DT B-NP O
visit NN I-NP O
was VBD B-VP O
ADMITTED NNP B-NP O
AS IN B-VP O
AN NNP B-NP O
INPATIENT NNP I-NP O
TO NNP I-NP O
FAIRM NNP I-NP O
OF NNP I-NP O
IJORDCOMPMAC NNP I-NP O
HOSPITAL NNP I-NP O
. . B-VP O
   
The DT O B-person
The DT B-NP B-person
patient JJ I-NP I-person
patient NN I-NP I-person
&apos;s NNP I-NP I-person
preliminary JJ O I-person
admitting VBG O I-person
physician NN B-NP I-person
is VBZ O O
SAPSCLYSS NNP B-NP B-person
, , O I-person
LEO NNP B-NP I-person
R NNP I-NP I-person
and CC O O
the DT B-NP O
preliminary JJ I-NP O
diagnosis NN I-NP O
is VBZ O O
WEAKNESS NNP B-NP B-problem
. . B-VP O
   
Please NNP B-NP O
note VB O O
this DT B-NP B-pronoun
information NN I-NP O
may MD O O
have VB O O
been VBN O O
updated VBN O O
on IN B-VP O
the DT B-NP O
inpatient JJ I-NP O
unit NN I-NP O
. . B-VP O
   
If IN B-VP O
you PRP O B-person
need VBP O O
additional JJ B-NP O
information NN I-NP O
please NN I-NP O
call VB O O
834-226-3369 JJ O O
. . B-VP O
   
PCP NNPS B-NP B-person
Name NN I-NP O
: : O O
ROSORB NNP B-NP B-person
, , O I-person
ASALEYSEAN NNP B-NP I-person
I PRP O I-person
Provider VBP O O
Number NNP B-NP O
: : O O
80629 CD O O
-EMPTYLINE- NN B-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
Admission NNP I-NP O
Date NNP I-NP O
: : O O
2011-12-17 JJ B-NP O
Discharge NN I-NP O
Date NNP I-NP O
: : O O
2012-01-14 JJ B-NP O
Date NNP I-NP O
of IN B-VP O
Birth NNP B-NP O
: : O O
1932-12-18 JJ B-NP O
Sex NN I-NP O
: : O O
M NNP B-NP O
Service NNP I-NP O
: : O O
NEUROLOGY JJ B-NP O
Allergies NNS I-NP O
: : O O
Bactrim NNP B-NP B-treatment
Attending NNP I-NP B-person
: : O O
Patricia NNP B-NP B-person
Q NNP I-NP I-person
Pendergrass NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
Chief NNP I-NP O
Complaint NNP I-NP O
: : O O
altered VBD B-VP B-problem
metnal JJ B-NP I-problem
status NN I-NP I-problem
Major NNP I-NP O
Surgical NNP I-NP O
or CC O O
Invasive JJ B-NP O
Procedure NN I-NP O
: : O O
bronchoscopy JJ B-NP B-test
History NNP I-NP O
of IN B-VP O
Present NNP B-NP O
Illness NNP I-NP O
: : O O
79 CD O B-person
- : O I-person
year-old JJ B-NP I-person
M NNP I-NP I-person
recently RB O O
diagnosed VBN O O
by IN B-VP O
biopsy NN B-NP B-test
with IN B-VP O
gliomatosis NN B-NP B-problem
cerebri NN I-NP I-problem
( ( O I-problem
grade JJ B-NP I-problem
II NNP I-NP I-problem
astrocytoma NN I-NP I-problem
) ) O I-problem
in IN B-VP O
8/04 CD O O
, , O O
being VBG O O
treated VBN O O
with IN B-VP O
XRT NNP B-NP B-treatment
, , O O
timidar NN B-NP B-treatment
. . B-VP O
   
She PRP O B-person
is VBZ O O
currently RB O O
on IN B-VP O
a DT B-NP B-treatment
decadron NN I-NP I-treatment
taper NN I-NP I-treatment
after IN B-VP O
it PRP O B-pronoun
was VBD B-VP O
increased VBN O O
several JJ B-NP O
months NNS I-NP O
ago RB O O
secondary JJ O O
to TO O O
increasing VBG O B-problem
ocular JJ B-NP I-problem
symptoms NNS I-NP I-problem
. . B-VP O
   
Seen JJ O O
by IN B-VP O
PMD NNP B-NP B-person
on IN B-VP O
12-14 JJ B-NP O
w/ NN I-NP O
symptoms NNS I-NP O
of IN B-VP O
cough JJ B-NP B-problem
productive NN I-NP O
of IN B-VP O
yellow JJ B-NP B-problem
sputum NN I-NP I-problem
, , O O
which WDT O B-pronoun
wife NN B-NP B-person
also RB O O
had VBD B-VP O
, , O O
prescribed VBN O O
zpak NN B-NP B-treatment
w/o NN I-NP O
improvement NN I-NP O
. . B-VP O
   
Pt NNP B-NP B-person
was VBD B-VP O
brought VBN O O
to TO O O
the DT B-NP O
Victor NNP I-NP O
for IN B-VP O
increasing VBG O B-problem
somnolence NN B-NP I-problem
over IN B-VP O
past JJ B-NP O
several JJ I-NP O
days-weeks NNS I-NP O
. . B-VP O
   
Over IN B-VP O
the DT O O
past JJ O O
two CD O O
weeks NNS B-NP O
, , O O
pt NN B-NP B-person
has VBZ O O
declined VBN O O
in IN B-VP O
status NN B-NP O
. . B-VP O
   
He PRP O B-person
is VBZ O O
confused VBN O B-problem
, , O O
has VBZ O O
had VBN O O
hallucinations NNS B-NP B-problem
. . B-VP O
   
Family RB O B-person
believed VBD B-VP O
pt NN B-NP B-person
was VBD B-VP O
becoming VBG O O
dehydrated VBN O B-problem
. . B-VP O
   
Also RB O O
, , O O
pt NN B-NP B-person
's POS O O
strength NN B-NP O
has VBZ O O
been VBN O O
declining VBG O O
over IN B-VP O
the DT O O
past JJ O O
2 CD O O
weeks NNS B-NP O
. . B-VP O
   
He PRP O B-person
used VBD B-VP O
to TO O O
be VB O O
able JJ O O
to TO O O
walk VB O O
with IN B-VP O
a DT B-NP B-treatment
walker NN I-NP I-treatment
, , O O
and CC O O
the DT B-NP O
past JJ I-NP O
few JJ I-NP O
days NNS I-NP O
has VBZ O O
required VBN O O
a DT B-NP B-treatment
wheelchair NN I-NP I-treatment
. . B-VP O
   
+ JJ B-NP O
incontinence NN I-NP B-problem
over IN B-VP O
the DT O O
past JJ O O
2 CD O O
weeks NNS B-NP O
. . B-VP O
   
+ JJ B-NP O
non-bloody JJ I-NP B-problem
diarrhea NN I-NP I-problem
x $ O O
1 CD O O
on IN B-VP O
DOA NNP B-NP O
. . B-VP O
   
In IN B-VP O
the DT B-NP O
Deborah NNP I-NP O
VS NNP I-NP B-test
on IN B-VP O
arrival NN B-NP O
were VBD B-VP O
T NNP B-NP B-test
: : O O
97.5 CD O O
; : O O
BP NNP B-NP B-test
: : O O
90/65 CD O O
; : O O
HR NNP B-NP B-test
: : O O
82 CD O O
; : O O
RR NNP B-NP B-test
: : O O
16 CD O O
; : O O
94 CD O O
on IN B-VP O
RA NNP B-NP O
. . B-VP O
   
CXR NNP B-NP B-test
shows VBZ O O
diffuse NN B-NP B-problem
b/l NN I-NP I-problem
infiltrates VBZ O I-problem
R NNP B-NP I-problem
> NNP I-NP I-problem
L NNP I-NP I-problem
and CC O O
pt NN B-NP B-person
was VBD B-VP O
found VBN O O
to TO O O
have VB O O
a DT B-NP B-problem
bandemia NN I-NP I-problem
. . B-VP O
   
LDH NNP B-NP B-test
was VBD B-VP O
511 CD O O
. . B-VP O
   
Pt NNP B-NP B-person
received VBD B-VP O
bactrim JJ O B-treatment
500 CD O O
mg NN B-NP O
x VBD B-VP O
1 CD O O
for IN B-VP O
possible JJ B-NP O
PCP NNP I-NP B-problem
. . B-VP O
   
Lillian JJ B-NP O
R. NNP I-NP O
/ NNP I-NP O
hypoxic NN I-NP B-problem
respiratory NN I-NP I-problem
distress NN I-NP I-problem
. . B-VP O
   
During IN B-VP O
admission NN B-NP O
, , O O
became VBD B-VP O
steadily RB O B-problem
more RBR O I-problem
SOB NNP B-NP I-problem
, , O O
increasing VBG O B-problem
lethargy NN B-NP I-problem
. . B-VP O
   
12-20 JJ O O
satting VBG O O
initially RB O O
~ $ O O
90% CD O O
on IN B-VP O
40% CD O O
face NN B-NP B-treatment
mask NN I-NP I-treatment
. . B-VP O
   
ABG $ O B-test
7.45/33/57 CD O O
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
switched VBN O O
to TO O O
a DT O B-treatment
100% CD O I-treatment
NRB NNP B-NP I-treatment
mask NN I-NP I-treatment
and CC O O
ABG NNP B-NP B-test
was VBD B-VP O
7.47/31/80 CD O O
. . B-VP O
   
On IN B-VP O
floor NN B-NP O
on IN B-VP O
day NN B-NP O
of IN B-VP O
transfer NN B-NP O
7.25/50/70 CD O O
on IN B-VP O
100% CD O B-treatment
NRB NNP B-NP I-treatment
. . B-VP O
   
During IN B-VP O
evaluation NN B-NP B-test
pt NNS I-NP O
responsive VBP O O
to TO O O
sternal JJ B-NP B-test
rub NN I-NP I-test
but CC O O
could MD O O
not RB O O
follow VB O O
commands NNS B-NP O
. . B-VP O
   
Intubated VBN O O
for IN B-VP O
failure NN B-NP B-problem
to TO O I-problem
protect VB O I-problem
airway RB O I-problem
, , O O
transferred VBD B-VP O
to TO O O
ICU NNP B-NP O
. . B-VP O
   
Past NNP B-NP O
Medical JJ B-NP O
History NN I-NP O
: : O O
PMHx NN B-NP O
: : O O
1. CD O O
Coronary JJ B-NP B-problem
artery NN I-NP I-problem
disease NN I-NP I-problem
s/p VBD B-VP O
MI NNP B-NP B-problem
20 CD O O
years NNS B-NP O
ago RB O O
2. CD O O
Hypertension NNP B-NP B-problem
3. CD O O
Hyperlipidemia NNP B-NP B-problem
4. CD O O
DJD NNP B-NP B-problem
in IN B-VP I-problem
the DT O I-problem
C-spine JJ O I-problem
5. CD O O
depression NN B-NP B-problem
6. CD O O
h/o NN B-NP O
DVT NNP I-NP B-problem
7. CD O O
Shingles NNP B-NP B-problem
recently RB O O
finished VBD B-VP O
treatment NN B-NP B-treatment
Social NNP I-NP O
History NNP I-NP O
: : O O
Landfill NNP B-NP O
worker SYM O O
- : O O
retired VBN O O
15-20 JJ B-NP O
pky NN I-NP O
h/o NN I-NP O
smoking NN I-NP O
, , O O
quit NN B-NP O
15 CD O O
yrs NN B-NP O
ago IN B-VP O
Denies NNP B-NP O
etoh VBP O O
/ NNP B-NP O
drugs NNS I-NP O
Family NNP I-NP O
History NN I-NP O
: : O O
non-contributory JJ O O
. . B-VP O
   
Physical JJ B-NP B-test
Exam NN I-NP I-test
: : O O
t NN B-NP B-test
98.9 CD O O
, , O B-test
bp RB O O
63/28 CD O O
on IN B-VP B-treatment
neo NN B-NP O
, , O B-test
p NN B-NP O
114 CD O O
, , O B-treatment
AC NNP B-NP B-treatment
fi02 VBD B-VP O
1/ CD O B-treatment
vt NN B-NP O
550/ CD O B-treatment
peep NN B-NP O
5/ CD O O
breathing NN B-NP O
at IN B-VP O
16/22 CD O O
, , O O
w/ JJR B-NP B-treatment
volumes NNS I-NP O
of IN B-VP O
500 CD O O
s NN B-NP O
. . B-VP O
   
Intubated VBN O B-treatment
, , O O
minimally RB O B-problem
responsive JJ O I-problem
, , O O
localized JJ B-NP O
pain NN I-NP O
. . B-VP O
   
PERRL NNP B-NP O
. . B-VP O
   
OP NNP B-NP O
clear JJ O O
. . B-VP O
   
MMM NNP B-NP O
. . B-VP O
   
JVD NNP B-NP B-problem
not RB O O
appreciated VBD B-VP O
03-07 JJ O O
to TO O O
deep VB O O
inspiratory JJ B-NP O
breaths NNS I-NP O
. . B-VP O
   
+ JJ B-NP O
bs NN I-NP O
. . B-VP O
   
Distended NNP B-NP B-problem
. . B-VP O
   
Soft NNP B-NP O
. . B-VP O
   
NT NNP B-NP B-problem
> VBZ O O
No DT B-NP O
le JJ I-NP B-problem
edema NN I-NP I-problem
. . B-VP O
   
Pertinent JJ B-NP O
Results NNS I-NP O
: : O O
2011-12-23 JJ O O
07:54 CD O O
PM NNP B-NP O
BLOOD NNP I-NP B-test
WBC NNP I-NP B-test
- : O O
9.7 CD O O
RBC NNP B-NP B-test
- : O O
3.02 CD O O
* NN B-NP O
Hgb NNP I-NP B-test
- : O O
10.0 CD O O
* NN B-NP O
Hct NNP I-NP B-test
- : O O
29.0 CD O O
* NN B-NP O
MCV NNP I-NP B-test
- : O O
96 CD O O
MCH NNP B-NP B-test
- : O O
33.1 CD O O
* NN B-NP O
MCHC NNP I-NP B-test
- : O O
34.4 CD O O
RDW NNP B-NP B-test
- : O O
17.7 CD O O
* JJ B-NP O
Plt NNP I-NP B-test
Ct NNP I-NP I-test
- : O O
307 CD O O
2011-12-23 JJ O O
07:54 CD O O
PM NNP B-NP O
BLOOD NNP I-NP B-test
Neuts NNP I-NP B-test
- : O O
88 CD O O
* NN B-NP O
Bands NNP I-NP B-test
- : O O
0 CD O O
Lymphs NNP B-NP B-test
- : O O
7 CD O O
* JJ B-NP O
Monos NNP I-NP B-test
- : O O
3 CD O O
Eos NNP B-NP B-test
- : O O
0 CD O O
Baso NNP B-NP B-test
- : O O
0 CD O O
Atyps NNP B-NP B-test
- : O O
0 CD O O
Metas NNP B-NP B-test
- : O O
1 CD O O
* NN B-NP O
Myelos NNP I-NP B-test
- : O O
1 CD O O
* JJ O O
2011-12-23 JJ O O
07:54 CD O O
PM NNP B-NP O
BLOOD NNP I-NP B-test
PT NNP I-NP B-test
- : O O
16.0 CD O O
* NN B-NP O
PTT NNP I-NP B-test
- : O O
35.7 CD O O
* JJ B-NP O
INR NNP I-NP B-test
( ( O I-test
PT NNP B-NP I-test
)- CD O I-test
1.6 CD O O
Chem NNP B-NP B-test
7 CD O I-test
: : O O
2011-12-23 JJ O O
07:54 CD O O
PM NNP B-NP O
BLOOD NNP I-NP B-test
Glucose NNP I-NP B-test
- : O O
108 CD O O
* JJ B-NP O
UreaN NNP I-NP B-test
- : O O
27 CD O O
* NN B-NP O
Creat NNP I-NP B-test
- : O O
1.9 CD O O
* NN B-NP O
Na NNP I-NP B-test
- : O O
132 CD O O
* NN B-NP O
K NNP I-NP B-test
- : O O
4.6 CD O O
Cl NNP B-NP B-test
- : O O
102 CD O O
HCO3 NNP B-NP B-test
- : O O
20 CD O O
* NN B-NP O
AnGap NNP I-NP B-test
- : O O
15 CD O O
2011-12-18 JJ O O
06:15 CD O O
AM NNP B-NP O
BLOOD NNP I-NP B-test
ALT NNP I-NP B-test
- : O O
29 CD O O
AST NNP B-NP B-test
- : O O
25 CD O O
LD NNP B-NP B-test
( ( O I-test
LDH NNP B-NP I-test
)- CD O I-test
400 CD O O
* NN B-NP O
AlkPhos NNP I-NP B-test
- : O O
52 CD O O
TotBili NNP B-NP B-test
- : O O
0.3 CD O O
2011-12-23 JJ O O
11:16 CD O O
PM NNP B-NP O
BLOOD NNP I-NP B-test
Type NNP I-NP B-test
- : O O
ART NNP B-NP O
pO2 VBZ O B-test
- : O O
202 CD O O
* NN B-NP O
pCO2 NN I-NP B-test
- : O O
40 CD O O
pH NN B-NP B-test
- : O O
7.29 CD O O
* NN B-NP O
calHCO3 NN I-NP B-test
- : O O
20 CD O O
* JJ B-NP O
Base NNP I-NP B-test
XS NNP I-NP I-test
-- : O O
6 CD O O
2011-12-20 JJ O O
07:53 CD O O
AM NNP B-NP O
BLOOD NNP I-NP B-test
Lactate NNP I-NP B-test
- : O O
1.1 CD O O
Brief JJ B-NP O
Hospital JJ I-NP O
Course NN I-NP O
: : O O
Impression NN B-NP O
: : O O
71 CD O O
yo NNS B-NP O
m JJ B-NP O
w/ JJ I-NP O
astrocytoma NN I-NP B-problem
on IN B-VP O
xrt NN B-NP B-treatment
and CC O O
chemotx NN B-NP B-treatment
, , O O
who WP O B-person
p/w VBD B-VP O
1 CD O O
wk NN B-NP O
h/o NN I-NP O
productive JJ B-NP B-problem
cough NN I-NP I-problem
, , O O
sick JJ B-NP B-person
contact NN I-NP I-person
, , O O
hypoxic NN B-NP B-problem
, , O O
now RB O O
intubated VBN O B-treatment
, , O O
w/ JJ O O
increasing VBG O B-problem
infiltrates NNS B-NP I-problem
b/l RB O I-problem
. . B-VP O
   
1) CD O O
Resp NNP B-NP B-problem
failure NN I-NP I-problem
- : O O
pt NN B-NP B-person
admitted VBD B-VP O
w/ JJ O O
primarily RB O B-problem
hypoxic JJ B-NP I-problem
respiratory JJ I-NP I-problem
failure NN I-NP I-problem
. . B-VP O
   
Following VBG O O
admission NN B-NP O
to TO O O
the DT B-NP O
floor NN I-NP O
the DT B-NP O
pt NN I-NP B-person
developed VBD B-VP O
increasing VBG O B-problem
hypoxia NN B-NP I-problem
and CC O O
somnolence NN B-NP B-problem
, , O O
requiring VBG O O
intubation NN B-NP O
on IN B-VP O
HD NNP B-NP O
5 CD O O
. . B-VP O
   
Pulm NNP B-NP O
had VBD B-VP O
previously RB O O
been VBN O O
consulted VBN O O
and CC O O
felt VBD B-VP O
that IN B-VP B-pronoun
presentation NN B-NP O
was VBD B-VP O
c/w JJ B-NP O
PCP NNP I-NP B-problem
, , O O
Joann NNP B-NP B-person
started VBD B-VP O
on IN B-VP O
Bactrim NNP B-NP B-treatment
. . B-VP O
   
Previously RB O O
treated VBN O O
for IN B-VP O
CAP NNP B-NP B-problem
as IN B-VP O
outpt NN B-NP O
but CC O O
hypoxia NN B-NP B-problem
continued VBD B-VP O
to TO O O
progress VB O O
. . B-VP O
   
Similar JJ B-NP O
lack NN I-NP O
of IN B-VP O
improvement NN B-NP O
w/ VBP O O
additional JJ B-NP B-treatment
broad JJ I-NP I-treatment
spectrum NN I-NP I-treatment
coverage NN I-NP I-treatment
following VBG O O
admission NN B-NP O
. . B-VP O
   
Pt NNP B-NP B-person
underwent JJ B-NP O
bronchoscopy NN I-NP B-test
on IN B-VP O
11-22 JJ O O
following VBG O O
transfer NN B-NP O
to TO O O
the DT B-NP O
ICU NNP I-NP O
for IN B-VP O
hypoxic JJ B-NP B-problem
respiratory JJ I-NP I-problem
failure NN I-NP I-problem
and CC O O
intubation NN B-NP O
( ( O O
7.25/52/70 CD O O
on IN B-VP O
100% CD O B-treatment
NRB NNP B-NP I-treatment
) ) O O
. . B-VP O
   
On IN B-VP O
admission NN B-NP O
to TO O O
the DT B-NP O
ICU NNP I-NP O
the DT O B-person
the DT B-NP B-treatment
pt NN I-NP I-person
pt NN I-NP I-treatment
' '' O I-treatment
steroid JJ B-NP I-treatment
dose NN I-NP I-treatment
was VBD B-VP O
increased VBN O O
to TO O O
8 CD O O
mg NNS B-NP O
bid VBD B-VP O
03-07 CD O O
to TO O O
a DT B-NP B-test
dead JJ I-NP I-test
space NN I-NP I-test
measurement NN I-NP I-test
of IN B-VP O
50% CD O O
. . B-VP O
   
Pt NN B-NP B-person
did VBD B-VP O
well RB O O
in IN B-VP O
the DT B-NP O
ICU NNP I-NP O
, , O O
w/ VBD B-VP O
his PRP$ O B-person
respiratory NN B-NP O
status NN I-NP O
steadily RB O O
improving VBG O O
and CC O O
was VBD B-VP O
extubated VBN O O
on IN B-VP O
01-03 NN B-NP O
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
subsequently RB O O
tranferred VBN O O
to TO O O
the DT B-NP O
floor NN I-NP O
, , O O
where WRB O O
he PRP O B-person
continued VBD B-VP O
to TO O O
have VB O O
a DT B-NP B-problem
stable JJ I-NP I-problem
oxygen NN I-NP I-problem
requirement NN I-NP I-problem
. . B-VP O
   
Repeat NNP B-NP B-test
CXR NNP I-NP I-test
was VBD B-VP O
unchanged JJ O O
from IN B-VP O
previously RB O O
in IN B-VP O
the DT B-NP O
ICU NNP I-NP O
( ( O O
official JJ B-NP O
read NN I-NP O
noted VBD B-VP O
mild JJ B-NP B-problem
CHF NNP I-NP I-problem
, , O O
but CC O O
pt NN B-NP B-person
was VBD B-VP O
continuing VBG O O
to TO O O
autodiurese JJ O O
and CC O O
has VBZ O O
remained VBN O O
net JJ B-NP O
negative JJ I-NP O
everyday NN I-NP O
while IN B-VP O
on IN B-VP O
the DT B-NP O
floor NN I-NP O
. . B-VP O
   
On IN B-VP O
discharge NN B-NP O
the DT B-NP B-person
patient NN I-NP I-person
has VBZ O O
stable JJ B-NP B-problem
O2 NNP I-NP I-problem
req NN I-NP I-problem
, , O O
90% CD O O
on IN B-VP O
RA NNP B-NP O
. . B-VP O
   
2) CD O O
astrocytoma JJ O B-problem
- : O I-problem
grade NN B-NP I-problem
II NNP I-NP I-problem
, , O O
as IN B-VP O
per IN B-VP O
d/w NN B-NP O
PMD NNP I-NP B-person
, , O O
Dr. NNP B-NP B-person
Holscher NNP I-NP I-person
, , O O
pt NN B-NP B-person
has VBZ O O
poor JJ B-NP O
prognosis NN I-NP O
, , O O
but CC O O
reasonable JJ O O
for IN B-VP O
ongoing VBG O B-treatment
treatment NN B-NP I-treatment
. . B-VP O
   
Pt NNP B-NP B-person
has VBZ O O
had VBN O O
two CD O O
recent JJ B-NP O
neg NNS I-NP O
head VBP O O
CT NNP B-NP O
s NN I-NP O
, , O O
so RB O O
unlikely JJ O O
the DT B-NP O
etiology NN I-NP O
of IN B-VP O
the DT O B-person
the DT B-NP B-problem
patient JJ I-NP I-person
patient NN I-NP I-problem
's POS O I-problem
MS NNP B-NP I-problem
change NN I-NP I-problem
. . B-VP O
   
Pt NNP B-NP B-person
was VBD B-VP O
continued VBN O O
on IN B-VP O
keppra NN B-NP B-treatment
during IN B-VP O
admission NN B-NP O
for IN B-VP O
sz JJ B-NP B-treatment
px NN I-NP I-treatment
. . B-VP O
   
Initially RB O O
he PRP O B-person
had VBD B-VP O
been VBN O O
on IN B-VP O
lamotrigine NN B-NP B-treatment
but CC O O
the DT O O
was VBD B-VP O
stopped VBN O O
in IN B-VP O
10/12 CD O O
when WRB O O
the DT B-NP B-person
pt NN I-NP I-person
was VBD B-VP O
noted VBN O O
to TO O O
be VB O O
developing VBG O O
a DT B-NP B-problem
new JJ I-NP I-problem
rash NN I-NP I-problem
. . B-VP O
   
Decadron NNP B-NP B-treatment
has VBZ O O
been VBN O O
steadily RB O O
tapered VBN O O
since IN B-VP O
arrival NN B-NP O
on IN B-VP O
the DT B-NP O
floor NN I-NP O
. . B-VP O
   
Now RB O O
continued VBN O O
on IN B-VP O
1 CD O O
mg NNS B-NP O
BID NNP I-NP O
, , O O
to TO O O
complete VB O O
a DT O O
7 CD O O
day NN B-NP O
course NN I-NP O
, , O O
which WDT O B-pronoun
will MD O O
be VB O O
tapered VBN O O
to TO O O
1 CD O O
mg NNS B-NP O
qday RB O O
on IN B-VP O
01-15 NN B-NP O
, , O O
and CC O O
subsequently RB O O
to TO O O
0.5 CD O O
mg NNS B-NP O
qday JJ O O
x VBP O O
7 CD O O
days NNS B-NP O
then RB O O
to TO O O
be VB O O
discontinued VBN O O
. . B-VP O
   
The DT O B-person
The DT B-NP B-treatment
patient JJ I-NP I-person
patient NN I-NP I-treatment
's POS O I-treatment
keppra NN B-NP I-treatment
should MD O O
be VB O O
continued VBN O O
for IN B-VP O
sz NN B-NP B-treatment
prophylaxis NN I-NP I-treatment
. . B-VP O
   
3) CD O O
MS NNP B-NP B-problem
change NN I-NP I-problem
- : O O
on IN B-VP O
admission NN B-NP O
pt NN I-NP B-person
was VBD B-VP O
agitated VBN O B-problem
, , O O
requiring VBG O O
restraints NNS B-NP B-treatment
and CC O O
antipsychotics NNS B-NP B-treatment
, , O O
however RB O O
as IN B-VP O
he PRP O B-person
became VBD B-VP O
increasingly RB O B-problem
hypoxic JJ O I-problem
he PRP O B-person
became VBD B-VP O
somnolent JJ O B-problem
. . B-VP O
   
In IN B-VP O
the DT B-NP O
ICU NNP I-NP O
the DT B-NP O
pt NN I-NP B-person
remained VBD B-VP O
stuporous JJ O B-problem
, , O O
responsive JJ O O
to TO O O
painful JJ B-NP B-test
stimuli NNS I-NP I-test
. . B-VP O
   
On IN B-VP O
the DT B-NP O
floor NN I-NP O
the DT B-NP B-person
patient NN I-NP I-person
intially RB O O
was VBD B-VP O
imporved VBN O O
, , O O
but CC O O
has VBZ O O
plateaued VBN O O
, , O O
responding VBG O O
to TO O O
simple VB O O
commands NNS B-NP O
and CC O O
verbalizing VBG O O
groans NNS B-NP O
but CC O O
no DT B-NP B-problem
real JJ I-NP I-problem
speech NN I-NP I-problem
. . B-VP O
   
Improvement NNP B-NP O
has VBZ O O
correlated VBN O O
w/ IN B-VP O
tapering NN B-NP O
of IN B-VP O
steroids NNS B-NP B-treatment
, , O O
one CD O O
of IN B-VP O
the DT B-NP O
causes NNS I-NP O
in IN B-VP O
the DT B-NP O
differential NN I-NP O
. . B-VP O
   
Pt NNP B-NP B-person
had VBD B-VP O
multiple JJ B-NP B-test
head NN I-NP I-test
CT NNP I-NP I-test
s NN I-NP O
which WDT O B-pronoun
ruled VBD B-VP O
out RP O O
progression NN B-NP O
of IN B-VP O
astrocytoma NN B-NP B-problem
. . B-VP O
   
MRI NNP B-NP B-test
has VBZ O O
been VBN O O
deferred VBN O O
given VBN O O
that IN B-VP B-pronoun
the DT B-NP B-person
pt NN I-NP I-person
currently RB O O
would MD O O
not RB O O
tolerate VB O O
the DT B-NP B-test
procedure NN I-NP I-test
. . B-VP O
   
EEG NNP B-NP B-test
was VBD B-VP O
w/o JJ B-NP O
evidence NN I-NP O
of IN B-VP O
epileptiform NN B-NP B-problem
activity NN I-NP I-problem
and CC O O
c/w NN B-NP O
toxic NN I-NP B-problem
encephalopathy NN I-NP I-problem
. . B-VP O
   
Plan NN B-NP O
to TO O O
continue VB O O
to TO O O
follow VB O O
MS NNP B-NP O
, , O O
expect VBP O O
improvement NN B-NP O
as IN B-VP O
steroids NNS B-NP B-treatment
are VBP O O
continued VBN O O
to TO O O
be VB O O
tapered VBN O O
. . B-VP O
   
4) CD O O
h/o NN B-NP O
DVT NNP I-NP B-problem
- : O O
cont NN B-NP O
heparin NN I-NP B-treatment
, , O O
previously RB O O
on IN B-VP O
enoxaparin JJ B-NP B-treatment
x10 JJ I-NP O
days NNS I-NP O
at IN B-VP O
treatment NN B-NP O
dose NN I-NP O
, , O O
followed VBN O O
by IN B-VP O
prophylactic JJ B-NP B-treatment
dose NN I-NP I-treatment
. . B-VP O
   
On IN B-VP O
admission NN B-NP O
, , O O
the DT B-NP B-person
pt NN I-NP I-person
was VBD B-VP O
started VBN O O
on IN B-VP O
treatment NN B-NP O
doses NNS I-NP O
of IN B-VP O
enoxaparin NN B-NP B-treatment
. . B-VP O
   
Upon IN B-VP O
transfer NN B-NP O
to TO O O
the DT B-NP O
Intensive NNP I-NP O
Care NNP I-NP O
Unit NNP I-NP O
the DT B-NP B-person
pt NN I-NP I-person
was VBD B-VP O
started VBN O O
on IN B-VP O
heparin NN B-NP B-treatment
gtt NN I-NP I-treatment
. . B-VP O
   
Course NNP B-NP O
was VBD B-VP O
c/b JJ O O
one CD O O
episode NN B-NP O
of IN B-VP O
gross JJ B-NP B-problem
hematochezia NN I-NP I-problem
on IN B-VP O
12-28 JJ O O
, , O O
w/ JJ B-NP O
concomitant NN I-NP B-problem
hct VBD B-VP I-problem
drop NN B-NP I-problem
of IN B-VP O
~ $ O O
3 CD O O
pts NNS B-NP O
. . B-VP O
   
B/L NNP B-NP B-test
lower JJR B-NP I-test
ext NN I-NP I-test
duplex JJ O I-test
us PRP O I-test
and CC O O
a DT B-NP B-test
cta NN I-NP I-test
were VBD B-VP O
performed VBN O O
, , O O
both DT O O
of IN B-VP O
which WDT O B-pronoun
were VBD B-VP O
negative JJ O O
. . B-VP O
   
Given VBN O O
that IN B-VP B-pronoun
the DT B-NP B-person
pt NN I-NP I-person
was VBD B-VP O
w/o JJ B-NP O
evidence NN I-NP O
of IN B-VP O
DVT NNP B-NP B-problem
it PRP O B-pronoun
was VBD B-VP O
felt VBN O O
that IN B-VP B-pronoun
the DT B-NP O
risks NNS I-NP O
of IN B-VP O
anticoagulation NN B-NP B-treatment
in IN B-VP O
the DT B-NP O
setting NN I-NP O
of IN B-VP O
gross JJ B-NP B-problem
GIB NNP I-NP I-problem
, , O O
outweigh VBP O O
the DT B-NP O
risks NNS I-NP O
of IN B-VP O
undetected JJ B-NP B-problem
deep JJ I-NP I-problem
vv NN I-NP I-problem
thrombosis/pe NN I-NP I-problem
. . B-VP O
   
Pt NNP B-NP B-person
was VBD B-VP O
continued VBN O O
on IN B-VP O
prophylactic JJ B-NP B-treatment
heparin NN I-NP I-treatment
. . B-VP O
   
4) CD O O
hypersensitivity NN B-NP B-problem
reaction NN I-NP I-problem
- : O O
on IN B-VP O
11-24 JJ B-NP O
pt NN I-NP B-person
was VBD B-VP O
noted VBN O O
to TO O O
have VB O O
developing VBG O O
rash NN B-NP B-problem
of IN B-VP I-problem
abdomen NNS B-NP I-problem
and CC O I-problem
anterior JJ B-NP I-problem
thighs NNS I-NP I-problem
. . B-VP O
   
Derm NNP B-NP O
initially RB O O
reviewed VBD B-VP O
and CC O O
thought VBD B-VP O
that IN B-VP B-pronoun
it PRP O B-pronoun
was VBD B-VP O
not RB O O
c/w JJ B-NP O
hypersensitivity NN I-NP B-problem
rxn NN I-NP I-problem
. . B-VP O
   
Over IN B-VP O
the DT O O
next JJ O O
the DT B-NP B-problem
rash NN I-NP I-problem
progressed VBD B-VP O
, , O O
and CC O O
the DT B-NP B-person
patient NN I-NP I-person
subsequently RB O O
began VBD B-VP O
spiking VBG O O
fevers NNS B-NP B-problem
to TO O O
approx VB O O
103 CD O O
F NNP B-NP O
, , O O
c/b NN B-NP O
hypotension NN I-NP B-problem
requiring VBG O O
aggressive JJ B-NP B-treatment
fluid NN I-NP I-treatment
repletion NN I-NP I-treatment
and CC O O
pressors NNS B-NP B-treatment
, , O O
and CC O O
tachycardia NN B-NP B-problem
to TO O O
the DT B-NP O
130s NNS I-NP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
also RB O O
developed VBD B-VP O
elevated JJ B-NP B-problem
transaminases NNS I-NP I-problem
and CC O I-problem
pancreatic JJ B-NP I-problem
enzymes NNS I-NP I-problem
during IN B-VP O
this DT B-NP B-pronoun
time NN I-NP O
. . B-VP O
   
On IN B-VP O
the DT B-NP O
second JJ I-NP O
day NN I-NP O
that IN B-VP B-pronoun
the DT B-NP B-problem
rash NN I-NP I-problem
had VBD B-VP O
been VBN O O
noted VBN O O
, , O O
Derm NNP B-NP O
was VBD B-VP O
asked VBN O O
to TO O O
see VB O O
again RB O O
, , O O
felt VBD B-VP O
c/w JJ B-NP O
hypersensitivity NN I-NP B-problem
, , O O
bactrim NN B-NP B-treatment
was VBD B-VP O
switched VBN O O
to TO O O
pentamidine VB O B-treatment
, , O O
and CC O O
lamictal NN B-NP B-treatment
was VBD B-VP O
held VBN O O
. . B-VP O
   
Pt NNP B-NP B-person
continued VBD B-VP O
to TO O O
have VB O O
elev VBN O B-problem
pancreatic JJ B-NP I-problem
enzymes NNS I-NP I-problem
and CC O O
pentamidine NN B-NP B-treatment
was VBD B-VP O
switched VBN O O
to TO O O
clinda/primaquine VB O B-treatment
. . B-VP O
   
Following VBG O O
discontinuation NN B-NP O
of IN B-VP O
the DT B-NP B-treatment
bactrim NN I-NP I-treatment
the DT B-NP B-person
patient NN I-NP I-person
defervesced VBD B-VP O
, , O O
and CC O O
remained VBD B-VP O
normotensive JJ O O
. . B-VP O
   
He PRP O B-person
received VBD B-VP O
one CD O O
dose NN B-NP O
of IN B-VP O
furosemide NN B-NP B-treatment
in IN B-VP O
the DT B-NP O
ICU NNP I-NP O
and CC O O
was VBD B-VP O
transferred VBN O O
to TO O O
the DT B-NP O
floor NN I-NP O
the DT B-NP O
next JJ I-NP O
day NN I-NP O
. . B-VP O
   
On IN B-VP O
arrival NN B-NP O
to TO O O
the DT B-NP O
floor NN I-NP O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
noted VBN O O
to TO O O
have VB O O
a DT B-NP B-problem
lacy NN I-NP I-problem
reticular JJ B-NP I-problem
rash NN I-NP I-problem
of IN B-VP I-problem
upper JJ B-NP I-problem
arms NNS I-NP I-problem
, , O O
which WDT O B-pronoun
resolved VBD B-VP O
over IN B-VP O
the DT O O
next JJ O O
48h CD O O
. . B-VP O
   
Felt NNP B-NP O
likely JJ O O
03-07 VBP O O
the DT B-NP B-treatment
sulfa NN I-NP I-treatment
moiety NN I-NP O
of IN B-VP O
the DT B-NP B-treatment
furosemide NN I-NP I-treatment
. . B-VP O
   
Plan NN B-NP O
for IN B-VP O
pt NN B-NP B-person
to TO O O
complete VB O O
total NN B-NP O
of IN B-VP O
28 CD O O
day NN B-NP O
course NN I-NP O
of IN B-VP O
therapy NN B-NP B-treatment
for IN B-VP O
PCP NNP B-NP B-problem
, , O O
James NNP B-NP B-person
will MD O O
be VB O O
completed VBN O O
on IN B-VP O
01-16 NN B-NP O
. . B-VP O
   
5) CD O O
Anemia NNP B-NP B-problem
- : O O
previous JJ B-NP B-test
w/u NN I-NP I-test
c/w NN I-NP O
ACD NNP I-NP B-problem
( ( O O
elev JJ B-NP B-problem
ferritin NN I-NP I-problem
, , O O
low JJ B-NP B-problem
transferrin NN I-NP I-problem
saturation NN I-NP I-problem
) ) O O
. . B-VP O
   
- : O O
transfuse NN B-NP B-test
threshold VBD B-VP I-test
< JJ O O
24 CD O O
6) CD O O
ARF NNP B-NP B-problem
- : O O
Cr NNP B-NP B-test
mildly RB O B-problem
elevated VBD B-VP I-problem
on IN B-VP O
tx NN B-NP O
to TO O O
ICU NNP B-NP O
, , O O
u JJ B-NP B-test
lytes NNS I-NP I-test
c/w VBP O O
prerenal JJ B-NP B-problem
azotemia NN I-NP I-problem
, , O O
which WDT O B-pronoun
resolved VBD B-VP O
w/ NN B-NP O
IVF NNP I-NP B-treatment
. . B-VP O
   
7) CD O O
hyponatremia NN B-NP B-problem
- : O O
also RB O O
hyponatremic VBP O B-problem
on IN B-VP O
transfer NN B-NP O
, , O O
resolved VBD B-VP O
w/ JJ B-NP O
ivf NN I-NP B-treatment
. . B-VP O
   
8) CD O O
CAD NNP B-NP B-problem
- : O O
w/ NN B-NP O
abnl NN I-NP B-problem
EF NNP I-NP I-problem
, , O O
however RB O O
pt RB O O
tolerated VBN O O
aggressive JJ B-NP B-treatment
fluid NN I-NP I-treatment
resusciation NN I-NP I-treatment
w/o NN I-NP O
significant JJ B-NP B-problem
hypoxia NN I-NP I-problem
. . B-VP O
   
Continued VBN O O
on IN B-VP O
valsartan NN B-NP B-treatment
, , O O
BB NNP B-NP B-treatment
continued VBD B-VP O
, , O O
statin VBD B-VP B-treatment
9) CD O O
Nutrition NNP B-NP O
- : O O
pt NN B-NP B-person
was VBD B-VP O
maintained VBN O O
on IN B-VP O
TFs NNP B-NP B-treatment
via IN B-VP O
post-pyloric JJ O B-treatment
10) CD O O
Px NN B-NP O
: : O O
Heparin NNP B-NP B-treatment
( ( O O
full JJ B-NP O
dose NN I-NP O
) ) O O
, , O O
IV NNP B-NP B-treatment
PPI NNP I-NP I-treatment
11) CD O O
Comm NNP B-NP O
: : O O
Family RB O B-person
very RB O O
involved JJ O O
at IN B-VP O
bedside NN B-NP O
, , O O
evaluating VBG O O
rehab NN B-NP B-treatment
today NN I-NP O
17) CD O O
DNR NNP B-NP O
, , O O
but CC O O
may MD O O
intubate VB O O
for IN B-VP O
reversible JJ B-NP O
causes NNS I-NP O
18) CD O O
Restraint NNP B-NP B-treatment
Medications NNPS I-NP O
on IN B-VP O
Admission NN B-NP O
: : O O
Meds NNS B-NP O
on IN B-VP O
Transfer NN B-NP O
: : O O
Acyclovir NNP B-NP B-treatment
Bactrim NNP I-NP B-treatment
Zoloft NNP I-NP B-treatment
Valsartan NNP I-NP B-treatment
Metoprolol NNP I-NP B-treatment
Keppra NNP I-NP B-treatment
Lovenox NNP I-NP B-treatment
Levofloxacin NNP I-NP B-treatment
Ambisone NNP I-NP B-treatment
Atrovent NNP I-NP B-treatment
nebs MD O I-treatment
Albuterol NNP B-NP B-treatment
nebs RB O I-treatment
Lasix NNP B-NP B-treatment
10 CD O O
mg NN B-NP O
qd NN I-NP O
Lipitor NNP I-NP B-treatment
Haldol NNP I-NP B-treatment
prn NN I-NP O
Discharge NNP I-NP O
Medications NNP I-NP O
: : O O
1. CD O O
Miconazole NNP B-NP B-treatment
Nitrate NNP I-NP I-treatment
2 CD O O
% NN B-NP O
Powder NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Appl NNP B-NP O
Topical NNP I-NP O
QID NNP I-NP O
( ( O O
4 CD O O
times NNS B-NP O
a DT B-NP O
day NN I-NP O
) ) O O
. . B-VP O
   
2. CD O O
Sertraline NNP B-NP B-treatment
HCl NNP I-NP I-treatment
50 CD O O
mg NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Tablet NNP B-NP O
PO NNP I-NP O
DAILY NNP I-NP O
( ( O O
Daily NNP B-NP O
) ) O O
. . B-VP O
   
3. CD O O
Albuterol NNP B-NP B-treatment
Sulfate NNP I-NP I-treatment
0.083 CD O O
% NN B-NP O
Solution NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Inhalation NN B-NP O
Q4H NNP I-NP O
( ( O O
every DT O O
4 CD O O
hours NNS B-NP O
) ) O O
. . B-VP O
   
4. CD O O
Ipratropium NNP B-NP B-treatment
Bromide NNP I-NP I-treatment
0.02 CD O O
% NN B-NP O
Solution NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Inhalation NN B-NP O
Q4H NNP I-NP O
( ( O O
every DT O O
4 CD O O
hours NNS B-NP O
) ) O O
. . B-VP O
   
5. CD O O
Senna NNP B-NP B-treatment
8.6 CD O O
mg NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Tablet NNP B-NP O
PO NNP I-NP O
BID NNP I-NP O
( ( O O
2 CD O O
times NNS B-NP O
a DT B-NP O
day NN I-NP O
) ) O O
as IN B-VP O
needed VBN O O
. . B-VP O
   
6. CD O O
Bisacodyl NNP B-NP B-treatment
10 CD O O
mg NN B-NP O
Suppository NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Suppository NNP B-NP O
Rectal NNP I-NP O
BID NNP I-NP O
( ( O O
2 CD O O
times NNS B-NP O
a DT B-NP O
day NN I-NP O
) ) O O
as IN B-VP O
needed VBN O O
for IN B-VP O
constipation NN B-NP B-problem
. . B-VP O
   
7. CD O O
Levetiracetam NNP B-NP B-treatment
500 CD O O
mg NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
Three CD O O
( ( O O
3 CD O O
) ) O O
Tablet NNP B-NP O
PO NNP I-NP O
BID NNP I-NP O
( ( O O
2 CD O O
times NNS B-NP O
a DT B-NP O
day NN I-NP O
) ) O O
. . B-VP O
   
8. CD O O
Nystatin NNP B-NP B-treatment
100,000 CD O O
unit NN B-NP O
/ NNP I-NP O
mL NN I-NP O
Suspension NNP I-NP O
Sig NNP I-NP O
: : O O
Five CD O O
( ( O O
5 CD O O
) ) O O
ML NNP B-NP O
PO NNP I-NP O
QID NNP I-NP O
( ( O O
4 CD O O
times NNS B-NP O
a DT B-NP O
day NN I-NP O
) ) O O
. . B-VP O
   
9. CD O O
Heparin NNP B-NP B-treatment
Sodium NNP I-NP I-treatment
( ( O I-treatment
Porcine NNP B-NP I-treatment
) ) O I-treatment
5,000 CD O O
unit NN B-NP O
/ NNP I-NP O
mL NN I-NP O
Solution NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Injection NN B-NP O
TID NNP I-NP O
( ( O O
3 CD O O
times NNS B-NP O
a DT B-NP O
day NN I-NP O
) ) O O
. . B-VP O
   
10. CD O O
Acetaminophen NNP B-NP B-treatment
325 CD O O
mg NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
1-2 JJ B-NP O
Tablets NNS I-NP O
PO NNP I-NP O
Q4-6H NNP I-NP O
( ( O O
every DT O O
4 CD O O
to TO O O
6 CD O O
hours NNS B-NP O
) ) O O
as IN B-VP O
needed VBN O O
. . B-VP O
   
11. CD O O
Primaquine NNP B-NP B-treatment
Phosphate NNP I-NP I-treatment
26.3 CD O O
mg NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
Two CD O O
( ( O O
2 CD O O
) ) O O
Tablet NNP B-NP O
PO NNP I-NP O
DAILY NNP I-NP O
( ( O O
Daily NNP B-NP O
) ) O O
for IN B-VP O
3 CD O O
days NNS B-NP O
. . B-VP O
   
12. CD O O
Metoprolol NNP B-NP B-treatment
Tartrate NNP I-NP I-treatment
25 CD O O
mg NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Tablet NNP B-NP O
PO NNP I-NP O
BID NNP I-NP O
( ( O O
2 CD O O
times NNS B-NP O
a DT B-NP O
day NN I-NP O
) ) O O
. . B-VP O
   
13. CD O O
Dexamethasone NNP B-NP B-treatment
0.5 CD O O
mg NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
Two CD O O
( ( O O
2 CD O O
) ) O O
Tablet NNP B-NP O
PO NNP I-NP O
Q12H NNP I-NP O
( ( O O
every DT O O
12 CD O O
hours NNS B-NP O
) ) O O
: : O O
Take VB O O
2 CD O O
tablet NN B-NP O
po NN I-NP O
bid NN I-NP O
for IN B-VP O
four CD O O
days NNS B-NP O
, , O O
then RB O O
2 CD O O
tablet NN B-NP O
po NN I-NP O
qday NN I-NP O
for IN B-VP O
7 CD O O
days NNS B-NP O
, , O O
then RB O O
take VB O O
one CD O O
tablet NN B-NP O
qday NN I-NP O
for IN B-VP O
7 CD O O
days NNS B-NP O
. . B-VP O
   
Then RB O O
stop VB O O
taking VBG O O
the DT B-NP B-treatment
medication NN I-NP I-treatment
. . B-VP O
   
14. CD O O
Acyclovir NNP B-NP B-treatment
Sodium NNP I-NP I-treatment
500 CD O O
mg NN B-NP O
Recon NNP I-NP O
Soln NNP I-NP O
Sig NNP I-NP O
: : O O
200mg CD O O
Recon NNP B-NP O
Solns NNP I-NP O
Intravenous NNP I-NP O
Q12H NNP I-NP O
( ( O O
every DT O O
12 CD O O
hours NNS B-NP O
) ) O O
. . B-VP O
   
15. CD O O
Pantoprazole NNP B-NP B-treatment
Sodium NNP I-NP I-treatment
40 CD O O
mg NN B-NP O
Recon NNP I-NP O
Soln NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Recon NNP B-NP O
Soln NNP I-NP O
Intravenous NNP I-NP O
Q12H NNP I-NP O
( ( O O
every DT O O
12 CD O O
hours NNS B-NP O
) ) O O
. . B-VP O
   
16. CD O O
Clindamycin NNP B-NP B-treatment
Phosphate NNP I-NP I-treatment
in IN B-VP O
D5W NNP B-NP B-treatment
600 CD O O
mg NN B-NP O
/ VBD B-VP O
50 CD O O
mL NN B-NP O
Piggyback NNP I-NP O
Sig NNP I-NP O
: : O O
600 CD O O
mg NN B-NP O
Intravenous NNP I-NP O
Q8H NNP I-NP O
( ( O O
every DT O O
8 CD O O
hours NNS B-NP O
) ) O O
for IN B-VP O
3 CD O O
days NNS B-NP O
. . B-VP O
   
Discharge JJ B-NP O
Disposition NN I-NP O
: : O O
Extended VBN O O
Care NNP B-NP O
Facility NNP I-NP O
: : O O
Danvers NNS B-NP O
State NNP I-NP O
Hospital NNP I-NP O
& CC O O
Rehab NNP B-NP O
Center NNP I-NP O
- : O O
Sterling NNP B-NP O
Medical NNP I-NP O
Center NNP I-NP O
Discharge NNP I-NP O
Diagnosis NNP I-NP O
: : O O
1) CD O O
PCP NNP B-NP B-problem
pna NN I-NP I-problem
2) CD O O
Astrocytoma NNP B-NP B-problem
3) CD O O
Hypersensitivity NNP B-NP B-problem
to TO O O
Bactrim VB O B-treatment
4) CD O O
Hematochezia NNP B-NP B-problem
5) CD O O
h/o NN B-NP O
DVT NNP I-NP B-problem
Discharge NNP I-NP O
Condition NNP I-NP O
: : O O
Good JJ O O
, , O O
still RB O O
w/ VBZ O O
altered JJ B-NP B-problem
mental JJ I-NP I-problem
status NN I-NP I-problem
but CC O O
improving VBG O O
. . B-VP O
   
Discharge NN B-NP O
Instructions NNS I-NP O
: : O O
1) CD O O
Take VB O O
your PRP$ O B-person
medications NNS B-NP B-treatment
2) CD O O
Attend NNP B-NP O
follow VBP O O
up RP O O
appointments NNS B-NP O
Followup NNP I-NP O
Instructions NNS I-NP O
: : O O
Provider NN B-NP O
: : O O
Irene NNP B-NP O
FIELD NNP I-NP O
SCREENING NNP I-NP O
Where NNP I-NP O
: : O O
Pembroke NNP B-NP O
Hospital NNP I-NP O
Winchester NNP I-NP O
Hospital NNP I-NP O
Phone NNP I-NP O
:( NNP I-NP O
217 CD O O
) ) O O
275 CD O O
6206 CD O O
Date NNP B-NP O
/ JJ B-NP O
Time NN I-NP O
: : O O
2012-02-13 JJ O O
1:30 CD O O
Provider NN B-NP O
: : O O
Annie NNP B-NP B-person
A. NN I-NP I-person
Payne NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
Where NNP I-NP O
: : O O
Pembroke NNP B-NP O
Hospital NNP I-NP O
Winchester NNP I-NP O
Hospital NNP I-NP O
Phone NNP I-NP O
:( NNP I-NP O
217 CD O O
) ) O O
275 CD O O
6206 CD O O
Date NNP B-NP O
/ JJ B-NP O
Time NN I-NP O
: : O O
2012-02-13 JJ O O
2:30 CD O O
Alfonso NNP B-NP B-person
Daniel NNP I-NP I-person
MD NNP I-NP I-person
13-431 JJ O O
Completed VBN O O
by IN B-VP O
: : O O
Bernadette NNP B-NP B-person
Sanders NNP I-NP I-person
MD NNP I-NP I-person
04-142 JJ O O
2012-01-14 CD O O
@ JJ O O
0914 CD O O
Signed VBN O O
electronically RB O O
by IN B-VP O
: : O O
DR. NNP B-NP B-person
Earnestine NNP I-NP I-person
Marsden NNP I-NP I-person
on IN B-VP O
: : O O
WED JJ O O
2012-03-21 JJ O O
1:21 CD O O
PM NNP B-NP O
( ( O O
End NNP B-NP O
of IN B-VP O
Report NNP B-NP O
) ) O O
-EMPTYLINE- VBP O O
-DOCSTART- JJ O O
-EMPTYLINE- $ O O
014894512 CD O O
FIH NNP B-NP O
0589930 CD O O
86515/6878 CD O O
801232 CD O O
10/27/1993 CD O O
12:00:00 CD O O
AM NNP B-NP O
OSTEOCHONDROMATOSIS NNP I-NP B-problem
, , O I-problem
RIGHT NNP B-NP I-problem
KNEE NNP I-NP I-problem
. . B-VP O
   
Unsigned VBD B-VP O
DIS NNP B-NP O
Report NNP I-NP O
Status NNP I-NP O
: : O O
Unsigned VBN O O
ADMISSION NNP B-NP O
DATE NNP I-NP O
: : O O
10-27-93 JJ B-NP O
DISCHARGE NNP I-NP O
DATE NNP I-NP O
: : O O
11-1-93 JJ B-NP O
PRINCIPAL NNP I-NP O
DIAGNOSIS NNP I-NP O
: : O O
Osteochondromatosis NN B-NP B-problem
, , O I-problem
right JJ B-NP I-problem
knee NN I-NP I-problem
. . B-VP O
   
HISTORY NNP B-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS NNP I-NP O
: : O O
This DT O B-pronoun
68 CD O O
year NN B-NP O
old JJ B-NP O
white JJ I-NP O
male NN I-NP O
who WP O B-person
had VBD B-VP O
a DT O O
seven CD O O
to TO O O
eight CD O O
year NN B-NP O
history NN I-NP O
of IN B-VP O
knee NN B-NP B-problem
pain NN I-NP I-problem
. . B-VP O
   
In IN B-VP O
1984 CD O O
, , O O
he PRP O B-person
had VBD B-VP O
the DT B-NP O
right JJ I-NP O
knee NN I-NP O
aspirated VBD B-VP O
and CC O O
was VBD B-VP O
noted VBN O O
to TO O O
have VB O O
some DT B-NP O
uric JJ I-NP B-problem
acid NN I-NP I-problem
crystals NNS I-NP I-problem
, , O O
although IN B-VP O
serum JJ B-NP B-test
uric JJ I-NP I-test
acid NN I-NP I-test
was VBD B-VP O
normal JJ O O
and CC O O
erythrocyte JJ B-NP B-test
sedimentation NN I-NP I-test
rate NN I-NP I-test
. . B-VP O
   
He PRP O B-person
continued VBD B-VP O
to TO O O
have VB O O
intermittent NN B-NP B-problem
symptoms NNS I-NP I-problem
and CC O O
was VBD B-VP O
noted VBN O O
to TO O O
have VB O O
some DT B-NP B-problem
fullness NN I-NP I-problem
in IN B-VP I-problem
the DT B-NP I-problem
suprapatellar JJ I-NP I-problem
pouch NN I-NP I-problem
. . B-VP O
   
Plain NNP B-NP B-test
films NNS I-NP I-test
taken VBN O O
by IN B-VP O
his PRP$ O B-person
his PRP$ O B-person
orthopedist NN B-NP I-person
in IN B-VP O
Mongcana NNP B-NP O
Ster NNP I-NP O
Staarv NNP I-NP O
revealed VBD B-VP O
some DT B-NP B-problem
soft JJ I-NP I-problem
tissue NN I-NP I-problem
calcification NN I-NP I-problem
within IN B-VP O
the DT O O
medial JJ O O
and CC O O
lateral JJ B-NP O
compartments NNS I-NP O
of IN B-VP O
the DT O O
joint JJ O O
. . B-VP O
   
an DT B-NP B-test
magnetic JJ I-NP I-test
resonance NN I-NP I-test
imaging NN I-NP I-test
study NN I-NP I-test
demonstrated VBD B-VP O
calcification NN B-NP B-problem
densities NNS I-NP I-problem
in IN B-VP I-problem
the DT B-NP I-problem
suprapatellar JJ I-NP I-problem
bursa NN I-NP I-problem
region NN I-NP I-problem
, , O O
also RB O O
with IN B-VP O
hypertrophia NN B-NP B-problem
of IN B-VP I-problem
the DT B-NP I-problem
synovium NN I-NP I-problem
. . B-VP O
   
It PRP O B-pronoun
was VBD B-VP O
felt VBN O O
that IN B-VP B-pronoun
the DT B-NP B-person
patient NN I-NP I-person
had VBD B-VP O
synovial JJ B-NP B-problem
chondromatosis NN I-NP I-problem
and CC O O
would MD O O
benefit VB O O
from IN B-VP O
an DT B-NP B-treatment
open JJ I-NP I-treatment
synovectomy NN I-NP I-treatment
and CC O O
debridement NN B-NP B-treatment
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
admitted VBN O O
for IN B-VP O
that DT O B-pronoun
that DT B-NP B-treatment
procedure NN I-NP I-treatment
. . B-VP O
   
PAST NNP B-NP O
MEDICAL NNP I-NP O
HISTORY NN I-NP O
: : O O
He PRP O B-person
had VBD B-VP O
tonsillectomy VBN O B-treatment
at IN B-VP O
the DT B-NP O
age NN I-NP O
of IN B-VP O
five CD O O
, , O O
and CC O O
appendectomy NN B-NP B-treatment
in IN B-VP O
1940 CD O O
. . B-VP O
   
He PRP O B-person
had VBD B-VP O
right JJ B-NP B-test
knee NN I-NP I-test
aspirations NNS I-NP I-test
done VBN O O
in IN B-VP O
1986 CD O O
, , O O
otherwise RB O O
, , O O
he PRP O B-person
does VBZ O O
not RB O O
suffer VB O O
from IN B-VP O
any DT B-NP B-problem
other JJ I-NP I-problem
medical JJ I-NP I-problem
problems NNS I-NP I-problem
. . B-VP O
   
ALLERGIES NNS B-NP O
: : O O
He PRP O B-person
has VBZ O O
no DT O O
known VBN O B-problem
drug NN B-NP I-problem
allergies NNS I-NP I-problem
. . B-VP O
   
MEDICATIONS NNP B-NP O
ON NNP I-NP O
ADMISSION NNP I-NP O
: : O O
He PRP O B-person
is VBZ O O
on IN B-VP O
______________ JJ O O
2 CD O O
tabs NNS B-NP O
PO NNP I-NP O
qd NN I-NP O
. . B-VP O
   
SOCIAL NNP B-NP O
HISTORY NNP I-NP O
: : O O
Married NNP B-NP O
and CC O O
lives VBZ O O
with IN B-VP O
his PRP$ O B-person
his PRP$ O B-person
wife NN B-NP I-person
in IN B-VP O
Forda NNP B-NP O
Minsas NNP I-NP O
Ve NNP I-NP O
, , O O
Wyoming NNP B-NP O
. . B-VP O
   
He PRP O B-person
is VBZ O O
a DT B-NP O
retired JJ I-NP O
school NN I-NP O
teacher NN I-NP O
by IN B-VP O
profession NN B-NP O
. . B-VP O
   
He PRP O B-person
has VBZ O O
a DT B-NP B-person
son NN I-NP I-person
who WP O B-person
is VBZ O O
an DT B-NP B-person
orthopedic JJ I-NP I-person
surgeon NN I-NP I-person
. . B-VP O
   
SOCIAL NNP B-NP O
HISTORY NN I-NP O
: : O O
He PRP O B-person
has VBZ O O
been VBN O O
a DT B-NP O
smoker NN I-NP O
for IN B-VP O
the DT O O
last JJ O O
50 CD O O
years NNS B-NP O
and CC O O
he PRP O B-person
drinks VBZ O O
alcohol NN B-NP O
occasionally RB O O
, , O O
but CC O O
stopped VBD B-VP O
in IN B-VP O
1987 CD O O
. . B-VP O
   
PHYSICAL JJ B-NP O
EXAMINATION NN I-NP O
: : O O
He PRP O B-person
is VBZ O O
healthy JJ O O
looking VBG O O
. . B-VP O
   
The DT B-NP B-test
general JJ I-NP I-test
physical JJ I-NP I-test
examination NN I-NP I-test
did VBD B-VP O
not RB O O
reveal VB O O
any DT B-NP B-problem
abnormality NN I-NP I-problem
. . B-VP O
   
Heart NNP B-NP B-test
, , O I-test
chest NN B-NP I-test
, , O I-test
and CC O I-test
abdominal JJ B-NP I-test
examinations NNS I-NP I-test
were VBD B-VP O
normal JJ O O
. . B-VP O
   
The DT B-NP B-test
right JJ I-NP I-test
knee NN I-NP I-test
examination NN I-NP I-test
showed VBD B-VP O
some DT B-NP B-problem
effusion NN I-NP I-problem
. . B-VP O
   
The DT B-NP O
range NN I-NP O
of IN B-VP O
motion NN B-NP O
was VBD B-VP O
15 CD O O
to TO O O
120 CD O O
degree NN B-NP O
on IN B-VP O
the DT B-NP O
right JJ I-NP O
side NN I-NP O
; : O O
and CC O O
on IN B-VP O
the DT B-NP O
left JJ I-NP O
side NN I-NP O
, , O O
it PRP O B-pronoun
was VBD B-VP O
zero VBN O O
to TO O O
135 CD O O
. . B-VP O
   
There EX O O
was VBD B-VP O
normal JJ B-NP O
muscle NN I-NP O
power NN I-NP O
. . B-VP O
   
The DT B-NP B-test
peripheral JJ I-NP I-test
pulses NNS I-NP I-test
were VBD B-VP O
palpable JJ O O
. . B-VP O
   
LABORATORY NNP B-NP O
DATA NNP I-NP O
: : O O
His PRP$ O B-person
His PRP$ O B-test
hematocrit NN B-NP I-test
was VBD B-VP O
44.4 CD O O
, , O O
with IN B-VP O
white JJ B-NP B-test
blood NN I-NP I-test
count NN I-NP I-test
of IN B-VP O
11.9 CD O O
, , O O
and CC O O
platelet NN B-NP B-test
count NN I-NP I-test
of IN B-VP O
410 CD O O
. . B-VP O
   
His PRP$ O B-person
His PRP$ O B-test
MCV NNP B-NP I-test
was VBD B-VP O
92 CD O O
, , O O
MCH NNP B-NP B-test
32.1 CD O O
, , O O
and CC O O
MCHE NNP B-NP B-test
34.8 CD O O
. . B-VP O
   
His PRP$ O B-person
His PRP$ O B-test
chest JJS B-NP I-test
X-ray NN I-NP I-test
did VBD B-VP O
not RB O O
reveal VB O O
any DT B-NP B-problem
abnormality NN I-NP I-problem
. . B-VP O
   
A DT B-NP B-test
electrocardiogram NN I-NP I-test
showed VBD B-VP O
nonspecific JJ B-NP B-problem
T-wave NNP I-NP I-problem
abnormalities NNS I-NP I-problem
, , O O
otherwise RB O O
, , O O
it PRP O B-pronoun
was VBD B-VP O
normal JJ O O
. . B-VP O
   
HOSPITAL NNP B-NP O
COURSE NNP I-NP O
: : O O
He PRP O B-person
underwent VBD B-VP O
right JJ B-NP B-treatment
knee NN I-NP I-treatment
open JJ B-NP I-treatment
synovectomy NN I-NP I-treatment
and CC O O
debridement NN B-NP B-treatment
of IN B-VP O
synovial JJ B-NP B-problem
chondromatosis NN I-NP I-problem
on IN B-VP O
10-28-93 JJ O O
. . B-VP O
   
Postoperatively RB O O
, , O O
he PRP O B-person
has VBZ O O
done VBN O O
well RB O O
. . B-VP O
   
He PRP O B-person
is VBZ O O
mobilized VBN O O
with IN B-VP O
the DT B-NP O
help NN I-NP O
of IN B-VP O
physical JJ B-NP B-treatment
therapy NN I-NP I-treatment
, , O O
on IN B-VP O
a DT B-NP B-treatment
continuous JJ I-NP I-treatment
passive JJ I-NP I-treatment
motion NN I-NP I-treatment
machine NN I-NP I-treatment
. . B-VP O
   
His PRP$ O B-person
discharge NN B-NP O
range NN I-NP O
of IN B-VP O
motion NN B-NP O
is VBZ O O
from IN B-VP O
zero NN B-NP O
to TO O O
40 CD O O
degrees NNS B-NP O
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
on IN B-VP O
pain NN B-NP B-treatment
medication NN I-NP I-treatment
and CC O O
he PRP O B-person
was VBD B-VP O
also RB O O
on IN B-VP O
Percocet NNP B-NP B-treatment
, , O O
but CC O O
now RB O O
he PRP O B-person
can MD O O
manage VB O O
without IN B-VP O
the DT B-NP O
Percocet NNP I-NP B-treatment
. . B-VP O
   
He PRP O B-person
is VBZ O O
on IN B-VP O
Coumadin NNP B-NP B-treatment
which WDT O B-pronoun
is VBZ O O
to TO O O
be VB O O
continued VBN O O
for IN B-VP O
six CD O O
weeks NNS B-NP O
. . B-VP O
   
MEDICATIONS NNP B-NP O
ON NNP I-NP O
DISCHARGE NNP I-NP O
: : O O
Percocet NNP B-NP B-treatment
1-2 CD O O
PO NNP B-NP O
q4h NN I-NP O
prn NN I-NP O
. . B-VP O
   
FOLLOW NNP B-NP O
UP NNPS I-NP O
: : O O
He PRP O B-person
will MD O O
be VB O O
followed VBN O O
up RP O O
in IN B-VP O
Cesa NNP B-NP O
, , O O
New NNP B-NP O
York NNP I-NP O
. . B-VP O
   
DISPOSITION NN B-NP O
: : O O
On IN B-VP O
discharge NN B-NP O
, , O O
he PRP O B-person
is VBZ O O
mobilized VBN O O
, , O O
partial JJ B-NP O
weight NN I-NP O
bearing VBG O O
with IN B-VP O
the DT B-NP O
help NN I-NP O
of IN B-VP O
a DT B-NP B-treatment
walker NN I-NP I-treatment
. . B-VP O
   
The DT B-NP O
condition NN I-NP O
on IN B-VP O
discharge NN B-NP O
is VBZ O O
good JJ O O
. . B-VP O
   
STA NNP B-NP B-person
AGE NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
DICTATING NNP I-NP O
FOR NNP I-NP O
: : O O
SHAA NNP B-NP B-person
STONGE NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
TR NNP I-NP O
: : O O
fu NN B-NP O
/ NNP I-NP O
bmot NN I-NP O
DD NNP I-NP O
: : O O
11-1-93 JJ B-NP O
TD NN I-NP O
: : O O
11/01/93 CD O O
CC NN B-NP O
: : O O
-EMPTYLINE- JJ B-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
389977469 CD O O
SH NNP B-NP O
30431630 CD O O
12/19/2004 CD O O
12:00:00 CD O O
AM NNP B-NP O
abdominal JJ B-NP B-problem
pain NN I-NP I-problem
DIS NNP I-NP O
Admission NNP I-NP O
Date NNP I-NP O
: : O O
12/19/2004 CD O O
Report NNP B-NP O
Status NNP I-NP O
: : O O
Discharge NN B-NP O
Date NNP I-NP O
: : O O
12/23/2004 CD O O
****** NN B-NP O
DISCHARGE NNP I-NP O
ORDERS****** NNP I-NP O
MEEDHEYSKUDZRO NNP I-NP B-person
, , O I-person
LEENLEE NNP B-NP I-person
C NNP I-NP I-person
360-93-28-7P31 JJ B-NP O
Room NN I-NP O
: : O O
3M-963 JJ B-NP O
Service NNP I-NP O
: : O O
PUL NNP B-NP O
DISCHARGE NNP I-NP O
PATIENT NNP I-NP B-person
ON NNP I-NP O
: : O O
12/23/04 CD O O
AT NNP B-NP O
05:00 CD O O
PM NNP B-NP O
CONTINGENT NNP I-NP O
UPON NNP I-NP O
Not RB O O
Applicable NNP B-NP O
WILL NNP I-NP O
D NNP I-NP O
/ NNP I-NP O
C NNP I-NP O
ORDER NNP I-NP O
BE NNP I-NP O
USED NNP I-NP O
AS IN B-VP O
THE NNP B-NP O
D NNP I-NP O
/ NNP I-NP O
C NNP I-NP O
SUMMARY NNP I-NP O
: : O O
YES JJ B-NP O
Attending NN I-NP B-person
: : O O
SADDCHIRD NNP B-NP B-person
, , O I-person
ALINE NNP B-NP I-person
CHPIE NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
CODE NNP I-NP O
STATUS NNP I-NP O
: : O O
No DT B-NP O
CPR NNP I-NP B-treatment
/ VBZ O O
No DT B-NP O
defib NN I-NP B-treatment
/ VBZ O O
No DT B-NP O
intubation NN I-NP B-treatment
/ VBZ O O
No DT B-NP O
pressors NNS I-NP B-treatment
/DISPOSITION VBP O O
: : O O
Home NNP B-NP O
w/ NN I-NP O
services NNS I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS NNP I-NP O
: : O O
ALBUTEROL NNP B-NP B-treatment
INHALER NNP I-NP I-treatment
2 CD O O
PUFF NNP B-NP O
INH NNP I-NP O
QID NNP I-NP O
PRN NNP I-NP O
Shortness NNP I-NP B-problem
of IN B-VP I-problem
Breath NNP B-NP I-problem
, , O O
Wheezing NNP B-NP B-problem
VITAMIN NNP I-NP B-treatment
C NNP I-NP I-treatment
( ( O I-treatment
ASCORBIC NNP B-NP I-treatment
ACID NNP I-NP I-treatment
) ) O I-treatment
500 CD O O
MG NNP B-NP O
PO NNP I-NP O
BID NNP I-NP O
MIACALCIN NNP I-NP B-treatment
( ( O I-treatment
CALCITONIN NNP B-NP I-treatment
- : O I-treatment
SALMON NN B-NP I-treatment
) ) O I-treatment
1 CD O O
SPRAY NNP B-NP O
INH NNP I-NP O
QD NNP I-NP O
Number NNP I-NP O
of IN B-VP O
Doses NNP B-NP O
Required NNP I-NP O
( ( O O
approximate JJ O O
) ) O O
: : O O
1MAG CD O B-treatment
CITRATE NNP B-NP I-treatment
( ( O I-treatment
CITRATE NNP B-NP I-treatment
OF NNP I-NP I-treatment
MAGNESIA NNP I-NP I-treatment
) ) O I-treatment
300 CD O O
MILLILITERS NNP B-NP O
PO NNP I-NP O
QD NNP I-NP O
PRN NNP I-NP O
Constipation NNP I-NP B-problem
COLACE NNP I-NP B-treatment
( ( O I-treatment
DOCUSATE NNP B-NP I-treatment
SODIUM NNP I-NP I-treatment
) ) O I-treatment
100 CD O O
MG NNP B-NP O
PO NNP I-NP O
TID NNP I-NP O
GLYBURIDE NNP I-NP B-treatment
5 CD O O
MG NNP B-NP O
PO NNP I-NP O
BID NNP I-NP O
Starting NNP I-NP O
IN NNP I-NP O
AM NNP I-NP O
on IN B-VP O
12/21/04 CD O O
LACTULOSE NNP B-NP B-treatment
30 CD O O
MILLILITERS NNP B-NP O
PO NNP I-NP O
Q6 NNP I-NP O
HOLD NNP I-NP O
IF NNP I-NP O
: : O O
diarrhea NN B-NP B-problem
SENNA NNP I-NP B-treatment
TABLETS NNP I-NP I-treatment
2 CD O O
TAB NNP B-NP O
PO NNP I-NP O
BID NNP I-NP O
SIMETHICONE NNP I-NP B-treatment
160 CD O O
MG NNP B-NP O
PO NNP I-NP O
QID NNP I-NP O
Starting VBG O O
Today NNP B-NP O
( ( O O
12/23 CD O O
) ) O O
PRN FW O O
Other JJ O O
: : O O
gas NN B-NP B-problem
, , O O
upset JJ B-NP B-problem
stomach NN I-NP I-problem
. . B-VP O
   
TAMOXIFEN $ O B-treatment
20 CD O O
MG NNP B-NP O
PO NNP I-NP O
QD NNP I-NP O
Override NNP I-NP O
Notice NNP I-NP O
: : O O
Override NNP B-NP O
added VBD B-VP O
on IN B-VP O
12/19/04 CD O O
by IN B-VP O
SAPMOORES NNP B-NP B-person
, , O I-person
NELL NNP B-NP I-person
RILET NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
on IN B-VP O
order NN B-NP O
for IN B-VP O
LEVOFLOXACIN NNP B-NP B-treatment
PO NNP I-NP I-treatment
( ( O O
ref JJ O O
# # O O
88006031 CD O O
) ) O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP B-problem
INTERACTION NNP I-NP I-problem
: : O O
TAMOXIFEN NNP B-NP B-treatment
CITRATE NNP I-NP I-treatment
and CC O O
LEVOFLOXACIN NNP B-NP B-treatment
Reason NNP I-NP O
for IN B-VP O
override NN B-NP O
: : O O
aware JJ B-NP O
MVI NNP I-NP B-treatment
THERAPEUTIC NNP I-NP I-treatment
W NNP I-NP I-treatment
/ NNP I-NP I-treatment
MINERALS NNP I-NP I-treatment
( ( O I-treatment
THERAP NNP B-NP I-treatment
VITS NNP I-NP I-treatment
/ NNP I-NP I-treatment
MINERALS NNP I-NP I-treatment
) ) O I-treatment
1 CD O O
TAB NNP B-NP O
PO NNP I-NP O
QD NNP I-NP O
PILOCARPINE NNP I-NP B-treatment
4% CD O I-treatment
SOLUTION NNP B-NP I-treatment
1 CD O O
DROP NNP B-NP O
OS NNP I-NP O
QID NNP I-NP O
FLONASE NNP I-NP B-treatment
( ( O I-treatment
FLUTICASONE NNP B-NP I-treatment
NASAL NNP I-NP I-treatment
SPRAY NNP I-NP I-treatment
) ) O I-treatment
2 CD O O
SPRAY NNP B-NP O
INH NNP I-NP O
BID NNP I-NP O
Number NNP I-NP O
of IN B-VP O
Doses NNP B-NP O
Required NNP I-NP O
( ( O O
approximate JJ O O
) ) O O
: : O O
2 CD O B-treatment
ALPHAGAN NNP B-NP I-treatment
( ( O I-treatment
BRIMONIDINE NNP B-NP I-treatment
TARTRATE NNP I-NP I-treatment
) ) O I-treatment
1 CD O O
DROP NNP B-NP O
OS NNP I-NP O
BID NNP I-NP O
Number NNP I-NP O
of IN B-VP O
Doses NNP B-NP O
Required NNP I-NP O
( ( O O
approximate JJ O O
) ) O O
: : O O
2 CD O B-treatment
LEVOFLOXACIN NNP B-NP I-treatment
250 CD O O
MG NNP B-NP O
PO NNP I-NP O
QD NNP I-NP O
X NNP I-NP O
1 CD O O
Days NNPS B-NP O
Starting VBG O O
Today NNP B-NP O
( ( O O
12/21 CD O O
) ) O O
Food NNP B-NP O
/ NNP I-NP O
Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Administer NNP I-NP O
iron NN I-NP B-treatment
products NNS I-NP I-treatment
a DT B-NP O
minimum NN I-NP O
of IN B-VP O
2 CD O O
hours NNS B-NP O
before IN B-VP O
or CC O O
after IN B-VP O
a DT B-NP B-treatment
levofloxacin NN I-NP I-treatment
or CC O O
ciprofloxacin NN B-NP B-treatment
dose VBP O O
dose JJ O O
If IN B-VP O
on IN B-VP O
tube NN B-NP B-treatment
feeds NNS I-NP I-treatment
, , O O
please VB O O
cycle NN B-NP O
( ( O O
hold VB O O
1 CD O O
hr NN B-NP O
before IN B-VP O
to TO O O
2 CD O O
hr NNS B-NP O
after IN B-VP O
) ) O O
Take VBP O O
2 CD O O
hours NNS B-NP O
before IN B-VP O
or CC O O
2 CD O O
hours NNS B-NP O
after IN B-VP O
dairy NN B-NP O
products NNS I-NP O
. . B-VP O
   
Alert NNP B-NP O
overridden JJ O O
: : O O
Override NNP B-NP O
added VBD B-VP O
on IN B-VP O
12/19/04 CD O O
by IN B-VP O
SAPMOORES NNP B-NP B-person
, , O I-person
NELL NNP B-NP I-person
RILET NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP B-problem
INTERACTION NNP I-NP I-problem
: : O O
TAMOXIFEN NNP B-NP B-treatment
CITRATE NNP I-NP I-treatment
and CC O O
LEVOFLOXACIN NNP B-NP B-treatment
Reason NNP I-NP O
for IN B-VP O
override NN B-NP O
: : O O
aware JJ B-NP O
CELEXA NNP I-NP B-treatment
( ( O I-treatment
CITALOPRAM NNP B-NP I-treatment
) ) O I-treatment
20 CD O O
MG NNP B-NP O
PO NNP I-NP O
QD NNP I-NP O
CALCIUM NNP I-NP B-treatment
CARB NNP I-NP I-treatment
+ NNP I-NP I-treatment
D NNP I-NP I-treatment
( ( O I-treatment
600MG CD O I-treatment
ELEM NNP B-NP I-treatment
CA NNP I-NP I-treatment
+ NNP I-NP I-treatment
VIT NNP I-NP I-treatment
D/200 NNP I-NP I-treatment
IU NNP I-NP I-treatment
) ) O I-treatment
1 CD O O
TAB NNP B-NP O
PO NNP I-NP O
BID NNP I-NP O
LUMIGAN NNP I-NP B-treatment
( ( O I-treatment
BIMATOPROST NNP B-NP I-treatment
0.03% CD O I-treatment
) ) O I-treatment
1 CD O O
DROP NNP B-NP O
OU NNP I-NP O
QHS NNP I-NP O
DIET NNP I-NP O
: : O O
No DT B-NP O
Restrictions NNP I-NP O
ACTIVITY NNP I-NP O
: : O O
as IN B-VP O
tolerated VBN O O
FOLLOW NNP B-NP O
UP NNP I-NP O
APPOINTMENT NNP I-NP O
( ( O O
S NNP B-NP O
) ) O O
: : O O
Dr. NNP B-NP B-person
Faleschird NNP I-NP I-person
, , O O
Dr. NNP B-NP B-person
Cuchbreunjesc NNP I-NP I-person
, , O O
Dr. NNP B-NP B-person
Roziesc NNP I-NP I-person
, , O O
ALLERGY NNP B-NP O
: : O O
CEFUROXIME NNP B-NP B-treatment
AXETILADMIT NNP I-NP O
DIAGNOSIS NNP I-NP O
: : O O
abdominal JJ B-NP B-problem
pain NN I-NP I-problem
PRINCIPAL NNP I-NP O
DISCHARGE NNP I-NP O
DIAGNOSIS NNP I-NP O
; : O O
Responsible NNP B-NP O
After IN B-VP O
Study NNP B-NP O
for IN B-VP O
Causing NNP B-NP O
Admission NNP I-NP O
) ) O O
abdominal VBP O B-problem
pain NN B-NP I-problem
OTHER NNP I-NP O
DIAGNOSIS NNP I-NP O
; : O O
Conditions NNP B-NP O
, , O O
Infections NNP B-NP O
, , O O
Complications NNP B-NP O
, , O O
affecting VBG O O
Treatment NNP B-NP O
/ NNP I-NP O
Stay NNP I-NP O
Allergies NNP I-NP B-problem
- : O O
PCN NNP B-NP B-treatment
- : O O
rash NN B-NP B-problem
- : O O
Bactrim NNP B-NP B-treatment
- : O O
hives VBZ O B-problem
- : O O
Erythro NNP B-NP B-treatment
- : O O
nausea NN B-NP B-problem
- : O O
Ceclor NNP B-NP B-treatment
- : O O
nausea NN B-NP B-problem
- : O O
Clarythro NNP B-NP B-treatment
= NNP I-NP O
rash NN I-NP B-problem
OPERATIONS NNP I-NP O
AND CC O O
PROCEDURES NNP B-NP O
: : O O
None NN B-NP O
. . B-VP O
   
OTHER CC O O
TREATMENTS NNP B-NP O
/ NNP I-NP O
PROCEDURES NNP I-NP O
( ( O O
NOT NNP B-NP O
IN NNP I-NP O
O.R. NNP I-NP O
) ) O O
NONEBRIEF NNP B-NP O
RESUME NNP I-NP O
OF NNP I-NP O
HOSPITAL NNP I-NP O
COURSE NNP I-NP O
: : O O
67 CD O B-person
y/o NN B-NP I-person
F NNP I-NP I-person
w/ NN I-NP O
hx NN I-NP O
poliomyelitis NN I-NP B-problem
, , O O
breast NN B-NP B-problem
CA NNP I-NP I-problem
stable NN I-NP O
on IN B-VP O
tamoxifen NN B-NP B-treatment
, , O O
vent JJ B-NP B-problem
dependent NN I-NP I-problem
in IN B-VP O
an DT B-NP B-treatment
iron NN I-NP I-treatment
lung NN I-NP I-treatment
admitted VBD B-VP O
w/ JJ O O
1 CD O O
day NN B-NP O
hx NN I-NP O
of IN B-VP O
abdominal JJ B-NP B-problem
pain NN I-NP I-problem
. . B-VP O
   
Pt NNP B-NP B-person
was VBD B-VP O
recently RB O O
admitted VBN O O
1 CD O O
week NN B-NP O
ago RB O O
w/ VBD B-VP O
epigastric JJ B-NP B-problem
pain NN I-NP I-problem
. . B-VP O
   
Pain VB O B-problem
worse JJR O O
with IN B-VP O
movement NN B-NP O
. . B-VP O
   
She PRP O B-person
denies VBZ O O
any DT B-NP B-problem
fever NN I-NP I-problem
, , O O
BRBPR NNP B-NP B-problem
, , O O
melena NN B-NP B-problem
, , O O
dysuria NN B-NP B-problem
. . B-VP O
   
On IN B-VP O
admision NN B-NP O
, , O O
T NNP B-NP B-test
97.5 CD O O
, , O O
HR NNP B-NP B-test
86 CD O O
, , O O
BP NNP B-NP B-test
111/47 CD O O
, , O O
R NNP B-NP B-test
20 CD O O
. . B-VP O
   
Sat NNP B-NP B-test
94% CD O O
on IN B-VP O
4L CD O B-treatment
. . B-VP O
   
Exam NNP B-NP B-test
notable JJ O O
for IN B-VP O
hyperactive JJ B-NP B-problem
bowel NN I-NP I-problem
sounds VBZ O I-problem
with IN B-VP O
abd JJ B-NP B-problem
distention NN I-NP I-problem
and CC O O
tenderness NN B-NP B-problem
to TO O O
palpation NN B-NP B-test
at IN B-VP I-test
LLQ NNP B-NP I-test
and CC O O
RLQ NNP B-NP O
. . B-VP O
   
No NNP B-NP O
rebound NN I-NP B-problem
or CC O O
guarding NN B-NP B-problem
. . B-VP O
   
Abd NNP B-NP B-test
CT NNP I-NP I-test
showed VBD B-VP O
stable JJ B-NP O
findings NNS I-NP O
compared VBN O O
to TO O O
12/10/04 CD O O
except IN B-VP O
for IN B-VP O
distended JJ B-NP B-problem
right NN I-NP I-problem
colon NN I-NP I-problem
consistent JJ O O
with IN B-VP O
ileus NN B-NP B-problem
. . B-VP O
   
Hospital JJ B-NP O
course NN I-NP O
: : O O
GI NN B-NP O
: : O O
pt NN B-NP B-person
&apos;s NNP I-NP O
clinical JJ B-NP O
picture NN I-NP O
was VBD B-VP O
consistent JJ O O
with IN B-VP O
constipation-related JJ B-NP B-problem
abdominal JJ I-NP I-problem
pain NN I-NP I-problem
. . B-VP O
   
pt NN B-NP B-person
was VBD B-VP O
started VBN O O
on IN B-VP O
bowel NN B-NP B-treatment
regimen NNS I-NP I-treatment
with IN B-VP O
Senna NNP B-NP B-treatment
, , O O
magcitrate NN B-NP B-treatment
and CC O O
Lactulose NNP B-NP B-treatment
. . B-VP O
   
Several JJ B-NP O
loose JJ I-NP O
bowel NN I-NP O
movements NNS I-NP O
were VBD B-VP O
induced VBN O O
with IN B-VP O
above JJ B-NP O
regimen NNS I-NP O
. . B-VP O
   
Her PRP$ O B-person
Her PRP$ O B-problem
abd JJ B-NP I-problem
distention NN I-NP I-problem
and CC O O
tenderness NN B-NP B-problem
improved VBN O O
after IN B-VP O
bowel NN B-NP O
movement NN I-NP O
. . B-VP O
   
ID NN B-NP O
: : O O
pt NN B-NP B-person
was VBD B-VP O
Levo NNP B-NP B-treatment
250mg CD O O
x VBD B-VP O
3 CD O O
days NNS B-NP O
for IN B-VP O
UTI NNP B-NP B-problem
( ( O O
pyuria NN B-NP B-problem
on IN B-VP O
admisstion NN B-NP O
) ) O O
. . B-VP O
   
Pulm NN B-NP O
: : O O
pt NN B-NP B-person
has VBZ O O
been VBN O O
using VBG O O
iron NN B-NP B-treatment
lung NN I-NP I-treatment
for IN B-VP O
breathing NN B-NP O
and CC O O
has VBZ O O
been VBN O O
satting VBG O O
well RB O O
duing VBG O O
her PRP$ O B-person
hospital NN B-NP O
course NN I-NP O
. . B-VP O
   
Code NN B-NP O
: : O O
DNR NNP B-NP O
/ NNP I-NP O
DNI NNP I-NP O
. . B-VP O
   
ADDITIONAL NNP B-NP O
COMMENTS NN I-NP O
: : O O
DISCHARGE JJ B-NP O
CONDITION NNP I-NP O
: : O O
Stable JJ B-NP O
TO NNP I-NP O
DO NNP I-NP O
/ NNP I-NP O
PLAN NNP I-NP O
: : O O
1. CD O O
Please NNP B-NP O
follow VB O O
up RP O O
with IN B-VP O
Dr. NNP B-NP B-person
Faleschird NNP I-NP I-person
, , O O
Dr. NNP B-NP B-person
Cuchbreunjesc NNP I-NP I-person
and CC O O
Dr. NNP B-NP B-person
Roziesc NNP I-NP I-person
. . B-VP O
   
No NNP B-NP O
dictated VBD B-VP O
summary JJ B-NP O
ENTERED NNP I-NP O
BY NNP I-NP O
: : O O
LEESEPLASSBREAN NNP B-NP B-person
, , O I-person
RIDELT NNP B-NP I-person
, , O I-person
M.D. NNP B-NP I-person
( ( O O
FR98 NNP B-NP O
) ) O O
12/23/04 CD O O
04:37 CD O O
PM NNP B-NP O
****** JJ B-NP O
END NNP I-NP O
OF NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
Admission NNP I-NP O
Date NNP I-NP O
: : O O
2018-08-02 JJ B-NP O
Discharge NN I-NP O
Date NNP I-NP O
: : O O
2018-08-08 JJ B-NP O
Date NNP I-NP O
of IN B-VP O
Birth NNP B-NP O
: : O O
1941-03-03 JJ B-NP O
Sex NN I-NP O
: : O O
F NNP B-NP O
Service NNP I-NP O
: : O O
MEDICINE JJ B-NP O
Allergies NNS I-NP O
: : O O
Penicillins NNS B-NP B-treatment
/ VBP O O
Codeine NNP B-NP B-treatment
/ NNP I-NP O
Heparin NNP I-NP B-treatment
Agents NNP I-NP I-treatment
/ NNP I-NP O
Levofloxacin NNP I-NP B-treatment
Attending NNP I-NP B-person
: : O O
Faye NNP B-NP B-person
B. NNP I-NP I-person
Jones NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
Chief NNP I-NP O
Complaint NNP I-NP O
: : O O
rectal NN B-NP B-problem
bleeding VBG O I-problem
Major NNP B-NP O
Surgical NNP I-NP O
or CC O O
Invasive JJ B-NP O
Procedure NN I-NP O
: : O O
colonoscopy NN B-NP B-test
egd NN I-NP B-test
GI NNP I-NP B-test
bleeding NN I-NP I-test
study NN I-NP I-test
History NNP I-NP O
of IN B-VP O
Present NNP B-NP O
Illness NNP I-NP O
: : O O
Patient NN B-NP B-person
is VBZ O O
a DT O O
77 CD O O
year NN B-NP O
old JJ B-NP O
female NN I-NP O
with IN B-VP O
a DT B-NP O
past JJ I-NP O
medical JJ I-NP O
history NN I-NP O
significant JJ O O
for IN B-VP O
GI NNP B-NP B-problem
bleeding VBG O I-problem
secondary JJ O O
to TO O O
arteriovenous JJ B-NP B-problem
malformations NNS I-NP I-problem
, , O O
who WP O B-person
presents VBZ O O
with IN B-VP O
maroon NN B-NP B-problem
stool NN I-NP I-problem
and CC O O
a DT B-NP B-problem
hematocrit JJ I-NP I-problem
drop NN I-NP I-problem
. . B-VP O
   
Three CD O O
days NNS B-NP O
ago RB O O
began VBD B-VP O
to TO O O
develop VB O O
black JJ B-NP B-problem
stools NNS I-NP I-problem
. . B-VP O
   
There EX O O
was VBD B-VP O
no DT B-NP O
clear JJ I-NP B-problem
blood NN I-NP I-problem
in IN B-VP O
the DT B-NP O
toilet NN I-NP O
bowl NN I-NP O
. . B-VP O
   
In IN B-VP O
addition NN B-NP O
, , O O
she PRP O B-person
developed VBD B-VP O
nausea NN B-NP B-problem
and CC O O
decreased VBD B-VP B-problem
PO NNP B-NP I-problem
intake NN I-NP I-problem
. . B-VP O
   
She PRP O B-person
had VBD B-VP O
a DT B-NP B-problem
cough JJ I-NP I-problem
productive NN I-NP O
of IN B-VP O
white JJ B-NP B-problem
sputum NN I-NP I-problem
and CC O O
felt VBD B-VP O
warm NN B-NP O
, , O O
although IN B-VP O
she PRP O B-person
did VBD B-VP O
not RB O O
record VB O O
her PRP$ O B-person
her PRP$ O B-test
temperature NN B-NP I-test
. . B-VP O
   
At IN B-VP O
dialysis NN B-NP B-treatment
on IN B-VP O
day NN B-NP O
of IN B-VP O
admission NN B-NP O
, , O O
she PRP O B-person
related VBD B-VP O
these DT B-NP B-pronoun
symptoms NNS I-NP O
for IN B-VP O
the DT B-NP O
first JJ I-NP O
time NN I-NP O
and CC O O
had VBD B-VP O
a DT B-NP B-problem
bloody JJ I-NP I-problem
bowel NN I-NP I-problem
movement NN I-NP I-problem
. . B-VP O
   
Concerned VBN O O
, , O O
the DT B-NP O
staff NN I-NP O
sent VBD B-VP O
her PRP$ O B-person
directly RB O O
to TO O O
the DT B-NP O
Nantucket NNP I-NP O
Cottage NNP I-NP O
Hospital NNP I-NP O
. . B-VP O
   
In IN B-VP O
the DT B-NP O
Deanna NNP I-NP O
, , O O
her PRP$ O B-person
her PRP$ O B-test
temperature NN B-NP I-test
was VBD B-VP O
96.5 CD O O
, , O O
HR NNP B-NP B-test
51 CD O O
, , O O
BP NNP B-NP B-test
112/60 CD O O
, , O O
RR NNP B-NP B-test
18 CD O O
, , O O
and CC O O
oxygen NN B-NP B-test
saturation NN I-NP I-test
was VBD B-VP O
98% CD O O
on IN B-VP O
ambient JJ B-NP O
air NN I-NP O
. . B-VP O
   
Her PRP$ O B-person
Her PRP$ O B-test
hematocrit NN B-NP I-test
was VBD B-VP O
measured VBN O O
at IN B-VP O
23.5 CD O O
, , O O
while IN B-VP O
her PRP$ O B-person
her PRP$ O B-test
baseline NN B-NP I-test
hematocrit NN I-NP I-test
is VBZ O O
in IN B-VP O
the DT O O
low JJ O O
30 CD O O
s. NN B-NP O
An DT B-NP B-test
NG NNP I-NP I-test
lavage NN I-NP I-test
was VBD B-VP O
performed VBN O O
and CC O O
there EX O B-pronoun
was VBD B-VP O
bilious JJ B-NP B-problem
return NN I-NP I-problem
. . B-VP O
   
Rectal JJ B-NP B-test
examination NN I-NP I-test
was VBD B-VP O
notable JJ O O
for IN B-VP O
guiaiac JJ B-NP B-problem
positive JJ I-NP I-problem
maroon NN I-NP I-problem
stool NN I-NP I-problem
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
type NN B-NP O
and CC O O
crossed VBN O O
and CC O O
transfused VBN O O
two CD O O
units NNS B-NP O
of IN B-VP O
packed JJ B-NP B-treatment
red JJ I-NP I-treatment
blood NN I-NP I-treatment
cells NNS I-NP I-treatment
. . B-VP O
   
IV NNP B-NP B-treatment
PPI NNP I-NP I-treatment
was VBD B-VP O
given VBN O O
and CC O O
the DT B-NP O
GI NNP I-NP O
team NN I-NP O
was VBD B-VP O
consulted VBN O O
and CC O O
she PRP O B-person
was VBD B-VP O
scheduled VBN O O
for IN B-VP O
colonoscopy NN B-NP B-test
and CC O O
EGD NNP B-NP B-test
on IN B-VP O
the DT B-NP O
morning NN I-NP O
of IN B-VP O
6/8 CD O O
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
transferred VBN O O
to TO O O
the DT B-NP O
CMED NNP I-NP O
CCU NNP I-NP O
for IN B-VP O
observation NN B-NP B-test
. . B-VP O
   
Past NNP B-NP O
Medical JJ B-NP O
History NN I-NP O
: : O O
DM2 NN B-NP B-problem
on IN B-VP O
insulin NN B-NP B-treatment
CRI NNP I-NP B-problem
03-30 JJ B-NP O
HTN NNP I-NP B-problem
and CC O O
DM NNP B-NP B-problem
nephropathy RB O I-problem
, , O O
with IN B-VP O
baseline JJ B-NP B-test
creatinine NN I-NP I-test
4-4.5 JJ B-NP O
Chronic NNP I-NP B-problem
GI NNP I-NP I-problem
bleeding NN I-NP I-problem
: : O O
documented VBN O B-problem
AVMs NNP B-NP I-problem
Anemia NNP I-NP B-problem
w/ VBP O O
baseline JJ B-NP B-test
hct NN I-NP I-test
27-30 JJ B-NP O
Thrombocytopenia NNP I-NP B-problem
Coagulopathy NNP I-NP B-problem
, , O O
HIT NNP B-NP B-problem
in IN B-VP O
2014 CD O O
Cardiomyopathy NNP B-NP B-problem
MRSA NNP I-NP B-problem
endocardiitis NN I-NP I-problem
( ( O O
01-28 JJ O O
) ) O O
CAD NNP B-NP B-problem
; : O O
status NN B-NP O
post NN I-NP O
coronary JJ B-NP B-treatment
artery NN I-NP I-treatment
bypass NN I-NP I-treatment
graft NN I-NP I-treatment
times NNS I-NP O
two CD O O
and CC O O
status NN B-NP O
post NN I-NP O
myocardial JJ B-NP B-problem
infarction NN I-NP I-problem
in IN B-VP O
2001 CD O O
and CC O O
2000 CD O O
. . B-VP O
   
Asthma NNP B-NP B-problem
Hypothyroidism NNP I-NP B-problem
Osteoarthritis NNP I-NP B-problem
Paroxysmal NNP I-NP B-problem
atrial JJ B-NP I-problem
fibrillation NN I-NP I-problem
PUD NNP I-NP B-problem
, , O O
Barrett NNP B-NP B-problem
's POS O I-problem
Esophagus NNP B-NP I-problem
CHF NNP I-NP B-problem
EF NNP I-NP B-test
50% CD O O
Social NNP B-NP O
History NN I-NP O
: : O O
Primarily RB O O
Togolese NNP B-NP O
speaking NN I-NP O
, , O O
wheelchair NN B-NP B-problem
bound NN I-NP I-problem
and CC O O
lives VBZ O O
alone RB O O
but CC O O
cared VBD B-VP O
for IN B-VP O
entirely RB O O
by IN B-VP O
her PRP$ O B-person
her PRP$ O B-person
daughter NN B-NP I-person
. . B-VP O
   
She PRP O B-person
denies VBZ O O
EtOH NNP B-NP O
, , O O
tobacco NN B-NP O
, , O O
and CC O O
drugs NNS B-NP O
. . B-VP O
   
Patient NNP B-NP B-person
has VBZ O O
8 CD O O
children NNS B-NP O
, , O O
40 CD O O
grandchildren NNS B-NP O
and CC O O
one CD O O
great-grandaughter NN B-NP O
. . B-VP O
   
Family JJ B-NP O
History NN I-NP O
: : O O
CAD NNP B-NP B-problem
and CC O O
DM NNP B-NP B-problem
Physical NNP I-NP O
Exam NNP I-NP O
: : O O
T NN B-NP B-test
: : O O
97.2 CD O O
BP NNP B-NP B-test
: : O O
127/57 CD O O
HR NNP B-NP B-test
: : O O
68 CD O O
RR NN B-NP B-test
: : O O
11 CD O O
O2saturation NN B-NP B-test
: : O O
97% CD O O
on IN B-VP O
ambient NN B-NP O
air NN I-NP O
Gen NNP I-NP O
: : O O
Pleasant NN B-NP O
, , O O
well RB O O
appearing VBG O O
heavy JJ O O
set VBN O O
woman NN B-NP O
laying VBG O O
in IN B-VP O
bed NN B-NP O
. . B-VP O
   
HEENT NN B-NP O
: : O O
Slight JJ B-NP B-problem
conjunctival NN I-NP I-problem
pallor NN I-NP I-problem
. . B-VP O
   
No DT B-NP O
scleral JJ I-NP B-problem
icterus NN I-NP I-problem
. . B-VP O
   
Slightly RB O B-problem
dry JJ B-NP I-problem
mucous JJ I-NP I-problem
membranes NNS I-NP I-problem
. . B-VP O
   
NECK NN B-NP O
: : O O
Supple NNP B-NP O
. . B-VP O
   
No DT B-NP O
JVD NNP I-NP B-problem
. . B-VP O
   
CV NN B-NP O
: : O O
RRR NNP B-NP O
. . B-VP O
   
Systolic NNP B-NP B-problem
murmur NN I-NP I-problem
in IN B-VP I-problem
right JJ B-NP I-problem
upper JJ I-NP I-problem
sternal JJ I-NP I-problem
border NN I-NP I-problem
. . B-VP O
   
Normal JJ B-NP O
S1 NNP I-NP O
and CC O O
S2 NNP B-NP O
. . B-VP O
   
No DT B-NP O
rubs NN I-NP B-problem
or CC O O
Andringa NNP B-NP B-problem
appreciated VBD B-VP O
. . B-VP O
   
LUNGS NN B-NP O
: : O O
Crackles NNS B-NP B-problem
in IN B-VP I-problem
lower JJR B-NP I-problem
lung NN I-NP I-problem
fields NNS I-NP I-problem
. . B-VP O
   
No DT B-NP O
wheezes NN I-NP B-problem
or CC O O
rhonci NN B-NP B-problem
appreciated VBN O O
. . B-VP O
   
ABD NN B-NP O
: : O O
Slightly RB O B-problem
hyperactive JJ B-NP I-problem
bowel NN I-NP I-problem
sounds VBZ O I-problem
throughout IN B-VP I-problem
. . B-VP O
   
Soft NNP B-NP O
. . B-VP O
   
Nontender NNP B-NP B-problem
and CC O O
nondistended VBN O B-problem
. . B-VP O
   
No DT B-NP O
guarding NN I-NP B-problem
or CC O O
rebound NN B-NP B-problem
. . B-VP O
   
Liver NNP B-NP O
edge VBZ O O
not RB O O
palpated VBN O O
. . B-VP O
   
No DT B-NP O
splenomegaly NN I-NP B-problem
appreciated VBD B-VP O
. . B-VP O
   
Guaiac NNP B-NP B-problem
positive JJ B-NP I-problem
maroon NN I-NP I-problem
stool NN I-NP I-problem
in IN B-VP O
Deanna NNP B-NP O
. . B-VP O
   
EXT NN B-NP O
: : O O
Warm JJ O O
and CC O O
well RB O O
perfused VBN O O
. . B-VP O
   
No DT B-NP O
clubbing NN I-NP B-problem
or CC O O
cyanosis NN B-NP B-problem
. . B-VP O
   
No DT B-NP O
lower JJR I-NP B-problem
extremity NN I-NP I-problem
edema NN I-NP I-problem
, , O I-problem
bilaterally RB O I-problem
. . B-VP O
   
2+ CD O B-test
dorsalis JJ B-NP I-test
pedis NN I-NP I-test
and CC O I-test
radial JJ B-NP I-test
pulse NN I-NP I-test
on IN B-VP I-test
left NN B-NP I-test
. . B-VP O
   
No DT B-NP B-problem
radial JJ I-NP I-problem
pulse NN I-NP I-problem
on IN B-VP I-problem
right NN B-NP I-problem
. . B-VP O
   
AV NNP B-NP B-treatment
fistula NN I-NP I-treatment
on IN B-VP O
right NN B-NP O
. . B-VP O
   
Pertinent JJ B-NP O
Results NNS I-NP O
: : O O
2018-08-07 JJ O O
12:56 CD O O
AM NNP B-NP O
BLOOD NNP I-NP B-test
WBC NNP I-NP B-test
- : O O
4.0 CD O O
RBC NNP B-NP B-test
- : O O
3.54 CD O O
* NN B-NP O
Hgb NNP I-NP B-test
- : O O
11.6 CD O O
* NN B-NP O
Hct NNP I-NP B-test
- : O O
32.9 CD O O
* NN B-NP O
MCV NNP I-NP B-test
- : O O
93 CD O O
MCH NNP B-NP B-test
- : O O
32.8 CD O O
* NN B-NP O
MCHC NNP I-NP B-test
- : O O
35.2 CD O O
* NN B-NP O
RDW NNP I-NP B-test
- : O O
18.5 CD O O
* JJ B-NP O
Plt NNP I-NP B-test
Ct NNP I-NP I-test
- : O O
65 CD O O
* JJ O O
2018-08-02 JJ O O
12:29 CD O O
PM NNP B-NP O
BLOOD NNP I-NP B-test
Hct NNP I-NP B-test
- : O O
23.5 CD O O
*# JJ O O
2018-08-02 JJ O O
04:40 CD O O
PM NNP B-NP O
BLOOD NNP I-NP B-test
WBC NNP I-NP B-test
- : O O
3.2 CD O O
* NN B-NP O
RBC NNP I-NP B-test
- : O O
2.49 CD O O
*# NN B-NP O
Hgb NNP I-NP B-test
- : O O
8.4 CD O O
*# NN B-NP O
Hct NNP I-NP B-test
- : O O
24.5 CD O O
*# NN B-NP O
MCV NNP I-NP B-test
- : O O
98 CD O O
MCH NNP B-NP B-test
- : O O
33.7 CD O O
* NN B-NP O
MCHC NNP I-NP B-test
- : O O
34.3 CD O O
RDW NNP B-NP B-test
- : O O
18.5 CD O O
* JJ B-NP O
Plt NNP I-NP B-test
Ct NNP I-NP I-test
- : O O
69 CD O O
* JJ O O
2018-08-06 JJ O O
04:52 CD O O
AM NNP B-NP O
BLOOD NNP I-NP B-test
PT NNP I-NP B-test
- : O O
14.7 CD O O
* NN B-NP O
PTT NNP I-NP B-test
- : O O
28.9 CD O O
INR NNP B-NP B-test
( ( O I-test
PT NNP B-NP I-test
)- CD O I-test
1.3 CD O O
* JJ O O
2018-08-07 JJ O O
12:56 CD O O
AM NNP B-NP O
BLOOD NNP I-NP B-test
UreaN NNP I-NP B-test
- : O O
27 CD O O
* NN B-NP O
Creat NNP I-NP B-test
- : O O
4.1 CD O O
* NN B-NP O
Na NNP I-NP B-test
- : O O
130 CD O O
* NN B-NP O
K NNP I-NP B-test
- : O O
3.7 CD O O
Cl NNP B-NP B-test
- : O O
94 CD O O
* NN B-NP O
HCO3 NNP I-NP B-test
- : O O
27 CD O O
AnGap NNP B-NP B-test
- : O O
13 CD O O
2018-08-06 JJ O O
04:52 CD O O
AM NNP B-NP O
BLOOD NNP I-NP B-test
Glucose NNP I-NP B-test
- : O O
129 CD O O
* JJ B-NP O
UreaN NNP I-NP B-test
- : O O
24 CD O O
* NN B-NP O
Creat NNP I-NP B-test
- : O O
3.4 CD O O
* NN B-NP O
Na NNP I-NP B-test
- : O O
134 CD O O
K NNP B-NP B-test
- : O O
3.2 CD O O
* NN B-NP O
Cl NNP I-NP B-test
- : O O
96 CD O O
HCO3 NNP B-NP B-test
- : O O
29 CD O O
AnGap NNP B-NP B-test
- : O O
12 CD O O
2018-08-02 JJ O O
04:40 CD O O
PM NNP B-NP O
BLOOD NNP I-NP B-test
Glucose NNP I-NP B-test
- : O O
187 CD O O
* JJ B-NP O
UreaN NNP I-NP B-test
- : O O
21 CD O O
* NN B-NP O
Creat NNP I-NP B-test
- : O O
2.0 CD O O
*# NN B-NP O
Na NNP I-NP B-test
- : O O
139 CD O O
K NNP B-NP B-test
- : O O
3.2 CD O O
* NN B-NP O
Cl NNP I-NP B-test
- : O O
96 CD O O
HCO3 NNP B-NP B-test
- : O O
35 CD O O
* NN B-NP O
AnGap NNP I-NP B-test
- : O O
11 CD O O
2018-08-07 JJ O O
12:56 CD O O
AM NNP B-NP O
BLOOD NNP I-NP B-test
Calcium NNP I-NP B-test
- : O O
8.0 CD O O
* NN B-NP O
Phos NNP I-NP B-test
- : O O
3.5 CD O O
Mg NNP B-NP B-test
- : O O
1.8 CD O O
Cardiology NNP B-NP O
Report NNP I-NP O
ECG NNP I-NP B-test
Study NNP I-NP I-test
Date NNP I-NP O
of IN B-VP O
2018-08-02 JJ O O
5:40:48 CD O O
PM NNP B-NP O
Sinus NNP I-NP B-problem
bradycardia NN I-NP I-problem
with IN B-VP O
markedly RB O B-problem
prolonged VBN O I-problem
P-R NNP B-NP I-problem
interval NN I-NP I-problem
and CC O O
Wenckebach NNP B-NP B-problem
type VBD B-VP I-problem
atrio-ventricular JJ B-NP B-problem
conduction NN I-NP I-problem
delay NN I-NP I-problem
. . B-VP O
   
Right JJ B-NP B-problem
bundle-branch JJ I-NP I-problem
block NN I-NP I-problem
. . B-VP O
   
Indeterminate NNP B-NP B-problem
frontal JJ B-NP I-problem
plane NN I-NP I-problem
QRS NNP I-NP I-problem
axis NN I-NP I-problem
. . B-VP O
   
Compared VBN O O
to TO O O
the DT B-NP B-test
previous JJ I-NP I-test
tracing NN I-NP I-test
of IN B-VP O
2017-10-12 JJ B-NP O
multiple JJ I-NP B-problem
abnormalities NNS I-NP I-problem
as IN B-VP O
previously RB O O
noted VBN O O
persist NN B-NP O
without IN B-VP O
major JJ B-NP B-problem
change NN I-NP I-problem
. . B-VP O
   
Read VBN O O
by IN B-VP O
: : O O
Dunn NNP B-NP B-person
, , O I-person
Rachel NNP B-NP I-person
Finch NNP I-NP I-person
Intervals NNP I-NP B-test
Axes NNP I-NP I-test
Rate NNP I-NP B-test
PR NNP I-NP B-test
QRS NNP I-NP B-test
QT/QTc NNP I-NP B-test
P NNP I-NP B-test
QRS NNP I-NP B-test
T NNP I-NP B-test
57 CD O O
0 CD O O
154 CD O O
670-32166 JJ B-NP O
-37 NNP I-NP O
2018-08-03 CD O O
5:40 CD O O
pm NN B-NP O
SEROLOGY/BLOOD NNP I-NP B-test
Source NN I-NP O
: : O O
Line-central JJ O B-treatment
. . B-VP O
   
** JJ B-NP O
FINAL NNP I-NP O
REPORT NNP I-NP O
2018-08-06 JJ B-NP O
** NNP I-NP O
HELICOBACTER NNP I-NP B-test
PYLORI NNP I-NP I-test
ANTIBODY NNP I-NP I-test
TEST NNP I-NP I-test
( ( O O
Final NNP B-NP O
2018-08-06 CD O O
) ) O O
: : O O
NEGATIVE VBN O O
BY NNP B-NP O
EIA NNP I-NP O
. . B-VP O
   
( ( O O
Reference NNP B-NP O
Range-Negative NNP I-NP O
) ) O O
. . B-VP O
   
GI NNP B-NP B-test
bleed VBD B-VP I-test
study SYM O I-test
- : O O
IMPRESSION NN B-NP O
: : O O
Active JJ B-NP B-problem
radiotracer NN I-NP I-problem
activity NN I-NP I-problem
in IN B-VP I-problem
the DT B-NP I-problem
right NN I-NP I-problem
lower RBR O I-problem
quadrant NN B-NP I-problem
in IN B-VP O
a DT B-NP O
serpingneous JJ I-NP O
f JJ I-NP O
fashion NN I-NP O
suggestive NN I-NP O
of IN B-VP O
distal JJ B-NP O
small JJ I-NP O
bowel NN I-NP O
. . B-VP O
   
EGD NNP B-NP B-test
- : O O
Impression NN B-NP O
: : O O
Angioectasias NNP B-NP B-problem
in IN B-VP I-problem
the DT B-NP I-problem
fundus NN I-NP I-problem
Angioectasias NNP I-NP B-problem
in IN B-VP I-problem
the DT B-NP I-problem
antrum NN I-NP I-problem
Angioectasias NNP I-NP B-problem
in IN B-VP I-problem
the DT B-NP I-problem
proximal JJ I-NP I-problem
jejunum NN I-NP I-problem
and CC O I-problem
mid NN B-NP I-problem
jejunum NN I-NP I-problem
Angioectasia NNP I-NP B-problem
in IN B-VP I-problem
the DT B-NP I-problem
duodenum NN I-NP I-problem
Otherwise NNP I-NP O
normal JJ B-NP O
small JJ I-NP O
bowel NN I-NP O
enteroscopy NN I-NP O
to TO O O
mid VB O O
jejunum JJ B-NP O
Recommendations NNS I-NP O
: : O O
No DT B-NP O
site NN I-NP O
of IN B-VP O
active JJ B-NP B-problem
bleeding NN I-NP I-problem
was VBD B-VP O
seen VBN O O
. . B-VP O
   
The DT B-NP B-problem
fundal JJ I-NP I-problem
AVMs NNP I-NP I-problem
are VBP O O
a DT B-NP O
potential JJ I-NP O
site NN I-NP O
of IN B-VP O
bleeding VBG O B-problem
although IN B-VP O
do NN B-NP O
not RB O O
explain VB O O
the DT B-NP O
extent NN I-NP O
of IN B-VP O
bleeding NN B-NP B-problem
. . B-VP O
   
Consider VB O O
endoscopic JJ B-NP B-treatment
argon NN I-NP I-treatment
plasma NN I-NP I-treatment
therapy NN I-NP I-treatment
Proceed NNP I-NP O
with IN B-VP O
colonoscopy NN B-NP B-test
. . B-VP O
   
Colonoscopy NNP B-NP B-test
- : O O
Impression NN B-NP O
: : O O
Blood NN B-NP B-problem
in IN B-VP I-problem
the DT B-NP I-problem
colon NN I-NP I-problem
Grade NNP I-NP B-problem
1 CD O I-problem
external JJ B-NP I-problem
hemorrhoids NNS I-NP I-problem
Angioectasia NNP I-NP B-problem
in IN B-VP I-problem
the DT B-NP I-problem
colon NN I-NP I-problem
Diverticulosis NNP I-NP B-problem
of IN B-VP I-problem
the DT B-NP I-problem
colon NN I-NP I-problem
Otherwise NNP I-NP O
normal JJ B-NP O
colonoscopy NN I-NP O
to TO O O
cecum VB O O
Brief NNP B-NP O
Hospital NNP I-NP O
Course NNP I-NP O
: : O O
Blood NNP B-NP B-problem
loss NN I-NP I-problem
anemia NN I-NP I-problem
from IN B-VP O
GI NNP B-NP B-problem
bleeding VBG O I-problem
- : O O
the DT B-NP B-problem
bleeding NN I-NP I-problem
was VBD B-VP O
likely RB O O
from IN B-VP O
an DT B-NP B-problem
AVM NNP I-NP I-problem
. . B-VP O
   
EGD NNP B-NP B-test
, , O O
colonoscopy NN B-NP B-test
and CC O O
tagged VBD B-VP B-test
scan JJ B-NP I-test
results NNS I-NP O
as IN B-VP O
above JJ O O
. . B-VP O
   
eventhough JJ B-NP O
uptake NN I-NP O
was VBD B-VP O
noted VBN O O
in IN B-VP O
the DT B-NP O
rt NN I-NP O
LQ NNP I-NP O
, , O O
no DT B-NP O
clear JJ I-NP O
site NN I-NP O
of IN B-VP O
bleeding NN B-NP B-problem
was VBD B-VP O
noticed VBN O O
on IN B-VP O
colonoscopy NN B-NP B-test
. . B-VP O
   
hence NN B-NP O
, , O O
no DT B-NP O
intervention NN I-NP B-treatment
was VBD B-VP O
performed VBN O O
. . B-VP O
   
she PRP O B-person
was VBD B-VP O
transfused VBN O O
with IN B-VP O
5 CD O O
units NNS B-NP O
of IN B-VP O
PRBC NNP B-NP B-treatment
in IN B-VP O
the DT B-NP O
ICU NNP I-NP O
andsent NN I-NP O
to TO O O
the DT B-NP O
Lahey NNP I-NP O
Clinic NNP I-NP O
- : O O
North NN B-NP O
Shore NNP I-NP O
. . B-VP O
   
Her PRP$ O B-person
Her PRP$ O B-test
hematocrit NN B-NP I-test
remained VBD B-VP O
stable JJ O O
for IN B-VP O
4 CD O O
days NNS B-NP O
prior RB O O
to TO O O
discharge VB O O
. . B-VP O
   
No DT B-NP O
further JJ I-NP B-problem
bleeding NN I-NP I-problem
noted VBD B-VP O
. . B-VP O
   
GI NNP B-NP B-person
consult NN I-NP I-person
team NN I-NP I-person
followed VBD B-VP O
pt NN B-NP B-person
in IN B-VP O
hospital NN B-NP O
. . B-VP O
   
On IN B-VP O
discussion NN B-NP O
with IN B-VP O
Dr NNP B-NP B-person
Leigh NNP I-NP I-person
and CC O O
Dr NNP B-NP B-person
White NNP I-NP I-person
from IN B-VP O
GI NNP B-NP O
- : O O
they PRP O B-pronoun
recommended VBD B-VP O
that IN B-VP O
she PRP O B-person
follow VB O O
with IN B-VP O
Dr. NNP B-NP B-person
Taylor NNP I-NP I-person
for IN B-VP O
consideration NN B-NP O
of IN B-VP O
argon JJ B-NP B-treatment
photocoagulation NN I-NP I-treatment
as IN B-VP O
out-patient JJ O O
. . B-VP O
   
Given VBN O O
the DT B-NP O
innumerable JJ I-NP O
number NN I-NP O
of IN B-VP O
AVM NNP B-NP B-problem
's POS O I-problem
, , O O
it PRP O B-pronoun
is VBZ O O
diffcult VBN O O
to TO O O
assess VB O O
which WDT O B-pronoun
the DT B-NP B-problem
culprit NN I-NP I-problem
lesion NN I-NP I-problem
is VBZ O O
and CC O O
GI NNP B-NP O
may MD O O
start VB O O
APL NNP B-NP B-treatment
from IN B-VP I-treatment
the DT B-NP I-treatment
fundus NN I-NP I-treatment
of IN B-VP O
stomach NN B-NP O
. . B-VP O
   
Patient NN B-NP B-person
to TO O O
get VB O O
CBC NNP B-NP B-test
checked VBN O O
with IN B-VP O
PCP NNP B-NP B-person
this DT B-NP B-pronoun
week NN I-NP O
as IN B-VP O
below NN B-NP O
. . B-VP O
   
ASA NNP B-NP B-treatment
was VBD B-VP O
held VBN O O
and CC O O
may MD O O
be VB O O
restarted VBN O O
if IN B-VP O
Hct NNP B-NP B-test
stable JJ O O
in IN B-VP O
clinic NN B-NP O
at IN B-VP O
the DT B-NP O
PCP NNP I-NP B-person
's POS O O
discretion NN B-NP O
. . B-VP O
   
Chronic NNP B-NP B-problem
thrombocytopenia NN I-NP I-problem
was VBD B-VP O
noted VBN O O
, , O O
however RB O O
the DT B-NP B-person
patient NN I-NP I-person
did VBD B-VP O
not RB O O
require VB O O
platelet NN B-NP B-treatment
transfusions NNS I-NP I-treatment
. . B-VP O
   
Has VBZ O O
a DT B-NP O
h/o NN I-NP O
HIT NNP I-NP B-problem
. . B-VP O
   
The DT B-NP B-treatment
metoprolol NN I-NP I-treatment
was VBD B-VP O
held VBN O O
during IN B-VP O
acute JJ O B-problem
bleeding VBG O I-problem
phase NN B-NP I-problem
and CC O O
restarted VBD B-VP O
prior RB O O
to TO O O
discharge VB O O
as IN B-VP O
her PRP$ O B-person
her PRP$ O B-test
BP NNP B-NP I-test
stabilized NN I-NP O
. . B-VP O
   
Other JJ B-NP B-problem
medical JJ I-NP I-problem
problems NNS I-NP I-problem
stable JJ O O
. . B-VP O
   
Dialysis NN B-NP B-treatment
was VBD B-VP O
continued VBN O O
3 CD O O
/ JJ B-NP O
week NN I-NP O
. . B-VP O
   
I PRP O B-person
personally RB O O
talked VBD B-VP O
with IN B-VP O
Dr NNP B-NP B-person
Pannell NNP I-NP I-person
at IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
discharge NN B-NP O
to TO O O
update VB O O
him PRP O B-person
with IN B-VP O
the DT B-NP O
hospital NN I-NP O
events NNS I-NP O
. . B-VP O
   
Medications NNS B-NP O
on IN B-VP O
Admission NN B-NP O
: : O O
- : O O
Atorvastatin $ O B-treatment
80 CD O O
mg NN B-NP O
QD NNP I-NP O
- : O O
Hydroxyzine NNP B-NP B-treatment
HCl NNP I-NP I-treatment
25 CD O O
mg NN B-NP O
Tablet NNP I-NP O
PO NNP I-NP O
Q4-6H NNP I-NP O
PRN NNP I-NP O
for IN B-VP O
itching VBG O B-problem
- : O O
Levothyroxine NN B-NP B-treatment
175 CD O O
mcg NN B-NP O
PO NNP I-NP O
qd SYM O O
- : O O
Albuterol $ O B-treatment
90 CD O O
mcg JJ B-NP O
1-2 JJ I-NP O
Puffs NNP I-NP O
INH NNP I-NP O
q6hr NN I-NP O
PRN NNP I-NP O
- : O O
Nitroglycerin NN B-NP B-treatment
0.3 CD O O
mg NN B-NP O
Tablet NNP I-NP O
PRN NNP I-NP O
- : O O
Metoprolol NNP B-NP B-treatment
Tartrate NNP I-NP I-treatment
12.5 CD O O
mg NN B-NP O
BID NNP I-NP O
- : O O
B NN B-NP B-treatment
Complex NNP I-NP I-treatment
- : O O
Vitamin NNP B-NP B-treatment
C NNP I-NP I-treatment
- : O O
Folic NNP B-NP B-treatment
Acid NNP I-NP I-treatment
1 CD O O
mg NN B-NP O
Capsule NNP I-NP O
QD NNP I-NP O
- : O O
Insulin NNP B-NP B-treatment
NPH NNP I-NP I-treatment
75-25 JJ O O
20units CD O O
qAM NN B-NP O
and CC O O
humalog NN B-NP B-treatment
sliding VBG O I-treatment
scale JJ B-NP I-treatment
Discharge NNP I-NP O
Medications NNS I-NP O
: : O O
1. CD O O
Atorvastatin NNP B-NP B-treatment
80 CD O O
mg NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Tablet NNP B-NP O
PO NNP I-NP O
DAILY NNP I-NP O
( ( O O
Daily NNP B-NP O
) ) O O
. . B-VP O
   
2. CD O O
Albuterol NNP B-NP B-treatment
90 CD O O
mcg NN B-NP O
/ NNP I-NP O
Actuation NNP I-NP O
Aerosol NNP I-NP O
Sig NNP I-NP O
: : O O
1-2 JJ B-NP O
Puffs NNP I-NP O
Inhalation NNP I-NP O
Q6H NNP I-NP O
( ( O O
every DT O O
6 CD O O
hours NNS B-NP O
) ) O O
as IN B-VP O
needed VBN O O
. . B-VP O
   
3. CD O O
Levothyroxine JJ O B-treatment
175 CD O O
mcg JJ B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Tablet NNP B-NP O
PO NNP I-NP O
DAILY NNP I-NP O
( ( O O
Daily NNP B-NP O
) ) O O
. . B-VP O
   
4. CD O O
Hydroxyzine NNP B-NP B-treatment
HCl NNP I-NP I-treatment
25 CD O O
mg NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Tablet NNP B-NP O
PO NNP I-NP O
Q4-6H NNP I-NP O
( ( O O
every DT O O
4 CD O O
to TO O O
6 CD O O
hours NNS B-NP O
) ) O O
as IN B-VP O
needed VBN O O
. . B-VP O
   
5. CD O O
B-Complex JJ O B-treatment
with IN B-VP O
Vitamin NNP B-NP B-treatment
C NNP I-NP I-treatment
Tablet NNP I-NP I-treatment
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Tablet NNP B-NP O
PO NNP I-NP O
DAILY NNP I-NP O
( ( O O
Daily NNP B-NP O
) ) O O
. . B-VP O
   
6. CD O O
Menthol NNP B-NP B-treatment
- : O I-treatment
Cetylpyridinium NN B-NP I-treatment
Cl NNP I-NP I-treatment
2 CD O O
mg NN B-NP O
Lozenge NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Lozenge NNP B-NP O
Mucous NNP I-NP O
membrane NN I-NP O
PRN NNP I-NP O
( ( O O
as IN B-VP O
needed VBN O O
) ) O O
. . B-VP O
   
7. CD O O
Pantoprazole JJ O B-treatment
40 CD O O
mg JJ B-NP O
Tablet NNP I-NP O
, , O O
Delayed NNP B-NP O
Release NNP I-NP O
( ( O O
E.C. NNP B-NP O
) ) O O
Sig NN B-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Tablet NN B-NP O
, , O O
Delayed NNP B-NP O
Release NNP I-NP O
( ( O O
E.C. NNP B-NP O
) ) O O
PO NNP B-NP O
Q12H NNP I-NP O
( ( O O
every DT O O
12 CD O O
hours NNS B-NP O
) ) O O
. . B-VP O
   
8. CD O O
Nitroglycerin NNP B-NP B-treatment
0.3 CD O O
mg NN B-NP O
Tablet NNP I-NP O
, , O O
Sublingual NNP B-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Sublingual NNP B-NP O
as RB O O
needed VBD B-VP O
as IN B-VP O
needed VBN O O
for IN B-VP O
chest NN B-NP B-problem
pain NN I-NP I-problem
. . B-VP O
   
9. CD O O
Insulin NNP B-NP B-treatment
Continue NNP I-NP O
to TO O O
take VB O O
the DT B-NP B-treatment
insulin NN I-NP I-treatment
as IN B-VP O
you PRP O B-person
were VBD B-VP O
taking VBG O O
prior JJ O O
to TO O O
the DT B-NP O
hospital NN I-NP O
visit NN I-NP O
10. CD O O
Outpatient NNP B-NP B-test
Lab NNP I-NP I-test
Work NNP I-NP I-test
CBC NNP I-NP B-test
( ( O O
to TO O O
be VB O O
checked VBN O O
by IN B-VP O
Dr NNP B-NP B-person
Pannell NNP I-NP I-person
444-1034 JJ O O
on IN B-VP O
2018-08-10 JJ O O
) ) O O
11. CD O O
Metoprolol NNP B-NP B-treatment
Tartrate NNP I-NP I-treatment
25 CD O O
mg NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
0.5 CD O O
Tablet NNP B-NP O
PO NNP I-NP O
BID NNP I-NP O
( ( O O
2 CD O O
times NNS B-NP O
a DT B-NP O
day NN I-NP O
) ) O O
. . B-VP O
   
Discharge NNP B-NP O
Disposition NNP I-NP O
: : O O
Home NN B-NP O
with IN B-VP O
Service NNP B-NP O
Discharge NNP I-NP O
Diagnosis NNP I-NP O
: : O O
Acute JJ B-NP B-problem
blood NN I-NP I-problem
loss NN I-NP I-problem
anemia NN I-NP I-problem
from IN B-VP O
rectal JJ O B-problem
bleeding VBG O I-problem
Thrombocytopenia NNP B-NP B-problem
- : O I-problem
chronic JJ B-NP I-problem
Secondary JJ I-NP O
diagnosis NN I-NP O
- : O O
HTN NNP B-NP B-problem
DM NNP I-NP B-problem
type VBD B-VP I-problem
1 CD O I-problem
CKD NNP B-NP B-problem
stage NN I-NP I-problem
5 CD O I-problem
Hypothyroidism NNP B-NP B-problem
Asthma NNP I-NP B-problem
Coronary NNP I-NP B-problem
artery NN I-NP I-problem
disease NN I-NP I-problem
Discharge NNP I-NP O
Condition: NNP I-NP O
stable JJ O O
. . B-VP O
   
Discharge JJ B-NP O
Instructions NNS I-NP O
: : O O
Weigh NNP B-NP O
yourself PRP O B-person
every DT B-NP O
morning NN I-NP O
, , O O
call VB O O
MD NNP B-NP B-person
if IN B-VP O
weight VBN O B-problem
> VBP O I-problem
3 CD O I-problem
lbs NN B-NP I-problem
. . B-VP O
   
Adhere NNP B-NP O
to TO O O
2 CD O B-treatment
gm NNS B-NP I-treatment
sodium JJ B-NP I-treatment
diet JJ I-NP I-treatment
Do NNP I-NP O
not RB O O
take VB O O
the DT B-NP B-treatment
aspirin NN I-NP I-treatment
unless IN B-VP O
you PRP O B-person
see VBP O O
Dr NNP B-NP B-person
Pannell NNP I-NP I-person
. . B-VP O
   
Continue VB O O
to TO O O
take VB O O
the DT B-NP B-treatment
insulin NN I-NP I-treatment
as IN B-VP O
you PRP O B-person
were VBD B-VP O
taking VBG O O
prior JJ O O
to TO O O
hospital JJ B-NP O
visit NN I-NP O
. . B-VP O
   
Keep VB O O
your PRP$ O B-person
appointments NNS B-NP O
. . B-VP O
   
Please NNP B-NP O
see VB O O
your PRP$ O B-person
your PRP$ O B-person
doctor NN B-NP I-person
( ( O O
Dr NNP B-NP B-person
Pannell NNP I-NP I-person
) ) O O
on IN B-VP O
Friday NNP B-NP O
2018-08-10 JJ O O
for IN B-VP O
a DT B-NP B-test
blood NN I-NP I-test
test NN I-NP I-test
( ( O O
cbc NN B-NP B-test
) ) O O
. . B-VP O
   
He PRP O B-person
has VBZ O O
asked VBN O O
you PRP O B-person
call VBP O O
the DT B-NP O
clinic JJ I-NP O
Friday NNP I-NP O
morning NN I-NP O
for IN B-VP O
a DT B-NP O
same JJ I-NP O
day NN I-NP O
appointment NN I-NP O
. . B-VP O
   
Continue VB O O
the DT B-NP B-treatment
dialysis NN I-NP I-treatment
three CD O O
times NNS B-NP O
a DT B-NP O
week NN I-NP O
. . B-VP O
   
Return NN B-NP O
to TO O O
the DT B-NP O
hospital NN I-NP O
if IN B-VP O
you PRP O B-person
notice VBP O O
bleeding VBG O B-problem
or CC O O
any DT B-NP B-problem
other JJ I-NP I-problem
symptoms NNS I-NP I-problem
of IN B-VP O
concern NN B-NP O
to TO O O
you PRP O B-person
. . B-VP O
   
Followup JJ B-NP O
Instructions NNS I-NP O
: : O O
Provider NN B-NP O
: : O O
Kim NNP B-NP O
Phone NNP I-NP O
: : O O
512 CD O O
0199 CD O O
Date NNP B-NP O
/ JJ B-NP O
Time NN I-NP O
: : O O
2018-08-17 JJ O O
9:30 CD O O
Gastroenterology NNP B-NP O
- : O O
9092 CD O O
N. NNP B-NP O
Eighth NNP I-NP O
Cir. NNP I-NP O
, , O O
Wisecup NNP B-NP O
Rose NNP I-NP O
- : O O
1st CD O O
floor NN B-NP O
. . B-VP O
   
Provider NN B-NP B-person
: : O O
Michelle NNP B-NP B-person
Susan NNP I-NP I-person
, , O I-person
MD NNP B-NP I-person
Phone NNP I-NP O
: : O O
( ( O O
544 CD O O
) ) O O
439-6335 JJ B-NP O
Date NNP I-NP O
/ NN I-NP O
Time NN I-NP O
: : O O
2018-08-14 JJ O O
8:20 CD O O
Primary NNP B-NP B-person
doctor NN I-NP I-person
- : O O
Dr NNP B-NP B-person
Shirley NNP I-NP I-person
, , O I-person
James NNP B-NP I-person
M. NNP I-NP I-person
444-1034 JJ O O
- : O O
please NN B-NP O
see VB O O
your PRP$ O B-person
your PRP$ O B-person
doctor NN B-NP I-person
Mary NNP I-NP B-person
Powell NNP I-NP I-person
2018-08-10 JJ O O
for IN B-VP O
a DT B-NP B-test
blood NN I-NP I-test
test NN I-NP I-test
( ( O O
cbc NN B-NP B-test
) ) O O
. . B-VP O
   
Dialysis NN B-NP B-treatment
as IN B-VP O
scheduled VBN O O
. . B-VP O
   
Ruby NNP B-NP B-person
Charles NNP I-NP I-person
MD NNP I-NP I-person
75-829 NNP I-NP O
Completed VBN O O
by IN B-VP O
: : O O
William NNP B-NP B-person
Charles NNP I-NP I-person
MD NNP I-NP I-person
75-829 JJ B-NP O
2018-08-08 JJ I-NP O
@ NN I-NP O
0822 CD O O
Signed NNP B-NP O
electronically RB O O
by IN B-VP O
: : O O
DR. NNP B-NP B-person
Stoll NNP I-NP I-person
Delacy NNP I-NP I-person
on IN B-VP O
: : O O
Sandra NNP B-NP O
2018-08-09 CD O O
4:36 CD O O
PM NNP B-NP O
( ( O O
End NNP B-NP O
of IN B-VP O
Report NNP B-NP O
) ) O O
-EMPTYLINE- VBP O O
-DOCSTART- JJ O O
-EMPTYLINE- $ O O
017480654 CD O O
FIH NNP B-NP O
6160323 CD O O
59147/s876 CD O O
971818 CD O O
2/15/1994 CD O O
12:00:00 CD O O
AM NNP B-NP O
CHRONIC NNP I-NP B-problem
MYELOMONOCYTIC NNP I-NP I-problem
LEUKEMIA NNP I-NP I-problem
, , O O
WITHOUT NNP B-NP O
REMISSION NNP I-NP O
, , O O
Unsigned VBD B-VP O
DIS NNP B-NP O
Report NNP I-NP O
Status NNP I-NP O
: : O O
Unsigned VBN O O
ADMISSION NNP B-NP O
DATE NNP I-NP O
: : O O
2/15/94 CD O O
DISCHARGE NNP B-NP O
DATE NNP I-NP O
: : O O
2/28/94 CD O O
PRINCIPAL NNP B-NP O
DIAGNOSIS NNP I-NP O
: : O O
Chronic NNP B-NP B-problem
myelomonocytic JJ B-NP I-problem
leukemia NN I-NP I-problem
, , O O
without IN B-VP O
remission NN B-NP O
, , O O
atrial JJ B-NP B-problem
fibrillation NN I-NP I-problem
, , O O
chronic JJ B-NP B-problem
airway NN I-NP I-problem
obstruction NN I-NP I-problem
, , O O
hypopotassemia NN B-NP B-problem
, , O O
cellulitis NN B-NP B-problem
, , O O
orbital JJ B-NP B-problem
hemorrhage NN I-NP I-problem
, , O O
protein NN B-NP B-problem
calorie NN I-NP I-problem
malnutrition NN I-NP I-problem
, , O O
gastrointestinal JJ B-NP B-problem
hemorrhage NN I-NP I-problem
, , O O
pulmonary JJ B-NP B-problem
hemorrhage NN I-NP I-problem
/ NNP I-NP O
pneumonia NN I-NP B-problem
, , O O
hyperglycemia NN B-NP B-problem
, , O O
renal JJ B-NP B-problem
insufficiency NN I-NP I-problem
, , O O
hyperuricemia NN B-NP B-problem
, , O O
hypophosphatemia NN B-NP B-problem
. . B-VP O
   
HISTORY NNP B-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS NNP I-NP O
: : O O
This DT O B-pronoun
This DT O B-person
75 CD O I-person
year NN B-NP I-person
old JJ B-NP I-person
male NN I-NP I-person
had VBD B-VP O
been VBN O O
noted VBN O O
to TO O O
be VB O O
anemic JJ O B-problem
with IN B-VP O
an DT B-NP B-problem
abnormal JJ I-NP I-problem
white JJ I-NP I-problem
blood NN I-NP I-problem
count NN I-NP I-problem
since IN B-VP O
at IN B-VP O
least JJS B-NP O
November NNP I-NP O
1993 CD O O
, , O O
while IN B-VP O
he PRP O B-person
was VBD B-VP O
living VBG O O
in IN B-VP O
Aersing NNP B-NP O
Rocuch NNP I-NP O
Sun NNP I-NP O
and CC O O
his PRP$ O B-person
his PRP$ O B-person
physicians NNS B-NP I-person
there EX O B-pronoun
had VBD B-VP O
begun VBN O O
to TO O O
manage VB O O
him PRP O B-person
with IN B-VP O
transfusions NNS B-NP B-treatment
, , O O
and CC O O
low JJ B-NP B-treatment
dose JJ I-NP I-treatment
hydroxyurea NN I-NP I-treatment
. . B-VP O
   
Apparently RB O O
, , O O
a DT B-NP B-test
bone NN I-NP I-test
marrow NN I-NP I-test
biopsy NN I-NP I-test
at IN B-VP O
the DT B-NP O
time NN I-NP O
confirmed VBD B-VP O
the DT B-NP O
diagnosis NN I-NP O
of IN B-VP O
chronic JJ B-NP B-problem
myelomonocytic JJ I-NP I-problem
leukemia NN I-NP I-problem
. . B-VP O
   
He PRP O B-person
came VBD B-VP O
to TO O O
this DT B-NP B-pronoun
country NN I-NP O
in IN B-VP O
late JJ B-NP O
December NNP I-NP O
1994 CD O O
to TO O O
live VB O O
with IN B-VP O
his PRP$ O B-person
his PRP$ O B-person
son NN B-NP I-person
for IN B-VP O
a DT B-NP O
few JJ I-NP O
months NNS I-NP O
and CC O O
was VBD B-VP O
referred VBN O O
to TO O O
me PRP O B-person
for IN B-VP O
follow VB O O
up RB O O
. . B-VP O
   
He PRP O B-person
had VBD B-VP O
been VBN O O
noting VBG O O
night NN B-NP B-problem
sweats NNS I-NP I-problem
, , O O
increasing VBG O B-problem
fatigue NN B-NP I-problem
, , O O
anorexia NN B-NP B-problem
, , O O
and CC O O
dyspnea NN B-NP B-problem
, , O O
which WDT O B-pronoun
were VBD B-VP O
not RB O O
particularly RB O O
improved VBN O O
by IN B-VP O
increased JJ B-NP B-treatment
transfusions NNS I-NP I-treatment
or CC O O
alterations NNS B-NP O
of IN B-VP O
hydroxy JJ B-NP B-treatment
urea NN I-NP I-treatment
. . B-VP O
   
He PRP O B-person
became VBD B-VP O
profoundly RB O B-problem
thrombocytopenic JJ O I-problem
, , O O
and CC O O
ultimately RB O O
was VBD B-VP O
admitted VBN O O
to TO O O
the DT B-NP O
hospital NN I-NP O
on IN B-VP O
2/15 CD O O
with IN B-VP O
headache NN B-NP B-problem
and CC O O
weakness NN B-NP B-problem
. . B-VP O
   
PAST NNP B-NP O
MEDICAL NNP I-NP O
HISTORY NNP I-NP O
: : O O
Significant NN B-NP O
for IN B-VP O
chronic JJ B-NP B-problem
atrial JJ I-NP I-problem
fibrillation NN I-NP I-problem
, , O O
managed VBD B-VP O
with IN B-VP O
an DT B-NP O
Italian JJ I-NP O
variation NN I-NP O
of IN B-VP O
Digoxin NNP B-NP B-treatment
, , O O
and CC O O
Amioadrone NNP B-NP B-treatment
, , O O
hypertension NN B-NP B-problem
managed VBD B-VP O
with IN B-VP O
an DT B-NP B-treatment
ACE NNP I-NP I-treatment
inhibitor NN I-NP I-treatment
, , O O
chronic JJ B-NP B-problem
obstructive JJ I-NP I-problem
pulmonary JJ I-NP I-problem
disease NN I-NP I-problem
managed VBD B-VP O
with IN B-VP O
a DT B-NP B-treatment
zanthine NN I-NP I-treatment
preparation NN I-NP I-treatment
and CC O O
low JJ B-NP B-treatment
dose NN I-NP I-treatment
steroids NNS I-NP I-treatment
, , O O
as RB O O
well RB O O
as IN B-VP O
an DT B-NP B-treatment
occasional JJ I-NP I-treatment
inhaler NN I-NP I-treatment
. . B-VP O
   
Other JJ B-NP B-problem
medical JJ I-NP I-problem
problems NNS I-NP I-problem
included VBD B-VP O
chronic JJ B-NP B-problem
liver NN I-NP I-problem
disease NN I-NP I-problem
of IN B-VP O
uncertain JJ B-NP O
etiology NN I-NP O
, , O O
for IN B-VP O
which WDT O B-pronoun
he PRP O B-person
had VBD B-VP O
been VBN O O
advised VBN O O
not RB O O
to TO O O
drink VB O O
any DT B-NP O
alcohol NN I-NP O
. . B-VP O
   
He PRP O B-person
also RB O O
had VBD B-VP O
a DT B-NP B-problem
penetrating JJ I-NP I-problem
injury NN I-NP I-problem
to TO O I-problem
the DT B-NP I-problem
right NN I-NP I-problem
eye NN I-NP I-problem
, , O O
which WDT O B-pronoun
had VBD B-VP O
rendered VBN O O
him PRP O B-person
blind IN B-VP B-problem
10 CD O O
years NNS B-NP O
previously RB O O
. . B-VP O
   
PHYSICAL JJ B-NP O
EXAMINATION NN I-NP O
: : O O
He PRP O B-person
was VBD B-VP O
a DT O O
chronically RB O O
ill JJ O O
appearing VBG O O
elderly JJ B-NP O
man NN I-NP O
, , O O
with IN B-VP O
a DT B-NP B-test
respiratory JJ I-NP I-test
rate NN I-NP I-test
of IN B-VP O
30 CD O O
, , O O
temperature NN B-NP B-test
99.6 CD O O
, , O O
pulse RB O B-test
100 CD O O
, , O O
and CC O O
irregularly RB O B-problem
irregular JJ O I-problem
, , O O
blood NN B-NP B-test
pressure NN I-NP I-test
148/71 CD O O
. . B-VP O
   
He PRP O B-person
had VBD B-VP O
some DT B-NP B-problem
petechiae NN I-NP I-problem
on IN B-VP I-problem
his PRP$ O B-person
his PRP$ O I-problem
extremities NNS B-NP I-problem
, , O O
as RB O O
well RB O O
as IN B-VP O
in IN B-VP O
his PRP$ O B-person
mucosal NN B-NP O
membranes NNS I-NP O
with IN B-VP O
some DT B-NP B-problem
hemorrhagic JJ I-NP I-problem
bullae NN I-NP I-problem
. . B-VP O
   
There EX O O
were VBD B-VP O
bibasilar JJ B-NP B-problem
rales NNS I-NP I-problem
with IN B-VP O
some DT B-NP B-problem
wheezing NN I-NP I-problem
. . B-VP O
   
He PRP O B-person
had VBD B-VP O
no DT B-NP O
cardiac JJ I-NP B-problem
murmur NN I-NP I-problem
. . B-VP O
   
His PRP$ O B-person
abdomen NN B-NP O
was VBD B-VP O
distended VBN O B-problem
with IN B-VP O
massive JJ B-NP B-problem
hepatosplenomegaly NN I-NP I-problem
, , O O
which WDT O B-pronoun
was VBD B-VP O
somewhat RB O B-problem
tender NN B-NP I-problem
. . B-VP O
   
The DT B-NP B-test
neurological JJ I-NP I-test
examination NN I-NP I-test
aside RB O O
from IN B-VP O
the DT B-NP B-problem
blind NN I-NP I-problem
right JJ B-NP I-problem
eye NN I-NP I-problem
was VBD B-VP O
unremarkable JJ O O
. . B-VP O
   
LABORATORY NNP B-NP O
DATA NNP I-NP O
: : O O
Included VBD B-VP O
a DT B-NP B-test
white JJ I-NP I-test
blood NN I-NP I-test
count NN I-NP I-test
of IN B-VP O
140,000 CD O O
, , O O
7% CD O B-test
polys NN B-NP I-test
, , O O
1% CD O B-test
bands NNS B-NP I-test
, , O O
3% CD O B-test
lymphs NN B-NP I-test
, , O O
1% CD O B-test
monos NNS B-NP I-test
, , O O
2 CD O B-test
basos NN B-NP I-test
, , O O
4 CD O B-test
blasts NNS B-NP I-test
, , O O
76% CD O B-test
pearl NN B-NP I-test
monocytes NNS I-NP I-test
, , O O
6% CD O B-test
meta NN B-NP I-test
&apos;s NN I-NP I-test
, , O O
3 CD O B-test
nucleated VBN O I-test
red JJ B-NP I-test
blood NN I-NP I-test
cells NNS I-NP I-test
. . B-VP O
   
There EX O B-pronoun
were VBD B-VP O
some DT B-NP O
oval JJ I-NP B-problem
tear JJ I-NP I-problem
drop NN I-NP I-problem
cells NNS I-NP I-problem
and CC O O
target NN B-NP B-problem
cells NNS I-NP I-problem
with IN B-VP O
a DT B-NP B-problem
few JJ I-NP I-problem
schistocytes NNS I-NP I-problem
. . B-VP O
   
The DT B-NP B-test
platelet NN I-NP I-test
count NN I-NP I-test
was VBD B-VP O
9,000 CD O O
, , O O
hematocrit NN B-NP B-test
was VBD B-VP O
26.5 CD O O
, , O O
with IN B-VP O
an DT B-NP B-test
mean JJ I-NP I-test
corpuscular JJ I-NP I-test
volume NN I-NP I-test
of IN B-VP O
about IN B-VP O
73 CD O O
. . B-VP O
   
His PRP$ O B-person
His PRP$ O B-test
prothrombin NN B-NP I-test
time NN I-NP I-test
and CC O O
partial JJ B-NP B-test
thromboplastin NN I-NP I-test
time NN I-NP I-test
were VBD B-VP O
normal JJ O O
. . B-VP O
   
His PRP$ O B-person
His PRP$ O B-test
uric JJ B-NP I-test
acid NN I-NP I-test
was VBD B-VP O
up RB O O
at IN B-VP O
97 CD O O
, , O O
his PRP$ O B-person
his PRP$ O B-test
total JJ B-NP I-test
bilirubin NN I-NP I-test
was VBD B-VP O
up RB O O
at IN B-VP O
1.8 CD O O
, , O O
his PRP$ O B-person
his PRP$ O B-test
LDH NNP B-NP I-test
was VBD B-VP O
428 CD O O
, , O O
his PRP$ O B-person
his PRP$ O B-test
phosphorus NN B-NP I-test
was VBD B-VP O
1.2 CD O O
, , O O
calcium NN B-NP B-test
8.6 CD O O
, , O O
Digoxin NNP B-NP B-test
level NN I-NP I-test
was VBD B-VP O
1.0 CD O O
, , O O
potassium NN B-NP B-test
on IN B-VP O
admission NN B-NP O
was VBD B-VP O
2.9 CD O O
, , O O
sodium NN B-NP B-test
135 CD O O
, , O O
BUN NNP B-NP B-test
and CC O O
creatinine VB O B-test
13/1.6 CD O O
, , O O
and CC O O
sugar NN B-NP B-test
of IN B-VP O
267 CD O O
. . B-VP O
   
A DT B-NP B-test
computerized JJ I-NP I-test
tomography NN I-NP I-test
scan NN I-NP I-test
of IN B-VP O
his PRP$ O B-person
head NN B-NP O
showed VBD B-VP O
no DT B-NP O
signs NNS I-NP O
of IN B-VP O
an DT B-NP B-problem
acute JJ I-NP I-problem
bleed NN I-NP I-problem
, , O O
a DT B-NP B-test
chest NN I-NP I-test
X-ray NN I-NP I-test
showed VBD B-VP O
no DT B-NP O
new JJ I-NP B-problem
infiltrates NNS I-NP I-problem
or CC O O
masses NNS B-NP B-problem
. . B-VP O
   
There EX O O
was VBD B-VP O
cardiomegaly NN B-NP B-problem
with IN B-VP O
prominent JJ B-NP B-problem
vascularity NN I-NP I-problem
, , O O
but CC O O
no DT B-NP O
effusions NNS I-NP B-problem
. . B-VP O
   
An DT B-NP B-test
electrocardiogram NN I-NP I-test
was VBD B-VP O
consistent JJ O O
with IN B-VP O
atrial JJ B-NP B-problem
fibrillation NN I-NP I-problem
. . B-VP O
   
HOSPITAL NNP B-NP O
COURSE NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
admitted VBN O O
to TO O O
the DT B-NP O
hospital NN I-NP O
and CC O O
begun VBN O O
on IN B-VP O
high JJ B-NP B-treatment
dose JJ I-NP I-treatment
Hydroxyurea NNP I-NP I-treatment
, , O O
with IN B-VP O
a DT B-NP O
gradual JJ I-NP O
improvement NN I-NP O
in IN B-VP O
his PRP$ O B-person
his PRP$ O B-test
white JJ B-NP I-test
blood NN I-NP I-test
count NN I-NP I-test
over IN B-VP O
the DT B-NP O
next JJ I-NP O
few JJ I-NP O
days NNS I-NP O
. . B-VP O
   
He PRP O B-person
did VBD B-VP O
spike VB O O
a DT B-NP B-problem
fever NN I-NP I-problem
and CC O O
began VBD B-VP O
Ancef NNP B-NP B-treatment
and CC O O
Gentamicin NNP B-NP B-treatment
, , O O
although IN B-VP O
cultures NNS B-NP B-test
never RB O O
revealed VBD B-VP O
a DT B-NP O
source NN I-NP O
for IN B-VP O
this DT O B-pronoun
. . B-VP O
   
He PRP O B-person
also RB O O
tried VBD B-VP O
Amicar NNP B-NP B-treatment
and CC O O
continued VBN O O
on IN B-VP O
low JJ B-NP B-treatment
dose NN I-NP I-treatment
Prednisone NNP I-NP I-treatment
. . B-VP O
   
His PRP$ O B-person
His PRP$ O B-problem
headache NN B-NP I-problem
improved VBD B-VP O
, , O O
but CC O O
her PRP$ O B-person
remained VBD B-VP O
profoundly RB O B-problem
weak JJ O I-problem
and CC O O
intermittently RB O B-problem
febrile JJ O I-problem
with IN B-VP O
dyspnea NN B-NP B-problem
. . B-VP O
   
There EX O O
was VBD B-VP O
hemoptysis NN B-NP B-problem
and CC O O
intermittent JJ B-NP B-problem
gastrointestinal JJ I-NP I-problem
bleeding NN I-NP I-problem
, , O O
while IN B-VP O
he PRP O B-person
remained VBD B-VP O
profoundly RB O B-problem
thrombocytopenia JJ O I-problem
. . B-VP O
   
Transfusions NNS B-NP B-treatment
of IN B-VP I-treatment
platelets NNS B-NP I-treatment
did VBD B-VP O
not RB O O
change VB O O
his PRP$ O B-person
his PRP$ O B-test
platelet NN B-NP I-test
count NN I-NP I-test
, , O O
presumably RB O O
because IN B-VP O
of IN B-VP O
sequestration NN B-NP B-problem
and CC O O
a DT B-NP B-problem
massive JJ I-NP I-problem
spleen NN I-NP I-problem
. . B-VP O
   
Amicar NNP B-NP B-treatment
was VBD B-VP O
of IN B-VP O
uncertain JJ B-NP O
value NN I-NP O
, , O O
but CC O O
used VBD B-VP O
intermittently RB O O
. . B-VP O
   
A DT B-NP B-test
bone NN I-NP I-test
marrow NN I-NP I-test
biopsy NN I-NP I-test
revealed VBD B-VP O
the DT B-NP O
transformation NN I-NP O
of IN B-VP O
his PRP$ O B-person
his PRP$ O B-problem
CMML NNP B-NP I-problem
to TO O O
acute VB O B-problem
myelogenous JJ B-NP I-problem
leukemia NN I-NP I-problem
, , O O
and CC O O
given VBN O O
his PRP$ O B-person
his PRP$ O B-problem
other JJ B-NP I-problem
underlying JJ I-NP I-problem
medical JJ I-NP I-problem
problems NNS I-NP I-problem
, , O O
we PRP O B-person
chose VBD B-VP O
chemotherapy NN B-NP B-treatment
with IN B-VP O
subcutaneous JJ B-NP B-treatment
Cystosine NNP I-NP I-treatment
Arabinoside NNP I-NP I-treatment
and CC O O
6-Thioguanine NNP B-NP B-treatment
, , O O
which WDT O B-pronoun
he PRP O B-person
tolerated VBD B-VP O
without IN B-VP O
incident NN B-NP O
and CC O O
this DT O B-pronoun
brought VBD B-VP O
his PRP$ O B-person
his PRP$ O B-test
white JJ B-NP I-test
blood NN I-NP I-test
count NN I-NP I-test
down RB O O
to TO O O
below IN B-VP O
1,000 CD O O
, , O O
and CC O O
his PRP$ O B-person
spleen JJ B-NP O
shrank NN I-NP O
noticeably RB O O
, , O O
but CC O O
he PRP O B-person
still RB O O
could MD O O
not RB O O
maintain VB O O
a DT B-NP O
bump NN I-NP O
in IN B-VP O
platelet NN B-NP B-test
count NN I-NP I-test
with IN B-VP O
platelet NN B-NP B-treatment
transfusions NNS I-NP I-treatment
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
intermittently RB O B-problem
congested VBN O I-problem
limiting VBG O O
our PRP$ O B-person
ability NN B-NP O
to TO O O
give VB O O
intravenous JJ B-NP B-treatment
fluid NN I-NP I-treatment
, , O O
for IN B-VP O
his PRP$ O B-person
his PRP$ O B-treatment
hydrea NN B-NP I-treatment
, , O O
although IN B-VP O
we PRP O B-person
kept VBD B-VP O
him PRP O B-person
on IN B-VP O
Allopurinol NNP B-NP B-treatment
. . B-VP O
   
The DT B-NP O
renal JJ I-NP O
function NN I-NP O
deteriorated VBD B-VP O
somewhat RB O O
, , O O
hampering VBG O O
our PRP$ O B-person
ability NN B-NP O
to TO O O
give VB O O
him PRP O B-person
his PRP$ O B-person
his PRP$ O B-treatment
Gentamicin NNP B-NP I-treatment
. . B-VP O
   
The DT B-NP B-person
family NN I-NP I-person
maintained VBD B-VP O
an DT B-NP O
extraordinary JJ I-NP O
vigil NN I-NP O
over IN B-VP O
the DT B-NP O
days NNS I-NP O
of IN B-VP O
his PRP$ O B-person
hospitalization NN B-NP O
, , O O
providing VBG O O
him PRP O B-person
with IN B-VP O
some DT B-NP O
food NN I-NP O
and CC O O
constant JJ B-NP O
attention NN I-NP O
, , O O
while IN B-VP O
we PRP O B-person
awaited VBD B-VP O
the DT B-NP O
results NNS I-NP O
of IN B-VP O
his PRP$ O B-person
his PRP$ O B-treatment
chemotherapy NN B-NP I-treatment
and CC O O
treatment NN B-NP B-treatment
of IN B-VP O
his PRP$ O B-person
his PRP$ O B-problem
infection NN B-NP I-problem
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
intermittently RB O B-problem
restless JJ O I-problem
and CC O O
somewhat RB O B-problem
confused JJ O I-problem
, , O O
and CC O O
as IN B-VP O
his PRP$ O B-person
respiratory NN B-NP O
status NN I-NP O
deteriorated VBN O O
, , O O
the DT B-NP B-person
family NN I-NP I-person
agreed VBD B-VP O
to TO O O
a DT B-NP B-treatment
low JJ I-NP I-treatment
dose JJ I-NP I-treatment
Morphine NNP I-NP I-treatment
drip NN I-NP I-treatment
which WDT O B-pronoun
made VBD B-VP O
him PRP O B-person
much RB O O
more RBR O O
comfortable JJ O O
. . B-VP O
   
They PRP O B-pronoun
agreed VBD B-VP O
with IN B-VP O
a DT B-NP O
do NN I-NP O
not RB O O
resuscitate VB O O
status NN B-NP O
early RB O O
on IN B-VP O
in IN B-VP O
the DT B-NP O
hospitalization NN I-NP O
and CC O O
in IN B-VP O
the DT B-NP O
course NN I-NP O
of IN B-VP O
being VBG O O
maintain VBN O O
on IN B-VP O
low JJ B-NP B-treatment
dose JJ I-NP I-treatment
Morphine NNP I-NP I-treatment
, , O O
he PRP O B-person
ultimately RB O O
expired VBD B-VP O
on IN B-VP O
2/28/94 CD O O
with IN B-VP O
the DT B-NP B-person
family NN I-NP I-person
present NN I-NP O
. . B-VP O
   
No DT B-NP O
autopsy NN I-NP B-test
was VBD B-VP O
obtained VBN O O
. . B-VP O
   
LENNI NNP B-NP B-person
BREUTZOLN NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
TR NNP I-NP O
: : O O
lj NN B-NP O
/ NNP I-NP O
bmot NN I-NP O
DD NNP I-NP O
: : O O
3/12/94 CD O O
TD NN B-NP O
: : O O
03/13/94 CD O O
CC NN B-NP O
: : O O
Dr. NNP B-NP B-person
Ca NNP I-NP I-person
Shuff NNP I-NP I-person
, , O O
FIH NNP B-NP O
Oregon NNP I-NP O
Dr. NNP I-NP B-person
Ille NNP I-NP I-person
Kote NNP I-NP I-person
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- VBD B-VP O
395715290 CD O O
PUOMC NNP B-NP O
2681723 CD O O
64704/9r71 CD O O
946667 CD O O
4/6/1995 CD O O
12:00:00 CD O O
AM NNP B-NP O
ACUTE NNP I-NP B-problem
MYOCARDIAL NNP I-NP I-problem
INFARCTION NNP I-NP I-problem
. . B-VP O
   
Unsigned VBD B-VP O
DIS NNP B-NP O
Report NNP I-NP O
Status NNP I-NP O
: : O O
Unsigned VBN O O
ADMISSION NNP B-NP O
DATE NNP I-NP O
: : O O
4/6/95 CD O O
DISCHARGE NNP B-NP O
DATE NNP I-NP O
: : O O
4/16/95 CD O O
PRINCIPAL NNP B-NP O
DIAGNOSIS NNP I-NP O
: : O O
Acute NNP B-NP B-problem
myocardial JJ B-NP I-problem
infarction NN I-NP I-problem
. . B-VP O
   
ASSOCIATED CC O O
DIAGNOSIS NNP B-NP O
: : O O
status NN B-NP O
post NN I-NP O
aortic JJ B-NP B-treatment
valve NN I-NP I-treatment
replacement NN I-NP I-treatment
, , O O
status NN B-NP O
post NN I-NP O
coronary JJ B-NP B-treatment
artery NN I-NP I-treatment
bypass NN I-NP I-treatment
grafting NN I-NP I-treatment
. . B-VP O
   
PRINCIPAL JJ B-NP O
PROCEDURE NN I-NP O
: : O O
Percutaneous JJ B-NP B-treatment
angioplasty NN I-NP I-treatment
of IN B-VP I-treatment
the DT B-NP I-treatment
right JJ I-NP I-treatment
coronary JJ I-NP I-treatment
artery NN I-NP I-treatment
, , O O
4/9/95 CD O O
. . B-VP O
   
OTHER NN B-NP O
PROCEDURES NNP I-NP O
: : O O
directional JJ B-NP B-treatment
angioplasty NN I-NP I-treatment
of IN B-VP I-treatment
the DT B-NP I-treatment
right JJ I-NP I-treatment
coronary JJ I-NP I-treatment
artery NN I-NP I-treatment
, , O I-treatment
left VBD B-VP I-treatment
main JJ O I-treatment
and CC O I-treatment
left VBD B-VP I-treatment
anterior RP O I-treatment
descending VBG O I-treatment
vessels NNS B-NP I-treatment
. . B-VP O
   
4/11/95 CD O O
. . B-VP O
   
DOCTORS NNP B-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
: : O O
Lanoxin NN B-NP B-treatment
0.375 CD O O
mg. JJ O O
daily RB O O
. . B-VP O
   
Coumadin NNP B-NP B-treatment
as IN B-VP O
adjusted VBN O O
by IN B-VP O
Prothrombin NNP B-NP B-test
times NNS I-NP I-test
, , O O
Isordil NNP B-NP B-treatment
20 CD O O
mg. NN B-NP O
tid NN I-NP O
, , O O
Micronase NNP B-NP B-treatment
1.25 CD O O
mg. JJ O O
daily RB O O
, , O O
aspirin VBZ O B-treatment
81 CD O O
mg. JJ O O
daily RB O O
, , O O
nitroglycerin RB O B-treatment
0.3 CD O O
mg. NNS B-NP O
SL NNP I-NP O
prn NN I-NP O
. . B-VP O
   
HISTORY NNP B-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
is VBZ O O
a DT B-NP O
seventy NN I-NP O
two CD O O
year NN B-NP O
old JJ B-NP O
man NN I-NP O
who WP O B-person
a DT B-NP O
number NN I-NP O
of IN B-VP O
years NNS B-NP O
ago RB O O
underwent JJ B-NP O
coronary JJ I-NP B-treatment
bypass NN I-NP I-treatment
surgery NN I-NP I-treatment
at IN B-VP O
another DT B-NP O
institution NN I-NP O
. . B-VP O
   
This DT O B-pronoun
took VBD B-VP O
place NN B-NP O
in IN B-VP O
1983 CD O O
. . B-VP O
   
In IN B-VP O
1992 CD O O
he PRP O B-person
underwent VBD B-VP O
redo JJ B-NP B-treatment
surgery NN I-NP I-treatment
and CC O O
aortic JJ B-NP B-treatment
valve NN I-NP I-treatment
replacement NN I-NP I-treatment
. . B-VP O
   
In IN B-VP O
April NNP B-NP O
1994 CD O O
he PRP O B-person
presented VBD B-VP O
with IN B-VP O
an DT B-NP B-problem
acute JJ I-NP I-problem
inferior JJ I-NP I-problem
myocardial JJ I-NP I-problem
infarction NN I-NP I-problem
and CC O O
was VBD B-VP O
given VBN O O
Streptokinase NNP B-NP B-treatment
. . B-VP O
   
He PRP O B-person
had VBD B-VP O
recurrent NN B-NP B-problem
pain NN I-NP I-problem
and CC O O
went VBD B-VP O
to TO O O
the DT B-NP O
Catheter NNP I-NP O
Laboratory NNP I-NP O
where WRB O O
a DT B-NP B-problem
proximal JJ I-NP I-problem
right JJ I-NP I-problem
coronary JJ I-NP I-problem
artery NN I-NP I-problem
lesion NN I-NP I-problem
was VBD B-VP O
angioplastied VBN O O
. . B-VP O
   
A DT B-NP O
relook JJ I-NP O
several JJ I-NP O
days NNS I-NP O
later RB O O
led VBD B-VP O
to TO O O
a DT B-NP B-treatment
repeat NN I-NP I-treatment
percutaneous JJ B-NP I-treatment
transluminal JJ I-NP I-treatment
coronary JJ I-NP I-treatment
angioplasty NN I-NP I-treatment
. . B-VP O
   
He PRP O B-person
has VBZ O O
has VBZ O O
stable VBN O B-problem
, , O I-problem
mild JJ B-NP I-problem
angina NN I-NP I-problem
, , O O
subsequently RB O O
, , O O
mostly RB O O
in IN B-VP O
the DT B-NP O
setting NN I-NP O
of IN B-VP O
stress NN B-NP B-problem
. . B-VP O
   
Slightly RB O O
increased VBN O O
in IN B-VP O
recent JJ B-NP O
months NNS I-NP O
. . B-VP O
   
On IN B-VP O
the DT B-NP O
day NN I-NP O
of IN B-VP O
admission NN B-NP O
, , O O
he PRP O B-person
was VBD B-VP O
involved VBN O O
in IN B-VP O
a DT B-NP O
minor JJ I-NP O
motor NN I-NP O
vehicle NN I-NP O
accident NN I-NP O
, , O O
and CC O O
there EX O O
was VBD B-VP O
some DT B-NP O
apparent JJ I-NP O
controversy NN I-NP O
with IN B-VP O
the DT B-NP O
driver NN I-NP O
of IN B-VP O
the DT B-NP O
other JJ I-NP O
vehicle NN I-NP O
, , O O
during IN B-VP O
the DT B-NP O
course NN I-NP O
of IN B-VP O
which WDT O B-pronoun
he PRP O B-person
developed VBD B-VP O
substernal JJ B-NP B-problem
chest NN I-NP I-problem
pain NN I-NP I-problem
radiating VBG O O
to TO O O
the DT B-NP O
left JJ I-NP O
arm NN I-NP O
and CC O O
shoulder NN B-NP O
. . B-VP O
   
This DT O B-pronoun
waxed JJ O O
and CC O O
waned VBD B-VP O
for IN B-VP O
thirty NN B-NP O
to TO O O
sixty VB O O
minutes NNS B-NP O
, , O O
and CC O O
he PRP O B-person
took VBD B-VP O
a DT B-NP O
number NN I-NP O
of IN B-VP O
nitroglycerins NNS B-NP B-treatment
. . B-VP O
   
After IN B-VP O
returning VBG O O
home NN B-NP O
after IN B-VP O
conferring VBG O O
with IN B-VP O
his PRP$ O B-person
his PRP$ O B-person
wife NN B-NP I-person
, , O O
and CC O O
the DT B-NP B-problem
pain NN I-NP I-problem
lasted VBD B-VP O
another DT B-NP O
half JJ I-NP O
hour NN I-NP O
, , O O
he PRP O B-person
came VBD B-VP O
to TO O O
the DT B-NP O
emergency NN I-NP O
room NN I-NP O
. . B-VP O
   
His PRP$ O B-person
His PRP$ O B-test
electrocardiogram NN B-NP I-test
showed VBD B-VP O
increased VBN O B-problem
T NNP B-NP I-problem
wave VBP O I-problem
inversions NNS B-NP I-problem
in IN B-VP I-problem
V3 NNP B-NP I-problem
and CC O O
V4 NNP B-NP O
and CC O O
1 CD O O
mm NN B-NP O
. . B-VP O
   
ST NNP B-NP B-problem
segment NN I-NP I-problem
depression NN I-NP I-problem
in IN B-VP I-problem
V3 NNP B-NP I-problem
through IN B-VP O
V6 NNP B-NP O
. . B-VP O
   
His PRP$ O B-person
His PRP$ O B-test
examination NN B-NP I-test
was VBD B-VP O
largely RB O O
benign JJ O O
after IN B-VP O
he PRP O B-person
was VBD B-VP O
made VBN O O
pain NN B-NP B-problem
free JJ O O
. . B-VP O
   
The DT B-NP B-test
pulse NN I-NP I-test
was VBD B-VP O
75 CD O O
, , O O
blood NN B-NP B-test
pressure NN I-NP I-test
120/80 CD O O
, , O O
respirations NNS B-NP B-test
18 CD O O
, , O O
and CC O O
he PRP O B-person
was VBD B-VP O
afebrile RB O B-problem
. . B-VP O
   
The DT B-NP O
jugular JJ I-NP O
veins NNS I-NP O
were VBD B-VP O
not RB O O
distended VBN O B-problem
, , O O
the DT B-NP B-test
carotid NN I-NP I-test
volume NN I-NP I-test
was VBD B-VP O
diminished VBN O B-problem
. . B-VP O
   
The DT B-NP O
chest NN I-NP O
was VBD B-VP O
clear JJ O O
and CC O O
the DT B-NP O
cardiac JJ I-NP O
rhythm NN I-NP O
was VBD B-VP O
regular JJ O O
. . B-VP O
   
There EX O O
were VBD B-VP O
normal JJ B-NP B-treatment
prothetic JJ I-NP I-treatment
valves NNS I-NP I-treatment
. . B-VP O
   
There EX O O
was VBD B-VP O
a DT B-NP B-problem
grade JJ I-NP I-problem
II-II NNP I-NP I-problem
apical NN I-NP I-problem
and CC O I-problem
systolic JJ B-NP I-problem
murmur NN I-NP I-problem
. . B-VP O
   
The DT B-NP O
abdomen NNS I-NP O
was VBD B-VP O
negative JJ O O
and CC O O
there EX O O
was VBD B-VP O
no DT B-NP O
edema NN I-NP B-problem
of IN B-VP I-problem
the DT B-NP I-problem
feet NNS I-NP I-problem
. . B-VP O
   
The DT B-NP B-test
electrocardiogram NN I-NP I-test
demonstrated VBD B-VP O
normal JJ B-NP O
sinus NNS I-NP O
rhythm VBP O O
with IN B-VP O
poor JJ B-NP B-problem
R NNP I-NP I-problem
wave NN I-NP I-problem
progression NN I-NP I-problem
, , O O
left VBD B-VP B-problem
atrial JJ B-NP I-problem
enlargement NN I-NP I-problem
and CC O O
T NNP B-NP B-problem
wave VBP O I-problem
inversion NN B-NP I-problem
in IN B-VP I-problem
leads VBZ O I-problem
V NNP B-NP I-problem
4 CD O I-problem
, , O I-problem
5 CD O I-problem
, , O O
and CC O O
-EMPTYLINE- NNP B-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
Admission NNP I-NP O
Date NNP I-NP O
: : O O
2015-07-09 JJ B-NP O
Discharge NN I-NP O
Date NNP I-NP O
: : O O
2015-07-17 JJ B-NP O
Date NNP I-NP O
of IN B-VP O
Birth NNP B-NP O
: : O O
1947-06-29 JJ B-NP O
Sex NN I-NP O
: : O O
F NNP B-NP O
Service: NNP I-NP O
ADDENDUM NNP I-NP O
: : O O
Leona NNP B-NP B-person
Wheeler NNP I-NP I-person
had VBD B-VP O
continued VBN O O
episodes NNS B-NP O
of IN B-VP O
atrial JJ B-NP B-problem
fibrillation NN I-NP I-problem
which WDT O B-pronoun
were VBD B-VP O
treated VBN O O
with IN B-VP O
intravenous JJ B-NP B-treatment
Amiodarone NNP I-NP I-treatment
and CC O O
later RB O O
intravenous JJ B-NP B-treatment
Diltiazem NNP I-NP I-treatment
. . B-VP O
   
Her PRP$ O B-person
Her PRP$ O B-treatment
Lopressor NNP B-NP I-treatment
dose NN I-NP I-treatment
was VBD B-VP O
progressively RB O O
increased VBN O O
to TO O O
100 CD O O
mg NN B-NP O
tid NN I-NP O
. . B-VP O
   
Amiodarone $ O B-treatment
400 CD O O
mg NN B-NP O
tid NN I-NP O
was VBD B-VP O
continued VBN O O
as RB O O
well RB O O
. . B-VP O
   
Due JJ O O
to TO O O
this DT O B-problem
this DT O B-pronoun
continued VBN O I-problem
atrial JJ B-NP I-problem
fibrillation NN I-NP I-problem
, , O O
Leona NNP B-NP B-person
Wheeler NNP I-NP I-person
was VBD B-VP O
anticoagulated VBN O O
with IN B-VP O
intravenous JJ B-NP B-treatment
Heparin NNP I-NP I-treatment
. . B-VP O
   
Coumadin NNP B-NP B-treatment
dose NN I-NP I-treatment
was VBD B-VP O
started VBN O O
and CC O O
her PRP$ O B-person
her PRP$ O B-test
INR NNP B-NP I-test
were VBD B-VP O
followed VBN O O
. . B-VP O
   
These DT B-NP B-pronoun
episodes NNS I-NP O
of IN B-VP O
atrial JJ B-NP B-problem
fibrillation NN I-NP I-problem
have VBP O O
diminished VBN O O
and CC O O
she PRP O B-person
has VBZ O O
been VBN O O
in IN B-VP O
sinus NN B-NP O
rhythm NN I-NP O
for IN B-VP O
over IN B-VP O
24 CD O O
hours NNS B-NP O
now RB O O
. . B-VP O
   
At IN B-VP O
this DT B-NP B-pronoun
time NN I-NP O
Leona NNP I-NP B-person
Wheeler NNP I-NP I-person
was VBD B-VP O
felt VBN O O
stable JJ O O
to TO O O
be VB O O
transferred VBN O O
to TO O O
rehabilitation VB O O
facility NN B-NP O
. . B-VP O
   
She PRP O B-person
will MD O O
be VB O O
monitored VBN O O
with IN B-VP O
a DT B-NP B-test
King NNP I-NP I-test
of IN B-VP I-test
Hearts NNP B-NP I-test
monitor NN I-NP I-test
. . B-VP O
   
Changes NNS B-NP O
to TO O O
discharge VB O O
medications NNS B-NP O
: : O O
Metoprolol NNP B-NP B-treatment
100 CD O O
mg NN B-NP O
tid NN I-NP O
, , O O
Amiodarone NNP B-NP B-treatment
400 CD O O
mg NN B-NP O
tid NN I-NP O
times NNS I-NP O
7 CD O O
days NNS B-NP O
, , O O
then RB O O
bid VBD B-VP O
times NNS B-NP O
14 CD O O
days NNS B-NP O
, , O O
then RB O O
q VBZ O O
d JJ B-NP O
times NNS I-NP O
14 CD O O
days NNS B-NP O
, , O O
then RB O O
200 CD O O
mg NNS B-NP O
q JJ B-NP O
d NN I-NP O
. . B-VP O
   
DISCHARGE NNP B-NP O
CONDITION NNP I-NP O
: : O O
Stable JJ O O
. . B-VP O
   
DISCHARGE JJ B-NP O
STATUS NNP I-NP O
: : O O
Leona NNP B-NP B-person
Wheeler NNP I-NP I-person
is VBZ O O
to TO O O
be VB O O
transferred VBN O O
on IN B-VP O
2015-07-17 JJ O O
to TO O O
a DT B-NP O
rehabilitation NN I-NP O
facility NN I-NP O
. . B-VP O
   
DISCHARGE NNP B-NP O
DIAGNOSIS NNP I-NP O
: : O O
1. CD O O
Status NNP B-NP O
post NN I-NP O
CABG NNP I-NP B-treatment
times RB O O
four CD O O
. . B-VP O
   
Meghan NNP B-NP B-person
G. NNP I-NP I-person
Bardin NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
43-132 CD O O
Dictated VBN O O
By IN B-VP O
: : O O
Louise NNP B-NP B-person
B. NNP I-NP I-person
Robertson NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
MEDQUIST36 NNP I-NP O
D NNP I-NP O
: : O O
2015-07-17 JJ O O
08:39 CD O O
T NN B-NP O
: : O O
2015-07-22 JJ O O
10:29 CD O O
JOB NNP B-NP O
# # O O
: : O O
72575 CD O O
Signed VBN O O
electronically RB O O
by IN B-VP O
: : O O
DR. NNP B-NP B-person
Derek NNP I-NP I-person
Vildosola NNP I-NP I-person
on IN B-VP O
: : O O
WED JJ O O
2015-07-29 JJ O O
1:15 CD O O
PM NNP B-NP O
( ( O O
End NNP B-NP O
of IN B-VP O
Report NNP B-NP O
) ) O O
-EMPTYLINE- VBP O O
-DOCSTART- JJ O O
-EMPTYLINE- $ O O
086326823 CD O O
FIH NNP B-NP O
6708320 CD O O
235967 CD O O
594818 CD O O
8/24/1998 CD O O
12:00:00 CD O O
AM NNP B-NP O
Discharge NNP I-NP O
Summary NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Report NNP I-NP O
Status NNP I-NP O
: : O O
Signed VBD B-VP O
DISCHARGE NNP B-NP O
SUMMARY NNP I-NP O
NAME NN I-NP O
: : O O
RIEFF NNP B-NP B-person
, , O I-person
ALB NNP B-NP I-person
P NNP I-NP I-person
UNIT NNP I-NP O
NUMBER NNP I-NP O
: : O O
185-64-30 JJ B-NP O
ADMISSION NNP I-NP O
DATE NNP I-NP O
: : O O
08/24/1998 CD O O
DISCHARGE NNP B-NP O
DATE NNP I-NP O
: : O O
09/14/1998 CD O O
PRINCIPAL NNP B-NP O
DIAGNOSIS NNP I-NP O
: : O O
Sternal JJ B-NP B-problem
wound NN I-NP I-problem
infection NN I-NP I-problem
. . B-VP O
   
ASSOCIATED NNP B-NP O
DIAGNOSES NNP I-NP O
: : O O
Infected VBN O B-problem
aortic JJ B-NP I-problem
graft NN I-NP I-problem
. . B-VP O
   
Hypertension NNP B-NP B-problem
. . B-VP O
   
PRINCIPAL NNP B-NP O
PROCEDURE NNP I-NP O
: : O O
08/31/98 CD O O
ascending VBG O B-treatment
aortic JJ B-NP I-treatment
root NN I-NP I-treatment
replacement NN I-NP I-treatment
with IN B-VP O
homograft NN B-NP B-treatment
with IN B-VP O
omentopexy NN B-NP B-treatment
. . B-VP O
   
ASSOCIATED NNP B-NP O
PROCEDURES NNP I-NP O
: : O O
09/02/98 CD O O
sternal JJ B-NP B-treatment
debridement NN I-NP I-treatment
. . B-VP O
   
Bilateral NNP B-NP B-treatment
pectoralis IN B-VP I-treatment
major JJ B-NP I-treatment
myocutaneous JJ I-NP I-treatment
advancement NN I-NP I-treatment
flap NN I-NP I-treatment
. . B-VP O
   
Right NNP B-NP B-treatment
superiorly RB O I-treatment
based VBN O I-treatment
rectus NN B-NP I-treatment
abdominis NN I-NP I-treatment
flap NN I-NP I-treatment
. . B-VP O
   
Primary JJ B-NP B-treatment
closure NN I-NP I-treatment
of IN B-VP O
wound NN B-NP B-problem
. . B-VP O
   
HISTORY NNP B-NP O
AND NNP I-NP O
REASON NNP I-NP O
FOR NNP I-NP O
HOSPITALIZATION NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
is VBZ O O
a DT O O
79 CD O O
year NN B-NP O
old JJ B-NP O
gentleman NN I-NP O
with IN B-VP O
a DT B-NP O
history NN I-NP O
of IN B-VP O
an DT O B-treatment
ascending VBG O I-treatment
aortic JJ B-NP I-treatment
graft NN I-NP I-treatment
replacement NN I-NP I-treatment
in IN B-VP O
1991 CD O O
for IN B-VP O
aortic JJ B-NP B-problem
dissection NN I-NP I-problem
. . B-VP O
   
At IN B-VP O
that DT B-NP B-pronoun
time NN I-NP O
the DT B-NP B-person
patient NN I-NP I-person
's POS O O
hospital JJ B-NP O
course NN I-NP O
was VBD B-VP O
complicated VBN O O
by IN B-VP O
a DT B-NP B-problem
sternal JJ I-NP I-problem
wound NN I-NP I-problem
infection NN I-NP I-problem
requiring VBG O O
a DT B-NP B-treatment
sternal JJ I-NP I-treatment
debridement NN I-NP I-treatment
and CC O O
subsequent JJ B-NP B-treatment
abdominal JJ I-NP I-treatment
flap NN I-NP I-treatment
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
then RB O O
continued VBN O O
by IN B-VP O
report NN B-NP O
on IN B-VP O
Dicloxacillin NNP B-NP B-treatment
for IN B-VP O
approximately RB O O
one CD O O
year NN B-NP O
following VBG O O
that IN B-VP B-pronoun
that DT B-NP B-treatment
reconstructive JJ I-NP I-treatment
operation NN I-NP I-treatment
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
apparently RB O O
did VBD B-VP O
well RB O O
until IN B-VP O
June NNP B-NP O
1998 CD O O
when WRB O O
he PRP O B-person
noted VBD B-VP O
a DT B-NP B-problem
bulge NN I-NP I-problem
in IN B-VP I-problem
his PRP$ O B-person
his PRP$ O I-problem
sternal JJ B-NP I-problem
area NN I-NP I-problem
. . B-VP O
   
A DT B-NP B-problem
ruptured JJ I-NP I-problem
aneurysm NN I-NP I-problem
or CC O O
pseudoaneurysm NN B-NP B-problem
at IN B-VP O
the DT B-NP O
junction NN I-NP O
of IN B-VP O
the DT B-NP B-treatment
graft NN I-NP I-treatment
and CC O O
arch NN B-NP O
was VBD B-VP O
diagnosed VBN O O
and CC O O
this DT O B-pronoun
was VBD B-VP O
subsequently RB O O
repaired VBN O O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
then RB O O
had VBD B-VP O
recurrent VBN O B-problem
bleeding VBG O I-problem
two CD O O
weeks NNS B-NP O
later RB O O
which WDT O B-pronoun
was VBD B-VP O
once RB O O
again RB O O
repaired VBN O O
. . B-VP O
   
However RB O O
the DT B-NP B-problem
same JJ I-NP I-problem
problem NN I-NP I-problem
recurred VBD B-VP O
for IN B-VP O
a DT B-NP O
third JJ I-NP O
time NN I-NP O
and CC O O
a DT B-NP B-test
computer NN I-NP I-test
tomogram NN I-NP I-test
scan NN I-NP I-test
at IN B-VP O
an DT B-NP O
outside JJ I-NP O
hospital NN I-NP O
showed VBD B-VP O
an DT B-NP B-problem
anterior JJ I-NP I-problem
hematoma NN I-NP I-problem
. . B-VP O
   
By IN B-VP O
report NN B-NP O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
at IN B-VP O
that DT B-NP B-pronoun
time NN I-NP O
told VBD B-VP O
that IN B-VP B-pronoun
there EX O O
was VBD B-VP O
no DT O O
more JJR O O
that DT O B-pronoun
could MD O O
be VB O O
done VBN O O
for IN B-VP O
him PRP O B-person
and CC O O
was VBD B-VP O
then RB O O
apparently RB O O
placed VBN O O
on IN B-VP O
comfort NN B-NP B-treatment
measures NNS I-NP I-treatment
and CC O O
pain VB O B-treatment
control NN B-NP I-treatment
at IN B-VP O
the DT B-NP O
outside JJ I-NP O
hospital NN I-NP O
. . B-VP O
   
However RB O O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
then RB O O
subsequently RB O O
transferred VBN O O
to TO O O
Fairm NNP B-NP O
of IN B-VP O
Ijordcompmac NNP B-NP O
Hospital NNP I-NP O
upon IN B-VP O
request NN B-NP O
of IN B-VP O
the DT B-NP B-person
family NN I-NP I-person
on IN B-VP O
8/24/98 CD O O
for IN B-VP O
further JJ B-NP B-test
evaluation NN I-NP I-test
and CC O O
possible JJ B-NP O
intervention NN I-NP B-treatment
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
evaluated VBN O O
by IN B-VP O
Dr. NNP B-NP B-person
Rhalt NNP I-NP I-person
of IN B-VP O
Dentvailr. NNP B-NP O
Medical NNP I-NP O
Center NNP I-NP O
. . B-VP O
   
As IN B-VP O
the DT O B-person
the DT B-NP B-test
patient JJ I-NP I-person
patient NN I-NP I-test
's POS O I-test
early JJ B-NP I-test
evaluation NN I-NP I-test
the DT B-NP B-person
patient NN I-NP I-person
underwent VBD B-VP O
an DT B-NP B-test
aortogram NN I-NP I-test
which WDT O B-pronoun
showed VBD B-VP O
an DT O B-treatment
ascending VBG O I-treatment
aortic JJ B-NP I-treatment
graft NN I-NP I-treatment
with IN B-VP O
bulging VBG O B-problem
flaps NNS B-NP I-problem
and CC O O
a DT B-NP B-problem
pseudoaneurysm NN I-NP I-problem
at IN B-VP O
the DT B-NP O
anastomosis NN I-NP O
of IN B-VP O
the DT B-NP B-treatment
graft NN I-NP I-treatment
and CC O O
arch NN B-NP O
just RB O O
below IN B-VP O
the DT B-NP O
great JJ I-NP O
vessels NNS I-NP O
. . B-VP O
   
There EX O O
was VBD B-VP O
no DT B-NP O
evidence NN I-NP O
for IN B-VP O
a DT B-NP B-problem
definite JJ I-NP I-problem
leak NN I-NP I-problem
but CC O O
there EX O O
was VBD B-VP O
evidence NN B-NP O
for IN B-VP O
gas NN B-NP B-problem
bubbles NNS I-NP I-problem
in IN B-VP O
the DT B-NP O
anterior JJ I-NP O
posterior JJ I-NP O
distal JJ I-NP O
ends NNS I-NP O
of IN B-VP O
the DT B-NP B-treatment
grafts NNS I-NP I-treatment
consistent NN I-NP O
with IN B-VP O
an DT B-NP B-problem
infectious JJ I-NP I-problem
process NN I-NP I-problem
. . B-VP O
   
At IN B-VP O
the DT B-NP O
same JJ I-NP O
time NN I-NP O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
seen VBN O O
in IN B-VP O
consultation NN B-NP O
by IN B-VP O
the DT B-NP O
Infectious NNP I-NP B-person
Disease NNP I-NP I-person
Service NNP I-NP O
who WP O B-person
upon IN B-VP O
culturing VBG O O
the DT O B-person
the DT B-NP B-problem
patient JJ I-NP I-person
patient NN I-NP I-problem
's POS O I-problem
sternal JJ B-NP I-problem
drainage NN I-NP I-problem
switched VBD B-VP O
the DT B-NP B-person
patient NN I-NP I-person
from IN B-VP O
intravenous JJ B-NP B-treatment
Unasyn NNP I-NP I-treatment
to TO O O
Levofloxacin VB O B-treatment
for IN B-VP O
what WP O O
appeared VBD B-VP O
to TO O O
be VB O O
Citrobacter NNP B-NP B-problem
and CC O O
Diphtheroids NNP B-NP B-problem
in IN B-VP O
the DT B-NP B-test
wound NN I-NP I-test
cultures VBZ O I-test
. . B-VP O
   
Subsequent JJ O O
to TO O O
starting VBG O O
this DT O B-pronoun
this DT O B-treatment
antibiotic JJ O I-treatment
regimen VBZ O I-treatment
the DT O B-person
the DT B-NP B-problem
patient JJ I-NP I-person
patient NN I-NP I-problem
's POS O I-problem
wound JJ B-NP I-problem
drainage NN I-NP I-problem
appeared VBD B-VP O
to TO O O
subside VB O O
. . B-VP O
   
Given VBN O O
all PDT O O
the DT B-NP O
findings NNS I-NP O
on IN B-VP O
the DT B-NP B-test
aortogram NN I-NP I-test
and CC O O
the DT B-NP B-test
subsequent JJ I-NP I-test
chest NN I-NP I-test
computer NN I-NP I-test
tomogram NN I-NP I-test
scan VBD B-VP I-test
it PRP O B-pronoun
was VBD B-VP O
discovered VBN O O
that IN B-VP B-pronoun
the DT B-NP B-person
patient NN I-NP I-person
's POS O O
only JJ B-NP O
real JJ I-NP O
surgical JJ I-NP O
option NN I-NP O
for IN B-VP O
cure NN B-NP O
was VBD B-VP O
a DT B-NP B-treatment
risky JJ I-NP I-treatment
operation NN I-NP I-treatment
that WDT O B-pronoun
involved VBD B-VP O
removal NN B-NP B-treatment
and CC O I-treatment
replacement NN B-NP I-treatment
of IN B-VP I-treatment
the DT B-NP I-treatment
aortic JJ I-NP I-treatment
graft NN I-NP I-treatment
probably RB O O
with IN B-VP O
homograft NN B-NP B-treatment
and CC O O
long JJ B-NP B-treatment
term NN I-NP I-treatment
antibiotic JJ B-NP I-treatment
coverage NN I-NP I-treatment
as RB O O
well RB O O
as IN B-VP O
a DT B-NP B-treatment
plastic JJ I-NP I-treatment
surgical JJ I-NP I-treatment
reconstructive JJ I-NP I-treatment
procedure NN I-NP I-treatment
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
understood VBD B-VP O
the DT B-NP O
risks NNS I-NP O
and CC O O
potential JJ B-NP O
benefits NNS I-NP O
of IN B-VP O
the DT B-NP B-treatment
procedure NN I-NP I-treatment
and CC O O
was VBD B-VP O
willing JJ O O
to TO O O
proceed VB O O
. . B-VP O
   
The DT B-NP B-person
patient JJ I-NP I-person
otherwise NN I-NP O
complained VBD B-VP O
of IN B-VP O
no DT B-NP O
angina NN I-NP B-problem
, , O O
no DT B-NP O
shortness NN I-NP B-problem
of IN B-VP I-problem
breath NN B-NP I-problem
, , O O
no DT B-NP O
paroxysmal JJ I-NP B-problem
nocturnal JJ I-NP I-problem
dyspnea NN I-NP I-problem
, , O O
no DT B-NP O
edema NN I-NP B-problem
, , O O
no DT B-NP O
palpitations NNS I-NP B-problem
or CC O O
symptoms NNS B-NP O
of IN B-VP O
syncope NN B-NP B-problem
. . B-VP O
   
He PRP O B-person
did VBD B-VP O
report VB O O
a DT O B-problem
20 CD O I-problem
lbs JJ B-NP I-problem
weight JJ I-NP I-problem
loss NN I-NP I-problem
over IN B-VP O
the DT B-NP O
last JJ I-NP O
several JJ I-NP O
months NNS I-NP O
. . B-VP O
   
PAST NNP B-NP O
MEDICAL NNP I-NP O
HISTORY NNP I-NP O
: : O O
1. CD O O
Thoracic NNP B-NP B-treatment
aneurysm NN I-NP I-treatment
repair NN I-NP I-treatment
. . B-VP O
   
2. CD O O
Hypertension NNP B-NP B-problem
. . B-VP O
   
3. CD O O
Status NNP B-NP O
post NN I-NP O
hernia NN I-NP B-treatment
repair NN I-NP I-treatment
. . B-VP O
   
MEDICATIONS NNP B-NP O
ON NNP I-NP O
ADMISSION NNP I-NP O
: : O O
1. CD O O
Lopressor NNP B-NP B-treatment
100 CD O O
mg NN B-NP O
po NN I-NP O
three CD O O
times NNS B-NP O
a DT B-NP O
day NN I-NP O
. . B-VP O
   
2. CD O O
Captopril NNP B-NP B-treatment
75 CD O O
mg NN B-NP O
po NN I-NP O
three CD O O
times NNS B-NP O
a DT B-NP O
day NN I-NP O
. . B-VP O
   
3. CD O O
Prilosec NNP B-NP B-treatment
20 CD O O
mg NN B-NP O
po NN I-NP O
per IN B-VP O
day NN B-NP O
. . B-VP O
   
4. CD O O
Hydralazine NNP B-NP B-treatment
12.5 CD O O
mg NN B-NP O
four CD O O
times NNS B-NP O
per IN B-VP O
day NN B-NP O
. . B-VP O
   
5. CD O O
Reglan NNP B-NP B-treatment
10 CD O O
mg NN B-NP O
po NN I-NP O
three CD O O
times NNS B-NP O
a DT B-NP O
day NN I-NP O
. . B-VP O
   
ALLERGIES NNP B-NP O
: : O O
No DT B-NP O
known JJ I-NP B-problem
drug NN I-NP I-problem
allergies NNS I-NP I-problem
. . B-VP O
   
FAMILY NNP B-NP O
HISTORY NNP I-NP O
: : O O
Noncontributory NN B-NP O
. . B-VP O
   
SOCIAL NNP B-NP O
HISTORY NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
married VBN O O
and CC O O
denied VBN O O
any DT B-NP O
tobacco NN I-NP O
or CC O O
alcohol NN B-NP O
use NN I-NP O
. . B-VP O
   
PHYSICAL JJ B-NP O
EXAMINATION NN I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
afebrile RB O B-problem
, , O O
vital JJ B-NP B-test
signs NNS I-NP I-test
were VBD B-VP O
stable JJ O O
. . B-VP O
   
Head NNP B-NP B-test
, , O I-test
eyes NNS B-NP I-test
, , O I-test
ears NNS B-NP I-test
, , O I-test
nose RB O I-test
and CC O I-test
throat JJ B-NP I-test
exam NN I-NP I-test
: : O O
negative JJ O O
. . B-VP O
   
Neck NNP B-NP O
was VBD B-VP O
supple RB O O
. . B-VP O
   
There EX O O
was VBD B-VP O
no DT B-NP O
jugular JJ I-NP B-problem
venous JJ I-NP I-problem
distention NN I-NP I-problem
. . B-VP O
   
2+ CD O B-test
carotids NNS B-NP I-test
without IN B-VP O
bruits NNS B-NP B-problem
. . B-VP O
   
Cardiovascular JJ B-NP B-test
exam NN I-NP I-test
: : O O
regular JJ B-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
with IN B-VP O
a DT O B-problem
2/6 CD O I-problem
diastolic JJ B-NP I-problem
___ NN I-NP O
and CC O O
a DT O B-problem
1/6 CD O I-problem
systolic JJ B-NP I-problem
ejection NN I-NP I-problem
murmur NN I-NP I-problem
. . B-VP O
   
His PRP$ O B-person
lungs NNS B-NP O
were VBD B-VP O
clear JJ O O
to TO O O
auscultation VB O B-test
bilaterally RB O O
without IN B-VP O
any DT B-NP O
evidence NN I-NP O
for IN B-VP O
crackles NNS B-NP B-problem
. . B-VP O
   
Extremities NNS B-NP O
: : O O
the DT B-NP B-person
patient NN I-NP I-person
had VBD B-VP O
2+ CD O B-test
femoral JJ B-NP I-test
pulses NNS I-NP I-test
and CC O O
1+ CD O B-test
pedal NN B-NP I-test
pulses NNS I-NP I-test
. . B-VP O
   
LABORATORY NNP B-NP O
AND CC O O
RADIOLOGIC NNP B-NP O
DATA NNP I-NP O
: : O O
Sodium NN B-NP B-test
137 CD O O
, , O O
potassium NN B-NP B-test
4.0 CD O O
, , O O
blood NN B-NP B-test
urea JJ B-NP I-test
nitrogen NN I-NP I-test
16 CD O O
, , O O
creatinine NN B-NP B-test
.9 NN I-NP O
, , O O
white JJ B-NP B-test
blood NN I-NP I-test
cell NN I-NP I-test
count NN I-NP I-test
4.9 CD O O
, , O O
hematocrit NN B-NP B-test
29.7 CD O O
, , O O
platelet NN B-NP B-test
count NN I-NP I-test
207 CD O O
. . B-VP O
   
The DT O B-person
The DT B-NP B-test
patient JJ I-NP I-person
patient NN I-NP I-test
's POS O I-test
preoperative JJ B-NP I-test
chest NN I-NP I-test
x-ray NN I-NP I-test
showed VBD B-VP O
bilateral JJ B-NP B-problem
effusions NNS I-NP I-problem
and CC O O
bibasilar JJ B-NP B-problem
atelectasis NN I-NP I-problem
. . B-VP O
   
PHYSICAL JJ B-NP O
EXAMINATION NN I-NP O
: : O O
The DT O B-person
The DT B-NP B-problem
patient JJ I-NP I-person
patient NN I-NP I-problem
's POS O I-problem
sternal JJ B-NP I-problem
incision NN I-NP I-problem
had VBD B-VP O
a DT B-NP O
superior JJ I-NP O
edge NN I-NP O
that WDT O B-pronoun
was VBD B-VP O
dehisced VBN O B-problem
with IN B-VP O
evidence NN B-NP O
for IN B-VP O
stay NN B-NP B-treatment
sutures NNS I-NP I-treatment
and CC O O
some DT B-NP O
superficial JJ I-NP B-treatment
closure NN I-NP I-treatment
sutures NNS I-NP I-treatment
exposed VBN O O
. . B-VP O
   
HOSPITAL NNP B-NP O
COURSE NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
initially RB O O
admitted VBN O O
to TO O O
the DT B-NP O
Cardiac NNP I-NP O
Surgical NNP I-NP O
Service NNP I-NP O
under IN B-VP O
Dr. NNP B-NP B-person
Rhalt NNP I-NP I-person
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
admitted VBN O O
to TO O O
the DT B-NP O
Cardiac NNP I-NP O
Surgical NNP I-NP O
Intensive NNP I-NP O
Care NNP I-NP O
Unit NNP I-NP O
given VBN O O
the DT B-NP B-person
patient NN I-NP I-person
's POS O O
precarious JJ B-NP O
condition NN I-NP O
. . B-VP O
   
Over IN B-VP O
the DT B-NP O
next JJ I-NP O
several JJ I-NP O
hospital NN I-NP O
days NNS I-NP O
the DT B-NP B-person
patient JJ I-NP I-person
underwent JJ I-NP O
aortogram NN I-NP B-test
as RB O O
well RB O O
as IN B-VP O
chest NN B-NP B-test
computer NN I-NP I-test
tomogram NN I-NP I-test
as IN B-VP O
outlined VBN O O
earlier RBR O O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
also RB O O
seen VBN O O
in IN B-VP O
consultation NN B-NP O
by IN B-VP O
the DT B-NP O
Infectious NNP I-NP B-person
Disease NNP I-NP I-person
Service NNP I-NP O
as RB O O
well RB O O
as IN B-VP O
the DT B-NP O
Cardiology NNP I-NP B-person
Service NNP I-NP O
who WP O B-person
assisted VBD B-VP O
in IN B-VP O
managing VBG O O
the DT O B-person
the DT B-NP B-problem
patient JJ I-NP I-person
patient NN I-NP I-problem
's POS O I-problem
intermittent JJ B-NP I-problem
hypertension NN I-NP I-problem
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
also RB O O
seen VBN O O
preoperatively RB O O
in IN B-VP O
consultation NN B-NP O
by IN B-VP O
the DT B-NP O
Plastic NNP I-NP B-person
Surgical NNP I-NP I-person
Service NNP I-NP I-person
for IN B-VP O
potential JJ B-NP B-treatment
sternal JJ I-NP I-treatment
reconstruction NN I-NP I-treatment
. . B-VP O
   
After IN B-VP O
lengthy JJ B-NP O
discussions NNS I-NP O
with IN B-VP O
the DT B-NP B-person
patient NN I-NP I-person
and CC O O
the DT O B-person
the DT B-NP B-person
patient JJ I-NP I-person
patient NN I-NP I-person
's POS O I-person
family NN B-NP I-person
as RB O O
well RB O O
as IN B-VP O
the DT B-NP O
various JJ I-NP O
consultant NN I-NP O
services NNS I-NP O
it PRP O B-pronoun
was VBD B-VP O
decided VBN O O
that IN B-VP B-pronoun
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
a DT B-NP O
viable JJ I-NP O
candidate NN I-NP O
for IN B-VP O
aortic JJ B-NP B-treatment
root NN I-NP I-treatment
replacement NN I-NP I-treatment
procedure NN I-NP I-treatment
using VBG O O
homograft NN B-NP B-treatment
. . B-VP O
   
This DT O B-pronoun
was VBD B-VP O
obtained VBN O O
on IN B-VP O
08/30/98 CD O O
by IN B-VP O
Dr. NNP B-NP B-person
Niste NNP I-NP I-person
Rhalt NNP I-NP I-person
of IN B-VP O
the DT B-NP O
Cardiac NNP I-NP B-person
Surgical NNP I-NP I-person
Service NNP I-NP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
then RB O O
subsequently RB O O
taken VBN O O
to TO O O
the DT B-NP O
Operating NN I-NP O
Room NNP I-NP O
on IN B-VP O
08/31/98 CD O O
with IN B-VP O
the DT B-NP O
preoperative JJ I-NP O
diagnosis NN I-NP O
of IN B-VP O
ascending VBG O B-problem
aortic JJ B-NP I-problem
graft NN I-NP I-problem
infection NN I-NP I-problem
. . B-VP O
   
The DT B-NP B-treatment
procedure NN I-NP I-treatment
performed VBD B-VP O
was VBD B-VP O
homograft JJ B-NP B-treatment
replacement NN I-NP I-treatment
of IN B-VP I-treatment
the DT O I-treatment
ascending VBG O I-treatment
aorta NN B-NP I-treatment
with IN B-VP O
omentopexy NN B-NP B-treatment
and CC O O
an DT B-NP B-problem
open JJ I-NP I-problem
chest NN I-NP I-problem
. . B-VP O
   
The DT B-NP O
aortic JJ I-NP O
perfusions NNS I-NP O
were VBD B-VP O
via IN B-VP O
the DT B-NP O
femoral JJ I-NP O
artery NN I-NP O
with IN B-VP O
venous JJ B-NP O
return NN I-NP O
by IN B-VP O
the DT B-NP O
femoral JJ I-NP O
vein NN I-NP O
. . B-VP O
   
The DT B-NP O
cardiopulmonary JJ I-NP O
bypass NN I-NP O
time NN I-NP O
was VBD B-VP O
one CD O O
hour NN B-NP O
and CC O O
49 CD O O
minutes NNS B-NP O
. . B-VP O
   
The DT B-NP B-treatment
graft NN I-NP I-treatment
used VBN O O
was VBD B-VP O
a DT B-NP B-treatment
homograft NN I-NP I-treatment
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
tolerated VBD B-VP O
the DT B-NP B-treatment
procedure NN I-NP I-treatment
fairly RB O O
well RB O O
and CC O O
was VBD B-VP O
transferred VBN O O
intubated VBN O B-treatment
to TO O O
the DT B-NP O
Cardiac NNP I-NP O
Surgical NNP I-NP O
Intensive NNP I-NP O
Care NNP I-NP O
Unit NNP I-NP O
with IN B-VP O
his PRP$ O B-person
his PRP$ O B-problem
chest NN B-NP I-problem
open JJ O I-problem
. . B-VP O
   
The DT B-NP O
immediate JJ I-NP O
postoperative JJ I-NP O
plans NNS I-NP O
were VBD B-VP O
for IN B-VP O
a DT B-NP O
short JJ I-NP O
Intensive NNP I-NP O
Care NNP I-NP O
Unit NNP I-NP O
stay NN I-NP O
and CC O O
subsequent JJ B-NP B-treatment
plastic NN I-NP I-treatment
surgical JJ B-NP I-treatment
reconstruction NN I-NP I-treatment
of IN B-VP I-treatment
the DT O B-person
the DT B-NP I-treatment
patient JJ I-NP I-person
patient NN I-NP I-treatment
's POS O I-treatment
sternum NN B-NP I-treatment
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
transferred VBN O O
to TO O O
the DT B-NP O
Cardiac NNP I-NP O
Surgical NNP I-NP O
Intensive NNP I-NP O
Care NNP I-NP O
Unit NNP I-NP O
in IN B-VP O
stable JJ B-NP O
condition NN I-NP O
. . B-VP O
   
There EX O O
he PRP O B-person
continued VBD B-VP O
to TO O O
be VB O O
hemodynamically RB O O
stable JJ O O
. . B-VP O
   
Of IN B-VP O
note NN B-NP O
, , O O
intraoperatively RB O B-test
multiple JJ B-NP I-test
tissue NN I-NP I-test
cultures NNS I-NP I-test
had VBD B-VP O
been VBN O O
sent VBN O O
. . B-VP O
   
In IN B-VP O
the DT B-NP O
Intensive NNP I-NP O
Care NNP I-NP O
Unit NNP I-NP O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
kept VBN O O
intubated JJ O B-treatment
and CC O O
sedated VBD B-VP B-treatment
until IN B-VP O
09/02/98 CD O O
which WDT O B-pronoun
was VBD B-VP O
postoperative JJ B-NP O
day NN I-NP O
no. IN B-VP O
1 CD O O
following VBG O O
the DT B-NP B-treatment
homograft NN I-NP I-treatment
replacement NN I-NP I-treatment
. . B-VP O
   
On IN B-VP O
that DT B-NP B-pronoun
day NN I-NP O
the DT B-NP O
Plastic NNP I-NP B-person
Surgical NNP I-NP I-person
Service NNP I-NP I-person
performed VBD B-VP O
further RBR O B-treatment
sternal JJ B-NP I-treatment
debridement NN I-NP I-treatment
and CC O O
subsequent JJ B-NP B-treatment
reconstruction NN I-NP I-treatment
using VBG O O
bilateral JJ B-NP B-treatment
pectoralis NNS I-NP I-treatment
major JJ B-NP I-treatment
myocutaneous JJ I-NP I-treatment
advancement NN I-NP I-treatment
flaps NNS I-NP I-treatment
and CC O O
right JJ O B-treatment
superiorly RB O I-treatment
rectus VBP O I-treatment
abdominis RB O I-treatment
flap JJ O I-treatment
to TO O O
cover VB O O
the DT O B-problem
the DT B-NP B-person
patient JJ I-NP I-problem
patient NN I-NP I-person
's POS O I-problem
sternal JJ B-NP I-problem
wound NN I-NP I-problem
with IN B-VP O
subsequent JJ B-NP B-treatment
primary JJ I-NP I-treatment
closure NN I-NP I-treatment
of IN B-VP O
that DT O B-pronoun
that DT B-NP B-problem
wound NN I-NP I-problem
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
tolerated VBD B-VP O
the DT B-NP B-treatment
procedure NN I-NP I-treatment
well RB O O
and CC O O
there EX O O
were VBD B-VP O
no DT B-NP O
complications NNS I-NP B-problem
. . B-VP O
   
A DT B-NP O
number NN I-NP O
of IN B-VP O
indwelling VBG O B-treatment
closed JJ B-NP I-treatment
suction NN I-NP I-treatment
drains NNS I-NP I-treatment
were VBD B-VP O
left VBN O O
in IN B-VP O
place NN B-NP O
so RB O O
as IN B-VP O
to TO O O
drain VB O O
the DT B-NP O
bed NN I-NP O
underneath IN B-VP O
the DT B-NP O
muscle NN I-NP O
flaps NNS I-NP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
then RB O O
transferred VBN O O
back RB O O
to TO O O
the DT B-NP O
Cardiac NNP I-NP O
Surgical NNP I-NP O
Intensive NNP I-NP O
Care NNP I-NP O
Unit NNP I-NP O
in IN B-VP O
stable JJ B-NP O
condition NN I-NP O
. . B-VP O
   
At IN B-VP O
this DT B-NP B-pronoun
point NN I-NP O
the DT B-NP B-person
patient NN I-NP I-person
continued VBD B-VP O
to TO O O
followed VBN O O
by IN B-VP O
Infectious NNP B-NP B-person
Disease NNP I-NP I-person
Service NNP I-NP O
and CC O O
continued VBD B-VP O
to TO O O
be VB O O
on IN B-VP O
intravenous JJ B-NP B-treatment
antibiotics NNS I-NP I-treatment
which WDT O B-pronoun
included VBD B-VP O
Vancomycin NNP B-NP B-treatment
and CC O O
Levofloxacin NNP B-NP B-treatment
. . B-VP O
   
The DT B-NP B-test
Operating NN I-NP I-test
Room NNP I-NP I-test
cultures VBZ O I-test
at IN B-VP O
that DT B-NP B-pronoun
point NN I-NP O
were VBD B-VP O
positive JJ O O
for IN B-VP O
Crinobactermium NN B-NP B-problem
with IN B-VP O
sputum NN B-NP B-test
cultures NNS I-NP I-test
being VBG O O
sensitive JJ O O
for IN B-VP O
yeast NN B-NP B-problem
and CC O O
gram NN B-NP B-problem
positive JJ B-NP I-problem
cocci NN I-NP I-problem
in IN B-VP I-problem
clusters NNS B-NP I-problem
. . B-VP O
   
Over IN B-VP O
the DT B-NP O
next JJ I-NP O
postoperative JJ I-NP O
day NN I-NP O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
awakened VBN O O
and CC O O
weaned VBN O O
to TO O O
extubate VB O O
without IN B-VP O
significant JJ B-NP B-problem
difficulties NNS I-NP I-problem
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
's POS O O
subsequent JJ B-NP O
postoperative JJ I-NP O
course NN I-NP O
was VBD B-VP O
characterized VBN O O
by IN B-VP O
persistent JJ B-NP B-problem
hypertension NN I-NP I-problem
which WDT O B-pronoun
required VBD B-VP O
a DT B-NP O
significant JJ I-NP O
amount NN I-NP O
of IN B-VP O
antihypertensives NNS B-NP B-treatment
including VBG O O
Lopressor NNP B-NP B-treatment
100 CD O O
mg NN B-NP O
po NN I-NP O
three CD O O
times NNS B-NP O
a DT B-NP O
day NN I-NP O
, , O O
Captopril NNP B-NP B-treatment
100 CD O O
mg NN B-NP O
po NN I-NP O
three CD O O
times NNS B-NP O
a DT B-NP O
day NN I-NP O
, , O O
as RB O O
well RB O O
as IN B-VP O
Procardia NNP B-NP B-treatment
. . B-VP O
   
The DT O B-person
patient JJ O I-person
otherwise RB O O
continued VBN O O
to TO O O
do VB O O
well RB O O
and CC O O
was VBD B-VP O
becoming VBG O O
more RB O O
oriented VBN O O
as IN B-VP O
time NN B-NP O
went VBD B-VP O
on IN B-VP O
and CC O O
as IN B-VP O
his PRP$ O B-person
his PRP$ O B-test
blood NN B-NP I-test
pressure NN I-NP I-test
was VBD B-VP O
brought VBN O O
under IN B-VP O
control NN B-NP O
. . B-VP O
   
Subsequently RB O O
on IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
no. NN I-NP O
8 CD O O
in IN B-VP O
the DT B-NP O
Intensive NNP I-NP O
Care NNP I-NP O
Unit NNP I-NP O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
felt VBN O O
to TO O O
be VB O O
ready JJ O O
for IN B-VP O
transfer NN B-NP O
to TO O O
the DT B-NP O
Cardiac NNP I-NP B-person
Surgical NNP I-NP I-person
Inpatient NNP I-NP I-person
Service NNP I-NP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
continued VBD B-VP O
to TO O O
be VB O O
followed VBN O O
by IN B-VP O
the DT B-NP O
Infectious NNP I-NP B-person
Disease NNP I-NP I-person
Service NNP I-NP O
who WP O B-person
felt VBD B-VP O
that IN B-VP B-pronoun
the DT O B-person
the DT B-NP B-treatment
patient JJ I-NP I-person
patient NN I-NP I-treatment
's POS O I-treatment
Jackson NNP B-NP I-treatment
Pratt NNP I-NP I-treatment
drains VBZ O I-treatment
needed VBN O O
to TO O O
stay VB O O
in IN B-VP O
as IN B-VP O
there EX O O
was VBD B-VP O
still RB O O
some DT B-NP B-problem
significant JJ I-NP I-problem
drainage NN I-NP I-problem
from IN B-VP O
them PRP O B-pronoun
. . B-VP O
   
As IN B-VP O
per IN B-VP O
the DT B-NP B-person
Infectious NNP I-NP I-person
Disease NNP I-NP I-person
Service NNP I-NP O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
continued VBN O O
on IN B-VP O
Levofloxacin NNP B-NP B-treatment
, , O O
Vancomycin NNP B-NP B-treatment
as IN B-VP O
antibiotic JJ B-NP B-treatment
coverage NN I-NP I-treatment
. . B-VP O
   
However RB O O
on IN B-VP O
09/08/98 CD O O
the DT B-NP B-person
Infectious NNP I-NP I-person
Disease NNP I-NP I-person
Service NNP I-NP O
was VBD B-VP O
made VBN O O
aware JJ O O
that IN B-VP B-pronoun
the DT O B-person
the DT B-NP B-test
patient JJ I-NP I-person
patient NN I-NP I-test
's POS O I-test
intraoperative JJ B-NP I-test
cultures NNS I-NP I-test
had VBD B-VP O
also RB O O
grown VBN O O
out RP O O
Mycoplasma NNP B-NP B-problem
humilius NN I-NP I-problem
. . B-VP O
   
Given VBN O O
this DT O B-pronoun
finding VBG O O
it PRP O B-pronoun
was VBD B-VP O
felt VBN O O
that IN B-VP B-pronoun
the DT B-NP B-person
patient NN I-NP I-person
would MD O O
certainly RB O O
need VB O O
long JJ B-NP B-treatment
term NN I-NP I-treatment
intravenous JJ B-NP I-treatment
antibiotics NNS I-NP I-treatment
to TO O O
include VB O O
at IN B-VP O
least JJS O O
six CD O O
weeks NNS B-NP O
of IN B-VP O
Vancomycin NNP B-NP B-treatment
and CC O O
then RB O O
subsequent JJ B-NP B-treatment
Levofloxacin NNP I-NP I-treatment
for IN B-VP O
the DT B-NP B-problem
Citrobacter NNP I-NP I-problem
and CC O O
Mycoplasma NNP B-NP B-problem
as RB O O
well RB O O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
scheduled VBN O O
for IN B-VP O
peripherally RB O B-treatment
inserted JJ B-NP I-treatment
central JJ I-NP I-treatment
catheter NN I-NP I-treatment
line NN I-NP I-treatment
placement NN I-NP I-treatment
knowing NN I-NP O
that IN B-VP B-pronoun
he PRP O B-person
was VBD B-VP O
going VBG O O
to TO O O
need VB O O
long JJ B-NP B-treatment
term NN I-NP I-treatment
intravenous JJ B-NP I-treatment
antibiotics NNS I-NP I-treatment
. . B-VP O
   
This DT O B-pronoun
was VBD B-VP O
placed VBN O O
on IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
no. NN I-NP O
9 CD O O
without IN B-VP O
any DT B-NP B-problem
difficulty NN I-NP I-problem
. . B-VP O
   
At IN B-VP O
the DT B-NP O
same JJ I-NP O
time NN I-NP O
the DT B-NP B-person
patient NN I-NP I-person
continued VBD B-VP O
to TO O O
be VB O O
stable JJ O O
on IN B-VP O
his PRP$ O B-person
his PRP$ O B-treatment
antihypertensive JJ B-NP I-treatment
regimen NNS I-NP I-treatment
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
becoming VBG O O
more JJR O O
mobile JJ O O
and CC O O
was VBD B-VP O
taking VBG O O
a DT B-NP B-treatment
high JJ I-NP I-treatment
protein NN I-NP I-treatment
high JJ B-NP I-treatment
calories NNS I-NP I-treatment
diet VBP O I-treatment
which WDT O B-pronoun
he PRP O B-person
tolerated VBD B-VP O
well RB O O
. . B-VP O
   
He PRP O B-person
continued VBD B-VP O
to TO O O
be VB O O
afebrile JJ O B-problem
and CC O O
otherwise RB O O
very RB O O
stable JJ O O
. . B-VP O
   
On IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
no. NN I-NP O
12 CD O O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
noted VBN O O
to TO O O
have VB O O
fallen VBN O O
and CC O O
subsequently RB O O
dislocating VBG O O
the DT B-NP O
PIP NNP I-NP O
joint NN I-NP O
of IN B-VP O
his PRP$ O B-person
left JJ B-NP O
middle JJ I-NP O
finger NN I-NP O
. . B-VP O
   
Subsequent JJ B-NP B-test
hand NN I-NP I-test
x-rays NNS I-NP I-test
obtained VBD B-VP O
showed VBD B-VP O
no DT B-NP O
evidence NN I-NP O
of IN B-VP O
fracture NN B-NP B-problem
but CC O O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
seen VBN O O
in IN B-VP O
consultation NN B-NP O
by IN B-VP O
the DT B-NP B-person
Plastic NNP I-NP I-person
Surgery NNP I-NP I-person
Hand NNP I-NP I-person
Service NNP I-NP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
will MD O O
benefit VB O O
from IN B-VP O
splinting VBG O B-treatment
of IN B-VP I-treatment
his PRP$ O B-person
his PRP$ O I-treatment
finger NN B-NP I-treatment
while IN B-VP O
the DT O B-problem
swelling VBG O I-problem
subsided VBD B-VP O
and CC O O
subsequent JJ B-NP B-treatment
early JJ I-NP I-treatment
mobilization NN I-NP I-treatment
to TO O O
prevent VB O O
any DT B-NP B-problem
rigidity NN I-NP I-problem
in IN B-VP I-problem
that DT O B-pronoun
that DT O I-problem
joint JJ O I-problem
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
also RB O O
seen VBN O O
subsequently RB O O
in IN B-VP O
consultation NN B-NP O
by IN B-VP O
the DT B-NP B-person
Plastic NNP I-NP I-person
Surgical NNP I-NP I-person
Service NNP I-NP I-person
who WP O B-person
discontinued VBD B-VP O
a DT B-NP O
number NN I-NP O
of IN B-VP O
the DT O B-person
the DT B-NP B-treatment
patient JJ I-NP I-person
patient NN I-NP I-treatment
's POS O I-treatment
indwelling NN B-NP I-treatment
drains NNS I-NP I-treatment
but CC O O
they PRP O B-person
felt VBD B-VP O
that IN B-VP B-pronoun
others NNS B-NP O
needed VBN O O
to TO O O
stay VB O O
while IN B-VP O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
sent VBN O O
to TO O O
rehabilitation NN B-NP O
. . B-VP O
   
These DT O B-pronoun
These DT B-NP B-treatment
drains NNS I-NP I-treatment
will MD O O
then RB O O
be VB O O
subsequently RB O O
taken VBN O O
out RP O O
by IN B-VP O
Dr. NNP B-NP B-person
General NNP I-NP I-person
upon IN B-VP O
his PRP$ O B-person
followup NN B-NP O
with IN B-VP O
the DT B-NP B-person
patient NN I-NP I-person
. . B-VP O
   
Prior NNP B-NP O
to TO O O
discharge VB O O
the DT B-NP B-person
patient NN I-NP I-person
also RB O O
underwent VBD B-VP O
an DT B-NP B-test
audiogram NN I-NP I-test
as IN B-VP O
a DT B-NP B-test
baseline NN I-NP I-test
hearing VBG O I-test
test NN B-NP I-test
while IN B-VP O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
to TO O O
stay VB O O
on IN B-VP O
long JJ B-NP B-treatment
term NN I-NP I-treatment
intravenous JJ B-NP I-treatment
antibiotics NNS I-NP I-treatment
. . B-VP O
   
The DT O B-person
patient JJ O I-person
otherwise RB O O
continued VBN O O
to TO O O
be VB O O
hemodynamically RB O O
stable JJ O O
making VBG O O
good JJ B-NP O
progress NN I-NP O
. . B-VP O
   
As IN B-VP O
a DT B-NP O
matter NN I-NP O
of IN B-VP O
fact NN B-NP O
the DT B-NP B-person
patient NN I-NP I-person
made VBD B-VP O
remarkable JJ B-NP O
progress NN I-NP O
given VBN O O
the DT B-NP O
severity NN I-NP O
of IN B-VP O
his PRP$ O B-person
his PRP$ O B-problem
disease NN B-NP I-problem
condition NN I-NP I-problem
prior RB O O
to TO O O
the DT B-NP B-treatment
operation NN I-NP I-treatment
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
's POS O O
condition NN B-NP O
continued VBD B-VP O
to TO O O
be VB O O
improved VBN O O
. . B-VP O
   
Given VBN O O
this DT O B-pronoun
finding VBG O O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
therefore RB O O
felt VBD B-VP O
to TO O O
be VB O O
ready JJ O O
for IN B-VP O
discharge NN B-NP O
to TO O O
a DT B-NP O
rehabilitation NN I-NP O
facility NN I-NP O
on IN B-VP O
09/13/1998 CD O O
. . B-VP O
   
In IN B-VP O
consultation NN B-NP O
with IN B-VP O
the DT B-NP O
Infectious NNP I-NP B-person
Disease NNP I-NP I-person
Service NNP I-NP O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
to TO O O
stay VB O O
on IN B-VP O
long JJ B-NP B-treatment
term NN I-NP I-treatment
intravenous JJ B-NP I-treatment
antibiotics NNS I-NP I-treatment
. . B-VP O
   
CONDITION NNP B-NP O
ON NNP I-NP O
DISCHARGE NNP I-NP O
: : O O
Good JJ O O
. . B-VP O
   
DISCHARGE JJ B-NP O
INSTRUCTIONS NNP I-NP O
: : O O
Diet NN B-NP O
: : O O
High JJ B-NP B-treatment
calorie NN I-NP I-treatment
, , O I-treatment
high JJ B-NP I-treatment
protein NN I-NP I-treatment
. . B-VP O
   
The DT O B-person
The DT B-NP B-treatment
patient JJ I-NP I-person
patient NN I-NP I-treatment
's POS O I-treatment
treatment NN B-NP I-treatment
will MD O O
include VB O O
typical JJ O B-treatment
peripherally RB O I-treatment
inserted JJ B-NP I-treatment
central JJ I-NP I-treatment
catheter NN I-NP I-treatment
line NN I-NP I-treatment
care NN I-NP I-treatment
with IN B-VP O
frequent JJ B-NP B-test
wound NN I-NP I-test
checks NNS I-NP I-test
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
prior RB O O
to TO O O
discharge VB O O
was VBD B-VP O
fitted VBN O O
with IN B-VP O
an DT B-NP B-treatment
orthoplast JJ I-NP I-treatment
finger NN I-NP I-treatment
splint NN I-NP I-treatment
as IN B-VP O
manufactured VBN O O
by IN B-VP O
Occupational NNP B-NP B-person
Therapy NNP I-NP I-person
Services NNPS I-NP O
Fairm NNP I-NP O
of IN B-VP O
Ijordcompmac NNP B-NP O
Hospital NNP I-NP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
also RB O O
instructed VBN O O
in IN B-VP O
range NN B-NP B-treatment
of IN B-VP I-treatment
motion NN B-NP I-treatment
exercises NNS I-NP I-treatment
for IN B-VP O
the DT B-NP O
left NN I-NP O
middle JJ B-NP O
finger NN I-NP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
on IN B-VP O
discharge NN B-NP O
is VBZ O O
to TO O O
have VB O O
twice RB O O
weekly JJ B-NP O
Vancomycin NNP I-NP B-test
peak NN I-NP I-test
and CC O I-test
trough NN B-NP I-test
levels NNS I-NP I-test
while IN B-VP O
he PRP O B-person
continues VBZ O O
on IN B-VP O
long JJ B-NP B-treatment
term NN I-NP I-treatment
Vancomycin NNP I-NP I-treatment
therapy NN I-NP I-treatment
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
instructed VBN O O
to TO O O
return VB O O
to TO O O
Fairm NNP B-NP O
of IN B-VP O
Ijordcompmac NNP B-NP O
Hospital NNP I-NP O
if IN B-VP O
he PRP O B-person
developed VBD B-VP O
any DT B-NP O
signs NNS I-NP O
of IN B-VP O
wound JJ B-NP B-problem
infection NN I-NP I-problem
such PDT O O
a DT B-NP B-problem
erythema NN I-NP I-problem
, , O O
drainage NN B-NP B-problem
, , O O
or CC O O
increasing VBG O B-problem
incisional JJ B-NP I-problem
pain NN I-NP I-problem
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
instructed VBN O O
to TO O O
be VB O O
vigilant JJ O O
for IN B-VP O
any DT B-NP B-problem
fevers NNS I-NP I-problem
or CC O O
chills NNS B-NP B-problem
. . B-VP O
   
MEDICATIONS NNP B-NP O
ON NNP I-NP O
DISCHARGE NNP I-NP O
: : O O
1. CD O O
Vancomycin NNP B-NP B-treatment
750 CD O O
mg NN B-NP O
intravenous JJ O O
q VBD B-VP O
18h. CD O O
2. CD O O
Levofloxacin NNP B-NP B-treatment
500 CD O O
mg NN B-NP O
po NN I-NP O
per IN B-VP O
day NN B-NP O
. . B-VP O
   
3. CD O O
Prilosec NNP B-NP B-treatment
20 CD O O
mg NN B-NP O
po NN I-NP O
per IN B-VP O
day NN B-NP O
. . B-VP O
   
4. CD O O
Captopril NNP B-NP B-treatment
100 CD O O
mg NN B-NP O
po NN I-NP O
three CD O O
times NNS B-NP O
a DT B-NP O
day NN I-NP O
. . B-VP O
   
5. CD O O
Lopressor NNP B-NP B-treatment
100 CD O O
mg NN B-NP O
po NN I-NP O
three CD O O
times NNS B-NP O
a DT B-NP O
day NN I-NP O
. . B-VP O
   
6. CD O O
Albuterol NNP B-NP B-treatment
nebulizers NNS I-NP I-treatment
q6h VBP O O
as IN B-VP O
needed VBN O O
. . B-VP O
   
7. CD O O
Atrovent JJ B-NP B-treatment
nebulizers NNS I-NP I-treatment
q6h VBP O O
as IN B-VP O
needed VBN O O
. . B-VP O
   
8. CD O O
Lasix NNP B-NP B-treatment
20 CD O O
mg NN B-NP O
po NN I-NP O
per IN B-VP O
day NN B-NP O
. . B-VP O
   
9. CD O O
Kay-Ciel JJ O B-treatment
20 CD O O
mEq NN B-NP O
po NN I-NP O
per IN B-VP O
day NN B-NP O
. . B-VP O
   
FOLLOWUP NN B-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
instructed VBN O O
that IN B-VP B-pronoun
he PRP O B-person
needed VBD B-VP O
to TO O O
followup VB O O
with IN B-VP O
Dr. NNP B-NP B-person
Rhalt NNP I-NP I-person
by IN B-VP O
calling VBG O O
his PRP$ O B-person
office NN B-NP O
for IN B-VP O
appointment NN B-NP O
at IN B-VP O
763-6361 JJ B-NP O
subsequent NN I-NP O
to TO O O
his PRP$ O B-person
discharge NN B-NP O
to TO O O
his PRP$ O B-person
rehabilitation NN B-NP O
facility NN I-NP O
in IN B-VP O
Oaksale NNP B-NP O
Lavalle NNP I-NP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
also RB O O
instructed VBN O O
to TO O O
followup VB O O
with IN B-VP O
Dr. NNP B-NP B-person
Both NNP I-NP I-person
of IN B-VP O
the DT B-NP O
Cardiology NNP I-NP B-person
Service NNP I-NP O
Fairm NNP I-NP O
of IN B-VP O
Ijordcompmac NNP B-NP O
Hospital NNP I-NP O
following VBG O O
his PRP$ O B-person
discharge NN B-NP O
so IN B-VP O
that IN B-VP B-pronoun
his PRP$ O B-person
his PRP$ O B-treatment
antihypertension NN B-NP I-treatment
medications NNS I-NP I-treatment
could MD O O
be VB O O
appropriately RB O O
adjusted VBN O O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
will MD O O
also RB O O
be VB O O
seen VBN O O
in IN B-VP O
followup NN B-NP O
by IN B-VP O
Dr. NNP B-NP B-person
Chpo NNP I-NP I-person
E. NNP I-NP I-person
Enla NNP I-NP I-person
General NNP I-NP O
of IN B-VP O
the DT B-NP O
Plastic NNP I-NP B-person
Surgery NNP I-NP I-person
Service NNP I-NP O
Fairm NNP I-NP O
of IN B-VP O
Ijordcompmac NNP B-NP O
Hospital NNP I-NP O
so IN B-VP O
that IN B-VP B-pronoun
his PRP$ O B-person
his PRP$ O B-treatment
indwelling VBG O I-treatment
Jackson NNP B-NP I-treatment
Pratt NNP I-NP I-treatment
drains VBZ O I-treatment
be VB O O
appropriately JJ B-NP O
management NN I-NP O
and CC O O
if IN B-VP O
needed VBN O O
be VB O O
discontinued VBN O O
by IN B-VP O
him PRP O B-person
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
will MD O O
also RB O O
be VB O O
followed VBN O O
by IN B-VP O
the DT B-NP B-person
Infectious NNP I-NP I-person
Disease NNP I-NP I-person
Service NNP I-NP O
so RB O O
as IN B-VP O
to TO O O
ascertain VB O O
the DT B-NP O
exact JJ I-NP O
length NN I-NP O
and CC O O
course NN B-NP O
of IN B-VP O
his PRP$ O B-person
his PRP$ O B-treatment
antibiotic JJ B-NP I-treatment
therapy NN I-NP I-treatment
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
instructed VBN O O
to TO O O
followup VB O O
with IN B-VP O
Dr. NNP B-NP B-person
Naco NNP I-NP I-person
Mesprhalt NNP I-NP I-person
of IN B-VP O
the DT B-NP O
Infectious NNP I-NP B-person
Disease NNP I-NP I-person
Service NNP I-NP O
by IN B-VP O
calling VBG O O
her PRP$ O B-person
office NN B-NP O
for IN B-VP O
an DT B-NP O
appointment NN I-NP O
at IN B-VP O
094-902-2879 JJ O O
to TO O O
be VB O O
seen VBN O O
in IN B-VP O
approximately RB O O
four CD O O
weeks NNS B-NP O
following VBG O O
the DT B-NP B-person
patient NN I-NP I-person
's POS O O
discharge NN B-NP O
. . B-VP O
   
Dr. NNP B-NP B-person
Dau NNP I-NP I-person
's POS O O
recommendation NN B-NP O
is VBZ O O
that IN B-VP B-pronoun
the DT B-NP B-person
patient NN I-NP I-person
is VBZ O O
to TO O O
stay VB O O
on IN B-VP O
Vancomycin NNP B-NP B-treatment
and CC O O
Levofloxacin NNP B-NP B-treatment
for IN B-VP O
approximately RB O O
six CD O O
weeks NNS B-NP O
following VBG O O
discharge NN B-NP O
and CC O O
then RB O O
subsequently RB O O
on IN B-VP O
antibiotic JJ B-NP B-treatment
regimen NNS I-NP I-treatment
for IN B-VP O
chronic JJ B-NP B-treatment
suppression NN I-NP I-treatment
. . B-VP O
   
RYNA NNP B-NP B-person
DAU NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
DICTATING NNP I-NP O
FOR NNP I-NP O
: : O O
NISTE NNP B-NP B-person
MA NNP I-NP I-person
RHALT NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
TR NNP I-NP O
: : O O
oq JJ B-NP O
DD NNP I-NP O
: : O O
09/13/1998 CD O O
TD NN B-NP O
: : O O
09/13/1998 CD O O
7:18 CD O O
A NNP B-NP O
cc NN I-NP O
: : O O
KEND NNP B-NP B-person
N NNP I-NP I-person
BOTH NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
CARDIAC NNP I-NP O
FELLOWS NNP I-NP O
ROOM NNP I-NP O
LOLI NNP I-NP O
MEMORIAL NNP I-NP O
MEDICAL NNP I-NP O
CENTER NNP I-NP O
NACO NNP I-NP B-person
MESPRHALT NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
INFECTIOUS NNP I-NP O
DISEASE NNP I-NP O
UNIT NNP I-NP O
CIL NNP I-NP O
HOSPITAL NNP I-NP O
RYNA NNP I-NP B-person
R NNP I-NP I-person
DAU NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
SURGICAL NNP I-NP O
RESIDENT NNP I-NP O
SURG NNP I-NP O
AG NNP I-NP O
NISTE NNP I-NP B-person
MA NNP I-NP I-person
RHALT NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
SURGERY NNP I-NP O
BROTROJEUNECOCK NNP I-NP O
HEALTH NNP I-NP O
CHPO NNP I-NP B-person
E NNP I-NP I-person
ENLA NNP I-NP I-person
GENERAL NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
SURGERY NNP I-NP O
ON NNP I-NP O
HOSPITAL NNP I-NP O
STAT NNP I-NP O
EDITED NNP I-NP O
09/15/1998 CD O O
RJ NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- VBD B-VP O
405728860 CD O O
FIH NNP B-NP O
7150860 CD O O
05849/1xpu CD O O
994032 CD O O
1/3/1994 CD O O
12:00:00 CD O O
AM NNP B-NP O
MEDIASTINAL NNP I-NP B-problem
TUMOR NNP I-NP I-problem
MASS NNP I-NP I-problem
. . B-VP O
   
Unsigned VBD B-VP O
DIS NNP B-NP O
Report NNP I-NP O
Status NNP I-NP O
: : O O
Unsigned VBN O O
ADMISSION NNP B-NP O
DATE NNP I-NP O
: : O O
1-3-94 JJ B-NP O
DISCHARGE NNP I-NP O
DATE NNP I-NP O
: : O O
1-9-94 JJ B-NP O
PRINCIPAL NNP I-NP O
DIAGNOSIS NNP I-NP O
: : O O
Mediastinal JJ B-NP B-problem
tumor NN I-NP I-problem
mass NN I-NP I-problem
. . B-VP O
   
ASSOCIATED CC O O
DIAGNOSIS NNPS B-NP O
: : O O
History NN B-NP O
of IN B-VP O
colon NN B-NP B-problem
cancer NN I-NP I-problem
, , O O
chronic JJ B-NP B-problem
obstructive JJ I-NP I-problem
pulmonary JJ I-NP I-problem
disease NN I-NP I-problem
, , O O
obesity NN B-NP B-problem
, , O O
hypertension NN B-NP B-problem
, , O O
history NN B-NP O
of IN B-VP O
myocardial JJ B-NP B-problem
infarction NN I-NP I-problem
. . B-VP O
   
SPECIAL NNP B-NP O
PROCEDURES NNP I-NP O
AND NNP I-NP O
OPERATIONS NNP I-NP O
: : O O
January NNP B-NP O
3 CD O O
, , O O
1994 CD O O
, , O O
median JJ B-NP B-test
sternotomy NN I-NP I-test
with IN B-VP O
mediastinal JJ B-NP B-test
exploration NN I-NP I-test
, , O O
radical JJ B-NP B-treatment
resection NN I-NP I-treatment
of IN B-VP O
tumor NN B-NP B-problem
and CC O O
aortopulmonary JJ B-NP O
window NN I-NP O
; : O O
partial JJ B-NP B-treatment
resection NN I-NP I-treatment
of IN B-VP I-treatment
adjacent JJ B-NP I-treatment
lung NN I-NP I-treatment
, , O O
en JJ B-NP B-treatment
bloc NN I-NP I-treatment
resection NN I-NP I-treatment
of IN B-VP I-treatment
vagus NN B-NP I-treatment
and CC O I-treatment
phrenic JJ B-NP I-treatment
nerves NNS I-NP I-treatment
; : O O
partial JJ B-NP B-treatment
pericardectomy NN I-NP I-treatment
; : O O
fiberoptic JJ B-NP B-test
bronchoscopy NN I-NP I-test
. . B-VP O
   
HISTORY NNP B-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
is VBZ O O
a DT O O
66 CD O O
year NN B-NP O
old JJ B-NP O
white JJ I-NP O
female NN I-NP O
with IN B-VP O
metastatic JJ B-NP B-problem
colon NN I-NP I-problem
carcinoma NN I-NP I-problem
with IN B-VP O
a DT B-NP B-problem
mass NN I-NP I-problem
in IN B-VP I-problem
the DT B-NP I-problem
left NN I-NP I-problem
superhilar JJ B-NP I-problem
region NN I-NP I-problem
, , O O
who WP O B-person
presents VBZ O O
for IN B-VP O
bronchoscopy NN B-NP B-test
, , O O
mediastinal JJ B-NP B-test
exploration NN I-NP I-test
and CC O O
resection NN B-NP B-treatment
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
in IN B-VP O
her PRP$ O B-person
usual JJ B-NP O
state NN I-NP O
of IN B-VP O
health NN B-NP O
until IN B-VP O
she PRP O B-person
experienced VBD B-VP O
the DT B-NP O
onset NN I-NP O
of IN B-VP O
abdominal JJ B-NP B-problem
pain NN I-NP I-problem
in IN B-VP O
early JJ O O
1992 CD O O
. . B-VP O
   
In IN B-VP O
December NNP B-NP O
of IN B-VP O
1992 CD O O
, , O O
she PRP O B-person
underwent VBD B-VP O
a DT B-NP B-treatment
transverse JJ I-NP I-treatment
colectomy NN I-NP I-treatment
for IN B-VP O
colon NN B-NP B-problem
carcinoma NN I-NP I-problem
which WDT O B-pronoun
was VBD B-VP O
Duke NNP B-NP B-problem
&apos;s NNP I-NP I-problem
grade VBD B-VP I-problem
B-II NNP B-NP I-problem
, , O O
lymph NN B-NP O
nodes NNS I-NP O
were VBD B-VP O
negative JJ O O
. . B-VP O
   
She PRP O B-person
received VBD B-VP O
postoperative JJ B-NP B-treatment
chemotherapy NN I-NP I-treatment
. . B-VP O
   
In IN B-VP O
September NNP B-NP O
of IN B-VP O
1992 CD O O
, , O O
she PRP O B-person
underwent VBD B-VP O
an DT B-NP B-test
exploratory JJ I-NP I-test
laparotomy NN I-NP I-test
because IN B-VP O
of IN B-VP O
an DT B-NP B-problem
increased JJ I-NP I-problem
level NN I-NP I-problem
of IN B-VP I-problem
CEA NNP B-NP I-problem
in IN B-VP O
her PRP$ O B-person
her PRP$ O B-test
blood NN B-NP I-test
with IN B-VP O
the DT B-NP O
presence NN I-NP O
of IN B-VP O
a DT B-NP B-problem
liver JJ I-NP I-problem
abnormality NN I-NP I-problem
on IN B-VP O
computerized JJ B-NP B-test
tomography NN I-NP I-test
scan NN I-NP I-test
. . B-VP O
   
The DT B-NP B-test
exploratory JJ I-NP I-test
laparotomy NN I-NP I-test
was VBD B-VP O
negative JJ O O
. . B-VP O
   
She PRP O B-person
continued VBD B-VP O
to TO O O
have VB O O
a DT B-NP B-problem
rise NN I-NP I-problem
in IN B-VP O
her PRP$ O B-test
her PRP$ O B-person
CEA NNP B-NP I-test
level NN I-NP I-test
which WDT O B-pronoun
prompted VBD B-VP O
a DT B-NP B-test
further JJ I-NP I-test
work NN I-NP I-test
up RB O I-test
. . B-VP O
   
In IN B-VP O
September NNP B-NP O
of IN B-VP O
1993 CD O O
, , O O
an DT O B-test
abdominal JJ O I-test
and CC O I-test
pelvic JJ B-NP I-test
computerized JJ I-NP I-test
tomography NN I-NP I-test
scan NN I-NP I-test
was VBD B-VP O
negative JJ O O
and CC O O
in IN B-VP O
June NNP B-NP O
of IN B-VP O
1993 CD O O
, , O O
she PRP O B-person
had VBD B-VP O
a DT B-NP B-test
negative JJ I-NP I-test
bone NN I-NP I-test
scan JJ O I-test
. . B-VP O
   
In IN B-VP O
December NNP B-NP O
of IN B-VP O
1994 CD O O
, , O O
a DT B-NP B-test
thoracic JJ I-NP I-test
computerized JJ I-NP I-test
tomography NN I-NP I-test
scan NN I-NP I-test
showed VBD B-VP O
a DT O B-problem
four CD O I-problem
centimeter NN B-NP I-problem
soft JJ B-NP I-problem
tissue NN I-NP I-problem
mass NN I-NP I-problem
on IN B-VP I-problem
the DT B-NP I-problem
left NN I-NP I-problem
suprahilar JJ B-NP I-problem
region NN I-NP I-problem
, , O O
adjacent JJ O O
to TO O O
the DT B-NP O
aortopulmonary JJ I-NP O
window NN I-NP O
. . B-VP O
   
She PRP O B-person
also RB O O
experienced VBD B-VP O
increased JJ B-NP B-problem
hoarseness NN I-NP I-problem
over IN B-VP O
the DT B-NP O
preceding JJ I-NP O
months NNS I-NP O
, , O O
which WDT O B-pronoun
was VBD B-VP O
due JJ O O
to TO O O
left JJ B-NP B-problem
vocal JJ I-NP I-problem
cord NN I-NP I-problem
paralysis NN I-NP I-problem
. . B-VP O
   
She PRP O B-person
also RB O O
complains VBZ O O
of IN B-VP O
increased JJ B-NP B-problem
shortness NN I-NP I-problem
of IN B-VP I-problem
breath NN B-NP I-problem
for IN B-VP O
the DT O O
preceding VBG O O
month NN B-NP O
and CC O O
now RB O O
presents NNS B-NP O
for IN B-VP O
mediastinal JJ B-NP B-test
exploration NN I-NP I-test
and CC O O
resection NN B-NP B-treatment
of IN B-VP O
her PRP$ O B-person
probable JJ B-NP O
metastatic JJ I-NP B-problem
mass NN I-NP I-problem
. . B-VP O
   
PAST NNP B-NP O
MEDICAL NNP I-NP O
HISTORY NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
has VBZ O O
a DT B-NP O
history NN I-NP O
of IN B-VP O
hypertension NN B-NP B-problem
, , O O
coronary JJ B-NP B-problem
artery NN I-NP I-problem
disease NN I-NP I-problem
, , O O
previous JJ B-NP B-problem
myocardial JJ I-NP I-problem
infarction NN I-NP I-problem
in IN B-VP O
1983 CD O O
, , O O
hypothyroidism NN B-NP B-problem
, , O O
history NN B-NP O
of IN B-VP O
breast NN B-NP B-problem
cancer NN I-NP I-problem
and CC O O
history NN B-NP O
of IN B-VP O
colon NN B-NP B-problem
cancer NN I-NP I-problem
. . B-VP O
   
PAST JJ B-NP O
SURGICAL JJ I-NP O
HISTORY NN I-NP O
: : O O
The DT B-NP O
past JJ I-NP O
surgical JJ I-NP O
history NN I-NP O
is VBZ O O
notable JJ O O
for IN B-VP O
a DT O O
1971 CD O O
mastectomy NN B-NP B-treatment
on IN B-VP I-treatment
the DT B-NP I-treatment
right NN I-NP I-treatment
, , O O
1937 CD O O
appendectomy NN B-NP B-treatment
, , O O
1991 CD O O
cholecystectomy NN B-NP B-treatment
, , O O
1992 CD O O
transverse NN B-NP B-treatment
colectomy NN I-NP I-treatment
, , O O
1992 CD O O
exploratory NN B-NP B-test
laparotomy NN I-NP I-test
, , O O
1991 CD O O
bilateral JJ B-NP B-treatment
cataract NN I-NP I-treatment
surgery NN I-NP I-treatment
. . B-VP O
   
MEDICATIONS NNP B-NP O
ON NNP I-NP O
ADMISSION NNP I-NP O
: : O O
Levoxine JJ O B-treatment
0.125 CD O O
mg NN B-NP O
PO NNP I-NP O
q.day NN I-NP O
, , O O
Vasotec NNP B-NP B-treatment
10 CD O O
mg NN B-NP O
PO NNP I-NP O
b.i.d. NN I-NP O
, , O O
Maxzide NNP B-NP B-treatment
75/50 CD O O
, , O O
30 CD O O
mg NN B-NP O
PO NNP I-NP O
q.day NN I-NP O
. . B-VP O
   
ALLERGIES CC O O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
is VBZ O O
allergic JJ O B-problem
to TO O O
sulfa VB O B-treatment
. . B-VP O
   
HABITS NNP B-NP O
: : O O
50 CD O O
pack NN B-NP O
year NN I-NP O
smoking VBG O O
history NN B-NP O
, , O O
still RB O O
smoking VBG O O
currently RB O O
. . B-VP O
   
Ethanol NNS B-NP O
: : O O
none NN B-NP O
. . B-VP O
   
PHYSICAL JJ B-NP O
EXAMINATION NN I-NP O
: : O O
On IN B-VP O
physical JJ B-NP B-test
examination NN I-NP I-test
, , O O
she PRP O B-person
is VBZ O O
an DT B-NP O
obese JJ I-NP O
white JJ I-NP O
female NN I-NP O
in IN B-VP O
no DT B-NP O
acute JJ I-NP B-problem
distress NN I-NP I-problem
with IN B-VP O
a DT B-NP B-problem
hoarse JJ I-NP I-problem
voice NN I-NP I-problem
. . B-VP O
   
The DT B-NP B-test
head NN I-NP I-test
, , O I-test
eyes NNS B-NP I-test
, , O I-test
ears NNS B-NP I-test
, , O I-test
nose RB O I-test
, , O I-test
throat NN B-NP I-test
examination NN I-NP I-test
shows VBZ O O
that IN B-VP B-pronoun
she PRP O B-person
is VBZ O O
normocephalic JJ O O
, , O O
atraumatic JJ O B-problem
, , O O
extra JJ B-NP O
ocular JJ I-NP O
movements NNS I-NP O
are VBP O O
intact JJ O O
, , O O
pupils JJ O O
equal JJ O O
, , O O
round NN B-NP O
, , O O
reactive JJ O O
to TO O O
light JJ O O
and CC O O
accommodation NN B-NP O
, , O O
and CC O O
the DT B-NP O
oropharynx NN I-NP O
was VBD B-VP O
clear JJ O O
, , O O
neck NN B-NP O
was VBD B-VP O
supple RB O O
without IN B-VP O
lymphadenopathy NN B-NP B-problem
, , O O
either DT O O
axillary JJ O O
or CC O O
supraclavicular JJ O O
. . B-VP O
   
Chest NNP B-NP O
is VBZ O O
clear JJ O O
with IN B-VP O
decreased JJ B-NP B-problem
breath NN I-NP I-problem
sounds NNS I-NP I-problem
at IN B-VP I-problem
the DT B-NP I-problem
left JJ I-NP I-problem
base NN I-NP I-problem
. . B-VP O
   
She PRP O B-person
has VBZ O O
a DT B-NP B-treatment
previous JJ I-NP I-treatment
right JJ I-NP I-treatment
mastectomy NN I-NP I-treatment
. . B-VP O
   
Cardiovascular JJ B-NP O
exam NN I-NP O
: : O O
regular JJ B-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
, , O O
without IN B-VP O
murmur NN B-NP B-problem
, , O O
rub NN B-NP B-problem
or CC O O
gallop NN B-NP B-problem
. . B-VP O
   
Abdomen NNS B-NP O
: : O O
obese JJ O B-problem
with IN B-VP O
multiple JJ O B-problem
well RB O I-problem
healed VBN O I-problem
surgical JJ B-NP I-problem
incisions NNS I-NP I-problem
, , O O
positive JJ B-NP O
bowel NN I-NP O
sounds NNS I-NP O
. . B-VP O
   
The DT B-NP B-test
rectal JJ I-NP I-test
examination NN I-NP I-test
is VBZ O O
guaiac JJ O B-test
negative JJ O O
without IN B-VP O
masses NNS B-NP B-problem
. . B-VP O
   
Extremities NNS B-NP O
: : O O
no DT B-NP O
clubbing NN I-NP B-problem
, , O O
cyanosis NN B-NP B-problem
or CC O O
edema NN B-NP B-problem
. . B-VP O
   
The DT B-NP B-test
neurological JJ I-NP I-test
examination NN I-NP I-test
is VBZ O O
nonfocal JJ O O
. . B-VP O
   
HOSPITAL NNP B-NP O
COURSE NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
admitted VBN O O
to TO O O
the DT B-NP O
Fairm NNP I-NP O
of IN B-VP O
Ijordcompmac NNP B-NP O
Hospital NNP I-NP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
brought VBN O O
to TO O O
the DT B-NP O
Operating NN I-NP O
Room NN I-NP O
on IN B-VP O
January NNP B-NP O
3 CD O O
, , O O
1994 CD O O
where WRB O O
she PRP O B-person
underwent VBD B-VP O
a DT B-NP B-treatment
median JJ I-NP I-treatment
sternotomy NN I-NP I-treatment
with IN B-VP O
removal NN B-NP B-treatment
of IN B-VP O
her PRP$ O B-person
her PRP$ O B-problem
mediastinal JJ B-NP I-problem
mass NN I-NP I-problem
. . B-VP O
   
This DT O B-pronoun
This DT B-NP B-problem
mass NN I-NP I-problem
was VBD B-VP O
situated VBN O O
in IN B-VP O
the DT B-NP O
aortopulmonary JJ I-NP O
window NN I-NP O
and CC O O
was VBD B-VP O
sent VBN O O
to TO O O
pathology NN B-NP O
. . B-VP O
   
The DT B-NP B-test
frozen JJ I-NP I-test
section NN I-NP I-test
analysis NN I-NP I-test
revealed VBD B-VP O
this DT O B-pronoun
to TO O O
be VB O O
adenocarcinoma RB O B-problem
, , O O
metastatic JJ B-NP B-problem
disease NN I-NP I-problem
from IN B-VP I-problem
the DT B-NP I-problem
colon NN I-NP I-problem
most RBS O O
likely JJ O O
. . B-VP O
   
She PRP O B-person
had VBD B-VP O
a DT B-NP B-treatment
chest NN I-NP I-treatment
tube NN I-NP I-treatment
placed VBD B-VP O
intraoperatively RB O O
and CC O O
another DT O O
placed VBN O O
postoperatively RB O O
in IN B-VP O
the DT B-NP O
recovery NN I-NP O
room NN I-NP O
, , O O
for IN B-VP O
what WP O O
was VBD B-VP O
presumed VBN O O
to TO O O
be VB O O
a DT B-NP B-problem
left JJ I-NP I-problem
pleural JJ I-NP I-problem
effusion NN I-NP I-problem
. . B-VP O
   
This DT O B-pronoun
This DT B-NP B-treatment
tube NN I-NP I-treatment
drained VBD B-VP O
only RB O O
a DT B-NP O
small JJ I-NP O
amount NN I-NP O
of IN B-VP O
fluid NN B-NP O
and CC O O
it PRP O B-pronoun
was VBD B-VP O
likely JJ O O
that IN B-VP B-pronoun
the DT B-NP B-problem
effusion NN I-NP I-problem
was VBD B-VP O
made VBN O O
to TO O O
look VB O O
more JJR O O
severe JJ O O
in IN B-VP O
the DT B-NP O
presence NN I-NP O
of IN B-VP O
left JJ B-NP B-problem
hemidiaphragm JJ I-NP I-problem
elevation NN I-NP I-problem
. . B-VP O
   
This DT O B-pronoun
This DT B-NP B-treatment
additional JJ I-NP I-treatment
chest NN I-NP I-treatment
tube NN I-NP I-treatment
was VBD B-VP O
removed VBN O O
the DT B-NP O
following JJ I-NP O
day NN I-NP O
. . B-VP O
   
Her PRP$ O B-person
Her PRP$ O B-test
postoperative JJ B-NP I-test
hematocrit NN I-NP I-test
was VBD B-VP O
31 CD O O
, , O O
compared VBN O O
to TO O O
a DT B-NP B-test
preoperative JJ I-NP I-test
level NN I-NP I-test
of IN B-VP O
43 CD O O
. . B-VP O
   
Her PRP$ O B-person
postoperative JJ B-NP O
recovery NN I-NP O
was VBD B-VP O
really RB O O
quite RB O O
remarkable JJ O O
. . B-VP O
   
Mediastinal JJ B-NP B-treatment
chest NN I-NP I-treatment
tube NN I-NP I-treatment
was VBD B-VP O
removed VBN O O
on IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
three CD O O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
discharged VBN O O
home NN B-NP O
in IN B-VP O
stable JJ B-NP O
condition NN I-NP O
on IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
six CD O O
. . B-VP O
   
DOCTORS VB O B-person
DISCHARGE JJ B-NP O
ORDERS NNS I-NP O
: : O O
Percocet NN B-NP B-treatment
for IN B-VP O
pain NN B-NP B-problem
. . B-VP O
   
Follow VB O O
up RP O O
with IN B-VP O
Dr. NNP B-NP B-person
Fede NNP I-NP I-person
Duhenile NNP I-NP I-person
. . B-VP O
   
She PRP O B-person
will MD O O
have VB O O
a DT B-NP B-person
home NN I-NP I-person
health NN I-NP I-person
aide NN I-NP I-person
to TO O O
visit VB O O
and CC O O
help VB O O
her PRP$ O B-person
with IN B-VP O
meals NNS B-NP O
. . B-VP O
   
CA NNP B-NP B-person
SHUFF NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
DICTATING NNP I-NP O
FOR NNP I-NP O
: : O O
FEDE NNP B-NP B-person
LEVEL NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
TR NNP I-NP O
: : O O
kw NN B-NP O
/ NNP I-NP O
bmot NN I-NP O
DD NNP I-NP O
: : O O
1-9-94 JJ B-NP O
TD NN I-NP O
: : O O
01/10/94 CD O O
CC NN B-NP O
: : O O
-EMPTYLINE- JJ B-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
Admission NNP I-NP O
Date NNP I-NP O
: : O O
2014-11-13 JJ B-NP O
Discharge NN I-NP O
Date NNP I-NP O
: : O O
2014-12-05 JJ B-NP O
Date NNP I-NP O
of IN B-VP O
Birth NNP B-NP O
: : O O
2014-11-13 JJ B-NP O
Sex NN I-NP O
: : O O
M NNP B-NP O
Service NNP I-NP O
: : O O
Neonatology NNP B-NP O
HISTORY NNP I-NP O
: : O O
Baby NNP B-NP B-person
Boy NNP I-NP I-person
Timberlake NNP I-NP I-person
was VBD B-VP O
born VBN O O
to TO O O
a DT O O
25 CD O O
- : O O
year-old JJ B-NP O
G-8 NNP I-NP O
, , O O
P-4 NNP B-NP O
to TO O O
5 CD O O
mom NN B-NP B-person
with IN B-VP O
Julie NNP B-NP O
type NN I-NP O
B NNP I-NP O
positive JJ O O
, , O O
antibody JJ O B-test
negative JJ O O
, , O O
hepatitis NN B-NP B-test
B NNP I-NP I-test
surface NN I-NP I-test
antigen NN I-NP I-test
negative JJ O O
, , O O
rubella NN B-NP B-test
immune NN I-NP I-test
, , O O
RPR NNP B-NP B-test
nonreactive NN I-NP O
, , O O
GBS NNP B-NP B-problem
positive JJ O I-problem
with IN B-VP O
a DT B-NP O
history NN I-NP O
of IN B-VP O
infrequent NN B-NP O
prenatal NN I-NP O
care NN I-NP O
since IN B-VP O
28 CD O O
weeks NNS B-NP O
time NN I-NP O
and CC O O
preterm JJ B-NP B-problem
labor NN I-NP I-problem
. . B-VP O
   
Mother NNP B-NP B-person
had VBD B-VP O
a DT B-NP O
history NN I-NP O
of IN B-VP O
anxiety NN B-NP B-problem
and CC O O
asthma NN B-NP B-problem
as RB O O
well RB O O
as IN B-VP O
moderate JJ B-NP O
cigarette NN I-NP O
smoking NN I-NP O
. . B-VP O
   
The DT B-NP B-person
baby NN I-NP I-person
was VBD B-VP O
delivered VBN O O
through IN B-VP O
normal JJ B-NP B-treatment
spontaneous JJ I-NP I-treatment
vaginal JJ I-NP I-treatment
delivery NN I-NP I-treatment
with IN B-VP O
brief JJ B-NP B-treatment
blow NN I-NP I-treatment
by IN B-VP I-treatment
with IN B-VP O
Apgars NNP B-NP B-test
of IN B-VP O
8 CD O O
and CC O O
9 CD O O
. . B-VP O
   
Father NN B-NP B-person
of IN B-VP O
baby NN B-NP B-person
not RB O O
involved VBN O O
at IN B-VP O
this DT B-NP B-pronoun
time NN I-NP O
. . B-VP O
   
The DT O B-person
The DT B-NP B-person
patient JJ I-NP I-person
patient NN I-NP I-person
's POS O I-person
pediatrician NN B-NP I-person
is VBZ O O
Wellesley NNP B-NP O
House NNP I-NP O
and CC O O
is VBZ O O
Dr NNP B-NP B-person
. . B-VP I-person
   
Shaw NNP B-NP I-person
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
has VBZ O O
many JJ B-NP B-person
siblings NNS I-NP I-person
, , O O
all DT O O
of IN B-VP O
which WDT O B-pronoun
are VBP O O
girls NNS B-NP O
. . B-VP O
   
PHYSICAL JJ B-NP O
EXAMINATION NN I-NP O
: : O O
On IN B-VP O
admission NN B-NP O
, , O O
the DT O B-person
the DT B-NP B-test
patient JJ I-NP I-person
patient NN I-NP I-test
's POS O I-test
birth NN B-NP I-test
weight NN I-NP I-test
was VBD B-VP O
1.705 CD O O
kilograms NNS B-NP O
, , O O
which WDT O B-pronoun
is VBZ O O
50th CD O O
percentile NN B-NP O
. . B-VP O
   
Length NNP B-NP B-test
was VBD B-VP O
40 CD O O
cm NN B-NP O
, , O O
50th CD O O
percentile NN B-NP O
. . B-VP O
   
Head NNP B-NP B-test
circumference NN I-NP I-test
was VBD B-VP O
30 CD O O
cm NN B-NP O
, , O O
50th CD O O
percentile NN B-NP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
born VBN O O
at IN B-VP O
32 CD O O
and CC O O
4/7 CD O O
weeks NNS B-NP O
gestation NN I-NP O
and CC O O
brought VBD B-VP O
directly RB O O
to TO O O
the DT B-NP O
CMED NNP I-NP O
CSRU NNP I-NP O
. . B-VP O
   
HOSPITAL NNP B-NP O
COURSE NNP I-NP O
: : O O
By IN B-VP O
systems NNS B-NP O
: : O O
Respiratory NNP B-NP O
. . B-VP O
   
After IN B-VP O
receiving VBG O O
brief JJ B-NP B-treatment
blow NN I-NP I-treatment
by IN B-VP I-treatment
oxygen NN B-NP I-treatment
in IN B-VP O
the DT B-NP O
delivery NN I-NP O
room NN I-NP O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
had VBD B-VP O
no DT B-NP O
further JJ I-NP O
episodes NNS I-NP O
of IN B-VP O
ventilatory JJ B-NP B-treatment
assistance NN I-NP I-treatment
required VBN O O
with IN B-VP O
good JJ B-NP O
respiratory NN I-NP O
rate NN I-NP O
consistently RB O O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
never RB O O
placed VBN O O
on IN B-VP O
caffeine NN B-NP B-treatment
. . B-VP O
   
He PRP O B-person
is VBZ O O
stable JJ O O
in IN B-VP O
room NN B-NP O
air NN I-NP O
at IN B-VP O
this DT B-NP B-pronoun
time NN I-NP O
. . B-VP O
   
Cardiovascular NNP B-NP O
. . B-VP O
   
No NNP B-NP O
active JJ B-NP O
issues NNS I-NP O
. . B-VP O
   
No DT B-NP O
history NN I-NP O
of IN B-VP O
hypotension NN B-NP B-problem
. . B-VP O
   
On IN B-VP O
no DT B-NP O
medications NNS I-NP B-treatment
at IN B-VP O
this DT B-NP B-pronoun
time NN I-NP O
. . B-VP O
   
Notably RB O O
with IN B-VP O
respect NN B-NP O
to TO O O
apnea VB O B-problem
and CC O O
bradycardia VB O B-problem
of IN B-VP I-problem
prematurity NN B-NP I-problem
, , O O
the DT B-NP B-person
patient NN I-NP I-person
has VBZ O O
reached VBN O O
5 CD O O
days NNS B-NP O
without IN B-VP O
significant JJ B-NP B-problem
apneic NN I-NP I-problem
or CC O I-problem
bradycardic JJ B-NP I-problem
spells NNS I-NP I-problem
as IN B-VP O
of IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
discharge NN B-NP O
. . B-VP O
   
Fluids NNP B-NP O
, , O O
electrolytes VBZ O O
and CC O O
nutrition NN B-NP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
reached VBD B-VP O
full JJ B-NP O
volume NN I-NP O
feeds NNS I-NP O
by IN B-VP O
day NN B-NP O
of IN B-VP O
life NN B-NP O
6 CD O O
and CC O O
had VBD B-VP O
calories NNS B-NP O
increased VBN O O
to TO O O
maximum VB O O
of IN B-VP O
26 CD O O
kilocalories NNS B-NP O
per IN B-VP O
ounce NN B-NP O
of IN B-VP O
Similac NNP B-NP B-treatment
special JJ B-NP I-treatment
care NN I-NP I-treatment
until IN B-VP O
2014-12-03 JJ O O
, , O O
at IN B-VP O
which WDT O B-pronoun
point NN B-NP O
this DT O B-pronoun
was VBD B-VP O
weaned VBN O O
to TO O O
24 CD O O
kilocalories NNS B-NP O
per IN B-VP O
ounce NN B-NP O
of IN B-VP O
straight JJ B-NP B-treatment
Similac NNP I-NP I-treatment
. . B-VP O
   
This DT O B-pronoun
is VBZ O O
the DT B-NP B-person
baby NN I-NP I-person
's POS O O
discharge NN B-NP O
feedings NNS I-NP O
and CC O O
he PRP O B-person
is VBZ O O
p.o. JJ B-NP O
ad NN I-NP O
lib NN I-NP O
with IN B-VP O
a DT B-NP O
minimum NN I-NP O
of IN B-VP O
130 CD O O
ml/kg/day NN B-NP O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
has VBZ O O
taken VBN O O
on IN B-VP O
an DT B-NP O
average NN I-NP O
greater JJR O O
than IN B-VP O
150 CD O O
ml/kg/day JJ B-NP O
ad NN I-NP O
lib NN I-NP O
over IN B-VP O
each DT O O
of IN B-VP O
the DT O O
past JJ O O
5 CD O O
days NNS B-NP O
. . B-VP O
   
GI NNP B-NP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
with IN B-VP O
peak JJ B-NP B-test
bilirubin NN I-NP I-test
of IN B-VP O
6.5 CD O O
on IN B-VP O
day NN B-NP O
of IN B-VP O
life NN B-NP O
3 CD O O
. . B-VP O
   
No DT B-NP O
phototherapy NN I-NP B-treatment
was VBD B-VP O
required VBN O O
. . B-VP O
   
Hematology NNP B-NP O
/ NNP I-NP O
Infectious NNP I-NP O
Disease NNP I-NP O
. . B-VP O
   
The DT O B-person
The DT B-NP B-test
patient JJ I-NP I-person
patient NN I-NP I-test
's POS O I-test
hematocrit NN B-NP I-test
at IN B-VP O
delivery NN B-NP O
was VBD B-VP O
48 CD O O
, , O O
with IN B-VP O
a DT B-NP B-test
white JJ I-NP I-test
count NN I-NP I-test
of IN B-VP O
11.2 CD O O
and CC O O
platelets NNS B-NP B-test
of IN B-VP O
301,000 CD O O
. . B-VP O
   
Initial JJ B-NP B-test
differential NN I-NP I-test
was VBD B-VP O
35 CD O B-test
polys NN B-NP I-test
and CC O O
zero NN B-NP B-test
bands NNS I-NP I-test
, , O O
not RB O O
suspicious JJ O O
for IN B-VP O
infectious JJ B-NP B-problem
condition NN I-NP I-problem
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
initially RB O O
treated VBN O O
with IN B-VP O
48 CD O O
hours NNS B-NP O
of IN B-VP O
ampicillin NN B-NP B-treatment
and CC O O
gentamicin NN B-NP B-treatment
until IN B-VP O
blood NN B-NP B-test
cultures NNS I-NP I-test
were VBD B-VP O
negative JJ O O
. . B-VP O
   
The DT B-NP O
infant NN I-NP O
has VBZ O O
had VBN O O
no DT B-NP O
antibiotics NNS I-NP B-treatment
since IN B-VP O
that DT B-NP B-pronoun
time NN I-NP O
. . B-VP O
   
Neurology NNP B-NP O
. . B-VP O
   
No DT B-NP O
issues NNS I-NP O
. . B-VP O
   
Sensory NNP B-NP O
. . B-VP O
   
Hearing VBG O B-test
screen NN B-NP I-test
was VBD B-VP O
performed VBN O O
with IN B-VP O
automated JJ B-NP B-test
auditory NN I-NP I-test
brainstem NN I-NP I-test
responses NNS I-NP I-test
and CC O O
was VBD B-VP O
normal JJ O O
on IN B-VP O
2014-11-24 JJ O O
. . B-VP O
   
Ophthalmology NNP B-NP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
did VBD B-VP O
not RB O O
qualify VB O O
for IN B-VP O
routine JJ B-NP B-test
ophthalmology NN I-NP I-test
exams NNS I-NP I-test
due JJ O O
to TO O O
his PRP$ O B-person
gestational JJ B-NP O
age NN I-NP O
at IN B-VP O
birth NN B-NP O
. . B-VP O
   
CONDITION NNP B-NP O
ON NNP I-NP O
DISCHARGE NNP I-NP O
: : O O
Stable JJ O O
. . B-VP O
   
DISCHARGE JJ B-NP O
DISPOSITION NNP I-NP O
: : O O
Home NN B-NP O
. . B-VP O
   
PRIMARY NNP B-NP O
PEDIATRICIAN NNP I-NP O
: : O O
Dr. NNP B-NP B-person
Shaw NNP I-NP I-person
at IN B-VP O
Wellesley NNP B-NP O
House NNP I-NP O
. . B-VP O
   
CARE NNP B-NP O
RECOMMENDATIONS NNP I-NP O
: : O O
1. CD O O
Feedings NNS B-NP O
at IN B-VP O
discharge NN B-NP O
- : O O
Similac NN B-NP B-treatment
24 CD O O
kilocalories NNS B-NP O
per IN B-VP O
ounce NN B-NP O
p.o. NN I-NP O
ad NN I-NP O
lib NN I-NP O
. . B-VP O
   
If IN B-VP O
the DT B-NP B-person
patient NN I-NP I-person
achieves VBZ O O
above IN B-VP O
adequate NN B-NP O
weight VBD B-VP O
gain NN B-NP O
of IN B-VP O
18-20 JJ B-NP O
grams NNS I-NP O
per IN B-VP O
kilogram FW O O
per IN B-VP O
day NN B-NP O
, , O O
consider VB O O
decreasing VBG O O
calories NNS B-NP O
to TO O O
standard VB O O
20 CD O O
kilocalories NNS B-NP O
per IN B-VP O
ounce NN B-NP O
. . B-VP O
   
2. CD O O
Car NNP B-NP B-test
seat NN I-NP I-test
positioning VBG O I-test
screening VBG O I-test
passed VBN O O
. . B-VP O
   
3. CD O O
State NNP B-NP B-test
newborn JJ B-NP I-test
screening NN I-NP I-test
sent VBD B-VP O
per IN B-VP O
protocol NN B-NP O
and CC O O
no DT B-NP O
abnormal JJ I-NP B-problem
reports NNS I-NP I-problem
have VBP O O
been VBN O O
received VBN O O
. . B-VP O
   
4. CD O O
Immunizations NNPS B-NP B-treatment
received VBD B-VP O
: : O O
Synagis NNP B-NP B-treatment
RSV NNP I-NP I-treatment
prophylaxis VBD B-VP I-treatment
given VBN O O
today NN B-NP O
due JJ O O
to TO O O
multiple JJ B-NP B-person
siblings NNS I-NP I-person
at IN B-VP O
home NN B-NP O
with IN B-VP O
daycare JJ B-NP O
exposure NN I-NP O
and CC O O
the DT B-NP B-person
patient NN I-NP I-person
being VBG O O
between IN B-VP O
32 CD O O
and CC O O
35 CD O O
weeks NNS B-NP O
. . B-VP O
   
Synagis NNP B-NP B-treatment
RSV NNP I-NP I-treatment
prophylaxis NN I-NP I-treatment
should MD O O
be VB O O
considered VBN O O
in IN B-VP O
general JJ O O
from IN B-VP O
November NNP B-NP O
through IN B-VP O
March NNP B-NP O
for IN B-VP O
infants NNS B-NP O
who WP O B-person
meet VBP O O
any DT O O
of IN B-VP O
the DT O O
following VBG O O
3 CD O O
criteria NNS B-NP O
: : O O
1. CD O O
Born NNP B-NP O
at IN B-VP O
less JJR O O
than IN B-VP O
32 CD O O
weeks NNS B-NP O
, , O O
2. CD O O
Born NNP B-NP O
between IN B-VP O
32 CD O O
and CC O O
35 CD O O
weeks NNS B-NP O
with IN B-VP O
2 CD O O
of IN B-VP O
the DT B-NP O
following NN I-NP O
: : O O
Daycare NNP B-NP O
during IN B-VP O
RSV NNP B-NP O
season NN I-NP O
, , O O
a DT B-NP O
smoker NN I-NP O
in IN B-VP O
the DT B-NP O
household NN I-NP O
, , O O
neuromuscular JJ B-NP B-problem
disease NN I-NP I-problem
, , O O
airway JJ B-NP B-problem
abnormalities NNS I-NP I-problem
or CC O O
school NN B-NP O
age NN I-NP O
sibling NN I-NP O
, , O O
or CC O O
3. CD O O
With IN B-VP O
chronic JJ B-NP B-problem
lung NN I-NP I-problem
disease NN I-NP I-problem
. . B-VP O
   
Influenza NNP B-NP B-treatment
immunization NN I-NP I-treatment
is VBZ O O
recommended VBN O O
annually RB O O
in IN B-VP O
the DT B-NP O
fall NN I-NP O
for IN B-VP O
all DT B-NP O
infants NNS I-NP O
once IN B-VP O
they PRP O B-pronoun
reach VBP O O
6 CD O O
months NNS B-NP O
of IN B-VP O
age NN B-NP O
. . B-VP O
   
Before IN B-VP O
this DT B-NP B-pronoun
age NN I-NP O
and CC O O
for IN B-VP O
the DT O O
first JJ O O
24 CD O O
months NNS B-NP O
of IN B-VP O
the DT B-NP O
child NN I-NP O
's POS O O
life NN B-NP O
, , O O
immunization NN B-NP B-treatment
against IN B-VP O
influenza NN B-NP B-problem
is VBZ O O
recommended VBN O O
for IN B-VP O
household NN B-NP O
contacts NNS I-NP O
and CC O O
out IN B-VP O
of IN B-VP O
home NN B-NP O
caregivers NNS I-NP O
. . B-VP O
   
FOLLOW NNP B-NP O
UP IN B-VP O
: : O O
VNA NNP B-NP B-person
and CC O O
pediatric JJ B-NP B-person
primary NN I-NP I-person
care NN I-NP I-person
physician JJ B-NP I-person
appointments NNS I-NP O
to TO O O
be VB O O
scheduled VBN O O
prior RB O O
to TO O O
discharge VB O O
. . B-VP O
   
DISCHARGE NNP B-NP O
DIAGNOSES NNP I-NP O
: : O O
1. CD O O
Prematurity NNP B-NP B-problem
. . B-VP O
   
2. CD O O
Apnea NNP B-NP B-problem
of IN B-VP I-problem
prematurity NN B-NP I-problem
. . B-VP O
   
3. CD O O
Rule NN B-NP O
out IN B-VP O
sepsis NN B-NP B-problem
. . B-VP O
   
Carol NNP B-NP B-person
Eddie NNP I-NP I-person
m.d VBD B-VP I-person
00-112 RB O O
Dictated VBN O O
By IN B-VP O
: : O O
John NNP B-NP B-person
KT NNP I-NP I-person
Bolling NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
MEDQUIST36 NNP I-NP O
D NNP I-NP O
: : O O
2014-12-05 JJ O O
15:53:11 CD O O
T NN B-NP O
: : O O
2014-12-05 JJ O O
16:49:10 CD O O
Job NNP B-NP O
# # O O
: : O O
28583 CD O O
Signed VBN O O
electronically RB O O
by IN B-VP O
: : O O
DR. NNP B-NP B-person
Carol NNP I-NP I-person
Warren NNP I-NP I-person
on IN B-VP O
: : O O
MON NNP B-NP O
2014-12-08 CD O O
11:49 CD O O
AM NNP B-NP O
( ( O O
End NNP B-NP O
of IN B-VP O
Report NNP B-NP O
) ) O O
-EMPTYLINE- VBP O O
-DOCSTART- JJ O O
-EMPTYLINE- $ O O
099147779 CD O O
WGH NNP B-NP O
2346613 CD O O
367017 CD O O
2170984 CD O O
11/17/2004 CD O O
12:00:00 CD O O
AM NNP B-NP O
Discharge NNP I-NP O
Summary NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Report NNP I-NP O
Status NNP I-NP O
: : O O
Signed VBD B-VP O
DISCHARGE NNP B-NP O
SUMMARY NNP I-NP O
NAME NN I-NP O
: : O O
BRENOCE NNP B-NP B-person
, , O I-person
T NNP B-NP I-person
N NNP I-NP I-person
UNIT NNP I-NP O
NUMBER NNP I-NP O
: : O O
254-05-39 JJ B-NP O
ADMISSION NNP I-NP O
DATE NNP I-NP O
: : O O
11/17/2004 CD O O
DISCHARGE NNP B-NP O
DATE NNP I-NP O
: : O O
11/26/2004 CD O O
PRINCIPAL NNP B-NP O
DIAGNOSIS NNP I-NP O
: : O O
Pneumonia NNP B-NP B-problem
. . B-VP O
   
ASSOCIATED NNP B-NP O
DIAGNOSIS NNP I-NP O
: : O O
1. CD O O
Pill NNP B-NP B-problem
esophagitis NN I-NP I-problem
. . B-VP O
   
2. CD O O
Right JJ B-NP B-problem
ventricular JJ I-NP I-problem
hypokinesis NN I-NP I-problem
. . B-VP O
   
OPERATIONS NNP B-NP O
/ JJ B-NP O
PROCEDURES NNP I-NP O
: : O O
Dobutamine NNP B-NP B-test
stress NN I-NP I-test
test NN I-NP I-test
, , O O
cardiac JJ B-NP B-test
ultrasound NN I-NP I-test
, , O O
EGD NNP B-NP B-test
, , O O
chest JJS O B-test
x-ray JJ O I-test
, , O O
PICC NNP B-NP B-treatment
placement NN I-NP I-treatment
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
is VBZ O O
a DT B-NP O
62-year-old JJ I-NP O
female NN I-NP O
with IN B-VP O
a DT B-NP O
history NN I-NP O
of IN B-VP O
diabetes NNS B-NP B-problem
mellitus NNS I-NP I-problem
, , O O
hypertension NN B-NP B-problem
, , O O
COPD NNP B-NP B-problem
, , O O
hypercholesterolemia NN B-NP B-problem
, , O O
depression NN B-NP B-problem
and CC O O
CHF NNP B-NP B-problem
who WP O B-person
was VBD B-VP O
lying VBG O O
in IN B-VP O
bed NN B-NP O
on IN B-VP O
the DT B-NP O
night NN I-NP O
prior RB O O
to TO O O
admission NN B-NP O
when WRB O O
she PRP O B-person
developed VBD B-VP O
left-sided JJ B-NP B-problem
chest NN I-NP I-problem
pain NN I-NP I-problem
located VBN O O
in IN B-VP O
the DT B-NP O
mid-breast JJ I-NP O
region NN I-NP O
with IN B-VP O
some DT O B-problem
fluttering VBG O I-problem
her PRP$ O B-person
her PRP$ O I-problem
chest NN B-NP I-problem
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
radiated VBD B-VP O
down IN B-VP O
her PRP$ O B-person
left JJ B-NP O
arm NN I-NP O
associated VBN O O
with IN B-VP O
some DT B-NP B-problem
nausea NN I-NP I-problem
, , O O
no DT B-NP O
shortness NN I-NP B-problem
of IN B-VP I-problem
breath NN B-NP I-problem
, , O O
cough NN B-NP B-problem
, , O O
vomiting VBG O B-problem
, , O O
diarrhea NN B-NP B-problem
. . B-VP O
   
She PRP O B-person
slept VBD B-VP O
through IN B-VP O
the DT B-NP O
night NN I-NP O
, , O O
woke VBD B-VP O
with IN B-VP O
persistent JJ B-NP B-problem
pain NN I-NP I-problem
. . B-VP O
   
She PRP O B-person
went VBD B-VP O
with IN B-VP O
her PRP$ O B-person
her PRP$ O B-person
her PRP$ O B-person
sister NN B-NP I-person
sister NN I-NP I-person
&apos;s NNP I-NP I-person
husband NN I-NP I-person
to TO O O
La NNP B-NP O
Community NNP I-NP O
Hospital NNP I-NP O
where WRB O O
she PRP O B-person
was VBD B-VP O
given VBN O O
sublingual JJ B-NP B-treatment
nitroglycerin NN I-NP I-treatment
with IN B-VP O
complete JJ B-NP O
relief NN I-NP O
of IN B-VP O
pain NN B-NP B-problem
. . B-VP O
   
She PRP O B-person
refused VBD B-VP O
ambulance NN B-NP O
to TO O O
the DT B-NP O
Emergency NNP I-NP O
Room NNP I-NP O
and CC O O
was VBD B-VP O
driven VBN O O
to TO O O
Well NNP B-NP O
General NNP I-NP O
Hospital NNP I-NP O
Emergency NNP I-NP O
Room NNP I-NP O
by IN B-VP O
her PRP$ O B-person
her PRP$ O B-person
sister NN B-NP I-person
. . B-VP O
   
She PRP O B-person
arrived VBD B-VP O
pain RB O B-problem
free JJ O O
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
given VBN O O
Aspirin NNP B-NP B-treatment
, , O O
Lopressor NNP B-NP B-treatment
and CC O O
Insulin NNP B-NP B-treatment
for IN B-VP O
hyperglycemia NN B-NP B-problem
. . B-VP O
   
EKG NNP B-NP B-test
was VBD B-VP O
unchanged JJ O O
compared VBN O O
to TO O O
the DT B-NP B-test
prior JJ I-NP I-test
EKG NNP I-NP I-test
several JJ B-NP O
months NNS I-NP O
ago RB O O
. . B-VP O
   
PAST NNP B-NP O
MEDICAL NNP I-NP O
HISTORY NNP I-NP O
: : O O
Insulin-dependent JJ B-NP B-problem
diabetes NNS I-NP I-problem
mellitus NN I-NP I-problem
, , O O
hypertension NN B-NP B-problem
, , O O
depression NN B-NP B-problem
, , O O
back RB O B-problem
pain NN B-NP I-problem
, , O O
COPD NNP B-NP B-problem
, , O O
allergic JJ B-NP B-problem
rhinitis NN I-NP I-problem
, , O O
GERD NNP B-NP B-problem
, , O O
obesity NN B-NP B-problem
, , O O
hyperlipidemia NN B-NP B-problem
. . B-VP O
   
ALLERGIES NN B-NP O
: : O O
Codeine NNP B-NP B-treatment
, , O O
reaction NN B-NP O
unknown JJ O O
. . B-VP O
   
MEDICATIONS NN B-NP O
: : O O
Atrovent NN B-NP B-treatment
. . B-VP O
   
Aspirin NNP B-NP B-treatment
. . B-VP O
   
Flonase NNP B-NP B-treatment
. . B-VP O
   
Quinine NNP B-NP B-treatment
Celebrex NNP I-NP B-treatment
. . B-VP O
   
Compazine NNP B-NP B-treatment
. . B-VP O
   
Oxybutynin NNP B-NP B-treatment
Amitriptyline NNP I-NP B-treatment
. . B-VP O
   
Zyrtec NNP B-NP B-treatment
. . B-VP O
   
Prozac NNP B-NP B-treatment
. . B-VP O
   
Trazodone NNP B-NP B-treatment
. . B-VP O
   
Humulin NNP B-NP B-treatment
70 CD O O
units NNS B-NP O
bid NN I-NP O
. . B-VP O
   
Albuterol NNP B-NP B-treatment
. . B-VP O
   
Lasix NNP B-NP B-treatment
40 CD O O
PO NNP B-NP O
bid NN I-NP O
. . B-VP O
   
Triamcinolone CD O B-treatment
cream NN B-NP I-treatment
. . B-VP O
   
Miconazole NNP B-NP B-treatment
cream NN I-NP I-treatment
Flovent NNP I-NP B-treatment
. . B-VP O
   
Nifedipine NNP B-NP B-treatment
ER NNP I-NP I-treatment
60 CD O O
daily RB O O
. . B-VP O
   
Lisinopril NNP B-NP B-treatment
, , O O
30 CD O O
daily RB O O
. . B-VP O
   
KCl NNP B-NP B-treatment
10 CD O O
mEq NN B-NP O
q JJ B-NP O
day NN I-NP O
. . B-VP O
   
Protonix NNP B-NP B-treatment
, , O O
40 CD O O
daily RB O O
. . B-VP O
   
Lipitor NNP B-NP B-treatment
, , O O
20 CD O O
daily RB O O
. . B-VP O
   
Methadone CD O B-treatment
10 CD O O
bid NN B-NP O
. . B-VP O
   
FAMILY NNP B-NP O
HISTORY NNP I-NP O
: : O O
Non-contributory JJ O O
. . B-VP O
   
HABITS NNS B-NP O
: : O O
Tobacco NN B-NP O
: : O O
Quit $ O O
20 CD O O
years NNS B-NP O
ago RB O O
. . B-VP O
   
Alcohol NN B-NP O
: : O O
Rare JJ B-NP O
drinks NNS I-NP O
per IN B-VP O
week NN B-NP O
. . B-VP O
   
SOCIAL NNP B-NP O
HISTORY NNP I-NP O
: : O O
Lives VBZ O O
along RB O O
, , O O
takes VBZ O O
care NN B-NP O
of IN B-VP O
herself NN B-NP B-person
. . B-VP O
   
Retired NNP B-NP O
. . B-VP O
   
Used VBN O O
to TO O O
work VB O O
in IN B-VP O
fast JJ B-NP O
food NN I-NP O
. . B-VP O
   
VITAL NNP B-NP O
SIGNS NNP I-NP O
: : O O
On IN B-VP O
admission NN B-NP O
blood NN I-NP B-test
pressure NN I-NP I-test
165/70 CD O O
. . B-VP O
   
temperature NN B-NP B-test
99.8 CD O O
, , O O
pulse RB O B-test
86 CD O O
, , O O
respiratory NN B-NP B-test
rate NN I-NP I-test
18 CD O O
. . B-VP O
   
PHYSICAL JJ B-NP O
EXAMINATION NN I-NP O
: : O O
Obese JJ O B-problem
, , O O
no DT B-NP O
acute JJ I-NP B-problem
distress NN I-NP I-problem
. . B-VP O
   
Multiple JJ B-NP O
tattoos NN I-NP O
. . B-VP O
   
Skin NNP B-NP O
normal JJ O O
. . B-VP O
   
HEENT NNP B-NP O
, , O O
ears VBZ O O
poor JJ B-NP B-problem
hearing NN I-NP I-problem
. . B-VP O
   
Extraocular JJ B-NP O
movements NNS I-NP O
intact JJ O O
. . B-VP O
   
Moist NNP B-NP O
mucous JJ B-NP O
membranes NNS I-NP O
. . B-VP O
   
No DT B-NP O
lymphadenopathy NN I-NP B-problem
. . B-VP O
   
Chest NNP B-NP O
, , O O
lungs VBZ O O
clear JJ O O
to TO O O
auscultation VB O B-test
with IN B-VP O
faint NN B-NP B-problem
wheezes NNS I-NP I-problem
, , O O
no DT B-NP O
rales NNS I-NP B-problem
. . B-VP O
   
Cardiac NNP B-NP O
, , O O
normal JJ B-NP O
S1 NNP I-NP O
, , O O
S2 NNP B-NP O
, , O O
no DT B-NP O
murmurs NN I-NP B-problem
, , O O
rubs NN B-NP B-problem
or CC O O
gallops NNS B-NP B-problem
. . B-VP O
   
Abdomen NNP B-NP O
soft JJ O O
, , O O
nontender NN B-NP B-problem
, , O O
nondistended VBD B-VP B-problem
. . B-VP O
   
Positive NNP B-NP O
bowel NN I-NP O
sounds NNS I-NP O
. . B-VP O
   
Neurologic NN B-NP O
: : O O
Alert NNP B-NP O
and CC O O
oriented VBN O O
x3 NNP B-NP O
. . B-VP O
   
Cranial NNP B-NP O
nerves NNS I-NP O
II NNP I-NP O
through IN B-VP O
XII NNP B-NP O
intact JJ O O
. . B-VP O
   
Motor NNP B-NP O
and CC O O
sensory JJ B-NP O
intact NN I-NP O
. . B-VP O
   
Extremities NNS B-NP O
: : O O
Feet NNP B-NP O
no DT B-NP O
edema NN I-NP B-problem
. . B-VP O
   
Pulses VBZ O O
2+ CD O B-test
PT NNP B-NP I-test
and CC O O
DP NNP B-NP B-test
. . B-VP O
   
LABORATORY NN B-NP O
: : O O
Unremarkable JJ O O
with IN B-VP O
normal JJ B-NP O
electrolytes NNS I-NP O
except IN B-VP O
for IN B-VP O
glucose NN B-NP B-test
of IN B-VP O
328 CD O O
. . B-VP O
   
CBC NNP B-NP B-test
, , O O
white JJ B-NP B-test
count NN I-NP I-test
6.7 CD O O
, , O O
hematocrit NN B-NP B-test
37.4 CD O O
, , O O
platelets NNS B-NP B-test
280 CD O O
. . B-VP O
   
Chest JJS B-NP B-test
x-ray NN I-NP I-test
was VBD B-VP O
low JJ B-NP B-problem
lung NN I-NP I-problem
volumes NNS I-NP I-problem
, , O O
no DT B-NP O
consolidation NN I-NP B-problem
. . B-VP O
   
EKG NNP B-NP B-test
showed VBD B-VP O
sinus JJ B-NP B-problem
brady NN I-NP I-problem
at IN B-VP O
16 CD O O
, , O O
normal JJ B-NP O
axis NN I-NP O
, , O O
normal JJ B-NP O
intervals NNS I-NP O
, , O O
no DT B-NP O
STT NNP I-NP B-problem
wave NN I-NP I-problem
abnormalities NNS I-NP I-problem
. . B-VP O
   
HOSPITAL NNP B-NP O
COURSE NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
admitted VBN O O
to TO O O
Team VB O O
Four NNP B-NP O
for IN B-VP O
cardiac JJ B-NP O
monitoring NN I-NP O
and CC O O
ruling VBG O O
out RP O O
for IN B-VP O
MI NNP B-NP B-problem
. . B-VP O
   
Hospital NNP B-NP O
course NN I-NP O
by IN B-VP O
system NN B-NP O
: : O O
1. CD O O
Cardiovascular NN B-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
ruled VBD B-VP O
out RP O O
for IN B-VP O
MI NNP B-NP B-problem
by IN B-VP O
cardiac JJ B-NP B-test
markers NNS I-NP I-test
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
set VBN O O
to TO O O
go VB O O
for IN B-VP O
a DT B-NP B-test
dobutamine NN I-NP I-test
stress NN I-NP I-test
test NN I-NP I-test
on IN B-VP O
11/16/04 CD O O
given VBN O O
her PRP$ O B-person
history NN B-NP O
of IN B-VP O
COPD NNP B-NP B-problem
, , O O
but CC O O
the DT B-NP B-test
stress JJ I-NP I-test
portion NN I-NP I-test
was VBD B-VP O
canceled VBN O O
when WRB O O
she PRP O B-person
was VBD B-VP O
down RB O O
there RB O O
due JJ O O
to TO O O
fever VB O B-problem
and CC O O
hypotension NN B-NP B-problem
. . B-VP O
   
The DT B-NP O
next JJ I-NP O
day NN I-NP O
, , O O
she PRP O B-person
underwent VBD B-VP O
a DT B-NP B-test
cardiac JJ I-NP I-test
echo NN I-NP I-test
( ( O I-test
transthoracic JJ B-NP I-test
echocardiogram NN I-NP I-test
) ) O I-test
. . B-VP O
   
This DT O B-pronoun
This DT B-NP B-test
echo NN I-NP I-test
showed VBD B-VP O
LV NNP B-NP B-test
ejection NN I-NP I-test
fraction NN I-NP I-test
of IN B-VP O
50% CD O O
with IN B-VP O
no DT B-NP O
wall NN I-NP B-problem
motion NN I-NP I-problem
abnormality NN I-NP I-problem
. . B-VP O
   
However RB O O
, , O O
the DT B-NP O
right JJ I-NP O
ventricular NN I-NP O
was VBD B-VP O
diffusely RB O B-problem
hypokinetic JJ O I-problem
. . B-VP O
   
It PRP O B-pronoun
was VBD B-VP O
suboptimally RB O O
imaged VBN O O
, , O O
so IN B-VP O
there EX O O
was VBD B-VP O
no DT B-NP O
RVSP NNP I-NP B-test
given VBN O O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
also RB O O
suffered VBD B-VP O
a DT B-NP B-problem
hypotensive JJ I-NP I-problem
episode NN I-NP I-problem
while IN B-VP O
in IN B-VP O
the DT B-NP O
endoscopy NN I-NP O
suite NN I-NP O
for IN B-VP O
her PRP$ O B-person
her PRP$ O B-test
EGD NN B-NP I-test
on IN B-VP O
11/17/04 CD O O
. . B-VP O
   
This DT O B-pronoun
responded VBD B-VP O
to TO O O
fluid VB O B-treatment
bolus NN B-NP I-treatment
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
then RB O O
transferred VBN O O
to TO O O
Medicine NNP B-NP O
Team NNP I-NP O
D NNP I-NP O
given VBN O O
her PRP$ O B-person
her PRP$ O B-problem
tenuous JJ B-NP I-problem
hemodynamic JJ I-NP I-problem
status NN I-NP I-problem
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
, , O O
several JJ B-NP O
days NNS I-NP O
later RB O O
11/23 CD O O
, , O O
underwent JJ O O
another DT B-NP B-test
dobutamine NN I-NP I-test
stress NN I-NP I-test
test NN I-NP I-test
. . B-VP O
   
This DT O B-pronoun
This DT B-NP B-test
stress JJ I-NP I-test
test NN I-NP I-test
, , O O
although IN B-VP O
complicated VBN O O
by IN B-VP O
hypotension NN B-NP B-problem
again RB O O
, , O O
to TO O O
the DT O O
60 CD O O
&apos;s NN B-NP O
or CC O O
70 CD O O
&apos;s NN B-NP O
was VBD B-VP O
completed VBN O O
and CC O O
there EX O O
was VBD B-VP O
some DT B-NP B-problem
mild JJ I-NP I-problem
anterior JJ I-NP I-problem
septal NN I-NP I-problem
thinning NN I-NP I-problem
, , O O
but CC O O
no DT B-NP O
evidence NN I-NP O
of IN B-VP O
ischemia NN B-NP B-problem
and CC O O
an DT B-NP B-test
EF NN I-NP I-test
from IN B-VP O
this DT O B-pronoun
this DT B-NP B-test
test NN I-NP I-test
was VBD B-VP O
76% CD O O
. . B-VP O
   
Clearly RB O O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
&apos;s NNP I-NP O
hemodynamic VBD B-VP O
vascular JJ B-NP O
status NN I-NP O
was VBD B-VP O
very RB O O
sensitive JJ O O
to TO O O
dobutamine VB O B-treatment
. . B-VP O
   
2. CD O O
Infectious JJ B-NP O
Disease NN I-NP O
: : O O
On IN B-VP O
hospital NN B-NP O
day NN I-NP O
#2 NNP I-NP O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
noted VBN O O
to TO O O
have VB O O
increased VBN O B-problem
dyspnea NN B-NP I-problem
on IN B-VP O
exertion NN B-NP O
. . B-VP O
   
The DT B-NP O
next JJ I-NP O
day NN I-NP O
she PRP O B-person
developed VBD B-VP O
a DT B-NP B-problem
fever NN I-NP I-problem
and CC O O
she PRP O B-person
was VBD B-VP O
started VBN O O
on IN B-VP O
levofloxacin NN B-NP B-treatment
for IN B-VP O
a DT B-NP O
potential JJ I-NP O
UTI NN I-NP B-problem
. . B-VP O
   
She PRP O B-person
continued VBD B-VP O
to TO O O
have VB O O
low-grade JJ B-NP B-problem
fevers NNS I-NP I-problem
and CC O O
on IN B-VP O
the DT B-NP O
next JJ I-NP O
day NN I-NP O
, , O O
11/17/04 CD O O
, , O O
her PRP$ O B-person
her PRP$ O B-test
chest NN B-NP I-test
x-ray NN I-NP I-test
showed VBD B-VP O
possible JJ B-NP O
new JJ I-NP B-problem
right JJ I-NP I-problem
upper JJ I-NP I-problem
lobe NN I-NP I-problem
infiltrates NNS I-NP I-problem
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
then RB O O
started VBN O O
on IN B-VP O
ceftriaxone NN B-NP B-treatment
and CC O O
azithromycin NN B-NP B-treatment
. . B-VP O
   
Her PRP$ O B-person
Her PRP$ O B-test
urine JJ B-NP I-test
legionella NN I-NP I-test
antigen NN I-NP I-test
was VBD B-VP O
negative JJ O O
. . B-VP O
   
On IN B-VP O
11/22/04 CD O O
, , O O
she PRP O B-person
was VBD B-VP O
noted VBN O O
to TO O O
have VB O O
gram-positive JJ B-NP B-problem
cocci NN I-NP I-problem
in IN B-VP O
her PRP$ O B-person
sputum NN B-NP O
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
started VBN O O
on IN B-VP O
vancomycin NN B-NP B-treatment
for IN B-VP O
this DT O B-pronoun
. . B-VP O
   
These DT O B-pronoun
These DT B-NP B-problem
bacteria NNS I-NP I-problem
turned VBD B-VP O
out RP O O
to TO O O
be VB O O
MRSA NNP B-NP B-problem
and CC O O
she PRP O B-person
was VBD B-VP O
continued VBN O O
on IN B-VP O
her PRP$ O B-person
her PRP$ O B-treatment
vancomycin NN B-NP I-treatment
. . B-VP O
   
She PRP O B-person
had VBD B-VP O
PICC NNP B-NP B-treatment
line NN I-NP I-treatment
placed VBN O O
on IN B-VP O
the DT B-NP O
day NN I-NP O
prior RB O O
to TO O O
discharge VB O O
for IN B-VP O
home NN B-NP B-treatment
vancomycin NN I-NP I-treatment
administration NN I-NP I-treatment
. . B-VP O
   
3. CD O O
GI NN B-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
had VBD B-VP O
an DT B-NP O
episode NN I-NP O
of IN B-VP O
nausea NN B-NP B-problem
on IN B-VP O
the DT B-NP O
morning NN I-NP O
of IN B-VP O
11/16/04 CD O O
associated VBN O O
with IN B-VP O
some DT B-NP B-problem
cough NN I-NP I-problem
, , O O
apparent JJ B-NP B-problem
emesis NN I-NP I-problem
. . B-VP O
   
GI NNP B-NP B-person
was VBD B-VP O
consulted VBN O O
for IN B-VP O
an DT B-NP B-test
EGD NNP I-NP I-test
, , O O
however RB O O
, , O O
while IN B-VP O
she PRP O B-person
was VBD B-VP O
in IN B-VP O
the DT B-NP O
Endoscopy NNP I-NP O
Suite NNP I-NP O
, , O O
as IN B-VP O
mentioned VBN O O
above IN B-VP O
, , O O
she PRP O B-person
had VBD B-VP O
a DT B-NP B-problem
hypotensive JJ I-NP I-problem
episode NN I-NP I-problem
, , O O
which WDT O B-pronoun
responded VBD B-VP O
to TO O O
some DT B-NP B-treatment
fluid NN I-NP I-treatment
boluses NNS I-NP I-treatment
. . B-VP O
   
Finally RB O O
, , O O
on IN B-VP O
the DT B-NP O
day NN I-NP O
prior RB O O
to TO O O
discharge VB O O
, , O O
she PRP O B-person
was VBD B-VP O
stabilized VBN O O
to TO O O
the DT B-NP O
point NN I-NP O
that IN B-VP B-pronoun
she PRP O B-person
could MD O O
have VB O O
her PRP$ O B-person
her PRP$ O B-test
EGD NNP B-NP I-test
. . B-VP O
   
The DT B-NP B-test
EGD NNPS I-NP I-test
did VBD B-VP O
show VB O O
three CD O B-problem
esophageal JJ B-NP I-problem
ulcers NNS I-NP I-problem
that WDT O B-pronoun
were VBD B-VP O
localized VBN O O
and CC O O
apparent JJ B-NP O
suggestion NN I-NP O
of IN B-VP O
pill NN B-NP B-problem
esophagitis NN I-NP I-problem
. . B-VP O
   
Her PRP$ O B-person
stomach NN B-NP O
and CC O O
duodenum NN B-NP O
were VBD B-VP O
normal JJ O O
and CC O O
it PRP O B-pronoun
was VBD B-VP O
suggested VBN O O
that IN B-VP B-pronoun
she PRP O B-person
change VBD B-VP O
her PRP O B-person
her PRP$ O B-treatment
Nexium NN B-NP I-treatment
doses VBZ O I-treatment
to TO O O
daily VB O O
and CC O O
that IN B-VP B-pronoun
she PRP O B-person
also RB O O
drink VBP O O
plenty NN B-NP O
of IN B-VP O
fluids NNS B-NP O
and CC O O
water NN B-NP O
with IN B-VP O
meals NNS B-NP O
, , O O
sit NN B-NP O
upright NN I-NP O
when WRB O O
she PRP O B-person
would MD O O
eat VB O O
her PRP$ O B-person
meals NNS B-NP O
to TO O O
decrease VB O O
the DT B-NP O
chance NN I-NP O
of IN B-VP O
pills NNS B-NP B-treatment
eroding VBG O O
her PRP$ O B-person
esophagus NN B-NP O
. . B-VP O
   
4. CD O O
Shortness NNP B-NP B-problem
of IN B-VP I-problem
breath NN B-NP I-problem
: : O O
As IN B-VP O
mentioned VBN O O
above IN B-VP O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
did VBD B-VP O
develop VB O O
MRSA NNP B-NP B-problem
pneumonia NN I-NP I-problem
that WDT O B-pronoun
was VBD B-VP O
started VBN O O
to TO O O
be VB O O
treated VBN O O
with IN B-VP O
vancomycin NN B-NP B-treatment
and CC O O
she PRP O B-person
did VBD B-VP O
also RB O O
develop VB O O
an DT B-NP B-problem
oxygen NN I-NP I-problem
requirement NN I-NP I-problem
the DT B-NP O
day NN I-NP O
prior RB O O
to TO O O
discharge VB O O
. . B-VP O
   
At IN B-VP O
most JJS O O
, , O O
her PRP$ O B-person
her PRP$ O B-problem
oxygen NN B-NP I-problem
requirement NN I-NP I-problem
was VBD B-VP O
4-5 JJ B-NP O
liters NNS I-NP O
and CC O O
on IN B-VP O
the DT B-NP O
day NN I-NP O
prior RB O O
to TO O O
discharge VB O O
, , O O
she PRP O B-person
was VBD B-VP O
satting VBG O O
well RB O O
on IN B-VP O
two CD O O
liters NNS B-NP O
of IN B-VP O
nasal JJ B-NP B-treatment
cannula NN I-NP I-treatment
. . B-VP O
   
This DT O B-pronoun
was VBD B-VP O
thought VBN O O
to TO O O
be VB O O
due JJ O O
to TO O O
her PRP$ O B-person
her PRP$ O B-problem
pneumonia NN B-NP I-problem
; : O O
however RB O O
, , O O
with IN B-VP O
her PRP$ O B-person
her PRP$ O B-problem
right JJ B-NP I-problem
ventricular JJ I-NP I-problem
hypokinesis NN I-NP I-problem
, , O O
it PRP O B-pronoun
is VBZ O O
also RB O O
possible JJ O O
that IN B-VP B-pronoun
she PRP O B-person
may MD O O
have VB O O
an DT B-NP O
element NN I-NP O
of IN B-VP O
pulmonary JJ B-NP B-problem
hypertension NN I-NP I-problem
and CC O O
may MD O O
warrant VB O O
further JJ B-NP O
investigation NN I-NP O
as IN B-VP O
an DT B-NP O
outpatient NN I-NP O
, , O O
for IN B-VP O
example NN B-NP O
, , O O
with IN B-VP O
chest JJ B-NP B-test
CT NNP I-NP I-test
. . B-VP O
   
5. CD O O
Derm NNPS B-NP O
: : O O
Several JJ B-NP O
days NNS I-NP O
prior RB O O
to TO O O
discharge VB O O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
developed VBD B-VP O
some DT B-NP B-problem
erythematous JJ I-NP I-problem
rash NN I-NP I-problem
under IN B-VP O
her PRP$ O B-person
left JJ B-NP O
breast NN I-NP O
and CC O O
left VBD B-VP O
side NN B-NP O
that IN B-VP B-pronoun
was VBD B-VP O
thought VBN O O
to TO O O
be VB O O
due JJ O O
to TO O O
yeast VB O B-problem
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
started VBN O O
on IN B-VP O
some DT B-NP B-treatment
Miconazole NNP I-NP I-treatment
Cream NNP I-NP I-treatment
. . B-VP O
   
The DT B-NP B-problem
rash NN I-NP I-problem
was VBD B-VP O
always RB O O
localized VBN O O
to TO O O
her PRP$ O B-person
left JJ B-NP O
side NN I-NP O
, , O O
sometimes RB O O
extending VBG O O
down RP O O
to TO O O
her PRP$ O B-person
leg NN B-NP O
, , O O
but CC O O
never RB O O
on IN B-VP O
the DT B-NP O
right JJ I-NP O
side NN I-NP O
. . B-VP O
   
The DT B-NP B-problem
rash NN I-NP I-problem
appeared VBD B-VP O
to TO O O
be VB O O
resolving VBG O O
by IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
discharge NN B-NP O
. . B-VP O
   
MEDICATIONS NNP B-NP O
ON NNP I-NP O
DISCHARGE NNP I-NP O
: : O O
Tums NNS B-NP B-treatment
, , O O
500-1250 JJ B-NP O
mg NN I-NP O
PO NNP I-NP O
tid NN I-NP O
. . B-VP O
   
Albuterol NNP B-NP B-treatment
inhaler NN I-NP I-treatment
. . B-VP O
   
Lipitor NNP B-NP B-treatment
, , O O
20 CD O O
daily RB O O
. . B-VP O
   
Prozac NNP B-NP B-treatment
, , O O
60 CD O O
daily RB O O
. . B-VP O
   
Flovent NNP B-NP B-treatment
inhaler NN I-NP I-treatment
, , O O
220 CD O O
mcg NN B-NP O
bid NN I-NP O
. . B-VP O
   
Atrovent NNP B-NP B-treatment
, , O O
two CD O O
puffs NNS B-NP O
qid RB O O
. . B-VP O
   
Ditropan NNP B-NP B-treatment
, , O O
5 CD O O
mg NN B-NP O
tid NN I-NP O
. . B-VP O
   
Colace NNP B-NP B-treatment
, , O O
100 CD O O
mg NN B-NP O
tid NN I-NP O
. . B-VP O
   
Aspirin NNP B-NP B-treatment
, , O O
325 CD O O
mg JJ O O
daily RB O O
. . B-VP O
   
Insulin NNP B-NP B-treatment
NPH NNP I-NP I-treatment
, , O O
36 CD O O
subcu NN B-NP O
q NN I-NP O
AM NNP I-NP O
, , O O
30 CD O O
subcu NN B-NP O
q NN I-NP O
PM NNP I-NP O
. . B-VP O
   
Nystatin NNP B-NP B-treatment
Mouthwash NNP I-NP I-treatment
Swish NNP I-NP O
and CC O O
Swallow NNP B-NP O
. . B-VP O
   
Nexium NNP B-NP B-treatment
, , O O
20 CD O O
mg NN B-NP O
PO NNP I-NP O
daily RB O O
. . B-VP O
   
Vancomycin NNP B-NP B-treatment
1 CD O O
gm NN B-NP O
IV NNP I-NP O
q12h NN I-NP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
will MD O O
follow-up VB O O
with IN B-VP O
her PRP$ O B-person
her PRP$ O B-person
primary JJ B-NP I-person
care NN I-NP I-person
provider NN I-NP I-person
, , O O
Dr. NNP B-NP B-person
Na NNP I-NP I-person
Fongbain NNP I-NP I-person
at IN B-VP O
the DT B-NP O
Cord NNP I-NP O
Memorial NNP I-NP O
Hospital NNP I-NP O
. . B-VP O
   
IEVE NNP B-NP B-person
MANUAL NNP I-NP I-person
, , O I-person
MD NNP B-NP I-person
DICTATING NNP I-NP O
FOR NNP I-NP O
: : O O
Electronically RB O O
Signed VBD B-VP O
IEVE NNP B-NP B-person
MANUAL NNP I-NP I-person
, , O I-person
MD NNP B-NP I-person
12/23/2004 CD O O
11:19 CD O O
_____________________________ NNS B-NP O
IEVE NNP I-NP B-person
MANUAL NNP I-NP I-person
, , O I-person
MD NNP B-NP I-person
TR NNP I-NP O
: : O O
mm NN B-NP O
DD NNP I-NP O
: : O O
11/25/2004 CD O O
TD NN B-NP O
: : O O
11/25/2004 CD O O
8:49 CD O O
P NNP B-NP O
367017 CD O O
cc NN B-NP O
: : O O
IEVE NNP B-NP B-person
MANUAL NNP I-NP I-person
, , O I-person
MD NNP B-NP I-person
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
Admission NNP I-NP O
Date NNP I-NP O
: : O O
2015-10-28 JJ B-NP O
Discharge NN I-NP O
Date NNP I-NP O
: : O O
2015-11-13 JJ B-NP O
Date NNP I-NP O
of IN B-VP O
Birth NNP B-NP O
: : O O
1941-08-30 JJ B-NP O
Sex NN I-NP O
: : O O
F NNP B-NP O
Service NNP I-NP O
: : O O
CARDIOTHORACIC JJ B-NP O
Allergies NNS I-NP O
: : O O
Tape NN B-NP O
/ VBZ O O
Benadryl NNP B-NP B-treatment
Attending NNP I-NP B-person
:Jordan NNP I-NP B-person
U NNP I-NP I-person
Kostohryz NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
Chief NNP I-NP O
Complaint NNP I-NP O
: : O O
Chest JJS B-NP B-problem
discomfort NN I-NP I-problem
Major NNP I-NP O
Surgical NNP I-NP O
or CC O O
Invasive JJ B-NP O
Procedure NN I-NP O
: : O O
2015-10-30 JJ B-NP O
Left NNP I-NP B-treatment
Carotid NNP I-NP I-treatment
Stenting NNP I-NP I-treatment
2015-11-02 JJ B-NP O
Coronary NNP I-NP B-treatment
Artery NNP I-NP I-treatment
Bypass NNP I-NP I-treatment
Graft NNP I-NP I-treatment
x VBD B-VP O
2 CD O O
( ( O O
Lima NNP B-NP B-treatment
to TO O I-treatment
LAD NNP B-NP I-treatment
, , O O
SVG NNP B-NP B-treatment
to TO O I-treatment
OM NNP B-NP I-treatment
) ) O O
History NNP B-NP O
of IN B-VP O
Present NNP B-NP O
Illness NNP I-NP O
: : O O
Ms. NNP B-NP B-person
Bridge NNP I-NP I-person
is VBZ O O
a DT O O
74 CD O O
y/o NN B-NP O
female NN I-NP O
admitted VBD B-VP O
to TO O O
outside JJ B-NP O
hospital NN I-NP O
on IN B-VP O
2015-10-21 JJ O O
with IN B-VP O
chest JJS B-NP B-problem
discomfort NN I-NP I-problem
, , O O
vomiting VBG O B-problem
and CC O O
shortness NN B-NP B-problem
of IN B-VP I-problem
breath NN B-NP I-problem
. . B-VP O
   
Initial JJ B-NP B-test
EKG NNP I-NP I-test
showed VBD B-VP O
ST NNP B-NP B-problem
depressions NNS I-NP I-problem
, , O O
but CC O O
cardiac JJ B-NP B-test
enzymes NNS I-NP I-test
were VBD B-VP O
not RB O O
elevated VBN O B-problem
. . B-VP O
   
She PRP O B-person
eventually RB O O
underwent VBD B-VP O
a DT B-NP B-test
cardiac JJ I-NP I-test
cath NN I-NP I-test
to TO O O
assess VB O O
coronary JJ B-NP B-problem
disease NN I-NP I-problem
which WDT O B-pronoun
revealed VBD B-VP O
three CD O B-problem
vessel NN B-NP I-problem
coronary JJ B-NP I-problem
artery NN I-NP I-problem
disease NN I-NP I-problem
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
then RB O O
transferred VBN O O
to TO O O
The DT B-NP O
Hospital NNP I-NP O
for IN B-VP O
Orthopedics NNP B-NP O
for IN B-VP O
surgical JJ B-NP B-treatment
intervention NN I-NP I-treatment
. . B-VP O
   
Past NNP B-NP O
Medical JJ B-NP O
History NN I-NP O
: : O O
Coronary JJ B-NP B-problem
Artery NNP I-NP I-problem
Disease NNP I-NP I-problem
, , O O
Hypertension NNP B-NP B-problem
, , O O
Hyperlipidemia NNP B-NP B-problem
, , O O
Diabetes NNP B-NP B-problem
Mellitus NNP I-NP I-problem
, , O O
Hypothyroid NNP B-NP B-problem
, , O O
h/o JJ B-NP O
Bilateral NNP I-NP B-problem
DVT NNP I-NP I-problem
's POS O O
( ( O O
on IN B-VP O
chronic NN B-NP B-treatment
coumadin NN I-NP I-treatment
therapy NN I-NP I-treatment
), NNP I-NP O
Pleural NNP I-NP B-problem
disorder NN I-NP I-problem
? . B-VP O
Sarcoidosis NNP B-NP B-problem
, , O O
Gastritis NNP B-NP B-problem
, , O O
B12 NNP B-NP B-problem
deficiency NN I-NP I-problem
, , O O
Chronic NNP B-NP B-problem
renal JJ B-NP I-problem
insufficiency NN I-NP I-problem
, , O O
s/p JJ B-NP O
Appendectomy NNP I-NP B-treatment
, , O O
s/p NN B-NP O
Lap NNP I-NP B-treatment
cholectomy NN I-NP I-treatment
, , O O
s/p JJ B-NP O
Total NNP I-NP B-treatment
abdominal JJ B-NP I-treatment
hysterectomy NN I-NP I-treatment
Social NNP I-NP O
History NNP I-NP O
: : O O
Denies VBZ O O
tobacco NN B-NP O
or CC O O
ETOH NNP B-NP O
use NN I-NP O
. . B-VP O
   
Lives VBZ O O
wth JJ B-NP O
husband NN I-NP B-person
. . B-VP O
   
Family JJ B-NP O
History NN I-NP O
: : O O
Mother NNP B-NP B-person
died VBD B-VP O
of IN B-VP O
MI NNP B-NP B-problem
at IN B-VP O
age NN B-NP O
55 CD O O
. . B-VP O
   
Brother NNP B-NP B-person
w/ VBD B-VP O
CAD NNP B-NP B-problem
since IN B-VP O
age NN B-NP O
40 CD O O
and CC O O
died VBD B-VP O
in IN B-VP O
70 CD O O
's POS O O
after IN B-VP O
cardiac JJ B-NP B-treatment
surgery NN I-NP I-treatment
. . B-VP O
   
Son NNP B-NP B-person
died VBD B-VP O
at IN B-VP O
14 CD O O
d/t NN B-NP O
ASD NNP I-NP B-problem
. . B-VP O
   
Physical JJ B-NP O
Exam NN I-NP O
: : O O
Gen NN B-NP O
: : O O
NAD NNP B-NP B-problem
Neck NNP I-NP O
: : O O
Supple NN B-NP O
, , O O
- : O O
JVD NN B-NP B-problem
, , O O
- : O O
Bruits NNS B-NP B-problem
Heart NNP I-NP O
: : O O
RRR NNP B-NP O
- : O O
c/r/m/g NN B-NP B-problem
Lungs NNS I-NP O
: : O O
CTAB NNP B-NP O
, , O O
coarse JJ B-NP B-problem
Abd NNP I-NP O
: : O O
Soft JJ O O
, , O O
NT/NT NNP B-NP B-problem
+ NNP I-NP O
BS NNP I-NP O
Ext NNP I-NP O
: : O O
Cool NNP B-NP O
, , O O
1 CD O O
+ NN B-NP O
pedal NN I-NP B-test
pulses NNS I-NP I-test
, , O O
- : O O
varicosities NNS B-NP B-problem
, , O O
- : O O
edema NN B-NP B-problem
Neuro NNP I-NP O
: : O O
A&O NNP B-NP O
x VBZ O O
3 CD O O
, , O O
MAE NNP B-NP O
, , O O
non-focal JJ O O
Some DT B-NP B-problem
rashes NNS I-NP I-problem
on IN B-VP I-problem
ACW NNP B-NP I-problem
around IN B-VP O
EKG NNP B-NP B-treatment
leads VBZ O I-treatment
Pertinent JJ B-NP O
Results NNS I-NP O
: : O O
CNIS JJ B-NP B-test
10-29 NNS I-NP O
: : O O
1. CD O O
60-69% JJ B-NP B-problem
stenosis NN I-NP I-problem
of IN B-VP I-problem
the DT B-NP I-problem
right JJ I-NP I-problem
internal JJ I-NP I-problem
carotid NN I-NP I-problem
artery NN I-NP I-problem
. . B-VP O
   
2. CD O O
80-99% JJ B-NP B-problem
stenosis NN I-NP I-problem
of IN B-VP I-problem
the DT B-NP I-problem
left JJ I-NP I-problem
internal JJ I-NP I-problem
carotid NN I-NP I-problem
artery NN I-NP I-problem
. . B-VP O
   
Echo JJ O B-test
11-02 JJ O O
: : O O
PRE-BYPASS NN B-NP O
: : O O
Left NNP B-NP O
ventricular VBZ O O
wall NN B-NP O
thickness NN I-NP O
, , O O
cavity NN B-NP O
size NN I-NP O
, , O O
and CC O O
systolic JJ B-NP O
function NN I-NP O
are VBP O O
normal JJ O O
( ( O O
LVEF>55% NNP B-NP B-test
). NNP I-NP O
Resting NNP I-NP B-problem
regional JJ B-NP I-problem
wall NN I-NP I-problem
motion NN I-NP I-problem
abnormalities NNS I-NP I-problem
include VBP O O
mild JJ B-NP B-problem
apical JJ I-NP I-problem
hypokinesis NN I-NP I-problem
. . B-VP O
   
The DT B-NP O
aortic JJ I-NP O
valve NN I-NP O
leaflets NNS I-NP O
( ( O O
3 CD O O
) ) O O
appear VBP O O
structurally RB O O
normal JJ O O
with IN B-VP O
good JJ B-NP O
leaflet NN I-NP O
excursion NN I-NP O
and CC O O
no DT B-NP O
aortic JJ I-NP B-problem
regurgitation NN I-NP I-problem
. . B-VP O
   
The DT B-NP O
mitral JJ I-NP O
valve NN I-NP O
appears VBZ O O
structurally RB O O
normal JJ O O
with IN B-VP O
trivial JJ B-NP B-problem
mitral JJ I-NP I-problem
regurgitation NN I-NP I-problem
. . B-VP O
   
There EX O O
are VBP O O
complex JJ O B-problem
(> $ O I-problem
4 CD O I-problem
mm NN B-NP I-problem
) ) O I-problem
atheroma NN B-NP I-problem
in IN B-VP I-problem
the DT B-NP I-problem
descending NN I-NP I-problem
thoracic NN I-NP I-problem
aorta NN I-NP I-problem
. . B-VP O
   
Mild NNP B-NP B-problem
tricuspid JJ B-NP I-problem
regurgitation NN I-NP I-problem
. . B-VP O
   
POST-BYPASS NN B-NP O
: : O O
Preserved VBN O O
Kindred NNP B-NP O
/ NNP I-NP O
North NNP I-NP O
Shore NNP I-NP O
- : O O
ventricular JJ B-NP O
systolic JJ I-NP O
fxn NN I-NP O
. . B-VP O
   
Trivial JJ B-NP B-problem
MR NNP I-NP I-problem
. . B-VP O
   
Edith NNP B-NP O
AI NNP I-NP O
. . B-VP O
   
Aorta NNP B-NP O
intact JJ O O
. . B-VP O
   
CT JJ O B-test
11-04 JJ O O
: : O O
No DT B-NP O
acute JJ I-NP B-problem
intracranial JJ I-NP I-problem
hemorrhage NN I-NP I-problem
. . B-VP O
   
Findings NNS B-NP O
consistent JJ O O
with IN B-VP O
small JJ B-NP B-problem
vessel NNS I-NP I-problem
ischemic JJ B-NP I-problem
changes NNS I-NP I-problem
. . B-VP O
   
MRI NNP B-NP B-test
would MD O O
be VB O O
more RBR O O
sensitive JJ O O
for IN B-VP O
the DT B-NP O
detection NN I-NP O
of IN B-VP O
acute JJ B-NP B-problem
infarction NN I-NP I-problem
. . B-VP O
   
CT NNP B-NP B-test
angiogram JJ O I-test
demonstrates VBZ O O
no DT B-NP O
stenosis NN I-NP B-problem
or CC O O
aneurysm NN B-NP B-problem
in IN B-VP I-problem
the DT B-NP I-problem
intracranial JJ I-NP I-problem
circulation NN I-NP I-problem
. . B-VP O
   
Slight NNP B-NP B-problem
irregularity NN I-NP I-problem
of IN B-VP O
the DT B-NP O
origin NN I-NP O
of IN B-VP O
the DT B-NP O
right JJ I-NP O
vertebral JJ I-NP O
artery NN I-NP O
may MD O O
be VB O O
atherosclerotic JJ O B-problem
in IN B-VP O
nature NN B-NP O
. . B-VP O
   
Normal NNP B-NP O
contrast NN I-NP O
enhancement NN I-NP O
seen VBN O O
in IN B-VP O
the DT B-NP B-treatment
left JJ I-NP I-treatment
common/internal JJ I-NP I-treatment
carotid NN I-NP I-treatment
artery NN I-NP I-treatment
stent NN I-NP I-treatment
. . B-VP O
   
Mild NNP B-NP B-problem
stenosis NN I-NP I-problem
of IN B-VP I-problem
the DT B-NP I-problem
proximal JJ I-NP I-problem
right JJ I-NP I-problem
internal JJ I-NP I-problem
carotid NN I-NP I-problem
artery NN I-NP I-problem
. . B-VP O
   
4 CD O B-problem
mm NN B-NP I-problem
left VBD B-VP I-problem
upper JJ B-NP I-problem
lobe NN I-NP I-problem
lung NN I-NP I-problem
nodule NN I-NP I-problem
. . B-VP O
   
In IN B-VP O
the DT B-NP O
absence NN I-NP O
of IN B-VP O
history NN B-NP O
of IN B-VP O
malignancy NN B-NP B-problem
, , O O
this DT O B-pronoun
is VBZ O O
statistically RB O O
benign JJ O O
. . B-VP O
   
One-year JJ B-NP O
followup NN I-NP O
may MD O O
be VB O O
considered VBN O O
. . B-VP O
   
CXR JJ O B-test
11-06 JJ O O
: : O O
Allowing NN B-NP O
for IN B-VP O
technical JJ B-NP O
changes NNS I-NP O
, , O O
no DT B-NP O
major JJ I-NP B-problem
adverse JJ I-NP I-problem
interval NN I-NP I-problem
change NN I-NP I-problem
has VBZ O O
occurred VBN O O
. . B-VP O
   
Bibasilar NNP B-NP B-problem
subsegmental JJ B-NP I-problem
atelectasis NN I-NP I-problem
together RB O O
with IN B-VP O
bilateral JJ B-NP B-problem
pleural JJ I-NP I-problem
effusions NNS I-NP I-problem
appear VBP O O
relatively RB O O
unchanged JJ O O
. . B-VP O
   
The DT B-NP O
mediastinum NN I-NP O
appears VBZ O O
unchanged JJ O O
. . B-VP O
   
Left-sided JJ B-NP B-treatment
subclavian JJ I-NP I-treatment
line NN I-NP I-treatment
is VBZ O O
unchanged JJ O O
in IN B-VP O
position NN B-NP O
. . B-VP O
   
There EX O O
is VBZ O O
evidence NN B-NP O
of IN B-VP O
prior JJ B-NP B-treatment
cardiac JJ I-NP I-treatment
surgery NN I-NP I-treatment
. . B-VP O
   
2015-11-13 JJ O O
06:15 CD O O
AM NNP B-NP O
BLOOD NNP I-NP O
WBC NNP I-NP B-test
- : O O
8.8 CD O O
RBC NNP B-NP B-test
- : O O
2.79 CD O O
* NN B-NP O
Hgb NNP I-NP B-test
- : O O
8.6 CD O O
* NN B-NP O
Hct NNP I-NP B-test
- : O O
25.4 CD O O
* NN B-NP O
MCV NNP I-NP B-test
- : O O
91 CD O O
MCH NNP B-NP B-test
- : O O
30.9 CD O O
MCHC NNP B-NP B-test
- : O O
33.8 CD O O
RDW NNP B-NP B-test
- : O O
15.6 CD O O
* JJ B-NP O
Plt NNP I-NP B-test
Ct NNP I-NP I-test
- : O O
583 CD O O
* JJ O O
2015-11-12 JJ O O
06:00 CD O O
AM NNP B-NP O
BLOOD NNP I-NP O
WBC NNP I-NP B-test
- : O O
7.7 CD O O
RBC NNP B-NP B-test
- : O O
2.73 CD O O
* NN B-NP O
Hgb NNP I-NP B-test
- : O O
8.3 CD O O
* NN B-NP O
Hct NNP I-NP B-test
- : O I-test
25.1 CD O O
* NN B-NP O
MCV NNP I-NP B-test
- : O O
92 CD O O
MCH NNP B-NP B-test
- : O O
30.4 CD O O
MCHC NNP B-NP B-test
- : O O
33.1 CD O O
RDW NNP B-NP B-test
- : O O
15.5 CD O O
Plt NNP B-NP B-test
Ct NNP I-NP I-test
- : O O
528 CD O O
* JJ O O
2015-11-13 JJ O O
06:15 CD O O
AM NNP B-NP O
BLOOD NNP I-NP O
Plt NNP I-NP B-test
Ct NNP I-NP I-test
- : O O
583 CD O O
* JJ O O
2015-11-13 JJ O O
06:15 CD O O
AM NNP B-NP O
BLOOD NNP I-NP O
PT NNP I-NP B-test
- : O O
18.0 CD O O
* NN B-NP O
PTT NNP I-NP B-test
- : O O
62.3 CD O O
* NN B-NP O
INR(PT) NNP I-NP B-test
- : O O
1.7 CD O O
* JJ O O
2015-11-12 JJ O O
06:00 CD O O
AM NNP B-NP O
BLOOD NNP I-NP O
PT NNP I-NP B-test
- : O O
15.5 CD O O
* NN B-NP O
PTT NNP I-NP B-test
- : O O
62.4 CD O O
* NN B-NP O
INR(PT) NNP I-NP B-test
- : O O
1.4 CD O O
* JJ O O
2015-11-11 JJ O O
05:45 CD O O
AM NNP B-NP O
BLOOD NNP I-NP O
PT NNP I-NP B-test
- : O O
14.5 CD O O
* NN B-NP O
PTT NNP I-NP B-test
- : O O
51.4 CD O O
* NN B-NP O
INR(PT) NNP I-NP B-test
- : O O
1.3 CD O O
* JJ O O
2015-11-13 JJ O O
06:15 CD O O
AM NNP B-NP O
BLOOD NNP I-NP O
Glucose NNP I-NP B-test
- : O O
96 CD O O
UreaN NNP B-NP B-test
- : O O
20 CD O O
Creat NNP B-NP B-test
- : O O
1.6 CD O O
* NN B-NP O
Na NNP I-NP B-test
- : O O
141 CD O O
K NNP B-NP B-test
- : O O
4.3 CD O O
Cl NNP B-NP B-test
- : O O
106 CD O O
HCO3 NNP B-NP B-test
- : O O
24 CD O O
AnGap NNP B-NP B-test
- : O O
15 CD O O
2015-11-12 JJ O O
06:00 CD O O
AM NNP B-NP O
BLOOD NNP I-NP O
Glucose NNP I-NP B-test
- : O O
85 CD O O
UreaN NNP B-NP B-test
- : O O
19 CD O O
Creat NNP B-NP B-test
- : O O
1.6 CD O O
* NN B-NP O
Na NNP I-NP B-test
- : O O
140 CD O O
K NNP B-NP B-test
- : O O
4.4 CD O O
Cl NNP B-NP B-test
- : O O
105 CD O O
HCO3 NNP B-NP B-test
- : O O
24 CD O O
AnGap NNP B-NP B-test
- : O O
15 CD O O
2015-11-11 JJ O O
05:45 CD O O
AM NNP B-NP O
BLOOD NNP I-NP O
Creat NNP I-NP B-test
- : O O
1.6 CD O O
* NN B-NP O
K NNP I-NP B-test
- : O O
4.7 CD O O
2015-10-28 JJ O O
03:30 CD O O
PM NNP B-NP O
BLOOD NNP I-NP O
Glucose NNP I-NP B-test
- : O O
98 CD O O
UreaN NNP B-NP B-test
- : O O
26 CD O O
* NN B-NP O
Creat NNP I-NP B-test
- : O O
1.6 CD O O
* NN B-NP O
Na NNP I-NP B-test
- : O O
140 CD O O
K NNP B-NP B-test
- : O O
4.6 CD O O
Cl NNP B-NP B-test
- : O O
104 CD O O
HCO3 NNP B-NP B-test
- : O O
27 CD O O
AnGap NNP B-NP B-test
- : O O
14 CD O O
Brief JJ B-NP O
Hospital JJ I-NP O
Course NN I-NP O
: : O O
Ms. NNP B-NP B-person
Bridge NNP I-NP I-person
was VBD B-VP O
admitted VBN O O
from IN B-VP O
OSH NNP B-NP O
for IN B-VP O
coronary JJ B-NP B-treatment
artery NN I-NP I-treatment
bypass NN I-NP I-treatment
surgery NN I-NP I-treatment
. . B-VP O
   
She PRP O B-person
underwent JJ O O
usual JJ O B-test
pre-operative JJ O I-test
testing VBG O I-test
along IN B-VP O
with IN B-VP O
carotid NN B-NP B-test
ultrasound NN I-NP I-test
. . B-VP O
   
CNIS NNP B-NP B-test
revealed VBD B-VP O
carotid JJ B-NP B-problem
stenosis NN I-NP I-problem
and CC O O
she PRP O B-person
ultimately RB O O
underwent JJ O O
left VBD B-VP B-treatment
carotid JJ B-NP I-treatment
stenting NN I-NP I-treatment
by IN B-VP O
vascular JJ B-NP O
surgery NN I-NP O
on IN B-VP O
10-30 JJ O O
. . B-VP O
   
Please NNP B-NP O
see VB O O
report NN B-NP O
for IN B-VP O
details NNS B-NP O
. . B-VP O
   
On IN B-VP O
11-02 JJ O O
she PRP O B-person
was VBD B-VP O
brought VBN O O
to TO O O
the DT B-NP O
operating NN I-NP O
room NN I-NP O
where WRB O O
she PRP O B-person
underwent VBD B-VP O
a DT B-NP B-treatment
coronary JJ I-NP I-treatment
artery NN I-NP I-treatment
bypass NN I-NP I-treatment
graft NN I-NP I-treatment
x VBD B-VP O
2 CD O O
. . B-VP O
   
Please VB O O
see JJ B-NP O
operative JJ I-NP O
report NN I-NP O
for IN B-VP O
surgical JJ B-NP O
details NNS I-NP O
. . B-VP O
   
She PRP O B-person
tolerated VBD B-VP O
the DT B-NP B-treatment
procedure NN I-NP I-treatment
well RB O O
and CC O O
was VBD B-VP O
transferred VBN O O
to TO O O
the DT B-NP O
CSRU NNP I-NP O
for IN B-VP O
invasive JJ B-NP B-test
monitoring NN I-NP I-test
in IN B-VP O
stable JJ B-NP O
condition NN I-NP O
. . B-VP O
   
Later RB O O
on IN B-VP O
op JJ B-NP O
day NN I-NP O
sedation NN I-NP B-treatment
was VBD B-VP O
weaned VBN O O
, , O O
she PRP O B-person
awoke VBD B-VP O
neurologically RB O O
intact JJ O O
and CC O O
was VBD B-VP O
extubated VBN O B-treatment
. . B-VP O
   
On IN B-VP O
post-op JJ B-NP O
day NN I-NP O
one CD O O
chest NN B-NP B-treatment
tubes NNS I-NP I-treatment
were VBD B-VP O
removed VBN O O
and CC O O
beta JJ B-NP B-treatment
blockers NNS I-NP I-treatment
and CC O O
diuretics NNS B-NP B-treatment
were VBD B-VP O
initiated VBN O O
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
gently RB O O
diuresed JJ B-NP O
towards NNS I-NP O
her PRP$ O B-person
pre-op JJ B-NP O
weight NN I-NP O
. . B-VP O
   
Also RB O O
on IN B-VP O
this DT B-NP B-pronoun
day NN I-NP O
she PRP O B-person
was VBD B-VP O
transferred VBN O O
to TO O O
the DT B-NP O
SDU NNP I-NP O
. . B-VP O
   
Early JJ O O
on IN B-VP O
post-op JJ B-NP O
day NN I-NP O
two CD O O
Ms. NNP B-NP B-person
Bridge NNP I-NP I-person
had VBD B-VP O
an DT B-NP O
episode NN I-NP O
of IN B-VP O
aphasia NN B-NP B-problem
. . B-VP O
   
She PRP O B-person
underwent VBD B-VP O
an DT B-NP B-test
immediate JJ I-NP I-test
head NN I-NP I-test
CT NNP I-NP I-test
and CC O O
Neuro NNP B-NP B-person
consult NN I-NP O
and CC O O
was VBD B-VP O
transferred VBN O O
back RB O O
to TO O O
the DT B-NP O
CSRU NNP I-NP O
. . B-VP O
   
CT NNP B-NP B-test
was VBD B-VP O
negative JJ O O
and CC O O
she PRP O B-person
returned VBD B-VP O
to TO O O
baseline VB O O
neuro JJ B-NP O
status NN I-NP O
without IN B-VP O
deficits NNS B-NP B-problem
by IN B-VP O
arrival NN B-NP O
to TO O O
CSRU NNP B-NP O
. . B-VP O
   
Neurology NNP B-NP O
concluded VBD B-VP O
episode NN B-NP B-problem
was VBD B-VP O
most RBS O O
concerning VBG O O
for IN B-VP O
TIA NNP B-NP B-problem
. . B-VP O
   
Epicardial NNP B-NP B-treatment
pacing VBG O I-treatment
wires NNS B-NP I-treatment
were VBD B-VP O
removed VBN O O
on IN B-VP O
post-op JJ B-NP O
day NN I-NP O
four CD O O
. . B-VP O
   
After IN B-VP O
remaining VBG O O
stable JJ O O
in IN B-VP O
the DT B-NP O
CSRU NNP I-NP O
for IN B-VP O
several JJ B-NP O
days NNS I-NP O
without IN B-VP O
change NN B-NP B-problem
in IN B-VP I-problem
neuro NN B-NP I-problem
status NN I-NP I-problem
she PRP O B-person
was VBD B-VP O
transferred VBN O O
back RB O O
to TO O O
the DT B-NP O
SDU NNP I-NP O
on IN B-VP O
post-op JJ B-NP O
day NN I-NP O
four CD O O
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
then RB O O
started VBN O O
on IN B-VP O
Heparin NNP B-NP B-treatment
with IN B-VP O
transition NN B-NP O
to TO O O
Coumadin NNP B-NP B-treatment
( ( O O
goal NN B-NP O
INR NNP I-NP B-test
of IN B-VP O
2-3 JJ O O
secondary JJ O O
to TO O O
h/o VB O O
bilateral JJ B-NP B-problem
DVT NNP I-NP I-problem
's). NNP I-NP O
During IN B-VP O
entire JJ B-NP O
post-op JJ I-NP O
course NN I-NP O
she PRP O B-person
was VBD B-VP O
followed VBN O O
by IN B-VP O
physical JJ B-NP O
therapy NN I-NP O
for IN B-VP O
strength NN B-NP O
and CC O O
mobility NN B-NP O
. . B-VP O
   
She PRP O B-person
continued VBD B-VP O
to TO O O
improve VB O O
steadily RB O O
over IN B-VP O
the DT B-NP O
next JJ I-NP O
several JJ I-NP O
days NNS I-NP O
without IN B-VP O
any DT B-NP O
other JJ I-NP O
post-op JJ I-NP O
complications NNS I-NP B-problem
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
discharged VBN O O
on IN B-VP O
post-op JJ B-NP O
day NN I-NP O
11 CD O O
. . B-VP O
   
Medications NNS B-NP O
on IN B-VP O
Admission NN B-NP O
: : O O
Meds NNS B-NP B-treatment
at IN B-VP O
home NN B-NP O
: : O O
Coumadin NNP B-NP B-treatment
, , O O
Levoxyl NNP B-NP B-treatment
, , O O
Folate NNP B-NP B-treatment
, , O O
Colace NNP B-NP B-treatment
, , O O
Byetta NNP B-NP B-treatment
, , O O
Verapamil NNP B-NP B-treatment
, , O O
Lisinopril NNP B-NP B-treatment
, , O O
Pravachol NNP B-NP B-treatment
, , O O
Nexium NNP B-NP B-treatment
, , O O
Lasix NNP B-NP B-treatment
, , O O
Celexa NNP B-NP B-treatment
Meds NNP I-NP B-treatment
at IN B-VP O
transfer NN B-NP O
: : O O
Levoxyl NNP B-NP B-treatment
, , O O
Celexa NNP B-NP B-treatment
, , O O
Folate NNP B-NP B-treatment
, , O O
Lopressor NNP B-NP B-treatment
, , O O
Colace NNP B-NP B-treatment
, , O O
RISS NNP B-NP B-treatment
, , O O
B12 NNP B-NP B-treatment
, , O O
Protonix NNP B-NP B-treatment
, , O O
Lasix NNP B-NP B-treatment
, , O O
Zocor NNP B-NP B-treatment
, , O O
Verapamil NNP B-NP B-treatment
, , O O
Lovenox NNP B-NP B-treatment
, , O O
Lisinopril NNP B-NP B-treatment
Discharge NNP I-NP O
Medications NNP I-NP O
: : O O
1. CD O O
Aspirin NNP B-NP B-treatment
81 CD O O
mg NN B-NP O
Tablet NNP I-NP O
, , O O
Delayed NNP B-NP O
Release NNP I-NP O
( ( O O
E.C. NNP B-NP O
) ) O O
Sig NN B-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Tablet NN B-NP O
, , O O
Delayed NNP B-NP O
Release NNP I-NP O
( ( O O
E.C. NNP B-NP O
) ) O O
PO NNP B-NP O
DAILY NNP I-NP O
( ( O O
Daily NNP B-NP O
). NNP I-NP O
Disp NNP I-NP O
:* VBD B-VP O
30 CD O O
Tablet NNP B-NP O
, , O O
Delayed NNP B-NP O
Release NNP I-NP O
( ( O O
E.C. NNP B-NP O
)(s)* NNP I-NP O
Refills NNP I-NP O
:* VBZ O O
0 CD O O
* NN B-NP O
2. CD O O
Pantoprazole NNP B-NP B-treatment
40 CD O O
mg NN B-NP O
Tablet NNP I-NP O
, , O O
Delayed NNP B-NP O
Release NNP I-NP O
( ( O O
E.C. NNP B-NP O
) ) O O
Sig NN B-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Tablet NN B-NP O
, , O O
Delayed NNP B-NP O
Release NNP I-NP O
( ( O O
E.C. NNP B-NP O
) ) O O
PO NNP B-NP O
Q24H NNP I-NP O
( ( O O
every DT O O
24 CD O O
hours NNS B-NP O
). JJ B-NP O
Disp NNP I-NP O
:* NNP I-NP O
30 CD O O
Tablet NNP B-NP O
, , O O
Delayed NNP B-NP O
Release NNP I-NP O
( ( O O
E.C. NNP B-NP O
)(s)* NNP I-NP O
Refills NNP I-NP O
:* VBZ O O
0 CD O O
* NN B-NP O
3. CD O O
Levothyroxine NNP B-NP B-treatment
125 CD O O
mcg NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Tablet NNP B-NP O
PO NNP I-NP O
DAILY NNP I-NP O
( ( O O
Daily NNP B-NP O
). NNP I-NP O
Disp NNP I-NP O
:* VBD B-VP O
30 CD O O
Tablet NNP B-NP O
(s)* NNP I-NP O
Refills NNP I-NP O
:* VBZ O O
0 CD O O
* NN B-NP O
4. CD O O
Simvastatin NNP B-NP B-treatment
40 CD O O
mg NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Tablet NNP B-NP O
PO NNP I-NP O
DAILY NNP I-NP O
( ( O O
Daily NNP B-NP O
). NNP I-NP O
Disp NNP I-NP O
:* VBD B-VP O
30 CD O O
Tablet NNP B-NP O
(s)* NNP I-NP O
Refills NNP I-NP O
:* VBZ O O
0 CD O O
* NN B-NP O
5. CD O O
Citalopram NNP B-NP B-treatment
20 CD O O
mg NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
0.5 CD O O
Tablet NNP B-NP O
PO NNP I-NP O
DAILY NNP I-NP O
( ( O O
Daily NNP B-NP O
). NNP I-NP O
Disp NNP I-NP O
:* VBD B-VP O
30 CD O O
Tablet NNP B-NP O
(s)* NNP I-NP O
Refills NNP I-NP O
:* VBZ O O
0 CD O O
* NN B-NP O
6. CD O O
Clopidogrel NNP B-NP B-treatment
75 CD O O
mg NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Tablet NNP B-NP O
PO NNP I-NP O
DAILY NNP I-NP O
( ( O O
Daily NNP B-NP O
). NNP I-NP O
Disp NNP I-NP O
:* VBD B-VP O
30 CD O O
Tablet NNP B-NP O
(s)* NNP I-NP O
Refills NNP I-NP O
:* VBZ O O
0 CD O O
* NN B-NP O
7. CD O O
Ferrous JJ B-NP B-treatment
Gluconate NNP I-NP I-treatment
300 CD O O
mg NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Tablet NNP B-NP O
PO NNP I-NP O
DAILY NNP I-NP O
( ( O O
Daily NNP B-NP O
). NNP I-NP O
Disp NNP I-NP O
:* VBD B-VP O
30 CD O O
Tablet NNP B-NP O
(s)* NNP I-NP O
Refills NNP I-NP O
:* VBZ O O
0 CD O O
* NN B-NP O
8. CD O O
Ascorbic NNP B-NP B-treatment
Acid NNP I-NP I-treatment
500 CD O O
mg NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Tablet NNP B-NP O
PO NNP I-NP O
BID NNP I-NP O
( ( O O
2 CD O O
times NNS B-NP O
a DT B-NP O
day NN I-NP O
). NNP I-NP O
Disp NNP I-NP O
:* VBD B-VP O
30 CD O O
Tablet NNP B-NP O
(s)* NNP I-NP O
Refills NNP I-NP O
:* VBZ O O
0 CD O O
* NN B-NP O
9. CD O O
Folic NNP B-NP B-treatment
Acid NNP I-NP I-treatment
1 CD O O
mg NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Tablet NNP B-NP O
PO NNP I-NP O
DAILY NNP I-NP O
( ( O O
Daily NNP B-NP O
). NNP I-NP O
Disp NNP I-NP O
:* VBD B-VP O
30 CD O O
Tablet NNP B-NP O
(s)* NNP I-NP O
Refills NNP I-NP O
:* VBZ O O
0 CD O O
* NN B-NP O
10. CD O O
Metoprolol NNP B-NP B-treatment
Tartrate NNP I-NP I-treatment
25 CD O O
mg NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Tablet NNP B-NP O
PO NNP I-NP O
BID NNP I-NP O
( ( O O
2 CD O O
times NNS B-NP O
a DT B-NP O
day NN I-NP O
). NNP I-NP O
Disp NNP I-NP O
:* VBD B-VP O
60 CD O O
Tablet NNP B-NP O
(s)* NNP I-NP O
Refills NNP I-NP O
:* VBZ O O
0 CD O O
* NN B-NP O
11. CD O O
Docusate NNP B-NP B-treatment
Sodium NNP I-NP I-treatment
100 CD O O
mg NN B-NP O
Capsule NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Capsule NNP B-NP O
PO NNP I-NP O
BID NNP I-NP O
( ( O O
2 CD O O
times NNS B-NP O
a DT B-NP O
day NN I-NP O
). NNP I-NP O
Disp NNP I-NP O
:* VBD B-VP O
30 CD O O
Capsule NNP B-NP O
(s)* NNP I-NP O
Refills NNP I-NP O
:* VBZ O O
0 CD O O
* NN B-NP O
12. CD O O
Coumadin NNP B-NP B-treatment
5 CD O O
mg NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Tablet NNP B-NP O
PO NNP I-NP O
once RB O O
a DT B-NP O
day NN I-NP O
: : O O
Check VB O O
INR NNP B-NP B-test
11-15 JJ O O
with IN B-VP O
results NNS B-NP O
called VBN O O
to TO O O
Dr. NNP B-NP O
Lynn NNP I-NP O
. . B-VP O
   
Disp NNP B-NP O
:* VBD B-VP O
30 CD O O
Tablet NNP B-NP O
(s)* NNP I-NP O
Refills NNP I-NP O
:* VBZ O O
0 CD O O
* NN B-NP O
13. CD O O
Tramadol NNP B-NP B-treatment
50 CD O O
mg NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Tablet NNP B-NP O
PO NNP I-NP O
Q4-6H NNP I-NP O
( ( O O
every DT O O
4 CD O O
to TO O O
6 CD O O
hours NNS B-NP O
) ) O O
as IN B-VP O
needed VBN O O
. . B-VP O
   
Disp NNP B-NP O
:* VBD B-VP O
50 CD O O
Tablet NNP B-NP O
(s)* NNP I-NP O
Refills NNP I-NP O
:* VBZ O O
0 CD O O
* NN B-NP O
14. CD O O
Lasix NNP B-NP B-treatment
40 CD O O
mg NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Tablet NNP B-NP O
PO NNP I-NP O
once RB O O
a DT B-NP O
day NN I-NP O
: : O O
40 CD O O
mg NNS B-NP O
daily JJ O O
x RB O O
1 CD O O
week NN B-NP O
then RB O O
40 CD O O
mg NNS B-NP O
every DT B-NP O
other JJ I-NP O
day NN I-NP O
as IN B-VP O
prior JJ O O
to TO O O
surgery VB O B-treatment
. . B-VP O
   
Disp NNP B-NP O
:* VBD B-VP O
30 CD O O
Tablet NNP B-NP O
(s)* NNP I-NP O
Refills NNP I-NP O
:* VBZ O O
0 CD O O
* NN B-NP O
Discharge NNP I-NP O
Disposition NNP I-NP O
: : O O
Extended VBN O O
Care NNP B-NP O
Discharge NNP I-NP O
Diagnosis NNP I-NP O
: : O O
Coronary JJ B-NP B-problem
Artery NNP I-NP I-problem
Disease NNP I-NP I-problem
s/p VBD B-VP O
Coronary NNP B-NP B-treatment
Artery NNP I-NP I-treatment
Bypass NNP I-NP I-treatment
Graft NNP I-NP I-treatment
x VBD B-VP O
2 CD O O
Post-operative JJ B-NP B-problem
Transient NNP I-NP I-problem
Ischemic NNP I-NP I-problem
Attack NNP I-NP I-problem
Carotid NNP I-NP B-problem
Stenosis NNP I-NP I-problem
s/p NN I-NP O
Left NNP I-NP B-treatment
Carotid NNP I-NP I-treatment
Stenting NNP I-NP I-treatment
PMH NNP I-NP O
: : O O
Hypertension NN B-NP B-problem
, , O O
Hyperlipidemia NNP B-NP B-problem
, , O O
Diabetes NNP B-NP B-problem
Mellitus NNP I-NP I-problem
, , O O
Hypothyroid NNP B-NP B-problem
, , O O
h/o JJ B-NP O
Bilateral NNP I-NP B-problem
DVT NNP I-NP I-problem
's, POS O O
Pleural NNP B-NP B-problem
disorder NN I-NP I-problem
? . B-VP O
Sarcoidosis NNP B-NP B-problem
, , O O
Gastritis NNP B-NP B-problem
, , O O
B12 NNP B-NP B-problem
deficiency NN I-NP I-problem
, , O O
Chronic NNP B-NP B-problem
renal JJ B-NP I-problem
insufficiency NN I-NP I-problem
, , O O
s/p JJ B-NP O
Appendectomy NNP I-NP B-treatment
, , O O
s/p NN B-NP O
Lap NNP I-NP B-treatment
cholectomy NN I-NP I-treatment
, , O O
s/p JJ B-NP O
Total NNP I-NP B-treatment
abdominal JJ B-NP I-treatment
hysterectomy NN I-NP I-treatment
Discharge NNP I-NP O
Condition NNP I-NP O
: : O O
good JJ B-NP O
Discharge NN I-NP O
Instructions NNS I-NP O
: : O O
Patient NN B-NP B-person
may MD O O
shower VB O O
, , O O
no DT B-NP O
baths NNS I-NP O
. . B-VP O
   
No DT B-NP O
creams NN I-NP B-treatment
, , O O
lotions NNS B-NP B-treatment
or CC O O
ointments NNS B-NP B-treatment
to TO O O
incisions NNS B-NP B-problem
. . B-VP O
   
No DT B-NP O
driving NN I-NP O
for IN B-VP O
at IN B-VP O
least JJS O O
one CD O O
month NN B-NP O
. . B-VP O
   
No CC O O
lifting VBG O O
more JJR O O
than IN B-VP O
10 CD O O
lbs NN B-NP O
for IN B-VP O
at IN B-VP O
least JJS O O
10 CD O O
weeks NNS B-NP O
from IN B-VP O
the DT B-NP O
date NN I-NP O
of IN B-VP O
surgery NN B-NP B-treatment
. . B-VP O
   
Monitor NNP B-NP O
wounds VBZ O B-problem
for IN B-VP O
signs NNS B-NP B-problem
of IN B-VP I-problem
infection NN B-NP I-problem
. . B-VP O
   
Please VB O O
call JJ O O
with IN B-VP O
any DT B-NP O
concerns NNS I-NP O
or CC O O
questions NNS B-NP O
. . B-VP O
   
VVp JJ B-NP O
Instructions NNS I-NP O
: : O O
Dr. NNP B-NP B-person
von NNP I-NP I-person
Sampson NNP I-NP I-person
in IN B-VP O
4 CD O O
weeks NNS B-NP O
Dr NNP I-NP B-person
Royer NNP I-NP I-person
in IN B-VP O
2-3 JJ B-NP O
weeks NNS I-NP O
Dr. NNP I-NP B-person
Lynn NNP I-NP I-person
in IN B-VP O
1-2 JJ B-NP O
weeks NNS I-NP O
Peterson NNP I-NP B-person
ver RB O I-person
Vasquez NNP B-NP I-person
MD NNP I-NP I-person
07-506 NN I-NP O
Completed VBN O O
by IN B-VP O
: : O O
Theresa NNP B-NP B-person
Leonore NNP I-NP I-person
NP NNP I-NP I-person
80-BXH JJ B-NP O
2015-11-13 JJ I-NP O
@ NN I-NP O
1100 CD O O
Signed NNP B-NP O
electronically RB O O
by IN B-VP O
: : O O
DR. NNP B-NP B-person
Ruby NNP I-NP I-person
von NNP I-NP I-person
der NN I-NP I-person
Smith NNP I-NP I-person
on: NN I-NP O
WED NNP I-NP O
2015-12-09 JJ O O
3:34 CD O O
PM NNP B-NP O
( ( O O
End NNP B-NP O
of IN B-VP O
Report NNP B-NP O
) ) O O
-EMPTYLINE- VBP O O
-DOCSTART- JJ O O
-EMPTYLINE- $ O O
421179499 CD O O
BH NNP B-NP O
0940729 CD O O
770923 CD O O
3/30/1997 CD O O
12:00:00 CD O O
AM NNP B-NP O
ASPIRATION NNP I-NP B-problem
PNEUMONIA NNP I-NP I-problem
. . B-VP O
   
Unsigned VBD B-VP O
DIS NNP B-NP O
Report NNP I-NP O
Status NNP I-NP O
: : O O
Unsigned VBD B-VP O
DISCHARGE NNP B-NP O
SUMMARY NNP I-NP O
NAME NN I-NP O
: : O O
STRAPEFREIRE NNP B-NP B-person
, , O I-person
VATALY NNP B-NP I-person
C NNP I-NP I-person
UNIT NNP I-NP O
NUMBER NNP I-NP O
: : O O
972-02-46 JJ B-NP O
ADMISSION NNP I-NP O
DATE NNP I-NP O
: : O O
03/30/97 CD O O
DISCHARGE NNP B-NP O
DATE NNP I-NP O
: : O O
04/01/97 CD O O
PRINCIPAL NNP B-NP O
DIAGNOSIS NNP I-NP O
: : O O
Aspiration NNP B-NP B-problem
pneumonia NN I-NP I-problem
. . B-VP O
   
ASSOCIATED CC O O
DIAGNOSIS NNP B-NP O
: : O O
Dementia NN B-NP B-problem
; : O O
congestive JJ B-NP B-problem
heart NN I-NP I-problem
failure NN I-NP I-problem
. . B-VP O
   
HISTORY NN B-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS NNP I-NP O
AND NNP I-NP O
REASON NNP I-NP O
FOR NNP I-NP O
HOSPITALIZATION NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
a DT B-NP O
108-year-old JJ I-NP O
nursing NN I-NP O
home NN I-NP O
resident NN I-NP O
, , O O
who WP O B-person
was VBD B-VP O
admitted VBN O O
with IN B-VP O
a DT B-NP O
two-day JJ I-NP O
history NN I-NP O
of IN B-VP O
increased JJ B-NP B-problem
respiratory NN I-NP I-problem
secretions NNS I-NP I-problem
and CC O O
a DT B-NP O
24-hour JJ I-NP O
history NN I-NP O
of IN B-VP O
elevated VBN O B-problem
fever NN B-NP I-problem
. . B-VP O
   
Despite IN B-VP O
Augmentin NNP B-NP B-treatment
, , O O
the DT O B-person
the DT B-NP B-problem
patient JJ I-NP I-person
patient NN I-NP I-problem
&apos;s NNP I-NP I-problem
delirium NN I-NP I-problem
worsened VBD B-VP O
in IN B-VP O
the DT O O
24 CD O O
hours NNS B-NP O
prior RB O O
to TO O O
admission NN B-NP O
, , O O
and CC O O
her PRP$ O B-person
her PRP$ O B-test
temperature NN B-NP I-test
was VBD B-VP O
up RB O O
to TO O O
102 CD O O
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
refusing VBG O O
to TO O O
take VB O O
p.o.&apos;s NN B-NP O
. . B-VP O
   
PAST NNP B-NP O
MEDICAL NNP I-NP O
HISTORY NNP I-NP O
: : O O
Recurrent JJ B-NP B-problem
urinary JJ I-NP I-problem
tract NN I-NP I-problem
infections NNS I-NP I-problem
, , O O
most JJS O O
recently RB O O
on IN B-VP O
2/23/97 CD O O
; : O O
recurrent JJ B-NP B-problem
aspiration NN I-NP I-problem
pneumonias NN I-NP I-problem
, , O O
most RBS O O
recently RB O O
on IN B-VP O
2/21/97 CD O O
; : O O
multi-infarct JJ B-NP B-problem
dementia NN I-NP I-problem
with IN B-VP O
associated JJ B-NP B-problem
dysphasia NN I-NP I-problem
; : O O
mitral JJ B-NP B-problem
regurgitation NN I-NP I-problem
; : O O
history NN B-NP O
of IN B-VP O
congestive JJ B-NP B-problem
heart NN I-NP I-problem
failure NN I-NP I-problem
; : O O
pernicious JJ B-NP B-problem
anemia NN I-NP I-problem
; : O O
chronic JJ B-NP B-problem
venous JJ I-NP I-problem
stasis NN I-NP I-problem
; : O O
status NN B-NP O
post NN I-NP O
left VBD B-VP B-problem
femoral JJ B-NP I-problem
neck NN I-NP I-problem
fracture NN I-NP I-problem
. . B-VP O
   
MEDICATIONS NNP B-NP O
ON NNP I-NP O
ADMISSION NNP I-NP O
: : O O
Augmentin $ O B-treatment
500 CD O O
mg NN B-NP O
t.i.d. NN I-NP O
Senokot NNP I-NP B-treatment
one CD O O
q.h.s. NN B-NP O
Sertraline NNP I-NP B-treatment
75 CD O O
mg NN B-NP O
q.day NN I-NP O
. . B-VP O
   
Aspirin $ O B-treatment
81 CD O O
mg NN B-NP O
q.day NN I-NP O
. . B-VP O
   
Vitamin NNP B-NP B-treatment
B12 NNP I-NP I-treatment
100 CD O O
mcg NN B-NP O
IM NNP I-NP O
q.month NN I-NP O
. . B-VP O
   
Urecholine VB O B-treatment
25 CD O O
mg NN B-NP O
t.i.d. NN I-NP O
Colace NNP I-NP B-treatment
. . B-VP O
   
SOCIAL NNP B-NP O
HISTORY NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
resides VBZ O O
in IN B-VP O
the DT B-NP O
Pcaer,ter NNP I-NP O
Medical NNP I-NP O
Center NNP I-NP O
, , O O
is VBZ O O
nonambulatory JJ O B-problem
, , O O
and CC O O
her PRP$ O B-person
code NN B-NP O
status NN I-NP O
is VBZ O O
do VBP O O
not RB O O
resuscitate VB O O
/ NNS B-NP O
do VBP O O
not RB O O
intubate VB O O
. . B-VP O
   
PHYSICAL JJ B-NP O
EXAMINATION NN I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
nonverbal JJ O B-problem
, , O O
but CC O O
was VBD B-VP O
able JJ O O
to TO O O
open VB O O
her PRP$ O B-person
eyes NNS B-NP O
and CC O O
nod NN B-NP O
. . B-VP O
   
No DT B-NP O
respiratory NN I-NP B-problem
distress NN I-NP I-problem
. . B-VP O
   
Her PRP$ O B-person
Her PRP$ O B-test
temperature NN B-NP I-test
was VBD B-VP O
102.2 CD O O
; : O O
blood NN B-NP B-test
pressure NN I-NP I-test
135/64 CD O O
; : O O
pulse JJ B-NP B-test
rate NN I-NP I-test
108 CD O O
; : O O
respirations NNS B-NP B-test
24 CD O O
; : O O
oxygen NN B-NP B-test
saturations NNS I-NP I-test
on IN B-VP I-test
room NN B-NP I-test
air NN I-NP I-test
94% CD O O
. . B-VP O
   
The DT B-NP B-test
head NN I-NP I-test
, , O I-test
eyes NNS B-NP I-test
, , O I-test
ears NNS B-NP I-test
, , O I-test
nose RB O I-test
and CC O I-test
throat VB O I-test
examination NN B-NP I-test
revealed VBD B-VP O
no DT B-NP O
ocular JJ I-NP B-problem
abnormalities NNS I-NP I-problem
. . B-VP O
   
Neck NNP B-NP O
- : O O
no DT B-NP O
lymphadenopathy NN I-NP B-problem
; : O O
no DT B-NP O
carotid NN I-NP B-problem
bruits VBZ O I-problem
; : O O
jugular JJ B-NP B-test
venous JJ I-NP I-test
pressure NN I-NP I-test
not RB O O
elevated VBN O B-problem
; : O O
no DT B-NP O
goiter NN I-NP B-problem
. . B-VP O
   
Chest NNP B-NP O
- : O O
reduced VBD B-VP B-problem
breath JJ B-NP I-problem
sounds NNS I-NP I-problem
at IN B-VP I-problem
the DT B-NP I-problem
bases NNS I-NP I-problem
with IN B-VP O
faint JJ B-NP B-problem
inspiratory NN I-NP I-problem
rhonchi VBD B-VP I-problem
anteriorly RB O I-problem
. . B-VP O
   
Cardiac NNP B-NP O
- : O O
regular JJ B-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
with IN B-VP O
frequent JJ B-NP B-problem
premature NN I-NP I-problem
beats NNS I-NP I-problem
and CC O O
a DT O B-problem
2/6 CD O I-problem
systolic JJ B-NP I-problem
ejection NN I-NP I-problem
murmur NN I-NP I-problem
at IN B-VP I-problem
the DT B-NP I-problem
apex NN I-NP I-problem
. . B-VP O
   
The DT B-NP O
abdomen NNS I-NP O
was VBD B-VP O
non-tender JJ O B-problem
, , O O
nondistended JJ O B-problem
, , O O
no DT B-NP O
hepatomegaly NN I-NP B-problem
, , O O
normal JJ B-NP O
bowel NN I-NP O
sounds NNS I-NP O
. . B-VP O
   
Extremities NNS B-NP O
- : O O
1+ CD O B-problem
edema NN B-NP I-problem
; : O O
2+ CD O B-test
pulses NNS B-NP I-test
. . B-VP O
   
Skin NNP B-NP O
- : O O
intact NN B-NP O
with IN B-VP O
diaper NN B-NP B-treatment
. . B-VP O
   
LABORATORY NNP B-NP O
DATA NNP I-NP O
: : O O
The DT B-NP B-test
sodium NN I-NP I-test
was VBD B-VP O
142 CD O O
; : O O
potassium NN B-NP B-test
4.5 CD O O
; : O O
chloride JJ O B-test
105 CD O O
; : O O
bicarbonate NN B-NP B-test
27 CD O O
; : O O
BUN NNP B-NP B-test
and CC O O
creatinine VB O B-test
31 CD O O
and CC O O
1.3 CD O O
; : O O
glucose JJ O B-test
107 CD O O
; : O O
total JJ B-NP B-test
protein NN I-NP I-test
7.7 CD O O
; : O O
albumin JJ O B-test
3.2 CD O O
; : O O
globulin NN B-NP B-test
4.5 CD O O
; : O O
uric JJ B-NP B-test
acid NN I-NP I-test
4.2 CD O O
; : O O
alkaline JJ B-NP B-test
phosphatase NN I-NP I-test
114 CD O O
; : O O
serum JJ B-NP B-test
glutamic JJ I-NP I-test
oxaloacetic JJ I-NP I-test
transaminase NN I-NP I-test
46 CD O O
; : O O
lactic JJ B-NP B-test
acid NN I-NP I-test
dehydrogenase NN I-NP I-test
370 CD O O
; : O O
white JJ B-NP B-test
blood NN I-NP I-test
count NN I-NP I-test
11,000 CD O O
with IN B-VP O
83 CD O O
polymorphonuclear JJ B-NP B-test
leukocytes NNS I-NP I-test
; : O O
hematocrit VBZ O B-test
42 CD O O
; : O O
platelet NN B-NP B-test
count NN I-NP I-test
227,000 CD O O
. . B-VP O
   
A DT B-NP B-test
chest JJ I-NP I-test
x-ray NN I-NP I-test
showed VBD B-VP O
consolidation JJ B-NP B-problem
bilateral JJ I-NP I-problem
lyin NN I-NP I-problem
the DT B-NP I-problem
lower JJR I-NP I-problem
lobes NN I-NP I-problem
. . B-VP O
   
HOSPITAL NNP B-NP O
COURSE NNP I-NP O
AND NNP I-NP O
TREATMENT NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
admitted VBN O O
for IN B-VP O
treatment NN B-NP B-treatment
of IN B-VP O
a DT B-NP O
presumed JJ I-NP O
aspiration NN I-NP B-problem
pneumonia NN I-NP I-problem
and CC O O
for IN B-VP O
rehydration NN B-NP B-treatment
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
started VBN O O
on IN B-VP O
Clindamycin NNP B-NP B-treatment
and CC O O
Ofloxacin NNP B-NP B-treatment
at IN B-VP O
renal JJ B-NP O
dose NN I-NP O
to TO O O
cover VB O O
the DT B-NP B-problem
aspiration NN I-NP I-problem
pneumonia NN I-NP I-problem
and CC O O
positive JJ B-NP B-problem
urine JJ I-NP I-problem
culture NN I-NP I-problem
, , O O
which WDT O B-pronoun
subsequently RB O O
came VBD B-VP O
back RB O O
. . B-VP O
   
She PRP O B-person
had VBD B-VP O
some DT B-NP B-problem
wheezing NN I-NP I-problem
, , O O
which WDT O B-pronoun
responded VBD B-VP O
well RB O O
to TO O O
Albuterol NNP B-NP B-treatment
nebulizers NNS I-NP I-treatment
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
generally RB O O
doing VBG O O
well RB O O
with IN B-VP O
resolution NN B-NP O
of IN B-VP O
her PRP$ O B-person
her PRP$ O B-test
temperature NN B-NP I-test
until IN B-VP O
4/1/97 CD O O
at IN B-VP O
9:20 CD O O
P.M. NNP B-NP O
, , O O
when WRB O O
she PRP O B-person
was VBD B-VP O
noted VBN O O
to TO O O
be VB O O
unresponsive JJ O B-problem
with IN B-VP O
fixed JJ O B-problem
dilated VBN O I-problem
pupils NNS B-NP I-problem
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
certified VBN O O
dead JJ O O
at IN B-VP O
9:20 CD O O
P.M. NNP B-NP O
MI NNP I-NP B-person
CUCHSLI NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
TR NNP I-NP O
: : O O
vgo NN B-NP O
DD NNP I-NP O
: : O O
05/11/97 CD O O
TD NN B-NP O
: : O O
05/15/97 CD O O
8:26 CD O O
Acc NN B-NP O
: : O O
MI NNP B-NP B-person
CUCHSLI NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
cc NN I-NP O
: : O O
Nursing NN B-NP B-person
Director NNP I-NP I-person
Pcaer,ter NNP I-NP O
Medical NNP I-NP O
Center NNP I-NP O
Sco NNP I-NP O
, , O O
Ohio NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
Admission NNP I-NP O
Date NNP I-NP O
: : O O
2010-02-05 JJ B-NP O
Discharge NN I-NP O
Date NNP I-NP O
: : O O
2010-02-06 JJ B-NP O
Date NNP I-NP O
of IN B-VP O
Birth NNP B-NP O
: : O O
1986-06-14 JJ B-NP O
Sex NN I-NP O
: : O O
F NNP B-NP O
Service NNP I-NP O
: : O O
TRAUMA NNP B-NP B-person
HISTORY NNP I-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
is VBZ O O
a DT O O
23 CD O O
year NN B-NP O
old JJ B-NP O
female NN I-NP O
, , O O
status NN B-NP O
post NN I-NP O
fall NN I-NP O
from IN B-VP O
standing VBG O O
position NN B-NP O
after IN B-VP O
slipping VBG O O
on IN B-VP O
ice NN B-NP O
. . B-VP O
   
She PRP O B-person
had VBD B-VP O
no DT B-NP O
loss NN I-NP B-problem
of IN B-VP I-problem
consciousness NN B-NP I-problem
. . B-VP O
   
She PRP O B-person
recalled VBD B-VP O
the DT B-NP O
entire JJ I-NP O
event NN I-NP O
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
found VBN O O
by IN B-VP O
family NN B-NP O
and CC O O
friends NNS B-NP O
to TO O O
be VB O O
somewhat RB O B-problem
confused JJ O I-problem
and CC O O
was VBD B-VP O
therefore RB O O
taken VBN O O
to TO O O
Newton-Wellesley NNP B-NP O
Hospital NNP I-NP O
thereafter RB O O
. . B-VP O
   
Workup NNP B-NP B-test
at IN B-VP O
the DT B-NP O
outside JJ I-NP O
hospital NN I-NP O
included VBD B-VP O
a DT B-NP B-test
CT NNP I-NP I-test
scan NN I-NP I-test
of IN B-VP I-test
the DT B-NP I-test
head NN I-NP I-test
revealing VBG O O
a DT B-NP O
possible JJ I-NP O
parietal JJ I-NP B-problem
subdural JJ I-NP I-problem
bleed NN I-NP I-problem
on IN B-VP I-problem
the DT B-NP I-problem
right JJ I-NP I-problem
side NN I-NP I-problem
. . B-VP O
   
The DT O B-person
The DT B-NP B-test
patient JJ I-NP I-person
patient NN I-NP I-test
's POS O I-test
GCS NNP B-NP I-test
was VBD B-VP O
15 CD O O
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
hemodynamically RB O O
stable JJ O O
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
thereafter RB O O
transferred VBN O O
to TO O O
Beverly NNP B-NP O
Hospital NNP I-NP O
for IN B-VP O
further JJ B-NP B-test
evaluation NN I-NP I-test
and CC O O
management NN B-NP B-treatment
. . B-VP O
   
PAST NNP B-NP O
MEDICAL NNP I-NP O
HISTORY NNP I-NP O
: : O O
Significant NN B-NP O
for IN B-VP O
depression NN B-NP B-problem
. . B-VP O
   
MEDICATIONS NNP B-NP O
ON NNP I-NP O
ADMISSION NNP I-NP O
: : O O
1. CD O O
Prozac NNP B-NP B-treatment
. . B-VP O
   
2. CD O O
Tetracycline NNP B-NP B-treatment
for IN B-VP O
acne NN B-NP B-problem
. . B-VP O
   
ALLERGIES NN B-NP O
: : O O
She PRP O B-person
has VBZ O O
no DT O O
known VBN O B-problem
drug NN B-NP I-problem
allergies NNS I-NP I-problem
. . B-VP O
   
PHYSICAL JJ B-NP O
EXAMINATION NN I-NP O
: : O O
On IN B-VP O
presentation NN B-NP O
, , O O
her PRP$ O B-test
her PRP$ O B-person
temperature NN B-NP I-test
was VBD B-VP O
98.8 CD O O
with IN B-VP O
a DT B-NP B-test
heart NN I-NP I-test
rate NN I-NP I-test
of IN B-VP O
100 CD O O
, , O O
blood NN B-NP B-test
pressure NN I-NP I-test
110/65 CD O O
, , O O
respiratory NN B-NP B-test
rate NN I-NP I-test
18 CD O O
, , O O
and CC O O
she PRP O B-person
was VBD B-VP O
saturating VBG O O
at IN B-VP O
100% CD O O
in IN B-VP O
room NN B-NP O
air NN I-NP O
. . B-VP O
   
In IN B-VP O
general JJ O O
, , O O
she PRP O B-person
is VBZ O O
well RB O O
appearing VBG O O
in IN B-VP O
no DT B-NP O
acute JJ I-NP B-problem
distress NN I-NP I-problem
. . B-VP O
   
Head NNP B-NP B-test
, , O I-test
eyes NNS B-NP I-test
, , O I-test
ears NNS B-NP I-test
, , O I-test
nose RB O I-test
and CC O I-test
throat VB O I-test
examination NN B-NP I-test
- : O O
The DT B-NP O
pupils NNS I-NP O
are VBP O O
equal JJ O O
, , O O
round NN B-NP O
, , O O
and CC O O
reactive JJ O O
to TO O O
light JJ O O
and CC O O
accommodation NN B-NP O
. . B-VP O
   
Extraocular JJ B-NP O
movements NNS I-NP O
are VBP O O
intact JJ O O
. . B-VP O
   
The DT B-NP O
oropharynx NN I-NP O
is VBZ O O
negative JJ O O
. . B-VP O
   
Face NN B-NP O
is VBZ O O
stable JJ O O
. . B-VP O
   
No DT B-NP O
obvious JJ I-NP O
evidence NN I-NP O
of IN B-VP O
trauma NN B-NP B-problem
. . B-VP O
   
She PRP O B-person
is VBZ O O
normocephalic JJ O O
otherwise RB O O
. . B-VP O
   
Trachea NNP B-NP O
was VBD B-VP O
midline NN B-NP O
. . B-VP O
   
The DT B-NP O
heart NN I-NP O
was VBD B-VP O
regular JJ O O
. . B-VP O
   
The DT B-NP O
lungs NNS I-NP O
were VBD B-VP O
clear JJ O O
to TO O O
auscultation VB O B-test
bilaterally RB O O
. . B-VP O
   
No DT B-NP O
crepitus NN I-NP B-problem
. . B-VP O
   
The DT B-NP O
abdomen NNS I-NP O
was VBD B-VP O
soft JJ O O
, , O O
nontender NN B-NP B-problem
, , O O
nondistended VBN O B-problem
. . B-VP O
   
Extremities NNS B-NP O
with IN B-VP O
no DT B-NP O
evidence NN I-NP O
of IN B-VP O
step-off NN B-NP B-problem
, , O O
palpable JJ B-NP O
pulses NNS I-NP O
peripherally RB O O
. . B-VP O
   
She PRP O B-person
had VBD B-VP O
brisk JJ B-NP O
capillary JJ I-NP O
refill NN I-NP O
. . B-VP O
   
Rectal JJ B-NP B-test
examination NN I-NP I-test
was VBD B-VP O
heme JJ O B-test
negative JJ O O
with IN B-VP O
normal JJ B-NP O
tone NN I-NP O
. . B-VP O
   
Neurologic NNP B-NP B-test
examination NN I-NP I-test
was VBD B-VP O
nonfocal JJ O O
. . B-VP O
   
Neurosensory NN B-NP O
was VBD B-VP O
intact JJ O O
and CC O O
she PRP O B-person
had VBD B-VP O
normal JJ B-NP O
motor NN I-NP O
examination NN I-NP O
with IN B-VP O
5/5 CD O O
strength NN B-NP O
throughout IN B-VP O
all DT O O
her PRP$ O B-person
upper NN B-NP O
and CC O O
lower JJR B-NP O
extremities NNS I-NP O
. . B-VP O
   
LABORATORY NNP B-NP O
DATA NNP I-NP O
: : O O
Admission NN B-NP B-test
laboratories NNS I-NP I-test
were VBD B-VP O
notable JJ O O
for IN B-VP O
a DT B-NP B-test
white JJ I-NP I-test
count NN I-NP I-test
of IN B-VP O
13.1 CD O O
, , O O
hematocrit NN B-NP B-test
34.0 CD O O
, , O O
platelet NN B-NP B-test
count NN I-NP I-test
280,000 CD O O
. . B-VP O
   
Chemistries NNS B-NP B-test
were VBD B-VP O
notable JJ O O
for IN B-VP O
a DT B-NP B-test
sodium NN I-NP I-test
of IN B-VP O
143 CD O O
, , O O
potassium NN B-NP B-test
3.2 CD O O
, , O O
chloride NN B-NP B-test
and CC O O
bicarbonate NN B-NP B-test
of IN B-VP O
104 CD O O
and CC O O
24 CD O O
, , O O
respectively RB O O
, , O O
with IN B-VP O
blood NN B-NP B-test
urea JJ B-NP I-test
nitrogen NN I-NP I-test
and CC O O
creatinine NN B-NP B-test
of IN B-VP O
7 CD O O
and CC O O
0.4 CD O O
, , O O
respectively RB O O
. . B-VP O
   
Blood NNP B-NP B-test
glucose NN I-NP I-test
was VBD B-VP O
116 CD O O
. . B-VP O
   
Her PRP$ O B-test
Her PRP$ O B-person
admission NN B-NP I-test
coagulation NN I-NP I-test
studies NNS I-NP I-test
were VBD B-VP O
notable JJ O O
for IN B-VP O
a DT B-NP B-test
prothrombin JJ I-NP I-test
time NN I-NP I-test
INR NNP I-NP B-test
of IN B-VP O
11.8 CD O O
and CC O O
0.9 CD O O
, , O O
respectively RB O O
with IN B-VP O
a DT B-NP B-test
partial JJ I-NP I-test
thromboplastin NN I-NP I-test
time NN I-NP I-test
of IN B-VP O
25.2 CD O O
. . B-VP O
   
Admission NN B-NP B-test
lactate NN I-NP I-test
was VBD B-VP O
0.8 CD O O
. . B-VP O
   
Amylase NNP B-NP B-test
was VBD B-VP O
87 CD O O
. . B-VP O
   
Fibrinogen NN B-NP B-test
was VBD B-VP O
346 CD O O
. . B-VP O
   
HCG NNP B-NP B-test
was VBD B-VP O
negative JJ O O
. . B-VP O
   
Serum NNP B-NP B-test
toxicology NN I-NP I-test
and CC O O
urine JJ B-NP B-test
toxicology NN I-NP I-test
were VBD B-VP O
negative JJ O O
. . B-VP O
   
Urinalysis NN B-NP B-test
obtained VBN O O
on IN B-VP O
admission NN B-NP O
was VBD B-VP O
additionally RB O O
negative JJ O O
. . B-VP O
   
She PRP O B-person
had VBD B-VP O
three CD O B-test
views NNS B-NP I-test
of IN B-VP I-test
the DT B-NP I-test
cervical JJ I-NP I-test
spine NN I-NP I-test
that WDT O B-pronoun
were VBD B-VP O
negative JJ O O
. . B-VP O
   
Chest JJS B-NP B-test
x-ray NN I-NP I-test
was VBD B-VP O
negative JJ O O
. . B-VP O
   
Pelvis NNP B-NP B-test
film NN I-NP I-test
was VBD B-VP O
negative JJ O O
. . B-VP O
   
Head NNP B-NP B-test
CT NNP I-NP I-test
from IN B-VP O
the DT B-NP O
outside JJ I-NP O
hospital NN I-NP O
just RB O O
revealed VBD B-VP O
a DT B-NP B-problem
small JJ I-NP I-problem
right JJ I-NP I-problem
parietal JJ I-NP I-problem
subdural JJ I-NP I-problem
blood NN I-NP I-problem
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
evaluated VBN O O
. . B-VP O
   
Her PRP$ O B-person
cervical JJ B-NP O
spine NN I-NP O
was VBD B-VP O
cleared VBN O O
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
off RB O O
TLS JJ B-NP B-treatment
precautions NNS I-NP I-treatment
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
sent VBN O O
to TO O O
the DT B-NP O
Intensive NNP I-NP O
Care NNP I-NP O
Unit NNP I-NP O
for IN B-VP O
monitoring VBG O O
overnight JJ O O
for IN B-VP O
neural JJ B-NP B-test
checks NNS I-NP I-test
and CC O O
neurosurgical JJ B-NP O
consultation NN I-NP O
was VBD B-VP O
obtained VBN O O
. . B-VP O
   
Neurosurgical JJ B-NP B-test
evaluation NN I-NP I-test
just RB O O
recommended VBN O O
serial JJ B-NP B-test
neurologic JJ I-NP I-test
checks NNS I-NP I-test
and CC O O
a DT B-NP B-test
repeat NN I-NP I-test
CAT NNP I-NP I-test
scan NN I-NP I-test
on IN B-VP O
the DT B-NP O
second JJ I-NP O
day NN I-NP O
of IN B-VP O
admission NN B-NP O
to TO O O
see VB O O
if IN B-VP O
there EX O O
was VBD B-VP O
any DT B-NP O
evidence NN I-NP O
of IN B-VP O
progression NN B-NP O
of IN B-VP O
the DT B-NP B-problem
bleeding NN I-NP I-problem
. . B-VP O
   
On IN B-VP O
2010-02-05 JJ O O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
had VBD B-VP O
a DT B-NP B-test
repeat NN I-NP I-test
CAT NNP I-NP I-test
scan NN I-NP I-test
of IN B-VP I-test
the DT B-NP I-test
head NN I-NP I-test
revealing VBG O O
no DT B-NP O
change NN I-NP O
in IN B-VP O
the DT B-NP B-problem
subdural JJ I-NP I-problem
bleed NN I-NP I-problem
. . B-VP O
   
Her PRP$ O B-person
Her PRP$ O B-test
neurologic JJ B-NP I-test
examination NN I-NP I-test
remained VBD B-VP O
nonfocal JJ O O
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
kept VBN O O
in IN B-VP O
the DT B-NP O
hospital NN I-NP O
for IN B-VP O
an DT O O
additional JJ O O
24 CD O O
hours NNS B-NP O
for IN B-VP O
further JJ B-NP B-test
evaluation NN I-NP I-test
. . B-VP O
   
By IN B-VP O
2010-02-06 JJ O O
, , O O
which WDT O B-pronoun
would MD O O
correlate VB O O
with IN B-VP O
hospital JJ B-NP O
day NN I-NP O
number NN I-NP O
two CD O O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
had VBD B-VP O
no DT B-NP O
complaints NNS I-NP O
except IN B-VP O
for IN B-VP O
some DT B-NP B-problem
small JJ I-NP I-problem
frontal JJ I-NP I-problem
pressure NN I-NP I-problem
in IN B-VP O
the DT B-NP O
region NN I-NP O
of IN B-VP O
where WRB O O
the DT B-NP B-problem
bleed NN I-NP I-problem
had VBD B-VP O
been VBN O O
localized VBN O O
on IN B-VP O
the DT B-NP O
right JJ I-NP O
side NN I-NP O
. . B-VP O
   
She PRP O B-person
remained VBD B-VP O
afebrile JJ O B-problem
and CC O O
hemodynamically RB O O
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
tolerating VBG O O
diet JJ O O
and CC O O
able JJ O O
to TO O O
ambulate VB O O
without IN B-VP O
difficulty NN B-NP O
. . B-VP O
   
She PRP O B-person
had VBD B-VP O
no DT B-NP O
other JJ I-NP O
complaints NNS I-NP O
by IN B-VP O
examination NN B-NP B-test
. . B-VP O
   
Her PRP$ O B-test
Her PRP$ O B-person
neurologic JJ B-NP I-test
examination NN I-NP I-test
remained VBD B-VP O
completely RB O O
nonfocal JJ O O
and CC O O
otherwise RB O O
normal JJ O O
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
seen VBN O O
by IN B-VP O
the DT B-NP O
trauma NN I-NP O
attending VBG O O
with IN B-VP O
Dr. NNP B-NP B-person
Walters NNP I-NP I-person
and CC O O
she PRP O B-person
was VBD B-VP O
cleared VBN O O
for IN B-VP O
discharge NN B-NP O
to TO O O
home NN B-NP O
. . B-VP O
   
MEDICATIONS NNP B-NP O
ON NNP I-NP O
DISCHARGE NNP I-NP O
: : O O
1. CD O O
Tylenol NNP B-NP B-treatment
#3 NNP I-NP I-treatment
one CD O O
to TO O O
two CD O O
tablets NNS B-NP O
p.o. JJ B-NP O
q JJ I-NP O
4-6 JJ I-NP O
hours NNS I-NP O
p.r.n. VBP O O
2. CD O O
Motrin NNP B-NP B-treatment
as IN B-VP O
needed VBN O O
. . B-VP O
   
3. CD O O
Prozac NNP B-NP B-treatment
20 CD O O
mg NN B-NP O
p.o. NN I-NP O
once RB O O
daily JJ O O
. . B-VP O
   
4. CD O O
Tetracycline NN B-NP B-treatment
which WDT O B-pronoun
she PRP O B-person
was VBD B-VP O
taking VBG O O
for IN B-VP O
her PRP$ O B-person
her PRP$ O B-problem
acne NN B-NP I-problem
. . B-VP O
   
FOLLOW-UP NN B-NP O
: : O O
She PRP O B-person
will MD O O
follow-up VB O O
with IN B-VP O
Dr. NNP B-NP B-person
Langley NNP I-NP I-person
in IN B-VP O
approximately RB O O
one CD O O
month NN B-NP O
. . B-VP O
   
Her PRP$ O B-person
trauma JJ B-NP O
clinic JJ I-NP O
follow-up NN I-NP O
is VBZ O O
strictly RB O O
p.r.n. JJ B-NP O
DISCHARGE NNP I-NP O
DIAGNOSES NNP I-NP O
: : O O
1. CD O O
Right NNP B-NP B-problem
parietal JJ B-NP I-problem
subdural JJ I-NP I-problem
bleed NN I-NP I-problem
, , O O
status NN B-NP O
post NN I-NP O
fall NN I-NP O
from IN B-VP O
standing VBG O O
position NN B-NP O
with IN B-VP O
no DT B-NP O
loss NN I-NP B-problem
of IN B-VP I-problem
consciousness NN B-NP I-problem
and CC O O
no DT B-NP O
neurologic JJ I-NP B-problem
deficits NNS I-NP I-problem
or CC O O
progression NN B-NP B-problem
. . B-VP O
   
2. CD O O
Depression NNP B-NP B-problem
. . B-VP O
   
3. CD O O
Acne NNP B-NP B-problem
. . B-VP O
   
DISCHARGE NNP B-NP O
STATUS NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
discharged VBN O O
to TO O O
home NN B-NP O
in IN B-VP O
stable JJ B-NP O
condition NN I-NP O
. . B-VP O
   
Charles NNP B-NP B-person
I. NNP I-NP I-person
. . B-VP I-person
   
Sanders NNP B-NP I-person
, , O I-person
M.D. NNP B-NP I-person
76-364 CD O O
Dictated VBN O O
By IN B-VP O
: : O O
Hayden NNP B-NP B-person
Y. NNP I-NP I-person
Ferguson NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
MEDQUIST36 NNP I-NP O
D NNP I-NP O
: : O O
2010-02-06 JJ O O
08:59 CD O O
T NN B-NP O
: : O O
2010-02-06 JJ O O
09:10 CD O O
JOB NNP B-NP O
#: VBD B-VP O
73118 CD O O
Signed VBN O O
electronically RB O O
by IN B-VP O
: : O O
DR. NNP B-NP B-person
Theresa NNP I-NP I-person
MOORMAN NNP I-NP I-person
on IN B-VP O
: : O O
FRI NNP B-NP O
2010-02-26 CD O O
3:21 CD O O
PM NNP B-NP O
( ( O O
End NNP B-NP O
of IN B-VP O
Report NNP B-NP O
) ) O O
-EMPTYLINE- VBP O O
-DOCSTART- JJ O O
-EMPTYLINE- $ O O
142995994 CD O O
SC NNP B-NP O
54818584 CD O O
976113 CD O O
1/23/1992 CD O O
12:00:00 CD O O
AM NNP B-NP O
Discharge NNP I-NP O
Summary NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date NNP I-NP O
: : O O
01/23/1992 CD O O
Report NNP B-NP O
Status NNP I-NP O
: : O O
Signed VBN O O
Discharge NNP B-NP O
Date NNP I-NP O
: : O O
01/26/1992 CD O O
DIAGNOSIS NNP B-NP O
ON NNP I-NP O
DISCHARGE NNP I-NP O
: : O O
1. CD O O
STATUS NNP B-NP O
POST NNP I-NP O
MOTORVEHICLE NNP I-NP O
ACCIDENT NNP I-NP O
WITH NNP I-NP O
TRANSIENT NNP I-NP B-problem
PARAPLEGIA NNP I-NP I-problem
. . B-VP O
   
2. CD O O
RIGHT JJ B-NP B-problem
HYDRONEPHROSIS NNP I-NP I-problem
ON NNP I-NP O
CT NNP I-NP B-test
SCAN NNP I-NP I-test
. . B-VP O
   
HISTORY NNP B-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
is VBZ O O
a DT O O
20 CD O O
year NN B-NP O
old JJ B-NP O
black JJ I-NP O
female NN I-NP O
who WP O B-person
was VBD B-VP O
a DT O O
pedestrian JJ O O
when WRB O O
struck VBN O O
by IN B-VP O
a DT B-NP O
car NN I-NP O
at IN B-VP O
apparent JJ B-NP O
high JJ I-NP O
speed NN I-NP O
. . B-VP O
   
There EX O O
was VBD B-VP O
apparent JJ B-NP B-problem
loss NN I-NP I-problem
of IN B-VP I-problem
consciousness NN B-NP I-problem
at IN B-VP O
the DT B-NP O
scene NN I-NP O
and CC O O
significant JJ B-NP O
deformity NN I-NP O
of IN B-VP O
the DT B-NP O
anterior JJ I-NP O
portion NN I-NP O
of IN B-VP O
the DT B-NP O
motorvehicle NN I-NP O
with IN B-VP O
positive JJ B-NP O
starring NN I-NP O
of IN B-VP O
the DT B-NP O
windshield NN I-NP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
conscious JJ O O
on IN B-VP O
the DT B-NP O
scene NN I-NP O
when WRB O O
evaluated VBN O O
by IN B-VP O
EMT NNP B-NP B-person
&apos;s NNP I-NP O
but CC O O
at IN B-VP O
the DT B-NP O
scene NN I-NP O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
apparently RB O B-problem
paraplegic JJ O I-problem
below IN B-VP I-problem
the DT B-NP I-problem
umbilicus NN I-NP I-problem
with IN B-VP O
absence NN B-NP B-problem
of IN B-VP I-problem
movement NN B-NP I-problem
and CC O I-problem
sensation NN B-NP I-problem
below IN B-VP I-problem
the DT B-NP I-problem
umbilicus NN I-NP I-problem
. . B-VP O
   
PAST NNP B-NP O
MEDICAL NNP I-NP O
HISTORY NNP I-NP O
: : O O
None NN B-NP O
. . B-VP O
   
PAST JJ B-NP O
SURGICAL JJ I-NP O
HISTORY NN I-NP O
: : O O
Status NNP B-NP O
post NN I-NP O
laparotomy NN I-NP B-treatment
for IN B-VP O
an DT B-NP B-problem
ovarian JJ I-NP I-problem
cyst NN I-NP I-problem
in IN B-VP O
1988 CD O O
. . B-VP O
   
MEDICATIONS NNP B-NP O
ON NNP I-NP O
ADMISSION NNP I-NP O
: : O O
None NN B-NP O
. . B-VP O
   
ALLERGIES NN B-NP O
: : O O
None NN B-NP O
. . B-VP O
   
She PRP O B-person
denies VBZ O O
cigarette NN B-NP O
use NN I-NP O
and CC O O
ethanol NN B-NP O
use NN I-NP O
as RB O O
well RB O O
as IN B-VP O
a DT B-NP O
recreational JJ I-NP O
drug NN I-NP O
use NN I-NP O
. . B-VP O
   
PHYSICAL JJ B-NP O
EXAMINATION NN I-NP O
: : O O
On IN B-VP O
initial JJ B-NP B-test
exam NN I-NP I-test
, , O O
her PRP$ O B-person
left JJ B-NP O
shoulder NN I-NP O
was VBD B-VP O
tender NN B-NP B-problem
to TO O O
palpation NN B-NP B-test
over IN B-VP O
the DT B-NP O
proximal JJ I-NP O
humerus NN I-NP O
with IN B-VP O
decreased JJ B-NP B-problem
range NN I-NP I-problem
of IN B-VP I-problem
motion NN B-NP I-problem
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
without IN B-VP O
the DT B-NP O
ability NN I-NP O
to TO O O
move VB O O
her PRP$ O B-person
left JJ B-NP O
lower JJR I-NP O
extremity NN I-NP O
with IN B-VP O
decreased JJ B-NP B-problem
sensation NN I-NP I-problem
in IN B-VP I-problem
the DT B-NP I-problem
left NN I-NP I-problem
leg NN I-NP I-problem
. . B-VP O
   
The DT B-NP O
right JJ I-NP O
leg NN I-NP O
was VBD B-VP O
with IN B-VP O
decreased JJ B-NP B-problem
range NN I-NP I-problem
of IN B-VP I-problem
motion NN B-NP I-problem
of IN B-VP O
thigh JJ B-NP O
flexion NN I-NP O
and CC O O
extension NN B-NP O
. . B-VP O
   
The DT B-NP O
back NN I-NP O
was VBD B-VP O
notable JJ O O
for IN B-VP O
tenderness NN B-NP B-problem
at IN B-VP O
the DT B-NP O
level NN I-NP O
of IN B-VP O
L3-L5 NNP B-NP O
. . B-VP O
   
LABORATORY NNP B-NP O
EXAMINATION NNP I-NP O
: : O O
Initial JJ B-NP B-test
radiologic NN I-NP I-test
evaluation NN I-NP I-test
showed VBD B-VP O
negative JJ B-NP O
C-spine NNP I-NP O
, , O O
thoracic NN B-NP O
spine NN I-NP O
, , O O
and CC O O
lumbosacral JJ B-NP O
spine NN I-NP O
films NNS I-NP O
. . B-VP O
   
Abdominal NNP B-NP B-test
CT NNP I-NP I-test
was VBD B-VP O
negative JJ O O
except IN B-VP O
for IN B-VP O
right JJ B-NP B-problem
hydronephrosis NN I-NP I-problem
with IN B-VP O
mild JJ B-NP B-problem
right JJ I-NP I-problem
hydroureter NN I-NP I-problem
. . B-VP O
   
Back NNP B-NP B-test
MRI NNP I-NP I-test
was VBD B-VP O
negative JJ O O
. . B-VP O
   
Film NNP B-NP B-test
of IN B-VP I-test
the DT B-NP I-test
left NN I-NP I-test
humerus NN I-NP I-test
was VBD B-VP O
also RB O O
negative JJ O O
. . B-VP O
   
HOSPITAL NNP B-NP O
COURSE NNP I-NP O
: : O O
A DT B-NP O
Neurosurgery NNP I-NP B-person
consultation NN I-NP O
was VBD B-VP O
obtained VBN O O
, , O O
and CC O O
it PRP O B-pronoun
was VBD B-VP O
their PRP$ O B-person
impression NN B-NP O
that IN B-VP B-pronoun
the DT O B-person
the DT B-NP B-problem
patient JJ I-NP I-person
patient NN I-NP I-problem
&apos;s NNP I-NP I-problem
paraplegia NN I-NP I-problem
might MD O O
possibly RB O O
represent VB O O
a DT B-NP B-problem
cord NN I-NP I-problem
concussion NN I-NP I-problem
, , O O
and CC O O
recommended VBD B-VP O
treatment NN B-NP B-treatment
with IN B-VP I-treatment
intravenous JJ B-NP I-treatment
steroids NNS I-NP I-treatment
for IN B-VP O
24 CD O O
hours NNS B-NP O
. . B-VP O
   
The DT O B-person
The DT B-NP B-problem
patient JJ I-NP I-person
patient NN I-NP I-problem
&apos;s NNP I-NP I-problem
paraplegia NN I-NP I-problem
resolved VBN O O
by IN B-VP O
the DT B-NP O
morning NN I-NP O
of IN B-VP O
her PRP$ O B-person
second JJ B-NP O
hospital JJ I-NP O
day NN I-NP O
, , O O
and CC O O
she PRP O B-person
maintained VBD B-VP O
5/5 CD O O
motor NN B-NP O
strength NN I-NP O
in IN B-VP O
all DT B-NP O
groups NNS I-NP O
. . B-VP O
   
A DT B-NP O
Urology NNP I-NP B-person
consultation NN I-NP O
was VBD B-VP O
obtained VBN O O
, , O O
and CC O O
it PRP O B-pronoun
was VBD B-VP O
recommended VBN O O
that IN B-VP B-pronoun
an DT B-NP B-test
IVP NNP I-NP I-test
be VB O O
obtained VBN O O
. . B-VP O
   
This DT O B-pronoun
was VBD B-VP O
obtained VBN O O
on IN B-VP O
the DT B-NP O
day NN I-NP O
of IN B-VP O
discharge NN B-NP O
, , O O
however RB O O
, , O O
due JJ O O
to TO O O
residual JJ B-NP B-problem
contrast NN I-NP I-problem
in IN B-VP I-problem
the DT B-NP I-problem
colon NN I-NP I-problem
from IN B-VP O
the DT O B-person
the DT B-NP B-test
patient JJ I-NP I-person
patient NN I-NP I-test
&apos;s NNP I-NP I-test
prior JJ B-NP I-test
abdominal JJ I-NP I-test
CT NNP I-NP I-test
scan NN I-NP I-test
, , O O
the DT B-NP B-test
exam NN I-NP I-test
was VBD B-VP O
postponed VBN O O
after IN B-VP O
a DT B-NP B-test
scout NN I-NP I-test
film NN I-NP I-test
was VBD B-VP O
obtained VBN O O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
fell VBD B-VP O
well RB O O
on IN B-VP O
the DT B-NP O
day NN I-NP O
of IN B-VP O
discharge NN B-NP O
. . B-VP O
   
She PRP O B-person
remained VBD B-VP O
afebrile JJ O B-problem
throughout IN B-VP O
her PRP$ O B-person
hospital JJ B-NP O
course NN I-NP O
. . B-VP O
   
Additionally RB O O
on IN B-VP O
the DT B-NP O
night NN I-NP O
before IN B-VP O
discharge NN B-NP O
, , O O
flexion NN B-NP B-test
and CC O I-test
extension NN B-NP I-test
views NNS I-NP I-test
of IN B-VP I-test
the DT B-NP I-test
lumbosacral JJ I-NP I-test
spine NN I-NP I-test
were VBD B-VP O
obtained VBN O O
, , O O
and CC O O
showed VBD B-VP O
no DT B-NP O
fracture NN I-NP B-problem
or CC O O
instability NN B-NP B-problem
. . B-VP O
   
DISPOSITION NN B-NP O
: : O O
CONDITION NN B-NP O
ON NNP I-NP O
DISCHARGE NNP I-NP O
: : O O
Good JJ O O
. . B-VP O
   
MEDICATIONS NNP B-NP O
ON NNP I-NP O
DISCHARGE NNP I-NP O
: : O O
Tylenol CD O B-treatment
650 CD O O
mg NN B-NP O
p.o. NN I-NP O
q4 NN I-NP O
hours NNS I-NP O
p.r.n. VBP O O
pain NN B-NP B-problem
. . B-VP O
   
She PRP O B-person
will MD O O
followup VB O O
in IN B-VP O
the DT B-NP O
Wardca NNP I-NP O
Presiew NNP I-NP O
Hospital NNP I-NP O
in IN B-VP O
one CD O O
week NN B-NP O
. . B-VP O
   
She PRP O B-person
will MD O O
have VB O O
an DT B-NP B-test
IVP NNP I-NP I-test
repeated VBD B-VP O
in IN B-VP O
one CD O O
week NN B-NP O
at IN B-VP O
which WDT O B-pronoun
time NN B-NP O
she PRP O B-person
should MD O O
have VB O O
cleared VBN O O
the DT B-NP B-problem
residual JJ I-NP I-problem
contrast NN I-NP I-problem
in IN B-VP I-problem
her PRP$ O B-person
her PRP$ O I-problem
colon NN B-NP I-problem
. . B-VP O
   
She PRP O B-person
will MD O O
have VB O O
urology JJ B-NP B-person
followup NNS I-NP O
after IN B-VP O
her PRP$ O B-person
her PRP$ O B-test
IVP NNP B-NP I-test
. . B-VP O
   
OP303/0134 NNP B-NP O
NARI NNP I-NP B-person
BLACK NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
SU1 NNP I-NP O
D NNP I-NP O
: : O O
01/26/92 CD O O
Batch NN B-NP O
: : O O
7505 CD O O
Report NN B-NP O
: : O O
K7798E74 NNP B-NP O
T NNP I-NP O
: : O O
01/27/92 CD O O
Dictated VBN O O
By IN B-VP O
: : O O
SHAZA NNP B-NP B-person
C. NNP I-NP I-person
SCHAUMANN NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- VBD B-VP O
435216075 CD O O
YC NNP B-NP O
93004953 CD O O
1966777 CD O O
5/26/2005 CD O O
12:00:00 CD O O
AM NNP B-NP O
Atypical NNP I-NP B-problem
chest NN I-NP I-problem
pain NN I-NP I-problem
DIS NNP I-NP O
Admission NNP I-NP O
Date NNP I-NP O
: : O O
05/26/2005 CD O O
Report NNP B-NP O
Status NNP I-NP O
: : O O
Discharge NN B-NP O
Date NNP I-NP O
: : O O
05/27/2005 CD O O
****** NN B-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
CHEAMPBUR NNP I-NP B-person
, , O I-person
STEENRA NNP B-NP I-person
R. NNP I-NP I-person
789-41-40-5 JJ B-NP O
N56 NNP I-NP O
Room NNP I-NP O
: : O O
0W-320 JJ B-NP O
Service NNP I-NP O
: : O O
CAR NNP B-NP O
DISCHARGE NNP I-NP O
PATIENT NNP I-NP B-person
ON NNP I-NP O
: : O O
05/27/05 CD O O
AT NNP B-NP O
05:30 CD O O
PM NNP B-NP O
CONTINGENT NNP I-NP O
UPON NNP I-NP O
Not RB O O
Applicable NNP B-NP O
WILL NNP I-NP O
D NNP I-NP O
/ NNP I-NP O
C NNP I-NP O
ORDER NNP I-NP O
BE NNP I-NP O
USED NNP I-NP O
AS IN B-VP O
THE NNP B-NP O
D NNP I-NP O
/ NNP I-NP O
C NNP I-NP O
SUMMARY NNP I-NP O
: : O O
YES JJ B-NP O
Attending NN I-NP B-person
: : O O
SEISE NNP B-NP B-person
, , O I-person
JR NNP B-NP I-person
, , O I-person
EJAKE NNP B-NP I-person
L. NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
CODE NNP I-NP O
STATUS NNP I-NP O
: : O O
Full NNP B-NP O
code NN I-NP O
DISPOSITION NNP I-NP O
: : O O
Home NNP B-NP O
DISCHARGE NNP I-NP O
MEDICATIONS NNP I-NP O
: : O O
ECASA NNP B-NP B-treatment
( ( O I-treatment
ASPIRIN NNP B-NP I-treatment
ENTERIC NNP I-NP I-treatment
COATED NNP I-NP I-treatment
) ) O I-treatment
81 CD O O
MG NNP B-NP O
PO NNP I-NP O
QD NNP I-NP O
LEVOXYL NNP I-NP B-treatment
( ( O I-treatment
LEVOTHYROXINE NNP B-NP I-treatment
SODIUM NNP I-NP I-treatment
) ) O I-treatment
25 CD O O
MCG NNP B-NP O
PO NNP I-NP O
QD NNP I-NP O
SYNAREL NNP I-NP B-treatment
( ( O I-treatment
NAFARELIN NNP B-NP I-treatment
ACETATE NNP I-NP I-treatment
) ) O I-treatment
1 CD O O
PUFF NNP B-NP O
NA NNP I-NP O
BID NNP I-NP O
NITROGLYCERIN NNP I-NP B-treatment
1/150 CD O O
( ( O O
0.4 CD O O
MG NNP B-NP O
) ) O O
1 CD O O
TAB NNP B-NP O
SL NNP I-NP O
Q5MIN NNP I-NP O
X NNP I-NP O
3 CD O O
doses NNS B-NP O
PRN NNP I-NP O
Chest NNP I-NP B-problem
Pain NNP I-NP I-problem
MULTIVITAMIN NNP I-NP B-treatment
THERAPEUTIC NNP I-NP I-treatment
( ( O I-treatment
THERAPEUTIC NNP B-NP I-treatment
MULTIVI NNP I-NP I-treatment
... : O I-treatment
) ) O I-treatment
1 CD O O
TAB NNP B-NP O
PO NNP I-NP O
QD NNP I-NP O
Alert NNP I-NP O
overridden NN I-NP O
: : O O
Override NNP B-NP O
added VBD B-VP O
on IN B-VP O
05/26/05 CD O O
by IN B-VP O
SAGELYSS NNP B-NP B-person
, , O I-person
TYTUMZE NNP B-NP I-person
V. NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
POTENTIALLY NNP I-NP O
SERIOUS NNP I-NP B-problem
INTERACTION NNP I-NP I-problem
: : O O
SIMVASTATIN NNP B-NP B-treatment
and CC O O
NIACIN NNP B-NP B-treatment
, , O O
VIT NNP B-NP B-treatment
. . B-VP O
   
B-3 NNP B-NP O
Reason NNP I-NP O
for IN B-VP O
override NN B-NP O
: : O O
ok JJ B-NP O
TOPROL NNP I-NP B-treatment
XL NNP I-NP I-treatment
( ( O I-treatment
METOPROLOL NNP B-NP I-treatment
( ( O I-treatment
SUST. NNP B-NP I-treatment
REL. NNP I-NP I-treatment
) ) O I-treatment
) ) O O
200 CD O O
MG NNP B-NP O
PO NNP I-NP O
QD NNP I-NP O
Food NNP I-NP O
/ NNP I-NP O
Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Take NNP I-NP O
consistently RB O O
with IN B-VP O
meals NNS B-NP O
or CC O O
on IN B-VP O
empty JJ B-NP O
stomach NN I-NP O
. . B-VP O
   
Number NNP B-NP O
of IN B-VP O
Doses NNP B-NP O
Required NNP I-NP O
( ( O O
approximate JJ O O
) ) O O
: : O O
8 CD O O
PLAVIX NNP B-NP B-treatment
( ( O I-treatment
CLOPIDOGREL NNP B-NP I-treatment
) ) O I-treatment
75 CD O O
MG NNP B-NP O
PO NNP I-NP O
QD NNP I-NP O
LIPITOR NNP I-NP B-treatment
( ( O I-treatment
ATORVASTATIN NNP B-NP I-treatment
) ) O I-treatment
40 CD O O
MG NNP B-NP O
PO NNP I-NP O
QD NNP I-NP O
Alert NNP I-NP O
overridden NN I-NP O
: : O O
Override NNP B-NP O
added VBD B-VP O
on IN B-VP O
05/27/05 CD O O
by IN B-VP O
: : O O
POTENTIALLY NNP B-NP O
SERIOUS NNP I-NP B-problem
INTERACTION NNP I-NP I-problem
: : O O
NIACIN NNP B-NP B-treatment
, , O O
VIT NNP B-NP B-treatment
. . B-VP O
   
B-3 NNP B-NP O
and CC O O
ATORVASTATIN NNP B-NP B-treatment
CALCIUM NNP I-NP I-treatment
Reason NNP I-NP O
for IN B-VP O
override NN B-NP O
: : O O
ok JJ B-NP O
DIET NNP I-NP O
: : O O
House NNP B-NP O
/ VBD B-VP O
Low NNP B-NP O
saturated VBD B-VP O
fat JJ B-NP O
low JJ I-NP O
cholesterol NN I-NP O
&lt; NNP I-NP O
FDI NNP I-NP O
&gt; NNP I-NP O
ACTIVITY NNP I-NP O
: : O O
Resume NNP B-NP O
regular JJ B-NP O
exercise NN I-NP O
FOLLOW NNP I-NP O
UP NNP I-NP O
APPOINTMENT NNP I-NP O
( ( O O
S NNP B-NP O
) ) O O
: : O O
Follow VB O O
up RP O O
with IN B-VP O
your PRP$ O B-person
your PRP$ O B-person
PCP NNP B-NP I-person
within IN B-VP O
2 CD O O
wks NNS B-NP O
, , O O
ALLERGY NNP B-NP O
: : O O
Morphine NNP B-NP B-treatment
, , O O
LEUPROLIDE NNP B-NP B-treatment
ADMIT NNP I-NP O
DIAGNOSIS NNP I-NP O
: : O O
Chest JJS B-NP B-problem
Pain NN I-NP I-problem
PRINCIPAL NNP I-NP O
DISCHARGE NNP I-NP O
DIAGNOSIS NNP I-NP O
; : O O
Responsible NNP B-NP O
After IN B-VP O
Study NNP B-NP O
for IN B-VP O
Causing NNP B-NP O
Admission NNP I-NP O
) ) O O
Atypical NNP B-NP B-problem
chest NN I-NP I-problem
pain NN I-NP I-problem
OTHER NNP I-NP O
DIAGNOSIS NNP I-NP O
; : O O
Conditions NNP B-NP O
, , O O
Infections NNP B-NP O
, , O O
Complications NNP B-NP O
, , O O
affecting VBG O O
Treatment NNP B-NP O
/ NNP I-NP O
Stay NNP I-NP O
s RB O O
/ VBZ O O
p JJ B-NP O
inferior JJ I-NP B-problem
STEMI NNP I-NP I-problem
( ( O O
2/17 CD O O
) ) O O
with IN B-VP O
stent NN B-NP B-treatment
to TO O I-treatment
RCA NNP B-NP I-treatment
; : O O
TTE NNP B-NP B-test
( ( O O
2/17 CD O O
) ) O O
- : O O
LVEF JJ O B-test
55-60% JJ O O
, , O O
inferobasal JJ B-NP B-problem
HK NNP I-NP I-problem
; : O O
cervical JJ B-NP B-problem
spinal JJ I-NP I-problem
stenosis NN I-NP I-problem
; : O O
hypothyroidism NN B-NP B-problem
; : O O
GERD NNP B-NP B-problem
; : O O
endometriosis NN B-NP B-problem
s NN I-NP O
/ NNP I-NP O
p NN I-NP O
laparotomy NN I-NP B-test
and CC O O
L NNP B-NP B-treatment
oophorectomy NN I-NP I-treatment
. . B-VP O
   
OPERATIONS NNP B-NP O
AND CC O O
PROCEDURES NNP B-NP O
: : O O
none NN B-NP O
OTHER NNP I-NP O
TREATMENTS NNP I-NP O
/ NNP I-NP O
PROCEDURES NNP I-NP O
( ( O O
NOT NNP B-NP O
IN NNP I-NP O
O.R. NNP I-NP O
) ) O O
ETT NNP B-NP B-test
- : O O
MIBI NN B-NP B-test
5/27/05 CD O O
- : O O
normal JJ O O
, , O O
no DT B-NP O
e NN I-NP O
/ VBZ O O
o JJ B-NP O
ischemia NN I-NP B-problem
. . B-VP O
   
BRIEF NNP B-NP O
RESUME NNP I-NP O
OF NNP I-NP O
HOSPITAL NNP I-NP O
COURSE NNP I-NP O
: : O O
45 CD O O
yo NN B-NP O
F NNP I-NP O
s NN I-NP O
/ NNP I-NP O
p NN I-NP O
recent JJ B-NP B-problem
inferior JJ I-NP I-problem
STEMI NNP I-NP I-problem
( ( O O
2/17 CD O O
) ) O O
w/ NN B-NP O
100% CD O O
RCA NNP B-NP O
stented VBD B-VP O
-&gt; JJ O O
0% CD O O
, , O O
and CC O O
residual JJ B-NP B-problem
LAD NNP I-NP I-problem
/ NNP I-NP I-problem
Diag1/LCx NNP I-NP I-problem
/ NNP I-NP I-problem
OM2 NNP I-NP I-problem
disease NN I-NP I-problem
. . B-VP O
   
Developed NNP B-NP O
burning VBG O B-problem
chest JJS B-NP I-problem
pain NN I-NP I-problem
before IN B-VP O
bedtime NN B-NP O
the DT B-NP O
night NN I-NP O
PTA NNP I-NP O
. . B-VP O
   
NO NNP B-NP O
associated VBD B-VP O
sxs RB O B-problem
/ JJ B-NP O
radiation NN I-NP B-problem
. . B-VP O
   
Slept NNP B-NP O
well RB O O
, , O O
but CC O O
on IN B-VP O
the DT O O
am VBP O O
of IN B-VP O
admission NN B-NP O
had VBD B-VP O
same JJ B-NP B-problem
burning NN I-NP I-problem
across IN B-VP I-problem
chest NN B-NP I-problem
( ( O O
&quot; FW O O
deeper JJR O O
than IN B-VP O
heartburn VB O B-problem
&quot; JJ O O
) ) O O
so RB O O
went VBD B-VP O
to TO O O
her PRP$ O B-person
her PRP$ O B-person
MD NNP B-NP I-person
&apos;s NNP I-NP O
office NN I-NP O
. . B-VP O
   
Transient JJ B-NP B-problem
diaphoresis NN I-NP I-problem
in IN B-VP O
MD NNP B-NP B-person
&apos;s NNP I-NP O
office NN I-NP O
that WDT O B-pronoun
patient NN B-NP B-person
attributed VBD B-VP O
to TO O O
heat VB O O
in IN B-VP O
room NN B-NP O
. . B-VP O
   
Patient NNP B-NP B-person
says VBZ O O
pain NN B-NP B-problem
is VBZ O O
similar JJ O O
in IN B-VP O
location NN B-NP O
and CC O O
quality NN B-NP O
to TO O O
the DT B-NP B-problem
pain NN I-NP I-problem
she PRP O B-person
had VBD B-VP O
with IN B-VP O
her PRP$ O B-person
her PRP$ O B-problem
MI NNP B-NP I-problem
, , O O
although IN B-VP O
with IN B-VP O
her PRP$ O B-person
her PRP$ O B-problem
MI NNP B-NP I-problem
the DT B-NP B-problem
pain NN I-NP I-problem
was VBD B-VP O
much RB O O
more JJR O O
intense JJ O O
( ( O O
20x CD O O
worse NN B-NP O
) ) O O
. . B-VP O
   
This DT O B-pronoun
is VBZ O O
1st CD O B-problem
pain NN B-NP I-problem
since IN B-VP O
MI NNP B-NP B-problem
( ( O O
though IN B-VP O
patient NN B-NP B-person
reports NNS I-NP O
chronic JJ B-NP B-problem
baseline NN I-NP I-problem
chest NN I-NP I-problem
tightness IN B-VP I-problem
x8-10 JJ B-NP O
years NNS I-NP O
of IN B-VP O
unclear JJ B-NP O
etiology NN I-NP O
) ) O O
. . B-VP O
   
CP NNP B-NP B-problem
/ NNP I-NP O
burning VBG O B-problem
lasted VBD B-VP O
several JJ B-NP O
hours NNS I-NP O
and CC O O
was VBD B-VP O
relieved VBN O O
after IN B-VP O
she PRP O B-person
received VBD B-VP O
Maalox NNP B-NP B-treatment
, , O O
lidocaine NN B-NP B-treatment
, , O O
and CC O O
NTG NNP B-NP B-treatment
in IN B-VP O
the DT B-NP O
ED NNP I-NP O
. . B-VP O
   
She PRP O B-person
reports VBZ O O
compliance NN B-NP O
with IN B-VP O
her PRP$ O B-treatment
her PRP$ O B-person
ASA NNP B-NP I-treatment
+ NNP I-NP O
plavix NN I-NP B-treatment
. . B-VP O
   
She PRP O B-person
is VBZ O O
active JJ O O
at IN B-VP O
baseline NN B-NP O
, , O O
participating VBG O O
in IN B-VP O
cardiac JJ B-NP B-treatment
rehab NN I-NP I-treatment
for IN B-VP O
2 CD O O
hrs NNS B-NP O
/ JJ B-NP O
week NN I-NP O
and CC O O
running VBG O O
up RB O O
and CC O O
down RB O O
stairs NNS B-NP O
at IN B-VP O
home NN B-NP O
without IN B-VP O
CP NNP B-NP B-problem
/ NNP I-NP O
SOB NNP I-NP B-problem
. . B-VP O
   
IN NNP B-NP O
ED NNP I-NP O
vitals NNS I-NP B-test
p86 VBP O B-test
bp RB O B-test
127/88 CD O O
sat VBD B-VP B-test
100% CD O O
. . B-VP O
   
NAD NNP B-NP B-problem
. . B-VP O
   
No DT B-NP O
JVD NNP I-NP B-problem
. . B-VP O
   
CTAB. NNP B-NP O
nl JJ B-NP O
s1s2 NN I-NP O
, , O O
reg NN B-NP O
, , O O
no DT B-NP O
m NN I-NP B-problem
/ NNP I-NP O
r. VBZ O B-problem
no DT B-NP O
chest NN I-NP B-problem
tenderness NN I-NP I-problem
. . B-VP O
   
abd JJ O O
soft JJ O O
, , O O
NT NNP B-NP B-problem
/ NNP I-NP O
ND NNP I-NP B-problem
, , O O
NABS. NNP B-NP O
ext NN I-NP O
wwp NN I-NP O
, , O O
no DT B-NP O
c NN I-NP B-problem
/ NNP I-NP O
c/e NN I-NP B-problem
, , O O
2+DP CD O B-test
&apos;s NN B-NP O
b NN I-NP O
/ NNP I-NP O
l. NN I-NP O
labs NN I-NP O
: : O O
A DT B-NP O
set NN I-NP O
: : O O
trop NN B-NP B-test
&lt; FW O I-test
assay NN B-NP I-test
, , O O
CK NNP B-NP B-test
67 CD O O
, , O O
MB NNP B-NP B-test
0.2 CD O O
. . B-VP O
   
EKG NNP B-NP B-test
- : O O
old JJ B-NP B-problem
TWI NNP I-NP I-problem
III NNP I-NP I-problem
. . B-VP O
   
A NNP B-NP O
/ JJ B-NP O
P NNP I-NP B-test
: : O O
45F CD O O
with IN B-VP O
recent JJ B-NP B-problem
inferior JJ I-NP I-problem
STEMI NNP I-NP I-problem
s NN I-NP O
/ NNP I-NP O
p NN I-NP O
stent NN I-NP B-treatment
to TO O I-treatment
RCA NNP B-NP I-treatment
. . B-VP O
   
1. CD O O
CV NN B-NP O
: : O O
( ( O O
I PRP O O
) ) O O
ROMI NNP B-NP B-test
negative JJ O O
. . B-VP O
   
ETT NNP B-NP B-test
MIBI NNP I-NP B-test
4/14 CD O O
without IN B-VP O
e NN B-NP O
/ NNP I-NP O
o NN I-NP O
ischemia NN I-NP B-problem
. . B-VP O
   
? . B-VP O
GERD NNP B-NP B-problem
as IN B-VP O
etiology NN B-NP O
of IN B-VP O
her PRP$ O B-person
her PRP$ O B-problem
chest NN B-NP I-problem
burning NN I-NP I-problem
. . B-VP O
   
cont NN B-NP O
asa NN I-NP B-treatment
, , O O
statin NN B-NP B-treatment
, , O O
plavix NN B-NP B-treatment
, , O O
bblkr NN B-NP B-treatment
. . B-VP O
   
( ( O O
P NNP B-NP O
) ) O O
Most JJS B-NP O
recent JJ I-NP O
echo NN I-NP B-test
: : O O
EF NNP B-NP B-test
55% CD O O
and CC O O
inf JJ B-NP B-problem
/ NNP I-NP I-problem
post NN I-NP I-problem
HK NNP I-NP I-problem
. . B-VP O
   
( ( O O
R NNP B-NP O
) ) O O
Patient NNP B-NP B-person
had VBD B-VP O
no DT B-NP O
events NNS I-NP O
on IN B-VP O
tele NN B-NP B-test
. . B-VP O
   
2. CD O O
ENDO NN B-NP O
: : O O
continue NN B-NP O
levoxyl NN I-NP B-treatment
for IN B-VP O
hypothyroidism NN B-NP B-problem
, , O O
synarel NN B-NP B-treatment
for IN B-VP O
endometriosis NN B-NP B-problem
. . B-VP O
   
3. CD O O
MSK NN B-NP O
: : O O
cervical JJ B-NP B-problem
spondylosis NN I-NP I-problem
, , O O
tylenol NN B-NP B-treatment
for IN B-VP O
pain NN B-NP B-problem
. . B-VP O
   
4. CD O O
GI NN B-NP O
: : O O
h NN B-NP O
/ JJ B-NP O
o JJ I-NP O
GERD- NNP I-NP B-problem
nexium NN I-NP B-treatment
. . B-VP O
   
FULL NNP B-NP O
CODE NNP I-NP O
ADDITIONAL NNP I-NP O
COMMENTS NNP I-NP O
: : O O
If IN B-VP O
you PRP O B-person
develop VBP O O
recurrent JJ B-NP B-problem
chest NN I-NP I-problem
pain NN I-NP I-problem
, , O O
shortness NN B-NP B-problem
of IN B-VP I-problem
breath NN B-NP I-problem
, , O O
or CC O O
any DT B-NP B-problem
other JJ I-NP I-problem
concerning NN I-NP I-problem
symptoms NNS I-NP I-problem
, , O O
call VB O O
your PRP$ O B-person
your PRP$ O B-person
doctor NN B-NP I-person
or CC O O
return NN B-NP O
to TO O O
the DT B-NP O
hospital NN I-NP O
. . B-VP O
   
Continue VB O O
taking VBG O O
all DT O O
of IN B-VP O
your PRP$ O B-treatment
your PRP$ O B-person
regular JJ B-NP I-treatment
home NN I-NP I-treatment
medications NNS I-NP I-treatment
. . B-VP O
   
Follow VB O O
up RP O O
with IN B-VP O
Dr. NNP B-NP B-person
Koteskismanhout NNP I-NP I-person
in IN B-VP O
July NNP B-NP O
. . B-VP O
   
DISCHARGE NNP B-NP O
CONDITION NNP I-NP O
: : O O
Stable JJ B-NP O
TO NNP I-NP O
DO NNP I-NP O
/ NNP I-NP O
PLAN NNP I-NP O
: : O O
No DT B-NP O
dictated JJ I-NP O
summary NN I-NP O
ENTERED NN I-NP O
BY NNP I-NP O
: : O O
SAGELYSS NNP B-NP B-person
, , O I-person
TYTUMZE NNP B-NP I-person
V. NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
( ( O O
FS69 NNP B-NP O
) ) O O
05/27/05 CD O O
05:33 CD O O
PM NNP B-NP O
****** JJ B-NP O
END NNP I-NP O
OF NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
Admission NNP I-NP O
Date NNP I-NP O
: : O O
2014-04-19 JJ B-NP O
Discharge NN I-NP O
Date NNP I-NP O
: : O O
2014-04-20 JJ B-NP O
Date NNP I-NP O
of IN B-VP O
Birth NNP B-NP O
: : O O
2014-04-19 JJ B-NP O
Sex NN I-NP O
: : O O
M NNP B-NP O
Service NNP I-NP O
: : O O
CMED NNP B-NP O
CSRU NNP I-NP O
HISTORY NNP I-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS NNP I-NP O
: : O O
Baby NNP B-NP B-person
Thomas NNP I-NP I-person
Moss NNP I-NP I-person
was VBD B-VP O
born VBN O O
at IN B-VP O
39 CD O O
and CC O O
1/2 CD O O
weeks NNS B-NP O
gestation NN I-NP O
to TO O O
a DT B-NP O
20-year-old JJ I-NP O
gravida NN I-NP O
IV NNP I-NP O
, , O O
para NN B-NP O
III NNP I-NP O
, , O O
now RB O O
IV NNP B-NP O
woman NN I-NP O
. . B-VP O
   
The DT O B-person
The DT B-NP B-test
mother NN I-NP I-person
mother NN I-NP I-test
's POS O I-test
prenatal JJ B-NP I-test
screens NNS I-NP I-test
were VBD B-VP O
blood NN B-NP B-test
type NN I-NP I-test
B NNP I-NP O
positive JJ O O
, , O O
antibody JJ O B-test
negative JJ O O
, , O O
rubella NN B-NP B-test
immune NN I-NP O
, , O O
RPR NNP B-NP B-test
nonreactive NN I-NP O
, , O O
hepatitis NN B-NP B-test
surface NN I-NP I-test
antigen NN I-NP I-test
negative JJ O O
and CC O O
group NN B-NP B-test
B NNP I-NP I-test
strep NN I-NP I-test
negative NN I-NP O
. . B-VP O
   
This DT B-NP B-pronoun
pregnancy NN I-NP O
was VBD B-VP O
complicated VBN O O
by IN B-VP O
a DT B-NP O
prenatal JJ I-NP O
diagnosis NN I-NP O
of IN B-VP O
a DT B-NP B-problem
congenital JJ I-NP I-problem
cystic JJ I-NP I-problem
adenomatoid NN I-NP I-problem
malformation NN I-NP I-problem
( ( O O
CCAM NNP B-NP B-problem
). VBZ O O
The DT B-NP B-person
mother NN I-NP I-person
was VBD B-VP O
followed VBN O O
in IN B-VP O
the DT B-NP O
Massachusetts NNP I-NP O
General NNP I-NP O
Hospital NNP I-NP O
Advanced NNP I-NP O
Fetal NNP I-NP O
Care NNP I-NP O
Center NNP I-NP O
and CC O O
was VBD B-VP O
followed VBN O O
by IN B-VP O
Dr. NNP B-NP B-person
Ralph NNP I-NP I-person
Wilson NNP I-NP I-person
. . B-VP O
   
The DT B-NP B-person
mother NN I-NP I-person
had VBD B-VP O
spontaneous JJ B-NP O
onset NN I-NP O
of IN B-VP O
labor NN B-NP O
and CC O O
progressed VBD B-VP O
to TO O O
a DT B-NP O
spontaneous JJ I-NP O
vaginal JJ I-NP O
delivery NN I-NP O
. . B-VP O
   
The DT B-NP B-person
infant NN I-NP I-person
emerged VBD B-VP O
vigorous JJ O O
with IN B-VP O
Apgars NNP B-NP B-test
of IN B-VP O
9 CD O O
at IN B-VP O
one CD O O
and CC O O
five CD O O
minutes NNS B-NP O
. . B-VP O
   
His PRP$ O B-person
His PRP$ O B-test
birth NN B-NP I-test
weight NN I-NP I-test
was VBD B-VP O
2905 CD O O
grams NNS B-NP O
. . B-VP O
   
PHYSICAL JJ B-NP O
EXAMINATION NN I-NP O
: : O O
Wt JJ O B-test
2905 CD O O
gm NN B-NP O
Length NNP I-NP B-test
19 CD O O
inches NNS B-NP O
HC NNP I-NP B-test
34.5 CD O O
cm VBD B-VP O
His PRP$ O B-person
His PRP$ O B-test
admission NN B-NP I-test
physical JJ B-NP I-test
exam NN I-NP I-test
reveals VBZ O O
a DT B-NP O
vigorous JJ I-NP O
nondysmorphic JJ I-NP O
term NN I-NP O
infant NN I-NP O
. . B-VP O
   
Anterior NNP B-NP O
fontanelle JJ O O
open JJ O O
and CC O O
flat JJ O O
. . B-VP O
   
Palate NNP B-NP O
intact JJ O O
. . B-VP O
   
Red NNP B-NP B-test
reflex VBD B-VP I-test
not RB O O
checked VBN O O
. . B-VP O
   
Neck NNP B-NP O
supple NN I-NP O
and CC O O
without IN B-VP O
masses NNS B-NP B-problem
. . B-VP O
   
Clavicles NNP B-NP O
intact JJ O O
. . B-VP O
   
Lungs NNS B-NP O
clear JJ O O
bilaterally RB O O
with IN B-VP O
slightly RB O B-problem
decreased VBN O I-problem
breath NN B-NP I-problem
sounds NNS I-NP I-problem
on IN B-VP I-problem
the DT B-NP I-problem
right NN I-NP I-problem
but CC O O
symmetric JJ B-NP O
chest JJS I-NP O
rise NN I-NP O
and CC O O
fall NN B-NP O
. . B-VP O
   
Heart NNP B-NP O
was VBD B-VP O
regular JJ B-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
, , O O
no DT B-NP O
murmur NN I-NP B-problem
. . B-VP O
   
Femoral JJ B-NP B-test
pulses NNS I-NP I-test
present JJ O O
bilaterally RB O O
. . B-VP O
   
Abdomen NNP B-NP O
soft JJ O O
, , O O
nontender NN B-NP B-problem
, , O O
nondistended VBD B-VP B-problem
, , O O
active JJ B-NP O
bowel NN I-NP O
sounds NNS I-NP O
. . B-VP O
   
Normal NNP B-NP O
male JJ B-NP O
genitalia NN I-NP O
, , O O
testes VBZ O O
descended VBN O O
bilaterally RB O O
. . B-VP O
   
No DT B-NP O
sacral JJ I-NP B-problem
anomalies NNS I-NP I-problem
. . B-VP O
   
Stable JJ B-NP O
hips NNS I-NP O
. . B-VP O
   
Patent NNP B-NP O
anus NN I-NP O
. . B-VP O
   
Age NNP B-NP O
appropriate JJ B-NP O
tone NN I-NP O
and CC O O
reflexes NNS B-NP O
. . B-VP O
   
CMED NNP B-NP O
CCU NNP I-NP O
: : O O
By IN B-VP O
systems NNS B-NP O
: : O O
Respiratory JJ B-NP O
status NN I-NP O
: : O O
He PRP O B-person
has VBZ O O
remained VBN O O
in IN B-VP O
room NN B-NP O
air NN I-NP O
well RB O O
saturated VBN O O
with IN B-VP O
comfortable JJ B-NP O
respirations NNS I-NP O
until IN B-VP O
approximately RB O O
22 CD O O
hours NNS B-NP O
of IN B-VP O
age NN B-NP O
when WRB O O
he PRP O B-person
started VBD B-VP O
with IN B-VP O
increased JJ B-NP B-problem
work NN I-NP I-problem
of IN B-VP I-problem
breathing VBG O I-problem
although IN B-VP O
he PRP O B-person
has VBZ O O
remained VBN O O
well-saturated JJ O O
in IN B-VP O
room NN B-NP O
air NN I-NP O
. . B-VP O
   
His PRP$ O B-person
His PRP$ O B-test
chest JJS B-NP I-test
x-ray NN I-NP I-test
was VBD B-VP O
initially RB O O
remarkable JJ O O
for IN B-VP O
some DT B-NP B-problem
mediastinal JJ I-NP I-problem
shift NN I-NP I-problem
due JJ O O
to TO O O
the DT B-NP B-problem
right-sided JJ I-NP I-problem
lesion NN I-NP I-problem
with IN B-VP O
increasing VBG O B-problem
shift NN B-NP I-problem
present NN I-NP O
on IN B-VP O
the DT O B-test
last JJ O I-test
x-ray JJ O I-test
. . B-VP O
   
Cardiovascular JJ B-NP O
status NN I-NP O
: : O O
He PRP O B-person
has VBZ O O
remained VBN O O
normotensive JJ O O
throughout IN B-VP O
his PRP$ O B-person
CMED NNP B-NP O
stay NN I-NP O
. . B-VP O
   
There EX O O
are VBP O O
no DT B-NP O
cardiovascular JJ I-NP B-problem
issues NNS I-NP I-problem
. . B-VP O
   
Fluid NNP B-NP O
, , O O
electrolytes VBZ O O
and CC O O
nutrition NN B-NP O
status NN I-NP O
: : O O
His PRP$ O B-test
His PRP$ O B-person
weight NN B-NP I-test
at IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
transfer NN B-NP O
is VBZ O O
2800 CD O O
grams NN B-NP O
. . B-VP O
   
He PRP O B-person
has VBZ O O
been VBN O O
breast VBN O O
feeding NN B-NP O
or CC O O
taking VBG O O
20 CD O B-treatment
calorie NN B-NP I-treatment
per IN B-VP I-treatment
ounce NN B-NP I-treatment
formula NN I-NP I-treatment
until IN B-VP O
the DT B-NP B-problem
increased JJ I-NP I-problem
respiratory NN I-NP I-problem
distress NN I-NP I-problem
so IN B-VP O
that DT O B-pronoun
at IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
transfer NN B-NP O
he PRP O B-person
is VBZ O O
NPO NNP B-NP B-treatment
with IN B-VP O
a DT B-NP B-treatment
peripheral JJ I-NP I-treatment
IV NNP I-NP I-treatment
with IN B-VP O
total JJ B-NP B-treatment
fluids NNS I-NP I-treatment
of IN B-VP O
150 CD O O
ml NNS B-NP O
/ JJ B-NP O
kg JJ I-NP O
/ NNP I-NP O
day NN I-NP O
of IN B-VP O
10% CD O B-treatment
dextrose NN B-NP I-treatment
with IN B-VP O
electrolytes NNS B-NP B-treatment
. . B-VP O
   
He PRP O B-person
has VBZ O O
had VBN O O
no DT B-NP O
blood NN I-NP B-test
work NN I-NP I-test
except IN B-VP O
for IN B-VP O
blood NN B-NP B-test
glucose NN I-NP I-test
checks NNS I-NP I-test
and CC O O
he PRP O B-person
has VBZ O O
been VBN O O
euglycemic JJ O O
throughout IN B-VP O
his PRP$ O B-person
CMED NNP B-NP O
stay NN I-NP O
with IN B-VP O
his PRP$ O B-person
his PRP$ O B-test
blood NN B-NP I-test
glucose NN I-NP I-test
being VBG O O
in IN B-VP O
the DT B-NP O
70s NNS I-NP O
. . B-VP O
   
Gastrointestinal JJ B-NP O
status NN I-NP O
: : O O
He PRP O B-person
has VBZ O O
passed VBN O O
meconium NN B-NP O
stool NN I-NP O
and CC O O
is VBZ O O
voiding VBG O O
with IN B-VP O
each DT B-NP O
diaper NN I-NP O
change NN I-NP O
. . B-VP O
   
He PRP O B-person
has VBZ O O
not RB O O
had VBN O O
a DT B-NP B-test
bilirubin NN I-NP I-test
checked VBN O O
. . B-VP O
   
Hematology NN B-NP O
: : O O
He PRP O B-person
has VBZ O O
not RB O O
had VBN O O
any DT B-NP B-test
blood NN I-NP I-test
work NN I-NP I-test
done VBN O O
. . B-VP O
   
Infectious JJ B-NP O
disease NN I-NP O
: : O O
He PRP O B-person
has VBZ O O
had VBN O O
no DT B-NP O
antibiotic JJ I-NP B-treatment
therapy NN I-NP I-treatment
or CC O O
blood NN B-NP B-test
cultures NNS I-NP I-test
sent VBD B-VP O
. . B-VP O
   
Sensory NN B-NP O
: : O O
Audiology NN B-NP O
: : O O
Hearing NN B-NP B-test
screening NN I-NP I-test
is VBZ O O
recommended VBN O O
prior RB O O
to TO O O
discharge VB O O
. . B-VP O
   
It PRP O B-pronoun
has VBZ O O
not RB O O
been VBN O O
done VBN O O
yet RB O O
. . B-VP O
   
Psychosocial NN B-NP O
: : O O
The DT B-NP B-person
mother NN I-NP I-person
has VBZ O O
3 CD O B-person
older JJR B-NP I-person
children NNS I-NP I-person
who WP O B-person
are VBP O O
alive JJ O O
and CC O O
well RB O O
. . B-VP O
   
Her PRP$ O B-person
Her PRP$ O B-person
own JJ B-NP I-person
mother NN I-NP I-person
has VBZ O O
been VBN O O
with IN B-VP O
her PRP$ O B-person
during IN B-VP O
this DT B-NP B-pronoun
stay NN I-NP O
. . B-VP O
   
The DT B-NP B-person
infant NN I-NP I-person
is VBZ O O
discharged VBN O O
in IN B-VP O
guarded JJ B-NP B-problem
condition NN I-NP I-problem
. . B-VP O
   
He PRP O B-person
is VBZ O O
being VBG O O
transferred VBN O O
to TO O O
Massachusetts NNP B-NP O
General NNP I-NP O
Hospital NNP I-NP O
Newborn NNP I-NP O
Intensive NNP I-NP O
Care NNP I-NP O
Unit NNP I-NP O
for IN B-VP O
continuing VBG O B-treatment
care NN B-NP I-treatment
. . B-VP O
   
His PRP$ O B-person
His PRP$ O B-person
primary JJ B-NP I-person
pediatric JJ I-NP I-person
care NN I-NP I-person
provider NN I-NP I-person
will MD O O
be VB O O
Dr. NNP B-NP B-person
Schrader NNP I-NP I-person
at IN B-VP O
Deaconess-Nashoba NNP B-NP O
Hospital NNP I-NP O
. . B-VP O
   
RECOMMENDATIONS NNP B-NP O
AFTER NNP I-NP O
DISCHARGE NNP I-NP O
: : O O
1. CD O O
Feedings NNS B-NP O
: : O O
The DT B-NP B-person
infant NN I-NP I-person
is VBZ O O
NPO NNP B-NP B-treatment
. . B-VP O
   
2. CD O O
He PRP O B-person
is VBZ O O
on IN B-VP O
peripheral JJ B-NP B-treatment
IV NNP I-NP I-treatment
of IN B-VP O
total JJ B-NP B-treatment
fluids NNS I-NP I-treatment
150 CD O O
ml NNS B-NP O
/ JJ B-NP O
kg JJ I-NP O
/ NNP I-NP O
day NN I-NP O
of IN B-VP O
10% CD O B-treatment
dextrose NN B-NP I-treatment
with IN B-VP O
2 CD O O
mEq NNS B-NP O
of IN B-VP O
sodium NN B-NP B-treatment
chloride NN I-NP I-treatment
per IN B-VP O
100 CD O O
ml NN B-NP O
and CC O O
1 CD O O
mEq NN B-NP O
of IN B-VP O
potassium NN B-NP B-treatment
chloride NN I-NP I-treatment
per IN B-VP O
100 CD O O
ml NN B-NP O
. . B-VP O
   
3. CD O O
He PRP O B-person
has VBZ O O
not RB O O
had VBN O O
a DT B-NP B-test
car NN I-NP I-test
seat NN I-NP I-test
position NN I-NP I-test
screening VBG O I-test
test NN B-NP I-test
. . B-VP O
   
4. CD O O
A NNP B-NP B-test
State NNP I-NP I-test
newborn JJ B-NP I-test
screen NN I-NP I-test
will MD O O
be VB O O
done VBN O O
prior RB O O
to TO O O
transfer VB O O
. . B-VP O
   
5. CD O O
He PRP O B-person
has VBZ O O
received VBN O O
no DT B-NP O
immunizations NNS I-NP B-treatment
. . B-VP O
   
DISCHARGE NNP B-NP O
DIAGNOSES NNP I-NP O
: : O O
1. CD O O
Term NNP B-NP B-person
male NN I-NP I-person
newborn NN I-NP I-person
. . B-VP O
   
2. CD O O
Right-sided JJ B-NP B-problem
congenital JJ I-NP I-problem
cystic JJ I-NP I-problem
adenomatoid NN I-NP I-problem
malformation NN I-NP I-problem
. . B-VP O
   
Kathy NNP B-NP B-person
Hougland NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
50AHB CD O O
Dictated VBN O O
By IN B-VP O
: : O O
Gina NNP B-NP B-person
C.K. NNP I-NP I-person
Brantner NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
MEDQUIST36 NNP I-NP O
D NNP I-NP O
: : O O
2014-04-20 JJ O O
07:20:44 CD O O
T NN B-NP O
: : O O
2014-04-20 JJ O O
10:08:45 CD O O
Job NNP B-NP O
#: VBD B-VP O
07882 CD O O
Signed VBN O O
electronically RB O O
by IN B-VP O
: : O O
DR. NNP B-NP B-person
Jaqueline NNP I-NP I-person
RHEIN NNP I-NP I-person
on IN B-VP O
: : O O
SUN NNP B-NP O
2014-04-20 CD O O
8:13 CD O O
PM NNP B-NP O
( ( O O
End NNP B-NP O
of IN B-VP O
Report NNP B-NP O
) ) O O
-EMPTYLINE- VBP O O
-DOCSTART- JJ O O
-EMPTYLINE- $ O O
166394283 CD O O
PUMC NNP B-NP O
1991524 CD O O
328713 CD O O
0095918 CD O O
12/02/2002 CD O O
12:00:00 CD O O
AM NNP B-NP O
Discharge NNP I-NP O
Summary NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Report NNP I-NP O
Status NNP I-NP O
: : O O
Signed VBD B-VP O
DISCHARGE NNP B-NP O
SUMMARY NNP I-NP O
NAME NN I-NP O
: : O O
KOTENORT NNP B-NP B-person
, , O I-person
OAN NNP B-NP I-person
R NNP I-NP I-person
UNIT NNP I-NP O
NUMBER NNP I-NP O
: : O O
105-24-06 JJ B-NP O
ADMISSION NNP I-NP O
DATE NNP I-NP O
: : O O
12/02/2002 CD O O
DISCHARGE NNP B-NP O
DATE NNP I-NP O
: : O O
12/04/2002 CD O O
PRINCIPAL NNP B-NP O
DIAGNOSIS NNP I-NP O
: : O O
Probably RB O O
sigmoid JJ B-NP B-problem
volvulus NN I-NP I-problem
. . B-VP O
   
HISTORY NNP B-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
is VBZ O O
an DT O O
81 CD O O
year NN B-NP O
old JJ B-NP O
female NN I-NP O
with IN B-VP O
a DT B-NP O
history NN I-NP O
of IN B-VP O
cerebrovascular JJ B-NP B-problem
accident NN I-NP I-problem
, , O O
atrial JJ B-NP B-problem
fibrillation NN I-NP I-problem
, , O O
hypothyroidism NN B-NP B-problem
and CC O O
dementia NN B-NP B-problem
who WP O B-person
is VBZ O O
status NN B-NP O
post NN I-NP O
laparoscopic NN I-NP B-treatment
cholecystectomy NN I-NP I-treatment
one CD O O
week NN B-NP O
ago IN B-VP O
who WP O B-person
currently RB O O
presents VBZ O O
with IN B-VP O
a DT O O
4 CD O O
day NN B-NP O
history NN I-NP O
of IN B-VP O
no DT B-NP B-problem
bowel NN I-NP I-problem
movement NN I-NP I-problem
. . B-VP O
   
She PRP O B-person
has VBZ O O
complaints NNS B-NP O
of IN B-VP O
abdominal JJ B-NP B-problem
distention NN I-NP I-problem
, , O O
emesis NN B-NP B-problem
, , O O
and CC O O
constipation NN B-NP B-problem
. . B-VP O
   
She PRP O B-person
has VBZ O O
no DT B-NP O
chest NN I-NP B-problem
pain NN I-NP I-problem
, , O O
shortness NN B-NP B-problem
of IN B-VP I-problem
breath NN B-NP I-problem
or CC O O
fever NN B-NP B-problem
. . B-VP O
   
She PRP O B-person
has VBZ O O
no DT B-NP O
nausea NN I-NP B-problem
or CC O O
vomiting NN B-NP B-problem
, , O O
chills NNS B-NP B-problem
, , O O
dysuria NNS B-NP B-problem
, , O O
hematochezia NN B-NP B-problem
, , O O
or CC O O
melena NN B-NP B-problem
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
discharged VBN O O
from IN B-VP O
the DT B-NP O
hospital NN I-NP O
on IN B-VP O
11/28/02 CD O O
to TO O O
a DT B-NP O
short JJ I-NP O
term NN I-NP O
rehabilitation NN I-NP O
facility NN I-NP O
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
found VBN O O
to TO O O
have VB O O
normal JJ B-NP O
bowel NN I-NP O
sounds NNS I-NP O
. . B-VP O
   
She PRP O B-person
presented VBD B-VP O
to TO O O
the DT B-NP O
Ponta,itri- NNP I-NP O
University NNP I-NP O
Medical NNP I-NP O
Center NNP I-NP O
Emergency NNP I-NP O
Department NNP I-NP O
on IN B-VP O
12/01/02 CD O O
for IN B-VP O
evaluation NN B-NP B-test
of IN B-VP O
this DT O B-pronoun
this DT B-NP B-problem
constipation NN I-NP I-problem
. . B-VP O
   
PAST NNP B-NP O
MEDICAL NNP I-NP O
HISTORY NNP I-NP O
: : O O
1. CD O O
Cerebrovascular JJ B-NP B-problem
accident NN I-NP I-problem
. . B-VP O
   
2. CD O O
Atrial JJ B-NP B-problem
fibrillation NN I-NP I-problem
on IN B-VP O
Coumadin NNP B-NP B-treatment
. . B-VP O
   
3. CD O O
Diabetes NNPS B-NP B-problem
mellitus VBP O I-problem
type JJ O I-problem
2 CD O I-problem
. . B-VP O
   
4. CD O O
Hypothyroidism NNP B-NP B-problem
. . B-VP O
   
5. CD O O
Mild NNP B-NP B-problem
dementia NN I-NP I-problem
. . B-VP O
   
6. CD O O
Proteinuria NNP B-NP B-problem
. . B-VP O
   
7. CD O O
Nephropathy NNP B-NP B-problem
. . B-VP O
   
8. CD O O
Anemia NNP B-NP B-problem
. . B-VP O
   
9. CD O O
Hearing NNP B-NP B-problem
impaired JJ O I-problem
. . B-VP O
   
PAST JJ B-NP O
SURGICAL JJ I-NP O
HISTORY NN I-NP O
: : O O
1. CD O O
Laparoscopic NNP B-NP B-treatment
cholecystectomy NN I-NP I-treatment
as IN B-VP O
above NN B-NP O
. . B-VP O
   
2. CD O O
Total JJ B-NP B-treatment
hip NN I-NP I-treatment
replacement NN I-NP I-treatment
in IN B-VP O
2002 CD O O
. . B-VP O
   
3. CD O O
Appendectomy NNP B-NP B-treatment
. . B-VP O
   
4. CD O O
Diskectomy NNP B-NP B-treatment
. . B-VP O
   
MEDICATIONS NNP B-NP O
ON NNP I-NP O
ADMISSION NNP I-NP O
: : O O
1. CD O O
Digoxin NNP B-NP B-treatment
.125 NNP I-NP O
mg NN I-NP O
qod NN I-NP O
, , O O
.25 NNP B-NP O
mg NN I-NP O
qod NN I-NP O
. . B-VP O
   
2. CD O O
Colace NNP B-NP B-treatment
100 CD O O
mg NN B-NP O
po NN I-NP O
tid NN I-NP O
. . B-VP O
   
3. CD O O
Levoxyl NNP B-NP B-treatment
100 CD O O
ugm JJ B-NP O
po NN I-NP O
qd NN I-NP O
. . B-VP O
   
4. CD O O
Prinivil NNP B-NP B-treatment
20 CD O O
mg NN B-NP O
po NN I-NP O
qd NN I-NP O
. . B-VP O
   
5. CD O O
Zantac NNP B-NP B-treatment
150 CD O O
mg NN B-NP O
po NN I-NP O
bid NN I-NP O
. . B-VP O
   
6. CD O O
Aspirin NNP B-NP B-treatment
325 CD O O
mg NN B-NP O
qd NN I-NP O
. . B-VP O
   
7. CD O O
Aricept IN B-VP B-treatment
5 CD O O
mg NNS B-NP O
po JJ B-NP O
qd NN I-NP O
. . B-VP O
   
8. CD O O
Glyburide NNP B-NP B-treatment
1.25 CD O O
mg NN B-NP O
po NN I-NP O
qam NN I-NP O
. . B-VP O
   
9. CD O O
Oxybutynin NNP B-NP B-treatment
5 CD O O
mg NN B-NP O
po NN I-NP O
bid NN I-NP O
. . B-VP O
   
10. CD O O
Coumadin NNP B-NP B-treatment
7.5 CD O O
mg NN B-NP O
on IN B-VP O
Sun NNP B-NP O
, , O O
Tues NNP B-NP O
, , O O
Wed NNP B-NP O
, , O O
Fri NNP B-NP O
and CC O O
Sat NNP B-NP O
. . B-VP O
   
5 CD O O
mg NN B-NP O
on IN B-VP O
Mon NNP B-NP O
and CC O O
Thurs NNP B-NP O
. . B-VP O
   
ALLERGIES NNP B-NP O
: : O O
Fluoroquinolones NNS B-NP B-treatment
. . B-VP O
   
SOCIAL NNP B-NP O
HISTORY NNP I-NP O
: : O O
No DT B-NP O
tobacco NN I-NP O
, , O O
alcohol NN B-NP O
or CC O O
drugs NNS B-NP O
. . B-VP O
   
PHYSICAL JJ B-NP O
EXAMINATION NN I-NP O
: : O O
Temperature NN B-NP B-test
96.7F CD O O
, , O O
pulse RB O B-test
63 CD O O
, , O O
respiratory NN B-NP B-test
rate NN I-NP I-test
20 CD O O
, , O O
blood NN B-NP B-test
pressure NN I-NP I-test
167/68 CD O O
, , O O
02 CD O O
sat VBD B-VP O
99% CD O O
on IN B-VP O
room NN B-NP O
air NN I-NP O
. . B-VP O
   
In IN B-VP O
general JJ O O
the DT B-NP B-person
patient NN I-NP I-person
is VBZ O O
in IN B-VP O
no DT B-NP O
apparent JJ I-NP B-problem
distress NN I-NP I-problem
. . B-VP O
   
Head NNP B-NP B-test
, , O I-test
eyes NNS B-NP I-test
, , O I-test
ears NNS B-NP I-test
, , O I-test
nose RB O I-test
and CC O I-test
throat VB O I-test
exam NN B-NP I-test
is VBZ O O
within IN B-VP O
normal JJ B-NP O
limits NNS I-NP O
. . B-VP O
   
Chest JJS O O
clear JJ O O
to TO O O
auscultation VB O O
bilaterally RB O O
. . B-VP O
   
Heart NNP B-NP O
regular JJ B-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
. . B-VP O
   
Abdomen NNP B-NP B-problem
grossly RB O I-problem
distended VBD B-VP I-problem
, , O O
tympanitic JJ O B-problem
, , O O
plus CC O O
right JJ B-NP B-problem
upper JJ I-NP I-problem
quadrant NN I-NP I-problem
tenderness NN I-NP I-problem
and CC O O
no DT B-NP O
rebound NN I-NP B-problem
. . B-VP O
   
Rectal NNP B-NP O
had VBD B-VP O
normal JJ B-NP O
tone NN I-NP O
, , O O
empty JJ B-NP B-problem
rectal NN I-NP I-problem
vault NN I-NP I-problem
, , O O
and CC O O
guaiac JJ O B-test
negative JJ O O
. . B-VP O
   
Extremities NNS B-NP O
were VBD B-VP O
warm JJ O O
and CC O O
well RB O O
perfused VBN O O
. . B-VP O
   
LABORATORY NNP B-NP O
AND CC O O
RADIOLOGIC NNP B-NP O
DATA NNP I-NP O
: : O O
On IN B-VP O
admission NN B-NP O
Digoxin NNP I-NP B-test
7.3 CD O O
, , O O
sodium NN B-NP B-test
142 CD O O
, , O O
potassium NN B-NP B-test
2.8 CD O O
( ( O O
was VBD B-VP O
supplemented VBN O O
) ) O O
, , O O
blood VBD B-VP B-test
urea JJ B-NP I-test
nitrogen NN I-NP I-test
15 CD O O
, , O O
creatinine NN B-NP B-test
.9 NN I-NP O
, , O O
calcium NN B-NP B-test
9.3 CD O O
, , O O
phosphorus NN B-NP B-test
1.9 CD O O
, , O O
magnesium NN B-NP B-test
1.8 CD O O
. . B-VP O
   
Liver NNP B-NP B-test
function NN I-NP I-test
tests NNS I-NP I-test
were VBD B-VP O
within IN B-VP O
normal JJ B-NP O
limits NNS I-NP O
. . B-VP O
   
Hematocrit NNP B-NP B-test
36 CD O O
, , O O
white JJ B-NP B-test
blood NN I-NP I-test
cell NN I-NP I-test
count NN I-NP I-test
8.3 CD O O
, , O O
platelets NNS B-NP B-test
342 CD O O
. . B-VP O
   
Electrocardiogram NN B-NP B-test
shows VBZ O O
sinus CC O B-problem
bradycardia NN B-NP I-problem
with IN B-VP O
Digitalis NNP B-NP B-problem
effect NN I-NP I-problem
. . B-VP O
   
Urinalysis NN B-NP B-test
is VBZ O O
pending VBG O O
. . B-VP O
   
Abdominal JJ B-NP B-test
series NN I-NP I-test
showed VBD B-VP O
non-specific JJ B-NP B-problem
dilatation NN I-NP I-problem
of IN B-VP I-problem
the DT B-NP I-problem
large JJ I-NP I-problem
bowel NN I-NP I-problem
with IN B-VP O
no DT B-NP O
evidence NN I-NP O
of IN B-VP O
ileus NN B-NP B-problem
. . B-VP O
   
CT NNP B-NP B-test
of IN B-VP I-test
the DT B-NP I-test
abdomen NNS I-NP I-test
and CC O I-test
pelvis NN B-NP I-test
showed VBD B-VP O
dilated JJ B-NP B-problem
colon NN I-NP I-problem
with IN B-VP O
a DT B-NP B-problem
large JJ I-NP I-problem
amount NN I-NP I-problem
of IN B-VP I-problem
fluid NN B-NP I-problem
. . B-VP O
   
There EX O O
was VBD B-VP O
no DT B-NP O
free JJ I-NP B-problem
air NN I-NP I-problem
and CC O O
no DT B-NP O
bowel NN I-NP B-problem
wall NN I-NP I-problem
thickening NN I-NP I-problem
. . B-VP O
   
There EX O O
was VBD B-VP O
no DT B-NP O
obstruction NN I-NP B-problem
. . B-VP O
   
Normal NNP B-NP O
appearing VBG O O
small JJ B-NP O
bowel NN I-NP O
. . B-VP O
   
HOSPITAL NNP B-NP O
COURSE NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
presented VBD B-VP O
to TO O O
the DT B-NP O
operating NN I-NP O
room NN I-NP O
late RB O O
at IN B-VP O
night NN B-NP O
on IN B-VP O
12/01/02 CD O O
and CC O O
was VBD B-VP O
admitted VBN O O
to TO O O
the DT B-NP O
floor NN I-NP O
early RB O O
on IN B-VP O
the DT B-NP O
morning NN I-NP O
on IN B-VP O
12/02/02 CD O O
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
placed VBN O O
on IN B-VP O
a DT B-NP B-treatment
bowel JJ I-NP I-treatment
regimen NN I-NP I-treatment
of IN B-VP O
Dulcolax NNP B-NP B-treatment
, , O O
Fleet NNP B-NP B-treatment
enema NN I-NP I-treatment
, , O O
and CC O O
Colace NNP B-NP B-treatment
. . B-VP O
   
On IN B-VP O
12/03/02 CD O O
the DT B-NP B-person
patient NN I-NP I-person
underwent NN I-NP O
a DT B-NP B-test
repeat NN I-NP I-test
KUB NNP I-NP I-test
which WDT O B-pronoun
was VBD B-VP O
suggestive NN B-NP O
of IN B-VP O
volvulus NN B-NP B-problem
. . B-VP O
   
She PRP O B-person
then RB O O
underwent VBD B-VP O
a DT B-NP B-test
CT NNP I-NP I-test
scan NN I-NP I-test
which WDT O B-pronoun
showed VBD B-VP O
no DT B-NP O
evidence NN I-NP O
of IN B-VP O
volvulus NN B-NP B-problem
. . B-VP O
   
Rigid JJ B-NP B-test
sigmoidoscopy NN I-NP I-test
revealed VBD B-VP O
no DT B-NP O
obvious JJ I-NP B-problem
mucosal NN I-NP I-problem
abnormalities NNS I-NP I-problem
but CC O O
during IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
the DT B-NP O
procedure NN I-NP O
22cc CD O O
of IN B-VP O
mucous JJ O B-problem
like IN B-VP I-problem
stool NN B-NP I-problem
was VBD B-VP O
evacuated VBN O O
with IN B-VP O
a DT B-NP B-problem
large JJ I-NP I-problem
amount NN I-NP I-problem
of IN B-VP I-problem
gas NN B-NP I-problem
. . B-VP O
   
Subsequent JJ O O
to TO O O
that IN B-VP B-pronoun
the DT B-NP B-person
patients NNS I-NP I-person
abdomen NNS I-NP O
was VBD B-VP O
significantly RB O B-problem
less JJR O I-problem
distended JJ O I-problem
and CC O O
her PRP$ O B-person
her PRP$ O B-problem
pain NN B-NP I-problem
decreased VBD B-VP O
as RB O O
well RB O O
. . B-VP O
   
On IN B-VP O
the DT B-NP O
following JJ I-NP O
day NN I-NP O
, , O O
hospital JJ B-NP O
day NN I-NP O
number NN I-NP O
3 CD O O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
doing VBG O O
well RB O O
. . B-VP O
   
The DT B-NP O
abdomen NNS I-NP O
was VBD B-VP O
again RB O O
far RB O B-problem
less RBR O I-problem
distended JJ O I-problem
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
tolerating VBG O O
clear JJ B-NP B-treatment
liquids NNS I-NP I-treatment
ad NN I-NP O
lib NN I-NP O
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
afebrile JJ O B-problem
with IN B-VP O
stable JJ B-NP O
vital JJ I-NP O
signs NNS I-NP O
. . B-VP O
   
A DT B-NP B-test
repeat NN I-NP I-test
KUB NNP I-NP I-test
was VBD B-VP O
performed VBN O O
which WDT O B-pronoun
showed VBD B-VP O
no DT B-NP O
evidence NN I-NP O
of IN B-VP O
volvulus NN B-NP B-problem
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
discharged VBN O O
back RB O O
to TO O O
a DT B-NP O
rehabilitation NN I-NP O
facility NN I-NP O
in IN B-VP O
good JJ B-NP O
condition NN I-NP O
. . B-VP O
   
MEDICATIONS NNP B-NP O
ON NNP I-NP O
DISCHARGE NNP I-NP O
: : O O
1. CD O O
Digoxin NNP B-NP B-treatment
.125 NNP I-NP O
mg NN I-NP O
qod NN I-NP O
, , O O
.25 NNP B-NP O
mg NN I-NP O
qod NN I-NP O
. . B-VP O
   
2. CD O O
Colace NNP B-NP B-treatment
100 CD O O
mg NN B-NP O
po NN I-NP O
tid NN I-NP O
. . B-VP O
   
3. CD O O
Levoxyl NNP B-NP B-treatment
100 CD O O
ugm JJ B-NP O
po NN I-NP O
qd NN I-NP O
. . B-VP O
   
4. CD O O
Prinivil NNP B-NP B-treatment
20 CD O O
mg NN B-NP O
po NN I-NP O
qd NN I-NP O
. . B-VP O
   
5. CD O O
Zantac NNP B-NP B-treatment
150 CD O O
mg NN B-NP O
po NN I-NP O
bid NN I-NP O
. . B-VP O
   
6. CD O O
Aspirin NNP B-NP B-treatment
325 CD O O
mg NN B-NP O
qd NN I-NP O
. . B-VP O
   
7. CD O O
Aricept IN B-VP B-treatment
5 CD O O
mg NNS B-NP O
po JJ B-NP O
qd NN I-NP O
. . B-VP O
   
8. CD O O
Glyburide NNP B-NP B-treatment
1.25 CD O O
mg NN B-NP O
po NN I-NP O
qam NN I-NP O
. . B-VP O
   
9. CD O O
Oxybutynin NNP B-NP B-treatment
5 CD O O
mg NN B-NP O
po NN I-NP O
bid NN I-NP O
. . B-VP O
   
10. CD O O
Coumadin NNP B-NP B-treatment
7.5 CD O O
mg NN B-NP O
on IN B-VP O
Sun NNP B-NP O
, , O O
Tues NNP B-NP O
, , O O
Wed NNP B-NP O
, , O O
Fri NNP B-NP O
and CC O O
Sat NNP B-NP O
. . B-VP O
   
5 CD O O
mg NN B-NP O
on IN B-VP O
Mon NNP B-NP O
and CC O O
Thurs NNP B-NP O
. . B-VP O
   
ERIN NNP B-NP B-person
KENGEKOTE NNP I-NP I-person
, , O I-person
MD NNP B-NP I-person
DICTATING NNP I-NP O
FOR NNP I-NP O
: : O O
Electronically RB O O
Signed VBD B-VP O
MAENZET NNP B-NP B-person
HEAD NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
12/25/2002 CD O O
12:48 CD O O
_____________________________ NN B-NP O
MAENZET NNP I-NP B-person
HEAD NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
TR NNP I-NP O
: : O O
su NN B-NP O
DD NNP I-NP O
: : O O
12/04/2002 CD O O
TD NN B-NP O
: : O O
12/04/2002 CD O O
2:34 CD O O
P NNP B-NP O
328713 CD O O
cc NN B-NP O
: : O O
ERIN NNP B-NP B-person
KENGEKOTE NNP I-NP I-person
, , O I-person
MD NNP B-NP I-person
Surg NNP I-NP O
Obrh NNP I-NP O
ALBI NNP I-NP B-person
OSHASON NNP I-NP I-person
HEAD NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
SURGERY NNP I-NP O
NIME NNP I-NP O
ETHILLBRID NNP I-NP O
HEALTHCARE NNP I-NP O
MAENZET NNP I-NP B-person
HEAD NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
Ston NNP I-NP O
Community NNP I-NP O
Hospital NNP I-NP O
5223 CD O O
Cannola NNP B-NP O
Creek NNP I-NP O
Rd NNP I-NP O
Granger NNP I-NP O
CO NNP I-NP O
78438 CD O O
STAT NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- VBD B-VP O
456424011 CD O O
PUOMC NNP B-NP O
4107358 CD O O
541797 CD O O
858595 CD O O
4/7/1997 CD O O
12:00:00 CD O O
AM NNP B-NP O
CORONARY NNP I-NP B-problem
ARTERY NNP I-NP I-problem
DISEASE NNP I-NP I-problem
. . B-VP O
   
Unsigned VBD B-VP O
DIS NNP B-NP O
Report NNP I-NP O
Status NNP I-NP O
: : O O
Unsigned VBD B-VP O
DISCHARGE NNP B-NP O
SUMMARY NNP I-NP O
NAME NNP I-NP O
: : O O
VESSELS NNP B-NP B-person
, , O I-person
TISTIE NNP B-NP I-person
D NNP I-NP I-person
UNIT NNP I-NP O
NUMBER NNP I-NP O
: : O O
125-10-86 JJ B-NP O
ADMISSION NNP I-NP O
DATE NNP I-NP O
: : O O
04/07/97 CD O O
DISCHARGE NNP B-NP O
DATE NNP I-NP O
: : O O
04/08/97 CD O O
PRINCIPAL NNP B-NP O
DIAGNOSIS NNP I-NP O
: : O O
coronary JJ B-NP B-problem
artery NN I-NP I-problem
disease NN I-NP I-problem
. . B-VP I-problem
   
ASSOCIATED CC O O
DIAGNOSIS NNP B-NP O
: : O O
Ischemic NNP B-NP B-problem
cardiomyopathy NN I-NP I-problem
, , O O
orthotopic JJ B-NP B-treatment
heart NN I-NP I-treatment
transplantation NN I-NP I-treatment
, , O O
hyperlipidemia NN B-NP B-problem
, , O O
hypertension NN B-NP B-problem
, , O O
coronary JJ B-NP B-problem
graft NN I-NP I-problem
disease NN I-NP I-problem
, , O O
medical JJ B-NP B-problem
noncompliance NN I-NP I-problem
. . B-VP O
   
PRINCIPAL JJ B-NP O
PROCEDURE NN I-NP O
: : O O
Cardiac JJ B-NP B-test
echocardiogram NN I-NP I-test
. . B-VP O
   
OTHER CC O O
PROCEDURES JJ O O
: : O O
None NN B-NP O
. . B-VP O
   
HISTORY NNP B-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS NNP I-NP O
: : O O
Mr. NNP B-NP B-person
Vessels NNP I-NP I-person
is VBZ O O
a DT B-NP O
49-year-old JJ I-NP O
man NN I-NP O
status NN I-NP O
post NN I-NP O
orthotopic IN B-VP B-treatment
heart NN B-NP I-treatment
transplantation NN I-NP I-treatment
in IN B-VP O
1991 CD O O
at IN B-VP O
Dautenorwe NNP B-NP O
Stuart NNP I-NP O
Erec NNP I-NP O
Hillpa NNP I-NP O
Of IN B-VP O
Hospital NNP B-NP O
who WP O B-person
is VBZ O O
admitted VBN O O
with IN B-VP O
dyspnea NN B-NP B-problem
and CC O O
severe JJ B-NP B-problem
heart NN I-NP I-problem
failure NN I-NP I-problem
. . B-VP O
   
Mr. NNP B-NP B-person
Vessels NNP I-NP I-person
&apos;s NNP I-NP O
postoperative JJ B-NP O
course NN I-NP O
has VBZ O O
been VBN O O
marked VBN O O
by IN B-VP O
CMV NNP B-NP B-problem
infection NN I-NP I-problem
, , O O
hypertension NN B-NP B-problem
, , O O
poorly RB O B-problem
controlled VBN O I-problem
lipids NNS B-NP I-problem
, , O O
peripheral JJ B-NP B-problem
vascular JJ I-NP I-problem
disease NN I-NP I-problem
, , O O
and CC O O
chronic JJ B-NP B-problem
renal JJ I-NP I-problem
insufficiency NN I-NP I-problem
with IN B-VP O
a DT B-NP B-test
creatinine NN I-NP I-test
of IN B-VP O
1.8 CD O O
or CC O O
so RB O O
. . B-VP O
   
Recently RB O O
he PRP O B-person
had VBD B-VP O
documented VBN O O
coronary JJ B-NP B-test
angiography NN I-NP I-test
based VBN O O
on IN B-VP O
a DT B-NP B-test
catheterization NN I-NP I-test
performed VBN O O
in IN B-VP O
January NNP B-NP O
1996 CD O O
with IN B-VP O
moderate JJ O B-problem
to TO O I-problem
diffuse VB O I-problem
atherosclerosis NN B-NP I-problem
. . B-VP O
   
A DT B-NP B-test
repeat NN I-NP I-test
angiogram NN I-NP I-test
performed VBD B-VP O
a DT B-NP O
year NN I-NP O
later RB O O
showed VBD B-VP O
marked JJ B-NP O
progression NN I-NP O
of IN B-VP O
coronary JJ B-NP B-problem
allograft NN I-NP I-problem
disease NN I-NP I-problem
. . B-VP O
   
A DT B-NP B-test
biopsy NN I-NP I-test
at IN B-VP O
that DT B-NP B-pronoun
time NN I-NP O
revealed VBD B-VP O
grade JJ O B-problem
1B CD O I-problem
rejection NN B-NP I-problem
with IN B-VP O
endothelialitis NN B-NP B-problem
and CC O O
eosinophils NNS B-NP B-problem
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
treated VBN O O
with IN B-VP O
pulsed JJ B-NP B-treatment
IV NNP I-NP I-treatment
steroids NNS I-NP I-treatment
and CC O O
Imuran NNP B-NP B-treatment
, , O O
was VBD B-VP O
augmented VBN O O
with IN B-VP O
mycophenolate NN B-NP B-treatment
Mofetil NNP I-NP I-treatment
. . B-VP O
   
Chest NNP B-NP B-test
x-ray NN I-NP I-test
showed VBD B-VP O
cariogenic JJ B-NP B-problem
pulmonary JJ I-NP I-problem
edema NN I-NP I-problem
and CC O O
he PRP O B-person
was VBD B-VP O
faring VBG O O
poorly RB O O
. . B-VP O
   
Prior NNP B-NP O
to TO O O
admission NN B-NP O
he PRP O B-person
was VBD B-VP O
seen VBN O O
approximately RB O O
1 CD O O
week NN B-NP O
in IN B-VP O
the DT B-NP O
office NN I-NP O
with IN B-VP O
mild JJ B-NP B-problem
congestive JJ I-NP I-problem
heart NN I-NP I-problem
failure NN I-NP I-problem
. . B-VP O
   
An DT B-NP B-test
echocardiogram NN I-NP I-test
then RB O O
revealed VBD B-VP O
an DT B-NP B-test
ejection NN I-NP I-test
fraction NN I-NP I-test
of IN B-VP O
40% CD O O
and CC O O
an DT B-NP B-test
endomyocardial JJ I-NP I-test
biopsy NN I-NP I-test
revealed VBD B-VP O
no DT B-NP O
ejection NN I-NP B-problem
. . B-VP O
   
PAST NNP B-NP O
MEDICAL NNP I-NP O
HISTORY NNP I-NP O
: : O O
Notable JJ O O
for IN B-VP O
coronary JJ B-NP B-problem
artery NN I-NP I-problem
disease NN I-NP I-problem
, , O O
coronary JJ B-NP B-problem
allograft NN I-NP I-problem
vasculopathy NN I-NP I-problem
, , O O
hyperlipidemia NN B-NP B-problem
, , O O
peripheral JJ B-NP B-problem
vascular JJ I-NP I-problem
disease NN I-NP I-problem
, , O O
CMV NNP B-NP B-problem
infection NN I-NP I-problem
, , O O
hypertension NN B-NP B-problem
, , O O
depression NN B-NP B-problem
, , O O
and CC O O
tricuspid JJ B-NP B-problem
regurgitation NN I-NP I-problem
. . B-VP O
   
Examination NNP B-NP B-test
revealed VBD B-VP O
a DT O O
tired JJ O O
, , O O
fatigued VBN O O
man NN B-NP O
with IN B-VP O
cool JJ B-NP B-problem
extremities NNS I-NP I-problem
. . B-VP O
   
His PRP$ O B-person
His PRP$ O B-test
blood NN B-NP I-test
pressure NN I-NP I-test
is VBZ O O
130/80 CD O O
and CC O O
heart NN B-NP B-test
rate NN I-NP I-test
was VBD B-VP O
100. CD O O
jugular JJ B-NP B-test
venous JJ I-NP I-test
pressure NN I-NP I-test
was VBD B-VP O
increasing VBG O O
. . B-VP O
   
Carotids NNS B-NP B-test
were VBD B-VP O
2+ CD O O
. . B-VP O
   
Crackles NNS B-NP B-problem
were VBD B-VP O
increased VBN O O
1/4 CD O O
of IN B-VP O
the DT B-NP O
way NN I-NP O
up RB O O
. . B-VP O
   
There EX O B-pronoun
was VBD B-VP O
a DT B-NP B-problem
left JJ I-NP I-problem
ventricular NN I-NP I-problem
heave NN I-NP I-problem
and CC O O
an DT B-NP B-problem
S3 NNP I-NP I-problem
galop NN I-NP I-problem
. . B-VP O
   
The DT B-NP O
abdomen NNS I-NP O
was VBD B-VP O
soft JJ O O
and CC O O
nontender NN B-NP B-problem
with IN B-VP O
a DT B-NP O
palpable JJ I-NP O
liver NN I-NP O
edge NN I-NP O
and CC O O
the DT B-NP B-test
pulses NNS I-NP I-test
were VBD B-VP O
diminished VBN O O
. . B-VP O
   
LABORATORY NNP B-NP O
DATA NNP I-NP O
: : O O
Revealed VBD B-VP O
a DT B-NP B-test
sodium NN I-NP I-test
136 CD O O
, , O O
potassium NN B-NP B-test
4.5 CD O O
, , O O
BUN NNP B-NP B-test
47 CD O O
, , O O
creatinine NN B-NP B-test
2.4 CD O O
, , O O
glucose VBD B-VP B-test
136. CD O O
hematocrit NN B-NP B-test
40% CD O O
. . B-VP O
   
The DT B-NP B-test
electrocardiogram NN I-NP I-test
revealed VBD B-VP O
poor JJ B-NP B-problem
R NNP I-NP I-problem
wave NN I-NP I-problem
progression NN I-NP I-problem
and CC O O
marked VBD B-VP B-problem
decrease NN B-NP I-problem
in IN B-VP I-problem
all DT B-NP I-problem
volts NNS I-NP I-problem
. . B-VP O
   
chest JJS B-NP B-test
x-ray JJ I-NP I-test
revealed JJ I-NP O
prominent JJ I-NP B-problem
pulmonary JJ I-NP I-problem
vessels NNS I-NP I-problem
and CC O O
enlarged JJ B-NP B-problem
heart NN I-NP I-problem
. . B-VP O
   
HOSPITAL NNP B-NP O
COURSE NNP I-NP O
AND NNP I-NP O
TREATMENT NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
admitted VBN O O
to TO O O
the DT B-NP O
hospital NN I-NP O
via IN B-VP O
the DT B-NP O
emergency NN I-NP O
room NN I-NP O
where WRB O O
a DT B-NP B-test
bedside NN I-NP I-test
echocardiogram NN I-NP I-test
was VBD B-VP O
performed VBN O O
. . B-VP O
   
The DT B-NP B-test
echocardiogram NN I-NP I-test
revealed VBD B-VP O
no DT B-NP O
pericardial JJ I-NP B-problem
effusion NN I-NP I-problem
, , O O
an DT B-NP B-test
ejection NN I-NP I-test
fraction NN I-NP I-test
of IN B-VP O
30% CD O O
and CC O O
worsening VBG O B-problem
systolic JJ B-NP I-problem
dysfunction NN I-NP I-problem
. . B-VP O
   
Hydrocortisone NN B-NP B-treatment
was VBD B-VP O
given VBN O O
1 CD O O
g NN B-NP O
in IN B-VP O
an DT B-NP O
attempt NN I-NP O
to TO O O
reverse VB O O
what WP O O
was VBD B-VP O
thought VBN O O
to TO O O
be VB O O
aggressive JJ B-NP B-problem
coronary JJ I-NP I-problem
allograft NN I-NP I-problem
vasculopathy NN I-NP I-problem
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
diuresed VBD B-VP O
and CC O O
responded VBD B-VP O
to TO O O
Lasix NNP B-NP B-treatment
100 CD O O
mg NN B-NP O
administered VBN O O
in IN B-VP O
the DT B-NP O
emergency NN I-NP O
room NN I-NP O
and CC O O
was VBD B-VP O
admitted VBN O O
to TO O O
a DT O O
monitored VBN O O
bed NN B-NP O
. . B-VP O
   
At IN B-VP O
4:30 CD O O
AM VBP O O
the DT B-NP O
following JJ I-NP O
morning NN I-NP O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
found VBN O O
in IN B-VP O
cardiac JJ B-NP B-problem
arrest NN I-NP I-problem
. . B-VP O
   
Despite IN B-VP O
intravenous JJ B-NP B-treatment
fluids NNS I-NP I-treatment
, , O O
intravenous JJ B-NP B-treatment
epinephrine NN I-NP I-treatment
, , O O
and CC O O
multiple JJ B-NP O
attempts NNS I-NP O
at IN B-VP O
defibrillation NN B-NP B-treatment
, , O O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
unable JJ O O
to TO O O
be VB O O
resuscitated VBN O O
. . B-VP O
   
Upon IN B-VP O
arrival NN B-NP O
of IN B-VP O
the DT O B-person
covering VBG O I-person
access NN B-NP I-person
physician IN B-VP I-person
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
being VBG O O
ventilated VBN O O
mechanically RB O O
and CC O O
CPR NNP B-NP B-treatment
was VBD B-VP O
being VBG O O
performed VBN O O
. . B-VP O
   
The DT B-NP B-test
rhythm NN I-NP I-test
revealed VBD B-VP O
sinus JJ B-NP B-problem
tachycardia NN I-NP I-problem
with IN B-VP O
no DT O O
palpable JJ O O
or CC O O
measurable JJ B-NP B-test
blood NN I-NP I-test
pressure NN I-NP I-test
. . B-VP O
   
There EX O B-pronoun
were VBD B-VP O
also RB O O
runs NNS B-NP O
of IN B-VP O
ventricular JJ B-NP B-problem
tachycardia NN I-NP I-problem
which WDT O B-pronoun
generated VBD B-VP O
into IN B-VP O
ventricular JJ B-NP B-problem
fibrillation NN I-NP I-problem
that WDT O B-pronoun
was VBD B-VP O
refractory NN B-NP O
to TO O O
multiple VB O B-treatment
cardioversions NNS B-NP I-treatment
. . B-VP O
   
A DT B-NP B-test
pericardiocentesis NN I-NP I-test
was VBD B-VP O
attempted VBN O O
with IN B-VP O
no DT B-NP O
yield NN I-NP O
of IN B-VP O
pericardial JJ B-NP O
fluid NN I-NP O
. . B-VP O
   
A DT B-NP B-treatment
transvenous JJ I-NP I-treatment
pacing NN I-NP I-treatment
wire NN I-NP I-treatment
was VBD B-VP O
attempted VBN O O
and CC O O
a DT B-NP O
pacing NN I-NP O
rhythm NN I-NP O
was VBD B-VP O
obtained VBN O O
but CC O O
with IN B-VP O
no DT B-NP O
palpable JJ I-NP B-test
blood NN I-NP I-test
pressure NN I-NP I-test
. . B-VP O
   
In IN B-VP O
total JJ O O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
defibrillated VBN O O
10 CD O O
times NNS B-NP O
, , O O
given VBN O O
5 CD O O
courses NNS B-NP O
of IN B-VP O
intravenous JJ B-NP B-treatment
epinephrine NN I-NP I-treatment
, , O O
one CD O O
course NN B-NP O
of IN B-VP O
intravenous JJ B-NP B-treatment
Atropine NNP I-NP I-treatment
and CC O O
intravenous JJ B-NP B-treatment
calcium NN I-NP I-treatment
x VBZ O O
1 CD O O
in IN B-VP O
addition NN B-NP O
to TO O O
an DT B-NP B-treatment
amp NN I-NP I-treatment
of IN B-VP I-treatment
bicarbonate NN B-NP I-treatment
. . B-VP O
   
The DT B-NP B-treatment
resuscitation NN I-NP I-treatment
efforts NNS I-NP I-treatment
were VBD B-VP O
discontinued VBN O O
at IN B-VP O
4:15 CD O O
AM NNP B-NP O
and CC O O
were VBD B-VP O
begun VBN O O
at IN B-VP O
3:38 CD O O
AM NNP B-NP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
pronounced VBN O O
dead JJ O B-problem
. . B-VP O
   
Patient JJ B-NP B-person
Patient NNP I-NP B-person
&apos;s NNP I-NP I-person
mother NN I-NP I-person
was VBD B-VP O
informed VBN O O
by IN B-VP O
Dr. NNP B-NP B-person
Vessels NNP I-NP I-person
. . B-VP O
   
An DT B-NP B-test
autopsy JJ I-NP I-test
permission NN I-NP O
was VBD B-VP O
granted VBN O O
. . B-VP O
   
DOCTOR NNP B-NP B-person
&apos;S NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
: : O O
None NN B-NP O
. . B-VP O
   
AKA NNP B-NP B-person
MAM NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
TR NNP I-NP O
: : O O
ok JJ B-NP O
DD NNP I-NP O
: : O O
05/14/97 CD O O
TD NN B-NP O
: : O O
05/17/97 CD O O
9:40 CD O O
A NNP B-NP O
cc NN I-NP O
: : O O
AKA NNP B-NP B-person
G NNP I-NP I-person
MAM NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
Admission NNP I-NP O
Date NNP I-NP O
: : O O
2019-03-29 JJ B-NP O
Discharge NN I-NP O
Date NNP I-NP O
: : O O
2019-04-01 JJ B-NP O
Date NNP I-NP O
of IN B-VP O
Birth NNP B-NP O
: : O O
1935-12-05 JJ B-NP O
Sex NN I-NP O
: : O O
M NNP B-NP O
Service NNP I-NP O
: : O O
NEUROLOGY JJ B-NP B-person
Allergies NNS I-NP O
: : O O
Lorazepam NNP B-NP B-treatment
/ NNP I-NP O
Penicillins NNP I-NP B-treatment
/ NNP I-NP O
Prednisone NNP I-NP B-treatment
/ NNP I-NP O
Hydrochlorothiazide NNP I-NP B-treatment
/ NNP I-NP O
Ceftriaxone NNP I-NP B-treatment
/ NNP I-NP O
Phenytoin NNP I-NP B-treatment
Attending NNP I-NP B-person
: : O O
Derrick NNP B-NP B-person
Z NNP I-NP I-person
Wooster NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
Chief NNP I-NP O
Complaint NNP I-NP O
: : O O
progressing VBG O B-problem
slowing NN B-NP I-problem
of IN B-VP I-problem
mentation NN B-NP I-problem
and CC O O
gait NN B-NP B-problem
difficulties NNS I-NP I-problem
since IN B-VP O
a DT B-NP O
week NN I-NP O
; : O O
evaluation NN B-NP B-test
for IN B-VP O
ICH NNP B-NP B-problem
Major NNP I-NP O
Surgical NNP I-NP O
or CC O O
Invasive JJ B-NP O
Procedure NN I-NP O
: : O O
None NN B-NP O
History NN I-NP O
of IN B-VP O
Present NNP B-NP O
Illness NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
is VBZ O O
a DT O O
83 CD O O
yo JJ B-NP O
R-handed JJ I-NP O
man NN I-NP O
with IN B-VP O
a DT B-NP O
history NN I-NP O
of IN B-VP O
multiple JJ B-NP B-problem
intracranial JJ I-NP I-problem
hemorrhages NNS I-NP I-problem
during IN B-VP O
the DT B-NP O
last JJ I-NP O
few JJ I-NP O
years NNS I-NP O
, , O O
pacemaker NN B-NP B-treatment
, , O O
hyperlipidemia NN B-NP B-problem
, , O O
arrhythmia NN B-NP B-problem
who WP O B-person
now RB O O
presents VBZ O O
with IN B-VP O
gradual JJ B-NP B-problem
decline NN I-NP I-problem
in IN B-VP I-problem
gait NN B-NP I-problem
and CC O O
slowing NN B-NP B-problem
of IN B-VP I-problem
mentation NN B-NP I-problem
over IN B-VP O
the DT B-NP O
last JJ I-NP O
week NN I-NP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
had VBD B-VP O
a DT B-NP O
fall NN I-NP O
about IN B-VP O
ten JJ B-NP O
days NNS I-NP O
ago RB O O
, , O O
when WRB O O
he PRP O B-person
was VBD B-VP O
walking VBG O O
the DT B-NP O
dog NN I-NP O
. . B-VP O
   
The DT B-NP O
leash NN I-NP O
got VBD B-VP O
wrapped VBN O O
around IN B-VP O
his PRP$ O B-person
legs NN B-NP O
. . B-VP O
   
According VBG O O
to TO O O
his PRP$ O B-person
his PRP$ O B-person
wife NN B-NP I-person
he PRP O B-person
had VBD B-VP O
a DT B-NP B-problem
small JJ I-NP I-problem
abrasion NN I-NP I-problem
on IN B-VP O
the DT B-NP O
top NN I-NP O
of IN B-VP O
his PRP$ O B-person
head NN B-NP O
, , O O
but CC O O
nothing NN B-NP O
major JJ O O
. . B-VP O
   
He PRP O B-person
did VBD B-VP O
not RB O O
complain VB O O
about IN B-VP O
a DT B-NP B-problem
headache NN I-NP I-problem
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
at IN B-VP O
baseline NN B-NP O
with IN B-VP O
respect NN B-NP O
to TO O O
his PRP$ O B-person
gait NN B-NP O
( ( O O
at IN B-VP O
baseline NN B-NP O
unsteady JJ O B-problem
, , O O
though IN B-VP O
he PRP O B-person
refuses VBZ O O
to TO O O
walk VB O O
with IN B-VP O
a DT B-NP B-treatment
walker NN I-NP I-treatment
) ) O O
and CC O O
his PRP$ O B-person
mentation NN B-NP O
( ( O O
at IN B-VP O
baseline NN B-NP O
difficulties NNS I-NP B-problem
with IN B-VP I-problem
memory NN B-NP I-problem
since IN B-VP O
months NNS B-NP O
; : O O
keeps VBZ O O
forgetting VBG O O
appointments NNS B-NP O
). JJ O O
Then RB O O
about IN B-VP O
a DT B-NP O
week NN I-NP O
ago RB O O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
and CC O O
his PRP$ O B-person
his PRP$ O B-person
wife NN B-NP I-person
noted VBD B-VP O
that IN B-VP B-pronoun
his PRP$ O B-person
gait NN B-NP O
became VBD B-VP O
even RB O B-problem
more RBR O I-problem
unsteady JJ O I-problem
, , O O
though IN B-VP O
he PRP O B-person
did VBD B-VP O
not RB O O
fall VB O O
. . B-VP O
   
He PRP O B-person
also RB O O
had VBD B-VP O
difficulties NNS B-NP B-problem
navigating VBG O O
through IN B-VP O
his PRP$ O B-person
apartment NN B-NP O
, , O O
having VBG O O
difficulties NNS B-NP B-problem
finding VBG O O
the DT B-NP O
fridge NN I-NP O
for IN B-VP O
example NN B-NP O
. . B-VP O
   
They PRP O B-person
were VBD B-VP O
concerned VBN O O
that IN B-VP B-pronoun
the DT B-NP O
fall NN I-NP O
might MD O O
have VB O O
caused VBN O O
another DT B-NP B-problem
bleed NN I-NP I-problem
, , O O
as IN B-VP O
had VBD B-VP O
happened VBN O O
in IN B-VP O
the DT B-NP O
past NN I-NP O
, , O O
and CC O O
this DT O B-pronoun
prompted VBD B-VP O
them PRP O B-person
to TO O O
come VB O O
to TO O O
the DT B-NP O
Deanna NNP I-NP O
. . B-VP O
   
No NNP B-NP O
headache NN I-NP B-problem
, , O O
neckpain NN B-NP B-problem
, , O O
nausea NN B-NP B-problem
, , O O
vomiting VBG O B-problem
or CC O O
focal JJ B-NP B-problem
weakness NN I-NP I-problem
/ NNP I-NP O
numbness NN I-NP B-problem
. . B-VP O
   
Review NNP B-NP O
of IN B-VP O
systems NNS B-NP O
: : O O
denies VBZ O O
any DT B-NP B-problem
fever NN I-NP I-problem
, , O O
chills NNS B-NP B-problem
, , O O
weight JJ B-NP B-problem
loss NN I-NP I-problem
, , O O
visual JJ B-NP B-problem
changes NNS I-NP I-problem
, , O O
hearing NN B-NP B-problem
changes NNS I-NP I-problem
, , O O
dysphagia NN B-NP B-problem
, , O O
tingling VBG O B-problem
, , O O
numbness RB O B-problem
, , O O
bowel-bladder JJ B-NP B-problem
dysfunction NN I-NP I-problem
, , O O
chest NN B-NP B-problem
pain NN I-NP I-problem
, , O O
shortness NN B-NP B-problem
of IN B-VP I-problem
breath NN B-NP I-problem
, , O O
abdominal JJ B-NP B-problem
pain NN I-NP I-problem
, , O O
dysuria NN B-NP B-problem
, , O O
hematuria NN B-NP B-problem
, , O O
or CC O O
bright RB O B-problem
red JJ B-NP I-problem
blood NN I-NP I-problem
per IN B-VP I-problem
rectum NN B-NP I-problem
. . B-VP O
   
His PRP$ O B-person
legs NNS B-NP O
have VBP O O
been VBN O O
feeling VBG O O
weaker NN B-NP B-problem
, , O I-problem
bilaterally RB O I-problem
since IN B-VP O
the DT B-NP O
last JJ I-NP O
week NN I-NP O
. . B-VP O
   
Past NNP B-NP O
Medical JJ B-NP O
History NN I-NP O
: : O O
1. CD O O
Previous JJ B-NP B-problem
interventricular JJ I-NP I-problem
hemorrhages NNS I-NP I-problem
: : O O
06-30 JJ O O
resolved VBD B-VP O
as IN B-VP O
of IN B-VP O
repeat NN B-NP B-test
head NN I-NP I-test
CT NNP I-NP I-test
one CD O O
month NN B-NP O
later RB O O
, , O O
no DT B-NP O
residual JJ I-NP B-problem
deficits; NN I-NP I-problem
03-03 NN I-NP O
: : O O
ICH NNP B-NP B-problem
in IN B-VP I-problem
3rd CD O I-problem
, , O I-problem
4th CD O I-problem
, , O I-problem
and CC O I-problem
L-lat JJ B-NP I-problem
ventricle NN I-NP I-problem
; : O O
no DT B-NP O
aneurysm NN I-NP B-problem
; : O O
07-01 JJ O O
: : O O
ICH NN B-NP B-problem
in IN B-VP I-problem
R-temporal JJ B-NP I-problem
lobe NN I-NP I-problem
; : O O
question NN B-NP O
of IN B-VP O
underlying VBG O B-problem
mass NN B-NP I-problem
at IN B-VP O
that DT B-NP B-pronoun
time NN I-NP O
per IN B-VP O
contrast NN B-NP B-test
CT NNP I-NP I-test
; : O O
decided VBD B-VP O
to TO O O
follow VB O O
up RP O O
with IN B-VP O
serial JJ B-NP B-test
scans NNS I-NP I-test
rather RB O O
than IN B-VP O
to TO O O
biopsy VB O B-test
2. CD O O
pacemaker NN B-NP B-treatment
placement NN I-NP I-treatment
for IN B-VP O
arrhythmia NN B-NP B-problem
, , O O
Afibb NNP B-NP B-problem
; : O O
during IN B-VP O
last JJ B-NP O
hospitalization NN I-NP O
episodes NNS I-NP O
of IN B-VP O
NSVT NNP B-NP B-problem
3. CD O O
history NN B-NP O
of IN B-VP O
slowness NN B-NP B-problem
of IN B-VP I-problem
gait NN B-NP I-problem
, , O O
? . B-VP O
parkinsons NNS B-NP B-problem
? . B-VP O
and CC O O
possibly RB O O
dementia NN B-NP B-problem
followed VBN O O
by IN B-VP O
Dr. NNP B-NP B-person
Ahern NNP I-NP I-person
( ( O I-person
Laurence NNP B-NP I-person
Eichorn NNP I-NP I-person
). NNP I-NP I-person
Sinemet NNP I-NP B-treatment
was VBD B-VP O
stopped VBN O O
during IN B-VP O
last JJ B-NP O
admission JJ I-NP O
06-30 NN I-NP O
as IN B-VP O
he PRP O B-person
was VBD B-VP O
thought VBN O O
to TO O O
NOT NNP B-NP O
have VB O O
PD NNP B-NP B-problem
. . B-VP O
   
4. CD O O
Depression NNP B-NP B-problem
5. CD O O
COPD NNP B-NP B-problem
6. CD O O
hyperlipidemia NN B-NP B-problem
7. CD O O
bilateral JJ B-NP B-treatment
cataract NN I-NP I-treatment
surgery NN I-NP I-treatment
8. CD O O
orthostatic JJ B-NP B-problem
hypotension NN I-NP I-problem
, , O O
on IN B-VP O
midodrine JJ B-NP B-treatment
Social NNP I-NP O
History NN I-NP O
: : O O
The DT B-NP O
pt. NN I-NP B-person
is VBZ O O
married VBN O O
, , O O
independent JJ O O
in IN B-VP O
ADLS NNP B-NP O
, , O O
lives VBZ O O
with IN B-VP O
wife NN B-NP B-person
in IN B-VP O
a DT B-NP O
retirement NN I-NP O
community NN I-NP O
. . B-VP O
   
Significant JJ B-NP O
tobacco NN I-NP O
history NN I-NP O
x $ O O
40 CD O O
yrs JJ B-NP O
x NN I-NP O
1ppd CD O O
, , O O
quit VBD B-VP O
20 CD O O
yrs NN B-NP O
ago RB O O
, , O O
Reported VBD B-VP O
occassional JJ B-NP O
glass NN I-NP O
of IN B-VP O
wine NN B-NP O
, , O O
no DT B-NP O
illicit NN I-NP O
drugs NNS I-NP O
He PRP O B-person
is VBZ O O
a DT B-NP O
retired JJ I-NP O
architect NN I-NP O
. . B-VP O
   
Wife NNP B-NP B-person
states VBZ O O
that IN B-VP B-pronoun
he PRP O B-person
would MD O O
NOT VB O O
want VB O O
to TO O O
be VB O O
recussitated VBN O O
, , O O
and CC O O
that IN B-VP B-pronoun
OSH NNP B-NP O
placed VBD B-VP O
ETT NNP B-NP B-treatment
before IN B-VP O
asking VBG O O
her PRP$ O B-person
. . B-VP O
   
Family JJ B-NP O
History NN I-NP O
: : O O
no DT B-NP O
kids NNS I-NP O
, , O O
no DT B-NP O
bleeds NNS I-NP B-problem
or CC O O
strokes NNS B-NP B-problem
in IN B-VP O
other JJ B-NP O
family NN I-NP O
members NNS I-NP O
Physical JJ B-NP O
Exam NNP I-NP O
: : O O
Vitals NNS B-NP B-test
: : O O
96.7 CD O O
HR60 NNP B-NP B-test
BP153/52 NNP I-NP B-test
, , O O
later RB O O
178/85 CD O O
RR NNP B-NP B-test
18T CD O O
sO298% NN B-NP B-test
RA NNP I-NP I-test
Gen NNP I-NP O
: : O O
NAD NNP B-NP B-problem
, , O O
in IN B-VP O
bed JJ B-NP O
HEENT NNP I-NP O
: : O O
mmm NN B-NP O
Neck NN I-NP O
: : O O
no DT B-NP O
LAD NNP I-NP B-problem
; : O O
no DT B-NP O
carotid NN I-NP B-problem
bruits VBZ O I-problem
; : O O
limited JJ B-NP B-problem
range NN I-NP I-problem
neck NN I-NP I-problem
movements NNS I-NP I-problem
bilaterally RB O I-problem
Lungs NNS B-NP O
: : O O
Clear JJ O O
to TO O O
auscultation VB O B-test
bilaterally RB O O
Cardiovascular JJ O O
: : O O
Regular JJ B-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
, , O O
normal JJ B-NP O
S1 NNP I-NP O
and CC O O
S2 NNP B-NP O
, , O O
no DT B-NP O
murmurs NN I-NP B-problem
, , O O
gallops NNS B-NP B-problem
and CC O O
rubs NNS B-NP B-problem
. . B-VP O
   
Abdomen NNS B-NP O
: : O O
normal JJ B-NP O
bowel NN I-NP O
sounds NNS I-NP O
, , O O
soft JJ O O
, , O O
nontender NN B-NP B-problem
, , O O
nondistended JJ B-NP B-problem
Extremities NNS I-NP O
: : O O
no DT B-NP O
edema; NN I-NP B-problem
cold JJ B-NP B-problem
feet NNS I-NP I-problem
bilaterally RB O I-problem
Mental JJ B-NP O
Status NNP I-NP O
: : O O
Awake NNP B-NP O
and CC O O
alert NN B-NP O
, , O O
cooperative JJ O O
with IN B-VP O
exam JJ O B-test
, , O O
normal JJ B-NP O
affect NN I-NP O
; : O O
facial JJ B-NP B-problem
expression NN I-NP I-problem
somewhat RB O I-problem
sparse JJ O I-problem
. . B-VP O
   
Oriented VBN O O
to TO O O
place NN B-NP O
and CC O O
person NN B-NP O
, , O O
not RB O O
date NN B-NP O
1996 CD O O
. . B-VP O
   
Attention NN B-NP O
: : O O
DOYbw NNP B-NP O
. . B-VP O
   
Memory NN B-NP O
: : O O
Registration NN B-NP O
: : O O
03-29 JJ B-NP O
items NNS I-NP O
; : O O
Recall NNP B-NP O
03-29 NN I-NP O
at IN B-VP O
5 CD O O
min NN B-NP O
. . B-VP O
   
Language NN B-NP O
: : O O
fluent NN B-NP O
; : O O
repetition NN B-NP O
: : O O
intact JJ O O
; : O O
Naming NNP B-NP O
intact NN I-NP O
; : O O
Comprehension NNP B-NP O
intact NN I-NP O
; : O O
no DT B-NP O
dysarthria NN I-NP B-problem
, , O O
no DT B-NP O
paraphasic JJ I-NP B-problem
errors NNS I-NP I-problem
. . B-VP O
   
East NNP B-NP O
Sandwich NNP I-NP O
: : O O
intact JJ O O
; : O O
3D-construction JJ O O
: : O O
poor JJ O O
, , O O
difficulties NNS B-NP B-problem
putting VBG O I-problem
handles NNS B-NP I-problem
in IN B-VP I-problem
clock NN B-NP I-problem
; : O O
No DT B-NP O
Apraxia NNP I-NP B-problem
. . B-VP O
   
No DT B-NP O
Neglect NNP I-NP B-problem
. . B-VP O
   
Unable JJ O O
to TO O O
do VB O O
luria NNS B-NP O
. . B-VP O
   
Named VBN O O
10 CD O O
animals NNS B-NP O
in IN B-VP O
1 CD O O
minute NN B-NP O
, , O O
no DT B-NP O
perseveration NN I-NP O
, , O O
but CC O O
no DT B-NP O
further JJ I-NP O
animals NNS I-NP O
after IN B-VP O
30 CD O O
secs NN B-NP O
. . B-VP O
   
Cranial JJ B-NP O
Nerves NNS I-NP O
: : O O
II NN B-NP O
: : O O
Visual JJ B-NP O
fields NNS I-NP O
are VBP O O
full JJ O O
to TO O O
confrontation NN B-NP O
, , O O
pupils VBZ O O
equally RB O O
round JJ O O
and CC O O
reactive JJ O O
to TO O O
light JJ O O
both DT O O
directly RB O O
and CC O O
consensually RB O O
, , O O
2.5 CD O O
--> NN B-NP O
2 CD O O
mm NN B-NP O
bilaterally RB O O
. . B-VP O
   
III NNP B-NP O
, , O O
IV NNP B-NP O
, , O O
VI NNP B-NP O
: : O O
Extraocular JJ B-NP O
movements NNS I-NP O
intact JJ O O
with IN B-VP O
few JJ B-NP O
beats NNS I-NP O
of IN B-VP O
horizontal JJ B-NP B-problem
endgaze NN I-NP I-problem
nystagmus NN I-NP I-problem
. . B-VP O
   
Limited NNP B-NP B-problem
CMED NNP I-NP I-problem
CCU NNP I-NP I-problem
movements NNS I-NP I-problem
in IN B-VP I-problem
upgaze NN B-NP I-problem
. . B-VP O
   
Fixation NN B-NP O
and CC O O
saccades NNS B-NP O
are VBP O O
normal JJ O O
. . B-VP O
   
V NN B-NP O
: : O O
Facial JJ B-NP O
sensation NN I-NP O
intact JJ O O
to TO O O
light JJ B-NP B-test
touch NN I-NP I-test
and CC O O
pinprick NN B-NP B-test
. . B-VP O
   
VII NN B-NP O
: : O O
Facial JJ B-NP O
movement NN I-NP O
symmetrical NN I-NP O
; : O O
no DT B-NP O
facial JJ I-NP B-problem
droop NN I-NP I-problem
. . B-VP O
   
VIII NN B-NP O
: : O O
Hearing NNP B-NP O
intact NN I-NP O
to TO O O
finger VB O B-test
rub VB O I-test
bilaterally RB O O
. . B-VP O
   
IX NN B-NP O
: : O O
Palate NN B-NP O
elevates NNS I-NP O
in IN B-VP O
midline NN B-NP O
. . B-VP O
   
XII NN B-NP O
: : O O
Tongue NNP B-NP O
protrudes NNS I-NP O
in IN B-VP O
midline NN B-NP O
, , O O
no DT B-NP O
fasciculations NNS I-NP B-problem
. . B-VP O
   
XI NN B-NP O
: : O O
Sternocleidomastoid NNP B-NP O
and CC O O
trapezius VB O O
normal JJ O O
bilaterally RB O O
. . B-VP O
   
Motor NNP B-NP O
System NN I-NP O
: : O O
Decreased VBN O B-problem
bulk NN B-NP I-problem
throughout IN B-VP I-problem
; : O O
tone NN B-NP O
normal JJ O O
bilaterally RB O O
. . B-VP O
   
No DT B-NP O
adventitious JJ I-NP B-problem
movements NNS I-NP I-problem
, , O O
no DT B-NP O
tremor NN I-NP B-problem
, , O O
no DT B-NP O
asterixis NN I-NP B-problem
. . B-VP O
   
Right NNP B-NP O
D NNP I-NP B-test
- : O O
5 CD O O
; : O O
T NNP B-NP B-test
- : O O
5 CD O O
; : O O
B NNP B-NP B-test
- : O O
5 CD O O
; : O O
WF NNP B-NP B-test
- : O O
5 CD O O
; : O O
WE NNP B-NP B-test
- : O O
5 CD O O
; : O O
FiF NNP B-NP B-test
- : O O
5 CD O O
; : O O
Bruner NNP B-NP B-test
- : O O
5 CD O O
; : O O
Ip NNP B-NP B-test
- : O O
5 CD O O
; : O O
Gl NNP B-NP B-test
- : O O
5 CD O O
; : O O
Q NNP B-NP B-test
- : O O
5- JJ O O
; : O O
H NNP B-NP B-test
- : O O
5 CD O O
; : O O
AF NNP B-NP B-test
- : O O
5 CD O O
; : O O
TF NNP B-NP B-test
- : O O
5 CD O O
; : O O
TE NNP B-NP B-test
- : O O
5 CD O O
Left NNP B-NP O
D NNP I-NP B-test
- : O O
5 CD O O
; : O O
T NNP B-NP B-test
- : O O
5 CD O O
; : O O
B NNP B-NP B-test
- : O O
5 CD O O
; : O O
WF NNP B-NP B-test
- : O O
5 CD O O
; : O O
WE NNP B-NP B-test
- : O O
5 CD O O
; : O O
FiF NNP B-NP B-test
- : O O
5 CD O O
; : O O
Bruner NNP B-NP B-test
- : O O
5 CD O O
; : O O
Ip NNP B-NP B-test
- : O O
5 CD O O
; : O O
Gl NNP B-NP B-test
- : O O
5 CD O O
; : O O
Q NNP B-NP B-test
- : O O
5- JJ O O
; : O O
H NNP B-NP B-test
- : O O
5 CD O O
; : O O
AF NNP B-NP B-test
- : O O
5 CD O O
; : O O
TF NNP B-NP B-test
- : O O
5 CD O O
; : O O
TE NNP B-NP B-test
- : O O
5- JJ B-NP O
No NNP I-NP O
pronator NN I-NP B-problem
drift NN I-NP I-problem
. . B-VP O
   
No DT B-NP O
rebound NN I-NP B-problem
. . B-VP O
   
Sensory JJ B-NP O
system NN I-NP O
: : O O
Sensation NNP B-NP O
intact NN I-NP O
to TO O O
light JJ B-NP B-test
touch NN I-NP I-test
, , O O
pin NN B-NP B-test
prick NN I-NP I-test
, , O O
temperature NN B-NP B-test
( ( O I-test
cold JJ O I-test
) ) O I-test
. . B-VP O
   
Decreased VBN O B-problem
vibration NN B-NP I-problem
in IN B-VP I-problem
feet NNS B-NP I-problem
and CC O I-problem
ankles NNS B-NP I-problem
bilaterally RB O I-problem
, , O O
some DT O O
in IN B-VP O
knees NNS B-NP O
; : O O
proprioception NN B-NP B-problem
decreased VBD B-VP I-problem
in IN B-VP I-problem
his PRP$ O B-person
his PRP$ O I-problem
feet NNS B-NP I-problem
bilaterally RB O I-problem
. . B-VP O
   
Reflexes NNS B-NP B-test
: : O O
Right RB O B-test
B NNP B-NP I-test
- : O O
2 CD O O
; : O O
T NNP B-NP B-test
- : O O
2 CD O O
; : O O
Br NNP B-NP B-test
- : O O
2 CD O O
; : O O
Pa NNP B-NP B-test
- : O O
1 CD O O
; : O O
Pl NNP B-NP B-test
- : O O
0 CD O O
Left NNP B-NP O
B NNP I-NP B-test
- : O O
2 CD O O
; : O O
T NNP B-NP B-test
- : O O
2 CD O O
; : O O
Br NNP B-NP B-test
- : O O
2 CD O O
; : O O
Pa NNP B-NP B-test
- : O O
1 CD O O
; : O O
Pl NNP B-NP B-test
- : O O
0 CD O O
( ( O O
Less JJR O O
brisk RB O O
than IN B-VP O
on IN B-VP O
R NNP B-NP O
, , O O
but CC O O
exam RB O B-test
limited VBD B-VP O
due JJ O O
to TO O O
cuff VB O O
) ) O O
Toes NNS B-NP O
: : O O
mute NN B-NP O
bilaterally RB O O
; : O O
TFL NNP B-NP B-problem
contracted VBD B-VP I-problem
on IN B-VP I-problem
the DT B-NP I-problem
L NNP I-NP I-problem
. . B-VP O
   
Coordination NN B-NP O
: : O O
Normal NNP B-NP O
Correa NNP I-NP O
, , O O
Kimberly NNP B-NP O
, , O O
HTS NNP B-NP O
. . B-VP O
   
No DT B-NP O
dysmetria NN I-NP B-problem
or CC O O
pastpointing NN B-NP B-problem
. . B-VP O
   
Gait NN B-NP O
: : O O
not RB O O
tested VBN O O
( ( O O
later RB O O
tested VBN O O
and CC O O
patient JJ O B-person
markedly RB O B-problem
unstable JJ O I-problem
on IN B-VP I-problem
feet NNS B-NP I-problem
) ) O O
Pertinent JJ B-NP O
Results NNS I-NP O
: : O O
2019-03-29 JJ O O
10:59 CD O O
PM NNP B-NP O
GLUCOSE NNP I-NP B-test
- : O O
89 CD O O
2019-03-29 JJ O O
10:59 CD O O
PM NNP B-NP O
CK NNP I-NP B-test
( ( O I-test
CPK NNP B-NP I-test
)- JJ O I-test
128 CD O O
2019-03-29 JJ O O
10:59 CD O O
PM NNP B-NP O
CK NNP I-NP B-test
- : O I-test
MB NNP B-NP I-test
- : O O
6 CD O O
cTropnT NN B-NP B-test
-< VBD B-VP O
0.01 CD O O
2019-03-29 JJ O O
04:00 CD O O
PM NNP B-NP O
URINE NNP I-NP B-test
HOURS NNP I-NP O
- : O O
RANDOM NNP B-NP O
2019-03-29 JJ O O
04:00 CD O O
PM NNP B-NP O
URINE NNP I-NP B-test
GR NNP I-NP B-test
HOLD NNP I-NP O
- : O O
HOLD VBP O O
2019-03-29 JJ O O
04:00 CD O O
PM NNP B-NP O
URINE NNP I-NP B-test
COLOR NNP I-NP B-test
- : O O
Straw NN B-NP O
APPEAR NNP I-NP B-test
- : O O
Clear JJ B-NP O
SP NNP I-NP B-test
Stickney NNP I-NP I-test
- : O O
1.017 CD O O
2019-03-29 JJ O O
04:00 CD O O
PM NNP B-NP O
URINE NNP I-NP B-test
BLOOD NNP I-NP B-test
- : O O
NEG NNP B-NP O
NITRITE NNP I-NP B-test
- : O O
NEG NNP B-NP O
PROTEIN NNP I-NP B-test
- : O O
NEG NNP B-NP O
GLUCOSE NNP I-NP B-test
- : O O
NEG NNP B-NP O
KETONE NNP I-NP B-test
- : O O
NEG NNP B-NP O
BILIRUBIN NNP I-NP B-test
- : O O
NEG NNP B-NP O
UROBILNGN NNP I-NP B-test
- : O O
NEG NNP B-NP O
PH NNP I-NP B-test
- : O O
7.0 CD O O
LEUK NNP B-NP B-test
- : O O
NEG NNP B-NP O
2019-03-29 JJ O O
02:00 CD O O
PM NNP B-NP O
GLUCOSE NNP I-NP B-test
- : O O
72 CD O O
UREA NNP B-NP B-test
N NNP I-NP I-test
- : O O
17 CD O O
CREAT NNP B-NP B-test
- : O O
0.8 CD O O
SODIUM NNP B-NP B-test
- : O O
140 CD O O
POTASSIUM NNP B-NP B-test
- : O O
4.4 CD O O
CHLORIDE NNP B-NP B-test
- : O O
103 CD O O
TOTAL NNP B-NP B-test
CO2 NNP I-NP I-test
- : O O
29 CD O O
ANION NNP B-NP B-test
GAP NNP I-NP I-test
- : O O
12 CD O O
2019-03-29 JJ O O
02:00 CD O O
PM NNP B-NP O
WBC NNP I-NP B-test
- : O O
6.7 CD O O
RBC NNP B-NP B-test
- : O O
4.53 CD O O
* NN B-NP O
HGB NNP I-NP B-test
- : O O
14.8 CD O O
HCT NNP B-NP B-test
- : O O
44.6 CD O O
MCV NNP B-NP B-test
- : O O
99 CD O O
* NN B-NP O
MCH NNP I-NP B-test
- : O O
32.8 CD O O
* NN B-NP O
MCHC NNP I-NP B-test
- : O O
33.3 CD O O
RDW NNP B-NP B-test
- : O O
12.6 CD O O
2019-03-29 JJ O O
02:00 CD O O
PM NNP B-NP O
NEUTS NNP I-NP B-test
- : O O
65.5 CD O O
LYMPHS NNP B-NP B-test
- : O O
25.8 CD O O
MONOS NNP B-NP B-test
- : O O
7.0 CD O O
EOS NNP B-NP B-test
- : O O
1.4 CD O O
BASOS NNP B-NP B-test
- : O O
0.2 CD O O
2019-03-29 JJ O O
02:00 CD O O
PM NNP B-NP O
MACROCYT NNP I-NP B-test
- : O O
1+ CD O O
2019-03-29 JJ O O
02:00 CD O O
PM NNP B-NP O
PLT NNP I-NP B-test
COUNT NNP I-NP I-test
- : O O
213 CD O O
2019-03-29 JJ O O
02:00 CD O O
PM NNP B-NP O
PT NNP I-NP B-test
- : O O
12.3 CD O O
PTT NNP B-NP B-test
- : O O
24.5 CD O O
INR NNP B-NP B-test
( ( O I-test
PT NNP B-NP I-test
)- CD O I-test
1.1 CD O O
CT NNP B-NP B-test
BRAIN NNP I-NP I-test
( ( O I-test
INITIAL NNP B-NP I-test
) ) O I-test
FINDINGS NN B-NP O
: : O O
There EX O O
is VBZ O O
a DT B-NP O
41 JJ I-NP O
x NN I-NP O
23 CD O O
mm JJ B-NP O
area NN I-NP O
of IN B-VP O
hyperdensity NN B-NP B-problem
within IN B-VP I-problem
the DT B-NP I-problem
right JJ I-NP I-problem
frontal NN I-NP I-problem
lobe NN I-NP I-problem
, , O O
with IN B-VP O
moderate JJ O B-problem
surrounding VBG O I-problem
vasogenic JJ B-NP I-problem
edema NN I-NP I-problem
( ( O O
series NN B-NP O
2 CD O O
, , O O
image NN B-NP O
23 CD O O
) ) O O
, , O O
compatible JJ O O
with IN B-VP O
acute JJ B-NP B-problem
intraparenchymal JJ I-NP I-problem
hemorrhage NN I-NP I-problem
. . B-VP O
   
The DT B-NP B-problem
chronic JJ I-NP I-problem
encephalomalacic NN I-NP I-problem
changes NNS I-NP I-problem
at IN B-VP I-problem
the DT B-NP I-problem
adjacent JJ I-NP I-problem
right JJ I-NP I-problem
frontal NN I-NP I-problem
lobe NN I-NP I-problem
and CC O O
the DT B-NP O
right JJ I-NP O
parietal NN I-NP O
/ NNP I-NP O
occipital JJ B-NP O
region NN I-NP O
remain VBP O O
stable JJ O O
in IN B-VP O
appearance NN B-NP O
. . B-VP O
   
There EX O O
is VBZ O O
mild JJ B-NP B-problem
mass NN I-NP I-problem
effect NN I-NP I-problem
upon IN B-VP I-problem
the DT B-NP I-problem
anterior JJ I-NP I-problem
Mims NNP I-NP I-problem
of IN B-VP O
the DT B-NP O
right JJ I-NP O
lateral JJ I-NP O
ventricle NN I-NP O
. . B-VP O
   
No DT B-NP O
further JJ I-NP O
intraaxial NN I-NP B-problem
or CC O I-problem
extraaxial JJ B-NP I-problem
fluid NN I-NP I-problem
collections NNS I-NP I-problem
or CC O O
hematoma NN B-NP B-problem
are VBP O O
identified VBN O O
. . B-VP O
   
There EX O O
is VBZ O O
no DT B-NP O
displacement NN I-NP B-problem
of IN B-VP I-problem
the DT O I-problem
normally RB O I-problem
midline JJ B-NP I-problem
structures NNS I-NP I-problem
, , O O
hydrocephalus NN B-NP B-problem
, , O O
or CC O O
effacement NN B-NP B-problem
of IN B-VP I-problem
the DT B-NP I-problem
basal NN I-NP I-problem
cisterns VBZ O I-problem
at IN B-VP O
present JJ O O
. . B-VP O
   
Review NNP B-NP B-test
of IN B-VP I-test
bone NN B-NP I-test
windows NNS I-NP I-test
demonstrates VBZ O O
no DT B-NP O
skull JJ I-NP B-problem
bulge NN I-NP I-problem
or CC O O
skull JJ B-NP B-problem
base NN I-NP I-problem
fracture NN I-NP I-problem
. . B-VP O
   
There EX O O
is VBZ O O
an DT B-NP B-problem
air NN I-NP I-problem
/ JJ B-NP I-problem
fluid NN I-NP I-problem
level NN I-NP I-problem
within IN B-VP I-problem
the DT B-NP I-problem
right JJ I-NP I-problem
maxillary NN I-NP I-problem
sinus SYM O I-problem
- : O O
? . B-VP O
acute JJ B-NP B-problem
sinusitis NN I-NP I-problem
, , O O
but CC O O
acute JJ B-NP B-problem
blood NN I-NP I-problem
cannot NN I-NP O
be VB O O
excluded VBN O O
, , O O
in IN B-VP O
the DT B-NP O
setting NN I-NP O
of IN B-VP O
acute JJ B-NP B-problem
trauma NN I-NP I-problem
. . B-VP O
   
CONCLUSION NN B-NP O
: : O O
41 CD O B-problem
x $ O I-problem
23 CD O I-problem
mm JJ B-NP I-problem
acute NN I-NP I-problem
intraparenchymal JJ B-NP I-problem
hematoma NN I-NP I-problem
at IN B-VP I-problem
the DT B-NP I-problem
right JJ I-NP I-problem
frontal NN I-NP I-problem
lobe NN I-NP I-problem
, , O O
causing VBG O O
mild JJ B-NP B-problem
mass NN I-NP I-problem
effect NN I-NP I-problem
upon IN B-VP I-problem
the DT B-NP I-problem
ipsilateral JJ I-NP I-problem
lateral JJ I-NP I-problem
ventricle NN I-NP I-problem
, , O O
suspicious JJ O O
of IN B-VP O
hemorrhage NN B-NP B-problem
secondary JJ O O
to TO O O
congophilic VB O B-problem
angiopathy RB O I-problem
in IN B-VP O
this DT B-NP B-pronoun
age NN I-NP O
group NN I-NP O
. . B-VP O
   
Chronic NNP B-NP B-problem
encephalomalacic NN I-NP I-problem
changes NNS I-NP I-problem
at IN B-VP I-problem
the DT B-NP I-problem
right JJ I-NP I-problem
frontal NN I-NP I-problem
lobe NN I-NP I-problem
and CC O O
right JJ B-NP O
parietal NN I-NP O
/ NNP I-NP O
occipital JJ B-NP O
region NN I-NP O
are VBP O O
unchanged JJ O O
in IN B-VP O
appearance NN B-NP O
since IN B-VP O
2018-11-27 JJ O O
. . B-VP O
   
REPEAT JJ B-NP B-test
HEAD NNP I-NP I-test
CT NNP I-NP I-test
03-30 NN I-NP O
: : O O
no DT B-NP O
significant JJ I-NP B-problem
change NN I-NP I-problem
from IN B-VP O
above IN B-VP O
. . B-VP O
   
EKG NN B-NP B-test
: : O O
Atrial JJ B-NP B-treatment
pacing NN I-NP I-treatment
. . B-VP O
   
Since IN B-VP O
the DT B-NP B-test
previous JJ I-NP I-test
tracing NN I-NP I-test
of IN B-VP O
2018-03-15 JJ B-NP O
atrial JJ I-NP B-treatment
pacing NN I-NP I-treatment
is VBZ O O
a DT B-NP O
new JJ I-NP O
finding NN I-NP O
. . B-VP O
   
The DT B-NP B-test
electrocardiogram NN I-NP I-test
is VBZ O O
otherwise RB O O
, , O O
unchanged JJ O O
and CC O O
continues VBZ O O
to TO O O
Weymouth NNP B-NP B-treatment
voltage NN I-NP I-treatment
in IN B-VP I-treatment
the DT B-NP I-treatment
limb NN I-NP I-treatment
leads VBZ O I-treatment
and CC O O
non-specific JJ B-NP B-problem
ST-T NNP I-NP I-problem
wave NN I-NP I-problem
abnormalities NNS I-NP I-problem
. . B-VP O
   
Read VBN O O
by IN B-VP O
: : O O
Stella NN B-NP B-person
, , O I-person
Kendra NNP B-NP I-person
B NNP I-NP I-person
. . B-VP I-person
   
Intervals NNS B-NP B-test
Axes NNP I-NP I-test
Rate NNP I-NP B-test
60 CD O O
PR NNP B-NP B-test
188 CD O O
QRS NNP B-NP B-test
104 CD O O
QT/QTc NNP B-NP B-test
460/460 CD O O
P NNP B-NP B-test
85 CD O O
QRS NNP B-NP B-test
55 CD O O
T NNP B-NP B-test
75 CD O O
Brief NNP B-NP O
Hospital NNP I-NP O
Course NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
is VBZ O O
a DT O O
83 CD O O
yo NN B-NP O
man NN I-NP O
with IN B-VP O
a DT B-NP O
history NN I-NP O
of IN B-VP O
past JJ B-NP B-problem
intracranial JJ I-NP I-problem
hemorrhages NNS I-NP I-problem
( ( O O
most RBS O O
recent JJ O O
07-01 JJ O O
with IN B-VP O
R-frontal JJ B-NP B-problem
hemorrhage NN I-NP I-problem
) ) O O
who WP O B-person
presented VBD B-VP O
with IN B-VP O
gradually RB O B-problem
slowing VBG O I-problem
of IN B-VP I-problem
mentation NN B-NP I-problem
and CC O O
increased VBD B-VP B-problem
gait NN B-NP I-problem
instability NN I-NP I-problem
since IN B-VP O
one CD O O
week NN B-NP O
. . B-VP O
   
On IN B-VP O
initial JJ O B-test
exam IN B-VP I-test
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
not RB O B-problem
oriented VBN O I-problem
to TO O I-problem
time NN B-NP I-problem
, , O O
seemed VBD B-VP O
somewhat RB O B-problem
slow JJ O I-problem
, , O O
and CC O O
had VBD B-VP O
difficulties NNS B-NP B-problem
generating VBG O I-problem
a DT B-NP I-problem
list NN I-NP I-problem
of IN B-VP I-problem
animals NNS B-NP I-problem
. . B-VP O
   
His PRP$ O B-person
cranial JJ B-NP O
nerves NNS I-NP O
and CC O O
strength NN B-NP O
were VBD B-VP O
full JJ O O
, , O O
and CC O O
the DT B-NP B-test
sensory JJ I-NP I-test
exam NN I-NP I-test
showed VBD B-VP O
mildly RB O B-problem
decreased VBN O I-problem
vibration NN B-NP I-problem
and CC O I-problem
proprioception NN B-NP I-problem
in IN B-VP I-problem
both DT B-NP I-problem
LE NNP I-NP I-problem
, , O O
suggesting VBG O O
peripheral JJ B-NP B-problem
neuropathy NN I-NP I-problem
. . B-VP O
   
A DT B-NP B-test
CT NNP I-NP I-test
was VBD B-VP O
performed VBN O O
in IN B-VP O
the DT B-NP O
Deanna NNP I-NP O
that WDT O B-pronoun
showed VBD B-VP O
a DT B-NP B-problem
new JJ I-NP I-problem
significant JJ I-NP I-problem
R-frontal JJ I-NP I-problem
intraparenchymal JJ I-NP I-problem
hemorrhage NN I-NP I-problem
in IN B-VP I-problem
the DT B-NP I-problem
same JJ I-NP I-problem
location NN I-NP I-problem
as IN B-VP O
the DT B-NP B-problem
prior JJ I-NP I-problem
bleed NN I-NP I-problem
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
seen VBN O O
by IN B-VP O
both DT B-NP O
neurology NN I-NP B-person
and CC O O
neurosurgery NN B-NP B-person
, , O O
and CC O O
the DT O B-person
two CD O I-person
teams NNS B-NP I-person
agreed VBD B-VP O
that IN B-VP B-pronoun
the DT B-NP O
etiology NN I-NP O
seemed VBD B-VP O
to TO O O
be VB O O
related VBN O O
to TO O O
underlying JJ B-NP B-problem
amyloidosis NN I-NP I-problem
. . B-VP O
   
During IN B-VP O
the DT B-NP O
last JJ I-NP O
admission NN I-NP O
the DT B-NP O
question NN I-NP O
of IN B-VP O
a DT B-NP B-problem
mass NN I-NP I-problem
underlying VBG O O
a DT B-NP B-problem
hemorrhage NN I-NP I-problem
in IN B-VP I-problem
the DT B-NP I-problem
R-frontal JJ I-NP I-problem
region NN I-NP I-problem
was VBD B-VP O
raised VBN O O
. . B-VP O
   
The DT B-NP O
location NN I-NP O
of IN B-VP O
the DT B-NP B-problem
hemorrhage NN I-NP I-problem
was VBD B-VP O
not RB O O
felt VBN O O
to TO O O
be VB O O
typical JJ O O
for IN B-VP O
hypertensive JJ B-NP B-problem
bleed NN I-NP I-problem
( ( O I-problem
cortical JJ O I-problem
) ) O I-problem
and CC O O
it PRP O B-pronoun
was VBD B-VP O
felt VBN O O
to TO O O
be VB O O
unlikely JJ O O
that IN B-VP B-pronoun
the DT B-NP O
recent JJ I-NP O
fall NN I-NP O
was VBD B-VP O
related VBN O O
to TO O O
the DT B-NP B-problem
bleed NN I-NP I-problem
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
could MD O O
not RB O O
undergo VB O O
an DT B-NP B-test
MRI NNP I-NP I-test
due JJ O O
to TO O O
his PRP$ O B-person
his PRP$ O B-treatment
pacer NN B-NP I-treatment
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
admitted VBN O O
to TO O O
the DT B-NP O
neurology NN I-NP O
ICU NNP I-NP O
for IN B-VP O
closer JJR B-NP B-test
monitoring NN I-NP I-test
and CC O O
was VBD B-VP O
stable JJ O O
overnight JJ O O
- : O O
BP NN B-NP B-test
was VBD B-VP O
initially RB O B-problem
elevated VBN O I-problem
and CC O O
required VBN O O
a DT B-NP B-treatment
labetalol JJ I-NP I-treatment
drip NN I-NP I-treatment
for IN B-VP O
< $ O O
24 CD O O
hours NNS B-NP O
, , O O
then RB O O
stabilized VBN O O
. . B-VP O
   
The DT B-NP B-test
goal NN I-NP I-test
SBP NNP I-NP I-test
of IN B-VP O
< NNP B-NP O
150 CD O O
was VBD B-VP O
achieved VBN O O
. . B-VP O
   
Coags NNP B-NP B-test
and CC O O
UA NNP B-NP B-test
were VBD B-VP O
checked VBN O O
and CC O O
were VBD B-VP O
normal JJ O O
. . B-VP O
   
For IN B-VP O
the DT B-NP O
question NN I-NP O
of IN B-VP O
seizure NN B-NP B-problem
activity NN I-NP I-problem
associated VBN O O
with IN B-VP O
a DT B-NP B-problem
cortical JJ I-NP I-problem
bleed NN I-NP I-problem
, , O O
he PRP O B-person
was VBD B-VP O
started VBN O O
prophylactically RB O O
on IN B-VP O
Keppra NNP B-NP B-treatment
( ( O O
given VBN O O
questionable JJ B-NP O
allergy NN I-NP B-problem
to TO O O
dilantin VB O B-treatment
) ) O O
, , O O
at IN B-VP O
500 CD O O
mg JJ B-NP O
bid NN I-NP O
; : O O
no DT B-NP O
seizure NN I-NP B-problem
activity NN I-NP I-problem
was VBD B-VP O
seen VBN O O
. . B-VP O
   
This DT B-NP B-treatment
medication NN I-NP I-treatment
should MD O O
be VB O O
continued VBN O O
as IN B-VP O
an DT B-NP O
outpatient NN I-NP O
at IN B-VP O
least JJS O O
while IN B-VP O
the DT B-NP B-problem
bleed NN I-NP I-problem
has VBZ O O
time NN B-NP O
to TO O O
clear VB O O
up RP O O
, , O O
with IN B-VP O
planned VBN O O
titration NN B-NP O
up RB O O
to TO O O
1000 CD O O
mg NN B-NP O
bid NN I-NP O
on IN B-VP O
04-05 NN B-NP O
. . B-VP O
   
Head NNP B-NP B-test
CT NNP I-NP I-test
repeated VBD B-VP O
on IN B-VP O
03-30 NN B-NP O
was VBD B-VP O
unchanged JJ O O
, , O O
and CC O O
the DT B-NP B-person
patient NN I-NP I-person
remained VBD B-VP O
stable JJ O O
with IN B-VP O
only JJ O O
very RB O O
suble JJ B-NP O
focal JJ I-NP O
exam NN I-NP O
findings NNS I-NP O
( ( O O
very RB O B-problem
mild RB O I-problem
right JJ B-NP I-problem
pronator NN I-NP I-problem
drift NN I-NP I-problem
) ) O O
as RB O O
well RB O O
as IN B-VP O
his PRP$ O B-person
his PRP$ O B-problem
persistently RB O I-problem
poor JJ B-NP I-problem
memory NN I-NP I-problem
related VBN O O
to TO O O
dementia VB O B-problem
. . B-VP O
   
The DT B-NP O
plan NN I-NP O
after IN B-VP O
24 CD O O
hours NNS B-NP O
was VBD B-VP O
to TO O O
transfer VB O O
him PRP O B-person
to TO O O
the DT B-NP O
floor NN I-NP O
, , O O
but CC O O
the DT B-NP O
hospital NN I-NP O
was VBD B-VP O
full JJ O O
and CC O O
he PRP O B-person
never RB O O
got VBD B-VP O
a DT B-NP O
bed NN I-NP O
. . B-VP O
   
Cardiovascularly NNP B-NP O
, , O O
lipitor NN B-NP B-treatment
and CC O O
amiodarone NN B-NP B-treatment
were VBD B-VP O
continued VBN O O
. . B-VP O
   
He PRP O B-person
could MD O O
not RB O O
get VB O O
an DT B-NP B-test
MRI NNP I-NP I-test
due JJ O O
to TO O O
his PRP$ O B-person
his PRP$ O B-treatment
pacemaker NN B-NP I-treatment
. . B-VP O
   
There EX O O
were VBD B-VP O
no DT B-NP O
telemetry NN I-NP B-problem
events NNS I-NP I-problem
, , O O
and CC O O
he PRP O B-person
ruled VBD B-VP O
out RP O O
by IN B-VP O
enzyme NN B-NP B-test
. . B-VP O
   
Pulmonlologically RB O O
, , O O
his PRP$ O B-person
his PRP$ O B-test
chest NN B-NP I-test
xray NN I-NP I-test
was VBD B-VP O
negative JJ O O
and CC O O
he PRP O B-person
complained VBD B-VP O
of IN B-VP O
no DT B-NP O
breathing NN I-NP B-problem
problems NNS I-NP I-problem
. . B-VP O
   
Endocrinologically RB O O
, , O O
BG NNP B-NP B-test
was VBD B-VP O
monitored VBN O O
to TO O O
improve VB O O
outcome NN B-NP O
in IN B-VP O
ICU NNP B-NP O
setting VBG O O
though IN B-VP O
he PRP O B-person
had VBD B-VP O
no DT B-NP O
history NN I-NP O
of IN B-VP O
DM NNP B-NP B-problem
. . B-VP O
   
Of IN B-VP O
note NN B-NP O
, , O O
Hba1c NNP B-NP B-test
done VBN O O
03-04 NN B-NP O
was VBD B-VP O
slightly RB O B-problem
elevated VBN O I-problem
( ( O O
" JJ B-NP O
borderline NN I-NP B-problem
DM NNP I-NP I-problem
" NNP I-NP O
) ) O O
at IN B-VP O
6.3 CD O O
; : O O
this DT O B-pronoun
was VBD B-VP O
repeated VBN O O
and CC O O
was VBD B-VP O
still RB O O
pending VBG O O
on IN B-VP O
the DT B-NP O
day NN I-NP O
of IN B-VP O
discharge NN B-NP O
. . B-VP O
   
Ins NNP B-NP B-test
/ NNP I-NP I-test
outs NNS I-NP I-test
and CC O O
electrolytes NNS B-NP B-test
were VBD B-VP O
monitored VBN O O
and CC O O
were VBD B-VP O
not RB O O
abnormal JJ O B-problem
; : O O
he PRP O B-person
was VBD B-VP O
on IN B-VP O
a DT B-NP B-treatment
bowel NN I-NP I-treatment
regimen NN I-NP I-treatment
, , O O
VD NNP B-NP B-treatment
boots NNS I-NP I-treatment
and CC O O
PUD NNP B-NP B-treatment
prophylaxis NN I-NP I-treatment
with IN B-VP O
protonix NN B-NP B-treatment
during IN B-VP O
the DT B-NP O
admission NN I-NP O
. . B-VP O
   
Walking NNP B-NP O
was VBD B-VP O
assessed VBN O O
later RB O O
and CC O O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
unstable JJ O B-problem
on IN B-VP I-problem
his PRP$ O B-person
his PRP$ O I-problem
feet NNS B-NP I-problem
. . B-VP O
   
PT NNP B-NP B-person
was VBD B-VP O
asked VBN O O
to TO O O
see VB O O
him PRP O B-person
for IN B-VP O
this DT B-NP B-problem
gait NN I-NP I-problem
problem NN I-NP I-problem
. . B-VP O
   
Brandon NNP B-NP B-person
felt VBD B-VP O
well RB O O
and CC O O
was VBD B-VP O
seen VBN O O
by IN B-VP O
PT NNP B-NP B-person
who WP O B-person
suggested VBD B-VP O
a DT B-NP O
rehab/Hahnemann JJ I-NP O
Hospital NNP I-NP O
( ( O O
Worcester NNP B-NP O
) ) O O
to TO O O
work VB O O
on IN B-VP O
walking VBG O O
with IN B-VP O
the DT B-NP O
eventual JJ I-NP O
goal NN I-NP O
of IN B-VP O
returning VBG O O
to TO O O
assisted VBN O O
living NN B-NP O
with IN B-VP O
his PRP$ O B-person
his PRP$ O B-person
wife NN B-NP I-person
when WRB O O
walking VBG O O
improved VBN O O
. . B-VP O
   
Follow-up NNP B-NP O
was VBD B-VP O
arranged VBN O O
with IN B-VP O
neurosurgery NN B-NP B-person
in IN B-VP O
5-6 JJ B-NP O
weeks NNS I-NP O
with IN B-VP O
repeat NN B-NP B-test
head NN I-NP I-test
ct NN I-NP I-test
to TO O O
be VB O O
arranged VBN O O
by IN B-VP O
neurosurgery JJ B-NP B-person
office NN I-NP I-person
to TO O O
make VB O O
sure JJ B-NP O
blood NN I-NP B-problem
has VBZ O O
cleared VBN O O
, , O O
and CC O O
if IN B-VP O
indicated VBN O O
, , O O
to TO O O
look VB O O
for IN B-VP O
a DT B-NP O
possible JJ I-NP O
underlying JJ I-NP B-problem
lesion NN I-NP I-problem
( ( O O
although IN B-VP O
unlikely RB O O
) ) O O
. . B-VP O
   
Medications NNS B-NP O
on IN B-VP O
Admission NN B-NP O
: : O O
Amiodarone $ O B-treatment
200 CD O O
mg JJ B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
0.5 CD O O
Tablet NNP B-NP O
PO NNP I-NP O
qod SYM O O
- : O O
in IN B-VP O
March NNP B-NP O
, , O O
should MD O O
be VB O O
on IN B-VP O
odd JJ B-NP O
days NNS I-NP O
. . B-VP O
   
Donepezil NNP B-NP B-treatment
5 CD O O
mg NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
Two CD O O
( ( O O
2 CD O O
) ) O O
Tablet NNP B-NP O
PO NNP I-NP O
HS NNP I-NP O
( ( O O
at IN B-VP O
bedtime NN B-NP O
) ) O O
. . B-VP O
   
Docusate NNP B-NP B-treatment
Sodium NNP I-NP I-treatment
100 CD O O
mg NN B-NP O
Capsule NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Capsule NNP B-NP O
PO NNP I-NP O
BID NNP I-NP O
( ( O O
2 CD O O
times NNS B-NP O
a DT B-NP O
day NN I-NP O
) ) O O
. . B-VP O
   
Multivitamin NNP B-NP B-treatment
Capsule NNP I-NP I-treatment
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Cap NNP B-NP O
PO NNP I-NP O
DAILY NNP I-NP O
( ( O O
Daily NNP B-NP O
) ) O O
. . B-VP O
   
Mirtazapine $ O B-treatment
30 CD O O
mg JJ B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
0.5 CD O O
Tablet NNP B-NP O
PO NNP I-NP O
HS NNP I-NP O
( ( O O
at IN B-VP O
bedtime NN B-NP O
) ) O O
. . B-VP O
   
Atorvastatin $ O B-treatment
10 CD O O
mg JJ B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Tablet NN B-NP O
PO NNP I-NP O
at IN B-VP O
bedtime NN B-NP O
. . B-VP O
   
Ocuvite NNP B-NP B-treatment
Tablet NNP I-NP I-treatment
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Tablet NNP B-NP O
PO NNP I-NP O
once RB O O
a DT B-NP O
day NN I-NP O
. . B-VP O
   
Artificial JJ B-NP B-treatment
Tears NNP I-NP I-treatment
Drops NNP I-NP I-treatment
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
drop NN B-NP O
Ophthalmic NNP I-NP O
twice RB O O
a DT B-NP O
day NN I-NP O
: : O O
ou NN B-NP O
. . B-VP O
   
Ensure NN B-NP B-treatment
Liquid NNP I-NP I-treatment
Sig NNP I-NP O
: : O O
0.5 CD O O
to TO O O
1 CD O O
can MD O O
PO NNP B-NP O
three CD O O
times NNS B-NP O
a DT B-NP O
day NN I-NP O
. . B-VP O
   
Midodrine NNP B-NP B-treatment
10 CD O O
mg NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
1.5 CD O O
Tablets NNS B-NP O
PO NNP I-NP O
twice RB O O
a DT B-NP O
day NN I-NP O
: : O O
at IN B-VP O
8am CD O O
and CC O O
noon RB O O
. . B-VP O
   
Ritalin NNP B-NP B-treatment
5 CD O O
mg NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
see NN B-NP O
below IN B-VP O
Tablet NNP B-NP O
PO NNP I-NP O
see VBP O O
below IN B-VP O
: : O O
1.5 CD O O
tablets NNS B-NP O
at IN B-VP O
10am CD O O
( ( O O
7.5mg CD O O
) ) O O
, , O O
1 CD O O
tablet NN B-NP O
2pm CD O O
( ( O O
5mg CD O O
) ) O O
. . B-VP O
   
Prilosec $ O B-treatment
20 CD O O
mg NN B-NP O
Capsule NNP I-NP O
, , O O
Delayed NNP B-NP O
Release NNP I-NP O
( ( O O
E.C. NNP B-NP O
) ) O O
Sig NN B-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Capsule NN B-NP O
, , O O
Delayed NNP B-NP O
Release NNP I-NP O
( ( O O
E.C. NNP B-NP O
) ) O O
PO NNP B-NP O
once RB O O
a DT B-NP O
day NN I-NP O
. . B-VP O
   
Guaifenesin NNP B-NP B-treatment
100 CD O O
mg NN B-NP O
/ VBD B-VP O
5 CD O O
mL NN B-NP O
Liquid NNP I-NP O
Sig NNP I-NP O
: : O O
01-28 JJ B-NP O
teaspoons NNS I-NP O
PO NNP I-NP O
every DT O O
six CD O O
( ( O O
6 CD O O
) ) O O
hours NNS B-NP O
as IN B-VP O
needed VBN O O
for IN B-VP O
cold JJ B-NP B-problem
symptoms NNS I-NP I-problem
. . B-VP O
   
Discharge NNP B-NP O
Medications NNPS I-NP O
: : O O
1. CD O O
Amiodarone $ O B-treatment
200 CD O O
mg JJ B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
0.5 CD O O
Tablet NNP B-NP O
PO NNP I-NP O
qod SYM O O
- : O O
in IN B-VP O
March NNP B-NP O
, , O O
should MD O O
be VB O O
on IN B-VP O
odd JJ B-NP O
days NNS I-NP O
. . B-VP O
   
2. CD O O
Donepezil NNP B-NP B-treatment
5 CD O O
mg NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
Two CD O O
( ( O O
2 CD O O
) ) O O
Tablet NNP B-NP O
PO NNP I-NP O
HS NNP I-NP O
( ( O O
at IN B-VP O
bedtime NN B-NP O
) ) O O
. . B-VP O
   
3. CD O O
Docusate NNP B-NP B-treatment
Sodium NNP I-NP I-treatment
100 CD O O
mg NN B-NP O
Capsule NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Capsule NNP B-NP O
PO NNP I-NP O
BID NNP I-NP O
( ( O O
2 CD O O
times NNS B-NP O
a DT B-NP O
day NN I-NP O
) ) O O
. . B-VP O
   
4. CD O O
Multivitamin NNP B-NP B-treatment
Capsule NNP I-NP I-treatment
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Cap NNP B-NP O
PO NNP I-NP O
DAILY NNP I-NP O
( ( O O
Daily NNP B-NP O
) ) O O
. . B-VP O
   
5. CD O O
Mirtazapine NNP B-NP B-treatment
30 CD O O
mg NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
0.5 CD O O
Tablet NNP B-NP O
PO NNP I-NP O
HS NNP I-NP O
( ( O O
at IN B-VP O
bedtime NN B-NP O
) ) O O
. . B-VP O
   
6. CD O O
Atorvastatin NNP B-NP B-treatment
10 CD O O
mg NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Tablet NN B-NP O
PO NNP I-NP O
at IN B-VP O
bedtime NN B-NP O
. . B-VP O
   
7. CD O O
Levetiracetam NNP B-NP B-treatment
500 CD O O
mg NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Tablet NNP B-NP O
PO NNP I-NP O
BID NNP I-NP O
( ( O O
2 CD O O
times NNS B-NP O
a DT B-NP O
day NN I-NP O
) ) O O
: : O O
on IN B-VP O
04-05 NN B-NP O
, , O O
please VB O O
increase VB O O
to TO O O
TWO NNP B-NP O
tablets NNS I-NP O
bid VBD B-VP O
( ( O O
1000 CD O O
mg RB O O
bid NN B-NP O
) ) O O
. . B-VP O
   
8. CD O O
Ocuvite NNP B-NP B-treatment
Tablet NNP I-NP I-treatment
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Tablet NNP B-NP O
PO NNP I-NP O
once RB O O
a DT B-NP O
day NN I-NP O
. . B-VP O
   
9. CD O O
Artificial JJ B-NP B-treatment
Tears NNP I-NP I-treatment
Drops NNP I-NP I-treatment
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
drop NN B-NP O
Ophthalmic NNP I-NP O
twice RB O O
a DT B-NP O
day NN I-NP O
: : O O
ou NN B-NP O
. . B-VP O
   
10. CD O O
Ensure NN B-NP B-treatment
Liquid NNP I-NP I-treatment
Sig NNP I-NP O
: : O O
0.5 CD O O
to TO O O
1 CD O O
can MD O O
PO NNP B-NP O
three CD O O
times NNS B-NP O
a DT B-NP O
day NN I-NP O
. . B-VP O
   
11. CD O O
Midodrine NNP B-NP B-treatment
10 CD O O
mg NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
1.5 CD O O
Tablets NNS B-NP O
PO NNP I-NP O
twice RB O O
a DT B-NP O
day NN I-NP O
: : O O
at IN B-VP O
8 CD O O
am VBP O O
and CC O O
noon NN B-NP O
. . B-VP O
   
12. CD O O
Ritalin NNP B-NP B-treatment
5 CD O O
mg NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
see NN B-NP O
below IN B-VP O
Tablet NNP B-NP O
PO NNP I-NP O
see VBP O O
below IN B-VP O
: : O O
1.5 CD O O
tablets NNS B-NP O
at IN B-VP O
10 CD O O
am VBP O O
( ( O O
7.5 CD O O
mg NN B-NP O
) ) O O
, , O O
1 CD O O
tablet NN B-NP O
2 CD O O
pm NN B-NP O
( ( O O
5 CD O O
mg NN B-NP O
) ) O O
. . B-VP O
   
13. CD O O
Prilosec NNP B-NP B-treatment
20 CD O O
mg NN B-NP O
Capsule NNP I-NP O
, , O O
Delayed NNP B-NP O
Release NNP I-NP O
( ( O O
E.C. NNP B-NP O
) ) O O
Sig NN B-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Capsule NN B-NP O
, , O O
Delayed NNP B-NP O
Release NNP I-NP O
( ( O O
E.C. NNP B-NP O
) ) O O
PO NNP B-NP O
once RB O O
a DT B-NP O
day NN I-NP O
. . B-VP O
   
14. CD O O
Guaifenesin NNP B-NP B-treatment
100 CD O O
mg NN B-NP O
/ VBD B-VP O
5 CD O O
mL NN B-NP O
Liquid NNP I-NP O
Sig NNP I-NP O
: : O O
01-28 JJ B-NP O
teaspoons NNS I-NP O
PO NNP I-NP O
every DT O O
six CD O O
( ( O O
6 CD O O
) ) O O
hours NNS B-NP O
as IN B-VP O
needed VBN O O
for IN B-VP O
cold JJ B-NP B-problem
symptoms NNS I-NP I-problem
. . B-VP O
   
Discharge NNP B-NP O
Disposition NNP I-NP O
: : O O
Extended VBN O O
Care NNP B-NP O
Discharge NNP I-NP O
Diagnosis NNP I-NP O
: : O O
Right RB O B-problem
sided VBD B-VP I-problem
intraparenchymal JJ B-NP I-problem
cerebral JJ I-NP I-problem
hemorrhage NN I-NP I-problem
Discharge NNP I-NP O
Condition NNP I-NP O
: : O O
Stable JJ O O
- : O O
still RB O O
with IN B-VP O
difficulty NN B-NP B-problem
walking NN I-NP I-problem
, , O O
and CC O O
mental JJ B-NP B-test
status NN I-NP I-test
exam NN I-NP I-test
with IN B-VP O
memory NN B-NP B-problem
loss NN I-NP I-problem
c/w NN I-NP O
dementia NN I-NP B-problem
, , O O
but CC O O
otherwise RB O O
no DT B-NP O
focal JJ I-NP B-problem
weakness NN I-NP I-problem
. . B-VP O
   
Discharge NNP B-NP O
Instructions NNPS I-NP O
: : O O
Please VB O O
call VB O O
MD NNP B-NP B-person
or CC O O
return VB O O
to TO O O
Deanna NNP B-NP O
if IN B-VP O
new JJ B-NP O
symptoms NNS I-NP O
suggestive NN I-NP O
of IN B-VP O
stroke NN B-NP B-problem
or CC O O
brain NN B-NP B-problem
hemorrhage NN I-NP I-problem
including VBG O O
weakness NN B-NP B-problem
, , O O
numbness JJ B-NP B-problem
/ NN I-NP O
tingling NN I-NP B-problem
, , O O
facial JJ B-NP B-problem
droop NN I-NP I-problem
, , O O
visual JJ B-NP B-problem
changes NNS I-NP I-problem
, , O O
vertigo NN B-NP B-problem
, , O O
loss NN B-NP B-problem
of IN B-VP I-problem
coordination NN B-NP I-problem
, , O O
or CC O O
worsened VBD B-VP B-problem
problems NNS B-NP I-problem
with IN B-VP I-problem
walking VBG O I-problem
. . B-VP O
   
Followup JJ B-NP O
Instructions NNS I-NP O
: : O O
Please NNP B-NP O
f/u VB O O
with IN B-VP O
Dr. NNP B-NP B-person
Hernandez NNP I-NP I-person
/ NNP I-NP O
neurosurgery NN I-NP B-person
in IN B-VP O
6 CD O O
weeks NNS B-NP O
- : O O
patient NN B-NP B-person
will MD O O
receive VB O O
a DT B-NP O
call NN I-NP O
from IN B-VP O
the DT B-NP O
neurosurgery NN I-NP B-person
office NN I-NP I-person
to TO O O
set VB O O
up RP O O
a DT B-NP B-test
repeat NN I-NP I-test
head NN I-NP I-test
CT NNP I-NP I-test
prior RB O O
and CC O O
to TO O O
schedule VB O O
this DT B-NP B-pronoun
visit NN I-NP O
. . B-VP O
   
Daniel NNP B-NP B-person
Laura NNP I-NP I-person
MD NNP I-NP I-person
, , O I-person
PHD NNP B-NP I-person
13-279 CD O O
Completed VBN O O
by IN B-VP O
: : O O
Charles NNP B-NP B-person
Rodriguez NNP I-NP I-person
MD NNP I-NP I-person
38-818 JJ B-NP O
2019-04-01 JJ I-NP O
@ NN I-NP O
1518 CD O O
Signed NNP B-NP O
electronically RB O O
by IN B-VP O
: : O O
DR. NNP B-NP B-person
Stacie NNP I-NP I-person
Henry NNP I-NP I-person
on IN B-VP O
: : O O
MON NNP B-NP O
2019-05-06 CD O O
12:14 CD O O
PM NNP B-NP O
( ( O O
End NNP B-NP O
of IN B-VP O
Report NNP B-NP O
) ) O O
-EMPTYLINE- VBP O O
-DOCSTART- JJ O O
-EMPTYLINE- $ O O
176318078 CD O O
FIH NNP B-NP O
4189699 CD O O
98761/1k47 CD O O
867797 CD O O
6/22/1994 CD O O
12:00:00 CD O O
AM NNP B-NP O
MITRAL NNP I-NP B-problem
STENOSIS NNP I-NP I-problem
. . B-VP O
   
Unsigned VBD B-VP O
DIS NNP B-NP O
Report NNP I-NP O
Status NNP I-NP O
: : O O
Unsigned VBN O O
ADMISSION NNP B-NP O
DATE NNP I-NP O
: : O O
06/22/94 CD O O
DISCHARGE NNP B-NP O
DATE NNP I-NP O
: : O O
07/04/94 CD O O
PRINCIPAL NNP B-NP O
DIAGNOSIS NNP I-NP O
: : O O
Mitral JJ B-NP B-problem
stenosis NN I-NP I-problem
. . B-VP O
   
ASSOCIATED CC O O
DIAGNOSIS NNP B-NP O
: : O O
Tricuspid JJ B-NP B-problem
insufficiency NN I-NP I-problem
, , O O
atrial JJ B-NP B-problem
fibrillation NN I-NP I-problem
, , O O
congestive JJ B-NP B-problem
heart NN I-NP I-problem
failure NN I-NP I-problem
, , O O
chronic JJ B-NP B-problem
obstructive JJ I-NP I-problem
pulmonary JJ I-NP I-problem
disease NN I-NP I-problem
, , O O
pulmonary JJ B-NP B-problem
hypertension NN I-NP I-problem
. . B-VP O
   
PRINCIPAL JJ B-NP O
PROCEDURE NNP I-NP O
: : O O
04/22/94 CD O O
, , O O
mitral JJ O B-treatment
valve FW O I-treatment
replacement NN B-NP I-treatment
and CC O O
tricuspid JJ B-NP B-treatment
valve NN I-NP I-treatment
reconstruction NN I-NP I-treatment
. . B-VP O
   
HISTORY NNP B-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS NNP I-NP O
: : O O
This DT O B-pronoun
This DT O B-person
68 CD O I-person
year NN B-NP I-person
old JJ B-NP I-person
female NN I-NP I-person
had VBD B-VP O
rheumatic JJ B-NP B-problem
fever NN I-NP I-problem
in IN B-VP O
the DT B-NP O
past NN I-NP O
, , O O
and CC O O
has VBZ O O
had VBN O O
chronic VBN O B-problem
atrial JJ B-NP I-problem
fibrillation NN I-NP I-problem
. . B-VP O
   
She PRP O B-person
has VBZ O O
had VBN O O
progressive JJ B-NP B-problem
heart NN I-NP I-problem
failure NN I-NP I-problem
and CC O O
an DT B-NP B-test
evaluation NN I-NP I-test
demonstrated VBD B-VP O
worsening VBG O B-problem
mitral JJ B-NP I-problem
stenosis NN I-NP I-problem
with IN B-VP O
severe JJ B-NP B-problem
pulmonary JJ I-NP I-problem
hypertension NN I-NP I-problem
. . B-VP O
   
Because IN B-VP O
of IN B-VP O
her PRP$ O B-person
deteriorating NN B-NP O
status NN I-NP O
, , O O
she PRP O B-person
underwent VBD B-VP O
prior JJ B-NP B-test
cardiac JJ I-NP I-test
catheterization NN I-NP I-test
, , O O
which WDT O B-pronoun
confirmed VBD B-VP O
severe JJ B-NP B-problem
mitral JJ I-NP I-problem
stenosis NN I-NP I-problem
with IN B-VP O
secondary JJ B-NP B-problem
tricuspid JJ I-NP I-problem
valve NN I-NP I-problem
regurgitation NN I-NP I-problem
due JJ O O
to TO O O
pulmonary JJ B-NP B-problem
hypertension NN I-NP I-problem
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
referred VBN O O
for IN B-VP O
valve NN B-NP B-treatment
surgery NN I-NP I-treatment
. . B-VP O
   
PAST NNP B-NP O
MEDICAL NNP I-NP O
HISTORY NNP I-NP O
is VBZ O O
remarkable JJ O O
for IN B-VP O
chronic JJ B-NP B-problem
lung NN I-NP I-problem
disease NN I-NP I-problem
due JJ O O
to TO O O
smoking VBG O O
. . B-VP O
   
She PRP O B-person
had VBD B-VP O
undergone PRP O O
a DT B-NP B-treatment
previous JJ I-NP I-treatment
nasal JJ I-NP I-treatment
arterial JJ I-NP I-treatment
embolization NN I-NP I-treatment
for IN B-VP O
treatment NN B-NP B-treatment
of IN B-VP O
recurrent NN B-NP B-problem
epistaxis NN I-NP I-problem
. . B-VP O
   
She PRP O B-person
had VBD B-VP O
a DT B-NP B-treatment
partial JJ I-NP I-treatment
gastrectomy NN I-NP I-treatment
in IN B-VP O
1972 CD O O
. . B-VP O
   
Her PRP$ O B-treatment
Her PRP$ O B-person
MEDICATIONS NN B-NP I-treatment
ON NNP I-NP I-treatment
ADMISSION NNP I-NP I-treatment
included VBD B-VP O
Coumadin NNP B-NP B-treatment
, , O O
digoxin NN B-NP B-treatment
, , O O
0.125 CD O O
, , O O
qD NN B-NP O
, , O O
Lasix NNP B-NP B-treatment
, , O O
40 CD O O
, , O O
q.i.d. NN B-NP O
, , O O
and CC O O
Vanceril NNP B-NP B-treatment
inhaler NN I-NP I-treatment
. . B-VP O
   
PERTINENT NNP B-NP B-test
EXAMINATION NNP I-NP I-test
demonstrated VBD B-VP O
mild JJ B-NP B-problem
elevation NN I-NP I-problem
of IN B-VP O
her PRP$ O B-person
her PRP$ O B-test
jugular JJ B-NP I-test
venous JJ I-NP I-test
pulse NN I-NP I-test
, , O O
with IN B-VP O
prominent JJ B-NP B-problem
V-waves NNS I-NP I-problem
, , O O
and CC O O
systolic JJ O B-problem
and CC O I-problem
diastolic JJ B-NP I-problem
murmurs NNS I-NP I-problem
. . B-VP O
   
Peripheral JJ B-NP B-test
pulses NNS I-NP I-test
were VBD B-VP O
all DT O O
intact JJ O O
, , O O
and CC O O
there RB O O
was VBD B-VP O
venous JJ B-NP B-problem
stasis NN I-NP I-problem
changes NNS I-NP I-problem
on IN B-VP I-problem
her PRP$ O B-person
her PRP$ O I-problem
legs NN B-NP I-problem
, , O O
with IN B-VP O
some DT B-NP B-problem
edema NN I-NP I-problem
. . B-VP O
   
HOSPITAL NNP B-NP O
COURSE NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
brought VBN O O
to TO O O
the DT B-NP O
Operating NN I-NP O
Room NNP I-NP O
, , O O
on IN B-VP O
April NNP B-NP O
22 CD O O
. . B-VP O
   
She PRP O B-person
underwent VBD B-VP O
a DT B-NP B-treatment
mitral JJ I-NP I-treatment
valve NN I-NP I-treatment
replacement NN I-NP I-treatment
, , O O
utilizing VBG O O
a DT O B-treatment
27 CD O O
mm NN B-NP O
. . B-VP O
   
St. NNP B-NP O
Jude NNP I-NP O
prosthesis NN I-NP O
, , O O
and CC O O
tricuspid JJ B-NP B-treatment
valve NN I-NP I-treatment
reconstruction NN I-NP I-treatment
by IN B-VP O
ring VBG O B-treatment
anuloplasty NN B-NP I-treatment
. . B-VP O
   
She PRP O B-person
weaned VBD B-VP O
from IN B-VP O
cardiopulmonary JJ B-NP B-treatment
bypass NN I-NP I-treatment
with IN B-VP O
good JJ B-NP O
hemodynamics NNS I-NP O
. . B-VP O
   
She PRP O B-person
initially RB O O
awoke VBD B-VP O
after IN B-VP O
surgery NN B-NP B-treatment
, , O O
with IN B-VP O
good JJ B-NP O
hemodynamics NNS I-NP O
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
transiently RB O O
in IN B-VP O
sinus NN B-NP O
rhythm NN I-NP O
, , O O
but CC O O
atrial JJ B-NP B-problem
fibrillation NN I-NP I-problem
recurred VBD B-VP O
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
extubated VBN O O
on IN B-VP O
the DT B-NP O
third JJ I-NP O
postoperative JJ I-NP O
day NN I-NP O
, , O O
and CC O O
was VBD B-VP O
initially RB O B-problem
slightly RB O I-problem
agitated VBN O I-problem
and CC O O
confused VBN O B-problem
, , O O
largely RB O O
due JJ O O
to TO O O
an DT B-NP B-problem
Intensive NNP I-NP I-problem
Care NNP I-NP I-problem
Unit NNP I-NP I-problem
psychosis NN I-NP I-problem
. . B-VP O
   
She PRP O B-person
continued VBD B-VP O
to TO O O
improve VB O O
, , O O
with IN B-VP O
mobilization NN B-NP O
of IN B-VP O
fluid NN B-NP O
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
initially RB O O
noted VBN O O
to TO O O
have VB O O
a DT B-NP B-problem
slow JJ I-NP I-problem
ventricular NN I-NP I-problem
response NN I-NP I-problem
in IN B-VP O
atrial JJ B-NP B-problem
fibrillation NN I-NP I-problem
, , O O
but CC O O
this DT O B-pronoun
gradually RB O O
improved VBN O O
over IN B-VP O
time NN B-NP O
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
initially RB O O
noted VBN O O
to TO O O
be VB O O
somewhat RB O B-problem
anemic JJ O I-problem
, , O O
and CC O O
received VBD B-VP O
transfusions NNS B-NP B-treatment
. . B-VP O
   
Coumadin NNP B-NP B-treatment
was VBD B-VP O
restarted VBN O O
, , O O
and CC O O
her PRP$ O B-person
her PRP$ O B-treatment
anticoagulation NN B-NP I-treatment
came VBD B-VP O
into IN B-VP O
range NN B-NP O
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
ultimately RB O O
discharged VBN O O
with IN B-VP O
a DT B-NP B-test
heart NN I-NP I-test
rate NN I-NP I-test
in IN B-VP O
the DT O O
90 CD O O
's POS O O
, , O O
and CC O O
with IN B-VP O
resolving VBG O B-problem
edema NN B-NP I-problem
and CC O O
a DT B-NP O
clear JJ I-NP O
chest NN I-NP O
. . B-VP O
   
Her PRP$ O B-person
Her PRP$ O B-treatment
MEDICATIONS NN B-NP I-treatment
ON NNP I-NP I-treatment
DISCHARGE NNP I-NP I-treatment
included VBD B-VP O
Lasix NNP B-NP B-treatment
, , O O
40 CD O O
, , O O
b.i.d. NN B-NP O
, , O O
potassium NN B-NP B-treatment
, , O O
20 CD O O
mEq. NN B-NP O
, , O O
b.i.d. NN B-NP O
, , O O
iron NN B-NP B-treatment
, , O O
and CC O O
folic JJ B-NP B-treatment
acid NN I-NP I-treatment
replacement NN I-NP I-treatment
, , O O
and CC O O
Coumadin NNP B-NP B-treatment
. . B-VP O
   
RIEMUND NNP B-NP B-person
C. NNP I-NP I-person
ALL NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
TR NNP I-NP O
: : O O
dun NN B-NP O
/ NNP I-NP O
bmot NN I-NP O
DD NNP I-NP O
: : O O
7/12/94 CD O O
TD NN B-NP O
: : O O
07/13/94 CD O O
CC NN B-NP O
: : O O
Dr. NNP B-NP B-person
Ca NNP I-NP I-person
Shuff NNP I-NP I-person
. . B-VP I-person
   
-EMPTYLINE- VB O O
-DOCSTART- JJ O O
-EMPTYLINE- $ O O
466217945 CD O O
BH NNP B-NP O
0568574 CD O O
158979 CD O O
3/7/2002 CD O O
12:00:00 CD O O
AM NNP B-NP O
Discharge NNP I-NP O
Summary NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Report NNP I-NP O
Status NNP I-NP O
: : O O
Signed VBD B-VP O
DISCHARGE NNP B-NP O
SUMMARY NNP I-NP O
NAME NN I-NP O
: : O O
JESCOBEJESC NNP B-NP B-person
, , O I-person
SON NNP B-NP I-person
UNIT NNP I-NP O
NUMBER NNP I-NP O
: : O O
485-03-93 JJ B-NP O
ADMISSION NNP I-NP O
DATE NNP I-NP O
: : O O
03/07/2002 CD O O
DISCHARGE NNP B-NP O
DATE NNP I-NP O
: : O O
03/13/2002 CD O O
PRIMARY NNP B-NP O
DIAGNOSIS NNP I-NP O
: : O O
Wound JJ B-NP B-problem
infection NN I-NP I-problem
. . B-VP O
   
ASSOCIATED CC O O
DIAGNOSIS NNP B-NP O
: : O O
None NN B-NP O
. . B-VP O
   
PRINCIPAL NNP B-NP O
PROCEDURES NNP I-NP O
: : O O
Incision NN B-NP B-treatment
and CC O O
drainage NN B-NP B-treatment
of IN B-VP O
wound JJ B-NP B-problem
infection NN I-NP I-problem
on IN B-VP O
3/7/02 CD O O
. . B-VP O
   
Abdominal JJ B-NP B-test
pelvic JJ I-NP I-test
CT NNP I-NP I-test
scan NN I-NP I-test
on IN B-VP O
3/10/02 CD O O
. . B-VP O
   
Fistulogram NNP B-NP B-test
on IN B-VP O
3/11/02 CD O O
. . B-VP O
   
Intravenous JJ B-NP B-treatment
antibiotics NNS I-NP I-treatment
. . B-VP O
   
HISTORY NNP B-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
is VBZ O O
a DT B-NP O
79-year-old JJ I-NP O
man NN I-NP O
status NN I-NP O
postradical JJ B-NP B-treatment
cystoprostatectomy NN I-NP I-treatment
with IN B-VP I-treatment
ileal JJ B-NP I-treatment
loop NN I-NP I-treatment
for IN B-VP O
locally RB O B-problem
invasive JJ B-NP I-problem
prostate NN I-NP I-problem
cancer NN I-NP I-problem
. . B-VP O
   
This DT O B-pronoun
This DT B-NP B-treatment
operation NN I-NP I-treatment
was VBD B-VP O
performed VBN O O
2/11/02 CD O O
by IN B-VP O
Dr. NNP B-NP B-person
Doje NNP I-NP I-person
Para NNP I-NP I-person
. . B-VP O
   
The DT B-NP O
postoperative JJ I-NP O
course NN I-NP O
was VBD B-VP O
complicated VBN O O
by IN B-VP O
atrial JJ B-NP B-problem
fibrillation NN I-NP I-problem
with IN B-VP O
transfer NN B-NP O
to TO O O
the DT B-NP O
Cardiac NNP I-NP O
Step-Down NNP I-NP O
Unit NNP I-NP O
. . B-VP O
   
This DT B-NP B-pronoun
transfer NN I-NP O
occurred VBD B-VP O
around IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
8 CD O O
for IN B-VP O
anticoagulation NN B-NP B-treatment
and CC O O
amiodarone NN B-NP B-treatment
load NN I-NP I-treatment
. . B-VP O
   
The DT B-NP B-treatment
anticoagulation NN I-NP I-treatment
was VBD B-VP O
stopped VBN O O
due RB O O
to TO O O
concern NN B-NP O
for IN B-VP O
postoperative JJ B-NP B-problem
bleeding NN I-NP I-problem
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
complained VBD B-VP O
of IN B-VP O
fevers NNS B-NP B-problem
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
presented VBD B-VP O
to TO O O
the DT B-NP O
emergency NN I-NP O
room NN I-NP O
on IN B-VP O
3/7/02 CD O O
, , O O
complaining VBG O O
of IN B-VP O
fevers NNS B-NP B-problem
since IN B-VP O
Monday NNP B-NP O
3/2/02 CD O O
. . B-VP O
   
He PRP O B-person
developed VBD B-VP O
erythema VB O B-problem
around IN B-VP O
the DT B-NP B-problem
wound NN I-NP I-problem
on IN B-VP O
Wednesday NNP B-NP O
and CC O O
was VBD B-VP O
seen VBN O O
by IN B-VP O
Dr. NNP B-NP B-person
Para NNP I-NP I-person
, , O O
who WP O B-person
started VBD B-VP O
Keflex NNP B-NP B-treatment
and CC O O
obtained VBD B-VP O
a DT B-NP B-test
CT NNP I-NP I-test
scan NN I-NP I-test
which WDT O B-pronoun
demonstrated VBD B-VP O
a DT B-NP B-problem
fluid NN I-NP I-problem
collection NN I-NP I-problem
at IN B-VP O
the DT B-NP O
site NN I-NP O
of IN B-VP O
erythema NN B-NP B-problem
. . B-VP O
   
The DT B-NP B-problem
fevers NNS I-NP I-problem
continued VBD B-VP O
as RB O O
high JJ O O
as IN B-VP O
102.5 CD O O
degrees NNS B-NP O
F NNP I-NP O
with IN B-VP O
chills NNS B-NP B-problem
on IN B-VP O
the DT B-NP O
morning NN I-NP O
of IN B-VP O
admission NN B-NP O
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
draining VBG O O
pus NN B-NP B-problem
from IN B-VP O
the DT B-NP B-problem
wound NN I-NP I-problem
site NN I-NP I-problem
with IN B-VP O
subsequent JJ B-NP O
relief NN I-NP O
of IN B-VP O
discomfort NN B-NP B-problem
at IN B-VP O
the DT B-NP O
site NN I-NP O
. . B-VP O
   
PAST NNP B-NP O
MEDICAL NNP I-NP O
HISTORY NNP I-NP O
: : O O
Hypertension NN B-NP B-problem
, , O O
atrial JJ B-NP B-problem
fibrillation NN I-NP I-problem
, , O O
gout NN B-NP B-problem
. . B-VP O
   
PAST JJ B-NP O
SURGICAL JJ I-NP O
HISTORY NN I-NP O
: : O O
Cystoprostatectomy NNP B-NP B-treatment
, , O O
bilateral JJ B-NP B-treatment
inguinal JJ I-NP I-treatment
hernia NN I-NP I-treatment
repair NN I-NP I-treatment
. . B-VP O
   
MEDICATIONS NNP B-NP O
ON NNP I-NP O
ADMISSION NNP I-NP O
: : O O
Keflex NNP B-NP B-treatment
500 CD O O
mg NN B-NP O
qid NN I-NP O
. . B-VP O
   
ALLERGIES NNP B-NP O
: : O O
No DT B-NP O
known JJ I-NP B-problem
drug NN I-NP I-problem
allergies NNS I-NP I-problem
. . B-VP O
   
PHYSICAL NNP B-NP O
EXAMINATION NNP I-NP O
ON NNP I-NP O
ADMISSION NNP I-NP O
: : O O
On IN B-VP O
presentation NN B-NP O
, , O O
temperature NN B-NP B-test
99.3 CD O O
degrees NNS B-NP O
F NNP I-NP O
, , O O
other JJ B-NP B-test
vital JJ I-NP I-test
signs NNS I-NP I-test
were VBD B-VP O
within IN B-VP O
normal JJ B-NP O
limits NNS I-NP O
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
in IN B-VP O
no DT B-NP O
acute NN I-NP B-problem
distress NN I-NP I-problem
, , O O
non-toxic JJ O B-problem
. . B-VP O
   
Cardiovascular JJ O O
: : O O
Regular JJ B-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
. . B-VP O
   
Pulmonary JJ O O
: : O O
Clear JJ O O
to TO O O
auscultation VB O B-test
bilaterally RB O O
. . B-VP O
   
Abdomen NNP B-NP O
soft JJ O O
and CC O O
there EX O O
was VBD B-VP O
wound NN B-NP B-problem
erythema NN I-NP I-problem
with IN B-VP O
three CD O B-problem
areas NNS B-NP I-problem
of IN B-VP I-problem
dehiscence NN B-NP I-problem
draining VBG O O
foul-smelling JJ O B-problem
, , O I-problem
purulent JJ B-NP I-problem
fluid NN I-NP I-problem
. . B-VP O
   
The DT B-NP O
fascia NN I-NP O
appeared VBD B-VP O
intact JJ O O
by IN B-VP O
probing VBG O B-test
. . B-VP O
   
The DT B-NP B-treatment
stoma NN I-NP I-treatment
was VBD B-VP O
pink JJ O O
and CC O O
functional JJ O O
. . B-VP O
   
The DT B-NP B-problem
wound NN I-NP I-problem
was VBD B-VP O
a DT B-NP B-problem
midline JJ I-NP I-problem
incision NN I-NP I-problem
for IN B-VP O
his PRP$ O B-treatment
his PRP$ O B-person
radical JJ B-NP I-treatment
cystoprostatectomy NN I-NP I-treatment
. . B-VP O
   
LABORATORY NNP B-NP O
DATA NNP I-NP O
: : O O
White NNP B-NP B-test
blood NN I-NP I-test
cell NN I-NP I-test
count NN I-NP I-test
16.9 CD O O
, , O O
hematocrit NN B-NP B-test
32.2 CD O O
, , O O
platelet NN B-NP B-test
count NN I-NP I-test
418 CD O O
, , O O
sodium NN B-NP B-test
131 CD O O
, , O O
potassium NN B-NP B-test
3.4 CD O O
, , O O
chloride RB O B-test
102 CD O O
, , O O
bicarbonate NN B-NP B-test
21.4 CD O O
, , O O
BUN27 NNP B-NP B-test
, , O O
creatinine NN B-NP B-test
1.4 CD O O
, , O O
glucose VBD B-VP B-test
150 CD O O
. . B-VP O
   
RADIOLOGIC JJ B-NP O
STUDIES NNPS I-NP O
: : O O
CT NNP B-NP B-test
scan JJ O I-test
3/5/02 CD O O
: : O O
A DT B-NP B-problem
fluid NN I-NP I-problem
collection NN I-NP I-problem
external NN I-NP I-problem
to TO O I-problem
the DT B-NP I-problem
fascia JJ I-NP I-problem
consistent NN I-NP O
with IN B-VP O
site NN B-NP O
of IN B-VP O
erythema NN B-NP B-problem
. . B-VP O
   
HOSPITAL NNP B-NP O
COURSE NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
admitted VBN O O
to TO O O
Urology NNP B-NP O
. . B-VP O
   
After IN B-VP O
the DT B-NP B-problem
wound NN I-NP I-problem
was VBD B-VP O
further RBR O O
opened VBN O O
, , O O
he PRP O B-person
was VBD B-VP O
started VBN O O
on IN B-VP O
ampicillin NN B-NP B-treatment
, , O O
Gentamicin NNP B-NP B-treatment
, , O O
and CC O O
Flagyl NNP B-NP B-treatment
antibiotics NNS I-NP I-treatment
and CC O O
he PRP O B-person
was VBD B-VP O
placed VBN O O
on IN B-VP O
a DT B-NP B-treatment
bid NN I-NP I-treatment
dressing VBG O I-treatment
change NN B-NP I-treatment
and CC O O
packing NN B-NP B-treatment
. . B-VP O
   
On IN B-VP O
hospital JJ B-NP O
day NN I-NP O
2 CD O O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
had VBD B-VP O
no DT B-NP O
complaints NNS I-NP O
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
afebrile JJ O B-problem
with IN B-VP O
stable JJ B-NP O
vital JJ I-NP O
signs NNS I-NP O
and CC O O
good JJ B-NP O
urine NN I-NP O
output NN I-NP O
. . B-VP O
   
The DT B-NP B-problem
wound NN I-NP I-problem
erythema NN I-NP I-problem
was VBD B-VP O
improving VBG O O
and CC O O
the DT B-NP B-problem
wound NN I-NP I-problem
was VBD B-VP O
packed VBN O O
twice RB O O
a DT B-NP O
day NN I-NP O
. . B-VP O
   
Wound NNP B-NP B-test
cultures NNS I-NP I-test
remained VBD B-VP O
negative JJ O O
at IN B-VP O
that DT B-NP B-pronoun
time NN I-NP O
. . B-VP O
   
We PRP O B-person
continued VBD B-VP O
his PRP$ O B-person
his PRP$ O B-treatment
ampicillin NN B-NP I-treatment
, , O O
Gentamicin NNP B-NP B-treatment
, , O O
and CC O O
Flagyl NNP B-NP B-treatment
. . B-VP O
   
By IN B-VP O
hospital JJ B-NP O
day NN I-NP O
4 CD O O
, , O O
he PRP O B-person
remained VBD B-VP O
afebrile JJ O B-problem
throughout IN B-VP O
his PRP$ O B-person
hospital NN B-NP O
course NN I-NP O
. . B-VP O
   
The DT B-NP B-test
wound NN I-NP I-test
cultures VBZ O I-test
demonstrated VBN O O
gram-positive JJ B-NP B-problem
cocci NN I-NP I-problem
in IN B-VP I-problem
clusters NNS B-NP I-problem
and CC O O
gram-negative JJ B-NP B-problem
rods NNS I-NP I-problem
. . B-VP O
   
Blood NNP B-NP B-test
cultures NNS I-NP I-test
remained VBD B-VP O
negative JJ O O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
continued VBN O O
on IN B-VP O
antibiotics NNS B-NP B-treatment
and CC O O
we PRP O B-person
obtained VBD B-VP O
a DT O B-test
CT JJ O I-test
scan JJ O I-test
to TO O O
check VB O O
for IN B-VP O
an DT B-NP B-problem
enterocutaneous JJ I-NP I-problem
fistula NN I-NP I-problem
. . B-VP O
   
We PRP O B-person
discontinued VBD B-VP O
his PRP$ O B-person
his PRP$ O B-treatment
Flagyl NN B-NP I-treatment
on IN B-VP O
that DT B-NP B-pronoun
day NN I-NP O
. . B-VP O
   
We PRP O B-person
contacted VBD B-VP O
the DT O B-person
the DT B-NP B-person
patient JJ I-NP I-person
patient NN I-NP I-person
&apos;s NNP I-NP I-person
primary JJ B-NP I-person
care NN I-NP I-person
physician NN I-NP I-person
, , O O
Dr. NNP B-NP B-person
Aslinke NNP I-NP I-person
______ NNP I-NP O
, , O O
regarding VBG O O
his PRP$ O B-treatment
his PRP$ O B-person
cardiac JJ B-NP I-treatment
medication NN I-NP I-treatment
management NN I-NP I-treatment
. . B-VP O
   
We PRP O B-person
agreed VBD B-VP O
that IN B-VP B-pronoun
he PRP O B-person
should MD O O
resume VB O O
his PRP$ O B-person
his PRP$ O B-treatment
atenolol NN B-NP I-treatment
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
started VBN O O
on IN B-VP O
2.5 CD O O
mg NNS B-NP O
PO NNP I-NP O
qd NN I-NP O
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
continued VBN O O
on IN B-VP O
his PRP$ O B-person
his PRP$ O B-treatment
dressing NN B-NP I-treatment
changes NNS I-NP I-treatment
. . B-VP O
   
We PRP O B-person
changed VBD B-VP O
the DT B-NP B-treatment
dressings NNS I-NP I-treatment
tid VBP O O
instead RB O O
of IN B-VP O
bid NN B-NP O
for IN B-VP O
continued JJ B-NP B-problem
drainage NN I-NP I-problem
. . B-VP O
   
The DT B-NP B-test
CT NNP I-NP I-test
scan VBD B-VP I-test
that DT O B-pronoun
was VBD B-VP O
obtained VBN O O
on IN B-VP O
3/10/02 CD O O
demonstrated JJ O O
no DT B-NP O
connection NN I-NP O
between IN B-VP O
bowel NN B-NP O
and CC O O
the DT B-NP B-problem
wound NN I-NP I-problem
. . B-VP O
   
The DT B-NP B-problem
drainage NN I-NP I-problem
had VBD B-VP O
been VBN O O
decreasing VBG O O
and CC O O
the DT B-NP B-person
patient NN I-NP I-person
continued VBD B-VP O
to TO O O
be VB O O
afebrile JJ O B-problem
. . B-VP O
   
On IN B-VP O
the DT B-NP O
following JJ I-NP O
day NN I-NP O
, , O O
3/11/02 CD O O
, , O O
a DT B-NP B-test
fistulogram NN I-NP I-test
was VBD B-VP O
obtained VBN O O
which WDT O B-pronoun
was VBD B-VP O
negative JJ O O
for IN B-VP O
a DT B-NP B-problem
fistula NN I-NP I-problem
from IN B-VP I-problem
the DT B-NP I-problem
bowel NN I-NP I-problem
to TO O O
the DT B-NP B-problem
wound NN I-NP I-problem
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
continued VBN O O
on IN B-VP O
ampicillin NN B-NP B-treatment
and CC O O
Gentamicin NNP B-NP B-treatment
. . B-VP O
   
Her PRP$ O B-person
remained VBD B-VP O
afebrile JJ O B-problem
with IN B-VP O
stable JJ B-NP O
vital JJ I-NP O
signs NNS I-NP O
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
comfortable JJ O O
and CC O O
erythema JJ O B-problem
continued VBN O O
to TO O O
decrease VB O O
with IN B-VP O
improvemeent NN B-NP O
in IN B-VP O
the DT B-NP O
appearance NN I-NP O
of IN B-VP O
the DT B-NP B-problem
wound NN I-NP I-problem
. . B-VP O
   
In IN B-VP O
consultation NN B-NP O
with IN B-VP O
Infectious JJ B-NP B-person
Disease NNP I-NP I-person
, , O O
it PRP O B-pronoun
was VBD B-VP O
agreed VBN O O
to TO O O
discharge VB O O
the DT B-NP B-person
patient NN I-NP I-person
on IN B-VP O
Augmentin NNP B-NP B-treatment
for IN B-VP O
coverage NN B-NP O
. . B-VP O
   
We PRP O B-person
obtained VBD B-VP O
sensitivities NNS B-NP B-test
of IN B-VP O
his PRP$ O B-person
his PRP$ O B-problem
wound NN B-NP I-problem
bacteria NN I-NP I-problem
. . B-VP O
   
His PRP$ O B-person
His PRP$ O B-treatment
intravenous JJ B-NP I-treatment
antibiotics NNS I-NP I-treatment
were VBD B-VP O
discontinued VBN O O
. . B-VP O
   
He PRP O B-person
remaineda VBZ O B-problem
febrile JJ O I-problem
with IN B-VP O
daily JJ B-NP O
improvement NN I-NP O
in IN B-VP O
the DT B-NP O
appearance NN I-NP O
of IN B-VP O
his PRP$ O B-person
his PRP$ O B-problem
wound NN B-NP I-problem
. . B-VP O
   
On IN B-VP O
hospital JJ B-NP O
day NN I-NP O
7 CD O O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
remained VBD B-VP O
afebrile JJ O B-problem
with IN B-VP O
stable JJ B-NP O
vital JJ I-NP O
signs NNS I-NP O
. . B-VP O
   
His PRP$ O B-person
His PRP$ O B-problem
wound NN B-NP I-problem
demonstrated VBD B-VP O
no DT B-NP O
erythema NN I-NP B-problem
with IN B-VP O
moderate JJ B-NP B-problem
dark JJ I-NP I-problem
drainage NN I-NP I-problem
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
will MD O O
be VB O O
discharged VBN O O
with IN B-VP O
WH NNP B-NP O
and CC O O
continued VBD B-VP B-treatment
dressing VBG O I-treatment
changes NNS B-NP I-treatment
bid NN I-NP O
. . B-VP O
   
DISCHARGE NNP B-NP O
INSTRUCTIONS NNP I-NP O
: : O O
1. CD O O
The DT B-NP B-person
patient NN I-NP I-person
will MD O O
be VB O O
sent VBN O O
home NN B-NP O
on IN B-VP O
7 CD O O
days NNS B-NP O
of IN B-VP O
Augmentin NNP B-NP B-treatment
PO NNP I-NP I-treatment
. . B-VP O
   
2. CD O O
The DT B-NP B-person
patient NN I-NP I-person
will MD O O
have VB O O
follow-up JJ O O
with IN B-VP O
Dr. NNP B-NP B-person
Para NNP I-NP I-person
in IN B-VP O
three CD O O
weeks NNS B-NP O
. . B-VP O
   
MEDICATIONS NNP B-NP O
ON NNP I-NP O
DISCHARGE NNP I-NP O
: : O O
Percocet NNP B-NP B-treatment
as IN B-VP O
needed VBN O O
for IN B-VP O
pain NN B-NP B-problem
. . B-VP O
   
Norvasc CC O B-treatment
2.5 CD O O
mg NN B-NP O
PO NNP I-NP O
qd NN I-NP O
. . B-VP O
   
Augmentin NNP B-NP B-treatment
500/125 CD O O
1 CD O O
tab NN B-NP O
PO NNP I-NP O
tid NN I-NP O
x VBD B-VP O
7 CD O O
days NNS B-NP O
. . B-VP O
   
LAKO NNP B-NP B-person
C NNP I-NP I-person
SCARVTWI NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
DICTATING NNP I-NP O
FOR NNP I-NP O
: : O O
Electronically RB O O
Signed VBD B-VP O
DOJE NNP B-NP B-person
EED NNP I-NP I-person
PARA NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
04/21/2002 CD O O
10:49 CD O O
_____________________________ NN B-NP O
DOJE NNP I-NP B-person
EED NNP I-NP I-person
PARA NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
TR NNP I-NP O
: : O O
yh NN B-NP O
DD NNP I-NP O
: : O O
03/13/2002 CD O O
TD NN B-NP O
: : O O
03/13/2002 CD O O
9:24 CD O O
A DT O O
158979 CD O O
cc NN B-NP O
: : O O
DOJE NNP B-NP B-person
EED NNP I-NP I-person
PARA NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
Admission NNP I-NP O
Date NNP I-NP O
: : O O
2019-12-28 JJ B-NP O
Discharge NN I-NP O
Date NNP I-NP O
: : O O
2020-01-20 JJ B-NP O
Date NNP I-NP O
of IN B-VP O
Birth NNP B-NP O
: : O O
2019-12-28 JJ B-NP O
Sex NN I-NP O
: : O O
F NNP B-NP O
Service NNP I-NP O
: : O O
CMED NNP B-NP O
CCU NNP I-NP O
HISTORY NNP I-NP O
: : O O
Baby NNP B-NP B-person
Girl NNP I-NP I-person
Rizza-Gannaway NNP I-NP I-person
is VBZ O O
the DT O O
1515 CD O O
gram JJ B-NP O
product NN I-NP O
of IN B-VP O
a DT O O
32 CD O O
and CC O O
06-30 JJ B-NP O
week NN I-NP O
twin NN I-NP O
gestation NN I-NP O
born VBN O O
to TO O O
a DT B-NP O
37-year-old JJ I-NP O
G NNP I-NP O
- : O O
2 CD O O
, , O O
P NNP B-NP O
- : O O
0 CD O O
, , O O
now RB O O
2 CD O O
, , O O
mother NN B-NP O
. . B-VP O
   
Prenatal JJ B-NP O
Edward NNP I-NP O
: : O O
A DT O O
negative JJ O O
, , O O
antibody JJ O B-test
negative JJ O O
, , O O
hepatitis JJ B-NP B-test
surface NN I-NP I-test
antigen NN I-NP I-test
negative JJ O O
, , O O
RPR NNP B-NP B-test
nonreactive NN I-NP O
, , O O
rubella NN B-NP B-test
immune NN I-NP O
and CC O O
GBS NNP B-NP B-test
negative JJ O O
. . B-VP O
   
Pregnancy NN B-NP O
was VBD B-VP O
IUI NNP B-NP O
assisted VBD B-VP O
for IN B-VP O
di-di JJ B-NP O
twin JJ I-NP O
gestation NN I-NP O
and CC O O
was VBD B-VP O
relatively RB O O
uncomplicated JJ O B-problem
until IN B-VP O
mother RB O O
presented VBN O O
on IN B-VP O
12-15 NNS B-NP O
, , O O
with IN B-VP O
spontaneous JJ B-NP O
rupture NN I-NP O
of IN B-VP O
membranes NNS B-NP O
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
found VBN O O
to TO O O
be VB O O
having VBG O O
preterm JJ B-NP B-problem
contractions NNS I-NP I-problem
without IN B-VP O
cervical JJ B-NP B-problem
change NN I-NP I-problem
and CC O O
was VBD B-VP O
admitted VBN O O
for IN B-VP O
bedrest NN B-NP B-treatment
. . B-VP O
   
She PRP O B-person
received VBD B-VP O
a DT B-NP O
full JJ I-NP O
course NN I-NP O
of IN B-VP O
betamethasone NN B-NP B-treatment
complete JJ O O
on IN B-VP O
12-17 JJ O O
, , O O
magnesium NN B-NP B-treatment
and CC O O
erythromycin NN B-NP B-treatment
for IN B-VP O
latency NN B-NP O
through IN B-VP O
12-21 JJ O O
. . B-VP O
   
Intermittent NNP B-NP B-problem
maternal JJ B-NP I-problem
hypertension NN I-NP I-problem
noted VBD B-VP O
but CC O O
without IN B-VP O
proteinuria NNS B-NP B-problem
. . B-VP O
   
Ultrasounds NNS B-NP B-test
have VBP O O
been VBN O O
reassuring VBG O O
with IN B-VP O
biophysicals NNS B-NP B-test
8 CD O O
out IN B-VP O
of IN B-VP O
8 CD O O
x2 NNS B-NP O
. . B-VP O
   
On IN B-VP O
the DT B-NP O
evening NN I-NP O
of IN B-VP O
12-27 JJ O O
, , O O
monitoring NN B-NP B-test
noted VBD B-VP O
child NN B-NP O
's POS O O
increased JJ B-NP B-problem
preterm NN I-NP I-problem
contractions NNS I-NP I-problem
, , O O
uterine JJ B-NP B-problem
tenderness NN I-NP I-problem
and CC O O
mildly RB O B-problem
increased VBD B-VP I-problem
fetal JJ B-NP I-problem
heart NN I-NP I-problem
rates NNS I-NP I-problem
, , O O
due JJ O O
to TO O O
concerns NNS B-NP O
of IN B-VP O
possible JJ B-NP O
chorioamnionitis NN I-NP B-problem
, , O O
the DT B-NP O
mother NN I-NP O
was VBD B-VP O
taken VBN O O
for IN B-VP O
cesarean JJ B-NP B-treatment
delivery NN I-NP I-treatment
. . B-VP O
   
The DT B-NP B-person
infant NN I-NP I-person
delivered VBN O O
with IN B-VP O
moderate JJ B-NP O
tone NN I-NP O
and CC O O
respiratory NN B-NP O
effort NN I-NP O
responding VBG O O
well RB O O
to TO O O
stimulation NN B-NP B-treatment
and CC O O
brief JJ B-NP B-treatment
blow NN I-NP I-treatment
by IN B-VP I-treatment
O2 NNP B-NP I-treatment
. . B-VP O
   
Apgars NNP B-NP B-test
were VBD B-VP O
8 CD O O
and CC O O
8 CD O O
. . B-VP O
   
PHYSICAL JJ B-NP O
EXAMINATION NN I-NP O
: : O O
On IN B-VP O
admission NN B-NP O
, , O O
weight NN B-NP B-test
1515 CD O O
grams NN B-NP O
, , O O
10th CD O O
to TO O O
25th CD O O
percentile NN B-NP O
, , O O
head NN B-NP B-test
circumference NN I-NP I-test
30 CD O O
cm NN B-NP O
, , O O
25th CD O O
to TO O O
50th CD O O
percentile NN B-NP O
, , O O
length VBZ O B-test
41 CD O O
cm NN B-NP O
, , O O
10th CD O O
to TO O O
25th CD O O
percentile NN B-NP O
. . B-VP O
   
Warm NNP B-NP O
, , O O
dry JJ O O
, , O O
premature JJ B-NP B-problem
infant NN I-NP B-person
, , O O
active JJ O O
with IN B-VP O
exam NN B-NP B-test
, , O O
mild JJ B-NP B-problem
respiratory NN I-NP I-problem
distress NN I-NP I-problem
at IN B-VP O
rest NN B-NP O
. . B-VP O
   
Overall JJ B-NP O
appearance NN I-NP O
consistent NN I-NP O
with IN B-VP O
estimated VBN O O
gestational JJ B-NP O
age NN I-NP O
. . B-VP O
   
Thin NNP B-NP O
, , O O
warm JJ O O
, , O O
dry JJ O O
, , O O
pink VB O O
, , O O
no DT B-NP O
rashes NNS I-NP B-problem
. . B-VP O
   
Fontanelle NNP B-NP O
soft JJ O O
and CC O O
flat JJ O O
. . B-VP O
   
Ears NNS B-NP O
normal JJ O O
. . B-VP O
   
Palate NNP B-NP O
intact JJ O O
. . B-VP O
   
Nondysmorphic NNP B-NP B-problem
. . B-VP O
   
Positive NNP B-NP O
red JJ B-NP B-test
reflex NN I-NP I-test
bilaterally RB O I-test
. . B-VP O
   
Neck NNP B-NP O
supple NN I-NP O
, , O O
no DT B-NP O
lesions NNS I-NP B-problem
. . B-VP O
   
Chest NNP B-NP O
moderately RB O O
aerated VBD B-VP O
. . B-VP O
   
Mild NNP B-NP B-problem
grunting VBG O I-problem
. . B-VP O
   
Cardiovascular JJ O O
: : O O
Regular JJ B-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
, , O O
no DT B-NP O
murmur NN I-NP B-problem
, , O O
femoral JJ B-NP B-test
pulses NNS I-NP I-test
2+ CD O O
. . B-VP O
   
Abdomen NNS B-NP O
soft JJ O O
, , O O
no DT B-NP O
hepatosplenomegaly NN I-NP B-problem
, , O O
quiet JJ B-NP O
bowel NN I-NP O
sounds NNS I-NP O
, , O O
3 CD O O
vessel NN B-NP O
cord NN I-NP O
. . B-VP O
   
CMED NNP B-NP O
CSRU NNP I-NP O
: : O O
Normal JJ B-NP O
female NN I-NP O
, , O O
anus JJ B-NP O
patent NN I-NP O
. . B-VP O
   
Hips NNP B-NP O
stable JJ O O
. . B-VP O
   
Back NNP B-NP O
normal JJ O O
. . B-VP O
   
No DT B-NP O
lesions NNS I-NP B-problem
. . B-VP O
   
Appropriate NNP B-NP O
tone NN I-NP O
and CC O O
activity NN B-NP O
for IN B-VP O
gestational JJ B-NP O
age NN I-NP O
. . B-VP O
   
HOSPITAL NNP B-NP O
COURSE NNP I-NP O
: : O O
By IN B-VP O
systems NNS B-NP O
: : O O
Respiratory NN B-NP O
: : O O
Pocasset NNP B-NP B-person
was VBD B-VP O
admitted VBN O O
to TO O O
the DT B-NP O
newborn JJ I-NP O
intensive JJ I-NP O
care NN I-NP O
unit NN I-NP O
with IN B-VP O
mild JJ B-NP B-problem
respiratory NN I-NP I-problem
distress NN I-NP I-problem
. . B-VP O
   
Chest NNP B-NP B-test
x-ray NN I-NP I-test
revealed VBD B-VP O
a DT B-NP B-problem
left NN I-NP I-problem
pneumothorax NN I-NP I-problem
which WDT O B-pronoun
resolved VBD B-VP O
on IN B-VP O
its PRP$ O O
own JJ O O
without IN B-VP O
intervention NN B-NP B-treatment
. . B-VP O
   
The DT B-NP B-person
infant NN I-NP I-person
has VBZ O O
remained VBN O O
in IN B-VP O
room NN B-NP O
air NN I-NP O
throughout IN B-VP O
her PRP$ O B-person
hospital JJ B-NP O
course NN I-NP O
with IN B-VP O
occasional JJ B-NP B-problem
apnea NN I-NP I-problem
and CC O O
bradycardia NN B-NP B-problem
episodes NNS I-NP I-problem
, , O O
the DT O O
last JJ O O
being VBG O O
documented VBN O O
on IN B-VP O
2020-01-14 JJ O O
. . B-VP O
   
Cardiovascular JJ O O
: : O O
Attleboro NNP B-NP O
has VBZ O O
been VBN O O
stable JJ O O
throughout IN B-VP O
her PRP$ O B-person
newborn JJ B-NP O
intensive JJ I-NP O
care NN I-NP O
course NN I-NP O
without IN B-VP O
issue NN B-NP O
. . B-VP O
   
Fluids NNP B-NP O
and CC O O
electrolytes NNS B-NP O
: : O O
Birth NNP B-NP B-test
weight NN I-NP I-test
was VBD B-VP O
1515 CD O O
grams NN B-NP O
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
initially RB O O
started VBN O O
on IN B-VP O
80 CD O O
cc NNS B-NP O
per IN B-VP O
kilo FW O O
per IN B-VP O
day NN B-NP O
of IN B-VP O
D10W NNP B-NP B-treatment
. . B-VP O
   
Enteral JJ B-NP B-treatment
feedings NNS I-NP I-treatment
were VBD B-VP O
initiated VBN O O
on IN B-VP O
day NN B-NP O
of IN B-VP O
life NN B-NP O
#1 NN I-NP O
. . B-VP O
   
Full NNP B-NP B-treatment
enteral JJ B-NP I-treatment
feedings NNS I-NP I-treatment
were VBD B-VP O
achieved VBN O O
by IN B-VP O
day NN B-NP O
of IN B-VP O
life NN B-NP O
#7 NNP I-NP O
. . B-VP O
   
The DT B-NP B-person
infant NN I-NP I-person
had VBD B-VP O
a DT B-NP O
course NN I-NP O
of IN B-VP O
heme JJ B-NP B-problem
positive JJ I-NP I-problem
stools NNS I-NP I-problem
with IN B-VP O
grossly RB O B-problem
bloody JJ B-NP I-problem
streaks NNS I-NP I-problem
and CC O O
mucus VB O B-problem
felt VBD B-VP O
to TO O O
be VB O O
protein JJ B-NP B-problem
allergy NN I-NP I-problem
. . B-VP O
   
The DT B-NP B-person
infant NN I-NP I-person
is VBZ O O
now RB O O
receiving VBG O O
breast NN B-NP O
milk NN I-NP O
with IN B-VP O
Nutramigen NNP B-NP B-treatment
powder NN I-NP I-treatment
concentrate NN I-NP I-treatment
to TO O O
24 CD O O
calorie NN B-NP O
. . B-VP O
   
Stools NNS B-NP O
have VBP O O
been VBN O O
negative JJ O O
to TO O O
trace VB O B-problem
positive JJ O I-problem
and CC O O
abdominal JJ B-NP B-test
exam NN I-NP I-test
is VBZ O O
reassuring VBG O O
. . B-VP O
   
Discharge NNP B-NP B-test
weight NN I-NP I-test
is VBZ O O
2040 CD O O
gm NN B-NP O
, , O O
the DT B-NP B-test
head NN I-NP I-test
circumference NN I-NP I-test
is VBZ O O
32 CD O O
cm NN B-NP O
and CC O O
the DT B-NP B-test
length NN I-NP I-test
is VBZ O O
46 CD O O
cm. NN B-NP O
. . B-VP O
   
GI NN B-NP O
: : O O
Peak NNP B-NP B-test
bilirubin NN I-NP I-test
was VBD B-VP O
on IN B-VP O
day NN B-NP O
of IN B-VP O
life NN B-NP O
#2 NN I-NP O
of IN B-VP O
4.8/0.3 CD O O
. . B-VP O
   
Hematology NN B-NP O
: : O O
Hematocrit NN B-NP B-test
on IN B-VP O
admission NN B-NP O
was VBD B-VP O
41 CD O O
. . B-VP O
   
The DT B-NP B-person
infant NN I-NP I-person
did VBD B-VP O
not RB O O
require VB O O
any DT B-NP B-treatment
blood NN I-NP I-treatment
transfusions NNS I-NP I-treatment
during IN B-VP O
this DT B-NP B-pronoun
hospital JJ I-NP O
course NN I-NP O
. . B-VP O
   
Infectious JJ B-NP O
disease NN I-NP O
: : O O
CBC NNP B-NP B-test
and CC O O
blood NN B-NP B-test
culture NN I-NP I-test
were VBD B-VP O
obtained VBN O O
on IN B-VP O
admission NN B-NP O
. . B-VP O
   
White NNP B-NP B-test
count NN I-NP I-test
was VBD B-VP O
4.8 CD O O
, , O O
7 CD O B-test
polys NN B-NP I-test
, , O O
zero CD O B-test
bands NNS B-NP I-test
, , O O
platelet NN B-NP B-test
count NN I-NP I-test
of IN B-VP O
316,000 CD O O
. . B-VP O
   
ANC NNP B-NP B-test
at IN B-VP O
that DT B-NP B-pronoun
time NN I-NP O
was VBD B-VP O
336 CD O O
. . B-VP O
   
A DT O B-test
24 CD O I-test
hour NN B-NP I-test
CBC NNP I-NP I-test
was VBD B-VP O
obtained VBN O O
. . B-VP O
   
White NNP B-NP B-test
blood NN I-NP I-test
cell NN I-NP I-test
count NN I-NP I-test
was VBD B-VP O
5.1 CD O O
, , O O
22 CD O B-test
polys NN B-NP I-test
, , O O
zero CD O B-test
bands NNS B-NP I-test
with IN B-VP O
a DT B-NP B-test
hematocrit NN I-NP I-test
of IN B-VP O
39.3 CD O O
and CC O O
platelets NNS B-NP B-test
of IN B-VP O
313,000 CD O O
. . B-VP O
   
The DT B-NP B-person
infant NN I-NP I-person
received VBD B-VP O
48 CD O O
hours NNS B-NP O
of IN B-VP O
ampicillin NN B-NP B-treatment
and CC O O
gentamicin NN B-NP B-treatment
which WDT O B-pronoun
were VBD B-VP O
discontinued VBN O O
with IN B-VP O
a DT B-NP O
negative JJ I-NP O
blood NN I-NP O
culture NN I-NP O
. . B-VP O
   
Neurology NN B-NP O
: : O O
The DT B-NP B-person
infant NN I-NP I-person
has VBZ O O
been VBN O O
appropriate JJ O O
for IN B-VP O
gestational JJ B-NP O
age NN I-NP O
. . B-VP O
   
Sensory NN B-NP O
: : O O
Audiology NNP B-NP B-test
hearing VBG O I-test
screen NN B-NP I-test
was VBD B-VP O
performed VBN O O
with IN B-VP O
automated JJ B-NP B-test
auditory NN I-NP I-test
brainstem NN I-NP I-test
responses NNS I-NP I-test
and CC O O
the DT B-NP B-person
infant NN I-NP I-person
passed VBN O O
on IN B-VP O
both DT B-NP O
ears NNS I-NP O
. . B-VP O
   
CONDITION NNP B-NP O
ON NNP I-NP O
DISCHARGE NNP I-NP O
: : O O
Stable JJ O O
. . B-VP O
   
DISCHARGE JJ B-NP O
DISPOSITION NN I-NP O
: : O O
To TO O O
home NN B-NP O
. . B-VP O
   
PRIMARY NNP B-NP B-person
PEDIATRICIAN NNP I-NP I-person
: : O O
Dr. NNP B-NP B-person
Donald NNP I-NP I-person
Carrion NNP I-NP I-person
, , O O
telephone NN B-NP O
number NN I-NP O
( ( O O
861 CD O O
) ) O O
840 CD O O
7928 CD O O
. . B-VP O
   
CARE VB O O
RECOMMENDATIONS NNP B-NP O
: : O O
1. CD O O
Continue NNP B-NP O
breast VBD B-VP O
milk NN B-NP O
24 CD O O
calories NNS B-NP O
of IN B-VP O
Nutramigen NNP B-NP B-treatment
for IN B-VP O
concentration NN B-NP O
. . B-VP O
   
2. CD O O
Medications NNS B-NP B-treatment
: : O O
The DT B-NP B-person
infant NN I-NP I-person
is VBZ O O
receiving VBG O O
Fer-in-Phillip NNP B-NP B-treatment
supplementation NN I-NP I-treatment
of IN B-VP O
0.15 CD O O
ml NNS B-NP O
p.o. JJ O O
once RB O O
daily JJ O O
. . B-VP O
   
3. CD O O
Car NNP B-NP B-test
seat NN I-NP I-test
position NN I-NP I-test
screening NN I-NP I-test
was VBD B-VP O
performed VBN O O
for IN B-VP O
screening NN B-NP O
and CC O O
the DT B-NP B-person
infant NN I-NP I-person
passed VBD B-VP O
. . B-VP O
   
4. CD O O
State NNP B-NP B-test
newborn JJ B-NP I-test
screens NNS I-NP I-test
have VBP O O
been VBN O O
sent VBN O O
per IN B-VP O
protocol NN B-NP O
, , O O
most RBS O O
recently RB O O
on IN B-VP O
01-11 NN B-NP O
, , O O
and CC O O
have VBP O O
been VBN O O
within IN B-VP O
normal JJ B-NP O
limits NNS I-NP O
. . B-VP O
   
5. CD O O
Immunizations NNPS B-NP B-treatment
received VBD B-VP O
: : O O
Hepatitis NN B-NP B-treatment
B NNP I-NP I-treatment
vaccine NN I-NP I-treatment
on IN B-VP O
2020-01-19 JJ O O
. . B-VP O
   
6. CD O O
Immunizations NNS B-NP B-treatment
recommended VBD B-VP O
: : O O
Synagis NNP B-NP B-treatment
RSV NNP I-NP I-treatment
prophylaxis NN I-NP I-treatment
should MD O O
be VB O O
considered VBN O O
from IN B-VP O
November NNP B-NP O
through IN B-VP O
March NNP B-NP O
for IN B-VP O
infants NNS B-NP B-person
who WP O B-person
meet VBP O O
any DT O O
of IN B-VP O
the DT O O
following VBG O O
3 CD O O
criteria NNS B-NP O
: : O O
Born VBN O O
at IN B-VP O
less JJR O O
than IN B-VP O
32 CD O O
weeks NNS B-NP O
, , O O
born VBN O O
between IN B-VP O
32 CD O O
and CC O O
35 CD O O
weeks NNS B-NP O
with IN B-VP O
2 CD O O
of IN B-VP O
the DT B-NP O
following NN I-NP O
: : O O
Daycare NNP B-NP O
during IN B-VP O
RSV NNP B-NP O
season NN I-NP O
, , O O
a DT B-NP O
smoker NN I-NP O
in IN B-VP O
the DT B-NP O
household NN I-NP O
, , O O
neuromuscular JJ B-NP B-problem
disease NN I-NP I-problem
, , O O
airway JJ B-NP B-problem
abnormalities NNS I-NP I-problem
or CC O O
school NN B-NP O
age NN I-NP O
sibling NN I-NP O
, , O O
or CC O O
3 CD O O
with IN B-VP O
chronic JJ B-NP B-problem
lung NN I-NP I-problem
disease NN I-NP I-problem
. . B-VP O
   
Influenza NNP B-NP B-treatment
immunization NN I-NP I-treatment
is VBZ O O
recommended VBN O O
annually RB O O
in IN B-VP O
the DT B-NP O
fall NN I-NP O
for IN B-VP O
all DT B-NP O
infants NNS I-NP B-person
once IN B-VP O
they PRP O B-pronoun
reach VBP O O
6 CD O O
months NNS B-NP O
of IN B-VP O
age NN B-NP O
. . B-VP O
   
Before IN B-VP O
this DT B-NP B-pronoun
age NN I-NP O
and CC O O
for IN B-VP O
the DT O O
first JJ O O
24 CD O O
months NNS B-NP O
of IN B-VP O
the DT B-NP O
child NN I-NP O
's POS O O
life NN B-NP O
, , O O
immunization NN B-NP B-treatment
against IN B-VP O
influenza NN B-NP B-problem
is VBZ O O
recommended VBN O O
for IN B-VP O
household NN B-NP O
contacts NNS I-NP O
and CC O O
out IN B-VP O
of IN B-VP O
home NN B-NP O
caregivers NNS I-NP O
. . B-VP O
   
DISCHARGE NNP B-NP O
DIAGNOSES NNP I-NP O
: : O O
1. CD O O
Premature NNP B-NP B-problem
twin NN I-NP B-person
#1 NNP I-NP O
born NN I-NP O
at IN B-VP O
32 CD O O
and CC O O
5/7 CD O O
weeks NNS B-NP O
. . B-VP O
   
2. CD O O
Rule NN B-NP O
out IN B-VP O
sepsis NN B-NP B-problem
with IN B-VP O
antibiotics NNS B-NP B-treatment
. . B-VP O
   
3. CD O O
Respiratory NNP B-NP B-problem
distress NN I-NP I-problem
with IN B-VP O
left JJ B-NP B-problem
pneumothorax NN I-NP I-problem
resolved VBD B-VP O
. . B-VP O
   
4. CD O O
Mild NNP B-NP B-problem
hyperbilirubinemia NN I-NP I-problem
. . B-VP O
   
5. CD O O
Mild NNP B-NP B-problem
apnea NN I-NP I-problem
and CC O O
bradycardia NN B-NP B-problem
of IN B-VP I-problem
prematurity NN B-NP I-problem
resolved VBN O O
. . B-VP O
   
6. CD O O
Possible JJ B-NP O
milk NN I-NP B-problem
proteine NN I-NP I-problem
allergy NN I-NP I-problem
FOLLOW NNP I-NP O
UP NNP I-NP O
: : O O
Appointments NNS B-NP O
recommended VBD B-VP O
: : O O
A DT B-NP B-test
hip NN I-NP I-test
ultrasound NN I-NP I-test
due JJ O O
to TO O O
breech VB O B-problem
/ NNP B-NP O
breech JJ B-NP B-problem
presentation NN I-NP I-problem
of IN B-VP O
twins NNS B-NP B-person
. . B-VP O
   
Tai NNP B-NP B-person
Pamela NNP I-NP I-person
Christopher NNP I-NP I-person
, , O O
Oklahoma NNP B-NP O
05158 CD O O
Dictated VBN O O
By IN B-VP O
: : O O
John NNP B-NP B-person
T NNP I-NP I-person
Hall NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
MEDQUIST36 NNP I-NP O
D NNP I-NP O
: : O O
2020-01-19 JJ O O
02:52:47 CD O O
T NN B-NP O
: : O O
2020-01-19 JJ O O
09:12:10 CD O O
Job NNP B-NP O
#: VBD B-VP O
76780 CD O O
Signed VBN O O
electronically RB O O
by IN B-VP O
: : O O
DR. NNP B-NP B-person
Charles NNP I-NP I-person
TRAN NNP I-NP I-person
on IN B-VP O
: : O O
MON NNP B-NP O
2020-01-20 CD O O
8:22 CD O O
AM NNP B-NP O
( ( O O
End NNP B-NP O
of IN B-VP O
Report NNP B-NP O
) ) O O
-EMPTYLINE- VBP O O
-DOCSTART- JJ O O
-EMPTYLINE- $ O O
176318078_c CD O O
FIH NNP B-NP O
4189699 CD O O
78088/7792 CD O O
080216 CD O O
8/21/1993 CD O O
12:00:00 CD O O
AM NNP B-NP O
EPISTAXIS NNP I-NP B-problem
. . B-VP O
   
Unsigned VBD B-VP O
DIS NNP B-NP O
Report NNP I-NP O
Status NNP I-NP O
: : O O
Unsigned VBN O O
ADMISSION NNP B-NP O
DATE NNP I-NP O
: : O O
8/21/93 CD O O
DISCHARGE NNP B-NP O
DATE NNP I-NP O
: : O O
8/23/93 CD O O
PRINCIPAL NNP B-NP O
DIAGNOSIS NNP I-NP O
: : O O
Epistaxis NNP B-NP B-problem
. . B-VP O
   
ASSOCIATED NNP B-NP O
DIAGNOSIS NNP I-NP O
: : O O
Mitral JJ B-NP B-problem
stenosis NN I-NP I-problem
, , O O
tricuspid JJ B-NP B-problem
regurgitation NN I-NP I-problem
, , O O
heart NN B-NP B-problem
failure NN I-NP I-problem
, , O O
chronic JJ B-NP B-problem
atrial JJ I-NP I-problem
fibrillation NN I-NP I-problem
, , O O
chronic JJ B-NP B-problem
ventricular NN I-NP I-problem
ectopy NN I-NP I-problem
, , O O
chronic JJ B-NP B-problem
obstructive JJ I-NP I-problem
pulmonary JJ I-NP I-problem
disease NN I-NP I-problem
. . B-VP O
   
ADVERSE JJ B-NP O
DRUG NNP I-NP O
REACTIONS NNP I-NP O
: : O O
Epistaxis NN B-NP B-problem
on IN B-VP O
Coumadin NNP B-NP B-treatment
in IN B-VP O
the DT B-NP O
past NN I-NP O
. . B-VP O
   
PRINCIPAL JJ B-NP O
PROCEDURE NN I-NP O
: : O O
Partial JJ B-NP B-treatment
embolization NN I-NP I-treatment
of IN B-VP I-treatment
blood NN B-NP I-treatment
supply NN I-NP I-treatment
to TO O O
nose VB O O
, , O O
8/22 CD O O
. . B-VP O
   
HISTORY NN B-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS NNP I-NP O
: : O O
This DT O B-pronoun
This DT O B-person
68 CD O I-person
year NN B-NP I-person
old JJ B-NP I-person
female NN I-NP I-person
has VBZ O O
rheumatic JJ B-NP B-problem
heart NN I-NP I-problem
disease NN I-NP I-problem
. . B-VP O
   
Mitral NNP B-NP B-treatment
and CC O I-treatment
possibly RB O I-treatment
tricuspid JJ B-NP I-treatment
valve NN I-NP I-treatment
surgery NN I-NP I-treatment
is VBZ O O
scheduled VBN O O
for IN B-VP O
Labor NNP B-NP O
Day NNP I-NP O
by IN B-VP O
Dr. NNP B-NP B-person
Riemund NNP I-NP I-person
C. NNP I-NP I-person
Kennedy NNP I-NP I-person
. . B-VP O
   
Her PRP$ O B-person
history NN B-NP O
is VBZ O O
detailed VBN O O
in IN B-VP O
the DT B-NP O
discharge NN I-NP O
summary NN I-NP O
of IN B-VP O
August NNP B-NP O
10 CD O O
of IN B-VP O
this DT B-NP B-pronoun
year NN I-NP O
. . B-VP O
   
She PRP O B-person
is VBZ O O
admitted VBN O O
now RB O O
for IN B-VP O
a DT B-NP B-treatment
neuro-interventional JJ I-NP I-treatment
radiology NN I-NP I-treatment
procedure NN I-NP I-treatment
to TO O O
decrease VB O O
the DT B-NP O
likelihood NN I-NP O
of IN B-VP O
epistaxis NN B-NP B-problem
on IN B-VP O
Coumadin NNP B-NP B-treatment
. . B-VP O
   
PHYSICAL NNP B-NP O
EXAMINATION NN I-NP O
: : O O
Chest NNP B-NP O
was VBD B-VP O
clear JJ O O
. . B-VP O
   
Right NNP B-NP B-problem
neck NN I-NP I-problem
and CC O I-problem
right JJ B-NP I-problem
groin NN I-NP I-problem
catheterization NN I-NP I-problem
sites NNS I-NP I-problem
were VBD B-VP O
benign JJ O O
. . B-VP O
   
No DT B-NP O
edema NN I-NP B-problem
. . B-VP O
   
Examination NN B-NP B-test
was VBD B-VP O
otherwise RB O O
unchanged JJ O O
. . B-VP O
   
LABORATORY NNP B-NP O
DATA NNP I-NP O
: : O O
Hematocrit NNP B-NP B-test
was VBD B-VP O
42 CD O O
, , O O
PT NNP B-NP B-test
was VBD B-VP O
10 CD O O
, , O O
potassium NN B-NP B-test
was VBD B-VP O
3.6 CD O O
, , O O
BUN NNP B-NP B-test
was VBD B-VP O
29 CD O O
, , O O
creatinine NN B-NP B-test
was VBD B-VP O
1.4 CD O O
, , O O
blood NN B-NP B-test
sugar NN I-NP I-test
was VBD B-VP O
111 CD O O
. . B-VP O
   
EKG NN B-NP B-test
showed VBD B-VP O
atrial JJ B-NP B-problem
fibrillation NN I-NP I-problem
, , O O
moderate JJ B-NP B-problem
ventricular NN I-NP I-problem
response NN I-NP I-problem
, , O O
right JJ B-NP B-problem
ventricular NN I-NP I-problem
hypertrophy NN I-NP I-problem
, , O O
right JJ B-NP B-problem
axis NN I-NP I-problem
deviation NN I-NP I-problem
. . B-VP O
   
HOSPITAL NNP B-NP O
COURSE NNP I-NP O
: : O O
The DT B-NP B-treatment
interventional JJ I-NP I-treatment
neuro-radiology JJ I-NP I-treatment
procedure NN I-NP I-treatment
was VBD B-VP O
performed VBN O O
by IN B-VP O
Dr. NNP B-NP B-person
A NNP I-NP I-person
Skizeis NNP I-NP I-person
, , O O
on IN B-VP O
August NNP B-NP O
22 CD O O
, , O O
via IN B-VP O
the DT B-NP O
right JJ I-NP O
femoral JJ I-NP O
artery NN I-NP O
. . B-VP O
   
The DT B-NP O
right JJ I-NP O
internal JJ I-NP O
maxillary JJ I-NP O
artery NN I-NP O
supply NN I-NP O
to TO O O
the DT B-NP O
nasal NN I-NP O
mucosa NN I-NP O
was VBD B-VP O
embolized VBN O B-treatment
. . B-VP O
   
The DT B-NP O
left JJ I-NP O
external JJ I-NP O
carotid NN I-NP O
artery NN I-NP O
was VBD B-VP O
occluded VBN O B-problem
at IN B-VP O
its PRP$ O O
origin NN B-NP O
, , O O
with IN B-VP O
collaterals NNS B-NP O
from IN B-VP O
the DT B-NP O
internal JJ I-NP O
carotid NN I-NP O
artery NN I-NP O
. . B-VP O
   
Thus RB O O
, , O O
embolization NN B-NP B-treatment
on IN B-VP I-treatment
the DT B-NP I-treatment
left JJ I-NP I-treatment
side NN I-NP I-treatment
was VBD B-VP O
not RB O O
possible JJ O O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
received VBD B-VP O
Coumadin NNP B-NP B-treatment
, , O O
10 CD O O
mg. NN B-NP O
, , O O
on IN B-VP O
the DT B-NP O
evening NN I-NP O
following VBG O O
the DT B-NP O
procedure NN I-NP O
, , O O
and CC O O
is VBZ O O
discharged VBN O O
the DT B-NP O
next JJ I-NP O
day NN I-NP O
. . B-VP O
   
Her PRP$ O B-test
Her NNP B-NP B-person
prothrombin NN I-NP I-test
time NN I-NP I-test
will MD O O
be VB O O
rechecked VBN O O
on IN B-VP O
August NNP B-NP O
27 CD O O
by IN B-VP O
her PRP$ O B-person
her PRP$ O B-person
primary JJ B-NP I-person
care NN I-NP I-person
physician NN I-NP I-person
, , O O
Dr. NNP B-NP B-person
Naka NNP I-NP I-person
Gift NNP I-NP I-person
. . B-VP O
   
Once RB O O
her PRP$ O B-person
her PRP$ O B-test
prothrombin NN B-NP I-test
time NN I-NP I-test
is VBZ O O
in IN B-VP O
therapeutic JJ B-NP O
range NN I-NP O
, , O O
she PRP O B-person
will MD O O
be VB O O
observed VBN O O
for IN B-VP O
epistaxis NN B-NP B-problem
. . B-VP O
   
She PRP O B-person
will MD O O
take VB O O
her PRP$ O B-person
last JJ B-NP O
dose NN I-NP O
of IN B-VP O
Coumadin NNP B-NP B-treatment
on IN B-VP O
September NNP B-NP O
1 CD O O
in IN B-VP O
anticipation NN B-NP O
of IN B-VP O
cardiac JJ B-NP B-treatment
surgery NN I-NP I-treatment
. . B-VP O
   
If IN B-VP O
her PRP$ O B-person
her PRP$ O B-test
prothrombin JJ B-NP I-test
time NN I-NP I-test
does VBZ O O
not RB O O
come VBN O O
into IN B-VP O
therapeutic JJ B-NP O
range NN I-NP O
promptly RB O O
, , O O
then RB O O
surgery NN B-NP B-treatment
may MD O O
be VB O O
delayed VBN O O
. . B-VP O
   
DISCHARGE JJ B-NP O
REGIMEN NNP I-NP O
: : O O
Coumadin NNP B-NP B-treatment
, , O O
5 CD O O
mg. NN B-NP O
, , O O
alternating VBG O O
with IN B-VP O
2.5 CD O O
mg. NNS B-NP O
, , O O
qD NN B-NP O
, , O O
digoxin NN B-NP B-treatment
, , O O
0.125 CD O O
mg. NN B-NP O
, , O O
qD NN B-NP O
, , O O
Lasix NNP B-NP B-treatment
, , O O
80 CD O O
mg. NN B-NP O
, , O O
qAM NN B-NP O
and CC O O
40 CD O O
mg. NN B-NP O
, , O O
qPM NN B-NP O
, , O O
Vanceril NNP B-NP B-treatment
, , O O
3 CD O O
puffs NNS B-NP O
, , O O
b.i.d. NN B-NP O
CA NNP I-NP B-person
N. NNP I-NP I-person
SHUFF NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
TR NNP I-NP O
: : O O
yqv NN B-NP O
/ NNP I-NP O
bmot NN I-NP O
DD NNP I-NP O
: : O O
8/23/93 CD O O
TD NN B-NP O
: : O O
08/23/93 CD O O
CC NN B-NP O
: : O O
A DT B-NP O
copy NN I-NP O
to TO O O
Dr. NNP B-NP B-person
Ca NNP I-NP I-person
Shuff NNP I-NP I-person
at IN B-VP O
Valtawnprinceel NNP B-NP O
Community NNP I-NP O
Memorial NNP I-NP O
Hospital NNP I-NP O
, , O O
a DT B-NP O
copy NN I-NP O
to TO O O
Dr. NNP B-NP B-person
A NNP I-NP I-person
Skizeis NNP I-NP I-person
, , O O
a DT B-NP O
copy NN I-NP O
to TO O O
Dr. NNP B-NP B-person
Riemund NNP I-NP I-person
C. NNP I-NP I-person
Kennedy NNP I-NP I-person
, , O O
and CC O O
three CD O O
copies NNS B-NP O
to TO O O
Dr. NNP B-NP B-person
Shuff NNP I-NP I-person
&apos;s NNP I-NP O
office NN I-NP O
. . B-VP O
   
-EMPTYLINE- CC O O
-DOCSTART- JJ B-NP O
-EMPTYLINE- JJ I-NP O
Admission NN I-NP O
Date NNP I-NP O
: : O O
2014-01-26 JJ B-NP O
Discharge NN I-NP O
Date NNP I-NP O
: : O O
2014-02-09 JJ B-NP O
Date NNP I-NP O
of IN B-VP O
Birth NNP B-NP O
: : O O
1937-06-05 JJ B-NP O
Sex NN I-NP O
: : O O
F NNP B-NP O
Service NNP I-NP O
: : O O
NSU NNP B-NP O
ADDENDUM NNP I-NP O
: : O O
Addendum NN B-NP O
from IN B-VP O
the DT B-NP O
dates NNS I-NP O
of IN B-VP O
2014-02-04 JJ O O
until IN B-VP O
2014-02-09 JJ O O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
had VBD B-VP O
no DT B-NP O
complications NNS I-NP B-problem
or CC O O
further JJ B-NP B-problem
events NNS I-NP I-problem
while IN B-VP O
in IN B-VP O
house NN B-NP O
. . B-VP O
   
On IN B-VP O
Thursday NNP B-NP O
- : O O
2014-02-06 JJ O O
- : O O
the DT B-NP B-person
patient NN I-NP I-person
did VBD B-VP O
have VB O O
two CD O O
episodes NNS B-NP O
of IN B-VP O
chest JJS B-NP B-problem
discomfort NN I-NP I-problem
; : O O
for IN B-VP O
which WDT O B-pronoun
he PRP O B-person
was VBD B-VP O
given VBN O O
nitroglycerin JJ O B-treatment
and CC O O
those DT O B-pronoun
resolved VBN O O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
did VBD B-VP O
have VB O O
an DT B-NP O
evaluation NN I-NP O
of IN B-VP O
electrocardiogram NN B-NP B-test
done VBN O O
by IN B-VP O
Cardiology NNP B-NP B-person
which WDT O B-pronoun
was VBD B-VP O
negative JJ O O
and CC O O
had VBD B-VP O
laboratory NN B-NP B-test
results NNS I-NP I-test
for IN B-VP O
rule NN B-NP O
out IN B-VP O
myocardial JJ B-NP B-problem
infarction NN I-NP I-problem
which WDT O B-pronoun
were VBD B-VP O
also RB O O
negative JJ O O
. . B-VP O
   
Cardiology NNP B-NP B-person
was VBD B-VP O
aware JJ O O
of IN B-VP O
the DT B-NP B-person
patient NN I-NP I-person
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
had VBD B-VP O
no DT B-NP O
further JJ I-NP O
episodes NNS I-NP O
of IN B-VP O
chest NN B-NP B-problem
discomfort NN I-NP I-problem
and CC O O
remained VBD B-VP O
afebrile RB O B-problem
while IN B-VP O
in IN B-VP O
house NN B-NP O
. . B-VP O
   
Per NNP B-NP O
Infectious NNP I-NP B-person
Disease NNP I-NP I-person
, , O O
okay NN B-NP O
for IN B-VP O
the DT B-NP B-person
patient NN I-NP I-person
to TO O O
be VB O O
discharged VBN O O
in IN B-VP O
stable JJ B-NP O
condition NN I-NP O
to TO O O
Waltham/Weston NNP B-NP O
Hospital NNP I-NP O
facility NN I-NP O
. . B-VP O
   
Penny NNP B-NP O
Clayton NNP I-NP O
, , O O
Texas NNP B-NP O
87120 CD O O
Dictated VBN O O
By IN B-VP O
: : O O
Eugene NNP B-NP B-person
F NNP I-NP I-person
Balboa NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
MEDQUIST36 NNP I-NP O
D NNP I-NP O
: : O O
2014-02-09 JJ O O
11:17:25 CD O O
T NN B-NP O
: : O O
2014-02-09 JJ O O
17:20:17 CD O O
Job NNP B-NP O
#: VBD B-VP O
66630 CD O O
Signed VBN O O
electronically RB O O
by IN B-VP O
: : O O
DR. NNP B-NP B-person
Elizabeth NNP I-NP I-person
Fernandez NNP I-NP I-person
on IN B-VP O
: : O O
MON NNP B-NP O
2014-02-10 CD O O
4:27 CD O O
PM NNP B-NP O
( ( O O
End NNP B-NP O
of IN B-VP O
Report NNP B-NP O
) ) O O
-EMPTYLINE- VBP O O
-DOCSTART- JJ O O
-EMPTYLINE- $ O O
487110437 CD O O
TGCHO NNP B-NP O
1128447 CD O O
662727 CD O O
10/15/1999 CD O O
12:00:00 CD O O
AM NNP B-NP O
Discharge NNP I-NP O
Summary NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Report NNP I-NP O
Status NNP I-NP O
: : O O
Signed VBD B-VP O
DISCHARGE NNP B-NP O
SUMMARY NNP I-NP O
NAME NN I-NP O
: : O O
FACTOR NN B-NP B-person
, , O I-person
REBEM NNP B-NP I-person
UNIT NNP I-NP O
NUMBER NNP I-NP O
: : O O
333-33-75 JJ B-NP O
ADMISSION NNP I-NP O
DATE NNP I-NP O
: : O O
10/15/1999 CD O O
DISCHARGE NNP B-NP O
DATE NNP I-NP O
: : O O
10/18/1999 CD O O
PRINCIPAL NNP B-NP O
DIAGNOSIS NNP I-NP O
: : O O
Acute NNP B-NP B-problem
inferior JJ B-NP I-problem
myocardial JJ I-NP I-problem
infarction NN I-NP I-problem
. . B-VP O
   
ASSOCIATED CC O O
DIAGNOSIS NNP B-NP O
: : O O
Hypertension NN B-NP B-problem
. . B-VP O
   
Gout NNP B-NP B-problem
. . B-VP O
   
SPECIAL NNP B-NP O
PROCEDURES NNP I-NP O
AND NNP I-NP O
OPERATIONS NNP I-NP O
: : O O
Stent JJ B-NP B-treatment
placement NN I-NP I-treatment
of IN B-VP I-treatment
the DT B-NP I-treatment
RCA NNP I-NP I-treatment
on IN B-VP O
October NNP B-NP O
15 CD O O
, , O O
1999 CD O O
. . B-VP O
   
OTHER CC O O
PROCEDURES NNP B-NP O
: : O O
Right JJ B-NP B-test
heart NN I-NP I-test
catheterization NN I-NP I-test
and CC O O
coronary JJ B-NP B-test
angiography NN I-NP I-test
on IN B-VP O
October NNP B-NP O
15 CD O O
, , O O
1999 CD O O
. . B-VP O
   
DOCTOR NNP B-NP B-person
&apos; NNP I-NP O
S NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
: : O O
Aspirin $ O B-treatment
325 CD O O
mg. NN B-NP O
qday NN I-NP O
. . B-VP O
   
Plavix CC O B-treatment
75 CD O O
mg. NN B-NP O
qday NN I-NP O
for IN B-VP O
four CD O O
weeks NNS B-NP O
. . B-VP O
   
Atenolol $ O B-treatment
50 CD O O
mg. NN B-NP O
qday NN I-NP O
. . B-VP O
   
HISTORY NNP B-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS NNP I-NP O
: : O O
Mr. NNP B-NP B-person
Factor NNP I-NP I-person
is VBZ O O
a DT O O
76 CD O O
year NN B-NP O
old JJ B-NP O
white JJ I-NP O
male NN I-NP O
with IN B-VP O
acute JJ B-NP B-problem
inferior JJ I-NP I-problem
myocardial JJ I-NP I-problem
infarction NN I-NP I-problem
, , O O
who WP O B-person
was VBD B-VP O
urgently RB O O
transferred VBN O O
by IN B-VP O
Dr. NNP B-NP B-person
Lenni NNP I-NP I-person
Factor NNP I-NP I-person
for IN B-VP O
cardiac JJ B-NP B-test
catheterization NN I-NP I-test
and CC O O
possible JJ B-NP O
angioplasty NN I-NP B-treatment
. . B-VP O
   
His PRP$ O B-person
only JJ B-NP O
cardiac JJ I-NP O
risk NN I-NP O
factor NN I-NP O
includes VBZ O O
hypertension NN B-NP B-problem
. . B-VP O
   
The DT B-NP O
night NN I-NP O
of IN B-VP O
Oct NNP B-NP O
14 CD O O
, , O O
1999 CD O O
the DT B-NP B-person
patient NN I-NP I-person
developed VBD B-VP O
chest JJS B-NP B-problem
discomfort NN I-NP I-problem
associated VBN O O
with IN B-VP O
shortness NN B-NP B-problem
of IN B-VP I-problem
breath NN B-NP I-problem
. . B-VP O
   
On IN B-VP O
October NNP B-NP O
15 CD O O
, , O O
1999 CD O O
at IN B-VP O
6 CD O O
AM VBP O O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
admitted VBN O O
to TO O O
No DT B-NP O
Verlmerver NNP I-NP O
Medical NNP I-NP O
Center NNP I-NP O
. . B-VP O
   
An DT B-NP B-test
electrocardiogram NN I-NP I-test
showed VBD B-VP O
acute JJ B-NP B-problem
inferior JJ I-NP I-problem
myocardial JJ I-NP I-problem
infarction NN I-NP I-problem
. . B-VP O
   
Due NNP B-NP O
to TO O O
unknown JJ B-NP O
duration NN I-NP O
of IN B-VP O
the DT B-NP B-problem
chest JJS I-NP I-problem
pain NN I-NP I-problem
the DT B-NP B-person
patient NN I-NP I-person
wastransferred VBD B-VP O
urgently RB O O
to TO O O
the DT B-NP O
TGCHO NNP I-NP O
for IN B-VP O
cardiac JJ B-NP B-test
catheterization NN I-NP I-test
. . B-VP O
   
Shortly RB O O
after IN B-VP O
Aggrastat NNP B-NP B-treatment
was VBD B-VP O
started VBN O O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
became VBD B-VP O
pain JJ O B-problem
free JJ O O
. . B-VP O
   
PAST NNP B-NP O
MEDICAL NNP I-NP O
HISTORY NNP I-NP O
: : O O
Hypertension NN B-NP B-problem
and CC O O
gout NN B-NP B-problem
. . B-VP O
   
PHYSICAL JJ B-NP O
EXAMINATION NN I-NP O
: : O O
Blood NNP B-NP B-test
pressure NN I-NP I-test
115/77 CD O O
. . B-VP O
   
The DT B-NP B-test
heart NN I-NP I-test
rate NN I-NP I-test
64 CD O O
. . B-VP O
   
JVP VB O B-test
6 CD O O
cm NN B-NP O
. . B-VP O
   
H20 NNP B-NP O
. . B-VP O
   
Carotid NNP B-NP B-test
upstroke VBD B-VP I-test
was VBD B-VP O
normal JJ O O
. . B-VP O
   
There EX O O
was VBD B-VP O
an DT B-NP B-problem
S4 NNP I-NP I-problem
. . B-VP O
   
The DT B-NP O
lungs NNS I-NP O
were VBD B-VP O
clear JJ O O
. . B-VP O
   
Abdomen NNP B-NP O
was VBD B-VP O
benign JJ O O
. . B-VP O
   
Femoral NNP B-NP B-test
and CC O I-test
distal JJ B-NP I-test
pulses NNS I-NP I-test
were VBD B-VP O
full JJ O O
. . B-VP O
   
There EX O O
was VBD B-VP O
no DT B-NP O
pedaledema NN I-NP B-problem
. . B-VP O
   
The DT B-NP B-test
neurological JJ I-NP I-test
examination NN I-NP I-test
was VBD B-VP O
nonfocal JJ O O
. . B-VP O
   
The DT B-NP B-test
electrocardiogram NN I-NP I-test
normal JJ B-NP O
sinus NN I-NP O
rhythm NN I-NP O
at IN B-VP O
62 CD O O
beats NNS B-NP O
per IN B-VP O
minute NN B-NP O
, , O O
small JJ B-NP B-problem
Qwaves NNS I-NP I-problem
in IN B-VP I-problem
3 CD O I-problem
and CC O I-problem
F NNP B-NP I-problem
, , O O
ST NNP B-NP B-problem
elevation NN I-NP I-problem
in IN B-VP I-problem
2 CD O I-problem
, , O I-problem
3 CD O I-problem
, , O I-problem
and CC O I-problem
F. NNP B-NP I-problem
ST NNP I-NP B-problem
Depression NNP I-NP I-problem
in IN B-VP I-problem
1 CD O I-problem
, , O I-problem
L NNP B-NP I-problem
and CC O I-problem
V2 NNP B-NP I-problem
and CC O I-problem
3 CD O I-problem
. . B-VP O
   
LABORATORY NNP B-NP O
DATA NNP I-NP O
: : O O
Peak NNP B-NP B-test
CPK NNP I-NP I-test
1117 CD O O
. . B-VP O
   
Total JJ B-NP B-test
cholesterol NN I-NP I-test
142 CD O O
. . B-VP O
   
LDL VB O B-test
56 CD O O
. . B-VP O
   
HDL $ O B-test
30 CD O O
. . B-VP O
   
Triglycerides NNS B-NP B-test
281 CD O O
. . B-VP O
   
HOSPITAL NNP B-NP O
COURSE NNP I-NP O
AND NNP I-NP O
TREATMENT NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
directly RB O O
admitted VBN O O
to TO O O
the DT B-NP O
cardiac JJ I-NP O
catheterization NN I-NP O
laboratory NN I-NP O
. . B-VP O
   
Coronary NNP B-NP B-test
angiography NN I-NP I-test
, , O O
right JJ B-NP B-test
heart NN I-NP I-test
catheterization NN I-NP I-test
and CC O O
percutaneous JJ B-NP B-treatment
intervention NN I-NP I-treatment
of IN B-VP I-treatment
the DT B-NP I-treatment
RCA NNP I-NP I-treatment
were VBD B-VP O
performed VBN O O
from IN B-VP O
the DT B-NP O
right JJ I-NP O
groin NN I-NP O
without IN B-VP O
complications NNS B-NP B-problem
. . B-VP O
   
The DT B-NP O
proximal JJ I-NP O
RCA NNP I-NP O
was VBD B-VP O
totally RB O B-problem
occluded VBN O I-problem
with IN B-VP O
good JJ B-NP O
left NN I-NP O
to TO O O
right JJ B-NP O
collaterals NNS I-NP O
. . B-VP O
   
The DT B-NP O
LAD NNP I-NP O
showed VBD B-VP O
a DT O B-problem
40% CD O I-problem
stenosis NN B-NP I-problem
in IN B-VP I-problem
the DT B-NP I-problem
proximal JJ I-NP I-problem
segment NN I-NP I-problem
. . B-VP O
   
The DT B-NP O
circumflex NN I-NP O
showed VBD B-VP O
mild JJ O B-problem
atherosclerotic JJ O I-problem
. . B-VP O
   
The DT B-NP B-problem
RCA NNP I-NP I-problem
occlusion NN I-NP I-problem
was VBD B-VP O
successfully RB O O
dilated VBN O O
and CC O O
sent VBN O O
using VBG O O
a DT O B-treatment
3.0 CD O I-treatment
X NN B-NP I-treatment
23 CD O I-treatment
mm NN B-NP I-treatment
Duet NNP I-NP I-treatment
with IN B-VP O
post NN B-NP B-treatment
stent NN I-NP I-treatment
dilatation NN I-NP I-treatment
up RB O O
to TO O O
16 CD O O
atmospheres NNS B-NP O
. . B-VP O
   
Following VBG O O
intervention NN B-NP B-treatment
right JJ B-NP B-test
heart NN I-NP I-test
catheterization NN I-NP I-test
was VBD B-VP O
performed VBN O O
to TO O O
rule VB O O
out RP O O
RV NNP B-NP B-problem
infarct NN I-NP I-problem
. . B-VP O
   
The DT B-NP B-test
RA NNP I-NP I-test
was VBD B-VP O
5 CD O O
. . B-VP O
   
PA NNP B-NP B-test
was VBD B-VP O
19/7 CD O O
with IN B-VP O
a DT B-NP B-test
mean NN I-NP I-test
of IN B-VP O
13 CD O O
. . B-VP O
   
PCW NNP B-NP B-test
was VBD B-VP O
11 CD O O
. . B-VP O
   
Of IN B-VP O
note NN B-NP O
there EX O O
was VBD B-VP O
a DT B-NP B-problem
clear JJ I-NP I-problem
A NNP I-NP I-problem
wave NN I-NP I-problem
in IN B-VP O
the DT B-NP B-test
RV NNP I-NP I-test
tracing NN I-NP I-test
, , O O
suggestive NN B-NP O
of IN B-VP O
RV NNP B-NP B-problem
infarct NN I-NP I-problem
. . B-VP O
   
The DT B-NP O
next JJ I-NP O
day NN I-NP O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
quite RB O B-problem
confused JJ O I-problem
and CC O O
disoriented VBN O B-problem
, , O O
which WDT O B-pronoun
gradually RB O O
disappeared VBD B-VP O
. . B-VP O
   
An DT B-NP B-test
echocardiogram NN I-NP I-test
was VBD B-VP O
performed VBN O O
to TO O O
evaluate VB O O
the DT B-NP B-test
LV NNP I-NP I-test
function NN I-NP I-test
, , O O
which WDT O B-pronoun
showed VBD B-VP O
an DT B-NP B-test
ejection NN I-NP I-test
fraction NN I-NP I-test
of IN B-VP O
53% CD O O
with IN B-VP O
inferoposteriorakinesis NN B-NP B-problem
/ JJ B-NP O
hypokinesis NN I-NP B-problem
. . B-VP O
   
The DT B-NP O
next JJ I-NP O
day NN I-NP O
the DT B-NP B-person
patient NN I-NP I-person
&apos;s NNP I-NP O
mental JJ B-NP O
status NN I-NP O
came VBD B-VP O
back RB O O
to TO O O
baseline NN B-NP O
and CC O O
he PRP O B-person
remained VBD B-VP O
free JJ O O
of IN B-VP O
angina NN B-NP B-problem
. . B-VP O
   
ASHEE NNP B-NP B-person
SHOULTSNER NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
Electronically NNP I-NP O
Signed VBD B-VP O
ASHEE NNP B-NP B-person
SHOULTSNER NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
11/07/1999 CD O O
11:06 CD O O
TR NN B-NP O
: : O O
ghu NN B-NP O
DD NNP I-NP O
: : O O
10/18/1999 CD O O
TD NN B-NP O
: : O O
10/18/1999 CD O O
10:59 CD O O
Acc NN B-NP O
: : O O
ASHEE NNP B-NP B-person
SHOULTSNER NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
Dr. NNP I-NP B-person
Lenni NNP I-NP I-person
Factor NNP I-NP I-person
No NNP I-NP O
Verlmerver NNP I-NP O
Medical NNP I-NP O
Center NNP I-NP O
Dr. NNP I-NP B-person
Tomedankell NNP I-NP I-person
Flowayles NNP I-NP I-person
No NNP I-NP O
Verlmerver NNP I-NP O
Medical NNP I-NP O
Center NNP I-NP O
STAT NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
Admission NNP I-NP O
Date NNP I-NP O
: : O O
2019-07-17 JJ B-NP O
Discharge NN I-NP O
Date NNP I-NP O
: : O O
2019-07-27 JJ B-NP O
Date NNP I-NP O
of IN B-VP O
Birth NNP B-NP O
: : O O
1980-01-29 JJ B-NP O
Sex NN I-NP O
: : O O
F NNP B-NP O
Service NNP I-NP O
: : O O
MEDICINE JJ B-NP O
Allergies NNS I-NP O
: : O O
Cephalosporins NNS B-NP B-treatment
/ VBP O O
Dilaudid NNP B-NP B-treatment
/ NNP I-NP O
Metoclopramide NNP I-NP B-treatment
Attending NNP I-NP B-person
: : O O
Bradley NNP B-NP B-person
A. NN I-NP I-person
Goldware NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
Chief NNP I-NP O
Complaint NNP I-NP O
: : O O
respiratory NN B-NP B-problem
failure NN I-NP I-problem
Major NNP I-NP O
Surgical NNP I-NP O
or CC O O
Invasive JJ B-NP O
Procedure NN I-NP O
: : O O
Intubation NNP B-NP B-treatment
Central NNP I-NP B-treatment
line NN I-NP I-treatment
placement NN I-NP I-treatment
Bronchoscopy NNP I-NP B-test
History NNP I-NP O
of IN B-VP O
Present NNP B-NP O
Illness NNP I-NP O
: : O O
This DT O B-pronoun
is VBZ O O
a DT O O
39 CD O O
year-old JJ B-NP O
female NN I-NP O
with IN B-VP O
a DT B-NP O
history NN I-NP O
of IN B-VP O
diabetes NNS B-NP B-problem
type VBP O I-problem
I PRP O I-problem
on IN B-VP O
an DT B-NP B-treatment
insulin NN I-NP I-treatment
pump NN I-NP I-treatment
, , O O
anemia NN B-NP B-problem
, , O O
hypothyroidism NN B-NP B-problem
, , O O
gastroparesis NN B-NP B-problem
, , O O
GERD NNP B-NP B-problem
, , O O
who WP O B-person
was VBD B-VP O
transferred VBN O O
from IN B-VP O
Mediplex NNP B-NP O
Rehab NNP I-NP O
Hospital NNP I-NP O
Hospital NNP I-NP O
for IN B-VP O
further JJ B-NP B-treatment
management NN I-NP I-treatment
of IN B-VP O
hypoxic NN B-NP B-problem
respiratory NN I-NP I-problem
failure NN I-NP I-problem
. . B-VP O
   
She PRP O B-person
arrived VBD B-VP O
at IN B-VP O
Mediplex NNP B-NP O
Rehab NNP I-NP O
Hospital NNP I-NP O
Hospital NNP I-NP O
on IN B-VP O
07-01 NNP B-NP O
for IN B-VP O
1 CD O O
day NN B-NP O
of IN B-VP O
nausea NN B-NP B-problem
and CC O O
vomiting NN B-NP B-problem
and CC O O
was VBD B-VP O
found VBN O O
to TO O O
be VB O O
febrile JJ O B-problem
to TO O O
99 CD O O
at IN B-VP O
that DT B-NP B-pronoun
time NN I-NP O
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
admitted VBN O O
for IN B-VP O
likely JJ B-NP O
gastroparesis NN I-NP B-problem
and CC O O
eventually RB O O
had VBD B-VP O
a DT B-NP B-test
complete JJ I-NP I-test
fever NN I-NP I-test
work-up NN I-NP I-test
that WDT O B-pronoun
included VBD B-VP O
a DT B-NP O
negative JJ I-NP O
chest NN I-NP O
x-ray NN I-NP O
, , O O
blood NN B-NP O
cultures NNS I-NP O
, , O O
and CC O O
urine JJ B-NP O
culture NN I-NP O
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
discharged VBN O O
on IN B-VP O
07-02 NN B-NP O
and CC O O
represented VBD B-VP O
that DT B-NP B-pronoun
day NN I-NP O
with IN B-VP O
continued JJ B-NP B-problem
nause NN I-NP I-problem
, , O O
vomiting VBG O B-problem
, , O O
and CC O O
fever NN B-NP B-problem
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
readmitted VBN O O
and CC O O
had VBD B-VP O
a DT B-NP B-test
complete JJ I-NP I-test
febrile NN I-NP I-test
work-up NN I-NP I-test
that WDT O B-pronoun
included VBD B-VP O
CT NNP B-NP B-test
abdomene NN I-NP I-test
/ NNP I-NP I-test
pelvis NN I-NP I-test
, , O O
chest JJ B-NP B-test
x-ray NN I-NP I-test
, , O O
blood NN B-NP B-test
culture NN I-NP I-test
's POS O O
, , O O
urine JJ B-NP B-test
cultures NNS I-NP I-test
, , O O
all DT O O
of IN B-VP O
which WDT O B-pronoun
were VBD B-VP O
unremarkable JJ O O
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
intubated VBN O O
on IN B-VP O
07-03 NN B-NP O
for IN B-VP O
progressive JJ B-NP B-problem
respiratory NN I-NP I-problem
failure NN I-NP I-problem
. . B-VP O
   
Workup NNP B-NP B-test
continued VBD B-VP O
to TO O O
be VB O O
negative JJ O O
. . B-VP O
   
Extubation NN B-NP B-treatment
was VBD B-VP O
attempted VBN O O
on IN B-VP O
07-14 NN B-NP O
, , O O
but CC O O
she PRP O B-person
was VBD B-VP O
re-intubated JJ O O
due JJ O O
to TO O O
inspiratory JJ B-NP B-problem
stridor NN I-NP I-problem
. . B-VP O
   
A DT B-NP B-test
CT NNP I-NP I-test
neck NN I-NP I-test
showed VBD B-VP O
soft JJ B-NP B-problem
tissue NN I-NP I-problem
swelling VBG O I-problem
obliterating VBG O O
the DT B-NP O
airway NN I-NP O
surrounding VBG O O
the DT B-NP B-treatment
ETT NNP I-NP I-treatment
tube NN I-NP I-treatment
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
transferred VBN O O
to TO O O
Providence NNP B-NP O
Behavioral NNP I-NP O
Health NNP I-NP O
Hospital NNP I-NP O
for IN B-VP O
further JJ B-NP O
management NN I-NP O
. . B-VP O
   
Past NNP B-NP O
Medical JJ B-NP O
History NN I-NP O
: : O O
1. CD O O
Type NN B-NP B-problem
I PRP O I-problem
diabetes VBZ O I-problem
diagnosed VBN O O
at IN B-VP O
age NN B-NP O
27 CD O O
. . B-VP O
   
She PRP O B-person
is VBZ O O
usually RB O O
managed VBN O O
on IN B-VP O
an DT B-NP B-treatment
insulin NN I-NP I-treatment
pump NN I-NP I-treatment
. . B-VP O
   
2. CD O O
Hashimoto NNP B-NP B-problem
's POS O I-problem
thyroiditis NN B-NP I-problem
. . B-VP O
   
3. CD O O
Gastroparesis NN B-NP B-problem
4. CD O O
History NNP B-NP O
of IN B-VP O
bulemia NN B-NP B-problem
5. CD O O
Anxiety NN B-NP B-problem
on IN B-VP O
clonazepam JJ O B-treatment
6. CD O O
History NN B-NP O
of IN B-VP O
diabetic JJ B-NP B-problem
foot NN I-NP I-problem
ulcer NN I-NP I-problem
. . B-VP O
   
Social JJ B-NP O
History NN I-NP O
: : O O
She PRP O B-person
is VBZ O O
married JJ O O
and CC O O
lives VBZ O O
with IN B-VP O
her PRP$ O B-person
her PRP$ O B-person
husband NN B-NP I-person
. . B-VP O
   
She PRP O B-person
has VBZ O O
a DT O O
10 CD O B-person
month NN B-NP I-person
old JJ B-NP I-person
child NN I-NP I-person
. . B-VP O
   
She PRP O B-person
denies VBZ O O
any DT B-NP O
alcohol NN I-NP O
, , O O
tobacco NN B-NP O
, , O O
or CC O O
other JJ B-NP O
drugs NNS I-NP O
. . B-VP O
   
Family RB O O
History JJ O O
: : O O
Non-contributory JJ O O
. . B-VP O
   
Physical JJ B-NP O
Exam NN I-NP O
: : O O
Vitals NNS B-NP B-test
: : O O
Temperature NN B-NP B-test
: : O O
98.8 CD O O
Pulse NN B-NP B-test
: : O O
79 CD O O
Blood NNP B-NP B-test
Pressure NN I-NP I-test
: : O O
125/89 CD O O
Respiratory JJ B-NP B-test
Rate NNP I-NP I-test
: : O O
12 CD O O
Oxygen NNP B-NP B-test
Saturation NN I-NP I-test
: : O O
100% CD O O
on IN B-VP O
AC NNP B-NP B-treatment
500x12 CD O O
, , O O
PEEP5 NNP B-NP B-treatment
, , O O
50% CD O O
GENERAL NNP B-NP O
: : O O
Intubated VBN O B-treatment
, , O O
sedated VBN O B-treatment
, , O O
not RB O B-problem
responsive JJ O I-problem
to TO O O
command VB O B-test
, , O O
retracts NNS B-NP O
to TO O O
pain VB O B-test
HEENT NNP B-NP O
: : O O
Anicteric NNP B-NP B-problem
sclera NN I-NP I-problem
bilat NN I-NP I-problem
. . B-VP O
   
Pupils NNP B-NP B-problem
minimally RB O I-problem
reactive JJ B-NP I-problem
NECK NN I-NP O
: : O O
No DT B-NP O
elevated JJ I-NP B-problem
JVP NNP I-NP I-problem
appreciated VBD B-VP O
. . B-VP O
   
CARDIAC NN B-NP O
: : O O
Regular JJ O O
, , O O
s1,s2 NN B-NP O
. . B-VP O
   
No DT B-NP O
murmurs JJ I-NP B-problem
RESPIRATORY NN I-NP O
: : O O
Clear JJ O O
to TO O O
auscultation VB O B-test
anteriorly RB O O
. . B-VP O
   
ABDOMEN NNP B-NP O
: : O O
Soft NNP B-NP O
. . B-VP O
   
Nondistended NNP B-NP B-problem
. . B-VP O
   
No DT O O
hepatosplenomegally RB O B-problem
. . B-VP O
   
Mildly RB O B-problem
hypoactive JJ B-NP I-problem
bowelsounds NNS I-NP I-problem
. . B-VP O
   
EXTREMITIES NNS B-NP O
: : O O
No DT B-NP O
edema NN I-NP B-problem
bilaterally RB O I-problem
. . B-VP O
   
Pulses NNS B-NP B-problem
diminished VBD B-VP I-problem
but CC O O
symmetric JJ O O
. . B-VP O
   
NEURO NN B-NP O
: : O O
Sedated VBN O B-treatment
. . B-VP O
   
Retracts NNS B-NP O
to TO O O
painful VB O B-test
stimuli JJ B-NP I-test
SKIN NNP I-NP O
: : O O
No DT B-NP O
rashes NNS I-NP B-problem
Pertinent VBD B-VP O
Results NNS B-NP O
: : O O
Hematology NN B-NP O
: : O O
WBC NNP B-NP B-test
- : O O
29.9 CD O O
HGB NNP B-NP B-test
- : O O
8.5 CD O O
HCT NNP B-NP B-test
- : O O
26.8 CD O O
PLT NNP B-NP B-test
COUNT NNP I-NP I-test
- : O O
323 CD O O
NEUTS NNP B-NP B-test
- : O O
75 CD O O
BANDS NNP B-NP B-test
- : O O
13 CD O O
LYMPHS NNP B-NP B-test
- : O O
6 CD O O
MONOS NNP B-NP B-test
- : O O
5 CD O O
EOS NNP B-NP B-test
- : O O
1 CD O O
BASOS NNP B-NP B-test
- : O O
0 CD O O
ATYPS NNP B-NP B-test
- : O O
0 CD O O
METAS NNP B-NP B-test
- : O O
0 CD O O
MYELOS NNP B-NP B-test
- : O O
0 CD O O
Chemistries NNS B-NP O
: : O O
SODIUM NNP B-NP B-test
- : O O
137 CD O O
POTASSIUM NNP B-NP B-test
- : O O
4.5 CD O O
CHLORIDE NNP B-NP B-test
- : O O
106 CD O O
TOTAL NNP B-NP B-test
CO2 NNP I-NP I-test
- : O O
22 CD O O
UREA NNP B-NP B-test
N NNP I-NP I-test
- : O O
41 CD O O
* NN B-NP O
CREAT NNP I-NP B-test
- : O O
1.3 CD O O
GLUCOSE NNP B-NP B-test
- : O O
231 CD O O
CALCIUM NNP B-NP B-test
- : O O
7.7 CD O O
PHOSPHATE NNP B-NP B-test
- : O O
3.6 CD O O
MAGNESIUM NNP B-NP B-test
- : O O
2.4 CD O O
Liver NNP B-NP O
Function NN I-NP O
: : O O
ALT NNP B-NP B-test
( ( O I-test
SGPT NNP B-NP I-test
)- CD O I-test
249 CD O O
AST NNP B-NP B-test
( ( O I-test
SGOT NNP B-NP I-test
)- RB O I-test
147 CD O O
LD NNP B-NP B-test
( ( O I-test
LDH NNP B-NP I-test
)- CD O I-test
241 CD O O
ALK NNP B-NP B-test
PHOS NNP I-NP I-test
- : O O
230 CD O O
AMYLASE NNP B-NP B-test
- : O O
28 CD O O
TOT NNP B-NP B-test
BILI NNP I-NP I-test
- : O O
0.9 CD O O
LIPASE NNP B-NP B-test
- : O O
12 CD O O
ALBUMIN NNP B-NP B-test
- : O O
2.6 CD O O
Coagulation NN B-NP O
: : O O
PT NNP B-NP B-test
- : O O
13.8 CD O O
PTT NNP B-NP B-test
- : O O
24.3 CD O O
INR NNP B-NP B-test
( ( O I-test
PT NNP B-NP I-test
)- CD O I-test
1.2 CD O O
Thyroid NN B-NP O
: : O O
TSH NNP B-NP B-test
- : O O
3.3 CD O O
Imaging NN B-NP O
: : O O
1. CD O O
Nexk NNP B-NP B-test
CT NNP I-NP I-test
: : O O
Increased VBD B-VP B-problem
soft JJ B-NP I-problem
tissues NNS I-NP I-problem
within IN B-VP I-problem
the DT B-NP I-problem
pharynx NN I-NP I-problem
. . B-VP O
   
This DT O B-pronoun
may MD O O
be VB O O
secondary JJ O O
to TO O O
soft JJ B-NP B-problem
tissue NN I-NP I-problem
swelling VBG O I-problem
as IN B-VP O
indicated VBN O O
in IN B-VP O
the DT B-NP B-person
patient NN I-NP I-person
's POS O O
history NN B-NP O
, , O O
and CC O O
some DT O O
may MD O O
be VB O O
secondary JJ O O
to TO O O
secretions NNS B-NP B-problem
above IN B-VP I-problem
the DT B-NP I-problem
ETT NNP I-NP I-problem
balloon NN I-NP I-problem
. . B-VP O
   
No DT B-NP O
retropharyngeal NN I-NP B-problem
fluid NN I-NP I-problem
is VBZ O O
identified VBN O O
. . B-VP O
   
Dependent JJ B-NP B-problem
atelectasis NN I-NP I-problem
is VBZ O O
present JJ O O
within IN B-VP O
the DT B-NP O
visualized JJ I-NP O
portions NNS I-NP O
of IN B-VP O
the DT B-NP O
lung NN I-NP O
apices NNS I-NP O
. . B-VP O
   
2. CD O O
Chest NNP B-NP B-test
CT NN I-NP I-test
: : O O
Bilateral NNP B-NP B-problem
lower JJR B-NP I-problem
lobe NN I-NP I-problem
consolidations NNS I-NP I-problem
mostly RB O O
in IN B-VP O
dependent JJ B-NP O
portion NN I-NP O
, , O O
with IN B-VP O
small JJ B-NP B-problem
pleural JJ I-NP I-problem
effusion NN I-NP I-problem
and CC O O
diffuse VB O B-problem
ground-glass JJ B-NP I-problem
opacity NN I-NP I-problem
in IN B-VP I-problem
bilateral JJ B-NP I-problem
upper NN I-NP I-problem
and CC O I-problem
lower JJR B-NP I-problem
lobes NNS I-NP I-problem
, , O O
consistent JJ O O
with IN B-VP O
ARDS NNP B-NP B-problem
with IN B-VP O
pulmonary JJ B-NP B-problem
edema NN I-NP I-problem
given VBN O O
the DT B-NP O
history NN I-NP O
. . B-VP O
   
Ground-glass NNP B-NP B-problem
opacity NN I-NP I-problem
is VBZ O O
somewhat RB O O
more RBR O O
prominent JJ O O
in IN B-VP O
right JJ B-NP O
upper JJ I-NP O
lobe NN I-NP O
, , O O
and CC O O
superimposed VBD B-VP B-problem
infection NN B-NP I-problem
cannot NN I-NP O
be VB O O
totally RB O O
excluded VBN O O
. . B-VP O
   
Brief JJ B-NP O
Hospital JJ I-NP O
Course NN I-NP O
: : O O
This DT O B-pronoun
is VBZ O O
a DT O O
39 CD O O
year-old JJ B-NP O
female NN I-NP O
with IN B-VP O
diabetes NNS B-NP B-problem
type VBP O I-problem
I PRP O I-problem
, , O O
hypothyroidism NN B-NP B-problem
, , O O
gastroparesis NN B-NP B-problem
who WP O B-person
was VBD B-VP O
transfered VBN O O
for IN B-VP O
hypoxic JJ B-NP B-problem
respiratory JJ I-NP I-problem
failure NN I-NP I-problem
. . B-VP O
   
1. CD O O
Hypoxic NNP B-NP B-problem
Rspiratory NNP I-NP I-problem
Failure NN I-NP I-problem
: : O O
She PRP O B-person
arrived VBD B-VP O
intubated JJ O B-treatment
and CC O O
sedated VBN O B-treatment
from IN B-VP O
Esteban NNP B-NP O
Hospital NNP I-NP O
. . B-VP O
   
On IN B-VP O
arrival NN B-NP O
a DT B-NP B-test
chest NN I-NP I-test
x-ray NN I-NP I-test
showed VBD B-VP O
perihilar JJ O B-problem
and CC O I-problem
bibasilar JJ B-NP I-problem
opacities NNS I-NP I-problem
, , O O
which WDT O B-pronoun
appeared VBD B-VP O
conistent NN B-NP O
with IN B-VP O
pulmonary JJ B-NP B-problem
edema NN I-NP I-problem
but CC O O
also RB O O
possibly RB O O
consistent JJ O O
with IN B-VP O
a DT B-NP B-problem
pneumonia NN I-NP I-problem
. . B-VP O
   
There EX O O
was VBD B-VP O
no DT B-NP O
evidence NN I-NP O
of IN B-VP O
ARDS NNP B-NP B-problem
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
known VBN O O
to TO O O
have VB O O
gram-positive JJ B-NP B-problem
cocci NN I-NP I-problem
in IN B-VP I-problem
her PRP$ O I-problem
her PRP$ O B-person
sputum NN B-NP I-problem
at IN B-VP O
the DT B-NP O
outside JJ I-NP O
hospital NN I-NP O
. . B-VP O
   
A DT B-NP B-test
bronchoscopy NN I-NP I-test
with IN B-VP O
BAL NNP B-NP B-test
was VBD B-VP O
performed VBN O O
and CC O O
a DT B-NP B-test
sputum NN I-NP I-test
sample NN I-NP I-test
eventually RB O O
grew VBD B-VP O
out RP O O
MRSA NNP B-NP B-problem
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
treated VBN O O
with IN B-VP O
vancomycin NN B-NP B-treatment
to TO O O
cover VB O O
her PRP$ O B-person
her PRP$ O B-problem
MRSA NNP B-NP I-problem
pneumonia NN I-NP I-problem
. . B-VP O
   
A DT B-NP B-test
CT JJ I-NP I-test
scan NN I-NP I-test
was VBD B-VP O
performed VBN O O
on IN B-VP O
07-17 NN B-NP O
to TO O O
evaluate VB O O
the DT B-NP B-problem
soft JJ I-NP I-problem
tissue NN I-NP I-problem
swelling VBG O I-problem
seen VBN O O
on IN B-VP O
CT NNP B-NP B-test
at IN B-VP O
the DT B-NP O
outside JJ I-NP O
hospital NN I-NP O
. . B-VP O
   
The DT B-NP B-test
CT NNP I-NP I-test
showed VBD B-VP O
increased VBN O B-problem
soft JJ B-NP I-problem
tissues NNS I-NP I-problem
within IN B-VP I-problem
the DT B-NP I-problem
pharynx NN I-NP I-problem
which WDT O B-pronoun
was VBD B-VP O
felt VBN O O
to TO O O
be VB O O
secondary JJ O O
to TO O O
prolonged JJ B-NP B-treatment
intubation NN I-NP I-treatment
/ NNP I-NP O
trauma NN I-NP B-problem
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
treated VBN O O
with IN B-VP O
steroids NNS B-NP B-treatment
for IN B-VP O
this DT O B-pronoun
this DT O B-problem
swelling VBG O I-problem
at IN B-VP O
the DT B-NP O
outside JJ I-NP O
hospital NN I-NP O
, , O O
and CC O O
these DT O B-pronoun
were VBD B-VP O
continued VBN O O
. . B-VP O
   
It PRP O B-pronoun
was VBD B-VP O
decided VBN O O
that IN B-VP B-pronoun
patient NN B-NP B-person
should MD O O
receive VB O O
one CD O O
more JJR B-NP O
trial NN I-NP O
off IN B-VP O
the DT B-NP B-treatment
vent NN I-NP I-treatment
before IN B-VP O
committing VBG O O
her PRP$ O B-person
to TO O O
a DT B-NP B-treatment
tracheotomy NN I-NP I-treatment
. . B-VP O
   
She PRP O B-person
did VBD B-VP O
well RB O O
on IN B-VP O
minimal JJ B-NP B-treatment
vent JJ I-NP I-treatment
settings NNS I-NP I-treatment
but CC O O
it PRP O B-pronoun
was VBD B-VP O
decided VBN O O
to TO O O
delay VB O O
extubating VBG O O
the DT B-NP B-person
patient NN I-NP I-person
until IN B-VP O
the DT B-NP O
morning NN I-NP O
of IN B-VP O
6/2 CD O O
. . B-VP O
   
Overnight NNP B-NP O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
became VBD B-VP O
hypoxic JJ O B-problem
, , O O
dropping VBG O O
to TO O O
the DT O O
80 CD O O
's POS O O
. . B-VP O
   
A DT B-NP B-test
chest JJ I-NP I-test
x-ray NN I-NP I-test
showed VBD B-VP O
that IN B-VP B-pronoun
the DT B-NP B-treatment
ET NNP I-NP I-treatment
tube NN I-NP I-treatment
was VBD B-VP O
displaced VBN O B-problem
to TO O O
very RB O O
high JJ O O
in IN B-VP O
the DT B-NP O
trachea NN I-NP O
. . B-VP O
   
The DT B-NP B-treatment
cuff NN I-NP I-treatment
was VBD B-VP O
deflated VBN O O
and CC O O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
extubated VBN O O
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
placed VBN O O
in IN B-VP O
supplemental JJ B-NP B-treatment
oxygen NN I-NP I-treatment
by IN B-VP O
shovel NN B-NP B-treatment
mask NN I-NP I-treatment
and CC O O
her PRP$ O B-test
her PRP$ O B-person
sats NNS B-NP I-test
immediately RB O O
improved VBN O O
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
weaned VBN O O
down RP O O
until IN B-VP O
she PRP O B-person
was VBD B-VP O
maintaining VBG O O
her PRP$ O B-test
her PRP$ O B-person
oxygen NN B-NP I-test
saturation NN I-NP I-test
above IN B-VP O
90% CD O O
on IN B-VP O
6L CD O O
by IN B-VP O
nasal JJ B-NP B-treatment
cannuala NN I-NP I-treatment
. . B-VP O
   
As IN B-VP O
she PRP O B-person
was VBD B-VP O
doing VBG O O
well RB O O
without IN B-VP O
evidence NN B-NP O
of IN B-VP O
stridor NN B-NP B-problem
, , O O
the DT B-NP B-treatment
steroids NNS I-NP I-treatment
were VBD B-VP O
stopped VBN O O
. . B-VP O
   
She PRP O B-person
did VBD B-VP O
well RB O O
and CC O O
was VBD B-VP O
weaned VBN O O
from IN B-VP O
supplemental JJ B-NP B-treatment
oxygen NN I-NP I-treatment
. . B-VP O
   
At IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
discharge NN B-NP O
, , O O
she PRP O B-person
was VBD B-VP O
oxygenating VBG O O
well RB O O
on IN B-VP O
room NN B-NP O
air NN I-NP O
. . B-VP O
   
She PRP O B-person
Will VBD B-VP O
need VB O O
to TO O O
complete VB O O
a DT O O
14 CD O O
day NN B-NP O
course NN I-NP O
of IN B-VP O
vancomycin NN B-NP B-treatment
for IN B-VP O
her PRP$ O B-problem
her PRP$ O B-person
MRSA NNP B-NP I-problem
pneumonia NN I-NP I-problem
on IN B-VP O
2019-07-30 JJ O O
. . B-VP O
   
2. CD O O
Enterobacter NNP B-NP B-problem
bacteremia NN I-NP I-problem
: : O O
She PRP O B-person
was VBD B-VP O
initially RB O O
covered VBN O O
broadly RB O O
with IN B-VP O
vancomycin NN B-NP B-treatment
, , O O
ciprofloxacin NN B-NP B-treatment
, , O O
and CC O O
falgyl NN B-NP B-treatment
. . B-VP O
   
She PRP O B-person
had VBD B-VP O
positive JJ B-NP B-problem
blood NN I-NP I-problem
cultures NNS I-NP I-problem
at IN B-VP O
Mediplex NNP B-NP O
Rehab NNP I-NP O
Hospital NNP I-NP O
Hospital NNP I-NP O
for IN B-VP O
gram NN B-NP B-problem
negative JJ B-NP I-problem
rods NNS I-NP I-problem
. . B-VP O
   
Subsequently RB O O
, , O O
zosyn NN B-NP B-treatment
was VBD B-VP O
added VBN O O
. . B-VP O
   
The DT B-NP B-test
cultures NNS I-NP I-test
grew VBD B-VP O
out RP O O
enterobacter JJ B-NP B-problem
cloacae NN I-NP I-problem
. . B-VP O
   
It PRP O B-pronoun
was VBD B-VP O
unclear JJ O O
the DT B-NP O
source NN I-NP O
of IN B-VP O
her PRP$ O B-problem
her PRP$ O B-person
bacteremia NN B-NP I-problem
. . B-VP O
   
Her PRP$ O B-test
Her PRP$ O B-person
stool NN B-NP I-test
cultures NNS I-NP I-test
were VBD B-VP O
negative JJ O O
. . B-VP O
   
Her PRP$ O B-treatment
Her PRP$ O B-person
central JJ B-NP I-treatment
line NN I-NP I-treatment
was VBD B-VP O
removed VBN O O
and CC O O
the DT B-NP B-treatment
tip NN I-NP I-treatment
was VBD B-VP O
culture NN B-NP O
negative JJ O O
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
transitioned VBN O O
to TO O O
on IN B-VP O
levofloxacin NN B-NP B-treatment
for IN B-VP O
her PRP$ O B-person
her PRP$ O B-problem
bacteremia NN B-NP I-problem
. . B-VP O
   
She PRP O B-person
had VBD B-VP O
no DT B-NP O
positive JJ I-NP B-problem
cultures NNS I-NP I-problem
during IN B-VP O
this DT B-NP B-pronoun
admission NN I-NP O
. . B-VP O
   
Once IN B-VP O
she PRP O B-person
was VBD B-VP O
more RBR O O
stable JJ O O
, , O O
an DT B-NP B-test
abdominal JJ I-NP I-test
CT NNP I-NP I-test
was VBD B-VP O
performed VBN O O
to TO O O
look VB O O
for IN B-VP O
an DT B-NP B-problem
abscess NN I-NP I-problem
. . B-VP O
   
This DT O B-test
This DT B-NP B-pronoun
study NN I-NP I-test
was VBD B-VP O
negative JJ O O
. . B-VP O
   
However RB O O
, , O O
the DT B-NP B-test
study NN I-NP I-test
was VBD B-VP O
limited VBN O O
due JJ O O
to TO O O
inadequate VB O O
po NN B-NP O
contrast NN I-NP O
intake NN I-NP O
by IN B-VP O
the DT B-NP B-person
patient NN I-NP I-person
; : O O
it PRP O B-pronoun
did VBD B-VP O
show VB O O
a DT B-NP O
question NN I-NP O
of IN B-VP O
a DT B-NP B-problem
cecal JJ I-NP I-problem
cystic JJ I-NP I-problem
lesion NN I-NP I-problem
verse NN I-NP O
normal JJ B-NP O
loop NN I-NP O
of IN B-VP O
bowel NN B-NP O
. . B-VP O
   
This DT O B-pronoun
This DT B-NP B-test
study NN I-NP I-test
will MD O O
need VB O O
to TO O O
be VB O O
repeated VBN O O
once IN B-VP O
she PRP O B-person
is VBZ O O
tolerating VBG O O
po NN B-NP O
's POS O O
. . B-VP O
   
She PRP O B-person
will MD O O
complete VB O O
a DT O O
14 CD O O
day NN B-NP O
course NN I-NP O
of IN B-VP O
levofloxacin NN B-NP B-treatment
for IN B-VP O
her PRP$ O B-person
her PRP$ O B-problem
bacteremia NN B-NP I-problem
on IN B-VP O
2019-07-30 JJ O O
. . B-VP O
   
3. CD O O
Diabetes NNPS B-NP B-problem
type NN I-NP I-problem
I PRP O I-problem
: : O O
She PRP O B-person
was VBD B-VP O
intially RB O O
maintained VBN O O
on IN B-VP O
an DT B-NP B-treatment
insulin NN I-NP I-treatment
drip NN I-NP I-treatment
for IN B-VP O
tight JJ B-NP B-treatment
glycemic JJ I-NP I-treatment
control NN I-NP I-treatment
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
followed VBN O O
by IN B-VP O
Albano NNP B-NP O
during IN B-VP O
the DT B-NP O
admission NN I-NP O
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
initially RB O O
maintained VBN O O
on IN B-VP O
D5W NNP B-NP B-treatment
, , O O
which WDT O B-pronoun
was VBD B-VP O
increased VBN O O
to TO O O
D10W NNP B-NP B-treatment
as IN B-VP O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
persistently RB O B-problem
borderline JJ B-NP I-problem
hypoglycemic NN I-NP I-problem
while IN B-VP O
on IN B-VP O
insulin NN B-NP B-treatment
drip NN I-NP I-treatment
. . B-VP O
   
Once IN B-VP O
she PRP O B-person
began VBD B-VP O
to TO O O
take VB O O
PO NNP B-NP O
's POS O O
, , O O
the DT B-NP B-treatment
insulin NN I-NP I-treatment
drip NN I-NP I-treatment
was VBD B-VP O
stopped VBN O O
and CC O O
patient NN B-NP B-person
was VBD B-VP O
started VBN O O
on IN B-VP O
glargine NN B-NP B-treatment
with IN B-VP O
a DT B-NP B-treatment
humalog NN I-NP I-treatment
sliding VBG O I-treatment
scale NN B-NP I-treatment
. . B-VP O
   
While IN B-VP O
her PRP$ O B-person
po NNS B-NP O
intake NN I-NP O
was VBD B-VP O
minimal JJ O O
she PRP O B-person
was VBD B-VP O
maintained VBN O O
on IN B-VP O
supplemental JJ B-NP B-treatment
IV NNP I-NP I-treatment
dextrose NN I-NP I-treatment
to TO O O
suppress VB O O
ketosis NN B-NP B-problem
. . B-VP O
   
While IN B-VP O
she PRP O B-person
was VBD B-VP O
on IN B-VP O
the DT B-NP B-treatment
IV NNP I-NP I-treatment
dextrose NN I-NP I-treatment
, , O O
she PRP O B-person
required VBD B-VP O
up RB O O
to TO O O
26 CD O O
units NNS B-NP O
of IN B-VP O
glargine NN B-NP B-treatment
for IN B-VP O
glycemic JJ B-NP B-treatment
control NN I-NP I-treatment
. . B-VP O
   
As IN B-VP O
she PRP O B-person
starting VBG O O
taking VBG O O
some DT B-NP O
foods NNS I-NP O
, , O O
her PRP$ O B-treatment
her PRP$ O B-person
glargine NN B-NP I-treatment
was VBD B-VP O
decrease NN B-NP O
. . B-VP O
   
At IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
discharge NN B-NP O
her PRP$ O B-treatment
her PRP$ O B-person
glargine NN B-NP I-treatment
was VBD B-VP O
10 CD O O
. . B-VP O
   
Her PRP$ O B-test
Her PRP$ O B-person
blood NN B-NP I-test
glucose NN I-NP I-test
were VBD B-VP O
under IN B-VP O
good JJ B-NP O
control NN I-NP O
. . B-VP O
   
The DT B-NP O
day NN I-NP O
prior RB O O
to TO O O
discharge VB O O
, , O O
she PRP O B-person
was VBD B-VP O
nauseated VBN O B-problem
and CC O O
not RB O O
taking VBG O O
pos NN B-NP O
. . B-VP O
   
Therefore NN B-NP O
, , O O
she PRP O B-person
received VBD B-VP O
1L CD O O
of IN B-VP O
D5 NNP B-NP B-treatment
, , O O
and CC O O
her PRP$ O B-person
her PRP$ O B-test
sugars NNS B-NP I-test
were VBD B-VP O
elevated VBN O B-problem
to TO O O
400 CD O O
the DT B-NP O
day NN I-NP O
of IN B-VP O
discharge NN B-NP O
. . B-VP O
   
4. CD O O
Gastroparesis NN B-NP B-problem
: : O O
She PRP O B-person
has VBZ O O
a DT B-NP O
history NN I-NP O
of IN B-VP O
gastroparesis NN B-NP B-problem
secondary JJ O O
to TO O O
long-standing JJ B-NP B-problem
type NN I-NP I-problem
I PRP O I-problem
diabetes VBZ O I-problem
. . B-VP O
   
Once IN B-VP O
she PRP O B-person
was VBD B-VP O
extubated VBN O O
, , O O
she PRP O B-person
was VBD B-VP O
nauseated VBN O B-problem
with IN B-VP O
emesis NN B-NP B-problem
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
intially RB O O
treated VBN O O
with IN B-VP O
erythromycin NN B-NP B-treatment
for IN B-VP O
pro-motility NN B-NP O
as IN B-VP O
she PRP O B-person
had VBD B-VP O
a DT B-NP B-problem
bad JJ I-NP I-problem
reaction NN I-NP I-problem
to TO O O
reglan VB O B-treatment
in IN B-VP O
the DT B-NP O
past NN I-NP O
. . B-VP O
   
She PRP O B-person
continued VBD B-VP O
to TO O O
remained VB O O
nauseated VBN O B-problem
so RB O O
she PRP O B-person
was VBD B-VP O
treated VBN O O
with IN B-VP O
phenergan NN B-NP B-treatment
, , O O
anzemet NN B-NP B-treatment
, , O O
zofran NN B-NP B-treatment
, , O O
and CC O O
ativan NN B-NP B-treatment
. . B-VP O
   
She PRP O B-person
intermittently RB O O
was VBD B-VP O
able JJ B-NP O
tolerate JJ I-NP O
pos NN I-NP O
. . B-VP O
   
Her PRP$ O B-person
Her PRP$ O B-problem
nausea NN B-NP I-problem
was VBD B-VP O
accompanied VBN O O
by IN B-VP O
abdominal JJ B-NP B-problem
pain NN I-NP I-problem
for IN B-VP O
which WDT O B-pronoun
she PRP O B-person
was VBD B-VP O
treated VBN O O
with IN B-VP O
morphine NN B-NP B-treatment
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
transitioned VBN O O
to TO O O
a DT B-NP B-treatment
PCA NNP I-NP I-treatment
for IN B-VP O
better JJR B-NP B-treatment
pain NN I-NP I-treatment
control NN I-NP I-treatment
. . B-VP O
   
She PRP O B-person
continued VBD B-VP O
to TO O O
have VB O O
nausea VBN O B-problem
despite IN B-VP O
an DT B-NP B-treatment
agressive JJ I-NP I-treatment
anti-emetic JJ I-NP I-treatment
regimen NNS I-NP I-treatment
. . B-VP O
   
It PRP O B-pronoun
was VBD B-VP O
felt VBN O O
that IN B-VP B-pronoun
her PRP$ O B-problem
her PRP$ O B-person
symptoms NNS B-NP I-problem
were VBD B-VP O
secondary JJ O O
to TO O O
gastroparesis NN B-NP B-problem
. . B-VP O
   
However RB O O
, , O O
other JJ B-NP O
causes NNS I-NP O
were VBD B-VP O
looked VBN O O
for IN B-VP O
including VBG O O
adrenal JJ B-NP B-problem
insufficiency NN I-NP I-problem
and CC O O
bowel NN B-NP B-problem
obstruction NN I-NP I-problem
. . B-VP O
   
She PRP O B-person
had VBD B-VP O
a DT B-NP O
normal JJ I-NP O
cortisol NN I-NP O
stimulation NN I-NP O
test NN I-NP O
. . B-VP O
   
A DT B-NP B-test
abdominal JJ I-NP I-test
plain NN I-NP I-test
film NN I-NP I-test
showed VBD B-VP O
non-specific JJ B-NP B-problem
bowel NN I-NP I-problem
gas NN I-NP I-problem
patterns NNS I-NP I-problem
that WDT O B-pronoun
may MD O O
represent VB O O
an DT B-NP B-problem
early JJ I-NP I-problem
obstruction NN I-NP I-problem
. . B-VP O
   
A DT B-NP B-treatment
NG NNP I-NP I-treatment
tube NN I-NP I-treatment
was VBD B-VP O
placed VBN O O
for IN B-VP O
decompression NN B-NP B-treatment
given VBN O O
the DT B-NP O
signs NNS I-NP O
of IN B-VP O
early JJ B-NP B-problem
obstruction NN I-NP I-problem
the DT B-NP O
day NN I-NP O
of IN B-VP O
transfer NN B-NP O
. . B-VP O
   
The DT B-NP B-person
GI NNP I-NP I-person
service NN I-NP I-person
was VBD B-VP O
consulted VBN O O
and CC O O
they PRP O B-pronoun
felt VBD B-VP O
that IN B-VP B-pronoun
her PRP$ O B-person
her PRP$ O B-problem
symptoms NNS B-NP I-problem
were VBD B-VP O
all DT B-NP O
gastroparesis NN I-NP B-problem
. . B-VP O
   
They PRP O B-pronoun
recommended VBD B-VP O
erythromycin NN B-NP B-treatment
and CC O O
zelnorm NN B-NP B-treatment
. . B-VP O
   
She PRP O B-person
should MD O O
eventually RB O O
have VB O O
a DT B-NP B-test
tissue NN I-NP I-test
transglutaminase NN I-NP I-test
to TO O O
rule VB O O
out RP O O
celiac JJ B-NP B-problem
disease NN I-NP I-problem
. . B-VP O
   
5. CD O O
Transaminitis NN B-NP B-problem
: : O O
Per NNP B-NP O
report NN I-NP O
, , O O
She PRP O B-person
had VBD B-VP O
elevated VBN O B-problem
LFTs NNP B-NP I-problem
at IN B-VP O
the DT B-NP O
outside JJ I-NP O
hospital NN I-NP O
. . B-VP O
   
A DT B-NP B-test
right JJ I-NP I-test
upper NN I-NP I-test
quadrant NN I-NP I-test
ultrasound NN I-NP I-test
was VBD B-VP O
performed VBN O O
and CC O O
was VBD B-VP O
negative JJ O O
for IN B-VP O
any DT B-NP B-problem
acute JJ I-NP I-problem
pathology NN I-NP I-problem
. . B-VP O
   
Her PRP$ O B-test
Her PRP$ O B-person
LFTs NNP B-NP I-test
trended VBD B-VP O
down RP O O
during IN B-VP O
this DT B-NP B-pronoun
admission NN I-NP O
. . B-VP O
   
6. CD O O
Hypothyroidism NN B-NP B-problem
: : O O
She PRP O B-person
was VBD B-VP O
maintained VBN O O
on IN B-VP O
her PRP$ O B-treatment
her PRP$ O B-person
levothyroxine NN B-NP I-treatment
. . B-VP O
   
While IN B-VP O
she PRP O B-person
was VBD B-VP O
not RB O O
taking VBG O O
adequate JJ B-NP O
pos NN I-NP O
, , O O
she PRP O B-person
was VBD B-VP O
on IN B-VP O
IV NNP B-NP B-treatment
levothyroxine NN I-NP I-treatment
. . B-VP O
   
7. CD O O
F/E/N NN B-NP O
: : O O
She PRP O B-person
was VBD B-VP O
NPO NNP B-NP B-treatment
while IN B-VP O
intubated VBN O B-treatment
and CC O O
recived VBN O O
tube JJ B-NP B-treatment
feedings NNS I-NP I-treatment
for IN B-VP O
nutrition NN B-NP O
. . B-VP O
   
After IN B-VP O
extubation NN B-NP O
, , O O
patient NN B-NP B-person
was VBD B-VP O
started VBN O O
on IN B-VP O
sips NNS B-NP O
and CC O O
had VBD B-VP O
a DT B-NP B-test
speech NN I-NP I-test
and CC O I-test
swallow JJ B-NP I-test
evaluation NN I-NP I-test
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
cleared VBN O O
to TO O O
advance VB O O
her PRP$ O B-person
diet JJ O O
as IN B-VP O
tolerated VBN O O
. . B-VP O
   
She PRP O B-person
only RB O O
tolerated VBD B-VP O
some DT B-NP O
clear JJ I-NP O
liquids NNS I-NP O
. . B-VP O
   
At IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
transfer NN B-NP O
, , O O
she PRP O B-person
was VBD B-VP O
NPO NNP B-NP B-treatment
given VBN O O
her PRP$ O B-person
her PRP$ O B-treatment
NG NNP B-NP I-treatment
tube NN I-NP I-treatment
. . B-VP O
   
8. CD O O
Prophylaxis NN B-NP B-treatment
: : O O
PPI NNP B-NP B-treatment
, , O O
Heparin NNP B-NP B-treatment
SQ NNP I-NP I-treatment
. . B-VP O
   
9. CD O O
Access NN B-NP O
: : O O
Her PRP$ O B-treatment
Her PRP$ O B-person
central JJ B-NP I-treatment
line NN I-NP I-treatment
was VBD B-VP O
removed VBN O O
given VBN O O
the DT B-NP O
concern NN I-NP O
for IN B-VP O
a DT B-NP B-problem
line NN I-NP I-problem
infection NN I-NP I-problem
. . B-VP O
   
She PRP O B-person
had VBD B-VP O
a DT B-NP B-treatment
double JJ I-NP I-treatment
lumen NNS I-NP I-treatment
PICC NNP I-NP I-treatment
place NN I-NP O
. . B-VP O
   
10. CD O O
CODE NN B-NP O
: : O O
FULL NNP B-NP B-treatment
11. CD O O
Dispo NN B-NP O
: : O O
She PRP O B-person
was VBD B-VP O
transfered VBN O O
back RB O O
to TO O O
Mediplex NNP B-NP O
Rehab NNP I-NP O
Hospital NNP I-NP O
Hospital NNP I-NP O
per IN B-VP O
the DT B-NP B-person
patient NN I-NP I-person
's POS O O
and CC O O
husband NN B-NP B-person
's POS O O
request NN B-NP O
so IN B-VP O
that IN B-VP B-pronoun
she PRP O B-person
would MD O O
be VB O O
closer JJR O O
to TO O O
home NN B-NP O
once RB O O
her PRP$ O B-person
respiratory NN B-NP O
status NN I-NP O
was VBD B-VP O
stable JJ O O
. . B-VP O
   
anti-GBM NN B-NP B-test
is VBZ O O
pending VBG O O
. . B-VP O
   
Medications NNS B-NP O
on IN B-VP O
Admission NN B-NP O
: : O O
Meds NNS B-NP O
: : O O
Vitamin NNP B-NP B-treatment
D NNP I-NP I-treatment
50000 CD O O
4662442 CD O O
one CD O O
time NN B-NP O
a DT B-NP O
week NN I-NP O
Cozaar NNP I-NP B-treatment
25 CD O O
mg NN B-NP O
1 CD O O
time NN B-NP O
per IN B-VP O
day NN B-NP O
Procrit NNP I-NP B-treatment
- : O O
Multidose JJ O O
20000 CD O O
u JJ B-NP O
/ NNP I-NP O
ml NN I-NP O
20,000 CD O O
units NNS B-NP O
SQ NNP I-NP O
every DT B-NP O
other JJ I-NP O
week NN I-NP O
Levoxyl NNP I-NP B-treatment
150 CD O O
mcg VBD B-VP O
1 CD O O
1 CD O O
time NN B-NP O
per IN B-VP O
day NN B-NP O
Iron NNP I-NP B-treatment
325 CD O O
( ( O O
65 CD O O
) ) O O
mg NN B-NP O
twice RB O O
a DT B-NP O
day NN I-NP O
Zoloft NNP I-NP B-treatment
100 CD O O
mg NN B-NP O
1 CD O O
per IN B-VP O
day NN B-NP O
, , O O
2 CD O O
TABS NNP B-NP O
Freestyle NNP I-NP O
as IN B-VP O
directed VBN O O
Clonazepam NNP B-NP B-treatment
0.5 CD O O
mg NN B-NP O
Humalog NNP I-NP B-treatment
100 CD O O
U NNP B-NP O
/ NNP I-NP O
ml VBZ O O
1 CD O O
as IN B-VP O
directed VBN O O
pump NN B-NP O
Zofran NNP I-NP B-treatment
8 CD O O
mg NN B-NP O
1 CD O O
as IN B-VP O
directed VBN O O
Prevacid NNP B-NP B-treatment
30 CD O O
mg VBD B-VP O
1 CD O O
1 CD O O
time NN B-NP O
per IN B-VP O
day NN B-NP O
Lorazepam NNP I-NP B-treatment
0.5 CD O O
mg NN B-NP O
1 CD O O
to TO O O
2 CD O O
tablets NNS B-NP O
twice RB O O
daily RB O O
if IN B-VP O
needed VBN O O
on IN B-VP O
transfer NN B-NP O
: : O O
Cipro JJ O B-treatment
400 CD O O
" JJ B-NP O
Vanco NNP I-NP B-treatment
1 CD O O
g NN B-NP O
qD NN I-NP O
Flagyl NNP I-NP B-treatment
500 CD O O
q8 NN B-NP O
Levophed NNP I-NP B-treatment
gtt NN I-NP I-treatment
Propofol NNP I-NP B-treatment
gtt NN I-NP I-treatment
Solumedrol NNP I-NP B-treatment
40 CD O O
q6 NN B-NP O
( ( O O
started VBN O O
07-14 NN B-NP O
) ) O O
Pepcid NNP B-NP B-treatment
FeSo4 NNP I-NP B-treatment
325 CD O O
' '' O O
Insulin NNP B-NP B-treatment
35 CD O O
lantus NN B-NP B-treatment
qhs NN I-NP O
Synthroid NNP I-NP B-treatment
150 CD O O
' '' O O
Losartan NNP B-NP B-treatment
25 CD O O
' '' O O
Zoloft NNP B-NP B-treatment
200 CD O O
' '' O O
Zelnorm NNP B-NP B-treatment
6 CD O O
" NNP B-NP O
MS NNP I-NP O
Lori NNP I-NP B-person
Harwood NNP I-NP I-person
Discharge NNP I-NP O
Medications NNP I-NP O
: : O O
1. CD O O
Sertraline NNP B-NP B-treatment
100 CD O O
mg NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
Two CD O O
( ( O O
2 CD O O
) ) O O
Tablet NNP B-NP O
PO NNP I-NP O
DAILY NNP I-NP O
( ( O O
Daily NNP B-NP O
) ) O O
. . B-VP O
   
2. CD O O
Heparin NNP B-NP B-treatment
( ( O I-treatment
Porcine NNP B-NP I-treatment
) ) O O
5,000 CD O O
unit NN B-NP O
/ NNP I-NP O
mL NN I-NP O
Solution NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Injection NN B-NP O
TID NNP I-NP O
( ( O O
3 CD O O
times NNS B-NP O
a DT B-NP O
day NN I-NP O
) ) O O
. . B-VP O
   
3. CD O O
Acetaminophen NNP B-NP B-treatment
500 CD O O
mg NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
Two CD O O
( ( O O
2 CD O O
) ) O O
Tablet NNP B-NP O
PO NNP I-NP O
BID NNP I-NP O
( ( O O
2 CD O O
times NNS B-NP O
a DT B-NP O
day NN I-NP O
) ) O O
as IN B-VP O
needed VBN O O
for IN B-VP O
headache NN B-NP B-problem
. . B-VP O
   
4. CD O O
Ondansetron NNP B-NP B-treatment
HCl NNP I-NP I-treatment
2 CD O O
mg NN B-NP O
/ NNP I-NP O
mL NN I-NP O
Solution NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
ML NNP B-NP O
Intravenous NNP I-NP O
Q12H NNP I-NP O
( ( O O
every DT O O
12 CD O O
hours NNS B-NP O
) ) O O
as IN B-VP O
needed VBN O O
for IN B-VP O
nausea NN B-NP B-problem
. . B-VP O
   
5. CD O O
Pyridoxine NNP B-NP B-treatment
50 CD O O
mg NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Tablet NNP B-NP O
PO NNP I-NP O
DAILY NNP I-NP O
( ( O O
Daily NNP B-NP O
) ) O O
. . B-VP O
   
6. CD O O
Olanzapine JJ O B-treatment
5 CD O O
mg JJ B-NP O
Tablet NNP I-NP O
, , O O
Rapid NNP B-NP O
Dissolve NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Tablet NN B-NP O
, , O O
Rapid NNP B-NP O
Dissolve NNP I-NP O
PO NNP I-NP O
BID NNP I-NP O
( ( O O
2 CD O O
times NNS B-NP O
a DT B-NP O
day NN I-NP O
) ) O O
. . B-VP O
   
7. CD O O
Insulin NNP B-NP B-treatment
Glargine NNP I-NP I-treatment
100 CD O O
unit NN B-NP O
/ NNP I-NP O
mL NN I-NP O
Cartridge NNP I-NP O
Sig NNP I-NP O
: : O O
Ten CD O O
( ( O O
10 CD O O
) ) O O
units NNS B-NP O
Subcutaneous NNP I-NP O
once RB O O
a DT B-NP O
day NN I-NP O
. . B-VP O
   
8. CD O O
Humalog NNP B-NP B-treatment
100 CD O O
unit NN B-NP O
/ NNP I-NP O
mL NN I-NP O
Cartridge NNP I-NP O
Sig NNP I-NP O
: : O O
asdir RB O O
Subcutaneous NNP B-NP O
once RB O O
a DT B-NP O
day NN I-NP O
: : O O
see VB O O
attached JJ B-NP O
sheet NN I-NP O
for IN B-VP O
sliding VBG O O
scale NN B-NP O
. . B-VP O
   
9. CD O O
Morphine NNP B-NP B-treatment
2 CD O O
mg NN B-NP O
/ NNP I-NP O
mL NN I-NP O
Syringe NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Injection NN B-NP O
Q4H NNP I-NP O
( ( O O
every DT O O
4 CD O O
hours NNS B-NP O
) ) O O
as IN B-VP O
needed VBN O O
. . B-VP O
   
10. CD O O
Tegaserod NNP B-NP B-treatment
Hydrogen NNP I-NP I-treatment
Maleate NNP I-NP I-treatment
6 CD O O
mg NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Tablet NNP B-NP O
PO NNP I-NP O
bid NN I-NP O
( ( O O
) ) O O
. . B-VP O
   
11. CD O O
Levofloxacin NNP B-NP B-treatment
500 CD O O
mg NN B-NP O
IV NNP I-NP O
Q24H NNP I-NP O
12. CD O O
Vancomycin NNP B-NP B-treatment
HCl NNP I-NP O
750 CD O O
mg NN B-NP O
IV NNP I-NP O
Q NNP I-NP O
12H CD O O
13. CD O O
Dolasetron NNP B-NP B-treatment
Mesylate NNP I-NP I-treatment
25 CD O O
mg NN B-NP O
IV NNP I-NP O
Q8H NNP I-NP O
: : O O
PRN NNP B-NP O
nausea VBZ O B-problem
14. CD O O
Promethazine NNP B-NP B-treatment
HCl NNP I-NP I-treatment
25 CD O O
mg NN B-NP O
IV NNP I-NP O
Q6H NNP I-NP O
: : O O
PRN NNP B-NP O
15. CD O O
Lorazepam NNP B-NP B-treatment
0.5-1 CD O O
mg NN B-NP O
IV NNP I-NP O
Q3-4H NN I-NP O
: : O O
PRN NNP B-NP O
anxiety NN I-NP B-problem
, , O O
nausea NN B-NP B-problem
hold NN I-NP O
for IN B-VP O
sedation NN B-NP B-problem
. . B-VP O
   
16. CD O O
Levothyroxine NNP B-NP B-treatment
Sodium NNP I-NP I-treatment
75 CD O O
mcg NN B-NP O
IV NNP I-NP O
DAILY NNP I-NP O
17. CD O O
Pantoprazole NNP B-NP B-treatment
40 CD O O
mg NN B-NP O
IV NNP I-NP O
Q12H NNP I-NP O
18. CD O O
Erythromycin NNP B-NP B-treatment
500 CD O O
mg NN B-NP O
IV NNP I-NP O
Q6H NNP I-NP O
Discharge NNP I-NP O
Disposition NNP I-NP O
: : O O
Extended VBN O O
Care NNP B-NP O
Discharge NNP I-NP O
Diagnosis NNP I-NP O
: : O O
MRSA NNP B-NP B-problem
pneumonia NN I-NP I-problem
Gastroparesis NNP I-NP B-problem
Enterobacter NNP I-NP B-problem
bacteremia NN I-NP I-problem
Diabetes NNP I-NP B-problem
type NN I-NP I-problem
I PRP O I-problem
Hypothyroidism NNP B-NP B-problem
Discharge NNP I-NP O
Condition NNP I-NP O
: : O O
Stable JJ O O
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
oxygenating VBG O O
well RB O O
on IN B-VP O
room NN B-NP O
air NN I-NP O
. . B-VP O
   
She PRP O B-person
continued VBD B-VP O
to TO O O
have VB O O
nausea NN B-NP B-problem
and CC O O
vomiting NN B-NP B-problem
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
unable JJ O O
to TO O O
tolerate VB O O
pos NN B-NP O
. . B-VP O
   
Discharge NNP B-NP O
Instructions NNPS I-NP O
: : O O
You PRP O B-person
are VBP O O
being VBG O O
transfered VBN O O
to TO O O
Mediplex NNP B-NP O
Rehab NNP I-NP O
Hospital NNP I-NP O
Hospital NNP I-NP O
for IN B-VP O
further RB O O
care NN B-NP O
as IN B-VP O
you PRP O B-person
have VBP O O
requested VBN O O
to TO O O
be VB O O
closer JJR O O
to TO O O
home NN B-NP O
. . B-VP O
   
Followup JJ B-NP O
Instructions NNS I-NP O
: : O O
You PRP O B-person
should MD O O
have VB O O
a DT B-NP B-test
anti-Tissue JJ I-NP I-test
Transglutaminase NNP I-NP I-test
Antibody NNP I-NP I-test
, , O O
IgA NNP B-NP B-test
to TO O O
rule VB O O
out RP O O
celiac JJ B-NP B-problem
disease NN I-NP I-problem
given VBN O O
your PRP$ O B-problem
your PRP$ O B-person
abdominal JJ B-NP I-problem
symptoms NNS I-NP I-problem
. . B-VP O
   
Jayme NNP B-NP B-person
Gary NNP I-NP I-person
MD NNP I-NP I-person
57-021 JJ O O
Completed VBN O O
by IN B-VP O
: : O O
Melvina NNP B-NP B-person
Holland NNP I-NP I-person
MD NNP I-NP I-person
20-010 JJ B-NP O
2019-07-27 JJ I-NP O
@ NN I-NP O
1645 CD O O
Signed NNP B-NP O
electronically RB O O
by IN B-VP O
: : O O
DR. NNP B-NP B-person
Melvin NNP I-NP I-person
N.I. NNP I-NP I-person
Lichtenberger NNP I-NP I-person
on IN B-VP O
: : O O
WED JJ O O
2019-07-31 JJ O O
7:26 CD O O
AM NNP B-NP O
( ( O O
End NNP B-NP O
of IN B-VP O
Report NNP B-NP O
) ) O O
-EMPTYLINE- VBP O O
-DOCSTART- JJ O O
-EMPTYLINE- $ O O
356529973_a CD O O
FIH NNP B-NP O
2102647 CD O O
14892/3n8v CD O O
481088 CD O O
7/9/1993 CD O O
12:00:00 CD O O
AM NNP B-NP O
OVARIAN NNP I-NP B-problem
MASS NNP I-NP I-problem
. . B-VP O
   
Unsigned VBD B-VP O
DIS NNP B-NP O
Report NNP I-NP O
Status NNP I-NP O
: : O O
Unsigned VBN O O
ADMISSION NNP B-NP O
DATE NNP I-NP O
: : O O
7-9-93 JJ B-NP O
DISCHARGE NNP I-NP O
DATE NNP I-NP O
: : O O
7-15-93 JJ B-NP O
PRINCIPAL NNP I-NP O
DIAGNOSIS NNP I-NP O
: : O O
Ovarian JJ B-NP B-problem
mass NN I-NP I-problem
. . B-VP O
   
ASSOCIATED CC O O
DIAGNOSIS NNP B-NP O
: : O O
Papanicolaou NNP B-NP B-test
smear VBP O I-test
positive JJ O O
for IN B-VP O
somomabodies NNS B-NP B-problem
, , O O
incontinence NN B-NP B-problem
. . B-VP O
   
PRINCIPAL JJ B-NP O
PROCEDURE NN I-NP O
: : O O
Total JJ B-NP B-treatment
abdominal JJ I-NP I-treatment
hysterectomy NN I-NP I-treatment
, , O O
bilateral JJ B-NP B-treatment
salpingo-oophorectomy NN I-NP I-treatment
, , O O
lysis NN B-NP B-treatment
of IN B-VP O
adhesions NNS B-NP B-problem
, , O O
open JJ B-NP B-treatment
laparoscopy NN I-NP I-treatment
, , O O
Birch NNP B-NP B-treatment
procedure NN I-NP I-treatment
, , O O
suprapubic JJ B-NP B-treatment
bladder NN I-NP I-treatment
catheter NN I-NP I-treatment
placement NN I-NP I-treatment
. . B-VP O
   
HISTORY NNP B-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
is VBZ O O
a DT O O
52 CD O O
year NN B-NP O
old JJ B-NP O
female NN I-NP O
with IN B-VP O
gravida JJ O O
3 CD O O
para NN B-NP O
3 CD O O
who WP O B-person
presents VBZ O O
with IN B-VP O
complains NNS B-NP O
of IN B-VP O
abdominal JJ B-NP B-problem
pain NN I-NP I-problem
and CC O O
enlarged VBD B-VP B-problem
ovary JJ O I-problem
by IN B-VP O
ultrasound NN B-NP B-test
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
is VBZ O O
also RB O O
complaining VBG O O
of IN B-VP O
several JJ B-NP B-problem
years NNS I-NP I-problem
urinary JJ B-NP I-problem
incontinence NN I-NP I-problem
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
&apos;s JJ B-NP O
recent JJ I-NP O
history NN I-NP O
is VBZ O O
also RB O O
notable JJ O O
for IN B-VP O
a DT B-NP B-test
Papanicolaou NNP I-NP I-test
smear NN I-NP I-test
which WDT O B-pronoun
revealed VBD B-VP O
somomabodies NNS B-NP B-problem
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
also RB O O
had VBD B-VP O
vaginal JJ B-NP B-problem
bleeding NN I-NP I-problem
in IN B-VP O
April NNP B-NP O
1992 CD O O
following VBG O O
radiation NN B-NP B-treatment
therapy NN I-NP I-treatment
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
initially RB O O
presented VBN O O
with IN B-VP O
hypercalcemia NN B-NP B-problem
and CC O O
underwent NN B-NP O
a DT B-NP B-treatment
parathyroidectomy NN I-NP I-treatment
on IN B-VP O
June NNP B-NP O
22 CD O O
, , O O
1993 CD O O
. . B-VP O
   
It PRP O B-pronoun
was VBD B-VP O
at IN B-VP O
that DT B-NP B-pronoun
time NN I-NP O
that IN B-VP B-pronoun
her PRP$ O B-person
her PRP$ O B-problem
abnormal JJ B-NP I-problem
Papanicolaou NNP I-NP I-problem
smear NN I-NP I-problem
was VBD B-VP O
obtained VBN O O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
is VBZ O O
now RB O O
admitted VBN O O
for IN B-VP O
exploratory JJ B-NP B-test
laparotomy NN I-NP I-test
. . B-VP O
   
PAST NNP B-NP O
MEDICAL NNP I-NP O
HISTORY NNP I-NP O
: : O O
The DT B-NP O
past JJ I-NP O
medical JJ I-NP O
history NN I-NP O
is VBZ O O
notable JJ O O
for IN B-VP O
lymphosarcoma NN B-NP B-problem
in IN B-VP O
1970 CD O O
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
treated VBN O O
with IN B-VP O
radiation NN B-NP B-treatment
therapy NN I-NP I-treatment
. . B-VP O
   
In IN B-VP O
1980 CD O O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
had VBD B-VP O
a DT B-NP B-problem
left JJ I-NP I-problem
axillary JJ I-NP I-problem
recurrence NN I-NP I-problem
that WDT O B-pronoun
was VBD B-VP O
treated VBN O O
with IN B-VP O
radiation NN B-NP B-treatment
therapy NN I-NP I-treatment
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
also RB O O
has VBZ O O
a DT B-NP O
history NN I-NP O
of IN B-VP O
hyperparathyroidism NN B-NP B-problem
secondary JJ O O
to TO O O
papillary JJ B-NP B-problem
thyroid NN I-NP I-problem
cancer NN I-NP I-problem
. . B-VP O
   
The DT B-NP O
history NN I-NP O
is VBZ O O
also RB O O
notable JJ O O
for IN B-VP O
gallstones NNS B-NP B-problem
, , O O
kidney NN B-NP B-problem
stones NNS I-NP I-problem
, , O O
episodic JJ B-NP B-problem
tachycardia NN I-NP I-problem
, , O O
chronic JJ B-NP B-problem
pancreatitis NN I-NP I-problem
. . B-VP O
   
Of IN B-VP O
note NN B-NP O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
also RB O O
has VBZ O O
a DT B-NP O
history NN I-NP O
of IN B-VP O
incontinence NN B-NP B-problem
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
also RB O O
has VBZ O O
hypothyroidism NN B-NP B-problem
. . B-VP O
   
PAST JJ B-NP O
SURGICAL JJ I-NP O
HISTORY NN I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
&apos;s NNP I-NP O
past JJ B-NP O
surgical JJ I-NP O
history NN I-NP O
is VBZ O O
notable JJ O O
for IN B-VP O
the DT B-NP B-treatment
removal NN I-NP I-treatment
of IN B-VP O
a DT B-NP B-problem
thyroid JJ I-NP I-problem
nodule NN I-NP I-problem
in IN B-VP O
February NNP B-NP O
1989 CD O O
. . B-VP O
   
This DT O B-pronoun
revealed VBD B-VP O
papillary JJ B-NP B-problem
thyroid NN I-NP I-problem
cancer NN I-NP I-problem
and CC O O
the DT B-NP B-person
patient NN I-NP I-person
received VBD B-VP O
radioactive JJ B-NP B-treatment
iodine JJ I-NP I-treatment
ablation NN I-NP I-treatment
. . B-VP O
   
In IN B-VP O
June NNP B-NP O
1993 CD O O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
had VBD B-VP O
a DT B-NP B-treatment
parathyroidectomy NN I-NP I-treatment
and CC O O
also RB O O
of IN B-VP O
note NN B-NP O
, , O O
in IN B-VP O
September NNP B-NP O
1992 CD O O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
had VBD B-VP O
an DT B-NP B-test
exploratory JJ I-NP I-test
laparotomy NN I-NP I-test
for IN B-VP O
pain NN B-NP B-problem
and CC O O
chronic JJ B-NP B-problem
pancreatitis NN I-NP I-problem
. . B-VP O
   
MEDICATIONS NNP B-NP O
ON NNP I-NP O
ADMISSION NNP I-NP O
: : O O
Include NNP B-NP O
Librax NNP I-NP B-treatment
1 CD O O
PO NNP B-NP O
before IN B-VP O
meals NNS B-NP O
, , O O
Pancrease NNP B-NP B-treatment
2 CD O O
tabs NN B-NP O
before IN B-VP O
meals NNS B-NP O
, , O O
Synthroid NNP B-NP B-treatment
0.125 CD O O
mg NN B-NP O
PO NNP I-NP O
qd NN I-NP O
. . B-VP O
   
Tenormin NNP B-NP B-treatment
50 CD O O
mg NN B-NP O
bid NN I-NP O
, , O O
Valium NNP B-NP B-treatment
5 CD O O
mg NN B-NP O
bid NN I-NP O
to TO O O
tid VB O O
, , O O
Premarin NNP B-NP B-treatment
0.625 CD O O
mg NN B-NP O
qd NN I-NP O
, , O O
Provera NNP B-NP B-treatment
2.5 CD O O
mg NN B-NP O
qod NN I-NP O
, , O O
Desyrel NNP B-NP B-treatment
50 CD O O
mg NN B-NP O
qhs NN I-NP O
. . B-VP O
   
ALLERGIES CC O O
: : O O
The DT O B-problem
The DT B-NP B-person
patient JJ I-NP I-problem
patient NN I-NP I-person
&apos;s NN I-NP I-problem
allergies NNS I-NP I-problem
include VBP O O
Septra NNP B-NP B-treatment
. . B-VP O
   
SOCIAL NNP B-NP O
HISTORY NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
&apos;s VBZ O O
social JJ B-NP O
history NN I-NP O
is VBZ O O
notable JJ O O
for IN B-VP O
a DT B-NP O
heavy JJ I-NP O
smoking NN I-NP O
history NN I-NP O
. . B-VP O
   
She PRP O B-person
is VBZ O O
interested JJ O O
in IN B-VP O
quitting VBG O O
smoking NN B-NP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
has VBZ O O
no DT B-NP O
history NN I-NP O
of IN B-VP O
alcohol NN B-NP O
abuse NN I-NP O
. . B-VP O
   
PHYSICAL JJ B-NP O
EXAMINATION NN I-NP O
: : O O
The DT O B-test
The DT B-NP B-person
patient JJ I-NP I-test
patient NN I-NP I-person
&apos;s NNP I-NP I-test
preoperative JJ B-NP I-test
examination NN I-NP I-test
is VBZ O O
notable JJ O O
for IN B-VP O
normal JJ B-NP O
breasts NNS I-NP O
, , O O
normal JJ B-NP O
heart NN I-NP O
and CC O O
lungs NNS B-NP O
. . B-VP O
   
The DT B-NP B-test
pelvic JJ I-NP I-test
examination NN I-NP I-test
is VBZ O O
normal JJ O O
except IN B-VP O
for IN B-VP O
the DT B-NP O
presence NN I-NP O
of IN B-VP O
a DT B-NP B-problem
full JJ I-NP I-problem
right NN I-NP I-problem
ovary NN I-NP I-problem
. . B-VP O
   
The DT B-NP B-test
rectovaginal JJ I-NP I-test
examination NN I-NP I-test
is VBZ O O
normal JJ O O
. . B-VP O
   
HOSPITAL NNP B-NP O
COURSE NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
judged VBN O O
to TO O O
be VB O O
at IN B-VP O
risk NN B-NP O
secondary JJ O O
to TO O O
her PRP$ O B-person
history NN B-NP O
of IN B-VP O
somomabodies NNS B-NP B-problem
and CC O O
vaginal JJ B-NP B-problem
bleeding NN I-NP I-problem
. . B-VP O
   
Her PRP$ O B-person
differential JJ B-NP O
diagnosis NN I-NP O
included VBD B-VP O
ovarian JJ B-NP B-problem
cancer NN I-NP I-problem
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
admitted VBN O O
on IN B-VP O
July NNP B-NP O
9 CD O O
to TO O O
the DT B-NP O
operating NN I-NP O
room NN I-NP O
. . B-VP O
   
She PRP O B-person
underwent VBD B-VP O
an DT B-NP B-treatment
open JJ I-NP I-treatment
laparoscopy NN I-NP I-treatment
, , O O
total JJ B-NP B-treatment
abdominal JJ I-NP I-treatment
hysterectomy NN I-NP I-treatment
, , O O
bilateral JJ B-NP B-treatment
salpingo-oophorectomy NN I-NP I-treatment
, , O O
lysis NN B-NP B-treatment
of IN B-VP O
adhesions NNS B-NP B-problem
, , O O
Birch NNP B-NP B-treatment
procedure NN I-NP I-treatment
, , O O
and CC O O
suprapubic JJ B-NP B-treatment
Foley NNP I-NP I-treatment
catheter NN I-NP I-treatment
placement NN I-NP I-treatment
and CC O O
Jackson-Pratt NNP B-NP B-treatment
drain NN I-NP I-treatment
placement NN I-NP I-treatment
. . B-VP O
   
The DT B-NP B-test
estimated JJ I-NP I-test
blood NN I-NP I-test
loss NN I-NP I-test
was VBD B-VP O
300 CD O O
cc NN B-NP O
. . B-VP O
   
There EX O O
were VBD B-VP O
no DT B-NP O
complications NNS I-NP B-problem
during IN B-VP O
the DT B-NP B-treatment
procedure NN I-NP I-treatment
and CC O O
the DT B-NP B-person
patient NN I-NP I-person
returned VBD B-VP O
to TO O O
the DT B-NP O
recovery NN I-NP O
room NN I-NP O
in IN B-VP O
stable JJ B-NP O
condition NN I-NP O
. . B-VP O
   
Postoperatively RB O O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
did VBD B-VP O
well RB O O
. . B-VP O
   
Her PRP$ O B-person
Her PRP$ O B-test
calcium NN B-NP I-test
was VBD B-VP O
followed VBN O O
daily JJ O O
and CC O O
repleted VBD B-VP O
as IN B-VP O
needed VBN O O
. . B-VP O
   
Her PRP$ O B-person
Her PRP$ O B-treatment
Jackson-Pratt JJ B-NP I-treatment
drain NN I-NP I-treatment
was VBD B-VP O
removed VBN O O
on IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
number NN I-NP O
two CD O O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
had VBD B-VP O
a DT B-NP B-test
temperature NN I-NP I-test
of IN B-VP O
101.6 CD O O
on IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
two CD O O
. . B-VP O
   
Her PRP$ O B-person
lungs NNS B-NP O
revealed VBD B-VP O
coarse JJ B-NP B-problem
breath NN I-NP I-problem
sounds NNS I-NP I-problem
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
encouraged VBN O O
to TO O O
ambulate VB O O
and CC O O
deep JJ B-NP O
breath NN I-NP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
started VBN O O
on IN B-VP O
nebulizer NN B-NP B-treatment
treatment NN I-NP I-treatment
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
did VBD B-VP O
well RB O O
and CC O O
her PRP$ O B-person
her PRP$ O B-treatment
suprapubic JJ B-NP I-treatment
tube NN I-NP I-treatment
was VBD B-VP O
clamped VBN O B-treatment
starting VBG O O
on IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
four CD O O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
voided VBD B-VP O
spontaneously RB O O
. . B-VP O
   
Clamping VBG O O
continued VBN O O
until IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
six CD O O
. . B-VP O
   
At IN B-VP O
this DT B-NP B-pronoun
time NN I-NP O
, , O O
her PRP$ O B-person
her PRP$ O B-test
post-void JJ B-NP I-test
residuals NNS I-NP I-test
range VBP O O
from IN B-VP O
2 CD O O
cc NN B-NP O
to TO O O
25 CD O O
cc NN B-NP O
. . B-VP O
   
The DT B-NP B-treatment
suprapubic JJ I-NP I-treatment
tube NN I-NP I-treatment
was VBD B-VP O
therefore RB O O
discontinued VBN O O
. . B-VP O
   
By IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
six CD O O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
also RB O O
tolerating VBG O O
a DT B-NP O
regular JJ I-NP O
diet NN I-NP O
and CC O O
passing NN B-NP O
flatus NN I-NP O
. . B-VP O
   
A DT B-NP B-test
chest JJ I-NP I-test
X-ray NN I-NP I-test
was VBD B-VP O
performed VBN O O
secondary JJ O O
to TO O O
the DT O B-problem
the DT B-NP B-person
patient JJ I-NP I-problem
patient NN I-NP I-person
&apos;s NNP I-NP I-problem
coarse VBZ O I-problem
breath NN B-NP I-problem
sounds NNS I-NP I-problem
, , O O
however RB O O
, , O O
the DT B-NP B-test
chest JJS I-NP I-test
X-ray NN I-NP I-test
was VBD B-VP O
clear JJ O O
except IN B-VP O
for IN B-VP O
a DT B-NP O
small JJ I-NP O
amount NN I-NP O
of IN B-VP O
atelectasis NN B-NP B-problem
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
discharged VBN O O
home NN B-NP O
. . B-VP O
   
final JJ B-NP B-test
pathology NN I-NP I-test
revealed VBD B-VP O
right JJ B-NP O
Fallopian NNP I-NP O
tube NN I-NP O
and CC O O
ovary JJ O O
with IN B-VP O
benign JJ B-NP B-problem
paratubal JJ I-NP I-problem
cysts NNS I-NP I-problem
and CC O O
adhesions NNS B-NP B-problem
. . B-VP O
   
The DT B-NP O
cervix NN I-NP O
revealed VBD B-VP O
squamous JJ B-NP B-problem
metaplasia NN I-NP I-problem
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
discharged VBN O O
home NN B-NP O
on IN B-VP O
admission NN B-NP B-treatment
medications NNS I-NP I-treatment
. . B-VP O
   
In IN B-VP O
addition NN B-NP O
, , O O
she PRP O B-person
will MD O O
take VB O O
Ciprofloxacin NNP B-NP B-treatment
for IN B-VP O
nine CD O O
more JJR B-NP O
days NNS I-NP O
. . B-VP O
   
She PRP O B-person
will MD O O
also RB O O
take VB O O
Percocet NNP B-NP B-treatment
. . B-VP O
   
DISPOSITION NN B-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
is VBZ O O
discharged VBN O O
to TO O O
home NN B-NP O
and CC O O
is VBZ O O
to TO O O
follow VB O O
up RP O O
with IN B-VP O
Dr. NNP B-NP B-person
Cancer NNP I-NP I-person
, , O O
as RB O O
well RB O O
as IN B-VP O
Dr. NNP B-NP B-person
Kotefold NNP I-NP I-person
and CC O O
Dr. NNP B-NP B-person
Cancer NNP I-NP I-person
. . B-VP O
   
KITRI NNP B-NP B-person
CURB NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
DICTATING NNP I-NP O
FOR NNP I-NP O
: : O O
EARNRA NNP B-NP B-person
CANCER NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
TR NNP I-NP O
: : O O
nx JJ B-NP O
/ NNP I-NP O
bmot NN I-NP O
DD NNP I-NP O
: : O O
07-15-93 JJ B-NP O
TD NN I-NP O
: : O O
07/16/93 CD O O
CC NN B-NP O
: : O O
Dr. NNP B-NP B-person
Ertca NNP I-NP I-person
Cancer NNP I-NP I-person
, , O O
Dr. NNP B-NP B-person
Kotefold NNP I-NP I-person
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- VBD B-VP O
600720722 CD O O
SC NNP B-NP O
86426538 CD O O
5408181 CD O O
9/17/2005 CD O O
12:00:00 CD O O
AM NNP B-NP O
pp NN I-NP O
DIS NNP I-NP O
Admission NNP I-NP O
Date NNP I-NP O
: : O O
09/17/2005 CD O O
Report NNP B-NP O
Status NNP I-NP O
: : O O
Discharge NN B-NP O
Date NNP I-NP O
: : O O
09/20/2005 CD O O
****** NNP B-NP O
FINAL NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
CRASSBELBKOTE NNP I-NP B-person
, , O I-person
NEE NNP B-NP I-person
537-39-30-6 JJ B-NP O
T83 NNP I-NP O
Room NNP I-NP O
: : O O
EIZ0-059 JJ B-NP O
Service NNP I-NP O
: : O O
OBS NNP B-NP O
DISCHARGE NNP I-NP O
PATIENT NNP I-NP B-person
ON NNP I-NP O
: : O O
09/20/05 CD O O
AT NNP B-NP O
10:00 CD O O
AM NNP B-NP O
CONTINGENT NNP I-NP O
UPON NNP I-NP O
HO NNP I-NP B-test
evaluation NN I-NP I-test
WILL NNP I-NP O
D NNP I-NP O
/ NNP I-NP O
C NNP I-NP O
ORDER NNP I-NP O
BE NNP I-NP O
USED NNP I-NP O
AS IN B-VP O
THE NNP B-NP O
D NNP I-NP O
/ NNP I-NP O
C NNP I-NP O
SUMMARY NNP I-NP O
: : O O
YES JJ B-NP O
Attending NN I-NP B-person
: : O O
GIENGPRATLSHUFF NNP B-NP B-person
, , O I-person
QUASARZELL NNP B-NP I-person
KATECHEL NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
, , O I-person
PH.D. NNP B-NP I-person
DISPOSITION NNP I-NP O
: : O O
Home NNP B-NP O
DISCHARGE NNP I-NP O
MEDICATIONS NNP I-NP O
: : O O
DIET NN B-NP O
: : O O
No DT B-NP O
Restrictions NNP I-NP O
ACTIVITY NNP I-NP O
: : O O
Resume NNP B-NP O
regular JJ B-NP O
exercise NN I-NP O
FOLLOW NNP I-NP O
UP NNP I-NP O
APPOINTMENT NNP I-NP O
( ( O O
S NNP B-NP O
) ) O O
: : O O
QH $ O O
2/6wks CD O O
, , O O
ALLERGY NNP B-NP O
: : O O
NKA NNP B-NP B-problem
ADMIT NNP I-NP O
DIAGNOSIS NNP I-NP O
: : O O
pp NN B-NP B-problem
/ NNP I-NP O
pps NN I-NP B-problem
PRINCIPAL NNP I-NP O
DISCHARGE NNP I-NP O
DIAGNOSIS NNP I-NP O
; : O O
Responsible NNP B-NP O
After IN B-VP O
Study NNP B-NP O
for IN B-VP O
Causing NNP B-NP O
Admission NNP I-NP O
) ) O O
pp VBZ O B-problem
OTHER NNP B-NP O
DIAGNOSIS NNP I-NP O
; : O O
Conditions NNP B-NP O
, , O O
Infections NNP B-NP O
, , O O
Complications NNP B-NP O
, , O O
affecting VBG O O
Treatment NNP B-NP O
/ NNP I-NP O
Stay NNP I-NP O
pp IN B-VP B-problem
OPERATIONS NNP B-NP O
AND CC O O
PROCEDURES NNP B-NP O
: : O O
Primary JJ B-NP O
Anesthesia NN I-NP O
: : O O
Epidural JJ B-NP B-treatment
Secondary JJ I-NP O
Anesthesia NN I-NP O
: : O O
Local JJ B-NP O
Procedures NNS I-NP O
: : O O
PPS NNP B-NP B-problem
, , O O
OTHER NNP B-NP O
TREATMENTS NNP I-NP O
/ NNP I-NP O
PROCEDURES NNP I-NP O
( ( O O
NOT NNP B-NP O
IN NNP I-NP O
O.R. NNP I-NP O
) ) O O
bilateral NN B-NP B-treatment
tubal JJ B-NP I-treatment
ligation NN I-NP I-treatment
BRIEF NNP I-NP O
RESUME NNP I-NP O
OF NNP I-NP O
HOSPITAL NNP I-NP O
COURSE NNP I-NP O
: : O O
G3 NNP B-NP O
T3 NNP I-NP O
P0 NNP I-NP O
A0 NNP I-NP O
L3 NNP I-NP O
Estimated VBD B-VP O
EDC NNP B-NP O
: : O O
Maternal JJ B-NP O
transfer NN I-NP O
: : O O
No DT B-NP O
ADDITIONAL NNP I-NP O
COMMENTS NN I-NP O
: : O O
DISCHARGE JJ B-NP O
CONDITION NNP I-NP O
: : O O
Stable JJ B-NP O
TO NNP I-NP O
DO NNP I-NP O
/ NNP I-NP O
PLAN NNP I-NP O
: : O O
No DT B-NP O
dictated JJ I-NP O
summary NN I-NP O
ENTERED NN I-NP O
BY NNP I-NP O
: : O O
JOAS NNP B-NP B-person
, , O I-person
CENI NNP B-NP I-person
, , O I-person
C.N.M. NNP B-NP I-person
( ( O O
FJ992 NNP B-NP O
) ) O O
09/19/05 CD O O
09:50 CD O O
AM NNP B-NP O
****** JJ B-NP O
END NN I-NP O
OF NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
Admission NNP I-NP O
Date NNP I-NP O
: : O O
2016-12-15 JJ B-NP O
Discharge NN I-NP O
Date NNP I-NP O
: : O O
2016-12-21 JJ B-NP O
Date NNP I-NP O
of IN B-VP O
Birth NNP B-NP O
: : O O
1980-08-17 JJ B-NP O
Sex NN I-NP O
: : O O
F NNP B-NP O
Service NNP I-NP O
: : O O
OBSTETRICS NNP B-NP O
/ NNP I-NP O
GYNECOLOGY NNP I-NP O
Allergies NNS I-NP O
: : O O
Sulfonamides NNS B-NP B-treatment
Attending VBG O B-person
: : O O
Melissa NNP B-NP B-person
P NNP I-NP I-person
Lowery NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
Chief NNP I-NP O
Complaint NNP I-NP O
: : O O
Term NNP B-NP O
pregnancy NN I-NP O
Major NNP I-NP O
Surgical NNP I-NP O
or CC O O
Invasive JJ B-NP O
Procedure NN I-NP O
: : O O
SVD NNP B-NP B-treatment
D&C NNP I-NP B-treatment
Supracervical NNP I-NP B-treatment
hysterectomy NN I-NP I-treatment
Reexploration NNP I-NP B-test
with IN B-VP O
vaginal JJ B-NP B-treatment
artery NN I-NP I-treatment
ligation NN I-NP I-treatment
Multiple NNP I-NP B-treatment
transfusions NNS I-NP I-treatment
History NNP I-NP O
of IN B-VP O
Present NNP B-NP O
Illness NNP I-NP O
: : O O
36 CD O O
yo NN B-NP O
G3P2 NNP I-NP O
at IN B-VP O
38+5 CD O O
weeks NNS B-NP O
GA NNP I-NP O
presented VBD B-VP O
to TO O O
L&D NNP B-NP O
for IN B-VP O
elective JJ B-NP B-treatment
induction NN I-NP I-treatment
of IN B-VP I-treatment
labor NN B-NP I-treatment
. . B-VP O
   
Antenatal JJ B-NP O
course NN I-NP O
benign NN I-NP O
. . B-VP O
   
Past NNP B-NP O
Medical JJ B-NP O
History NN I-NP O
: : O O
PMHx NN B-NP O
: : O O
Narcolepsy NNP B-NP B-problem
. . B-VP O
   
R NNP B-NP B-problem
inguinal JJ B-NP I-problem
hernia NN I-NP I-problem
. . B-VP O
   
ObHx CC O O
: : O O
SVDX2 JJ B-NP B-treatment
Social NNP I-NP O
History NN I-NP O
: : O O
Married NNP B-NP O
. . B-VP O
   
No NNP B-NP O
T/E/D NNP I-NP O
Family NNP I-NP O
History NNP I-NP O
: : O O
NC NNP B-NP O
Physical NNP I-NP O
Exam NNP I-NP O
: : O O
Vital JJ B-NP B-test
signs NNS I-NP I-test
stable JJ O O
on IN B-VP O
admission NN B-NP O
. . B-VP O
   
Heart NNP B-NP O
RRR NNP I-NP O
Lungs NNP I-NP O
CTAB NNP I-NP O
Abd NNP I-NP B-problem
Gravid NNP I-NP I-problem
, , O O
NT NNP B-NP B-problem
Ext NNP I-NP O
without IN B-VP O
edema NN B-NP B-problem
Cervix NNP I-NP O
1 CD O O
cm NN B-NP O
dilated VBN O O
. . B-VP O
   
Pertinent JJ B-NP O
Results NNS I-NP O
: : O O
2016-12-15 JJ O O
03:31 CD O O
PM NNP B-NP O
BLOOD NNP I-NP B-test
WBC NNP I-NP B-test
- : O O
6.2 CD O O
RBC NNP B-NP B-test
- : O O
3.82 CD O O
* NN B-NP O
Hgb NNP I-NP B-test
- : O O
12.2 CD O O
Hct NNP B-NP B-test
- : O O
34.5 CD O O
* NN B-NP O
MCV NNP I-NP B-test
- : O O
91 CD O O
MCH NNP B-NP B-test
- : O O
32.0 CD O O
MCHC NNP B-NP B-test
- : O O
35.4 CD O O
* NN B-NP O
RDW NNP I-NP B-test
- : O O
12.7 CD O O
Plt NNP B-NP B-test
Ct NNP I-NP I-test
- : O O
246 CD O O
2016-12-21 JJ O O
07:45 CD O O
AM NNP B-NP O
BLOOD NNP I-NP B-test
WBC NNP I-NP B-test
- : O O
6.6 CD O O
RBC NNP B-NP B-test
- : O O
2.79 CD O O
* NN B-NP O
Hgb NNP I-NP B-test
- : O O
8.5 CD O O
* NN B-NP O
Hct NNP I-NP B-test
- : O O
23.9 CD O O
* NN B-NP O
MCV NNP I-NP B-test
- : O O
86 CD O O
MCH NNP B-NP B-test
- : O O
30.5 CD O O
MCHC NNP B-NP B-test
- : O O
35.7 CD O O
* NN B-NP O
RDW NNP I-NP B-test
- : O O
16.9 CD O O
* JJ B-NP O
Plt NNP I-NP B-test
Ct NNP I-NP I-test
- : O O
222 CD O O
# # O O
Brief NNP B-NP O
Hospital NNP I-NP O
Course NNP I-NP O
: : O O
After IN B-VP O
admission NN B-NP O
to TO O O
L&D NNP B-NP O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
administered VBN O O
Pitocin NNP B-NP B-treatment
for IN B-VP O
elective JJ B-NP B-treatment
induction NN I-NP I-treatment
of IN B-VP I-treatment
labor NN B-NP I-treatment
and CC O O
progressed VBD B-VP O
uneventfully RB O O
and CC O O
went VBD B-VP O
on IN B-VP O
to TO O O
deliver VB O O
a DT B-NP O
viable JJ I-NP O
female NN I-NP B-person
infant NN I-NP I-person
, , O O
weight NN B-NP B-test
3595 CD O O
g NN B-NP O
, , O O
Apgars NNP B-NP B-test
11-11 CD O O
. . B-VP O
   
EBL NNP B-NP B-problem
during IN B-VP O
delivery NN B-NP O
was VBD B-VP O
300 CD O O
cc NN B-NP O
. . B-VP O
   
Patient NNP B-NP B-person
was VBD B-VP O
transferred VBN O O
to TO O O
the DT B-NP O
PP NNP I-NP O
floor NN I-NP O
in IN B-VP O
stable JJ B-NP O
condition NN I-NP O
. . B-VP O
   
Soon NN B-NP O
after IN B-VP O
transfer NN B-NP O
, , O O
patient NN B-NP B-person
had VBD B-VP O
a DT B-NP B-problem
large JJ I-NP I-problem
post NN I-NP I-problem
partum NN I-NP I-problem
hemorrhage NN I-NP I-problem
. . B-VP O
   
This DT O B-pronoun
was VBD B-VP O
treated VBN O O
with IN B-VP O
transfer NN B-NP O
back RB O O
to TO O O
L&D NNP B-NP O
, , O O
bimanual JJ B-NP B-treatment
massage NN I-NP I-treatment
, , O O
administration NN B-NP O
of IN B-VP O
various JJ B-NP B-treatment
uterotonics NNS I-NP I-treatment
, , O O
namely RB O O
pitocin JJ O B-treatment
100 CD O O
U NNP B-NP O
, , O O
Methergine NNP B-NP B-treatment
x NNP I-NP O
1 CD O O
, , O O
Hemabate NNP B-NP B-treatment
x NNP I-NP O
1 CD O O
, , O O
and CC O O
cytotec JJ O B-treatment
1000 CD O O
mcgs NN B-NP O
with IN B-VP O
minimal JJ B-NP O
response NN I-NP O
. . B-VP O
   
Patient JJ B-NP B-person
underwent JJ I-NP O
suction NN I-NP B-treatment
curettage NN I-NP I-treatment
and CC O O
finally RB O O
a DT B-NP B-treatment
supercervical JJ I-NP I-treatment
hysterectomy NN I-NP I-treatment
. . B-VP O
   
EBL JJ O B-problem
4000 CD O O
cc NN B-NP O
; : O O
IVF NNP B-NP B-treatment
6000 CD O O
cc NN B-NP O
crystalloid NN I-NP B-treatment
; : O O
U/O NNP B-NP B-test
3500 CD O O
cc NN B-NP O
. . B-VP O
   
Products NNS B-NP O
: : O O
8 CD O B-treatment
units NNS B-NP I-treatment
RBC NNP I-NP I-treatment
, , O O
6FFP CD O B-treatment
, , O O
1 CD O B-treatment
cryo NN B-NP I-treatment
, , O O
1 CD O B-treatment
pack NN B-NP I-treatment
plt NN I-NP I-treatment
. . B-VP O
   
After IN B-VP O
this DT O B-pronoun
this DT B-NP B-treatment
procedure NN I-NP I-treatment
, , O O
the DT B-NP B-person
patient NN I-NP I-person
again RB O O
hemorrhaged VBN O O
in IN B-VP O
the DT B-NP O
ICU NNP I-NP O
and CC O O
was VBD B-VP O
taken VBN O O
back RB O O
to TO O O
the DT B-NP O
OR NNP I-NP O
for IN B-VP O
reexploration NN B-NP B-test
and CC O O
ligation NN B-NP B-treatment
of IN B-VP O
a DT B-NP B-problem
bleeding JJ I-NP I-problem
vaginal JJ I-NP I-problem
artery NN I-NP I-problem
. . B-VP O
   
EBL JJ O B-problem
3500 CD O O
; : O O
IVF NNP B-NP B-treatment
4000 CD O O
; : O O
UO NNP B-NP B-test
45 CD O O
; : O O
RBC NNP B-NP B-treatment
9U CD O O
; : O O
Plt NNP B-NP B-treatment
12 CD O O
pack NN B-NP O
; : O O
1u CD O B-treatment
Cryo NNP B-NP I-treatment
; : O O
6U CD O B-treatment
FFP NNP B-NP I-treatment
. . B-VP O
   
For IN B-VP O
details NNS B-NP O
of IN B-VP O
these DT O B-treatment
these DT B-NP B-pronoun
procedures NNS I-NP I-treatment
, , O O
please VB O O
see VB O O
op JJ B-NP O
notes NNS I-NP O
dictated VBN O O
by IN B-VP O
Dr. NNP B-NP B-person
Day NNP I-NP I-person
on IN B-VP O
2016-12-16 JJ O O
. . B-VP O
   
Overall JJ O O
, , O O
the DT B-NP B-person
pt NN I-NP I-person
maintained VBD B-VP O
good JJ B-NP O
BP NNP I-NP B-test
throughout IN B-VP O
and CC O O
was VBD B-VP O
on IN B-VP O
pressors NNS B-NP B-treatment
only RB O O
briefly VBP O O
. . B-VP O
   
Hct NNP B-NP B-test
was VBD B-VP O
maintained VBN O O
in IN B-VP O
stable JJ B-NP O
range NN I-NP O
with IN B-VP O
product NN B-NP B-treatment
transfusions NNS I-NP I-treatment
. . B-VP O
   
Patient NN B-NP B-person
did VBD B-VP O
well RB O O
and CC O O
was VBD B-VP O
extubated VBN O O
uneventfully RB O O
on IN B-VP O
12-17 JJ O O
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
transferred VBN O O
from IN B-VP O
the DT B-NP O
ICU NNP I-NP O
back RB O O
to TO O O
the DT B-NP O
PP NNP I-NP O
floor NN I-NP O
on IN B-VP O
12-19 JJ O O
. . B-VP O
   
There EX O O
, , O O
she PRP O B-person
made VBD B-VP O
great JJ B-NP O
progress NN I-NP O
. . B-VP O
   
Her PRP$ O B-person
Her NNP B-NP B-test
vital NN I-NP I-test
signs NNS I-NP I-test
were VBD B-VP O
stable JJ O O
, , O O
she PRP O B-person
remained VBD B-VP O
afebrile RB O B-problem
off IN B-VP O
antibiotics NNS B-NP B-treatment
. . B-VP O
   
Her PRP$ O B-person
Her PRP$ O B-problem
pain NN B-NP I-problem
was VBD B-VP O
controlled VBN O O
with IN B-VP O
percocet NN B-NP B-treatment
and CC O O
motrin NN B-NP B-treatment
. . B-VP O
   
Her PRP$ O B-person
Her PRP$ O B-treatment
foley NN B-NP I-treatment
was VBD B-VP O
removed VBN O O
and CC O O
she PRP O B-person
voided VBD B-VP O
without IN B-VP O
problems NNS B-NP B-problem
. . B-VP O
   
She PRP O B-person
John NNP B-NP O
, , O O
tolerated VBD B-VP O
a DT B-NP O
regular JJ I-NP O
diet NN I-NP O
, , O O
and CC O O
was VBD B-VP O
discharged VBN O O
home NN B-NP O
in IN B-VP O
good JJ B-NP O
condition NN I-NP O
on IN B-VP O
12-21 JJ O O
. . B-VP O
   
Medications NNS B-NP O
on IN B-VP O
Admission NN B-NP O
: : O O
Cylert NNP B-NP B-treatment
. . B-VP O
   
Discharge NNP B-NP O
Medications NNPS I-NP O
: : O O
1. CD O O
Ibuprofen NNP B-NP B-treatment
600 CD O O
mg NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Tablet NNP B-NP O
PO NNP I-NP O
Q6H NNP I-NP O
( ( O O
every DT O O
6 CD O O
hours NNS B-NP O
) ) O O
as IN B-VP O
needed VBN O O
. . B-VP O
   
Disp NNP B-NP O
:* VBD B-VP O
25 CD O O
Tablet NNP B-NP O
( ( O O
s JJ B-NP O
)* NN I-NP O
Refills NNS I-NP O
: : O O
* $ O O
0 CD O O
* $ O O
2. CD O O
Oxycodone NNP B-NP B-treatment
- : O I-treatment
Acetaminophen NNP B-NP I-treatment
5-325 JJ B-NP O
mg NN I-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
1-2 JJ B-NP O
Tablets NNS I-NP O
PO NNP I-NP O
Q4-6H NNP I-NP O
( ( O O
every DT O O
4 CD O O
to TO O O
6 CD O O
hours NNS B-NP O
) ) O O
as IN B-VP O
needed VBN O O
. . B-VP O
   
Disp NNP B-NP O
:* VBD B-VP O
30 CD O O
Tablet NNP B-NP O
( ( O O
s JJ B-NP O
)* NNP I-NP O
Refills NNP I-NP O
:* VBZ O O
0 CD O O
* NN B-NP O
Discharge NNP I-NP O
Disposition NNP I-NP O
: : O O
Home NNP B-NP O
Discharge NNP I-NP O
Diagnosis NNP I-NP O
: : O O
Full JJ B-NP O
term NN I-NP O
pregnancy NN I-NP O
, , O O
s/p JJ B-NP O
SVD NNP I-NP B-treatment
Uterine NNP I-NP B-problem
atony NN I-NP I-problem
, , O O
postpartum NN B-NP B-problem
hemorrhage NN I-NP I-problem
Severe NNP I-NP B-problem
anemia NN I-NP I-problem
Discharge NNP I-NP O
Condition NNP I-NP O
: : O O
Stable JJ B-NP O
Discharge NN I-NP O
Instructions NNS I-NP O
: : O O
Follow NNP B-NP O
printed VBD B-VP O
instructions NNS B-NP O
Followup NNP I-NP O
Instructions NNS I-NP O
: : O O
6 CD O O
wks NN B-NP O
for IN B-VP O
postpartum NN B-NP B-test
exam NN I-NP I-test
MOnday NNP I-NP O
for IN B-VP O
staple JJ B-NP B-treatment
removal NN I-NP I-treatment
. . B-VP O
   
James NNP B-NP B-person
Tricia NNP I-NP I-person
MD NNP I-NP I-person
61-345 JJ O O
Completed VBN O O
by IN B-VP O
: : O O
Greg NNP B-NP B-person
Allen NNP I-NP I-person
MD NNP I-NP I-person
53-372 JJ B-NP O
2016-12-22 JJ I-NP O
@ NN I-NP O
1825 CD O O
Signed NNP B-NP O
electronically RB O O
by IN B-VP O
: : O O
DR. NNP B-NP B-person
Katherine NNP I-NP I-person
Beaulieu NNP I-NP I-person
Brush NNP I-NP I-person
on IN B-VP O
: : O O
WED JJ O O
2017-01-25 JJ O O
12:05 CD O O
AM NNP B-NP O
( ( O O
End NNP B-NP O
of IN B-VP O
Report NNP B-NP O
) ) O O
-EMPTYLINE- VBP O O
-DOCSTART- JJ O O
-EMPTYLINE- $ O O
736743101 CD O O
PUOMC NNP B-NP O
2427050 CD O O
19324/7383 CD O O
418074 CD O O
4/17/1995 CD O O
12:00:00 CD O O
AM NNP B-NP O
NECROTIZING NNP I-NP B-problem
PANCREATITIS NNP I-NP I-problem
. . B-VP O
   
Unsigned VBD B-VP O
DIS NNP B-NP O
Report NNP I-NP O
Status NNP I-NP O
: : O O
Unsigned VBN O O
ADMISSION NNP B-NP O
DATE NNP I-NP O
: : O O
4/17/95 CD O O
DISCHARGE NNP B-NP O
DATE NNP I-NP O
: : O O
07/16/95 CD O O
DATE NN B-NP O
OF NNP I-NP O
BIRTH NNP I-NP O
: : O O
7/2/1928 CD O O
. . B-VP O
   
PRINCIPAL JJ B-NP O
DIAGNOSIS NNP I-NP O
: : O O
Necrotizing NNP B-NP B-problem
pancreatitis NN I-NP I-problem
. . B-VP O
   
ASSOCIATED CC O O
DIAGNOSIS NNP B-NP O
: : O O
1. CD O O
Wegener NNP B-NP B-problem
&apos;s JJ B-NP I-problem
granulomatosis NN I-NP I-problem
. . B-VP O
   
2. CD O O
Coronary JJ B-NP B-problem
artery NN I-NP I-problem
disease NN I-NP I-problem
, , O O
status NN B-NP O
post NN I-NP O
anterior RB O B-problem
myocardial JJ B-NP I-problem
infarction NN I-NP I-problem
in IN B-VP O
1993 CD O O
. . B-VP O
   
3. CD O O
Left VBD B-VP B-problem
ventricular JJ B-NP I-problem
aneurysm NN I-NP I-problem
. . B-VP O
   
4. CD O O
Dementia NNP B-NP B-problem
. . B-VP O
   
5. CD O O
Gallstone NNP B-NP B-problem
pancreatitis NN I-NP I-problem
. . B-VP O
   
6. CD O O
Fungal NNP B-NP B-problem
cystitis NN I-NP I-problem
. . B-VP O
   
7. CD O O
Intra-abdominal JJ B-NP B-problem
infection NN I-NP I-problem
. . B-VP O
   
8. CD O O
Total JJ B-NP B-problem
parenteral JJ I-NP I-problem
nutrition NN I-NP I-problem
dependent NN I-NP I-problem
. . B-VP O
   
PRINCIPAL JJ B-NP O
PROCEDURE NN I-NP O
: : O O
Exploratory JJ B-NP B-test
laparotomy NN I-NP I-test
, , O O
left VBD B-VP B-treatment
colectomy NN B-NP I-treatment
, , O O
end-transverse JJ B-NP B-treatment
colostomy NN I-NP I-treatment
, , O O
drainage NN B-NP B-treatment
of IN B-VP O
pancreatic JJ B-NP B-problem
necrosis NN I-NP I-problem
. . B-VP O
   
Date NNP B-NP O
of IN B-VP O
operation NN B-NP O
: : O O
4/28/95 CD O O
. . B-VP O
   
HISTORY NN B-NP O
AND NNP I-NP O
REASON NNP I-NP O
FOR NNP I-NP O
ADMISSION NNP I-NP O
: : O O
Mr. NNP B-NP B-person
Mass NNP I-NP I-person
was VBD B-VP O
a DT O O
56 CD O O
year NN B-NP O
old JJ B-NP O
white JJ I-NP O
male NN I-NP O
who WP O B-person
was VBD B-VP O
transferred VBN O O
from IN B-VP O
Vassdiysey NNP B-NP O
Medical NNP I-NP O
Center NNP I-NP O
for IN B-VP O
rule NN B-NP O
out IN B-VP O
pancreatic JJ B-NP B-problem
pseudocyst NN I-NP I-problem
. . B-VP O
   
Mr. NNP B-NP B-person
Mass NNP I-NP I-person
had VBD B-VP O
a DT B-NP O
past JJ I-NP O
medical JJ I-NP O
history NN I-NP O
which WDT O B-pronoun
included VBD B-VP O
Wegener NNP B-NP B-problem
&apos;s NNP I-NP I-problem
granulomatosis NN I-NP I-problem
, , O O
history NN B-NP O
of IN B-VP O
an DT B-NP B-problem
anterior JJ I-NP I-problem
myocardial JJ I-NP I-problem
infarction NN I-NP I-problem
, , O O
and CC O O
gallstone NN B-NP B-problem
pancreatitis NN I-NP I-problem
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
admitted VBN O O
to TO O O
Vassdiysey NNP B-NP O
Medical NNP I-NP O
Center NNP I-NP O
with IN B-VP O
severe JJ B-NP B-problem
recurrent NN I-NP I-problem
pancreatitis NN I-NP I-problem
, , O O
nausea NN B-NP B-problem
, , O O
vomiting NN B-NP B-problem
, , O O
and CC O O
abdominal JJ B-NP B-problem
pain NN I-NP I-problem
. . B-VP O
   
His PRP$ O B-person
His PRP$ O B-test
amylase NN B-NP I-test
on IN B-VP O
admission NN B-NP O
there EX O O
was VBD B-VP O
1,961 CD O O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
had VBD B-VP O
two CD O O
recent JJ B-NP O
admissions NNS I-NP O
for IN B-VP O
pancreatitis NN B-NP B-problem
in IN B-VP O
January NNP B-NP O
1994 CD O O
, , O O
and CC O O
August NNP B-NP O
1994 CD O O
. . B-VP O
   
On IN B-VP O
his PRP$ O B-person
current JJ B-NP O
admission NN I-NP O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
admitted VBN O O
to TO O O
Free NNP B-NP O
Medical NNP I-NP O
Center NNP I-NP O
. . B-VP O
   
His PRP$ O B-person
His PRP$ O B-test
amylase NN B-NP I-test
decreased VBD B-VP O
to TO O O
51 CD O O
, , O O
and CC O O
the DT O O
increased VBN O O
back RB O O
to TO O O
151 CD O O
on IN B-VP O
hospital JJ B-NP O
day NN I-NP O
#10 NNP I-NP O
. . B-VP O
   
At IN B-VP O
that DT B-NP B-pronoun
time NN I-NP O
, , O O
he PRP O B-person
spiked VBD B-VP O
a DT B-NP B-test
temperature NN I-NP I-test
to TO O O
103 CD O O
. . B-VP O
   
He PRP O B-person
also RB O O
became VBD B-VP O
increasingly RB O B-problem
confused VBN O I-problem
. . B-VP O
   
A DT B-NP B-test
computerized JJ I-NP I-test
tomography NN I-NP I-test
scan JJ O I-test
done VBN O O
on IN B-VP O
4/16/95 CD O O
showed VBD B-VP O
a DT B-NP B-problem
large JJ I-NP I-problem
&quot; NNP I-NP I-problem
pseudocyst NN I-NP I-problem
&quot; NN I-NP I-problem
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
transferred VBN O O
to TO O O
Ph NNP B-NP O
University NNP I-NP O
Of IN B-VP O
Medical NNP B-NP O
Center NNP I-NP O
for IN B-VP O
further JJ B-NP B-test
surgical JJ I-NP I-test
evaluation NN I-NP I-test
.&apos; NNP I-NP O
PAST NNP I-NP O
MEDICAL NNP I-NP O
HISTORY NNP I-NP O
: : O O
1. CD O O
As IN B-VP O
above NN B-NP O
. . B-VP O
   
2. CD O O
Coronary JJ B-NP B-problem
artery NN I-NP I-problem
disease NN I-NP I-problem
, , O O
status NN B-NP O
post NN I-NP O
anterior RB O B-problem
myocardial JJ B-NP I-problem
infarction NN I-NP I-problem
, , O O
in IN B-VP O
1993 CD O O
. . B-VP O
   
Ejection NNP B-NP B-test
fraction NN I-NP I-test
was VBD B-VP O
felt VBN O O
to TO O O
be VB O O
35% CD O O
in IN B-VP O
1993 CD O O
. . B-VP O
   
Recent JJ O B-test
echocardiogram JJ O I-test
suggests VBZ O O
ejection NN B-NP B-test
fraction NN I-NP I-test
of IN B-VP O
15% CD O O
. . B-VP O
   
3. CD O O
Wegener NNP B-NP B-problem
&apos;s JJ B-NP I-problem
granulomatosis NN I-NP I-problem
, , O O
with IN B-VP O
associated VBN O B-problem
chronic JJ B-NP I-problem
renal JJ I-NP I-problem
insufficiency NN I-NP I-problem
. . B-VP O
   
4. CD O O
Mild NNP B-NP B-problem
dementia NN I-NP I-problem
. . B-VP O
   
MEDICATIONS NN B-NP O
: : O O
Vitamin NNP B-NP B-treatment
K NNP I-NP I-treatment
, , O O
10 CD O O
mg. NN B-NP O
, , O O
IM NNP B-NP O
, , O O
q-week JJ O O
. . B-VP O
   
2. CD O O
Pepcid NNP B-NP B-treatment
, , O O
20 CD O O
mg. NN B-NP O
, , O O
intravenously RB O O
, , O O
q12h. VBD B-VP O
3. CD O O
Digoxin NNP B-NP B-treatment
, , O O
0.125 CD O O
mg. NN B-NP O
, , O O
intravenously RB O O
, , O O
qD NN B-NP O
. . B-VP O
   
4. CD O O
Imipenem NNP B-NP B-treatment
, , O O
500 CD O O
mg. NN B-NP O
, , O O
intravenously RB O O
, , O O
q6h. VBD B-VP O
5. CD O O
Nitropaste NNP B-NP B-treatment
, , O O
one-half JJ B-NP O
inch NN I-NP O
to TO O O
chest VB O O
wall NN B-NP O
, , O O
q6h. RB O O
6. CD O O
Vasotec NNP B-NP B-treatment
. . B-VP O
   
7. CD O O
Alterajel NNP B-NP B-treatment
. . B-VP O
   
8. CD O O
Lasix NNP B-NP B-treatment
, , O O
20 CD O O
mg. NN B-NP O
, , O O
po NN B-NP O
, , O O
qD NN B-NP O
. . B-VP O
   
9. CD O O
Haldol NNP B-NP B-treatment
. . B-VP O
   
10. CD O O
Demerol NNP B-NP B-treatment
, , O O
prn NN B-NP O
. . B-VP O
   
ALLERGIES NN B-NP O
: : O O
Ativan NNP B-NP B-treatment
. . B-VP O
   
PHYSICAL NNP B-NP O
EXAMINATION NN I-NP O
: : O O
In IN B-VP O
general JJ O O
, , O O
confused JJ B-NP B-person
white JJ I-NP I-person
man NN I-NP I-person
, , O O
in IN B-VP O
mild JJ B-NP B-problem
distress NN I-NP I-problem
. . B-VP O
   
Vital JJ B-NP O
signs NNS I-NP O
: : O O
Temperature NN B-NP B-test
was VBD B-VP O
102 CD O O
, , O O
heart NN B-NP B-test
rate NN I-NP I-test
was VBD B-VP O
110 CD O O
, , O O
respiratory NN B-NP B-test
rate NN I-NP I-test
was VBD B-VP O
22 CD O O
, , O O
blood NN B-NP B-test
pressure NN I-NP I-test
was VBD B-VP O
113/63 CD O O
. . B-VP O
   
His PRP$ O B-person
head NN B-NP O
, , O O
eyes NNS B-NP O
, , O O
ears NNS B-NP O
, , O O
nose RB O O
, , O O
throat NN B-NP O
was VBD B-VP O
benign JJ O O
. . B-VP O
   
His PRP$ O B-person
neck NN B-NP O
was VBD B-VP O
supple JJ O O
. . B-VP O
   
Lungs NNS B-NP O
: : O O
Rales NNS B-NP B-problem
at IN B-VP I-problem
the DT B-NP I-problem
right JJ I-NP I-problem
base NN I-NP I-problem
, , O O
bilateral JJ O B-problem
decreased VBN O I-problem
breath NN B-NP I-problem
sounds NNS I-NP I-problem
at IN B-VP I-problem
the DT B-NP I-problem
bases NNS I-NP I-problem
. . B-VP O
   
Cor NN B-NP O
: : O O
Regular JJ B-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
, , O O
S1 NNP B-NP O
and CC O O
S2 NNP B-NP O
, , O O
no DT B-NP O
extra JJ I-NP B-problem
heart NN I-NP I-problem
sounds VBZ O I-problem
, , O O
abdomen NNS B-NP B-problem
distended VBD B-VP I-problem
with IN B-VP O
an DT B-NP B-problem
epigastric JJ I-NP I-problem
mass NN I-NP I-problem
noted VBD B-VP O
, , O O
mildly RB O B-problem
tender NN B-NP I-problem
to TO O O
palpation NN B-NP B-test
, , O O
no DT B-NP O
guarding NN I-NP B-problem
. . B-VP O
   
Bowel NNP B-NP O
sounds VBZ O O
were VBD B-VP O
present JJ O O
. . B-VP O
   
The DT B-NP B-test
neurological JJ I-NP I-test
examination NN I-NP I-test
was VBD B-VP O
nonfocal JJ O O
. . B-VP O
   
LABORATORY NNP B-NP O
DATA NNP I-NP O
: : O O
White NNP B-NP B-test
count NN I-NP I-test
was VBD B-VP O
14.4 CD O O
, , O O
hematocrit NN B-NP B-test
was VBD B-VP O
36.2 CD O O
, , O O
platelet NN B-NP B-test
count NN I-NP I-test
was VBD B-VP O
217 CD O O
, , O O
sodium NN B-NP B-test
was VBD B-VP O
135 CD O O
, , O O
potassium NN B-NP B-test
was VBD B-VP O
3.3 CD O O
, , O O
chloride NN B-NP B-test
was VBD B-VP O
99 CD O O
, , O O
bicarbonate NN B-NP B-test
was VBD B-VP O
25 CD O O
, , O O
BUN NNP B-NP B-test
was VBD B-VP O
40 CD O O
, , O O
creatinine NN B-NP B-test
was VBD B-VP O
1.9 CD O O
, , O O
glucose NN B-NP B-test
was VBD B-VP O
124 CD O O
, , O O
urinalysis NN B-NP B-test
was VBD B-VP O
negative JJ O O
, , O O
PT NNP B-NP B-test
was VBD B-VP O
12.2 CD O O
, , O O
PTT NNP B-NP B-test
was VBD B-VP O
24.5 CD O O
, , O O
calcium NN B-NP B-test
was VBD B-VP O
7.8 CD O O
, , O O
phosphorus NN B-NP B-test
was VBD B-VP O
3.7 CD O O
, , O O
albumin NN B-NP B-test
was VBD B-VP O
2.3 CD O O
, , O O
total JJ B-NP B-test
bilirubin NN I-NP I-test
was VBD B-VP O
1.3 CD O O
, , O O
alkaline JJ B-NP B-test
phosphatase NN I-NP I-test
was VBD B-VP O
202 CD O O
, , O O
SGPT NNP B-NP B-test
was VBD B-VP O
32 CD O O
, , O O
SGOT NNP B-NP B-test
was VBD B-VP O
64 CD O O
, , O O
LDH NNP B-NP B-test
was VBD B-VP O
998 CD O O
, , O O
amylase NN B-NP B-test
was VBD B-VP O
150 CD O O
. . B-VP O
   
EKG NNP B-NP B-test
revealed VBD B-VP O
sinus JJ B-NP B-problem
tachycardia NN I-NP I-problem
at IN B-VP O
107 CD O O
beats NNS B-NP O
per IN B-VP O
minute NN B-NP O
. . B-VP O
   
Evidence NN B-NP O
of IN B-VP O
old JJ B-NP B-problem
left JJ I-NP I-problem
anterior JJ I-NP I-problem
septal JJ I-NP I-problem
infarct NN I-NP I-problem
. . B-VP O
   
Chest JJS B-NP B-test
X-ray NN I-NP I-test
: : O O
Large JJ O B-problem
left VBD B-VP I-problem
ventricle NN B-NP I-problem
, , O O
bilateral JJ B-NP B-problem
atelectasis NN I-NP I-problem
or CC O O
effusion NN B-NP B-problem
. . B-VP O
   
Abdominal NNP B-NP B-test
computerized VBD B-VP I-test
tomography JJ O I-test
scan JJ O I-test
: : O O
Pancreatitis NN B-NP B-problem
, , O O
fluid NN B-NP B-problem
collection NN I-NP I-problem
in IN B-VP I-problem
the DT B-NP I-problem
lesser JJR I-NP I-problem
sac NN I-NP I-problem
. . B-VP O
   
A DT B-NP B-problem
perisplenic JJ I-NP I-problem
effusion NN I-NP I-problem
was VBD B-VP O
noted VBN O O
which WDT O B-pronoun
appeared VBD B-VP O
to TO O O
communicate VB O O
with IN B-VP O
the DT B-NP B-problem
lesser JJR I-NP I-problem
sac NN I-NP I-problem
collection NN I-NP I-problem
. . B-VP O
   
Gallbladder NNP B-NP O
was VBD B-VP O
visualized VBN O O
with IN B-VP O
stones NNS B-NP B-problem
. . B-VP O
   
IN NNP B-NP O
SUMMARY NNP I-NP O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
considered VBN O O
to TO O O
have VB O O
severe JJ O B-problem
necrotizing VBG O I-problem
pancreatitis NN B-NP I-problem
, , O O
with IN B-VP O
severe JJ B-NP B-problem
cardiac JJ I-NP I-problem
disease NN I-NP I-problem
. . B-VP O
   
HOSPITAL NNP B-NP O
COURSE NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
admitted VBN O O
, , O O
placed VBN O O
on IN B-VP O
intravenous JJ B-NP B-treatment
fluids NNS I-NP I-treatment
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
continued VBN O O
on IN B-VP O
his PRP$ O B-person
his PRP$ O B-treatment
imipenem NN B-NP I-treatment
, , O I-treatment
intravenously RB O I-treatment
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
started VBN O O
on IN B-VP O
total JJ B-NP B-treatment
parenteral JJ I-NP I-treatment
nutrition NN I-NP I-treatment
. . B-VP O
   
On IN B-VP O
4/17/95 CD O O
, , O O
GI NNP B-NP B-person
Interventional NNP I-NP I-person
Radiology NNP I-NP I-person
performed VBD B-VP O
drainage NN B-NP B-treatment
of IN B-VP O
the DT B-NP B-problem
peripancreatic JJ I-NP I-problem
fluid NN I-NP I-problem
collection NN I-NP I-problem
. . B-VP O
   
Approximately RB O O
one CD O O
liter NN B-NP O
of IN B-VP O
brownish JJ B-NP B-problem
fluid NN I-NP I-problem
was VBD B-VP O
obtained VBN O O
and CC O O
sent VBN O O
for IN B-VP O
culture NN B-NP B-test
. . B-VP O
   
The DT B-NP B-treatment
drainage NN I-NP I-treatment
catheter NN I-NP I-treatment
was VBD B-VP O
left VBN O O
in IN B-VP O
a DT B-NP B-problem
pseudocyst NN I-NP I-problem
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
evaluated VBN O O
by IN B-VP O
Cardiology NNP B-NP B-person
. . B-VP O
   
A DT B-NP B-test
Persantine NNP I-NP I-test
Thallium NNP I-NP I-test
study NN I-NP I-test
demonstrated VBD B-VP O
a DT B-NP B-problem
large JJ I-NP I-problem
infarct NN I-NP I-problem
, , O O
involving VBG O O
the DT B-NP O
posteroseptal NN I-NP O
, , O O
anteroseptal JJ B-NP O
areas NNS I-NP O
. . B-VP O
   
Left NNP B-NP B-problem
ventricular JJ B-NP I-problem
aneurysm NN I-NP I-problem
was VBD B-VP O
also RB O O
noted VBN O O
; : O O
however RB O O
, , O O
no DT B-NP O
ischemia NN I-NP B-problem
was VBD B-VP O
seen VBN O O
. . B-VP O
   
An DT B-NP B-test
echocardiogram NN I-NP I-test
was VBD B-VP O
done VBN O O
. . B-VP O
   
The DT B-NP B-test
echocardiogram NN I-NP I-test
showed VBD B-VP O
terrible JJ B-NP B-problem
left JJ I-NP I-problem
ventricular JJ I-NP I-problem
function NN I-NP I-problem
, , O O
with IN B-VP O
left JJ B-NP B-problem
ventricular JJ I-NP I-problem
aneurysm NN I-NP I-problem
. . B-VP O
   
The DT B-NP O
right JJ I-NP O
ventricle NN I-NP O
appeared VBD B-VP O
to TO O O
be VB O O
acceptable JJ O O
. . B-VP O
   
The DT B-NP B-treatment
percutaneous JJ I-NP I-treatment
drainage NN I-NP I-treatment
catheter NN I-NP I-treatment
continued VBD B-VP O
to TO O O
have VB O O
high JJ B-NP O
output NN I-NP O
. . B-VP O
   
The DT B-NP O
fluid NN I-NP O
was VBD B-VP O
sent VBN O O
for IN B-VP O
amylase NN B-NP B-test
, , O O
which WDT O B-pronoun
came VBD B-VP O
back RB O O
53,230 CD O O
. . B-VP O
   
On IN B-VP O
4/28/95 CD O O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
had VBD B-VP O
new JJ B-NP O
onset NN I-NP O
of IN B-VP O
abdominal JJ B-NP B-problem
pain NN I-NP I-problem
. . B-VP O
   
His PRP$ O B-test
His PRP$ O B-person
white JJ B-NP I-test
count NN I-NP I-test
had VBD B-VP O
bumped VBN O O
from IN B-VP O
8.3 CD O O
on IN B-VP O
admission NN B-NP O
to TO O O
18.5 CD O O
, , O O
on IN B-VP O
4/27 CD O O
. . B-VP O
   
A DT B-NP B-test
computerized JJ I-NP I-test
tomography NN I-NP I-test
scan NN I-NP I-test
of IN B-VP I-test
the DT B-NP I-test
abdomen NNS I-NP I-test
was VBD B-VP O
performed VBN O O
. . B-VP O
   
Approximately RB O O
100 CD O O
cc.&apos;s NN B-NP O
of IN B-VP O
thick JJ B-NP B-problem
brownish JJ I-NP I-problem
material NN I-NP I-problem
was VBD B-VP O
aspirated VBN O O
through IN B-VP O
the DT B-NP B-treatment
indwelling NN I-NP I-treatment
catheter NN I-NP I-treatment
. . B-VP O
   
The DT B-NP B-test
computerized JJ I-NP I-test
tomography NN I-NP I-test
scan NN I-NP I-test
showed VBD B-VP O
the DT B-NP B-treatment
catheter NN I-NP I-treatment
tip NN I-NP I-treatment
in IN B-VP O
good JJ B-NP O
position NN I-NP O
. . B-VP O
   
Because IN B-VP O
of IN B-VP O
the DT O B-person
the DT B-NP B-problem
patient JJ I-NP I-person
patient NN I-NP I-problem
&apos;s NN I-NP I-problem
deteriorating VBG O I-problem
state NN B-NP I-problem
, , O O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
brought VBN O O
to TO O O
the DT B-NP O
operating NN I-NP O
room NN I-NP O
on IN B-VP O
4/28/95 CD O O
. . B-VP O
   
An DT B-NP B-test
exploratory JJ I-NP I-test
laparotomy NN I-NP I-test
was VBD B-VP O
performed VBN O O
. . B-VP O
   
The DT B-NP O
splenic JJ I-NP O
flexure NN I-NP O
had VBD B-VP O
a DT B-NP B-problem
purulent JJ I-NP I-problem
exudative JJ I-NP I-problem
process NN I-NP I-problem
along IN B-VP I-problem
the DT B-NP I-problem
antimesenteric JJ I-NP I-problem
surface NN I-NP I-problem
. . B-VP O
   
Thus RB O O
, , O O
the DT B-NP O
splenic JJ I-NP O
flexure NN I-NP O
and CC O O
a DT B-NP O
portion NN I-NP O
of IN B-VP O
the DT O O
descending VBG O O
colon NN B-NP O
were VBD B-VP O
resected VBN O B-treatment
. . B-VP O
   
The DT B-NP B-person
patient JJ I-NP I-person
underwent NN I-NP O
a DT B-NP B-treatment
left JJ I-NP I-treatment
colectomy NN I-NP I-treatment
with IN B-VP O
end JJ B-NP B-treatment
transverse NN I-NP I-treatment
colostomy NN I-NP I-treatment
, , O O
and CC O O
oversewing NN B-NP B-treatment
of IN B-VP I-treatment
the DT B-NP I-treatment
descending NN I-NP I-treatment
colon NN I-NP I-treatment
. . B-VP O
   
Drainage NN B-NP B-treatment
of IN B-VP O
the DT B-NP B-problem
pancreatic JJ I-NP I-problem
necrosis NN I-NP I-problem
was VBD B-VP O
also RB O O
done VBN O O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
tolerated VBD B-VP O
the DT B-NP B-treatment
procedure NN I-NP I-treatment
fairly RB O O
well RB O O
, , O O
and CC O O
was VBD B-VP O
transferred VBN O O
to TO O O
the DT B-NP O
Intensive NNP I-NP O
Care NNP I-NP O
Unit NNP I-NP O
. . B-VP O
   
In IN B-VP O
the DT B-NP O
Intensive NNP I-NP O
Care NNP I-NP O
Unit NNP I-NP O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
had VBD B-VP O
a DT B-NP O
prolonged JJ I-NP O
course NN I-NP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
then RB O O
extubated VBN O O
on IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
#2 NNP I-NP O
, , O O
but CC O O
remained VBD B-VP O
pressor-dependent JJ O B-problem
. . B-VP O
   
He PRP O B-person
remained VBD B-VP O
on IN B-VP O
imipenem NN B-NP B-treatment
, , O O
and CC O O
Vancomycin NNP B-NP B-treatment
was VBD B-VP O
also RB O O
started VBN O O
. . B-VP O
   
Thereafter RB O O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
had VBD B-VP O
a DT O B-problem
long JJ O I-problem
and CC O I-problem
complicated JJ B-NP I-problem
postoperative JJ I-NP I-problem
course NN I-NP I-problem
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
eventually RB O O
transferred VBN O O
to TO O O
the DT B-NP O
floor NN I-NP O
, , O O
where WRB O O
he PRP O B-person
remained VBD B-VP O
meta-stable JJ O O
. . B-VP O
   
He PRP O B-person
had VBD B-VP O
repeated VBN O O
episodes NNS B-NP O
of IN B-VP O
hypotension NN B-NP B-problem
to TO O O
80-90 JJ B-NP B-test
systolic/40-50 JJ I-NP I-test
diastolic NN I-NP I-test
. . B-VP O
   
These DT O B-pronoun
resolved VBN O O
without IN B-VP O
incident NN B-NP O
. . B-VP O
   
He PRP O B-person
also RB O O
had VBD B-VP O
repeated VBN O B-problem
temperature NN B-NP I-problem
spikes NNS I-NP I-problem
. . B-VP O
   
After IN B-VP O
repeated VBN O B-test
work NN B-NP I-test
ups RB O I-test
, , O O
it PRP O B-pronoun
was VBD B-VP O
felt VBN O O
that IN B-VP B-pronoun
these DT O B-pronoun
were VBD B-VP O
probably RB O O
due JJ O O
to TO O O
remaining VBG O B-problem
infection NN B-NP I-problem
in IN B-VP I-problem
the DT B-NP I-problem
peripancreatic JJ I-NP I-problem
area NN I-NP I-problem
. . B-VP O
   
His PRP$ O B-person
His PRP$ O B-treatment
drainage NN B-NP I-treatment
tube NN I-NP I-treatment
from IN B-VP I-treatment
the DT B-NP I-treatment
peripancreatic JJ I-NP I-treatment
area NN I-NP I-treatment
was VBD B-VP O
gradually RB O O
advanced JJ O O
, , O O
and CC O O
eventually RB O O
discontinued VBN O O
. . B-VP O
   
Mr. NNP B-NP B-person
Mass NNP I-NP I-person
was VBD B-VP O
placed VBN O O
on IN B-VP O
multiple JJ B-NP O
courses NNS I-NP O
of IN B-VP O
antibiotics NNS B-NP B-treatment
. . B-VP O
   
Most JJS O O
recently RB O O
, , O O
he PRP O B-person
was VBD B-VP O
on IN B-VP O
a DT O O
28 CD O O
day NN B-NP O
course NN I-NP O
of IN B-VP O
Vancomycin NNP B-NP B-treatment
, , O O
ofloxacin NN B-NP B-treatment
, , O O
and CC O O
Flagyl NNP B-NP B-treatment
, , O O
for IN B-VP O
blood NN B-NP B-test
cultures NNS I-NP I-test
that WDT O B-pronoun
were VBD B-VP O
positive JJ O O
for IN B-VP O
gram JJ B-NP B-problem
positive JJ I-NP I-problem
cocci NN I-NP I-problem
and CC O O
enteric JJ O B-problem
and CC O I-problem
non-enteric JJ B-NP I-problem
gram NN I-NP I-problem
negative JJ B-NP I-problem
rods NNS I-NP I-problem
. . B-VP O
   
This DT O B-pronoun
This DT O B-treatment
28 CD O I-treatment
day NN B-NP I-treatment
course NN I-NP I-treatment
was VBD B-VP O
completed VBN O O
on IN B-VP O
07/15/95 CD O O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
also RB O O
treated VBN O O
initially RB O O
with IN B-VP O
amphotericin-B JJ O B-treatment
and CC O O
then RB O O
with IN B-VP O
fluconazole NN B-NP B-treatment
for IN B-VP O
a DT B-NP B-test
computerized JJ I-NP I-test
tomography NN I-NP I-test
guided VBD B-VP I-test
aspirate NN B-NP I-test
of IN B-VP O
a DT B-NP B-problem
small JJ I-NP I-problem
fluid NN I-NP I-problem
collection NN I-NP I-problem
around IN B-VP I-problem
his PRP$ O B-person
his PRP$ O I-problem
pancreas NN B-NP I-problem
, , O O
which WDT O B-pronoun
grew VBD B-VP O
Candida NNP B-NP B-problem
albicans NNS I-NP I-problem
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
also RB O O
had VBD B-VP O
several JJ B-NP O
episodes NNS I-NP O
of IN B-VP O
fungal JJ B-NP B-problem
cystitis NN I-NP I-problem
with IN B-VP O
Torulopsis NNP B-NP B-problem
glabrata NN I-NP I-problem
, , O O
going VBG O O
from IN B-VP O
his PRP$ O B-person
his PRP$ O B-test
urine NN B-NP I-test
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
treated VBN O O
with IN B-VP O
amphotericin-B JJ B-NP B-treatment
bladder NN I-NP I-treatment
washes NNS I-NP I-treatment
for IN B-VP O
this DT O B-pronoun
. . B-VP O
   
Mr. NNP B-NP B-person
Mass NNP I-NP I-person
was VBD B-VP O
initially RB O O
anticoagulated VBN O B-treatment
for IN B-VP O
his PRP$ O B-person
his PRP$ O B-problem
left JJ B-NP I-problem
ventricular JJ I-NP I-problem
aneurysm NN I-NP I-problem
. . B-VP O
   
He PRP O B-person
remained VBD B-VP O
stable JJ O O
from IN B-VP O
a DT B-NP O
cardiac JJ I-NP O
fashion NN I-NP O
. . B-VP O
   
He PRP O B-person
did VBD B-VP O
have VB O O
problems NNS B-NP B-problem
with IN B-VP O
po JJ B-NP O
intake NN I-NP O
. . B-VP O
   
He PRP O B-person
had VBD B-VP O
repeated VBN O O
bouts NNS B-NP O
of IN B-VP O
small-volume JJ B-NP B-problem
emesis NN I-NP I-problem
that WDT O B-pronoun
may MD O O
have VB O O
been VBN O O
secondary JJ O O
to TO O O
reflux VB O B-problem
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
treated VBN O O
with IN B-VP O
a DT B-NP O
variety NN I-NP O
of IN B-VP O
anti-emetics NNS B-NP B-treatment
, , O O
most JJS O O
recently RB O O
Granisetron NNP B-NP B-treatment
, , O O
with IN B-VP O
only JJ B-NP O
mild JJ I-NP O
success NN I-NP O
. . B-VP O
   
He PRP O B-person
remained VBD B-VP O
total JJ B-NP B-problem
parenteral JJ I-NP I-problem
nutrition-dependent NN I-NP I-problem
throughout IN B-VP O
his PRP$ O B-person
hospital NN B-NP O
course NN I-NP O
. . B-VP O
   
By IN B-VP O
the DT B-NP O
end NN I-NP O
of IN B-VP O
June NNP B-NP O
, , O O
it PRP O B-pronoun
became VBD B-VP O
clear JJ O O
that IN B-VP B-pronoun
Mr. NNP B-NP B-person
Mass NNP I-NP I-person
would MD O O
require VB O O
aggressive JJ B-NP B-treatment
surgical JJ I-NP I-treatment
intervention NN I-NP I-treatment
in IN B-VP O
order NN B-NP O
to TO O O
eradicate VB O O
his PRP$ O B-person
his PRP$ O B-problem
intra-abdominal JJ B-NP I-problem
bursts NNS I-NP I-problem
of IN B-VP I-problem
intermittent JJ B-NP I-problem
sepsis NN I-NP I-problem
; : O O
however RB O O
, , O O
long JJ B-NP O
discussions NNS I-NP O
with IN B-VP O
the DT B-NP B-person
patient NN I-NP I-person
and CC O O
his PRP$ O B-person
his PRP$ O B-person
wife NN B-NP I-person
, , O O
who WP O B-person
was VBD B-VP O
his PRP$ O B-person
his PRP$ O B-person
health-care NN B-NP I-person
proxy NN I-NP I-person
, , O O
revealed VBD B-VP O
that IN B-VP B-pronoun
they PRP O B-pronoun
felt VBD B-VP O
that IN B-VP B-pronoun
no DT B-NP O
further JJ I-NP B-treatment
aggressive JJ I-NP I-treatment
intervention NN I-NP I-treatment
be VB O O
attempted VBN O O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
had VBD B-VP O
been VBN O O
made VBN O O
a DT B-NP O
do NN I-NP O
not RB O O
resuscitate VB O O
do VB O O
not RB O O
intubate VB O O
patient NN B-NP B-person
earlier RBR O O
in IN B-VP O
his PRP$ O B-person
hospital NN B-NP O
stay NN I-NP O
. . B-VP O
   
Multiple JJ B-NP O
discussions NNS I-NP O
were VBD B-VP O
held VBN O O
between IN B-VP O
Dr. NNP B-NP B-person
Mass NNP I-NP I-person
, , O O
the DT B-NP O
rest NN I-NP O
of IN B-VP O
the DT B-NP B-person
surgical JJ I-NP I-person
team NN I-NP I-person
, , O O
and CC O O
the DT O B-person
the DT B-NP B-person
patient JJ I-NP I-person
patient NN I-NP I-person
&apos;s NNP I-NP I-person
wife NN I-NP I-person
, , O O
with IN B-VP O
this DT B-NP B-pronoun
same JJ I-NP O
result NN I-NP O
. . B-VP O
   
After IN B-VP O
discussion NN B-NP O
with IN B-VP O
the DT O B-person
the DT B-NP B-person
patient JJ I-NP I-person
patient NN I-NP I-person
&apos;s NNP I-NP I-person
primary JJ B-NP I-person
doctor NN I-NP I-person
, , O O
Dr. NNP B-NP B-person
Douet NNP I-NP I-person
at IN B-VP O
Vassdiysey NNP B-NP O
Medical NNP I-NP O
Center NNP I-NP O
, , O O
it PRP O B-pronoun
was VBD B-VP O
felt VBN O O
that IN B-VP B-pronoun
the DT B-NP B-person
patient NN I-NP I-person
and CC O O
his PRP$ O B-person
his PRP$ O B-person
family NN B-NP I-person
would MD O O
be VB O O
best RB O O
served VBN O O
if IN B-VP O
the DT B-NP B-person
patient NN I-NP I-person
were VBD B-VP O
transferred VBN O O
to TO O O
Vassdiysey NNP B-NP O
Medical NNP I-NP O
Center NNP I-NP O
. . B-VP O
   
Of IN B-VP O
note NN B-NP O
, , O O
given VBN O O
the DT B-NP B-person
patient NN I-NP I-person
&apos;s NNP I-NP O
do VBP O O
not RB O O
resuscitate VB O O
status NN B-NP O
and CC O O
the DT B-NP B-problem
risk NN I-NP I-problem
for IN B-VP I-problem
bleeding NN B-NP I-problem
, , O O
the DT O B-person
the DT B-NP B-treatment
patient JJ I-NP I-person
patient NN I-NP I-treatment
&apos;s NNP I-NP I-treatment
Coumadin NNP I-NP I-treatment
was VBD B-VP O
stopped VBN O O
without IN B-VP O
incident JJ B-NP O
several JJ I-NP O
weeks NNS I-NP O
before IN B-VP O
transfer NN B-NP O
. . B-VP O
   
DOCTORS NNP B-NP B-person
DISCHARGE NNP I-NP O
INSTRUCTIONS NNP I-NP O
: : O O
MEDICATIONS NN B-NP O
: : O O
1. CD O O
Heparin NNP B-NP B-treatment
, , O O
5,000 CD O O
units NNS B-NP O
, , O O
sc. NN B-NP O
, , O O
b.i.d. VBD B-VP O
2. CD O O
Lisinopril NNP B-NP B-treatment
, , O O
20 CD O O
mg. NN B-NP O
, , O O
po NN B-NP O
, , O O
qD NN B-NP O
. . B-VP O
   
3. CD O O
Isordil NNP B-NP B-treatment
, , O O
10 CD O O
mg. NN B-NP O
, , O O
po NN B-NP O
, , O O
t.i.d. VBZ O O
4. CD O O
Nitropaste NNP B-NP B-treatment
, , O O
1 CD O O
inch NN B-NP O
to TO O O
chest VB O O
wall NN B-NP O
, , O O
q8h. RB O O
5. CD O O
Carafate NNP B-NP B-treatment
, , O O
one CD O O
gram NN B-NP O
, , O O
po NN B-NP O
or CC O O
per IN B-VP O
nasogastric JJ B-NP B-treatment
tube NN I-NP I-treatment
, , O O
q.i.d. NN B-NP O
, , O O
Cardizem NNP B-NP B-treatment
, , O O
30 CD O O
mg. NN B-NP O
, , O O
po NN B-NP O
, , O O
q6h NN B-NP O
, , O O
digoxin NN B-NP B-treatment
, , O O
0.25 CD O O
mg. NN B-NP O
, , O O
po NN B-NP O
or CC O O
intravenously RB O O
, , O O
qD NN B-NP O
, , O O
fluconazole NN B-NP B-treatment
, , O O
200 CD O O
mg. NN B-NP O
, , O O
qD NN B-NP O
, , O O
for IN B-VP O
five CD O O
more JJR B-NP O
days NNS I-NP O
, , O O
after IN B-VP O
transfer NN B-NP O
, , O O
for IN B-VP O
a DT B-NP O
total NN I-NP O
of IN B-VP O
a DT O O
14 CD O O
day NN B-NP O
course NN I-NP O
, , O O
total JJ B-NP B-treatment
parenteral JJ I-NP I-treatment
nutrition NN I-NP I-treatment
to TO O O
meet VB O O
the DT B-NP B-person
patient NN I-NP I-person
&apos;s NNP I-NP O
nutritional JJ B-NP O
needs NNS I-NP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
has VBZ O O
an DT B-NP B-treatment
ostomy JJ I-NP I-treatment
appliance NN I-NP I-treatment
around IN B-VP O
the DT B-NP O
former JJ I-NP O
site NN I-NP O
of IN B-VP O
his PRP$ O B-person
his PRP$ O B-treatment
pancreatic JJ B-NP I-treatment
fistula NN I-NP I-treatment
drain NN I-NP I-treatment
. . B-VP O
   
This DT B-NP B-pronoun
area NN I-NP O
has VBZ O O
continued VBN O O
to TO O O
drain VB O O
and CC O O
it PRP O B-pronoun
is VBZ O O
felt VBN O O
that IN B-VP B-pronoun
it PRP O B-pronoun
could MD O O
be VB O O
best RB O O
managed VBN O O
by IN B-VP O
an DT B-NP B-treatment
ostomy JJ I-NP I-treatment
appliance NN I-NP I-treatment
and CC O O
stoma NN B-NP B-treatment
care NN I-NP I-treatment
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
is VBZ O O
also RB O O
treated VBN O O
with IN B-VP O
shots NNS B-NP B-treatment
of IN B-VP I-treatment
morphine NN B-NP I-treatment
for IN B-VP O
intermittent NN B-NP B-problem
pain NN I-NP I-problem
. . B-VP O
   
I PRP O B-person
DRAIN NNP B-NP I-person
, , O I-person
M.D. NNP B-NP I-person
DICTATING NNP I-NP O
FOR NNP I-NP O
: : O O
LIASUN NNP B-NP B-person
L. NNP I-NP I-person
MASS NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
TR NNP I-NP O
: : O O
aet NN B-NP O
/ NNP I-NP O
bmot NN I-NP O
DD NNP I-NP O
: : O O
07/16/95 CD O O
TD NN B-NP O
: : O O
07/15/95 CD O O
CC NN B-NP O
: : O O
STAT NNP B-NP O
discharge NN I-NP O
summary NN I-NP O
. . B-VP O
   
Copies NNS B-NP O
to TO O O
Dr. NNP B-NP B-person
Liasun NNP I-NP I-person
Mass NNP I-NP I-person
, , O O
Dr. NNP B-NP B-person
Tomedankell NNP I-NP I-person
New NNP I-NP I-person
of IN B-VP O
Cardiology NNP B-NP B-person
, , O O
and CC O O
Dr. NNP B-NP B-person
Scosthuang NNP I-NP I-person
of IN B-VP O
Vassdiysey NNP B-NP O
Medical NNP I-NP O
Center NNP I-NP O
. . B-VP O
   
Please NNP B-NP O
have VBP O O
a DT B-NP O
copy NN I-NP O
in IN B-VP O
the DT B-NP O
chart NN I-NP O
; : O O
the DT B-NP B-person
patient NN I-NP I-person
will MD O O
be VB O O
leaving VBG O O
on IN B-VP O
the DT B-NP O
morning NN I-NP O
of IN B-VP O
07/16/95 CD O O
. . B-VP O
   
-EMPTYLINE- VB O O
-DOCSTART- JJ O O
-EMPTYLINE- $ O O
649917202 CD O O
DH NNP B-NP O
8205558 CD O O
997074 CD O O
322941 CD O O
3/25/2001 CD O O
12:00:00 CD O O
AM NNP B-NP O
Discharge NNP I-NP O
Summary NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Report NNP I-NP O
Status NNP I-NP O
: : O O
Signed VBD B-VP O
DISCHARGE NNP B-NP O
SUMMARY NNP I-NP O
NAME NN I-NP O
: : O O
DULDKOTE NNP B-NP B-person
, , O I-person
EI NNP B-NP I-person
N NNP I-NP I-person
UNIT NNP I-NP O
NUMBER NNP I-NP O
: : O O
904-33-96 JJ B-NP O
ADMISSION NNP I-NP O
DATE NNP I-NP O
: : O O
03/25/2001 CD O O
DISCHARGE NNP B-NP O
DATE NNP I-NP O
: : O O
03/26/2001 CD O O
CHIEF NNP B-NP O
COMPLAINT NNP I-NP O
: : O O
Right JJ B-NP B-problem
shoulder NN I-NP I-problem
instability NN I-NP I-problem
. . B-VP O
   
HISTORY NNP B-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS NNP I-NP O
: : O O
This DT O B-pronoun
is VBZ O O
a DT B-NP O
30-year-old JJ I-NP O
right JJ I-NP O
hand NN I-NP O
dominant JJ B-NP O
gentleman NN I-NP O
who WP O B-person
pleasant VBP O O
Software NNP B-NP O
Engineer NNP I-NP O
. . B-VP O
   
In IN B-VP O
1989 CD O O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
dunking VBG O O
a DT B-NP O
basketball NN I-NP O
and CC O O
injured VBD B-VP O
his PRP$ O B-person
right JJ B-NP O
shoulder NN I-NP O
with IN B-VP O
abduction NN B-NP B-problem
external JJ B-NP I-problem
rotation NN I-NP I-problem
injury NN I-NP I-problem
. . B-VP O
   
He PRP O B-person
has VBZ O O
had VBN O O
persistent JJ B-NP B-problem
pain NN I-NP I-problem
over IN B-VP O
the DT B-NP O
years NNS I-NP O
which WDT O B-pronoun
has VBZ O O
worsened VBN O O
in IN B-VP O
the DT B-NP O
past JJ I-NP O
several JJ I-NP O
months NNS I-NP O
including VBG O O
inability NN B-NP B-problem
to TO O I-problem
sleep VB O I-problem
. . B-VP O
   
PAST NNP B-NP O
MEDICAL NNP I-NP O
HISTORY NNP I-NP O
: : O O
Is VBZ O O
unremarkable JJ O O
. . B-VP O
   
PAST JJ B-NP O
SURGICAL JJ I-NP O
HISTORY NN I-NP O
: : O O
Knee NNP B-NP B-treatment
surgery NN I-NP I-treatment
. . B-VP O
   
ALLERGIES NNP B-NP O
: : O O
No DT B-NP O
known JJ I-NP B-problem
drug NN I-NP I-problem
allergies NNS I-NP I-problem
. . B-VP O
   
MEDICATIONS NNP B-NP O
ON NNP I-NP O
ADMISSION NNP I-NP O
: : O O
None NN B-NP O
. . B-VP O
   
SOCIAL NNP B-NP O
HISTORY NNP I-NP O
: : O O
Occasional JJ B-NP O
alcohol NN I-NP O
, , O O
does VBZ O O
not RB O O
smoke VB O O
. . B-VP O
   
PHYSICAL JJ B-NP O
EXAMINATION NN I-NP O
: : O O
In IN B-VP O
Clinic NNP B-NP O
his PRP$ O B-person
his PRP$ O B-test
cervical JJ B-NP I-test
spine NN I-NP I-test
examination NN I-NP I-test
was VBD B-VP O
benign JJ O O
. . B-VP O
   
Shoulder NNP B-NP B-test
elevation NN I-NP I-test
is VBZ O O
170 CD O O
degrees NNS B-NP O
with IN B-VP O
70 CD O O
degrees NNS B-NP O
of IN B-VP O
external JJ B-NP O
rotation NN I-NP O
and CC O O
internal JJ B-NP O
rotation NN I-NP O
of IN B-VP O
the DT B-NP O
right JJ I-NP O
shoulder NN I-NP O
to TO O O
T9 NNP B-NP O
vertebra NNP I-NP O
versus NN I-NP O
T7 NNP I-NP O
on IN B-VP O
the DT B-NP O
left NN I-NP O
. . B-VP O
   
Rotator NNP B-NP O
cuff JJ B-NP O
measures NNS I-NP O
4-5 JJ O O
on IN B-VP O
the DT B-NP O
right NN I-NP O
and CC O O
5 CD O O
out IN B-VP O
of IN B-VP O
5 CD O O
on IN B-VP O
the DT B-NP O
left NN I-NP O
. . B-VP O
   
Mild NNP B-NP B-problem
pain NN I-NP I-problem
with IN B-VP O
resistive JJ B-NP B-test
test NN I-NP I-test
and CC O O
his PRP$ O B-person
his PRP$ O B-test
Pigott NNP B-NP I-test
sign NN I-NP I-test
is VBZ O O
mildly RB O O
positive JJ O O
on IN B-VP O
the DT B-NP O
right NN I-NP O
, , O O
negative JJ O O
on IN B-VP O
the DT B-NP O
left NN I-NP O
. . B-VP O
   
There EX O O
is VBZ O O
1 CD O B-problem
cm. NN B-NP I-problem
sulcus NN I-NP I-problem
sign NN I-NP I-problem
bilaterally RB O I-problem
. . B-VP O
   
Laxity NNP B-NP B-problem
is VBZ O O
noted VBN O O
as RB O O
well RB O O
as IN B-VP O
markedly RB O B-problem
positive JJ B-NP I-problem
apprehension NN I-NP I-problem
sign NN I-NP I-problem
on IN B-VP I-problem
the DT B-NP I-problem
right NN I-NP I-problem
. . B-VP O
   
Biceps NNS B-NP O
are VBP O O
normal JJ O O
. . B-VP O
   
HOSPITAL NNP B-NP O
COURSE NNP I-NP O
AND NNP I-NP O
TREATMENT NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
admitted VBN O O
to TO O O
the DT B-NP O
Hospital NNP I-NP O
and CC O O
was VBD B-VP O
taken VBN O O
to TO O O
the DT B-NP O
operating NN I-NP O
room NN I-NP O
for IN B-VP O
an DT B-NP B-treatment
open JJ I-NP I-treatment
Bankart NNP I-NP I-treatment
procedure NN I-NP I-treatment
with IN B-VP O
biceps NNS B-NP B-treatment
tenodesis NN I-NP I-treatment
( ( O O
Please NNP B-NP O
see VB O O
the DT B-NP O
operative JJ I-NP O
note NN I-NP O
for IN B-VP O
full JJ B-NP O
details NNS I-NP O
) ) O O
. . B-VP O
   
Postoperatively RB O O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
did VBD B-VP O
very RB O O
well RB O O
and CC O O
was VBD B-VP O
neurovascularly RB O O
intact JJ O O
. . B-VP O
   
His PRP$ O B-problem
His PRP$ O B-person
wound NN B-NP I-problem
was VBD B-VP O
intact JJ O O
, , O O
clean JJ O O
and CC O O
dry JJ O O
and CC O O
it PRP O B-pronoun
was VBD B-VP O
covered VBN O O
with IN B-VP O
perioperative JJ B-NP B-treatment
antibiotics NNS I-NP I-treatment
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
discharged VBN O O
to TO O O
home NN B-NP O
on IN B-VP O
Percocet NNP B-NP B-treatment
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
given VBN O O
strict JJ B-NP O
instructions NNS I-NP O
to TO O O
limit VB O O
his PRP$ O B-person
external JJ B-NP O
rotation NN I-NP O
no RB O O
more JJR O O
than IN B-VP O
30 CD O O
degrees NNS B-NP O
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
seen VBN O O
by IN B-VP O
physical JJ B-NP B-person
therapy NN I-NP I-person
prior RB O O
to TO O O
discharge VB O O
. . B-VP O
   
FOLLOW NNP B-NP O
UP NNPS I-NP O
: : O O
He PRP O B-person
is VBZ O O
to TO O O
follow VB O O
up RP O O
with IN B-VP O
Dr. NNP B-NP B-person
Rach NNP I-NP I-person
Breutznedeaisscarvwierst NNP I-NP I-person
in IN B-VP O
Clinic NNP B-NP O
. . B-VP O
   
MEDICATIONS NNP B-NP O
ON NNP I-NP O
DISCHARGE NNP I-NP O
: : O O
Percocet NNP B-NP B-treatment
1-2 JJ B-NP O
tablets NNS I-NP O
PO NNP I-NP O
q.4-6 JJ B-NP O
hours NNS I-NP O
prn VBP O O
pain NN B-NP B-problem
. . B-VP O
   
MA NNP B-NP B-person
ANSHI NNP I-NP I-person
PIERNREUKOTEFILLE NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
DICTATING NNP I-NP O
FOR NNP I-NP O
: : O O
Electronically RB O O
Signed VBD B-VP O
RACH NNP B-NP B-person
HY NNP I-NP I-person
BREUTZNEDEAISSCARVWIERST NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
05/20/2001 CD O O
18:29 CD O O
_____________________________ JJ B-NP O
RACH NNP I-NP B-person
HY NNP I-NP I-person
BREUTZNEDEAISSCARVWIERST NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
TR NNP I-NP O
: : O O
wlk NN B-NP O
DD NNP I-NP O
: : O O
03/26/2001 CD O O
TD NN B-NP O
: : O O
03/31/2001 CD O O
10:13 CD O O
A NNP B-NP O
cc NN I-NP O
: : O O
RACH NNP B-NP B-person
HY NNP I-NP I-person
BREUTZNEDEAISSCARVWIERST NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
Admission NNP I-NP O
Date NNP I-NP O
: : O O
2019-10-10 JJ B-NP O
Discharge NN I-NP O
Date NNP I-NP O
: : O O
2019-10-19 JJ B-NP O
Date NNP I-NP O
of IN B-VP O
Birth NNP B-NP O
: : O O
1994-01-10 JJ B-NP O
Sex NN I-NP O
: : O O
M NNP B-NP O
Service NNP I-NP O
: : O O
ORTHOPAEDICS JJ B-NP O
Allergies NNS I-NP O
: : O O
Patient NN B-NP B-person
recorded VBD B-VP O
as IN B-VP O
having VBG O O
No NNP B-NP O
Known NNP I-NP B-problem
Allergies NNPS I-NP I-problem
to TO O O
Drugs NNP B-NP B-treatment
Attending NNP I-NP B-person
: : O O
George NNP B-NP B-person
G NNP I-NP I-person
Lindsey NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
Chief NNP I-NP O
Complaint NNP I-NP O
: : O O
s/p JJ B-NP O
fall NN I-NP O
with IN B-VP O
Left NNP B-NP B-problem
arm NN I-NP I-problem
pain NN I-NP I-problem
Major NNP I-NP O
Surgical NNP I-NP O
or CC O O
Invasive JJ B-NP O
Procedure NN I-NP O
: : O O
2019-10-11 JJ O O
: : O O
ORIF NN B-NP B-treatment
Left NNP I-NP B-problem
distal JJ B-NP I-problem
radius JJ I-NP I-problem
fracture NN I-NP I-problem
History NNP I-NP O
of IN B-VP O
Present NNP B-NP O
Illness NNP I-NP O
: : O O
Mr. NNP B-NP B-person
Steadman NNP I-NP I-person
is VBZ O O
a DT O O
25 CD O O
year NN B-NP O
old JJ B-NP O
man NN I-NP O
who WP O B-person
was VBD B-VP O
locked VBN O O
out IN B-VP O
of IN B-VP O
his PRP$ O B-person
apartment NN B-NP O
and CC O O
tried VBD B-VP O
to TO O O
enter VB O O
by IN B-VP O
climbing VBG O O
up RP O O
two CD O O
stories NNS B-NP O
to TO O O
get VB O O
in IN B-VP O
by IN B-VP O
a DT B-NP O
window NN I-NP O
. . B-VP O
   
He PRP O B-person
fell VBD B-VP O
15-20 JJ B-NP O
feet NNS I-NP O
onto IN B-VP O
concrete NN B-NP O
, , O O
denies VBZ O O
any DT B-NP O
loss NN I-NP B-problem
of IN B-VP I-problem
consiousness NN B-NP I-problem
. . B-VP O
   
Past NNP B-NP O
Medical JJ B-NP O
History NN I-NP O
: : O O
denies VBZ O O
Social NNP B-NP O
History NNP I-NP O
: : O O
+ETOH NN B-NP O
, , O O
had VBD B-VP O
12 CD O O
cans NNS B-NP O
of IN B-VP O
beer NN B-NP O
prior RB O O
to TO O O
accident VB O O
Family NNP B-NP O
History NNP I-NP O
: : O O
n/a JJ B-NP O
Physical NNP I-NP O
Exam NN I-NP O
: : O O
Upon IN B-VP O
admission NN B-NP O
: : O O
Alert NNP B-NP O
and CC O O
oriented VBN O O
Cardiac NNP B-NP O
: : O O
Tachycardiac NNP B-NP B-problem
120-140 CD O O
, , O O
regular JJ B-NP O
Chest NNP I-NP O
: : O O
Clear JJ O O
to TO O O
auscultation VB O B-test
Abdomen NNS B-NP O
: : O O
Soft JJ B-NP O
non-tender JJ I-NP B-problem
non-distended JJ I-NP B-problem
Extremities NNS I-NP O
: : O O
Left NNP B-NP B-problem
elbow NN I-NP I-problem
, , O I-problem
gross JJ B-NP I-problem
deformity NN I-NP I-problem
swelling VBG O I-problem
over IN B-VP I-problem
dorsal JJ B-NP I-problem
forearm NN I-NP I-problem
, , O O
gross JJ B-NP B-problem
deformity NN I-NP I-problem
left VBD B-VP I-problem
wrist NN B-NP I-problem
, , O O
no DT B-NP O
skin JJ I-NP B-problem
lacerations NNS I-NP I-problem
. . B-VP O
   
SILT NNP B-NP O
R/U/M NNP I-NP O
LUE NNP I-NP O
Bilateral NNP I-NP O
lower JJR B-NP O
extremities NNS I-NP O
: : O O
+ JJ B-NP O
sensation NN I-NP O
, , O O
movment NN B-NP O
, , O O
pulses NNS B-NP O
, , O O
some DT B-NP B-problem
pain NN I-NP I-problem
with IN B-VP O
ROM NNP B-NP O
Brief NNP I-NP O
Hospital NNP I-NP O
Course NNP I-NP O
: : O O
Mr. NNP B-NP B-person
Steadman NNP I-NP I-person
is VBZ O O
a DT O O
25 CD O O
year NN B-NP O
old JJ B-NP O
man NN I-NP O
who WP O B-person
presented VBD B-VP O
to TO O O
the DT O O
The DT B-NP O
Hospital NNP I-NP O
for IN B-VP O
Orthopedics NNPS B-NP O
on IN B-VP O
2019-10-10 JJ O O
via IN B-VP O
ambulance NN B-NP O
after IN B-VP O
falling VBG O O
15-20 JJ B-NP O
feet NNS I-NP O
onto IN B-VP O
concrete NN B-NP O
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
evaluated VBN O O
by IN B-VP O
the DT B-NP O
trauma NN I-NP B-person
surgery NN I-NP I-person
department NN I-NP O
and CC O O
the DT B-NP O
orthopaedic JJ I-NP B-person
surgery NN I-NP I-person
department NN I-NP O
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
intoxicated VBN O O
and CC O O
tachycardic VBN O B-problem
in IN B-VP O
the DT B-NP O
trauma NN I-NP O
bay NN I-NP O
. . B-VP O
   
His PRP$ O B-problem
His PRP$ O B-person
injuries NNS B-NP I-problem
were VBD B-VP O
identified VBN O O
as IN B-VP O
a DT B-NP B-problem
left NN I-NP I-problem
elbow NN I-NP I-problem
disloaction NN I-NP I-problem
with IN B-VP O
was VBD B-VP O
reduced VBN O O
and CC O O
splinted VBN O O
. . B-VP O
   
Also RB O O
a DT B-NP B-problem
left JJ I-NP I-problem
distal JJ I-NP I-problem
radius NN I-NP I-problem
fracture NN I-NP I-problem
with IN B-VP O
was VBD B-VP O
reduced VBN O O
and CC O O
splinted VBN O O
. . B-VP O
   
Also RB O O
a DT B-NP B-problem
Left NNP I-NP I-problem
non NN I-NP I-problem
displaced VBD B-VP I-problem
sacral JJ B-NP I-problem
wing NN I-NP I-problem
fracture NN I-NP I-problem
and CC O O
left VBD B-VP B-problem
inferior JJ B-NP I-problem
pubic JJ I-NP I-problem
ramus NN I-NP I-problem
fx NN I-NP I-problem
extending VBG O O
the DT O O
to TO O O
inferior VB O O
acetabulum NN B-NP O
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
admitted VBN O O
to TO O O
the DT B-NP O
trauma NN I-NP O
intensive JJ B-NP O
care NN I-NP O
unit NN I-NP O
due JJ O O
to TO O O
his PRP$ O B-problem
his PRP$ O B-person
tachycardia NN B-NP I-problem
which WDT O B-pronoun
was VBD B-VP O
not RB O O
resolved VBN O O
with IN B-VP O
pain JJ B-NP B-treatment
medication NN I-NP I-treatment
. . B-VP O
   
On IN B-VP O
2019-10-11 JJ O O
he PRP O B-person
was VBD B-VP O
started VBN O O
on IN B-VP O
lopressor NN B-NP B-treatment
for IN B-VP O
his PRP$ O B-person
his PRP$ O B-problem
tachycardia NN B-NP I-problem
which WDT O B-pronoun
had VBD B-VP O
good JJ B-NP O
effect NN I-NP O
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
then RB O O
transfered VBN O O
to TO O O
the DT B-NP O
floor NN I-NP O
in IN B-VP O
the DT B-NP O
care NN I-NP O
of IN B-VP O
the DT B-NP O
orthopaedic JJ I-NP B-person
surgery NN I-NP I-person
service NN I-NP O
. . B-VP O
   
Also RB O O
on IN B-VP O
2019-10-11 JJ O O
he PRP O B-person
was VBD B-VP O
taken VBN O O
to TO O O
the DT B-NP O
operating NN I-NP O
room NN I-NP O
for IN B-VP O
an DT B-NP B-treatment
ORIF NNP I-NP I-treatment
of IN B-VP O
his PRP$ O B-person
his PRP$ O B-problem
left JJ B-NP I-problem
distal JJ I-NP I-problem
radius NN I-NP I-problem
fracture NN I-NP I-problem
. . B-VP O
   
His PRP$ O B-problem
His PRP$ O B-person
pelvis NN B-NP I-problem
fracture NN I-NP I-problem
are VBP O O
closed VBN O O
treated JJ O O
and CC O O
he PRP O B-person
can MD O O
be VB O O
weight JJ B-NP O
bearing NN I-NP O
as IN B-VP O
tolerated VBN O O
on IN B-VP O
his PRP$ O B-person
right JJ B-NP O
leg NN I-NP O
and CC O O
and CC O O
nonweight JJ B-NP O
bearing NN I-NP O
on IN B-VP O
his PRP$ O B-person
left JJ B-NP O
leg NN I-NP O
. . B-VP O
   
He PRP O B-person
tolerated VBD B-VP O
the DT B-NP B-treatment
procedure NN I-NP I-treatment
without IN B-VP O
difficulty NN B-NP B-problem
. . B-VP O
   
He PRP O B-person
begain VBD B-VP O
to TO O O
work VB O O
with IN B-VP O
physical JJ B-NP B-person
therapy NN I-NP I-person
to TO O O
improve VB O O
his PRP$ O B-person
strenght NN B-NP O
and CC O O
mobility NN B-NP O
. . B-VP O
   
His PRP$ O B-test
His PRP$ O B-person
heart NN B-NP I-test
rate NN I-NP I-test
continued VBD B-VP O
to TO O O
be VB O O
well RB O O
controlled VBN O O
with IN B-VP O
his PRP$ O B-person
his PRP$ O B-treatment
lopressor NN B-NP I-treatment
. . B-VP O
   
Throught NNP B-NP O
the DT B-NP O
stay NN I-NP O
his PRP$ O B-test
his PRP$ O B-person
labs NN B-NP I-test
remained VBD B-VP O
normal JJ O O
and CC O O
his PRP$ O B-problem
his PRP$ O B-person
pain NN B-NP I-problem
controlled VBD B-VP O
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
discharged VBN O O
home NN B-NP O
in IN B-VP O
stable JJ B-NP O
conditions NNS I-NP O
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
instructed VBN O O
to TO O O
follow VB O O
up RP O O
with IN B-VP O
Dr. NNP B-NP B-person
Conway NNP I-NP I-person
in IN B-VP O
2 CD O O
weeks NNS B-NP O
and CC O O
an DT B-NP O
appointment NN I-NP O
was VBD B-VP O
made VBN O O
on IN B-VP O
11-15 NNS B-NP O
for IN B-VP O
him PRP O B-person
at IN B-VP O
the DT B-NP O
Louis NNP I-NP O
Schubert NNP I-NP O
Community NNP I-NP O
Health NNP I-NP O
Center NNP I-NP O
to TO O O
follow VB O O
his PRP$ O B-test
his PRP$ O B-person
heart NN B-NP I-test
rate NN I-NP I-test
and CC O O
continued VBD B-VP O
need NN B-NP O
for IN B-VP O
lopressor NN B-NP B-treatment
. . B-VP O
   
Medications NNS B-NP O
on IN B-VP O
Admission NN B-NP O
: : O O
none NN B-NP O
Discharge NNP I-NP O
Medications NNP I-NP O
: : O O
1. CD O O
Docusate NNP B-NP B-treatment
Sodium NNP I-NP I-treatment
100 CD O O
mg NN B-NP O
Capsule NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Capsule NNP B-NP O
PO NNP I-NP O
BID NNP I-NP O
( ( O O
2 CD O O
times NNS B-NP O
a DT B-NP O
day NN I-NP O
) ) O O
. . B-VP O
   
Disp NNP B-NP O
:* VBD B-VP O
60 CD O O
Capsule NNP B-NP O
( ( O O
s JJ B-NP O
)* NNP I-NP O
Refills NNP I-NP O
:* VBZ O O
2 CD O O
* NN B-NP O
2. CD O O
Enoxaparin NNP B-NP B-treatment
30 CD O O
mg NN B-NP O
/ VBD B-VP O
0.3 CD O O
mL NN B-NP O
Syringe NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
30 CD O O
mg JJ B-NP O
syringe NN I-NP O
Subcutaneous NNP I-NP O
Q12H NNP I-NP O
( ( O O
every DT O O
12 CD O O
hours NNS B-NP O
) ) O O
for IN B-VP O
4 CD O O
weeks NNS B-NP O
. . B-VP O
   
Disp NNP B-NP O
:* VBD B-VP O
56 CD O O
30 CD O O
mg NN B-NP O
syringe NN I-NP O
* NNP I-NP O
Refills NNP I-NP O
:* VBZ O O
0 CD O O
* NN B-NP O
3. CD O O
Oxycodone NNP B-NP B-treatment
- : O O
Acetaminophen NNP B-NP B-treatment
5-325 JJ B-NP O
mg NN I-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
1-2 JJ B-NP O
Tablets NNS I-NP O
PO NNP I-NP O
Q4-6H NNP I-NP O
( ( O O
every DT O O
4 CD O O
to TO O O
6 CD O O
hours NNS B-NP O
) ) O O
as IN B-VP O
needed VBN O O
. . B-VP O
   
Disp NNP B-NP O
:* VBD B-VP O
90 CD O O
Tablet NNP B-NP O
( ( O O
s JJ B-NP O
)* NNP I-NP O
Refills NNP I-NP O
:* VBZ O O
0 CD O O
* NN B-NP O
4. CD O O
Metoprolol NNP B-NP B-treatment
Tartrate NNP I-NP I-treatment
25 CD O O
mg NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
0.5 CD O O
Tablet NNP B-NP O
PO NNP I-NP O
BID NNP I-NP O
( ( O O
2 CD O O
times NNS B-NP O
a DT B-NP O
day NN I-NP O
) ) O O
. . B-VP O
   
Disp NNP B-NP O
:* VBD B-VP O
30 CD O O
Tablet NNP B-NP O
( ( O O
s JJ B-NP O
)* NNP I-NP O
Refills NNP I-NP O
:* VBZ O O
0 CD O O
* NN B-NP O
Discharge NNP I-NP O
Disposition NNP I-NP O
: : O O
Home NNP B-NP O
Discharge NNP I-NP O
Diagnosis NNP I-NP O
: : O O
s/p JJ B-NP O
fall NN I-NP O
from IN B-VP O
15-20 JJ B-NP O
feet NNS I-NP O
Discharge NNP I-NP O
Condition NNP I-NP O
: : O O
Stable JJ B-NP O
Discharge NN I-NP O
Instructions NNS I-NP O
: : O O
Continue VB O O
to TO O O
be VB O O
non-weight JJ B-NP O
bearing NN I-NP O
on IN B-VP O
your PRP$ O B-person
left JJ B-NP O
leg NN I-NP O
Continue NNP I-NP O
to TO O O
wear VB O O
your PRP$ O B-treatment
your PRP$ O B-person
left JJ B-NP I-treatment
arm NN I-NP I-treatment
splint NN I-NP I-treatment
, , O O
but CC O O
take VB O O
it PRP O B-pronoun
off RP O O
daily JJ O O
to TO O O
inspect VB O O
your PRP$ O B-person
skin NN B-NP O
Continue VB O O
your PRP$ O B-treatment
your PRP$ O B-person
Lovenox JJ B-NP I-treatment
injections NNS I-NP I-treatment
as IN B-VP O
instructed JJ O O
If IN B-VP O
you PRP O B-person
notice VBP O O
any DT B-NP O
increase NN I-NP B-problem
in IN B-VP I-problem
swelling VBG O I-problem
or CC O O
erythemia NN B-NP B-problem
at IN B-VP O
the DT B-NP B-problem
incisions NNS I-NP I-problem
, , O O
or CC O O
if IN B-VP O
you PRP O B-person
become VBP O O
short JJ O B-problem
of IN B-VP I-problem
breath NN B-NP I-problem
or CC O O
if IN B-VP O
you PRP O B-person
have VBP O O
a DT B-NP B-test
temperature NN I-NP I-test
greater JJR O O
than IN B-VP O
101.4 CD O O
please NN B-NP O
call VB O O
the DT B-NP O
office NN I-NP O
or CC O O
go VB O O
to TO O O
the DT B-NP O
emergency NN I-NP O
room NN I-NP O
Physical NNP I-NP O
Therapy NN I-NP O
: : O O
Activity NN B-NP O
: : O O
Activity NN B-NP O
as IN B-VP O
tolerated JJ B-NP O
Left NNP I-NP O
upper JJ B-NP O
extremity NN I-NP O
: : O O
Non NNP B-NP O
weight VBD B-VP O
bearing VBG O O
Non-weight JJ B-NP O
bearing NN I-NP O
left VBD B-VP O
leg JJ B-NP O
Treatments NNP I-NP O
Frequency NN I-NP O
: : O O
splint NN B-NP B-treatment
to TO O I-treatment
left VB O I-treatment
arm NN B-NP I-treatment
Followup NNP I-NP O
Instructions NNS I-NP O
: : O O
Please NN B-NP O
follow VB O O
up RP O O
with IN B-VP O
Dr. NNP B-NP B-person
Bergeron NNP I-NP I-person
in IN B-VP O
clinic NN B-NP O
in IN B-VP O
2 CD O O
weeks NNS B-NP O
, , O O
please VB O O
call VB O O
953 CD O O
6923 CD O O
to TO O O
Posada NNP B-NP O
that IN B-VP B-pronoun
appointment NN B-NP O
. . B-VP O
   
An DT B-NP O
appointment NN I-NP O
has VBZ O O
been VBN O O
made VBN O O
for IN B-VP O
you PRP O B-person
with IN B-VP O
Nurse NNP B-NP O
Daniel NNP I-NP B-person
Crump NNP I-NP I-person
at IN B-VP O
the DT B-NP O
Loretta NNP I-NP O
Schubert NNP I-NP O
Community NNP I-NP O
Health NNP I-NP O
Center NNP I-NP O
on IN B-VP O
Friday NNP B-NP O
Novemeber NNP I-NP O
24 CD O O
at IN B-VP O
2pm CD O O
. . B-VP O
   
It PRP O B-pronoun
is VBZ O O
located VBN O O
at IN B-VP O
2249 CD O O
S. NNP B-NP O
Lincoln NNP I-NP O
Ave. NNP I-NP O
in IN B-VP O
Nantucket NNP B-NP O
Cottage NNP I-NP O
Hospital NNP I-NP O
the DT B-NP O
phone NN I-NP O
to TO O O
the DT B-NP O
clinic NN I-NP O
is VBZ O O
( ( O O
451 CD O O
) ) O O
376-3200 CD O O
. . B-VP O
   
They PRP O B-pronoun
will MD O O
monitor VB O O
your PRP$ O B-person
your PRP$ O B-test
blood NN B-NP I-test
pressure NN I-NP I-test
and CC O O
heart NN B-NP B-test
rate NN I-NP I-test
and CC O O
lopressor NN B-NP B-treatment
. . B-VP O
   
Gregory NNP B-NP B-person
Robert NNP I-NP I-person
MD NNP I-NP I-person
06-807 NN I-NP O
Completed VBN O O
by IN B-VP O
: : O O
Genevieve NNP B-NP B-person
Gehlert NNP I-NP I-person
PA NNP I-NP I-person
80-BZQ JJ B-NP O
2019-10-19 JJ I-NP O
@ NN I-NP O
1248 CD O O
Signed NNP B-NP O
electronically RB O O
by IN B-VP O
: : O O
DR. NNP B-NP B-person
Ron NNP I-NP I-person
Scott NNP I-NP I-person
on IN B-VP O
: : O O
WED JJ O O
2019-11-27 JJ O O
7:42 CD O O
AM NNP B-NP O
( ( O O
End NNP B-NP O
of IN B-VP O
Report NNP B-NP O
) ) O O
-EMPTYLINE- VBP O O
-DOCSTART- JJ O O
-EMPTYLINE- $ O O
892163777 CD O O
TGCHO NNP B-NP O
3997057 CD O O
299593 CD O O
8/5/1998 CD O O
12:00:00 CD O O
AM NNP B-NP O
RULE NNP I-NP O
OUT NNP I-NP O
FOR NNP I-NP O
MYOCARDIAL NNP I-NP B-problem
INFARCTION NNP I-NP I-problem
Unsigned VBD B-VP O
DIS NNP B-NP O
Report NNP I-NP O
Status NNP I-NP O
: : O O
Unsigned VBD B-VP O
DISCHARGE NNP B-NP O
SUMMARY NNP I-NP O
NAME NN I-NP O
: : O O
FYFEREOSKOTE NNP B-NP B-person
, , O I-person
CILLMA NNP B-NP I-person
M NNP I-NP I-person
UNIT NNP I-NP O
NUMBER NNP I-NP O
: : O O
333-10-08 JJ B-NP O
ADMISSION NNP I-NP O
DATE NNP I-NP O
: : O O
08/05/98 CD O O
DISCHARGE NNP B-NP O
DATE NNP I-NP O
: : O O
08/07/98 CD O O
PRINCIPAL NNP B-NP O
DIAGNOSIS NNP I-NP O
: : O O
Rule NN B-NP O
out IN B-VP O
for IN B-VP O
myocardial JJ B-NP B-problem
infarction NN I-NP I-problem
ASSOCIATED NNP I-NP O
DIAGNOSIS NNP I-NP O
: : O O
1 CD O O
) ) O O
aortic JJ B-NP B-problem
insufficiency NN I-NP I-problem
; : O O
2 CD O O
) ) O O
Parkinson NNP B-NP B-problem
's POS O I-problem
Disease NNP B-NP I-problem
; : O O
3 CD O O
) ) O O
a DT B-NP O
history NN I-NP O
of IN B-VP O
colon NN B-NP B-problem
carcinoma NN I-NP I-problem
; : O O
4 CD O O
) ) O O
congestive JJ B-NP B-problem
heart NN I-NP I-problem
failure NN I-NP I-problem
. . B-VP O
   
PRINCIPAL JJ B-NP O
PROCEDURE NNP I-NP O
: : O O
An DT B-NP B-test
exercise NN I-NP I-test
tolerance NN I-NP I-test
test NN I-NP I-test
with IN B-VP O
imaging NN B-NP B-test
. . B-VP O
   
CHIEF JJ B-NP O
COMPLAINT NN I-NP O
: : O O
Right RB O B-problem
sided VBD B-VP I-problem
chest JJS B-NP I-problem
pain NN I-NP I-problem
by IN B-VP O
several JJ B-NP O
hours NNS I-NP O
. . B-VP O
   
HISTORY NNP B-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS NNP I-NP O
: : O O
Miss NNP B-NP B-person
Siehjesc NNP I-NP I-person
is VBZ O O
an DT B-NP O
85-year-old JJ I-NP O
woman NN I-NP O
with IN B-VP O
a DT B-NP O
past JJ I-NP O
medical JJ I-NP O
history NN I-NP O
significant JJ O O
for IN B-VP O
Parkinson NNP B-NP B-problem
's POS O I-problem
Disease NNP B-NP I-problem
of IN B-VP O
ten CD O O
years NNS B-NP O
duration NN I-NP O
, , O O
supraventricular JJ B-NP B-problem
tachycardia NN I-NP I-problem
, , O O
and CC O O
a DT B-NP O
history NN I-NP O
of IN B-VP O
colon NN B-NP B-problem
carcinoma NN I-NP I-problem
, , O O
who WP O B-person
was VBD B-VP O
in IN B-VP O
her PRP$ O B-person
usual JJ B-NP O
state NN I-NP O
of IN B-VP O
health NN B-NP O
until IN B-VP O
11:30 CD O O
on IN B-VP O
the DT B-NP O
morning NN I-NP O
of IN B-VP O
admission NN B-NP O
when WRB O O
she PRP O B-person
felt VBD B-VP O
the DT B-NP O
acute NN I-NP O
on IN B-VP O
set NN B-NP O
of IN B-VP O
5 CD O O
out IN B-VP O
of IN B-VP O
10 CD O O
right NN B-NP B-problem
sided VBD B-VP I-problem
chest JJS B-NP I-problem
pain NN I-NP I-problem
with IN B-VP O
radiation NN B-NP B-problem
to TO O I-problem
her PRP$ O B-person
her PRP$ O I-problem
sternum NN B-NP I-problem
but CC O O
not RB O O
to TO O O
her PRP$ O B-person
neck NN B-NP O
or CC O O
arms NNS B-NP O
or CC O O
back RB O O
. . B-VP O
   
It PRP O B-pronoun
was VBD B-VP O
not RB O O
relieved VBN O O
by IN B-VP O
2 CD O B-treatment
sublingual JJ B-NP I-treatment
nitroglycerins NNS I-NP I-treatment
. . B-VP O
   
She PRP O B-person
did VBD B-VP O
state NN B-NP O
that IN B-VP B-pronoun
she PRP O B-person
experienced VBD B-VP O
some DT B-NP B-problem
shortness NN I-NP I-problem
of IN B-VP I-problem
breath NN B-NP I-problem
( ( O O
her PRP$ O B-person
usual JJ B-NP O
anginal JJ I-NP O
equivalent NN I-NP O
) ) O O
and CC O O
believes VBZ O O
she PRP O B-person
did VBD B-VP O
experience VB O O
some DT B-NP B-problem
lightheadedness NN I-NP I-problem
as RB O O
well RB O O
, , O O
but CC O O
denies VBZ O O
blacking VBG O O
out RP O O
or CC O O
falling VBG O O
. . B-VP O
   
While IN B-VP O
the DT B-NP B-problem
pain NN I-NP I-problem
was VBD B-VP O
initially RB O O
intermittent JJ O O
, , O O
it PRP O B-pronoun
became VBD B-VP O
steady JJ O O
at IN B-VP O
about IN B-VP O
1:00 CD O O
p.m. NN B-NP O
at IN B-VP O
which WDT O B-pronoun
time NN B-NP O
she PRP O B-person
presented VBD B-VP O
to TO O O
the DT B-NP O
Tecal NNP I-NP O
Galecounxopt NNP I-NP O
Community NNP I-NP O
Hospital NNP I-NP O
Emergency NNP I-NP O
Room NNP I-NP O
and CC O O
following VBG O O
this DT B-NP B-pronoun
experience NN I-NP O
a DT B-NP O
spontaneous JJ I-NP O
remission NN I-NP O
of IN B-VP O
her PRP$ O B-person
her PRP$ O B-problem
right NN B-NP I-problem
sided VBD B-VP I-problem
pain NN B-NP I-problem
. . B-VP O
   
Since IN B-VP O
that DT B-NP B-pronoun
time NN I-NP O
she PRP O B-person
has VBZ O O
experience NN B-NP O
occasional JJ B-NP O
episodes NNS I-NP O
of IN B-VP O
the DT B-NP B-problem
same JJ I-NP I-problem
focal JJ I-NP I-problem
chest NN I-NP I-problem
pain NN I-NP I-problem
but CC O O
finds VBZ O O
that IN B-VP B-pronoun
it PRP O B-pronoun
spontaneously RB O O
remits VBZ O O
. . B-VP O
   
It PRP O B-pronoun
is VBZ O O
made VBN O O
better RB O O
by IN B-VP O
direct JJ B-NP B-treatment
pressure NN I-NP I-treatment
to TO O I-treatment
the DT B-NP I-treatment
point NN I-NP I-treatment
and CC O O
she PRP O B-person
recalls VBZ O O
no DT B-NP O
factors NNS I-NP O
which WDT O B-pronoun
worsened VBD B-VP O
it PRP O B-pronoun
. . B-VP O
   
She PRP O B-person
is VBZ O O
admitted VBN O O
to TO O O
rule VB O O
out RP O O
myocardial JJ B-NP B-problem
infarction NN I-NP I-problem
. . B-VP O
   
PAST NNP B-NP O
MEDICAL NNP I-NP O
HISTORY NNP I-NP O
: : O O
1 CD O O
) ) O O
Parkinson NNP B-NP B-problem
's POS O I-problem
Disease NNP B-NP I-problem
; : O O
2 CD O O
) ) O O
hypertension NN B-NP B-problem
; : O O
3 CD O O
) ) O O
aorticsclerosis NN B-NP B-problem
; : O O
4 CD O O
) ) O O
history NN B-NP O
of IN B-VP O
colon NN B-NP B-problem
carcinoma NN I-NP I-problem
; : O O
5 CD O O
) ) O O
severe JJ B-NP B-problem
kyphosis NN I-NP I-problem
. . B-VP O
   
ALLERGIES NN B-NP O
: : O O
Codeine NNP B-NP B-treatment
. . B-VP O
   
MEDICATIONS NNP B-NP O
ON NNP I-NP O
ADMISSION NNP I-NP O
: : O O
1 CD O O
) ) O O
Lasix FW O B-treatment
20 CD O O
mg. NN B-NP O
PO NNP I-NP O
q.d. RB O O
2 CD O O
) ) O O
Sinemet VBD B-VP B-treatment
25/100 CD O O
1 CD O O
t.i.d. NN B-NP O
3 CD O O
) ) O O
Cogentin NNP B-NP B-treatment
0.5 CD O O
mg. NN B-NP O
1 CD O O
tabs NN B-NP O
PO NNP I-NP O
q.a.m. NN I-NP O
and CC O O
1 CD O O
q.noon NN B-NP O
as RB O O
well RB O O
as IN B-VP O
1 CD O O
q.h.s. $ O O
4 CD O O
) ) O O
Eldepryl NNP B-NP B-treatment
5 CD O O
mg. NN B-NP O
PO NNP I-NP O
b.i.d. VBZ O O
5 CD O O
) ) O O
Enteric NNP B-NP B-treatment
coated VBD B-VP I-treatment
aspirin RB O I-treatment
325 CD O O
mg. NNS B-NP O
PO NNP I-NP O
q.d. RB O O
6 CD O O
) ) O O
Potassium NNP B-NP B-treatment
chloride $ O I-treatment
10 CD O O
mEq. NN B-NP O
PO NNP I-NP O
q.d. VBZ O O
SOCIAL NNP B-NP O
HISTORY NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
smoked VBD B-VP O
one CD O O
pack NN B-NP O
of IN B-VP O
cigarettes NNS B-NP O
per IN B-VP O
day NN B-NP O
from IN B-VP O
age NN B-NP O
16 CD O O
to TO O O
50 CD O O
. . B-VP O
   
She PRP O B-person
quit VBD B-VP O
35 CD O O
years NNS B-NP O
ago RB O O
. . B-VP O
   
She PRP O B-person
takes VBZ O O
one CD O O
sip NN B-NP O
of IN B-VP O
wine NN B-NP O
on IN B-VP O
Fridays NNS B-NP O
. . B-VP O
   
She PRP O B-person
denies VBZ O O
any DT B-NP O
history NN I-NP O
of IN B-VP O
elicit JJ B-NP O
drug NN I-NP O
use NN I-NP O
. . B-VP O
   
She PRP O B-person
did VBD B-VP O
not RB O O
work NN B-NP O
after IN B-VP O
the DT B-NP O
age NN I-NP O
of IN B-VP O
approximately RB O O
65 CD O O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
is VBZ O O
now RB O O
widowed VBN O O
. . B-VP O
   
She PRP O B-person
lives VBZ O O
with IN B-VP O
her PRP$ O B-person
her PRP$ O B-person
single JJ B-NP I-person
daughter NN I-NP I-person
. . B-VP O
   
She PRP O B-person
does VBZ O O
have VB O O
one CD O B-person
son NN B-NP I-person
who WP O B-person
died VBD B-VP O
at IN B-VP O
the DT B-NP O
age NN I-NP O
of IN B-VP O
21 CD O O
years NNS B-NP O
old JJ O O
. . B-VP O
   
FAMILY NNP B-NP O
HISTORY NNP I-NP O
: : O O
Is VBZ O O
significant JJ O O
for IN B-VP O
a DT B-NP B-person
father NN I-NP I-person
who WP O B-person
had VBD B-VP O
a DT B-NP B-problem
stroke NN I-NP I-problem
and CC O O
also RB O O
suffered VBD B-VP O
from IN B-VP O
hypertension NN B-NP B-problem
. . B-VP O
   
She PRP O B-person
denies VBZ O O
any DT B-NP O
family NN I-NP O
history NN I-NP O
of IN B-VP O
diabetes NNS B-NP B-problem
mellitus NNS I-NP I-problem
. . B-VP O
   
PHYSICAL JJ B-NP O
EXAMINATION NN I-NP O
: : O O
The DT B-NP B-test
vital JJ I-NP I-test
signs NNS I-NP I-test
showed VBD B-VP O
a DT B-NP B-test
temperature NN I-NP I-test
of IN B-VP O
96.8 CD O O
, , O O
heart NN B-NP B-test
rate NN I-NP I-test
80 CD O O
, , O O
blood NN B-NP B-test
pressure NN I-NP I-test
180/78 CD O O
, , O O
respiratory NN B-NP B-test
rate NN I-NP I-test
18 CD O O
, , O O
and CC O O
she PRP O B-person
was VBD B-VP O
satting VBG O B-test
95 CD O O
percent NN B-NP O
on IN B-VP O
two CD O B-treatment
liters NNS B-NP I-treatment
nasal JJ B-NP I-treatment
cannula NN I-NP I-treatment
. . B-VP O
   
In IN B-VP O
general JJ O O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
resting VBG O O
comfortably RB O O
in IN B-VP O
bed NN B-NP O
with IN B-VP O
a DT B-NP B-problem
visible JJ I-NP I-problem
tremor NN I-NP I-problem
of IN B-VP I-problem
her PRP$ O I-problem
her PRP$ O B-person
right JJ B-NP I-problem
hand NN I-NP I-problem
and CC O I-problem
foot NN B-NP I-problem
. . B-VP O
   
The DT B-NP O
head NN I-NP O
, , O O
eyes NNS B-NP O
, , O O
ears NNS B-NP O
, , O O
nose RB O O
and CC O O
throat NN B-NP O
, , O O
normocephalic JJ O O
, , O O
atraumatic JJ O B-problem
, , O O
pupils JJ O O
equal JJ O O
, , O O
round NN B-NP O
, , O O
reactive JJ O O
to TO O O
light JJ O O
and CC O O
accommodation NN B-NP O
, , O O
extraocular JJ B-NP O
muscles NNS I-NP O
intact JJ O O
, , O O
sclera JJ B-NP B-problem
anicteric NN I-NP I-problem
. . B-VP O
   
Neck NN B-NP O
: : O O
supple NN B-NP O
, , O O
no DT B-NP O
bruits NNS I-NP B-problem
, , O O
nodes NNS B-NP B-problem
or CC O O
thyromegaly NN B-NP B-problem
. . B-VP O
   
Thorax NN B-NP O
: : O O
crackles NNS B-NP B-problem
at IN B-VP I-problem
both DT B-NP I-problem
bases NNS I-NP I-problem
, , O O
kyphotic JJ O B-problem
, , O O
no DT B-NP O
costovertebral JJ I-NP B-problem
angle NN I-NP I-problem
tenderness NN I-NP I-problem
. . B-VP O
   
Cardiovascular JJ B-NP O
exam NN I-NP O
: : O O
regular JJ B-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
with IN B-VP O
1 CD O B-problem
out IN B-VP I-problem
of IN B-VP I-problem
6 CD O I-problem
systolic JJ B-NP I-problem
ejection NN I-NP I-problem
murmur NN I-NP I-problem
. . B-VP O
   
Abdomen NNS B-NP O
: : O O
soft JJ O O
, , O O
well RB O B-problem
healed VBN O I-problem
scar NN B-NP I-problem
, , O O
positive JJ B-NP O
bowel NN I-NP O
sounds NNS I-NP O
, , O O
no DT B-NP O
tenderness NN I-NP B-problem
or CC O O
organomegaly NN B-NP B-problem
noted VBN O O
. . B-VP O
   
Extremities NNS B-NP O
: : O O
without IN B-VP O
clubbing VBG O B-problem
, , O O
claudication NN B-NP B-problem
, , O O
or CC O O
edema NN B-NP B-problem
. . B-VP O
   
Rectal JJ O O
: : O O
negative JJ O O
per IN B-VP O
the DT B-NP O
emergency NN I-NP O
room NN I-NP O
. . B-VP O
   
Neurologically RB O O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
alert JJ O O
and CC O O
oriented JJ B-NP O
x3 NN I-NP O
. . B-VP O
   
Tremors NNS B-NP B-problem
of IN B-VP I-problem
the DT B-NP I-problem
right JJ I-NP I-problem
hand NN I-NP I-problem
and CC O I-problem
foot NN B-NP I-problem
at IN B-VP O
rest NN B-NP O
. . B-VP O
   
Equivocal JJ B-NP B-problem
cogwheeling NN I-NP I-problem
on IN B-VP I-problem
the DT B-NP I-problem
right NN I-NP I-problem
, , O O
normal JJ B-NP O
tone NN I-NP O
on IN B-VP O
the DT B-NP O
left NN I-NP O
. . B-VP O
   
LABORATORY NNP B-NP O
DATA NNP I-NP O
: : O O
The DT O B-person
The DT B-NP B-test
patient JJ I-NP I-person
patient NN I-NP I-test
's POS O I-test
SMA NNP B-NP I-test
7 CD O I-test
was VBD B-VP O
notable JJ O O
for IN B-VP O
a DT B-NP B-test
BUN NNP I-NP I-test
of IN B-VP O
28 CD O O
, , O O
creatinine NN B-NP B-test
1.3 CD O O
, , O O
and CC O O
a DT B-NP B-test
glucose NN I-NP I-test
of IN B-VP O
102 CD O O
. . B-VP O
   
Extended VBN O O
chemistries NNS B-NP B-test
were VBD B-VP O
within IN B-VP O
normal JJ B-NP O
limits NNS I-NP O
with IN B-VP O
a DT B-NP B-test
creatine JJ I-NP I-test
kinase NN I-NP I-test
of IN B-VP O
122 CD O O
and CC O O
no DT B-NP O
measured JJ I-NP B-test
methylene NN I-NP I-test
blue JJ B-NP I-test
fraction NN I-NP I-test
given VBN O O
the DT B-NP O
low JJ I-NP O
value NN I-NP O
. . B-VP O
   
The DT B-NP B-test
complete JJ I-NP I-test
blood NN I-NP I-test
count NN I-NP I-test
was VBD B-VP O
notable JJ O O
for IN B-VP O
a DT B-NP B-test
white JJ I-NP I-test
count NN I-NP I-test
of IN B-VP O
5.3,000 CD O O
, , O O
hematocrit VBD B-VP B-test
39 CD O O
1/2 CD O O
and CC O O
platelet NN B-NP B-test
count NN I-NP I-test
of IN B-VP O
180,000 CD O O
and CC O O
normal JJ B-NP O
coags NNS I-NP O
were VBD B-VP O
measured VBN O O
. . B-VP O
   
RADIOLOGY NNP B-NP O
: : O O
Portable JJ B-NP B-test
chest JJS I-NP I-test
x-ray NN I-NP I-test
was VBD B-VP O
without IN B-VP O
evidence NN B-NP O
of IN B-VP O
congestive JJ B-NP B-problem
heart NN I-NP I-problem
failure NN I-NP I-problem
or CC O O
pneumonia NN B-NP B-problem
. . B-VP O
   
HOSPITAL NNP B-NP O
COURSE NNP I-NP O
AND NNP I-NP O
TREATMENT NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
proceeded VBD B-VP O
to TO O O
rule VB O O
out RP O O
formyocardial JJ B-NP B-problem
infarction NN I-NP I-problem
by IN B-VP O
enzymes NNS B-NP B-test
. . B-VP O
   
Additionally RB O O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
underwent VBD B-VP O
a DT B-NP B-test
exercise NN I-NP I-test
stress NN I-NP I-test
test NN I-NP I-test
on IN B-VP O
8/6/98 CD O O
with IN B-VP O
a DT B-NP B-test
heart NN I-NP I-test
rate NN I-NP I-test
proceeding VBG O O
from IN B-VP O
76 CD O O
to TO O O
93 CD O O
beats NNS B-NP O
per IN B-VP O
minute NN B-NP O
. . B-VP O
   
There EX O O
were VBD B-VP O
no DT B-NP O
electrocardiogram JJ I-NP B-problem
changes NNS I-NP I-problem
noted VBD B-VP O
and CC O O
there EX O O
were VBD B-VP O
no DT B-NP O
arrhythmias NN I-NP B-problem
noted VBD B-VP O
as RB O O
well RB O O
. . B-VP O
   
During IN B-VP O
the DT B-NP B-test
test NN I-NP I-test
the DT B-NP B-person
patient NN I-NP I-person
experienced VBD B-VP O
no DT B-NP O
chest JJ I-NP B-problem
pressure NN I-NP I-problem
or CC O O
pain NN B-NP B-problem
or CC O O
dyspnea NN B-NP B-problem
and CC O O
nuclear JJ B-NP B-test
medical JJ I-NP I-test
imaging NN I-NP I-test
was VBD B-VP O
without IN B-VP O
evidence NN B-NP O
of IN B-VP O
ischemia NN B-NP B-problem
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
in IN B-VP O
this DT B-NP B-pronoun
fashion NN I-NP O
discharged VBD B-VP O
from IN B-VP O
the DT B-NP O
service NN I-NP O
to TO O O
continue VB O O
on IN B-VP O
her PRP$ O B-treatment
her PRP$ O B-person
current JJ B-NP I-treatment
medications NNS I-NP I-treatment
and CC O O
to TO O O
call VB O O
in IN B-VP O
oneweek NN B-NP O
to TO O O
follow VB O O
up RP O O
with IN B-VP O
Dr. NNP B-NP B-person
Sterpbreutzsterp NNP I-NP I-person
and CC O O
Cardiology NNP B-NP B-person
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
already RB O O
had VBD B-VP O
a DT O O
follow JJ O O
up RP O O
appointment NN B-NP O
with IN B-VP O
Dr. NNP B-NP B-person
Sterpbreutzsterp NNP I-NP I-person
in IN B-VP O
three CD O O
weeks NNS B-NP O
, , O O
and CC O O
was VBD B-VP O
instructed VBN O O
to TO O O
keep VB O O
that DT B-NP B-pronoun
appointment NN I-NP O
. . B-VP O
   
CONDITION NNP B-NP O
ON NNP I-NP O
DISCHARGE NNP I-NP O
: : O O
Good JJ O O
. . B-VP O
   
MEDICATIONS NNP B-NP O
ON NNP I-NP O
DISCHARGE NNP I-NP O
: : O O
1) CD O O
Lasix NNP B-NP B-treatment
20 CD O O
mg. NN B-NP O
PO NNP I-NP O
q.d. VBZ O O
2) CD O O
Sinemet NNP B-NP B-treatment
25/100 CD O O
PO NNP B-NP O
t.i.d. VBD B-VP O
3) CD O O
Cogentin NNP B-NP B-treatment
0.5 CD O O
mg. NN B-NP O
2 CD O O
tabs NN B-NP O
q.a.m. NN I-NP O
, , O O
1 CD O O
q.lunch JJ B-NP O
time NN I-NP O
, , O O
1 CD O O
q.bed JJ B-NP O
time NN I-NP O
. . B-VP O
   
4) CD O O
Eldepryl NNP B-NP B-treatment
5 CD O O
mg. NN B-NP O
PO NNP I-NP O
q.d. VBZ O O
5) CD O O
Enteric NNP B-NP B-treatment
coated VBD B-VP I-treatment
aspirin RB O I-treatment
325 CD O O
mg. NNS B-NP O
PO NNP I-NP O
q.d. VBD B-VP O
6) CD O O
Potassium NNP B-NP B-treatment
chloride NN I-NP I-treatment
10 CD O O
mEq. NN B-NP O
PO NNP I-NP O
q.d. VBZ O O
7) CD O O
Metoprolol NNP B-NP B-treatment
25 CD O O
mg. NN B-NP O
PO NNP I-NP O
b.i.d. NN I-NP O
DOCTOR NNP I-NP B-person
' POS O O
S NNP B-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
will MD O O
follow VB O O
up RP O O
with IN B-VP O
her PRP$ O B-person
her PRP$ O B-person
primary JJ B-NP I-person
care NN I-NP I-person
physician NN I-NP I-person
, , O O
Dr. NNP B-NP B-person
Stoa NNP I-NP I-person
Sterpbreutzsterp NNP I-NP I-person
as IN B-VP O
has VBZ O O
already RB O O
been VBN O O
scheduled VBN O O
three CD O O
weeks NNS B-NP O
after IN B-VP O
the DT B-NP O
discharge NN I-NP O
date NN I-NP O
. . B-VP O
   
NILA NNP B-NP B-person
H. NNP I-NP I-person
LEFT NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
DICTATING NNP I-NP O
FOR NNP I-NP O
: : O O
STOA NNP B-NP B-person
STERPBREUTZSTERP NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
TR NNP I-NP O
: : O O
fgz JJ B-NP O
DD NNP I-NP O
: : O O
10/12/98 CD O O
TD NN B-NP O
: : O O
10/17/98 CD O O
11:52 CD O O
Acc NN B-NP O
: : O O
NILA NNP B-NP B-person
H NNP I-NP I-person
LEFT NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
STOA NNP I-NP B-person
STERPBREUTZSTERP NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- VBD B-VP O
693519617 CD O O
PUOMC NNP B-NP O
2328487 CD O O
769151 CD O O
388371 CD O O
12/16/1997 CD O O
12:00:00 CD O O
AM NNP B-NP O
END-STAGE JJ B-NP B-problem
RENAL NNP I-NP I-problem
DISEASE NNP I-NP I-problem
. . B-VP O
   
Unsigned VBD B-VP O
DIS NNP B-NP O
Report NNP I-NP O
Status NNP I-NP O
: : O O
Unsigned VBD B-VP O
DISCHARGE NNP B-NP O
SUMMARY NNP I-NP O
NAME NNP I-NP O
: : O O
LESS NNP B-NP B-person
, , O I-person
LIESEANALE NNP B-NP I-person
UNIT NNP I-NP O
NUMBER NNP I-NP O
: : O O
589-25-50 JJ B-NP O
ADMISSION NNP I-NP O
DATE NNP I-NP O
: : O O
12/16/97 CD O O
DISCHARGE NNP B-NP O
DATE NNP I-NP O
: : O O
01/16/98 CD O O
PRINCIPAL NNP B-NP O
DIAGNOSIS NNP I-NP O
: : O O
End-stage JJ B-NP B-problem
renal JJ I-NP I-problem
disease NN I-NP I-problem
. . B-VP O
   
ASSOCIATED CC O O
DIAGNOSIS NNP B-NP O
: : O O
1. CD O O
Right NNP B-NP B-treatment
nephrectomy NN I-NP I-treatment
. . B-VP O
   
2. CD O O
Cadaveric NNP B-NP B-treatment
renal JJ B-NP I-treatment
transplant NN I-NP I-treatment
. . B-VP O
   
3. CD O O
Acute JJ B-NP B-problem
thrombosis NN I-NP I-problem
. . B-VP O
   
4. CD O O
Transplant JJ B-NP B-treatment
nephrectomy NN I-NP I-treatment
. . B-VP O
   
5. CD O O
Pulmonary JJ B-NP B-problem
emboli NN I-NP I-problem
. . B-VP O
   
6. CD O O
Hypertension NNP B-NP B-problem
. . B-VP O
   
7. CD O O
Coronary JJ B-NP B-problem
artery NN I-NP I-problem
disease NN I-NP I-problem
. . B-VP O
   
8. CD O O
Chronic NNP B-NP B-problem
obstructive JJ B-NP I-problem
pulmonary JJ I-NP I-problem
disease NN I-NP I-problem
. . B-VP O
   
9. CD O O
Hypercoagulable JJ B-NP B-problem
state NN I-NP I-problem
. . B-VP O
   
10. CD O O
Perforated VBD B-VP B-problem
viscus NN B-NP I-problem
. . B-VP O
   
11. CD O O
Abdominal JJ B-NP B-problem
abscesses NNS I-NP I-problem
. . B-VP O
   
12. CD O O
Sepsis NNP B-NP B-problem
. . B-VP O
   
13. CD O O
Respiratory JJ B-NP B-problem
failure NN I-NP I-problem
. . B-VP O
   
HISTORY NN B-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
a DT B-NP O
53-year-old JJ I-NP O
male NN I-NP O
with IN B-VP O
a DT B-NP O
longstanding JJ I-NP O
history NN I-NP O
of IN B-VP O
renal JJ B-NP B-problem
disease NN I-NP I-problem
with IN B-VP O
multiple JJ B-NP B-problem
complications NNS I-NP I-problem
and CC O O
problems NNS B-NP B-problem
related VBN O O
to TO O O
vascular JJ B-NP O
access NN I-NP O
and CC O O
hypercoagulable JJ B-NP B-problem
state NN I-NP I-problem
. . B-VP O
   
These DT O B-pronoun
culminated VBN O O
in IN B-VP O
an DT B-NP B-treatment
attempted JJ I-NP I-treatment
cadaveric NN I-NP I-treatment
kidney NN I-NP I-treatment
transplant NN I-NP I-treatment
undertaken VBN O O
on IN B-VP O
12/16/97 CD O O
, , O O
which WDT O B-pronoun
was VBD B-VP O
complicated VBN O O
by IN B-VP O
thrombosis NN B-NP B-problem
and CC O O
necrosis NN B-NP B-problem
of IN B-VP I-problem
the DT B-NP I-problem
cadaveric JJ I-NP I-problem
renal JJ I-NP I-problem
vein NN I-NP I-problem
within IN B-VP O
24 CD O O
hours NNS B-NP O
. . B-VP O
   
This DT O B-pronoun
required VBD B-VP O
a DT B-NP B-treatment
transplant JJ I-NP I-treatment
nephrectomy NN I-NP I-treatment
. . B-VP O
   
HOSPITAL NNP B-NP O
COURSE NNP I-NP O
AND NNP I-NP O
TREATMENT NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
&apos;s NNP I-NP O
course NN I-NP O
was VBD B-VP O
subsequently RB O O
characterized VBN O O
by IN B-VP O
recurrent NN B-NP B-problem
pneumonias NN I-NP I-problem
, , O O
possibly RB O O
due JJ O O
to TO O O
aspiration NN B-NP B-problem
, , O O
and CC O O
by IN B-VP O
hemodynamic JJ B-NP B-problem
instability NN I-NP I-problem
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
transferred VBN O O
to TO O O
the DT B-NP O
Medical NNP I-NP O
Intensive NNP I-NP O
Care NNP I-NP O
Unit NNP I-NP O
from IN B-VP O
the DT B-NP O
Transplant NNP I-NP O
Service NNP I-NP O
for IN B-VP O
ventilatory JJ B-NP B-treatment
management NN I-NP I-treatment
in IN B-VP O
the DT B-NP O
setting NN I-NP O
of IN B-VP O
hypotension NN B-NP B-problem
. . B-VP O
   
On IN B-VP O
transfer NN B-NP O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
not RB O O
sedated VBN O B-treatment
, , O O
but CC O O
was VBD B-VP O
unresponsive JJ O B-problem
and CC O O
extremely RB O B-problem
dyssynchronous JJ O I-problem
with IN B-VP O
the DT B-NP B-treatment
ventilator NN I-NP I-treatment
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
found VBN O O
to TO O O
have VB O O
substantial JJ B-NP B-problem
auto NN I-NP I-problem
PEEP NNP I-NP I-problem
with IN B-VP O
an DT O B-problem
elevated VBN O I-problem
dead JJ B-NP I-problem
space NN I-NP I-problem
. . B-VP O
   
A DT B-NP B-test
pulmonary JJ I-NP I-test
arteriogram NN I-NP I-test
on IN B-VP O
01/03/98 CD O O
demonstrated JJ B-NP O
multiple JJ I-NP B-problem
pulmonary JJ I-NP I-problem
emboli NN I-NP I-problem
, , O O
likely RB O O
less JJR O O
than IN B-VP O
one CD O O
week NN B-NP O
old JJ O O
, , O O
possibly RB O O
introduced VBN O O
at IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
the DT B-NP B-problem
renal JJ I-NP I-problem
vein NN I-NP I-problem
thrombosis NN I-NP I-problem
of IN B-VP O
12/19/97 CD O O
. . B-VP O
   
An DT B-NP B-treatment
inferior JJ I-NP I-treatment
vena NN I-NP I-treatment
cava NN I-NP I-treatment
filter NN I-NP I-treatment
was VBD B-VP O
placed VBN O O
; : O O
lower JJR B-NP B-test
extremity NN I-NP I-test
noninvasive JJ B-NP I-test
studies NNS I-NP I-test
were VBD B-VP O
negative JJ O O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
required VBN O O
high JJ B-NP B-treatment
pressures NNS I-NP I-treatment
to TO O O
ventilate VB O O
adequately RB O O
, , O O
possibly RB O O
related VBN O O
to TO O O
an DT B-NP B-problem
abdominal JJ I-NP I-problem
compartment NN I-NP I-problem
syndrome NN I-NP I-problem
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
had VBD B-VP O
undergone JJ O O
two CD O B-treatment
abdominal JJ B-NP I-treatment
procedures NNS I-NP I-treatment
following VBG O O
explantation NN B-NP O
. . B-VP O
   
The DT B-NP O
physiology NN I-NP O
at IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
transfer NN B-NP O
to TO O O
the DT B-NP O
Medical NNP I-NP O
Intensive NNP I-NP O
Care NNP I-NP O
Unit NNP I-NP O
was VBD B-VP O
consistent JJ O O
with IN B-VP O
a DT B-NP B-problem
septic JJ I-NP I-problem
process NN I-NP I-problem
. . B-VP O
   
CT NNP B-NP B-test
scan JJ O I-test
demonstrated VBD B-VP O
retroperitoneal JJ B-NP B-problem
collection NN I-NP I-problem
containing VBG O O
both DT B-NP O
free JJ I-NP B-problem
air NN I-NP I-problem
and CC O O
extravasated VBD B-VP B-problem
contrast NN B-NP I-problem
material NN I-NP I-problem
. . B-VP O
   
For IN B-VP O
the DT B-NP O
concern NN I-NP O
of IN B-VP O
a DT B-NP B-problem
perforated JJ I-NP I-problem
viscus NN I-NP I-problem
, , O O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
taken VBN O O
to TO O O
exploratory JJ B-NP B-test
laparotomy NN I-NP I-test
on IN B-VP O
01/06/98 CD O O
, , O O
during IN B-VP O
which WDT O B-pronoun
the DT B-NP O
bowel NN I-NP O
was VBD B-VP O
run VBN O O
without IN B-VP O
evidence NN B-NP O
of IN B-VP O
perforation NN B-NP B-problem
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
remained VBD B-VP O
unstable JJ O B-problem
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
taken VBN O O
to TO O O
fluoroscopy VB O B-test
, , O O
where WRB O O
oral JJ B-NP B-test
contrast NN I-NP I-test
was VBD B-VP O
demonstrated VBN O O
to TO O O
be VB O O
extravasating VBG O O
through IN B-VP O
a DT B-NP O
posterior JJ I-NP O
duodenum NN I-NP O
. . B-VP O
   
For IN B-VP O
this DT B-NP B-pronoun
reason NN I-NP O
, , O O
he PRP O B-person
was VBD B-VP O
taken VBN O O
again RB O O
to TO O O
the DT B-NP O
operating NN I-NP O
room NN I-NP O
on IN B-VP O
01/08/98 CD O O
, , O O
at IN B-VP O
which WDT O B-pronoun
time NN B-NP O
a DT B-NP B-treatment
gastrojejunostomy NN I-NP I-treatment
was VBD B-VP O
performed VBN O O
with IN B-VP O
stapling VBG O B-treatment
across IN B-VP I-treatment
the DT B-NP I-treatment
gastroduodenal JJ I-NP I-treatment
junction NN I-NP I-treatment
, , O O
introduction NN B-NP O
of IN B-VP O
five CD O B-treatment
Jackson-Pratt JJ B-NP I-treatment
drains NNS I-NP I-treatment
into IN B-VP O
the DT B-NP B-problem
retroperitoneal JJ I-NP I-problem
mass NN I-NP I-problem
, , O O
cholecystotomy NN B-NP B-treatment
tube NN I-NP I-treatment
, , O O
gastrostomy NN B-NP B-treatment
tube NN I-NP I-treatment
, , O O
and CC O O
jejunostomy NN B-NP B-treatment
tube NN I-NP I-treatment
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
had VBD B-VP O
an DT O B-problem
extensive JJ O I-problem
estimated VBN O I-problem
blood NN B-NP I-problem
loss NN I-NP I-problem
requiring VBG O O
multiple JJ B-NP B-treatment
blood NN I-NP I-treatment
products NNS I-NP I-treatment
and CC O O
fluid JJ B-NP B-treatment
resuscitation NN I-NP I-treatment
therapy NN I-NP I-treatment
. . B-VP O
   
Accompanying VBG O O
this DT O B-pronoun
during IN B-VP O
this DT B-NP B-pronoun
period NN I-NP O
were VBD B-VP O
elevations NNS B-NP B-problem
in IN B-VP O
liver NN B-NP B-test
function NN I-NP I-test
studies NNS I-NP I-test
and CC O O
amylase NN B-NP B-test
and CC O O
lipase NN B-NP B-test
consistent NN I-NP O
with IN B-VP O
pancreatic JJ B-NP B-problem
inflammation NN I-NP I-problem
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
aggressively RB O O
treated VBN O O
with IN B-VP O
fluid JJ B-NP B-treatment
resuscitation NN I-NP I-treatment
and CC O O
pressors NNS B-NP B-treatment
for IN B-VP O
his PRP$ O B-person
his PRP$ O B-problem
septic JJ B-NP I-problem
physiology NN I-NP I-problem
. . B-VP O
   
There EX O O
was VBD B-VP O
no DT B-NP O
evidence NN I-NP O
of IN B-VP O
cardiac JJ B-NP B-problem
tamponade NN I-NP I-problem
or CC O O
specific JJ B-NP B-problem
underlying JJ I-NP I-problem
coronary JJ I-NP I-problem
dysfunction NN I-NP I-problem
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
treated VBN O O
with IN B-VP O
appropriate JJ B-NP B-treatment
antibiotics NNS I-NP I-treatment
for IN B-VP O
his PRP$ O B-person
his PRP$ O B-problem
Serratia NNP B-NP I-problem
pneumonia NN I-NP I-problem
, , O O
as RB O O
well RB O O
as IN B-VP O
for IN B-VP O
his PRP$ O B-person
his PRP$ O B-problem
abdominal JJ B-NP I-problem
process NN I-NP I-problem
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
felt VBN O O
to TO O O
have VB O O
an DT O B-problem
underlying VBG O I-problem
hypercoagulable JJ B-NP I-problem
state NN I-NP I-problem
, , O O
thought VBD B-VP O
to TO O O
be VB O O
the DT B-NP O
source NN I-NP O
for IN B-VP O
the DT B-NP B-problem
repeated JJ I-NP I-problem
clots NNS I-NP I-problem
. . B-VP O
   
Because IN B-VP O
of IN B-VP O
the DT B-NP B-problem
bleeding NN I-NP I-problem
problems NNS I-NP I-problem
, , O O
however RB O O
, , O O
it PRP O B-pronoun
was VBD B-VP O
felt VBN O O
that IN B-VP B-pronoun
full JJ B-NP B-treatment
heparinization NN I-NP I-treatment
would MD O O
not RB O O
be VB O O
prudent JJ O O
, , O O
and CC O O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
treated VBN O O
with IN B-VP O
pneumo-boots NNS B-NP B-treatment
and CC O O
subcutaneous JJ B-NP B-treatment
heparin NN I-NP I-treatment
. . B-VP O
   
Attention NN B-NP O
was VBD B-VP O
paid VBN O O
to TO O O
a DT B-NP O
variety NN I-NP O
of IN B-VP O
metabolic JJ O B-problem
and CC O I-problem
electrolyte JJ B-NP I-problem
abnormalities NNS I-NP I-problem
, , O O
which WDT O B-pronoun
were VBD B-VP O
corrected VBN O O
appropriately RB O O
. . B-VP O
   
Nonetheless RB O O
, , O O
Mr. NNP B-NP B-person
Less NNP I-NP I-person
continued VBD B-VP O
to TO O O
remain VB O O
critically RB O B-problem
ill VB O I-problem
with IN B-VP O
only JJ O O
very RB O O
transient JJ B-NP O
mild NN I-NP O
improvement NN I-NP O
with IN B-VP O
drainage NN B-NP B-treatment
of IN B-VP O
additional JJ B-NP B-problem
retroperitoneal NN I-NP I-problem
fluid NN I-NP I-problem
. . B-VP O
   
He PRP O B-person
remained VBD B-VP O
pressor JJ B-NP B-problem
dependent NN I-NP I-problem
, , O O
as RB O O
well RB O O
as IN B-VP O
dependent JJ O B-problem
upon IN B-VP O
mechanical JJ B-NP B-treatment
ventilatory NN I-NP I-treatment
assistance NN I-NP I-treatment
. . B-VP O
   
His PRP$ O B-person
course NN B-NP O
was VBD B-VP O
complicated VBN O O
by IN B-VP O
atrial JJ B-NP B-problem
fibrillation NN I-NP I-problem
requiring VBG O O
cardioversion NN B-NP B-treatment
. . B-VP O
   
He PRP O B-person
had VBD B-VP O
an DT B-NP B-problem
ongoing JJ I-NP I-problem
requirement NN I-NP I-problem
for IN B-VP O
high JJ B-NP B-treatment
volume NN I-NP I-treatment
resuscitation NN I-NP I-treatment
and CC O O
was VBD B-VP O
persistently RB O B-problem
acidotic JJ O I-problem
despite IN B-VP O
CV-VVH NNP B-NP B-treatment
in IN B-VP O
the DT B-NP O
face NN I-NP O
of IN B-VP O
bicarbonate JJ B-NP B-treatment
replenishment NN I-NP I-treatment
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
also RB O O
appeared VBD B-VP O
to TO O O
have VB O O
stool NN B-NP O
from IN B-VP O
his PRP$ O B-person
his PRP$ O B-problem
Jackson-Pratt NNP B-NP I-problem
site NN I-NP I-problem
and CC O O
right JJ B-NP B-problem
oblique NN I-NP I-problem
incision NN I-NP I-problem
. . B-VP O
   
Bloody JJ B-NP B-problem
drainage NN I-NP I-problem
from IN B-VP O
his PRP$ O B-person
his PRP$ O B-problem
increasingly RB O I-problem
distended VBN O I-problem
abdomen NNS B-NP I-problem
was VBD B-VP O
noted VBN O O
. . B-VP O
   
Extensive JJ B-NP O
discussions NNS I-NP O
were VBD B-VP O
carried VBN O O
out RP O O
with IN B-VP O
Mrs. NNP B-NP B-person
Less NNP I-NP I-person
condition NN I-NP O
was VBD B-VP O
irretrievable JJ O O
. . B-VP O
   
It PRP O B-pronoun
was VBD B-VP O
felt VBN O O
that IN B-VP B-pronoun
the DT B-NP B-person
patient NN I-NP I-person
had VBD B-VP O
continued VBN O O
massive JJ B-NP B-problem
retroperitoneal NN I-NP I-problem
contamination NN I-NP I-problem
and CC O O
probable JJ B-NP O
multiple JJ I-NP B-problem
enteric JJ I-NP I-problem
fistulae NN I-NP I-problem
from IN B-VP O
an DT B-NP B-problem
ischemic JJ I-NP I-problem
bowel NN I-NP I-problem
. . B-VP O
   
Dr. NNP B-NP B-person
Cantsleddjesc NNP I-NP I-person
felt VBD B-VP O
that IN B-VP B-pronoun
no DT B-NP O
surgical JJ I-NP B-treatment
approach NN I-NP I-treatment
to TO O O
this DT O B-pronoun
this DT B-NP B-problem
problem NN I-NP I-problem
or CC O O
further JJ B-NP B-treatment
intervention NN I-NP I-treatment
or CC O O
radiologic NN B-NP B-treatment
procedures NNS I-NP I-treatment
would MD O O
be VB O O
helpful JJ O O
. . B-VP O
   
All DT B-NP B-person
physicians NNS I-NP I-person
and CC O O
the DT B-NP B-person
family NN I-NP I-person
were VBD B-VP O
in IN B-VP O
agreement NN B-NP O
that IN B-VP B-pronoun
the DT O O
most RBS O O
appropriate JJ B-NP O
approach NN I-NP O
was VBD B-VP O
to TO O O
institute VB O O
comfort NN B-NP B-treatment
measures NNS I-NP I-treatment
. . B-VP O
   
This DT O B-pronoun
was VBD B-VP O
done VBN O O
, , O O
and CC O O
the DT B-NP B-person
patient NN I-NP I-person
appeared VBD B-VP O
to TO O O
be VB O O
comfortable JJ O O
at IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
death NN B-NP O
with IN B-VP O
his PRP$ O B-person
his PRP$ O B-person
family NN B-NP I-person
at IN B-VP O
his PRP$ O B-person
side NN B-NP O
on IN B-VP O
1/16/98 CD O O
. . B-VP O
   
I PRP O B-person
L. NNP B-NP I-person
STERPSKOLK NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
TR NNP I-NP O
: : O O
vcp NN B-NP O
DD NNP I-NP O
: : O O
05/25/98 CD O O
TD NN B-NP O
: : O O
05/30/98 CD O O
8:30 CD O O
A NNP B-NP O
cc NN I-NP O
: : O O
LE NNP B-NP B-person
FREIERM NNP I-NP I-person
, , O I-person
JR NNP B-NP I-person
, , O I-person
M.D. NNP B-NP I-person
KIVERL NNP I-NP B-person
NA NNP I-NP I-person
CANTSLEDDJESC NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
I PRP O B-person
LYNIN NNP B-NP I-person
STERPSKOLK NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
ETI NNP I-NP B-person
CHAELKA NNP I-NP I-person
MULKEVI NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
cc NN I-NP O
: : O O
Dr. NNP B-NP B-person
Less NNP I-NP I-person
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
Admission NNP I-NP O
Date NNP I-NP O
: : O O
2017-09-13 JJ B-NP O
Discharge NN I-NP O
Date NNP I-NP O
: : O O
2017-09-15 JJ B-NP O
Date NNP I-NP O
of IN B-VP O
Birth NNP B-NP O
: : O O
1972-05-09 JJ B-NP O
Sex NN I-NP O
: : O O
F NNP B-NP O
Service NNP I-NP O
: : O O
NSU NNP B-NP O
HISTORY NNP I-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
is VBZ O O
a DT O O
45 CD O O
- : O O
year-old JJ B-NP O
female NN I-NP O
here RB O O
for IN B-VP O
a DT B-NP B-test
diagnostic JJ I-NP I-test
cerebral JJ I-NP I-test
angiogram NN I-NP I-test
with IN B-VP O
coiling NN B-NP B-treatment
. . B-VP O
   
HOSPITAL NNP B-NP O
COURSE NNP I-NP O
: : O O
On IN B-VP O
admission NN B-NP O
, , O O
the DT O B-person
the DT B-NP B-test
patient JJ I-NP I-person
patient NN I-NP I-test
's POS O I-test
vital JJ B-NP I-test
signs NNS I-NP I-test
were VBD B-VP O
stable JJ O O
. . B-VP O
   
Her PRP$ O B-test
Her PRP$ O B-person
blood NN B-NP I-test
pressure NN I-NP I-test
was VBD B-VP O
102/82 CD O O
. . B-VP O
   
Her PRP$ O B-person
Her PRP$ O B-test
heart NN B-NP I-test
rate NN I-NP I-test
was VBD B-VP O
71 CD O O
. . B-VP O
   
Her PRP$ O B-person
Her PRP$ O B-test
SPO2 NNP B-NP I-test
was VBD B-VP O
98 CD O O
percent NN B-NP O
on IN B-VP O
room NN B-NP O
air NN I-NP O
. . B-VP O
   
MEDICATIONS NNP B-NP O
ON NNP I-NP O
ADMISSION NNP I-NP O
: : O O
1. CD O O
Plavix NNP B-NP B-treatment
75 CD O O
mg NN B-NP O
times NNS I-NP O
6 CD O O
doses NNS B-NP O
. . B-VP O
   
2. CD O O
Xanax NNP B-NP B-treatment
q.d. VBD B-VP O
3. CD O O
Prozac NNP B-NP B-treatment
20 CD O O
mg NN B-NP O
q.d. NN I-NP O
4. CD O O
Cyclobenzaprine NNP B-NP B-treatment
10 CD O O
mg NN B-NP O
q.d. NN I-NP O
5. CD O O
Aspirin NNP B-NP B-treatment
325 CD O O
mg NN B-NP O
times NNS I-NP O
3 CD O O
doses NNS B-NP O
. . B-VP O
   
6. CD O O
Vitamin NNP B-NP B-treatment
E NNP I-NP I-treatment
. . B-VP O
   
PAST NNP B-NP O
SURGICAL NNP I-NP O
HISTORY NNP I-NP O
: : O O
Tubal JJ B-NP B-treatment
ligation NN I-NP I-treatment
, , O O
1986 CD O O
. . B-VP O
   
Cystectomy NNP B-NP B-treatment
, , O O
1992 CD O O
and CC O O
1998 CD O O
. . B-VP O
   
Breast NNP B-NP B-treatment
lesion NN I-NP I-treatment
excision NN I-NP I-treatment
, , O O
1989 CD O O
. . B-VP O
   
ALLERGIES CC O O
: : O O
TETRACYCLINE NNP B-NP B-treatment
. . B-VP O
   
SOCIAL NNP B-NP O
HISTORY NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
uses VBZ O O
alcohol RB O O
socially RB O O
; : O O
was VBD B-VP O
a DT B-NP O
smoker NN I-NP O
, , O O
used VBD B-VP O
tobacco NN B-NP O
, , O O
she PRP O B-person
quit VBD B-VP O
4 CD O O
years NNS B-NP O
ago RB O O
; : O O
denies NNS B-NP O
using VBG O O
recreational JJ B-NP O
drug NN I-NP O
. . B-VP O
   
PAST NNP B-NP O
MEDICAL NNP I-NP O
HISTORY NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
had VBD B-VP O
complaint NN B-NP O
of IN B-VP O
headaches NNS B-NP B-problem
in IN B-VP O
the DT B-NP O
past NN I-NP O
. . B-VP O
   
She PRP O B-person
has VBZ O O
fibromyalgia VBN O B-problem
and CC O O
a DT B-NP O
history NN I-NP O
of IN B-VP O
slurred JJ B-NP B-problem
speech NN I-NP I-problem
. . B-VP O
   
Her PRP$ O B-person
last JJ B-NP O
menstrual JJ I-NP O
period NN I-NP O
was VBD B-VP O
on IN B-VP O
2017-08-29 JJ O O
. . B-VP O
   
HOSPITAL NNP B-NP O
COURSE NNP I-NP O
: : O O
On IN B-VP O
2017-09-13 CD O O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
brought VBN O O
to TO O O
the DT B-NP O
operating NN I-NP O
room NN I-NP O
and CC O O
underwent NN B-NP O
a DT B-NP B-treatment
coiling NN I-NP I-treatment
with IN B-VP O
stent JJ B-NP B-treatment
placement NN I-NP I-treatment
of IN B-VP O
the DT B-NP B-problem
left NN I-NP I-problem
carotid NN I-NP I-problem
ophthalmic JJ B-NP I-problem
aneurysm NN I-NP I-problem
. . B-VP O
   
The DT B-NP B-person
patient JJ I-NP I-person
underwent JJ I-NP O
coiling NN I-NP B-treatment
and CC O O
stent JJ B-NP B-treatment
placement NN I-NP I-treatment
without IN B-VP O
complications NNS B-NP B-problem
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
discharged VBN O O
to TO O O
the DT B-NP O
PACU NNP I-NP O
in IN B-VP O
stable JJ B-NP O
condition NN I-NP O
. . B-VP O
   
Postoperative JJ B-NP B-test
check NN I-NP I-test
, , O O
the DT O B-test
the DT B-NP B-person
patient JJ I-NP I-test
patient NN I-NP I-person
's POS O I-test
vital JJ B-NP I-test
signs NNS I-NP I-test
were VBD B-VP O
stable JJ O O
. . B-VP O
   
Her PRP$ O B-person
Her PRP$ O B-test
temperature NN B-NP I-test
was VBD B-VP O
96.3 CD O O
degrees NNS B-NP O
, , O O
blood NN B-NP B-test
pressure NN I-NP I-test
was VBD B-VP O
128/63 CD O O
. . B-VP O
   
Her PRP$ O B-person
Her PRP$ O B-test
pulse NN B-NP I-test
was VBD B-VP O
61 CD O O
, , O O
respirations NNS B-NP B-test
12 CD O O
, , O O
and CC O O
her PRP$ O B-test
her PRP$ O B-person
O2 NNP B-NP I-test
saturation NN I-NP I-test
was VBD B-VP O
98 CD O O
percent NN B-NP O
on IN B-VP O
room NN B-NP O
air NN I-NP O
. . B-VP O
   
Her PRP$ O B-person
Her PRP$ O B-test
labs NN B-NP I-test
showed VBD B-VP O
a DT B-NP B-test
white JJ I-NP I-test
blood NN I-NP I-test
count NN I-NP I-test
of IN B-VP O
7.7 CD O O
, , O O
hematocrit NN B-NP B-test
of IN B-VP O
33.3 CD O O
, , O O
and CC O O
platelets NNS B-NP B-test
were VBD B-VP O
305 CD O O
. . B-VP O
   
Her PRP$ O B-test
Her NNP B-NP B-person
coags NN I-NP I-test
, , O O
her PRP$ O B-test
her PRP$ O B-person
PT NNP B-NP I-test
was VBD B-VP O
14.5 CD O O
, , O O
PTT NNP B-NP B-test
was VBD B-VP O
143.4 CD O O
, , O O
and CC O O
her PRP$ O B-test
her PRP$ O B-person
INR NNP B-NP I-test
was VBD B-VP O
1.3 CD O O
. . B-VP O
   
Her PRP$ O B-test
Her PRP$ O B-person
electrolytes NNS B-NP I-test
were VBD B-VP O
all DT O O
within IN B-VP O
normal JJ B-NP O
limits NNS I-NP O
. . B-VP O
   
On IN B-VP O
physical JJ B-NP B-test
exam NN I-NP I-test
, , O O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
awake RB O O
, , O O
alert NN B-NP O
, , O O
and CC O O
oriented VBD B-VP O
times NNS B-NP O
3 CD O O
. . B-VP O
   
She PRP O B-person
had VBD B-VP O
a DT B-NP O
symmetric JJ I-NP O
smile NN I-NP O
. . B-VP O
   
Her PRP$ O B-person
extraocular JJ B-NP O
movements NNS I-NP O
were VBD B-VP O
full JJ O O
. . B-VP O
   
Her PRP$ O B-person
pupils NNS B-NP O
were VBD B-VP O
3 CD O O
to TO O O
2 CD O O
bilaterally RB O O
, , O O
briskly RB O O
reactive NN B-NP O
. . B-VP O
   
The DT B-NP O
visual JJ I-NP O
fields NNS I-NP O
were VBD B-VP O
intact JJ O O
. . B-VP O
   
Her PRP$ O B-person
strength NN B-NP O
was VBD B-VP O
05-31 JJ O O
throughout IN B-VP O
except IN B-VP O
for IN B-VP O
right NN B-NP O
was VBD B-VP O
not RB O O
tested VBN O O
due JJ O O
to TO O O
the DT B-NP B-problem
angiocele NN I-NP I-problem
in IN B-VP I-problem
her PRP$ O I-problem
her PRP$ O B-person
groin NN B-NP I-problem
. . B-VP O
   
Angiocele NNP B-NP B-problem
was VBD B-VP O
intact JJ O O
without IN B-VP O
hematoma NN B-NP B-problem
, , O O
and CC O O
she PRP O B-person
exhibited VBD B-VP O
strong JJ B-NP O
pedal NN I-NP O
pulses NNS I-NP O
on IN B-VP O
the DT B-NP O
right JJ I-NP O
side NN I-NP O
. . B-VP O
   
The DT B-NP B-test
assessment NN I-NP I-test
at IN B-VP O
that DT B-NP B-pronoun
time NN I-NP O
was VBD B-VP O
she PRP O B-person
was VBD B-VP O
neurologically RB O O
stable JJ O O
. . B-VP O
   
The DT B-NP O
plan NN I-NP O
was VBD B-VP O
q. JJ B-NP O
1-hour JJ I-NP O
neuro NN I-NP B-test
checks NNS I-NP I-test
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
started VBN O O
on IN B-VP O
a DT B-NP B-treatment
heparin NN I-NP I-treatment
drip NN I-NP I-treatment
at IN B-VP O
800 CD O O
per IN B-VP O
hour NN B-NP O
. . B-VP O
   
Her PRP$ O B-person
Her PRP$ O B-test
PTT NN B-NP I-test
goes VBZ O O
50 CD O O
to TO O O
60 CD O O
at IN B-VP O
that DT B-NP B-pronoun
time NN I-NP O
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
cleared VBN O O
to TO O O
take VB O O
sips NNS B-NP O
of IN B-VP O
clear JJ B-NP O
fluids NNS I-NP O
and CC O O
was VBD B-VP O
to TO O O
remain VB O O
flat JJ O O
for IN B-VP O
4 CD O O
hours NNS B-NP O
. . B-VP O
   
On IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
1 CD O O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
alert JJ O O
and CC O O
oriented VBD B-VP O
times NNS B-NP O
3 CD O O
. . B-VP O
   
She PRP O B-person
exhibited VBD B-VP O
no DT B-NP O
drift NN I-NP B-problem
. . B-VP O
   
Her PRP$ O B-person
Her PRP$ O B-test
IPs NN B-NP I-test
were VBD B-VP O
full JJ O O
at IN B-VP O
5/5 CD O O
. . B-VP O
   
She PRP O B-person
had VBD B-VP O
no DT B-NP O
hematoma NN I-NP B-problem
in IN B-VP I-problem
her PRP$ O I-problem
her PRP$ O B-person
groin NN B-NP I-problem
site NN I-NP I-problem
. . B-VP O
   
Visual JJ B-NP O
fields NNS I-NP O
were VBD B-VP O
full JJ O O
, , O O
her PRP$ O B-person
pupils NNS B-NP O
were VBD B-VP O
round VBN O O
and CC O O
reactive JJ O O
bilaterally RB O O
. . B-VP O
   
Her PRP$ O B-test
Her NNP B-NP B-person
vital NN I-NP I-test
signs NNS I-NP I-test
were VBD B-VP O
stable JJ O O
with IN B-VP O
a DT B-NP B-test
temperature NN I-NP I-test
of IN B-VP O
97.8 CD O O
degrees NNS B-NP O
, , O O
blood NN B-NP B-test
pressure NN I-NP I-test
was VBD B-VP O
104 CD O O
to TO O O
121 CD O O
over IN B-VP O
50s CD O O
. . B-VP O
   
Pulse NNP B-NP B-test
was VBD B-VP O
60 CD O O
to TO O O
70 CD O O
. . B-VP O
   
Respirations NNS B-NP B-test
were VBD B-VP O
15 CD O O
, , O O
and CC O O
she PRP O B-person
was VBD B-VP O
saturating VBG O O
at IN B-VP O
96 CD O O
percent NN B-NP O
on IN B-VP O
room NN B-NP O
air NN I-NP O
. . B-VP O
   
Her PRP$ O B-person
Her PRP$ O B-test
PTT NN B-NP I-test
at IN B-VP O
that DT B-NP B-pronoun
time NN I-NP O
was VBD B-VP O
67.8 CD O O
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
started VBN O O
on IN B-VP O
aspirin NN B-NP B-treatment
325 CD O O
mg NN B-NP O
q.d. NN I-NP O
and CC O O
Plavix NNP B-NP B-treatment
75 CD O O
mg NN B-NP O
q.d. NN I-NP O
On IN B-VP O
2017-09-14 JJ O O
, , O O
she PRP O B-person
was VBD B-VP O
transferred VBN O O
to TO O O
the DT B-NP O
regular JJ I-NP O
floor NN I-NP O
at IN B-VP O
Far NNP B-NP O
5 CD O O
. . B-VP O
   
Postoperative JJ B-NP O
day NN I-NP O
2 CD O O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
stable JJ O O
without IN B-VP O
events NNS B-NP O
, , O O
all DT B-NP B-test
vital JJ I-NP I-test
signs NNS I-NP I-test
were VBD B-VP O
stable JJ O O
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
moving VBG O O
all DT B-NP O
extremities NNS I-NP O
and CC O O
exhibiting VBG O O
good JJ B-NP O
strength NN I-NP O
. . B-VP O
   
Her PRP$ O B-person
visual JJ B-NP O
fields NNS I-NP O
were VBD B-VP O
intact JJ O O
. . B-VP O
   
Her PRP$ O B-person
extraocular JJ B-NP O
movements NNS I-NP O
were VBD B-VP O
full JJ O O
. . B-VP O
   
Angio NNP B-NP B-problem
site NN I-NP I-problem
was VBD B-VP O
clean JJ O O
, , O O
dry JJ O O
, , O O
and CC O O
intact JJ O O
without IN B-VP O
bleeding VBG O B-problem
or CC O O
drainage NN B-NP B-problem
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
to TO O O
be VB O O
discharged VBN O O
today NN B-NP O
and CC O O
encouraged VBD B-VP O
to TO O O
ambulate VB O O
on IN B-VP O
her PRP$ O B-person
own JJ O O
. . B-VP O
   
Discharge NNP B-NP O
condition NN I-NP O
for IN B-VP O
this DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
good JJ O O
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
ambulating VBG O O
on IN B-VP O
her PRP$ O B-person
own JJ O O
and CC O O
tolerating VBG O O
a DT B-NP O
p.o. NN I-NP O
diet NN I-NP O
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
discharged VBN O O
to TO O O
home NN B-NP O
in IN B-VP O
stable JJ B-NP O
condition NN I-NP O
. . B-VP O
   
MEDICATIONS NNP B-NP O
ON NNP I-NP O
DISCHARGE NNP I-NP O
: : O O
1. CD O O
Plavix NNP B-NP B-treatment
75 CD O O
mg NN B-NP O
q.d. NN I-NP O
2. CD O O
Aspirin NNP B-NP B-treatment
325 CD O O
mg NN B-NP O
q.d. NN I-NP O
DISCHARGE NNP I-NP O
INSTRUCTIONS NNP I-NP O
: : O O
She PRP O B-person
is VBZ O O
to TO O O
continue VB O O
taking VBG O O
medications NNS B-NP B-treatment
as IN B-VP O
prescribed NN B-NP O
. . B-VP O
   
She PRP O B-person
is VBZ O O
to TO O O
undergo VB O O
no DT B-NP O
strenuous JJ I-NP O
activity NN I-NP O
until IN B-VP O
follow-up JJ O O
in IN B-VP O
2 CD O O
weeks NNS B-NP O
. . B-VP O
   
FINAL JJ B-NP O
DIAGNOSIS NN I-NP O
: : O O
She PRP O B-person
is VBZ O O
status NN B-NP O
post NN I-NP O
coiling VBG O B-treatment
with IN B-VP O
stent JJ B-NP B-treatment
placement NN I-NP I-treatment
for IN B-VP O
left JJ B-NP B-problem
carotid NN I-NP I-problem
ophthalmic JJ B-NP I-problem
aneurysm NN I-NP I-problem
. . B-VP O
   
RECOMMENDED JJ B-NP O
FOLLOW-UP NN I-NP O
: : O O
She PRP O B-person
is VBZ O O
following VBG O O
up RP O O
with IN B-VP O
Dr. NNP B-NP B-person
Mcmaster NNP I-NP I-person
on IN B-VP O
2017-09-29 JJ O O
at IN B-VP O
11:30 CD O O
a.m. NN B-NP O
She PRP O B-person
is VBZ O O
also RB O O
to TO O O
follow VB O O
up RP O O
with IN B-VP O
her PRP$ O B-person
her PRP$ O B-person
primary JJ B-NP I-person
care NN I-NP I-person
physician NN I-NP I-person
to TO O O
review VB O O
her PRP$ O B-person
her PRP$ O B-treatment
hypertensive JJ B-NP I-treatment
medications NNS I-NP I-treatment
. . B-VP O
   
SURGICAL JJ B-NP O
INTERVENTION NN I-NP O
: : O O
Coiling NN B-NP B-treatment
with IN B-VP O
a DT B-NP B-treatment
stent JJ I-NP I-treatment
placement NN I-NP I-treatment
for IN B-VP O
left JJ B-NP B-problem
carotid NN I-NP I-problem
artery NN I-NP I-problem
aneurysm NN I-NP I-problem
. . B-VP O
   
CONDITION NNP B-NP O
ON NNP I-NP O
DISCHARGE NNP I-NP O
: : O O
She PRP O B-person
is VBZ O O
neurologically RB O O
stable JJ O O
. . B-VP O
   
Helen NNP B-NP B-person
Cynthia NNP I-NP I-person
, , O O
New NNP B-NP O
York NNP I-NP O
10969 CD O O
Dictated VBN O O
By IN B-VP O
: : O O
Scott NNP B-NP B-person
T NNP I-NP I-person
Little NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
MEDQUIST36 NNP I-NP O
D NNP I-NP O
: : O O
2017-09-15 JJ O O
09:28:45 CD O O
T NN B-NP O
: : O O
2017-09-15 JJ O O
15:37:05 CD O O
Job NNP B-NP O
# # O O
: : O O
23470 CD O O
Signed VBN O O
electronically RB O O
by IN B-VP O
: : O O
DR. NNP B-NP B-person
Mae NNP I-NP I-person
Behlmer NNP I-NP I-person
on IN B-VP O
: : O O
MON NNP B-NP O
2017-10-09 CD O O
5:18 CD O O
AM NNP B-NP O
( ( O O
End NNP B-NP O
of IN B-VP O
Report NNP B-NP O
) ) O O
-EMPTYLINE- VBP O O
-DOCSTART- JJ O O
-EMPTYLINE- $ O O
991193550 CD O O
PUOMC NNP B-NP O
1585733 CD O O
16900/0678 CD O O
362005 CD O O
11/30/1995 CD O O
12:00:00 CD O O
AM NNP B-NP O
GASTRIC NNP I-NP B-problem
ULCER NNP I-NP I-problem
AND NNP I-NP O
GASTRIC NNP I-NP B-problem
PERICARDIAL NNP I-NP I-problem
FISTULA NNP I-NP I-problem
, , O O
Unsigned VBD B-VP O
DIS NNP B-NP O
Report NNP I-NP O
Status NNP I-NP O
: : O O
Unsigned VBN O O
ADMISSION NNP B-NP O
DATE NNP I-NP O
: : O O
11-30-95 JJ B-NP O
DISCHARGE NNP I-NP O
DATE NNP I-NP O
: : O O
12-29-95 JJ B-NP O
PRINCIPAL NNP I-NP O
DIAGNOSIS NNP I-NP O
: : O O
Gastric JJ B-NP B-problem
ulcer NN I-NP I-problem
and CC O O
gastric JJ B-NP B-problem
pericardial JJ I-NP I-problem
fistula NN I-NP I-problem
, , O O
constricting VBG O B-problem
pericarditis NN B-NP I-problem
, , O O
adult NN B-NP B-problem
respiratory NN I-NP I-problem
distress NN I-NP I-problem
syndrome NN I-NP I-problem
, , O O
status NN B-NP O
post NN I-NP O
gunshot NN I-NP B-problem
wounds NNS I-NP I-problem
and CC O O
paraplegia NN B-NP B-problem
since IN B-VP O
1991 CD O O
of IN B-VP O
T4 NNP B-NP O
on IN B-VP O
down RB O O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
has VBZ O O
a DT B-NP B-treatment
Greenfield NNP I-NP I-treatment
filter NN I-NP I-treatment
in IN B-VP O
. . B-VP O
   
He PRP O B-person
has VBZ O O
multiple JJ B-NP B-problem
decubiti NN I-NP I-problem
on IN B-VP I-problem
his PRP$ O B-person
his PRP$ O I-problem
buttocks NNS B-NP I-problem
and CC O I-problem
penis NN B-NP I-problem
. . B-VP O
   
He PRP O B-person
had VBD B-VP O
a DT B-NP B-treatment
gastric JJ I-NP I-treatment
pull NN I-NP I-treatment
up RB O I-treatment
in IN B-VP O
1992 CD O O
of IN B-VP O
the DT B-NP O
stomach NN I-NP O
into IN B-VP O
the DT B-NP O
left JJ I-NP O
thorax NN I-NP O
and CC O O
he PRP O B-person
has VBZ O O
a DT B-NP B-treatment
transverse JJ I-NP I-treatment
colostomy NN I-NP I-treatment
and CC O O
a DT B-NP B-problem
sinus NN I-NP I-problem
tract NN I-NP I-problem
on IN B-VP I-problem
the DT B-NP I-problem
abdomen NNS I-NP I-problem
. . B-VP O
   
ALLERGIES NNS B-NP O
: : O O
Bactrim NNP B-NP B-treatment
and CC O O
Vancomycin NNP B-NP B-treatment
. . B-VP O
   
MEDICATIONS NNP B-NP O
ON NNP I-NP O
ADMISSION NNP I-NP O
: : O O
Albuterol NNP B-NP B-treatment
inhaler NN I-NP I-treatment
. . B-VP O
   
Amphotericin NNP B-NP B-treatment
B NNP I-NP I-treatment
40 CD O O
mg. NN B-NP O
qday NN I-NP O
. . B-VP O
   
Ceftazidime NNP B-NP B-treatment
1 CD O O
gram NN B-NP O
intravenous JJ O O
q RB O O
8 CD O O
. . B-VP O
   
Ciprofloxacin VB O B-treatment
500 CD O O
mg. NN B-NP O
po. NN I-NP O
q12 NN I-NP O
. . B-VP O
   
Cisapride NNP B-NP B-treatment
10 CD O O
mg. NN B-NP O
po. NN I-NP O
qid NN I-NP O
. . B-VP O
   
Dakin NNP B-NP B-treatment
&apos;s NNP I-NP I-treatment
solution NN I-NP I-treatment
1/4 CD O O
strength NN B-NP O
to TO O O
ulcer NN B-NP O
of IN B-VP O
penis NN B-NP O
. . B-VP O
   
Benadryl NNP B-NP B-treatment
50 CD O O
mg. NN B-NP O
intravenous JJ B-NP O
tid NN I-NP O
prn NN I-NP O
. . B-VP O
   
______________ JJ B-NP O
capsule NN I-NP B-treatment
1 CD O O
po. NN B-NP O
tid NN I-NP O
. . B-VP O
   
Lasix NNP B-NP B-treatment
prn NN I-NP O
. . B-VP O
   
Nystatin NNP B-NP B-treatment
swish JJ O I-treatment
and CC O I-treatment
swallow JJ B-NP I-treatment
tid NN I-NP O
. . B-VP O
   
Percocet NNP B-NP B-treatment
po. NN I-NP O
q4 NN I-NP O
to TO O O
6 CD O O
prn NN B-NP O
. . B-VP O
   
Trazodone CD O B-treatment
50 CD O O
mg. NN B-NP O
qhs. NN I-NP O
multivitamins VBZ O B-treatment
1 CD O O
po. NN B-NP O
qd NN I-NP O
. . B-VP O
   
HISTORY NNP B-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
is VBZ O O
a DT O O
25 CD O O
year NN B-NP O
old JJ O O
who WP O B-person
has VBZ O O
a DT B-NP O
history NN I-NP O
of IN B-VP O
a DT B-NP B-problem
gunshot JJ I-NP I-problem
wound NN I-NP I-problem
many JJ B-NP O
years NNS I-NP O
ago RB O O
and CC O O
has VBZ O O
had VBN O O
multiple JJ B-NP B-treatment
surgical JJ I-NP I-treatment
procedures NNS I-NP I-treatment
since IN B-VP O
then RB O O
. . B-VP O
   
Most JJS O O
recently RB O O
he PRP O B-person
was VBD B-VP O
admitted VBN O O
to TO O O
an DT B-NP O
outside JJ I-NP O
hospital NN I-NP O
with IN B-VP O
a DT B-NP B-problem
drug NN I-NP I-problem
overdose NN I-NP I-problem
in IN B-VP O
adult NN B-NP B-problem
respiratory NN I-NP I-problem
distress NN I-NP I-problem
syndrome NN I-NP I-problem
and CC O O
ultimately RB O O
found VBN O O
to TO O O
have VB O O
Candidal NNP B-NP B-problem
pericarditis NN I-NP I-problem
which WDT O B-pronoun
eventually RB O O
led VBD B-VP O
to TO O O
constrictive VB O B-problem
pericarditis NN B-NP I-problem
. . B-VP O
   
He PRP O B-person
had VBD B-VP O
a DT B-NP B-treatment
pericardial JJ I-NP I-treatment
window NN I-NP I-treatment
. . B-VP O
   
He PRP O B-person
had VBD B-VP O
a DT B-NP B-test
barium NN I-NP I-test
swallow NN I-NP I-test
and CC O O
endoscopy NN B-NP B-test
and CC O O
was VBD B-VP O
said VBD B-VP O
not RB O O
to TO O O
have VB O O
gastric JJ O B-problem
or CC O I-problem
pericardial JJ B-NP I-problem
ulcer NN I-NP I-problem
. . B-VP O
   
He PRP O B-person
had VBD B-VP O
previous JJ B-NP B-treatment
substernal JJ I-NP I-treatment
gastric JJ I-NP I-treatment
bypass NN I-NP I-treatment
because IN B-VP O
of IN B-VP O
an DT B-NP B-problem
interruption NN I-NP I-problem
of IN B-VP I-problem
his PRP$ O I-problem
his PRP$ O B-person
esophagus NN B-NP I-problem
at IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
his PRP$ O B-problem
his PRP$ O B-person
gunshot NN B-NP I-problem
wound NN I-NP I-problem
. . B-VP O
   
He PRP O B-person
had VBD B-VP O
been VBN O O
noted VBN O O
to TO O O
have VB O O
an DT B-NP B-problem
ulcer NN I-NP I-problem
and CC O O
ultimately RB O O
when WRB O O
he PRP O B-person
stabilized VBD B-VP O
it PRP O B-pronoun
was VBD B-VP O
our PRP$ O B-person
feeling NN B-NP O
that IN B-VP B-pronoun
he PRP O B-person
most RBS O O
likely JJ O O
had VBD B-VP O
a DT B-NP B-problem
gastric JJ I-NP I-problem
pericardial JJ I-NP I-problem
ulcer NN I-NP I-problem
and CC O O
he PRP O B-person
was VBD B-VP O
transferred VBN O O
here RB O O
for IN B-VP O
further JJ B-NP B-treatment
management NN I-NP I-treatment
. . B-VP O
   
We PRP O B-person
discussed VBD B-VP O
the DT B-NP O
risks NNS I-NP O
with IN B-VP O
his PRP$ O B-person
his PRP$ O B-person
family NN B-NP I-person
. . B-VP O
   
It PRP O B-pronoun
was VBD B-VP O
a DT O O
very RB O O
high JJ B-NP O
risk NN I-NP O
in IN B-VP O
very RB O B-problem
poor JJ B-NP I-problem
condition NN I-NP I-problem
and CC O O
a DT B-NP O
cachectic JJ I-NP B-problem
cachectic NN I-NP B-person
malnourished VBD B-VP B-problem
malnourished VBN O I-person
edematous JJ B-NP B-problem
edematous JJ I-NP I-person
individuals NNS I-NP I-person
who WP O B-person
have VBP O O
very RB O B-problem
high JJ B-NP I-problem
venous JJ I-NP I-problem
pressures NNS I-NP I-problem
and CC O O
shortness NN B-NP B-problem
of IN B-VP I-problem
breath NN B-NP I-problem
. . B-VP O
   
The DT B-NP B-person
family NN I-NP I-person
understood VBD B-VP O
that IN B-VP B-pronoun
this DT O B-pronoun
was VBD B-VP O
a DT B-NP B-treatment
life NN I-NP I-treatment
saving VBG O I-treatment
procedure NN B-NP I-treatment
and CC O O
only RB O O
carried VBD B-VP O
with IN B-VP O
it PRP O B-pronoun
approximately RB O O
50% CD O O
chance NN B-NP O
of IN B-VP O
success NN B-NP O
. . B-VP O
   
SPECIAL NNP B-NP O
PROCEDURES NNP I-NP O
AND NNP I-NP O
OPERATIONS NNP I-NP O
: : O O
esophagoscopy NN B-NP B-test
, , O O
bronchoscopy NN B-NP B-test
, , O O
pericardectomy NN B-NP B-treatment
, , O O
excision NN B-NP B-treatment
of IN B-VP O
gastric JJ B-NP B-problem
ulcer NN I-NP I-problem
, , O O
repair NN B-NP B-treatment
of IN B-VP O
gastric JJ B-NP B-problem
ulcer NN I-NP I-problem
and CC O O
pectoralis NN B-NP B-treatment
major JJ B-NP I-treatment
myocutaneous JJ I-NP I-treatment
flap NN I-NP I-treatment
performed VBN O O
on IN B-VP O
December NNP B-NP O
4 CD O O
, , O O
1995 CD O O
by IN B-VP O
Dr. NNP B-NP B-person
Reg NNP I-NP I-person
Cranka NNP I-NP I-person
and CC O O
Dr. NNP B-NP B-person
Win NNP I-NP I-person
Shufffyfe NNP I-NP I-person
. . B-VP O
   
In IN B-VP O
lieu NN B-NP O
of IN B-VP O
a DT B-NP O
standard JJ I-NP O
discharge NN I-NP O
summary JJ O O
given VBN O O
this DT B-NP B-person
patient NN I-NP I-person
&apos;s NN I-NP O
complicated VBD B-VP O
hospital JJ B-NP O
course NN I-NP O
and CC O O
associated JJ B-NP B-problem
illnesses NNS I-NP I-problem
I PRP O B-person
feel VBP O O
it PRP O B-pronoun
best JJS O O
to TO O O
just RB O O
provide VB O O
a DT B-NP O
system NN I-NP O
summary JJ O O
concerning VBG O O
this DT B-NP B-person
patient NN I-NP I-person
&apos;s NNP I-NP O
current JJ B-NP O
status NN I-NP O
. . B-VP O
   
1. CD O O
Neurologic NNP B-NP O
and CC O O
Psychologic NNP B-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
is VBZ O O
on IN B-VP O
Nortriptyline NNP B-NP B-treatment
for IN B-VP O
depression NN B-NP B-problem
. . B-VP O
   
He PRP O B-person
is VBZ O O
a DT B-NP B-problem
paraplegic NN I-NP I-problem
from IN B-VP I-problem
T4 NNP B-NP I-problem
down RB O I-problem
. . B-VP O
   
Otherwise VB O O
he PRP O B-person
is VBZ O O
awake JJ O O
, , O O
alert JJ O O
and CC O O
appropriate JJ O O
and CC O O
can MD O O
respond VB O O
to TO O O
questions NNS B-NP O
and CC O O
can MD O O
move VB O O
his PRP$ O B-person
upper JJ B-NP O
extremities NNS I-NP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
however RB O O
spends VBZ O O
most JJS O O
of IN B-VP O
his PRP$ O B-person
time NN B-NP O
at IN B-VP O
bedrest JJS O O
due JJ O O
to TO O O
decubiti VB O B-problem
ulcer JJ B-NP I-problem
disease NN I-NP I-problem
. . B-VP O
   
2. CD O O
Cardiac JJ O O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
had VBD B-VP O
constrictive JJ B-NP B-problem
pericarditis NN I-NP I-problem
that WDT O B-pronoun
was VBD B-VP O
relieved VBN O O
by IN B-VP O
his PRP$ O B-person
his PRP$ O B-treatment
surgical JJ B-NP I-treatment
procedure NN I-NP I-treatment
. . B-VP O
   
He PRP O B-person
had VBD B-VP O
a DT B-NP B-test
cardiac JJ I-NP I-test
catheterization NN I-NP I-test
on IN B-VP O
December NNP B-NP O
1 CD O O
, , O O
1995 CD O O
that WDT O B-pronoun
showed VBD B-VP O
no DT B-NP O
complications NNS I-NP B-problem
, , O O
elevated VBD B-VP B-problem
right JJ B-NP I-problem
atrial JJ I-NP I-problem
pressure NN I-NP I-problem
and CC O O
moderate JJ B-NP B-problem
pulmonary JJ I-NP I-problem
hypertension NN I-NP I-problem
. . B-VP O
   
The DT B-NP B-test
cardiac JJ I-NP I-test
output NN I-NP I-test
was VBD B-VP O
five CD O O
liters NNS B-NP O
per IN B-VP O
minute NN B-NP O
with IN B-VP O
an DT B-NP B-test
index NN I-NP I-test
at IN B-VP O
2.9 CD O O
liters NNS B-NP O
per IN B-VP O
minute NN B-NP O
per IN B-VP O
meter NN B-NP O
2 CD O O
which WDT O B-pronoun
is VBZ O O
normal JJ O O
. . B-VP O
   
A DT B-NP O
full JJ I-NP O
copy NN I-NP O
of IN B-VP O
the DT B-NP O
cardiac JJ I-NP O
catheterization NN I-NP O
report NN I-NP O
is VBZ O O
enclosed VBN O O
with IN B-VP O
his PRP$ O B-person
transfer NN B-NP O
materials NNS I-NP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
also RB O O
underwent JJ B-NP O
cardiac JJ I-NP B-test
ultrasound NN I-NP I-test
on IN B-VP O
December NNP B-NP O
11 CD O O
, , O O
1995 CD O O
that WDT O B-pronoun
showed VBD B-VP O
abnormal JJ B-NP B-problem
right JJ I-NP I-problem
ventricle NN I-NP I-problem
wall NN I-NP I-problem
motion NN I-NP I-problem
, , O O
trace NN B-NP B-problem
mitral JJ B-NP I-problem
regurgitation NN I-NP I-problem
, , O O
normal JJ O O
left VBD B-VP O
ventricular JJ B-NP O
size NN I-NP O
and CC O O
function NN B-NP O
with IN B-VP O
an DT O B-test
estimated VBN O I-test
ejection NN B-NP I-test
fraction NN I-NP I-test
of IN B-VP O
64% CD O O
. . B-VP O
   
There EX O O
is VBZ O O
Doppler NNP B-NP B-test
evidence NN I-NP O
of IN B-VP O
tricuspid JJ B-NP B-problem
insufficiency NN I-NP I-problem
and CC O O
right JJ B-NP B-problem
atrial JJ I-NP I-problem
dilatation NN I-NP I-problem
. . B-VP O
   
There EX O O
is VBZ O O
trace JJ B-NP B-problem
pulmonary JJ I-NP I-problem
insufficiency NN I-NP I-problem
. . B-VP O
   
The DT B-NP O
right JJ I-NP O
ventricle NN I-NP O
is VBZ O O
dilated VBN O B-problem
and CC O O
diffusely RB O B-problem
hypokinetic JJ O I-problem
and CC O O
there EX O O
is VBZ O O
no DT B-NP O
evidence NN I-NP O
of IN B-VP O
constrictive JJ B-NP B-problem
physiology NN I-NP I-problem
which WDT O B-pronoun
was VBD B-VP O
seen VBN O O
on IN B-VP O
December NNP B-NP O
6 CD O O
, , O O
1995 CD O O
. . B-VP O
   
A DT B-NP O
copy NN I-NP O
of IN B-VP O
this DT O B-test
this DT B-NP B-pronoun
ultrasound NN I-NP I-test
is VBZ O O
also RB O O
found VBN O O
in IN B-VP O
his PRP$ O B-person
records NNS B-NP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
is VBZ O O
on IN B-VP O
no DT B-NP O
specific JJ I-NP B-treatment
medications NNS I-NP I-treatment
for IN B-VP O
his PRP$ O B-person
his PRP$ O B-problem
cardiac JJ B-NP I-problem
condition NN I-NP I-problem
. . B-VP O
   
3. CD O O
Respiratory NN B-NP O
: : O O
the DT B-NP B-person
patient NN I-NP I-person
is VBZ O O
status NN B-NP O
post NN I-NP O
thoracotomy NN I-NP B-treatment
and CC O O
has VBZ O O
staples NNS B-NP B-treatment
and CC O O
sutures NNS B-NP B-treatment
on IN B-VP I-treatment
his PRP$ O B-person
his PRP$ O I-treatment
chest NN B-NP I-treatment
. . B-VP O
   
These DT O B-pronoun
may MD O O
be VB O O
removed VBN O O
when WRB O O
the DT B-NP B-problem
incisions NNS I-NP I-problem
are VBP O O
noted VBN O O
to TO O O
be VB O O
well RB O O
healed VBN O O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
is VBZ O O
approximately RB O O
three CD O O
weeks NNS B-NP O
following VBG O O
his PRP$ O B-treatment
his PRP$ O B-person
procedure NN B-NP I-treatment
and CC O O
several JJ O O
of IN B-VP O
these DT O B-pronoun
these DT B-NP B-treatment
stitches NNS I-NP I-treatment
will MD O O
be VB O O
removed VBN O O
prior RB O O
to TO O O
discharge VB O O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
is VBZ O O
on IN B-VP O
oxygen NN B-NP B-treatment
by IN B-VP O
face NN B-NP B-treatment
mask NN I-NP I-treatment
and CC O O
his PRP$ O B-person
his PRP$ O B-test
saturations NNS B-NP I-test
have VBP O O
been VBN O O
remaining VBG O O
normal JJ O O
. . B-VP O
   
His PRP$ O B-treatment
His PRP$ O B-person
medications NNS B-NP I-treatment
for IN B-VP O
his PRP$ O B-person
respiratory NN B-NP O
system NN I-NP O
are VBP O O
Albuterol NNP B-NP B-treatment
nebulizer RB O I-treatment
0.5 CD O O
mg. NNS B-NP O
2.5 CD O O
cc. NN B-NP O
q4hours NNS I-NP O
. . B-VP O
   
3. CD O O
GI NN B-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
has VBZ O O
had VBN O O
gastric JJ B-NP B-treatment
ulcer JJ I-NP I-treatment
repair NN I-NP I-treatment
and CC O O
also RB O O
has VBZ O O
a DT B-NP B-treatment
colostomy NN I-NP I-treatment
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
has VBZ O O
a DT B-NP B-problem
sinus NN I-NP I-problem
tract NN I-NP I-problem
that WDT O B-pronoun
was VBD B-VP O
studied VBN O O
with IN B-VP O
a DT B-NP B-test
fistulogram NN I-NP I-test
on IN B-VP O
December NNP B-NP O
25 CD O O
, , O O
1995 CD O O
. . B-VP O
   
This DT O B-pronoun
showed VBD B-VP O
no DT B-NP O
communication NN I-NP B-problem
with IN B-VP I-problem
the DT B-NP I-problem
intestines NNS I-NP I-problem
and CC O O
was VBD B-VP O
simply RB O O
a DT B-NP B-problem
sinus NN I-NP I-problem
tract NN I-NP I-problem
. . B-VP O
   
There EX O O
is VBZ O O
no DT B-NP O
fistula NN I-NP B-problem
seen VBN O O
. . B-VP O
   
Dr. NNP B-NP B-person
Asha NNP I-NP I-person
Vengloan NNP I-NP I-person
of IN B-VP O
General NNP B-NP B-person
Surgery NNP I-NP I-person
consulted VBD B-VP O
on IN B-VP O
the DT B-NP B-person
patient NN I-NP I-person
and CC O O
concluded VBD B-VP O
the DT B-NP B-person
patient NN I-NP I-person
does VBZ O O
not RB O O
require VB O O
any DT B-NP B-treatment
surgical JJ I-NP I-treatment
treatment NN I-NP I-treatment
of IN B-VP O
this DT O B-pronoun
this DT B-NP B-problem
problem NN I-NP I-problem
at IN B-VP O
the DT B-NP O
current JJ I-NP O
time NN I-NP O
and CC O O
the DT B-NP B-treatment
best JJS I-NP I-treatment
treatment NN I-NP I-treatment
for IN B-VP O
this DT B-NP B-pronoun
situation NN I-NP O
would MD O O
be VB O O
to TO O O
increase VB O O
the DT B-NP B-person
patient JJ I-NP I-person
&apos;s JJ I-NP O
nutrition NN I-NP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
takes VBZ O O
poorly RB O O
his PRP$ O B-person
po. NN B-NP O
diet NN I-NP O
. . B-VP O
   
However RB O O
he PRP O B-person
is VBZ O O
able JJ O O
to TO O O
swallow VB O O
and CC O O
tolerate VB O O
po&apos;s NN B-NP O
. . B-VP O
   
He PRP O B-person
just RB O O
claims NNS B-NP O
to TO O O
have VB O O
no DT B-NP B-problem
appetite NN I-NP I-problem
and CC O O
has VBZ O O
very RB O B-problem
poor JJ B-NP I-problem
effort NN I-NP I-problem
with IN B-VP O
feeding NN B-NP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
is VBZ O O
able JJ O O
to TO O O
tolerate VB O O
po. JJ B-NP B-treatment
medicines NNS I-NP I-treatment
. . B-VP O
   
4. CD O O
GU NN B-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
has VBZ O O
an DT B-NP B-problem
ulcer NN I-NP I-problem
on IN B-VP I-problem
his PRP$ O I-problem
his PRP$ O B-person
penis NN B-NP I-problem
that WDT O B-pronoun
has VBZ O O
been VBN O O
treated VBN O O
with IN B-VP O
dressing NN B-NP B-treatment
changes NNS I-NP I-treatment
. . B-VP O
   
It PRP O B-pronoun
has VBZ O O
been VBN O O
noted VBN O O
to TO O O
be VB O O
improving VBG O O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
has VBZ O O
a DT B-NP B-treatment
Foley NNP I-NP I-treatment
catheter NN I-NP I-treatment
in IN B-VP O
and CC O O
when WRB O O
the DT B-NP O
penile NN I-NP O
skin NN I-NP O
is VBZ O O
very RB O O
well RB O O
healed VBN O O
his PRP$ O B-person
his PRP$ O B-treatment
Foley NNP B-NP I-treatment
catheter NN I-NP I-treatment
may MD O O
be VB O O
removed VBN O O
. . B-VP O
   
Until IN B-VP O
this DT B-NP B-pronoun
time NN I-NP O
he PRP O B-person
should MD O O
be VB O O
kept VBN O O
on IN B-VP O
three CD O O
times NNS B-NP O
daily RB O O
wet VBP O B-treatment
to TO O I-treatment
dry VB O I-treatment
dressing NN B-NP I-treatment
changes NNS I-NP I-treatment
. . B-VP O
   
5. CD O O
Skin NN B-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
has VBZ O O
multiple JJ B-NP B-problem
decubiti NN I-NP I-problem
over IN B-VP O
his PRP$ O B-person
body NN B-NP O
, , O O
in IN B-VP O
particular JJ O O
his PRP$ O B-person
perineum NN B-NP O
and CC O O
buttocks NNS B-NP O
have VBP O O
large JJ B-NP B-problem
decubiti NN I-NP I-problem
. . B-VP O
   
Plastic NNP B-NP B-person
Surgery NNP I-NP I-person
was VBD B-VP O
consulted VBN O O
Dr. NNP B-NP B-person
Ca NNP I-NP I-person
Shuff NNP I-NP I-person
who WP O B-person
saw VBD B-VP O
the DT B-NP B-person
patient NN I-NP I-person
and CC O O
decided VBD B-VP O
that IN B-VP B-pronoun
the DT B-NP B-person
patient NN I-NP I-person
is VBZ O O
not RB O O
a DT B-NP O
surgical JJ I-NP O
candidate NN I-NP O
at IN B-VP O
this DT B-NP B-pronoun
point NN I-NP O
. . B-VP O
   
These DT O B-pronoun
These DT B-NP B-problem
wounds NNS I-NP I-problem
should MD O O
be VB O O
treated VBN O O
with IN B-VP O
three CD O O
times NNS B-NP O
daily RB O O
wet VBP O B-treatment
to TO O I-treatment
dry VB O I-treatment
dressings NNS B-NP I-treatment
. . B-VP O
   
The DT B-NP B-person
patient JJ I-NP I-person
&apos;s NN I-NP O
activity NN I-NP O
should MD O O
be VB O O
limited VBN O O
to TO O O
being VBG O O
up RP O O
in IN B-VP O
a DT B-NP O
chair NN I-NP O
only RB O O
for IN B-VP O
several JJ B-NP O
minutes NNS I-NP O
per IN B-VP O
day NN B-NP O
and CC O O
sit NN B-NP O
on IN B-VP O
a DT B-NP O
special JJ I-NP O
pad NN I-NP O
that IN B-VP B-pronoun
the DT B-NP B-person
family NN I-NP I-person
has VBZ O O
purchased VBN O O
. . B-VP O
   
6. CD O O
Infectious JJ B-NP O
Disease NN I-NP O
: : O O
The DT O B-test
The DT B-NP B-person
patient JJ I-NP I-test
patient NN I-NP I-person
&apos;s NNP I-NP I-test
white JJ B-NP I-test
count NN I-NP I-test
at IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
discharge NN B-NP O
is VBZ O O
within IN B-VP O
normal JJ B-NP O
limits NNS I-NP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
remains VBZ O O
on IN B-VP O
Fluconazole NNP B-NP B-treatment
. . B-VP O
   
His PRP$ O B-treatment
His PRP$ O B-person
other JJ B-NP I-treatment
antibiotics NNS I-NP I-treatment
were VBD B-VP O
discontinued VBN O O
. . B-VP O
   
His PRP$ O B-person
His PRP$ O B-test
most RBS O I-test
recent JJ B-NP I-test
cultures NNS I-NP I-test
are VBP O O
negative JJ O O
. . B-VP O
   
The DT B-NP B-test
chest JJS I-NP I-test
X-ray NN I-NP I-test
shows VBZ O O
no DT B-NP O
evidence NN I-NP O
of IN B-VP O
pneumonia NN B-NP B-problem
. . B-VP O
   
7. CD O O
Pain NNP B-NP B-problem
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
has VBZ O O
been VBN O O
very RB O O
closely RB O O
with IN B-VP O
the DT B-NP O
Pain NNP I-NP B-person
Service NNP I-NP I-person
here RB O O
while IN B-VP O
admitted VBN O O
. . B-VP O
   
He PRP O B-person
has VBZ O O
been VBN O O
placed VBN O O
on IN B-VP O
Oxycodone NNP B-NP B-treatment
10 CD O O
mg. NN B-NP O
po. NN I-NP O
q3hours NNS I-NP O
as IN B-VP O
needed VBN O O
for IN B-VP O
pain NN B-NP B-problem
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
had VBD B-VP O
a DT B-NP B-treatment
PCA NNP I-NP I-treatment
and CC O O
several JJ B-NP B-treatment
other JJ I-NP I-treatment
medications NNS I-NP I-treatment
have VBP O O
been VBN O O
discontinued VBN O O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
has VBZ O O
strong JJ O O
narcotic JJ O O
seeking VBG O O
behavior NN B-NP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
for IN B-VP O
sleep NN B-NP O
was VBD B-VP O
given VBN O O
Benadryl NNP B-NP B-treatment
25 CD O O
to TO O O
50 CD O O
mg. NNS B-NP O
qhs. NN I-NP O
and CC O O
was VBD B-VP O
not RB O O
allowed VBN O O
any DT B-NP O
increases NNS I-NP O
in IN B-VP O
his PRP$ O B-person
his PRP$ O B-treatment
narcotics NNS B-NP I-treatment
after IN B-VP O
weaning VBG O O
him PRP O B-person
down RP O O
to TO O O
just RB O O
requiring VBG O O
the DT B-NP B-treatment
Oxycodone NNP I-NP I-treatment
. . B-VP O
   
A NNP B-NP O
complete JJ B-NP O
summary NN I-NP O
of IN B-VP O
the DT O B-person
the DT B-NP B-treatment
patient JJ I-NP I-person
patient NN I-NP I-treatment
&apos;s NN I-NP I-treatment
medications NNS I-NP I-treatment
are VBP O O
as IN B-VP O
follows VBZ O O
: : O O
Cimetidine NN B-NP B-treatment
300 CD O O
mg. NN B-NP O
intravenous JJ B-NP O
q6hours NNS I-NP O
. . B-VP O
   
Albuterol NNP B-NP B-treatment
nebulizer VBD B-VP I-treatment
0.5 CD O O
mg. NN B-NP O
2.5 CD O O
cc. NN B-NP O
q4hours NNS I-NP O
. . B-VP O
   
Senokot NNP B-NP B-treatment
two CD O O
tablets NNS B-NP O
po. VBP O O
bid NN B-NP O
or CC O O
Metamucil NNP B-NP B-treatment
one CD O O
tablespoon NN B-NP O
po. NN I-NP O
bid NN I-NP O
. . B-VP O
   
Nortriptyline CC O B-treatment
25 CD O O
mg. NN B-NP O
po. NN I-NP O
qhs NN I-NP O
. . B-VP O
   
KCL NNP B-NP B-treatment
40 CD O O
mEq. NN B-NP O
po. NN I-NP O
bid NN I-NP O
. . B-VP O
   
Saline NNP B-NP B-treatment
wet NN I-NP I-treatment
to TO O I-treatment
dry VB O I-treatment
dressing NN B-NP I-treatment
changes NNS I-NP I-treatment
three CD O O
times NNS B-NP O
daily RB O O
to TO O O
penis VB O B-problem
and CC O I-problem
pelvis VB O I-problem
decubiti NN B-NP I-problem
, , O O
40% CD O B-treatment
humidified VBD B-VP I-treatment
oxygen NN B-NP I-treatment
, , O O
Fluconazole NNP B-NP B-treatment
200 CD O O
mg. NN B-NP O
po. NN I-NP O
bid NN I-NP O
. . B-VP O
   
Lasix $ O B-treatment
2.5 CD O O
mg. NN B-NP O
intravenous JJ B-NP O
qid NN I-NP O
. . B-VP O
   
Prilosec CC O B-treatment
20 CD O O
mg. NN B-NP O
po. NN I-NP O
qd NN I-NP O
. . B-VP O
   
Benadryl $ O B-treatment
25 CD O O
to TO O O
50 CD O O
mg. NNS B-NP O
po. JJ B-NP O
qhs JJ I-NP O
prn NN I-NP O
. . B-VP O
   
Oxycodone CC O B-treatment
10 CD O O
mg. NN B-NP O
po. NN I-NP O
q3 NN I-NP O
hours NNS I-NP O
prn VBP O O
. . B-VP O
   
Physicians NNPS B-NP B-person
that IN B-VP B-pronoun
took VBD B-VP O
care NN B-NP O
of IN B-VP O
this DT B-NP B-person
patient NN I-NP I-person
while IN B-VP O
at IN B-VP O
the DT B-NP O
Ph NNP I-NP O
University NNP I-NP O
Of IN B-VP O
Medical NNP B-NP O
Center NNP I-NP O
are VBP O O
as IN B-VP O
follows VBZ O O
: : O O
Admitting VBG O B-person
Physician NNP B-NP I-person
and CC O I-person
Thoracic NNP B-NP I-person
Surgeon NNP I-NP I-person
: : O O
Reg NNP B-NP B-person
Cranka NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
Consulting NNP I-NP O
General NNP I-NP B-person
Surgeon NNP I-NP I-person
was VBD B-VP O
Asha NNP B-NP B-person
Vengloan NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
Consulting NNP I-NP O
Urology NNP I-NP B-person
was VBD B-VP O
Ryna NNP B-NP B-person
Baker NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
Consulting NNP I-NP O
Plastic NNP I-NP B-person
Surgeon NNP I-NP I-person
: : O O
Ca NNP B-NP B-person
Shuff NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
Consulting NNP I-NP O
Cardiologist NN I-NP B-person
: : O O
Cealme NNP B-NP B-person
Maressythe NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
Consulting NNP I-NP O
Cardiac NNP I-NP B-person
Surgeon NNP I-NP I-person
: : O O
Win NNP B-NP B-person
Shufffyfe NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
Infectious NNP I-NP B-person
Disease NNP I-NP I-person
Consultant NNP I-NP I-person
: : O O
Dr. NNP B-NP B-person
Jesc NNP I-NP I-person
. . B-VP O
   
Psychiatry NN B-NP B-person
: : O O
Dr. NNP B-NP B-person
Rencobe NNP I-NP I-person
and CC O O
Dr. NNP B-NP B-person
Saddbeem NNP I-NP I-person
. . B-VP O
   
Pain NNP B-NP B-person
Service NNP I-NP I-person
: : O O
Dr. NNP B-NP B-person
Shuff NNP I-NP I-person
. . B-VP O
   
In IN B-VP O
summary JJ O O
this DT O B-pronoun
is VBZ O O
a DT O O
25 CD O O
year NN B-NP O
old JJ B-NP O
male NN I-NP O
with IN B-VP O
a DT O O
very RB O O
complicated JJ B-NP O
history NN I-NP O
and CC O O
a DT B-NP O
patient NN I-NP B-person
of IN B-VP O
Dr. NNP B-NP B-person
Breunkays NNP I-NP I-person
&apos;s NNP I-NP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
seen VBN O O
at IN B-VP O
Ph NNP B-NP O
University NNP I-NP O
Of IN B-VP O
Medical NNP B-NP O
Center NNP I-NP O
for IN B-VP O
problem NN B-NP O
regarding VBG O O
his PRP$ O B-person
his PRP$ O B-problem
constrictive JJ B-NP I-problem
pericarditis NN I-NP I-problem
and CC O O
underwent NN B-NP O
a DT B-NP B-treatment
surgical JJ I-NP I-treatment
procedure NN I-NP I-treatment
to TO O O
correct VB O O
this DT O B-pronoun
. . B-VP O
   
Followup NNP B-NP B-test
cardiac JJ B-NP I-test
studies NNS I-NP I-test
showed VBD B-VP O
there EX O O
was VBD B-VP O
a DT B-NP O
resolution NN I-NP O
of IN B-VP O
his PRP$ O B-person
his PRP$ O B-problem
constrictive JJ B-NP I-problem
pericarditis NN I-NP I-problem
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
also RB O O
had VBD B-VP O
a DT B-NP B-problem
gastric JJ I-NP I-problem
ulcer NN I-NP I-problem
repaired VBN O O
at IN B-VP O
the DT B-NP O
same JJ I-NP O
time NN I-NP O
. . B-VP O
   
Other JJ B-NP O
issues NNS I-NP O
of IN B-VP O
the DT B-NP B-person
patient NN I-NP I-person
are VBP O O
chronic JJ O O
and CC O O
most JJS O O
likely JJ O O
will MD O O
be VB O O
followed VBN O O
up RP O O
in IN B-VP O
hospitals NNS B-NP O
closer VBP O O
to TO O O
the DT B-NP B-person
patient NN I-NP I-person
&apos;s NNP I-NP O
home NN I-NP O
. . B-VP O
   
If IN B-VP O
there EX O O
are VBP O O
any DT B-NP O
questions NNS I-NP O
regarding VBG O O
his PRP$ O B-person
care NN B-NP O
they PRP O B-pronoun
should MD O O
be VB O O
directed VBN O O
to TO O O
Dr. NNP B-NP B-person
Cranka NNP I-NP I-person
&apos;s NNP I-NP O
office NN I-NP O
at IN B-VP O
Ph NNP B-NP O
University NNP I-NP O
Of IN B-VP O
Medical NNP B-NP O
Center NNP I-NP O
and CC O O
we PRP O B-person
will MD O O
be VB O O
happy JJ O O
to TO O O
contact VB O O
any DT O O
or CC O O
all DT O O
of IN B-VP O
the DT B-NP O
consultations NNS I-NP O
concerned VBN O O
with IN B-VP O
Hauth NNP B-NP B-person
&apos;s NNP I-NP O
care NN I-NP O
. . B-VP O
   
Hauth NNP B-NP B-person
is VBZ O O
a DT O O
very RB O O
complicated JJ B-NP O
patient NN I-NP B-person
and CC O O
it PRP O B-pronoun
was VBD B-VP O
our PRP$ O B-person
pleasure NN B-NP O
to TO O O
provide VB O O
care NN B-NP O
for IN B-VP O
him PRP O B-person
at IN B-VP O
Ph NNP B-NP O
University NNP I-NP O
Of IN B-VP O
Medical NNP B-NP O
Center NNP I-NP O
. . B-VP O
   
CA NNP B-NP B-person
SHUFF NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
DICTATING NNP I-NP O
FOR NNP I-NP O
: : O O
REG NNP B-NP B-person
CRANKA NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
TR NNP I-NP O
: : O O
fp NN B-NP O
/ NNP I-NP O
bmot NN I-NP O
DD NNP I-NP O
: : O O
12-27-95 JJ B-NP O
TD NN I-NP O
: : O O
12/27/95 CD O O
CC NN B-NP O
: : O O
STAT NN B-NP O
: : O O
Goman NNP B-NP O
4 CD O O
-EMPTYLINE- NNP B-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- VBD B-VP O
704319103 CD O O
PUMC NNP B-NP O
6340505 CD O O
274938 CD O O
7752547 CD O O
10/14/2004 CD O O
12:00:00 CD O O
AM NNP B-NP O
ED NNP I-NP O
Discharge NNP I-NP O
Summary NNP I-NP O
Unsigned VBD B-VP O
DIS NNP B-NP O
Report NNP I-NP O
Status NNP I-NP O
: : O O
Unsigned VBD B-VP O
ED NNP B-NP O
DISCHARGE NNP I-NP O
NOTIFICATION NNP I-NP O
/ NNP I-NP O
SUMMARY NNP I-NP O
A NNP I-NP B-person
, , O I-person
MIFER NNP B-NP I-person
MRN NNP I-NP O
: : O O
6340505 CD O O
Age NNP B-NP O
: : O O
41y CD O O
REGISTRATION NNP B-NP O
DATE NNP I-NP O
: : O O
10/14/2004 CD O O
03:51 CD O O
PM NNP B-NP O
Provider NN I-NP B-person
: : O O
KOTEJESCZUK NNP B-NP B-person
, , O I-person
M.D. NNP B-NP I-person
STOCKADALELEEFNATHE NNP I-NP I-person
PRELIMINARY NNP I-NP O
REPORT NNP I-NP O
PCP NNP I-NP B-person
notified VBN O O
by IN B-VP O
MD NNP B-NP B-person
: : O O
E-mail JJ B-NP O
PCP NNP I-NP B-person
Benefits NNP I-NP O
Assigned NNP I-NP O
: : O O
Y PRP$ O O
Discharge NNP B-NP O
Date NNP I-NP O
/ JJ B-NP O
Time NNP I-NP O
: : O O
10/14/2004 CD O O
21:17 CD O O
Discharge NN B-NP O
Status NNP I-NP O
: : O O
Discharged VBN O O
Condition NNP B-NP O
on IN B-VP O
Discharge NNP B-NP O
: : O O
Stable JJ B-NP O
Patient NNP I-NP B-person
States NNPS I-NP O
Complaint NNP I-NP O
: : O O
CP NNP B-NP B-problem
Standardized NNP I-NP I-problem
Discharge NNP I-NP O
Instructions NNS I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
given VBN O O
printed JJ B-NP O
instructions NNS I-NP O
for IN B-VP O
chest NN B-NP B-problem
pain NN I-NP I-problem
( ( O O
English NNP B-NP O
) ) O O
. . B-VP O
   
Diagnosis NN B-NP O
: : O O
lt NN B-NP B-problem
arm/ NN I-NP I-problem
chest NN I-NP I-problem
pain NN I-NP I-problem
Treatment NNP I-NP O
Rendered NNP I-NP O
: : O O
ekg JJ B-NP B-test
= NNP I-NP O
normal JJ O O
, , O O
cxr JJ O B-test
normal JJ O O
, , O O
ddimer JJ B-NP B-test
/ NNP I-NP O
cardiac NN I-NP B-test
enzymes RB O I-test
negative JJ B-NP O
Discharge NNP I-NP O
Medications NNS I-NP O
: : O O
ibuprofen NN B-NP B-treatment
as IN B-VP O
needed VBN O O
Follow NNP B-NP O
up RP O O
Service NNP B-NP O
: : O O
call NN B-NP O
dr NN I-NP B-person
koorskote VB O I-person
&apos;s NNP B-NP O
office NN I-NP O
tomorrow NN I-NP O
PCP NNP I-NP B-person
Name NN I-NP O
: : O O
KOORSKOTE NNP B-NP B-person
, , O I-person
SHARA NNP B-NP I-person
G NNP I-NP I-person
Provider NNP I-NP B-person
Number NNP I-NP O
: : O O
00708 CD O O
This DT B-NP B-pronoun
report NN I-NP O
was VBD B-VP O
created VBN O O
by IN B-VP O
STOCKADALELEEFNATHE NNP B-NP B-person
, , O I-person
LISHE NNP B-NP I-person
, , O I-person
M.D. NNP B-NP I-person
10/14/2004 CD O O
09:35 CD O O
PM NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
Admission NNP I-NP O
Date NNP I-NP O
: : O O
2017-07-12 JJ B-NP O
Discharge NN I-NP O
Date NNP I-NP O
: : O O
2017-07-17 JJ B-NP O
Date NNP I-NP O
of IN B-VP O
Birth NNP B-NP O
: : O O
1959-10-16 JJ B-NP O
Sex NN I-NP O
: : O O
F NNP B-NP O
Service NNP I-NP O
: : O O
MEDICINE JJ B-NP O
Allergies NNS I-NP O
: : O O
Clindamycin NNP B-NP B-treatment
/ NNP I-NP O
Erythromycin NNP I-NP B-treatment
Base NNP I-NP I-treatment
/ NNP I-NP O
Amoxicillin NNP I-NP B-treatment
/ NNP I-NP O
Keflex NNP I-NP B-treatment
/ NNP I-NP O
Wellbutrin NNP I-NP B-treatment
Attending NNP I-NP B-person
: : O O
Jerry NNP B-NP B-person
R NNP I-NP I-person
Morris NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
Chief NNP I-NP O
Complaint NNP I-NP O
: : O O
syncope NN B-NP B-problem
and CC O O
hypotension NN B-NP B-problem
on IN B-VP O
Heywood NNP B-NP O
Memorial NNP I-NP O
Hospital NNP I-NP O
4 CD O O
Major NNP B-NP O
Surgical NNP I-NP O
or CC O O
Invasive JJ B-NP O
Procedure NN I-NP O
: : O O
Central JJ B-NP B-treatment
line NN I-NP I-treatment
attempted VBN O O
but CC O O
never RB O O
placed VBD B-VP O
History NNP B-NP O
of IN B-VP O
Present NNP B-NP O
Illness NNP I-NP O
: : O O
57 CD O B-person
y/o NNS B-NP I-person
F NNP I-NP I-person
with IN B-VP O
multiple JJ B-NP B-problem
medical JJ I-NP I-problem
problems NNS I-NP I-problem
including VBG O O
polyendocrine JJ B-NP B-problem
deficiency NN I-NP I-problem
comprised VBD B-VP O
of IN B-VP O
adrenal JJ B-NP B-problem
insufficiency NN I-NP I-problem
, , O O
DM NNP B-NP B-problem
, , O O
premature NN B-NP B-problem
ovarian JJ B-NP I-problem
failure NN I-NP I-problem
, , O O
hypoparathyroidism NN B-NP B-problem
, , O O
addison NN B-NP B-problem
's POS O I-problem
disease NN B-NP I-problem
and CC O O
also RB O O
breast NN B-NP B-problem
CA NNP I-NP I-problem
and CC O O
depression NN B-NP B-problem
with IN B-VP O
multiple JJ B-NP O
suicide NN I-NP O
attempts NNS I-NP O
in IN B-VP O
the DT B-NP O
past NN I-NP O
who WP O B-person
originally RB O O
presented VBN O O
s/p JJ B-NP O
tylenol NN I-NP B-problem
with IN B-VP I-problem
codeine NN B-NP I-problem
overdose NN I-NP I-problem
and CC O O
hypotension NN B-NP B-problem
, , O O
was VBD B-VP O
intubated VBN O O
and CC O O
admitted VBN O O
to TO O O
the DT B-NP O
FICU NNP I-NP O
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
eventually RB O O
stabilized VBN O O
and CC O O
transfered VBN O O
out IN B-VP O
of IN B-VP O
the DT B-NP O
ICU NNP I-NP O
to TO O O
the DT B-NP O
medical JJ I-NP O
Mary NNP I-NP O
Lane NNP I-NP O
Hospital NNP I-NP O
. . B-VP O
   
Subsequently RB O O
, , O O
she PRP O B-person
was VBD B-VP O
transfered VBN O O
to TO O O
the DT B-NP O
psychiatric JJ I-NP O
Mary NNP I-NP O
Lane NNP I-NP O
Hospital NNP I-NP O
in IN B-VP O
Boston NNP B-NP O
Medical NNP I-NP O
Center NNP I-NP O
4 CD O O
for IN B-VP O
further JJ B-NP B-test
psychiatric JJ I-NP I-test
w/u NN I-NP I-test
. . B-VP O
   
This DT B-NP B-pronoun
morning NN I-NP O
, , O O
2017-07-12 CD O O
, , O O
Ms. NNP B-NP B-person
Gallegos NNP I-NP I-person
King NNP I-NP I-person
feeling VBG O O
weaker JJR O B-problem
than IN B-VP I-problem
usual JJ O I-problem
. . B-VP O
   
She PRP O B-person
noted VBD B-VP O
that IN B-VP B-pronoun
she PRP O B-person
had VBD B-VP O
increased VBN O B-problem
pain NN B-NP I-problem
in IN B-VP I-problem
her PRP$ O I-problem
her PRP$ O B-person
lower JJR B-NP I-problem
back NN I-NP I-problem
, , O O
which WDT O B-pronoun
she PRP O B-person
attributed VBD B-VP O
to TO O O
her PRP$ O B-person
her PRP$ O B-problem
arthritis NN B-NP I-problem
. . B-VP O
   
She PRP O B-person
ate VBD B-VP O
a DT B-NP O
normal JJ I-NP O
breakfast NN I-NP O
of IN B-VP O
cereal NN B-NP O
and CC O O
milk NN B-NP O
. . B-VP O
   
Later RB O O
that IN B-VP B-pronoun
am VBP O O
, , O O
she PRP O B-person
stood VBD B-VP O
from IN B-VP O
her PRP$ O B-treatment
her PRP$ O B-person
wheelchair NN B-NP I-treatment
, , O O
had VBD B-VP O
a DT B-NP B-problem
prodrome NN I-NP I-problem
of IN B-VP I-problem
LH NNP B-NP I-problem
and CC O O
then RB O O
reports NNS B-NP O
LOC NNP I-NP B-problem
and CC O O
fall NN B-NP O
. . B-VP O
   
She PRP O B-person
denies VBZ O O
any DT B-NP B-problem
tunnel NN I-NP I-problem
vision NN I-NP I-problem
, , O O
darkened VBN O B-problem
vision NN B-NP I-problem
, , O O
or CC O O
focal JJ B-NP B-problem
weakness NN I-NP I-problem
this DT B-NP B-pronoun
morning NN I-NP O
. . B-VP O
   
No DT B-NP O
bowel NN I-NP B-problem
/ VBZ O I-problem
bladder JJR B-NP I-problem
incont NN I-NP I-problem
, , O O
no DT B-NP O
aura NN I-NP B-problem
, , O O
no DT B-NP O
postictal JJ I-NP B-problem
state NN I-NP I-problem
. . B-VP O
   
She PRP O B-person
does VBZ O O
not RB O O
recall VB O O
falling VBG O O
, , O O
but CC O O
does VBZ O O
recall VB O O
waking VBG O O
up RP O O
with IN B-VP O
people NNS B-NP O
surrounding VBG O O
her PRP$ O B-person
. . B-VP O
   
During IN B-VP O
the DT B-NP O
fall NN I-NP O
she PRP O B-person
hit VBD B-VP O
her PRP O B-person
nose JJ O O
and CC O O
her PRP$ O B-person
R NNP B-NP O
knee NN I-NP O
. . B-VP O
   
She PRP O B-person
does VBZ O O
not RB O O
recall VB O O
hitting VBG O O
her PRP$ O B-person
head NN B-NP O
. . B-VP O
   
She PRP O B-person
does VBZ O O
not RB O O
describe VB O O
decreased JJ B-NP B-problem
PO NNP I-NP I-problem
intake NN I-NP I-problem
from IN B-VP O
her PRP$ O B-person
norm NN B-NP O
this DT B-NP B-pronoun
morning NN I-NP O
, , O O
but CC O O
did VBD B-VP O
feel VB O O
dehydrated VBN O B-problem
at IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
her PRP$ O B-person
fall NN B-NP O
. . B-VP O
   
LOC NNP B-NP B-problem
was VBD B-VP O
unwitnessed VBN O O
. . B-VP O
   
Early JJ O O
this DT B-NP B-pronoun
morning NN I-NP O
before IN B-VP O
breakfast NN B-NP O
her PRP$ O B-test
her PRP$ O B-person
BS NNP B-NP I-test
was VBD B-VP O
reportedly RB O O
145 CD O O
, , O O
and CC O O
after IN B-VP O
LOC NNP B-NP B-problem
, , O O
her PRP$ O B-test
her PRP$ O B-person
BS NNP B-NP I-test
was VBD B-VP O
reportedly RB O O
207 CD O O
. . B-VP O
   
She PRP O B-person
reports VBZ O O
that IN B-VP B-pronoun
her PRP$ O B-test
her PRP$ O B-person
BP NNP B-NP I-test
was VBD B-VP O
read VBN O O
at IN B-VP O
60/48 CD O O
after IN B-VP O
her PRP$ O B-person
fall NN B-NP O
. . B-VP O
   
Her PRP$ O B-test
Her NNP B-NP B-person
systolic NN I-NP I-test
BP NNP I-NP I-test
measurements NNS I-NP I-test
have VBP O O
been VBN O O
running VBG O O
around RB O O
100-110 CD O O
over IN B-VP O
the DT B-NP O
past JJ I-NP O
few JJ I-NP O
weeks NNS I-NP O
. . B-VP O
   
Ms. NNP B-NP B-person
Cassata NNP I-NP I-person
has VBZ O O
a DT B-NP O
history NN I-NP O
of IN B-VP O
" NNP B-NP O
passing VBG O B-problem
out RP O I-problem
" NN B-NP O
in IN B-VP O
August NNP B-NP O
of IN B-VP O
2004 CD O O
, , O O
( ( O O
? . B-VP O
7 CD O O
hours NNS B-NP O
) ) O O
, , O O
and CC O O
reports NNS B-NP O
that IN B-VP B-pronoun
this DT B-NP B-pronoun
episode NN I-NP O
did VBD B-VP O
not RB O O
feel VB O O
similar JJ O O
. . B-VP O
   
ROS NN B-NP O
: : O O
She PRP O B-person
denies VBZ O O
any DT B-NP B-problem
recent JJ I-NP I-problem
nausea NN I-NP I-problem
, , O O
but CC O O
had VBD B-VP O
an DT B-NP O
episode NN I-NP O
of IN B-VP O
vomiting VBG O B-problem
last JJ B-NP O
week NN I-NP O
. . B-VP O
   
She PRP O B-person
denies VBZ O O
any DT B-NP B-problem
pain NN I-NP I-problem
with IN B-VP I-problem
urination NN B-NP I-problem
or CC O O
incontinence NN B-NP B-problem
. . B-VP O
   
She PRP O B-person
also RB O O
denies VBZ O O
any DT B-NP B-problem
recent JJ I-NP I-problem
cough NN I-NP I-problem
, , O O
chest NN B-NP B-problem
pain NN I-NP I-problem
, , O O
chest NN B-NP B-problem
palpitations NNS I-NP I-problem
, , O O
heart NN B-NP B-problem
racing NN I-NP I-problem
. . B-VP O
   
She PRP O B-person
reports VBZ O O
2 CD O O
nights NNS B-NP O
with IN B-VP O
soaking VBG O B-problem
NS NNP B-NP I-problem
. . B-VP O
   
Denies VBZ O O
subj JJ B-NP B-problem
/ NNP I-NP I-problem
obj NN I-NP I-problem
fevers NNS I-NP I-problem
or CC O O
chills NNS B-NP B-problem
. . B-VP O
   
She PRP O B-person
describes VBZ O O
her PRP$ O B-person
mood NN B-NP O
as IN B-VP O
depressed JJ O B-problem
, , O O
however RB O O
she PRP O B-person
denies VBZ O O
suicidal JJ B-NP B-problem
ideation NN I-NP I-problem
at IN B-VP O
this DT B-NP B-pronoun
time NN I-NP O
. . B-VP O
   
She PRP O B-person
reports VBZ O O
that IN B-VP B-pronoun
she PRP O B-person
took VBD B-VP O
all DT O B-treatment
her PRP$ O I-treatment
her PRP$ O B-person
medications NNS B-NP I-treatment
as IN B-VP O
usual JJ O O
this DT B-NP B-pronoun
morning NN I-NP O
, , O O
with IN B-VP O
no DT B-NP O
changes NNS I-NP O
. . B-VP O
   
Past NNP B-NP O
Medical JJ B-NP O
History NN I-NP O
: : O O
1) CD O O
Polyendocrine NNP B-NP B-problem
deficiency NN I-NP I-problem
syndrome NN I-NP I-problem
Type NNP I-NP I-problem
I PRP O I-problem
which WDT O B-pronoun
is VBZ O O
comprised VBN O O
of IN B-VP O
the DT B-NP O
following NN I-NP O
: : O O
a) JJ B-NP O
Hypoparathyroidism NNP I-NP B-problem
, , O O
dxed JJ O O
1954 CD O O
b) IN B-VP O
Addison NNP B-NP B-problem
's POS O I-problem
disease NN B-NP I-problem
, , O O
dxed JJ O O
1960 CD O O
c) NN B-NP O
Premature NNP I-NP B-problem
ovarian JJ B-NP I-problem
failure NN I-NP I-problem
, , O O
dxed JJ O O
1967 CD O O
d) NN B-NP O
Alopecia NNP I-NP B-problem
areata NN I-NP I-problem
and CC O I-problem
totalis NN B-NP I-problem
, , O O
dxed VBD B-VP O
1970s CD O O
e) RB O O
mucocutaneous JJ B-NP B-problem
candidiasis NN I-NP I-problem
f) NN I-NP O
Diabetes NNP I-NP B-problem
type NN I-NP I-problem
I PRP O I-problem
2) CD O O
colonic JJ B-NP B-problem
dysfunction NN I-NP I-problem
alternating VBG O O
with IN B-VP O
diarrhea NN B-NP B-problem
and CC O O
constipation NN B-NP B-problem
3) CD O O
? . B-VP O
unstable JJ B-NP B-problem
serum NN I-NP I-problem
calcium NN I-NP I-problem
since IN B-VP O
1999 CD O O
4) CD O O
Generalized NNP B-NP B-problem
osteoarthritis NN I-NP I-problem
5) CD O O
depression NN B-NP B-problem
requiring VBG O O
ECT NNP B-NP B-treatment
therapy NN I-NP I-treatment
in IN B-VP O
the DT O O
past JJ O O
6) CD O O
bilateral JJ B-NP B-problem
Neuropathy NNP I-NP I-problem
of IN B-VP I-problem
lower JJR B-NP I-problem
extremities NNS I-NP I-problem
7) CD O O
Bilateral NNP B-NP B-problem
cataracts NNS I-NP I-problem
8) CD O O
PVD NNP B-NP B-problem
9) CD O O
Spontaneous NNP B-NP B-problem
dislocation NN I-NP I-problem
of IN B-VP I-problem
left JJ B-NP I-problem
hip NN I-NP I-problem
in IN B-VP O
2014 CD O O
10) CD O O
GERD NNP B-NP B-problem
11) CD O O
Low NNP B-NP B-problem
grade VBD B-VP I-problem
anemia RB O I-problem
12) CD O O
Elevated VBD B-VP B-problem
liver NN B-NP I-problem
enzymes RB O I-problem
13) CD O O
h/o JJ B-NP O
amputation NN I-NP B-treatment
of IN B-VP I-treatment
right JJ O I-treatment
2nd CD O I-treatment
toe NN B-NP I-treatment
secondary JJ O O
to TO O O
osteomyelitis VB O B-problem
in IN B-VP O
2005 CD O O
14) CD O O
h/o JJ B-NP O
hemorrhoidectomy NN I-NP B-treatment
in IN B-VP O
2007 CD O O
15) CD O O
h/o NN B-NP O
left VBD B-VP B-treatment
hip JJ B-NP I-treatment
joint JJ I-NP I-treatment
replacement NN I-NP I-treatment
in IN B-VP O
2008 CD O O
16) CD O O
h/o NN B-NP O
total JJ B-NP B-treatment
hysterectomy NN I-NP I-treatment
in IN B-VP O
2009 CD O O
17) CD O O
h/o NN B-NP O
breast NN I-NP B-problem
CA NNP I-NP I-problem
s/p NN I-NP O
mastectomies NNS I-NP B-treatment
18) CD O O
recent JJ B-NP O
suicide NN I-NP O
attempt NN I-NP O
with IN B-VP O
tylenol NN B-NP B-treatment
#3 NN I-NP I-treatment
requiring VBG O O
CMED NNP B-NP O
admission NN I-NP O
but CC O O
relatively RB O O
Jennifer NNP B-NP O
transaminitis NN I-NP B-problem
with IN B-VP O
full JJ B-NP O
recovery NN I-NP O
PCP NNP I-NP B-person
at IN B-VP O
Cynthia NNP B-NP O
( ( O O
656 CD O O
) ) O O
302 CD O O
4444 CD O O
Dr. NNP B-NP B-person
Mosier NNP I-NP I-person
. . B-VP O
   
Has NNP B-NP O
been VBN O O
hospitalized VBN O O
at IN B-VP O
Pocasset NNP B-NP O
Mental NNP I-NP O
Health NNP I-NP O
Center NNP I-NP O
and CC O O
Children NNP B-NP O
's POS O O
Hospital NNP B-NP O
Boston NNP I-NP O
numerous JJ B-NP O
times NNS I-NP O
. . B-VP O
   
Social JJ B-NP O
History NN I-NP O
: : O O
lives NNS B-NP O
in IN B-VP O
VA NNP B-NP O
Hospital NNP I-NP O
Northampton NNP I-NP O
. . B-VP O
   
Denies NNP B-NP O
etoh NN I-NP O
, , O O
illicits NNS B-NP O
. . B-VP O
   
Multiple NNP B-NP O
past JJ B-NP O
suicide NN I-NP O
attempts NNS I-NP O
. . B-VP O
   
Medically NNP B-NP O
savvy JJ O O
- : O O
has VBZ O O
spent VBN O O
much RB O O
of IN B-VP O
her PRP$ O B-person
life NN B-NP O
in IN B-VP O
the DT B-NP O
hospital NN I-NP O
with IN B-VP O
her PRP$ O B-problem
her PRP$ O B-person
multiple JJ B-NP I-problem
medical JJ I-NP I-problem
problems NNS I-NP I-problem
. . B-VP O
   
Family RB O B-person
History NN B-NP O
: : O O
father NN B-NP B-person
with IN B-VP O
history NN B-NP O
of IN B-VP O
liver NN B-NP B-problem
cancer NN I-NP I-problem
at IN B-VP O
a DT B-NP O
late JJ I-NP O
age NN I-NP O
Physical JJ B-NP O
Exam NN I-NP O
: : O O
T $ O B-test
98.4 CD O O
RR NNP B-NP B-test
20 CD O O
Sat NNP B-NP B-test
100% CD O O
RA NNP B-NP O
, , O O
P NNP B-NP B-test
100 CD O O
in IN B-VP O
bed NN B-NP O
& CC O O
same JJ B-NP O
standing NN I-NP O
, , O O
BP NNP B-NP B-test
= VBZ O O
120/65 CD O O
in IN B-VP O
bed NN B-NP O
, , O O
same JJ B-NP O
standing NN I-NP O
. . B-VP O
   
Gen NNP B-NP O
: : O O
NAD NNP B-NP B-problem
, , O O
cooperative JJ O O
and CC O O
conversant JJ O O
, , O O
able JJ O O
to TO O O
ambulate VB O O
independently RB O O
around IN B-VP O
room NN B-NP O
using VBG O O
crutches NNS B-NP B-treatment
HEENT NNP I-NP O
: : O O
NCAT NNP B-NP B-problem
, , O O
no DT B-NP O
tenderness NN I-NP B-problem
to TO O O
palpation NN B-NP B-test
of IN B-VP I-test
scalp NN B-NP I-test
, , O O
PERRL NNP B-NP O
, , O O
EOMI NNP B-NP O
, , O O
alopecia NN B-NP B-problem
, , O O
no DT B-NP O
scleral JJ I-NP B-problem
icterus NN I-NP I-problem
, , O O
mucus NN B-NP B-problem
membranes NNS I-NP I-problem
moderately RB O I-problem
dry JJ O I-problem
, , O O
slight JJ B-NP O
amount NN I-NP O
of IN B-VP O
crusted VBN O B-problem
blood NN B-NP I-problem
on IN B-VP I-problem
tip NN B-NP I-problem
of IN B-VP O
R NNP B-NP O
nostril NN I-NP O
from IN B-VP O
fall NN B-NP B-problem
injury NN I-NP I-problem
Neck NNP I-NP O
: : O O
supple NN B-NP O
, , O O
no DT B-NP O
supraclavicular JJ I-NP B-problem
LAD NNP I-NP I-problem
, , O O
no DT B-NP O
JVD NNP I-NP B-problem
CV NNP I-NP O
: : O O
tachycardic NN B-NP B-problem
, , O O
regular JJ B-NP O
rhythm NN I-NP O
, , O O
III/VI NNP B-NP B-problem
systolic NN I-NP I-problem
, , O O
crescendo-decrescendo NN B-NP B-problem
at IN B-VP I-problem
USB NNP B-NP I-problem
bilaterally RB O I-problem
. . B-VP O
   
Harsher NNP B-NP B-problem
holosystolic JJ B-NP I-problem
murmur NN I-NP I-problem
at IN B-VP I-problem
the DT B-NP I-problem
apex JJ I-NP I-problem
heard NN I-NP O
best JJS O O
with IN B-VP O
bell NN B-NP O
. . B-VP O
   
Pulm NN B-NP O
: : O O
CTAB NNP B-NP O
aside RB O O
from IN B-VP O
slightly RB O B-problem
dull JJ B-NP I-problem
breath NN I-NP I-problem
sounds NNS I-NP I-problem
at IN B-VP I-problem
the DT B-NP I-problem
bases NNS I-NP I-problem
Abd NNP I-NP O
: : O O
soft JJ O O
, , O O
slightly RB O B-problem
obese JJ O I-problem
, , O O
nondistended JJ O B-problem
, , O O
+BS JJ B-NP O
Ext NNP I-NP O
: : O O
no DT B-NP O
edema NN I-NP B-problem
/ VBZ O O
cyanosis NN B-NP B-problem
, , O O
2+ CD O B-test
peripheral JJ B-NP I-test
pulses NNS I-NP I-test
, , O O
small JJ O B-problem
1 CD O I-problem
cm JJ B-NP I-problem
abrasion NN I-NP I-problem
on IN B-VP I-problem
R NNP B-NP I-problem
knee NN I-NP I-problem
, , O O
no DT B-NP O
active JJ I-NP B-problem
bleeding NN I-NP I-problem
, , O O
no DT B-NP O
brusing NN I-NP B-problem
, , O O
no DT B-NP O
limited JJ I-NP O
ROM NNP I-NP B-problem
, , O O
no DT B-NP O
signs NNS I-NP O
of IN B-VP O
effusion NN B-NP B-problem
Neuro NNP I-NP O
: : O O
A&Ox3 NNP B-NP O
, , O O
no DT B-NP O
asterixis NN I-NP B-problem
, , O O
strength NN B-NP O
4+ CD O O
/ NN B-NP O
5 CD O O
equal JJ O O
throughout IN B-VP O
, , O O
sensation NN B-NP O
light VBD B-VP O
touch JJ O O
intact JJ O O
, , O O
toes NNS B-NP O
upgoing VBG O O
bilaterally RB O O
, , O O
no DT B-NP O
pronator NN I-NP B-problem
drift NN I-NP I-problem
. . B-VP O
   
Gait NNP B-NP O
does VBZ O O
not RB O O
appear VB O O
unsteady JJ O B-problem
, , O O
uses VBZ O O
crutches NNS B-NP B-treatment
for IN B-VP O
support NN B-NP O
. . B-VP O
   
Pertinent JJ B-NP O
Results NNS I-NP O
: : O O
ADMISSION NNP B-NP O
LABS NNP I-NP O
: : O O
2017-07-12 JJ O O
10:40 CD O O
AM NNP B-NP O
BLOOD NNP I-NP B-test
WBC NNP I-NP B-test
- : O O
17.1 CD O O
* NN B-NP O
RBC NNP I-NP B-test
- : O O
3.37 CD O O
* NN B-NP O
Hgb NNP I-NP B-test
- : O O
10.1 CD O O
* NN B-NP O
Hct NNP I-NP B-test
- : O O
30.1 CD O O
* NN B-NP O
MCV NNP I-NP B-test
- : O O
89 CD O O
MCH NNP B-NP B-test
- : O O
30.0 CD O O
MCHC NNP B-NP B-test
- : O O
33.6 CD O O
RDW NNP B-NP B-test
- : O O
18.8 CD O O
* JJ B-NP O
Plt NNP I-NP B-test
Ct NNP I-NP I-test
- : O O
526 CD O O
* JJ O O
2017-07-12 JJ O O
10:40 CD O O
AM NNP B-NP O
BLOOD NNP I-NP B-test
Neuts NNP I-NP B-test
- : O O
86 CD O O
* NN B-NP O
Bands NNP I-NP B-test
- : O O
5 CD O O
Lymphs NNP B-NP B-test
- : O O
4 CD O O
* JJ B-NP O
Monos NNP I-NP B-test
- : O O
5 CD O O
Eos NNP B-NP B-test
- : O O
0 CD O O
Baso NNP B-NP B-test
- : O O
0 CD O O
Atyps NNP B-NP B-test
- : O O
0 CD O O
Metas NNP B-NP B-test
- : O O
0 CD O O
Myelos NNP B-NP B-test
- : O O
0 CD O O
2017-07-12 JJ O O
10:40 CD O O
AM NNP B-NP O
BLOOD NNP I-NP B-test
Plt NNP I-NP B-test
Smr NNP I-NP I-test
- : O O
HIGH NNP B-NP B-problem
Plt NNP I-NP I-problem
Ct NNP I-NP I-problem
- : O O
526 CD O O
* JJ O O
2017-07-13 JJ O O
05:30 CD O O
AM NNP B-NP O
BLOOD NNP I-NP B-test
PT NNP I-NP B-test
- : O O
11.3 CD O O
PTT NNP B-NP B-test
- : O O
24.9 CD O O
INR NNP B-NP B-test
( ( O I-test
PT NNP B-NP I-test
)- JJ O I-test
1.0 CD O O
2017-07-11 JJ O O
08:00 CD O O
AM NNP B-NP O
BLOOD NNP I-NP B-test
Glucose NNP I-NP B-test
- : O O
137 CD O O
* JJ B-NP O
UreaN NNP I-NP B-test
- : O O
19 CD O O
Creat NNP B-NP B-test
- : O O
1.0 CD O O
Na NNP B-NP B-test
- : O O
142 CD O O
K NNP B-NP B-test
- : O O
4.0 CD O O
Cl NNP B-NP B-test
- : O O
105 CD O O
HCO3 NNP B-NP B-test
- : O O
29 CD O O
AnGap NNP B-NP B-test
- : O O
12 CD O O
2017-07-13 JJ O O
05:30 CD O O
AM NNP B-NP O
BLOOD NNP I-NP B-test
ALT NNP I-NP B-test
- : O O
85 CD O O
* NN B-NP O
AST NNP I-NP B-test
- : O O
238 CD O O
* JJ B-NP O
LD NNP I-NP B-test
( ( O I-test
LDH NNP B-NP I-test
)- CD O I-test
316 CD O O
* NN B-NP O
CK NNP I-NP B-test
( ( O I-test
CPK NNP B-NP I-test
)- CD O I-test
55 CD O O
AlkPhos NNP B-NP B-test
- : O O
122 CD O O
* JJ B-NP O
Amylase NNP I-NP B-test
- : O O
65 CD O O
TotBili NNP B-NP B-test
- : O O
0.3 CD O O
2017-07-13 JJ O O
05:30 CD O O
AM NNP B-NP O
BLOOD NNP I-NP B-test
Lipase NNP I-NP B-test
- : O O
35 CD O O
2017-07-14 JJ O O
05:20 CD O O
AM NNP B-NP O
BLOOD NNP I-NP B-test
CK NNP I-NP B-test
- : O I-test
MB NNP B-NP I-test
- : O O
NotDone NN B-NP O
cTropnT NN I-NP B-test
-< VBD B-VP O
0.01 CD O O
2017-07-13 JJ O O
01:12 CD O O
PM NNP B-NP O
BLOOD NNP I-NP B-test
CK NNP I-NP B-test
- : O I-test
MB NNP B-NP I-test
- : O O
2 CD O O
cTropnT NN B-NP B-test
-< VBD B-VP O
0.01 CD O O
2017-07-13 JJ O O
05:30 CD O O
AM NNP B-NP O
BLOOD NNP I-NP B-test
CK NNP I-NP B-test
- : O I-test
MB NNP B-NP I-test
- : O O
NotDone NN B-NP O
cTropnT NN I-NP B-test
-< VBD B-VP O
0.01 CD O O
2017-07-11 JJ O O
08:00 CD O O
AM NNP B-NP O
BLOOD NNP I-NP B-test
Albumin NNP I-NP B-test
- : O O
3.4 CD O O
Calcium NNP B-NP B-test
- : O O
8.0 CD O O
* NN B-NP O
Phos NNP I-NP B-test
- : O O
5.0 CD O O
* NN B-NP O
Mg NNP I-NP B-test
- : O O
1.6 CD O O
2017-07-13 JJ O O
01:12 CD O O
PM NNP B-NP O
BLOOD NNP I-NP B-test
HBsAg NNP I-NP B-test
- : O O
NEGATIVE NNP B-NP O
HBsAb NNP I-NP B-test
- : O O
NEGATIVE NNP B-NP O
HBcAb NNP I-NP B-test
- : O O
NEGATIVE JJ O O
2017-07-13 JJ O O
05:30 CD O O
AM NNP B-NP O
BLOOD NNP I-NP B-test
Acetmnp NNP I-NP B-test
- : O O
NEG NNP B-NP O
2017-07-13 JJ O O
01:12 CD O O
PM NNP B-NP O
BLOOD NNP I-NP B-test
HCV NNP I-NP B-test
Ab NNP I-NP I-test
- : O O
NEGATIVE JJ O O
2017-07-13 JJ O O
08:40 CD O O
AM NNP B-NP O
BLOOD NNP I-NP B-test
Type NNP I-NP B-test
- : O O
ART NNP B-NP O
pO2 VBZ O B-test
- : O O
72 CD O O
* NN B-NP O
pCO2 NN I-NP B-test
- : O O
34 CD O O
* NN B-NP O
pH NN I-NP B-test
- : O O
7.46 CD O O
* NN B-NP O
calHCO3 NN I-NP B-test
- : O O
25 CD O O
Base NNP B-NP B-test
XS NNP I-NP I-test
- : O O
0 CD O O
2017-07-13 JJ O O
08:40 CD O O
AM NNP B-NP O
BLOOD NNP I-NP B-test
Lactate NNP I-NP B-test
- : O O
2.0 CD O O
2017-07-13 JJ O O
08:40 CD O O
AM NNP B-NP O
BLOOD NNP I-NP B-test
freeCa NN I-NP B-test
- : O O
0.90 CD O O
* JJ B-NP O
STUDIES NNP I-NP O
: : O O
EKG NN B-NP B-test
: : O O
2017-07-12 JJ B-NP O
NSR NNP I-NP O
, , O O
normal JJ B-NP O
axis NN I-NP O
, , O O
likely JJ B-NP O
V1 NNP I-NP B-problem
and CC O I-problem
V2 NNP B-NP I-problem
reversal NN I-NP I-problem
, , O O
TWI NNP B-NP B-problem
in IN B-VP I-problem
V2 NNP B-NP I-problem
, , O O
? . B-VP O
ST NNP B-NP B-problem
depr VBD B-VP I-problem
< $ O O
0.5 CD O O
mm NN B-NP O
in IN B-VP O
II NNP B-NP O
and CC O O
V5/6 NNP B-NP O
- : O O
repeat NN B-NP B-test
EKG NN I-NP I-test
without IN B-VP O
these DT O B-pronoun
these DT B-NP B-problem
changes NNS I-NP I-problem
. . B-VP O
   
No DT B-NP O
change NN I-NP O
from IN B-VP O
prior JJ B-NP B-test
EKG NNP I-NP I-test
. . B-VP O
   
CXR NNP B-NP B-test
2017-07-12 JJ O O
: : O O
Heart NNP B-NP O
normal JJ O O
in IN B-VP O
size NN B-NP O
, , O O
mediastinal JJ O O
and CC O O
hilar JJ B-NP O
contours NNS I-NP O
are VBP O O
normal JJ O O
. . B-VP O
   
Pulmonary JJ B-NP O
vascularity NN I-NP O
is VBZ O O
normal JJ O O
, , O O
lungs NNS B-NP O
are VBP O O
clear JJ O O
. . B-VP O
   
No DT B-NP O
effusions NNS I-NP B-problem
or CC O O
pneumothorax NN B-NP B-problem
. . B-VP O
   
Multiple NNP B-NP B-problem
healed VBD B-VP I-problem
bilateral JJ B-NP I-problem
rib NN I-NP I-problem
fractures NNS I-NP I-problem
are VBP O O
demonstrated VBN O O
. . B-VP O
   
Clips NNS B-NP B-treatment
in IN B-VP I-treatment
the DT B-NP I-treatment
left NN I-NP I-treatment
axilla NN I-NP I-treatment
demonstrate NN I-NP O
prior JJ B-NP B-treatment
lymph NN I-NP I-treatment
node DT B-NP I-treatment
dissection NN I-NP I-treatment
. . B-VP O
   
Overall NNP B-NP O
, , O O
no DT B-NP O
acute JJ I-NP B-problem
cardiopulmonary JJ I-NP I-problem
abnormality NN I-NP I-problem
. . B-VP O
   
2017-07-13 JJ B-NP O
CXR NN I-NP B-test
: : O O
UPRIGHT NNP B-NP O
AP NNP I-NP O
VIEW NNP I-NP O
OF IN B-VP O
THE NNP B-NP O
CHEST NNP I-NP O
: : O O
Aside RB O O
from IN B-VP O
low JJ B-NP B-problem
lung NN I-NP I-problem
volumes NNS I-NP I-problem
, , O O
the DT B-NP O
lungs NNS I-NP O
are VBP O O
clear JJ O O
. . B-VP O
   
The DT B-NP O
heart NN I-NP O
size NN I-NP O
, , O O
and CC O O
mediastinal JJ O O
and CC O O
hilar JJ B-NP O
contours NNS I-NP O
are VBP O O
normal JJ O O
. . B-VP O
   
The DT B-NP O
pleurae NN I-NP O
are VBP O O
normal JJ O O
. . B-VP O
   
Clips NNS B-NP B-treatment
in IN B-VP I-treatment
the DT B-NP I-treatment
left NN I-NP I-treatment
axilla NN I-NP I-treatment
denote NN I-NP O
prior RB O B-treatment
lymph JJ B-NP I-treatment
node JJ I-NP I-treatment
dissection NN I-NP I-treatment
. . B-VP O
   
Multiple JJ O B-problem
bilateral JJ O I-problem
healed VBN O I-problem
rib NN B-NP I-problem
fractures NNS I-NP I-problem
are VBP O O
present JJ O O
. . B-VP O
   
2017-07-13 JJ B-NP O
RUQ NNP I-NP B-test
U/S NNP I-NP I-test
: : O O
IMPRESSION NN B-NP O
: : O O
1. CD O O
Normal NNP B-NP O
liver NN I-NP O
. . B-VP O
   
No DT B-NP O
evidence NN I-NP O
of IN B-VP O
bile JJ B-NP B-problem
duct NN I-NP I-problem
dilatation NN I-NP I-problem
. . B-VP O
   
2. CD O O
Gallbladder NNP B-NP B-problem
polyp NN I-NP I-problem
and CC O O
possible JJ B-NP O
tiny JJ I-NP B-problem
stones NNS I-NP I-problem
. . B-VP O
   
No DT B-NP O
cholecystitis NN I-NP B-problem
. . B-VP O
   
2017-07-14 JJ B-NP O
ECHO NN I-NP B-test
: : O O
Conclusions NNS B-NP O
: : O O
The DT B-NP O
left JJ I-NP O
atrium NN I-NP O
is VBZ O O
normal JJ O O
in IN B-VP O
size NN B-NP O
. . B-VP O
   
There EX O O
is VBZ O O
mild JJ O B-problem
symmetric JJ O I-problem
left VBD B-VP I-problem
ventricular JJ B-NP I-problem
hypertrophy NN I-NP I-problem
. . B-VP O
   
The DT B-NP B-test
left JJ I-NP I-test
ventricular JJ I-NP I-test
cavity NN I-NP I-test
size NN I-NP I-test
is VBZ O O
normal JJ O O
. . B-VP O
   
Overall JJ O B-test
left VBD B-VP I-test
ventricular JJ B-NP I-test
systolic JJ I-NP I-test
function NN I-NP I-test
is VBZ O O
normal JJ O O
( ( O O
LVEF NNP B-NP B-test
> VBZ O O
55% CD O O
). NN B-NP O
Right NNP I-NP B-test
ventricular JJ B-NP I-test
chamber NN I-NP I-test
size NN I-NP I-test
and CC O O
free JJ B-NP O
wall NN I-NP O
motion NN I-NP O
are VBP O O
normal JJ O O
. . B-VP O
   
The DT B-NP O
aortic JJ I-NP O
valve NN I-NP O
leaflets NNS I-NP O
are VBP O O
moderately RB O B-problem
thickened VBN O I-problem
. . B-VP O
   
There EX O O
is VBZ O O
mild JJ B-NP B-problem
aortic JJ I-NP I-problem
valve NN I-NP I-problem
stenosis NN I-NP I-problem
. . B-VP O
   
Trace NNP B-NP B-problem
aortic JJ B-NP I-problem
regurgitation NN I-NP I-problem
is VBZ O O
seen VBN O O
. . B-VP O
   
The DT B-NP O
mitral JJ I-NP O
valve NN I-NP O
leaflets NNS I-NP O
are VBP O O
mildly RB O B-problem
thickened VBN O I-problem
. . B-VP O
   
No DT B-NP O
mitral JJ I-NP B-problem
regurgitation NN I-NP I-problem
is VBZ O O
seen VBN O O
. . B-VP O
   
There EX O O
is VBZ O O
a DT B-NP B-problem
small JJ I-NP I-problem
pericardial JJ I-NP I-problem
effusion NN I-NP I-problem
. . B-VP O
   
There EX O O
are VBP O O
no DT B-NP O
echocardiographic JJ I-NP O
signs NNS I-NP O
of IN B-VP O
tamponade NN B-NP B-problem
. . B-VP O
   
Compared VBN O O
with IN B-VP O
the DT B-NP O
report NN I-NP O
of IN B-VP O
the DT B-NP B-test
prior JJ I-NP I-test
study NN I-NP I-test
( ( O O
images NNS B-NP O
unavailable JJ O O
for IN B-VP O
review NN B-NP O
) ) O O
of IN B-VP O
2017-06-13 JJ O O
, , O O
there EX O O
is VBZ O O
no DT B-NP O
significant JJ I-NP B-problem
change NN I-NP I-problem
. . B-VP O
   
DISCHARGE NNP B-NP O
LABS NNP I-NP O
: : O O
2017-07-17 JJ O O
04:50 CD O O
AM NNP B-NP O
BLOOD NNP I-NP B-test
WBC NNP I-NP B-test
- : O O
7.2 CD O O
RBC NNP B-NP B-test
- : O O
2.69 CD O O
* NN B-NP O
Hgb NNP I-NP B-test
- : O O
8.0 CD O O
* NN B-NP O
Hct NNP I-NP B-test
- : O O
24.0 CD O O
* NN B-NP O
MCV NNP I-NP B-test
- : O O
89 CD O O
MCH NNP B-NP B-test
- : O O
29.7 CD O O
MCHC NNP B-NP B-test
- : O O
33.3 CD O O
RDW NNP B-NP B-test
- : O O
18.7 CD O O
* JJ B-NP O
Plt NNP I-NP B-test
Ct NNP I-NP I-test
- : O O
363 CD O O
2017-07-17 JJ O O
04:50 CD O O
AM NNP B-NP O
BLOOD NNP I-NP B-test
Plt NNP I-NP B-test
Ct NNP I-NP I-test
- : O O
363 CD O O
2017-07-17 JJ O O
04:50 CD O O
AM NNP B-NP O
BLOOD NNP I-NP B-test
Glucose NNP I-NP B-test
- : O O
60 CD O O
* JJ B-NP O
UreaN NNP I-NP B-test
- : O O
13 CD O O
Creat NNP B-NP B-test
- : O O
0.9 CD O O
Na NNP B-NP B-test
- : O O
147 CD O O
* NN B-NP O
K NNP I-NP B-test
- : O O
3.0 CD O O
* NN B-NP O
Cl NNP I-NP B-test
- : O O
109 CD O O
* NN B-NP O
HCO3 NNP I-NP B-test
- : O O
29 CD O O
AnGap NNP B-NP B-test
- : O O
12 CD O O
2017-07-17 JJ O O
04:50 CD O O
AM NNP B-NP O
BLOOD NNP I-NP B-test
ALT NNP I-NP B-test
- : O O
73 CD O O
* NN B-NP O
AST NNP I-NP B-test
- : O O
50 CD O O
* JJ B-NP O
LD NNP I-NP B-test
( ( O I-test
LDH NNP B-NP I-test
)- CD O O
195 CD O O
AlkPhos NNP B-NP B-test
- : O O
112 CD O O
TotBili NNP B-NP B-test
- : O O
0.3 CD O O
2017-07-15 JJ O O
06:47 CD O O
AM NNP B-NP O
BLOOD NNP I-NP B-test
Lipase NNP I-NP B-test
- : O O
17 CD O O
2017-07-17 JJ O O
04:50 CD O O
AM NNP B-NP O
BLOOD NNP I-NP B-test
Calcium NNP I-NP B-test
- : O O
8.2 CD O O
* NN B-NP O
Phos NNP I-NP B-test
- : O O
3.2 CD O O
Mg NNP B-NP B-test
- : O O
1.5 CD O O
* JJ O O
2017-07-13 JJ O O
01:12 CD O O
PM NNP B-NP O
BLOOD NNP I-NP B-test
HBsAg NNP I-NP B-test
- : O O
NEGATIVE NNP B-NP O
HBsAb NNP I-NP B-test
- : O O
NEGATIVE NNP B-NP O
HBcAb NNP I-NP B-test
- : O O
NEGATIVE JJ O O
2017-07-13 JJ O O
05:30 CD O O
AM NNP B-NP O
BLOOD NNP I-NP B-test
Acetmnp NNP I-NP B-test
- : O O
NEG NNP B-NP O
2017-07-13 JJ O O
01:12 CD O O
PM NNP B-NP O
BLOOD NNP I-NP B-test
HCV NNP I-NP B-test
Ab NNP I-NP I-test
- : O O
NEGATIVE JJ B-NP O
Brief JJ I-NP O
Hospital JJ I-NP O
Course NN I-NP O
: : O O
BRIEF JJ B-NP O
OVERVIEW NNP I-NP O
: : O O
57 CD O B-person
yo NNS B-NP I-person
F NNP I-NP I-person
with IN B-VP O
h/o JJ B-NP O
polyglandular JJ I-NP B-problem
autoimmune NN I-NP I-problem
syndrome VBN O I-problem
initially RB O O
admitted VBN O O
in IN B-VP O
May NNP B-NP O
to TO O O
FICU NNP B-NP O
for IN B-VP O
suicide RB O B-problem
overdose JJ O I-problem
then RB O O
transferred VBD B-VP O
to TO O O
Whittier NNP B-NP O
Rehab NNP I-NP O
Hospital NNP I-NP O
4 CD O O
for IN B-VP O
depression NN B-NP B-problem
, , O O
who WP O B-person
was VBD B-VP O
transferred VBN O O
to TO O O
the DT B-NP O
medical JJ I-NP O
floor NN I-NP O
for IN B-VP O
a DT B-NP B-problem
syncopal JJ I-NP I-problem
episode NN I-NP I-problem
and CC O O
hypotension NN B-NP B-problem
to TO O O
60 CD O B-test
systolic NN B-NP I-test
that WDT O B-pronoun
returned VBD B-VP O
to TO O O
baseline VB O O
with IN B-VP O
2.5L CD O O
IVF NNS B-NP B-treatment
who WP O B-person
was VBD B-VP O
subsequently RB O O
transferred VBN O O
to TO O O
the DT B-NP O
CMED NNP I-NP O
CSRU NNP I-NP O
for IN B-VP O
a DT B-NP O
recurrent JJ I-NP O
episode NN I-NP O
of IN B-VP O
hypotension NN B-NP B-problem
, , O O
fevers NNS B-NP B-problem
and CC O O
concern NN B-NP O
for IN B-VP O
sepsis NN B-NP B-problem
. . B-VP O
   
Initially RB O O
when WRB O O
she PRP O B-person
arrived VBD B-VP O
to TO O O
the DT B-NP O
floor NN I-NP O
she PRP O B-person
was VBD B-VP O
afebrile RB O B-problem
, , O O
normotensive JJ O O
without IN B-VP O
signs NNS B-NP O
of IN B-VP O
orthostasis NN B-NP B-problem
, , O O
had VBD B-VP O
a DT B-NP O
negative JJ I-NP O
UA NNP I-NP O
, , O O
a DT B-NP O
clear JJ I-NP O
chest NN I-NP O
xray NN I-NP O
and CC O O
no DT B-NP O
signs NNS I-NP O
/ VBP O O
symptoms NNS B-NP O
of IN B-VP O
a DT B-NP B-problem
fever NN I-NP I-problem
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
slightly RB O B-problem
tachycardic JJ O I-problem
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
initially RB O O
not RB O O
started VBN O O
on IN B-VP O
antibiotics NNS B-NP B-treatment
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
given VBN O O
a DT O B-treatment
standing VBG O I-treatment
IVF NNP B-NP I-treatment
order NN I-NP I-treatment
. . B-VP O
   
Overnight NNP B-NP O
she PRP O B-person
became VBD B-VP O
febrile JJ O B-problem
to TO O O
102.3 CD O O
, , O O
increasingly RB O B-problem
tachycardic JJ O I-problem
to TO O O
125 CD O O
, , O O
and CC O O
hypotensive JJ O B-problem
to TO O O
80 CD O B-test
systolic NN B-NP I-test
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
started VBN O O
on IN B-VP O
stress NN B-NP B-treatment
dose JJ B-NP I-treatment
steroids NNS I-NP I-treatment
and CC O O
levo NN B-NP B-treatment
, , O O
flagyl NN B-NP B-treatment
, , O O
and CC O O
vanco NN B-NP B-treatment
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
given VBN O O
4L CD O O
of IN B-VP O
fluid NN B-NP B-treatment
boluses NNS I-NP I-treatment
and CC O O
transfered VBD B-VP O
to TO O O
the DT B-NP O
CMED NNP I-NP O
CSRU NNP I-NP O
. . B-VP O
   
In IN B-VP O
the DT B-NP O
CMED NNP I-NP O
CSRU NNP I-NP O
, , O O
repeated VBD B-VP O
attempts NNS B-NP O
to TO O O
place VB O O
lines NNS B-NP B-treatment
were VBD B-VP O
unsuccessful JJ O O
. . B-VP O
   
The DT B-NP B-treatment
above JJ I-NP I-treatment
treatments NNS I-NP I-treatment
were VBD B-VP O
continued VBN O O
. . B-VP O
   
Urine NNP B-NP B-test
cultures NNS I-NP I-test
returned VBD B-VP O
with IN B-VP O
10-100,000 JJ B-NP O
organisms NNS I-NP O
coag VBP O B-problem
negative JJ B-NP I-problem
staph NN I-NP I-problem
. . B-VP O
   
Blood NNP B-NP B-test
cultures NNS I-NP I-test
remained VBD B-VP O
negative JJ O O
. . B-VP O
   
Vital JJ B-NP B-test
signs NNS I-NP I-test
stabilized VBN O O
and CC O O
she PRP O B-person
was VBD B-VP O
transfered VBN O O
back RB O O
to TO O O
the DT B-NP O
medical JJ I-NP O
floor NN I-NP O
after IN B-VP O
2 CD O O
days NNS B-NP O
in IN B-VP O
the DT B-NP O
ICU NNP I-NP O
. . B-VP O
   
Stress NNP B-NP B-treatment
dose JJ B-NP I-treatment
steroids NNS I-NP I-treatment
were VBD B-VP O
planned VBN O O
for IN B-VP O
a DT O O
7 CD O O
day NN B-NP O
course NN I-NP O
, , O O
antibiotics NNS B-NP B-treatment
were VBD B-VP O
peeled VBN O O
back RB O O
to TO O O
levofloxacin VB O B-treatment
alone RB O O
, , O O
and CC O O
a DT B-NP B-test
R NNP I-NP I-test
hip NN I-NP I-test
film NN I-NP I-test
revealed VBD B-VP O
no DT B-NP O
loosening NN I-NP B-problem
nor CC O O
inflammation NN B-NP B-problem
. . B-VP O
   
Echo NNP B-NP B-test
showed VBD B-VP O
normal JJ B-NP O
function NN I-NP O
, , O O
trace NN B-NP B-problem
AR NNP I-NP I-problem
, , O O
and CC O O
no DT B-NP O
MR NNP I-NP B-problem
. . B-VP O
   
She PRP O B-person
had VBD B-VP O
a DT B-NP O
normal JJ I-NP O
RUQ NNP I-NP O
US NNP I-NP O
, , O O
as RB O O
well RB O O
. . B-VP O
   
On IN B-VP O
the DT B-NP O
floor NN I-NP O
the DT B-NP B-person
patient NN I-NP I-person
remained VBD B-VP O
stable JJ O O
hemodynamically RB O O
without IN B-VP O
recurrent NN B-NP B-problem
fever NN I-NP I-problem
and CC O O
was VBD B-VP O
stable JJ O O
for IN B-VP O
transfer NN B-NP O
back RB O O
to TO O O
Franciscan NNP B-NP O
Children NNP I-NP O
's POS O O
Hospital NNP B-NP O
& CC O O
Rehab NNP B-NP O
Center NNP I-NP O
4 CD O O
. . B-VP O
   
At IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
discharge NN B-NP O
, , O O
her PRP$ O B-test
her PRP$ O B-person
potassium NN B-NP I-test
had VBD B-VP O
been VBN O O
low JJ O B-problem
despite IN B-VP O
repletion NN B-NP B-treatment
, , O O
Na NNP B-NP B-test
was VBD B-VP O
elevated VBN O B-problem
, , O O
as IN B-VP O
was VBD B-VP O
blood NN B-NP B-test
pressure NN I-NP I-test
. . B-VP O
   
On IN B-VP O
recommendation NN B-NP O
from IN B-VP O
endocrine NN B-NP O
, , O O
her PRP$ O B-treatment
her PRP$ O B-person
fludrocortisone NN B-NP I-treatment
was VBD B-VP O
decreased VBN O O
from IN B-VP O
0.2 CD O O
to TO O O
0.1 CD O O
( ( O O
higher JJR O O
than IN B-VP O
required VBN O O
doses NNS B-NP O
of IN B-VP O
fludrocort NN B-NP B-treatment
can MD O O
cause VB O O
these DT O B-problem
these DT B-NP B-pronoun
symptoms NNS I-NP I-problem
. . B-VP O
   
) ) O O
. . B-VP O
   
1. CD O O
Hypotension NN B-NP B-problem
: : O O
Patient NN B-NP B-person
presented VBD B-VP O
after IN B-VP O
episode NN B-NP O
of IN B-VP O
hypotension NN B-NP B-problem
and CC O O
syncope NN B-NP B-problem
on IN B-VP O
Mass. NNP B-NP O
Mental NNP I-NP O
Health NNP I-NP O
Center NNP I-NP O
5 CD O O
. . B-VP O
   
Initially RB O O
it PRP O B-pronoun
was VBD B-VP O
felt VBN O O
that IN B-VP B-pronoun
this DT O B-pronoun
was VBD B-VP O
a DT B-NP O
result NN I-NP O
of IN B-VP O
poor JJ B-NP B-problem
PO NNP I-NP I-problem
intake NN I-NP I-problem
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
afebrile RB O B-problem
without IN B-VP O
orthostatic JJ B-NP B-problem
vital NN I-NP I-problem
signs NNS I-NP I-problem
nor CC O O
hypotension NN B-NP B-problem
. . B-VP O
   
She PRP O B-person
had VBD B-VP O
no DT B-NP O
symptoms NNS I-NP O
of IN B-VP O
infectious JJ B-NP B-problem
source NN I-NP I-problem
, , O O
normal JJ B-NP O
UA NNP I-NP O
, , O O
normal JJ B-NP O
chest NN I-NP O
xray NN I-NP O
, , O O
and CC O O
no DT B-NP O
symptoms NNS I-NP O
nor CC O O
signs NNS B-NP O
of IN B-VP O
injury NN B-NP B-problem
after IN B-VP O
her PRP$ O B-person
fall NN B-NP O
with IN B-VP O
syncope NN B-NP B-problem
. . B-VP O
   
Neuro NNP B-NP B-test
exam NN I-NP I-test
was VBD B-VP O
normal JJ O O
. . B-VP O
   
Subsequently RB O O
overnight JJ O O
, , O O
she PRP O B-person
developed VBD B-VP O
a DT B-NP B-problem
fever NN I-NP I-problem
to TO O O
102.3 CD O O
and CC O O
recurrent JJ B-NP B-problem
hypotension NN I-NP I-problem
in IN B-VP O
the DT B-NP O
setting NN I-NP O
of IN B-VP O
fevers NNS B-NP B-problem
and CC O O
tachycardia NN B-NP B-problem
that WDT O B-pronoun
was VBD B-VP O
concerning VBG O O
for IN B-VP O
an DT B-NP B-problem
infectious JJ I-NP I-problem
source NN I-NP I-problem
. . B-VP O
   
She PRP O B-person
still RB O O
had VBD B-VP O
no DT B-NP O
localizing JJ I-NP O
signs NNS I-NP O
of IN B-VP O
infection NN B-NP B-problem
and CC O O
culture NN B-NP B-test
data NNS I-NP I-test
was VBD B-VP O
negative JJ O O
to TO O O
be VB O O
negative JJ O O
. . B-VP O
   
RUQ NNP B-NP B-test
US NNP I-NP I-test
was VBD B-VP O
ordered VBN O O
and CC O O
returned VBN O O
without IN B-VP O
signs NNS B-NP O
of IN B-VP O
infection NN B-NP B-problem
later RB O O
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
started VBN O O
on IN B-VP O
stress NN B-NP B-treatment
dose JJ B-NP I-treatment
steroids NNS I-NP I-treatment
. . B-VP O
   
She PRP O B-person
had VBD B-VP O
cultures NNS B-NP B-test
drawn VBN O O
, , O O
was VBD B-VP O
given VBN O O
tylenol NN B-NP B-treatment
( ( O O
tylenol JJ B-NP B-test
screen NN I-NP I-test
prior RB O O
to TO O O
this DT O B-pronoun
this DT B-NP B-treatment
dose NN I-NP I-treatment
was VBD B-VP O
negative JJ O O
, , O O
as IN B-VP O
was VBD B-VP O
a DT B-NP B-test
urine JJ I-NP I-test
tox NN I-NP I-test
) ) O O
, , O O
was VBD B-VP O
started VBN O O
on IN B-VP O
levofloxacin NN B-NP B-treatment
, , O O
metronidazole NN B-NP B-treatment
, , O O
and CC O O
vancomycin NN B-NP B-treatment
to TO O O
cover VB O O
emperically RB O O
for IN B-VP O
hospital NN B-NP B-problem
aquired VBD B-VP I-problem
pneumonia NN B-NP I-problem
, , O O
GI NNP B-NP B-problem
sources NNS I-NP I-problem
, , O O
and CC O O
a DT B-NP O
potential JJ I-NP O
hip NN I-NP B-problem
infection NN I-NP I-problem
. . B-VP O
   
Her PRP$ O B-person
Her PRP$ O B-test
transaminases NNS B-NP I-test
were VBD B-VP O
slightly RB O B-problem
elevated VBN O I-problem
, , O O
which WDT O B-pronoun
was VBD B-VP O
later RB O O
attributed VBN O O
to TO O O
shock VB O B-problem
liver RB O I-problem
as IN B-VP O
a DT B-NP O
result NN I-NP O
of IN B-VP O
her PRP$ O B-person
period NN B-NP O
of IN B-VP O
hypotension NN B-NP B-problem
. . B-VP O
   
Lipase NNP B-NP B-test
and CC O O
amylase NN B-NP B-test
remained VBD B-VP O
normal JJ O O
. . B-VP O
   
In IN B-VP O
the DT B-NP O
ICU NNP I-NP O
she PRP O B-person
also RB O O
received VBD B-VP O
an DT B-NP B-test
echo NN I-NP I-test
that WDT O B-pronoun
revealed VBD B-VP O
normal JJ B-NP O
function NN I-NP O
and CC O O
little JJ B-NP B-problem
valvular JJ I-NP I-problem
disease NN I-NP I-problem
( ( O O
she PRP O B-person
has VBZ O O
two CD O B-problem
loud JJ B-NP I-problem
systolic JJ I-NP I-problem
murmurs NNS I-NP I-problem
on IN B-VP O
exam NN B-NP B-test
) ) O O
, , O O
and CC O O
a DT B-NP B-test
hip NN I-NP I-test
film NN I-NP I-test
revealing VBG O O
no DT B-NP O
inflammation NN I-NP B-problem
nor CC O O
loosening NN B-NP B-problem
. . B-VP O
   
Urine JJ B-NP B-test
culture NN I-NP I-test
twice RB O O
grew VBD B-VP O
10-100,000 CD O O
coag NNS B-NP B-problem
negative JJ B-NP I-problem
staph NN I-NP I-problem
. . B-VP O
   
A DT B-NP B-treatment
line NN I-NP I-treatment
could MD O O
not RB O O
be VB O O
placed VBN O O
for IN B-VP O
technical JJ B-NP O
reasons NNS I-NP O
, , O O
however RB O O
after IN B-VP O
4L CD O O
NS NNP B-NP B-treatment
on IN B-VP O
the DT B-NP O
floor NN I-NP O
and CC O O
01-30 NN B-NP O
more RBR O O
in IN B-VP O
the DT B-NP O
ICU NNP I-NP O
via IN B-VP O
peripheral JJ B-NP B-treatment
IV NNP I-NP I-treatment
's POS O O
she PRP O B-person
was VBD B-VP O
stable JJ O O
. . B-VP O
   
She PRP O B-person
remained VBD B-VP O
hemodynamically RB O O
stable JJ O O
with IN B-VP O
good JJ B-NP O
UOP NNP I-NP O
in IN B-VP O
the DT B-NP O
setting NN I-NP O
of IN B-VP O
being VBG O O
started VBN O O
on IN B-VP O
abx NN B-NP B-treatment
and CC O O
stress NN B-NP B-treatment
dose JJ B-NP I-treatment
steroids NNS I-NP I-treatment
. . B-VP O
   
The DT B-NP B-treatment
steroids NNS I-NP I-treatment
were VBD B-VP O
thought VBN O O
to TO O O
have VB O O
helped VBN O O
significantly RB O O
in IN B-VP O
in IN B-VP O
the DT B-NP O
setting NN I-NP O
of IN B-VP O
Addison NNP B-NP B-problem
's POS O I-problem
with IN B-VP O
possibely RB O O
superimposed VBN O B-problem
infection NN B-NP I-problem
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
planned VBN O O
for IN B-VP O
a DT O O
7 CD O O
day NN B-NP O
course NN I-NP O
of IN B-VP O
stress NN B-NP B-treatment
dose NN I-NP I-treatment
steroids NNS I-NP I-treatment
followed VBN O O
by IN B-VP O
a DT B-NP O
return NN I-NP O
to TO O O
her PRP$ O B-treatment
her PRP$ O B-person
basal NN B-NP I-treatment
predinisone NN I-NP I-treatment
/ NNP I-NP O
fludrocortisone NN I-NP B-treatment
dose NN I-NP I-treatment
. . B-VP O
   
2. CD O O
Elevated JJ B-NP B-problem
LFTs NNP I-NP I-problem
: : O O
LFTs NNP B-NP B-test
wre NN I-NP O
elevated VBD B-VP B-problem
at IN B-VP O
presentation NN B-NP O
. . B-VP O
   
Initially RB O O
the DT B-NP O
differential NN I-NP O
was VBD B-VP O
thought VBN O O
to TO O O
include VB O O
shock NN B-NP B-problem
liver NN I-NP I-problem
from IN B-VP O
hypotension NN B-NP B-problem
, , O O
hepatitis NN B-NP B-problem
, , O O
cholangitis NN B-NP B-problem
or CC O O
choledocholithiasis NN B-NP B-problem
. . B-VP O
   
Hepatitis NNP B-NP B-test
serologies NNS I-NP I-test
were VBD B-VP O
negative JJ O O
and CC O O
the DT B-NP O
pt NN I-NP O
was VBD B-VP O
eventually RB O O
felt VBN O O
to TO O O
have VB O O
had VBN O O
shock VBN O B-problem
liver RB O I-problem
from IN B-VP O
her PRP$ O B-problem
her PRP$ O B-person
hypotensive JJ B-NP I-problem
episode NN I-NP I-problem
as IN B-VP O
the DT B-NP B-problem
transaminitis NN I-NP I-problem
resolved VBD B-VP O
over IN B-VP O
time NN B-NP O
. . B-VP O
   
3. CD O O
Hypoparathyroidism NN B-NP B-problem
: : O O
This DT O B-pronoun
is VBZ O O
a DT B-NP B-problem
chronic JJ I-NP I-problem
problem NN I-NP I-problem
. . B-VP O
   
calcium NN B-NP B-test
levels NNS I-NP I-test
were VBD B-VP O
followed VBN O O
with IN B-VP O
a DT B-NP O
goal NN I-NP O
to TO O O
keep VB O O
them PRP O B-pronoun
around RB O O
8.0 CD O O
by IN B-VP O
continuing VBG O O
Calcium NNP B-NP B-treatment
carbonate NN I-NP I-treatment
, , O O
calcitriol NN B-NP B-treatment
. . B-VP O
   
The DT B-NP B-person
pt NN I-NP I-person
required VBN O O
calcium NN B-NP B-treatment
gluconate NN I-NP I-treatment
x1 VBD B-VP O
the DT B-NP O
day NN I-NP O
prior RB O O
to TO O O
discharge VB O O
. . B-VP O
   
Per NNP B-NP O
endocrine NN I-NP B-person
at IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
discharge NN B-NP O
, , O O
the DT B-NP B-person
pt NN I-NP I-person
may MD O O
need VB O O
an DT B-NP O
increase NN I-NP O
in IN B-VP O
calcium NN B-NP B-treatment
PO NNP I-NP I-treatment
, , O O
but CC O O
at IN B-VP O
this DT B-NP B-pronoun
time NN I-NP O
they PRP O B-pronoun
recommended VBD B-VP O
no DT B-NP O
change NN I-NP O
. . B-VP O
   
It PRP O B-pronoun
will MD O O
need VB O O
to TO O O
be VB O O
monitored VBN O O
over IN B-VP O
time NN B-NP O
. . B-VP O
   
4. CD O O
Addison NNP B-NP B-problem
's- CD O I-problem
The DT B-NP B-person
patient NN I-NP I-person
is VBZ O O
on IN B-VP O
basal NN B-NP B-treatment
prednisone NN I-NP I-treatment
/ NNP I-NP O
fludrocortisone NN I-NP B-treatment
. . B-VP O
   
These DT O B-pronoun
were VBD B-VP O
initially RB O O
continued VBN O O
as IN B-VP O
above NN B-NP O
and CC O O
later RB O O
, , O O
when WRB O O
she PRP O B-person
became VBD B-VP O
hypotensive JJ O B-problem
and CC O O
febrile JJ O B-problem
, , O O
stress JJ B-NP B-treatment
dose JJ I-NP I-treatment
steroids NNS I-NP I-treatment
were VBD B-VP O
started VBN O O
and CC O O
planned VBN O O
for IN B-VP O
a DT O O
7 CD O O
day NN B-NP O
course NN I-NP O
followed VBN O O
by IN B-VP O
a DT B-NP O
return NN I-NP O
to TO O O
her PRP$ O B-person
prior JJ B-NP O
dose NN I-NP O
of IN B-VP O
prednisone NN B-NP B-treatment
. . B-VP O
   
At IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
discharge NN B-NP O
, , O O
her PRP$ O B-test
her PRP$ O B-person
potassium NN B-NP I-test
had VBD B-VP O
been VBN O O
low JJ O B-problem
despite IN B-VP O
repletion NN B-NP B-treatment
, , O O
Na NNP B-NP B-test
was VBD B-VP O
elevated VBN O B-problem
, , O O
as IN B-VP O
was VBD B-VP O
blood NN B-NP B-test
pressure NN I-NP I-test
. . B-VP O
   
On IN B-VP O
recommendation NN B-NP O
from IN B-VP O
endocrine NN B-NP B-person
, , O O
her PRP$ O B-person
her PRP$ O B-treatment
fludrocortisone NN B-NP I-treatment
was VBD B-VP O
decreased VBN O O
from IN B-VP O
0.2 CD O O
to TO O O
0.1 CD O O
( ( O O
higher JJR O O
than IN B-VP O
required VBN O O
doses NNS B-NP O
of IN B-VP O
fludrocort NN B-NP B-treatment
can MD O O
cause VB O O
these DT O B-pronoun
these DT B-NP B-problem
symptoms. NNS I-NP I-problem
) ) O O
. . B-VP O
   
5. CD O O
DM NN B-NP B-problem
: : O O
Light NN B-NP O
followed VBD B-VP O
the DT B-NP B-person
patient NN I-NP I-person
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
continued VBN O O
on IN B-VP O
her PRP$ O B-person
prior JJ B-NP O
dose NN I-NP O
of IN B-VP O
steroids NNS B-NP B-treatment
with IN B-VP O
sliding VBG O B-treatment
scale JJ O I-treatment
per IN B-VP O
patient NN B-NP B-person
using VBG O O
a DT O B-treatment
1:15 CD O I-treatment
carb NN B-NP I-treatment
counting VBG O I-treatment
scheme NN B-NP I-treatment
with IN B-VP O
a DT O B-treatment
1:30 CD O I-treatment
correction NN B-NP I-treatment
factor NN I-NP I-treatment
. . B-VP O
   
On IN B-VP O
the DT B-NP O
day NN I-NP O
of IN B-VP O
discharge NN B-NP O
her PRP$ O B-treatment
her PRP$ O B-person
glargine NN B-NP I-treatment
was VBD B-VP O
decreased VBN O O
by IN B-VP O
one CD O O
unit NN B-NP O
because IN B-VP O
her PRP$ O B-test
her PRP$ O B-person
glucose NN B-NP I-test
remained VBD B-VP O
somewhat RB O B-problem
low JJ O I-problem
in IN B-VP O
the DT B-NP O
mornings NNS I-NP O
. . B-VP O
   
6. CD O O
R NNP B-NP B-problem
Hip NNP I-NP I-problem
pain NN I-NP I-problem
: : O O
Later RB O O
in IN B-VP O
her PRP$ O B-person
hospital NN B-NP O
course NN I-NP O
, , O O
the DT B-NP B-person
pt NN I-NP I-person
complained VBD B-VP O
of IN B-VP O
hip NN B-NP B-problem
pain NN I-NP I-problem
. . B-VP O
   
A DT B-NP B-test
R NNP I-NP I-test
hip NN I-NP I-test
film NN I-NP I-test
was VBD B-VP O
negative JJ O O
for IN B-VP O
pathology NN B-NP B-problem
or CC O O
failure NN B-NP B-problem
of IN B-VP O
her PRP$ O B-treatment
her PRP$ O B-person
hip NN B-NP I-treatment
replacement NN I-NP I-treatment
. . B-VP O
   
Pain NN B-NP B-problem
was VBD B-VP O
controlled VBN O O
with IN B-VP O
tylenol NN B-NP B-treatment
and CC O O
the DT B-NP B-person
pt NN I-NP I-person
was VBD B-VP O
reassured VBN O O
. . B-VP O
   
PT NNP B-NP B-person
was VBD B-VP O
consulted VBN O O
. . B-VP O
   
The DT B-NP B-person
pt NN I-NP I-person
uses VBZ O O
a DT B-NP B-treatment
wheelchair NN I-NP I-treatment
often RB O O
at IN B-VP O
baseline NN B-NP O
due JJ O O
to TO O O
pain VB O B-problem
from IN B-VP O
arthritis NN B-NP B-problem
. . B-VP O
   
7. CD O O
Depression NN B-NP B-problem
: : O O
The DT B-NP B-person
pt NN I-NP I-person
was VBD B-VP O
being VBG O O
treated VBN O O
at IN B-VP O
Mediplex NNP B-NP O
Rehab NNP I-NP O
Hospital NNP I-NP O
4 CD O O
for IN B-VP O
suicidal JJ B-NP B-problem
ideation NN I-NP I-problem
and CC O O
a DT B-NP O
suicide JJ I-NP B-problem
attempt NN I-NP I-problem
on IN B-VP O
original JJ B-NP O
admission NN I-NP O
with IN B-VP O
tylenol NN B-NP B-treatment
and CC O O
oxycodone NN B-NP B-treatment
. . B-VP O
   
She PRP O B-person
had VBD B-VP O
planned VBN O O
this DT B-NP B-pronoun
attempt NN I-NP O
carefully RB O O
without IN B-VP O
the DT B-NP O
knowledge NN I-NP O
of IN B-VP O
those DT O B-pronoun
close JJ O O
to TO O O
her PRP$ O B-person
and CC O O
very RB O O
much RB O O
expected VBN O O
her PRP$ O B-person
attempt NN B-NP O
to TO O O
work NN B-NP O
. . B-VP O
   
She PRP O B-person
had VBD B-VP O
been VBN O O
depressed VBN O B-problem
for IN B-VP O
some DT B-NP O
time NN I-NP O
but CC O O
her PRP$ O B-person
her PRP$ O B-person
loved JJ B-NP I-person
ones NNS I-NP I-person
were VBD B-VP O
very RB O O
surprised JJ O O
at IN B-VP O
her PRP$ O B-person
attempt NN B-NP O
. . B-VP O
   
She PRP O B-person
remained VBD B-VP O
very RB O B-problem
depressed JJ O I-problem
at IN B-VP O
her PRP$ O B-person
inpatient JJ B-NP O
admission NN I-NP O
and CC O O
refractory NN B-NP B-problem
to TO O O
treatment NN B-NP B-treatment
. . B-VP O
   
One CD O O
day NN B-NP O
prior RB O O
to TO O O
her PRP$ O B-person
transfer NN B-NP O
to TO O O
the DT B-NP O
medical JJ I-NP O
floor NN I-NP O
she PRP O B-person
was VBD B-VP O
sectioned VBN O O
to TO O O
initiate VB O O
ECT NNP B-NP B-treatment
, , O O
which WDT O B-pronoun
she PRP O B-person
had VBD B-VP O
previously RB O O
refused VBN O O
. . B-VP O
   
As IN B-VP O
a DT B-NP O
result NN I-NP O
, , O O
she PRP O B-person
was VBD B-VP O
maintained VBN O O
on IN B-VP O
her PRP$ O B-treatment
her PRP$ O B-person
ativan NN B-NP I-treatment
, , O O
mirtazapine NN B-NP B-treatment
, , O O
risperidone NN B-NP B-treatment
, , O O
duloxetine NN B-NP B-treatment
. . B-VP O
   
She PRP O B-person
did VBD B-VP O
not RB O O
exhibit VB O O
psychotic JJ B-NP B-problem
symptoms NNS I-NP I-problem
. . B-VP O
   
She PRP O B-person
had VBD B-VP O
a DT O B-person
1:1 CD O I-person
sitter NN B-NP I-person
at IN B-VP O
all DT B-NP O
times NNS I-NP O
. . B-VP O
   
She PRP O B-person
denied VBD B-VP O
any DT B-NP B-problem
suicidality NN I-NP I-problem
but CC O O
did VBD B-VP O
endorse DT B-NP O
depression NN I-NP B-problem
. . B-VP O
   
She PRP O B-person
denied VBD B-VP O
HI NNP B-NP B-problem
, , O O
SI NNP B-NP B-problem
, , O O
and CC O O
illusions NNS B-NP B-problem
/ VBP O O
hallucinations NNS B-NP B-problem
. . B-VP O
   
Her PRP$ O B-person
mood NN B-NP O
appeared VBD B-VP O
stable JJ O O
throughout IN B-VP O
her PRP$ O B-person
hospitalization NN B-NP O
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
followed VBN O O
by IN B-VP O
psychiatry NN B-NP B-person
in IN B-VP O
consultation NN B-NP O
while IN B-VP O
she PRP O B-person
was VBD B-VP O
on IN B-VP O
the DT B-NP O
medical JJ I-NP O
floor NN I-NP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
did VBD B-VP O
have VB O O
heparin VBN O B-treatment
subcutaneously RB O I-treatment
while IN B-VP O
on IN B-VP O
the DT B-NP O
medical JJ I-NP O
floor NN I-NP O
and CC O O
in IN B-VP O
the DT B-NP O
ICU NNP I-NP O
. . B-VP O
   
She PRP O B-person
remained VBD B-VP O
full JJ B-NP B-treatment
code NN I-NP I-treatment
throughout IN B-VP O
the DT B-NP O
hospitalization NN I-NP O
. . B-VP O
   
As IN B-VP O
on IN B-VP O
prior JJ B-NP O
hospitalization NN I-NP O
, , O O
her PRP$ O B-person
HCP NNP B-NP O
was VBD B-VP O
shared VBN O O
by IN B-VP O
Dianne NNP B-NP B-person
White NNP I-NP I-person
. . B-VP O
   
Medications NNS B-NP O
on IN B-VP O
Admission NN B-NP O
: : O O
Meds NNS B-NP O
on IN B-VP O
transfer NN B-NP O
: : O O
Fludrocortisone CD O B-treatment
Acetate NNP B-NP I-treatment
0.2 CD O O
mg NN B-NP O
PO NNP I-NP O
DAILY NNP I-NP O
07-12 CD O O
@ NN B-NP O
1033 CD O O
Acetaminophen NNP B-NP B-treatment
650 CD O O
mg NN B-NP O
PO NNP I-NP O
BID NNP I-NP O
07-11 CD O O
@ NN B-NP O
1503 CD O O
View NNP B-NP O
Ibuprofen NNP I-NP B-treatment
400 CD O O
mg NN B-NP O
PO NNP I-NP O
BID NNP I-NP O
07-11 CD O O
@ NN B-NP O
1503 CD O O
View NNP B-NP O
Ibuprofen NNP I-NP B-treatment
400 CD O O
mg NN B-NP O
PO NNP I-NP O
Q8H NNP I-NP O
: : O O
PRN NNP B-NP O
07-11 CD O O
@ NN B-NP O
1503 CD O O
View NNP B-NP O
Insulin NNP I-NP B-treatment
SC NNP I-NP I-treatment
( ( O O
per IN B-VP O
Insulin NNP B-NP O
Flowsheet NNP I-NP O
) ) O O
Risperidone VBD B-VP B-treatment
1 CD O O
mg NN B-NP O
PO NNP I-NP O
HS NNP I-NP O
07-10 CD O O
@ NN B-NP O
1135 CD O O
View NNP B-NP O
Risperidone NNP I-NP B-treatment
0.5 CD O O
mg NN B-NP O
PO NNP I-NP O
DAILY NNP I-NP O
07-10 CD O O
@ NN B-NP O
1135 CD O O
View NNP B-NP O
Potassium NNP I-NP B-treatment
Chloride NNP I-NP I-treatment
20 CD O O
mEq NN B-NP O
PO NNP I-NP O
BID NNP I-NP O
Calcium NNP I-NP B-treatment
Carbonate NNP I-NP I-treatment
1500 CD O O
mg NN B-NP O
PO NNP I-NP O
TID NNP I-NP O
07-04 CD O O
@ NN B-NP O
1126 CD O O
View NNP B-NP O
Mirtazapine NNP I-NP B-treatment
15 CD O O
mg NN B-NP O
PO NNP I-NP O
HS NNP I-NP O
07-03 CD O O
@ NN B-NP O
1220 CD O O
View NNP B-NP O
Duloxetine NNP I-NP B-treatment
30 CD O O
mg NN B-NP O
PO NNP I-NP O
BID NNP I-NP O
Start NNP I-NP O
: : O O
In IN B-VP O
am VBP O O
07-03 JJ B-NP O
@ NN I-NP O
1214 CD O O
Psyllium NN B-NP B-treatment
1 CD O O
PKT NNP B-NP O
PO NNP I-NP O
TID NNP I-NP O
: : O O
PRN NNP B-NP O
06-30 CD O O
@ NN B-NP O
1248 CD O O
View NNP B-NP O
Memantine NNP I-NP B-treatment
* NNP I-NP O
N NNP I-NP O
F* NNP I-NP O
10 CD O O
mg JJ O O
Oral JJ O O
daily JJ O O
06-27 CD O O
@ JJ O O
1124 CD O O
View NNP B-NP O
Calcitriol NNP I-NP B-treatment
0.25 CD O O
mcg NN B-NP O
PO NNP I-NP O
EVERY NNP I-NP O
OTHER NNP I-NP O
DAY NNP I-NP O
t/th/s/s VBD B-VP O
Calcitriol NNP B-NP B-treatment
0.5 CD O O
mcg NN B-NP O
PO NNP I-NP O
EVERY NNP I-NP O
OTHER NNP I-NP O
DAY NNP I-NP O
06-27 CD O O
@ NN B-NP O
1051 CD O O
Lorazepam NNP B-NP B-treatment
2 CD O O
mg NN B-NP O
PO NNP I-NP O
HS NNP I-NP O
06-23 CD O O
@ NN B-NP O
1215 CD O O
View NNP B-NP O
Alendronate NNP I-NP B-treatment
Sodium NNP I-NP I-treatment
70 CD O O
mg NN B-NP O
PO NNP I-NP O
QSUN NNP I-NP O
06-22 CD O O
@ NN B-NP O
1106 CD O O
View NNP B-NP O
Lactulose NNP I-NP B-treatment
60 CD O O
ml NN B-NP O
PO NNP I-NP O
QTHUR NNP I-NP O
06-21 CD O O
@ NN B-NP O
1600 CD O O
View NNP B-NP O
Milk NNP I-NP B-treatment
of IN B-VP I-treatment
Magnesia NNP B-NP I-treatment
60 CD O O
ml NN B-NP O
PO NNP I-NP O
QTHUR NNP I-NP O
06-21 CD O O
@ NN B-NP O
1600 CD O O
View NNP B-NP O
Arimidex NNP I-NP B-treatment
* NNP I-NP O
N NNP I-NP O
F* NNP I-NP O
1 CD O O
mg JJ O O
Oral JJ O O
daily JJ O O
06-21 CD O O
@ JJ O O
1414 CD O O
View NNP B-NP O
Magnesium NNP I-NP B-treatment
Oxide NNP I-NP I-treatment
400 CD O O
mg NN B-NP O
PO NNP I-NP O
BID NNP I-NP O
06-20 CD O O
@ NN B-NP O
2017 CD O O
View NNP B-NP O
Atorvastatin NNP I-NP B-treatment
20 CD O O
mg NN B-NP O
PO NNP I-NP O
DAILY NNP I-NP O
06-20 CD O O
@ NN B-NP O
2017 CD O O
View NNP B-NP O
Docusate NNP I-NP B-treatment
Sodium NNP I-NP I-treatment
100 CD O O
mg NN B-NP O
PO NNP I-NP O
TID NNP I-NP O
06-20 CD O O
@ NN B-NP O
2017 CD O O
View NNP B-NP O
Pantoprazole NNP I-NP B-treatment
40 CD O O
mg NN B-NP O
PO NNP I-NP O
Q24H NNP I-NP O
06-20 CD O O
@ NN B-NP O
2017 CD O O
View NNP B-NP O
Prednisone NNP I-NP B-treatment
2.5 CD O O
mg NN B-NP O
PO NNP I-NP O
Q3PM NNP I-NP O
06-20 CD O O
@ NN B-NP O
2017 CD O O
View NNP B-NP O
Prednisone NNP I-NP B-treatment
5 CD O O
mg NN B-NP O
PO NNP I-NP O
QAM NNP I-NP O
06-20 CD O O
@ NN B-NP O
2017 CD O O
View NNP B-NP O
Chlorothiazide NNP I-NP B-treatment
500 CD O O
mg NN B-NP O
PO NNP I-NP O
DAILY NNP I-NP O
06-20 CD O O
@ NN B-NP O
2017 CD O O
View NNP B-NP O
Aspirin NNP I-NP B-treatment
81 CD O O
mg NN B-NP O
PO NNP I-NP O
DAILY NNP I-NP O
Multivitamins NNP I-NP B-treatment
1 CD O O
CAP NNP B-NP O
PO NNP I-NP O
DAILY NNP I-NP O
Allergies NNS I-NP O
: : O O
Clindamycin NNP B-NP B-treatment
/ NNP I-NP O
Erythromycin NNP I-NP B-treatment
Base NNP I-NP I-treatment
/ NNP I-NP O
Amoxicillin NNP I-NP B-treatment
/ NNP I-NP O
Keflex NNP I-NP B-treatment
/ NNP I-NP O
Wellbutrin NNP I-NP B-treatment
Discharge NNP I-NP O
Medications NNP I-NP O
: : O O
1. CD O O
Risperidone NNP B-NP B-treatment
0.5 CD O O
mg NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
Two CD O O
( ( O O
2 CD O O
) ) O O
Tablet NNP B-NP O
PO NNP I-NP O
HS NNP I-NP O
( ( O O
at IN B-VP O
bedtime NN B-NP O
) ) O O
. . B-VP O
   
2. CD O O
Risperidone CD O B-treatment
0.5 CD O O
mg NNS B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Tablet NNP B-NP O
PO NNP I-NP O
DAILY NNP I-NP O
( ( O O
Daily NNP B-NP O
) ) O O
. . B-VP O
   
3. CD O O
Mirtazapine NNP B-NP B-treatment
15 CD O O
mg NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Tablet NNP B-NP O
PO NNP I-NP O
HS NNP I-NP O
( ( O O
at IN B-VP O
bedtime NN B-NP O
) ) O O
. . B-VP O
   
4. CD O O
Duloxetine NNP B-NP B-treatment
30 CD O O
mg NN B-NP O
Capsule NNP I-NP O
, , O O
Delayed NNP B-NP O
Release NNP I-NP O
( ( O O
E.C. NNP B-NP O
) ) O O
Sig NN B-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Capsule NN B-NP O
, , O O
Delayed NNP B-NP O
Release NNP I-NP O
( ( O O
E.C. NNP B-NP O
) ) O O
PO NNP B-NP O
BID NNP I-NP O
( ( O O
2 CD O O
times NNS B-NP O
a DT B-NP O
day NN I-NP O
) ) O O
. . B-VP O
   
5. CD O O
Calcitriol NNP B-NP B-treatment
0.25 CD O O
mcg NN B-NP O
Capsule NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Capsule NNP B-NP O
PO NNP I-NP O
EVERY NNP I-NP O
OTHER NNP I-NP O
DAY NNP I-NP O
( ( O O
Every NNP B-NP O
Other JJ B-NP O
Day NNP I-NP O
) ) O O
. . B-VP O
   
6. CD O O
Calcitriol NNP B-NP B-treatment
0.5 CD O O
mcg NN B-NP O
Capsule NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Capsule NNP B-NP O
PO NNP I-NP O
EVERY NNP I-NP O
OTHER NNP I-NP O
DAY NNP I-NP O
( ( O O
Every NNP B-NP O
Other JJ B-NP O
Day NNP I-NP O
) ) O O
. . B-VP O
   
7. CD O O
Alendronate NNP B-NP B-treatment
70 CD O O
mg NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Tablet NNP B-NP O
PO NNP I-NP O
QSUN NNP I-NP O
( ( O O
every DT B-NP O
Sunday NNP I-NP O
) ) O O
. . B-VP O
   
8. CD O O
Lactulose JJ O B-treatment
10 CD O O
g NN B-NP O
/ VBD B-VP O
15 CD O O
mL NN B-NP O
Syrup NNP I-NP O
Sig NNP I-NP O
: : O O
Sixty NNP B-NP O
( ( O O
60 CD O O
) ) O O
ML NNP B-NP O
PO NNP I-NP O
EVERY NNP I-NP O
THURSDAY NNP I-NP O
( ( O O
) ) O O
. . B-VP O
   
9. CD O O
Magnesium NNP B-NP B-treatment
Hydroxide NNP I-NP I-treatment
400 CD O O
mg NN B-NP O
/ VBD B-VP O
5 CD O O
mL JJ B-NP O
Suspension NNP I-NP O
Sig NNP I-NP O
: : O O
Thirty NNP B-NP O
( ( O O
30 CD O O
) ) O O
ML NNP B-NP O
PO NNP I-NP O
Q6H NNP I-NP O
( ( O O
every DT O O
6 CD O O
hours NNS B-NP O
) ) O O
as IN B-VP O
needed VBN O O
. . B-VP O
   
10. CD O O
Anastrozole JJ O B-treatment
1 CD O O
mg JJ B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Tablet NNP B-NP O
PO NNP I-NP O
daily RB O O
( ( O O
) ) O O
. . B-VP O
   
11. CD O O
Atorvastatin NNP B-NP B-treatment
20 CD O O
mg NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Tablet NNP B-NP O
PO NNP I-NP O
DAILY NNP I-NP O
( ( O O
Daily NNP B-NP O
) ) O O
. . B-VP O
   
12. CD O O
Docusate NNP B-NP B-treatment
Sodium NNP I-NP I-treatment
100 CD O O
mg NN B-NP O
Capsule NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Capsule NNP B-NP O
PO NNP I-NP O
TID NNP I-NP O
( ( O O
3 CD O O
times NNS B-NP O
a DT B-NP O
day NN I-NP O
) ) O O
. . B-VP O
   
13. CD O O
Pantoprazole JJ O B-treatment
40 CD O O
mg JJ B-NP O
Tablet NNP I-NP O
, , O O
Delayed NNP B-NP O
Release NNP I-NP O
( ( O O
E.C. NNP B-NP O
) ) O O
Sig NN B-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Tablet NN B-NP O
, , O O
Delayed NNP B-NP O
Release NNP I-NP O
( ( O O
E.C. NNP B-NP O
) ) O O
PO NNP B-NP O
Q24H NNP I-NP O
( ( O O
every DT O O
24 CD O O
hours NNS B-NP O
) ) O O
. . B-VP O
   
14. CD O O
Aspirin NNP B-NP B-treatment
81 CD O O
mg NN B-NP O
Tablet NNP I-NP O
, , O O
Chewable JJ B-NP O
Sig NN I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Tablet NN B-NP O
, , O O
Chewable JJ B-NP O
PO NNP I-NP O
DAILY NNP I-NP O
( ( O O
Daily NNP B-NP O
) ) O O
. . B-VP O
   
15. CD O O
Multivitamin NNP B-NP B-treatment
Capsule NNP I-NP I-treatment
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Cap NNP B-NP O
PO NNP I-NP O
DAILY NNP I-NP O
( ( O O
Daily NNP B-NP O
) ) O O
. . B-VP O
   
16. CD O O
Ibuprofen NNP B-NP B-treatment
400 CD O O
mg NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Tablet NNP B-NP O
PO NNP I-NP O
BID NNP I-NP O
( ( O O
2 CD O O
times NNS B-NP O
a DT B-NP O
day NN I-NP O
) ) O O
. . B-VP O
   
17. CD O O
Ferrous JJ B-NP B-treatment
Sulfate NNP I-NP I-treatment
325 CD O O
( ( O O
65 CD O O
) ) O O
mg NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Tablet NNP B-NP O
PO NNP I-NP O
DAILY NNP I-NP O
( ( O O
Daily NNP B-NP O
) ) O O
. . B-VP O
   
18. CD O O
Maalox NNP B-NP B-treatment
200-200-20 JJ B-NP O
mg NN I-NP O
/ $ O O
5 CD O O
mL JJ B-NP O
Suspension NNP I-NP O
Sig NNP I-NP O
: : O O
Fifteen NNP B-NP O
( ( O O
15 CD O O
) ) O O
ML NNP B-NP O
PO NNP I-NP O
PRN NNP I-NP O
( ( O O
as IN B-VP O
needed VBN O O
) ) O O
. . B-VP O
   
19. CD O O
Levofloxacin NNP B-NP B-treatment
500 CD O O
mg NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Tablet NNP B-NP O
PO NNP I-NP O
Q24H NNP I-NP O
( ( O O
every DT O O
24 CD O O
hours NNS B-NP O
) ) O O
for IN B-VP O
2 CD O O
days NNS B-NP O
. . B-VP O
   
20. CD O O
Calcium NNP B-NP B-treatment
Carbonate NNP I-NP I-treatment
500 CD O O
mg NN B-NP O
Tablet NNP I-NP O
, , O O
Chewable JJ B-NP O
Sig NN I-NP O
: : O O
Three NNP B-NP O
( ( O O
3 CD O O
) ) O O
Tablet NN B-NP O
, , O O
Chewable JJ B-NP O
PO NNP I-NP O
TID NNP I-NP O
( ( O O
3 CD O O
times NNS B-NP O
a DT B-NP O
day NN I-NP O
) ) O O
. . B-VP O
   
21. CD O O
Calcium NNP B-NP B-treatment
Carbonate NNP I-NP I-treatment
500 CD O O
mg NN B-NP O
Tablet NNP I-NP O
, , O O
Chewable JJ B-NP O
Sig NN I-NP O
: : O O
Three NNP B-NP O
( ( O O
3 CD O O
) ) O O
Tablet NN B-NP O
, , O O
Chewable JJ B-NP O
PO NNP I-NP O
QID NNP I-NP O
( ( O O
4 CD O O
times NNS B-NP O
a DT B-NP O
day NN I-NP O
) ) O O
. . B-VP O
   
22. CD O O
Heparin NNP B-NP B-treatment
( ( O I-treatment
Porcine NNP B-NP I-treatment
) ) O I-treatment
5,000 CD O O
unit NN B-NP O
/ NNP I-NP O
mL NN I-NP O
Solution NNP I-NP O
Sig NNP I-NP O
: : O O
5000 CD O O
( ( O O
5000 CD O O
) ) O O
units NNS B-NP O
Injection NNP I-NP O
TID NNP I-NP O
( ( O O
3 CD O O
times NNS B-NP O
a DT B-NP O
day NN I-NP O
) ) O O
. . B-VP O
   
23. CD O O
Prednisone NN B-NP B-treatment
5 CD O O
mg NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Tablet NNP B-NP O
PO NNP I-NP O
DAILY NNP I-NP O
( ( O O
Daily NNP B-NP O
) ) O O
. . B-VP O
   
24. CD O O
Prednisone NN B-NP B-treatment
2.5 CD O O
mg NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Tablet NNP B-NP O
PO NNP I-NP O
Q NNP I-NP O
3PM CD O O
( ( O O
) ) O O
. . B-VP O
   
25. CD O O
Chlorothiazide NNP B-NP B-treatment
250 CD O O
mg NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
Two CD O O
( ( O O
2 CD O O
) ) O O
Tablet NNP B-NP O
PO NNP I-NP O
DAILY NNP I-NP O
( ( O O
Daily NNP B-NP O
) ) O O
. . B-VP O
   
26. CD O O
Fludrocortisone CD O B-treatment
0.1 CD O O
mg NNS B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Tablet NNP B-NP O
PO NNP I-NP O
DAILY NNP I-NP O
( ( O O
Daily NNP B-NP O
) ) O O
. . B-VP O
   
27. CD O O
Potassium NNP B-NP B-treatment
Chloride NNP I-NP I-treatment
10 CD O O
mEq NN B-NP O
Capsule NNP I-NP O
, , O O
Sustained VBD B-VP O
Release NNP B-NP O
Sig NNP I-NP O
: : O O
Four CD O O
( ( O O
4 CD O O
) ) O O
Capsule NN B-NP O
, , O O
Sustained VBD B-VP O
Release NNP B-NP O
PO NNP I-NP O
DAILY NNP I-NP O
( ( O O
Daily NNP B-NP O
) ) O O
. . B-VP O
   
28. CD O O
Lorazepam NNP B-NP B-treatment
1 CD O O
mg NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
0.5 CD O O
Tablet NNP B-NP O
PO NNP I-NP O
Q6H NNP I-NP O
( ( O O
every DT O O
6 CD O O
hours NNS B-NP O
) ) O O
as IN B-VP O
needed VBN O O
. . B-VP O
   
29. CD O O
Memantine NNP B-NP B-treatment
5 CD O O
mg NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Tablet NNP B-NP O
PO NNP I-NP O
daily RB O O
( ( O O
) ) O O
. . B-VP O
   
30. CD O O
Insulin NNP B-NP B-treatment
Glargine NNP I-NP I-treatment
100 CD O O
unit NN B-NP O
/ NNP I-NP O
mL NN I-NP O
Solution NNP I-NP O
Sig NNP I-NP O
: : O O
AS IN B-VP O
INSTRUCTED NNP B-NP O
Subcutaneous NNP I-NP O
twice RB O O
a DT B-NP O
day NN I-NP O
: : O O
7 CD O O
units NNS B-NP O
in IN B-VP O
the DT B-NP O
morning NN I-NP O
, , O O
18 CD O O
units NNS B-NP O
in IN B-VP O
the DT B-NP O
evening NN I-NP O
. . B-VP O
   
Discharge NNP B-NP O
Disposition NNP I-NP O
: : O O
Extended VBN O O
Care NNP B-NP O
Facility NNP I-NP O
: : O O
Quincy NNP B-NP O
Medical NNP I-NP O
Center NNP I-NP O
4 CD O O
Discharge NNP B-NP O
Diagnosis NNP I-NP O
: : O O
Hypotension NNP B-NP B-problem
Early NNP I-NP B-problem
Sepsis NNP I-NP I-problem
Adrenal NNP I-NP B-problem
Insufficiency NNP I-NP I-problem
Diabetes NNP I-NP B-problem
I PRP O I-problem
Hypocalcemia NNP B-NP B-problem
( ( O O
Hypoparathyroidism NNP B-NP B-problem
) ) O O
Depression NNP B-NP B-problem
Transaminitis NNP I-NP B-problem
Discharge NNP I-NP O
Condition NNP I-NP O
: : O O
Stable JJ B-NP O
vitals NNS I-NP O
, , O O
depressed VBN O B-problem
. . B-VP O
   
Discharge NNP B-NP O
Instructions NNPS I-NP O
: : O O
You PRP O B-person
were VBD B-VP O
admitted VBN O O
with IN B-VP O
a DT B-NP B-problem
low JJ I-NP I-problem
blood NN I-NP I-problem
pressure NN I-NP I-problem
and CC O O
developed VBD B-VP O
a DT B-NP B-problem
fever NN I-NP I-problem
. . B-VP O
   
You PRP O B-person
are VBP O O
finishing VBG O O
a DT B-NP O
course NN I-NP O
of IN B-VP O
antibiotics NNS B-NP B-treatment
and CC O O
have VBP O O
been VBN O O
stable JJ O O
for IN B-VP O
days NNS B-NP O
. . B-VP O
   
If IN B-VP O
you PRP O B-person
lose VBP O O
consciousness NN B-NP O
, , O O
develop VB O O
a DT B-NP B-problem
low JJ I-NP I-problem
BP NNP I-NP I-problem
, , O O
have VBP O O
lightheadedness VBN O B-problem
with IN B-VP O
standing NN B-NP O
, , O O
develop VB O O
a DT B-NP B-problem
fever NN I-NP I-problem
, , O O
or CC O O
have VBP O O
other JJ B-NP B-problem
worrisome NN I-NP I-problem
symptoms NNS I-NP I-problem
, , O O
please VB O O
seek VB O O
medical JJ B-NP B-treatment
care NN I-NP I-treatment
. . B-VP O
   
Followup NNP B-NP O
Instructions NNPS I-NP O
: : O O
As IN B-VP O
planned VBN O O
- : O O
continued VBN O O
consultation NN B-NP O
by IN B-VP O
Light NNP B-NP O
and CC O O
Endocrine NNP B-NP B-person
Vivian NNP I-NP B-person
LIEN NNP I-NP I-person
MD NNP I-NP I-person
88-143 CD O O
Completed VBN O O
by IN B-VP O
: : O O
Mildred NNP B-NP B-person
BERRY NNP I-NP I-person
MD NNP I-NP I-person
38-748 JJ O O
2017-07-18 CD O O
@ JJ O O
0548 CD O O
Signed VBN O O
electronically RB O O
by IN B-VP O
: : O O
DR. NNP B-NP B-person
Edith NNP I-NP I-person
LIEN NNP I-NP I-person
on IN B-VP O
: : O O
MON NNP B-NP O
2017-07-24 CD O O
1:03 CD O O
PM NNP B-NP O
( ( O O
End NNP B-NP O
of IN B-VP O
Report NNP B-NP O
) ) O O
-EMPTYLINE- VBP O O
-DOCSTART- JJ O O
-EMPTYLINE- $ O O
018636330 CD O O
DH NNP B-NP O
5425710 CD O O
123524 CD O O
0144918 CD O O
6/2/2005 CD O O
12:00:00 CD O O
AM NNP B-NP O
Discharge NNP I-NP O
Summary NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Report NNP I-NP O
Status NNP I-NP O
: : O O
Signed VBD B-VP O
DISCHARGE NNP B-NP O
SUMMARY NNP I-NP O
NAME NN I-NP O
: : O O
KOTE NNP B-NP B-person
, , O I-person
OA NNP B-NP I-person
UNIT NNP I-NP O
NUMBER NNP I-NP O
: : O O
509-22-30 JJ B-NP O
ADMISSION NNP I-NP O
DATE NNP I-NP O
: : O O
06/02/2005 CD O O
DISCHARGE NNP B-NP O
DATE NNP I-NP O
: : O O
06/05/2005 CD O O
PRINCIPAL NNP B-NP O
DIAGNOSIS NNP I-NP O
: : O O
C5-6 JJ B-NP B-problem
disc NN I-NP I-problem
herniation NN I-NP I-problem
with IN B-VP O
cord NN B-NP B-problem
compression NN I-NP I-problem
and CC O O
myelopathy NN B-NP B-problem
. . B-VP O
   
PRINCIPAL JJ B-NP O
PROCEDURE NN I-NP O
: : O O
Microscopic NNP B-NP B-treatment
anterior RB O I-treatment
cervical JJ B-NP I-treatment
diskectomy NN I-NP I-treatment
at IN B-VP I-treatment
C5-6 NNP B-NP I-treatment
and CC O O
fusion NN B-NP B-treatment
. . B-VP O
   
HISTORY NNP B-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
is VBZ O O
a DT B-NP O
63-year-old JJ I-NP O
female NN I-NP O
with IN B-VP O
a DT B-NP O
three-year JJ I-NP O
history NN I-NP O
of IN B-VP O
bilateral JJ B-NP B-problem
hand NN I-NP I-problem
numbness NN I-NP I-problem
and CC O O
occasional JJ B-NP B-problem
weakness NN I-NP I-problem
. . B-VP O
   
Within IN B-VP O
the DT B-NP O
past JJ I-NP O
year NN I-NP O
, , O O
these DT O B-problem
these DT B-NP B-pronoun
symptoms NNS I-NP I-problem
have VBP O O
progressively RB O O
gotten VBN O O
worse JJR O O
, , O O
to TO O O
encompass VB O O
also RB O O
her PRP$ O B-person
feet NNS B-NP O
. . B-VP O
   
She PRP O B-person
had VBD B-VP O
a DT B-NP B-test
workup NN I-NP I-test
by IN B-VP O
her PRP$ O B-person
her PRP$ O B-person
neurologist NN B-NP I-person
and CC O O
an DT B-NP B-test
MRI NNP I-NP I-test
revealed VBD B-VP O
a DT B-NP B-problem
C5-6 JJ I-NP I-problem
disc NN I-NP I-problem
herniation NN I-NP I-problem
with IN B-VP O
cord NN B-NP B-problem
compression NN I-NP I-problem
and CC O O
a DT B-NP B-problem
T2 NNP I-NP I-problem
signal JJ B-NP I-problem
change NN I-NP I-problem
at IN B-VP O
that DT B-NP B-pronoun
level NN I-NP O
. . B-VP O
   
PAST NNP B-NP O
MEDICAL NNP I-NP O
HISTORY NNP I-NP O
: : O O
Significant NN B-NP O
for IN B-VP O
hypertension NN B-NP B-problem
, , O O
hyperlipidemia NN B-NP B-problem
. . B-VP O
   
MEDICATIONS NNP B-NP O
ON NNP I-NP O
ADMISSION NNP I-NP O
: : O O
Lipitor NN B-NP B-treatment
, , O O
Flexeril NNP B-NP B-treatment
, , O O
hydrochlorothiazide NN B-NP B-treatment
and CC O O
Norvasc NNP B-NP B-treatment
. . B-VP O
   
ALLERGIES NN B-NP O
: : O O
She PRP O B-person
has VBZ O O
no DT O O
known VBN O B-problem
drug NN B-NP I-problem
allergy NN I-NP I-problem
. . B-VP O
   
SOCIAL NNP B-NP O
HISTORY NN I-NP O
: : O O
She PRP O B-person
smokes VBZ O O
one CD O O
pack NN B-NP O
per IN B-VP O
day NN B-NP O
x45 CD O O
years NNS B-NP O
. . B-VP O
   
She PRP O B-person
occasionally RB O O
drinks VBZ O O
alcohol NN B-NP O
. . B-VP O
   
PHYSICAL JJ B-NP O
EXAMINATION NN I-NP O
: : O O
She PRP O B-person
had VBD B-VP O
5/5 CD O O
strength NN B-NP O
in IN B-VP O
bilateral JJ B-NP O
upper NN I-NP O
and CC O O
lower JJR B-NP O
extremities NNS I-NP O
. . B-VP O
   
She PRP O B-person
had VBD B-VP O
a DT B-NP B-test
Hoffman NNP I-NP I-test
&apos;s NNP I-NP I-test
sign NN I-NP I-test
greater JJR O O
on IN B-VP O
the DT B-NP O
right NN I-NP O
than IN B-VP O
the DT B-NP O
left NN I-NP O
and CC O O
she PRP O B-person
had VBD B-VP O
10 CD O B-problem
beats NNS B-NP I-problem
of IN B-VP I-problem
clonus NN B-NP I-problem
in IN B-VP O
the DT B-NP O
right JJ I-NP O
foot NN I-NP O
and CC O O
3-5 JJ B-NP B-problem
beats NNS I-NP I-problem
in IN B-VP I-problem
the DT B-NP I-problem
left JJ I-NP I-problem
foot NN I-NP I-problem
. . B-VP O
   
She PRP O B-person
had VBD B-VP O
hyperreflexia VBN O B-problem
in IN B-VP O
both DT O O
the DT B-NP O
bilateral JJ I-NP O
upper NN I-NP O
and CC O O
lower JJR B-NP O
extremities NNS I-NP O
. . B-VP O
   
HOSPITAL NNP B-NP O
COURSE NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
tolerated VBD B-VP O
a DT B-NP B-treatment
C5-6 JJ I-NP I-treatment
ACDF NNP I-NP I-treatment
by IN B-VP O
Dr. NNP B-NP B-person
Miezetri NNP I-NP I-person
Gach NNP I-NP I-person
quite RB O O
well RB O O
. . B-VP O
   
She PRP O B-person
had VBD B-VP O
a DT B-NP B-test
postoperative JJ I-NP I-test
CT NNP I-NP I-test
scan NN I-NP I-test
that WDT O B-pronoun
revealed VBD B-VP O
partial JJ B-NP B-problem
decompression NN I-NP I-problem
of IN B-VP I-problem
the DT B-NP I-problem
spinal JJ I-NP I-problem
canal NN I-NP I-problem
and CC O O
good JJ B-NP O
placement NN I-NP O
of IN B-VP O
her PRP$ O B-person
her PRP$ O B-treatment
hardware NN B-NP I-treatment
. . B-VP O
   
Immediately RB O O
postop JJ O O
, , O O
her PRP$ O B-person
her PRP$ O B-test
exam NN B-NP I-test
only RB O O
improved VBD B-VP O
slightly RB O O
in IN B-VP O
her PRP$ O B-person
her PRP$ O B-problem
hyperreflexia NN B-NP I-problem
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
ambulating VBG O O
by IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
number NN I-NP O
two CD O O
. . B-VP O
   
She PRP O B-person
tolerated VBD B-VP O
a DT B-NP O
regular JJ I-NP O
diet NN I-NP O
. . B-VP O
   
Her PRP$ O B-person
Her PRP$ O B-problem
pain NN B-NP I-problem
was VBD B-VP O
under IN B-VP O
good JJ B-NP O
control NN I-NP O
with IN B-VP O
PO NNP B-NP B-treatment
pain NN I-NP I-treatment
medications NNS I-NP I-treatment
and CC O O
she PRP O B-person
was VBD B-VP O
deemed VBN O O
suitable JJ O O
for IN B-VP O
discharge NN B-NP O
. . B-VP O
   
DISCHARGE JJ B-NP O
ORDERS NNS I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
asked VBN O O
to TO O O
call VB O O
Dr. NNP B-NP B-person
Miezetri NNP I-NP I-person
Gach NNP I-NP I-person
&apos;s NNP I-NP O
office NN I-NP O
for IN B-VP O
a DT B-NP O
follow-up JJ I-NP O
appointment NN I-NP O
and CC O O
wound NN B-NP B-test
check NN I-NP I-test
. . B-VP O
   
She PRP O B-person
is VBZ O O
asked VBN O O
to TO O O
call VB O O
with IN B-VP O
any DT B-NP O
fevers NNS I-NP B-problem
, , O O
chills NNS B-NP B-problem
, , O O
increasing VBG O B-problem
weakness NN B-NP I-problem
or CC O O
numbness NN B-NP B-problem
or CC O O
any DT B-NP O
bowel NN I-NP B-problem
and CC O I-problem
bladder NN B-NP I-problem
disruption NN I-NP I-problem
. . B-VP O
   
DISCHARGE NNP B-NP O
MEDICATIONS NNP I-NP O
: : O O
She PRP O B-person
was VBD B-VP O
discharged VBN O O
on IN B-VP O
the DT B-NP O
following JJ I-NP O
medications NNS I-NP O
. . B-VP O
   
1. CD O O
Colace NNP B-NP B-treatment
, , O O
100 CD O O
mg NN B-NP O
PO NNP I-NP O
bid NN I-NP O
. . B-VP O
   
2. CD O O
Zantac NNP B-NP B-treatment
, , O O
150 CD O O
mg NN B-NP O
PO NNP I-NP O
bid NN I-NP O
. . B-VP O
   
3. CD O O
Percocet NNP B-NP B-treatment
, , O O
5/325 CD O O
, , O O
1-2 JJ B-NP O
tabs NN I-NP O
PO NNP I-NP O
q4-6h JJ B-NP O
prn NN I-NP O
pain NN I-NP B-problem
. . B-VP O
   
4. CD O O
Lipitor NNP B-NP B-treatment
, , O O
10 CD O O
mg NN B-NP O
PO NNP I-NP O
daily RB O O
. . B-VP O
   
5. CD O O
Hydrochlorothiazide NNP B-NP B-treatment
, , O O
25 CD O O
mg NN B-NP O
PO NNP I-NP O
daily RB O O
. . B-VP O
   
6. CD O O
Norvasc NNP B-NP B-treatment
, , O O
5 CD O O
mg NN B-NP O
PO NNP I-NP O
daily RB O O
. . B-VP O
   
LALIND NNP B-NP B-person
KOTE NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
DICTATING NNP I-NP O
FOR NNP I-NP O
: : O O
Electronically RB O O
Signed VBD B-VP O
MIEZETRI NNP B-NP B-person
NIMIRY NNP I-NP I-person
POP NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
08/01/2005 CD O O
18:50 CD O O
_____________________________ NN B-NP O
MIEZETRI NNP I-NP B-person
NIMIRY NNP I-NP I-person
POP NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
TR NNP I-NP O
: : O O
qg NN B-NP O
DD NNP I-NP O
: : O O
07/30/2005 CD O O
TD NN B-NP O
: : O O
07/31/2005 CD O O
9:43 CD O O
A DT O O
123524 CD O O
cc NN B-NP O
: : O O
MIEZETRI NNP B-NP B-person
NIMIRY NNP I-NP I-person
POP NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- VBD B-VP O
747495092 CD O O
CTMC NNP B-NP O
91057356 CD O O
183023 CD O O
7/3/1998 CD O O
12:00:00 CD O O
AM NNP B-NP O
AMPULLARY NNP I-NP B-problem
ADENOCARCINOMA NNP I-NP I-problem
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date NNP I-NP O
: : O O
07/03/1998 CD O O
Report NNP B-NP O
Status NNP I-NP O
: : O O
Signed VBN O O
Discharge NNP B-NP O
Date NNP I-NP O
: : O O
07/10/1998 CD O O
PRINCIPAL NNP B-NP O
DIAGNOSIS NNP I-NP O
: : O O
AMPULLARY NNP B-NP B-problem
ADENOCARCINOMA NNP I-NP I-problem
. . B-VP O
   
HISTORY NNP B-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS NNP I-NP O
: : O O
This DT O B-pronoun
is VBZ O O
a DT O O
50 CD O O
year NN B-NP O
old JJ B-NP O
man NN I-NP O
in IN B-VP O
his PRP$ O B-person
usual JJ B-NP O
state NN I-NP O
of IN B-VP O
health NN B-NP O
until IN B-VP O
two CD O O
weeks NNS B-NP O
prior RB O O
to TO O O
admission NN B-NP O
when WRB O O
the DT B-NP B-person
patient NN I-NP I-person
developed VBD B-VP O
epigastric JJ B-NP B-problem
pain NN I-NP I-problem
after IN B-VP O
meals NNS B-NP O
. . B-VP O
   
The DT B-NP O
next JJ I-NP O
morning NN I-NP O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
felt VBD B-VP O
dizzy NN B-NP B-problem
and CC O O
went VBD B-VP O
to TO O O
his PRP$ O B-person
his PRP$ O B-person
private JJ B-NP I-person
medical JJ I-NP I-person
doctor NN I-NP I-person
at IN B-VP O
Eifro NNP B-NP O
Medical NNP I-NP O
Center NNP I-NP O
, , O O
and CC O O
was VBD B-VP O
found VBN O O
to TO O O
have VB O O
elevated VBN O B-problem
bilirubins NNS B-NP I-problem
, , O I-problem
alkaline JJ B-NP I-problem
phosphatase NN I-NP I-problem
, , O I-problem
and CC O I-problem
transaminases NNS B-NP I-problem
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
reported VBD B-VP O
fatigue JJ O B-problem
and CC O O
nausea NN B-NP B-problem
, , O O
as RB O O
well RB O O
as IN B-VP O
noted VBN O O
coca NN B-NP B-problem
cola NN I-NP I-problem
colored VBD B-VP I-problem
urine JJ O I-problem
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
has VBZ O O
been VBN O O
constipated VBN O B-problem
with IN B-VP O
hard JJ B-NP B-problem
stool NN I-NP I-problem
, , O O
but CC O O
no DT B-NP O
bright JJ I-NP B-problem
red JJ I-NP I-problem
blood NN I-NP I-problem
per IN B-VP I-problem
rectum NN B-NP I-problem
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
also RB O O
reported VBD B-VP O
an DT O B-problem
18 CD O I-problem
lb NN B-NP I-problem
weight NN I-NP I-problem
loss NN I-NP I-problem
over IN B-VP O
the DT B-NP O
last JJ I-NP O
4-5 JJ I-NP O
months NNS I-NP O
. . B-VP O
   
PAST NNP B-NP O
MEDICAL NNP I-NP O
HISTORY NNP I-NP O
: : O O
Significant NNP B-NP O
only RB O O
for IN B-VP O
history NN B-NP O
of IN B-VP O
hypertension NN B-NP B-problem
. . B-VP O
   
PAST JJ B-NP O
SURGICAL JJ I-NP O
HISTORY NN I-NP O
: : O O
None NN B-NP O
. . B-VP O
   
MEDICATIONS NN B-NP O
: : O O
Serax NNP B-NP B-treatment
p.r.n. VBZ O O
insomnia NN B-NP B-problem
; : O O
iron NN B-NP B-treatment
; : O O
MVI NNP B-NP B-treatment
. . B-VP O
   
ALLERGIES NNP B-NP O
: : O O
No DT B-NP O
known JJ I-NP B-problem
drug NN I-NP I-problem
allergies NNS I-NP I-problem
. . B-VP O
   
PHYSICAL JJ B-NP O
EXAMINATION NN I-NP O
: : O O
VITAL JJ B-NP O
SIGNS NN I-NP O
: : O O
BP NNP B-NP B-test
120/80 CD O O
, , O O
temp RB O B-test
96 CD O O
, , O O
pulse RB O B-test
78 CD O O
, , O O
respiratory NN B-NP B-test
rate NN I-NP I-test
18 CD O O
. . B-VP O
   
GENERAL NNP B-NP O
: : O O
No DT B-NP O
acute NN I-NP B-problem
distress NN I-NP I-problem
. . B-VP O
   
SKIN NN B-NP O
: : O O
The DT B-NP O
skin NN I-NP O
is VBZ O O
jaundiced VBN O B-problem
. . B-VP O
   
NODES NNP B-NP O
: : O O
No DT B-NP O
lymph NN I-NP O
nodes RB O O
palpated VBN O O
. . B-VP O
   
HEENT NN B-NP O
: : O O
Notable JJ O O
for IN B-VP O
scleral JJ B-NP B-problem
icterus NN I-NP I-problem
. . B-VP O
   
LUNGS NN B-NP O
: : O O
Clear JJ O O
to TO O O
auscultation VB O B-test
bilaterally RB O I-test
, , O O
no DT B-NP O
wheezes NN I-NP B-problem
, , O O
rales NNS B-NP B-problem
, , O O
or CC O O
rhonchi NN B-NP B-problem
. . B-VP O
   
HEART NN B-NP O
: : O O
Regular JJ B-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
, , O O
no DT B-NP O
murmur NN I-NP B-problem
. . B-VP O
   
ABDOMEN NNP B-NP O
: : O O
Soft JJ O O
, , O O
bowel JJ B-NP O
sounds NNS I-NP O
present JJ O O
, , O O
tenderness JJ B-NP B-problem
present NN I-NP O
in IN B-VP O
epigastrium NN B-NP O
to TO O O
moderate VB O B-test
palpation NN B-NP I-test
. . B-VP O
   
There EX O O
was VBD B-VP O
no DT B-NP O
rebound NN I-NP B-problem
and CC O O
no DT B-NP O
hepatosplenomegaly NN I-NP B-problem
. . B-VP O
   
No DT B-NP O
incisional JJ I-NP B-problem
scars NNS I-NP I-problem
. . B-VP O
   
EXTREMITIES NN B-NP O
: : O O
Warm JJ O O
, , O O
with IN B-VP O
no DT B-NP O
edema NN I-NP B-problem
and CC O O
palpable JJ B-NP O
pulses NNS I-NP O
bilaterally RB O O
. . B-VP O
   
LABORATORY NNP B-NP O
DATA NNP I-NP O
: : O O
Na NNP B-NP B-test
134 CD O O
, , O O
K NNP B-NP B-test
4.2 CD O O
, , O O
Cl NNP B-NP B-test
98 CD O O
, , O O
bicarb NN B-NP B-test
26 CD O O
, , O O
BUN NNP B-NP B-test
11 CD O O
, , O O
creatinine NN B-NP B-test
0.5 CD O O
, , O O
glucose VBD B-VP B-test
119 CD O O
. . B-VP O
   
CBC NNP B-NP B-test
- : O O
White NNP B-NP B-test
count NN I-NP I-test
7.5 CD O O
, , O O
hematocrit NN B-NP B-test
28.5 CD O O
, , O O
platelets NNS B-NP B-test
452 CD O O
. . B-VP O
   
PT VB O B-test
16.2 CD O O
, , O O
PTT NNP B-NP B-test
34.7 CD O O
, , O O
INR NNP B-NP B-test
1.8 CD O O
. . B-VP O
   
LDH VB O B-test
254 CD O O
, , O O
amylase NN B-NP B-test
727 CD O O
, , O O
lipase NN B-NP B-test
8600 CD O O
. . B-VP O
   
HOSPITAL NNP B-NP O
COURSE NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
admitted VBN O O
preoperatively RB O O
for IN B-VP O
surgery NN B-NP B-treatment
on IN B-VP O
7/4/98 CD O O
. . B-VP O
   
The DT O B-person
The DT B-NP B-test
patient JJ I-NP I-person
patient NN I-NP I-test
&apos;s NN I-NP I-test
workup VBD B-VP I-test
up RB O I-test
until IN B-VP O
that DT B-NP B-pronoun
time NN I-NP O
included VBD B-VP O
a DT B-NP O
diagnosis NN I-NP O
of IN B-VP O
periampullary JJ B-NP B-problem
adenocarcinoma NN I-NP I-problem
, , O O
which WDT O B-pronoun
was VBD B-VP O
proven VBN O O
by IN B-VP O
EGD NNP B-NP B-test
directed VBD B-VP I-test
biopsy NN B-NP I-test
, , O O
and CC O O
a DT B-NP B-problem
left JJ I-NP I-problem
renal JJ I-NP I-problem
mass NN I-NP I-problem
, , O O
which WDT O B-pronoun
was VBD B-VP O
biopsied VBN O O
and CC O O
found VBN O O
to TO O O
be VB O O
an DT B-NP B-problem
oncocytoma NN I-NP I-problem
. . B-VP O
   
On IN B-VP O
7/4/98 CD O O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
underwent NN I-NP O
a DT B-NP B-treatment
Whipple JJ I-NP I-treatment
procedure NN I-NP I-treatment
, , O O
which WDT O B-pronoun
proceeded VBD B-VP O
without IN B-VP O
complications NNS B-NP B-problem
. . B-VP O
   
Postoperatively RB O O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
did VBD B-VP O
extremely RB O O
well RB O O
and CC O O
was VBD B-VP O
extubated VBN O O
the DT B-NP O
following JJ I-NP O
morning NN I-NP O
. . B-VP O
   
The DT B-NP B-treatment
NG NNP I-NP I-treatment
tube NN I-NP I-treatment
was VBD B-VP O
D/C&apos;d NNP B-NP O
on IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
#2 NNP I-NP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
to TO O O
be VB O O
transferred VBN O O
to TO O O
the DT B-NP O
floor NN I-NP O
on IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
#2 NNP I-NP O
, , O O
however RB O O
, , O O
due JJ O O
to TO O O
the DT B-NP O
lack NN I-NP O
of IN B-VP O
beds NNS B-NP O
, , O O
he PRP O B-person
remained VBD B-VP O
in IN B-VP O
the DT B-NP O
ICU NNP I-NP O
until IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
#3 NNP I-NP O
. . B-VP O
   
On IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
#4 NNP I-NP O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
began VBD B-VP O
tolerating VBG O O
clear JJ B-NP B-treatment
liquids NNS I-NP I-treatment
and CC O O
his PRP$ O B-person
diet NN B-NP O
was VBD B-VP O
advanced VBN O O
as IN B-VP O
tolerated VBN O O
by IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
#6 NNP I-NP O
and CC O O
7 CD O O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
out IN B-VP O
of IN B-VP O
bed NN B-NP O
, , O O
doing VBG O O
fine JJ O O
, , O O
and CC O O
tolerating VBG O O
a DT B-NP O
regular JJ I-NP O
diet NN I-NP O
on IN B-VP O
7/10/98 CD O O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
is VBZ O O
to TO O O
be VB O O
discharged VBN O O
to TO O O
home NN B-NP O
with IN B-VP O
services NNS B-NP O
and CC O O
in IN B-VP O
stable JJ B-NP O
condition NN I-NP O
. . B-VP O
   
DISCHARGE JJ B-NP O
MEDICATIONS NNP I-NP O
: : O O
Sandostatin NNP B-NP B-treatment
100 CD O O
mcg NN B-NP O
subcu. NN I-NP O
b.i.d. NN I-NP O
; : O O
Percocet NNP B-NP B-treatment
1-2 JJ B-NP O
tabs NNS I-NP O
q.3-4h. JJ B-NP O
p.r.n. NN I-NP O
pain NN I-NP B-problem
; : O O
Axid NNP B-NP B-treatment
150 CD O O
mg NN B-NP O
p.o. NN I-NP O
b.i.d. NN I-NP O
; : O O
Colace NNP B-NP B-treatment
100 CD O O
mg NN B-NP O
p.o. NN I-NP O
b.i.d. NN I-NP O
DISCHARGE NNP I-NP O
FOLLOW-UP NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
has VBZ O O
been VBN O O
instructed VBN O O
to TO O O
follow-up JJ O O
with IN B-VP O
Dr. NNP B-NP B-person
Red NNP I-NP I-person
in IN B-VP O
one CD O O
week NN B-NP O
and CC O O
in IN B-VP O
the DT B-NP O
Urology NNP I-NP O
Clinic NNP I-NP O
in IN B-VP O
three CD O O
weeks NNS B-NP O
. . B-VP O
   
DISCHARGE NNP B-NP O
DISPOSITION NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
is VBZ O O
discharged VBN O O
to TO O O
home VB O O
on IN B-VP O
7/10/98 CD O O
. . B-VP O
   
CONDITION NN B-NP O
ON NNP I-NP O
DISCHARGE NNP I-NP O
: : O O
Stable JJ B-NP O
condition NN I-NP O
. . B-VP O
   
Dictated VBN O O
By IN B-VP O
: : O O
MALICHARLEAR NNP B-NP B-person
KROENER NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
EB85 NNP I-NP O
Attending NNP I-NP B-person
: : O O
LEAND NNP B-NP B-person
L. NNP I-NP I-person
KROENER NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
QW18 NNP I-NP O
FO508/6558 NNP I-NP O
Batch NNP I-NP O
: : O O
54270 CD O O
Index NNP B-NP O
No. NN I-NP O
YCCYST5DG2 NNP I-NP O
D NNP I-NP O
: : O O
07/10/98 CD O O
T NN B-NP O
: : O O
07/12/98 CD O O
CC NN B-NP O
: : O O
1. CD O O
LEAND NNP B-NP B-person
L. NNP I-NP I-person
KROENER NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
Admission NNP I-NP O
Date NNP I-NP O
: : O O
2018-12-29 JJ B-NP O
Discharge NN I-NP O
Date NNP I-NP O
: : O O
2019-01-04 JJ B-NP O
Date NNP I-NP O
of IN B-VP O
Birth NNP B-NP O
: : O O
2018-12-29 JJ B-NP O
Sex NN I-NP O
: : O O
M NNP B-NP O
Service NNP I-NP O
: : O O
Neonatology NNP B-NP B-person
HISTORY NNP I-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS NNP I-NP O
: : O O
Baby NNP B-NP B-person
Davis NNP I-NP I-person
is VBZ O O
the DT B-NP O
3.160 JJ I-NP O
kilogram JJ I-NP O
product NN I-NP O
of IN B-VP O
a DT B-NP O
term NN I-NP O
pregnancy NN I-NP O
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
born VBN O O
to TO O O
a DT O O
38 CD O O
- : O O
year-old JJ B-NP O
gravida NN I-NP O
I PRP O O
, , O O
para RB O O
0 CD O O
( ( O O
now RB O O
1 CD O O
) ) O O
mother NN B-NP B-person
at IN B-VP O
37 CD O O
and CC O O
1/7 CD O O
weeks NNS B-NP O
. . B-VP O
   
The DT B-NP O
pregnancy NN I-NP O
was VBD B-VP O
benign JJ O O
with IN B-VP O
an DT B-NP O
EDC NNP I-NP O
of IN B-VP O
2019-01-18 JJ O O
. . B-VP O
   
Prenatal JJ B-NP B-test
screens NNS I-NP I-test
were VBD B-VP O
O NNP B-NP O
positive JJ O O
, , O O
antibody JJ O B-test
negative JJ O O
, , O O
hepatitis JJ B-NP B-test
surface NN I-NP I-test
antigen NN I-NP I-test
negative JJ O O
, , O O
rapid JJ B-NP B-test
plasma NN I-NP I-test
reagent NN I-NP I-test
nonreactive JJ O O
, , O O
rubella NN B-NP B-test
immune NN I-NP O
, , O O
group NN B-NP B-test
B NNP I-NP I-test
strep NN I-NP I-test
negative NN I-NP O
. . B-VP O
   
The DT B-NP B-person
infant NN I-NP I-person
delivered VBN O O
by IN B-VP O
spontaneous JJ B-NP O
vaginal JJ I-NP O
delivery NN I-NP O
with IN B-VP O
Apgar NNP B-NP B-test
scores NNS I-NP I-test
of IN B-VP O
8 CD O O
at IN B-VP O
one CD O O
minute NN B-NP O
and CC O O
8 CD O O
at IN B-VP O
five CD O O
minutes NNS B-NP O
. . B-VP O
   
PHYSICAL JJ B-NP O
EXAMINATION NN I-NP O
: : O O
On IN B-VP O
admission NN B-NP O
, , O O
the DT B-NP B-person
Baby NNP I-NP I-person
Lucas NNP I-NP I-person
is VBZ O O
well RB O O
appearing VBG O O
, , O O
no DT B-NP O
jaundice NN I-NP B-problem
. . B-VP O
   
He PRP O B-person
has VBZ O O
bilateral JJ B-NP O
breath NN I-NP O
sounds NNS I-NP O
that WDT O B-pronoun
are VBP O O
clear JJ O O
and CC O O
equal JJ O O
. . B-VP O
   
The DT B-NP B-test
heart NN I-NP I-test
rate NN I-NP I-test
is VBZ O O
regular JJ O O
without IN B-VP O
murmur NN B-NP B-problem
. . B-VP O
   
Pulses NNS B-NP B-test
are VBP O O
2+ CD O O
and CC O O
symmetrical JJ O O
. . B-VP O
   
The DT B-NP O
abdomen NNS I-NP O
is VBZ O O
soft JJ O O
and CC O O
nontender NN B-NP B-problem
with IN B-VP O
no DT B-NP O
hepatosplenomegaly NN I-NP B-problem
. . B-VP O
   
His PRP$ O B-person
His PRP$ O B-test
weight NN B-NP I-test
is VBZ O O
3.160 CD O O
kilograms NNS B-NP O
( ( O O
7 CD O O
pounds NNS B-NP O
3 CD O O
ounces NNS B-NP O
) ) O O
at IN B-VP O
birth NN B-NP O
. . B-VP O
   
He PRP O B-person
is VBZ O O
circumcised VBN O O
with IN B-VP O
testes NNS B-NP O
descended VBN O O
bilaterally RB O O
. . B-VP O
   
His PRP$ O B-person
hips NNS B-NP O
are VBP O O
stable JJ O O
. . B-VP O
   
His PRP$ O B-person
tone NN B-NP O
is VBZ O O
normal JJ O O
. . B-VP O
   
Normal JJ B-NP O
neonatal JJ I-NP O
reflexes NNS I-NP O
. . B-VP O
   
He PRP O B-person
is VBZ O O
tolerating VBG O O
his PRP$ O B-person
feedings NNS B-NP O
well RB O O
. . B-VP O
   
HOSPITAL NNP B-NP O
COURSE NNP I-NP O
: : O O
1. CD O O
Respiratory NNP B-NP O
. . B-VP O
   
Without IN B-VP O
issues NNS B-NP O
on IN B-VP O
this DT B-NP B-pronoun
admission NN I-NP O
. . B-VP O
   
Breath NNP B-NP O
sounds NNS I-NP O
are VBP O O
clear JJ O O
and CC O O
equal JJ O O
. . B-VP O
   
2. CD O O
Cardiovascular NNP B-NP O
. . B-VP O
   
Without IN B-VP O
issues NNS B-NP O
on IN B-VP O
this DT B-NP B-pronoun
admission NN I-NP O
. . B-VP O
   
He PRP O B-person
had VBD B-VP O
a DT B-NP O
regular JJ I-NP O
heart NN I-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
, , O O
no DT B-NP O
murmur NN I-NP B-problem
, , O O
pulses NNS B-NP B-test
were VBD B-VP O
2+ CD O O
and CC O O
symmetric JJ O O
. . B-VP O
   
3. CD O O
Fluids NNP B-NP O
, , O O
electrolytes VBZ O O
and CC O O
nutrition NN B-NP O
. . B-VP O
   
The DT O B-test
The DT B-NP B-person
baby NN I-NP I-test
baby NN I-NP I-person
's POS O I-test
weight NN B-NP I-test
was VBD B-VP O
3.160 CD O O
kilograms NNS B-NP O
( ( O O
7 CD O O
pounds NNS B-NP O
3 CD O O
ounces NNS B-NP O
). RB O O
He PRP O B-person
is VBZ O O
breast JJ O O
and CC O O
bottle JJ B-NP O
feeding NN I-NP O
every DT O O
3 CD O O
hours NNS B-NP O
with IN B-VP O
expressed VBN O O
breast NN B-NP O
milk NN I-NP O
and CC O O
/ NN B-NP O
or CC O O
Enfamil NNP B-NP B-treatment
. . B-VP O
   
He PRP O B-person
is VBZ O O
feeding VBG O O
well RB O O
. . B-VP O
   
His PRP$ O B-person
His PRP$ O B-test
discharge NN B-NP I-test
weight NN I-NP I-test
is VBZ O O
3025 CD O O
gm NN B-NP O
, , O O
and CC O O
has VBZ O O
been VBN O O
stable JJ O O
for IN B-VP O
past JJ O O
2 CD O O
days NNS B-NP O
. . B-VP O
   
4. CD O O
Gastrointestinal NNP B-NP O
. . B-VP O
   
The DT O B-person
The DT B-NP B-test
baby NN I-NP I-person
baby NN I-NP I-test
's POS O I-test
bilirubin NN B-NP I-test
on IN B-VP O
2018-12-31 JJ O O
, , O O
was VBD B-VP O
15.5 CD O O
/ JJ O O
0.5 CD O O
at IN B-VP O
which WDT O B-pronoun
time NN B-NP O
double JJ B-NP B-treatment
phototherapy NN I-NP I-treatment
was VBD B-VP O
started VBN O O
. . B-VP O
   
On IN B-VP O
01-01 NN B-NP O
, , O O
his PRP$ O B-person
his PRP$ O B-test
bilirubin NN B-NP I-test
was VBD B-VP O
17.3 CD O O
/ JJ O O
0.4 CD O O
at IN B-VP O
which WDT O B-pronoun
time NN B-NP O
triple NN I-NP B-treatment
phototherapy NN I-NP I-treatment
was VBD B-VP O
started VBN O O
and CC O O
then RB O O
his PRP$ O B-test
his PRP$ O B-person
subsequent NN B-NP I-test
bilirubins NNS I-NP I-test
are VBP O O
16.5 CD O O
/ JJ O O
0.4 CD O O
on IN B-VP O
2019-01-01 JJ O O
, , O O
and CC O O
16.2 CD O O
/ NNS B-NP O
0.5 CD O O
on IN B-VP O
2019-01-02 JJ O O
. . B-VP O
   
Phototherapy NNP B-NP B-treatment
was VBD B-VP O
discontinued VBN O O
on IN B-VP O
2019-01-04 JJ O O
for IN B-VP O
a DT B-NP B-test
bilirubin NN I-NP I-test
of IN B-VP O
12.1 CD O O
, , O O
and CC O O
a DT B-NP B-test
rebound NN I-NP I-test
bilirubin NN I-NP I-test
will MD O O
be VB O O
checked VBN O O
on IN B-VP O
01-05 NN B-NP O
. . B-VP O
   
5. CD O O
Hematology NNP B-NP O
. . B-VP O
   
The DT B-NP B-test
hematocrit NN I-NP I-test
on IN B-VP O
01-02 NN B-NP O
, , O O
was VBD B-VP O
61 CD O O
with IN B-VP O
a DT B-NP B-test
reticulocyte NN I-NP I-test
of IN B-VP O
2.6% CD O O
. . B-VP O
   
His PRP$ O B-person
His PRP$ O B-test
blood NN B-NP I-test
type NN I-NP I-test
is VBZ O O
A+ NNP B-NP O
, , O O
Coombs NNP B-NP B-test
negative JJ O O
. . B-VP O
   
6. CD O O
Infectious JJ B-NP O
disease NN I-NP O
. . B-VP O
   
No DT B-NP O
issues NNS I-NP O
on IN B-VP O
this DT B-NP B-pronoun
admission NN I-NP O
. . B-VP O
   
7. CD O O
Neurological NNP B-NP O
. . B-VP O
   
The DT B-NP B-person
baby NN I-NP I-person
has VBZ O O
been VBN O O
appropriate JJ O O
for IN B-VP O
gestational JJ B-NP O
age NN I-NP O
with IN B-VP O
normal JJ B-NP O
newborn JJ I-NP O
reflexes NNS I-NP O
. . B-VP O
   
8. CD O O
Sensory NNP B-NP O
. . B-VP O
   
Auditory NNP B-NP B-test
hearing VBG O I-test
screening NN B-NP I-test
was VBD B-VP O
performed VBN O O
with IN B-VP O
automated JJ B-NP O
brainstem NN I-NP O
responses NNS I-NP O
. . B-VP O
   
The DT B-NP B-person
infant NN I-NP I-person
passed VBD B-VP O
both DT B-NP O
ears NNS I-NP O
on IN B-VP O
2018-12-30 JJ O O
. . B-VP O
   
9. CD O O
Psychosocial NNP B-NP O
. . B-VP O
   
The DT B-NP O
family NN I-NP O
is VBZ O O
invested VBN O O
and CC O O
involved VBN O O
. . B-VP O
   
CONDITION NNP B-NP O
ON NNP I-NP O
DISCHARGE NNP I-NP O
: : O O
Stable JJ O O
. . B-VP O
   
DISCHARGE JJ B-NP O
DISPOSITION NNP I-NP O
: : O O
Home NN B-NP O
. . B-VP O
   
PRIMARY NNP B-NP O
PEDIATRIC NNP I-NP O
CARE NNP I-NP O
: : O O
Source NN B-NP O
of IN B-VP O
primary JJ B-NP O
pediatric JJ I-NP O
care NN I-NP O
is VBZ O O
David NNP B-NP B-person
Bull NNP I-NP I-person
at IN B-VP O
1899 CD O O
S. NNP B-NP O
Fifth NNP I-NP O
Rd. NNP I-NP O
, , O O
Salem NNP B-NP O
, , O O
Florida NNP B-NP O
92564 CD O O
. . B-VP O
   
Phone NN B-NP O
is VBZ O O
( ( O O
( ( O O
256 CD O O
) ) O O
348-3764 NN B-NP O
. . B-VP O
   
CARE NNP B-NP O
RECOMMENDATIONS NNP I-NP O
: : O O
1. CD O O
Continue NNP B-NP O
breast VBD B-VP O
feeding VBG O O
with IN B-VP O
post-feed JJ B-NP B-treatment
supplemental JJ I-NP I-treatment
EBM NNP I-NP I-treatment
. . B-VP O
   
2. CD O O
Follow-up JJ B-NP B-test
bilirubin NN I-NP I-test
in IN B-VP O
1 CD O O
day NN B-NP O
; : O O
f/u NN B-NP O
with IN B-VP O
PMD NNP B-NP B-person
in IN B-VP O
1-3 JJ B-NP O
days NNS I-NP O
. . B-VP O
   
3. CD O O
Medications NNS B-NP O
: : O O
Not RB O O
applicable JJ O O
. . B-VP O
   
4. CD O O
Car NNP B-NP B-test
seat NN I-NP I-test
position NN I-NP I-test
and CC O I-test
screening NN B-NP I-test
: : O O
Not RB O O
applicable JJ O O
. . B-VP O
   
5. CD O O
State NNP B-NP B-test
newborn JJ B-NP I-test
screens NNS I-NP I-test
were VBD B-VP O
sent VBN O O
on IN B-VP O
2018-12-31 JJ O O
, , O O
and CC O O
the DT B-NP O
results NNS I-NP O
are VBP O O
pending VBG O O
. . B-VP O
   
6. CD O O
Immunizations NNPS B-NP B-treatment
received VBD B-VP O
: : O O
Hepatitis NN B-NP B-treatment
B NNP I-NP I-treatment
vaccine NN I-NP I-treatment
on IN B-VP O
12-31 CD O O
, , O O
2006 CD O O
. . B-VP O
   
7. CD O O
Immunization NN B-NP B-treatment
recommended VBD B-VP O
: : O O
Influenza NNP B-NP B-treatment
immunization NN I-NP I-treatment
is VBZ O O
recommended VBN O O
annually RB O O
in IN B-VP O
the DT B-NP O
fall NN I-NP O
for IN B-VP O
all DT B-NP B-person
infants NNS I-NP I-person
once IN B-VP O
they PRP O B-pronoun
reach VBP O O
6 CD O O
months NNS B-NP O
of IN B-VP O
age NN B-NP O
. . B-VP O
   
Before IN B-VP O
this DT B-NP B-pronoun
age NN I-NP O
( ( O O
and CC O O
for IN B-VP O
the DT O O
first JJ O O
24 CD O O
months NNS B-NP O
of IN B-VP O
the DT B-NP O
child NN I-NP O
's POS O O
life NN B-NP O
) ) O O
, , O O
immunization NN B-NP B-treatment
against IN B-VP O
influenza NN B-NP B-problem
is VBZ O O
recommended VBN O O
for IN B-VP O
all DT B-NP O
household NN I-NP O
contacts NNS I-NP O
and CC O O
out IN B-VP O
of IN B-VP O
home NN B-NP O
caregivers NNS I-NP O
. . B-VP O
   
DISCHARGE NNP B-NP O
DIAGNOSES NNP I-NP O
: : O O
1. CD O O
Term NNP B-NP O
( ( O O
37 CD O O
and CC O O
1/7 CD O O
weeks NNS B-NP O
) ) O O
appropriate VBP O O
for IN B-VP O
gestational JJ B-NP O
age NN I-NP O
male NN I-NP B-person
neonate NN I-NP I-person
. . B-VP O
   
2. CD O O
Exaggerated JJ B-NP B-problem
physiologic JJ I-NP I-problem
hyperbilirubinemia NN I-NP I-problem
responsive NN I-NP O
to TO O O
phototherapy VB O B-treatment
. . B-VP O
   
Nicole NNP B-NP B-person
Monica NNP I-NP I-person
, , O I-person
MD NNP B-NP I-person
48-041 CD O O
Dictated VBN O O
By IN B-VP O
: : O O
Michelle NNP B-NP B-person
A NNP I-NP I-person
Sweeney NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
MEDQUIST36 NNP I-NP O
D NNP I-NP O
: : O O
2019-01-02 JJ O O
12:16:10 CD O O
T NN B-NP O
: : O O
2019-01-02 JJ O O
13:00:35 CD O O
Job NNP B-NP O
# # O O
: : O O
38170 CD O O
Signed VBN O O
electronically RB O O
by IN B-VP O
: : O O
DR. NNP B-NP B-person
Victoria NNP I-NP I-person
Cox NNP I-NP I-person
on IN B-VP O
: : O O
FRI NNP B-NP O
2019-01-04 CD O O
11:25 CD O O
AM NNP B-NP O
( ( O O
End NNP B-NP O
of IN B-VP O
Report NNP B-NP O
) ) O O
-EMPTYLINE- VBP O O
-DOCSTART- JJ O O
-EMPTYLINE- $ O O
332803550 CD O O
PUOMC NNP B-NP O
6548851 CD O O
97371/52b3 CD O O
854510 CD O O
6/22/1993 CD O O
12:00:00 CD O O
AM NNP B-NP O
CHRONIC NNP I-NP B-problem
OBSTRUCTIVE NNP I-NP I-problem
PULMONARY NNP I-NP I-problem
DISEASE NNP I-NP I-problem
Unsigned NNP I-NP O
DIS NNP I-NP O
Report NNP I-NP O
Status NNP I-NP O
: : O O
Unsigned VBN O O
ADMISSION NNP B-NP O
DATE NNP I-NP O
: : O O
06-22-93 JJ B-NP O
DISCHARGE NNP I-NP O
DATE NNP I-NP O
: : O O
06-27-93 JJ B-NP O
PRINCIPAL NNP I-NP O
DIAGNOSIS NNP I-NP O
: : O O
Chronic JJ B-NP B-problem
obstructive JJ I-NP I-problem
pulmonary JJ I-NP I-problem
disease NN I-NP I-problem
ASSOCIATED NNP I-NP O
DIAGNOSES NNP I-NP O
: : O O
Steroid JJ B-NP B-problem
complications NNS I-NP I-problem
, , O O
including VBG O O
cataract NN B-NP B-problem
, , O O
osteoporosis NN B-NP B-problem
, , O O
diffuse NN B-NP B-problem
fibrocystic JJ B-NP I-problem
breast NN I-NP I-problem
disease NN I-NP I-problem
, , O O
trigeminal JJ B-NP B-problem
neuralgia NN I-NP I-problem
. . B-VP O
   
HISTORY NNP B-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS NNP I-NP O
: : O O
Mrs. NNP B-NP B-person
Cast NNP I-NP I-person
is VBZ O O
a DT O O
50 CD O O
year NN B-NP O
old JJ B-NP O
white JJ I-NP O
female NN I-NP O
with IN B-VP O
a DT B-NP O
history NN I-NP O
of IN B-VP O
chronic JJ B-NP B-problem
obstructive JJ I-NP I-problem
pulmonary JJ I-NP I-problem
disease NN I-NP I-problem
and CC O O
evidence NN B-NP O
of IN B-VP O
severe JJ B-NP B-problem
lobular JJ I-NP I-problem
emphysema NN I-NP I-problem
, , O O
who WP O B-person
has VBZ O O
progressive JJ B-NP B-problem
shortness NN I-NP I-problem
of IN B-VP I-problem
breath NN B-NP I-problem
and CC O O
inability NN B-NP O
to TO O O
carry VB O O
on IN B-VP O
with IN B-VP O
activities NNS B-NP O
of IN B-VP O
daily JJ B-NP O
living NN I-NP O
without IN B-VP O
assistance NN B-NP O
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
admitted VBN O O
to TO O O
the DT B-NP O
hospital NN I-NP O
for IN B-VP O
a DT B-NP B-test
pre NN I-NP I-test
lung NN I-NP I-test
transplant JJ B-NP I-test
evaluation NN I-NP I-test
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
has VBZ O O
been VBN O O
steroid JJ B-NP B-problem
dependent NN I-NP I-problem
for IN B-VP O
two CD O O
years NNS B-NP O
and CC O O
has VBZ O O
been VBN O O
intubated VBN O B-treatment
in IN B-VP O
the DT O O
past JJ O O
only RB O O
once RB O O
for IN B-VP O
a DT B-NP B-treatment
surgical JJ I-NP I-treatment
repair NN I-NP I-treatment
of IN B-VP I-treatment
trigeminal JJ B-NP I-treatment
neuralgia NN I-NP I-treatment
. . B-VP O
   
Her PRP$ O B-person
previous JJ B-NP O
occupation NN I-NP O
was VBD B-VP O
an DT B-NP O
executive NN I-NP O
secretary NN I-NP O
, , O O
home NN B-NP O
trainer NN I-NP O
/ NNP I-NP O
nurse NN I-NP O
, , O O
rental JJ B-NP O
aide NN I-NP O
. . B-VP O
   
She PRP O B-person
has VBZ O O
no DT B-NP O
history NN I-NP O
of IN B-VP O
asbestos NN B-NP B-problem
exposure NN I-NP I-problem
or CC O O
tuberculosis NN B-NP B-problem
exposure NN I-NP I-problem
. . B-VP O
   
PAST NNP B-NP O
MEDICAL NNP I-NP O
HISTORY NNP I-NP O
: : O O
Notable JJ O O
for IN B-VP O
a DT B-NP O
history NN I-NP O
of IN B-VP O
trigeminal JJ B-NP B-problem
neuralgia NN I-NP I-problem
, , O O
left VBD B-VP B-treatment
shoulder NN B-NP I-treatment
surgery NN I-NP I-treatment
, , O O
fibrocystic JJ B-NP B-problem
breast NN I-NP I-problem
disease NN I-NP I-problem
, , O O
endometriosis NN B-NP B-problem
and CC O O
status NN B-NP O
post NN I-NP O
total JJ B-NP B-problem
abdominal JJ I-NP I-problem
hysterectomy NN I-NP I-problem
. . B-VP O
   
ALLERGIES CC O O
: : O O
History NN B-NP O
of IN B-VP O
gastrointestinal JJ B-NP B-problem
intolerance NN I-NP I-problem
to TO O O
Tetracycline NNP B-NP B-treatment
, , O O
Erythromycin NNP B-NP B-treatment
, , O O
declomycin NN B-NP B-treatment
associated VBN O O
with IN B-VP O
edema NN B-NP B-problem
and CC O O
rash NN B-NP B-problem
, , O O
Talwin NNP B-NP B-treatment
associated VBN O O
with IN B-VP O
disorientation NN B-NP B-problem
and CC O O
gastrointestinal JJ B-NP B-problem
symptoms NNS I-NP I-problem
, , O O
Dilantin NNP B-NP B-treatment
has VBZ O O
caused VBN O O
rash NN B-NP B-problem
and CC O O
edema NN B-NP B-problem
, , O O
morphine NN B-NP B-treatment
associated VBN O O
with IN B-VP O
itching NN B-NP B-problem
and CC O O
gastrointestinal JJ B-NP B-problem
symptoms NNS I-NP I-problem
, , O O
Demerol NNP B-NP B-treatment
unclear VBP O O
. . B-VP O
   
SOCIAL NNP B-NP O
HISTORY NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
is VBZ O O
a DT B-NP O
divorced JJ I-NP O
mother NN I-NP O
of IN B-VP O
two CD O O
on IN B-VP O
Medicaid NNP B-NP O
. . B-VP O
   
FAMILY NNP B-NP O
HISTORY NNP I-NP O
: : O O
Non NNP B-NP O
contributory NN I-NP O
. . B-VP O
   
PHYSICAL JJ B-NP O
EXAMINATION NN I-NP O
: : O O
Notable JJ O O
for IN B-VP O
her PRP$ O B-person
her PRP$ O B-problem
diffuse NN B-NP I-problem
expiratory NN I-NP I-problem
wheezes NNS I-NP I-problem
and CC O O
scattered JJ B-NP B-problem
expiratory NN I-NP I-problem
crackles NNS I-NP I-problem
. . B-VP O
   
Cranial JJ B-NP O
nerves NNS I-NP O
were VBD B-VP O
intact JJ O O
except IN B-VP O
for IN B-VP O
paresthesias NN B-NP B-problem
on IN B-VP O
the DT B-NP O
left NN I-NP O
in IN B-VP O
the DT B-NP O
VII NNP I-NP O
and CC O O
VIII NNP B-NP O
distribution NN I-NP O
. . B-VP O
   
The DT B-NP O
breasts NNS I-NP O
were VBD B-VP O
notable JJ O O
for IN B-VP O
fibrocystic JJ B-NP B-problem
changes NNS I-NP I-problem
. . B-VP O
   
LABORATORY NNP B-NP O
DATA NNP I-NP O
: : O O
Serum NNP B-NP B-test
sodium NN I-NP I-test
141 CD O O
, , O O
potassium NN B-NP B-test
4.0 CD O O
, , O O
chloride RB O B-test
106 CD O O
, , O O
C02 NNP B-NP B-test
29.6 CD O O
, , O O
calcium NN B-NP B-test
9.2 CD O O
, , O O
phosphorus NN B-NP B-test
3.6 CD O O
. . B-VP O
   
Magnesium NN B-NP B-test
1.7 CD O O
. . B-VP O
   
BUN NNP B-NP B-test
12 CD O O
, , O O
creatinine NN B-NP B-test
0.6 CD O O
, , O O
glucose RB O B-test
92 CD O O
, , O O
uric JJ B-NP B-test
acid NN I-NP I-test
3.3. CD O O
Cholesterol NNP B-NP B-test
236 CD O O
, , O O
triglycerides NNS B-NP B-test
115 CD O O
, , O O
HDL NNP B-NP B-test
99 CD O O
, , O O
LDL NNP B-NP B-test
114 CD O O
, , O O
total JJ B-NP B-test
protein NN I-NP I-test
6.2 CD O O
, , O O
globulin NN B-NP B-test
2.6 CD O O
, , O O
direct JJ B-NP B-test
bilirubin NN I-NP I-test
0 CD O O
, , O O
total JJ B-NP B-test
bilirubin NN I-NP I-test
0.2 CD O O
, , O O
alkaline JJ B-NP B-test
phosphatase NN I-NP I-test
59 CD O O
, , O O
amylase NN B-NP B-test
64 CD O O
, , O O
SGOT NNP B-NP B-test
16 CD O I-test
, , O O
LDH NNP B-NP B-test
141 CD O I-test
, , O O
CPK NNP B-NP B-test
57 CD O O
. . B-VP O
   
The DT B-NP B-test
LH NNP I-NP I-test
was VBD B-VP O
4.9 CD O O
, , O O
FSH NNP B-NP B-test
3.3 CD O O
. . B-VP O
   
TSH NNP B-NP B-test
was VBD B-VP O
124 CD O O
, , O O
cortisol NN B-NP B-test
2.1 CD O O
, , O O
25 CD O B-test
hydroxy NN B-NP I-test
vitamin NN I-NP I-test
D NNP I-NP I-test
, , O I-test
and CC O I-test
125 CD O I-test
dihydroxy JJ B-NP I-test
vitamin NN I-NP I-test
D NNP I-NP I-test
levels NNS I-NP I-test
were VBD B-VP O
pending VBG O O
. . B-VP O
   
Urine NNP B-NP B-test
cotenine JJ B-NP I-test
level NN I-NP O
none NN I-NP O
detected VBN O O
. . B-VP O
   
Estradialol NNP B-NP B-test
pending VBG O O
. . B-VP O
   
White NNP B-NP B-test
blood NN I-NP I-test
count NN I-NP I-test
9.6 CD O O
, , O O
hematocrit NN B-NP B-test
38.8 CD O O
, , O O
platelet NN B-NP B-test
348,000 CD O O
, , O O
mean JJ B-NP B-test
corpuscular JJ I-NP I-test
volume NN I-NP I-test
85 CD O O
and CC O O
86 CD O O
, , O O
MCH NNP B-NP B-test
29 CD O O
, , O O
MCHC NNP B-NP B-test
34 CD O O
. . B-VP O
   
PT VB O B-test
9.5/10.0 CD O O
, , O O
PTT NNP B-NP B-test
23.9 CD O O
. . B-VP O
   
Urinalysis NN B-NP B-test
was VBD B-VP O
normal JJ O O
. . B-VP O
   
Sed NNP B-NP B-test
rate NN I-NP I-test
6 CD O O
. . B-VP O
   
Varicella NNP B-NP B-test
antibody NN I-NP I-test
positive JJ O O
, , O O
CMV NNP B-NP B-test
antibody NN I-NP I-test
positive JJ O O
, , O O
toxo JJ O B-test
negative JJ O O
, , O O
RPR NNP B-NP B-test
non RB O O
reactive VBP O O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
A+ NNP B-NP O
. . B-VP O
   
FEV1 NNP B-NP B-test
0.78 CD O O
liters NNS B-NP O
, , O O
vital JJ B-NP B-test
capacity NN I-NP I-test
2.12 CD O O
liters NNS B-NP O
, , O O
total JJ B-NP B-test
lung NN I-NP I-test
capacity NN I-NP I-test
5.51 CD O O
liters NNS B-NP O
, , O O
single JJ B-NP B-test
breath NN I-NP I-test
DLCO NNP I-NP I-test
5.3 CD O O
( ( O O
25% CD O O
predicted VBN O O
) ) O O
. . B-VP O
   
Cardiopulmonary JJ B-NP B-test
exercise NN I-NP I-test
study NN I-NP I-test
results NNS I-NP O
are VBP O O
pending VBG O O
. . B-VP O
   
Echocardiogram NNP B-NP B-test
showed VBD B-VP O
normal JJ B-NP O
right JJ I-NP O
ventricular NN I-NP O
and CC O O
left VBD B-VP O
ventricular JJ B-NP O
size NN I-NP O
and CC O O
systolic JJ B-NP O
function NN I-NP O
. . B-VP O
   
A DT B-NP B-test
left NN I-NP I-test
and CC O I-test
right JJ B-NP I-test
heart NN I-NP I-test
catheterization NN I-NP I-test
and CC O O
coronary JJ B-NP B-test
angiogram NN I-NP I-test
revealed VBD B-VP O
aortic JJ O B-test
120/70 CD O O
, , O O
mean JJ O B-test
95 CD O O
, , O O
PA NNP B-NP B-test
26/10 CD O O
, , O O
mean JJ O B-test
17 CD O O
, , O O
PC NN B-NP B-test
7 CD O O
, , O O
RV NNP B-NP B-test
26/6 CD O O
, , O O
RA NNP B-NP B-test
4 CD O O
, , O O
cardiac JJ B-NP B-test
output NN I-NP I-test
5.7 CD O O
, , O O
index NN B-NP B-test
3.8 CD O O
. . B-VP O
   
Systemic NNP B-NP B-test
arterial JJ B-NP I-test
resistance NN I-NP I-test
12/81 CD O O
. . B-VP O
   
The DT B-NP B-test
electrocardiogram NN I-NP I-test
showed VBD B-VP O
a DT B-NP B-problem
short JJ I-NP I-problem
PR NNP I-NP I-problem
interval NN I-NP I-problem
with IN B-VP O
no DT B-NP O
delta NN I-NP B-problem
wave NN I-NP I-problem
, , O O
clockwise NN B-NP B-problem
rotation NN I-NP I-problem
present NN I-NP I-problem
. . B-VP O
   
A DT B-NP B-test
quantitative JJ I-NP I-test
VQ NNP I-NP I-test
scan NN I-NP I-test
of IN B-VP O
the DT B-NP O
lung NN I-NP O
showed VBD B-VP O
42% CD O O
ventilation NN B-NP B-test
to TO O I-test
the DT B-NP I-test
left NN I-NP I-test
, , O O
57% CD O O
ventilation NN B-NP B-test
to TO O I-test
the DT B-NP I-test
right NN I-NP I-test
, , O O
42% CD O O
perfusion NN B-NP B-test
to TO O I-test
the DT B-NP I-test
left NN I-NP I-test
, , O O
57% CD O O
perfusion NN B-NP B-test
to TO O I-test
the DT B-NP I-test
right NN I-NP I-test
. . B-VP O
   
Abdominal NNP B-NP B-test
ultrasound NN I-NP I-test
was VBD B-VP O
unremarkable JJ O O
. . B-VP O
   
HIV NNP B-NP B-test
testing VBG O I-test
results NNS B-NP O
pending VBG O O
. . B-VP O
   
Hepatitis NNP B-NP B-test
serologies VBZ O I-test
pending VBG O O
. . B-VP O
   
HOSPITAL NNP B-NP O
COURSE NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
seen VBN O O
in IN B-VP O
consultation NN B-NP O
by IN B-VP O
a DT B-NP O
variety NN I-NP O
of IN B-VP O
consultants NNS B-NP B-person
including VBG O O
Infectious JJ B-NP B-person
Disease NNP I-NP I-person
, , O O
Cardiology NNP B-NP B-person
, , O O
Endocrine NNP B-NP B-person
, , O O
Psychiatry NNP B-NP B-person
, , O O
ENT NNP B-NP B-person
, , O O
and CC O O
Neuro-ophthalmology NNP B-NP B-person
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
noted VBN O O
to TO O O
have VB O O
mild JJ B-NP B-problem
cataracts NNS I-NP I-problem
, , O O
possibly RB O O
due JJ O O
to TO O O
chronic JJ B-NP B-treatment
steroids NNS I-NP I-treatment
, , O O
as RB O O
well RB O O
as IN B-VP O
a DT B-NP B-problem
subtle JJ I-NP I-problem
temporal JJ I-NP I-problem
disc NN I-NP I-problem
pallor NN I-NP I-problem
OD NNP I-NP I-problem
, , O O
possibly RB O O
due JJ O O
to TO O O
previous JJ B-NP O
episode NN I-NP O
of IN B-VP O
optic JJ B-NP B-problem
neuritis NN I-NP I-problem
. . B-VP O
   
No DT B-NP O
acute JJ I-NP B-problem
pathology NN I-NP I-problem
was VBD B-VP O
noted VBN O O
and CC O O
no DT B-NP O
treatment NN I-NP B-problem
was VBD B-VP O
necessary JJ O O
at IN B-VP O
this DT B-NP B-pronoun
time NN I-NP O
. . B-VP O
   
Dr. NNP B-NP B-person
Koteelks NNP I-NP I-person
indicated VBD B-VP O
that IN B-VP B-pronoun
the DT B-NP B-person
patient NN I-NP I-person
did VBD B-VP O
not RB O O
have VB O O
sinus VBN O B-problem
problems NNS B-NP I-problem
currently RB O O
but CC O O
thought VBD B-VP O
that IN B-VP B-pronoun
the DT B-NP B-problem
trigeminal JJ I-NP I-problem
pain NN I-NP I-problem
might MD O O
be VB O O
investigated VBN O O
further RBR O O
and CC O O
that IN B-VP B-pronoun
the DT B-NP B-problem
sphenoid NN I-NP I-problem
might MD O O
account VB O O
for IN B-VP O
some DT O O
of IN B-VP O
the DT O B-person
the DT B-NP B-problem
patient JJ I-NP I-person
patient NN I-NP I-problem
&apos;s NNP I-NP I-problem
discomfort NN I-NP I-problem
. . B-VP O
   
If IN B-VP O
so RB O O
, , O O
he PRP O B-person
considers VBZ O O
the DT B-NP O
possibility NN I-NP O
that IN B-VP B-pronoun
this DT O B-pronoun
could MD O O
be VB O O
opened VBN O O
. . B-VP O
   
This DT O B-pronoun
is VBZ O O
left VBN O O
for IN B-VP O
further RB O O
follow VB O O
up RP O O
as IN B-VP O
an DT B-NP O
outpatient NN I-NP O
. . B-VP O
   
Dr. NNP B-NP B-person
Tikkerth NNP I-NP I-person
felt VBD B-VP O
that IN B-VP B-pronoun
the DT B-NP B-person
patient NN I-NP I-person
had VBD B-VP O
mild JJ B-NP B-problem
adjustment NN I-NP I-problem
related VBN O I-problem
anxiety NN B-NP I-problem
under IN B-VP O
good JJ B-NP O
control NN I-NP O
with IN B-VP O
a DT B-NP O
history NN I-NP O
of IN B-VP O
tobacco NN B-NP O
abuse NN I-NP O
in IN B-VP O
the DT B-NP O
past NN I-NP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
completed VBD B-VP O
the DT B-NP B-test
studies NNS I-NP I-test
and CC O O
to TO O O
be VB O O
informed VBN O O
of IN B-VP O
the DT B-NP O
results NNS I-NP O
as IN B-VP O
an DT B-NP O
outpatient NN I-NP O
. . B-VP O
   
She PRP O B-person
knows VBZ O O
to TO O O
return VB O O
to TO O O
her PRP$ O B-person
her PRP$ O B-person
local JJ B-NP I-person
physician NN I-NP I-person
for IN B-VP O
her PRP$ O B-treatment
her PRP$ O B-person
routine JJ B-NP I-treatment
care NN I-NP I-treatment
with IN B-VP O
her PRP$ O B-person
her PRP$ O B-problem
condition NN B-NP I-problem
unchanged JJ O O
at IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
discharge NN B-NP O
. . B-VP O
   
I PRP O B-person
L. NNP B-NP I-person
STERPSKOLK NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
TR NNP I-NP O
: : O O
bg NN B-NP O
/ NNP I-NP O
bmot NN I-NP O
DD NNP I-NP O
: : O O
09-08-93 JJ B-NP O
TD NN I-NP O
: : O O
09/09/93 CD O O
CC NN B-NP O
: : O O
-EMPTYLINE- JJ B-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
766212923 CD O O
ELMVH NNP B-NP O
70097548 CD O O
1264110 CD O O
11/9/2003 CD O O
12:00:00 CD O O
AM NNP B-NP O
GASTROINTESTINAL NNP I-NP B-problem
BLEEDING NNP I-NP I-problem
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date NNP I-NP O
: : O O
11/09/2003 CD O O
Report NNP B-NP O
Status NNP I-NP O
: : O O
Signed VBN O O
Discharge NNP B-NP O
Date NNP I-NP O
: : O O
11/16/2003 CD O O
ATTENDING NN B-NP B-person
: : O I-person
GROSRIANNE NNP B-NP B-person
SISANDLEE NNP I-NP I-person
JERGJESC NNP I-NP I-person
M.D. NNP I-NP I-person
SERVICE NNP I-NP O
: : O O
GMS NNP B-NP O
1 CD O O
Medical NNP B-NP O
Service NNP I-NP O
. . B-VP O
   
DISCHARGE NNP B-NP O
DIAGNOSIS NNP I-NP O
: : O O
GI NNP B-NP B-problem
bleed NN I-NP I-problem
. . B-VP O
   
DISCHARGE NNP B-NP O
CONDITION NNP I-NP O
: : O O
Stable JJ O O
. . B-VP O
   
HOSPITAL NNP B-NP O
COURSE NNP I-NP O
: : O O
Patient JJ B-NP B-person
&apos;s NNP I-NP O
hospital NN I-NP O
course NN I-NP O
is VBZ O O
as IN B-VP O
follows VBZ O O
: : O O
Patient NN B-NP B-person
is VBZ O O
an DT B-NP O
84-year-old JJ I-NP O
male NN I-NP O
who WP O B-person
was VBD B-VP O
transferred VBN O O
from IN B-VP O
an DT B-NP O
outside JJ I-NP O
hospital NN I-NP O
with IN B-VP O
a DT B-NP B-problem
low JJ I-NP I-problem
hematocrit NN I-NP I-problem
of IN B-VP O
21 CD O O
and CC O O
with IN B-VP O
guaiac-positive JJ B-NP B-problem
stool NN I-NP I-problem
. . B-VP O
   
The DT B-NP O
day NN I-NP O
prior RB O O
to TO O O
admission NN B-NP O
, , O O
he PRP O B-person
experienced VBD B-VP O
dyspnea NN B-NP B-problem
on IN B-VP O
exertion NN B-NP O
, , O O
and CC O O
on IN B-VP O
the DT B-NP O
day NN I-NP O
of IN B-VP O
admission NN B-NP O
he PRP O B-person
collapsed VBD B-VP O
and CC O O
complained VBD B-VP O
of IN B-VP O
substantial JJ B-NP B-problem
weakness NN I-NP I-problem
. . B-VP O
   
He PRP O B-person
denied VBD B-VP O
any DT B-NP B-problem
melana NN I-NP I-problem
, , O O
any DT B-NP B-problem
hematemesis NN I-NP I-problem
, , O O
nausea NN B-NP B-problem
or CC O O
vomiting NN B-NP B-problem
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
taken VBN O O
to TO O O
an DT B-NP O
outside JJ I-NP O
hospital NN I-NP O
at IN B-VP O
the DT B-NP O
time NN I-NP O
at IN B-VP O
which WDT O B-pronoun
time NN B-NP O
it PRP O B-pronoun
was VBD B-VP O
found VBN O O
that IN B-VP B-pronoun
his PRP$ O B-person
his PRP$ O B-test
hematocrit NN B-NP I-test
was VBD B-VP O
21 CD O O
, , O O
blood NN B-NP B-test
pressure NN I-NP I-test
90/60 CD O O
, , O O
and CC O O
his PRP$ O B-test
his PRP$ O B-person
INR NNP B-NP I-test
was VBD B-VP O
3.3 CD O O
. . B-VP O
   
Of IN B-VP O
note NN B-NP O
, , O O
he PRP O B-person
is VBZ O O
anti-coagulated JJ O B-treatment
for IN B-VP O
an DT B-NP B-treatment
artificial JJ I-NP I-treatment
heart NN I-NP I-treatment
valve NN I-NP I-treatment
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
at IN B-VP O
that DT B-NP B-pronoun
point NN I-NP O
given VBN O O
1 CD O B-treatment
unit NN B-NP I-treatment
of IN B-VP I-treatment
packed JJ B-NP I-treatment
red JJ I-NP I-treatment
blood NN I-NP I-treatment
cells NNS I-NP I-treatment
. . B-VP O
   
On IN B-VP O
further JJ B-NP O
questioning NN I-NP O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
reported VBD B-VP O
that IN B-VP B-pronoun
he PRP O B-person
started VBD B-VP O
to TO O O
feel VB O O
&quot; JJ B-NP O
different JJ I-NP O
&quot; JJ I-NP O
several JJ I-NP O
days NNS I-NP O
ago RB O O
with IN B-VP O
slowing VBG O B-problem
and CC O I-problem
difficult JJ B-NP I-problem
ambulation NN I-NP I-problem
progressing VBG O O
to TO O O
complete VB O O
inability NN B-NP O
to TO O O
ambulate VB O O
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
also RB O O
short JJ O B-problem
of IN B-VP I-problem
breath NN B-NP I-problem
with IN B-VP O
ambulation NN B-NP O
, , O O
but CC O O
he PRP O B-person
does VBZ O O
have VB O O
baseline JJ B-NP B-problem
shortness NN I-NP I-problem
of IN B-VP I-problem
breath NN B-NP I-problem
with IN B-VP O
exertion NN B-NP O
. . B-VP O
   
He PRP O B-person
denied VBD B-VP O
any DT B-NP B-problem
chest JJS I-NP I-problem
pain NN I-NP I-problem
, , O O
dysuria NN B-NP B-problem
, , O O
loss NN B-NP B-problem
of IN B-VP I-problem
consciousness NN B-NP I-problem
, , O O
fevers NNS B-NP B-problem
, , O O
chills NNS B-NP B-problem
or CC O O
any DT B-NP O
history NN I-NP O
of IN B-VP O
myocardial JJ B-NP B-problem
infarction NN I-NP I-problem
. . B-VP O
   
Patient NNP B-NP B-person
was VBD B-VP O
last JJ O O
admitted JJ O O
to TO O O
Padrugmoff NNP B-NP O
Hospital NNP I-NP O
with IN B-VP O
a DT B-NP B-test
hematocrit NN I-NP I-test
of IN B-VP O
24.5 CD O O
, , O O
and CC O O
was VBD B-VP O
asymptomatic JJ O B-problem
prior RB O O
to TO O O
admission NN B-NP O
. . B-VP O
   
At IN B-VP O
that DT B-NP B-pronoun
time NN I-NP O
, , O O
he PRP O B-person
had VBD B-VP O
guaiac-positive JJ O B-problem
and CC O O
had VBD B-VP O
a DT B-NP B-test
small JJ I-NP I-test
bowel NN I-NP I-test
follow VBP O I-test
through IN B-VP I-test
which WDT O B-pronoun
was VBD B-VP O
negative JJ O O
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
transfused VBN O O
4 CD O B-treatment
units NNS B-NP I-treatment
during IN B-VP O
that DT B-NP B-pronoun
admission NN I-NP O
and CC O O
discharged VBN O O
with IN B-VP O
a DT B-NP B-test
hematocrit NN I-NP I-test
of IN B-VP O
34 CD O O
on IN B-VP O
vitamin NN B-NP B-treatment
C NNP I-NP I-treatment
and CC O O
iron NN B-NP B-treatment
sulfate NN I-NP I-treatment
. . B-VP O
   
EXAM NNP B-NP O
ON NNP I-NP O
ARRIVAL NNP I-NP O
IN NNP I-NP O
THE NNP I-NP O
LO NNP I-NP O
HOSPITAL NNP I-NP O
EMERGENCY NNP I-NP O
ROOM NNP I-NP O
: : O O
On IN B-VP O
arrival NN B-NP O
at IN B-VP O
the DT B-NP O
Lo NNP I-NP O
Hospital NNP I-NP O
Emergency NNP I-NP O
Room NNP I-NP O
: : O O
He PRP O B-person
was VBD B-VP O
found VBN O O
to TO O O
have VB O O
a DT B-NP B-test
temperature NN I-NP I-test
of IN B-VP O
97.4 CD O O
, , O O
heart NN B-NP B-test
rate NN I-NP I-test
65 CD O O
, , O O
pressure NN B-NP B-test
107/52 CD O O
, , O O
respiratory NN B-NP B-test
rate NN I-NP I-test
22 CD O O
and CC O O
saturating VBG O B-test
100% CD O O
on IN B-VP O
2 CD O O
L NNP B-NP O
of IN B-VP O
a DT B-NP B-treatment
nasal JJ I-NP I-treatment
cannula NN I-NP I-treatment
. . B-VP O
   
General JJ B-NP B-test
exam NN I-NP I-test
at IN B-VP O
the DT B-NP O
time NN I-NP O
was VBD B-VP O
notable JJ O O
for IN B-VP O
pale JJ B-NP B-problem
mucous JJ I-NP I-problem
membranes NNS I-NP I-problem
, , O O
left VBD B-VP B-problem
lateral JJ B-NP I-problem
eye NN I-NP I-problem
deviation NN I-NP I-problem
, , O O
clear JJ B-NP O
lungs NNS I-NP O
, , O O
2/6 CD O B-problem
holosystolic JJ B-NP I-problem
murmur NN I-NP I-problem
, , O O
best JJS B-NP O
heard NN I-NP O
at IN B-VP O
the DT B-NP O
apex NN I-NP O
, , O O
abdomen NNS B-NP O
was VBD B-VP O
mildly RB O B-problem
distended JJ O I-problem
but CC O O
was VBD B-VP O
soft JJ O O
and CC O O
nontender NN B-NP B-problem
and CC O O
his PRP$ O B-person
extremities NNS B-NP O
were VBD B-VP O
without IN B-VP O
edema NN B-NP B-problem
and CC O O
skin NN B-NP O
without IN B-VP O
any DT B-NP B-problem
rashes NNS I-NP I-problem
. . B-VP O
   
PAST NNP B-NP O
MEDICAL NNP I-NP O
HISTORY NNP I-NP O
: : O O
Is VBZ O O
as IN B-VP O
follows VBZ O O
: : O O
History NN B-NP O
of IN B-VP O
coronary JJ B-NP B-problem
artery NN I-NP I-problem
disease NN I-NP I-problem
with IN B-VP O
status NN B-NP O
post NN I-NP O
two-vessel JJ B-NP B-treatment
CABG NNP I-NP I-treatment
in IN B-VP O
1986 CD O O
, , O O
also RB O O
he PRP O B-person
was VBD B-VP O
treated VBN O O
for IN B-VP O
congestive JJ B-NP B-problem
heart NN I-NP I-problem
failure NN I-NP I-problem
, , O O
hypertension NN B-NP B-problem
, , O O
aortic JJ B-NP B-treatment
valve NN I-NP I-treatment
replacement NN I-NP I-treatment
, , O O
and CC O O
mitral JJ B-NP B-treatment
valve NNS I-NP I-treatment
replacement NN I-NP I-treatment
with IN B-VP O
St. NNP B-NP B-treatment
Jude NNP I-NP I-treatment
&apos;s NNP I-NP I-treatment
valve NN I-NP I-treatment
in IN B-VP O
09/2001 CD O O
, , O O
atrial JJ B-NP B-problem
fibrillation NN I-NP I-problem
, , O O
history NN B-NP O
of IN B-VP O
prior JJ B-NP B-problem
GI NNP I-NP I-problem
bleed NN I-NP I-problem
requiring VBG O O
blood NN B-NP B-treatment
transfusions NNS I-NP I-treatment
during IN B-VP O
which WDT O B-pronoun
he PRP O B-person
also RB O O
had VBD B-VP O
a DT B-NP B-test
colonoscopy NN I-NP I-test
on IN B-VP O
05/2003 CD O O
which WDT O B-pronoun
demonstrated VBD B-VP O
no DT B-NP O
neoplasia NN I-NP B-problem
and CC O O
scattered VBD B-VP B-problem
diverticuli NNS B-NP I-problem
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
also RB O O
, , O O
following VBG O O
his PRP$ O B-problem
his PRP$ O B-person
first JJ B-NP I-problem
GI NNP I-NP I-problem
bleed NN I-NP I-problem
, , O O
had VBD B-VP O
an DT B-NP B-test
EEG NNP I-NP I-test
done VBN O O
in IN B-VP O
07/2003 CD O O
which WDT O B-pronoun
showed VBD B-VP O
gastritis NN B-NP B-problem
with IN B-VP O
oozing VBG O B-problem
and CC O O
evidence NN B-NP O
of IN B-VP O
a DT B-NP B-problem
recent JJ I-NP I-problem
bleed NN I-NP I-problem
. . B-VP O
   
ALLERGIES NNP B-NP O
: : O O
No DT B-NP O
known JJ I-NP B-problem
drug NN I-NP I-problem
allergies NNS I-NP I-problem
. . B-VP O
   
MEDICATIONS NN B-NP O
: : O O
Included VBN O O
Lasix NNP B-NP B-treatment
, , O O
Lopressor NNP B-NP B-treatment
, , O O
Coumadin NNP B-NP B-treatment
, , O O
Diovan NNP B-NP B-treatment
, , O O
torsemide NN B-NP B-treatment
, , O O
Flomax NNP B-NP B-treatment
, , O O
Protonix NNP B-NP B-treatment
, , O O
Senekot NNP B-NP B-treatment
, , O O
potassium NN B-NP B-treatment
, , O O
vitamin FW O B-treatment
C NNP B-NP I-treatment
, , O O
iron NN B-NP B-treatment
, , O O
and CC O O
a DT B-NP B-treatment
multivitamin NN I-NP I-treatment
. . B-VP O
   
SOCIAL NNP B-NP O
HISTORY NNP I-NP O
: : O O
Notable JJ O O
for IN B-VP O
no DT B-NP O
tobacco NN I-NP O
, , O O
no DT B-NP O
alcohol NN I-NP O
. . B-VP O
   
He PRP O B-person
has VBZ O O
a DT B-NP B-person
wife NN I-NP I-person
with IN B-VP O
Alzheimer NNP B-NP B-problem
&apos;s NNP I-NP O
who WP O B-person
lives VBZ O O
in IN B-VP O
a DT B-NP O
skilled-nursing JJ I-NP O
facility NN I-NP O
. . B-VP O
   
LABORATORY NNP B-NP O
DATA NNP I-NP O
: : O O
Notable JJ O O
for IN B-VP O
a DT B-NP B-test
BUN NNP I-NP I-test
and CC O O
creatinine NN B-NP B-test
of IN B-VP O
78 CD O O
, , O O
1.7 CD O O
; : O O
for IN B-VP O
a DT B-NP B-test
sodium NN I-NP I-test
, , O O
potassium NN B-NP B-test
139 CD O O
and CC O O
3.6 CD O O
; : O O
chloride NN B-NP B-test
and CC O O
bicarb NN B-NP B-test
108 CD O O
, , O O
21 CD O O
. . B-VP O
   
White NNP B-NP B-test
count NN I-NP I-test
7 CD O O
, , O O
hematocrit NN B-NP B-test
24.2 CD O O
, , O O
platelet NN B-NP B-test
count NN I-NP I-test
was VBD B-VP O
183 CD O O
. . B-VP O
   
His PRP$ O B-person
His PRP$ O B-test
INR NNP B-NP I-test
was VBD B-VP O
also RB O O
3.4 CD O O
. . B-VP O
   
PTT NNP B-NP B-test
was VBD B-VP O
55 CD O O
. . B-VP O
   
His PRP$ O B-person
His PRP$ O B-test
EKG NNP B-NP I-test
was VBD B-VP O
notable JJ O O
for IN B-VP O
right JJ B-NP B-problem
bundle NN I-NP I-problem
branch NN I-NP I-problem
block NN I-NP I-problem
, , O O
left VBD B-VP B-problem
axis JJ B-NP I-problem
deviation NN I-NP I-problem
, , O O
but CC O O
was VBD B-VP O
in IN B-VP O
sinus JJ B-NP O
rhythm NN I-NP O
. . B-VP O
   
His PRP$ O B-person
His PRP$ O B-test
UA NNP B-NP I-test
had VBD B-VP O
10-17 JJ B-NP B-problem
white JJ I-NP I-problem
blood NN I-NP I-problem
cells NNS I-NP I-problem
; : O O
trace NN B-NP B-problem
leukocyte NN I-NP I-problem
esterase NN I-NP I-problem
hyaline NN I-NP B-problem
casts VBZ O I-problem
numbering VBG O O
60-70 JJ O O
. . B-VP O
   
His PRP$ O B-person
His PRP$ O B-test
chest JJS B-NP I-test
x-ray NN I-NP I-test
was VBD B-VP O
notable JJ O O
for IN B-VP O
clear JJ B-NP O
lungs NNS I-NP O
with IN B-VP O
no DT B-NP O
edema NN I-NP B-problem
or CC O O
infiltrates NNS B-NP B-problem
and CC O O
small JJ B-NP B-problem
bilateral JJ I-NP I-problem
effusions NNS I-NP I-problem
. . B-VP O
   
OTHER NNP B-NP O
NOTALBE NNP I-NP O
LABS NNP I-NP O
: : O O
Patient NN B-NP B-person
was VBD B-VP O
found VBN O O
to TO O O
have VB O O
a DT B-NP B-test
troponin NN I-NP I-test
of IN B-VP O
0.71 CD O O
on IN B-VP O
admission NN B-NP O
with IN B-VP O
a DT B-NP B-test
CK NNP I-NP I-test
of IN B-VP O
46 CD O O
and CC O O
CKMB NNP B-NP B-test
of IN B-VP O
3.4 CD O O
. . B-VP O
   
ASSESSMENT NN B-NP O
: : O O
At IN B-VP O
that DT B-NP B-pronoun
time NN I-NP O
, , O O
it PRP O B-pronoun
was VBD B-VP O
felt VBN O O
that IN B-VP B-pronoun
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
likely JJ O O
having VBG O O
a DT B-NP B-problem
repeat NN I-NP I-problem
GI NNP I-NP I-problem
bleed NN I-NP I-problem
and CC O O
while IN B-VP O
he PRP O B-person
was VBD B-VP O
hemodynamically RB O O
stable JJ O O
, , O O
he PRP O B-person
had VBD B-VP O
evidently RB O O
lost VBN O O
a DT B-NP O
substantial JJ I-NP O
amount NN I-NP O
of IN B-VP O
blood NN B-NP O
. . B-VP O
   
HOSPITAL NNP B-NP O
COURSE NNP I-NP O
: : O O
1. CD O O
GI NNP B-NP O
: : O O
Patient NN B-NP B-person
was VBD B-VP O
transfused VBN O O
2 CD O B-treatment
units NNS B-NP I-treatment
of IN B-VP I-treatment
packed JJ B-NP I-treatment
red JJ I-NP I-treatment
blood NN I-NP I-treatment
cells NNS I-NP I-treatment
overnight RB O O
, , O O
the DT B-NP O
first JJ I-NP O
night NN I-NP O
after IN B-VP O
admission NN B-NP O
and CC O O
his PRP$ O B-test
his PRP$ O B-person
hematocrit NN B-NP I-test
bumped VBD B-VP O
up RP O O
appropriately RB O O
. . B-VP O
   
He PRP O B-person
remained VBD B-VP O
hemodynamically RB O O
stable JJ O O
throughout IN B-VP O
his PRP$ O B-person
admission NN B-NP O
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
continued VBN O O
on IN B-VP O
a DT B-NP B-treatment
proton NN I-NP I-treatment
pump NN I-NP I-treatment
inhibitor NN I-NP I-treatment
and CC O O
on IN B-VP O
iron NN B-NP B-treatment
sulfate NN I-NP I-treatment
and CC O O
vitamin NN B-NP B-treatment
C NNP I-NP I-treatment
. . B-VP O
   
His PRP$ O B-treatment
His PRP$ O B-person
Coumadin NNP B-NP I-treatment
was VBD B-VP O
held VBN O O
at IN B-VP O
the DT B-NP O
time NN I-NP O
given VBN O O
the DT B-NP B-problem
bleeding NN I-NP I-problem
, , O O
even RB O O
though IN B-VP O
it PRP O B-pronoun
was VBD B-VP O
important JJ O O
to TO O O
keep VB O O
his PRP$ O B-person
his PRP$ O B-test
INR NNP B-NP I-test
2.5-3.5 CD O O
, , O O
given VBN O O
his PRP$ O B-treatment
his PRP$ O B-person
artificial JJ B-NP I-treatment
valve NN I-NP I-treatment
it PRP O B-pronoun
was VBD B-VP O
felt VBN O O
that IN B-VP B-pronoun
the DT B-NP O
risk NN I-NP O
of IN B-VP O
continued JJ B-NP B-problem
bleeding NN I-NP I-problem
was VBD B-VP O
to TO O O
great JJ O O
to TO O O
continue VB O O
the DT B-NP B-treatment
Coumadin NNP I-NP I-treatment
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
subsequently RB O O
seen VBN O O
by IN B-VP O
the DT B-NP O
GI NNP I-NP B-person
team NN I-NP I-person
who WP O B-person
performed VBD B-VP O
an DT B-NP B-test
upper JJ I-NP I-test
endoscopy NN I-NP I-test
which WDT O B-pronoun
demonstrated VBD B-VP O
the DT B-NP O
following NN I-NP O
: : O O
In IN B-VP O
the DT B-NP O
esophagus NN I-NP O
, , O O
there EX O O
was VBD B-VP O
a DT B-NP B-problem
small JJ I-NP I-problem
hiatal NN I-NP I-problem
hernia NN I-NP I-problem
and CC O O
in IN B-VP O
the DT B-NP O
stomach NN I-NP O
there EX O O
is VBZ O O
evidence NN B-NP O
of IN B-VP O
erosive JJ B-NP B-problem
gastritis NN I-NP I-problem
of IN B-VP I-problem
the DT B-NP I-problem
body NN I-NP I-problem
of IN B-VP O
the DT B-NP O
stomach NN I-NP O
and CC O O
the DT B-NP O
antrum NN I-NP O
, , O O
the DT O O
mucous JJ O O
appeared VBD B-VP O
edematous JJ O B-problem
. . B-VP O
   
A DT B-NP B-problem
small JJ I-NP I-problem
polyp NN I-NP I-problem
was VBD B-VP O
found VBN O O
in IN B-VP O
the DT B-NP O
fundus NN I-NP O
which WDT O B-pronoun
stigmata NN B-NP B-problem
of IN B-VP O
old JJ B-NP B-problem
bleeding NN I-NP I-problem
; : O O
an DT B-NP B-treatment
Endoclip NNP I-NP I-treatment
was VBD B-VP O
applied VBN O O
to TO O O
this DT O B-pronoun
. . B-VP O
   
Another DT B-NP B-problem
polyp NN I-NP I-problem
was VBD B-VP O
found VBN O O
in IN B-VP O
the DT B-NP O
antrum NN I-NP O
and CC O O
cold JJ B-NP B-test
biopsies NNS I-NP I-test
were VBD B-VP O
obtained VBN O O
there RB O O
. . B-VP O
   
In IN B-VP O
the DT B-NP O
duodenum NN I-NP O
, , O O
a DT B-NP B-problem
small JJ I-NP I-problem
AVM NNP I-NP I-problem
was VBD B-VP O
noted VBN O O
in IN B-VP O
the DT B-NP O
second JJ I-NP O
portion NN I-NP O
of IN B-VP O
the DT B-NP O
duodenum NN I-NP O
and CC O O
was VBD B-VP O
cauterized VBN O O
. . B-VP O
   
The DT B-NP B-test
biopsy NN I-NP I-test
subsequently RB O O
demonstrated VBD B-VP O
a DT B-NP B-problem
hyperplastic JJ I-NP I-problem
polyp NN I-NP I-problem
with IN B-VP O
acute NN B-NP B-problem
and CC O I-problem
chronic JJ B-NP I-problem
inflammation NN I-NP I-problem
and CC O O
erosion NN B-NP B-problem
and CC O O
reactive JJ B-NP B-problem
epithelial JJ I-NP I-problem
changes NNS I-NP I-problem
but CC O O
no DT B-NP O
dysplasia NN I-NP B-problem
. . B-VP O
   
Also RB O O
of IN B-VP O
note NN B-NP O
, , O O
prior RB O O
to TO O O
the DT B-NP B-test
upper JJ I-NP I-test
endoscopy NN I-NP I-test
, , O O
the DT B-NP B-person
patient NN I-NP I-person
received VBD B-VP O
fresh JJ B-NP B-treatment
frozen JJ I-NP I-treatment
plasma NN I-NP I-treatment
to TO O O
reverse VB O O
his PRP$ O B-treatment
his PRP$ O B-person
anticoagulation NN B-NP I-treatment
. . B-VP O
   
Patient NNP B-NP B-person
remained VBD B-VP O
hemodynamically RB O O
stable JJ O O
during IN B-VP O
and CC O O
after IN B-VP O
the DT B-NP B-test
upper JJ I-NP I-test
endoscopy NN I-NP I-test
and CC O O
his PRP$ O B-test
his PRP$ O B-person
hematocrit NN B-NP I-test
remained VBD B-VP O
above IN B-VP O
30 CD O O
following VBG O O
this DT O B-pronoun
until IN B-VP O
the DT B-NP O
point NN I-NP O
of IN B-VP O
discharge NN B-NP O
. . B-VP O
   
His PRP$ O B-test
His PRP$ O B-person
last JJ B-NP I-test
recorded JJ I-NP I-test
hematocrit NN I-NP I-test
on IN B-VP O
discharge NN B-NP O
was VBD B-VP O
31.3 CD O O
. . B-VP O
   
His PRP$ O B-person
His PRP$ O B-test
last JJ B-NP I-test
BUN NNP I-NP I-test
and CC O O
creatinine NN B-NP B-test
were VBD B-VP O
42 CD O O
and CC O O
1.5 CD O O
with IN B-VP O
an DT B-NP B-test
INR NNP I-NP I-test
of IN B-VP O
2.5 CD O O
. . B-VP O
   
Consideration NN B-NP O
was VBD B-VP O
given VBN O O
to TO O O
performing VBG O O
a DT B-NP B-test
repeat NN I-NP I-test
colonoscopy NN I-NP I-test
. . B-VP O
   
This DT O B-pronoun
was VBD B-VP O
discussed VBN O O
with IN B-VP O
the DT B-NP O
GI NNP I-NP B-person
Service NNP I-NP I-person
who WP O B-person
felt VBD B-VP O
that IN B-VP B-pronoun
this DT O B-pronoun
was VBD B-VP O
not RB O O
necessary JJ O O
given VBN O O
the DT B-NP B-test
recent JJ I-NP I-test
colonoscopy NN I-NP I-test
that IN B-VP B-pronoun
he PRP O B-person
had VBD B-VP O
had VBN O O
in IN B-VP O
05/2003 CD O O
. . B-VP O
   
2. CD O O
Cardiovascular JJ O O
: : O O
A DT O O
: : O O
Ischemia NN B-NP B-problem
: : O O
Patient JJ B-NP B-person
Patient NNP I-NP B-problem
&apos;s NNP I-NP I-problem
troponin NN I-NP I-problem
bump NN I-NP I-problem
was VBD B-VP O
found VBN O O
to TO O O
be VB O O
likely JJ O O
to TO O O
demand VB O B-problem
ischemia NN B-NP I-problem
in IN B-VP O
the DT B-NP O
setting NN I-NP O
of IN B-VP O
his PRP$ O B-problem
his PRP$ O B-person
GI NNP B-NP I-problem
bleed NN I-NP I-problem
, , O O
it PRP O B-pronoun
was VBD B-VP O
not RB O O
felt VBD B-VP O
that IN B-VP B-pronoun
he PRP O B-person
was VBD B-VP O
having VBG O O
acute JJ B-NP B-problem
coronary JJ I-NP I-problem
syndrome NN I-NP I-problem
. . B-VP O
   
On IN B-VP O
discharge NN B-NP O
, , O O
he PRP O B-person
was VBD B-VP O
continued VBN O O
on IN B-VP O
his PRP$ O B-person
his PRP$ O B-treatment
aspirin NN B-NP I-treatment
, , O O
simvastatin NN B-NP B-treatment
and CC O O
his PRP$ O B-treatment
his PRP$ O B-person
Lopressor NNP B-NP I-treatment
which WDT O B-pronoun
was VBD B-VP O
initially RB O O
held VBN O O
, , O O
and CC O O
subsequently RB O O
restarted VBN O O
. . B-VP O
   
B NN B-NP O
: : O O
Rhythm NN B-NP O
: : O O
Patient NNP B-NP B-person
continued VBD B-VP O
to TO O O
be VB O O
in IN B-VP O
A-fib. NNP B-NP B-problem
throughout IN B-VP O
the DT B-NP O
admission NN I-NP O
and CC O O
was VBD B-VP O
restarted VBN O O
on IN B-VP O
his PRP$ O B-person
his PRP$ O B-treatment
Coumadin NNP B-NP I-treatment
concurrently RB O O
with IN B-VP O
heparin NN B-NP B-treatment
. . B-VP O
   
Heparin NNP B-NP B-treatment
was VBD B-VP O
subsequently RB O O
DCd NNP B-NP O
once RB O O
his PRP$ O B-person
his PRP$ O B-test
INR NNP B-NP I-test
reached VBD B-VP O
a DT B-NP O
therapeutic JJ I-NP O
level NN I-NP O
between IN B-VP O
2.5-3.5 JJ O O
. . B-VP O
   
His PRP$ O B-person
His PRP$ O B-test
last JJ B-NP I-test
reported JJ I-NP I-test
INR NNP I-NP I-test
on IN B-VP O
discharge NN B-NP O
was VBD B-VP O
2.5 CD O O
. . B-VP O
   
C NN B-NP O
: : O O
Valves NNS B-NP B-treatment
: : O O
Patient NN B-NP B-person
had VBD B-VP O
, , O O
as IN B-VP O
noted VBN O O
above IN B-VP O
, , O O
his PRP$ O B-person
his PRP$ O B-treatment
anticoagulation NN B-NP I-treatment
was VBD B-VP O
initially RB O O
reversed VBN O O
despite IN B-VP O
his PRP$ O B-person
having VBG O O
artificial JJ B-NP B-treatment
valves NNS I-NP I-treatment
. . B-VP O
   
However RB O O
, , O O
his PRP$ O B-person
his PRP$ O B-treatment
Coumadin NNP B-NP I-treatment
was VBD B-VP O
subsequently RB O O
restarted VBN O O
and CC O O
he PRP O B-person
achieved VBD B-VP O
therapeutic JJ B-NP O
INR NNP I-NP B-test
levels NNS I-NP I-test
before IN B-VP O
discharge NN B-NP O
. . B-VP O
   
D NN B-NP O
: : O O
Pump NN B-NP O
: : O O
Patient NN B-NP B-person
, , O O
during IN B-VP O
this DT B-NP B-pronoun
hospital JJ I-NP O
course NN I-NP O
, , O O
became VBD B-VP O
hypervolemic JJ O B-problem
likely JJ O O
due JJ O O
to TO O O
his PRP$ O B-person
his PRP$ O B-treatment
diuretics NNS B-NP I-treatment
being VBG O O
held VBN O O
and CC O O
due JJ O O
to TO O O
his PRP$ O B-person
receiving VBG O O
blood NN B-NP B-treatment
products NNS I-NP I-treatment
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
diuresed VBN O O
initially RB O O
with IN B-VP O
one CD O O
dose NN B-NP O
of IN B-VP O
Lasix NNP B-NP B-treatment
and CC O O
subsequently RB O O
with IN B-VP O
one CD O O
dose NN B-NP O
of IN B-VP O
torsemide NN B-NP B-treatment
after IN B-VP O
it PRP O B-pronoun
was VBD B-VP O
discovered VBN O O
that IN B-VP B-pronoun
he PRP O B-person
developed VBD B-VP O
thrombocytopenia VB O B-problem
on IN B-VP O
a DT B-NP O
prior JJ I-NP O
admission NN I-NP O
in IN B-VP O
reaction NN B-NP O
to TO O O
Lasix NNP B-NP B-treatment
. . B-VP O
   
He PRP O B-person
subsequently RB O O
was VBD B-VP O
diuresed VBN O O
to TO O O
a DT B-NP O
euvolemic JJ I-NP O
state NN I-NP O
. . B-VP O
   
Of IN B-VP O
note NN B-NP O
, , O O
he PRP O B-person
did VBD B-VP O
not RB O O
become VB O O
thrombocytopenic JJ O B-problem
on IN B-VP O
this DT B-NP B-pronoun
admission NN I-NP O
. . B-VP O
   
DISPOSITION NN B-NP O
: : O O
Was NNP B-NP O
discharged VBN O O
on IN B-VP O
11/16/2003 CD O O
in IN B-VP O
stable JJ B-NP O
condition NN I-NP O
with IN B-VP O
the DT B-NP B-test
last JJ I-NP I-test
recorded JJ I-NP I-test
hematocrit NN I-NP I-test
of IN B-VP O
31.3 CD O O
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
asked VBN O O
to TO O O
continue VB O O
on IN B-VP O
his PRP$ O B-person
his PRP$ O B-treatment
Nexium NN B-NP I-treatment
, , O O
iron NN B-NP B-treatment
and CC O O
vitamin NN B-NP B-treatment
C NNP I-NP I-treatment
and CC O O
was VBD B-VP O
continued VBN O O
on IN B-VP O
his PRP$ O B-person
his PRP$ O B-treatment
other JJ B-NP I-treatment
home NN I-NP I-treatment
medications NNS I-NP I-treatment
. . B-VP O
   
DISCHARGE NNP B-NP O
MEDICATIONS NNP I-NP O
: : O O
His PRP$ O B-person
His PRP$ O B-treatment
final JJ B-NP I-treatment
medications NNS I-NP I-treatment
on IN B-VP O
discharge NN B-NP O
were VBD B-VP O
as IN B-VP O
follows VBZ O O
: : O O
Aspirin NNP B-NP B-treatment
325 CD O O
, , O O
he PRP O B-person
was VBD B-VP O
restarted VBN O O
on IN B-VP O
a DT B-NP B-treatment
PPI NNP I-NP I-treatment
, , O O
also RB O O
on IN B-VP O
iron NN B-NP B-treatment
, , O O
vitamin FW O B-treatment
C NNP B-NP I-treatment
, , O O
Lopressor NNP B-NP B-treatment
12.5 CD O O
b.i.d NN B-NP O
. . B-VP O
   
Of IN B-VP O
note NN B-NP O
, , O O
this DT O B-pronoun
was VBD B-VP O
at IN B-VP O
a DT B-NP O
decreased JJ I-NP O
dose NN I-NP O
compared VBN O O
to TO O O
that DT O B-pronoun
which WDT O B-pronoun
he PRP O B-person
came VBD B-VP O
in IN B-VP O
on IN B-VP O
, , O O
Coumadin NNP B-NP B-treatment
7.5 CD O O
, , O O
mg NN B-NP O
, , O O
torsemide RB O B-treatment
100 CD O O
q.d. NN B-NP O
, , O O
sucralfate NN B-NP B-treatment
, , O O
simvastatin NN B-NP B-treatment
, , O O
Diovan NNP B-NP B-treatment
. . B-VP O
   
CONDITION NNP B-NP O
ON NNP I-NP O
DISCHARGE NNP I-NP O
: : O O
He PRP O B-person
was VBD B-VP O
discharged VBN O O
in IN B-VP O
stable JJ B-NP O
condition NN I-NP O
with IN B-VP O
instructions NNS B-NP O
to TO O O
follow VB O O
up RP O O
with IN B-VP O
his PRP$ O B-person
his PRP$ O B-person
PCP NN B-NP I-person
as RB O O
well RB O O
as IN B-VP O
to TO O O
follow VB O O
up RP O O
with IN B-VP O
the DT B-NP O
Anticoagulation NNP I-NP O
Clinic NNP I-NP O
and CC O O
Dr. NNP B-NP B-person
Gilbert NNP I-NP I-person
. . B-VP O
   
eScription NN B-NP O
document NN I-NP O
: : O O
4-9918752 JJ B-NP O
IEEHttd NNP I-NP O
Tel NNP I-NP O
Dictated VBN O O
By IN B-VP O
: : O O
NETPEAKE NNP B-NP B-person
, , O I-person
SHIRLH NNP B-NP I-person
Attending NNP I-NP B-person
: : O O
JERGJESC NNP B-NP B-person
, , O I-person
GROSRIANNE NNP B-NP I-person
SISANDLEE NNP I-NP I-person
Dictation NNP I-NP O
ID NNP I-NP O
4535172 CD O O
D NNP B-NP O
: : O O
12/22/03 CD O O
T NN B-NP O
: : O O
12/22/03 CD O O
-EMPTYLINE- NN B-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
Admission NNP I-NP O
Date NNP I-NP O
: : O O
2017-05-14 JJ B-NP O
Discharge NN I-NP O
Date NNP I-NP O
: : O O
2017-06-26 JJ B-NP O
Date NNP I-NP O
of IN B-VP O
Birth NNP B-NP O
: : O O
2017-05-14 JJ B-NP O
Sex NN I-NP O
: : O O
F NNP B-NP O
Service NNP I-NP O
: : O O
CMED NNP B-NP O
CCU NNP I-NP O
HISTORY NNP I-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS NNP I-NP O
: : O O
Jadiara NNP B-NP B-person
Harrison NNP I-NP I-person
is VBZ O O
twin JJ B-NP B-person
#1 NNP I-NP I-person
born NN I-NP O
to TO O O
a DT O O
17 CD O O
year-old JJ B-NP O
primiparous JJ I-NP O
mother NN I-NP B-person
at IN B-VP O
31 CD O O
weeks NNS B-NP O
gestation NN I-NP O
. . B-VP O
   
Mother NNP B-NP B-person
was VBD B-VP O
admitted VBN O O
to TO O O
the DT B-NP O
Nantucket NNP I-NP O
Cottage NNP I-NP O
Hospital NNP I-NP O
from IN B-VP O
Lawrence NNP B-NP O
General NNP I-NP O
Hospital NNP I-NP O
Hospital NNP I-NP O
on IN B-VP O
05-01 JJ O O
with IN B-VP O
cervical JJ B-NP O
effacement NN I-NP O
and CC O O
preterm JJ B-NP B-problem
labor NN I-NP I-problem
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
treated VBN O O
with IN B-VP O
magnesium NN B-NP B-treatment
sulfate NN I-NP I-treatment
. . B-VP O
   
She PRP O B-person
had VBD B-VP O
previously RB O O
been VBN O O
admitted VBN O O
here RB O O
at IN B-VP O
the DT O O
24th CD O O
week NN B-NP O
after IN B-VP O
a DT B-NP O
motor NN I-NP O
vehicle NN I-NP O
accident. IN B-VP O
She PRP O B-person
was VBD B-VP O
treated VBN O O
with IN B-VP O
tocolysis NN B-NP B-treatment
and CC O O
betamethasone NN B-NP B-treatment
at IN B-VP O
that DT B-NP B-pronoun
time NN I-NP O
. . B-VP O
   
Due JJ O O
to TO O O
progressing VBG O O
labor NN B-NP O
and CC O O
presentation NN B-NP O
of IN B-VP O
twins NNS B-NP B-person
, , O O
delivery NN B-NP O
was VBD B-VP O
by IN B-VP O
Cesarean JJ B-NP B-treatment
section NN I-NP I-treatment
. . B-VP O
   
Prenatal JJ B-NP B-test
screens NNS I-NP I-test
were VBD B-VP O
notable JJ O O
for IN B-VP O
blood NN B-NP B-test
type NN I-NP I-test
0 CD O O
positive JJ O O
, , O O
antibody JJ O B-test
negative JJ O O
, , O O
hepatitis NN B-NP B-test
B NNP I-NP I-test
surface NN I-NP I-test
antigen NN I-NP I-test
negative JJ O O
, , O O
RPR NNP B-NP B-test
nonreactive NN I-NP O
. . B-VP O
   
Rubella NN B-NP B-test
status NN I-NP I-test
was VBD B-VP O
not RB O O
documented VBN O O
. . B-VP O
   
Group NNP B-NP B-test
B NNP I-NP I-test
strep NN I-NP I-test
status NN I-NP I-test
was VBD B-VP O
unknown JJ O O
. . B-VP O
   
Infant NNP B-NP B-person
emerged VBD B-VP O
from IN B-VP O
the DT B-NP B-problem
breech JJ I-NP I-problem
position NN I-NP I-problem
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
vigorous JJ O O
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
given VBN O O
blow-by JJ B-NP B-treatment
oxygen NN I-NP I-treatment
and CC O O
stimulation NN B-NP B-treatment
. . B-VP O
   
Her PRP$ O B-person
Her PRP$ O B-test
Apgars NNP B-NP I-test
were VBD B-VP O
7 CD O O
at IN B-VP O
1 CD O O
minute NN B-NP O
and CC O O
9 CD O O
at IN B-VP O
5 CD O O
minutes NNS B-NP O
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
brought VBN O O
to TO O O
the DT B-NP O
CMED NNP I-NP O
CSRU NNP I-NP O
for IN B-VP O
further JJ B-NP B-test
evaluation NN I-NP I-test
. . B-VP O
   
PHYSICAL JJ B-NP O
EXAMINATION NN I-NP O
: : O O
ON JJ B-NP O
admission NN I-NP O
, , O O
physical JJ B-NP B-test
examination NN I-NP I-test
reveals VBZ O O
a DT B-NP B-problem
non JJ I-NP I-problem
dysmorphic JJ I-NP I-problem
infant NN I-NP I-problem
, , O O
well RB O O
saturated VBN O O
and CC O O
perfused VBN O O
with IN B-VP O
multiple JJ B-NP B-problem
bruises NNS I-NP I-problem
noted VBD B-VP O
over IN B-VP O
the DT B-NP O
upper JJ I-NP O
legs NN I-NP O
, , O O
left VBD B-VP O
arm NN B-NP O
and CC O O
chest NN B-NP O
. . B-VP O
   
No DT B-NP O
bony NN I-NP B-problem
abnormalities VBZ O I-problem
or CC O O
petechiae NN B-NP B-problem
noted VBN O O
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
moving VBG O O
all DT B-NP O
joints NNS I-NP O
and CC O O
extremities NNS B-NP O
well RB O O
. . B-VP O
   
HEENT NN B-NP O
: : O O
Within IN B-VP O
normal JJ B-NP O
limits NNS I-NP O
. . B-VP O
   
CV NN B-NP O
: : O O
Normal JJ B-NP O
S1 NNP I-NP O
and CC O O
S2 NNP B-NP O
without IN B-VP O
a DT B-NP B-problem
murmur NN I-NP I-problem
. . B-VP O
   
Lungs NNS B-NP O
were VBD B-VP O
clear JJ O O
. . B-VP O
   
Abdomen NNP B-NP O
was VBD B-VP O
benign JJ O O
. . B-VP O
   
Genitalia NNP B-NP O
normal JJ O O
. . B-VP O
   
Premature JJ B-NP B-person
female NN I-NP I-person
. . B-VP O
   
Neuro CC O O
: : O O
Non NNP B-NP O
focal JJ O O
and CC O O
age NN B-NP O
appropriate NN I-NP O
. . B-VP O
   
Hips NNP B-NP O
normal JJ O O
, , O O
held VBD B-VP O
in IN B-VP O
the DT B-NP O
breech JJ I-NP O
position NN I-NP O
. . B-VP O
   
Anus NNP B-NP O
patent NN I-NP O
. . B-VP O
   
Spine NNP B-NP O
intact JJ O O
. . B-VP O
   
HOSPITAL NNP B-NP O
COURSE NNP I-NP O
: : O O
Respiratory NN B-NP O
: : O O
On IN B-VP O
admission NN B-NP O
, , O O
infant NN B-NP B-person
did VBD B-VP O
not RB O O
require VB O O
supplemental JJ B-NP B-treatment
oxygen NN I-NP I-treatment
or CC O O
respiratory JJ B-NP B-treatment
support NN I-NP I-treatment
. . B-VP O
   
Since IN B-VP O
that DT B-NP B-pronoun
time NN I-NP O
, , O O
Jadiara NNP B-NP B-person
has VBZ O O
always RB O O
been VBN O O
in IN B-VP O
room NN B-NP O
air NN I-NP O
without IN B-VP O
requiring VBG O O
supplemental JJ B-NP B-treatment
oxygen NN I-NP I-treatment
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
noted VBN O O
to TO O O
have VB O O
apnea NN B-NP B-problem
of IN B-VP I-problem
prematurity NN B-NP I-problem
, , O O
treated VBN O O
with IN B-VP O
caffeine NN B-NP B-treatment
until IN B-VP O
2017-06-04 JJ O O
. . B-VP O
   
Since IN B-VP O
that DT B-NP B-pronoun
time NN I-NP O
, , O O
she PRP O B-person
has VBZ O O
had VBN O O
very RB O B-problem
rare JJ B-NP I-problem
spells NNS I-NP I-problem
, , O O
with IN B-VP O
none NN B-NP O
for IN B-VP O
over IN B-VP O
one CD O O
week NN B-NP O
by IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
discharge NN B-NP O
. . B-VP O
   
Cardiovascular NN B-NP O
: : O O
She PRP O B-person
was VBD B-VP O
hemodynamically RB O O
stable JJ O O
upon IN B-VP O
admission NN B-NP O
with IN B-VP O
normal JJ B-NP O
blood NN I-NP O
pressures NNS I-NP O
and CC O O
heart NN B-NP O
rate NN I-NP O
. . B-VP O
   
On IN B-VP O
day NN B-NP O
of IN B-VP O
life NN B-NP O
15 CD O O
, , O O
she PRP O B-person
was VBD B-VP O
noted VBN O O
to TO O O
have VB O O
a DT B-NP B-problem
murmur NN I-NP I-problem
, , O O
eventually RB O O
prompting VBG O O
evaluation NN B-NP B-test
by IN B-VP I-test
ECHO NNP B-NP I-test
. . B-VP O
   
The DT B-NP B-test
ECHO NNP I-NP I-test
revealed VBD B-VP O
an DT B-NP B-problem
anomalous JJ I-NP I-problem
left NN I-NP I-problem
coronary NN I-NP I-problem
, , O O
with IN B-VP O
one CD O O
end NN B-NP O
entering VBG O O
the DT B-NP O
right JJ I-NP O
ventricular NN I-NP O
outflow IN B-VP O
tract NN B-NP O
and CC O O
the DT B-NP O
other JJ I-NP O
end NN I-NP O
not RB O O
clearly RB O O
defined VBN O O
. . B-VP O
   
It PRP O B-pronoun
was VBD B-VP O
unable JJ O O
to TO O O
be VB O O
delineated VBN O O
whether IN B-VP O
this DT O B-pronoun
represented VBD B-VP O
an DT O B-problem
anomalous JJ O I-problem
left VBD B-VP I-problem
coronary JJ B-NP I-problem
artery NN I-NP I-problem
arising VBG O I-problem
from IN B-VP I-problem
the DT B-NP I-problem
pulmonary JJ I-NP I-problem
artery NN I-NP I-problem
( ( O I-problem
LCAPA NNP B-NP I-problem
) ) O I-problem
or CC O O
a DT B-NP B-problem
left JJ I-NP I-problem
coronary JJ I-NP I-problem
artery NN I-NP I-problem
fistula NN I-NP I-problem
to TO O I-problem
the DT B-NP I-problem
pulmonar NN I-NP I-problem
artery NN I-NP I-problem
. . B-VP O
   
The DT B-NP O
right JJ I-NP O
coronary NN I-NP O
was VBD B-VP O
prominent JJ O O
, , O O
and CC O O
there RB O O
appeared VBD B-VP O
to TO O O
be VB O O
coronary JJ B-NP B-problem
artery NN I-NP I-problem
collateral NN I-NP I-problem
vessels NNS I-NP I-problem
in IN B-VP I-problem
the DT B-NP I-problem
posterior JJ I-NP I-problem
apical JJ I-NP I-problem
myocardium NN I-NP I-problem
. . B-VP O
   
A DT B-NP B-problem
small JJ I-NP I-problem
apical JJ I-NP I-problem
muscular NN I-NP I-problem
VSD NNP I-NP I-problem
was VBD B-VP O
also RB O O
noted VBN O O
. . B-VP O
   
Several JJ B-NP B-test
additional JJ I-NP I-test
ECHOs NNP I-NP I-test
were VBD B-VP O
performed VBN O O
, , O O
including VBG O O
an DT B-NP B-test
ECHO NN I-NP I-test
in IN B-VP O
the DT B-NP O
cardiology NN I-NP O
department NN I-NP O
at IN B-VP O
HealthSouth NNP B-NP O
Rehab NNP I-NP O
Hospital NNP I-NP O
of IN B-VP O
Western NNP B-NP O
Mass. NNP I-NP O
, , O O
but CC O O
the DT B-NP O
anatomy NN I-NP O
of IN B-VP O
the DT B-NP O
left JJ I-NP O
coronary JJ I-NP O
artery NN I-NP O
could MD O O
not RB O O
be VB O O
further RB O O
defined VBN O O
. . B-VP O
   
Due JJ O O
to TO O O
the DT B-NP O
risks NNS I-NP O
of IN B-VP O
coronary JJ B-NP B-problem
ischemia NN I-NP I-problem
if IN B-VP O
this DT O B-pronoun
represented VBD B-VP O
an DT B-NP B-problem
LCAPA NNP I-NP I-problem
, , O O
the DT B-NP B-person
infant NN I-NP I-person
was VBD B-VP O
followed VBN O O
with IN B-VP O
regular JJ B-NP B-test
ECHOs NNP I-NP I-test
and CC O O
EKGs NNP B-NP B-test
during IN B-VP O
the DT B-NP O
remainder NN I-NP O
of IN B-VP O
hospitalization NN B-NP O
, , O O
with IN B-VP O
no DT B-NP O
evidence NN I-NP O
of IN B-VP O
ischemia NN B-NP B-problem
, , O O
valvular JJ B-NP B-problem
regurgitation NN I-NP I-problem
, , O O
or CC O O
compromised VBD B-VP B-problem
ventricular JJ B-NP I-problem
function NN I-NP I-problem
. . B-VP O
   
She PRP O B-person
will MD O O
be VB O O
continued VBN O O
to TO O O
be VB O O
followed VBN O O
closely RB O O
by IN B-VP O
cardiology NN B-NP B-person
as IN B-VP O
an DT B-NP O
outpatient NN I-NP O
, , O O
with IN B-VP O
likely JJ B-NP O
plans NNS I-NP O
for IN B-VP O
cardiac JJ B-NP B-test
catheterization NN I-NP I-test
and CC O O
surgical JJ B-NP B-treatment
repair NN I-NP I-treatment
when WRB O O
she PRP O B-person
grows VBZ O O
to TO O O
3.5 CD O O
to TO O O
4 CD O O
kg NN B-NP O
. . B-VP O
   
Fluids NNP B-NP O
, , O O
electrolytes VBZ O O
and CC O O
nutrition NN B-NP O
: : O O
The DT B-NP B-person
infant NN I-NP I-person
was VBD B-VP O
initially RB O O
maintained VBN O O
on IN B-VP O
IVF NNP B-NP B-treatment
, , O O
with IN B-VP O
introduction NN B-NP O
of IN B-VP O
enteral JJ B-NP B-treatment
feeds NNS I-NP I-treatment
on IN B-VP O
day NN B-NP O
of IN B-VP O
life NN B-NP O
2 CD O O
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
advanced VBN O O
to TO O O
full JJ B-NP B-treatment
volume NN I-NP I-treatment
enteral JJ B-NP I-treatment
feeds NNS I-NP I-treatment
by IN B-VP O
day NN B-NP O
of IN B-VP O
life NN B-NP O
7 CD O O
, , O O
and CC O O
then RB O O
to TO O O
a DT B-NP O
maximum JJ I-NP O
caloric JJ I-NP O
density NN I-NP O
of IN B-VP O
28 CD O O
cals NNS B-NP O
/ JJ B-NP O
oz NN I-NP O
. . B-VP O
   
Oral JJ B-NP O
feedings NNS I-NP O
were VBD B-VP O
introduced VBN O O
as IN B-VP O
tolerated VBN O O
. . B-VP O
   
By IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
discharge NN B-NP O
, , O O
infant NN B-NP B-person
is VBZ O O
feedign JJ B-NP O
BM NNP I-NP O
or CC O O
enfamil VB O B-treatment
24 CD O O
cals NNS B-NP O
/ JJ B-NP O
oz JJ I-NP O
PO NNP I-NP O
ad NN I-NP O
lib NN I-NP O
, , O O
with IN B-VP O
adequate JJ B-NP O
intake NN I-NP O
and CC O O
adequate JJ B-NP O
weight NN I-NP O
gain NN I-NP O
. . B-VP O
   
Last JJ B-NP B-test
nutrition NN I-NP I-test
labs NNS I-NP I-test
were VBD B-VP O
on IN B-VP O
06-20 JJ O O
with IN B-VP O
AP NNP B-NP B-test
of IN B-VP O
208 CD O O
, , O O
Ca NNP B-NP B-test
10.8 CD O O
, , O O
and CC O O
Phos NNP B-NP B-test
7.4. CD O O
Gastrointestinal NNP B-NP O
: : O O
The DT B-NP B-person
infant NN I-NP I-person
required VBN O O
phototherapy NN B-NP B-treatment
for IN B-VP O
hyperbilirubinemia NN B-NP B-problem
through IN B-VP O
day NN B-NP O
of IN B-VP O
life NN B-NP O
7 CD O O
, , O O
with IN B-VP O
peak JJ B-NP B-test
bilirubin NN I-NP I-test
of IN B-VP O
7 CD O O
/ JJ O O
0.3 CD O O
on IN B-VP O
day NN B-NP O
of IN B-VP O
life NN B-NP O
3 CD O O
, , O O
and CC O O
last JJ B-NP B-test
bilirubin NN I-NP I-test
of IN B-VP O
4.9 CD O O
/ JJ O O
0.3 CD O O
on IN B-VP O
day NN B-NP O
of IN B-VP O
life NN B-NP O
9 CD O O
. . B-VP O
   
Hematologic NNP B-NP O
/ NNP I-NP O
Infectious NNP I-NP O
disease NN I-NP O
: : O O
CBC NNP B-NP B-test
and CC O O
blood NN B-NP B-test
culture NN I-NP I-test
were VBD B-VP O
obtained VBN O O
upon IN B-VP O
admission NN B-NP O
revealing VBG O O
a DT B-NP B-test
white JJ I-NP I-test
blood NN I-NP I-test
cell NN I-NP I-test
count NN I-NP I-test
of IN B-VP O
9.0 CD O O
with IN B-VP O
25 CD O B-test
polys NNS B-NP I-test
and CC O O
0 CD O B-test
bands NNS B-NP I-test
; : O O
hematocrit NN B-NP B-test
was VBD B-VP O
46.9% CD O O
and CC O O
platelets NNS B-NP B-test
of IN B-VP O
222,000 CD O O
. . B-VP O
   
Baby NNP B-NP B-person
received VBD B-VP O
48 CD O O
hours NNS B-NP O
of IN B-VP O
Ampicillin NNP B-NP B-treatment
and CC O O
Gentamycin NNP B-NP B-treatment
with IN B-VP O
negative JJ B-NP O
cultures NNS I-NP O
and CC O O
a DT B-NP O
stable JJ I-NP O
clinical JJ I-NP O
course NN I-NP O
. . B-VP O
   
Infant NNP B-NP B-person
was VBD B-VP O
treated VBN O O
with IN B-VP O
supplemental JJ B-NP B-treatment
iron NN I-NP I-treatment
, , O O
and CC O O
did VBD B-VP O
not RB O O
receive VB O O
any DT B-NP B-treatment
blood NN I-NP I-treatment
transfusions NNS I-NP I-treatment
. . B-VP O
   
Last JJ B-NP B-test
Hct NNP I-NP I-test
was VBD B-VP O
30.6 CD O O
on IN B-VP O
06-20 NN B-NP O
with IN B-VP O
a DT B-NP B-test
reticulocyte NN I-NP I-test
count NN I-NP I-test
of IN B-VP O
6.5%. CD O O
Neurologic NNP B-NP O
: : O O
Baby NNP B-NP B-person
has VBZ O O
been VBN O O
appropriate JJ O O
for IN B-VP O
gestational JJ B-NP O
age NN I-NP O
. . B-VP O
   
Social JJ O O
: : O O
Mother NN B-NP B-person
is VBZ O O
17 CD O O
years NNS B-NP O
old JJ O O
, , O O
and CC O O
has VBZ O O
been VBN O O
accompanied VBN O O
on IN B-VP O
the DT B-NP O
majority NN I-NP O
of IN B-VP O
her PRP$ O B-person
visits NNS B-NP O
by IN B-VP O
her PRP$ O B-person
her PRP$ O B-person
parents NNS B-NP I-person
, , O O
both DT O B-person
of IN B-VP O
whom WP O O
are VBP O O
students NNS B-NP O
. . B-VP O
   
The DT O B-person
The DT B-NP B-person
infant JJ I-NP I-person
infant NN I-NP I-person
's POS O I-person
maternal JJ B-NP I-person
grandparents NNS I-NP I-person
have VBP O O
been VBN O O
very RB O O
involved JJ O O
in IN B-VP O
her PRP$ O B-person
care NN B-NP O
. . B-VP O
   
Sensory NN B-NP O
: : O O
Initial JJ B-NP B-test
opthalmologic JJ I-NP I-test
exam NN I-NP I-test
on IN B-VP O
06-05 NN B-NP O
revealed VBN O O
immature NN B-NP B-problem
retinas NN I-NP I-problem
in IN B-VP O
zone NN B-NP O
3 CD O O
, , O O
and CC O O
repeat NN B-NP B-test
exam NN I-NP I-test
on IN B-VP O
06-26 JJ B-NP O
revealed JJ I-NP O
mature NN I-NP O
retinas VBZ O O
bilaterally RB O O
. . B-VP O
   
Infant NNP B-NP B-person
passed VBD B-VP O
hearing VBG O B-test
screen NN B-NP I-test
prior RB O O
to TO O O
discharge VB O O
. . B-VP O
   
CONDITION NNP B-NP O
ON NNP I-NP O
DISCHARGE NNP I-NP O
: : O O
Good JJ O O
. . B-VP O
   
DISCHARGE NNP B-NP O
DISPOSITION NNP I-NP O
: : O O
To TO O O
home NN B-NP O
. . B-VP O
   
PRIMARY NNP B-NP B-person
PEDIATRICIAN NNP I-NP I-person
: : O O
Dr. NNP B-NP B-person
Robinson NNP I-NP I-person
, , O O
Lawrence NNP B-NP O
General NNP I-NP O
Hospital NNP I-NP O
Hospital NNP I-NP O
Pediatrics NNP I-NP O
, , O O
4952 CD O O
Washington NNP B-NP O
St. NNP I-NP O
in IN B-VP O
Dr. NNP B-NP O
John NNP I-NP O
C. NNP I-NP O
Corrigan NNP I-NP O
Mental NNP I-NP O
Health NNP I-NP O
Center NNP I-NP O
. . B-VP O
   
( ( O O
589 CD O O
) ) O O
690-3703 NN B-NP O
. . B-VP O
   
CARE NNP B-NP O
RECOMMENDATIONS NNP I-NP O
: : O O
Diet JJ O O
: : O O
Enfamil NN B-NP B-treatment
or CC O O
breast NN B-NP O
milk NN I-NP O
24 CD O O
calories NNS B-NP O
per IN B-VP O
oz NN B-NP O
, , O O
with IN B-VP O
enfamil JJ B-NP O
powder NN I-NP O
. . B-VP O
   
Medications NNS B-NP O
: : O O
Ferinsol NNP B-NP B-treatment
0.2 CD O O
mL NN B-NP O
po NN I-NP O
qd NN I-NP O
. . B-VP O
   
Newborn CC O B-test
screen NN B-NP I-test
: : O O
Sent NN B-NP O
as IN B-VP O
per IN B-VP O
protocol; NN B-NP O
one CD O B-test
specimen NN B-NP I-test
from IN B-VP O
2017-05-28 JJ O O
returned VBN O O
with IN B-VP O
borderline NN B-NP B-problem
low JJ B-NP I-problem
thyroxine NN I-NP I-problem
, , O O
but CC O O
repeat NN B-NP B-test
was VBD B-VP O
within IN B-VP O
normal JJ B-NP O
limits NNS I-NP O
. . B-VP O
   
Immunizations NNS B-NP B-treatment
: : O O
Hepatitis NN B-NP B-treatment
B NNP I-NP I-treatment
vaccine NN I-NP I-treatment
given VBN O O
06-17 NNP B-NP O
. . B-VP O
   
Car NNP B-NP O
seat NN I-NP O
: : O O
Car NN B-NP B-test
seat NN I-NP I-test
safety NN I-NP I-test
screening VBG O I-test
passed VBN O O
prior RB O O
to TO O O
discharge VB O O
. . B-VP O
   
Follow-up NN B-NP O
: : O O
Infant NN B-NP B-person
will MD O O
follow-up VB O O
with IN B-VP O
primary JJ B-NP B-person
pediatrician NN I-NP I-person
within IN B-VP O
2 CD O O
days NNS B-NP O
of IN B-VP O
discharge NN B-NP O
, , O O
and CC O O
will MD O O
see VB O O
Dr. NNP B-NP B-person
Dale NNP I-NP I-person
Merkel NNP I-NP I-person
of IN B-VP O
Pediatric NNP B-NP O
Cardiology NNP I-NP O
in IN B-VP O
Dr. NNP B-NP B-person
John NNP I-NP I-person
C. NNP I-NP I-person
Corrigan NNP I-NP I-person
Mental NNP I-NP O
Health NNP I-NP O
Center NNP I-NP O
on IN B-VP O
2017-07-07 JJ O O
at IN B-VP O
1:30 CD O O
pm NN B-NP O
. . B-VP O
   
Due NNP B-NP O
to TO O O
breech VB O B-problem
presentation NN B-NP I-problem
, , O O
a DT B-NP B-test
hip NN I-NP I-test
ultrasound NN I-NP I-test
can MD O O
be VB O O
considered VBN O O
in IN B-VP O
2-4 JJ B-NP O
weeks NNS I-NP O
. . B-VP O
   
DISCHARGE NNP B-NP O
DIAGNOSES NNP I-NP O
: : O O
1. CD O O
Prematurity NN B-NP B-problem
at IN B-VP O
31 CD O O
weeks NNS B-NP O
, , O O
twin JJ B-NP B-person
#1 NNP I-NP I-person
. . B-VP O
   
2. CD O O
Breech NNP B-NP B-problem
presentation NN I-NP I-problem
. . B-VP O
   
3. CD O O
Sepsis NNP B-NP B-problem
suspect NN I-NP O
ruled VBD B-VP O
out RP O O
with IN B-VP O
antibiotics NNS B-NP B-treatment
. . B-VP O
   
4. CD O O
Physiologic NNP B-NP B-problem
jaundice NN I-NP I-problem
. . B-VP O
   
5. CD O O
Apnea NNP B-NP B-problem
of IN B-VP I-problem
prematurity NN B-NP I-problem
. . B-VP O
   
6. CD O O
Anemia NNP B-NP B-problem
of IN B-VP I-problem
prematurity NN B-NP I-problem
. . B-VP O
   
7. CD O O
Aberrant JJ O B-problem
left VBD B-VP I-problem
coronary JJ B-NP I-problem
artery NN I-NP I-problem
. . B-VP O
   
8. CD O O
Muscular JJ B-NP B-problem
ventricular JJ I-NP I-problem
septal NN I-NP I-problem
defect NN I-NP I-problem
. . B-VP O
   
Lisa NNP B-NP B-person
Annie NNP I-NP I-person
, , O I-person
MD NNP B-NP I-person
50ABQ CD O O
Dictated VBN O O
By IN B-VP O
: : O O
Ehtel NNP B-NP B-person
Z NNP I-NP I-person
Ebert NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
MEDQUIST36 NNP I-NP O
D NNP I-NP O
: : O O
2017-06-02 JJ O O
03:49:08 CD O O
T NN B-NP O
: : O O
2017-06-02 JJ O O
05:32:26 CD O O
Job NNP B-NP O
# # O O
: : O O
12559 CD O O
Signed VBN O O
electronically RB O O
by IN B-VP O
: : O O
DR. NNP B-NP B-person
Ann NNP I-NP I-person
Nguyen NNP I-NP I-person
on IN B-VP O
: : O O
TUE NNP B-NP O
2017-06-27 CD O O
8:40 CD O O
AM NNP B-NP O
( ( O O
End NNP B-NP O
of IN B-VP O
Report NNP B-NP O
) ) O O
-EMPTYLINE- VBP O O
-DOCSTART- JJ O O
-EMPTYLINE- $ O O
388755206 CD O O
SC NNP B-NP O
28741969 CD O O
9895112 CD O O
12/1/2003 CD O O
12:00:00 CD O O
AM NNP B-NP O
s JJ B-NP O
/ NNP I-NP O
p NN I-NP O
cesarean NN I-NP B-treatment
DIS NNP I-NP O
Admission NNP I-NP O
Date NNP I-NP O
: : O O
12/01/2003 CD O O
Report NNP B-NP O
Status NNP I-NP O
: : O O
Discharge NN B-NP O
Date NNP I-NP O
: : O O
12/06/2003 CD O O
****** NN B-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
STENOBE NNP I-NP B-person
, , O I-person
LANDEM NNP B-NP I-person
847-02-84-0 JJ B-NP O
J73 NNP I-NP O
Room NNP I-NP O
: : O O
GHA74-9086 JJ B-NP O
Service NNP I-NP O
: : O O
OBS NNP B-NP O
DISCHARGE NNP I-NP O
PATIENT NNP I-NP B-person
ON NNP I-NP O
: : O O
12/06/03 CD O O
AT NNP B-NP O
10:00 CD O O
AM NNP B-NP O
CONTINGENT NNP I-NP O
UPON NNP I-NP O
Attending NNP I-NP B-test
evaluation NN I-NP I-test
WILL NNP I-NP O
D NNP I-NP O
/ NNP I-NP O
C NNP I-NP O
ORDER NNP I-NP O
BE NNP I-NP O
USED NNP I-NP O
AS IN B-VP O
THE NNP B-NP O
D NNP I-NP O
/ NNP I-NP O
C NNP I-NP O
SUMMARY NNP I-NP O
: : O O
YES JJ B-NP O
Attending NN I-NP B-person
: : O O
CLOZPLU NNP B-NP B-person
, , O I-person
A NNP B-NP I-person
A NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
DISPOSITION NNP I-NP O
: : O O
Home NNP B-NP O
DISCHARGE NNP I-NP O
MEDICATIONS NNP I-NP O
: : O O
COLACE NNP B-NP B-treatment
( ( O I-treatment
DOCUSATE NNP B-NP I-treatment
SODIUM NNP I-NP I-treatment
) ) O I-treatment
100 CD O O
MG NNP B-NP O
PO NNP I-NP O
BID NNP I-NP O
IBUPROFEN NNP I-NP B-treatment
600 CD O O
MG NNP B-NP O
PO NNP I-NP O
Q6H NNP I-NP O
PRN NNP I-NP O
PAIN NNP I-NP O
ALDOMET NNP I-NP B-treatment
( ( O I-treatment
METHYLDOPA NNP B-NP I-treatment
) ) O I-treatment
250 CD O O
MG NNP B-NP O
PO NNP I-NP O
BID NNP I-NP O
PERCOCET NNP I-NP B-treatment
1-2 JJ B-NP O
TAB NNP I-NP O
PO NNP I-NP O
Q4H NNP I-NP O
PRN NNP I-NP O
PAIN NNP I-NP B-problem
DIET NNP I-NP O
: : O O
No DT B-NP O
Restrictions NNP I-NP O
ACTIVITY NNP I-NP O
: : O O
Resume NNP B-NP O
regular JJ B-NP O
exercise NN I-NP O
FOLLOW NNP I-NP O
UP NNP I-NP O
APPOINTMENT NNP I-NP O
( ( O O
S NNP B-NP O
) ) O O
: : O O
Your PRP$ O B-person
Your PRP$ O B-person
obstetrician JJ O I-person
6 CD O O
weeks NNS B-NP O
, , O O
No NNP B-NP O
Known NNP I-NP B-problem
Allergies NNP I-NP I-problem
ADMIT NNP I-NP O
DIAGNOSIS NNP I-NP O
: : O O
s NN B-NP O
/ NNP I-NP O
p NN I-NP O
cesarean NN I-NP B-treatment
PRINCIPAL NNP I-NP O
DISCHARGE NNP I-NP O
DIAGNOSIS NNP I-NP O
; : O O
Responsible NNP B-NP O
After IN B-VP O
Study NNP B-NP O
for IN B-VP O
Causing NNP B-NP O
Admission NNP I-NP O
) ) O O
s VBD B-VP O
/ JJ B-NP O
p JJ I-NP O
cesarean NN I-NP B-treatment
OTHER NNP I-NP O
DIAGNOSIS NNP I-NP O
; : O O
Conditions NNP B-NP O
, , O O
Infections NNP B-NP O
, , O O
Complications NNP B-NP O
, , O O
affecting VBG O O
Treatment NNP B-NP O
/ NNP I-NP O
Stay NNP I-NP O
s RB O O
/ VBZ O O
p JJ B-NP O
cesarean JJ I-NP B-treatment
OPERATIONS NNP I-NP O
AND NNP I-NP O
PROCEDURES NNP I-NP O
: : O O
Primary JJ B-NP O
Anesthesia NN I-NP O
: : O O
Epidural JJ B-NP B-treatment
Vaginal JJ I-NP O
delivery NN I-NP O
: : O O
Undelivered VBN O O
Cesarean JJ B-NP O
Status NNP I-NP O
: : O O
Primary JJ B-NP O
Urgency NN I-NP O
: : O O
Emergent JJ B-NP O
Indications NNS I-NP O
: : O O
Non-reassuring JJ B-NP B-problem
fetal JJ I-NP I-problem
status NN I-NP I-problem
, , O O
Uterine NNP B-NP O
incision NN I-NP O
type NN I-NP O
: : O O
Transverse JJ B-NP O
Placenta NNP I-NP O
: : O O
Delivery NN B-NP O
: : O O
Manual JJ B-NP O
Condition NN I-NP O
: : O O
Normal JJ B-NP O
Staff NNP I-NP O
Obstetrician NNP I-NP B-person
( ( O O
supervising VBG O O
) ) O O
: : O O
CLOZPLU NNP B-NP B-person
, , O I-person
A NNP B-NP I-person
A NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
Delivery NNP I-NP O
OTHER NNP I-NP O
TREATMENTS NNP I-NP O
/ NNP I-NP O
PROCEDURES NNP I-NP O
( ( O O
NOT NNP B-NP O
IN NNP I-NP O
O.R. NNP I-NP O
) ) O O
IV NNP B-NP B-treatment
ABX NNP I-NP I-treatment
BRIEF NNP I-NP O
RESUME NNP I-NP O
OF NNP I-NP O
HOSPITAL NNP I-NP O
COURSE NNP I-NP O
: : O O
G9 NNP B-NP O
T3 NNP I-NP O
P0 NNP I-NP O
A5 NNP I-NP O
L3 NNP I-NP O
Estimated VBD B-VP O
EDC NNP B-NP O
: : O O
11/28/03 CD O O
Indications NNS B-NP O
for IN B-VP O
induction NN B-NP O
: : O O
Post NN B-NP B-problem
dates NNS I-NP I-problem
Complications NNP I-NP O
of IN B-VP O
labor NN B-NP O
: : O O
, , O O
Other JJ O O
- : O O
bradycardia JJ B-NP B-problem
Maternal NNP I-NP O
transfer NN I-NP O
: : O O
No DT B-NP O
Initial NNP I-NP O
newborn JJ B-NP O
exam NN I-NP O
: : O O
No DT B-NP O
observed JJ I-NP B-problem
abnormalities NNS I-NP I-problem
Baby NNP I-NP B-person
1 CD O I-person
MRN NNP B-NP O
: : O O
32859272 CD O O
Delivery NN B-NP O
date NN I-NP O
: : O O
12/02/03 CD O O
03:20 CD O O
PM NNP B-NP O
Apgars NNP I-NP B-test
7,8 CD O O
Weight NNP B-NP B-test
: : O O
9lb CD O O
15 CD O O
oz NN B-NP O
4508 CD O O
grams NNS B-NP O
Sex NN I-NP O
: : O O
Male JJ B-NP O
ADDITIONAL NNP I-NP O
COMMENTS NNP I-NP O
: : O O
no DT B-NP O
heavy JJ I-NP O
lifting NN I-NP O
; : O O
nothing NN B-NP O
in IN B-VP O
the DT B-NP O
vagina NN I-NP O
for IN B-VP O
6 CD O O
weeks NNS B-NP O
-- : O O
no DT B-NP O
intercourse NN I-NP O
, , O O
no DT B-NP O
douching NN I-NP O
, , O O
no DT B-NP O
tampons NNS I-NP O
; : O O
call VB O O
for IN B-VP O
fever NN B-NP B-problem
above IN B-VP I-problem
100.5 CD O I-problem
, , O O
worsening VBG O B-problem
abdominal JJ B-NP I-problem
pain NN I-NP I-problem
, , O O
heavy JJ B-NP B-problem
bleeding NN I-NP I-problem
, , O O
or CC O O
any DT B-NP B-problem
other JJ I-NP I-problem
concern NN I-NP I-problem
; : O O
no DT O O
driving VBG O O
while IN B-VP O
taking VBG O O
percocet JJ B-NP B-treatment
DISCHARGE NNP I-NP O
CONDITION NNP I-NP O
: : O O
Stable JJ B-NP O
TO NNP I-NP O
DO NNP I-NP O
/ NNP I-NP O
PLAN NNP I-NP O
: : O O
No DT B-NP O
dictated JJ I-NP O
summary NN I-NP O
ENTERED NN I-NP O
BY NNP I-NP O
: : O O
HAXKOTE NNP B-NP B-person
, , O I-person
A NNP B-NP I-person
N. NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
( ( O O
ZL69 NNP B-NP O
) ) O O
12/06/03 CD O O
09:04 CD O O
AM NNP B-NP O
****** JJ B-NP O
END NN I-NP O
OF NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- VBD B-VP O
044687343 CD O O
ELMVH NNP B-NP O
01719921 CD O O
1626859 CD O O
3/13/2006 CD O O
12:00:00 CD O O
AM NNP B-NP O
COPD NNP I-NP B-problem
flare NN I-NP I-problem
DIS NNP I-NP O
Admission NNP I-NP O
Date NNP I-NP O
: : O O
03/13/2006 CD O O
Report NNP B-NP O
Status NNP I-NP O
: : O O
Discharge NN B-NP O
Date NNP I-NP O
: : O O
03/19/2006 CD O O
****** NNP B-NP O
FINAL NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
FREIERMLINKENEIGHCAABLINFARST NNP I-NP B-person
, , O I-person
ANEA NNP B-NP I-person
770-09-54-2 CD O O
O32 NNP B-NP O
Room NNP I-NP O
: : O O
39K-128 JJ B-NP O
Service NNP I-NP O
: : O O
MED NNP B-NP O
DISCHARGE NNP I-NP O
PATIENT NNP I-NP B-person
ON NNP I-NP O
: : O O
03/19/06 CD O O
AT NNP B-NP O
01:00 CD O O
PM NNP B-NP O
CONTINGENT NNP I-NP O
UPON NNP I-NP O
Not RB O O
Applicable NNP B-NP O
WILL NNP I-NP O
D NNP I-NP O
/ NNP I-NP O
C NNP I-NP O
ORDER NNP I-NP O
BE NNP I-NP O
USED NNP I-NP O
AS IN B-VP O
THE NNP B-NP O
D NNP I-NP O
/ NNP I-NP O
C NNP I-NP O
SUMMARY NNP I-NP O
: : O O
YES JJ B-NP O
Attending NN I-NP B-person
: : O O
ALBFYFEAYLES NNP B-NP B-person
, , O I-person
LORRE NNP B-NP I-person
EZO NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
CODE NNP I-NP O
STATUS NNP I-NP O
: : O O
Full NNP B-NP O
code NN I-NP O
DISPOSITION NNP I-NP O
: : O O
Villeflardsbroo NNP B-NP O
Ands NNP I-NP O
Tho NNP I-NP O
Cardhako NNP I-NP O
General NNP I-NP O
Hospital NNP I-NP O
DISCHARGE NNP I-NP O
MEDICATIONS NNP I-NP O
: : O O
ACETYLSALICYLIC NNP B-NP B-treatment
ACID NNP I-NP I-treatment
81 CD O O
MG NNP B-NP O
PO NNP I-NP O
DAILY NNP I-NP O
ALBUTEROL NNP I-NP B-treatment
NEBULIZER NNP I-NP I-treatment
2.5 CD O O
MG NNP B-NP O
NEB NNP I-NP O
Q4H NNP I-NP O
Starting VBG O O
Today NNP B-NP O
( ( O O
03/17 CD O O
) ) O O
PRN NNP B-NP O
Shortness NNP I-NP B-problem
of IN B-VP I-problem
Breath NNP B-NP I-problem
LISINOPRIL NNP I-NP B-treatment
10 CD O O
MG NNP B-NP O
PO NNP I-NP O
DAILY NNP I-NP O
NIFEREX-150 NNP I-NP B-treatment
150 CD O O
MG NNP B-NP O
PO NNP I-NP O
BID NNP I-NP O
PREDNISONE NNP I-NP B-treatment
Taper NNP I-NP I-treatment
PO NNP I-NP I-treatment
Give NNP I-NP O
50 CD O O
mg NN B-NP O
q NN I-NP O
24 CD O O
h NN B-NP O
X NNP I-NP O
1 CD O O
dose NN B-NP O
( ( O O
s NN B-NP O
) ) O O
, , O O
then RB O O
Give VB O O
40 CD O O
mg NN B-NP O
q NN I-NP O
24 CD O O
h NN B-NP O
X NNP I-NP O
1 CD O O
dose NN B-NP O
( ( O O
s NN B-NP O
) ) O O
, , O O
then RB O O
Give VB O O
30 CD O O
mg NN B-NP O
q NN I-NP O
24 CD O O
h NN B-NP O
X NNP I-NP O
1 CD O O
dose NN B-NP O
( ( O O
s NN B-NP O
) ) O O
, , O O
then RB O O
Give VB O O
20 CD O O
mg NN B-NP O
q NN I-NP O
24 CD O O
h NN B-NP O
X NNP I-NP O
1 CD O O
dose NN B-NP O
( ( O O
s NN B-NP O
) ) O O
, , O O
then RB O O
Give VB O O
10 CD O O
mg NN B-NP O
q NN I-NP O
24 CD O O
h NN B-NP O
X NNP I-NP O
1 CD O O
dose NN B-NP O
( ( O O
s NN B-NP O
) ) O O
, , O O
then RB O O
Starting VBG O O
Today NNP B-NP O
( ( O O
03/17 CD O O
) ) O O
CLARITIN NNP B-NP B-treatment
( ( O I-treatment
LORATADINE NNP B-NP I-treatment
) ) O I-treatment
10 CD O O
MG NNP B-NP O
PO NNP I-NP O
DAILY NNP I-NP O
Food NNP I-NP O
/ NNP I-NP O
Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Avoid NNP I-NP O
grapefruit NN I-NP O
unless IN B-VP O
MD NNP B-NP B-person
instructs NNS I-NP O
otherwise RB O O
. . B-VP O
   
Give VB O O
on IN B-VP O
an DT B-NP O
empty JJ I-NP O
stomach NN I-NP O
( ( O O
give JJ O O
1hr CD O O
before IN B-VP O
or CC O O
2hr CD O O
after IN B-VP O
food NN B-NP O
) ) O O
SINGULAIR NNP B-NP B-treatment
( ( O I-treatment
MONTELUKAST NNP B-NP I-treatment
) ) O I-treatment
10 CD O O
MG NNP B-NP O
PO NNP I-NP O
BEDTIME NNP I-NP O
ADVAIR NNP I-NP B-treatment
DISKUS NNP I-NP I-treatment
500/50 CD O I-treatment
( ( O I-treatment
FLUTICASONE NNP B-NP I-treatment
PROPIONATE/... NNP I-NP I-treatment
) ) O I-treatment
1 CD O O
PUFF NNP B-NP O
INH NNP I-NP O
BID NNP I-NP O
CALTRATE NNP I-NP B-treatment
+ NNP I-NP I-treatment
D NNP I-NP I-treatment
1 CD O O
TAB NNP B-NP O
PO NNP I-NP O
BID NNP I-NP O
LANTUS NNP I-NP B-treatment
( ( O I-treatment
INSULIN NNP B-NP I-treatment
GLARGINE NNP I-NP I-treatment
) ) O I-treatment
35 CD O O
UNITS NNP B-NP O
SC NNP I-NP O
QAM NNP I-NP O
DUONEB NNP I-NP B-treatment
( ( O I-treatment
ALBUTEROL NNP B-NP I-treatment
AND NNP I-NP I-treatment
IPRATROPIUM NNP I-NP I-treatment
NEBULIZER NNP I-NP I-treatment
) ) O I-treatment
3/0.5 CD O O
MG NNP B-NP O
NEB NNP I-NP O
Q6H NNP I-NP O
Starting VBG O O
Today NNP B-NP O
( ( O O
03/17 CD O O
) ) O O
PRN NNP B-NP O
Shortness NNP I-NP B-problem
of IN B-VP I-problem
Breath NNP B-NP I-problem
, , O O
Wheezing NNP B-NP B-problem
NOVOLOG NNP I-NP B-treatment
( ( O I-treatment
INSULIN NNP B-NP I-treatment
ASPART NNP I-NP I-treatment
) ) O I-treatment
4 CD O O
UNITS NNP B-NP O
SC NNP I-NP O
AC NNP I-NP O
Instructions NNS I-NP O
: : O O
standing VBG O B-treatment
pre-meal JJ B-NP I-treatment
novolog NN I-NP I-treatment
. . B-VP O
   
give VB O O
when WRB O O
patient NN B-NP B-person
will MD O O
eat VB O O
and CC O O
food NN B-NP O
is VBZ O O
in IN B-VP O
the DT B-NP O
room NN I-NP O
. . B-VP O
   
NOVOLOG NNP B-NP B-treatment
( ( O I-treatment
INSULIN NNP B-NP I-treatment
ASPART NNP I-NP I-treatment
) ) O I-treatment
Sliding VBG O I-treatment
Scale NNP B-NP I-treatment
( ( O O
subcutaneously RB O O
) ) O O
SC NNP B-NP O
AC NNP I-NP O
Instructions NNS I-NP O
: : O O
pre-meal JJ B-NP B-treatment
correction NN I-NP I-treatment
dose NN I-NP I-treatment
. . B-VP O
   
give VB O O
in IN B-VP O
addition NN B-NP O
to TO O O
standing VBG O B-treatment
pre-meal JJ B-NP I-treatment
novolog NN I-NP I-treatment
when WRB O O
patient NN B-NP B-person
will MD O O
eat VB O O
and CC O O
food NN B-NP O
is VBZ O O
in IN B-VP O
the DT B-NP O
room NN I-NP O
. . B-VP O
   
If IN B-VP O
BS NNP B-NP B-test
is VBZ O O
less JJR O O
than IN B-VP O
125 CD O O
, , O O
then RB O O
give VB O O
0 CD O O
units NNS B-NP O
subcutaneously RB O O
If IN B-VP O
BS NNP B-NP B-test
is VBZ O O
125-150 JJ O O
, , O O
then RB O O
give VB O O
2 CD O O
units NNS B-NP O
subcutaneously RB O O
If IN B-VP O
BS NNP B-NP B-test
is VBZ O O
151-200 CD O O
, , O O
then RB O O
give VB O O
3 CD O O
units NNS B-NP O
subcutaneously RB O O
If IN B-VP O
BS NNP B-NP B-test
is VBZ O O
201-250 JJ O O
, , O O
then RB O O
give VB O O
4 CD O O
units NNS B-NP O
subcutaneously RB O O
If IN B-VP O
BS NNP B-NP B-test
is VBZ O O
251-300 JJ O O
, , O O
then RB O O
give VB O O
6 CD O O
units NNS B-NP O
subcutaneously RB O O
If IN B-VP O
BS NNP B-NP B-test
is VBZ O O
301-350 JJ O O
, , O O
then RB O O
give VB O O
8 CD O O
units NNS B-NP O
subcutaneously RB O O
If IN B-VP O
BS NNP B-NP B-test
is VBZ O O
351-400 CD O O
, , O O
then RB O O
give VB O O
10 CD O O
units NNS B-NP O
subcutaneously RB O O
and CC O O
call VB O O
HO NNP B-NP B-person
Call NNP I-NP O
HO NNP I-NP B-person
if IN B-VP O
BS NNP B-NP B-test
is VBZ O O
greater JJR O O
than IN B-VP O
400 CD O O
PROTONIX NNP B-NP B-treatment
( ( O I-treatment
PANTOPRAZOLE NNP B-NP I-treatment
) ) O I-treatment
40 CD O O
MG NNP B-NP O
PO NNP I-NP O
DAILY NNP I-NP O
COMBIVENT NNP I-NP B-treatment
( ( O I-treatment
IPRATROPIUM NNP B-NP I-treatment
AND NNP I-NP I-treatment
ALBUTEROL NNP I-NP I-treatment
SULFATE NNP I-NP I-treatment
) ) O I-treatment
2 CD O O
PUFF NNP B-NP O
INH NNP I-NP O
QID NNP I-NP O
FOSAMAX NNP I-NP B-treatment
( ( O I-treatment
ALENDRONATE NNP B-NP I-treatment
) ) O I-treatment
70 CD O O
MG NNP B-NP O
PO NNP I-NP O
QWEEK NNP I-NP O
Food NNP I-NP O
/ NNP I-NP O
Drug NNP I-NP O
Interaction NNP I-NP O
Instruction NNP I-NP O
Give NNP I-NP O
on IN B-VP O
an DT B-NP O
empty JJ I-NP O
stomach NN I-NP O
( ( O O
give JJ O O
1hr CD O O
before IN B-VP O
or CC O O
2hr CD O O
after IN B-VP O
food NN B-NP O
) ) O O
Take VBP O O
with IN B-VP O
8 CD O O
oz NN B-NP O
of IN B-VP O
plain JJ B-NP O
water NN I-NP O
SPIRIVA NNP I-NP B-treatment
( ( O I-treatment
TIOTROPIUM NNP B-NP I-treatment
) ) O I-treatment
18 CD O O
MCG NNP B-NP O
INH NNP I-NP O
DAILY NNP I-NP O
DIET NNP I-NP O
: : O O
House NNP B-NP O
/ VBD B-VP O
Low NNP B-NP O
chol NN I-NP O
/ NNP I-NP O
low JJ B-NP O
sat. NN I-NP O
fat JJ B-NP O
DIET NNP I-NP O
: : O O
House NNP B-NP O
/ VBZ O O
ADA NNP B-NP O
1800 CD O O
cals NNS B-NP O
/ JJ B-NP O
dy JJ I-NP O
ACTIVITY NN I-NP O
: : O O
walk NN B-NP O
with IN B-VP O
assist JJ O O
per IN B-VP O
PT NNP B-NP B-test
eval NN I-NP I-test
FOLLOW NNP I-NP O
UP NNP I-NP O
APPOINTMENT NNP I-NP O
( ( O O
S NNP B-NP O
) ) O O
: : O O
Dr NNP B-NP B-person
Zuknocegrend NNP I-NP I-person
PCP NNP I-NP I-person
4/24 CD O O
130 CD O O
, , O O
Dr. NNP B-NP B-person
Pump NNP I-NP I-person
3/25/05 CD O O
1:30 CD O O
, , O O
ALLERGY NNP B-NP O
: : O O
NKA NNP B-NP O
ADMIT NNP I-NP O
DIAGNOSIS NNP I-NP O
: : O O
COPD NNP B-NP B-problem
flare NN I-NP I-problem
PRINCIPAL NNP I-NP O
DISCHARGE NNP I-NP O
DIAGNOSIS NNP I-NP O
; : O O
Responsible NNP B-NP O
After IN B-VP O
Study NNP B-NP O
for IN B-VP O
Causing NNP B-NP O
Admission NNP I-NP O
) ) O O
COPD NNP B-NP B-problem
flare NN I-NP I-problem
OTHER NNP I-NP O
DIAGNOSIS NNP I-NP O
; : O O
Conditions NNP B-NP O
, , O O
Infections NNP B-NP O
, , O O
Complications NNP B-NP O
, , O O
affecting VBG O O
Treatment NNP B-NP O
/ NNP I-NP O
Stay NNP I-NP O
COPD NNP I-NP B-problem
( ( O I-problem
chronic JJ O I-problem
obstructive VBP O I-problem
pulmonary JJ B-NP I-problem
disease NN I-NP I-problem
) ) O I-problem
DM NNP B-NP B-problem
cervical JJ B-NP B-problem
DJD NNP I-NP I-problem
( ( O O
) ) O O
iron NN B-NP B-problem
deficiency NN I-NP I-problem
anemia NN I-NP I-problem
( ( O I-problem
iron JJ B-NP I-problem
deficiency NN I-NP I-problem
anemia NN I-NP I-problem
) ) O I-problem
cervical NN B-NP B-problem
and CC O I-problem
lumbar NN B-NP I-problem
djd NN I-NP I-problem
( ( O O
12 CD O O
) ) O O
osa NN B-NP B-problem
( ( O I-problem
sleep JJ B-NP I-problem
apnea NN I-NP I-problem
) ) O I-problem
s NN B-NP O
/ NNP I-NP O
p NN I-NP O
tb NN I-NP B-treatment
treatment NN I-NP I-treatment
( ( O O
5 CD O O
) ) O O
OPERATIONS NNP B-NP O
AND CC O O
PROCEDURES NNP B-NP O
: : O O
OTHER NNP B-NP O
TREATMENTS NNP I-NP O
/ NNP I-NP O
PROCEDURES NNP I-NP O
( ( O O
NOT NNP B-NP O
IN NNP I-NP O
O.R. NNP I-NP O
) ) O O
na VBP O O
BRIEF JJ B-NP O
RESUME NNP I-NP O
OF NNP I-NP O
HOSPITAL NNP I-NP O
COURSE NNP I-NP O
: : O O
CC NN B-NP O
: : O O
weakness NN B-NP B-problem
HPI NNP I-NP O
: : O O
75 CD O O
y NN B-NP O
/ NNP I-NP O
o VBZ O O
F NNP B-NP O
with IN B-VP O
DM NNP B-NP B-problem
, , O O
COPD NNP B-NP B-problem
on IN B-VP O
2L CD O B-treatment
NC NNP B-NP I-treatment
and CC O O
Bipap NNP B-NP B-treatment
at IN B-VP O
night NN B-NP O
p NN I-NP O
/ NNP I-NP O
w VBZ O O
generalized VBN O B-problem
weakness NN B-NP I-problem
and CC O O
fatigue NN B-NP B-problem
, , O O
urinary JJ B-NP B-problem
incontinence NN I-NP I-problem
and CC O O
shaking NN B-NP B-problem
as RB O O
well RB O O
as IN B-VP O
increased VBN O B-problem
sputum NN B-NP I-problem
production NN I-NP I-problem
. . B-VP O
   
Per NNP B-NP O
daughter NN I-NP B-person
these DT O B-pronoun
these DT B-NP B-problem
symptoms NNS I-NP I-problem
are VBP O O
typical JJ O O
of IN B-VP O
COPD NNP B-NP B-problem
flare NN I-NP I-problem
. . B-VP O
   
ROS NNP B-NP O
otherwise RB O O
negative JJ O O
. . B-VP O
   
Admission NN B-NP O
Status NN I-NP O
: : O O
ED NN B-NP O
: : O O
REc&apos;d NNP B-NP O
duonebs NN I-NP B-treatment
, , O O
solumedrol NN B-NP B-treatment
125 CD O O
Vitals NNS B-NP O
: : O O
t97.5 NN B-NP O
, , O O
hr NN B-NP B-test
117 CD O O
, , O O
bp156/81 NN B-NP O
, , O O
rr28 NN B-NP O
, , O O
o2 JJ B-NP B-test
sats NNS I-NP I-test
87% CD O O
RA NNP B-NP O
; : O O
95% CD O O
4L CD O O
Exam NN B-NP O
: : O O
NAD NNP B-NP B-problem
, , O O
pleasant NN B-NP O
, , O O
speaking VBG O O
in IN B-VP O
complete JJ B-NP O
sentences NNS I-NP O
, , O O
poor JJ B-NP B-problem
air NN I-NP I-problem
movement NN I-NP I-problem
bilaterally RB O I-problem
, , O O
L NNP B-NP O
&gt; NNP I-NP O
R NNP I-NP O
, , O O
no DT B-NP O
wheezes NN I-NP B-problem
or CC O O
rales NNS B-NP B-problem
, , O O
rrr NN B-NP O
, , O O
distant NN B-NP O
, , O O
abd JJ B-NP O
benign NN I-NP O
, , O O
no DT B-NP O
edema NN I-NP B-problem
, , O O
alert NN B-NP O
and CC O O
oriented VBN O O
times NNS B-NP O
three CD O O
, , O O
no DT B-NP O
focal JJ I-NP B-problem
deficits NNS I-NP I-problem
, , O O
conversant JJ B-NP O
Studies NNS I-NP O
: : O O
- : O O
EKG NNP B-NP B-test
sinus VBD B-VP O
92 CD O O
, , O O
no DT B-NP O
ST NNP I-NP B-problem
changes NNS I-NP I-problem
- : O O
CXR NNP B-NP B-test
no DT B-NP O
focal JJ I-NP B-problem
consolidation NN I-NP I-problem
or CC O O
edema NN B-NP B-problem
, , O O
old JJ B-NP B-problem
biapical JJ I-NP I-problem
scarring NN I-NP I-problem
ABG NNP I-NP B-test
7.34/79/74 CD O O
U NNP B-NP B-test
/ VBD B-VP I-test
A NNP B-NP I-test
negative JJ B-NP O
Daily JJ I-NP O
Status NN I-NP O
: : O O
improving NN B-NP O
, , O O
but CC O O
still RB O B-problem
poor JJ B-NP I-problem
air NN I-NP I-problem
movement NN I-NP I-problem
, , O O
diffusely RB O B-problem
wheezy VBP O I-problem
on IN B-VP O
exam NN B-NP B-test
, , O O
at IN B-VP O
baseline NN B-NP O
2L CD O B-treatment
o2 JJ B-NP I-treatment
requirement NN I-NP I-treatment
A NNP I-NP O
/ NNP I-NP O
P NNP I-NP O
: : O O
75 CD O O
y NN B-NP O
/ NNP I-NP O
o VBZ O O
F NNP B-NP O
with IN B-VP O
h JJ B-NP O
/ JJ I-NP O
o NN I-NP O
COPD NNP I-NP B-problem
c NN I-NP O
/ NN I-NP O
b NN I-NP O
frequent JJ B-NP B-problem
exacerbations NNS I-NP I-problem
p VBP O O
/ JJ B-NP O
w JJ I-NP O
typical JJ I-NP B-problem
flare NN I-NP I-problem
symptoms NNS I-NP I-problem
. . B-VP O
   
Problem NNP B-NP O
List NN I-NP O
: : O O
CV NNP B-NP O
- : O O
Ischemia NNP B-NP B-problem
ASA NNP I-NP B-treatment
, , O O
lisinopril JJ B-NP B-treatment
Pump NNP I-NP I-treatment
no DT B-NP O
evidence NN I-NP O
of IN B-VP O
failure NN B-NP B-problem
Rhythm NNP I-NP O
Resp NNP I-NP O
- : O O
COPD NNP B-NP B-problem
flare SYM O B-problem
- : O O
steroids NNS B-NP B-treatment
, , O O
cont VBP O O
prednisone NN B-NP B-treatment
60 CD O O
, , O O
taper JJR O O
slowly RB O O
as IN B-VP O
tolerated VBN O O
, , O O
duonebs NN B-NP B-treatment
, , O O
advair NN B-NP B-treatment
, , O O
singulair NN B-NP B-treatment
, , O O
spiriva NN B-NP B-treatment
, , O O
claritin NN B-NP B-treatment
azithromycin NN I-NP B-treatment
for IN B-VP O
atypical JJ B-NP B-problem
bronchitis NN I-NP I-problem
to TO O O
complete VB O O
a DT O O
5 CD O O
day NN B-NP O
course NN I-NP O
, , O O
keep VB O O
o2 JJ O B-test
sat JJ O I-test
90-94 CD O O
, , O O
home NN B-NP B-treatment
nocturnal JJ B-NP I-treatment
CPAP NNP I-NP I-treatment
not RB O O
tolerated VBD B-VP O
in IN B-VP O
house NN B-NP O
, , O O
does VBZ O O
well RB O O
on IN B-VP O
nc NNS B-NP B-treatment
, , O O
appears VBZ O O
ato RB O O
be VB O O
at IN B-VP O
baseline JJ B-NP O
Renal NNP I-NP O
- : O O
Cr NN B-NP B-test
0.8 CD O O
, , O O
stress NN B-NP B-problem
incontinence NN I-NP I-problem
by IN B-VP O
symptoms NNS B-NP B-problem
with IN B-VP O
increased JJ B-NP B-problem
cough NN I-NP I-problem
, , O O
no DT B-NP O
evidence NN I-NP O
of IN B-VP O
uti JJ O B-problem
, , O O
cont NN B-NP O
to TO O O
closely RB O O
monitor VB O O
GI NNP B-NP O
- : O O
Bowel NNP B-NP B-treatment
regimen NNS I-NP I-treatment
Heme NNP I-NP O
- : O O
Chronic NNP B-NP B-problem
Fe NNP I-NP I-problem
deficiency NN I-NP I-problem
anemia NN I-NP I-problem
, , O O
cont NN B-NP O
iron NN I-NP B-treatment
Endo NNP I-NP O
- : O O
DM NN B-NP B-problem
on IN B-VP O
insulin NN B-NP B-treatment
with IN B-VP O
steroids NNS B-NP B-treatment
ID NNP I-NP O
- : O O
afebrile NN B-NP B-problem
, , O O
no DT B-NP O
wbc NN I-NP B-test
, , O O
started VBD B-VP O
on IN B-VP O
Azithromycin NNP B-NP B-treatment
for IN B-VP O
COPD NNP B-NP B-problem
flare NN I-NP I-problem
FEN NNP I-NP O
- : O O
ADA NNP B-NP B-treatment
diet JJ B-NP I-treatment
PPx NNP I-NP O
- : O O
Lovenox NNP B-NP B-treatment
, , O O
PPI NNP B-NP B-treatment
Dispo NNP I-NP O
- : O O
to TO O O
rehab VB O O
when WRB O O
resp NN B-NP O
status NN I-NP O
improved VBN O O
, , O O
PT NNP B-NP B-person
consulted VBD B-VP O
Code NNP B-NP O
- : O O
FC NNP B-NP O
ADDITIONAL NNP I-NP O
COMMENTS NNP I-NP O
: : O O
DISCHARGE JJ B-NP O
CONDITION NNP I-NP O
: : O O
Stable JJ B-NP O
TO NNP I-NP O
DO NNP I-NP O
/ NNP I-NP O
PLAN NN I-NP O
: : O O
f JJ B-NP O
/ NNP I-NP O
u NN I-NP O
with IN B-VP O
PCP NNP B-NP B-person
and CC O O
Dr. NNP B-NP B-person
Pump NNP I-NP I-person
as IN B-VP O
scheduled VBN O O
, , O O
return VB O O
to TO O O
ED NNP B-NP O
with IN B-VP O
worsening VBG O B-problem
sob NN B-NP I-problem
or CC O O
increased JJ B-NP B-problem
cough NN I-NP I-problem
or CC O O
sputum NN B-NP B-problem
production NN I-NP I-problem
No NNP I-NP O
dictated VBD B-VP O
summary JJ B-NP O
ENTERED NNP I-NP O
BY NNP I-NP O
: : O O
TIKWELD NNP B-NP B-person
, , O I-person
WILLAIDE NNP B-NP I-person
V. NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
( ( O O
QT296 NNP B-NP O
) ) O O
03/19/06 CD O O
10:53 CD O O
AM NNP B-NP O
****** JJ B-NP O
END NN I-NP O
OF NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
Admission NNP I-NP O
Date NNP I-NP O
: : O O
2014-12-29 JJ B-NP O
Discharge NN I-NP O
Date NNP I-NP O
: : O O
2015-01-20 JJ B-NP O
Date NNP I-NP O
of IN B-VP O
Birth NNP B-NP O
: : O O
1944-09-05 JJ B-NP O
Sex NN I-NP O
: : O O
M NNP B-NP O
Service NNP I-NP O
: : O O
SURGERY JJ B-NP O
Allergies NNS I-NP O
: : O O
Patient NN B-NP B-person
recorded VBD B-VP O
as IN B-VP O
having VBG O O
No NNP B-NP O
Known NNP I-NP B-problem
Allergies NNPS I-NP I-problem
to TO O O
Drugs NNP B-NP B-treatment
Attending NNP I-NP B-person
: : O O
Patricia NNP B-NP B-person
H NNP I-NP I-person
Leonard NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
Chief NNP I-NP O
Complaint NNP I-NP O
: : O O
End NN B-NP B-problem
stage NN I-NP I-problem
liver VBD B-VP I-problem
disease JJ B-NP I-problem
Major NNP I-NP O
Surgical NNP I-NP O
or CC O O
Invasive JJ B-NP O
Procedure NN I-NP O
: : O O
Piggyback NNP B-NP B-treatment
orthotopic VBZ O I-treatment
liver RB O I-treatment
transplant JJ B-NP I-treatment
Liver NNP I-NP B-test
biopsy NN I-NP I-test
History NNP I-NP O
of IN B-VP O
Present NNP B-NP O
Illness NNP I-NP O
: : O O
Mr. NNP B-NP B-person
Reese NNP I-NP I-person
is VBZ O O
a DT O O
70 CD O O
- : O O
year-old JJ B-NP O
gentleman NN I-NP O
with IN B-VP O
end NN B-NP B-problem
stage NN I-NP I-problem
liver JJ B-NP I-problem
disease NN I-NP I-problem
secondary JJ O O
to TO O O
alcoholic JJ B-NP B-problem
cirrhosis NN I-NP I-problem
. . B-VP O
   
Of IN B-VP O
note NN B-NP O
, , O O
he PRP O B-person
underwent JJ B-NP O
radiofrequency NN I-NP B-treatment
ablation NN I-NP I-treatment
of IN B-VP I-treatment
two CD O I-treatment
small JJ B-NP I-treatment
liver NN I-NP I-treatment
nodules NNS I-NP I-treatment
, , O O
one CD O O
in IN B-VP O
segment NN B-NP O
VI NNP I-NP O
and CC O O
the DT O O
other JJ O O
in IN B-VP O
the DT B-NP O
caudate NN I-NP O
lobe NN I-NP O
. . B-VP O
   
Both DT O O
are VBP O O
less JJR O O
than IN B-VP O
2 CD O O
cm NN B-NP O
. . B-VP O
   
Cytology NN B-NP B-test
on IN B-VP O
these DT O B-problem
these DT B-NP B-pronoun
nodules NNS I-NP I-problem
was VBD B-VP O
suspicious JJ O O
for IN B-VP O
hepatocellular JJ B-NP B-problem
carcinoma NN I-NP I-problem
. . B-VP O
   
The DT B-NP B-treatment
ablation NN I-NP I-treatment
was VBD B-VP O
done VBN O O
on IN B-VP O
2013-12-04 JJ O O
. . B-VP O
   
He PRP O B-person
had VBD B-VP O
decompensation NN B-NP O
of IN B-VP O
his PRP$ O B-person
his PRP$ O B-problem
cirrhosis NN B-NP I-problem
in IN B-VP O
2011 CD O O
with IN B-VP O
ascites NNS B-NP B-problem
and CC O O
SBP NNP B-NP B-problem
. . B-VP O
   
He PRP O B-person
also RB O O
had VBD B-VP O
encephalopathy CC O B-problem
during IN B-VP O
that DT B-NP B-pronoun
period NN I-NP O
. . B-VP O
   
The DT B-NP O
liver NN I-NP O
was VBD B-VP O
from IN B-VP O
a DT O O
62 CD O O
year-old JJ B-NP O
gentleman NN I-NP O
who WP O B-person
had VBD B-VP O
died VBN O O
from IN B-VP O
CVA NNP B-NP B-problem
with IN B-VP O
normal JJ B-NP O
liver NN I-NP O
function NN I-NP O
. . B-VP O
   
He PRP O B-person
has VBZ O O
no DT B-NP O
history NN I-NP O
of IN B-VP O
a DT B-NP B-problem
GI NNP I-NP I-problem
bleed NN I-NP I-problem
or CC O O
varices NNS B-NP B-problem
by IN B-VP O
endoscopy NN B-NP B-test
. . B-VP O
   
His PRP$ O B-person
last JJ B-NP O
drink NN I-NP O
was VBD B-VP O
in IN B-VP O
2009-11-11 JJ O O
. . B-VP O
   
Prior VB O O
to TO O O
this DT O B-pronoun
, , O O
he PRP O B-person
drank VBD B-VP O
a DT B-NP O
bottle NN I-NP O
of IN B-VP O
wine NN B-NP O
a DT B-NP O
day NN I-NP O
Past NNP I-NP O
Medical NNP I-NP O
History NN I-NP O
: : O O
His PRP$ O B-person
past JJ B-NP O
medical JJ I-NP O
history NN I-NP O
is VBZ O O
also RB O O
remarkable JJ O O
for IN B-VP O
non-insulin JJ B-NP B-problem
dependent NN I-NP I-problem
diabetes NNS I-NP I-problem
and CC O O
hypertension NN B-NP B-problem
. . B-VP O
   
He PRP O B-person
has VBZ O O
coronary JJ B-NP B-problem
artery NN I-NP I-problem
disease NN I-NP I-problem
and CC O O
underwent NN B-NP O
a DT B-NP B-treatment
CABG NNP I-NP I-treatment
in IN B-VP O
1998 CD O O
. . B-VP O
   
He PRP O B-person
has VBZ O O
a DT B-NP O
history NN I-NP O
of IN B-VP O
gastroesophageal NN B-NP B-problem
reflux NN I-NP I-problem
disease NN I-NP I-problem
and CC O O
anemia NN B-NP B-problem
. . B-VP O
   
He PRP O B-person
also RB O O
has VBZ O O
had VBD B-VP O
a DT B-NP B-treatment
prior JJ I-NP I-treatment
inguinal JJ I-NP I-treatment
hernia NN I-NP I-treatment
repair NN I-NP I-treatment
. . B-VP O
   
Social JJ B-NP O
History NN I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
obtained VBD B-VP O
a DT B-NP O
degree NN I-NP O
in IN B-VP O
law NN B-NP O
. . B-VP O
   
He PRP O B-person
worked VBD B-VP O
for IN B-VP O
the DT B-NP O
attorney NN I-NP O
general NN I-NP O
's POS O O
office NN B-NP O
early RB O O
in IN B-VP O
his PRP$ O B-person
career NN B-NP O
but CC O O
eventually RB O O
started VBD B-VP O
his PRP$ O B-person
own JJ B-NP O
business NN I-NP O
in IN B-VP O
foreign JJ B-NP O
currency NN I-NP O
exchange NN I-NP O
from IN B-VP O
which WDT O B-pronoun
he PRP O B-person
retired VBD B-VP O
in IN B-VP O
2009 CD O O
. . B-VP O
   
He PRP O B-person
does VBZ O O
not RB O O
smoke VB O O
, , O O
and CC O O
there EX O O
is VBZ O O
no DT B-NP O
history NN I-NP O
of IN B-VP O
IV NNP B-NP O
drug NN I-NP O
abuse NN I-NP O
. . B-VP O
   
Physical JJ B-NP O
Exam NN I-NP O
: : O O
On IN B-VP O
pre-operative JJ B-NP B-test
exam NN I-NP I-test
, , O O
he PRP O B-person
was VBD B-VP O
awake RB O O
, , O O
alert NN B-NP O
, , O O
and CC O O
oriented VBD B-VP O
x3 NNP B-NP O
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
not RB O O
in IN B-VP O
any DT B-NP B-problem
apparent JJ I-NP I-problem
distress NN I-NP I-problem
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
afebrile RB O B-problem
with IN B-VP O
normal JJ B-NP O
vitals NNS I-NP O
. . B-VP O
   
He PRP O B-person
is VBZ O O
6 CD O O
feet NNS B-NP O
1 CD O O
inches NNS B-NP O
tall JJ O O
and CC O O
has VBZ O O
a DT B-NP B-test
pre-op JJ I-NP I-test
weight NN I-NP I-test
of IN B-VP O
181 CD O O
pounds NNS B-NP O
. . B-VP O
   
He PRP O B-person
had VBD B-VP O
no DT B-NP O
pallor NN I-NP B-problem
or CC O O
obvious JJ B-NP B-problem
jaundice NN I-NP I-problem
. . B-VP O
   
He PRP O B-person
had VBD B-VP O
no DT B-NP O
asterixis NN I-NP B-problem
. . B-VP O
   
He PRP O B-person
had VBD B-VP O
palmar VBN O B-problem
erythema RB O I-problem
. . B-VP O
   
There EX O O
was VBD B-VP O
no DT B-NP O
clubbing NN I-NP B-problem
. . B-VP O
   
He PRP O B-person
had VBD B-VP O
no DT B-NP O
lymphadenopathy NN I-NP B-problem
. . B-VP O
   
His PRP$ O B-person
chest NN B-NP O
was VBD B-VP O
clear JJ O O
to TO O O
ascultation NN B-NP B-test
. . B-VP O
   
His PRP$ O B-person
His PRP$ O B-test
heart NN B-NP I-test
sounds VBZ O I-test
were VBD B-VP O
regular JJ B-NP O
rate NN I-NP O
rhythm NN I-NP O
. . B-VP O
   
His PRP$ O B-person
abdomen NNS B-NP O
is VBZ O O
soft JJ O O
and CC O O
nontender NN B-NP B-problem
. . B-VP O
   
No DT B-NP O
masses NNS I-NP B-problem
or CC O O
viscera NN B-NP B-problem
was VBD B-VP O
felt RB O O
. . B-VP O
   
He PRP O B-person
had VBD B-VP O
good JJ B-NP O
femoral JJ I-NP O
pulses NNS I-NP O
bilaterally RB O O
. . B-VP O
   
He PRP O B-person
had VBD B-VP O
no DT B-NP O
pedal JJ I-NP B-problem
edema NN I-NP I-problem
or CC O O
lower JJR B-NP B-problem
extremity NN I-NP I-problem
lesions NNS I-NP I-problem
. . B-VP O
   
His PRP$ O B-person
His PRP$ O B-test
neurological JJ B-NP I-test
exam NN I-NP I-test
was VBD B-VP O
intact JJ O O
. . B-VP O
   
Pertinent JJ B-NP O
Results NNS I-NP O
: : O O
2014-12-30 JJ O O
10:34 CD O O
AM NNP B-NP O
BLOOD NNP I-NP B-test
ALT NNP I-NP B-test
- : O O
699 CD O O
* NN B-NP O
AST NNP I-NP B-test
- : O O
1434 CD O O
* NN B-NP O
AlkPhos NNP I-NP B-test
- : O O
65 CD O O
Amylase NNP B-NP B-test
- : O O
46 CD O O
TotBili NNP B-NP B-test
- : O O
5.9 CD O O
* JJ O O
2015-01-01 JJ O O
11:46 CD O O
AM NNP B-NP O
BLOOD NNP I-NP B-test
ALT NNP I-NP B-test
- : O O
1423 CD O O
* NN B-NP O
AST NNP I-NP B-test
- : O O
1066 CD O O
* NN B-NP O
AlkPhos NNP I-NP B-test
- : O O
72 CD O O
TotBili NNP B-NP B-test
- : O O
6.2 CD O O
* JJ O O
2015-01-19 JJ O O
04:47 CD O O
AM NNP B-NP O
BLOOD NNP I-NP B-test
ALT NNP I-NP B-test
- : O O
355 CD O O
* NN B-NP O
AST NNP I-NP B-test
- : O O
90 CD O O
* NN B-NP O
AlkPhos NNP I-NP B-test
- : O O
352 CD O O
* NN B-NP O
TotBili NNP I-NP B-test
- : O O
3.2 CD O O
* JJ B-NP O
Brief NNP I-NP O
Hospital NNP I-NP O
Course NNP I-NP O
: : O O
Mr. NNP B-NP B-person
Reese NNP I-NP I-person
Jones NNP I-NP O
the DT B-NP B-treatment
procedure NN I-NP I-treatment
well RB O O
. . B-VP O
   
Post-operatively RB O O
, , O O
he PRP O B-person
was VBD B-VP O
slow JJ O O
to TO O O
recover VB O O
but CC O O
did VBD B-VP O
progressed VBN O O
nicely RB O O
. . B-VP O
   
Within IN B-VP O
the DT B-NP O
fist JJ I-NP O
few JJ I-NP O
days NNS I-NP O
after IN B-VP O
the DT B-NP B-treatment
surgery NN I-NP I-treatment
, , O O
his PRP$ O B-person
his PRP$ O B-test
liver NN B-NP I-test
function NN I-NP I-test
tests NNS I-NP I-test
were VBD B-VP O
elevated VBN O B-problem
to TO O O
as RB O O
high JJ O O
as IN B-VP O
1484 CD O O
for IN B-VP O
ALT NNP B-NP B-test
, , O O
915 CD O O
for IN B-VP O
AST NNP B-NP B-test
, , O O
and CC O O
7.6 CD O O
for IN B-VP O
total JJ B-NP B-test
bilirubin NN I-NP I-test
. . B-VP O
   
His PRP$ O B-person
His PRP$ O B-test
Alk NNP B-NP I-test
Phos NNP I-NP I-test
were VBD B-VP O
inititially RB O O
low JJ O B-problem
a DT B-NP O
few JJ I-NP O
days NNS I-NP O
after IN B-VP O
the DT B-NP B-treatment
operation NN I-NP I-treatment
, , O O
but CC O O
it PRP O B-pronoun
rised VBD B-VP O
up RB O O
to TO O O
422 CD O O
two CD O O
weeks NNS B-NP O
after IN B-VP O
, , O O
but CC O O
down-trended JJ O O
, , O O
as IN B-VP O
with IN B-VP O
the DT B-NP O
rest NN I-NP O
of IN B-VP O
his PRP$ O B-person
his PRP$ O B-test
liver NN B-NP I-test
function NN I-NP I-test
test NN I-NP I-test
by IN B-VP O
the DT B-NP O
time NN I-NP O
he PRP O B-person
left VBD B-VP O
the DT B-NP O
hospital NN I-NP O
. . B-VP O
   
Several JJ B-NP O
tests NNS I-NP O
, , O O
including VBG O O
Duplex NNP B-NP B-test
Ultrasound NNP I-NP I-test
, , O O
CT NNP B-NP B-test
of IN B-VP I-test
the DT B-NP I-test
Abdomen NNP I-NP I-test
, , O O
and CC O O
Abdominal NNP B-NP B-test
A-gram NNP I-NP I-test
all DT O O
showed VBD B-VP O
patent NN B-NP O
right NN I-NP O
and CC O O
left VBD B-VP O
hepatic JJ B-NP O
arteries NNS I-NP O
arising VBG O O
from IN B-VP O
the DT B-NP O
celiac JJ I-NP O
trunk NN I-NP O
. . B-VP O
   
An DT B-NP B-test
ERCP NN I-NP I-test
was VBD B-VP O
also RB O O
done VBN O O
, , O O
showing VBG O O
a DT O B-problem
filling VBG O I-problem
defect NN B-NP I-problem
from IN B-VP O
a DT B-NP B-problem
narrowed JJ I-NP I-problem
donor NN I-NP I-problem
duct NN I-NP I-problem
, , O O
but CC O O
no DT B-NP O
strictures NNS I-NP B-problem
. . B-VP O
   
A DT B-NP B-treatment
sphincterotomy JJ I-NP I-treatment
wss NN I-NP O
done VBN O O
to TO O O
drain VB O O
the DT B-NP B-problem
sludge NN I-NP I-problem
from IN B-VP I-problem
the DT B-NP I-problem
central JJ I-NP I-problem
common JJ I-NP I-problem
duct NN I-NP I-problem
. . B-VP O
   
There EX O O
was VBD B-VP O
a DT B-NP B-problem
small JJ I-NP I-problem
bleed NN I-NP I-problem
resulting VBG O O
from IN B-VP O
the DT B-NP B-treatment
sphincterotomy NN I-NP I-treatment
, , O O
but CC O O
it PRP O B-pronoun
was VBD B-VP O
controlled VBN O O
by IN B-VP O
epinepherine NN B-NP B-treatment
injections NNS I-NP I-treatment
. . B-VP O
   
Initial JJ B-NP B-test
biopsy NN I-NP I-test
of IN B-VP I-test
the DT B-NP I-test
allograft NN I-NP I-test
three CD O O
days NNS B-NP O
after IN B-VP O
the DT B-NP B-treatment
operation NN I-NP I-treatment
was VBD B-VP O
consistent JJ O O
with IN B-VP O
preservation NN B-NP B-problem
/ NNP I-NP I-problem
ischemic JJ B-NP I-problem
injury NN I-NP I-problem
. . B-VP O
   
Result NNP B-NP O
of IN B-VP O
a DT B-NP B-test
second JJ I-NP I-test
biopsy NN I-NP I-test
, , O O
which WDT O B-pronoun
was VBD B-VP O
done VBN O O
three CD O O
weeks NNS B-NP O
after IN B-VP O
the DT B-NP B-treatment
operation NN I-NP I-treatment
, , O O
is VBZ O O
still RB O O
pending VBG O O
. . B-VP O
   
During IN B-VP O
his PRP$ O B-person
hospital NN B-NP O
stay NN I-NP O
, , O O
his PRP$ O B-person
his PRP$ O B-test
blood NN B-NP I-test
glucose NN I-NP I-test
were VBD B-VP O
elevated VBN O B-problem
and CC O O
labile JJ O B-problem
ranging VBG O O
from IN B-VP O
below IN B-VP B-problem
normal JJ B-NP I-problem
values NNS I-NP I-problem
[ VBP O O
40-60 JJ O O
's] CD O O
to TO O O
the DT O O
200-300 JJ O O
's POS O O
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
completely RB O O
assymptomatic JJ O B-problem
while IN B-VP O
below IN B-VP B-problem
normal JJ B-NP I-problem
values NNS I-NP I-problem
. . B-VP O
   
At IN B-VP O
one CD O O
point NN B-NP O
, , O O
he PRP O B-person
had VBD B-VP O
to TO O O
be VB O O
on IN B-VP O
an DT B-NP B-treatment
insulin NN I-NP I-treatment
drip NN I-NP I-treatment
. . B-VP O
   
However RB O O
with IN B-VP O
the DT B-NP O
help NN I-NP O
of IN B-VP O
Albano NNP B-NP B-person
, , O O
his PRP$ O B-person
his PRP$ O B-test
blood NN B-NP I-test
glucose NN I-NP I-test
began VBD B-VP O
to TO O O
normalize VB O O
. . B-VP O
   
He PRP O B-person
has VBZ O O
also RB O O
been VBN O O
working VBG O O
with IN B-VP O
Physical NNP B-NP B-person
Therapy NNP I-NP I-person
to TO O O
regain VB O O
his PRP$ O B-person
strength NN B-NP O
. . B-VP O
   
He PRP O B-person
has VBZ O O
been VBN O O
ambulating VBG O O
on IN B-VP O
his PRP$ O B-person
own JJ B-NP O
several JJ I-NP O
times NNS I-NP O
a DT B-NP O
day NN I-NP O
. . B-VP O
   
Also RB O O
, , O O
he PRP O B-person
has VBZ O O
been VBN O O
afebrile IN B-VP B-problem
with IN B-VP O
stable JJ B-NP O
vitals NNS I-NP O
, , O O
tolerating VBG O O
a DT B-NP O
regular JJ I-NP O
diet NN I-NP O
, , O O
producing VBG O O
good JJ B-NP O
urine NN I-NP O
and CC O O
adequate JJ B-NP O
stool NN I-NP O
. . B-VP O
   
Furthermore RB O O
, , O O
he PRP O B-person
has VBZ O O
had VBN O O
no DT B-NP O
complaints NNS I-NP B-problem
, , O O
including VBG O O
pain NN B-NP B-problem
, , O O
while IN B-VP O
his PRP$ O B-person
his PRP$ O B-test
lab NN B-NP I-test
values NNS I-NP I-test
are VBP O O
normalizing VBG O O
. . B-VP O
   
He PRP O B-person
will MD O O
be VB O O
discharged VBN O O
to TO O O
home NN B-NP O
, , O O
in IN B-VP O
good JJ B-NP O
condition NN I-NP O
, , O O
with IN B-VP O
very RB O O
specific JJ B-NP O
intructions NNS I-NP O
to TO O O
follow VB O O
up RP O O
with IN B-VP O
Albano NNP B-NP O
for IN B-VP O
his PRP$ O B-person
his PRP$ O B-treatment
diabetic JJ B-NP I-treatment
care NN I-NP I-treatment
and CC O O
the DT B-NP O
Transplant NNP I-NP O
Clinic NNP I-NP O
for IN B-VP O
his PRP$ O B-person
his PRP$ O B-treatment
transplant NN B-NP I-treatment
care NN I-NP I-treatment
. . B-VP O
   
Discharge NNP B-NP O
Medications NNPS I-NP O
: : O O
1. CD O O
Trimethoprim NNP B-NP B-treatment
- : O I-treatment
Sulfamethoxazole JJ B-NP I-treatment
80-400 JJ I-NP O
mg NN I-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Tablet NNP B-NP O
PO NNP I-NP O
DAILY NNP I-NP O
( ( O O
Daily NNP B-NP O
) ) O O
. . B-VP O
   
Disp NNP B-NP O
:* VBD B-VP O
30 CD O O
Tablet NNP B-NP O
( ( O O
s JJ B-NP O
)* NNP I-NP O
Refills NNP I-NP O
:* VBZ O O
2 CD O O
* NN B-NP O
2. CD O O
Pantoprazole NNP B-NP B-treatment
40 CD O O
mg NN B-NP O
Tablet NNP I-NP O
, , O O
Delayed NNP B-NP O
Release NNP I-NP O
( ( O O
E.C. NNP B-NP O
) ) O O
Sig NN B-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Tablet NN B-NP O
, , O O
Delayed NNP B-NP O
Release NNP I-NP O
( ( O O
E.C. NNP B-NP O
) ) O O
PO NNP B-NP O
Q24H NNP I-NP O
( ( O O
every DT O O
24 CD O O
hours NNS B-NP O
) ) O O
. . B-VP O
   
Disp NNP B-NP O
:* VBD B-VP O
30 CD O O
Tablet NNP B-NP O
, , O O
Delayed NNP B-NP O
Release NNP I-NP O
( ( O O
E.C. NNP B-NP O
)( NNP I-NP O
s VBD B-VP O
)* NNP B-NP O
Refills NNP I-NP O
:* VBZ O O
2 CD O O
* NN B-NP O
3. CD O O
Mycophenolate NNP B-NP B-treatment
Mofetil NNP I-NP I-treatment
500 CD O O
mg NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
Two CD O O
( ( O O
2 CD O O
) ) O O
Tablet NNP B-NP O
PO NNP I-NP O
BID NNP I-NP O
( ( O O
2 CD O O
times NNS B-NP O
a DT B-NP O
day NN I-NP O
) ) O O
. . B-VP O
   
Disp NNP B-NP O
:* VBD B-VP O
120 CD O O
Tablet NNP B-NP O
( ( O O
s JJ B-NP O
)* NNP I-NP O
Refills NNP I-NP O
:* VBZ O O
2 CD O O
* NN B-NP O
4. CD O O
Prednisone NNP B-NP B-treatment
5 CD O O
mg NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
Three CD O O
( ( O O
3 CD O O
) ) O O
Tablet NNP B-NP O
PO NNP I-NP O
DAILY NNP I-NP O
( ( O O
Daily NNP B-NP O
) ) O O
. . B-VP O
   
Disp NNP B-NP O
:* VBD B-VP O
30 CD O O
Tablet NNP B-NP O
( ( O O
s JJ B-NP O
)* NNP I-NP O
Refills NNP I-NP O
:* VBZ O O
2 CD O O
* NN B-NP O
5. CD O O
Valganciclovir NNP B-NP B-treatment
450 CD O O
mg NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
Two CD O O
( ( O O
2 CD O O
) ) O O
Tablet NNP B-NP O
PO NNP I-NP O
DAILY NNP I-NP O
( ( O O
Daily NNP B-NP O
) ) O O
. . B-VP O
   
Disp NNP B-NP O
:* VBD B-VP O
60 CD O O
Tablet NNP B-NP O
( ( O O
s JJ B-NP O
)* NNP I-NP O
Refills NNP I-NP O
:* VBZ O O
2 CD O O
* NN B-NP O
6. CD O O
Ursodiol NNP B-NP B-treatment
300 CD O O
mg NN B-NP O
Capsule NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Capsule NNP B-NP O
PO NNP I-NP O
TID NNP I-NP O
( ( O O
3 CD O O
times NNS B-NP O
a DT B-NP O
day NN I-NP O
) ) O O
. . B-VP O
   
7. CD O O
Metoprolol NNP B-NP B-treatment
Tartrate NNP I-NP I-treatment
25 CD O O
mg NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
1.5 CD O O
Tablets NNS B-NP O
PO NNP I-NP O
BID NNP I-NP O
( ( O O
2 CD O O
times NNS B-NP O
a DT B-NP O
day NN I-NP O
) ) O O
. . B-VP O
   
8. CD O O
Acetaminophen NNP B-NP B-treatment
325 CD O O
mg NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
1-2 JJ B-NP O
Tablets NNS I-NP O
PO NNP I-NP O
Q4-6H NNP I-NP O
( ( O O
every DT O O
4 CD O O
to TO O O
6 CD O O
hours NNS B-NP O
) ) O O
as IN B-VP O
needed VBN O O
. . B-VP O
   
9. CD O O
Fluconazole JJ O B-treatment
200 CD O O
mg JJ B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
Two CD O O
( ( O O
2 CD O O
) ) O O
Tablet NNP B-NP O
PO NNP I-NP O
Q24H NNP I-NP O
( ( O O
every DT O O
24 CD O O
hours NNS B-NP O
) ) O O
. . B-VP O
   
Disp NNP B-NP O
:* VBD B-VP O
60 CD O O
Tablet NNP B-NP O
( ( O O
s JJ B-NP O
)* NNP I-NP O
Refills NNP I-NP O
:* VBZ O O
2 CD O O
* NN B-NP O
10. CD O O
Insulin NNP B-NP B-treatment
SS NNP I-NP I-treatment
and CC O O
fixed VBN O B-treatment
dose JJ B-NP I-treatment
Fingerstick NNP I-NP B-test
QACHS NNP I-NP O
, , O O
3 CD O O
AM NNP B-NP O
Insulin NNP I-NP B-treatment
SC NNP I-NP I-treatment
Fixed NNP I-NP I-treatment
Dose NNP I-NP I-treatment
Orders NNP I-NP O
Breakfast NNP I-NP O
NPH NNP I-NP B-treatment
17 CD O O
Units NNP B-NP O
Insulin NNP I-NP B-treatment
SC NNP I-NP I-treatment
Sliding NNP I-NP I-treatment
Scale NNP I-NP I-treatment
Breakfast NNP I-NP O
Lunch NNP I-NP O
Dinner NNP I-NP O
Bedtime NNP I-NP O
Regular NNP I-NP O
Regular NNP I-NP O
Regular NNP I-NP O
Regular NNP I-NP O
Glucose NNP I-NP O
Insulin NNP I-NP O
Dose NNP I-NP O
Insulin NNP I-NP O
Dose NNP I-NP O
Insulin NNP I-NP O
Dose NNP I-NP O
Insulin NNP I-NP O
Dose NNP I-NP O
0-60 JJ B-NP O
mg NN I-NP O
/ NNP I-NP O
dL VBZ O O
4 CD O O
oz. NN B-NP O
Juice NNP I-NP O
4 CD O O
oz. NN B-NP O
Juice NNP I-NP O
4 CD O O
oz. NN B-NP O
Juice NNP I-NP O
4 CD O O
oz. JJ B-NP O
Juice NNP I-NP O
61-120 JJ B-NP O
mg NN I-NP O
/ NNP I-NP O
dL VBZ O O
1 CD O O
Units NNS B-NP O
0 CD O O
Units NNS B-NP O
0 CD O O
Units NNS B-NP O
0 CD O O
Units NNS B-NP O
121-160 JJ B-NP O
mg NN I-NP O
/ NNP I-NP O
dL VBZ O O
2 CD O O
Units NNS B-NP O
0 CD O O
Units NNS B-NP O
1 CD O O
Units NNS B-NP O
0 CD O O
Units NNS B-NP O
161-200 JJ B-NP O
mg NN I-NP O
/ NNP I-NP O
dL VBZ O O
3 CD O O
Units NNS B-NP O
4 CD O O
Units NNS B-NP O
2 CD O O
Units NNS B-NP O
0 CD O O
Units NNS B-NP O
201-240 JJ B-NP O
mg NN I-NP O
/ NNP I-NP O
dL VBZ O O
5 CD O O
Units NNS B-NP O
6 CD O O
Units NNS B-NP O
4 CD O O
Units NNS B-NP O
0 CD O O
Units NNS B-NP O
241-280 JJ B-NP O
mg NN I-NP O
/ NNP I-NP O
dL VBZ O O
6 CD O O
Units NNS B-NP O
7 CD O O
Units NNS B-NP O
5 CD O O
Units NNS B-NP O
1 CD O O
Units NNS B-NP O
281-320 JJ B-NP O
mg NN I-NP O
/ NNP I-NP O
dL VBZ O O
7 CD O O
Units NNS B-NP O
8 CD O O
Units NNS B-NP O
6 CD O O
Units NNS B-NP O
2 CD O O
Units NNS B-NP O
321-360 JJ B-NP O
mg NN I-NP O
/ NNP I-NP O
dL VBZ O O
9 CD O O
Units NNS B-NP O
10 CD O O
Units NNS B-NP O
8 CD O O
Units NNS B-NP O
3 CD O O
Units NNS B-NP O
361-400 JJ B-NP O
mg NN I-NP O
/ NNP I-NP O
dL VBZ O O
11 CD O O
Units NNS B-NP O
11 CD O O
Units NNS B-NP O
10 CD O O
Units NNS B-NP O
4 CD O O
Units NNS B-NP O
> VBD B-VP O
400 CD O O
mg NN B-NP O
/ NNP I-NP O
dL NN I-NP O
Notify NNP I-NP O
M.D. NNP I-NP O
Notify NNP I-NP O
M.D. NNP I-NP O
Notify NNP I-NP O
M.D. NNP I-NP O
Notify NNP I-NP O
M.D. NNP I-NP O
11. CD O O
Tacrolimus NNP B-NP B-treatment
0.5 CD O O
mg NN B-NP O
Capsule NNP I-NP O
Sig NNP I-NP O
: : O O
Three CD O O
( ( O O
3 CD O O
) ) O O
Capsule NNP B-NP O
PO NNP I-NP O
twice RB O O
a DT B-NP O
day NN I-NP O
. . B-VP O
   
Disp NNP B-NP O
:* VBD B-VP O
180 CD O O
Capsule NNP B-NP O
( ( O O
s JJ B-NP O
)* NNP I-NP O
Refills NNP I-NP O
:* VBZ O O
0 CD O O
* NN B-NP O
12. CD O O
Insulin NNP B-NP B-treatment
NPH NNP I-NP I-treatment
Human NNP I-NP I-treatment
Recomb NNP I-NP I-treatment
100 CD O O
unit NN B-NP O
/ NNP I-NP O
mL NN I-NP O
Cartridge NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Subcutaneous NNP B-NP O
at IN B-VP O
breakfast NN B-NP O
: : O O
Please NNP B-NP O
take VB O O
as IN B-VP O
prescribed VBN O O
by IN B-VP O
Albano NNP B-NP B-person
/ NNP I-NP O
Transplant NNP I-NP B-person
Team NNP I-NP I-person
. . B-VP O
   
Disp NNP B-NP O
:* VBD B-VP O
10 CD O O
* NNP B-NP O
Refills NNP I-NP O
:* VBZ O O
2 CD O O
* NN B-NP O
13. CD O O
Insulin NNP B-NP B-treatment
Regular NNP I-NP I-treatment
Human NNP I-NP I-treatment
300 CD O O
unit NN B-NP O
/ VBD B-VP O
3 CD O O
mL JJ B-NP O
Insulin NNP I-NP O
Pen NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Subcutaneous NNP B-NP O
four CD O O
times NNS B-NP O
a DT B-NP O
day NN I-NP O
: : O O
Please NNP B-NP O
take VB O O
as IN B-VP O
prescribed VBN O O
by IN B-VP O
Albano NNP B-NP B-person
/ NNP I-NP O
Transplant NNP I-NP B-person
team NN I-NP I-person
. . B-VP O
   
Disp NNP B-NP O
:* VBD B-VP O
10 CD O O
* NNP B-NP O
Refills NNP I-NP O
:* VBZ O O
2 CD O O
* NN B-NP O
14. CD O O
Insulin NNP B-NP B-treatment
Syringe NNP I-NP I-treatment
Needless NNP I-NP I-treatment
( ( O O
Disp NNP B-NP O
) ) O O
1 CD O O
mL JJ B-NP O
Syringe NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Miscell. NNP B-NP O
as IN B-VP O
directed VBN O O
by IN B-VP O
Albano NNP B-NP B-person
/ NNP I-NP O
Trasplant NNP I-NP B-person
. . B-VP O
   
Disp NNP B-NP O
:* VBD B-VP O
150 CD O O
* NNP B-NP O
Refills NNP I-NP O
:* VBZ O O
2 CD O O
* NN B-NP O
Discharge NNP I-NP O
Disposition NNP I-NP O
: : O O
Home NN B-NP O
with IN B-VP O
Service NNP B-NP O
Discharge NNP I-NP O
Diagnosis NNP I-NP O
: : O O
End NN B-NP B-problem
stage NN I-NP I-problem
liver JJ B-NP I-problem
disease NN I-NP I-problem
Discharge NNP I-NP O
Condition NNP I-NP O
: : O O
Good JJ B-NP O
Discharge NN I-NP O
Instructions NNS I-NP O
: : O O
Please NNP B-NP O
take VB O O
medications NNS B-NP B-treatment
as IN B-VP O
prescribed JJ O O
and CC O O
read JJ B-NP O
warning NN I-NP O
labels NNS I-NP O
carefully RB O O
. . B-VP O
   
If IN B-VP O
symptoms NNS B-NP O
such JJ O O
as IN B-VP O
fever NN B-NP B-problem
/ NNP I-NP O
chills NNS I-NP B-problem
, , O O
nausea NN B-NP B-problem
/ NNP I-NP O
vomiting NN I-NP B-problem
, , O O
increasing VBG O B-problem
pain NN B-NP I-problem
/ NNP I-NP O
redness NN I-NP B-problem
/ NNP I-NP O
purulent NN I-NP B-problem
discharge NN I-NP I-problem
from IN B-VP O
incision NN B-NP B-problem
, , O O
increasing VBG O B-problem
jaundice NN B-NP I-problem
, , O O
please VB O O
call NN B-NP O
or CC O O
go VB O O
to TO O O
the DT B-NP O
emergency NN I-NP O
room NN I-NP O
immediately RB O O
. . B-VP O
   
Remember NNP B-NP O
to TO O O
call VB O O
for IN B-VP O
a DT O O
follow JJ O O
up RP O O
appointment NN B-NP O
( ( O O
bellow NN B-NP O
) ) O O
. . B-VP O
   
Light JJ B-NP O
activities NNS I-NP O
until IN B-VP O
seen VBN O O
in IN B-VP O
clinic JJ O O
. . B-VP O
   
May NNP B-NP O
eat NN I-NP O
regular JJ B-NP O
food NN I-NP O
. . B-VP O
   
May NNP B-NP O
shower NN I-NP O
but CC O O
no DT B-NP O
baths NNS I-NP O
. . B-VP O
   
Pat NNP B-NP O
incision NN I-NP B-problem
wounds NNS I-NP I-problem
dry JJ O O
, , O O
do VBP O O
not RB O O
scrub VB O O
wound NN B-NP B-problem
when WRB O O
showering VBG O O
. . B-VP O
   
Absolutely RB O O
no DT B-NP O
smoking NN I-NP O
. . B-VP O
   
Followup JJ B-NP O
Instructions NNS I-NP O
: : O O
Provider NN B-NP O
: : O O
Francis NNP B-NP B-person
Britni NNP I-NP I-person
, , O I-person
MD NNP B-NP I-person
Phone NNP I-NP O
:( NNP I-NP O
646 CD O O
) ) O O
444-8240 JJ B-NP O
Date NNP I-NP O
/ NN I-NP O
Time NN I-NP O
: : O O
2015-01-22 JJ O O
10:40 CD O O
Provider NN B-NP O
: : O O
Francis NNP B-NP B-person
Britni NNP I-NP I-person
, , O I-person
MD NNP B-NP I-person
Phone NNP I-NP O
:( NNP I-NP O
646 CD O O
) ) O O
444-8240 JJ B-NP O
Date NNP I-NP O
/ NN I-NP O
Time NN I-NP O
: : O O
2015-01-29 JJ O O
10:40 CD O O
Provider NN B-NP O
: : O O
Francis NNP B-NP B-person
Britni NNP I-NP I-person
, , O I-person
MD NNP B-NP I-person
Phone NNP I-NP O
:( NNP I-NP O
646 CD O O
) ) O O
444-8240 JJ B-NP O
Date NNP I-NP O
/ NN I-NP O
Time NN I-NP O
: : O O
2015-02-05 JJ O O
9:20 CD O O
Please NNP B-NP O
follow VB O O
up RP O O
with IN B-VP O
Albano NNP B-NP B-person
, , O O
as IN B-VP O
direct JJ O O
by IN B-VP O
them PRP O B-pronoun
, , O O
a DT B-NP O
few JJ I-NP O
days NNS I-NP O
after IN B-VP O
discharge NN B-NP O
from IN B-VP O
the DT B-NP O
hospital NN I-NP O
( ( O O
( ( O O
371 CD O O
) ) O O
400 CD O O
5776 CD O O
. . B-VP O
   
Francis NNP B-NP B-person
Britni NNP I-NP I-person
MD NNP I-NP I-person
34-902 JJ O O
Completed VBN O O
by IN B-VP O
: : O O
Wayne NNP B-NP B-person
Chris NNP I-NP I-person
MD NNP I-NP I-person
18-062 JJ B-NP O
2015-01-20 JJ I-NP O
@ NN I-NP O
1208 CD O O
Signed NNP B-NP O
electronically RB O O
by IN B-VP O
: : O O
DR. NNP B-NP B-person
Francis NNP I-NP I-person
VU NNP I-NP I-person
Vila NNP I-NP I-person
on IN B-VP O
: : O O
MON NNP B-NP O
2015-01-26 CD O O
6:12 CD O O
PM NNP B-NP O
( ( O O
End NNP B-NP O
of IN B-VP O
Report NNP B-NP O
) ) O O
-EMPTYLINE- VBP O O
-DOCSTART- JJ O O
-EMPTYLINE- $ O O
950452368 CD O O
CTMC NNP B-NP O
25445040 CD O O
808386 CD O O
5/9/1998 CD O O
12:00:00 CD O O
AM NNP B-NP O
EXTERNAL NNP I-NP B-problem
WOUND NNP I-NP I-problem
INFECTIONS NNP I-NP I-problem
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date NNP I-NP O
: : O O
05/09/1998 CD O O
Report NNP B-NP O
Status NNP I-NP O
: : O O
Signed VBN O O
Discharge NNP B-NP O
Date NNP I-NP O
: : O O
05/25/1998 CD O O
PRINCIPAL NNP B-NP O
DIAGNOSIS NNP I-NP O
: : O O
STERNAL NNP B-NP B-problem
WOUND NNP I-NP I-problem
INFECTION NNP I-NP I-problem
. . B-VP O
   
HISTORY NNP B-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
is VBZ O O
a DT B-NP O
74-year-old JJ I-NP O
woman NN I-NP O
, , O O
well RB O O
known VBN O O
to TO O O
the DT B-NP O
cardiac JJ I-NP B-person
surgery NN I-NP I-person
service NN I-NP O
, , O O
readmitted VBN O O
from IN B-VP O
Glasmif/putdi NNP B-NP O
Health NNP I-NP O
Network NNP I-NP O
with IN B-VP O
sternal JJ B-NP B-problem
wound NN I-NP I-problem
infection NN I-NP I-problem
. . B-VP O
   
She PRP O B-person
has VBZ O O
been VBN O O
previously RB O O
hospitalized VBN O O
on IN B-VP O
12 CD O O
April NNP B-NP O
1998 CD O O
for IN B-VP O
the DT B-NP B-problem
same JJ I-NP I-problem
diagnosis NN I-NP I-problem
. . B-VP O
   
She PRP O B-person
is VBZ O O
now RB O O
coming VBG O O
for IN B-VP O
surgical JJ B-NP B-treatment
treatment NN I-NP I-treatment
, , O O
wound NN B-NP B-treatment
debridement NN I-NP I-treatment
, , O O
and CC O O
possible JJ B-NP O
wound NN I-NP B-treatment
closure NN I-NP I-treatment
with IN B-VP I-treatment
bilateral JJ B-NP I-treatment
pectoralis NNS I-NP I-treatment
flap NN I-NP I-treatment
. . B-VP O
   
She PRP O B-person
underwent JJ B-NP O
coronary JJ I-NP B-treatment
artery NN I-NP I-treatment
bypass NN I-NP I-treatment
graft NN I-NP I-treatment
times NNS I-NP O
two CD O O
with IN B-VP O
saphenous JJ B-NP B-treatment
vein NN I-NP I-treatment
graft NN I-NP I-treatment
on IN B-VP O
29 CD O O
March NNP B-NP O
1998 CD O O
. . B-VP O
   
Of IN B-VP O
note NN B-NP O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
is VBZ O O
status NN B-NP B-problem
post NN I-NP I-problem
lymphoma NN I-NP I-problem
with IN B-VP O
treatment NN B-NP O
of IN B-VP O
chemotherapy NN B-NP B-treatment
and CC O O
radiation NN B-NP B-treatment
six CD O O
years NNS B-NP O
ago RB O O
, , O O
and CC O O
is VBZ O O
an DT B-NP B-problem
insulin-dependent JJ I-NP I-problem
diabetic NN I-NP I-problem
. . B-VP O
   
PAST NNP B-NP O
MEDICAL NNP I-NP O
HISTORY NNP I-NP O
: : O O
Insulin-dependent JJ B-NP B-problem
diabetes NNS I-NP I-problem
mellitus NN I-NP I-problem
, , O O
lymphoma NN B-NP B-problem
as IN B-VP O
above IN B-VP O
, , O O
ulcerative JJ B-NP B-problem
colitis NN I-NP I-problem
, , O O
melanoma NN B-NP B-problem
status NN I-NP O
post NN I-NP O
excision NN I-NP B-treatment
in IN B-VP I-treatment
right JJ B-NP I-treatment
upper JJ I-NP I-treatment
extremity NN I-NP I-treatment
, , O O
hypertension NN B-NP B-problem
, , O O
hypothyroidism NN B-NP B-problem
, , O O
congestive JJ B-NP B-problem
heart NN I-NP I-problem
failure NN I-NP I-problem
, , O O
and CC O O
coronary JJ B-NP B-problem
artery NN I-NP I-problem
disease NN I-NP I-problem
with IN B-VP O
bypass NN B-NP B-treatment
grafting NN I-NP I-treatment
. . B-VP O
   
PAST JJ B-NP O
SURGICAL JJ I-NP O
HISTORY NN I-NP O
: : O O
She PRP O B-person
is VBZ O O
status NN B-NP O
post NN I-NP O
left VBD B-VP B-treatment
knee JJ B-NP I-treatment
replacement NN I-NP I-treatment
and CC O O
status NN B-NP O
post NN I-NP O
multiple JJ B-NP B-treatment
prior JJ I-NP I-treatment
surgeries NNS I-NP I-treatment
and CC O O
reconstruction NN B-NP B-treatment
of IN B-VP I-treatment
the DT B-NP I-treatment
knee NN I-NP I-treatment
. . B-VP O
   
Status NNP B-NP O
post NN I-NP O
cholecystectomy NN I-NP B-treatment
, , O O
lumbar NN B-NP B-treatment
diskectomy NN I-NP I-treatment
, , O O
and CC O O
tonsillectomy NN B-NP B-treatment
with IN B-VP O
adenoidectomy NN B-NP B-treatment
. . B-VP O
   
ALLERGIES NN B-NP O
: : O O
Erythromycin NNP B-NP B-treatment
, , O O
vancomycin NN B-NP B-treatment
, , O O
and CC O O
Bacitracin NNP B-NP B-treatment
. . B-VP O
   
ADMISSION NNP B-NP O
MEDICATIONS NNP I-NP O
: : O O
Elavil JJ O B-treatment
50 CD O O
mg NN B-NP O
p.o. NN I-NP O
q.h.s. NN I-NP O
, , O O
coated VBD B-VP B-treatment
aspirin RB O I-treatment
325 CD O O
mg NNS B-NP O
p.o. JJ B-NP O
p.day NN I-NP O
, , O O
Tegretol NNP B-NP B-treatment
100 CD O O
mg NN B-NP O
p.o. NN I-NP O
b.i.d. NN I-NP O
, , O O
Ancef NNP B-NP B-treatment
1 CD O O
gm NN B-NP O
IV NNP I-NP O
q.12h. NN I-NP O
times NNS I-NP O
seven CD O O
days NNS B-NP O
, , O O
Vasotec NNP B-NP B-treatment
5 CD O O
mg NN B-NP O
p.o. NN I-NP O
q.day NN I-NP O
, , O O
Synthroid NNP B-NP B-treatment
0.025 CD O O
mg NN B-NP O
p.o. NN I-NP O
q.day NN I-NP O
, , O O
Asacol NNP B-NP B-treatment
400 CD O O
mg NN B-NP O
q.a.m. NN I-NP O
and CC O O
800 CD O O
mg NN B-NP O
q.p.m. NN I-NP O
, , O O
Lopressor NNP B-NP B-treatment
25 CD O O
mg NN B-NP O
p.o. NN I-NP O
b.i.d. NN I-NP O
, , O O
Prilosec NNP B-NP B-treatment
20 CD O O
mg NN B-NP O
p.o. NN I-NP O
q.day NN I-NP O
, , O O
and CC O O
insulin VBZ O B-treatment
70/30 CD O O
26 CD O O
units NNS B-NP O
in IN B-VP O
the DT B-NP O
morning NN I-NP O
and CC O O
12 CD O O
units NNS B-NP O
at IN B-VP O
night NN B-NP O
. . B-VP O
   
PHYSICAL JJ B-NP O
EXAMINATION NN I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
admitted VBN O O
with IN B-VP O
a DT B-NP O
blood NN I-NP B-test
pressure NN I-NP I-test
of IN B-VP O
140/80 CD O O
, , O O
temperature NN B-NP B-test
101.3 CD O O
, , O O
pulse RB O B-test
84 CD O O
, , O O
and CC O O
respiratory NN B-NP B-test
rate NN I-NP I-test
22 CD O O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
is VBZ O O
obese JJ O B-problem
with IN B-VP O
unremarkable JJ B-NP O
physical JJ I-NP O
examination NN I-NP O
except IN B-VP O
for IN B-VP O
a DT B-NP B-problem
systolic JJ I-NP I-problem
murmur NN I-NP I-problem
, , O I-problem
I PRP O I-problem
/ VBP O I-problem
VI NNP B-NP I-problem
and CC O O
erythema NN B-NP B-problem
over IN B-VP I-problem
the DT B-NP I-problem
sternal JJ I-NP I-problem
wound NN I-NP I-problem
and CC O O
upper JJ B-NP O
third NN I-NP O
. . B-VP O
   
The DT B-NP B-problem
wound NN I-NP I-problem
had VBD B-VP O
a DT B-NP B-problem
beefy NN I-NP I-problem
red JJ B-NP I-problem
cellulitic JJ I-NP I-problem
area NN I-NP I-problem
surrounding VBG O O
an DT B-NP O
open JJ I-NP O
area NN I-NP O
, , O O
blanching VBG O O
to TO O O
touch VB O O
. . B-VP O
   
There EX O O
was VBD B-VP O
no DT B-NP O
purulence NN I-NP B-problem
or CC O O
discharge NN B-NP B-problem
noted VBN O O
. . B-VP O
   
HOSPITAL NNP B-NP O
COURSE NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
placed VBN O O
on IN B-VP O
IV NNP B-NP B-treatment
antibiotics NNS I-NP I-treatment
, , O O
Ancef NNP B-NP B-treatment
1 CD O O
gm NN B-NP O
q.8h. NN I-NP O
On IN B-VP O
10 CD O O
May NNP B-NP O
1998 CD O O
, , O O
she PRP O B-person
underwent VBD B-VP O
sternal JJ B-NP B-treatment
wound NN I-NP I-treatment
debridement NN I-NP I-treatment
and CC O I-treatment
closure NN B-NP I-treatment
, , O O
performed VBN O O
by IN B-VP O
Dr. NNP B-NP B-person
Falccouette NNP I-NP I-person
and CC O O
Dr. NNP B-NP B-person
Shuffzeln NNP I-NP I-person
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
switched VBN O O
to TO O O
ampicillin VB O B-treatment
, , O O
gentamicin NN B-NP B-treatment
, , O O
and CC O O
clindamycin NN B-NP B-treatment
, , O O
according VBG O O
to TO O O
the DT B-NP B-test
culture NN I-NP I-test
, , O O
Enterococci NNP B-NP B-problem
and CC O O
Staphylococcus NNP B-NP B-problem
in IN B-VP O
the DT B-NP B-problem
wound NN I-NP I-problem
. . B-VP O
   
Due NNP B-NP O
to TO O O
the DT B-NP B-problem
persistent JJ I-NP I-problem
fevers NNS I-NP I-problem
, , O O
the DT B-NP B-person
patient JJ I-NP I-person
underwent JJ I-NP O
vancomycin NN I-NP B-treatment
desensitization NN I-NP I-treatment
in IN B-VP O
the DT B-NP O
surgical JJ I-NP O
Intensive NNP I-NP O
Care NNP I-NP O
Unit NNP I-NP O
followed VBN O O
by IN B-VP O
a DT B-NP B-treatment
change NN I-NP I-treatment
of IN B-VP I-treatment
antibiotics NNS B-NP I-treatment
to TO O O
vancomycin VB O B-treatment
and CC O O
levofloxacin VB O B-treatment
. . B-VP O
   
Further JJ B-NP B-test
cultures NNS I-NP I-test
from IN B-VP I-test
sputum NN B-NP I-test
and CC O I-test
urine NN B-NP I-test
revealed VBN O O
yeast RB O B-problem
sensitive JJ O O
to TO O O
Diflucan NNP B-NP B-treatment
, , O O
which WDT O B-pronoun
was VBD B-VP O
administered VBN O O
shortly RB O O
after IN B-VP O
. . B-VP O
   
Because IN B-VP O
of IN B-VP O
expected VBN O B-treatment
long JJ B-NP I-treatment
term NN I-NP I-treatment
antibiotic JJ B-NP I-treatment
administration NN I-NP I-treatment
, , O O
a DT B-NP B-treatment
PICC NNP I-NP I-treatment
line NN I-NP I-treatment
was VBD B-VP O
placed VBN O O
and CC O O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
prepared VBN O O
for IN B-VP O
transfer NN B-NP O
back RB O O
to TO O O
Fo NNP B-NP O
Hospital NNP I-NP O
. . B-VP O
   
As IN B-VP O
a DT B-NP B-problem
small JJ I-NP I-problem
complication NN I-NP I-problem
, , O O
the DT B-NP B-person
patient NN I-NP I-person
opened VBD B-VP O
a DT B-NP B-problem
left JJ I-NP I-problem
ankle NN I-NP I-problem
wound IN B-VP I-problem
post NN B-NP O
saphenous JJ B-NP B-treatment
vein NN I-NP I-treatment
harvest NN I-NP I-treatment
, , O O
which WDT O B-pronoun
persists VBZ O O
up RP O O
until IN B-VP O
now RB O O
and CC O O
is VBZ O O
of IN B-VP O
a DT B-NP O
size NN I-NP O
2 CD O O
x NN B-NP O
1 CD O O
cm NN B-NP O
. . B-VP O
   
Due NNP B-NP O
to TO O O
difficult JJ B-NP B-problem
ambulation NN I-NP I-problem
, , O O
the DT B-NP B-person
patient NN I-NP I-person
developed VBD B-VP O
a DT B-NP B-problem
small JJ I-NP I-problem
ulcer NN I-NP I-problem
in IN B-VP I-problem
the DT B-NP I-problem
sacral JJ I-NP I-problem
area NN I-NP I-problem
, , O O
which WDT O B-pronoun
was VBD B-VP O
treated VBN O O
with IN B-VP O
Duoderm NNP B-NP B-treatment
dressing VBG O I-treatment
. . B-VP O
   
During IN B-VP O
the DT B-NP O
course NN I-NP O
of IN B-VP O
hospitalization NN B-NP O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
followed VBN O O
by IN B-VP O
cardiac JJ B-NP B-person
surgery NN I-NP I-person
, , O O
cardiology NN B-NP B-person
, , O O
infectious JJ B-NP B-person
disease NN I-NP I-person
, , O O
allergy NN B-NP B-person
, , O O
and CC O O
medicine NN B-NP B-person
, , O O
including VBG O O
GI NNP B-NP B-person
teams NNS I-NP I-person
. . B-VP O
   
DISCHARGE NNP B-NP O
MEDICATIONS NNP I-NP O
: : O O
Elavil NN B-NP B-treatment
by IN B-VP O
mouth NN B-NP O
15 CD O O
mg NN B-NP O
every DT B-NP O
night NN I-NP O
, , O O
Dulcolax NNP B-NP B-treatment
rectally RB O O
10 CD O O
mg NN B-NP O
once RB O O
a DT B-NP O
day NN I-NP O
, , O O
Tegretol NNP B-NP B-treatment
by IN B-VP O
mouth NN B-NP O
100 CD O O
mg NN B-NP O
twice RB O O
a DT B-NP O
day NN I-NP O
, , O O
Benadryl NNP B-NP B-treatment
by IN B-VP O
mouth NN B-NP O
25 CD O O
mg NN B-NP O
three CD O O
times NNS B-NP O
a DT B-NP O
day NN I-NP O
, , O O
Colace NNP B-NP B-treatment
by IN B-VP O
mouth NN B-NP O
200 CD O O
mg NN B-NP O
twice RB O O
a DT B-NP O
day NN I-NP O
, , O O
Vasotec NNP B-NP B-treatment
by IN B-VP O
mouth NN B-NP O
10 CD O O
mg NN B-NP O
twice RB O O
a DT B-NP O
day NN I-NP O
, , O O
EOC NNP B-NP B-treatment
/ NNP I-NP I-treatment
LOC NNP I-NP I-treatment
p.r./p.o. VBP O O
one CD O O
each DT O O
once RB O O
a DT B-NP O
day NN I-NP O
as IN B-VP O
needed VBN O O
for IN B-VP O
constipation NN B-NP B-problem
, , O O
Lasix NNP B-NP B-treatment
by IN B-VP O
mouth NN B-NP O
80 CD O O
mg NN B-NP O
every DT B-NP O
morning NN I-NP O
, , O O
insulin NN B-NP B-treatment
regular JJ O O
according VBG O O
to TO O O
insulin VB O O
scale NN B-NP O
, , O O
Synthroid NNP B-NP B-treatment
by IN B-VP O
mouth NN B-NP O
25 CD O O
mcg NN B-NP O
once RB O O
a DT B-NP O
day NN I-NP O
, , O O
Maalox NNP B-NP B-treatment
Plus NNP I-NP I-treatment
Extra NNP I-NP I-treatment
Strength NNP I-NP I-treatment
by IN B-VP O
mouth NN B-NP O
15 CD O O
ml NN B-NP O
every DT O O
six CD O O
hours NNS B-NP O
as IN B-VP O
needed VBN O O
for IN B-VP O
indigestion NN B-NP B-problem
, , O O
Milk NNP B-NP O
of IN B-VP O
Magnesia NNP B-NP B-treatment
by IN B-VP O
mouth NN B-NP O
30 CD O O
ml NN B-NP O
once RB O O
a DT B-NP O
day NN I-NP O
as IN B-VP O
needed VBN O O
for IN B-VP O
constipation NN B-NP B-problem
, , O O
Asacol NNP B-NP B-treatment
by IN B-VP O
mouth NN B-NP O
400 CD O O
mg NN B-NP O
every DT B-NP O
morning NN I-NP O
, , O O
Asacol NNP B-NP B-treatment
800 CD O O
mg NN B-NP O
every DT B-NP O
night NN I-NP O
, , O O
Lopressor NNP B-NP B-treatment
by IN B-VP O
mouth NN B-NP O
25 CD O O
mg NN B-NP O
twice RB O O
a DT B-NP O
day NN I-NP O
, , O O
Miracle NNP B-NP B-treatment
cream NN I-NP I-treatment
topically RB O O
on IN B-VP O
skin NN B-NP O
once RB O O
a DT B-NP O
day NN I-NP O
, , O O
nystatin JJ O B-treatment
swish JJ O I-treatment
and CC O I-treatment
swallow JJ O I-treatment
by IN B-VP O
mouth NN B-NP O
5 CD O O
ml NN B-NP O
four CD O O
times NNS B-NP O
a DT B-NP O
day NN I-NP O
, , O O
Percocet NNP B-NP B-treatment
by IN B-VP O
mouth VBG O O
one CD O O
tab NN B-NP O
every DT O O
four CD O O
hours NNS B-NP O
as IN B-VP O
needed VBN O O
for IN B-VP O
pain NN B-NP B-problem
, , O O
and CC O O
vancomycin NN B-NP B-treatment
by IN B-VP O
infusion NN B-NP O
1 CD O O
gm NN B-NP O
every DT O O
18 CD O O
hours NNS B-NP O
; : O O
instructions NNS B-NP O
in IN B-VP O
250 CD O O
ml NNS B-NP O
slow JJ B-NP B-treatment
IV NNP I-NP I-treatment
infusion NN I-NP I-treatment
over IN B-VP O
one CD O O
hour NN B-NP O
. . B-VP O
   
Note NN B-NP O
, , O O
please VB O O
draw JJ B-NP O
blood NN I-NP O
for IN B-VP O
vancomycin NN B-NP B-test
levels NNS I-NP I-test
on IN B-VP O
25 CD O O
May NNP B-NP O
1998 CD O O
, , O O
before IN B-VP O
the DT B-NP O
next JJ I-NP O
dose NN I-NP O
, , O O
to TO O O
get VB O O
the DT B-NP B-test
trough JJ I-NP I-test
level NN I-NP I-test
. . B-VP O
   
Keep VB O O
vancomycin NN B-NP B-test
trough IN B-VP I-test
between IN B-VP O
10-20 JJ O O
, , O O
but CC O O
not RB O O
less JJR O O
due JJ O O
to TO O O
desensitization NN B-NP B-problem
. . B-VP O
   
Vancomycin NNP B-NP B-test
levels NNS I-NP I-test
should MD O O
be VB O O
checked VBN O O
every DT B-NP O
third JJ I-NP O
day NN I-NP O
for IN B-VP O
four CD O O
to TO O O
six CD O O
weeks NNS B-NP O
, , O O
according VBG O O
to TO O O
IMD NNP B-NP O
. . B-VP O
   
Nizatidine NNP B-NP B-treatment
by IN B-VP O
mouth NN B-NP O
150 CD O O
mg NN B-NP O
twice RB O O
a DT B-NP O
day NN I-NP O
, , O O
insulin NN B-NP B-treatment
70/30 CD O O
human JJ B-NP O
injection NN I-NP O
under IN B-VP O
skin JJ O O
12 CD O O
units NNS B-NP O
every DT B-NP O
night NN I-NP O
, , O O
insulin NN B-NP B-treatment
70/30 CD O O
human JJ B-NP O
injection NN I-NP O
subcutaneous JJ O O
26 CD O O
units NNS B-NP O
every DT B-NP O
morning NN I-NP O
, , O O
Lovenox NNP B-NP B-treatment
injection NN I-NP O
under IN B-VP O
skin NN B-NP O
40 CD O O
mg NN B-NP O
once RB O O
a DT B-NP O
day NN I-NP O
, , O O
and CC O O
levofloxacin NN B-NP B-treatment
by IN B-VP O
mouth NN B-NP O
250 CD O O
mg NN B-NP O
once RB O O
a DT B-NP O
day NN I-NP O
. . B-VP O
   
Dictated VBN O O
By IN B-VP O
: : O O
NALA NNP B-NP B-person
BEST NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
KJ76 NNP I-NP O
Attending NNP I-NP B-person
: : O O
JOFREDD NNP B-NP B-person
N. NNP I-NP I-person
FALCCOUETTE NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
CA8 NNP I-NP O
XX584/6088 NNP I-NP O
Batch NNP I-NP O
: : O O
3679 CD O O
Index NNP B-NP O
No. NNP I-NP O
W9YYL76XV1 NNP I-NP O
D NNP I-NP O
: : O O
05/25/98 CD O O
T NN B-NP O
: : O O
05/25/98 CD O O
CC NN B-NP O
: : O O
1. CD O O
LAELK NNP B-NP O
MEMORIAL NNP I-NP O
HOSPITAL NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- VBD B-VP O
917563546 CD O O
ELMVH NNP B-NP O
73397283 CD O O
7646550 CD O O
1/23/2003 CD O O
12:00:00 CD O O
AM NNP B-NP O
Discharge NNP I-NP O
Summary NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date NNP I-NP O
: : O O
Report NN B-NP O
Status NN I-NP O
: : O O
Signed VBN O O
Discharge NNP B-NP O
Date NNP I-NP O
: : O O
01/23/2003 CD O O
Date NNP B-NP O
of IN B-VP O
Discharge NNP B-NP O
: : O O
01/23/2003 CD O O
ATTENDING NN B-NP B-person
: : O O
DOTA NNP B-NP B-person
SPACE NNP I-NP I-person
M.D. NNP I-NP I-person
ADMITTING NNP I-NP O
DIAGNOSIS NNP I-NP O
: : O O
Lumbar NNP B-NP B-problem
spinal JJ B-NP I-problem
stenosis NN I-NP I-problem
. . B-VP O
   
PRINCIPAL JJ B-NP O
PROCEDURE NN I-NP O
: : O O
L2 NNP B-NP B-treatment
to TO O I-treatment
L5 NNP B-NP I-treatment
laminectomy NN I-NP I-treatment
, , O O
L2 NNP B-NP B-treatment
through IN B-VP I-treatment
L5 NNP B-NP I-treatment
posterior JJ B-NP I-treatment
fusion NN I-NP I-treatment
with IN B-VP O
segmental JJ B-NP B-treatment
instrumentation NN I-NP I-treatment
. . B-VP O
   
HISTORY NNP B-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
is VBZ O O
a DT B-NP O
50-year-old JJ I-NP O
female NN I-NP O
with IN B-VP O
history NN B-NP O
of IN B-VP O
low JJ O B-problem
back RB O I-problem
pain NN B-NP I-problem
radiating NN I-NP B-problem
to TO O I-problem
both DT B-NP I-problem
legs NNS I-NP I-problem
. . B-VP O
   
She PRP O B-person
had VBD B-VP O
increasing VBG O B-problem
symptoms NNS B-NP I-problem
overtime RB O O
, , O O
not RB O O
controlled VBN O O
by IN B-VP O
conservative JJ B-NP B-treatment
management NN I-NP I-treatment
. . B-VP O
   
She PRP O B-person
therefore RB O O
elected VBD B-VP O
to TO O O
undergo VB O O
surgical JJ B-NP B-treatment
treatment NN I-NP I-treatment
. . B-VP O
   
PAST NNP B-NP O
MEDICAL NNP I-NP O
HISTORY NN I-NP O
: : O O
Her PRP$ O B-person
past JJ B-NP O
medical JJ I-NP O
history NN I-NP O
is VBZ O O
notable JJ O O
for IN B-VP O
bilateral JJ B-NP B-problem
lower JJR I-NP I-problem
extremity NN I-NP I-problem
venous JJ B-NP I-problem
insufficiency NN I-NP I-problem
with IN B-VP O
edema NN B-NP B-problem
, , O O
hypertension NN B-NP B-problem
. . B-VP O
   
She PRP O B-person
takes VBZ O O
lisinopril JJ B-NP B-treatment
/ NNP I-NP O
hydrochlorothiazide NN I-NP B-treatment
20/25 CD O O
mg NN B-NP O
p.o. NN I-NP O
q.d. NN I-NP O
, , O O
Vioxx NNP B-NP B-treatment
50 CD O O
mg NN B-NP O
p.o. NN I-NP O
q.d. NN I-NP O
, , O O
Lipitor NNP B-NP B-treatment
10 CD O O
mg NN B-NP O
p.o. NN I-NP O
q.d. NN I-NP O
, , O O
Nortriptyline NNP B-NP B-treatment
25 CD O O
mg NN B-NP O
p.o. NN I-NP O
q.h.s. NN I-NP O
, , O O
Neurontin NNP B-NP B-treatment
300 CD O O
mg NN B-NP O
p.o. NN I-NP O
t.i.d. NN I-NP O
ALLERGIES NN I-NP O
: : O O
She PRP O B-person
has VBZ O O
nausea NN B-NP B-problem
with IN B-VP O
Codeine NNP B-NP B-treatment
otherwise RB O O
no DT O O
known VBN O B-problem
drug NN B-NP I-problem
allergies NNS I-NP I-problem
. . B-VP O
   
PAST JJ B-NP O
SURGICAL JJ I-NP O
HISTORY NN I-NP O
: : O O
Past JJ B-NP O
surgical JJ I-NP O
history NN I-NP O
is VBZ O O
notable JJ O O
of IN B-VP O
D NNP B-NP B-test
and CC O O
C NNP B-NP B-test
in IN B-VP O
1980 CD O O
and CC O O
cyst JJ B-NP B-treatment
excision NN I-NP I-treatment
. . B-VP O
   
HABITS NN B-NP O
: : O O
She PRP O B-person
denies VBZ O O
smoking VBG O O
or CC O O
alcohol NN B-NP O
. . B-VP O
   
PHYSICAL JJ B-NP O
EXAMINATION NN I-NP O
: : O O
On IN B-VP O
examination NN B-NP B-test
, , O O
her PRP$ O B-person
lungs NNS B-NP O
were VBD B-VP O
clear JJ O O
. . B-VP O
   
She PRP O B-person
had VBD B-VP O
a DT B-NP O
regular JJ I-NP O
heart NN I-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
. . B-VP O
   
She PRP O B-person
had VBD B-VP O
2+ CD O B-test
bilateral JJ B-NP I-test
DP NNP I-NP I-test
and CC O O
radial JJ B-NP B-test
pulses NNS I-NP I-test
. . B-VP O
   
She PRP O B-person
has VBZ O O
mild JJ O B-problem
swelling VBG O I-problem
in IN B-VP I-problem
both DT B-NP I-problem
lower JJR I-NP I-problem
extremities NNS I-NP I-problem
. . B-VP O
   
She PRP O B-person
has VBZ O O
pain NN B-NP B-problem
with IN B-VP O
straight JJ B-NP O
leg NN I-NP O
raise NN I-NP O
, , O O
left VBD B-VP O
greater JJR O O
than IN B-VP O
right NN B-NP O
and CC O O
5/5 CD O O
strength NN B-NP O
in IN B-VP O
right JJ B-NP O
quads NNS I-NP O
compared VBN O O
to TO O O
4/5 CD O O
on IN B-VP O
the DT B-NP O
left NN I-NP O
. . B-VP O
   
Please NNP B-NP O
see VB O O
Dr. NNP B-NP B-person
Uph NNP I-NP I-person
&apos;s NNP I-NP O
office NN I-NP O
note NN I-NP O
for IN B-VP O
further JJ B-NP O
details NNS I-NP O
. . B-VP O
   
HOSPITAL NNP B-NP O
COURSE NN I-NP O
: : O O
She PRP O B-person
was VBD B-VP O
taken VBN O O
to TO O O
the DT B-NP O
operating NN I-NP O
room NN I-NP O
on IN B-VP O
01/16/2003 CD O O
for IN B-VP O
decompression NN B-NP B-treatment
at IN B-VP I-treatment
L2 NNP B-NP I-treatment
, , O I-treatment
L5 NNP B-NP I-treatment
and CC O O
laminectomy NN B-NP B-treatment
with IN B-VP O
posterior JJ O B-treatment
instrumented VBN O I-treatment
fusion NN B-NP I-treatment
at IN B-VP I-treatment
L3 NNP B-NP I-treatment
to TO O I-treatment
L5 NNP B-NP I-treatment
. . B-VP O
   
She PRP O B-person
tolerated VBD B-VP O
the DT B-NP B-treatment
surgery NN I-NP I-treatment
well RB O O
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
transferred VBN O O
to TO O O
recovery NN B-NP O
room NN I-NP O
in IN B-VP O
stable JJ B-NP O
condition NN I-NP O
. . B-VP O
   
She PRP O B-person
received VBD B-VP O
blood NN B-NP B-treatment
transfusions NNS I-NP I-treatment
intraoperatively RB O O
and CC O O
postoperatively RB O O
in IN B-VP O
addition NN B-NP O
to TO O O
autologous JJ B-NP B-treatment
blood NN I-NP I-treatment
. . B-VP O
   
Her PRP$ O B-test
Her PRP$ O B-person
hematocrit NN B-NP I-test
was VBD B-VP O
stable JJ O O
postoperatively RB O O
. . B-VP O
   
Her PRP$ O B-test
Her PRP$ O B-person
neurologic JJ B-NP I-test
exam NN I-NP I-test
was VBD B-VP O
stable JJ O O
postoperatively RB O O
with IN B-VP O
5/5 CD O O
bilaterally RB O O
, , O O
tibial JJ O O
, , O O
EHL NNP B-NP O
, , O O
FHL NNP B-NP O
, , O O
gastroc NN B-NP O
soleus NN I-NP O
, , O O
and CC O O
intact JJ B-NP O
quadriceps NNS I-NP O
. . B-VP O
   
She PRP O B-person
has VBZ O O
intact JJ B-NP O
sensation NN I-NP O
L3 NNP I-NP O
to TO O O
S1 NNP B-NP O
and CC O O
bilateral JJ B-NP O
lower JJR I-NP O
extremities NNS I-NP O
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
fitted VBN O O
for IN B-VP O
Verholl NNP B-NP B-treatment
Aet NNP I-NP I-treatment
over IN B-VP I-treatment
leg JJ B-NP I-treatment
brace NN I-NP I-treatment
and CC O O
mobilized VBN O O
out IN B-VP O
of IN B-VP O
the DT B-NP O
bed NN I-NP O
in IN B-VP O
the DT B-NP B-treatment
brace NN I-NP I-treatment
with IN B-VP O
physical JJ B-NP B-treatment
therapy NN I-NP I-treatment
. . B-VP O
   
Her PRP$ O B-problem
Her PRP$ O B-person
wounds NNS B-NP I-problem
were VBD B-VP O
stable JJ O O
without IN B-VP O
any DT B-NP B-problem
erythema NN I-NP I-problem
or CC O O
drainage NN B-NP B-problem
. . B-VP O
   
She PRP O B-person
reported VBD B-VP O
nausea NN B-NP B-problem
on IN B-VP O
pain NN B-NP B-treatment
medications NNS I-NP I-treatment
. . B-VP O
   
Her PRP$ O B-person
Her PRP$ O B-treatment
pain NN B-NP I-treatment
medications NNS I-NP I-treatment
were VBD B-VP O
changed VBN O O
around IN B-VP O
until IN B-VP O
an DT B-NP O
acceptable JJ I-NP O
regime NN I-NP O
was VBD B-VP O
accomplished VBN O O
. . B-VP O
   
She PRP O B-person
is VBZ O O
stable JJ O O
for IN B-VP O
discharge NN B-NP O
to TO O O
rehab VB O O
. . B-VP O
   
DISCHARGE NNP B-NP O
ACTIVITY NN I-NP O
: : O O
She PRP O B-person
should MD O O
continue VB O O
to TO O O
wear VB O O
the DT B-NP B-treatment
brace NN I-NP I-treatment
when WRB O O
out IN B-VP O
of IN B-VP O
bed NN B-NP O
and CC O O
there EX O O
should MD O O
be VB O O
no DT B-NP O
heavy JJ I-NP O
lifting NN I-NP O
, , O O
twisting VBG O O
or CC O O
bending VBG O O
activities NNS B-NP O
. . B-VP O
   
She PRP O B-person
will MD O O
need VB O O
to TO O O
follow VB O O
up RP O O
with IN B-VP O
Dr. NNP B-NP B-person
Uph NNP I-NP I-person
on IN B-VP O
02/21/03 CD O O
at IN B-VP O
9:30 CD O O
a.m. RB O O
DISCHARGE NNP B-NP O
MEDICATIONS NNP I-NP O
: : O O
Tylenol CD O B-treatment
650 CD O O
mg NN B-NP O
p.o. NN I-NP O
q.4h. NN I-NP O
p.r.n. NN I-NP O
, , O O
Benadryl NNP B-NP B-treatment
25 CD O O
mg NN B-NP O
p.o. NN I-NP O
q.h.s. NN I-NP O
p.r.n. NN I-NP O
, , O O
Colace NNP B-NP B-treatment
100 CD O O
mg NN B-NP O
p.o. NN I-NP O
q.i.d. NN I-NP O
, , O O
Nortriptyline NNP B-NP B-treatment
25 CD O O
mg NN B-NP O
p.o. NN I-NP O
q.h.s. NN I-NP O
, , O O
Simvastatin NNP B-NP B-treatment
10 CD O O
mg NN B-NP O
p.o. NN I-NP O
q.h.s. NN I-NP O
, , O O
Metamucil NNP B-NP B-treatment
one CD O O
packet NN B-NP O
p.o. NN I-NP O
b.i.d. NN I-NP O
p.r.n. NN I-NP O
, , O O
Neurontin NNP B-NP B-treatment
300 CD O O
mg NN B-NP O
p.o. NN I-NP O
t.i.d. NN I-NP O
, , O O
Levsinex NNP B-NP B-treatment
0.375 CD O O
mg NN B-NP O
p.o. NN I-NP O
q.12h. NN I-NP O
, , O O
Lisinopril NNP B-NP B-treatment
/ NNP I-NP O
hydrochlorothiazide RB O B-treatment
20/25 CD O O
mg NNS B-NP O
p.o. JJ B-NP O
q.d. NN I-NP O
, , O O
hydrocortisone NN B-NP B-treatment
topical JJ B-NP I-treatment
ointment NN I-NP I-treatment
to TO O O
affected JJ B-NP B-problem
areas NNS I-NP I-problem
, , O O
MS NNP B-NP B-treatment
Contin NNP I-NP I-treatment
30 CD O O
mg NN B-NP O
p.o. NN I-NP O
b.i.d. NN I-NP O
, , O O
MSIR NNP B-NP B-treatment
15 CD O O
to TO O O
30 CD O O
mg NNS B-NP O
p.o. JJ B-NP O
q.4h. JJ I-NP O
p.r.n. NN I-NP O
pain NN I-NP B-problem
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
should MD O O
continue VB O O
to TO O O
have VB O O
dry JJ B-NP B-treatment
sterile JJ I-NP I-treatment
dressings NNS I-NP I-treatment
to TO O O
her PRP$ O B-person
her PRP$ O B-problem
back NN B-NP I-problem
and CC O I-problem
iliac NN B-NP I-problem
crest NN I-NP I-problem
wounds VBZ O I-problem
until IN B-VP O
follow VB O O
up RP O O
with IN B-VP O
Dr. NNP B-NP B-person
Uph NNP I-NP I-person
. . B-VP O
   
Should MD O O
there RB O O
be VB O O
any DT B-NP B-problem
wound JJ I-NP I-problem
erythema NN I-NP I-problem
or CC O O
drainage NN B-NP B-problem
, , O O
please VB O O
contact JJ B-NP O
Dr. NNP I-NP B-person
Uph NNP I-NP I-person
&apos;s NNP I-NP O
office NN I-NP O
immediately RB O O
. . B-VP O
   
eScription NN B-NP O
document NN I-NP O
: : O O
2-7712488 JJ B-NP O
ZNHKjeu NNP I-NP O
Tel NNP I-NP O
Dictated VBN O O
By IN B-VP O
: : O O
MAULPLACKAGNELEEB NNP B-NP B-person
, , O I-person
INACHELLE NNP B-NP I-person
Attending NNP I-NP B-person
: : O O
SPACE NNP B-NP B-person
, , O I-person
DOTA NNP B-NP I-person
Dictation NNP I-NP O
ID NNP I-NP O
3624752 CD O O
D NNP B-NP O
: : O O
01/23/03 CD O O
T NN B-NP O
: : O O
01/23/03 CD O O
-EMPTYLINE- NN B-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
Admission NNP I-NP O
Date NNP I-NP O
: : O O
2019-02-28 JJ B-NP O
Discharge NN I-NP O
Date NNP I-NP O
: : O O
2019-03-26 JJ B-NP O
Date NNP I-NP O
of IN B-VP O
Birth NNP B-NP O
: : O O
1943-06-17 JJ B-NP O
Sex NN I-NP O
: : O O
M NNP B-NP O
Service NNP I-NP O
: : O O
CARDIOTHORACIC JJ B-NP O
Allergies NNS I-NP O
: : O O
Morphine NNP B-NP B-treatment
Sulfate NNP I-NP I-treatment
/ NNP I-NP O
Codeine NNP I-NP B-treatment
/ NNP I-NP O
Keflex NNP I-NP B-treatment
/ NNP I-NP O
Sudafed NNP I-NP B-treatment
Attending NNP I-NP B-person
: : O O
Willa NNP B-NP B-person
D NNP I-NP I-person
Garcia NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
Chief NNP I-NP O
Complaint NNP I-NP O
: : O O
Fever NNP B-NP B-problem
/ NNP I-NP O
+ NNP I-NP O
BC NNP I-NP B-problem
w/ VBD B-VP O
h/o JJ B-NP O
MV NNP I-NP B-problem
endocarditis NN I-NP I-problem
Major NNP I-NP O
Surgical NNP I-NP O
or CC O O
Invasive JJ B-NP O
Procedure NN I-NP O
: : O O
Mitral JJ B-NP B-treatment
Valve NNP I-NP I-treatment
Replacement NNP I-NP I-treatment
with IN B-VP O
31 CD O B-treatment
mm NNS B-NP I-treatment
SJM NNP I-NP I-treatment
Biocor NNP I-NP I-treatment
Tissue NNP I-NP I-treatment
valve FW O I-treatment
/ NNP B-NP I-treatment
della NN I-NP I-treatment
Copeland NNP I-NP B-treatment
resection NN I-NP I-treatment
on IN B-VP O
2019-03-19 JJ B-NP O
History NNP I-NP O
of IN B-VP O
Present NNP B-NP O
Illness NNP I-NP O
: : O O
Mr. NNP B-NP B-person
Pizano NNP I-NP I-person
is VBZ O O
a DT O O
75 CD O O
y/o NN B-NP O
man NN I-NP O
who WP O B-person
has VBZ O O
a DT B-NP O
PMHx NNP I-NP O
significant JJ O O
for IN B-VP O
Enterococcus NNP B-NP B-problem
mitral JJ B-NP I-problem
valve NN I-NP I-problem
endocarditis NN I-NP I-problem
which WDT O B-pronoun
has VBZ O O
been VBN O O
treated VBN O O
since IN B-VP O
09-19 NN B-NP O
. . B-VP O
   
He PRP O B-person
has VBZ O O
had VBD B-VP O
2 CD O O
6 CD O O
week NN B-NP O
courses NNS I-NP O
of IN B-VP O
antibiotics NNS B-NP B-treatment
with IN B-VP O
recurrent JJ B-NP B-problem
bacteremia NN I-NP I-problem
. . B-VP O
   
He PRP O B-person
had VBD B-VP O
a DT B-NP B-test
TEE NNP I-NP I-test
on IN B-VP O
2019-01-22 CD O O
which WDT O B-pronoun
revealed VBD B-VP O
thickened VBD B-VP B-problem
mitral JJ B-NP I-problem
leaflets NNS I-NP I-problem
with IN B-VP O
small JJ B-NP B-problem
vegetations NNS I-NP I-problem
on IN B-VP I-problem
both DT O I-problem
anterior JJ O I-problem
and CC O I-problem
posterior JJ B-NP I-problem
leaflets NNS I-NP I-problem
with IN B-VP O
moderate JJ O B-problem
to TO O I-problem
severe VB O I-problem
mitral JJ B-NP I-problem
regurgitation NN I-NP I-problem
. . B-VP O
   
He PRP O B-person
has VBZ O O
preserved VBN O O
LV NNP B-NP O
systolic JJ B-NP O
function NN I-NP O
with IN B-VP O
mild JJ B-NP B-problem
TR NNP I-NP I-problem
and CC O O
AR NNP B-NP B-problem
and CC O O
LAE NNP B-NP B-problem
without IN B-VP O
abscess NN B-NP B-problem
. . B-VP O
   
He PRP O B-person
had VBD B-VP O
a DT B-NP B-test
repeat NN I-NP I-test
TEE NNP I-NP I-test
on IN B-VP O
02-19 NNP B-NP O
which WDT O B-pronoun
revealed VBD B-VP O
4 CD O B-problem
+ JJ B-NP I-problem
MR NNP I-NP I-problem
. . B-VP O
   
Thomasine NNP B-NP B-person
was VBD B-VP O
tranferred VBN O O
from IN B-VP O
MWMC NNP B-NP O
( ( O O
where WRB O O
he PRP O B-person
was VBD B-VP O
admitted VBN O O
on IN B-VP O
02-15 NN B-NP O
with IN B-VP O
fevers NNS B-NP B-problem
and CC O O
positive JJ B-NP B-problem
blood NN I-NP I-problem
cultures NNS I-NP I-problem
) ) O O
to TO O O
IDMC NNP B-NP O
for IN B-VP O
further JJ B-NP B-treatment
treatment NN I-NP I-treatment
and CC O O
possibly RB O O
MVR NNP B-NP B-treatment
. . B-VP O
   
Past NNP B-NP O
Medical JJ B-NP O
History NN I-NP O
: : O O
h/o JJ B-NP O
Mitral NNP I-NP B-problem
Valve NNP I-NP I-problem
Endocarditis NNP I-NP I-problem
Hypertension NNP I-NP B-problem
h/o NN I-NP O
CVA NNP I-NP B-problem
Spinal NNP I-NP B-problem
Stenosis NNP I-NP I-problem
s/p VBD B-VP O
Lumbar NNP B-NP B-treatment
Laminectomy NNP I-NP I-treatment
x VBD B-VP O
3 CD O O
Parkinson NNP B-NP B-problem
's POS O I-problem
disease NN B-NP I-problem
h/o NN I-NP O
paranoid JJ B-NP B-problem
delusions NNS I-NP I-problem
MGUS NNP I-NP B-problem
vs NN I-NP O
MM NNP I-NP B-problem
Social NNP I-NP O
History NNP I-NP O
: : O O
Lives NNS B-NP O
in IN B-VP O
nursing NN B-NP O
home NN I-NP O
. . B-VP O
   
Quit NNP B-NP O
smoking VBG O O
3.5 CD O O
years NNS B-NP O
ago RB O O
. . B-VP O
   
Denies VBZ O O
ETOH NNP B-NP O
. . B-VP O
   
Family NNP B-NP O
History NNP I-NP O
: : O O
Non-contributory JJ B-NP O
Physical NNP I-NP O
Exam NNP I-NP O
: : O O
Preop NNP B-NP O
General NNP I-NP O
: : O O
Elderly JJ B-NP B-person
man NN I-NP I-person
in IN B-VP O
NAD NNP B-NP B-problem
, , O O
VSS NNP B-NP O
HEENT NNP I-NP O
: : O O
NC/AT NNP B-NP B-problem
, , O O
PERRLA NNP B-NP O
, , O O
EOMI NNP B-NP O
, , O O
poor JJ B-NP B-problem
dentition NN I-NP I-problem
Neck NNP I-NP O
: : O O
Supple NN B-NP O
, , O O
FROM NNP B-NP O
, , O O
- : O O
thyromegaly NN B-NP B-problem
, , O O
- : O O
lymphadenopathy NN B-NP B-problem
, , O O
Carotids NNP B-NP B-test
2 CD O O
+ NNP B-NP O
Bilat NNP I-NP O
w/out IN B-VP O
bruits NNS B-NP B-problem
Lungs NNS I-NP O
: : O O
CTAB NNP B-NP O
- : O O
w/r/r JJ B-NP B-problem
Heart NNP I-NP O
: : O O
RRR NNP B-NP O
, , O O
+ NNP B-NP O
S1S2 NNP I-NP O
, , O O
02-18 JJ B-NP O
mumrmur NN I-NP B-problem
Abd NNP I-NP O
: : O O
Soft JJ B-NP O
NT/ND NNP I-NP B-problem
, , O O
+ NNP B-NP O
BS NNP I-NP O
without IN B-VP O
masses NNS B-NP B-problem
or CC O O
hepatomegaly JJ B-NP B-problem
/ JJ I-NP O
splenomegaly NN I-NP B-problem
Ext NNP I-NP O
: : O O
Warm NNP B-NP O
, , O O
dry JJ O O
- : O O
c/c/e NN B-NP B-problem
, , O O
pulses VBZ O B-test
2+ CD O O
throughout IN B-VP O
Neuro NNP B-NP O
: : O O
Non-focal JJ O O
, , O O
MAE NNP B-NP O
Skin NNP I-NP O
: : O O
well-healed JJ B-NP B-problem
surgical JJ I-NP I-problem
scars NNS I-NP I-problem
on IN B-VP I-problem
lower JJR B-NP I-problem
back NN I-NP I-problem
Discharge NNP I-NP O
Gen NNP I-NP O
: : O O
NAD NNP B-NP B-problem
/ NNP I-NP O
VSS NNP I-NP O
Neuro NNP I-NP O
: : O O
Alert NNP B-NP O
, , O O
non RB O O
focal JJ B-NP O
exam NN I-NP O
Pulm NNP I-NP O
: : O O
CTA NNP B-NP O
bilat VBZ O O
Card NNP B-NP O
: : O O
RRR NNP B-NP O
, , O O
sternum NN B-NP O
stable JJ O O
, , O O
incision JJ B-NP B-problem
clean NN I-NP O
and CC O O
dry JJ O O
, , O O
no DT B-NP O
erythema NN I-NP B-problem
/ VBZ O O
drainage JJ B-NP B-problem
Abdm NNP I-NP O
: : O O
soft JJ O O
, , O O
NT NNP B-NP B-problem
/ NNP I-NP O
ND NNP I-NP B-problem
/ NNP I-NP O
NABS NNP I-NP B-problem
Ext NNP I-NP O
: : O O
warm NN B-NP O
well NN I-NP O
perfused VBN O O
, , O O
no DT B-NP O
C/C/E NNP I-NP B-problem
Pertinent NNP I-NP O
Results NNP I-NP O
: : O O
2019-02-28 JJ O O
07:30 CD O O
PM NNP B-NP O
GLUCOSE NNP I-NP B-test
- : O O
94 CD O O
UREA NNP B-NP B-test
N NNP I-NP I-test
- : O O
21 CD O O
* NN B-NP O
CREAT NNP I-NP B-test
- : O O
1.3 CD O O
* JJ B-NP O
SODIUM NNP I-NP B-test
- : O O
138 CD O O
POTASSIUM NNP B-NP B-test
- : O O
5.0 CD O O
CHLORIDE NNP B-NP B-test
- : O O
105 CD O O
TOTAL NNP B-NP B-test
CO2 NNP I-NP I-test
- : O O
25 CD O O
ANION NNP B-NP B-test
GAP NNP I-NP I-test
- : O O
13 CD O O
2019-02-28 JJ O O
07:30 CD O O
PM NNP B-NP O
ALT NNP I-NP B-test
( ( O I-test
SGPT NNP B-NP I-test
)- CD O I-test
6 CD O O
AST NNP B-NP B-test
( ( O I-test
SGOT NNP B-NP I-test
)- RB O I-test
20 CD O O
LD NNP B-NP B-test
( ( O I-test
LDH NNP B-NP I-test
)- CD O I-test
255 CD O O
* NN B-NP O
ALK NNP I-NP B-test
PHOS NNP I-NP I-test
- : O O
134 CD O O
* JJ B-NP O
TOT NNP I-NP B-test
BILI NNP I-NP I-test
- : O O
0.4 CD O O
2019-02-28 JJ O O
07:30 CD O O
PM NNP B-NP O
CALCIUM NNP I-NP B-test
- : O O
9.3 CD O O
PHOSPHATE NNP B-NP B-test
- : O O
3.7 CD O O
MAGNESIUM NNP B-NP B-test
- : O O
2.3 CD O O
2019-02-28 JJ O O
07:30 CD O O
PM NNP B-NP O
WBC NNP I-NP B-test
- : O O
4.9 CD O O
RBC NNP B-NP B-test
- : O O
4.27 CD O O
* NN B-NP O
HGB NNP I-NP B-test
- : O O
11.3 CD O O
* NN B-NP O
HCT NNP I-NP B-test
- : O O
35.1 CD O O
* NN B-NP O
MCV NNP I-NP B-test
- : O O
82 CD O O
MCH NNP B-NP B-test
- : O O
26.4 CD O O
* NN B-NP O
MCHC NNP I-NP B-test
- : O O
32.2 CD O O
RDW NNP B-NP B-test
- : O O
17.4 CD O O
* JJ O O
2019-02-28 JJ O O
07:30 CD O O
PM NNP B-NP O
NEUTS NNP I-NP B-test
- : O O
66.3 CD O O
LYMPHS NNP B-NP B-test
- : O O
25.0 CD O O
MONOS NNP B-NP B-test
- : O O
5.7 CD O O
EOS NNP B-NP B-test
- : O O
0.1 CD O O
BASOS NNP B-NP B-test
- : O O
2.9 CD O O
* JJ O O
2019-02-28 JJ O O
07:30 CD O O
PM NNP B-NP O
PLT NNP I-NP B-test
COUNT NNP I-NP I-test
- : O O
187 CD O O
2019-02-28 JJ O O
07:30 CD O O
PM NNP B-NP O
PT NNP I-NP B-test
- : O O
13.1 CD O O
PTT NNP B-NP B-test
- : O O
30.1 CD O O
INR NNP B-NP B-test
( ( O I-test
PT NNP B-NP I-test
)- JJ O I-test
1.1 CD O O
2019-02-28 JJ O O
06:27 CD O O
PM NNP B-NP O
URINE NNP I-NP B-test
COLOR NNP I-NP B-test
- : O O
Amber NNP B-NP O
APPEAR NNP I-NP B-test
- : O O
Clear JJ B-NP O
SP NNP I-NP B-test
Stickney NNP I-NP I-test
- : O O
1.015 CD O O
2019-03-23 JJ O O
05:31 CD O O
AM NNP B-NP O
BLOOD NNP I-NP B-test
WBC NNP I-NP B-test
- : O O
8.6 CD O O
RBC NNP B-NP B-test
- : O O
3.43 CD O O
* NN B-NP O
Hgb NNP I-NP B-test
- : O O
9.9 CD O O
* NN B-NP O
Hct NNP I-NP B-test
- : O O
28.7 CD O O
* NN B-NP O
MCV NNP I-NP B-test
- : O O
84 CD O O
MCH NNP B-NP B-test
- : O O
28.9 CD O O
MCHC NNP B-NP B-test
- : O O
34.5 CD O O
RDW NNP B-NP B-test
- : O O
17.8 CD O O
* JJ B-NP O
Plt NNP I-NP B-test
Ct NNP I-NP I-test
- : O O
120 CD O O
* JJ O O
2019-03-25 JJ O O
01:53 CD O O
AM NNP B-NP O
BLOOD NNP I-NP B-test
Glucose NNP I-NP B-test
- : O O
95 CD O O
UreaN NNP B-NP B-test
- : O O
35 CD O O
* NN B-NP O
Creat NNP I-NP B-test
- : O O
1.4 CD O O
* NN B-NP O
Na NNP I-NP B-test
- : O O
136 CD O O
K NNP B-NP B-test
- : O O
4.9 CD O O
Cl NNP B-NP B-test
- : O O
105 CD O O
HCO3 NNP B-NP B-test
- : O O
21 CD O O
* NN B-NP O
AnGap NNP I-NP B-test
- : O O
15 CD O O
2019-03-25 JJ O O
04:47 CD O O
PM NNP B-NP O
BLOOD NNP I-NP B-test
PT NNP I-NP B-test
- : O O
14.1 CD O O
* NN B-NP O
PTT NNP I-NP B-test
- : O O
29.4 CD O O
INR NNP B-NP B-test
( ( O I-test
PT NNP B-NP I-test
)- CD O O
1.3 CD O O
* NN B-NP O
Brief NNP I-NP O
Hospital NNP I-NP O
Course NNP I-NP O
: : O O
As IN B-VP O
mentioned VBN O O
in IN B-VP O
the DT B-NP O
HPI NNP I-NP O
, , O O
Mr. NNP B-NP B-person
Mcculley NNP I-NP I-person
was VBD B-VP O
transferred VBN O O
from IN B-VP O
MWMC NNP B-NP O
to TO O O
Nantucket NNP B-NP O
Cottage NNP I-NP O
Hospital NNP I-NP O
for IN B-VP O
ongoing VBG O O
care NN B-NP O
( ( O O
? . B-VP O
MVR NNP B-NP B-treatment
). NNP I-NP O
And CC O O
Infectious NNP B-NP B-person
disease NN I-NP I-person
consult NN I-NP O
was VBD B-VP O
immediately RB O O
made VBN O O
. . B-VP O
   
IV NNP B-NP B-treatment
Daptomycin NNP I-NP I-treatment
was VBD B-VP O
continued VBN O O
via IN B-VP O
PICC NNP B-NP B-treatment
line NN I-NP I-treatment
which WDT O B-pronoun
was VBD B-VP O
inserted VBN O O
on IN B-VP O
02-20 NN B-NP O
at IN B-VP O
MWMC NNP B-NP O
. . B-VP O
   
Mr NNP B-NP B-person
Stutts NNP I-NP I-person
had VBD B-VP O
an DT B-NP B-test
extensive JJ I-NP I-test
preop NN I-NP I-test
evaluation NN I-NP I-test
including VBG O O
cardiology NN B-NP B-person
, , O O
infectious JJ B-NP B-person
diseases NNS I-NP I-person
, , O O
orthopedics NNS B-NP B-person
, , O O
psychiatry NN B-NP B-person
and CC O O
ethics NNS B-NP B-person
services NNS I-NP I-person
. . B-VP O
   
He PRP O B-person
ultimately RB O O
was VBD B-VP O
brought VBN O O
to TO O O
the DT B-NP O
operating NN I-NP O
room NN I-NP O
on IN B-VP O
03-19 JJ O O
. . B-VP O
   
At IN B-VP O
that DT B-NP B-pronoun
time NN I-NP O
he PRP O B-person
had VBD B-VP O
a DT B-NP B-treatment
Mitral NNP I-NP I-treatment
Valve NNP I-NP I-treatment
replacement NN I-NP I-treatment
, , O O
aortoomy NN B-NP B-treatment
, , O O
and CC O O
left VBD B-VP B-treatment
atrial JJ B-NP I-treatment
appendage NN I-NP I-treatment
resection NN I-NP I-treatment
. . B-VP O
   
His PRP$ O B-person
His PRP$ O B-treatment
bypass NN B-NP I-treatment
time NN I-NP I-treatment
was VBD B-VP O
103 CD O O
minutes NNS B-NP O
/ VBP O O
crossclamp JJ O B-treatment
89 CD O O
mins NNS B-NP O
. . B-VP O
   
Please NNP B-NP O
see VBP O O
OR NNP B-NP O
report NN I-NP O
for IN B-VP O
full JJ B-NP O
details NNS I-NP O
. . B-VP O
   
He PRP O B-person
tolerated VBD B-VP O
the DT B-NP B-treatment
surgery NN I-NP I-treatment
well RB O O
and CC O O
was VBD B-VP O
transferred VBN O O
from IN B-VP O
the DT B-NP O
OR NNP I-NP O
to TO O O
the DT B-NP O
CSRU NNP I-NP O
on IN B-VP O
Epinephrinne NNP B-NP B-treatment
and CC O O
Propofol NNP B-NP B-treatment
infusions NNS I-NP I-treatment
. . B-VP O
   
He PRP O B-person
did VBD B-VP O
well RB O O
in IN B-VP O
immediate JJ B-NP O
postoperative JJ I-NP O
period NN I-NP O
. . B-VP O
   
Following VBG O O
surgery NN B-NP B-treatment
his PRP$ O B-person
his PRP$ O B-treatment
anesthesia NN B-NP I-treatment
was VBD B-VP O
reversed VBN O O
, , O O
he PRP O B-person
was VBD B-VP O
weaned VBN O O
from IN B-VP O
ventilator NN B-NP B-treatment
and CC O O
successfully RB O O
extubated VBN O O
. . B-VP O
   
His PRP$ O B-person
His PRP$ O B-treatment
iv NN B-NP I-treatment
medications NNS I-NP I-treatment
were VBD B-VP O
also RB O O
weaned VBN O O
to TO O O
off RB O O
. . B-VP O
   
On IN B-VP O
POD1 NNP B-NP O
His PRP$ O B-person
His PRP$ O B-treatment
PA NNP B-NP I-treatment
line NN I-NP I-treatment
and CC O O
chest NN B-NP B-treatment
tubes NNS I-NP I-treatment
were VBD B-VP O
removed VBN O O
, , O O
he PRP O B-person
was VBD B-VP O
also RB O O
started VBN O O
on IN B-VP O
Beta NNP B-NP B-treatment
blockers NNS I-NP I-treatment
and CC O O
diuretics NNS B-NP B-treatment
. . B-VP O
   
On IN B-VP O
POD2 NNP B-NP O
the DT B-NP B-person
patient NN I-NP I-person
remained VBD B-VP O
hemodynamically RB O O
stable JJ O O
and CC O O
was VBD B-VP O
transferred VBN O O
from IN B-VP O
the DT B-NP O
ICU NNP I-NP O
to TO O O
F2 NNP B-NP O
for IN B-VP O
continued JJ B-NP O
postop NN I-NP O
care NN I-NP O
. . B-VP O
   
Over IN B-VP O
the DT B-NP O
next JJ I-NP O
several JJ I-NP O
days NNS I-NP O
with IN B-VP O
the DT B-NP O
assisstance NN I-NP O
of IN B-VP O
the DT B-NP B-person
nursing NN I-NP I-person
staff NN I-NP I-person
and CC O O
physical JJ B-NP B-person
therapy NN I-NP I-person
the DT B-NP B-person
patients NNS I-NP I-person
activity NN I-NP O
level NN I-NP O
was VBD B-VP O
advanced JJ O O
, , O O
he PRP O B-person
was VBD B-VP O
transitioned VBN O O
to TO O O
all DT B-NP B-treatment
oral JJ I-NP I-treatment
medications NNS I-NP I-treatment
with IN B-VP O
the DT B-NP O
exception NN I-NP O
of IN B-VP O
his PRP$ O B-person
his PRP$ O B-treatment
antibiotics NNS B-NP I-treatment
. . B-VP O
   
On IN B-VP O
POD7 NNP B-NP O
it PRP O B-pronoun
was VBD B-VP O
decided VBN O O
that IN B-VP B-pronoun
the DT B-NP B-person
pt NN I-NP I-person
was VBD B-VP O
stable JJ O O
and CC O O
ready JJ O O
for IN B-VP O
discharge NN B-NP O
to TO O O
rehabilitation NN B-NP O
. . B-VP O
   
It PRP O B-pronoun
should MD O O
be VB O O
noted VBN O O
that IN B-VP B-pronoun
the DT B-NP B-person
patient NN I-NP I-person
did VBD B-VP O
have VB O O
episodes NNS B-NP O
of IN B-VP O
postoperative JJ B-NP B-problem
atrial JJ I-NP I-problem
fibrillation NN I-NP I-problem
, , O O
he PRP O B-person
was VBD B-VP O
seen VBN O O
by IN B-VP O
the DT B-NP O
Electrophysiology NNP I-NP B-person
service NN I-NP O
, , O O
started VBN O O
on IN B-VP O
Procainamide NNP B-NP B-treatment
and CC O O
Coumadin NNP B-NP B-treatment
. . B-VP O
   
Medications NNS B-NP O
on IN B-VP O
Admission NN B-NP O
: : O O
Aricept $ O B-treatment
10 CD O O
mg NN B-NP O
qd NN I-NP O
, , O O
Aspirin NNP B-NP B-treatment
81 CD O O
mg NN B-NP O
qd NN I-NP O
, , O O
Folic NNP B-NP B-treatment
acid NN I-NP I-treatment
, , O O
Gabapentin NNP B-NP B-treatment
200 CD O O
mg NN B-NP O
tid NN I-NP O
, , O O
Lopressor NNP B-NP B-treatment
12.5 CD O O
mg NN B-NP O
bid NN I-NP O
, , O O
Lisinopril NNP B-NP B-treatment
5 CD O O
mg NN B-NP O
qd NN I-NP O
, , O O
Daptomycin NNP B-NP B-treatment
420 CD O O
mg NN B-NP O
IV NNP I-NP O
qd NN I-NP O
, , O O
Protonix NNP B-NP B-treatment
40 CD O O
mg NN B-NP O
qd NN I-NP O
, , O O
Seroquel NNP B-NP B-treatment
50 CD O O
mg NN B-NP O
tid NN I-NP O
, , O O
Heparin NNP B-NP B-treatment
5000 CD O O
units NNS B-NP O
SQ NNP I-NP O
tid NN I-NP O
, , O O
Colace NNP B-NP B-treatment
100 CD O O
mg NN B-NP O
bid NN I-NP O
, , O O
Lactulose NNP B-NP B-treatment
15 CD O O
mg NN B-NP O
bid NN I-NP O
, , O O
Comtan NNP B-NP B-treatment
200 CD O O
mg NN B-NP O
qd NN I-NP O
, , O O
Mirapex NNP B-NP B-treatment
1.5 CD O O
mg NN B-NP O
tid NN I-NP O
, , O O
Sinemet NNP B-NP B-treatment
50 CD O O
/ VBD B-VP O
200 CD O O
mg NN B-NP O
tid NN I-NP O
Discharge NNP I-NP O
Medications NNP I-NP O
: : O O
1. CD O O
Furosemide IN B-VP B-treatment
20 CD O O
mg NNS B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Tablet NNP B-NP O
PO NNP I-NP O
once RB O O
a DT B-NP O
day NN I-NP O
for IN B-VP O
2 CD O O
weeks NNS B-NP O
. . B-VP O
   
2. CD O O
Potassium NNP B-NP B-treatment
Chloride NNP I-NP I-treatment
20 CD O O
mEq NN B-NP O
Packet NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Packet NNP B-NP O
PO NNP I-NP O
once RB O O
a DT B-NP O
day NN I-NP O
for IN B-VP O
2 CD O O
weeks NNS B-NP O
. . B-VP O
   
3. CD O O
Docusate NNP B-NP B-treatment
Sodium NNP I-NP I-treatment
100 CD O O
mg NN B-NP O
Capsule NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Capsule NNP B-NP O
PO NNP I-NP O
BID NNP I-NP O
( ( O O
2 CD O O
times NNS B-NP O
a DT B-NP O
day NN I-NP O
) ) O O
. . B-VP O
   
4. CD O O
Pantoprazole JJ O B-treatment
40 CD O O
mg JJ B-NP O
Tablet NNP I-NP O
, , O O
Delayed NNP B-NP O
Release NNP I-NP O
( ( O O
E.C. NNP B-NP O
) ) O O
Sig NN B-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Tablet NN B-NP O
, , O O
Delayed NNP B-NP O
Release NNP I-NP O
( ( O O
E.C. NNP B-NP O
) ) O O
PO NNP B-NP O
Q24H NNP I-NP O
( ( O O
every DT O O
24 CD O O
hours NNS B-NP O
) ) O O
. . B-VP O
   
5. CD O O
Aspirin NNP B-NP B-treatment
81 CD O O
mg NN B-NP O
Tablet NNP I-NP O
, , O O
Delayed NNP B-NP O
Release NNP I-NP O
( ( O O
E.C. NNP B-NP O
) ) O O
Sig NN B-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Tablet NN B-NP O
, , O O
Delayed NNP B-NP O
Release NNP I-NP O
( ( O O
E.C. NNP B-NP O
) ) O O
PO NNP B-NP O
DAILY NNP I-NP O
( ( O O
Daily NNP B-NP O
) ) O O
. . B-VP O
   
6. CD O O
Magnesium NNP B-NP B-treatment
Hydroxide NNP I-NP I-treatment
400 CD O O
mg NN B-NP O
/ VBD B-VP O
5 CD O O
mL JJ B-NP O
Suspension NNP I-NP O
Sig NNP I-NP O
: : O O
Thirty NNP B-NP O
( ( O O
30 CD O O
) ) O O
ML NNP B-NP O
PO NNP I-NP O
HS NNP I-NP O
( ( O O
at IN B-VP O
bedtime NN B-NP O
) ) O O
as IN B-VP O
needed VBN O O
for IN B-VP O
constipation NN B-NP B-problem
. . B-VP O
   
7. CD O O
Entacapone CD O B-treatment
200 CD O O
mg NNS B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Tablet NNP B-NP O
PO NNP I-NP O
TID NNP I-NP O
( ( O O
3 CD O O
times NNS B-NP O
a DT B-NP O
day NN I-NP O
) ) O O
. . B-VP O
   
8. CD O O
Pramipexole JJ O B-treatment
0.25 CD O O
mg JJ B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
Six NNP B-NP O
( ( O O
6 CD O O
) ) O O
Tablet NNP B-NP O
PO NNP I-NP O
TID NNP I-NP O
( ( O O
3 CD O O
times NNS B-NP O
a DT B-NP O
day NN I-NP O
) ) O O
. . B-VP O
   
9. CD O O
Carbidopa NNP B-NP B-treatment
- : O I-treatment
Levodopa NN B-NP I-treatment
50 CD O O
- : O O
200 CD O O
mg JJ B-NP O
Tablet NNP I-NP O
Sustained NNP I-NP O
Release NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Tablet NNP B-NP O
PO NNP I-NP O
TID NNP I-NP O
( ( O O
3 CD O O
times NNS B-NP O
a DT B-NP O
day NN I-NP O
) ) O O
. . B-VP O
   
10. CD O O
Quetiapine JJ O B-treatment
25 CD O O
mg JJ B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
Two CD O O
( ( O O
2 CD O O
) ) O O
Tablet NNP B-NP O
PO NNP I-NP O
DAILY NNP I-NP O
( ( O O
Daily NNP B-NP O
) ) O O
. . B-VP O
   
11. CD O O
Procainamide NNP B-NP B-treatment
250 CD O O
mg NN B-NP O
Capsule NNP I-NP O
Sig NNP I-NP O
: : O O
Three CD O O
( ( O O
3 CD O O
) ) O O
Capsule NNP B-NP O
PO NNP I-NP O
Q6H NNP I-NP O
( ( O O
every DT O O
6 CD O O
hours NNS B-NP O
) ) O O
: : O O
x $ O O
6 CD O O
weeks NNS B-NP O
. . B-VP O
   
12. CD O O
Acetaminophen NNP B-NP B-treatment
- : O I-treatment
Codeine NNP B-NP I-treatment
300-30 JJ B-NP O
mg NN I-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Tablet NNP B-NP O
PO NNP I-NP O
Q4H NNP I-NP O
( ( O O
every DT O O
4 CD O O
hours NNS B-NP O
) ) O O
as IN B-VP O
needed VBN O O
. . B-VP O
   
13. CD O O
Warfarin NNP B-NP B-treatment
1 CD O O
mg NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
as IN B-VP O
directed VBN O O
Tablet NNP B-NP O
PO NNP I-NP O
DAILY NNP I-NP O
( ( O O
Daily NNP B-NP O
) ) O O
. . B-VP O
   
14. CD O O
Daptomycin NNP B-NP B-treatment
500 CD O O
mg NN B-NP O
Recon NNP I-NP O
Soln NNP I-NP O
Sig NNP I-NP O
: : O O
Four CD O O
90y CD O O
( ( O O
480 CD O O
) ) O O
mg NN B-NP O
Intravenous JJ B-NP O
Q24H NNP I-NP O
( ( O O
every DT O O
24 CD O O
hours NNS B-NP O
) ) O O
: : O O
thru JJ B-NP O
05-02 NN I-NP O
. . B-VP O
   
Discharge NNP B-NP O
Disposition NNP I-NP O
: : O O
Extended VBN O B-treatment
Care NNP B-NP I-treatment
Discharge NNP I-NP O
Diagnosis NNP I-NP O
: : O O
mitral JJ B-NP B-problem
valve NN I-NP I-problem
endocarditis NN I-NP I-problem
s/p NN I-NP O
MV NNP I-NP B-treatment
replacement NN I-NP I-treatment
HTN NNP I-NP B-problem
s/p NN I-NP O
CVA NNP I-NP B-problem
Spinal NNP I-NP B-problem
stenosis NN I-NP I-problem
s/p NN I-NP O
Lumbar NNP I-NP B-treatment
Laminectomy NNP I-NP I-treatment
Parkingson NNP I-NP B-problem
's POS O I-problem
h/o NN B-NP O
paranoid NN I-NP B-problem
delusions NNS I-NP I-problem
MGUS NNP I-NP B-problem
vs NN I-NP O
MM NNP I-NP B-problem
Discharge NNP I-NP O
Condition NNP I-NP O
: : O O
good JJ B-NP O
Discharge NN I-NP O
Instructions NNS I-NP O
: : O O
May NNP B-NP O
take VB O O
shower NN B-NP O
. . B-VP O
   
Wash JJ B-NP O
incisions NNS I-NP B-problem
with IN B-VP O
warm JJ B-NP O
water NN I-NP O
and CC O O
gentle JJ B-NP O
soap NN I-NP O
. . B-VP O
   
Do VB O O
no DT O O
take VB O O
bath NN B-NP O
or CC O O
swim NN B-NP O
. . B-VP O
   
Do NNP B-NP O
not RB O O
apply VB O O
lotions NNS B-NP B-treatment
, , O O
creams NNS B-NP B-treatment
, , O O
ointments NNS B-NP B-treatment
or CC O O
powders NNS B-NP B-treatment
to TO O O
incision NN B-NP B-problem
. . B-VP O
   
Do NNP B-NP O
not RB O O
drive VB O O
for IN B-VP O
1 CD O O
month NN B-NP O
. . B-VP O
   
Do VB O O
not RB O O
lift VB O O
more JJR O O
than IN B-VP O
10 CD O O
pounds NNS B-NP O
for IN B-VP O
2 CD O O
months NNS B-NP O
. . B-VP O
   
Please NNP B-NP O
contact JJ B-NP O
office NN I-NP O
if IN B-VP O
you PRP O B-person
develop VBP O O
a DT B-NP B-problem
fever NN I-NP I-problem
more JJR O O
than IN B-VP O
101.5 CD O O
or CC O O
notice JJ B-NP O
drainage NN I-NP B-problem
from IN B-VP O
chest JJ B-NP B-problem
incision NN I-NP I-problem
. . B-VP O
   
Followup JJ B-NP O
Instructions NNS I-NP O
: : O O
Dr. NNP B-NP B-person
Portsche NNP I-NP I-person
in IN B-VP O
4 CD O O
weeks NNS B-NP O
Dr. NNP I-NP B-person
Bravo NNP I-NP I-person
( ( O O
PCP NNP B-NP B-person
) ) O O
in IN B-VP O
1-2 JJ B-NP O
weeks NNS I-NP O
Infectious JJ B-NP B-person
disease JJ I-NP I-person
Provider NN I-NP I-person
: : O O
Marsha NNP B-NP B-person
Harriet NNP I-NP I-person
, , O I-person
MD NNP B-NP I-person
Phone NNP I-NP O
: : O O
574-5036 JJ B-NP O
Date NNP I-NP O
/ NN I-NP O
Time NN I-NP O
: : O O
2019-04-29 JJ O O
10:00 CD O O
Jeffrey NNP B-NP B-person
Everett NNP I-NP I-person
MD NNP I-NP I-person
23-815 JJ O O
Completed VBN O O
by IN B-VP O
: : O O
MARK NNP B-NP B-person
Carolyn NNP I-NP I-person
NP NNP I-NP I-person
80-AUO JJ B-NP O
2019-03-26 JJ I-NP O
@ NN I-NP O
1033 CD O O
Signed NNP B-NP O
electronically RB O O
by IN B-VP O
: : O O
DR. NNP B-NP B-person
Millard NNP I-NP I-person
Fornataro NNP I-NP I-person
on IN B-VP O
: : O O
FRI NNP B-NP O
2019-03-29 CD O O
4:45 CD O O
PM NNP B-NP O
( ( O O
End NNP B-NP O
of IN B-VP O
Report NNP B-NP O
) ) O O
-EMPTYLINE- VBP O O
-DOCSTART- JJ O O
-EMPTYLINE- $ O O
988183518 CD O O
PUOMC NNP B-NP O
7961198 CD O O
290757 CD O O
137082 CD O O
1/25/1997 CD O O
12:00:00 CD O O
AM NNP B-NP O
CRYPTOGENIC NNP I-NP B-problem
CIRRHOSIS NNP I-NP I-problem
. . B-VP O
   
Unsigned VBD B-VP O
DIS NNP B-NP O
Report NNP I-NP O
Status NNP I-NP O
: : O O
Unsigned VBD B-VP O
DISCHARGE NNP B-NP O
SUMMARY NNP I-NP O
NAME NN I-NP O
: : O O
BOEHKOTE NNP B-NP B-person
, , O I-person
SONA NNP B-NP I-person
S NNP I-NP I-person
UNIT NNP I-NP O
NUMBER NNP I-NP O
: : O O
457-95-71 JJ B-NP O
ADMISSION NNP I-NP O
DATE NNP I-NP O
: : O O
01/25/97 CD O O
DISCHARGE NNP B-NP O
DATE NNP I-NP O
: : O O
01/30/97 CD O O
PRINCIPAL NNP B-NP O
DIAGNOSIS NNP I-NP O
: : O O
Cryptogenic JJ B-NP B-problem
cirrhosis NN I-NP I-problem
. . B-VP O
   
ASSOCIATED CC O O
DIAGNOSIS NNP B-NP O
: : O O
Variceal NNP B-NP B-problem
bleeding NN I-NP I-problem
. . B-VP O
   
PRINCIPAL JJ B-NP O
PROCEDURE NN I-NP O
: : O O
Variceal JJ B-NP B-treatment
banding NN I-NP I-treatment
. . B-VP O
   
HISTORY NNP B-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
is VBZ O O
a DT B-NP O
70-year-old JJ I-NP O
female NN I-NP O
with IN B-VP O
cryptogenic JJ B-NP B-problem
cirrhosis NN I-NP I-problem
. . B-VP O
   
She PRP O B-person
has VBZ O O
a DT B-NP O
history NN I-NP O
of IN B-VP O
esophageal JJ B-NP B-problem
varices NNS I-NP I-problem
and CC O O
a DT B-NP O
history NN I-NP O
of IN B-VP O
an DT B-NP B-problem
Upper NNP I-NP I-problem
GI NNP I-NP I-problem
bleed NN I-NP I-problem
. . B-VP O
   
She PRP O B-person
has VBZ O O
had VBD B-VP O
one CD O O
pervious JJ B-NP O
episode NN I-NP O
of IN B-VP O
variceal NN B-NP B-problem
bleeding VBG O I-problem
with IN B-VP O
an DT B-NP O
unclear JJ I-NP O
date NN I-NP O
. . B-VP O
   
However RB O O
she PRP O B-person
is VBZ O O
followed VBN O O
by IN B-VP O
a DT B-NP O
Dr. NNP I-NP B-person
Joasscchird NNP I-NP I-person
at IN B-VP O
Vaila NNP B-NP O
Medical NNP I-NP O
Center NNP I-NP O
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
in IN B-VP O
her PRP$ O B-person
usual JJ B-NP O
state NN I-NP O
of IN B-VP O
health NN B-NP O
until IN B-VP O
one CD O O
day NN B-NP O
prior RB O O
to TO O O
admission NN B-NP O
when WRB O O
she PRP O B-person
felt VBD B-VP O
increasing VBG O B-problem
fatigue NN B-NP I-problem
, , O O
nausea NN B-NP B-problem
and CC O O
vomiting VBG O B-problem
productive NN B-NP O
of IN B-VP O
bright JJ B-NP B-problem
red JJ I-NP I-problem
blood NN I-NP I-problem
and CC O O
coffee NN B-NP B-problem
ground NN I-NP I-problem
emesis NN I-NP I-problem
. . B-VP O
   
She PRP O B-person
also RB O O
had VBD B-VP O
some DT O B-problem
black JJ O I-problem
, , O I-problem
tarry JJ B-NP I-problem
stool NN I-NP I-problem
in IN B-VP O
her PRP$ O B-person
her PRP$ O B-treatment
colostomy NN B-NP I-treatment
bag NN I-NP I-treatment
. . B-VP O
   
At IN B-VP O
Vaila NNP B-NP O
Medical NNP I-NP O
Center NNP I-NP O
, , O O
she PRP O B-person
had VBD B-VP O
a DT B-NP B-test
hematocrit NN I-NP I-test
of IN B-VP O
25 CD O O
and CC O O
was VBD B-VP O
transfused VBN O O
2 CD O O
units NNS B-NP O
of IN B-VP O
packed JJ B-NP B-treatment
red JJ I-NP I-treatment
blood NN I-NP I-treatment
cells NNS I-NP I-treatment
. . B-VP O
   
She PRP O B-person
had VBD B-VP O
an DT B-NP B-test
upper JJ I-NP I-test
endoscopy NN I-NP I-test
at IN B-VP O
Va NNP B-NP O
Sit NNP I-NP O
Namar NNP I-NP O
Healthcare NNP I-NP O
showing VBG O O
an DT B-NP O
esophagus NN I-NP O
filled VBN O O
with IN B-VP O
clots NNS B-NP B-problem
and CC O O
small JJ B-NP O
amount NN I-NP O
of IN B-VP O
bleeding VBG O B-problem
varices NNS B-NP I-problem
, , O O
clot NN B-NP B-problem
in IN B-VP I-problem
the DT B-NP I-problem
stomach NN I-NP I-problem
with IN B-VP O
antral JJ B-NP B-problem
gastritis NN I-NP I-problem
, , O O
and CC O O
a DT B-NP O
normal JJ I-NP O
duodenum NN I-NP O
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
started VBN O O
on IN B-VP O
Pitressin NNP B-NP B-treatment
, , O O
a DT B-NP B-treatment
Blakemore NNP I-NP I-treatment
tube NN I-NP I-treatment
was VBD B-VP O
inserted VBN O O
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
transferred VBN O O
to TO O O
the DT B-NP O
Ph NNP I-NP O
University NNP I-NP O
Of IN B-VP O
Medical NNP B-NP O
Center NNP I-NP O
Intensive NNP I-NP O
Care NNP I-NP O
Unit NNP I-NP O
where WRB O O
on IN B-VP O
January NNP B-NP O
25 CD O O
in IN B-VP O
the DT B-NP O
morning NN I-NP O
her PRP$ O B-person
her PRP$ O B-test
hematocrit NN B-NP I-test
was VBD B-VP O
found VBN O O
to TO O O
be VB O O
27.4 CD O O
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
transfused VBN O O
another DT O O
2 CD O O
units NNS B-NP O
of IN B-VP O
packed JJ B-NP B-treatment
red JJ I-NP I-treatment
blood NN I-NP I-treatment
cells NNS I-NP I-treatment
over IN B-VP O
the DT B-NP O
course NN I-NP O
of IN B-VP O
the DT B-NP O
day NN I-NP O
and CC O O
her PRP$ O B-person
her PRP$ O B-test
hematocrit NN B-NP I-test
improved VBD B-VP O
to TO O O
29.4 CD O O
and CC O O
then RB O O
31.2 CD O O
. . B-VP O
   
The DT B-NP O
GI NNP I-NP B-person
service NN I-NP I-person
was VBD B-VP O
consulted VBN O O
and CC O O
an DT B-NP B-test
upper JJ I-NP I-test
endoscopy NN I-NP I-test
study NN I-NP I-test
showed VBD B-VP O
grade JJ B-NP B-problem
III NNP I-NP I-problem
varices NNS I-NP I-problem
with IN B-VP O
no DT B-NP O
active JJ I-NP B-problem
bleeding NN I-NP I-problem
and CC O O
a DT B-NP B-problem
clean JJ I-NP I-problem
base NN I-NP I-problem
gastric JJ B-NP I-problem
ulcer NN I-NP I-problem
possibly RB O O
secondary JJ O O
to TO O O
the DT B-NP B-treatment
Blakemore NNP I-NP I-treatment
tube NN I-NP I-treatment
. . B-VP O
   
Her PRP$ O B-person
Her PRP$ O B-problem
varices NNS B-NP I-problem
had VBD B-VP O
stigmata NNS B-NP B-problem
of IN B-VP O
recent JJ B-NP B-problem
bleeding NN I-NP I-problem
, , O O
were VBD B-VP O
banded VBN O B-treatment
successfully RB O O
. . B-VP O
   
after IN B-VP O
the DT B-NP B-treatment
procedure NN I-NP I-treatment
and CC O O
2 CD O O
more JJR B-NP O
units NNS I-NP O
of IN B-VP O
packed JJ B-NP B-treatment
red JJ I-NP I-treatment
blood NN I-NP I-treatment
cells NNS I-NP I-treatment
, , O O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
hemodynamically RB O O
stable JJ O O
and CC O O
hematocrit NN B-NP B-test
was VBD B-VP O
stable JJ O O
at IN B-VP O
31.2 CD O O
. . B-VP O
   
At IN B-VP O
that DT B-NP B-pronoun
time NN I-NP O
she PRP O B-person
was VBD B-VP O
transferred VBN O O
from IN B-VP O
the DT B-NP O
Intensive NNP I-NP O
Care NNP I-NP O
Unit NNP I-NP O
to TO O O
Coden NNP B-NP O
2 CD O O
for IN B-VP O
the DT B-NP O
Lemgarson NNP I-NP O
Hospital NNP I-NP O
service NN I-NP O
. . B-VP O
   
PAST NNP B-NP O
MEDICAL NNP I-NP O
HISTORY NNP I-NP O
: : O O
Cryptogenic JJ B-NP B-problem
cirrhosis NN I-NP I-problem
with IN B-VP O
an DT B-NP B-test
unclear JJ I-NP I-test
work NN I-NP I-test
up RB O I-test
. . B-VP O
   
Diverticular NNP B-NP B-problem
bleed VBD B-VP I-problem
requiring VBG O O
colostomy NN B-NP B-treatment
on IN B-VP O
May NNP B-NP O
96 CD O O
. . B-VP O
   
Spinal JJ B-NP B-problem
stenosis NN I-NP I-problem
. . B-VP O
   
Hysterectomy NNP B-NP B-treatment
at IN B-VP O
the DT B-NP O
age NN I-NP O
of IN B-VP O
32 CD O O
. . B-VP O
   
No DT B-NP O
coronary JJ I-NP B-problem
disease NN I-NP I-problem
, , O O
no DT B-NP O
diabetes NNS I-NP B-problem
and CC O O
no DT B-NP O
hypertension NN I-NP B-problem
. . B-VP O
   
She PRP O B-person
had VBD B-VP O
medications NNS B-NP B-treatment
on IN B-VP O
transfer NN B-NP O
which WDT O B-pronoun
included VBD B-VP O
Synthroid NNP B-NP B-treatment
0.15 CD O O
mg NN B-NP O
QD NNP I-NP O
, , O O
Zoloft NNP B-NP B-treatment
50 CD O O
mg NN B-NP O
QD NNP I-NP O
, , O O
Inderal NNP B-NP B-treatment
10 CD O O
mg NN B-NP O
BID NNP I-NP O
, , O O
Prilosec NNP B-NP B-treatment
20 CD O O
mg NN B-NP O
QD NNP I-NP O
, , O O
Neomycin NNP B-NP B-treatment
500 CD O O
TID NNP B-NP O
, , O O
Feosol NNP B-NP B-treatment
3 CD O O
mg NN B-NP O
and CC O O
Darvocet NNP B-NP B-treatment
PRN NNP I-NP O
. . B-VP O
   
She PRP O B-person
has VBZ O O
allergies NNS B-NP B-problem
to TO O O
Morphine NNP B-NP B-treatment
, , O O
Percocet NNP B-NP B-treatment
, , O O
Codeine NNP B-NP B-treatment
, , O O
Penicillin NNP B-NP B-treatment
, , O O
Xanax NNP B-NP B-treatment
and CC O O
Toradol NNP B-NP B-treatment
. . B-VP O
   
SOCIAL NNP B-NP O
HISTORY NN I-NP O
: : O O
She PRP O B-person
does VBZ O O
not RB O O
smoke VB O O
tobacco NN B-NP O
. . B-VP O
   
She PRP O B-person
uses VBZ O O
only RB O O
occasional JJ B-NP O
alcohol NN I-NP O
and CC O O
she PRP O B-person
is VBZ O O
not RB O O
sexually RB O O
active JJ O O
. . B-VP O
   
Her PRP$ O B-person
Her PRP$ O B-person
husband NN B-NP I-person
died VBD B-VP O
of IN B-VP O
lung NN B-NP B-problem
cancer NN I-NP I-problem
. . B-VP O
   
She PRP O B-person
lives VBZ O O
alone RB O O
in IN B-VP O
Burg NNP B-NP O
Chi NNP I-NP O
Sternafre NNP I-NP O
, , O O
Massachusetts NNP B-NP O
. . B-VP O
   
Her PRP$ O B-person
Her PRP$ O B-person
friends NNS B-NP I-person
check VBP O O
up RP O O
on IN B-VP O
her PRP O B-person
. . B-VP O
   
She PRP O B-person
does VBZ O O
not RB O O
have VB O O
a DT B-NP O
home NN I-NP O
health NN I-NP O
aide NN I-NP O
. . B-VP O
   
She PRP O B-person
has VBZ O O
3 CD O B-person
kids NNS B-NP I-person
who WP O B-person
live VBP O O
far RB O O
away RB O O
. . B-VP O
   
She PRP O B-person
is VBZ O O
able JJ O O
at IN B-VP O
baseline NN B-NP O
to TO O O
walk VB O O
one CD O O
flight NN B-NP O
of IN B-VP O
stairs NNS B-NP O
, , O O
2 CD O O
floor NN B-NP O
apartment NN I-NP O
. . B-VP O
   
FAMILY NNP B-NP O
HISTORY NNP I-NP O
: : O O
Non NNP B-NP O
contributory NN I-NP O
and CC O O
unavailable JJ O O
as IN B-VP O
she PRP O B-person
is VBZ O O
adopted VBN O O
. . B-VP O
   
PHYSICAL JJ B-NP O
EXAMINATION NN I-NP O
: : O O
She PRP O B-person
is VBZ O O
an DT O O
obese JJ O O
, , O O
elderly JJ B-NP O
woman NN I-NP O
in IN B-VP O
no DT B-NP O
acute JJ I-NP B-problem
distress NN I-NP I-problem
. . B-VP O
   
vital JJ B-NP O
signs NNS I-NP O
: : O O
158/60 CD O O
with IN B-VP O
a DT B-NP B-test
heart NN I-NP I-test
rate NN I-NP I-test
of IN B-VP O
85 CD O O
, , O O
temperature NN B-NP B-test
99.7 CD O O
, , O O
respirations NNS B-NP B-test
14 CD O O
. . B-VP O
   
Her PRP$ O B-person
neck NN B-NP O
showed VBD B-VP O
no DT B-NP O
JVD NNP I-NP B-problem
. . B-VP O
   
Lungs NNS B-NP O
clear JJ O O
to TO O O
auscultation NN B-NP B-test
. . B-VP O
   
Her PRP$ O B-person
abdomen NNS B-NP O
was VBD B-VP O
obese JJ O B-problem
and CC O O
distended VBN O B-problem
with IN B-VP O
good JJ B-NP O
bowel NN I-NP O
sounds NNS I-NP O
, , O O
large JJ B-NP B-problem
ventral JJ I-NP I-problem
hernia NN I-NP I-problem
. . B-VP O
   
Colostomy NNP B-NP B-treatment
with IN B-VP O
black JJ B-NP B-problem
stool NN I-NP I-problem
. . B-VP O
   
She PRP O B-person
had VBD B-VP O
some DT B-NP B-problem
mid JJ I-NP I-problem
epigastric JJ I-NP I-problem
tenderness NN I-NP I-problem
and CC O O
no DT B-NP O
rebound NN I-NP B-problem
. . B-VP O
   
Her PRP$ O B-person
heart NN B-NP O
showed VBD B-VP O
a DT B-NP O
regular JJ I-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
with IN B-VP O
an DT B-NP O
S1-S2 NNP I-NP O
, , O O
no DT B-NP O
murmur NN I-NP B-problem
. . B-VP O
   
Her PRP$ O B-person
Her PRP$ O B-test
neurological JJ B-NP I-test
exam NN I-NP I-test
was VBD B-VP O
alert JJ O O
and CC O O
oriented VBN O O
. . B-VP O
   
She PRP O B-person
had VBD B-VP O
5 CD O O
out IN B-VP O
of IN B-VP O
5 CD O O
strength NN B-NP O
bilaterally RB O O
and CC O O
her PRP$ O B-person
toes NNS B-NP O
were VBD B-VP O
downgoing VBG O O
. . B-VP O
   
She PRP O B-person
had VBD B-VP O
no DT B-NP O
evidence NN I-NP O
of IN B-VP O
asterixis NN B-NP B-problem
. . B-VP O
   
Her PRP$ O B-person
skin NN B-NP O
looked VBD B-VP O
very RB O O
bronze JJ O O
and CC O O
tan JJ O O
, , O O
especially RB O O
in IN B-VP O
the DT B-NP O
sun NN I-NP O
exposed VBD B-VP O
areas NNS B-NP O
. . B-VP O
   
She PRP O B-person
had VBD B-VP O
no DT B-NP O
spider NN I-NP B-problem
angiomata NN I-NP I-problem
, , O O
no DT B-NP O
palmar NN I-NP B-problem
erythema NN I-NP I-problem
, , O O
no DT B-NP O
xanthomas NNP I-NP B-problem
and CC O O
no DT B-NP O
caput NN I-NP B-problem
medusae NN I-NP I-problem
. . B-VP O
   
She PRP O B-person
did VBD B-VP O
not RB O O
look VB O O
teric JJ O B-problem
( ( O O
??? JJ O O
) ) O O
. . B-VP O
   
LABORATORY NNP B-NP O
DATA NNP I-NP O
: : O O
Notable JJ O O
for IN B-VP O
sodium NN B-NP B-test
141 CD O O
, , O O
potassium NN B-NP B-test
4.2 CD O O
, , O O
chloride RB O B-test
109 CD O O
, , O O
bicarb NN B-NP B-test
19.8 CD O O
, , O O
BUN NNP B-NP B-test
38 CD O O
, , O O
creatinine NN B-NP B-test
1.2 CD O O
and CC O O
glucose JJ O B-test
388 CD O O
. . B-VP O
   
She PRP O B-person
had VBD B-VP O
a DT B-NP B-problem
pneumonia NN I-NP I-problem
of IN B-VP O
31 CD O O
, , O O
calcium NN B-NP B-test
was VBD B-VP O
7.5 CD O O
, , O O
phosphorous JJ O B-test
3.0 CD O O
, , O O
magnesium NN B-NP B-test
1.3 CD O O
. . B-VP O
   
Her PRP$ O B-person
Her PRP$ O B-test
bilirubin NN B-NP I-test
was VBD B-VP O
1.4 CD O O
total NN B-NP O
, , O O
0.2 CD O O
direct JJ O B-test
. . B-VP O
   
alkaline JJ B-NP B-test
phosphatase NN I-NP I-test
101 CD O O
. . B-VP O
   
SGPT NNP B-NP B-test
22 CD O O
, , O O
SGOT NNP B-NP B-test
41 CD O O
, , O O
amylase NN B-NP B-test
31 CD O O
, , O O
lipase JJR O B-test
less JJR O O
than IN B-VP O
1 CD O O
. . B-VP O
   
LDH NNP B-NP B-test
was VBD B-VP O
38.9 CD O O
, , O O
CK NNP B-NP B-test
was VBD B-VP O
66 CD O O
, , O O
her PRP$ O B-person
her PRP$ O B-test
hematocrit NN B-NP I-test
was VBD B-VP O
27.4 CD O O
, , O O
white JJ B-NP B-test
count NN I-NP I-test
was VBD B-VP O
8.0 CD O O
and CC O O
her PRP$ O B-person
her PRP$ O B-test
platelets NNS B-NP I-test
were VBD B-VP O
55 CD O O
. . B-VP O
   
PT NNP B-NP B-test
was VBD B-VP O
14.5 CD O O
, , O O
PTT NNP B-NP B-test
25.5 CD O O
. . B-VP O
   
HOSPITAL NNP B-NP O
COURSE NNP I-NP O
AND NNP I-NP O
TREATMENT NNP I-NP O
: : O O
As IN B-VP O
described VBN O O
above IN B-VP O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
transfused VBN O O
an DT O B-treatment
additional JJ O I-treatment
2 CD O I-treatment
units NNS B-NP I-treatment
in IN B-VP O
the DT B-NP O
Intensive NNP I-NP O
Care NNP I-NP O
Unit NNP I-NP O
and CC O O
the DT B-NP B-person
patient NN I-NP I-person
also RB O O
received VBD B-VP O
an DT B-NP B-test
upper JJ I-NP I-test
endoscopy NN I-NP I-test
study NN I-NP I-test
and CC O O
her PRP$ O B-person
her PRP$ O B-problem
varices NNS B-NP I-problem
were VBD B-VP O
banded VBN O B-treatment
. . B-VP O
   
On IN B-VP O
transfer NN B-NP O
to TO O O
the DT B-NP O
Lemgarson NNP I-NP O
Hospital NNP I-NP O
service NN I-NP O
, , O O
her PRP$ O B-person
her PRP$ O B-test
hematocrit NN B-NP I-test
was VBD B-VP O
31.2 CD O O
, , O O
white JJ B-NP B-test
count NN I-NP I-test
11.1 CD O O
and CC O O
a DT B-NP B-test
platelet NN I-NP I-test
count NN I-NP I-test
80 CD O O
. . B-VP O
   
Her PRP$ O B-person
Her PRP$ O B-test
PT NNP B-NP I-test
was VBD B-VP O
13.1 CD O O
, , O O
PTT NNP B-NP B-test
26.7 CD O O
. . B-VP O
   
The DT B-NP O
rest NN I-NP O
of IN B-VP O
her PRP$ O B-person
her PRP$ O B-test
labs NN B-NP I-test
were VBD B-VP O
unremarkable JJ O O
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
watched VBN O O
very RB O O
closely RB O O
while IN B-VP O
on IN B-VP O
the DT B-NP O
floor NN I-NP O
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
on IN B-VP O
GI NNP B-NP B-treatment
bleed VBD B-VP I-treatment
precautions NNS B-NP I-treatment
at IN B-VP O
all DT B-NP O
times NNS I-NP O
, , O O
was VBD B-VP O
too RB O O
large JJ O O
for IN B-VP O
IV NNP B-NP B-treatment
. . B-VP O
   
She PRP O B-person
had VBD B-VP O
a DT B-NP B-problem
clot NN I-NP I-problem
at IN B-VP O
the DT B-NP O
blood NN I-NP O
bank NN I-NP O
and CC O O
she PRP O B-person
had VBD B-VP O
BID NNP B-NP B-test
hematocrits NNS I-NP I-test
checked VBN O O
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
kept JJ B-NP O
NPO NNP I-NP B-treatment
until IN B-VP O
January NNP B-NP O
26 CD O O
when WRB O O
she PRP O B-person
began VBD B-VP O
to TO O O
feel VB O O
hungry JJ O O
. . B-VP O
   
At IN B-VP O
that DT B-NP B-pronoun
time NN I-NP O
clear JJ B-NP B-treatment
liquids NNS I-NP I-treatment
were VBD B-VP O
started VBN O O
. . B-VP O
   
All DT O O
of IN B-VP O
her PRP$ O B-person
stools NNS B-NP O
were VBD B-VP O
guaiaced VBN O O
. . B-VP O
   
She PRP O B-person
also RB O O
began VBD B-VP O
Nadolol NNP B-NP B-treatment
40 CD O O
mg NN B-NP O
QD NNP I-NP O
to TO O O
reduce VB O O
her PRP$ O B-person
her PRP$ O B-problem
portal JJ B-NP I-problem
hypertension NN I-NP I-problem
. . B-VP O
   
The DT B-NP O
GI NNP I-NP B-person
consult NN I-NP I-person
team NN I-NP I-person
continued VBD B-VP O
to TO O O
follow VB O O
her PRP O B-person
. . B-VP O
   
We PRP O B-person
also RB O O
tried VBD B-VP O
to TO O O
contact VB O O
her PRP$ O B-person
her PRP$ O B-person
physician NN B-NP I-person
at IN B-VP O
Va NNP B-NP O
Sit NNP I-NP O
Namar NNP I-NP O
Healthcare NNP I-NP O
and CC O O
was VBD B-VP O
unsuccessful JJ O O
. . B-VP O
   
Therefore IN B-VP O
we PRP O B-person
decided VBD B-VP O
to TO O O
work VB O B-test
up RP O I-test
her PRP$ O B-person
cirrhosis NN B-NP B-problem
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
described VBN O O
as IN B-VP O
having VBG O O
_______ JJ B-NP O
cirrhosis NN I-NP B-problem
and CC O O
we PRP O B-person
decided VBD B-VP O
that IN B-VP B-pronoun
we PRP O B-person
wanted VBD B-VP O
to TO O O
try VB O O
to TO O O
figure VB O O
out RP O O
the DT B-NP O
etiology NN I-NP O
. . B-VP O
   
Her PRP$ O B-person
Her NNP B-NP B-test
ferritin NN I-NP I-test
and CC O O
iron NN B-NP B-test
studies NNS I-NP I-test
did VBD B-VP O
not RB O O
reveal VB O O
any DT B-NP O
evidence NN I-NP O
of IN B-VP O
hemochromatosis NN B-NP B-problem
and CC O O
her PRP$ O B-person
her PRP$ O B-test
hep NN B-NP I-test
serologies NNS I-NP I-test
were VBD B-VP O
all DT O O
negative JJ O O
. . B-VP O
   
She PRP O B-person
also RB O O
had VBD B-VP O
negative JJ B-NP O
antimitochondrial JJ I-NP O
antibody NN I-NP O
and CC O O
she PRP O B-person
also RB O O
had VBD B-VP O
no DT B-NP O
evidence NN I-NP O
of IN B-VP O
ceruloplasmin NN B-NP B-problem
. . B-VP O
   
Over IN B-VP O
the DT B-NP O
course NN I-NP O
of IN B-VP O
her PRP$ O B-person
admission NN B-NP O
were VBD B-VP O
also RB O O
sent VBN O O
an DT B-NP B-test
alpha-1-antitrypsin NN I-NP I-test
, , O O
which WDT O B-pronoun
was VBD B-VP O
negative JJ O O
. . B-VP O
   
She PRP O B-person
did VBD B-VP O
very RB O O
well RB O O
over IN B-VP O
the DT B-NP O
course NN I-NP O
of IN B-VP O
her PRP$ O B-person
admission NN B-NP O
with IN B-VP O
no DT B-NP O
evidence NN I-NP O
of IN B-VP O
further JJ B-NP B-problem
bleeding NN I-NP I-problem
. . B-VP O
   
Her PRP$ O B-person
Her PRP$ O B-test
hematocrit NN B-NP I-test
stayed VBD B-VP O
stable JJ O O
at IN B-VP O
approximately RB O O
32 CD O O
. . B-VP O
   
We PRP O B-person
also RB O O
did VBD B-VP O
an DT B-NP B-test
ultrasound NN I-NP I-test
guided VBD B-VP I-test
paracentesis NN B-NP I-test
. . B-VP O
   
The DT B-NP B-test
peritoneal JJ I-NP I-test
fluid NN I-NP I-test
showed VBD B-VP O
a DT B-NP B-test
glucose NN I-NP I-test
of IN B-VP O
244 CD O O
, , O O
total JJ B-NP B-test
protein NN I-NP I-test
0.8 CD O O
and CC O O
a DT B-NP B-test
albumin NN I-NP I-test
of IN B-VP O
0.5 CD O O
, , O O
globulin NN B-NP B-test
0.3 CD O O
, , O O
amylase NN B-NP B-test
16 CD O O
, , O O
LDH NNP B-NP B-test
of IN B-VP O
51 CD O O
. . B-VP O
   
The DT B-NP B-test
serum NN I-NP I-test
albumin NN I-NP I-test
gradient NN I-NP I-test
was VBD B-VP O
1.8 CD O O
consistent JJ O O
with IN B-VP O
portal JJ B-NP B-problem
hypertension NN I-NP I-problem
. . B-VP O
   
The DT B-NP B-test
cell NN I-NP I-test
count NN I-NP I-test
showed VBD B-VP O
a DT B-NP B-test
white JJ I-NP I-test
blood NN I-NP I-test
cell NN I-NP I-test
count NN I-NP I-test
of IN B-VP O
160 CD O O
with IN B-VP O
16% CD O B-test
polys NN B-NP I-test
. . B-VP O
   
She PRP O B-person
therefore VBD B-VP O
_________ JJ B-NP O
criteria NNS I-NP O
for IN B-VP O
a DT B-NP B-problem
spontaneous JJ I-NP I-problem
bacterial JJ I-NP I-problem
peritonitis NN I-NP I-problem
. . B-VP O
   
Her PRP$ O B-person
Her PRP$ O B-test
platelet NN B-NP I-test
count NN I-NP I-test
stayed VBD B-VP O
persistently RB O B-problem
low JJ O I-problem
and CC O O
we PRP O B-person
decided VBD B-VP O
that IN B-VP B-pronoun
it PRP O B-pronoun
might MD O O
be VB O O
due JJ O O
to TO O O
Cimetidine NNP B-NP B-treatment
. . B-VP O
   
Therefore IN B-VP O
we PRP O B-person
switched VBD B-VP O
her PRP O B-person
Cimetidine NNP B-NP B-treatment
to TO O O
Prilosec NNP B-NP B-treatment
. . B-VP O
   
By IN B-VP O
the DT O O
2th CD O O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
feeling VBG O O
very RB O O
well RB O O
and CC O O
desired VBD B-VP O
to TO O O
transfer VB O O
or CC O O
discharge VB O O
to TO O O
home NN B-NP O
. . B-VP O
   
She PRP O B-person
wanted VBD B-VP O
to TO O O
be VB O O
closer JJR O O
to TO O O
North NNP B-NP O
Dakota NNP I-NP O
. . B-VP O
   
After IN B-VP O
discussion NN B-NP O
with IN B-VP O
her PRP$ O B-person
her PRP$ O B-person
private JJ B-NP I-person
physician NN I-NP I-person
, , O O
Dr. NNP B-NP B-person
Joasscchird NNP I-NP I-person
, , O O
tel. JJ B-NP O
090-249-6079 NN I-NP O
, , O O
at IN B-VP O
Va NNP B-NP O
Sit NNP I-NP O
Namar NNP I-NP O
Healthcare NNP I-NP O
and CC O O
Dr. NNP B-NP B-person
Acrookesjo NNP I-NP I-person
at IN B-VP O
Do NNP B-NP O
Of IN B-VP O
Hospital NNP B-NP O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
judged VBN O O
to TO O O
be VB O O
fit JJ O O
for IN B-VP O
discharge NN B-NP O
and CC O O
she PRP O B-person
was VBD B-VP O
sent VBN O O
home NN B-NP O
with IN B-VP O
AH NNP B-NP B-treatment
and CC O O
physical JJ B-NP B-treatment
therapy NN I-NP I-treatment
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
quite RB O O
able JJ O O
to TO O O
climb VB O O
stairs NNS B-NP O
on IN B-VP O
her PRP$ O B-person
own JJ O O
in IN B-VP O
the DT B-NP O
hospital NN I-NP O
. . B-VP O
   
She PRP O B-person
is VBZ O O
to TO O O
follow VB O O
up RP O O
with IN B-VP O
Dr. NNP B-NP B-person
Acrookesjo NNP I-NP I-person
in IN B-VP O
one CD O O
week NN B-NP O
and CC O O
Dr. NNP B-NP B-person
Work NNP I-NP I-person
the DT B-NP O
gastrointestinal JJ I-NP B-person
fellow NN I-NP I-person
here RB O O
at IN B-VP O
PUOMC NNP B-NP O
in IN B-VP O
2 CD O O
weeks NNS B-NP O
. . B-VP O
   
She PRP O B-person
may MD O O
require VB O O
a DT B-NP B-test
repeat NN I-NP I-test
upper JJ B-NP I-test
endoscopy NN I-NP I-test
study NN I-NP I-test
to TO O O
see VB O O
if IN B-VP O
she PRP O B-person
needs VBZ O O
any DT B-NP B-treatment
rebanding NN I-NP I-treatment
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
however RB O O
complained VBD B-VP O
of IN B-VP O
a DT B-NP B-problem
persistent JJ I-NP I-problem
wheeze NN I-NP I-problem
with IN B-VP O
beta NN B-NP B-treatment
blocker NN I-NP I-treatment
, , O O
therefore IN B-VP O
it PRP O B-pronoun
was VBD B-VP O
agreed VBN O O
that IN B-VP B-pronoun
we PRP O B-person
would MD O O
stop VB O O
the DT B-NP B-treatment
beta NN I-NP I-treatment
blocker NN I-NP I-treatment
until IN B-VP O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
followed VBN O O
up RP O O
as IN B-VP O
an DT B-NP O
outpatient NN I-NP O
. . B-VP O
   
MEDICATIONS NNP B-NP O
ON NNP I-NP O
DISCHARGE NNP I-NP O
: : O O
Zoloft JJ O B-treatment
50 CD O O
mg NN B-NP O
PO NNP I-NP O
QD NNP I-NP O
, , O O
Lactulose NNP B-NP B-treatment
15 CD O O
g NN B-NP O
PO NNP I-NP O
BID NNP I-NP O
, , O O
Synthroid NNP B-NP B-treatment
0.15 CD O O
mg NN B-NP O
PO NNP I-NP O
QD NNP I-NP O
, , O O
Prilosec NNP B-NP B-treatment
20 CD O O
mg NN B-NP O
PO NNP I-NP O
BID NNP I-NP O
. . B-VP O
   
CONDITION NNP B-NP O
ON NNP I-NP O
DISCHARGE NNP I-NP O
: : O O
Good JJ O O
. . B-VP O
   
LENTNY NNP B-NP B-person
WORK NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
TR NNP I-NP O
: : O O
zs NN B-NP O
DD NNP I-NP O
: : O O
03/06/97 CD O O
TD NN B-NP O
: : O O
03/10/97 CD O O
2:14 CD O O
P NNP B-NP O
cc NN I-NP O
: : O O
LENTNY NNP B-NP B-person
MAYLUTYNA NNP I-NP I-person
WORK NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
Admission NNP I-NP O
Date NNP I-NP O
: : O O
2011-10-17 JJ B-NP O
Discharge NN I-NP O
Date NNP I-NP O
: : O O
2011-10-31 JJ B-NP O
Date NNP I-NP O
of IN B-VP O
Birth NNP B-NP O
: : O O
1955-09-01 JJ B-NP O
Sex NN I-NP O
: : O O
M NNP B-NP O
Service NNP I-NP O
: : O O
Cardiothor NNP B-NP O
HISTORY NNP I-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS NNP I-NP O
: : O O
This DT O B-pronoun
is VBZ O O
a DT B-NP O
56 JJ I-NP O
year-old JJ I-NP O
gentleman NN I-NP O
with IN B-VP O
severe JJ B-NP B-problem
aortic JJ I-NP I-problem
stenosis NN I-NP I-problem
, , O O
reports NNS B-NP O
having VBG O O
been VBN O O
told VBN O O
he PRP O B-person
had VBD B-VP O
a DT B-NP B-problem
heart NN I-NP I-problem
murmur VBZ O I-problem
many JJ B-NP O
years NNS I-NP O
ago RB O O
but CC O O
just RB O O
recently RB O O
diagnosed VBN O O
with IN B-VP O
aortic JJ B-NP B-problem
stenosis NN I-NP I-problem
. . B-VP O
   
He PRP O B-person
has VBZ O O
had VBN O O
mild VBN O B-problem
dyspnea NNS B-NP I-problem
on IN B-VP O
exertion NN B-NP O
increasing VBG O O
over IN B-VP O
the DT B-NP O
past JJ I-NP O
couple NN I-NP O
of IN B-VP O
months NNS B-NP O
prior RB O O
to TO O O
admission NN B-NP O
. . B-VP O
   
An DT B-NP B-test
echocardiogram NN I-NP I-test
in IN B-VP O
2011-09-05 JJ O O
revealed VBD B-VP O
a DT B-NP B-test
left JJ I-NP I-test
ventricular JJ I-NP I-test
ejection NN I-NP I-test
fraction NN I-NP I-test
of IN B-VP O
20 CD O O
to TO O O
25% CD O O
. . B-VP O
   
PAST NNP B-NP O
MEDICAL NNP I-NP O
HISTORY NNP I-NP O
: : O O
1. CD O O
Cigarette NNP B-NP O
smoking NN I-NP O
. . B-VP O
   
2. CD O O
Insulin NNP B-NP B-problem
dependent NN I-NP I-problem
diabetes VBZ O I-problem
mellitus NN B-NP I-problem
. . B-VP O
   
3. CD O O
Proteinuria NNP B-NP B-problem
. . B-VP O
   
4. CD O O
Aortic JJ B-NP B-problem
stenosis NN I-NP I-problem
. . B-VP O
   
5. CD O O
Cellulitis NNP B-NP B-problem
. . B-VP O
   
6. CD O O
Gangrene NNP B-NP B-problem
of IN B-VP I-problem
his PRP$ O B-person
his PRP$ O I-problem
left JJ B-NP I-problem
second JJ I-NP I-problem
toe NN I-NP I-problem
in IN B-VP O
2010-06-06 JJ O O
followed VBN O O
by IN B-VP O
an DT B-NP B-treatment
amputation NN I-NP I-treatment
. . B-VP O
   
7. CD O O
Left VBD B-VP B-treatment
common JJ B-NP I-treatment
femoral JJ I-NP I-treatment
dorsalis NN I-NP I-treatment
pedis NN I-NP I-treatment
bypass NN I-NP I-treatment
graft NN I-NP I-treatment
. . B-VP O
   
8. CD O O
Right JJ B-NP B-treatment
leg NN I-NP I-treatment
bypass NN I-NP I-treatment
graft NN I-NP I-treatment
in IN B-VP O
1999 CD O O
. . B-VP O
   
9. CD O O
Right RB O B-treatment
below IN B-VP I-treatment
the DT B-NP I-treatment
knee NN I-NP I-treatment
amputation NN I-NP I-treatment
in IN B-VP O
2008 CD O O
. . B-VP O
   
ALLERGIES CC O O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
states VBZ O O
he PRP O B-person
has VBZ O O
no DT O O
known VBN O B-problem
drug NN B-NP I-problem
allergies NNS I-NP I-problem
. . B-VP O
   
MEDICATIONS NN B-NP O
: : O O
1. CD O O
Aspirin NNP B-NP B-treatment
325 CD O O
mg NN B-NP O
po NN I-NP O
q JJ B-NP O
day NN I-NP O
. . B-VP O
   
2. CD O O
Vasotec JJ O B-treatment
7.5 CD O O
mg NN B-NP O
po NN I-NP O
q JJ B-NP O
day NN I-NP O
. . B-VP O
   
3. CD O O
Humalog NNP B-NP B-treatment
insulin NN I-NP I-treatment
sliding VBG O I-treatment
scale NN B-NP I-treatment
with IN B-VP O
meals NNS B-NP O
and CC O O
at IN B-VP O
bedtime NN B-NP O
. . B-VP O
   
4. CD O O
Humulin NNP B-NP B-treatment
Walters NNP I-NP I-treatment
insulin VBP O I-treatment
24 CD O O
units NNS B-NP O
subcutaneous JJ B-NP O
q JJ I-NP O
A.M. NNP I-NP O
and CC O O
8 CD O O
to TO O O
16 CD O O
in IN B-VP O
the DT B-NP O
evening NN I-NP O
depending VBG O O
upon IN B-VP O
where WRB O O
his PRP$ O B-person
his PRP$ O B-test
blood NN B-NP I-test
sugar NN I-NP I-test
has VBZ O O
been VBN O O
. . B-VP O
   
Preoperative JJ B-NP B-test
laboratory NN I-NP I-test
values NNS I-NP I-test
were VBD B-VP O
unremarkable JJ O O
. . B-VP O
   
The DT B-NP B-person
patient JJ I-NP I-person
underwent JJ I-NP O
cardiac JJ I-NP B-test
catheterization NN I-NP I-test
on IN B-VP O
2011-10-17 JJ O O
which WDT O B-pronoun
revealed VBD B-VP O
a DT O B-problem
20% CD O I-problem
left VBD B-VP I-problem
vein NN B-NP I-problem
osteal JJ B-NP I-problem
lesion NN I-NP I-problem
as RB O O
well RB O O
as IN B-VP O
70% CD O B-problem
LAD NNP B-NP I-problem
lesion NN I-NP I-problem
and CC O O
an DT O B-problem
80% CD O I-problem
right JJ B-NP I-problem
coronary NN I-NP I-problem
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
taken VBN O O
to TO O O
the DT B-NP O
operating NN I-NP O
room NN I-NP O
on IN B-VP O
2011-10-18 JJ O O
where WRB O O
he PRP O B-person
underwent VBD B-VP O
an DT B-NP B-treatment
aortic JJ I-NP I-treatment
valve NN I-NP I-treatment
replacement NN I-NP I-treatment
with IN B-VP O
#23 NNP B-NP B-treatment
mm VBP O I-treatment
pericardial JJ B-NP I-treatment
valve NN I-NP I-treatment
as RB O O
well RB O O
as IN B-VP O
coronary JJ B-NP B-treatment
artery NN I-NP I-treatment
bypass NN I-NP I-treatment
graft NN I-NP I-treatment
times NNS I-NP O
two CD O O
with IN B-VP O
a DT B-NP O
LIMA NNP I-NP O
to TO O O
the DT B-NP O
LAD NNP I-NP O
and CC O O
saphenous JJ B-NP O
vein NN I-NP O
to TO O O
the DT B-NP O
acute JJ I-NP O
marginal NN I-NP O
. . B-VP O
   
Postoperatively RB O O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
transported VBN O O
to TO O O
the DT B-NP O
cardiac NN I-NP O
surgery NN I-NP O
recovery NN I-NP O
unit NN I-NP O
on IN B-VP O
Milrinone NNP B-NP B-treatment
, , O O
Neo-Synephrine NNP B-NP B-treatment
and CC O O
Levophed NNP B-NP B-treatment
drip NN I-NP I-treatment
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
weaned VBN O O
from IN B-VP O
mechanical JJ B-NP B-treatment
ventilation NN I-NP I-treatment
and CC O O
subsequently RB O O
extubated VBN O O
on IN B-VP O
the DT B-NP O
night NN I-NP O
of IN B-VP O
surgery NN B-NP B-treatment
. . B-VP O
   
He PRP O B-person
remained VBD B-VP O
on IN B-VP O
Levophed NNP B-NP B-treatment
, , O O
Milrinone NNP B-NP B-treatment
and CC O O
Neo-Synephrine NNP B-NP B-treatment
drips NNS I-NP I-treatment
and CC O O
was VBD B-VP O
hemodynamically RB O O
stable JJ O O
. . B-VP O
   
N. NNP B-NP O
Saez NNP I-NP O
clinic JJ B-NP O
consult NN I-NP O
was VBD B-VP O
obtained VBN O O
due JJ O O
to TO O O
hyperglycemia VB O B-problem
and CC O O
the DT B-NP O
need NN I-NP O
for IN B-VP O
insulin NN B-NP B-treatment
drip NN I-NP I-treatment
in IN B-VP O
the DT B-NP O
Intensive NNP I-NP O
Care NNP I-NP O
Unit NNP I-NP O
. . B-VP O
   
On IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
the DT B-NP B-treatment
Milrinone NNP I-NP I-treatment
was VBD B-VP O
weaned VBN O O
down RP O O
. . B-VP O
   
The DT B-NP B-treatment
Levophed NNP I-NP I-treatment
had VBD B-VP O
been VBN O O
discontinued VBN O O
as IN B-VP O
the DT B-NP B-treatment
Neo-Synephrine NNP I-NP I-treatment
and CC O O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
beginning VBG O O
to TO O O
progress VB O O
hemodynamically RB O O
. . B-VP O
   
Upon IN B-VP O
discontinuation NN B-NP O
of IN B-VP O
the DT B-NP B-treatment
Milrinone NNP I-NP I-treatment
the DT O B-person
the DT B-NP B-test
patient JJ I-NP I-person
patient NN I-NP I-test
's POS O I-test
SV02 NNP B-NP I-test
had VBD B-VP O
dropped VBN O O
significantly RB O O
in IN B-VP O
the DT O O
low JJ O O
50 CD O O
s. NN B-NP O
The DT B-NP B-person
patient NN I-NP I-person
had VBD B-VP O
decreased VBN O B-problem
exercise NN B-NP I-problem
tolerance NN I-NP I-problem
and CC O O
therefore NN B-NP O
was VBD B-VP O
placed VBN O O
back RP O O
on IN B-VP O
his PRP$ O B-person
his PRP$ O B-treatment
milrinone NN B-NP I-treatment
to TO O O
keep VB O O
his PRP$ O B-person
his PRP$ O B-test
cardiac NN B-NP I-test
index NN I-NP I-test
greater JJR O O
than IN B-VP O
2.0 CD O O
. . B-VP O
   
Over IN B-VP O
the DT B-NP O
next JJ I-NP O
couple NN I-NP O
of IN B-VP O
days NNS B-NP O
it PRP O B-pronoun
was VBD B-VP O
very RB O O
slowly RB O O
decreased VBN O O
as IN B-VP O
his PRP$ O B-person
his PRP$ O B-treatment
Ace NNP B-NP I-treatment
inhibitors NNS I-NP I-treatment
were VBD B-VP O
increased VBN O O
orally RB O O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
ultimately RB O O
was VBD B-VP O
weaned VBN O O
off RP O O
the DT B-NP B-treatment
Milrinone NNP I-NP I-treatment
, , O O
transitioned VBD B-VP O
to TO O O
Captopril NNP B-NP B-treatment
on IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
five CD O O
and CC O O
remained VBD B-VP O
hemodynamically RB O O
stable JJ O O
. . B-VP O
   
Once IN B-VP O
the DT B-NP B-person
patient NN I-NP I-person
had VBD B-VP O
remained VBN O O
off IN B-VP O
of IN B-VP O
inotropics NNS B-NP B-treatment
for IN B-VP O
approximately RB O O
24 CD O O
hours NNS B-NP O
, , O O
he PRP O B-person
had VBD B-VP O
been VBN O O
given VBN O O
diuretics NNS B-NP B-treatment
and CC O O
Ace NNP B-NP B-treatment
inhibitors NNS I-NP I-treatment
and CC O O
remained VBD B-VP O
hemodynamically RB O O
stable JJ O O
he PRP O B-person
was VBD B-VP O
transferred VBN O O
from IN B-VP O
the DT B-NP O
Intensive NNP I-NP O
Care NNP I-NP O
Unit NNP I-NP O
to TO O O
the DT B-NP O
Telemetry NNP I-NP O
floor NN I-NP O
on IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
six CD O O
. . B-VP O
   
A DT B-NP B-test
physical JJ I-NP I-test
therapy NN I-NP I-test
evaluation NN I-NP I-test
was VBD B-VP O
obtained VBN O O
for IN B-VP O
assistance NN B-NP O
and CC O O
mobility NN B-NP O
. . B-VP O
   
Cardiac NNP B-NP B-treatment
rehabilitation NN I-NP I-treatment
was VBD B-VP O
initiated VBN O O
at IN B-VP O
that DT B-NP B-pronoun
time NN I-NP O
. . B-VP O
   
On IN B-VP O
2011-10-24 JJ B-NP O
postoperative JJ I-NP O
day NN I-NP O
six CD O O
consultation NN B-NP O
heart NN I-NP B-person
failure NN I-NP I-person
cardiology NN I-NP I-person
service NN I-NP I-person
was VBD B-VP O
obtained VBN O O
. . B-VP O
   
It PRP O B-pronoun
was VBD B-VP O
their PRP$ O B-person
recommendation NN B-NP O
to TO O O
continue VB O O
Ace NNP B-NP B-treatment
inhibitors NNS I-NP I-treatment
, , O O
to TO O O
continue VB O O
daily JJ B-NP B-test
weights NNS I-NP I-test
, , O O
to TO O O
switch VB O O
the DT B-NP B-person
patient NN I-NP I-person
to TO O O
a DT B-NP B-treatment
long JJ I-NP I-treatment
acting JJ I-NP I-treatment
beta-blocker NN I-NP I-treatment
and CC O O
to TO O O
enroll VB O O
the DT B-NP B-person
patient NN I-NP I-person
in IN B-VP O
postoperative JJ B-NP B-treatment
cardiac JJ I-NP I-treatment
rehabilitation NN I-NP I-treatment
as RB O O
well RB O O
as IN B-VP O
to TO O O
make VB O O
sure JJ O O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
on IN B-VP O
statin NN B-NP B-treatment
drugs NNS I-NP I-treatment
. . B-VP O
   
These DT B-NP B-pronoun
measures NNS I-NP O
were VBD B-VP O
all DT O O
instituted VBN O O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
continued VBD B-VP O
to TO O O
progress VB O O
from IN B-VP O
cardiac JJ B-NP O
rehabilitation NN I-NP O
and CC O O
physical JJ B-NP O
therapy NN I-NP O
standpoint NN I-NP O
while IN B-VP O
on IN B-VP O
the DT B-NP O
floor NN I-NP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
remained VBD B-VP O
hemodynamically RB O O
stable JJ O O
over IN B-VP O
the DT B-NP O
next JJ I-NP O
few JJ I-NP O
days NNS I-NP O
, , O O
continued VBD B-VP O
to TO O O
increase VB O O
with IN B-VP O
physical JJ B-NP B-treatment
therapy NN I-NP I-treatment
and CC O O
ambulation NN B-NP O
. . B-VP O
   
His PRP$ O B-person
His PRP$ O B-test
blood NN B-NP I-test
sugars NNS I-NP I-test
were VBD B-VP O
followed VBN O O
by IN B-VP O
the DT B-NP O
Cape NNP I-NP O
Cod NNP I-NP O
Hospital NNP I-NP O
Clinic NNP I-NP O
service NN I-NP O
and CC O O
insulin NN B-NP B-treatment
has VBZ O O
been VBN O O
adjusted VBN O O
accordingly RB O O
. . B-VP O
   
Today NN B-NP O
, , O O
2011-10-31 JJ O O
, , O O
postoperative JJ B-NP O
day NN I-NP O
13 CD O O
the DT B-NP B-person
patient NN I-NP I-person
remains VBZ O O
stable JJ O O
and CC O O
ready JJ O O
for IN B-VP O
discharge NN B-NP O
to TO O O
home NN B-NP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
's POS O O
condition NN B-NP O
today NN I-NP O
is VBZ O O
as IN B-VP O
follows VBZ O O
: : O O
Temperature NN B-NP B-test
96.9 CD O O
F NNP B-NP O
, , O O
pulse RB O B-test
84 CD O O
, , O O
respiratory NN B-NP B-test
rate NN I-NP I-test
18 CD O O
, , O O
blood NN B-NP B-test
pressure NN I-NP I-test
106/59 CD O O
. . B-VP O
   
Most RBS O B-test
recent JJ B-NP I-test
laboratory NN I-NP I-test
values NNS I-NP I-test
are VBP O O
from IN B-VP O
2011-10-25 CD O O
which WDT O B-pronoun
revealed VBD B-VP O
a DT B-NP B-test
white JJ I-NP I-test
blood NN I-NP I-test
cell NN I-NP I-test
count NN I-NP I-test
8.4000 CD O O
, , O O
hematocrit NN B-NP B-test
35 CD O O
, , O O
platelet NN B-NP B-test
count NN I-NP I-test
202,000. CD O O
Sodium NNP B-NP B-test
133 CD O O
, , O O
potassium NN B-NP B-test
4.4 CD O O
, , O O
chloride RB O B-test
93 CD O O
, , O O
CO2 NNP B-NP B-test
30 CD O O
, , O O
BUN NNP B-NP B-test
24 CD O O
, , O O
creatinine NN B-NP B-test
0.7 CD O O
, , O O
glucose VBD B-VP B-test
198 CD O O
. . B-VP O
   
The DT O B-person
The DT B-NP B-test
patient JJ I-NP I-person
patient NN I-NP I-test
's POS O I-test
finger NN B-NP I-test
stick VBD B-VP I-test
blood NN B-NP I-test
glucose NN I-NP I-test
levels NNS I-NP I-test
range VBP O O
from IN B-VP O
151 CD O O
to TO O O
390 CD O O
over IN B-VP O
the DT O O
past JJ O O
24 CD O O
hours NNS B-NP O
and CC O O
his PRP$ O B-person
his PRP$ O B-treatment
insulin NN B-NP I-treatment
scale NN I-NP I-treatment
has VBZ O O
been VBN O O
adjusted VBN O O
upward RB O O
to TO O O
compensate VB O O
for IN B-VP O
that DT O B-pronoun
. . B-VP O
   
Neurologically RB O O
the DT B-NP B-person
patient NN I-NP I-person
is VBZ O O
grossly RB O O
intact JJ O O
. . B-VP O
   
Pulmonary JJ B-NP B-test
exam NN I-NP I-test
he PRP O B-person
is VBZ O O
clear JJ B-NP O
upper JJ I-NP O
lobes NN I-NP O
, , O O
diminished VBD B-VP B-problem
bilateral JJ B-NP I-problem
bases NNS I-NP I-problem
left VBD B-VP O
greater JJR O O
than IN B-VP O
right RB O O
. . B-VP O
   
Coronary JJ B-NP B-test
exam NN I-NP I-test
is VBZ O O
regular JJ B-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
. . B-VP O
   
His PRP$ O B-person
abdomen NNS B-NP O
is VBZ O O
benign JJ O O
. . B-VP O
   
His PRP$ O B-person
sternum NN B-NP O
is VBZ O O
stable. VBN O O
His PRP$ O B-person
His PRP$ O B-problem
incision NN B-NP I-problem
is VBZ O O
clean JJ O O
and CC O O
dry JJ B-NP O
Steri NNP I-NP B-treatment
Strips NNP I-NP I-treatment
intact NN I-NP O
. . B-VP O
   
His PRP$ O B-person
extremities NNS B-NP O
are VBP O O
warm JJ O O
and CC O O
well RB O O
perfused VBN O O
with IN B-VP O
minimal JJ B-NP B-problem
edema NN I-NP I-problem
of IN B-VP I-problem
his PRP$ O B-person
his PRP$ O I-problem
left JJ B-NP I-problem
foot NN I-NP I-problem
as RB O O
well RB O O
as IN B-VP O
his PRP$ O B-person
right JJ B-NP O
stump NN I-NP O
. . B-VP O
   
He PRP O B-person
is VBZ O O
able JJ O O
to TO O O
apply VB O O
his PRP$ O B-person
his PRP$ O B-treatment
prosthesis NN B-NP I-treatment
and CC O O
ambulate NN B-NP O
as RB O O
well RB O O
. . B-VP O
   
DISCHARGE NNP B-NP O
MEDICATIONS NNP I-NP O
: : O O
1. CD O O
Lasix NNP B-NP B-treatment
40 CD O O
mg NN B-NP O
po NN I-NP O
bid NN I-NP O
. . B-VP O
   
2. CD O O
Potassium NNP B-NP B-treatment
Chloride NNP I-NP I-treatment
20 CD O O
milliequivalents NNS B-NP O
po JJ B-NP O
bid NN I-NP O
. . B-VP O
   
3. CD O O
Colace NNP B-NP B-treatment
100 CD O O
mg NN B-NP O
po NN I-NP O
bid NN I-NP O
. . B-VP O
   
4. CD O O
Zantac NNP B-NP B-treatment
150 CD O O
mg NN B-NP O
po NN I-NP O
bid NN I-NP O
. . B-VP O
   
5. CD O O
Aspirin NNP B-NP B-treatment
325 CD O O
mg NN B-NP O
po NN I-NP O
qd NN I-NP O
. . B-VP O
   
6. CD O O
Captopril NNP B-NP B-treatment
25 CD O O
mg NN B-NP O
po NN I-NP O
tid NN I-NP O
. . B-VP O
   
7. CD O O
Digoxin NNP B-NP B-treatment
0.25 CD O O
mg NN B-NP O
po NN I-NP O
q JJ B-NP O
day NN I-NP O
. . B-VP O
   
8. CD O O
Atorvastatin NNP B-NP B-treatment
10 CD O O
mg NN B-NP O
po NN I-NP O
q JJ B-NP O
day NN I-NP O
. . B-VP O
   
9. CD O O
Toprol NNP B-NP B-treatment
XL NNP I-NP I-treatment
100 CD O O
mg NN B-NP O
po NN I-NP O
q JJ B-NP O
day NN I-NP O
. . B-VP O
   
10. CD O O
Bollin NNP B-NP B-treatment
insulin NN I-NP I-treatment
18 CD O O
units NNS B-NP O
subcutaneous JJ B-NP O
q JJ I-NP O
A.M. NNP I-NP O
, , O O
Richard NNP B-NP B-treatment
insulin VBZ O I-treatment
14 CD O O
units NNS B-NP O
subcutaneous JJ O O
q CD O O
P.M. NNP B-NP O
11. CD O O
Sliding NNP B-NP B-treatment
scale NN I-NP I-treatment
Humalog NNP I-NP I-treatment
regular JJ B-NP I-treatment
insulin NN I-NP I-treatment
for IN B-VP O
breakfast NN B-NP O
is VBZ O O
blood VBN O B-test
glucose NN B-NP I-test
of IN B-VP O
151 CD O O
to TO O O
200 CD O O
equal JJ O O
4 CD O O
units NNS B-NP O
, , O O
201 CD O O
to TO O O
250 CD O O
equal JJ O O
6 CD O O
units NNS B-NP O
, , O O
251 CD O O
to TO O O
350 CD O O
equal JJ O O
12 CD O O
units NNS B-NP O
, , O O
greater JJR O O
than IN B-VP O
350 CD O O
equals NNS B-NP O
15 CD O O
units NNS B-NP O
. . B-VP O
   
For IN B-VP O
lunch NN B-NP O
blood NN I-NP B-test
glucose NN I-NP I-test
of IN B-VP O
101 CD O O
to TO O O
150 CD O O
equals NNS B-NP O
4 CD O O
units NNS B-NP O
, , O O
151 CD O O
to TO O O
200 CD O O
equals NNS B-NP O
7 CD O O
units NNS B-NP O
, , O O
201 CD O O
to TO O O
250 CD O O
equals NNS B-NP O
8 CD O O
units NNS B-NP O
, , O O
251 CD O O
to TO O O
350 CD O O
equals NNS B-NP O
12 CD O O
units NNS B-NP O
, , O O
greater JJR O O
than IN B-VP O
350 CD O O
equals NNS B-NP O
15 CD O O
units NNS B-NP O
. . B-VP O
   
Dinner NNP B-NP O
blood VBD B-VP B-test
glucose RB O I-test
101 CD O O
to TO O O
150 CD O O
equals NNS B-NP O
2 CD O O
units NNS B-NP O
, , O O
151 CD O O
to TO O O
200 CD O O
equals NNS B-NP O
3 CD O O
units NNS B-NP O
, , O O
201 CD O O
to TO O O
250 CD O O
equals NNS B-NP O
6 CD O O
units NNS B-NP O
, , O O
251 CD O O
to TO O O
350 CD O O
equals NNS B-NP O
12 CD O O
units NNS B-NP O
, , O O
greater JJR O O
than IN B-VP O
350 CD O O
equals NNS B-NP O
15 CD O O
units NNS B-NP O
. . B-VP O
   
DISCHARGE NNP B-NP O
CONDITION NNP I-NP O
: : O O
Stable JJ O O
. . B-VP O
   
DISCHARGE JJ B-NP O
DIAGNOSIS NNP I-NP O
: : O O
1. CD O O
Aortic JJ B-NP B-problem
stenosis NN I-NP I-problem
. . B-VP O
   
2. CD O O
Coronary JJ B-NP B-problem
artery NN I-NP I-problem
disease NN I-NP I-problem
. . B-VP O
   
3. CD O O
Type NN B-NP B-problem
I PRP O I-problem
diabetes VBZ O I-problem
mellitus NN B-NP I-problem
. . B-VP O
   
4. CD O O
Peripheral JJ B-NP B-problem
vascular JJ I-NP I-problem
disease NN I-NP I-problem
. . B-VP O
   
FOLLOW NNP B-NP O
UP NNP I-NP O
: : O O
Dr. NNP B-NP B-person
Lloyd NNP I-NP I-person
van FW O I-person
de FW O I-person
Clark NNP B-NP I-person
in IN B-VP O
approximately RB O O
one CD O O
month NN B-NP O
postoperative NN I-NP O
. . B-VP O
   
Please VB O O
call VB O O
the DT B-NP O
office NN I-NP O
at IN B-VP O
( ( O O
854 CD O O
) ) O O
787-3243 NN B-NP O
for IN B-VP O
an DT B-NP O
appointment NN I-NP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
is VBZ O O
also RB O O
to TO O O
follow VB O O
up RP O O
with IN B-VP O
his PRP$ O B-person
his PRP$ O B-person
primary JJ B-NP I-person
care NN I-NP I-person
physician NN I-NP I-person
for IN B-VP O
diabetes JJ B-NP B-treatment
management NN I-NP I-treatment
. . B-VP O
   
He PRP O B-person
is VBZ O O
to TO O O
follow VB O O
up RP O O
with IN B-VP O
Dr. NNP B-NP B-person
East NNP I-NP I-person
here RB O O
at IN B-VP O
the DT B-NP O
Heart NNP I-NP O
Failure NNP I-NP O
Clinic NNP I-NP O
to TO O O
continue VB O O
follow VB O O
up RP O O
with IN B-VP O
cardiac JJ B-NP B-treatment
rehabilitation NN I-NP I-treatment
and CC O O
heart NN B-NP B-treatment
failure NN I-NP I-treatment
management NN I-NP I-treatment
. . B-VP O
   
Brown NNP B-NP B-person
des VBZ O I-person
Stone NNP B-NP I-person
, , O I-person
M.D. NNP B-NP I-person
07-760 CD O O
Dictated VBN O O
By IN B-VP O
: : O O
Anthony NNP B-NP B-person
O NNP I-NP I-person
Carreno NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
MEDQUIST36 NNP I-NP O
D NNP I-NP O
: : O O
2011-10-31 JJ O O
10:25 CD O O
T NN B-NP O
: : O O
2011-10-31 JJ O O
10:45 CD O O
JOB NNP B-NP O
#: VBD B-VP O
02527 CD O O
Signed VBN O O
electronically RB O O
by IN B-VP O
: : O O
DR. NNP B-NP B-person
John NNP I-NP I-person
della NN I-NP I-person
Hopper NNP I-NP I-person
on IN B-VP O
: : O O
WED JJ O O
2011-11-16 JJ O O
7:16 CD O O
PM NNP B-NP O
( ( O O
End NNP B-NP O
of IN B-VP O
Report NNP B-NP O
) ) O O
-EMPTYLINE- VBP O O
-DOCSTART- JJ O O
-EMPTYLINE- $ O O
105732749 CD O O
FIH NNP B-NP O
7017973 CD O O
715894 CD O O
55714 CD O O
9/10/1999 CD O O
12:00:00 CD O O
AM NNP B-NP O
Discharge NNP I-NP O
Summary NNP I-NP O
Unsigned VBD B-VP O
DIS NNP B-NP O
Report NNP I-NP O
Status NNP I-NP O
: : O O
Unsigned VBD B-VP O
DISCHARGE NNP B-NP O
SUMMARY NNP I-NP O
NAME NN I-NP O
: : O O
STERPKOTENEISH NNP B-NP B-person
, , O I-person
LYDELL NNP B-NP I-person
A NNP I-NP I-person
UNIT NNP I-NP O
NUMBER NNP I-NP O
: : O O
712-67-96 JJ B-NP O
ADMISSION NNP I-NP O
DATE NNP I-NP O
: : O O
09/10/1999 CD O O
DISCHARGE NNP B-NP O
DATE NNP I-NP O
: : O O
09/14/1999 CD O O
PRINCIPAL NNP B-NP O
DIAGNOSIS NNP I-NP O
: : O O
Pancreatic JJ B-NP B-problem
carcinoma NN I-NP I-problem
. . B-VP O
   
PRINCIPAL JJ B-NP O
PROCEDURE NN I-NP O
: : O O
Laparoscopy NN B-NP B-test
with IN B-VP O
biopsy NN B-NP B-test
for IN B-VP O
diagnosis NN B-NP O
. . B-VP O
   
HISTORY NNP B-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS NNP I-NP O
: : O O
Ms. NNP B-NP B-person
Sterpkoteneish NNP I-NP I-person
is VBZ O O
a DT B-NP O
69-year-old JJ I-NP O
woman NN I-NP O
, , O O
who WP O B-person
over IN B-VP O
the DT O O
past JJ O O
six CD O O
months NNS B-NP O
has VBZ O O
noted VBN O O
increasing VBG O B-problem
pain NN B-NP I-problem
in IN B-VP I-problem
her PRP$ O B-person
her PRP$ O I-problem
left JJ B-NP I-problem
upper JJ I-NP I-problem
quadrant NN I-NP I-problem
radiating VBG O O
to TO O O
the DT B-NP O
back NN I-NP O
. . B-VP O
   
She PRP O B-person
described VBD B-VP O
the DT B-NP B-problem
pain NN I-NP I-problem
as IN B-VP O
being VBG O O
exacerbated VBN O O
by IN B-VP O
eating VBG O O
and CC O O
described VBD B-VP O
an DT B-NP B-problem
associated JJ I-NP I-problem
weight NN I-NP I-problem
loss NN I-NP I-problem
. . B-VP O
   
She PRP O B-person
presented VBD B-VP O
to TO O O
her PRP$ O B-person
her PRP$ O B-person
primary JJ B-NP I-person
care NN I-NP I-person
physician NN I-NP I-person
, , O O
Dr. NNP B-NP B-person
Tlandtaze NNP I-NP I-person
, , O O
in IN B-VP O
Aersing NNP B-NP O
Rocuch NNP I-NP O
Sun NNP I-NP O
, , O O
who WP O B-person
obtained VBD B-VP O
a DT B-NP B-test
CT NNP I-NP I-test
scan NN I-NP I-test
, , O O
which WDT O B-pronoun
demonstrated VBD B-VP O
a DT B-NP B-problem
mass NN I-NP I-problem
in IN B-VP O
the DT B-NP O
tail NN I-NP O
of IN B-VP O
the DT B-NP O
pancreas NN I-NP O
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
then RB O O
referred VBN O O
to TO O O
the DT B-NP O
Fairm NNP I-NP O
of IN B-VP O
Ijordcompmac NNP B-NP O
Hospital NNP I-NP O
under IN B-VP O
the DT B-NP O
El NNP I-NP O
Memorial NNP I-NP O
and CC O O
was VBD B-VP O
seen VBN O O
by IN B-VP O
Dr. NNP B-NP B-person
Blinjesc NNP I-NP I-person
, , O O
who WP O B-person
scheduled VBD B-VP O
her PRP O B-person
for IN B-VP O
an DT B-NP B-test
exploratory JJ I-NP I-test
laparoscopy NN I-NP I-test
. . B-VP O
   
PAST NNP B-NP O
MEDICAL NNP I-NP O
HISTORY NNP I-NP O
: : O O
Is VBZ O O
significant JJ O O
for IN B-VP O
spinal JJ B-NP B-problem
stenosis NN I-NP I-problem
and CC O O
a DT B-NP O
series NN I-NP O
of IN B-VP O
operations NNS B-NP B-treatment
including VBG O O
repair NN B-NP B-treatment
of IN B-VP O
a DT B-NP B-problem
ureteral JJ I-NP I-problem
stricture NN I-NP I-problem
; : O O
cataract JJ B-NP B-treatment
implants NNS I-NP I-treatment
; : O O
two CD O B-treatment
partial JJ B-NP I-treatment
hysterectomies NNS I-NP I-treatment
; : O O
and CC O O
an DT B-NP B-treatment
appendectomy NN I-NP I-treatment
. . B-VP O
   
MEDICATIONS NNP B-NP O
ON NNP I-NP O
ADMISSION NNP I-NP O
: : O O
Oxycontin NNP B-NP B-treatment
10 CD O O
mg NN B-NP O
PO NNP I-NP O
q.day NN I-NP O
. . B-VP O
   
Darvocet NNP B-NP B-treatment
. . B-VP O
   
Estratab NNP B-NP B-treatment
. . B-VP O
   
Aspirin NNP B-NP B-treatment
325 CD O O
mg NN B-NP O
PO NNP I-NP O
q.day NN I-NP O
. . B-VP O
   
ALLERGIES NNP B-NP O
: : O O
No DT B-NP O
known JJ I-NP B-problem
drug NN I-NP I-problem
allergies NNS I-NP I-problem
. . B-VP O
   
PHYSICAL JJ B-NP O
EXAMINATION NN I-NP O
: : O O
The DT B-NP B-test
blood NN I-NP I-test
pressure NN I-NP I-test
was VBD B-VP O
150/86 CD O O
; : O O
pulse JJ O B-test
82 CD O O
; : O O
respirations NNS B-NP B-test
16 CD O O
. . B-VP O
   
Lungs NNS B-NP O
were VBD B-VP O
clear JJ O O
to TO O O
auscultation VB O B-test
bilaterally RB O O
. . B-VP O
   
Heart NN B-NP O
: : O O
regular JJ B-NP O
S1 NNP I-NP O
and CC O O
S2 NNP B-NP O
; : O O
no DT B-NP O
murmurs NN I-NP B-problem
. . B-VP O
   
Abdomen NNS B-NP O
: : O O
soft JJ O O
; : O O
nontender CC O O
; : O O
no DT B-NP O
palpable JJ I-NP B-problem
masses NNS I-NP I-problem
. . B-VP O
   
HOSPITAL NNP B-NP O
COURSE NNP I-NP O
AND NNP I-NP O
TREATMENT NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
admitted VBN O O
through IN B-VP O
same JJ B-NP O
day NN I-NP O
surgery NN I-NP O
and CC O O
taken VBN O O
to TO O O
the DT B-NP O
operating NN I-NP O
room NN I-NP O
where WRB O O
Dr. NNP B-NP B-person
Blinjesc NNP I-NP I-person
, , O O
assisted VBN O O
by IN B-VP O
Dr. NNP B-NP B-person
Zockbeathe NNP I-NP I-person
, , O O
performed VBD B-VP O
a DT B-NP B-test
diagnostic JJ I-NP I-test
laparoscopy NN I-NP I-test
with IN B-VP O
peritoneal JJ B-NP B-test
washings NNS I-NP I-test
. . B-VP O
   
Findings NNS B-NP O
included VBD B-VP O
no DT B-NP B-problem
gross JJ I-NP I-problem
evidence NN I-NP I-problem
seating NN I-NP I-problem
in IN B-VP I-problem
the DT B-NP I-problem
abdominal JJ I-NP I-problem
wall NN I-NP I-problem
; : O O
one CD O B-problem
nodule NN B-NP I-problem
on IN B-VP O
the DT B-NP O
posterior JJ I-NP O
surface NN I-NP O
of IN B-VP O
the DT B-NP O
right JJ I-NP O
lobe NN I-NP O
of IN B-VP O
the DT B-NP O
liver NN I-NP O
; : O O
one CD O B-problem
nodule NN B-NP I-problem
in IN B-VP O
the DT B-NP O
inferior JJ I-NP O
edge NN I-NP O
of IN B-VP O
the DT B-NP O
falciform NN I-NP O
ligament NN I-NP O
. . B-VP O
   
Specimens NNP B-NP B-test
sent VBD B-VP O
to TO O O
pathology VB O O
included JJ B-NP O
peritoneal JJ I-NP B-test
washings NNS I-NP I-test
and CC O O
permanent JJ B-NP B-test
specimens NNS I-NP I-test
from IN B-VP I-test
the DT B-NP I-test
liver NN I-NP I-test
and CC O O
falciform NN B-NP B-problem
nodules NNS I-NP I-problem
. . B-VP O
   
There EX O O
were VBD B-VP O
no DT B-NP O
complications NNS I-NP B-problem
, , O O
and CC O O
the DT B-NP B-person
patient NN I-NP I-person
tolerated VBD B-VP O
the DT B-NP B-test
procedure NN I-NP I-test
well RB O O
. . B-VP O
   
Postoperatively RB O O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
had VBD B-VP O
some DT B-NP B-problem
abdominal JJ I-NP I-problem
bloating NN I-NP I-problem
with IN B-VP O
evidence NN B-NP O
of IN B-VP O
subcutaneous JJ B-NP B-problem
emphysema NN I-NP I-problem
over IN B-VP I-problem
the DT B-NP I-problem
abdomen NNS I-NP I-problem
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
uncomfortable JJ O B-problem
and CC O O
slow JJ O O
to TO O O
have VB O O
bowel NN B-NP O
movements NNS I-NP O
, , O O
although IN B-VP O
she PRP O B-person
did VBD B-VP O
have VB O O
flatus NN B-NP O
. . B-VP O
   
She PRP O B-person
tolerated VBD B-VP O
a DT B-NP O
full JJ I-NP O
diet NN I-NP O
well RB O O
, , O O
but CC O O
continued VBD B-VP O
to TO O O
have VB O O
abdominal JJ B-NP B-problem
cramping NN I-NP I-problem
and CC O O
a DT B-NP B-problem
mild JJ I-NP I-problem
ileus NN I-NP I-problem
for IN B-VP O
the DT O O
following JJ O O
three CD O O
days NNS B-NP O
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
treated VBN O O
with IN B-VP O
repeated VBN O B-treatment
Fleet NNP B-NP I-treatment
&apos;s NNP I-NP I-treatment
enemas NN I-NP I-treatment
, , O O
and CC O O
on IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
three CD O O
, , O O
she PRP O B-person
had VBD B-VP O
a DT B-NP O
number NN I-NP O
of IN B-VP O
bowel NN B-NP O
movements NNS I-NP O
, , O O
was VBD B-VP O
considerably RB O O
more RBR O O
comfortable JJ O O
, , O O
and CC O O
deemed VBD B-VP O
ready JJ O O
for IN B-VP O
discharge NN B-NP O
. . B-VP O
   
CONDITION NNP B-NP O
ON NNP I-NP O
DISCHARGE NNP I-NP O
: : O O
Was NNP B-NP O
excellent NN I-NP O
. . B-VP O
   
MEDICATIONS NNP B-NP O
ON NNP I-NP O
DISCHARGE NNP I-NP O
: : O O
Included VBD B-VP O
aspirin JJ O B-treatment
325 CD O O
mg NN B-NP O
PO NNP I-NP O
q.day NN I-NP O
. . B-VP O
   
Percocet NNP B-NP B-treatment
one CD O O
to TO O O
two CD O O
whenever WRB O O
necessary JJ O O
q. RB O O
four CD O O
to TO O O
six CD O O
hours NNS B-NP O
for IN B-VP O
pain NN B-NP B-problem
. . B-VP O
   
Estratab NNP B-NP B-treatment
one CD O O
PO NNP B-NP O
q.day NN I-NP O
. . B-VP O
   
At IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
discharge NN B-NP O
, , O O
cytopathology NN B-NP B-test
specimens NNS I-NP I-test
had VBD B-VP O
been VBN O O
negative JJ O O
, , O O
and CC O O
surgical JJ B-NP B-test
pathology NN I-NP I-test
specimens NNS I-NP I-test
were VBD B-VP O
still RB O O
pending VBG O O
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
instructed VBN O O
to TO O O
call VB O O
Dr. NNP B-NP B-person
Blinjesc NNP I-NP I-person
for IN B-VP O
the DT B-NP O
results NNS I-NP O
of IN B-VP O
these DT O B-test
these DT B-NP B-pronoun
tests NNS I-NP I-test
and CC O O
to TO O O
follow VB O O
up RP O O
with IN B-VP O
him PRP O B-person
for IN B-VP O
further JJ B-NP O
management NN I-NP O
if IN B-VP O
necessary JJ O O
. . B-VP O
   
STA NNP B-NP B-person
BODEJOVE NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
DICTATING NNP I-NP O
FOR NNP I-NP O
: : O O
______________________________ NN B-NP O
LONSHI NNP I-NP B-person
OCK NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
TR NNP I-NP O
: : O O
hjr NN B-NP O
DD NNP I-NP O
: : O O
09/14/1999 CD O O
TD NN B-NP O
: : O O
09/17/1999 CD O O
2:26 CD O O
P NNP B-NP O
cc NN I-NP O
: : O O
LONSHI NNP B-NP B-person
OCK NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
cc NN I-NP O
: : O O
Telshey NNP B-NP B-person
K. NNP I-NP I-person
Swatlleebtik NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
Rinime NNP I-NP O
Hawnspantkote NNP I-NP O
Arkansas NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
Admission NNP I-NP O
Date NNP I-NP O
: : O O
2015-09-30 JJ B-NP O
Discharge NN I-NP O
Date NNP I-NP O
: : O O
2015-10-02 JJ B-NP O
Date NNP I-NP O
of IN B-VP O
Birth NNP B-NP O
: : O O
1958-01-16 JJ B-NP O
Sex NN I-NP O
: : O O
F NNP B-NP O
Service NNP I-NP O
: : O O
MEDICAL NNP B-NP O
ICU NNP I-NP O
CHIEF NNP I-NP O
COMPLAINT NNP I-NP O
: : O O
Change NN B-NP B-problem
in IN B-VP I-problem
mental JJ B-NP I-problem
status NN I-NP I-problem
. . B-VP O
   
HISTORY NNP B-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS NNP I-NP O
: : O O
This DT O B-pronoun
is VBZ O O
a DT B-NP O
57-year-old JJ I-NP O
nursing NN I-NP O
home NN I-NP O
resident NN I-NP O
female NN I-NP O
, , O O
who WP O B-person
had VBD B-VP O
been VBN O O
in IN B-VP O
her PRP$ O B-person
usual JJ B-NP O
state NN I-NP O
of IN B-VP O
health NN B-NP O
until IN B-VP O
about IN B-VP O
three CD O O
weeks NNS B-NP O
ago RB O O
when WRB O O
the DT B-NP B-person
daughter NN I-NP I-person
noted VBD B-VP O
she PRP O B-person
was VBD B-VP O
sleeping VBG O O
more JJR O O
. . B-VP O
   
Per NNP B-NP O
record NN I-NP O
, , O O
she PRP O B-person
has VBZ O O
had VBN O O
multiple JJ B-NP O
episodes NNS I-NP O
in IN B-VP O
the DT B-NP O
last JJ I-NP O
week NN I-NP O
of IN B-VP O
changes NNS B-NP B-problem
in IN B-VP I-problem
mental JJ B-NP I-problem
status NN I-NP I-problem
. . B-VP O
   
EMTs NNP B-NP O
called VBD B-VP O
many JJ B-NP O
times NNS I-NP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
would MD O O
awake VB O O
prior JJ O O
to TO O O
arrival VB O O
and CC O O
not RB O O
need VB O O
transfer NN B-NP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
seen VBN O O
at IN B-VP O
the DT B-NP O
Leonard NNP I-NP O
Morse/Metrowest NNP I-NP O
Medical NNP I-NP O
Center NNP I-NP O
on IN B-VP O
09-28 NNP B-NP O
. . B-VP O
   
No NNP B-NP O
localizing VBG O O
etiology NN B-NP O
of IN B-VP O
delta JJ B-NP B-problem
MS NNP I-NP I-problem
. . B-VP O
   
That IN B-VP B-pronoun
evening VBG O O
she PRP O B-person
was VBD B-VP O
unresponsive JJ O B-problem
and CC O O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
brought VBN O O
to TO O O
Amesbury NNP B-NP O
Hospital NNP I-NP O
Hospital NNP I-NP O
. . B-VP O
   
There EX O O
her PRP$ O B-person
oxygen NN B-NP O
she PRP O B-person
was VBD B-VP O
sating VBG O O
65% CD O O
on IN B-VP O
room NN B-NP O
air NN I-NP O
, , O O
increased VBD B-VP O
to TO O O
98% CD O O
with IN B-VP O
a DT B-NP B-treatment
nonrebreather JJ I-NP I-treatment
mask NN I-NP I-treatment
. . B-VP O
   
There EX O O
an DT B-NP B-test
ABG NNP I-NP I-test
was VBD B-VP O
done VBN O O
which WDT O B-pronoun
showed VBD B-VP O
an DT B-NP B-test
ABG NNP I-NP I-test
of IN B-VP O
7.42 CD O O
, , O O
62 CD O O
, , O O
and CC O O
55 CD O O
. . B-VP O
   
She PRP O B-person
had VBD B-VP O
a DT B-NP B-test
head NN I-NP I-test
CT NNP I-NP I-test
that WDT O B-pronoun
was VBD B-VP O
negative JJ O O
. . B-VP O
   
Chest JJS O B-test
x-ray JJ O I-test
that DT O B-pronoun
was VBD B-VP O
questionable JJ O O
left VBD B-VP B-problem
lower JJR B-NP I-problem
lobe NN I-NP I-problem
infiltrate NN I-NP I-problem
. . B-VP O
   
Lumbar NNP B-NP B-test
puncture NN I-NP I-test
was VBD B-VP O
performed VBN O O
and CC O O
the DT B-NP B-test
micro NN I-NP I-test
cultures NNS I-NP I-test
are VBP O O
still RB O O
pending VBG O O
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
seen VBN O O
by IN B-VP O
Psychiatry NNP B-NP B-person
at IN B-VP O
the DT B-NP O
outside JJ I-NP O
hospital NN I-NP O
, , O O
but CC O O
noted VBD B-VP O
there EX O O
was VBD B-VP O
no DT B-NP O
psychoses NNS I-NP B-problem
, , O O
but CC O O
delirium NN B-NP B-problem
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
's POS O O
mental JJ B-NP O
status NN I-NP O
waxed NN I-NP O
and CC O O
waned VBD B-VP O
there RB O O
. . B-VP O
   
She PRP O B-person
also RB O O
had VBD B-VP O
a DT B-NP B-test
K NNP I-NP I-test
of IN B-VP O
6.0 CD O O
and CC O O
given VBN O O
30 CD O O
of IN B-VP O
Kayexalate NNP B-NP B-treatment
, , O O
5 CD O O
of IN B-VP O
Haldol NNP B-NP B-treatment
, , O O
2 CD O O
mg NN B-NP O
of IN B-VP O
Ativan NNP B-NP B-treatment
given VBN O O
for IN B-VP O
agitation NN B-NP B-problem
, , O O
and CC O O
2 CD O O
mg NN B-NP O
of IN B-VP O
ceftriaxone NN B-NP B-treatment
was VBD B-VP O
given VBN O O
for IN B-VP O
a DT B-NP B-test
temperature NN I-NP I-test
of IN B-VP O
101.3 CD O O
with IN B-VP O
a DT B-NP O
concern NN I-NP O
for IN B-VP O
meningitis NN B-NP B-problem
as IN B-VP O
a DT B-NP B-test
LP NNP I-NP I-test
was VBD B-VP O
done VBN O O
prior RB O O
. . B-VP O
   
Patient NNP B-NP B-person
was VBD B-VP O
transferred VBN O O
to TO O O
the DT B-NP O
Kindred NNP I-NP O
Hospital NNP I-NP O
Melendez NNP I-NP O
the DT O B-person
the DT B-NP B-person
patient JJ I-NP I-person
patient NN I-NP I-person
's POS O I-person
primary JJ B-NP I-person
care NN I-NP I-person
provider NN I-NP I-person
was VBD B-VP O
here RB O O
. . B-VP O
   
She PRP O B-person
is VBZ O O
currently RB O O
being VBG O O
seen VBN O O
by IN B-VP O
Addison NNP B-NP O
Gilbert NNP I-NP O
Hospital NNP I-NP O
Group NNP I-NP O
. . B-VP O
   
On IN B-VP O
arrival NN B-NP O
to TO O O
Mass. NNP B-NP O
Eye NNP I-NP O
& CC O O
Ear NNP B-NP O
Infirmary NNP I-NP O
, , O O
she PRP O B-person
was VBD B-VP O
unresponsive JJ O B-problem
with IN B-VP O
an DT B-NP B-test
oxygen NN I-NP I-test
saturation NN I-NP I-test
of IN B-VP O
72% CD O O
on IN B-VP O
6 CD O B-treatment
liters NNS B-NP I-treatment
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
placed VBN O O
on IN B-VP O
50% CD O B-treatment
vent NN B-NP I-treatment
mask NN I-NP I-treatment
, , O O
which WDT O B-pronoun
improved VBD B-VP O
her PRP O B-person
oxygenation NN B-NP O
to TO O O
97% CD O O
. . B-VP O
   
Patient NN B-NP B-person
was VBD B-VP O
placed VBN O O
on IN B-VP O
BiPAP NNP B-NP B-treatment
. . B-VP O
   
Original NNP B-NP B-test
ABG NNP I-NP I-test
here RB O O
before RB O O
BiPAP NNP B-NP B-treatment
was VBD B-VP O
7.19 CD O O
, , O O
102 CD O O
, , O O
and CC O O
92 CD O O
. . B-VP O
   
After IN B-VP O
being VBG O O
placed VBN O O
on IN B-VP O
BiPAP NNP B-NP B-treatment
, , O O
her PRP$ O B-person
her PRP$ O B-test
blood NN B-NP I-test
pressure NN I-NP I-test
decreased VBD B-VP B-problem
to TO O O
the DT O O
80s CD O O
. . B-VP O
   
She PRP O B-person
responded VBD B-VP O
to TO O O
1 CD O O
liter NN B-NP O
of IN B-VP O
IV NNP B-NP B-treatment
fluids NNS I-NP I-treatment
, , O O
normal JJ B-NP B-treatment
saline NN I-NP I-treatment
and CC O O
blood NN B-NP B-test
pressure NN I-NP I-test
remained VBD B-VP O
stable JJ O O
. . B-VP O
   
Patient NNP B-NP B-person
had VBD B-VP O
peripheral JJ B-NP B-treatment
IV NNP I-NP I-treatment
x1 NN I-NP O
placed VBD B-VP O
and CC O O
right JJ B-NP B-treatment
femoral JJ I-NP I-treatment
line NN I-NP I-treatment
placed VBN O O
in IN B-VP O
the DT B-NP O
Matthew NNP I-NP O
. . B-VP O
   
When WRB O O
laying VBG O O
flat JJ O O
, , O O
her PRP$ O B-person
sats NNS B-NP O
decreased VBD B-VP B-problem
to TO O O
50% CD O O
on IN B-VP O
30% CD O O
FIO2 NNP B-NP B-treatment
, , O O
PEEP NNP B-NP B-treatment
of IN B-VP O
10 CD O O
, , O O
and CC O O
pressure NN B-NP B-treatment
support NN I-NP I-treatment
of IN B-VP O
5 CD O O
. . B-VP O
   
Her PRP$ O B-person
Her PRP$ O B-test
ABG NN B-NP I-test
at IN B-VP O
the DT B-NP O
time NN I-NP O
was VBD B-VP O
7.24 CD O O
, , O O
91 CD O O
, , O O
and CC O O
38 CD O O
. . B-VP O
   
Once RB O O
the DT B-NP B-person
patient NN I-NP I-person
sat VBD B-VP O
up RP O O
, , O O
her PRP$ O B-person
sats NNS B-NP B-test
improved VBN O O
and CC O O
her PRP$ O B-person
airway NN B-NP O
was VBD B-VP O
no RB O O
longer RB O O
obstructed VBN O O
. . B-VP O
   
After IN B-VP O
a DT B-NP O
history NN I-NP O
on IN B-VP O
BiPAP NNP B-NP B-treatment
about IN B-VP O
a DT B-NP O
half NN I-NP O
an DT B-NP O
hour NN I-NP O
, , O O
her PRP$ O B-person
her PRP$ O B-test
ABG NNP B-NP I-test
was VBD B-VP O
7.29 CD O O
, , O O
79 CD O O
, , O O
and CC O O
106 CD O O
on IN B-VP O
30% CD O O
pressure NN B-NP B-treatment
support NN I-NP I-treatment
of IN B-VP O
5 CD O O
and CC O O
PEEP NNP B-NP B-treatment
of IN B-VP O
10 CD O O
. . B-VP O
   
Patient NN B-NP B-person
was VBD B-VP O
intermittently RB O O
awaking VBG O O
. . B-VP O
   
She PRP O B-person
denied VBD B-VP O
any DT B-NP O
pain NN I-NP B-problem
and CC O O
was VBD B-VP O
not RB O O
answering VBG O O
questions NNS B-NP O
at IN B-VP O
the DT B-NP O
time NN I-NP O
. . B-VP O
   
PAST NNP B-NP O
MEDICAL NNP I-NP O
HISTORY NNP I-NP O
: : O O
1. CD O O
Obstructive-sleep JJ B-NP B-problem
apnea NN I-NP I-problem
? . B-VP O
2. CD O O
Morbid NNP B-NP B-problem
obesity NN I-NP I-problem
. . B-VP O
   
3. CD O O
Congestive JJ B-NP B-problem
heart NN I-NP I-problem
failure NN I-NP I-problem
, , O O
unknown JJ B-NP O
EF NNP I-NP B-test
. . B-VP O
   
4. CD O O
Hypertension NNP B-NP B-problem
. . B-VP O
   
5. CD O O
Diabetes NNPS B-NP B-problem
mellitus NN I-NP I-problem
. . B-VP O
   
6. CD O O
Depression NNP B-NP B-problem
. . B-VP O
   
7. CD O O
Nursing NNP B-NP O
home NN I-NP O
resident NN I-NP O
. . B-VP O
   
8. CD O O
Dyspnea NNP B-NP B-problem
on IN B-VP O
exertion NN B-NP O
. . B-VP O
   
9. CD O O
History NN B-NP O
of IN B-VP O
fibroids NNS B-NP B-problem
. . B-VP O
   
10. CD O O
Hypercholesterolemia NNP B-NP B-problem
. . B-VP O
   
SOCIAL NNP B-NP O
HISTORY NN I-NP O
: : O O
She PRP O B-person
is VBZ O O
a DT B-NP O
nursing NN I-NP O
home NN I-NP O
resident NN I-NP O
. . B-VP O
   
Does VBZ O O
not RB O O
ambulate VB O O
. . B-VP O
   
Denies NNPS B-NP O
alcohol NN I-NP O
or CC O O
tobacco NN B-NP O
use NN I-NP O
. . B-VP O
   
MEDICATIONS NNP B-NP O
ON NNP I-NP O
TRANSFER NNP I-NP O
FROM NNP I-NP O
NURSING NNP I-NP O
HOME NNP I-NP O
: : O O
1. CD O O
Lasix NNP B-NP B-treatment
40 CD O O
q.d. NN B-NP O
2. CD O O
Senna NNP B-NP B-treatment
two CD O O
tablets NNS B-NP O
q.6h. VBP O O
3. CD O O
Metoprolol NNP B-NP B-treatment
25 CD O O
mg NN B-NP O
b.i.d. NN I-NP O
4. CD O O
Metformin NNP B-NP B-treatment
1,000 CD O O
mg NN B-NP O
b.i.d. NN I-NP O
5. CD O O
Colace NNP B-NP B-treatment
. . B-VP O
   
6. CD O O
Niferex NNP B-NP B-treatment
one CD O O
tablet NN B-NP O
b.i.d. NN I-NP O
7. CD O O
Cozaar NNP B-NP B-treatment
25 CD O O
mg NN B-NP O
q.d. NN I-NP O
8. CD O O
Ranitidine NNP B-NP B-treatment
150 CD O O
mg NN B-NP O
p.o. NN I-NP O
q.d. VBD B-VP O
9. CD O O
Peroxetine NNP B-NP B-treatment
40 CD O O
mg NN B-NP O
p.o. NN I-NP O
q.d. VBD B-VP O
10. CD O O
Insulin NNP B-NP B-treatment
: : O O
NPH NNP B-NP B-treatment
70 CD O O
units NNS B-NP O
q.a.m. RB O O
, , O O
50 CD O O
units NNS B-NP O
q.p.m. RB O O
, , O O
regular JJ B-NP B-treatment
insulin-sliding JJ I-NP I-treatment
scale NN I-NP I-treatment
. . B-VP O
   
11. CD O O
SubQ NNP B-NP B-treatment
Heparin NNP I-NP I-treatment
5,000 CD O O
q.8h. NN B-NP O
12. CD O O
Lactulose NNP B-NP B-treatment
. . B-VP O
   
13. CD O O
Multivitamins NNP B-NP B-treatment
. . B-VP O
   
14. CD O O
Albuterol NNP B-NP B-treatment
inhalers NNS I-NP I-treatment
prn VBP O O
. . B-VP O
   
ALLERGIES NNS B-NP O
: : O O
Penicillin NN B-NP B-treatment
: : O O
Shortness NN B-NP B-problem
of IN B-VP I-problem
breath NN B-NP I-problem
. . B-VP O
   
PHYSICAL JJ B-NP O
EXAMINATION NN I-NP O
: : O O
Vital JJ B-NP O
signs NNS I-NP O
: : O O
Heart NNP B-NP B-test
rate NN I-NP I-test
108 CD O O
, , O O
blood NN B-NP B-test
pressure NN I-NP I-test
140/82 CD O O
, , O O
oxygen NN B-NP B-test
saturation NN I-NP I-test
96% CD O O
, , O O
respiratory JJ B-NP B-test
rate NN I-NP I-test
of IN B-VP O
22 CD O O
on IN B-VP O
BiPAP NNP B-NP B-treatment
5/10/30% CD O O
. . B-VP O
   
In IN B-VP O
general JJ O O
, , O O
sleepy JJ O B-problem
but CC O O
arousable JJ O O
. . B-VP O
   
Arousable JJ O O
intermittently RB O O
to TO O O
voice NN B-NP B-test
. . B-VP O
   
HEENT NN B-NP O
: : O O
Pupils VBZ O B-test
3 CD O O
mm NN B-NP O
reactive NN I-NP O
. . B-VP O
   
Neck NN B-NP O
: : O O
Obese JJ O B-problem
, , O O
unable JJ O O
to TO O O
assess VB O O
lymphadenopathy JJ O B-problem
or CC O O
jugular JJ B-NP B-problem
venous JJ I-NP I-problem
distention NN I-NP I-problem
. . B-VP O
   
Lungs NNS B-NP O
: : O O
Poor NNP B-NP B-problem
effort NN I-NP I-problem
, , O O
no DT B-NP O
wheezes NN I-NP B-problem
, , O O
rales NNS B-NP B-problem
, , O O
or CC O O
rhonchi NN B-NP B-problem
. . B-VP O
   
Cardiovascular JJ O O
: : O O
Distant JJ B-NP B-problem
heart NN I-NP I-problem
sounds VBZ O I-problem
, , O O
tachycardia NN B-NP B-problem
, , O O
regular JJ B-NP O
rhythm NN I-NP O
. . B-VP O
   
Abdomen NNP B-NP O
is VBZ O O
obese JJ O B-problem
, , O O
nontender NN B-NP B-problem
, , O O
decreased VBD B-VP B-problem
bowel NN B-NP I-problem
sounds NNS I-NP I-problem
. . B-VP O
   
Extremities NNS B-NP O
: : O O
Obese NNP B-NP B-problem
, , O O
no DT B-NP O
edema NN I-NP B-problem
, , O O
2+ CD O O
pulses NNS B-NP B-test
. . B-VP O
   
Neurologic NN B-NP O
: : O O
Responding VBG O O
to TO O O
commands NNS B-NP O
. . B-VP O
   
Moving VBG O O
all DT B-NP O
extremities NNS I-NP O
well RB O O
. . B-VP O
   
Toes NNS B-NP O
are VBP O O
downgoing VBG O O
. . B-VP O
   
PERTINENT JJ B-NP O
LABORATORIES NNPS I-NP O
: : O O
White NNP B-NP B-test
blood NN I-NP I-test
cell NN I-NP I-test
count NN I-NP I-test
12.8 CD O O
( ( O O
79% CD O O
polys NN B-NP B-test
, , O O
13% CD O O
lymphocytes NNS B-NP B-test
, , O O
8 CD O O
monocytes NNS B-NP B-test
, , O O
nucleated VBD B-VP B-test
RBCs NNP B-NP I-test
1% CD O O
),hematocrit NN B-NP B-test
31.7 CD O O
. . B-VP O
   
Potassium NN B-NP B-test
5.2 CD O O
, , O O
creatinine NN B-NP B-test
1.3 CD O O
, , O O
BUN NNP B-NP B-test
35 CD O O
, , O O
glucose RB O B-test
152 CD O O
, , O O
D NNP B-NP B-test
dimer NN I-NP I-test
1636 CD O O
, , O O
INR NNP B-NP B-test
1.3 CD O O
. . B-VP O
   
Urinalysis NN B-NP B-test
: : O O
Moderate NNP B-NP B-test
leukocytes NNS I-NP I-test
, , O O
06-09 JJ B-NP O
RBCs NNP I-NP B-test
, , O O
21-50 JJ B-NP O
lymphocytes NNS I-NP B-test
, , O O
many JJ B-NP B-problem
bacteria NNS I-NP I-problem
, , O O
06-09 JJ B-NP O
epithelial JJ I-NP B-test
cells NNS I-NP I-test
. . B-VP O
   
Tox NNP B-NP B-test
screen JJ O I-test
negative JJ O O
. . B-VP O
   
Urine JJ B-NP B-test
cultures NNS I-NP I-test
pending VBG O O
. . B-VP O
   
LABORATORIES NNP B-NP O
AT NNP I-NP O
OUTSIDE NNP I-NP O
HOSPITAL NNP I-NP O
: : O O
White NNP B-NP B-test
count NN I-NP I-test
11.8 CD O O
( ( O O
90% CD O O
polys NN B-NP B-test
, , O O
4% CD O O
lymphocytes NNS B-NP B-test
, , O O
5% CD O O
monocytes NNS B-NP B-test
, , O O
1% CD O O
basophils NNS B-NP B-test
, , O O
3% CD O O
nucleated JJ B-NP B-test
RBCs NNP I-NP I-test
). NNP I-NP O
Potassium NNP I-NP B-test
6.6 CD O O
, , O O
creatinine NN B-NP B-test
1.4 CD O O
, , O O
alkaline JJ B-NP B-test
phosphatase NN I-NP I-test
302 CD O O
, , O O
T NNP B-NP B-test
bilirubin VBZ O I-test
0.6 CD O O
, , O O
AST NNP B-NP B-test
25 CD O O
, , O O
ALT NNP B-NP B-test
84 CD O O
, , O O
CK NNP B-NP B-test
of IN B-VP O
15 CD O O
, , O O
troponin NN B-NP B-test
0.01 CD O O
. . B-VP O
   
Chest JJS O B-test
x-ray JJ O I-test
: : O O
Left NNP B-NP B-problem
lower JJR B-NP I-problem
lobe NN I-NP I-problem
basal NN I-NP I-problem
opacity NN I-NP I-problem
. . B-VP O
   
EKG NN B-NP B-test
: : O O
Sinus JJ B-NP B-problem
tachycardia NN I-NP I-problem
at IN B-VP O
106 CD O O
beats NNS B-NP O
per IN B-VP O
minute NN B-NP O
, , O O
left VBD B-VP B-problem
axis JJ B-NP I-problem
deviation NN I-NP I-problem
, , O O
T-wave JJ B-NP B-problem
inversions NNS I-NP I-problem
in IN B-VP I-problem
leads NNS B-NP I-problem
I PRP O I-problem
and CC O I-problem
aVL VB O I-problem
that DT O B-pronoun
are VBP O O
old JJ O O
. . B-VP O
   
No DT B-NP O
QRS NNP I-NP B-problem
widening NN I-NP I-problem
and CC O O
no DT B-NP O
peak JJ I-NP B-problem
T NNP I-NP I-problem
waves NNS I-NP I-problem
. . B-VP O
   
This DT O B-pronoun
is VBZ O O
in IN B-VP O
comparison NN B-NP O
to TO O O
2015-09-27 JJ B-NP O
EKG NNP I-NP B-test
. . B-VP O
   
Chest NNP B-NP B-test
x-ray JJ O I-test
rotated VBD B-VP O
low JJ B-NP B-problem
lung NN I-NP I-problem
volumes NNS I-NP I-problem
, , O O
hazy JJ B-NP B-problem
opacities NNS I-NP I-problem
at IN B-VP I-problem
bases NNS B-NP I-problem
. . B-VP O
   
Echocardiogram NNP B-NP B-test
in IN B-VP O
2010 CD O O
: : O O
Mild-to-moderate JJ B-NP B-problem
MR NNP I-NP I-problem
, , O O
TR NNP B-NP B-problem
. . B-VP O
   
HOSPITAL NNP B-NP O
COURSE NNP I-NP O
: : O O
1. CD O O
Hypercarbic NNP B-NP B-problem
respiratory JJ B-NP I-problem
failure NN I-NP I-problem
issues NNS I-NP I-problem
: : O O
The DT B-NP B-person
patient NN I-NP I-person
presented VBN O O
with IN B-VP O
changes NNS B-NP B-problem
in IN B-VP I-problem
mental JJ B-NP I-problem
status NN I-NP I-problem
, , O O
pCO2 NN B-NP B-test
of IN B-VP O
100 CD O O
, , O O
pH NN B-NP B-test
of IN B-VP O
7.19 CD O O
, , O O
decreasing VBG O B-problem
sats NNS B-NP I-problem
on IN B-VP O
arrival NN B-NP O
likely JJ B-NP O
element NN I-NP O
of IN B-VP O
obstructive-sleep JJ B-NP B-problem
apnea NN I-NP I-problem
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
monitored VBN O O
overnight RB O O
. . B-VP O
   
She PRP O B-person
had VBD B-VP O
admitted VBN O O
to TO O O
the DT B-NP O
CMED NNP I-NP O
and CC O O
had VBD B-VP O
multiple JJ B-NP O
episodes NNS I-NP O
of IN B-VP O
apnea NN B-NP B-problem
throughout IN B-VP O
the DT B-NP O
night NN I-NP O
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
placed VBN O O
on IN B-VP O
pressure NN B-NP B-treatment
support NN I-NP I-treatment
, , O O
which WDT O B-pronoun
improved VBD B-VP O
her PRP O B-person
her PRP$ O B-test
saturations NNS B-NP I-test
and CC O O
decreased VBD B-VP O
her PRP$ O B-person
hypercarbia NN B-NP B-problem
. . B-VP O
   
Patient NNP B-NP B-person
improved VBD B-VP O
that IN B-VP B-pronoun
her PRP$ O B-person
mental JJ B-NP O
status NN I-NP O
with IN B-VP O
improvement NN B-NP O
of IN B-VP O
her PRP$ O B-person
oxygenation NN B-NP O
and CC O O
ventilation NN B-NP O
as RB O O
well RB O O
as IN B-VP O
for IN B-VP O
correction NN B-NP O
of IN B-VP O
her PRP$ O B-person
respiratory JJ B-NP B-problem
acidosis NN I-NP I-problem
. . B-VP O
   
Patient NNP B-NP B-person
was VBD B-VP O
eventually RB O O
placed VBN O O
on IN B-VP O
BiPAP NNP B-NP B-treatment
on IN B-VP O
hospital NN B-NP O
day NN I-NP O
three CD O O
, , O O
on IN B-VP O
the DT B-NP O
date NN I-NP O
prior RB O O
to TO O O
discharge VB O O
of IN B-VP O
BiPAP NNP B-NP B-treatment
settings NNS I-NP O
of IN B-VP O
12/8/5 CD O B-treatment
liters NNS B-NP I-treatment
of IN B-VP I-treatment
oxygen NN B-NP I-treatment
with IN B-VP O
saturations NNS B-NP B-test
of IN B-VP O
96% CD O O
with IN B-VP O
a DT B-NP B-test
gas NN I-NP I-test
of IN B-VP O
7.38 CD O O
, , O O
67 CD O O
, , O O
and CC O O
91 CD O O
with IN B-VP O
an DT B-NP O
aim NN I-NP O
of IN B-VP O
a DT B-NP O
goal NN I-NP O
pCO2 NN I-NP B-test
of IN B-VP O
67 CD O O
. . B-VP O
   
She PRP O B-person
only RB O O
had VBD B-VP O
one CD O O
episode NN B-NP O
of IN B-VP O
apnea NN B-NP B-problem
on IN B-VP O
the DT B-NP O
day NN I-NP O
prior RB O O
to TO O O
discharge VB O O
. . B-VP O
   
2. CD O O
Delta NNP B-NP B-problem
MS/mental NNP I-NP I-problem
status NN I-NP I-problem
issues NNS I-NP I-problem
: : O O
Most JJS O O
likely JJ O O
her PRP$ O B-person
waxing NN B-NP B-problem
and CC O I-problem
waning VBG O I-problem
mental JJ B-NP I-problem
status NN I-NP I-problem
and CC O O
hypercarbia/hypoxia NN B-NP B-problem
compounded VBN O O
by IN B-VP O
infection NN B-NP B-problem
of IN B-VP I-problem
pneumonia NN B-NP I-problem
and CC O O
UTI NNP B-NP B-problem
. . B-VP O
   
With IN B-VP O
improvements NNS B-NP O
of IN B-VP O
her PRP$ O B-person
ventilation NN B-NP O
and CC O O
oxygenation NN B-NP B-test
and CC O O
treatment NN B-NP B-treatment
with IN B-VP O
levofloxacin NN B-NP B-treatment
of IN B-VP O
her PRP$ O B-person
UTI NNP B-NP B-problem
and CC O O
pneumonia NN B-NP B-problem
, , O O
her PRP$ O B-person
mental JJ B-NP O
status NN I-NP O
greatly RB O O
improved VBN O O
on IN B-VP O
hospital JJ B-NP O
day NN I-NP O
two CD O O
without IN B-VP O
further JJ B-NP B-problem
waxing NN I-NP I-problem
and CC O I-problem
waning NN B-NP I-problem
. . B-VP O
   
Her PRP$ O B-person
Her PRP$ O B-person
daughters NNS B-NP I-person
came VBD B-VP O
by IN B-VP O
and CC O O
visited VBD B-VP O
her PRP O B-person
, , O O
and CC O O
reported VBD B-VP O
that IN B-VP B-pronoun
she PRP O B-person
was VBD B-VP O
at IN B-VP O
her PRP$ O B-person
baseline NN B-NP O
mental JJ B-NP O
status NN I-NP O
on IN B-VP O
the DT B-NP O
day NN I-NP O
prior RB O O
to TO O O
discharge VB O O
. . B-VP O
   
B12 NNP B-NP B-test
, , O O
folate NN B-NP B-test
, , O O
RPR NNP B-NP B-test
were VBD B-VP O
all DT B-NP O
sent NN I-NP O
that WDT O B-pronoun
were VBD B-VP O
unremarkable JJ O O
as IN B-VP O
causes NNS B-NP O
for IN B-VP O
delta JJ B-NP B-problem
MS NNP I-NP I-problem
. . B-VP O
   
We PRP O B-person
are VBP O O
awaiting VBG O O
results NNS B-NP O
of IN B-VP O
the DT B-NP B-test
lumbar NN I-NP I-test
puncture NN I-NP I-test
from IN B-VP O
the DT B-NP O
outside JJ I-NP O
hospital NN I-NP O
, , O O
but CC O O
on IN B-VP O
hospital JJ B-NP O
day NN I-NP O
two CD O O
. . B-VP O
   
Those DT O B-pronoun
Those DT B-NP B-test
cultures NNS I-NP I-test
are VBP O O
still RB O O
pending VBG O O
at IN B-VP O
the DT B-NP O
time NN I-NP O
. . B-VP O
   
Patient NN B-NP B-person
was VBD B-VP O
also RB O O
given VBN O O
multivites NNS B-NP B-treatment
. . B-VP O
   
3. CD O O
Fever NNP B-NP B-problem
issues NNS I-NP I-problem
: : O O
The DT B-NP B-person
patient NN I-NP I-person
initially RB O O
presented VBN O O
with IN B-VP O
T NNP B-NP B-test
max NN I-NP I-test
of IN B-VP O
101.3 CD O O
at IN B-VP O
outside JJ B-NP O
hospital NN I-NP O
with IN B-VP O
increasing VBG O B-problem
white JJ B-NP I-problem
blood NN I-NP I-problem
cell NN I-NP I-problem
counts NNS I-NP I-problem
and CC O O
a DT B-NP B-problem
positive JJ I-NP I-problem
urinalysis NN I-NP I-problem
. . B-VP O
   
A DT B-NP B-test
chest JJ I-NP I-test
x-ray NN I-NP I-test
with IN B-VP O
bilateral JJ B-NP B-problem
patchy NN I-NP I-problem
infiltrates NNS I-NP I-problem
likely JJ B-NP O
pneumonia NN I-NP B-problem
and CC O O
UTI NNP B-NP B-problem
. . B-VP O
   
Upon IN B-VP O
calling VBG O O
the DT B-NP O
outside JJ I-NP O
hospital NN I-NP O
, , O O
the DT B-NP O
urine NN I-NP O
was VBD B-VP O
growing VBG O O
out RP O O
Klebsiella NNP B-NP B-problem
, , O O
and CC O O
patient NN B-NP B-person
was VBD B-VP O
given VBN O O
a DT O O
10 CD O O
day NN B-NP O
course NN I-NP O
of IN B-VP O
levofloxacin NN B-NP B-treatment
to TO O O
cover VB O O
both DT O O
the DT B-NP B-problem
pneumonia NN I-NP I-problem
and CC O O
UTI NNP B-NP B-problem
. . B-VP O
   
Blood NNP B-NP B-test
cultures NNS I-NP I-test
and CC O O
urine JJ B-NP B-test
cultures NNS I-NP I-test
are VBP O O
still RB O O
pending VBG O O
at IN B-VP O
this DT B-NP B-pronoun
hospital NN I-NP O
visit NN I-NP O
and CC O O
the DT B-NP O
CSF NNP I-NP B-test
fluid NN I-NP I-test
from IN B-VP O
Whitter NNP B-NP O
Rehabilitation NNP I-NP O
Hospital NNP I-NP O
needs VBZ O O
to TO O O
be VB O O
further RB O O
evaluated VBN O O
. . B-VP O
   
Patient NN B-NP B-person
on IN B-VP O
the DT B-NP O
day NN I-NP O
of IN B-VP O
discharge NN B-NP O
was VBD B-VP O
afebrile JJ O B-problem
with IN B-VP O
a DT O B-problem
decreasing VBG O I-problem
white JJ B-NP I-problem
count NN I-NP I-problem
x48 NN I-NP O
hours NNS I-NP O
. . B-VP O
   
4. CD O O
Acute NNP B-NP B-problem
renal JJ B-NP I-problem
failure NN I-NP I-problem
issues NNS I-NP I-problem
: : O O
Creatinine NNP B-NP B-test
initially RB O O
presented VBD B-VP O
at IN B-VP O
1.3 CD O O
. . B-VP O
   
Patient NN B-NP B-person
is VBZ O O
known VBN O O
to TO O O
have VB O O
a DT B-NP O
baseline NN I-NP O
of IN B-VP O
1.0 CD O O
, , O O
most RBS O O
likely JJ B-NP O
hypovolemia NN I-NP B-problem
and CC O O
prerenal NN B-NP O
. . B-VP O
   
A DT B-NP B-test
FENa NNP I-NP I-test
was VBD B-VP O
sent VBN O O
, , O O
was VBD B-VP O
0.3% CD O O
. . B-VP O
   
Patient NN B-NP B-person
was VBD B-VP O
gently RB O O
hydrated VBN O O
and CC O O
IV NNP B-NP B-treatment
fluids NNS I-NP I-treatment
started VBD B-VP O
up RP O O
on IN B-VP O
a DT B-NP B-treatment
p.o. NN I-NP I-treatment
diet JJ B-NP I-treatment
regimen NNS I-NP I-treatment
. . B-VP O
   
On IN B-VP O
hospital JJ B-NP O
day NN I-NP O
two CD O O
, , O O
her PRP$ O B-person
creatinine NN B-NP O
returned VBN O O
to TO O O
0.8 CD O O
, , O O
and CC O O
she PRP O B-person
remained VBD B-VP O
with IN B-VP O
a DT B-NP B-test
creatinine NN I-NP I-test
of IN B-VP O
0.8 CD O O
for IN B-VP O
the DT B-NP O
remainder NN I-NP O
of IN B-VP O
her PRP$ O B-person
hospital NN B-NP O
stay NN I-NP O
. . B-VP O
   
Patient's NNP B-NP B-person
K NNP I-NP B-test
was VBD B-VP O
followed VBN O O
, , O O
and CC O O
trended VBD B-VP O
back RB O O
down RB O O
to TO O O
normal JJ O O
on IN B-VP O
the DT B-NP O
day NN I-NP O
of IN B-VP O
discharge NN B-NP O
at IN B-VP O
3.9 CD O O
. . B-VP O
   
5. CD O O
Elevated JJ B-NP B-problem
transaminases NNS I-NP I-problem
: : O O
Patient NNP B-NP B-person
had VBD B-VP O
no DT B-NP O
right JJ I-NP B-problem
upper NN I-NP I-problem
quadrant NN I-NP I-problem
pain NN I-NP I-problem
. . B-VP O
   
Stewart NNP B-NP B-test
sign NN I-NP I-test
was VBD B-VP O
negative JJ O O
. . B-VP O
   
A DT B-NP B-test
right JJ I-NP I-test
upper NN I-NP I-test
quadrant NN I-NP I-test
ultrasound NN I-NP I-test
was VBD B-VP O
performed VBN O O
that IN B-VP B-pronoun
showed VBD B-VP O
no DT O O
hepatic JJ O B-problem
or CC O I-problem
biliary JJ B-NP I-problem
pathology NN I-NP I-problem
likely RB O O
due JJ O O
to TO O O
acute VB O B-problem
phase NN B-NP I-problem
stress NN I-NP I-problem
changes NNS I-NP I-problem
given VBN O O
the DT B-NP O
fact NN I-NP O
that IN B-VP B-pronoun
she PRP O B-person
had VBD B-VP O
no DT B-NP O
clinical JJ I-NP B-problem
symptoms NNS I-NP I-problem
. . B-VP O
   
There EX O O
is VBZ O O
no DT B-NP O
need NN I-NP O
to TO O O
followup VB O O
these DT O B-test
these DT B-NP B-pronoun
transaminases NNS I-NP I-test
. . B-VP O
   
6. CD O O
Congestive JJ B-NP B-problem
heart NN I-NP I-problem
failure NN I-NP I-problem
history NN I-NP O
: : O O
Patient NN B-NP B-person
was VBD B-VP O
stable JJ O O
without IN B-VP O
evidence NN B-NP O
of IN B-VP O
CHF NNP B-NP B-problem
on IN B-VP O
chest JJS B-NP B-test
x-ray NN I-NP I-test
. . B-VP O
   
Followed VBD B-VP O
her PRP$ O B-person
sats NNS B-NP O
likely JJ O O
due JJ O O
to TO O O
obstructive-sleep JJ B-NP B-problem
apnea NN I-NP I-problem
and CC O O
hypoventilation NN B-NP B-problem
. . B-VP O
   
Patient NNP B-NP B-person
was VBD B-VP O
restarted VBN O O
on IN B-VP O
her PRP$ O B-person
her PRP$ O B-treatment
beta NN B-NP I-treatment
blocker NN I-NP I-treatment
and CC O O
.......- JJ B-NP O
receptor NN I-NP B-treatment
blocker NN I-NP I-treatment
on IN B-VP O
hospital JJ B-NP O
day NN I-NP O
two CD O O
given VBN O O
that IN B-VP B-pronoun
her PRP$ O B-person
creatinine NN B-NP O
had VBD B-VP O
stabilized VBN O O
. . B-VP O
   
Patient NNP B-NP B-person
had VBD B-VP O
no DT B-NP O
further JJ I-NP B-problem
cardiac NN I-NP I-problem
issues NNS I-NP I-problem
at IN B-VP O
this DT B-NP B-pronoun
time NN I-NP O
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
on IN B-VP O
telemetry NN B-NP B-test
without IN B-VP O
any DT B-NP O
episodes NNS I-NP O
of IN B-VP O
any DT B-NP B-problem
rhythm JJ I-NP I-problem
abnormalities NNS I-NP I-problem
. . B-VP O
   
7. CD O O
CMED NNP B-NP O
CCU NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
had VBD B-VP O
some DT B-NP B-problem
vaginal JJ I-NP I-problem
bleeding NN I-NP I-problem
x2 JJ B-NP O
days NNS I-NP O
. . B-VP O
   
Patient NNP B-NP B-person
had VBD B-VP O
a DT B-NP O
history NN I-NP O
of IN B-VP O
fibroids NNS B-NP B-problem
during IN B-VP O
this DT B-NP B-pronoun
hospitalization NN I-NP O
. . B-VP O
   
Followed VBD B-VP O
her PRP$ O B-person
examination NN B-NP O
. . B-VP O
   
Her PRP$ O B-person
Her PRP$ O B-test
hematocrit NN B-NP I-test
remained VBD B-VP O
stable JJ O O
throughout IN B-VP O
this DT B-NP B-pronoun
course NN I-NP O
. . B-VP O
   
Patient NNP B-NP B-person
is VBZ O O
strongly RB O O
encouraged VBN O O
to TO O O
followup VB O O
with IN B-VP O
her PRP$ O B-person
her PRP$ O B-person
outside JJ B-NP I-person
primary JJ I-NP I-person
care NN I-NP I-person
provider NN I-NP I-person
to TO O O
followup VB O O
for IN B-VP O
the DT B-NP B-problem
vaginal JJ I-NP I-problem
bleeding NN I-NP I-problem
given VBN O O
her PRP$ O B-person
history NN B-NP O
of IN B-VP O
fibroids NNS B-NP B-problem
and CC O O
question NN B-NP O
metaplasia NN I-NP B-problem
of IN B-VP I-problem
the DT B-NP I-problem
endometrium NN I-NP I-problem
. . B-VP O
   
8. CD O O
Heme NN B-NP O
: : O O
Her PRP$ O B-person
Her PRP$ O B-test
hematocrit NN B-NP I-test
remained VBD B-VP O
stable JJ O O
. . B-VP O
   
She PRP O B-person
had VBD B-VP O
a DT B-NP O
history NN I-NP O
of IN B-VP O
nucleated JJ B-NP B-problem
RBCs NNP I-NP I-problem
likely RB O O
secondary JJ O O
to TO O O
stress VB O B-problem
and CC O O
hypoxia VB O B-problem
during IN B-VP O
this DT B-NP B-pronoun
admission NN I-NP O
. . B-VP O
   
Hemolysis NN B-NP B-test
laboratories NNS I-NP I-test
were VBD B-VP O
negative JJ O O
. . B-VP O
   
Patient NN B-NP B-person
was VBD B-VP O
restarted VBN O O
on IN B-VP O
her PRP$ O B-person
her PRP$ O B-treatment
iron NN B-NP I-treatment
supplementation NN I-NP I-treatment
. . B-VP O
   
Reticulocyte NNP B-NP B-test
count NN I-NP I-test
was VBD B-VP O
performed VBN O O
that IN B-VP B-pronoun
was VBD B-VP O
negative JJ O O
. . B-VP O
   
9. CD O O
FEN NN B-NP O
: : O O
She PRP O B-person
was VBD B-VP O
NPO NNP B-NP B-treatment
with IN B-VP O
a DT B-NP B-problem
decrease NN I-NP I-problem
in IN B-VP I-problem
her PRP$ O I-problem
mental JJ B-NP I-problem
status NN I-NP I-problem
. . B-VP O
   
We PRP O B-person
slowly RB O O
advanced VBD B-VP O
her PRP O O
diet NN B-NP O
as IN B-VP O
her PRP$ O B-person
mental JJ B-NP O
status NN I-NP O
improved VBN O O
and CC O O
repleted VBD B-VP O
her PRP$ O B-person
electrolytes NNS B-NP O
, , O O
and CC O O
started VBD B-VP O
on IN B-VP O
her PRP$ O B-person
her PRP$ O B-treatment
p.o. JJ B-NP I-treatment
medications NNS I-NP I-treatment
on IN B-VP O
hospital JJ B-NP O
day NN I-NP O
two CD O O
. . B-VP O
   
10. CD O O
Diabetes NNS B-NP B-problem
: : O O
Patient NN B-NP B-person
had VBD B-VP O
q.i.d. JJ B-NP O
fingersticks NNS I-NP B-test
with IN B-VP O
a DT B-NP B-treatment
Humalog NNP I-NP I-treatment
sliding VBG O I-treatment
scale NN B-NP I-treatment
and CC O O
NPH NNP B-NP B-treatment
doses NNS I-NP I-treatment
were VBD B-VP O
cut VBN O O
in IN B-VP O
half NN B-NP O
while IN B-VP O
she PRP O B-person
was VBD B-VP O
NPO NNP B-NP B-treatment
, , O O
and CC O O
they PRP O B-pronoun
were VBD B-VP O
brought VBN O O
back RB O O
to TO O O
her PRP$ O B-person
normal JJ B-NP O
doses NNS I-NP O
on IN B-VP O
the DT B-NP O
day NN I-NP O
of IN B-VP O
discharge NN B-NP O
with IN B-VP O
a DT B-NP O
full JJ I-NP O
diet NN I-NP O
. . B-VP O
   
11. CD O O
Code NNP B-NP O
status NN I-NP O
: : O O
Full NNP B-NP B-treatment
. . B-VP O
   
Two CD O B-person
daughters NNS B-NP I-person
came VBD B-VP O
by IN B-VP O
and CC O O
requested VBD B-VP O
to TO O O
be VB O O
health NN B-NP O
care NN I-NP O
proxies NNS I-NP O
as IN B-VP O
patient NN B-NP B-person
approved VBD B-VP O
. . B-VP O
   
Documentation NN B-NP O
is VBZ O O
in IN B-VP O
her PRP$ O B-person
medical JJ B-NP O
chart NN I-NP O
. . B-VP O
   
12. CD O O
Prophylaxis NN B-NP B-treatment
: : O O
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
on IN B-VP O
subQ JJ B-NP B-treatment
Heparin NNP I-NP I-treatment
for IN B-VP O
DVT NNP B-NP B-problem
and CC O O
ranitidine NN B-NP B-treatment
for IN B-VP O
GI NNP B-NP B-treatment
prophylaxis NN I-NP I-treatment
. . B-VP O
   
DISPOSITION: VB O O
The DT B-NP B-person
patient NN I-NP I-person
is VBZ O O
to TO O O
be VB O O
discharged VBN O O
today NN B-NP O
to TO O O
Lahey NNP B-NP O
Clinic NNP I-NP O
- : O O
North NN B-NP O
Shore NNP I-NP O
Hospital NNP I-NP O
for IN B-VP O
long-term JJ B-NP B-treatment
pulmonary JJ I-NP I-treatment
........ NN I-NP I-treatment
therapy NN I-NP I-treatment
and CC O O
further JJ B-NP O
evaluation NN I-NP B-test
of IN B-VP O
her PRP$ O B-person
obstructive-sleep JJ B-NP B-problem
apnea NN I-NP I-problem
. . B-VP I-problem
   
DISCHARGE NNP B-NP O
CONDITION NNP I-NP O
: : O O
Patient NN B-NP B-person
was VBD B-VP O
stable JJ O O
with IN B-VP O
complete JJ B-NP O
clearance NN I-NP O
of IN B-VP O
her PRP$ O B-person
mental JJ B-NP O
status NN I-NP O
, , O O
advancement NN B-NP O
of IN B-VP O
her PRP$ O B-person
diet JJ O O
, , O O
blood NN B-NP B-test
pressure NN I-NP I-test
, , O O
and CC O O
heart NN B-NP B-test
rate NN I-NP I-test
remained VBD B-VP O
stable JJ O O
, , O O
and CC O O
her PRP$ O B-person
her PRP$ O B-test
oxygen NN B-NP I-test
saturations NNS I-NP I-test
were VBD B-VP O
well RB O O
above IN B-VP O
90% CD O O
during IN B-VP O
the DT B-NP O
daytime NN I-NP O
on IN B-VP O
2 CD O B-treatment
liters NNS B-NP I-treatment
nasal JJ B-NP I-treatment
cannula NN I-NP I-treatment
and CC O O
at IN B-VP O
night NN B-NP O
on IN B-VP O
the DT B-NP B-treatment
BiPAP NNP I-NP I-treatment
settings NNS I-NP O
described VBN O O
above IN B-VP O
. . B-VP O
   
Physical JJ B-NP B-person
Therapy NNP I-NP I-person
consult NN I-NP O
is VBZ O O
pending VBG O O
today NN B-NP O
. . B-VP O
   
DISCHARGE NNP B-NP O
MEDICATIONS NNP I-NP O
: : O O
1. CD O O
NPH NNP B-NP B-treatment
70 CD O O
units NNS B-NP O
q.a.m. RB O O
, , O O
50 CD O O
units NNS B-NP O
q.p.m. RB O O
2. CD O O
Humalog NNP B-NP B-treatment
sliding VBG O I-treatment
scale NN B-NP I-treatment
. . B-VP O
   
3. CD O O
SubQ NNP B-NP B-treatment
Heparin NNP I-NP I-treatment
5,000 CD O O
units NNS B-NP O
t.i.d. RB O O
4. CD O O
Ranitidine NNP B-NP B-treatment
150 CD O O
mg NN B-NP O
p.o. NN I-NP O
b.i.d. VBD B-VP O
5. CD O O
Multivitamin NNP B-NP B-treatment
x1 NNP I-NP O
. . B-VP O
   
6. CD O O
Losartan NNP B-NP B-treatment
25 CD O O
mg NN B-NP O
p.o. NN I-NP O
q.d. $ O O
7. CD O O
Iron NNP B-NP B-treatment
supplementation NN I-NP I-treatment
150 CD O O
mg NN B-NP O
p.o. NN I-NP O
q.d. VBD B-VP O
8. CD O O
Levofloxacin NNP B-NP B-treatment
day NN I-NP O
four CD O O
of IN B-VP O
10 CD O O
to TO O O
be VB O O
completed VBN O O
for IN B-VP O
a DT B-NP O
full JJ I-NP O
10-day JJ I-NP O
course NN I-NP O
, , O O
500 CD O O
mg NN B-NP O
p.o. NN I-NP O
q.d. VBD B-VP O
9. CD O O
Metoprolol NNP B-NP B-treatment
25 CD O O
mg NN B-NP O
p.o. NN I-NP O
b.i.d. VBD B-VP O
10. CD O O
Colace NNP B-NP B-treatment
100 CD O O
mg NN B-NP O
p.o. NN I-NP O
b.i.d. NN I-NP O
Mark NNP I-NP B-person
Nibbe NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
87-896 CD O O
Dictated VBN O O
By IN B-VP O
: : O O
Jeffrey NNP B-NP B-person
N. NNP I-NP I-person
Elvington NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
MEDQUIST36 NNP I-NP O
D NNP I-NP O
: : O O
2015-10-02 JJ O O
08:19 CD O O
T NN B-NP O
: : O O
2015-10-02 JJ O O
08:20 CD O O
JOB NNP B-NP O
# # O O
: : O O
15790 CD O O
Signed VBN O O
electronically RB O O
by IN B-VP O
: : O O
DR. NNP B-NP B-person
Mark NNP I-NP I-person
Nibbe NNP I-NP I-person
on IN B-VP O
: : O O
TUE NNP B-NP O
2015-10-06 CD O O
9:46 CD O O
PM NNP B-NP O
( ( O O
End NNP B-NP O
of IN B-VP O
Report NNP B-NP O
) ) O O
-EMPTYLINE- VBP O O
-DOCSTART- JJ O O
-EMPTYLINE- $ O O
100007275 CD O O
OMH NNP B-NP O
4153022 CD O O
539937 CD O O
1/4/2001 CD O O
12:00:00 CD O O
AM NNP B-NP O
ED NNP I-NP O
Discharge NNP I-NP O
Summary NNP I-NP O
Unsigned VBD B-VP O
DIS NNP B-NP O
Report NNP I-NP O
Status NNP I-NP O
: : O O
Unsigned VBD B-VP O
ED NNP B-NP O
DISCHARGE NNP I-NP O
NOTIFICATION NNP I-NP O
RHALTDEALBBREUTZ NNP I-NP B-person
, , O I-person
STA NNP B-NP I-person
MRN NNP I-NP O
: : O O
4153022 CD O O
Age NNP B-NP O
: : O O
94y CD O O
REGISTRATION NNP B-NP O
DATE NNP I-NP O
: : O O
01/04/2001 CD O O
07:21 CD O O
PM NNP B-NP O
PRELIMINARY NNP I-NP O
REPORT NNP I-NP O
This DT O B-pronoun
is VBZ O O
to TO O O
notify VB O O
you PRP O B-person
that IN B-VP B-pronoun
your PRP$ O B-person
your PRP$ O B-person
patient NN B-NP I-person
, , O O
RHALTDEALBBREUTZ NNP B-NP B-person
, , O I-person
STA NNP B-NP I-person
arrived VBD B-VP O
in IN B-VP O
the DT B-NP O
Emergency NNP I-NP O
Department NNP I-NP O
at IN B-VP O
Oaksgekesser/ NNP B-NP O
Memorial NNP I-NP O
Hospital NNP I-NP O
on IN B-VP O
01/04/2001 CD O O
07:21 CD O O
PM NNP B-NP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
presented VBN O O
with IN B-VP O
a DT B-NP O
chief JJ I-NP O
complaint NN I-NP O
of IN B-VP O
PNEUMONIA NNP B-NP B-problem
. . B-VP O
   
Following VBG O O
evaluation NN B-NP B-test
and CC O O
treatment NN B-NP B-treatment
, , O O
the DT B-NP B-person
patient NN I-NP I-person
&apos;s JJ B-NP O
disposition NN I-NP O
at IN B-VP O
the DT B-NP O
end NN I-NP O
of IN B-VP O
the DT B-NP O
visit NN I-NP O
was VBD B-VP O
ADMITTED NNP B-NP O
AS IN B-VP O
AN NNP B-NP O
INPATIENT NNP I-NP O
TO NNP I-NP O
OAKSGEKESSER/ NNP I-NP O
MEMORIAL NNP I-NP O
HOSPITAL NNP I-NP O
. . B-VP O
   
Your PRP$ O B-person
Your PRP$ O B-person
patient NN B-NP I-person
was VBD B-VP O
admitted VBN O O
under IN B-VP O
the DT B-NP O
care NN I-NP O
of IN B-VP O
TUBBOLM NNP B-NP B-person
, , O I-person
LISSWHITI NNP B-NP I-person
N NNP I-NP I-person
with IN B-VP O
a DT B-NP O
preliminary JJ I-NP O
diagnosis NN I-NP O
of IN B-VP O
PNEUMONIA NNP B-NP B-problem
. . B-VP O
   
If IN B-VP O
you PRP O B-person
need VBP O O
additional JJ B-NP O
information NN I-NP O
please NN I-NP O
call VB O O
598-754-5083 JJ O O
. . B-VP O
   
PCP NNPS B-NP B-person
Name NN I-NP O
: : O O
AJESC NNP B-NP B-person
, , O I-person
DARLMA NNP B-NP I-person
MARGEA NNP I-NP I-person
L NNP I-NP I-person
Provider NNP I-NP B-person
Number NNP I-NP O
: : O O
63669 CD O O
-EMPTYLINE- NN B-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- VBZ O O
134300717 CD O O
FIH NNP B-NP O
9099750 CD O O
22777/5p0t CD O O
355178 CD O O
2/23/1993 CD O O
12:00:00 CD O O
AM NNP B-NP O
DEEP NNP I-NP B-problem
VENOUS NNP I-NP I-problem
THROMBOSIS NNP I-NP I-problem
OF NNP I-NP I-problem
RIGHT NNP I-NP I-problem
LOWER NNP I-NP I-problem
EXTREMITY NNP I-NP I-problem
. . B-VP O
   
Unsigned VBD B-VP O
DIS NNP B-NP O
Report NNP I-NP O
Status NNP I-NP O
: : O O
Unsigned VBN O O
ADMISSION NNP B-NP O
DATE NNP I-NP O
: : O O
2-23-93 JJ B-NP O
DISCHARGE NNP I-NP O
DATE NNP I-NP O
: : O O
2-24-93 JJ B-NP O
PRINCIPAL NNP I-NP O
DIAGNOSIS NNP I-NP O
: : O O
Deep NNP B-NP B-problem
venous JJ B-NP I-problem
thrombosis NN I-NP I-problem
of IN B-VP I-problem
right JJ B-NP I-problem
lower JJR I-NP I-problem
extremity NN I-NP I-problem
. . B-VP O
   
ASSOCIATED CC O O
DIAGNOSIS NNP B-NP O
: : O O
Metastatic JJ B-NP B-problem
melanoma NN I-NP I-problem
. . B-VP O
   
HISTORY NNP B-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS NNP I-NP O
: : O O
This DT O B-pronoun
is VBZ O O
the DT B-NP O
second JJ I-NP O
Fairm NNP I-NP O
of IN B-VP O
Ijordcompmac NNP B-NP O
Hospital NNP I-NP O
admission NN I-NP O
for IN B-VP O
Taroby NNP B-NP B-person
Patient NNP I-NP I-person
, , O O
a DT O O
70 CD O O
year NN B-NP O
old JJ B-NP O
male NN I-NP O
with IN B-VP O
a DT B-NP O
history NN I-NP O
of IN B-VP O
metastatic JJ B-NP B-problem
melanoma NN I-NP I-problem
. . B-VP O
   
His PRP$ O B-person
His PRP$ O B-problem
melanoma NN B-NP I-problem
was VBD B-VP O
originally RB O O
diagnosed VBN O O
last JJ B-NP O
fall NN I-NP O
when WRB O O
he PRP O B-person
presented VBD B-VP O
with IN B-VP O
lesions NNS B-NP B-problem
in IN B-VP I-problem
the DT B-NP I-problem
liver NN I-NP I-problem
and CC O I-problem
spleen NN B-NP I-problem
, , O O
and CC O O
a DT B-NP B-test
chest NN I-NP I-test
CT NN I-NP I-test
showed VBD B-VP O
left JJ B-NP B-problem
upper JJ I-NP I-problem
lobe NN I-NP I-problem
nodules NNS I-NP I-problem
. . B-VP O
   
A DT B-NP B-test
head NN I-NP I-test
CT NNP I-NP I-test
scan NN I-NP I-test
was VBD B-VP O
negative JJ O O
, , O O
but CC O O
an DT B-NP B-test
MRI NNP I-NP I-test
scan NN I-NP I-test
of IN B-VP I-test
the DT B-NP I-test
spine NN I-NP I-test
showed VBD B-VP O
an DT B-NP O
L5 NNP I-NP B-problem
metastasis NN I-NP I-problem
with IN B-VP O
a DT B-NP B-problem
fracture NN I-NP I-problem
and CC O O
had VBD B-VP O
with IN B-VP O
epidural JJ O B-problem
and CC O I-problem
paraspinal JJ B-NP I-problem
extension NN I-NP I-problem
. . B-VP O
   
In IN B-VP O
addition NN B-NP O
, , O O
there EX O O
was VBD B-VP O
a DT B-NP B-problem
T11 NNP I-NP I-problem
metastasis NN I-NP I-problem
with IN B-VP O
cord NN B-NP B-problem
compression NN I-NP I-problem
. . B-VP O
   
Approximately RB O O
one CD O O
week NN B-NP O
ago RB O O
, , O O
he PRP O B-person
was VBD B-VP O
admitted VBN O O
to TO O O
the DT B-NP O
Fairm NNP I-NP O
of IN B-VP O
Ijordcompmac NNP B-NP O
Hospital NNP I-NP O
for IN B-VP O
chemotherapy NN B-NP B-treatment
with IN B-VP O
DTIC NNP B-NP B-treatment
and CC O O
Tamoxifen NNP B-NP B-treatment
. . B-VP O
   
At IN B-VP O
that DT B-NP B-pronoun
time NN I-NP O
, , O O
he PRP O B-person
also RB O O
began VBD B-VP O
radiation JJ B-NP B-treatment
therapy NN I-NP I-treatment
to TO O O
his PRP$ O B-person
lumbosacral JJ B-NP O
spine NN I-NP O
. . B-VP O
   
He PRP O B-person
is VBZ O O
continuing VBG O O
on IN B-VP O
the DT B-NP B-treatment
radiation NN I-NP I-treatment
therapy NN I-NP I-treatment
to TO O O
date NN B-NP O
. . B-VP O
   
On IN B-VP O
February NNP B-NP O
23 CD O O
, , O O
Mr. NNP B-NP B-person
Patient NNP I-NP I-person
presented VBD B-VP O
to TO O O
Dr. NNP B-NP B-person
Patient NNP I-NP I-person
&apos;s NNP I-NP O
office NN I-NP O
with IN B-VP O
two CD O B-problem
major JJ B-NP I-problem
symptoms NNS I-NP I-problem
. . B-VP O
   
First RB O O
, , O O
he PRP O B-person
had VBD B-VP O
right JJ B-NP B-problem
lower JJR I-NP I-problem
extremity NN I-NP I-problem
swelling VBG O I-problem
and CC O O
lower JJR B-NP B-test
extremity NN I-NP I-test
noninvasives NNS I-NP I-test
confirmed VBD B-VP O
the DT B-NP O
diagnosis NN I-NP O
of IN B-VP O
a DT B-NP B-problem
femoral JJ I-NP I-problem
deep JJ I-NP I-problem
venous JJ I-NP I-problem
thrombosis NN I-NP I-problem
. . B-VP O
   
Second JJ O O
, , O O
he PRP O B-person
had VBD B-VP O
a DT B-NP B-problem
witnessed JJ I-NP I-problem
episode NN I-NP I-problem
in IN B-VP O
which WDT O B-pronoun
his PRP$ O B-person
eyes NNS B-NP O
rolled VBD B-VP O
to TO O O
the DT B-NP O
back NN I-NP O
of IN B-VP O
his PRP$ O B-person
head NN B-NP O
and CC O O
there EX O O
was VBD B-VP O
a DT B-NP O
question NN I-NP O
of IN B-VP O
some DT B-NP B-problem
seizure NN I-NP I-problem
activity NN I-NP I-problem
. . B-VP O
   
In IN B-VP O
the DT B-NP O
past NN I-NP O
, , O O
he PRP O B-person
has VBZ O O
not RB O O
been VBN O O
known VBN O O
to TO O O
have VB O O
a DT B-NP O
history NN I-NP O
of IN B-VP O
CNS NNP B-NP B-problem
metastases NNS I-NP I-problem
. . B-VP O
   
The DT B-NP O
episode NN I-NP O
of IN B-VP O
potential JJ B-NP B-problem
seizure NN I-NP I-problem
activity NN I-NP I-problem
occurred VBD B-VP O
in IN B-VP O
the DT B-NP O
setting NN I-NP O
of IN B-VP O
a DT B-NP O
bowel NN I-NP O
movement NN I-NP O
and CC O O
may MD O O
have VB O O
been VBN O O
associated VBN O O
with IN B-VP O
vasovagal JJ B-NP B-problem
activity NN I-NP I-problem
. . B-VP O
   
PAST NNP B-NP O
MEDICAL NNP I-NP O
HISTORY NNP I-NP O
: : O O
The DT B-NP O
past JJ I-NP O
medical JJ I-NP O
history NN I-NP O
is VBZ O O
as IN B-VP O
above IN B-VP O
. . B-VP O
   
FAMILY NNP B-NP B-person
HISTORY NNP I-NP O
: : O O
Noncontributory NN B-NP O
. . B-VP O
   
REVIEW NNP B-NP O
OF NNPS I-NP O
SYSTEMS NNP I-NP O
: : O O
The DT B-NP B-test
review NN I-NP I-test
of IN B-VP I-test
systems NNS B-NP I-test
is VBZ O O
negative JJ O O
, , O O
except IN B-VP O
as IN B-VP O
above NN B-NP O
. . B-VP O
   
ALLERGIES NN B-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
has VBZ O O
no DT O O
known VBN O B-problem
drug NN B-NP I-problem
allergies NNS I-NP I-problem
. . B-VP O
   
PHYSICAL JJ B-NP O
EXAMINATION NN I-NP O
: : O O
The DT B-NP B-test
physical JJ I-NP I-test
examination NN I-NP I-test
reveals VBZ O O
a DT B-NP O
pleasant NN I-NP O
70 CD O O
year NN B-NP O
old JJ B-NP O
male NN I-NP O
in IN B-VP O
no DT B-NP O
acute JJ I-NP B-problem
distress NN I-NP I-problem
. . B-VP O
   
The DT B-NP B-test
blood NN I-NP I-test
pressure NN I-NP I-test
was VBD B-VP O
113/70 CD O O
, , O O
pulse RB O B-test
66 CD O O
, , O O
respirations NNS B-NP B-test
20 CD O O
, , O O
and CC O O
a DT B-NP B-test
temperature NN I-NP I-test
of IN B-VP O
96.8 CD O O
. . B-VP O
   
HEENT NNP B-NP B-test
showed VBD B-VP O
pupils NNS B-NP O
equal JJ O O
, , O O
round NN B-NP O
, , O O
reactive JJ O O
to TO O O
light JJ O O
and CC O O
accommodation NN B-NP O
, , O O
and CC O O
extra JJ B-NP O
ocular JJ I-NP O
movements NNS I-NP O
intact JJ O O
. . B-VP O
   
The DT B-NP O
sclerae NN I-NP O
were VBD B-VP O
anicteric JJ O O
. . B-VP O
   
The DT B-NP O
neck NN I-NP O
was VBD B-VP O
supple JJ O O
, , O O
without IN B-VP O
jugular JJ B-NP B-problem
venous JJ I-NP I-problem
distention NN I-NP I-problem
or CC O O
increased VBN O B-problem
thyroid NN B-NP I-problem
. . B-VP O
   
Nodes NNS B-NP O
: : O O
There EX O O
was VBD B-VP O
no DT O O
appreciable JJ O B-problem
cervical JJ O I-problem
, , O I-problem
supraclavicular JJ O I-problem
, , O I-problem
axillary JJ O I-problem
, , O I-problem
or CC O I-problem
inguinal JJ B-NP I-problem
adenopathy NN I-NP I-problem
. . B-VP O
   
The DT B-NP O
chest NN I-NP O
was VBD B-VP O
clear JJ O O
to TO O O
auscultation NN B-NP B-test
and CC O O
percussion NN B-NP B-test
. . B-VP O
   
Cardiac JJ O O
: : O O
regular JJ B-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
, , O O
with IN B-VP O
a DT O B-problem
I PRP O I-problem
/ VBP O I-problem
VI NNP B-NP I-problem
systolic JJ B-NP I-problem
ejection NN I-NP I-problem
murmur NN I-NP I-problem
. . B-VP O
   
The DT B-NP O
abdomen NNS I-NP O
showed VBD B-VP O
a DT O O
10 CD O O
cm NN B-NP O
liver NN I-NP O
with IN B-VP O
the DT B-NP O
edge NN I-NP O
palpable JJ O O
2 CD O O
fingerbreadths NNS B-NP O
below IN B-VP O
the DT B-NP O
right JJ I-NP O
costal NN I-NP O
margin NN I-NP O
. . B-VP O
   
The DT B-NP B-test
extremity NN I-NP I-test
exam NN I-NP I-test
was VBD B-VP O
notable JJ O O
for IN B-VP O
2+ CD O B-problem
pitting VBG O I-problem
edema NN B-NP I-problem
in IN B-VP I-problem
the DT B-NP I-problem
right NN I-NP I-problem
lower JJR B-NP I-problem
extremity NN I-NP I-problem
extending VBG O O
to TO O O
the DT B-NP O
knee NN I-NP O
. . B-VP O
   
The DT B-NP B-test
neurological JJ I-NP I-test
examination NN I-NP I-test
was VBD B-VP O
nonfocal JJ O O
. . B-VP O
   
HOSPITAL NNP B-NP O
COURSE NNP I-NP O
: : O O
Mr. NNP B-NP B-person
Patient NNP I-NP I-person
underwent JJ B-NP O
venogram NN I-NP B-test
and CC O O
inferior JJ B-NP B-treatment
vena NN I-NP I-treatment
cava NN I-NP I-treatment
filter NN I-NP I-treatment
placement NN I-NP I-treatment
on IN B-VP O
February NNP B-NP O
23 CD O O
, , O O
1993 CD O O
and CC O O
was VBD B-VP O
then RB O O
he PRP O B-person
was VBD B-VP O
admitted VBN O O
to TO O O
the DT B-NP O
Fairm NNP I-NP O
of IN B-VP O
Ijordcompmac NNP B-NP O
Hospital NNP I-NP O
for IN B-VP O
postoperative JJ B-NP B-treatment
care NN I-NP I-treatment
. . B-VP O
   
He PRP O B-person
tolerated VBD B-VP O
the DT B-NP B-treatment
procedure NN I-NP I-treatment
well RB O O
. . B-VP O
   
In IN B-VP O
addition NN B-NP O
, , O O
the DT B-NP O
second JJ I-NP O
major JJ I-NP O
event NN I-NP O
that WDT O B-pronoun
had VBD B-VP O
occurred VBN O O
yesterday NN B-NP O
was VBD B-VP O
a DT B-NP B-problem
neurologic JJ I-NP I-problem
event NN I-NP I-problem
of IN B-VP O
some DT B-NP O
kind NN I-NP O
. . B-VP O
   
Over IN B-VP O
the DT O O
24 CD O O
hours NNS B-NP O
of IN B-VP O
in IN B-VP O
house NN B-NP O
hospitalization NN I-NP O
, , O O
he PRP O B-person
did VBD B-VP O
not RB O O
have VB O O
any DT B-NP B-problem
further JJ I-NP I-problem
neurologic JJ I-NP I-problem
activity NN I-NP I-problem
and CC O O
was VBD B-VP O
able JJ O O
to TO O O
ambulate VB O O
without IN B-VP O
assistance NN B-NP O
prior RB O O
to TO O O
discharge VB O O
. . B-VP O
   
He PRP O B-person
will MD O O
be VB O O
scheduled VBN O O
for IN B-VP O
an DT B-NP B-test
MRI NNP I-NP I-test
scan NN I-NP I-test
, , O O
Neurology NNP B-NP B-person
consult NN I-NP O
, , O O
and CC O O
an DT B-NP B-test
EEG NNP I-NP I-test
next JJ B-NP O
week NN I-NP O
as IN B-VP O
an DT O O
out IN B-VP O
patient NN B-NP O
. . B-VP O
   
Mr. NNP B-NP B-person
Patient NNP I-NP I-person
was VBD B-VP O
a DT B-NP O
poor JJ I-NP O
candidate NN I-NP O
for IN B-VP O
anticoagulation NN B-NP B-treatment
because IN B-VP O
of IN B-VP O
his PRP$ O B-person
history NN B-NP O
of IN B-VP O
metastatic JJ B-NP B-problem
melanoma NN I-NP I-problem
and CC O O
the DT B-NP O
question NN I-NP O
of IN B-VP O
CNS NNP B-NP B-problem
metastases NNS I-NP I-problem
. . B-VP O
   
An DT B-NP B-treatment
IVC NNP I-NP I-treatment
filter NN I-NP I-treatment
placement NN I-NP I-treatment
was VBD B-VP O
accomplished VBN O O
without IN B-VP O
complication NN B-NP B-problem
. . B-VP O
   
He PRP O B-person
is VBZ O O
stable JJ O O
on IN B-VP O
February NNP B-NP O
24 CD O O
and CC O O
ready JJ O O
for IN B-VP O
discharge NN B-NP O
to TO O O
home NN B-NP O
. . B-VP O
   
PROCEDURES NNP B-NP O
: : O O
IVC NNP B-NP B-treatment
filter NN I-NP I-treatment
placement NN I-NP I-treatment
. . B-VP O
   
COMPLICATIONS NN B-NP O
: : O O
None NN B-NP O
. . B-VP O
   
MEDICATIONS NNP B-NP O
ON NNP I-NP O
DISCHARGE NNP I-NP O
: : O O
Decadron NNP B-NP B-treatment
4 CD O O
mg NN B-NP O
PO NNP I-NP O
bid NN I-NP O
, , O O
Dilantin NNP B-NP B-treatment
100 CD O O
mg NN B-NP O
PO NNP I-NP O
tid NN I-NP O
. . B-VP O
   
CONDITION NNP B-NP O
ON NNP I-NP O
DISCHARGE NNP I-NP O
: : O O
Stable JJ O O
. . B-VP O
   
DISPOSITION NN B-NP O
: : O O
Mr. NNP B-NP B-person
Patient NNP I-NP I-person
will MD O O
be VB O O
discharged VBN O O
to TO O O
home NN B-NP O
. . B-VP O
   
He PRP O B-person
will MD O O
have VB O O
follow VB O O
up RP O O
arranged VBN O O
with IN B-VP O
Dr. NNP B-NP B-person
Guabenfranda NNP I-NP I-person
Patient NNP I-NP I-person
. . B-VP O
   
ESTIMATED NNP B-NP O
DISABILITY NNP I-NP O
AND NNP I-NP O
PROBABLE NNP I-NP O
DURATION NNP I-NP O
: : O O
Permanent NN B-NP O
. . B-VP O
   
CA NNP B-NP B-person
SHUFF NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
DICTATING NNP I-NP O
FOR NNP I-NP O
: : O O
GUABENFRANDA NNP B-NP B-person
PATIENT NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
TR NNP I-NP O
: : O O
it PRP O O
/ VBZ O O
bmot JJ B-NP O
DD NNP I-NP O
: : O O
2-24-93 JJ B-NP O
TD NN I-NP O
: : O O
02/26/93 CD O O
CC NN B-NP O
: : O O
-EMPTYLINE- JJ B-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
﻿Admission NN I-NP O
Date NNP I-NP O
: : O O
2010-07-15 JJ B-NP O
Discharge NN I-NP O
Date NNP I-NP O
: : O O
2010-07-18 JJ B-NP O
Date NNP I-NP O
of IN B-VP O
Birth NNP B-NP O
: : O O
1978-01-25 JJ B-NP O
Sex NN I-NP O
: : O O
F NNP B-NP O
Service NNP I-NP O
: : O O
KULAND NNP B-NP O
HISTORY NNP I-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
is VBZ O O
a DT B-NP O
32-year-old JJ I-NP O
white JJ I-NP O
female NN I-NP O
with IN B-VP O
history NN B-NP O
of IN B-VP O
diabetes NNS B-NP B-problem
type VBP O I-problem
1 CD O I-problem
and CC O O
migraines NNS B-NP B-problem
who WP O B-person
presented VBD B-VP O
with IN B-VP O
complaints NNS B-NP O
of IN B-VP O
nausea NN B-NP B-problem
, , O O
diarrhea NN B-NP B-problem
and CC O O
vomiting VBG O B-problem
for IN B-VP O
24 CD O O
hours NNS B-NP O
. . B-VP O
   
Patient JJ B-NP B-person
states NNS I-NP O
she PRP O B-person
was VBD B-VP O
unable JJ O O
to TO O O
take VB O O
her PRP$ O B-treatment
her PRP$ O B-person
usual JJ B-NP I-treatment
insulin NN I-NP I-treatment
regimen NNS I-NP I-treatment
because IN B-VP O
she PRP O B-person
was VBD B-VP O
vomiting VBG O B-problem
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
denied VBD B-VP O
any DT B-NP O
fevers NNS I-NP B-problem
, , O O
chills NNS B-NP B-problem
, , O O
chest JJS B-NP B-problem
pain NN I-NP I-problem
, , O O
shortness NN B-NP B-problem
of IN B-VP I-problem
breath NN B-NP I-problem
or CC O O
dysuria NNS B-NP B-problem
but CC O O
does VBZ O O
state NN B-NP O
she PRP O B-person
had VBD B-VP O
her PRP O B-person
her PRP$ O B-problem
usual JJ B-NP I-problem
migraine NN I-NP I-problem
headache NN I-NP I-problem
the DT B-NP O
night NN I-NP O
prior RB O O
to TO O O
admission NN B-NP O
. . B-VP O
   
The DT O B-test
The DT B-NP B-person
patient JJ I-NP I-test
patient NN I-NP I-person
's POS O I-test
arterial JJ B-NP I-test
blood NN I-NP I-test
gases NNS I-NP I-test
in IN B-VP O
the DT B-NP O
Emergency NNP I-NP O
Department NNP I-NP O
were VBD B-VP O
7.19 CD O O
, , O O
22 CD O O
and CC O O
109 CD O O
with IN B-VP O
a DT B-NP B-test
bicarbonate NN I-NP I-test
of IN B-VP O
9 CD O O
and CC O O
a DT B-NP B-test
fingerstick NN I-NP I-test
of IN B-VP O
greater JJR O O
than IN B-VP O
500 CD O O
. . B-VP O
   
Patient NN B-NP B-person
was VBD B-VP O
given VBN O O
two CD O B-treatment
boluses NNS B-NP I-treatment
of IN B-VP I-treatment
15 CD O I-treatment
units NNS B-NP I-treatment
of IN B-VP I-treatment
regular JJ B-NP I-treatment
insulin NN I-NP I-treatment
and CC O O
was VBD B-VP O
started VBN O O
on IN B-VP O
an DT B-NP B-treatment
insulin NN I-NP I-treatment
drip NN I-NP I-treatment
of IN B-VP O
one CD O O
unit NN B-NP O
per IN B-VP O
hour NN B-NP O
and CC O O
given VBN O O
a DT B-NP B-treatment
total NN I-NP I-treatment
of IN B-VP I-treatment
five CD O I-treatment
liters NNS B-NP I-treatment
of IN B-VP I-treatment
normal JJ B-NP I-treatment
saline NN I-NP I-treatment
. . B-VP O
   
Her PRP$ O B-person
Her PRP$ O B-test
fingersticks NNS B-NP I-test
decreased VBN O O
with IN B-VP O
the DT B-NP B-treatment
insulin NN I-NP I-treatment
drip NN I-NP I-treatment
and CC O O
the DT B-NP B-treatment
intravenous JJ I-NP I-treatment
fluids NNS I-NP I-treatment
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
admitted VBN O O
to TO O O
the DT B-NP O
Intensive NNP I-NP O
Care NNP I-NP O
Unit NNP I-NP O
for IN B-VP O
an DT B-NP B-treatment
insulin NN I-NP I-treatment
drip NN I-NP I-treatment
and CC O O
frequent JJ B-NP B-test
blood NN I-NP I-test
sugar NN I-NP I-test
monitoring NN I-NP I-test
and CC O O
Chem-7 JJ B-NP B-test
monitoring NN I-NP I-test
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
did VBD B-VP O
well RB O O
overnight VBN O O
in IN B-VP O
the DT B-NP O
Medical NNP I-NP O
Intensive NNP I-NP O
Care NNP I-NP O
Unit NNP I-NP O
. . B-VP O
   
Her PRP$ O B-person
Her PRP$ O B-test
anion NN B-NP I-test
gap NN I-NP I-test
closed VBD B-VP O
and CC O O
her PRP$ O B-person
her PRP$ O B-test
fingersticks NNS B-NP I-test
were VBD B-VP O
less JJR O O
than IN B-VP O
200 CD O O
. . B-VP O
   
Her PRP$ O B-person
Her PRP$ O B-treatment
NPH NNP B-NP I-treatment
and CC O O
a DT B-NP B-treatment
regular JJ I-NP I-treatment
sliding NN I-NP I-treatment
scale NN I-NP I-treatment
were VBD B-VP O
started VBN O O
and CC O O
her PRP$ O B-person
her PRP$ O B-treatment
drip NN B-NP I-treatment
was VBD B-VP O
discontinued VBN O O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
denied VBD B-VP O
any DT O B-problem
more RBR O I-problem
gastrointestinal JJ B-NP I-problem
symptoms NNS I-NP I-problem
. . B-VP O
   
PAST NNP B-NP O
MEDICAL NNP I-NP O
HISTORY NNP I-NP O
: : O O
Includes NNP B-NP O
diabetes NNS I-NP B-problem
, , O O
diagnosed VBN O O
at IN B-VP O
age NN B-NP O
14 CD O O
. . B-VP O
   
Multiple NNP B-NP O
episodes NNS I-NP O
of IN B-VP O
diabetic JJ B-NP B-problem
ketoacidosis NN I-NP I-problem
in IN B-VP O
the DT B-NP O
past NN I-NP O
, , O O
migraine NN B-NP B-problem
headaches NNS I-NP I-problem
and CC O O
attention NN B-NP B-problem
deficit NN I-NP I-problem
disorder NN I-NP I-problem
. . B-VP O
   
MEDICATIONS NNP B-NP O
AT NNP I-NP O
HOME NNP I-NP O
: : O O
Included VBD B-VP O
Wellbutrin NNP B-NP B-treatment
, , O O
Imitrex NNP B-NP B-treatment
, , O O
Tylenol NNP B-NP B-treatment
, , O O
Humalog NNP B-NP B-treatment
sliding VBG O I-treatment
scale NN B-NP I-treatment
and CC O O
NPH NNP B-NP B-treatment
insulin VBP O I-treatment
two CD O O
units NNS B-NP O
in IN B-VP O
the DT B-NP O
morning NN I-NP O
, , O O
7 CD O O
units NNS B-NP O
at IN B-VP O
noon NN B-NP O
and CC O O
13 CD O O
units NNS B-NP O
at IN B-VP O
bedtime NN B-NP O
. . B-VP O
   
ALLERGIES CC O O
: : O O
Patient NN B-NP B-person
has VBZ O O
allergies NNS B-NP B-problem
to TO O O
penicillin VB O B-treatment
. . B-VP O
   
She PRP O B-person
gets VBZ O O
hives NNS B-NP B-problem
. . B-VP O
   
Bactrim NNP B-NP B-treatment
, , O O
she PRP O B-person
gets VBZ O O
hives NNS B-NP B-problem
. . B-VP O
   
Percocet NNP B-NP B-treatment
and CC O O
erythromycin NN B-NP B-treatment
, , O O
she PRP O B-person
gets VBZ O O
gastrointestinal JJ B-NP B-problem
upset NN I-NP I-problem
and CC O O
Keflex NNP B-NP B-treatment
she PRP O B-person
gets VBZ O O
hives NNS B-NP B-problem
. . B-VP O
   
SOCIAL NNP B-NP O
HISTORY NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
lives VBZ O O
with IN B-VP O
mother NN B-NP B-person
and CC O O
father NN B-NP B-person
. . B-VP O
   
She PRP O B-person
had VBD B-VP O
a DT B-NP O
recent JJ I-NP O
pregnancy NN I-NP O
with IN B-VP O
a DT O O
five CD O O
month NN B-NP O
stay NN I-NP O
at IN B-VP O
Erich NNP B-NP O
Lindemann NNP I-NP O
Mental NNP I-NP O
Health NNP I-NP O
Center NNP I-NP O
. . B-VP O
   
Patient NNP B-NP B-person
had VBD B-VP O
a DT B-NP B-treatment
cesarean JJ I-NP I-treatment
section NN I-NP I-treatment
at IN B-VP O
eight CD O O
months NNS B-NP O
. . B-VP O
   
The DT B-NP B-person
baby NN I-NP I-person
is VBZ O O
now RB O O
healthy JJ O O
, , O O
about RB O O
four CD O O
months NNS B-NP O
old JJ O O
. . B-VP O
   
Tobacco NNP B-NP O
history NN I-NP O
, , O O
three CD O O
cigarettes NNS B-NP O
a DT B-NP O
week NN I-NP O
. . B-VP O
   
Denies NNPS B-NP O
alcohol NN I-NP O
or CC O O
drugs NNS B-NP O
. . B-VP O
   
FAMILY NNP B-NP O
HISTORY NNP I-NP O
: : O O
Hypertension NN B-NP B-problem
. . B-VP O
   
PHYSICAL NNP B-NP O
EXAM NNP I-NP O
ON NNP I-NP O
ADMISSION NNP I-NP O
: : O O
Includes VBZ O O
a DT B-NP B-test
temperature NN I-NP I-test
of IN B-VP O
99.9 CD O O
. . B-VP O
   
Pulse NNP B-NP B-test
of IN B-VP O
94 CD O O
. . B-VP O
   
Blood NNP B-NP B-test
pressure NN I-NP I-test
of IN B-VP O
138/49 CD O O
. . B-VP O
   
Patient NN B-NP B-person
was VBD B-VP O
generally RB O B-problem
ill-appearing JJ O I-problem
and CC O O
nauseated JJ O B-problem
, , O O
but CC O O
alert JJ O O
and CC O O
oriented VBD B-VP O
times NNS B-NP O
three CD O O
. . B-VP O
   
Head NN B-NP O
, , O O
eyes NNS B-NP O
, , O O
ears NNS B-NP O
, , O O
nose RB O O
and CC O O
throat JJ B-NP O
exam NN I-NP O
: : O O
Pupils NNP B-NP O
equal JJ O O
, , O O
round NN B-NP O
and CC O O
reactive JJ O O
to TO O O
light JJ O O
. . B-VP O
   
Oropharynx CC O O
clear JJ O O
. . B-VP O
   
Dry NNP B-NP O
mucous JJ B-NP O
membranes NNS I-NP O
. . B-VP O
   
Neck NNP B-NP O
supple NN I-NP O
, , O O
no DT B-NP O
lymphadenopathy NN I-NP B-problem
. . B-VP O
   
Chest NNP B-NP O
clear JJ O O
to TO O O
auscultation NN B-NP B-test
. . B-VP O
   
Heart NNP B-NP O
regular JJ O O
. . B-VP O
   
Abdomen NNP B-NP O
soft JJ O O
, , O O
nontender NN B-NP B-problem
, , O O
nondistended VBN O B-problem
. . B-VP O
   
Extremities NNS B-NP O
: : O O
No DT B-NP O
edema NN I-NP B-problem
. . B-VP O
   
Neurological JJ B-NP B-test
exam NN I-NP I-test
: : O O
Alert NNP B-NP O
and CC O O
oriented VBN O O
times NNS B-NP O
three CD O O
. . B-VP O
   
Cranial JJ B-NP B-test
nerves NNS I-NP I-test
II NNP I-NP I-test
through IN B-VP I-test
XII NNP B-NP I-test
are VBP O O
intact JJ O O
, , O O
nonfocal JJ O O
, , O O
moving VBG O O
all DT B-NP O
extremities NNS I-NP O
. . B-VP O
   
LABORATORY NN B-NP O
ON JJ B-NP O
ADMISSION NN I-NP O
: : O O
White NNP B-NP B-test
blood NN I-NP I-test
cell NN I-NP I-test
count NN I-NP I-test
of IN B-VP O
22.8 CD O O
, , O O
hematocrit NN B-NP B-test
of IN B-VP O
42.1 CD O O
. . B-VP O
   
Sodium NN B-NP B-test
of IN B-VP O
136 CD O O
, , O O
chloride RB O B-test
96 CD O O
, , O O
bicarbonate NN B-NP B-test
8 CD O O
, , O O
BUN NNP B-NP B-test
25 CD O O
, , O O
creatinine NN B-NP B-test
1.2 CD O O
, , O O
glucose VBD B-VP B-test
720 CD O O
. . B-VP O
   
Arterial JJ B-NP B-test
blood NN I-NP I-test
gases NNS I-NP I-test
showed VBD B-VP O
a DT B-NP B-test
pH NN I-NP I-test
of IN B-VP O
7.19 CD O O
, , O O
pCO2 NN B-NP B-test
of IN B-VP O
22 CD O O
and CC O O
PO2 NNP B-NP B-test
of IN B-VP O
102 CD O O
and CC O O
a DT B-NP B-test
potassium NN I-NP I-test
of IN B-VP O
3.9 CD O O
. . B-VP O
   
Chest JJS B-NP B-test
x-ray NN I-NP I-test
was VBD B-VP O
negative JJ O O
for IN B-VP O
infiltrate NN B-NP B-problem
. . B-VP O
   
Electrocardiogram NNP B-NP B-test
was VBD B-VP O
normal JJ B-NP O
sinus JJ I-NP O
rhythm NN I-NP O
with IN B-VP O
a DT B-NP B-problem
T NNP I-NP I-problem
wave NN I-NP I-problem
inversion NN I-NP I-problem
in IN B-VP I-problem
V2 NNP B-NP I-problem
, , O O
but CC O O
no DT B-NP O
ST NNP I-NP B-problem
segment NN I-NP I-problem
elevations NNS I-NP I-problem
. . B-VP O
   
HOSPITAL NNP B-NP O
COURSE NNP I-NP O
: : O O
As IN B-VP O
above IN B-VP O
, , O O
and CC O O
once RB O O
transferred VBN O O
to TO O O
the DT B-NP O
floor NN I-NP O
, , O O
patient NN B-NP B-person
had VBD B-VP O
fingersticks NNS B-NP B-test
monitored VBN O O
every DT O O
four CD O O
hours NNS B-NP O
with IN B-VP O
a DT O B-treatment
sliding VBG O I-treatment
scale NN B-NP I-treatment
. . B-VP O
   
Patient NNP B-NP B-person
reached VBD B-VP O
goal NN B-NP O
of IN B-VP O
fingersticks NNS B-NP B-test
between IN B-VP O
50 CD O O
and CC O O
300 CD O O
, , O O
which WDT O B-pronoun
is VBZ O O
what WP O O
she PRP O B-person
maintains VBZ O O
at IN B-VP O
home NN B-NP O
. . B-VP O
   
Sliding VBG O B-treatment
scale NN B-NP I-treatment
was VBD B-VP O
adjusted VBN O O
as IN B-VP O
necessary JJ O O
. . B-VP O
   
Patient NN B-NP B-person
was VBD B-VP O
continued VBN O O
on IN B-VP O
intravenous JJ B-NP B-treatment
fluids NNS I-NP I-treatment
until IN B-VP O
taking VBG O O
good JJ B-NP O
po NN I-NP O
. . B-VP O
   
Infectious JJ B-NP O
Disease NN I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
had VBD B-VP O
an DT O B-problem
elevated VBN O I-problem
white JJ B-NP I-problem
count NN I-NP I-problem
upon IN B-VP O
admission NN B-NP O
, , O O
however RB O O
, , O O
white JJ B-NP B-test
count NN I-NP I-test
came VBD B-VP O
down RB O O
to TO O O
7.1 CD O O
and CC O O
prior RB O O
to TO O O
discharge VB O O
, , O O
patient NN B-NP B-person
was VBD B-VP O
afebrile JJ O B-problem
and CC O O
no DT B-NP O
clear JJ I-NP O
etiology NN I-NP O
for IN B-VP O
elevated JJ B-NP B-problem
white JJ I-NP I-problem
blood NN I-NP I-problem
cell NN I-NP I-problem
on IN B-VP O
admission NN B-NP O
, , O O
questionably RB O O
secondary JJ O O
to TO O O
short JJ B-NP B-problem
gastrointestinal JJ I-NP I-problem
infection NN I-NP I-problem
, , O O
however RB O O
, , O O
patient NN B-NP B-person
is VBZ O O
completely RB O O
symptom JJ O O
free JJ O O
upon IN B-VP O
discharge NN B-NP O
. . B-VP O
   
Fluid NNP B-NP O
, , O O
electrolytes VBZ O O
and CC O O
nutrition NN B-NP O
: : O O
The DT O B-test
The DT B-NP B-person
patient JJ I-NP I-test
patient NN I-NP I-person
's POS O I-test
electrolytes NNS B-NP I-test
were VBD B-VP O
repleted VBN O O
as IN B-VP O
necessary JJ O O
. . B-VP O
   
Potassium NN B-NP B-treatment
was VBD B-VP O
given VBN O O
with IN B-VP O
her PRP$ O B-person
her PRP$ O B-treatment
intravenous JJ B-NP I-treatment
fluids NNS I-NP I-treatment
and CC O O
phosphate NN B-NP B-treatment
will MD O O
be VB O O
repleted VBN O O
as IN B-VP O
patient NN B-NP B-person
increases VBZ O O
her PRP$ O B-person
po JJ B-NP O
intake NN I-NP O
. . B-VP O
   
CONDITION NNP B-NP O
OF IN B-VP O
DISCHARGE NNP B-NP O
: : O O
Good JJ O O
. . B-VP O
   
DISCHARGE JJ B-NP O
STATUS NNP I-NP O
: : O O
To TO O O
home NN B-NP O
. . B-VP O
   
DISCHARGE NNP B-NP O
DIAGNOSES NNP I-NP O
: : O O
1. CD O O
Diabetic JJ B-NP B-problem
ketoacidosis NN I-NP I-problem
. . B-VP O
   
2. CD O O
Viral JJ B-NP B-problem
gastroenteritis NN I-NP I-problem
. . B-VP O
   
DISCHARGE NNP B-NP O
MEDICATIONS NNP I-NP O
: : O O
Includes VBZ O O
her PRP$ O B-treatment
her PRP$ O B-person
regular JJ B-NP I-treatment
insulin NN I-NP I-treatment
sliding VBG O I-treatment
scale NN B-NP I-treatment
and CC O O
her PRP$ O B-person
her PRP$ O B-treatment
NPH NNP B-NP I-treatment
fixed VBN O O
scale NN B-NP O
of IN B-VP O
7 CD O O
units NNS B-NP O
in IN B-VP O
the DT B-NP O
morning NN I-NP O
, , O O
2 CD O O
units NNS B-NP O
at IN B-VP O
noon NN B-NP O
and CC O O
13 CD O O
units NNS B-NP O
at IN B-VP O
bedtime NN B-NP O
. . B-VP O
   
Patient NNP B-NP B-person
was VBD B-VP O
instructed VBN O O
to TO O O
decrease VB O O
her PRP$ O B-person
her PRP$ O B-treatment
evening NN B-NP I-treatment
dose NN I-NP I-treatment
if IN B-VP O
she PRP O B-person
does VBZ O O
not RB O O
continue VB O O
to TO O O
take VB O O
good JJ B-NP O
po NN I-NP O
. . B-VP O
   
Patient NNP B-NP B-person
will MD O O
also RB O O
continue VB O O
on IN B-VP O
her PRP$ O B-treatment
her PRP$ O B-person
Wellbutrin NNP B-NP I-treatment
and CC O O
Imitrex NNP B-NP B-treatment
as IN B-VP O
needed VBN O O
for IN B-VP O
migraines NNS B-NP B-problem
. . B-VP O
   
FOLLOW-UP JJ B-NP O
PLANS NNS I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
is VBZ O O
to TO O O
follow-up JJ O O
with IN B-VP O
her PRP$ O B-person
her PRP$ O B-person
endocrinologist NN B-NP I-person
at IN B-VP O
the DT B-NP O
Mahoney NNP I-NP O
, , O O
as RB O O
well RB O O
as IN B-VP O
her PRP$ O B-person
her PRP$ O B-person
primary JJ B-NP I-person
care NN I-NP I-person
physician NN I-NP I-person
. . B-VP O
   
Diane NNP B-NP B-person
Sands NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
11-089 CD O O
Dictated VBN O O
By IN B-VP O
: : O O
Pamela NNP B-NP B-person
F. NNP I-NP I-person
Williams NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
MEDQUIST36 NNP I-NP O
D NNP I-NP O
: : O O
2010-07-20 JJ O O
21:01 CD O O
T NN B-NP O
: : O O
2010-07-20 JJ O O
21:01 CD O O
JOB NNP B-NP O
#: VBD B-VP O
65230 CD O O
Signed VBN O O
electronically RB O O
by IN B-VP O
: : O O
DR. NNP B-NP B-person
Timothy NNP I-NP I-person
Clemons NNP I-NP I-person
on IN B-VP O
: : O O
MON NNP B-NP O
2010-07-26 CD O O
11:01 CD O O
AM NNP B-NP O
( ( O O
End NNP B-NP O
of IN B-VP O
Report NNP B-NP O
) ) O O
-EMPTYLINE- VBP O O
-DOCSTART- JJ O O
-EMPTYLINE- $ O O
143748600 CD O O
SC NNP B-NP O
43243309 CD O O
095342 CD O O
09/30/2000 CD O O
12:00:00 CD O O
AM NNP B-NP O
atypical JJ B-NP B-problem
chest NN I-NP I-problem
pain NN I-NP I-problem
DIS NNP I-NP O
Admission NNP I-NP O
Date NNP I-NP O
: : O O
09/30/2000 CD O O
Report NNP B-NP O
Status NNP I-NP O
: : O O
Discharge NN B-NP O
Date NNP I-NP O
: : O O
10/01/2000 CD O O
****** NN B-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
FALC NNP I-NP B-person
, , O I-person
COLL NNP B-NP I-person
891-57-52-0 CD O O
T37 NNP B-NP O
Room NNP I-NP O
: : O O
53X-785 JJ B-NP O
Service NNP I-NP O
: : O O
CAR NNP B-NP O
DISCHARGE NNP I-NP O
PATIENT NNP I-NP B-person
ON NNP I-NP O
: : O O
10/01/00 CD O O
AT NNP B-NP O
03:30 CD O O
PM NNP B-NP O
CONTINGENT NNP I-NP O
UPON NNP I-NP O
ETT NNP I-NP O
WILL NNP I-NP O
D NNP I-NP O
/ NNP I-NP O
C NNP I-NP O
ORDER NNP I-NP O
BE NNP I-NP O
USED NNP I-NP O
AS IN B-VP O
THE NNP B-NP O
D NNP I-NP O
/ NNP I-NP O
C NNP I-NP O
SUMMARY NNP I-NP O
: : O O
YES JJ B-NP O
Attending NN I-NP B-person
: : O O
KOTEZUSTLEEB NNP B-NP B-person
, , O I-person
LIJO NNP B-NP I-person
LIFLE NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
CODE NNP I-NP O
STATUS NNP I-NP O
: : O O
Full NNP B-NP O
code NN I-NP O
DISPOSITION NNP I-NP O
: : O O
Home NNP B-NP O
DISCHARGE NNP I-NP O
MEDICATIONS NNP I-NP O
: : O O
ALBUTEROL NNP B-NP B-treatment
INHALER NNP I-NP I-treatment
2 CD O O
PUFF NNP B-NP O
INH NNP I-NP O
QID NNP I-NP O
Instructions NNP I-NP O
: : O O
PLEASE NNP B-NP O
USE NNP I-NP O
WITH NNP I-NP O
SPACER NNP I-NP B-treatment
( ( O O
PLEASE NNP B-NP O
INSTRUCT NNP I-NP O
PATIENT NNP I-NP B-person
) ) O O
ECASA NNP B-NP B-treatment
( ( O I-treatment
ASPIRIN NNP B-NP I-treatment
ENTERIC NNP I-NP I-treatment
COATED NNP I-NP I-treatment
) ) O I-treatment
325 CD O O
MG NNP B-NP O
PO NNP I-NP O
QD NNP I-NP O
WELLBUTRIN NNP I-NP B-treatment
( ( O I-treatment
BUPROPION NNP B-NP I-treatment
HCL NNP I-NP I-treatment
) ) O I-treatment
150 CD O O
MG NNP B-NP O
PO NNP I-NP O
BID NNP I-NP O
GEMFIBROZIL NNP I-NP B-treatment
600 CD O O
MG NNP B-NP O
PO NNP I-NP O
BID NNP I-NP O
ZESTRIL NNP I-NP B-treatment
( ( O I-treatment
LISINOPRIL NNP B-NP I-treatment
) ) O I-treatment
20 CD O O
MG NNP B-NP O
PO NNP I-NP O
QD NNP I-NP O
ZANTAC NNP I-NP B-treatment
( ( O I-treatment
RANITIDINE NNP B-NP I-treatment
HCL NNP I-NP I-treatment
) ) O I-treatment
150 CD O O
MG NNP B-NP O
PO NNP I-NP O
BID NNP I-NP O
SERZONE NNP I-NP B-treatment
( ( O I-treatment
NEFAZODONE NNP B-NP I-treatment
) ) O I-treatment
300 CD O O
MG NNP B-NP O
PO NNP I-NP O
QHS NNP I-NP O
ZYPREXA NNP I-NP B-treatment
( ( O I-treatment
OLANZAPINE NNP B-NP I-treatment
) ) O I-treatment
5 CD O O
MG NNP B-NP O
PO NNP I-NP O
QHS NNP I-NP O
Number NNP I-NP O
of IN B-VP O
Doses NNP B-NP O
Required NNP I-NP O
( ( O O
approximate JJ O O
) ) O O
: : O O
4 CD O O
GLUCOPHAGE NNP B-NP B-treatment
( ( O I-treatment
METFORMIN NNP B-NP I-treatment
) ) O I-treatment
850 CD O O
MG NNP B-NP O
PO NNP I-NP O
TID NNP I-NP O
Starting VBG O O
ON NNP B-NP O
10/03/00 CD O O
( ( O O
10/03 CD O O
) ) O O
ACTOS $ O B-treatment
30 CD O O
MG NNP B-NP O
PO NNP I-NP O
QD NNP I-NP O
DIET NNP I-NP O
: : O O
House NNP B-NP O
/ VBZ O O
ADA NNP B-NP O
2100 CD O O
cals NNS B-NP O
/ VBP O O
dy JJ B-NP O
RETURN NNP I-NP O
TO NNP I-NP O
WORK NNP I-NP O
: : O O
Immediately RB O O
FOLLOW NNP B-NP O
UP NNP I-NP O
APPOINTMENT NNP I-NP O
( ( O O
S NNP B-NP O
) ) O O
: : O O
Dr. NNP B-NP B-person
Rotrysbreunkorc NNP I-NP I-person
1-2 JJ B-NP O
weeks NNS I-NP O
, , O O
ALLERGY NNP B-NP O
: : O O
Penicillins NNS B-NP B-treatment
ADMIT VBP O O
DIAGNOSIS NNP B-NP O
: : O O
atypical JJ B-NP B-problem
cp NN I-NP I-problem
PRINCIPAL NNP I-NP O
DISCHARGE NNP I-NP O
DIAGNOSIS NNP I-NP O
; : O O
Responsible NNP B-NP O
After IN B-VP O
Study NNP B-NP O
for IN B-VP O
Causing NNP B-NP O
Admission NNP I-NP O
) ) O O
atypical JJ B-NP B-problem
chest NN I-NP I-problem
pain NN I-NP I-problem
OTHER NNP I-NP O
DIAGNOSIS NNP I-NP O
; : O O
Conditions NNP B-NP O
, , O O
Infections NNP B-NP O
, , O O
Complications NNP B-NP O
, , O O
affecting VBG O O
Treatment NNP B-NP O
/ NNP I-NP O
Stay NNP I-NP O
dm NN I-NP B-problem
( ( O I-problem
diabetes VBZ O I-problem
mellitus NN B-NP I-problem
) ) O I-problem
anxiety NN B-NP B-problem
( ( O I-problem
anxiety NN B-NP I-problem
) ) O I-problem
htn NN B-NP B-problem
( ( O I-problem
hypertension NN B-NP I-problem
) ) O I-problem
gerd NN B-NP B-problem
( ( O I-problem
esophageal JJ B-NP I-problem
reflux NN I-NP I-problem
) ) O I-problem
OPERATIONS NNP B-NP O
AND CC O O
PROCEDURES NNP B-NP O
: : O O
OTHER NNP B-NP O
TREATMENTS NNP I-NP O
/ NNP I-NP O
PROCEDURES NNP I-NP O
( ( O O
NOT NNP B-NP O
IN NNP I-NP O
O.R. NNP I-NP O
) ) O O
BRIEF NNP B-NP O
RESUME NNP I-NP O
OF NNP I-NP O
HOSPITAL NNP I-NP O
COURSE NNP I-NP O
: : O O
41 CD O B-person
yo NN B-NP I-person
man NN I-NP I-person
with IN B-VP O
CRFs NNP B-NP B-problem
of IN B-VP O
DM NNP B-NP B-problem
Type NNP I-NP I-problem
II NNP I-NP I-problem
, , O O
high JJ B-NP B-problem
cholesterol NN I-NP I-problem
, , O O
smoking VBG O O
history NN B-NP O
, , O O
family NN B-NP O
hx NN I-NP O
, , O O
HTN NNP B-NP B-problem
p VBZ O O
/ NNP B-NP O
w NNP I-NP O
episodes NNS I-NP B-problem
of IN B-VP I-problem
atypical JJ B-NP I-problem
CP NNP I-NP I-problem
x NNP I-NP I-problem
1 CD O I-problem
week NN B-NP I-problem
, , O O
with IN B-VP O
rest NN B-NP O
and CC O O
exertion NN B-NP O
. . B-VP O
   
also RB O O
has VBZ O O
h VBN O O
/ NNP B-NP O
o JJ B-NP O
anxiety NN I-NP B-problem
and CC O O
GERD NNP B-NP B-problem
. . B-VP O
   
No NNP B-NP O
assoicated VBD B-VP B-problem
Sx NNP B-NP I-problem
. . B-VP O
   
Here RB O O
, , O O
had VBD B-VP O
T NNP B-NP B-problem
wave VBP O I-problem
flattening VBG O I-problem
laterally RB O I-problem
and CC O I-problem
inferiorly RB O I-problem
with IN B-VP O
pain NN B-NP B-problem
that WDT O B-pronoun
resolved VBD B-VP O
pain RB O B-problem
free JJ O O
, , O O
but CC O O
not RB O O
clear JJ O O
that IN B-VP B-pronoun
lead JJ B-NP B-test
placement NN I-NP I-test
is VBZ O O
the DT O O
same JJ O O
. . B-VP O
   
Had NNP B-NP O
Chest NNP I-NP B-test
CT NNP I-NP I-test
to TO O O
r VB O O
/ NNP B-NP O
o JJ B-NP O
dissection NN I-NP B-problem
( ( O O
due JJ O O
to TO O O
back VB O B-problem
pain NN B-NP I-problem
) ) O O
which WDT O B-pronoun
was VBD B-VP O
neg. RB O O
Ruled VBN O O
out RP O O
for IN B-VP O
MI NNP B-NP B-problem
. . B-VP O
   
Will NNP B-NP O
plan NN I-NP O
on IN B-VP O
ETT NNP B-NP B-test
. . B-VP O
   
Holding VBG O O
Metformin NNP B-NP B-treatment
until IN B-VP O
Friday NNP B-NP O
due JJ O O
to TO O O
CT NNP B-NP B-test
with IN B-VP I-test
contrast NN B-NP I-test
. . B-VP O
   
ADDITIONAL JJ B-NP O
COMMENTS NN I-NP O
: : O O
smoking NN B-NP B-person
cessation NN I-NP I-person
group NN I-NP I-person
will MD O O
contact VB O O
you PRP O B-person
at IN B-VP O
home NN B-NP O
DISCHARGE NNP I-NP O
CONDITION NNP I-NP O
: : O O
Stable JJ B-NP O
TO NNP I-NP O
DO NNP I-NP O
/ NNP I-NP O
PLAN NN I-NP O
: : O O
you PRP O B-person
will MD O O
be VB O O
contacted VBN O O
at IN B-VP O
home NN B-NP O
by IN B-VP O
the DT B-NP B-person
smoking NN I-NP I-person
cessation NN I-NP I-person
program NN I-NP I-person
No NNP I-NP O
dictated VBD B-VP O
summary JJ B-NP O
ENTERED NNP I-NP O
BY NNP I-NP O
: : O O
WIERST NNP B-NP B-person
, , O I-person
STO NNP B-NP I-person
L. NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
( ( O O
RR86 NNP B-NP O
) ) O O
10/01/00 CD O O
02:33 CD O O
PM NNP B-NP O
****** JJ B-NP O
END NNP I-NP O
OF NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
Admission NNP I-NP O
Date NNP I-NP O
: : O O
2013-09-05 JJ B-NP O
Discharge NN I-NP O
Date NNP I-NP O
: : O O
2013-09-12 JJ B-NP O
Date NNP I-NP O
of IN B-VP O
Birth NNP B-NP O
: : O O
1934-08-29 JJ B-NP O
Sex NN I-NP O
: : O O
M NNP B-NP O
Service NNP I-NP O
: : O O
MEDICINE JJ B-NP O
Allergies NNS I-NP O
: : O O
Patient NN B-NP B-person
recorded VBD B-VP O
as IN B-VP O
having VBG O O
No NNP B-NP O
Known NNP I-NP B-problem
Allergies NNPS I-NP I-problem
to TO O O
Drugs NNP B-NP B-treatment
Attending NNP I-NP B-person
: : O O
Mary NNP B-NP B-person
N NNP I-NP I-person
Major NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
Chief NNP I-NP O
Complaint NNP I-NP O
: : O O
change NN B-NP B-problem
in IN B-VP I-problem
mental JJ B-NP I-problem
status NN I-NP I-problem
Major NNP I-NP O
Surgical NNP I-NP O
or CC O O
Invasive JJ B-NP O
Procedure NN I-NP O
: : O O
None NN B-NP O
History NN I-NP O
of IN B-VP O
Present NNP B-NP O
Illness NNP I-NP O
: : O O
HPI NN B-NP O
: : O O
This DT O B-pronoun
is VBZ O O
a DT O O
79 CD O O
y/o NN B-NP O
M NNP I-NP O
with IN B-VP O
h/o NN B-NP O
of IN B-VP O
HTN NNP B-NP B-problem
, , O O
DM NNP B-NP B-problem
, , O O
recent JJ B-NP B-problem
CVA NNP I-NP I-problem
Theresa NNP I-NP O
, , O O
chronic JJ B-NP B-problem
respiratory NN I-NP I-problem
failure NN I-NP I-problem
on IN B-VP O
vent NN B-NP B-treatment
, , O O
trached VBN O B-treatment
, , O O
ESRD NNP B-NP B-problem
on IN B-VP O
HD NNP B-NP B-treatment
who WP O B-person
was VBD B-VP O
sent VBN O O
from IN B-VP O
rehab NN B-NP O
facility NN I-NP O
for IN B-VP O
worsening VBG O B-problem
mental JJ B-NP I-problem
status NN I-NP I-problem
. . B-VP O
   
Per NNP B-NP O
refferal JJ B-NP O
notes NNS I-NP O
, , O O
he PRP O B-person
went VBD B-VP O
to TO O O
hemodyalisis VB O B-treatment
today NN B-NP O
in IN B-VP O
the DT B-NP O
morning NN I-NP O
. . B-VP O
   
1 CD O O
L NNP B-NP O
was VBD B-VP O
removed VBN O O
. . B-VP O
   
At IN B-VP O
about IN B-VP O
2:30 CD O O
pm NN B-NP O
, , O O
he PRP O B-person
was VBD B-VP O
found VBN O O
to TO O O
have VB O O
worsening VBG O B-problem
mental JJ B-NP I-problem
status NN I-NP I-problem
. . B-VP O
   
In IN B-VP O
that DT B-NP B-pronoun
setting NN I-NP O
he PRP O B-person
was VBD B-VP O
hypotensive JJ O B-problem
down RB O O
to TO O O
the DT O O
92/45 CD O O
, , O O
and CC O O
was VBD B-VP O
given VBN O O
1 CD O B-treatment
L NNP B-NP I-treatment
NS NNP I-NP I-treatment
. . B-VP O
   
Fs NNP B-NP B-test
was VBD B-VP O
also RB O O
checked JJ O O
179 CD O O
. . B-VP O
   
At IN B-VP O
that DT B-NP B-pronoun
time NN I-NP O
, , O O
it PRP O B-pronoun
seems VBZ O O
that IN B-VP B-pronoun
he PRP O B-person
had VBD B-VP O
been VBN O O
on IN B-VP O
T NNP B-NP B-treatment
peace NN I-NP I-treatment
since IN B-VP O
4 CD O O
am VBP O O
today NN B-NP O
. . B-VP O
   
At IN B-VP O
2:30 CD O O
he PRP O B-person
was VBD B-VP O
also RB O O
found VBN O O
with IN B-VP O
sats NNS B-NP B-test
in IN B-VP O
the DT O O
90% CD O O
. . B-VP O
   
ABG NNP B-NP B-test
done VBN O O
7.1 CD O O
, , O O
89/72 CD O O
- : O O
he PRP O B-person
was VBD B-VP O
placed VBN O O
on IN B-VP O
AC NNP B-NP B-treatment
600 CD O O
/ NNP B-NP O
0.4 CD O O
and CC O O
6 CD O O
PEEP NNP B-NP B-treatment
- : O O
sats VBZ O B-test
up IN B-VP O
to TO O O
94% CD O O
. . B-VP O
   
Given VBN O O
persistent JJ B-NP B-problem
lethargy NN I-NP I-problem
, , O O
patient NN B-NP B-person
was VBD B-VP O
sent VBN O O
to TO O O
Falkener NNP B-NP O
Amanda NNP I-NP O
. . B-VP O
   
Of IN B-VP O
note NN B-NP O
, , O O
after IN B-VP O
interview NN B-NP O
with IN B-VP O
HCP NNP B-NP B-person
, , O O
at IN B-VP O
around IN B-VP O
07-23 NNP B-NP O
, , O O
patient NN B-NP B-person
started VBD B-VP O
having VBG O O
episodes NNS B-NP O
of IN B-VP O
dizziness NN B-NP B-problem
, , O O
and CC O O
had VBD B-VP O
unstable JJ B-NP B-problem
gait NN I-NP I-problem
. . B-VP O
   
he PRP O B-person
was VBD B-VP O
taken VBN O O
to TO O O
Williams NNP B-NP O
ICU NNP I-NP O
until IN B-VP O
08-09 JJ O O
when WRB O O
he PRP O B-person
was VBD B-VP O
discharged VBN O O
to TO O O
Waltham/Weston NNP B-NP O
Hospital NNP I-NP O
Rehab NNP I-NP O
. . B-VP O
   
he PRP O B-person
had VBD B-VP O
a DT B-NP B-treatment
peg NN I-NP I-treatment
tube NN I-NP I-treatment
and CC O O
tracheostomy NN B-NP B-treatment
prior RB O O
to TO O O
d/c VB O O
. . B-VP O
   
He PRP O B-person
had VBD B-VP O
been VBN O O
chronicallyl JJ B-NP B-problem
vent JJ I-NP I-problem
dependent NN I-NP I-problem
. . B-VP O
   
His PRP$ O B-person
His PRP$ O B-person
companion NN B-NP I-person
states NNS I-NP O
that IN B-VP B-pronoun
they PRP O B-pronoun
have VBP O O
been VBN O O
trying VBG O O
to TO O O
wean VB O O
him PRP O B-person
down RP O O
at IN B-VP O
rehab NN B-NP O
. . B-VP O
   
his PRP$ O B-person
basline NN B-NP O
mental NN I-NP O
staus NN I-NP O
apparently RB O O
responds VBZ O O
with IN B-VP O
his PRP$ O B-person
head NN B-NP O
shaking NN I-NP O
, , O O
and CC O O
also RB O O
try VB O O
to TO O O
write VB O O
sentences NNS B-NP O
. . B-VP O
   
In IN B-VP O
the DT B-NP O
Amanda NNP I-NP O
: : O O
VS NNP B-NP B-test
T NNP I-NP B-test
103 CD O O
rectal JJ B-NP O
BP90/44 NNP I-NP B-test
HR NNP I-NP B-test
: : O O
84 CD O O
RR NNP B-NP B-test
16 CD O O
Sats NNPS B-NP B-test
: : O O
98 CD O O
+ NN B-NP B-problem
guiac JJ B-NP I-problem
stool NN I-NP I-problem
. . B-VP O
   
He PRP O B-person
received VBD B-VP O
tylenol NN B-NP B-treatment
, , O O
levofloxacin VBZ O B-treatment
500 CD O O
mg NN B-NP O
IV NNP I-NP O
, , O O
Flagyl NNP B-NP B-treatment
500 CD O O
mg NN B-NP O
and CC O O
Vancomycin NNP B-NP B-treatment
and CC O O
I PRP O B-treatment
L NNP B-NP I-treatment
NS NNP I-NP I-treatment
. . B-VP O
   
ROS NN B-NP O
: : O O
difficult JJ O O
to TO O O
obtain VB O O
2x2 CD O O
to TO O O
patient VB O B-person
mental JJ B-NP O
status NN I-NP O
baselin NN I-NP O
Past NNP I-NP O
Medical NNP I-NP O
History NN I-NP O
: : O O
CVA NNP B-NP B-problem
Theresa NNP I-NP O
/ NNP I-NP O
2006 CD O O
HTN NNP B-NP B-problem
DM NNP I-NP B-problem
CRI NNP I-NP B-problem
on IN B-VP O
HD NNP B-NP B-treatment
since IN B-VP O
Theresa NNP B-NP O
( ( O O
Tu, NNP B-NP O
Thurs, NNP I-NP O
Sat NNP I-NP O
) ) O O
Neuropathy NNP B-NP B-problem
right JJ B-NP I-problem
leg NN I-NP I-problem
s/p NN I-NP O
cCY VBP O B-treatment
Social NNP B-NP O
History NNP I-NP O
: : O O
Uset NN B-NP O
to TO O O
be VB O O
truck NN B-NP O
driver NN I-NP O
. . B-VP O
   
Retired VBN O O
15 CD O O
years NNS B-NP O
ago RB O O
. . B-VP O
   
He PRP O B-person
has VBZ O O
1 CD O B-person
son NN B-NP I-person
, , O O
two CD O B-person
grandson NN B-NP I-person
. . B-VP O
   
smoking VBG O O
(-), JJ B-NP O
alcohol NN I-NP O
- : O O
Family RB O O
History NN B-NP O
: : O O
brother NN B-NP B-person
died VBD B-VP O
cerebral JJ B-NP B-problem
aneurysm NN I-NP I-problem
Brother NNP I-NP B-person
Sabina NNP I-NP B-problem
cancer NN I-NP I-problem
brother NN I-NP B-person
prostate NN I-NP B-problem
cancer NN I-NP I-problem
father NN I-NP B-person
Randall NNP I-NP O
Physical NNP I-NP O
Exam NNP I-NP O
: : O O
Physical JJ B-NP O
Exam NN I-NP O
: : O O
Vitals NNS B-NP B-test
: : O O
T NN B-NP B-test
: : O O
99 CD O O
P NN B-NP B-test
: : O O
84 CD O O
BP NNP B-NP B-test
: : O O
145/62 CD O O
AC NNP B-NP B-treatment
: : O O
600 CD O O
, , O O
x VBD B-VP O
12 CD O O
/ JJ O O
0.5 CD O O
/ JJ O O
5 CD O O
SaO2 NN B-NP B-test
: : O O
100% CD O O
General NNP B-NP O
: : O O
Awake NNP B-NP O
, , O O
alert NN B-NP O
, , O O
responding VBG O O
to TO O O
voice NN B-NP O
. . B-VP O
   
HEENT NN B-NP O
: : O O
PEERLA NNP B-NP O
, , O O
no DT B-NP O
JVD NNP I-NP B-problem
. . B-VP O
   
+ VB O O
tracheostomy JJ B-NP B-treatment
Pulmonary NNP I-NP O
: : O O
clear JJ O O
anteriorly RB O O
. . B-VP O
   
decrease VB O B-problem
breath JJ B-NP I-problem
sounds NNS I-NP I-problem
bases NNS I-NP I-problem
. . B-VP O
   
Cardiac NN B-NP O
: : O O
RRR NNP B-NP O
, , O O
nl RB O O
. . B-VP O
   
S1S2 NNP B-NP O
, , O O
soft JJ B-NP B-problem
holosytolic NN I-NP I-problem
murmur NN I-NP I-problem
apex JJ B-NP I-problem
Abdomen NNS I-NP O
: : O O
soft JJ O O
, , O O
NT/ND NNP B-NP B-problem
, , O O
normoactive JJ B-NP O
bowel NN I-NP O
sounds NNS I-NP O
, , O O
no DT B-NP O
masses NNS I-NP B-problem
or CC O O
organomegaly RB O B-problem
noted VBN O O
. . B-VP O
   
+ JJ B-NP O
g NN I-NP B-treatment
tube NN I-NP I-treatment
Extremities NNS I-NP O
: : O O
Left NNP B-NP B-treatment
arm NN I-NP I-treatment
AVF NNP I-NP I-treatment
1+ CD O B-problem
trace NN B-NP I-problem
edemalymphadenopathy NN I-NP I-problem
noted VBD B-VP O
. . B-VP O
   
Skin NNP B-NP O
: : O O
no DT B-NP O
rashes NNS I-NP B-problem
, , O O
small JJ B-NP B-problem
decubit NN I-NP I-problem
in IN B-VP I-problem
the DT B-NP I-problem
back NN I-NP I-problem
. . B-VP O
   
Neurologic NN B-NP O
: : O O
alert NN B-NP O
, , O O
awake NN B-NP O
, , O O
partially RB O O
interacting VBG O O
and CC O O
responding VBG O O
to TO O O
comands NNS B-NP O
. . B-VP O
   
decreased VBN O B-problem
reflexes NNS B-NP I-problem
Lower JJR B-NP I-problem
extremities NNS I-NP I-problem
. . B-VP O
   
bilaterally RB O O
. . B-VP O
   
spastic JJ B-NP O
right JJ I-NP O
upper JJ I-NP O
extremity NN I-NP O
. . B-VP O
   
Pertinent JJ B-NP O
Results NNS I-NP O
: : O O
141 CD O O
103 CD O O
53 CD O O
167 CD O O
AGap NNP B-NP B-test
= VBD B-VP O
14 CD O O
-------------> JJ O O
5.7 CD O O
30 CD O O
3.6 CD O O
CK NN B-NP B-test
: : O O
29 CD O O
MB NN B-NP B-test
: : O O
Notdone CD O O
Trop NNP B-NP B-test
-* NNP I-NP O
T NNP I-NP O
*: VBD B-VP O
0.44 CD O O
Comments NNS B-NP O
: : O O
Notified VBN O O
Glenn NNP B-NP B-person
Shives VBZ O I-person
2013-09-05 JJ O O
6:50 CD O O
p NN B-NP O
Ctropnt NNP I-NP B-test
> VBZ O O
0.10 CD O O
Ng NNP B-NP O
/ NNP I-NP O
Ml NNP I-NP O
Suggests NNP I-NP O
Acute NNP I-NP B-problem
Mi NNP I-NP I-problem
Ca NNP I-NP B-test
: : O O
8.6 CD O O
Mg NNP B-NP B-test
: : O O
2.4 CD O O
P NN B-NP B-test
: : O O
5.0 CD O O
Other JJ B-NP O
Blood NNP I-NP O
Chemistry NN I-NP O
: : O O
proBNP NN B-NP B-test
: : O O
11065 CD O O
WBC NNP B-NP B-test
15.2 CD O O
Plat NNP B-NP B-test
395 CD O O
HCT NNP B-NP B-test
: : O O
28.4 CD O O
N NNP B-NP B-test
: : O O
89.8 CD O O
Band NNP B-NP B-test
: : O O
0 CD O O
L NN B-NP B-test
: : O O
5.8 CD O O
M NNP B-NP B-test
: : O O
4.1 CD O O
E NN B-NP B-test
: : O O
0.3 CD O O
Bas NNP B-NP B-test
: : O O
0.1 CD O O
PT NN B-NP B-test
: : O O
12.1 CD O O
PTT NN B-NP B-test
: : O O
37.5 CD O O
INR NN B-NP B-test
: : O O
1.0 CD O O
2013-09-05 JJ O O
5:04 CD O O
p NN B-NP O
Green NNP I-NP O
Top NNP I-NP O
K NNP I-NP B-test
: : O O
5.5 CD O O
Lactate NN B-NP B-test
: : O O
1.3 CD O O
Brief NNP B-NP O
Hospital NNP I-NP O
Course NNP I-NP O
: : O O
Assessment NN B-NP O
and CC O O
Plan NN B-NP O
: : O O
This DT O B-pronoun
is VBZ O O
a DT O O
79 CD O O
y/o NN B-NP O
M NNP I-NP O
with IN B-VP O
h/o NN B-NP O
HTN NNP I-NP B-problem
, , O O
DM NNP B-NP B-problem
, , O O
recent JJ B-NP B-problem
CVA NNP I-NP I-problem
, , O O
chronic JJ B-NP B-problem
ventilatory NN I-NP I-problem
failure NN I-NP I-problem
, , O O
CRI NNP B-NP B-problem
on IN B-VP O
HD NNP B-NP B-treatment
who WP O B-person
presents VBZ O O
with IN B-VP O
change NN B-NP B-problem
in IN B-VP I-problem
MS NNP B-NP I-problem
and CC O O
febrile NN B-NP B-problem
in IN B-VP O
the DT B-NP O
Amanda NNP I-NP O
, , O O
admitted VBD B-VP O
to TO O O
CMED NNP B-NP O
. . B-VP O
   
# # O O
Altered NNP B-NP B-problem
mental JJ B-NP I-problem
status NN I-NP I-problem
: : O O
Ct JJ O B-test
scan JJ O I-test
with IN B-VP O
no DT B-NP O
evidence NN I-NP O
of IN B-VP O
new JJ B-NP B-problem
intracraneal JJ I-NP I-problem
bleeding NN I-NP I-problem
. . B-VP O
   
Patient NNP B-NP B-person
febrile NN I-NP B-problem
in IN B-VP O
the DT B-NP O
Amanda NNP I-NP O
. . B-VP O
   
High NNP B-NP B-problem
WBC NNP I-NP I-problem
. . B-VP O
   
It PRP O B-pronoun
was VBD B-VP O
thought VBN O O
that IN B-VP B-pronoun
it PRP O B-pronoun
could MD O O
have VB O O
been VBN O O
a DT B-NP O
combination NN I-NP O
of IN B-VP O
hypotension NN B-NP B-problem
, , O O
hypercapnia NN B-NP B-problem
and CC O O
infection NN B-NP B-problem
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
initially RB O O
started VBN O O
on IN B-VP O
broad JJ B-NP B-treatment
spectrum NN I-NP I-treatment
antibiotics NNS I-NP I-treatment
. . B-VP O
   
Despite IN B-VP O
having VBG O O
a DT B-NP B-problem
profund NN I-NP I-problem
limitation NN I-NP I-problem
communicating VBG O I-problem
given VBN O O
his PRP$ O B-person
his PRP$ O B-problem
neurological JJ B-NP I-problem
status NN I-NP I-problem
, , O O
his PRP$ O B-person
his PRP$ O B-problem
mental JJ B-NP I-problem
changes NNS I-NP I-problem
seemed VBD B-VP O
to TO O O
improved VBN O O
initially RB O O
. . B-VP O
   
However RB O O
later RB O O
on IN B-VP O
during IN B-VP O
his PRP$ O B-person
course NN B-NP O
, , O O
his PRP$ O B-person
mental JJ B-NP O
status NN I-NP O
deteriorated VBD B-VP O
, , O O
being VBG O O
even RB O O
less RBR O B-problem
responsive JJ O I-problem
. . B-VP O
   
# # O O
ID NNP B-NP O
: : O O
Patient NN B-NP B-person
febrile NN I-NP B-problem
and CC O O
with IN B-VP O
a DT B-NP B-problem
high JJ I-NP I-problem
WBC NNP I-NP I-problem
on IN B-VP O
admission NN B-NP O
. . B-VP O
   
After IN B-VP O
starting VBG O O
broad JJ B-NP B-treatment
spectrum NN I-NP I-treatment
antibiotics NNS I-NP I-treatment
- : O O
cefepime NN B-NP B-treatment
- : O O
vancomycin NN B-NP B-treatment
and CC O O
flagyl NN B-NP B-treatment
( ( O O
for IN B-VP O
initial JJ B-NP O
concern NN I-NP O
of IN B-VP O
aspiration NN B-NP B-problem
pneumonia NN I-NP I-problem
), IN B-VP O
he PRP O B-person
responded VBD B-VP O
clinically RB O O
. . B-VP O
   
Urine NNP B-NP B-test
cx NN I-NP I-test
from IN B-VP O
Rehab NNP B-NP O
showed VBD B-VP O
gram JJ B-NP B-problem
negative JJ I-NP I-problem
rods NNS I-NP I-problem
> VBP O B-problem
100 CD O I-problem
K NNP B-NP I-problem
enterobacter NN I-NP I-problem
cloacae NN I-NP I-problem
. . B-VP O
   
Urine NNP B-NP B-test
Cx NNP I-NP I-test
in IN B-VP O
house NN B-NP O
grew VBD B-VP O
Citrobacter NNP B-NP B-problem
Freundi NNP I-NP I-problem
and CC O O
his PRP$ O B-person
his PRP$ O B-test
sputum NN B-NP I-test
grew VBD B-VP O
Acinetobacter NNP B-NP B-problem
Baummani NNP I-NP I-problem
. . B-VP O
   
Since IN B-VP O
there EX O O
was VBD B-VP O
no DT B-NP O
more JJR I-NP O
evidence NN I-NP O
of IN B-VP O
gram NN B-NP B-problem
positive JJ B-NP I-problem
infections NNS I-NP I-problem
, , O O
vancomycin NN B-NP B-treatment
was VBD B-VP O
discontinued VBN O O
and CC O O
cefepime NN B-NP B-treatment
was VBD B-VP O
kept VBN O O
. . B-VP O
   
# # O O
Fevers NNS B-NP B-problem
: : O O
in IN B-VP O
the DT B-NP O
Amanda NNP I-NP O
, , O O
high JJ B-NP B-problem
WBC NNP I-NP I-problem
, , O O
possible JJ B-NP O
pneumonia NN I-NP B-problem
. . B-VP O
   
Also RB O O
possible JJ B-NP O
source NN I-NP O
sinus NN I-NP B-problem
infections NNS I-NP I-problem
given VBN O O
findings NNS B-NP O
on IN B-VP O
intial JJ B-NP B-test
CT NNP I-NP I-test
( ( O O
see VBP O O
summary JJ O O
in IN B-VP O
significant JJ B-NP O
studies NNS I-NP O
). IN B-VP O
He PRP O B-person
did VBD B-VP O
not RB O O
spike VB O O
any DT B-NP O
fevers NNS I-NP B-problem
after IN B-VP O
being VBG O O
transfer NN B-NP O
to TO O O
the DT B-NP O
CMED NNP I-NP O
from IN B-VP O
the DT B-NP O
Amanda NNP I-NP O
. . B-VP O
   
# # O O
Resp NNP B-NP O
: : O O
Patient NN B-NP B-person
was VBD B-VP O
intermitentely RB O O
switched VBN O O
from IN B-VP O
AC NNP B-NP B-treatment
to TO O O
Pressure VB O B-treatment
support NN B-NP I-treatment
trials NNS I-NP I-treatment
. . B-VP O
   
However RB O O
, , O O
after IN B-VP O
Patient NNP B-NP B-person
did VBD B-VP O
well RB O O
. . B-VP O
   
Then RB O O
trach VBZ O B-treatment
mask NN B-NP I-treatment
trials NNS I-NP I-treatment
were VBD B-VP O
done VBN O O
. . B-VP O
   
He PRP O B-person
tolerated VBD B-VP O
this DT B-NP B-pronoun
well NN I-NP O
, , O O
although IN B-VP O
he PRP O B-person
required VBD B-VP O
PS NNP B-NP B-treatment
overnight MD O O
. . B-VP O
   
# # O O
ESRD NNP B-NP B-problem
on IN B-VP O
hemodyalisis NN B-NP B-treatment
: : O O
Renal JJ B-NP B-person
service NN I-NP I-person
was VBD B-VP O
consulted VBN O O
and CC O O
HD NNP B-NP B-treatment
was VBD B-VP O
continued VBN O O
. . B-VP O
   
# # O O
CV NNP B-NP O
: : O O
Rhythm NN B-NP B-test
: : O O
NSR NNP B-NP O
, , O O
not RB O O
tachycardic JJ O B-problem
. . B-VP O
   
Pump NN B-NP B-test
: : O O
With IN B-VP O
trace NN B-NP O
of IN B-VP O
lower JJR B-NP B-problem
extremity NN I-NP I-problem
edema NN I-NP I-problem
. . B-VP O
   
X CC O B-test
ray NN B-NP I-test
suggested VBD B-VP O
some DT B-NP B-problem
pulmonary JJ I-NP I-problem
edema NN I-NP I-problem
on IN B-VP O
admission NN B-NP O
. . B-VP O
   
Despite IN B-VP O
this DT B-NP B-pronoun
findings NNS I-NP O
, , O O
he PRP O B-person
was VBD B-VP O
supported VBN O O
with IN B-VP O
40% CD O B-treatment
FIO2 NNP B-NP I-treatment
most JJS O O
of IN B-VP O
the DT B-NP O
time NN I-NP O
. . B-VP O
   
CAD NN B-NP B-problem
: : O O
On IN B-VP O
admission NN B-NP O
Ck NNP I-NP B-test
low JJ O O
normal JJ O O
, , O O
MB NNP B-NP B-test
not RB O O
done VBN O O
. . B-VP O
   
Troponin $ O B-test
0.44. CD O O
It PRP O B-pronoun
was VBD B-VP O
more RBR O O
likely JJ O O
due JJ O O
to TO O O
CRI NNP B-NP B-problem
. . B-VP O
   
Second NNP B-NP O
set VBD B-VP O
12 CD O O
hours NNS B-NP O
apart RB O O
, , O O
showed VBD B-VP O
no DT B-NP O
changes NNS I-NP B-problem
. . B-VP O
   
s/p JJ B-NP O
stroke NN I-NP B-problem
: : O O
continue NN B-NP O
aspirin NN I-NP B-treatment
, , O O
statin NN B-NP B-treatment
, , O O
plavix JJ O B-treatment
# # O O
Hypotension NN B-NP B-problem
: : O O
per IN B-VP O
referral JJ B-NP O
form NN I-NP O
. . B-VP O
   
Intially NNP B-NP O
concern NN I-NP O
for IN B-VP O
sepsis NN B-NP B-problem
in IN B-VP O
the DT B-NP O
setting NN I-NP O
of IN B-VP O
fevers NNS B-NP B-problem
and CC O O
high JJ B-NP B-problem
blood NN I-NP I-problem
count NN I-NP I-problem
. . B-VP O
   
His PRP$ O B-person
His PRP$ O B-treatment
BP NNP B-NP I-treatment
medications NNS I-NP I-treatment
were VBD B-VP O
held VBN O O
on IN B-VP O
admission NN B-NP O
. . B-VP O
   
Patient NN B-NP B-person
did VBD B-VP O
not RB O O
require VB O O
pressors NNS B-NP B-treatment
. . B-VP O
   
His PRP$ O B-person
His PRP$ O B-test
blood NN B-NP I-test
pressure NN I-NP I-test
remained VBD B-VP O
stable JJ O O
and CC O O
BP NNP B-NP B-treatment
meds NNS I-NP I-treatment
were VBD B-VP O
restarted VBN O O
. . B-VP O
   
# # O O
FEN NNP B-NP O
: : O O
Tube NN B-NP B-treatment
feedings NNS I-NP I-treatment
were VBD B-VP O
started VBN O O
thorugh IN B-VP O
peg NN B-NP B-treatment
tube NN I-NP I-treatment
. . B-VP O
   
On IN B-VP O
2013-09-08 JJ O O
, , O O
patient NN B-NP B-person
pulled VBD B-VP O
out RP O O
peg JJ B-NP B-treatment
tube NN I-NP I-treatment
. . B-VP O
   
Temporary JJ B-NP B-treatment
foley NN I-NP I-treatment
was VBD B-VP O
placed VBN O O
and CC O O
on IN B-VP O
2013-09-11 JJ O O
, , O O
On IN B-VP O
2013-09-12 JJ O O
after IN B-VP O
deterioration NN B-NP B-problem
of IN B-VP I-problem
his PRP$ O B-person
his PRP$ O I-problem
mental NN B-NP I-problem
status NN I-NP I-problem
and CC O I-problem
also RB O I-problem
of IN B-VP I-problem
his PRP$ O B-person
his PRP$ O I-problem
blood NN B-NP I-problem
pressure NN I-NP I-problem
, , O O
goals NNS B-NP O
of IN B-VP O
care NN B-NP O
were VBD B-VP O
discussed VBN O O
with IN B-VP O
his PRP$ O B-person
his PRP$ O B-person
HCP NNP B-NP I-person
. . B-VP O
   
It PRP O B-pronoun
was VBD B-VP O
decided VBN O O
to TO O O
direct JJ B-NP O
goals NNS I-NP O
of IN B-VP O
care NN B-NP O
towards NNS I-NP O
confort NN I-NP B-treatment
care NN I-NP I-treatment
. . B-VP O
   
Patient NNP B-NP B-person
passed VBD B-VP O
away RB O O
accompanied VBN O O
by IN B-VP O
his PRP$ O B-person
his PRP$ O B-person
significant JJ O I-person
other JJ O I-person
. . B-VP O
   
Medications NNS B-NP O
on IN B-VP O
Admission NN B-NP O
: : O O
Novolin NNP B-NP B-treatment
16 CD O O
U NNP B-NP O
q VBD B-VP O
12h CD O O
Aranesp NNP B-NP B-treatment
40 CD O O
mcg NN B-NP O
sc NN I-NP O
Prozac NNP I-NP B-treatment
liquid VBD B-VP I-treatment
20 CD O O
mg NN B-NP O
q NN I-NP O
am VBP O O
Heparin NNP B-NP B-treatment
3000 CD O O
U NNP B-NP O
tu NN I-NP O
, , O O
thursday JJ B-NP O
saturday JJ I-NP O
Norvasc NNP I-NP B-treatment
10 CD O O
mg JJ B-NP O
daily JJ I-NP O
GT NNP I-NP O
Tylenol NNP I-NP B-treatment
PRN NNP I-NP O
Reglan NNP I-NP B-treatment
5 CD O O
mg NN B-NP O
q NN I-NP O
6h CD O O
, , O O
fergon VBD B-VP B-treatment
300 CD O O
mg NNS B-NP O
BID NNP I-NP O
Plavix NNP I-NP B-treatment
75 CD O O
mg NN B-NP O
GT NNP I-NP O
nephrocaps VBZ O B-treatment
1 CD O O
daily JJ O O
novolin RB O B-treatment
Sliding VBG O I-treatment
scale JJ B-NP I-treatment
heparin NN I-NP B-treatment
sc NN I-NP O
5000 CD O O
q NN B-NP O
8h CD O O
Protonix NNP B-NP B-treatment
40 CD O O
mg JJ B-NP O
daily JJ I-NP O
GT NNP I-NP O
Combivent NNP I-NP B-treatment
2 CD O O
puff NN B-NP O
qid NN I-NP O
inh NN I-NP O
zocor NN I-NP B-treatment
10 CD O O
mg NN B-NP O
Tab NNP I-NP O
/ NNP I-NP O
day NN I-NP O
GT NNP I-NP O
aspirin VBZ O B-treatment
325 CD O O
mg NN B-NP O
tab NN I-NP O
Ferrlecit NNP I-NP B-treatment
Sodium NNP I-NP I-treatment
ferric JJ B-NP I-treatment
gluconate NN I-NP I-treatment
Mo-We NNP I-NP O
Fr NNP I-NP O
IV NNP I-NP O
Discharge NNP I-NP O
Medications NNP I-NP O
: : O O
n/a JJ B-NP O
Discharge NNP I-NP O
Disposition NNP I-NP O
: : O O
Extended VBN O O
Care NNP B-NP O
Discharge NNP I-NP O
Diagnosis NNP I-NP O
: : O O
1. CD O O
Change NNP B-NP B-problem
in IN B-VP I-problem
Mental NNP B-NP I-problem
status NN I-NP I-problem
2. CD O O
Urinary NNP B-NP B-problem
tract NN I-NP I-problem
Infection NNP I-NP I-problem
3. CD O O
Chronic NNP B-NP B-problem
respiratory NN I-NP I-problem
failure NN I-NP I-problem
Secondary NNP I-NP O
: : O O
1. CD O O
Hypertension NNP B-NP B-problem
2. CD O O
Diabetes NNP B-NP B-problem
Mellitus NNP I-NP I-problem
3. CD O O
End NNP B-NP B-problem
stage NN I-NP I-problem
renal JJ B-NP I-problem
disease NN I-NP I-problem
on IN B-VP O
HD NNP B-NP B-treatment
Discharge NNP I-NP O
Condition NNP I-NP O
: : O O
expired VBD B-VP O
Discharge NNP B-NP O
Instructions NNS I-NP O
: : O O
n/a NN B-NP O
Followup NNP I-NP O
Instructions NNP I-NP O
: : O O
n/a NN B-NP O
Z. NNP I-NP B-person
Mcbride NNP I-NP I-person
WEISS NNP I-NP I-person
MD NNP I-NP I-person
51-615 JJ O O
Completed VBN O O
by IN B-VP O
: : O O
Martha NNP B-NP B-person
Fairley NNP I-NP I-person
MD NNP I-NP I-person
53-063 JJ O O
2013-11-12 CD O O
@ JJ O O
2057 CD O O
Signed VBN O O
electronically RB O O
by IN B-VP O
: : O O
DR. NNP B-NP B-person
V NNP I-NP I-person
Osterman NNP I-NP I-person
WEISS NNP I-NP I-person
on IN B-VP O
: : O O
WED JJ O O
2013-11-13 JJ O O
8:40 CD O O
AM NNP B-NP O
( ( O O
End NNP B-NP O
of IN B-VP O
Report NNP B-NP O
) ) O O
-EMPTYLINE- VBP O O
-DOCSTART- JJ O O
-EMPTYLINE- $ O O
843566350 CD O O
RWH NNP B-NP O
0025596 CD O O
526208 CD O O
0555812 CD O O
1/12/2005 CD O O
12:00:00 CD O O
AM NNP B-NP O
ED NNP I-NP O
Discharge NNP I-NP O
Summary NNP I-NP O
Unsigned VBD B-VP O
DIS NNP B-NP O
Report NNP I-NP O
Status NNP I-NP O
: : O O
Unsigned VBD B-VP O
ED NNP B-NP O
DISCHARGE NNP I-NP O
NOTIFICATION NNP I-NP O
/ NNP I-NP O
SUMMARY NNP I-NP O
KOTEA NNP I-NP B-person
, , O I-person
TORTHEOA NNP B-NP I-person
MRN NNP I-NP O
: : O O
0025596 CD O O
Age NNP B-NP O
: : O O
47y CD O O
REGISTRATION NNP B-NP O
DATE NNP I-NP O
: : O O
01/12/2005 CD O O
06:07 CD O O
AM JJ B-NP O
Provider NN I-NP B-person
: : O O
THAA NN B-NP B-person
WAGES NNP I-NP I-person
PRELMINARY NNP I-NP O
REPORT NNP I-NP O
Benefits NNP I-NP O
Assigned NNP I-NP O
: : O O
N NNP B-NP O
Discharge NNP I-NP O
Note NNP I-NP O
Date NNP I-NP O
/ JJ B-NP O
Time NNP I-NP O
: : O O
01/12/2005 CD O O
09:17 CD O O
Discharge NN B-NP O
Status NNP I-NP O
: : O O
Discharged VBN O O
Condition NNP B-NP O
on IN B-VP O
Discharge NNP B-NP O
: : O O
Stable JJ B-NP O
Patient NNP I-NP B-person
States NNPS I-NP O
Complaint NNP I-NP O
: : O O
MIGRAINES NNP B-NP B-problem
FOR NNP I-NP O
10 CD O O
DAYS NNP B-NP O
Standardized NNP I-NP O
Discharge NNP I-NP O
Instructions NNS I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
given VBN O O
printed JJ B-NP O
instructions NNS I-NP O
for IN B-VP O
headache NN B-NP B-problem
( ( O O
English NNP B-NP O
) ) O O
. . B-VP O
   
Diagnosis NN B-NP O
: : O O
Headache NNP B-NP B-problem
Treatment NNP I-NP O
Rendered NNP I-NP O
: : O O
MD NNP B-NP B-treatment
evaluation NN I-NP I-treatment
, , O O
head NN B-NP B-test
CT NNP I-NP I-test
Discharge NNP I-NP O
Medications NNS I-NP O
: : O O
None NN B-NP O
Follow NNP I-NP O
up RP O O
Service NNP B-NP O
: : O O
Please NNP B-NP O
follow VB O O
up RP O O
with IN B-VP O
Dr. NNP B-NP B-person
Ner NNP I-NP I-person
PCP NNP I-NP B-person
Name NN I-NP O
: : O O
ANERM NNP B-NP B-person
, , O I-person
CHRETTA NNP B-NP I-person
Provider NNP I-NP B-person
Number NNP I-NP O
: : O O
25911 CD O O
This DT B-NP B-pronoun
report NN I-NP O
was VBD B-VP O
created VBN O O
by IN B-VP O
WAGES NNP B-NP B-person
, , O I-person
THAA NNP B-NP I-person
01/12/2005 CD O O
09:18 CD O O
AM NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- VBD B-VP O
145980160 CD O O
FIH NNP B-NP O
6382196 CD O O
94916/ly7e CD O O
289653 CD O O
06/30/1993 CD O O
12:00:00 CD O O
AM NNP B-NP O
PROSTATE NNP I-NP B-problem
CANCER NNP I-NP I-problem
. . B-VP O
   
Unsigned VBD B-VP O
DIS NNP B-NP O
Report NNP I-NP O
Status NNP I-NP O
: : O O
Unsigned VBN O O
ADMISSION NNP B-NP O
DATE NNP I-NP O
: : O O
06-30-93 JJ B-NP O
DISCHARGE NNP I-NP O
DATE NNP I-NP O
: : O O
07-06-93 JJ B-NP O
PRINCIPAL NNP I-NP O
DIAGNOSIS NNP I-NP O
: : O O
Prostate NN B-NP B-problem
cancer NN I-NP I-problem
. . B-VP O
   
SPECIAL NNP B-NP O
PROCEDURES NNP I-NP O
AND NNP I-NP O
OPERATIONS NNP I-NP O
: : O O
Radical JJ B-NP B-treatment
retropubic NN I-NP I-treatment
prostatectomy NN I-NP I-treatment
, , O O
bilateral JJ B-NP B-treatment
lymph NN I-NP I-treatment
node DT B-NP I-treatment
dissection NN I-NP I-treatment
. . B-VP O
   
HISTORY NNP B-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
is VBZ O O
a DT O O
67 CD O O
year NN B-NP O
old JJ B-NP O
white JJ I-NP O
male NN I-NP O
with IN B-VP O
a DT B-NP O
recent JJ I-NP O
history NN I-NP O
of IN B-VP O
urinary JJ B-NP B-problem
frequency NN I-NP I-problem
Q2-3H NNP I-NP O
, , O O
stranguria NN B-NP B-problem
, , O O
nocturia JJ O B-problem
x JJ O O
3-4 JJ O O
per IN B-VP O
night NN B-NP O
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
found VBN O O
on IN B-VP O
physical JJ B-NP B-test
exam NN I-NP I-test
to TO O O
have VB O O
an DT B-NP B-problem
asymmetric JJ I-NP I-problem
prostate NN I-NP I-problem
with IN B-VP O
prominence NN B-NP B-problem
on IN B-VP I-problem
the DT B-NP I-problem
left NN I-NP I-problem
and CC O O
a DT B-NP O
question NN I-NP O
of IN B-VP O
a DT B-NP B-problem
nodule NN I-NP I-problem
. . B-VP O
   
Repeat NNP B-NP B-test
exam JJ O I-test
one CD O O
month NN B-NP O
later RB O O
showed VBD B-VP O
a DT B-NP B-problem
firm JJ I-NP I-problem
left-sided JJ I-NP I-problem
lobe NN I-NP I-problem
. . B-VP O
   
Transrectal NNP B-NP B-test
ultrasound NN I-NP I-test
showed VBD B-VP O
a DT B-NP B-problem
hypoechoic JJ I-NP I-problem
left-sided JJ I-NP I-problem
mass NN I-NP I-problem
in IN B-VP I-problem
the DT B-NP I-problem
peripheral JJ I-NP I-problem
zone NN I-NP I-problem
. . B-VP O
   
A DT B-NP B-test
biopsy NN I-NP I-test
showed VBD B-VP O
moderately RB O B-problem
to TO O I-problem
poorly RB O I-problem
differentiated VBN O I-problem
Grade NNP B-NP I-problem
III-IV NNP I-NP I-problem
adenocarcinoma NN I-NP I-problem
on IN B-VP I-problem
the DT B-NP I-problem
left NN I-NP I-problem
. . B-VP O
   
The DT B-NP O
right JJ I-NP O
lobe NN I-NP O
was VBD B-VP O
within IN B-VP O
normal JJ B-NP O
limits NNS I-NP O
. . B-VP O
   
This DT O B-pronoun
was VBD B-VP O
done VBN O O
on IN B-VP O
05/05/93 CD O O
at IN B-VP O
FIH NNP B-NP O
. . B-VP O
   
He PRP O B-person
also RB O O
had VBD B-VP O
a DT B-NP O
3-4 JJ I-NP O
year NN I-NP O
history NN I-NP O
of IN B-VP O
impotence NN B-NP B-problem
. . B-VP O
   
PAST NNP B-NP O
MEDICAL NNP I-NP O
HISTORY NNP I-NP O
: : O O
Significant NN B-NP O
for IN B-VP O
non-insulin JJ B-NP B-problem
diabetes NNS I-NP I-problem
mellitus NNS I-NP I-problem
, , O O
for IN B-VP O
which WDT O B-pronoun
he PRP O B-person
takes VBZ O O
Diabeta NNP B-NP B-treatment
, , O O
one CD O O
QD NNP B-NP O
; : O O
right JJ B-NP B-problem
eye NN I-NP I-problem
cataract NN I-NP I-problem
, , O O
operated VBN O O
on IN B-VP O
three CD O O
years NNS B-NP O
ago RB O O
. . B-VP O
   
ALLERGIES NN B-NP O
: : O O
He PRP O B-person
is VBZ O O
allergic JJ O B-problem
to TO O O
Motrin NNP B-NP B-treatment
. . B-VP O
   
MEDICATIONS NNP B-NP O
ON NNP I-NP O
ADMISSION NNP I-NP O
: : O O
Diabeta NNP B-NP B-treatment
, , O O
one CD O O
QD NNP B-NP O
. . B-VP O
   
SOCIAL NNP B-NP O
HISTORY NNP I-NP O
: : O O
No DT O O
smoking VBG O O
history NN B-NP O
. . B-VP O
   
PHYSICAL JJ B-NP O
EXAMINATION NN I-NP O
: : O O
He PRP O B-person
was VBD B-VP O
a DT B-NP O
well NN I-NP O
developed NN I-NP O
, , O O
well RB O O
nourished JJ B-NP O
white JJ I-NP O
male NN I-NP O
. . B-VP O
   
HEENT NN B-NP O
: : O O
within IN B-VP O
normal JJ B-NP O
limits NNS I-NP O
. . B-VP O
   
His PRP$ O B-person
neck NN B-NP O
was VBD B-VP O
supple JJ O O
with IN B-VP O
no DT B-NP O
jugular JJ I-NP B-problem
venous JJ I-NP I-problem
distention NN I-NP I-problem
or CC O O
thyromegaly NN B-NP B-problem
. . B-VP O
   
Chest NNP B-NP O
was VBD B-VP O
clear JJ O O
to TO O O
percussion NN B-NP B-test
and CC O O
auscultation NN B-NP B-test
. . B-VP O
   
Heart NN B-NP O
: : O O
regular JJ B-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
with IN B-VP O
normal JJ B-NP O
S1 NNP I-NP O
and CC O O
S2 NNP B-NP O
, , O O
no DT B-NP O
murmurs NN I-NP B-problem
. . B-VP I-problem
   
The DT B-NP O
abdomen NNS I-NP O
was VBD B-VP O
soft JJ O O
and CC O O
non-tender JJ O B-problem
with IN B-VP O
no DT B-NP O
masses NNS I-NP B-problem
or CC O O
organomegaly NN B-NP B-problem
. . B-VP O
   
No DT B-NP O
costovertebral JJ I-NP B-problem
angle NN I-NP I-problem
tenderness NN I-NP I-problem
. . B-VP O
   
His PRP$ O B-test
His PRP$ O B-person
genitourinary JJ B-NP I-test
exam NN I-NP I-test
showed VBD B-VP O
an DT B-NP O
uncircumcised JJ I-NP O
male NN I-NP O
with IN B-VP O
normal JJ B-NP O
scrotal JJ I-NP O
contents NNS I-NP O
. . B-VP O
   
Rectal JJ O O
: : O O
There EX O O
was VBD B-VP O
a DT B-NP B-problem
firm JJ I-NP I-problem
nodule NN I-NP I-problem
in IN B-VP O
the DT B-NP O
left JJ I-NP O
lobe NN I-NP O
of IN B-VP O
the DT B-NP O
prostate NN I-NP O
in IN B-VP O
the DT B-NP O
lateral JJ I-NP O
aspect NN I-NP O
. . B-VP O
   
Extremities NNS B-NP O
: : O O
No DT B-NP O
clubbing NN I-NP B-problem
, , O I-problem
cyanosis NN B-NP B-problem
or CC O O
edema NN B-NP B-problem
. . B-VP O
   
Pulses VBZ O B-test
2+ CD O O
. . B-VP O
   
Neurological JJ O O
: : O O
Nonfocal JJ O O
. . B-VP O
   
LABORATORY NNP B-NP O
DATA NNP I-NP O
: : O O
Sodium NN B-NP B-test
141 CD O O
, , O O
potassium NN B-NP B-test
4.1 CD O O
, , O O
chloride RB O B-test
104 CD O O
, , O O
bicarbonate NN B-NP B-test
28.8 CD O O
, , O O
BUN NNP B-NP B-test
17 CD O O
, , O O
creatinine NN B-NP B-test
0.9 CD O O
, , O O
glucose VBD B-VP B-test
118 CD O O
. . B-VP O
   
His PRP$ O B-test
His PRP$ O B-person
white JJ B-NP I-test
blood NN I-NP I-test
count NN I-NP I-test
was VBD B-VP O
7100 CD O O
, , O O
hematocrit VBD B-VP B-test
35.9 CD O O
, , O O
platelet NN B-NP B-test
count NN I-NP I-test
258,000 CD O O
. . B-VP O
   
PT VB O B-test
9.4/10.3 CD O O
, , O O
PTT NNP B-NP B-test
27 CD O O
. . B-VP O
   
His PRP$ O B-test
His PRP$ O B-person
urinalysis NN B-NP I-test
showed VBD B-VP O
marked JJ B-NP B-problem
occult NN I-NP I-problem
blood NN I-NP I-problem
and CC O O
positive JJ B-NP B-problem
white JJ I-NP I-problem
blood NN I-NP I-problem
cell NN I-NP I-problem
screen NN I-NP I-problem
but CC O O
was VBD B-VP O
otherwise RB O O
negative JJ O O
. . B-VP O
   
His PRP$ O B-person
His PRP$ O B-test
chest JJS B-NP I-test
X-ray NN I-NP I-test
was VBD B-VP O
normal JJ O O
. . B-VP O
   
EKG NN B-NP B-test
: : O O
normal JJ B-NP O
sinus NN I-NP O
rhythm NN I-NP O
at IN B-VP O
73 CD O O
beats NNS B-NP O
per IN B-VP O
minute NN B-NP O
. . B-VP O
   
HOSPITAL NNP B-NP O
COURSE NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
brought VBN O O
to TO O O
the DT B-NP O
operating NN I-NP O
room NN I-NP O
on IN B-VP O
06/30/93 CD O O
after IN B-VP O
informed JJ B-NP O
consent NN I-NP O
was VBD B-VP O
obtained VBN O O
. . B-VP O
   
A DT B-NP B-treatment
radical JJ I-NP I-treatment
retropubic NN I-NP I-treatment
prostatectomy NN I-NP I-treatment
with IN B-VP O
bilateral JJ B-NP B-treatment
lymph NN I-NP I-treatment
node JJ B-NP I-treatment
dissection NN I-NP I-treatment
was VBD B-VP O
done VBN O O
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
afebrile JJ O B-problem
postoperatively RB O O
with IN B-VP O
vital JJ B-NP B-test
signs NNS I-NP I-test
stable JJ O O
. . B-VP O
   
His PRP$ O B-test
His PRP$ O B-person
potassium NN B-NP I-test
was VBD B-VP O
3.7 CD O O
and CC O O
his PRP$ O B-test
his PRP$ O B-person
hematocrit NN B-NP I-test
33 CD O O
. . B-VP O
   
His PRP$ O B-person
postoperative JJ B-NP O
course NN I-NP O
was VBD B-VP O
remarkable JJ O O
for IN B-VP O
a DT B-NP B-problem
low JJ I-NP I-problem
grade NN I-NP I-problem
temperature NN I-NP I-problem
to TO O O
101.7 CD O O
. . B-VP O
   
His PRP$ O B-person
His PRP$ O B-test
blood NN B-NP I-test
cultures NNS I-NP I-test
and CC O O
chest JJS O B-test
X-ray JJ O I-test
were VBD B-VP O
negative JJ O O
. . B-VP O
   
He PRP O B-person
had VBD B-VP O
flatus VBN O O
on IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
# # O O
3 CD O O
. . B-VP O
   
His PRP$ O B-person
His PRP$ O B-treatment
Jackson-Pratt NNP B-NP I-treatment
drained VBD B-VP O
about IN B-VP O
35-40 JJ B-NP O
cc NNS I-NP O
per IN B-VP O
day NN B-NP O
and CC O O
was VBD B-VP O
discontinued VBN O O
on IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
# # O O
3 CD O O
. . B-VP O
   
His PRP$ O B-test
His PRP$ O B-person
hematocrit NN B-NP I-test
on IN B-VP O
07/03 CD O O
was VBD B-VP O
28.1 CD O O
. . B-VP O
   
On IN B-VP O
that DT B-NP B-pronoun
day NN I-NP O
he PRP O B-person
was VBD B-VP O
slightly RB O B-problem
diaphoretic JJ O I-problem
with IN B-VP O
some DT B-NP B-problem
tachycardia NN I-NP I-problem
to TO O O
100 CD O O
. . B-VP O
   
The DT O O
remaining VBG O O
unit NN B-NP O
of IN B-VP O
autologous JJ B-NP B-treatment
packed NNS I-NP I-treatment
red JJ B-NP I-treatment
blood NN I-NP I-treatment
cells NNS I-NP I-treatment
was VBD B-VP O
transfused VBN O O
. . B-VP O
   
A DT B-NP O
cardiology NN I-NP B-person
consult NN I-NP O
was VBD B-VP O
obtained VBN O O
for IN B-VP O
this DT B-NP B-pronoun
episode NN I-NP O
of IN B-VP O
diaphoresis NN B-NP B-problem
with IN B-VP O
tachycardia NN B-NP B-problem
, , O O
as RB O O
well RB O O
as IN B-VP O
for IN B-VP O
an DT B-NP B-test
EKG NNP I-NP I-test
being VBG O O
read VBN O O
as IN B-VP O
having VBG O O
anterolateral JJ B-NP B-problem
changes NNS I-NP I-problem
. . B-VP O
   
He PRP O B-person
had VBD B-VP O
no DT B-NP O
symptoms NNS I-NP B-problem
of IN B-VP O
chest JJS B-NP B-problem
pain NN I-NP I-problem
or CC O O
myocardial JJ B-NP B-problem
ischemia NN I-NP I-problem
. . B-VP O
   
A DT B-NP B-test
repeat NN I-NP I-test
EKG NNP I-NP I-test
showed VBD B-VP O
no DT B-NP O
changes NNS I-NP B-problem
. . B-VP O
   
He PRP O B-person
subsequently RB O O
did VBD B-VP O
well RB O O
, , O O
with IN B-VP O
a DT B-NP B-test
repeat NN I-NP I-test
hematocrit NN I-NP I-test
of IN B-VP O
34.3 CD O O
after IN B-VP O
the DT B-NP B-treatment
transfusion NN I-NP I-treatment
. . B-VP O
   
His PRP$ O B-person
His PRP$ O B-test
creatinine NN B-NP I-test
was VBD B-VP O
1.2 CD O O
on IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
# # O O
5 CD O O
. . B-VP O
   
On IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
# # O O
6 CD O O
his PRP$ O B-person
his PRP$ O B-problem
low JJ B-NP I-problem
grade NN I-NP I-problem
temperature NN I-NP I-problem
resolved VBN O O
. . B-VP O
   
His PRP$ O B-person
His PRP$ O B-test
vital JJ B-NP I-test
signs NNS I-NP I-test
were VBD B-VP O
stable JJ O O
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
discharged VBN O O
home NN B-NP O
on IN B-VP O
Percocet NNP B-NP B-treatment
and CC O O
Keflex NNP B-NP B-treatment
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
discharged VBN O O
in IN B-VP O
good JJ B-NP O
condition NN I-NP O
. . B-VP O
   
He PRP O B-person
will MD O O
follow VB O O
up RP O O
with IN B-VP O
Dr. NNP B-NP B-person
Iechalette NNP I-NP I-person
Cancer NNP I-NP I-person
in IN B-VP O
his PRP$ O B-person
office NN B-NP O
. . B-VP O
   
SIE NNP B-NP B-person
ROOM NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
DICTATING NNP I-NP O
FOR NNP I-NP O
: : O O
IECHALETTE NNP B-NP B-person
ROOM NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
TR NNP I-NP O
: : O O
btt NN B-NP O
/ NNP I-NP O
bmot NN I-NP O
DD NNP I-NP O
: : O O
07-07-93 JJ B-NP O
TD NN I-NP O
: : O O
07/08/93 CD O O
CC NN B-NP O
: : O O
Dr. NNP B-NP B-person
Na NNP I-NP I-person
Dussmum NNP I-NP I-person
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- VBD B-VP O
420033129 CD O O
YC NNP B-NP O
87142319 CD O O
129591 CD O O
12/12/1996 CD O O
12:00:00 CD O O
AM NNP B-NP O
Discharge NNP I-NP O
Summary NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date NNP I-NP O
: : O O
12/12/1996 CD O O
Report NNP B-NP O
Status NNP I-NP O
: : O O
Signed VBN O O
Discharge NNP B-NP O
Date NNP I-NP O
: : O O
12/16/1996 CD O O
PRINCIPAL NNP B-NP O
DIAGNOSIS NNP I-NP O
: : O O
STATUS NNP B-NP O
POST NNP I-NP O
TOTAL NNP I-NP B-treatment
ABDOMINAL NNP I-NP I-treatment
HYSTERECTOMY NNP I-NP I-treatment
AND NNP I-NP O
BILATERAL NNP I-NP B-treatment
SALPINGO-OOPHORECTOMY NNP I-NP I-treatment
. . B-VP O
   
ASSOCIATED NNP B-NP O
DIAGNOSIS NNP I-NP O
: : O O
1) CD O O
MENORRHAGIA NNP B-NP B-problem
. . B-VP O
   
2) CD O O
PELVIC NNP B-NP B-problem
PAIN NNP I-NP I-problem
. . B-VP O
   
3) CD O O
ENDOMETRIOSIS NNP B-NP B-problem
. . B-VP O
   
PRINCIPAL NNP B-NP O
PROCEDURE NNP I-NP O
: : O O
TAH-BSO JJ O B-treatment
. . B-VP O
   
HISTORY NNP B-NP O
/ NNP I-NP O
REASON NNP I-NP O
FOR NNP I-NP O
HOSPITALIZATION NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
is VBZ O O
a DT O O
42 CD O O
year NN B-NP O
old JJ B-NP O
gravida NN I-NP O
II NNP I-NP O
, , O O
para NN B-NP O
I PRP O O
female VBP O O
with IN B-VP O
a DT B-NP O
long JJ I-NP O
history NN I-NP O
of IN B-VP O
menorrhagia NN B-NP B-problem
and CC O O
pelvic JJ B-NP B-problem
pain NN I-NP I-problem
. . B-VP O
   
She PRP O B-person
also RB O O
has VBZ O O
a DT B-NP O
history NN I-NP O
of IN B-VP O
endometriosis NN B-NP B-problem
that WDT O B-pronoun
is VBZ O O
symptomatic JJ O B-problem
. . B-VP O
   
She PRP O B-person
used VBD B-VP O
Danocrine NNP B-NP B-treatment
for IN B-VP O
approximately RB O O
nine CD O O
months NNS B-NP O
and CC O O
was VBD B-VP O
pain RB O B-problem
free JJ O O
, , O O
but CC O O
was VBD B-VP O
unable JJ O O
to TO O O
tolerate VB O O
the DT B-NP B-problem
side NN I-NP I-problem
effects NNS I-NP I-problem
. . B-VP O
   
She PRP O B-person
is VBZ O O
status NN B-NP O
post NN I-NP O
several JJ B-NP B-test
laparoscopies NNS I-NP I-test
in IN B-VP O
the DT B-NP O
past NN I-NP O
with IN B-VP O
which WDT O B-pronoun
she PRP O B-person
was VBD B-VP O
diagnosed VBN O O
with IN B-VP O
endometriosis NN B-NP B-problem
. . B-VP O
   
She PRP O B-person
has VBZ O O
recently RB O O
been VBN O O
on IN B-VP O
Depo-Provera NNP B-NP B-treatment
and CC O O
has VBZ O O
had VBN O O
episodes NNS B-NP O
of IN B-VP O
break-through JJ B-NP B-problem
bleeding NN I-NP I-problem
for IN B-VP O
six CD O O
weeks NNS B-NP O
at IN B-VP O
a DT B-NP O
time NN I-NP O
. . B-VP O
   
She PRP O B-person
desired VBD B-VP O
surgical JJ B-NP B-treatment
therapy NN I-NP I-treatment
. . B-VP O
   
HOSPITAL NNP B-NP O
COURSE NNP I-NP O
: : O O
On IN B-VP O
12/12/96 CD O O
she PRP O B-person
had VBD B-VP O
an DT B-NP B-treatment
uncomplicated JJ I-NP I-treatment
total JJ I-NP I-treatment
abdominal JJ I-NP I-treatment
hysterectomy NN I-NP I-treatment
and CC O O
bilateral JJ B-NP B-treatment
salpingo-oophorectomy NN I-NP I-treatment
. . B-VP O
   
Estimated VBN O B-problem
blood NN B-NP I-problem
loss NN I-NP I-problem
was VBD B-VP O
100 CD O O
cc NN B-NP O
and CC O O
she PRP O B-person
tolerated VBD B-VP O
the DT B-NP B-treatment
procedure NN I-NP I-treatment
well RB O O
. . B-VP O
   
On IN B-VP O
postop JJ B-NP O
day NN I-NP O
number NN I-NP O
one CD O O
she PRP O B-person
was VBD B-VP O
afebrile RB O B-problem
and CC O O
doing VBG O O
well RB O O
with IN B-VP O
a DT B-NP B-treatment
PCA NNP I-NP I-treatment
for IN B-VP O
pain NN B-NP B-treatment
control NN I-NP I-treatment
. . B-VP O
   
On IN B-VP O
postop JJ B-NP O
day NN I-NP O
number NN I-NP O
two CD O O
she PRP O B-person
was VBD B-VP O
also RB O O
afebrile JJ O B-problem
and CC O O
had VBD B-VP O
not RB O O
passed VBN O O
any DT B-NP B-problem
flatus NN I-NP I-problem
yet RB O O
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
ambulating VBG O O
frequently RB O O
. . B-VP O
   
Her PRP$ O B-test
Her PRP$ O B-person
hematocrit NN B-NP I-test
was VBD B-VP O
34.2 CD O O
and CC O O
stable JJ O O
from IN B-VP O
her PRP$ O B-person
preoperative JJ B-NP O
value NN I-NP O
. . B-VP O
   
On IN B-VP O
postop JJ B-NP O
day NN I-NP O
number NN I-NP O
three CD O O
her PRP$ O B-person
abdomen NNS B-NP O
was VBD B-VP O
noted VBN O O
to TO O O
be VB O O
distended VBN O B-problem
with IN B-VP O
a DT B-NP B-test
few JJ I-NP I-test
bowel NN I-NP I-test
sounds NNS I-NP I-test
and CC O O
she PRP O B-person
still RB O O
had VBD B-VP O
not RB O O
passed VBN O O
gas NN B-NP B-problem
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
decreased VBD B-VP O
the DT B-NP O
amount NN I-NP O
of IN B-VP O
Demerol NNP B-NP B-treatment
she PRP O B-person
was VBD B-VP O
using VBG O O
and CC O O
supplemented VBN O O
with IN B-VP O
Tylenol NNP B-NP B-treatment
and CC O O
continued VBD B-VP O
her PRP$ O B-person
frequent JJ B-NP O
ambulation NN I-NP O
. . B-VP O
   
On IN B-VP O
postop JJ B-NP O
day NN I-NP O
number NN I-NP O
four CD O O
she PRP O B-person
had VBD B-VP O
passed VBN O O
flatus NN B-NP B-problem
and CC O O
was VBD B-VP O
feeling VBG O O
much JJ O O
better RBR O O
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
discharged VBN O O
to TO O O
home NN B-NP O
in IN B-VP O
good JJ B-NP O
condition NN I-NP O
on IN B-VP O
the DT B-NP B-treatment
following JJ I-NP I-treatment
medications NNS I-NP I-treatment
. . B-VP O
   
DISCHARGE NNP B-NP O
MEDICATIONS NNP I-NP O
: : O O
Demerol NN B-NP B-treatment
for IN B-VP O
pain NN B-NP B-problem
. . B-VP O
   
Motrin NNP B-NP B-treatment
for IN B-VP O
pain NN B-NP B-problem
. . B-VP O
   
Colace NNP B-NP B-treatment
stool NN I-NP I-treatment
softener NN I-NP I-treatment
. . B-VP O
   
DISPOSITION NN B-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
should MD O O
follow-up VB O O
with IN B-VP O
Dr. NNP B-NP B-person
Side NNP I-NP I-person
in IN B-VP O
two CD O O
weeks NNS B-NP O
. . B-VP O
   
Dictated VBN O O
By IN B-VP O
: : O O
IEDEARC NNP B-NP B-person
SIDE NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
LB28 NNP I-NP O
Attending NNP I-NP B-person
: : O O
MITERY NNP B-NP B-person
D. NNP I-NP I-person
LOSS NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
CB51 NNP I-NP O
II795/2112 NNP I-NP O
Batch NNP I-NP O
: : O O
42100 CD O O
Index NNP B-NP O
No. NN I-NP O
ZMFX3O4G1 NNP I-NP O
D NNP I-NP O
: : O O
01/04/97 CD O O
T NN B-NP O
: : O O
01/06/97 CD O O
CC NN B-NP O
: : O O
1. CD O O
MITERY NNP B-NP B-person
D. NNP I-NP I-person
LOSS NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
NT11 NNP I-NP O
[ NNP I-NP O
report NN I-NP O
_ NNP I-NP O
end NN I-NP O
] NN I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- VBD B-VP O
156406283 CD O O
HLGMC NNP B-NP O
7213645 CD O O
64723/51cy CD O O
5/28/1993 CD O O
12:00:00 CD O O
AM NNP B-NP O
Discharge NNP I-NP O
Summary NNP I-NP O
Unsigned VBD B-VP O
DIS NNP B-NP O
Report NNP I-NP O
Status NNP I-NP O
: : O O
Unsigned VBN O O
ADMISSION NNP B-NP O
DATE NNP I-NP O
: : O O
5-28-93 JJ B-NP O
DISCHARGE NNP I-NP O
DATE NNP I-NP O
: : O O
6-4-93 JJ B-NP O
HISTORY NNP I-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
is VBZ O O
a DT O O
58 CD O O
year NN B-NP O
old JJ B-NP O
right JJ I-NP O
hand NN I-NP O
dominant JJ B-NP O
white JJ I-NP O
male NN I-NP O
with IN B-VP O
a DT B-NP O
long JJ I-NP O
history NN I-NP O
of IN B-VP O
hypertension NN B-NP B-problem
, , O O
changed VBD B-VP O
his PRP$ O B-person
his PRP$ O B-treatment
medications NNS B-NP I-treatment
from IN B-VP O
Aldomet NNP B-NP B-treatment
to TO O O
Clonidine NNP B-NP B-treatment
six CD O O
weeks NNS B-NP O
ago RB O O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
has VBZ O O
a DT B-NP O
history NN I-NP O
of IN B-VP O
adult NN B-NP B-problem
onset VBN O I-problem
diabetes NNS B-NP I-problem
mellitus RBR O I-problem
, , O O
ankylosing VBG O B-problem
spondylitis NN B-NP I-problem
, , O O
status NN B-NP O
post NN I-NP O
myocardial JJ B-NP B-problem
infarction NN I-NP I-problem
in IN B-VP O
&apos;96 NNP B-NP O
( ( O O
? . B-VP O
) ) O O
now RB O O
with IN B-VP O
acute JJ B-NP O
onset NN I-NP O
of IN B-VP O
left JJ B-NP B-problem
face NN I-NP I-problem
and CC O I-problem
arm NN B-NP I-problem
greater JJR O I-problem
than IN B-VP I-problem
leg JJR B-NP I-problem
hemiplegia NN I-NP I-problem
and CC O O
primary JJ B-NP B-problem
hemisensory JJ I-NP I-problem
loss NN I-NP I-problem
on IN B-VP I-problem
the DT B-NP I-problem
left NN I-NP I-problem
. . B-VP O
   
Briefly NNP B-NP O
, , O O
he PRP O B-person
was VBD B-VP O
talking VBG O O
to TO O O
a DT B-NP B-person
friend NN I-NP I-person
at IN B-VP O
5:30 CD O O
p.m. NN B-NP O
the DT B-NP O
day NN I-NP O
prior RB O O
to TO O O
admission NN B-NP O
, , O O
when WRB O O
he PRP O B-person
had VBD B-VP O
to TO O O
grab VB O O
his PRP$ O B-person
locker NN B-NP O
and CC O O
sit VB O O
down RP O O
. . B-VP O
   
His PRP$ O B-person
voice NN B-NP O
became VBD B-VP O
slurred JJ O B-problem
and CC O O
he PRP O B-person
had VBD B-VP O
a DT B-NP B-problem
mild JJ I-NP I-problem
central JJ I-NP I-problem
dull NN I-NP I-problem
headache NN I-NP I-problem
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
unable JJ O O
to TO O O
move VB O O
the DT B-NP O
left JJ I-NP O
side NN I-NP O
of IN B-VP O
his PRP$ O B-person
body NN B-NP O
and CC O O
felt VBD B-VP O
numb NNS B-NP B-problem
on IN B-VP I-problem
that DT O B-pronoun
that DT B-NP I-problem
side NN I-NP I-problem
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
taken VBN O O
to TO O O
Wayskemedcalltown NNP B-NP O
Talmi NNP I-NP O
and CC O O
transferred VBN O O
to TO O O
Heaonboburg NNP B-NP O
Linpack NNP I-NP O
Grant NNP I-NP O
Medical NNP I-NP O
Center NNP I-NP O
with IN B-VP O
a DT B-NP B-test
computerized JJ I-NP I-test
tomography NN I-NP I-test
scan JJ O I-test
showing VBG O O
a DT O B-problem
1x2 CD O I-problem
thalamic JJ B-NP I-problem
capsular JJ I-NP I-problem
hemorrhage NN I-NP I-problem
without IN B-VP O
superficial JJ B-NP B-problem
mass NN I-NP I-problem
effect NN I-NP I-problem
. . B-VP O
   
His PRP$ O B-person
His PRP$ O B-test
blood NN B-NP I-test
pressure NN I-NP I-test
was VBD B-VP O
220/110 CD O O
there RB O O
. . B-VP O
   
He PRP O B-person
denies VBZ O O
any DT B-NP O
visual JJ I-NP B-problem
symptoms NNS I-NP I-problem
or CC O O
cortical-type NN B-NP B-problem
symptoms NNS I-NP I-problem
. . B-VP O
   
He PRP O B-person
is VBZ O O
a DT B-NP O
heavy JJ I-NP O
smoker NN I-NP O
and CC O O
drinks VBZ O O
2-3 JJ B-NP O
shots NNS I-NP O
per IN B-VP O
day NN B-NP O
at IN B-VP O
times NNS B-NP O
. . B-VP O
   
MEDICATIONS NNP B-NP O
ON NNP I-NP O
ADMISSION NNP I-NP O
: : O O
Vasotec JJ O B-treatment
40 CD O O
mg NN B-NP O
q.day NN I-NP O
, , O O
Soma NNP B-NP B-treatment
1 CD O O
tablet NN B-NP O
q.day NN I-NP O
, , O O
Demerolprn NNP B-NP B-treatment
, , O O
Clonidine NNP B-NP B-treatment
. . B-VP O
   
ALLERGIES NN B-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
has VBZ O O
no DT O O
known VBN O B-problem
drug NN B-NP I-problem
allergies NNS I-NP I-problem
. . B-VP O
   
PAST NNP B-NP O
MEDICAL NNP I-NP O
HISTORY NNP I-NP O
: : O O
As IN B-VP O
described VBN O O
above IN B-VP O
. . B-VP O
   
FAMILY NNP B-NP O
HISTORY NNP I-NP O
: : O O
The DT B-NP O
family NN I-NP O
history NN I-NP O
is VBZ O O
positive JJ O O
for IN B-VP O
diabetes NNS B-NP B-problem
mellitus NNS I-NP I-problem
, , O O
positive JJ O O
for IN B-VP O
cancer NN B-NP B-problem
. . B-VP O
   
SOCIAL NNP B-NP O
HISTORY NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
lives VBZ O O
with IN B-VP O
two CD O B-person
people NNS B-NP I-person
in IN B-VP O
Cinglendda NNP B-NP O
. . B-VP O
   
PHYSICAL NNP B-NP O
EXAMINATION NN I-NP O
: : O O
On IN B-VP B-test
physical JJ B-NP I-test
examination NN I-NP I-test
, , O O
patient NN B-NP B-person
is VBZ O O
in IN B-VP O
no DT B-NP O
acute NN I-NP B-problem
distress NN I-NP I-problem
, , O O
afebrile RB O B-problem
, , O O
blood NN B-NP B-test
pressure NN I-NP I-test
134/80 CD O O
, , O O
heart NN B-NP B-test
rate NN I-NP I-test
80 CD O O
and CC O O
regular JJ O O
, , O O
no DT B-NP O
bruits NNS I-NP B-problem
. . B-VP O
   
Cardiovascular JJ B-NP B-test
exam NN I-NP I-test
: : O O
regular JJ B-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
with IN B-VP O
a DT B-NP B-problem
I/VI NNP I-NP I-problem
systolic JJ B-NP I-problem
ejection NN I-NP I-problem
murmur NN I-NP I-problem
. . B-VP O
   
His PRP$ O B-person
lungs NNS B-NP O
were VBD B-VP O
clear JJ O O
to TO O O
auscultation NN B-NP B-test
and CC O O
percussion NN B-NP B-test
. . B-VP O
   
The DT B-NP O
abdomen NNS I-NP O
was VBD B-VP O
soft JJ O O
and CC O O
non-tender JJ O B-problem
, , O O
obese JJ O B-problem
, , O O
with IN B-VP O
normal JJ B-NP O
bowel NN I-NP O
sounds NNS I-NP O
. . B-VP O
   
Back NNP B-NP O
and CC O O
neck NN B-NP O
were VBD B-VP O
stiff JJ O B-problem
and CC O O
sore NN B-NP B-problem
, , O O
without IN B-VP O
localizing VBG O B-problem
tenderness NN B-NP I-problem
. . B-VP O
   
On IN B-VP O
neurological JJ B-NP B-test
examination NN I-NP I-test
, , O O
mental JJ B-NP O
status NN I-NP O
alert NN I-NP O
and CC O O
oriented VBD B-VP O
x NNP B-NP O
three CD O O
, , O O
good JJ B-NP O
memory NN I-NP O
, , O O
fluent JJ B-NP O
speech NN I-NP O
, , O O
good JJ B-NP O
repetition NN I-NP O
and CC O O
naming NN B-NP O
. . B-VP O
   
Able JJ O O
to TO O O
describe VB O O
two CD O O
routes NNS B-NP O
from IN B-VP O
house NN B-NP O
to TO O O
the DT B-NP O
CMH NNP I-NP O
. . B-VP O
   
The DT B-NP O
cranial JJ I-NP O
nerves NNS I-NP O
showed VBD B-VP O
full JJ B-NP O
visual JJ I-NP O
fields NNS I-NP O
without IN B-VP O
extinction NN B-NP B-problem
, , O O
pupils VBZ O O
5 CD O O
to TO O O
3 CD O O
bilaterally RB O O
and CC O O
equal JJ O O
, , O O
disks NNS B-NP O
flat JJ O O
, , O O
lower JJR O B-problem
left VBD B-VP I-problem
facial JJ B-NP I-problem
decreased JJ I-NP I-problem
sensation NN I-NP I-problem
to TO O I-problem
temperature NN B-NP I-problem
, , O O
pin NN B-NP B-test
prick NN I-NP I-test
on IN B-VP O
the DT B-NP O
left NN I-NP O
V1 NNP I-NP O
through IN B-VP O
V3 NNP B-NP O
, , O O
tongue NN B-NP B-problem
deviates NNS I-NP I-problem
to TO O I-problem
the DT B-NP I-problem
left NN I-NP I-problem
, , O O
good JJ B-NP O
gag NN I-NP O
, , O O
decreased VBN O B-problem
shrug NN B-NP I-problem
on IN B-VP I-problem
the DT B-NP I-problem
left NN I-NP I-problem
. . B-VP O
   
Motor NNP B-NP B-test
examination NN I-NP I-test
showed VBD B-VP O
full JJ B-NP O
power NN I-NP O
on IN B-VP O
the DT B-NP O
right JJ I-NP O
arm NN I-NP O
and CC O O
leg NN B-NP O
, , O O
could MD O O
barely RB O O
flex JJ B-NP O
fingers NNS I-NP O
of IN B-VP O
the DT B-NP O
left JJ I-NP O
hand NN I-NP O
, , O O
pulls NNS B-NP O
left VBD B-VP O
arm NN B-NP O
medially RB O O
only RB O O
. . B-VP O
   
Left NNP B-NP O
leg NN I-NP O
could MD O O
flex VB O O
2/5 CD O O
and CC O O
wiggle NN B-NP O
toes NNS I-NP O
. . B-VP O
   
On IN B-VP O
sensory JJ B-NP B-test
examination NN I-NP I-test
, , O O
had VBD B-VP O
decreased VBN O B-problem
pin NN B-NP I-problem
prick NN I-NP I-problem
, , O I-problem
temperature NN B-NP I-problem
, , O I-problem
vibration NN B-NP I-problem
in IN B-VP O
the DT B-NP O
left JJ I-NP O
side NN I-NP O
of IN B-VP O
the DT B-NP O
body NN I-NP O
. . B-VP O
   
The DT O B-test
finger-to-nose JJ O I-test
was VBD B-VP O
okay VBN O O
on IN B-VP O
the DT B-NP O
right NN I-NP O
. . B-VP O
   
On IN B-VP O
reflex JJ B-NP B-test
examination NN I-NP I-test
, , O O
2 CD O O
on IN B-VP O
the DT B-NP O
right JJ I-NP O
upper JJ I-NP O
extremity NN I-NP O
, , O O
2+ CD O O
on IN B-VP O
the DT B-NP O
left JJ I-NP O
upper JJ I-NP O
extremity NN I-NP O
, , O O
2 CD O O
on IN B-VP O
the DT B-NP O
right JJ I-NP O
knee NN I-NP O
, , O O
0 CD O O
on IN B-VP O
the DT B-NP O
right JJ I-NP O
ankle NN I-NP O
, , O O
with IN B-VP O
down RP O O
going VBG O O
toe NN B-NP O
on IN B-VP O
the DT B-NP O
right NN I-NP O
. . B-VP O
   
Three CD O O
on IN B-VP O
the DT B-NP O
left NN I-NP O
knee NN I-NP O
, , O O
4 CD O O
on IN B-VP O
the DT B-NP O
left NN I-NP O
ankle NN I-NP O
with IN B-VP O
upgoing JJ B-NP B-problem
toe NN I-NP I-problem
and CC O O
clonus NN B-NP B-problem
on IN B-VP O
the DT B-NP O
left NN I-NP O
. . B-VP O
   
LABORATORY NNP B-NP O
DATA NNP I-NP O
: : O O
Electrolytes NNS B-NP B-test
were VBD B-VP O
within IN B-VP O
normal JJ B-NP O
limits NNS I-NP O
, , O O
glucose JJ O B-test
192 CD O O
, , O O
BUN NNP B-NP B-test
and CC O O
creatinine VB O B-test
9/0.7 CD O O
, , O O
hematocrit NN B-NP B-test
49.5 CD O O
, , O O
white JJ B-NP B-test
blood NN I-NP I-test
count NN I-NP I-test
7.9 CD O O
, , O O
platelet NN B-NP B-test
count NN I-NP I-test
166,000 CD O O
, , O O
65% CD O O
polys NN B-NP B-test
, , O O
3 CD O O
bands NNS B-NP B-test
, , O O
24% CD O O
lymphs NN B-NP B-test
. . B-VP O
   
The DT B-NP B-test
electrocardiogram NN I-NP I-test
showed VBD B-VP O
normal JJ B-NP O
sinus NNS I-NP O
rhythm VBP O O
with IN B-VP O
old JJ B-NP B-problem
Q NNP I-NP I-problem
wave NN I-NP I-problem
inferior JJ B-NP I-problem
myocardial JJ I-NP I-problem
infarction NN I-NP I-problem
. . B-VP O
   
Head NNP B-NP B-test
computerized VBD B-VP I-test
tomography NN B-NP I-test
scan NN I-NP I-test
showed VBD B-VP O
1.5 CD O B-problem
to TO O I-problem
2 CD O I-problem
centimeter NN B-NP I-problem
bleed NN I-NP I-problem
in IN B-VP I-problem
the DT B-NP I-problem
right JJ I-NP I-problem
thalamus NN I-NP I-problem
extending VBG O O
to TO O O
the DT B-NP O
internal JJ I-NP O
capsule NN I-NP O
with IN B-VP O
mild JJ B-NP B-problem
distortion NN I-NP I-problem
only RB O O
, , O O
no DT B-NP O
shift NN I-NP B-problem
. . B-VP O
   
The DT B-NP B-test
chest JJS I-NP I-test
X-ray NN I-NP I-test
was VBD B-VP O
clear JJ O O
. . B-VP O
   
HOSPITAL NNP B-NP O
COURSE NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
admitted VBN O O
to TO O O
the DT B-NP O
floor NN I-NP O
for IN B-VP O
observation NN B-NP O
. . B-VP O
   
The DT B-NP B-test
neurological JJ I-NP I-test
examination NN I-NP I-test
on IN B-VP O
discharge NN B-NP O
was VBD B-VP O
no DT B-NP O
movement NN I-NP B-problem
in IN B-VP I-problem
the DT B-NP I-problem
hand NN I-NP I-problem
on IN B-VP O
the DT B-NP O
left NN I-NP O
or CC O O
arm NN B-NP O
. . B-VP O
   
Slight NNP B-NP O
abductive JJ O O
and CC O O
adductive JJ B-NP O
movement NN I-NP O
on IN B-VP O
the DT O O
left VBN O O
only RB O O
in IN B-VP O
the DT B-NP O
upper JJ I-NP O
extremity NN I-NP O
. . B-VP O
   
On IN B-VP O
the DT B-NP O
lower JJR I-NP O
extremity NN I-NP O
, , O O
could MD O O
wiggle VB O B-test
toes NNS B-NP I-test
, , O O
flexor NN B-NP B-test
and CC O O
plantar NN B-NP B-test
, , O O
3+/5 CD O O
, , O O
quadriceps VBZ O O
4/5 CD O O
on IN B-VP O
the DT B-NP O
left NN I-NP O
. . B-VP O
   
2. CD O O
hypertension NN B-NP B-problem
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
managed VBN O O
with IN B-VP O
Vasotec NNP B-NP B-treatment
, , O O
Nifedipine NNP B-NP B-treatment
and CC O O
Clonidine NNP B-NP B-treatment
with IN B-VP O
blood NN B-NP B-test
pressure NN I-NP I-test
under IN B-VP O
good JJ B-NP O
control NN I-NP O
at IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
discharge NN B-NP O
, , O O
average JJ O O
125 CD O O
systolic JJ O B-test
, , O O
70 CD O O
diastolic NN B-NP B-test
, , O O
heart NN B-NP B-test
rate NN I-NP I-test
of IN B-VP O
72 CD O O
. . B-VP O
   
Also RB O O
managed VBN O O
with IN B-VP O
Valium NNP B-NP B-treatment
5 CD O O
mg NN B-NP O
PO NNP I-NP O
t.i.d. NN I-NP O
Muscle NNP I-NP B-problem
spasms NNS I-NP I-problem
were VBD B-VP O
managed VBN O O
with IN B-VP O
Flexeril NNP B-NP B-treatment
10 CD O O
PO NNP B-NP O
t.i.d. VBD B-VP O
3. CD O O
diabetes NNS B-NP B-problem
mellitus RB O I-problem
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
started VBN O O
on IN B-VP O
2.5 CD O O
of IN B-VP O
Micronase NNP B-NP B-treatment
with IN B-VP O
resulting VBG O B-test
sugars NNS B-NP I-test
as RB O O
low JJ O O
as IN B-VP O
63 CD O O
, , O O
decreased VBD B-VP O
to TO O O
1.25 CD O O
mg NNS B-NP O
q.day RB O O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
is VBZ O O
discharged VBN O O
in IN B-VP O
fair JJ B-NP O
condition NN I-NP O
with IN B-VP O
medical JJ B-NP O
approval NN I-NP O
to TO O O
the DT B-NP O
Pasi NNP I-NP O
. . B-VP O
   
MEDICATIONS NNP B-NP O
ON NNP I-NP O
DISCHARGE NNP I-NP O
: : O O
Vasotec JJ O B-treatment
20 CD O O
mg NN B-NP O
PO NNP I-NP O
b.i.d. NN I-NP O
, , O O
Clonidine NNP B-NP B-treatment
0.2 CD O O
mg NN B-NP O
PO NNP I-NP O
b.i.d. NN I-NP O
, , O O
Nifedipine NNP B-NP B-treatment
20 CD O O
mg NN B-NP O
PO NNP I-NP O
t.i.d. NN I-NP O
, , O O
Flexeril NNP B-NP B-treatment
10 CD O O
mg NN B-NP O
PO NNP I-NP O
t.i.d. NN I-NP O
, , O O
Valium NNP B-NP B-treatment
5 CD O O
mg NN B-NP O
PO NNP I-NP O
t.i.d. NN I-NP O
, , O O
Micronase NNP B-NP B-treatment
1.25 CD O O
mg NN B-NP O
q.day NN I-NP O
. . B-VP O
   
ADVERSE JJ B-NP O
DRUG NNP I-NP O
REACTIONS NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
found VBN O O
to TO O O
be VB O O
allergic JJ O B-problem
to TO O O
Percocet NNP B-NP B-treatment
and CC O O
Percodan NNP B-NP B-treatment
during IN B-VP O
his PRP$ O B-person
hospital JJ B-NP O
course NN I-NP O
. . B-VP O
   
DISCHARGE JJ B-NP O
DIAGNOSIS NNP I-NP O
: : O O
Right JJ B-NP B-problem
thalamic JJ I-NP I-problem
hemorrhage NN I-NP I-problem
, , O O
hypertension NN B-NP B-problem
, , O O
diabetes VBZ O B-problem
mellitus NN B-NP I-problem
. . B-VP O
   
ROBTHER NNP B-NP B-person
TIMES NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
DICTATING NNP I-NP O
FOR NNP I-NP O
: : O O
SHAA NNP B-NP B-person
LEFT NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
TR NNP I-NP O
: : O O
nj JJ B-NP O
/ NNP I-NP O
bmot NN I-NP O
DD NNP I-NP O
: : O O
6-4-93 JJ B-NP O
TD NN I-NP O
: : O O
06/04/93 CD O O
CC NN B-NP O
: : O O
Dr. NNP B-NP B-person
Namarce NNP I-NP I-person
Aldridge NNP I-NP I-person
Pasi NNP I-NP I-person
STAT NNP I-NP I-person
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
Admission NNP I-NP O
Date NNP I-NP O
: : O O
2009-06-23 JJ B-NP O
Discharge NN I-NP O
Date NNP I-NP O
: : O O
2009-07-12 JJ B-NP O
Date NNP I-NP O
of IN B-VP O
Birth NNP B-NP O
: : O O
1926-02-07 JJ B-NP O
Sex NN I-NP O
: : O O
M NNP B-NP O
Service NNP I-NP O
: : O O
CMI NNP B-NP O
; : O O
then RB O O
to TO O O
Medcine NNP B-NP O
; : O O
then RB O O
transferred VBD B-VP O
to TO O O
CCU NNP B-NP O
CHIEF NNP I-NP O
COMPLAINT NNP I-NP O
: : O O
Renal JJ B-NP B-problem
failure NN I-NP I-problem
. . B-VP O
   
HISTORY NN B-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
is VBZ O O
an DT B-NP O
83-year-old JJ I-NP O
male NN I-NP O
with IN B-VP O
a DT B-NP O
history NN I-NP O
of IN B-VP O
diabetes NNS B-NP B-problem
mellitus NNS I-NP I-problem
, , O O
steroid-treated JJ B-NP B-problem
polymyalgia NN I-NP I-problem
rheumatica NN I-NP I-problem
, , O O
hypertension NN B-NP B-problem
, , O O
benign JJ B-NP B-problem
prostatic JJ I-NP I-problem
hypertrophy NN I-NP I-problem
, , O O
and CC O O
high JJ B-NP B-problem
cholesterol NN I-NP I-problem
who WP O B-person
presented VBD B-VP O
for IN B-VP O
a DT B-NP B-test
lower JJR I-NP I-test
extremity NN I-NP I-test
peripheral JJ B-NP I-test
angiography NN I-NP I-test
for IN B-VP O
bilateral JJ B-NP B-problem
foot NN I-NP I-problem
ulcers NNS I-NP I-problem
, , O O
and CC O O
he PRP O B-person
was VBD B-VP O
found VBN O O
to TO O O
an DT O B-problem
evaluated VBN O I-problem
blood NN B-NP I-problem
urea JJ B-NP I-problem
nitrogen NN I-NP I-problem
, , O I-problem
and CC O I-problem
creatinine NN B-NP I-problem
, , O I-problem
and CC O I-problem
potassium NN B-NP I-problem
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
notes VBZ O O
he PRP O B-person
developed VBD B-VP O
worsening VBG O B-problem
foot NN B-NP I-problem
pain NN I-NP I-problem
and CC O O
ulcers NNS B-NP B-problem
four CD O O
months NNS B-NP O
ago RB O O
. . B-VP O
   
Due NNP B-NP O
to TO O O
his PRP$ O B-person
his PRP$ O B-problem
worsening VBG O I-problem
blood NN B-NP I-problem
glucose NN I-NP I-problem
, , O O
he PRP O B-person
was VBD B-VP O
started VBN O O
on IN B-VP O
insulin NN B-NP B-treatment
. . B-VP O
   
His PRP$ O B-problem
His PRP$ O B-person
foot NN B-NP I-problem
ulcers NNS I-NP I-problem
continued VBD B-VP O
to TO O O
develop VB O O
, , O O
and CC O O
the DT B-NP B-person
patient NN I-NP I-person
complained VBD B-VP O
of IN B-VP O
pain NN B-NP B-problem
in IN B-VP I-problem
his PRP$ O B-person
his PRP$ O I-problem
feet NNS B-NP I-problem
; : O O
primarily RB O O
at IN B-VP O
night NN B-NP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
referred VBN O O
to TO O O
for IN B-VP O
Vascular JJ B-NP O
consultation NN I-NP O
because IN B-VP O
of IN B-VP O
the DT B-NP B-problem
ulcerations NNS I-NP I-problem
and CC O O
pain NN B-NP B-problem
and CC O O
scheduled VBN O O
for IN B-VP O
a DT B-NP B-test
lower JJR I-NP O
extremity NN I-NP O
angiography NN I-NP O
on IN B-VP O
the DT B-NP O
day NN I-NP O
of IN B-VP O
admission NN B-NP O
, , O O
but CC O O
due JJ O O
to TO O O
his PRP$ O B-person
his PRP$ O B-problem
renal JJ B-NP I-problem
failure NN I-NP I-problem
the DT B-NP O
procedure NN I-NP O
was VBD B-VP O
cancelled VBN O O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
showed VBD B-VP O
peaked JJ B-NP B-problem
T NNP I-NP I-problem
waves NNS I-NP I-problem
on IN B-VP O
electrocardiogram NN B-NP B-test
, , O O
and CC O O
he PRP O B-person
was VBD B-VP O
transferred VBN O O
to TO O O
Medicine NNP B-NP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
denied VBD B-VP O
any DT B-NP O
oliguria NN I-NP B-problem
, , O O
hematuria NN B-NP B-problem
, , O O
dysuria NN B-NP B-problem
, , O O
foamy JJ B-NP B-problem
urine NN I-NP I-problem
, , O O
flank NN B-NP B-problem
pain NN I-NP I-problem
, , O O
abdominal JJ B-NP B-problem
pain NN I-NP I-problem
, , O O
or CC O O
urinary JJ B-NP B-problem
hesitancy NN I-NP I-problem
. . B-VP O
   
He PRP O B-person
has VBZ O O
complained VBN O O
of IN B-VP O
fatigue NN B-NP B-problem
, , O O
anorexia NN B-NP B-problem
, , O O
and CC O O
a DT B-NP B-problem
10-pound JJ I-NP I-problem
weight NN I-NP I-problem
loss NN I-NP I-problem
in IN B-VP O
the DT O O
last JJ O O
four CD O O
months NNS B-NP O
. . B-VP O
   
He PRP O B-person
gets VBZ O O
short JJ O B-problem
of IN B-VP I-problem
breath NN B-NP I-problem
with IN B-VP O
one CD O O
flight NN B-NP O
of IN B-VP O
stairs NN B-NP O
. . B-VP O
   
He PRP O B-person
denies VBZ O O
any DT B-NP B-problem
fevers NNS I-NP I-problem
, , O O
chills NNS B-NP B-problem
, , O O
recent JJ B-NP B-problem
infections NNS I-NP I-problem
, , O O
chest JJS B-NP B-problem
pain NN I-NP I-problem
, , O O
orthopnea NN B-NP B-problem
, , O O
nausea NN B-NP B-problem
, , O O
vomiting VBG O B-problem
, , O O
diarrhea NN B-NP B-problem
, , O O
hematemesis NN B-NP B-problem
, , O O
melena NN B-NP B-problem
, , O O
or CC O O
hematochezia NN B-NP B-problem
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
also RB O O
notes VBZ O O
he PRP O B-person
has VBZ O O
had VBD B-VP O
hoarseness VBN O B-problem
for IN B-VP O
the DT O O
last JJ O O
two CD O O
to TO O O
three CD O O
weeks NNS B-NP O
. . B-VP O
   
PAST NNP B-NP O
MEDICAL NNP I-NP O
HISTORY NNP I-NP O
: : O O
1. CD O O
Diabetes VBZ O B-problem
mellitus NNS B-NP I-problem
times NNS I-NP O
four CD O O
years NNS B-NP O
; : O O
recently RB O O
started VBD B-VP O
insulin NN B-NP B-treatment
and CC O O
metformin NN B-NP B-treatment
due JJ O O
to TO O O
his PRP$ O B-person
his PRP$ O B-treatment
concurrent NN B-NP I-treatment
steroid NN I-NP I-treatment
use NN I-NP I-treatment
. . B-VP O
   
Last JJ B-NP O
hemoglobin JJ I-NP B-test
A1c NNP I-NP I-test
was VBD B-VP O
11.4 CD O O
. . B-VP O
   
2. CD O O
Polymyalgia NNP B-NP B-problem
rheumatica NN I-NP I-problem
diagnosed VBD B-VP O
four CD O O
years NNS B-NP O
ago RB O O
; : O O
on IN B-VP O
steroids NNS B-NP B-treatment
. . B-VP O
   
3. CD O O
Benign NNP B-NP B-problem
prostatic JJ B-NP I-problem
hypertrophy NN I-NP I-problem
, , O O
status NN B-NP O
post NN I-NP O
transurethral JJ B-NP B-treatment
resection NN I-NP I-treatment
of IN B-VP I-treatment
prostate NN B-NP I-treatment
. . B-VP O
   
4. CD O O
Hypertension NNP B-NP B-problem
. . B-VP O
   
5. CD O O
High NNP B-NP B-problem
cholesterol NN I-NP I-problem
. . B-VP O
   
6. CD O O
Lower NNP B-NP B-problem
extremity NN I-NP I-problem
edema NN I-NP I-problem
. . B-VP O
   
MEDICATIONS NNP B-NP O
ON NNP I-NP O
ADMISSION NNP I-NP O
: : O O
Methylprednisolone CD O B-treatment
4 CD O O
mg NN B-NP O
q. NN I-NP O
a.m. NN I-NP O
and CC O O
2 CD O O
mg NN B-NP O
p.o. NN I-NP O
q.h.s. NN I-NP O
, , O O
spironolactone NN B-NP B-treatment
50 CD O O
mg NN B-NP O
p.o. NN I-NP O
q.d. NN I-NP O
, , O O
metformin NN B-NP B-treatment
1500 CD O O
mg NN B-NP O
p.o. NN I-NP O
q.h.s. NN I-NP O
, , O O
Pravastatin NNP B-NP B-treatment
10 CD O O
mg NN B-NP O
p.o. NN I-NP O
q.h.s. NN I-NP O
, , O O
lisinopril VBZ O B-treatment
20 CD O O
mg NN B-NP O
p.o. NN I-NP O
q. NN I-NP O
a.m. NN I-NP O
, , O O
Lasix NNP B-NP B-treatment
80 CD O O
mg NN B-NP O
p.o. NN I-NP O
q. NN I-NP O
a.m. NN I-NP O
, , O O
Tylenol NNP B-NP B-treatment
as IN B-VP O
needed VBN O O
, , O O
insulin JJ O B-treatment
regular JJ O I-treatment
22 CD O O
units NNS B-NP O
in IN B-VP O
the DT B-NP O
morning NN I-NP O
and CC O O
12 CD O O
units NNS B-NP O
at IN B-VP O
night NN B-NP O
( ( O O
lispro JJ B-NP B-treatment
regular JJ I-NP I-treatment
). NN I-NP O
ALLERGIES NNP I-NP O
: : O O
No DT B-NP O
known JJ I-NP B-problem
drug NN I-NP I-problem
allergies NNS I-NP I-problem
. . B-VP O
   
FAMILY NNP B-NP O
HISTORY NNP I-NP O
: : O O
Type NN B-NP B-problem
1 CD O I-problem
diabetes NNS B-NP I-problem
in IN B-VP O
twin NN B-NP B-person
brother NN I-NP I-person
, , O O
type NN B-NP B-problem
2 CD O I-problem
diabetes NNS B-NP I-problem
in IN B-VP O
mother NN B-NP B-person
and CC O O
brother NN B-NP B-person
. . B-VP O
   
SOCIAL NNP B-NP O
HISTORY NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
is VBZ O O
a DT B-NP O
former JJ I-NP O
smoker NN I-NP O
; : O O
he PRP O B-person
quit VBD B-VP O
50 CD O O
years NNS B-NP O
ago RB O O
. . B-VP O
   
He PRP O B-person
drinks VBZ O O
one CD O O
glass NN B-NP O
of IN B-VP O
wine NN B-NP O
per IN B-VP O
night NN B-NP O
. . B-VP O
   
He PRP O B-person
is VBZ O O
married JJ O O
and CC O O
lives VBZ O O
with IN B-VP O
his PRP$ O B-person
his PRP$ O B-person
wife NN B-NP I-person
. . B-VP O
   
John NNP B-NP B-person
was VBD B-VP O
in IN B-VP O
the DT B-NP O
Army NNP I-NP O
during IN B-VP O
World NNP B-NP O
War NNP I-NP O
II NNP I-NP O
. . B-VP O
   
PHYSICAL NNP B-NP O
EXAMINATION NNP I-NP O
ON NNP I-NP O
PRESENTATION NNP I-NP O
: : O O
On IN B-VP O
admission NN B-NP O
, , O O
temperature NN B-NP B-test
was VBD B-VP O
98.1 CD O O
, , O O
blood NN B-NP B-test
pressure NN I-NP I-test
was VBD B-VP O
140/70 CD O O
, , O O
pulse NN B-NP B-test
was VBD B-VP O
95 CD O O
, , O O
respiratory NN B-NP B-test
rate NN I-NP I-test
was VBD B-VP O
18 CD O O
, , O O
oxygen NN B-NP B-test
saturation NN I-NP I-test
was VBD B-VP O
98% CD O O
on IN B-VP O
room NN B-NP O
air NN I-NP O
. . B-VP O
   
In IN B-VP O
general JJ O O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
a DT B-NP O
thin JJ I-NP O
white JJ I-NP O
male NN I-NP O
, , O O
lying VBG O O
in IN B-VP O
bed NN B-NP O
, , O O
in IN B-VP O
no DT B-NP O
acute NN I-NP B-problem
distress NN I-NP I-problem
, , O O
with IN B-VP O
a DT B-NP B-problem
hoarse JJ I-NP I-problem
voice NN I-NP I-problem
. . B-VP O
   
Head NNP B-NP O
, , O O
eyes NNS B-NP O
, , O O
ears NNS B-NP O
, , O O
nose RB O O
, , O O
and CC O O
throat NN B-NP O
revealed VBD B-VP O
pupils NNS B-NP O
were VBD B-VP O
equally RB O O
round JJ O O
and CC O O
reactive JJ O O
to TO O O
light JJ O O
and CC O O
accommodation NN B-NP O
. . B-VP O
   
Extraocular JJ B-NP O
movements NNS I-NP O
were VBD B-VP O
intact JJ O O
. . B-VP O
   
Sclerae NNP B-NP O
were VBD B-VP O
anicteric JJ O B-problem
. . B-VP O
   
Mucous JJ B-NP O
membranes NNS I-NP O
were VBD B-VP O
moist JJ O O
. . B-VP O
   
Neck NNP B-NP O
revealed VBD B-VP O
no DT B-NP O
lymphadenopathy NN I-NP B-problem
. . B-VP O
   
No DT B-NP O
thyromegaly NN I-NP B-problem
. . B-VP O
   
No DT B-NP O
jugular JJ I-NP B-problem
venous JJ I-NP I-problem
distention NN I-NP I-problem
. . B-VP O
   
Cardiovascular JJ B-NP B-test
examination NN I-NP I-test
revealed VBD B-VP O
a DT B-NP O
regular JJ I-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
. . B-VP O
   
Normal NNP B-NP O
first JJ B-NP O
heart NN I-NP O
sound NN I-NP O
and CC O O
second JJ B-NP O
heart NN I-NP O
sound NN I-NP O
. . B-VP O
   
A DT O B-problem
2/6 CD O I-problem
systolic JJ B-NP I-problem
murmur NN I-NP I-problem
at IN B-VP I-problem
the DT B-NP I-problem
upper JJ I-NP I-problem
sternal JJ I-NP I-problem
border NN I-NP I-problem
. . B-VP O
   
Lungs NNS B-NP O
were VBD B-VP O
clear JJ O O
to TO O O
auscultation VB O B-test
bilaterally RB O O
with IN B-VP O
faint NN B-NP B-problem
lower RBR O I-problem
lobe NN B-NP I-problem
crackles NNS I-NP I-problem
on IN B-VP I-problem
the DT B-NP I-problem
left NN I-NP I-problem
. . B-VP O
   
Back NNP B-NP O
revealed VBD B-VP O
no DT B-NP O
costovertebral JJ I-NP B-problem
angle NN I-NP I-problem
tenderness NN I-NP I-problem
. . B-VP O
   
The DT B-NP O
abdomen NNS I-NP O
was VBD B-VP O
soft JJ O O
and CC O O
nontender NN B-NP B-problem
. . B-VP O
   
No DT B-NP O
rebound NN I-NP B-problem
or CC O O
guarding NN B-NP B-problem
. . B-VP O
   
No DT B-NP O
hepatosplenomegaly NN I-NP B-problem
. . B-VP O
   
Extremities NNS B-NP O
revealed VBD B-VP O
2+ CD O B-test
femoral JJ B-NP I-test
pulses NNS I-NP I-test
bilaterally RB O I-test
, , O O
1+ CD O B-test
dorsalis NN B-NP I-test
pedis NN I-NP I-test
pulses VBZ O I-test
bilaterally RB O I-test
. . B-VP O
   
No DT B-NP O
lower JJR I-NP B-problem
extremity NN I-NP I-problem
edema NN I-NP I-problem
. . B-VP O
   
Left NNP B-NP O
foot NN I-NP O
with IN B-VP O
a DT B-NP B-problem
dry JJ I-NP I-problem
crusted JJ I-NP I-problem
ulcer NN I-NP I-problem
over IN B-VP O
the DT B-NP O
medial JJ I-NP O
aspect NN I-NP O
of IN B-VP O
the DT B-NP O
first JJ I-NP O
metatarsal NN I-NP O
head NN I-NP O
and CC O O
the DT B-NP O
lateral JJ I-NP O
posterior JJ I-NP O
heel NN I-NP O
. . B-VP O
   
On IN B-VP O
the DT B-NP B-problem
right JJ I-NP I-problem
foot NN I-NP I-problem
dry JJ O I-problem
crusted VBD B-VP I-problem
ulcer NN B-NP I-problem
over IN B-VP O
the DT B-NP O
medial JJ I-NP O
aspect NN I-NP O
of IN B-VP O
the DT B-NP O
first JJ I-NP O
metatarsal NN I-NP O
head NN I-NP O
and CC O O
medial JJ B-NP O
posterior NN I-NP O
heel NN I-NP O
. . B-VP O
   
Neurologic NNP B-NP B-test
examination NN I-NP I-test
was VBD B-VP O
grossly RB O O
intact JJ O O
. . B-VP O
   
PERTINENT NNP B-NP O
LABORATORY NNP I-NP O
DATA NNP I-NP O
ON NNP I-NP O
PRESENTATION NNP I-NP O
: : O O
On IN B-VP O
admission NN B-NP O
, , O O
white JJ B-NP B-test
blood NN I-NP I-test
cell NN I-NP I-test
count NN I-NP I-test
was VBD B-VP O
11 CD O O
, , O O
hematocrit NN B-NP B-test
was VBD B-VP O
30 CD O O
, , O O
platelets NNS B-NP B-test
were VBD B-VP O
269 CD O O
. . B-VP O
   
Sodium NN B-NP B-test
was VBD B-VP O
139 CD O O
, , O O
potassium NN B-NP B-test
was VBD B-VP O
6.1 CD O O
, , O O
chloride NN B-NP B-test
was VBD B-VP O
102 CD O O
, , O O
bicarbonate NN B-NP B-test
was VBD B-VP O
18 CD O O
, , O O
blood NN B-NP B-test
urea JJ B-NP I-test
nitrogen NN I-NP I-test
was VBD B-VP O
100 CD O O
, , O O
creatinine NN B-NP B-test
was VBD B-VP O
2.3 CD O O
, , O O
and CC O O
blood NN B-NP B-test
glucose NN I-NP I-test
was VBD B-VP O
189 CD O O
. . B-VP O
   
FENa NNP B-NP B-test
was VBD B-VP O
0.37 CD O O
. . B-VP O
   
RADIOLOGY NNP B-NP O
/ JJ B-NP O
IMAGING NN I-NP O
: : O O
Renal JJ B-NP B-test
ultrasound NN I-NP I-test
was VBD B-VP O
normal JJ O O
. . B-VP O
   
HOSPITAL NNP B-NP O
COURSE NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
is VBZ O O
an DT O O
83 CD O O
- : O O
year-old JJ B-NP O
male NN I-NP O
with IN B-VP O
a DT B-NP O
history NN I-NP O
of IN B-VP O
diabetes NNS B-NP B-problem
, , O O
steroid-treated JJ B-NP B-problem
polymyalgia NN I-NP I-problem
rheumatica NN I-NP I-problem
, , O O
hypertension NN B-NP B-problem
, , O O
benign JJ B-NP B-problem
prostatic JJ I-NP I-problem
hypertrophy NN I-NP I-problem
, , O O
and CC O O
high JJ B-NP B-problem
cholesterol NN I-NP I-problem
without IN B-VP O
presented VBN O O
to TO O O
the DT B-NP O
hospital NN I-NP O
for IN B-VP O
lower JJR B-NP B-test
extremity NN I-NP I-test
angiograph NN I-NP I-test
; : O O
however RB O O
, , O O
that DT O B-pronoun
was VBD B-VP O
deferred VBN O O
due JJ O O
to TO O O
new JJ O B-problem
onset VBN O I-problem
renal JJ B-NP I-problem
failure NN I-NP I-problem
. . B-VP O
   
1. CD O O
RENAL JJ B-NP B-problem
FAILURE NN I-NP I-problem
: : O O
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
initially RB O O
thought VBN O O
to TO O O
be VB O O
prerenal JJ O B-problem
, , O O
and CC O O
his PRP$ O B-person
renal JJ B-NP O
status NN I-NP O
improved VBN O O
after IN B-VP O
hydration NN B-NP B-treatment
and CC O O
increased VBD B-VP B-treatment
oral JJ B-NP I-treatment
intake NN I-NP I-treatment
. . B-VP O
   
He PRP O B-person
did VBD B-VP O
have VB O O
a DT B-NP B-test
magnetic JJ I-NP I-test
resonance NN I-NP I-test
angiography NN I-NP I-test
of IN B-VP I-test
his PRP$ O B-person
his PRP$ O I-test
kidneys NN B-NP I-test
which WDT O B-pronoun
showed VBD B-VP O
mild JJ B-NP B-problem
right-sided JJ I-NP I-problem
renal JJ I-NP I-problem
artery NN I-NP I-problem
stenosis NN I-NP I-problem
. . B-VP O
   
His PRP$ O B-person
renal JJ B-NP O
function NN I-NP O
fluctuated VBD B-VP O
throughout IN B-VP O
his PRP$ O B-person
hospital NN B-NP O
stay NN I-NP O
, , O O
and CC O O
when WRB O O
he PRP O B-person
was VBD B-VP O
in IN B-VP O
the DT B-NP O
Medical NNP I-NP O
Intensive NNP I-NP O
Care NNP I-NP O
Unit NNP I-NP O
he PRP O B-person
did VBD B-VP O
have VB O O
decreased VBN O B-problem
urine JJ B-NP I-problem
output NN I-NP I-problem
in IN B-VP O
the DT B-NP O
setting NN I-NP O
of IN B-VP O
cardiogenic JJ B-NP B-problem
shock NN I-NP I-problem
. . B-VP O
   
2. CD O O
CARDIOVASCULAR NN B-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
with IN B-VP O
severe JJ B-NP B-problem
peripheral JJ I-NP I-problem
vascular JJ I-NP I-problem
disease NN I-NP I-problem
. . B-VP O
   
During IN B-VP O
his PRP$ O B-person
hospital NN B-NP O
stay NN I-NP O
, , O O
he PRP O B-person
developed VBD B-VP O
some DT B-NP B-problem
nonsustained JJ I-NP I-problem
ventricular JJ I-NP I-problem
tachycardia NN I-NP I-problem
. . B-VP O
   
He PRP O B-person
also RB O O
became VBD B-VP O
hypotensive JJ O B-problem
on IN B-VP O
07-02 NN B-NP O
in IN B-VP O
the DT B-NP O
setting NN I-NP O
of IN B-VP O
infection NN B-NP B-problem
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
had VBD B-VP O
a DT B-NP B-treatment
central JJ I-NP I-treatment
line NN I-NP I-treatment
placed VBN O O
and CC O O
went VBD B-VP O
into IN B-VP O
sustained VBN O B-problem
ventricular JJ B-NP I-problem
tachycardia NN I-NP I-problem
that WDT O B-pronoun
was VBD B-VP O
treated VBN O O
with IN B-VP O
lidocaine NN B-NP B-treatment
. . B-VP O
   
After IN B-VP O
being VBG O O
treated VBN O O
with IN B-VP O
lidocaine NN B-NP B-treatment
, , O O
the DT B-NP B-person
patient NN I-NP I-person
became VBD B-VP O
apneic JJ O B-problem
requiring VBG O O
intubation NN B-NP B-treatment
and CC O O
transfer NN B-NP O
to TO O O
the DT B-NP O
Coronary NNP I-NP O
Care NNP I-NP O
Unit NNP I-NP O
. . B-VP O
   
His PRP$ O B-person
His PRP$ O B-problem
nonsustained JJ B-NP I-problem
ventricular JJ I-NP I-problem
tachycardia NN I-NP I-problem
was VBD B-VP O
treated VBN O O
with IN B-VP O
a DT B-NP B-treatment
lidocaine JJ I-NP I-treatment
drip NN I-NP I-treatment
. . B-VP O
   
It PRP O B-pronoun
was VBD B-VP O
found VBN O O
that IN B-VP B-pronoun
he PRP O B-person
had VBD B-VP O
elevated VBN O B-problem
troponins NNS B-NP I-problem
and CC O O
likely JJ O O
an DT B-NP B-problem
ischemic JJ I-NP I-problem
event NN I-NP I-problem
on IN B-VP O
the DT B-NP O
07-02 NN I-NP O
. . B-VP O
   
A DT B-NP B-test
repeat NN I-NP I-test
echocardiogram NN I-NP I-test
showed VBD B-VP O
a DT B-NP B-problem
decreased JJ I-NP I-problem
ejection NN I-NP I-problem
fraction NN I-NP I-problem
from IN B-VP O
prior RB O O
. . B-VP O
   
He PRP O B-person
had VBD B-VP O
a DT B-NP B-test
cardiac JJ I-NP I-test
catheterization NN I-NP I-test
which WDT O B-pronoun
revealed VBD B-VP O
3-vessel JJ B-NP B-problem
disease NN I-NP I-problem
. . B-VP O
   
Cardiothoracic NNP B-NP B-person
Surgery NNP I-NP I-person
was VBD B-VP O
consulted VBN O O
, , O O
and CC O O
due JJ O O
to TO O O
the DT O B-problem
the DT B-NP B-person
patient JJ I-NP I-problem
patient NN I-NP I-person
's POS O I-problem
acute JJ B-NP I-problem
illness NN I-NP I-problem
, , O O
they PRP O B-person
wanted VBD B-VP O
to TO O O
re-evaluate VB O O
after IN B-VP O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
extubated VBN O O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
continued VBD B-VP O
to TO O O
have VB O O
intermittent JJ B-NP O
episodes NNS I-NP O
of IN B-VP O
ventricular JJ B-NP B-problem
tachycardia NN I-NP I-problem
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
continued VBN O O
on IN B-VP O
lidocaine NN B-NP B-treatment
and CC O O
eventually RB O O
changed VBN O O
over IN B-VP O
to TO O O
amiodarone VB O B-treatment
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
noted VBN O O
to TO O O
be VB O O
cardiogenic JJ B-NP B-problem
shock NN I-NP I-problem
requiring VBG O O
pressors NNS B-NP B-treatment
. . B-VP O
   
Of IN B-VP O
note NN B-NP O
, , O O
he PRP O B-person
likely RB O O
suffered VBD B-VP O
a DT B-NP B-problem
second JJ I-NP I-problem
ischemic JJ I-NP I-problem
event NN I-NP I-problem
during IN B-VP O
his PRP$ O B-person
Coronary NNP B-NP O
Care NNP I-NP O
Unit NNP I-NP O
stay NN I-NP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
did VBD B-VP O
have VB O O
a DT B-NP B-test
Swan-Ganz JJ I-NP I-test
catheter NN I-NP I-test
in IN B-VP O
place NN B-NP O
and CC O O
had VBD B-VP O
a DT B-NP B-problem
low JJ I-NP I-problem
cardiac NN I-NP I-problem
output NN I-NP I-problem
. . B-VP O
   
The DT O B-person
The DT B-NP B-person
patient JJ I-NP I-person
patient NN I-NP I-person
's POS O I-person
family NN B-NP I-person
eventually RB O O
decided VBD B-VP O
to TO O O
withdraw VB O O
care NN B-NP O
, , O O
and CC O O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
extubated VBN O O
and CC O O
passed VBN O O
away RB O O
on IN B-VP O
2009-07-12 JJ O O
. . B-VP O
   
2. CD O O
INFECTIOUS JJ B-NP O
DISEASE NN I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
initially RB O O
treated VBN O O
with IN B-VP O
levofloxacin NN B-NP B-treatment
for IN B-VP O
a DT B-NP B-problem
left NN I-NP I-problem
lower JJR B-NP I-problem
lobe NN I-NP I-problem
infiltrate NN I-NP I-problem
and CC O O
a DT B-NP B-problem
urinary JJ I-NP I-problem
tract NN I-NP I-problem
infection NN I-NP I-problem
. . B-VP O
   
He PRP O B-person
then RB O O
developed VBD B-VP O
positive JJ B-NP B-problem
blood NN I-NP I-problem
cultures NNS I-NP I-problem
with IN B-VP O
Staphylococcus NNP B-NP B-problem
aureus RB O I-problem
sensitive JJ O O
to TO O O
levofloxacin VB O B-treatment
, , O O
and CC O O
that DT O B-pronoun
was VBD B-VP O
continued VBN O O
. . B-VP O
   
When WRB O O
the DT B-NP B-person
patient NN I-NP I-person
became VBD B-VP O
hypotensive JJ O B-problem
and CC O O
required JJ B-NP O
intubation NN I-NP B-treatment
and CC O O
pressors NNS B-NP B-treatment
, , O O
his PRP$ O B-person
his PRP$ O B-treatment
antibiotics NNS B-NP I-treatment
were VBD B-VP O
broadened VBN O O
, , O O
and CC O O
he PRP O B-person
was VBD B-VP O
put VBN O O
on IN B-VP O
stress-dose JJ B-NP B-treatment
steroids NNS I-NP I-treatment
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
found VBN O O
to TO O O
have VB O O
bilateral JJ B-NP B-problem
Staphylococcus NNP I-NP I-problem
pneumonia NN I-NP I-problem
. . B-VP O
   
3. CD O O
PULMONARY NN B-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
required VBN O O
intubation NN B-NP B-treatment
in IN B-VP O
the DT B-NP O
setting NN I-NP O
of IN B-VP O
hypotension NN B-NP B-problem
and CC O O
ventricular JJ B-NP B-problem
tachycardia NN I-NP I-problem
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
actually RB O O
extubated VBN O O
on IN B-VP O
07-09 JJ O O
, , O O
but CC O O
then RB O O
reintubated VBD B-VP O
one CD O O
hour NN B-NP O
later RB O O
due JJ O O
to TO O O
hypoxia VB O B-problem
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
also RB O O
found VBN O O
to TO O O
have VB O O
a DT B-NP B-problem
bilateral JJ I-NP I-problem
Staphylococcus NNP I-NP I-problem
pneumonia NN I-NP I-problem
. . B-VP O
   
DISCHARGE NNP B-NP O
DISPOSITION NNP I-NP O
: : O O
On IN B-VP O
07-12 NN B-NP O
, , O O
after IN B-VP O
and CC O O
extensive JJ B-NP O
family NN I-NP B-person
meeting NN I-NP O
, , O O
the DT B-NP B-person
family NN I-NP I-person
decided VBD B-VP O
to TO O O
extubate VB O O
the DT B-NP B-person
patient NN I-NP I-person
and CC O O
make VB O O
him PRP O B-person
comfortable JJ O O
, , O O
and CC O O
he PRP O B-person
passed VBD B-VP O
away RB O O
at IN B-VP O
5:20 CD O O
on IN B-VP O
2009-07-12 JJ O O
. . B-VP O
   
Hattie NNP B-NP B-person
L NNP I-NP I-person
Breaux NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
33-679 CD O O
Dictated VBN O O
By IN B-VP O
: : O O
Larry NNP B-NP B-person
W. NNP I-NP I-person
Nagy NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
MEDQUIST36 NNP I-NP O
D NNP I-NP O
: : O O
2009-12-03 JJ O O
09:18 CD O O
T NN B-NP O
: : O O
2009-12-08 JJ O O
10:47 CD O O
JOB NNP B-NP O
#: VBD B-VP O
32151 CD O O
Signed VBN O O
electronically RB O O
by IN B-VP O
: : O O
DR. NNP B-NP B-person
Stephanie NNP I-NP I-person
Francis NNP I-NP I-person
on IN B-VP O
: : O O
TUE NNP B-NP O
2009-12-08 CD O O
4:59 CD O O
PM NNP B-NP O
( ( O O
End NNP B-NP O
of IN B-VP O
Report NNP B-NP O
) ) O O
-EMPTYLINE- VBP O O
-DOCSTART- JJ B-NP O
-EMPTYLINE- NNP I-NP O
Admission NNP I-NP O
Date NNP I-NP O
: : O O
2018-10-25 JJ B-NP O
Discharge NN I-NP O
Date NNP I-NP O
: : O O
2018-11-01 JJ B-NP O
Date NNP I-NP O
of IN B-VP O
Birth NNP B-NP O
: : O O
1943-11-06 JJ B-NP O
Sex NN I-NP O
: : O O
M NNP B-NP O
Service NNP I-NP O
: : O O
MEDICINE JJ B-NP O
Allergies NNS I-NP O
: : O O
Patient NN B-NP B-person
recorded VBD B-VP O
as IN B-VP O
having VBG O O
No NNP B-NP O
Known NNP I-NP B-problem
Allergies NNPS I-NP I-problem
to TO O I-problem
Drugs NNP B-NP I-problem
Attending NNP I-NP B-person
: : O O
Kelly NNP B-NP B-person
L. NNP I-NP I-person
Bradley NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
Addendum NNP I-NP O
: : O O
Explained VBD B-VP O
to TO O O
pt VB O B-person
which WDT O B-pronoun
of IN B-VP O
the DT B-NP B-treatment
meds NNS I-NP I-treatment
he PRP O B-person
should MD O O
no RB O O
longer RBR O O
take VB O O
that IN B-VP B-pronoun
he PRP O B-person
was VBD B-VP O
taking VBG O O
pre-admission NN B-NP O
. . B-VP O
   
Also RB O O
, , O O
explained VBD B-VP O
which WDT O B-pronoun
meds NNS B-NP B-treatment
are VBP O O
new JJ O O
. . B-VP O
   
Wife NNP B-NP B-person
verbally RB O O
agrees VBZ O O
to TO O O
understanding VBG O O
. . B-VP O
   
Discharge JJ B-NP O
Medications NNS I-NP O
: : O O
1. CD O O
Diltiazem NNP B-NP B-treatment
HCl NNP I-NP O
240 CD O O
mg NN B-NP O
Capsule NNP I-NP O
, , O O
Sustained VBD B-VP O
Release NNP B-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Capsule NN B-NP O
, , O O
Sustained VBD B-VP O
Release NNP B-NP O
PO NNP I-NP O
DAILY NNP I-NP O
( ( O O
Daily NNP B-NP O
). VBZ O O
2. CD O O
Simvastatin NNP B-NP B-treatment
40 CD O O
mg NN B-NP O
Tablet NNP I-NP O
Sig: NNP I-NP O
One NNP I-NP O
( ( O O
1 CD O O
) ) O O
Tablet NNP B-NP O
PO NNP I-NP O
DAILY NNP I-NP O
( ( O O
Daily NNP B-NP O
). VBZ O O
3. CD O O
Albuterol-Ipratropium JJ B-NP B-treatment
103-18 JJ I-NP O
mcg NN I-NP O
/ NNP I-NP O
Actuation NNP I-NP O
Aerosol NNP I-NP O
Sig NNP I-NP O
: : O O
02-26 JJ B-NP O
Puffs NNP I-NP O
Inhalation NNP I-NP O
Q6H NNP I-NP O
( ( O O
every DT O O
6 CD O O
hours NNS B-NP O
) ) O O
as IN B-VP O
needed VBN O O
. . B-VP O
   
4. CD O O
Fluticasone-Salmeterol JJ B-NP B-treatment
250-50 JJ I-NP O
mcg NN I-NP O
/ NNP I-NP O
Dose NNP I-NP O
Disk NNP I-NP O
with IN B-VP O
Device NNP B-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Disk NN B-NP O
with IN B-VP O
Device NNP B-NP O
Inhalation NNP I-NP O
BID NNP I-NP O
( ( O O
2 CD O O
times NNS B-NP O
a DT B-NP O
day NN I-NP O
). POS O O
5. CD O O
Terazosin NNP B-NP B-treatment
1 CD O O
mg NN B-NP O
Capsule NNP I-NP O
Sig NNP I-NP O
: : O O
Two CD O O
( ( O O
2 CD O O
) ) O O
Capsule NNP B-NP O
PO NNP I-NP O
HS NNP I-NP O
( ( O O
at IN B-VP O
bedtime NN B-NP O
). $ O O
6. CD O O
Acetaminophen NNP B-NP B-treatment
325 CD O O
mg NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
1-2 JJ B-NP O
Tablets NNS I-NP O
PO NNP I-NP O
Q4-6H NNP I-NP O
( ( O O
every DT O O
4 CD O O
to TO O O
6 CD O O
hours NNS B-NP O
) ) O O
as IN B-VP O
needed VBN O O
. . B-VP O
   
7. CD O O
Nimodipine JJ O B-treatment
30 CD O O
mg NN B-NP O
Capsule NNP I-NP O
Sig NNP I-NP O
: : O O
Two CD O O
( ( O O
2 CD O O
) ) O O
Capsule NNP B-NP O
PO NNP I-NP O
Q4H NNP I-NP O
( ( O O
every DT O O
4 CD O O
hours NNS B-NP O
) ) O O
for IN B-VP O
2 CD O O
weeks NNS B-NP O
. . B-VP O
   
Disp NNP B-NP O
:* VBD B-VP O
168 CD O O
Capsule NNP B-NP O
(s)* NNP I-NP O
Refills NNP I-NP O
:* VBZ O O
0 CD O O
* NN B-NP O
8. CD O O
Ferrous JJ B-NP B-treatment
Sulfate NNP I-NP I-treatment
325 CD O O
( ( O O
65 CD O O
) ) O O
mg NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Tablet NNP B-NP O
PO NNP I-NP O
DAILY NNP I-NP O
( ( O O
Daily NNP B-NP O
). NNP I-NP O
Disp NNP I-NP O
:* VBD B-VP O
30 CD O O
Tablet NNP B-NP O
(s)* NNP I-NP O
Refills NNP I-NP O
:* VBZ O O
2 CD O O
* NN B-NP O
9. CD O O
Aspirin NNP B-NP B-treatment
81 CD O O
mg NN B-NP O
Tablet NNP I-NP O
, , O O
Chewable JJ B-NP O
Sig NN I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Tablet NN B-NP O
, , O O
Chewable JJ B-NP O
PO NNP I-NP O
DAILY NNP I-NP O
( ( O O
Daily NNP B-NP O
). VBZ O O
10. CD O O
Ipratropium NNP B-NP B-treatment
Bromide NNP I-NP I-treatment
0.02 CD O O
% NN B-NP O
Solution NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Inhalation NN B-NP O
Q6H NNP I-NP O
( ( O O
every DT O O
6 CD O O
hours NNS B-NP O
). RB O O
11. CD O O
Simvastatin NNP B-NP B-treatment
40 CD O O
mg NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Tablet NNP B-NP O
PO NNP I-NP O
DAILY NNP I-NP O
( ( O O
Daily NNP B-NP O
). VBZ O O
12. CD O O
Hydralazine NNP B-NP B-treatment
25 CD O O
mg NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
1.5 CD O O
Tablets NNS B-NP O
PO NNP I-NP O
TID NNP I-NP O
( ( O O
3 CD O O
times NNS B-NP O
a DT B-NP O
day NN I-NP O
). NNP I-NP O
Disp NNP I-NP O
:* VBD B-VP O
135 CD O O
Tablet NNP B-NP O
(s)* NNP I-NP O
Refills NNP I-NP O
:* VBZ O O
2 CD O O
* NN B-NP O
13. CD O O
Metoprolol NNP B-NP B-treatment
Tartrate NNP I-NP I-treatment
25 CD O O
mg NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
1.5 CD O O
Tablets NNS B-NP O
PO NNP I-NP O
BID NNP I-NP O
( ( O O
2 CD O O
times NNS B-NP O
a DT B-NP O
day NN I-NP O
). NNP I-NP O
Disp NNP I-NP O
:* VBD B-VP O
90 CD O O
Tablet NNP B-NP O
(s)* NNP I-NP O
Refills NNP I-NP O
:* VBZ O O
2 CD O O
* NN B-NP O
14. CD O O
Isosorbide NNP B-NP B-treatment
Dinitrate NNP I-NP I-treatment
20 CD O O
mg NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Tablet NNP B-NP O
PO NNP I-NP O
TID NNP I-NP O
( ( O O
3 CD O O
times NNS B-NP O
a DT B-NP O
day NN I-NP O
). NNP I-NP O
Disp NNP I-NP O
:* VBD B-VP O
90 CD O O
Tablet NNP B-NP O
(s)* NNP I-NP O
Refills NNP I-NP O
:* VBZ O O
2 CD O O
* NN B-NP O
15. CD O O
Clopidogrel NNP B-NP B-treatment
75 CD O O
mg NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Tablet NNP B-NP O
PO NNP I-NP O
DAILY NNP I-NP O
( ( O O
Daily NNP B-NP O
). VBZ O O
16. CD O O
Glipizide NNP B-NP B-treatment
5 CD O O
mg NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Tablet NNP B-NP O
PO NNP I-NP O
once RB O O
a DT B-NP O
day NN I-NP O
. . B-VP O
   
Disp NNP B-NP O
:* VBD B-VP O
30 CD O O
Tablet NNP B-NP O
(s)* NNP I-NP O
Refills NNP I-NP O
:* VBZ O O
2 CD O O
* NN B-NP O
Discharge NNP I-NP O
Disposition NNP I-NP O
: : O O
Home NN B-NP O
with IN B-VP O
Service NNP B-NP O
Jacob NNP I-NP B-person
Montegut NNP I-NP I-person
MD NNP I-NP I-person
71-786 JJ O O
Completed VBN O O
by IN B-VP O
: : O O
Oscar NNP B-NP B-person
Jerome NNP I-NP I-person
Julian NNP I-NP I-person
MD NNP I-NP I-person
39-824 JJ B-NP O
2018-11-01 JJ I-NP O
@ NN I-NP O
1610 CD O O
Signed NNP B-NP O
electronically RB O O
by IN B-VP O
: : O O
DR. NNP B-NP B-person
Joyce NNP I-NP I-person
Arney NNP I-NP I-person
on IN B-VP O
: : O O
MON NNP B-NP O
2018-12-03 CD O O
10:55 CD O O
PM NNP B-NP O
( ( O O
End NNP B-NP O
of IN B-VP O
Report NNP B-NP O
) ) O O
-EMPTYLINE- VBP O O
-DOCSTART- JJ O O
-EMPTYLINE- $ O O
188543380 CD O O
NVH NNP B-NP O
24217709 CD O O
06/07/2000 CD O O
12:00:00 CD O O
AM NNP B-NP O
CHRONIC NNP I-NP B-problem
MYELOGENOUS NNP I-NP I-problem
LEUKEMIA NNP I-NP I-problem
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date NNP I-NP O
: : O O
06/07/2000 CD O O
Report NNP B-NP O
Status NNP I-NP O
: : O O
Signed VBN O O
Discharge NNP B-NP O
Date NNP I-NP O
: : O O
07/02/2000 CD O O
PRINCIPAL NNP B-NP O
DIAGNOSIS NNP I-NP O
: : O O
CML NNP B-NP B-problem
. . B-VP O
   
OTHER NNP B-NP O
DIAGNOSES NNP I-NP O
: : O O
1. CD O O
STATUS NNP B-NP O
POST NNP I-NP O
BONE NNP I-NP B-treatment
MARROW NNP I-NP I-treatment
TRANSPLANT NNP I-NP I-treatment
. . B-VP O
   
2. CD O O
INTRAPARENCHYMAL NNP B-NP B-problem
BLEED NNP I-NP I-problem
. . B-VP O
   
HISTORY NNP B-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS NNP I-NP O
: : O O
Mr. NNP B-NP B-person
Larsen NNP I-NP I-person
was VBD B-VP O
a DT B-NP O
50-year-old JJ I-NP O
salesman NN I-NP O
who WP O B-person
in IN B-VP O
12/26 CD O O
was VBD B-VP O
noted VBN O O
to TO O O
have VB O O
an DT B-NP B-problem
elevated JJ I-NP I-problem
platelet NN I-NP I-problem
count NN I-NP I-problem
of IN B-VP O
778,000 CD O O
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
found VBN O O
to TO O O
have VB O O
CML NNP B-NP B-problem
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
admitted VBN O O
on IN B-VP O
06/07/00 CD O O
for IN B-VP O
a DT O B-treatment
matched VBN O I-treatment
, , O I-treatment
unrelated JJ B-NP I-treatment
donor NN I-NP I-treatment
bone NN I-NP I-treatment
marrow NN I-NP I-treatment
transplant NN I-NP I-treatment
. . B-VP O
   
PHYSICAL JJ B-NP O
EXAMINATION NN I-NP O
: : O O
Unremarkable JJ O O
. . B-VP O
   
LABORATORY NNP B-NP O
DATA NNP I-NP O
: : O O
White NNP B-NP B-test
blood NN I-NP I-test
cell NN I-NP I-test
count NN I-NP I-test
of IN B-VP O
24.409 CD O O
and CC O O
platelets NNS B-NP B-test
of IN B-VP O
956,000 CD O O
. . B-VP O
   
HOSPITAL NNP B-NP O
COURSE NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
received VBD B-VP O
his PRP$ O B-treatment
his PRP$ O B-person
bone NN B-NP I-treatment
marrow NN I-NP I-treatment
transplant NN I-NP I-treatment
on IN B-VP O
06/12/00 CD O O
. . B-VP O
   
His PRP$ O B-person
course NN B-NP O
was VBD B-VP O
then RB O O
complicated VBN O O
by IN B-VP O
fevers NNS B-NP B-problem
and CC O O
neutropenia NN B-NP B-problem
which WDT O B-pronoun
were VBD B-VP O
treated VBN O O
with IN B-VP O
antibiotics NNS B-NP B-treatment
and CC O O
a DT B-NP B-problem
diffuse NN I-NP I-problem
erythroderm NN I-NP I-problem
felt VBD B-VP O
to TO O O
be VB O O
a DT B-NP B-problem
drug NN I-NP I-problem
reaction NN I-NP I-problem
. . B-VP O
   
On IN B-VP O
06/24/00 CD O O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
found VBN O O
to TO O O
have VB O O
pulmonary JJ B-NP B-problem
infiltrates NNS I-NP I-problem
and CC O O
some DT B-NP B-problem
hemoptysis NN I-NP I-problem
. . B-VP O
   
A DT B-NP B-test
bronchoscopy NN I-NP I-test
was VBD B-VP O
done VBN O O
and CC O O
there EX O B-pronoun
was VBD B-VP O
blood NN B-NP B-problem
found VBN O O
in IN B-VP O
the DT B-NP O
upper JJ I-NP O
airways NNS I-NP O
but CC O O
no DT B-NP O
evidence NN I-NP O
of IN B-VP O
blood NN B-NP B-problem
in IN B-VP I-problem
alveoli NNS B-NP I-problem
so IN B-VP O
it PRP O B-pronoun
was VBD B-VP O
not RB O O
felt VBN O O
to TO O O
be VB O O
DAH NNP B-NP B-problem
. . B-VP O
   
On IN B-VP O
06/26/00 CD O O
due JJ O O
to TO O O
agitation NN B-NP B-problem
, , O O
change NN B-NP B-problem
in IN B-VP I-problem
mental JJ B-NP I-problem
status NN I-NP I-problem
and CC O O
increased VBD B-VP B-problem
respiratory NN B-NP I-problem
distress NN I-NP I-problem
, , O O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
intubated VBN O B-treatment
. . B-VP O
   
It PRP O B-pronoun
was VBD B-VP O
felt VBN O O
at IN B-VP O
that DT B-NP B-pronoun
time NN I-NP O
that IN B-VP B-pronoun
the DT O B-problem
changing VBG O I-problem
mental JJ B-NP I-problem
status NN I-NP I-problem
and CC O O
respiratory NN B-NP B-problem
distress NN I-NP I-problem
might MD O O
be VB O O
due JJ O O
to TO O O
a DT B-NP O
combination NN I-NP O
of IN B-VP O
medication NN B-NP B-treatment
and CC O O
worsening VBG O B-problem
mucositis NN B-NP I-problem
. . B-VP O
   
Although IN B-VP O
the DT O B-treatment
the DT B-NP B-person
patient JJ I-NP I-treatment
patient NN I-NP I-person
&apos;s NN I-NP I-treatment
pain NN I-NP I-treatment
and CC O I-treatment
sedation NN B-NP I-treatment
meds NNS I-NP I-treatment
were VBD B-VP O
adjusted VBN O O
he PRP O B-person
continued VBD B-VP O
to TO O O
be VB O O
agitated VBN O B-problem
and CC O O
there EX O O
was VBD B-VP O
difficulty NN B-NP O
weaning VBG O O
him PRP O B-person
off RP O O
the DT B-NP B-treatment
vent NN I-NP I-treatment
. . B-VP O
   
Because IN B-VP O
of IN B-VP O
this DT O B-pronoun
this DT B-NP B-problem
continued JJ I-NP I-problem
agitation NN I-NP I-problem
, , O O
a DT B-NP B-test
head NN I-NP I-test
CT NNP I-NP I-test
was VBD B-VP O
performed VBN O O
on IN B-VP O
07/01/00 CD O O
and CC O O
it PRP O B-pronoun
revealed VBD B-VP O
an DT B-NP B-problem
intraparenchymal JJ I-NP I-problem
hemorrhage NN I-NP I-problem
. . B-VP O
   
Neurosurgery NNP B-NP B-person
was VBD B-VP O
consulted VBN O O
but CC O O
due JJ O O
to TO O O
the DT B-NP O
severity NN I-NP O
of IN B-VP O
the DT B-NP B-problem
bleed NN I-NP I-problem
surgery NN I-NP B-treatment
was VBD B-VP O
not RB O O
considered VBN O O
an DT B-NP O
option NN I-NP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
gradually RB O O
lost VBD B-VP O
brain NN B-NP O
systolic JJ B-NP O
ejection NN I-NP O
murmur NN I-NP O
function NN I-NP O
and CC O O
was VBD B-VP O
pronounced VBN O O
dead JJ O B-problem
on IN B-VP O
07/02/00 CD O O
. . B-VP O
   
Dictated VBN O O
By IN B-VP O
: : O O
LAYMIE NNP B-NP B-person
LARSEN NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
EM08 NNP I-NP O
Attending NNP I-NP B-person
: : O O
ANA NNP B-NP B-person
V. NNP I-NP I-person
A NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
ZM0 NNP I-NP O
LB414/6537 NNP I-NP O
Batch NNP I-NP O
: : O O
67043 CD O O
Index NNP B-NP O
No. NN I-NP O
EZCDQ560N8 NNP I-NP O
D NNP I-NP O
: : O O
07/19/00 CD O O
T NN B-NP O
: : O O
07/20/00 CD O O
-EMPTYLINE- NN B-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
﻿Admission NN I-NP O
Date NNP I-NP O
: : O O
2012-05-08 JJ B-NP O
Discharge NN I-NP O
Date NNP I-NP O
: : O O
2012-05-18 JJ B-NP O
Date NNP I-NP O
of IN B-VP O
Birth NNP B-NP O
: : O O
2012-05-08 JJ B-NP O
Sex NN I-NP O
: : O O
M NNP B-NP O
Service NNP I-NP O
: : O O
Neonatology NNP B-NP O
HISTORY NNP I-NP O
: : O O
Baby NNP B-NP B-person
Barbara NNP I-NP I-person
Stead NNP I-NP I-person
is VBZ O O
a DT B-NP O
term NN I-NP O
infant NN I-NP O
admitted VBN O O
with IN B-VP O
increasing VBG O B-problem
head NN B-NP I-problem
circumference NN I-NP I-problem
and CC O O
bruising NN B-NP B-problem
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
born VBN O O
to TO O O
a DT B-NP B-person
31-year-old JJ I-NP I-person
G1 NNP I-NP I-person
P0 NNP I-NP I-person
now RB O I-person
1 CD O I-person
mother NN B-NP I-person
with IN B-VP O
unremarkable JJ B-NP O
prenatal JJ I-NP O
screens NNS I-NP O
as IN B-VP O
follows VBZ O O
: : O O
O NNP B-NP O
positive JJ O O
, , O O
antibody JJ O B-test
negative JJ O O
, , O O
hepatitis NN B-NP B-test
B NNP I-NP I-test
surface NN I-NP I-test
antigen NN I-NP I-test
negative JJ O O
, , O O
RPR NNP B-NP B-test
nonreactive NN I-NP O
, , O O
rubella NN B-NP B-test
immune JJ B-NP I-test
PREGNANCY NNP I-NP O
HISTORY NNP I-NP O
: : O O
Estimated VBN O O
date NN B-NP O
of IN B-VP O
delivery NN B-NP O
was VBD B-VP O
2012-05-14 JJ O O
for IN B-VP O
estimated VBN O O
gestational JJ B-NP O
age NN I-NP O
of IN B-VP O
39-1/7 JJ B-NP O
weeks NNS I-NP O
. . B-VP O
   
Pregnancy NNP B-NP O
was VBD B-VP O
complicated VBN O O
by IN B-VP O
oligohydramnios NNS B-NP B-problem
with IN B-VP O
an DT B-NP B-test
AFI NNP I-NP I-test
of IN B-VP O
3.5 CD O O
and CC O O
by IN B-VP O
multiple JJ B-NP B-test
evaluations NNS I-NP I-test
for IN B-VP O
decreased JJ B-NP B-problem
fetal JJ I-NP I-problem
movement NN I-NP I-problem
. . B-VP O
   
There EX O B-pronoun
was VBD B-VP O
spontaneous JJ B-NP B-problem
onset NN I-NP I-problem
of IN B-VP I-problem
labor NN B-NP I-problem
progressing VBG O O
through IN B-VP O
vacuum NN B-NP B-treatment
assisted VBN O I-treatment
vaginal JJ B-NP I-treatment
delivery NN I-NP I-treatment
under IN B-VP O
epidural JJ B-NP B-treatment
anesthesia NN I-NP I-treatment
. . B-VP O
   
clear JJ B-NP O
amniotic JJ I-NP O
fluid NN I-NP O
, , O O
no DT B-NP O
antepartum JJ I-NP B-problem
maternal JJ I-NP I-problem
fever NN I-NP I-problem
or CC O O
fetal JJ B-NP B-problem
tachycardia NN I-NP I-problem
, , O O
no DT B-NP O
antepartum NN I-NP B-treatment
antibiotic JJ B-NP I-treatment
prophylaxis NN I-NP I-treatment
. . B-VP O
   
Baby NNP B-NP B-person
was VBD B-VP O
vigorous JJ O O
at IN B-VP O
delivery NN B-NP O
, , O O
was VBD B-VP O
bulb JJ B-NP B-treatment
suction NN I-NP I-treatment
, , O O
dried VBN O O
, , O O
and CC O O
had VBD B-VP O
free JJ B-NP B-treatment
flow NN I-NP I-treatment
oxygen NN I-NP I-treatment
administered VBD B-VP O
briefly NN B-NP O
. . B-VP O
   
Apgars NNS B-NP B-test
were VBD B-VP O
nine CD O O
and CC O O
nine CD O O
. . B-VP O
   
In IN B-VP O
the DT B-NP O
Newborn NNP I-NP O
Nursery NNP I-NP O
, , O O
he PRP O B-person
initially RB O O
had VBD B-VP O
a DT B-NP B-problem
caput NN I-NP I-problem
which WDT O B-pronoun
increased VBD B-VP O
in IN B-VP O
the DT B-NP O
amount NN I-NP O
of IN B-VP O
swelling VBG O B-problem
and CC O O
bruising VBG O B-problem
in IN B-VP O
the DT O O
subsequent JJ O O
24 CD O O
hours NNS B-NP O
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
then RB O O
referred VBN O O
to TO O O
the DT B-NP O
CMED NNP I-NP O
CCU NNP I-NP O
for IN B-VP O
assessment NN B-NP B-test
and CC O O
management NN B-NP B-treatment
of IN B-VP O
the DT O B-problem
increased VBN O I-problem
bleeding NN B-NP I-problem
. . B-VP O
   
PHYSICAL NNP B-NP O
EXAMINATION NNP I-NP O
UPON NNP I-NP O
ADMISSION NNP I-NP O
TO NNP I-NP O
THE NNP I-NP O
CMED NNP I-NP O
CCU NNP I-NP O
: : O O
Birth NNP B-NP B-test
weight NN I-NP I-test
was VBD B-VP O
3850 CD O O
grams NNS B-NP O
. . B-VP O
   
Head NNP B-NP B-test
circumference NN I-NP I-test
was VBD B-VP O
41 CD O O
cm NN B-NP O
. . B-VP O
   
HEENT NNP B-NP B-test
was VBD B-VP O
significant JJ O O
for IN B-VP O
swelling VBG O B-problem
of IN B-VP I-problem
the DT B-NP I-problem
scalp JJ I-NP I-problem
tissue NN I-NP I-problem
in IN B-VP O
generalized JJ B-NP O
distribution NN I-NP O
with IN B-VP O
ecchymosis NN B-NP B-problem
extending VBG O O
from IN B-VP O
the DT B-NP O
occiput NN I-NP O
to TO O O
the DT B-NP O
posterior JJ I-NP O
auricular JJ I-NP O
area NN I-NP O
and CC O O
dorsal JJ B-NP O
aspect NN I-NP O
of IN B-VP O
the DT B-NP O
neck NN I-NP O
to TO O O
the DT B-NP O
mid JJ I-NP O
cervical JJ I-NP O
level NN I-NP O
. . B-VP O
   
Ears NNS B-NP O
were VBD B-VP O
displaced VBN O O
forward RB O O
. . B-VP O
   
Eyes NNS B-NP O
were VBD B-VP O
normal JJ O O
. . B-VP O
   
Neck NNP B-NP O
and CC O O
mouth NN B-NP O
were VBD B-VP O
normal JJ O O
. . B-VP O
   
No DT B-NP O
nasal JJ I-NP B-problem
flaring NN I-NP I-problem
. . B-VP O
   
Chest NNP B-NP O
: : O O
No DT B-NP O
retractions NNS I-NP B-problem
, , O O
good JJ B-NP O
breath NN I-NP O
sounds NNS I-NP O
bilaterally RB O O
, , O O
no DT B-NP O
crackles NNS I-NP B-problem
. . B-VP O
   
Cardiovascular JJ O O
: : O O
Regular JJ O O
, , O O
rate NN B-NP O
, , O O
and CC O O
rhythm NN B-NP O
. . B-VP O
   
Femoral JJ B-NP B-test
pulses NNS I-NP I-test
normal JJ O O
, , O O
S1 NNP B-NP O
, , O O
S2 NNP B-NP O
were VBD B-VP O
normal JJ O O
. . B-VP O
   
There EX O B-pronoun
was VBD B-VP O
a DT O B-problem
1/6 CD O I-problem
systolic JJ B-NP I-problem
ejection NN I-NP I-problem
murmur NN I-NP I-problem
in IN B-VP O
the DT O O
upper JJ O O
left VBD B-VP O
sternal JJ B-NP O
border NN I-NP O
without IN B-VP O
radiation NN B-NP B-problem
. . B-VP O
   
Abdomen NNP B-NP O
was VBD B-VP O
soft JJ O O
, , O O
nontender NN B-NP B-problem
, , O O
no DT B-NP O
organomegaly NN I-NP B-problem
, , O O
no DT B-NP O
masses NNS I-NP B-problem
. . B-VP O
   
Bowel NNP B-NP B-test
sounds NNS I-NP I-test
are VBP O O
active JJ O O
and CC O O
patent NN B-NP O
. . B-VP O
   
CNS NNP B-NP O
active JJ O O
, , O O
responsive JJ O O
to TO O O
stimulation NN B-NP B-test
. . B-VP O
   
Pupils NNS B-NP O
are VBP O O
reactive JJ O O
to TO O O
light JJ O O
. . B-VP O
   
Tone NN B-NP B-test
is VBZ O O
normal JJ O O
, , O O
moving VBG O O
all DT B-NP O
limbs NNS I-NP O
symmetrically RB O O
, , O O
irritable JJ O B-problem
with IN B-VP O
palpation NN B-NP B-test
of IN B-VP I-test
the DT B-NP I-test
scalp NN I-NP I-test
. . B-VP O
   
Suck NNP B-NP B-test
, , O O
root NN B-NP B-test
, , O O
gag NN B-NP B-test
, , O O
grasp NN B-NP B-test
, , O O
and CC O O
morrow NN B-NP B-test
were VBD B-VP O
normal JJ O O
. . B-VP O
   
Skin NN B-NP O
: : O O
Pale NNP B-NP O
as IN B-VP O
above IN B-VP O
, , O O
nonicteric JJ O B-problem
. . B-VP O
   
Musculoskeletal JJ O O
: : O O
Normal JJ B-NP O
spine NN I-NP O
, , O O
hip NN B-NP O
, , O O
clavicles NNS B-NP O
, , O O
small JJ B-NP B-problem
mass NN I-NP I-problem
at IN B-VP O
the DT B-NP O
site NN I-NP O
of IN B-VP O
previous JJ B-NP B-treatment
right JJ I-NP I-treatment
quadriceps NNS I-NP I-treatment
intramuscular JJ B-NP I-treatment
injection NN I-NP I-treatment
. . B-VP O
   
An DT B-NP B-test
initial JJ I-NP I-test
head NN I-NP I-test
CT NNP I-NP I-test
scan NN I-NP I-test
had VBD B-VP O
revealed VBN O O
extracranial JJ B-NP B-problem
soft JJ I-NP I-problem
tissue NN I-NP I-problem
swelling VBG O I-problem
most JJS O O
prominently RB O O
at IN B-VP O
the DT B-NP O
right JJ I-NP O
frontal-parietal-occipital JJ I-NP O
area NN I-NP O
extending VBG O O
to TO O O
the DT B-NP O
left NN I-NP O
and CC O O
to TO O O
the DT B-NP O
upper JJ I-NP O
cervical JJ I-NP O
region NN I-NP O
. . B-VP O
   
Ventricles NNS B-NP O
were VBD B-VP O
symmetrical JJ O O
and CC O O
not RB O O
compressed VBN O O
. . B-VP O
   
No DT B-NP O
gross JJ I-NP B-problem
intraparenchymal JJ I-NP I-problem
hemorrhage NN I-NP I-problem
. . B-VP O
   
But CC O O
upon IN B-VP O
further JJ B-NP O
radiology NN I-NP O
attending VBG O O
Stoughton NNP B-NP O
, , O O
there EX O B-pronoun
was VBD B-VP O
a DT B-NP B-problem
small JJ I-NP I-problem
bilateral JJ I-NP I-problem
occipital JJ I-NP I-problem
subdural JJ I-NP I-problem
hemorrhage NN I-NP I-problem
noted VBD B-VP O
. . B-VP O
   
The DT B-NP B-test
initial JJ I-NP I-test
hematocrit NN I-NP I-test
was VBD B-VP O
21.2 CD O O
, , O O
platelets NNS B-NP B-test
186 CD O O
. . B-VP O
   
PT NNP B-NP B-test
was VBD B-VP O
14.6 CD O O
, , O O
PTT NNP B-NP B-test
77 CD O O
with IN B-VP O
an DT B-NP B-test
INR NNP I-NP I-test
of IN B-VP O
1.4 CD O O
. . B-VP O
   
Fibrinogen NN B-NP B-test
was VBD B-VP O
192 CD O O
. . B-VP O
   
D-dimer NN B-NP B-test
was VBD B-VP O
negative JJ O O
. . B-VP O
   
ASSESSMENT NN B-NP O
: : O O
This DT O B-pronoun
is VBZ O O
a DT B-NP O
term NN I-NP O
infant NN I-NP O
with IN B-VP O
significant JJ B-NP B-problem
subgaleal JJ I-NP I-problem
hematoma NN I-NP I-problem
with IN B-VP O
apparent JJ B-NP O
extension NN I-NP O
over IN B-VP O
the DT O O
past JJ O O
six CD O O
hours NNS B-NP O
. . B-VP O
   
There EX O B-pronoun
was VBD B-VP O
also RB O O
elevation NN B-NP B-problem
of IN B-VP O
the DT B-NP B-test
PTT NNP I-NP I-test
suggesting VBG O O
possible JJ B-NP O
inborn JJ I-NP B-problem
coagulopathy NN I-NP I-problem
. . B-VP O
   
There EX O B-pronoun
is VBZ O O
also RB O O
critical JJ B-NP B-problem
anemia NN I-NP I-problem
secondary JJ O O
to TO O O
the DT B-NP B-problem
subgaleal JJ I-NP I-problem
hemorrhage NN I-NP I-problem
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
admitted VBN O O
to TO O O
the DT B-NP O
CMED NNP I-NP O
CCU NNP I-NP O
for IN B-VP O
further JJ B-NP B-treatment
management NN I-NP I-treatment
. . B-VP O
   
SUMMARY NNP B-NP O
OF IN B-VP O
HOSPITAL NNP B-NP O
COURSE NNP I-NP O
BY NNP I-NP O
SYSTEMS NNP I-NP O
: : O O
1. CD O O
Respiratory NN B-NP O
: : O O
Patient NN B-NP B-person
has VBZ O O
been VBN O O
on IN B-VP O
room NN B-NP O
air NN I-NP O
maintaining VBG O O
sats NNS B-NP B-test
above IN B-VP O
95% CD O O
. . B-VP O
   
No DT B-NP O
apnea NN I-NP B-problem
or CC O O
bradycardia NN B-NP B-problem
. . B-VP O
   
2. CD O O
Cardiovascular JJ O O
: : O O
There EX O B-pronoun
was VBD B-VP O
an DT B-NP B-problem
initial JJ I-NP I-problem
murmur NN I-NP I-problem
on IN B-VP O
admission NN B-NP O
likely RB O O
secondary JJ O O
to TO O O
severe VB O B-problem
anemia NN B-NP I-problem
which WDT O B-pronoun
has VBZ O O
since IN B-VP O
resolved VBN O O
. . B-VP O
   
He PRP O B-person
remained VBD B-VP O
hemodynamically RB O O
stable JJ O O
throughout IN B-VP O
this DT B-NP B-pronoun
admission NN I-NP O
. . B-VP O
   
3. CD O O
FEN NN B-NP O
: : O O
Patient NN B-NP B-person
was VBD B-VP O
restarted VBN O O
on IN B-VP O
po NN B-NP O
feeds NNS I-NP O
as IN B-VP O
of IN B-VP O
day NN B-NP O
of IN B-VP O
life NN B-NP O
three CD O O
after IN B-VP O
the DT B-NP B-problem
bleeding NN I-NP I-problem
had VBD B-VP O
stabilized VBN O O
. . B-VP O
   
He PRP O B-person
has VBZ O O
been VBN O O
taking VBG O O
breast JJ B-NP O
milk NN I-NP O
or CC O O
Enfamil NNP B-NP B-treatment
20 CD O O
po NN B-NP O
adlib NN I-NP O
. . B-VP O
   
His PRP$ O B-person
His PRP$ O B-test
admission NN B-NP I-test
weight NN I-NP I-test
was VBD B-VP O
3850 CD O O
grams NN B-NP O
. . B-VP O
   
His PRP$ O B-person
His PRP$ O B-test
weight NN B-NP I-test
on IN B-VP I-test
discharge NN B-NP I-test
was VBD B-VP O
4055 CD O O
. . B-VP O
   
4. CD O O
GI NN B-NP O
: : O O
Given VBN O O
the DT B-NP O
significant JJ I-NP O
amount NN I-NP O
of IN B-VP O
bleeding NN B-NP B-problem
, , O O
baby NN B-NP B-person
was VBD B-VP O
started VBN O O
prophylactically RB O O
on IN B-VP O
phototherapy NN B-NP B-treatment
. . B-VP O
   
His PRP$ O B-test
His PRP$ O B-person
bilirubin NN B-NP I-test
peaked VBD B-VP O
on IN B-VP O
day NN B-NP O
of IN B-VP O
life NN B-NP O
three CD O O
at IN B-VP O
5.4 CD O O
with IN B-VP O
a DT B-NP B-test
subsequent JJ I-NP I-test
bilirubin NN I-NP I-test
of IN B-VP O
4.6 CD O O
at IN B-VP O
which WDT O B-pronoun
time NN B-NP O
phototherapy NN I-NP B-treatment
was VBD B-VP O
discontinued VBN O O
. . B-VP O
   
5. CD O O
Hematology NN B-NP O
: : O O
Given VBN O O
the DT B-NP O
rapid JJ I-NP O
extension NN I-NP O
of IN B-VP O
the DT B-NP B-problem
subgaleal NN I-NP I-problem
bleed NN I-NP I-problem
, , O O
coagulopathy JJ B-NP B-test
workup NN I-NP I-test
was VBD B-VP O
initiated VBN O O
revealing VBG O O
an DT B-NP B-problem
elevated JJ I-NP I-problem
PTT NNP I-NP I-problem
level NN I-NP I-problem
of IN B-VP O
77 CD O O
as RB O O
well RB O O
as IN B-VP O
factor NN B-NP B-test
8 CD O I-test
level NN B-NP I-test
that WDT O B-pronoun
was VBD B-VP O
below IN B-VP O
detection NN B-NP O
in IN B-VP O
the DT B-NP O
presence NN I-NP O
of IN B-VP O
normal JJ B-NP O
factors NNS I-NP O
5 CD O O
, , O O
9 CD O O
, , O O
10 CD O O
, , O O
and CC O O
11 CD O O
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
started VBN O O
on IN B-VP O
a DT O B-treatment
50 CD O I-treatment
units NNS B-NP I-treatment
/ VBP O I-treatment
kg JJ B-NP I-treatment
bolus NN I-NP I-treatment
of IN B-VP I-treatment
factor NN B-NP I-treatment
8 CD O I-treatment
followed VBN O O
by IN B-VP O
continuous JJ B-NP B-treatment
factor NN I-NP I-treatment
8 CD O I-treatment
infusions NNS B-NP I-treatment
at IN B-VP O
50 CD O O
units NNS B-NP O
/ VBP O O
kg JJ B-NP O
/ NNP I-NP O
day NN I-NP O
divided VBD B-VP O
until IN B-VP O
hourly JJ B-NP O
infusion NN I-NP O
rates NNS I-NP O
at IN B-VP O
05-10 NNP B-NP O
. . B-VP O
   
Subsequent NNP B-NP B-test
factor NN I-NP I-test
8 CD O I-test
levels NNS B-NP I-test
varied VBN O O
with IN B-VP O
an DT B-NP B-test
initial JJ I-NP I-test
factor NN I-NP I-test
8 CD O I-test
level NN B-NP I-test
of IN B-VP O
18 CD O O
after IN B-VP O
the DT B-NP B-treatment
bolus NN I-NP I-treatment
with IN B-VP O
which WDT O B-pronoun
he PRP O B-person
received VBD B-VP O
another DT B-NP O
bolus NN I-NP B-treatment
of IN B-VP I-treatment
factor NN B-NP I-treatment
8 CD O I-treatment
of IN B-VP O
50 CD O O
units NNS B-NP O
/ NNP I-NP O
kg NN I-NP O
and CC O O
increased VBD B-VP B-treatment
factor NN B-NP I-treatment
8 CD O I-treatment
infusion NN B-NP I-treatment
rate NN I-NP I-treatment
to TO O O
65 CD O O
units NNS B-NP O
/ VBP O O
kg JJ B-NP O
/ NNP I-NP O
day NN I-NP O
. . B-VP O
   
As IN B-VP O
of IN B-VP O
05-17 NN B-NP O
, , O O
he PRP O B-person
was VBD B-VP O
switched VBN O O
over IN B-VP O
to TO O O
bolus VB O B-treatment
infusion NN B-NP I-treatment
in IN B-VP O
preparation NN B-NP O
of IN B-VP O
continued JJ B-NP B-treatment
home NN I-NP I-treatment
factor NN I-NP I-treatment
8 CD O I-treatment
administration NN B-NP I-treatment
. . B-VP O
   
His PRP$ O B-person
His PRP$ O B-test
peak NN B-NP I-test
level NN I-NP I-test
after IN B-VP O
a DT B-NP O
bolus NN I-NP O
of IN B-VP O
75 CD O O
units NNS B-NP O
/ NNP I-NP O
kg NN I-NP O
of IN B-VP O
factor NN B-NP B-treatment
8 CD O I-treatment
was VBD B-VP O
131 CD O O
. . B-VP O
   
A DT B-NP B-test
trough JJ I-NP I-test
level NN I-NP I-test
at IN B-VP O
20 CD O O
hours NNS B-NP O
after IN B-VP O
the DT B-NP B-treatment
bolus NN I-NP I-treatment
on IN B-VP O
day NN B-NP O
of IN B-VP O
discharge NN B-NP O
was VBD B-VP O
29 CD O O
. . B-VP O
   
He PRP O B-person
will MD O O
continue VB O O
to TO O O
receive VB O O
factor NN B-NP B-treatment
8 CD O I-treatment
bolus JJ B-NP I-treatment
q NNS I-NP O
day NN I-NP O
for IN B-VP O
a DT B-NP O
total NN I-NP O
of IN B-VP O
2-3 JJ B-NP O
weeks NNS I-NP O
in IN B-VP O
light NN B-NP O
of IN B-VP O
the DT B-NP B-problem
intracranial JJ I-NP I-problem
hemorrhage NN I-NP I-problem
, , O O
and CC O O
will MD O O
be VB O O
followed VBN O O
by IN B-VP O
Hematology NNP B-NP B-person
visiting VBG O I-person
nurse JJ B-NP I-person
Michael NNP I-NP B-person
Edwards NNP I-NP I-person
level NN I-NP O
checks NNS I-NP O
at IN B-VP O
home NN B-NP O
. . B-VP O
   
Currently RB O O
, , O O
the DT B-NP B-treatment
infusion NN I-NP I-treatment
of IN B-VP O
factor NN B-NP B-treatment
8 CD O I-treatment
are VBP O O
going VBG O O
through IN B-VP O
a DT B-NP B-treatment
jugular NN I-NP I-treatment
Broviac NNP I-NP I-treatment
which WDT O B-pronoun
was VBD B-VP O
placed VBN O O
on IN B-VP O
05-15 NN B-NP O
for IN B-VP O
administration NN B-NP O
of IN B-VP O
factor NN B-NP B-treatment
. . B-VP O
   
His PRP$ O B-person
His PRP$ O B-test
last JJ B-NP I-test
PTT NNP I-NP I-test
on IN B-VP O
05-16 NNP B-NP O
was VBD B-VP O
68.3 CD O O
. . B-VP O
   
The DT B-NP B-test
last JJ I-NP I-test
hematocrit NN I-NP I-test
was VBD B-VP O
on IN B-VP O
05-16 NN B-NP O
of IN B-VP O
54.5 CD O O
. . B-VP O
   
6. CD O O
Neurology NN B-NP O
: : O O
Baby NNP B-NP B-person
Mary NNP I-NP I-person
Stead NNP I-NP I-person
initially RB O O
presented VBD B-VP O
with IN B-VP O
significant JJ B-NP B-problem
subgaleal JJ I-NP I-problem
bleed NN I-NP I-problem
as RB O O
well RB O O
as IN B-VP O
a DT B-NP B-problem
small JJ I-NP I-problem
subdural JJ I-NP I-problem
hemorrhage NN I-NP I-problem
. . B-VP O
   
A DT B-NP B-test
repeat NN I-NP I-test
head NN I-NP I-test
CT NNP I-NP I-test
scan JJ O I-test
on IN B-VP O
05-15 NN B-NP O
had VBD B-VP O
shown VBN O O
the DT B-NP O
resolution NN I-NP O
of IN B-VP O
the DT B-NP B-problem
subdural JJ I-NP I-problem
hematoma NN I-NP I-problem
and CC O O
significant JJ B-NP O
improvement NN I-NP O
of IN B-VP O
the DT B-NP B-problem
subgaleal JJ I-NP I-problem
bleed NN I-NP I-problem
. . B-VP O
   
His PRP$ O B-person
His PRP$ O B-test
head NN B-NP I-test
ultrasound NN I-NP I-test
on IN B-VP O
05-14 NN B-NP O
reveals NNS I-NP O
no DT B-NP O
interventricular JJ I-NP B-problem
hemorrhage NN I-NP I-problem
. . B-VP O
   
He PRP O B-person
had VBD B-VP O
remained VBN O O
neurologically RB O O
stable JJ O O
. . B-VP O
   
His PRP$ O B-person
His PRP$ O B-test
head NN B-NP I-test
circumference NN I-NP I-test
on IN B-VP O
05-18 NN B-NP O
was VBD B-VP O
36.5 CD O O
cm NN B-NP O
with IN B-VP O
a DT B-NP B-test
maximum JJ I-NP I-test
head NN I-NP I-test
circumference NN I-NP I-test
on IN B-VP O
admission NN B-NP O
of IN B-VP O
40.5 CD O O
cm NN B-NP O
. . B-VP O
   
7. CD O O
Social JJ O O
: : O O
Both DT B-NP B-person
parents NNS I-NP I-person
are VBP O O
very RB O O
involved JJ O O
in IN B-VP O
the DT B-NP O
care NN I-NP O
of IN B-VP O
Baby NNP B-NP B-person
Norman NNP I-NP I-person
Stead NNP I-NP I-person
. . B-VP O
   
They PRP O B-pronoun
have VBP O O
been VBN O O
informed VBN O O
up RP O O
to TO O O
date NN B-NP O
on IN B-VP O
his PRP$ O B-person
needs NNS B-NP O
, , O O
discharge NN B-NP O
from IN B-VP O
the DT B-NP O
hospital NN I-NP O
. . B-VP O
   
Teaching NN B-NP O
has VBZ O O
been VBN O O
completed VBN O O
on IN B-VP O
the DT B-NP O
care NN I-NP O
of IN B-VP O
the DT B-NP B-treatment
Boviak NNP I-NP I-treatment
as RB O O
well RB O O
as IN B-VP O
administration NN B-NP O
of IN B-VP O
factor NN B-NP B-treatment
8 CD O I-treatment
. . B-VP O
   
8. CD O O
Sensory JJ O O
: : O O
Audiology NN B-NP O
: : O O
Hearing NN B-NP B-test
screen NN I-NP I-test
was VBD B-VP O
performed VBN O O
automated JJ B-NP O
auditory NN I-NP O
brain NN I-NP O
stem NN I-NP O
responses NNS I-NP O
and CC O O
Baby NNP B-NP B-person
David NNP I-NP I-person
Stead NNP I-NP I-person
passed VBD B-VP O
bilaterally RB O O
. . B-VP O
   
CONDITION NNP B-NP O
ON NNP I-NP O
DISCHARGE NNP I-NP O
: : O O
Baby NNP B-NP B-person
Julian NNP I-NP I-person
Stead NNP I-NP I-person
had VBD B-VP O
been VBN O O
stable JJ O O
with IN B-VP O
improvement NN B-NP O
of IN B-VP O
the DT B-NP B-problem
subgaleal NN I-NP I-problem
bleed NN I-NP I-problem
and CC O O
good JJ B-NP O
peak NN I-NP O
and CC O O
trough JJ B-NP O
factor NN I-NP O
8 CD O O
levels NNS B-NP O
after IN B-VP O
the DT B-NP B-treatment
bolus JJ I-NP I-treatment
infusion NN I-NP I-treatment
. . B-VP O
   
DISPOSITION NN B-NP O
: : O O
Baby NNP B-NP B-person
Corine NNP I-NP I-person
Stead NNP I-NP I-person
is VBZ O O
to TO O O
be VB O O
discharged VBN O O
home NN B-NP O
with IN B-VP O
parents NNS B-NP B-person
with IN B-VP O
close JJ B-NP O
Hematology NNP I-NP B-person
VNA NNP I-NP I-person
followup NN I-NP O
. . B-VP O
   
NAME NN B-NP O
OF NNP I-NP O
PRIMARY NNP I-NP B-person
PEDIATRICIAN NNP I-NP I-person
: : O O
Dr. NNP B-NP B-person
Pearly NNP I-NP I-person
Reilly NNP I-NP I-person
, , O O
208-4200 JJ O O
. . B-VP O
   
CARE NNP B-NP O
AND CC O O
RECOMMENDATIONS NNP B-NP O
: : O O
1. CD O O
Feeds NNS B-NP O
at IN B-VP O
discharge NN B-NP O
: : O O
Breast NNP B-NP O
milk NN I-NP O
Enfamil NNP I-NP B-treatment
20 CD O O
po NN B-NP O
adlib NN I-NP O
as IN B-VP O
tolerated VBN O O
. . B-VP O
   
2. CD O O
Medications NNS B-NP O
: : O O
Factor NN B-NP B-treatment
8 CD O I-treatment
boluses NNS B-NP I-treatment
at IN B-VP O
75 CD O O
units NNS B-NP O
/ VBP O O
kg JJ B-NP O
/ NNP I-NP O
day NN I-NP O
. . B-VP O
   
3. CD O O
Car NNP B-NP B-test
seat NN I-NP I-test
position NN I-NP I-test
screening VBG O I-test
passed VBN O O
. . B-VP O
   
4. CD O O
State NNP B-NP B-test
Newborn NNP I-NP I-test
Screen NNP I-NP I-test
sent VBD B-VP O
. . B-VP O
   
5. CD O O
Immunizations NNS B-NP O
: : O O
Received VBN O O
hepatitis NN B-NP B-treatment
B NNP I-NP I-treatment
vaccination NN I-NP I-treatment
on IN B-VP O
05-16 JJ O O
. . B-VP O
   
FOLLOW-UP JJ B-NP O
APPOINTMENT NN I-NP O
: : O O
Scheduled VBN O O
for IN B-VP O
05-21 NN B-NP O
. . B-VP O
   
DISCHARGE NNP B-NP O
DIAGNOSIS NNP I-NP O
: : O O
1. CD O O
Factor NN B-NP B-problem
8 CD O I-problem
deficiency NN B-NP I-problem
. . B-VP O
   
2. CD O O
Subgaleal JJ B-NP B-problem
hemorrhage NN I-NP I-problem
, , O O
resolved VBN O O
. . B-VP O
   
3. CD O O
Small JJ B-NP B-problem
occipital JJ I-NP I-problem
subdural JJ I-NP I-problem
hemorrhage NN I-NP I-problem
, , O O
resolved VBN O O
Reviewed VBN O O
By IN B-VP O
: : O O
Mavis NNP B-NP B-person
W. NNP I-NP I-person
Mobley, NNP I-NP I-person
M.D. NNP I-NP I-person
21-114 JJ O O
Dictated VBN O O
By IN B-VP O
: : O O
William NNP B-NP B-person
A. NN I-NP I-person
Hunter NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
MEDQUIST36 NNP I-NP O
D NNP I-NP O
: : O O
2012-05-18 JJ O O
13:58 CD O O
T NN B-NP O
: : O O
2012-05-18 JJ O O
14:22 CD O O
JOB NNP B-NP O
#: VBD B-VP O
93716 CD O O
Signed VBN O O
electronically RB O O
by IN B-VP O
: : O O
DR. NNP B-NP B-person
George NNP I-NP I-person
Sherwood NNP I-NP I-person
on IN B-VP O
: : O O
MON NNP B-NP O
2012-05-21 JJ O O
11:57 CD O O
AM NNP B-NP O
( ( O O
End NNP B-NP O
of IN B-VP O
Report NNP B-NP O
) ) O O
-EMPTYLINE- VBP O O
-DOCSTART- JJ O O
-EMPTYLINE- $ O O
013496896 CD O O
FIH NNP B-NP O
4925669 CD O O
21983/7jk2 CD O O
129165 CD O O
02/22/1992 CD O O
12:00:00 CD O O
AM NNP B-NP O
LEFT NNP I-NP B-problem
CORONARY NNP I-NP I-problem
ARTERY NNP I-NP I-problem
STENOSIS NNP I-NP I-problem
. . B-VP O
   
Unsigned VBD B-VP O
DIS NNP B-NP O
Report NNP I-NP O
Status NNP I-NP O
: : O O
Unsigned VBN O O
ADMISSION NNP B-NP O
DATE NNP I-NP O
: : O O
02/22/92 CD O O
DISCHARGE NNP B-NP O
DATE NNP I-NP O
: : O O
03/08/92 CD O O
PRINCIPAL NNP B-NP O
DIAGNOSIS NNP I-NP O
: : O O
left VBD B-VP B-problem
coronary JJ B-NP I-problem
artery NN I-NP I-problem
stenosis NN I-NP I-problem
. . B-VP O
   
ASSOCIATED CC O O
DIAGNOSIS NNP B-NP O
: : O O
diabetes NNS B-NP B-problem
mellitus VBP O I-problem
with IN B-VP O
diabetic JJ B-NP B-problem
renopathy NN I-NP I-problem
, , O O
renovascular JJ B-NP B-problem
occlusive JJ I-NP I-problem
disease NN I-NP I-problem
, , O O
with IN B-VP O
thrombosis NN B-NP B-problem
of IN B-VP I-problem
the DT B-NP I-problem
right JJ I-NP I-problem
renal JJ I-NP I-problem
artery NN I-NP I-problem
, , O O
hypertension NN B-NP B-problem
, , O O
probably RB O O
renal JJ B-NP O
vascular NN I-NP O
, , O O
hypertensive JJ B-NP B-problem
cardiac JJ I-NP I-problem
disease NN I-NP I-problem
with IN B-VP O
history NN B-NP O
of IN B-VP O
congestive JJ B-NP B-problem
heart NN I-NP I-problem
failure NN I-NP I-problem
, , O O
chronic JJ B-NP B-problem
renal JJ I-NP I-problem
insufficiency NN I-NP I-problem
, , O O
coronary JJ B-NP B-problem
artery NN I-NP I-problem
disease NN I-NP I-problem
. . B-VP O
   
PRINCIPAL JJ B-NP O
PROCEDURE NNP I-NP O
: : O O
03/03/92 CD O O
- : O O
left VBD B-VP B-treatment
carotid JJ B-NP I-treatment
endarterectomy NN I-NP I-treatment
with IN B-VP O
continuous JJ B-NP B-test
interoperative JJ I-NP I-test
electroencephalogram NN I-NP I-test
monitoring NN I-NP I-test
and CC O O
saphenous JJ B-NP B-treatment
vein NNS I-NP I-treatment
patch VBP O I-treatment
closure NN B-NP I-treatment
. . B-VP O
   
ASSOCIATED NNP B-NP O
PROCEDURES NNP I-NP O
: : O O
Sep/24/05 NNP B-NP O
cardiac JJ B-NP B-test
catheterization NN I-NP I-test
and CC O O
coronary JJ B-NP B-test
angiography NN I-NP I-test
, , O O
02/23/92 CD O O
- : O O
transfemoral JJ B-NP B-test
aortogram NN I-NP I-test
, , O O
bilateral JJ B-NP B-test
carotid NN I-NP I-test
arteriogram NN I-NP I-test
, , O O
abdominal JJ B-NP B-test
aortogram NN I-NP I-test
. . B-VP O
   
HISTORY NNP B-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS NNP I-NP O
: : O O
Patient NN B-NP B-person
is VBZ O O
a DT O O
72 CD O O
year NN B-NP O
old JJ B-NP O
female NN I-NP O
with IN B-VP O
known VBN O B-problem
carotid NN B-NP I-problem
stenosis NN I-NP I-problem
, , O O
and CC O O
recent JJ B-NP B-test
carotid NN I-NP I-test
noninvasives NNS I-NP I-test
at IN B-VP O
an DT B-NP O
outside JJ I-NP O
hospital NN I-NP O
, , O O
which WDT O B-pronoun
showed VBD B-VP O
90% CD O B-problem
left NNS B-NP I-problem
sided VBD B-VP I-problem
stenosis NN B-NP I-problem
. . B-VP O
   
She PRP O B-person
has VBZ O O
not RB O O
had VBN O O
a DT B-NP B-problem
stroke NN I-NP I-problem
, , O O
or CC O O
transient JJ B-NP B-problem
ischemic JJ I-NP I-problem
attack NN I-NP I-problem
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
recently RB O O
discharged VBN O O
from IN B-VP O
the DT B-NP O
Per NNP I-NP O
Naplesspecrycet NNP I-NP O
Hospital NNP I-NP O
after IN B-VP O
an DT B-NP O
admission NN I-NP O
for IN B-VP O
congestive JJ B-NP B-problem
heart NN I-NP I-problem
failure NN I-NP I-problem
. . B-VP O
   
PAST NNP B-NP O
MEDICAL NNP I-NP O
HISTORY NNP I-NP O
: : O O
As IN B-VP O
noted VBN O O
. . B-VP O
   
PAST JJ B-NP O
SURGICAL JJ I-NP O
HISTORY NN I-NP O
: : O O
Significant NN B-NP O
for IN B-VP O
having VBG O O
had VBD B-VP O
a DT B-NP B-treatment
cholecystectomy NN I-NP I-treatment
and CC O O
hysterectomy NN B-NP B-treatment
, , O O
tonsillectomy NN B-NP B-treatment
and CC O O
adenoidectomy NN B-NP B-treatment
, , O O
and CC O O
mastoidectomy NN B-NP B-treatment
. . B-VP O
   
MEDICATIONS NNP B-NP O
ON NNP I-NP O
ADMISSION NNP I-NP O
: : O O
Insulin NNP B-NP B-treatment
44 CD O O
units NNS B-NP O
NPH NNP I-NP B-treatment
qam NN I-NP O
; : O O
8 CD O O
units NNS B-NP O
qpm RB O O
; : O O
Vasotec NNP B-NP B-treatment
2.5 CD O O
qd NN B-NP O
; : O O
Lasix NNP B-NP B-treatment
40 CD O O
qd NN B-NP O
; : O O
Mevacor NNP B-NP B-treatment
40 CD O O
qd NN B-NP O
; : O O
Cardizem NNP B-NP B-treatment
CD NNP I-NP I-treatment
180 CD O O
qd NN B-NP O
; : O O
Ciprofloxacin NNP B-NP B-treatment
for IN B-VP O
urinary JJ B-NP B-problem
tract NN I-NP I-problem
infection NN I-NP I-problem
; : O O
aspirin NN B-NP B-treatment
. . B-VP O
   
ALLERGIES NN B-NP O
: : O O
Seldane NNP B-NP B-treatment
causes VBZ O O
gastrointestinal JJ B-NP B-problem
distress NN I-NP I-problem
. . B-VP O
   
PHYSICAL JJ B-NP O
EXAMINATION NN I-NP O
: : O O
Clear JJ B-NP O
chest NN I-NP O
. . B-VP O
   
Cardiac JJ O O
: : O O
regular JJ B-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
. . B-VP O
   
Extremities NNS B-NP O
: : O O
revealed VBD B-VP O
2+ CD O B-test
carotid NN B-NP I-test
pulses NNS I-NP I-test
with IN B-VP O
bruits NNS B-NP B-problem
bilaterally RB O I-problem
, , O O
2+ CD O B-test
radial NN B-NP I-test
, , O O
2+ CD O B-test
femoral JJ O I-test
, , O O
1+ CD O B-test
dorsalis NN B-NP I-test
pedis NN I-NP I-test
bilaterally RB O I-test
. . B-VP O
   
LABORATORY NNP B-NP O
DATA NNP I-NP O
ON NNP I-NP O
ADMISSION NNP I-NP O
: : O O
Significant NN B-NP O
for IN B-VP O
BUN NNP B-NP B-test
and CC O O
creatinine VB O B-test
33/2.4 CD O O
. . B-VP O
   
HOSPITAL NNP B-NP O
COURSE NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
admitted VBN O O
to TO O O
the DT B-NP O
Tau NNP I-NP O
Memorial NNP I-NP O
Hospital NNP I-NP O
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
seen VBN O O
by IN B-VP O
Dr. NNP B-NP B-person
Freiermthalskush NNP I-NP I-person
of IN B-VP O
the DT B-NP O
renal JJ I-NP B-person
service NN I-NP I-person
for IN B-VP O
management NN B-NP B-treatment
of IN B-VP O
her PRP$ O B-person
her PRP$ O B-problem
chronic JJ B-NP I-problem
renal JJ I-NP I-problem
insufficiency NN I-NP I-problem
. . B-VP O
   
On IN B-VP O
02/22 CD O O
, , O O
she PRP O B-person
underwent JJ B-NP O
angiography NN I-NP B-test
, , O O
which WDT O B-pronoun
revealed VBD B-VP O
minimal JJ B-NP B-problem
right JJ I-NP I-problem
internal JJ I-NP I-problem
carotid NN I-NP I-problem
artery NN I-NP I-problem
disease NN I-NP I-problem
, , O O
and CC O O
proximal JJ O B-problem
left VBD B-VP I-problem
internal JJ B-NP I-problem
carotid NN I-NP I-problem
artery NN I-NP I-problem
stenosis NN I-NP I-problem
, , O O
2 CD O O
cm NN B-NP O
in IN B-VP O
length NN B-NP O
for IN B-VP O
the DT O O
1 CD O O
mm NN B-NP O
residual JJ B-NP O
lumen NNS I-NP O
. . B-VP O
   
The DT O O
left JJ O O
anterior JJ O O
communicating VBG O O
artery NN B-NP O
fell VBD B-VP O
from IN B-VP O
the DT B-NP O
right NN I-NP O
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
also RB O O
seen VBN O O
by IN B-VP O
Cardiology NNP B-NP B-person
, , O O
and CC O O
she PRP O B-person
underwent JJ B-NP O
cardiac JJ I-NP B-test
catheterization NN I-NP I-test
, , O O
as IN B-VP O
part NN B-NP O
of IN B-VP O
her PRP$ O B-test
her PRP$ O B-person
preop JJ B-NP I-test
evaluation NN I-NP I-test
, , O O
which WDT O B-pronoun
revealed VBD B-VP O
normal JJ O O
resting VBG O O
hemodynamics NNS B-NP O
, , O O
and CC O O
a DT B-NP O
moderate JJ I-NP O
posterior NN I-NP O
descending VBG O O
artery NN B-NP O
, , O O
and CC O O
obtuse IN B-VP B-problem
marginal JJ B-NP I-problem
stenoses NNS I-NP I-problem
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
, , O O
therefore RB O O
, , O O
cleared VBD B-VP O
for IN B-VP O
the DT B-NP O
operating NN I-NP O
room NN I-NP O
, , O O
and CC O O
on IN B-VP O
3/3/92 CD O O
, , O O
she PRP O B-person
underwent VBD B-VP O
a DT B-NP B-treatment
left JJ I-NP I-treatment
carotid NN I-NP I-treatment
endarterectomy NN I-NP I-treatment
, , O O
with IN B-VP O
continuous JJ B-NP B-test
electroencephalogram NNS I-NP I-test
monitoring NN I-NP I-test
and CC O O
vein JJ B-NP B-treatment
patch NN I-NP I-treatment
angioplasty NN I-NP I-treatment
, , O O
which WDT O B-pronoun
was VBD B-VP O
uneventful JJ O O
. . B-VP O
   
Her PRP$ O B-person
postoperative JJ B-NP O
course NN I-NP O
was VBD B-VP O
marked VBN O O
only RB O O
by IN B-VP O
prolonged JJ B-NP B-problem
ileus NN I-NP I-problem
, , O O
perhaps RB O O
secondary JJ O O
to TO O O
constipation NN B-NP B-problem
, , O O
with IN B-VP O
persistent JJ B-NP B-problem
vomiting NN I-NP I-problem
, , O O
requiring VBG O O
intravenous JJ B-NP B-treatment
fluids NNS I-NP I-treatment
, , O O
however RB O O
, , O O
on IN B-VP O
03/07/92 CD O O
, , O O
she PRP O B-person
had VBD B-VP O
a DT B-NP O
large JJ I-NP O
bowel NN I-NP O
movement NN I-NP O
, , O O
after IN B-VP O
aggressive JJ B-NP B-treatment
bowel NN I-NP I-treatment
regime NN I-NP I-treatment
, , O O
felt VBD B-VP O
significantly RB O O
better JJR O O
, , O O
was VBD B-VP O
able JJ O O
to TO O O
tolerate VB O O
PO NNP B-NP O
&apos;s NNP I-NP O
. . B-VP O
   
She PRP O B-person
is VBZ O O
now RB O O
able JJ O O
to TO O O
be VB O O
discharged VBN O O
home NN B-NP O
on IN B-VP O
her PRP$ O B-treatment
her PRP$ O B-person
admission NN B-NP I-treatment
medications NNS I-NP I-treatment
, , O O
with IN B-VP O
the DT B-NP O
exception NN I-NP O
of IN B-VP O
the DT B-NP O
fact NN I-NP O
that IN B-VP B-pronoun
Vasotec NNP B-NP B-treatment
was VBD B-VP O
increased VBN O O
to TO O O
10 CD O O
mg NNS B-NP O
PO NNP I-NP O
bid NN I-NP O
. . B-VP O
   
SHERMENE NNP B-NP B-person
JESCSELC NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
DICTATING NNP I-NP O
FOR NNP I-NP O
: : O O
LENNI NNP B-NP B-person
BREUTZOLN NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
. . B-VP O
   
TR NN B-NP O
: : O O
pv NN B-NP O
/ NNP I-NP O
bmot NN I-NP O
DD NNP I-NP O
: : O O
03/08/92 CD O O
TD NN B-NP O
: : O O
03/10/92 CD O O
CC NN B-NP O
: : O O
Dr. NNP B-NP B-person
Person NNP I-NP I-person
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- VBD B-VP O
245096078 CD O O
FIH NNP B-NP O
9174858 CD O O
12/February CD O O
997359 CD O O
11/3/1992 CD O O
12:00:00 CD O O
AM NNP B-NP O
Discharge NNP I-NP O
Summary NNP I-NP O
Unsigned VBD B-VP O
DIS NNP B-NP O
Report NNP I-NP O
Status NNP I-NP O
: : O O
Unsigned VBN O O
ADMISSION NNP B-NP O
DATE NNP I-NP O
: : O O
11/3/92 CD O O
DISCHARGE NNP B-NP O
DATE NNP I-NP O
: : O O
12/6/92 CD O O
HISTORY NNP B-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
is VBZ O O
a DT O O
68 CD O O
year NN B-NP O
old JJ O O
, , O O
right RB O O
handed VBN O O
caucasian JJ B-NP O
female NN I-NP O
, , O O
former JJ B-NP O
R.N. NNP I-NP O
who WP O B-person
complained VBD B-VP O
of IN B-VP O
several JJ B-NP O
days NNS I-NP O
of IN B-VP O
vertigo NN B-NP B-problem
, , O O
one CD O O
day NN B-NP O
of IN B-VP O
double JJ B-NP B-problem
vision NN I-NP I-problem
, , O O
dysarthria NN B-NP B-problem
and CC O O
worsening NN B-NP O
of IN B-VP O
vertigo NN B-NP B-problem
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
seen VBN O O
at IN B-VP O
the DT B-NP O
outside JJ I-NP O
hospital NN I-NP O
and CC O O
put VB O O
on IN B-VP O
aspirin NN B-NP B-treatment
for IN B-VP O
two CD O O
days NNS B-NP O
. . B-VP O
   
An DT B-NP B-test
magnetic JJ I-NP I-test
resonance NN I-NP I-test
imaging NN I-NP I-test
study NN I-NP I-test
showed VBD B-VP O
basilar JJ B-NP B-problem
artery NN I-NP I-problem
disease NN I-NP I-problem
, , O O
questionable JJ B-NP O
aneurysm NN I-NP B-problem
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
transferred VBN O O
to TO O O
the DT B-NP O
Fairm NNP I-NP O
of IN B-VP O
Ijordcompmac NNP B-NP O
Hospital NNP I-NP O
. . B-VP O
   
An DT B-NP B-test
angiogram NN I-NP I-test
on IN B-VP O
11/3 CD O O
was VBD B-VP O
consistent JJ O O
with IN B-VP O
thrombosis NN B-NP B-problem
at IN B-VP I-problem
the DT B-NP I-problem
mid NN I-NP I-problem
basilar JJ B-NP I-problem
artery NN I-NP I-problem
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
put VBN O O
on IN B-VP O
heparin NN B-NP B-treatment
and CC O O
was VBD B-VP O
stable JJ O O
since IN B-VP O
. . B-VP O
   
PAST NNP B-NP O
MEDICAL NNP I-NP O
HISTORY NNP I-NP O
: : O O
Hypertension NN B-NP B-problem
for IN B-VP O
20 CD O O
years NNS B-NP O
, , O O
high JJ B-NP B-problem
cholesterol NN I-NP I-problem
, , O O
coronary JJ B-NP B-problem
artery NN I-NP I-problem
disease NN I-NP I-problem
with IN B-VP O
episodes NNS B-NP O
of IN B-VP O
angina NN B-NP B-problem
, , O O
no DT B-NP O
history NN I-NP O
of IN B-VP O
myocardial JJ B-NP B-problem
infarction NN I-NP I-problem
, , O O
exercise NN B-NP B-test
treadmill NN I-NP I-test
or CC O O
evaluation NN B-NP B-test
. . B-VP O
   
She PRP O B-person
has VBZ O O
had VBD B-VP O
an DT B-NP B-treatment
inguinal JJ I-NP I-treatment
hernia NN I-NP I-treatment
repair NN I-NP I-treatment
. . B-VP O
   
A DT B-NP B-treatment
left JJ I-NP I-treatment
breast NN I-NP I-treatment
lumpectomy NN I-NP I-treatment
was VBD B-VP O
reportedly RB O O
benign JJ O B-test
. . B-VP O
   
ALLERGIES NN B-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
has VBZ O O
no DT O O
known VBN O B-problem
drug NN B-NP I-problem
allergies NNS I-NP I-problem
. . B-VP O
   
MEDICATIONS NNP B-NP O
ON NNP I-NP O
ADMISSION NNP I-NP O
: : O O
Mevicor NNP B-NP B-treatment
60 CD O O
mg. NN B-NP O
PO NNP I-NP O
q.d. NN I-NP O
, , O O
Cardizem NNP B-NP B-treatment
90 CD O O
mg. NN B-NP O
w NN I-NP O
release NN I-NP O
PO NNP I-NP O
q.d. NN I-NP O
, , O O
Questran NNP B-NP B-treatment
one CD O O
pack NN B-NP O
q.i.d. NN I-NP O
, , O O
Niacin NNP B-NP B-treatment
500 CD O O
mg. NN B-NP O
PO NNP I-NP O
b.i.d. VBZ O O
SOCIAL NNP B-NP O
HISTORY NN I-NP O
: : O O
She PRP O B-person
is VBZ O O
a DT O O
one CD O O
pack NN B-NP O
per IN B-VP O
day NN B-NP O
smoker NN I-NP O
for IN B-VP O
the DT B-NP O
last JJ I-NP O
forty NN I-NP O
years NNS I-NP O
, , O O
denies VBZ O O
alcohol NN B-NP O
, , O O
is VBZ O O
a DT B-NP O
former JJ I-NP O
nurse NN I-NP O
with IN B-VP O
the DT B-NP O
Storm NNP I-NP O
Mor NNP I-NP O
Hospital NNP I-NP O
And CC O O
Medical NNP B-NP O
Center NNP I-NP O
. . B-VP O
   
PHYSICAL NNP B-NP O
EXAMINATION NN I-NP O
: : O O
Her PRP$ O B-person
Her PRP$ O B-test
blood NN B-NP I-test
pressure NN I-NP I-test
was VBD B-VP O
190/90 CD O O
when WRB O O
I PRP O B-person
first RB O O
saw VBD B-VP O
her PRP O B-person
on IN B-VP O
her PRP$ O B-person
second JJ B-NP O
hospital JJ I-NP O
day NN I-NP O
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
afebrile RB O B-problem
, , O O
in IN B-VP O
sinus NN B-NP O
rhythm NN I-NP O
, , O O
pulse RB O O
60 CD O O
. . B-VP O
   
Neck NN B-NP O
supple NN I-NP O
. . B-VP O
   
Lungs NNS B-NP O
clear JJ O O
. . B-VP O
   
Heart NN B-NP O
: : O O
regular JJ B-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
, , O O
without IN B-VP O
ectopy NN B-NP B-problem
. . B-VP O
   
A DT B-NP B-problem
II NNP I-NP I-problem
/ NNP I-NP I-problem
VI NNP I-NP I-problem
systolic JJ B-NP I-problem
ejection NN I-NP I-problem
murmur NN I-NP I-problem
is VBZ O O
at IN B-VP O
the DT B-NP O
base NN I-NP O
, , O O
minimal JJ B-NP B-problem
radiation NN I-NP I-problem
to TO O I-problem
the DT B-NP I-problem
carotids NNS I-NP I-problem
. . B-VP O
   
Abdomen NNS B-NP O
: : O O
soft JJ O O
, , O O
without IN B-VP O
hepatosplenomegaly NN B-NP B-problem
. . B-VP O
   
Extremities NNS B-NP O
: : O O
normal JJ B-NP O
pulses NNS I-NP O
, , O O
no DT B-NP O
clubbing NN I-NP B-problem
, , O O
cyanosis NN B-NP B-problem
or CC O O
edema NN B-NP B-problem
. . B-VP O
   
The DT B-NP B-test
neurological JJ I-NP I-test
examination NN I-NP I-test
: : O O
post NN B-NP O
angiogram IN B-VP B-test
her PRP$ O B-person
eyes NNS B-NP O
were VBD B-VP O
closed VBN O O
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
very RB O O
responsive JJ O O
, , O O
somewhat RB O B-problem
sleepy JJ O I-problem
, , O O
she PRP O B-person
complained VBD B-VP O
of IN B-VP O
chest NN B-NP B-problem
pain NN I-NP I-problem
, , O O
which WDT O B-pronoun
was VBD B-VP O
diffuse NN B-NP O
, , O O
non-localizing JJ O O
without IN B-VP O
electrocardiogram JJ B-NP B-problem
changes NNS I-NP I-problem
and CC O O
persisted VBN O O
for IN B-VP O
several JJ B-NP O
days NNS I-NP O
and CC O O
then RB O O
went VBD B-VP O
away RB O O
completely RB O O
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
oriented VBN O O
to TO O O
person NN B-NP O
, , O O
place NN B-NP O
, , O O
time NN B-NP O
and CC O O
purpose NN B-NP O
, , O O
she PRP O B-person
recalled VBD B-VP O
three CD O O
out IN B-VP O
of IN B-VP O
three CD O O
objects NNS B-NP O
at IN B-VP O
five CD O O
minutes NNS B-NP O
, , O O
she PRP O B-person
is VBZ O O
able JJ O O
to TO O O
do VB O O
calculations NNS B-NP O
. . B-VP O
   
She PRP O B-person
maintained VBD B-VP O
her PRP O B-person
fixation NN B-NP O
on IN B-VP O
the DT B-NP O
conversation NN I-NP O
well RB O O
. . B-VP O
   
The DT B-NP B-test
cranial JJ I-NP I-test
nerve NN I-NP I-test
exam NN I-NP I-test
: : O O
pupils NNS B-NP O
reactive VBP O O
to TO O O
light NN B-NP O
, , O O
extra JJ B-NP B-test
ocular JJ I-NP I-test
movements NNS I-NP I-test
show VBP O O
good JJ B-NP O
upgaze NN I-NP O
up RB O O
to TO O O
3 CD O O
mm. NNS B-NP O
, , O O
good JJ O O
down RP O O
gaze NN B-NP O
. . B-VP O
   
Right JJ B-NP B-test
lateral JJ I-NP I-test
gaze NN I-NP I-test
, , O O
the DT B-NP O
right NN I-NP O
eye NN I-NP O
had VBD B-VP O
2 CD O O
mm. NN B-NP O
of IN B-VP O
sclera NN B-NP O
showing NN I-NP O
, , O O
the DT B-NP O
left NN I-NP O
eye NN I-NP O
was VBD B-VP O
normal JJ O O
, , O O
and CC O O
there EX O O
are VBP O O
a DT B-NP O
few JJ I-NP O
beats NNS I-NP O
of IN B-VP O
right JJ O B-problem
beading VBG O I-problem
nystagmus RB O I-problem
. . B-VP O
   
The DT B-NP B-test
left JJ I-NP I-test
lateral JJ I-NP I-test
gaze NN I-NP I-test
, , O O
the DT B-NP O
left NN I-NP O
eye NN I-NP O
had VBD B-VP O
1 CD O O
mm. NN B-NP O
of IN B-VP O
lateral JJ B-NP O
sclera NN I-NP O
showing NN I-NP O
. . B-VP O
   
Disks NNS B-NP O
were VBD B-VP O
flat JJ O O
. . B-VP O
   
Sensory JJ B-NP O
limb NN I-NP O
of IN B-VP O
the DT B-NP O
right JJ I-NP O
eye NN I-NP O
corneal NN I-NP B-test
reflex NN I-NP I-test
is VBZ O O
slowed VBN O B-problem
, , O O
otherwise RB O O
normal JJ O O
. . B-VP O
   
Seventh NNP B-NP B-problem
nerve NN I-NP I-problem
weakness NN I-NP I-problem
on IN B-VP O
the DT B-NP O
right NN I-NP O
in IN B-VP O
a DT B-NP O
central JJ I-NP O
pattern NN I-NP O
is VBZ O O
present JJ O O
. . B-VP O
   
Soft JJ B-NP O
palate NN I-NP O
was VBD B-VP O
in IN B-VP O
the DT B-NP O
midline NN I-NP O
and CC O O
moved VBD B-VP O
upward RB O O
nicely RB O O
, , O O
but CC O O
did VBD B-VP O
not RB O O
respond VB O O
to TO O O
gag VB O O
. . B-VP O
   
Tongue NNP B-NP O
protrudes VBZ O O
2 CD O O
cm. NN B-NP O
with IN B-VP O
slight JJ B-NP B-problem
deviation NN I-NP I-problem
to TO O I-problem
the DT B-NP I-problem
right NN I-NP I-problem
. . B-VP O
   
Sensory NNP B-NP B-test
exam NN I-NP I-test
was VBD B-VP O
not RB O O
remarkable JJ O O
, , O O
cerebellar JJ B-NP B-test
exam NN I-NP I-test
was VBD B-VP O
not RB O O
possible JJ O O
. . B-VP O
   
Motor NNP B-NP B-test
exam NN I-NP I-test
showed VBD B-VP O
greater JJR O O
than IN B-VP O
4+ CD O O
strength NN B-NP O
bilateral JJ B-NP O
upper JJ I-NP O
extremities NNS I-NP O
and CC O O
psoas NN B-NP O
unable JJ O O
to TO O O
lift VB O O
off RP O O
bed NN B-NP O
. . B-VP O
   
Quadraceps VBZ O B-test
2+ CD O O
on IN B-VP O
the DT B-NP O
left NN I-NP O
and CC O O
3+ CD O O
on IN B-VP O
the DT B-NP O
right NN I-NP O
. . B-VP O
   
Gastroc. NNP B-NP B-test
3 CD O O
on IN B-VP O
the DT B-NP O
left NN I-NP O
and CC O O
4+ CD O O
on IN B-VP O
the DT B-NP O
right NN I-NP O
. . B-VP O
   
Tibialis $ O B-test
3 CD O O
on IN B-VP O
the DT B-NP O
left NN I-NP O
, , O O
5+ CD O O
on IN B-VP O
the DT B-NP O
right NN I-NP O
. . B-VP O
   
Reflexes NNP B-NP B-test
were VBD B-VP O
diffuse RB O O
3+ CD O O
, , O O
toes NNS B-NP B-problem
upgoing VBG O I-problem
bilaterally RB O I-problem
. . B-VP O
   
LABORATORY NNP B-NP O
DATA NNP I-NP O
: : O O
On IN B-VP O
admission NN B-NP O
, , O O
electrocardiogram NN B-NP B-test
showed VBD B-VP O
less JJR O O
than IN B-VP O
1 CD O O
mm. NN B-NP O
of IN B-VP O
ST NNP B-NP B-problem
depression NN I-NP I-problem
in IN B-VP I-problem
V4 NNP B-NP I-problem
to TO O I-problem
V6 NNP B-NP I-problem
, , O O
which WDT O B-pronoun
is VBZ O O
likely JJ O O
the DT B-NP B-person
patient JJ I-NP I-person
&apos;s NNP I-NP O
baseline NN I-NP O
. . B-VP O
   
CK NNP B-NP B-test
&apos;s NNPS I-NP O
were VBD B-VP O
mildly RB O B-problem
elevated VBN O I-problem
but CC O O
the DT B-NP B-test
MB NNP I-NP I-test
fractions NNS I-NP I-test
were VBD B-VP O
not RB O O
remarkable JJ O O
. . B-VP O
   
A DT B-NP B-test
chest JJ I-NP I-test
X-ray NN I-NP I-test
showed VBD B-VP O
some DT O B-problem
left VBD B-VP I-problem
lower JJR B-NP I-problem
lobe NN I-NP I-problem
atelectasis NN I-NP I-problem
. . B-VP O
   
Admitting VBG O B-test
creatinine NN B-NP I-test
was VBD B-VP O
.7 NNP B-NP O
, , O O
glucose VBD B-VP B-test
131 CD O O
, , O O
white JJ B-NP B-test
blood NN I-NP I-test
count NN I-NP I-test
was VBD B-VP O
10,000 CD O O
, , O O
hematocrit NN B-NP B-test
was VBD B-VP O
40 CD O O
, , O O
liver RB O B-test
enzymes VBZ O I-test
normal JJ B-NP O
range NN I-NP O
. . B-VP O
   
HOSPITAL NNP B-NP O
COURSE NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
taken VBN O O
to TO O O
the DT B-NP O
Intensive NNP I-NP O
Care NNP I-NP O
Unit NNP I-NP O
after IN B-VP O
her PRP$ O B-test
her PRP$ O B-person
angiogram NN B-NP I-test
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
aggressively RB O O
anticoagulated VBN O O
with IN B-VP O
heparin NN B-NP B-treatment
. . B-VP O
   
A DT B-NP B-problem
small JJ I-NP I-problem
intimal JJ I-NP I-problem
tear NN I-NP I-problem
in IN B-VP O
the DT B-NP O
arch NN I-NP O
of IN B-VP O
the DT B-NP O
aorta NN I-NP O
during IN B-VP O
the DT B-NP B-test
angiogram NN I-NP I-test
, , O O
was VBD B-VP O
without IN B-VP O
sequelae NN B-NP B-problem
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
doing VBG O O
well RB O O
with IN B-VP O
at IN B-VP O
least JJS O O
4+ CD O O
strength NN B-NP O
in IN B-VP O
all DT O O
of IN B-VP O
her PRP$ O B-person
extremities NNS B-NP O
, , O O
when WRB O O
on IN B-VP O
11/13 CD O O
, , O O
she PRP O B-person
had VBD B-VP O
an DT B-NP B-problem
acute JJ I-NP I-problem
drop NN I-NP I-problem
in IN B-VP O
her PRP$ O B-person
her PRP$ O B-test
systolic JJ B-NP I-test
blood NN I-NP I-test
pressure NN I-NP I-test
to TO O O
70 CD O O
for IN B-VP O
unclear JJ B-NP O
reasons NNS I-NP O
and CC O O
without IN B-VP O
evidence NN B-NP O
of IN B-VP O
acute JJ B-NP B-problem
sepsis NN I-NP I-problem
. . B-VP O
   
This DT O B-pronoun
was VBD B-VP O
accompanied VBN O O
by IN B-VP O
substantial JJ B-NP B-problem
decrement NN I-NP I-problem
in IN B-VP I-problem
neurologic JJ B-NP I-problem
function NN I-NP I-problem
. . B-VP O
   
For IN B-VP O
a DT B-NP O
short JJ I-NP O
time NN I-NP O
, , O O
she PRP O B-person
seemed VBD B-VP O
&quot; JJ O O
locked VBN O B-problem
in IN B-VP I-problem
&quot; NN B-NP O
. . B-VP O
   
She PRP O B-person
has VBZ O O
made VBN O O
slow JJ B-NP O
progress NN I-NP O
since IN B-VP O
then RB O O
and CC O O
at IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
discharge NN B-NP O
has VBZ O O
4-strength CD O O
at IN B-VP O
the DT B-NP O
left NN I-NP O
elbow NN I-NP O
and CC O O
4+ CD O O
in IN B-VP O
the DT B-NP O
left JJ I-NP O
wrist NN I-NP O
and CC O O
hand NN B-NP O
. . B-VP O
   
Trace NNP B-NP O
movement NN I-NP O
of IN B-VP O
the DT B-NP O
right JJ I-NP O
elbow NN I-NP O
and CC O O
4-strength NN B-NP O
of IN B-VP O
the DT B-NP O
right JJ I-NP O
wrist NN I-NP O
and CC O O
hand NN B-NP O
. . B-VP O
   
4-to JJ O O
4+ CD O O
strength NN B-NP O
at IN B-VP O
the DT B-NP O
left NN I-NP O
ankle NN I-NP O
, , O O
4+ CD O O
strength NN B-NP O
at IN B-VP O
the DT B-NP O
right JJ I-NP O
knee NN I-NP O
and CC O O
right JJ B-NP O
ankle NN I-NP O
. . B-VP O
   
She PRP O B-person
is VBZ O O
unable JJ O O
to TO O O
lift VB O O
either RB O O
foot NN B-NP O
off IN B-VP O
the DT B-NP O
bed NN I-NP O
. . B-VP O
   
The DT B-NP O
extra JJ I-NP O
ocular JJ I-NP O
movements NNS I-NP O
are VBP O O
full JJ O O
. . B-VP O
   
Tongue NNP B-NP O
protrudes VBZ O O
4 CD O O
cm NN B-NP O
. . B-VP O
   
She PRP O B-person
is VBZ O O
drowsy VBN O B-problem
at IN B-VP O
times NNS B-NP O
, , O O
but CC O O
generally RB O O
alert JJ O O
, , O O
responsive JJ O O
, , O O
interactive JJ O O
, , O O
able JJ O O
to TO O O
talk VB O O
in IN B-VP O
two CD O O
to TO O O
three CD O O
word NN B-NP O
sentences NNS I-NP O
when WRB O O
she PRP O B-person
wants VBZ O O
to TO O O
. . B-VP O
   
She PRP O B-person
has VBZ O O
severe JJ B-NP B-problem
memory NN I-NP I-problem
deficits NNS I-NP I-problem
, , O O
but CC O O
nevertheless RB O O
, , O O
is VBZ O O
able JJ O O
to TO O O
engage VB O O
in IN B-VP O
conversation NN B-NP O
, , O O
answers NNS B-NP O
questions NNS I-NP O
, , O O
names NNS B-NP O
things NNS I-NP O
well RB O O
, , O O
does VBZ O O
calculations NNS B-NP O
and CC O O
recognizes VBZ O O
family NN B-NP B-person
members NNS I-NP I-person
and CC O O
states NNS B-NP O
preferences NNS I-NP O
. . B-VP O
   
She PRP O B-person
has VBZ O O
been VBN O O
working VBG O O
with IN B-VP O
Speech NNP B-NP B-person
Therapy NNP I-NP I-person
, , O O
occupational JJ B-NP B-person
therapy NN I-NP I-person
and CC O O
physical JJ B-NP B-person
therapy NN I-NP I-person
closely RB O O
and CC O O
should MD O O
continue VB O O
to TO O O
show VB O O
improvement NN B-NP O
. . B-VP O
   
She PRP O B-person
is VBZ O O
anticoagulated VBN O B-treatment
on IN B-VP O
Coumadin NNP B-NP B-treatment
and CC O O
this DT O B-pronoun
has VBZ O O
been VBN O O
stable JJ O O
. . B-VP O
   
She PRP O B-person
is VBZ O O
do JJ O O
not RB O O
resuscitate VB O O
in IN B-VP O
agreement NN B-NP O
with IN B-VP O
the DT B-NP O
wishes NNS I-NP O
of IN B-VP O
her PRP$ O B-person
her PRP$ O B-person
multiple JJ B-NP I-person
family NN I-NP I-person
members NNS I-NP I-person
. . B-VP O
   
Follow VB O O
up RP O O
computerized JJ B-NP B-test
tomography NN I-NP I-test
scans NNS I-NP I-test
and CC O O
magnetic JJ B-NP B-test
resonance NN I-NP I-test
imaging VBG O I-test
studies NNS B-NP I-test
have VBP O O
shown VBN O O
infarction NN B-NP B-problem
in IN B-VP I-problem
bilateral JJ B-NP I-problem
basis NN I-NP I-problem
pontis NN I-NP I-problem
, , O I-problem
mid NN B-NP I-problem
brain NN I-NP I-problem
, , O I-problem
the DT B-NP I-problem
superior JJ I-NP I-problem
cerebellar JJ I-NP I-problem
areas NNS I-NP I-problem
, , O I-problem
left VBD B-VP I-problem
thalamus NN B-NP I-problem
, , O I-problem
bilateral JJ B-NP I-problem
temporal JJ I-NP I-problem
lobes NNS I-NP I-problem
medially RB O I-problem
and CC O I-problem
inferiorly RB O I-problem
and CC O I-problem
left VBD B-VP I-problem
posterior JJ O I-problem
communicating VBG O I-problem
artery NN B-NP I-problem
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
had VBD B-VP O
fevers NNS B-NP B-problem
sporadically RB O O
during IN B-VP O
this DT B-NP B-pronoun
hospitalization NN I-NP O
with IN B-VP O
rising VBG O B-problem
white JJ B-NP I-problem
blood NN I-NP I-problem
counts NNS I-NP I-problem
. . B-VP O
   
A DT B-NP B-test
chest JJ I-NP I-test
X-ray NN I-NP I-test
documented VBD B-VP O
a DT B-NP B-problem
progressing NN I-NP I-problem
left VBD B-VP I-problem
lower JJR B-NP I-problem
lobe NN I-NP I-problem
infiltrate NN I-NP I-problem
. . B-VP O
   
Initially RB O O
this DT O B-pronoun
improved VBN O O
on IN B-VP O
Clindamycin NNP B-NP B-treatment
and CC O O
Cefotetan NNP B-NP B-treatment
, , O O
but CC O O
fevers NNS B-NP B-problem
recurred VBD B-VP O
on IN B-VP O
this DT O B-treatment
this DT B-NP B-pronoun
antibiotic JJ I-NP I-treatment
regimen NNS I-NP I-treatment
. . B-VP O
   
Sputum NNP B-NP B-test
grew VBD B-VP O
out RP O O
Klebsiella NNP B-NP B-problem
pneumoniae NN I-NP I-problem
, , O O
and CC O O
she PRP O B-person
was VBD B-VP O
treated VBN O O
with IN B-VP O
Gentamicin NNP B-NP B-treatment
and CC O O
Ancef NNP B-NP B-treatment
for IN B-VP O
14 CD O O
days NNS B-NP O
intravenous JJ O O
( ( O O
bug JJ O B-problem
being VBG O O
sensitive JJ O O
to TO O O
these DT O B-treatment
these DT O B-pronoun
two CD O I-treatment
drugs NNS B-NP I-treatment
) ) O O
. . B-VP O
   
A DT B-NP B-problem
left JJ I-NP I-problem
pleural JJ I-NP I-problem
effusion NN I-NP I-problem
developed VBD B-VP O
and CC O O
this DT O B-pronoun
was VBD B-VP O
tapped VBN O O
with IN B-VP O
ultrasound JJ B-NP B-test
guidance NN I-NP I-test
, , O O
and CC O O
found VBD B-VP O
to TO O O
be VB O O
sterile JJ O O
, , O O
and CC O O
without IN B-VP O
evidence NN B-NP O
of IN B-VP O
empyema NN B-NP B-problem
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
is VBZ O O
on IN B-VP O
Ciprofloxacin NNP B-NP B-treatment
. . B-VP O
   
The DT B-NP O
day NN I-NP O
of IN B-VP O
discharge NN B-NP O
is VBZ O O
day NN B-NP O
#3 NNP I-NP O
of IN B-VP O
7 CD O O
, , O O
after IN B-VP O
which WDT O B-pronoun
antibiotics NNS B-NP B-treatment
should MD O O
be VB O O
totally RB O O
discontinued VBN O O
. . B-VP O
   
She PRP O B-person
has VBZ O O
developed VBN O O
bad JJ B-NP B-problem
thrush NN I-NP I-problem
in IN B-VP O
this DT B-NP B-pronoun
setting NN I-NP O
, , O O
she PRP O B-person
is VBZ O O
not RB O O
yet RB O O
able JJ O O
to TO O O
swallow VB O O
and CC O O
so RB O O
she PRP O B-person
is VBZ O O
on IN B-VP O
Nystatin NNP B-NP B-treatment
swish JJ O I-treatment
and CC O I-treatment
spit JJ O I-treatment
five CD O O
times NNS B-NP O
a DT B-NP O
day NN I-NP O
. . B-VP O
   
She PRP O B-person
also RB O O
gets VBZ O O
Peridex NNP B-NP B-treatment
to TO O O
clean VB O O
out RP O O
her PRP$ O B-person
mouth NN B-NP O
. . B-VP O
   
Once RB O O
her PRP$ O B-test
her PRP$ O B-person
liver NN B-NP I-test
enzymes NNS I-NP I-test
are VBP O O
completely RB O O
normal JJ O O
, , O O
a DT O O
seven CD O O
day NN B-NP O
course NN I-NP O
of IN B-VP O
Fluconazol NNP B-NP B-treatment
may MD O O
be VB O O
helpful JJ O O
if IN B-VP O
the DT B-NP B-problem
thrush NN I-NP I-problem
is VBZ O O
not RB O O
spontaneously RB O O
resolving VBG O O
off IN B-VP O
of IN B-VP O
antibiotics NNS B-NP B-treatment
. . B-VP O
   
She PRP O B-person
has VBZ O O
been VBN O O
afebrile RB O B-problem
for IN B-VP O
greater JJR O O
than IN B-VP O
10 CD O O
days NNS B-NP O
, , O O
including VBG O O
several JJ B-NP O
days NNS I-NP O
on IN B-VP O
oral JJ B-NP B-treatment
antibiotics NNS I-NP I-treatment
. . B-VP O
   
The DT O B-person
The DT B-NP B-test
patient JJ I-NP I-person
patient NN I-NP I-test
&apos;s NN I-NP I-test
liver NN I-NP I-test
enzymes NNS I-NP I-test
were VBD B-VP O
noted VBN O O
to TO O O
be VB O O
elevated VBN O B-problem
mid JJ B-NP O
way NN I-NP O
through IN B-VP O
her PRP$ O B-person
hospital JJ B-NP O
course NN I-NP O
, , O O
to TO O O
about IN B-VP O
three CD O O
times NNS B-NP O
normal JJ O O
, , O O
especially RB O O
the DT B-NP O
SGOT NNP I-NP B-test
and CC O O
SGPT NNP B-NP B-test
. . B-VP O
   
These DT O B-pronoun
have VBP O O
spontaneously RB O O
reversed VBN O O
, , O O
and CC O O
are VBP O O
nearly RB O O
normal JJ O O
at IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
discharge NN B-NP O
. . B-VP O
   
A DT B-NP B-test
right JJ I-NP I-test
upper NN I-NP I-test
quadrant NN I-NP I-test
ultrasound NN I-NP I-test
documented VBD B-VP O
gallstones NNS B-NP B-problem
, , O O
without IN B-VP O
evidence NN B-NP O
of IN B-VP O
common JJ B-NP B-problem
bile JJ I-NP I-problem
duct NN I-NP I-problem
dilatation NN I-NP I-problem
or CC O O
active JJ B-NP B-problem
cholecystitis NN I-NP I-problem
. . B-VP O
   
The DT B-NP O
exact JJ I-NP O
cause NN I-NP O
of IN B-VP O
her PRP$ O B-problem
her PRP$ O B-person
liver NN B-NP I-problem
enzyme DT B-NP I-problem
elevation NN I-NP I-problem
is VBZ O O
unclear JJ O O
, , O O
but CC O O
we PRP O B-person
are VBP O O
being VBG O O
careful JJ O O
about IN B-VP O
administering VBG O O
drugs NNS B-NP B-treatment
, , O O
which WDT O B-pronoun
might MD O O
irritate VB O O
the DT B-NP O
liver NN I-NP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
had VBD B-VP O
a DT B-NP B-problem
steady JJ I-NP I-problem
decline NN I-NP I-problem
in IN B-VP O
her PRP$ O B-person
her PRP$ O B-test
hematocrit NN B-NP I-test
during IN B-VP O
this DT B-NP B-pronoun
hospitalization NN I-NP O
. . B-VP O
   
Iron NNP B-NP B-test
studies NNS I-NP I-test
are VBP O O
all DT O O
entirely RB O O
normal JJ O O
, , O O
her PRP$ O B-problem
her PRP$ O B-person
anemia NN B-NP I-problem
is VBZ O O
attributed VBN O O
to TO O O
anemia VB O B-problem
or CC O I-problem
chronic JJ B-NP I-problem
disease NN I-NP I-problem
with IN B-VP O
hypoproliferation NN B-NP B-problem
as RB O O
well RB O O
as IN B-VP O
multiple JJ B-NP B-test
phlebotomies NNS I-NP I-test
. . B-VP O
   
The DT B-NP O
plan NN I-NP O
is VBZ O O
to TO O O
give VB O O
her PRP$ O B-person
folic JJ B-NP B-treatment
acid NN I-NP I-treatment
, , O O
but CC O O
not RB O O
iron VB O B-treatment
. . B-VP O
   
The DT O B-test
The DT B-NP B-person
patient JJ I-NP I-test
patient NN I-NP I-person
&apos;s NN I-NP I-test
potassiums NNS I-NP I-test
have VBP O O
been VBN O O
repeatedly RB O O
low JJ O O
and CC O O
require JJ B-NP O
daily JJ I-NP B-test
checks NNS I-NP I-test
and CC O O
repletion NN B-NP B-treatment
. . B-VP O
   
This DT O B-pronoun
is VBZ O O
thought VBN O O
due RB O O
to TO O O
the DT B-NP O
extensive JJ I-NP O
course NN I-NP O
of IN B-VP O
Gentamicin NNP B-NP B-treatment
which WDT O B-pronoun
she PRP O B-person
received VBD B-VP O
. . B-VP O
   
This DT O B-pronoun
must MD O O
be VB O O
carefully RB O O
checked VBN O O
despite IN B-VP O
the DT O O
standing VBG O O
order NN B-NP O
for IN B-VP O
potassium NN B-NP B-treatment
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
has VBZ O O
had VBN O O
low JJ B-NP B-problem
sodiums NNS I-NP I-problem
during IN B-VP O
this DT B-NP B-pronoun
hospitalization NN I-NP O
. . B-VP O
   
This DT O B-pronoun
may MD O O
due VB O O
to TO O O
her PRP$ O B-person
her PRP$ O B-problem
central JJ B-NP I-problem
nervous JJ I-NP I-problem
system NN I-NP I-problem
process NN I-NP I-problem
or CC O O
her PRP$ O B-problem
her PRP$ O B-person
pulmonary JJ B-NP I-problem
process NN I-NP I-problem
, , O O
with IN B-VP O
fluids NNS B-NP B-treatment
administered VBN O I-treatment
as IN B-VP O
described NN B-NP O
, , O O
she PRP O B-person
should MD O O
not RB O O
have VB O O
any DT B-NP B-problem
problems NNS I-NP I-problem
from IN B-VP O
this DT O B-pronoun
. . B-VP O
   
Her PRP$ O B-person
Her PRP$ O B-test
sodiums NNS B-NP I-test
were VBD B-VP O
never RB O O
below IN B-VP O
130 CD O O
. . B-VP O
   
She PRP O B-person
does VBZ O O
well RB O O
with IN B-VP O
tube NN B-NP B-treatment
feeds NNS I-NP I-treatment
. . B-VP O
   
Her PRP$ O B-person
Her PRP$ O B-treatment
tube NN B-NP I-treatment
feeds NNS I-NP I-treatment
orders NNS I-NP O
are VBP O O
as IN B-VP O
follow JJ O O
: : O O
full JJ B-NP O
strength NN I-NP O
Replete NNP I-NP O
with IN B-VP O
fiber NN B-NP B-treatment
at IN B-VP O
70 CD O O
cc. NNS B-NP O
per IN B-VP O
hour NN B-NP O
. . B-VP O
   
In IN B-VP O
addition NN B-NP O
, , O O
the DT O B-person
patient JJ O I-person
gets VBZ O O
250 CD O O
cc. NN B-NP O
of IN B-VP O
juice NN B-NP B-treatment
( ( O O
not RB O O
water NN B-NP O
) ) O O
three CD O O
times NNS B-NP O
a DT B-NP O
day NN I-NP O
. . B-VP O
   
She PRP O B-person
also RB O O
gets VBZ O O
Lactinex NNP B-NP B-treatment
granules NNS I-NP I-treatment
three CD O O
packages NNS B-NP O
in IN B-VP O
each DT B-NP O
bottle NN I-NP O
of IN B-VP O
tube NN B-NP B-treatment
feeds NNS I-NP I-treatment
. . B-VP O
   
She PRP O B-person
also RB O O
gets VBZ O O
Metamucil NNP B-NP B-treatment
one CD O O
teaspoon NN B-NP O
with IN B-VP O
the DT B-NP O
first JJ I-NP O
bolus NN I-NP O
of IN B-VP O
juice NN B-NP B-treatment
each DT B-NP O
day NN I-NP O
. . B-VP O
   
Please NNP B-NP O
note NN I-NP O
that IN B-VP B-pronoun
evaluation NN B-NP B-test
by IN B-VP O
the DT O B-person
swallowing VBG O I-person
therapist NN B-NP I-person
, , O O
showed VBD B-VP O
that IN B-VP B-pronoun
the DT B-NP B-person
patient NN I-NP I-person
is VBZ O O
aspirating VBG O B-problem
at IN B-VP O
this DT B-NP B-pronoun
time NN I-NP O
, , O O
but CC O O
there EX O O
is VBZ O O
great JJ B-NP O
hope NN I-NP O
from IN B-VP O
the DT B-NP O
nature NN I-NP O
of IN B-VP O
her PRP$ O B-person
her PRP$ O B-problem
deficit NN B-NP I-problem
and CC O O
the DT B-NP O
good JJ I-NP O
movements NNS I-NP O
of IN B-VP O
her PRP$ O B-person
tongue NN B-NP O
that IN B-VP B-pronoun
normal JJ B-NP O
swallowing NN I-NP O
should MD O O
return VB O O
soon RB O O
. . B-VP O
   
It PRP O B-pronoun
is VBZ O O
for IN B-VP O
this DT B-NP B-pronoun
reason NN I-NP O
that IN B-VP B-pronoun
she PRP O B-person
is VBZ O O
discharged VBN O O
with IN B-VP O
an DT B-NP B-treatment
nasogastric JJ I-NP I-treatment
tube NN I-NP I-treatment
and CC O O
that IN B-VP B-pronoun
no DT B-NP O
plans NNS I-NP O
for IN B-VP O
G NNP B-NP B-treatment
tube NN I-NP I-treatment
placement NN I-NP I-treatment
are VBP O O
made VBN O O
at IN B-VP O
this DT B-NP B-pronoun
time NN I-NP O
. . B-VP O
   
She PRP O B-person
has VBZ O O
a DT B-NP O
history NN I-NP O
of IN B-VP O
of IN B-VP O
angina NN B-NP B-problem
without IN B-VP O
myocardial JJ B-NP B-problem
infarction NN I-NP I-problem
that WDT O B-pronoun
has VBZ O O
not RB O O
been VBN O O
worked VBN O O
up RP O O
. . B-VP O
   
She PRP O B-person
did VBD B-VP O
have VB O O
brief NN B-NP B-problem
chest JJS B-NP I-problem
pain NN I-NP I-problem
twice RB O O
during IN B-VP O
this DT B-NP B-pronoun
admission NN I-NP O
that WDT O B-pronoun
did VBD B-VP O
not RB O O
correlate VB O O
with IN B-VP O
electrocardiogram JJ B-NP B-problem
changes NNS I-NP I-problem
. . B-VP O
   
In IN B-VP O
the DT B-NP O
first JJ I-NP O
week NN I-NP O
of IN B-VP O
November NNP B-NP O
, , O O
her PRP$ O B-person
her PRP$ O B-test
electrocardiogram NN B-NP I-test
showed VBD B-VP O
T NNP B-NP B-problem
wave VBP O I-problem
inversions NNS B-NP I-problem
in IN B-VP I-problem
the DT B-NP I-problem
lateral JJ I-NP I-problem
leads NNS I-NP I-problem
, , O O
correlating VBG O O
with IN B-VP O
an DT B-NP B-problem
increase NN I-NP I-problem
in IN B-VP O
the DT B-NP B-test
LDH NNP I-NP I-test
, , O O
but CC O O
not RB O O
CK NNP B-NP B-test
. . B-VP O
   
This DT O B-pronoun
did VBD B-VP O
not RB O O
normalize VB O O
with IN B-VP O
administration NN B-NP O
of IN B-VP O
Isordil NNP B-NP B-treatment
and CC O O
the DT B-NP B-person
patient NN I-NP I-person
denied VBD B-VP O
chest JJS B-NP B-problem
pain NN I-NP I-problem
at IN B-VP O
this DT B-NP B-pronoun
time NN I-NP O
. . B-VP O
   
As IN B-VP O
of IN B-VP O
4/7 CD O O
, , O O
her PRP$ O B-test
her PRP$ O B-person
electrocardiogram NN B-NP I-test
had VBD B-VP O
reverted VBN O O
back RB O O
to TO O O
normal JJ O O
and CC O O
there EX O O
is VBZ O O
no DT B-NP O
evidence NN I-NP O
of IN B-VP O
congestive JJ B-NP B-problem
heart NN I-NP I-problem
failure NN I-NP I-problem
or CC O O
continued VBN O B-problem
electrocardiogram JJ B-NP I-problem
changes NNS I-NP I-problem
, , O O
and CC O O
chest JJS B-NP B-problem
pain NN I-NP I-problem
is VBZ O O
absent JJ O O
. . B-VP O
   
Her PRP$ O B-test
Her PRP$ O B-person
cholesterol NN B-NP I-test
was VBD B-VP O
350 CD O O
here RB O O
. . B-VP O
   
She PRP O B-person
has VBZ O O
been VBN O O
off IN B-VP O
of IN B-VP O
her PRP$ O B-person
her PRP$ O B-treatment
hypercholesterol NN B-NP I-treatment
medicines NNS I-NP I-treatment
. . B-VP O
   
These DT O B-pronoun
can MD O O
be VB O O
restarted VBN O O
when WRB O O
it PRP O B-pronoun
is VBZ O O
deemed VBN O O
reasonable JJ O O
, , O O
in IN B-VP O
view NN B-NP O
of IN B-VP O
her PRP$ O B-person
her PRP$ O B-problem
acute JJ B-NP I-problem
disease NN I-NP I-problem
and CC O O
recently RB O B-problem
elevated VBD B-VP I-problem
liver JJ B-NP I-problem
enzymes NNS I-NP I-problem
. . B-VP O
   
Note NN B-NP O
that IN B-VP B-pronoun
the DT B-NP B-test
liver NN I-NP I-test
enzymes NNS I-NP I-test
were VBD B-VP O
normal JJ O O
on IN B-VP O
admission NN B-NP O
, , O O
at IN B-VP O
which WDT O B-pronoun
time NN B-NP O
she PRP O B-person
was VBD B-VP O
taking VBG O O
all DT O O
of IN B-VP O
the DT B-NP B-treatment
above JJ I-NP I-treatment
cholesterol NN I-NP I-treatment
medicines NNS I-NP I-treatment
. . B-VP O
   
MEDICATIONS NNP B-NP O
ON NNP I-NP O
DISCHARGE NNP I-NP O
: : O O
Metamucil NNP B-NP B-treatment
1 CD O O
teaspoon NN B-NP O
q.d. NN I-NP O
, , O O
with IN B-VP O
first JJ B-NP O
bolus NN I-NP O
of IN B-VP O
juice NN B-NP B-treatment
, , O O
juice NN B-NP B-treatment
250 CD O O
cc. NN B-NP O
down RB O O
nasogastric JJ B-NP B-treatment
tube NN I-NP I-treatment
t.i.d. NN I-NP O
, , O O
tube NN B-NP B-treatment
feeds NNS I-NP I-treatment
as IN B-VP O
above IN B-VP O
, , O O
Lactinex NNP B-NP B-treatment
as IN B-VP O
above IN B-VP O
, , O O
Tagamet NNP B-NP B-treatment
800 CD O O
mg. NN B-NP O
nasogastric JJ B-NP B-treatment
tube NN I-NP I-treatment
qhs NN I-NP O
, , O O
Nystatin NNP B-NP B-treatment
swish NN I-NP I-treatment
and CC O I-treatment
spit NN B-NP I-treatment
10 CD O O
cc. NN B-NP O
five CD O O
times NNS B-NP O
a DT B-NP O
day NN I-NP O
, , O O
Cardizem NNP B-NP B-treatment
slow VB O I-treatment
release NN B-NP I-treatment
90 CD O O
mg. NN B-NP O
PO NNP I-NP O
q.d. NN I-NP O
, , O O
Folic NNP B-NP B-treatment
Acid NNP I-NP I-treatment
1 CD O O
mg. NN B-NP O
PO NNP I-NP O
q.d. NN I-NP O
, , O O
Ciprofloxacin NNP B-NP B-treatment
500 CD O O
mg. NN B-NP O
PO NNP I-NP O
b.i.d. NN I-NP O
, , O O
discontinue NN B-NP O
on IN B-VP O
12/10/92 CD O O
KayCiel NNP B-NP B-treatment
30 CD O O
mEq. VBD B-VP O
down RB O O
nasogastric JJ B-NP B-treatment
tube NN I-NP I-treatment
q.d. NN I-NP O
, , O O
Peridex NNP B-NP B-treatment
10 CD O O
cc. NN B-NP O
swish NN I-NP O
and CC O O
spit NN B-NP O
q.i.d. NN I-NP O
, , O O
Coumadin NNP B-NP B-treatment
4 CD O O
mg. NN B-NP O
nasogastric JJ B-NP O
tube NN I-NP O
on IN B-VP O
odd JJ B-NP O
days NNS I-NP O
, , O O
alternating VBG O O
with IN B-VP O
5 CD O O
mg. NNS B-NP O
nasogastric JJ B-NP O
tube NN I-NP O
on IN B-VP O
even JJ B-NP O
days NNS I-NP O
, , O O
once RB O O
daily JJ O O
, , O O
Tylenol NNP B-NP B-treatment
650 CD O O
mg. NN B-NP O
PO NNP I-NP O
and CC O O
PR NNP B-NP O
q6hours NNS I-NP O
PRN NNP I-NP O
pain NN I-NP B-problem
, , O O
Nystatin NNP B-NP B-treatment
powder NN I-NP I-treatment
to TO O O
axilla VB O O
and CC O O
groin VB O O
as IN B-VP O
needed VBN O O
. . B-VP O
   
DISCHARGE JJ B-NP O
DIAGNOSIS NNP I-NP O
: : O O
Basilar JJ B-NP B-problem
artery NN I-NP I-problem
stenosis NN I-NP I-problem
with IN B-VP O
basilar JJ B-NP B-problem
thrombosis NN I-NP I-problem
and CC O O
&quot; NNP B-NP O
top NN I-NP B-problem
of IN B-VP I-problem
the DT B-NP I-problem
basilar JJ I-NP I-problem
&quot; NNP I-NP I-problem
syndrome NN I-NP I-problem
. . B-VP O
   
Includes NNP B-NP O
recent JJ B-NP B-problem
infarct NN I-NP I-problem
to TO O I-problem
pons NNS B-NP I-problem
, , O I-problem
mid NN B-NP I-problem
brain NN I-NP I-problem
, , O I-problem
left VBD B-VP I-problem
thalamus NN B-NP I-problem
, , O I-problem
bilateral JJ B-NP I-problem
temporal JJ I-NP I-problem
lobes NNS I-NP I-problem
and CC O I-problem
left VBD B-VP I-problem
visual JJ B-NP I-problem
cortex NN I-NP I-problem
, , O O
on IN B-VP O
Coumadin NNP B-NP B-treatment
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
is VBZ O O
do JJ O O
not RB O O
resuscitate VB O O
at IN B-VP O
family NN B-NP B-person
&apos;s NNP I-NP O
request NN I-NP O
. . B-VP O
   
Left NNP B-NP B-problem
lower JJR B-NP I-problem
lobe NN I-NP I-problem
pneumonia NN I-NP I-problem
, , O O
resolving VBG O O
now RB O O
on IN B-VP O
oral JJ B-NP B-treatment
antibiotics NNS I-NP I-treatment
. . B-VP O
   
Gallstones NNS B-NP B-problem
, , O O
thought VBN O O
to TO O O
be VB O O
inactive JJ O O
. . B-VP O
   
Improving VBG O O
liver RB O B-problem
enzyme JJ B-NP I-problem
elevation NN I-NP I-problem
. . B-VP O
   
Anemia NNP B-NP B-problem
, , O O
discharge NN B-NP B-test
hematocrit NN I-NP I-test
28 CD O O
, , O O
not RB O O
iron VB O B-problem
deficient NN B-NP I-problem
. . B-VP O
   
Low JJ B-NP B-problem
potassium NN I-NP I-problem
, , O O
thought VBD B-VP O
due JJ O O
to TO O O
Gentamicin NNP B-NP B-treatment
. . B-VP O
   
Low NNP B-NP B-problem
sodium NN I-NP I-problem
, , O O
responsive JJ O O
to TO O O
fluid VB O B-treatment
restriction NN B-NP I-treatment
. . B-VP O
   
History NN B-NP O
of IN B-VP O
coronary JJ B-NP B-problem
artery NN I-NP I-problem
disease NN I-NP I-problem
. . B-VP O
   
Thrush NNP B-NP B-problem
. . B-VP O
   
High NNP B-NP B-problem
cholesterol NN I-NP I-problem
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
needs VBZ O O
prothrombin JJ B-NP B-test
time NN I-NP I-test
checked VBD B-VP O
daily RB O O
, , O O
patient JJ B-NP B-person
needs NNS I-NP O
potassium NN I-NP B-test
checked VBD B-VP O
daily RB O O
, , O O
patient JJ B-NP B-person
needs NNS I-NP O
sodium NN I-NP B-test
checked VBN O O
at IN B-VP O
least JJS O O
every DT B-NP O
other JJ I-NP O
day NN I-NP O
. . B-VP O
   
DO NNP B-NP B-person
JOASSCCHIRD NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
DICTATING NNP I-NP O
FOR NNP I-NP O
: : O O
NAREA NNP B-NP B-person
SWALLOW NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
TR NNP I-NP O
: : O O
sw NN B-NP O
/ NNP I-NP O
bmot NN I-NP O
DD NNP I-NP O
: : O O
12/6/92 CD O O
TD NN B-NP O
: : O O
12/06/92 CD O O
CC NN B-NP O
: : O O
Dr. NNP B-NP B-person
Namarce NNP I-NP I-person
May NNP I-NP I-person
STAT NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
Admission NNP I-NP O
Date NNP I-NP O
: : O O
2014-08-07 JJ B-NP O
Discharge NN I-NP O
Date NNP I-NP O
: : O O
2014-08-09 JJ B-NP O
Date NNP I-NP O
of IN B-VP O
Birth NNP B-NP O
: : O O
1958-03-14 JJ B-NP O
Sex NN I-NP O
: : O O
M NNP B-NP O
Service NNP I-NP O
: : O O
NEUROSURG NNP B-NP O
HISTORY NNP I-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS NNP I-NP O
: : O O
This DT O B-pronoun
is VBZ O O
a DT O O
56 JJ O O
- : O O
year-old JJ B-NP O
man NN I-NP O
without IN B-VP O
any DT B-NP O
significant JJ I-NP O
past JJ I-NP O
medical JJ I-NP O
history NN I-NP O
who WP O B-person
presented VBD B-VP O
to TO O O
the DT B-NP O
emergency NN I-NP O
room NN I-NP O
after IN B-VP O
the DT B-NP O
sudden JJ I-NP O
onset NN I-NP O
of IN B-VP O
headache NN B-NP B-problem
while IN B-VP O
he PRP O B-person
was VBD B-VP O
riding VBG O O
a DT B-NP O
bicycle NN I-NP O
. . B-VP O
   
He PRP O B-person
characterized VBD B-VP O
this DT O B-pronoun
this DT B-NP B-problem
headache NN I-NP I-problem
as IN B-VP O
the DT B-NP B-problem
worst JJS I-NP I-problem
headache NN I-NP I-problem
of IN B-VP O
his PRP$ O B-person
life NN B-NP O
and CC O O
had VBD B-VP O
associated VBN O O
nausea NN B-NP B-problem
and CC O O
vomiting VBG O B-problem
times NNS B-NP O
one CD O O
. . B-VP O
   
He PRP O B-person
also RB O O
complained VBD B-VP O
of IN B-VP O
dizziness NN B-NP B-problem
at IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
headache NN B-NP B-problem
onset NN I-NP O
. . B-VP O
   
He PRP O B-person
presented VBD B-VP O
to TO O O
the DT B-NP O
Edith NNP I-NP O
Nourse NNP I-NP O
Rogers NNP I-NP O
Memorial NNP I-NP O
VA NNP I-NP O
Hospital NNP I-NP O
emergency NN I-NP O
room NN I-NP O
, , O O
where WRB O O
an DT B-NP B-test
initial JJ I-NP I-test
head NN I-NP I-test
CT NNP I-NP I-test
scan NN I-NP I-test
was VBD B-VP O
read VBN O O
as IN B-VP O
negative JJ O O
. . B-VP O
   
However RB O O
, , O O
a DT B-NP B-test
lumbar NN I-NP I-test
puncture NN I-NP I-test
was VBD B-VP O
done VBN O O
, , O O
in IN B-VP O
which WDT O B-pronoun
tube NN B-NP O
1 CD O O
showed VBD B-VP O
4800 CD O B-test
red JJ B-NP I-test
blood NN I-NP I-test
cells NNS I-NP I-test
and CC O O
tube NN B-NP O
4 CD O O
showed VBD B-VP O
4000 CD O B-test
red JJ B-NP I-test
blood NN I-NP I-test
cells NNS I-NP I-test
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
sent VBN O O
for IN B-VP O
an DT B-NP B-test
MRI NNP I-NP I-test
of IN B-VP I-test
the DT B-NP I-test
head NN I-NP I-test
, , O O
which WDT O B-pronoun
raised VBD B-VP O
the DT B-NP O
question NN I-NP O
of IN B-VP O
a DT B-NP B-problem
right JJ I-NP I-problem
posterior JJ I-NP I-problem
cerebral JJ I-NP I-problem
artery NN I-NP I-problem
aneurysm NN I-NP I-problem
. . B-VP O
   
The DT B-NP B-test
CT NNP I-NP I-test
scan NN I-NP I-test
was VBD B-VP O
revealed VBN O O
and CC O O
, , O O
on IN B-VP O
second JJ B-NP O
analysis NN I-NP O
, , O O
it PRP O B-pronoun
was VBD B-VP O
thought VBN O O
that IN B-VP B-pronoun
it PRP O B-pronoun
was VBD B-VP O
suspicious JJ O O
for IN B-VP O
a DT B-NP B-problem
subarachnoid JJ I-NP I-problem
hemorrhage NN I-NP I-problem
in IN B-VP I-problem
the DT B-NP I-problem
suprasellar JJ I-NP I-problem
cistern NN I-NP I-problem
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
then RB O O
admitted VBN O O
for IN B-VP O
further JJ B-NP B-test
evaluation NN I-NP I-test
. . B-VP O
   
PAST NNP B-NP O
MEDICAL NNP I-NP O
HISTORY NNP I-NP O
: : O O
The DT B-NP O
past JJ I-NP O
medical JJ I-NP O
history NN I-NP O
was VBD B-VP O
significant JJ O O
for IN B-VP O
left JJ B-NP B-treatment
shoulder NN I-NP I-treatment
surgery NN I-NP I-treatment
in IN B-VP O
2014-03-06 JJ O O
for IN B-VP O
repair NN B-NP B-treatment
of IN B-VP O
a DT B-NP B-problem
" NNP I-NP I-problem
minor JJ B-NP I-problem
rotator NN I-NP I-problem
cuff NN I-NP I-problem
tear JJ B-NP I-problem
" NN I-NP O
and CC O O
removal NN B-NP B-treatment
of IN B-VP O
osteophytes NNS B-NP B-problem
. . B-VP O
   
Otherwise RB O O
, , O O
the DT B-NP O
past JJ I-NP O
medical JJ I-NP O
history NN I-NP O
was VBD B-VP O
insignificant JJ O O
. . B-VP O
   
MEDICATIONS NNP B-NP O
ON NNP I-NP O
ADMISSION NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
on IN B-VP O
no DT B-NP O
medications NNS I-NP B-treatment
. . B-VP O
   
ALLERGIES NN B-NP O
: : O O
There EX O O
were VBD B-VP O
no DT O O
known VBN O B-problem
drug NN B-NP I-problem
allergies NNS I-NP I-problem
. . B-VP O
   
FAMILY NNP B-NP B-person
HISTORY NNP I-NP O
: : O O
The DT B-NP B-person
father NN I-NP I-person
had VBD B-VP O
leukemia NN B-NP B-problem
and CC O O
the DT B-NP B-person
mother NN I-NP I-person
had VBD B-VP O
gastrointestinal JJ B-NP B-problem
cancer NN I-NP I-problem
. . B-VP O
   
There EX O O
was VBD B-VP O
no DT B-NP O
family NN I-NP B-person
history NN I-NP O
of IN B-VP O
aneurysms NNS B-NP B-problem
. . B-VP O
   
SOCIAL NNP B-NP O
HISTORY NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
a DT B-NP O
nonsmoker NN I-NP O
and CC O O
used VBD B-VP O
no DT B-NP O
ethanol NN I-NP O
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
married VBN O O
, , O O
with IN B-VP O
children NNS B-NP B-person
, , O O
and CC O O
was VBD B-VP O
a DT B-NP O
church NN I-NP O
minister NN I-NP O
. . B-VP O
   
PHYSICAL JJ B-NP O
EXAMINATION NN I-NP O
: : O O
On IN B-VP O
physical JJ B-NP B-test
examination NN I-NP I-test
, , O O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
resting VBG O O
comfortably RB O O
when WRB O O
seen VBN O O
, , O O
slightly RB O B-problem
sleepy NN B-NP I-problem
at IN B-VP O
first JJ O O
but CC O O
readily RB O O
arousable JJ O O
, , O O
awake VB O O
, , O O
alert VB O O
, , O O
oriented VBN O O
and CC O O
conversant JJ O O
. . B-VP O
   
Of IN B-VP O
note NN B-NP O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
had VBD B-VP O
been VBN O O
given VBN O O
2 CD O O
mg NN B-NP O
of IN B-VP O
Ativan NNP B-NP B-treatment
before IN B-VP O
the DT B-NP B-test
examination NN I-NP I-test
. . B-VP O
   
The DT B-NP O
face NN I-NP O
was VBD B-VP O
symmetric JJ O O
. . B-VP O
   
The DT B-NP O
tongue NN I-NP O
was VBD B-VP O
midline NN B-NP O
. . B-VP O
   
The DT B-NP O
neck NN I-NP O
was VBD B-VP O
supple JJ O O
with IN B-VP O
full JJ B-NP O
range NN I-NP O
of IN B-VP O
motion NN B-NP O
. . B-VP O
   
There EX O O
was VBD B-VP O
no DT B-NP O
rigidity NN I-NP B-problem
, , O O
but CC O O
the DT B-NP O
neck NN I-NP O
was VBD B-VP O
slightly RB O B-problem
painful JJ O I-problem
at IN B-VP O
extreme JJ B-NP B-test
flexion NN I-NP I-test
. . B-VP O
   
The DT B-NP B-test
general JJ I-NP I-test
examination NN I-NP I-test
was VBD B-VP O
essentially RB O O
unremarkable JJ O O
, , O O
as IN B-VP O
per IN B-VP O
previous JJ B-NP O
notes NNS I-NP O
. . B-VP O
   
On IN B-VP O
examination NN B-NP B-test
of IN B-VP I-test
the DT B-NP I-test
extremities NNS I-NP I-test
, , O O
the DT B-NP B-person
patient NN I-NP I-person
moved VBD B-VP O
all DT B-NP O
extremities NNS I-NP O
and CC O O
had VBD B-VP O
strength NN B-NP O
of IN B-VP O
5/5 CD O O
in IN B-VP O
all DT O O
of IN B-VP O
the DT B-NP O
muscle NN I-NP O
groups NNS I-NP O
tested VBN O O
in IN B-VP O
the DT O O
upper JJ O O
and CC O O
lower JJR B-NP O
extremities NNS I-NP O
. . B-VP O
   
The DT B-NP B-test
sensory JJ I-NP I-test
examination NN I-NP I-test
was VBD B-VP O
intact JJ O O
to TO O O
light JJ B-NP B-test
touch NN I-NP I-test
. . B-VP O
   
There EX O O
was VBD B-VP O
a DT O B-problem
very RB O I-problem
slight JJ B-NP I-problem
inward NN I-NP I-problem
pronator NN I-NP I-problem
drift NN I-NP I-problem
of IN B-VP I-problem
the DT B-NP I-problem
left JJ I-NP I-problem
hand NN I-NP I-problem
. . B-VP O
   
Finger NNP B-NP B-test
- : O I-test
nose JJ O I-test
- : O I-test
finger NN B-NP I-test
testing VBG O I-test
and CC O O
heel VB O B-test
- : O I-test
to TO O I-test
- : O I-test
shin JJ O I-test
testing VBG O I-test
were VBD B-VP O
normal JJ O O
. . B-VP O
   
Rapid JJ O O
alternating VBG O O
movement NN B-NP O
was VBD B-VP O
normal JJ O O
. . B-VP O
   
The DT B-NP O
toes NNS I-NP O
were VBD B-VP O
downgoing VBG O O
bilaterally RB O O
. . B-VP O
   
Gait NNP B-NP O
was VBD B-VP O
reported VBN O O
to TO O O
be VB O O
normal JJ O O
, , O O
as IN B-VP O
per IN B-VP O
the DT B-NP O
emergency NN I-NP O
room NN I-NP O
staff NN I-NP O
. . B-VP O
   
There EX O O
was VBD B-VP O
no DT B-NP O
ataxia NN I-NP B-problem
noted VBD B-VP O
. . B-VP O
   
LABORATORY NN B-NP O
: : O O
Laboratory NN B-NP B-test
values NNS I-NP I-test
were VBD B-VP O
as IN B-VP O
per IN B-VP O
the DT B-NP O
History NNP I-NP O
of IN B-VP O
Present NNP B-NP O
Illness NNP I-NP O
. . B-VP O
   
RADIOLOGY NN B-NP O
: : O O
Neurological JJ B-NP B-test
imaging NN I-NP I-test
data NNS I-NP O
was VBD B-VP O
as IN B-VP O
per IN B-VP O
the DT B-NP O
History NNP I-NP O
of IN B-VP O
Present NNP B-NP O
Illness NNP I-NP O
. . B-VP O
   
HOSPITAL NNP B-NP O
COURSE NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
admitted VBN O O
to TO O O
the DT B-NP O
surgical JJ I-NP O
intensive JJ I-NP O
care NN I-NP O
unit NN I-NP O
, , O O
where WRB O O
a DT B-NP B-test
continued JJ I-NP I-test
cerebral JJ I-NP I-test
angiogram NN I-NP I-test
was VBD B-VP O
done VBN O O
that DT O B-pronoun
was VBD B-VP O
essentially RB O O
normal JJ O O
, , O O
without IN B-VP O
evidence NN B-NP O
of IN B-VP O
any DT B-NP B-problem
obvious JJ I-NP I-problem
aneurysm NN I-NP I-problem
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
observed VBN O O
for IN B-VP O
two CD O O
days NNS B-NP O
with IN B-VP O
a DT B-NP B-test
repeat NN I-NP I-test
CT NNP I-NP I-test
scan JJ O I-test
showing VBG O O
no DT B-NP O
changes NNS I-NP B-problem
from IN B-VP O
the DT B-NP B-test
previous JJ I-NP I-test
examination NN I-NP I-test
. . B-VP O
   
The DT B-NP B-problem
headache NN I-NP I-problem
stabilized VBN O O
after IN B-VP O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
transferred VBN O O
to TO O O
the DT B-NP O
floor NN I-NP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
continued VBD B-VP O
to TO O O
do VB O O
well RB O O
and CC O O
the DT B-NP O
decision NN I-NP O
was VBD B-VP O
made VBN O O
to TO O O
discharge VB O O
him PRP O B-person
. . B-VP O
   
DISCHARGE NNP B-NP O
INSTRUCTIONS NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
discharged VBN O O
with IN B-VP O
strict JJ B-NP O
instructions NNS I-NP O
to TO O O
return VB O O
to TO O O
the DT B-NP O
emergency NN I-NP O
room NN I-NP O
, , O O
should MD O O
there RB O O
be VB O O
an DT B-NP O
exacerbation NN I-NP O
of IN B-VP O
symptoms NNS B-NP B-problem
. . B-VP O
   
CONDITION NNP B-NP O
ON NNP I-NP O
DISCHARGE NNP I-NP O
: : O O
Stable JJ O O
. . B-VP O
   
DISCHARGE JJ B-NP O
DIAGNOSES NNP I-NP O
: : O O
Ruled VBN O O
out RP O O
subarachnoid JJ B-NP B-problem
hemorrhage NN I-NP I-problem
. . B-VP O
   
Michael NNP B-NP B-person
Lawrence NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
41-707 CD O O
Dictated VBN O O
By IN B-VP O
: : O O
Lena NNP B-NP B-person
D. NNP I-NP I-person
Mannie NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
MEDQUIST36 NNP I-NP O
D NNP I-NP O
: : O O
2014-08-09 JJ O O
14:04 CD O O
T NN B-NP O
: : O O
2014-08-09 JJ O O
15:27 CD O O
JOB NNP B-NP O
#: VBD B-VP O
45402 CD O O
Signed VBN O O
electronically RB O O
by IN B-VP O
: : O O
DR. NNP B-NP B-person
Michael NNP I-NP I-person
Jackson NNP I-NP I-person
on IN B-VP O
: : O O
FRI NNP B-NP O
2014-09-05 CD O O
11:39 CD O O
AM NNP B-NP O
( ( O O
End NNP B-NP O
of IN B-VP O
Report NNP B-NP O
) ) O O
-EMPTYLINE- VBP O O
-DOCSTART- JJ O O
-EMPTYLINE- $ O O
262912613 CD O O
CTMC NNP B-NP O
43279523 CD O O
551881 CD O O
6/25/1990 CD O O
12:00:00 CD O O
AM NNP B-NP O
Discharge NNP I-NP O
Summary NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date NNP I-NP O
: : O O
06/25/1990 CD O O
Report NNP B-NP O
Status NNP I-NP O
: : O O
Signed VBN O O
Discharge NNP B-NP O
Date NNP I-NP O
: : O O
07/05/1990 CD O O
PRINCIPLE NNP B-NP O
DIAGNOSIS NNP I-NP O
: : O O
LEFT NNP B-NP B-problem
KNEE NNP I-NP I-problem
OSTEOARTHRITIS NNP I-NP I-problem
. . B-VP O
   
PROCEDURE NN B-NP O
: : O O
LEFT NNP B-NP B-treatment
TOTAL NNP I-NP I-treatment
KNEE NNP I-NP I-treatment
ARTHROPLASTY NNP I-NP I-treatment
ON NNP I-NP O
6/26/90 CD O O
. . B-VP O
   
HISTORY NN B-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
is VBZ O O
a DT B-NP O
78-year-old JJ I-NP O
female NN I-NP O
who WP O B-person
has VBZ O O
had VBN O O
osteoarthritis VBN O B-problem
and CC O O
noted VBD B-VP O
the DT B-NP O
sudden JJ I-NP O
onset NN I-NP O
of IN B-VP O
left JJ B-NP B-problem
knee NN I-NP I-problem
pain NN I-NP I-problem
in IN B-VP O
09/89 CD O O
. . B-VP O
   
Since IN B-VP O
that DT B-NP B-pronoun
time NN I-NP O
, , O O
she PRP O B-person
has VBZ O O
used VBN O O
a DT B-NP B-treatment
cane NN I-NP I-treatment
and CC O O
she PRP O B-person
was VBD B-VP O
referred VBN O O
to TO O O
Dr. NNP B-NP B-person
Koors NNP I-NP I-person
. . B-VP O
   
MRI NNP B-NP B-test
demonstrated VBD B-VP O
a DT B-NP B-problem
left JJ I-NP I-problem
femoral JJ I-NP I-problem
condyle NN I-NP I-problem
osteonecrotic JJ B-NP I-problem
defect NN I-NP I-problem
and CC O O
degenerative JJ B-NP B-problem
meniscus NN I-NP I-problem
. . B-VP O
   
She PRP O B-person
climbs VBZ O O
stairs JJ O O
one CD O O
at IN B-VP O
a DT B-NP O
time NN I-NP O
and CC O O
denied VBD B-VP O
rest NN B-NP B-problem
pain NN I-NP I-problem
. . B-VP O
   
She PRP O B-person
can MD O O
one CD O O
walk NN B-NP O
without IN B-VP O
difficulties NNS B-NP B-problem
. . B-VP O
   
She PRP O B-person
presented VBD B-VP O
for IN B-VP O
an DT B-NP B-treatment
elective JJ I-NP I-treatment
left NN I-NP I-treatment
total JJ B-NP I-treatment
knee NN I-NP I-treatment
arthroplasty NN I-NP I-treatment
. . B-VP O
   
PAST NNP B-NP O
MEDICAL NNP I-NP O
HISTORY NNP I-NP O
: : O O
Pneumonia NNP B-NP B-problem
one CD O O
and CC O O
a DT B-NP O
half JJ I-NP O
years NNS I-NP O
ago RB O O
. . B-VP O
   
Hepatitis $ O B-problem
35 CD O O
years NNS B-NP O
ago RB O O
. . B-VP O
   
Anxiety NNP B-NP B-problem
neurosis NN I-NP I-problem
for IN B-VP O
which WDT O B-pronoun
she PRP O B-person
has VBZ O O
received VBN O O
shock NN B-NP B-treatment
therapy NN I-NP I-treatment
in IN B-VP O
the DT B-NP O
past NN I-NP O
. . B-VP O
   
PAST JJ B-NP O
SURGICAL JJ I-NP O
HISTORY NN I-NP O
: : O O
Total JJ B-NP B-treatment
abdominal JJ I-NP I-treatment
hysterectomy NN I-NP I-treatment
. . B-VP O
   
MEDICATIONS NN B-NP O
: : O O
On IN B-VP O
admission NN B-NP O
included VBD B-VP O
Tylenol NNP B-NP B-treatment
. . B-VP O
   
ALLERGIES NNP B-NP O
: : O O
DOXEPIN NNP B-NP B-treatment
CAUSES NNP I-NP O
ITCHING NNP I-NP B-problem
. . B-VP O
   
HABITS NN B-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
does VBZ O O
not RB O O
smoke VB O O
. . B-VP O
   
She PRP O B-person
drinks VBZ O O
one CD O O
to TO O O
two CD O O
glasses NNS B-NP O
of IN B-VP O
scotch NN B-NP O
per IN B-VP O
day NN B-NP O
. . B-VP O
   
PHYSICAL JJ B-NP O
EXAMINATION NN I-NP O
: : O O
On IN B-VP O
admission NN B-NP O
was VBD B-VP O
only RB O O
significant JJ O O
for IN B-VP O
her PRP$ O B-test
her PRP$ O B-person
orthopaedic JJ B-NP I-test
exam NN I-NP I-test
. . B-VP O
   
Her PRP$ O B-person
left JJ B-NP O
knee NN I-NP O
had VBD B-VP O
5 CD O O
degrees NNS B-NP O
of IN B-VP O
valgus NN B-NP B-problem
, , O O
120 CD O O
degrees NNS B-NP O
of IN B-VP O
flexion NN B-NP O
, , O O
full JJ B-NP O
extension NN I-NP O
and CC O O
slight JJ B-NP B-problem
valgus NN I-NP I-problem
instability NN I-NP I-problem
. . B-VP O
   
She PRP O B-person
had VBD B-VP O
no DT B-NP O
Lachmann NNP I-NP B-problem
or CC O O
anterior JJ B-NP B-problem
drawer NN I-NP I-problem
, , O O
she PRP O B-person
did VBD B-VP O
have VB O O
a DT B-NP B-problem
mild JJ I-NP I-problem
effusion NN I-NP I-problem
. . B-VP O
   
She PRP O B-person
had VBD B-VP O
normal JJ B-NP O
sensation NN I-NP O
and CC O O
pulses NNS B-NP O
in IN B-VP O
both DT B-NP O
legs NNS I-NP O
. . B-VP O
   
LABORATORY NNP B-NP O
DATA NNP I-NP O
: : O O
On IN B-VP O
admission NN B-NP O
included VBD B-VP O
a DT B-NP B-test
hematocrit NN I-NP I-test
of IN B-VP O
34.2 CD O O
. . B-VP O
   
Potassium NN B-NP B-test
4.4 CD O O
. . B-VP O
   
HOSPITAL NNP B-NP O
COURSE NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
cleared VBN O O
for IN B-VP O
surgery NN B-NP B-treatment
by IN B-VP O
Dr. NNP B-NP B-person
Lupevickette NNP I-NP I-person
Ca NNP I-NP I-person
. . B-VP O
   
Her PRP$ O B-person
Her PRP$ O B-test
EKG NNP B-NP I-test
was VBD B-VP O
normal JJ O O
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
therefore RB O O
taken VBN O O
to TO O O
the DT B-NP O
Operating NN I-NP O
Room NNP I-NP O
on IN B-VP O
6/26 CD O O
and CC O O
underwent VB O O
a DT B-NP B-treatment
left JJ I-NP I-treatment
total JJ I-NP I-treatment
knee NN I-NP I-treatment
arthroplasty NN I-NP I-treatment
losing VBG O O
200 CD O O
cc NN B-NP O
of IN B-VP O
blood NN B-NP O
in IN B-VP O
the DT B-NP B-treatment
procedure NN I-NP I-treatment
with IN B-VP O
two CD O B-treatment
drains NNS B-NP I-treatment
left VBN O O
in IN B-VP O
which WDT O B-pronoun
were VBD B-VP O
removed VBN O O
on IN B-VP O
the DT B-NP O
first JJ I-NP O
postoperative JJ I-NP O
day NN I-NP O
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
slightly RB O B-problem
agitated VBN O I-problem
on IN B-VP O
the DT B-NP O
first JJ I-NP O
postoperative JJ I-NP O
day NN I-NP O
but CC O O
this DT O B-pronoun
resolved VBN O O
by IN B-VP O
the DT B-NP O
second JJ I-NP O
postoperative JJ I-NP O
day NN I-NP O
. . B-VP O
   
Her PRP$ O B-person
Her PRP$ O B-treatment
epidural JJ B-NP I-treatment
catheter NN I-NP I-treatment
was VBD B-VP O
removed VBN O O
on IN B-VP O
6/29 CD O O
. . B-VP O
   
The DT B-NP B-treatment
Foley NNP I-NP I-treatment
catheter NN I-NP I-treatment
was VBD B-VP O
removed VBN O O
on IN B-VP O
6/29 CD O O
and CC O O
she PRP O B-person
had VBD B-VP O
no DT B-NP O
difficulties NNS I-NP B-problem
voiding VBG O I-problem
. . B-VP O
   
Psychiatry NNP B-NP B-person
Service NNP I-NP I-person
saw VBD B-VP O
her PRP$ O B-person
on IN B-VP O
6/28 CD O O
and CC O O
recommended VBD B-VP O
avoiding VBG O O
benzodiazepines NNS B-NP B-treatment
and CC O O
Haldol NNP B-NP B-treatment
for IN B-VP O
agitation NN B-NP B-problem
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
prophylaxed VBN O O
with IN B-VP O
Kefzol NNP B-NP B-treatment
perioperatively RB O O
and CC O O
with IN B-VP O
Coumadin NNP B-NP B-treatment
postoperatively RB O O
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
also RB O O
given VBN O O
whiskey JJ B-NP B-treatment
spirits NNS I-NP I-treatment
because IN B-VP O
of IN B-VP O
the DT B-NP O
fact NN I-NP O
that IN B-VP B-pronoun
she PRP O B-person
drank VBD B-VP O
one CD O O
to TO O O
two CD O O
drinks NNS B-NP O
of IN B-VP O
scotch NN B-NP O
per IN B-VP O
day NN B-NP O
. . B-VP O
   
Her PRP$ O B-person
Her PRP$ O B-test
hematocrit NN B-NP I-test
was VBD B-VP O
31.4 CD O O
on IN B-VP O
6/29 CD O O
with IN B-VP O
a DT B-NP B-test
PT NNP I-NP I-test
of IN B-VP O
18.2 CD O O
Her PRP$ O B-test
Her NNP B-NP B-person
PT NNP I-NP I-test
drifted VBD B-VP O
down RB O O
to TO O O
a DT B-NP O
level NN I-NP O
of IN B-VP O
12.9 CD O O
by IN B-VP O
7/3 CD O O
and CC O O
therefore JJR O O
she PRP O B-person
will MD O O
be VB O O
discharged VBN O O
with IN B-VP O
4 CD O O
mg NNS B-NP O
of IN B-VP O
Coumadin NNP B-NP B-treatment
per IN B-VP O
day NN B-NP O
to TO O O
be VB O O
followed VBN O O
by IN B-VP O
the DT B-NP O
Coumadin NNP I-NP O
Clinic NNP I-NP O
at IN B-VP O
Cowerin NNP B-NP O
Tonli NNP I-NP O
Medical NNP I-NP O
Center NNP I-NP O
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
discharged VBN O O
with IN B-VP O
a DT B-NP O
prescription NN I-NP O
for IN B-VP O
Tylenol NNP B-NP B-treatment
#3 NNP I-NP I-treatment
with IN B-VP O
Physical NNP B-NP B-treatment
Therapy NNP I-NP I-treatment
. . B-VP O
   
She PRP O B-person
did VBD B-VP O
quite RB O O
well RB O O
with IN B-VP O
Physical NNP B-NP B-treatment
Therapy NNP I-NP I-treatment
and CC O O
was VBD B-VP O
ambulating VBG O O
with IN B-VP O
a DT B-NP B-treatment
walker NN I-NP I-treatment
and CC O O
crutches NNS B-NP B-treatment
by IN B-VP O
7/3/90 CD O O
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
able JJ O O
to TO O O
flex VB O O
her PRP$ O B-person
knees NNS B-NP O
to TO O O
90 CD O O
degrees NNS B-NP O
by IN B-VP O
that DT B-NP B-pronoun
time NN I-NP O
. . B-VP O
   
She PRP O B-person
developed VBD B-VP O
no DT B-NP O
problems NNS I-NP O
with IN B-VP O
edema NN B-NP B-problem
or CC O O
with IN B-VP O
her PRP$ O B-problem
her PRP$ O B-person
wound NN B-NP I-problem
during IN B-VP O
her PRP$ O B-person
hospital NN B-NP O
stay NN I-NP O
. . B-VP O
   
She PRP O B-person
will MD O O
follow-up VB O O
with IN B-VP O
Dr. NNP B-NP B-person
Koors NNP I-NP I-person
in IN B-VP O
approximately RB O O
five CD O O
weeks NNS B-NP O
. . B-VP O
   
________________________________ JJ B-NP O
IA605/6041 NNP I-NP O
DE NNP I-NP B-person
KOORS NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
CU2 NNP I-NP O
D NNP I-NP O
: : O O
07/03/90 CD O O
Batch NN B-NP O
: : O O
1726 CD O O
Report NN B-NP O
: : O O
J0929X49 NNP B-NP O
T NNP I-NP O
: : O O
07/04/90 CD O O
Dicatated VBN O O
By IN B-VP O
: : O O
LENTNY NNP B-NP B-person
FARSTNAPPSSHEE NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
﻿Admission NN I-NP O
Date NNP I-NP O
: : O O
2014-07-30 JJ B-NP O
Discharge NN I-NP O
Date NNP I-NP O
: : O O
2014-08-04 JJ B-NP O
Date NNP I-NP O
of IN B-VP O
Birth NNP B-NP O
: : O O
1930-08-11 JJ B-NP O
Sex NN I-NP O
: : O O
F NNP B-NP O
Service NNP I-NP O
: : O O
MEDICINE JJ B-NP O
Allergies NNS I-NP O
: : O O
Penicillins NNS B-NP B-treatment
Attending VBG O B-person
: : O O
William NNP B-NP B-person
Q. NNP I-NP I-person
Williams NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
Chief NNP I-NP O
Complaint NNP I-NP O
: : O O
dyspnea NN B-NP B-problem
Major NNP I-NP O
Surgical NNP I-NP O
or CC O O
Invasive JJ B-NP O
Procedure NN I-NP O
: : O O
None NN B-NP O
History NN I-NP O
of IN B-VP O
Present NNP B-NP O
Illness NNP I-NP O
: : O O
This DT O B-pronoun
is VBZ O O
an DT O O
83 CD O O
y/o NNS B-NP O
female JJ O O
with IN B-VP O
moderate JJ B-NP B-problem
AS NNP I-NP I-problem
, , O O
s/p VBD B-VP O
MVR NNP B-NP B-treatment
27 CD O O
years NNS B-NP O
ago RB O O
, , O O
s/p NN B-NP O
PPM NNP I-NP B-treatment
, , O O
DM NNP B-NP B-problem
, , O O
CHF NNP B-NP B-problem
, , O O
p/w NN B-NP O
dsypnea NN I-NP B-problem
and CC O O
increased JJ B-NP B-problem
work NN I-NP I-problem
of IN B-VP I-problem
breathing VBG O I-problem
x JJ B-NP O
4-5 JJ I-NP O
days NNS I-NP O
. . B-VP O
   
Per NNP B-NP O
family NN I-NP B-person
, , O O
the DT B-NP B-person
patient NN I-NP I-person
has VBZ O O
had VBN O O
worsening VBG O B-problem
CHF/volume NNP B-NP I-problem
overload NN I-NP I-problem
over IN B-VP O
the DT B-NP O
last JJ I-NP O
several JJ I-NP O
weeks NNS I-NP O
, , O O
requiring VBG O O
supplemental JJ B-NP B-treatment
O2 NNP I-NP I-treatment
at IN B-VP O
rehab NN B-NP O
. . B-VP O
   
Over IN B-VP O
the DT B-NP O
last JJ I-NP O
few JJ I-NP O
days NNS I-NP O
, , O O
she PRP O B-person
has VBZ O O
been VBN O O
noted VBN O O
to TO O O
be VB O O
more JJR O B-problem
short JJ O I-problem
of IN B-VP I-problem
breath NN B-NP I-problem
and CC O O
having VBG O O
sats NNS B-NP B-test
to TO O O
60% CD O O
on IN B-VP O
RA NNP B-NP O
. . B-VP O
   
Her PRP$ O B-treatment
Her PRP$ O B-person
lasix NN B-NP I-treatment
was VBD B-VP O
increased VBN O O
to TO O O
60 CD O O
mg NNS B-NP O
bid NN I-NP O
. . B-VP O
   
Beginning VBG O O
today NN B-NP O
, , O O
she PRP O B-person
was VBD B-VP O
noted VBN O O
to TO O O
be VB O O
in IN B-VP O
hypoxic JJ B-NP B-problem
respiratory NN I-NP I-problem
distress NN I-NP I-problem
, , O O
87-91% JJ O O
on IN B-VP O
2L/NC CD O B-treatment
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
increased VBN O O
to TO O O
5L CD O O
, , O O
with IN B-VP O
her PRP$ O B-person
her PRP$ O B-test
sats NN B-NP I-test
going VBG O O
up RB O O
to TO O O
97% CD O O
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
also RB O O
noted VBN O O
to TO O O
be VB O O
more JJR O B-problem
confused JJ O I-problem
over IN B-VP O
the DT B-NP O
last JJ I-NP O
few JJ I-NP O
days NNS I-NP O
and CC O O
especially RB O O
today NN B-NP O
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
given VBN O O
lasix NN B-NP B-treatment
and CC O O
2 CD O B-treatment
mg NN B-NP I-treatment
IV NNP I-NP I-treatment
morphine NN I-NP I-treatment
at IN B-VP O
New NNP B-NP O
England NNP I-NP O
Sinai NNP I-NP O
Hospital NNP I-NP O
& CC O O
Rehab NNP B-NP O
Center NNP I-NP O
Rehab NNP I-NP O
, , O O
and CC O O
sent VBD B-VP O
to TO O O
Nantucket NNP B-NP O
Cottage NNP I-NP O
Hospital NNP I-NP O
for IN B-VP O
further JJ B-NP B-test
evaluation NN I-NP I-test
. . B-VP O
   
En NNP B-NP O
route NN I-NP O
, , O O
she PRP O B-person
was VBD B-VP O
given VBN O O
additional JJ B-NP B-treatment
lasix NN I-NP I-treatment
of IN B-VP O
60 CD O O
mg NNS B-NP O
IV NNP I-NP O
and CC O O
nitro JJ B-NP B-treatment
spray NN I-NP I-treatment
x VBD B-VP O
2 CD O O
. . B-VP O
   
In IN B-VP O
the DT B-NP O
Deanna NNP I-NP O
, , O O
her PRP$ O B-person
her PRP$ O B-test
VS NNP B-NP I-test
were VBD B-VP O
Tc NNP B-NP B-test
97.2 CD O O
, , O O
BP NNP B-NP B-test
146/25 CD O O
, , O O
HR NNP B-NP B-test
70 CD O O
, , O O
RR NNP B-NP B-test
27 CD O O
, , O O
SaO2 NNP B-NP B-test
95%/NRB CD O B-treatment
. . B-VP O
   
Foley NNP B-NP B-treatment
was VBD B-VP O
placed VBN O O
in IN B-VP O
Deanna NNP B-NP O
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
given VBN O O
40 CD O O
mg JJ B-NP O
IV NNP I-NP B-treatment
lasix NN I-NP I-treatment
and CC O O
325 CD O O
mg NN B-NP O
ASA NNP I-NP B-treatment
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
placed VBN O O
on IN B-VP O
BiPAP NNP B-NP B-treatment
for IN B-VP O
comfort NN B-NP O
at IN B-VP O
30% CD O O
FiO2 NNP B-NP B-treatment
, , O O
5 CD O O
PEEP NNP B-NP B-treatment
, , O O
12 CD O O
PS NNP B-NP B-treatment
. . B-VP O
   
Admitted VBN O O
to TO O O
the DT B-NP O
CMED NNP I-NP O
CSRU NNP I-NP O
for IN B-VP O
further JJ B-NP B-treatment
management NN I-NP I-treatment
. . B-VP O
   
Per NNP B-NP O
family NN I-NP B-person
, , O O
besides IN B-VP O
the DT B-NP B-problem
dyspnea NN I-NP I-problem
and CC O O
SOB NNP B-NP B-problem
, , O O
the DT B-NP B-person
patient NN I-NP I-person
has VBZ O O
had VBN O O
no DT B-NP O
other JJ I-NP B-problem
symptoms NNS I-NP I-problem
, , O O
including VBG O O
f/c/s NN B-NP B-problem
, , O O
CP NNP B-NP B-problem
, , O O
palpitations NNS B-NP B-problem
, , O O
abd NN B-NP B-problem
pain NN I-NP I-problem
, , O O
n/v/diarrhea NN B-NP B-problem
. . B-VP O
   
She PRP O B-person
has VBZ O O
had VBD B-VP O
decreased VBN O B-problem
appetite RB O I-problem
over IN B-VP O
the DT B-NP O
last JJ I-NP O
few JJ I-NP O
days NNS I-NP O
in IN B-VP O
the DT B-NP O
context NN I-NP O
of IN B-VP O
increasing VBG O B-problem
confusion NN B-NP I-problem
. . B-VP O
   
Past NNP B-NP O
Medical JJ B-NP O
History NN I-NP O
: : O O
1. CD O O
Moderate NNP B-NP B-problem
AS IN B-VP I-problem
2. CD O O
s/p NN B-NP O
MVR NNP I-NP B-treatment
3. CD O O
s/p NN B-NP O
PPM NNP I-NP B-treatment
4. CD O O
A NNP B-NP B-problem
fib NN I-NP I-problem
5. CD O O
DM NNP B-NP B-problem
2 CD O I-problem
on IN B-VP O
insulin NN B-NP B-treatment
6. CD O O
Hypercholesterolemia NNP B-NP B-problem
7. CD O O
Gout NNP B-NP B-problem
8. CD O O
Depression NNP B-NP B-problem
9. CD O O
? . B-VP O
Pulmonary JJ B-NP B-problem
fibrosis NN I-NP I-problem
10. CD O O
CHF/CAD NNP B-NP B-problem
, , O O
last JJ B-NP B-test
EF NNP I-NP I-test
55% CD O O
4/06 CD O O
Social JJ B-NP O
History NN I-NP O
: : O O
Lives NNS B-NP O
at IN B-VP O
Salem NNP B-NP O
Hospital NNP I-NP O
- : O O
North NN B-NP O
Shore NNP I-NP O
Medical NNP I-NP O
Center NNP I-NP O
Rehab NNP I-NP O
. . B-VP O
   
Prior NNP B-NP O
h/o JJ B-NP O
heavy JJ I-NP O
tobacco NN I-NP O
use NN I-NP O
. . B-VP O
   
Ambulates NNS B-NP O
at IN B-VP O
baseline NN B-NP O
. . B-VP O
   
Family JJ B-NP O
History NN I-NP O
: : O O
Mother NN B-NP B-person
with IN B-VP O
h/o NN B-NP O
emphysema NN I-NP B-problem
, , O O
CAD NNP B-NP B-problem
Physical NNP I-NP O
Exam NNP I-NP O
: : O O
General JJ O O
: : O O
Asleep NN B-NP O
, , O O
easily RB O O
arousable JJ O O
. . B-VP O
   
On IN B-VP O
BiPAP NNP B-NP B-treatment
, , O O
NAD NNP B-NP B-problem
HEENT NNP I-NP O
: : O O
NC/AT NNP B-NP O
, , O O
PERRL NNP B-NP O
, , O O
EOMI NNP B-NP O
. . B-VP O
   
MMM NNP B-NP O
, , O O
OP NNP B-NP O
clear JJ B-NP O
Neck NN I-NP O
: : O O
+ NN B-NP O
elevated VBD B-VP B-problem
JVD NNP B-NP I-problem
to TO O O
earlobe VB O O
, , O O
supple JJ B-NP O
Chest NNP I-NP O
: : O O
decreased VBN O B-problem
BS NNP B-NP I-problem
at IN B-VP O
bases NNS B-NP O
with IN B-VP O
few JJ B-NP B-problem
crackles NNS I-NP I-problem
b/l VBP O I-problem
CV NNP B-NP O
: : O O
RRR NNP B-NP O
3/6 CD O O
HSM NNP B-NP B-problem
, , O O
loudest JJS O O
at IN B-VP O
LUSB NNP B-NP O
Abd NNP I-NP O
: : O O
soft JJ O O
, , O O
NT/ND NNP B-NP B-problem
, , O O
NABS NNP B-NP O
Ext NNP I-NP O
: : O O
2 CD O O
+ NN B-NP O
pitting VBG O B-problem
edema NN B-NP I-problem
b/l NN I-NP I-problem
, , O O
warm JJ O O
with IN B-VP O
faint JJ B-NP O
DP NNP I-NP O
Pertinent NNP I-NP O
Results NNP I-NP O
: : O O
2014-07-30 JJ O O
01:30PM CD O O
WBC NNP B-NP B-test
- : O O
9.6 CD O O
RBC NNP B-NP B-test
- : O O
4.02 CD O O
* NN B-NP O
HGB NNP I-NP B-test
- : O O
11.4 CD O O
* NN B-NP O
HCT NNP I-NP B-test
- : O O
36.3 CD O O
MCV NNP B-NP B-test
- : O O
90 CD O O
MCH NNP B-NP B-test
- : O O
28.4 CD O O
MCHC NNP B-NP B-test
- : O O
31.4 CD O O
RDW NNP B-NP B-test
- : O O
17.8 CD O O
* JJ O O
2014-07-30 JJ O O
01:30PM CD O O
NEUTS NNP B-NP B-test
- : O O
87.0 CD O O
* NN B-NP O
LYMPHS NNP I-NP B-test
- : O O
6.7 CD O O
* JJ B-NP O
MONOS NNP I-NP B-test
- : O O
5.0 CD O O
EOS NNP B-NP B-test
- : O O
0.9 CD O O
BASOS NNP B-NP B-test
- : O O
0.4 CD O O
2014-07-30 JJ O O
01:30PM CD O O
PLT NNP B-NP B-test
COUNT NNP I-NP I-test
- : O O
161 CD O O
2014-07-30 JJ O O
01:30PM CD O O
PT NNP B-NP B-test
- : O O
23.2 CD O O
* JJ B-NP O
INR NNP I-NP B-test
( ( O O
PT NNP B-NP O
) ) O O
- : O O
2.3 CD O O
* JJ O O
2014-07-30 JJ O O
01:30PM CD O O
cTropnT NN B-NP B-test
- : O O
0.08 CD O O
* JJ O O
2014-07-30 JJ O O
01:30PM CD O O
CK NNP B-NP B-test
( ( O I-test
CPK NNP B-NP I-test
) ) O I-test
- : O O
37 CD O O
2014-07-30 JJ O O
01:30PM CD O O
cTropnT NN B-NP B-test
- : O O
0.08 CD O O
* JJ O O
2014-07-30 JJ O O
01:30PM CD O O
CK-MB JJ O B-test
- : O O
NotDone NN B-NP O
proBNP NN I-NP B-test
- : O O
5313 CD O O
* IN B-VP O
2014-07-30 JJ O O
01:30PM CD O O
GLUCOSE NNP B-NP B-test
- : O O
173 CD O O
* JJ B-NP O
UREA NNP I-NP B-test
N NNP I-NP I-test
- : O O
52 CD O O
* NN B-NP O
CREAT NNP I-NP B-test
- : O O
1.5 CD O O
* JJ B-NP O
SODIUM NNP I-NP B-test
- : O O
145 CD O O
POTASSIUM NNP B-NP B-test
- : O O
4.8 CD O O
CHLORIDE NNP B-NP B-test
- : O O
100 CD O O
TOTAL NNP B-NP B-test
CO2 NNP I-NP I-test
- : O O
40 CD O O
* JJ B-NP O
ANION NNP I-NP B-test
GAP NNP I-NP I-test
- : O O
10 CD O O
2014-07-30 JJ O O
01:45PM CD O O
TYPE NNP B-NP O
- : O O
ART NNP B-NP B-test
PO2 NNP I-NP I-test
- : O O
249 CD O O
* NN B-NP O
PCO2 NNP I-NP B-test
- : O O
99 CD O O
* NN B-NP O
PH NNP I-NP B-test
- : O O
7.28 CD O O
* JJ B-NP O
TOTAL NNP I-NP B-test
CO2 NNP I-NP I-test
- : O O
49 CD O O
* JJ B-NP O
BASE NNP I-NP B-test
XS NNP I-NP I-test
- : O O
15 CD O O
INTUBATED NNP B-NP O
- : O O
NOT NNP B-NP O
INTUBA NNP I-NP O
2014-07-30 JJ O O
06:20PM CD O O
TYPE NNP B-NP O
- : O O
ART NNP B-NP B-test
TEMP NNP I-NP I-test
- : O O
37.0 CD O O
O2-90 JJ B-NP O
O2 NNP I-NP B-treatment
FLOW NNP I-NP I-treatment
- : O O
5 CD O O
PO2 NNP B-NP B-test
- : O O
63 CD O O
* NN B-NP O
PCO2 NNP I-NP B-test
- : O O
81 CD O O
* NN B-NP O
PH NNP I-NP B-test
- : O O
7.39 CD O O
TOTAL NNP B-NP B-test
CO2 NNP I-NP I-test
- : O O
51 CD O O
* JJ B-NP O
BASE NNP I-NP B-test
XS NNP I-NP I-test
- : O O
19 CD O O
AADO2 NNP B-NP B-test
- : O O
513 CD O O
REQ NNP B-NP B-test
O2 NNP I-NP I-test
- : O O
84 CD O O
INTUBATED NNP B-NP O
- : O O
NOT NNP B-NP O
INTUBA NNP I-NP O
COMMENTS NNP I-NP O
- : O O
NASAL NNP B-NP O
Harper NNP I-NP O
Echo NNP I-NP B-test
: : O O
The DT B-NP O
left JJ I-NP O
atrium NN I-NP O
is VBZ O O
mildly RB O B-problem
dilated VBN O I-problem
. . B-VP O
   
There EX O O
is VBZ O O
mild JJ O B-problem
symmetric JJ O I-problem
left VBD B-VP I-problem
ventricular JJ B-NP I-problem
hypertrophy NN I-NP I-problem
. . B-VP O
   
The DT B-NP B-test
left JJ I-NP I-test
ventricular JJ I-NP I-test
cavity NN I-NP I-test
size NN I-NP I-test
is VBZ O O
normal JJ O O
. . B-VP O
   
Overall JJ O B-test
left VBD B-VP I-test
ventricular JJ B-NP I-test
systolic JJ I-NP I-test
function NN I-NP I-test
is VBZ O O
normal JJ O O
( ( O O
LVEF NNP B-NP B-test
70% CD O O
). NN B-NP O
There EX O O
is VBZ O O
no DT B-NP O
ventricular JJ I-NP B-problem
septal NN I-NP I-problem
defect NN I-NP I-problem
. . B-VP O
   
The DT B-NP O
right JJ I-NP O
ventricular NN I-NP O
free JJ B-NP O
wall NN I-NP O
is VBZ O O
hypertrophied VBN O B-problem
. . B-VP O
   
The DT B-NP O
right JJ I-NP O
ventricular NN I-NP O
cavity NN I-NP O
is VBZ O O
dilated VBN O B-problem
. . B-VP O
   
Right JJ B-NP B-test
ventricular JJ I-NP I-test
systolic JJ I-NP I-test
function NN I-NP I-test
appears VBZ O O
depressed VBN O B-problem
. . B-VP O
   
The DT B-NP O
aortic JJ I-NP O
arch NN I-NP O
is VBZ O O
mildly RB O B-problem
dilated VBN O I-problem
. . B-VP O
   
There EX O O
are VBP O O
focal JJ B-NP B-problem
calcifications NNS I-NP I-problem
in IN B-VP I-problem
the DT B-NP I-problem
aortic JJ I-NP I-problem
arch NN I-NP I-problem
. . B-VP O
   
There EX O O
are VBP O O
three CD O B-problem
aortic JJ B-NP I-problem
valve NN I-NP I-problem
leaflets NNS I-NP I-problem
. . B-VP O
   
The DT B-NP O
aortic JJ I-NP O
valve NN I-NP O
leaflets NNS I-NP O
are VBP O O
moderately RB O B-problem
thickened VBN O I-problem
. . B-VP O
   
There EX O O
is VBZ O O
at IN B-VP O
least JJS B-NP O
moderate JJ I-NP B-problem
aortic JJ I-NP I-problem
valve NN I-NP I-problem
stenosis NN I-NP I-problem
. . B-VP O
   
A DT B-NP B-treatment
bileaflet JJ I-NP I-treatment
mitral JJ I-NP I-treatment
valve NN I-NP I-treatment
prosthesis NN I-NP I-treatment
is VBZ O O
present JJ O O
. . B-VP O
   
The DT B-NP B-test
gradients NNS I-NP I-test
are VBP O O
higher JJR O O
than IN B-VP O
expected VBN O O
for IN B-VP O
this DT B-NP B-pronoun
type NN I-NP O
of IN B-VP O
prosthesis NN B-NP B-treatment
. . B-VP O
   
The DT B-NP O
tricuspid JJ I-NP O
valve NN I-NP O
leaflets NNS I-NP O
are VBP O O
mildly RB O B-problem
thickened VBN O I-problem
. . B-VP O
   
There EX O O
is VBZ O O
moderate JJ B-NP B-problem
pulmonary JJ I-NP I-problem
artery NN I-NP I-problem
systolic JJ B-NP I-problem
hypertension NN I-NP I-problem
. . B-VP O
   
The DT B-NP B-test
end-diastolic JJ I-NP I-test
pulmonic JJ I-NP I-test
regurgitation NN I-NP I-test
velocity NN I-NP I-test
is VBZ O O
increased VBN O B-problem
suggesting VBG O O
pulmonary JJ B-NP B-problem
artery NN I-NP I-problem
diastolic JJ B-NP I-problem
hypertension NN I-NP I-problem
. . B-VP O
   
There EX O O
is VBZ O O
no DT B-NP O
pericardial JJ I-NP B-problem
effusion NN I-NP I-problem
. . B-VP O
   
Compared VBN O O
with IN B-VP O
the DT B-NP O
findings NNS I-NP O
of IN B-VP O
the DT B-NP B-test
prior JJ I-NP I-test
study NN I-NP I-test
( ( O O
images NNS B-NP O
reviewed VBN O O
) ) O O
of IN B-VP O
2013-06-18 JJ O O
, , O O
the DT B-NP B-test
pressure NN I-NP I-test
gradient NN I-NP I-test
across IN B-VP O
the DT B-NP B-treatment
mitral JJ I-NP I-treatment
valve NN I-NP I-treatment
prosthesis NN I-NP I-treatment
is VBZ O O
increased VBN O B-problem
. . B-VP O
   
IMPRESSION NN B-NP O
: : O O
AP NNP B-NP B-test
chest JJS O I-test
compared VBN O O
to TO O O
07-30 CD O O
through IN B-VP O
26 CD O O
: : O O
Mild NNP B-NP B-problem
pulmonary JJ B-NP I-problem
edema NN I-NP I-problem
is VBZ O O
unchanged JJ O O
. . B-VP O
   
Bilateral JJ B-NP B-problem
pleural JJ I-NP I-problem
effusion NN I-NP I-problem
small JJ O O
on IN B-VP O
the DT B-NP O
right NN I-NP O
and CC O O
moderate VB O O
on IN B-VP O
the DT B-NP O
left NN I-NP O
is VBZ O O
stable JJ O O
. . B-VP O
   
Severe JJ B-NP B-problem
cardiomegaly NN I-NP I-problem
and CC O O
left VBD B-VP B-problem
lower JJR B-NP I-problem
lobe NN I-NP I-problem
atelectasis NN I-NP I-problem
unchanged JJ O O
. . B-VP O
   
No DT B-NP O
pneumothorax NN I-NP B-problem
. . B-VP O
   
Transvenous JJ B-NP B-treatment
right JJ I-NP I-treatment
ventricular NN I-NP I-treatment
pacer NN I-NP I-treatment
lead NN I-NP I-treatment
in IN B-VP O
standard JJ B-NP O
placement NN I-NP O
. . B-VP O
   
ECG NN B-NP B-test
: : O O
Ventricular NNP B-NP O
paced VBD B-VP O
rhythm NN B-NP O
. . B-VP O
   
Compared VBN O O
to TO O O
the DT B-NP B-test
previous JJ I-NP I-test
tracing NN I-NP I-test
of IN B-VP O
2014-07-30 JJ O O
no DT B-NP O
significant JJ I-NP O
change NN I-NP O
. . B-VP O
   
Intervals NNS B-NP O
Axes NNP I-NP O
Rate NNP I-NP B-test
PR NNP I-NP B-test
QRS NNP I-NP B-test
QT/QTc NNP I-NP B-test
P NNP I-NP B-test
QRS NNP I-NP B-test
T NNP I-NP B-test
70 CD O O
0 CD O O
160 CD O O
466/486.42 CD O O
0 CD O O
-71 JJ O O
112 CD O O
Brief JJ B-NP O
Hospital JJ I-NP O
Course NN I-NP O
: : O O
A/P NNP B-NP O
- : O O
83yo CD O B-person
F NNP B-NP I-person
with IN B-VP O
valvular JJ B-NP B-problem
disorder NN I-NP I-problem
, , O O
AF NNP B-NP B-problem
, , O O
and CC O O
h/o NN B-NP O
CAD NNP I-NP B-problem
a/w NN I-NP O
hypercarbic NN I-NP B-problem
respiratory JJ B-NP I-problem
failure NN I-NP I-problem
. . B-VP O
   
# # O O
Respiratory JJ B-NP B-problem
failure NN I-NP I-problem
- : O O
She PRP O B-person
was VBD B-VP O
admitted VBN O O
to TO O O
the DT B-NP O
CMED NNP I-NP O
CSRU NNP I-NP O
for IN B-VP O
her PRP$ O B-problem
her PRP$ O B-person
repiratory NN B-NP I-problem
failure NN I-NP I-problem
which WDT O B-pronoun
was VBD B-VP O
thought VBN O O
to TO O O
be VB O O
secondary JJ O O
to TO O O
CHF NNP B-NP B-problem
. . B-VP O
   
Pt NNP B-NP B-person
was VBD B-VP O
diuresed VBN O O
with IN B-VP O
iv JJ B-NP B-treatment
lasix NN I-NP I-treatment
/ NNP I-NP O
acetazolamide NN I-NP B-treatment
and CC O O
given VBN O O
iv JJ B-NP B-treatment
morphine NN I-NP I-treatment
/ NNP I-NP O
prn NN I-NP O
for IN B-VP O
respiratory NN B-NP B-problem
distress NN I-NP I-problem
and CC O O
BIPAP NNP B-NP B-treatment
was VBD B-VP O
tried VBN O O
. . B-VP O
   
However RB O O
, , O O
hypercarbia NN B-NP B-problem
( ( O O
04-11 JJ B-NP O
metabolic JJ I-NP B-problem
alkalosis NN I-NP I-problem
) ) O O
remained VBD B-VP O
in IN B-VP O
the DT O O
90s CD O O
. . B-VP O
   
Pt NNP B-NP B-person
was VBD B-VP O
mentating VBG O O
okay NN B-NP O
, , O O
having VBG O O
conversations NNS B-NP O
with IN B-VP O
intermittent JJ B-NP B-problem
somnolence NN I-NP I-problem
despite IN B-VP O
hypercarbia NN B-NP B-problem
. . B-VP O
   
TTE NNP B-NP B-test
showed VBD B-VP O
preserved VBN O O
EF NNP B-NP O
with IN B-VP O
moderate JJ B-NP B-problem
AS NNP I-NP I-problem
and CC O O
moderate JJ B-NP B-problem
MS NNP I-NP I-problem
and CC O O
mod VB O B-problem
pulm NN B-NP I-problem
HTN NNP I-NP I-problem
. . B-VP O
   
Cardiology NNP B-NP B-person
was VBD B-VP O
consulted VBN O O
and CC O O
thought VBN O O
MS NNP B-NP B-problem
Harold NNP I-NP O
Holcomb NNP I-NP O
to TO O O
her PRP$ O B-person
her PRP$ O B-problem
her PRP$ O B-person
pulm NN B-NP I-problem
edema NN I-NP I-problem
and CC O O
pulm NN B-NP B-problem
HTN NNP I-NP I-problem
. . B-VP O
   
Cardiology NNP B-NP B-person
recommended VBD B-VP O
d/cing VBG O O
digoxin NN B-NP B-treatment
and CC O O
starting VBG O O
amiodarone NN B-NP B-treatment
. . B-VP O
   
Family RB O B-person
declined VBD B-VP O
valvuloplasty NN B-NP B-treatment
. . B-VP O
   
For IN B-VP O
possible JJ B-NP O
COPD NNP I-NP B-problem
, , O O
pt NN B-NP B-person
was VBD B-VP O
started VBN O O
on IN B-VP O
steroids NNS B-NP B-treatment
and CC O O
nebs NNS B-NP B-treatment
on IN B-VP O
08-03 NN B-NP O
. . B-VP O
   
Pt NNP B-NP B-person
is VBZ O O
currently RB O O
satting VBG O B-test
90s CD O O
on IN B-VP O
1 CD O O
L NNP B-NP O
NC NNP I-NP B-treatment
while IN B-VP O
sitting VBG O O
in IN B-VP O
a DT B-NP O
chair NN I-NP O
but CC O O
needs VBZ O O
more RBR O B-treatment
O2 NNP B-NP I-treatment
when WRB O O
supine NN B-NP O
. . B-VP O
   
Pt NNP B-NP B-person
is VBZ O O
a DT B-NP O
mouth NN I-NP O
breather NN I-NP O
and CC O O
occasionally RB O O
needs VBZ O O
a DT B-NP B-treatment
face NN I-NP I-treatment
mask NN I-NP I-treatment
. . B-VP O
   
Pt NNP B-NP B-person
will MD O O
need VB O O
I/Os NNP B-NP B-test
monitored VBD B-VP O
to TO O O
goal NN B-NP O
even RB O O
to TO O O
slightly RB O O
negative JJ O O
as IN B-VP O
she PRP O B-person
was VBD B-VP O
diursed VBN O O
4.8 CD O O
L NNP B-NP O
during IN B-VP O
her PRP$ O B-person
CMED NNP B-NP O
stay NN I-NP O
. . B-VP O
   
Depending VBG O O
on IN B-VP O
her PRP$ O B-test
her PRP$ O B-person
I/O NNP B-NP I-test
, , O O
lasix NN B-NP B-treatment
and CC O O
acetazolamide NN B-NP B-treatment
can MD O O
be VB O O
decreased VBN O O
or CC O O
discontinued VBN O O
. . B-VP O
   
If IN B-VP O
she PRP O B-person
were VBD B-VP O
to TO O O
decompensate VB O O
at IN B-VP O
the DT B-NP O
rehab NN I-NP O
, , O O
goals NNS B-NP O
of IN B-VP O
care NN B-NP O
will MD O O
need VB O O
to TO O O
be VB O O
readdressed VBN O O
. . B-VP O
   
# # O O
h/o NN B-NP O
CAD NNP I-NP B-problem
- : O O
There EX O O
were VBD B-VP O
new JJ B-NP O
changes NNS I-NP O
on IN B-VP O
EKG NNP B-NP B-test
but CC O O
pt NN B-NP B-person
was VBD B-VP O
ruled VBN O O
out RP O O
with IN B-VP O
3 CD O O
sets NNS B-NP O
of IN B-VP O
negative JJ B-NP O
cardiac JJ I-NP O
enzymes NNS I-NP O
. . B-VP O
   
Pt NNP B-NP B-person
was VBD B-VP O
continued VBN O O
on IN B-VP O
BB NNP B-NP B-treatment
, , O O
ASA NNP B-NP B-treatment
, , O O
and CC O O
nitrates NNS B-NP B-treatment
. . B-VP O
   
# # O O
Acid NNP B-NP O
/ NNP I-NP O
base NN I-NP O
status NN I-NP O
- : O O
Respiratory JJ B-NP B-problem
acidosis NN I-NP I-problem
with IN B-VP O
metabolic JJ B-NP O
compensation NN I-NP O
. . B-VP O
   
Appears NNS B-NP O
to TO O O
be VB O O
chronic JJ O O
in IN B-VP O
nature NN B-NP O
given VBN O O
degree NN B-NP O
of IN B-VP O
metabolic JJ B-NP O
compensation NN I-NP O
with IN B-VP O
acute JJ B-NP O
component NN I-NP O
earlier RB O O
today NN B-NP O
. . B-VP O
   
Pt NNP B-NP B-person
failed VBD B-VP O
BIPAP NNP B-NP B-treatment
and CC O O
pCO2 NN B-NP B-test
remained VBN O O
in IN B-VP O
the DT O O
90s CD O O
but CC O O
maintaining VBG O O
mentation NN B-NP O
. . B-VP O
   
# # O O
Renal JJ B-NP B-problem
insufficiency NN I-NP I-problem
- : O O
baseline NN B-NP B-test
Cr NNP I-NP I-test
unknown JJ O O
, , O O
may MD O O
have VB O O
CRI NNP B-NP B-problem
from IN B-VP O
DM NNP B-NP B-problem
. . B-VP O
   
Creatinine NNP B-NP B-test
stayed VBD B-VP O
stable JJ O O
from IN B-VP O
1.3-1.5 JJ O O
. . B-VP O
   
Will MD O O
need VB O O
to TO O O
renally VB O O
dose VB O O
all DT B-NP B-treatment
medications NNS I-NP I-treatment
. . B-VP O
   
# # O O
A DT B-NP B-problem
fib NN I-NP I-problem
- : O O
continued VBN O O
BB NNP B-NP B-treatment
. . B-VP O
   
Per NNP B-NP O
cardiology NN I-NP B-person
consult NN I-NP O
recs NN I-NP O
, , O O
discontinued VBN O O
digoxin NN B-NP B-treatment
and CC O O
started VBD B-VP O
amiodarone NN B-NP B-treatment
. . B-VP O
   
Due NNP B-NP O
to TO O O
elevated VB O B-problem
INR NNP B-NP I-problem
, , O O
coumadin NN B-NP B-treatment
was VBD B-VP O
held VBN O O
. . B-VP O
   
Pt NNP B-NP B-person
is VBZ O O
also RB O O
paced VBN O O
. . B-VP O
   
Pt NNP B-NP B-person
needs VBZ O O
to TO O O
be VB O O
on IN B-VP O
amiodarone JJ O B-treatment
400mg CD O O
BID NNP B-NP O
x VBD B-VP O
7 CD O O
days NNS B-NP O
( ( O O
loading VBG O O
dose NN B-NP O
) ) O O
and CC O O
then RB O O
400mg CD O O
daily RB O O
for IN B-VP O
maintenance NN B-NP O
. . B-VP O
   
# # O O
DM NNP B-NP B-problem
- : O O
insulin NN B-NP B-treatment
standing VBG O O
+ NNP B-NP O
HISS NNP I-NP O
, , O O
FS NNP B-NP O
qid RB O O
# # O O
Depression NNP B-NP B-problem
- : O O
continued VBD B-VP B-treatment
home JJ B-NP I-treatment
regimen NNS I-NP I-treatment
# # O O
F/E/N NNP B-NP O
- : O O
NPO NNP B-NP O
initially RB O O
while IN B-VP O
on IN B-VP O
BIPAP NNP B-NP B-treatment
and CC O O
now RB O O
low JJ B-NP B-treatment
sodium NN I-NP I-treatment
cardiac NN I-NP I-treatment
diet NN I-NP I-treatment
. . B-VP O
   
# # O O
PPx NNP B-NP O
- : O O
supratherpeutic JJ B-NP B-problem
INR NNP I-NP I-problem
# # O O
Access NNP B-NP O
- : O O
PIV NNP B-NP B-treatment
# # O O
Code NNP B-NP O
- : O O
DNR/DNI NNP B-NP O
. . B-VP O
   
No NNP B-NP O
pressors NNS I-NP B-treatment
or CC O O
central JJ B-NP B-treatment
line NN I-NP I-treatment
per IN B-VP O
HCP NNP B-NP B-person
. . B-VP O
   
If IN B-VP O
she PRP O B-person
were VBD B-VP O
to TO O O
decompensate VB O O
at IN B-VP O
the DT B-NP O
rehab NN I-NP O
, , O O
goals NNS B-NP O
of IN B-VP O
care NN B-NP O
will MD O O
need VB O O
to TO O O
be VB O O
readressed VBN O O
. . B-VP O
   
# # O O
Communication NNP B-NP O
- : O O
Evelyn NNP B-NP B-person
Matos NNP I-NP I-person
( ( O O
niece RB O B-person
) ) O O
492 CD O O
- : O O
9977 CD O O
, , O O
cell NN B-NP O
( ( O O
921 CD O O
) ) O O
815 CD O O
- : O O
7040 CD O O
Medications NNS B-NP O
on IN B-VP O
Admission NN B-NP O
: : O O
Coumadin NNP B-NP B-treatment
2.5 CD O O
mg NN B-NP O
/ VBD B-VP O
3 CD O O
mg NN B-NP O
Insulin NNP I-NP B-treatment
- : O O
Humulin NNP B-NP B-treatment
N NNP I-NP I-treatment
36 CD O O
U NNP B-NP O
daily JJ O O
/ VBD B-VP O
14 CD O O
U NNP B-NP O
qhs NN I-NP O
Lasix NNP I-NP B-treatment
40 CD O O
mg NN B-NP O
bid NN I-NP O
Venlafaxine NNP I-NP B-treatment
XR NNP I-NP O
75 CD O O
mg NN B-NP O
qd NN I-NP O
Sorbitol NNP I-NP B-treatment
Metoprolol NNP I-NP B-treatment
25 CD O O
mg NN B-NP O
bid NN I-NP O
Imdur NNP I-NP B-treatment
30 CD O O
mg NN B-NP O
qd NN I-NP O
Hydralazine NNP I-NP B-treatment
50 CD O O
mg NN B-NP O
bid NN I-NP O
Digoxin NNP I-NP B-treatment
0.125 CD O O
qd RB O O
Oscal JJ O B-treatment
250 CD O O
mg NN B-NP O
+ NNP I-NP O
D NNP I-NP O
Tylenol NNP I-NP B-treatment
prn FW O O
Morphine NNP B-NP B-treatment
sulfate VBP O I-treatment
4 CD O O
mg NN B-NP O
q2 NN I-NP O
hrs NN I-NP O
prn NN I-NP O
Discharge NNP I-NP O
Medications NNP I-NP O
: : O O
1. CD O O
NPH NNP B-NP B-treatment
18 CD O O
units NNS B-NP O
qam RB O O
and CC O O
7 CD O O
units NNS B-NP O
qhs RB O O
2. CD O O
Humalog NNP B-NP B-treatment
Per NNP I-NP O
sliding VBG O O
scale NN B-NP O
q NN I-NP O
breakfast NN I-NP O
, , O O
lunch NN B-NP O
, , O O
and CC O O
dinner RB O O
3. CD O O
Venlafaxine NNP B-NP B-treatment
37.5 CD O O
mg NN B-NP O
Capsule NNP I-NP O
, , O O
Sust NNP B-NP O
. . B-VP O
   
Release NNP B-NP O
24 CD O O
hr NN B-NP O
Sig NN I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Capsule NN B-NP O
, , O O
Sust NNP B-NP O
. . B-VP O
   
Release NNP B-NP O
24 CD O O
hr NN B-NP O
PO NNP I-NP O
DAILY NNP I-NP O
( ( O O
Daily NNP B-NP O
). VBZ O O
4. CD O O
Aspirin NNP B-NP B-treatment
325 CD O O
mg NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Tablet NNP B-NP O
PO NNP I-NP O
DAILY NNP I-NP O
( ( O O
Daily NNP B-NP O
). VBZ O O
5. CD O O
Isosorbide NNP B-NP B-treatment
Mononitrate NNP I-NP I-treatment
30 CD O O
mg NN B-NP O
Tablet NNP I-NP O
Sustained NNP I-NP O
Release NNP I-NP O
24 CD O O
hr NN B-NP O
Sig NN I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Tablet NN B-NP O
Sustained VBD B-VP O
Release NNP B-NP O
24 CD O O
hr NN B-NP O
PO NNP I-NP O
DAILY NNP I-NP O
( ( O O
Daily NNP B-NP O
). VBZ O O
6. CD O O
Metoprolol NNP B-NP B-treatment
Tartrate NNP I-NP I-treatment
25 CD O O
mg NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Tablet NNP B-NP O
PO NNP I-NP O
BID NNP I-NP O
( ( O O
2 CD O O
times NNS B-NP O
a DT B-NP O
day NN I-NP O
). POS O O
7. CD O O
Albuterol NNP B-NP B-treatment
Sulfate NNP I-NP I-treatment
0.083 CD O O
% NN B-NP O
( ( O O
0.83 CD O O
mg NN B-NP O
/ NNP I-NP O
mL NN I-NP O
) ) O O
Solution NN B-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Inhalation NN B-NP O
Q6H NNP I-NP O
( ( O O
every DT O O
6 CD O O
hours NNS B-NP O
). RB O O
8. CD O O
Ipratropium NNP B-NP B-treatment
Bromide NNP I-NP I-treatment
0.02 CD O O
% NN B-NP O
Solution NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Inhalation NN B-NP O
Q6H NNP I-NP O
( ( O O
every DT O O
6 CD O O
hours NNS B-NP O
). RB O O
9. CD O O
Albuterol NNP B-NP B-treatment
Sulfate NNP I-NP I-treatment
0.083 CD O O
% NN B-NP O
( ( O O
0.83 CD O O
mg NN B-NP O
/ NNP I-NP O
mL NN I-NP O
) ) O O
Solution NN B-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Inhalation NN B-NP O
Q2H NNP I-NP O
( ( O O
every DT O O
2 CD O O
hours NNS B-NP O
) ) O O
as IN B-VP O
needed VBN O O
. . B-VP O
   
10. CD O O
Prednisone NN B-NP B-treatment
20 CD O O
mg NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
Two CD O O
( ( O O
2 CD O O
) ) O O
Tablet NNP B-NP O
PO NNP I-NP O
DAILY NNP I-NP O
( ( O O
Daily NNP B-NP O
) ) O O
for IN B-VP O
4 CD O O
days NNS B-NP O
. . B-VP O
   
11. CD O O
Furosemide IN B-VP B-treatment
10 CD O O
mg NNS B-NP O
/ JJ B-NP O
mL JJ I-NP O
Solution NNP I-NP O
Sig NNP I-NP O
: : O O
Forty NNP B-NP O
( ( O O
40 CD O O
) ) O O
mg NN B-NP O
Injection NNP I-NP O
BID NNP I-NP O
( ( O O
2 CD O O
times NNS B-NP O
a DT B-NP O
day NN I-NP O
). POS O O
12. CD O O
Acetazolamide NNP B-NP B-treatment
Sodium NNP I-NP I-treatment
500 CD O O
mg NN B-NP O
Recon NNP I-NP O
Soln NNP I-NP O
Sig NNP I-NP O
: : O O
Two CD O O
Hundred NNP B-NP O
Fifty NNP I-NP O
( ( O O
250 CD O O
) ) O O
Recon NNP B-NP O
Soln NNP I-NP O
Injection NNP I-NP O
Q12H NNP I-NP O
( ( O O
every DT O O
12 CD O O
hours NNS B-NP O
). RB O O
13. CD O O
Morphine NNP B-NP B-treatment
2 CD O O
mg NN B-NP O
/ NNP I-NP O
mL NN I-NP O
Syringe NNP I-NP O
Sig NNP I-NP O
: : O O
1-2 JJ B-NP O
mg NN I-NP O
Injection NNP I-NP O
Q4H NNP I-NP O
( ( O O
every DT O O
4 CD O O
hours NNS B-NP O
) ) O O
as IN B-VP O
needed VBN O O
. . B-VP O
   
14. CD O O
Amiodarone $ O B-treatment
200 CD O O
mg JJ B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
Two CD O O
( ( O O
2 CD O O
) ) O O
Tablet NNP B-NP O
PO NNP I-NP O
BID NNP I-NP O
( ( O O
2 CD O O
times NNS B-NP O
a DT B-NP O
day NN I-NP O
) ) O O
for IN B-VP O
7 CD O O
days NNS B-NP O
. . B-VP O
   
15. CD O O
Amiodarone $ O B-treatment
400 CD O O
mg JJ B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Tablet NNP B-NP O
PO NNP I-NP O
once RB O O
a DT B-NP O
day NN I-NP O
: : O O
after IN B-VP O
finishing VBG O O
400mg CD O O
BID NNP B-NP O
x VBD B-VP O
6 CD O O
days NNS B-NP O
. . B-VP O
   
Discharge JJ B-NP O
Disposition NN I-NP O
: : O O
Extended VBN O O
Care NNP B-NP O
Facility NNP I-NP O
: : O O
Whidden NNP B-NP O
Memorial NNP I-NP O
Hospital NNP I-NP O
for IN B-VP O
the DT B-NP O
Aged NNP I-NP O
- : O O
LTC NNP B-NP O
Discharge NNP I-NP O
Diagnosis NNP I-NP O
: : O O
Primary JJ B-NP O
diagnoses NNS I-NP O
: : O O
Diastolic NNP B-NP B-problem
congestive VBP O I-problem
heart NN B-NP I-problem
failure NN I-NP I-problem
Aortic NNP I-NP B-problem
stenosis NN I-NP I-problem
Mitral NNP I-NP B-problem
stenosis NN I-NP I-problem
Possible NNP I-NP O
chronic NN I-NP B-problem
obstructive NN I-NP I-problem
lung NN I-NP I-problem
disease NN I-NP I-problem
Secondary JJ B-NP O
diagnoses NNS I-NP O
: : O O
Coronary JJ B-NP B-problem
artery NN I-NP I-problem
disease NN I-NP I-problem
Chronic NNP I-NP B-problem
kidney NN I-NP I-problem
disease NN I-NP I-problem
Depression NNP I-NP B-problem
Diabetes VBZ O B-problem
mellitus FW O I-problem
Discharge NNP B-NP O
Condition NNP I-NP O
: : O O
Stable JJ O O
, , O O
satting VBG O O
98% CD O O
on IN B-VP O
1L CD O B-treatment
via IN B-VP I-treatment
NC NNP B-NP I-treatment
, , O O
sitting VBG O O
up RP O O
in IN B-VP O
a DT B-NP O
chair NN I-NP O
Discharge NNP I-NP O
Instructions NNP I-NP O
: : O O
Please NNP B-NP O
call VB O O
your PRP$ O B-person
your PRP$ O B-person
doctor NN B-NP I-person
at IN B-VP O
the DT B-NP O
rehabilitation NN I-NP O
if IN B-VP O
you PRP O B-person
develop VBP O O
any DT B-NP O
shortness NN I-NP B-problem
of IN B-VP I-problem
breath NN B-NP I-problem
, , O O
chest NN B-NP B-problem
pain NN I-NP I-problem
, , O O
nausea NN B-NP B-problem
, , O O
vomiting VBG O B-problem
, , O O
or CC O O
any DT B-NP B-problem
other JJ I-NP I-problem
concerning NN I-NP I-problem
symptoms NNS I-NP I-problem
. . B-VP O
   
Please NNP B-NP O
take VB O O
medications NNS B-NP B-treatment
as IN B-VP O
instructed JJ O O
. . B-VP O
   
Keep VB O O
all DT O O
your PRP$ O B-person
follow-up JJ B-NP O
appointments NNS I-NP O
. . B-VP O
   
Followup NNP B-NP O
Instructions NNPS I-NP O
: : O O
Provider NN B-NP B-person
: : O O
David NNP B-NP B-person
Phone NNP I-NP O
: : O O
912-6800-0569 JJ B-NP O
Date NNP I-NP O
/ NN I-NP O
Time NN I-NP O
: : O O
2014-08-11 JJ O O
1:00 CD O O
Jim NNP B-NP B-person
Stanley NNP I-NP I-person
MD NNP I-NP I-person
78-708 JJ O O
Completed VBN O O
by IN B-VP O
: : O O
Junko NNP B-NP B-person
Alpha NNP I-NP I-person
MD NNP I-NP I-person
22-842 JJ O O
2014-08-04 CD O O
@ JJ O O
1725 CD O O
Signed VBN O O
electronically RB O O
by IN B-VP O
: : O O
DR. NNP B-NP B-person
Jane NNP I-NP I-person
B. NNP I-NP I-person
Hardy NNP I-NP I-person
on IN B-VP O
: : O O
Sandra NNP B-NP O
2014-08-07 CD O O
11:10 CD O O
AM NNP B-NP O
( ( O O
End NNP B-NP O
of IN B-VP O
Report NNP B-NP O
) ) O O
-EMPTYLINE- VBP O O
-DOCSTART- JJ O O
-EMPTYLINE- $ O O
270045381 CD O O
BH NNP B-NP O
6676757 CD O O
650129 CD O O
10/10/1997 CD O O
12:00:00 CD O O
AM NNP B-NP O
LEFT NNP I-NP B-problem
PROXIMAL NNP I-NP I-problem
HUMERUS NNP I-NP I-problem
FRACTURE NNP I-NP I-problem
. . B-VP O
   
Unsigned VBD B-VP O
DIS NNP B-NP O
Report NNP I-NP O
Status NNP I-NP O
: : O O
Unsigned VBD B-VP O
DISCHARGE NNP B-NP O
SUMMARY NNP I-NP O
NAME NN I-NP O
: : O O
JUNK NNP B-NP B-person
, , O I-person
KACHOLERA NNP B-NP I-person
UNIT NNP I-NP O
NUMBER NNP I-NP O
: : O O
482-31-51 JJ B-NP O
ADMISSION NNP I-NP O
DATE NNP I-NP O
: : O O
10/10/97 CD O O
DISCHARGE NNP B-NP O
DATE NNP I-NP O
: : O O
10/23/97 CD O O
PRINCIPAL NNP B-NP O
DIAGNOSIS NNP I-NP O
: : O O
Left NNP B-NP B-problem
proximal JJ B-NP I-problem
humerus NN I-NP I-problem
fracture NN I-NP I-problem
. . B-VP O
   
ASSOCIATED CC O O
DIAGNOSIS NNP B-NP O
: : O O
Adult-onset JJ B-NP B-problem
diabetes NNS I-NP I-problem
mellitus VBP O I-problem
x JJ O O
40 CD O O
years NNS B-NP O
, , O O
history NN B-NP O
of IN B-VP O
silent JJ B-NP B-problem
myocardial JJ I-NP I-problem
infarction NN I-NP I-problem
, , O O
coronary JJ B-NP B-treatment
artery NN I-NP I-treatment
bypass NN I-NP I-treatment
graft NN I-NP I-treatment
( ( O O
three CD O O
vessels NNS B-NP O
in IN B-VP O
1987 CD O O
) ) O O
, , O O
history NN B-NP O
of IN B-VP O
chronic NN B-NP B-problem
, , O I-problem
stable JJ B-NP I-problem
angina NN I-NP I-problem
pectoris NN I-NP I-problem
, , O O
Fournier NNP B-NP B-problem
&apos;s NNP I-NP I-problem
gangrene NN I-NP I-problem
versus NN I-NP O
necrotizing VBG O B-problem
fasciitis NN B-NP I-problem
, , O O
congestive JJ B-NP B-problem
heart NN I-NP I-problem
failure NN I-NP I-problem
in IN B-VP O
03/97 CD O O
while IN B-VP O
in IN B-VP O
the DT B-NP O
hospital NN I-NP O
for IN B-VP O
a DT B-NP B-problem
rib NN I-NP I-problem
fracture NN I-NP I-problem
, , O O
glaucoma NN B-NP B-problem
, , O O
diabetic JJ B-NP B-problem
retinopathy NN I-NP I-problem
with IN B-VP O
blindness NN B-NP B-problem
in IN B-VP I-problem
the DT B-NP I-problem
right NN I-NP I-problem
eye NN I-NP I-problem
, , O O
history NN B-NP O
of IN B-VP O
gastric JJ B-NP B-treatment
stapling NN I-NP I-treatment
, , O O
left VBD B-VP B-problem
rib JJ B-NP I-problem
fracture NN I-NP I-problem
, , O O
right JJ B-NP B-treatment
femur NN I-NP I-treatment
surgery NN I-NP I-treatment
. . B-VP O
   
PRINCIPAL JJ B-NP O
PROCEDURE NN I-NP O
: : O O
Left VBN O B-treatment
shoulder NN B-NP I-treatment
hemiarthroplasty NN I-NP I-treatment
. . B-VP O
   
OTHER CC O O
PROCEDURES NNP B-NP O
: : O O
Upper NNP B-NP B-test
endoscopy VBZ O I-test
x $ O O
2 CD O O
. . B-VP O
   
HISTORY NN B-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
is VBZ O O
a DT B-NP O
65-year-old JJ I-NP O
male NN I-NP O
with IN B-VP O
a DT B-NP O
past JJ I-NP O
medical JJ I-NP O
history NN I-NP O
of IN B-VP O
diabetes NNS B-NP B-problem
mellitus NNS I-NP I-problem
, , O O
three-vessel JJ B-NP B-treatment
coronary JJ I-NP I-treatment
artery NN I-NP I-treatment
bypassgraft NN I-NP I-treatment
, , O O
congestive JJ B-NP B-problem
heart NN I-NP I-problem
failure NN I-NP I-problem
, , O O
who WP O B-person
presents VBZ O O
with IN B-VP O
a DT B-NP B-problem
humeral JJ I-NP I-problem
fracture NN I-NP I-problem
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
is VBZ O O
admitted VBN O O
for IN B-VP O
preoperative JJ O B-test
and CC O I-test
orthopedic JJ B-NP I-test
evaluations NNS I-NP I-test
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
presented VBN O O
with IN B-VP O
a DT B-NP B-problem
comminuted JJ I-NP I-problem
fracture NN I-NP I-problem
of IN B-VP I-problem
the DT B-NP I-problem
proximal JJ I-NP I-problem
left NN I-NP I-problem
humerus NN I-NP I-problem
when WRB O O
he PRP O B-person
slipped VBD B-VP O
over IN B-VP O
the DT B-NP O
stairs NNS I-NP O
, , O O
about IN B-VP O
to TO O O
board NN B-NP O
an DT B-NP O
airplane NN I-NP O
back RB O O
to TO O O
Jeglas NNP B-NP O
Blvd. NNP I-NP O
, , O O
Jolouisrowarlihis NNP B-NP O
, , O O
Alabama NNP B-NP O
86071 CD O O
. . B-VP O
   
The DT B-NP B-problem
fracture NN I-NP I-problem
was VBD B-VP O
seen VBN O O
by IN B-VP O
Orthopedics NNS B-NP B-person
and CC O O
was VBD B-VP O
reduced VBN O O
. . B-VP O
   
During IN B-VP O
conscious JJ B-NP B-treatment
sedation NN I-NP I-treatment
, , O O
the DT B-NP B-person
patient NN I-NP I-person
developed VBD B-VP O
bigeminy NN B-NP B-problem
( ( O O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
sedated VBN O O
, , O O
did VBD B-VP O
not RB O O
feel VB O O
chest JJS B-NP B-problem
pain NN I-NP I-problem
or CC O O
shortness NN B-NP B-problem
of IN B-VP I-problem
breath NN B-NP I-problem
) ) O O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
presented VBD B-VP O
to TO O O
Bri NNP B-NP O
Health NNP I-NP O
in IN B-VP O
order NN B-NP O
to TO O O
be VB O O
evaluated VBN O O
for IN B-VP O
preoperative JJ B-NP B-test
clearance NN I-NP I-test
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
reported VBN O O
to TO O O
have VB O O
had VBN O O
a DT B-NP B-problem
myocardial JJ I-NP I-problem
infarction NN I-NP I-problem
in IN B-VP O
the DT B-NP O
past NN I-NP O
( ( O O
EKG NNP B-NP B-test
positive JJ O O
for IN B-VP O
ischemia NN B-NP B-problem
, , O O
exercise NN B-NP B-test
tolerance NN I-NP I-test
test NN I-NP I-test
positive JJ O O
, , O O
cardiac JJ B-NP B-test
catheterization NN I-NP I-test
positive JJ O O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
is VBZ O O
now RB O O
status NN B-NP O
posta JJ B-NP O
three-vessel JJ I-NP B-treatment
coronary JJ I-NP I-treatment
artery NN I-NP I-treatment
bypass NN I-NP I-treatment
graft NN I-NP I-treatment
in IN B-VP O
1987 CD O O
) ) O O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
also RB O O
hada JJ B-NP O
history NN I-NP O
of IN B-VP O
arrhythmia NN B-NP B-problem
, , O O
found VBD B-VP O
approximately RB O O
ten JJ B-NP O
years NNS I-NP O
ago RB O O
, , O O
unknown RP O O
what WP O O
type NN B-NP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
on IN B-VP O
coumadin NN B-NP B-treatment
recently RB O O
, , O O
? . B-VP O
whether IN B-VP O
for IN B-VP O
the DT B-NP O
arrhythmia NN I-NP B-problem
. . B-VP O
   
Coumadin NNP B-NP B-treatment
was VBD B-VP O
reportedly RB O O
discontinued VBN O O
approximately RB O O
six CD O O
months NNS B-NP O
ago RB O O
secondary JJ O O
to TO O O
planned VBN O O
surgery NN B-NP B-treatment
for IN B-VP O
diabetic JJ B-NP B-problem
retinopathy NN I-NP I-problem
and CC O O
glaucoma NN B-NP B-problem
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
did VBD B-VP O
not RB O O
have VB O O
chest JJS B-NP B-problem
pain NN I-NP I-problem
until IN B-VP O
approximately RB O O
1-1/2 CD O O
years NNS B-NP O
ago RB O O
, , O O
when WRB O O
he PRP O B-person
began VBD B-VP O
to TO O O
have VB O O
chest JJS B-NP B-problem
tightness NN I-NP I-problem
( ( O I-problem
pressure NN B-NP I-problem
) ) O I-problem
approximately RB O O
every DT O O
three CD O O
months NNS B-NP O
with IN B-VP O
stress NN B-NP B-problem
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
has VBZ O O
no DT B-NP O
chest NN I-NP B-problem
pain NN I-NP I-problem
when WRB O O
walking VBG O O
slowly RB O O
and CC O O
can MD O O
walk VB O O
approximately RB O O
1.5 CD O O
miles NNS B-NP O
. . B-VP O
   
He PRP O B-person
can MD O O
climb VB O O
approximately RB O O
three CD O O
flights NNS B-NP O
of IN B-VP O
stairs NNS B-NP O
before IN B-VP O
becoming VBG O O
short JJ O B-problem
of IN B-VP I-problem
breath NN B-NP I-problem
. . B-VP O
   
He PRP O B-person
does VBZ O O
become VB O O
slightly RB O B-problem
short JJ O I-problem
of IN B-VP I-problem
breath NN B-NP I-problem
when WRB O O
lifting VBG O O
furniture NN B-NP O
. . B-VP O
   
On IN B-VP O
the DT B-NP O
day NN I-NP O
of IN B-VP O
admission NN B-NP O
, , O O
when WRB O O
he PRP O B-person
fell VBD B-VP O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
experiencing VBG O O
no DT B-NP O
chest NN I-NP B-problem
pain NN I-NP I-problem
, , O O
no DT B-NP O
shortness NN I-NP B-problem
of IN B-VP I-problem
breath NN B-NP I-problem
, , O O
and CC O O
had VBD B-VP O
no DT B-NP O
loss NN I-NP B-problem
of IN B-VP I-problem
consciousness NN B-NP I-problem
, , O O
no DT B-NP O
head NN I-NP B-problem
trauma NN I-NP I-problem
with IN B-VP I-problem
fall NN B-NP I-problem
. . B-VP O
   
REVIEW NNP B-NP O
OF NNPS I-NP O
SYSTEMS NNP I-NP O
: : O O
No DT B-NP O
fevers NNS I-NP B-problem
or CC O O
chills NNS B-NP B-problem
, , O O
no DT B-NP O
chest NN I-NP B-problem
pain NN I-NP I-problem
, , O O
no DT B-NP O
shortness NN I-NP B-problem
of IN B-VP I-problem
breath NN B-NP I-problem
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
has VBZ O O
stable JJ B-NP B-problem
three-pillow JJ I-NP I-problem
orthopnea NN I-NP I-problem
and CC O O
occasional JJ B-NP B-problem
paroxysmal JJ I-NP I-problem
nocturnal JJ I-NP I-problem
dyspnea NN I-NP I-problem
. . B-VP O
   
He PRP O B-person
has VBZ O O
a DT B-NP B-problem
chronic JJ I-NP I-problem
cough NN I-NP I-problem
with IN B-VP O
clear JJ B-NP B-problem
sputum NN I-NP I-problem
. . B-VP O
   
No DT B-NP O
hemoptysis NN I-NP B-problem
, , O O
hematemesis NN B-NP B-problem
, , O O
abdominal JJ B-NP B-problem
pain NN I-NP I-problem
, , O O
black JJ O B-problem
or CC O I-problem
tarry JJ B-NP I-problem
stools NNS I-NP I-problem
, , O O
dysuria NNS B-NP B-problem
/ VBP O O
frequency/urgency NN B-NP B-problem
. . B-VP O
   
PAST NNP B-NP O
MEDICAL NNP I-NP O
HISTORY NNP I-NP O
: : O O
Some DT B-NP O
type NN I-NP O
of IN B-VP O
cardiac JJ B-NP B-problem
arrhythmia NN I-NP I-problem
, , O O
diagnosed VBD B-VP O
approximately RB O O
ten JJ B-NP O
years NNS I-NP O
ago RB O O
. . B-VP O
   
History NN B-NP O
of IN B-VP O
coronary JJ B-NP B-problem
artery NN I-NP I-problem
disease NN I-NP I-problem
status NN I-NP O
post NN I-NP O
silent JJ B-NP B-problem
myocardial JJ I-NP I-problem
infarction NN I-NP I-problem
in IN B-VP O
the DT O O
past JJ O O
and CC O O
three-vessel JJ B-NP B-treatment
coronary JJ I-NP I-treatment
artery NN I-NP I-treatment
bypass NN I-NP I-treatment
graft NN I-NP I-treatment
in IN B-VP O
1987 CD O O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
has VBZ O O
been VBN O O
experiencing VBG O O
chronic JJ O B-problem
, , O I-problem
stable JJ B-NP I-problem
angina NN I-NP I-problem
pectoris NN I-NP I-problem
over IN B-VP O
the DT O O
past JJ O O
one CD O O
to TO O O
one CD O O
and CC O O
a DT B-NP O
half JJ I-NP O
years NNS I-NP O
approximately RB O O
once RB O O
every DT O O
three CD O O
months NNS B-NP O
. . B-VP O
   
History NNP B-NP O
of IN B-VP O
congestive JJ B-NP B-problem
heart NN I-NP I-problem
failure NN I-NP I-problem
, , O O
diagnosed VBD B-VP O
approximately RB O O
eight CD O O
years NNS B-NP O
ago RB O O
. . B-VP O
   
Diabetes VBZ O B-problem
mellitus NN B-NP I-problem
for IN B-VP O
approximately RB O O
40 CD O O
years NNS B-NP O
. . B-VP O
   
Fournier NNP B-NP B-problem
&apos;s NNP I-NP I-problem
gangrene NN I-NP I-problem
versus NN I-NP O
necrotizing VBG O B-problem
fasciitis NN B-NP I-problem
. . B-VP O
   
Glaucoma NNP B-NP B-problem
. . B-VP O
   
Diabetic NNP B-NP B-problem
retinopathy NN I-NP I-problem
with IN B-VP O
the DT B-NP B-person
patient NN I-NP I-person
blind NN I-NP B-problem
in IN B-VP I-problem
right JJ B-NP I-problem
eye NN I-NP I-problem
. . B-VP O
   
PAST JJ B-NP O
SURGICAL JJ I-NP O
HISTORY NN I-NP O
: : O O
Cholecystectomy NNP B-NP B-treatment
. . B-VP O
   
Status NNP B-NP O
post NN I-NP O
gastric NN I-NP B-treatment
stapling NN I-NP I-treatment
. . B-VP O
   
Left NNP B-NP B-problem
rib JJ B-NP I-problem
fracture NN I-NP I-problem
. . B-VP O
   
Right NNP B-NP B-treatment
femur NN I-NP I-treatment
surgery NN I-NP I-treatment
approximately RB O O
two CD O O
years NNS B-NP O
ago RB O O
. . B-VP O
   
Righteye NNP B-NP B-treatment
surgery NN I-NP I-treatment
for IN B-VP O
glaucoma NN B-NP B-problem
in IN B-VP O
05/97 CD O O
. . B-VP O
   
Laser NNP B-NP B-treatment
surgery NN I-NP I-treatment
for IN B-VP O
retinopathy NN B-NP B-problem
. . B-VP O
   
MEDICATIONS NNP B-NP O
ON NNP I-NP O
ADMISSION NNP I-NP O
: : O O
Humulin NNP B-NP B-treatment
70/30 CD O O
with IN B-VP O
30 CD O O
units NNS B-NP O
subq.q.a.m. RB O O
and CC O O
20 CD O O
units NNS B-NP O
subq.q.p.m. RB O O
Vasotec NNP B-NP B-treatment
20 CD O O
mg. NN B-NP O
q. NN I-NP O
a.m. RB O O
Prozac NNP B-NP B-treatment
40 CD O O
mg. NN B-NP O
q.d. NN I-NP O
Lasix NNP I-NP B-treatment
40 CD O O
mg. NN B-NP O
q.d. JJ B-NP O
K-Dur NNP I-NP B-treatment
approximately RB O O
28 CD O O
? . B-VP O
mEq NN B-NP O
q.d. NN I-NP O
Atropine NNP I-NP B-treatment
1% CD O O
1 CD O O
GTT NNP B-NP O
OD NNP I-NP O
b.i.d. VBD B-VP O
Ocufen NNP B-NP B-treatment
0.03% CD O O
1 CD O O
GTT NNP B-NP O
OD NNP I-NP O
t.i.d. JJ B-NP O
Ventolin NNP I-NP B-treatment
metered-dose JJ B-NP O
inhaler NN I-NP O
. . B-VP O
   
ALLERGIES NNP B-NP O
: : O O
no DT B-NP O
known JJ I-NP B-problem
drug NN I-NP I-problem
allergies NNS I-NP I-problem
. . B-VP O
   
TOBACCO NN B-NP O
: : O O
Formerly RB O O
smoked VBD B-VP O
3 CD O O
packs NNS B-NP O
per IN B-VP O
day NN B-NP O
x $ O O
25 CD O O
years NNS B-NP O
; : O O
2 CD O O
cigars NNS B-NP O
per IN B-VP O
day NN B-NP O
x NNP I-NP O
approximately RB O O
6 CD O O
months NNS B-NP O
. . B-VP O
   
He PRP O B-person
quit VBD B-VP O
all DT B-NP O
tobacco NN I-NP O
approximately RB O O
27 CD O O
years NNS B-NP O
ago RB O O
. . B-VP O
   
ETOH NN B-NP O
: : O O
Rare NNP B-NP O
. . B-VP O
   
SOCIAL NNP B-NP O
HISTORY NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
is VBZ O O
retired VBN O O
, , O O
lives VBZ O O
with IN B-VP O
his PRP$ O B-person
his PRP$ O B-person
wife NN B-NP I-person
and CC O O
one CD O B-person
son NN B-NP I-person
, , O O
who WP O B-person
is VBZ O O
47 CD O O
years NNS B-NP O
old JJ O O
and CC O O
had VBD B-VP O
multiple VBN O B-problem
myeloma NN B-NP I-problem
and CC O O
renal JJ B-NP B-problem
failure NN I-NP I-problem
. . B-VP O
   
PHYSICAL JJ B-NP O
EXAMINATION NN I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
is VBZ O O
alert JJ O O
and CC O O
oriented VBN O O
and CC O O
has VBZ O O
a DT B-NP B-treatment
sling NN I-NP I-treatment
for IN B-VP O
his PRP$ O B-person
his PRP$ O B-problem
left JJ B-NP I-problem
humeral JJ I-NP I-problem
fracture NN I-NP I-problem
. . B-VP O
   
Blood NNP B-NP B-test
pressure NN I-NP I-test
120/70 CD O O
, , O O
temperature NN B-NP B-test
97.8 CD O O
F NNP B-NP O
, , O O
pulse RB O B-test
68 CD O O
, , O O
respirations NNS B-NP B-test
22 CD O O
, , O O
Sa02 NNP B-NP B-test
on IN B-VP O
2 CD O O
L NNP B-NP O
94% CD O O
. . B-VP O
   
HEENT NN B-NP O
: : O O
Right-sided JJ B-NP B-problem
ptosis NN I-NP I-problem
, , O O
right RB O O
eye NN B-NP O
not RB O O
reactive JJ O O
to TO O O
light JJ O O
, , O O
cataract JJ O B-problem
present JJ O O
, , O O
patient JJ B-NP B-person
blind NN I-NP B-problem
in IN B-VP I-problem
that DT O B-pronoun
that WDT O I-problem
eye NN B-NP I-problem
, , O O
left VBD B-VP O
eye NN B-NP O
reactive NN I-NP O
to TO O O
light NN B-NP O
, , O O
cataract NN B-NP B-problem
also RB O O
present JJ O O
in IN B-VP O
that DT B-NP B-pronoun
eye NN I-NP O
. . B-VP O
   
Extraocular JJ B-NP B-test
movements NNS I-NP I-test
- : O O
conjugated VBN O O
eye NN B-NP O
movement NN I-NP O
intact JJ O O
. . B-VP O
   
Oropharynx NNP B-NP O
moist NN I-NP O
, , O O
without IN B-VP O
lesions NNS B-NP B-problem
. . B-VP O
   
Mild NNP B-NP B-problem
right JJ B-NP I-problem
facial JJ I-NP I-problem
droop NN I-NP I-problem
. . B-VP O
   
Sensation NNP B-NP O
intact JJ O O
. . B-VP O
   
No DT B-NP O
slurred JJ I-NP B-problem
speech NN I-NP I-problem
. . B-VP O
   
Cardiac JJ O O
: : O O
regular JJ B-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
, , O O
no DT B-NP O
murmur NN I-NP B-problem
appreciated VBD B-VP O
, , O O
normal JJ B-NP O
S1 NNP I-NP O
and CC O O
S2 NNP B-NP O
. . B-VP O
   
Chest NNP B-NP O
/ JJ B-NP O
lungs NNS I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
is VBZ O O
diffusely RB O B-problem
wheezy JJ O I-problem
upon IN B-VP O
presentation NN B-NP O
. . B-VP O
   
Abdomen NNP B-NP B-problem
distended VBD B-VP I-problem
, , O O
mild JJ B-NP B-problem
tenderness NN I-NP I-problem
on IN B-VP I-problem
the DT B-NP I-problem
left NN I-NP I-problem
, , O O
bowel VB O B-test
sounds NNS B-NP I-test
present JJ O O
, , O O
nohepatosplenomegaly JJ O B-problem
. . B-VP O
   
Extremities NNS B-NP O
: : O O
1+ CD O B-problem
edema NN B-NP I-problem
of IN B-VP I-problem
the DT B-NP I-problem
ankles NNS I-NP I-problem
, , O O
pulses NNS B-NP B-test
present VBP O O
bilaterally RB O O
. . B-VP O
   
No UH O O
calf NN B-NP B-problem
tenderness NN I-NP I-problem
. . B-VP O
   
Rectal JJ O O
: : O O
Guaiac NNP B-NP B-test
negative JJ O O
. . B-VP O
   
Neurological JJ O O
: : O O
Non-focal JJ O O
, , O O
except IN B-VP O
unable JJ O O
to TO O O
assess VB O O
left JJ B-NP O
upper JJ I-NP O
extremity NN I-NP O
secondary JJ O O
to TO O O
the DT O B-person
the DT B-NP B-problem
patient JJ I-NP I-person
patient NN I-NP I-problem
&apos;s NNP I-NP I-problem
broken VBZ O I-problem
humeral JJ B-NP I-problem
fracture NN I-NP I-problem
. . B-VP O
   
LABORATORY NNP B-NP O
DATA NNP I-NP O
: : O O
sodium NN B-NP B-test
135 CD O O
, , O O
potassium NN B-NP B-test
4.1 CD O O
, , O O
chloride RB O B-test
101 CD O O
, , O O
C02 NNP B-NP B-test
28.4 CD O O
, , O O
BUN NNP B-NP B-test
17 CD O O
, , O O
creatinine NN B-NP B-test
1.0 CD O O
, , O O
glucose RB O B-test
302 CD O O
, , O O
calcium NN B-NP B-test
8.6 CD O O
, , O O
phosphorus NN B-NP B-test
2.5 CD O O
, , O O
magnesium NN B-NP B-test
1.6 CD O O
, , O O
total JJ B-NP B-test
protein NN I-NP I-test
6.7 CD O O
, , O O
albumin RB O B-test
3.3 CD O O
, , O O
globulin NN B-NP B-test
3.4 CD O O
, , O O
uric JJ B-NP B-test
acid NN I-NP I-test
6.3 CD O O
, , O O
totalbilirubin NN B-NP B-test
.7 NNP I-NP O
, , O O
alkaline JJ B-NP B-test
phosphatase NN I-NP I-test
93 CD O O
, , O O
SGOT NNP B-NP B-test
20 CD O O
, , O O
LDH NNP B-NP B-test
258 CD O O
, , O O
CPK NNP B-NP B-test
95 CD O O
, , O O
whiteblood NN B-NP B-test
count NN I-NP I-test
15.3 CD O O
, , O O
hematocrit NN B-NP B-test
49.7 CD O O
, , O O
platelet NN B-NP B-test
count NN I-NP I-test
159 CD O O
, , O O
MCV NNP B-NP B-test
98 CD O O
. . B-VP O
   
RADIOLOGIC JJ B-NP O
STUDIES NNPS I-NP O
: : O O
Chest NNP B-NP B-test
x-ray JJ O I-test
10/10/97 CD O O
: : O O
Elevated VBN O B-problem
left VBD B-VP I-problem
hemidiaphragm NN B-NP I-problem
of IN B-VP O
uncertain JJ B-NP O
etiology NN I-NP O
or CC O O
duration NN B-NP O
. . B-VP O
   
Postoperative JJ B-NP B-problem
changes NNS I-NP I-problem
of IN B-VP I-problem
the DT B-NP I-problem
sternum NN I-NP I-problem
and CC O I-problem
media NNS B-NP I-problem
stinum NN I-NP I-problem
were VBD B-VP O
seen VBN O O
and CC O O
no DT B-NP O
acute JJ I-NP B-problem
pulmonary JJ I-NP I-problem
disease NN I-NP I-problem
was VBD B-VP O
visualized VBN O O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
also RB O O
had VBD B-VP O
a DT B-NP B-test
shoulder NN I-NP I-test
film NN I-NP I-test
done VBN O O
on IN B-VP O
10/10/97 CD O O
that WDT O B-pronoun
showed VBD B-VP O
a DT O B-problem
severely RB O I-problem
comminuted JJ B-NP I-problem
fracture NN I-NP I-problem
of IN B-VP I-problem
the DT O I-problem
proximal JJ O I-problem
left VBD B-VP I-problem
humerus NN B-NP I-problem
with IN B-VP O
proximal JJ B-NP B-problem
distraction NN I-NP I-problem
. . B-VP O
   
A DT B-NP B-problem
lucency NN I-NP I-problem
and CC O I-problem
irregularity NN B-NP I-problem
of IN B-VP I-problem
the DT B-NP I-problem
glenoid NN I-NP I-problem
, , O O
possibly RB O O
representing VBG O O
a DT B-NP B-problem
fracture NN I-NP I-problem
, , O O
was VBD B-VP O
also RB O O
seen VBN O O
, , O O
and CC O O
a DT B-NP B-test
CT NNP I-NP I-test
scan NN I-NP I-test
was VBD B-VP O
therefore RB O O
obtained VBN O O
in IN B-VP O
order NN B-NP O
to TO O O
evaluate VB O O
this DT B-NP B-pronoun
area NN I-NP O
. . B-VP O
   
This DT O B-test
This DT B-NP B-pronoun
CT NNP I-NP I-test
scan NN I-NP I-test
, , O O
done VBN O O
also RB O O
on IN B-VP O
10/10/97 CD O O
, , O O
again RB O O
showed VBD B-VP O
the DT O B-problem
severely RB O I-problem
comminuted JJ B-NP I-problem
fracture NN I-NP I-problem
of IN B-VP I-problem
the DT O I-problem
proximal JJ O I-problem
left VBD B-VP I-problem
humerus NN B-NP I-problem
. . B-VP O
   
Two CD O B-problem
major JJ B-NP I-problem
fracture NN I-NP I-problem
fragments NNS I-NP I-problem
were VBD B-VP O
seen VBN O O
at IN B-VP O
the DT B-NP O
humeral JJ I-NP O
head NN I-NP O
, , O O
articulating VBG O O
with IN B-VP O
the DT B-NP O
glenoid NN I-NP O
fossa NN I-NP O
. . B-VP O
   
The DT B-NP B-problem
fracture NN I-NP I-problem
fragments NNS I-NP I-problem
retained VBD B-VP O
their PRP$ O B-pronoun
proper JJ B-NP O
site NN I-NP O
of IN B-VP O
articulation NN B-NP O
with IN B-VP O
the DT B-NP O
glenoid NN I-NP O
fossa NN I-NP O
. . B-VP O
   
Innumerable JJ B-NP B-problem
smaller JJR I-NP I-problem
fracture NN I-NP I-problem
fragments NNS I-NP I-problem
were VBD B-VP O
interposed VBN O O
between IN B-VP O
the DT B-NP B-problem
fracture NN I-NP I-problem
fragment NN I-NP I-problem
and CC O O
the DT B-NP O
distal JJ I-NP O
humeral JJ I-NP O
shaft NN I-NP O
. . B-VP O
   
The DT B-NP O
glenoid JJ I-NP O
fossa NN I-NP O
was VBD B-VP O
intact JJ O O
. . B-VP O
   
No DT B-NP O
scapular JJ I-NP B-problem
fractures NNS I-NP I-problem
were VBD B-VP O
present JJ O O
. . B-VP O
   
EKG NN B-NP B-test
: : O O
normal JJ B-NP O
sinus NN I-NP O
rhythm NN I-NP O
at IN B-VP O
72 CD O O
beats NNS B-NP B-test
/ VBP O I-test
minute NN B-NP I-test
, , O O
intraventricular JJ B-NP B-problem
conduction NN I-NP I-problem
delay NN I-NP I-problem
, , O O
Q NNP B-NP B-problem
- : O I-problem
waves NNS B-NP I-problem
seen VBN O I-problem
in IN B-VP I-problem
II NNP B-NP I-problem
, , O I-problem
III NNP B-NP I-problem
, , O I-problem
and CC O I-problem
AVF NNP B-NP I-problem
with IN B-VP O
probable JJ B-NP O
old JJ I-NP B-problem
inferior JJ I-NP I-problem
myocardial JJ I-NP I-problem
infarction NN I-NP I-problem
. . B-VP O
   
T NNP B-NP B-problem
- : O I-problem
waves NNS B-NP I-problem
were VBD B-VP I-problem
also RB O I-problem
noted VBN O I-problem
to TO O I-problem
be VB O I-problem
inverted VBN O I-problem
in IN B-VP I-problem
I PRP O I-problem
and CC O I-problem
AVL NNP B-NP I-problem
. . B-VP O
   
Ventricular NNP B-NP B-problem
bigeminy NN I-NP I-problem
was VBD B-VP O
also RB O O
seen VBN O O
. . B-VP O
   
HOSPITAL NNP B-NP O
COURSE NNP I-NP O
AND NNP I-NP O
TREATMENT NNP I-NP O
: : O O
1. CD O O
ORTHOPEDICS NN B-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
has VBZ O O
a DT O B-problem
severely RB O I-problem
comminuted JJ B-NP I-problem
fracture NN I-NP I-problem
of IN B-VP I-problem
the DT O I-problem
proximal JJ O I-problem
left VBD B-VP I-problem
humerus NN B-NP I-problem
. . B-VP O
   
He PRP O B-person
is VBZ O O
status NN B-NP O
post NN I-NP O
a DT B-NP B-treatment
hemiarthroplasty NN I-NP I-treatment
on IN B-VP O
10/17/97 CD O O
. . B-VP O
   
He PRP O B-person
received VBD B-VP O
Ancef NNP B-NP B-treatment
preoperatively RB O O
. . B-VP O
   
Physical JJ B-NP B-person
Therapy NN I-NP I-person
has VBZ O O
been VBN O O
seeing VBG O O
the DT B-NP B-person
patient NN I-NP I-person
and CC O O
putting VBG O O
him PRP O B-person
through IN B-VP O
passive JJ B-NP B-treatment
external JJ I-NP I-treatment
rotation NN I-NP I-treatment
to TO O O
the DT B-NP O
neutral JJ I-NP O
position NN I-NP O
of IN B-VP O
the DT B-NP O
left JJ I-NP O
shoulder NN I-NP O
and CC O O
forward JJ B-NP O
flexion NN I-NP O
with IN B-VP O
physical JJ B-NP B-treatment
physical JJ I-NP B-person
therapy NN I-NP I-treatment
therapy NN I-NP I-person
assistance NN I-NP I-treatment
. . B-VP O
   
Brittle NNP B-NP B-problem
bones NNS I-NP I-problem
were VBD B-VP O
noted VBN O O
during IN B-VP O
the DT B-NP B-treatment
operation NN I-NP I-treatment
. . B-VP O
   
A DT B-NP B-test
bone NN I-NP I-test
density NN I-NP I-test
scan NN I-NP I-test
would MD O O
be VB O O
recommended VBN O O
as IN B-VP O
an DT B-NP O
outpatient NN I-NP O
, , O O
in IN B-VP O
order NN B-NP O
to TO O O
evaluate VB O O
this DT O B-pronoun
. . B-VP O
   
2. CD O O
NEUROLOGICAL NN B-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
has VBZ O O
right JJ B-NP B-problem
facial JJ I-NP I-problem
droop NN I-NP I-problem
, , O O
right JJ B-NP B-problem
ptosis NN I-NP I-problem
, , O O
stable JJ O O
and CC O O
present JJ O O
for IN B-VP O
greater JJR O O
than IN B-VP O
one CD O O
year NN B-NP O
. . B-VP O
   
3. CD O O
CARDIOVASCULAR NNP B-NP O
: : O O
No DT B-NP O
chest NN I-NP B-problem
pain NN I-NP I-problem
, , O O
no DT B-NP O
shortness NN I-NP B-problem
of IN B-VP I-problem
breath NN B-NP I-problem
, , O O
1+ CD O B-problem
ankle NN B-NP I-problem
edema NN I-NP I-problem
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
ruled VBN O O
out RP O O
for IN B-VP O
a DT B-NP B-problem
myocardial JJ I-NP I-problem
infarction NN I-NP I-problem
, , O O
given VBN O O
his PRP$ O B-person
fall NN B-NP O
at IN B-VP O
the DT B-NP O
airport NN I-NP O
and CC O O
bigeminy NN B-NP B-problem
seen VBN O O
on IN B-VP O
electrocardiogram NN B-NP B-test
that IN B-VP B-pronoun
he PRP O B-person
developed VBD B-VP O
during IN B-VP O
conscious JJ B-NP B-treatment
sedation NN I-NP I-treatment
during IN B-VP O
reduction NN B-NP B-treatment
of IN B-VP I-treatment
the DT B-NP I-treatment
fracture NN I-NP I-treatment
. . B-VP O
   
Cardiology NNP B-NP B-person
was VBD B-VP O
consulted VBN O O
and CC O O
aspirin JJ O B-treatment
and CC O O
beta JJ B-NP B-treatment
blocker NN I-NP I-treatment
added VBD B-VP O
to TO O O
his PRP$ O B-person
his PRP$ O B-treatment
regimen NNS B-NP I-treatment
, , O O
as RB O O
well RB O O
as IN B-VP O
chest JJS B-NP B-treatment
wall NN I-NP I-treatment
nitroglycerin NN I-NP I-treatment
around IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
surgery NN B-NP B-treatment
, , O O
which WDT O B-pronoun
was VBD B-VP O
subsequently RB O O
discontinued VBN O O
. . B-VP O
   
An DT B-NP B-test
adenosine JJ I-NP I-test
SESTAMIBI NNP I-NP I-test
was VBD B-VP O
performed VBN O O
on IN B-VP O
10/12/97 CD O O
, , O O
which WDT O B-pronoun
showed VBD B-VP O
a DT B-NP O
negative JJ I-NP O
electrocardiogram NN I-NP O
for IN B-VP O
ischemia NN B-NP B-problem
and CC O O
cardiac JJ B-NP B-test
perfusion NN I-NP I-test
scans NNS I-NP I-test
, , O O
with IN B-VP O
a DT O B-problem
moderate-sized JJ O I-problem
, , O I-problem
dense NN B-NP I-problem
, , O I-problem
fixed VBN O I-problem
inferior JJ B-NP I-problem
defect JJ I-NP I-problem
indicative NN I-NP O
of IN B-VP O
scar NN B-NP B-problem
. . B-VP O
   
A DT O B-problem
small JJ O I-problem
/ JJ O I-problem
moderate-sized JJ O I-problem
, , O I-problem
mild-intensity NN B-NP I-problem
, , O I-problem
reversible JJ B-NP I-problem
posterior JJ I-NP I-problem
lateral JJ I-NP I-problem
defect NN I-NP I-problem
was VBD B-VP O
also RB O O
seen VBN O O
, , O O
indicative JJ O O
of IN B-VP O
mild JJ B-NP B-problem
/ NNP I-NP I-problem
moderate NN I-NP I-problem
ischemia NN I-NP I-problem
. . B-VP O
   
An DT B-NP B-test
echocardiogram NN I-NP I-test
was VBD B-VP O
performed VBN O O
on IN B-VP O
Columbus NNP B-NP O
Day NNP I-NP O
which WDT O B-pronoun
showed VBD B-VP O
an DT B-NP B-test
ejection NN I-NP I-test
fraction NN I-NP I-test
of IN B-VP O
50% CD O O
, , O O
left VBD B-VP B-problem
atrial JJ B-NP I-problem
enlargement NN I-NP I-problem
, , O O
thickening NN B-NP B-problem
of IN B-VP I-problem
the DT B-NP I-problem
aortic JJ I-NP I-problem
wall NN I-NP I-problem
consistent NN I-NP O
with IN B-VP O
atherosclerotic JJ B-NP B-problem
changes NNS I-NP I-problem
, , O O
left VBD B-VP O
ventricle NN B-NP O
size NN I-NP O
, , O O
and CC O O
systolic JJ B-NP O
function NN I-NP O
within IN B-VP O
normal JJ B-NP O
limits NNS I-NP O
. . B-VP O
   
Cardiac NNP B-NP B-test
monitor NN I-NP I-test
was VBD B-VP O
placed VBN O O
on IN B-VP O
the DT B-NP B-person
patient NN I-NP I-person
, , O O
given VBN O O
the DT B-NP B-problem
bigeminy NN I-NP I-problem
, , O O
and CC O O
he PRP O B-person
did VBD B-VP O
rule VB O O
out IN B-VP O
for IN B-VP O
myocardial JJ B-NP B-problem
infarction NN I-NP I-problem
. . B-VP O
   
Cardiology NNP B-NP B-person
recommended VBD B-VP O
that IN B-VP B-pronoun
in IN B-VP O
addition NN B-NP O
to TO O O
the DT B-NP B-treatment
medications NNS I-NP I-treatment
already RB O O
stated VBN O O
above IN B-VP O
, , O O
his PRP$ O B-person
his PRP$ O B-test
hematocrit NN B-NP I-test
be VB O O
kept VBN O O
greater JJR O O
than IN B-VP O
30 CD O O
. . B-VP O
   
After IN B-VP O
his PRP$ O B-person
his PRP$ O B-treatment
procedure NN B-NP I-treatment
on IN B-VP O
10/17/97 CD O O
, , O O
elevated VBN O B-problem
CPKs NNP B-NP I-problem
were VBD B-VP O
noted VBN O O
on IN B-VP O
10/19/97 CD O O
to TO O O
10/20/97 CD O O
, , O O
and CC O O
the DT B-NP O
first JJ I-NP O
level NN I-NP O
was VBD B-VP O
744 CD O O
, , O O
CPK NNP B-NP B-test
# # O O
2 CD O O
635 CD O O
, , O O
and CC O O
CPK NNP B-NP B-test
# # O O
3 CD O O
461 CD O O
. . B-VP O
   
MB NNP B-NP B-problem
fractionations NNS I-NP I-problem
of IN B-VP O
the DT B-NP B-test
CPKs NNP I-NP I-test
were VBD B-VP O
all DT O O
negative JJ O O
and CC O O
were VBD B-VP O
thought VBN O O
to TO O O
be VB O O
secondary JJ O O
to TO O O
the DT B-NP B-person
patient NN I-NP I-person
&apos;s NN I-NP O
beginning VBG O O
physical JJ B-NP O
therapy NN I-NP O
on IN B-VP O
10/19/97 CD O O
, , O O
and CC O O
all DT B-NP O
muscular NN I-NP O
in IN B-VP O
origin NN B-NP O
. . B-VP O
   
4. CD O O
GASTROENTEROLOGY NN B-NP O
: : O O
GI NNP B-NP B-person
was VBD B-VP O
consulted VBN O O
on IN B-VP O
10/15/97 CD O O
for IN B-VP O
melena NN B-NP B-problem
, , O O
decreased VBD B-VP B-problem
hematocrit NN B-NP I-problem
prior RB O O
to TO O O
his PRP$ O B-person
his PRP$ O B-treatment
humeral JJ B-NP I-treatment
fixation NN I-NP I-treatment
surgery NN I-NP I-treatment
. . B-VP O
   
Upper NNP B-NP B-test
endoscopy VBD B-VP I-test
x JJ O I-test
2 CD O I-test
were VBD B-VP O
done VBN O O
. . B-VP O
   
The DT O O
first JJ O O
was VBD B-VP O
on IN B-VP O
10/15/97 CD O O
, , O O
which WDT O B-pronoun
showed VBD B-VP O
clotted VBD B-VP B-problem
blood NN B-NP I-problem
in IN B-VP I-problem
the DT B-NP I-problem
esophagus NN I-NP I-problem
. . B-VP O
   
The DT B-NP O
stomach NN I-NP O
had VBD B-VP O
evidence NN B-NP O
of IN B-VP O
prior JJ B-NP B-treatment
surgery NN I-NP I-treatment
and CC O O
old JJ B-NP B-problem
blood NN I-NP I-problem
in IN B-VP I-problem
the DT B-NP I-problem
stomach NN I-NP I-problem
. . B-VP O
   
It PRP O B-pronoun
was VBD B-VP O
thought VBN O O
that IN B-VP B-pronoun
the DT B-NP B-problem
blood NN I-NP I-problem
in IN B-VP I-problem
the DT B-NP I-problem
esophagus NN I-NP I-problem
was VBD B-VP O
secondary JJ O O
to TO O O
a DT B-NP O
possible JJ I-NP O
Mallory-Weiss JJ I-NP B-problem
tear NN I-NP I-problem
. . B-VP O
   
A DT B-NP B-test
second JJ I-NP I-test
endoscopy NN I-NP I-test
was VBD B-VP O
also RB O O
performed VBN O O
several JJ B-NP O
days NNS I-NP O
later RB O O
, , O O
in IN B-VP O
order NN B-NP O
to TO O O
rule VB O O
out RP O O
a DT B-NP B-problem
gastric JJ I-NP I-problem
ulcer NN I-NP I-problem
, , O O
and CC O O
also RB O O
because IN B-VP O
the DT B-NP B-person
patient NN I-NP I-person
had VBD B-VP O
had VBN O O
another DT B-NP O
episode NN I-NP O
of IN B-VP O
melena NN B-NP B-problem
. . B-VP O
   
A DT B-NP B-problem
gastric JJ I-NP I-problem
ulcer NN I-NP I-problem
was VBD B-VP O
found VBN O O
and CC O O
this DT O B-pronoun
was VBD B-VP O
biopsied VBN O O
and CC O O
pathology NN B-NP B-test
is VBZ O O
pending VBG O O
at IN B-VP O
this DT B-NP B-pronoun
time NN I-NP O
. . B-VP O
   
This DT B-NP B-pronoun
report NN I-NP O
needs VBZ O O
to TO O O
be VB O O
followed VBN O O
up RP O O
, , O O
and CC O O
will MD O O
be VB O O
available JJ O O
at IN B-VP O
Bri NNP B-NP O
Health NNP I-NP O
in IN B-VP O
the DT B-NP O
Pathology NNP I-NP O
Department NNP I-NP O
some DT B-NP O
time NN I-NP O
within IN B-VP O
the DT O O
next JJ O O
three CD O O
to TO O O
seven CD O O
days NNS B-NP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
also RB O O
needs VBZ O O
a DT B-NP B-test
repeat NN I-NP I-test
endoscopy NN I-NP I-test
and CC O O
a DT B-NP B-test
GI NNP I-NP I-test
follow-up JJ B-NP I-test
appointment NN I-NP O
inapproximately RB O O
two CD O O
months NNS B-NP O
. . B-VP O
   
I PRP O B-person
have VBP O O
spoken VBN O O
with IN B-VP O
the DT B-NP B-person
patient NN I-NP I-person
in IN B-VP O
detail NN B-NP O
, , O O
and CC O O
he PRP O B-person
will MD O O
be VB O O
getting VBG O O
in IN B-VP O
touch NN B-NP O
with IN B-VP O
his PRP$ O B-person
his PRP$ O B-person
primary-care NN B-NP I-person
physician NN I-NP I-person
, , O O
Dr. NNP B-NP B-person
Fordwoodall NNP I-NP I-person
Stick NNP I-NP I-person
, , O O
in IN B-VP O
Ranegei NNP B-NP O
Pkwy NNP I-NP O
, , O O
Verertliet NNP B-NP O
, , O O
South NNP B-NP O
Carolina NNP I-NP O
62156 CD O O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
is VBZ O O
to TO O O
arrange VB O O
follow VB O O
up RP O O
with IN B-VP O
a DT B-NP B-person
GI NNP I-NP I-person
doctor NN I-NP I-person
in IN B-VP O
Jotar NNP B-NP O
Boulevard NNP I-NP O
, , O O
Cunahtampfordama NNP B-NP O
, , O O
South NNP B-NP O
Dakota NNP I-NP O
62848 CD O O
through IN B-VP O
his PRP$ O B-person
his PRP$ O B-person
primary-care JJ B-NP I-person
physician NN I-NP I-person
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
initially RB O O
on IN B-VP O
Cimetidine NNP B-NP B-treatment
and CC O O
Carafate NNP B-NP B-treatment
here RB O O
at IN B-VP O
Bri NNP B-NP O
Health NNP I-NP O
, , O O
and CC O O
then RB O O
switched VBD B-VP O
to TO O O
Prilosec VB O B-treatment
20 CD O O
mg JJ B-NP O
bid NN I-NP O
. . B-VP O
   
5. CD O O
PULMONARY NN B-NP O
: : O O
The DT O B-person
The DT B-NP B-test
patient JJ I-NP I-person
patient NN I-NP I-test
&apos;s NN I-NP I-test
admitting VBG O I-test
chest JJS B-NP I-test
x-ray NN I-NP I-test
showed VBD B-VP O
an DT B-NP B-problem
elevated JJ I-NP I-problem
left NN I-NP I-problem
hemidiaphragm NN I-NP I-problem
consistent JJ O O
with IN B-VP O
atelectasis NN B-NP B-problem
versus NN I-NP O
splinting VBG O B-problem
on IN B-VP I-problem
that IN B-VP B-pronoun
that DT B-NP I-problem
side NN I-NP I-problem
. . B-VP O
   
Incentive JJ B-NP B-treatment
spirometry NN I-NP I-treatment
was VBD B-VP O
started VBN O O
. . B-VP O
   
Albuterol NNP B-NP B-treatment
and CC O I-treatment
Atrovent NNP B-NP I-treatment
nebulizers NNS I-NP I-treatment
were VBD B-VP O
done VBN O O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
received VBD B-VP O
chest JJ B-NP B-treatment
physical JJ I-NP I-treatment
therapy NN I-NP I-treatment
bid NN I-NP O
. . B-VP O
   
6. CD O O
ENDOCRINE NN B-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
needs VBZ O O
still RB O O
better RBR O O
diabetes NNS B-NP B-treatment
control NN I-NP I-treatment
. . B-VP O
   
He PRP O B-person
has VBZ O O
been VBN O O
somewhat RB O O
noncompliant JJ O O
with IN B-VP O
his PRP$ O B-person
diet NN B-NP O
( ( O O
eating VBG O O
Pringle NNP B-NP O
&apos;s NN I-NP O
in IN B-VP O
the DT B-NP O
room NN I-NP O
) ) O O
. . B-VP O
   
His PRP$ O B-person
His PRP$ O B-treatment
NPH NNP B-NP I-treatment
was VBD B-VP O
recently RB O O
increased VBN O O
today NN B-NP O
( ( O O
10/23/97 CD O O
) ) O O
to TO O O
24 CD O O
units NNS B-NP O
in IN B-VP O
the DT B-NP O
a.m. NN I-NP O
and CC O O
14 CD O O
units NNS B-NP O
in IN B-VP O
the DT B-NP O
p.m. NN I-NP O
with IN B-VP O
CZI NNP B-NP B-treatment
sliding-scale JJ B-NP I-treatment
coverage NN I-NP I-treatment
. . B-VP O
   
7. CD O O
INFECTIOUS JJ B-NP O
DISEASE NN I-NP O
: : O O
The DT O B-person
The DT B-NP B-test
patient JJ I-NP I-person
patient NN I-NP I-test
urinalysis NN I-NP I-test
on IN B-VP O
10/19/97 CD O O
showed VBD B-VP O
moderate JJ B-NP B-problem
occult NN I-NP I-problem
blood NN I-NP I-problem
, , O O
pH NN B-NP B-test
5 CD O O
, , O O
albumin RB O B-test
1+ CD O O
, , O O
white JJ B-NP B-test
blood NN I-NP I-test
cells NNS I-NP I-test
present JJ O O
, , O O
2-50 JJ B-NP O
red JJ I-NP B-test
blood NN I-NP I-test
cell NN I-NP I-test
, , O O
10-20 JJ B-NP O
white JJ I-NP B-test
blood NN I-NP I-test
cells NNS I-NP I-test
, , O O
few JJ B-NP B-problem
bacteria NNS I-NP I-problem
, , O O
and CC O O
moderate JJ B-NP B-problem
bladder NN I-NP I-problem
epithelial JJ B-NP I-problem
cells NNS I-NP I-problem
. . B-VP O
   
Floxin NNP B-NP B-treatment
200 CD O O
mg NN B-NP O
po NN I-NP O
bid NN I-NP O
was VBD B-VP O
begun VBN O O
. . B-VP O
   
However RB O O
, , O O
his PRP$ O B-person
his PRP$ O B-test
urine JJ B-NP I-test
culture NN I-NP I-test
from IN B-VP O
the DT B-NP O
same JJ I-NP O
day NN I-NP O
remained VBD B-VP O
negative JJ O O
, , O O
and CC O O
this DT O B-pronoun
was VBD B-VP O
discontinued VBN O O
two CD O O
days NNS B-NP O
later RB O O
. . B-VP O
   
A DT B-NP B-test
repeat NN I-NP I-test
urinalysis NN I-NP I-test
on IN B-VP O
10/22/97 CD O O
was VBD B-VP O
negative JJ O O
. . B-VP O
   
8. CD O O
RENAL NN B-NP O
: : O O
After IN B-VP O
the DT O B-person
the DT B-NP B-treatment
patient JJ I-NP I-person
patient NN I-NP I-treatment
&apos;s JJ B-NP I-treatment
procedure NN I-NP I-treatment
, , O O
he PRP O B-person
was VBD B-VP O
felt VBN O O
to TO O O
be VB O O
volume NN B-NP B-problem
overloaded VBN O I-problem
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
given VBN O O
Lasix NNP B-NP B-treatment
40 CD O O
mg NN B-NP O
IV NNP I-NP O
x VBZ O O
1 CD O O
and CC O O
also RB O O
had VBD B-VP O
Nitro NNP B-NP B-treatment
paste NN I-NP I-treatment
around IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
his PRP$ O B-person
his PRP$ O B-treatment
surgery NN B-NP I-treatment
and CC O O
beta NN B-NP B-treatment
blocker NN I-NP I-treatment
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
became VBD B-VP O
slightly RB O B-problem
hypotensive JJ O I-problem
on IN B-VP O
the DT B-NP O
night NN I-NP O
of IN B-VP O
10/18/97 CD O O
with IN B-VP O
systolic JJ B-NP B-test
blood NN I-NP I-test
pressures NNS I-NP I-test
in IN B-VP O
the DT O O
80s CD O O
to TO O O
90s. CD O O
His PRP$ O B-person
His PRP$ O B-test
BUN/ NNP B-NP I-test
creatinine NN I-NP I-test
rose VBD B-VP O
from IN B-VP O
16/1.2 CD O O
on IN B-VP O
10/18/97 CD O O
to TO O O
25/1.9 CD O O
on IN B-VP O
10/18/97 CD O O
to TO O O
22/9.1 CD O O
to TO O O
today NN B-NP O
&apos;s NNP I-NP O
labs NN I-NP O
, , O O
which WDT O B-pronoun
are VBP O O
15/0.7 CD O O
on IN B-VP O
10/23/97 CD O O
. . B-VP O
   
9. CD O O
HEMATOLOGY NN B-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
transfused VBD B-VP O
2 CD O O
units NNS B-NP O
on IN B-VP O
10/15/97 CD O O
for IN B-VP O
a DT B-NP B-test
hematocrit NN I-NP I-test
of IN B-VP O
27.6 CD O O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
transfused VBD B-VP O
2 CD O O
units NNS B-NP O
of IN B-VP O
10/16/97 CD O O
for IN B-VP O
a DT B-NP B-test
hematocrit NN I-NP I-test
of IN B-VP O
30.03 CD O O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
transfused VBD B-VP O
1 CD O O
unit NN B-NP O
on IN B-VP O
10/18/97 CD O O
for IN B-VP O
a DT B-NP B-test
hematocrit NN I-NP I-test
of IN B-VP O
29.4 CD O O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
transfused VBD B-VP O
1 CD O O
unit NN B-NP O
on IN B-VP O
10/19/97 CD O O
for IN B-VP O
a DT B-NP B-test
hematocrit NN I-NP I-test
of IN B-VP O
27.9 CD O O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
transfused VBD B-VP O
2 CD O O
units NNS B-NP O
on IN B-VP O
10/20/97 CD O O
for IN B-VP O
a DT B-NP B-test
hematocrit NN I-NP I-test
of IN B-VP O
28.2.10 CD O O
. . B-VP O
   
FEN NN B-NP O
: : O O
Repleting NNP B-NP O
potassium NN I-NP B-treatment
, , O O
magnesium NN B-NP B-treatment
, , O O
phosphorus NN B-NP B-treatment
as IN B-VP O
needed VBN O O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
noted VBN O O
to TO O O
be VB O O
slightly RB O B-problem
hyponatremic JJ O I-problem
over IN B-VP O
the DT B-NP O
past JJ I-NP O
few JJ I-NP O
days NNS I-NP O
, , O O
with IN B-VP O
sodiums NNS B-NP B-test
in IN B-VP O
the DT B-NP O
128-132 JJ I-NP O
range NN I-NP O
, , O O
but CC O O
this DT O B-pronoun
was VBD B-VP O
secondary JJ O O
to TO O O
elevated VBN O B-problem
glucose JJ B-NP I-problem
fingerstick JJ I-NP I-problem
blood NN I-NP I-problem
sugars NNS I-NP I-problem
. . B-VP O
   
CONDITION NNP B-NP O
ON NNP I-NP O
DISCHARGE NNP I-NP O
: : O O
Stable JJ O O
, , O O
good JJ O O
. . B-VP O
   
MEDICATIONS NNP B-NP O
ON NNP I-NP O
DISCHARGE NNP I-NP O
: : O O
NPH NNP B-NP B-treatment
insulin VBZ O I-treatment
24 CD O O
units NNS B-NP O
subq. VBP O O
q. JJ O O
a.m. RB O O
NPH NNP B-NP B-treatment
insulin NN I-NP I-treatment
14 CD O O
units NNS B-NP O
subq. VBP O O
q. JJ B-NP O
p.m. NN I-NP O
CZI NNP I-NP B-treatment
sliding VBG O I-treatment
scale NN B-NP I-treatment
on IN B-VP O
a DT B-NP O
q. JJ I-NP O
a.c. NN I-NP O
and CC O O
q. JJ B-NP O
h.s. NN I-NP O
fingerstick JJ B-NP B-test
basis NN I-NP O
with IN B-VP O
the DT O O
following VBG O O
scale NN B-NP O
: : O O
FBS NNP B-NP B-test
less JJR O O
than IN B-VP O
200 CD O O
= JJ O O
0 CD O O
units NNS B-NP O
of IN B-VP O
CZI NNP B-NP B-treatment
FBS NNP I-NP B-test
201-250 JJ B-NP O
= NNP I-NP O
2 CD O O
units NNS B-NP O
of IN B-VP O
CZI NNP B-NP B-treatment
FBS NNP I-NP B-test
251-300 JJ B-NP O
= NNP I-NP O
4 CD O O
units NNS B-NP O
of IN B-VP O
CZI NNP B-NP B-treatment
FBS NNP I-NP B-test
301-350 JJ B-NP O
= NNP I-NP O
6 CD O O
units NNS B-NP O
of IN B-VP O
CZI NNP B-NP B-treatment
FBS NNP I-NP B-test
351-400 JJ B-NP O
= NNP I-NP O
8 CD O O
units NNS B-NP O
of IN B-VP O
CZI NNP B-NP B-treatment
FBS NNP I-NP B-test
greater JJR O O
than IN B-VP O
400 CD O O
= JJ O O
10 CD O O
units NNS B-NP O
of IN B-VP O
CZI NNP B-NP B-treatment
. . B-VP O
   
Atropine NNP B-NP B-treatment
sulfate NN I-NP I-treatment
1 CD O O
GTT NNP B-NP O
1% CD O O
OD NNP B-NP O
b.i.d. NN I-NP O
Ocufen NNP I-NP B-treatment
0.03% CD O O
1 CD O O
GTT NNP B-NP O
OD NNP I-NP O
t.i.d. VBD B-VP O
Vasotec NNP B-NP B-treatment
20 CD O O
mg. NN B-NP O
p.o.q. NN I-NP O
a.m. RB O O
Prozac NNP B-NP B-treatment
40 CD O O
mg.p.o.q. NN B-NP O
a.m. RB O O
Oxygen NNP B-NP B-treatment
2-4 JJ B-NP O
L NNP I-NP O
to TO O O
keep VB O O
Sa02 NNP B-NP B-test
greater JJR O O
than IN B-VP O
or CC O O
equal JJ O O
to TO O O
94-95% CD O O
and CC O O
wean JJ O O
as IN B-VP O
tolerated JJ O O
. . B-VP O
   
Colace NNP B-NP B-treatment
100 CD O O
mg. NN B-NP O
p.o. NN I-NP O
t.i.d. NN I-NP O
Senokot NNP I-NP B-treatment
1 CD O O
p.o. NN B-NP O
q. JJ B-NP O
h.s. NN I-NP O
Nystatin NNP I-NP B-treatment
powder NN I-NP O
to TO O O
affected JJ B-NP B-problem
area NN I-NP I-problem
t.i.d. NN I-NP O
Lopressor NNP I-NP B-treatment
25 CD O O
mg. NN B-NP O
p.o. NN I-NP O
b.i.d. NN I-NP O
Atrovent NNP I-NP B-treatment
0.8/2.5 CD O O
c.c. NN B-NP O
normal JJ B-NP B-treatment
saline NN I-NP I-treatment
nebulizers NNS I-NP I-treatment
q. VBP O O
8 CD O O
h. NNS B-NP O
Albuterol NNP I-NP B-treatment
2.5/5 CD O O
c.c. NN B-NP O
normal JJ B-NP B-treatment
saline NN I-NP I-treatment
nebulizers NNS I-NP I-treatment
q. VBP O O
4 CD O O
h. NN B-NP O
with IN B-VP O
q. JJ O O
2 CD O O
h. JJ B-NP O
p.r.n. NN I-NP O
Percocet NNP I-NP B-treatment
1-2 JJ B-NP O
p.o. NN I-NP O
q. NN I-NP O
4 CD O O
h. NN B-NP O
p.r.n. NN I-NP O
pain NN I-NP B-problem
. . B-VP O
   
Prilosec CC O B-treatment
20 CD O O
mg. NN B-NP O
p.o. NN I-NP O
b.i.d. NN I-NP O
Vexol NNP I-NP B-treatment
1% CD O O
1 CD O O
GTT NNP B-NP O
OD NNP I-NP O
b.i.d. VBD B-VP O
Lasix NNP B-NP B-treatment
40 CD O O
mg. NN B-NP O
p.o. NN I-NP O
q.d. NN I-NP O
KCl NNP I-NP B-treatment
20 CD O O
mEq NN B-NP O
p.o. NN I-NP O
q.d. NN I-NP O
Tylenol NNP I-NP B-treatment
650 CD O O
mg. NN B-NP O
p.o. NN I-NP O
q. VBD B-VP O
12 CD O O
h. NN B-NP O
p.r.n. NN I-NP O
Ativan NNP I-NP B-treatment
1 CD O O
mg. NN B-NP O
p.o. NN I-NP O
q. JJ B-NP O
h.s. JJ I-NP O
p.r.n. NNS I-NP O
SAY NNP I-NP B-person
REKE NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
TR NNP I-NP O
: : O O
vr NN B-NP O
DD NNP I-NP O
: : O O
TD NN B-NP O
: : O O
10/23/97 CD O O
3:05 CD O O
Pcc NN B-NP O
: : O O
NABETH NNP B-NP B-person
NA NNP I-NP I-person
GLYNCRED NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
MI NNP I-NP B-person
T NNP I-NP I-person
THULRO NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
/ NNP I-NP O
Fordwoodall NNP I-NP B-person
Stick NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
7922 CD O O
Fordknoxtall NNP B-NP O
Illinois NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
Admission NNP I-NP O
Date NNP I-NP O
: : O O
2019-04-06 JJ B-NP O
Discharge NN I-NP O
Date NNP I-NP O
: : O O
2019-04-15 JJ B-NP O
Date NNP I-NP O
of IN B-VP O
Birth NNP B-NP O
: : O O
1938-02-19 JJ B-NP O
Sex NN I-NP O
: : O O
M NNP B-NP O
Service NNP I-NP O
: : O O
ORTHOPAEDICS JJ B-NP O
Allergies NNS I-NP O
: : O O
Patient NN B-NP B-person
recorded VBD B-VP O
as IN B-VP O
having VBG O O
No NNP B-NP O
Known NNP I-NP B-problem
Allergies NNPS I-NP I-problem
to TO O I-problem
Drugs NNP B-NP I-problem
Attending NNP I-NP B-person
: : O O
Woodrow NNP B-NP B-person
Y NNP I-NP I-person
Williams NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
Addendum NNP I-NP O
: : O O
On IN B-VP O
2019-04-12 NN B-NP O
he PRP O B-person
was VBD B-VP O
transfused VBN O O
with IN B-VP O
2 CD O O
units NNS B-NP O
of IN B-VP O
packed JJ B-NP B-treatment
red JJ I-NP I-treatment
blood NN I-NP I-treatment
cells NNS I-NP I-treatment
due JJ O O
to TO O O
post-operative JJ B-NP B-problem
anemia NN I-NP I-problem
. . B-VP O
   
Mr. NNP B-NP B-person
Minton NNP I-NP I-person
did VBD B-VP O
not RB O O
get VB O O
his PRP$ O B-treatment
his PRP$ O B-person
IVIG NNP B-NP I-treatment
until IN B-VP O
2019-04-14 JJ O O
. . B-VP O
   
The DT B-NP B-treatment
infusion NN I-NP I-treatment
was VBD B-VP O
completed VBN O O
without IN B-VP O
incidence NN B-NP O
. . B-VP O
   
He PRP O B-person
remained VBD B-VP O
stable JJ O O
with IN B-VP O
his PRP$ O B-person
his PRP$ O B-test
vital JJ B-NP I-test
signs NNS I-NP I-test
and CC O O
lab NN B-NP B-test
data NNS I-NP I-test
within IN B-VP O
normal JJ B-NP O
limits NNS I-NP O
. . B-VP O
   
Chief JJ B-NP O
Complaint NN I-NP O
: : O O
see NN B-NP O
below IN B-VP O
Pertinent JJ B-NP O
Results NNS I-NP O
: : O O
2019-04-15 JJ O O
09:25 CD O O
AM NNP B-NP O
BLOOD NNP I-NP B-test
WBC NNP I-NP I-test
- : O O
3.8 CD O O
* NN B-NP O
RBC NNP I-NP B-test
- : O O
2.88 CD O O
* NN B-NP O
Hgb NNP I-NP B-test
- : O O
8.9 CD O O
* NN B-NP O
Hct NNP I-NP B-test
- : O O
25.9 CD O O
* NN B-NP O
MCV NNP I-NP B-test
- : O O
90 CD O O
MCH NNP B-NP B-test
- : O O
30.9 CD O O
MCHC NNP B-NP B-test
- : O O
34.3 CD O O
RDW NNP B-NP B-test
- : O O
16.4 CD O O
* JJ B-NP O
Plt NNP I-NP B-test
Ct NNP I-NP I-test
- : O O
194 CD O O
2019-04-14 JJ O O
08:50 CD O O
AM NNP B-NP O
BLOOD NNP I-NP B-test
WBC NNP I-NP I-test
- : O O
6.5 CD O O
RBC NNP B-NP B-test
- : O O
3.02 CD O O
* NN B-NP O
Hgb NNP I-NP B-test
- : O O
9.4 CD O O
* NN B-NP O
Hct NNP I-NP B-test
- : O O
27.1* CD O O
MCV NNP B-NP B-test
- : O O
90 CD O O
MCH NNP B-NP B-test
- : O O
31.0 CD O O
MCHC NNP B-NP B-test
- : O O
34.6 CD O O
RDW NNP B-NP B-test
- : O O
16.3 CD O O
* JJ B-NP O
Plt NNP I-NP B-test
Ct NNP I-NP I-test
- : O O
169 CD O O
2019-04-13 JJ O O
08:40 CD O O
AM NNP B-NP O
BLOOD NNP I-NP B-test
WBC NNP I-NP I-test
- : O O
6.7 CD O O
RBC NNP B-NP B-test
- : O O
3.07 CD O O
* NN B-NP O
Hgb NNP I-NP B-test
- : O O
9.3 CD O O
* NN B-NP O
Hct NNP I-NP B-test
- : O O
27.1 CD O O
* NN B-NP O
MCV NNP I-NP B-test
- : O O
88 CD O O
MCH NNP B-NP B-test
- : O O
30.4 CD O O
MCHC NNP B-NP B-test
- : O O
34.5 CD O O
RDW NNP B-NP B-test
- : O O
16.2 CD O O
* JJ B-NP O
Plt NNP I-NP B-test
Ct NNP I-NP I-test
- : O O
144 CD O O
* JJ O O
2019-04-12 JJ O O
08:00 CD O O
PM NNP B-NP O
BLOOD NNP I-NP B-test
Hct NNP I-NP I-test
- : O O
26.5 CD O O
* JJ O O
2019-04-12 JJ O O
06:35 CD O O
AM NNP B-NP O
BLOOD NNP I-NP B-test
Hct NNP I-NP I-test
- : O O
23.6 CD O O
* JJ O O
2019-04-11 JJ O O
12:55 CD O O
PM NNP B-NP O
BLOOD NNP I-NP B-test
Hct NNP I-NP I-test
- : O O
27.1 CD O O
* JJ O O
2019-04-11 JJ O O
09:50 CD O O
AM NNP B-NP O
BLOOD NNP I-NP B-test
WBC NNP I-NP I-test
- : O O
4.8 CD O O
RBC NNP B-NP B-test
- : O O
3.02 CD O O
* NN B-NP O
Hgb NNP I-NP B-test
- : O O
9.5 CD O O
* NN B-NP O
Hct NNP I-NP B-test
- : O O
26.7 CD O O
* NN B-NP O
MCV NNP I-NP B-test
- : O O
89 CD O O
MCH NNP B-NP B-test
- : O O
31.4 CD O O
MCHC NNP B-NP B-test
- : O O
35.5 CD O O
* NN B-NP O
RDW NNP I-NP B-test
- : O O
15.2 CD O O
Plt NNP B-NP B-test
Ct NNP I-NP I-test
- : O O
103 CD O O
* JJ O O
2019-04-11 JJ O O
06:27 CD O O
AM NNP B-NP O
BLOOD NNP I-NP B-test
WBC NNP I-NP I-test
- : O O
4.4 CD O O
RBC NNP B-NP B-test
- : O O
3.03 CD O O
* NN B-NP O
Hgb NNP I-NP B-test
- : O O
9.5 CD O O
* NN B-NP O
Hct NNP I-NP B-test
- : O O
26.7 CD O O
* NN B-NP O
MCV NNP I-NP B-test
- : O O
88 CD O O
MCH NNP B-NP B-test
- : O O
31.2 CD O O
MCHC NNP B-NP B-test
- : O O
35.4 CD O O
* NN B-NP O
RDW NNP I-NP B-test
- : O O
14.7 CD O O
Plt NNP B-NP B-test
Ct NNP I-NP I-test
- : O O
94 CD O O
* JJ O O
2019-04-10 JJ O O
06:30 CD O O
AM NNP B-NP O
BLOOD NNP I-NP B-test
WBC NNP I-NP I-test
- : O O
4.6 CD O O
RBC NNP B-NP B-test
- : O O
2.81 CD O O
* NN B-NP O
Hgb NNP I-NP B-test
- : O O
8.9 CD O O
* NN B-NP O
Hct NNP I-NP B-test
- : O O
24.8 CD O O
* NN B-NP O
MCV NNP I-NP B-test
- : O O
88 CD O O
MCH NNP B-NP B-test
- : O O
31.7 CD O O
MCHC NNP B-NP B-test
- : O O
36.0 CD O O
* NN B-NP O
RDW NNP I-NP B-test
- : O O
15.2 CD O O
Plt NNP B-NP B-test
Ct NNP I-NP I-test
- : O O
95 CD O O
* JJ O O
2019-04-09 JJ O O
06:45 CD O O
AM NNP B-NP O
BLOOD NNP I-NP B-test
WBC NNP I-NP I-test
- : O O
5.0 CD O O
RBC NNP B-NP B-test
- : O O
3.33 CD O O
* NN B-NP O
Hgb NNP I-NP B-test
- : O O
10.4 CD O O
* NN B-NP O
Hct NNP I-NP B-test
- : O O
29.2 CD O O
* NN B-NP O
MCV NNP I-NP B-test
- : O O
88 CD O O
MCH NNP B-NP B-test
- : O O
31.2 CD O O
MCHC NNP B-NP B-test
- : O O
35.5 CD O O
* NN B-NP O
RDW NNP I-NP B-test
- : O O
15.0 CD O O
Plt NNP B-NP B-test
Ct NNP I-NP I-test
- : O O
72 CD O O
* JJ O O
2019-04-08 JJ O O
12:27 CD O O
AM NNP B-NP O
BLOOD NNP I-NP B-test
WBC NNP I-NP I-test
- : O O
4.9 CD O O
RBC NNP B-NP B-test
- : O O
3.11 CD O O
* NN B-NP O
Hgb NNP I-NP B-test
- : O O
9.9 CD O O
* NN B-NP O
Hct NNP I-NP B-test
- : O O
27.1 CD O O
* NN B-NP O
MCV NNP I-NP B-test
- : O O
87 CD O O
MCH NNP B-NP B-test
- : O O
32.0 CD O O
MCHC NNP B-NP B-test
- : O O
36.6 CD O O
* NN B-NP O
RDW NNP I-NP B-test
- : O O
15.5 CD O O
Plt NNP B-NP B-test
Ct NNP I-NP I-test
- : O O
107 CD O O
* JJ O O
2019-04-07 JJ O O
04:53 CD O O
PM NNP B-NP O
BLOOD NNP I-NP B-test
WBC NNP I-NP I-test
- : O O
4.4 CD O O
RBC NNP B-NP B-test
- : O O
2.92 CD O O
* NN B-NP O
Hgb NNP I-NP B-test
- : O O
9.6 CD O O
*# NN B-NP O
Hct NNP I-NP B-test
- : O O
25.8 CD O O
* NN B-NP O
MCV NNP I-NP B-test
- : O O
88 CD O O
MCH NNP B-NP B-test
- : O O
32.8 CD O O
* NN B-NP O
MCHC NNP I-NP B-test
- : O O
37.1 CD O O
* NN B-NP O
RDW NNP I-NP B-test
- : O O
14.9 CD O O
Plt NNP B-NP B-test
Ct NNP I-NP I-test
- : O O
81 CD O O
* JJ O O
2019-04-07 JJ O O
11:00 CD O O
AM NNP B-NP O
BLOOD NNP I-NP B-test
WBC NNP I-NP I-test
- : O O
4.4 CD O O
RBC NNP B-NP B-test
- : O O
2.34 CD O O
*# NN B-NP O
Hgb NNP I-NP B-test
- : O O
7.5 CD O O
* NN B-NP O
Hct NNP I-NP B-test
- : O O
21.2 CD O O
*# NN B-NP O
MCV NNP I-NP B-test
- : O O
91 CD O O
MCH NNP B-NP B-test
- : O O
32.1 CD O O
* NN B-NP O
MCHC NNP I-NP B-test
- : O O
35.4 CD O O
* NN B-NP O
RDW NNP I-NP B-test
- : O O
14.5 CD O O
Plt NNP B-NP B-test
Ct NNP I-NP I-test
- : O O
94 CD O O
* JJ O O
2019-04-07 JJ O O
06:00 CD O O
AM NNP B-NP O
BLOOD NNP I-NP B-test
WBC NNP I-NP I-test
- : O O
3.2 CD O O
*# NN B-NP O
RBC NNP I-NP B-test
- : O O
3.14 CD O O
* NN B-NP O
Hgb NNP I-NP B-test
- : O O
10.0 CD O O
* NN B-NP O
Hct NNP I-NP B-test
- : O O
28.9 CD O O
* NN B-NP O
MCV NNP I-NP B-test
- : O O
92 CD O O
MCH NNP B-NP B-test
- : O O
32.0 CD O O
MCHC NNP B-NP B-test
- : O O
34.8 CD O O
RDW NNP B-NP B-test
- : O O
14.1 CD O O
Plt NNP B-NP B-test
Ct NNP I-NP I-test
- : O O
82 CD O O
*# JJ O O
2019-04-06 JJ O O
10:40 CD O O
AM NNP B-NP O
BLOOD NNP I-NP B-test
WBC NNP I-NP I-test
- : O O
2.1 CD O O
* NN B-NP O
RBC NNP I-NP B-test
- : O O
3.51 CD O O
* NN B-NP O
Hgb NNP I-NP B-test
- : O O
10.9 CD O O
* NN B-NP O
Hct NNP I-NP B-test
- : O O
31.7 CD O O
* NN B-NP O
MCV NNP I-NP B-test
- : O O
90 CD O O
MCH NNP B-NP B-test
- : O O
31.1 CD O O
MCHC NNP B-NP B-test
- : O O
34.5 CD O O
RDW NNP B-NP B-test
- : O O
14.3 CD O O
Plt NNP B-NP B-test
Ct NNP I-NP I-test
- : O O
50 CD O O
* JJ O O
2019-04-15 JJ O O
09:25 CD O O
AM NNP B-NP O
BLOOD NNP I-NP B-test
Plt NNP I-NP I-test
Ct NNP I-NP I-test
- : O O
194 CD O O
2019-04-14 JJ O O
08:50 CD O O
AM NNP B-NP O
BLOOD NNP I-NP B-test
Plt NNP I-NP I-test
Ct NNP I-NP I-test
- : O O
169 CD O O
2019-04-14 JJ O O
08:50 CD O O
AM NNP B-NP O
BLOOD NNP I-NP B-test
PT NNP I-NP I-test
- : O O
12.0 CD O O
INR(PT) NNP B-NP B-test
- : O O
1.0 CD O O
2019-04-15 JJ O O
09:25 CD O O
AM NNP B-NP O
BLOOD NNP I-NP B-test
Glucose NNP I-NP I-test
- : O O
134 CD O O
* JJ B-NP O
UreaN NNP I-NP B-test
- : O O
19 CD O O
Creat NNP B-NP B-test
- : O O
0.8 CD O O
Na NNP B-NP B-test
- : O O
135 CD O O
K NNP B-NP B-test
- : O O
3.5 CD O O
Cl NNP B-NP B-test
- : O O
100 CD O O
HCO3 NNP B-NP B-test
- : O O
28 CD O O
AnGap NNP B-NP B-test
- : O O
11 CD O O
Discharge NNP B-NP O
Medications NNS I-NP O
: : O O
1. CD O O
Cholecalciferol NNP B-NP B-treatment
( ( O I-treatment
Vitamin NNP B-NP I-treatment
D3 NNP I-NP I-treatment
) ) O I-treatment
400 CD O O
unit NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Tablet NNP B-NP O
PO NNP I-NP O
DAILY NNP I-NP O
( ( O O
Daily NNP B-NP O
). VBZ O O
2. CD O O
Pantoprazole NNP B-NP B-treatment
40 CD O O
mg NN B-NP O
Tablet NNP I-NP O
, , O O
Delayed NNP B-NP O
Release NNP I-NP O
( ( O O
E.C. NNP B-NP O
) ) O O
Sig NN B-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Tablet NN B-NP O
, , O O
Delayed NNP B-NP O
Release NNP I-NP O
( ( O O
E.C. NNP B-NP O
) ) O O
PO NNP B-NP O
Q24H NNP I-NP O
( ( O O
every DT O O
24 CD O O
hours NNS B-NP O
). RB O O
3. CD O O
Lorazepam NNP B-NP B-treatment
0.5 CD O O
mg NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Tablet NNP B-NP O
PO NNP I-NP O
TID NNP I-NP O
( ( O O
3 CD O O
times NNS B-NP O
a DT B-NP O
day NN I-NP O
) ) O O
as IN B-VP O
needed VBN O O
for IN B-VP O
anxiety NN B-NP B-problem
. . B-VP O
   
4. CD O O
Acetaminophen NNP B-NP B-treatment
325 CD O O
mg NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
Two CD O O
( ( O O
2 CD O O
) ) O O
Tablet NNP B-NP O
PO NNP I-NP O
Q4H NNP I-NP O
( ( O O
every DT O O
4 CD O O
hours NNS B-NP O
). RB O O
5. CD O O
Lisinopril NNP B-NP B-treatment
5 CD O O
mg NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Tablet NNP B-NP O
PO NNP I-NP O
BID NNP I-NP O
( ( O O
2 CD O O
times NNS B-NP O
a DT B-NP O
day NN I-NP O
). POS O O
6. CD O O
Senna NNP B-NP B-treatment
8.6 CD O O
mg NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Tablet NNP B-NP O
PO NNP I-NP O
BID NNP I-NP O
( ( O O
2 CD O O
times NNS B-NP O
a DT B-NP O
day NN I-NP O
) ) O O
as IN B-VP O
needed VBN O O
. . B-VP O
   
7. CD O O
Docusate NNP B-NP B-treatment
Sodium NNP I-NP I-treatment
100 CD O O
mg NN B-NP O
Capsule NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Capsule NNP B-NP O
PO NNP I-NP O
BID NNP I-NP O
( ( O O
2 CD O O
times NNS B-NP O
a DT B-NP O
day NN I-NP O
). POS O O
8. CD O O
Enoxaparin NNP B-NP B-treatment
30 CD O O
mg NN B-NP O
/ VBD B-VP O
0.3 CD O O
mL NN B-NP O
Syringe NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Subcutaneous JJ B-NP O
Q12H NNP I-NP O
( ( O O
every DT O O
12 CD O O
hours NNS B-NP O
) ) O O
for IN B-VP O
4 CD O O
weeks NNS B-NP O
. . B-VP O
   
9. CD O O
Oxycodone CD O B-treatment
5 CD O O
mg NNS B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Tablet NNP B-NP O
PO NNP I-NP O
Q4-6H NNP I-NP O
( ( O O
every DT O O
4 CD O O
to TO O O
6 CD O O
hours NNS B-NP O
) ) O O
as IN B-VP O
needed VBN O O
. . B-VP O
   
10. CD O O
Bisacodyl NNP B-NP B-treatment
5 CD O O
mg NN B-NP O
Tablet NNP I-NP O
, , O O
Delayed NNP B-NP O
Release NNP I-NP O
( ( O O
E.C. NNP B-NP O
) ) O O
Sig NNP B-NP O
: : O O
Two CD O O
( ( O O
2 CD O O
) ) O O
Tablet NN B-NP O
, , O O
Delayed NNP B-NP O
Release NNP I-NP O
( ( O O
E.C. NNP B-NP O
) ) O O
PO NNP B-NP O
DAILY NNP I-NP O
( ( O O
Daily NNP B-NP O
) ) O O
as IN B-VP O
needed VBN O O
. . B-VP O
   
11. CD O O
Magnesium NNP B-NP B-treatment
Hydroxide NNP I-NP I-treatment
400 CD O O
mg NN B-NP O
/ VBD B-VP O
5 CD O O
mL JJ B-NP O
Suspension NNP I-NP O
Sig NNP I-NP O
: : O O
Thirty NNP B-NP O
( ( O O
30 CD O O
) ) O O
ML NNP B-NP O
PO NNP I-NP O
Q6H NNP I-NP O
( ( O O
every DT O O
6 CD O O
hours NNS B-NP O
) ) O O
as IN B-VP O
needed VBN O O
. . B-VP O
   
12. CD O O
Trazodone CD O B-treatment
50 CD O O
mg NNS B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Tablet NNP B-NP O
PO NNP I-NP O
HS NNP I-NP O
( ( O O
at IN B-VP O
bedtime NN B-NP O
) ) O O
as IN B-VP O
needed VBN O O
for IN B-VP O
insomnia NN B-NP B-problem
. . B-VP O
   
Discharge NNP B-NP O
Disposition NNP I-NP O
: : O O
Extended VBN O O
Care NNP B-NP O
Facility NNP I-NP O
: : O O
Lemuel NNP B-NP O
Shattuck NNP I-NP O
Hospital NNP I-NP O
- : O O
Malden NNP B-NP O
Michelle NNP I-NP B-person
Franklin NNP I-NP I-person
MD NNP I-NP I-person
31-164 JJ O O
Completed VBN O O
by IN B-VP O
: : O O
Celia NNP B-NP B-person
Gloria NNP I-NP I-person
NP NNP I-NP I-person
80-CCZ JJ O O
2019-04-15 CD O O
@ JJ O O
1049 CD O O
Signed VBN O O
electronically RB O O
by IN B-VP O
: : O O
DR. NNP B-NP B-person
Michelle NNP I-NP I-person
K. NNP I-NP I-person
Partin NNP I-NP I-person
on IN B-VP O
: : O O
WED JJ O O
2019-04-17 JJ O O
1:13 CD O O
PM NNP B-NP O
( ( O O
End NNP B-NP O
of IN B-VP O
Report NNP B-NP O
) ) O O
-EMPTYLINE- VBP O O
-DOCSTART- JJ O O
-EMPTYLINE- $ O O
284487129 CD O O
CTMC NNP B-NP O
42669672 CD O O
466333 CD O O
01/16/1996 CD O O
12:00:00 CD O O
AM NNP B-NP O
Discharge NNP I-NP O
Summary NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date NNP I-NP O
: : O O
01/16/1996 CD O O
Report NNP B-NP O
Status NNP I-NP O
: : O O
Signed VBN O O
Discharge NNP B-NP O
Date NNP I-NP O
: : O O
01/20/1996 CD O O
PROBLEM NNP B-NP O
LIST NNP I-NP O
: : O O
1. CD O O
INSULIN NNP B-NP B-problem
DEPENDENT NNP I-NP I-problem
DIABETES NNP I-NP I-problem
MELLITUS NNP I-NP I-problem
2. CD O O
PRIOR NNP B-NP O
HISTORY NNP I-NP O
OF NNP I-NP O
ANTERIOR NNP I-NP B-problem
MYOCARDIAL NNP I-NP I-problem
INFARCTION NNP I-NP I-problem
3. CD O O
EPISODE NNP B-NP O
OF NNP I-NP O
PULMONARY NNP I-NP B-problem
EDEMA NNP I-NP I-problem
4. CD O O
HYPERCHOLESTEROLEMIA NNP B-NP B-problem
CHIEF NNP I-NP O
COMPLAINT NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
is VBZ O O
a DT O O
40 CD O O
year NN B-NP O
old JJ B-NP O
male NN I-NP O
with IN B-VP O
a DT B-NP O
history NN I-NP O
of IN B-VP O
prior JJ B-NP B-problem
anterior JJ I-NP I-problem
myocardial JJ I-NP I-problem
infarction NN I-NP I-problem
and CC O O
insulin NN B-NP B-problem
dependent NN I-NP I-problem
diabetes VBZ O I-problem
mellitus NNS B-NP I-problem
who WP O B-person
was VBD B-VP O
transferred VBN O O
from IN B-VP O
an DT B-NP O
outside JJ I-NP O
hospital NN I-NP O
after IN B-VP O
an DT B-NP O
episode NN I-NP O
of IN B-VP O
acute JJ B-NP B-problem
shortness NN I-NP I-problem
of IN B-VP I-problem
breath NN B-NP I-problem
and CC O O
pulmonary JJ B-NP B-problem
edema NN I-NP I-problem
. . B-VP O
   
HISTORY NNP B-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
has VBZ O O
a DT B-NP O
history NN I-NP O
four CD O O
years NNS B-NP O
ago RB O O
of IN B-VP O
being VBG O O
admitted VBN O O
to TO O O
the DT B-NP O
Etearal NNP I-NP O
Etsystems/ NNP I-NP O
Hospital NNP I-NP O
after IN B-VP O
suffering VBG O O
an DT B-NP B-problem
acute JJ I-NP I-problem
anterior JJ I-NP I-problem
myocardial JJ I-NP I-problem
infarction NN I-NP I-problem
. . B-VP O
   
The DT B-NP O
course NN I-NP O
had VBD B-VP O
multiple JJ B-NP B-problem
complications NNS I-NP I-problem
requiring VBG O O
pressors NNS B-NP B-treatment
. . B-VP O
   
He PRP O B-person
had VBD B-VP O
a DT B-NP B-test
cardiac JJ I-NP I-test
catheterization NN I-NP I-test
performed VBD B-VP O
which WDT O B-pronoun
revealed VBD B-VP O
a DT O B-problem
three CD O I-problem
vessel NN B-NP I-problem
coronary JJ B-NP I-problem
artery NN I-NP I-problem
disease NN I-NP I-problem
with IN B-VP O
an DT B-NP B-problem
occluded JJ I-NP I-problem
RCA NNP I-NP I-problem
, , O O
70%-80% JJ B-NP B-problem
proximal NN I-NP I-problem
LAD NNP I-NP I-problem
, , O O
and CC O O
a DT B-NP B-problem
high JJ I-NP I-problem
grade NN I-NP I-problem
left VBD B-VP I-problem
circumflex JJ B-NP I-problem
lesion NN I-NP I-problem
after IN B-VP I-problem
the DT B-NP I-problem
OM NNP I-NP I-problem
with IN B-VP O
distal JJ O B-problem
left VBD B-VP I-problem
circumflex JJ B-NP I-problem
occlusion NN I-NP I-problem
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
subsequently RB O O
medically RB O O
management NN B-NP O
after IN B-VP O
this DT O B-treatment
this DT B-NP B-pronoun
hospitalization NN I-NP I-treatment
and CC O O
has VBZ O O
done VBN O O
very RB O O
well RB O O
. . B-VP O
   
His PRP$ O B-person
His PRP$ O B-test
most RBS O I-test
recent JJ B-NP I-test
echocardiogram NN I-NP I-test
in IN B-VP O
April NNP B-NP O
of IN B-VP O
1996 CD O O
showed VBD B-VP O
an DT B-NP B-test
ejection NN I-NP I-test
fraction NN I-NP I-test
of IN B-VP O
20% CD O O
with IN B-VP O
a DT B-NP B-problem
thin JJ I-NP I-problem
fibrotic JJ I-NP I-problem
septum NN I-NP I-problem
with IN B-VP O
akinesis NN B-NP B-problem
and CC O O
moderately RB O B-problem
severe JJ B-NP I-problem
hypokinesis NN I-NP I-problem
in IN B-VP I-problem
all DT B-NP I-problem
other JJ I-NP I-problem
regions NNS I-NP I-problem
except IN B-VP O
for IN B-VP O
the DT B-NP O
lateral JJ I-NP O
wall NN I-NP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
also RB O O
had VBD B-VP O
an DT B-NP B-test
electrocardiogram NN I-NP I-test
in IN B-VP O
April NNP B-NP O
of IN B-VP O
1996 CD O O
which WDT O B-pronoun
was VBD B-VP O
negative JJ B-NP O
following NN I-NP O
, , O O
however RB O O
was VBD B-VP O
at IN B-VP O
a DT B-NP O
low JJ I-NP O
workload NN I-NP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
&apos;s NN I-NP O
was VBD B-VP O
most RBS O O
recently RB O O
admitted VBN O O
to TO O O
Centdick NNP B-NP O
Naco NNP I-NP O
Hospital NNP I-NP O
Medical NNP I-NP O
Center NNP I-NP O
on IN B-VP O
Martin NNP B-NP O
Luther NNP I-NP O
King NNP I-NP O
Day NNP I-NP O
after IN B-VP O
becoming VBG O O
acutely RB O B-problem
short JJ O I-problem
of IN B-VP I-problem
breath NN B-NP I-problem
after IN B-VP O
a DT O O
five CD O O
minute NN B-NP O
walk NN I-NP O
. . B-VP O
   
He PRP O B-person
had VBD B-VP O
no DT B-NP O
chest NN I-NP B-problem
pain NN I-NP I-problem
, , O O
palpitations NNS B-NP B-problem
, , O O
diaphoresis NN B-NP B-problem
, , O O
or CC O O
nausea NN B-NP B-problem
. . B-VP O
   
He PRP O B-person
called VBD B-VP O
the DT B-NP O
EMT NNP I-NP B-person
&apos;s NNP I-NP O
and CC O O
was VBD B-VP O
found VBN O O
to TO O O
be VB O O
in IN B-VP O
pulmonary JJ B-NP B-problem
edema NN I-NP I-problem
by IN B-VP O
chest JJ B-NP B-test
x-ray NN I-NP I-test
at IN B-VP O
Centdick NNP B-NP O
Naco NNP I-NP O
Hospital NNP I-NP O
Medical NNP I-NP O
Center NNP I-NP O
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
diuresed VBN O B-treatment
and CC O O
ruled VBN O O
out RP O O
for IN B-VP O
myocardial JJ B-NP B-problem
infarction NN I-NP I-problem
. . B-VP O
   
His PRP$ O B-test
His PRP$ O B-person
ECG NNP B-NP I-test
showed VBD B-VP O
no DT B-NP O
ischemic JJ I-NP B-problem
changes NNS I-NP I-problem
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
then RB O O
transferred VBN O O
to TO O O
the DT B-NP O
Retelk NNP I-NP O
County NNP I-NP O
Medical NNP I-NP O
Center NNP I-NP O
for IN B-VP O
further JJ B-NP B-treatment
management NN I-NP I-treatment
. . B-VP O
   
PAST NNP B-NP O
MEDICAL NNP I-NP O
HISTORY NNP I-NP O
: : O O
(1) JJ B-NP O
Insulin NNP I-NP B-problem
dependent NN I-NP I-problem
diabetes VBZ O I-problem
mellitus RBS O I-problem
x JJ O O
15 CD O O
years NNS B-NP O
with IN B-VP O
no DT B-NP O
retinopathy NN I-NP B-problem
or CC O O
foot NN B-NP B-problem
lesions NNS I-NP I-problem
. . B-VP O
   
(2) JJ B-NP O
Bilateral NNP I-NP B-problem
cataracts NNS I-NP I-problem
. . B-VP O
   
(3) NN B-NP O
In IN B-VP O
1967 CD O O
he PRP O B-person
had VBD B-VP O
an DT B-NP B-treatment
orchiopexy NN I-NP I-treatment
for IN B-VP O
undescended JJ B-NP B-problem
testicle NN I-NP I-problem
. . B-VP O
   
(4) JJ B-NP O
Coronary JJ I-NP B-problem
artery NN I-NP I-problem
disease NN I-NP I-problem
as IN B-VP O
above NN B-NP O
. . B-VP O
   
ALLERGIES NNP B-NP O
: : O O
No DT B-NP O
known JJ I-NP B-problem
drug NN I-NP I-problem
allergies NNS I-NP I-problem
. . B-VP O
   
MEDICATIONS NNP B-NP O
ON NNP I-NP O
ADMISSION NNP I-NP O
: : O O
Aspirin $ O B-treatment
325 CD O O
mg NN B-NP O
p.o. NN I-NP O
q. JJ B-NP O
day NN I-NP O
, , O O
Capoten NNP B-NP B-treatment
25 CD O O
mg NN B-NP O
p.o. NN I-NP O
q.8h. NN I-NP O
, , O O
NPH NNP B-NP B-treatment
insulin VBZ O I-treatment
28 CD O O
units NNS B-NP O
q.a.m. RB O O
and CC O O
10 CD O O
units NNS B-NP O
q.p.m. RB O O
, , O O
Regular NNP B-NP B-treatment
insulin NN I-NP I-treatment
4 CD O O
units NNS B-NP O
q.a.m. RB O O
and CC O O
4 CD O O
units NNS B-NP O
q.p.m. RB O O
, , O O
simvastatin VBD B-VP B-treatment
20 CD O O
mg NN B-NP O
p.o. NN I-NP O
q. JJ B-NP O
day NN I-NP O
, , O O
digoxin NN B-NP B-treatment
0.25 CD O O
mg. JJ B-NP O
SOCIAL NNP I-NP O
HISTORY NN I-NP O
: : O O
He PRP O B-person
lives VBZ O O
with IN B-VP O
his PRP$ O B-person
his PRP$ O B-person
two CD O I-person
brothers NNS B-NP I-person
and CC O O
is VBZ O O
on IN B-VP O
disability NN B-NP O
. . B-VP O
   
He PRP O B-person
has VBZ O O
a DT B-NP O
ten NN I-NP O
pack JJ B-NP O
year NN I-NP O
history NN I-NP O
of IN B-VP O
smoking NN B-NP O
, , O O
quit NN B-NP O
in IN B-VP O
1990 CD O O
. . B-VP O
   
He PRP O B-person
does VBZ O O
not RB O O
drink VB O O
alcohol NN B-NP O
. . B-VP O
   
FAMILY NNP B-NP O
HISTORY NNP I-NP O
: : O O
His PRP$ O B-person
His PRP$ O B-person
mother NN B-NP I-person
and CC O O
father NN B-NP B-person
both DT O O
died VBD B-VP O
secondary JJ O O
to TO O O
myocardial JJ B-NP B-problem
infarction NN I-NP I-problem
. . B-VP O
   
One CD O O
of IN B-VP O
his PRP$ O B-person
his PRP$ O B-person
brothers NNS B-NP I-person
has VBZ O O
had VBD B-VP O
a DT B-NP B-problem
myocardial JJ I-NP I-problem
infarction NN I-NP I-problem
. . B-VP O
   
PHYSICAL JJ B-NP O
EXAMINATION NN I-NP O
: : O O
Temperature NN B-NP B-test
100.3 CD O O
, , O O
heart NN B-NP B-test
rate NN I-NP I-test
76 CD O O
, , O O
blood NN B-NP B-test
pressure NN I-NP I-test
100/78 CD O O
, , O O
respiratory NN B-NP B-test
rate NN I-NP I-test
16 CD O O
, , O O
and CC O O
an DT B-NP B-test
oxygen NN I-NP I-test
saturation NN I-NP I-test
of IN B-VP O
96% CD O O
on IN B-VP O
two CD O O
liters NNS B-NP O
. . B-VP O
   
NECK NN B-NP O
: : O O
No DT B-NP O
jugular NN I-NP B-problem
venous JJ B-NP I-problem
distention NN I-NP I-problem
. . B-VP O
   
CHEST NN B-NP O
: : O O
Clear JJ O O
to TO O O
auscultation VB O B-test
with IN B-VP O
no DT B-NP O
wheezes NN I-NP B-problem
or CC O O
rales NNS B-NP B-problem
. . B-VP O
   
CARDIOVASCULAR NN B-NP O
: : O O
Regular JJ B-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
with IN B-VP O
no DT B-NP O
extra JJ I-NP B-problem
heart NN I-NP I-problem
sounds NNS I-NP I-problem
and CC O O
no DT B-NP O
murmurs NN I-NP B-problem
. . B-VP O
   
ABDOMEN NN B-NP O
: : O O
Benign NNP B-NP O
. . B-VP O
   
EXTREMITIES NNP B-NP O
: : O O
No DT B-NP O
edema NN I-NP B-problem
with IN B-VP O
2+ CD O O
pulses NNS B-NP O
. . B-VP O
   
LABORATORY NNP B-NP O
DATA NNP I-NP O
: : O O
BUN NNP B-NP B-test
25 CD O O
and CC O O
creatinine VB O B-test
1.4 CD O O
. . B-VP O
   
White NNP B-NP B-test
count NN I-NP I-test
6 CD O O
and CC O O
hematocrit $ O B-test
41.5 CD O O
. . B-VP O
   
PT VB O B-test
14.1 CD O O
with IN B-VP O
an DT B-NP B-test
INR NNP I-NP I-test
of IN B-VP O
1.4 CD O O
, , O O
PTT NNP B-NP B-test
36.7 CD O O
. . B-VP O
   
Chest VB O B-test
x-ray JJ O I-test
showed VBN O O
no DT B-NP O
infiltrates NNS I-NP B-problem
and CC O O
no DT B-NP O
pulmonary JJ I-NP B-problem
edema NN I-NP I-problem
. . B-VP O
   
Urinalysis NN B-NP B-test
was VBD B-VP O
negative JJ O O
. . B-VP O
   
Electrocardiogram NNP B-NP B-test
showed VBD B-VP O
normal JJ B-NP O
sinus NN I-NP O
rhythm NN I-NP O
at IN B-VP O
63 CD O O
with IN B-VP O
normal JJ B-NP O
intervals NNS I-NP O
. . B-VP O
   
He PRP O B-person
had VBD B-VP O
flat JJ B-NP B-problem
T NNP I-NP I-problem
waves NNS I-NP I-problem
in IN B-VP I-problem
I PRP O I-problem
and CC O I-problem
aVL NN B-NP I-problem
, , O O
which WDT O B-pronoun
were VBD B-VP O
unchanged JJ O O
from IN B-VP O
previous JJ B-NP B-test
ECG NNP I-NP I-test
. . B-VP O
   
HOSPITAL NNP B-NP O
COURSE NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
admitted VBN O O
for IN B-VP O
further JJ B-NP B-treatment
management NN I-NP I-treatment
of IN B-VP O
his PRP$ O B-person
his PRP$ O B-problem
pulmonary JJ B-NP I-problem
edema NN I-NP I-problem
. . B-VP O
   
It PRP O B-pronoun
was VBD B-VP O
felt VBN O O
that IN B-VP B-pronoun
the DT B-NP B-person
patient NN I-NP I-person
possibly RB O O
had VBD B-VP O
a DT B-NP O
worsening NN I-NP O
of IN B-VP O
his PRP$ O B-person
his PRP$ O B-problem
coronary JJ B-NP I-problem
artery NN I-NP I-problem
disease NN I-NP I-problem
and CC O O
therefore RB O O
underwent JJ B-NP O
cardiac JJ I-NP B-test
catheterization NN I-NP I-test
on IN B-VP O
01/17/96 CD O O
. . B-VP O
   
At IN B-VP O
cardiac JJ B-NP B-test
catheterization NN I-NP I-test
he PRP O B-person
had VBD B-VP O
an DT B-NP B-test
RA NNP I-NP I-test
pressure NN I-NP I-test
of IN B-VP O
8 CD O O
, , O O
an DT B-NP B-test
RV NNP I-NP I-test
pressure NN I-NP I-test
of IN B-VP O
52/10 CD O O
, , O O
PA NNP B-NP B-test
pressure NN I-NP I-test
of IN B-VP O
60/25 CD O O
, , O O
and CC O O
wedge NN B-NP B-test
of IN B-VP O
26 CD O O
. . B-VP O
   
His PRP$ O B-person
coronary JJ B-NP O
arteries NNS I-NP O
revealed VBD B-VP O
an DT O B-problem
80% CD O I-problem
stenosis NN B-NP I-problem
and CC O O
a DT B-NP B-problem
large JJ I-NP I-problem
OM NNP I-NP I-problem
. . B-VP O
   
The DT O O
dominant JJ O O
left VBD B-VP O
circumflex NN B-NP O
was VBD B-VP O
occluded VBN O B-problem
with IN B-VP O
left-to-left JJ B-NP B-problem
filling NN I-NP I-problem
. . B-VP O
   
He PRP O B-person
also RB O O
had VBD B-VP O
a DT O B-problem
50% CD O I-problem
LAD NNP B-NP I-problem
stenosis NN I-NP I-problem
, , O O
a DT O B-problem
100% CD O I-problem
large JJ B-NP I-problem
DT NNP I-NP I-problem
stenosis NN I-NP I-problem
and CC O O
a DT B-NP O
nondominant JJ I-NP O
RCA NNP I-NP O
with IN B-VP O
left JJ B-NP O
RCA NNP I-NP O
collaterals NNS I-NP O
. . B-VP O
   
It PRP O B-pronoun
was VBD B-VP O
felt VBN O O
that IN B-VP B-pronoun
this DT O B-pronoun
this DT B-NP B-test
cardiac JJ I-NP I-test
catheterization NN I-NP I-test
was VBD B-VP O
not RB O O
significantly RB O O
changed VBN O O
from IN B-VP O
his PRP$ O B-person
his PRP$ O B-test
previous JJ B-NP I-test
catheterization NN I-NP I-test
. . B-VP O
   
Given VBN O O
his PRP$ O B-person
his PRP$ O B-problem
high JJ B-NP I-problem
right-sided JJ I-NP I-problem
filling NN I-NP I-problem
pressure NN I-NP I-problem
, , O O
he PRP O B-person
was VBD B-VP O
started VBN O O
on IN B-VP O
Lasix NNP B-NP B-treatment
for IN B-VP O
diuresis NN B-NP B-treatment
and CC O O
his PRP$ O B-person
his PRP$ O B-treatment
Captopril NNP B-NP I-treatment
was VBD B-VP O
increased VBN O O
for IN B-VP O
greater JJR B-NP B-treatment
afterload NN I-NP I-treatment
reduction NN I-NP I-treatment
. . B-VP O
   
It PRP O B-pronoun
was VBD B-VP O
felt VBN O O
that IN B-VP B-pronoun
the DT B-NP B-person
patient NN I-NP I-person
should MD O O
have VB O O
an DT B-NP B-treatment
augmented JJ I-NP I-treatment
medical JJ I-NP I-treatment
regimen NNS I-NP I-treatment
and CC O O
as IN B-VP O
an DT B-NP O
outpatient NN I-NP O
undergo NN I-NP O
an DT B-NP B-test
exercise NN I-NP I-test
tolerance NN I-NP I-test
test NN I-NP I-test
with IN B-VP O
viability NN B-NP B-test
evaluation NN I-NP I-test
to TO O O
determine VB O O
whether IN B-VP O
he PRP O B-person
would MD O O
benefit VB O O
from IN B-VP O
revascularization NN B-NP B-treatment
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
restarted VBN O O
on IN B-VP O
Coumadin NNP B-NP B-treatment
for IN B-VP O
his PRP$ O B-person
his PRP$ O B-problem
low JJ B-NP I-problem
ejection NN I-NP I-problem
fraction NN I-NP I-problem
and CC O O
started VBD B-VP O
on IN B-VP O
diuresis NN B-NP B-treatment
with IN B-VP O
IV NNP B-NP B-treatment
Lasix NNP I-NP I-treatment
for IN B-VP O
two CD O O
days NNS B-NP O
and CC O O
then RB O O
switched VBD B-VP O
to TO O O
an DT B-NP B-treatment
oral JJ I-NP I-treatment
Lasix NNP I-NP I-treatment
regimen NNS I-NP I-treatment
. . B-VP O
   
DISPOSITION NN B-NP O
: : O O
He PRP O B-person
was VBD B-VP O
discharged VBN O O
to TO O O
home NN B-NP O
in IN B-VP O
stable JJ B-NP O
condition NN I-NP O
and CC O O
feeling NN B-NP O
well RB O O
. . B-VP O
   
DISCHARGE NNP B-NP O
MEDICATIONS NNP I-NP O
: : O O
Insulin NNP B-NP B-treatment
NPH NNP I-NP I-treatment
10 CD O O
units NNS B-NP O
q.p.m. RB O O
and CC O O
28 CD O O
units NNS B-NP O
q.a.m. RB O O
, , O O
insulin NN B-NP B-treatment
Regular JJ O I-treatment
4 CD O O
units NNS B-NP O
q.a.m. RB O O
and CC O O
4 CD O O
units NNS B-NP O
q.p.m. RB O O
, , O O
aspirin VBZ O B-treatment
325 CD O O
mg NN B-NP O
p.o. NN I-NP O
q. JJ B-NP O
day NN I-NP O
, , O O
digoxin NN B-NP B-treatment
0.25 CD O O
mg NN B-NP O
p.o. NN I-NP O
q. JJ B-NP O
day NN I-NP O
, , O O
simvastatin VBD B-VP B-treatment
20 CD O O
mg NN B-NP O
p.o. NN I-NP O
q. JJ B-NP O
day NN I-NP O
, , O O
captopril VBP O B-treatment
37.5 CD O O
mg NN B-NP O
p.o. NN I-NP O
t.i.d. NN I-NP O
, , O O
Coumadin NNP B-NP B-treatment
5 CD O O
mg NN B-NP O
p.o. NN I-NP O
q.h.s. NN I-NP O
, , O O
Lasix NNP B-NP B-treatment
20 CD O O
mg NN B-NP O
p.o. NN I-NP O
q. JJ B-NP O
day NN I-NP O
. . B-VP O
   
FOLLOW-UP NN B-NP O
: : O O
He PRP O B-person
is VBZ O O
to TO O O
see VB O O
Dr. NNP B-NP B-person
Ench NNP I-NP I-person
in IN B-VP O
two CD O O
weeks NNS B-NP O
to TO O O
check VB O O
his PRP$ O B-person
his PRP$ O B-test
PT NNP B-NP I-test
and CC O O
INR NNP B-NP B-test
, , O O
also RB O O
to TO O O
check VB O O
for IN B-VP O
potassium NN B-NP B-test
. . B-VP O
   
Dictated VBN O O
By IN B-VP O
: : O O
CA NNP B-NP B-person
X. NNP I-NP I-person
SCGACH NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
YG59 NNP I-NP O
Attending NNP I-NP B-person
: : O O
JEMALKYLE NNP B-NP B-person
J. NNP I-NP I-person
EHKOTE NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
BI7 NNP I-NP O
PJ387/3762 NNP I-NP O
Batch NNP I-NP O
: : O O
37377 CD O O
Index NNP B-NP O
No. NN I-NP O
WDXZUZ7Y9B NNP I-NP O
D NNP I-NP O
: : O O
01/20/96 CD O O
T NN B-NP O
: : O O
01/20/96 CD O O
-EMPTYLINE- NN B-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
Admission NNP I-NP O
Date NNP I-NP O
: : O O
2013-03-27 JJ B-NP O
Discharge NN I-NP O
Date NNP I-NP O
: : O O
2013-04-01 JJ B-NP O
Date NNP I-NP O
of IN B-VP O
Birth NNP B-NP O
: : O O
1954-08-12 JJ B-NP O
Sex NN I-NP O
: : O O
F NNP B-NP O
Service NNP I-NP O
: : O O
NEUROSURGERY JJ B-NP O
Allergies NNS I-NP O
: : O O
Shellfish JJ B-NP O
Attending NN I-NP B-person
: : O O
Sam NNP B-NP B-person
K. NNP I-NP I-person
Laudato NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
Chief NNP I-NP O
Complaint NNP I-NP O
: : O O
s/p NN B-NP O
MVC NNP I-NP O
Major NNP I-NP O
Surgical NNP I-NP O
or CC O O
Invasive JJ B-NP O
Procedure NN I-NP O
: : O O
none NN B-NP O
History NN I-NP O
of IN B-VP O
Present NNP B-NP O
Illness NNP I-NP O
: : O O
58 CD O O
yo NNS B-NP O
female JJ B-NP O
s/p JJ I-NP O
high JJ I-NP O
speed NN I-NP O
MVC NNP I-NP O
. . B-VP O
   
She PRP O B-person
lost VBD B-VP O
contaol NN B-NP O
of IN B-VP O
her PRP$ O B-person
car NN B-NP O
, , O O
she PRP O B-person
hit VBD B-VP O
the DT B-NP O
Barnes NNPS I-NP O
rails NNS I-NP O
then RB O O
the DT B-NP O
car NN I-NP O
stopped VBD B-VP O
. . B-VP O
   
Another DT B-NP O
car NN I-NP O
was VBD B-VP O
coming VBG O O
behind IN B-VP O
her PRP O B-person
did VBD B-VP O
not RB O O
see VB O O
her PRP$ O B-person
car NN B-NP O
, , O O
hit NN B-NP O
again RB O O
, , O O
the DT B-NP B-person
person NN I-NP I-person
checked VBD B-VP O
the DT B-NP O
car NN I-NP O
, , O O
she PRP O B-person
was VBD B-VP O
not RB O O
inside RB O O
. . B-VP O
   
+LOC NN B-NP B-problem
, , O O
GCS:14 NNP B-NP B-test
. . B-VP O
   
She PRP O B-person
ejected VBD B-VP O
. . B-VP O
   
She PRP O B-person
brought VBD B-VP O
by IN B-VP O
EMS NNP B-NP B-person
to TO O O
Nantucket NNP B-NP O
Cottage NNP I-NP O
Hospital NNP I-NP O
for IN B-VP O
furher JJR B-NP B-test
evaluation NN I-NP I-test
. . B-VP O
   
Past NNP B-NP O
Medical JJ B-NP O
History NN I-NP O
: : O O
1. CD O O
EtOH NNP B-NP O
addiction NN I-NP O
in IN B-VP O
past JJ O O
2. CD O O
h/o NN B-NP O
depression NN I-NP B-problem
3. CD O O
? . B-VP O
h/o NN B-NP O
hypomania VBD B-VP B-problem
4. CD O O
L5-S1 JJ B-NP B-problem
spondylolisthesis NN I-NP I-problem
all DT O O
: : O O
no DT B-NP O
known JJ I-NP B-problem
drug NN I-NP I-problem
allergies NNS I-NP I-problem
Social NNP I-NP O
History NN I-NP O
: : O O
divorced VBN O O
twice RB O O
. . B-VP O
   
smokes NNS B-NP O
1ppd CD O O
for IN B-VP O
many JJ B-NP O
years NNS I-NP O
, , O O
no DT B-NP O
EtOH NNP I-NP O
or CC O O
illicit JJ B-NP O
drug NN I-NP O
use NN I-NP O
. . B-VP O
   
Family JJ B-NP B-person
History NN I-NP O
: : O O
brother NN B-NP B-person
who WP O B-person
was VBD B-VP O
alcoholic JJ B-NP O
Physical NNP I-NP O
Exam NNP I-NP O
: : O O
O NN B-NP O
: : O O
T NN B-NP B-test
: : O O
100.1 CD O O
BP NNP B-NP B-test
: : O O
162/84 CD O O
HR NNP B-NP B-test
: : O O
80 CD O O
RR NN B-NP B-test
: : O O
20 CD O O
O2Sats NNS B-NP B-test
: : O O
100 CD O O
Gen NN B-NP O
: : O O
lying NN B-NP O
in IN B-VP O
strecther NN B-NP O
, , O O
NAD NNP B-NP B-problem
, , O O
shaking VBG O B-problem
om JJ B-NP I-problem
bilateral JJ I-NP I-problem
lower JJR I-NP I-problem
extremities NNS I-NP I-problem
. . B-VP O
   
HEENT NN B-NP O
: : O O
Neck NN B-NP O
Supple NNP I-NP O
, , O O
right RB O O
CMED NNP B-NP O
CCU NNP I-NP O
ecchymotic JJ O B-problem
and CC O O
edematous JJ O B-problem
, , O O
c-collor NN B-NP B-treatment
in IN B-VP O
place NN B-NP O
. . B-VP O
   
Lungs NNS B-NP O
: : O O
CTA NNP B-NP O
bilaterally RB O O
. . B-VP O
   
Cardiac JJ O O
: : O O
RRR NNP B-NP O
. . B-VP O
   
S1/S2 NNP B-NP O
. . B-VP O
   
Abd NNP B-NP O
: : O O
Soft JJ O O
, , O O
NT NNP B-NP B-problem
, , O O
BS+ NNP B-NP O
Extrem NNP I-NP O
: : O O
Cool NNP B-NP O
, , O O
No NNP B-NP O
C/C/E NNP I-NP B-problem
. . B-VP O
   
Neuro NN B-NP O
: : O O
Mental JJ B-NP O
status NN I-NP O
: : O O
Awake NNP B-NP O
and CC O O
alert NN B-NP O
, , O O
cooperative JJ O O
with IN B-VP O
exam JJ O B-test
, , O O
normal JJ B-NP O
affect NN I-NP O
. . B-VP O
   
Orientation NN B-NP O
: : O O
Oriented VBN O O
to TO O O
person NN B-NP O
, , O O
place NN B-NP O
, , O O
and CC O O
date NN B-NP O
. . B-VP O
   
Language NN B-NP O
: : O O
Speech JJ B-NP O
fluent NN I-NP O
with IN B-VP O
good JJ B-NP O
comprehension NN I-NP O
and CC O O
repetition NN B-NP O
. . B-VP O
   
Naming NNP B-NP O
intact JJ O O
. . B-VP O
   
No DT B-NP O
dysarthria NN I-NP B-problem
or CC O O
paraphasic JJ B-NP B-problem
errors NNS I-NP I-problem
. . B-VP O
   
Cranial JJ B-NP O
Nerves NNS I-NP O
: : O O
I: NNP B-NP O
Not RB O O
tested VBD B-VP O
II: NNP B-NP O
Pupils NNP I-NP O
equally RB O O
round VBD B-VP O
and CC O O
reactive JJ O O
to TO O O
light JJ O O
, , O O
3to CD O O
2 CD O O
mm NN B-NP O
bilaterally RB O O
. . B-VP O
   
Visual JJ B-NP O
fields NNS I-NP O
are VBP O O
full JJ O O
to TO O O
confrontation NN B-NP B-test
. . B-VP O
   
III NNP B-NP O
, , O O
IV NNP B-NP O
, , O O
VI: NNP B-NP O
Extraocular NNP I-NP O
movements NNS I-NP O
intact JJ O O
bilaterally RB O O
without IN B-VP O
nystagmus NN B-NP B-problem
. . B-VP O
   
V NNP B-NP O
, , O O
VII: NNP B-NP O
Facial NNP I-NP O
strength NN I-NP O
and CC O O
sensation NN B-NP O
intact JJ O O
and CC O O
symmetric JJ O O
. . B-VP O
   
VIII: NNP B-NP O
Hearing NNP I-NP O
intact JJ O O
to TO O O
finger VB O B-test
rub VB O I-test
bilaterally RB O O
. . B-VP O
   
IX NNP B-NP O
, , O O
X: NNP B-NP O
Palatal NNP I-NP O
elevation NN I-NP O
symmetrical NN I-NP O
. . B-VP O
   
XI: CC O O
Sternocleidomastoid NNP B-NP O
and CC O O
trapezius VB O O
normal JJ O O
bilaterally RB O O
. . B-VP O
   
XII: NNP B-NP O
Tongue NNP I-NP O
midline NN I-NP O
without IN B-VP O
fasciculations NNS B-NP B-problem
. . B-VP O
   
Motor NNP B-NP O
: : O O
Normal JJ B-NP O
bulk NN I-NP O
and CC O O
tone NN B-NP O
bilaterally RB O O
. . B-VP O
   
No UH O O
abnormal JJ B-NP B-problem
movements NNS I-NP I-problem
, , O O
tremors NNS B-NP B-problem
. . B-VP O
   
Strength NNP B-NP B-test
full JJ B-NP O
power NN I-NP O
05-31 JJ B-NP O
execept NN I-NP O
Right NNP I-NP O
Dubord NNP I-NP O
03-31 NNP I-NP O
. . B-VP O
   
No NNP B-NP O
pronator NN I-NP B-problem
drift NN I-NP I-problem
Sensation NN I-NP B-test
: : O O
Intact JJ O O
to TO O O
light JJ B-NP B-test
touch NN I-NP I-test
, , O O
propioception NN B-NP B-test
, , O O
pinprick JJ B-NP B-test
execept NN I-NP O
decreased VBN O B-problem
sensation NN B-NP I-problem
L5-S1 NNP I-NP I-problem
distrubution NN I-NP I-problem
. . B-VP O
   
Reflexes NNS B-NP B-test
: : O O
Right NN B-NP O
: : O O
B NNP B-NP B-test
- : O O
2 CD O O
; : O O
T NNP B-NP B-test
- : O O
2 CD O O
; : O O
Br NNP B-NP B-test
- : O O
2 CD O O
; : O O
Pa NNP B-NP B-test
- : O O
2 CD O O
; : O O
Ac NNP B-NP B-test
- : O O
2 CD O O
Left VBD B-VP O
: : O O
B NNP B-NP B-test
- : O O
2 CD O O
; : O O
T NNP B-NP B-test
- : O O
2 CD O O
; : O O
Br NNP B-NP B-test
- : O O
2 CD O O
; : O O
Pa NNP B-NP B-test
- : O O
2 CD O O
; : O O
Ac NNP B-NP B-test
- : O O
2 CD O O
Toes NNP B-NP O
downgoing VBG O O
bilaterally RB O O
Coordination NNP B-NP O
: : O O
normal JJ B-NP O
finger-nose-finger JJ I-NP B-test
Pertinent JJ I-NP O
Results NNS I-NP O
: : O O
2013-03-27 JJ O O
12:59 CD O O
AM NNP B-NP O
URINE NNP I-NP B-test
COLOR NNP I-NP I-test
- : O O
Yellow JJ B-NP O
APPEAR NNP I-NP B-test
- : O O
Clear JJ B-NP O
SP NNP I-NP B-test
Stickney NNP I-NP I-test
- : O O
1.032 CD O O
2013-03-27 JJ O O
12:59 CD O O
AM NNP B-NP O
URINE NNP I-NP B-test
BLOOD NNP I-NP I-test
- : O O
NEG NNP B-NP O
NITRITE NNP I-NP B-test
- : O O
NEG NNP B-NP O
PROTEIN NNP I-NP B-test
- : O O
TR NNP B-NP O
GLUCOSE NNP I-NP B-test
- : O O
NEG NNP B-NP O
KETONE NNP I-NP B-test
- : O O
50 CD O O
BILIRUBIN NNP B-NP B-test
- : O O
NEG NNP B-NP O
UROBILNGN NNP I-NP B-test
- : O O
1 CD O O
PH NNP B-NP B-test
- : O O
7.0 CD O O
LEUK NNP B-NP B-test
- : O O
NEG NNP B-NP O
2013-03-27 JJ O O
12:59 CD O O
AM NNP B-NP O
URINE NNP I-NP B-test
RBC- NNP I-NP I-test
0-2 JJ B-NP O
WBC NNP I-NP B-test
- : O O
0 CD O O
BACTERIA NNP B-NP B-test
- : O O
NONE NN B-NP O
YEAST NNP I-NP B-test
- : O O
NONE NN B-NP O
EPI NNP I-NP B-test
- : O O
0-2 JJ O O
2013-03-27 JJ O O
12:59 CD O O
AM NNP B-NP O
WBC NNP I-NP B-test
- : O O
5.0 CD O O
RBC NNP B-NP B-test
- : O O
4.23 CD O O
HGB NNP B-NP B-test
- : O O
13.4 CD O O
HCT NNP B-NP B-test
- : O O
38.5 CD O O
MCV NNP B-NP B-test
- : O O
91 CD O O
MCH NNP B-NP B-test
- : O O
31.8 CD O O
MCHC NNP B-NP B-test
- : O O
34.9 CD O O
RDW NNP B-NP B-test
- : O O
12.7 CD O O
2013-03-27 JJ O O
12:59 CD O O
AM NNP B-NP O
PLT NNP I-NP B-test
COUNT NNP I-NP I-test
- : O O
213 CD O O
2013-03-27 JJ O O
12:59 CD O O
AM NNP B-NP O
URINE NNP I-NP B-test
bnzodzpn SYM O I-test
- : O O
NEG NNP B-NP O
barbitrt SYM O B-test
- : O O
NEG NN B-NP O
opiates VBZ O B-test
- : O O
NEG NNP B-NP O
cocaine NN I-NP B-test
- : O O
NEG NNP B-NP O
amphetmn SYM O B-test
- : O O
POS NNP B-NP O
mthdone SYM O B-test
- : O O
NEG NNP B-NP O
2013-03-27 JJ O O
01:09 CD O O
AM NNP B-NP O
HGB NNP I-NP B-test
- : O O
13.4 CD O O
calcHCT NN B-NP B-test
- : O O
40 CD O O
O2 NNP B-NP B-test
SAT NNP I-NP I-test
- : O O
95 CD O O
CARBOXYHB NNP B-NP B-test
- : O O
1.2 CD O O
MET NNP B-NP B-test
HGB NNP I-NP I-test
- : O O
0.2 CD O O
2013-03-27 JJ O O
12:59 CD O O
AM NNP B-NP O
UREA NNP I-NP B-test
N NNP I-NP I-test
- : O O
21 CD O O
* NN B-NP O
CREAT NNP I-NP B-test
- : O O
0.8 CD O O
2013-03-27 JJ O O
02:25 CD O O
AM NNP B-NP O
PT NNP I-NP B-test
- : O O
13.2 CD O O
* NN B-NP O
PTT NNP I-NP B-test
- : O O
22.9 CD O O
INR(PT) NNP B-NP B-test
- : O O
1.2 CD O O
* JJ B-NP O
Brief NNP I-NP O
Hospital NNP I-NP O
Course NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
admitted VBN O O
to TO O O
Nantucket NNP B-NP O
Cottage NNP I-NP O
Hospital NNP I-NP O
on IN B-VP O
2013-03-27 JJ O O
following VBG O O
a DT B-NP O
motor NN I-NP O
vehicle NN I-NP O
crash NN I-NP O
as IN B-VP O
described VBN O O
previously RB O O
. . B-VP O
   
Chest NNP B-NP B-test
and CC O I-test
pelvis JJ B-NP I-test
X-rays NNS I-NP I-test
were VBD B-VP O
negative JJ O O
for IN B-VP O
fractures NNS B-NP B-problem
. . B-VP O
   
A DT B-NP B-test
CT NN I-NP I-test
of IN B-VP I-test
her PRP$ O B-person
her PRP$ O I-test
head NN B-NP I-test
demonstrated VBD B-VP O
intraparenchymal JJ O B-problem
and CC O I-problem
extraaxial JJ B-NP I-problem
blood NN I-NP I-problem
( ( O I-problem
mostly RB O I-problem
subarachnoid VBN O I-problem
) ) O I-problem
in IN B-VP I-problem
bilateral JJ B-NP I-problem
cerebral JJ I-NP I-problem
hemispheres NNS I-NP I-problem
, , O O
right RB O O
greater JJR O O
than IN B-VP O
left JJR O O
, , O O
in IN B-VP O
a DT B-NP O
pattern NN I-NP O
indicating VBG O O
contrecoup JJ B-NP B-problem
injury NN I-NP I-problem
. . B-VP O
   
A DT B-NP B-test
CT NN I-NP I-test
of IN B-VP I-test
her PRP$ O B-person
her PRP$ O I-test
C-spine NNP B-NP I-test
revealed VBD B-VP O
a DT B-NP O
possible JJ I-NP O
fracture NN I-NP B-problem
of IN B-VP I-problem
right JJ B-NP I-problem
C7 NNP I-NP I-problem
pedicle NN I-NP I-problem
. . B-VP O
   
A DT B-NP B-test
CT NN I-NP I-test
of IN B-VP I-test
her PRP$ O B-person
her PRP$ O I-test
chest NN B-NP I-test
revealed VBD B-VP O
bliateral JJ B-NP B-problem
lung NN I-NP I-problem
nodules NNS I-NP I-problem
and CC O O
a DT B-NP B-problem
right JJ I-NP I-problem
thyroid NN I-NP I-problem
nodule NN I-NP I-problem
. . B-VP O
   
A DT B-NP B-test
CT NN I-NP I-test
of IN B-VP I-test
her PRP$ O B-person
her PRP$ O I-test
sinues NNS B-NP I-test
revealed VBD B-VP O
no DT B-NP O
fractures NNS I-NP B-problem
. . B-VP O
   
X-rays NNS B-NP B-test
of IN B-VP I-test
her PRP$ O B-person
her PRP$ O I-test
right NN B-NP I-test
lower RBR O I-test
extremity NN B-NP I-test
were VBD B-VP O
negative JJ O O
for IN B-VP O
any DT B-NP B-problem
acute JJ I-NP I-problem
injury NN I-NP I-problem
. . B-VP O
   
A DT B-NP O
neurosurgery JJ I-NP B-person
consult NN I-NP O
was VBD B-VP O
obtained VBN O O
. . B-VP O
   
Our PRP$ O B-person
recommendations NNS B-NP O
were VBD B-VP O
to TO O O
load VB O O
her PRP$ O B-person
with IN B-VP O
Dilantin NNP B-NP B-treatment
and CC O O
then RB O O
continue VB O O
at IN B-VP O
100 CD O O
mg NN B-NP O
PO NNP I-NP O
TID NNP I-NP O
. . B-VP O
   
The DT B-NP B-person
orthopedics NNS I-NP I-person
spine JJ B-NP I-person
service NN I-NP I-person
saw VBD B-VP O
her PRP$ O B-person
and CC O O
put VB O O
her PRP$ O B-person
in IN B-VP O
a DT O B-treatment
C-collar JJ O I-treatment
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
admitted VBN O O
to TO O O
the DT B-NP O
trauma NN I-NP O
ICU NNP I-NP O
. . B-VP O
   
A NNP B-NP B-test
repeat NN I-NP I-test
head NN I-NP I-test
CT NNP I-NP I-test
12 CD O O
hours NNS B-NP O
after IN B-VP O
the DT O O
first JJ O O
was VBD B-VP O
largely RB O O
unchanged JJ O O
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
transferred VBN O O
to TO O O
step VB O O
down RP O O
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
having VBG O O
some DT B-NP B-problem
pain NN I-NP I-problem
issues NNS I-NP I-problem
and CC O O
morphine NN B-NP B-treatment
was VBD B-VP O
making VBG O O
her PRP$ O B-person
" JJ B-NP O
jittery NN I-NP B-problem
." NN I-NP O
On IN B-VP O
HD NNP B-NP O
2 CD O O
she PRP O B-person
was VBD B-VP O
switched VBN O O
to TO O O
Fioricet NNP B-NP B-treatment
, , O O
which WDT O B-pronoun
helped VBD B-VP O
with IN B-VP O
her PRP$ O B-person
her PRP$ O B-problem
headaches NNS B-NP I-problem
. . B-VP O
   
A DT B-NP B-test
repeact JJ I-NP I-test
head NN I-NP I-test
CT NNP I-NP I-test
was VBD B-VP O
unchanged JJ O O
. . B-VP O
   
An DT B-NP B-test
MRI NN I-NP I-test
of IN B-VP I-test
her PRP$ O B-person
her PRP$ O I-test
C-spine NN B-NP I-test
was VBD B-VP O
done VBN O O
to TO O O
evaluate VB O O
for IN B-VP O
ligamentous JJ B-NP B-problem
injury NN I-NP I-problem
, , O O
but CC O O
this DT O B-pronoun
was VBD B-VP O
extremely RB O B-test
limited JJ B-NP I-test
examination NN I-NP I-test
due JJ O O
to TO O O
patient JJ B-NP B-person
motion NN I-NP O
and CC O O
the DT B-NP O
signal NN I-NP O
in IN B-VP O
the DT B-NP O
spinal JJ I-NP O
cord NN I-NP O
could MD O O
not RB O O
be VB O O
adequately RB O O
assessed VBN O O
for IN B-VP O
edema NN B-NP B-problem
. . B-VP O
   
As IN B-VP O
per IN B-VP O
CMED NNP B-NP B-person
CSRU NNP I-NP I-person
spine NN I-NP I-person
, , O O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
instructed VBN O O
to TO O O
follow-up NN B-NP O
in IN B-VP O
2 CD O O
weeks NNS B-NP O
for IN B-VP O
repeat NN B-NP B-test
X-rays NNS I-NP I-test
. . B-VP O
   
On IN B-VP O
discharge NN B-NP O
she PRP O B-person
was VBD B-VP O
awake RB O O
, , O O
alert NN B-NP O
and CC O O
orientated VBD B-VP O
X3 NNP B-NP O
with IN B-VP O
c/o JJ B-NP O
mild JJ I-NP B-problem
headache NN I-NP I-problem
. . B-VP O
   
She PRP O B-person
had VBD B-VP O
full JJ B-NP B-test
strength NN I-NP I-test
motor NN I-NP I-test
exam NN I-NP I-test
, , O O
no DT B-NP O
pronator NN I-NP B-problem
drift NN I-NP I-problem
and CC O O
PERRLA NNP B-NP O
with IN B-VP O
full JJ B-NP O
EOM NNP I-NP O
s. NN I-NP O
She PRP O B-person
was VBD B-VP O
ambulating VBG O O
without IN B-VP O
difficulties NNS B-NP B-problem
. . B-VP O
   
On IN B-VP O
04-01 JJ O O
she PRP O B-person
was VBD B-VP O
seen VBN O O
by IN B-VP O
physical JJ B-NP B-person
therapy NN I-NP I-person
was VBD B-VP O
thought VBN O O
to TO O O
benefit VB O O
from IN B-VP O
acute JJ B-NP B-treatment
rehabilitation NN I-NP I-treatment
. . B-VP O
   
She PRP O B-person
had VBD B-VP O
a DT B-NP B-test
head NN I-NP I-test
CT NNP I-NP I-test
prior RB O O
to TO O O
discharge VB O O
that DT O B-pronoun
showed VBD B-VP O
resolution NN B-NP O
of IN B-VP O
the DT B-NP B-problem
subarachnoid JJ I-NP I-problem
hemorrhage NN I-NP I-problem
. . B-VP O
   
Follow-up NNP B-NP O
in IN B-VP O
1 CD O O
month NN B-NP O
with IN B-VP O
neurosurgery NN B-NP B-person
for IN B-VP O
a DT B-NP B-test
repeat NN I-NP I-test
head NN I-NP I-test
CT NNP I-NP I-test
was VBD B-VP O
arranged VBN O O
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
discharged VBN O O
on IN B-VP O
fioricet NN B-NP B-treatment
and CC O O
dilantin NN B-NP B-treatment
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
counseled VBN O O
to TO O O
follow-up JJ O O
with IN B-VP O
her PRP$ O B-person
her PRP$ O B-person
PCP NNP B-NP I-person
F NNP I-NP O
6-12 JJ B-NP O
months NNS I-NP O
regading VBG O O
the DT B-NP B-problem
right JJ I-NP I-problem
thyroid NN I-NP I-problem
nodule NN I-NP I-problem
and CC O O
the DT B-NP B-problem
bilateral JJ I-NP I-problem
small JJ I-NP I-problem
lung NN I-NP I-problem
nodules NNS I-NP I-problem
seen VBN O O
on IN B-VP O
her PRP$ O B-person
her PRP$ O B-test
chest NN B-NP I-test
CT NNP I-NP I-test
. . B-VP O
   
Medications NNS B-NP O
on IN B-VP O
Admission NN B-NP O
: : O O
1. CD O O
celexa NN B-NP B-treatment
2. CD O O
premarin NN B-NP B-treatment
3. CD O O
trazodone NN B-NP B-treatment
4. CD O O
6-MP JJ O B-treatment
5. CD O O
Prednisone NNP B-NP B-treatment
Discharge NNP I-NP O
Medications NNP I-NP O
: : O O
1. CD O O
Phenytoin NNP B-NP B-treatment
Sodium NNP I-NP I-treatment
Extended VBD B-VP I-treatment
100 CD O O
mg NN B-NP O
Capsule NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Capsule NNP B-NP O
PO NNP I-NP O
TID NNP I-NP O
( ( O O
3 CD O O
times NNS B-NP O
a DT B-NP O
day NN I-NP O
) ) O O
for IN B-VP O
1 CD O O
months NNS B-NP O
. . B-VP O
   
Disp NNP B-NP O
:* VBD B-VP O
90 CD O O
Capsule NNP B-NP O
(s)* NNP I-NP O
Refills NNP I-NP O
:* VBZ O O
0 CD O O
* NN B-NP O
2. CD O O
Acetaminophen NNP B-NP B-treatment
- : O O
Caff NNP B-NP B-treatment
- : O O
Butalbital JJ B-NP B-treatment
504-61-78 JJ I-NP O
mg NN I-NP O
Capsule NNP I-NP O
Sig NNP I-NP O
: : O O
01-28 JJ B-NP O
Tablets NNS I-NP O
PO NNP I-NP O
Q4-6H NNP I-NP O
( ( O O
every DT O O
4 CD O O
to TO O O
6 CD O O
hours NNS B-NP O
) ) O O
as IN B-VP O
needed VBN O O
for IN B-VP O
1 CD O O
months NNS B-NP O
. . B-VP O
   
Disp NNP B-NP O
:* VBD B-VP O
60 CD O O
Tablet NNP B-NP O
(s)* NNP I-NP O
Refills NNP I-NP O
:* VBZ O O
0 CD O O
* NN B-NP O
3. CD O O
Citalopram NNP B-NP B-treatment
20 CD O O
mg NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Tablet NNP B-NP O
PO NNP I-NP O
DAILY NNP I-NP O
( ( O O
Daily NNP B-NP O
). VBZ O O
4. CD O O
Metoprolol NNP B-NP B-treatment
Tartrate NNP I-NP I-treatment
25 CD O O
mg NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Tablet NNP B-NP O
PO NNP I-NP O
BID NNP I-NP O
( ( O O
2 CD O O
times NNS B-NP O
a DT B-NP O
day NN I-NP O
). POS O O
5. CD O O
Hydromorphone NNP B-NP B-treatment
2 CD O O
mg NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
1-2 JJ B-NP O
Tablets NNS I-NP O
PO NNP I-NP O
Q4H NNP I-NP O
( ( O O
every DT O O
4 CD O O
hours NNS B-NP O
) ) O O
as IN B-VP O
needed VBN O O
for IN B-VP O
pain NN B-NP B-problem
. . B-VP O
   
Disp NNP B-NP O
:* VBD B-VP O
40 CD O O
Tablet NNP B-NP O
(s)* NNP I-NP O
Refills NNP I-NP O
:* VBZ O O
0 CD O O
* NN B-NP O
6. CD O O
Docusate NNP B-NP B-treatment
Sodium NNP I-NP I-treatment
100 CD O O
mg NN B-NP O
Capsule NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Capsule NNP B-NP O
PO NNP I-NP O
BID NNP I-NP O
( ( O O
2 CD O O
times NNS B-NP O
a DT B-NP O
day NN I-NP O
): NNP I-NP O
Use NNP I-NP O
while IN B-VP O
taking VBG O O
narcotics NNS B-NP B-treatment
. . B-VP O
   
7. CD O O
Phenytoin NNP B-NP B-treatment
Sodium NNP I-NP I-treatment
Extended VBD B-VP I-treatment
100 CD O O
mg NN B-NP O
Capsule NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Capsule NNP B-NP O
PO NNP I-NP O
TID NNP I-NP O
( ( O O
3 CD O O
times NNS B-NP O
a DT B-NP O
day NN I-NP O
). NNP I-NP O
Disp NNP I-NP O
:* VBD B-VP O
90 CD O O
Capsule NNP B-NP O
(s)* NNP I-NP O
Refills NNP I-NP O
:* VBZ O O
0 CD O O
* NN B-NP O
Discharge NNP I-NP O
Disposition NNP I-NP O
: : O O
Extended VBN O O
Care NNP B-NP O
Facility NNP I-NP O
: : O O
St. NNP B-NP O
Anne's NNP I-NP O
Hospital NNP I-NP O
- : O O
Burlington NNP B-NP O
Discharge NNP I-NP O
Diagnosis NNP I-NP O
: : O O
Head NNP B-NP B-problem
trauma NN I-NP I-problem
with IN B-VP O
subarachnoid JJ B-NP B-problem
hemorrhage NN I-NP I-problem
C7 NNP I-NP B-problem
fracture NN I-NP I-problem
Discharge NNP I-NP O
Condition NNP I-NP O
: : O O
neurologically RB O O
stable JJ B-NP O
Discharge NNP I-NP O
Instructions NNS I-NP O
: : O O
Call NN B-NP O
for IN B-VP O
severe JJ B-NP B-problem
headache NN I-NP I-problem
or CC O O
any DT B-NP B-problem
other JJ I-NP I-problem
problems NNS I-NP I-problem
. . B-VP O
   
Please NNP B-NP O
take VB O O
Fioricet NNP B-NP B-treatment
as IN B-VP O
directed VBN O O
for IN B-VP O
headaches NNS B-NP B-problem
. . B-VP O
   
Please NNP B-NP O
do VBP O O
not RB O O
drive VB O O
while IN B-VP O
on IN B-VP O
this DT O B-pronoun
this DT B-NP B-treatment
medication NN I-NP I-treatment
. . B-VP O
   
Please NNP B-NP O
continue VBP O O
to TO O O
wear VB O O
your PRP$ O B-person
your PRP$ O B-treatment
C-collar JJ O I-treatment
at IN B-VP O
all DT B-NP O
times NNS I-NP O
. . B-VP O
   
Please NNP B-NP O
continue VBP O O
Dilantin NNP B-NP B-treatment
as IN B-VP O
directed VBN O O
for IN B-VP O
seizure NN B-NP B-treatment
prophylaxis NN I-NP I-treatment
. . B-VP O
   
Followup JJ B-NP O
Instructions NNS I-NP O
: : O O
Follow VB O O
up RP O O
with IN B-VP O
Dr. NNP B-NP B-person
Kelley NNP I-NP I-person
in IN B-VP O
4 CD O O
weeks NNS B-NP O
with IN B-VP O
head NN B-NP B-test
CT NNP I-NP I-test
- : O O
call NN B-NP O
716 CD O O
3268 CD O O
Please NNP B-NP O
also RB O O
follow-up VBP O O
with IN B-VP O
Dr. NNP B-NP B-person
Obrecht NNP I-NP I-person
of IN B-VP O
CMED NNP B-NP O
CCU NNP I-NP O
spine NN I-NP O
in IN B-VP O
2 CD O O
weeks NNS B-NP O
for IN B-VP O
flexion NN B-NP B-test
/ CD O I-test
extension NN B-NP I-test
X-rays NNS I-NP I-test
(( VBP O O
228 CD O O
) ) O O
411-7660 NN B-NP O
) ) O O
Please NNP B-NP O
follow-up JJ O O
with IN B-VP O
your PRP$ O B-person
your PRP$ O B-person
PCP NNP B-NP I-person
N NNP I-NP O
6-12 JJ B-NP O
months NNS I-NP O
reguading VBG O O
the DT B-NP B-problem
right JJ I-NP I-problem
thyroid NN I-NP I-problem
nodule NN I-NP I-problem
and CC O O
the DT B-NP B-problem
bilateral JJ I-NP I-problem
small JJ I-NP I-problem
lung NN I-NP I-problem
nodules NNS I-NP I-problem
seen VBN O O
on IN B-VP O
your PRP$ O B-test
your PRP$ O B-person
chest NN B-NP I-test
CT NNPS I-NP I-test
. . B-VP O
   
Vernia NNP B-NP B-person
Diana NNP I-NP I-person
MD NNP I-NP I-person
76-016 JJ O O
Completed VBN O O
by IN B-VP O
: : O O
Sonya NNP B-NP B-person
Ramona NNP I-NP I-person
NP NNP I-NP I-person
80-AKY JJ B-NP O
2013-04-01 JJ I-NP O
@ NN I-NP O
1453 CD O O
Signed NNP B-NP O
electronically RB O O
by IN B-VP O
: : O O
DR. NNP B-NP B-person
Shirley NNP I-NP I-person
Bennett NNP I-NP I-person
on IN B-VP O
: : O O
Sandra NNP B-NP O
2013-05-02 CD O O
4:53 CD O O
PM NNP B-NP O
( ( O O
End NNP B-NP O
of IN B-VP O
Report NNP B-NP O
) ) O O
-EMPTYLINE- VBP O O
-DOCSTART- JJ O O
-EMPTYLINE- $ O O
320422564 CD O O
CTMC NNP B-NP O
09300549 CD O O
340424 CD O O
06/16/1997 CD O O
12:00:00 CD O O
AM NNP B-NP O
BILIARY NNP I-NP B-problem
OBSTRUCTION NNP I-NP I-problem
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date NNP I-NP O
: : O O
06/16/1997 CD O O
Report NNP B-NP O
Status NNP I-NP O
: : O O
Signed VBN O O
Discharge NNP B-NP O
Date NNP I-NP O
: : O O
06/18/1997 CD O O
PROBLEM NNP B-NP O
LIST NNP I-NP O
: : O O
1. CD O O
RECTAL NNP B-NP B-problem
CARCINOMA NNP I-NP I-problem
, , O O
STATUS NNP B-NP O
POST NNP I-NP O
PARTIAL NNP I-NP B-treatment
COLECTOMY NNP I-NP I-treatment
. . B-VP O
   
2. CD O O
METASTATIC NNP B-NP B-problem
COLON NNP I-NP I-problem
CARCINOMA NNP I-NP I-problem
. . B-VP O
   
3. CD O O
HYPERTENSION NNP B-NP B-problem
. . B-VP O
   
4. CD O O
AORTIC NNP B-NP B-problem
STENOSIS NNP I-NP I-problem
WITH NNP I-NP O
PORCINE NNP I-NP B-treatment
VALVE NNP I-NP I-treatment
. . B-VP O
   
5. CD O O
URINARY NNP B-NP B-problem
TRACT NNP I-NP I-problem
INFECTION NNP I-NP I-problem
. . B-VP O
   
6. CD O O
CHOLANGITIS NNP B-NP B-problem
. . B-VP O
   
7. CD O O
ANEMIA NNPS B-NP B-problem
. . B-VP O
   
HISTORY NNP B-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS NNP I-NP O
: : O O
This DT O B-pronoun
is VBZ O O
a DT O O
70 CD O O
year NN B-NP O
old JJ B-NP O
gentleman NN I-NP O
with IN B-VP O
metastatic JJ B-NP B-problem
rectal JJ I-NP I-problem
cancer NN I-NP I-problem
who WP O B-person
presented VBD B-VP O
with IN B-VP O
biliary JJ B-NP B-problem
obstruction NN I-NP I-problem
. . B-VP O
   
In IN B-VP O
the DT B-NP O
past NN I-NP O
, , O O
he PRP O B-person
had VBD B-VP O
biliary JJ B-NP B-treatment
stents NNS I-NP I-treatment
placed VBD B-VP O
which WDT O B-pronoun
clotted VBD B-VP O
off RP O O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
admitted VBN O O
to TO O O
the DT B-NP O
Short NNP I-NP O
Stay NNP I-NP O
Unit NNP I-NP O
for IN B-VP O
further JJ B-NP B-test
evaluation NN I-NP I-test
. . B-VP O
   
The DT B-NP O
day NN I-NP O
prior RB O O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
had VBD B-VP O
endoscopic VBN O B-test
retrograde NN B-NP I-test
cholangiopancreatography NN I-NP I-test
done VBN O O
with IN B-VP O
dilated JJ B-NP B-problem
ducts NNS I-NP I-problem
times NNS I-NP O
two CD O O
and CC O O
eventually RB O O
had VBD B-VP O
interventional JJ B-NP B-person
radiology NN I-NP I-person
attempt NN I-NP O
to TO O O
place NN B-NP O
percutaneous JJ B-NP B-treatment
drains NNS I-NP I-treatment
to TO O O
decompress VB O O
his PRP$ O B-person
biliary JJ B-NP O
tree NN I-NP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
had VBD B-VP O
two CD O B-treatment
drains NNS B-NP I-treatment
placed VBN O O
after IN B-VP O
a DT B-NP B-treatment
prolonged JJ I-NP I-treatment
course NN I-NP I-treatment
and CC O O
difficult JJ B-NP B-treatment
procedure NN I-NP I-treatment
. . B-VP O
   
After IN B-VP O
being VBG O O
transferred VBN O O
from IN B-VP O
the DT B-NP O
interventional JJ I-NP O
radiology NN I-NP O
table NN I-NP O
to TO O O
the DT B-NP O
stretcher NN I-NP O
, , O O
one CD O O
of IN B-VP O
his PRP$ O B-person
his PRP$ O B-treatment
lateral JJ B-NP I-treatment
percutaneous JJ I-NP I-treatment
drains NNS I-NP I-treatment
had VBD B-VP O
been VBN O O
pulled VBN O O
out RP O O
inadvertently RB O O
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
admitted VBN O O
to TO O O
the DT B-NP O
Short NNP I-NP O
Stay NNP I-NP O
Unit NNP I-NP O
, , O O
given VBN O O
Ancef NNP B-NP B-treatment
and CC O O
Gentamicin NNP B-NP B-treatment
per IN B-VP O
the DT B-NP B-person
team NN I-NP I-person
for IN B-VP O
antibiotic JJ B-NP B-treatment
prophylaxis NN I-NP I-treatment
and CC O O
observed VBD B-VP O
overnight RB O O
. . B-VP O
   
PAST NNP B-NP O
MEDICAL NNP I-NP O
HISTORY NNP I-NP O
: : O O
As IN B-VP O
above IN B-VP O
. . B-VP O
   
ALLERGIES NNS B-NP O
: : O O
None NN B-NP O
. . B-VP O
   
MEDICATIONS NNP B-NP O
ON NNP I-NP O
ADMISSION NNP I-NP O
: : O O
Cipro NNP B-NP B-treatment
500 CD O O
mg NN B-NP O
p.o. NN I-NP O
b.i.d. NN I-NP O
, , O O
Vasotec NNP B-NP B-treatment
10 CD O O
mg NN B-NP O
q.d. JJ B-NP O
SOCIAL NNP I-NP O
HISTORY NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
denies VBZ O O
any DT B-NP O
alcohol NN I-NP O
or CC O O
tobacco NN B-NP O
. . B-VP O
   
FAMILY NNP B-NP O
HISTORY NNP I-NP O
: : O O
Significant NN B-NP O
for IN B-VP O
colon NN B-NP B-problem
carcinoma NN I-NP I-problem
. . B-VP O
   
REVIEW NNP B-NP O
OF NNPS I-NP O
SYSTEMS NNP I-NP O
: : O O
Unremarkable JJ O O
. . B-VP O
   
PHYSICAL JJ B-NP O
EXAMINATION NN I-NP O
: : O O
Temperature NN B-NP B-test
was VBD B-VP O
99.1 CD O O
, , O O
blood NN B-NP B-test
pressure NN I-NP I-test
132/74 CD O O
, , O O
heart NN B-NP B-test
rate NN I-NP I-test
80 CD O O
, , O O
respirations NNS B-NP B-test
18 CD O O
, , O O
02 CD O B-test
sat VBD B-VP I-test
99% CD O O
on IN B-VP O
room NN B-NP O
air NN I-NP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
an DT B-NP O
alert NN I-NP O
, , O O
jaundiced VBD B-VP O
gentleman NN B-NP O
in IN B-VP O
no DT B-NP O
acute JJ I-NP B-problem
distress NN I-NP I-problem
. . B-VP O
   
LUNGS NN B-NP O
: : O O
were VBD B-VP O
clear JJ O O
to TO O O
auscultation NN B-NP B-test
. . B-VP O
   
HEART NN B-NP O
: : O O
had VBD B-VP O
a DT B-NP O
regular JJ I-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
with IN B-VP O
a DT B-NP B-problem
II NNP I-NP I-problem
/ NNP I-NP I-problem
VI NNP I-NP I-problem
systolic JJ B-NP I-problem
murmur NN I-NP I-problem
at IN B-VP I-problem
the DT B-NP I-problem
right JJ I-NP I-problem
sternal JJ I-NP I-problem
border NN I-NP I-problem
. . B-VP O
   
ABDOMEN NN B-NP O
: : O O
was VBD B-VP O
soft JJ O O
, , O O
nontender NN B-NP B-problem
, , O O
with IN B-VP O
good JJ B-NP O
bowel NN I-NP O
sounds NNS I-NP O
. . B-VP O
   
He PRP O B-person
had VBD B-VP O
midline NN B-NP B-treatment
catheter NN I-NP I-treatment
that WDT O B-pronoun
was VBD B-VP O
still RB O O
in IN B-VP O
place NN B-NP O
and CC O O
was VBD B-VP O
draining VBG O O
bile NN B-NP O
. . B-VP O
   
EXTREMITIES NNS B-NP O
: : O O
were VBD B-VP O
without IN B-VP O
edema NN B-NP B-problem
. . B-VP O
   
NEUROLOGICAL NN B-NP O
: : O O
exam NN B-NP B-test
within IN B-VP O
normal JJ B-NP O
limits NNS I-NP O
. . B-VP O
   
LABORATORY NN B-NP O
: : O O
White NNP B-NP B-test
count NN I-NP I-test
was VBD B-VP O
8.2 CD O O
, , O O
hematocrit NN B-NP B-test
35 CD O O
. . B-VP O
   
AST NNP B-NP B-test
was VBD B-VP O
175 CD O O
, , O O
ALT NNP B-NP B-test
76 CD O O
, , O O
LDH NNP B-NP B-test
454 CD O O
. . B-VP O
   
Total JJ B-NP B-test
bilirubin NN I-NP I-test
was VBD B-VP O
12 CD O O
and CC O O
direct JJ B-NP B-test
bilirubin NN I-NP I-test
8 CD O O
. . B-VP O
   
Alkaline NNP B-NP B-test
phosphatase NN I-NP I-test
was VBD B-VP O
372 CD O O
. . B-VP O
   
HOSPITAL NNP B-NP O
COURSE NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
admitted VBN O O
to TO O O
the DT B-NP O
Short NNP I-NP O
Stay NNP I-NP O
Unit NNP I-NP O
and CC O O
continued VBN O O
to TO O O
receive VB O O
antibiotics NNS B-NP B-treatment
overnight JJ O O
. . B-VP O
   
The DT B-NP O
next JJ I-NP O
morning NN I-NP O
, , O O
he PRP O B-person
was VBD B-VP O
doing VBG O O
well RB O O
with IN B-VP O
the DT B-NP B-treatment
intact JJ I-NP I-treatment
drain NN I-NP I-treatment
draining VBG O O
bilious JJ B-NP O
material NN I-NP O
without IN B-VP O
any DT B-NP O
difficulty NN I-NP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
doing VBG O O
well RB O O
with IN B-VP O
minimal JJ O O
to TO O O
no DT O O
belly RB O B-problem
pain NN B-NP I-problem
and CC O O
no DT B-NP O
nausea NN I-NP B-problem
or CC O O
vomiting NN B-NP B-problem
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
taken VBN O O
back RB O O
to TO O O
surgery NN B-NP O
by IN B-VP O
the DT B-NP B-person
interventional JJ I-NP I-person
radiology NN I-NP I-person
team NN I-NP I-person
and CC O O
had VBD B-VP O
a DT B-NP B-treatment
second JJ I-NP I-treatment
drain NN I-NP I-treatment
placed VBD B-VP O
without IN B-VP O
any DT B-NP O
difficulty NN I-NP O
and CC O O
was VBD B-VP O
transferred VBN O O
back RB O O
to TO O O
the DT B-NP O
Short NNP I-NP O
Stay NNP I-NP O
Unit NNP I-NP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
observed VBN O O
overnight RB O O
without IN B-VP O
any DT B-NP B-problem
problems NNS I-NP I-problem
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
tolerating VBG O O
p.o. NN B-NP O
and CC O O
feeling VBG O O
back RB O O
to TO O O
his PRP$ O B-person
baseline NN B-NP O
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
discharged VBN O O
in IN B-VP O
stable JJ B-NP O
condition NN I-NP O
. . B-VP O
   
DISCHARGE JJ B-NP O
MEDICATIONS NNP I-NP O
: : O O
Same NN B-NP O
as IN B-VP O
admission NN B-NP O
. . B-VP O
   
He PRP O B-person
will MD O O
continue VB O O
Cipro NNP B-NP B-treatment
p.o. NN I-NP I-treatment
for IN B-VP O
prophylaxis NN B-NP B-treatment
. . B-VP O
   
FOLLOW-UP JJ O O
: : O O
Follow-up JJ O O
with IN B-VP O
Dr. NNP B-NP B-person
Loydsadd NNP I-NP I-person
in IN B-VP O
one CD O O
to TO O O
two CD O O
weeks NNS B-NP O
. . B-VP O
   
He PRP O B-person
is VBZ O O
also RB O O
to TO O O
have VB O O
AH NNP B-NP B-treatment
for IN B-VP O
his PRP$ O B-person
his PRP$ O B-treatment
home NN B-NP I-treatment
stent NN I-NP I-treatment
care NN I-NP I-treatment
. . B-VP O
   
Dictated VBN O O
By IN B-VP O
: : O O
Attending NN B-NP B-person
: : O O
LILLBI NNP B-NP B-person
FYFEBREUN NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
KE15 NNP I-NP O
TB326/0625 NNP I-NP O
Batch NNP I-NP O
: : O O
56777 CD O O
Index NNP B-NP O
No. NN I-NP O
M2ZRS51Y3Q NNP I-NP O
D NNP I-NP O
: : O O
06/18/97 CD O O
T NN B-NP O
: : O O
06/21/97 CD O O
-EMPTYLINE- NN B-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
﻿Admission NN I-NP O
Date NNP I-NP O
: : O O
2014-07-24 JJ B-NP O
Discharge NN I-NP O
Date NNP I-NP O
: : O O
2014-08-09 JJ B-NP O
Date NNP I-NP O
of IN B-VP O
Birth NNP B-NP O
: : O O
1946-08-07 JJ B-NP O
Sex NN I-NP O
: : O O
F NNP B-NP O
Service NNP I-NP O
: : O O
BLUE NNP B-NP O
GENERAL NNP I-NP O
SURGERY NNP I-NP O
HISTORY NNP I-NP O
OF IN B-VP O
THE NNP B-NP O
PRESENT NNP I-NP O
ILLNESS NNP I-NP O
: : O O
Mrs. NNP B-NP B-person
Gonzalez NNP I-NP I-person
is VBZ O O
a DT B-NP O
patient NN I-NP O
with IN B-VP O
a DT B-NP O
prior JJ I-NP O
medical JJ I-NP O
history NN I-NP O
including VBG O O
hypothyroidism NN B-NP B-problem
, , O O
iron-deficiency NN B-NP B-problem
anemia NN I-NP I-problem
, , O O
osteoporosis NN B-NP B-problem
, , O O
increased VBD B-VP B-problem
cholesterol NN B-NP I-problem
, , O O
peptic JJ B-NP B-problem
ulcer NN I-NP I-problem
disease NN I-NP I-problem
, , O O
chronic JJ B-NP B-problem
constipation NN I-NP I-problem
, , O O
and CC O O
status NN B-NP O
post NN I-NP O
appendectomy NN I-NP B-treatment
as RB O O
well RB O O
as IN B-VP O
status NN B-NP O
post NN I-NP O
hysterectomy NN I-NP B-treatment
and CC O O
bilateral JJ B-NP B-treatment
salpingo-oophorectomy NN I-NP I-treatment
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
transferred VBN O O
from IN B-VP O
an DT B-NP O
outside JJ I-NP O
hospital NN I-NP O
for IN B-VP O
evaluation NN B-NP B-test
and CC O O
treatment NN B-NP B-treatment
of IN B-VP O
adenocarcinoma NN B-NP B-problem
involving VBG O O
the DT B-NP O
transverse NN I-NP O
colon NN I-NP O
and CC O O
gallbladder NN B-NP O
. . B-VP O
   
At IN B-VP O
the DT B-NP O
outside JJ I-NP O
hospital NN I-NP O
the DT B-NP B-person
patient NN I-NP I-person
had VBD B-VP O
already RB O O
seemed VBN O O
some DT B-NP B-test
workup NN I-NP I-test
for IN B-VP O
a DT B-NP O
couple JJ I-NP O
weeks NNS I-NP O
duration NN I-NP O
of IN B-VP O
bilateral JJ B-NP B-problem
upper JJ I-NP I-problem
quadrant NN I-NP I-problem
pain NN I-NP I-problem
which WDT O B-pronoun
occasionally RB O O
radiated VBD B-VP O
to TO O O
her PRP$ O B-person
back NN B-NP O
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
also RB O O
complaining VBG O O
of IN B-VP O
fatigue NN B-NP B-problem
for IN B-VP O
two CD O O
weeks NNS B-NP O
but CC O O
a DT B-NP O
good JJ I-NP O
appetite NN I-NP O
and CC O O
the DT B-NP B-person
patient NN I-NP I-person
denied VBD B-VP O
weight JJ B-NP B-problem
loss NN I-NP I-problem
, , O O
melena NN B-NP B-problem
, , O O
or CC O O
bright RB O B-problem
red JJ B-NP I-problem
blood NN I-NP I-problem
per IN B-VP I-problem
rectum NN B-NP I-problem
. . B-VP O
   
A DT B-NP B-test
CAT JJ I-NP I-test
scan NN I-NP I-test
of IN B-VP I-test
the DT B-NP I-test
abdomen NNS I-NP I-test
showed VBD B-VP O
air-fluid JJ B-NP B-problem
levels NNS I-NP I-problem
in IN B-VP I-problem
the DT B-NP I-problem
gallbladder NN I-NP I-problem
. . B-VP O
   
It PRP O B-pronoun
also RB O O
showed VBD B-VP O
a DT B-NP B-problem
thickened JJ I-NP I-problem
gallbladder NN I-NP I-problem
wall NN I-NP I-problem
as RB O O
well RB O O
as IN B-VP O
a DT B-NP B-problem
dilated JJ I-NP I-problem
common JJ I-NP I-problem
bile NN I-NP I-problem
duct NN I-NP I-problem
. . B-VP O
   
Incidentally RB O O
, , O O
it PRP O B-pronoun
also RB O O
showed VBD B-VP O
diverticulosis NN B-NP B-problem
. . B-VP O
   
A DT B-NP B-test
HIDA JJ I-NP I-test
scan NN I-NP I-test
at IN B-VP O
the DT B-NP O
other JJ I-NP O
hospital NN I-NP O
did VBD B-VP O
not RB O O
show VB O O
filling NN B-NP B-problem
of IN B-VP I-problem
the DT B-NP I-problem
gallbladder NN I-NP I-problem
indicating VBG O O
some DT B-NP O
sort NN I-NP O
of IN B-VP O
cystic JJ B-NP B-problem
duct NN I-NP I-problem
obstruction NN I-NP I-problem
. . B-VP O
   
The DT B-NP B-test
first JJ I-NP I-test
imaging NN I-NP I-test
study NN I-NP I-test
that WDT O B-pronoun
was VBD B-VP O
done VBN O O
at IN B-VP O
Hahnemann NNP B-NP O
General NNP I-NP O
Hospital NNP I-NP O
was VBD B-VP O
a DT B-NP B-test
MRCP NNP I-NP I-test
which WDT O B-pronoun
revealed VBD B-VP O
an DT B-NP B-problem
enhanced JJ I-NP I-problem
thickened JJ I-NP I-problem
gallbladder NN I-NP I-problem
wall NN I-NP I-problem
consistent NN I-NP O
with IN B-VP O
chronic JJ B-NP B-problem
cholecystitis NN I-NP I-problem
. . B-VP O
   
A DT O O
differential JJ O O
according VBG O O
to TO O O
the DT B-NP B-test
imaging NN I-NP I-test
included VBD B-VP O
a DT B-NP B-problem
fistula NN I-NP I-problem
with IN B-VP O
adjacent JJ B-NP B-problem
inflammatory JJ I-NP I-problem
change NN I-NP I-problem
but CC O O
also RB O O
carcinoma VBD B-VP B-problem
or CC O O
adenomatosis NN B-NP B-problem
. . B-VP O
   
In IN B-VP O
addition, NN B-NP O
also RB O O
the DT B-NP B-test
MRCP NNP I-NP I-test
showed VBD B-VP O
a DT B-NP B-problem
mass NN I-NP I-problem
near IN B-VP O
the DT B-NP O
region NN I-NP O
of IN B-VP O
the DT B-NP O
neck NN I-NP O
of IN B-VP O
the DT B-NP O
gallbladder NN I-NP O
. . B-VP O
   
Of IN B-VP O
note NN B-NP O
, , O O
at IN B-VP O
the DT B-NP O
outside JJ I-NP O
hospital NN I-NP O
, , O O
an DT B-NP B-test
endoscopy NN I-NP I-test
and CC O O
colonoscopy NN B-NP B-test
were VBD B-VP O
performed VBN O O
. . B-VP O
   
The DT B-NP B-test
colonoscopy NN I-NP I-test
showed VBD B-VP O
two CD O B-problem
polyps NNS B-NP I-problem
and CC O O
also RB O O
a DT B-NP O
region NN I-NP O
in IN B-VP O
the DT B-NP O
transverse NN I-NP O
colon NN I-NP O
that WDT O B-pronoun
was VBD B-VP O
biopsied VBN O O
. . B-VP O
   
This DT O B-pronoun
This DT B-NP B-test
biopsy NN I-NP I-test
came VBD B-VP O
back RB O O
as IN B-VP O
positive JJ O O
for IN B-VP O
adenocarcinoma NN B-NP B-problem
. . B-VP O
   
The DT B-NP O
diagnosis NN I-NP O
of IN B-VP O
adenocarcinoma NN B-NP B-problem
was VBD B-VP O
already RB O O
established VBN O O
prior RB O O
to TO O O
her PRP$ O B-person
admission NN B-NP O
at IN B-VP O
this DT B-NP B-pronoun
hospital NN I-NP O
. . B-VP O
   
HOSPITAL NNP B-NP O
COURSE NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
scheduled VBN O O
for IN B-VP O
an DT B-NP O
operative JJ I-NP O
date NN I-NP O
on IN B-VP O
2014-07-29 JJ O O
and CC O O
over IN B-VP O
the DT B-NP O
next JJ I-NP O
few JJ I-NP O
days NNS I-NP O
she PRP O B-person
was VBD B-VP O
given VBN O O
a DT B-NP B-treatment
low-residual JJ I-NP I-treatment
diet NN I-NP I-treatment
. . B-VP O
   
She PRP O B-person
had VBD B-VP O
her PRP O B-person
belly RB O O
cleaned VBD B-VP O
with IN B-VP O
Hibiclens NNP B-NP B-treatment
one CD O O
a DT B-NP O
day NN I-NP O
and CC O O
once RB O O
an DT B-NP B-test
adequate JJ I-NP I-test
preoperative JJ I-NP I-test
evaluation NN I-NP I-test
was VBD B-VP O
performed VBN O O
, , O O
she PRP O B-person
was VBD B-VP O
given VBN O O
a DT B-NP B-treatment
bowel NN I-NP I-treatment
prep NN I-NP I-treatment
on IN B-VP O
Monday NNP B-NP O
afternoon NN I-NP O
and CC O O
evening NN B-NP O
in IN B-VP O
preparation NN B-NP O
for IN B-VP O
an DT B-NP B-test
exploratory JJ I-NP O
laparotomy NN I-NP O
on IN B-VP O
Tuesday NNP B-NP O
, , O O
2014-07-29 JJ O O
. . B-VP O
   
On IN B-VP O
the DT B-NP O
morning NN I-NP O
of IN B-VP O
2014-07-29 JJ O O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
taken VBN O O
to TO O O
the DT B-NP O
Operating NN I-NP O
Room NNP I-NP O
and CC O O
underwent VBD B-VP O
a DT B-NP B-treatment
cholecystectomy NN I-NP I-treatment
, , O O
partial JJ B-NP B-treatment
hepatectomy NN I-NP I-treatment
, , O O
partial JJ B-NP B-treatment
lymph NN I-NP I-treatment
node NN I-NP I-treatment
dissection NN I-NP I-treatment
, , O O
a DT B-NP B-treatment
colocolostomy NN I-NP I-treatment
, , O O
partial JJ B-NP B-treatment
colectomy NN I-NP I-treatment
, , O O
and CC O O
in IN B-VP O
addition NN B-NP O
a DT B-NP B-treatment
gastrostomy NN I-NP I-treatment
and CC O O
a DT B-NP B-treatment
feeding JJ I-NP I-treatment
jejunostomy NN I-NP I-treatment
were VBD B-VP O
also RB O O
put VBN O O
in IN B-VP O
place NN B-NP O
. . B-VP O
   
Please VB O O
refer NN B-NP O
to TO O O
the DT O O
previously RB O O
dictated VBN O O
operative JJ B-NP O
notes NNS I-NP O
for IN B-VP O
the DT B-NP O
details NNS I-NP O
of IN B-VP O
this DT O B-pronoun
this DT B-NP B-treatment
surgery NN I-NP I-treatment
. . B-VP O
   
Briefly NNP B-NP O
, , O O
the DT B-NP B-treatment
surgery NN I-NP I-treatment
on IN B-VP O
2014-07-29 JJ O O
revealed VBD B-VP O
a DT B-NP B-problem
carcinoma NN I-NP I-problem
of IN B-VP I-problem
the DT B-NP I-problem
gallbladder NN I-NP I-problem
with IN B-VP O
a DT B-NP B-problem
cholecystocolonic JJ I-NP I-problem
fistula NN I-NP I-problem
which WDT O B-pronoun
crossed VBD B-VP O
into IN B-VP O
the DT B-NP O
liver NN I-NP O
as RB O O
well RB O O
as IN B-VP O
metastatic JJ B-NP B-problem
adenopathy NN I-NP I-problem
around IN B-VP I-problem
the DT B-NP I-problem
portal JJ I-NP I-problem
nodes NNS I-NP I-problem
as RB O O
well RB O O
as IN B-VP O
retroperitoneal NN B-NP B-problem
nodes NNS I-NP I-problem
around IN B-VP I-problem
the DT B-NP I-problem
inferior JJ I-NP I-problem
vena NN I-NP I-problem
cava NN I-NP I-problem
and CC O I-problem
the DT B-NP I-problem
hepatic JJ I-NP I-problem
artery NN I-NP I-problem
. . B-VP O
   
In IN B-VP O
addition NN B-NP O
to TO O O
the DT B-NP B-treatment
gastrostomy NN I-NP I-treatment
and CC O O
feeding VBG O B-treatment
jejunostomy NN B-NP I-treatment
tube NN I-NP I-treatment
, , O O
two CD O B-treatment
Belmont-Gardner NN B-NP I-treatment
drains NNS I-NP I-treatment
were VBD B-VP O
placed VBN O O
. . B-VP O
   
The DT O B-person
The DT B-NP B-problem
patient JJ I-NP I-person
patient NN I-NP I-problem
's POS O I-problem
pain NN B-NP I-problem
postoperatively RB O O
was VBD B-VP O
controlled VBN O O
with IN B-VP O
an DT B-NP B-treatment
epidural JJ I-NP I-treatment
catheter NN I-NP I-treatment
. . B-VP O
   
However RB O O
, , O O
the DT O B-treatment
epidural JJ O I-treatment
had VBD B-VP O
the DT B-NP O
consequence NN I-NP O
of IN B-VP O
causing VBG O O
a DT B-NP O
bit NN I-NP O
of IN B-VP O
a DT B-NP B-problem
hypotension NN I-NP I-problem
in IN B-VP O
the DT B-NP B-person
patient NN I-NP I-person
and CC O O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
admitted VBN O O
to TO O O
the DT B-NP O
Surgical NNP I-NP O
ICU NNP I-NP O
for IN B-VP O
the DT B-NP O
first JJ I-NP O
postoperative JJ I-NP O
day NN I-NP O
. . B-VP O
   
In IN B-VP O
addition NN B-NP O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
had VBD B-VP O
low JJ B-NP B-problem
hematocrits NNS I-NP I-problem
which WDT O B-pronoun
required VBD B-VP O
a DT B-NP B-treatment
transfusion NN I-NP I-treatment
of IN B-VP I-treatment
packed JJ B-NP I-treatment
red JJ I-NP I-treatment
blood NN I-NP I-treatment
cells NNS I-NP I-treatment
. . B-VP O
   
In IN B-VP O
addition NN B-NP O
, , O O
on IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
number NN I-NP O
two CD O O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
transferred VBN O O
out RP O O
to TO O O
the DT B-NP O
floor NN I-NP O
and CC O O
she PRP O B-person
was VBD B-VP O
doing VBG O O
better RBR O O
in IN B-VP O
terms NNS B-NP O
of IN B-VP O
pain NN B-NP B-treatment
control NN I-NP I-treatment
on IN B-VP O
a DT B-NP B-treatment
Dilaudid NNP I-NP I-treatment
PCA NNP I-NP I-treatment
machine NN I-NP I-treatment
. . B-VP O
   
On IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
number NN I-NP O
two CD O O
, , O O
interestingly RB O O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
complaining VBG O O
of IN B-VP O
sensitivity NN B-NP B-problem
to TO O I-problem
light NN B-NP I-problem
from IN B-VP O
an DT B-NP O
unknown JJ I-NP O
etiology NN I-NP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
's POS O O
postoperative JJ B-NP O
course NN I-NP O
was VBD B-VP O
unremarkable JJ O O
aside RB O O
from IN B-VP O
the DT B-NP B-problem
photophobia NN I-NP I-problem
. . B-VP O
   
On IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
number NN I-NP O
two CD O O
, , O O
an DT B-NP B-person
Oncology NNP I-NP I-person
consult NN I-NP I-person
with IN B-VP O
Dr. NNP B-NP B-person
Natalie NNP I-NP I-person
Mcalister NNP I-NP I-person
was VBD B-VP O
obtained VBN O O
and CC O O
follow-up JJ B-NP O
appointments NNS I-NP O
were VBD B-VP O
scheduled VBN O O
with IN B-VP O
him PRP O B-person
as IN B-VP O
an DT B-NP O
outpatient NN I-NP O
. . B-VP O
   
Following VBG O O
that IN B-VP B-pronoun
, , O O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
slowly RB O O
advanced JJ O O
to TO O O
clear JJ B-NP B-treatment
liquids NNS I-NP I-treatment
and CC O O
to TO O O
a DT B-NP O
regular JJ I-NP O
diet NN I-NP O
once IN B-VP O
her PRP$ O B-person
bowels NNS B-NP O
began VBD B-VP O
working VBG O O
when WRB O O
she PRP O B-person
began VBD B-VP O
having VBG O O
flatus NN B-NP O
. . B-VP O
   
Her PRP$ O B-person
bowel NN B-NP O
function NN I-NP O
was VBD B-VP O
slow JJ O O
to TO O O
develop VB O O
and CC O O
she PRP O B-person
needed VBD B-VP O
to TO O O
remain VB O O
n.p.o. JJ O B-treatment
until IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
number NN I-NP O
six CD O O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
also RB O O
given VBN O O
supplemental JJ B-NP B-treatment
tube NN I-NP I-treatment
feedings NNS I-NP I-treatment
to TO O O
supplement VB O O
her PRP$ O B-person
calories NNS B-NP O
and CC O O
caloric JJ B-NP O
intake NN I-NP O
. . B-VP O
   
On IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
number NN I-NP O
seven CD O O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
tolerating VBG O O
her PRP$ O B-person
her PRP$ O B-treatment
clear JJ B-NP I-treatment
liquid JJ I-NP I-treatment
diet NN I-NP I-treatment
and CC O O
her PRP$ O B-treatment
her PRP$ O B-person
tube NN B-NP I-treatment
feeds NNS I-NP I-treatment
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
started VBN O O
on IN B-VP O
p.o. NN B-NP B-treatment
medicines NNS I-NP I-treatment
and CC O O
her PRP$ O B-treatment
her PRP$ O B-person
first JJ B-NP I-treatment
Belmont-Gardner NNP I-NP I-treatment
drain NN I-NP I-treatment
was VBD B-VP O
pulled VBN O O
due JJ O O
to TO O O
scant JJ B-NP O
output NN I-NP O
. . B-VP O
   
By IN B-VP O
2014-08-09 JJ O O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
tolerating VBG O O
a DT B-NP O
full JJ I-NP O
solid JJ I-NP O
diet NN I-NP O
as RB O O
well RB O O
as IN B-VP O
her PRP$ O B-treatment
her PRP$ O B-person
tube NN B-NP I-treatment
feeds NNS I-NP I-treatment
. . B-VP O
   
Between IN B-VP O
the DT O O
two CD O O
of IN B-VP O
those DT O B-pronoun
, , O O
her PRP$ O B-person
caloric JJ B-NP O
intake NN I-NP O
was VBD B-VP O
sufficient JJ O O
for IN B-VP O
her PRP$ O B-person
to TO O O
sustain VB O O
herself PRP O B-person
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
discharged VBN O O
to TO O O
home NN B-NP O
with IN B-VP O
services NNS B-NP O
including VBG O O
tube JJ B-NP B-treatment
feedings NNS I-NP I-treatment
for IN B-VP O
her PRP$ O B-person
home NN B-NP O
care NN I-NP O
. . B-VP O
   
Therefore RB O O
, , O O
she PRP O B-person
was VBD B-VP O
discharged VBN O O
on IN B-VP O
2014-08-09 JJ O O
in IN B-VP O
good JJ B-NP O
condition NN I-NP O
. . B-VP O
   
DISCHARGE JJ B-NP O
DIAGNOSIS NNP I-NP O
: : O O
1. CD O O
Metastatic JJ B-NP B-problem
gallbladder NN I-NP I-problem
cancer NN I-NP I-problem
. . B-VP O
   
2. CD O O
Status NNP B-NP O
post NN I-NP O
cholecystectomy NN I-NP B-treatment
. . B-VP O
   
3. CD O O
Status NNP B-NP O
post NN I-NP O
transverse NN I-NP B-treatment
colectomy NN I-NP I-treatment
with IN B-VP O
anastomosis NN B-NP B-treatment
. . B-VP O
   
4. CD O O
G NNP B-NP B-treatment
tube NN I-NP I-treatment
placement NN I-NP I-treatment
. . B-VP O
   
5. CD O O
Feeding VBG O B-treatment
jejunostomy NN B-NP I-treatment
. . B-VP O
   
6. CD O O
Hypothyroidism NNP B-NP B-problem
. . B-VP O
   
7. CD O O
Blood NNP B-NP B-problem
loss NN I-NP I-problem
requiring VBG O O
transfusion NN B-NP B-treatment
. . B-VP O
   
DISCHARGE NNP B-NP O
MEDICATIONS NNP I-NP O
: : O O
1. CD O O
Levothyroxine NNP B-NP B-treatment
100 CD O O
micrograms NNS B-NP O
orally RB O O
once RB O O
a DT B-NP O
day NN I-NP O
. . B-VP O
   
2. CD O O
Pantoprazole NNP B-NP B-treatment
one CD O O
tablet NN B-NP O
once IN B-VP O
a DT B-NP O
day NN I-NP O
. . B-VP O
   
3. CD O O
Ambien NNP B-NP B-treatment
10 CD O O
mg NN B-NP O
orally RB O O
before RB O O
bed NN B-NP O
. . B-VP O
   
4. CD O O
Tylenol NNP B-NP B-treatment
# # O O
3 CD O O
one CD O O
tablet NN B-NP O
every DT O O
four CD O O
hours NNS B-NP O
as IN B-VP O
needed VBN O O
for IN B-VP O
pain NN B-NP B-problem
. . B-VP O
   
5. CD O O
Reglan NNP B-NP B-treatment
10 CD O O
mg NN B-NP O
four CD O O
times NNS B-NP O
a DT B-NP O
day NN I-NP O
before IN B-VP O
meals NNS B-NP O
and CC O O
at IN B-VP O
bedtime NN B-NP O
. . B-VP O
   
6. CD O O
Colace NNP B-NP B-treatment
100 CD O O
mg NN B-NP O
twice RB O O
a DT B-NP O
day NN I-NP O
. . B-VP O
   
DISCHARGE NNP B-NP O
INSTRUCTIONS NNP I-NP O
: : O O
Follow-up NN B-NP O
with IN B-VP O
the DT B-NP B-person
Visiting NNP I-NP I-person
Nurses NNP I-NP I-person
Association NNP I-NP I-person
to TO O O
arrange VB O O
assistance NN B-NP O
with IN B-VP O
her PRP$ O B-person
her PRP$ O B-treatment
tube NN B-NP I-treatment
feeding NN I-NP I-treatment
and CC O O
her PRP$ O B-person
activities NNS B-NP O
of IN B-VP O
daily JJ B-NP O
living NN I-NP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
is VBZ O O
also RB O O
scheduled VBN O O
for IN B-VP O
an DT B-NP O
appointment NN I-NP O
with IN B-VP O
Dr. NNP B-NP B-person
Patterson NNP I-NP I-person
approximately RB O O
two CD O O
weeks NNS B-NP O
after IN B-VP O
her PRP$ O B-person
discharge NN B-NP O
from IN B-VP O
the DT B-NP O
hospital NN I-NP O
. . B-VP O
   
Heather NNP B-NP B-person
FISCHER NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
91-657 CD O O
Dictated VBN O O
By IN B-VP O
: : O O
Raymond NNP B-NP B-person
Q. NNP I-NP I-person
Martinez NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
MEDQUIST36 NNP I-NP O
D NNP I-NP O
: : O O
2014-08-16 JJ O O
01:23 CD O O
T NN B-NP O
: : O O
2014-08-16 JJ O O
13:25 CD O O
JOB NNP B-NP O
#: VBD B-VP O
23786 CD O O
Signed VBN O O
electronically RB O O
by IN B-VP O
: : O O
DR. NNP B-NP B-person
Brian NNP I-NP I-person
S NNP I-NP I-person
Heath NNP I-NP I-person
on IN B-VP O
: : O O
Danielle NNP B-NP O
2014-08-28 CD O O
2:52 CD O O
PM NNP B-NP O
( ( O O
End NNP B-NP O
of IN B-VP O
Report NNP B-NP O
) ) O O
-EMPTYLINE- VBP O O
-DOCSTART- JJ O O
-EMPTYLINE- $ O O
333521954 CD O O
FIH NNP B-NP O
9558642 CD O O
616751 CD O O
7916543 CD O O
2/23/2005 CD O O
12:00:00 CD O O
AM NNP B-NP O
ED NNP I-NP O
Discharge NNP I-NP O
Summary NNP I-NP O
Unsigned VBD B-VP O
DIS NNP B-NP O
Report NNP I-NP O
Status NNP I-NP O
: : O O
Unsigned VBD B-VP O
ED NNP B-NP O
DISCHARGE NNP I-NP O
NOTIFICATION NNP I-NP O
/ NNP I-NP O
SUMMARY NNP I-NP O
WIEGNEIGH NNP I-NP B-person
, , O I-person
YLA NNP B-NP I-person
MRN NNP I-NP O
: : O O
9558642 CD O O
Age NNP B-NP O
: : O O
53y CD O O
REGISTRATION NNP B-NP O
DATE NNP I-NP O
: : O O
02/23/2005 CD O O
05:41 CD O O
AM JJ B-NP O
Provider NN I-NP B-person
: : O O
GETZSIEH NNP B-NP B-person
, , O I-person
M.D. NNP B-NP I-person
WORK NNP I-NP I-person
PRELIMINARY NNP I-NP O
REPORT NNP I-NP O
PCP NNP I-NP B-person
notified VBN O O
by IN B-VP O
MD NNP B-NP B-person
: : O O
Yes-Direct JJ B-NP O
contact NN I-NP O
with IN B-VP O
PCP NNP B-NP B-person
Discharge NNP I-NP O
Date NNP I-NP O
/ JJ B-NP O
Time NNP I-NP O
: : O O
02/23/2005 CD O O
13:38 CD O O
Discharge NN B-NP O
Status NNP I-NP O
: : O O
Discharged VBN O O
Condition NNP B-NP O
on IN B-VP O
Discharge NNP B-NP O
: : O O
Stable JJ B-NP O
Patient NNP I-NP B-person
States NNPS I-NP O
Complaint NNP I-NP O
: : O O
CHEST NN B-NP B-problem
PAIN NNP I-NP I-problem
/ NNP I-NP O
SOB NNP I-NP B-problem
Diagnosis NNP I-NP O
: : O O
R NNP B-NP B-problem
Lung NNP I-NP I-problem
Mass NNP I-NP I-problem
, , O O
likely JJ B-NP O
cancer NN I-NP B-problem
Treatment NNP I-NP O
Rendered NNP I-NP O
: : O O
Physical JJ B-NP B-test
Examination NN I-NP I-test
, , O O
Laboratory NNP B-NP B-test
Evaluation NNP I-NP I-test
, , O O
CXR NNP B-NP B-test
, , O O
Chest NNP B-NP B-test
CT NNP I-NP I-test
Discharge NNP I-NP O
Medications NNP I-NP O
: : O O
Vicodin NNP B-NP B-treatment
1-2 JJ B-NP O
TABS NNP I-NP O
PO NNP I-NP O
Q6H NNP I-NP O
PRN NNP I-NP O
pain NN I-NP B-problem
, , O O
# # O O
50 CD O O
, , O O
no DT B-NP O
refills NNS I-NP O
Disposition NNP I-NP O
, , O O
Follow NNP B-NP O
up RB O O
and CC O O
Instructions NNS B-NP O
to TO O O
Patient VB O B-person
: : O O
Oncologist NN B-NP B-person
, , O O
Dr. NNP B-NP B-person
Ala NNP I-NP I-person
Aixknoleskaysneighslemteelenortkote NNP I-NP I-person
, , O O
will MD O O
call VB O O
you PRP O B-person
will MD O O
your PRP$ O B-person
appt NN B-NP O
. . B-VP O
   
You PRP O B-person
can MD O O
call VB O O
576-598-7570 JJ O O
if IN B-VP O
you PRP O B-person
need VBP O O
to TO O O
reschedule VB O O
. . B-VP O
   
We PRP O B-person
are VBP O O
scheduling VBG O O
you PRP O B-person
for IN B-VP O
a DT B-NP B-test
needle JJ I-NP I-test
biopsy NN I-NP I-test
by IN B-VP O
interventional JJ B-NP B-person
radiology NN I-NP I-person
for IN B-VP O
some DT B-NP O
time NN I-NP O
in IN B-VP O
the DT B-NP O
next JJ I-NP O
week NN I-NP O
. . B-VP O
   
they PRP O B-pronoun
will MD O O
call VB O O
you PRP O B-person
to TO O O
set VB O O
up RP O O
appt NN B-NP O
. . B-VP O
   
PCP NNP B-NP B-person
Name NN I-NP O
: : O O
NIQUE NNP B-NP B-person
, , O I-person
TOYA NNP B-NP I-person
N NNP I-NP I-person
Provider NNP I-NP B-person
Number NNP I-NP O
: : O O
21636 CD O O
This DT B-NP B-pronoun
report NN I-NP O
was VBD B-VP O
created VBN O O
by IN B-VP O
WORK NNP B-NP B-person
, , O I-person
SHELLBETHA NNP B-NP I-person
, , O I-person
M.D. NNP B-NP I-person
02/23/2005 CD O O
01:59 CD O O
PM NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
Admission NNP I-NP O
Date NNP I-NP O
: : O O
2014-03-22 JJ B-NP O
Discharge NN I-NP O
Date NNP I-NP O
: : O O
2014-03-28 JJ B-NP O
Date NNP I-NP O
of IN B-VP O
Birth NNP B-NP O
: : O O
1983-03-15 JJ B-NP O
Sex NN I-NP O
: : O O
M NNP B-NP O
Service NNP I-NP O
: : O O
ORT NNP B-NP O
ADDENDUM NNP I-NP O
: : O O
Mr. NNP B-NP B-person
Olander NNP I-NP I-person
had VBD B-VP O
acute JJ B-NP B-problem
blood NN I-NP I-problem
loss NN I-NP I-problem
anemia NN I-NP I-problem
from IN B-VP O
the DT B-NP O
combination NN I-NP O
of IN B-VP O
the DT B-NP B-problem
gunshot NN I-NP I-problem
wound NN I-NP I-problem
to TO O I-problem
the DT B-NP I-problem
right JJ I-NP I-problem
distal NN I-NP I-problem
femur NN I-NP I-problem
as RB O O
well RB O O
as IN B-VP O
requirements NNS B-NP O
for IN B-VP O
urgent JJ B-NP B-treatment
open JJ I-NP I-treatment
reduction NN I-NP I-treatment
, , O O
internal JJ B-NP B-treatment
fixation NN I-NP I-treatment
. . B-VP O
   
His PRP$ O B-test
His PRP$ O B-person
hematocrit NN B-NP I-test
dropped VBD B-VP O
down RB O O
to TO O O
the DT B-NP O
level NN I-NP O
of IN B-VP O
20 CD O O
. . B-VP O
   
Although IN B-VP O
he PRP O B-person
remained VBD B-VP O
hemodynamically RB O O
stable JJ O O
, , O O
we PRP O B-person
elected VBD B-VP O
to TO O O
move VB O O
ahead RB O O
and CC O O
transfuse VB O O
him PRP O B-person
with IN B-VP O
nonautologous JJ B-NP B-treatment
PRBC NNP I-NP I-treatment
. . B-VP O
   
Bertha NNP B-NP B-person
Patrick NNP I-NP I-person
, , O I-person
MD NNP B-NP I-person
20AAQ CD O O
Dictated VBN O O
By IN B-VP O
: : O O
Rose NNP B-NP B-person
D. NNP I-NP I-person
Bordelon NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
MEDQUIST36 NNP I-NP O
D NNP I-NP O
: : O O
2014-04-11 JJ O O
13:18:08 CD O O
T NN B-NP O
: : O O
2014-04-12 JJ O O
09:36:49 CD O O
Job NNP B-NP O
#: VBD B-VP O
32074 CD O O
Signed VBN O O
electronically RB O O
by IN B-VP O
: : O O
DR. NNP B-NP B-person
Josefa NNP I-NP I-person
V. NNP I-NP I-person
Wynn NNP I-NP I-person
on IN B-VP O
: : O O
WED JJ O O
2014-04-16 JJ O O
2:19 CD O O
PM NNP B-NP O
( ( O O
End NNP B-NP O
of IN B-VP O
Report NNP B-NP O
) ) O O
-EMPTYLINE- VBP O O
-DOCSTART- JJ O O
-EMPTYLINE- $ O O
337702516 CD O O
WGH NNP B-NP O
9387380 CD O O
310695 CD O O
271735 CD O O
9/15/2000 CD O O
12:00:00 CD O O
AM NNP B-NP O
Discharge NNP I-NP O
Summary NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Report NNP I-NP O
Status NNP I-NP O
: : O O
Signed VBD B-VP O
DISCHARGE NNP B-NP O
SUMMARY NNP I-NP O
NAME NN I-NP O
: : O O
FREIERMLINKENEIGHCAABLINFARST NNP B-NP B-person
, , O I-person
ANEA NNP B-NP I-person
UNIT NNP I-NP O
NUMBER NNP I-NP O
: : O O
008-08-33 JJ B-NP O
ADMISSION NNP I-NP O
DATE NNP I-NP O
: : O O
09/15/2000 CD O O
DISCHARGE NNP B-NP O
DATE NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
admitted VBN O O
to TO O O
the DT B-NP O
hospital NN I-NP O
on IN B-VP O
July NNP B-NP O
12th CD O O
for IN B-VP O
a DT B-NP B-treatment
chole NN I-NP I-treatment
with IN B-VP O
a DT B-NP O
principle JJ I-NP O
diagnosis NN I-NP O
of IN B-VP O
recurrent NN B-NP B-problem
biliary JJ B-NP I-problem
colic NN I-NP I-problem
. . B-VP O
   
HISTORY NNP B-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
is VBZ O O
a DT O O
42 CD O O
year NN B-NP O
old JJ O O
with IN B-VP O
recurrent JJ B-NP B-problem
biliary JJ I-NP I-problem
colic NN I-NP I-problem
. . B-VP O
   
She PRP O B-person
has VBZ O O
had VBN O O
ultrasound VBN O B-problem
proven RB O I-problem
gallstones NNS B-NP I-problem
for IN B-VP O
ten JJ B-NP O
years NNS I-NP O
, , O O
seen VBN O O
on IN B-VP O
an DT B-NP B-test
earlier JJR I-NP I-test
obstetric JJ I-NP I-test
ultrasound NN I-NP I-test
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
has VBZ O O
had VBN O O
no DT B-NP O
symptoms NNS I-NP B-problem
until IN B-VP O
approximately RB O O
two CD O O
years NNS B-NP O
ago RB O O
when WRB O O
she PRP O B-person
began VBD B-VP O
having VBG O O
classic JJ B-NP B-problem
biliary JJ I-NP I-problem
colic NN I-NP I-problem
pain NN I-NP I-problem
with IN B-VP O
right JJ B-NP B-problem
upper JJ I-NP I-problem
quadrant NN I-NP I-problem
epigastric JJ B-NP I-problem
pain NN I-NP I-problem
radiating VBG O O
to TO O O
midback VB O O
with IN B-VP O
nausea NN B-NP B-problem
, , O O
but CC O O
without IN B-VP O
vomiting VBG O B-problem
. . B-VP O
   
Onset NNP B-NP O
was VBD B-VP O
an DT B-NP O
hour NN I-NP O
to TO O O
1 CD O O
hour NN B-NP O
after IN B-VP O
meals NNS B-NP O
, , O O
worse JJR O O
with IN B-VP O
greasy JJ B-NP O
meals NNS I-NP O
, , O O
lasting VBG O O
five CD O O
minutes NNS B-NP O
to TO O O
two CD O O
hours NNS B-NP O
. . B-VP O
   
Episodes NNS B-NP B-problem
have VBP O O
been VBN O O
increasing VBG O O
in IN B-VP O
frequency NN B-NP O
over IN B-VP O
the DT B-NP O
last JJ I-NP O
few JJ I-NP O
months NNS I-NP O
. . B-VP O
   
She PRP O B-person
has VBZ O O
had VBD B-VP O
no DT B-NP O
fevers NNS I-NP B-problem
, , O O
chills NNS B-NP B-problem
, , O O
respiratory NN B-NP B-problem
symptoms NNS I-NP I-problem
, , O O
diarrhea NN B-NP B-problem
, , O O
bright JJ B-NP B-problem
red JJ I-NP I-problem
blood NN I-NP I-problem
per IN B-VP I-problem
rectum NN B-NP I-problem
or CC O O
melena NN B-NP B-problem
. . B-VP O
   
She PRP O B-person
has VBZ O O
not RB O O
found VBN O O
any DT B-NP O
relieve NN I-NP O
with IN B-VP O
any DT O O
over IN B-VP B-treatment
the DT B-NP I-treatment
counter NN I-NP I-treatment
medications NNS I-NP I-treatment
. . B-VP O
   
She PRP O B-person
has VBZ O O
no DT B-NP O
family NN I-NP O
history NN I-NP O
of IN B-VP O
gallbladder NN B-NP B-problem
or CC O O
pancreatic JJ B-NP B-problem
disease NN I-NP I-problem
. . B-VP O
   
She PRP O B-person
has VBZ O O
had VBD B-VP O
no DT B-NP O
significant JJ I-NP O
weight JJ I-NP B-problem
loss NN I-NP I-problem
. . B-VP O
   
No DT B-NP O
anorexia NN I-NP B-problem
. . B-VP O
   
An DT B-NP B-test
ultrasound NN I-NP I-test
on IN B-VP O
1/25/00 CD O O
showed VBD B-VP O
six CD O B-problem
gallstones NNS B-NP I-problem
without IN B-VP O
cholecystitis NN B-NP B-problem
. . B-VP O
   
She PRP O B-person
has VBZ O O
no DT B-NP O
history NN I-NP O
of IN B-VP O
liver NN B-NP B-problem
disease NN I-NP I-problem
, , O O
hepatitis NN B-NP B-problem
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
is VBZ O O
from IN B-VP O
45 CD O O
Sidewonly NNP B-NP O
Blvd NNP I-NP O
, , O O
Fresa NNP B-NP O
Loharanleah NNP I-NP O
, , O O
Maryland NNP B-NP O
. . B-VP O
   
Has NNP B-NP O
lived VBN O O
in IN B-VP O
896 CD O O
Lokatspur NNP B-NP O
Pkwy NNP I-NP O
, , O O
Ingrich NNP B-NP O
Vepobuffh NNP I-NP O
, , O O
Indiana NNP B-NP O
for IN B-VP O
25 CD O O
years NNS B-NP O
and CC O O
works VBZ O O
as IN B-VP O
a DT B-NP O
teaching NN I-NP O
assistant NN I-NP O
in IN B-VP O
a DT B-NP O
second JJ I-NP O
grade NN I-NP O
in IN B-VP O
Satlnonew NNP B-NP O
Rollglend NNP I-NP O
Pabridrham NNP I-NP O
. . B-VP O
   
PAST NNP B-NP O
MEDICAL NNP I-NP O
HISTORY NNP I-NP O
: : O O
Significant NN B-NP O
for IN B-VP O
a DT B-NP B-treatment
left JJ I-NP I-treatment
ear NN I-NP I-treatment
operation NN I-NP I-treatment
approximately RB O O
30 CD O O
years NNS B-NP O
ago RB O O
with IN B-VP O
left JJ B-NP B-treatment
TM NNP I-NP I-treatment
reconstruction NN I-NP I-treatment
in IN B-VP O
December NNP B-NP O
1999 CD O O
at IN B-VP O
Hitch NNP B-NP O
Hospital NNP I-NP O
. . B-VP O
   
MEDS NNP B-NP O
ON NNP I-NP O
ADMISSION NNP I-NP O
: : O O
Only RB O O
multivitamins VBZ O B-treatment
. . B-VP O
   
ALLERGIES NNP B-NP O
: : O O
No DT B-NP O
known JJ I-NP B-problem
drug NN I-NP I-problem
allergies NNS I-NP I-problem
SOCIAL NNP I-NP O
HISTORY NN I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
denies VBZ O O
tobacco NN B-NP O
and CC O O
/ NN B-NP O
or CC O O
alcohol NN B-NP O
use NN I-NP O
. . B-VP O
   
REVIEW NNP B-NP O
OF NNPS I-NP O
SYSTEMS NNP I-NP O
: : O O
Noncontributory NN B-NP O
. . B-VP O
   
PHYSICAL JJ B-NP O
EXAMINATION NN I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
is VBZ O O
a DT O O
healthy JJ O O
appearing VBG O O
female JJ O O
looking VBG O O
her PRP$ O B-person
stated JJ B-NP O
age NN I-NP O
in IN B-VP O
no DT B-NP O
apparent JJ I-NP B-problem
distress NN I-NP I-problem
. . B-VP O
   
She PRP O B-person
is VBZ O O
anicteric JJ O B-problem
without IN B-VP O
rash NN B-NP B-problem
or CC O O
HEENT NNP B-NP O
. . B-VP O
   
Significant NNP B-NP O
for IN B-VP O
left JJ B-NP B-problem
TM NNP I-NP I-problem
scarring VBG O I-problem
without IN B-VP O
acute JJ B-NP B-problem
inflammation NN I-NP I-problem
or CC O O
drainage NN B-NP B-problem
. . B-VP O
   
Oropharynx NNP B-NP O
is VBZ O O
moist JJ O O
. . B-VP O
   
No DT B-NP O
lymphadenopathy NN I-NP B-problem
is VBZ O O
noted VBN O O
. . B-VP O
   
Thyroid NNP B-NP O
is VBZ O O
nonpalpable JJ O O
. . B-VP O
   
She PRP O B-person
is VBZ O O
without IN B-VP O
bruits NNS B-NP B-problem
or CC O O
JVD NNP B-NP B-problem
. . B-VP O
   
Lungs NNS B-NP O
are VBP O O
bilaterally RB O O
clear JJ O O
to TO O O
auscultation NN B-NP B-test
. . B-VP O
   
Cardiac NNP B-NP B-test
exam NN I-NP I-test
; : O O
she PRP O B-person
has VBZ O O
positive JJ B-NP O
S1 NNP I-NP O
, , O O
S2 NNP B-NP O
without IN B-VP O
murmur NN B-NP B-problem
, , O O
rub NN B-NP B-problem
or CC O O
gallop VB O B-problem
. . B-VP O
   
Rate NNP B-NP B-test
was VBD B-VP O
75 CD O O
. . B-VP O
   
Abdomen NNS B-NP O
is VBZ O O
soft JJ O O
and CC O O
nontender NN B-NP B-problem
without IN B-VP O
hepatosplenomegaly NN B-NP B-problem
or CC O O
mass NN B-NP B-problem
. . B-VP O
   
She PRP O B-person
has VBZ O O
no DT B-NP O
rebound NN I-NP B-problem
or CC O O
guarding NN B-NP B-problem
. . B-VP O
   
Her PRP$ O B-person
Her NNP B-NP B-test
rectal NN I-NP I-test
exam NN I-NP I-test
is VBZ O O
guaiac JJ O O
negative JJ O O
. . B-VP O
   
Her PRP$ O B-person
extremities NNS B-NP O
are VBP O O
without IN B-VP O
normal JJ B-NP O
limits NNS I-NP O
with IN B-VP O
+2 NN B-NP O
pulses NNS I-NP O
throughout IN B-VP O
. . B-VP O
   
She PRP O B-person
is VBZ O O
neurologically RB O O
intact JJ O O
. . B-VP O
   
HOSPITAL NNP B-NP O
COURSE NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
admitted VBN O O
for IN B-VP O
the DT B-NP B-treatment
lap NN I-NP I-treatment
coli NN I-NP I-treatment
with IN B-VP O
an DT B-NP B-test
intraoperative JJ I-NP I-test
cholangiogram NN I-NP I-test
by IN B-VP O
Dr. NNP B-NP B-person
Sterp NNP I-NP I-person
under IN B-VP O
general JJ B-NP B-treatment
anesthesia NN I-NP I-treatment
. . B-VP O
   
A DT B-NP O
separate JJ I-NP O
operative JJ I-NP O
note NN I-NP O
has VBZ O O
been VBN O O
dictated VBN O O
. . B-VP O
   
Operative JJ B-NP O
course NN I-NP O
and CC O O
recovery NN B-NP O
were VBD B-VP O
without IN B-VP O
complication NN B-NP B-problem
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
admitted VBN O O
to TO O O
floor NN B-NP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
afebrile RB O B-problem
, , O O
vital JJ B-NP B-test
signs NNS I-NP I-test
were VBD B-VP O
stable JJ O O
. . B-VP O
   
She PRP O B-person
is VBZ O O
taking VBG O O
po JJ B-NP O
&apos;s NN I-NP O
. . B-VP O
   
She PRP O B-person
is VBZ O O
ambulatory JJ O O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
will MD O O
be VB O O
discharged VBN O O
to TO O O
home NN B-NP O
in IN B-VP O
stable JJ B-NP O
condition NN I-NP O
with IN B-VP O
a DT O O
follow JJ O O
up RP O O
appointment NN B-NP O
with IN B-VP O
Dr. NNP B-NP B-person
Sterp NNP I-NP I-person
. . B-VP O
   
DISCHARGE NNP B-NP O
MEDICATIONS NNP I-NP O
: : O O
Percocet NNP B-NP B-treatment
5 CD O O
mg NN B-NP O
in IN B-VP O
325 CD O O
mg NN B-NP O
one CD O O
to TO O O
two CD O O
tabs NNS B-NP O
po VBP O O
q4 NN B-NP O
to TO O O
6 CD O O
prn NN B-NP O
pain NN I-NP B-problem
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
will MD O O
be VB O O
discharged VBN O O
in IN B-VP O
stable JJ B-NP O
condition NN I-NP O
. . B-VP O
   
Follow VB O O
up RP O O
as RB O O
mentioned VBN O O
will MD O O
be VB O O
with IN B-VP O
Dr. NNP B-NP B-person
Sterp NNP I-NP I-person
. . B-VP O
   
______________________ VB O O
SANTDEL NNP B-NP B-person
GLOTZRHALT NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
TR NNP I-NP O
: : O O
sxu NN B-NP O
DD NNP I-NP O
: : O O
09/15/2000 CD O O
TD NN B-NP O
: : O O
09/21/2000 CD O O
10:58 CD O O
P NNP B-NP O
cc NN I-NP O
: : O O
MINAQUEENALT NNP B-NP B-person
MASHINEUSSHA NNP I-NP I-person
STERP NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
Admission NNP I-NP O
Date NNP I-NP O
: : O O
2019-02-01 JJ B-NP O
Discharge NN I-NP O
Date NNP I-NP O
: : O O
2019-02-09 JJ B-NP O
Date NNP I-NP O
of IN B-VP O
Birth NNP B-NP O
: : O O
1940-04-28 JJ B-NP O
Sex NN I-NP O
: : O O
M NNP B-NP O
Service NNP I-NP O
: : O O
MEDICINE JJ B-NP O
Allergies NNS I-NP O
: : O O
Patient NN B-NP B-person
recorded VBD B-VP O
as IN B-VP O
having VBG O O
No NNP B-NP O
Known NNP I-NP B-problem
Allergies NNPS I-NP I-problem
to TO O O
Drugs NNP B-NP B-treatment
Attending NNP I-NP B-person
: : O O
Nicholas NNP B-NP B-person
E. NNP I-NP I-person
E. NNP I-NP I-person
Collard NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
Chief NNP I-NP O
Complaint NNP I-NP O
: : O O
Abdominal NNP B-NP B-problem
pain NN I-NP I-problem
Major NNP I-NP O
Surgical NNP I-NP O
or CC O O
Invasive JJ B-NP O
Procedure NN I-NP O
: : O O
Intubation NN B-NP O
ERCP NNP I-NP B-test
with IN B-VP O
stent JJ B-NP B-treatment
Blood NNP I-NP B-treatment
transfusion NN I-NP I-treatment
History NNP I-NP O
of IN B-VP O
Present NNP B-NP O
Illness NNP I-NP O
: : O O
Pt NNP B-NP B-person
is VBZ O O
a DT O O
78 CD O O
yo NN B-NP O
male NN I-NP O
with IN B-VP O
h/o PDT O O
A DT B-NP B-problem
fib NN I-NP I-problem
, , O O
s/p JJ B-NP O
multiple JJ I-NP B-problem
CVA NNP I-NP I-problem
s, NN I-NP O
CHF NNP I-NP B-problem
, , O O
HTN NNP B-NP B-problem
, , O O
DM2 NNP B-NP B-problem
admitted VBD B-VP O
to TO O O
Mediplex NNP B-NP O
Rehab NNP I-NP O
Hospital NNP I-NP O
Robert NNP I-NP O
on IN B-VP O
02-01 JJ O O
with IN B-VP O
abdominal JJ B-NP B-problem
pain NN I-NP I-problem
and CC O O
n/v NN B-NP B-problem
since IN B-VP O
that DT B-NP B-pronoun
morning NN I-NP O
. . B-VP O
   
Pt NNP B-NP B-test
Pt NNP I-NP B-person
's POS O I-test
vitals NNS B-NP I-test
on IN B-VP O
admission NN B-NP O
wer NN I-NP O
significant JJ O O
for IN B-VP O
T NNP B-NP B-test
104 CD O O
, , O O
SBP NNP B-NP B-test
100 CD O O
s, NN B-NP O
HR NNP I-NP B-test
in IN B-VP O
the DT O O
120 CD O O
s. NN B-NP O
RUQ NNP I-NP B-test
U/s NNP I-NP I-test
demonstrated VBD B-VP O
multiple JJ B-NP B-problem
small JJ I-NP I-problem
gallstones NNS I-NP I-problem
with IN B-VP O
sludges NNS B-NP B-problem
without IN B-VP O
evidence NN B-NP O
of IN B-VP O
pericholecystic JJ B-NP B-problem
fluid NN I-NP I-problem
or CC O O
significant JJ B-NP B-problem
dilatation NN I-NP I-problem
of IN B-VP I-problem
the DT B-NP I-problem
gallbladder NN I-NP I-problem
. . B-VP O
   
Surgery NN B-NP O
was VBD B-VP O
consulted VBN O O
for IN B-VP O
concern NN B-NP O
of IN B-VP O
cholangitis NN B-NP B-problem
with IN B-VP O
probable JJ B-NP O
sepsis NN I-NP B-problem
. . B-VP O
   
Pt NNP B-NP B-person
was VBD B-VP O
admitted VBN O O
to TO O O
the DT B-NP O
CMED NNP I-NP O
CCU NNP I-NP O
, , O O
intubated VBD B-VP B-treatment
overnight JJ O O
for IN B-VP O
ERCP NNP B-NP B-test
procedure NN I-NP I-test
and CC O O
fluid JJ B-NP B-treatment
resuscitation NN I-NP I-treatment
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
placed VBN O O
on IN B-VP O
zosyn NN B-NP B-treatment
. . B-VP O
   
Pt NNP B-NP B-test
Pt NNP I-NP B-person
's POS O I-test
INR NNP B-NP I-test
was VBD B-VP O
eleveted VBN O B-problem
as IN B-VP O
he PRP O B-person
was VBD B-VP O
on IN B-VP O
home NN B-NP B-treatment
coumadin NN I-NP I-treatment
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
given VBN O O
4 CD O B-treatment
units NNS B-NP I-treatment
FFP NNP I-NP I-treatment
in IN B-VP O
anticipation NN B-NP O
of IN B-VP O
ERCP NNP B-NP B-test
the DT B-NP O
following JJ I-NP O
day NN I-NP O
. . B-VP O
   
On IN B-VP O
02-02 JJ B-NP O
ERCP NNP I-NP B-test
demonstrated VBD B-VP O
a DT B-NP B-problem
large JJ I-NP I-problem
filling NN I-NP I-problem
defect NN I-NP I-problem
in IN B-VP I-problem
the DT B-NP I-problem
distal JJ I-NP I-problem
duct NN I-NP I-problem
representing VBG O O
a DT B-NP B-problem
stone NN I-NP I-problem
with IN B-VP O
CBD NNP B-NP B-problem
dilatation NN I-NP I-problem
. . B-VP O
   
A DT B-NP B-treatment
biliary JJ I-NP I-treatment
stent NN I-NP I-treatment
was VBD B-VP O
placed VBN O O
after IN B-VP O
the DT B-NP B-treatment
removal NN I-NP I-treatment
of IN B-VP O
the DT B-NP B-problem
stone NN I-NP I-problem
. . B-VP O
   
Pt NNP B-NP B-person
was VBD B-VP O
extubated VBN O O
the DT B-NP O
next JJ I-NP O
day NN I-NP O
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
then RB O O
transferred VBN O O
to TO O O
the DT B-NP O
medicine NN I-NP O
service NN I-NP O
. . B-VP O
   
Past NNP B-NP O
Medical JJ B-NP O
History NN I-NP O
: : O O
1) CD O O
Atrial NNP B-NP B-problem
fibrillation NN I-NP I-problem
2) CD O O
s/p NN B-NP O
MVR NNP I-NP B-treatment
( ( O I-treatment
mechanical JJ O I-treatment
) ) O I-treatment
3) CD O O
CHF NNP B-NP B-problem
EF NNP I-NP B-test
15% CD O O
4) CD O O
HTN NNP B-NP B-problem
5) CD O O
multiple JJ B-NP B-problem
CVA NNP I-NP I-problem
s NN I-NP O
( ( O O
last JJ O O
1998 CD O O
) ) O O
6) CD O O
Hypercholesterolemia $ O B-problem
7) CD O O
Type NNP B-NP B-problem
II NNP I-NP I-problem
DM NNP I-NP I-problem
8) CD O O
Multiple NNP B-NP B-problem
prior RB O I-problem
UTI NNP B-NP I-problem
Social NNP I-NP O
History NNP I-NP O
: : O O
Lives NNS B-NP O
in IN B-VP O
Danvers NNS B-NP O
with IN B-VP O
wife NN B-NP B-person
, , O O
denies VBZ O O
Timothy NNP B-NP O
or CC O O
alcohol NN B-NP O
. . B-VP O
   
Family JJ B-NP O
History NN I-NP O
: : O O
NC NNP B-NP O
Physical NNP I-NP O
Exam NNP I-NP O
: : O O
upon NN B-NP O
tx NN I-NP O
to TO O O
medicine VB O O
service NN B-NP O
T NNP I-NP B-test
: : O O
99.0 CD O O
; : O O
BP NNP B-NP B-test
142/61 CD O O
; : O O
Pulse NNP B-NP B-test
65 CD O O
; : O O
Resp NNP B-NP B-test
20 CD O O
; : O O
O2 NNP B-NP B-test
sat VBD B-VP I-test
96% CD O O
RA NNP B-NP O
Gen NNP I-NP O
- : O O
Alert NNP B-NP O
, , O O
no DT B-NP O
acute NN I-NP B-problem
distress NN I-NP I-problem
HEENT NNP I-NP O
- : O O
mucous JJ B-NP B-problem
membranes NNS I-NP I-problem
slightly RB O I-problem
dry JJ B-NP I-problem
Neck NNP I-NP O
- : O O
no DT B-NP O
JVD NNP I-NP B-problem
, , O O
no DT B-NP O
cervical JJ I-NP B-problem
lymphadenopathy NN I-NP I-problem
Chest NNP I-NP O
- : O O
CTA NNP B-NP O
b/l NN I-NP O
with IN B-VP O
good JJ B-NP O
air NN I-NP O
entry NN I-NP O
CV NNP I-NP O
- : O O
Normal NNP B-NP O
S1/S2 NNP I-NP O
, , O O
irreg NN B-NP B-problem
irreg NN I-NP I-problem
Abd NNP I-NP O
- : O O
Soft JJ O O
, , O O
nontender NN B-NP B-problem
, , O O
mild JJ B-NP B-problem
distension NN I-NP I-problem
, , O O
normoactive JJ B-NP O
bowel NN I-NP O
sounds VBZ O O
Extr NNP B-NP O
- : O O
No DT B-NP O
edema NN I-NP B-problem
. . B-VP O
   
2+ CD O O
DP NNP B-NP B-test
pulses NNS I-NP I-test
bilaterally RB O O
Neur NNP B-NP O
: : O O
A NNP B-NP O
& CC O O
O NNP B-NP O
X3 NNP I-NP O
, , O O
dysarthric JJ B-NP B-problem
speech NN I-NP I-problem
, , O O
CN NNP B-NP O
: : O O
mild NN B-NP B-problem
left VBD B-VP I-problem
facial JJ B-NP I-problem
droop NN I-NP I-problem
, , O O
o/w JJ O O
appears VBZ O O
intact JJ O O
; : O O
4/5 CD O O
strength NN B-NP O
on IN B-VP O
flex NN B-NP O
at IN B-VP O
elbows NNS B-NP O
b/l VBP O O
, , O O
legs JJ B-NP O
06-22 JJ I-NP O
strength NN I-NP O
, , O O
DTR NNP B-NP O
s VBZ O O
intact JJ O O
, , O O
sensation JJ B-NP O
intact JJ I-NP O
Skin NNP I-NP O
- : O O
No DT B-NP O
rash NN I-NP B-problem
Pertinent VBD B-VP O
Results NNS B-NP O
: : O O
ERCP JJ B-NP O
report NN I-NP O
: : O O
Four CD O B-test
fluoroscopic NN B-NP I-test
images NNS I-NP I-test
and CC O O
ERCP NNP B-NP B-test
are VBP O O
provided VBN O O
. . B-VP O
   
A DT B-NP B-problem
large JJ I-NP I-problem
filling NN I-NP I-problem
defect NN I-NP I-problem
is VBZ O O
seen VBN O O
in IN B-VP O
the DT B-NP O
distal JJ I-NP O
duct NN I-NP O
representing VBG O O
a DT B-NP B-problem
stone NN I-NP I-problem
. . B-VP O
   
The DT B-NP O
common JJ I-NP O
duct NN I-NP O
is VBZ O O
dilated VBN O B-problem
. . B-VP O
   
Subsequent JJ B-NP B-treatment
biliary JJ I-NP I-treatment
stent NN I-NP I-treatment
was VBD B-VP O
placed VBN O O
after IN B-VP O
the DT B-NP B-treatment
removal NN I-NP I-treatment
of IN B-VP O
the DT B-NP B-problem
stone NN I-NP I-problem
. . B-VP O
   
Blood NNP B-NP B-test
cultures NNS I-NP I-test
: : O O
2019-02-01 JJ O O
( ( O O
4 CD O O
of IN B-VP O
4 CD O O
bottles NNS B-NP O
) ) O O
E.coli NNP B-NP B-problem
CXR NNP I-NP B-test
: : O O
Pulmonary JJ B-NP B-problem
edema NN I-NP I-problem
. . B-VP O
   
ECHO NN B-NP B-test
: : O O
The DT B-NP O
left JJ I-NP O
atrium NN I-NP O
is VBZ O O
markedly RB O B-problem
dilated VBN O I-problem
. . B-VP O
   
There EX O O
is VBZ O O
mild JJ O B-problem
symmetric JJ O I-problem
left VBD B-VP I-problem
ventricular JJ B-NP I-problem
hypertrophy NN I-NP O
. . B-VP O
   
The DT B-NP O
left JJ I-NP O
ventricular JJ I-NP O
cavity NN I-NP O
is VBZ O O
moderately RB O B-problem
dilated VBN O I-problem
. . B-VP O
   
There EX O B-pronoun
is VBZ O O
moderate JJ O I-problem
global JJ O I-problem
left VBD B-VP I-problem
ventricular JJ B-NP I-problem
hypokinesis NN I-NP O
. . B-VP O
   
Overall JJ O O
left VBD B-VP O
ventricular JJ B-NP O
systolic JJ I-NP O
function NN I-NP O
is VBZ O O
moderately RB O B-problem
depressed JJ O I-problem
. . B-VP O
   
Right JJ B-NP B-test
ventricular JJ I-NP I-test
chamber NN I-NP I-test
size NN I-NP I-test
and CC O O
free JJ B-NP O
wall NN I-NP O
motion NN I-NP O
are VBP O O
normal JJ O O
. . B-VP O
   
Right JJ B-NP B-test
ventricular JJ I-NP I-test
systolic JJ I-NP I-test
function NN I-NP I-test
is VBZ O O
normal JJ O O
. . B-VP O
   
[ JJ B-NP O
Intrinsic NNP I-NP B-test
right NN I-NP I-test
ventricular NN I-NP I-test
systolic JJ B-NP I-test
function NN I-NP I-test
is VBZ O O
likely JJ O O
more RBR O B-problem
depressed JJ O I-problem
given VBN O O
the DT B-NP O
severity NN I-NP O
of IN B-VP O
tricuspid JJ B-NP B-problem
regurgitation NN I-NP I-problem
.] VBD B-VP O
The DT B-NP O
aortic JJ I-NP O
valve NN I-NP O
leaflets NNS I-NP O
( ( O O
3 CD O O
) ) O O
are VBP O O
mildly RB O B-problem
thickened VBN O I-problem
. . B-VP O
   
There EX O B-pronoun
is VBZ O O
no DT B-NP O
aortic JJ I-NP B-problem
valve NN I-NP I-problem
stenosis NN I-NP I-problem
. . B-VP O
   
Mild NNP B-NP B-problem
( ( O I-problem
1+ CD O I-problem
) ) O I-problem
aortic JJ B-NP I-problem
regurgitation NN I-NP I-problem
is VBZ O O
seen VBN O O
. . B-VP O
   
A DT B-NP B-treatment
bileaflet JJ I-NP I-treatment
mitral JJ I-NP I-treatment
valve NN I-NP I-treatment
prosthesis NN I-NP I-treatment
is VBZ O O
present JJ O O
. . B-VP O
   
The DT B-NP B-test
transmitral JJ I-NP I-test
gradient NN I-NP I-test
is VBZ O O
normal JJ O O
for IN B-VP O
this DT O B-pronoun
this DT B-NP B-treatment
prosthesis NN I-NP I-treatment
. . B-VP O
   
No DT B-NP O
mitral JJ I-NP B-problem
regurgitation NN I-NP I-problem
is VBZ O O
seen VBN O O
. . B-VP O
   
Mild NNP B-NP B-problem
( ( O I-problem
1+ CD O I-problem
) ) O I-problem
mitral JJ B-NP I-problem
regurgitation NN I-NP I-problem
is VBZ O O
seen VBN O O
. . B-VP O
   
[ NNS B-NP O
Due JJ O O
to TO O O
acoustic JJ B-NP O
shadowing NN I-NP O
, , O O
the DT B-NP O
severity NN I-NP O
of IN B-VP O
mitral JJ B-NP B-problem
regurgitation NN I-NP I-problem
may MD O O
be VB O O
significantly RB O O
UNDERestimated VBN O O
.] PDT O O
The DT B-NP O
tricuspid JJ I-NP O
valve NN I-NP O
leaflets NNS I-NP O
are VBP O O
mildly RB O B-problem
thickened VBN O I-problem
. . B-VP O
   
Moderate NNP B-NP B-problem
[ VBD B-VP I-problem
2+ CD O I-problem
] NNP B-NP I-problem
tricuspid JJ B-NP I-problem
regurgitation NN I-NP I-problem
is VBZ O O
seen VBN O O
. . B-VP O
   
There EX O O
is VBZ O O
mild JJ B-NP B-problem
pulmonary JJ I-NP I-problem
artery NN I-NP I-problem
systolic JJ B-NP I-problem
hypertension NN I-NP I-problem
. . B-VP O
   
There EX O O
is VBZ O O
no DT B-NP O
pericardial JJ I-NP B-problem
effusion NN I-NP I-problem
. . B-VP O
   
Labs VB O O
on IN B-VP O
admission NN B-NP O
: : O O
2019-02-01 JJ O O
03:20 CD O O
PM NNP B-NP O
BLOOD NNP I-NP B-test
WBC NNP I-NP B-test
- : O O
11.7 CD O O
*# NN B-NP O
RBC NNP I-NP B-test
- : O O
4.72 CD O O
Hgb NNP B-NP B-test
- : O O
14.1 CD O O
Hct NNP B-NP B-test
- : O O
42.7 CD O O
MCV NNP B-NP B-test
- : O O
91 CD O O
MCH NNP B-NP B-test
- : O O
29.9 CD O O
MCHC NNP B-NP B-test
- : O O
33.1 CD O O
RDW NNP B-NP B-test
- : O O
14.9 CD O O
Plt NNP B-NP B-test
Ct NNP I-NP I-test
- : O O
91 CD O O
* JJ O O
2019-02-01 JJ O O
03:20 CD O O
PM NNP B-NP O
BLOOD NNP I-NP B-test
Neuts NNP I-NP B-test
- : O O
94.6 CD O O
* NN B-NP O
Bands NNP I-NP B-test
- : O O
0 CD O O
Lymphs NNP B-NP B-test
- : O O
2.7 CD O O
* JJ B-NP O
Monos NNP I-NP B-test
- : O O
1.9 CD O O
* NN B-NP O
Eos NNP I-NP B-test
- : O O
0.4 CD O O
Baso NNP B-NP B-test
- : O O
0.4 CD O O
2019-02-01 JJ O O
03:20 CD O O
PM NNP B-NP O
BLOOD NNP I-NP B-test
PT NNP I-NP B-test
- : O O
28.0 CD O O
* NN B-NP O
PTT NNP I-NP B-test
- : O O
26.7 CD O O
INR(PT) NNP B-NP B-test
- : O O
2.9 CD O O
* JJ O O
2019-02-01 JJ O O
03:20 CD O O
PM NNP B-NP O
BLOOD NNP I-NP B-test
Glucose NNP I-NP B-test
- : O O
202 CD O O
* JJ B-NP O
UreaN NNP I-NP B-test
- : O O
31 CD O O
* NN B-NP O
Creat NNP I-NP B-test
- : O O
1.3 CD O O
* NN B-NP O
Na NNP I-NP B-test
- : O O
141 CD O O
K NNP B-NP B-test
- : O O
4.0 CD O O
Cl NNP B-NP B-test
- : O O
102 CD O O
HCO3 NNP B-NP B-test
- : O O
27 CD O O
AnGap NNP B-NP B-test
- : O O
16 CD O O
2019-02-01 JJ O O
03:20 CD O O
PM NNP B-NP O
BLOOD NNP I-NP B-test
ALT NNP I-NP B-test
- : O O
167 CD O O
* NN B-NP O
AST NNP I-NP B-test
- : O O
218 CD O O
* NN B-NP O
AlkPhos NNP I-NP B-test
- : O O
108 CD O O
Amylase NNP B-NP B-test
- : O O
117 CD O O
* NN B-NP O
TotBili NNP I-NP B-test
- : O O
3.6 CD O O
* JJ O O
2019-02-02 JJ O O
03:54 CD O O
PM NNP B-NP O
BLOOD NNP I-NP B-test
Lipase NNP I-NP B-test
- : O O
992 CD O O
* JJ O O
2019-02-01 JJ O O
03:20 CD O O
PM NNP B-NP O
BLOOD NNP I-NP B-test
Albumin NNP I-NP B-test
- : O O
4.8 CD O O
Calcium NNP B-NP B-test
- : O O
9.4 CD O O
Phos NNP B-NP B-test
- : O O
1.9 CD O O
* NN B-NP O
Mg NNP I-NP B-test
- : O O
2.0 CD O O
2019-02-01 JJ O O
04:15 CD O O
PM NNP B-NP O
BLOOD NNP I-NP B-test
Digoxin NNP I-NP B-test
- : O O
0.3 CD O O
* JJ O O
2019-02-01 JJ O O
11:43 CD O O
PM NNP B-NP O
BLOOD NNP I-NP B-test
Type NNP I-NP I-test
- : O O
ART NNP B-NP O
Temp NNP I-NP B-test
- : O O
38.3 CD O O
PEEP NNP B-NP B-treatment
- : O O
5 CD O O
pO2 NN B-NP B-test
- : O O
115 CD O O
* NN B-NP O
pCO2 NN I-NP B-test
- : O O
36 CD O O
pH NN B-NP B-test
- : O O
7.33 CD O O
* NN B-NP O
calTCO2 NN I-NP B-test
- : O O
20 CD O O
* JJ B-NP O
Base NNP I-NP B-test
XS NNP I-NP I-test
- : O O
-6 NN B-NP O
Intubat NNP I-NP O
- : O O
INTUBATED NNP B-NP B-treatment
2019-02-01 JJ O O
04:06 CD O O
PM NNP B-NP O
BLOOD NNP I-NP B-test
Lactate NNP I-NP B-test
- : O O
3.4 CD O O
* JJ O O
2019-02-01 JJ O O
08:00 CD O O
PM NNP B-NP O
BLOOD NNP I-NP B-test
Lactate NNP I-NP B-test
- : O O
6.4 CD O O
* JJ B-NP O
Labs NNP I-NP O
on IN B-VP O
discharge NN B-NP O
: : O O
2019-02-06 JJ O O
06:30 CD O O
AM NNP B-NP O
BLOOD NNP I-NP B-test
WBC NNP I-NP B-test
- : O O
7.4 CD O O
RBC NNP B-NP B-test
- : O O
3.82 CD O O
* NN B-NP O
Hgb NNP I-NP B-test
- : O O
11.3 CD O O
* NN B-NP O
Hct NNP I-NP B-test
- : O O
34.7 CD O O
* NN B-NP O
MCV NNP I-NP B-test
- : O O
91 CD O O
MCH NNP B-NP B-test
- : O O
29.5 CD O O
MCHC NNP B-NP B-test
- : O O
32.5 CD O O
RDW NNP B-NP B-test
- : O O
15.1 CD O O
Plt NNP B-NP B-test
Ct NNP I-NP I-test
- : O O
92 CD O O
* JJ O O
2019-02-09 JJ O O
04:45 CD O O
AM NNP B-NP O
BLOOD NNP I-NP B-test
PT NNP I-NP B-test
- : O O
19.6 CD O O
* NN B-NP O
PTT NNP I-NP B-test
- : O O
74.9 CD O O
* NN B-NP O
INR(PT) NNP I-NP B-test
- : O O
1.9 CD O O
* JJ O O
2019-02-07 JJ O O
09:00 CD O O
AM NNP B-NP O
BLOOD NNP I-NP B-test
Glucose NNP I-NP B-test
- : O O
124 CD O O
* JJ B-NP O
UreaN NNP I-NP B-test
- : O O
26 CD O O
* NN B-NP O
Creat NNP I-NP B-test
- : O O
1.2 CD O O
Na NNP B-NP B-test
- : O O
140 CD O O
K NNP B-NP B-test
- : O O
3.7 CD O O
Cl NNP B-NP B-test
- : O O
102 CD O O
HCO3 NNP B-NP B-test
- : O O
29 CD O O
AnGap NNP B-NP B-test
- : O O
13 CD O O
2019-02-07 JJ O O
09:00 CD O O
AM NNP B-NP O
BLOOD NNP I-NP B-test
ALT NNP I-NP B-test
- : O O
62 CD O O
* NN B-NP O
AST NNP I-NP B-test
- : O O
45 CD O O
* NN B-NP O
AlkPhos NNP I-NP B-test
- : O O
105 CD O O
TotBili NNP B-NP B-test
- : O O
2.2 CD O O
* JJ O O
2019-02-04 JJ O O
02:40 CD O O
AM NNP B-NP O
BLOOD NNP I-NP B-test
Lipase NNP I-NP B-test
- : O O
74 CD O O
* JJ O O
2019-02-07 JJ O O
09:00 CD O O
AM NNP B-NP O
BLOOD NNP I-NP B-test
Mg NNP I-NP B-test
- : O O
2.0 CD O O
2019-02-04 JJ O O
02:50 CD O O
AM NNP B-NP O
BLOOD NNP I-NP B-test
Lactate NNP I-NP B-test
- : O O
1.0 CD O O
Brief JJ B-NP O
Hospital JJ I-NP O
Course NN I-NP O
: : O O
Pt NNP B-NP B-person
is VBZ O O
a DT O O
78 CD O O
yo NN B-NP O
male NN I-NP O
with IN B-VP O
atrial JJ B-NP B-problem
fibrillation NN I-NP I-problem
, , O O
s/p JJ B-NP O
multiple JJ I-NP B-problem
CVA NNP I-NP I-problem
s, NN I-NP O
CHF NNP I-NP B-problem
, , O O
HTN NNP B-NP B-problem
, , O O
DM2 NNP B-NP B-problem
transferred VBD B-VP O
from IN B-VP O
the DT B-NP O
CMED NNP I-NP O
CCU NNP I-NP O
s/p POS O O
intervention NN B-NP B-treatment
for IN B-VP O
cholangitis NN B-NP B-problem
. . B-VP O
   
1) CD O O
Acute JJ B-NP B-problem
cholangitis NN I-NP I-problem
: : O O
Pt NNP B-NP B-person
was VBD B-VP O
admitted VBN O O
to TO O O
the DT B-NP O
ICU NNP I-NP O
, , O O
intubated VBN O O
, , O O
and CC O O
ERCP NNP B-NP B-test
performed VBD B-VP O
, , O O
likely JJ B-NP O
stone NN I-NP B-problem
obstructing VBG O O
CBD NNP B-NP O
. . B-VP O
   
Stent NNP B-NP B-treatment
was VBD B-VP O
placed VBN O O
and CC O O
patient NN B-NP B-person
was VBD B-VP O
treated VBN O O
with IN B-VP O
antibiotics NNS B-NP B-treatment
( ( O O
Zosyn NNP B-NP B-treatment
- : O O
> NN B-NP O
Ciprofloxacin NNP I-NP B-treatment
). NNP I-NP O
Per NNP I-NP O
ERCP NNP I-NP B-person
fellow NN I-NP I-person
, , O O
plan NN B-NP O
is VBZ O O
for IN B-VP O
patient NN B-NP B-person
to TO O O
return VB O O
in IN B-VP O
four CD O O
weeks NNS B-NP O
to TO O O
see VB O O
Dr. NNP B-NP B-person
Suzanne NNP I-NP I-person
Davis NNP I-NP I-person
, , O O
at IN B-VP O
which WDT O B-pronoun
time NN B-NP O
he PRP O B-person
will MD O O
likely RB O O
have VB O O
repeat NN B-NP B-test
cholangiogram NN I-NP I-test
and CC O O
removal NN B-NP B-treatment
of IN B-VP O
stent NN B-NP B-treatment
and CC O O
stone NN B-NP B-problem
. . B-VP O
   
If IN B-VP O
this DT O B-pronoun
is VBZ O O
still RB O O
problematic JJ O O
, , O O
pt NN B-NP B-person
may MD O O
also RB O O
need VB O O
a DT B-NP B-treatment
sphincterotomy NN I-NP I-treatment
. . B-VP O
   
Dr.Demby NNP B-NP B-person
secretary NN I-NP I-person
will MD O O
contact VB O O
patient NN B-NP B-person
at IN B-VP O
home NN B-NP O
the DT B-NP O
week NN I-NP O
after IN B-VP O
discharge NN B-NP O
to TO O O
schedule VB O O
this DT O B-pronoun
for IN B-VP O
the DT B-NP O
end NN I-NP O
of IN B-VP O
January NNP B-NP O
. . B-VP O
   
Pt NNP B-NP B-person
is VBZ O O
to TO O O
continue VB O O
ciprofloxacin NN B-NP B-treatment
for IN B-VP O
a DT O O
complete JJ O O
14 CD O O
day NN B-NP O
course NN I-NP O
. . B-VP O
   
2) CD O O
Mechanical JJ B-NP B-treatment
mitral JJ I-NP I-treatment
valve NN I-NP I-treatment
: : O O
Anticoagulation NN B-NP B-treatment
was VBD B-VP O
reversed VBN O O
for IN B-VP O
ERCP NNP B-NP B-test
. . B-VP O
   
After IN B-VP O
this DT O B-pronoun
he PRP O B-person
was VBD B-VP O
anticoagulated VBN O O
with IN B-VP O
heparin JJ B-NP B-treatment
drip NN I-NP I-treatment
. . B-VP O
   
INR NNP B-NP B-test
was VBD B-VP O
1.9 CD O O
on IN B-VP O
discharge NN B-NP O
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
given VBN O O
sc JJ B-NP B-treatment
lovenox NN I-NP I-treatment
x VBD B-VP O
1 CD O O
and CC O O
will MD O O
continue VB O O
this DT O B-pronoun
the DT B-NP O
day NN I-NP O
after IN B-VP O
discharge NN B-NP O
bid NN I-NP O
for IN B-VP O
one CD O O
day NN B-NP O
. . B-VP O
   
VNA NNP B-NP B-person
will MD O O
check VB O O
his PRP$ O B-person
his PRP$ O B-test
INR NNP B-NP I-test
at IN B-VP O
home NN B-NP O
and CC O O
page VB O O
his PRP$ O B-person
his PRP$ O B-person
PCP NN B-NP I-person
with IN B-VP O
the DT B-NP O
results NNS I-NP O
. . B-VP O
   
3) CD O O
Atrial JJ B-NP B-problem
fibrillation NN I-NP I-problem
: : O O
Rate NN B-NP O
controlled VBN O O
and CC O O
on IN B-VP O
warfarin NNS B-NP B-treatment
. . B-VP O
   
While IN B-VP O
in IN B-VP O
the DT B-NP O
hospital NN I-NP O
he PRP O B-person
had VBD B-VP O
several JJ B-NP O
episodes NNS I-NP O
of IN B-VP O
pauses NNS B-NP B-problem
, , O O
none NN B-NP O
longer JJR O O
than IN B-VP O
2.5 CD O O
seconds NNS B-NP O
. . B-VP O
   
His PRP$ O B-person
His PRP$ O B-treatment
digoxin NN B-NP I-treatment
was VBD B-VP O
held VBN O O
and CC O O
his PRP$ O B-person
his PRP$ O B-treatment
metoprolol NN B-NP I-treatment
was VBD B-VP O
titrated VBN O O
down RP O O
from IN B-VP O
his PRP$ O B-person
his PRP$ O B-treatment
home NN B-NP I-treatment
dose NN I-NP I-treatment
. . B-VP O
   
Once IN B-VP O
the DT B-NP B-treatment
digoxin NN I-NP I-treatment
was VBD B-VP O
no RB O O
longer RB O O
having VBG O O
effect NN B-NP O
, , O O
metoprolol NN B-NP B-treatment
was VBD B-VP O
titrated VBN O O
back RB O O
to TO O O
home NN B-NP B-treatment
dose NN I-NP I-treatment
. . B-VP O
   
4) CD O O
CHF NN B-NP B-problem
: : O O
Pt NNP B-NP B-person
was VBD B-VP O
oxygen JJ B-NP B-problem
dependent NN I-NP I-problem
for IN B-VP O
most JJS O O
of IN B-VP O
the DT B-NP O
hospital NN I-NP O
course NN I-NP O
, , O O
CXR NNP B-NP B-test
was VBD B-VP O
consistent JJ O O
with IN B-VP O
pulmonary JJ B-NP B-problem
edema NN I-NP I-problem
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
diuresed VBN O O
with IN B-VP O
lasix NN B-NP B-treatment
with IN B-VP O
good JJ B-NP O
effect NN I-NP O
. . B-VP O
   
Volume NN B-NP B-problem
overload NN I-NP I-problem
likely RB O O
ocurred VBN O O
in IN B-VP O
the DT B-NP O
setting NN I-NP O
of IN B-VP O
IV NNP B-NP B-treatment
fluids NNS I-NP I-treatment
given VBN O O
in IN B-VP O
the DT B-NP O
ICU NNP I-NP O
. . B-VP O
   
Did NNP B-NP O
not RB O O
require VB O O
lasix NN B-NP B-treatment
on IN B-VP O
discharge NN B-NP O
. . B-VP O
   
5) CD O O
E. NNP B-NP B-problem
coli NNS I-NP I-problem
bacteremia VBP O I-problem
/ JJ B-NP O
sepsis NN I-NP B-problem
: : O O
Source NN B-NP O
of IN B-VP O
acute JJ B-NP B-problem
cholangitis NN I-NP I-problem
as IN B-VP O
above NN B-NP O
. . B-VP O
   
Pt NNP B-NP B-person
required VBD B-VP O
3 CD O O
day NN B-NP O
stay VB O O
in IN B-VP O
the DT B-NP O
surgical JJ I-NP O
ICU NNP I-NP O
and CC O O
intubation NN B-NP B-treatment
as IN B-VP O
above NN B-NP O
. . B-VP O
   
6) CD O O
Intubation NN B-NP B-treatment
: : O O
Pt NNP B-NP B-person
was VBD B-VP O
97% CD O O
on IN B-VP O
room NN B-NP O
air NN I-NP O
on IN B-VP O
arrival NN B-NP O
to TO O O
Cindy NNP B-NP O
, , O O
developed VBD B-VP O
rapid JJ B-NP B-problem
ventricular JJ I-NP I-problem
reponse NN I-NP I-problem
to TO O O
a DT B-NP B-problem
fib NN I-NP I-problem
which WDT O B-pronoun
was VBD B-VP O
treated VBN O O
, , O O
but CC O O
after IN B-VP O
that DT B-NP B-pronoun
period NN I-NP O
of IN B-VP O
time NN B-NP O
required VBN O O
oxygen NN B-NP B-treatment
, , O O
presumably RB O O
for IN B-VP O
pulmonary JJ B-NP B-problem
edema NN I-NP I-problem
. . B-VP O
   
In IN B-VP O
the DT B-NP O
Lori NNP I-NP O
pt NN I-NP B-person
was VBD B-VP O
given VBN O O
3L CD O B-treatment
NS NNP B-NP I-treatment
as RB O O
well RB O O
as IN B-VP O
1 CD O O
unit NN B-NP O
of IN B-VP O
FFP NNP B-NP B-treatment
, , O O
and CC O O
oxygen NN B-NP B-problem
requirements NNS I-NP I-problem
contimued VBN O O
to TO O O
climb VB O O
. . B-VP O
   
In IN B-VP O
the DT B-NP O
CMED NNP I-NP O
CCU NNP I-NP O
pt NN I-NP B-person
was VBD B-VP O
intubated VBN O O
for IN B-VP O
ERCP NNP B-NP B-test
procedure NN I-NP I-test
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
extubated VBN O O
the DT B-NP O
next JJ I-NP O
morning NN I-NP O
. . B-VP O
   
Medications NNS B-NP O
on IN B-VP O
Admission NN B-NP O
: : O O
Lisinopril $ O B-treatment
2.5 CD O O
qday NN B-NP O
, , O O
Buspiron NNP B-NP B-treatment
20 CD O O
mg NN B-NP O
po NN I-NP O
qday NN I-NP O
, , O O
Digoxin NNP B-NP B-treatment
, , O O
Doxasozin NNP B-NP B-treatment
8 CD O O
mg NN B-NP O
qhs NN I-NP O
, , O O
Glyburide NNP B-NP B-treatment
2.5 CD O O
mg NN B-NP O
qday NN I-NP O
, , O O
metoprolol FW O B-treatment
bid NN B-NP O
, , O O
atorvastatin VBZ O B-treatment
20 CD O O
mg NN B-NP O
qday NN I-NP O
, , O O
warfarin WP O B-treatment
5 CD O O
mg NN B-NP O
qday JJ B-NP O
Discharge NNP I-NP O
Medications NNS I-NP O
: : O O
1. CD O O
Ciprofloxacin NNP B-NP B-treatment
500 CD O O
mg NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Tablet NNP B-NP O
PO NNP I-NP O
Q12H NNP I-NP O
( ( O O
every DT O O
12 CD O O
hours NNS B-NP O
) ) O O
for IN B-VP O
6 CD O O
days NNS B-NP O
. . B-VP O
   
Disp NNP B-NP O
:* VBD B-VP O
12 CD O O
Tablet NNP B-NP O
(s)* NNP I-NP O
Refills NNP I-NP O
:* VBZ O O
0 CD O O
* NN B-NP O
2. CD O O
Medications NNS B-NP B-treatment
Continue VBP O O
all DT B-NP B-treatment
other JJ I-NP I-treatment
home NN I-NP I-treatment
medications NNS I-NP I-treatment
EXCEPT NNP I-NP O
do VBP O O
not RB O O
take VB O O
digoxin NN B-NP B-treatment
. . B-VP O
   
Discharge NNP B-NP O
Disposition NNP I-NP O
: : O O
Home NN B-NP O
with IN B-VP O
Service NNP B-NP O
Discharge NNP I-NP O
Diagnosis NNP I-NP O
: : O O
Primary JJ B-NP O
diagnosis NN I-NP O
: : O O
acute JJ B-NP B-problem
cholangitis NN I-NP I-problem
Secondary JJ B-NP O
diagnosis NN I-NP O
: : O O
anticoagulation NN B-NP B-treatment
with IN B-VP O
a DT B-NP B-treatment
mechanical JJ I-NP I-treatment
valve NN I-NP I-treatment
Atrial NNP I-NP B-problem
fibrillation NN I-NP I-problem
Diabetes NNP I-NP B-problem
Mellitus NNP I-NP I-problem
Congestive NNP I-NP B-problem
heart NN I-NP I-problem
failure NN I-NP I-problem
Discharge NNP I-NP O
Condition NNP I-NP O
: : O O
stable JJ O O
, , O O
will MD O O
work VB O O
with IN B-VP O
home NN B-NP B-person
PT NNP I-NP I-person
Discharge NNP I-NP O
Instructions NNP I-NP O
: : O O
Please NNP B-NP O
continue VBP O O
Ciprofloxacin NNP B-NP B-treatment
antibiotic JJ O I-treatment
until IN B-VP O
2019-02-14 JJ O O
. . B-VP O
   
Dr. NNP B-NP B-person
Mcfarlane NNP I-NP I-person
is VBZ O O
the DT B-NP O
doctor NN I-NP B-person
who WP O B-person
performed VBD B-VP O
the DT B-NP B-treatment
procedure NN I-NP I-treatment
to TO O O
place VB O O
a DT B-NP B-treatment
stent NN I-NP I-treatment
in IN B-VP I-treatment
your PRP$ O B-person
your PRP$ O I-treatment
bile NN B-NP I-treatment
duct NN I-NP I-treatment
( ( O O
a DT B-NP O
tube NN I-NP O
that WDT O B-pronoun
drains VBZ O O
the DT B-NP O
liver NN I-NP O
). VBD B-VP O
His PRP$ O B-person
His PRP$ O B-person
nurse NN B-NP I-person
is VBZ O O
going VBG O O
to TO O O
contact VB O O
you PRP O B-person
at IN B-VP O
home NN B-NP O
to TO O O
schedule VB O O
a DT B-NP O
time NN I-NP O
for IN B-VP O
a DT B-NP B-treatment
repeat NN I-NP I-treatment
procedure NN I-NP I-treatment
to TO O O
remove VB O O
that IN B-VP B-treatment
that DT B-NP B-pronoun
stent NN I-NP I-treatment
. . B-VP O
   
You PRP O B-person
will MD O O
have VB O O
your PRP$ O B-person
blood NN B-NP O
drawn NN I-NP O
tomorrow NN I-NP O
( ( O O
2019-02-10 JJ O O
) ) O O
by IN B-VP O
VNA NNP B-NP B-person
. . B-VP O
   
It PRP O B-pronoun
will MD O O
be VB O O
called VBN O O
in IN B-VP O
to TO O O
Dr. NNP B-NP B-person
Hamasaki NNP I-NP I-person
office NN I-NP O
and CC O O
he PRP O B-person
will MD O O
call VB O O
you PRP O B-person
to TO O O
see VB O O
how WRB O O
to TO O O
change VB O O
your PRP$ O B-person
your PRP$ O B-treatment
coumadin NN B-NP I-treatment
. . B-VP O
   
You PRP O B-person
will MD O O
also RB O O
take VB O O
lovenox NN B-NP B-treatment
subcutaneous JJ B-NP I-treatment
injections NNS I-NP I-treatment
tomorrow NN I-NP O
, , O O
2019-02-10 JJ O O
. . B-VP O
   
You PRP O B-person
will MD O O
take VB O O
one CD O O
if IN B-VP O
the DT B-NP O
morning NN I-NP O
and CC O O
one CD O O
at IN B-VP O
night NN B-NP O
. . B-VP O
   
Continue NNP B-NP O
all DT O O
of IN B-VP O
your PRP$ O B-person
your PRP$ O B-treatment
medications NNS B-NP I-treatment
except IN B-VP O
for IN B-VP O
digoxin NN B-NP B-treatment
. . B-VP O
   
Followup JJ B-NP O
Instructions NNS I-NP O
: : O O
Dr. NNP B-NP B-person
Mcfarlane NNP I-NP I-person
is VBZ O O
the DT B-NP B-person
doctor NN I-NP I-person
who WP O B-person
performed VBD B-VP O
the DT B-NP B-treatment
procedure NN I-NP I-treatment
to TO O O
place VB O O
a DT B-NP B-treatment
stent NN I-NP I-treatment
in IN B-VP I-treatment
your PRP$ O B-person
your PRP$ O I-treatment
bile NN B-NP I-treatment
duct NN I-NP I-treatment
( ( O O
a DT B-NP O
tube NN I-NP O
that WDT O B-pronoun
drains VBZ O O
the DT B-NP O
liver NN I-NP O
). VBD B-VP O
His PRP$ O B-person
His PRP$ O B-person
nurse NN B-NP I-person
is VBZ O O
going VBG O O
to TO O O
contact VB O O
you PRP O B-person
at IN B-VP O
home NN B-NP O
to TO O O
schedule VB O O
a DT B-NP O
time NN I-NP O
for IN B-VP O
a DT B-NP B-treatment
repeat NN I-NP I-treatment
procedure NN I-NP I-treatment
to TO O O
remove VB O O
that IN B-VP B-treatment
that DT B-NP B-pronoun
stent NN I-NP I-treatment
. . B-VP O
   
Before IN B-VP O
you PRP O B-person
have VBP O O
the DT B-NP B-treatment
procedure NN I-NP I-treatment
with IN B-VP O
Dr. NNP B-NP B-person
Morris NNP I-NP I-person
you PRP O B-person
will MD O O
need VB O O
to TO O O
talk VB O O
to TO O O
Dr. NNP B-NP B-person
Moya NNP I-NP I-person
to TO O O
see VB O O
if IN B-VP O
you PRP O B-person
need VBP O O
to TO O O
stop VB O O
your PRP$ O B-person
your PRP$ O B-treatment
coumadin NN B-NP I-treatment
/ NN I-NP O
warfarin NN I-NP B-treatment
for IN B-VP O
a DT B-NP O
few JJ I-NP O
days NNS I-NP O
. . B-VP O
   
Shirley NNP B-NP B-person
Anthony NNP I-NP I-person
MD NNP I-NP I-person
56-333 JJ O O
Completed VBN O O
by IN B-VP O
: : O O
Donald NNP B-NP B-person
Beverly NNP I-NP I-person
MD NNP I-NP I-person
74-194 JJ B-NP O
2019-02-09 JJ I-NP O
@ NN I-NP O
1644 CD O O
Signed NNP B-NP O
electronically RB O O
by IN B-VP O
: : O O
DR. NNP B-NP B-person
Shirley NNP I-NP I-person
V NNP I-NP I-person
Usher NNP I-NP I-person
on IN B-VP O
: : O O
SAT NNP B-NP O
2019-02-09 CD O O
5:32 CD O O
PM NNP B-NP O
( ( O O
End NNP B-NP O
of IN B-VP O
Report NNP B-NP O
) ) O O
-EMPTYLINE- VBP O O
-DOCSTART- JJ O O
-EMPTYLINE- $ O O
745431641 CD O O
WGH NNP B-NP O
2464448 CD O O
333887 CD O O
3473372 CD O O
9/16/2004 CD O O
12:00:00 CD O O
AM NNP B-NP O
ED NNP I-NP O
Discharge NNP I-NP O
Summary NNP I-NP O
Unsigned VBD B-VP O
DIS NNP B-NP O
Report NNP I-NP O
Status NNP I-NP O
: : O O
Unsigned VBD B-VP O
ED NNP B-NP O
DISCHARGE NNP I-NP O
NOTIFICATION NNP I-NP O
/ NNP I-NP O
SUMMARY NNP I-NP O
KOTEA NNP I-NP B-person
, , O I-person
TORTHEOA NNP B-NP I-person
MRN NNP I-NP O
: : O O
2464448 CD O O
Age NNP B-NP O
: : O O
59y CD O O
REGISTRATION NNP B-NP O
DATE NNP I-NP O
: : O O
09/16/2004 CD O O
09:22 CD O O
AM JJ B-NP O
Provider NN I-NP B-person
: : O O
YERTREY JJ B-NP B-person
SUMCHIRDKAYSMAVVEINDREPS NNP I-NP I-person
PRELIMINARY NNP I-NP O
REPORT NNP I-NP O
PCP NNP I-NP B-person
notified VBN O O
by IN B-VP O
MD NNP B-NP B-person
: : O O
Yes SYM O O
- : O O
Direct JJ B-NP O
contact NN I-NP O
with IN B-VP O
PCP NNP B-NP B-person
Benefits NNP I-NP O
Assigned NNP I-NP O
: : O O
N NNP B-NP O
Discharge NNP I-NP O
Date NNP I-NP O
/ JJ B-NP O
Time NNP I-NP O
: : O O
09/16/2004 CD O O
17:48 CD O O
Discharge NN B-NP O
Status NNP I-NP O
: : O O
Discharged VBN O O
Condition NNP B-NP O
on IN B-VP O
Discharge NNP B-NP O
: : O O
Stable JJ B-NP O
Patient NNP I-NP B-person
States NNPS I-NP O
Complaint NNP I-NP O
: : O O
CP NNP B-NP B-problem
Standardized NNP I-NP O
Discharge NNP I-NP O
Instructions NNS I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
given VBN O O
printed JJ B-NP O
instructions NNS I-NP O
for IN B-VP O
chest NN B-NP B-problem
pain NN I-NP I-problem
( ( O O
English NNP B-NP O
) ) O O
. . B-VP O
   
Diagnosis NN B-NP O
: : O O
Noncardiac JJ B-NP B-problem
chest NN I-NP I-problem
pain NN I-NP I-problem
Treatment NNP I-NP O
Rendered NNP I-NP O
: : O O
Labs NNP B-NP B-test
stable JJ O O
, , O O
NTG NNP B-NP B-treatment
sublingual JJ O I-treatment
, , O O
stress JJ B-NP B-test
MIBI NNP I-NP I-test
was VBD B-VP O
negative JJ O O
for IN B-VP O
ischemia NN B-NP B-problem
. . B-VP O
   
Discharge NNP B-NP O
Medications NNPS I-NP O
: : O O
Continue VB O O
current JJ B-NP B-treatment
medication NN I-NP I-treatment
Disposition NNP I-NP O
, , O O
Follow NNP B-NP O
up RB O O
and CC O O
Instructions NNS B-NP O
to TO O O
Patient VB O B-person
: : O O
Follow VB O O
up RP O O
as RB O O
scheduled VBN O O
with IN B-VP O
Dr. NNP B-NP B-person
Fyfechird NNP I-NP I-person
. . B-VP O
   
Return NNP B-NP O
to TO O O
the DT B-NP O
ED NNP I-NP O
for IN B-VP O
worsening VBG O B-problem
chest JJS B-NP I-problem
pain NN I-NP I-problem
, , O O
shortness NN B-NP B-problem
of IN B-VP I-problem
breath NN B-NP I-problem
, , O O
nausea NN B-NP B-problem
/ NNP I-NP O
vomiting NN I-NP B-problem
, , O O
fever RB O B-problem
/ NNP B-NP O
chills NNS I-NP B-problem
, , O O
weakness NN B-NP B-problem
/ NNP I-NP O
dizziness/numbness NN I-NP B-problem
, , O O
or CC O O
any DT B-NP B-problem
other JJ I-NP I-problem
problems NNS I-NP I-problem
. . B-VP O
   
PCP NNP B-NP B-person
Name NN I-NP O
: : O O
SLANDTIF NNP B-NP B-person
, , O I-person
ASTHEO NNP B-NP I-person
D NNP I-NP I-person
Provider NNP I-NP O
Number NNP I-NP O
: : O O
49422 CD O O
This DT B-NP B-pronoun
report NN I-NP O
was VBD B-VP O
created VBN O O
by IN B-VP O
SUMCHIRDKAYSMAVVEINDREPS NNP B-NP B-person
, , O I-person
YERTREY NNP B-NP I-person
09/16/2004 CD O O
05:53 CD O O
PM NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- VBD B-VP O
405507617 CD O O
FIH NNP B-NP O
2887168 CD O O
132052 CD O O
543394 CD O O
11/12/2002 CD O O
12:00:00 CD O O
AM NNP B-NP O
Discharge NNP I-NP O
Summary NNP I-NP O
Unsigned VBD B-VP O
DIS NNP B-NP O
Report NNP I-NP O
Status NNP I-NP O
: : O O
Unsigned VBD B-VP O
DISCHARGE NNP B-NP O
SUMMARY NNP I-NP O
NAME NN I-NP O
: : O O
SPALDFREIERMPLCA NNP B-NP B-person
, , O I-person
IEOLY NNP B-NP I-person
E NNP I-NP I-person
UNIT NNP I-NP O
NUMBER NNP I-NP O
: : O O
251-62-95 JJ B-NP O
ADMISSION NNP I-NP O
DATE NNP I-NP O
: : O O
11/12/2002 CD O O
DISCHARGE NNP B-NP O
DATE NNP I-NP O
: : O O
11/15/2002 CD O O
PRINCIPAL NNP B-NP O
DIAGNOSIS NNP I-NP O
: : O O
Alzheimer NNP B-NP B-problem
&apos;s NNP I-NP I-problem
disease NN I-NP I-problem
secondary NN I-NP O
to TO O O
Down NNP B-NP B-problem
&apos;s NNP I-NP I-problem
syndrome NN I-NP I-problem
. . B-VP O
   
CHIEF JJ B-NP O
COMPLAINT NN I-NP O
: : O O
This DT O B-pronoun
is VBZ O O
a DT O O
44 CD O O
year-old JJ B-NP O
right NN I-NP O
handed VBN O O
woman NN B-NP O
with IN B-VP O
Down NNP B-NP B-problem
&apos;s NNP I-NP I-problem
syndrome NN I-NP I-problem
who WP O B-person
presents VBZ O O
with IN B-VP O
falling VBG O B-problem
and CC O O
a DT B-NP B-problem
decrease NN I-NP I-problem
in IN B-VP I-problem
her PRP$ O I-problem
her PRP$ O B-person
activities NNS B-NP I-problem
of IN B-VP O
daily JJ B-NP O
living NN I-NP O
. . B-VP O
   
HISTORY NNP B-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS NNP I-NP O
: : O O
This DT O B-pronoun
is VBZ O O
a DT O O
44 CD O O
year-old JJ B-NP O
right NN I-NP O
handed VBN O O
woman NN B-NP O
with IN B-VP O
Down NNP B-NP B-problem
&apos;s NNP I-NP I-problem
syndrome NN I-NP I-problem
who WP O B-person
presents VBZ O O
with IN B-VP O
increased JJ O B-problem
falling VBG O I-problem
and CC O O
gait NN B-NP B-problem
unsteadiness NN I-NP I-problem
and CC O O
an DT O B-problem
increased VBN O I-problem
inability NN B-NP I-problem
to TO O O
perform VB O O
her PRP$ O B-person
activities NNS B-NP O
of IN B-VP O
daily JJ B-NP O
living NN I-NP O
over IN B-VP O
the DT O O
past JJ O O
three CD O O
years NNS B-NP O
. . B-VP O
   
The DT B-NP O
diagnosis NN I-NP O
of IN B-VP O
Alzheimer NNP B-NP B-problem
&apos;s NNP I-NP I-problem
was VBD B-VP O
made VBN O O
in IN B-VP O
1998 CD O O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
had VBD B-VP O
an DT B-NP B-test
MRI NNP I-NP I-test
at IN B-VP O
an DT B-NP O
outside JJ I-NP O
hospital NN I-NP O
which WDT O B-pronoun
showed VBD B-VP O
enlarged JJ B-NP B-problem
lateral JJ I-NP I-problem
ventricles NNS I-NP I-problem
and CC O O
the DT B-NP O
possible JJ I-NP O
diagnosis NN I-NP O
of IN B-VP O
normal JJ B-NP B-problem
pressure NN I-NP I-problem
hydrocephalus NN I-NP I-problem
was VBD B-VP O
entertained VBN O O
and CC O O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
admitted VBN O O
for IN B-VP O
diagnostic JJ B-NP B-test
lumbar NN I-NP I-test
puncture NN I-NP I-test
. . B-VP O
   
PAST NNP B-NP O
MEDICAL NNP I-NP O
HISTORY NNP I-NP O
: : O O
Notable JJ O O
for IN B-VP O
Down NNP B-NP B-problem
&apos;s NNP I-NP I-problem
syndrome NN I-NP I-problem
, , O O
Altzheimer NNP B-NP B-problem
&apos;s NNP I-NP I-problem
disease NN I-NP I-problem
secondary NN I-NP O
to TO O O
Down NNP B-NP B-problem
&apos;s NNP I-NP I-problem
syndrome NN I-NP I-problem
diagnosed VBD B-VP O
in IN B-VP O
1998 CD O O
, , O O
status NN B-NP O
post NN I-NP O
multiple NN I-NP B-problem
falls VBZ O I-problem
, , O O
no DT B-NP O
heart NN I-NP B-problem
disease NN I-NP I-problem
, , O O
ankle NN B-NP B-treatment
surgery NN I-NP I-treatment
and CC O O
an DT B-NP B-problem
abnormal JJ I-NP I-problem
EEG NNP I-NP I-problem
. . B-VP O
   
MEDICATIONS NN B-NP O
: : O O
Include NNP B-NP O
Lamictal NNP I-NP B-treatment
50 CD O O
mgs NN B-NP O
bid NN I-NP O
, , O O
Aricept NNP B-NP B-treatment
10 CD O O
mgs NN B-NP O
qhs NN I-NP O
, , O O
BuSpar NNP B-NP B-treatment
15 CD O O
mgs NN B-NP O
bid NN I-NP O
, , O O
Trazodone CD O B-treatment
100 CD O O
mgs NN B-NP O
qhs NN I-NP O
. . B-VP O
   
ALLERGIES NN B-NP O
: : O O
There EX O O
are VBP O O
no DT B-NP O
known JJ I-NP B-problem
drug NN I-NP I-problem
allergies NNS I-NP I-problem
. . B-VP O
   
SOCIAL NNP B-NP O
HISTORY NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
lives VBZ O O
at IN B-VP O
home NN B-NP O
with IN B-VP O
her PRP$ O B-person
her PRP$ O B-person
family NN B-NP I-person
. . B-VP O
   
REVIEW NNP B-NP O
OF NNPS I-NP O
SYSTEMS NNP I-NP O
: : O O
Notable JJ O O
for IN B-VP O
decreased JJ B-NP B-problem
ability NN I-NP I-problem
to TO O O
do VB O O
her PRP$ O B-person
activities NNS B-NP O
of IN B-VP O
daily JJ B-NP O
living NN I-NP O
, , O O
a DT B-NP B-problem
decrease NN I-NP I-problem
in IN B-VP I-problem
her PRP$ O B-person
her PRP$ O I-problem
language NN B-NP I-problem
, , O O
some DT B-NP B-problem
urinary JJ I-NP I-problem
accidents NNS I-NP I-problem
, , O O
increased VBD B-VP B-problem
falls NNS B-NP I-problem
and CC O O
a DT B-NP B-problem
poor JJ I-NP I-problem
gait NN I-NP I-problem
. . B-VP O
   
PHYSICAL JJ B-NP O
EXAMINATION NN I-NP O
: : O O
Noted VBN O O
for IN B-VP O
friendly JJ O O
, , O O
jovial JJ O O
44 CD O O
year-old JJ B-NP O
woman NN I-NP O
with IN B-VP O
Down NNP B-NP B-problem
&apos;s NNP I-NP I-problem
. . B-VP O
   
Vital JJ B-NP O
signs NNS I-NP O
: : O O
Blood NNP B-NP B-test
pressure NN I-NP I-test
150/82 CD O O
, , O O
heart NN B-NP B-test
rate NN I-NP I-test
88 CD O O
, , O O
respiratory NN B-NP B-test
rate NN I-NP I-test
18 CD O O
. . B-VP O
   
HEENT NNP B-NP B-test
examination NN I-NP I-test
is VBZ O O
notable JJ O O
for IN B-VP O
bilateral JJ B-NP B-problem
esotropia NN I-NP I-problem
. . B-VP O
   
Chest NNP B-NP O
was VBD B-VP O
clear JJ O O
to TO O O
auscultation NN B-NP B-test
. . B-VP O
   
Cardiac NNP B-NP B-test
examination NN I-NP I-test
was VBD B-VP O
regular JJ B-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
. . B-VP O
   
Abdominal JJ B-NP B-test
examination NN I-NP I-test
was VBD B-VP O
soft JJ O O
, , O O
non-tender JJ O B-problem
, , O O
positive JJ B-NP O
bowel NN I-NP O
sounds NNS I-NP O
. . B-VP O
   
Extremities NNS B-NP O
: : O O
Left NNP B-NP O
ankle NN I-NP O
was VBD B-VP O
notable JJ O O
for IN B-VP O
swelling VBG O B-problem
secondary JJ O O
to TO O O
status NN B-NP O
post NN I-NP O
left VBD B-VP B-treatment
ankle RP O I-treatment
surgery NN B-NP I-treatment
. . B-VP O
   
Skin NN B-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
had VBD B-VP O
back RP O B-problem
folliculitis NN B-NP I-problem
. . B-VP O
   
Neuro NNP B-NP B-test
examination NN I-NP I-test
was VBD B-VP O
notable JJ O O
for IN B-VP O
a DT B-NP O
patient NN I-NP B-person
who WP O B-person
was VBD B-VP O
alert JJ O O
and CC O O
oriented VBD B-VP O
x $ O O
1 CD O O
. . B-VP O
   
She PRP O B-person
could MD O O
identify VB O O
her PRP$ O B-person
her PRP$ O B-person
siblings NNS B-NP I-person
. . B-VP O
   
She PRP O B-person
can MD O O
name VB O O
several JJ B-NP O
words NNS I-NP O
such JJ O O
as IN B-VP O
thumb NN B-NP O
, , O O
watch NN B-NP O
and CC O O
knuckle NN B-NP O
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
unable JJ O O
to TO O O
name VB O O
glasses NNS B-NP O
. . B-VP O
   
Cranial JJ B-NP O
nerves NNS I-NP O
notable JJ O O
for IN B-VP O
bilateral JJ B-NP B-problem
esotropia NN I-NP I-problem
. . B-VP O
   
Her PRP$ O B-person
extraocular JJ B-NP O
motions NNS I-NP O
were VBD B-VP O
full JJ O O
. . B-VP O
   
The DT B-NP O
face NN I-NP O
was VBD B-VP O
symmetrical JJ O O
. . B-VP O
   
The DT B-NP O
motor NN I-NP O
tone NN I-NP O
was VBD B-VP O
within IN B-VP O
normal JJ B-NP O
limits NNS I-NP O
in IN B-VP O
the DT O O
upper JJ O O
and CC O O
lower JJR B-NP O
extremities NNS I-NP O
. . B-VP O
   
The DT B-NP O
strength NN I-NP O
was VBD B-VP O
5 CD O O
out IN B-VP O
of IN B-VP O
5 CD O O
. . B-VP O
   
Reflexes NNS B-NP B-test
were VBD B-VP O
2+ CD O O
bilaterally RB O O
with IN B-VP O
down RP O O
going VBG O O
toes NNS B-NP O
. . B-VP O
   
Her PRP$ O B-person
gait NN B-NP O
was VBD B-VP O
notable JJ O O
for IN B-VP O
requiring VBG O O
assist NN B-NP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
walked VBD B-VP O
with IN B-VP O
her PRP$ O B-person
her PRP$ O B-problem
feet NNS B-NP I-problem
externally RB O I-problem
rotated VBN O I-problem
with IN B-VP O
a DT O B-problem
wide JJ O I-problem
based VBN O I-problem
gait NN B-NP I-problem
with IN B-VP O
shuffling VBG O B-problem
short JJ B-NP I-problem
steps NNS I-NP I-problem
with IN B-VP O
a DT B-NP B-problem
tendency NN I-NP I-problem
to TO O I-problem
fall VB O I-problem
back RB O I-problem
and CC O O
she PRP O B-person
was VBD B-VP O
unable JJ O O
to TO O O
walk VB O O
without IN B-VP O
assist NN B-NP O
. . B-VP O
   
MRI NNP B-NP B-test
, , O O
as IN B-VP O
discussed VBN O O
, , O O
was VBD B-VP O
done VBN O O
at IN B-VP O
outside JJ B-NP O
hospital NN I-NP O
and CC O O
demonstrated VBD B-VP O
large JJ B-NP B-problem
ventricles NNS I-NP I-problem
. . B-VP O
   
HOSPITAL NNP B-NP O
COURSE NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
admitted VBN O O
to TO O O
the DT B-NP O
Arkzie- NNP I-NP O
Memorial NNP I-NP O
for IN B-VP O
lumbar NN B-NP B-test
puncture NN I-NP I-test
. . B-VP O
   
On IN B-VP O
the DT B-NP O
night NN I-NP O
of IN B-VP O
admission NN B-NP O
lumbar NN I-NP B-test
puncture NN I-NP I-test
was VBD B-VP O
attempted VBN O O
on IN B-VP O
the DT B-NP O
floor NN I-NP O
, , O O
but CC O O
we PRP O B-person
were VBD B-VP O
unable JJ O O
to TO O O
get VB O O
cerebral JJ B-NP O
spinal JJ I-NP O
fluid NN I-NP O
due JJ O O
to TO O O
difficulty NN B-NP O
with IN B-VP O
compliance NN B-NP O
with IN B-VP O
the DT B-NP B-person
patient NN I-NP I-person
who WP O B-person
was VBD B-VP O
severely RB O B-problem
agitated JJ O I-problem
and CC O O
would MD O O
not RB O O
comply VB O O
with IN B-VP O
the DT B-NP B-test
examination NN I-NP I-test
. . B-VP O
   
On IN B-VP O
hospital JJ B-NP O
day NN I-NP O
the DT B-NP B-person
patient NN I-NP I-person
underwent JJ B-NP O
conscious JJ I-NP B-treatment
sedation NN I-NP I-treatment
in IN B-VP O
the DT B-NP O
operating NN I-NP O
room NN I-NP O
where WRB O O
lumbar NN B-NP B-test
puncture NN I-NP I-test
was VBD B-VP O
performed VBN O O
. . B-VP O
   
Opening JJ B-NP B-test
pressure NN I-NP I-test
was VBD B-VP O
17 CD O O
and CC O O
approximately RB O O
20-25 JJ B-NP O
cc NN I-NP O
of IN B-VP O
CSF NNP B-NP O
was VBD B-VP O
removed VBN O O
. . B-VP O
   
CSF NNP B-NP B-test
was VBD B-VP O
notable JJ O O
for IN B-VP O
sugar JJ B-NP B-test
level NN I-NP I-test
of IN B-VP O
65 CD O O
and CC O O
total JJ B-NP B-test
protein JJ I-NP I-test
level NN I-NP I-test
of IN B-VP O
56 CD O O
. . B-VP O
   
OTHER NNP B-NP O
LABORATORIES NNPS I-NP O
THAT NNP I-NP B-pronoun
WERE NNP I-NP O
NOTABLE NNP I-NP O
: : O O
Vitamin NNP B-NP B-test
B12 NNP I-NP I-test
of IN B-VP O
855 CD O O
, , O O
folic JJ B-NP B-test
acid NN I-NP I-test
of IN B-VP O
15.4 CD O O
. . B-VP O
   
Chem-7 NN B-NP B-test
was VBD B-VP O
within IN B-VP O
normal JJ B-NP O
limits NNS I-NP O
. . B-VP O
   
Tube NNP B-NP O
and CC O O
requisition NN B-NP O
of IN B-VP O
the DT B-NP O
CSF NNP I-NP B-test
labeled VBD B-VP I-test
tube RB O I-test
# # O I-test
1 CD O I-test
was VBD B-VP O
notable JJ O O
for IN B-VP O
color NN B-NP B-test
pink NN I-NP O
, , O O
turbidity NN B-NP B-test
slight NN I-NP O
, , O O
xanthochromia NNP B-NP B-test
yes UH O O
, , O O
red JJ B-NP B-test
blood NN I-NP I-test
cells NNS I-NP I-test
3,800 CD O O
, , O O
white JJ B-NP B-test
blood NN I-NP I-test
cells NNS I-NP I-test
3 CD O O
, , O O
neutrophils RB O B-test
58 CD O O
, , O O
bands VBZ O B-test
4 CD O O
, , O O
lymphs VBD B-VP B-test
29 CD O O
, , O O
monos FW O B-test
6 CD O O
, , O O
eos VBD B-VP B-test
2 CD O O
and CC O O
basos $ O B-test
1 CD O O
. . B-VP O
   
CSF NNP B-NP B-test
tube NN I-NP I-test
labeled VBD B-VP I-test
# # O I-test
4 CD O I-test
was VBD B-VP O
notable JJ O O
for IN B-VP O
CSF NNP B-NP B-test
color NN I-NP I-test
pink NN I-NP O
, , O O
CSF NNP B-NP B-test
turbidity NN I-NP I-test
slight NN I-NP O
, , O O
CSF NNP B-NP B-test
xanthochromia NNP I-NP I-test
yes UH O O
, , O O
CSF NNP B-NP B-test
RBCs NNP I-NP I-test
3,900 CD O O
, , O O
CSF NNP B-NP B-test
white JJ B-NP I-test
blood NN I-NP I-test
cells NNS I-NP I-test
3 CD O O
, , O O
CSF NNP B-NP B-test
neutrophils VBZ O I-test
61 CD O O
, , O O
CSF NNP B-NP B-test
bands VBZ O I-test
3 CD O O
, , O O
CSF NNP B-NP B-test
lymphs VBZ O I-test
31 CD O O
, , O O
CSF NNP B-NP B-test
monos VBD B-VP I-test
1 CD O O
, , O O
CSF NNP B-NP B-test
eos VBZ O I-test
3 CD O O
, , O O
CSF NNP B-NP B-test
basos VBD B-VP I-test
1 CD O O
. . B-VP O
   
CSF NNP B-NP B-test
gram NN I-NP I-test
stain NN I-NP I-test
was VBD B-VP O
notable JJ O O
for IN B-VP O
no DT B-NP O
polys NN I-NP B-test
and CC O O
no DT O O
organisms JJ O B-problem
seen VBN O O
. . B-VP O
   
The DT B-NP B-test
fluid JJ I-NP I-test
culture NN I-NP I-test
was VBD B-VP O
no DT B-NP O
growth NN I-NP O
to TO O O
date NN B-NP O
. . B-VP O
   
One CD O O
day NN B-NP O
prior RB O O
to TO O O
lumbar VB O B-test
puncture NN B-NP I-test
, , O O
an DT B-NP B-test
aerobic JJ I-NP I-test
culture NN I-NP I-test
was VBD B-VP O
similarly RB O O
pending VBG O O
. . B-VP O
   
Lyme NNP B-NP B-test
capture NN I-NP I-test
was VBD B-VP O
pending VBG O O
and CC O O
at IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
discharge NN B-NP O
. . B-VP O
   
Other JJ B-NP O
notable JJ I-NP O
tests NNS I-NP O
: : O O
RPR NNP B-NP B-test
card NN I-NP I-test
test NN I-NP I-test
was VBD B-VP O
negative JJ O O
. . B-VP O
   
Because IN B-VP O
of IN B-VP O
poor JJ B-NP O
compliance NN I-NP O
with IN B-VP O
the DT B-NP B-test
gait NN I-NP I-test
examination NN I-NP I-test
it PRP O B-pronoun
was VBD B-VP O
very RB O O
difficult JJ O O
to TO O O
assess VB O O
changing VBG O B-problem
gait JJ B-NP I-problem
post NN I-NP O
lumbar NN I-NP B-test
puncture NN I-NP I-test
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
&apos;s NNP I-NP O
gait NN I-NP O
remained VBD B-VP O
wide JJ O B-problem
based VBN O I-problem
and CC O O
shuffling VBG O B-problem
and CC O O
requiring VBG O O
assist NN B-NP O
. . B-VP O
   
Her PRP$ O B-person
mental JJ B-NP O
status NN I-NP O
remained VBD B-VP O
similarly RB O O
to TO O O
her PRP$ O B-person
her PRP$ O B-test
admission NN B-NP I-test
examination NN I-NP I-test
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
discharged VBN O O
to TO O O
home VB O O
on IN B-VP O
11/15/02 CD O O
with IN B-VP O
instructions NNS B-NP O
to TO O O
the DT B-NP B-person
family NN I-NP I-person
to TO O O
observe VB O O
her PRP$ O B-person
gait NN B-NP O
in IN B-VP O
her PRP$ O B-person
home NN B-NP O
environment NN I-NP O
and CC O O
to TO O O
observe VB O O
her PRP$ O B-person
behavior NN B-NP O
in IN B-VP O
her PRP$ O B-person
home NN B-NP O
environment NN I-NP O
over IN B-VP O
the DT B-NP O
next JJ I-NP O
day NN I-NP O
and CC O O
to TO O O
report VB O O
back RB O O
to TO O O
the DT B-NP B-person
primary JJ I-NP I-person
neurologist NN I-NP I-person
, , O O
Dr. NNP B-NP B-person
Flythegach NNP I-NP I-person
, , O O
as IN B-VP O
to TO O O
changes NNS B-NP O
. . B-VP O
   
DISCHARGE NNP B-NP O
MEDICATIONS NNP I-NP O
: : O O
Were RB O O
as IN B-VP O
they PRP O B-pronoun
were VBD B-VP O
on IN B-VP O
admission NN B-NP O
. . B-VP O
   
The DT O B-person
The DT B-NP B-test
patient JJ I-NP I-person
patient NN I-NP I-test
&apos;s NNP I-NP I-test
neuro CC O I-test
examination NN B-NP I-test
was VBD B-VP O
largely RB O O
unchanged JJ O O
from IN B-VP O
the DT B-NP B-test
admission NN I-NP I-test
neuro DT B-NP I-test
examination NN I-NP I-test
. . B-VP O
   
LATO NNP B-NP B-person
TIKFREIERM NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
DICTATING NNP I-NP O
FOR NNP I-NP O
: : O O
_____________________________ NN B-NP O
LATO NNP I-NP B-person
TIKFREIERM NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
TR NNP I-NP O
: : O O
yh NN B-NP O
DD NNP I-NP O
: : O O
11/14/2002 CD O O
TD NN B-NP O
: : O O
11/19/2002 CD O O
3:35 CD O O
P NNP B-NP O
cc NN I-NP O
: : O O
SIE NNP B-NP B-person
FLYTHEGACH NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
TIFFILL NNP I-NP B-person
SAPNINS NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
STA NNP I-NP B-person
THERNLIN NNP I-NP I-person
BALLOON NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
LATO NNP I-NP B-person
TIKFREIERM NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
/PCP NNP I-NP B-person
, , O O
Jofredd NNP B-NP B-person
Mones NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
Admission NNP I-NP O
Date NNP I-NP O
: : O O
2015-01-19 JJ B-NP O
Discharge NN I-NP O
Date NNP I-NP O
: : O O
2015-01-22 JJ B-NP O
Date NNP I-NP O
of IN B-VP O
Birth NNP B-NP O
: : O O
1948-02-29 JJ B-NP O
Sex NN I-NP O
: : O O
F NNP B-NP O
Service NNP I-NP O
: : O O
CCU NNP B-NP O
DISCHARGE NNP I-NP O
SUMMARY NNP I-NP O
ADDENDUM NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
during IN B-VP O
her PRP$ O B-person
admission NN B-NP O
from IN B-VP O
2015-01-19 JJ O O
to TO O O
2015-01-22 JJ O O
during IN B-VP O
that DT B-NP B-pronoun
admission NN I-NP O
she PRP O B-person
had VBD B-VP O
an DT B-NP B-test
echocardiogram NN I-NP I-test
which WDT O B-pronoun
revealed VBD B-VP O
essentially RB O O
an DT B-NP B-test
ejection NN I-NP I-test
fraction NN I-NP I-test
of IN B-VP O
40% CD O O
with IN B-VP O
a DT B-NP B-problem
patent NN I-NP I-problem
foramen NNS I-NP I-problem
ovale VBP O I-problem
mildly RB O B-problem
dilated VBN O I-problem
left JJ B-NP I-problem
atrium NN I-NP I-problem
. . B-VP O
   
It PRP O B-pronoun
also RB O O
showed VBD B-VP O
intraseptal JJ O B-problem
and CC O I-problem
inferior JJ B-NP I-problem
akinesis NN I-NP I-problem
. . B-VP O
   
Additionally RB O O
because IN B-VP O
of IN B-VP O
her PRP$ O B-person
history NN B-NP O
of IN B-VP O
contrast NN B-NP B-problem
allergy NN I-NP I-problem
, , O O
she PRP O B-person
was VBD B-VP O
given VBN O O
Solu-Medrol NNP B-NP B-treatment
40 CD O O
milligrams NNS B-NP O
IV NNP I-NP O
prior RB O O
to TO O O
the DT B-NP B-test
procedure NN I-NP I-test
. . B-VP O
   
She PRP O B-person
did VBD B-VP O
not RB O O
have VB O O
any DT B-NP B-problem
untoward JJ I-NP I-problem
affects NNS I-NP I-problem
or CC O O
allergic JJ B-NP B-problem
reactions NNS I-NP I-problem
to TO O O
the DT B-NP B-test
procedure NN I-NP I-test
. . B-VP O
   
Barbara NNP B-NP B-person
Gallant NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
66-480 CD O O
Dictated VBN O O
By IN B-VP O
: : O O
Troy NNP B-NP B-person
X. NNP I-NP I-person
Hall NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
MEDQUIST36 NNP I-NP O
D NNP I-NP O
: : O O
2015-03-12 JJ O O
18:30 CD O O
T NN B-NP O
: : O O
2015-03-16 JJ O O
11:19 CD O O
JOB NNP B-NP O
#: VBD B-VP O
24204 CD O O
Signed VBN O O
electronically RB O O
by IN B-VP O
: : O O
DR. NNP B-NP B-person
Barbara NNP I-NP I-person
Rogers NNP I-NP I-person
on IN B-VP O
: : O O
WED JJ O O
2015-03-25 JJ O O
9:51 CD O O
AM NNP B-NP O
( ( O O
End NNP B-NP O
of IN B-VP O
Report NNP B-NP O
) ) O O
-EMPTYLINE- VBP O O
-DOCSTART- JJ O O
-EMPTYLINE- $ O O
125667950 CD O O
PRGH NNP B-NP O
10805085 CD O O
360731 CD O O
10/22/2000 CD O O
12:00:00 CD O O
AM NNP B-NP O
CHRONIC NNP I-NP B-problem
LYMPHOCYTIC NNP I-NP I-problem
LEUKEMIA NNP I-NP I-problem
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date NNP I-NP O
: : O O
10/22/2000 CD O O
Report NNP B-NP O
Status NNP I-NP O
: : O O
Signed VBN O O
Discharge NNP B-NP O
Date NNP I-NP O
: : O O
11/17/2000 CD O O
PRINCIPAL NNP B-NP O
DIAGNOSIS NNP I-NP O
: : O O
CHRONIC NNP B-NP B-problem
LYMPHOCYTIC NNP I-NP I-problem
LEUKEMIA NNP I-NP I-problem
. . B-VP O
   
OTHER NNP B-NP O
PROBLEMS NNP I-NP O
: : O O
1. CD O O
FREQUENT NNP B-NP B-problem
HEADACHES NNP I-NP I-problem
. . B-VP O
   
2. CD O O
CHOLECYSTITIS NNP B-NP B-problem
. . B-VP O
   
3. CD O O
SPASTIC NNP B-NP B-problem
COLON NNP I-NP I-problem
. . B-VP O
   
HISTORY NNP B-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
is VBZ O O
a DT B-NP O
47-year-old JJ I-NP O
man NN I-NP O
with IN B-VP O
advanced JJ B-NP B-problem
stage NN I-NP I-problem
chronic JJ B-NP I-problem
lymphocytic JJ I-NP I-problem
leukemia NN I-NP I-problem
who WP O B-person
was VBD B-VP O
admitted VBN O O
for IN B-VP O
autologous JJ B-NP B-treatment
bone NN I-NP I-treatment
marrow NN I-NP I-treatment
transplant NN I-NP I-treatment
as IN B-VP O
per IN B-VP O
protocol NN B-NP O
94-055 CD O O
of IN B-VP O
the DT B-NP O
Santusli NNP I-NP O
Hospital NNP I-NP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
originally RB O O
diagnosed VBN O O
in IN B-VP O
06/98 CD O O
during IN B-VP O
a DT B-NP B-test
routine JJ I-NP I-test
physical NN I-NP I-test
when WRB O O
he PRP O B-person
was VBD B-VP O
noted VBN O O
to TO O O
have VB O O
a DT B-NP B-test
white JJ I-NP I-test
blood NN I-NP I-test
cell NN I-NP I-test
count NN I-NP I-test
of IN B-VP O
20,000 CD O O
, , O O
weight JJ B-NP B-problem
loss NN I-NP I-problem
, , O O
and CC O O
swelling VBG O B-problem
in IN B-VP I-problem
his PRP$ O B-person
his PRP$ O I-problem
neck NN B-NP I-problem
and CC O I-problem
groin NN B-NP I-problem
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
watched VBN O O
after IN B-VP O
his PRP$ O B-person
his PRP$ O B-problem
initial JJ B-NP I-problem
diagnosis NN I-NP I-problem
, , O O
but CC O O
six CD O O
months NNS B-NP O
later RB O O
he PRP O B-person
developed VBD B-VP O
rapidly RB O B-problem
increasing VBG O I-problem
leukocytosis NN B-NP I-problem
and CC O O
he PRP O B-person
became VBD B-VP O
more RBR O B-problem
symptomatic JJ O I-problem
. . B-VP O
   
After IN B-VP O
treatment NN B-NP B-treatment
with IN B-VP I-treatment
three CD O I-treatment
cycles NNS B-NP I-treatment
of IN B-VP I-treatment
fludarabine NN B-NP I-treatment
he PRP O B-person
had VBD B-VP O
90% CD O B-problem
involvement NN B-NP I-problem
of IN B-VP I-problem
his PRP$ O I-problem
his PRP$ O B-person
intratrabecular JJ B-NP I-problem
space NN I-NP I-problem
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
therefore RB O O
treated VBN O O
with IN B-VP O
three CD O B-treatment
cycles NNS B-NP I-treatment
of IN B-VP I-treatment
fludarabine NN B-NP I-treatment
in IN B-VP O
combination NN B-NP O
with IN B-VP O
cytoxan NN B-NP B-treatment
. . B-VP O
   
After IN B-VP O
this DT B-NP B-treatment
therapy NN I-NP I-treatment
he PRP O B-person
achieved VBD B-VP O
a DT B-NP B-problem
protocol NN I-NP I-problem
eligible JJ B-NP I-problem
minimal JJ I-NP I-problem
disease NN I-NP I-problem
state NN I-NP I-problem
. . B-VP O
   
However RB O O
, , O O
he PRP O B-person
did VBD B-VP O
have VB O O
relative JJ B-NP B-problem
pancytopenia NN I-NP I-problem
following VBG O O
this DT B-NP B-treatment
therapy NN I-NP I-treatment
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
taken VBN O O
to TO O O
bone VB O B-treatment
marrow NN B-NP I-treatment
harvest NN I-NP I-treatment
in IN B-VP O
08/22 CD O O
at IN B-VP O
which WDT O B-pronoun
time NN B-NP O
insufficient NN I-NP B-problem
cells NNS I-NP I-problem
were VBD B-VP O
obtained VBN O O
to TO O O
proceed VB O O
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
returned VBN O O
previous JJ O O
to TO O O
this DT B-NP B-pronoun
admission NN I-NP O
for IN B-VP O
repeat NN B-NP B-treatment
bone NN I-NP I-treatment
marrow NN I-NP I-treatment
harvest NN I-NP I-treatment
and CC O O
at IN B-VP O
that DT B-NP B-pronoun
time NN I-NP O
he PRP O B-person
was VBD B-VP O
given VBN O O
Neupogen NNP B-NP B-treatment
prior RB O O
to TO O O
his PRP$ O B-person
his PRP$ O B-treatment
harvest NN B-NP I-treatment
, , O O
and CC O O
sufficient JJ B-NP O
cells NNS I-NP O
were VBD B-VP O
not RB O O
obtained VBN O O
to TO O O
proceed VB O O
with IN B-VP O
autologous JJ B-NP B-treatment
bone NN I-NP I-treatment
marrow NN I-NP I-treatment
transplantation NN I-NP I-treatment
. . B-VP O
   
His PRP$ O B-person
His PRP$ O B-test
most RBS O I-test
recent JJ B-NP I-test
bone NN I-NP I-test
marrow NN I-NP I-test
biopsy NN I-NP I-test
revealed VBD B-VP O
less JJR O B-problem
than IN B-VP I-problem
5% CD O I-problem
of IN B-VP I-problem
intratrabecular JJ B-NP I-problem
space NN I-NP I-problem
involvement NN I-NP I-problem
. . B-VP O
   
Recent JJ B-NP B-test
CT NNP I-NP I-test
scan NN I-NP I-test
showed VBD B-VP O
no DT B-NP O
significant JJ I-NP B-problem
lymphadenopathy NN I-NP I-problem
. . B-VP O
   
The DT B-NP O
spleen NN I-NP O
was VBD B-VP O
within IN B-VP O
normal JJ B-NP O
limits NNS I-NP O
. . B-VP O
   
PAST NNP B-NP O
MEDICAL NNP I-NP O
HISTORY NNP I-NP O
: : O O
1. CD O O
Episode NNP B-NP O
of IN B-VP O
pneumonia NN B-NP B-problem
in IN B-VP O
1996 CD O O
. . B-VP O
   
2. CD O O
At IN B-VP O
the DT B-NP O
age NN I-NP O
of IN B-VP O
40 CD O O
he PRP O B-person
had VBD B-VP O
problems NNS B-NP O
with IN B-VP O
frequent JJ B-NP B-problem
headaches NNS I-NP I-problem
. . B-VP O
   
3. CD O O
Episodes NNS B-NP O
of IN B-VP O
cholecystitis NN B-NP B-problem
and CC O O
spastic JJ B-NP B-problem
colon NN I-NP I-problem
. . B-VP O
   
MEDICATIONS NNP B-NP O
ON NNP I-NP O
ADMISSION NNP I-NP O
: : O O
No DT B-NP O
medications NNS I-NP B-treatment
upon IN B-VP O
admission NN B-NP O
. . B-VP O
   
ALLERGIES NNP B-NP O
: : O O
No DT B-NP O
known JJ I-NP B-problem
drug NN I-NP I-problem
allergies NNS I-NP I-problem
. . B-VP O
   
SOCIAL NNP B-NP O
HISTORY NN I-NP O
: : O O
He PRP O B-person
works VBZ O O
as IN B-VP O
an DT B-NP O
airline NN I-NP O
pilot NN I-NP O
for IN B-VP O
Vent NNP B-NP O
He PRP O B-person
is VBZ O O
currently RB O O
flying VBG O O
on IN B-VP O
Hwy NNP B-NP O
routes NNS I-NP O
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
married VBN O O
for IN B-VP O
many JJ B-NP O
years NNS I-NP O
. . B-VP O
   
He PRP O B-person
has VBZ O O
three CD O B-person
children NNS B-NP I-person
. . B-VP O
   
He PRP O B-person
is VBZ O O
separated VBN O O
and CC O O
has VBZ O O
a DT O O
very RB O O
supportive JJ B-NP O
new JJ I-NP B-person
partner NN I-NP I-person
. . B-VP O
   
FAMILY NNP B-NP B-person
HISTORY NNP I-NP O
: : O O
His PRP$ O B-person
father NN B-NP O
had VBD B-VP O
prostate JJ B-NP B-problem
cancer NN I-NP I-problem
. . B-VP O
   
Mother NNP B-NP B-person
had VBD B-VP O
breast VBN O B-problem
cancer NN B-NP I-problem
. . B-VP O
   
Has VBZ O O
a DT B-NP O
cousin NN I-NP B-person
with IN B-VP O
a DT B-NP B-problem
brain NN I-NP I-problem
tumor NN I-NP I-problem
. . B-VP O
   
No DT B-NP O
family NN I-NP B-person
history NN I-NP O
of IN B-VP O
leukemia NN B-NP B-problem
or CC O O
lymphoma NN B-NP B-problem
. . B-VP O
   
He PRP O B-person
has VBZ O O
one CD O O
sister NN B-NP B-person
and CC O O
one CD O O
brother NN B-NP B-person
who WP O B-person
are VBP O O
alive JJ O O
and CC O O
well RB O O
. . B-VP O
   
They PRP O B-pronoun
are VBP O O
not RB O O
HLA NNP B-NP O
matched VBD B-VP O
. . B-VP O
   
REVIEW NNP B-NP O
OF NNPS I-NP O
SYSTEMS NNP I-NP O
: : O O
On IN B-VP O
admission NN B-NP O
he PRP O B-person
had VBD B-VP O
no DT B-NP O
upper JJ I-NP B-problem
respiratory NN I-NP I-problem
tract NN I-NP I-problem
symptoms NNS I-NP I-problem
, , O O
recent JJ B-NP B-problem
infections NNS I-NP I-problem
, , O O
chest JJS B-NP B-problem
pain NN I-NP I-problem
, , O O
shortness NN B-NP B-problem
of IN B-VP I-problem
breath NN B-NP I-problem
, , O O
nausea NN B-NP B-problem
or CC O O
vomiting NN B-NP B-problem
, , O O
change NN B-NP B-problem
in IN B-VP I-problem
bowel NN B-NP I-problem
habits NNS I-NP I-problem
or CC O O
abdomen NNS B-NP B-problem
pain VBP O I-problem
. . B-VP O
   
He PRP O B-person
did VBD B-VP O
complain NN B-NP O
of IN B-VP O
frequent JJ B-NP B-problem
headaches NNS I-NP I-problem
. . B-VP O
   
Following VBG O O
his PRP$ O B-person
his PRP$ O B-treatment
recent JJ B-NP I-treatment
bone NN I-NP I-treatment
marrow NN I-NP I-treatment
harvest NN I-NP I-treatment
he PRP O B-person
had VBD B-VP O
protracted VBN O O
episodes NNS B-NP O
of IN B-VP O
nausea NN B-NP B-problem
and CC O O
vomiting NN B-NP B-problem
. . B-VP O
   
All DT B-NP O
other JJ I-NP O
systems NNS I-NP O
were VBD B-VP O
negative JJ O O
. . B-VP O
   
PHYSICAL JJ B-NP O
EXAMINATION NN I-NP O
: : O O
On IN B-VP O
admission NN B-NP O
. . B-VP O
   
GENERAL NN B-NP O
: : O O
He PRP O B-person
was VBD B-VP O
well-appearing JJ O O
and CC O O
in IN B-VP O
no DT B-NP O
apparent JJ I-NP B-problem
distress NN I-NP I-problem
. . B-VP O
   
Performance NN B-NP O
status NN I-NP O
was VBD B-VP O
0 CD O O
. . B-VP O
   
VITAL JJ B-NP O
SIGNS NN I-NP O
: : O O
Weight NNP B-NP B-test
70.4 CD O O
kilograms NNS B-NP O
, , O O
temperature NN B-NP B-test
96.5 CD O O
, , O O
respiratory NN B-NP B-test
rate NN I-NP I-test
20 CD O O
, , O O
blood NN B-NP B-test
pressure NN I-NP I-test
105/60 CD O O
, , O O
pulse RB O B-test
76 CD O O
. . B-VP O
   
SKIN NN B-NP O
: : O O
Unremarkable JJ O O
without IN B-VP O
rashes NNS B-NP B-problem
or CC O O
lesions NNS B-NP B-problem
. . B-VP O
   
HEENT NN B-NP O
: : O O
Sclerae NNP B-NP B-problem
anicteric NN I-NP I-problem
. . B-VP O
   
Pupils NNP B-NP O
equal JJ O O
, , O O
round NN B-NP O
and CC O O
reactive JJ O O
to TO O O
light JJ O O
. . B-VP O
   
Oropharynx NNP B-NP O
, , O O
lips VBZ O O
, , O O
teeth NNS B-NP O
and CC O O
gums NNS B-NP O
were VBD B-VP O
without IN B-VP O
lesions NNS B-NP B-problem
and CC O O
without IN B-VP O
evidence NN B-NP O
of IN B-VP O
mucositis NN B-NP B-problem
. . B-VP O
   
NECK NN B-NP O
: : O O
Supple NN B-NP O
with IN B-VP O
a DT B-NP O
normal JJ I-NP O
thyroid JJ I-NP O
gland NN I-NP O
. . B-VP O
   
No DT O O
cervical JJ O B-problem
, , O I-problem
supraclavicular JJ O I-problem
or CC O I-problem
axillary JJ B-NP I-problem
adenopathy NN I-NP I-problem
. . B-VP O
   
CHEST NN B-NP O
: : O O
Clear JJ O O
. . B-VP O
   
HEART NN B-NP O
: : O O
Heart NNP B-NP B-test
sounds VBZ O I-test
normal JJ O O
. . B-VP O
   
ABDOMEN NN B-NP O
: : O O
Soft JJ O O
, , O O
nontender NN B-NP B-problem
, , O O
without IN B-VP O
any DT B-NP B-problem
masses NNS I-NP I-problem
and CC O O
without IN B-VP O
any DT B-NP B-problem
hepatosplenomegaly NN I-NP I-problem
. . B-VP O
   
GU NNP B-NP O
: : O O
Normal JJ B-NP O
testes NNS I-NP O
and CC O O
penis NN B-NP O
. . B-VP O
   
EXTREMITIES NN B-NP O
: : O O
Without IN B-VP O
clubbing VBG O B-problem
, , O O
cyanosis NN B-NP B-problem
or CC O O
edema NN B-NP B-problem
. . B-VP O
   
NEURO CC O O
: : O O
Normal JJ O O
with IN B-VP O
intact JJ B-NP O
cranial JJ I-NP O
nerves NNS I-NP O
, , O O
deep JJ B-NP O
tendon NN I-NP O
reflexes NNS I-NP O
and CC O O
normal JJ B-NP O
motor NN I-NP O
/ NNP I-NP O
sensory NN I-NP O
exam NN I-NP O
. . B-VP O
   
LABORATORY NNP B-NP O
DATA NNP I-NP O
: : O O
Electrolytes NNS B-NP B-test
were VBD B-VP O
within IN B-VP O
normal JJ B-NP O
limits NNS I-NP O
. . B-VP O
   
Liver NNP B-NP B-test
function NN I-NP I-test
tests NNS I-NP I-test
were VBD B-VP O
within IN B-VP O
normal JJ B-NP O
limits NNS I-NP O
. . B-VP O
   
White NNP B-NP B-test
blood NN I-NP I-test
cell NN I-NP I-test
count NN I-NP I-test
10.4 CD O O
, , O O
hemoglobin NN B-NP B-test
11.9 CD O O
, , O O
platelets NNS B-NP B-test
124 CD O O
, , O O
PT NNP B-NP B-test
and CC O O
PTT NNP B-NP B-test
were VBD B-VP O
within IN B-VP O
normal JJ B-NP O
limits NNS I-NP O
. . B-VP O
   
HOSPITAL NNP B-NP O
COURSE NNP I-NP O
: : O O
1 CD O O
) ) O O
Oncology NN B-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
admitted VBN O O
on IN B-VP O
10/22/00 CD O O
and CC O O
received VBD B-VP O
cytoxan NNS B-NP B-treatment
and CC O O
total JJ B-NP B-treatment
body NN I-NP I-treatment
irradiation NN I-NP I-treatment
per IN B-VP O
protocol NN B-NP O
. . B-VP O
   
Autologous JJ B-NP B-treatment
bone NN I-NP I-treatment
marrow NN I-NP I-treatment
infusion NN I-NP I-treatment
occurred VBD B-VP O
on IN B-VP O
10/29/00 CD O O
and CC O O
was VBD B-VP O
uneventful JJ O O
. . B-VP O
   
His PRP$ O B-person
post-transplant JJ B-NP O
course NN I-NP O
was VBD B-VP O
complicated VBN O O
by IN B-VP O
pain NN B-NP B-problem
from IN B-VP O
mucositis NN B-NP B-problem
and CC O O
recalcitrant JJ B-NP B-problem
nausea NN I-NP I-problem
and CC O I-problem
vomiting NN B-NP I-problem
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
did VBD B-VP O
not RB O O
tolerate VB O O
antiemetics NNS B-NP B-treatment
well RB O O
and CC O O
it PRP O B-pronoun
was VBD B-VP O
subsequently RB O O
decided VBN O O
to TO O O
avoid VB O O
phenothiazides NNS B-NP B-treatment
secondary JJ O O
to TO O O
jitteryness NN B-NP B-problem
and CC O O
restless NN B-NP B-problem
legs NNS I-NP I-problem
. . B-VP O
   
2 CD O O
) ) O O
Infectious JJ B-NP O
Disease NN I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
remained VBD B-VP O
afebrile JJ O B-problem
until IN B-VP O
day NN B-NP O
+11 VBD B-VP O
when WRB O O
he PRP O B-person
spiked VBD B-VP O
and CC O O
was VBD B-VP O
started VBN O O
on IN B-VP O
ceftazidime NN B-NP B-treatment
. . B-VP O
   
Blood NNP B-NP B-test
cultures NNS I-NP I-test
and CC O O
urine JJ B-NP B-test
cultures NNS I-NP I-test
were VBD B-VP O
all DT O O
negative JJ O O
. . B-VP O
   
3 CD O O
) ) O O
Heme NN B-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
acquired VBD B-VP O
intermittent JJ B-NP B-treatment
transfusions NNS I-NP I-treatment
for IN B-VP O
pancytopenia NN B-NP B-problem
. . B-VP O
   
4 CD O O
) ) O O
FEN NN B-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
unable JJ O O
to TO O O
tolerate VB O O
adequate JJ B-NP O
p.o.&apos;s NN I-NP O
in IN B-VP O
the DT B-NP O
last JJ I-NP O
several JJ I-NP O
days NNS I-NP O
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
well RB O O
nourished VBN O O
so RB O O
TPN NNP B-NP B-treatment
was VBD B-VP O
not RB O O
started VBN O O
. . B-VP O
   
I PRP O B-test
&apos;s VBP O I-test
and CC O I-test
O NNP B-NP I-test
&apos;s NNP I-NP I-test
were VBD B-VP O
balanced VBN O O
and CC O O
maintained VBN O O
with IN B-VP O
IV NNP B-NP B-treatment
fluids NNS I-NP I-treatment
. . B-VP O
   
DISCHARGE NNP B-NP O
MEDICATIONS NNP I-NP O
: : O O
Tylenol CD O B-treatment
650 CD O O
mg NN B-NP O
p.o. NN I-NP O
q. JJ B-NP O
4-6h JJ I-NP O
p.r.n. NN I-NP O
headache NN I-NP B-problem
or CC O O
pain NN B-NP B-problem
; : O O
acyclovir CC O B-treatment
400 CD O O
mg NN B-NP O
p.o. NN I-NP O
t.i.d.; NN I-NP O
acyclovir JJ B-NP B-treatment
topical JJ I-NP I-treatment
t.i.d. NN I-NP O
to TO O O
be VB O O
applied VBN O O
to TO O O
lesion VB O B-problem
on IN B-VP I-problem
corner NN B-NP I-problem
of IN B-VP I-problem
mouth NN B-NP I-problem
; : O O
Peridex NNP B-NP B-treatment
15 CD O O
ml NN B-NP O
p.o. NN I-NP O
b.i.d.; NN I-NP O
Mycelex NNP I-NP B-treatment
1 CD O O
troche NN B-NP O
p.o. NN I-NP O
t.i.d.; VBD B-VP O
g-csf JJ O O
404 CD O O
mcg NN B-NP O
subcu NN I-NP O
q.d.; VBZ O O
folic JJ O B-treatment
acid RB O I-treatment
1 CD O O
mg NNS B-NP O
p.o. JJ B-NP O
q.d.; JJ I-NP O
lorazepam JJ I-NP B-treatment
1-2 JJ I-NP O
mg NN I-NP O
p.o. NN I-NP O
q. JJ B-NP O
4-6h JJ I-NP O
p.r.n. NN I-NP O
nausea NN I-NP B-problem
and CC O O
vomiting NN B-NP B-problem
; : O O
Miracle NNP B-NP B-treatment
Cream NNP I-NP I-treatment
topical JJ B-NP O
q.d. NN I-NP O
p.r.n. JJ B-NP O
perianal JJ I-NP B-problem
irritation NN I-NP I-problem
; : O O
Eucerin NNP B-NP B-treatment
Cream NNP I-NP I-treatment
topical JJ B-NP O
b.i.d.; NN I-NP O
Zantac NNP I-NP B-treatment
150 CD O O
mg NN B-NP O
p.o. NN I-NP O
b.i.d.; NN I-NP O
Restoril NNP I-NP B-treatment
15-30 JJ B-NP O
mg NN I-NP O
p.o. NN I-NP O
q. JJ B-NP O
h.s. NN I-NP O
p.r.n. NN I-NP O
insomnia NN I-NP B-problem
; : O O
multivitamin CC O B-treatment
1 CD O O
tablet NN B-NP O
p.o. NN I-NP O
q.d.; RB O O
viscous JJ B-NP B-treatment
lidocaine NN I-NP I-treatment
15 CD O O
ml NN B-NP O
p.o. NN I-NP O
q. $ O O
3h CD O O
can MD O O
be VB O O
applied VBN O O
to TO O O
corner NN B-NP O
of IN B-VP O
mouth NN B-NP O
or CC O O
lips NNS B-NP O
p.r.n. VBP O O
pain NN B-NP B-treatment
control NN I-NP I-treatment
. . B-VP O
   
CONDITION NNP B-NP O
UPON NNP I-NP O
DISCHARGE NNP I-NP O
: : O O
Stable JJ O O
. . B-VP O
   
FOLLOWUP NN B-NP O
: : O O
Follow NNP B-NP O
up RP O O
appointment NN B-NP O
with IN B-VP O
Die NNP B-NP B-person
Anoort NNP I-NP I-person
and CC O O
Tomedankell NNP B-NP B-person
Care NNP I-NP I-person
on IN B-VP O
11/18/00 CD O O
at IN B-VP O
9:30 CD O O
a.m. NN B-NP O
( ( O O
one CD O O
day NN B-NP O
after IN B-VP O
discharge NN B-NP O
) ) O O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
knows VBZ O O
to TO O O
go VB O O
to TO O O
Sper NNP B-NP O
Medical NNP I-NP O
Center NNP I-NP O
every DT B-NP O
day NN I-NP O
for IN B-VP O
line NN B-NP B-treatment
care NN I-NP I-treatment
, , O O
blood NN B-NP B-test
draws NNS I-NP I-test
, , O O
and CC O O
monitoring NN B-NP B-test
. . B-VP O
   
Dictated VBN O O
By IN B-VP O
: : O O
CONRELLIE NNP B-NP B-person
KOTERUDES NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
VJ31 NNP I-NP O
Attending NNP I-NP B-person
: : O O
SUOT NNP B-NP B-person
CARE NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
OB89 NNP I-NP O
RL958/5760 NNP I-NP O
Batch NNP I-NP O
: : O O
24769 CD O O
Index NNP B-NP O
No. NN I-NP O
GFNC2Z5N8Q NNP I-NP O
D NNP I-NP O
: : O O
11/22/00 CD O O
T NN B-NP O
: : O O
11/22/00 CD O O
CC NN B-NP O
: : O O
1. CD O O
TOMEDANKELL NNP B-NP B-person
CARE NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
RE04 NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- VBD B-VP O
412141256 CD O O
FIH NNP B-NP O
3833231 CD O O
39626/6vf7 CD O O
817292 CD O O
10/3/1994 CD O O
12:00:00 CD O O
AM NNP B-NP O
Discharge NNP I-NP O
Summary NNP I-NP O
Unsigned VBD B-VP O
DIS NNP B-NP O
Report NNP I-NP O
Status NNP I-NP O
: : O O
Unsigned VBN O O
ADMISSION NNP B-NP O
DATE NNP I-NP O
: : O O
10-03-94 JJ B-NP O
DISCHARGE NNP I-NP O
DATE NNP I-NP O
: : O O
10-06-94 JJ B-NP O
HISTORY NNP I-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS NNP I-NP O
: : O O
This DT O B-pronoun
This DT O B-person
85 CD O I-person
year NN B-NP I-person
old JJ B-NP I-person
man NN I-NP I-person
was VBD B-VP O
admitted VBN O O
because IN B-VP O
of IN B-VP O
the DT B-NP O
new JJ I-NP O
onset NN I-NP O
of IN B-VP O
focal JJ B-NP B-problem
left-sided JJ I-NP I-problem
seizure NN I-NP I-problem
and CC O O
unresponsiveness NN B-NP B-problem
. . B-VP O
   
He PRP O B-person
had VBD B-VP O
a DT B-NP O
past JJ I-NP O
history NN I-NP O
of IN B-VP O
ischemic JJ B-NP B-problem
cardiomyopathy NN I-NP I-problem
with IN B-VP O
an DT B-NP B-test
ejection NN I-NP I-test
fraction NN I-NP I-test
of IN B-VP O
10 CD O O
, , O O
mild FW O B-problem
aortic JJ B-NP I-problem
stenosis NN I-NP I-problem
and CC O O
a DT B-NP B-problem
right JJ I-NP I-problem
middle JJ I-NP I-problem
cerebral JJ I-NP I-problem
artery NN I-NP I-problem
territory NN I-NP I-problem
stroke NN I-NP I-problem
in IN B-VP O
07/94 CD O O
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
at IN B-VP O
Orlak NNP B-NP O
on IN B-VP O
the DT B-NP O
day NN I-NP O
of IN B-VP O
admission NN B-NP O
and CC O O
was VBD B-VP O
found VBN O O
unresponsive JJ O B-problem
with IN B-VP O
left JJ B-NP B-problem
tonic-clonic JJ I-NP I-problem
movements NNS I-NP I-problem
, , O O
greater JJR O O
in IN B-VP O
the DT B-NP O
arms NNS I-NP O
than IN B-VP O
in IN B-VP O
the DT B-NP O
legs NN I-NP O
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
transferred VBN O O
to TO O O
Fairm NNP B-NP O
of IN B-VP O
Ijordcompmac NNP B-NP O
Hospital NNP I-NP O
, , O O
where WRB O O
seizures NNS B-NP B-problem
were VBD B-VP O
stopped VBN O O
with IN B-VP O
2 CD O O
mg NNS B-NP O
of IN B-VP O
Ativan NNP B-NP B-treatment
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
loaded VBN O O
with IN B-VP O
IV NNP B-NP B-treatment
Dilantin NNP I-NP I-treatment
. . B-VP O
   
He PRP O B-person
remained VBD B-VP O
unresponsive JJ O B-problem
with IN B-VP O
poor JJ B-NP B-problem
airway NN I-NP I-problem
protection NN I-NP I-problem
. . B-VP O
   
PHYSICAL JJ B-NP O
EXAMINATION NN I-NP O
: : O O
Eyes NNS B-NP O
were VBD B-VP O
deviated VBN O B-problem
to TO O I-problem
the DT B-NP I-problem
left NN I-NP I-problem
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
flaccid VBN O B-problem
bilaterally RB O I-problem
. . B-VP O
   
He PRP O B-person
had VBD B-VP O
no DT B-NP O
oculocephalic JJ I-NP B-problem
reflexes NNS I-NP I-problem
. . B-VP O
   
After IN B-VP O
one CD O O
hour NN B-NP O
his PRP$ O B-person
eyes NNS B-NP O
were VBD B-VP O
midline JJ O O
and CC O O
he PRP O B-person
remained VBD B-VP O
unresponsive JJ O B-problem
. . B-VP O
   
HOSPITAL NNP B-NP O
COURSE NNP I-NP O
: : O O
By IN B-VP O
the DT B-NP B-person
patient NN I-NP I-person
and CC O O
his PRP$ O B-person
his PRP$ O B-person
family NN B-NP I-person
&apos;s NNP I-NP O
prior RB O O
wishes VBZ O O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
extubated VBN O O
. . B-VP O
   
An DT B-NP B-test
electroencephalogram NN I-NP I-test
revealed VBD B-VP O
generalized JJ B-NP B-problem
slowing NN I-NP I-problem
without IN B-VP O
ictal JJ B-NP B-problem
events NNS I-NP I-problem
. . B-VP O
   
He PRP O B-person
had VBD B-VP O
no DT B-NP O
carotid NN I-NP B-problem
bruits VBZ O I-problem
. . B-VP O
   
He PRP O B-person
had VBD B-VP O
stertorous JJ B-NP B-problem
breathing NN I-NP I-problem
, , O O
positional JJ B-NP B-problem
tremors NNS I-NP I-problem
of IN B-VP I-problem
the DT B-NP I-problem
left JJ I-NP I-problem
upper JJ I-NP I-problem
extremity NN I-NP I-problem
, , O O
a DT B-NP B-problem
spastic JJ I-NP I-problem
left NN I-NP I-problem
hemiparesis NN I-NP I-problem
in IN B-VP I-problem
flexion NN B-NP I-problem
. . B-VP O
   
He PRP O B-person
withdrew VBD B-VP O
both DT B-NP O
legs NNS I-NP O
to TO O O
painful JJ B-NP B-test
stimuli NNS I-NP I-test
. . B-VP O
   
The DT B-NP O
right JJ I-NP O
upper JJ I-NP O
extremity NN I-NP O
was VBD B-VP O
flaccid JJ O B-problem
and CC O O
paresthetic JJ O B-problem
. . B-VP O
   
Again NNP B-NP O
, , O O
comfort NN B-NP B-treatment
measures NNS I-NP I-treatment
only RB O I-treatment
were VBD B-VP O
undertaken VBN O O
as IN B-VP O
per IN B-VP O
the DT B-NP B-person
patient NN I-NP I-person
&apos;s NNP I-NP O
previous JJ B-NP O
wishes NNS I-NP O
and CC O O
the DT B-NP B-person
family NN I-NP I-person
&apos;s NNP I-NP O
current JJ B-NP O
insistence NN I-NP O
. . B-VP O
   
At IN B-VP O
1:15 CD O O
PM NNP B-NP O
on IN B-VP O
10/06/94 CD O O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
found VBN O O
unresponsive JJ O B-problem
with IN B-VP O
no DT B-NP O
heart NN I-NP B-problem
sounds VBZ O I-problem
, , O O
carotid NN B-NP B-problem
pulse NN I-NP I-problem
, , O O
respiratory JJ B-NP B-problem
excursions NNS I-NP I-problem
, , O O
or CC O O
pupillary JJ B-NP B-problem
reactions NNS I-NP I-problem
. . B-VP O
   
His PRP$ O B-person
His PRP$ O B-person
family NN B-NP I-person
was VBD B-VP O
notified VBN O O
. . B-VP O
   
Consent NN B-NP O
for IN B-VP O
autopsy NN B-NP B-test
was VBD B-VP O
denied VBN O O
. . B-VP O
   
DISCHARGE NNP B-NP O
DIAGNOSIS NNP I-NP O
: : O O
1. CD O O
Left NNP B-NP B-problem
middle JJ B-NP I-problem
cerebral JJ I-NP I-problem
artery NN I-NP I-problem
territory NN I-NP I-problem
cerebral JJ B-NP I-problem
infarction NN I-NP I-problem
. . B-VP O
   
2. CD O O
Cardiomyopathy NNP B-NP B-problem
. . B-VP O
   
3. CD O O
Residual NNP B-NP O
of IN B-VP O
previous JJ B-NP B-problem
right JJ I-NP I-problem
middle JJ I-NP I-problem
cerebral JJ I-NP I-problem
artery NN I-NP I-problem
stroke NN I-NP I-problem
. . B-VP O
   
RE NNP B-NP B-person
RHALTFETHFONGPOCE NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
TR NNP I-NP O
: : O O
cnm NN B-NP O
/ NNP I-NP O
bmot NN I-NP O
DD NNP I-NP O
: : O O
10-18-94 JJ B-NP O
TD NN I-NP O
: : O O
10/19/94 CD O O
CC NN B-NP O
: : O O
-EMPTYLINE- JJ B-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
1191042 CD O O
Admission NNP B-NP O
Date NNP I-NP O
: : O O
2015-04-21 JJ B-NP O
Discharge NN I-NP O
Date NNP I-NP O
: : O O
2015-04-29 JJ B-NP O
Date NNP I-NP O
of IN B-VP O
Birth NNP B-NP O
: : O O
2015-04-21 JJ B-NP O
Sex NN I-NP O
: : O O
M NNP B-NP O
Service NNP I-NP O
: : O O
CMED JJ B-NP O
HISTORY NN I-NP O
: : O O
Baby NNP B-NP B-person
Daniel NNP I-NP I-person
Holman NNP I-NP I-person
was VBD B-VP O
born VBN O O
at IN B-VP O
39 CD O O
and CC O O
3/7 CD O O
weeks NNS B-NP O
gestation NN I-NP O
( ( O O
EDC NNP B-NP O
2015-04-25 CD O O
). NNP B-NP O
His PRP$ O B-person
His PRP$ O B-person
mother NN B-NP I-person
is VBZ O O
a DT B-NP O
31-year-old JJ I-NP O
female NN I-NP O
gravida NN I-NP O
2 CD O O
, , O O
para NN B-NP O
1 CD O O
, , O O
now RB O O
2 CD O O
. . B-VP O
   
Prenatal JJ B-NP B-test
screens NNS I-NP I-test
: : O O
blood NN B-NP B-test
type NN I-NP I-test
A NNP I-NP O
positive JJ O O
, , O O
antibody JJ O B-test
negative JJ O O
, , O O
rubella NN B-NP B-test
immune NN I-NP O
, , O O
RPR NNP B-NP B-test
nonreactive NN I-NP O
, , O O
hepatitis NN B-NP B-test
B NNP I-NP I-test
surface NN I-NP I-test
antigen NN I-NP I-test
negative JJ O O
, , O O
GBS NNP B-NP B-test
unknown RB O O
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
born VBN O O
by IN B-VP O
repeat NN B-NP B-treatment
C-section NN I-NP I-treatment
. . B-VP O
   
There EX O O
was VBD B-VP O
artificial JJ B-NP B-treatment
rupture NN I-NP I-treatment
of IN B-VP I-treatment
membranes NNS B-NP I-treatment
was VBD B-VP O
performed VBN O O
at IN B-VP O
the DT B-NP B-treatment
delivery NN I-NP I-treatment
. . B-VP O
   
Amniotic JJ B-NP O
fluid NN I-NP O
was VBD B-VP O
clear JJ O O
. . B-VP O
   
Mother NNP B-NP B-person
received VBD B-VP O
epidural JJ O B-treatment
and CC O O
spinal JJ B-NP B-treatment
anesthesia NN I-NP I-treatment
. . B-VP O
   
Baby NNP B-NP B-person
was VBD B-VP O
vigorous JJ O O
at IN B-VP O
birth NN B-NP O
and CC O O
received VBD B-VP O
routine JJ B-NP O
DR NNP I-NP B-person
Johnson NNP I-NP I-person
. . B-VP O
   
Apgars NNP B-NP B-test
were VBD B-VP O
9 CD O O
and CC O O
9 CD O O
at IN B-VP O
1 CD O O
and CC O O
5 CD O O
minutes NNS B-NP O
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
transferred VBN O O
to TO O O
the DT B-NP O
newborn JJ I-NP O
nursery NN I-NP O
for IN B-VP O
further JJ B-NP B-treatment
care NN I-NP I-treatment
. . B-VP O
   
In IN B-VP O
the DT B-NP O
newborn JJ I-NP O
nursery NN I-NP O
he PRP O B-person
was VBD B-VP O
started VBN O O
on IN B-VP O
PO NNP B-NP B-treatment
feedings NNS I-NP I-treatment
on IN B-VP O
demand NN B-NP O
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
noted VBN O O
to TO O O
be VB O O
large JJ O B-problem
for IN B-VP I-problem
gestational JJ B-NP I-problem
age NN I-NP I-problem
with IN B-VP O
a DT B-NP B-test
weight NN I-NP I-test
of IN B-VP O
4525 CD O O
grams NNS B-NP O
. . B-VP O
   
His PRP$ O B-person
His PRP$ O B-test
d-sticks NNS B-NP I-test
were VBD B-VP O
greater JJR O O
than IN B-VP O
80 CD O O
. . B-VP O
   
At IN B-VP O
5 CD O O
hours NNS B-NP O
of IN B-VP O
life NN B-NP O
he PRP O B-person
was VBD B-VP O
noted VBN O O
to TO O O
have VB O O
grunting NN B-NP B-problem
and CC O O
flaring NN B-NP B-problem
and CC O O
E.C. NNP B-NP O
Bovell NNP I-NP O
consult NN I-NP O
was VBD B-VP O
done VBN O O
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
in IN B-VP O
mild JJ B-NP B-problem
respiratory NN I-NP I-problem
distress NN I-NP I-problem
and CC O O
a DT B-NP O
diagnosis NN I-NP O
of IN B-VP O
transient JJ B-NP B-problem
tachypnea NN I-NP I-problem
of IN B-VP I-problem
the DT B-NP I-problem
newborn NN I-NP I-problem
was VBD B-VP O
made VBN O O
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
observed VBN O O
in IN B-VP O
the DT B-NP O
nursery NN I-NP O
for IN B-VP O
progression NN B-NP B-problem
of IN B-VP I-problem
symptoms NNS B-NP I-problem
. . B-VP O
   
At IN B-VP O
16 CD O O
hours NNS B-NP O
of IN B-VP O
life NN B-NP O
he PRP O B-person
was VBD B-VP O
noted VBN O O
to TO O O
have VB O O
increased VBN O B-problem
work NN B-NP I-problem
of IN B-VP I-problem
breathing VBG O I-problem
with IN B-VP O
tachypnea NN B-NP B-problem
, , O O
flaring VBG O B-problem
and CC O O
grunting VBG O B-problem
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
also RB O O
noted VBN O O
to TO O O
have VB O O
axillary JJ B-NP B-test
temperature NN I-NP I-test
of IN B-VP O
100.4 CD O O
and CC O O
a DT B-NP B-test
rectal JJ I-NP I-test
temperature NN I-NP I-test
of IN B-VP O
100.9 CD O O
. . B-VP O
   
At IN B-VP O
this DT B-NP B-pronoun
point NN I-NP O
CMED NNP I-NP O
was VBD B-VP O
consulted VBN O O
again RB O O
and CC O O
he PRP O B-person
was VBD B-VP O
transferred VBN O O
to TO O O
the DT B-NP O
CMED NNP I-NP O
triage NN I-NP O
for IN B-VP O
further JJ B-NP B-treatment
care NN I-NP I-treatment
. . B-VP O
   
PHYSICAL JJ B-NP O
EXAMINATION NN I-NP O
: : O O
Birth NNP B-NP B-test
weight NN I-NP I-test
of IN B-VP O
4525 CD O O
grams NNS B-NP O
which WDT O B-pronoun
is VBZ O O
greater JJR O O
than IN B-VP O
90th CD O O
percentile NN B-NP O
; : O O
length CC O B-test
54 CD O O
cm NN B-NP O
which WDT O B-pronoun
is VBZ O O
greater JJR O O
than IN B-VP O
90th CD O O
percentile NN B-NP O
; : O O
head NN B-NP B-test
circumference NN I-NP I-test
37 CD O O
cm NN B-NP O
which WDT O B-pronoun
is VBZ O O
greater JJR O O
than IN B-VP O
90th CD O O
percentile NN B-NP O
. . B-VP O
   
D-sticks NNS B-NP B-test
of IN B-VP O
117 CD O O
. . B-VP O
   
Large NN B-NP B-problem
for IN B-VP I-problem
gestational JJ B-NP I-problem
age NN I-NP I-problem
appearance NN I-NP I-problem
of IN B-VP O
an DT B-NP O
infant NN I-NP B-person
with IN B-VP O
tachypnea NN B-NP B-problem
, , O O
grunting VBG O B-problem
and CC O O
flaring VBG O B-problem
. . B-VP O
   
HEENT NN B-NP O
: : O O
Anterior JJ B-NP O
fontanel NNS I-NP O
open JJ O O
and CC O O
flat JJ O O
. . B-VP O
   
Bilateral NNP B-NP B-test
red JJ B-NP I-test
reflexes NNS I-NP I-test
. . B-VP O
   
Patent NN B-NP O
nares NNS I-NP O
. . B-VP O
   
Mild NNP B-NP B-problem
flaring VBG O I-problem
. . B-VP O
   
Neck NNP B-NP O
supple NN I-NP O
. . B-VP O
   
Clavicles NNP B-NP O
stable JJ O O
. . B-VP O
   
RESPIRATORY NN B-NP O
: : O O
Tachypneic NN B-NP B-problem
with IN B-VP O
mild JJ B-NP B-problem
retractions NNS I-NP I-problem
, , O O
increased VBD B-VP B-problem
work NN B-NP I-problem
of IN B-VP I-problem
breathing NN B-NP I-problem
, , O O
clear JJ O O
and CC O O
equal JJ B-NP O
breath NN I-NP O
sounds NNS I-NP O
. . B-VP O
   
CARDIOVASCULAR NN B-NP O
: : O O
Normal JJ B-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
. . B-VP O
   
Normal NNP B-NP O
S1 NNP I-NP O
and CC O O
S2 NNP B-NP O
without IN B-VP O
murmur NN B-NP B-problem
. . B-VP O
   
Brachial JJ B-NP B-test
pulses NNS I-NP I-test
equal JJ B-NP O
femoral JJ I-NP B-test
pulses NNS I-NP I-test
and CC O O
are VBP O O
2+ CD O O
. . B-VP O
   
ABDOMEN NN B-NP O
: : O O
Soft JJ O O
, , O O
nontender NN B-NP B-problem
, , O O
nondistended VBN O B-problem
. . B-VP O
   
No DT B-NP O
hepatosplenomegaly NN I-NP B-problem
. . B-VP O
   
Patent NNP B-NP O
anus NN I-NP O
. . B-VP O
   
Umbilical JJ B-NP O
stump NN I-NP O
dry NN I-NP O
. . B-VP O
   
GENITALIA NNP B-NP O
: : O O
Normal JJ B-NP O
male NN I-NP O
. . B-VP O
   
Testes VBZ O O
distended VBD B-VP O
bilaterally RB O O
. . B-VP O
   
NEUROLOGIC NN B-NP O
: : O O
Alert NNP B-NP O
and CC O O
crying VBG O O
. . B-VP O
   
Normal NNP B-NP O
tone NN I-NP O
and CC O O
neonatal JJ B-NP B-test
reflexes NNS I-NP I-test
. . B-VP O
   
EXTREMITIES NN B-NP O
: : O O
Warm JJ O O
and CC O O
pink NN B-NP O
. . B-VP O
   
Moves VBZ O O
all DT B-NP O
extremities NNS I-NP O
well RB O O
. . B-VP O
   
Hips NNP B-NP O
stable JJ O O
. . B-VP O
   
Skin NNP B-NP O
pink NN I-NP O
and CC O O
capillary JJ B-NP B-test
refill NN I-NP I-test
less JJR O O
than IN B-VP O
2 CD O O
seconds NNS B-NP O
. . B-VP O
   
Spine NNP B-NP O
straight VBD B-VP O
and CC O O
no DT B-NP O
abnormalities NNS I-NP B-problem
. . B-VP O
   
SUMMARY NNP B-NP O
OF IN B-VP O
HOSPITAL NNP B-NP O
COURSE NNP I-NP O
BY NNP I-NP O
SYSTEMS NNP I-NP O
: : O O
RESPIRATORY NN B-NP O
: : O O
The DT B-NP O
infant NN I-NP B-person
was VBD B-VP O
placed VBN O O
on IN B-VP O
CPAP NNP B-NP B-treatment
on IN B-VP O
admission NN B-NP O
to TO O O
the DT B-NP O
CMED NNP I-NP O
and CC O O
remained VBD B-VP O
on IN B-VP O
CPAP NNP B-NP B-treatment
until IN B-VP O
day NN B-NP O
of IN B-VP O
life NN B-NP O
2 CD O O
at IN B-VP O
which WDT O B-pronoun
time NN B-NP O
he PRP O B-person
weaned VBD B-VP O
to TO O O
nasal VB O B-treatment
cannula NN B-NP I-treatment
and CC O O
then RB O O
subsequently RB O O
to TO O O
room NN B-NP O
air NN I-NP O
on IN B-VP O
day NN B-NP O
of IN B-VP O
life NN B-NP O
3 CD O O
. . B-VP O
   
He PRP O B-person
has VBZ O O
remained VBN O O
on IN B-VP O
room NN B-NP O
air NN I-NP O
since IN B-VP O
that DT B-NP B-pronoun
time NN I-NP O
and CC O O
has VBZ O O
had VBN O O
no DT B-NP O
issues NNS I-NP O
with IN B-VP O
apnea NN B-NP B-problem
or CC O O
desaturation NN B-NP B-problem
since IN B-VP O
being VBG O O
on IN B-VP O
room NN B-NP O
air NN I-NP O
. . B-VP O
   
Initial JJ B-NP B-test
chest JJS I-NP I-test
x-ray NN I-NP I-test
in IN B-VP O
the DT B-NP O
CMED NNP I-NP O
showed VBD B-VP O
haziness NN B-NP B-problem
in IN B-VP I-problem
the DT B-NP I-problem
left NN I-NP I-problem
lower JJR B-NP I-problem
lobe NN I-NP I-problem
and CC O O
patchy JJ B-NP B-problem
areas NNS I-NP I-problem
on IN B-VP I-problem
the DT B-NP I-problem
right JJ I-NP I-problem
side NN I-NP I-problem
consistent JJ O O
with IN B-VP O
concerns NNS B-NP O
for IN B-VP O
pneumonia NN B-NP B-problem
. . B-VP O
   
The DT B-NP B-person
infant NN I-NP I-person
was VBD B-VP O
treated VBN O O
for IN B-VP O
pneumonia NN B-NP B-problem
from IN B-VP O
admission NN B-NP O
to TO O O
the DT B-NP O
CMED NNP I-NP O
. . B-VP O
   
CARDIOVASCULAR NN B-NP O
: : O O
The DT B-NP B-person
infant NN I-NP I-person
has VBZ O O
maintained VBN O O
stable JJ B-NP O
cardiovascular JJ I-NP O
status NN I-NP O
with IN B-VP O
normal JJ B-NP O
heart NN I-NP O
rates NNS I-NP O
and CC O O
blood NN B-NP B-test
pressures NNS I-NP I-test
and CC O O
no DT B-NP O
murmurs NN I-NP B-problem
. . B-VP O
   
FLUIDS NNP B-NP O
, , O O
ELECTROLYTES NNP B-NP O
AND CC O O
NUTRITION NNP B-NP O
: : O O
The DT B-NP B-person
infant NN I-NP I-person
was VBD B-VP O
started VBN O O
on IN B-VP O
IV NNP B-NP B-treatment
fluids NNS I-NP I-treatment
on IN B-VP O
admission NN B-NP O
to TO O O
the DT B-NP O
CMED NNP I-NP O
. . B-VP O
   
Electrolytes NNS B-NP B-test
were VBD B-VP O
measured VBN O O
on IN B-VP O
day NN B-NP O
of IN B-VP O
life NN B-NP O
2 CD O O
and CC O O
were VBD B-VP O
stable JJ O O
at IN B-VP O
that DT B-NP B-pronoun
time NN I-NP O
. . B-VP O
   
No DT B-NP O
further JJ I-NP B-test
electrolytes NNS I-NP I-test
have VBP O O
been VBN O O
measured VBN O O
. . B-VP O
   
Enteral JJ B-NP B-treatment
feedings NNS I-NP I-treatment
were VBD B-VP O
initiated VBN O O
on IN B-VP O
day NN B-NP O
of IN B-VP O
life NN B-NP O
3 CD O O
and CC O O
the DT B-NP O
infant NN I-NP B-person
has VBZ O O
been VBN O O
ad NN B-NP B-treatment
lib NN I-NP I-treatment
PO NNP I-NP I-treatment
feeding NN I-NP I-treatment
on IN B-VP O
demand NN B-NP O
since IN B-VP O
that DT B-NP B-pronoun
time NN I-NP O
. . B-VP O
   
His PRP$ O B-person
His PRP$ O B-test
discharge NN B-NP I-test
weight NN I-NP I-test
is VBZ O O
4180 CD O O
grams NN B-NP O
. . B-VP O
   
GASTROINTESTINAL NN B-NP O
: : O O
Bilirubin NNP B-NP B-test
level NN I-NP I-test
was VBD B-VP O
peaked VBN O O
on IN B-VP O
day NN B-NP O
of IN B-VP O
life NN B-NP O
4 CD O O
to TO O O
10.9/0.3 CD O O
. . B-VP O
   
He PRP O B-person
has VBZ O O
required VBN O O
no DT B-NP O
phototherapy NN I-NP B-treatment
. . B-VP O
   
HEMATOLOGY NN B-NP O
: : O O
Hematocrit NN B-NP B-test
was VBD B-VP O
done VBN O O
on IN B-VP O
admission NN B-NP O
to TO O O
the DT B-NP O
CMED NNP I-NP O
. . B-VP O
   
Hematocrit NNP B-NP B-test
was VBD B-VP O
41 CD O O
, , O O
platelet NN B-NP B-test
count NN I-NP I-test
of IN B-VP O
404,000 CD O O
. . B-VP O
   
No DT B-NP O
further JJ I-NP O
hematocrit NN I-NP B-test
or CC O O
platelets NNS B-NP B-test
have VBP O O
been VBN O O
measured VBN O O
. . B-VP O
   
Blood NNP B-NP B-test
typing NN I-NP I-test
has VBZ O O
been VBN O O
done VBN O O
on IN B-VP O
this DT O B-pronoun
this DT B-NP B-person
infant NN I-NP I-person
. . B-VP O
   
The DT O B-test
The DT B-NP B-person
baby NN I-NP I-test
baby NN I-NP I-person
's POS O I-test
blood NN B-NP I-test
type NN I-NP I-test
is VBZ O O
B NNP B-NP O
negative JJ O O
, , O O
antibody JJ O B-test
negative JJ O O
. . B-VP O
   
INFECTIOUS JJ B-NP O
DISEASE NN I-NP O
: : O O
CBC NNP B-NP B-test
and CC O O
blood NN B-NP B-test
culture NN I-NP I-test
were VBD B-VP O
screened VBN O O
on IN B-VP O
admission NN B-NP O
. . B-VP O
   
CBC NNP B-NP B-test
was VBD B-VP O
benign VBN O O
with IN B-VP O
22,000 CD O O
whites NNS B-NP B-test
, , O O
80 CD O O
poly NN B-NP B-test
's, POS O I-test
0 CD O O
bands NNS B-NP B-test
, , O O
15 CD O O
lymphs NN B-NP B-test
. . B-VP O
   
Ampicillin NNP B-NP B-treatment
and CC O O
gentamycin NN B-NP B-treatment
were VBD B-VP O
initiated VBN O O
on IN B-VP O
admission NN B-NP O
and CC O O
an DT B-NP B-test
LP NNP I-NP I-test
was VBD B-VP O
done VBN O O
due JJ O O
to TO O O
the DT B-NP O
clinical JJ I-NP O
issues NNS I-NP O
of IN B-VP O
respiratory NN B-NP B-problem
distress NN I-NP I-problem
and CC O O
fever NN B-NP B-problem
on IN B-VP O
admission NN B-NP O
to TO O O
the DT B-NP O
CMED NNP I-NP O
. . B-VP O
   
CSF NNP B-NP B-test
showed VBD B-VP O
white JJ B-NP B-test
count NN I-NP I-test
of IN B-VP O
7 CD O O
, , O O
reds VBZ O B-test
4 CD O O
, , O O
protein RB O B-test
119 CD O O
, , O O
glucose VBD B-VP B-test
69 CD O O
. . B-VP O
   
The DT B-NP O
infant NN I-NP B-person
was VBD B-VP O
treated VBN O O
for IN B-VP O
7 CD O O
days NNS B-NP O
of IN B-VP O
presumed JJ B-NP O
pneumonia NN I-NP B-problem
with IN B-VP O
ampicillin NN B-NP B-treatment
and CC O O
gentamycin NN B-NP B-treatment
. . B-VP O
   
Antibiotics NNS B-NP B-treatment
were VBD B-VP O
discontinued VBN O O
on IN B-VP O
the DT B-NP O
evening NN I-NP O
of IN B-VP O
2015-04-28 JJ O O
. . B-VP O
   
NEUROLOGY NN B-NP O
: : O O
The DT B-NP B-person
infant NN I-NP I-person
has VBZ O O
maintained VBN O O
a DT B-NP O
normal JJ I-NP O
neurologic JJ I-NP O
examination NN I-NP O
. . B-VP O
   
SENSORY NN B-NP O
: : O O
Hearing NN B-NP B-test
screen NN I-NP I-test
was VBD B-VP O
performed VBN O O
with IN B-VP O
automated JJ B-NP B-test
auditory NN I-NP I-test
brain NN I-NP I-test
stem NN I-NP I-test
responses NNS I-NP I-test
and CC O O
the DT B-NP O
results NNS I-NP O
was VBD B-VP O
the DT B-NP B-person
infant JJ I-NP I-person
passing NN I-NP O
in IN B-VP O
both DT B-NP O
ears NNS I-NP O
. . B-VP O
   
PSYCHOSOCIAL NNP B-NP O
: : O O
A DT B-NP B-person
Arbour NNP I-NP I-person
Hospital NNP I-NP I-person
social JJ B-NP I-person
worker NN I-NP I-person
has VBZ O O
been VBN O O
involved VBN O O
with IN B-VP O
the DT B-NP B-person
family NN I-NP I-person
. . B-VP O
   
The DT B-NP O
contact JJ I-NP B-person
social JJ I-NP I-person
worker NN I-NP I-person
can MD O O
be VB O O
reached VBN O O
at IN B-VP O
( ( O O
374 CD O O
) ) O O
419-2007 NN B-NP O
. . B-VP O
   
There EX O O
are VBP O O
no DT B-NP O
active JJ I-NP B-problem
ongoing NN I-NP I-problem
issues NNS I-NP I-problem
at IN B-VP O
this DT B-NP B-pronoun
time NN I-NP O
. . B-VP O
   
CONDITION NNP B-NP O
ON NNP I-NP O
DISCHARGE NNP I-NP O
: : O O
Good JJ O O
. . B-VP O
   
DISCHARGE NNP B-NP O
DISPOSITION NNP I-NP O
: : O O
Home NN B-NP O
with IN B-VP O
the DT B-NP O
parents NNS I-NP B-person
. . B-VP O
   
NAME NN B-NP O
OF NNP I-NP O
PRIMARY NNP I-NP B-person
PEDIATRICIAN NNP I-NP I-person
: : O O
Dr. NNP B-NP B-person
Gene NNP I-NP I-person
Hardy NNP I-NP I-person
from IN B-VP O
Webster NNP B-NP O
Pediatrics NNP I-NP O
. . B-VP O
   
Telephone NNP B-NP O
No. NN I-NP O
: : O O
( ( O O
309 CD O O
) ) O O
642-6861 CD O O
fax NN B-NP O
( ( O O
515 CD O O
) ) O O
568-6798 NN B-NP O
. . B-VP O
   
CARE NNP B-NP O
RECOMMENDATIONS NNP I-NP O
: : O O
1. CD O O
Ad NNP B-NP B-treatment
lib NN I-NP I-treatment
PO NNP I-NP I-treatment
feedings NNS I-NP I-treatment
of IN B-VP O
Similac NNP B-NP B-treatment
20 CD O I-treatment
cal JJ B-NP I-treatment
/ NN I-NP I-treatment
oz NN I-NP I-treatment
with IN B-VP I-treatment
iron NN B-NP I-treatment
. . B-VP O
   
2. CD O O
Medications NNS B-NP B-treatment
: : O O
None NN B-NP O
. . B-VP O
   
3. CD O O
State NNP B-NP B-test
newborn JJ B-NP I-test
screen NN I-NP I-test
was VBD B-VP O
sent VBN O O
on IN B-VP O
2015-04-24 JJ O O
and CC O O
results NNS B-NP O
are VBP O O
pending VBG O O
. . B-VP O
   
4. CD O O
Immunizations NNPS B-NP B-treatment
received VBD B-VP O
: : O O
Hepatitis NN B-NP B-treatment
B NNP I-NP I-treatment
vaccine NN I-NP I-treatment
was VBD B-VP O
given VBN O O
on IN B-VP O
2015-04-25 JJ O O
. . B-VP O
   
5. CD O O
Immunizations NNS B-NP B-treatment
Recommended VBD B-VP O
: : O O
6. CD O O
Synagis NNP B-NP B-treatment
RSV NNP I-NP I-treatment
prophylaxis NN I-NP I-treatment
should MD O O
be VB O O
considered VBN O O
from IN B-VP O
November NNP B-NP O
through IN B-VP O
March NNP B-NP O
for IN B-VP O
infants NNS B-NP B-person
who WP O B-person
meet VBP O O
any DT O O
of IN B-VP O
the DT O O
following JJ O O
three CD O O
criteria NNS B-NP O
. . B-VP O
   
A. NNP B-NP O
Born NNP I-NP O
at IN B-VP O
less JJR O O
than IN B-VP O
32 CD O O
weeks NNS B-NP O
gestation NN I-NP O
. . B-VP O
   
B. NNP B-NP O
Born NNP I-NP O
between IN B-VP O
32 CD O O
and CC O O
35 CD O O
weeks NNS B-NP O
gestation NN I-NP O
with IN B-VP O
two CD O O
of IN B-VP O
the DT B-NP O
following NN I-NP O
: : O O
daycare NN B-NP O
during IN B-VP O
the DT B-NP O
RSV NNP I-NP O
season NN I-NP O
a DT B-NP B-person
smoker NN I-NP I-person
in IN B-VP O
the DT B-NP O
household NN I-NP O
, , O O
neuromuscular JJ B-NP B-problem
disease NN I-NP I-problem
, , O O
airway NN B-NP B-problem
abnormalities NNS I-NP I-problem
, , O O
or CC O O
school NN B-NP B-person
age NN I-NP I-person
siblings NNS I-NP I-person
C. NNP I-NP O
with IN B-VP O
chronic JJ B-NP B-problem
lung NN I-NP I-problem
disease NN I-NP I-problem
. . B-VP O
   
7. CD O O
Influenza NNP B-NP B-treatment
immunization NN I-NP I-treatment
is VBZ O O
recommended VBN O O
annually RB O O
in IN B-VP O
the DT B-NP O
fall NN I-NP O
for IN B-VP O
all DT B-NP B-person
infants NNS I-NP I-person
once IN B-VP O
they PRP O B-person
reach VBP O O
6 CD O O
months NNS B-NP O
of IN B-VP O
age NN B-NP O
. . B-VP O
   
Before IN B-VP O
this DT B-NP B-pronoun
age NN I-NP O
and CC O O
for IN B-VP O
the DT O O
first JJ O O
24 CD O O
months NNS B-NP O
of IN B-VP O
the DT B-NP O
child NN I-NP B-person
's POS O O
life NN B-NP O
, , O O
immunization NN B-NP B-treatment
against IN B-VP O
influenza NN B-NP B-problem
is VBZ O O
recommended VBN O O
for IN B-VP O
household NN B-NP B-person
contacts NNS I-NP I-person
and CC O O
out IN B-VP B-person
of IN B-VP I-person
home NN B-NP I-person
caregivers NNS I-NP I-person
. . B-VP O
   
DISCHARGE NNP B-NP O
DIAGNOSES NNP I-NP O
: : O O
1. CD O O
Presumed NNP B-NP O
pneumonia NN I-NP B-problem
, , O O
treated VBN O O
. . B-VP O
   
2. CD O O
Large NN B-NP B-problem
for IN B-VP I-problem
gestational JJ B-NP I-problem
age NN I-NP I-problem
term NN I-NP O
male NN I-NP O
. . B-VP O
   
3. CD O O
Respiratory NNP B-NP B-problem
distress NN I-NP I-problem
, , O O
resolved VBN O O
. . B-VP O
   
4. CD O O
Mild NNP B-NP B-problem
hyperbilirubinemia NN I-NP I-problem
, , O O
resolving VBG O O
. . B-VP O
   
Claudia NNP B-NP B-person
Ernest NNP I-NP I-person
, , O I-person
MD NNP B-NP I-person
50AAD CD O O
Dictated VBN O O
By IN B-VP O
: : O O
Stan NNP B-NP B-person
C. NNP I-NP I-person
Haaz NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
MEDQUIST36 NNP I-NP O
D NNP I-NP O
: : O O
2015-04-28 JJ O O
23:50:08 CD O O
T NN B-NP O
: : O O
2015-04-29 JJ O O
02:50:40 CD O O
Job NNP B-NP O
#: VBD B-VP O
76623 CD O O
Signed VBN O O
electronically RB O O
by IN B-VP O
: : O O
DR. NNP B-NP B-person
Maria NNP I-NP I-person
L NNP I-NP I-person
Ulabarro NNP I-NP I-person
on IN B-VP O
: : O O
WED JJ O O
2015-04-29 JJ O O
2:21 CD O O
PM NNP B-NP O
( ( O O
End NNP B-NP O
of IN B-VP O
Report NNP B-NP O
) ) O O
-EMPTYLINE- VBP O O
-DOCSTART- JJ O O
-EMPTYLINE- $ O O
424729395 CD O O
DH NNP B-NP O
0011649 CD O O
07013 CD O O
908447 CD O O
6/14/2001 CD O O
12:00:00 CD O O
AM NNP B-NP O
OB NNP I-NP O
Discharge NNP I-NP O
Summary NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Report NNP I-NP O
Status NNP I-NP O
: : O O
Signed VBD B-VP O
OB NNP B-NP O
EMR NNP I-NP O
L NNP I-NP O
and CC O O
D NNP B-NP O
DISCHARGE NNP I-NP O
SUMMARY NNP I-NP O
NAME NN I-NP O
: : O O
XARAH NNP B-NP B-person
RATIA NNP I-NP I-person
SERVICE NNP I-NP I-person
UNIT NNP I-NP O
NUMBER NNP I-NP O
: : O O
642-07-90 JJ B-NP O
ADMISSION NNP I-NP O
DATE NNP I-NP O
: : O O
20010614 CD O O
DISCHARGE NNP B-NP O
DATE NNP I-NP O
: : O O
20010616 CD O O
PRINCIPAL NNP B-NP O
DISCHARGE NNP I-NP O
DIAGNOSIS NNP I-NP O
: : O O
Abnormal JJ B-NP B-problem
Fetal NNP I-NP I-problem
Heart NNP I-NP I-problem
Rate NNP I-NP I-problem
/ NNP I-NP I-problem
Rhythm NNP I-NP I-problem
- : O O
Delivered NNP B-NP O
ASSOCIATED NNP I-NP O
DIAGNOSES NNP I-NP O
: : O O
Abnormal JJ B-NP B-problem
Pap NNP I-NP I-problem
Test NNP I-NP I-problem
, , O O
history NN B-NP O
of IN B-VP O
PRINCIPAL NNP B-NP O
PROCEDURE NNP I-NP O
OR NNP I-NP O
OPERATION NNP I-NP O
: : O O
Vacuum NNP B-NP B-treatment
Extraction NNP I-NP I-treatment
ASSOCIATED NNP I-NP O
PROCEDURES NNP I-NP O
OR NNP I-NP O
OPERATIONS NNP I-NP O
: : O O
POSTPARTUM NNP B-NP O
DIAGNOSTIC NNP I-NP O
PROCEDURES NNP I-NP O
: : O O
None NN B-NP O
POSTPARTUM NNP I-NP O
THERAPEUTIC NNP I-NP O
PROCEDURES NNP I-NP O
: : O O
None NN B-NP O
OTHER NNP I-NP O
POSTPARTUM NNP I-NP O
THERAPIES NNP I-NP O
: : O O
Routine JJ B-NP B-treatment
Post NNP I-NP I-treatment
Partum NNP I-NP I-treatment
Care NNP I-NP I-treatment
HISTORY NNP I-NP O
AND NNP I-NP O
REASON NNP I-NP O
FOR NNP I-NP O
HOSPITALIZATION NNP I-NP O
: : O O
Active JJ B-NP B-problem
Labor NNP I-NP I-problem
PHYSICAL NNP I-NP O
EXAMINATION NNP I-NP O
: : O O
HEIGHT $ O B-test
49 CD O O
HEENT NNP B-NP B-test
NORMAL NNP I-NP O
MOUTH NNP I-NP O
NORMAL NNP I-NP O
NECK NNP I-NP O
NORMAL NNP I-NP O
BREASTS NNP I-NP O
NORMAL NNP I-NP O
NIPPLES NNP I-NP O
NORMAL NNP I-NP O
CHEST NNP I-NP O
NORMAL NNP I-NP O
COR NNP I-NP O
NORMAL NNP I-NP O
ABDOMEN NNP I-NP O
NORMAL NNP I-NP O
gravid NN I-NP O
, , O O
+ NNP B-NP O
FHR NNP I-NP O
, , O O
NT NNP B-NP O
EXTREM NNP I-NP O
NORMAL NNP I-NP O
SKIN NNP I-NP O
NORMAL NNP I-NP O
NODES NNP I-NP O
NORMAL NNP I-NP O
VULVA NNP I-NP O
NORMAL NNP I-NP O
VAGINA NNP I-NP O
NORMAL NNP I-NP O
CERVIX NNP I-NP O
NORMAL NNP I-NP O
4-5/100% JJ B-NP O
OS NNP I-NP O
NORMAL NNP I-NP O
closed VBD B-VP O
, , O O
firm NN B-NP O
, , O O
-CMT NNP B-NP O
ADNEXAE NNP I-NP O
NORMAL NNP I-NP O
UTERUS NNP I-NP O
NORMAL NNP I-NP O
term NN I-NP O
7-7.5 JJ O O
# # O O
vtx JJ B-NP O
UTERINE NNP I-NP O
SIZE NNP I-NP O
IN NNP I-NP O
WEEKS NNP I-NP O
NORMAL NNP I-NP O
term NN I-NP O
HOSPITAL NNP I-NP O
COURSE NNP I-NP O
( ( O O
include VBP O O
complications NNS B-NP O
if IN B-VP O
any DT O O
) ) O O
: : O O
This DT O B-pronoun
This DT O B-person
23 CD O I-person
year NN B-NP I-person
old JJ B-NP I-person
Gravida NNP I-NP I-person
2 CD O I-person
Para NNP B-NP I-person
1001 CD O I-person
was VBD B-VP O
admitted VBN O O
to TO O O
the DT B-NP O
Naliheall NNP I-NP O
County NNP I-NP O
Memorial NNP I-NP O
Hospital NNP I-NP O
Obstetrical NNP I-NP O
service NN I-NP O
on IN B-VP O
06/14/2001 CD O O
at IN B-VP O
01:29 CD O O
pm NN B-NP O
for IN B-VP O
the DT B-NP O
indication NN I-NP O
( ( O O
s JJ O O
) ) O O
: : O O
active JJ B-NP B-problem
labor NN I-NP I-problem
. . B-VP O
   
She PRP O B-person
delivered VBD B-VP O
a DT O O
3263 CD O O
gram NN B-NP O
female JJ B-NP O
infant NN I-NP B-person
at IN B-VP O
06/14/2001 CD O O
at IN B-VP O
06:40 CD O O
pm NN B-NP O
with IN B-VP O
apgar JJ B-NP B-test
scores NNS I-NP I-test
of IN B-VP O
8 CD O O
and CC O O
8 CD O O
at IN B-VP O
one CD O O
and CC O O
five CD O O
minutes NNS B-NP O
respectively RB O O
at IN B-VP O
40.3 CD O O
weeks NNS B-NP O
gestation NN I-NP O
via IN B-VP O
vacuum NN B-NP B-treatment
extraction NN I-NP I-treatment
. . B-VP O
   
During IN B-VP O
her PRP$ O B-person
labor NN B-NP O
she PRP O B-person
encountered VBD B-VP O
the DT B-NP O
following JJ I-NP O
complication NN I-NP O
( ( O O
s JJ O O
) ) O O
: : O O
fetal JJ B-NP B-problem
bradycardia NN I-NP I-problem
. . B-VP O
   
During IN B-VP O
her PRP$ O B-person
her PRP$ O B-treatment
delivery NN B-NP I-treatment
she PRP O B-person
encountered VBD B-VP O
the DT B-NP O
following JJ I-NP O
complication NN I-NP O
( ( O O
s JJ O O
) ) O O
: : O O
nuchal JJ B-NP B-problem
cord NN I-NP I-problem
, , O O
times CC O O
two CD O O
. . B-VP O
   
Postpartum VB O O
she PRP O B-person
encountered VBD B-VP O
the DT B-NP O
following JJ I-NP O
complication NN I-NP O
( ( O O
s JJ O O
) ) O O
: : O O
none NN B-NP O
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
discharged VBN O O
on IN B-VP O
06/16/2001 CD O O
at IN B-VP O
12:00 CD O O
pm NN B-NP O
in IN B-VP O
stable JJ B-NP O
condition NN I-NP O
. . B-VP O
   
DISCHARGE NNP B-NP O
ACTIVITY NNP I-NP O
: : O O
No DT B-NP O
Restrictions NNP I-NP O
DISCHARGE NNP I-NP O
DIET NNP I-NP O
: : O O
No DT B-NP O
Restrictions NNP I-NP O
POSTPARTUM NNP I-NP O
DISPOSITION NNP I-NP O
: : O O
Home NN B-NP O
With IN B-VP O
Self-Care NNP B-NP O
( ( O O
Routine NNP B-NP O
Discharge NNP I-NP O
) ) O O
POSTPARTUM NNP B-NP O
CARE NNP I-NP O
SITE NNP I-NP O
: : O O
Burnrise NNP B-NP O
Memorial NNP I-NP O
Hospital NNP I-NP O
POSTPARTUM NNP I-NP O
RETURN NNP I-NP O
APPOINTMENT NNP I-NP O
( ( O O
DAYS NNP B-NP O
) ) O O
: : O O
42 CD O O
BREAST NNP B-NP O
FEEDING NN I-NP O
AT NNP I-NP O
DISCHARGE NNP I-NP O
: : O O
Yes PRP$ O O
POSTPARTUM NNP B-NP O
MEASLES NNP I-NP O
/ NNP I-NP O
MUMPS/RUBELLA NNP I-NP O
VACCINE NNP I-NP O
: : O O
Not RB O O
Indicated NNP B-NP O
Electronically RB O O
Signed VBD B-VP O
: : O O
American NNP B-NP B-person
, , O O
06/16/2001 CD O O
5:14:05 CD O O
PM NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
Admission NNP I-NP O
Date NNP I-NP O
: : O O
2011-11-18 JJ B-NP O
Discharge NN I-NP O
Date NNP I-NP O
: : O O
2011-11-22 JJ B-NP O
Date NNP I-NP O
of IN B-VP O
Birth NNP B-NP O
: : O O
1950-04-21 JJ B-NP O
Sex NN I-NP O
: : O O
M NNP B-NP O
Service NNP I-NP O
: : O O
CCU NNP B-NP O
REASON NNP I-NP O
FOR NNP I-NP O
ADMISSION NNP I-NP O
: : O O
Acute NNP B-NP B-problem
inferior JJ B-NP I-problem
myocardial JJ I-NP I-problem
infarction NN I-NP I-problem
and CC O O
right JJ B-NP B-problem
ventricular NN I-NP I-problem
infarction NN I-NP I-problem
. . B-VP O
   
HISTORY NNP B-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
is VBZ O O
a DT O O
61 JJ O O
- : O O
year-old JJ B-NP O
Caucasian-speaking JJ I-NP O
woman NN I-NP O
with IN B-VP O
a DT B-NP O
history NN I-NP O
of IN B-VP O
hypercholesterolemia NN B-NP B-problem
and CC O O
tobacco NN B-NP O
use NN I-NP O
who WP O B-person
developed VBD B-VP O
waxing VBG O B-problem
and CC O I-problem
waning VBG O I-problem
left VBD B-VP I-problem
substernal JJ B-NP I-problem
chest NN I-NP I-problem
pain NN I-NP I-problem
with IN B-VP O
radiation NN B-NP B-problem
to TO O I-problem
the DT B-NP I-problem
left JJ I-NP I-problem
shoulder NN I-NP I-problem
on IN B-VP O
2011-11-17 JJ O O
which WDT O B-pronoun
lasted VBD B-VP O
that IN B-VP B-pronoun
entire JJ B-NP O
day NN I-NP O
. . B-VP O
   
Upon IN B-VP O
waking VBG O O
on IN B-VP O
the DT B-NP O
morning NN I-NP O
of IN B-VP O
admission NN B-NP O
, , O O
she PRP O B-person
had VBD B-VP O
10/10 CD O O
chest JJS B-NP B-problem
pain NN I-NP I-problem
associated VBN O O
with IN B-VP O
nausea NN B-NP B-problem
. . B-VP O
   
She PRP O B-person
presented VBD B-VP O
to TO O O
Charlton NNP B-NP O
Memorial NNP I-NP O
Hospital NNP I-NP O
Hospital NNP I-NP O
Emergency NNP I-NP O
Department NNP I-NP O
with IN B-VP O
inferior JJ B-NP B-problem
ST NNP I-NP I-problem
elevations NNS I-NP I-problem
; : O O
at IN B-VP O
which WDT O B-pronoun
time NN B-NP O
she PRP O B-person
became VBD B-VP O
acutely RB O B-problem
hypotensive JJ O I-problem
to TO O O
a DT B-NP B-test
systolic JJ I-NP I-test
blood NN I-NP I-test
pressure NN I-NP I-test
of IN B-VP O
70 CD O O
to TO O O
80 CD O O
after IN B-VP O
receiving VBG O O
one CD O O
ublingual JJ B-NP B-treatment
nitroglycerin NN I-NP I-treatment
. . B-VP O
   
She PRP O B-person
then RB O O
became VBD B-VP O
bradycardic JJ O B-problem
which WDT O B-pronoun
responded VBD B-VP O
to TO O O
atropine VB O B-treatment
and CC O O
intravenous JJ B-NP B-treatment
fluids NNS I-NP I-treatment
. . B-VP O
   
In IN B-VP O
addition NN B-NP O
, , O O
she PRP O B-person
was VBD B-VP O
given VBN O O
aspirin RB O B-treatment
, , O O
Plavix NNP B-NP B-treatment
, , O O
heparin NN B-NP B-treatment
, , O O
and CC O O
morphine NN B-NP B-treatment
. . B-VP O
   
Immediately RB O O
prior JJ O O
to TO O O
transfer VB O O
to TO O O
Worcester NNP B-NP O
State NNP I-NP O
Hospital NNP I-NP O
, , O O
she PRP O B-person
went VBD B-VP O
into IN B-VP O
ventricular JJ B-NP B-problem
fibrillation NN I-NP I-problem
arrest NN I-NP I-problem
at IN B-VP O
12:30 CD O O
p.m. NN B-NP O
, , O O
at IN B-VP O
which WDT O B-pronoun
time NN B-NP O
she PRP O B-person
was VBD B-VP O
intubated VBN O B-treatment
and CC O O
defibrillated VBN O B-treatment
back RB O O
to TO O O
sinus VB O O
rhythm NN B-NP O
after IN B-VP O
five CD O B-treatment
shocks NNS B-NP I-treatment
. . B-VP O
   
She PRP O B-person
received VBD B-VP O
an DT B-NP B-treatment
amiodarone NN I-NP I-treatment
bolus NN I-NP I-treatment
of IN B-VP O
150 CD O O
mg NNS B-NP O
intravenously RB O O
and CC O O
was VBD B-VP O
continued VBN O O
on IN B-VP O
an DT B-NP B-treatment
amiodarone NN I-NP I-treatment
drip NN I-NP I-treatment
while IN B-VP O
CMED NNP B-NP O
CSRU-flighted NNP I-NP O
to TO O O
Boston NNP B-NP O
Regional NNP I-NP O
Medical NNP I-NP O
Centerr NNP I-NP O
where WRB O O
she PRP O B-person
underwent VBD B-VP O
a DT B-NP B-test
catheterization NN I-NP I-test
. . B-VP O
   
The DT B-NP B-test
cardiac JJ I-NP I-test
catheterization NN I-NP I-test
revealed VBD B-VP O
a DT B-NP B-problem
total JJ I-NP I-problem
occlusion NN I-NP I-problem
of IN B-VP I-problem
the DT B-NP I-problem
proximal JJ I-NP I-problem
right JJ I-NP I-problem
coronary JJ I-NP I-problem
artery NN I-NP I-problem
and CC O O
diffuse VB O B-problem
right JJ B-NP I-problem
coronary JJ I-NP I-problem
artery NN I-NP I-problem
disease NN I-NP I-problem
. . B-VP O
   
She PRP O B-person
received VBD B-VP O
three CD O B-treatment
stents NNS B-NP I-treatment
to TO O I-treatment
the DT B-NP I-treatment
right JJ I-NP I-treatment
coronary NN I-NP I-treatment
artery NN I-NP I-treatment
which WDT O B-pronoun
was VBD B-VP O
complicated VBN O O
by IN B-VP O
a DT B-NP B-problem
proximal JJ I-NP I-problem
dissection NN I-NP I-problem
. . B-VP O
   
She PRP O B-person
had VBD B-VP O
good JJ B-NP O
post NN I-NP B-test
percutaneous JJ B-NP I-test
coronary JJ I-NP I-test
intervention NN I-NP I-test
angiographic JJ B-NP I-test
results NNS I-NP I-test
. . B-VP O
   
Incidentally NNP B-NP O
, , O O
an DT B-NP B-test
aortogram NN I-NP I-test
during IN B-VP O
the DT B-NP B-test
catheterization NN I-NP I-test
revealed VBD B-VP O
a DT B-NP B-problem
Debakey NNP I-NP I-problem
class NN I-NP I-problem
I PRP O I-problem
aortic JJ O I-problem
ascending VBG O I-problem
aneurysm NN B-NP I-problem
, , O O
and CC O O
the DT B-NP B-person
patient NN I-NP I-person
had VBD B-VP O
a DT B-NP B-test
pulmonary JJ I-NP I-test
capillary JJ I-NP I-test
wedge NN I-NP I-test
pressure NN I-NP I-test
of IN B-VP O
20 CD O O
at IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
catheterization NN B-NP B-test
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
transferred VBN O O
to TO O O
the DT B-NP O
Coronary NNP I-NP O
Care NNP I-NP O
Unit NNP I-NP O
in IN B-VP O
stable JJ B-NP O
condition NN I-NP O
and CC O O
still RB O O
intubated VBN O B-treatment
. . B-VP O
   
PAST NNP B-NP O
MEDICAL NNP I-NP O
HISTORY NNP I-NP O
: : O O
Hypercholesterolemia NNP B-NP B-problem
. . B-VP O
   
MEDICATIONS NNP B-NP O
ON NNP I-NP O
ADMISSION NNP I-NP O
: : O O
" NN B-NP O
Flumaran NNP I-NP B-treatment
" NNP I-NP O
for IN B-VP O
circulatory NN B-NP B-problem
problems NNS I-NP I-problem
. . B-VP O
   
She PRP O B-person
receives VBZ O O
this DT O B-treatment
this DT B-NP B-pronoun
medication NN I-NP I-treatment
by IN B-VP O
mail NN B-NP O
from IN B-VP O
her PRP$ O B-person
her PRP$ O B-person
relatives NNS B-NP I-person
in IN B-VP O
Jill NNP B-NP O
. . B-VP O
   
MEDICATIONS NNP B-NP O
ON NNP I-NP O
ADMISSION NNP I-NP O
TO NNP I-NP O
CORONARY NNP I-NP O
CARE NNP I-NP O
0408398 CD O O
. . B-VP O
   
Amiodarone NN B-NP B-treatment
drip NN I-NP I-treatment
. . B-VP O
   
2. CD O O
Integrilin NNP B-NP B-treatment
drip NN I-NP I-treatment
. . B-VP O
   
3. CD O O
Intravenous JJ B-NP B-treatment
fluids NNS I-NP I-treatment
. . B-VP O
   
ALLERGIES NNS B-NP O
: : O O
A DT B-NP O
question NN I-NP O
of IN B-VP O
a DT B-NP B-treatment
SULFA NNP I-NP I-treatment
allergy NN I-NP B-problem
. . B-VP O
   
SOCIAL NNP B-NP O
HISTORY NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
lives VBZ O O
alone RB O O
in IN B-VP O
Woburn NNP B-NP O
. . B-VP O
   
She PRP O B-person
came VBD B-VP O
from IN B-VP O
Czech NNP B-NP O
Republic NNP I-NP O
14 CD O O
years NNS B-NP O
ago RB O O
. . B-VP O
   
She PRP O B-person
works VBZ O O
as IN B-VP O
a DT B-NP O
nursing NN I-NP O
assistant NN I-NP O
in IN B-VP O
a DT B-NP O
nursing NN I-NP O
home NN I-NP O
. . B-VP O
   
She PRP O B-person
smokes VBD B-VP O
approximately RB O O
one CD O O
and CC O O
a DT B-NP O
half JJ I-NP O
packs NNS I-NP O
of IN B-VP O
cigarettes NNS B-NP O
per IN B-VP O
day NN B-NP O
for IN B-VP O
the DT O O
last JJ O O
30 CD O O
years NNS B-NP O
. . B-VP O
   
FAMILY NNP B-NP B-person
HISTORY NNP I-NP O
: : O O
Family RB O B-person
history NN B-NP O
is VBZ O O
not RB O O
significant JJ O O
for IN B-VP O
any DT B-NP O
early JJ I-NP O
history NN I-NP O
of IN B-VP O
coronary JJ B-NP B-problem
artery NN I-NP I-problem
disease NN I-NP I-problem
. . B-VP O
   
PHYSICAL NNP B-NP O
EXAMINATION NNP I-NP O
ON NNP I-NP O
PRESENTATION NNP I-NP O
: : O O
Examination NN B-NP B-test
on IN B-VP O
admission NN B-NP O
to TO O O
the DT B-NP O
Coronary NNP I-NP O
Care NNP I-NP O
Unit NNP I-NP O
revealed VBD B-VP O
blood NN B-NP B-test
pressure NN I-NP I-test
was VBD B-VP O
100/57 CD O O
, , O O
with IN B-VP O
a DT B-NP B-test
mean JJ I-NP I-test
arterial JJ I-NP I-test
pressure NN I-NP I-test
of IN B-VP O
75 CD O O
, , O O
heart NN B-NP B-test
rate NN I-NP I-test
was VBD B-VP O
sinus VBN O O
rhythm NN B-NP O
at IN B-VP O
75 CD O O
, , O O
temperature NN B-NP B-test
was VBD B-VP O
97.6 CD O O
, , O O
oxygen NN B-NP B-test
saturation NN I-NP I-test
was VBD B-VP O
99% CD O O
on IN B-VP O
assist NN B-NP B-treatment
control NN I-NP I-treatment
with IN B-VP O
a DT B-NP B-treatment
tidal JJ I-NP I-treatment
volume NN I-NP I-treatment
of IN B-VP O
600 CD O O
on IN B-VP O
60% CD O O
FIO2 NNP B-NP B-treatment
, , O O
5 CD O O
of IN B-VP O
positive JJ B-NP B-treatment
end-expiratory JJ I-NP I-treatment
pressure NN I-NP I-treatment
. . B-VP O
   
In IN B-VP O
general JJ O O
, , O O
she PRP O B-person
was VBD B-VP O
sedated VBN O B-treatment
at IN B-VP O
the DT B-NP O
time NN I-NP O
, , O O
responsive JJ O O
to TO O O
stimuli VB O O
, , O O
and CC O O
was VBD B-VP O
following VBG O O
commands NNS B-NP O
. . B-VP O
   
She PRP O B-person
had VBD B-VP O
moist NN B-NP O
mucous JJ B-NP O
membranes NNS I-NP O
. . B-VP O
   
Her PRP$ O B-person
Her PRP$ O B-test
carotids NNS B-NP I-test
were VBD B-VP O
2+ CD O O
bilaterally RB O O
. . B-VP O
   
Her PRP$ O B-person
lungs NNS B-NP O
were VBD B-VP O
clear JJ O O
to TO O O
auscultation VB O B-test
anteriorly RB O O
. . B-VP O
   
Her PRP$ O B-person
heart NN B-NP O
revealed VBD B-VP O
a DT B-NP O
regular JJ I-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
with IN B-VP O
a DT B-NP B-problem
faint JJ I-NP I-problem
second JJ I-NP I-problem
heart NN I-NP I-problem
sound NN I-NP I-problem
and CC O O
second JJ B-NP O
heart NN I-NP O
sound NN I-NP O
. . B-VP O
   
No DT B-NP O
audible JJ I-NP B-problem
extra JJ I-NP I-problem
heart NN I-NP I-problem
sounds VBZ O I-problem
. . B-VP O
   
Her PRP$ O B-person
abdomen NNS B-NP O
was VBD B-VP O
obese JJ O B-problem
and CC O O
had VBD B-VP O
positive JJ B-NP O
bowel NN I-NP O
sounds VBZ O O
. . B-VP O
   
It PRP O B-pronoun
was VBD B-VP O
soft JJ O O
and CC O O
nontender NN B-NP B-problem
. . B-VP O
   
She PRP O B-person
had VBD B-VP O
peripheral JJ B-NP B-problem
edema NN I-NP I-problem
with IN B-VP O
2+ CD O B-test
peripheral JJ B-NP I-test
pulses NNS I-NP I-test
bilaterally RB O I-test
. . B-VP O
   
PERTINENT NNP B-NP O
LABORATORY NNP I-NP O
DATA NNP I-NP O
ON NNP I-NP O
PRESENTATION NN I-NP O
: : O O
Her PRP$ O B-person
Her PRP$ O B-test
laboratories NNS B-NP I-test
at IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
transfer NN B-NP O
to TO O O
Saint NNP B-NP O
Vincent NNP I-NP O
Hospital NNP I-NP O
revealed VBD B-VP O
white JJ B-NP B-test
blood NN I-NP I-test
cell NN I-NP I-test
count NN I-NP I-test
was VBD B-VP O
11.5 CD O O
, , O O
hematocrit NN B-NP B-test
was VBD B-VP O
42 CD O O
on IN B-VP O
admission NN B-NP O
, , O O
platelets NNS B-NP B-test
were VBD B-VP O
242 CD O O
. . B-VP O
   
Chemistry-7 NN B-NP B-test
was VBD B-VP O
unremarkable JJ O O
. . B-VP O
   
Creatine NNP B-NP B-test
kinase NN I-NP I-test
on IN B-VP O
admission NN B-NP O
was VBD B-VP O
309 CD O O
, , O O
with IN B-VP O
a DT B-NP B-test
MB NNP I-NP I-test
of IN B-VP O
19.6 CD O O
, , O O
an DT B-NP B-test
index NN I-NP I-test
of IN B-VP O
6.3 CD O O
, , O O
and CC O O
an DT B-NP B-test
initial JJ I-NP I-test
troponin NN I-NP I-test
of IN B-VP O
0.73 CD O O
. . B-VP O
   
RADIOLOGY NNP B-NP O
/ JJ B-NP O
IMAGING NN I-NP O
: : O O
A DT B-NP B-test
chest JJ I-NP I-test
x-ray NN I-NP I-test
revealed VBD B-VP O
an DT B-NP B-problem
enlarged JJ I-NP I-problem
mediastinum NN I-NP I-problem
with IN B-VP O
clear JJ B-NP O
lung NN I-NP O
fields NNS I-NP O
bilaterally RB O O
. . B-VP O
   
Initial JJ B-NP B-test
electrocardiogram NN I-NP I-test
showed VBD B-VP O
a DT B-NP O
normal JJ I-NP O
sinus NN I-NP O
rhythm NN I-NP O
at IN B-VP O
65 CD O O
, , O O
normal JJ B-NP O
axis NN I-NP O
, , O O
2-mm JJ B-NP B-problem
ST NNP I-NP I-problem
elevations NNS I-NP I-problem
in IN B-VP I-problem
lead JJ B-NP I-problem
III NNP I-NP I-problem
, , O O
1-mm JJ B-NP B-problem
ST NNP I-NP I-problem
elevations NNS I-NP I-problem
in IN B-VP I-problem
aVF NN B-NP I-problem
and CC O I-problem
V1 NNP B-NP I-problem
, , O O
1-mm JJ B-NP B-problem
ST NNP I-NP I-problem
depressions NNS I-NP I-problem
in IN B-VP I-problem
I PRP O I-problem
and CC O I-problem
aVL VB O I-problem
; : O O
consistent NN B-NP O
with IN B-VP O
an DT O B-problem
inferior JJ O I-problem
and CC O I-problem
right JJ B-NP I-problem
ventricular NN I-NP I-problem
infarction NN I-NP I-problem
. . B-VP O
   
Right-sided JJ B-NP B-test
electrocardiograms NN I-NP I-test
showed VBD B-VP O
1-mm JJ B-NP B-problem
ST NNP I-NP I-problem
elevations NNS I-NP I-problem
in IN B-VP I-problem
V4 NNP B-NP I-problem
; : O O
consistent JJ O O
with IN B-VP O
a DT B-NP B-problem
right JJ I-NP I-problem
ventricular NN I-NP I-problem
infarct NN I-NP I-problem
. . B-VP O
   
Electrocardiogram NNP B-NP B-test
status NN I-NP O
post NN I-NP O
percutaneous JJ B-NP B-treatment
coronary JJ I-NP I-treatment
intervention NN I-NP I-treatment
revealed VBD B-VP O
a DT B-NP O
normal JJ I-NP O
sinus NN I-NP O
rhythm NN I-NP O
at IN B-VP O
84 CD O O
, , O O
with IN B-VP O
a DT B-NP O
normal JJ I-NP O
axis NN I-NP O
, , O O
and CC O O
normalizing NN B-NP O
of IN B-VP O
the DT B-NP B-problem
inferior JJ I-NP I-problem
ST NNP I-NP I-problem
segments NNS I-NP I-problem
, , O O
with IN B-VP O
Q NNP B-NP B-problem
waves NNS I-NP I-problem
evolving VBG O O
in IN B-VP O
leads NNS B-NP O
III NNP I-NP O
and CC O O
aVF NN B-NP O
. . B-VP O
   
An DT B-NP B-test
echocardiogram JJ I-NP I-test
status NN I-NP O
post NN I-NP O
percutaneous JJ B-NP B-treatment
coronary JJ I-NP I-treatment
intervention NN I-NP I-treatment
revealed VBD B-VP O
an DT B-NP B-problem
akinetic JJ I-NP I-problem
inferior NN I-NP I-problem
wall NN I-NP I-problem
and CC O I-problem
right JJ B-NP I-problem
ventricle NN I-NP I-problem
, , O O
mild JJ B-NP B-problem
mitral JJ I-NP I-problem
regurgitation NN I-NP I-problem
, , O O
and CC O O
ascending VBG O O
aorta NN B-NP O
measuring VBG O O
5 CD O O
cm NN B-NP O
. . B-VP O
   
There EX O O
was VBD B-VP O
no DT B-NP O
effusion NN I-NP B-problem
. . B-VP O
   
HOSPITAL NNP B-NP O
COURSE NNP I-NP O
: : O O
1. CD O O
CARDIOVASCULAR NNP B-NP O
SYSTEM NNP I-NP O
: : O O
On IN B-VP O
the DT B-NP O
night NN I-NP O
of IN B-VP O
admission NN B-NP O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
experienced VBD B-VP O
post NN B-NP B-problem
catheterization NN I-NP I-problem
hypotension NN I-NP I-problem
which WDT O B-pronoun
required VBD B-VP O
intravenous JJ B-NP B-treatment
fluids NNS I-NP I-treatment
and CC O O
dopamine NN B-NP B-treatment
. . B-VP O
   
Electrocardiogram VB O B-test
the DT B-NP O
following JJ I-NP O
morning NN I-NP O
revealed VBD B-VP O
normalization NN B-NP O
of IN B-VP O
her PRP$ O B-person
ST NNP B-NP O
segments NNS I-NP O
with IN B-VP O
evolution NN B-NP B-problem
of IN B-VP I-problem
Q NNP B-NP I-problem
waves NNS I-NP I-problem
. . B-VP O
   
Her PRP$ O B-person
Her PRP$ O B-treatment
dopamine NN B-NP I-treatment
was VBD B-VP O
weaned VBN O O
off RP O O
the DT B-NP O
following JJ I-NP O
day NN I-NP O
, , O O
and CC O O
her PRP$ O B-person
her PRP$ O B-treatment
heparin NN B-NP I-treatment
was VBD B-VP O
discontinued VBN O O
secondary JJ O O
to TO O O
a DT B-NP B-problem
right JJ I-NP I-problem
groin NN I-NP I-problem
hematoma NN I-NP I-problem
which WDT O B-pronoun
had VBD B-VP O
developed VBN O O
after IN B-VP O
the DT B-NP B-treatment
sheath NN I-NP I-treatment
had VBD B-VP O
been VBN O O
pulled VBN O O
out RP O O
by IN B-VP O
the DT B-NP B-person
fellow NN I-NP I-person
. . B-VP O
   
Her PRP$ O B-test
Her PRP$ O B-person
creatine NN B-NP I-test
kinases NNS I-NP I-test
climbed VBD B-VP O
; : O O
reaching VBG O O
a DT B-NP O
peak NN I-NP O
of IN B-VP O
3523 CD O O
, , O O
which WDT O B-pronoun
was VBD B-VP O
down RB O O
to TO O O
1500 CD O O
at IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
discharge NN B-NP O
. . B-VP O
   
Also RB O O
noted VBD B-VP O
on IN B-VP O
the DT B-NP O
day NN I-NP O
of IN B-VP O
11-20 JJ O O
, , O O
the DT B-NP B-person
patient JJ I-NP I-person
self-extubated JJ I-NP O
herself NN I-NP B-person
. . B-VP O
   
For IN B-VP O
her PRP$ O B-person
her PRP$ O B-problem
coronary JJ B-NP I-problem
artery NN I-NP I-problem
disease NN I-NP I-problem
, , O O
status NN B-NP O
post NN I-NP O
catheterization NN I-NP B-test
, , O O
she PRP O B-person
was VBD B-VP O
given VBN O O
Integrilin NNP B-NP B-treatment
for IN B-VP O
18 CD O O
hours NNS B-NP O
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
continued VBN O O
on IN B-VP O
aspirin NN B-NP B-treatment
, , O O
Plavix NNP B-NP B-treatment
, , O O
and CC O O
Lipitor NNP B-NP B-treatment
. . B-VP O
   
For IN B-VP O
her PRP$ O B-person
rhythm NN B-NP O
, , O O
amiodarone NN B-NP B-treatment
was VBD B-VP O
discontinued VBN O O
as IN B-VP O
she PRP O B-person
was VBD B-VP O
maintained VBN O O
in IN B-VP O
sinus NN B-NP O
rhythm NN I-NP O
after IN B-VP O
moving VBG O O
to TO O O
the DT B-NP O
floor NN I-NP O
. . B-VP O
   
For IN B-VP O
pump NN B-NP O
, , O O
once RB O O
transferred VBN O O
out IN B-VP O
of IN B-VP O
the DT B-NP O
Coronary NNP I-NP O
Care NNP I-NP O
Unit NNP I-NP O
on IN B-VP O
2011-11-20 JJ O O
, , O O
a DT B-NP B-treatment
beta NN I-NP I-treatment
blocker NN I-NP I-treatment
was VBD B-VP O
begun VBN O O
at IN B-VP O
12.5 CD O O
mg NN B-NP O
of IN B-VP O
Lopressor NNP B-NP B-treatment
p.o. NN I-NP O
b.i.d. NN I-NP O
which WDT O B-pronoun
was VBD B-VP O
titrated VBN O O
to TO O O
25 CD O O
mg NN B-NP O
at IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
discharge NN B-NP O
. . B-VP O
   
Also RB O O
, , O O
at IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
discharge NN B-NP O
, , O O
for IN B-VP O
increased VBN O B-treatment
afterload NN B-NP I-treatment
reduction NN I-NP I-treatment
, , O O
she PRP O B-person
was VBD B-VP O
started VBN O O
on IN B-VP O
lisinopril NN B-NP B-treatment
5 CD O O
mg NN B-NP O
p.o. NN I-NP O
q.d. NN I-NP O
On IN B-VP O
2011-11-21 JJ O O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
experienced VBD B-VP O
atypical JJ B-NP B-problem
chest NN I-NP I-problem
pain NN I-NP I-problem
which WDT O B-pronoun
was VBD B-VP O
made VBN O O
worse NN B-NP O
with IN B-VP O
inspiration NN B-NP O
and CC O O
movement NN B-NP O
. . B-VP O
   
It PRP O B-pronoun
was VBD B-VP O
not RB O O
associated VBN O O
with IN B-VP O
any DT B-NP B-problem
nausea NN I-NP I-problem
or CC O O
vomiting NN B-NP B-problem
. . B-VP O
   
It PRP O B-pronoun
did VBD B-VP O
not RB O O
radiate VB O O
. . B-VP O
   
It PRP O B-pronoun
was VBD B-VP O
felt VBN O O
to TO O O
be VB O O
pain JJ O B-problem
secondary JJ O O
to TO O O
her PRP$ O B-person
her PRP$ O B-problem
self-extubation NN B-NP I-problem
and CC O O
noncardiac JJ B-NP B-problem
chest NN I-NP I-problem
pain NN I-NP I-problem
. . B-VP O
   
An DT B-NP B-test
electrocardiogram NN I-NP I-test
was VBD B-VP O
checked VBN O O
which WDT O B-pronoun
revealed VBD B-VP O
no DT B-NP O
ST NNP I-NP B-problem
changes NNS I-NP I-problem
, , O O
and CC O O
there EX O O
was VBD B-VP O
no DT B-NP O
increase NN I-NP O
in IN B-VP O
her PRP$ O B-person
downward JJ B-NP O
trending NN I-NP O
creatine NN I-NP B-test
phosphokinases NNS I-NP I-test
. . B-VP O
   
No DT B-NP O
further JJ I-NP B-treatment
intervention NN I-NP I-treatment
was VBD B-VP O
done VBN O O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
treated VBN O O
with IN B-VP O
Tylenol NNP B-NP B-treatment
orally RB O I-treatment
as RB O O
well RB O O
as IN B-VP O
Ativan NNP B-NP B-treatment
for IN B-VP O
anxiety NN B-NP B-problem
that IN B-VP B-pronoun
she PRP O B-person
had VBD B-VP O
about IN B-VP O
going VBG O O
home NN B-NP O
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
pain RB O B-problem
free JJ O O
on IN B-VP O
the DT B-NP O
day NN I-NP O
of IN B-VP O
discharge NN B-NP O
. . B-VP O
   
Regarding VBG O O
her PRP$ O B-person
her PRP$ O B-problem
aortic JJ B-NP I-problem
ascending NN I-NP I-problem
aneurysm NN I-NP I-problem
, , O O
Cardiothoracic NNP B-NP B-person
Surgery NNP I-NP I-person
was VBD B-VP O
consulted VBN O O
regarding VBG O O
further JJ B-NP B-test
workup NN I-NP I-test
. . B-VP O
   
At IN B-VP O
their PRP$ O B-person
request NN B-NP O
, , O O
a DT B-NP B-test
CT NNP I-NP I-test
scan NN I-NP I-test
of IN B-VP I-test
the DT B-NP I-test
chest NN I-NP I-test
with IN B-VP O
contrast NN B-NP B-test
was VBD B-VP O
performed VBN O O
on IN B-VP O
the DT B-NP O
day NN I-NP O
of IN B-VP O
discharge NN B-NP O
. . B-VP O
   
Dr. NNP B-NP B-person
Streeter NNP I-NP I-person
from IN B-VP O
Cardiothoracic NNP B-NP B-person
Surgery NNP I-NP I-person
will MD O O
follow VB O O
up RP O O
with IN B-VP O
the DT B-NP B-person
patient NN I-NP I-person
for IN B-VP O
further JJ B-NP B-treatment
management NN I-NP I-treatment
in IN B-VP O
approximately RB O O
one CD O O
month NN B-NP O
as IN B-VP O
an DT B-NP O
outpatient NN I-NP O
. . B-VP O
   
His PRP$ O B-person
office NN B-NP O
will MD O O
contact VB O O
her PRP$ O B-person
to TO O O
make VB O O
that DT B-NP B-pronoun
appointment NN I-NP O
. . B-VP O
   
2. CD O O
PULMONARY NNP B-NP O
SYSTEM NNP I-NP O
: : O O
As IN B-VP O
stated VBN O O
above IN B-VP O
, , O O
the DT B-NP B-person
patient JJ I-NP I-person
self-extubated JJ I-NP O
herself NN I-NP B-person
. . B-VP O
   
She PRP O B-person
complained VBD B-VP O
of IN B-VP O
a DT B-NP B-problem
sore NN I-NP I-problem
throat NN I-NP I-problem
which WDT O B-pronoun
was VBD B-VP O
likely RB O O
the DT B-NP O
etiology NN I-NP O
of IN B-VP O
her PRP$ O B-person
her PRP$ O B-problem
atypical JJ B-NP I-problem
chest NN I-NP I-problem
complaints NNS I-NP I-problem
. . B-VP O
   
This DT O B-pronoun
resolved VBN O O
with IN B-VP O
Tylenol NNP B-NP B-treatment
and CC O O
as IN B-VP O
needed JJ B-NP O
doses NNS I-NP O
of IN B-VP O
oxycodone NN B-NP B-treatment
. . B-VP O
   
Her PRP$ O B-person
lungs NNS B-NP O
remained VBD B-VP O
clear JJ O O
to TO O O
auscultation VB O B-test
bilaterally RB O O
throughout IN B-VP O
the DT B-NP O
remainder NN I-NP O
of IN B-VP O
her PRP$ O B-person
hospital JJ B-NP O
course NN I-NP O
. . B-VP O
   
At IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
this DT B-NP B-pronoun
dictation NN I-NP O
, , O O
the DT B-NP B-test
CT NNP I-NP I-test
of IN B-VP I-test
her PRP$ O B-person
her PRP$ O I-test
chest NN B-NP I-test
was VBD B-VP O
still RB O O
pending VBG O O
. . B-VP O
   
The DT B-NP O
official JJ I-NP O
result NN I-NP O
was VBD B-VP O
not RB O O
yet RB O O
in IN B-VP O
. . B-VP O
   
3. CD O O
FLUIDS NNP B-NP O
/ NN I-NP O
ELECTROLYTES NNP I-NP O
/ NNP I-NP O
NUTRITION NNP I-NP O
: : O O
The DT O B-person
The DT B-NP B-test
patient JJ I-NP I-person
patient NN I-NP I-test
's POS O I-test
electrolytes NNS B-NP I-test
sere RB O O
managed VBN O O
daily RB O O
and CC O O
repleted VBN O O
on IN B-VP O
an DT O O
as IN B-VP O
needed JJ B-NP O
basis NN I-NP O
. . B-VP O
   
She PRP O B-person
did VBD B-VP O
receive VB O O
intravenous JJ B-NP B-treatment
K-Phos NNP I-NP I-treatment
for IN B-VP O
a DT B-NP B-problem
low JJ I-NP I-problem
phosphorous NN I-NP I-problem
of IN B-VP O
1.5 CD O O
. . B-VP O
   
Her PRP$ O B-person
Her PRP$ O B-test
phosphorous JJ O I-test
rose VBD B-VP O
appropriately RB O O
to TO O O
3.6 CD O O
at IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
discharge NN B-NP O
. . B-VP O
   
DISCHARGE NNP B-NP O
FOLLOWUP NNP I-NP O
: : O O
1. CD O O
The DT B-NP B-person
patient NN I-NP I-person
has VBZ O O
an DT B-NP O
appointment NN I-NP O
to TO O O
initiate VB O O
primary JJ B-NP O
care NN I-NP O
, , O O
as IN B-VP O
she PRP O B-person
no RB O O
longer RBR O O
had VBD B-VP O
a DT B-NP B-person
primary JJ I-NP I-person
care NN I-NP I-person
physician NN I-NP I-person
. . B-VP O
   
Claire NNP B-NP B-person
was VBD B-VP O
to TO O O
see VB O O
Dr. NNP B-NP B-person
Michael NNP I-NP I-person
Majerowski NNP I-NP I-person
at IN B-VP O
the DT B-NP O
Sturdy NNP I-NP O
Memorial NNP I-NP O
Clinic NNP I-NP O
on IN B-VP O
the DT B-NP O
east JJ I-NP O
campus NN I-NP O
, , O O
on IN B-VP O
Bissonette NNP B-NP O
Six NNP I-NP O
, , O O
in IN B-VP O
the DT B-NP O
South NNP I-NP O
Suite NNP I-NP O
, , O O
on IN B-VP O
31-05-03 JJ O O
at IN B-VP O
11:30 CD O O
a.m. RB O O
2. CD O O
In IN B-VP O
addition NN B-NP O
, , O O
as IN B-VP O
stated VBN O O
above IN B-VP O
, , O O
Dr.Hastings NNP B-NP B-person
office NN I-NP O
from IN B-VP O
Cardiothoracic NNP B-NP B-person
Surgery NNP I-NP I-person
will MD O O
be VB O O
in IN B-VP O
contact NN B-NP O
with IN B-VP O
Ms. NNP B-NP B-person
Williams NNP I-NP I-person
to TO O O
arrange VB O O
followup NN B-NP O
for IN B-VP O
her PRP$ O B-person
her PRP$ O B-problem
ascending NN B-NP I-problem
aortic JJ B-NP I-problem
aneurysm NN I-NP I-problem
in IN B-VP O
approximately RB O O
one CD O O
month NN B-NP O
. . B-VP O
   
MEDICATIONS NNP B-NP O
ON NNP I-NP O
DISCHARGE NNP I-NP O
: : O O
1. CD O O
Lisinopril NNP B-NP B-treatment
5 CD O O
mg NN B-NP O
p.o. NN I-NP O
q.d. VBD B-VP O
2. CD O O
Lopressor NNP B-NP B-treatment
25 CD O O
mg NN B-NP O
p.o. NN I-NP O
b.i.d. VBD B-VP O
3. CD O O
Plavix NNP B-NP B-treatment
75 CD O O
mg NN B-NP O
p.o. NN I-NP O
q.d. VBD B-VP O
4. CD O O
Lipitor NNP B-NP B-treatment
10 CD O O
mg NN B-NP O
p.o. NN I-NP O
q.d. VBD B-VP O
5. CD O O
Protonix NNP B-NP B-treatment
40 CD O O
mg NN B-NP O
p.o. NN I-NP O
q.d. VBD B-VP O
6. CD O O
Enteric-coated JJ B-NP B-treatment
aspirin NN I-NP I-treatment
325 CD O O
mg NN B-NP O
p.o. NN I-NP O
q.d. JJ B-NP O
CONDITION NNP I-NP O
AT NNP I-NP O
DISCHARGE NNP I-NP O
: : O O
Condition NN B-NP O
on IN B-VP O
discharge NN B-NP O
was VBD B-VP O
stable JJ O O
. . B-VP O
   
DISCHARGE JJ B-NP O
DIAGNOSES NNP I-NP O
: : O O
1. CD O O
Inferior NNP B-NP B-problem
myocardial JJ B-NP I-problem
infarction NN I-NP I-problem
and CC O O
right JJ B-NP B-problem
ventricular NN I-NP I-problem
infarction NN I-NP I-problem
. . B-VP O
   
Status NNP B-NP O
post NN I-NP O
cardiac NN I-NP B-test
catheterization NN I-NP I-test
and CC O O
stents NNS B-NP B-treatment
times NNS I-NP O
three CD O O
of IN B-VP O
the DT B-NP O
right JJ I-NP O
coronary JJ I-NP O
artery NN I-NP O
. . B-VP O
   
2. CD O O
Hypertension NNP B-NP B-problem
. . B-VP O
   
3. CD O O
Hypercholesterolemia NNP B-NP B-problem
. . B-VP O
   
Rosemary NNP B-NP B-person
D NNP I-NP I-person
Mccluskey NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
39-696 CD O O
Dictated VBN O O
By IN B-VP O
: : O O
Harriet NNP B-NP B-person
E. NNP I-NP I-person
Evans NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
MEDQUIST36 NNP I-NP O
D NNP I-NP O
: : O O
2011-11-22 JJ O O
14:09 CD O O
T NN B-NP O
: : O O
2011-11-23 JJ O O
11:59 CD O O
JOB NNP B-NP O
#: VBD B-VP O
15087 CD O O
Signed VBN O O
electronically RB O O
by IN B-VP O
: : O O
DR. NNP B-NP B-person
Sandra NNP I-NP I-person
BURGER NNP I-NP I-person
on IN B-VP O
: : O O
WED JJ O O
2011-11-30 JJ O O
9:46 CD O O
AM NNP B-NP O
( ( O O
End NNP B-NP O
of IN B-VP O
Report NNP B-NP O
) ) O O
-EMPTYLINE- VBP O O
-DOCSTART- JJ O O
-EMPTYLINE- $ O O
879492218 CD O O
YC NNP B-NP O
53470378 CD O O
3210349 CD O O
6/26/2004 CD O O
12:00:00 CD O O
AM NNP B-NP O
PNEUMONIA NNP I-NP B-problem
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date NNP I-NP O
: : O O
06/26/2004 CD O O
Report NNP B-NP O
Status NNP I-NP O
: : O O
Signed VBN O O
Discharge NNP B-NP O
Date NNP I-NP O
: : O O
07/08/2004 CD O O
ATTENDING NN B-NP B-person
: : O O
MALTA NNP B-NP B-person
FYFEZEISLEITZ NNP I-NP I-person
MD NNP I-NP I-person
CHIEF NNP I-NP O
COMPLAINT NNP I-NP O
: : O O
Shortness NN B-NP B-problem
of IN B-VP I-problem
breath NN B-NP I-problem
. . B-VP O
   
HISTORY NNP B-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
is VBZ O O
a DT B-NP O
38-year-old JJ I-NP O
gentleman NN I-NP O
, , O O
Spanish-speaking NNP B-NP O
, , O O
from IN B-VP O
the DT B-NP O
Taheimpromong NNP I-NP O
, , O O
with IN B-VP O
no DT B-NP O
significant JJ I-NP O
past JJ I-NP O
medical JJ I-NP O
history NN I-NP O
, , O O
who WP O B-person
presents VBZ O O
with IN B-VP O
shortness NN B-NP B-problem
of IN B-VP I-problem
breath NN B-NP I-problem
x $ O O
2 CD O O
months NNS B-NP O
as RB O O
well RB O O
as IN B-VP O
a DT B-NP B-problem
dry JJ I-NP I-problem
cough NN I-NP I-problem
x RB O O
1 CD O O
month NN B-NP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
in IN B-VP O
his PRP$ O B-person
usual JJ B-NP O
state NN I-NP O
of IN B-VP O
health NN B-NP O
until IN B-VP O
two CD O O
months NNS B-NP O
prior RB O O
to TO O O
admission NN B-NP O
when WRB O O
he PRP O B-person
began VBD B-VP O
to TO O O
notice VB O O
shortness NN B-NP B-problem
of IN B-VP I-problem
breath NN B-NP I-problem
on IN B-VP O
climbing VBG O O
flights NNS B-NP O
of IN B-VP O
stairs NNS B-NP O
. . B-VP O
   
He PRP O B-person
stated VBD B-VP O
that IN B-VP B-pronoun
this DT O B-pronoun
became VBD B-VP O
worse JJR O O
over IN B-VP O
the DT B-NP O
last JJ I-NP O
month NN I-NP O
until IN B-VP O
he PRP O B-person
was VBD B-VP O
noted VBN O O
to TO O O
be VB O O
short JJ O B-problem
of IN B-VP I-problem
breath NN B-NP I-problem
at IN B-VP O
rest NN B-NP O
. . B-VP O
   
He PRP O B-person
also RB O O
states VBZ O O
that IN B-VP B-pronoun
he PRP O B-person
has VBZ O O
had VBD B-VP O
a DT O B-problem
dry JJ O I-problem
and CC O I-problem
nonproductive JJ B-NP I-problem
cough NN I-NP I-problem
for IN B-VP O
one CD O O
month NN B-NP O
. . B-VP O
   
He PRP O B-person
denied VBD B-VP O
any DT B-NP O
fevers NNS I-NP B-problem
, , O O
chills NNS B-NP B-problem
, , O O
or CC O O
night NN B-NP B-problem
sweats NNS I-NP I-problem
. . B-VP O
   
No DT B-NP O
nausea NN I-NP B-problem
, , O O
vomiting VBG O B-problem
, , O O
or CC O O
diarrhea NN B-NP B-problem
. . B-VP O
   
He PRP O B-person
did VBD B-VP O
note VB O O
some DT B-NP B-problem
weight JJ I-NP I-problem
loss NN I-NP I-problem
over IN B-VP O
the DT B-NP O
past JJ I-NP O
several JJ I-NP O
months NNS I-NP O
, , O O
though IN B-VP O
the DT B-NP O
amount NN I-NP O
was VBD B-VP O
unknown JJ O O
. . B-VP O
   
He PRP O B-person
denied VBD B-VP O
any DT B-NP O
contact NN I-NP O
with IN B-VP O
TB NNP B-NP B-person
positive JJ B-NP I-person
patients NNS I-NP I-person
. . B-VP O
   
He PRP O B-person
describes VBZ O O
a DT B-NP O
negative JJ I-NP O
PPD NNP I-NP O
one CD O O
year NN B-NP O
prior RB O O
to TO O O
admission NN B-NP O
when WRB O O
he PRP O B-person
was VBD B-VP O
in IN B-VP O
prison NN B-NP O
for IN B-VP O
one CD O O
week NN B-NP O
. . B-VP O
   
He PRP O B-person
did VBD B-VP O
travel VB O O
to TO O O
the DT B-NP O
Taheimpromong NNP I-NP O
, , O O
last JJ O O
in IN B-VP O
01/2004 CD O O
for IN B-VP O
three CD O O
weeks NNS B-NP O
. . B-VP O
   
He PRP O B-person
did VBD B-VP O
note VB O O
multiple JJ B-NP B-person
female JJ I-NP I-person
sexual JJ I-NP I-person
partners NNS I-NP I-person
, , O O
although IN B-VP O
described VBN O O
using VBG O O
condoms NNS B-NP O
except IN B-VP O
with IN B-VP O
his PRP$ O B-person
his PRP$ O B-person
wife NN B-NP I-person
. . B-VP O
   
He PRP O B-person
denies VBZ O O
any DT B-NP O
IV NNP I-NP O
drug NN I-NP O
use NN I-NP O
, , O O
did VBD B-VP O
describe VB O O
cocaine NN B-NP O
use IN B-VP O
last JJ O O
two CD O O
months NNS B-NP O
ago RB O O
. . B-VP O
   
He PRP O B-person
did VBD B-VP O
drink VB O O
alcohol NN B-NP O
three CD O O
drinks NNS B-NP O
per IN B-VP O
day NN B-NP O
, , O O
no DT B-NP O
withdrawal NN I-NP B-problem
symptoms NNS I-NP I-problem
. . B-VP O
   
In IN B-VP O
emergency NN B-NP O
room NN I-NP O
, , O O
he PRP O B-person
was VBD B-VP O
noted VBN O O
to TO O O
be VB O O
afebrile JJ O B-problem
with IN B-VP O
stable JJ B-NP O
vital JJ I-NP O
signs NNS I-NP O
, , O O
was VBD B-VP O
treated VBN O O
with IN B-VP O
IV NNP B-NP B-treatment
fluids NNS I-NP I-treatment
, , O O
azithromycin NN B-NP B-treatment
, , O O
and CC O O
cefuroxime NN B-NP B-treatment
. . B-VP O
   
PAST NNP B-NP O
MEDICAL NNP I-NP O
HISTORY NNP I-NP O
: : O O
None NN B-NP O
. . B-VP O
   
MEDICATIONS NN B-NP O
: : O O
None NN B-NP O
. . B-VP O
   
ALLERGIES NNP B-NP O
: : O O
No DT B-NP O
known JJ I-NP B-problem
drug NN I-NP I-problem
allergies NNS I-NP I-problem
. . B-VP O
   
SOCIAL NNP B-NP O
HISTORY NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
lives VBZ O O
currently RB O O
with IN B-VP O
a DT B-NP B-person
friend NN I-NP I-person
, , O O
he PRP O B-person
is VBZ O O
from IN B-VP O
the DT B-NP O
Taheimpromong NNP I-NP O
and CC O O
has VBZ O O
lived VBN O O
here RB O O
for IN B-VP O
13 CD O O
years NNS B-NP O
, , O O
he PRP O B-person
does VBZ O O
note VB O O
multiple JJ B-NP B-person
sexual JJ I-NP I-person
partners NNS I-NP I-person
, , O O
although IN B-VP O
he PRP O B-person
notes VBZ O O
using VBG O O
condoms NNS B-NP O
with IN B-VP O
everyone NN B-NP O
except IN B-VP O
his PRP$ O B-person
his PRP$ O B-person
wife NN B-NP I-person
, , O O
he PRP O B-person
reportedly RB O O
had VBD B-VP O
a DT B-NP O
negative JJ I-NP O
PPD NNP I-NP O
during IN B-VP O
his PRP$ O B-person
prison NN B-NP O
stay VB O O
one CD O O
year NN B-NP O
ago RB O O
for IN B-VP O
one CD O O
week NN B-NP O
. . B-VP O
   
He PRP O B-person
traveled VBD B-VP O
to TO O O
the DT B-NP O
Taheimpromong NNP I-NP O
last JJ O O
in IN B-VP O
01/2004 CD O O
for IN B-VP O
one CD O O
month NN B-NP O
. . B-VP O
   
He PRP O B-person
does VBZ O O
drink VB O O
alcohol VB O O
three CD O O
drinks NNS B-NP O
per IN B-VP O
day NN B-NP O
, , O O
denies VBZ O O
any DT B-NP O
current JJ I-NP O
tobacco NN I-NP O
use NN I-NP O
. . B-VP O
   
FAMILY NNP B-NP O
HISTORY NNP I-NP O
: : O O
Sister NN B-NP B-person
with IN B-VP O
bone NN B-NP B-problem
cancer NN I-NP I-problem
. . B-VP O
   
PHYSICAL NNP B-NP O
EXAMINATION NNP I-NP O
UPON NNP I-NP O
ADMISSION NNP I-NP O
: : O O
Temperature NN B-NP B-test
97.4 CD O O
, , O O
heart NN B-NP B-test
rate NN I-NP I-test
100 CD O O
, , O O
blood NN B-NP B-test
pressure NN I-NP I-test
142/89 CD O O
, , O O
and CC O O
O2 NNP B-NP B-test
saturation NN I-NP I-test
94% CD O O
on IN B-VP O
room NN B-NP O
air NN I-NP O
. . B-VP O
   
General NNP B-NP B-test
exam NN I-NP I-test
revealed VBD B-VP O
a DT O B-person
well-developed JJ O I-person
, , O I-person
well-nourished JJ B-NP I-person
gentleman NN I-NP I-person
in IN B-VP O
no DT B-NP O
acute JJ I-NP B-problem
distress NN I-NP I-problem
. . B-VP O
   
HEENT NNP B-NP B-test
exam NN I-NP I-test
revealed VBD B-VP O
sclerae NN B-NP B-problem
to TO O O
be VB O O
injected VBN O O
. . B-VP O
   
Pupils NNP B-NP O
equal JJ O O
, , O O
round NN B-NP O
, , O O
and CC O O
reactive JJ O O
to TO O O
light NN B-NP O
. . B-VP O
   
No DT B-NP O
lymphadenopathy NN I-NP B-problem
was VBD B-VP O
noted VBN O O
in IN B-VP O
the DT B-NP O
neck NN I-NP O
, , O O
there EX O O
was VBD B-VP O
a DT B-NP O
question NN I-NP O
of IN B-VP O
right JJ B-NP B-problem
axillary JJ I-NP I-problem
lymphadenopathy NN I-NP I-problem
. . B-VP O
   
Chest NNP B-NP B-test
exam NN I-NP I-test
reveals NNS I-NP O
coarse VBP O B-problem
rhonchi NN B-NP I-problem
with IN B-VP O
some DT B-NP B-problem
bibasilar JJ I-NP I-problem
crackles NNS I-NP I-problem
. . B-VP O
   
Abdominal NNP B-NP B-test
exam NN I-NP I-test
revealed VBD B-VP O
soft JJ O O
, , O O
nontender NN B-NP O
, , O O
and CC O O
nondistended VBD B-VP O
abdomen NNS B-NP O
. . B-VP O
   
Heart NNP B-NP B-test
exam NN I-NP I-test
was VBD B-VP O
regular JJ B-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
, , O O
tachycardic JJ O B-problem
, , O O
with IN B-VP O
a DT B-NP B-problem
flat JJ I-NP I-problem
jugular NN I-NP I-problem
venous JJ B-NP I-problem
pressure NN I-NP I-problem
. . B-VP O
   
His PRP$ O B-person
extremities NNS B-NP O
were VBD B-VP O
without IN B-VP O
cyanosis NN B-NP B-problem
, , O O
clubbing VBG O B-problem
, , O O
or CC O O
edema NN B-NP B-problem
. . B-VP O
   
His PRP$ O B-person
skin NN B-NP O
was VBD B-VP O
clear JJ O O
, , O O
without IN B-VP O
rashes NNS B-NP B-problem
. . B-VP O
   
There EX O O
is VBZ O O
no DT B-NP O
hepatosplenomegaly NN I-NP B-problem
noted VBD B-VP O
on IN B-VP O
abdominal JJ B-NP B-test
exam NN I-NP I-test
. . B-VP O
   
Neuro NNP B-NP B-test
exam NN I-NP I-test
was VBD B-VP O
alert JJ O O
and CC O O
oriented VBD B-VP O
x $ O O
3 CD O O
. . B-VP O
   
LABORATORY NNP B-NP O
DATA NNP I-NP O
UPON NNP I-NP O
ADMISSION NNP I-NP O
: : O O
Sodium NN B-NP B-test
139 CD O O
, , O O
potassium NN B-NP B-test
3.5 CD O O
, , O O
chloride RB O B-test
103 CD O O
, , O O
bicarbonate NN B-NP B-test
25 CD O O
, , O O
BUN NNP B-NP B-test
9 CD O O
, , O O
creatinine NN B-NP B-test
0.9 CD O O
, , O O
and CC O O
glucose RB O B-test
83 CD O O
. . B-VP O
   
White NNP B-NP B-test
blood NN I-NP I-test
cell NN I-NP I-test
count NN I-NP I-test
11.2 CD O O
, , O O
hematocrit NN B-NP B-test
43.2 CD O O
, , O O
and CC O O
platelets VBZ O B-test
447,000 CD O O
. . B-VP O
   
EKG NNP B-NP O
upon IN B-VP O
admission NN B-NP O
: : O O
Sinus JJ B-NP B-problem
tachycardia NN I-NP I-problem
at IN B-VP O
100 CD O O
. . B-VP O
   
Chest VB O O
x-ray JJ B-NP O
upon JJ I-NP O
admission NN I-NP O
: : O O
Diffuse NNP B-NP B-problem
interstitial JJ B-NP I-problem
process NN I-NP I-problem
/ NNP I-NP O
consolidation NN I-NP B-problem
. . B-VP O
   
HOSPITAL NNP B-NP O
COURSE NNP I-NP O
BY NNP I-NP O
SYSTEM NNP I-NP O
: : O O
1. CD O O
Pulmonary NNP B-NP O
/ NNP I-NP O
Infectious NNP I-NP O
Disease NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
&apos;s NNP I-NP O
differential JJ B-NP O
diagnosis NN I-NP O
included VBD B-VP O
initially RB O O
a DT B-NP O
question NN I-NP O
of IN B-VP O
an DT B-NP B-problem
atypical JJ I-NP I-problem
pneumonia NN I-NP I-problem
or CC O O
PCP NNP B-NP B-problem
. . B-VP O
   
His PRP$ O B-person
His PRP$ O B-test
PPD NNP B-NP I-test
has VBZ O O
been VBN O O
negative JJ O O
one CD O O
year NN B-NP O
prior RB O O
to TO O O
admission NN B-NP O
, , O O
PPD NNP B-NP B-test
was VBD B-VP O
rechecked VBN O O
during IN B-VP O
this DT B-NP O
admission NN I-NP O
and CC O O
was VBD B-VP O
negative JJ O O
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
ruled VBN O O
out RP O O
for IN B-VP O
tuberculosis NN B-NP B-problem
with IN B-VP O
an DT B-NP B-test
induced JJ I-NP I-test
sputum NN I-NP I-test
x VBD B-VP O
3 CD O O
, , O O
which WDT O B-pronoun
showed VBD B-VP O
no DT B-NP O
AFB NNP I-NP B-problem
. . B-VP O
   
Chest NNP B-NP B-test
CT NNP I-NP I-test
showed VBD B-VP O
bibasilar JJ B-NP B-problem
diffuse NN I-NP I-problem
infiltrates NNS I-NP I-problem
, , O O
PCP NNP B-NP B-test
was VBD B-VP O
negative JJ O O
. . B-VP O
   
Thus RB O O
initially RB O O
he PRP O B-person
had VBD B-VP O
been VBN O O
started VBN O O
on IN B-VP O
prednisone NN B-NP B-treatment
and CC O O
Bactrim NNP B-NP B-treatment
, , O O
this DT O B-pronoun
was VBD B-VP O
discontinued VBN O O
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
continued VBN O O
on IN B-VP O
azithromycin NN B-NP B-treatment
and CC O O
cefuroxime NN B-NP B-treatment
until IN B-VP O
bronchoscopy JJ B-NP B-test
results NNS I-NP O
were VBD B-VP O
known VBN O O
, , O O
negative JJ O O
. . B-VP O
   
Thus RB O O
they PRP O B-pronoun
were VBD B-VP O
discontinued VBN O O
. . B-VP O
   
He PRP O B-person
initially RB O O
had VBD B-VP O
refused VBN O O
HIV NNP B-NP B-test
testing NN I-NP I-test
, , O O
however RB O O
, , O O
was VBD B-VP O
finally RB O O
consented VBN O O
, , O O
HIV NNP B-NP B-problem
was VBD B-VP O
noted VBN O O
to TO O O
be VB O O
negative JJ O O
. . B-VP O
   
Pulmonary JJ B-NP B-person
consult NN I-NP O
was VBD B-VP O
invited VBN O O
, , O O
initially RB O O
the DT B-NP B-person
patient NN I-NP I-person
refused VBD B-VP O
bronchoscopy NN B-NP B-test
, , O O
however RB O O
, , O O
did VBD B-VP O
agree VB O O
to TO O O
it PRP O B-pronoun
during IN B-VP O
his PRP$ O B-person
hospital NN B-NP O
stay NN I-NP O
. . B-VP O
   
The DT B-NP O
results NNS I-NP O
were VBD B-VP O
negative JJ O O
for IN B-VP O
Micro NNP B-NP B-problem
, , O O
most JJS B-NP O
likely JJ I-NP O
diagnosis NN I-NP O
as IN B-VP O
per IN B-VP O
review NN B-NP B-test
of IN B-VP I-test
pathology NN B-NP I-test
is VBZ O O
organizing VBG O B-problem
pneumonia NN B-NP I-problem
with IN B-VP O
possible JJ B-NP O
diagnosis NN I-NP O
of IN B-VP O
BOOP NNP B-NP B-problem
and CC O O
chronic JJ B-NP B-problem
inhalational JJ I-NP I-problem
injury NN I-NP I-problem
was VBD B-VP O
a DT B-NP O
possibility NN I-NP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
required VBN O O
supplemental JJ B-NP B-treatment
oxygen NN I-NP I-treatment
to TO O O
keep VB O O
his PRP$ O B-person
his PRP$ O B-test
oxygen NN B-NP I-test
saturation NN I-NP I-test
greater JJR O O
than IN B-VP O
93% CD O O
. . B-VP O
   
Ambulatory JJ B-NP B-test
saturation NN I-NP I-test
was VBD B-VP O
82% CD O O
on IN B-VP O
room NN B-NP O
air NN I-NP O
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
treated VBN O O
with IN B-VP O
supportive JJ B-NP B-treatment
medical JJ I-NP I-treatment
therapy NN I-NP I-treatment
for IN B-VP O
his PRP$ O B-person
his PRP$ O B-problem
cough NN B-NP I-problem
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
to TO O O
follow VB O O
up RP O O
with IN B-VP O
pulmonary JJ O B-person
as IN B-VP O
an DT B-NP O
outpatient NN I-NP O
. . B-VP O
   
2. CD O O
Cardiovascular JJ O O
: : O O
Echocardiogram NN B-NP B-test
was VBD B-VP O
checked VBN O O
to TO O O
rule VB O O
out IN B-VP O
CHF NNP B-NP B-problem
, , O O
showed VBD B-VP O
LVH NNP B-NP B-problem
and CC O O
trace NN B-NP B-problem
TR NNP I-NP I-problem
, , O O
ejection NN B-NP B-test
fraction NN I-NP I-test
of IN B-VP O
60% CD O O
without IN B-VP O
any DT B-NP O
pulmonary JJ I-NP B-problem
hypertension NN I-NP I-problem
. . B-VP O
   
3. CD O O
Heme JJ B-NP O
/ID NN I-NP O
: : O O
Hepatitis NN B-NP B-test
serologies NNS I-NP I-test
were VBD B-VP O
negative JJ O O
. . B-VP O
   
4. CD O O
FEN NN B-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
kept VBN O O
on IN B-VP O
a DT B-NP O
house NN I-NP O
diet NN I-NP O
. . B-VP O
   
His PRP$ O B-person
His PRP$ O B-test
electrolytes NNS B-NP I-test
were VBD B-VP O
repeated VBN O O
p.r.n. RB O O
5. CD O O
Prophylaxis NNS B-NP O
: : O O
Lovenox NNP B-NP B-treatment
. . B-VP O
   
6. CD O O
Code NNP B-NP O
status NN I-NP O
: : O O
Full NNP B-NP O
. . B-VP O
   
7. CD O O
Disposition NN B-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
discharged VBN O O
to TO O O
home NN B-NP O
in IN B-VP O
satisfactory JJ B-NP O
condition NN I-NP O
with IN B-VP O
home NN B-NP B-treatment
oxygen NN I-NP I-treatment
. . B-VP O
   
Multiple JJ B-NP O
conversations NNS I-NP O
were VBD B-VP O
had VBN O O
with IN B-VP O
the DT B-NP B-person
patient NN I-NP I-person
as RB O O
well RB O O
as IN B-VP O
an DT B-NP B-person
interpreter NN I-NP I-person
stating VBG O O
the DT B-NP O
importance NN I-NP O
of IN B-VP O
not RB O O
smoking VBG O O
and CC O O
keeping VBG O O
flames NNS B-NP O
away RB O O
from IN B-VP O
his PRP$ O B-person
his PRP$ O B-treatment
oxygen NN B-NP I-treatment
tank NN I-NP I-treatment
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
sent VBN O O
home NN B-NP O
with IN B-VP O
LDAMC NNP B-NP B-person
services NNS I-NP I-person
to TO O O
help VB O O
with IN B-VP O
his PRP$ O B-person
his PRP$ O B-treatment
medications NNS B-NP I-treatment
as RB O O
well RB O O
as IN B-VP O
oxygen NN B-NP O
education NN I-NP O
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
told VBN O O
to TO O O
call VB O O
a DT B-NP B-person
doctor NN I-NP I-person
or CC O O
come VBN O O
to TO O O
the DT B-NP O
emergency NN I-NP O
room NN I-NP O
should MD O O
he PRP O B-person
have VB O O
any DT B-NP B-problem
further JJ I-NP I-problem
troubles NNS I-NP I-problem
, , O O
breathing NN B-NP O
, , O O
chest NN B-NP B-problem
pain NN I-NP I-problem
, , O O
or CC O O
fevers NNS B-NP B-problem
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
to TO O O
follow VB O O
up RP O O
with IN B-VP O
Dr. NNP B-NP B-person
Malta NNP I-NP I-person
at IN B-VP O
Firmert NNP B-NP O
Hospital NNP I-NP O
on IN B-VP O
07/23/04 CD O O
at IN B-VP O
3:00 CD O O
p.m. NN B-NP O
, , O O
as RB O O
well RB O O
as IN B-VP O
Dr. NNP B-NP B-person
Shawn NNP I-NP I-person
Leick NNP I-NP I-person
at IN B-VP O
the DT B-NP O
Stonho NNP I-NP O
Health NNP I-NP O
Care NNP I-NP O
pulmonary JJ B-NP O
division NN I-NP O
as IN B-VP O
directed VBN O O
. . B-VP O
   
DISCHARGE JJ B-NP O
MEDICATIONS NNP I-NP O
: : O O
1. CD O O
Prednisone NN B-NP B-treatment
60 CD O O
mg NN B-NP O
p.o. NN I-NP O
q.a.m. RB O O
2. CD O O
Bactrim NNP B-NP B-treatment
double JJ B-NP I-treatment
strength NN I-NP I-treatment
one CD O O
tablet NN B-NP O
p.o. NN I-NP O
q.d. NN I-NP O
for IN B-VP O
PCP NNP B-NP B-treatment
prophylaxis NN I-NP I-treatment
during IN B-VP O
his PRP$ O B-person
his PRP$ O B-treatment
steroid JJ B-NP I-treatment
course NN I-NP I-treatment
. . B-VP O
   
eScription NN B-NP O
document NN I-NP O
: : O O
0-3054851 JJ B-NP O
WEBCtug NNP I-NP O
Tel NNP I-NP O
CC NNP I-NP O
: : O O
Mata NNP B-NP B-person
Fyfezeisleitz NNP I-NP I-person
MD NNP I-NP I-person
Verla NNP I-NP O
Dictated VBN O O
By IN B-VP O
: : O O
KOTEHARBE NNP B-NP B-person
, , O I-person
THRYNE NNP B-NP I-person
Attending NNP I-NP B-person
: : O O
FYFEZEISLEITZ NNP B-NP B-person
, , O I-person
MATA NNP B-NP I-person
Dictation NNP I-NP O
ID NNP I-NP O
5149122 CD O O
D NNP B-NP O
: : O O
11/06/04 CD O O
T NN B-NP O
: : O O
11/07/04 CD O O
-EMPTYLINE- NN B-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- VBZ O O
433651389 CD O O
CTMC NNP B-NP O
81247987 CD O O
625670 CD O O
08/16/1998 CD O O
12:00:00 CD O O
AM NNP B-NP O
MENTAL NNP I-NP B-problem
STATUS NNP I-NP I-problem
CHANGE NNP I-NP I-problem
, , O O
CELLULITIS NNP B-NP B-problem
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date NNP I-NP O
: : O O
08/16/1998 CD O O
Report NNP B-NP O
Status NNP I-NP O
: : O O
Signed VBN O O
Discharge NNP B-NP O
Date NNP I-NP O
: : O O
08/18/1998 CD O O
PRINCIPAL NNP B-NP O
DIAGNOSIS NNP I-NP O
: : O O
MENTAL NNP B-NP B-problem
STATUS NNP I-NP I-problem
CHANGES NNP I-NP I-problem
. . B-VP O
   
OTHER NNP B-NP O
DIAGNOSES NNP I-NP O
: : O O
1) CD O O
AORTIC NNP B-NP B-problem
STENOSIS NNP I-NP I-problem
. . B-VP O
   
2) CD O O
MITRAL JJ B-NP B-problem
REGURGITATION NNP I-NP I-problem
. . B-VP O
   
3) CD O O
STATUS NNP B-NP O
POST NNP I-NP O
FALL NNP I-NP B-problem
. . B-VP O
   
4) CD O O
HISTORY NNP B-NP O
OF NNP I-NP O
TRANSIENT NNP I-NP B-problem
ISCHEMIC NNP I-NP I-problem
ATTACK NNP I-NP I-problem
/ NNP I-NP O
CEREBROVASCULAR NNP I-NP B-problem
ACCIDENT NNP I-NP I-problem
. . B-VP O
   
5) CD O O
RIGHT NNP B-NP B-problem
LOWER NNP I-NP I-problem
EXTREMITY NNP I-NP I-problem
WOUND NNP I-NP I-problem
. . B-VP O
   
6) CD O O
ATRIAL NNP B-NP B-problem
FIBRILLATION NNP I-NP I-problem
. . B-VP O
   
HISTORY NNP B-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
is VBZ O O
an DT O O
88 CD O O
year-old JJ B-NP O
woman NN I-NP O
undergoing VBG O O
treatment NN B-NP B-treatment
for IN B-VP O
a DT B-NP B-problem
right JJ I-NP I-problem
lower JJR I-NP I-problem
extremity NN I-NP I-problem
cellulitis NN I-NP I-problem
who WP O B-person
was VBD B-VP O
transferred VBN O O
from IN B-VP O
Child NNP B-NP O
for IN B-VP O
worsening VBG O B-problem
cellulitis NN B-NP I-problem
and CC O O
new JJ B-NP B-problem
confusion NN I-NP I-problem
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
has VBZ O O
a DT B-NP O
history NN I-NP O
of IN B-VP O
severe JJ B-NP B-problem
aortic JJ I-NP I-problem
stenosis NN I-NP I-problem
and CC O O
was VBD B-VP O
recently RB O O
admitted VBN O O
to TO O O
the DT B-NP O
Retelk NNP I-NP O
County NNP I-NP O
Medical NNP I-NP O
Center NNP I-NP O
for IN B-VP O
a DT B-NP O
Nafcillin NNP I-NP B-problem
sensitive JJ B-NP I-problem
Staphylococcus NNP I-NP I-problem
aureus NN I-NP I-problem
cellulitis NN I-NP I-problem
of IN B-VP I-problem
the DT B-NP I-problem
right JJ I-NP I-problem
leg NN I-NP I-problem
treated VBN O O
with IN B-VP O
a DT B-NP B-treatment
course NN I-NP I-treatment
of IN B-VP I-treatment
Nafcillin NNP B-NP I-treatment
and CC O O
Levofloxacin NNP B-NP B-treatment
. . B-VP O
   
There EX O O
was VBD B-VP O
also RB O O
a DT B-NP B-problem
right JJ I-NP I-problem
leg NN I-NP I-problem
fluid NN I-NP I-problem
collection NN I-NP I-problem
that WDT O B-pronoun
was VBD B-VP O
incised VBN O O
and CC O O
drained VBN O O
on IN B-VP O
August NNP B-NP O
1 CD O O
, , O O
1998 CD O O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
sent VBN O O
to TO O O
rehabilitation VB O B-treatment
on IN B-VP O
Levofloxacin NNP B-NP B-treatment
orally RB O O
. . B-VP O
   
Although IN B-VP O
details NNS B-NP O
were VBD B-VP O
not RB O O
available JJ O O
at IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
admission NN B-NP O
, , O O
apparently RB O O
, , O O
she PRP O B-person
had VBD B-VP O
done VBN O O
well RB O O
until IN B-VP O
the DT O O
24 CD O O
hours NNS B-NP O
proceeding VBG O O
admission NN B-NP O
when WRB O O
the DT B-NP B-problem
cellulitis NN I-NP I-problem
was VBD B-VP O
felt VBN O O
to TO O O
be VB O O
worsening VBG O O
. . B-VP O
   
She PRP O B-person
had VBD B-VP O
also RB O O
been VBN O O
noted VBN O O
to TO O O
be VB O O
confused VBN O B-problem
and CC O O
combative JJ O B-problem
during IN B-VP O
that DT O B-pronoun
24 CD O O
hour NN B-NP O
period NN I-NP O
. . B-VP O
   
As IN B-VP O
her PRP$ O B-person
baseline NN B-NP O
mental NN I-NP O
status NN I-NP O
is VBZ O O
completely RB O O
alert JJ O O
and CC O O
oriented VBN O O
, , O O
this DT B-NP B-pronoun
caused JJ I-NP O
concern NN I-NP O
amongst IN B-VP O
the DT B-NP B-person
staff NN I-NP I-person
of IN B-VP O
the DT B-NP O
rehabilitation NN I-NP O
center NN I-NP O
and CC O O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
transferred VBN O O
to TO O O
the DT B-NP O
Retelk NNP I-NP O
County NNP I-NP O
Medical NNP I-NP O
Center NNP I-NP O
. . B-VP O
   
PAST NNP B-NP O
MEDICAL NNP I-NP O
HISTORY NNP I-NP O
: : O O
1) CD O O
Aortic JJ B-NP B-problem
stenosis NN I-NP I-problem
, , O I-problem
severe JJ O I-problem
, , O O
echocardiogram JJ O B-test
in IN B-VP O
July NNP B-NP O
of IN B-VP O
1998 CD O O
with IN B-VP O
a DT B-NP B-test
peak JJ I-NP I-test
gradient NN I-NP I-test
of IN B-VP O
6-8 JJ B-NP O
mm NN I-NP O
of IN B-VP O
mercury NN B-NP O
, , O O
aortic JJ B-NP B-test
valve NN I-NP I-test
area NN I-NP I-test
calculated VBD B-VP O
to TO O O
be VB O O
0.5 CD O O
cm NN B-NP O
squared VBN O O
by IN B-VP O
the DT B-NP O
continuity NN I-NP B-test
equation NN I-NP I-test
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
has VBZ O O
a DT B-NP O
history NN I-NP O
of IN B-VP O
congestive JJ B-NP B-problem
heart NN I-NP I-problem
failure NN I-NP I-problem
. . B-VP O
   
Calculated VBN O B-test
ejection NN B-NP I-test
fraction NN I-NP I-test
was VBD B-VP O
45-50% JJ O O
. . B-VP O
   
2) CD O O
Mitral JJ B-NP B-problem
regurgitation NN I-NP I-problem
, , O O
2+ CD O O
on IN B-VP O
July NNP B-NP O
of IN B-VP O
1998 CD O O
echocardiogram NN B-NP B-test
. . B-VP O
   
3) CD O O
History NN B-NP O
of IN B-VP O
atrial JJ B-NP B-problem
fibrillation NN I-NP I-problem
. . B-VP O
   
4) CD O O
History NN B-NP O
of IN B-VP O
cerebrovascular JJ B-NP B-problem
disease NN I-NP I-problem
. . B-VP O
   
5) CD O O
Hypertension NNP B-NP B-problem
. . B-VP O
   
6) CD O O
History NN B-NP O
of IN B-VP O
temporal JJ B-NP B-problem
arteritis NN I-NP I-problem
on IN B-VP O
chronic JJ B-NP B-treatment
steroids NNS I-NP I-treatment
. . B-VP O
   
7) CD O O
History NN B-NP O
of IN B-VP O
colitis NN B-NP B-problem
. . B-VP O
   
8) CD O O
History NN B-NP O
of IN B-VP O
vertebral JJ B-NP B-problem
body NN I-NP I-problem
fractures NNS I-NP I-problem
. . B-VP O
   
MEDICATIONS NNP B-NP O
ON NNP I-NP O
ADMISSION NNP I-NP O
: : O O
1) CD O O
Digoxin NNP B-NP B-treatment
0.125 CD O O
mg NN B-NP O
p.o. NN I-NP O
q. JJ B-NP O
day NN I-NP O
. . B-VP O
   
2) CD O O
Lasix NNP B-NP B-treatment
80 CD O O
mg NN B-NP O
p.o. NN I-NP O
b.i.d. VBD B-VP O
3) CD O O
Aspirin NNP B-NP B-treatment
81 CD O O
mg NN B-NP O
p.o. NN I-NP O
q. JJ B-NP O
day NN I-NP O
. . B-VP O
   
4) CD O O
Coumadin NNP B-NP B-treatment
2 CD O O
mg NN B-NP O
p.o. NN I-NP O
q.h.s. VBD B-VP O
5) CD O O
Zaroxolyn NNP B-NP B-treatment
2.5 CD O O
mg NN B-NP O
p.o. NN I-NP O
q. JJ B-NP O
day NN I-NP O
. . B-VP O
   
6) CD O O
Toprol NNP B-NP B-treatment
XL NNP I-NP I-treatment
50 CD O O
mg NN B-NP O
p.o. NN I-NP O
q. JJ B-NP O
day NN I-NP O
. . B-VP O
   
7) CD O O
Potassium NN B-NP B-treatment
20 CD O O
mEq NN B-NP O
p.o. NN I-NP O
q. JJ B-NP O
day NN I-NP O
. . B-VP O
   
8) CD O O
Prednisone NN B-NP B-treatment
5 CD O O
mg NN B-NP O
p.o. NN I-NP O
q.o.d. VBD B-VP O
9) CD O O
Fosamax NNP B-NP B-treatment
10 CD O O
mg NN B-NP O
p.o. NN I-NP O
q. JJ B-NP O
day NN I-NP O
. . B-VP O
   
10) CD O O
Levofloxacin NNP B-NP B-treatment
250 CD O O
mg NN B-NP O
p.o. NN I-NP O
q. JJ B-NP O
day NN I-NP O
. . B-VP O
   
11) CD O O
Axid NNP B-NP B-treatment
150 CD O O
mg NN B-NP O
p.o. NN I-NP O
b.i.d. VBD B-VP O
12) CD O O
Buspar NNP B-NP B-treatment
5 CD O O
mg NN B-NP O
p.o. NN I-NP O
t.i.d. VBD B-VP O
13) CD O O
Zyrtec NNP B-NP B-treatment
10 CD O O
mg NN B-NP O
p.o. NN I-NP O
q. JJ B-NP O
day NN I-NP O
. . B-VP O
   
ALLERGIES NN B-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
had VBD B-VP O
no DT O O
known VBN O B-problem
drug NN B-NP I-problem
allergies NNS I-NP I-problem
. . B-VP O
   
SOCIAL NNP B-NP O
HISTORY NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
is VBZ O O
presently RB O O
staying VBG O O
at IN B-VP O
the DT B-NP O
Gangistown NNP I-NP O
Hospital NNP I-NP O
Center NNP I-NP O
. . B-VP O
   
She PRP O B-person
has VBZ O O
a DT B-NP O
son NN I-NP B-person
who WP O B-person
is VBZ O O
actively RB O O
involved VBN O O
in IN B-VP O
her PRP$ O B-person
care NN B-NP O
. . B-VP O
   
PHYSICAL JJ B-NP O
EXAMINATION NN I-NP O
: : O O
Physical JJ B-NP B-test
examination NN I-NP I-test
on IN B-VP O
admission NN B-NP O
revealed VBD B-VP O
an DT B-NP O
elderly JJ I-NP O
woman NN I-NP O
, , O O
sleeping NN B-NP O
, , O O
responsive JJ O O
only RB O O
to TO O O
noxious JJ B-NP B-test
stimuli NNS I-NP I-test
after IN B-VP O
having VBG O O
received VBD B-VP O
some DT B-NP B-treatment
sedation NN I-NP I-treatment
in IN B-VP O
the DT B-NP O
emergency NN I-NP O
department NN I-NP O
. . B-VP O
   
Vital JJ B-NP B-test
signs NNS I-NP I-test
: : O O
Heart NNP B-NP B-test
rate NN I-NP I-test
60 CD O O
, , O O
respiratory NN B-NP B-test
rate NN I-NP I-test
18 CD O O
, , O O
blood NN B-NP B-test
pressure NN I-NP I-test
116/80 CD O O
, , O O
temperature NN B-NP B-test
97.1 CD O O
degrees NNS B-NP O
, , O O
oxygen NN B-NP B-test
saturation NN I-NP I-test
93% CD O O
on IN B-VP O
room NN B-NP O
air NN I-NP O
. . B-VP O
   
Head NN B-NP B-test
and CC O I-test
neck NN B-NP I-test
examination NN I-NP I-test
was VBD B-VP O
benign JJ O O
. . B-VP O
   
Skin NNP B-NP B-test
examination NN I-NP I-test
was VBD B-VP O
notable JJ O O
for IN B-VP O
a DT B-NP B-problem
leg JJ I-NP I-problem
ulcer NN I-NP I-problem
and CC O O
cellulitis NN B-NP B-problem
to TO O O
be VB O O
delineated VBN O O
below IN B-VP O
. . B-VP O
   
There EX O O
were VBD B-VP O
no DT B-NP O
spider NN I-NP B-problem
angiomata NN I-NP I-problem
. . B-VP O
   
Neck NNP B-NP O
was VBD B-VP O
supple JJ O O
with IN B-VP O
no DT B-NP O
thyromegaly NN I-NP B-problem
. . B-VP O
   
Lungs NNS B-NP O
were VBD B-VP O
clear JJ O O
to TO O O
auscultation VB O B-test
bilaterally RB O I-test
. . B-VP O
   
The DT B-NP B-test
heart NN I-NP I-test
examination NN I-NP I-test
revealed VBD B-VP O
that IN B-VP B-pronoun
the DT B-NP B-person
patient NN I-NP I-person
had VBD B-VP O
a DT O B-problem
sustained VBN O I-problem
PMI NNP B-NP I-problem
which WDT O B-pronoun
was VBD B-VP O
located VBN O O
in IN B-VP O
the DT B-NP O
left NN I-NP O
mid NN I-NP O
clavicular JJ B-NP O
line NN I-NP O
, , O O
S1 NNP B-NP O
, , O O
near IN B-VP B-problem
complete JJ B-NP I-problem
obliteration NN I-NP I-problem
of IN B-VP I-problem
the DT B-NP I-problem
second JJ I-NP I-problem
heart NN I-NP I-problem
sound NN I-NP I-problem
by IN B-VP O
a DT O B-problem
two CD O I-problem
out IN B-VP I-problem
of IN B-VP I-problem
six CD O I-problem
high JJ O I-problem
pitched VBN O I-problem
murmur NN B-NP I-problem
peaking VBG O O
at IN B-VP O
mid NN B-NP O
to TO O O
late VB O O
systole NN B-NP O
and CC O O
heard NN B-NP O
across IN B-VP O
the DT B-NP O
precordium NN I-NP O
. . B-VP O
   
It PRP O B-pronoun
radiates VBZ O O
to TO O O
both DT B-NP O
carotids NNS I-NP O
bilaterally RB O O
. . B-VP O
   
There EX O O
was VBD B-VP O
also RB O O
a DT O B-problem
blowing VBG O I-problem
holosystolic JJ O I-problem
murmur FW O I-problem
heard NN B-NP O
at IN B-VP O
the DT B-NP B-person
patient NN I-NP I-person
&apos;s NNP I-NP O
apex NN I-NP O
to TO O O
axilla NN B-NP O
. . B-VP O
   
There EX O O
was VBD B-VP O
no DT B-NP O
S3 NNP I-NP B-problem
appreciated VBD B-VP O
. . B-VP O
   
Vascular JJ B-NP B-test
examination NN I-NP I-test
was VBD B-VP O
notable JJ O O
for IN B-VP O
1+ CD O B-problem
carotid NN B-NP I-problem
impulses NNS I-NP I-problem
which WDT O B-pronoun
were VBD B-VP O
diminished VBN O O
and CC O O
delayed VBN O O
and CC O O
the DT B-NP O
above NN I-NP O
mentioned VBD B-VP O
transmitted JJ B-NP B-problem
cardiac JJ I-NP I-problem
murmurs NN I-NP I-problem
. . B-VP O
   
Abdominal JJ B-NP B-test
examination NN I-NP I-test
revealed VBD B-VP O
that IN B-VP B-pronoun
the DT B-NP O
abdomen NNS I-NP O
was VBD B-VP O
soft JJ O O
, , O O
non-tender JJ O B-problem
, , O O
non-distended JJ O B-problem
, , O O
no DT B-NP O
organomegaly NN I-NP B-problem
, , O O
no DT B-NP O
masses NNS I-NP B-problem
, , O O
normal JJ B-NP O
active JJ I-NP O
bowel NN I-NP O
sounds NNS I-NP O
. . B-VP O
   
The DT O B-person
The DT B-NP B-test
patient JJ I-NP I-person
patient NN I-NP I-test
&apos;s NNP I-NP I-test
extremity NN I-NP I-test
examination NN I-NP I-test
was VBD B-VP O
notable JJ O O
for IN B-VP O
erythema NN B-NP B-problem
of IN B-VP I-problem
the DT B-NP I-problem
right JJ I-NP I-problem
calf NN I-NP I-problem
with IN B-VP O
a DT B-NP B-problem
small JJ I-NP I-problem
ulcer NN I-NP I-problem
with IN B-VP O
a DT O O
relatively RB O O
clean JJ B-NP O
base NN I-NP O
. . B-VP O
   
Neurological JJ B-NP B-test
examination NN I-NP I-test
revealed VBD B-VP O
that IN B-VP B-pronoun
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
quite RB O B-problem
sedated VBN O I-problem
at IN B-VP O
this DT B-NP B-pronoun
time NN I-NP O
having VBG O O
received VBN O O
some DT B-NP O
medications NNS I-NP B-treatment
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
arousable JJ O O
only RB O O
to TO O O
painful JJ B-NP B-test
stimuli NN I-NP I-test
. . B-VP O
   
Her PRP$ O B-person
pupils NNS B-NP O
were VBD B-VP O
reactive JJ O O
bilaterally RB O O
. . B-VP O
   
Her PRP$ O B-person
face NN B-NP O
was VBD B-VP O
symmetric JJ O O
. . B-VP O
   
She PRP O B-person
had VBD B-VP O
an DT B-NP O
intact JJ I-NP O
gag NN I-NP O
reflex NN I-NP O
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
able JJ O O
to TO O O
move VB O O
all DT O O
four CD O O
of IN B-VP O
her PRP$ O B-person
extremities NNS B-NP O
in IN B-VP O
response NN B-NP O
to TO O O
pain NN B-NP B-test
. . B-VP O
   
Her PRP$ O B-person
Her PRP$ O B-test
deep JJ B-NP I-test
tendon NN I-NP I-test
reflexes NNS I-NP I-test
were VBD B-VP O
slightly RB O O
diminished VBN O O
at IN B-VP O
1+ CD O O
bilaterally RB O O
, , O O
but CC O O
symmetric JJ O O
. . B-VP O
   
LABORATORY NN B-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
&apos;s NNP I-NP O
laboratory NN I-NP O
data NNS I-NP O
on IN B-VP O
admission NN B-NP O
is VBZ O O
as IN B-VP O
follows VBZ O O
: : O O
Sodium NN B-NP B-test
was VBD B-VP O
142 CD O O
, , O O
potassium NN B-NP B-test
3.3 CD O O
, , O O
chloride RB O B-test
99 CD O O
, , O O
BUN NNP B-NP B-test
23 CD O O
, , O O
creatinine NN B-NP B-test
1.1 CD O O
. . B-VP O
   
AST NNP B-NP B-test
was VBD B-VP O
25 CD O O
, , O O
alkaline JJ B-NP B-test
phosphatase NN I-NP I-test
130 CD O O
, , O O
total JJ B-NP B-test
bilirubin NN I-NP I-test
3.2 CD O O
, , O O
albumin RB O B-test
3.4 CD O O
, , O O
calcium NN B-NP B-test
8.8 CD O O
. . B-VP O
   
Digoxin NNP B-NP B-test
level NN I-NP I-test
was VBD B-VP O
0.8 CD O O
. . B-VP O
   
Hematocrit NNP B-NP B-test
was VBD B-VP O
33.0 CD O O
, , O O
platelet NN B-NP B-test
count NN I-NP I-test
627 CD O O
, , O O
white JJ B-NP B-test
blood NN I-NP I-test
cell NN I-NP I-test
count NN I-NP I-test
10,000 CD O O
, , O O
MCV NNP B-NP B-test
79.8 CD O O
. . B-VP O
   
Coagulation NN B-NP B-test
studies NNS I-NP I-test
revealed VBD B-VP O
a DT B-NP O
PT NNP I-NP B-test
of IN B-VP O
17.4 CD O O
seconds NNS B-NP O
with IN B-VP O
an DT B-NP B-test
INR NNP I-NP I-test
of IN B-VP O
2.1 CD O O
, , O O
PTT NNP B-NP B-test
25.5 CD O O
. . B-VP O
   
The DT O B-person
The DT B-NP B-test
patient JJ I-NP I-person
patient NN I-NP I-test
&apos;s NNP I-NP I-test
admission NN I-NP I-test
chest JJS O I-test
x-ray JJ O I-test
revealed VBD B-VP O
no DT B-NP O
infiltrate NN I-NP B-problem
, , O O
no DT B-NP O
congestive JJ I-NP B-problem
heart NN I-NP I-problem
failure NN I-NP I-problem
. . B-VP O
   
Head NNP B-NP B-test
CT NNP I-NP I-test
scan JJ O I-test
performed VBN O O
in IN B-VP O
the DT B-NP O
emergency NN I-NP O
department NN I-NP O
revealed VBD B-VP O
no DT B-NP O
bleed NN I-NP B-problem
. . B-VP O
   
Urinalysis NN B-NP B-test
revealed VBD B-VP O
trace NN B-NP B-problem
microscopic NN I-NP I-problem
hematuria NN I-NP I-problem
with IN B-VP O
47 CD O O
red JJ B-NP O
blood NN I-NP O
cells NNS I-NP O
per IN B-VP O
high JJ B-NP O
powered JJ I-NP O
field NN I-NP O
, , O O
1+ CD O B-problem
bacteria NNS B-NP I-problem
. . B-VP O
   
HOSPITAL NNP B-NP O
COURSE NNP I-NP O
: : O O
1) CD O O
Mental NNP B-NP B-problem
status NN I-NP I-problem
changes NNS I-NP I-problem
: : O O
On IN B-VP O
admission NN B-NP O
to TO O O
the DT B-NP O
emergency NN I-NP O
room NN I-NP O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
somewhat RB O O
argumentative JJ O B-problem
and CC O O
confused VBD B-VP B-problem
as RB O O
well RB O O
as IN B-VP O
uncooperative JJ O B-problem
with IN B-VP I-problem
procedures NNS B-NP I-problem
. . B-VP O
   
A DT B-NP B-test
neurologic JJ I-NP I-test
work-up NN I-NP I-test
was VBD B-VP O
undertaken JJ O O
which WDT O B-pronoun
included VBD B-VP O
a DT B-NP B-test
CT NNP I-NP I-test
scan NN I-NP I-test
of IN B-VP I-test
the DT B-NP I-test
head NN I-NP I-test
which WDT O B-pronoun
revealed VBD B-VP O
no DT B-NP O
acute JJ I-NP B-problem
bleed NN I-NP I-problem
and CC O O
a DT B-NP B-test
lumbar NN I-NP I-test
puncture NN I-NP I-test
which WDT O B-pronoun
revealed VBD B-VP O
a DT B-NP B-test
glucose NN I-NP I-test
of IN B-VP O
72 CD O O
, , O O
protein RB O B-test
65 CD O O
, , O O
white JJ B-NP B-test
blood NN I-NP I-test
cell NN I-NP I-test
count NN I-NP I-test
19 CD O O
, , O O
red JJ B-NP B-test
blood NN I-NP I-test
cell NN I-NP I-test
count NN I-NP I-test
11,500 CD O O
with IN B-VP O
no DT B-NP O
evidence NN I-NP O
of IN B-VP O
xanthrochromasia NN B-NP B-problem
. . B-VP O
   
The DT B-NP B-person
Neurology NNP I-NP I-person
Service NNP I-NP I-person
evaluated VBD B-VP O
the DT B-NP B-person
patient NN I-NP I-person
who WP O B-person
felt VBD B-VP O
that IN B-VP B-pronoun
her PRP$ O B-person
her PRP$ O B-problem
agitation NN B-NP I-problem
was VBD B-VP O
most RBS O O
likely JJ O O
due JJ O O
to TO O O
infection NN B-NP B-problem
, , O O
her PRP$ O B-person
her PRP$ O B-treatment
multiple JJ B-NP I-treatment
medications NNS I-NP I-treatment
, , O O
or CC O O
her PRP$ O B-person
her PRP$ O B-problem
metabolic JJ B-NP I-problem
condition NN I-NP I-problem
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
&apos;s NNP I-NP O
mental JJ B-NP O
status NN I-NP O
slowly RB O O
began VBD B-VP O
to TO O O
recover VB O O
, , O O
however RB O O
on IN B-VP O
the DT B-NP O
morning NN I-NP O
of IN B-VP O
the DT B-NP O
first JJ I-NP O
day NN I-NP O
of IN B-VP O
admission NN B-NP O
, , O O
August NNP B-NP O
16 CD O O
, , O O
1998 CD O O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
found VBN O O
after IN B-VP O
having VBG O O
fallen VBN O O
. . B-VP O
   
A DT B-NP B-test
neurological JJ I-NP I-test
examination NN I-NP I-test
was VBD B-VP O
performed VBN O O
which WDT O B-pronoun
revealed VBD B-VP O
no DT B-NP O
abnormality NN I-NP B-problem
and CC O O
imaging NN B-NP B-test
included VBD B-VP O
a DT B-NP B-test
head NN I-NP I-test
scan JJ O I-test
which WDT O B-pronoun
revealed VBD B-VP O
no DT B-NP O
bleed NN I-NP B-problem
and CC O O
a DT B-NP B-test
cervical JJ I-NP I-test
spine NN I-NP I-test
series NN I-NP I-test
which WDT O B-pronoun
revealed VBD B-VP O
degenerative JJ B-NP B-problem
joint JJ I-NP I-problem
disease NN I-NP I-problem
but CC O O
no DT B-NP O
obvious JJ I-NP B-problem
fracture NN I-NP I-problem
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
decided VBD B-VP O
not RB O O
to TO O O
pursue VB O O
further JJ O B-test
testing VBG O I-test
with IN B-VP O
a DT B-NP B-test
neck NN I-NP I-test
CT NNP I-NP I-test
scan NN I-NP I-test
. . B-VP O
   
At IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
discharge NN B-NP O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
&apos;s NNP I-NP O
mental NN I-NP O
status NN I-NP O
is VBZ O O
back RB O O
to TO O O
its PRP$ O O
baseline NN B-NP O
. . B-VP O
   
2) CD O O
Right NNP B-NP B-problem
lower JJR B-NP I-problem
extremity NN I-NP I-problem
cellulitis NN I-NP I-problem
: : O O
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
evaluated VBN O O
by IN B-VP O
the DT B-NP O
Surgical NNP I-NP B-person
Service NNP I-NP I-person
who WP O B-person
felt VBD B-VP O
that IN B-VP B-pronoun
the DT B-NP B-problem
wound NN I-NP I-problem
was VBD B-VP O
clean JJ O O
with IN B-VP O
some DT B-NP B-problem
erythema NN I-NP I-problem
but CC O O
without IN B-VP O
evidence NN B-NP O
of IN B-VP O
true JJ B-NP B-problem
cellulitis NN I-NP I-problem
. . B-VP O
   
The DT O B-treatment
The DT B-NP B-person
patient JJ I-NP I-treatment
patient NN I-NP I-person
&apos;s NN I-NP I-treatment
antibiotics NNS I-NP I-treatment
were VBD B-VP O
discontinued VBN O O
with IN B-VP O
the DT B-NP O
thought NN I-NP O
that WDT O B-pronoun
prolonged VBD B-VP B-treatment
antibiotics NNS B-NP I-treatment
only RB O O
put VBD B-VP O
her PRP O B-person
at IN B-VP O
more JJR B-NP O
risk NN I-NP O
for IN B-VP O
infection NN B-NP B-problem
. . B-VP O
   
3) CD O O
Cardiac JJ O O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
has VBZ O O
a DT B-NP O
history NN I-NP O
of IN B-VP O
critical JJ B-NP B-problem
aortic JJ I-NP I-problem
stenosis NN I-NP I-problem
and CC O O
mitral JJ B-NP B-problem
regurgitation NN I-NP I-problem
. . B-VP O
   
Fortunately RB O O
, , O O
these DT B-NP B-pronoun
issues NNS I-NP O
were VBD B-VP O
not RB O O
active JJ O O
during IN B-VP O
the DT B-NP O
present JJ I-NP O
admission NN I-NP O
. . B-VP O
   
4) CD O O
Status NNP B-NP O
post NN I-NP O
fall NN I-NP B-problem
: : O O
The DT B-NP B-person
patient NN I-NP I-person
did VBD B-VP O
fall VB O O
while IN B-VP O
inhouse NN B-NP O
. . B-VP O
   
A DT B-NP B-test
head NN I-NP I-test
CT NNP I-NP I-test
scan JJ O I-test
and CC O O
cervical JJ B-NP B-test
spine NN I-NP I-test
series NN I-NP I-test
were VBD B-VP O
negative JJ O O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
appeared VBD B-VP O
to TO O O
have VB O O
no DT B-NP O
deficits NNS I-NP B-problem
at IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
discharge NN B-NP O
. . B-VP O
   
5) CD O O
Atrial JJ B-NP B-problem
fibrillation NN I-NP I-problem
: : O O
The DT O B-person
The DT B-NP B-treatment
patient JJ I-NP I-person
patient NN I-NP I-treatment
&apos;s NNP I-NP I-treatment
Coumadin NNP I-NP I-treatment
was VBD B-VP O
continued VBN O O
. . B-VP O
   
6) CD O O
Abnormal JJ B-NP B-problem
liver NN I-NP I-problem
function NN I-NP I-problem
tests NNS I-NP I-problem
: : O O
On IN B-VP O
admission NN B-NP O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
noted VBN O O
to TO O O
have VB O O
elevated VBN O B-problem
bilirubins NNS B-NP I-problem
in IN B-VP O
the DT O O
3 CD O O
range NN B-NP O
and CC O O
mildly RB O B-problem
elevated VBD B-VP I-problem
alkaline JJ B-NP I-problem
phosphatase NN I-NP I-problem
consistent NN I-NP O
with IN B-VP O
a DT B-NP O
cholestatic JJ I-NP B-problem
picture NN I-NP I-problem
. . B-VP O
   
These DT O B-test
These DT B-NP B-pronoun
liver JJR I-NP I-test
function NN I-NP I-test
tests NNS I-NP I-test
will MD O O
be VB O O
followed VBN O O
closely RB O O
as IN B-VP O
an DT B-NP O
outpatient NN I-NP O
. . B-VP O
   
MEDICATIONS NNP B-NP O
ON NNP I-NP O
DISCHARGE NNP I-NP O
: : O O
1) CD O O
Aspirin NNP B-NP B-treatment
81 CD O O
mg NN B-NP O
p.o. NN I-NP O
q. JJ B-NP O
day NN I-NP O
. . B-VP O
   
2) CD O O
Digoxin NNP B-NP B-treatment
0.125 CD O O
mg NN B-NP O
p.o. NN I-NP O
q. NN I-NP O
AM NNP I-NP O
. . B-VP O
   
3) CD O O
Lasix NNP B-NP B-treatment
40 CD O O
mg NN B-NP O
p.o. NN I-NP O
b.i.d. VBD B-VP O
4) CD O O
Zaroxolyn NNP B-NP B-treatment
0.25 CD O O
mg NN B-NP O
p.o. NN I-NP O
q. JJ B-NP O
day NN I-NP O
. . B-VP O
   
5) CD O O
Prednisone NN B-NP B-treatment
5 CD O O
mg NN B-NP O
p.o. NN I-NP O
q.o.d. VBD B-VP O
6) CD O O
Coumadin NNP B-NP B-treatment
2 CD O O
mg NN B-NP O
p.o. NN I-NP O
q.h.s. VBD B-VP O
7) CD O O
Kay NNP B-NP B-treatment
Ciel NNP I-NP I-treatment
20 CD O O
mEq NN B-NP O
p.o. NN I-NP O
q. JJ B-NP O
day NN I-NP O
. . B-VP O
   
8) CD O O
Fosamax NNP B-NP B-treatment
10 CD O O
mg NN B-NP O
p.o. NN I-NP O
q. JJ B-NP O
day NN I-NP O
. . B-VP O
   
9) CD O O
Amitriptyline NNP B-NP B-treatment
10 CD O O
mg NN B-NP O
p.o. NN I-NP O
q.h.s. VBD B-VP O
10) CD O O
Buspar NNP B-NP B-treatment
5 CD O O
mg NN B-NP O
p.o. NN I-NP O
t.i.d. JJ B-NP O
FOLLOW-UP NN I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
will MD O O
be VB O O
followed VBN O O
at IN B-VP O
rehabilitation NN B-NP B-treatment
by IN B-VP O
her PRP$ O B-person
her PRP$ O B-person
primary JJ B-NP I-person
care NN I-NP I-person
physician NN I-NP I-person
, , O O
Dr. NNP B-NP B-person
Both NNP I-NP I-person
. . B-VP O
   
Dictated VBN O O
By IN B-VP O
: : O O
TIA NNP B-NP B-person
BREUNMULL NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
OH29 NNP I-NP O
Attending NNP I-NP B-person
: : O O
RA NNP B-NP B-person
S. NNP I-NP I-person
BOTH NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
YT79 NNP I-NP O
WH234/2364 NNP I-NP O
Batch NNP I-NP O
: : O O
4025 CD O O
Index NNP B-NP O
No. NNP I-NP O
FSYAMR79X6 NNP I-NP O
D NNP I-NP O
: : O O
08/18/98 CD O O
T NN B-NP O
: : O O
08/18/98 CD O O
-EMPTYLINE- NN B-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
Admission NNP I-NP O
Date: NNP I-NP O
2014-03-31 JJ B-NP O
Discharge NNP I-NP O
Date NNP I-NP O
: : O O
2014-04-01 JJ B-NP O
Date NNP I-NP O
of IN B-VP O
Birth NNP B-NP O
: : O O
2014-03-31 JJ B-NP O
Sex NN I-NP O
: : O O
M NNP B-NP O
Service NNP I-NP O
: : O O
CMED JJ B-NP O
HISTORY NN I-NP O
: : O O
Baby NNP B-NP B-person
Alfonso NNP I-NP I-person
Carroll NNP I-NP I-person
is VBZ O O
a DT B-NP O
full JJ I-NP O
term NN I-NP O
infant NN I-NP O
born VBN O O
at IN B-VP O
3.325 CD O O
kg NN B-NP O
to TO O O
a DT B-NP B-person
35-year-old JJ I-NP I-person
G2 NNP I-NP I-person
, , O I-person
P1 NNP B-NP I-person
, , O I-person
now RB O I-person
2 CD O I-person
mother NN B-NP I-person
. . B-VP O
   
Prenatal NNP B-NP B-test
screens VBZ O I-test
- : O O
blood NN B-NP B-test
type NN I-NP I-test
O NNP I-NP O
positive JJ O O
, , O O
antibody JJ O B-test
screen JJ O I-test
negative JJ O O
, , O O
hepatitis NN B-NP B-test
B NNP I-NP I-test
surface NN I-NP I-test
antigen NN I-NP I-test
negative JJ O O
, , O O
RPR NNP B-NP B-test
nonreactive NN I-NP O
, , O O
rubella NN B-NP B-test
immune NN I-NP O
. . B-VP O
   
GBS NNP B-NP B-problem
negative JJ O O
. . B-VP O
   
Maternal JJ B-NP O
history NN I-NP O
notable JJ O O
for IN B-VP O
hypothyroidism NN B-NP B-problem
on IN B-VP O
Levoxyl NNP B-NP B-treatment
. . B-VP O
   
Primary JJ B-NP B-treatment
cesarean JJ I-NP I-treatment
section NN I-NP I-treatment
with IN B-VP O
previous JJ B-NP O
pregnancy NN I-NP O
for IN B-VP O
arrest NN B-NP B-problem
of IN B-VP I-problem
descent NN B-NP I-problem
. . B-VP O
   
Other JJ B-NP B-treatment
meds NNS I-NP I-treatment
: : O O
Paxil NNP B-NP B-treatment
. . B-VP O
   
This DT B-NP B-pronoun
pregnancy NN I-NP O
is VBZ O O
complicated VBN O O
by IN B-VP O
a DT B-NP B-problem
cyst NN I-NP I-problem
noted VBD B-VP O
on IN B-VP O
the DT B-NP O
umbilical JJ I-NP O
cord NN I-NP O
on IN B-VP O
fetal JJ B-NP B-test
ultrasound NN I-NP I-test
study NN I-NP I-test
at IN B-VP O
18 CD O O
weeks NNS B-NP O
gestation NN I-NP O
. . B-VP O
   
Mother NNP B-NP B-person
presented VBD B-VP O
in IN B-VP O
spontaneous JJ B-NP O
labor NN I-NP O
. . B-VP O
   
No DT B-NP O
perineal JJ I-NP B-problem
sepsis NN I-NP I-problem
risk NN I-NP I-problem
factors NNS I-NP I-problem
. . B-VP O
   
No DT B-NP O
maternal JJ I-NP B-problem
fever NN I-NP I-problem
. . B-VP O
   
No DT B-NP O
prolonged JJ I-NP B-problem
rupture NN I-NP I-problem
of IN B-VP I-problem
membranes NNS B-NP I-problem
. . B-VP O
   
Clear JJ B-NP O
amniotic JJ I-NP O
fluid NN I-NP O
. . B-VP O
   
Anesthesia NNP B-NP B-treatment
by IN B-VP O
epidural JJ O B-treatment
. . B-VP O
   
Vaginal JJ B-NP O
delivery NN I-NP O
. . B-VP O
   
Apgars NNS B-NP B-test
were VBD B-VP O
8 CD O O
and CC O O
9 CD O O
. . B-VP O
   
PHYSICAL JJ B-NP O
EXAMINATION NN I-NP O
: : O O
Weight JJ O B-test
3.325 CD O O
kg NN B-NP O
, , O O
length NN B-NP B-test
was VBD B-VP O
20 CD O O
inches NNS B-NP O
i.e. JJ O O
51 CD O O
cm NN B-NP O
, , O O
head NN B-NP B-test
circumference NN I-NP I-test
34.5 CD O O
cm NN B-NP O
. . B-VP O
   
Nondysmorphic JJ B-NP B-problem
infant NN I-NP B-person
. . B-VP O
   
Active NNP B-NP O
, , O O
pink VBP O O
newborn VBN O B-person
in IN B-VP O
no DT B-NP O
distress NN I-NP B-problem
on IN B-VP O
radiate NN B-NP B-treatment
warmer NN I-NP I-treatment
. . B-VP O
   
Anterior NNP B-NP O
fontanel NN I-NP O
soft JJ O O
and CC O O
flat JJ O O
. . B-VP O
   
Palate NNP B-NP O
and CC O O
clavicles NNS B-NP O
intact JJ O O
. . B-VP O
   
Neck NNP B-NP O
supple NN I-NP O
. . B-VP O
   
Lungs NNS B-NP O
clear JJ O O
to TO O O
apex VB O O
and CC O O
equal JJ O O
. . B-VP O
   
CARDIOVASCULAR NN B-NP O
: : O O
Regular JJ B-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
. . B-VP O
   
No DT B-NP O
murmurs NN I-NP B-problem
. . B-VP O
   
2+ CD O B-test
femoral JJ B-NP I-test
pulses NNS I-NP I-test
. . B-VP O
   
ABDOMEN NN B-NP O
: : O O
Soft JJ O O
. . B-VP O
   
Positive JJ B-NP O
bowel NN I-NP O
sounds NNS I-NP O
. . B-VP O
   
Umbilical JJ B-NP O
cord NN I-NP O
with IN B-VP O
Braintree NNP B-NP O
jelly RB O B-problem
cysts VBZ O I-problem
but CC O O
also RB O O
with IN B-VP O
pink JJ B-NP B-problem
tubular JJ I-NP I-problem
discoloration NN I-NP I-problem
at IN B-VP I-problem
base NN B-NP I-problem
. . B-VP O
   
Umbilical JJ B-NP O
ring NN I-NP O
intact JJ O O
. . B-VP O
   
Normal JJ B-NP O
male NN I-NP B-person
. . B-VP O
   
Testes VBZ O O
down RP O O
bilaterally RB O O
. . B-VP O
   
Patent NNP B-NP O
anus NN I-NP O
. . B-VP O
   
No DT B-NP O
sacral JJ I-NP B-problem
anomalies NNS I-NP I-problem
. . B-VP O
   
EXTREMITIES NNS B-NP O
: : O O
Pink NN B-NP O
and CC O O
well RB O O
perfused VBN O O
. . B-VP O
   
SUMMARY NNP B-NP O
OF IN B-VP O
HOSPITAL NNP B-NP O
COURSE NNP I-NP O
BY NNP I-NP O
SYSTEMS NNP I-NP O
: : O O
RESPIRATORY NN B-NP O
: : O O
He PRP O B-person
has VBZ O O
been VBN O O
stable JJ O O
in IN B-VP O
room NN B-NP O
air NN I-NP O
throughout IN B-VP O
hospital JJ B-NP O
course NN I-NP O
. . B-VP O
   
CARDIOVASCULAR NNP B-NP O
: : O O
No DT B-NP O
cardiovascular JJ I-NP B-problem
issues NNS I-NP I-problem
. . B-VP O
   
FLUIDS NNP B-NP O
, , O O
ELECTROLYTES NNP B-NP O
AND CC O O
NUTRITION NNP B-NP O
: : O O
Infant NNP B-NP B-person
initiated VBD B-VP O
on IN B-VP O
60 CD O O
cc NNS B-NP O
per IN B-VP O
kg FW O O
per IN B-VP O
day NN B-NP O
of IN B-VP O
D10W NNP B-NP B-treatment
. . B-VP O
   
D-sticks NNS B-NP B-test
have VBP O O
been VBN O O
stable JJ O O
. . B-VP O
   
Infant NN B-NP B-person
is VBZ O O
allowed VBN O O
to TO O O
ad NN B-NP O
lib NN I-NP O
breast NN I-NP O
feed NN I-NP O
which WDT O B-pronoun
he PRP O B-person
is VBZ O O
doing VBG O O
vigorously RB O O
. . B-VP O
   
GASTROINTESTINAL NN B-NP O
: : O O
Infant NN B-NP B-person
is VBZ O O
ad NN B-NP O
lib NN I-NP O
feeding NN I-NP O
. . B-VP O
   
An DT B-NP B-test
abdominal JJ I-NP I-test
ultrasound NN I-NP I-test
was VBD B-VP O
performed VBN O O
. . B-VP O
   
Initial JJ B-NP O
impression NN I-NP O
included VBD B-VP O
omphalocele NN B-NP B-problem
with IN B-VP O
further JJ B-NP B-test
imaging NN I-NP I-test
of IN B-VP I-test
the DT B-NP I-test
bowel NN I-NP I-test
to TO O O
be VB O O
done VBN O O
. . B-VP O
   
Surgery NN B-NP O
was VBD B-VP O
consulted VBN O O
and CC O O
Dr. NNP B-NP B-person
Boston NNP I-NP I-person
took VBD B-VP O
patient NN B-NP B-person
to TO O O
OR NNP B-NP O
for IN B-VP O
exploration NN B-NP B-test
of IN B-VP I-test
cord NN B-NP I-test
on IN B-VP O
04-01 NN B-NP O
. . B-VP O
   
Urachal NNP B-NP B-problem
duct NN I-NP I-problem
remnanr NN I-NP I-problem
found VBD B-VP O
, , O O
removed VBN O O
and CC O O
bladder NN B-NP O
repaired VBN O O
. . B-VP O
   
Post NNP B-NP O
op JJ B-NP O
course NN I-NP O
unremrakable JJ O O
. . B-VP O
   
PAtient NNP B-NP B-person
began VBD B-VP O
feeding VBG O O
first RB O O
post NN B-NP O
op JJ B-NP O
day NN I-NP O
and CC O O
has VBZ O O
done VBN O O
well RB O O
. . B-VP O
   
HEMATOLOGY NN B-NP O
: : O O
Hematocrit NN B-NP B-test
on IN B-VP O
admission NN B-NP O
was VBD B-VP O
52.8 CD O O
. . B-VP O
   
The DT B-NP B-person
infant NN I-NP I-person
does VBZ O O
not RB O O
require VB O O
a DT B-NP B-treatment
new JJ I-NP I-treatment
blood NN I-NP I-treatment
transfusion NN I-NP I-treatment
. . B-VP O
   
INFECTIOUS JJ B-NP O
DISEASE NN I-NP O
: : O O
CBC NNP B-NP B-test
and CC O O
blood NN B-NP B-test
culture NN I-NP I-test
obtained VBN O O
on IN B-VP O
admission NN B-NP O
. . B-VP O
   
Initial JJ B-NP B-test
CBC NNP I-NP I-test
had VBD B-VP O
a DT B-NP B-test
white JJ I-NP I-test
count NN I-NP I-test
of IN B-VP O
20 CD O O
, , O O
platelet NN B-NP B-test
count NN I-NP I-test
of IN B-VP O
386 CD O O
, , O O
63 CD O O
polys NN B-NP B-test
, , O O
2 CD O O
bands NNS B-NP B-test
, , O O
23 CD O O
lymphs NN B-NP B-test
. . B-VP O
   
Blood NNP B-NP B-test
cultures NNS I-NP I-test
remained VBD B-VP O
negative JJ O O
at IN B-VP O
this DT B-NP B-pronoun
time NN I-NP O
. . B-VP O
   
Infant NNP B-NP B-person
has VBZ O O
not RB O O
received VBN O O
any DT B-NP B-treatment
antibiotics NNS I-NP I-treatment
. . B-VP O
   
NEUROLOGIC NN B-NP O
: : O O
Infant NN B-NP B-person
has VBZ O O
been VBN O O
appropriate JJ O O
for IN B-VP O
gestational JJ B-NP O
age NN I-NP O
. . B-VP O
   
SENSORY NN B-NP O
: : O O
Hearing NN B-NP B-test
screen NN I-NP I-test
has VBZ O O
not RB O O
yet RB O O
been VBN O O
performed VBN O O
but CC O O
should MD O O
be VB O O
done VBN O O
prior RB O O
to TO O O
discharge VB O O
. . B-VP O
   
CONDITION NNP B-NP O
ON NNP I-NP O
DISCHARGE NNP I-NP O
: : O O
Stable JJ O O
. . B-VP O
   
DISCHARGE JJ B-NP O
DISPOSITION NN I-NP O
: : O O
To TO O O
Massachusetts NNP B-NP O
General NNP I-NP O
Hospital NNP I-NP O
. . B-VP O
   
NAME NN B-NP O
OF NNP I-NP O
PRIMARY NNP I-NP B-person
PEDIATRICIAN NNP I-NP I-person
: : O O
Dr. NNP B-NP B-person
Joan NNP I-NP I-person
Derringer NNP I-NP I-person
. . B-VP O
   
DISCHARGE NNP B-NP O
DIAGNOSES NNP I-NP O
: : O O
Urachal JJ B-NP B-problem
duct NN I-NP I-problem
remnant NN I-NP I-problem
. . B-VP O
   
CARE NNP B-NP O
RECOMMENDATIONS NNP I-NP O
: : O O
1. CD O O
Dressing VBG O B-treatment
to TO O O
remain VB O O
in IN B-VP O
place NN B-NP O
for IN B-VP O
10 CD O O
days NNS B-NP O
unless IN B-VP O
signs NNS B-NP O
of IN B-VP O
bleeding NN B-NP B-problem
, , O O
infection NN B-NP B-problem
or CC O O
is VBZ O O
soiled VBN O O
. . B-VP O
   
2. CD O O
F/U NNP B-NP O
with IN B-VP O
primary JJ B-NP B-person
pediatricians NNS I-NP I-person
in IN B-VP O
3-4 JJ B-NP O
days NNS I-NP O
or CC O O
earlier JJR O O
as IN B-VP O
needed VBN O O
. . B-VP O
   
3. CD O O
F/U NNP B-NP O
appt NN I-NP O
with IN B-VP O
Dr NNP B-NP B-person
Boston NNP I-NP I-person
, , O O
Massachusetts NNP B-NP O
General NNP I-NP O
Hospital NNP I-NP O
Surgery NNP I-NP O
in IN B-VP O
approx RB O O
4 CD O O
weeks NNS B-NP O
. . B-VP O
   
Mother NNP B-NP B-person
has VBZ O O
Dr NNP B-NP B-person
Fishman's NNP I-NP I-person
contact NN I-NP O
information NN I-NP O
. . B-VP O
   
Emma NNP B-NP B-person
Nicolas NNP I-NP I-person
, , O I-person
MD NNP B-NP I-person
79-770 CD O O
Dictated VBN O O
By IN B-VP O
: : O O
Jerry NNP B-NP B-person
E NNP I-NP I-person
Ross NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
MEDQUIST36 NNP I-NP O
D NNP I-NP O
: : O O
2014-04-01 JJ O O
01:57:51 CD O O
T NN B-NP O
: : O O
2014-04-01 JJ O O
02:59:13 CD O O
Job NNP B-NP O
#: VBD B-VP O
96281 CD O O
Signed VBN O O
electronically RB O O
by IN B-VP O
: : O O
DR. NNP B-NP B-person
James NNP I-NP I-person
GRAY NNP I-NP I-person
on IN B-VP O
: : O O
Roger NNP B-NP O
2014-04-03 JJ O O
3:20 CD O O
PM NNP B-NP O
( ( O O
End NNP B-NP O
of IN B-VP O
Report NNP B-NP O
) ) O O
-EMPTYLINE- VBP O O
-DOCSTART- JJ B-NP O
-EMPTYLINE- NNP I-NP O
Admission NNP I-NP O
Date NNP I-NP O
: : O O
2009-08-17 JJ B-NP O
Discharge NN I-NP O
Date NNP I-NP O
: : O O
2009-09-10 JJ B-NP O
Date NNP I-NP O
of IN B-VP O
Birth NNP B-NP O
: : O O
1951-04-02 JJ B-NP O
Sex NN I-NP O
: : O O
M NNP B-NP O
Service NNP I-NP O
: : O O
BLUE NNP B-NP O
GENERAL NNP I-NP O
SURGERY NNP I-NP O
Attending NNP I-NP B-person
: : O O
Terry NNP B-NP B-person
U NNP I-NP I-person
Cheatom NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
HISTORY NNP I-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS NNP I-NP O
: : O O
Mr. NNP B-NP B-person
Cordano NNP I-NP I-person
is VBZ O O
a DT B-NP O
58-year-old JJ I-NP O
gentlemen NNS I-NP O
with IN B-VP O
a DT B-NP O
past JJ I-NP O
medical JJ I-NP O
history NN I-NP O
significant JJ O O
for IN B-VP O
primary JJ O B-problem
sclerosing VBG O I-problem
cholangitis NN B-NP I-problem
who WP O B-person
presented VBD B-VP O
with IN B-VP O
a DT B-NP O
chief JJ I-NP O
complaint NN I-NP O
of IN B-VP O
endoscopic NN B-NP B-test
retrograde NN I-NP I-test
cholangiopancreatography NN I-NP I-test
endoscopic NN I-NP B-test
retrograde NN I-NP I-test
cholangiopancreatography NN I-NP I-test
and CC O O
percutaneous JJ B-NP B-test
transhepatic JJ I-NP I-test
cholangiogram NN I-NP I-test
. . B-VP O
   
The DT O B-treatment
most RBS O I-treatment
recent JJ B-NP I-treatment
percutaneous JJ I-NP I-treatment
transluminal JJ I-NP I-treatment
coronary NN I-NP I-treatment
angioplasty NN I-NP I-treatment
was VBD B-VP O
done VBN O O
in IN B-VP O
2009-07-25 JJ O O
. . B-VP O
   
At IN B-VP O
the DT B-NP O
time NN I-NP O
an DT O B-treatment
8 CD O I-treatment
Caucasian JJ B-NP I-treatment
catheter NN I-NP I-treatment
was VBD B-VP O
placed VBN O O
in IN B-VP O
the DT B-NP O
common JJ I-NP O
hepatic/bioduct NN I-NP O
for IN B-VP O
external JJ B-NP B-treatment
drainage NN I-NP I-treatment
. . B-VP O
   
The DT B-NP B-test
endoscopic NN I-NP I-test
retrograde NN I-NP I-test
cholangiopancreatography NN I-NP I-test
also RB O O
showed VBD B-VP O
the DT B-NP O
presence NN I-NP O
proximal JJ B-NP O
common JJ I-NP O
bile NN I-NP O
duct NN I-NP O
. . B-VP O
   
Nodularities NNS B-NP B-problem
in IN B-VP I-problem
the DT B-NP I-problem
common JJ I-NP I-problem
bile NN I-NP I-problem
duct NN I-NP I-problem
visualized VBN O O
by IN B-VP O
endoscopic NN B-NP B-test
retrograde NN I-NP I-test
cholangiopancreatography NN I-NP I-test
was VBD B-VP O
also RB O O
worrisome JJ O O
for IN B-VP O
cholangiocarcinoma NN B-NP B-problem
and CC O O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
admitted VBN O O
to TO O O
the DT B-NP O
Blue NNP I-NP O
General NNP I-NP O
Surgery NNP I-NP O
Service NNP I-NP O
for IN B-VP O
possible JJ B-NP O
surgical JJ I-NP B-treatment
interventions NNS I-NP I-treatment
. . B-VP O
   
PAST NNP B-NP O
MEDICAL NNP I-NP O
HISTORY NNP I-NP O
: : O O
Ulcerative JJ B-NP B-problem
colitis NN I-NP I-problem
, , O O
primary JJ O B-problem
sclerosing VBG O I-problem
cholangitis NN B-NP I-problem
. . B-VP O
   
PAST JJ B-NP O
SURGICAL JJ I-NP O
HISTORY NN I-NP O
: : O O
Status NNP B-NP O
post NN I-NP O
placement NN I-NP B-treatment
of IN B-VP I-treatment
percutaneous JJ B-NP I-treatment
transhepatic JJ I-NP I-treatment
biliary JJ I-NP I-treatment
drainage NN I-NP I-treatment
with IN B-VP O
placement NN B-NP B-treatment
of IN B-VP I-treatment
8 CD O I-treatment
Caucasian JJ B-NP I-treatment
nephrostomy NN I-NP I-treatment
catheter NN I-NP I-treatment
in IN B-VP O
the DT B-NP O
common JJ I-NP O
bile NN I-NP O
duct NN I-NP O
. . B-VP O
   
ALLERGIES NNP B-NP O
: : O O
No DT B-NP O
known JJ I-NP B-problem
drug NN I-NP I-problem
allergies NNS I-NP I-problem
. . B-VP O
   
MEDICATIONS NNP B-NP O
ON NNP I-NP O
ADMISSION NNP I-NP O
: : O O
1. CD O O
Ursodiol NNP B-NP B-treatment
600 CD O O
mg NN B-NP O
t.i.d. NN I-NP O
2. CD O O
Ambien NNP B-NP B-treatment
5 CD O O
mg NN B-NP O
q.h.s. JJ B-NP O
PHYSICAL NNP I-NP O
EXAMINATION NNP I-NP O
ON NNP I-NP O
ADMISSION NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
is VBZ O O
a DT O O
jaundiced JJ O O
looking VBG O O
gentlemen NNS B-NP O
in IN B-VP O
no DT B-NP O
acute JJ I-NP B-problem
distress NN I-NP I-problem
. . B-VP O
   
The DT B-NP O
head NN I-NP O
is VBZ O O
normocephalic JJ O O
, , O O
atraumatic JJ O B-problem
and CC O O
eyes NNS B-NP O
are VBP O O
icteric JJ O B-problem
. . B-VP O
   
The DT B-NP O
neck NN I-NP O
is VBZ O O
supple JJ O O
with IN B-VP O
no DT B-NP O
lymphadenopathy NN I-NP B-problem
. . B-VP O
   
The DT B-NP O
chest NN I-NP O
is VBZ O O
clear JJ O O
to TO O O
auscultation VB O B-test
bilaterally RB O O
. . B-VP O
   
The DT B-NP O
heart NN I-NP O
has VBZ O O
a DT B-NP O
regular JJ I-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
with IN B-VP O
normal JJ B-NP O
S1 NNP I-NP O
, , O O
S2 NNP B-NP O
. . B-VP O
   
There EX O O
is VBZ O O
no DT B-NP O
murmurs NN I-NP B-problem
. . B-VP O
   
The DT B-NP O
abdomen NNS I-NP O
was VBD B-VP O
soft JJ O O
, , O O
nontender NN B-NP B-problem
, , O O
no DT B-NP O
masses NNS I-NP B-problem
and CC O O
nondistended JJ O B-problem
. . B-VP O
   
There EX O O
is VBZ O O
no DT B-NP O
hepatosplenomegaly NN I-NP B-problem
. . B-VP O
   
Rectal JJ B-NP B-test
exam NN I-NP I-test
showed VBD B-VP O
no DT B-NP O
masses NNS I-NP B-problem
and CC O O
is VBZ O O
guaiac JJ O B-test
negative JJ O O
. . B-VP O
   
The DT B-NP O
extremities NNS I-NP O
have VBP O O
distal JJ B-NP O
pulses NNS I-NP O
and CC O O
were VBD B-VP O
warm JJ O O
and CC O O
well RB O O
perfused VBN O O
. . B-VP O
   
Neurological JJ B-NP B-test
exam NN I-NP I-test
was VBD B-VP O
grossly RB O O
intact JJ O O
. . B-VP O
   
LABORATORY NNP B-NP O
STUDIES NNP I-NP O
AT NNP I-NP O
ADMISSION NNP I-NP O
: : O O
A DT B-NP B-test
white JJ I-NP I-test
blood NN I-NP I-test
cell NN I-NP I-test
count NN I-NP I-test
of IN B-VP O
14.2 CD O O
, , O O
hematocrit NN B-NP B-test
of IN B-VP O
35.3 CD O O
, , O O
platelet NN B-NP B-test
count NN I-NP I-test
of IN B-VP O
449,000 CD O O
. . B-VP O
   
Sodium NN B-NP B-test
of IN B-VP O
130 CD O O
, , O O
potassium NN B-NP B-test
3.5 CD O O
, , O O
chloride RB O B-test
93 CD O O
, , O O
bicarbonate NN B-NP B-test
28 CD O O
, , O O
BUN NNP B-NP B-test
15 CD O O
, , O O
creatinine NN B-NP B-test
1.1, CD O O
prothrombin NN B-NP B-test
time NN I-NP I-test
14.1 CD O O
, , O O
partial JJ B-NP B-test
thrombin NN I-NP I-test
time NN I-NP I-test
29.7 CD O O
. . B-VP O
   
INR NNP B-NP B-test
1.4 CD O O
. . B-VP O
   
ALT $ O B-test
106 CD O O
, , O O
AST NNP B-NP B-test
149 CD O O
, , O O
alkaline JJ B-NP B-test
phosphatase NN I-NP I-test
242 CD O O
. . B-VP O
   
Total JJ B-NP B-test
bilirubin NN I-NP I-test
10.1 CD O O
, , O O
amylase NN B-NP B-test
90 CD O O
and CC O O
lipase VBD B-VP B-test
112 CD O O
. . B-VP O
   
RADIOLOGICAL JJ B-NP O
STUDIES NNP I-NP O
AT NNP I-NP O
TIME NNP I-NP O
OF NNP I-NP O
ADMISSION NNP I-NP O
: : O O
Chest JJS B-NP B-test
x-ray NN I-NP I-test
revealed VBD B-VP O
minimal JJ B-NP B-problem
left JJ I-NP I-problem
base NN I-NP I-problem
atelectasis NN I-NP I-problem
and CC O O
elevation NN B-NP B-problem
of IN B-VP I-problem
left JJ B-NP I-problem
hemidiaphragm NN I-NP I-problem
. . B-VP O
   
A DT O B-test
CT JJ O I-test
scan JJ O I-test
with IN B-VP I-test
po NN B-NP I-test
contrast NN I-NP I-test
showed VBD B-VP O
dilation NN B-NP B-problem
of IN B-VP I-problem
intrahepatic JJ B-NP I-problem
common JJ I-NP I-problem
bile NN I-NP I-problem
duct NN I-NP I-problem
which WDT O B-pronoun
is VBZ O O
improved VBN O O
from IN B-VP O
previous JJ B-NP B-test
studies NNS I-NP I-test
. . B-VP O
   
It PRP O B-pronoun
is VBZ O O
also RB O O
noted VBN O O
that IN B-VP B-pronoun
there EX O O
was VBD B-VP O
splenomegaly NN B-NP B-problem
. . B-VP O
   
HOSPITAL NNP B-NP O
COURSE NNP I-NP O
: : O O
Mr. NNP B-NP B-person
Cordano NNP I-NP I-person
was VBD B-VP O
admitted VBN O O
on IN B-VP O
2009-08-17 JJ O O
for IN B-VP O
a DT B-NP B-treatment
replacement NN I-NP I-treatment
of IN B-VP I-treatment
transhepatic JJ B-NP I-treatment
biliary JJ I-NP I-treatment
drainage NN I-NP I-treatment
catheter NN I-NP I-treatment
. . B-VP O
   
At IN B-VP O
that DT B-NP B-pronoun
time NN I-NP O
, , O O
cholangiogram NN B-NP B-test
confirmed VBD B-VP O
that IN B-VP B-pronoun
there EX O O
was VBD B-VP O
a DT B-NP B-problem
distal JJ I-NP I-problem
stricture NN I-NP I-problem
of IN B-VP I-problem
the DT B-NP I-problem
common JJ I-NP I-problem
bile NN I-NP I-problem
duct NN I-NP I-problem
. . B-VP O
   
An DT B-NP B-test
endoscopic NN I-NP I-test
retrograde NN I-NP I-test
cholangiopancreatography NN I-NP I-test
also RB O O
demonstrated VBD B-VP O
similar JJ B-NP O
findings NNS I-NP O
and CC O O
it PRP O B-pronoun
is VBZ O O
noted VBN O O
there EX O O
was VBD B-VP O
nodularity NN B-NP B-problem
in IN B-VP I-problem
the DT B-NP I-problem
common JJ I-NP I-problem
bile NN I-NP I-problem
duct NN I-NP I-problem
which WDT O B-pronoun
is VBZ O O
worrisome JJ O O
for IN B-VP O
cholangiocarcinoma NN B-NP B-problem
. . B-VP O
   
Therefore RB O O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
taken VBN O O
to TO O O
the DT B-NP O
Operating NN I-NP O
Room NN I-NP O
on IN B-VP O
2009-08-24 JJ O O
for IN B-VP O
a DT B-NP B-treatment
Whipple JJ I-NP I-treatment
procedure NN I-NP I-treatment
versus NN I-NP O
hepaticojejunostomy NN I-NP B-treatment
. . B-VP O
   
On IN B-VP O
exploration NN B-NP B-test
of IN B-VP I-test
the DT B-NP I-test
abdomen NNS I-NP I-test
revealed VBD B-VP O
significant JJ B-NP B-problem
nodularity NN I-NP I-problem
of IN B-VP I-problem
the DT B-NP I-problem
liver NN I-NP I-problem
indicating NN I-NP O
of IN B-VP O
advanced JJ B-NP B-problem
cirrhosis NN I-NP I-problem
. . B-VP O
   
Intraoperative JJ B-NP O
frozen JJ I-NP O
section NN I-NP O
of IN B-VP O
the DT B-NP O
distal NN I-NP O
and CC O O
proximal JJ B-NP O
common JJ I-NP O
bile NN I-NP O
duct NN I-NP O
in IN B-VP O
the DT B-NP O
region NN I-NP B-problem
nodularity NN I-NP I-problem
, , O O
which WDT O B-pronoun
is VBZ O O
identified VBN O O
previously RB O O
by IN B-VP O
endoscopic NN B-NP B-test
retrograde NN I-NP I-test
cholangiopancreatography NN I-NP I-test
, , O O
and CC O O
regional JJ B-NP O
lymph NN I-NP O
nodes NNS I-NP O
were VBD B-VP O
all DT O O
sent VBN O O
to TO O O
pathology NN B-NP B-test
. . B-VP O
   
They PRP O B-pronoun
were VBD B-VP O
all DT O O
negative JJ O O
for IN B-VP O
malignancy NN B-NP B-problem
and CC O O
therefore VB O O
a DT B-NP B-treatment
hepaticojejunostomy NN I-NP I-treatment
was VBD B-VP O
performed VBN O O
. . B-VP O
   
Cholangiogram NNP B-NP B-test
on IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
number NN I-NP O
two CD O O
showed VBD B-VP O
no DT B-NP O
evidence NN I-NP O
of IN B-VP O
leakage NN B-NP B-problem
at IN B-VP I-problem
the DT B-NP I-problem
anastomosis NN I-NP I-problem
site NN I-NP I-problem
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
tolerated VBD B-VP O
the DT B-NP B-treatment
procedure NN I-NP I-treatment
well RB O O
and CC O O
he PRP O B-person
was VBD B-VP O
sent VBN O O
to TO O O
the DT B-NP O
floor NN I-NP O
in IN B-VP O
stable JJ B-NP O
condition NN I-NP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
's POS O O
postoperative JJ B-NP O
course NN I-NP O
was VBD B-VP O
notable JJ O O
for IN B-VP O
an DT B-NP B-problem
elevation NN I-NP I-problem
in IN B-VP O
white JJ B-NP B-test
blood NN I-NP I-test
cell NN I-NP I-test
count NN I-NP O
peaking VBG O O
at IN B-VP O
30.0 CD O O
on IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
number NN I-NP O
two CD O O
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
given VBN O O
Unasyn NNP B-NP B-treatment
for IN B-VP O
empiric JJ B-NP B-treatment
antibiotic JJ I-NP I-treatment
treatment NN I-NP I-treatment
. . B-VP O
   
At IN B-VP O
the DT B-NP O
time NN I-NP O
, , O O
blood NN B-NP O
, , O O
urine JJ O O
and CC O O
bile NN B-NP O
was VBD B-VP O
sent VBN O O
for IN B-VP O
culture NN B-NP B-test
, , O O
which WDT O B-pronoun
were VBD B-VP O
all DT O O
negative JJ O O
. . B-VP O
   
A DT B-NP B-test
chest JJ I-NP I-test
x-ray NN I-NP I-test
was VBD B-VP O
also RB O O
negative JJ O O
for IN B-VP O
any DT B-NP B-problem
pneumonia NN I-NP I-problem
. . B-VP O
   
Postoperatively RB O O
, , O O
Mr. NNP B-NP B-person
Cordano NNP I-NP I-person
also RB O O
suffered VBD B-VP O
from IN B-VP O
low JJ B-NP B-problem
urine JJ I-NP I-problem
output NN I-NP I-problem
ranges VBZ O O
between IN B-VP O
25 CD O O
to TO O O
30 CD O O
cc NNS B-NP O
per IN B-VP O
hour NN B-NP O
. . B-VP O
   
Fractional JJ B-NP B-test
excretion NN I-NP I-test
of IN B-VP I-test
sodium NN B-NP I-test
was VBD B-VP O
less JJR O O
than IN B-VP O
1% CD O O
suggesting VBG O O
a DT B-NP B-problem
prerenal JJ I-NP I-problem
etiology NN I-NP I-problem
. . B-VP O
   
The DT B-NP B-test
sodium NN I-NP I-test
creatinine NN I-NP I-test
peaked VBD B-VP O
at IN B-VP O
2.0 CD O O
and CC O O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
treated VBN O O
with IN B-VP O
boluses NNS B-NP B-treatment
of IN B-VP I-treatment
intravenous JJ B-NP I-treatment
fluid NN I-NP I-treatment
and CC O O
intravenous JJ B-NP B-treatment
albumin NN I-NP I-treatment
infusion NN I-NP I-treatment
was VBD B-VP O
also RB O O
administered VBN O O
. . B-VP O
   
He PRP O B-person
responded VBD B-VP O
well RB O O
to TO O O
this DT O B-treatment
this DT B-NP B-pronoun
regimen NNS I-NP I-treatment
and CC O O
made VBD B-VP O
adequate JJ B-NP O
urine JJ I-NP O
output NN I-NP O
. . B-VP O
   
At IN B-VP O
the DT B-NP O
same JJ I-NP O
time NN I-NP O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
also RB O O
developed VBD B-VP O
distentions NNS B-NP B-problem
of IN B-VP I-problem
the DT B-NP I-problem
abdomen NNS I-NP I-problem
consistent JJ O O
with IN B-VP O
accumulation NN B-NP B-problem
of IN B-VP I-problem
ascitic JJ B-NP I-problem
fluid NN I-NP I-problem
. . B-VP O
   
He PRP O B-person
also RB O O
had VBD B-VP O
significant JJ B-NP B-problem
lower JJR I-NP I-problem
extremity NN I-NP I-problem
and CC O I-problem
scrotum NN B-NP I-problem
edema NN I-NP I-problem
. . B-VP O
   
On IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
number NN I-NP O
eight CD O O
, , O O
the DT O B-test
the DT B-NP B-person
patient JJ I-NP I-test
patient NN I-NP I-person
's POS O I-test
oxygen NN B-NP I-test
saturation NN I-NP I-test
dropped VBD B-VP O
to TO O O
85% CD O O
on IN B-VP O
room NN B-NP O
air NN I-NP O
and CC O O
he PRP O B-person
was VBD B-VP O
transferred VBN O O
to TO O O
the DT B-NP O
Surgical NNP I-NP O
Intensive NNP I-NP O
Care NNP I-NP O
Unit NNP I-NP O
for IN B-VP O
fluid JJ B-NP B-treatment
management NN I-NP I-treatment
. . B-VP O
   
Chest NNP B-NP B-test
x-ray NN I-NP I-test
and CC O O
sputum JJ B-NP B-test
culture NN I-NP I-test
obtained VBN O O
at IN B-VP O
the DT B-NP O
time NN I-NP O
were VBD B-VP O
negative JJ O O
and CC O O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
treated VBN O O
with IN B-VP O
100% CD O B-treatment
nonrebreather NN B-NP I-treatment
which WDT O B-pronoun
improved VBD B-VP O
his PRP$ O B-test
his PRP$ O B-person
oxygenation NN B-NP I-test
. . B-VP O
   
While IN B-VP O
he PRP O B-person
is VBZ O O
in IN B-VP O
the DT B-NP O
Surgical NNP I-NP O
Intensive NNP I-NP O
Care NNP I-NP O
Unit NNP I-NP O
, , O O
paracentesis NN B-NP B-test
was VBD B-VP O
performed VBN O O
and CC O O
it PRP O B-pronoun
revealed VBD B-VP O
greater JJR O O
than IN B-VP O
24,000 CD O O
white JJ B-NP B-test
blood NN I-NP I-test
cell NN I-NP I-test
count NN I-NP I-test
in IN B-VP O
the DT B-NP B-problem
ascites NNS I-NP I-problem
which WDT O B-pronoun
is VBZ O O
consistent JJ O O
with IN B-VP O
SVT NNP B-NP B-problem
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
given VBN O O
Zosyn NNP B-NP B-treatment
for IN B-VP O
empiric JJ B-NP B-treatment
treatment NN I-NP I-treatment
. . B-VP O
   
Gram NNP B-NP B-test
stain NN I-NP I-test
and CC O O
culture NN B-NP B-test
of IN B-VP O
the DT B-NP B-problem
ascites NNS I-NP I-problem
failed VBD B-VP O
to TO O O
identify VB O O
any DT B-NP B-problem
organism NN I-NP I-problem
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
weaned VBN O O
from IN B-VP O
oxygen NN B-NP B-problem
requirement NN I-NP I-problem
and CC O O
was VBD B-VP O
continued VBN O O
on IN B-VP O
normal JJ B-NP B-treatment
saline NN I-NP I-treatment
boluses NNS I-NP I-treatment
and CC O O
intravenous JJ B-NP B-treatment
albumin NN I-NP I-treatment
for IN B-VP O
treatment NN B-NP O
of IN B-VP O
prerenal JJ B-NP B-problem
azotemia NN I-NP I-problem
. . B-VP O
   
Somatostatin NNP B-NP B-treatment
and CC O O
midodrine NN B-NP B-treatment
were VBD B-VP O
also RB O O
given VBN O O
for IN B-VP O
this DT B-NP B-problem
condition NN I-NP I-problem
and CC O O
he PRP O B-person
also RB O O
received VBD B-VP O
packed JJ B-NP B-treatment
red JJ I-NP I-treatment
blood NN I-NP I-treatment
cells NNS I-NP I-treatment
. . B-VP O
   
On IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
number NN I-NP O
ten NN I-NP O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
returned VBD B-VP O
to TO O O
the DT B-NP O
floor NN I-NP O
with IN B-VP O
improved JJ B-NP O
renal JJ I-NP O
function NN I-NP O
and CC O O
without IN B-VP O
oxygen NN B-NP B-problem
requirement NN I-NP I-problem
. . B-VP O
   
The DT B-NP B-treatment
somatostatin NN I-NP I-treatment
and CC O O
the DT B-NP B-treatment
midodrine NN I-NP I-treatment
were VBD B-VP O
discontinued VBN O O
and CC O O
the DT B-NP O
regimen NNS I-NP O
of IN B-VP O
Lasix NNP B-NP B-treatment
and CC O O
spironolactone NN B-NP B-treatment
was VBD B-VP O
started VBN O O
for IN B-VP O
diuresis NN B-NP B-treatment
. . B-VP O
   
His PRP$ O B-person
His PRP$ O B-test
creatinine NN B-NP I-test
levels NNS I-NP I-test
trended VBN O O
toward IN B-VP O
normal JJ O O
and CC O O
the DT B-NP B-test
fractional JJ I-NP I-test
excretion NN I-NP I-test
of IN B-VP I-test
sodium NN B-NP I-test
also RB O O
increased VBD B-VP O
indicating VBG O O
a DT B-NP O
resolution NN I-NP O
of IN B-VP O
the DT B-NP B-problem
prerenal JJ I-NP I-problem
kidney NN I-NP I-problem
failure NN I-NP I-problem
. . B-VP O
   
On IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
number NN I-NP O
17 CD O O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
discharged VBN O O
. . B-VP O
   
At IN B-VP O
the DT B-NP O
time NN I-NP O
he PRP O B-person
took VBD B-VP O
good JJ B-NP O
po NN I-NP O
. . B-VP O
   
He PRP O B-person
has VBZ O O
a DT B-NP B-treatment
PICC NNP I-NP I-treatment
line NN I-NP I-treatment
in IN B-VP O
place NN B-NP O
for IN B-VP O
continued JJ B-NP O
treatment NN I-NP O
with IN B-VP O
Rocephin NNP B-NP B-treatment
and CC O O
he PRP O B-person
will MD O O
have VB O O
a DT B-NP B-person
visiting NN I-NP I-person
nurse NN I-NP I-person
to TO O O
help VB O O
him PRP O B-person
to TO O O
administer VB O O
these DT B-NP B-treatment
medications NNS I-NP I-treatment
. . B-VP O
   
While IN B-VP O
in IN B-VP O
the DT B-NP O
hospital NN I-NP O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
received VBD B-VP O
initial JJ O B-test
work-up JJ O I-test
including VBG O O
echocardiogram NN B-NP B-test
, , O O
electrocardiogram NN B-NP B-test
and CC O O
serology NN B-NP B-test
studies NNS I-NP I-test
to TO O O
be VB O O
listed VBN O O
for IN B-VP O
liver NN B-NP B-treatment
transplant NN I-NP I-treatment
. . B-VP O
   
MEDICATIONS NNP B-NP O
ON NNP I-NP O
DISCHARGE NNP I-NP O
: : O O
1. CD O O
Rocephin NNP B-NP B-treatment
1 CD O O
gram NN B-NP O
q.d. NN I-NP O
2. CD O O
Furosemide NNP B-NP B-treatment
10 CD O O
mg NN B-NP O
q.d. NN I-NP O
3. CD O O
Spironolactone NNP B-NP B-treatment
100 CD O O
mg NN B-NP O
q.d. NN I-NP O
4. CD O O
Ursodiol NNP B-NP B-treatment
600 CD O O
mg NN B-NP O
po NN I-NP O
t.i.d. JJ B-NP O
CONDITION NNP I-NP O
ON NNP I-NP O
DISCHARGE NNP I-NP O
: : O O
Stable JJ O O
. . B-VP O
   
DISCHARGE JJ B-NP O
STATUS NNP I-NP O
: : O O
To TO O O
home NN B-NP O
with IN B-VP O
services NNS B-NP O
. . B-VP O
   
DISCHARGE JJ B-NP O
DIAGNOSIS NNP I-NP O
: : O O
PSC NNP B-NP B-problem
, , O O
status NN B-NP O
post NN I-NP O
hepaticojejunostomy NN I-NP B-treatment
. . B-VP O
   
Hope NNP B-NP B-person
Raymond NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
, , O I-person
Ph.D. NNP B-NP I-person
02-366 CD O O
Dictated VBN O O
By IN B-VP O
: : O O
Alden NNP B-NP B-person
B. NNP I-NP I-person
Edwards NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
MEDQUIST36 NNP I-NP O
D NNP I-NP O
: : O O
2009-10-02 JJ O O
09:08 CD O O
T NN B-NP O
: : O O
2009-10-02 JJ O O
09:08 CD O O
JOB NNP B-NP O
#: VBD B-VP O
86749 CD O O
Signed VBN O O
electronically RB O O
by IN B-VP O
: : O O
DR. NNP B-NP B-person
Mary NNP I-NP I-person
Jones NNP I-NP I-person
on IN B-VP O
: : O O
SUN NNP B-NP O
2009-10-04 CD O O
1:08 CD O O
PM NNP B-NP O
( ( O O
End NNP B-NP O
of IN B-VP O
Report NNP B-NP O
) ) O O
-EMPTYLINE- VBP O O
-DOCSTART- JJ O O
-EMPTYLINE- $ O O
517414339 CD O O
PUOMC NNP B-NP O
4351342 CD O O
88500 CD O O
099515 CD O O
12/26/1996 CD O O
12:00:00 CD O O
AM NNP B-NP O
HYPERPARATHYROIDISM NNP I-NP B-problem
. . B-VP O
   
Unsigned VBD B-VP O
DIS NNP B-NP O
Report NNP I-NP O
Status NNP I-NP O
: : O O
Unsigned VBD B-VP O
DISCHARGE NNP B-NP O
SUMMARY NNP I-NP O
NAME NN I-NP O
: : O O
HOUGHTJESCSLEM NNP B-NP B-person
, , O I-person
RIESHINJIN NNP B-NP I-person
R NNP I-NP I-person
UNIT NNP I-NP O
NUMBER NNP I-NP O
: : O O
948-14-32 JJ B-NP O
ADMISSION NNP I-NP O
DATE NNP I-NP O
: : O O
12/26/96 CD O O
DISCHARGE NNP B-NP O
DATE NNP I-NP O
: : O O
01/01/97 CD O O
PRINCIPAL NNP B-NP O
DIAGNOSIS NNP I-NP O
: : O O
hyperparathyroidism NN B-NP B-problem
. . B-VP O
   
ASSOCIATED CC O O
DIAGNOSIS NNP B-NP O
: : O O
1. CD O O
status NN B-NP O
post NN I-NP O
mitral JJ B-NP B-treatment
valve NN I-NP I-treatment
replacement NN I-NP I-treatment
, , O O
2. CD O O
hypertension NN B-NP B-problem
, , O O
3. CD O O
atrial JJ B-NP B-problem
fibrillation NN I-NP I-problem
, , O O
4. CD O O
hypertrophic JJ B-NP B-problem
obstructive JJ I-NP I-problem
cardiomyopathy NN I-NP I-problem
, , O O
5. CD O O
osteoarthritis NN B-NP B-problem
, , O O
6. CD O O
right JJ B-NP B-problem
cheek NN I-NP I-problem
basal NN I-NP I-problem
cell NN I-NP I-problem
carcinoma NN I-NP I-problem
, , O O
7. CD O O
glaucoma NN B-NP B-problem
, , O O
8. CD O O
non-insulin JJ B-NP B-problem
dependent NN I-NP I-problem
diabetes VBZ O I-problem
mellitus RBS O I-problem
, , O O
9. CD O O
status NN B-NP O
post NN I-NP O
laparoscopic NN I-NP B-treatment
cholecystectomy NN I-NP I-treatment
, , O O
10. CD O O
status NN B-NP O
post NN I-NP O
dilation NN I-NP B-treatment
and CC O I-treatment
curettage NN B-NP I-treatment
, , O O
11. CD O O
status NN B-NP O
post NN I-NP O
cataract NN I-NP B-treatment
surgery NN I-NP I-treatment
, , O O
12. CD O O
status NN B-NP O
post NN I-NP O
left VBD B-VP B-test
breast NN B-NP I-test
biopsy NN I-NP I-test
. . B-VP O
   
PRINCIPAL JJ B-NP O
PROCEDURE NN I-NP O
: : O O
Parathyroidectomy NN B-NP B-treatment
on IN B-VP O
12-27-96 JJ O O
. . B-VP O
   
HISTORY NNP B-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
is VBZ O O
an DT B-NP O
83-year-old JJ I-NP O
female NN I-NP O
who WP O B-person
presents VBZ O O
for IN B-VP O
surgical JJ B-NP B-test
evaluation NN I-NP I-test
for IN B-VP O
her PRP$ O B-person
her PRP$ O B-problem
hyperparathyroidism NN B-NP I-problem
. . B-VP O
   
This DT O B-pronoun
is VBZ O O
an DT B-NP O
83-year-old JJ I-NP O
female NN I-NP O
with IN B-VP O
a DT B-NP O
history NN I-NP O
of IN B-VP O
hypertrophic JJ B-NP B-problem
obstructive JJ I-NP I-problem
cardiomyopathy NN I-NP I-problem
, , O O
status NN B-NP O
post NN I-NP O
mitral JJ B-NP B-treatment
valve NN I-NP I-treatment
replacement NN I-NP I-treatment
in IN B-VP O
1988 CD O O
, , O O
chronic JJ B-NP B-problem
atrial JJ I-NP I-problem
fibrillation NN I-NP I-problem
, , O O
hypertension NN B-NP B-problem
, , O O
who WP O B-person
presents VBZ O O
for IN B-VP O
parathyroidectomy NN B-NP B-treatment
. . B-VP O
   
In IN B-VP O
August NNP B-NP O
of IN B-VP O
1996 CD O O
while IN B-VP O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
at IN B-VP O
Retelk NNP B-NP O
County NNP I-NP O
Medical NNP I-NP O
Center NNP I-NP O
for IN B-VP O
replacement NN B-NP B-treatment
of IN B-VP I-treatment
her PRP$ O B-person
her PRP$ O I-treatment
knees NNS B-NP I-treatment
bilaterally RB O I-treatment
, , O O
and CC O O
on IN B-VP O
preoperative JJ B-NP B-test
evaluation NN I-NP I-test
she PRP O B-person
was VBD B-VP O
noted VBN O O
to TO O O
have VB O O
a DT B-NP B-problem
high JJ I-NP I-problem
calcium NN I-NP I-problem
and CC O O
therefore RB O O
the DT B-NP B-treatment
surgery NN I-NP I-treatment
was VBD B-VP O
canceled VBN O O
. . B-VP O
   
Further RBR O B-test
testing VBG O I-test
revealed JJ B-NP O
hyperparathyroidism NN I-NP B-problem
as IN B-VP O
evidenced VBN O O
by IN B-VP O
an DT B-NP B-problem
elevated JJ I-NP I-problem
PTH NNP I-NP I-problem
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
reports VBZ O O
no DT B-NP O
masses NNS I-NP B-problem
in IN B-VP I-problem
her PRP$ O B-person
her PRP$ O I-problem
neck NN B-NP I-problem
. . B-VP O
   
She PRP O B-person
has VBZ O O
noticed VBN O O
some DT B-NP O
generalized JJ I-NP B-problem
hoarseness NN I-NP I-problem
in IN B-VP I-problem
her PRP$ O I-problem
her PRP$ O B-person
voice NN B-NP I-problem
for IN B-VP O
the DT B-NP O
past JJ I-NP O
5-6 JJ I-NP O
months NNS I-NP O
. . B-VP O
   
In IN B-VP O
addition NN B-NP O
, , O O
she PRP O B-person
has VBZ O O
some DT B-NP B-problem
dysphagia NN I-NP I-problem
, , O O
particularly RB O O
has VBZ O O
had VBN O O
some DT B-NP B-problem
difficulties NNS I-NP I-problem
with IN B-VP I-problem
swallowing NN B-NP I-problem
. . B-VP O
   
She PRP O B-person
has VBZ O O
been VBN O O
seen VBN O O
by IN B-VP O
Dr. NNP B-NP B-person
Tokbelb NNP I-NP I-person
, , O O
her PRP$ O B-person
her PRP$ O B-person
primary JJ B-NP I-person
care NN I-NP I-person
physician NN I-NP I-person
in IN B-VP O
Itgreenredan NNP B-NP O
Hospital NNP I-NP O
, , O O
and CC O O
also RB O O
Dr. NNP B-NP B-person
Kotefyfechird NNP I-NP I-person
, , O O
her PRP$ O B-person
her PRP$ O B-person
cardiologist NN B-NP I-person
, , O O
and CC O O
also RB O O
an DT B-NP B-person
endocrinologist NN I-NP I-person
at IN B-VP O
Retelk NNP B-NP O
County NNP I-NP O
Medical NNP I-NP O
Center NNP I-NP O
. . B-VP O
   
PAST NNP B-NP O
MEDICAL NNP I-NP O
HISTORY NNP I-NP O
: : O O
1. CD O O
status NN B-NP O
post NN I-NP O
mitral JJ B-NP B-treatment
valve NN I-NP I-treatment
replacement NN I-NP I-treatment
in IN B-VP O
1988 CD O O
. . B-VP O
   
She PRP O B-person
has VBZ O O
a DT B-NP B-treatment
St. NNP I-NP I-treatment
Jude NNP I-NP I-treatment
&apos;s NNP I-NP I-treatment
mechanical JJ B-NP I-treatment
valve NN I-NP I-treatment
and CC O O
has VBZ O O
been VBN O O
on IN B-VP O
Coumadin NNP B-NP B-treatment
since IN B-VP O
then RB O O
, , O O
2. CD O O
hypertension NN B-NP B-problem
, , O O
she PRP O B-person
has VBZ O O
had VBN O O
hypertension NN B-NP B-problem
for IN B-VP O
15 CD O O
years NNS B-NP O
, , O O
3. CD O O
atrial JJ B-NP B-problem
fibrillation NN I-NP I-problem
, , O O
she PRP O B-person
is VBZ O O
status NN B-NP O
post NN I-NP O
cardioversion NN I-NP B-treatment
3-25-94 CD O O
, , O O
4. CD O O
hypertrophic JJ B-NP B-problem
obstructive JJ I-NP I-problem
cardiomyopathy NN I-NP I-problem
, , O O
5. CD O O
osteoarthritis NN B-NP B-problem
; : O O
she PRP O B-person
is VBZ O O
to TO O O
receive VB O O
bilateral JJ B-NP B-treatment
total JJ I-NP I-treatment
knee NN I-NP I-treatment
replacements NNS I-NP I-treatment
at IN B-VP O
some DT B-NP O
time NN I-NP O
in IN B-VP O
the DT B-NP O
near JJ I-NP O
future NN I-NP O
, , O O
6. CD O O
right JJ B-NP B-problem
cheek NN I-NP I-problem
basal NN I-NP I-problem
cell NN I-NP I-problem
carcinoma NN I-NP I-problem
to TO O O
be VB O O
removed VBN O O
in IN B-VP O
the DT B-NP O
future NN I-NP O
, , O O
7. CD O O
history NN B-NP O
of IN B-VP O
glaucoma NN B-NP B-problem
, , O O
8. CD O O
non JJ B-NP B-problem
insulin NN I-NP I-problem
dependent NN I-NP I-problem
diabetes VBZ O I-problem
mellitus CD O I-problem
which WDT O B-pronoun
was VBD B-VP O
diagnosed VBN O O
in IN B-VP O
March NNP B-NP O
, , O O
1995 CD O O
, , O O
9. CD O O
shingles NNS B-NP B-problem
. . B-VP O
   
PAST JJ B-NP O
SURGICAL JJ I-NP O
HISTORY NN I-NP O
: : O O
1. CD O O
laparoscopic NN B-NP B-treatment
cholecystectomy NN I-NP I-treatment
03/93 CD O O
by IN B-VP O
Dr. NNP B-NP B-person
Sapmal NNP I-NP I-person
, , O O
2. CD O O
dilation NN B-NP B-treatment
and CC O I-treatment
curettage NN B-NP I-treatment
in IN B-VP O
1992 CD O O
for IN B-VP O
polyps NNS B-NP B-problem
, , O O
3. CD O O
left VBD B-VP B-test
breast NN B-NP I-test
biopsy NN I-NP I-test
which WDT O B-pronoun
was VBD B-VP O
benign NN B-NP O
, , O O
4. CD O O
cataract NN B-NP B-treatment
surgery NN I-NP I-treatment
. . B-VP O
   
ALLERGIES NNP B-NP O
: : O O
No DT B-NP O
known JJ I-NP B-problem
drug NN I-NP I-problem
allergies NNS I-NP I-problem
. . B-VP O
   
MEDICATIONS NNP B-NP O
ON NNP I-NP O
ADMISSION NNP I-NP O
: : O O
1. CD O O
Lopid NNP B-NP B-treatment
600 CD O O
mg NN B-NP O
PO NNP I-NP O
b.i.d. NN I-NP O
, , O O
2. CD O O
K-Dur JJ O B-treatment
20 CD O O
mg NN B-NP O
PO NNP I-NP O
q.day NN I-NP O
, , O O
3. CD O O
Lasix NNP B-NP B-treatment
40 CD O O
mg NN B-NP O
PO NNP I-NP O
q.day NN I-NP O
, , O O
4. CD O O
Coumadin NNP B-NP B-treatment
2.5 CD O O
mg NN B-NP O
PO NNP I-NP O
q.day NN I-NP O
which WDT O B-pronoun
was VBD B-VP O
last JJ O O
taken VBN O O
two CD O O
days NNS B-NP O
prior RB O O
to TO O O
admission NN B-NP O
, , O O
5. CD O O
Norvasc NNP B-NP B-treatment
500 CD O O
mg NN B-NP O
PO NNP I-NP O
q.day NN I-NP O
, , O O
6. CD O O
Digoxin NNP B-NP B-treatment
.25 NNP I-NP O
mg NN I-NP O
PO NNP I-NP O
q.day NN I-NP O
, , O O
7. CD O O
Lopressor NNP B-NP B-treatment
50 CD O O
mg NN B-NP O
PO NNP I-NP O
b.i.d. NN I-NP O
, , O O
8. CD O O
Glucotrol NNP B-NP B-treatment
10 CD O O
XL NNP B-NP O
qam NN I-NP O
, , O O
9. CD O O
Timoptic JJ O B-treatment
0.5% CD O O
b.i.d. NN B-NP O
to TO O O
both DT B-NP O
eyes NNS I-NP O
, , O O
10. CD O O
Pilocarpine NNP B-NP B-treatment
gel NN I-NP I-treatment
qhs NN I-NP O
to TO O O
both DT B-NP O
eyes NNS I-NP O
. . B-VP O
   
FAMILY NNP B-NP O
HISTORY NNP I-NP O
: : O O
There EX O O
is VBZ O O
no DT B-NP O
family NN I-NP O
history NN I-NP O
of IN B-VP O
parathyroid NN B-NP B-problem
or CC O I-problem
thyroid NN B-NP I-problem
diseases NNS I-NP I-problem
. . B-VP O
   
SOCIAL NNP B-NP O
HISTORY NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
is VBZ O O
widowed VBN O O
. . B-VP O
   
She PRP O B-person
lives VBZ O O
alone RB O O
but CC O O
is VBZ O O
completely RB O O
independent JJ O O
. . B-VP O
   
She PRP O B-person
visits VBZ O O
her PRP$ O B-person
her PRP$ O B-person
daughter NN B-NP I-person
once RB O O
a DT B-NP O
week NN I-NP O
. . B-VP O
   
No DT B-NP O
ethanol NN I-NP O
or CC O O
tobacco NN B-NP O
use NN I-NP O
. . B-VP O
   
REVIEW NNP B-NP O
OF NNPS I-NP O
SYSTEMS NNP I-NP O
: : O O
The DT B-NP B-test
review NN I-NP I-test
of IN B-VP I-test
systems NNS B-NP I-test
is VBZ O O
significant JJ O O
for IN B-VP O
a DT B-NP O
history NN I-NP O
of IN B-VP O
dyspnea NN B-NP B-problem
on IN B-VP I-problem
exertion NN B-NP I-problem
. . B-VP O
   
At IN B-VP O
present JJ O O
, , O O
she PRP O B-person
can MD O O
walk VB O O
one CD O O
to TO O O
two CD O O
blocks NNS B-NP O
before IN B-VP O
having VBG O O
to TO O O
stop VB O O
because IN B-VP O
of IN B-VP O
shortness NN B-NP B-problem
of IN B-VP I-problem
breath NN B-NP I-problem
. . B-VP O
   
When WRB O O
walking VBG O O
outside RB O O
, , O O
she PRP O B-person
stops VBZ O O
multiple JJ B-NP O
times NNS I-NP O
because IN B-VP O
of IN B-VP O
shortness NN B-NP B-problem
of IN B-VP I-problem
breath NN B-NP I-problem
. . B-VP O
   
She PRP O B-person
sleeps VBZ O O
with IN B-VP O
two CD O O
pillows NNS B-NP O
at IN B-VP O
night NN B-NP O
. . B-VP O
   
She PRP O B-person
gets VBZ O O
short JJ O B-problem
of IN B-VP I-problem
breath NN B-NP I-problem
walking VBG O O
up RP O O
steps NNS B-NP O
. . B-VP O
   
PHYSICAL JJ B-NP O
EXAMINATION NN I-NP O
: : O O
On IN B-VP O
physical JJ B-NP B-test
examination NN I-NP I-test
, , O O
she PRP O B-person
is VBZ O O
a DT B-NP O
pleasant JJ I-NP O
woman NN I-NP O
in IN B-VP O
no DT B-NP O
acute JJ I-NP B-problem
distress NN I-NP I-problem
. . B-VP O
   
Her PRP$ O B-person
Her PRP$ O B-test
pulse NN B-NP I-test
is VBZ O O
72 CD O O
, , O O
irregularly RB O O
irregular JJ O O
, , O O
blood NN B-NP B-test
pressure NN I-NP I-test
96/60 CD O O
, , O O
temperature NN B-NP B-test
97.9 CD O O
, , O O
respirations NNS B-NP B-test
18 CD O O
. . B-VP O
   
The DT B-NP B-test
head NN I-NP I-test
, , O I-test
eyes NNS B-NP I-test
, , O I-test
ears NNS B-NP I-test
, , O I-test
nose RB O I-test
and CC O I-test
throat JJ B-NP I-test
examination NN I-NP I-test
is VBZ O O
notable JJ O O
for IN B-VP O
pupils NNS B-NP O
which WDT O B-pronoun
have VBP O O
irregular JJ B-NP B-problem
border NN I-NP I-problem
and CC O O
are VBP O O
very RB O B-problem
sluggishly RB O I-problem
reactive JJ O I-problem
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
reports NNS I-NP O
that IN B-VP B-pronoun
she PRP O B-person
will MD O O
have VB O O
revision NN B-NP B-treatment
of IN B-VP I-treatment
cataract NN B-NP I-treatment
surgery NN I-NP I-treatment
. . B-VP O
   
Neck NNP B-NP O
and CC O O
lungs NNS B-NP O
are VBP O O
unremarkable JJ O O
. . B-VP O
   
Cardiovascular JJ B-NP B-test
exam NN I-NP I-test
: : O O
III NNP B-NP B-problem
/ NNP I-NP I-problem
VI NNP I-NP I-problem
systolic JJ B-NP I-problem
click NN I-NP I-problem
and CC O O
irregularly RB O B-problem
irregular JJ B-NP I-problem
rhythm NN I-NP I-problem
. . B-VP O
   
The DT B-NP O
abdomen NNS I-NP O
was VBD B-VP O
benign NN B-NP O
. . B-VP O
   
She PRP O B-person
is VBZ O O
guaiac JJ O O
negative JJ O O
on IN B-VP O
rectal JJ B-NP B-test
examination NN I-NP I-test
. . B-VP O
   
Extremities NNS B-NP O
: : O O
unremarkable JJ O O
. . B-VP O
   
LABORATORY NNP B-NP O
DATA NNP I-NP O
: : O O
Admission NNP B-NP O
white JJ B-NP B-test
blood NN I-NP I-test
count NN I-NP I-test
4.3 CD O O
, , O O
hematocrit NN B-NP B-test
31.0 CD O O
, , O O
electrolytes NNS B-NP B-test
were VBD B-VP O
all DT O O
within IN B-VP O
normal JJ B-NP O
limits NNS I-NP O
, , O O
glucose JJ O B-test
218 CD O O
, , O O
prothrombin JJ B-NP B-test
time NN I-NP I-test
on IN B-VP O
admission NN B-NP O
was VBD B-VP O
15.1 CD O O
with IN B-VP O
INR NNP B-NP B-test
of IN B-VP O
1.5 CD O O
, , O O
partial JJ B-NP B-test
thromboplastin NN I-NP I-test
time NN I-NP I-test
23.3 CD O O
. . B-VP O
   
The DT B-NP B-test
electrocardiogram NN I-NP I-test
showed VBD B-VP O
atrial JJ B-NP B-problem
fibrillation NN I-NP I-problem
with IN B-VP O
slow JJ B-NP B-problem
ventricular NN I-NP I-problem
response NN I-NP I-problem
and CC O O
digitalis JJ B-NP B-problem
effect NN I-NP I-problem
as RB O O
well RB O O
as IN B-VP O
left VBN O B-problem
ventricular JJ B-NP I-problem
hypertrophy NN I-NP I-problem
. . B-VP O
   
IMPRESSION NNP B-NP O
ON NNP I-NP O
ADMISSION NNP I-NP O
: : O O
Impression NN B-NP O
was VBD B-VP O
that IN B-VP B-pronoun
this DT O B-pronoun
was VBD B-VP O
an DT B-NP O
83-year-old JJ I-NP O
female NN I-NP O
with IN B-VP O
cardiac JJ B-NP B-problem
history NN I-NP I-problem
, , O O
dyspnea NN B-NP B-problem
on IN B-VP I-problem
exertion NN B-NP I-problem
, , O O
increased VBD B-VP B-problem
calcium NN B-NP I-problem
and CC O O
hyperparathyroidism NN B-NP B-problem
who WP O B-person
presents VBZ O O
for IN B-VP O
parathyroidectomy NN B-NP B-treatment
. . B-VP O
   
HOSPITAL NNP B-NP O
COURSE NNP I-NP O
AND NNP I-NP O
TREATMENT NNP I-NP O
: : O O
On IN B-VP O
the DT B-NP O
day NN I-NP O
of IN B-VP O
admission NN B-NP O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
brought VBN O O
to TO O O
the DT B-NP O
operating NN I-NP O
room NN I-NP O
for IN B-VP O
parathyroidectomy NN B-NP B-treatment
. . B-VP O
   
The DT B-NP O
right JJ I-NP O
superior JJ I-NP O
parathyroid NN I-NP O
gland NN I-NP O
was VBD B-VP O
found VBN O O
to TO O O
be VB O O
markedly RB O B-problem
enlarged VBN O I-problem
and CC O O
consistent JJ O O
with IN B-VP O
an DT B-NP B-problem
adenoma NN I-NP I-problem
. . B-VP O
   
Her PRP$ O B-person
right JJ B-NP O
superior JJ I-NP O
parathyroid NN I-NP O
gland NN I-NP O
was VBD B-VP O
removed VBN O O
and CC O O
the DT B-NP O
rest NN I-NP O
of IN B-VP O
her PRP$ O B-person
parathyroid JJ B-NP O
glands NNS I-NP O
were VBD B-VP O
left VBN O O
in IN B-VP O
place NN B-NP O
. . B-VP O
   
Postoperatively RB O O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
did VBD B-VP O
well RB O O
and CC O O
was VBD B-VP O
able JJ O O
to TO O O
cough VB O O
and CC O O
phonate VB O O
completely RB O O
with IN B-VP O
no DT B-NP O
changes NNS I-NP B-problem
from IN B-VP O
preoperative NN B-NP O
. . B-VP O
   
The DT B-NP O
plan NN I-NP O
was VBD B-VP O
to TO O O
start VB O O
her PRP$ O B-person
on IN B-VP O
heparin NN B-NP B-treatment
and CC O O
Coumadin NNP B-NP B-treatment
and CC O O
discontinue VB O O
her PRP$ O B-treatment
her PRP$ O B-person
heparin NN B-NP I-treatment
when WRB O O
her PRP$ O B-test
her PRP$ O B-person
Coumadin NNP B-NP I-test
levels NNS I-NP I-test
became VBD B-VP O
therapeutic JJ O O
as IN B-VP O
judged VBN O O
by IN B-VP O
the DT B-NP B-test
prothrombin NN I-NP I-test
time NN I-NP I-test
/ NNP I-NP O
INR NNP I-NP B-test
. . B-VP O
   
However RB O O
, , O O
on IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
number NN I-NP O
two CD O O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
in IN B-VP O
the DT B-NP O
afternoon NN I-NP O
noticed VBD B-VP O
some DT B-NP B-problem
tingling NN I-NP I-problem
in IN B-VP I-problem
her PRP$ O B-person
her PRP$ O I-problem
hands NNS B-NP I-problem
and CC O O
also RB O O
some DT O B-problem
tingling VBG O I-problem
hear JJ O I-problem
her PRP$ O B-person
her PRP$ O I-problem
perioral JJ B-NP I-problem
region NN I-NP I-problem
. . B-VP O
   
She PRP O B-person
had VBD B-VP O
a DT B-NP O
negative JJ I-NP O
Chvostek NNP I-NP O
&apos;s NNP I-NP O
and CC O O
negative JJ B-NP O
Trousseau NNP I-NP O
&apos;s NNP I-NP O
sign NN I-NP O
. . B-VP O
   
She PRP O B-person
had VBD B-VP O
no DT B-NP O
muscular JJ I-NP B-problem
weakness NN I-NP I-problem
noted VBD B-VP O
. . B-VP O
   
An DT B-NP B-test
ionized JJ I-NP I-test
calcium NN I-NP I-test
was VBD B-VP O
drawn VBN O O
which WDT O B-pronoun
was VBD B-VP O
low JJ O O
at IN B-VP O
1.0 CD O O
. . B-VP O
   
As IN B-VP O
a DT B-NP O
result NN I-NP O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
started VBN O O
on IN B-VP O
Os-Cal NNP B-NP B-treatment
250 CD O O
mg NN B-NP O
PO NNP I-NP O
q.i.d. NN I-NP O
On IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
number NN I-NP O
three CD O O
, , O O
her PRP$ O B-person
her PRP$ O B-test
ionized JJ B-NP I-test
calcium NN I-NP I-test
was VBD B-VP O
1.06 CD O O
and CC O O
her PRP$ O B-treatment
her PRP$ O B-person
Os-Cal NNP B-NP I-treatment
was VBD B-VP O
increased VBN O O
to TO O O
500 CD O O
q.i.d. NN B-NP O
However RB O O
, , O O
her PRP O B-person
her PRP$ O B-problem
ionized JJ B-NP I-problem
calcium NN I-NP I-problem
decreased VBD B-VP I-problem
to TO O O
0.97 CD O O
and CC O O
she PRP O B-person
was VBD B-VP O
given VBN O O
one CD O O
amp NN B-NP O
of IN B-VP O
calcium NN B-NP B-treatment
gluconate NN I-NP I-treatment
. . B-VP O
   
On IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
number NN I-NP O
five CD O O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
felt VBD B-VP O
fine JJ O O
and CC O O
had VBD B-VP O
an DT B-NP B-test
INR NNP I-NP I-test
of IN B-VP O
1.9 CD O O
with IN B-VP O
a DT B-NP B-test
prothrombin JJ I-NP I-test
time NN I-NP I-test
of IN B-VP O
16.6 CD O O
. . B-VP O
   
Her PRP$ O B-person
Her PRP$ O B-test
calcium NN B-NP I-test
was VBD B-VP O
8.5 CD O O
, , O O
albumin RB O B-test
3.6 CD O O
, , O O
and CC O O
phosphate VB O B-test
4.5 CD O O
. . B-VP O
   
She PRP O B-person
had VBD B-VP O
had VBN O O
no DT B-NP O
further JJ I-NP O
episodes NNS I-NP O
of IN B-VP O
tingling VBG O B-problem
in IN B-VP I-problem
her PRP$ O B-person
her PRP$ O I-problem
fingers NNS B-NP I-problem
after IN B-VP O
the DT B-NP O
initial JJ I-NP O
episode NN I-NP O
which WDT O B-pronoun
had VBD B-VP O
prompted VBN O O
us PRP O O
originally RB O O
to TO O O
draw VB O O
the DT B-NP B-test
ionized JJ I-NP I-test
calcium NN I-NP I-test
. . B-VP O
   
CONDITION NNP B-NP O
ON NNP I-NP O
DISCHARGE NNP I-NP O
: : O O
Good JJ O O
. . B-VP O
   
MEDICATIONS NNP B-NP O
ON NNP I-NP O
DISCHARGE NNP I-NP O
: : O O
1. CD O O
Coumadin NNP B-NP B-treatment
5 CD O O
mg NN B-NP O
PO NNP I-NP O
q.day NN I-NP O
, , O O
then RB O O
she PRP O B-person
will MD O O
follow VB O O
up RP O O
with IN B-VP O
her PRP$ O B-person
her PRP$ O B-person
primary JJ B-NP I-person
care NN I-NP I-person
physician NN I-NP I-person
and CC O O
decide VB O O
the DT B-NP O
dosage NN I-NP O
thereafter RB O O
, , O O
2. CD O O
Lopid NNP B-NP B-treatment
600 CD O O
mg NN B-NP O
PO NNP I-NP O
b.i.d. NN I-NP O
, , O O
3. CD O O
K-Dur JJ O B-treatment
20 CD O O
mg NN B-NP O
PO NNP I-NP O
q.day NN I-NP O
, , O O
4. CD O O
Os-Cal JJ O B-treatment
500 CD O O
mg NN B-NP O
PO NNP I-NP O
q.i.d. NN I-NP O
, , O O
5. CD O O
Rocaltrol NNP B-NP B-treatment
0.25 CD O O
mg NN B-NP O
PO NNP I-NP O
b.i.d. NN I-NP O
, , O O
6. CD O O
Lasix NNP B-NP B-treatment
40 CD O O
mg NN B-NP O
PO NNP I-NP O
q.day NN I-NP O
, , O O
7. CD O O
Norvasc NNP B-NP B-treatment
5 CD O O
mg NN B-NP O
PO NNP I-NP O
q.day NN I-NP O
, , O O
8. CD O O
Digoxin NNP B-NP B-treatment
.25 NNP I-NP O
mg NN I-NP O
PO NNP I-NP O
q.day NN I-NP O
, , O O
9. CD O O
Lopressor NNP B-NP B-treatment
50 CD O O
mg NN B-NP O
PO NNP I-NP O
b.i.d. NN I-NP O
, , O O
10. CD O O
Glucotrol NNP B-NP B-treatment
10 CD O O
mg NN B-NP O
qam NN I-NP O
. . B-VP O
   
FOLLOW NNP B-NP O
UP NNP I-NP O
: : O O
For IN B-VP O
follow VB O O
up RP O O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
is VBZ O O
to TO O O
call VB O O
for IN B-VP O
an DT B-NP O
appointment NN I-NP O
with IN B-VP O
Dr. NNP B-NP B-person
Sapmal NNP I-NP I-person
. . B-VP O
   
In IN B-VP O
addition NN B-NP O
, , O O
she PRP O B-person
is VBZ O O
to TO O O
follow VB O O
up RP O O
with IN B-VP O
her PRP$ O B-person
her PRP$ O B-person
primary JJ B-NP I-person
care NN I-NP I-person
physician NN I-NP I-person
to TO O O
check VB O O
her PRP$ O B-person
her PRP$ O B-test
prothrombin NN B-NP I-test
time NN I-NP I-test
/ JJ B-NP O
INR NNP I-NP B-test
as RB O O
well RB O O
as IN B-VP O
calcium NN B-NP B-test
, , O I-test
albumin NN B-NP I-test
and CC O I-test
phosphate NN B-NP I-test
levels NNS I-NP I-test
. . B-VP O
   
She PRP O B-person
will MD O O
be VB O O
sent VBN O O
home NN B-NP O
with IN B-VP O
home NN B-NP O
Arnsperni NNP I-NP O
Health NNP I-NP O
. . B-VP O
   
LENNI NNP B-NP B-person
BREUTZOLN NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
DICTATING NNP I-NP O
FOR NNP I-NP O
: : O O
_____________________ NN B-NP O
RIEEA NNP I-NP B-person
SAPMAL NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
TR NNP I-NP O
: : O O
hzu NN B-NP O
DD NNP I-NP O
: : O O
New NNP B-NP O
Years NNP I-NP O
Day NNP I-NP O
TD NNP I-NP O
: : O O
01/06/97 CD O O
2:48 CD O O
P NNP B-NP O
cc NN I-NP O
: : O O
RIEEA NNP B-NP B-person
ODEE NNP I-NP I-person
SAPMAL NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
CEALME NNP I-NP B-person
LEOE NNP I-NP I-person
MARESSYTHE NNP I-NP I-person
Dr. NNP I-NP B-person
Tokbelb NNP I-NP I-person
Welle NNP I-NP O
Health NNP I-NP O
Sonsant NNP I-NP O
. . B-VP O
   
-EMPTYLINE- VB O O
-DOCSTART- JJ B-NP O
-EMPTYLINE- NNP I-NP O
Admission NNP I-NP O
Date NNP I-NP O
: : O O
2015-06-05 JJ B-NP O
Discharge NN I-NP O
Date NNP I-NP O
: : O O
2015-06-10 JJ B-NP O
Date NNP I-NP O
of IN B-VP O
Birth NNP B-NP O
: : O O
2015-06-05 JJ B-NP O
Sex NN I-NP O
: : O O
M NNP B-NP O
Service NNP I-NP O
: : O O
Neonatology NNP B-NP O
HISTORY NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
is VBZ O O
a DT B-NP B-person
1,770 JJ I-NP I-person
gram NN I-NP I-person
male NN I-NP I-person
infant NN I-NP I-person
born VBN O O
by IN B-VP O
stat JJ B-NP B-treatment
cesarean JJ I-NP I-treatment
section NN I-NP I-treatment
for IN B-VP O
fetal JJ B-NP B-problem
bradycardia NN I-NP I-problem
at IN B-VP O
30-6/7 JJ B-NP O
weeks NNS I-NP O
gestation NN I-NP O
to TO O O
a DT B-NP B-person
29-year-old JJ I-NP I-person
gravida NN I-NP I-person
3 CD O I-person
, , O I-person
para VBZ O I-person
0 CD O I-person
now RB O I-person
1 CD O I-person
mother NN B-NP I-person
. . B-VP O
   
The DT B-NP O
pregnancy NN I-NP O
was VBD B-VP O
unremarkable JJ O O
until IN B-VP O
2015-06-01 JJ O O
when WRB O O
the DT B-NP B-person
mother NN I-NP I-person
presented VBD B-VP O
to TO O O
Shriner NNP B-NP O
's POS O O
Hospital NNP B-NP O
for IN B-VP O
Crippled NNP B-NP O
Children NNP I-NP O
for IN B-VP O
increased VBN O B-problem
blood NN B-NP I-problem
pressure NN I-NP I-problem
and CC O O
proteinuria NN B-NP B-problem
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
transferred VBN O O
to TO O O
Charles NNP B-NP O
River NNP I-NP O
Hospital NNP I-NP O
and CC O O
was VBD B-VP O
treated VBN O O
with IN B-VP O
magnesium NN B-NP B-treatment
sulfate NN I-NP I-treatment
and CC O O
betamethasone NN B-NP B-treatment
. . B-VP O
   
The DT B-NP O
morning NN I-NP O
of IN B-VP O
admission NN B-NP O
the DT B-NP B-person
mother NN I-NP I-person
developed VBD B-VP O
vaginal JJ B-NP B-problem
bleeding NN I-NP I-problem
and CC O O
fetal JJ B-NP B-problem
bradycardia NN I-NP I-problem
was VBD B-VP O
noted VBN O O
. . B-VP O
   
Therefore RB O O
, , O O
a DT B-NP B-treatment
stat JJ I-NP I-treatment
cesarean JJ I-NP I-treatment
section NN I-NP I-treatment
was VBD B-VP O
performed VBN O O
. . B-VP O
   
The DT B-NP B-person
infant NN I-NP I-person
emerged VBD B-VP O
limp NN B-NP B-problem
and CC O O
without IN B-VP O
spontaneous JJ B-NP B-problem
respiratory NN I-NP I-problem
effort NN I-NP I-problem
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
given VBN O O
bag JJ B-NP B-treatment
mask NN I-NP I-treatment
ventilation NN I-NP I-treatment
with IN B-VP O
good JJ B-NP O
response NN I-NP O
. . B-VP O
   
Apgar NNP B-NP B-test
scores NNS I-NP I-test
were VBD B-VP O
6 CD O O
at IN B-VP O
one CD O O
minute NN B-NP O
and CC O O
8 CD O O
at IN B-VP O
five CD O O
minutes NNS B-NP O
. . B-VP O
   
PRENATAL NNP B-NP O
SCREENS NNP I-NP O
: : O O
O+ NNP B-NP O
, , O O
hepatitis NN B-NP B-test
B NNP I-NP I-test
surface NN I-NP I-test
antigen NN I-NP I-test
negative JJ O O
, , O O
RPR NNP B-NP B-test
nonreactive NN I-NP O
, , O O
rubella NN B-NP B-test
immune NN I-NP O
. . B-VP O
   
ADMISSION NNP B-NP O
PHYSICAL NNP I-NP O
EXAMINATION NNP I-NP O
: : O O
The DT B-NP O
birth NN I-NP B-test
weight NN I-NP I-test
was VBD B-VP O
1,770 CD O O
grams NNS B-NP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
in IN B-VP O
mild NN B-NP B-problem
to TO O I-problem
moderate VB O I-problem
respiratory NN B-NP I-problem
distress NN I-NP I-problem
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
a DT B-NP O
nondysmorphic JJ I-NP O
male NN I-NP O
. . B-VP O
   
Anterior NNP B-NP O
fontanel NN I-NP O
was VBD B-VP O
soft JJ O O
, , O O
open JJ O O
and CC O O
flat JJ O O
. . B-VP O
   
The DT B-NP O
ears NNS I-NP O
and CC O O
eyes NNS B-NP O
were VBD B-VP O
normally RB O O
placed VBN O O
. . B-VP O
   
The DT B-NP O
palate NN I-NP O
was VBD B-VP O
intact JJ O O
. . B-VP O
   
The DT B-NP O
oropharynx NN I-NP O
was VBD B-VP O
benign JJ O O
. . B-VP O
   
Neck NNP B-NP O
was VBD B-VP O
supple VBN O O
without IN B-VP O
masses NNS B-NP B-problem
or CC O O
defects NNS B-NP B-problem
. . B-VP O
   
The DT B-NP O
lungs NNS I-NP O
were VBD B-VP O
coarse JJ O B-problem
bilaterally RB O I-problem
with IN B-VP O
moderate JJ B-NP B-problem
retractions NNS I-NP I-problem
. . B-VP O
   
The DT B-NP B-test
cardiovascular JJ I-NP I-test
examination NN I-NP I-test
revealed VBD B-VP O
S1 NNP B-NP B-test
and CC O O
S2 NNP B-NP B-test
regular JJ O O
, , O O
no DT B-NP O
murmurs NN I-NP B-problem
, , O O
2+ CD O B-test
femoral JJ B-NP I-test
pulses NNS I-NP I-test
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
warm JJ O O
and CC O O
well RB O O
perfused VBN O O
. . B-VP O
   
The DT B-NP O
abdomen NNS I-NP O
was VBD B-VP O
benign JJ O O
, , O O
flat JJ O O
, , O O
nontender FW O B-problem
, , O O
nondistended VBD B-VP B-problem
, , O O
no DT B-NP O
hepatosplenomegaly NN I-NP B-problem
. . B-VP O
   
He PRP O B-person
had VBD B-VP O
a DT B-NP O
normal JJ I-NP O
male JJ I-NP O
phallus NN I-NP O
and CC O O
bilaterally RB O O
descended VBN O O
testes NNS B-NP O
. . B-VP O
   
The DT B-NP O
anus NN I-NP O
was VBD B-VP O
patent NN B-NP O
and CC O O
normally RB O O
placed VBN O O
. . B-VP O
   
Hips NNS B-NP O
were VBD B-VP O
stable JJ O O
without IN B-VP O
clunk NN B-NP B-problem
. . B-VP O
   
The DT B-NP O
extremities NNS I-NP O
were VBD B-VP O
normal JJ O O
in IN B-VP O
appearance NN B-NP O
. . B-VP O
   
The DT B-NP O
skin NN I-NP O
was VBD B-VP O
without IN B-VP O
lesions NNS B-NP B-problem
. . B-VP O
   
The DT B-NP B-test
neurological JJ I-NP I-test
examination NN I-NP I-test
was VBD B-VP O
appropriate JJ O O
for IN B-VP O
age NN B-NP O
with IN B-VP O
normal JJ B-NP O
tone NN I-NP O
and CC O O
strength NN B-NP O
and CC O O
appropriate JJ B-NP O
reflexes NNS I-NP O
. . B-VP O
   
HOSPITAL NNP B-NP O
COURSE NNP I-NP O
: : O O
1. CD O O
Cardiovascular NN B-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
remained VBD B-VP O
cardiovascularly RB O O
stable JJ O O
throughout IN B-VP O
the DT B-NP O
admission NN I-NP O
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
noted VBN O O
to TO O O
have VB O O
some DT B-NP B-problem
apnea NN I-NP I-problem
and CC O O
bradycardic JJ B-NP B-problem
spells NNS I-NP I-problem
of IN B-VP I-problem
prematurity NN B-NP I-problem
and CC O O
was VBD B-VP O
therefore RB O O
started VBN O O
on IN B-VP O
caffeine NN B-NP B-treatment
. . B-VP O
   
With IN B-VP O
the DT B-NP O
initiation NN I-NP O
of IN B-VP O
caffeine NN B-NP B-treatment
therapy NN I-NP I-treatment
the DT B-NP B-person
patient NN I-NP I-person
has VBZ O O
had VBN O O
no DT O O
more RBR O O
apnea NN B-NP B-problem
or CC O O
bradycardic JJ B-NP B-problem
events NNS I-NP I-problem
. . B-VP O
   
2. CD O O
Respiratory NN B-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
initially RB O O
started VBN O O
on IN B-VP O
nasal NN B-NP B-treatment
prong JJ B-NP I-treatment
CPAP NNP I-NP I-treatment
at IN B-VP O
6 CD O O
and CC O O
required VBD B-VP O
additional JJ B-NP B-treatment
oxygen NN I-NP I-treatment
to TO O O
35% CD O O
. . B-VP O
   
However RB O O
by IN B-VP O
24 CD O O
hours NNS B-NP O
he PRP O B-person
transitioned VBD B-VP O
to TO O O
low-flow JJ B-NP B-treatment
nasal JJ I-NP I-treatment
cannula NN I-NP I-treatment
and CC O O
on IN B-VP O
day NN B-NP O
of IN B-VP O
life NN B-NP O
five CD O O
transitioned VBN O O
to TO O O
room NN B-NP O
air NN I-NP O
where WRB O O
he PRP O B-person
currently RB O O
remains VBZ O O
. . B-VP O
   
3. CD O O
Fluids NNP B-NP O
, , O O
electrolytes VBZ O O
and CC O O
nutrition NN B-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
initially RB O O
maintained VBN O O
on IN B-VP O
intravenous JJ B-NP B-treatment
fluids NNS I-NP I-treatment
only RB O O
and CC O O
when WRB O O
his PRP$ O B-person
his PRP$ O B-problem
respiratory NN B-NP I-problem
distress NN I-NP I-problem
resolved VBD B-VP O
he PRP O B-person
was VBD B-VP O
transitioned VBN O O
to TO O O
enteral JJ B-NP B-treatment
feeds NNS I-NP I-treatment
. . B-VP O
   
The DT B-NP O
morning NN I-NP O
of IN B-VP O
transfer NN B-NP O
his PRP$ O B-person
his PRP$ O B-treatment
IV NNP B-NP I-treatment
came VBD B-VP O
out RP O O
so RB O O
he PRP O B-person
has VBZ O O
just RB O O
been VBN O O
advanced VBN O O
to TO O O
120 CD O O
cc NNS B-NP O
per IN B-VP O
kg FW O O
per IN B-VP O
day NN B-NP O
of IN B-VP O
PE-20 NNP B-NP B-treatment
and CC O O
his PRP$ O B-person
tolerating VBG O O
these DT O B-pronoun
these DT B-NP B-treatment
PG NNP I-NP I-treatment
feedings NNS I-NP I-treatment
without IN B-VP O
difficulty NN B-NP O
. . B-VP O
   
Last JJ B-NP B-test
set NN I-NP I-test
of IN B-VP I-test
electrolytes NNS B-NP I-test
on IN B-VP O
06-08 NN B-NP O
, , O O
DOL3 NNP B-NP O
: : O O
Na NNP B-NP B-test
145 CD O O
, , O O
K NNP B-NP B-test
4.3 CD O O
, , O O
Cl NNP B-NP B-test
110 CD O O
, , O O
tCO2 VBD B-VP B-test
25 CD O O
. . B-VP O
   
Discharge NN B-NP B-test
Wt NNP I-NP I-test
1645 CD O O
gms NN B-NP O
. . B-VP O
   
4. CD O O
Hematology NN B-NP O
: : O O
His PRP$ O B-person
His PRP$ O B-test
admission NN B-NP I-test
complete JJ B-NP I-test
blood NN I-NP I-test
count NN I-NP I-test
was VBD B-VP O
notable JJ O O
for IN B-VP O
a DT B-NP B-test
white JJ I-NP I-test
count NN I-NP I-test
of IN B-VP O
11.8 CD O O
, , O O
25 CD O B-test
polys NN B-NP I-test
and CC O O
no DT B-NP O
bands NNS I-NP B-test
. . B-VP O
   
Hematocrit NNP B-NP B-test
was VBD B-VP O
45 CD O O
, , O O
platelet NN B-NP B-test
count NN I-NP I-test
270 CD O O
. . B-VP O
   
He PRP O B-person
developed VBD B-VP O
physiologic JJ B-NP B-problem
hyperbilirubinemia NN I-NP I-problem
( ( O O
peak JJ B-NP B-test
bili NN I-NP I-test
8.6/0.3 CD O O
on IN B-VP O
06-08 NN B-NP O
, , O O
DOL3 NNP B-NP O
) ) O O
for IN B-VP O
which WDT O B-pronoun
he PRP O B-person
was VBD B-VP O
treated VBN O O
with IN B-VP O
a DT B-NP B-treatment
single JJ I-NP I-treatment
phototherapy NN I-NP I-treatment
. . B-VP O
   
His PRP$ O B-person
His PRP$ O B-test
most RBS O I-test
recent JJ B-NP I-test
bilirubin NN I-NP I-test
was VBD B-VP O
6.6 CD O O
on IN B-VP O
day NN B-NP O
of IN B-VP O
life NN B-NP O
six CD O O
, , O O
the DT B-NP O
day NN I-NP O
of IN B-VP O
discharge NN B-NP O
, , O O
and CC O O
his PRP$ O B-person
his PRP$ O B-treatment
phototherapy NN B-NP I-treatment
was VBD B-VP O
discontinued. NN B-NP O
He PRP O B-person
will MD O O
need VB O O
a DT B-NP B-test
rebound NN I-NP I-test
bilirubin NN I-NP I-test
level NN I-NP I-test
in IN B-VP O
am VBP O O
. . B-VP O
   
5. CD O O
Infectious JJ B-NP O
disease NN I-NP O
: : O O
Blood NN B-NP B-test
culture NN I-NP I-test
was VBD B-VP O
sent VBN O O
but CC O O
he PRP O B-person
was VBD B-VP O
never RB O O
started VBN O O
on IN B-VP O
antibiotics NNS B-NP B-treatment
. . B-VP O
   
The DT B-NP B-test
blood NN I-NP I-test
culture NN I-NP I-test
remained VBD B-VP O
sterile JJ O O
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
noted VBN O O
to TO O O
have VB O O
an DT B-NP B-problem
erythematous JJ I-NP I-problem
perianal JJ I-NP I-problem
rash NN I-NP I-problem
and CC O O
for IN B-VP O
this DT O B-pronoun
was VBD B-VP O
started VBN O O
on IN B-VP O
Nystatin NNP B-NP B-treatment
powder NN I-NP I-treatment
. . B-VP O
   
The DT B-NP B-person
parents NNS I-NP I-person
were VBD B-VP O
updated VBN O O
throughout IN B-VP O
the DT B-NP O
admission NN I-NP O
and CC O O
a DT B-NP O
family NN I-NP B-person
meeting NN I-NP O
was VBD B-VP O
held VBN O O
on IN B-VP O
2015-06-09 JJ O O
. . B-VP O
   
6. CD O O
Sensory NN B-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
has VBZ O O
not RB O O
had VBN O O
an DT B-NP O
CMED NNP I-NP B-test
examination NN I-NP I-test
or CC O O
hearing JJ B-NP B-test
test NN I-NP I-test
. . B-VP O
   
CONDITION NN B-NP O
ON NNP I-NP O
DISCHARGE NNP I-NP O
: : O O
Good JJ O O
. . B-VP O
   
DISPOSITION NN B-NP O
: : O O
To TO O O
Kindred NNP B-NP O
Hospital NNP I-NP O
Special NNP I-NP O
Care NNP I-NP O
Nursery NNP I-NP O
. . B-VP O
   
NAME NN B-NP O
OF IN B-VP O
PEDIATRICIAN NNP B-NP B-person
: : O O
Hale NNP B-NP B-person
Air NNP I-NP I-person
Force NNP I-NP I-person
Base NNP I-NP I-person
Pediatrics NNP I-NP I-person
. . B-VP O
   
CARE NNP B-NP O
AND CC O O
RECOMMENDATIONS NNP B-NP O
: : O O
Feeds NNS B-NP B-treatment
at IN B-VP O
discharge NN B-NP O
are VBP O O
PE-20 NNP B-NP B-treatment
currently RB O O
at IN B-VP O
120 CD O O
cc NN B-NP O
per IN B-VP O
kg FW O O
per IN B-VP O
day NN B-NP O
due JJ O O
to TO O O
advance VB O O
15 CD O O
cc NN B-NP O
per IN B-VP O
kg FW O O
per IN B-VP O
day NN B-NP O
to TO O O
a DT B-NP O
total NN I-NP O
of IN B-VP O
150 CD O O
cc NNS B-NP O
per IN B-VP O
kg FW O O
per IN B-VP O
day NN B-NP O
. . B-VP O
   
DISCHARGE NNP B-NP O
MEDICATIONS NNP I-NP O
: : O O
Caffeine NN B-NP B-treatment
12 CD O O
mg NN B-NP O
pg NN I-NP O
q NN I-NP O
day. NN I-NP O
He PRP O B-person
has VBZ O O
not RB O O
had VBN O O
his PRP$ O B-person
06-10 JJ B-NP O
dose NN I-NP O
. . B-VP O
   
STATE NNP B-NP O
NEWBORN NNP I-NP O
SCREENING NNP I-NP O
STATUS NNP I-NP O
: : O O
He PRP O B-person
is VBZ O O
due JJ O O
to TO O O
have VB O O
his PRP$ O B-person
his PRP$ O B-test
state NN B-NP I-test
screen NN I-NP I-test
sent VBD B-VP O
today NN B-NP O
. . B-VP O
   
IMMUNIZATIONS NN B-NP O
: : O O
Not RB O O
yet RB O O
received VBN O O
. . B-VP O
   
Synagis NNP B-NP B-treatment
RSV NNP I-NP I-treatment
prophylaxis NN I-NP I-treatment
should MD O O
be VB O O
considered VBN O O
from IN B-VP O
October NNP B-NP O
through IN B-VP O
April NNP B-NP O
for IN B-VP O
infants NNS B-NP B-person
who WP O B-person
meet VBP O O
any DT O O
of IN B-VP O
the DT B-NP O
following JJ I-NP O
criteria NNS I-NP O
: : O O
1. CD O O
Born NNP B-NP O
at IN B-VP O
less JJR O O
than IN B-VP O
32 CD O O
weeks NNS B-NP O
. . B-VP O
   
2. CD O O
Born NNP B-NP O
at IN B-VP O
32-35 JJ B-NP O
weeks NNS I-NP O
with IN B-VP O
plans NNS B-NP O
for IN B-VP O
day NN B-NP O
care NN I-NP O
during IN B-VP O
RSV NNP B-NP O
season NN I-NP O
with IN B-VP O
a DT B-NP O
smoker NN I-NP O
in IN B-VP O
the DT B-NP O
household NN I-NP O
, , O O
or CC O O
with IN B-VP O
preschool JJ B-NP B-person
age NN I-NP I-person
siblings NNS I-NP I-person
. . B-VP O
   
3. CD O O
With IN B-VP O
chronic JJ B-NP B-problem
lung NN I-NP I-problem
disease NN I-NP I-problem
. . B-VP O
   
Influenza NNP B-NP B-treatment
vaccination NN I-NP I-treatment
should MD O O
be VB O O
considered VBN O O
annually RB O O
in IN B-VP O
the DT B-NP O
fall NN I-NP O
for IN B-VP O
preterm JJ B-NP B-person
infants NNS I-NP I-person
with IN B-VP O
chronic JJ B-NP B-problem
lung NN I-NP I-problem
disease NN I-NP I-problem
once IN B-VP O
they PRP O B-pronoun
reach VBP O O
six CD O O
months NNS B-NP O
of IN B-VP O
age NN B-NP O
. . B-VP O
   
Before IN B-VP O
this DT B-NP B-pronoun
age NN I-NP O
, , O O
the DT B-NP B-person
family NN I-NP I-person
and CC O O
other JJ B-NP B-person
caregivers NNS I-NP I-person
should MD O O
be VB O O
considered VBN O O
for IN B-VP O
immunization NN B-NP B-treatment
against IN B-VP O
influenza NN B-NP B-problem
to TO O O
protect VB O O
the DT B-NP B-person
infant NN I-NP I-person
. . B-VP O
   
DISCHARGE NNP B-NP O
DIAGNOSES NNP I-NP O
: : O O
1. CD O O
Prematurity NN B-NP B-problem
at IN B-VP O
30-6/7 JJ B-NP O
weeks NNS I-NP O
. . B-VP O
   
2. CD O O
Rule NN B-NP O
out IN B-VP O
sepsis NN B-NP B-problem
, , O O
off RB O O
antibiotics NNS B-NP B-treatment
. . B-VP O
   
3. CD O O
Apnea NNP B-NP B-problem
and CC O O
bradycardia NN B-NP B-problem
of IN B-VP I-problem
prematurity NN B-NP I-problem
. . B-VP O
   
4. CD O O
Hyperbilirubinemia NNP B-NP B-problem
. . B-VP O
   
5. CD O O
Feeding VBG O B-problem
immaturity NN B-NP I-problem
. . B-VP O
   
Freddy NNP B-NP B-person
Stephen NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
55-454 CD O O
Dictated NNP B-NP O
By:Nathan NNP I-NP B-person
D. NNP I-NP I-person
Delgadillo NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
MEDQUIST36 NNP I-NP O
D NNP I-NP O
: : O O
2015-06-10 JJ O O
09:35 CD O O
T NN B-NP O
: : O O
2015-06-10 JJ O O
09:51 CD O O
JOB# NNPS B-NP O
: : O O
53951 CD O O
Signed VBN O O
electronically RB O O
by IN B-VP O
: : O O
DR. NNP B-NP B-person
Freddy NNP I-NP I-person
King NNP I-NP I-person
on IN B-VP O
: : O O
WED JJ O O
2015-06-10 JJ O O
11:54 CD O O
AM NNP B-NP O
( ( O O
End NNP B-NP O
of IN B-VP O
Report NNP B-NP O
) ) O O
-EMPTYLINE- VBP O O
-DOCSTART- JJ O O
-EMPTYLINE- $ O O
544907529 CD O O
RWH NNP B-NP O
2746299 CD O O
006349 CD O O
700114 CD O O
4/4/2002 CD O O
12:00:00 CD O O
AM NNP B-NP O
ED NNP I-NP O
Discharge NNP I-NP O
Summary NNP I-NP O
Unsigned VBD B-VP O
DIS NNP B-NP O
Report NNP I-NP O
Status NNP I-NP O
: : O O
Unsigned VBD B-VP O
ED NNP B-NP O
DISCHARGE NNP I-NP O
NOTIFICATION NNP I-NP O
JESCWIERST NNP I-NP B-person
, , O I-person
MA NNP B-NP I-person
MRN NNP I-NP O
: : O O
2746299 CD O O
Age NNP B-NP O
: : O O
55y CD O O
REGISTRATION NNP B-NP O
DATE NNP I-NP O
: : O O
04/04/2002 CD O O
01:09 CD O O
AM NNP B-NP O
PRELIMINARY NNP I-NP O
REPORT NNP I-NP O
This DT O B-pronoun
is VBZ O O
to TO O O
notify VB O O
you PRP O B-person
that IN B-VP B-pronoun
your PRP$ O B-person
your PRP$ O B-person
patient NN B-NP I-person
, , O O
JESCWIERST NNP B-NP B-person
, , O I-person
MA NNP B-NP I-person
arrived VBD B-VP O
in IN B-VP O
the DT B-NP O
Emergency NNP I-NP O
Department NNP I-NP O
at IN B-VP O
Ro NNP B-NP O
Woodma NNP I-NP O
Healthcare NNP I-NP O
on IN B-VP O
04/04/2002 CD O O
01:09 CD O O
AM NNP B-NP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
presented VBN O O
with IN B-VP O
a DT B-NP O
chief JJ I-NP O
complaint NN I-NP O
of IN B-VP O
EPIGASTRIC NNP B-NP B-problem
PAIN NNP I-NP I-problem
/ NNP I-NP O
ABD NNP I-NP B-problem
PAIN NNP I-NP I-problem
. . B-VP O
   
Following VBG O O
evaluation NN B-NP B-test
and CC O O
treatment NN B-NP B-treatment
, , O O
the DT B-NP B-person
patient NN I-NP I-person
&apos;s JJ B-NP O
disposition NN I-NP O
at IN B-VP O
the DT B-NP O
end NN I-NP O
of IN B-VP O
the DT B-NP O
visit NN I-NP O
was VBD B-VP O
ADMITTED NNP B-NP O
AS IN B-VP O
AN NNP B-NP O
INPATIENT NNP I-NP O
TO NNP I-NP O
RO NNP I-NP O
WOODMA NNP I-NP O
HEALTHCARE NNP I-NP O
. . B-VP O
   
The DT O B-person
The DT B-NP B-person
patient JJ I-NP I-person
patient NN I-NP I-person
&apos;s NNP I-NP I-person
preliminary JJ O I-person
admitting VBG O I-person
physician NN B-NP I-person
is VBZ O O
PRIESDOUET NNP B-NP B-person
, , O I-person
CH NNP B-NP I-person
J NNP I-NP I-person
and CC O O
the DT B-NP O
preliminary JJ I-NP O
diagnosis NN I-NP O
is VBZ O O
CHOLECYSTITIS NNP B-NP B-problem
. . B-VP O
   
Please NNP B-NP O
note VB O O
this DT B-NP B-pronoun
information NN I-NP O
may MD O O
have VB O O
been VBN O O
updated VBN O O
on IN B-VP O
the DT B-NP O
inpatient JJ I-NP O
unit NN I-NP O
. . B-VP O
   
If IN B-VP O
you PRP O B-person
need VBP O O
additional JJ B-NP O
information NN I-NP O
please NN I-NP O
call VB O O
662-747-1199 JJ O O
. . B-VP O
   
PCP NNPS B-NP B-person
Name NN I-NP O
: : O O
GRENDZISKLEEB NNP B-NP B-person
, , O I-person
FACISA NNP B-NP I-person
T NNP I-NP I-person
Provider NNP I-NP O
Number NNP I-NP O
: : O O
11181 CD O O
-EMPTYLINE- NN B-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
Admission NNP I-NP O
Date NNP I-NP O
: : O O
2016-11-21 JJ B-NP O
Discharge NN I-NP O
Date NNP I-NP O
: : O O
2016-11-30 JJ B-NP O
Date NNP I-NP O
of IN B-VP O
Birth NNP B-NP O
: : O O
1953-10-19 JJ B-NP O
Sex NN I-NP O
: : O O
M NNP B-NP O
Service NNP I-NP O
: : O O
CMED NNP B-NP B-person
CCU NNP I-NP I-person
CHIEF NNP I-NP O
COMPLAINT NNP I-NP O
AND NNP I-NP O
HISTORY NNP I-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS NNP I-NP O
: : O O
Mr. NNP B-NP B-person
Jackson NNP I-NP I-person
is VBZ O O
a DT B-NP O
63-year-old JJ I-NP O
male NN I-NP O
with IN B-VP O
squamous JJ B-NP B-problem
cell NN I-NP I-problem
carcinoma NN I-NP I-problem
of IN B-VP O
the DT B-NP O
floor NN I-NP O
of IN B-VP O
mouth NN B-NP O
( ( O O
stage NN B-NP B-problem
T2 NNP I-NP I-problem
N0 NNP I-NP I-problem
) ) O O
that WDT O B-pronoun
was VBD B-VP O
biopsied VBN O O
by IN B-VP O
his PRP$ O B-person
his PRP$ O B-person
dentist NN B-NP I-person
. . B-VP O
   
Pathology NNP B-NP B-test
was VBD B-VP O
reviewed VBN O O
revealing VBG O O
invasive JJ B-NP B-problem
squamous JJ I-NP I-problem
cell NN I-NP I-problem
carcinoma NN I-NP I-problem
. . B-VP O
   
He PRP O B-person
presented VBD B-VP O
on IN B-VP O
2016-11-21 JJ O O
for IN B-VP O
resection NN B-NP B-treatment
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
admitted VBN O O
on IN B-VP O
2016-11-21 JJ O O
following VBG O O
his PRP$ O B-treatment
his PRP$ O B-person
surgery NN B-NP I-treatment
. . B-VP O
   
He PRP O B-person
underwent VBD B-VP O
a DT B-NP B-treatment
joint JJ I-NP I-treatment
procedure NN I-NP I-treatment
by IN B-VP O
Otolaryngology NNP B-NP B-person
and CC O O
Plastic NNP B-NP B-person
Surgery NNP I-NP I-person
. . B-VP O
   
PAST NNP B-NP O
MEDICAL NNP I-NP O
HISTORY NNP I-NP O
: : O O
Includes VBZ O O
hypertension NN B-NP B-problem
and CC O O
chronic JJ B-NP B-problem
obstructive JJ I-NP I-problem
pulmonary JJ I-NP I-problem
disease NN I-NP I-problem
. . B-VP O
   
PAST JJ B-NP O
SURGICAL JJ I-NP O
HISTORY NN I-NP O
: : O O
Polypectomy NN B-NP B-treatment
in IN B-VP O
2011 CD O O
, , O O
tooth DT B-NP B-treatment
extraction NN I-NP I-treatment
( ( O O
all DT O O
) ) O O
in IN B-VP O
1980 CD O O
, , O O
and CC O O
hernia NN B-NP B-problem
in IN B-VP O
1977 CD O O
. . B-VP O
   
ALLERGIES CC O O
: : O O
TOMATO NNP B-NP O
( ( O O
causing VBG O O
anaphylaxis NN B-NP B-problem
) ) O O
and CC O O
TETANUS NNP B-NP B-treatment
SHOT NNP I-NP I-treatment
. . B-VP O
   
MEDICATIONS NNP B-NP O
ON NNP I-NP O
ADMISSION NNP I-NP O
: : O O
Triamterene/hydrochlorothiazide RB O B-treatment
37.5/25 CD O O
mg NN B-NP O
one CD O O
tablet NN B-NP O
by IN B-VP O
mouth NN B-NP O
once RB O O
daily JJ O O
and CC O O
lorazepam JJ O B-treatment
1 CD O O
mg NN B-NP O
three CD O O
times NNS B-NP O
daily RB O O
as IN B-VP O
needed VBN O O
( ( O O
for IN B-VP O
anxiety NN B-NP B-problem
) ) O O
. . B-VP O
   
SOCIAL NNP B-NP O
HISTORY NN I-NP O
: : O O
He PRP O B-person
has VBZ O O
a DT O O
half-pack JJ O O
per IN B-VP O
day NN B-NP O
smoking VBG O O
history NN B-NP O
and CC O O
drinks NNS B-NP O
approximately RB O O
three CD O O
to TO O O
four CD O O
alcoholic JJ B-NP O
beverages NNS I-NP O
per IN B-VP O
day NN B-NP O
. . B-VP O
   
PROCEDURES NNP B-NP O
PERFORMED: NNP I-NP O
1. CD O O
Tracheostomy NNP B-NP B-treatment
. . B-VP O
   
2. CD O O
Diagnostic JJ B-NP B-test
laryngoscopy NN I-NP I-test
and CC O O
biopsy NN B-NP B-test
. . B-VP O
   
3. CD O O
Bilateral NNP B-NP B-treatment
supraomohyoid NN I-NP I-treatment
neck NN I-NP I-treatment
dissection NN I-NP I-treatment
. . B-VP O
   
4. CD O O
Resection NNP B-NP B-treatment
of IN B-VP O
floor NN B-NP O
of IN B-VP O
mouth JJ B-NP B-problem
tumor NN I-NP I-problem
. . B-VP O
   
SUMMARY NNP B-NP O
OF IN B-VP O
HOSPITAL NNP B-NP O
COURSE NNP I-NP O
: : O O
Surgeon NN B-NP B-person
was VBD B-VP O
Dr. NNP B-NP B-person
Kelsey NNP I-NP I-person
K NNP I-NP I-person
Sanchez NNP I-NP I-person
. . B-VP O
   
Assistant NNP B-NP B-person
was VBD B-VP O
Dr. NNP B-NP B-person
Justin NNP I-NP I-person
K.. NNP I-NP I-person
Velez NNP I-NP I-person
. . B-VP O
   
Frozen NNP B-NP B-test
section NN I-NP I-test
sent VBD B-VP O
to TO O O
pathology VB O B-person
revealing VBG O O
invasive JJ B-NP B-problem
squamous JJ I-NP I-problem
cell NN I-NP I-problem
carcinoma NN I-NP I-problem
. . B-VP O
   
No DT B-NP O
complications NNS I-NP B-problem
. . B-VP O
   
The DT B-NP B-person
Plastic NNP I-NP I-person
Team NNP I-NP I-person
then RB O O
took VBD B-VP O
over RP O O
for IN B-VP O
reconstruction NN B-NP B-treatment
consisting NN I-NP O
of IN B-VP O
radial JJ B-NP B-treatment
forearm NN I-NP I-treatment
free JJ B-NP I-treatment
flap NN I-NP I-treatment
to TO O O
floor NN B-NP O
of IN B-VP O
mouth NN B-NP O
. . B-VP O
   
Surgeon NNP B-NP B-person
was VBD B-VP O
Dr. NNP B-NP B-person
Jude. NNP I-NP I-person
Christopher NNP I-NP I-person
Swinney NNP I-NP I-person
. . B-VP O
   
Total NNP B-NP B-treatment
intravenous JJ B-NP I-treatment
fluids NNS I-NP I-treatment
of IN B-VP O
7300 CD O O
cc NN B-NP O
. . B-VP O
   
Estimated VBN O B-problem
blood NN B-NP I-problem
loss NN I-NP I-problem
of IN B-VP O
300 CD O O
cc NN B-NP O
. . B-VP O
   
Urine NNP B-NP B-test
output NN I-NP I-test
of IN B-VP O
900 CD O O
cc NN B-NP O
. . B-VP O
   
No DT B-NP O
complications NNS I-NP B-problem
. . B-VP O
   
In IN B-VP O
addition NN B-NP O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
prepared VBN O O
for IN B-VP O
an DT B-NP B-treatment
attempted JJ I-NP I-treatment
percutaneous JJ I-NP I-treatment
endoscopic NN I-NP I-treatment
gastrostomy NN I-NP I-treatment
tube NN I-NP I-treatment
. . B-VP O
   
The DT B-NP B-treatment
percutaneous JJ I-NP I-treatment
endoscopic NN I-NP I-treatment
gastrostomy NN I-NP I-treatment
was VBD B-VP O
unsuccessful JJ O O
, , O O
and CC O O
the DT B-NP B-treatment
procedure NN I-NP I-treatment
was VBD B-VP O
converted VBN O O
to TO O O
an DT B-NP B-treatment
open JJ I-NP I-treatment
gastrostomy NN I-NP I-treatment
tube NN I-NP I-treatment
which WDT O B-pronoun
then RB O O
proceeded VBD B-VP O
without IN B-VP O
complications NNS B-NP B-problem
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
admitted VBN O O
to TO O O
the DT B-NP O
Surgical NNP I-NP O
Intensive NNP I-NP O
Care NNP I-NP O
Unit NNP I-NP O
postoperatively RB O O
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
sedated VBN O B-treatment
and CC O O
ventilated VBN O B-treatment
by IN B-VP O
his PRP$ O B-person
his PRP$ O B-treatment
tracheostomy NN B-NP I-treatment
6 CD O I-treatment
cuff NN B-NP I-treatment
Shiley NNP I-NP I-treatment
tube NN I-NP I-treatment
. . B-VP O
   
He PRP O B-person
had VBD B-VP O
three CD O O
Westwood-Pocasset NNP B-NP B-treatment
drains NNS I-NP I-treatment
- : O O
two CD O O
in IN B-VP O
the DT B-NP O
neck NN I-NP O
and CC O O
one CD O O
in IN B-VP O
his PRP$ O B-person
right JJ B-NP O
arm NN I-NP O
. . B-VP O
   
G-tube NN B-NP B-treatment
was VBD B-VP O
to TO O O
gravity NN B-NP O
, , O O
Foley NNP B-NP B-treatment
to TO O O
gravity NN B-NP O
, , O O
left VBD B-VP B-treatment
radial JJ B-NP I-treatment
A-line NNP I-NP I-treatment
. . B-VP O
   
The DT B-NP B-treatment
flap NN I-NP I-treatment
was VBD B-VP O
pink VBN O O
with IN B-VP O
a DT B-NP B-test
strong JJ I-NP I-test
Doppler NNP I-NP I-test
signal NN I-NP I-test
. . B-VP O
   
He PRP O B-person
underwent JJ B-NP O
flap JJ I-NP B-test
checks NNS I-NP I-test
every DT O O
15 CD O O
minutes NNS B-NP O
initially RB O O
with IN B-VP O
a DT B-NP B-treatment
dextran JJ I-NP I-treatment
infusion NN I-NP I-treatment
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
placed VBN O O
on IN B-VP O
Unasyn NNP B-NP B-treatment
3 CD O O
grams NNS B-NP O
IV NNP I-NP O
q.6h. NN I-NP O
Nothing NN I-NP O
by IN B-VP O
mouth NN B-NP O
initially RB O O
with IN B-VP O
morphine NN B-NP B-treatment
as IN B-VP O
needed VBN O O
for IN B-VP O
pain NN B-NP B-problem
and CC O O
Ativan NNP B-NP B-treatment
around IN B-VP O
the DT B-NP O
clock NN I-NP O
for IN B-VP O
delirium NN B-NP B-treatment
tremens NNS I-NP I-treatment
prophylaxis VBP O I-treatment
. . B-VP O
   
In IN B-VP O
addition NN B-NP O
, , O O
he PRP O B-person
received VBD B-VP O
metoprolol JJ B-NP B-treatment
q.4.h. NN I-NP O
, , O O
a DT B-NP B-treatment
regular JJ I-NP I-treatment
insulin NN I-NP I-treatment
sliding VBG O I-treatment
scale NN B-NP I-treatment
, , O O
and CC O O
adequate JJ B-NP O
gastrointestinal JJ I-NP O
prophylaxis NN I-NP O
with IN B-VP O
Protonix NNP B-NP B-treatment
. . B-VP O
   
Postoperative NNP B-NP B-test
laboratories NNS I-NP I-test
revealed VBD B-VP O
sodium NN B-NP B-test
was VBD B-VP O
134 CD O O
, , O O
potassium NN B-NP B-test
was VBD B-VP O
4.1 CD O O
, , O O
chloride NN B-NP B-test
was VBD B-VP O
102 CD O O
, , O O
bicarbonate NN B-NP B-test
was VBD B-VP O
28 CD O O
, , O O
blood NN B-NP B-test
urea JJ B-NP I-test
nitrogen NN I-NP I-test
was VBD B-VP O
18 CD O O
, , O O
creatinine NN B-NP B-test
was VBD B-VP O
0.8 CD O O
, , O O
and CC O O
glucose NN B-NP B-test
was VBD B-VP O
148 CD O O
. . B-VP O
   
Calcium NN B-NP B-test
was VBD B-VP O
7.6 CD O O
. . B-VP O
   
Magnesium NN B-NP B-test
was VBD B-VP O
2.2 CD O O
. . B-VP O
   
Complete JJ B-NP B-test
blood NN I-NP I-test
count NN I-NP I-test
revealed VBD B-VP O
white JJ B-NP B-test
count NN I-NP I-test
was VBD B-VP O
5.4 CD O O
, , O O
hematocrit NN B-NP B-test
was VBD B-VP O
31.3 CD O O
, , O O
and CC O O
platelets NNS B-NP B-test
were VBD B-VP O
160 CD O O
. . B-VP O
   
ALT NNP B-NP B-test
was VBD B-VP O
14 CD O O
, , O O
AST NNP B-NP B-test
was VBD B-VP O
31 CD O O
, , O O
alkaline JJ B-NP B-test
phosphatase NN I-NP I-test
was VBD B-VP O
42 CD O O
, , O O
total JJ B-NP B-test
bilirubin NN I-NP I-test
was VBD B-VP O
0.9 CD O O
, , O O
albumin NN B-NP B-test
was VBD B-VP O
2.2 CD O O
. . B-VP O
   
A DT B-NP B-test
chest JJ I-NP I-test
x-ray NN I-NP I-test
postoperatively RB O O
showed VBD B-VP O
clear JJ B-NP O
lung NN I-NP O
fields NNS I-NP O
. . B-VP O
   
Tracheostomy NNP B-NP B-treatment
tube NN I-NP I-treatment
in IN B-VP O
good JJ B-NP O
position NN I-NP O
. . B-VP O
   
No DT B-NP O
pneumothorax NN I-NP B-problem
. . B-VP O
   
By IN B-VP O
systems NNS B-NP O
: : O O
CMED NNP B-NP O
CSRU NNP I-NP O
and CC O O
Plastic NNP B-NP B-person
Surgery NNP I-NP I-person
flap NN I-NP B-test
checks NNS I-NP I-test
, , O O
tracheostomy EX O B-treatment
care NN B-NP I-treatment
, , O O
and CC O O
Westwood-Pocasset NNP B-NP B-treatment
management. NN I-NP I-treatment
Cardiovascular NNP I-NP O
: : O O
Lopressor NNP B-NP B-treatment
5 CD O O
intravenously RB O O
q.4.h. JJ B-NP O
Respiratory NNP I-NP O
: : O O
Nebulizers NNS B-NP B-treatment
as IN B-VP O
needed VBN O O
, , O O
weaning VBG O O
from IN B-VP O
ventilation NN B-NP B-treatment
. . B-VP O
   
Gastrointestinal JJ O O
: : O O
Medications NNS B-NP B-treatment
per IN B-VP O
gastrostomy NN B-NP B-treatment
tube NN I-NP I-treatment
on IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
one CD O O
. . B-VP O
   
Genitourinary JJ O O
: : O O
Foley NNP B-NP B-treatment
catheter NN I-NP I-treatment
for IN B-VP O
strict JJ B-NP B-test
monitoring NN I-NP I-test
of IN B-VP I-test
ins NNS B-NP I-test
and CC O I-test
outs NNS B-NP I-test
. . B-VP O
   
Hematologic NNP B-NP O
: : O O
Hematocrit NNP B-NP B-test
stable JJ O O
. . B-VP O
   
Infectious JJ B-NP O
Disease NN I-NP O
: : O O
Unasyn NN B-NP B-treatment
for IN B-VP O
antibiotic JJ B-NP B-treatment
coverage NN I-NP I-treatment
. . B-VP O
   
Flap NNP B-NP B-test
checks NNS I-NP I-test
carried VBD B-VP O
out RP O O
q.2h. NN B-NP O
initially RB O O
in IN B-VP O
the DT B-NP O
Surgical NNP I-NP O
Intensive NNP I-NP O
Care NNP I-NP O
Unit NNP I-NP O
showing VBG O O
positive JJ B-NP O
biphasic JJ I-NP O
Doppler NNP I-NP O
signals NNS I-NP O
. . B-VP O
   
Pink NNP B-NP B-treatment
flap NN I-NP I-treatment
with IN B-VP O
good JJ B-NP O
refill NN I-NP O
. . B-VP O
   
Right JJ B-NP O
arm NN I-NP O
neurovascularly RB O O
intact JJ O O
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
weaned VBN O O
from IN B-VP O
ventilation NN B-NP B-treatment
on IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
one CD O O
to TO O O
pressure VB O B-treatment
support NN B-NP I-treatment
ventilation NN I-NP I-treatment
and CC O O
then RB O O
to TO O O
spontaneous JJ O O
breathing VBG O O
on IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
two CD O O
. . B-VP O
   
His PRP$ O B-person
His PRP$ O B-test
Westwood-Pocasset NNP B-NP I-test
output NN I-NP I-test
for IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
one CD O O
on IN B-VP O
the DT B-NP O
left NN I-NP O
was VBD B-VP O
60 CD O O
, , O O
right RB O O
neck NN B-NP O
93 CD O O
, , O O
in IN B-VP O
the DT B-NP O
arm NN I-NP O
20 CD O O
. . B-VP O
   
Tube NNP B-NP B-treatment
feedings NNS I-NP I-treatment
were VBD B-VP O
started VBN O O
48 CD O O
hours NNS B-NP O
after IN B-VP O
the DT B-NP B-treatment
procedure NN I-NP I-treatment
. . B-VP O
   
The DT B-NP O
cuff NN I-NP O
on IN B-VP O
his PRP$ O B-person
his PRP$ O B-treatment
tracheostomy NN B-NP I-treatment
tube NN I-NP I-treatment
was VBD B-VP O
put VBN O O
down RP O O
on IN B-VP O
11-23 JJ O O
, , O O
postoperative JJ B-NP O
day NN I-NP O
two CD O O
which WDT O B-pronoun
he PRP O B-person
tolerated VBD B-VP O
well RB O O
with IN B-VP O
minimal JJ B-NP B-problem
secretions NNS I-NP I-problem
and CC O O
a DT B-NP O
strong JJ I-NP O
adequate JJ I-NP O
cough NN I-NP O
. . B-VP O
   
Due NNP B-NP O
to TO O O
bed VB O O
issues NNS B-NP O
, , O O
he PRP O B-person
was VBD B-VP O
transferred VBN O O
from IN B-VP O
the DT B-NP O
Surgical NNP I-NP O
Intensive NNP I-NP O
Care NNP I-NP O
Unit NNP I-NP O
to TO O O
the DT B-NP O
Medical NNP I-NP O
Intensive NNP I-NP O
Care NNP I-NP O
Unit NNP I-NP O
on IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
three CD O O
. . B-VP O
   
His PRP$ O B-person
His PRP$ O B-treatment
tube NN B-NP I-treatment
feedings NNS I-NP I-treatment
were VBD B-VP O
advanced JJ O O
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
out IN B-VP O
of IN B-VP O
bed NN B-NP O
to TO O O
a DT B-NP O
chair NN I-NP O
. . B-VP O
   
He PRP O B-person
continued VBD B-VP O
with IN B-VP O
pulmonary JJ B-NP B-treatment
toilet NN I-NP I-treatment
and CC O O
q.2h. NN B-NP B-test
flap NN I-NP I-test
checks NNS I-NP I-test
. . B-VP O
   
The DT B-NP B-treatment
Westwood-Pocasset NNP I-NP I-treatment
in IN B-VP I-treatment
his PRP$ O B-person
his PRP$ O I-treatment
right NN B-NP I-treatment
arm NN I-NP I-treatment
was VBD B-VP O
removed VBN O O
on IN B-VP O
2016-11-25 JJ O O
. . B-VP O
   
His PRP$ O B-person
His PRP$ O B-treatment
tracheostomy NN B-NP I-treatment
was VBD B-VP O
changed VBN O O
to TO O O
a DT O B-treatment
6 CD O I-treatment
cuffless NN B-NP I-treatment
Shiley NNP I-NP I-treatment
on IN B-VP O
2016-11-26 JJ O O
and CC O O
sutures NNS B-NP B-treatment
in IN B-VP O
place NN B-NP O
with IN B-VP O
a DT B-NP B-treatment
3-0 JJ I-NP I-treatment
silk NN I-NP I-treatment
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
tolerated VBD B-VP O
this DT O B-treatment
this DT B-NP B-pronoun
procedure NN I-NP I-treatment
well RB O O
. . B-VP O
   
This DT O B-pronoun
is VBZ O O
the DT B-NP O
end NN I-NP O
of IN B-VP O
part NN B-NP O
1 CD O O
of IN B-VP O
this DT B-NP B-pronoun
dictation NN I-NP O
summary NN I-NP O
for IN B-VP O
Patricia NNP B-NP B-person
Jackson NNP I-NP I-person
. . B-VP O
   
To TO O O
be VB O O
continued VBN O O
in IN B-VP O
a DT B-NP O
separate JJ I-NP O
dictation NN I-NP O
. . B-VP O
   
Nola NNP B-NP B-person
Daniel NNP I-NP I-person
, , O O
Hawaii NNP B-NP O
31699 CD O O
Dictated NNP B-NP O
By:Joe NNP I-NP B-person
C. NNP I-NP I-person
Roa NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
MEDQUIST36 NNP I-NP O
D NNP I-NP O
: : O O
2016-11-30 JJ O O
10:56:11 CD O O
T NN B-NP O
: : O O
2016-11-30 JJ O O
11:44:01 CD O O
Job# NNPS B-NP O
: : O O
77004 CD O O
Signed VBN O O
electronically RB O O
by IN B-VP O
: : O O
DR. NNP B-NP B-person
Michael NNP I-NP I-person
Z NNP I-NP I-person
Waldroup NNP I-NP I-person
on IN B-VP O
: : O O
MON NNP B-NP O
2016-12-19 CD O O
10:13 CD O O
AM NNP B-NP O
( ( O O
End NNP B-NP O
of IN B-VP O
Report NNP B-NP O
) ) O O
-EMPTYLINE- VBP O O
-DOCSTART- JJ O O
-EMPTYLINE- $ O O
555509347 CD O O
PUMC NNP B-NP O
7264645 CD O O
16649 CD O O
8815716 CD O O
8/31/2004 CD O O
12:00:00 CD O O
AM NNP B-NP O
OB NNP I-NP O
Discharge NNP I-NP O
Summary NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Report NNP I-NP O
Status NNP I-NP O
: : O O
Signed VBD B-VP O
OB NNP B-NP O
EMR NNP I-NP O
L NNP I-NP O
and CC O O
D NNP B-NP O
DISCHARGE NNP I-NP O
SUMMARY NNP I-NP O
NAME NN I-NP O
: : O O
THON NNP B-NP B-person
MERI NNP I-NP I-person
CINKGUAY NNP I-NP I-person
UNIT NNP I-NP O
NUMBER NNP I-NP O
: : O O
069-81-00 JJ B-NP O
ADMISSION NNP I-NP O
DATE NNP I-NP O
: : O O
20040831 CD O O
DISCHARGE NNP B-NP O
DATE NNP I-NP O
: : O O
20040903 CD O O
PRINCIPAL NNP B-NP O
DISCHARGE NNP I-NP O
DIAGNOSIS NNP I-NP O
: : O O
Vaginal JJ B-NP B-treatment
Delivery NNP I-NP I-treatment
With IN B-VP O
Second NNP B-NP B-problem
Degree NNP I-NP I-problem
Laceration NNP I-NP I-problem
ASSOCIATED NNP I-NP O
DIAGNOSES NNP I-NP O
: : O O
Low JJ B-NP B-problem
Lying NNP I-NP I-problem
Placenta NNP I-NP I-problem
; : O O
Past NNP B-NP O
Medical NNP I-NP O
History NNP I-NP O
, , O O
history NN B-NP O
of IN B-VP O
; : O O
Urinary NNP B-NP B-problem
Tract NNP I-NP I-problem
Infection NNP I-NP I-problem
, , O O
history NN B-NP O
of IN B-VP O
PRINCIPAL NNP B-NP O
PROCEDURE NNP I-NP O
OR NNP I-NP O
OPERATION NNP I-NP O
: : O O
Spontaneous JJ B-NP B-treatment
Vertex NNP I-NP I-treatment
Vaginal NNP I-NP I-treatment
Delivery NNP I-NP I-treatment
ASSOCIATED NNP I-NP O
PROCEDURES NNP I-NP O
OR NNP I-NP O
OPERATIONS NNP I-NP O
: : O O
POSTPARTUM NNP B-NP O
DIAGNOSTIC NNP I-NP O
PROCEDURES NNP I-NP O
: : O O
None NN B-NP O
POSTPARTUM NNP I-NP O
THERAPEUTIC NNP I-NP O
PROCEDURES NNP I-NP O
: : O O
None NN B-NP O
OTHER NNP I-NP O
POSTPARTUM NNP I-NP O
THERAPIES NNP I-NP O
: : O O
Routine JJ B-NP B-treatment
Post NNP I-NP I-treatment
Partum NNP I-NP I-treatment
Care NNP I-NP I-treatment
HISTORY NNP I-NP O
AND NNP I-NP O
REASON NNP I-NP O
FOR NNP I-NP O
HOSPITALIZATION NNP I-NP O
: : O O
Active JJ B-NP B-problem
Labor NNP I-NP I-problem
PHYSICAL NNP I-NP O
EXAMINATION NNP I-NP O
: : O O
HEIGHT $ O B-test
66 CD O O
HEENT NNP B-NP B-test
NORMAL NNP I-NP O
NECK NNP I-NP O
NORMAL NNP I-NP O
BREASTS NNP I-NP O
NORMAL NNP I-NP O
NIPPLES NNP I-NP O
NORMAL NNP I-NP O
CHEST NNP I-NP O
NORMAL NNP I-NP O
COR NNP I-NP O
NORMAL NNP I-NP O
ABDOMEN NNP I-NP O
NORMAL NNP I-NP O
EXTREM NNP I-NP O
NORMAL NNP I-NP O
SKIN NNP I-NP O
NORMAL NNP I-NP O
NODES NNP I-NP O
NORMAL NNP I-NP O
VULVA NNP I-NP O
NORMAL NNP I-NP O
VAGINA NNP I-NP O
NORMAL NNP I-NP O
CERVIX NNP I-NP O
NORMAL NNP I-NP O
OS NNP I-NP O
NORMAL NNP I-NP O
ADNEXAE NNP I-NP O
NORMAL NNP I-NP O
UTERUS NNP I-NP O
NORMAL NNP I-NP O
UTERINE NNP I-NP O
SIZE NNP I-NP O
IN NNP I-NP O
WEEKS NNP I-NP O
NORMAL NNP I-NP O
12 CD O O
HOSPITAL NNP B-NP O
COURSE NNP I-NP O
( ( O O
include VBP O O
complications NNS B-NP O
if IN B-VP O
any DT O O
) ) O O
: : O O
This DT O B-pronoun
This DT O B-person
34 CD O I-person
year NN B-NP I-person
old JJ B-NP I-person
Gravida NNP I-NP O
1 CD O O
Para NNP B-NP O
0000 CD O O
was VBD B-VP O
admitted VBN O O
to TO O O
the DT B-NP O
Bap NNP I-NP O
Spald NNP I-NP O
Hospital NNP I-NP O
Obstetrical NNP I-NP O
service NN I-NP O
on IN B-VP O
08/31/2004 CD O O
at IN B-VP O
06:00 CD O O
am VBP O O
for IN B-VP O
the DT B-NP O
indication NN I-NP O
( ( O O
s JJ O O
) ) O O
: : O O
active JJ B-NP B-problem
labor NN I-NP I-problem
. . B-VP O
   
She PRP O B-person
delivered VBD B-VP O
a DT O B-person
3550 CD O I-person
gram NN B-NP I-person
male NN I-NP I-person
infant NN I-NP I-person
on IN B-VP O
08/31/2004 CD O O
at IN B-VP O
09:33 CD O O
pm NN B-NP O
with IN B-VP O
apgar JJ B-NP B-test
scores NNS I-NP I-test
of IN B-VP O
9 CD O O
and CC O O
9 CD O O
at IN B-VP O
one CD O O
and CC O O
five CD O O
minutes NNS B-NP O
respectively RB O O
at IN B-VP O
41.0 CD O O
weeks NNS B-NP O
gestation NN I-NP O
via IN B-VP O
spontaneous JJ O B-treatment
vertex FW O I-treatment
vaginal JJ B-NP I-treatment
delivery NN I-NP I-treatment
. . B-VP O
   
During IN B-VP O
her PRP$ O B-person
her PRP$ O B-problem
labor NN B-NP I-problem
she PRP O B-person
encountered VBD B-VP O
the DT B-NP O
following JJ I-NP O
complication NN I-NP O
( ( O O
s JJ O O
) ) O O
: : O O
chorioamnionitis NN B-NP B-problem
. . B-VP O
   
During IN B-VP O
her PRP$ O B-person
her PRP$ O B-treatment
delivery NN B-NP I-treatment
she PRP O B-person
encountered VBD B-VP O
the DT B-NP O
following JJ I-NP O
complication NN I-NP O
( ( O O
s JJ O O
) ) O O
: : O O
nuchal JJ B-NP B-problem
cord NN I-NP I-problem
. . B-VP O
   
Postpartum NNP B-NP O
she PRP O B-person
encountered VBD B-VP O
the DT B-NP O
following JJ I-NP O
complication NN I-NP O
( ( O O
s JJ O O
) ) O O
: : O O
none NN B-NP O
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
discharged VBN O O
on IN B-VP O
09/03/2004 CD O O
at IN B-VP O
12:07 CD O O
pm NN B-NP O
in IN B-VP O
good JJ B-NP O
condition NN I-NP O
. . B-VP O
   
DISCHARGE NNP B-NP O
ACTIVITY NNP I-NP O
: : O O
No DT B-NP O
Restrictions NNP I-NP O
DISCHARGE NNP I-NP O
DIET NNP I-NP O
: : O O
No DT B-NP O
Restrictions NNP I-NP O
POSTPARTUM NNP I-NP O
DISPOSITION NNP I-NP O
: : O O
Home NN B-NP O
With IN B-VP O
Self-Care NNP B-NP O
( ( O O
Routine NNP B-NP O
Discharge NNP I-NP O
) ) O O
POSTPARTUM NNP B-NP O
CARE NNP I-NP O
SITE NNP I-NP O
: : O O
Cinpipecoursspi NNP B-NP O
Hospital NNP I-NP O
Health NNP I-NP O
Center NNP I-NP O
POSTPARTUM NNP I-NP O
RETURN NNP I-NP O
APPOINTMENT NNP I-NP O
( ( O O
DAYS NNP B-NP O
) ) O O
: : O O
42 CD O O
BREAST NNP B-NP O
FEEDING NN I-NP O
AT NNP I-NP O
DISCHARGE NNP I-NP O
: : O O
Yes PRP$ O O
POSTPARTUM NNP B-NP O
MEASLES NNP I-NP O
/ NNP I-NP O
MUMPS/RUBELLA NNP I-NP O
VACCINE NNP I-NP O
: : O O
Not RB O O
Indicated NNP B-NP O
MEDICATION NNP I-NP O
( ( O O
S NNP B-NP O
) ) O O
ON NNP B-NP O
DISCHARGE NNP I-NP O
: : O O
Multivitamins NNS B-NP B-treatment
And CC O O
Folate NNP B-NP B-treatment
( ( O I-treatment
Fam NNP B-NP I-treatment
Pren NNP I-NP I-treatment
Forte NNP I-NP I-treatment
) ) O I-treatment
Electronically RB O O
Signed VBN O O
: : O O
Pada NNP B-NP B-person
Post NNP I-NP I-person
, , O I-person
MD NNP B-NP I-person
09/03/2004 CD O O
9:51:35 CD O O
PM NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
Admission NNP I-NP O
Date NNP I-NP O
: : O O
2009-12-28 JJ B-NP O
Discharge NN I-NP O
Date NNP I-NP O
: : O O
2009-12-31 JJ B-NP O
Date NNP I-NP O
of IN B-VP O
Birth NNP B-NP O
: : O O
1964-03-23 JJ B-NP O
Sex NN I-NP O
: : O O
F NNP B-NP O
Service NNP I-NP O
: : O O
NEUROMEDIC NNP B-NP O
HISTORY NNP I-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS NNP I-NP O
: : O O
Mrs. NNP B-NP B-person
Wisniewski NNP I-NP I-person
is VBZ O O
a DT B-NP O
45-year-old JJ I-NP O
woman NN I-NP O
with IN B-VP O
multiple JJ B-NP B-problem
familial JJ I-NP I-problem
cavernous JJ I-NP I-problem
hemangiomas NN I-NP I-problem
. . B-VP O
   
She PRP O B-person
is VBZ O O
right-handed JJ O O
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
in IN B-VP O
her PRP$ O B-person
usual JJ B-NP O
state NN I-NP O
of IN B-VP O
health NN B-NP O
until IN B-VP O
one CD O O
and CC O O
a DT B-NP O
half JJ I-NP O
weeks NNS I-NP O
prior RB O O
to TO O O
admission NN B-NP O
. . B-VP O
   
She PRP O B-person
developed VBD B-VP O
an DT B-NP B-problem
ear JJ I-NP I-problem
ache NN I-NP I-problem
, , O O
for IN B-VP O
which WDT O B-pronoun
she PRP O B-person
saw VBD B-VP O
her PRP O B-person
her PRP$ O B-person
primary JJ B-NP I-person
care NN I-NP I-person
physician NN I-NP I-person
, , O O
Evelyn NNP B-NP B-person
was VBD B-VP O
prescribed VBN O O
cortisone JJ B-NP B-treatment
drops NNS I-NP I-treatment
. . B-VP O
   
A DT B-NP O
few JJ I-NP O
days NNS I-NP O
later RB O O
she PRP O B-person
complained VBD B-VP O
of IN B-VP O
dizziness NN B-NP B-problem
. . B-VP O
   
This DT O B-pronoun
was VBD B-VP O
mostly RB O O
described VBN O O
as IN B-VP O
feeling VBG O O
unsteady JJ O B-problem
on IN B-VP I-problem
her PRP$ O B-person
her PRP$ O I-problem
feet NNS B-NP I-problem
. . B-VP O
   
She PRP O B-person
stated VBD B-VP O
that IN B-VP B-pronoun
she PRP O B-person
had VBD B-VP O
trouble NN B-NP O
knowing VBG O O
if IN B-VP O
her PRP$ O B-person
feet NNS B-NP O
were VBD B-VP O
touching VBG O O
the DT B-NP O
ground NN I-NP O
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
seen VBN O O
again RB O O
by IN B-VP O
primary JJ B-NP B-person
care NN I-NP I-person
physician NN I-NP I-person
, , O O
Roderick NNP B-NP B-person
since IN B-VP O
she PRP O B-person
had VBD B-VP O
complaints NNS B-NP O
of IN B-VP O
dizziness NN B-NP B-problem
, , O O
as RB O O
well RB O O
as IN B-VP O
a DT B-NP O
new JJ I-NP O
complaint NN I-NP O
of IN B-VP O
decreased JJ B-NP B-problem
hearing NN I-NP I-problem
and CC O O
the DT B-NP O
sensation NN I-NP O
of IN B-VP O
static JJ O B-problem
in IN B-VP I-problem
her PRP$ O B-person
her PRP$ O I-problem
ears NNS B-NP I-problem
, , O O
meniere EX O B-problem
's POS O I-problem
disease NN B-NP I-problem
was VBD B-VP O
considered VBN O O
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
given VBN O O
an DT B-NP B-treatment
oral JJ I-NP I-treatment
prednisone NN I-NP I-treatment
taper NN I-NP I-treatment
. . B-VP O
   
This DT O B-pronoun
This DT B-NP B-problem
unsteady JJ I-NP I-problem
gait NN I-NP I-problem
progressed VBN O O
, , O O
and CC O O
then RB O O
she PRP O B-person
subsequently RB O O
started VBD B-VP O
to TO O O
develop VB O O
a DT B-NP B-problem
pins NNS I-NP I-problem
and CC O I-problem
needle JJ B-NP I-problem
feeling NN I-NP I-problem
in IN B-VP I-problem
the DT B-NP I-problem
face NN I-NP I-problem
, , O I-problem
hands NNS B-NP I-problem
and CC O I-problem
feet NNS B-NP I-problem
bilaterally RB O I-problem
. . B-VP O
   
Her PRP$ O B-person
hearing NN B-NP O
got VBD B-VP O
progressively RB O B-problem
worse JJR O I-problem
and CC O O
the DT B-NP B-problem
sound NN I-NP I-problem
of IN B-VP I-problem
static JJ O I-problem
increased VBN O O
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
very RB O B-problem
fatigued JJ O I-problem
. . B-VP O
   
At IN B-VP O
an DT B-NP O
outside JJ I-NP O
hospital NN I-NP O
, , O O
head NN B-NP B-test
CT NNP I-NP I-test
revealed VBD B-VP O
a DT O B-problem
1.5 CD O I-problem
cm NN B-NP I-problem
diameter NN I-NP I-problem
hyperdense NN I-NP I-problem
mass NN I-NP I-problem
in IN B-VP I-problem
the DT B-NP I-problem
pons NNS I-NP I-problem
, , O O
slightly RB O O
off IN B-VP O
center NN B-NP O
to TO O O
the DT B-NP O
right NN I-NP O
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
transferred VBN O O
here RB O O
for IN B-VP O
further JJ B-NP O
care NN I-NP O
. . B-VP O
   
PAST NNP B-NP O
MEDICAL NNP I-NP O
HISTORY NNP I-NP O
: : O O
Notable JJ O O
for IN B-VP O
multiple JJ B-NP B-problem
cavernous JJ I-NP I-problem
hemangiomas NN I-NP I-problem
. . B-VP O
   
She PRP O B-person
has VBZ O O
had VBN O O
at IN B-VP B-problem
least JJS O I-problem
two CD O I-problem
bleeding VBG O I-problem
episodes NNS B-NP I-problem
in IN B-VP O
the DT B-NP O
past NN I-NP O
, , O O
mostly RB O O
described VBN O O
as IN B-VP O
being VBG O O
accompanied VBN O O
by IN B-VP O
generalized JJ B-NP B-problem
weakness NN I-NP I-problem
. . B-VP O
   
She PRP O B-person
has VBZ O O
had VBN O O
at IN B-VP B-problem
least JJS O I-problem
two CD O I-problem
generalized JJ B-NP I-problem
seizures NNS I-NP I-problem
in IN B-VP O
the DT O O
past JJ O O
, , O O
but CC O O
she PRP O B-person
has VBZ O O
not RB O O
had VBN O O
one CD O O
since IN B-VP O
she PRP O B-person
was VBD B-VP O
26 CD O O
years NNS B-NP O
old JJ O O
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
never RB O O
on IN B-VP O
an DT O B-treatment
anticonvulsant JJ O I-treatment
due JJ O O
to TO O O
her PRP$ O B-person
former JJ B-NP O
beliefs NN I-NP O
as IN B-VP O
N. NNP B-NP O
Derk NNP I-NP O
Scientist NNP I-NP O
. . B-VP O
   
She PRP O B-person
no RB O O
longer RBR O O
observes VBZ O O
that IN B-VP B-pronoun
belief NN B-NP O
system NN I-NP O
. . B-VP O
   
MEDICATIONS NN B-NP O
: : O O
Prednisone NN B-NP B-treatment
taper NN I-NP I-treatment
as IN B-VP O
above NN B-NP O
. . B-VP O
   
ALLERGIES NNS B-NP O
: : O O
None NN B-NP O
. . B-VP O
   
FAMILY NNP B-NP O
HISTORY NNP I-NP O
: : O O
Strong JJ B-NP O
maternal JJ I-NP O
history NN I-NP O
of IN B-VP O
hemangiomas NN B-NP B-problem
. . B-VP O
   
PHYSICAL JJ B-NP O
EXAMINATION NN I-NP O
: : O O
Temperature NN B-NP B-test
99.2 CD O O
. . B-VP O
   
Pulse JJ O B-test
60 CD O O
. . B-VP O
   
Blood NNP B-NP B-test
pressure NN I-NP I-test
120/80 CD O O
. . B-VP O
   
Respiratory JJ B-NP B-test
rate NN I-NP I-test
14 CD O O
. . B-VP O
   
In IN B-VP O
general JJ O O
, , O O
she PRP O B-person
was VBD B-VP O
a DT B-NP O
thin JJ I-NP O
well-appearing JJ I-NP O
woman NN I-NP O
in IN B-VP O
no DT B-NP O
acute JJ I-NP B-problem
distress NN I-NP I-problem
. . B-VP O
   
Sclera NNP B-NP O
were VBD B-VP O
anicteric JJ O B-problem
. . B-VP O
   
Neck NNP B-NP O
was VBD B-VP O
supple JJ O O
. . B-VP O
   
Chest NNP B-NP O
was VBD B-VP O
clear JJ O O
. . B-VP O
   
Cardiovascular JJ B-NP B-test
exam NN I-NP I-test
revealed VBD B-VP O
a DT B-NP O
regular JJ I-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
with IN B-VP O
no DT B-NP O
murmurs NNS I-NP B-problem
, , O O
rubs NNS B-NP B-problem
or CC O O
gallops NNS B-NP B-problem
. . B-VP O
   
Abdomen NNP B-NP O
soft JJ O O
, , O O
nontender NN B-NP B-problem
and CC O O
distended VBD B-VP B-problem
. . B-VP O
   
Extremities NNS B-NP O
showed VBD B-VP O
no DT B-NP O
edema NN I-NP B-problem
. . B-VP O
   
Neurologically RB O O
, , O O
she PRP O B-person
was VBD B-VP O
awoken VBN O O
from IN B-VP O
sleep NN B-NP O
by IN B-VP O
voice NN B-NP O
, , O O
cooperative JJ O O
, , O O
but CC O O
mildly RB O B-problem
drowsy NN B-NP I-problem
. . B-VP O
   
She PRP O B-person
became VBD B-VP O
more RBR O O
alert JJ O O
during IN B-VP O
the DT B-NP O
remainder NN I-NP O
of IN B-VP O
the DT B-NP B-test
exam NN I-NP I-test
. . B-VP O
   
Speech NNP B-NP O
was VBD B-VP O
fluent JJ O O
but CC O O
slow JJ O B-problem
, , O O
and CC O O
there RB O O
was VBD B-VP O
long JJ B-NP B-problem
response NN I-NP I-problem
latencies NNS I-NP I-problem
before IN B-VP O
she PRP O B-person
would MD O O
initiate VB O O
speech NN B-NP O
. . B-VP O
   
She PRP O B-person
otherwise RB O O
had VBD B-VP O
normal JJ B-NP O
spontaneous JJ I-NP O
movements NNS I-NP O
and CC O O
facial JJ B-NP O
expression NN I-NP O
and CC O O
did VBD B-VP O
not RB O O
appear VB O O
to TO O O
be VB O O
abulic JJ O B-problem
. . B-VP O
   
She PRP O B-person
had VBD B-VP O
normal JJ B-NP O
comprehension NN I-NP O
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
able JJ O O
to TO O O
give VB O O
a DT B-NP O
detailed JJ I-NP O
history NN I-NP O
in IN B-VP O
an DT B-NP O
organized JJ I-NP O
manner NN I-NP O
. . B-VP O
   
There EX O O
was VBD B-VP O
no DT B-NP O
dysarthria NN I-NP B-problem
. . B-VP O
   
Language NN B-NP O
was VBD B-VP O
normal JJ O O
. . B-VP O
   
There EX O O
was VBD B-VP O
no DT B-NP O
evidence NN I-NP O
of IN B-VP O
any DT B-NP B-problem
special JJ I-NP I-problem
neglect NN I-NP I-problem
. . B-VP O
   
Pupils NNP B-NP O
equal JJ O O
, , O O
round NN B-NP O
and CC O O
reactive JJ O O
to TO O O
light JJ O O
. . B-VP O
   
Visual JJ B-NP O
fields NNS I-NP O
were VBD B-VP O
full JJ O O
. . B-VP O
   
Extraocular JJ B-NP O
movements NNS I-NP O
were VBD B-VP O
full JJ O O
with IN B-VP O
normal JJ B-NP O
smooth JJ I-NP O
pursuit NN I-NP O
to TO O O
the DT B-NP O
left NN I-NP O
. . B-VP O
   
Pursuit NNP B-NP O
was VBD B-VP O
interrupted VBN O O
by IN B-VP O
>.....< NN B-NP O
when WRB O O
tracking VBG O O
from IN B-VP O
left VBN O O
to TO O O
right VB O O
. . B-VP O
   
She PRP O B-person
had VBD B-VP O
sustained VBN O B-problem
gaze JJ O I-problem
holding VBG O I-problem
nystagmus NN B-NP I-problem
in IN B-VP O
both DT B-NP O
horizontal JJ I-NP O
directions NNS I-NP O
. . B-VP O
   
There EX O O
was VBD B-VP O
no DT B-NP O
rotary JJ I-NP B-problem
component NN I-NP I-problem
. . B-VP O
   
She PRP O B-person
had VBD B-VP O
a DT O B-problem
mildly RB O I-problem
widened VBN O I-problem
right RB O I-problem
palpable JJ B-NP I-problem
fissure NN I-NP I-problem
. . B-VP O
   
There EX O O
was VBD B-VP O
decreased VBN O B-problem
excursion NN B-NP I-problem
of IN B-VP I-problem
the DT B-NP I-problem
right JJ I-NP I-problem
mouth NN I-NP I-problem
and CC O O
flattening NN B-NP B-problem
of IN B-VP I-problem
the DT B-NP I-problem
right JJ I-NP I-problem
nasolabial JJ I-NP I-problem
fold NN I-NP I-problem
( ( O I-problem
mild JJ O I-problem
) ) O I-problem
. . B-VP O
   
Light JJ B-NP O
touch NN I-NP O
was VBD B-VP O
subjectively RB O B-problem
abnormal JJ O I-problem
on IN B-VP O
both DT B-NP O
sides NNS I-NP O
of IN B-VP O
the DT B-NP O
face NN I-NP O
. . B-VP O
   
Hearing NNP B-NP O
was VBD B-VP O
diminished VBN O B-problem
for IN B-VP O
conversational JJ B-NP O
speech NN I-NP O
. . B-VP O
   
Palate NNP B-NP O
and CC O O
tongue NN B-NP O
moved VBD B-VP O
normally RB O O
in IN B-VP O
the DT B-NP O
midline NN I-NP O
. . B-VP O
   
There EX O O
was VBD B-VP O
a DT B-NP B-problem
mild JJ I-NP I-problem
left JJ I-NP I-problem
pronator NN I-NP I-problem
drift NN I-NP I-problem
. . B-VP O
   
Finger NNP B-NP B-test
tapping VBG O I-test
and CC O O
rapid JJ O B-test
alternating VBG O I-test
movements NNS B-NP I-test
were VBD B-VP O
slow JJ O B-problem
on IN B-VP I-problem
the DT B-NP I-problem
left NN I-NP I-problem
and CC O O
she PRP O B-person
had VBD B-VP O
trouble NN B-NP B-problem
isolating VBG O I-problem
individual JJ B-NP I-problem
finger NN I-NP I-problem
movements NNS I-NP I-problem
. . B-VP O
   
There EX O O
was VBD B-VP O
mild JJ B-NP B-problem
finger-to-nose JJ I-NP I-problem
dysmetria NN I-NP I-problem
on IN B-VP I-problem
the DT B-NP I-problem
left NN I-NP I-problem
. . B-VP O
   
Power NNP B-NP O
was VBD B-VP O
mildly RB O B-problem
diminished VBN O I-problem
in IN B-VP I-problem
the DT B-NP I-problem
finger NN I-NP I-problem
extensors NNS I-NP I-problem
and CC O O
hand NN B-NP O
intrinsics NNS I-NP O
on IN B-VP O
the DT B-NP O
left NN I-NP O
, , O O
otherwise RB O O
, , O O
power NN B-NP O
was VBD B-VP O
full JJ O O
throughout IN B-VP O
. . B-VP O
   
Reflexes NNS B-NP B-test
were VBD B-VP O
brisk VBN O O
in IN B-VP O
the DT B-NP O
legs NN I-NP O
with IN B-VP O
4-5 JJ B-NP O
beats NNS I-NP O
of IN B-VP O
clonus NN B-NP B-problem
at IN B-VP I-problem
the DT B-NP I-problem
ankles NNS I-NP I-problem
bilaterally RB O I-problem
. . B-VP O
   
She PRP O B-person
had VBD B-VP O
bilateral JJ B-NP B-problem
upgoing NN I-NP I-problem
toes NNS I-NP I-problem
. . B-VP O
   
She PRP O B-person
made VBD B-VP O
mistakes NNS B-NP B-problem
with IN B-VP I-problem
position NN B-NP I-problem
sense NN I-NP I-problem
, , O O
roughly RB O O
at IN B-VP O
chance NN B-NP O
level NN I-NP O
with IN B-VP O
both DT B-NP O
great JJ I-NP O
toes NNS I-NP O
and CC O O
the DT B-NP O
left NN I-NP O
first RB O O
finger NN B-NP O
, , O O
position NN B-NP O
sense NN I-NP O
in IN B-VP O
the DT B-NP O
right JJ I-NP O
limb NN I-NP O
seems VBZ O O
preserved VBN O O
. . B-VP O
   
Gait NNP B-NP O
was VBD B-VP O
wide JJ O B-problem
based VBN O I-problem
, , O O
very RB O B-problem
unsteady JJ O I-problem
, , O O
veering VBG O O
to TO O O
the DT B-NP O
left NN I-NP O
and CC O O
to TO O O
the DT B-NP O
right NN I-NP O
. . B-VP O
   
She PRP O B-person
retropulsed VBD B-VP B-problem
and CC O O
would MD O O
have VB O O
pitched VBN O O
backwards NNS B-NP O
without IN B-VP O
the DT B-NP O
assistance NN I-NP O
of IN B-VP O
the DT B-NP O
examiner NN I-NP O
. . B-VP O
   
LABORATORIES CC O O
: : O O
White NNP B-NP B-test
blood NN I-NP I-test
cell NN I-NP I-test
count NN I-NP I-test
7.8 CD O O
with IN B-VP O
86% CD O O
polymorphonuclear JJ B-NP B-test
cells NNS I-NP I-test
, , O O
11.1 CD O O
lymphocytes NNS B-NP B-test
, , O O
hemoglobin NN B-NP B-test
14.3 CD O O
, , O O
hematocrit NN B-NP B-test
40.5 CD O O
, , O O
MCV NNP B-NP B-test
88 CD O O
, , O O
INR NNP B-NP B-test
1.0 CD O O
, , O O
PTT NNP B-NP B-test
24.7 CD O O
, , O O
PT NNP B-NP B-test
12.3 CD O O
, , O O
platelet NN B-NP B-test
count NN I-NP I-test
295,000 CD O O
, , O O
glucose RB O B-test
81 CD O O
, , O O
BUN NNP B-NP B-test
15 CD O O
, , O O
creatinine NN B-NP B-test
0.8 CD O O
, , O O
sodium NN B-NP B-test
142 CD O O
, , O O
potassium NN B-NP B-test
4.2 CD O O
, , O O
chloride RB O B-test
104 CD O O
, , O O
CO2 NNP B-NP B-test
26 CD O O
, , O O
calcium NN B-NP B-test
9.3 CD O O
, , O O
phosphate NN B-NP B-test
4.8 CD O O
, , O O
magnesium NN B-NP B-test
2.3 CD O O
. . B-VP O
   
MRI NNP B-NP B-test
of IN B-VP I-test
the DT B-NP I-test
brain NN I-NP I-test
revealed VBD B-VP O
multiple JJ B-NP B-problem
foci JJ I-NP I-problem
susceptibility NN I-NP I-problem
artifact NN I-NP I-problem
within IN B-VP I-problem
the DT B-NP I-problem
brain NN I-NP I-problem
. . B-VP O
   
These DT O B-pronoun
were VBD B-VP O
seen VBN O O
best JJS O O
in IN B-VP O
gradient NN B-NP B-test
echocardiogram NN I-NP I-test
images NNS I-NP I-test
. . B-VP O
   
There EX O O
was VBD B-VP O
a DT B-NP O
large JJ I-NP O
focus NN I-NP O
of IN B-VP O
subacute JJ B-NP B-problem
blood NN I-NP I-problem
products NNS I-NP I-problem
in IN B-VP I-problem
the DT B-NP I-problem
mid NN I-NP I-problem
to TO O I-problem
low JJ B-NP I-problem
pons NNS I-NP I-problem
suggesting VBG O O
recent JJ B-NP B-problem
hemorrhage NN I-NP I-problem
into IN B-VP I-problem
a DT B-NP I-problem
cavernous JJ I-NP I-problem
angioma NN I-NP I-problem
. . B-VP O
   
There EX O O
was VBD B-VP O
some DT O B-problem
mild JJ O I-problem
surrounding VBG O I-problem
edema NN B-NP I-problem
. . B-VP O
   
There EX O O
are VBP O O
also RB O O
tiny JJ B-NP B-problem
foci NNS I-NP I-problem
artifact NN I-NP I-problem
within IN B-VP I-problem
the DT B-NP I-problem
cerebellum NN I-NP I-problem
and CC O I-problem
base NN B-NP I-problem
of IN B-VP I-problem
the DT B-NP I-problem
pons NNS I-NP I-problem
. . B-VP O
   
There EX O O
was VBD B-VP O
a DT B-NP O
larger JJR I-NP O
area NN I-NP O
of IN B-VP O
susceptibility NN B-NP B-problem
artifact NN I-NP I-problem
in IN B-VP I-problem
the DT B-NP I-problem
left JJ I-NP I-problem
temporal JJ I-NP I-problem
lobe NN I-NP I-problem
, , O I-problem
right JJ B-NP I-problem
frontal NN I-NP I-problem
lobe NN I-NP I-problem
, , O I-problem
and CC O I-problem
the DT B-NP I-problem
splenius NN I-NP I-problem
of IN B-VP I-problem
the DT B-NP I-problem
corpus NN I-NP I-problem
collasum NN I-NP I-problem
. . B-VP O
   
The DT B-NP O
brain NN I-NP O
parenchyma NN I-NP O
was VBD B-VP O
otherwise RB O O
normal JJ O O
. . B-VP O
   
There EX O O
was VBD B-VP O
mild JJ B-NP B-problem
enhancement NN I-NP I-problem
of IN B-VP I-problem
the DT B-NP I-problem
pontine NN I-NP I-problem
hemorrhagic JJ B-NP I-problem
mass NN I-NP I-problem
but CC O O
none NN B-NP O
elsewhere RB O O
. . B-VP O
   
There EX O O
was VBD B-VP O
no DT B-NP O
areas NNS I-NP B-problem
of IN B-VP I-problem
restricted JJ B-NP I-problem
diffusion NN I-NP I-problem
to TO O O
indicate VB O O
infarction NN B-NP B-problem
. . B-VP O
   
MRA NNP B-NP B-test
of IN B-VP I-test
the DT B-NP I-test
brain NN I-NP I-test
was VBD B-VP O
unremarkable JJ O O
. . B-VP O
   
There EX O O
was VBD B-VP O
no DT B-NP O
communication NN I-NP O
>.......< VBZ O O
in IN B-VP O
the DT B-NP O
visualized JJ I-NP O
vessels NNS I-NP O
and CC O O
the DT B-NP O
angiomas NN I-NP B-problem
. . B-VP O
   
Follow-up JJ B-NP B-test
CT NNP I-NP I-test
was VBD B-VP O
obtained VBN O O
the DT B-NP O
second JJ I-NP O
day NN I-NP O
of IN B-VP O
admission NN B-NP O
. . B-VP O
   
There EX O O
was VBD B-VP O
no DT B-NP O
evidence NN I-NP O
of IN B-VP O
developing VBG O B-problem
hydrocephalus NN B-NP I-problem
, , O O
which WDT O B-pronoun
was VBD B-VP O
a DT B-NP O
concern NN I-NP O
due JJ O O
to TO O O
the DT O B-problem
surrounding VBG O I-problem
edema NN B-NP I-problem
, , O O
and CC O O
possible JJ B-NP O
suppression NN I-NP B-problem
of IN B-VP I-problem
the DT B-NP I-problem
fourth JJ I-NP I-problem
ventricle NN I-NP I-problem
. . B-VP O
   
There EX O O
was VBD B-VP O
no DT B-NP O
significant JJ I-NP B-problem
change NN I-NP I-problem
in IN B-VP I-problem
size NN B-NP I-problem
of IN B-VP O
the DT B-NP B-problem
subacute JJ I-NP I-problem
pontine NN I-NP I-problem
hemorrhage NN I-NP I-problem
. . B-VP O
   
HOSPITAL NNP B-NP O
COURSE NNP I-NP O
: : O O
Mrs. NNP B-NP B-person
Wisniewski NNP I-NP I-person
is VBZ O O
a DT O O
45 CD O O
- : O O
year-old JJ B-NP O
woman NN I-NP O
with IN B-VP O
a DT B-NP O
strong JJ I-NP O
family NN I-NP O
history NN I-NP O
of IN B-VP O
cavernous JJ B-NP B-problem
angiomas NN I-NP I-problem
. . B-VP O
   
She PRP O B-person
has VBZ O O
had VBD B-VP O
several JJ O B-problem
prior RB O I-problem
bleeding VBG O I-problem
events NNS B-NP I-problem
and CC O O
presented VBN O O
with IN B-VP O
a DT B-NP B-problem
subacute NN I-NP I-problem
bleed NN I-NP I-problem
in IN B-VP I-problem
the DT B-NP I-problem
mid NN I-NP I-problem
to TO O I-problem
lower JJR B-NP I-problem
pons NNS I-NP I-problem
. . B-VP O
   
There EX O O
was VBD B-VP O
relatively RB O O
central JJ O O
in IN B-VP O
location NN B-NP O
, , O O
with IN B-VP O
only RB O O
a DT B-NP O
slight JJ I-NP O
right-sided JJ I-NP O
predominance NN I-NP O
. . B-VP O
   
Her PRP$ O B-person
Her PRP$ O B-test
physical JJ B-NP I-test
examination NN I-NP I-test
remained VBD B-VP O
relatively RB O O
unchanged JJ O O
, , O O
with IN B-VP O
resolution NN B-NP O
of IN B-VP O
the DT B-NP B-problem
subtle NN I-NP I-problem
left VBD B-VP I-problem
hand NN B-NP I-problem
weakness NN I-NP I-problem
and CC O O
right JJ B-NP B-problem
facial JJ I-NP I-problem
weakness NN I-NP I-problem
. . B-VP O
   
Her PRP$ O B-person
gait NN B-NP O
remained VBD B-VP O
severely RB O B-problem
ataxic JJ O I-problem
, , O O
likely JJ O O
secondary JJ O O
to TO O O
sensory JJ B-NP B-problem
deafferentation NN I-NP I-problem
, , O O
as RB O O
well RB O O
as IN B-VP O
involvement NN B-NP O
of IN B-VP O
crossing VBG O B-problem
pontine JJ B-NP I-problem
cerebellar JJ I-NP I-problem
fibers NNS I-NP I-problem
. . B-VP O
   
Therefore RB O O
, , O O
it PRP O B-pronoun
was VBD B-VP O
recommended VBN O O
that IN B-VP B-pronoun
she PRP O B-person
have VBP O O
aggressive JJ B-NP B-treatment
Physical NNP I-NP I-treatment
Therapy NNP I-NP I-treatment
at IN B-VP O
an DT B-NP O
Acute NNP I-NP O
Rehabilitation NNP I-NP O
Center NNP I-NP O
. . B-VP O
   
The DT B-NP O
case NN I-NP O
was VBD B-VP O
discussed VBN O O
with IN B-VP O
Dr. NNP B-NP B-person
Harold NNP I-NP I-person
from IN B-VP O
the DT B-NP O
Falmouth NNP I-NP O
Hospital NNP I-NP O
. . B-VP O
   
He PRP O B-person
has VBZ O O
followed VBN O O
this DT O B-pronoun
this DT B-NP B-person
family NN I-NP I-person
in IN B-VP O
the DT B-NP O
past NN I-NP O
and CC O O
will MD O O
see VB O O
her PRP$ O B-person
in IN B-VP O
follow-up JJ O O
. . B-VP O
   
We PRP O B-person
will MD O O
arrange VB O O
to TO O O
have VB O O
a DT B-NP O
copy NN I-NP O
of IN B-VP O
the DT B-NP B-test
MRI NNP I-NP I-test
scans VBZ O I-test
sent VBN O O
to TO O O
him PRP O B-person
. . B-VP O
   
DISCHARGE NNP B-NP O
DIAGNOSES NNP I-NP O
: : O O
1. CD O O
Familial NNP B-NP B-problem
cavernous JJ B-NP I-problem
hemangiomas NN I-NP I-problem
, , O O
status NN B-NP O
post NN I-NP O
a DT B-NP B-problem
subacute NN I-NP I-problem
pontine NN I-NP I-problem
hemorrhage NN I-NP I-problem
. . B-VP O
   
2. CD O O
Severe JJ B-NP B-problem
gait NN I-NP I-problem
ataxia NN I-NP I-problem
. . B-VP O
   
DISCHARGE NNP B-NP O
MEDICATIONS NNP I-NP O
: : O O
1. CD O O
Gabapentin NNP B-NP B-treatment
100 CD O O
mg NN B-NP O
po NN I-NP O
t.i.d. NN I-NP O
for IN B-VP O
paresthesias NN B-NP B-problem
. . B-VP O
   
2. CD O O
Colace NNP B-NP B-treatment
100 CD O O
mg NN B-NP O
po NN I-NP O
b.i.d. VBD B-VP O
3. CD O O
Zantac NNP B-NP B-treatment
150 CD O O
mg NN B-NP O
po NN I-NP O
b.i.d. VBD B-VP O
4. CD O O
Prednisone NNP B-NP B-treatment
taper NN I-NP I-treatment
completed VBN O O
. . B-VP O
   
Andre NNP B-NP B-person
R. NNP I-NP I-person
RATAN NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
23-397 CD O O
Dictated VBN O O
By IN B-VP O
: : O O
Maria NNP B-NP B-person
A NNP I-NP I-person
Singler NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
MEDQUIST36 NNP I-NP O
D NNP I-NP O
: : O O
2009-12-31 JJ O O
14:05 CD O O
T NN B-NP O
: : O O
2009-12-31 JJ O O
14:57 CD O O
JOB NNP B-NP O
#: VBD B-VP O
71678 CD O O
Signed VBN O O
electronically RB O O
by IN B-VP O
: : O O
DR. NNP B-NP B-person
Juan NNP I-NP I-person
R. NNP I-NP I-person
RATAN NNP I-NP I-person
on IN B-VP O
: : O O
TUE NNP B-NP O
2010-03-02 CD O O
8:13 CD O O
PM NNP B-NP O
( ( O O
End NNP B-NP O
of IN B-VP O
Report NNP B-NP O
) ) O O
-EMPTYLINE- VBP O O
-DOCSTART- JJ B-NP O
-EMPTYLINE- NNP I-NP O
Admission NNP I-NP O
Date: NNP I-NP O
2011-02-08 JJ B-NP O
Discharge NNP I-NP O
Date NNP I-NP O
: : O O
2011-02-14 JJ B-NP O
Date NNP I-NP O
of IN B-VP O
Birth NNP B-NP O
: : O O
1953-05-15 JJ B-NP O
Sex NN I-NP O
: : O O
M NNP B-NP O
Service NNP I-NP O
: : O O
CMED NNP B-NP O
HISTORY NNP I-NP O
OF IN B-VP O
THE NNP B-NP O
PRESENT NNP I-NP O
ILLNESS NNP I-NP O
: : O O
Briefly NN B-NP O
, , O O
this DT O B-pronoun
is VBZ O O
a DT B-NP O
57-year-old JJ I-NP O
gentleman NN I-NP O
with IN B-VP O
a DT B-NP O
history NN I-NP O
of IN B-VP O
COPD NNP B-NP B-problem
, , O O
status NN B-NP O
post NN I-NP O
intubation NN I-NP B-treatment
six CD O O
years NNS B-NP O
ago RB O O
but CC O O
not RB O O
on IN B-VP O
home NN B-NP B-treatment
02 CD O I-treatment
with IN B-VP O
recent JJ B-NP O
FEV1 NNP I-NP B-test
27% CD O O
of IN B-VP O
predicted VBN O O
value NN B-NP O
, , O O
and CC O O
FEV1/FVC NNP B-NP B-test
ratio VBP O I-test
56% CD O O
of IN B-VP O
hypercholesterolemia NN B-NP B-problem
, , O O
who WP O B-person
was VBD B-VP O
admitted VBN O O
for IN B-VP O
COPD NNP B-NP B-problem
exacerbation NN I-NP I-problem
and CC O O
worsening NN B-NP O
of IN B-VP O
upper JJ B-NP B-problem
respiratory NN I-NP I-problem
tract JJ B-NP I-problem
infection NN I-NP I-problem
symptoms NNS I-NP I-problem
for IN B-VP O
a DT B-NP O
week NN I-NP O
prior RB O O
to TO O O
admission NN B-NP O
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
afebrile JJ O B-problem
with IN B-VP O
stable JJ B-NP O
vital JJ I-NP O
signs NNS I-NP O
on IN B-VP O
presentation NN B-NP O
to TO O O
HOSPITAL NNP B-NP O
COURSE NNP I-NP O
: : O O
He PRP O B-person
was VBD B-VP O
started VBN O O
on IN B-VP O
p.o. NN B-NP B-treatment
steroids NNS I-NP I-treatment
and CC O O
to TO O O
CMED NNP B-NP O
for IN B-VP O
management NN B-NP B-treatment
of IN B-VP O
COPD NNP B-NP B-problem
exacerbation NN I-NP I-problem
but CC O O
he PRP O B-person
appeared VBD B-VP O
in IN B-VP O
more RBR O B-problem
respiratory JJ B-NP I-problem
distress NN I-NP I-problem
overnight NN I-NP O
and CC O O
was VBD B-VP O
started VBN O O
on IN B-VP O
IV NNP B-NP B-treatment
Solu-Medrol NNP I-NP I-treatment
and CC O O
more RBR O B-treatment
frequent JJ B-NP I-treatment
nebulizers NNS I-NP I-treatment
for IN B-VP O
COPD NNP B-NP B-problem
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
also RB O O
started VBN O O
on IN B-VP O
antibiotics NNS B-NP B-treatment
for IN B-VP O
possible JJ B-NP O
bronchitis NN I-NP B-problem
or CC O O
community-acquired JJ B-NP B-problem
pneumonia NN I-NP I-problem
. . B-VP O
   
Given VBN O O
his PRP$ O B-person
his PRP$ O B-problem
tenuous JJ B-NP I-problem
respiratory NN I-NP I-problem
status NN I-NP I-problem
, , O O
he PRP O B-person
was VBD B-VP O
transferred VBN O O
to TO O O
the DT B-NP O
FICU NNP I-NP O
with IN B-VP O
closer JJR B-NP B-test
observation NN I-NP I-test
. . B-VP O
   
He PRP O B-person
did VBD B-VP O
not RB O O
require VB O O
intubation NN B-NP B-treatment
and CC O O
improved VBN O O
with IN B-VP O
q. JJ O O
two CD O O
hour NN B-NP O
nebulizers NNS I-NP B-treatment
and CC O O
chest JJS B-NP B-treatment
PT NN I-NP I-treatment
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
again RB O O
transferred VBN O O
to TO O O
the DT B-NP O
CMED NNP I-NP O
Service NNP I-NP O
for IN B-VP O
further JJ B-NP B-treatment
management NN I-NP I-treatment
of IN B-VP O
his PRP$ O B-person
his PRP$ O B-problem
COPD NNP B-NP I-problem
exacerbation NN I-NP I-problem
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
continued VBN O O
on IN B-VP O
p.o. NN B-NP B-treatment
prednisone NN I-NP I-treatment
and CC O O
frequent JJ B-NP B-treatment
nebulizers NNS I-NP I-treatment
for IN B-VP O
COPD NNP B-NP B-problem
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
evaluated VBN O O
by IN B-VP O
the DT B-NP B-person
physical JJ I-NP I-person
therapist NN I-NP I-person
in IN B-VP O
the DT B-NP O
hospital NN I-NP O
and CC O O
was VBD B-VP O
found VBN O O
to TO O O
desaturate VB O B-problem
to TO O O
84% CD O O
with IN B-VP O
ambulating VBG O O
on IN B-VP O
room NN B-NP O
air NN I-NP O
. . B-VP O
   
Therefore NNP B-NP O
, , O O
home NN B-NP B-treatment
02 CD O I-treatment
was VBD B-VP O
recommended VBN O O
on IN B-VP O
discharge NN B-NP O
. . B-VP O
   
DISCHARGE NNP B-NP O
CONDITION NNP I-NP O
: : O O
Stable JJ O O
. . B-VP O
   
DISCHARGE JJ B-NP O
STATUS NNP I-NP O
: : O O
To TO O O
home NN B-NP O
. . B-VP O
   
DISCHARGE NNP B-NP O
DIAGNOSIS NNP I-NP O
: : O O
1. CD O O
Chronic NNP B-NP B-problem
obstructive JJ B-NP I-problem
pulmonary JJ I-NP I-problem
disease NN I-NP I-problem
exacerbation NN I-NP I-problem
. . B-VP O
   
2. CD O O
Bronchitis NNP B-NP B-problem
. . B-VP O
   
3. CD O O
Community-acquired JJ B-NP B-problem
pneumonia NN I-NP I-problem
. . B-VP O
   
4. CD O O
Rule NN B-NP O
out IN B-VP O
myocardial JJ B-NP B-problem
infarction NN I-NP I-problem
. . B-VP O
   
DISCHARGE NNP B-NP O
MEDICATIONS NNP I-NP O
: : O O
1. CD O O
Flovent NNP B-NP B-treatment
two CD O O
puffs NNS B-NP O
b.i.d. VBD B-VP O
2. CD O O
Levofloxacin NNP B-NP B-treatment
500 CD O O
mg NN B-NP O
p.o. NN I-NP O
q.d. NN I-NP O
for IN B-VP O
another DT O O
11 CD O O
days NNS B-NP O
for IN B-VP O
a DT B-NP O
total NN I-NP O
of IN B-VP O
a DT O O
14 CD O O
day NN B-NP O
course NN I-NP O
. . B-VP O
   
3. CD O O
Albuterol NNP B-NP B-treatment
inhaler NN I-NP I-treatment
one CD O O
to TO O O
two CD O O
puffs NNS B-NP O
q. RB O O
four CD O O
to TO O O
six CD O O
hours NNS B-NP O
p.r.n. VBP O O
4. CD O O
Aspirin NNP B-NP B-treatment
81 CD O O
mg NN B-NP O
p.o. NN I-NP O
q.d. VBD B-VP O
5. CD O O
Salmeterol NNP B-NP B-treatment
one CD O O
to TO O O
two CD O O
puffs NNS B-NP O
b.i.d. VBD B-VP O
6. CD O O
Oxygen NNP B-NP B-treatment
2 CD O I-treatment
liters NNS B-NP I-treatment
nasal JJ B-NP I-treatment
cannula NN I-NP I-treatment
with IN B-VP O
ambulating VBG O O
as IN B-VP O
needed VBN O O
. . B-VP O
   
7. CD O O
Prednisone NNP B-NP B-treatment
taper NN I-NP I-treatment
with IN B-VP O
40 CD O O
mg NNS B-NP O
p.o. JJ B-NP O
q.d. NNS I-NP O
for IN B-VP O
two CD O O
days NNS B-NP O
, , O O
30 CD O O
mg NN B-NP O
p.o. NN I-NP O
q.d. NN I-NP O
for IN B-VP O
two CD O O
days NNS B-NP O
, , O O
20 CD O O
mg NN B-NP O
p.o. NN I-NP O
q.d. NN I-NP O
for IN B-VP O
two CD O O
days NNS B-NP O
, , O O
10 CD O O
mg NN B-NP O
p.o. NN I-NP O
q.d. NN I-NP O
for IN B-VP O
two CD O O
days NNS B-NP O
. . B-VP O
   
DISCHARGE JJ O O
FOLLOW-UP JJ O O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
will MD O O
see VB O O
his PRP$ O B-person
his PRP$ O B-person
PCP NN B-NP I-person
in IN B-VP O
one CD O O
to TO O O
two CD O O
weeks NNS B-NP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
will MD O O
also RB O O
see VB O O
his PRP$ O B-person
his PRP$ O B-person
pulmonologist NN B-NP I-person
, , O O
Dr. NNP B-NP B-person
Daniel NNP I-NP I-person
Bell NNP I-NP I-person
, , O O
appointment NN B-NP O
was VBD B-VP O
made VBN O O
on IN B-VP O
discharge NN B-NP O
. . B-VP O
   
John NNP B-NP B-person
C NNP I-NP I-person
Stalnaker NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
35-693 CD O O
Dictated VBN O O
By IN B-VP O
: : O O
Margaret NNP B-NP B-person
BT NNP I-NP I-person
Mahaffey NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
MEDQUIST36 NNP I-NP O
D NNP I-NP O
: : O O
2011-02-19 JJ O O
10:21 CD O O
T NN B-NP O
: : O O
2011-02-21 JJ O O
18:42 CD O O
JOB NNP B-NP O
#: VBD B-VP O
74873 CD O O
Signed VBN O O
electronically RB O O
by IN B-VP O
: : O O
DR. NNP B-NP B-person
Kate NNP I-NP I-person
Gentry NNP I-NP I-person
on IN B-VP O
: : O O
MON NNP B-NP O
2011-03-07 CD O O
4:08 CD O O
PM NNP B-NP O
( ( O O
End NNP B-NP O
of IN B-VP O
Report NNP B-NP O
) ) O O
-EMPTYLINE- VBP O O
-DOCSTART- JJ O O
-EMPTYLINE- $ O O
655358166 CD O O
WGH NNP B-NP O
5367777 CD O O
33714 CD O O
8114836 CD O O
10/12/2004 CD O O
12:00:00 CD O O
AM NNP B-NP O
OB NNP I-NP O
Discharge NNP I-NP O
Summary NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Report NNP I-NP O
Status NNP I-NP O
: : O O
Signed VBD B-VP O
OB NNP B-NP O
EMR NNP I-NP O
L NNP I-NP O
and CC O O
D NNP B-NP O
DISCHARGE NNP I-NP O
SUMMARY NNP I-NP O
NAME NN I-NP O
: : O O
JUARISY NNP B-NP B-person
DUHESMITRE NNP I-NP I-person
UNIT NNP I-NP O
NUMBER NNP I-NP O
: : O O
683-54-33 JJ B-NP O
ADMISSION NNP I-NP O
DATE NNP I-NP O
: : O O
20041012 CD O O
DISCHARGE NNP B-NP O
DATE NNP I-NP O
: : O O
20041015 CD O O
PRINCIPAL NNP B-NP O
DISCHARGE NNP I-NP O
DIAGNOSIS NNP I-NP O
: : O O
Vaginal JJ B-NP B-treatment
Delivery NNP I-NP I-treatment
With IN B-VP O
Second NNP B-NP B-problem
Degree NNP I-NP I-problem
Laceration NNP I-NP I-problem
ASSOCIATED NNP I-NP O
DIAGNOSES NNP I-NP O
: : O O
Abnormal JJ B-NP B-problem
Pap NNP I-NP I-problem
Test NNP I-NP I-problem
, , O O
history NN B-NP O
of IN B-VP O
; : O O
Bacterial NNP B-NP B-problem
Vaginitis NNP I-NP I-problem
; : O O
Contraception NNP B-NP B-treatment
Management NNP I-NP I-treatment
; : O O
Hiv NNP B-NP O
Counseled VBD B-VP O
PRINCIPAL NNP B-NP O
PROCEDURE NNP I-NP O
OR NNP I-NP O
OPERATION NNP I-NP O
: : O O
Spontaneous JJ B-NP B-treatment
Vertex NNP I-NP I-treatment
Vaginal NNP I-NP I-treatment
Delivery NNP I-NP I-treatment
ASSOCIATED NNP I-NP O
PROCEDURES NNP I-NP O
OR NNP I-NP O
OPERATIONS NNP I-NP O
: : O O
POSTPARTUM NNP B-NP O
DIAGNOSTIC NNP I-NP O
PROCEDURES NNP I-NP O
: : O O
None NN B-NP O
OTHER NNP I-NP O
POSTPARTUM NNP I-NP O
THERAPIES NNP I-NP O
: : O O
Antimicrobial JJ B-NP B-treatment
Therapy NNP I-NP I-treatment
HISTORY NNP I-NP O
AND NNP I-NP O
REASON NNP I-NP O
FOR NNP I-NP O
HOSPITALIZATION NNP I-NP O
: : O O
Srom NN B-NP B-problem
In IN B-VP O
Labor NNP B-NP B-problem
PHYSICAL NNP I-NP O
EXAMINATION NNP I-NP O
: : O O
MOUTH NNP B-NP O
NORMAL NNP I-NP O
NECK NNP I-NP O
NORMAL NNP I-NP O
thyroid NN I-NP O
wnl NN I-NP O
BREASTS NNP I-NP O
NORMAL NNP I-NP O
no DT B-NP O
distinct JJ I-NP B-problem
masses NNS I-NP I-problem
NIPPLES NNP I-NP O
NORMAL NNP I-NP O
inverted VBD B-VP B-problem
[ NNP B-NP O
b NN I-NP O
] NN I-NP O
, , O O
evert JJ B-NP O
w NN I-NP O
/ NNP I-NP O
stimulation NN I-NP B-treatment
CHEST NNP I-NP O
NORMAL NNP I-NP O
LCTA NNP I-NP O
COR NNP I-NP O
NORMAL NNP I-NP O
RRR NNP I-NP O
ABDOMEN NNP I-NP O
NORMAL NNP I-NP O
gravid JJ B-NP O
EXTREM NNP I-NP O
NORMAL NNP I-NP O
SKIN NNP I-NP O
NORMAL NNP I-NP O
NODES NNP I-NP O
NORMAL NNP I-NP O
VULVA NNP I-NP O
NORMAL NNP I-NP O
no DT B-NP O
lesions NNS I-NP B-problem
, , O O
white JJ B-NP B-problem
d NN I-NP I-problem
/ NN I-NP I-problem
c NN I-NP I-problem
at IN B-VP I-problem
introitus JJ B-NP I-problem
VAGINA NNP I-NP O
NORMAL NNP I-NP O
sml VBD B-VP B-problem
amt RB O I-problem
thin JJ B-NP I-problem
white JJ I-NP I-problem
d NN I-NP I-problem
/ NNP I-NP I-problem
c VBZ O I-problem
ph JJ O B-test
4.5 CD O O
, , O O
koh FW O B-test
+amine NN B-NP O
, , O O
NS NNP B-NP B-test
+clue NNP I-NP O
, , O O
neg NN B-NP O
trich JJ B-NP B-test
CERVIX NNP I-NP O
NORMAL NNP I-NP O
1/100/0 CD O O
srom NN B-NP B-problem
clear JJ B-NP O
OS NNP I-NP O
NORMAL NNP I-NP O
closed VBD B-VP O
ADNEXAE NNP B-NP O
NORMAL NNP I-NP O
no DT B-NP O
palp NN I-NP B-problem
masses VBZ O I-problem
, , O O
NT NNP B-NP O
UTERUS NNP I-NP O
NORMAL NNP I-NP O
gravid JJ B-NP O
UTERINE NNP I-NP O
SIZE NNP I-NP O
IN NNP I-NP O
WEEKS NNP I-NP O
NORMAL NNP I-NP O
term NN I-NP O
RECTUM NNP I-NP O
NORMAL NNP I-NP O
no DT B-NP O
ext JJ I-NP B-problem
lesions NNS I-NP I-problem
HOSPITAL NNP I-NP O
COURSE NNP I-NP O
( ( O O
include VBP O O
complications NNS B-NP O
if IN B-VP O
any DT O O
) ) O O
: : O O
This DT O B-person
This DT O B-pronoun
21 CD O I-person
year NN B-NP I-person
old JJ B-NP I-person
Gravida NNP I-NP I-person
2 CD O I-person
Para NNP B-NP I-person
0010 CD O I-person
was VBD B-VP O
admitted VBN O O
to TO O O
the DT B-NP O
Life NNP I-NP O
Valley NNP I-NP O
Medical NNP I-NP O
Center NNP I-NP O
Obstetrical NNP I-NP O
service NN I-NP O
on IN B-VP O
10/12/2004 CD O O
at IN B-VP O
08:41 CD O O
am VBP O O
for IN B-VP O
the DT B-NP O
indication NN I-NP O
( ( O O
s JJ O O
) ) O O
: : O O
srom NN B-NP B-problem
in IN B-VP O
labor NN B-NP B-problem
. . B-VP O
   
She PRP O B-person
delivered VBD B-VP O
a DT O B-person
3680 CD O I-person
gram NN B-NP I-person
male NN I-NP I-person
infant NN I-NP I-person
on IN B-VP O
10/12/2004 CD O O
at IN B-VP O
10:17 CD O O
pm NN B-NP O
with IN B-VP O
apgar JJ B-NP B-test
scores NNS I-NP I-test
of IN B-VP O
9 CD O O
and CC O O
9 CD O O
at IN B-VP O
one CD O O
and CC O O
five CD O O
minutes NNS B-NP O
respectively RB O O
at IN B-VP O
40.0 CD O O
weeks NNS B-NP O
gestation NN I-NP O
via IN B-VP O
spontaneous JJ O B-treatment
vertex FW O I-treatment
vaginal JJ B-NP I-treatment
delivery NN I-NP I-treatment
. . B-VP O
   
During IN B-VP O
her PRP$ O B-person
her PRP$ O B-problem
labor NN B-NP I-problem
she PRP O B-person
encountered VBD B-VP O
the DT B-NP O
following JJ I-NP O
complication NN I-NP O
( ( O O
s JJ O O
) ) O O
: : O O
srom NN B-NP B-problem
. . B-VP O
   
During IN B-VP O
her PRP$ O B-person
her PRP$ O B-treatment
delivery NN B-NP I-treatment
she PRP O B-person
encountered VBD B-VP O
the DT B-NP O
following JJ I-NP O
complication NN I-NP O
( ( O O
s JJ O O
) ) O O
: : O O
none NN B-NP O
. . B-VP O
   
Postpartum NNP B-NP O
she PRP O B-person
encountered VBD B-VP O
the DT B-NP O
following JJ I-NP O
complication NN I-NP O
( ( O O
s JJ O O
) ) O O
: : O O
none NN B-NP O
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
discharged VBN O O
on IN B-VP O
10/15/2004 CD O O
at IN B-VP O
01:52 CD O O
pm NN B-NP O
in IN B-VP O
good JJ B-NP O
condition NN I-NP O
. . B-VP O
   
DISCHARGE NNP B-NP O
ACTIVITY NNP I-NP O
: : O O
No DT B-NP O
Restrictions NNP I-NP O
DISCHARGE NNP I-NP O
DIET NNP I-NP O
: : O O
No DT B-NP O
Restrictions NNP I-NP O
POSTPARTUM NNP I-NP O
DISPOSITION NNP I-NP O
: : O O
Home NN B-NP O
Under IN B-VP O
Care NNP B-NP O
Of IN B-VP O
Home NNP B-NP O
Health NNP I-NP O
Agency NNP I-NP O
POSTPARTUM NNP I-NP O
CARE NNP I-NP O
SITE NNP I-NP O
: : O O
Alle NNP B-NP O
Rehabilitation NNP I-NP O
Hospital NNP I-NP O
POSTPARTUM NNP I-NP O
RETURN NNP I-NP O
APPOINTMENT NNP I-NP O
( ( O O
DAYS NNP B-NP O
) ) O O
: : O O
42 CD O O
BREAST NNP B-NP O
FEEDING NN I-NP O
AT NNP I-NP O
DISCHARGE NNP I-NP O
: : O O
Yes PRP$ O O
MEDICATION NNP B-NP O
( ( O O
S NNP B-NP O
) ) O O
ON NNP B-NP O
DISCHARGE NNP I-NP O
: : O O
Metronidazole JJ B-NP B-treatment
Tablets NNS I-NP I-treatment
( ( O I-treatment
Flagyl NNP B-NP I-treatment
) ) O I-treatment
; : O O
Multivitamins NNP B-NP B-treatment
And CC O I-treatment
Folate NNP B-NP I-treatment
Capsules NNP I-NP I-treatment
( ( O I-treatment
Stuart NNP B-NP I-treatment
Prenatal NNP I-NP I-treatment
With IN B-VP I-treatment
Folate NNP B-NP I-treatment
) ) O I-treatment
Electronically RB O O
Signed VBN O O
: : O O
Thorerogodlethrelf PRP O B-person
, , O I-person
Cisperna NNP B-NP I-person
M NNP I-NP I-person
10/17/2004 CD O O
6:01:02 CD O O
PM NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
Admission NNP I-NP O
Date NNP I-NP O
: : O O
2017-08-14 JJ B-NP O
Discharge NN I-NP O
Date NNP I-NP O
: : O O
2017-08-23 JJ B-NP O
Date NNP I-NP O
of IN B-VP O
Birth NNP B-NP O
: : O O
1943-08-23 JJ B-NP O
Sex NN I-NP O
: : O O
M NNP B-NP O
Service NNP I-NP O
: : O O
MEDICINE JJ B-NP O
Allergies NNS I-NP O
: : O O
Sulfonamides NNS B-NP B-treatment
Attending VBG O B-person
: : O O
Marcus NNP B-NP B-person
W. NNP I-NP I-person
Kelley NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
Chief NNP I-NP O
Complaint NNP I-NP O
: : O O
Transfer NN B-NP O
from IN B-VP O
Athol NNP B-NP O
Memorial NNP I-NP O
Hospital NNP I-NP O
for IN B-VP O
acute NN B-NP O
on IN B-VP O
chronic JJ B-NP B-problem
respiratory NN I-NP I-problem
distress NN I-NP I-problem
. . B-VP O
   
Major JJ O O
Surgical JJ O O
or CC O O
Invasive JJ B-NP O
Procedure NN I-NP O
: : O O
Lumbar NNP B-NP B-test
puncture NN I-NP I-test
on IN B-VP O
08-16 JJ B-NP O
History NNP I-NP O
of IN B-VP O
Present NNP B-NP O
Illness NNP I-NP O
: : O O
Mr. NNP B-NP B-person
Lockley NNP I-NP I-person
is VBZ O O
a DT O O
73 CD O O
yo NN B-NP O
male NN I-NP O
with IN B-VP O
a DT O O
complicated VBN O O
past JJ B-NP O
medical JJ I-NP O
history NN I-NP O
, , O O
recently RB O O
discharged VBN O O
from IN B-VP O
St. NNP B-NP O
Margaret NNP I-NP O
's POS O O
Center NNP B-NP O
for IN B-VP O
Women NNP B-NP O
& CC O O
Infants NNP B-NP O
on IN B-VP O
08-02 NNP B-NP O
following VBG O O
a DT B-NP O
prolonged JJ I-NP O
admission NN I-NP O
for IN B-VP O
STEMI NNP B-NP B-problem
, , O O
respiratory JJ B-NP B-problem
failure NN I-NP I-problem
felt VBD B-VP O
secondary JJ O O
to TO O O
pulmonary JJ B-NP B-problem
edema NN I-NP I-problem
requiring VBG O O
intubation NN B-NP O
and CC O O
subsequent JJ B-NP B-treatment
tracheostomy NN I-NP I-treatment
02-22 JJ B-NP O
failure NN I-NP B-problem
to TO O I-problem
wean VB O I-problem
, , O O
sepsis NN B-NP B-problem
and CC O O
C.difficile NNP B-NP B-problem
colitis NN I-NP I-problem
treated VBD B-VP O
with IN B-VP O
Vancomycin NNP B-NP B-treatment
and CC O O
Flagyl NNP B-NP B-treatment
with IN B-VP O
a DT B-NP O
course NN I-NP O
of IN B-VP O
Levophed NNP B-NP B-treatment
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
discharged VBN O O
to TO O O
Athol NNP B-NP O
Memorial NNP I-NP O
Hospital NNP I-NP O
for IN B-VP O
continued JJ B-NP B-treatment
weaning NN I-NP I-treatment
. . B-VP O
   
Per NNP B-NP O
Dr. NNP I-NP O
John NNP I-NP O
C. NNP I-NP O
Corrigan NNP I-NP O
Mental NNP I-NP O
Health NNP I-NP O
Center NNP I-NP O
, , O O
patient NN B-NP B-person
remained VBD B-VP O
ventilator JJ B-NP B-problem
dependent NN I-NP I-problem
, , O O
intermittently RB O O
on IN B-VP O
PS NNP B-NP B-treatment
20/5 CD O O
and CC O O
back RB O O
on IN B-VP O
AC NNP B-NP B-treatment
15/5/500/0.35 CD O O
on IN B-VP O
08-08 NN B-NP O
. . B-VP O
   
At IN B-VP O
OSH NNP B-NP O
, , O O
sputum NN B-NP B-test
cultures NNS I-NP I-test
grew VBD B-VP O
Pseudomonas NNP B-NP B-problem
and CC O O
MRSA NNP B-NP B-problem
, , O O
and CC O O
he PRP O B-person
was VBD B-VP O
restarted VBN O O
on IN B-VP O
Zosyn NNP B-NP B-treatment
( ( O O
08-08 JJ O O
) ) O O
and CC O O
Vancomycin NNP B-NP B-treatment
( ( O O
08-09 JJ B-NP O
). NN I-NP O
He PRP O B-person
completed VBD B-VP O
his PRP$ O B-person
course NN B-NP O
of IN B-VP O
Vancomycin NNP B-NP B-treatment
on IN B-VP O
2017-08-10 JJ O O
. . B-VP O
   
However RB O O
, , O O
today NN B-NP O
around IN B-VP O
17:45 CD O O
, , O O
while IN B-VP O
being VBG O O
moved VBN O O
by IN B-VP O
the DT B-NP O
nursing NN I-NP O
staff NN I-NP O
, , O O
Mr. NNP B-NP B-person
Lockley NNP I-NP I-person
Bosche NNP I-NP I-person
started VBD B-VP O
coughing VBG O B-problem
. . B-VP O
   
Suctioned VBN O O
X JJ O O
1 CD O O
, , O O
mucus NN B-NP O
not RB O O
cleared VBN O O
. . B-VP O
   
He PRP O B-person
then RB O O
became VBD B-VP O
dusky JJ O B-problem
and CC O O
cyanotic JJ O B-problem
, , O O
and CC O O
stopped VBD B-VP B-problem
breathing VBG O I-problem
on IN B-VP O
his PRP$ O B-person
own JJ O O
. . B-VP O
   
A DT B-NP O
code NN I-NP O
was VBD B-VP O
called VBN O O
, , O O
+ NNP B-NP O
pulse RB O B-test
. . B-VP O
   
Patient NN B-NP B-person
placed VBD B-VP O
on IN B-VP O
FiO2 NNP B-NP B-treatment
100% CD O O
. . B-VP O
   
Vitals NNS B-NP B-test
reportedly RB O O
HR NNP B-NP B-test
88-98 CD O O
, , O O
BP NNP B-NP B-test
150/80 CD O O
. . B-VP O
   
ABG NNP B-NP B-test
done VBN O O
on IN B-VP O
FiO2 NNP B-NP B-treatment
100% CD O O
7.36/66/417/98% CD O O
. . B-VP O
   
At IN B-VP O
Vencor NNP B-NP O
Hospital NNP I-NP O
, , O O
BP NNP B-NP B-problem
dropped VBD B-VP I-problem
to TO O O
90 CD O O
, , O O
and CC O O
patient NN B-NP B-person
was VBD B-VP O
started VBN O O
on IN B-VP O
NS NNP B-NP B-treatment
IVF NNP I-NP I-treatment
, , O O
with IN B-VP O
improvement NN B-NP O
in IN B-VP O
BP NNP B-NP B-test
. . B-VP O
   
EKG NNP B-NP B-test
without IN B-VP O
acute JJ B-NP B-problem
changes NNS I-NP I-problem
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
transferred VBN O O
to TO O O
St. NNP B-NP O
Margaret NNP I-NP O
's POS O O
Center NNP B-NP O
for IN B-VP O
Women NNP B-NP O
& CC O O
Infants NNP B-NP O
John NNP I-NP O
for IN B-VP O
further JJ B-NP B-treatment
management NN I-NP I-treatment
on IN B-VP O
AC NNP B-NP B-treatment
, , O O
RR NNP B-NP B-treatment
15 CD O O
, , O O
PEEP NNP B-NP B-treatment
5 CD O O
, , O O
Vt NNP B-NP B-treatment
500 CD O O
, , O O
Fi02 NNP B-NP B-treatment
1.0 CD O O
. . B-VP O
   
In IN B-VP O
John NNP B-NP O
, , O O
BP NNP B-NP B-test
80/60 CD O O
, , O O
HR NNP B-NP B-test
80 CD O O
. . B-VP O
   
Continued VBN O O
on IN B-VP O
IVF NNP B-NP B-treatment
( ( O O
received VBN O O
total JJ O O
2300 CD O O
cc NN B-NP O
) ) O O
, , O O
with IN B-VP O
improved JJ B-NP O
BP NNP I-NP B-test
to TO O O
SBP NNP B-NP B-test
105-118 JJ O O
. . B-VP O
   
Stool NNP B-NP B-test
sent VBD B-VP O
for IN B-VP O
C.diff NNP B-NP B-problem
and CC O O
given VBN O O
Flagyl NNP B-NP B-treatment
500 CD O O
mg NN B-NP O
PO NNP I-NP O
X NNP I-NP O
1 CD O O
dose NN B-NP O
. . B-VP O
   
Past NNP B-NP O
Medical JJ B-NP O
History NN I-NP O
: : O O
1. CD O O
Non-small NN B-NP B-problem
cell NN I-NP I-problem
lung NN I-NP I-problem
cancer NN I-NP I-problem
s/p NN I-NP O
XRT NNP I-NP B-treatment
and CC O O
chemotherapy NN B-NP B-treatment
in IN B-VP O
French JJ B-NP O
Guiana NNP I-NP O
, , O O
s/p RB O O
right JJ B-NP B-treatment
pneumonectomy NN I-NP I-treatment
in IN B-VP O
2016-09-21 JJ O O
for IN B-VP O
recurrence NN B-NP B-problem
. . B-VP O
   
Chronic NNP B-NP B-problem
left VBD B-VP I-problem
pleural JJ B-NP I-problem
effusion NN I-NP I-problem
. . B-VP O
   
2. CD O O
SSS NNP B-NP B-problem
status NN I-NP O
post NN I-NP O
PM/ICD NNP I-NP B-treatment
placement NN I-NP I-treatment
3. CD O O
COPD/bronchiectasis NNP B-NP B-problem
4. CD O O
Hypertension NNP B-NP B-problem
5. CD O O
CAD NNP B-NP B-problem
, , O O
with IN B-VP O
known VBN O O
TO NNP B-NP O
RCA NNP I-NP O
. . B-VP O
   
6. CD O O
CHF NNP B-NP B-problem
with IN B-VP O
EF NNP B-NP B-test
25% CD O O
on IN B-VP O
last JJ B-NP B-test
echo NN I-NP I-test
on IN B-VP O
2017-07-19 JJ O O
7. CD O O
BPH NNP B-NP B-problem
8. CD O O
Depression NNP B-NP B-problem
9. CD O O
Left NNP B-NP B-problem
femoral JJ B-NP I-problem
AV NNP I-NP I-problem
fistula VBD B-VP I-problem
2017-04-19 JJ O O
10. CD O O
Recent JJ B-NP B-problem
MRSA NNP I-NP I-problem
pneumonia NN I-NP I-problem
and CC O O
sepsis NN B-NP B-problem
2017-07-21 JJ O O
, , O O
treated VBN O O
with IN B-VP O
Vancomycin NNP B-NP B-treatment
11. CD O O
C. NNP B-NP B-problem
difficile NN I-NP I-problem
colitis NN I-NP I-problem
treated VBN O O
with IN B-VP O
Flagyl NNP B-NP B-treatment
( ( O O
completed VBN O O
08-10 NN B-NP O
) ) O O
12. CD O O
Status NNP B-NP O
post NN I-NP O
PEG NNP I-NP B-treatment
tube NN I-NP I-treatment
placement NN I-NP I-treatment
2017-07-21 JJ O O
13. CD O O
Status NNP B-NP O
post NN I-NP O
tracheostomy NN I-NP B-treatment
2017-07-21 JJ B-NP O
02-22 JJ I-NP O
failure NN I-NP B-problem
to TO O I-problem
wean VB O I-problem
14. CD O O
Status NNP B-NP O
post NN I-NP O
partial JJ B-NP B-treatment
colectomy NN I-NP I-treatment
1972 CD O O
Social NNP B-NP O
History NNP I-NP O
: : O O
Son NN B-NP B-person
is VBZ O O
next JJ O O
of IN B-VP O
kin NN B-NP O
. . B-VP O
   
See VB O O
below IN B-VP O
for IN B-VP O
contact NN B-NP O
information NN I-NP O
. . B-VP O
   
He PRP O B-person
has VBZ O O
been VBN O O
living VBG O O
at IN B-VP O
The DT B-NP O
Cooley NNP I-NP O
Dickinson NNP I-NP O
Hospital NNP I-NP O
House NNP I-NP O
since IN B-VP O
2017-08-02 JJ O O
. . B-VP O
   
Per NNP B-NP O
Dr. NNP I-NP O
John NNP I-NP O
C. NNP I-NP O
Corrigan NNP I-NP O
Mental NNP I-NP O
Health NNP I-NP O
Center NNP I-NP O
, , O O
at IN B-VP O
baseline NN B-NP O
, , O O
patient NN B-NP B-person
not RB O O
interactive JJ O O
. . B-VP O
   
Opens VBZ O O
eyes NNS B-NP O
spontaneously RB O O
, , O O
withdraws NNS B-NP O
to TO O O
painful JJ B-NP B-test
stimulus NN I-NP I-test
. . B-VP O
   
Family JJ B-NP B-person
History NN I-NP O
: : O O
Non-contributory JJ B-NP O
Physical NNP I-NP O
Exam NNP I-NP O
: : O O
PHYSICAL NNP B-NP O
EXAM NNP I-NP O
on IN B-VP O
admission NN B-NP O
: : O O
VITALS NN B-NP O
: : O O
BP NNP B-NP B-test
90s-118/47-59 CD O O
, , O O
HR NNP B-NP B-test
80-90s CD O O
. . B-VP O
   
Vent NN B-NP B-treatment
: : O O
AC NNP B-NP B-treatment
, , O O
RR NNP B-NP B-treatment
15 CD O O
, , O O
PEEP NNP B-NP B-treatment
5 CD O O
, , O O
Vt NNP B-NP B-treatment
500 CD O O
cc NN B-NP O
, , O O
FiO2 NNP B-NP B-treatment
1.0 CD O O
. . B-VP O
   
GEN NN B-NP O
: : O O
Intubated VBN O B-treatment
, , O O
opens VBZ O O
eyes NNS B-NP O
, , O O
responds VBZ O O
to TO O O
painful JJ B-NP B-test
stimulus NN I-NP I-test
. . B-VP O
   
HEENT NN B-NP O
: : O O
Pupils NNP B-NP B-problem
minimally RB O I-problem
reactive VBP O I-problem
. . B-VP O
   
Sclera NNP B-NP B-problem
anicteric NN I-NP I-problem
. . B-VP O
   
NECK NN B-NP O
: : O O
Unable JJ O O
to TO O O
assess VB O O
JVP NNP B-NP B-test
. . B-VP O
   
RESP NNP B-NP O
: : O O
Bronchial JJ B-NP B-problem
breathing NN I-NP I-problem
over IN B-VP I-problem
right JJ B-NP I-problem
hemithorax NN I-NP I-problem
. . B-VP O
   
Ronchorous JJ B-NP B-problem
breath NN I-NP I-problem
sounds VBZ O I-problem
left JJ B-NP I-problem
chest NN I-NP I-problem
. . B-VP O
   
Limited JJ B-NP B-test
examination NN I-NP I-test
. . B-VP O
   
CVS NN B-NP O
: : O O
RRR NNP B-NP O
. . B-VP O
   
Normal NNP B-NP O
S1 NNP I-NP O
, , O O
S2 NNP B-NP O
. . B-VP O
   
+ NN B-NP O
S4 NNP I-NP B-problem
. . B-VP O
   
No NNP B-NP O
murmur NN I-NP B-problem
appreciated VBD B-VP O
. . B-VP O
   
GI NNP B-NP O
: : O O
PEG NN B-NP B-treatment
in IN B-VP O
place NN B-NP O
, , O O
site NN B-NP O
without IN B-VP O
drainage NN B-NP B-problem
. . B-VP O
   
BS NNP B-NP O
present JJ O O
, , O O
hypoactive JJ O B-problem
. . B-VP O
   
Abdomen NNP B-NP O
soft JJ O O
. . B-VP O
   
No DT O O
grimacing VBG O B-problem
with IN B-VP O
palpation NN B-NP B-test
. . B-VP O
   
CMED NN B-NP O
: : O O
Foley NNP B-NP B-treatment
in IN B-VP O
place NN B-NP O
. . B-VP O
   
EXT NN B-NP O
: : O O
2+ CD O B-problem
edema IN B-VP I-problem
both DT B-NP I-problem
upper JJ I-NP I-problem
extremities NNS I-NP I-problem
, , O O
sacral JJ B-NP B-problem
edema NN I-NP I-problem
. . B-VP O
   
Cool NNP B-NP B-problem
extremities NNS I-NP I-problem
. . B-VP O
   
Good JJ B-NP O
pedal NN I-NP O
pulses VBZ O O
peripherally RB O O
. . B-VP O
   
NEURO NN B-NP O
: : O O
Limited JJ B-NP B-test
examination NN I-NP I-test
. . B-VP O
   
Withdraws UH O O
to TO O O
painful JJ B-NP B-test
stimulus NN I-NP I-test
. . B-VP O
   
Moves VBZ O O
all DT O O
4 CD O O
extremities NNS B-NP O
. . B-VP O
   
Pertinent JJ B-NP O
Results NNS I-NP O
: : O O
LABS NN B-NP O
: : O O
WBC NNP B-NP B-test
- : O O
4.9 CD O O
RBC NNP B-NP B-test
- : O O
2.92 CD O O
* NN B-NP O
HGB NNP I-NP B-test
- : O O
8.8 CD O O
* NN B-NP O
HCT NNP I-NP B-test
- : O O
26.2 CD O O
* NN B-NP O
MCV NNP I-NP B-test
- : O O
90 CD O O
MCH NNP B-NP B-test
- : O O
30.1 CD O O
MCHC NNP B-NP B-test
- : O O
33.5 CD O O
RDW NNP B-NP B-test
- : O O
18.5 CD O O
* NN B-NP O
NEUTS NNP I-NP B-test
- : O O
86.5 CD O O
* NN B-NP O
LYMPHS NNP I-NP B-test
- : O O
7.5 CD O O
* JJ B-NP O
MONOS NNP I-NP B-test
- : O O
4.7 CD O O
EOS NNP B-NP B-test
- : O O
1.2 CD O O
BASOS NNP B-NP B-test
- : O O
0.1 CD O O
PLT NNP B-NP B-test
COUNT NNP I-NP I-test
- : O O
145 CD O O
* NN B-NP O
GLUCOSE NNP I-NP B-test
- : O O
91 CD O O
UREA NNP B-NP B-test
N NNP I-NP I-test
- : O O
21 CD O O
* NN B-NP O
CREAT NNP I-NP B-test
- : O O
0.6 CD O O
SODIUM NNP B-NP B-test
- : O O
143 CD O O
POTASSIUM NNP B-NP B-test
- : O O
4.2 CD O O
CHLORIDE NNP B-NP B-test
- : O O
106 CD O O
TOTAL NNP B-NP B-test
CO2 NNP I-NP I-test
- : O O
32 CD O O
ANION NNP B-NP B-test
GAP NNP I-NP I-test
- : O O
9 CD O O
LACTATE NNP B-NP B-test
- : O O
1.4 CD O O
K+ NNP B-NP B-test
- : O O
3.9 CD O O
ABG NN B-NP B-test
: : O O
2017-08-14 JJ O O
07:30 CD O O
PM NNP B-NP O
TYPE NNP I-NP O
- : O O
ART NNP B-NP B-test
PO2 NNP I-NP I-test
- : O O
468 CD O O
* NN B-NP O
PCO2 NNP I-NP B-test
- : O O
44 CD O O
PH NNP B-NP B-test
- : O O
7.50 CD O O
* JJ B-NP O
TOTAL NNP I-NP B-test
CO2 NNP I-NP I-test
- : O O
36 CD O O
* JJ B-NP O
BASE NNP I-NP B-test
XS NNP I-NP I-test
- : O O
10 CD O O
INTUBATED NNP B-NP B-treatment
- : O O
INTUBATED NNP B-NP B-treatment
EKG NNP I-NP B-test
( ( O O
at IN B-VP O
Athol NNP B-NP O
Memorial NNP I-NP O
Hospital NNP I-NP O
, , O O
17:11 CD O O
) ) O O
: : O O
Atrial JJ B-NP B-problem
fibrillation NN I-NP I-problem
, , O O
occasional JJ B-NP B-treatment
V-paced NNP I-NP I-treatment
, , O O
rate NN B-NP B-test
74 CD O O
. . B-VP O
   
Normal JJ B-NP O
axis NN I-NP O
. . B-VP O
   
Old NNP B-NP B-problem
TWI NNP I-NP I-problem
V4-6 NNP I-NP I-problem
. . B-VP O
   
EKG NNP B-NP B-test
in IN B-VP O
John NNP B-NP O
: : O O
Afib NNP B-NP B-problem
, , O O
occasional JJ B-NP B-treatment
V-paced NNP I-NP I-treatment
, , O O
rate NN B-NP B-test
83 CD O O
bpm NN B-NP O
. . B-VP O
   
Normal JJ B-NP O
axis NN I-NP O
. . B-VP O
   
Long NNP B-NP B-problem
QT NNP I-NP I-problem
interval NN I-NP I-problem
( ( O O
QTc NNP B-NP B-test
462 CD O O
ms NN B-NP O
). NNP I-NP O
ST NNP I-NP B-problem
depressions NNS I-NP I-problem
V4 NNP I-NP I-problem
, , O I-problem
5 CD O I-problem
. . B-VP O
   
Mild NNP B-NP B-problem
ST NNP I-NP I-problem
elevation NN I-NP I-problem
in IN B-VP I-problem
V3 NNP B-NP I-problem
. . B-VP O
   
Old NNP B-NP B-problem
TWI NNP I-NP I-problem
V4-6 NNP I-NP I-problem
. . B-VP O
   
**************** NN B-NP O
IMAGING NN I-NP O
: : O O
2017-08-14 JJ B-NP O
CXR NN I-NP B-test
: : O O
ETT NN B-NP B-treatment
in IN B-VP O
correct JJ B-NP O
position NN I-NP O
. . B-VP O
   
PM NNP B-NP B-treatment
wires VBZ O I-treatment
in IN B-VP O
good JJ B-NP O
position NN I-NP O
. . B-VP O
   
S/p NNP B-NP O
right JJ B-NP B-treatment
pneumonectomy NN I-NP I-treatment
. . B-VP O
   
Blunting NNP B-NP B-problem
of IN B-VP I-problem
left NN B-NP I-problem
CPA NNP I-NP I-problem
likely JJ B-NP O
effusion NN I-NP B-problem
. . B-VP O
   
New NNP B-NP B-problem
lower JJR O I-problem
left VBD B-VP I-problem
lateral JJ B-NP I-problem
CW NNP I-NP I-problem
opacity NN I-NP I-problem
, , O O
likely RB O O
loculated JJ B-NP B-problem
pleural JJ I-NP I-problem
fluid NN I-NP I-problem
. . B-VP O
   
2017-07-19 JJ B-NP O
ECHO NN I-NP B-test
: : O O
Left-to-right JJ B-NP B-problem
shunt NN I-NP I-problem
across IN B-VP I-problem
the DT B-NP I-problem
interatrial JJ I-NP I-problem
septum NN I-NP I-problem
. . B-VP O
   
LVEF NNP B-NP B-test
25% CD O O
. . B-VP O
   
Resting VBG O B-test
WMA NNP B-NP I-test
include VBP O O
mid NN B-NP B-problem
to TO O I-problem
distal JJ B-NP I-problem
septal JJ I-NP I-problem
akinesis NN I-NP I-problem
, , O O
apical JJ B-NP B-problem
akinesis NN I-NP I-problem
, , O O
inferior JJ B-NP B-problem
akinesis/hypokinesis NN I-NP I-problem
, , O O
and CC O O
mid NN B-NP B-problem
to TO O I-problem
distal JJ B-NP I-problem
anterolateral JJ I-NP I-problem
hypokinesis NN I-NP I-problem
/ JJ B-NP O
akinesis NN I-NP B-problem
. . B-VP O
   
No DT B-NP O
definite JJ I-NP O
apical JJ I-NP B-problem
thrombus NN I-NP I-problem
seen VBN O O
( ( O O
cannot JJ B-NP O
exclude NN I-NP O
). NNP I-NP O
01-22+ JJ B-NP O
AR NNP I-NP B-problem
. . B-VP O
   
Trivial NNP B-NP B-problem
MR NNP I-NP I-problem
. . B-VP O
   
1+ CD O O
TR NNP B-NP B-problem
. . B-VP O
   
2017-08-16 JJ B-NP O
CT NNP I-NP B-test
head NN I-NP I-test
: : O O
New NNP B-NP B-problem
rounded VBD B-VP I-problem
low-density JJ B-NP I-problem
area NN I-NP I-problem
measuring VBG O O
2.5 CD O O
cm NN B-NP O
in IN B-VP O
left JJ B-NP O
basal NN I-NP O
ganglia NNS I-NP O
, , O O
which WDT O B-pronoun
partially RB O O
extends VBZ O O
to TO O O
the DT B-NP O
left NN I-NP O
thalamus NN I-NP O
, , O O
probably RB O O
representing VBG O O
subacute JJ B-NP B-problem
infarction NN I-NP I-problem
. . B-VP O
   
On IN B-VP O
this DT O B-pronoun
this DT B-NP B-test
head NN I-NP I-test
CT NNP I-NP I-test
without IN B-VP O
contrast NN B-NP O
, , O O
the DT B-NP B-test
evaluation NN I-NP I-test
is VBZ O O
limited VBN O O
. . B-VP O
   
2017-08-16 JJ B-NP O
CTA NNP I-NP B-test
chest NN I-NP I-test
: : O O
No DT B-NP O
evidence NN I-NP O
for IN B-VP O
pulmonary JJ B-NP B-problem
embolism NN I-NP I-problem
. . B-VP O
   
Findings NNS B-NP O
consistent JJ O O
with IN B-VP O
failure NN B-NP B-problem
or CC O O
fluid NN B-NP B-problem
overload NN I-NP I-problem
. . B-VP O
   
Development NNP B-NP O
of IN B-VP O
small JJ B-NP B-problem
loculated JJ I-NP I-problem
pleural JJ I-NP I-problem
fluid NN I-NP I-problem
collection NN I-NP I-problem
along IN B-VP I-problem
the DT B-NP I-problem
periphery NN I-NP I-problem
of IN B-VP O
the DT B-NP O
left NN I-NP O
major JJ B-NP O
fissure NN I-NP O
or CC O O
so-called JJ B-NP O
pseudotumor NN I-NP O
, , O O
consistent JJ O O
with IN B-VP O
the DT B-NP B-test
recent JJ I-NP I-test
chest NN I-NP I-test
x-ray NN I-NP I-test
. . B-VP O
   
Unchanged VBN O O
appearance NN B-NP O
of IN B-VP O
right JJ B-NP B-treatment
pneumonectomy NN I-NP I-treatment
. . B-VP O
   
2017-08-16 JJ B-NP O
ECHO NN I-NP B-test
: : O O
The DT B-NP O
left JJ I-NP O
atrium NN I-NP O
is VBZ O O
normal JJ O O
in IN B-VP O
size NN B-NP O
. . B-VP O
   
Overall JJ B-NP B-test
LVEF NNP I-NP I-test
is VBZ O O
difficult JJ O O
to TO O O
assess VB O O
due JJ O O
to TO O O
poor JJ B-NP O
echo JJ I-NP B-test
windows NNS I-NP I-test
although IN B-VP O
the DT B-NP B-test
basal NN I-NP I-test
LV NNP I-NP I-test
appeas RB O O
hyperdynamic VBZ O B-problem
without IN B-VP O
regional JJ B-NP B-problem
contraction NN I-NP I-problem
abnormality NN I-NP I-problem
( ( O O
suspect JJ B-NP O
significant JJ I-NP O
improvement NN I-NP O
compared VBN O O
to TO O O
prior VB O B-test
study NN B-NP I-test
dated VBN O O
2017-07-18 CD O O
). JJ B-NP O
No NNP I-NP O
masses NNS I-NP B-problem
or CC O O
thrombi NNS B-NP B-problem
are VBP O O
seen VBN O O
in IN B-VP O
the DT B-NP O
left JJ I-NP O
ventricle NN I-NP O
( ( O O
due JJ O O
to TO O O
poor JJ B-NP O
echo JJ I-NP B-test
windows NNS I-NP I-test
cannot VBP O O
fully RB O O
exclude VBP O O
). PDT O O
The DT O O
ascending VBG O O
aorta NN B-NP O
is VBZ O O
mildly RB O B-problem
dilated VBN O I-problem
. . B-VP O
   
There EX O O
is VBZ O O
no DT B-NP O
aortic JJ I-NP B-problem
valve NN I-NP I-problem
stenosis NN I-NP I-problem
. . B-VP O
   
Mild NNP B-NP B-problem
( ( O I-problem
1+ CD O I-problem
) ) O I-problem
aortic JJ B-NP I-problem
regurgitation NN I-NP I-problem
is VBZ O O
seen VBN O O
. . B-VP O
   
Trivial JJ B-NP B-problem
mitral JJ I-NP I-problem
regurgitation NN I-NP I-problem
is VBZ O O
seen VBN O O
. . B-VP O
   
The DT B-NP B-test
left JJ I-NP I-test
ventricular JJ I-NP I-test
inflow NN I-NP I-test
pattern NN I-NP I-test
suggests VBZ O O
impaired JJ B-NP B-problem
relaxation NN I-NP I-problem
. . B-VP O
   
There EX O O
is VBZ O O
a DT B-NP B-problem
small JJ I-NP I-problem
pericardial JJ I-NP I-problem
effusion NN I-NP I-problem
. . B-VP O
   
There EX O O
are VBP O O
no DT B-NP O
echocardiographic JJ I-NP B-test
signs NNS I-NP I-test
of IN B-VP O
tamponade JJ B-NP B-problem
2017-08-17 JJ I-NP O
EEG NN I-NP B-test
: : O O
Markedly RB O B-problem
abnormal JJ B-NP I-problem
portable JJ I-NP I-problem
EEG NNS I-NP I-problem
due JJ O O
to TO O O
the DT B-NP B-problem
voltage NN I-NP I-problem
suppression NN I-NP I-problem
over IN B-VP I-problem
the DT B-NP I-problem
left NN I-NP I-problem
hemisphere NN I-NP I-problem
and CC O O
due JJ O O
to TO O O
the DT B-NP B-problem
bursts NNS I-NP I-problem
of IN B-VP I-problem
generalized JJ B-NP I-problem
slowing NN I-NP I-problem
and CC O O
right NN B-NP B-problem
hemisphere RB O I-problem
slowing VBG O I-problem
. . B-VP O
   
The DT B-NP B-problem
first JJ I-NP I-problem
abnormality NN I-NP I-problem
raises VBZ O O
the DT B-NP O
possibility NN I-NP O
of IN B-VP O
material NN B-NP B-problem
( ( O I-problem
such JJ O I-problem
as IN B-VP I-problem
subdural JJ B-NP I-problem
fluid NN I-NP I-problem
) ) O I-problem
interposed VBD B-VP I-problem
between IN B-VP I-problem
the DT B-NP I-problem
brain NN I-NP I-problem
and CC O O
recording VBG O O
electrodes NNS B-NP O
or CC O O
widespread JJ B-NP B-problem
cortical JJ I-NP I-problem
dysfunction NN I-NP I-problem
on IN B-VP I-problem
that IN B-VP B-pronoun
that DT B-NP I-problem
side NN I-NP I-problem
. . B-VP O
   
Anatomic JJ B-NP O
correlation NN I-NP O
would MD O O
be VB O O
of IN B-VP O
interest NN B-NP O
if IN B-VP O
clinically RB O O
indicated VBN O O
. . B-VP O
   
The DT B-NP B-problem
generalized JJ I-NP I-problem
slowing NN I-NP I-problem
indicates VBZ O O
a DT B-NP B-problem
non NN I-NP I-problem
specific JJ B-NP I-problem
dysfunction NN I-NP I-problem
in IN B-VP I-problem
midline JJ B-NP I-problem
structures NNS I-NP I-problem
. . B-VP O
   
There EX O O
was VBD B-VP O
also RB O O
evidence NN B-NP O
of IN B-VP O
subcortical JJ B-NP B-problem
dysfunction NN I-NP I-problem
on IN B-VP I-problem
the DT B-NP I-problem
right JJ I-NP I-problem
side NN I-NP I-problem
. . B-VP O
   
No DT B-NP O
epileptiform NN I-NP B-problem
features NNS I-NP I-problem
were VBD B-VP O
seen VBN O O
. . B-VP O
   
MICRO NNP B-NP O
DATA NNP I-NP O
: : O O
2017-08-17 JJ B-NP O
STOOL NNP I-NP B-test
CLOSTRIDIUM NNP I-NP I-test
DIFFICILE NNP I-NP I-test
TOXIN NNP I-NP I-test
ASSAY NNP I-NP I-test
- : O O
PENDING VBD B-VP O
2017-08-16 JJ B-NP O
CSF NNP I-NP O
; : O O
SPINAL NNP B-NP B-test
FLUID NNP I-NP I-test
GRAM NNP I-NP I-test
STAIN NNP I-NP I-test
- : O O
neg NN B-NP O
FLUID NNP I-NP B-test
CULTURE NNP I-NP I-test
- : O O
neg NN B-NP O
; : O O
FUNGAL NNP B-NP B-test
CULTURE NNP I-NP I-test
- : O O
PENDING NN B-NP O
; : O O
ACID NNP B-NP B-test
FAST NNP I-NP I-test
CULTURE NNP I-NP I-test
- : O O
PENDING NN B-NP O
; : O O
VIRAL NNP B-NP B-test
CULTURE NNP I-NP I-test
- : O O
PENDING NN B-NP O
2017-08-15 JJ B-NP O
SPUTUM NNP I-NP B-test
CULTURE NNP I-NP I-test
- : O O
PRELIMINARY NNP B-NP O
{ ( O O
PSEUDOMONAS NNP B-NP B-problem
AERUGINOSA NNP I-NP I-problem
} ) O O
2017-08-15 JJ B-NP O
BLOOD NNP I-NP B-test
CULTURE NNP I-NP I-test
NGTD NNP I-NP O
2017-08-15 JJ B-NP O
URINE NNP I-NP B-test
CULTURE NNP I-NP I-test
- : O O
FINAL NNP B-NP O
2017-08-15 CD O O
BLOOD NNP B-NP B-test
CULTURE NNP I-NP I-test
NGTD NNP I-NP O
Brief NNP I-NP O
Hospital NNP I-NP O
Course NNP I-NP O
: : O O
Mr. NNP B-NP B-person
Lockley NNP I-NP I-person
was VBD B-VP O
admitted VBN O O
with IN B-VP O
respiratory JJ B-NP B-problem
failure NN I-NP I-problem
, , O O
thought VBN O O
to TO O O
be VB O O
related VBN O O
to TO O O
mucus VB O B-problem
plugging NN B-NP I-problem
as RB O O
well RB O O
as IN B-VP O
a DT B-NP B-problem
pseudomonal JJ I-NP I-problem
pneumonia NN I-NP I-problem
. . B-VP O
   
Both DT O O
of IN B-VP O
these DT B-NP B-pronoun
etiologies NNS I-NP O
were VBD B-VP O
treated VBN O O
, , O O
and CC O O
he PRP O B-person
continued VBD B-VP O
to TO O O
oxygenate VB O O
and CC O O
ventilate VB O O
well RB O O
on IN B-VP O
his PRP$ O B-person
his PRP$ O B-treatment
usual JJ B-NP I-treatment
ventilator NN I-NP I-treatment
settings NNS I-NP I-treatment
. . B-VP O
   
However RB O O
, , O O
the DT B-NP O
issue NN I-NP O
that WDT O B-pronoun
dominated VBD B-VP O
the DT B-NP O
admission NN I-NP O
was VBD B-VP O
his PRP$ O B-person
his PRP$ O B-problem
recent JJ B-NP I-problem
acute JJ I-NP I-problem
decline NN I-NP I-problem
in IN B-VP I-problem
mental JJ B-NP I-problem
status NN I-NP I-problem
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
thoroughly RB O O
evaluated VBN O O
by IN B-VP O
neurology NN B-NP B-person
and CC O O
underwent JJ B-NP O
head NN I-NP B-test
CT NNP I-NP I-test
, , O O
MRI NNP B-NP B-test
, , O O
LP NNP B-NP B-test
, , O O
and CC O O
EEG NNP B-NP B-test
. . B-VP O
   
This DT O B-test
This DT O B-pronoun
work-up JJ O I-test
demonstrated VBD B-VP O
a DT B-NP B-problem
small JJ I-NP I-problem
left NN I-NP I-problem
basal NN I-NP I-problem
ganglia JJ B-NP I-problem
infarct NN I-NP I-problem
, , O O
likely JJ B-NP O
cardioembolic NN I-NP B-problem
. . B-VP O
   
However RB O O
, , O O
they PRP O B-pronoun
felt VBD B-VP O
this DT B-NP B-pronoun
event NN I-NP O
could MD O O
not RB O O
account VB O O
for IN B-VP O
his PRP$ O B-person
his PRP$ O B-problem
new JJ O I-problem
, , O I-problem
severe JJ B-NP I-problem
global JJ I-NP I-problem
deficit NN I-NP I-problem
; : O O
this DT O B-pronoun
was VBD B-VP O
thought VBN O O
to TO O O
be VB O O
secondary JJ O O
to TO O O
a DT O B-problem
more RBR O I-problem
pervasive JJ B-NP I-problem
process NN I-NP I-problem
, , O O
likely RB O O
anoxic JJ B-NP B-problem
encephalopathy NNS I-NP I-problem
, , O O
for IN B-VP O
which WDT O B-pronoun
the DT B-NP O
prognosis NN I-NP O
is VBZ O O
extremely RB O O
grim JJ O O
. . B-VP O
   
This DT O B-pronoun
was VBD B-VP O
discussed VBN O O
at IN B-VP O
length NN B-NP O
in IN B-VP O
several JJ B-NP O
family NN I-NP B-person
meetings NNS I-NP O
involving VBG O O
the DT O B-person
the DT B-NP B-person
patient JJ I-NP I-person
patient NN I-NP I-person
's POS O I-person
wife NN B-NP I-person
, , O O
son NN B-NP B-person
, , O O
primary JJ B-NP B-person
care NN I-NP I-person
doctor NN I-NP I-person
, , O O
ICU NNP B-NP B-person
attending NN I-NP I-person
, , O O
and CC O O
neurology NN B-NP B-person
consultant NN I-NP I-person
in IN B-VP O
the DT B-NP O
presence NN I-NP O
of IN B-VP O
a DT B-NP B-person
Asian JJ I-NP I-person
interpreter NN I-NP I-person
. . B-VP O
   
The DT B-NP O
end NN I-NP O
result NN I-NP O
of IN B-VP O
these DT B-NP B-pronoun
discussion NN I-NP O
was VBD B-VP O
that IN B-VP B-pronoun
the DT B-NP B-person
patient NN I-NP I-person
's POS O O
wishes NNS B-NP O
would MD O O
not RB O O
be VB O O
consistent JJ O O
with IN B-VP O
this DT B-NP B-pronoun
new JJ I-NP O
level NN I-NP O
of IN B-VP O
functioning VBG O O
from IN B-VP O
which WDT O B-pronoun
he PRP O B-person
had VBD B-VP O
little JJ B-NP O
hope NN I-NP O
of IN B-VP O
recovery NN B-NP O
; : O O
the DT B-NP B-person
family NN I-NP I-person
decided VBD B-VP O
to TO O O
make VB O O
him PRP O B-person
comfort VB O B-treatment
measures NNS B-NP I-treatment
only RB O I-treatment
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
disconnected VBN O O
from IN B-VP O
the DT B-NP B-treatment
ventilator NN I-NP I-treatment
and CC O O
all DT B-NP B-treatment
medications NNS I-NP I-treatment
beyond IN B-VP O
a DT B-NP B-treatment
morphine JJ I-NP I-treatment
drip NN I-NP I-treatment
were VBD B-VP O
stopped VBN O O
, , O O
and CC O O
he PRP O B-person
expired VBD B-VP O
shortly RB O O
thereafter RB O O
. . B-VP O
   
The DT B-NP B-person
family NN I-NP I-person
was VBD B-VP O
present JJ O O
. . B-VP O
   
Medications NNS B-NP O
on IN B-VP O
Admission NN B-NP O
: : O O
Jevity NN B-NP B-treatment
1.2 CD O O
65 CD O O
mL NN B-NP O
/ FW O O
hour NN B-NP O
continuous JJ O O
with IN B-VP O
water NN B-NP O
240 CD O O
cc NN B-NP O
q NN I-NP O
8 CD O O
hours NNS B-NP O
Lasix NNP I-NP B-treatment
40 CD O O
mg NN B-NP O
IV NNP I-NP O
QAM NNP I-NP O
( ( O O
given VBN O O
08-14 NN B-NP O
) ) O O
Vancomycin VBZ O B-treatment
1 CD O O
gm NN B-NP O
IV NNP I-NP O
q VBZ O O
36 CD O O
hours NNS B-NP O
( ( O O
last JJ B-NP O
dose NN I-NP O
at IN B-VP O
2000 CD O O
on IN B-VP O
08-13 NN B-NP O
) ) O O
. . B-VP O
   
Started VBN O O
on IN B-VP O
08-09 NN B-NP O
) ) O O
ASA NNP B-NP B-treatment
325 CD O O
mg NN B-NP O
PO NNP I-NP O
QD NNP I-NP O
Lansoprazole NNP I-NP B-treatment
30 CD O O
mg NN B-NP O
PO NNP I-NP O
QAM NNP I-NP O
Heparin NNP I-NP B-treatment
5000 CD O O
units NNS B-NP O
SC NNP I-NP O
TID NNP I-NP O
Zosyn NNP I-NP B-treatment
4.5 CD O O
gm NN B-NP O
IV NNP I-NP O
q VBZ O O
8 CD O O
hours NNS B-NP O
( ( O O
last JJ B-NP O
dose NN I-NP O
on IN B-VP O
08-14 NN B-NP O
at IN B-VP O
1400 CD O O
) ) O O
, , O O
started VBD B-VP O
08-08 NN B-NP O
. . B-VP O
   
Metoprolol NNP B-NP B-treatment
37.5 CD O O
mg NN B-NP O
q NN I-NP O
12 CD O O
hours NNS B-NP O
( ( O O
last JJ B-NP O
dose NN I-NP O
07/25 CD O O
in IN B-VP O
AM NNP B-NP O
) ) O O
Protein NNP B-NP B-treatment
/ NNP I-NP I-treatment
Soy NNP I-NP I-treatment
supplement VBD B-VP I-treatment
2 CD O O
scoops NNS B-NP O
q RB O O
12 CD O O
hours NNS B-NP O
Ipratropium NNP I-NP B-treatment
/ NNP I-NP O
Albuterol NNP I-NP B-treatment
inhaler VBZ O I-treatment
4 CD O O
puffs NNS B-NP O
QID NNP I-NP O
Completed NNP I-NP O
course NN I-NP O
of IN B-VP O
Flagyl NNP B-NP B-treatment
07-25 JJ B-NP O
--> NNP I-NP O
08-10 NN I-NP O
. . B-VP O
   
Discharge NNP B-NP O
Disposition NNP I-NP O
: : O O
Expired NNP B-NP O
Discharge NNP I-NP O
Diagnosis NNP I-NP O
: : O O
Anoxic NNP B-NP B-problem
encephalopathy VBZ O I-problem
Acute NNP B-NP B-problem
respiratory NN I-NP I-problem
failure NN I-NP I-problem
Chronic NNP I-NP B-problem
respiratory NN I-NP I-problem
failure NN I-NP I-problem
Pseudomonal NNP I-NP B-problem
pneumonia NN I-NP I-problem
Volume NN I-NP B-problem
overload NN I-NP I-problem
Chronic NNP I-NP B-problem
obstructive JJ B-NP I-problem
pulmonary JJ I-NP I-problem
disease NN I-NP I-problem
Bronchiectasis NNP I-NP B-problem
Hyponatremia NNP I-NP B-problem
Anemia NNP I-NP B-problem
of IN B-VP I-problem
chronic JJ B-NP I-problem
disease NN I-NP I-problem
Secondary NNP I-NP O
: : O O
1. CD O O
Non-small NN B-NP B-problem
cell NN I-NP I-problem
lung NN I-NP I-problem
cancer NN I-NP I-problem
s/p NN I-NP O
XRT NNP I-NP B-treatment
and CC O O
chemotherapy NN B-NP B-treatment
in IN B-VP O
Western JJ B-NP O
Sahara NNP I-NP O
, , O O
s/p RB O O
right JJ B-NP B-treatment
pneumonectomy NN I-NP I-treatment
in IN B-VP O
2016-09-21 JJ O O
for IN B-VP O
recurrence NN B-NP B-problem
. . B-VP O
   
Chronic NNP B-NP B-problem
left VBD B-VP I-problem
pleural JJ B-NP I-problem
effusion NN I-NP I-problem
. . B-VP O
   
2. CD O O
Sick NNP B-NP B-problem
Sinus NNP I-NP I-problem
Syndrome NNP I-NP I-problem
status NN I-NP O
post NN I-NP O
PM/ICD NNP I-NP B-treatment
placement NN I-NP I-treatment
3. CD O O
COPD/bronchiectasis NNP B-NP B-problem
4. CD O O
Hypertension NNP B-NP B-problem
5. CD O O
CAD NNP B-NP B-problem
, , O O
with IN B-VP O
known VBN O O
TO NNP B-NP O
RCA NNP I-NP O
. . B-VP O
   
6. CD O O
CHF NNP B-NP B-problem
with IN B-VP O
EF NNP B-NP B-test
25% CD O O
on IN B-VP O
last JJ B-NP B-test
echo NN I-NP I-test
on IN B-VP O
2017-07-19 JJ O O
7. CD O O
BPH NNP B-NP B-problem
8. CD O O
Depression NNP B-NP B-problem
9. CD O O
Left NNP B-NP B-problem
femoral JJ B-NP I-problem
AV NNP I-NP I-problem
fistula VBD B-VP I-problem
2017-04-19 JJ O O
10. CD O O
Recent JJ B-NP B-problem
MRSA NNP I-NP I-problem
pneumonia NN I-NP I-problem
and CC O O
sepsis NN B-NP B-problem
2017-07-21 JJ O O
, , O O
treated VBN O O
with IN B-VP O
Vancomycin NNP B-NP B-treatment
11. CD O O
C. NNP B-NP B-problem
difficile NN I-NP I-problem
colitis NN I-NP I-problem
treated VBN O O
with IN B-VP O
Flagyl NNP B-NP B-treatment
( ( O O
completed VBN O O
08-10 NN B-NP O
) ) O O
12. CD O O
Status NNP B-NP O
post NN I-NP O
PEG NNP I-NP B-treatment
tube NN I-NP I-treatment
placement NN I-NP I-treatment
2017-07-21 JJ O O
13. CD O O
Status NNP B-NP O
post NN I-NP O
tracheostomy NN I-NP B-treatment
2017-07-21 JJ B-NP O
02-22 JJ I-NP O
failure NN I-NP B-problem
to TO O I-problem
wean VB O I-problem
14. CD O O
Status NNP B-NP O
post NN I-NP O
partial JJ B-NP B-treatment
colectomy NN I-NP I-treatment
1972 CD O O
Discharge NNP B-NP O
Condition NNP I-NP O
: : O O
Expired VBD B-VP O
Johnnie NNP B-NP B-person
Callez NNP I-NP I-person
MD NNP I-NP I-person
61-750 JJ O O
Completed VBN O O
by IN B-VP O
: : O O
Opal NNP B-NP B-person
Anne NNP I-NP I-person
MD NNP I-NP I-person
40-158 JJ O O
2017-08-23 CD O O
@ JJ O O
2054 CD O O
Signed VBN O O
electronically RB O O
by IN B-VP O
: : O O
DR. NNP B-NP B-person
Teresa NNP I-NP I-person
Loper NNP I-NP I-person
on IN B-VP O
: : O O
FRI NNP B-NP O
2017-09-22 CD O O
4:29 CD O O
PM NNP B-NP O
( ( O O
End NNP B-NP O
of IN B-VP O
Report NNP B-NP O
) ) O O
-EMPTYLINE- VBP O O
-DOCSTART- JJ O O
-EMPTYLINE- $ O O
126304158 CD O O
PRGH NNP B-NP O
30872450 CD O O
619542 CD O O
2/10/1998 CD O O
12:00:00 CD O O
AM NNP B-NP O
CORONARY NNP I-NP B-problem
ARTERY NNP I-NP I-problem
DISEASE NNP I-NP I-problem
Unsigned VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date NNP I-NP O
: : O O
02/10/1998 CD O O
Report NNP B-NP O
Status NNP I-NP O
: : O O
Unsigned VBN O O
Discharge NNP B-NP O
Date NNP I-NP O
: : O O
02/26/1998 CD O O
HISTORY NNP B-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
is VBZ O O
a DT B-NP O
69 JJ I-NP O
year-old JJ I-NP O
white JJ I-NP O
gentleman NN I-NP O
who WP O B-person
is VBZ O O
status NN B-NP O
post NN I-NP O
a DT B-NP B-treatment
coronary JJ I-NP I-treatment
artery NN I-NP I-treatment
bypass NN I-NP I-treatment
graft NN I-NP I-treatment
in IN B-VP O
1985 CD O O
with IN B-VP O
a DT B-NP B-problem
large JJ I-NP I-problem
anterior JJ I-NP I-problem
septal JJ I-NP I-problem
myocardial JJ I-NP I-problem
infarction NN I-NP I-problem
intraoperatively RB O O
. . B-VP O
   
Two CD O O
years NNS B-NP O
after IN B-VP O
this DT B-NP B-treatment
operation NN I-NP I-treatment
, , O O
he PRP O B-person
required VBD B-VP O
a DT B-NP B-treatment
pacer NN I-NP I-treatment
implantation NN I-NP I-treatment
for IN B-VP O
sick JJ B-NP B-problem
sinus NN I-NP I-problem
syndrome NN I-NP I-problem
. . B-VP O
   
The DT B-NP B-person
patient JJ I-NP I-person
presents NNS I-NP O
now RB O O
with IN B-VP O
progressive JJ B-NP B-problem
dyspnea NN I-NP I-problem
, , O O
but CC O O
no DT B-NP O
anginal JJ I-NP B-problem
pain NN I-NP I-problem
. . B-VP O
   
Ejection NNP B-NP B-test
fraction NN I-NP I-test
was VBD B-VP O
noted VBN O O
to TO O O
be VB O O
20% CD O O
. . B-VP O
   
He PRP O B-person
is VBZ O O
status NN B-NP O
post NN I-NP O
multiple NN I-NP B-treatment
angioplasty JJ B-NP I-treatment
stents NNS I-NP I-treatment
. . B-VP O
   
He PRP O B-person
presents VBZ O O
now RB O O
for IN B-VP O
possible JJ B-NP O
reoperative JJ I-NP B-treatment
coronary JJ I-NP I-treatment
artery NN I-NP I-treatment
bypass NN I-NP I-treatment
graft NN I-NP I-treatment
. . B-VP O
   
PAST NNP B-NP O
MEDICAL NNP I-NP O
HISTORY NNP I-NP O
: : O O
1 CD O O
) ) O O
Non-insulin NNP B-NP B-problem
dependent NN I-NP I-problem
diabetes VBZ O I-problem
mellitus NN B-NP I-problem
. . B-VP O
   
2 CD O O
) ) O O
Coronary JJ B-NP B-problem
artery NN I-NP I-problem
disease NN I-NP I-problem
, , O O
status NN B-NP O
post NN I-NP O
coronary JJ B-NP B-treatment
artery NN I-NP I-treatment
bypass NN I-NP I-treatment
graft NN I-NP I-treatment
, , O O
status NN B-NP O
post NN I-NP O
anterior RB O B-problem
myocardial JJ B-NP I-problem
infarction NN I-NP I-problem
, , O O
sick JJ B-NP B-problem
sinus NN I-NP I-problem
syndrome NN I-NP I-problem
, , O O
status NN B-NP O
post NN I-NP O
a DT B-NP B-treatment
VVI NNP I-NP I-treatment
pacer NN I-NP I-treatment
placement NN I-NP I-treatment
. . B-VP O
   
Cardiac NNP B-NP B-test
catheterization NN I-NP I-test
demonstrates VBZ O O
severe JJ B-NP B-problem
triple JJ I-NP I-problem
vessel NN I-NP I-problem
coronary JJ B-NP I-problem
artery NN I-NP I-problem
disease NN I-NP I-problem
, , O O
RCA NNP B-NP B-problem
100% CD O I-problem
occluded VBD B-VP I-problem
, , O O
saphenous JJ B-NP B-treatment
vein NN I-NP I-treatment
graft NN I-NP I-treatment
to TO O O
OM1 NNP B-NP B-treatment
graft NN I-NP I-treatment
was VBD B-VP O
100% CD O B-problem
occluded JJ O I-problem
and CC O O
a DT B-NP O
patent NN I-NP O
LIMA NNP I-NP O
, , O O
but CC O O
severely RB O B-problem
diseased JJ B-NP I-problem
LAD NNP I-NP I-problem
. . B-VP O
   
MEDICATIONS NNP B-NP O
ON NNP I-NP O
ADMISSION NNP I-NP O
: : O O
1 CD O O
) ) O O
Enteric NNP B-NP B-treatment
coated VBD B-VP I-treatment
aspirin RB O I-treatment
325 CD O O
mg NNS B-NP O
p.o. JJ B-NP O
q. JJ I-NP O
day NN I-NP O
. . B-VP O
   
2 CD O O
) ) O O
Capoten NNP B-NP B-treatment
25 CD O O
mg NN B-NP O
p.o. NN I-NP O
t.i.d. IN B-VP O
3 CD O O
) ) O O
Lanoxin NN B-NP B-treatment
0.25 CD O O
mg NN B-NP O
p.o. NN I-NP O
q. JJ B-NP O
day NN I-NP O
. . B-VP O
   
4 CD O O
) ) O O
Cardizem NNP B-NP B-treatment
125 CD O O
mg NN B-NP O
p.o. NN I-NP O
q. JJ B-NP O
day NN I-NP O
. . B-VP O
   
5 CD O O
) ) O O
Glucotrol NNP B-NP B-treatment
XL $ O I-treatment
10 CD O O
mg NN B-NP O
p.o. NN I-NP O
b.i.d. IN B-VP O
6 CD O O
) ) O O
Glucophage NN B-NP B-treatment
500 CD O O
mg NN B-NP O
p.o. NN I-NP O
q. JJ B-NP O
day NN I-NP O
. . B-VP O
   
7 CD O O
) ) O O
Amaryl $ O B-treatment
2 CD O O
mg NN B-NP O
p.o. NN I-NP O
q.h.s. JJ B-NP O
PHYSICAL NNP I-NP O
EXAMINATION NN I-NP O
: : O O
Physical JJ B-NP B-test
examination NN I-NP I-test
revealed VBD B-VP O
that IN B-VP B-pronoun
the DT B-NP B-test
vital JJ I-NP I-test
signs NNS I-NP I-test
were VBD B-VP O
stable JJ O O
. . B-VP O
   
Lungs NNS B-NP O
were VBD B-VP O
clear JJ O O
to TO O O
auscultation VB O B-test
bilaterally RB O O
. . B-VP O
   
Heart NNP B-NP O
was VBD B-VP O
irregular JJ O B-problem
with IN B-VP O
no DT B-NP O
murmurs NN I-NP B-problem
palpated VBD B-VP O
. . B-VP O
   
Abdomen NNP B-NP O
was VBD B-VP O
benign JJ O O
. . B-VP O
   
Pulses NNS B-NP B-test
were VBD B-VP O
2+ CD O O
throughout IN B-VP O
. . B-VP O
   
HOSPITAL NNP B-NP O
COURSE NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
admitted VBN O O
to TO O O
the DT B-NP O
Verg NNP I-NP O
Medical NNP I-NP O
Center NNP I-NP O
. . B-VP O
   
Subsequent NNP B-NP B-test
exercise NN I-NP I-test
treadmill NN I-NP I-test
test NN I-NP I-test
demonstrated VBD B-VP O
no DT B-NP O
evidence NN I-NP O
of IN B-VP O
ischemia NN B-NP B-problem
by IN B-VP O
EKG NNP B-NP B-test
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
subsequently RB O O
taken VBN O O
to TO O O
the DT B-NP O
operating NN I-NP O
room NN I-NP O
where WRB O O
he PRP O B-person
underwent VBD B-VP O
a DT B-NP B-treatment
reoperative JJ I-NP I-treatment
coronary JJ I-NP I-treatment
artery NN I-NP I-treatment
bypass NN I-NP I-treatment
graft NN I-NP I-treatment
times NNS I-NP I-treatment
three CD O I-treatment
with IN B-VP O
a DT B-NP B-treatment
subaortic JJ I-NP I-treatment
proximal NN I-NP I-treatment
graft NN I-NP I-treatment
from IN B-VP O
the DT B-NP O
aorta NN I-NP O
to TO O O
the DT B-NP O
OM1 NNP I-NP O
and CC O O
then RB O O
OM2 NNP B-NP O
and CC O O
aorta NN B-NP O
to TO O O
the DT B-NP O
LAD NNP I-NP O
with IN B-VP O
a DT B-NP B-treatment
wide JJ I-NP I-treatment
graft NN I-NP I-treatment
per IN B-VP O
Dr. NNP B-NP B-person
Lumar NNP I-NP I-person
Jongguild NNP I-NP I-person
. . B-VP O
   
Postoperatively RB O O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
ventilated VBN O O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
weaned VBN O O
off RP O O
an DT B-NP B-treatment
Epinephrine NN I-NP I-treatment
drip NN I-NP I-treatment
. . B-VP O
   
Rhythm NNP B-NP B-test
became VBD B-VP O
more RBR O O
stable JJ O O
. . B-VP O
   
Balloon NN B-NP B-treatment
was VBD B-VP O
weaned VBN O O
and CC O O
finally RB O O
discontinued VBN O O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
extubated VBN O O
. . B-VP O
   
His PRP$ O B-person
His PRP$ O B-treatment
Melranon NNP B-NP I-treatment
was VBD B-VP O
weaned VBN O O
off RP O O
and CC O O
his PRP$ O B-treatment
his PRP$ O B-person
ACE NNP B-NP I-treatment
inhibitor NN I-NP I-treatment
began VBD B-VP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
started VBN O O
on IN B-VP O
Amiodarone NNP B-NP B-treatment
and CC O O
diuresed VBN O O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
&apos;s NNP I-NP O
lower JJR B-NP O
extremities NNS I-NP O
began VBD B-VP O
to TO O O
swell VB O O
and CC O O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
begun VBN O O
on IN B-VP O
Hirudin NNP B-NP B-treatment
for IN B-VP O
deep RB O B-problem
venous JJ B-NP I-problem
thrombosis NN I-NP I-problem
. . B-VP O
   
The DT O B-person
The DT B-NP B-problem
patient JJ I-NP I-person
patient NN I-NP I-problem
&apos;s NNP I-NP I-problem
heparin NN I-NP I-problem
induced VBD B-VP I-problem
thrombocytopenia NN B-NP I-problem
became VBD B-VP O
positive JJ O O
and CC O O
so RB O O
he PRP O B-person
is VBZ O O
allergic JJ O B-problem
to TO O O
heparin VB O B-treatment
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
begun VBN O O
on IN B-VP O
Coumadin NNP B-NP B-treatment
and CC O O
he PRP O B-person
stayed VBD B-VP O
several JJ B-NP O
days NNS I-NP O
for IN B-VP O
Coumadinization NNP B-NP B-treatment
and CC O O
was VBD B-VP O
finally RB O O
discharged VBN O O
on IN B-VP O
therapeutic JJ B-NP B-treatment
Coumadin NNP I-NP I-treatment
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
tolerated VBD B-VP O
a DT B-NP O
regular JJ I-NP O
diet NN I-NP O
on IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
number NN I-NP O
thirteen NN I-NP O
from IN B-VP O
his PRP$ O B-treatment
his PRP$ O B-person
reoperative JJ B-NP I-treatment
coronary JJ I-NP I-treatment
artery NN I-NP I-treatment
bypass NN I-NP I-treatment
graft NN I-NP I-treatment
. . B-VP O
   
MEDICATIONS NNP B-NP O
ON NNP I-NP O
DISCHARGE NNP I-NP O
: : O O
1 CD O O
) ) O O
Amiodarone $ O B-treatment
400 CD O O
mg NN B-NP O
p.o. NN I-NP O
q. JJ B-NP O
day NN I-NP O
. . B-VP O
   
2 CD O O
) ) O O
Captopril NNP B-NP B-treatment
50 CD O O
mg NN B-NP O
p.o. NN I-NP O
t.i.d. IN B-VP O
3 CD O O
) ) O O
Digoxin NN B-NP B-treatment
0.125 CD O O
mg NN B-NP O
p.o. NN I-NP O
q. JJ B-NP O
day NN I-NP O
. . B-VP O
   
4 CD O O
) ) O O
Colace NN B-NP B-treatment
100 CD O O
mg NN B-NP O
p.o. NN I-NP O
t.i.d. IN B-VP O
5 CD O O
) ) O O
Lasix FW O B-treatment
80 CD O O
mg NN B-NP O
p.o. NN I-NP O
b.i.d. IN B-VP O
6 CD O O
) ) O O
Potassium NNP B-NP B-treatment
chloride $ O I-treatment
40 CD O O
mEq NN B-NP O
p.o. NN I-NP O
b.i.d. IN B-VP O
7 CD O O
) ) O O
Glucophage NN B-NP B-treatment
500 CD O O
mg NN B-NP O
p.o. NN I-NP O
q. JJ B-NP O
day NN I-NP O
. . B-VP O
   
8 CD O O
) ) O O
Glucotrol NNP B-NP B-treatment
XL $ O I-treatment
10 CD O O
mg NN B-NP O
p.o. NN I-NP O
b.i.d. IN B-VP O
9 CD O O
) ) O O
Coumadin NNP B-NP B-treatment
5 CD O O
mg NN B-NP O
p.o. NN I-NP O
q. JJ B-NP O
day NN I-NP O
. . B-VP O
   
FOLLOW-UP NN B-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
instructed VBN O O
to TO O O
follow-up JJ O O
with IN B-VP O
Dr. NNP B-NP B-person
Lumar NNP I-NP I-person
Jongguild NNP I-NP I-person
. . B-VP O
   
Dictated VBN O O
By IN B-VP O
: : O O
RAMAG NNP B-NP B-person
TROISQUARCKAYS NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
JB48 NNP I-NP O
Attending NNP I-NP B-person
: : O O
LUMAR NNP B-NP B-person
R. NNP I-NP I-person
JONGGUILD NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
NJ48 NNP I-NP O
RO267/6080 NNP I-NP O
Batch NNP I-NP O
: : O O
5076 CD O O
Index NNP B-NP O
No. NNP I-NP O
KHQTW3FS3 NNP I-NP O
D NNP I-NP O
: : O O
04/26/98 CD O O
T NN B-NP O
: : O O
04/27/98 CD O O
-EMPTYLINE- NN B-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- VBZ O O
688127038 CD O O
EH NNP B-NP O
47449520 CD O O
204512 CD O O
3/5/2002 CD O O
12:00:00 CD O O
AM NNP B-NP O
TCA NNP I-NP B-problem
overdose JJ B-NP I-problem
DIS NNP I-NP O
Admission NNP I-NP O
Date NNP I-NP O
: : O O
03/05/2002 CD O O
Report NNP B-NP O
Status NNP I-NP O
: : O O
Discharge NN B-NP O
Date NNP I-NP O
: : O O
03/07/2002 CD O O
****** NN B-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
HULLEKOTE NNP I-NP B-person
, , O I-person
AU NNP B-NP I-person
329-72-53-3 CD O O
Z23 NNP B-NP O
Room NNP I-NP O
: : O O
29Z-191 JJ B-NP O
Service NNP I-NP O
: : O O
MED NNP B-NP O
DISCHARGE NNP I-NP O
PATIENT NNP I-NP B-person
ON NNP I-NP O
: : O O
03/07/02 CD O O
AT NNP B-NP O
11:00 CD O O
AM NNP B-NP O
CONTINGENT NNP I-NP O
UPON NNP I-NP O
Not RB O O
Applicable NNP B-NP O
WILL NNP I-NP O
D NNP I-NP O
/ NNP I-NP O
C NNP I-NP O
ORDER NNP I-NP O
BE NNP I-NP O
USED NNP I-NP O
AS IN B-VP O
THE NNP B-NP O
D NNP I-NP O
/ NNP I-NP O
C NNP I-NP O
SUMMARY NNP I-NP O
: : O O
YES JJ B-NP O
Attending NN I-NP B-person
: : O O
UPHMADRE NNP B-NP B-person
, , O I-person
CIOUSALE NNP B-NP I-person
N. NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
CODE NNP I-NP O
STATUS NNP I-NP O
: : O O
Full NNP B-NP O
code NN I-NP O
DISPOSITION NNP I-NP O
: : O O
Rehabilitation NNP B-NP O
DISCHARGE NNP I-NP O
MEDICATIONS NNP I-NP O
: : O O
FOLATE NN B-NP B-treatment
( ( O I-treatment
FOLIC NNP B-NP I-treatment
ACID NNP I-NP I-treatment
) ) O I-treatment
1 CD O O
MG NNP B-NP O
PO NNP I-NP O
QD NNP I-NP O
ZANTAC NNP I-NP B-treatment
( ( O I-treatment
RANITIDINE NNP B-NP I-treatment
HCL NNP I-NP I-treatment
) ) O I-treatment
150 CD O O
MG NNP B-NP O
PO NNP I-NP O
BID NNP I-NP O
MVI NNP I-NP B-treatment
THERAPEUTIC NNP I-NP I-treatment
W NNP I-NP I-treatment
/ NNP I-NP I-treatment
MINERALS NNP I-NP I-treatment
( ( O I-treatment
THERAP NNP B-NP I-treatment
VITS NNP I-NP I-treatment
/ NNP I-NP I-treatment
MINERALS NNP I-NP I-treatment
) ) O I-treatment
1 CD O O
TAB NNP B-NP O
PO NNP I-NP O
QD NNP I-NP O
THIAMINE NNP I-NP B-treatment
HCL NNP I-NP I-treatment
100 CD O O
MG NNP B-NP O
PO NNP I-NP O
QD NNP I-NP O
DIET NNP I-NP O
: : O O
No DT B-NP O
Restrictions NNP I-NP O
Activity NNP I-NP O
- : O O
As IN B-VP O
tolerated VBN O O
FOLLOW NNP B-NP O
UP NNP I-NP O
APPOINTMENT NNP I-NP O
( ( O O
S NNP B-NP O
) ) O O
: : O O
Dr. NNP B-NP B-person
Ee NNP I-NP I-person
, , O O
patient NN B-NP B-person
to TO O O
arrange VB O O
, , O O
No DT B-NP O
Known NNP I-NP B-problem
Allergies NNP I-NP I-problem
ADMIT NNP I-NP O
DIAGNOSIS NNP I-NP O
: : O O
TCA NNP B-NP B-problem
overdose VBP O I-problem
PRINCIPAL NNP B-NP O
DISCHARGE NNP I-NP O
DIAGNOSIS NNP I-NP O
; : O O
Responsible NNP B-NP O
After IN B-VP O
Study NNP B-NP O
for IN B-VP O
Causing NNP B-NP O
Admission NNP I-NP O
) ) O O
TCA NNP B-NP B-problem
overdose VBP O I-problem
OTHER NNP B-NP O
DIAGNOSIS NNP I-NP O
; : O O
Conditions NNP B-NP O
, , O O
Infections NNP B-NP O
, , O O
Complications NNP B-NP O
, , O O
affecting VBG O O
Treatment NNP B-NP O
/ NNP I-NP O
Stay NNP I-NP O
depression NN I-NP B-problem
( ( O I-problem
depression NN B-NP I-problem
) ) O I-problem
OPERATIONS NNP B-NP O
AND CC O O
PROCEDURES NNP B-NP O
: : O O
OTHER NNP B-NP O
TREATMENTS NNP I-NP O
/ NNP I-NP O
PROCEDURES NNP I-NP O
( ( O O
NOT NNP B-NP O
IN NNP I-NP O
O.R. NNP I-NP O
) ) O O
None NN B-NP O
BRIEF NNP I-NP O
RESUME NNP I-NP O
OF NNP I-NP O
HOSPITAL NNP I-NP O
COURSE NNP I-NP O
: : O O
32 CD O B-person
y NN B-NP I-person
/ NNP I-NP I-person
o VBZ O I-person
woman NN B-NP I-person
with IN B-VP O
h JJ B-NP O
/ JJ I-NP O
o NN I-NP O
anxiety NN I-NP B-problem
and CC O O
depression NN B-NP B-problem
and CC O O
prior JJ B-NP B-problem
suicide NN I-NP I-problem
attempt NN I-NP I-problem
presents NNS I-NP O
with IN B-VP O
TCA NNP B-NP B-problem
and CC O I-problem
celexa NN B-NP I-problem
overdose RB O I-problem
, , O O
tremulous JJ O B-problem
/ CD O O
light-headed JJ O B-problem
, , O O
felt VBD B-VP O
better RBR O O
post NN B-NP O
charcoal NN I-NP B-treatment
. . B-VP O
   
No DT B-NP O
EKG NNP I-NP O
changes NNS I-NP O
, , O O
marijuana NN B-NP B-test
in IN B-VP I-test
urine NN B-NP I-test
, , O O
HCO3 NNP B-NP B-test
22 CD O O
. . B-VP O
   
Transferred VBN O O
to TO O O
floor NN B-NP O
on IN B-VP O
day NN B-NP O
of IN B-VP O
admission NN B-NP O
with IN B-VP O
no DT B-NP O
acute JJ I-NP B-problem
medical JJ I-NP I-problem
issues NNS I-NP I-problem
; : O O
awaiting VBG O O
psych NN B-NP B-test
eval NN I-NP I-test
. . B-VP O
   
Not RB O O
actively RB O B-problem
suicidal JJ O I-problem
. . B-VP O
   
3/7 CD O O
-- : O O
repeat NN B-NP B-test
HCO3 NNP I-NP I-test
24 CD O O
and CC O O
26 CD O O
without IN B-VP O
bicarb NN B-NP B-treatment
drip NN I-NP I-treatment
. . B-VP O
   
EKG NNP B-NP B-test
without IN B-VP O
changes NNS B-NP O
. . B-VP O
   
Patient NNP B-NP B-person
felt VBD B-VP O
well RB O O
, , O O
tolerating VBG O O
POs NNP B-NP O
. . B-VP O
   
BEST NNP B-NP B-test
team NN I-NP I-test
eval NN I-NP I-test
found VBD B-VP O
bed NN B-NP O
at IN B-VP O
psych NN B-NP O
rehab NN I-NP O
facility NN I-NP O
. . B-VP O
   
OF NNP B-NP O
NOTE NNP I-NP O
, , O O
Nortriptyline NNP B-NP B-test
level NN I-NP I-test
came VBD B-VP O
back RB O O
as IN B-VP O
43 CD O O
( ( O O
SUBTHERAPEUTIC NNP B-NP O
-- : O O
NORMAL NNP B-NP O
50-150 JJ O O
) ) O O
. . B-VP O
   
ADDITIONAL JJ B-NP O
COMMENTS NN I-NP O
: : O O
DISCHARGE JJ B-NP O
CONDITION NNP I-NP O
: : O O
Stable JJ B-NP O
TO NNP I-NP O
DO NNP I-NP O
/ NNP I-NP O
PLAN NNP I-NP O
: : O O
No DT B-NP O
dictated JJ I-NP O
summary NN I-NP O
ENTERED NN I-NP O
BY NNP I-NP O
: : O O
KOTEKEESECRANKBERF NNP B-NP B-person
, , O I-person
LA NNP B-NP I-person
A. NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
( ( O O
JG92 NNP B-NP O
) ) O O
03/07/02 CD O O
10:56 CD O O
AM NNP B-NP O
****** JJ B-NP O
END NN I-NP O
OF NNP I-NP O
DISCHARGE NNP I-NP O
ORDERS NNP I-NP O
****** NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
Admission NNP I-NP O
Date NNP I-NP O
: : O O
2018-12-26 JJ B-NP O
Discharge NN I-NP O
Date NNP I-NP O
: : O O
2019-01-10 JJ B-NP O
Date NNP I-NP O
of IN B-VP O
Birth NNP B-NP O
: : O O
1949-02-09 JJ B-NP O
Sex NN I-NP O
: : O O
F NNP B-NP O
Service NNP I-NP O
: : O O
MEDICINE JJ B-NP O
Allergies NNS I-NP O
: : O O
Losartan NNP B-NP B-treatment
/ NNP I-NP O
Aspirin NNP I-NP B-treatment
/ NNP I-NP O
Lisinopril-Hctz NNP I-NP B-treatment
Attending NNP I-NP B-person
: : O O
Donald NNP B-NP B-person
I PRP O I-person
Patrick NNP B-NP I-person
, , O I-person
M.D. NNP B-NP I-person
Chief NNP I-NP O
Complaint NNP I-NP O
: : O O
fever NN B-NP B-problem
Major NNP I-NP O
Surgical NNP I-NP O
or CC O O
Invasive JJ B-NP O
Procedure NN I-NP O
: : O O
Intubation NN B-NP B-treatment
for IN B-VP O
airway NN B-NP B-treatment
protection NN I-NP I-treatment
tunneled VBD B-VP B-treatment
line NN B-NP I-treatment
change NN I-NP O
over IN B-VP O
wire JJ B-NP B-treatment
2019-01-08 JJ I-NP O
History NN I-NP O
of IN B-VP O
Present NNP B-NP O
Illness NNP I-NP O
: : O O
69 CD O O
y/o NNS B-NP O
female JJ B-NP O
wtih JJ I-NP O
PMH NNP I-NP O
significant JJ O O
for IN B-VP O
ESRD NNP B-NP B-problem
on IN B-VP O
HD NNP B-NP B-treatment
, , O O
type NN B-NP B-problem
2 CD O I-problem
DM NNP B-NP I-problem
, , O O
and CC O O
recent JJ B-NP B-problem
PE NNP I-NP I-problem
resulting VBG O O
in IN B-VP O
PEA NNP B-NP B-problem
arrest NN I-NP I-problem
admitted VBD B-VP O
through IN B-VP O
the DT B-NP O
Juan NNP I-NP O
with IN B-VP O
sepsis NN B-NP B-problem
of IN B-VP O
unknown JJ B-NP O
etiology NN I-NP O
. . B-VP O
   
Pt NNP B-NP B-person
was VBD B-VP O
recently RB O O
admitted VBN O O
to TO O O
The DT B-NP O
Hospital NNP I-NP O
for IN B-VP O
Orthopedics NNPS B-NP O
from IN B-VP O
12-07 JJ O O
thorugh IN B-VP O
12-14 JJ O O
with IN B-VP O
hypotension NN B-NP B-problem
thought VBN O O
to TO O O
be VB O O
secondary JJ O O
to TO O O
overdiuresis VB O B-problem
at IN B-VP O
HD. NNP B-NP B-treatment
However RB O O
, , O O
a DT B-NP B-problem
septic JJ I-NP I-problem
component NN I-NP I-problem
to TO O O
the DT B-NP B-problem
hypotension NN I-NP I-problem
was VBD B-VP O
also RB O O
considered VBN O O
as IN B-VP O
the DT B-NP B-person
pt NN I-NP I-person
was VBD B-VP O
found VBN O O
to TO O O
have VB O O
citrobacter NN B-NP B-problem
in IN B-VP I-problem
her PRP$ O B-person
her PRP$ O I-problem
urine NN B-NP I-problem
and CC O O
C NNP B-NP B-problem
diff NN I-NP I-problem
in IN B-VP I-problem
her PRP$ O B-person
her PRP$ O I-problem
stool NN B-NP I-problem
. . B-VP O
   
Pt NNP B-NP B-person
was VBD B-VP O
then RB O O
discharged VBN O O
to TO O O
Arbour-Fuller NNP B-NP O
Hospital NNP I-NP O
Senior NNP I-NP O
Life NNP I-NP O
where WRB O O
she PRP O B-person
was VBD B-VP O
in IN B-VP O
her PRP$ O B-person
normal JJ B-NP O
state NN I-NP O
of IN B-VP O
health NN B-NP O
until IN B-VP O
three CD O O
days NNS B-NP O
ago RB O O
. . B-VP O
   
Her PRP$ O B-person
Her PRP$ O B-person
son NN B-NP I-person
reports NNS I-NP O
that IN B-VP B-pronoun
she PRP O B-person
then RB O O
developed VBD B-VP O
a DT B-NP B-problem
headache NN I-NP I-problem
and CC O O
fevers NNS B-NP B-problem
started VBD B-VP O
three CD O O
days NNS B-NP O
ago RB O O
which WDT O B-pronoun
were VBD B-VP O
treated VBN O O
with IN B-VP O
tylenol NN B-NP B-treatment
. . B-VP O
   
Then RB O O
, , O O
this DT B-NP B-pronoun
morning NN I-NP O
she PRP O B-person
developed VBD B-VP O
fatigue NN B-NP B-problem
and CC O O
did VBD B-VP O
not RB O O
eat VB O O
well RB O O
. . B-VP O
   
He PRP O B-person
He PRP O B-person
son VBZ O I-person
also RB O O
notes NNS B-NP O
that IN B-VP B-pronoun
she PRP O B-person
appeared VBD B-VP O
to TO O O
be VB O O
working VBG O B-problem
hard JJ O I-problem
to TO O I-problem
breath VB O I-problem
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
found VBN O O
to TO O O
be VB O O
febrile JJ O B-problem
to TO O O
101.9 CD O O
and CC O O
received VBD B-VP O
levoflox NNS B-NP B-treatment
and CC O O
vancomycin NN B-NP B-treatment
. . B-VP O
   
Pt NNP B-NP B-person
was VBD B-VP O
then RB O O
sent VBN O O
to TO O O
the DT O O
The DT B-NP O
Hospital NNP I-NP O
for IN B-VP O
Orthopedics NNP B-NP O
Juan NNP I-NP O
for IN B-VP O
further JJ B-NP B-test
evaluation NN I-NP I-test
. . B-VP O
   
Per NNP B-NP O
notes NNS I-NP O
, , O O
pt NN B-NP B-person
denied VBD B-VP O
SOB NNP B-NP B-problem
, , O O
CP NNP B-NP B-problem
, , O O
and CC O O
abdominal JJ B-NP B-problem
pain NN I-NP I-problem
prior RB O O
to TO O O
intubation NN B-NP B-treatment
. . B-VP O
   
She PRP O B-person
did VBD B-VP O
complain NN B-NP O
of IN B-VP O
a DT B-NP B-problem
left JJ I-NP I-problem
frontal JJ I-NP I-problem
headache NN I-NP I-problem
. . B-VP O
   
In IN B-VP O
the DT B-NP O
Juan NNP I-NP O
, , O O
the DT O B-person
the DT B-NP B-test
pt NN I-NP I-person
pt NN I-NP I-test
's POS O I-test
VS NNP B-NP I-test
were VBD B-VP O
singificant JJ O O
for IN B-VP O
a DT B-NP B-problem
fever NN I-NP I-problem
of IN B-VP O
103.8 CD O O
, , O O
tachycardia NN B-NP B-problem
in IN B-VP O
the DT O O
130s-150s JJ O O
, , O O
and CC O O
initial JJ B-NP B-problem
hypertensive NN I-NP I-problem
in IN B-VP O
the DT B-NP O
140s NNS I-NP O
. . B-VP O
   
Her PRP$ O B-person
Her PRP$ O B-test
oxygen NN B-NP I-test
saturation NN I-NP I-test
was VBD B-VP O
96% CD O O
on IN B-VP O
RA NNP B-NP O
but CC O O
she PRP O B-person
was VBD B-VP O
tachypneic JJ O B-problem
to TO O O
31 CD O O
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
obtunded VBN O B-problem
and CC O O
was VBD B-VP O
thus RB O O
intubated VBN O B-treatment
for IN B-VP O
airway NN B-NP B-treatment
protection NN I-NP I-treatment
. . B-VP O
   
Post-intubation NN B-NP O
, , O O
the DT O B-person
the DT B-NP B-test
pt NN I-NP I-person
pt NN I-NP I-test
's POS O I-test
BP NNP B-NP I-test
acutely RB O O
dropped VBD B-VP O
to TO O O
58/19 CD O O
in IN B-VP O
the DT B-NP O
setting NN I-NP O
of IN B-VP O
propofol NN B-NP B-treatment
. . B-VP O
   
When WRB O O
this DT B-NP B-treatment
medication NN I-NP I-treatment
was VBD B-VP O
discontinued VBN O O
, , O O
her PRP$ O B-person
her PRP$ O B-test
BP NNP B-NP I-test
came VBD B-VP O
back RB O O
up IN B-VP O
to TO O O
the DT O O
70s-90s JJ O O
/ JJ O O
30s-50s JJ O O
. . B-VP O
   
Pt NNP B-NP B-person
was VBD B-VP O
then RB O O
initiated VBN O O
on IN B-VP O
the DT B-NP B-treatment
sepsis NN I-NP I-treatment
protocol NN I-NP I-treatment
. . B-VP O
   
In IN B-VP O
the DT B-NP O
Juan NNP I-NP O
, , O O
she PRP O B-person
received VBD B-VP O
vancomycin NN B-NP B-treatment
, , O O
levofloxacin NN B-NP B-treatment
, , O O
flagyl NN B-NP B-treatment
, , O O
and CC O O
cefepime NN B-NP B-treatment
( ( O O
2 CD O O
gm NN B-NP O
). NN I-NP O
She PRP O B-person
received VBD B-VP O
a DT B-NP O
total NN I-NP O
of IN B-VP O
4 CD O O
liters NNS B-NP O
of IN B-VP O
NS NNP B-NP B-treatment
then RB O O
was VBD B-VP O
started VBN O O
on IN B-VP O
levophed NN B-NP B-treatment
for IN B-VP O
continued JJ B-NP B-problem
hypotension NN I-NP I-problem
. . B-VP O
   
Pt NNP B-NP B-person
is VBZ O O
now RB O O
transferred VBN O O
to TO O O
the DT B-NP O
FICU NNP I-NP O
for IN B-VP O
further JJ B-NP B-treatment
care NN I-NP I-treatment
. . B-VP O
   
Per NNP B-NP O
pt NN I-NP B-person
pt NN I-NP B-person
's POS O I-person
son NN B-NP I-person
, , O O
she PRP O B-person
is VBZ O O
bedbound VBN O B-problem
at IN B-VP O
baseline NN B-NP O
due JJ O O
to TO O O
her PRP$ O B-person
her PRP$ O B-problem
multiple JJ B-NP I-problem
LE NNP I-NP I-problem
femur NN I-NP I-problem
fractures NNS I-NP I-problem
. . B-VP O
   
Past NNP B-NP O
Medical JJ B-NP O
History NN I-NP O
: : O O
1. CD O O
Type NNP B-NP B-problem
2 CD O I-problem
diabetes NNS B-NP I-problem
mellitus VBP O I-problem
2. CD O O
Diabetic NNP B-NP B-problem
nephropathy JJ O I-problem
resulting VBG O O
in IN B-VP O
ESRD NNP B-NP B-problem
for IN B-VP O
which WDT O B-pronoun
she PRP O B-person
is VBZ O O
on IN B-VP O
HD NNP B-NP B-treatment
. . B-VP O
   
Pt NNP B-NP B-person
was VBD B-VP O
due JJ O O
for IN B-VP O
HD NNP B-NP B-treatment
but CC O O
missed VBD B-VP O
it PRP O B-pronoun
secondary JJ O O
to TO O O
her PRP$ O B-person
her PRP$ O B-problem
illness NN B-NP I-problem
. . B-VP O
   
She PRP O B-person
normally RB O O
receives VBZ O O
HD NNP B-NP B-treatment
on IN B-VP O
Mon NNP B-NP O
, , O O
Wed NNP B-NP O
, , O O
and CC O O
Fri NNP B-NP O
. . B-VP O
   
3. CD O O
Status NNP B-NP B-problem
post NN I-NP I-problem
left VBD B-VP I-problem
femur JJ B-NP I-problem
fracture NN I-NP I-problem
4. CD O O
Hyponatremia NNP B-NP B-problem
5. CD O O
Hypercholesterolemia NNP B-NP B-problem
6. CD O O
Unsteady NNP B-NP B-problem
gait NN I-NP I-problem
7. CD O O
Cataracts VBZ O B-problem
8. CD O O
Back NNP B-NP B-problem
pain NN I-NP I-problem
9. CD O O
Hypertension NNP B-NP B-problem
10. CD O O
Anemia NNP B-NP B-problem
of IN B-VP I-problem
chronic JJ B-NP I-problem
disease NN I-NP I-problem
11. CD O O
S/P NNP B-NP O
L NNP I-NP O
shoulder NN I-NP B-treatment
hemiarthroplasty NN I-NP I-treatment
following VBG O O
a DT B-NP B-problem
left JJ I-NP I-problem
humeral JJ I-NP I-problem
fracuture NN I-NP I-problem
in IN B-VP O
2018-11-10- JJ B-NP O
Dumas NNP I-NP O
was VBD B-VP O
complicated VBN O O
by IN B-VP O
a DT B-NP B-problem
PEA NNP I-NP I-problem
arrest NN I-NP I-problem
secondary NN I-NP O
to TO O O
PE NNP B-NP B-problem
. . B-VP O
   
12. CD O O
PE NNP B-NP B-problem
2018-11-17 JJ O O
leading VBG O O
to TO O O
PEA NNP B-NP B-problem
arrest VB O I-problem
Social NNP B-NP O
History NNP I-NP O
: : O O
Lives VBZ O O
with IN B-VP O
son NN B-NP B-person
who WP O B-person
is VBZ O O
very RB O O
involved JJ O O
and CC O O
well RB O O
informed JJ O O
regarding VBG O O
her PRP$ O B-person
care NN B-NP O
needs NNS I-NP O
. . B-VP O
   
Non NNP B-NP O
smoker NN I-NP O
. . B-VP O
   
No DT B-NP O
EtOH NNP I-NP O
Family NNP I-NP O
History NNP I-NP O
: : O O
Noncontributory NNP B-NP O
Physical NNP I-NP O
Exam NNP I-NP O
: : O O
94.5 CD O O
132/50 CD O O
108 CD O O
15 CD O O
100% CD O O
AC NNP B-NP B-treatment
500 CD O O
/ VBD B-VP O
15 CD O O
/ NNP B-NP O
.50 NNP I-NP O
/ NNP I-NP O
PEEP NNP I-NP B-treatment
5 CD O O
Gen NNP B-NP O
- : O O
Sedated VBD B-VP B-treatment
and CC O O
intubated VBD B-VP B-treatment
. . B-VP O
   
Grimaces NNS B-NP O
eyes NNS I-NP O
when WRB O O
they PRP O B-pronoun
are VBP O O
opened VBN O O
. . B-VP O
   
HEENT NNP B-NP O
- : O O
NC NN B-NP O
AT NNP I-NP O
. . B-VP O
   
Right NNP B-NP O
pupil NN I-NP O
ERRL NNP I-NP O
. . B-VP O
   
Surgical NNP B-NP O
left VBD B-VP O
pupil NN B-NP O
. . B-VP O
   
Anicteric NNP B-NP B-problem
sclera NN I-NP I-problem
. . B-VP O
   
MMM NNP B-NP O
. . B-VP O
   
Cardiac NNP B-NP O
- : O O
RRR NNP B-NP O
. . B-VP O
   
S1 NNP B-NP O
S2 NNP I-NP O
. . B-VP O
   
No DT B-NP O
m,r,g NN I-NP B-problem
. . B-VP O
   
Pulm NNP B-NP O
- : O O
CTA NNP B-NP O
anteriorlly RB O O
. . B-VP O
   
Abdomen NNP B-NP O
- : O O
Obese JJ O B-problem
. . B-VP O
   
Soft NNP B-NP O
. . B-VP O
   
NT NNP B-NP B-problem
. . B-VP O
   
ND NNP B-NP B-problem
. . B-VP O
   
Positive NNP B-NP O
bowel NN I-NP O
sounds NNS I-NP O
. . B-VP O
   
Extremities NNS B-NP O
- : O O
Feet NNP B-NP B-problem
mildly RB O I-problem
cool VBP O I-problem
. . B-VP O
   
2+ CD O B-test
DP NNP B-NP I-test
pulses NNS I-NP I-test
bilaterally RB O I-test
. . B-VP O
   
2+ CD O B-problem
pitting VBG O I-problem
edema JJ B-NP I-problem
bilateral JJ I-NP I-problem
LE NNP I-NP I-problem
. . B-VP O
   
Skin NNP B-NP B-problem
breakdown NN I-NP I-problem
between IN B-VP I-problem
toes NNS B-NP I-problem
. . B-VP O
   
Pressure NN B-NP B-problem
ulcers NNS I-NP I-problem
under IN B-VP I-problem
bilateral JJ B-NP I-problem
LE NNP I-NP I-problem
right NN I-NP O
above IN B-VP O
the DT B-NP O
ankles NNS I-NP O
. . B-VP O
   
Do VBP O O
not RB O O
appear VB O O
infected VBN O B-problem
. . B-VP O
   
Question NNP B-NP O
mild JJ B-NP B-problem
erythema NN I-NP I-problem
and CC O O
warmth NN B-NP B-problem
of IN B-VP I-problem
left JJ B-NP I-problem
LE NNP I-NP I-problem
. . B-VP O
   
Neuro NNP B-NP O
- : O O
Sedated VBN O B-treatment
. . B-VP O
   
Downgoing VBG O O
toes NNS B-NP O
bilaterally RB O O
. . B-VP O
   
Scruntches NNP B-NP O
eyes NNS I-NP O
closed VBD B-VP O
when WRB O O
try NN B-NP O
to TO O O
open VB O O
them PRP O B-pronoun
. . B-VP O
   
Pertinent JJ B-NP O
Results NNS I-NP O
: : O O
2018-12-26 JJ O O
11:10 CD O O
PM NNP B-NP O
LACTATE NNP I-NP B-test
- : O O
1.8 CD O O
2018-12-26 JJ O O
10:53 CD O O
PM NNP B-NP O
CRP NNP I-NP B-test
- : O O
46.2 CD O O
* JJ O O
2018-12-26 JJ O O
10:53 CD O O
PM NNP B-NP O
SED NNP I-NP B-test
RATE NNP I-NP I-test
- : O O
33 CD O O
* JJ O O
2018-12-26 JJ O O
09:54 CD O O
PM NNP B-NP O
TYPE NNP I-NP O
- : O O
MIX NNP B-NP O
TEMP NNP I-NP B-test
- : O O
35.6 CD O O
RATES NNPS B-NP B-treatment
-/ VBP O O
15 CD O O
TIDAL NNP B-NP B-treatment
VOL NNP I-NP I-treatment
- : O O
500 CD O O
PEEP NNP B-NP B-treatment
- : O O
5 CD O O
O2 NNP B-NP B-treatment
- : O O
50 CD O O
PO2 NNP B-NP B-test
- : O O
34 CD O O
* NN B-NP O
PCO2 NNP I-NP B-test
- : O O
39 CD O O
PH NNP B-NP B-test
- : O O
7.32 CD O O
* JJ B-NP O
TOTAL NNP I-NP B-test
CO2 NNP I-NP I-test
- : O O
21 CD O O
BASE NNP B-NP B-test
XS NNP I-NP I-test
- : O O
-6 SYM O O
- : O O
ASSIST NNP B-NP B-treatment
/ NNP I-NP I-treatment
CON NNP I-NP I-treatment
INTUBATED NNP I-NP B-treatment
- : O O
INTUBATED NNP B-NP B-treatment
2018-12-26 JJ O O
09:54 CD O O
PM NNP B-NP O
LACTATE NNP I-NP B-test
- : O O
1.6 CD O O
2018-12-26 JJ O O
09:44 CD O O
PM NNP B-NP O
GLUCOSE NNP I-NP B-test
- : O O
210 CD O O
* JJ B-NP O
UREA NNP I-NP B-test
N NNP I-NP I-test
- : O O
29 CD O O
* NN B-NP O
CREAT NNP I-NP B-test
- : O O
3.2 CD O O
* JJ B-NP O
SODIUM NNP I-NP B-test
- : O O
139 CD O O
POTASSIUM NNP B-NP B-test
- : O O
3.9 CD O O
CHLORIDE NNP B-NP B-test
- : O O
112 CD O O
* JJ B-NP O
TOTAL NNP I-NP B-test
CO2 NNP I-NP I-test
- : O O
17 CD O O
* JJ B-NP O
ANION NNP I-NP B-test
GAP NNP I-NP I-test
- : O O
14 CD O O
2018-12-26 JJ O O
09:44 CD O O
PM NNP B-NP O
CALCIUM NNP I-NP B-test
- : O O
6.2 CD O O
* NN B-NP O
PHOSPHATE NNP I-NP B-test
- : O O
1.7 CD O O
* JJ B-NP O
MAGNESIUM NNP I-NP B-test
- : O O
0.9 CD O O
* JJ O O
2018-12-26 JJ O O
09:44 CD O O
PM NNP B-NP O
CORTISOL NNP I-NP B-test
- : O O
10.3 CD O O
2018-12-26 JJ O O
09:44 CD O O
PM NNP B-NP O
WBC NNP I-NP B-test
- : O O
9.0 CD O O
RBC NNP B-NP B-test
- : O O
2.93 CD O O
* NN B-NP O
HGB NNP I-NP B-test
- : O O
9.0 CD O O
* NN B-NP O
HCT NNP I-NP B-test
- : O O
29.7 CD O O
* NN B-NP O
MCV NNP I-NP B-test
- : O O
101 CD O O
* NN B-NP O
MCH NNP I-NP B-test
- : O O
30.8 CD O O
MCHC NNP B-NP B-test
- : O O
30.4 CD O O
* NN B-NP O
RDW NNP I-NP B-test
- : O O
24.1 CD O O
* JJ O O
2018-12-26 JJ O O
09:44 CD O O
PM NNP B-NP O
NEUTS NNP I-NP B-test
- : O O
65.2 CD O O
LYMPHS NNP B-NP B-test
- : O O
25.2 CD O O
MONOS NNP B-NP B-test
- : O O
6.0 CD O O
EOS NNP B-NP B-test
- : O O
3.3 CD O O
BASOS NNP B-NP B-test
- : O O
0.4 CD O O
2018-12-26 JJ O O
09:44 CD O O
PM NNP B-NP O
HYPOCHROM NNP I-NP B-test
- : O O
3+ CD O O
ANISOCYT NNP B-NP B-test
- : O O
3+ CD O O
POIKILOCY NNP B-NP B-test
- : O O
1+ CD O O
MACROCYT NNP B-NP B-test
- : O O
3+ CD O O
MICROCYT NNP B-NP B-test
- : O O
1+ CD O O
2018-12-26 JJ O O
09:44 CD O O
PM NNP B-NP O
PLT NNP I-NP B-test
COUNT NNP I-NP I-test
- : O O
177 CD O O
2018-12-26 JJ O O
08:28 CD O O
PM NNP B-NP O
CORTISOL NNP I-NP B-test
- : O O
9.3 CD O O
2018-12-26 JJ O O
08:28 CD O O
PM NNP B-NP O
URINE NNP I-NP B-test
COLOR NNP I-NP B-test
- : O O
Yellow JJ B-NP O
APPEAR NNP I-NP B-test
- : O O
SlHazy NNP B-NP O
SP NNP I-NP O
Barajas NNP I-NP O
- : O O
1.005 CD O O
2018-12-26 JJ O O
08:28 CD O O
PM NNP B-NP O
URINE NNP I-NP B-test
BLOOD NNP I-NP B-test
- : O O
LGE NNP B-NP O
NITRITE NNP I-NP B-test
- : O O
NEG NNP B-NP O
PROTEIN NNP I-NP B-test
- : O O
500 CD O O
GLUCOSE NNP B-NP B-test
- : O O
TR NNP B-NP O
KETONE NNP I-NP B-test
- : O O
NEG NNP B-NP O
BILIRUBIN NNP I-NP B-test
- : O O
NEG NNP B-NP O
UROBILNGN NNP I-NP B-test
- : O O
NEG NNP B-NP O
PH NNP I-NP B-test
- : O O
7.0 CD O O
LEUK NNP B-NP B-test
- : O O
NEG NNP B-NP O
2018-12-26 JJ O O
08:28 CD O O
PM NNP B-NP O
URINE NNP I-NP B-test
RBC NNP I-NP B-test
- : O O
225 CD O O
* NN B-NP O
WBC NNP I-NP B-test
- : O O
8 CD O O
* NN B-NP O
BACTERIA NNP I-NP B-test
- : O O
NONE NN B-NP O
YEAST NNP I-NP B-test
- : O O
NONE NN B-NP O
EPI NNP I-NP B-test
- : O O
< JJ O O
1 CD O O
2018-12-26 JJ O O
02:40 CD O O
PM NNP B-NP O
CK NNP I-NP B-test
( ( O I-test
CPK NNP B-NP I-test
)- CD O I-test
350 CD O O
* JJ O O
2018-12-26 JJ O O
02:40 CD O O
PM NNP B-NP O
CK NNP I-NP B-test
- : O I-test
MB NNP B-NP I-test
- : O O
3 CD O O
cTropnT NN B-NP B-test
- : O O
0.40 CD O O
* JJ B-NP O
MICRO NNP I-NP O
: : O O
sputum JJ B-NP B-test
12-27 NNS I-NP O
: : O O
grm NN B-NP B-test
stn NN I-NP I-test
and CC O O
cx NN B-NP B-test
negative JJ B-NP O
infl NN I-NP B-test
A NNP I-NP I-test
and CC O I-test
B NNP B-NP I-test
12-27 JJ O O
: : O O
negative JJ B-NP O
CSF NNP I-NP B-test
grm NN I-NP I-test
stn NN I-NP I-test
/ NNP I-NP O
cx NN I-NP B-test
: : O O
negative JJ B-NP O
urine JJ I-NP B-test
cx NN I-NP I-test
12-26 JJ O O
: : O O
> JJ O O
100K CD O O
VRE NNP B-NP B-problem
likely JJ O O
colonized VBN O O
, , O O
01-03 JJ B-NP O
yest NN I-NP B-problem
and CC O O
VRE NNP B-NP B-problem
c VBP O B-test
diff JJ B-NP I-test
neg NN I-NP O
: : O O
12-28 JJ O O
, , O O
12-31 JJ O O
, , O O
01-01 JJ O O
, , O O
01-02 JJ O O
. . B-VP O
   
bld JJ O B-test
cx JJ O I-test
12-26 JJ O O
, , O O
12-27 JJ O O
, , O O
12-28 JJ O O
, , O O
12-31 JJ O O
- : O O
NG NN B-NP O
. . B-VP O
   
01-01 JJ O O
, , O O
01-02 JJ B-NP O
X NN I-NP O
3 CD O O
, , O O
01-03 JJ O O
, , O O
01-04 JJ O O
, , O O
11/27X CD O O
2 CD O O
NGTD NNP B-NP O
. . B-VP O
   
Catheter NNP B-NP B-test
tip VBD B-VP I-test
01-05 CD O O
, , O O
NG NNP B-NP O
. . B-VP O
   
C. NNP B-NP B-test
Diff NNP I-NP I-test
B NNP I-NP I-test
- : O O
negative JJ B-NP O
Tunnled NNP I-NP B-test
catheter NN I-NP I-test
tip NN I-NP I-test
01-08 JJ O O
- : O O
ngtd JJ B-NP O
HERPES NNP I-NP B-test
SIMPLEX NNP I-NP I-test
VIRUS NNP I-NP I-test
PCR NNP I-NP I-test
- : O O
PND NN B-NP O
Brief NNP I-NP O
Hospital NNP I-NP O
Course NNP I-NP O
: : O O
A/P NN B-NP O
: : O O
69 CD O O
y/o NNS B-NP O
female JJ B-NP O
wtih JJ I-NP O
PMH NNP I-NP O
significant JJ O O
for IN B-VP O
ESRD NNP B-NP B-problem
on IN B-VP O
HD NNP B-NP B-treatment
, , O O
type NN B-NP B-problem
2 CD O I-problem
DM NNP B-NP I-problem
, , O O
and CC O O
recent JJ B-NP B-problem
PE NNP I-NP I-problem
resulting VBG O O
in IN B-VP O
PEA NNP B-NP B-problem
arrest NN I-NP I-problem
admitted VBD B-VP O
through IN B-VP O
the DT B-NP O
Juan NNP I-NP O
with IN B-VP O
sepsis NN B-NP B-problem
of IN B-VP O
unknown JJ B-NP O
etiology NN I-NP O
. . B-VP O
   
1. CD O O
Sepsis NNP B-NP B-problem
/ NNP I-NP O
ID- NNP I-NP O
Started NNP I-NP O
on IN B-VP O
sepsis NN B-NP B-treatment
protocol NN I-NP I-treatment
. . B-VP O
   
Unclear JJ B-NP O
etiology NN I-NP O
headache NN I-NP B-problem
over IN B-VP O
the DT O O
three CD O O
days NNS B-NP O
prior RB O O
to TO O O
admission NN B-NP O
in IN B-VP O
association NN B-NP O
with IN B-VP O
fever NN B-NP B-problem
was VBD B-VP O
concerning VBG O O
for IN B-VP O
a DT B-NP O
CNS NNP I-NP O
etiology NN I-NP O
. . B-VP O
   
Covered VBD B-VP O
broadly RB O O
with IN B-VP O
vancomycin NN B-NP B-treatment
, , O O
flagyl NN B-NP B-treatment
, , O O
and CC O O
cefipime NN B-NP B-treatment
. . B-VP O
   
Given NNP B-NP O
stress NN I-NP B-treatment
dose NN I-NP I-treatment
steroids NNS I-NP I-treatment
empirically RB O O
and CC O O
Sanchez NNP B-NP O
stim NN I-NP O
showed VBD B-VP O
cortisol NN B-NP B-test
of IN B-VP O
9.3 CD O O
--> JJ O O
10.3 CD O O
therefore RB O O
steroids NNS B-NP B-treatment
continued VBD B-VP O
. . B-VP O
   
CXR NNP B-NP B-test
, , O O
LP NNP B-NP B-test
, , O O
UA NNP B-NP B-test
and CC O O
abdominal JJ B-NP B-test
CT NNP I-NP I-test
showed VBD B-VP O
no DT B-NP O
sign NN I-NP O
of IN B-VP O
infection NN B-NP B-problem
. . B-VP O
   
PICC NNP B-NP B-treatment
line NN I-NP I-treatment
was VBD B-VP O
removed VBN O O
empirically RB O O
. . B-VP O
   
Tip NNP B-NP B-treatment
could MD O O
not RB O O
be VB O O
cultured VBN O O
due JJ O O
to TO O O
contamination NN B-NP O
. . B-VP O
   
Cultures NNS B-NP B-test
drawn VBD B-VP O
off RP O O
the DT B-NP B-treatment
HD NNP I-NP I-treatment
cath NN I-NP I-treatment
are VBP O O
negative JJ O O
to TO O O
date NN B-NP O
. . B-VP O
   
Patient NNP B-NP B-person
Patient NNP I-NP B-problem
's POS O I-problem
LE NNP B-NP I-problem
ulcers NNPS I-NP I-problem
appear VBP O O
chronic JJ O O
and CC O O
do VBP O O
not RB O O
appear VB O O
to TO O O
be VB O O
the DT B-NP O
source NN I-NP O
of IN B-VP O
infection NN B-NP B-problem
. . B-VP O
   
Her PRP$ O B-person
left JJ B-NP O
knee NN I-NP O
is VBZ O O
slightly RB O B-problem
erythematous JJ O I-problem
compared VBN O O
to TO O O
the DT B-NP O
right NN I-NP O
but CC O O
not RB O O
impressive JJ O O
. . B-VP O
   
Joint NNP B-NP O
is VBZ O O
mobile JJ O O
. . B-VP O
   
Nasal NNP B-NP B-test
washings NNS I-NP I-test
for IN B-VP O
influenza NN B-NP B-problem
were VBD B-VP O
negative JJ O O
; : O O
culture NN B-NP B-test
pending VBG O O
. . B-VP O
   
Patient NNP B-NP B-person
improved VBD B-VP O
over IN B-VP O
the DT B-NP O
next JJ I-NP O
few JJ I-NP O
days NNS I-NP O
. . B-VP O
   
Steroids NNS B-NP B-treatment
were VBD B-VP O
discontinued VBN O O
. . B-VP O
   
On IN B-VP O
12-18 JJ B-NP O
flagyl NN I-NP B-treatment
and CC O O
cefepime NN B-NP B-treatment
were VBD B-VP O
discontinued VBN O O
as IN B-VP O
all DT B-NP B-test
culture NN I-NP I-test
data NNS I-NP I-test
negative JJ O O
to TO O O
date NN B-NP O
. . B-VP O
   
Plan NN B-NP O
to TO O O
continue VB O O
vancomycin NN B-NP B-treatment
for IN B-VP O
08-19 JJ B-NP O
day NN I-NP O
course NN I-NP O
to TO O O
treat VB O O
empiric JJ B-NP B-problem
line NN I-NP I-problem
infection NN I-NP I-problem
. . B-VP O
   
Urine JJ B-NP B-test
culture NN I-NP I-test
came VBD B-VP O
back RB O O
positive JJ O O
for IN B-VP O
VRE NNP B-NP B-problem
, , O O
however RB O O
, , O O
since IN B-VP O
patient NN B-NP B-person
improved VBN O O
without IN B-VP O
treatement NN B-NP B-treatment
( ( O O
ie JJ B-NP O
Linezolid NNP I-NP B-treatment
) ) O O
initially RB O O
. . B-VP O
   
After IN B-VP O
transfer NN B-NP O
to TO O O
the DT B-NP O
floor NN I-NP O
when WRB O O
she PRP O B-person
was VBD B-VP O
stable JJ O O
. . B-VP O
   
On IN B-VP O
the DT B-NP O
floor NN I-NP O
the DT B-NP B-treatment
Vancomycin NNP I-NP I-treatment
was VBD B-VP O
discontinued VBN O O
as IN B-VP O
the DT B-NP B-test
catheter NN I-NP I-test
tip JJ B-NP I-test
culture NN I-NP I-test
was VBD B-VP O
negative JJ O O
. . B-VP O
   
ID NNP B-NP B-person
was VBD B-VP O
consulted VBN O O
who WP O B-person
suggested VBD B-VP O
broad JJ B-NP B-treatment
spectrum NN I-NP I-treatment
antibiotics NNS I-NP I-treatment
if IN B-VP O
she PRP O B-person
were VBD B-VP O
to TO O O
spike VB O O
. . B-VP O
   
When WRB O O
pt NN B-NP B-person
spiked VBD B-VP O
a DT B-NP B-problem
temperature NN I-NP I-problem
and CC O O
became VBD B-VP O
hypotensive JJ O B-problem
she PRP O B-person
was VBD B-VP O
started VBN O O
on IN B-VP O
Linezolid NNP B-NP B-treatment
was VBD B-VP O
started VBN O O
for IN B-VP O
presumed JJ B-NP O
VRE NNP I-NP B-problem
infection NN I-NP I-problem
in IN B-VP I-problem
the DT B-NP I-problem
urine NN I-NP I-problem
. . B-VP O
   
She PRP O B-person
will MD O O
be VB O O
treated VBN O O
for IN B-VP O
total JJ O O
14 CD O O
day NN B-NP O
course NN I-NP O
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
also RB O O
started VBN O O
on IN B-VP O
fluconazole NN B-NP B-treatment
for IN B-VP O
yeast NN B-NP B-problem
in IN B-VP I-problem
the DT B-NP I-problem
urine NN I-NP I-problem
, , O O
to TO O O
be VB O O
treated VBN O O
with IN B-VP O
fluconazole NN B-NP B-treatment
for IN B-VP O
total JJ O O
7 CD O O
days NNS B-NP O
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
given VBN O O
Flagyl NNP B-NP B-treatment
for IN B-VP O
presumed JJ B-NP O
C. NNP I-NP B-problem
Diff. NNP I-NP I-problem
Colitis NNP I-NP I-problem
, , O O
however RB O O
this DT O B-pronoun
was VBD B-VP O
stopped VBN O O
when WRB O O
C. NNP B-NP B-test
Diff NNP I-NP I-test
B NNP I-NP I-test
toxin NN I-NP I-test
came VBD B-VP O
back RB O O
negative JJ O O
on IN B-VP O
2019-01-10 JJ O O
. . B-VP O
   
The DT B-NP B-treatment
tunneled JJ I-NP I-treatment
catheter NN I-NP I-treatment
line NN I-NP I-treatment
was VBD B-VP O
changed VBN O O
over IN B-VP O
a DT B-NP B-treatment
wire NN I-NP I-treatment
and CC O O
the DT B-NP B-test
tip NN I-NP I-test
was VBD B-VP O
also RB O O
negative JJ O O
. . B-VP O
   
2. CD O O
Respiratory NNP B-NP O
- : O O
Intubated VBN O B-treatment
for IN B-VP O
airway NN B-NP B-treatment
protection NN I-NP I-treatment
due JJ O O
to TO O O
change VB O B-problem
in IN B-VP I-problem
mental JJ B-NP I-problem
status NN I-NP I-problem
. . B-VP O
   
Extubated VBN O B-treatment
12-28 JJ O O
with IN B-VP O
no DT B-NP O
incident NN I-NP O
. . B-VP O
   
3. CD O O
ECG NNP B-NP B-problem
changes NNS I-NP I-problem
- : O O
Patient NN B-NP B-person
had VBD B-VP O
an DT B-NP O
episode NN I-NP O
of IN B-VP O
chest NN B-NP B-problem
pain NN I-NP I-problem
during IN B-VP O
her PRP$ O B-person
hospital NN B-NP O
stay NN I-NP O
that WDT O B-pronoun
was VBD B-VP O
both DT O O
right JJ O O
and CC O O
left VBD B-VP O
sided VBN O O
with IN B-VP O
no DT B-NP O
radiation NN I-NP O
and CC O O
no DT O O
associated VBN O B-problem
symptoms NNS B-NP I-problem
. . B-VP O
   
ECG NNP B-NP B-test
showed VBD B-VP O
new JJ B-NP B-problem
diffuse NN I-NP I-problem
TWI NNP I-NP I-problem
in IN B-VP I-problem
all DT B-NP I-problem
leads NNS I-NP I-problem
. . B-VP O
   
Cardiac JJ B-NP B-test
enzymes NNS I-NP I-test
were VBD B-VP O
cycled VBN O O
and CC O O
were VBD B-VP O
normal JJ O O
. . B-VP O
   
Echo NNP B-NP B-test
was VBD B-VP O
obtained VBN O O
which WDT O B-pronoun
showed VBD B-VP O
WMA NNP B-NP B-problem
and CC O O
EF NNP B-NP B-test
of IN B-VP O
35-40% NNP B-NP O
. . B-VP O
   
Pt NNP B-NP B-person
was VBD B-VP O
note RB O O
started VBN O O
on IN B-VP O
ASA NNP B-NP B-treatment
as IN B-VP O
she PRP O B-person
does VBZ O O
not RB O O
tolerate VB O O
this DT B-NP B-pronoun
well NN I-NP O
, , O O
BB NNP B-NP B-treatment
was VBD B-VP O
also RB O O
not RB O O
started VBD B-VP O
given VBN O O
SBPs NNP B-NP B-test
in IN B-VP O
the DT O O
110s CD O O
. . B-VP O
   
Statin NN B-NP B-treatment
was VBD B-VP O
also RB O O
deffered VBN O O
. . B-VP O
   
She PRP O B-person
may MD O O
be VB O O
started VBN O O
on IN B-VP O
ASA NNP B-NP B-treatment
, , O O
BB NNP B-NP B-treatment
, , O O
statin NN B-NP B-treatment
by IN B-VP O
PCP NNP B-NP B-person
as IN B-VP O
Stephen NNP B-NP O
. . B-VP O
   
4. CD O O
Shoulder NNP B-NP B-problem
fracture NN I-NP I-problem
- : O O
Patient NN B-NP B-person
is VBZ O O
s/p PDT O O
a DT B-NP B-problem
left JJ I-NP I-problem
hip NN I-NP I-problem
fracture NN I-NP I-problem
( ( O O
decision NN B-NP O
not RB O O
to TO O O
operate VB O O
) ) O O
and CC O O
a DT B-NP B-problem
left JJ I-NP I-problem
shoulder NN I-NP I-problem
fracture NN I-NP I-problem
with IN B-VP O
hemiarthroplasty JJ B-NP B-treatment
11-14 NNS I-NP O
. . B-VP O
   
Patient NN B-NP B-person
was VBD B-VP O
found VBN O O
to TO O O
have VB O O
a DT B-NP B-problem
new JJ I-NP I-problem
humerus NN I-NP I-problem
fracture NN I-NP I-problem
distal NN I-NP I-problem
to TO O I-problem
the DT B-NP I-problem
hardware NN I-NP I-problem
on IN B-VP O
film NN B-NP B-test
this DT B-NP B-pronoun
admission NN I-NP O
. . B-VP O
   
Assumed VBN O O
to TO O O
be VB O O
secondary JJ O O
to TO O O
trauma VB O B-problem
when WRB O O
moving VBG O O
patient NN B-NP B-person
into IN B-VP O
ambulance NN B-NP O
. . B-VP O
   
CMED NNP B-NP B-person
service NN I-NP I-person
was VBD B-VP O
consulted VBN O O
and CC O O
recommended VBN O O
wtd NN B-NP B-treatment
woulnd NN I-NP I-treatment
care NN I-NP I-treatment
and CC O O
sling NN B-NP B-treatment
at IN B-VP O
all DT B-NP O
times NNS I-NP O
. . B-VP O
   
Wound NNP B-NP B-treatment
care NN I-NP I-treatment
should MD O O
be VB O O
continued VBN O O
as IN B-VP O
described NN B-NP O
after IN B-VP O
discharge NN B-NP O
. . B-VP O
   
5. CD O O
Type JJ O B-problem
2 CD O I-problem
DM NNP B-NP I-problem
- : O O
Patient NN B-NP B-person
was VBD B-VP O
initially RB O O
covered VBN O O
with IN B-VP O
an DT B-NP B-treatment
insulin NN I-NP I-treatment
drip NN I-NP I-treatment
while IN B-VP O
septic JJ O B-problem
and CC O O
then RB O O
transitioned VBD B-VP O
back RB O O
to TO O O
insulin VB O B-treatment
sliding VBG O I-treatment
scale NN B-NP I-treatment
. . B-VP O
   
6. CD O O
ESRD NNP B-NP B-problem
on IN B-VP O
HD NNP B-NP B-treatment
- : O O
Pt NN B-NP B-person
has VBZ O O
ESRD NNP B-NP B-problem
secondary JJ O O
to TO O O
her PRP$ O B-person
her PRP$ O B-problem
DM NNP B-NP I-problem
and CC O O
is VBZ O O
on IN B-VP O
HD NNP B-NP B-treatment
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
dialysed VBN O O
but CC O O
was VBD B-VP O
slightly RB O O
limited VBN O O
by IN B-VP O
hypotension NN B-NP B-problem
. . B-VP O
   
Dialyzed VBN O O
12-28 JJ O O
with IN B-VP O
plan NN B-NP O
to TO O O
dialyze VB O O
again RB O O
12-31 JJ O O
. . B-VP O
   
Her PRP$ O B-person
Her PRP$ O B-treatment
dialysis NN B-NP I-treatment
was VBD B-VP O
managed VBN O O
by IN B-VP O
renal JJ B-NP B-person
service NN I-NP I-person
in IN B-VP O
house NN B-NP O
. . B-VP O
   
7. CD O O
PE NNP B-NP B-problem
( ( O O
11-14 JJ B-NP O
)- NN I-NP O
On IN B-VP O
heparin NN B-NP B-treatment
drip NN I-NP I-treatment
. . B-VP O
   
Restared NNP B-NP O
coumadin NN I-NP B-treatment
on IN B-VP O
12-29 JJ O O
. . B-VP O
   
Heparin NNP B-NP B-treatment
discontinued VBD B-VP O
on IN B-VP O
01-01 NN B-NP O
when WRB O O
INR NNP B-NP B-test
was VBD B-VP O
2.0 CD O O
. . B-VP O
   
Coumadin NNP B-NP B-treatment
was VBD B-VP O
stopped VBN O O
and CC O O
she PRP O B-person
received VBD B-VP O
fFP NN B-NP B-treatment
for IN B-VP O
tunneled JJ B-NP B-treatment
line NN I-NP I-treatment
change NN I-NP O
over IN B-VP O
a DT B-NP B-treatment
wire NN I-NP I-treatment
. . B-VP O
   
Coumadin NNP B-NP B-treatment
was VBD B-VP O
restarted VBN O O
at IN B-VP O
a DT B-NP O
dose NN I-NP O
of IN B-VP O
2 CD O O
mg NN B-NP O
qhs NN I-NP O
. . B-VP O
   
This DT O B-pronoun
should MD O O
be VB O O
titrated VBN O O
after IN B-VP O
discharge NN B-NP O
for IN B-VP O
INR NNP B-NP B-test
goal NN I-NP I-test
of IN B-VP O
2-3 JJ O O
. . B-VP O
   
8. CD O O
PVD NNPS B-NP B-problem
: : O O
Dry NNP B-NP B-problem
gangrene NN I-NP I-problem
of IN B-VP I-problem
toes NNS B-NP I-problem
bilaterally RB O I-problem
w/ VBP O O
necrosis NN B-NP B-problem
of IN B-VP I-problem
the DT B-NP I-problem
heels NNS I-NP I-problem
and CC O I-problem
posterior JJ B-NP I-problem
calf NN I-NP I-problem
. . B-VP O
   
Continue VB O O
to TO O O
monitor VB O B-test
for IN B-VP O
sign NN B-NP O
of IN B-VP O
infection NN B-NP B-problem
. . B-VP O
   
On IN B-VP O
vit NN B-NP B-treatment
C. NNP I-NP I-treatment
and CC O O
zinc NN B-NP B-treatment
as RB O O
well RB O O
to TO O O
aid VB O O
w/ NN B-NP O
wound IN B-VP O
healing VBG O O
. . B-VP O
   
Wound NNP B-NP B-person
care NN I-NP I-person
consult NN I-NP O
given VBN O O
anasarca NN B-NP B-problem
to TO O O
prevent VB O O
decub NN B-NP B-problem
. . B-VP O
   
9. CD O O
Left NNP B-NP O
UE NNP I-NP O
markedly RB O O
more RBR O B-problem
edematous JJ O I-problem
than IN B-VP O
right JJ B-NP O
UE NNP I-NP O
, , O O
this DT O B-pronoun
could MD O O
be VB O O
from IN B-VP O
fracture NN B-NP B-problem
, , O O
or CC O O
there EX O O
could MD O O
be VB O O
a DT B-NP B-problem
clot NN I-NP I-problem
, , O O
an DT B-NP B-problem
abscess NN I-NP I-problem
in IN B-VP I-problem
the DT B-NP I-problem
area NN I-NP I-problem
also RB O O
a DT B-NP O
possiblity NN I-NP O
. . B-VP O
   
Ultrasound IN B-VP B-test
without IN B-VP O
clot NN B-NP B-problem
. . B-VP O
   
Continue NNP B-NP O
elevation NN I-NP B-treatment
and CC O O
tight JJ O B-treatment
dressing VBG O I-treatment
to TO O I-treatment
LUE NNP B-NP I-treatment
> NNP I-NP O
10. CD O O
Access NNP B-NP O
- : O O
Left VBD B-VP B-treatment
IJ NNP B-NP I-treatment
placed VBD B-VP O
12-26 JJ O O
in IN B-VP O
Juan NNP B-NP O
was VBD B-VP O
discontinued VBN O O
during IN B-VP O
the DT B-NP O
hospitilization NN I-NP O
. . B-VP O
   
Right JJ B-NP B-treatment
dialysis NN I-NP I-treatment
catheter NN I-NP I-treatment
( ( O O
2018-11-05 JJ O O
) ) O O
was VBD B-VP O
changed VBN O O
over IN B-VP O
a DT B-NP B-treatment
wire NN I-NP I-treatment
2019-01-08 JJ O O
. . B-VP O
   
PICC NNP B-NP B-treatment
line NN I-NP I-treatment
placed VBD B-VP O
2019-01-08 JJ O O
, , O O
this DT O B-pronoun
should MD O O
be VB O O
discontinued VBN O O
immediately RB O O
after IN B-VP O
pt NN B-NP B-person
finishes VBZ O O
the DT B-NP B-treatment
linezolid JJ I-NP I-treatment
course NN I-NP I-treatment
. . B-VP O
   
11. CD O O
Code NNP B-NP O
status NN I-NP O
- : O O
Initially RB O O
full JJ B-NP O
code NN I-NP O
then RB O O
made VBD B-VP O
DNR NNP B-NP O
/ NNP I-NP O
DNI NNP I-NP O
after IN B-VP O
family NN B-NP B-person
meeting NN I-NP O
on IN B-VP O
02-27 NN B-NP O
. . B-VP O
   
Made VBN O O
full JJ B-NP O
code NN I-NP O
again RB O O
on IN B-VP O
12-30 NNS B-NP O
after IN B-VP O
family NN B-NP B-person
meeting NN I-NP O
with IN B-VP O
son NN B-NP B-person
. . B-VP O
   
Larry NNP B-NP B-person
would MD O O
like VB O O
everything NN B-NP O
done VBN O O
. . B-VP O
   
12. CD O O
Communication NNP B-NP O
- : O O
With IN B-VP O
pt JJ B-NP B-person
pt NN I-NP B-person
's POS O I-person
son NN B-NP I-person
. . B-VP O
   
His PRP$ O B-person
name NN B-NP O
is VBZ O O
Andrea NNP B-NP B-person
and CC O O
his PRP$ O B-person
phone NN B-NP O
number NN I-NP O
is VBZ O O
794 CD O O
1029 CD O O
x. NN B-NP O
1385 CD O O
. . B-VP O
   
Medications NNS B-NP O
on IN B-VP O
Admission NN B-NP O
: : O O
1. CD O O
Ascorbic NNP B-NP B-treatment
acid VBD B-VP I-treatment
500 CD O O
mg NNS B-NP O
BID NNP I-NP O
2. CD O O
Folic NNP B-NP B-treatment
acid VBD B-VP I-treatment
1 CD O O
mg JJ O O
daily RB O O
3. CD O O
Humulin NNP B-NP B-treatment
insulin NN I-NP I-treatment
2 CD O O
units NNS B-NP O
QAM NNP I-NP O
4. CD O O
RISS NNP B-NP B-treatment
5. CD O O
Pantoprazole NNP B-NP B-treatment
40 CD O O
mg NN B-NP O
BID NNP I-NP O
6. CD O O
Neutra NNP B-NP B-treatment
phos NN I-NP I-treatment
2 CD O O
tabs NNS B-NP O
BID NNP I-NP O
7. CD O O
Vitamin NNP B-NP B-treatment
B NNP I-NP I-treatment
complex JJ O I-treatment
1 CD O O
tab JJ O O
daily RB O O
8. CD O O
Coumadin NNP B-NP B-treatment
- : O O
Dose NNP B-NP O
unknown JJ O O
9. CD O O
Tylenol NNP B-NP B-treatment
650 CD O O
mg NN B-NP O
Q4H NNP I-NP O
PRN NNP I-NP O
10. CD O O
Ondansetron NNP B-NP B-treatment
4 CD O O
mg NN B-NP O
Q6H NNP I-NP O
PRN NNP I-NP O
Discharge NNP I-NP O
Medications NNP I-NP O
: : O O
1. CD O O
Ascorbic NNP B-NP B-treatment
Acid NNP I-NP I-treatment
500 CD O O
mg NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Tablet NNP B-NP O
PO NNP I-NP O
BID NNP I-NP O
( ( O O
2 CD O O
times NNS B-NP O
a DT B-NP O
day NN I-NP O
) ) O O
. . B-VP O
   
2. CD O O
Folic NNP B-NP B-treatment
Acid NNP I-NP I-treatment
1 CD O O
mg NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Tablet NNP B-NP O
PO NNP I-NP O
DAILY NNP I-NP O
( ( O O
Daily NNP B-NP O
) ) O O
. . B-VP O
   
3. CD O O
Zinc NNP B-NP B-treatment
Sulfate NNP I-NP I-treatment
220 CD O O
mg NN B-NP O
Capsule NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Capsule NNP B-NP O
PO NNP I-NP O
DAILY NNP I-NP O
( ( O O
Daily NNP B-NP O
) ) O O
. . B-VP O
   
4. CD O O
Acetaminophen NNP B-NP B-treatment
325 CD O O
mg NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
1-2 JJ B-NP O
Tablets NNS I-NP O
PO NNP I-NP O
Q4-6H NNP I-NP O
( ( O O
every DT O O
4 CD O O
to TO O O
6 CD O O
hours NNS B-NP O
) ) O O
as IN B-VP O
needed VBN O O
. . B-VP O
   
5. CD O O
Papain NNP B-NP B-treatment
- : O I-treatment
Urea VBD B-VP I-treatment
544 CD O O
287 CD O O
0616 CD O O
unit NN B-NP O
- : O O
mg NN B-NP O
/ JJ B-NP O
g NN I-NP O
Ointment NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Appl NNP B-NP O
Topical NNP I-NP O
DAILY NNP I-NP O
( ( O O
Daily NNP B-NP O
) ) O O
. . B-VP O
   
6. CD O O
Ipratropium NNP B-NP B-treatment
Bromide NNP I-NP I-treatment
0.02 CD O O
% NN B-NP O
Solution NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Inhalation NN B-NP O
Q4H NNP I-NP O
( ( O O
every DT O O
4 CD O O
hours NNS B-NP O
) ) O O
. . B-VP O
   
7. CD O O
Calcium NNP B-NP B-treatment
Acetate NNP I-NP I-treatment
667 CD O O
mg NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Tablet NNP B-NP O
PO NNP I-NP O
TID NNP I-NP O
W/ NNP I-NP O
MEALS NNP I-NP O
( ( O O
3 CD O O
TIMES NNP B-NP O
A NNP I-NP O
DAY NNP I-NP O
WITH NNP I-NP O
MEALS NNP I-NP O
) ) O O
. . B-VP O
   
8. CD O O
Metoprolol NNP B-NP B-treatment
Tartrate NNP I-NP I-treatment
25 CD O O
mg NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
0.5 CD O O
Tablet NNP B-NP O
PO NNP I-NP O
TID NNP I-NP O
( ( O O
3 CD O O
times NNS B-NP O
a DT B-NP O
day NN I-NP O
) ) O O
: : O O
Hold NN B-NP O
for IN B-VP O
SBP NNP B-NP O
< NNP I-NP O
100 CD O O
, , O O
HR NNP B-NP O
< VBZ O O
60 CD O O
. . B-VP O
   
9. CD O O
Fluconazole JJ O B-treatment
200 CD O O
mg JJ B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Tablet NNP B-NP O
PO NNP I-NP O
Q24H NNP I-NP O
( ( O O
every DT O O
24 CD O O
hours NNS B-NP O
) ) O O
for IN B-VP O
2 CD O O
days NNS B-NP O
. . B-VP O
   
10. CD O O
Insulin NNP B-NP B-treatment
Regular NNP I-NP I-treatment
Human NNP I-NP I-treatment
300 CD O O
unit NN B-NP O
/ VBD B-VP O
3 CD O O
mL JJ B-NP O
Insulin NNP I-NP O
Pen NNP I-NP O
Sig NNP I-NP O
: : O O
as IN B-VP O
directed VBN O O
Subcutaneous NNP B-NP O
four CD O O
times NNS B-NP O
a DT B-NP O
day NN I-NP O
: : O O
Please NNP B-NP O
administer RB O O
8 CD O O
units NNS B-NP O
glargine VBP O B-treatment
at IN B-VP O
dinner NN B-NP O
and CC O O
regular JJ B-NP B-treatment
insulin NN I-NP I-treatment
sliding VBG O I-treatment
scale NN B-NP I-treatment
as IN B-VP O
prescribed NN B-NP O
. . B-VP O
   
11. CD O O
Warfarin NNP B-NP B-treatment
2 CD O O
mg NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Tablet NNP B-NP O
PO NNP I-NP O
HS NNP I-NP O
( ( O O
at IN B-VP O
bedtime NN B-NP O
) ) O O
: : O O
Titrate NN B-NP O
dose NN I-NP O
to TO O O
Goal NNP B-NP O
INR NNP I-NP B-test
03-15 NNP I-NP O
. . B-VP O
   
Tablet NNP B-NP O
( ( O O
s NN B-NP O
) ) O O
12. CD O O
Linezolid JJ O B-treatment
600 CD O O
mg NN B-NP O
IV NNP I-NP O
Q12H NNP I-NP O
13. CD O O
Heparin NNP B-NP B-treatment
Flush NNP I-NP I-treatment
PICC NNP I-NP I-treatment
( ( O O
100 CD O O
units NNS B-NP O
/ NNP I-NP O
ml NN I-NP O
) ) O O
2 CD O O
ml JJ B-NP O
IV NNP I-NP O
DAILY NNP I-NP O
: : O O
PRN NNP B-NP O
10 CD O O
ml NN B-NP O
NS NNP I-NP O
followed VBN O O
by IN B-VP O
2 CD O O
ml NNS B-NP O
of IN B-VP O
100 CD O O
Units NNS B-NP O
/ VBP O O
ml JJ B-NP O
heparin NN I-NP B-treatment
( ( O O
200 CD O O
units NNS B-NP O
heparin RB O B-treatment
) ) O O
each DT B-NP O
lumen JJ I-NP B-treatment
Daily NNP I-NP O
and CC O O
PRN NNP B-NP O
. . B-VP O
   
Inspect NNP B-NP O
site NN I-NP O
every DT B-NP O
shift NN I-NP O
. . B-VP O
   
14. CD O O
Heparin NNP B-NP B-treatment
Flush NNP I-NP I-treatment
CVL NNP I-NP I-treatment
( ( O O
100 CD O O
units NNS B-NP O
/ NNP I-NP O
ml NN I-NP O
) ) O O
1 CD O O
ml JJ B-NP O
IV NNP I-NP O
DAILY NNP I-NP O
: : O O
PRN NNP B-NP O
10ml CD O O
NS NNP B-NP B-treatment
followed VBN O O
by IN B-VP O
1ml CD O O
of IN B-VP O
100 CD O O
units/ml JJ B-NP O
heparin NN I-NP B-treatment
( ( O O
100 CD O O
units NNS B-NP O
heparin RB O B-treatment
) ) O O
each DT B-NP O
lumen NNS I-NP B-treatment
QD NNP I-NP O
and CC O O
PRN NNP B-NP O
. . B-VP O
   
Inspect NNP B-NP O
site NN I-NP O
every DT B-NP O
shift NN I-NP O
15. CD O O
Dolasetron NNP B-NP B-treatment
Mesylate NNP I-NP I-treatment
12.5 CD O O
mg NN B-NP O
IV NNP I-NP O
Q8H NNP I-NP O
: : O O
PRN NNP B-NP O
16. CD O O
medication NN B-NP B-treatment
Please NNP I-NP O
complete VB O O
a DT O O
total JJ O O
14 CD O O
day NN B-NP O
course NN I-NP O
of IN B-VP O
linezolid JJ O B-treatment
. . B-VP O
   
Stop NNP B-NP O
linezolid NN I-NP B-treatment
on IN B-VP O
2019-01-17 JJ O O
. . B-VP O
   
The DT B-NP B-treatment
PICC NNP I-NP I-treatment
line NN I-NP I-treatment
should MD O O
be VB O O
discontinued VBN O O
promptly RB O O
after IN B-VP O
the DT B-NP B-treatment
linezolid JJ I-NP I-treatment
course NN I-NP I-treatment
is VBZ O O
completed VBN O O
. . B-VP O
   
Discharge NNP B-NP O
Disposition NNP I-NP O
: : O O
Extended VBN O O
Care NNP B-NP O
Facility NNP I-NP O
: : O O
Newton-Wellesley NNP B-NP O
Hospital NNP I-NP O
for IN B-VP O
the DT B-NP O
Aged NNP I-NP O
- : O O
Acute NNP B-NP O
Rehab NNP I-NP O
Discharge NNP I-NP O
Diagnosis NNP I-NP O
: : O O
Sepsis NN B-NP B-problem
-? NNP I-NP O
source NN I-NP O
Chronic NNP I-NP B-problem
Kidney NNP I-NP I-problem
disease NN I-NP I-problem
- : O O
on IN B-VP O
hemodialysis NN B-NP B-treatment
type NN I-NP B-problem
2 CD O I-problem
diabetes NNS B-NP I-problem
hypercholestrolemia JJ B-NP B-problem
anemia NN I-NP B-problem
of IN B-VP I-problem
chornic JJ B-NP I-problem
disease NN I-NP I-problem
h/o NN I-NP O
PE NNP I-NP B-problem
, , O O
s/p NN B-NP O
PEA NNP I-NP B-problem
arrest IN B-VP I-problem
11-14 JJ B-NP O
Discharge NNP I-NP O
Condition NNP I-NP O
: : O O
Stable JJ B-NP O
Discharge NN I-NP O
Instructions NNS I-NP O
: : O O
You PRP O B-person
were VBD B-VP O
admitted VBN O O
with IN B-VP O
low JJ B-NP B-problem
blood NN I-NP I-problem
pressure NN I-NP I-problem
and CC O O
fevers NNS B-NP B-problem
likely RB O O
due JJ O O
to TO O O
an DT B-NP B-problem
infection NN I-NP I-problem
. . B-VP O
   
Although IN B-VP O
there EX O O
was VBD B-VP O
never RB O O
any DT B-NP B-problem
bacteria NNS I-NP I-problem
isolated VBN O O
from IN B-VP O
the DT B-NP B-test
blood NN I-NP I-test
you PRP O B-person
had VBD B-VP O
some DT B-NP B-problem
bacteria NNS I-NP I-problem
in IN B-VP I-problem
the DT B-NP I-problem
urine NN I-NP I-problem
which WDT O B-pronoun
you PRP O B-person
are VBP O O
being VBG O O
treated VBN O O
for IN B-VP O
. . B-VP O
   
It PRP O B-pronoun
is VBZ O O
important JJ O O
that IN B-VP B-pronoun
you PRP O B-person
complete VBP O O
the DT B-NP B-treatment
antibiotic JJ I-NP I-treatment
course NN I-NP I-treatment
as IN B-VP O
prescribed JJ O O
. . B-VP O
   
Please NNP B-NP O
continue VBP O O
to TO O O
take VB O O
all DT B-NP B-treatment
medications NNS I-NP I-treatment
as IN B-VP O
prescirbed NN B-NP O
and CC O O
follow VB O O
up RP O O
with IN B-VP O
all DT O O
your PRP$ O B-person
appointments NNS B-NP O
. . B-VP O
   
If IN B-VP O
you PRP O B-person
have VBP O O
chest VBN O B-problem
pain NN B-NP I-problem
, , O O
shortness NN B-NP B-problem
of IN B-VP I-problem
breath NN B-NP I-problem
, , O O
diahrrea NN B-NP B-problem
or CC O O
fevers NNS B-NP B-problem
please VBP O O
contact VB O O
your PRP$ O B-person
your PRP$ O B-person
PCP NNP B-NP I-person
. . B-VP O
   
Robert NNP B-NP O
the DT B-NP B-problem
shortness NN I-NP I-problem
of IN B-VP I-problem
breath NN B-NP I-problem
gets VBZ O O
worse JJR B-NP O
please NN I-NP O
return VB O O
to TO O O
emergency NN B-NP O
room NN I-NP O
. . B-VP O
   
If IN B-VP O
you PRP O B-person
have VBP O O
fevers NNS B-NP B-problem
please VB O O
contact VB O O
your PRP$ O B-person
your PRP$ O B-person
PCP NN B-NP I-person
or CC O O
return NN B-NP O
to TO O O
the DT B-NP O
emergency NN I-NP O
room NN I-NP O
. . B-VP O
   
Followup JJ B-NP O
Instructions NNS I-NP O
: : O O
Please VB O O
call VB O O
( ( O O
664 CD O O
) ) O O
369-9786 CD O O
to TO O O
set VB O O
up RP O O
an DT B-NP O
appointment NN I-NP O
with IN B-VP O
your PRP$ O B-person
your PRP$ O B-person
primary JJ B-NP I-person
care NN I-NP I-person
doctor NN I-NP I-person
Dr. NNP I-NP B-person
Andrew NNP I-NP I-person
Shelton NNP I-NP I-person
in IN B-VP O
1-2 JJ B-NP O
wks NN I-NP O
after IN B-VP O
discharge NN B-NP O
. . B-VP O
   
Cleveland NNP B-NP B-person
Barbara NNP I-NP I-person
MD NNP I-NP I-person
00-732 NN I-NP O
Completed VBN O O
by IN B-VP O
: : O O
Sharon NNP B-NP B-person
Frank NNP I-NP I-person
MD NNP I-NP I-person
75-572 JJ B-NP O
2019-01-10 JJ I-NP O
@ NN I-NP O
1333 CD O O
Signed NNP B-NP O
electronically RB O O
by IN B-VP O
: : O O
DR. NNP B-NP B-person
Janice NNP I-NP I-person
Oconnell NNP I-NP I-person
on IN B-VP O
: : O O
Kent NNP B-NP O
2019-01-10 JJ O O
3:28 CD O O
PM NNP B-NP O
( ( O O
End NNP B-NP O
of IN B-VP O
Report NNP B-NP O
) ) O O
-EMPTYLINE- VBP O O
-DOCSTART- JJ O O
-EMPTYLINE- $ O O
693008750 CD O O
HLGMC NNP B-NP O
6001356 CD O O
014235 CD O O
9/18/2001 CD O O
12:00:00 CD O O
AM NNP B-NP O
ED NNP I-NP O
Discharge NNP I-NP O
Summary NNP I-NP O
Unsigned VBD B-VP O
DIS NNP B-NP O
Report NNP I-NP O
Status NNP I-NP O
: : O O
Unsigned VBD B-VP O
ED NNP B-NP O
DISCHARGE NNP I-NP O
NOTIFICATION NNP I-NP O
HUHTLAND NNP I-NP B-person
, , O I-person
CIE NNP B-NP I-person
MRN NNP I-NP O
: : O O
6001356 CD O O
Age NNP B-NP O
: : O O
82y CD O O
REGISTRATION NNP B-NP O
DATE NNP I-NP O
: : O O
09/18/2001 CD O O
10:52 CD O O
AM NNP B-NP O
PRELIMINARY NNP I-NP O
REPORT NNP I-NP O
This DT O B-pronoun
is VBZ O O
to TO O O
notify VB O O
you PRP O B-person
that IN B-VP B-pronoun
your PRP$ O B-person
your PRP$ O B-person
patient NN B-NP I-person
, , O O
HUHTLAND NNP B-NP B-person
, , O I-person
CIE NNP B-NP I-person
arrived VBD B-VP O
in IN B-VP O
the DT B-NP O
Emergency NNP I-NP O
Department NNP I-NP O
at IN B-VP O
Heaonboburg NNP B-NP O
Linpack NNP I-NP O
Grant NNP I-NP O
Medical NNP I-NP O
Center NNP I-NP O
on IN B-VP O
09/18/2001 CD O O
10:52 CD O O
AM NNP B-NP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
presented VBN O O
with IN B-VP O
a DT B-NP O
chief JJ I-NP O
complaint NN I-NP O
of IN B-VP O
WHEEZES NNP B-NP B-problem
. . B-VP O
   
Following VBG O O
evaluation NN B-NP B-test
and CC O O
treatment NN B-NP B-treatment
, , O O
the DT B-NP B-person
patient NN I-NP I-person
&apos;s JJ B-NP O
disposition NN I-NP O
at IN B-VP O
the DT B-NP O
end NN I-NP O
of IN B-VP O
the DT B-NP O
visit NN I-NP O
was VBD B-VP O
ADMITTED NNP B-NP O
AS IN B-VP O
AN NNP B-NP O
INPATIENT NNP I-NP O
TO NNP I-NP O
HEAONBOBURG NNP I-NP O
LINPACK NNP I-NP O
GRANT NNP I-NP O
MEDICAL NNP I-NP O
CENTER NNP I-NP O
. . B-VP O
   
Your PRP$ O B-person
Your PRP$ O B-person
patient NN B-NP I-person
was VBD B-VP O
admitted VBN O O
under IN B-VP O
the DT B-NP O
care NN I-NP O
of IN B-VP O
SAPSCLYSS NNP B-NP B-person
, , O I-person
LEO NNP B-NP I-person
R NNP I-NP I-person
with IN B-VP O
a DT B-NP O
preliminary JJ I-NP O
diagnosis NN I-NP O
of IN B-VP O
PNEUMONIA NNP B-NP B-problem
, , O O
. . B-VP O
   
If IN B-VP O
you PRP O B-person
need VBP O O
additional JJ B-NP O
information NN I-NP O
please NN I-NP O
call VB O O
605-304-8547 JJ O O
. . B-VP O
   
PCP NNPS B-NP B-person
Name NN I-NP O
: : O O
SC NNP B-NP B-person
, , O I-person
JUSONKIM NNP B-NP I-person
N NNP I-NP I-person
Provider NNP I-NP O
Number NNP I-NP O
: : O O
96078 CD O O
-EMPTYLINE- NN B-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
Admission NNP I-NP O
Date NNP I-NP O
: : O O
2012-04-20 JJ B-NP O
Discharge NN I-NP O
Date NNP I-NP O
: : O O
2012-05-01 JJ B-NP O
Date NNP I-NP O
of IN B-VP O
Birth NNP B-NP O
: : O O
1952-06-24 JJ B-NP O
Sex NN I-NP O
: : O O
M NNP B-NP O
Service NNP I-NP O
: : O O
Medicine NNP B-NP O
HISTORY NNP I-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS NNP I-NP O
: : O O
This DT O B-pronoun
is VBZ O O
a DT O O
59 CD O O
year NN B-NP O
old JJ B-NP O
male NN I-NP O
with IN B-VP O
a DT B-NP O
past JJ I-NP O
medical JJ I-NP O
history NN I-NP O
significant JJ O O
for IN B-VP O
an DT B-NP B-treatment
atrioseptal JJ I-NP I-treatment
defect NN I-NP I-treatment
repair NN I-NP I-treatment
at IN B-VP O
age NN B-NP O
18 CD O O
, , O O
congestive JJ B-NP B-problem
heart NN I-NP I-problem
failure NN I-NP I-problem
with IN B-VP O
an DT B-NP B-test
ejection NN I-NP I-test
fraction NN I-NP I-test
of IN B-VP O
45% CD O O
and CC O O
a DT B-NP B-problem
recent JJ I-NP I-problem
cardiac JJ I-NP I-problem
myocardial NN I-NP I-problem
infarction NN I-NP I-problem
, , O O
pulmonary JJ B-NP B-problem
hypertension NN I-NP I-problem
and CC O O
mitral JJ B-NP B-problem
regurgitation NN I-NP I-problem
, , O O
and CC O O
atrial JJ B-NP B-problem
fibrillation NN I-NP I-problem
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
seen VBN O O
by IN B-VP O
his PRP$ O B-person
his PRP$ O B-person
primary JJ B-NP I-person
care NN I-NP I-person
physician JJ O I-person
the DT B-NP O
day NN I-NP O
before IN B-VP O
admission NN B-NP O
and CC O O
complained VBN O O
of IN B-VP O
two CD O O
weeks NNS B-NP O
of IN B-VP O
increasing VBG O B-problem
shortness NN B-NP I-problem
of IN B-VP I-problem
breath NN B-NP I-problem
and CC O O
fatigue NN B-NP B-problem
, , O O
weight VBD B-VP B-problem
gain NN B-NP I-problem
and CC O O
abdominal JJ B-NP B-problem
fullness NN I-NP I-problem
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
sent VBN O O
to TO O O
the DT B-NP O
Emergency NNP I-NP O
Department NNP I-NP O
for IN B-VP O
further JJ B-NP B-test
evaluation NN I-NP I-test
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
reported VBD B-VP O
feeling NN B-NP O
at IN B-VP O
his PRP$ O B-person
baseline NN B-NP O
with IN B-VP O
chronic JJ B-NP B-problem
mild NNS I-NP I-problem
dyspnea VBP O I-problem
on IN B-VP O
exertion NN B-NP O
until IN B-VP O
two CD O O
weeks NNS B-NP O
prior RB O O
to TO O O
admission NN B-NP O
. . B-VP O
   
During IN B-VP O
this DT B-NP B-pronoun
period NN I-NP O
he PRP O B-person
had VBD B-VP O
also RB O O
been VBN O O
weaned VBN O O
off IN B-VP O
of IN B-VP O
his PRP$ O B-person
his PRP$ O B-treatment
Digoxin NN B-NP I-treatment
starting VBG O O
early JJ O O
in IN B-VP O
February NNP B-NP O
. . B-VP O
   
Over IN B-VP O
the DT O O
two CD O O
weeks NNS B-NP O
prior RB O O
to TO O O
admission NN B-NP O
he PRP O B-person
had VBD B-VP O
noticed VBN O O
an DT O B-problem
increasing VBG O I-problem
heart NN B-NP I-problem
rate NN I-NP I-problem
from IN B-VP O
his PRP$ O B-person
baseline NN B-NP O
in IN B-VP O
the DT O O
60s CD O O
to TO O O
a DT B-NP B-test
heart NN I-NP I-test
rate NN I-NP I-test
in IN B-VP O
the DT O O
120s CD O O
. . B-VP O
   
He PRP O B-person
had VBD B-VP O
also RB O O
some DT O B-problem
increased VBD B-VP I-problem
shortness NN B-NP I-problem
of IN B-VP I-problem
breath NN B-NP I-problem
and CC O O
a DT O B-problem
10 CD O I-problem
pound NN B-NP I-problem
weight VBD B-VP I-problem
gain NN B-NP I-problem
and CC O O
new JJ O O
three CD O O
to TO O O
four CD O O
pillow NN B-NP B-problem
orthopnea NN I-NP I-problem
with IN B-VP O
a DT B-NP B-problem
dry JJ I-NP I-problem
cough NN I-NP I-problem
. . B-VP O
   
He PRP O B-person
denied VBD B-VP O
fevers NNS B-NP B-problem
, , O O
chills NNS B-NP B-problem
, , O O
nausea NN B-NP B-problem
or CC O O
vomiting NN B-NP B-problem
, , O O
chest VBP O B-problem
pain NN B-NP I-problem
or CC O O
diaphoresis NN B-NP B-problem
. . B-VP O
   
PAST NNP B-NP O
MEDICAL NNP I-NP O
HISTORY NNP I-NP O
: : O O
Atrioseptal JJ B-NP B-treatment
defect NN I-NP I-treatment
repair NN I-NP I-treatment
in IN B-VP O
1970 CD O O
, , O O
cardiomyopathy NN B-NP B-problem
, , O O
right-sided JJ B-NP B-problem
congestive JJ I-NP I-problem
heart NN I-NP I-problem
failure NN I-NP I-problem
, , O O
pulmonary JJ B-NP B-problem
hypertension NN I-NP I-problem
, , O O
history NN B-NP O
of IN B-VP O
atrial JJ B-NP B-problem
fibrillation NN I-NP I-problem
and CC O O
atrial JJ B-NP B-problem
flutter NN I-NP I-problem
, , O O
history NN B-NP O
of IN B-VP O
prostate NN B-NP B-problem
cancer NN I-NP I-problem
, , O O
status NN B-NP B-treatment
post NN I-NP I-treatment
brachytherapy NN I-NP I-treatment
, , O O
history NN B-NP O
of IN B-VP O
rectal JJ B-NP B-problem
bleeding NN I-NP I-problem
, , O O
obstructive JJ B-NP B-problem
sleep NN I-NP I-problem
apnea NN I-NP I-problem
on IN B-VP O
CPAP NNP B-NP B-treatment
. . B-VP O
   
ALLERGIES NNP B-NP O
: : O O
ACE NNP B-NP B-treatment
inhibitors NNS I-NP I-treatment
, , O O
possible JJ B-NP O
allergy NN I-NP B-problem
to TO O O
barium NN B-NP B-treatment
reported VBN O O
by IN B-VP O
the DT B-NP B-person
patient NN I-NP I-person
during IN B-VP O
a DT B-NP B-treatment
barium NN I-NP I-treatment
swallow JJ O I-treatment
25 CD O O
years NNS B-NP O
ago RB O O
. . B-VP O
   
MEDICATIONS NNP B-NP O
ON NNP I-NP O
ADMISSION NNP I-NP O
: : O O
Digoxin NN B-NP B-treatment
0.125 CD O O
, , O O
discontinued VBD B-VP O
one CD O O
month NN B-NP O
prior RB O O
to TO O O
admission NN B-NP O
, , O O
Toprol NNP B-NP B-treatment
XL NNP I-NP I-treatment
100 CD O O
mg JJ O O
daily RB O O
, , O O
Trazodone NNP B-NP B-treatment
50 CD O O
mg NN B-NP O
once RB O O
daily JJ O O
, , O O
Lipitor NNP B-NP B-treatment
10 CD O O
mg JJ O O
daily RB O O
, , O O
Diovan NNP B-NP B-treatment
40 CD O O
mg JJ O O
daily RB O O
, , O O
Atrovent NNP B-NP B-treatment
/ NNP I-NP O
Albuterol NNP I-NP B-treatment
prn NN I-NP O
, , O O
Pulmicort NNP B-NP B-treatment
, , O O
Coumadin NNP B-NP B-treatment
2.5 CD O O
mg JJ O O
daily RB O O
, , O O
Vitamin NNP B-NP B-treatment
E NNP I-NP I-treatment
, , O O
Vitamin NNP B-NP B-treatment
C NNP I-NP I-treatment
, , O O
iron NN B-NP B-treatment
supplement NN I-NP I-treatment
. . B-VP O
   
SOCIAL NNP B-NP O
HISTORY NNP I-NP O
: : O O
Remote JJ B-NP O
history NN I-NP O
of IN B-VP O
tobacco NN B-NP O
, , O O
occasional JJ B-NP O
alcohol NN I-NP O
use NN I-NP O
. . B-VP O
   
He PRP O B-person
is VBZ O O
a DT B-NP O
retired JJ I-NP O
fire NN I-NP O
fighter NN I-NP O
. . B-VP O
   
LABORATORY NNP B-NP O
DATA NNP I-NP O
: : O O
White NNP B-NP B-test
blood NN I-NP I-test
cell NN I-NP I-test
count NN I-NP I-test
10.5 CD O O
, , O O
hematocrit NN B-NP B-test
38.1 CD O O
, , O O
platelets NNS B-NP B-test
254 CD O O
, , O O
INR NNP B-NP B-test
1.8 CD O O
. . B-VP O
   
Sodium NN B-NP B-test
140 CD O O
, , O O
potassium NN B-NP B-test
5.2 CD O O
, , O O
BUN NNP B-NP B-test
38 CD O O
, , O O
creatinine NN B-NP B-test
.7 NN I-NP O
, , O O
TSH NNP B-NP B-test
1.8 CD O O
, , O O
Digoxin NNP B-NP B-test
level NN I-NP I-test
less JJR O O
than IN B-VP O
0.2 CD O O
. . B-VP O
   
Serial JJ B-NP B-test
cardiac JJ I-NP I-test
enzymes NNS I-NP I-test
negative JJ O O
. . B-VP O
   
ALT NNP B-NP B-test
14 CD O O
, , O O
AST NNP B-NP B-test
31 CD O O
, , O O
alkaline JJ B-NP B-test
phosphatase NN I-NP I-test
283 CD O O
, , O O
total JJ B-NP B-test
bilirubin NN I-NP I-test
1.0 CD O O
, , O O
amylase NN B-NP B-test
71 CD O O
, , O O
glucose JJ B-NP B-test
tolerance NN I-NP I-test
test NN I-NP I-test
317 CD O O
. . B-VP O
   
Electrocardiogram NN B-NP B-test
showed VBD B-VP O
atrial JJ B-NP B-problem
fibrillation NN I-NP I-problem
with IN B-VP O
rapid JJ B-NP B-problem
ventricular JJ I-NP I-problem
response NN I-NP I-problem
and CC O O
atrial JJ B-NP B-problem
flutter NN I-NP I-problem
. . B-VP O
   
Echocardiogram NNP B-NP B-test
showed VBD B-VP O
moderate JJ O B-problem
dilated VBN O I-problem
left JJ B-NP I-problem
atrium NN I-NP I-problem
, , O O
no DT B-NP O
atrioseptal JJ I-NP B-problem
defect NN I-NP I-problem
, , O O
severe JJ O B-problem
global JJ O I-problem
left VBD B-VP I-problem
ventricular JJ B-NP I-problem
hypokinesis NN I-NP I-problem
with IN B-VP O
severe JJ O B-problem
left VBN O I-problem
ventricular JJ B-NP I-problem
systolic JJ I-NP I-problem
function NN I-NP I-problem
and CC O O
moderately RB O B-problem
dilated VBD B-VP I-problem
right JJ B-NP I-problem
ventricle NN I-NP I-problem
. . B-VP O
   
There EX O O
was VBD B-VP O
global JJ B-NP B-problem
hypokinesis NN I-NP I-problem
apical JJ O I-problem
throughout IN B-VP I-problem
the DT B-NP I-problem
right JJ I-NP I-problem
ventricle NN I-NP I-problem
and CC O O
abnormal JJ B-NP B-problem
septal JJ I-NP I-problem
motion NN I-NP I-problem
consistent NN I-NP O
with IN B-VP O
right JJ B-NP B-problem
ventricular NN I-NP I-problem
volume NN I-NP I-problem
overload NN I-NP I-problem
. . B-VP O
   
Moderate NNP B-NP B-problem
to TO O I-problem
severe VB O I-problem
3+ CD O I-problem
mitral JJ B-NP I-problem
regurgitation NN I-NP I-problem
and CC O O
3+ CD O B-problem
tricuspid JJ B-NP I-problem
regurgitation NN I-NP I-problem
along IN B-VP O
with IN B-VP O
moderate JJ B-NP B-problem
pulmonary JJ I-NP I-problem
early JJ I-NP I-problem
systolic JJ I-NP I-problem
hypertension NN I-NP I-problem
. . B-VP O
   
Of IN B-VP O
note NN B-NP O
, , O O
this DT O B-pronoun
this DT B-NP B-test
echocardiogram NN I-NP I-test
was VBD B-VP O
performed VBN O O
when WRB O O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
tachycardiac JJ O B-problem
. . B-VP O
   
HOSPITAL NNP B-NP O
COURSE NNP I-NP O
: : O O
1. CD O O
Hypotension NNP B-NP B-problem
- : O O
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
initially RB O O
mildly RB O B-problem
hypotensive JJ O I-problem
with IN B-VP O
systolic JJ B-NP B-test
blood NN I-NP I-test
pressures NNS I-NP I-test
in IN B-VP O
the DT O O
80s CD O O
. . B-VP O
   
Upon IN B-VP O
admission NN B-NP O
it PRP O B-pronoun
was VBD B-VP O
unclear JJ O O
whether IN B-VP O
or CC O O
not RB O O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
volume NN B-NP B-problem
overloaded VBD B-VP I-problem
or CC O O
volume NN B-NP B-problem
depleted VBN O I-problem
. . B-VP O
   
Initially RB O O
he PRP O B-person
was VBD B-VP O
treated VBN O O
with IN B-VP O
intravenous JJ B-NP B-treatment
fluids NNS I-NP I-treatment
with IN B-VP O
a DT B-NP O
dramatic JJ I-NP O
response NN I-NP O
in IN B-VP O
his PRP$ O B-person
his PRP$ O B-test
systolic JJ B-NP I-test
blood NN I-NP I-test
pressure NN I-NP I-test
. . B-VP O
   
However RB O O
, , O O
subsequent VBD B-VP O
it PRP O B-pronoun
was VBD B-VP O
determined VBN O O
that IN B-VP B-pronoun
the DT O B-person
the DT B-NP B-problem
patient JJ I-NP I-person
patient NN I-NP I-problem
's POS O I-problem
hypotension NN B-NP I-problem
may MD O O
have VB O O
been VBN O O
related VBN O O
to TO O O
his PRP$ O B-person
his PRP$ O B-problem
rapid JJ B-NP I-problem
ventricular JJ I-NP I-problem
response NN I-NP I-problem
and CC O O
right JJ B-NP B-problem
heart NN I-NP I-problem
failure NN I-NP I-problem
. . B-VP O
   
Therefore IN B-VP O
the DT B-NP O
focus NN I-NP O
of IN B-VP O
treatment NN B-NP B-treatment
was VBD B-VP O
changed VBN O O
to TO O O
controlling VBG O O
his PRP$ O B-person
his PRP$ O B-test
rate NN B-NP I-test
. . B-VP O
   
2. CD O O
Atrial JJ B-NP B-problem
fibrillation NN I-NP I-problem
- : O O
The DT O B-person
The DT B-NP B-treatment
patient JJ I-NP I-person
patient NN I-NP I-treatment
's POS O I-treatment
Digoxin NNP B-NP I-treatment
had VBD B-VP O
been VBN O O
weaned VBN O O
off RP O O
prior JJ O O
to TO O O
his PRP$ O B-person
admission NN B-NP O
. . B-VP O
   
It PRP O B-pronoun
was VBD B-VP O
felt VBN O O
that IN B-VP B-pronoun
this DT O B-pronoun
potentially RB O O
had VBD B-VP O
lead VBN O O
to TO O O
his PRP$ O B-person
his PRP$ O B-problem
atrial JJ B-NP I-problem
flutter NN I-NP I-problem
and CC O O
atrial JJ B-NP B-problem
fibrillation NN I-NP I-problem
with IN B-VP O
rapid JJ B-NP B-problem
ventricular JJ I-NP I-problem
response NN I-NP I-problem
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
loaded VBN O O
once RB O O
again RB O O
with IN B-VP O
Digoxin NNP B-NP B-treatment
and CC O O
his PRP$ O B-person
his PRP$ O B-treatment
beta NN B-NP I-treatment
blocker NN I-NP I-treatment
was VBD B-VP O
increased VBN O O
to TO O O
100 CD O O
mg NN B-NP O
of IN B-VP O
Lopressor NNP B-NP B-treatment
, , O O
three CD O O
times NNS B-NP O
a DT B-NP O
day NN I-NP O
. . B-VP O
   
In IN B-VP O
addition NN B-NP O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
started VBN O O
on IN B-VP O
Verapamil NNP B-NP B-treatment
since IN B-VP O
his PRP$ O B-test
his PRP$ O B-person
heart NN B-NP I-test
rate NN I-NP I-test
had VBD B-VP O
remained VBN O O
mildly RB O B-problem
tachycardiac JJ O I-problem
in IN B-VP O
the DT O O
low JJ O O
100s CD O O
. . B-VP O
   
3. CD O O
Congestive JJ B-NP B-problem
heart NN I-NP I-problem
failure NN I-NP I-problem
- : O O
During IN B-VP O
the DT B-NP O
initial JJ I-NP O
course NN I-NP O
of IN B-VP O
the DT B-NP B-person
patient NN I-NP I-person
's POS O O
admission NN B-NP O
, , O O
it PRP O B-pronoun
was VBD B-VP O
unclear JJ O O
as IN B-VP O
to TO O O
whether IN B-VP O
or CC O O
not RB O O
he PRP O B-person
was VBD B-VP O
volume NN B-NP B-problem
overloaded VBD B-VP I-problem
or CC O O
volume NN B-NP B-problem
depleted VBN O I-problem
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
initially RB O O
treated VBN O O
with IN B-VP O
intravenous JJ B-NP B-treatment
fluids NNS I-NP I-treatment
, , O O
however RB O O
, , O O
subsequently RB O O
he PRP O B-person
was VBD B-VP O
diuresed VBN O O
when WRB O O
he PRP O B-person
became VBD B-VP O
symptomatic JJ O B-problem
and CC O O
short JJ O B-problem
of IN B-VP I-problem
breath NN B-NP I-problem
. . B-VP O
   
Chest NNP B-NP B-test
x-rays JJ O I-test
revealed VBD B-VP O
evidence NN B-NP O
of IN B-VP O
congestive JJ B-NP B-problem
heart NN I-NP I-problem
failure NN I-NP I-problem
. . B-VP O
   
The DT B-NP O
decision NN I-NP O
was VBD B-VP O
made VBN O O
to TO O O
have VB O O
the DT B-NP B-person
patient NN I-NP I-person
undergo VBZ O O
a DT B-NP B-test
cardiac JJ I-NP I-test
catheterization NN I-NP I-test
to TO O O
fully RB O O
evaluate VB O O
the DT B-NP O
hemodynamics NNS I-NP O
to TO O O
determine VB O O
the DT B-NP O
etiology NN I-NP O
of IN B-VP O
the DT O B-person
the DT B-NP B-problem
patient JJ I-NP I-person
patient NN I-NP I-problem
's POS O I-problem
heart NN B-NP I-problem
failure NN I-NP I-problem
. . B-VP O
   
In IN B-VP O
addition NN B-NP O
, , O O
plans NNS B-NP O
were VBD B-VP O
made VBN O O
to TO O O
evaluate VB O O
the DT B-NP B-person
patient NN I-NP I-person
's POS O O
cardiac JJ B-NP O
arteries NNS I-NP O
to TO O O
determine VB O O
if IN B-VP O
he PRP O B-person
had VBD B-VP O
any DT B-NP O
component NN I-NP O
of IN B-VP O
ischemic JJ B-NP B-problem
cardiomyopathy NN I-NP I-problem
. . B-VP O
   
4. CD O O
Abnormal JJ B-NP B-test
liver NN I-NP I-test
function NN I-NP I-test
tests VBZ O I-test
- : O O
The DT B-NP B-person
patient NN I-NP I-person
had VBD B-VP O
an DT O B-problem
isolated VBN O I-problem
, , O I-problem
elevated JJ B-NP I-problem
alkaline NN I-NP I-problem
phosphatase NN I-NP I-problem
with IN B-VP O
a DT B-NP B-problem
confirmatory JJ I-NP I-problem
elevation NN I-NP I-problem
in IN B-VP O
his PRP$ O B-person
his PRP$ O B-test
gamma NN B-NP I-test
glutamyl NN I-NP I-test
transferase NN I-NP I-test
. . B-VP O
   
An DT B-NP B-test
ultrasound NN I-NP I-test
of IN B-VP I-test
the DT B-NP I-test
right JJ I-NP I-test
upper JJ I-NP I-test
quadrant NN I-NP I-test
did VBD B-VP O
not RB O O
reveal VB O O
any DT B-NP B-problem
cholelithiasis NN I-NP I-problem
or CC O O
cholecystitis NN B-NP B-problem
, , O O
however RB O O
, , O O
an DT B-NP B-problem
irregular JJ I-NP I-problem
hepatic JJ I-NP I-problem
contour NN I-NP I-problem
was VBD B-VP O
seen VBN O O
which WDT O B-pronoun
is VBZ O O
suggestive JJ O O
of IN B-VP O
underlying VBG O B-problem
chronic JJ B-NP I-problem
liver NN I-NP I-problem
disease NN I-NP I-problem
. . B-VP O
   
There EX O O
was VBD B-VP O
some DT B-NP O
concern NN I-NP O
that IN B-VP B-pronoun
the DT B-NP B-person
patient NN I-NP I-person
may MD O O
have VB O O
a DT B-NP B-problem
partial JJ I-NP I-problem
biliary JJ I-NP I-problem
obstruction NN I-NP I-problem
and CC O O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
sent VBN O O
for IN B-VP O
an DT B-NP B-test
magnetic JJ I-NP I-test
resonance NN I-NP I-test
cholangiopancreatography NN I-NP I-test
to TO O O
further JJ O O
evaluate VB O O
the DT B-NP O
biliary JJ I-NP O
system NN I-NP O
. . B-VP O
   
Magnetic JJ B-NP B-test
resonance NN I-NP I-test
cholangiopancreatography NN I-NP I-test
did VBD B-VP O
not RB O O
reveal VB O O
any DT B-NP O
evidence NN I-NP O
of IN B-VP O
biliary JJ B-NP B-problem
dilatation NN I-NP I-problem
or CC O O
of IN B-VP O
any DT O B-problem
obstructing VBG O I-problem
pancreatic JJ B-NP I-problem
mass NN I-NP I-problem
. . B-VP O
   
Again NNP B-NP O
seen VBN O O
was VBD B-VP O
a DT O B-problem
slightly RB O I-problem
irregular JJ B-NP I-problem
contour NN I-NP I-problem
of IN B-VP I-problem
the DT B-NP I-problem
liver NN I-NP I-problem
with IN B-VP O
dilated JJ B-NP B-problem
hepatic JJ I-NP I-problem
veins NNS I-NP I-problem
suggesting VBG O O
chronic JJ B-NP B-problem
hepatic JJ I-NP I-problem
vascular JJ I-NP I-problem
congestion NN I-NP I-problem
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
also RB O O
revealed VBD B-VP O
a DT B-NP O
prior JJ I-NP O
history NN I-NP O
of IN B-VP O
heavy JJ B-NP O
alcohol NN I-NP O
use NN I-NP O
for IN B-VP O
approximately RB O O
20 CD O O
years NNS B-NP O
, , O O
during IN B-VP O
the DT O O
mid JJ O O
1950s CD O O
to TO O O
mid VB O O
1970s CD O O
. . B-VP O
   
It PRP O B-pronoun
was VBD B-VP O
felt VBN O O
that IN B-VP B-pronoun
he PRP O B-person
may MD O O
have VB O O
had VBD B-VP O
some DT B-NP O
component NN I-NP O
of IN B-VP O
vascular JJ B-NP B-problem
congestion NN I-NP I-problem
from IN B-VP O
his PRP$ O B-person
his PRP$ O B-problem
congestive JJ B-NP I-problem
heart NN I-NP I-problem
failure NN I-NP I-problem
as RB O O
well RB O O
as IN B-VP O
possibly RB O O
some DT B-NP B-problem
mild JJ I-NP I-problem
cirrhotic JJ I-NP I-problem
changes NNS I-NP I-problem
secondary VBP O O
to TO O O
his PRP$ O B-person
previous JJ B-NP O
alcohol NN I-NP O
use NN I-NP O
. . B-VP O
   
5. CD O O
Fall NNP B-NP O
- : O O
The DT B-NP B-person
patient NN I-NP I-person
had VBD B-VP O
a DT B-NP O
mechanical JJ I-NP O
fall NN I-NP O
during IN B-VP O
his PRP$ O B-person
admission NN B-NP O
. . B-VP O
   
He PRP O B-person
did VBD B-VP O
not RB O O
sleep VB O O
at IN B-VP O
all PDT O O
the DT B-NP O
night NN I-NP O
before IN B-VP O
and CC O O
was VBD B-VP O
extremely RB O B-problem
fatigued VBN O I-problem
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
walking VBG O O
in IN B-VP O
the DT B-NP O
hall NN I-NP O
, , O O
dragging VBG O O
his PRP$ O B-person
his PRP$ O B-treatment
intravenous JJ B-NP I-treatment
pole NN I-NP I-treatment
when WRB O O
he PRP O B-person
tripped VBD B-VP O
over IN B-VP O
the DT B-NP O
foot NN I-NP O
of IN B-VP O
the DT B-NP O
pole NN I-NP O
and CC O O
lost VBD B-VP O
his PRP$ O B-person
balance NN B-NP O
. . B-VP O
   
He PRP O B-person
fell VBD B-VP O
backwards NNS B-NP O
, , O O
landing VBG O O
on IN B-VP O
his PRP$ O B-person
buttocks NNS B-NP O
and CC O O
bumped VBD B-VP O
his PRP$ O B-person
head NN B-NP O
. . B-VP O
   
His PRP$ O B-person
His PRP$ O B-test
neurological JJ B-NP I-test
examination NN I-NP I-test
at IN B-VP O
that DT B-NP B-pronoun
time NN I-NP O
was VBD B-VP O
nonfocal JJ O O
and CC O O
the DT B-NP O
head NN I-NP O
was VBD B-VP O
atraumatic JJ O B-problem
without IN B-VP O
any DT B-NP O
evidence NN I-NP O
of IN B-VP O
a DT B-NP B-problem
hematoma NN I-NP I-problem
. . B-VP O
   
A DT B-NP B-test
computerized JJ I-NP I-test
axial JJ I-NP I-test
tomography NN I-NP I-test
scan NN I-NP I-test
of IN B-VP I-test
his PRP$ O B-person
his PRP$ O I-test
head NN B-NP I-test
at IN B-VP O
that DT B-NP B-pronoun
time NN I-NP O
did VBD B-VP O
not RB O O
reveal VB O O
any DT O B-problem
extra JJ O I-problem
or CC O I-problem
intracranial JJ B-NP I-problem
hemorrhage NN I-NP I-problem
. . B-VP O
   
6. CD O O
Rectal JJ O B-problem
bleeding VBG O I-problem
- : O O
The DT B-NP B-person
patient NN I-NP I-person
has VBZ O O
a DT B-NP O
history NN I-NP O
of IN B-VP O
rectal JJ B-NP B-problem
bleeding NN I-NP I-problem
, , O O
ever RB O O
since IN B-VP O
his PRP$ O B-person
his PRP$ O B-treatment
brachytherapy NN B-NP I-treatment
for IN B-VP O
his PRP$ O B-person
his PRP$ O B-problem
prostate NN B-NP I-problem
cancer NN I-NP I-problem
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
has VBZ O O
been VBN O O
treated VBN O O
with IN B-VP O
Argon NNP B-NP B-treatment
laser NN I-NP I-treatment
therapy NN I-NP I-treatment
in IN B-VP O
the DT B-NP O
past NN I-NP O
for IN B-VP O
his PRP$ O B-person
his PRP$ O B-problem
rectal NN B-NP I-problem
bleeding NN I-NP I-problem
and CC O O
it PRP O B-pronoun
is VBZ O O
recommended VBN O O
that IN B-VP B-pronoun
he PRP O B-person
follow VB O O
up RP O O
with IN B-VP O
his PRP$ O B-person
his PRP$ O B-person
gastroenterologist NN B-NP I-person
for IN B-VP O
repeat NN B-NP B-treatment
Argon NNP I-NP I-treatment
laser NN I-NP I-treatment
therapy NN I-NP I-treatment
. . B-VP O
   
The DT B-NP O
remainder NN I-NP O
of IN B-VP O
the DT B-NP O
hospital NN I-NP O
course NN I-NP O
will MD O O
be VB O O
dictated VBN O O
by IN B-VP O
the DT O O
covering VBG O B-person
intern JJ O I-person
. . B-VP O
   
Sheila NNP B-NP B-person
Providence NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
50-442 CD O O
Dictated VBN O O
By IN B-VP O
: : O O
Marjorie NNP B-NP B-person
I. NNP I-NP I-person
Taylor NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
MEDQUIST36 NNP I-NP O
D NNP I-NP O
: : O O
2012-05-01 JJ O O
22:34 CD O O
T NN B-NP O
: : O O
2012-05-02 JJ O O
06:55 CD O O
JOB NNP B-NP O
#: VBD B-VP O
79270 CD O O
Signed VBN O O
electronically RB O O
by IN B-VP O
: : O O
DR. NNP B-NP B-person
Jane NNP I-NP I-person
Nix NNP I-NP I-person
on IN B-VP O
: : O O
MON NNP B-NP O
2012-05-07 CD O O
9:28 CD O O
AM NNP B-NP O
( ( O O
End NNP B-NP O
of IN B-VP O
Report NNP B-NP O
) ) O O
-EMPTYLINE- VBP O O
-DOCSTART- JJ O O
-EMPTYLINE- $ O O
891864133 CD O O
RWH NNP B-NP O
4713221 CD O O
093061 CD O O
136986 CD O O
3/17/2000 CD O O
12:00:00 CD O O
AM NNP B-NP O
ED NNP I-NP O
Discharge NNP I-NP O
Summary NNP I-NP O
Unsigned VBD B-VP O
DIS NNP B-NP O
Report NNP I-NP O
Status NNP I-NP O
: : O O
Unsigned VBD B-VP O
ED NNP B-NP O
DISCHARGE NNP I-NP O
NOTIFICATION NNP I-NP O
/ NNP I-NP O
SUMMARY NNP I-NP O
CUCHSPARDCAMPMOTTELAMN NNP I-NP B-person
, , O I-person
LARIN NNP B-NP I-person
MRN NNP I-NP O
: : O O
4713221 CD O O
Age NNP B-NP O
: : O O
47y CD O O
REGISTRATION NNP B-NP O
DATE NNP I-NP O
: : O O
03/17/2000 CD O O
01:25 CD O O
PM NNP B-NP O
Provider NN I-NP B-person
: : O O
VA NNP B-NP B-person
LARDESPRABLEYL NNP I-NP I-person
PRELIMINARY NNP I-NP O
REPORT NNP I-NP O
Benefits NNP I-NP O
Assigned NNP I-NP O
: : O O
Y PRP$ O O
Discharge NNP B-NP O
Date NNP I-NP O
/ JJ B-NP O
Time NNP I-NP O
: : O O
03/17/2000 CD O O
16:31 CD O O
Discharge NN B-NP O
Status NNP I-NP O
: : O O
Discharged NNP B-NP O
Patient NNP I-NP B-person
States NNPS I-NP O
Complaint NNP I-NP O
: : O O
R NNP B-NP O
/ NNP I-NP O
O NNP I-NP O
HEMMOROIDS NNP I-NP B-problem
Diagnosis NN I-NP O
: : O O
perianal JJ O B-problem
and CC O I-problem
perivaginal JJ B-NP I-problem
pruritis NN I-NP I-problem
Treatment NNP I-NP O
Rendered NNP I-NP O
: : O O
pelvic JJ B-NP B-test
exam NN I-NP I-test
Discharge NNP I-NP O
Medications NNS I-NP O
: : O O
none NN B-NP O
Disposition NNP I-NP O
, , O O
Follow NNP B-NP O
up RB O O
and CC O O
Instructions NNS B-NP O
to TO O O
Patient VB O B-person
: : O O
Please VB O O
call VB O O
( ( O O
994 CD O O
) ) O O
944-4238 CD O O
in IN B-VP O
2-3 JJ B-NP O
days NNS I-NP O
to TO O O
obtain VB O O
results NNS B-NP O
of IN B-VP O
the DT B-NP B-test
lab NN I-NP I-test
tests NNS I-NP I-test
that WDT O B-pronoun
were VBD B-VP O
ordered VBN O O
. . B-VP O
   
If IN B-VP O
tests NNS B-NP O
are VBP O O
positive JJ O B-problem
, , O O
follow VB O O
up RP O O
with IN B-VP O
your PRP$ O B-person
your PRP$ O B-person
primary JJ B-NP I-person
care NN I-NP I-person
doctor NN I-NP I-person
of IN B-VP O
gynecologist NN B-NP B-person
. . B-VP O
   
This DT B-NP B-pronoun
report NN I-NP O
was VBD B-VP O
created VBN O O
by IN B-VP O
LARDESPRABLEYL NNP B-NP B-person
, , O I-person
VA NNP B-NP I-person
03/17/2000 CD O O
04:33 CD O O
PM NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- VBD B-VP O
708739405 CD O O
DH NNP B-NP O
0606127 CD O O
65761 CD O O
4209641 CD O O
10/29/2003 CD O O
12:00:00 CD O O
AM NNP B-NP O
OB NNP I-NP O
Discharge NNP I-NP O
Summary NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Report NNP I-NP O
Status NNP I-NP O
: : O O
Signed VBD B-VP O
OB NNP B-NP O
EMR NNP I-NP O
L NNP I-NP O
and CC O O
D NNP B-NP O
DISCHARGE NNP I-NP O
SUMMARY NNP I-NP O
NAME NN I-NP O
: : O O
SYSCO NNP B-NP B-person
TAMARCE NNP I-NP I-person
DOSE NNP I-NP I-person
UNIT NNP I-NP O
NUMBER NNP I-NP O
: : O O
372-13-02 JJ B-NP O
ADMISSION NNP I-NP O
DATE NNP I-NP O
: : O O
20031029 CD O O
DISCHARGE NNP B-NP O
DATE NNP I-NP O
: : O O
20041101 CD O O
PRINCIPAL NNP B-NP O
DISCHARGE NNP I-NP O
DIAGNOSIS NNP I-NP O
: : O O
Normal JJ B-NP B-treatment
Vaginal NNP I-NP I-treatment
Delivery NNP I-NP I-treatment
ASSOCIATED NNP I-NP O
DIAGNOSES NNP I-NP O
: : O O
Current JJ B-NP O
Smoker NNP I-NP O
, , O O
history NN B-NP O
of IN B-VP O
; : O O
Depression NNP B-NP B-problem
, , O O
history NN B-NP O
of IN B-VP O
; : O O
Isoimmunization NNP B-NP B-problem
, , O I-problem
Rh NNP B-NP I-problem
; : O O
Undesired NNP B-NP B-problem
Fertility NNP I-NP I-problem
PRINCIPAL NNP I-NP O
PROCEDURE NNP I-NP O
OR NNP I-NP O
OPERATION NNP I-NP O
: : O O
Spontaneous JJ B-NP B-treatment
Vertex NNP I-NP I-treatment
Vaginal NNP I-NP I-treatment
Delivery NNP I-NP I-treatment
ASSOCIATED NNP I-NP O
PROCEDURES NNP I-NP O
OR NNP I-NP O
OPERATIONS NNP I-NP O
: : O O
POSTPARTUM NNP B-NP O
DIAGNOSTIC NNP I-NP O
PROCEDURES NNP I-NP O
: : O O
None NN B-NP O
POSTPARTUM NNP I-NP O
THERAPEUTIC NNP I-NP O
PROCEDURES NNP I-NP O
: : O O
None NN B-NP O
OTHER NNP I-NP O
POSTPARTUM NNP I-NP O
THERAPIES NNP I-NP O
: : O O
Pp JJ B-NP B-treatment
Sterilization NNP I-NP I-treatment
HISTORY NNP I-NP O
AND NNP I-NP O
REASON NNP I-NP O
FOR NNP I-NP O
HOSPITALIZATION NNP I-NP O
: : O O
Early JJ B-NP B-problem
Labor NNP I-NP I-problem
/ NNP I-NP O
Rule NNP I-NP O
Out NNP I-NP O
Labor NNP I-NP B-problem
PHYSICAL NNP I-NP O
EXAMINATION NNP I-NP O
: : O O
HEIGHT NNP B-NP O
HOSPITAL NNP I-NP O
COURSE NNP I-NP O
( ( O O
include VBP O O
complications NNS B-NP O
if IN B-VP O
any DT O O
) ) O O
: : O O
This DT O B-person
This DT O B-pronoun
22 CD O I-person
year NN B-NP I-person
old JJ B-NP I-person
Gravida NNP I-NP I-person
4 CD O I-person
Para NNP B-NP I-person
2012 CD O I-person
was VBD B-VP O
admitted VBN O O
to TO O O
the DT B-NP O
Naliheall NNP I-NP O
County NNP I-NP O
Memorial NNP I-NP O
Hospital NNP I-NP O
Obstetrical NNP I-NP B-person
service NN I-NP O
on IN B-VP O
10/29/2003 CD O O
at IN B-VP O
11:14 CD O O
pm NN B-NP O
for IN B-VP O
the DT B-NP O
indication NN I-NP O
( ( O O
s JJ O O
) ) O O
: : O O
early JJ B-NP B-problem
labor NN I-NP I-problem
/ NNP I-NP O
rule NN I-NP O
out IN B-VP O
labor NN B-NP B-problem
. . B-VP O
   
She PRP O B-person
delivered VBD B-VP O
a DT O B-person
3263 CD O I-person
gram NN B-NP I-person
female JJ B-NP I-person
infant NN I-NP I-person
on IN B-VP O
10/30/2003 CD O O
at IN B-VP O
05:03 CD O O
am VBP O O
with IN B-VP O
apgar JJ B-NP B-test
scores NNS I-NP I-test
of IN B-VP O
8 CD O O
and CC O O
9 CD O O
at IN B-VP O
one CD O O
and CC O O
five CD O O
minutes NNS B-NP O
respectively RB O O
at IN B-VP O
40.1 CD O O
weeks NNS B-NP O
gestation NN I-NP O
via IN B-VP O
spontaneous JJ O B-treatment
vertex FW O I-treatment
vaginal JJ B-NP I-treatment
delivery NN I-NP I-treatment
. . B-VP O
   
During IN B-VP O
her PRP$ O B-person
her PRP$ O B-problem
labor NN B-NP I-problem
she PRP O B-person
encountered VBD B-VP O
the DT B-NP O
following JJ I-NP O
complication NN I-NP O
( ( O O
s JJ O O
) ) O O
: : O O
none NN B-NP O
. . B-VP O
   
During IN B-VP O
her PRP$ O B-person
her PRP$ O B-treatment
delivery NN B-NP I-treatment
she PRP O B-person
encountered VBD B-VP O
the DT B-NP O
following JJ I-NP O
complication NN I-NP O
( ( O O
s JJ O O
) ) O O
: : O O
nuchal JJ B-NP B-problem
cord NN I-NP I-problem
, , O O
x JJ O O
1- JJ O O
reduced VBN O O
prior JJ O O
to TO O O
delivery NN B-NP B-treatment
. . B-VP O
   
Postpartum NNP B-NP O
she PRP O B-person
encountered VBD B-VP O
the DT B-NP O
following JJ I-NP O
complication NN I-NP O
( ( O O
s JJ O O
) ) O O
: : O O
none NN B-NP O
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
discharged VBN O O
on IN B-VP O
11/01/2004 CD O O
at IN B-VP O
12:00 CD O O
pm NN B-NP O
in IN B-VP O
good JJ B-NP O
condition NN I-NP O
. . B-VP O
   
DISCHARGE JJ B-NP O
ORDERS NNP I-NP O
( ( O O
medications NNS B-NP B-treatment
instructions NNS I-NP O
to TO O O
patient VB O B-person
, , O O
follow-up JJ B-NP O
care NN I-NP O
) ) O O
: : O O
DISCHARGE JJ B-NP O
ACTIVITY NNP I-NP O
: : O O
No DT B-NP O
Restrictions NNP I-NP O
DISCHARGE NNP I-NP O
DIET NNP I-NP O
: : O O
No DT B-NP O
Restrictions NNP I-NP O
POSTPARTUM NNP I-NP O
DISPOSITION NNP I-NP O
: : O O
Home NN B-NP O
With IN B-VP O
Self-Care NNP B-NP O
( ( O O
Routine NNP B-NP O
Discharge NNP I-NP O
) ) O O
POSTPARTUM NNP B-NP O
CARE NNP I-NP O
SITE NNP I-NP O
: : O O
Uval JJ B-NP O
General NNP I-NP O
Hospital NNP I-NP O
POSTPARTUM NNP I-NP O
RETURN NNP I-NP O
APPOINTMENT NNP I-NP O
( ( O O
DAYS NNP B-NP O
) ) O O
: : O O
42 CD O O
BREAST NNP B-NP O
FEEDING NN I-NP O
AT NNP I-NP O
DISCHARGE NNP I-NP O
: : O O
No DT B-NP O
POSTPARTUM NNP I-NP O
RH NNP I-NP O
IMMUNE NNP I-NP O
GLOBULIN NNP I-NP O
: : O O
Given VBN O O
POSTPARTUM NNP B-NP O
MEASLES NNP I-NP O
/ NNP I-NP O
MUMPS/RUBELLA NNP I-NP O
VACCINE NNP I-NP O
: : O O
Not RB O O
Indicated NNP B-NP O
MEDICATION NNP I-NP O
( ( O O
S NNP B-NP O
) ) O O
ON NNP B-NP O
DISCHARGE NNP I-NP O
: : O O
Multivitamins NNS B-NP B-treatment
And CC O O
Folate NNP B-NP B-treatment
Electronically NNP I-NP O
Signed VBD B-VP O
: : O O
Ockgiernruss NNP B-NP B-person
, , O I-person
Riret NNP B-NP I-person
R NNP I-NP I-person
12/18/2003 CD O O
7:53:30 CD O O
PM NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
Admission NNP I-NP O
Date NNP I-NP O
: : O O
Discharge NN B-NP O
Date NNP I-NP O
: : O O
2014-01-24 JJ B-NP O
Date NNP I-NP O
of IN B-VP O
Birth NNP B-NP O
: : O O
1928-11-23 JJ B-NP O
Sex NN I-NP O
: : O O
F NNP B-NP O
Service NNP I-NP O
: : O O
Internal JJ B-NP B-treatment
Medicine NNP I-NP I-treatment
During IN B-VP O
the DT O O
last JJ O O
four CD O O
hospital NN B-NP O
days NNS I-NP O
, , O O
the DT O O
continued VBN O O
to TO O O
do VB O O
relatively RB O O
well RB O O
. . B-VP O
   
Her PRP$ O B-person
renal JJ B-NP O
function NN I-NP O
significantly RB O O
improved VBN O O
, , O O
and CC O O
her PRP$ O B-person
her PRP$ O B-test
discharge NN B-NP I-test
creatinine NN I-NP I-test
was VBD B-VP O
3.1 CD O O
. . B-VP O
   
Of IN B-VP O
note NN B-NP O
, , O O
her PRP$ O B-person
her PRP$ O B-test
blood NN B-NP I-test
pressure NN I-NP I-test
significantly RB O O
improved VBN O O
in IN B-VP O
the DT O O
120s-130s JJ O O
which WDT O B-pronoun
assured VBD B-VP O
better JJR B-NP O
perfusion NN I-NP O
in IN B-VP O
her PRP$ O B-person
kidneys NN B-NP O
. . B-VP O
   
She PRP O B-person
received VBD B-VP O
intermittent JJ B-NP O
doses NNS I-NP O
of IN B-VP O
Lasix NNP B-NP B-treatment
to TO O O
assure VB O O
overall JJ B-NP O
negative JJ I-NP O
intakes NNS I-NP O
and CC O O
outputs NNS B-NP O
. . B-VP O
   
She PRP O B-person
progressed VBD B-VP O
beautifully RB O O
with IN B-VP O
physical JJ B-NP B-treatment
therapy NN I-NP I-treatment
and CC O O
occupational JJ B-NP B-treatment
therapy NN I-NP I-treatment
and CC O O
was VBD B-VP O
able JJ O O
to TO O O
ambulate VB O O
with IN B-VP O
assistance NN B-NP O
. . B-VP O
   
She PRP O B-person
has VBZ O O
very RB O B-problem
mild JJ O I-problem
left VBD B-VP I-problem
lower JJR B-NP I-problem
extremity NN I-NP I-problem
pain NN I-NP I-problem
which WDT O B-pronoun
is VBZ O O
largely RB O O
unchanged JJ O O
. . B-VP O
   
DISCHARGE JJ B-NP O
CONDITION NN I-NP O
: : O O
Stable JJ O O
. . B-VP O
   
DISCHARGE JJ B-NP O
DIAGNOSES NNP I-NP O
: : O O
1. CD O O
Coronary JJ B-NP B-problem
artery NN I-NP I-problem
disease NN I-NP I-problem
. . B-VP O
   
2. CD O O
Congestive JJ B-NP B-problem
heart NN I-NP I-problem
failure NN I-NP I-problem
. . B-VP O
   
3. CD O O
Acute NNP B-NP B-problem
renal JJ B-NP I-problem
failure NN I-NP I-problem
. . B-VP O
   
4. CD O O
Acute NNP B-NP B-problem
myocardial JJ B-NP I-problem
infarction NN I-NP I-problem
. . B-VP O
   
5. CD O O
Osteomyelitis NNP B-NP B-problem
. . B-VP O
   
6. CD O O
Diabetes NNPS B-NP B-problem
mellitus NN I-NP I-problem
. . B-VP O
   
DISPOSITION NN B-NP O
: : O O
Discharged VBN O O
to TO O O
a DT B-NP O
rehabilitation NN I-NP O
facility NN I-NP O
. . B-VP O
   
DISCHARGE NNP B-NP O
MEDICATIONS NNP I-NP O
: : O O
1. CD O O
Amiodarone $ O B-treatment
200 CD O O
mg NN B-NP O
p.o. NN I-NP O
q JJ B-NP O
day NN I-NP O
. . B-VP O
   
2. CD O O
Warfarin NNP B-NP B-treatment
3 CD O O
mg NN B-NP O
p.o. NN I-NP O
q VBD B-VP O
h.s. JJ O O
3. CD O O
Renagel NNP B-NP B-treatment
1600 CD O O
mg NN B-NP O
p.o. NN I-NP O
t.i.d. VBD B-VP O
4. CD O O
Aspirin NNP B-NP B-treatment
325 CD O O
mg NN B-NP O
p.o. NN I-NP O
q JJ B-NP O
day NN I-NP O
. . B-VP O
   
5. CD O O
Miconazole NNP B-NP B-treatment
powder NN I-NP I-treatment
2% CD O O
t.i.d. NN B-NP O
6. CD O O
Levofloxacin NNP B-NP B-treatment
250 CD O O
mg NN B-NP O
p.o. NN I-NP O
q48 NN I-NP O
hours NNS I-NP O
for IN B-VP O
the DT O O
next JJ O O
five CD O O
weeks NNS B-NP O
for IN B-VP O
osteomyelitis NN B-NP B-problem
. . B-VP O
   
7. CD O O
Flagyl NNP B-NP B-treatment
500 CD O O
mg NN B-NP O
p.o. NN I-NP O
t.i.d. NN I-NP O
for IN B-VP O
the DT O O
next JJ O O
five CD O O
weeks NNS B-NP O
for IN B-VP O
osteomyelitis NN B-NP B-problem
. . B-VP O
   
8. CD O O
Protonix NNP B-NP B-treatment
40 CD O O
mg NN B-NP O
p.o. NN I-NP O
q JJ B-NP O
day NN I-NP O
. . B-VP O
   
9. CD O O
Magnesium NNP B-NP B-treatment
Oxide NNP I-NP I-treatment
800 CD O O
mg NN B-NP O
p.o. NN I-NP O
b.i.d. VBD B-VP O
10. CD O O
Epogen NN B-NP B-treatment
5000 CD O O
units NNS B-NP O
two CD O O
times NNS B-NP O
weekly RB O O
, , O O
on IN B-VP O
Monday NNP B-NP O
and CC O O
Thursday NNP B-NP O
. . B-VP O
   
11. CD O O
Colace NNP B-NP B-treatment
100 CD O O
mg NN B-NP O
p.o. NN I-NP O
b.i.d. VBD B-VP O
12. CD O O
Lasix NNP B-NP B-treatment
80 CD O O
mg NN B-NP O
p.o. NN I-NP O
b.i.d. VBD B-VP O
13. CD O O
NPH NNP B-NP B-treatment
insulin NN I-NP I-treatment
7 CD O O
units NNS B-NP O
in IN B-VP O
the DT B-NP O
morning NN I-NP O
and CC O O
5 CD O O
units NNS B-NP O
at IN B-VP O
night NN B-NP O
. . B-VP O
   
14. CD O O
Regular JJ B-NP B-treatment
insulin NN I-NP I-treatment
sliding VBG O I-treatment
scale NN B-NP I-treatment
. . B-VP O
   
Richard NNP B-NP B-person
U. NNP I-NP I-person
Walker NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
36-781 CD O O
Dictated VBN O O
By IN B-VP O
: : O O
Levi NNP B-NP B-person
G. NNP I-NP I-person
Savage NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
MEDQUIST36 NNP I-NP O
D NNP I-NP O
: : O O
2014-01-24 JJ O O
13:13 CD O O
T NN B-NP O
: : O O
2014-01-24 JJ O O
13:45 CD O O
JOB NNP B-NP O
#: VBD B-VP O
12151 CD O O
Signed VBN O O
electronically RB O O
by IN B-VP O
: : O O
DR. NNP B-NP B-person
Kelly NNP I-NP I-person
Hunter NNP I-NP I-person
YANG NNP I-NP I-person
on IN B-VP O
: : O O
FRI NNP B-NP O
2014-01-31 CD O O
2:04 CD O O
PM NNP B-NP O
( ( O O
End NNP B-NP O
of IN B-VP O
Report NNP B-NP O
) ) O O
-EMPTYLINE- VBP O O
-DOCSTART- JJ B-NP O
-EMPTYLINE- NNP I-NP O
Admission NNP I-NP O
Date NNP I-NP O
: : O O
2014-02-21 JJ B-NP O
Discharge NN I-NP O
Date NNP I-NP O
: : O O
2014-03-25 JJ B-NP O
Date NNP I-NP O
of IN B-VP O
Birth NNP B-NP O
: : O O
1928-07-25 JJ B-NP O
Sex NN I-NP O
: : O O
F NNP B-NP O
Service NNP I-NP O
: : O O
SURGERY JJ B-NP B-person
Allergies NNS I-NP O
: : O O
Sulfa NNP B-NP B-treatment
( ( O I-treatment
Sulfonamides NNP B-NP I-treatment
) ) O I-treatment
Attending NN B-NP B-person
: : O O
Mattie NNP B-NP B-person
R. NNP I-NP I-person
A. NNP I-NP I-person
Hamilton NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
Chief NNP I-NP O
Complaint NNP I-NP O
: : O O
Nausea NN B-NP B-problem
, , O O
vomiting VBG O B-problem
, , O O
Abdominal NNP B-NP B-problem
pain NN I-NP I-problem
, , O O
distention NN B-NP B-problem
. . B-VP O
   
Major JJ O O
Surgical JJ O O
or CC O O
Invasive JJ B-NP O
Procedure NN I-NP O
: : O O
1. CD O O
Subtotal NNP B-NP B-treatment
colectomy NN I-NP I-treatment
, , O O
end NN B-NP B-treatment
ileostomy NN I-NP I-treatment
, , O O
Hartmann's NNP B-NP B-treatment
pouch RB O I-treatment
, , O O
G-tube NNP B-NP B-treatment
2. CD O O
Completion NNP B-NP B-treatment
sigmoid NN I-NP I-treatment
colectomy NN I-NP I-treatment
, , O O
repair NN B-NP B-treatment
of IN B-VP O
colovesicular JJ B-NP B-problem
fistula NN I-NP I-problem
, , O O
small JJ B-NP B-treatment
bowel NN I-NP I-treatment
repair NN I-NP I-treatment
History NNP I-NP O
of IN B-VP O
Present NNP B-NP O
Illness NNP I-NP O
: : O O
Ms NNP B-NP B-person
Crossman NNP I-NP I-person
is VBZ O O
an DT O O
84 CD O O
year NN B-NP O
old JJ B-NP O
female NN I-NP O
with IN B-VP O
complaints NNS B-NP O
of IN B-VP O
abdominal JJ B-NP B-problem
pain NN I-NP I-problem
, , O O
diarrhea NN B-NP B-problem
, , O O
nausea NN B-NP B-problem
and CC O O
vomiting VBG O B-problem
x RB O O
1 CD O O
week NN B-NP O
, , O O
who WP O B-person
presented VBD B-VP O
to TO O O
an DT B-NP O
outside JJ I-NP O
hospital NN I-NP O
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
transferred VBN O O
to TO O O
Arbour NNP B-NP O
Hospital NNP I-NP O
on IN B-VP O
2015-02-21 JJ O O
for IN B-VP O
bowel NN B-NP B-problem
obstruction NN I-NP I-problem
, , O O
ischemia NN B-NP B-problem
and CC O O
worsening VBG O B-problem
abdominal JJ B-NP I-problem
distention NN I-NP I-problem
and CC O O
pain NN B-NP B-problem
. . B-VP O
   
Past NNP B-NP O
Medical JJ B-NP O
History NN I-NP O
: : O O
CAD NNP B-NP B-problem
s/p NN I-NP O
MI NNP I-NP B-problem
, , O O
HTN NNP B-NP B-problem
, , O O
DMII NNP B-NP B-problem
Social NNP I-NP O
History NNP I-NP O
: : O O
Lives VBZ O O
independently RB O O
, , O O
but CC O O
in IN B-VP O
the DT B-NP O
same JJ I-NP O
building NN I-NP O
with IN B-VP O
daughter NN B-NP B-person
. . B-VP O
   
Amy $ O B-person
3 CD O O
children NNS B-NP B-person
, , O O
2 CD O O
daughters NNS B-NP B-person
and CC O O
1 CD O O
son NN B-NP B-person
. . B-VP O
   
Daughter NNP B-NP B-person
Lurline NNP I-NP I-person
is VBZ O O
Durable JJ B-NP O
Power NN I-NP O
of IN B-VP O
Attorney NNP B-NP O
. . B-VP O
   
The DT B-NP B-person
other JJ I-NP I-person
daughter NN I-NP I-person
was VBD B-VP O
recently RB O O
in IN B-VP O
a DT B-NP O
car NN I-NP O
accident NN I-NP O
and CC O O
underwent JJ B-NP O
surgery NN I-NP B-treatment
at IN B-VP O
Saint NNP B-NP O
Vincent NNP I-NP O
Hospital NNP I-NP O
. . B-VP O
   
Family NNP B-NP O
History NNP I-NP O
: : O O
NC NNP B-NP O
Physical NNP I-NP O
Exam NNP I-NP O
: : O O
At IN B-VP O
time NN B-NP O
of IN B-VP O
discharge NN B-NP O
: : O O
Afebrile NNP B-NP B-problem
, , O O
VSS NNP B-NP O
A&O NNP I-NP O
X NNP I-NP O
3 CD O O
, , O O
NAD NNP B-NP B-problem
RRR NNP I-NP O
CTAB NNP I-NP O
, , O O
mildly RB O B-problem
decreased VBD B-VP I-problem
breath NN B-NP I-problem
sounds NNS I-NP I-problem
b/l VBP O I-problem
Abd NNP B-NP O
soft JJ O O
, , O O
NT/ND NNP B-NP B-problem
, , O O
+ NNP B-NP O
bs NN I-NP O
, , O O
no DT B-NP O
masses NNS I-NP B-problem
, , O O
ostomy NN B-NP B-treatment
in IN B-VP I-treatment
RLQ NNP B-NP I-treatment
pink NN I-NP O
, , O O
with IN B-VP O
stool JJ B-NP O
G-tube NNP I-NP B-treatment
in IN B-VP O
place NN B-NP O
LE NNP I-NP B-problem
trace NN I-NP I-problem
edema NN I-NP I-problem
Pertinent NNP I-NP O
Results NNP I-NP O
: : O O
2014-02-21 JJ O O
12:20 CD O O
PM NNP B-NP O
BLOOD NNP I-NP B-test
WBC NNP I-NP B-test
- : O O
10.2 CD O O
RBC NNP B-NP B-test
- : O O
5.32 CD O O
Hgb NNP B-NP B-test
- : O O
14.9 CD O O
Hct NNP B-NP B-test
- : O O
43.4 CD O O
MCV NNP B-NP B-test
- : O O
82 CD O O
MCH NNP B-NP B-test
- : O O
28.0 CD O O
MCHC NNP B-NP B-test
- : O O
34.4 CD O O
RDW NNP B-NP B-test
- : O O
16.0 CD O O
* JJ B-NP O
Plt NNP I-NP B-test
Ct NNP I-NP I-test
- : O O
204 CD O O
2014-02-21 JJ O O
12:20 CD O O
PM NNP B-NP O
BLOOD NNP I-NP B-test
PT NNP I-NP B-test
- : O O
12.9 CD O O
PTT NNP B-NP B-test
- : O O
32.5 CD O O
INR(PT) NNP B-NP B-test
- : O O
1.1 CD O O
2014-02-21 JJ O O
12:20 CD O O
PM NNP B-NP O
BLOOD NNP I-NP B-test
Glucose NNP I-NP B-test
- : O O
345 CD O O
* JJ B-NP O
UreaN NNP I-NP B-test
- : O O
34 CD O O
* NN B-NP O
Creat NNP I-NP B-test
- : O O
1.0 CD O O
Na NNP B-NP B-test
- : O O
137 CD O O
K NNP B-NP B-test
- : O O
4.3 CD O O
Cl NNP B-NP B-test
- : O O
99 CD O O
HCO3 NNP B-NP B-test
- : O O
24 CD O O
AnGap NNP B-NP B-test
- : O O
18 CD O O
2014-02-21 JJ O O
12:20 CD O O
PM NNP B-NP O
BLOOD NNP I-NP B-test
ALT NNP I-NP B-test
- : O O
17 CD O O
AST NNP B-NP B-test
- : O O
27 CD O O
AlkPhos NNP B-NP B-test
- : O O
119 CD O O
* JJ B-NP O
Amylase NNP I-NP B-test
- : O O
27 CD O O
TotBili NNP B-NP B-test
- : O O
0.9 CD O O
2014-02-21 JJ O O
12:20 CD O O
PM NNP B-NP O
BLOOD NNP I-NP B-test
Lipase NNP I-NP B-test
- : O O
11 CD O O
2014-02-21 JJ O O
12:20 CD O O
PM NNP B-NP O
BLOOD NNP I-NP B-test
CK-MB NNP I-NP B-test
- : O O
7 CD O O
cTropnT NN B-NP B-test
-< VBD B-VP O
0.01 CD O O
2014-03-09 JJ O O
02:59 CD O O
AM NNP B-NP O
BLOOD NNP I-NP B-test
cTropnT NN I-NP B-test
- : O O
0.21 CD O O
* JJ O O
2014-03-09 JJ O O
11:29 CD O O
AM NNP B-NP O
BLOOD NNP I-NP B-test
CK-MB NNP I-NP B-test
- : O O
35 CD O O
* JJ B-NP O
MB NNP I-NP B-test
Indx NNP I-NP I-test
- : O O
25.5 CD O O
* NN B-NP O
cTropnT NN I-NP B-test
- : O O
0.45 CD O O
* JJ O O
2014-03-09 JJ O O
07:52 CD O O
PM NNP B-NP O
BLOOD NNP I-NP B-test
CK-MB NNP I-NP B-test
- : O O
NotDone NN B-NP O
cTropnT NN I-NP B-test
- : O O
0.55 CD O O
* JJ O O
2014-03-10 JJ O O
05:25 CD O O
PM NNP B-NP O
BLOOD NNP I-NP B-test
cTropnT SYM O B-test
- : O O
0.42 CD O O
* JJ O O
2014-03-11 JJ O O
02:00 CD O O
AM NNP B-NP O
BLOOD NNP I-NP B-test
cTropnT NN I-NP B-test
- : O O
0.45 CD O O
* JJ O O
2014-03-19 JJ O O
07:13 CD O O
AM NNP B-NP O
BLOOD NNP I-NP B-test
CK-MB NNP I-NP B-test
- : O O
3 CD O O
cTropnT NN B-NP B-test
- : O O
0.19 CD O O
* JJ O O
2014-03-19 JJ O O
01:33 CD O O
PM NNP B-NP O
BLOOD NNP I-NP B-test
CK-MB NNP I-NP B-test
- : O O
NotDone NN B-NP O
cTropnT NN I-NP B-test
- : O O
0.17 CD O O
* JJ O O
2014-03-21 JJ O O
09:58 CD O O
AM NNP B-NP O
BLOOD NNP I-NP B-test
CK-MB NNP I-NP B-test
- : O O
NotDone NN B-NP O
cTropnT NN I-NP B-test
- : O O
0.06 CD O O
* JJ B-NP O
03-07 JJ I-NP O
wound NN I-NP B-test
swab NN I-NP I-test
: : O O
VRE NNP B-NP B-problem
CT NNP I-NP B-test
Abd NNP I-NP I-test
02-21 NN I-NP O
: : O O
1. CD O O
Markedly RB O B-problem
dilated VBN O I-problem
colon NN B-NP I-problem
throughout IN B-VP O
ascending VBG O O
, , O O
transverse NN B-NP O
, , O O
and CC O O
descending VBG O O
colon NN B-NP O
with IN B-VP O
air-fluid JJ B-NP B-problem
levels NNS I-NP I-problem
, , O O
overall RB O O
unchanged JJ O O
since IN B-VP O
prior JJ B-NP B-test
study NN I-NP I-test
performed VBD B-VP O
on IN B-VP O
the DT B-NP O
same JJ I-NP O
day NN I-NP O
with IN B-VP O
pneumatosis NN B-NP B-problem
in IN B-VP I-problem
the DT B-NP I-problem
ascending NN I-NP I-problem
colon NN I-NP I-problem
. . B-VP O
   
Sigmoid JJ B-NP B-problem
diverticulosis NN I-NP I-problem
with IN B-VP O
focal JJ B-NP B-problem
narrowing NN I-NP I-problem
of IN B-VP I-problem
the DT B-NP I-problem
sigmoid JJ I-NP I-problem
colon NN I-NP I-problem
just RB O O
distal JJ O O
to TO O O
the DT B-NP B-problem
dilatation NN I-NP I-problem
with IN B-VP O
wall NN B-NP B-problem
thickening NN I-NP I-problem
, , O O
due JJ O O
to TO O O
diverticulitis VB O B-problem
. . B-VP O
   
This DT B-NP B-pronoun
area NN I-NP I-pronoun
can MD O O
be VB O O
a DT B-NP O
leading JJ I-NP O
point NN I-NP O
of IN B-VP O
obstruction NN B-NP B-problem
. . B-VP O
   
An DT B-NP B-problem
underlying JJ I-NP I-problem
mass NN I-NP I-problem
lesion NN I-NP I-problem
or CC O O
cancer NN B-NP B-problem
cannot NN I-NP O
be VB O O
excluded VBN O O
in IN B-VP O
this DT B-NP B-pronoun
area NN I-NP I-pronoun
, , O O
and CC O O
further RB O B-test
clinical JJ B-NP I-test
investigation NN I-NP I-test
is VBZ O O
recommended VBN O O
. . B-VP O
   
2. CD O O
Limited JJ B-NP B-test
evaluation NN I-NP I-test
for IN B-VP O
known VBN O B-problem
sigmoid-vesicle NN B-NP I-problem
fistula NN I-NP I-problem
. . B-VP O
   
3. CD O O
Small JJ B-NP B-problem
amount NN I-NP I-problem
of IN B-VP I-problem
ascites NNS B-NP I-problem
, , O O
somewhat RB O O
increased VBD B-VP O
anterior JJ O O
to TO O O
the DT B-NP O
liver NN I-NP O
. . B-VP O
   
4. CD O O
Bilateral NNP B-NP B-problem
renal JJ B-NP I-problem
cysts NNS I-NP I-problem
. . B-VP O
   
5. CD O O
Heavy NNP B-NP B-problem
calcification NN I-NP I-problem
of IN B-VP I-problem
the DT B-NP I-problem
aorta NN I-NP I-problem
and CC O I-problem
SMA NNP B-NP I-problem
and CC O I-problem
its PRP$ O I-problem
branches NNS B-NP I-problem
. . B-VP O
   
Due NNP B-NP O
to TO O O
atherosclerosis VB O B-problem
, , O O
assessment NN B-NP B-test
of IN B-VP I-test
the DT B-NP I-test
intraluminal JJ I-NP I-test
process NN I-NP I-test
of IN B-VP O
these DT B-NP B-pronoun
branches NNS I-NP O
is VBZ O O
limited JJ O O
. . B-VP O
   
CTA/CT NNP B-NP B-test
abd JJ B-NP I-test
03-07 NN I-NP O
: : O O
1. CD O O
No DT B-NP O
evidence NN I-NP O
of IN B-VP O
pulmonary JJ B-NP B-problem
embolism NN I-NP I-problem
. . B-VP O
   
Small JJ B-NP B-problem
bilateral JJ I-NP I-problem
pleural JJ I-NP I-problem
effusions NNS I-NP I-problem
with IN B-VP O
compressive JJ B-NP B-problem
atelectasis NN I-NP I-problem
. . B-VP O
   
2. CD O O
Left VBD B-VP B-problem
lower JJR O I-problem
quadrant JJ O I-problem
thick-walled JJ O I-problem
peripherally RB O I-problem
enhancing VBG O I-problem
fluid NN B-NP I-problem
collection NN I-NP I-problem
, , O O
which WDT O B-pronoun
appears VBZ O O
to TO O O
communicate VB O O
with IN B-VP O
the DT B-NP O
sutured JJ I-NP O
end NN I-NP O
of IN B-VP O
the DT B-NP O
proximal JJ I-NP O
sigmoid NN I-NP O
colon NN I-NP O
via IN B-VP O
a DT B-NP B-problem
small JJ I-NP I-problem
collection NN I-NP I-problem
of IN B-VP I-problem
extraluminal JJ B-NP I-problem
gas NN I-NP I-problem
. . B-VP O
   
In IN B-VP O
the DT B-NP O
correct JJ I-NP O
clincial JJ I-NP O
setting NN I-NP O
, , O O
this DT O B-pronoun
could MD O O
be VB O O
consistent JJ O O
with IN B-VP O
an DT B-NP B-problem
abscess NN I-NP I-problem
. . B-VP O
   
3. CD O O
Moderate NNP B-NP B-problem
intraabdominal JJ B-NP I-problem
ascites NNS I-NP I-problem
. . B-VP O
   
4. CD O O
Status NNP B-NP O
post NN I-NP O
ileostomy NN I-NP B-treatment
without IN B-VP O
evidence NN B-NP O
of IN B-VP O
small-bowel JJ B-NP B-problem
obstruction NN I-NP I-problem
. . B-VP O
   
5. CD O O
Distended VBD B-VP B-problem
gallbladder NN B-NP I-problem
. . B-VP O
   
6. CD O O
Diverticulosis NN B-NP B-problem
within IN B-VP I-problem
the DT B-NP I-problem
right JJ I-NP I-problem
remnant NN I-NP I-problem
sigmoid NN I-NP I-problem
colon NN I-NP I-problem
. . B-VP O
   
03-21 JJ B-NP O
VCUG NNP I-NP B-test
- : O O
no DT B-NP O
leak JJ I-NP B-problem
Brief NNP I-NP O
Hospital NNP I-NP O
Course NNP I-NP O
: : O O
Ms NNP B-NP B-person
Crossman NNP I-NP I-person
was VBD B-VP O
admitted VBN O O
on IN B-VP O
2015-02-21 JJ O O
from IN B-VP O
an DT B-NP O
outside JJ I-NP O
hospital NN I-NP O
to TO O O
the DT B-NP O
ICU NNP I-NP O
. . B-VP O
   
Neuro NN B-NP O
: : O O
Developed JJ B-NP O
confusion NN I-NP B-problem
during IN B-VP O
her PRP$ O B-person
first JJ O O
5 CD O O
days NNS B-NP O
in IN B-VP O
the DT B-NP O
ICU NNP I-NP O
. . B-VP O
   
Post-operatively NNP B-NP O
mental JJ B-NP O
status NN I-NP O
improved VBN O O
. . B-VP O
   
Intermitent NNP B-NP B-problem
delirium NN I-NP I-problem
throughout IN B-VP O
admission NN B-NP O
. . B-VP O
   
Required VBN O O
restraints NNS B-NP B-treatment
to TO O O
prevent VB O O
DC NNP B-NP O
of IN B-VP O
pertinent JJ B-NP B-treatment
therapies NNS I-NP I-treatment
while IN B-VP O
in IN B-VP O
the DT B-NP O
ICU NNP I-NP O
. . B-VP O
   
Currently NNP B-NP O
AAOx3 NNP I-NP O
. . B-VP O
   
Cardiovascular NN B-NP O
: : O O
Complained VBN O O
of IN B-VP O
chest NN B-NP B-problem
pain NN I-NP I-problem
during IN B-VP O
first JJ B-NP O
few JJ I-NP O
days NNS I-NP O
of IN B-VP O
admission NN B-NP O
, , O O
a DT B-NP O
cardiology NN I-NP O
consult NN I-NP O
was VBD B-VP O
obtained VBN O O
. . B-VP O
   
She PRP O B-person
recieved VBD B-VP O
serial JJ B-NP B-test
enzymes NNS I-NP I-test
and CC O O
EKGs NNP B-NP B-test
. . B-VP O
   
Troponins NNS B-NP B-test
remained VBD B-VP O
mildly RB O B-problem
elevated VBN O I-problem
as RB O O
high JJ O O
as IN B-VP O
0.6 CD O O
throughout IN B-VP O
her PRP$ O B-person
admission NN B-NP O
, , O O
and CC O O
most JJS B-NP O
recent JJ I-NP O
result NN I-NP O
now RB O O
0.1 CD O O
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
treated VBN O O
in IN B-VP O
IUC NNP B-NP O
for IN B-VP O
unstable JJ B-NP B-problem
angina NN I-NP I-problem
with IN B-VP O
nitroglycerin NN B-NP B-treatment
. . B-VP O
   
It PRP O B-pronoun
was VBD B-VP O
recommended VBN O O
to TO O O
maximize VB O O
her PRP$ O B-treatment
her PRP$ O B-person
medical JJ B-NP I-treatment
treatment NN I-NP I-treatment
with IN B-VP O
Beta NNP B-NP B-treatment
blockers NNS I-NP I-treatment
, , O O
aspirin NN B-NP B-treatment
, , O O
a DT B-NP B-treatment
statin NN I-NP I-treatment
and CC O O
an DT B-NP B-treatment
ACE NNP I-NP I-treatment
Inhibitor NNP I-NP I-treatment
. . B-VP O
   
Required VBN O O
diuresis NN B-NP B-treatment
of IN B-VP O
> $ O O
9 CD O O
L NNP B-NP O
while IN B-VP O
in IN B-VP O
the DT B-NP O
ICU NNP I-NP O
, , O O
after IN B-VP O
2nd CD O B-treatment
surgery NN B-NP I-treatment
. . B-VP O
   
Continues NNS B-NP O
to TO O O
have VB O O
trace NN B-NP B-problem
lower JJR B-NP I-problem
extremity NN I-NP I-problem
edema NN I-NP I-problem
, , O O
and CC O O
recieves VBZ O O
lasix JJ B-NP B-treatment
po NN I-NP I-treatment
. . B-VP O
   
Respiratory NN B-NP O
: : O O
She PRP O B-person
was VBD B-VP O
intubated VBN O B-treatment
briefly IN B-VP O
post-op JJ B-NP O
subtotal JJ I-NP B-treatment
colectomy NN I-NP I-treatment
and CC O O
again RB O O
for IN B-VP O
several JJ B-NP O
days NNS I-NP O
after IN B-VP O
second JJ B-NP B-treatment
surgery NN I-NP I-treatment
. . B-VP O
   
Recieved VBN O O
nebulizer JJ B-NP B-treatment
treatments NNS I-NP I-treatment
post-op NN I-NP O
in IN B-VP O
the DT B-NP O
ICU NNP I-NP O
, , O O
after IN B-VP O
successfully RB O O
extubated VBN O O
. . B-VP O
   
Gastrointestinal JJ O O
: : O O
Her PRP$ O B-test
Her PRP$ O B-person
initial JJ B-NP I-test
CT NNP I-NP I-test
scan NN I-NP I-test
showed VBD B-VP O
dilated JJ B-NP B-problem
Turner NNP I-NP I-problem
colon NN I-NP I-problem
, , O O
wall NN B-NP B-problem
thickening NN I-NP I-problem
and CC O O
pneumatosis NN B-NP B-problem
see VBP O O
pertinent JJ B-NP O
results NNS I-NP O
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
initially RB O O
treated VBN O O
nonoperatively RB O O
with IN B-VP O
IV NNP B-NP B-treatment
fluids NNS I-NP I-treatment
, , O O
antibiotics NNS B-NP B-treatment
, , O O
serial JJ B-NP B-test
exams NN I-NP I-test
and CC O O
NGT NNP B-NP B-treatment
decompression NN I-NP I-treatment
. . B-VP O
   
On IN B-VP O
HD#5 NNP B-NP O
flexible JJ B-NP B-test
sigmoidoscopy NN I-NP I-test
was VBD B-VP O
performed VBN O O
for IN B-VP O
colonic JJ B-NP B-treatment
decompression NN I-NP I-treatment
. . B-VP O
   
On IN B-VP O
HD#6 NNP B-NP O
, , O O
colonscopy NN B-NP B-test
was VBD B-VP O
performed VBN O O
for IN B-VP O
decompression NN B-NP B-treatment
, , O O
and CC O O
revealed VBD B-VP O
pseudomembrane NN B-NP B-problem
and CC O O
friable JJ B-NP B-problem
colonic JJ I-NP I-problem
tissue NN I-NP I-problem
. . B-VP O
   
Her PRP$ O B-person
abdomen NNS B-NP O
remained VBD B-VP O
tender NN B-NP B-problem
and CC O O
distended VBD B-VP B-problem
despite IN B-VP O
attempted JJ B-NP O
decompression NN I-NP B-treatment
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
taken VBN O O
to TO O O
the DT B-NP O
OR NNP I-NP O
for IN B-VP O
Subtotal NNP B-NP B-treatment
Colectomy NNP I-NP I-treatment
, , O O
G NNP B-NP B-treatment
tube NN I-NP I-treatment
and CC O O
ileostomy NN B-NP B-treatment
due JJ O O
to TO O O
unresponsiveness JJ O B-problem
to TO O O
non-operative JJ B-NP B-treatment
treatment NN I-NP I-treatment
. . B-VP O
   
Ileostomy NNP B-NP B-treatment
remains VBZ O O
pink JJ O O
and CC O O
intact JJ O O
, , O O
draining VBG O O
green-brown JJ B-NP O
soft JJ I-NP O
stool NN I-NP O
. . B-VP O
   
Her PRP$ O B-person
post-operative JJ B-NP O
course NN I-NP O
continued VBD B-VP O
uneventfully RB O O
in IN B-VP O
the DT B-NP O
ICU NNP I-NP O
, , O O
and CC O O
she PRP O B-person
was VBD B-VP O
transferred VBN O O
to TO O O
the DT B-NP O
floor NN I-NP O
POD#6 NNP I-NP O
. . B-VP O
   
She PRP O B-person
developed VBD B-VP O
additional JJ B-NP B-problem
abdominal JJ I-NP I-problem
tenderness NN I-NP I-problem
and CC O O
distention NN B-NP B-problem
. . B-VP O
   
Her PRP$ O B-person
Her NNP B-NP B-test
HCT NNP I-NP I-test
dropped VBD B-VP O
and CC O O
she PRP O B-person
recieved VBD B-VP O
1 CD O B-treatment
unit NN B-NP I-treatment
PRBCs NNP I-NP I-treatment
. . B-VP O
   
Geriatric NNP B-NP O
consult NN I-NP O
was VBD B-VP O
obtained VBN O O
to TO O O
assist VB O O
with IN B-VP O
management NN B-NP O
. . B-VP O
   
On IN B-VP O
POD#8 NNP B-NP O
a DT B-NP B-test
CT NNP I-NP I-test
scan NN I-NP I-test
was VBD B-VP O
obtained VBN O O
which WDT O B-pronoun
revealed VBD B-VP O
an DT B-NP B-problem
abcess NN I-NP I-problem
with IN B-VP O
a DT B-NP B-problem
colovesicular JJ I-NP I-problem
fistula NN I-NP I-problem
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
taken VBN O O
to TO O O
the DT B-NP O
OR NNP I-NP O
for IN B-VP O
exploration NN B-NP B-test
and CC O O
drainage NN B-NP B-treatment
. . B-VP O
   
She PRP O B-person
recieved VBD B-VP O
further JJ B-NP B-treatment
resection NN I-NP I-treatment
of IN B-VP I-treatment
remaining VBG O I-treatment
colon NN B-NP I-treatment
, , O O
repair NN B-NP B-treatment
of IN B-VP O
a DT B-NP B-problem
leak NN I-NP I-problem
from IN B-VP I-problem
Relaford NNP B-NP I-problem
pouch JJ O I-problem
and CC O O
repair NN B-NP B-treatment
of IN B-VP O
colovesicular JJ B-NP B-problem
fistula NN I-NP I-problem
. . B-VP O
   
After IN B-VP O
her PRP$ O B-person
her PRP$ O B-treatment
2nd CD O I-treatment
surgery NN B-NP I-treatment
she PRP O B-person
returned VBD B-VP O
to TO O O
the DT B-NP O
ICU NNP I-NP O
and CC O O
improved VBN O O
steadily RB O O
. . B-VP O
   
Abdomen NNS B-NP O
remained VBD B-VP O
soft JJ O O
and CC O O
nontender NN B-NP B-problem
. . B-VP O
   
She PRP O B-person
remained VBD B-VP O
on IN B-VP O
IV NNP B-NP B-treatment
antibiotics NNS I-NP I-treatment
x VBP O O
14 CD O O
days NNS B-NP O
and CC O O
required JJ B-NP O
pressors NNS I-NP B-treatment
for IN B-VP O
the DT B-NP O
first JJ I-NP O
few JJ I-NP O
days NNS I-NP O
post-op RB O O
. . B-VP O
   
Her PRP$ O B-problem
Her PRP$ O B-person
incision NN B-NP I-problem
has VBZ O O
remained VBN O O
clean JJ O O
, , O O
dry JJ O O
, , O O
intact JJ O O
, , O O
with IN B-VP O
staples NNS B-NP B-treatment
removed VBN O O
on IN B-VP O
POD# NNP B-NP O
27/18 CD O O
. . B-VP O
   
Genitourinary NN B-NP O
: : O O
She PRP O B-person
had VBD B-VP O
a DT B-NP B-treatment
foley JJ I-NP I-treatment
catheter NN I-NP I-treatment
from IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
admission NN B-NP O
. . B-VP O
   
POD# CC O O
23/14 CD O O
she PRP O B-person
recieved VBD B-VP O
a DT B-NP B-test
cystoscopy NN I-NP I-test
which WDT O B-pronoun
revealed VBD B-VP O
no DT B-NP O
leak NN I-NP B-problem
. . B-VP O
   
Her PRP$ O B-treatment
Her PRP$ O B-person
foley NN B-NP I-treatment
was VBD B-VP O
subsequently RB O O
dc JJ O O
'd MD O O
. . B-VP O
   
Musculoskeletal NN B-NP O
: : O O
Has NNP B-NP O
suffered VBN O O
significant JJ B-NP B-problem
deconditioning NN I-NP I-problem
since IN B-VP O
admission NN B-NP O
, , O O
but CC O O
has VBZ O O
consisitently RB O O
recieved VBN O O
PT NNP B-NP B-treatment
. . B-VP O
   
See VB O O
PT NNP B-NP O
note VB O O
for IN B-VP O
further JJ B-NP B-test
assessment NN I-NP I-test
and CC O O
discussion NN B-NP O
. . B-VP O
   
Nutrition NN B-NP O
: : O O
She PRP O B-person
was VBD B-VP O
held VBN O O
NPO NNP B-NP B-treatment
at IN B-VP O
admission NN B-NP O
, , O O
and CC O O
initiated VBN O O
on IN B-VP O
TPN NNP B-NP B-treatment
by IN B-VP O
HD#3 NNP B-NP O
. . B-VP O
   
Post-operatively RB O O
she PRP O B-person
began VBD B-VP O
on IN B-VP O
TF NNP B-NP B-treatment
s, NN I-NP O
and CC O O
the DT B-NP B-treatment
TPN NNP I-NP I-treatment
was VBD B-VP O
weaned VBN O O
down RP O O
. . B-VP O
   
By IN B-VP O
POD# NNP B-NP O
05-29 JJ O O
she PRP O B-person
was VBD B-VP O
having VBG O O
high JJ B-NP B-problem
residuals NNS I-NP I-problem
on IN B-VP O
TF NNP B-NP B-treatment
s, NN I-NP O
so RB O O
TPN NNP B-NP B-treatment
was VBD B-VP O
reinitiated VBN O O
. . B-VP O
   
Tf NNP B-NP B-treatment
's POS O O
were VBD B-VP O
dc JJ O O
'ed JJ O O
prior RB O O
to TO O O
second JJ B-NP B-treatment
surgery NN I-NP I-treatment
. . B-VP O
   
POD# NNP B-NP O
15/6 CD O O
, , O O
she PRP O B-person
resumed VBD B-VP O
TF NNP B-NP B-treatment
's POS O O
and CC O O
TPN NNP B-NP B-treatment
was VBD B-VP O
tapered VBN O O
again RB O O
. . B-VP O
   
TF JJ B-NP O
goals NNS I-NP O
were VBD B-VP O
achieved VBN O O
and CC O O
TPN NNP B-NP B-treatment
dc VBP O O
'ed. VBZ O O
A NNP B-NP O
diet JJ O O
by IN B-VP O
mouth NN B-NP O
was VBD B-VP O
initiated VBN O O
. . B-VP O
   
At IN B-VP O
time NN B-NP O
of IN B-VP O
discharge NN B-NP O
she PRP O B-person
is VBZ O O
tolerating VBG O O
a DT B-NP O
regular JJ I-NP O
diet NN I-NP O
with IN B-VP O
TF NNP B-NP B-treatment
's POS O O
at IN B-VP O
goal NN B-NP O
. . B-VP O
   
Patient NNP B-NP B-person
is VBZ O O
an DT B-NP B-problem
insulin JJ I-NP I-problem
dependent JJ I-NP I-problem
diabetic NN I-NP I-problem
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
followed VBN O O
by IN B-VP O
Cape NNP B-NP O
Cod NNP I-NP O
Hospital NNP I-NP O
Clinic NNP I-NP O
for IN B-VP O
treatment NN B-NP B-treatment
of IN B-VP O
persistent JJ B-NP B-problem
hyperglycemia NN I-NP I-problem
. . B-VP O
   
Pain NN B-NP B-problem
: : O O
Her PRP$ O B-person
Her PRP$ O B-problem
pain NN B-NP I-problem
was VBD B-VP O
controlled VBN O O
with IN B-VP O
IV NNP B-NP B-treatment
pain VBP O I-treatment
medicines NNS B-NP I-treatment
while IN B-VP O
in IN B-VP O
ICU NNP B-NP O
. . B-VP O
   
She PRP O B-person
has VBZ O O
been VBN O O
adequately RB O O
controlled VBN O O
with IN B-VP O
Tylenol NNP B-NP B-treatment
, , O O
Motrin NNP B-NP B-treatment
& CC O O
Oxycodone NNP B-NP B-treatment
by IN B-VP O
mouth NN B-NP O
, , O O
per IN B-VP O
recommendations NNS B-NP O
by IN B-VP O
Geriatrics NNP B-NP O
. . B-VP O
   
POD# NNP B-NP O
22/15 CD O O
Ms NNP B-NP B-person
Crossman NNP I-NP I-person
was VBD B-VP O
transferred VBN O O
to TO O O
3 CD O O
North NN B-NP O
where WRB O O
she PRP O B-person
continued VBD B-VP O
to TO O O
progress VB O O
well RB O O
with IN B-VP O
PT NNP B-NP B-treatment
, , O O
increasing VBG O O
PO NNP B-NP O
intake NN I-NP O
, , O O
tolerating VBG O O
TF NNP B-NP B-treatment
s, NN I-NP O
and CC O O
weaning VBG O O
from IN B-VP O
nasal JJ B-NP B-treatment
cannula NN I-NP I-treatment
oxygen NN I-NP I-treatment
. . B-VP O
   
She PRP O B-person
has VBZ O O
remained VBN O O
stable JJ O O
with IN B-VP O
no DT B-NP O
acute JJ I-NP B-problem
events NNS I-NP I-problem
. . B-VP O
   
She PRP O B-person
is VBZ O O
discharged VBN O O
to TO O O
rehab VB O O
on IN B-VP O
POD# NNP B-NP O
27/18 CD O O
. . B-VP O
   
Medications NNS B-NP O
on IN B-VP O
Admission NN B-NP O
: : O O
Norvasc NNP B-NP B-treatment
Atenolol NNP I-NP B-treatment
Isosorbide NNP I-NP B-treatment
Lasix NNP I-NP B-treatment
Insulin NNP I-NP B-treatment
Discharge NNP I-NP O
Medications NNP I-NP O
: : O O
1. CD O O
Heparin NNP B-NP B-treatment
( ( O I-treatment
Porcine NNP B-NP I-treatment
) ) O I-treatment
5,000 CD O O
unit NN B-NP O
/ NNP I-NP O
mL NN I-NP O
Solution NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
mL NN B-NP O
Injection NNP I-NP O
TID NNP I-NP O
( ( O O
3 CD O O
times NNS B-NP O
a DT B-NP O
day NN I-NP O
). POS O O
2. CD O O
Acetaminophen NNP B-NP B-treatment
325 CD O O
mg NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
1-2 JJ B-NP O
Tablets NNS I-NP O
PO NNP I-NP O
Q4-6H NNP I-NP O
( ( O O
every DT O O
4 CD O O
to TO O O
6 CD O O
hours NNS B-NP O
) ) O O
as IN B-VP O
needed VBN O O
. . B-VP O
   
3. CD O O
Polyvinyl NNP B-NP B-treatment
Alcohol NNP I-NP I-treatment
- : O O
Povidone CD O B-treatment
1.4-0.6 JJ B-NP O
% NN I-NP O
Dropperette NNP I-NP O
Sig NNP I-NP O
: : O O
02-25 JJ B-NP O
Drops NNP I-NP O
Ophthalmic NNP I-NP O
PRN NNP I-NP O
( ( O O
as IN B-VP O
needed VBN O O
). NN B-NP O
4. CD O O
Metoprolol NNP B-NP B-treatment
Tartrate NNP I-NP I-treatment
25 CD O O
mg NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Tablet NNP B-NP O
PO NNP I-NP O
TID NNP I-NP O
( ( O O
3 CD O O
times NNS B-NP O
a DT B-NP O
day NN I-NP O
). POS O O
5. CD O O
Aspirin NNP B-NP B-treatment
81 CD O O
mg NN B-NP O
Tablet NNP I-NP O
, , O O
Chewable JJ B-NP O
Sig NN I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Tablet NN B-NP O
, , O O
Chewable JJ B-NP O
PO NNP I-NP O
DAILY NNP I-NP O
( ( O O
Daily NNP B-NP O
). VBZ O O
6. CD O O
Atorvastatin NNP B-NP B-treatment
10 CD O O
mg NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Tablet NNP B-NP O
PO NNP I-NP O
DAILY NNP I-NP O
( ( O O
Daily NNP B-NP O
). VBZ O O
7. CD O O
Lisinopril NNP B-NP B-treatment
5 CD O O
mg NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
0.5 CD O O
Tablet NNP B-NP O
PO NNP I-NP O
DAILY NNP I-NP O
( ( O O
Daily NNP B-NP O
). VBZ O O
8. CD O O
Furosemide NNP B-NP B-treatment
40 CD O O
mg NN B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
1.5 CD O O
Tablets NNS B-NP O
PO NNP I-NP O
BID NNP I-NP O
( ( O O
2 CD O O
times NNS B-NP O
a DT B-NP O
day NN I-NP O
). POS O O
9. CD O O
Ipratropium NNP B-NP B-treatment
Bromide NNP I-NP I-treatment
17 CD O O
mcg NN B-NP O
/ NNP I-NP O
Actuation NNP I-NP O
Aerosol NNP I-NP O
Sig NNP I-NP O
: : O O
Two CD O O
( ( O O
2 CD O O
) ) O O
Puff NNP B-NP O
Inhalation NNP I-NP O
Q4-6H NNP I-NP O
( ( O O
every DT O O
4 CD O O
to TO O O
6 CD O O
hours NNS B-NP O
) ) O O
as IN B-VP O
needed VBN O O
. . B-VP O
   
10. CD O O
Albuterol NNP B-NP B-treatment
90 CD O O
mcg NN B-NP O
/ NNP I-NP O
Actuation NNP I-NP O
Aerosol NNP I-NP O
Sig NNP I-NP O
: : O O
1-2 JJ B-NP O
Puffs NNP I-NP O
Inhalation NNP I-NP O
Q6H NNP I-NP O
( ( O O
every DT O O
6 CD O O
hours NNS B-NP O
) ) O O
as IN B-VP O
needed VBN O O
. . B-VP O
   
11. CD O O
Oxycodone CD O B-treatment
5 CD O O
mg NNS B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Tablet NNP B-NP O
PO NNP I-NP O
Q4-6H NNP I-NP O
( ( O O
every DT O O
4 CD O O
to TO O O
6 CD O O
hours NNS B-NP O
) ) O O
as IN B-VP O
needed VBN O O
for IN B-VP O
pain NN B-NP B-problem
. . B-VP O
   
12. CD O O
Docusate NNP B-NP B-treatment
Sodium NNP I-NP I-treatment
100 CD O O
mg NN B-NP O
Capsule NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Capsule NNP B-NP O
PO NNP I-NP O
BID NNP I-NP O
( ( O O
2 CD O O
times NNS B-NP O
a DT B-NP O
day NN I-NP O
). POS O O
13. CD O O
Potassium NNP B-NP B-treatment
Chloride NNP I-NP I-treatment
20 CD O O
mEq NN B-NP O
Tab NNP I-NP O
Sust NNP I-NP O
. . B-VP O
   
Rel NNP B-NP O
. . B-VP O
   
Particle NNP B-NP O
/ NNP I-NP O
Crystal NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Tab NNP B-NP O
Sust NNP I-NP O
. . B-VP O
   
Rel NNP B-NP O
. . B-VP O
   
Particle NNP B-NP O
/ NNP I-NP O
Crystal NNP I-NP O
PO NNP I-NP O
once RB O O
a DT B-NP O
day NN I-NP O
. . B-VP O
   
14. CD O O
Glargine NNP B-NP B-treatment
Sig NNP I-NP O
: : O O
Twenty CD O O
Two CD O O
( ( O O
22 CD O O
) ) O O
units NNS B-NP O
at IN B-VP O
bedtime NN B-NP O
. . B-VP O
   
15. CD O O
Miconazole NNP B-NP B-treatment
Nitrate NNP I-NP I-treatment
2 CD O O
% NN B-NP O
Powder NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Appl NNP B-NP O
Topical NNP I-NP O
BID NNP I-NP O
( ( O O
2 CD O O
times NNS B-NP O
a DT B-NP O
day NN I-NP O
) ) O O
as IN B-VP O
needed VBN O O
. . B-VP O
   
16. CD O O
Miconazole NNP B-NP B-treatment
Nitrate NNP I-NP I-treatment
2 CD O O
% NN B-NP O
Cream NNP I-NP O
Sig NNP I-NP O
: : O O
One CD O O
( ( O O
1 CD O O
) ) O O
Appl NNP B-NP O
Topical NNP I-NP O
BID NNP I-NP O
( ( O O
2 CD O O
times NNS B-NP O
a DT B-NP O
day NN I-NP O
). POS O O
17. CD O O
Ibuprofen NNP B-NP B-treatment
100 CD O O
mg/5 NN B-NP O
mL NN I-NP O
Suspension NNP I-NP O
Sig NNP I-NP O
: : O O
Twenty NNP B-NP O
( ( O O
20 CD O O
) ) O O
mL NN B-NP O
PO NNP I-NP O
Q8H NNP I-NP O
( ( O O
every DT O O
8 CD O O
hours NNS B-NP O
) ) O O
as IN B-VP O
needed VBN O O
. . B-VP O
   
18. CD O O
Debrox NNP B-NP B-treatment
6.5 CD O O
% NN B-NP O
Drops NNP I-NP O
Sig NNP I-NP O
: : O O
Five CD O O
( ( O O
5 CD O O
) ) O O
Drop NNP B-NP O
Otic NNP I-NP O
BID NNP I-NP O
( ( O O
2 CD O O
times NNS B-NP O
a DT B-NP O
day NN I-NP O
) ) O O
for IN B-VP O
5 CD O O
days NNS B-NP O
: : O O
both DT B-NP O
ears NNS I-NP O
. . B-VP O
   
19. CD O O
Trazodone CD O B-treatment
50 CD O O
mg NNS B-NP O
Tablet NNP I-NP O
Sig NNP I-NP O
: : O O
1 CD O O
/ IN B-VP O
2-1 JJ B-NP O
Tablet NNP I-NP O
PO NNP I-NP O
HS NNP I-NP O
( ( O O
at IN B-VP O
bedtime NN B-NP O
). NNP I-NP O
Discharge NNP I-NP O
Disposition NNP I-NP O
: : O O
Extended VBN O O
Care NNP B-NP O
Discharge NNP I-NP O
Diagnosis NNP I-NP O
: : O O
Hurtado NNP B-NP B-problem
Colon NNP I-NP I-problem
Diverticulitis NNP I-NP B-problem
S/P NNP I-NP O
Subtotal NNP I-NP B-treatment
Colectomy NNP I-NP I-treatment
, , O O
Ileostomy NNP B-NP B-treatment
, , O O
Gastrostomy NNP B-NP B-treatment
tube NN I-NP I-treatment
S/P NNP I-NP O
Exploratory NNP I-NP B-test
laparotomy NN I-NP I-test
, , O O
resection NN B-NP B-treatment
of IN B-VP I-treatment
small JJ B-NP I-treatment
intestine NN I-NP I-treatment
with IN B-VP O
primary JJ B-NP B-treatment
anastomosis NN I-NP I-treatment
, , O O
Sigmoid NNP B-NP B-treatment
colectomy NN I-NP I-treatment
, , O O
repair NN B-NP B-treatment
of IN B-VP O
colovesicular JJ B-NP B-problem
fistula NN I-NP I-problem
Unstable JJ B-NP B-problem
Angina NNP I-NP I-problem
Discharge NNP I-NP O
Condition NNP I-NP O
: : O O
stable JJ B-NP O
Discharge NN I-NP O
Instructions NNS I-NP O
: : O O
Please NNP B-NP O
call VB O O
the DT B-NP B-person
surgeon NN I-NP I-person
or CC O O
return NN B-NP O
to TO O O
the DT B-NP O
Emergency NNP I-NP O
Department NNP I-NP O
if IN B-VP O
you PRP O B-person
develop VBP O O
chest JJS B-NP B-problem
pain NN I-NP I-problem
, , O O
shortness NN B-NP B-problem
of IN B-VP I-problem
breath NN B-NP I-problem
, , O O
fever RB O B-problem
greater JJR O I-problem
than IN B-VP I-problem
101.5 CD O I-problem
, , O O
foul JJ B-NP B-problem
smelling NN I-NP I-problem
or CC O I-problem
colorful JJ B-NP I-problem
drainage NN I-NP I-problem
from IN B-VP O
your PRP$ O B-person
your PRP$ O B-problem
incisions NNS B-NP I-problem
, , O O
redness NN B-NP B-problem
or CC O O
swelling NN B-NP B-problem
, , O O
severe JJ B-NP B-problem
abdominal JJ I-NP I-problem
pain NN I-NP I-problem
or CC O O
distention NN B-NP B-problem
, , O O
persistent JJ B-NP B-problem
nausea NN I-NP I-problem
or CC O O
vomiting NN B-NP B-problem
, , O O
inability NN B-NP B-problem
to TO O I-problem
eat VB O I-problem
or CC O I-problem
drink VB O I-problem
, , O O
or CC O O
any DT B-NP O
other JJ I-NP B-problem
symptoms NNS I-NP I-problem
which WDT O B-pronoun
are VBP O O
concerning VBG O O
to TO O O
you PRP O B-person
. . B-VP O
   
No DT B-NP O
tub JJ I-NP O
baths NNS I-NP O
or CC O O
swimming VBG O O
. . B-VP O
   
You PRP O B-person
may MD O O
shower VB O O
. . B-VP O
   
If IN B-VP O
there EX O O
is VBZ O O
clear JJ B-NP B-problem
drainage NN I-NP I-problem
from IN B-VP O
your PRP$ O B-person
your PRP$ O B-problem
incisions NNS B-NP I-problem
, , O O
cover NN B-NP O
with IN B-VP O
a DT B-NP B-treatment
dry JJ I-NP I-treatment
dressing NN I-NP I-treatment
. . B-VP O
   
Leave NNP B-NP O
white JJ B-NP B-treatment
strips NNS I-NP I-treatment
above IN B-VP O
your PRP$ O B-person
your PRP$ O B-problem
incisions NNS B-NP I-problem
in IN B-VP O
place NN B-NP O
, , O O
allow VB O O
them PRP O B-pronoun
to TO O O
fall VB O O
off RP O O
on IN B-VP O
their PRP$ O B-pronoun
own JJ O O
. . B-VP O
   
Activity NN B-NP O
: : O O
No DT B-NP O
heavy JJ I-NP O
lifting NN I-NP O
of IN B-VP O
items NNS B-NP O
12-08 JJ B-NP O
pounds NNS I-NP O
until IN B-VP O
the DT O O
follow JJ O O
up RP O O
appointment NN B-NP O
with IN B-VP O
your PRP$ O B-person
your PRP$ O B-person
doctor NN B-NP I-person
. . B-VP O
   
Medications NNS B-NP O
: : O O
Resume VB O O
your PRP$ O B-person
home NN B-NP B-treatment
medications NNS I-NP I-treatment
. . B-VP O
   
You PRP O B-person
should MD O O
take VB O O
a DT B-NP B-treatment
stool NN I-NP I-treatment
softener NN I-NP I-treatment
, , O O
Colace NNP B-NP B-treatment
100 CD O O
mg NN B-NP O
twice RB O O
daily RB O O
as IN B-VP O
needed VBN O O
for IN B-VP O
constipation NN B-NP B-problem
. . B-VP O
   
You PRP O B-person
will MD O O
be VB O O
given VBN O O
pain JJ B-NP B-treatment
medication NN I-NP I-treatment
which WDT O B-pronoun
may MD O O
make VB O O
you PRP O B-person
drowsy VB O B-problem
. . B-VP O
   
Followup NNP B-NP O
Instructions NNPS I-NP O
: : O O
Provider NN B-NP B-person
: : O O
Joe NNP B-NP B-person
Kari NNP I-NP I-person
, , O I-person
MD NNP B-NP I-person
Phone NNP I-NP O
:( NNP I-NP O
625 CD O O
) ) O O
747-8259 CD O O
Date NNP B-NP O
/ JJ B-NP O
Time NN I-NP O
: : O O
2014-04-11 JJ O O
1:15 CD O O
Joe NNP B-NP B-person
Kari NNP I-NP I-person
MD NNP I-NP I-person
09-697 NN I-NP O
Completed VBN O O
by IN B-VP O
: : O O
Carol NNP B-NP B-person
Robert NNP I-NP I-person
NP NNP I-NP I-person
80-CIY JJ B-NP O
2014-03-25 JJ I-NP O
@ NN I-NP O
0837 CD O O
Signed NNP B-NP O
electronically RB O O
by IN B-VP O
: : O O
DR. NNP B-NP B-person
Marion NNP I-NP I-person
SCHNEIDER NNP I-NP I-person
on IN B-VP O
: : O O
Sandra NNP B-NP B-person
2014-03-25 CD O O
12:56 CD O O
PM NNP B-NP O
( ( O O
End NNP B-NP O
of IN B-VP O
Report NNP B-NP O
) ) O O
-EMPTYLINE- VBP O O
-DOCSTART- JJ O O
-EMPTYLINE- $ O O
139391631 CD O O
GH NNP B-NP O
97368061 CD O O
7/20/1999 CD O O
12:00:00 CD O O
AM NNP B-NP O
NEUROPATHIC NNP I-NP B-problem
PAIN NNP I-NP I-problem
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date NNP I-NP O
: : O O
07/20/1999 CD O O
Report NNP B-NP O
Status NNP I-NP O
: : O O
Signed VBN O O
Discharge NNP B-NP O
Date NNP I-NP O
: : O O
07/26/1999 CD O O
PRINCIPAL NNP B-NP O
DIAGNOSIS NNP I-NP O
: : O O
Post NNP B-NP B-problem
thoracotomy VBZ O I-problem
syndrome NN B-NP I-problem
. . B-VP O
   
PRINCIPAL JJ B-NP O
PROCEDURE NN I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
had VBD B-VP O
a DT B-NP B-test
spinal JJ I-NP I-test
cord NN I-NP I-test
stimulator NN I-NP I-test
trial NN I-NP I-test
on IN B-VP O
07/21/99 CD O O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
had VBD B-VP O
an DT B-NP B-test
epidural JJ I-NP I-test
trial NN I-NP I-test
on IN B-VP O
07/24/99 CD O O
. . B-VP O
   
HISTORY NN B-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
is VBZ O O
a DT O O
65 CD O O
year NN B-NP O
old JJ B-NP O
female NN I-NP O
with IN B-VP O
post NN B-NP B-problem
thoracotomy NN I-NP I-problem
syndrome NN I-NP I-problem
that WDT O B-pronoun
occurred VBD B-VP O
on IN B-VP O
the DT B-NP O
site NN I-NP O
of IN B-VP O
her PRP$ O B-person
her PRP$ O B-problem
thoracotomy JJ B-NP I-problem
incision NN I-NP I-problem
. . B-VP O
   
She PRP O B-person
had VBD B-VP O
a DT B-NP B-problem
thoracic JJ I-NP I-problem
aortic JJ I-NP I-problem
aneurysm NN I-NP I-problem
repaired VBN O O
in IN B-VP O
the DT O O
past JJ O O
and CC O O
subsequently RB O O
developed VBD B-VP O
neuropathic JJ B-NP B-problem
pain NN I-NP I-problem
at IN B-VP O
the DT B-NP B-problem
incision NN I-NP I-problem
site NN I-NP I-problem
. . B-VP O
   
She PRP O B-person
is VBZ O O
currently RB O O
on IN B-VP O
Vicodin NNP B-NP B-treatment
, , O O
one CD O O
to TO O O
two CD O O
tablets NNS B-NP O
every DT O O
four CD O O
hours NNS B-NP O
p.r.n. RB O O
, , O O
Fentanyl NNP B-NP B-treatment
patch VBP O I-treatment
25 CD O O
mcg FW O O
an DT B-NP O
hour NN I-NP O
, , O O
change NN B-NP O
of IN B-VP O
patch NN B-NP O
every DT O O
72 CD O O
hours NNS B-NP O
, , O O
Elavil NNP B-NP B-treatment
50 CD O O
mgq NN B-NP O
.h.s. NN I-NP O
, , O O
Neurontin NNP B-NP B-treatment
600 CD O O
mg NN B-NP O
p.o. NN I-NP O
t.i.d. NN I-NP O
with IN B-VP O
still RB O O
what WP O O
she PRP O B-person
reports VBZ O O
as IN B-VP O
stabbing VBG O B-problem
left-sided JJ B-NP I-problem
chest NN I-NP I-problem
pain NN I-NP I-problem
that WDT O B-pronoun
can MD O O
be VB O O
as RB O O
severe JJ O O
as IN B-VP O
a DT O O
7/10. CD O O
She PRP O B-person
has VBZ O O
failed VBN O O
conservative JJ B-NP B-treatment
therapy NN I-NP I-treatment
and CC O O
is VBZ O O
admitted VBN O O
for IN B-VP O
a DT B-NP B-test
spinal JJ I-NP I-test
cord NN I-NP I-test
stimulator NN I-NP I-test
trial NN I-NP I-test
. . B-VP O
   
PAST NNP B-NP O
MEDICAL NNP I-NP O
HISTORY NNP I-NP O
: : O O
1. CD O O
Hypertension NNP B-NP B-problem
. . B-VP O
   
2. CD O O
Hypothyroidism NNP B-NP B-problem
. . B-VP O
   
3. CD O O
Paraplegia NNP B-NP B-problem
status NN I-NP O
post NN I-NP O
thoracic NN I-NP B-treatment
aortic JJ B-NP I-treatment
aneurysm NN I-NP I-treatment
repair NN I-NP I-treatment
. . B-VP O
   
4. CD O O
Left NNP B-NP B-problem
hemidiaphragmatic JJ B-NP I-problem
paralysis NN I-NP I-problem
, , O O
history NN B-NP O
of IN B-VP O
recurrent NN B-NP B-problem
lung NN I-NP I-problem
infections NNS I-NP I-problem
. . B-VP O
   
5. CD O O
Sacral JJ B-NP B-problem
decubitus NN I-NP I-problem
ulcer NN I-NP I-problem
. . B-VP O
   
6. CD O O
Home NNP B-NP B-treatment
oxygen NN I-NP I-treatment
at IN B-VP O
two CD O O
liters NNS B-NP O
a DT B-NP O
minute NN I-NP O
when WRB O O
she PRP O B-person
is VBZ O O
at IN B-VP O
home NN B-NP O
; : O O
she PRP O B-person
does VBZ O O
not RB O O
use VB O O
the DT B-NP B-treatment
oxygen NN I-NP I-treatment
when WRB O O
she PRP O B-person
is VBZ O O
in IN B-VP O
a DT B-NP B-treatment
wheelchair NN I-NP I-treatment
or CC O O
is VBZ O O
out IN B-VP O
of IN B-VP O
the DT B-NP O
house NN I-NP O
. . B-VP O
   
MEDICATIONS NNP B-NP O
ON NNP I-NP O
DISCHARGE NNP I-NP O
: : O O
1. CD O O
Atrovent NNP B-NP B-treatment
nebulizers NNS I-NP I-treatment
0.5 CD O O
mg NNS B-NP O
mixed JJ O O
with IN B-VP O
albuterol NN B-NP B-treatment
, , O O
nebulizer NN B-NP B-treatment
is VBZ O O
given VBN O O
every DT O O
six CD O O
hours NNS B-NP O
. . B-VP O
   
2. CD O O
Norvasc NNP B-NP B-treatment
2.5 CD O O
mg NN B-NP O
p.o. NN I-NP O
q JJ B-NP O
day NN I-NP O
. . B-VP O
   
3. CD O O
Colistin NNP B-NP B-treatment
30 CD O O
mg NN B-NP O
nebulizer NN I-NP O
twice RB O O
a DT B-NP O
day NN I-NP O
, , O O
give VB O O
30 CD O O
minutes NNS B-NP O
post VBP O O
albuterol NN B-NP B-treatment
and CC O O
Atrovent NNP B-NP B-treatment
. . B-VP O
   
4. CD O O
Pressure NN B-NP B-treatment
, , O I-treatment
dermal JJ B-NP I-treatment
ulcer NN I-NP I-treatment
care NN I-NP I-treatment
b.i.d. IN B-VP O
dressing VBG O B-treatment
change NN B-NP I-treatment
with IN B-VP O
antibiotic JJ B-NP B-treatment
solution NN I-NP I-treatment
. . B-VP O
   
5. CD O O
Neurontin NNP B-NP B-treatment
600 CD O O
mg NN B-NP O
p.o. NN I-NP O
t.i.d. VBD B-VP O
6. CD O O
Colace NNP B-NP B-treatment
100 CD O O
mg NN B-NP O
p.o. NN I-NP O
b.i.d. VBD B-VP O
7. CD O O
Albuterol NNP B-NP B-treatment
neb RB O I-treatment
2.5 CD O O
mg NN B-NP O
every DT O O
six CD O O
hours NNS B-NP O
, , O O
30 CD O O
minutes NNS B-NP O
before IN B-VP O
Colistin NNP B-NP B-treatment
. . B-VP O
   
8. CD O O
Amitriptyline NNP B-NP B-treatment
50 CD O O
mg VBD B-VP O
q.h.s. RB O O
9. CD O O
Vitamin NNP B-NP B-treatment
C NNP I-NP I-treatment
500 CD O O
mg NN B-NP O
p.o. NN I-NP O
b.i.d. VBD B-VP O
10. CD O O
Calcium NNP B-NP B-treatment
carbonate NN I-NP I-treatment
125.0 CD O O
mg NN B-NP O
t.i.d. NN I-NP O
11. CD O O
Fentanyl NNP B-NP B-treatment
patch NN I-NP I-treatment
25 CD O O
mcg NN B-NP O
an DT B-NP O
hour NN I-NP O
, , O O
change NN B-NP O
patch NN I-NP O
every DT O O
72 CD O O
hours NNS B-NP O
. . B-VP O
   
12. CD O O
Folate NNP B-NP B-treatment
1 CD O O
mg NN B-NP O
p.o. NN I-NP O
q JJ B-NP O
day NN I-NP O
. . B-VP O
   
13. CD O O
Synthroid JJ O B-treatment
50 CD O O
mcg NN B-NP O
p.o. NN I-NP O
q JJ B-NP O
day NN I-NP O
. . B-VP O
   
14. CD O O
Zinc NNP B-NP B-treatment
sulfate NN I-NP I-treatment
220 CD O O
mg NN B-NP O
p.o. NN I-NP O
q JJ B-NP O
day NN I-NP O
. . B-VP O
   
15. CD O O
Multivitamin NNP B-NP B-treatment
, , O O
one CD O O
tablet NN B-NP O
p.o. NN I-NP O
q JJ B-NP O
day NN I-NP O
. . B-VP O
   
16. CD O O
Hydrocodone $ O B-treatment
5 CD O I-treatment
mg NN B-NP I-treatment
with IN B-VP I-treatment
Tylenol NNP B-NP I-treatment
, , O O
one CD O O
to TO O O
two CD O O
tablets NNS B-NP O
every DT O O
four CD O O
hours NNS B-NP O
p.r.n. RB O O
pain VBP O B-problem
. . B-VP O
   
17. CD O O
Milk NN B-NP B-treatment
of IN B-VP I-treatment
Magnesia NNP B-NP I-treatment
30 CD O O
cc NN B-NP O
p.o. NN I-NP O
q JJ B-NP O
day NN I-NP O
constipation NN I-NP B-problem
. . B-VP O
   
ALLERGIES NN B-NP O
: : O O
PENICILLIN NNP B-NP B-treatment
. . B-VP O
   
SOCIAL NNP B-NP O
HISTORY NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
lives VBZ O O
in IN B-VP O
Napro NNP B-NP O
with IN B-VP O
her PRP$ O B-person
her PRP$ O B-person
husband NN B-NP I-person
who WP O B-person
is VBZ O O
her PRP$ O B-person
primary JJ B-NP O
caregiver NN I-NP O
. . B-VP O
   
She PRP O B-person
is VBZ O O
not RB O O
a DT B-NP O
smoker NN I-NP O
. . B-VP O
   
She PRP O B-person
has VBZ O O
approximately RB O O
one CD O O
glass NN B-NP O
of IN B-VP O
wine JJ O O
every DT B-NP O
day NN I-NP O
. . B-VP O
   
PHYSICAL JJ B-NP O
EXAMINATION NN I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
is VBZ O O
well-appearing JJ O O
in IN B-VP O
no DT B-NP O
acute JJ I-NP B-problem
distress NN I-NP I-problem
. . B-VP O
   
Blood NNP B-NP B-test
pressure NN I-NP I-test
is VBZ O O
150/90 CD O O
, , O O
heart NN B-NP B-test
rate NN I-NP I-test
of IN B-VP O
90 CD O O
, , O O
respiratory NN B-NP B-test
rate NN I-NP I-test
20 CD O O
with IN B-VP O
saturation NN B-NP B-test
of IN B-VP O
98% CD O O
. . B-VP O
   
HEENT NN B-NP O
: : O O
Pupils NNS B-NP O
are VBP O O
equal JJ O O
and CC O O
reactive JJ O O
to TO O O
light NN B-NP O
. . B-VP O
   
The DT B-NP B-person
patient JJ I-NP I-person
wears NNS I-NP O
dentures VBZ O B-treatment
. . B-VP O
   
Neck NN B-NP O
: : O O
Full NNP B-NP O
range NN I-NP O
of IN B-VP O
motion NN B-NP O
with IN B-VP O
no DT B-NP O
lymphadenopathy NN I-NP B-problem
. . B-VP O
   
Chest JJS O O
: : O O
Clear JJ O O
to TO O O
auscultation VB O B-test
on IN B-VP O
the DT B-NP O
right NN I-NP O
. . B-VP O
   
Decreased VBN O B-problem
breath NN B-NP I-problem
sounds NNS I-NP I-problem
on IN B-VP I-problem
the DT B-NP I-problem
left JJ I-NP I-problem
base NN I-NP I-problem
with IN B-VP O
coarse JJ B-NP B-problem
rales NNS I-NP I-problem
on IN B-VP I-problem
the DT B-NP I-problem
left JJ I-NP I-problem
base NN I-NP I-problem
. . B-VP O
   
Cardiovascular JJ O O
: : O O
Regular JJ B-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
with IN B-VP O
normal JJ B-NP O
S1 NNP I-NP O
and CC O O
S2 NNP B-NP O
. . B-VP O
   
Abdomen NNS B-NP O
: : O O
Soft NNP B-NP O
, , O O
nondistended VBD B-VP B-problem
, , O O
nontender NN B-NP B-problem
. . B-VP O
   
Positive JJ B-NP O
bowel NN I-NP O
sounds NNS I-NP O
. . B-VP O
   
Back RB O O
: : O O
Clear JJ O O
. . B-VP O
   
Epidural JJ B-NP B-treatment
site NN I-NP I-treatment
is VBZ O O
without IN B-VP O
erythema NN B-NP B-problem
, , O O
drainage NN B-NP B-problem
or CC O O
tenderness NN B-NP B-problem
. . B-VP O
   
Left NNP B-NP O
buttock NN I-NP O
area NN I-NP O
has VBZ O O
a DT B-NP B-treatment
dressing NN I-NP I-treatment
over IN B-VP O
the DT B-NP B-problem
sacral JJ I-NP I-problem
decubitus NN I-NP I-problem
ulcer NN I-NP I-problem
. . B-VP O
   
Extremities NNS B-NP O
: : O O
Well-profused JJ O O
. . B-VP O
   
4/5 CD O O
motor NN B-NP O
strength NN I-NP O
in IN B-VP O
the DT B-NP O
upper JJ I-NP O
extremities NNS I-NP O
bilaterally RB O O
. . B-VP O
   
Flaccid NNP B-NP B-problem
paralysis NN I-NP I-problem
of IN B-VP I-problem
bilateral JJ B-NP I-problem
lower JJR I-NP I-problem
extremities NNS I-NP I-problem
. . B-VP O
   
HOSPITAL NNP B-NP O
COURSE NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
admitted VBN O O
on IN B-VP O
07/20/99 CD O O
for IN B-VP O
a DT B-NP O
history NN I-NP O
of IN B-VP O
left JJ B-NP B-problem
chest JJS I-NP I-problem
wall NN I-NP I-problem
pain NN I-NP I-problem
from IN B-VP O
postthoracotomy JJ B-NP B-problem
syndrome NN I-NP I-problem
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
developed VBD B-VP O
the DT B-NP B-problem
syndrome NN I-NP I-problem
after IN B-VP O
her PRP$ O B-person
her PRP$ O B-treatment
thoracic NN B-NP I-treatment
aortic JJ B-NP I-treatment
aneurysm NN I-NP I-treatment
repair NN I-NP I-treatment
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
failed VBD B-VP O
the DT B-NP B-treatment
conservative JJ I-NP I-treatment
therapy NN I-NP I-treatment
and CC O O
is VBZ O O
admitted VBN O O
for IN B-VP O
a DT B-NP B-test
spinal JJ I-NP I-test
cord NN I-NP I-test
stimulator NN I-NP I-test
trial NN I-NP I-test
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
had VBD B-VP O
a DT B-NP B-treatment
spinal JJ I-NP I-treatment
cord NN I-NP I-treatment
stimulator NN I-NP I-treatment
placed VBD B-VP O
on IN B-VP O
07/21/99 CD O O
. . B-VP O
   
She PRP O B-person
underwent VBD B-VP O
the DT B-NP B-treatment
procedure NN I-NP I-treatment
and CC O O
tolerated VBD B-VP O
the DT B-NP B-treatment
procedure NN I-NP I-treatment
very RB O O
well RB O O
. . B-VP O
   
The DT B-NP B-treatment
spinal JJ I-NP I-treatment
cord NN I-NP I-treatment
stimulator NN I-NP I-treatment
was VBD B-VP O
programmed VBN O O
with IN B-VP O
setting NN B-NP O
of IN B-VP O
a DT B-NP O
rate NN I-NP O
of IN B-VP O
80 CD O O
, , O O
power NN B-NP O
450 CD O O
and CC O O
4.0 CD O O
amps NNS B-NP O
. . B-VP O
   
Channel NNP B-NP O
1 CD O O
was VBD B-VP O
negative JJ O O
, , O O
2 CD O O
was VBD B-VP O
neutral JJ O O
, , O O
3 CD O O
was VBD B-VP O
neutral JJ O O
, , O O
4 CD O O
was VBD B-VP O
positive JJ O O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
the DT O O
next JJ O O
two CD O O
days NNS B-NP O
did VBD B-VP O
not RB O O
notice VB O O
any DT B-NP O
significant JJ I-NP O
change NN I-NP O
in IN B-VP O
her PRP$ O B-person
her PRP$ O B-problem
pain NN B-NP I-problem
pattern NN I-NP I-problem
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
also RB O O
noted VBN O O
to TO O O
have VB O O
a DT B-NP O
lot NN I-NP O
of IN B-VP O
musculoskeletal JJ B-NP B-problem
component NN I-NP I-problem
of IN B-VP O
her PRP$ O B-person
her PRP$ O B-problem
pain NN B-NP I-problem
. . B-VP O
   
So RB O O
, , O O
an DT B-NP B-treatment
epidural JJ I-NP I-treatment
catheter NN I-NP I-treatment
was VBD B-VP O
placed VBN O O
on IN B-VP O
07/23/99 CD O O
. . B-VP O
   
The DT B-NP B-treatment
epidural NN I-NP I-treatment
was VBD B-VP O
placed VBN O O
in IN B-VP O
the DT B-NP O
L1-2 JJ I-NP O
region NN I-NP O
and CC O O
the DT B-NP B-treatment
catheter NN I-NP I-treatment
was VBD B-VP O
placed VBN O O
in IN B-VP O
the DT B-NP O
T7 NNP I-NP O
region NN I-NP O
using VBG O O
fluoroscope NN B-NP B-treatment
to TO O O
guide VB O O
the DT B-NP B-treatment
catheter NN I-NP I-treatment
. . B-VP O
   
Within IN B-VP O
the DT B-NP O
next JJ I-NP O
couple NN I-NP O
of IN B-VP O
days NNS B-NP O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
noticed VBD B-VP O
a DT B-NP O
significant JJ I-NP O
improvement NN I-NP O
in IN B-VP O
her PRP$ O B-person
her PRP$ O B-problem
pain NN B-NP I-problem
pattern NN I-NP I-problem
. . B-VP O
   
The DT B-NP B-problem
stabbing NN I-NP I-problem
, , O I-problem
sharp JJ B-NP I-problem
pain NN I-NP I-problem
that IN B-VP B-pronoun
she PRP O B-person
occasionally RB O O
has VBZ O O
on IN B-VP O
the DT B-NP O
left NN I-NP O
chest JJS B-NP O
wall NN I-NP O
was VBD B-VP O
significantly RB O O
diminished VBN O O
and CC O O
she PRP O B-person
also RB O O
noticed VBD B-VP O
periods NNS B-NP O
of IN B-VP O
time NN B-NP O
when WRB O O
she PRP O B-person
did VBD B-VP O
not RB O O
have VB O O
any DT O O
of IN B-VP O
that DT O B-problem
that DT B-NP B-pronoun
pain NN I-NP I-problem
. . B-VP O
   
The DT B-NP B-treatment
epidural JJ I-NP I-treatment
catheter NN I-NP I-treatment
had VBD B-VP O
a DT B-NP B-treatment
morphine JJ I-NP I-treatment
infusion NN I-NP I-treatment
initially RB O O
started VBD B-VP O
at IN B-VP O
1 CD O O
mg NNS B-NP O
a DT B-NP O
day NN I-NP O
and CC O O
increased VBD B-VP O
to TO O O
3 CD O O
mg NNS B-NP O
a DT B-NP O
day NN I-NP O
in IN B-VP O
a DT B-NP O
period NN I-NP O
of IN B-VP O
three CD O O
days NNS B-NP O
. . B-VP O
   
The DT B-NP B-treatment
epidural NN I-NP I-treatment
was VBD B-VP O
discontinued VBN O O
on IN B-VP O
07/26/99 CD O O
and CC O O
was VBD B-VP O
considered VBN O O
a DT B-NP O
successful JJ I-NP O
trial NN I-NP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
will MD O O
schedule VB O O
with IN B-VP O
the DT B-NP O
Pain NNP I-NP O
Clinic NNP I-NP O
regarding VBG O O
upcoming JJ B-NP O
epidural JJ I-NP B-treatment
pump NN I-NP I-treatment
placement NN I-NP I-treatment
. . B-VP O
   
During IN B-VP O
her PRP$ O B-person
hospitalization NN B-NP O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
also RB O O
seen VBN O O
by IN B-VP O
the DT B-NP O
Plastic NNP I-NP B-person
Service NNP I-NP I-person
. . B-VP O
   
Dr. NNP B-NP B-person
Falccouette NNP I-NP I-person
would MD O O
like VB O O
to TO O O
perform VB O O
an DT B-NP B-treatment
excision NN I-NP I-treatment
and CC O O
closure NN B-NP B-treatment
flap NN I-NP I-treatment
of IN B-VP O
her PRP$ O B-problem
her PRP$ O B-person
left JJ B-NP I-problem
ischial JJ I-NP I-problem
decubitusin NN I-NP I-problem
the DT B-NP O
near JJ I-NP O
future NN I-NP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
discharged VBN O O
in IN B-VP O
stable JJ B-NP O
conditionand NN I-NP O
will MD O O
follow VB O O
up RP O O
for IN B-VP O
( ( O O
1 CD O O
) ) O O
sacral JJ B-NP B-treatment
decubitus NN I-NP I-treatment
closure NN I-NP I-treatment
, , O O
and CC O O
( ( O O
2 CD O O
) ) O O
placement NN B-NP B-treatment
of IN B-VP I-treatment
epidural JJ B-NP I-treatment
pump NN I-NP I-treatment
in IN B-VP O
the DT B-NP O
future NN I-NP O
. . B-VP O
   
DISCHARGE NNP B-NP O
INSTRUCTIONS NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
will MD O O
have VB O O
SMH NNP B-NP B-person
Service NNP I-NP I-person
that WDT O B-pronoun
comes VBZ O O
to TO O O
her PRP$ O B-person
home NN B-NP O
once IN B-VP O
a DT B-NP O
day NN I-NP O
for IN B-VP O
adressing VBG O B-treatment
change NN B-NP I-treatment
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
will MD O O
follow VB O O
up RP O O
with IN B-VP O
Dr. NNP B-NP B-person
Kayschird NNP I-NP I-person
to TO O O
schedule VB O O
for IN B-VP O
the DT B-NP B-treatment
epidural JJ I-NP I-treatment
pump NN I-NP I-treatment
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
will MD O O
follow VB O O
up RP O O
with IN B-VP O
Dr. NNP B-NP B-person
Falccouette NNP I-NP I-person
to TO O O
schedule VB O O
for IN B-VP O
excision NN B-NP B-treatment
and CC O O
closure NN B-NP B-treatment
of IN B-VP O
her PRP$ O B-person
her PRP$ O B-problem
left JJ B-NP I-problem
ischial JJ I-NP I-problem
sacral JJ I-NP I-problem
decubitus NN I-NP I-problem
. . B-VP O
   
Dictated VBN O O
By IN B-VP O
: : O O
ECI NNP B-NP B-person
JESCSLAND NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
OO63 NNP I-NP O
Attending NNP I-NP B-person
: : O O
FOMAIRE NNP B-NP B-person
KOTEKOTEJESCDREWE NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
RY93 NNP I-NP O
KE526/9219 NNP I-NP O
Batch NNP I-NP O
: : O O
37707 CD O O
Index NNP B-NP O
No. NN I-NP O
RWRF75BSI NNP I-NP O
D NNP I-NP O
: : O O
07/26/99 CD O O
T NN B-NP O
: : O O
07/26/99 CD O O
CC NN B-NP O
: : O O
JOFREDD NNP B-NP B-person
N. NNP I-NP I-person
FALCCOUETTE NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
SV7 NNP I-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- VBD B-VP O
915093496 CD O O
RWH NNP B-NP O
0802338 CD O O
045989 CD O O
2923113 CD O O
12/13/2002 CD O O
12:00:00 CD O O
AM NNP B-NP O
Discharge NNP I-NP O
Summary NNP I-NP O
Signed VBD B-VP O
DIS NNP B-NP O
Report NNP I-NP O
Status NNP I-NP O
: : O O
Signed VBD B-VP O
DISCHARGE NNP B-NP O
SUMMARY NNP I-NP O
NAME NN I-NP O
: : O O
GIENGBEENEA NNP B-NP B-person
, , O I-person
NAA NNP B-NP I-person
UNIT NNP I-NP O
NUMBER NNP I-NP O
: : O O
799-54-08 JJ B-NP O
ADMISSION NNP I-NP O
DATE NNP I-NP O
: : O O
12/13/2002 CD O O
DISCHARGE NNP B-NP O
DATE NNP I-NP O
: : O O
12/14/2002 CD O O
ADMITTING NN B-NP O
DIAGNOSIS NNP I-NP O
: : O O
1. CD O O
Undesired NNP B-NP B-problem
fertility NN I-NP I-problem
. . B-VP O
   
2. CD O O
Undesired JJ B-NP B-problem
adiposity NN I-NP I-problem
. . B-VP O
   
HISTORY NNP B-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
is VBZ O O
a DT O O
30 CD O O
-year-old JJ B-NP O
Gravida NNP I-NP O
III NNP I-NP O
, , O O
Para NNP B-NP O
II NNP I-NP O
who WP O B-person
presented VBD B-VP O
desiring VBG O O
definitive JJ B-NP B-treatment
surgical JJ I-NP I-treatment
sterilization NN I-NP I-treatment
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
extensively RB O O
counseled VBN O O
regarding VBG O O
other JJ B-NP O
methods NNS I-NP O
of IN B-VP O
birth NN B-NP B-treatment
control NN I-NP I-treatment
and CC O O
desired VBD B-VP O
to TO O O
proceed VB O O
with IN B-VP O
definitive JJ B-NP B-treatment
surgical JJ I-NP I-treatment
therapy NN I-NP I-treatment
. . B-VP O
   
In IN B-VP O
addition NN B-NP O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
desired VBD B-VP O
liposuction NN B-NP B-treatment
of IN B-VP I-treatment
varying VBG O I-treatment
areas NNS B-NP I-treatment
as RB O O
well RB O O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
consented VBN O O
for IN B-VP O
both DT B-NP B-treatment
procedures NNS I-NP I-treatment
and CC O O
brought VBD B-VP O
to TO O O
the DT B-NP O
Operating NN I-NP O
Room NNP I-NP O
. . B-VP O
   
PAST NNP B-NP O
MEDICAL NNP I-NP O
HISTORY NNP I-NP O
: : O O
None NN B-NP O
. . B-VP O
   
PAST JJ B-NP O
SURGICAL JJ I-NP O
HISTORY NN I-NP O
: : O O
Appendectomy NN B-NP B-treatment
at IN B-VP O
the DT B-NP O
age NN I-NP O
of IN B-VP O
14 CD O O
, , O O
open JJ O O
. . B-VP O
   
PAST JJ B-NP O
OBSTETRIC NNP I-NP O
HISTORY NN I-NP O
: : O O
Spontaneous JJ B-NP B-problem
vaginal JJ I-NP I-problem
delivery NN I-NP I-problem
x NN I-NP O
2 CD O O
. . B-VP O
   
PAST JJ B-NP O
GYN NNP I-NP O
HISTORY NN I-NP O
: : O O
Regular JJ B-NP O
menses NNS I-NP O
, , O O
on IN B-VP O
Ortho-Tri-Cyclen NNP B-NP B-treatment
. . B-VP O
   
No NNP B-NP O
history NN I-NP O
of IN B-VP O
sexually RB O B-problem
transmitted VBN O I-problem
disease NN B-NP I-problem
, , O O
no DT B-NP O
history NN I-NP O
of IN B-VP O
domestic JJ B-NP O
violence NN I-NP O
. . B-VP O
   
MEDICATIONS NNP B-NP O
ON NNP I-NP O
ADMISSION NNP I-NP O
: : O O
1. CD O O
Ortho NNP B-NP B-treatment
Tri-Cyclen NNP I-NP I-treatment
. . B-VP O
   
ALLERGIES NNP B-NP O
: : O O
No DT B-NP O
known JJ I-NP B-problem
drug NN I-NP I-problem
allergies NNS I-NP I-problem
. . B-VP O
   
PHYSICAL JJ B-NP O
EXAMINATION NN I-NP O
: : O O
Height $ O B-test
5 CD O O
&apos; $ O O
1 CD O O
&quot; NNP B-NP O
, , O O
weight VBD B-VP B-test
138 CD O O
lb. JJ B-NP O
Blood NNP I-NP B-test
pressure NN I-NP I-test
: : O O
130/82 CD O O
and CC O O
heart NN B-NP B-test
rate NN I-NP I-test
80 CD O O
. . B-VP O
   
Breasts NNS B-NP O
: : O O
no DT B-NP O
masses NNS I-NP B-problem
. . B-VP O
   
Lungs NNS B-NP O
: : O O
clear JJ O O
to TO O O
auscultation NN B-NP B-test
and CC O O
percussion NN B-NP B-test
bilaterally RB O O
. . B-VP O
   
Heart NN B-NP O
: : O O
regular JJ B-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
, , O O
S1-S2 NNP B-NP O
. . B-VP O
   
Abdomen NNS B-NP O
: : O O
soft JJ O O
, , O O
nontender NN B-NP B-problem
, , O O
nondistended VBN O B-problem
. . B-VP O
   
Extremities NNS B-NP O
: : O O
within IN B-VP O
normal JJ O O
. . B-VP O
   
Pelvic NNP B-NP B-test
exam RB O I-test
revealed VBD B-VP O
normal JJ B-NP O
vulva NN I-NP O
, , O O
vagina FW O O
normal JJ O O
, , O O
cervix JJ O O
normal JJ O O
, , O O
uterus JJ O O
anteverted VBD B-VP O
, , O O
small JJ O O
, , O O
nontender NN B-NP B-problem
. . B-VP O
   
Adnexa NNP B-NP O
: : O O
no DT B-NP O
masses NNS I-NP B-problem
or CC O O
tenderness NN B-NP B-problem
. . B-VP O
   
Rectal JJ O O
: : O O
deferred VBN O O
. . B-VP O
   
HOSPITAL NNP B-NP O
COURSE NNP I-NP O
AND NNP I-NP O
TREATMENT NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
admitted VBN O O
to TO O O
the DT B-NP O
Operating NN I-NP O
Room NN I-NP O
where WRB O O
she PRP O B-person
underwent VBD B-VP O
an DT B-NP B-treatment
unremarkable JJ I-NP I-treatment
laparoscopic NN I-NP I-treatment
tubal JJ B-NP I-treatment
ligation NN I-NP I-treatment
. . B-VP O
   
This DT O B-pronoun
was VBD B-VP O
done VBN O O
with IN B-VP O
Falope NNP B-NP B-treatment
rings NNS I-NP I-treatment
. . B-VP O
   
The DT B-NP B-problem
estimated JJ I-NP I-problem
blood NN I-NP I-problem
loss NN I-NP I-problem
was VBD B-VP O
minimal JJ O O
and CC O O
the DT B-NP B-person
patient NN I-NP I-person
received VBD B-VP O
600 CD O O
cc. NN B-NP O
of IN B-VP O
intravenous JJ B-NP B-treatment
fluid NN I-NP I-treatment
. . B-VP O
   
Of IN B-VP O
note NN B-NP O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
had VBD B-VP O
a DT B-NP O
negative JJ I-NP O
urine JJ I-NP O
pregnancy NN I-NP O
test NN I-NP O
prior RB O O
to TO O O
the DT B-NP B-treatment
surgery NN I-NP I-treatment
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
then RB O O
underwent JJ B-NP O
liposuction NN I-NP B-treatment
of IN B-VP I-treatment
her PRP$ O B-person
her PRP$ O I-treatment
abdomen NNS B-NP I-treatment
, , O I-treatment
inner JJ B-NP I-treatment
thighs NNS I-NP I-treatment
, , O I-treatment
hips NNS B-NP I-treatment
, , O I-treatment
flanks NNS B-NP I-treatment
, , O I-treatment
chest NN B-NP I-treatment
and CC O I-treatment
arms NNS B-NP I-treatment
with IN B-VP O
Dr. NNP B-NP B-person
Chain NNP I-NP I-person
. . B-VP O
   
She PRP O B-person
did VBD B-VP O
well RB O O
and CC O O
was VBD B-VP O
admitted VBN O O
to TO O O
the DT B-NP O
GYN NNP I-NP O
Service NNP I-NP O
postoperatively RB O O
because IN B-VP O
the DT B-NP B-person
patient NN I-NP I-person
had VBD B-VP O
persistent JJ B-NP B-problem
pain NN I-NP I-problem
. . B-VP O
   
On IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
#one NN I-NP O
, , O O
she PRP O B-person
was VBD B-VP O
then RB O O
stable JJ O O
with IN B-VP O
no DT B-NP O
complaints NNS I-NP B-problem
. . B-VP O
   
She PRP O B-person
remained VBD B-VP O
afebrile RB O B-problem
. . B-VP O
   
Her PRP$ O B-person
Her PRP$ O B-treatment
Foley NNP B-NP I-treatment
was VBD B-VP O
removed VBN O O
. . B-VP O
   
Her PRP$ O B-person
diet NN B-NP O
was VBD B-VP O
advanced VBN O O
without IN B-VP O
difficulty NN B-NP O
and CC O O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
stable JJ O O
for IN B-VP O
discharge NN B-NP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
to TO O O
follow VB O O
up RP O O
in IN B-VP O
several JJ B-NP O
days NNS I-NP O
time NN I-NP O
with IN B-VP O
Dr. NNP B-NP B-person
Chain NNP I-NP I-person
of IN B-VP O
the DT B-NP O
Plastics NNPS I-NP O
Clinic NNP I-NP O
. . B-VP O
   
DISCHARGE NNP B-NP O
MEDICATIONS NNP I-NP O
: : O O
Motrin NNP B-NP B-treatment
and CC O O
Percocet NNP B-NP B-treatment
as IN B-VP O
needed VBN O O
. . B-VP O
   
PADA NNP B-NP B-person
MARONNESSGRE NNP I-NP I-person
CHAIN NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
DICTATING NNP I-NP O
FOR NNP I-NP O
: : O O
Electronically RB O O
Signed VBD B-VP O
PADA NNP B-NP B-person
MARONNESSGRE NNP I-NP I-person
CHAIN NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
04/25/2003 CD O O
09:50 CD O O
_____________________________ NN B-NP O
PADA NNP I-NP B-person
MARONNESSGRE NNP I-NP I-person
CHAIN NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
TR NNP I-NP O
: : O O
wwi NN B-NP O
DD NNP I-NP O
: : O O
04/17/2003 CD O O
TD NN B-NP O
: : O O
04/18/2003 CD O O
8:28 CD O O
A DT O O
045989 CD O O
cc NN B-NP O
: : O O
PADA NNP B-NP B-person
MARONNESSGRE NNP I-NP I-person
CHAIN NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
Admission NNP I-NP O
Date NNP I-NP O
: : O O
2013-02-12 JJ B-NP O
Discharge NN I-NP O
Date NNP I-NP O
: : O O
2013-02-16 JJ B-NP O
Date NNP I-NP O
of IN B-VP O
Birth NNP B-NP O
: : O O
1937-03-25 JJ B-NP O
Sex NN I-NP O
: : O O
F NNP B-NP O
Service NNP I-NP O
: : O O
CARDIOTHORACIC NNP B-NP O
HISTORY NNP I-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
referred VBN O O
from IN B-VP O
an DT B-NP O
outside JJ I-NP O
hospital NN I-NP O
with IN B-VP O
a DT B-NP O
chief JJ I-NP O
complaint NN I-NP O
of IN B-VP O
increasing VBG O B-problem
shortness NN B-NP I-problem
of IN B-VP I-problem
breath NN B-NP I-problem
and CC O O
tires NNS B-NP B-problem
easily RB O I-problem
with IN B-VP O
exertion NN B-NP O
. . B-VP O
   
Admitted VBN O O
to TO O O
Bay NNP B-NP O
State NNP I-NP O
Medical NNP I-NP O
Center NNP I-NP O
Hospital NNP I-NP O
in IN B-VP O
2012-10-22 JJ O O
in IN B-VP O
congestive JJ B-NP B-problem
heart NN I-NP I-problem
failure NN I-NP I-problem
at IN B-VP O
that DT B-NP B-pronoun
time NN I-NP O
. . B-VP O
   
Via NNP B-NP O
echocardiogram NN I-NP B-test
, , O O
found VBN O O
to TO O O
have VB O O
aortic JJ B-NP B-problem
stenosis NN I-NP I-problem
. . B-VP O
   
Referred VBN O O
to TO O O
Memorial NNP B-NP O
Hospital NNP I-NP O
( ( O O
Worcester NNP B-NP O
) ) O O
for IN B-VP O
cardiac JJ B-NP B-test
catheterization NN I-NP I-test
to TO O O
further JJ O O
evaluate VB O O
her PRP$ O B-problem
her PRP$ O B-person
aortic JJ B-NP I-problem
stenosis NN I-NP I-problem
. . B-VP O
   
Cardiac JJ B-NP B-test
catheterization NN I-NP I-test
done VBN O O
on IN B-VP O
01-07 NN B-NP O
showed VBD B-VP O
an DT B-NP B-test
aortic JJ I-NP I-test
valve NN I-NP I-test
area NN I-NP I-test
of IN B-VP O
.38 NNP B-NP O
cm.sq. NN I-NP O
, , O O
with IN B-VP O
a DT B-NP B-test
mean JJ I-NP I-test
gradient NN I-NP I-test
of IN B-VP O
62 CD O O
, , O O
and CC O O
a DT B-NP B-test
peak JJ I-NP I-test
gradient NN I-NP I-test
of IN B-VP O
85 CD O O
. . B-VP O
   
Moderate NNP B-NP B-problem
pulmonary JJ B-NP I-problem
hypertension NN I-NP I-problem
, , O O
PA NNP B-NP B-test
pressure NN I-NP I-test
48/24 CD O O
, , O O
1+ CD O B-problem
mitral JJ B-NP I-problem
regurgitation NN I-NP I-problem
, , O O
severe JJ B-NP B-problem
aortic JJ I-NP I-problem
stenosis NN I-NP I-problem
with IN B-VP O
an DT B-NP B-test
LVEDP NNP I-NP I-test
of IN B-VP O
19 CD O O
and CC O O
an DT B-NP B-test
ejection NN I-NP I-test
fraction NN I-NP I-test
of IN B-VP O
43% CD O O
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
then RB O O
referred VBN O O
to TO O O
Cardiothoracic NNP B-NP O
Surgery NNP I-NP O
for IN B-VP O
aortic JJ B-NP B-treatment
valve NN I-NP I-treatment
replacement NN I-NP I-treatment
. . B-VP O
   
PAST NNP B-NP O
MEDICAL NNP I-NP O
HISTORY NNP I-NP O
: : O O
1. CD O O
Aortic JJ B-NP B-problem
stenosis NN I-NP I-problem
2. CD O O
Diabetes NNPS B-NP B-problem
mellitus VBP O I-problem
Type NNP B-NP I-problem
2 CD O I-problem
3. CD O O
Right JJ B-NP B-treatment
hip NN I-NP I-treatment
replacement NN I-NP I-treatment
4. CD O O
Noninsulin NNP B-NP B-problem
dependent NN I-NP I-problem
diabetes VBZ O I-problem
mellitus JJ B-NP I-problem
MEDICATIONS NNP I-NP O
ON NNP I-NP O
ADMISSION NNP I-NP O
: : O O
Include NNP B-NP O
Glucovance NNP I-NP B-treatment
5/500 CD O O
one CD O O
tablet NN B-NP O
twice RB O O
a DT B-NP O
day NN I-NP O
, , O O
Univasc NNP B-NP B-treatment
7.5 CD O O
mg NN B-NP O
once RB O O
daily JJ O O
, , O O
lasix JJ O B-treatment
20 CD O O
mg NN B-NP O
every DT B-NP O
other JJ I-NP O
day NN I-NP O
, , O O
and CC O O
aspirin RB O B-treatment
325 CD O O
mg NNS B-NP O
once RB O O
daily RB O O
. . B-VP O
   
ALLERGIES NNP B-NP O
: : O O
No DT B-NP O
known JJ I-NP B-problem
drug NN I-NP I-problem
allergies NNS I-NP I-problem
. . B-VP O
   
FAMILY NNP B-NP O
HISTORY NNP I-NP O
: : O O
Significant NN B-NP O
for IN B-VP O
her PRP$ O B-person
her PRP$ O B-person
father NN B-NP I-person
, , O O
who WP O B-person
died VBD B-VP O
at IN B-VP O
50 CD O O
years NNS B-NP O
from IN B-VP O
myocarditis NN B-NP B-problem
. . B-VP O
   
SOCIAL NNP B-NP O
HISTORY NN I-NP O
: : O O
She PRP O B-person
lives VBZ O O
alone RB O O
in IN B-VP O
Methuen NNP B-NP O
with IN B-VP O
five CD O O
stairs NNS B-NP O
. . B-VP O
   
She PRP O B-person
has VBZ O O
a DT B-NP O
remote JJ I-NP O
tobacco NN I-NP O
history NN I-NP O
, , O O
quit NN B-NP O
in IN B-VP O
October NNP B-NP O
, , O O
one CD O O
pack NN B-NP O
per IN B-VP O
day NN B-NP O
for IN B-VP O
50 CD O O
years NNS B-NP O
. . B-VP O
   
No DT B-NP O
alcohol NN I-NP O
use NN I-NP O
. . B-VP O
   
PHYSICAL JJ B-NP O
EXAMINATION NN I-NP O
: : O O
Vital JJ B-NP O
signs NNS I-NP O
: : O O
Heart NNP B-NP B-test
rate NN I-NP I-test
108 CD O O
and CC O O
regular JJ O O
, , O O
blood NN B-NP B-test
pressure NN I-NP I-test
145/76 CD O O
, , O O
respiratory NN B-NP B-test
rate NN I-NP I-test
20 CD O O
, , O O
height VBD B-VP B-test
5'2" CD O O
, , O O
weight VBD B-VP B-test
141 CD O O
pounds NNS B-NP O
. . B-VP O
   
General JJ O O
: : O O
Healthy-appearing JJ B-NP O
woman NN I-NP O
, , O O
in IN B-VP O
no DT B-NP O
acute JJ I-NP B-problem
distress NN I-NP I-problem
. . B-VP O
   
Skin NNP B-NP O
: : O O
No DT B-NP O
lesions NNS I-NP B-problem
or CC O O
rashes NNS B-NP B-problem
. . B-VP O
   
Head NNP B-NP O
, , O O
eyes NNS B-NP O
, , O O
ears NNS B-NP O
, , O O
nose RB O O
and CC O O
throat NN B-NP O
: : O O
Pupils NNP B-NP O
equal JJ O O
, , O O
round NN B-NP O
and CC O O
reactive JJ O O
to TO O O
light JJ O O
, , O O
extraocular JJ B-NP O
movements NNS I-NP O
intact JJ O O
, , O O
anicteric JJ O B-problem
, , O O
not RB O O
injected VBN O B-problem
. . B-VP O
   
Oropharynx NN B-NP O
: : O O
Mucous JJ B-NP O
membranes NNS I-NP O
moist NN I-NP O
. . B-VP O
   
Neck NN B-NP O
: : O O
Supple NN B-NP O
, , O O
no DT B-NP O
lymphadenopathy NN I-NP B-problem
, , O O
no DT B-NP O
jugular JJ I-NP B-problem
venous JJ I-NP I-problem
distention NN I-NP I-problem
, , O O
no DT B-NP O
thyromegaly NN I-NP B-problem
. . B-VP O
   
Chest JJS O O
: : O O
Clear JJ O O
to TO O O
auscultation VB O B-test
bilaterally RB O O
. . B-VP O
   
Heart NN B-NP O
: : O O
Regular JJ B-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
, , O O
S1 NNP B-NP O
, , O O
S2 NNP B-NP O
, , O O
with IN B-VP O
III/VI NNP B-NP B-problem
blowing VBG O I-problem
murmur NN B-NP I-problem
. . B-VP O
   
Abdomen NNS B-NP O
: : O O
Soft NNP B-NP O
, , O O
nontender NN B-NP B-problem
, , O O
nondistended VBD B-VP B-problem
, , O O
normal JJ B-NP O
active JJ I-NP O
bowel NN I-NP O
sounds NNS I-NP O
, , O O
no DT B-NP O
hepatosplenomegaly NN I-NP B-problem
. . B-VP O
   
Extremities NNS B-NP O
: : O O
Warm NNP B-NP O
and CC O O
well RB O O
perfused VBN O O
, , O O
with IN B-VP O
no DT B-NP O
cyanosis NN I-NP B-problem
, , O O
clubbing VBG O B-problem
or CC O O
edema NN B-NP B-problem
, , O O
no DT B-NP O
varicosities NNS I-NP B-problem
. . B-VP O
   
Neurological JJ O O
: : O O
Cranial JJ B-NP O
nerves NNS I-NP O
II NNP I-NP O
through IN B-VP O
XII NNP B-NP O
grossly RB O O
intact JJ O O
. . B-VP O
   
Moves NNS B-NP O
all DT B-NP O
extremities NNS I-NP O
. . B-VP O
   
Strength NNP B-NP B-test
5/5 CD O O
in IN B-VP O
upper JJ O O
and CC O O
lower JJR B-NP O
extremities NNS I-NP O
. . B-VP O
   
Sensation NNP B-NP O
intact JJ O O
in IN B-VP O
all DT B-NP O
dermatomes NNS I-NP O
. . B-VP O
   
Pulses NNS B-NP B-test
: : O O
Femoral JJ O B-test
2 CD O O
+ NNP B-NP O
bilaterally RB O O
, , O O
dorsalis NNS B-NP B-test
pedis VBP O I-test
1 CD O O
+ NNP B-NP O
bilaterally RB O O
, , O O
posterior JJ O B-test
tibial JJ O I-test
1 CD O O
+ NNP B-NP O
bilaterally RB O O
, , O O
and CC O O
radial JJ O B-test
2 CD O O
+ NNP B-NP O
bilaterally RB O O
. . B-VP O
   
No UH O O
carotid JJ B-NP B-problem
bruits NNS I-NP I-problem
were VBD B-VP O
noted VBN O O
. . B-VP O
   
LABORATORY NNP B-NP O
DATA NNP I-NP O
: : O O
White NNP B-NP B-test
count NN I-NP I-test
5.3 CD O O
, , O O
hematocrit NN B-NP B-test
43 CD O O
, , O O
platelets NNS B-NP B-test
200 CD O O
. . B-VP O
   
Sodium NN B-NP B-test
138 CD O O
, , O O
potassium NN B-NP B-test
4.9 CD O O
, , O O
chloride RB O B-test
102 CD O O
, , O O
CO2 NNP B-NP B-test
25 CD O O
, , O O
BUN NNP B-NP B-test
24 CD O O
, , O O
creatinine NN B-NP B-test
0.9 CD O O
, , O O
glucose VBD B-VP B-test
309 CD O O
. . B-VP O
   
Electrocardiogram NNS B-NP B-test
: : O O
Rate NN B-NP B-test
of IN B-VP O
91 CD O O
, , O O
first RB O B-problem
degree JJ B-NP I-problem
AV NNP I-NP I-problem
block NN I-NP I-problem
, , O O
intervals NNS B-NP B-test
.22 VBP O O
, , O O
.92 NNP B-NP O
, , O O
.36 NNP B-NP O
, , O O
with IN B-VP O
left JJ B-NP B-problem
ventricular JJ I-NP I-problem
hypertrophy NN I-NP I-problem
. . B-VP O
   
Chest NNP B-NP B-test
x-ray NN I-NP I-test
is VBZ O O
pending VBG O O
at IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
physical JJ O B-test
. . B-VP O
   
HOSPITAL NNP B-NP O
COURSE NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
a DT B-NP O
direct JJ I-NP O
admission NN I-NP O
to TO O O
the DT B-NP O
operating NN I-NP O
room NN I-NP O
on IN B-VP O
02-12 NN B-NP O
, , O O
at IN B-VP O
which WDT O B-pronoun
time NN B-NP O
she PRP O B-person
underwent VBD B-VP O
an DT B-NP O
aortic JJ I-NP B-treatment
valve NN I-NP I-treatment
replacement NN I-NP I-treatment
. . B-VP O
   
Please NNP B-NP O
see VB O O
the DT B-NP O
operative JJ I-NP O
report NN I-NP O
for IN B-VP O
full JJ B-NP O
details NNS I-NP O
. . B-VP O
   
In IN B-VP O
summary JJ O O
, , O O
she PRP O B-person
had VBD B-VP O
an DT B-NP B-treatment
aortic JJ I-NP I-treatment
valve NN I-NP I-treatment
replacement NN I-NP I-treatment
with IN B-VP O
a DT B-NP B-treatment
#21 JJ I-NP I-treatment
mosaic NN I-NP I-treatment
porcine NN I-NP I-treatment
valve NN I-NP I-treatment
. . B-VP O
   
She PRP O B-person
tolerated VBD B-VP O
the DT B-NP B-treatment
operation NN I-NP I-treatment
well RB O O
, , O O
and CC O O
was VBD B-VP O
transferred VBN O O
from IN B-VP O
the DT B-NP O
operating NN I-NP O
room NN I-NP O
to TO O O
the DT B-NP O
Cardiothoracic NNP I-NP O
Intensive NNP I-NP O
Care NNP I-NP O
Unit NNP I-NP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
did VBD B-VP O
well RB O O
in IN B-VP O
the DT B-NP O
immediate JJ I-NP O
postoperative JJ I-NP O
period NN I-NP O
, , O O
however RB O O
, , O O
her PRP$ O B-test
her PRP$ O B-person
blood NN B-NP I-test
pressure NN I-NP I-test
remained VBD B-VP O
somewhat RB O B-problem
labile JJ O I-problem
. . B-VP O
   
Therefore NN B-NP O
, , O O
she PRP O B-person
was VBD B-VP O
continued VBN O O
on IN B-VP O
a DT B-NP B-treatment
Neo-Synephrine JJ I-NP I-treatment
drip NN I-NP I-treatment
to TO O O
maintain VB O O
a DT B-NP B-test
systolic JJ I-NP I-test
blood NN I-NP I-test
pressure NN I-NP I-test
greater JJR O O
than IN B-VP O
110 CD O O
. . B-VP O
   
In IN B-VP O
addition NN B-NP O
, , O O
she PRP O B-person
was VBD B-VP O
slow JJ O O
to TO O O
awaken VB O O
after IN B-VP O
her PRP$ O B-treatment
her PRP$ O B-person
anesthesia NN B-NP I-treatment
was VBD B-VP O
reversed VBN O O
, , O O
and CC O O
in IN B-VP O
several JJ B-NP O
attempts NNS I-NP O
to TO O O
wean VB O O
from IN B-VP O
the DT B-NP B-treatment
ventilator NN I-NP I-treatment
, , O O
she PRP O B-person
developed VBD B-VP O
a DT B-NP B-problem
respiratory JJ I-NP I-problem
acidosis NN I-NP I-problem
. . B-VP O
   
She PRP O B-person
therefore RB O O
remained VBD B-VP O
on IN B-VP O
the DT B-NP B-treatment
ventilator NN I-NP I-treatment
throughout IN B-VP O
the DT B-NP O
day NN I-NP O
of IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
one CD O O
. . B-VP O
   
On IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
two CD O O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
remained VBD B-VP O
hemodynamically RB O O
stable JJ O O
. . B-VP O
   
Her PRP$ O B-treatment
Her PRP$ O B-person
Neo-Synephrine JJ B-NP I-treatment
drip NN I-NP I-treatment
was VBD B-VP O
weaned VBN O O
to TO O O
off VB O O
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
again RB O O
weaned VBN O O
from IN B-VP O
the DT B-NP B-treatment
ventilator NN I-NP I-treatment
, , O O
and CC O O
successfully RB O O
extubated JJ O O
. . B-VP O
   
Her PRP$ O B-person
Her PRP$ O B-treatment
chest NN B-NP I-treatment
tubes NNS I-NP I-treatment
were VBD B-VP O
discontinued VBN O O
and CC O O
, , O O
at IN B-VP O
the DT B-NP O
end NN I-NP O
of IN B-VP O
the DT B-NP O
day NN I-NP O
, , O O
she PRP O B-person
was VBD B-VP O
transferred VBN O O
from IN B-VP O
the DT B-NP O
Cardiothoracic NNP I-NP O
Intensive NNP I-NP O
Care NNP I-NP O
Unit NNP I-NP O
to TO O O
the DT B-NP O
floor NN I-NP O
for IN B-VP O
continuing VBG O B-treatment
postoperative JJ B-NP I-treatment
care NN I-NP I-treatment
and CC O O
cardiac JJ B-NP B-treatment
rehabilitation NN I-NP I-treatment
. . B-VP O
   
After IN B-VP O
being VBG O O
transferred VBN O O
to TO O O
the DT B-NP O
floor NN I-NP O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
did VBD B-VP O
well RB O O
. . B-VP O
   
Over IN B-VP O
the DT B-NP O
next JJ I-NP O
several JJ I-NP O
days NNS I-NP O
, , O O
her PRP$ O B-person
activity NN B-NP O
level NN I-NP O
was VBD B-VP O
increased VBN O O
with IN B-VP O
the DT B-NP O
assistance NN I-NP O
of IN B-VP O
Physical NNP B-NP B-person
Therapy NNP I-NP I-person
and CC O O
the DT B-NP B-person
nursing JJ I-NP I-person
staff NN I-NP I-person
. . B-VP O
   
She PRP O B-person
remained VBD B-VP O
hemodynamically RB O O
stable JJ O O
. . B-VP O
   
Her PRP$ O B-person
respiratory JJ B-NP O
condition NN I-NP O
remained VBD B-VP O
stable JJ O O
and CC O O
, , O O
on IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
four CD O O
, , O O
she PRP O B-person
was VBD B-VP O
deemed VBN O O
stable JJ O O
and CC O O
ready JJ O O
to TO O O
be VB O O
transferred VBN O O
to TO O O
rehabilitation VB O O
for IN B-VP O
continuing VBG O B-treatment
postoperative JJ B-NP I-treatment
care NN I-NP I-treatment
and CC O O
physical JJ B-NP B-treatment
therapy NN I-NP O
. . B-VP O
   
At IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
transfer NN B-NP O
, , O O
the DT O B-person
the DT B-NP B-test
patient JJ I-NP I-person
patient NN I-NP I-test
's POS O I-test
physical JJ B-NP I-test
examination NN I-NP I-test
is VBZ O O
as IN B-VP O
follows VBZ O O
: : O O
Vital JJ B-NP O
signs NNS I-NP O
: : O O
Temperature NN B-NP B-test
98.4 CD O O
, , O O
heart NN B-NP B-test
rate NN I-NP I-test
78 CD O O
and CC O O
sinus JJ B-NP B-test
rhythm NN I-NP I-test
, , O O
blood NN B-NP B-test
pressure NN I-NP I-test
106/50 CD O O
, , O O
respiratory NN B-NP B-test
rate NN I-NP I-test
18 CD O O
, , O O
oxygen NN B-NP B-test
saturation NN I-NP I-test
97% CD O O
on IN B-VP O
room NN B-NP O
air NN I-NP O
. . B-VP O
   
Weight NNP B-NP B-test
preoperatively RB O O
was VBD B-VP O
67 CD O O
kg NN B-NP O
, , O O
at IN B-VP O
discharge NN B-NP O
is VBZ O O
70.9 CD O O
kg NN B-NP O
. . B-VP O
   
Laboratory NNP B-NP B-test
data NNS I-NP I-test
on IN B-VP O
02-15 NN B-NP O
: : O O
White NNP B-NP B-test
count NN I-NP I-test
4.1 CD O O
, , O O
hematocrit NN B-NP B-test
23 CD O O
, , O O
platelets NNS B-NP B-test
144 CD O O
. . B-VP O
   
Sodium NN B-NP B-test
141 CD O O
, , O O
potassium NN B-NP B-test
4.3 CD O O
, , O O
chloride RB O B-test
108 CD O O
, , O O
CO2 NNP B-NP B-test
25 CD O O
, , O O
BUN NNP B-NP B-test
24 CD O O
, , O O
creatinine NN B-NP B-test
0.8 CD O O
, , O O
glucose VBD B-VP B-test
140 CD O O
. . B-VP O
   
Physical JJ B-NP O
examination NN I-NP O
: : O O
Alert NNP B-NP O
and CC O O
oriented VBD B-VP O
x NNP B-NP O
3 CD O O
, , O O
moves NNS B-NP O
all DT B-NP O
extremities NNS I-NP O
, , O O
conversant NN B-NP O
. . B-VP O
   
Respiratory NN B-NP O
: : O O
Scattered VBN O B-problem
rhonchi NN B-NP I-problem
with IN B-VP O
diminished JJ B-NP B-problem
breath NN I-NP I-problem
sounds NNS I-NP I-problem
in IN B-VP I-problem
the DT B-NP I-problem
bases NNS I-NP I-problem
. . B-VP O
   
Cor NN B-NP O
: : O O
Regular JJ B-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
, , O O
S1 NNP B-NP O
, , O O
S2 NNP B-NP O
, , O O
with IN B-VP O
soft JJ B-NP B-problem
systolic JJ I-NP I-problem
ejection NN I-NP I-problem
murmur NN I-NP I-problem
. . B-VP O
   
Sternum NNP B-NP O
is VBZ O O
stable JJ O O
. . B-VP O
   
Incision NN B-NP B-problem
with IN B-VP O
staples NNS B-NP B-treatment
, , O O
open JJ O O
to TO O O
air NN B-NP O
, , O O
clean JJ O O
and CC O O
dry JJ O O
. . B-VP O
   
Abdomen NNS B-NP O
: : O O
Soft NNP B-NP O
, , O O
nontender NN B-NP B-problem
, , O O
nondistended VBD B-VP B-problem
, , O O
normal JJ B-NP O
active JJ I-NP O
bowel NN I-NP O
sounds NNS I-NP O
. . B-VP O
   
Extremities NNS B-NP O
: : O O
Warm NNP B-NP O
and CC O O
well RB O O
perfused VBN O O
, , O O
with IN B-VP O
no DT B-NP O
cyanosis NN I-NP B-problem
, , O O
clubbing VBG O B-problem
or CC O O
edema NN B-NP B-problem
. . B-VP O
   
DISCHARGE NNP B-NP O
MEDICATIONS NNP I-NP O
: : O O
Ranitidine JJ O B-treatment
150 CD O O
mg NN B-NP O
twice RB O O
a DT B-NP O
day NN I-NP O
, , O O
enteric-coated JJ B-NP B-treatment
aspirin NN I-NP I-treatment
325 CD O O
mg NN B-NP O
once RB O O
daily JJ O O
, , O O
Glucovance NNP B-NP B-treatment
5/500 CD O O
one CD O O
tablet NN B-NP O
twice RB O O
a DT B-NP O
day NN I-NP O
, , O O
metoprolol RB O B-treatment
25 CD O O
mg NN B-NP O
twice RB O O
a DT B-NP O
day NN I-NP O
, , O O
Furosemide NNP B-NP B-treatment
20 CD O O
mg NN B-NP O
once RB O O
daily JJ O O
for IN B-VP O
14 CD O O
days NNS B-NP O
, , O O
potassium NN B-NP B-treatment
chloride NN I-NP I-treatment
20 CD O O
mEq NN B-NP O
once RB O O
daily JJ O O
for IN B-VP O
14 CD O O
days NNS B-NP O
, , O O
Colace NNP B-NP B-treatment
100 CD O O
mg NN B-NP O
twice RB O O
a DT B-NP O
day NN I-NP O
, , O O
Niferex NNP B-NP B-treatment
150 CD O O
mg NN B-NP O
once RB O O
daily JJ O O
, , O O
Percocet NNP B-NP B-treatment
5/325 CD O O
one CD O O
to TO O O
two CD O O
tablets NNS B-NP O
every DT O O
four CD O O
hours NNS B-NP O
as IN B-VP O
needed VBN O O
, , O O
ibuprofen JJ O B-treatment
400 CD O O
mg NN B-NP O
every DT O O
six CD O O
hours NNS B-NP O
as IN B-VP O
needed VBN O O
. . B-VP O
   
DISCHARGE JJ B-NP O
DIAGNOSIS NNP I-NP O
: : O O
1. CD O O
Aortic JJ B-NP B-problem
stenosis NN I-NP I-problem
status NN I-NP O
post NN I-NP O
aortic JJ B-NP B-treatment
valve NN I-NP I-treatment
replacement NN I-NP I-treatment
with IN B-VP O
a DT B-NP B-treatment
#21 JJ I-NP I-treatment
mosaic NN I-NP I-treatment
porcine NN I-NP I-treatment
valve VBP O I-treatment
2. CD O O
Diabetes NNPS B-NP B-problem
mellitus VBP O I-problem
Type NNP B-NP I-problem
2 CD O I-problem
3. CD O O
Right JJ B-NP B-treatment
hip NN I-NP I-treatment
replacement NN I-NP I-treatment
CONDITION NNP I-NP O
ON NNP I-NP O
TRANSFER NNP I-NP O
: : O O
Stable JJ O O
. . B-VP O
   
DISCHARGE JJ B-NP O
INSTRUCTIONS NN I-NP O
: : O O
She PRP O B-person
is VBZ O O
to TO O O
have VB O O
follow VBN O O
up RP O O
with IN B-VP O
Dr. NNP B-NP B-person
Bloomfield NNP I-NP I-person
in IN B-VP O
one CD O O
month NN B-NP O
, , O O
and CC O O
follow VB O O
up RP O O
in IN B-VP O
the DT B-NP O
Wound NNP I-NP O
Clinic NNP I-NP O
in IN B-VP O
two CD O O
weeks NNS B-NP O
. . B-VP O
   
Alice NNP B-NP B-person
S. NNP I-NP I-person
Shadle NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
37-538 CD O O
Dictated VBN O O
By IN B-VP O
: : O O
James NNP B-NP B-person
F. NNP I-NP I-person
Buchanan NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
MEDQUIST36 NNP I-NP O
D NNP I-NP O
: : O O
2013-02-15 JJ O O
18:35 CD O O
T NN B-NP O
: : O O
2013-02-16 JJ O O
01:03 CD O O
JOB NNP B-NP O
#: VBD B-VP O
59205 CD O O
Signed VBN O O
electronically RB O O
by IN B-VP O
: : O O
DR. NNP B-NP B-person
Richard NNP I-NP I-person
Gray NNP I-NP I-person
on IN B-VP O
: : O O
Tommy NNP B-NP O
2013-02-17 CD O O
12:05 CD O O
AM NNP B-NP O
( ( O O
End NNP B-NP O
of IN B-VP O
Report NNP B-NP O
) ) O O
-EMPTYLINE- VBP O O
-DOCSTART- JJ O O
-EMPTYLINE- $ O O
139964603 CD O O
NVH NNP B-NP O
40876531 CD O O
11/17/2003 CD O O
12:00:00 CD O O
AM NNP B-NP O
PELVIC NNP I-NP B-problem
MASS NNP I-NP I-problem
Signed VBD B-VP O
DIS NNP B-NP O
Admission NNP I-NP O
Date NNP I-NP O
: : O O
11/17/2003 CD O O
Report NNP B-NP O
Status NNP I-NP O
: : O O
Signed VBN O O
Discharge NNP B-NP O
Date NNP I-NP O
: : O O
12/22/2003 CD O O
ATTENDING NN B-NP B-person
: : O O
DAY NNP B-NP B-person
SECOND NNP I-NP I-person
MD NNP I-NP I-person
This DT B-NP B-pronoun
dictation NN I-NP O
goes VBZ O O
through IN B-VP O
12/21/03 CD O O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
received VBD B-VP O
care NN B-NP O
on IN B-VP O
the DT B-NP O
Baydell NNP I-NP O
Medical NNP I-NP O
Center NNP I-NP O
. . B-VP O
   
PRINCIPAL NNP B-NP O
DIAGNOSIS NNP I-NP O
: : O O
Pelvic JJ B-NP B-problem
mass NN I-NP I-problem
. . B-VP O
   
PROBLEMS NN B-NP O
: : O O
Include NNP B-NP O
hypertension NN I-NP B-problem
. . B-VP O
   
HISTORY NNP B-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS NNP I-NP O
: : O O
This DT O B-pronoun
is VBZ O O
a DT B-NP O
57-year-old JJ I-NP O
female NN I-NP O
status NN I-NP O
post NN I-NP O
ERT NNP I-NP B-treatment
with IN B-VP O
recurrence NN B-NP O
of IN B-VP O
a DT B-NP B-problem
pelvic JJ I-NP I-problem
mass NN I-NP I-problem
and CC O O
resection NN B-NP B-treatment
at IN B-VP O
an DT B-NP O
outside JJ I-NP O
hospital NN I-NP O
in IN B-VP O
06/22 CD O O
. . B-VP O
   
Per IN B-VP O
the DT B-NP B-person
patient NN I-NP I-person
, , O O
the DT B-NP B-problem
mass NN I-NP I-problem
was VBD B-VP O
benign JJ O O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
developed VBD B-VP O
severe JJ O B-problem
left VBN O I-problem
lower RBR O I-problem
quadrant JJ B-NP I-problem
pain NN I-NP I-problem
in IN B-VP O
07/24 CD O O
. . B-VP O
   
An DT B-NP B-test
MRI NNP I-NP I-test
was VBD B-VP O
done VBN O O
on IN B-VP O
08/27/03 CD O O
that WDT O B-pronoun
showed VBD B-VP O
an DT O B-problem
8 CD O I-problem
cm NN B-NP I-problem
left VBD B-VP I-problem
lower JJR B-NP I-problem
quadrant JJ I-NP I-problem
mass NN I-NP I-problem
with IN B-VP O
both DT O B-problem
cystic JJ O I-problem
and CC O I-problem
solid JJ B-NP I-problem
components NNS I-NP I-problem
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
started VBN O O
on IN B-VP O
Lupron NNP B-NP B-treatment
on IN B-VP O
10/18/03 CD O O
, , O O
but CC O O
pain NN B-NP B-problem
was VBD B-VP O
not RB O O
affected VBN O O
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
put VBN O O
on IN B-VP O
Vicodin NNP B-NP B-treatment
ES NNP I-NP I-treatment
and CC O O
Ultram NNP B-NP B-treatment
with IN B-VP O
minimal JJ B-NP O
relief NN I-NP O
. . B-VP O
   
On IN B-VP O
11/16/03 CD O O
, , O O
the DT O B-problem
the DT B-NP B-person
patient JJ I-NP I-problem
patient NN I-NP I-person
&apos;s NNP I-NP I-problem
pain NN I-NP I-problem
increased VBD B-VP O
and CC O O
she PRP O B-person
presented VBD B-VP O
to TO O O
an DT B-NP O
outside JJ I-NP O
hospital NN I-NP O
with IN B-VP O
nausea NN B-NP B-problem
and CC O O
vomiting NN B-NP B-problem
and CC O O
an DT B-NP B-problem
inability NN I-NP I-problem
to TO O I-problem
tolerate VB O I-problem
p.o. NNS B-NP I-problem
intake VB O I-problem
. . B-VP O
   
The DT B-NP B-problem
left NN I-NP I-problem
lower RBR O I-problem
quadrant NN B-NP I-problem
pain NN I-NP I-problem
in IN B-VP I-problem
the DT B-NP I-problem
groin NN I-NP I-problem
radiated VBD B-VP O
to TO O O
the DT B-NP O
left JJ I-NP O
knee NN I-NP O
. . B-VP O
   
No DT B-NP O
fevers NNS I-NP B-problem
or CC O O
chills NNS B-NP B-problem
, , O O
no DT B-NP O
vaginal JJ I-NP B-problem
discharge NN I-NP I-problem
or CC O O
bleeding NN B-NP B-problem
. . B-VP O
   
Potassium NN B-NP B-test
at IN B-VP O
the DT B-NP O
outside JJ I-NP O
hospital NN I-NP O
was VBD B-VP O
3.1 CD O O
. . B-VP O
   
White NNP B-NP B-test
count NN I-NP I-test
was VBD B-VP O
27.3 CD O O
with IN B-VP O
16% CD O B-test
bands NNS B-NP I-test
. . B-VP O
   
Hematocrit NNP B-NP B-test
was VBD B-VP O
28.7 CD O O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
transferred VBN O O
to TO O O
NVH NNP B-NP O
after IN B-VP O
receiving VBG O O
intravenous JJ B-NP B-treatment
fluid NN I-NP I-treatment
with IN B-VP O
potassium NN B-NP B-treatment
, , O O
Demerol NNP B-NP B-treatment
for IN B-VP O
pain NN B-NP B-treatment
control NN I-NP I-treatment
and CC O O
clindamycin NN B-NP B-treatment
, , O O
Valium NNP B-NP B-treatment
and CC O O
droperidol NN B-NP B-treatment
. . B-VP O
   
PAST NNP B-NP O
MEDICAL NNP I-NP O
HISTORY NNP I-NP O
: : O O
Hypothyroidism NN B-NP B-problem
, , O O
arthritis NN B-NP B-problem
, , O O
hypertension NN B-NP B-problem
, , O O
hypercholesterolemia NN B-NP B-problem
, , O O
anemia NN B-NP B-problem
and CC O O
asthma NN B-NP B-problem
. . B-VP O
   
SURGICAL JJ B-NP O
HISTORY NN I-NP O
: : O O
A DT B-NP B-treatment
TAH-BSO NN I-NP I-treatment
in IN B-VP O
1980 CD O O
and CC O O
an DT B-NP B-test
exploratory JJ I-NP I-test
laparotomy NN I-NP I-test
with IN B-VP O
resection NN B-NP B-treatment
of IN B-VP O
a DT B-NP B-problem
pelvic JJ I-NP I-problem
mass NN I-NP I-problem
in IN B-VP O
06/22 CD O O
. . B-VP O
   
MEDICATIONS NN B-NP O
AT NNP I-NP O
HOME NNP I-NP O
: : O O
1. CD O O
Vicodin NNP B-NP B-treatment
75/750 CD O O
p.r.n. NN B-NP O
2. CD O O
Ultram NNP B-NP B-treatment
. . B-VP O
   
3. CD O O
Verapamil NNP B-NP B-treatment
240 CD O O
mg NN B-NP O
b.i.d. NN I-NP O
4. CD O O
Synthroid NNP B-NP B-treatment
100 CD O O
mcg NN B-NP O
q.d. NN I-NP O
5. CD O O
HCTZ NNP B-NP B-treatment
25 CD O O
mg NN B-NP O
q.d. NN I-NP O
6. CD O O
Arthrotec NNP B-NP B-treatment
0.2 CD O O
mg NN B-NP O
b.i.d. NN I-NP O
7. CD O O
Advair NNP B-NP B-treatment
250/50 CD O O
mcg NN B-NP O
one CD O O
puff NN B-NP O
q.a.m. NN I-NP O
8. CD O O
Tofranil NNP B-NP B-treatment
. . B-VP O
   
9. CD O O
Ambien NNP B-NP B-treatment
10 CD O O
mg VBD B-VP O
q.h.s. RB O O
10. CD O O
Trazadone CD O B-treatment
150 CD O O
mg NNS B-NP O
q.h.s. RB O O
11. CD O O
Ferrous JJ B-NP B-treatment
sulfate NN I-NP I-treatment
325 CD O O
mg NN B-NP O
t.i.d. NN I-NP O
12. CD O O
Colace NNP B-NP B-treatment
. . B-VP O
   
ALLERGIES NN B-NP O
: : O O
Her PRP$ O B-person
Her PRP$ O B-problem
allergies NNS B-NP I-problem
are VBP O O
penicillin NN B-NP B-treatment
, , O O
which WDT O B-pronoun
cause VBP O O
throat NN B-NP B-problem
edema NN I-NP I-problem
. . B-VP O
   
SOCIAL NNP B-NP O
HISTORY NNP I-NP O
: : O O
No DT B-NP O
tobacco NN I-NP O
, , O O
alcohol NN B-NP O
or CC O O
drug NN B-NP O
use NN I-NP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
admitted VBN O O
to TO O O
NVH NNP B-NP O
and CC O O
started VBD B-VP O
on IN B-VP O
vancomycin NN B-NP B-treatment
, , O O
levofloxacin NN B-NP B-treatment
and CC O O
Flagyl NNP B-NP B-treatment
. . B-VP O
   
Cultures NNS B-NP B-test
were VBD B-VP O
taken VBN O O
. . B-VP O
   
Blood NNP B-NP B-test
cultures NNS I-NP I-test
were VBD B-VP O
done VBN O O
for IN B-VP O
a DT B-NP O
possible JJ I-NP O
rectosigmoid JJ I-NP B-problem
mass NN I-NP I-problem
or CC O O
fistula NN B-NP B-problem
and CC O O
a DT B-NP B-test
CT NNP I-NP I-test
showed VBD B-VP I-test
questionable JJ B-NP O
abscess JJ I-NP B-problem
versus NN I-NP O
tumor NN I-NP B-problem
in IN B-VP I-problem
the DT B-NP I-problem
left NN I-NP I-problem
lower RBR O I-problem
quadrant NN B-NP I-problem
. . B-VP O
   
Blood NNP B-NP B-test
cultures VBZ O I-test
done VBN O O
on IN B-VP O
11/17/03 CD O O
grew VBD B-VP O
C. NNP B-NP B-problem
perfringens NNS I-NP I-problem
. . B-VP O
   
Other JJ B-NP B-test
blood NN I-NP I-test
culture NN I-NP I-test
was VBD B-VP O
negative JJ O O
. . B-VP O
   
On IN B-VP O
11/20/03 CD O O
, , O O
a DT B-NP B-test
PE NNP I-NP I-test
protocol NN I-NP I-test
CT NNP I-NP I-test
was VBD B-VP O
negative JJ O O
for IN B-VP O
both DT B-NP O
DVT NNP I-NP B-problem
and CC O O
PE NNP B-NP B-problem
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
taken VBN O O
to TO O O
the DT B-NP O
operating NN I-NP O
room NN I-NP O
for IN B-VP O
bilateral JJ B-NP B-treatment
stent NN I-NP I-treatment
placement NN I-NP I-treatment
, , O O
resection NN B-NP B-treatment
of IN B-VP O
the DT B-NP B-problem
pelvic JJ I-NP I-problem
mass NN I-NP I-problem
, , O O
lysis NN B-NP B-treatment
of IN B-VP O
adhesions NNS B-NP B-problem
, , O O
left VBD B-VP B-treatment
ureterolysis NN B-NP I-treatment
, , O O
rectosigmoid JJ B-NP B-treatment
resection NN I-NP I-treatment
, , O O
SBR NNP B-NP B-treatment
, , O O
removal NN B-NP B-treatment
of IN B-VP O
a DT B-NP B-problem
vaginal JJ I-NP I-problem
tumor NN I-NP I-problem
, , O O
omentectomy RB O B-treatment
complicated VBN O O
by IN B-VP O
an DT B-NP B-problem
enterotomy NN I-NP I-problem
and CC O O
was VBD B-VP O
admitted VBN O O
to TO O O
the DT B-NP O
ICU NNP I-NP O
postoperatively RB O O
on IN B-VP O
11/21/03 CD O O
. . B-VP O
   
Postoperative JJ B-NP O
course NN I-NP O
by IN B-VP O
systems NNS B-NP O
is VBZ O O
as IN B-VP O
follows VBZ O O
: : O O
1. CD O O
Neuro NN B-NP O
: : O O
She PRP O B-person
had VBD B-VP O
a DT B-NP B-treatment
PCEA NNP I-NP I-treatment
for IN B-VP O
pain NN B-NP B-problem
, , O O
then RB O O
a DT B-NP B-treatment
Dilaudid NNP I-NP I-treatment
PCA NNP I-NP I-treatment
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
anxious JJ O B-problem
with IN B-VP O
depression NN B-NP B-problem
poorly RB O I-problem
controlled VBN O I-problem
until IN B-VP O
12/14/03 CD O O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
seen VBN O O
by IN B-VP O
Onc NNP B-NP B-person
Psychiatry NNP I-NP I-person
consult NN I-NP O
, , O O
who WP O B-person
recommended VBD B-VP O
imipramine NN B-NP B-treatment
75 CD O O
mg NN B-NP O
; : O O
that WDT O B-pronoun
was VBD B-VP O
subsequently RB O O
increased VBN O O
to TO O O
150 CD O O
mg NNS B-NP O
p.o. JJ B-NP O
q.h.s. NN I-NP O
, , O O
trazadone NN B-NP B-treatment
100 CD O O
mg NN B-NP O
q.h.s. NN I-NP O
and CC O O
Ambien NNP B-NP B-treatment
10 CD O O
mg VBD B-VP O
q.h.s. RB O O
2. CD O O
Cardiovascular JJ O O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
has VBZ O O
baseline VBN O B-problem
hypertension NN B-NP I-problem
that WDT O B-pronoun
was VBD B-VP O
difficult JJ O O
to TO O O
control VB O O
. . B-VP O
   
In IN B-VP O
the DT B-NP O
ICU NNP I-NP O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
on IN B-VP O
enalapril NN B-NP B-treatment
, , O O
hydralazine NN B-NP B-treatment
and CC O O
labetalol NN B-NP B-treatment
. . B-VP O
   
After IN B-VP O
a DT B-NP O
Cardiology NNP I-NP B-person
consulton NN I-NP O
12/13/03 CD O O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
started VBN O O
on IN B-VP O
metoprolol NN B-NP B-treatment
100 CD O O
mg NN B-NP O
p.o. NN I-NP O
q.i.d. NN I-NP O
, , O O
lisinopril VBZ O B-treatment
10 CD O O
mg NN B-NP O
q.d. NN I-NP O
, , O O
hydrochlorothiazide RB O B-treatment
25 CD O O
mg NN B-NP O
q.d. NN I-NP O
. . B-VP O
   
Hydralazine NNP B-NP B-treatment
was VBD B-VP O
stopped VBN O O
. . B-VP O
   
Blood NNP B-NP B-test
pressure NN I-NP I-test
stayed VBD B-VP O
high JJ O B-problem
with IN B-VP O
an DT B-NP B-test
SBP NNP I-NP I-test
in IN B-VP O
the DT O O
170s CD O O
, , O O
so RB O O
amlodipine JJ O B-treatment
10 CD O O
mg NN B-NP O
q.d. NN I-NP O
was VBD B-VP O
added VBN O O
and CC O O
that IN B-VP B-test
blood NN B-NP I-test
pressure NN I-NP I-test
was VBD B-VP O
still RB O B-problem
elevated VBN O I-problem
. . B-VP O
   
At IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
transfer NN B-NP O
to TO O O
the DT B-NP O
________ NNP I-NP O
Onc NNP I-NP O
Service NNP I-NP O
, , O O
blood NN B-NP B-test
pressure NN I-NP I-test
was VBD B-VP O
within IN B-VP O
the DT B-NP O
normal JJ I-NP O
range NN I-NP O
. . B-VP O
   
3. CD O O
Pulmonary JJ O O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
extubated VBN O O
on IN B-VP O
11/22/03 CD O O
. . B-VP O
   
Once RB O O
the DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
extubated VBN O O
, , O O
after IN B-VP O
the DT B-NP B-treatment
third JJ I-NP I-treatment
surgery NN I-NP I-treatment
, , O O
the DT B-NP B-person
patient NN I-NP I-person
could MD O O
not RB O O
be VB O O
weaned VBN O O
off RP O O
2 CD O B-treatment
liters NNS B-NP I-treatment
of IN B-VP I-treatment
nasal JJ B-NP I-treatment
cannula NN I-NP I-treatment
and CC O O
was VBD B-VP O
to TO O O
______ VB O O
to TO O O
20 CD O O
breaths NNS B-NP O
per IN B-VP O
minute NN B-NP O
despite IN B-VP O
nebulizer JJ B-NP B-treatment
treatment NN I-NP I-treatment
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
restarted VBN O O
on IN B-VP O
Advair NNP B-NP B-treatment
and CC O O
by IN B-VP O
12/15/03 CD O O
, , O O
was VBD B-VP O
weaned VBN O O
to TO O O
room NN B-NP O
air NN I-NP O
likely RB O O
an DT B-NP O
effective JJ I-NP O
Advair NNP I-NP B-treatment
and CC O O
control NN B-NP O
of IN B-VP O
anxiety NN B-NP B-problem
and CC O O
psychiatric JJ B-NP B-problem
issues NNS I-NP I-problem
. . B-VP O
   
4. CD O O
GI NNPS B-NP O
: : O O
On IN B-VP O
postoperative JJ B-NP O
day NN I-NP O
4 CD O O
, , O O
after IN B-VP O
the DT B-NP B-treatment
initial JJ I-NP I-treatment
surgery NN I-NP I-treatment
, , O O
the DT B-NP B-person
patient NN I-NP I-person
had VBD B-VP O
increased VBN O B-problem
shortness NN B-NP I-problem
of IN B-VP I-problem
breath NN B-NP I-problem
and CC O O
tachycardia NN B-NP B-problem
with IN B-VP O
abdominal JJ B-NP B-problem
pain NN I-NP I-problem
. . B-VP O
   
A DT B-NP B-test
chest JJ I-NP I-test
x-ray NN I-NP I-test
revealed VBD B-VP O
increased JJ B-NP B-problem
free JJ I-NP I-problem
air NN I-NP I-problem
under IN B-VP I-problem
the DT B-NP I-problem
diaphragm NN I-NP I-problem
. . B-VP O
   
A DT B-NP B-test
CT NNP I-NP I-test
revealed VBD B-VP O
a DT B-NP O
large JJ I-NP O
amount NN I-NP O
of IN B-VP O
free JJ B-NP B-problem
air NN I-NP I-problem
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
taken VBN O O
to TO O O
the DT B-NP O
OR NNP I-NP O
on IN B-VP O
postop JJ B-NP O
day NN I-NP O
5 CD O O
for IN B-VP O
emergent JJ B-NP B-test
exploratory NN I-NP I-test
laparotomy NN I-NP I-test
that WDT O B-pronoun
disclosed VBD B-VP O
a DT B-NP B-problem
small JJ I-NP I-problem
bowel NN I-NP I-problem
enterotomy NN I-NP I-problem
with IN B-VP O
2 CD O O
liters NNS B-NP O
of IN B-VP O
bilious JJ B-NP B-problem
fluid NN I-NP I-problem
within IN B-VP I-problem
the DT B-NP I-problem
peritoneum NN I-NP I-problem
. . B-VP O
   
On IN B-VP O
postop JJ B-NP O
day NN I-NP O
9 CD O O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
had VBD B-VP O
a DT O B-problem
similar JJ O I-problem
increased VBN O I-problem
abdominal JJ B-NP I-problem
pain NN I-NP I-problem
episode NN I-NP I-problem
and CC O O
was VBD B-VP O
taken VBN O O
back RB O O
to TO O O
the DT B-NP O
operating NN I-NP O
room NN I-NP O
for IN B-VP O
another DT B-NP B-test
emergent JJ I-NP I-test
exploratory NN I-NP I-test
laparotomy NN I-NP I-test
revealing VBG O O
another DT B-NP B-problem
peroration NN I-NP I-problem
at IN B-VP O
the DT B-NP B-problem
site NN I-NP I-problem
of IN B-VP I-problem
previous JJ B-NP I-problem
repair NN I-NP I-problem
. . B-VP O
   
Intraoperatively RB O B-treatment
, , O O
the DT B-NP B-person
patient NN I-NP I-person
suffered VBD B-VP O
hypotension NN B-NP B-problem
with IN B-VP O
induction NN B-NP O
and CC O O
respiratory NN B-NP B-problem
insufficiency NN I-NP I-problem
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
transferred VBN O O
to TO O O
the DT B-NP O
ICU NNP I-NP O
intubated VBD B-VP B-treatment
with IN B-VP O
stable JJ O O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
kept VBN O O
NPO NNP B-NP B-treatment
with IN B-VP O
an DT B-NP B-treatment
NG NNP I-NP I-treatment
tube NN I-NP I-treatment
until IN B-VP O
postop JJ B-NP O
day NN I-NP O
14 CD O O
and_____ NN B-NP O
started VBD B-VP O
on IN B-VP O
clear JJ B-NP B-treatment
sips NNS I-NP I-treatment
with IN B-VP O
TPN NNP B-NP B-treatment
for IN B-VP O
nutritional JJ B-NP B-treatment
supplementation NN I-NP I-treatment
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
intermittently RB O O
tolerated VBD B-VP O
diet JJ B-NP B-treatment
advancement NN I-NP I-treatment
, , O O
but CC O O
then RB O O
would MD O O
vomit VB O O
and CC O O
would MD O O
have VB O O
the DT B-NP B-treatment
NG NNP I-NP I-treatment
tube NN I-NP I-treatment
replaced VBD B-VP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
, , O O
at IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
transfer NN B-NP O
, , O O
was VBD B-VP O
tolerating VBG O O
clears NNS B-NP B-treatment
with IN B-VP O
low JJ B-NP B-problem
stoma NN I-NP I-problem
output NN I-NP I-problem
, , O O
likely RB O O
to TO O O
tolerate VB O O
slow JJ B-NP O
advancement NN I-NP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
still RB O O
had VBD B-VP O
a DT B-NP B-treatment
PICC NNP I-NP I-treatment
line NN I-NP I-treatment
at IN B-VP O
the DT B-NP O
time NN I-NP O
, , O O
although IN B-VP O
TPN NNP B-NP B-treatment
was VBD B-VP O
being VBG O O
held VBN O O
and CC O O
calorie JJ B-NP B-treatment
counts NNS I-NP I-treatment
were VBD B-VP O
done VBN O O
to TO O O
evaluate VB O O
the DT B-NP O
benefit NN I-NP O
of IN B-VP O
p.o. JJ B-NP O
nutrition NN I-NP O
. . B-VP O
   
5. CD O O
GU NNP B-NP O
: : O O
No DT B-NP O
issues NNS I-NP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
generally RB O O
had VBD B-VP O
good JJ B-NP O
urine JJ I-NP O
output NN I-NP O
. . B-VP O
   
Presumably RB O O
, , O O
should MD O O
follow VB O O
up RP O O
with IN B-VP O
the DT B-NP O
Urology NNP I-NP O
Clinic NNP I-NP O
for IN B-VP O
removal NN B-NP B-treatment
of IN B-VP I-treatment
the DT B-NP I-treatment
ureteral JJ I-NP I-treatment
stents NNS I-NP I-treatment
at IN B-VP O
some DT B-NP O
point NN I-NP O
. . B-VP O
   
6. CD O O
Infectious JJ B-NP B-problem
Disease NN I-NP I-problem
: : O O
Blood NN B-NP B-test
cultures NNS I-NP I-test
mentioned VBD B-VP O
previously RB O O
were VBD B-VP O
positive JJ O O
for IN B-VP O
C. NNP B-NP B-problem
perfringens NNS I-NP I-problem
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
started VBN O O
on IN B-VP O
empiricvancomycin NN B-NP B-treatment
, , O O
levofloxacin NN B-NP B-treatment
and CC O O
Flagyl NNP B-NP B-treatment
after IN B-VP O
the DT B-NP B-test
second JJ I-NP I-test
exploratory JJ I-NP I-test
laparotomy NN I-NP I-test
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
started VBN O O
on IN B-VP O
vancomycin NN B-NP B-treatment
, , O O
levofloxacin NN B-NP B-treatment
, , O O
Flagyl NNP B-NP B-treatment
, , O O
doxycycline NN B-NP B-treatment
and CC O O
fluconazole NN B-NP B-treatment
. . B-VP O
   
Blood NNP B-NP B-test
cultures NNS I-NP I-test
drawn VBP O O
on IN B-VP O
12/01/03 CD O O
were VBD B-VP O
negative JJ O O
. . B-VP O
   
JP NNP B-NP B-treatment
drain NN I-NP I-treatment
was VBD B-VP O
cultured VBN O B-test
on IN B-VP O
12/11/03 CD O O
along IN B-VP O
with IN B-VP O
aurine JJ B-NP B-test
culture NN I-NP I-test
. . B-VP O
   
TLC NNP B-NP B-test
, , O O
TIB NNP B-NP B-test
and CC O O
blood NN B-NP B-test
culture NN I-NP I-test
were VBD B-VP O
all DT O O
negative JJ O O
. . B-VP O
   
These DT O B-pronoun
were VBD B-VP O
cultured VBN O O
because IN B-VP O
the DT O B-person
the DT B-NP B-test
patient JJ I-NP I-person
patient NN I-NP I-test
&apos;s NNP I-NP I-test
white JJ B-NP I-test
blood NN I-NP I-test
count NN I-NP I-test
was VBD B-VP O
increasing VBG O O
to TO O O
the DT B-NP O
mid NN I-NP O
20s CD O O
without IN B-VP O
fever NN B-NP B-problem
or CC O O
other JJ B-NP B-problem
symptoms NNS I-NP I-problem
for IN B-VP O
explanation NN B-NP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
, , O O
at IN B-VP O
the DT B-NP O
time NN I-NP O
of IN B-VP O
transfer NN B-NP O
, , O O
to TO O O
the DT B-NP O
Gyn NNP I-NP B-person
/ NNP I-NP I-person
Onc NNP I-NP I-person
Service NNP I-NP O
was VBD B-VP O
not RB O O
antibiotics NNS B-NP B-treatment
and CC O O
the DT B-NP B-test
white JJ I-NP I-test
blood NN I-NP I-test
cell NN I-NP I-test
count NN I-NP I-test
was VBD B-VP O
trending VBG O O
down RB O O
. . B-VP O
   
7. CD O O
Heme NN B-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
stable JJ O O
. . B-VP O
   
She PRP O B-person
was VBD B-VP O
receiving VBG O O
sub JJ B-NP B-treatment
.q. NNP I-NP I-treatment
heparin NN I-NP I-treatment
for IN B-VP O
DVT NNP B-NP B-treatment
prophylaxis NN I-NP I-treatment
postoperatively RB O O
. . B-VP O
   
On IN B-VP O
postop JJ B-NP O
day NN I-NP O
6 CD O O
, , O O
an DT B-NP O
ID NNP I-NP B-person
consult NN I-NP O
noted VBD B-VP O
erythema NN B-NP B-problem
at IN B-VP O
the DT B-NP B-treatment
right JJ I-NP I-treatment
IJ NNP I-NP I-treatment
line NN I-NP I-treatment
site NN I-NP I-treatment
. . B-VP O
   
On IN B-VP O
postop JJ B-NP O
day NN I-NP O
8 CD O O
, , O O
the DT B-NP B-treatment
right JJ I-NP I-treatment
IJ NNP I-NP I-treatment
line NN I-NP I-treatment
was VBD B-VP O
pulled VBN O O
. . B-VP O
   
The DT B-NP O
tip NN I-NP O
was VBD B-VP O
cultured VBN O O
with IN B-VP O
no DT B-NP O
growth NN I-NP B-problem
. . B-VP O
   
On IN B-VP O
postop JJ B-NP O
day NN I-NP O
9 CD O O
, , O O
bilateral JJ B-NP B-test
upper JJ I-NP I-test
extremity NN I-NP I-test
Dopplers NNP I-NP I-test
revealed VBD B-VP O
a DT B-NP B-problem
right JJ I-NP I-problem
IJ NNP I-NP I-problem
clot NN I-NP I-problem
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
started VBN O O
on IN B-VP O
heparin NN B-NP B-treatment
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
transitioned VBD B-VP O
to TO O O
Lovenox NNP B-NP B-treatment
on IN B-VP O
12/09/03 CD O O
after IN B-VP O
a DT B-NP O
Cardiology NNP I-NP B-person
consult NN I-NP O
indicated VBD B-VP O
increased VBD B-VP O
survival NN B-NP O
with IN B-VP O
Lovenox NNP B-NP B-treatment
therapy NN I-NP I-treatment
. . B-VP O
   
8. CD O O
Endocrine NN B-NP O
: : O O
Has VBZ O O
a DT B-NP O
history NN I-NP O
of IN B-VP O
hypothyroidism NN B-NP B-problem
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
on IN B-VP O
home NN B-NP B-treatment
Synthroid NNP I-NP I-treatment
dose NN I-NP I-treatment
during IN B-VP O
her PRP$ O B-person
hospitalization NN B-NP O
, , O O
insulin NN B-NP B-treatment
sliding VBG O I-treatment
scale NN B-NP I-treatment
with IN B-VP O
q.6h. JJ B-NP O
fingersticks NNS I-NP B-test
while IN B-VP O
she PRP O B-person
was VBD B-VP O
on IN B-VP O
TPN NNP B-NP B-treatment
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
transferred VBN O O
to TO O O
the DT B-NP O
Gynecologic NNP I-NP B-person
Oncology NNP I-NP I-person
Service NNP I-NP O
on IN B-VP O
12/21/03 CD O O
. . B-VP O
   
The DT B-NP O
rest NN I-NP O
of IN B-VP O
the DT B-NP O
dictation NN I-NP O
is VBZ O O
to TO O O
follow VB O O
. . B-VP O
   
eScription NN B-NP O
document NN I-NP O
: : O O
2-9396725 JJ B-NP O
JFDDaua NNP I-NP O
Tel NNP I-NP O
Dictated VBN O O
By IN B-VP O
: : O O
FOORDRIG NNP B-NP B-person
, , O I-person
LA NNP B-NP I-person
BOMA NNP I-NP I-person
Attending NNP I-NP B-person
: : O O
SECOND NNP B-NP B-person
, , O I-person
CA NNP B-NP I-person
Dictation NNP I-NP O
ID NNP I-NP O
0750210 CD O O
D NNP B-NP O
: : O O
12/24/03 CD O O
T NN B-NP O
: : O O
12/24/03 CD O O
-EMPTYLINE- NN B-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- VBZ O O
917989835 CD O O
RWH NNP B-NP O
5427551 CD O O
405831 CD O O
9660879 CD O O
01/09/2002 CD O O
12:00:00 CD O O
AM NNP B-NP O
ED NNP I-NP O
Discharge NNP I-NP O
Summary NNP I-NP O
Unsigned VBD B-VP O
DIS NNP B-NP O
Report NNP I-NP O
Status NNP I-NP O
: : O O
Unsigned VBD B-VP O
ED NNP B-NP O
DISCHARGE NNP I-NP O
NOTIFICATION NNP I-NP O
/ NNP I-NP O
SUMMARY NNP I-NP O
STERPMOONE NNP I-NP B-person
, , O I-person
NY NNP B-NP I-person
MRN NNP I-NP O
: : O O
5427551 CD O O
Age NNP B-NP O
: : O O
37y CD O O
REGISTRATION NNP B-NP O
DATE NNP I-NP O
: : O O
01/09/2002 CD O O
01:27 CD O O
PM NNP B-NP O
Provider NN I-NP B-person
: : O O
NONOK NNP B-NP B-person
AYREKEMPE NNP I-NP I-person
PRELIMINARY NNP I-NP O
REPORT NNP I-NP O
PCP NNP I-NP B-person
notified VBN O O
by IN B-VP O
MD NNP B-NP B-person
: : O O
Left VBD B-VP O
message NN B-NP O
with IN B-VP O
answering VBG O O
service NN B-NP O
or CC O O
PCP NNP B-NP B-person
office NN I-NP O
Benefits NNS I-NP O
Assigned VBN O O
: : O O
Y JJ B-NP O
Discharge NNP I-NP O
Date NNP I-NP O
/ JJ B-NP O
Time NNP I-NP O
: : O O
01/09/2002 CD O O
17:02 CD O O
Discharge NN B-NP O
Status NNP I-NP O
: : O O
Discharged VBN O O
Condition NNP B-NP O
on IN B-VP O
Discharge NNP B-NP O
: : O O
Stable JJ B-NP O
Patient NNP I-NP B-person
States NNPS I-NP O
Complaint NNP I-NP O
: : O O
EVAL NNP B-NP B-test
Standardized NNP I-NP O
Discharge NNP I-NP O
Instructions NNP I-NP O
: : O O
Schedule NN B-NP O
outpatient JJ B-NP O
psychiatry NN I-NP O
appointment NN I-NP O
Necrestneysagiles NNP I-NP O
Medical NNP I-NP O
Center NNP I-NP O
. . B-VP O
   
Contact NNP B-NP O
BRIDC NNP I-NP O
BRESCA NNP I-NP O
DENONE NNP I-NP O
HEALTH NNP I-NP O
CARE NNP I-NP O
( ( O O
558-927-7217 JJ O O
) ) O O
for IN B-VP O
appointment NN B-NP O
w/ NN I-NP O
therapist NN I-NP B-person
. . B-VP O
   
Needs VBZ O O
to TO O O
speak VB O O
w/ JJ B-NP O
PCP NNP I-NP B-person
in IN B-VP O
order NN B-NP O
to TO O O
switch VB O O
provider NN B-NP O
Diagnosis NN I-NP O
: : O O
PTSD NNP B-NP B-problem
Discharge NNP I-NP O
Medications NNP I-NP O
: : O O
.5 NN B-NP B-treatment
Risperdal NNP I-NP I-treatment
Disposition NNP I-NP O
, , O O
Follow NNP B-NP O
up RB O O
and CC O O
Instructions NNS B-NP O
to TO O O
Patient VB O B-person
: : O O
Continue NNP B-NP O
w/ VBD B-VP O
Risperdal NNP B-NP B-treatment
per IN B-VP O
new JJ B-NP O
psychiatrist NN I-NP B-person
B NNP I-NP B-treatment
and CC O I-treatment
W NNP B-NP I-treatment
and CC O O
work NN B-NP O
w/ NNS I-NP O
therapist VBP O B-person
re: JJ B-NP O
historical JJ I-NP O
issues NNS I-NP O
. . B-VP O
   
If IN B-VP O
symptoms NNS B-NP B-problem
continue VBP O O
to TO O O
be VB O O
overwhelming VBG O B-problem
return NN B-NP O
to TO O O
V NNP B-NP O
or CC O O
call VB O O
1-903-263-5797 JJ B-NP O
PCP NNP I-NP B-person
Name NN I-NP O
: : O O
SHUFFNEG NNP B-NP B-person
, , O I-person
SOA NNP B-NP I-person
W NNP I-NP I-person
Provider NNP I-NP B-person
Number NNP I-NP O
: : O O
80157 CD O O
This DT B-NP B-pronoun
report NN I-NP O
was VBD B-VP O
created VBN O O
by IN B-VP O
AYREKEMPE NNP B-NP B-person
, , O I-person
NONOK NNP B-NP I-person
01/09/2002 CD O O
05:09 CD O O
PM NNP B-NP O
-EMPTYLINE- NNP I-NP O
-DOCSTART- NNP I-NP O
-EMPTYLINE- NNP I-NP O
Admission NNP I-NP O
Date NNP I-NP O
: : O O
2015-09-16 JJ B-NP O
Discharge NN I-NP O
Date NNP I-NP O
: : O O
2015-09-21 JJ B-NP O
Date NNP I-NP O
of IN B-VP O
Birth NNP B-NP O
: : O O
1962-09-26 JJ B-NP O
Sex NN I-NP O
: : O O
M NNP B-NP O
Service NNP I-NP O
: : O O
CARDIOTHOR NNP B-NP B-person
REASON NNP I-NP O
FOR NNP I-NP O
ADMISSION NNP I-NP O
: : O O
Mitral JJ B-NP B-treatment
valve NN I-NP I-treatment
repair NN I-NP I-treatment
. . B-VP O
   
HISTORY NNP B-NP O
OF NNP I-NP O
PRESENT NNP I-NP O
ILLNESS NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
is VBZ O O
a DT O O
52 CD O O
year NN B-NP O
old JJ B-NP O
Czech NNP I-NP O
speaking NN I-NP O
gentleman NN I-NP O
with IN B-VP O
a DT B-NP O
history NN I-NP O
of IN B-VP O
severe JJ B-NP B-problem
mitral JJ I-NP I-problem
regurgitation NN I-NP I-problem
. . B-VP O
   
For IN B-VP O
the DT B-NP O
past JJ I-NP O
several JJ I-NP O
years NNS I-NP O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
has VBZ O O
continued VBN O O
to TO O O
have VB O O
significant JJ B-NP B-problem
exercise NN I-NP I-problem
intolerance NN I-NP I-problem
which WDT O B-pronoun
has VBZ O O
limited VBN O O
his PRP$ O B-person
ability NN B-NP O
to TO O O
work VB O O
. . B-VP O
   
He PRP O B-person
reports VBZ O O
severe JJ B-NP B-problem
dyspnea NN I-NP I-problem
on IN B-VP O
exertion NN B-NP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
had VBD B-VP O
a DT B-NP O
recent JJ I-NP O
admission NN I-NP O
earlier RBR O O
in IN B-VP O
the DT B-NP O
month NN I-NP O
and CC O O
he PRP O B-person
was VBD B-VP O
discharged VBN O O
on IN B-VP O
2015-09-10 JJ O O
, , O O
after IN B-VP O
undergoing VBG O O
cardiac JJ B-NP B-test
catheterization NN I-NP I-test
. . B-VP O
   
This DT O B-pronoun
was VBD B-VP O
significant JJ O O
for IN B-VP O
demonstrating VBG O O
no DT B-NP O
flow-limited JJ I-NP B-problem
disease NN I-NP I-problem
in IN B-VP I-problem
the DT B-NP I-problem
coronaries NNS I-NP I-problem
but CC O O
several JJ B-NP B-problem
fistulae NN I-NP I-problem
from IN B-VP O
the DT B-NP O
left NN I-NP O
anterior JJ B-NP O
descending NN I-NP O
to TO O O
the DT B-NP O
PA NNP I-NP O
. . B-VP O
   
Several NNP B-NP O
of IN B-VP O
these DT O B-pronoun
were VBD B-VP O
coil NNS B-NP B-treatment
embolized VBN O I-treatment
during IN B-VP O
this DT B-NP B-pronoun
admission NN I-NP O
. . B-VP O
   
He PRP O B-person
tolerated VBD B-VP O
this DT B-NP B-pronoun
well NN I-NP O
, , O O
was VBD B-VP O
sent VBN O O
home NN B-NP O
, , O O
and CC O O
now RB O O
returns VBZ O O
for IN B-VP O
his PRP$ O B-treatment
his PRP$ O B-person
mitral JJ B-NP I-treatment
valve NN I-NP I-treatment
repair NN I-NP I-treatment
. . B-VP O
   
PAST NNP B-NP O
MEDICAL NNP I-NP O
HISTORY NNP I-NP O
: : O O
1. CD O O
Mitral NNP B-NP B-problem
valve NN I-NP I-problem
regurgitation NN I-NP I-problem
. . B-VP O
   
PAST JJ B-NP O
SURGICAL JJ I-NP O
HISTORY NN I-NP O
: : O O
None NN B-NP O
. . B-VP O
   
MEDICATIONS NNP B-NP O
ON NNP I-NP O
ADMISSION NNP I-NP O
: : O O
1. CD O O
Atenolol NNP B-NP B-treatment
25 CD O O
mg NN B-NP O
p.o. NN I-NP O
q. JJ B-NP O
day NN I-NP O
. . B-VP O
   
2. CD O O
Enteric-coated JJ B-NP B-treatment
aspirin NN I-NP I-treatment
325 CD O O
mg NN B-NP O
p.o. NN I-NP O
q. JJ B-NP O
day NN I-NP O
. . B-VP O
   
3. CD O O
Nitroglycerin NNP B-NP B-treatment
sublingual JJ B-NP I-treatment
p.r.n. NN I-NP O
ALLERGIES NNP I-NP O
: : O O
No DT B-NP O
known JJ I-NP B-problem
drug NN I-NP I-problem
allergies NNS I-NP I-problem
. . B-VP O
   
SOCIAL NNP B-NP O
HISTORY NNP I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
is VBZ O O
currently RB O O
on IN B-VP O
Disability NNP B-NP O
and CC O O
lives VBZ O O
at IN B-VP O
home NN B-NP O
with IN B-VP O
his PRP$ O B-person
his PRP$ O B-person
wife NN B-NP I-person
. . B-VP O
   
Kimberly NNP B-NP B-person
was VBD B-VP O
born VBN O O
in IN B-VP O
Great NNP B-NP O
Britain NNP I-NP O
. . B-VP O
   
He PRP O B-person
denies VBZ O O
any DT B-NP O
ETOH NNP I-NP O
or CC O O
tobacco NN B-NP O
use NN I-NP O
. . B-VP O
   
FAMILY NNP B-NP O
HISTORY NNP I-NP O
: : O O
Negative JJ O O
. . B-VP O
   
PHYSICAL JJ B-NP O
EXAMINATION NN I-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
is VBZ O O
in IN B-VP O
no DT B-NP O
acute JJ I-NP B-problem
distress NN I-NP I-problem
. . B-VP O
   
Temperature NN B-NP B-test
is VBZ O O
98.3 CD O O
F. NNP B-NP O
; : O O
pulse NN B-NP B-test
is VBZ O O
76 CD O O
; : O O
blood NN B-NP B-test
pressure NN I-NP I-test
113/52 CD O O
; : O O
breathing VBG O B-test
18 CD O O
; : O O
98% CD O O
on IN B-VP O
room NN B-NP O
air NN I-NP O
. . B-VP O
   
HEENT NN B-NP O
: : O O
The DT B-NP B-person
patient NN I-NP I-person
is VBZ O O
missing VBG O B-problem
many JJ B-NP I-problem
teeth NNS I-NP I-problem
. . B-VP O
   
Oropharynx NNP B-NP O
is VBZ O O
clear JJ O O
. . B-VP O
   
There EX O O
is VBZ O O
no DT B-NP O
cervical JJ I-NP B-problem
lymphadenopathy NN I-NP I-problem
. . B-VP O
   
Supple NNP B-NP O
neck NN I-NP O
. . B-VP O
   
Heart NNP B-NP O
is VBZ O O
regular JJ B-NP O
rate NN I-NP O
and CC O O
rhythm NN B-NP O
with IN B-VP O
a DT B-NP B-problem
III/VI NNP I-NP I-problem
systolic JJ B-NP I-problem
ejection NN I-NP I-problem
murmur NN I-NP I-problem
. . B-VP O
   
His PRP$ O B-person
lungs NNS B-NP O
are VBP O O
clear JJ O O
to TO O O
auscultation VB O B-test
bilaterally RB O O
. . B-VP O
   
Abdomen NNP B-NP O
is VBZ O O
soft JJ O O
and CC O O
nontender NN B-NP B-problem
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
has VBZ O O
no DT B-NP O
cyanosis NN I-NP B-problem
, , O O
clubbing VBG O B-problem
or CC O O
edema NN B-NP B-problem
in IN B-VP I-problem
extremities NNS B-NP I-problem
. . B-VP O
   
LABORATORY NN B-NP O
: : O O
On IN B-VP O
admission NN B-NP O
include VBP O O
a DT B-NP B-test
white JJ I-NP I-test
blood NN I-NP I-test
cell NN I-NP I-test
count NN I-NP I-test
of IN B-VP O
5.6 CD O O
, , O O
hematocrit NN B-NP B-test
of IN B-VP O
32.5 CD O O
, , O O
platelets NNS B-NP B-test
of IN B-VP O
202 CD O O
. . B-VP O
   
Sodium NN B-NP B-test
of IN B-VP O
140 CD O O
, , O O
potassium NN B-NP B-test
of IN B-VP O
3.5 CD O O
, , O O
BUN NNP B-NP B-test
of IN B-VP O
4 CD O O
, , O O
creatinine NN B-NP B-test
of IN B-VP O
0.6 CD O O
, , O O
glucose NN B-NP B-test
of IN B-VP O
137 CD O O
. . B-VP O
   
Chest NNP B-NP B-test
x-ray NN I-NP I-test
shows VBZ O O
no DT B-NP O
infiltrate NN I-NP B-problem
or CC O O
pneumothorax NN B-NP B-problem
. . B-VP O
   
Cardiac JJ B-NP B-test
catheterization NN I-NP I-test
demonstrates VBZ O O
no DT B-NP O
significant JJ I-NP B-problem
disease NN I-NP I-problem
in IN B-VP I-problem
the DT B-NP I-problem
coronary JJ I-NP I-problem
arteries NNS I-NP I-problem
. . B-VP O
   
Two CD O O
branches NNS B-NP O
of IN B-VP O
an DT O B-problem
left JJ O I-problem
anterior JJ O I-problem
descending VBG O I-problem
to TO O I-problem
PA NNP B-NP I-problem
fistula NN I-NP I-problem
which WDT O B-pronoun
was VBD B-VP O
successfully RB O O
coiled VBN O O
. . B-VP O
   
There EX O O
is VBZ O O
a DT B-NP B-problem
persistent JJ I-NP I-problem
flow NN I-NP I-problem
through IN B-VP O
an DT B-NP O
inferior JJ I-NP O
branch NN I-NP O
of IN B-VP O
the DT O O
left JJ O O
anterior JJ O O
descending VBG O O
to TO O O
PA NNP B-NP B-problem
fistula NN I-NP I-problem
and CC O O
a DT B-NP O
persistent JJ I-NP O
branch NN I-NP O
of IN B-VP O
the DT B-NP B-problem
circumflex NN I-NP I-problem
to TO O I-problem
PA NNP B-NP I-problem
branch NN I-NP I-problem
fistula NN I-NP I-problem
which WDT O B-pronoun
anatomically RB O O
were VBD B-VP O
not RB O O
suitable JJ O O
for IN B-VP O
coil NN B-NP B-treatment
embolization NN I-NP I-treatment
. . B-VP O
   
Ejection NNP B-NP B-test
fraction NN I-NP I-test
was VBD B-VP O
60% CD O O
. . B-VP O
   
HOSPITAL NNP B-NP O
COURSE NNP I-NP O
: : O O
On IN B-VP O
the DT B-NP O
day NN I-NP O
of IN B-VP O
admission NN B-NP O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
went VBD B-VP O
to TO O O
the DT B-NP O
Operating NN I-NP O
Room NNP I-NP O
and CC O O
underwent VBD B-VP O
a DT O O
minimally RB O O
invasive JJ B-NP O
mitral JJ I-NP B-treatment
valve NN I-NP I-treatment
repair NN I-NP I-treatment
. . B-VP O
   
He PRP O B-person
tolerated VBD B-VP O
this DT O B-pronoun
this DT B-NP B-treatment
procedure NN I-NP I-treatment
well RB O O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
brought VBN O O
to TO O O
the DT B-NP O
cardiothoracic NN I-NP O
Intensive NNP I-NP O
Care NNP I-NP O
Unit NNP I-NP O
in IN B-VP O
stable JJ B-NP O
condition NN I-NP O
on IN B-VP O
minimal JJ B-NP B-treatment
pressor NN I-NP I-treatment
support NN I-NP I-treatment
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
successfully RB O O
weaned VBN O O
off RP O O
this DT B-NP B-treatment
support NN I-NP I-treatment
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
fully RB O O
weaned VBN O O
from IN B-VP O
ventilatory JJ B-NP B-treatment
support NN I-NP I-treatment
secondary JJ O O
to TO O O
a DT B-NP B-problem
persistent JJ I-NP I-problem
acidemia NN I-NP I-problem
. . B-VP O
   
This DT O B-pronoun
was VBD B-VP O
treated VBN O O
with IN B-VP O
sodium NN B-NP B-treatment
bicarbonate NN I-NP I-treatment
and CC O O
a DT B-NP B-treatment
Swan-Ganz NNP I-NP I-treatment
was VBD B-VP O
placed VBN O O
to TO O O
provide VB O O
close JJ B-NP B-test
hemodynamic JJ I-NP I-test
monitoring NN I-NP I-test
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
found VBN O O
to TO O O
have VB O O
stable JJ B-NP O
hemodynamics NNS I-NP O
with IN B-VP O
appropriate JJ B-NP O
mixed JJ I-NP O
venous JJ I-NP B-test
saturations NNS I-NP I-test
in IN B-VP O
the DT O O
70% CD O O
range NN B-NP O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
was VBD B-VP O
corrected VBN O O
to TO O O
a DT B-NP O
normal JJ I-NP O
pH NN I-NP O
of IN B-VP O
7.41 CD O O
by IN B-VP O
the DT B-NP O
first JJ I-NP O
postoperative JJ I-NP O
night NN I-NP O
and CC O O
remained VBD B-VP O
stable JJ O O
. . B-VP O
   
He PRP O B-person
was VBD B-VP O
then RB O O
weaned VBN O O
off IN B-VP O
of IN B-VP O
ventilatory JJ B-NP B-treatment
support NN I-NP I-treatment
and CC O O
was VBD B-VP O
successfully RB O O
extubated VBN O O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
did VBD B-VP O
have VB O O
a DT B-NP B-problem
slight JJ I-NP I-problem
bit NN I-NP I-problem
of IN B-VP I-problem
confusion NN B-NP I-problem
early JJ O O
in IN B-VP O
post-extubation NN B-NP O
course NN I-NP O
which WDT O B-pronoun
cleared VBD B-VP O
. . B-VP O
   
This DT O B-pronoun
was VBD B-VP O
also RB O O
compounded VBN O O
by IN B-VP O
a DT B-NP O
language NN I-NP O
barrier NN I-NP O
since IN B-VP O
the DT B-NP B-person
patient NN I-NP I-person
cannot NN I-NP O
speak JJ B-NP O
English NNP I-NP O
. . B-VP O
   
In IN B-VP O
addition NN B-NP O
, , O O
the DT B-NP B-person
patient NN I-NP I-person
's POS O O
early JJ B-NP O
postoperative JJ I-NP O
course NN I-NP O
had VBD B-VP O
a DT B-NP O
tremendous JJ I-NP O
urine NN I-NP B-test
output NN I-NP I-test
. . B-VP O
   
It PRP O B-pronoun
was VBD B-VP O
equally RB O O
up RB O O
to TO O O
700 CD O O
cc. NNS B-NP O
an DT B-NP O
hour NN I-NP O
and CC O O
a DT B-NP B-test
renal JJ I-NP I-test
consultation NN I-NP I-test
was VBD B-VP O
obtained VBN O O
. . B-VP O
   
He PRP O B-person
underwent VBD B-VP O
a DT B-NP B-test
head NN I-NP I-test
CT NNP I-NP I-test
scan NN I-NP I-test
to TO O O
rule VB O O
out RP O O
intracranial JJ B-NP B-problem
pathology NN I-NP I-problem
leading VBG O O
to TO O O
diabetes NNS B-NP B-problem
insipidus RB O I-problem
. . B-VP O
   
This DT O B-pronoun
was VBD B-VP O
negative JJ O O
. . B-VP O
   
The DT O B-person
The DT B-NP B-test
patient JJ I-NP I-person
patient NN I-NP I-test
's POS O I-test
serum NN B-NP I-test
and CC O O
urine JJ B-NP B-test
electrolytes NNS I-NP I-test
indicated VBD B-VP O
that IN B-VP B-pronoun
this DT B-NP O
diuresis NN I-NP O
was VBD B-VP O
appropriate JJ O O
. . B-VP O
   
The DT O B-test
The DT B-NP B-person
patient JJ I-NP I-test
patient NN I-NP I-person
's POS O I-test
urine JJ B-NP I-test
output NN I-NP I-test
has VBZ O O
decreased VBN O O
and CC O O
his PRP$ O B-person
his PRP$ O B-test
BUN NNP B-NP I-test
and CC O O
creatinine NN B-NP B-test
remained VBD B-VP O
normal JJ O O
. . B-VP O
   
The DT O B-person
The DT B-NP B-treatment
patient JJ I-NP I-person
patient NN I-NP I-treatment
's POS O I-treatment
Foley NNP B-NP I-treatment
was VBD B-VP O
discontinued VBN O O
. . B-VP O
   
He PRP O B-person
had VBD B-VP O
developed VBN O O
some DT B-NP B-problem
hematuria NN I-NP I-problem
which WDT O B-pronoun
has VBZ O O
resolved VBN O O
. . B-VP O
   
The DT B-NP B-person
patient NN I-NP I-person
has VBZ O O
remained VBN O O
stable JJ O O
and CC O O
is VBZ O O
now RB O O
ready JJ O O
for IN B-VP O
discharge NN B-NP O
to TO O O
home NN B-NP O
with IN B-VP O
follow-up JJ O O
in IN B-VP O
approximately RB O O
four CD O O
weeks NNS B-NP O
. . B-VP O
   
DISCHARGE NNP B-NP O
DIAGNOSES NNP I-NP O
: : O O
1. CD O O
Mitral NNP B-NP B-problem
regurgitation NN I-NP I-problem
status NN I-NP O
post NN I-NP O
minimally RB O B-treatment
invasive JJ B-NP I-treatment
mitral JJ I-NP I-treatment
valve NN I-NP I-treatment
repair NN I-NP I-treatment
. . B-VP O
   
DISCHARGE NNP B-NP O
MEDICATIONS NNP I-NP O
: : O O
1. CD O O
Lopressor NNP B-NP B-treatment
75 CD O O
mg NN B-NP O
p.o. NN I-NP O
twice RB O O
a DT B-NP O
day NN I-NP O
. . B-VP O
   
2. CD O O
Colace NNP B-NP B-treatment
100 CD O O
mg NN B-NP O
p.o. NN I-NP O
twice RB O O
a DT B-NP O
day NN I-NP O
. . B-VP O
   
3. CD O O
Percocet NNP B-NP B-treatment
one CD O O
to TO O O
two CD O O
p.o. NNS B-NP O
q. RB O O
four CD O O
hours NNS B-NP O
p.r.n. VBP O O
4. CD O O
Aspirin NNP B-NP B-treatment
325 CD O O
mg NN B-NP O
p.o. NN I-NP O
q. JJ B-NP O
day NN I-NP O
. . B-VP O
   
CONDITION NNP B-NP O
ON NNP I-NP O
DISCHARGE NNP I-NP O
: : O O
Stable JJ O O
. . B-VP O
   
DIGibsonE JJ B-NP O
INSTRUCTIONS NN I-NP O
: : O O
1. CD O O
The DT B-NP B-person
patient NN I-NP I-person
will MD O O
follow-up VB O O
with IN B-VP O
Dr. NNP B-NP B-person
de FW O I-person
las FW O I-person
Grau NNP B-NP I-person
in IN B-VP O
four CD O O
weeks NNS B-NP O
. . B-VP O
   
2. CD O O
He PRP O B-person
will MD O O
follow-up VB O O
with IN B-VP O
his PRP$ O B-person
his PRP$ O B-person
primary JJ B-NP I-person
care NN I-NP I-person
physician NN I-NP I-person
, , O O
Dr. NNP B-NP B-person
Blake NNP I-NP I-person
, , O O
in IN B-VP O
two CD O O
weeks NNS B-NP O
. . B-VP O
   
3. CD O O
The DT B-NP B-person
patient NN I-NP I-person
will MD O O
call VB O O
for IN B-VP O
any DT B-NP B-problem
fevers NNS I-NP I-problem
or CC O O
difficulties NNS B-NP B-problem
with IN B-VP I-problem
the DT B-NP I-problem
wound NN I-NP I-problem
care NN I-NP I-problem
, , O O
and CC O O
will MD O O
be VB O O
instructed VBN O O
with IN B-VP O
an DT B-NP O
interpreter NN I-NP O
present NN I-NP O
. . B-VP O
   
Bruce NNP B-NP B-person
lou JJ B-NP I-person
Murphy NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
07-760 CD O O
Dictated VBN O O
By IN B-VP O
: : O O
Ellen NNP B-NP B-person
V NNP I-NP I-person
Wise NNP I-NP I-person
, , O I-person
M.D. NNP B-NP I-person
MEDQUIST36 NNP I-NP O
D NNP I-NP O
: : O O
2015-09-21 JJ O O
08:34 CD O O
T NN B-NP O
: : O O
2015-09-26 JJ O O
15:44 CD O O
JO NNP B-NP O
B#: NNP I-NP O
18430 CD O O
Signed NNP B-NP O
electronically RB O O
by IN B-VP O
: : O O
DR. NNP B-NP B-person
Mary NNP I-NP I-person
van NN I-NP I-person
den NN I-NP I-person
Mosley NNP I-NP I-person
on IN B-VP O
: : O O
WED JJ O O
2015-10-14 JJ O O
7:16 CD O O
PM NNP B-NP O
( ( O O
End NNP B-NP O
of IN B-VP O
Report NNP B-NP O
) ) O O
-EMPTYLINE- VBP O O
